<SEC-DOCUMENT>0001493152-24-035624.txt : 20240910
<SEC-HEADER>0001493152-24-035624.hdr.sgml : 20240910
<ACCEPTANCE-DATETIME>20240910160130
ACCESSION NUMBER:		0001493152-24-035624
CONFORMED SUBMISSION TYPE:	S-4
PUBLIC DOCUMENT COUNT:		83
FILED AS OF DATE:		20240910
DATE AS OF CHANGE:		20240910

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bowen Acquisition Corp
		CENTRAL INDEX KEY:			0001973056
		STANDARD INDUSTRIAL CLASSIFICATION:	SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282021
		FILM NUMBER:		241290039

	BUSINESS ADDRESS:	
		STREET 1:		420 LEXINGTON AVE, SUITE 2446
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10170
		BUSINESS PHONE:		203-998-5540

	MAIL ADDRESS:	
		STREET 1:		420 LEXINGTON AVE, SUITE 2446
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10170
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-4
<SEQUENCE>1
<FILENAME>forms-4.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:BOWN="http://bowenspac.com/20240630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_BOWN_bowenspac.com_20240630 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20240101_20240630 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0001973056 -->
<!-- Field: Set; Name: xdx; ID: xdx_079_XDX_forms%2D4.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_068_RMB_0_iso4217%2D%2DCNY -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-01-01to2024-06-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-06-30" id="Fact000004" name="dei:EntityCentralIndexKey">0001973056</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl0047" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-06-30" id="xdx2ixbrl0082" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31" id="xdx2ixbrl0083" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-06-30" id="xdx2ixbrl0099" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl0100" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-06-30" id="xdx2ixbrl0141" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-12-31" id="xdx2ixbrl0142" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-04-012023-06-30" id="xdx2ixbrl0154" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-04-012023-06-30" id="xdx2ixbrl0159" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2023-04-012023-06-30" id="xdx2ixbrl0169" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2023-02-172023-06-30" id="xdx2ixbrl0171" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-04-012023-06-30" id="xdx2ixbrl0174" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-02-172023-06-30" id="xdx2ixbrl0176" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30" id="xdx2ixbrl0179" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-04-012023-06-30_custom_RedeemableOrdinarySharesMember" id="xdx2ixbrl0187" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-04-012023-06-30_custom_RedeemableOrdinarySharesMember" id="xdx2ixbrl0189" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-02-172023-06-30_custom_RedeemableOrdinarySharesMember" id="xdx2ixbrl0195" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-02-172023-06-30_custom_RedeemableOrdinarySharesMember" id="xdx2ixbrl0197" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-04-012023-06-30_custom_RedeemableOrdinarySharesMember" id="xdx2ixbrl0203" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-04-012023-06-30_custom_RedeemableOrdinarySharesMember" id="xdx2ixbrl0205" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-02-172023-06-30_custom_RedeemableOrdinarySharesMember" id="xdx2ixbrl0211" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-02-172023-06-30_custom_RedeemableOrdinarySharesMember" id="xdx2ixbrl0213" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-04-012023-06-30_custom_NonRedeemableOrdinarySharesMember" id="xdx2ixbrl0223" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-04-012023-06-30_custom_NonRedeemableOrdinarySharesMember" id="xdx2ixbrl0225" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0241" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0247" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0248" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0252" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0253" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0258" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0264" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0265" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0269" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0270" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0275" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-16_us-gaap_CommonStockMember" id="xdx2ixbrl0281" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-16_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0282" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-16_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0283" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-16" id="xdx2ixbrl0284" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-02-16_us-gaap_CommonStockMember" id="xdx2ixbrl0286" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-02-172023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0290" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-02-172023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0297" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0302" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0303" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0307" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0308" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2023-02-172023-06-30" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2023-02-172023-06-30" id="xdx2ixbrl0359" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2023-02-172023-06-30" id="xdx2ixbrl0362" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-02-172023-06-30" id="xdx2ixbrl0365" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:ProceedsFromIssuanceOfFounderShares" contextRef="From2024-01-01to2024-06-30" id="xdx2ixbrl0379" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-01-01to2024-06-30" id="xdx2ixbrl0397" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-02-16" id="xdx2ixbrl0404" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2023-02-172023-06-30" id="xdx2ixbrl0428" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:DeferredOfferingCostsPaidByRelatedParty" contextRef="From2024-01-01to2024-06-30" id="xdx2ixbrl0430" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:PrepaidExpensesPaidByRelatedParty" contextRef="From2024-01-01to2024-06-30" id="xdx2ixbrl0433" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:NoncashOfferingCostsAdjustedFromPrepaidExpenses" contextRef="From2024-01-01to2024-06-30" id="xdx2ixbrl0436" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:DeferredOfferingCostsIncludedInAccruedExpenses" contextRef="From2024-01-01to2024-06-30" id="xdx2ixbrl0439" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" contextRef="From2024-01-01to2024-06-30" id="xdx2ixbrl0442" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:OfferingCostsChargedToAPICFounderShares" contextRef="From2024-01-01to2024-06-30" id="xdx2ixbrl0445" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30" id="xdx2ixbrl0535" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:AccretionOfTemporaryEquityIntoRedemptionValue" contextRef="From2023-04-012023-06-30" id="xdx2ixbrl0540" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:AccretionOfTemporaryEquityIntoRedemptionValue" contextRef="From2023-02-172023-06-30" id="xdx2ixbrl0542" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:NetLossIncludingAccretionOfEquityIntoRedemptionValue" contextRef="From2023-04-012023-06-30" id="xdx2ixbrl0545" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0567" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0569" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0575" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0577" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="BOWN:OwnershipPercentage" contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0591" unitRef="Pure" xs:nil="true"/>
  <ix:nonFraction name="BOWN:OwnershipPercentage" contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0595" unitRef="Pure" xs:nil="true"/>
  <ix:nonFraction name="BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity" contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0603" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity" contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember" id="xdx2ixbrl0604" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity" contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0605" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount" contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember" id="xdx2ixbrl0609" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount" contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember" id="xdx2ixbrl0611" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount" contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0612" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount" contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember" id="xdx2ixbrl0613" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount" contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0614" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount" contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember" id="xdx2ixbrl0615" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0621" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember" id="xdx2ixbrl0622" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0623" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0642" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0644" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0650" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0652" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0674" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0676" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember" id="xdx2ixbrl0678" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember" id="xdx2ixbrl0680" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0682" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember" id="xdx2ixbrl0684" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="BOWN:NonCashOfferingCostsChargedToAdditionalPaidinCapital" contextRef="From2023-04-012023-06-30" id="xdx2ixbrl0745" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31" id="xdx2ixbrl0956" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl0966" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-12-31" id="xdx2ixbrl0986" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-16_us-gaap_CommonStockMember" id="xdx2ixbrl1022" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-16_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1023" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-16_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1024" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-16" id="xdx2ixbrl1025" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-02-16_us-gaap_CommonStockMember" id="xdx2ixbrl1027" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-16_us-gaap_CommonStockMember" id="xdx2ixbrl1029" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-16_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1030" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-16_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1031" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-16" id="xdx2ixbrl1032" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-02-16_us-gaap_CommonStockMember" id="xdx2ixbrl1034" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1038" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueToUnderwriter" contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1045" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits" contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1052" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueProceedsFromOverallotment" contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1059" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueSaleOfPrivateUnits" contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1066" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits" contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1073" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1078" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits" contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1080" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1083" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment" contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1085" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1088" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts" contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1090" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1095" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1100" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1102" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1105" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1107" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1110" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1115" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1116" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1121" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1128" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-02-16" id="xdx2ixbrl1174" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:IncomeEarnedOnTrustAccount" contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember" id="xdx2ixbrl1294" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="BOWN:AccretionOfTemporaryEquityIntoRedemptionValue" contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember" id="xdx2ixbrl1297" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1506" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1507" unitRef="USD" xs:nil="true"/>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="bown-20240630.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-01-01to2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-06-30_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_custom_RedeemableOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_custom_RedeemableOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-06-30_custom_RedeemableOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-06-30_custom_RedeemableOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_custom_NonRedeemableOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_custom_NonRedeemableOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-06-30_custom_NonRedeemableOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-06-30_custom_NonRedeemableOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_custom_RedeemableOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_custom_NonRedeemableOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_srt_MaximumMember_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-06-30_srt_MaximumMember_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-16_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-16_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-16_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-142023-07-14_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-14</xbrli:startDate>
        <xbrli:endDate>2023-07-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-14_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-14</xbrli:startDate>
        <xbrli:endDate>2023-07-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-14_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-172023-07-17_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-17</xbrli:startDate>
        <xbrli:endDate>2023-07-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-18</xbrli:startDate>
        <xbrli:endDate>2023-07-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-18_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-182023-07-18_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-18</xbrli:startDate>
        <xbrli:endDate>2023-07-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-182023-07-18_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-18</xbrli:startDate>
        <xbrli:endDate>2023-07-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-182024-01-18_custom_MergerSharesMember_custom_AgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BOWN:MergerSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-18</xbrli:startDate>
        <xbrli:endDate>2024-01-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-182024-01-18_custom_EarnoutSharesMember_custom_AgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BOWN:EarnoutSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-18</xbrli:startDate>
        <xbrli:endDate>2024-01-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ShenzhenQianzhiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BOWN:ShenzhenQianzhiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-18_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_CashMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_custom_RedeemableSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_custom_NonRedeemableSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-06-30_custom_RedeemableSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-06-30_custom_NonRedeemableSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_custom_RedeemableSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_custom_NonRedeemableSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-06-30_custom_RedeemableSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-06-30_custom_NonRedeemableSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_custom_RedeemableSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_custom_NonRedeemableSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-142023-07-14_us-gaap_OverAllotmentOptionMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-14</xbrli:startDate>
        <xbrli:endDate>2023-07-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-142023-07-14_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-14</xbrli:startDate>
        <xbrli:endDate>2023-07-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember_custom_SponsorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-14</xbrli:startDate>
        <xbrli:endDate>2023-07-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember_custom_EBCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:EBCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-14</xbrli:startDate>
        <xbrli:endDate>2023-07-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-14</xbrli:startDate>
        <xbrli:endDate>2023-07-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_SponsorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_EBCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:EBCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-272023-02-27_custom_SponsorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-27</xbrli:startDate>
        <xbrli:endDate>2023-02-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-272023-02-27_custom_SponsorsMember_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-27</xbrli:startDate>
        <xbrli:endDate>2023-02-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-15_custom_EBCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:EBCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-15_custom_EBCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:EBCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-27_custom_PromissoryNoteMember_custom_SponsorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BOWN:PromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-272023-02-27_custom_PromissoryNoteMember_custom_SponsorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BOWN:PromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-27</xbrli:startDate>
        <xbrli:endDate>2023-02-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BOWN:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BOWN:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-06-30_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_SponsorsMember_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-03-31_custom_TenXGlobalCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BOWN:TenXGlobalCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-142023-07-14_custom_AccountingServiceAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-14</xbrli:startDate>
        <xbrli:endDate>2023-07-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_custom_AccountingServiceAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_custom_AccountingServiceAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-06-30_custom_AccountingServiceAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-06-30_custom_AccountingServiceAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-112023-07-11_custom_SponsorsMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-11</xbrli:startDate>
        <xbrli:endDate>2023-07-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-27_custom_PromissoryNoteMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BOWN:PromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RelatedPartyMember_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RelatedPartyMember_custom_AccountingServicesExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">BOWN:AccountingServicesExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_custom_TenXGlobalCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BOWN:TenXGlobalCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-172023-12-31_custom_AccountingServiceAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-17</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_AccountingServiceAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_AccountingServiceAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_AccountingServiceAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_custom_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">BOWN:MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-06-30_custom_BusinessCombinationMarketingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:BusinessCombinationMarketingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_BusinessCombinationMarketingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:BusinessCombinationMarketingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_custom_QianzhiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BOWN:QianzhiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-06-30_custom_QianzhiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BOWN:QianzhiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_QianzhiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BOWN:QianzhiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-312024-07-31_custom_QianzhiMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BOWN:QianzhiMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-31</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_BusinessCombinationMarketingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:BusinessCombinationMarketingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-182024-01-18_us-gaap_SubsequentEventMember_custom_MergerSharesMember_custom_AgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BOWN:MergerSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-18</xbrli:startDate>
        <xbrli:endDate>2024-01-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-182024-01-18_us-gaap_SubsequentEventMember_custom_EarnoutSharesMember_custom_AgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BOWN:EarnoutSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-18</xbrli:startDate>
        <xbrli:endDate>2024-01-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-15_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001973056</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="RMB">
      <xbrli:measure>iso4217:CNY</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000215" toRefs="Footnote000234"/>
  <ix:relationship fromRefs="Fact000217" toRefs="Footnote000234"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
filed with the Securities and Exchange Commission on September 10, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
No. 333-[&#9679;]</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_909_edei--DocumentType_c20240101__20240630_zvulQGbwjBu6"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" id="Fact000011" name="dei:DocumentType">S-4</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGISTRATION
STATEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>UNDER</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>THE
SECURITIES ACT OF 1933</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_902_edei--EntityRegistrantName_c20240101__20240630_zFFVmgeKKrf9"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" id="Fact000012" name="dei:EntityRegistrantName">Bowen
Acquisition Corp</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20240101__20240630_z1vOWHjosgS3"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" format="ixt-sec:edgarprovcountryen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Cayman
    Islands</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6770</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N/A</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or Other Jurisdiction of</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporation
    or Organization)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary
                                            Standard Industrial</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification
    Code Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span><b>For co-registrants,
see &#8220;Table of Co-Registrants&#8221; on the following page.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20240101__20240630_zBMWATVoFvL"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" id="Fact000014" name="dei:EntityAddressAddressLine1">420
Lexington Avenue</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressAddressLine2_c20240101__20240630_zS4ma8RC5pad"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" id="Fact000015" name="dei:EntityAddressAddressLine2">Suite 2446</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20240101__20240630_zT9pmoQl0OH9"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" id="Fact000016" name="dei:EntityAddressCityOrTown">New
York</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20240101__20240630_z1j9M6uQqbeg"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span> <span id="xdx_900_edei--EntityAddressPostalZipCode_c20240101__20240630_zk2oZNxlSllb"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" id="Fact000018" name="dei:EntityAddressPostalZipCode">10170</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--CityAreaCode_c20240101__20240630_zrir5A5QWnwa"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" id="Fact000019" name="dei:CityAreaCode">(203)</ix:nonNumeric></span>
<span id="xdx_90A_edei--LocalPhoneNumber_c20240101__20240630_zIpTZMEco0dl"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" id="Fact000020" name="dei:LocalPhoneNumber">998-5540</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--ContactPersonnelName_c20240101__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zGNQOvr9pnla"><ix:nonNumeric contextRef="From2024-01-012024-06-30_dei_BusinessContactMember" id="Fact000021" name="dei:ContactPersonnelName">Jiangang
Luo</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressAddressLine1_c20240101__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zR6pfHQCl4Nl"><ix:nonNumeric contextRef="From2024-01-012024-06-30_dei_BusinessContactMember" id="Fact000022" name="dei:EntityAddressAddressLine1">420
Lexington Avenue</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressAddressLine2_c20240101__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z07FkCimlASg"><ix:nonNumeric contextRef="From2024-01-012024-06-30_dei_BusinessContactMember" id="Fact000023" name="dei:EntityAddressAddressLine2">Suite 2446</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressCityOrTown_c20240101__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zlX4q4ygVxB9"><ix:nonNumeric contextRef="From2024-01-012024-06-30_dei_BusinessContactMember" id="Fact000024" name="dei:EntityAddressCityOrTown">New
York</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20240101__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zaej4DCm8Oqb"><ix:nonNumeric contextRef="From2024-01-012024-06-30_dei_BusinessContactMember" format="ixt-sec:stateprovnameen" id="Fact000025" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span> <span id="xdx_90C_edei--EntityAddressPostalZipCode_c20240101__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zJGDssyal6si"><ix:nonNumeric contextRef="From2024-01-012024-06-30_dei_BusinessContactMember" id="Fact000026" name="dei:EntityAddressPostalZipCode">10170</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--CityAreaCode_c20240101__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zGW6t8sl4Qy5"><ix:nonNumeric contextRef="From2024-01-012024-06-30_dei_BusinessContactMember" id="Fact000027" name="dei:CityAreaCode">(203)</ix:nonNumeric></span>
<span id="xdx_901_edei--LocalPhoneNumber_c20240101__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zyugEicqmGk3"><ix:nonNumeric contextRef="From2024-01-012024-06-30_dei_BusinessContactMember" id="Fact000028" name="dei:LocalPhoneNumber">998-5540</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
address, including zip code, and telephone number, including area code, of agent for service)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Copies
to:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>David
                                            A. Miller</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jeffrey
    M. Gallant</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eric
    T. Schwartz</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Graubard
    Miller</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>405
    Lexington Avenue, 44<sup>th</sup> Floor</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
    York, New York 10174</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(212)
    818-8800</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jie
                                            Chengying Xiu</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Michael
    Goldstein</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Steven
    L. Glauberman</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Becker
    &amp; Poliakoff, P.A.<br/>
    45 Broadway, 17<sup>th</sup> Floor<br/>
    New York, NY 10006</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(212)
    599-3322</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximate
date of commencement of proposed sale to the public: <b>As soon as practicable after (i) this registration statement is declared effective
and (ii) upon completion of the applicable transactions described in the enclosed proxy statement/prospectus.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the securities being registered on this Form are being offered in connection with the formation of a holding company and there is compliance
with General Instruction G, check the following box. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following
box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Registrant and Co-Registrant:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--EntityFilerCategory_c20240101__20240630_zmqKnrJSyuBj"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" format="ixt-sec:entityfilercategoryen" id="Fact000029" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--EntitySmallBusiness_c20240101__20240630_z3vxwM2fETqa"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" format="ixt:booleantrue" id="Fact000030" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20240101__20240630_z7LhRWp7j95b"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" format="ixt:booleantrue" id="Fact000031" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <span id="xdx_90A_edei--EntityExTransitionPeriod_c20240101__20240630_ztiRyvi1O6gf"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" format="ixt:booleanfalse" id="Fact000032" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
applicable, place an X in the box to designate the appropriate rule provision relied upon in conducting this transaction:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
Act Rule 13e-4(i) (Cross-Border Issuer Tender Offer) &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
Act Rule 14d-1(d) (Cross-Border Third-Party Tender Offer) &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Registrant and Co-Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its
effective date until the Registrant and Co-Registrant shall file a further amendment which specifically states that this Registration
Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration
Statement shall become effective on such date as the SEC, acting pursuant to Section 8(a), may determine.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CO-REGISTRANTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exact
    Name of&#160;Co-Registrant&#160;as Specified in its Charter<sup>(1)(2)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State
    or<br/> Other<br/> Jurisdiction<br/> of Incorporation<br/> or Organization</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Primary<br/>
    Standard<br/> Industrial<br/> Classification<br/> Code Number</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.R.S.
    Employer<br/> Identification<br/> Number</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
    Group Holding (Cayman) Limited</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
    Islands</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2840</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The Co-Registrant&#160;has the following principal executive office:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: center; text-indent: -23.75pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c/o
Qianzhi Group Holding (Cayman) Limited</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1705,
Block B, KK 100 Building</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5016
East Shennan Road</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luohu
District, Shenzhen</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guangdong
Province, 518000</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">People&#8217;s
Republic of China</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: center; text-indent: -23.75pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: justify; text-indent: -23.75pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
The agent for service for the Co-Registrant&#160;is:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: justify; text-indent: -23.75pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cogency
Global Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">122
East 42<sup>nd</sup> Street, 18<sup>th</sup> Floor</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10168</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(212)
947-7200</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: center; text-indent: -24pt; background-color: white"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>The
information in this preliminary proxy statement/prospectus is not complete and may be changed. The registrant may not sell the securities
described in this preliminary proxy statement/prospectus until the registration statement filed with the U.S. Securities and Exchange
Commission, of which this proxy statement/prospectus is a part, is declared effective. This preliminary proxy statement/prospectus is
not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or
sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">PRELIMINARY
PROXY STATEMENT/PROSPECTUS<br/>
SUBJECT TO COMPLETION, DATED SEPTEMBER 10, 2024</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROXY
STATEMENT FOR THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF<br/>
BOWEN ACQUISITION CORP</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS
FOR 8,646,377 ORDINARY SHARES OF<br/>
BOWEN ACQUISITION CORP</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BOWEN
ACQUISITION CORP<br/>
420 Lexington Ave, Suite 2446<br/>
New York, NY 10170</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LETTER
TO BOWEN SHAREHOLDERS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Bowen Acquisition Corp Shareholder:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are cordially invited to attend an extraordinary general meeting of Bowen Acquisition Corp, a Cayman Islands exempted company (&#8220;<span style="font-weight: normal"><i>Bowen</i></span>&#8221;),
which will be held on [&#9679;], 2024, at [&#9679;] [a.m./p.m.], Eastern Time, as a virtual meeting, or at such other time, on such other
date and at such other place to which the meeting may be postponed or adjourned (the &#8220;<span style="font-weight: normal"><i>Shareholder
Meeting</i></span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
can participate in the Shareholder Meeting, vote and submit questions via live webcast by visiting <i>https://www.cstproxy.com/bowenacquisition/[&#9679;]</i>.
Please see &#8220;<i>Questions and Answers about the Bowen Shareholder Proposals &#8212; How do I attend the virtual Shareholder Meeting?</i>&#8221;
in the accompanying proxy statement/prospectus for more information. Even if you are planning on attending the Shareholder Meeting online,
please promptly submit your proxy vote online, or, if you received a printed form of proxy in the mail, by completing, dating, signing
and returning the enclosed proxy, so your shares will be represented at the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 18, 2024, Bowen entered into an Agreement and Plan of Reorganization (the &#8220;<span style="font-weight: normal"><i>Business
Combination Agreement</i></span>&#8221;), by and among Bowen, Bowen Merger Sub, a Cayman Islands exempted company and a wholly owned
subsidiary of Bowen (&#8220;<span style="font-weight: normal"><i>Merger Sub</i></span>&#8221;), Shenzhen Qianzhi BioTechnology Co.
Ltd., a company incorporated in the People&#8217;s Republic of China and a wholly owned subsidiary of NewCo (as defined below)
(&#8220;<span style="font-weight: normal"><i>Qianzhi</i></span>&#8221;), and Qianzhi Group Holding (Cayman) Limited, a newly formed
Cayman Islands company (&#8220;<span style="font-weight: normal"><i>NewCo</i></span>&#8221;). The Business Combination Agreement and
the transactions contemplated thereby (the &#8220;<span style="font-weight: normal"><i>Business Combination</i></span>&#8221; or the
&#8220;<span style="font-weight: normal"><i>Transactions</i></span>&#8221;) were approved by the boards of directors of Bowen (the
&#8220;<span style="font-weight: normal"><i>Bowen Board</i></span>&#8221;), Merger Sub, Qianzhi and NewCo. The Business Combination
Agreement contemplates that, at the closing of the Business Combination (the &#8220;<span style="font-weight: normal"><i>Closing</i></span>&#8221;),
upon the terms and subject to the conditions of the Business Combination Agreement and in accordance with the Companies Act
(Revised) of the Cayman Islands, as amended (the &#8220;<span style="font-weight: normal"><i>Cayman Companies
Act</i></span>&#8221;), Merger Sub will merge with and into NewCo (the &#8220;<span style="font-weight: normal"><i>Merger</i></span>&#8221;),
with NewCo being the surviving company of the Merger (&#8220;<span style="font-weight: normal"><i>Surviving
Company</i></span>&#8221;) and becoming a wholly owned subsidiary of Bowen. As used in this proxy statement/prospectus, &#8220;<span style="font-weight: normal"><i>New
Bowen</i></span>&#8221; refers to Bowen after giving effect to the consummation of the Business Combination. Bowen has retained
Newbridge Securities to evaluate the fairness, from a financial point of view, to Bowen&#8217;s public shareholders of the
consideration to be paid to the Qianzhi equityholders in the Merger. For more information, please see the section entitled
&#8220;<i>Shareholder Proposal No. 1: The Business Combination Proposal &#8212; Opinion of Newbridge Securities, Fairness Opinion
Provider,&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
preparation for the Transactions, Qianzhi completed a restructuring (the &#8220;<span style="font-weight: normal"><i>Restructuring</i></span>&#8221;)
in which it became a wholly owned subsidiary of NewCo by the issuance of ordinary shares of NewCo (&#8220;<span style="font-weight: normal"><i>NewCo
Ordinary Shares</i></span>&#8221;) to the holders of Qianzhi&#8217;s ordinary shares in exchange for the previously outstanding
ordinary shares of Qianzhi.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, at the effective time of the Merger (the &#8220;<span style="font-weight: normal"><i>Effective
Time</i></span>&#8221;), all of the NewCo Ordinary Shares issued and outstanding immediately prior to the Effective Time other than (i)
NewCo Ordinary Shares held by Bowen or Qianzhi or their respective wholly owned subsidiaries and (ii) those NewCo Ordinary Shares
owned by the holders of NewCo Ordinary Shares who have validly exercised and not effectively withdrawn or lost their rights to dissent
from the Merger pursuant to the Cayman Companies Act, will be automatically converted into the right to receive an aggregate of (a) 7,246,377
ordinary shares of Bowen (&#8220;<span style="font-weight: normal"><i>Bowen Ordinary Shares</i></span>&#8221;), a portion of which shall
be deposited in escrow to provide for indemnification in accordance with the Business Combination Agreement (the &#8220;<span style="font-weight: normal"><i>Merger
Shares</i></span>&#8221;), and (b) the right to receive earnout consideration of up to an aggregate of 1,400,000 Bowen Ordinary Shares
(the &#8220;<span style="font-weight: normal"><i>Earnout Shares</i></span>&#8221;), as described further below. The Merger Shares and
Earnout Shares are referred to herein collectively as the &#8220;<span style="font-weight: normal"><i>Merger Consideration</i></span>.&#8221;
The Merger Shares to be deposited in escrow are referred to herein as the &#8220;<span style="font-weight: normal"><i>Escrow Shares</i></span>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the Business Combination Agreement, the parties are using commercially reasonable efforts to solicit investors (the &#8220;<span style="font-weight: normal"><i>PIPE
Investors</i></span>&#8221;) to enter into subscription agreements with Bowen, on terms approved by Qianzhi, pursuant to which
the PIPE Investors will purchase, concurrently with the closing of the Merger, equity or equity-linked securities of Bowen in an aggregate
amount of $5.0 million (the &#8220;<span style="font-weight: normal"><i>PIPE Financing</i></span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
units of Bowen (&#8220;<span style="font-weight: normal"><i>Bowen Units</i></span>&#8221;), each consisting of one Bowen Ordinary Share
and one right to receive one-tenth of one Bowen Ordinary Share upon consummation of the Business Combination (collectively, the &#8220;<span style="font-weight: normal"><i>Bowen
Rights</i></span>&#8221;), and the Bowen Ordinary Shares and Bowen Rights are currently listed on The Nasdaq Global Market (&#8220;<span style="font-weight: normal"><i>Nasdaq</i></span>&#8221;)
under the symbols &#8220;BOWNU,&#8221; &#8220;BOWN&#8221; and &#8220;BOWNR,&#8221; respectively. The closing price of the Bowen Units,
Bowen Ordinary Shares and Bowen Rights on [X], 2024 was $[X], $[X] and $[X], respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
prior to the Effective Time, the Bowen Units will automatically separate into their component securities and, as a result, will no longer
trade as an independent security. The Bowen Rights will automatically convert into Bowen Ordinary Shares in accordance with their terms
upon consummation of the Business Combination and no longer trade. Upon the Closing, the ordinary shares of New Bowen (&#8220;<span style="font-weight: normal"><i>New
Bowen Ordinary Shares</i></span>&#8221;) are expected to be listed on Nasdaq under the symbol &#8220;MERA&#8221;. It is a condition
to the consummation of the Transactions that the New Bowen Ordinary Shares to be issued in the Merger be approved for listing on Nasdaq
(subject only to official notice of issuance thereof and public holder requirements), but there can be no assurance such listing condition
will be met. If such listing condition is not met, the Transactions will not be consummated unless the listing condition is waived by
the parties to the Business Combination Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notice of the Shareholder Meeting and proxy statement/prospectus describe the business Bowen will conduct at the Shareholder
Meeting and provide information about Bowen that you should consider when you vote your shares. As more fully described in the accompanying
proxy statement/prospectus, which is dated [&#9679;], 2024, and is first being mailed to shareholders on or about that date, the Shareholder
Meeting will be held for the purpose of considering and voting on the following proposals:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
                                            Proposal No. 1 &#8212; Business Combination Proposal &#8212; </i>a proposal, as an ordinary
                                            resolution, to adopt and approve the Business Combination Agreement, a copy of which is
                                            attached herein as <i><span style="text-decoration: underline">Annex A</span></i>, and the transactions contemplated thereby,
                                            including the Business Combination, in all respects (the &#8220;<span style="font-weight: normal"><i>Business
                                            Combination Proposal</i></span>&#8221;);</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 2 &#8212; Name Change Proposal &#8212;</i> a proposal, as a special resolution, subject to the proposed name conforming
    with section 30 of the Companies Act (Revised) of the Cayman Islands, to approve the change of name of Bowen from Bowen Acquisition
    Corp to &#8220;Emerald, Inc.&#8221;, effective from the Effective Time (the &#8220;<i>Name Change Proposal</i>&#8221;);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 3 &#8212; Capitalization Amendment Proposal &#8212;</i> a proposal, as a special resolution, to approve the increase
    of the authorized share capital of Bowen from US$20,200, divided into 2,000,000 Preferred Shares of par value US$0.0001 each and
    200,000,000 Ordinary Shares of par value US$0.0001 each, to US$25,200, divided into 2,000,000 Preferred Shares of par value US$0.0001
    each and 250,000,000 Ordinary Shares of par value US$0.0001 each, by the creation of 50,000,000 additional Ordinary Shares of par
    value US$0.0001 each (the &#8220;<i>Capitalization Amendment Proposal</i>&#8221;);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 4 &#8212; Charter Amendment Proposal A &#8211; Board Unification Proposal </i>&#8211; a proposal, as a special resolution,
    to remove the provisions of Bowen&#8217;s Amended and Restated Memorandum and Articles of Association (the &#8220;<i>Existing Charter</i>&#8221;)
    dividing the Bowen Board into classes (the &#8220;<i>Board Unification Proposal</i>&#8221;):</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 5 &#8212; Charter Amendment Proposal B &#8211; Proposed Charter Adoption Proposal </i>&#8211; a proposal, as a special
    resolution, to approve the amendment and restatement of the Existing Charter, including without limitation, the consequential changes
    resulting from the Name Change Proposal (if approved), the Capitalization Amendment Proposal (if approved) and the Board Unification
    Proposal (if approved) and the removal of non-substantive, non-governance provisions applicable only to special purpose acquisition
    companies that will no longer be applicable to Bowen after the consummation of the Business Combination, by deletion in their entirety
    and substitution in their place by the proposed second amended and restated memorandum and articles of association of Bowen, the
    substantial form of which is attached herein as <i><span style="text-decoration: underline">Annex D</span>, </i>with effect upon the Effective Time (the &#8220;<i>Proposed
    Charter Adoption Proposal</i>&#8221;, and together with the Board Unification Proposal, collectively, the &#8220;<i>Charter Amendment
    Proposals</i>&#8221;);</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 6 &#8212; Nasdaq Proposal &#8212; </i>a proposal, as an ordinary resolution, to approve, for purpose of complying with
    Nasdaq Listing Rule 5635(a) and (b), the issuance of Bowen Ordinary Shares in connection with the Merger in all respects (the &#8220;<i>Nasdaq
    Proposal</i>&#8221;);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 7 &#8212; Equity Incentive Plan Proposal &#8212; </i>a proposal, as an ordinary resolution, to approve and adopt the
    2024 Long-Term Incentive Equity Plan of Bowen (the &#8220;<i>2024 Incentive Plan</i>&#8221;), to be effective from the Effective
    Time (the &#8220;<i>Equity Incentive Plan Proposal</i>&#8221;);</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 8 &#8212; Director Election Proposal &#8212; </i>a proposal, as an ordinary resolution, to elect five (5) members to
    serve terms on the Bowen Board, with effect from the Effective Time until their respective successors are duly elected and qualified
    (the &#8220;<i>Director Election Proposal</i>&#8221;); and</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 9 &#8212; Adjournment Proposal &#8212; </i>a proposal, as an ordinary resolution, to adjourn the Shareholder Meeting
    to a later date or dates, if necessary or desirable, at the determination of the Bowen Board that more time is necessary to consummate
    the Business Combination for any reason (the &#8220;<i>Adjournment Proposal</i>&#8221;).</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the foregoing proposals is more fully described in the accompanying proxy statement/prospectus. Please take the time to read carefully
each of the proposals in the accompanying proxy statement/prospectus before you vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
contemplated by the Existing Charter, the holders of Bowen Ordinary Shares issued as part of the Bowen Units sold in Bowen&#8217;s initial
public offering (the &#8220;<span style="font-weight: normal"><i>IPO</i></span>,&#8221; and such shares, the &#8220;<span style="font-weight: normal"><i>Public
Shares</i></span>,&#8221; and the holders of such Public Shares, the &#8220;<span style="font-weight: normal"><i>Public Shareholders</i></span>&#8221;)
may elect to redeem all or a portion of their Public Shares in exchange for their pro rata portion of the funds held in a trust account
(the &#8220;<span style="font-weight: normal"><i>Trust Account</i></span>&#8221;) established in connection with the IPO to hold a portion
of the proceeds of the IPO, if the Business Combination is consummated, regardless of how such Public Shareholders vote, or whether they
vote at all, on the Business Combination Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
[X], 2024, the most recent practicable date prior to the date of this proxy statement/prospectus, the redemption price per share would
have been approximately $[X], based on the aggregate amount on deposit in the Trust Account of approximately $[X] as of [X], 2024 (including
interest not previously released to Bowen but net of expected taxes payable), divided by the total number of then outstanding Public
Shares. The redemption price per share may increase between the date of this proxy statement/prospectus and the date that is two business
days prior to the Shareholder Meeting due to any interest that accrues on the amount on deposit in the Trust Account prior to such date,
although we expect the redemption price two business days prior to the Shareholder Meeting will be approximately the same as the amount
set forth above. The closing price of the Public Shares on [X], 2024, the most recent practicable date prior to the date of this proxy
statement/prospectus, was $[X] per share. If the closing price of the Public Shares was to remain the same until the date of the Shareholder
Meeting, exercising redemption rights would result in a Public Shareholder receiving approximately $[X] [more/less] per share than if
the shares were sold in the open market (based on the current per share redemption price). Bowen cannot assure shareholders that they
will be able to sell their Public Shares in the open market, even if the market price per share is lower than the redemption price stated
above, as there may not be sufficient liquidity in its securities when such shareholders wish to sell their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">Since the IPO, Bowen has not taken part in any material financing transactions,
and, other than the PIPE Financing, Bowen will not take part in any such material financing transactions prior to or in connection with
the consummation of the Business Combination. The PIPE Financing is described further in the section of the accompanying proxy statement/prospectus
entitled &#8220;<i>Proposal 1: The Business Combination Proposal &#8212; Third-Party PIPE Financing</i>&#8221;.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
consummation of the Business Combination, the former NewCo equityholders will beneficially own approximately 46.7% of the combined voting
power of New Bowen Ordinary Shares and NewCo&#8217;s majority equityholder will beneficially own approximately 36.4% of the combined
voting power of New Bowen Ordinary Shares, assuming no redemptions by the Public Shareholders of Bowen&#8217;s Public Shares, a total
of 690,000 Bowen Ordinary Shares are issued upon the conversion of the Bowen Rights, the Earnout Shares have been issued, and excluding
the effect of the issuance of securities in the proposed PIPE Financing. However, assuming the maximum number of redemptions by the Public
Shareholders of Bowen&#8217;s Public Shares (and the other assumptions remain accurate), NewCo&#8217;s majority equityholder would beneficially
own 58% of the combined voting power of New Bowen Ordinary Shares and in such event, New Bowen would be a &#8220;controlled company&#8221;
as defined in the corporate governance rules of Nasdaq. For so long as New Bowen is a controlled company under that definition, it
would be permitted to elect to rely on certain exemptions from the Nasdaq corporate governance rules. As a result, investors may not
have the same protection afforded to shareholders of companies that are subject to these corporate governance requirements. New Bowen&#8217;s
status as a controlled company could cause its securities to look less attractive to certain investors or otherwise harm the trading
price. Please see &#8220;<i>Risk Factors &#8212; If New Bowen meets the definition of a &#8220;controlled company&#8221; under the rules
of the Nasdaq Listing Rule, it may choose to exempt from certain corporate governance requirements that could have an adverse effect
on the public shareholders.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record
holders of Bowen Ordinary Shares at the close of business on [&#9679;], 2024 (the &#8220;<span style="font-weight: normal"><i>Record
Date</i></span>&#8221;) are entitled to vote or have their votes cast at the Shareholder Meeting. On the Record Date, there were 9,166,500
issued and outstanding Bowen Ordinary Shares, including the Bowen Ordinary Shares included in the Bowen Units. The Bowen Rights do not
have voting rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen is not an operating company but a Cayman Islands holding company. Upon the consummation of the Business Combination, New Bowen
will conduct its operations through Qianzhi, its wholly-owned subsidiary, which is based China. The securities registered herein are
securities of Bowen, not those of Qianzhi. Therefore, investors in New Bowen are not acquiring equity interests in any operating company
but instead are acquiring interest in a Cayman Islands holding company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holding company structure involves unique risks to investors. As a holding company, New Bowen may rely on dividends from its subsidiaries
for cash requirements, including any payment of dividends to its shareholders. The ability of Qianzhi to pay dividends or make distributions
to New Bowen may be restricted by laws and regulations applicable to them or the debt they incur on their own behalf or the instruments
governing their debt. In addition, PRC regulatory authorities could disallow this holding company structure and limit or hinder New Bowen&#8217;s
ability to conduct its business through, receive dividends or distributions from, or transfer funds to, Qianzhi or list on a U.S. or
other foreign exchange, which could result in a material adverse change to New Bowen&#8217;s business and cause the value of the securities
of New Bowen to significantly decline. <span style="letter-spacing: 0.2pt">New Bowen&#8217;s board of directors has complete discretion
on whether to distribute dividends subject to its Amended and Restated Memorandum and Articles of Association and certain restrictions
under Cayman Islands law. Under Cayman Islands law, a Cayman Islands company may pay a dividend out of either profit or share premium
account, provided that in no circumstances may a dividend be paid if this would result in the company being unable to pay its debts as
they fall due in the ordinary course of business. The decision to distribute dividends is based on several factors, including financial
performance, growth prospects, and liquidity requirements. To date, no dividend or distributions have been made by the subsidiaries of
New Bowen to New Bowen </span>and New Bowen has not paid any dividends or made any distributions to its shareholders. As of the date
of this proxy statement/prospectus, no dividends, distributions, or any other transfers of cash or other assets have occurred among New
Bowen, its subsidiaries, or its investors. <span style="letter-spacing: 0.2pt">For further details of cash and asset flows between New
Bowen and its subsidiaries, see &#8220;<i>Summary of the Proxy Statement/ Prospectus&#8201;&#8212;&#8201;Cash and Asset Flows through
Qianzhi&#8217;s Organization</i>&#8221; </span>and Qianzhi&#8217;s audited consolidated financial statements for the years ended March
31, 2024 and 2023. Following the consummation of the Business Combination, New Bowen intends to keep any future earnings to finance the
expansion of its business, and it does not anticipate that any cash dividends will be paid in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
New Bowen determines to pay dividends on any of its Ordinary Shares in the future, as a holding company, it will be dependent on receipt
of funds from Qianzhi and/or other subsidiaries affiliated with Qianzhi. However, as the PRC government imposes control over currency
conversion, it has the authority to conduct exchange transfer reviews, which may impose certain limitations on New Bowen&#8217;s ability
to transfer cash between it, its subsidiaries, and its investors, such as: (i) New Bowen is restricted from providing capital or loans
to its PRC subsidiaries, which may adversely affect the operations of its PRC subsidiaries; (ii) following the consummation of the Business
Combination, New Bowen&#8217;s PRC subsidiaries may be restricted from paying dividends to New Bowen; and (iii) if New Bowen is unable
to obtain dividends from its PRC subsidiaries, it may adversely impact its dividends distribution to investors. See &#8220;<i>Risk Factors&#8212;Risks
Relating to Doing Business in the PRC&#8212;PRC regulations of loans and direct investment by offshore holding companies to PRC entities
may delay or prevent us from using the proceeds of our offshore financing to make loans or additional capital contributions to our PRC
subsidiary, which could materially and adversely affect our liquidity and our ability to fund and expand our business.&#8221;</i> Further,
to the extent cash or assets in the business are in the PRC or a PRC entity, the funds or assets may not be available to fund operations
or for other use outside of the PRC, due to interventions in or the imposition of restrictions and limitations on the ability of New
Bowen or its subsidiaries by the PRC government to transfer cash or assets. There is no assurance the PRC government will not intervene
in or impose restrictions on the ability of New Bowen or its subsidiaries to transfer cash or assets. See &#8220;<i>Risk Factors&#8212;Risks
Relating to Doing Business in the PRC&#8212;We rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund
any cash and financing requirements we may have, and any limitation on the ability of our PRC subsidiaries to make payments to us could
have a material and adverse effect on our ability to conduct our business.&#8221;</i> <span style="letter-spacing: 0.2pt">Qianzhi has
established, and New Bowen expects to apply the same, cash management policies to direct how funds are transferred among New Bowen and
its subsidiaries to ensure the efficient and compliant handling of funds. These policies dictate that, each cash transfer shall (i)&#160;go
through approval processes, ensuring that only authorized personnel are involved in the transaction, (ii) be properly recorded to facilitate
audits and financial reviews, and (iii) be in compliance with all applicable laws and regulations, including anti-money laundering and
know-your-customer requirements.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
faces various risks and uncertainties relating to doing business in China. Qianzhi has substantial business operations in mainland China,
and it is subject to complex and evolving laws and regulations of mainland China. For example, it faces risks associated with regulatory
approvals on overseas offerings, anti-monopoly regulatory actions, and oversight on cybersecurity, data security and data privacy. It
also faces potential risks in the future if its auditors are not able to be inspected the Public Company Accounting Oversight Board (the
&#8220;<span style="font-weight: normal"><i>PCAOB</i></span>&#8221;) which may impact its ability to conduct certain businesses, accept
foreign investments, or list and conduct offerings on a United States or other foreign exchange. The PRC government&#8217;s significant
authority in regulating Qianzhi&#8217;s operations and the PRC government&#8217;s oversight and control over offerings conducted overseas
by, and foreign investment in, China-based issuers could result in a material adverse change in Qianzhi&#8217;s operations and the value
of its securities, significantly limit or completely hinder its ability to continue to offer securities to investors, or cause the value
of such securities to significantly decline or become worthless. <span style="letter-spacing: 0.2pt">For a detailed description of risks
relating to doing business in China, see &#8220;<i>Risk Factors&#8201;&#8212;&#8201;Risks Relating to Doing Business in the PRC</i>.&#8221;
</span>More specifically, on February&#160;17, 2023, the China Securities Regulatory Commission (the &#8220;<i>CSRC</i>&#8221;) promulgated
the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies, or the &#8220;Trial Measures,&#8221;
and five supporting guidelines, which became effective on March&#160;31, 2023. Pursuant to the Trial Measures, PRC domestic companies
that seek to offer or list securities overseas, both directly and indirectly, shall complete filing procedures with the CSRC pursuant
to the requirements of the Trial Measures within three working days following their submission of an initial public offering or listing
application. If a domestic company fails to complete required filing procedures or conceals any material fact or falsifies any major
content in its filing documents, such domestic company may be subject to administrative penalties, such as an order to rectify, warnings,
and fines, and its controlling shareholders, actual controllers, the person directly in charge and other directly liable persons may
also be subject to administrative penalties, such as warnings and fines. The Trial Measures specify that the offering and listing of
an issuer shall be deemed as an indirect overseas offering and listing of a PRC domestic company if, among other features, the issuer
derives over 50% of the revenue, net income, total assets, or net assets from mainland China within the most recent completed fiscal
year. Based on Trial Measures and supporting guidelines, we are required to complete the filing procedures with the CSRC in connection
with this Business Combination. As of the date of this proxy statement/prospectus, we have not completed the filing procedures with the
CSRC. We cannot assure you that we can complete the filing procedures in a timely manner or at all. Additionally, on December&#160;28,
2021, 13 governmental departments of the PRC, including the Cyberspace Administration of China (the &#8220;<i>CAC</i>&#8221;), issued
the Cybersecurity Review Measures, which became effective on February&#160;15, 2022. As of the date of this proxy statement/prospectus,
none of NewCo, Qianzhi, or their subsidiaries have been involved in any investigations on cybersecurity review initiated by any PRC regulatory
authority, nor has any of them received any inquiry, notice, or sanction related to cybersecurity review under the Cybersecurity Review
Measures. As confirmed by its PRC counsel, Jingsh &amp; H Y Leung, as of the date of this proxy statement/prospectus, Qianzhi&#8217;s
operations and listing are not expected to be affected by, or subject to, cybersecurity review by the CAC under the Cybersecurity Review
Measures, given that it is not (i) a network platform operator engaging in data processing activities that affect or may affect national
security; (ii) a critical information infrastructure operator purchasing cyber products or services that affect or may affect national
security; or (iii) a network platform operator with the personal information data of more than one million users.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen&#8217;s securities will be prohibited from trading on a national securities exchange or in the over-the-counter trading market
in the United States under the Holding Foreign Companies Accountable Act (&#8220;<span style="font-weight: normal"><i>HFCAA</i></span>&#8221;)
if the Securities and Exchange Commission (the &#8220;<span style="font-weight: normal"><i>SEC</i></span>&#8221;) determines that it
has filed audit reports issued by a registered public accounting firm that has not been subject to inspections by the PCAOB for two
consecutive years. On December 16, 2021, the PCAOB issued a report to notify the SEC of its determination that the PCAOB was unable
to inspect or investigate completely registered public accounting firms headquartered in mainland China and Hong Kong.
Subsequently, on December 15, 2022, the PCAOB announced that it was able to secure complete access to inspect and investigate
PCAOB-registered public accounting firms headquartered in mainland China and Hong Kong in 2022. Qianzhi&#8217;s auditor is, and
following consummation of the Business Combination New Bowen&#8217;s auditor will be, headquartered in Rowland Heights, California
and is, and will be, subject to PCAOB inspections to assess its compliance with the applicable professional standards. The PCAOB
currently has access to inspect the working papers of Qianzhi&#8217;s, and New Bowen&#8217;s, auditor and Qianzhi&#8217;s, and New
Bowen&#8217;s, auditor was not subject to the determinations announced by the PCAOB on December 16, 2021. Each year, the PCAOB
will determine whether it can inspect and investigate completely audit firms in mainland China and Hong Kong, among other
jurisdictions. If the PCAOB determines in the future that it no longer has full access to inspect and investigate completely
accounting firms in mainland China and New Bowen uses an accounting firm headquartered in one of these jurisdictions to issue an
audit report on its financial statements filed with the SEC, New Bowen would be identified as a Commission-Identified Issuer
following the filing of the annual report for the relevant fiscal year. In accordance with the HFCAA, New Bowen&#8217;s securities
would be prohibited from being traded on a national securities exchange or in the over-the-counter trading market in the United
States if it is identified as a Commission-Identified Issuer for two consecutive years in the future. If New Bowen&#8217;s
securities are prohibited from trading in the United States, there is no certainty that it will be able to list on a non-U.S.
exchange or that a market for its securities will develop outside of the United States. In the event of such prohibition, the Nasdaq
may determine to delist our securities. The delisting of New Bowen&#8217;s securities, or the threat of their being delisted, may
materially and adversely affect the value of your investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;<i>Risk Factors</i>&#8221; beginning on page 47 of the accompanying proxy statement/prospectus for a discussion of information
that should be considered in connection with an investment in New Bowen&#8217;s securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>SPAC
Sponsor Compensation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the SEC&#8217;s rules governing special purpose acquisition companies (SPACs), securities of Bowen and promissory notes from Bowen
issued to any entity and/or person primarily responsible for organizing, directing or managing the business and affairs of the SPAC,
such as Bowen, excluding its officers and directors who are not affiliates of any such entity (&#8220;<i>SPAC Sponsors</i>&#8221;), may
be considered &#8220;compensation&#8221; awarded to or earned by a SPAC Sponsor. In accordance with the SEC rules, Createcharm Holdings
Ltd (&#8220;<i>Createcharm</i>&#8221;) and Bowen Holding LP (&#8220;<i>Bowen Holding</i>&#8221;) are deemed to be Bowen&#8217;s SPAC
Sponsors. Each of Bowen&#8217;s SPAC Sponsors, and their affiliates, including the details of their involvement with Bowen, background
about their key personnel and the involvement of such key personnel with other SPACs, is described further in the section of this proxy
statement/prospectus titled &#8220;<i>Information about Bowen &#8211; SPAC Sponsors and their Affiliates</i>&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information regarding the SPAC Sponsor compensation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Post-Business<br/>
    Combination <br/>New Bowen<br/>
    Ordinary<br/>
    Shares</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: justify">Bowen Holding</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">569,250</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Createcharm</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,531,710</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 27, 2023, Bowen Holding acquired an aggregate of 1,725,000 Bowen Ordinary Shares (the &#8220;<i>Founder Shares</i>&#8221;) for
an aggregate purchase price of $25,000. Thereafter, it transferred an aggregate of 1,155,750 Founder Shares to Createcharm for the same
price per share it initially paid. Subsequently, in Bowen&#8217;s IPO and simultaneous private placement, Createcharm purchased 341,782
Private Placement Units (as defined below), including Private Placement Units purchased in connection with the exercise by the underwriters
of the IPO of the overallotment option. Each Private Placement Unit is comprised of one Bowen Ordinary Share and one Bowen Right, each
Bowen Right to be converted automatically into 1/10 (one-tenth) of one Bowen Ordinary Share upon consummation by Bowen of an initial
business combination. Createcharm paid a purchase price of $10.00 per Private Placement Unit, which is identical to the purchase price
paid for the Bowen Units sold in the IPO, and the Private Placement Units are substantially similar to the Bowen Units sold in the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
the SPAC Sponsors collectively paid an aggregate of $3,442,820 ($3,434,570 by Createcharm and $8,250 by Bowen Holding) for 2,100,960
Bowen Ordinary Shares as of the closing of the IPO and exercise of the underwriters&#8217; overallotment option &#8212; Bowen Holding
paid $8,250 for 569,250 shares (or approximately $0.01 per share) and Createcharm paid $3,434,570 for 1,531,710 shares (or approximately
$2.24 per share). The IPO and exercise of the underwriters&#8217; overallotment option resulted in the sale and issuance of 6,900,000
shares for $69,000,000 before expenses, which discounts the existence and value of the Bowen Rights that were included along with the
Bowen Ordinary Shares in the Bowen Units that were sold in the IPO for $10.00 per Bowen Unit. Such discounting has been effected to conservatively
estimate the dilution caused by IPO Sponsor&#8217;s investment in and holdings of Bowen as of the closing of the IPO and exercise of
the underwriters&#8217; overallotment option. In accordance with the above, as of immediately following the IPO, including underwriters&#8217;
full exercise of their over-allotment option, counting the SPAC Sponsors&#8217; investment and holdings and those of Bowen&#8217;s public
shareholders, Bowen had a net tangible book value of $72,442,820 and 8,966,782 Bowen Ordinary Shares outstanding, or approximately $8.08
net tangible book value per share. As such, the SPAC Sponsors&#8217; holdings and investment resulted in dilution of approximately $1.92
per Bowen Ordinary Share held by Bowen&#8217;s Public Shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
the SPAC Sponsors&#8217; holdings, as of the consummation of the Business Combination, they will collectively hold 2,100,960 New
Bowen Ordinary Shares. Createcharm will hold 1,531,710 New Bowen Ordinary Shares, comprised of the 1,497,532 Bowen Ordinary Shares
it currently holds and 34,178 New Bowen Ordinary Shares to be received in respect of its Bowen Rights, and Bowen Holding will hold
569,250 New Bowen Ordinary Shares, comprised of the 569,250 Bowen Ordinary Shares it currently holds. The New Bowen Ordinary Shares
to be held by the SPAC Sponsors following the Business Combination will be identical to the New Bowen Ordinary Shares to be held by
Bowen&#8217;s Public Shareholders in every respect. Because only the 34,178 New Bowen Ordinary Shares to be issued in respect of the
Bowen Rights held by Createcharm will be new issuances, only those securities could result in additional material dilution to
Bowen&#8217;s Public Shareholders, and because the Public Shareholders will also be issued New Bowen Ordinary Shares in respect of
their Bowen Rights, in the same proportion to Createcharm or greater than that of Createcharm, since Public Shareholders who redeem
their Bowen Ordinary Shares will still keep and receive New Bowen Ordinary Shares in respect of the Bowen Rights from their Bowen
Units, the issuance to Createcharm of New Bowen Ordinary Shares in respect of its Bowen Rights could reasonably be seen as not
causing any additional substantial dilution to the Public Shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Important Information:</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
about the Shareholder Meeting, the Business Combination, the Merger and other related business to be considered by the shareholders of
Bowen at the Shareholder Meeting is included in the accompanying proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Whether
or not you plan to attend the Shareholder Meeting, all shareholders of Bowen are urged to carefully read the accompanying proxy statement/prospectus,
including the Annexes and the accompanying financial statements of Bowen, NewCo and Qianzhi carefully and in their entirety. In particular,
you are urged to read carefully the section entitled &#8220;<i>Risk Factors</i>&#8221; beginning on page 47 of the accompanying proxy
statement/prospectus.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>After
careful consideration, the Bowen Board has unanimously determined that the foregoing proposals are advisable and in the best interests
of Bowen and its shareholders, approved the Business Combination Agreement and the Business Combination and recommends that shareholders
of Bowen vote &#8220;FOR&#8221; the Business Combination Proposal and &#8220;FOR&#8221; all other proposals presented to shareholders
of Bowen in the accompanying proxy statement/prospectus. When you consider the Bowen Board&#8217;s recommendation of these proposals,
you should keep in mind that certain directors and officers of Bowen have interests in the Business Combination that may conflict with
your interests as a shareholder. Please see the section entitled &#8220;<i>Shareholder Proposal No. 1: The Business Combination Proposal
&#8212; Interests of Certain Persons in the Business Combination</i>&#8221; in the accompanying proxy statement/prospectus for additional
information.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Your
vote is very important.</span> Whether or not you plan to attend the Shareholder Meeting, please vote as soon as possible by following the
instructions in the accompanying proxy statement to make sure that your shares are represented and voted at the Shareholder Meeting.
If you hold your shares in &#8220;street name&#8221; through a bank, broker or other nominee, you will need to follow the instructions
provided to you by your bank, broker or other nominee to ensure that your shares are represented and voted at the Shareholder Meeting.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you sign, date and return your proxy card without indicating how you wish to vote, your proxy will be voted &#8220;FOR&#8221; each of
the proposals presented at the Shareholder Meeting. If you fail to return your proxy card or fail to instruct your bank, broker or other
nominee how to vote, and do not attend the Shareholder Meeting in person virtually, the effect will be, among other things, that your
shares will not be counted for purposes of determining whether a quorum is present at the Shareholder Meeting and will not be voted.
An abstention will be counted towards the quorum requirement but will not count as a vote cast at the Shareholder Meeting. We expect
that all proposals being voted on at the Shareholder Meeting will be considered non-routine under the rules of the NYSE, which generally
controls the ability of brokers to vote or not vote shares held in street name on certain matters, and therefore we do not expect any
broker non-votes to be submitted and broker non-votes will therefore have no impact on quorum. If you are a shareholder of record and
you attend the Shareholder Meeting and wish to vote virtually, you may withdraw your proxy and vote in person virtually.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TO
EXERCISE YOUR REDEMPTION RIGHTS, YOU MUST DEMAND IN WRITING THAT YOUR BOWEN ORDINARY SHARES ARE REDEEMED FOR A PRO RATA PORTION OF THE
FUNDS HELD IN THE TRUST ACCOUNT AND TENDER YOUR SHARES TO BOWEN&#8217;S TRANSFER AGENT AT LEAST TWO BUSINESS DAYS PRIOR TO THE INITIALLY
SCHEDULED VOTE AT THE SHAREHOLDER MEETING. YOU MAY TENDER YOUR SHARES BY EITHER TENDERING OR DELIVERING YOUR BOWEN ORDINARY SHARES (AND
CERTIFICATES (IF ANY)) AND OTHER REDEMPTION FORMS TO THE TRANSFER AGENT OR BY TENDERING OR DELIVERING YOUR BOWEN ORDINARY SHARES (AND
SHARE CERTIFICATES (IF ANY) AND OTHER REDEMPTION FORMS) ELECTRONICALLY USING THE DEPOSITORY TRUST COMPANY&#8217;S DWAC (DEPOSIT WITHDRAWAL
AT CUSTODIAN) SYSTEM. IF YOU HOLD THE SHARES IN STREET NAME, YOU WILL NEED TO INSTRUCT THE ACCOUNT EXECUTIVE AT YOUR BANK OR BROKER TO
WITHDRAW THE SHARES FROM YOUR ACCOUNT IN ORDER TO EXERCISE YOUR REDEMPTION RIGHTS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enclosed
is the proxy statement/prospectus containing detailed information about the Shareholder Meeting, the Business Combination Proposal and
the other proposals described herein. Whether or not you plan to attend the Shareholder Meeting, Bowen urges you to read this material
carefully and vote your shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors of Bowen Acquisition Corp</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Na
    Gai</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairwoman
    of the Board of Directors</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT
THIS PROXY STATEMENT/PROSPECTUS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document, which forms part of a registration statement on Form S-4 filed with the U.S. Securities and Exchange Commission (the &#8220;<span style="font-weight: normal"><i>SEC</i></span>&#8221;)
by Bowen (File No. 333-[&#9679;]), constitutes a prospectus of Bowen under Section 5 of the U.S. Securities Act of 1933, as amended,
with respect to certain securities of Bowen to be issued in connection with the Business Combination. This document also constitutes
a notice of meeting and a proxy statement under Section 14(a) of the Securities Exchange Act of 1934, as amended, for an extraordinary
general meeting of shareholders to be held in connection with the Business Combination and at which Bowen shareholders will be asked
to consider and vote upon a proposal to adopt the Business Combination Agreement and approve the Business Combination, among other matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADDITIONAL
INFORMATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may request copies of this proxy statement/prospectus and any other publicly available information concerning Bowen, without charge,
by mailing a written request to Bowen Acquisition Corp, 420 Lexington Ave, Suite 2446, New York, NY 10170, or by calling (203) 998-5540;
or Laurel Hill Advisory Group, Bowen&#8217;s proxy solicitor, by calling [X] (toll free), or for banks and brokers, by calling [X] (collect),
or by emailing [X]; or from the SEC through the SEC website at <i>http://www.sec.gov</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order for a Bowen shareholder to receive timely delivery of the applicable documents in advance of the extraordinary general meeting
to be held on [&#9679;], 2024, such shareholder must request the information no later than five business days prior to the date of the
meeting, or by [&#9679;], 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BOWEN
ACQUISITION CORP<br/>
420 Lexington Ave, Suite 2446<br/>
New York, NY 10170</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF AN EXTRAODRINAY GENERAL MEETING OF SHAREHOLDERS<br/>
OF BOWEN ACQUISITION CORP<br/>
TO BE HELD ON [&#9679;], 2024</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Shareholders of Bowen Acquisition Corp:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
IS HEREBY GIVEN that an extraordinary general meeting of the shareholders of Bowen Acquisition Corp, a Cayman Islands exempted company
(&#8220;<span style="font-weight: normal"><i>Bowen</i></span>&#8221;), will be held on [&#9679;], 2024, at [&#9679;] [a.m./p.m.], Eastern
Time, as a virtual meeting, or at such other time, on such other date and at such other place to which the meeting may be postponed or
adjourned (the &#8220;<span style="font-weight: normal"><i>Shareholder Meeting</i></span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
can participate in the Shareholder Meeting, vote, and submit questions via live webcast by visiting <i>https://www.cstproxy.com/bowenacquisition/[&#9679;]</i>.
Please see &#8220;<i>Questions and Answers about the Bowen Shareholder Proposals &#8212; How do I attend the virtual Shareholder Meeting?</i>&#8221;
in the accompanying proxy statement/prospectus for more information. Even if you are planning on attending the Shareholder Meeting online,
please promptly submit your proxy vote online, or, if you received a printed form of proxy in the mail, by completing, dating, signing
and returning the enclosed proxy, so your shares will be represented at the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 18, 2024, Bowen entered into an Agreement and Plan of Reorganization (the &#8220;<span style="font-weight: normal"><i>Business
Combination Agreement</i></span>&#8221;), by and among Bowen, Bowen Merger Sub, a Cayman Islands exempted company and a wholly owned
subsidiary of Bowen (&#8220;<span style="font-weight: normal"><i>Merger Sub</i></span>&#8221;), Shenzhen Qianzhi BioTechnology Co. Ltd.,
a company incorporated in the People&#8217;s Republic of China and a wholly owned subsidiary of NewCo (as defined below) (&#8220;<span style="font-weight: normal"><i>Qianzhi</i></span>&#8221;),
and Qianzhi Group Holding (Cayman) Limited, a newly formed Cayman Islands company (&#8220;<span style="font-weight: normal"><i>NewCo</i></span>&#8221;).
The Business Combination agreement and the transactions contemplated thereby (the &#8220;<span style="font-weight: normal"><i>Business
Combination</i></span>&#8221; or the &#8220;<span style="font-weight: normal"><i>Transactions</i></span>&#8221;) were approved by the
boards of directors of Bowen (the &#8220;<span style="font-weight: normal"><i>Bowen Board</i></span>&#8221;), Merger Sub, Qianzhi
and NewCo. The Business Combination Agreement contemplates that, at the closing of the Business Combination (the &#8220;<span style="font-weight: normal"><i>Closing</i></span>&#8221;),
upon the terms and subject to the conditions of the Business Combination Agreement and in accordance with the Companies Act (Revised)
of the Cayman Islands, as amended (the &#8220;<span style="font-weight: normal"><i>Cayman Companies Act</i></span>&#8221;), Merger Sub
will merge with and into NewCo (the &#8220;<span style="font-weight: normal"><i>Merger</i></span>&#8221;), with NewCo being the surviving
company of the Merger (&#8220;<span style="font-weight: normal"><i>Surviving Company</i></span>&#8221;) and becoming a wholly owned subsidiary
of Bowen. As used in this proxy statement/prospectus, &#8220;<span style="font-weight: normal"><i>New Bowen</i></span>&#8221; refers
to Bowen after giving effect to the consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are cordially invited to attend the Shareholder Meeting that will be held for the purpose of considering and voting upon, and if
thought fit, passing and approving the following resolutions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
                                            Proposal No. 1 &#8212; Business Combination Proposal &#8212; as an ordinary resolution, that
                                            the Business Combination Agreement, a copy of which is attached to this proxy statement/prospectus
                                            as <span style="text-decoration: underline">Annex A</span>, and the transactions contemplated thereby, including the Business
                                            Combination be approved and authorized in all respects (the &#8220;<span style="font-weight: normal">Business
                                            Combination Proposal</span>&#8221;);</i></span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 2 &#8212;Name Change Proposal &#8212; </i>as a special resolution, that subject to the proposed name conforming with
    section 30 of the Companies Act (Revised) of the Cayman Islands, the name of Bowen be changed to &#8220;Emerald, Inc.&#8221;, effective
    from the effective time of the Merger (the &#8220;<i>Effective Time</i>&#8221;) (the &#8220;<i>Name Change Proposal</i>&#8221;);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 3 &#8212;Capitalization Amendment Proposal &#8212; </i>as a special resolution, that the increase of the authorized
    share capital of Bowen from US$20,200, divided into 2,000,000 Preferred Shares of par value US$0.0001 each and 200,000,000 Ordinary
    Shares of par value US$0.0001 each, to US$25,200, divided into 2,000,000 Preferred Shares of par value US$0.0001 each and 250,000,000
    Ordinary Shares of par value US$0.0001 each, by the creation of 50,000,000 additional Ordinary Shares of par value US$0.0001 each
    be approved and authorized in all respects (the &#8220;<i>Capitalization Amendment Proposal</i>&#8221;);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 4 &#8212; Charter Amendment Proposal A &#8212; Board Unification Proposal </i>&#8211; as a special resolution, that
    the provisions of Bowen&#8217;s Amended and Restated Memorandum and Articles of Association (the &#8220;<i>Existing Charter</i>&#8221;)
    dividing the Bowen Board into classes be removed (the &#8220;<i>Board Unification Proposal</i>&#8221;):</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 5 &#8212; Charter Amendment Proposal B &#8212; Proposed Charter Adoption Proposal </i>&#8211; as a special resolution,
    that the amendment and restatement of the existing memorandum and articles of association of Bowen, including without limitation,
    the consequential changes resulting from the Name Change Proposal (if approved), the Capitalization Amendment Proposal (if approved)
    and the Board Unification Proposal (if approved) and the removal of non-substantive, non-governance provisions applicable only to
    special purpose acquisition companies that will no longer be applicable to Bowen after the consummation of the Business Combination,
    by deletion in their entirety and substitution in their place by the proposed second amended and restated memorandum and articles
    of association of Bowen, the substantial form of which is attached the accompanying proxy statement as <i><span style="text-decoration: underline">Annex D</span>, </i>with
    effect upon the Effective Time, be approved and authorized in all respects (the &#8220;<i>Proposed Charter Adoption Proposal</i>&#8221;,
    and together with the Name Change Proposal, the Capitalization Amendment Proposal and the Board Unification Proposal, collectively,
    the &#8220;<i>Charter Amendment Proposals</i>&#8221;);</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->viii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 6 &#8212; Nasdaq Proposal &#8212; </i>as an ordinary resolution, that for purpose of complying with Nasdaq Listing Rule
    5635(a) and (b), the issuance of Bowen Ordinary Shares in connection with the Merger be approved and authorized in all respects (the
    &#8220;<i>Nasdaq Proposal</i>&#8221;);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 7 &#8212; Equity Incentive Plan Proposal &#8212;</i> as an ordinary resolution, that the 2024 Long-Term Incentive Equity
    Plan of Bowen (the &#8220;<i>2024 Incentive Plan</i>&#8221;), with effect upon the Effective Time, be approved and adopted in all
    respects (the &#8220;<i>Equity Incentive Plan Proposal</i>&#8221;);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 8 &#8212; Director Election Proposal &#8212; </i>as an ordinary resolution, that five (5) new directors be elected to
    serve terms on the Bowen Board, with effect from the Effective Time until their respective successors are duly elected and qualified
    (the &#8220;<i>Director Election Proposal</i>&#8221;); and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 9 &#8212; Adjournment Proposal &#8212; </i>as an ordinary resolution, that the Shareholder Meeting be adjourned to a
    later date or dates, if necessary or desirable, at the determination of the Bowen Board that more time is necessary to consummate
    the Business Combination for any reason (the &#8220;<i>Adjournment Proposal</i>&#8221;).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
as more fully described below in the accompanying proxy statement/prospectus, which is dated [&#9679;], 2024 and is first being mailed
to shareholders on or about that date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record
holders of Bowen Ordinary Shares at the close of business on [&#9679;], 2024 (the &#8220;<span style="font-weight: normal"><i>Record
Date</i></span>&#8221;) are entitled to vote or have their votes cast at the Shareholder Meeting. On the Record Date, there were 9,166,500
issued and outstanding Bowen Ordinary Shares, including the Bowen Ordinary Shares included in the units of Bowen (the &#8220;<i>Bowen
Units</i>&#8221;). Each Bowen Unit consists of one Bowen Ordinary Share and one right to receive one-tenth of one Bowen Ordinary Share
upon consummation of the Business Combination (collectively, the &#8220;<span style="font-weight: normal"><i>Bowen Rights</i></span>&#8221;).
The Bowen Rights do not have voting rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>After
careful consideration, the Bowen Board has approved the Business Combination Agreement and the Business Combination and recommends that
shareholders of Bowen vote &#8220;FOR&#8221; the Business Combination Proposal and &#8220;FOR&#8221; all other proposals presented to
shareholders of Bowen in the accompanying proxy statement/prospectus. When you consider the Bowen Board&#8217;s recommendation of these
proposals, you should keep in mind that certain directors and officers of Bowen have interests in the Business Combination that may conflict
with your interests as a shareholder. Please see the section entitled &#8220;<i>Shareholder Proposal No. 1: The Business Combination
Proposal &#8212; Interests of Certain Persons in the Business Combination</i>&#8221; in the accompanying proxy statement/prospectus for
additional information.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
contemplated by the Existing Charter, the holders of Bowen Ordinary Shares issued as part of the Bowen Units sold in Bowen&#8217;s initial
public offering (the &#8220;<span style="font-weight: normal"><i>IPO</i></span>,&#8221; and such shares, the &#8220;<span style="font-weight: normal"><i>Public
Shares</i></span>,&#8221; and the holders of such Public Shares, the &#8220;<span style="font-weight: normal"><i>Public Shareholders</i></span>&#8221;)
may elect to redeem all or a portion of their Public Shares in exchange for their pro rata portion of the funds held in a trust account
(the &#8220;<span style="font-weight: normal"><i>Trust Account</i></span>&#8221;) established in connection with the IPO to hold a portion
of the proceeds of the IPO if the Business Combination is consummated, regardless of how such Public Shareholders vote, or whether they
vote at all, on the Business Combination Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
[X], 2024, the most recent practicable date prior to the date of this proxy statement/prospectus, the redemption price per share would
have been approximately $[X], based on the aggregate amount on deposit in the Trust Account of approximately $[X] as of [X], 2024 (including
interest not previously released to Bowen but net of expected taxes payable), divided by the total number of then outstanding shares
of Public Shares. The redemption price per share may increase between the date of this proxy statement/prospectus and the date that is
two business days prior to the Shareholder Meeting due to any interest that accrues on the amount on deposit in the Trust Account prior
to such date, although we expect the redemption price two business days prior to the Shareholder Meeting will be approximately the same
as the amount set forth above. The closing price of Public Shares on [X], 2024, the most recent practicable date prior to the date of
this proxy statement, was $[X] per share. If the closing price of the Public Shares was to remain the same until the date of the Shareholder
Meeting, exercising redemption rights would result in a Public Shareholder receiving approximately $[X] [more/less] per share than if
the shares were sold in the open market (based on the current per share redemption price). Bowen cannot assure shareholders that they
will be able to sell their Public Shares in the open market, even if the market price per share is lower than the redemption price stated
above, as there may not be sufficient liquidity in its securities when such shareholders wish to sell their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ix<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO
EXERCISE YOUR REDEMPTION RIGHTS, YOU MUST DEMAND IN WRITING THAT YOUR BOWEN ORDINARY SHARES ARE REDEEMED FOR A PRO RATA PORTION OF THE
FUNDS HELD IN THE TRUST ACCOUNT AND TENDER YOUR SHARES TO BOWEN&#8217;S TRANSFER AGENT AT LEAST TWO BUSINESS DAYS PRIOR TO THE VOTE AT
THE SHAREHOLDER MEETING. YOU MAY TENDER YOUR SHARES BY EITHER TENDERING OR DELIVERING YOUR BOWEN ORDINARY SHARES (AND SHARE CERTIFICATES
(IF ANY) AND OTHER REDEMPTION FORMS) TO THE TRANSFER AGENT OR BY TENDERING OR DELIVERING YOUR BOWEN ORDINARY SHARES (AND SHARE CERTIFICATES
(IF ANY) AND OTHER REDEMPTION FORMS) ELECTRONICALLY USING THE DEPOSITORY TRUST COMPANY&#8217;S DWAC (DEPOSIT WITHDRAWAL AT CUSTODIAN)
SYSTEM. IF YOU HOLD THE SHARES IN STREET NAME, YOU WILL NEED TO INSTRUCT THE ACCOUNT EXECUTIVE AT YOUR BANK OR BROKER TO WITHDRAW THE
SHARES FROM YOUR ACCOUNT IN ORDER TO EXERCISE YOUR REDEMPTION RIGHTS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of each of the Name Change Proposal, Capitalization Amendment Proposal, Board Unification Proposal and Proposed Charter
Adoption Proposal requires a special resolution under Cayman Islands law, being the affirmative vote of the holders of at least two-thirds
(2/3) of the Bowen Ordinary Shares represented in person virtually or by proxy and entitled to vote thereon and who vote at the Shareholder
Meeting. The approval of each of the other proposals requires an ordinary resolution, being the affirmative vote of the holders of a
majority of the Bowen Ordinary Shares represented in person virtually or by proxy and entitled to vote thereon and who vote at the Shareholder
Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen&#8217;s
sponsors, Createcharm Holdings Ltd. and Bowen Holding LP (the &#8220;<span style="font-weight: normal"><i>Sponsors</i></span>&#8221;),
and Bowen&#8217;s officers and directors have agreed, subject to applicable securities laws, to vote any Bowen Ordinary Shares owned
by them, including the Bowen Founder Shares and Bowen Private Shares (each as defined below), in favor of each of the proposals
presented at the Shareholder Meeting, and have agreed to waive their redemption rights with respect to any Bowen Ordinary Shares owned
by them in connection with this Shareholder Meeting. This is unlike some other similarly structured transactions where the insiders
vote in accordance with the public holders and therefore a majority of unaffiliated shareholders would be required to approve a proposed
transaction. Because of this agreement to vote in favor of the Business Combination Proposal, the transaction is not structured such
that the vote of a majority of unaffiliated shareholders is required to approve the Business Combination Proposal. In addition, the
IPO Underwriter (as defined below) has agreed to waive its redemption rights with respect to the Bowen Representative Shares (as defined
below) and Bowen Private Shares held by it. The Bowen Founder Shares, the Bowen Representative Shares and the Bowen Private Shares will
be excluded from the pro rata calculation used to determine the per-share redemption price. As of the date of the accompanying proxy
statement/prospectus, the Sponsors hold approximately 22.2% of the issued and outstanding Bowen Ordinary Shares and Bowen&#8217;s officers
and directors do not own any Bowen Ordinary Shares (excluding any securities indirectly owned by officers or directors as a result of
his or her membership interest in the Sponsors).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying proxy statement/prospectus contains important information about the Shareholder Meeting, the Business Combination and the
proposals described above. Whether or not you plan to attend the Shareholder Meeting, Bowen urges you to read this material carefully
and vote your shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying proxy statement is dated [&#9679;], 2024 and is first being mailed to shareholders on or about that date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors of Bowen Acquisition Corp</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Na
    Gai</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairwoman
    of the Board of Directors</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->x<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
OF CONTENTS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_001">FREQUENTLY
    USED TERMS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_002">TRADEMARKS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_003">MARKET
    AND INDUSTRY DATA</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_004">CAUTIONARY
    NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">5</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_005">QUESTIONS
    AND ANSWERS ABOUT THE BOWEN SHAREHOLDER PROPOSALS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">6</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_006">SUMMARY
    OF THE PROXY STATEMENT/PROSPECTUS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">21</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_007">SUMMARY
    UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">44</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_008">COMPARATIVE
    PER SHARE DATA</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_009">TICKER
    SYMBOLS AND DIVIDEND INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">46</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_010">RISK
    FACTORS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">47</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_011">MEETING
    OF BOWEN SHAREHOLDERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">102</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_012">PROPOSAL
    1: THE BUSINESS COMBINATION PROPOSAL</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">108</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: -10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#al_001">PROPOSALS
    2 THROUGH 5: THE CHARTER AMENDMENT PROPOSALS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">131</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_014">PROPOSAL
    6: THE NASDAQ PROPOSAL</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">135</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_015">PROPOSAL
    7: THE INCENTIVE PLAN PROPOSAL</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">136</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_016">PROPOSAL
    8: THE DIRECTOR ELECTION PROPOSAL</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">140</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_017">PROPOSAL
    9: THE ADJOURNMENT PROPOSAL</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">141</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_018">UNAUDITED
    PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">142</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_019">
    MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">149</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_020">INFORMATION
    ABOUT BOWEN</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">156</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_021">BOWEN&#8217;S
    MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">163</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_022">INFORMATION
    ABOUT NEWCO AND QIANZHI</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_023">QIANZHI&#8217;S
    MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">199</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_024">DIRECTORS
    AND EXECUTIVE OFFICERS OF NEW BOWEN AFTER THE BUSINESS COMBINATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">221</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_025">EXECUTIVE
    OFFICER AND DIRECTOR COMPENSATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">225</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_026">CERTAIN
    RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">228</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_027">BENEFICIAL
    OWNERSHIP OF SECURITIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">232</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_028">DESCRIPTION
OF SECURITIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">234</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_029">ENFORCEABILITY
    OF CIVIL LIABILITIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">238</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_030">SHARES
    ELIGIBLE FOR FUTURE SALE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">239</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_031">APPRAISAL
    RIGHTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">240</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_032">HOUSEHOLDING
    INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">240</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_033">TRANSFER
    AGENT AND REGISTRAR</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">240</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_034">SUBMISSION
    OF PROPOSALS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">240</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_035">FUTURE
    PROPOSALS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">240</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_036">WHERE
    YOU CAN FIND MORE INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">240</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_037">LEGAL
    MATTERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">241</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_038">EXPERTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">241</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_039">SHAREHOLDER
    COMMUNICATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">241</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_040">INDEX TO FINANCIAL STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-1<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_041">ANNEX
    A &#8212; AGREEMENT AND PLAN OF REORGANIZATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_042">ANNEX
    B &#8212; 2024 EQUITY INCENTIVE PLAN</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">B-1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_043">ANNEX
    C &#8212; FAIRNESS OPINION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">C-1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_044">ANNEX
    D &#8212; PROPOSED CHARTER OF NEW BOWEN</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">D-1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#bm_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNEX E &#8211; </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM OF PROXY CARD</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">E-1</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->xi<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_001"></span>FREQUENTLY
USED TERMS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise stated in this proxy statement/prospectus or the context otherwise requires:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>ASC</i></span>&#8221;
                                            means the FASB&#8217;s Accounting Standards Codification.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Bowen</i></span>&#8221;
                                            means Bowen Acquisition Corp, a Cayman Islands exempted company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Bowen
                                            Founder Shares</i></span>&#8221; means the Bowen Ordinary Shares issued to the Sponsors prior
                                            to the IPO.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Bowen
                                            Ordinary Shares</i></span>&#8221; means the ordinary shares, par value $0.0001 per share,
                                            of Bowen.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Bowen
                                            Private Rights</i></span>&#8221; means the Bowen Rights included as part of Bowen Private
                                            Units.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Bowen
                                            Private Shares</i></span>&#8221; means the Bowen Ordinary Shares included as part of the
                                            Bowen Private Units.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Bowen
                                            Private Units</i></span>&#8221; means the Bowen Units purchased by the Sponsors and the IPO
                                            Underwriter in a private placement concurrently with the IPO.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Bowen
                                            Representative Shares</i></span>&#8221; means the Bowen Ordinary Shares purchased by the
                                            IPO Underwriter prior to the IPO.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Bowen
                                            Rights</i></span>&#8221; means the issued and outstanding rights of Bowen, each entitling
                                            the holder to receive one-tenth of one Bowen Ordinary Share, issued pursuant to the Rights
                                            Agreement, dated July 11, 2023, between Bowen and Continental Stock Transfer &amp; Trust
                                            Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Bowen
                                            Units</i></span>&#8221; means the units of Bowen that consist of one Bowen Ordinary Share
                                            and one Bowen Right.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Business
                                            Combination</i></span>&#8221; means the transactions contemplated by the Business Combination
                                            Agreement, including the Merger.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Business
                                            Combination Agreement</i></span>&#8221; means that certain Agreement and Plan of Reorganization,
                                            dated as of January 18, 2024, by and among Bowen, Merger Sub, Qianzhi and NewCo, as the same
                                            may be amended from time to time, attached to this proxy statement/prospectus as <i><span style="text-decoration: underline">Annex
                                            A</span></i>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Business
                                            Combination Proposal</i></span>&#8221; means the proposal to be considered at the Shareholder
                                            Meeting to approve the Business Combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Cayman
                                            Companies Act</i></span>&#8221; means the Companies Act (Revised) of the Cayman Islands,
                                            as amended from time to time.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Closing</i></span>&#8221;
                                            means the closing of the Business Combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Closing
                                            Date</i></span>&#8221; means the date on which the Closing occurs.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Condition
                                            Precedent Proposal</i></span>&#8221; means the Business Combination Proposal.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Continental</i></span>&#8221;
                                            means Continental Stock Transfer &amp; Trust Company, trustee of Bowen&#8217;s Trust Account,
                                            rights agent of Bowen&#8217;s Rights and transfer agent of Bowen&#8217;s Ordinary Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Earnout
                                            Consideration</i></span>&#8221; means up to 1,400,000 Bowen Ordinary Shares, which shall
                                            be deposited with Continental, as Earnout Escrow Agent, and subject to contingent release
                                            based upon the achievement of certain future performance metrics as further set forth in
                                            the Business Combination Agreement and the Earnout Escrow Agreement.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Earnout
                                            Escrow Agreement</i></span>&#8221; means that certain escrow agreement to be entered into
                                            with the Earnout Escrow Agent prior to the Closing and in a form reasonably agreed to by
                                            the Parties, which shall cover the treatment and release of the Earnout Consideration.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Earnout
                                            Shares</i></span>&#8221; means the 1,400,000 Bowen Ordinary Shares which shall be deposited
                                            with the Earnout Escrow Agent as Earnout Consideration.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Exchange
                                            Act</i></span>&#8221; means the Securities Exchange Act of 1934, as amended.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Existing
                                            Charter</i></span>&#8221; means Bowen&#8217;s amended and restated memorandum and articles
                                            of association as adopted by special resolution dated 13 July 2023.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>FASB</i></span>&#8221;
                                            means the Financial Accounting Standard Board.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Founder
                                            Shares</i></span>&#8221; mean the 1,725,000 Bowen Ordinary Shares acquired by the Insiders
                                            prior to the IPO;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Indemnification
                                            Escrow Agreement</i></span>&#8221; means that certain escrow agreement to be entered into
                                            with the Escrow Agent prior to the Closing and in a form reasonably agreed to by the Parties,
                                            which shall cover the treatment and release of the Escrow Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Indemnity
                                            Escrow Shares</i></span>&#8221; means the portion of Merger Shares that will be deposited
                                            with the Indemnity Escrow Agent to provide for indemnification in accordance with the Business
                                            Combination Agreement.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Insiders</i></span>&#8221;
                                            means the Sponsors and each of the directors and officers of Bowen.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>IPO</i></span>&#8221;
                                            means the initial public offering Bowen consummated on July 14, 2023.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>IPO
                                            Registration Statement</i></span>&#8221; means the Registration Statement on Form S-1 filed
                                            with the SEC on May 19, 2023, as amended, and declared effective on July 11, 2023 (File No.
                                            333- 272076).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>IPO
                                            Underwriter</i></span>&#8221; means EarlyBirdCapital Inc.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Merger</i></span>&#8221;
                                            means the merger of Merger Sub with and into NewCo, wherein the separate corporate existence
                                            of Merger Sub shall cease and NewCo shall continue as the Surviving Company after the Merger
                                            and as a wholly-owned subsidiary of Bowen.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Merger
                                            Consideration</i></span>&#8221; means Merger Shares and Earnout Shares, collectively.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Merger
                                            Shares</i></span>&#8221; means 7,246,377 Bowen Ordinary Shares, a portion of which shall
                                            be deposited in escrow to provide for indemnification in accordance with the Business Combination
                                            Agreement.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Merger
                                            Sub</i></span>&#8221; means Bowen Merger Sub, a Cayman Islands exempted company and wholly-owned
                                            subsidiary of Bowen.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Nasdaq</i></span>&#8221;
                                            means the Nasdaq Stock Market.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>New
                                            Bowen</i></span>&#8221; means Bowen following the closing
                                            of the Business Combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>NewCo</i></span>&#8221;
                                            means Qianzhi Group Holding (Cayman) Limited.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>PIPE
                                            Financing</i></span>&#8221; means the proposed private financing of up to $5,000,000.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>PIPE
                                            Investors</i></span>&#8221; means any investors in the PIPE Financing.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Proposed
                                            Charter</i></span>&#8221; means the proposed second amended and restated memorandum and articles
                                            of association of Bowen to be in effect upon the Closing (assuming approval of the Proposed
                                            Charter Adoption Proposal).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Public
                                            Rights</i></span>&#8221; means the Bowen Rights included in the Pubic Units.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Public
                                            Shares</i></span>&#8221; means the Bowen Ordinary Shares included in the Pubic Units.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Public
                                            Shareholders</i></span>&#8221; means holders of the Public Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Public
                                            Units</i></span>&#8221; means the Bowen Units issued by Bowen in the IPO.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Qianzhi</i></span>&#8221;
                                            means Shenzhen Qianzhi BioTechnology Co. Ltd., a company incorporated in the People&#8217;s
                                            Republic of China.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Qianzhi
                                            Ordinary Shares</i></span>&#8221; means Qianzhi&#8217;s Ordinary Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Record
                                            Date</i></span>&#8221; means [&#9679;], 2024.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Registration
                                            Statement</i></span>&#8221; means the registration statement on Form S-4 of which this proxy
                                            statement/prospectus forms a part, as the same may be amended from time to time.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Rights
                                            Agreement</i></span>&#8221; means the Rights Agreement dated as of July 11, 2023, between
                                            Bowen and Continental.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Right
                                            Holders</i></span>&#8221; means holders of the Bowen Rights.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>SEC</i></span>&#8221;
                                            means the U.S. Securities and Exchange Commission.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Securities
                                            Act</i></span>&#8221; means the Securities Act of 1933, as amended.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Shareholder
                                            Meeting</i></span>&#8221; means the extraordinary general meeting of Bowen where holders
                                            of Bowen Ordinary Shares will be asked to consider and vote upon the Business Combination
                                            Proposal, among other proposals, and to approve the Business Combination and adopt the Business
                                            Combination Agreement.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Sponsors</i></span>&#8221;
                                            means Createcharm Holdings Ltd, a British Virgin Islands company, and Bowen Holding LP, a
                                            Delaware limited liability company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>U.S.
                                            GAAP</i></span>&#8221; means the accounting principles generally accepted in the United States
                                            of America.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="font-weight: normal"><i>Voting
                                            and Support Agreement</i></span>&#8221; means that certain Voting and Support Agreement,
                                            dated as of January 18, 2024, by and among Qianzhi, Bowen and the shareholders of Qianzhi
                                            thereto.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_002"></span>TRADEMARKS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
has proprietary rights to certain of the trademarks and trade names used in this proxy statement/prospectus. This proxy statement/prospectus
also contains trademarks, service marks, copyrights and trade names of other companies, which are the property of their respective owners.
Bowen and Qianzhi do not intend their use or display of other companies&#8217; trademarks, copyrights or trade names to imply a relationship
with, or endorsement or sponsorship of Bowen or Qianzhi by, any other companies. Solely for convenience, our trademarks and trade names
referred to in this proxy statement/prospectus may appear without the &#174; or &#8482; symbols, but such references are not intended
to indicate, in any way, that Bowen or Qianzhi will not assert, to the fullest extent under applicable law, its rights or the right of
the applicable licensor to these trademarks and trade names.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_003"></span>MARKET
AND INDUSTRY DATA</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement/prospectus includes industry position and industry data and forecasts that Bowen and Qianzhi obtained or derived from
internal company reports, independent third-party publications and other industry data. Some data are also based on good faith estimates,
which are derived from internal company analyses or review of internal company reports as well as the independent sources referred to
above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
as to industry position are based on market data currently available. While neither Bowen nor Qianzhi are aware of any misstatements
regarding the industry data presented herein, these estimates involve risks and uncertainties and are subject to change based on various
factors, including those discussed under the heading &#8220;<i>Risk Factors</i>&#8221; in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_004"></span>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement/prospectus contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E
of the Exchange Act. These forward-looking statements include, among other things, statements about the parties&#8217; ability to close
the Business Combination, the timing of the Closing, the anticipated benefits of the Business Combination, and the financial conditions,
results of operations, earnings outlook and prospects of Bowen and Qianzhi during the period following the consummation of the Business
Combination. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances,
including any underlying assumptions, are forward-looking statements. Forward-looking statements are typically identified by words such
as &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;outlook,&#8221;
&#8220;estimate,&#8221; &#8220;forecast,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;may,&#8221;
&#8220;might,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;should,&#8221; &#8220;would,&#8221;
&#8220;will,&#8221; &#8220;seek,&#8221; &#8220;target,&#8221; and other similar words and expressions, but the absence of these words
does not mean that a statement is not forward-looking.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forward-looking statements are based on information available as of the date of this proxy statement/prospectus and on the current expectations,
forecasts and assumptions of the management of Bowen and Qianzhi, involve a number of judgments, risks and uncertainties, and are inherently
subject to changes in circumstances and their potential effects and speak only as of the date of such statements. There can be no assurance
that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks and uncertainties
that may cause actual results or performance to be materially different from those expressed, contemplated or implied by these forward-looking
statements. These risks and uncertainties include, but are not limited to, those factors described in &#8220;<i>Risk Factors</i>,&#8221;
those discussed and identified in public filings made with the SEC by Bowen and the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            occurrence of any event, change or other circumstances that could give rise to the termination
                                            of the Business Combination Agreement;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            inability to consummate the Business Combination, including due to any failure to obtain
                                            approval of the Bowen Shareholders or NewCo Shareholders or other conditions to the Closing
                                            in the Business Combination Agreement;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                            in obtaining, or the inability to obtain, any necessary regulatory approvals required to
                                            complete the Business Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            inability to obtain, or maintain, the listing of the New Bowen Ordinary Shares on Nasdaq
                                            following the Business Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
                                            related to the Business Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in applicable laws or regulations; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            possibility that Bowen or Qianzhi may be adversely affected by other economic, business,
                                            and/or competitive factors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
one or more of these risks or uncertainties materialize, or should any of the assumptions made by the management of Bowen or Qianzhi
prove incorrect, actual results may vary in material respects from those projected in or contemplated by these forward-looking statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
subsequent written and oral forward-looking statements concerning the Business Combination or other matters addressed in this proxy statement/prospectus
and attributable to Bowen or Qianzhi or any person acting on their behalf are expressly qualified in their entirety by the cautionary
statements contained or referred to in this proxy statement/prospectus. Except to the extent required by applicable law or regulation,
neither Bowen nor Qianzhi undertakes any obligation to update these forward-looking statements to reflect events or circumstances after
the date of this proxy statement/prospectus or to reflect the occurrence of unanticipated events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_005"></span>QUESTIONS
AND ANSWERS ABOUT THE BOWEN SHAREHOLDER PROPOSALS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
questions and answers below highlight only selected information from this document and only briefly address certain commonly asked questions
about the proposals to be presented at the Shareholder Meeting, including with respect to the proposed Business Combination. The following
questions and answers do not include all the information that may be important to Bowen shareholders. Shareholders are urged to read
carefully this entire proxy statement/prospectus, including the Annexes and other documents referred to herein, to fully understand the
proposals to be presented at the Shareholder Meeting and the voting procedures for the Shareholder Meeting.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Why
                                            am I receiving this proxy statement/prospectus?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            are receiving this proxy statement/prospectus in connection with the Shareholder Meeting.
                                            Bowen is holding the Shareholder Meeting to consider and vote upon the proposals described
                                            below. <b>Your vote is important. You are encouraged to vote as soon as possible after carefully
                                            reviewing this proxy statement/prospectus.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen&#8217;s
shareholders are being asked to consider and vote upon the Business Combination Proposal to approve the Business Combination Agreement
and the Business Combination contemplated thereby. The Business Combination Agreement provides that, among other things, upon the Closing,
Merger Sub will merge with and into NewCo, with NewCo being the surviving company of such Merger and becoming a wholly owned subsidiary
of Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, at the Effective Time, all of the NewCo Ordinary Shares issued and outstanding immediately prior
to the Effective Time other than (i) NewCo Ordinary Shares held by Bowen or Qianzhi or their respective wholly owned subsidiaries
and (ii) those NewCo Ordinary Shares owned by the holders of NewCo Ordinary Shares who have validly exercised and not effectively withdrawn
or lost their rights to dissent from the Merger pursuant to the Cayman Companies Act, will be automatically converted into the right
to receive an aggregate of (a) 7,246,377 Bowen Ordinary Shares, a portion of which shall be deposited in escrow to provide for indemnification
in accordance with the Business Combination Agreement, and (b) the right to receive earnout consideration of up to an aggregate of 1,400,000
Bowen Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the Business Combination Agreement, the parties are using commercially reasonable efforts to solicit PIPE Investors to
enter into subscription agreements with Bowen, on terms approved by Qianzhi, pursuant to which the PIPE Investors will purchase,
concurrently with the closing of the Merger, equity or equity-linked securities of Bowen in an aggregate amount of $5.0 million, in the
PIPE Financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
at the Effective Time, each Bowen Right issued and outstanding immediately prior to the Effective Time shall be converted into one-tenth
of one Bowen Ordinary Share. Each Bowen Unit that is outstanding immediately prior to the Effective Time will be automatically separated
into one Bowen Ordinary Share and one-tenth of one Bowen Ordinary Share (as the Bowen Rights included therein will automatically convert
into Bowen Ordinary Shares in accordance with the terms of the Bowen Rights).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen&#8217;s
shareholders are also being asked to consider and vote upon the Name Change Proposal, Capitalization Amendment Proposal, the Charter
Amendment Proposals, the Nasdaq Proposal, the Equity Incentive Plan Proposal, the Director Election Proposal and the Adjournment
Proposal, each as described in more detail below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            is the expected per share value of the cash from the Trust Account to be received
                                            by New Bowen in the Business Combination?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            described in the sections entitled &#8220;<i>Summary of the Proxy Statement/Prospectus &#8212;
                                            Sources and Uses of Funds for the Business Combination</i>,&#8221; and &#8220;<i>&#8212;
                                            What happens if a substantial number of Public Shareholders exercise their redemption rights?</i>&#8221;,
                                            the net cash to the balance sheet of New Bowen and the total number of New Bowen Ordinary
                                            Shares outstanding on the Closing will depend upon the extent to which Public Shareholders
                                            exercise their redemption rights. Although the parties to the Business Combination have deemed
                                            the value of the Bowen Ordinary Shares to be issued in the Merger to be equal to per share
                                            amount held in the Trust Account, the cash value per share of the Bowen Ordinary Shares and
                                            the trading price of Bowen Ordinary Shares following the Business Combination could be substantially
                                            less than such amount.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is a calculation, on a per Bowen Ordinary Share basis, of the estimated net cash to be received by New Bowen from the Trust
Account in a no redemption scenario, 25% redemption scenario, 75% redemption scenario, and the maximum redemption scenario. Such calculations
are based upon (i) cash held in the Trust Account as of June 30, 2024 of approximately $10.62 per Public Share (rounded
to the nearest cent) and (ii) estimated transaction expenses of $3,145,944. The total number of shares outstanding in the table
below gives effect to the issuance of Merger Shares, the conversion of the Bowen Rights into Bowen Ordinary Shares, the issuance
of Earnout Shares and the issuance of Bowen Ordinary Shares in the PIPE Financing upon consummation of the Business Combination.
The calculations do not assume the receipt of any Bowen Ordinary Shares under the 2024 Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    <br/>
    No <br/>
    Redemption<sup>(1)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    <br/>
    25% <br/>
    Redemption<sup>(2)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    <br/>
    75% <br/>
    Redemption<sup>(3)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    <br/>
    Maximum <br/>
    Redemption<sup>(4)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen Ordinary Shares Not Redeemed</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,900,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,175,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,725,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    Cash Proceeds of Trust Account at $10.62 per Share</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>

<p style="margin: 0; font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">73,284,700</span></p>


<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">$</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,965,200</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,326,200</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated Transaction Expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,145,944</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,145,944</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,145,944</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,145,944</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Shares Outstanding<sup>(5)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,039,026</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,314,026</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,864,026</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,139,026</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Cash per Share of Bowen Ordinary Shares Outstanding</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.68</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.99</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.09</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A
    *</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">*</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Amount
                                            is less than zero.</td></tr>
                                                                                                                                      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
                                                                                                                                      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            scenario assumes that no Public Shares are redeemed by Public Shareholders.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            scenario assumes that 1,725,000 Public Shares are redeemed by Public Shareholders.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            scenario assumes that 5,175,000 Public Shares are redeemed by Public Shareholders.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            scenario assumes that 6,900,000 Public Shares are redeemed by Public Shareholders.</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
                                                                                                                                                      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">(5)</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Includes
                                            (i) an aggregate of 690,000 Bowen Ordinary Shares to be issued upon conversion of the outstanding
                                            Bowen Rights upon consummation of the Business Combination; (ii) an aggregate of 36,150 Bowen
                                            Ordinary Shares to be issued upon conversion of the Bowen Private Rights upon consummation
                                            of the Business Combination; (iii) an aggregate of 500,000 Bowen Ordinary Shares to be issued in <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
PIPE Financing; and (iv) an aggregate of 1,400,000 Earnout Shares</span>.</td></tr>
                                                                                                                                                      </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            are the specific proposals on which I am being asked to vote at the Shareholder Meeting?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
                                            shareholders are being asked to consider and vote on the following proposals:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
                                            Proposal No. 1 &#8212; Business Combination Proposal &#8212; </i>a proposal, as an ordinary
                                            resolution, to adopt and approve the Business Combination Agreement, a copy of which is
                                            attached herein as <i><span style="text-decoration: underline">Annex A</span></i>, and the transactions contemplated thereby,
                                            including the Business Combination (the &#8220;<span style="font-weight: normal"><i>Business
                                            Combination Proposal</i></span>&#8221;);</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 2 &#8212; Name Change Proposal &#8212; </i>a proposal, as a special resolution, subject to the proposed name conforming
    with section 30 of the Companies Act (Revised) of the Cayman Islands, to approve the change of name of Bowen from Bowen Acquisition
    Corp to &#8220;Emerald, Inc.&#8221;, effective from the Effective Time (the &#8220;<i>Name Change Proposal</i>&#8221;);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 3 &#8212; Capitalization Amendment Proposal &#8212; </i>a proposal, as a special resolution, to approve an increase
    to the authorized share capital of Bowen from US$20,200, divided into 2,000,000 Preferred Shares of par value US$0.0001 each and
    200,000,000 Ordinary Shares of par value US$0.0001 each, to US$25,200 divided into 2,000,000 Preferred Shares of par value US$0.0001
    each and 250,000,000 Ordinary Shares of par value US$0.0001 each, by the creation of additional 50,000,000 Ordinary Shares of par
    value US$0.0001 each (the &#8220;<i>Capitalization Amendment Proposal</i>&#8221;);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 4 &#8212; Charter Amendment Proposal A &#8212; Board Unification Proposal &#8212; </i>a proposal, as a special resolution,
    to remove the provisions of the <i>Existing Charter</i> dividing the Bowen Board into classes (the &#8220;<i>Board Unification Proposal</i>&#8221;):</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 5 &#8212; Charter Amendment Proposal B &#8212; Proposed Charter Adoption Proposal </i>&#8211; a proposal, as a special
    resolution, to approve the amendment and restatement of the Existing Charter, including without limitation, the consequential changes
    resulting from the Name Change Proposal (if approved), the Capitalization Amendment Proposal (if approved) and the Board Unification
    Proposal (if approved) and the removal of non-substantive, non-governance provisions applicable only to special purpose acquisition
    companies that will no longer be applicable to Bowen after the consummation of the Business Combination, by deletion in their entirety
    and substitution in their place by the proposed second amended and restated memorandum and articles of association of Bowen, the
    substantial form of which is attached herein as <i><span style="text-decoration: underline">Annex D</span>, </i>with effect upon the Effective Time (the &#8220;<i>Proposed
    Charter Adoption Proposal</i>&#8221;, and together with the Board Unification Proposal, collectively, the &#8220;<i>Charter Amendment
    Proposals</i>&#8221;);</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 6 &#8212; Nasdaq Proposal &#8212; </i>a proposal, as an ordinary resolution, to approve, for purpose of complying with
    Nasdaq Listing Rule 5635(a) and (b), the issuance of Bowen Ordinary Shares in connection with the Merger in all respects (the &#8220;<i>Nasdaq
    Proposal</i>&#8221;);</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 7 &#8212; Equity Incentive Plan Proposal &#8212; </i>a proposal, as an ordinary resolution, to approve and adopt the
    2024 Long-Term Incentive Equity Plan of Bowen (the &#8220;<i>2024 Incentive Plan</i>&#8221;), to be effective from the Effective
    Time (the &#8220;<i>Equity Incentive Plan Proposal</i>&#8221;);</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
                                            Proposal No. 8 &#8212; Director Election Proposal &#8212; </i>a proposal, as an ordinary
                                            resolution, to elect five (5) members to serve terms on the Bowen Board, with effect from
                                            the Effective Time until their respective successors are duly elected and qualified (the
                                            &#8220;<i>Director Election Proposal</i>&#8221;); and</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    Proposal No. 9 &#8212; Adjournment Proposal &#8212; </i>a proposal, as an ordinary resolution, to adjourn the Shareholder Meeting
    to a later date or dates, if necessary or desirable, at the determination of the Bowen Board that more time is necessary to consummate
    the Business Combination for any reason (the &#8220;<i>Adjournment Proposal</i>&#8221;).</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, please see &#8220;<i>Shareholder Proposal No. 1: The Business Combination Proposal</i>,&#8221; &#8220;<i>Shareholder
Proposal No. 2: The Name Change Proposal,&#8221; &#8220;Shareholder Proposal No. 3: The Capitalization Amendment Proposal,&#8221;
&#8220;Shareholder Proposal No. 4: The Board Unification Proposal,&#8221; &#8220;Shareholder Proposal No. 5: The Proposed Charter Adoption
Proposal,&#8221; &#8220;Shareholder Proposal No. 6: The Nasdaq Proposal,&#8221; &#8220;Shareholder Proposal No. 7: The Equity
Incentive Plan Proposal,&#8221; &#8220;Shareholder Proposal No. 8: The Director Election Proposal&#8221; and &#8220;Shareholder
Proposal No. 9: The Adjournment Proposal.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>After
careful consideration, the Bowen Board has unanimously determined that the foregoing proposals are advisable and in the best interests
of Bowen and its shareholders and unanimously recommends that you vote &#8220;FOR&#8221; or give instruction to vote &#8220;FOR&#8221;
each of these proposals.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
existence of financial and personal interests of Bowen&#8217;s directors and officers may result in conflicts of interest, including
a conflict between what may be in the best interests of Bowen and its shareholders and what may be best for an officer&#8217;s or director&#8217;s
personal interests when determining to recommend that shareholders vote for the proposals. See the sections entitled &#8220;<i>Shareholder
Proposal No. 1: The Business Combination Proposal &#8212; Interests of Certain Persons in the Business Combination&#8221; and &#8220;Beneficial
Ownership of Securities</i>&#8221; for further discussion of these considerations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
VOTE OF SHAREHOLDERS IS IMPORTANT. SHAREHOLDERS ARE URGED TO SUBMIT THEIR PROXIES AS SOON AS POSSIBLE AFTER CAREFULLY REVIEWING THIS
PROXY STATEMENT/PROSPECTUS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Are
                                            the proposals conditioned on one another?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            of the Name Change Proposal, Capitalization Amendment Proposal, Charter Amendment
                                            Proposals, the Nasdaq Proposal, the Director Election Proposal and the Equity Incentive Plan
                                            Proposal is conditioned on the approval and adoption of the Condition Precedent Proposal.
                                            The Adjournment Proposal is not conditioned upon the approval of any other proposal.
                                            The Adjournment Proposal will only be put forth for a vote if Bowen and Qianzhi
                                            mutually determine that additional time is required to consummate the Business Combination.
                                            If the Adjournment Proposal is put forth for a vote, none of the other proposals
                                            will be presented.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Why
                                            is Bowen proposing the Business Combination Proposal?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
                                            is a Cayman Islands exempted company formed for the purpose of effecting a merger, share
                                            exchange, asset acquisition, share purchase, reorganization, or similar business combination
                                            with one or more businesses. While Bowen&#8217;s efforts in identifying prospective target
                                            businesses were not limited to a particular geographic region, Bowen has focused its search
                                            on businesses throughout Asia. In its review of Qianzhi, the Bowen Board considered a variety
                                            of factors weighing positively and negatively in connection with the Business Combination.
                                            After careful consideration, the Bowen Board has determined that the positive factors outweighed
                                            the negative factors and that the Business Combination presents an attractive business combination
                                            opportunity and is in the best interests of Public Shareholders. The Bowen Board believes
                                            that, based on its review and consideration, the Business Combination with Qianzhi presents
                                            an opportunity to increase shareholder value. However, there can be no assurance that the
                                            anticipated benefits of the Business Combination will be achieved. Approval of the Business
                                            Combination by holders of Bowen Ordinary Shares is required by the Business Combination Agreement
                                            and the Existing Charter.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            will happen in the Business Combination?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
                                            to the terms of the Business Combination Agreement, Bowen and Qianzhi will complete a business
                                            combination, which will be effected through the merger of Merger Sub with and into NewCo,
                                            the parent of Qianzhi, with NewCo being the surviving company of such Merger and continuing
                                            in existence as a wholly owned subsidiary of Bowen. For information on how the Business Combination
                                            will affect the securities of Bowen and NewCo, please see &#8220;<i>&#8212; Why am I receiving
                                            this proxy statement/prospectus?</i>&#8221; above and &#8220;<i>Proposal No. 1: The Business
                                            Combination</i>&#8221; below.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            happens if a substantial number of Public Shareholders exercise their redemption rights?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
                                            Shareholders may vote &#8220;FOR&#8221; the Business Combination and still exercise their
                                            redemption rights. In addition, there is no minimum cash condition to the closing of the
                                            Business Combination. Accordingly, the Business Combination may be consummated even though
                                            the funds available from the Trust Account and the number of Public Shareholders are reduced
                                            substantially as a result of redemptions by Public Shareholders.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Ordinary Shares to be issued in the Merger will dilute the equity interests of Bowen&#8217;s existing shareholders and may adversely
affect prevailing market prices for Public Shares. The Public Shareholders who do not redeem their Public Shares may experience dilution
from several additional sources to varying degrees in connection with and after the Business Combination. Additionally, New Bowen following
the Closing may determine, subject to the receipt of any shareholder or stock exchange approvals that may be required, to issue more
of Bowen Ordinary Shares or other equity securities of equal or senior rank in connection with privately negotiated transactions following
the consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of Bowen Ordinary Shares (or other equity securities of equal or senior rank) could have the following effects for holders of
Public Shares who elect not to redeem their shares:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">your
                                            proportionate ownership interest in New Bowen following the Closing will decrease;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            relative voting strength of the previously outstanding Bowen Ordinary Shares following the
                                            Business Combination will be diminished; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            market price of the Bowen Ordinary Shares may decline.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tables below show the anticipated ownership of New Bowen upon completion of the Business Combination, along with other potential sources
of dilution. The tables show the potential impact of redemptions on the share ownership by non-redeeming shareholders in (i) a no redemption
scenario, (ii) 25% redemption scenario, (iii) 75% redemption scenario, and (iv) maximum redemption scenario. The levels of ownership
presented in the tables below assume that 500,000 shares in connection with the PIPE Financing and 1,400,000 Earnout Shares have been issued. The information in the tables below has been rounded to the nearest whole number or the nearest decimal. Therefore,
the sum of the numbers in a column may not conform exactly to the total figure given for that column in the below table. In addition,
certain percentages presented in the tables below reflect calculations based upon the underlying information prior to rounding and, accordingly,
may not conform exactly to the percentages that would be derived if the relevant calculations were based upon the rounded numbers or
may not sum due to rounding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming No Redemption<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming 25% Redemption<sup>(2)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming 75% Redemption<sup>(3)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming Maximum Redemption<sup>(4)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Shareholders</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ownership <br/> in Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equity <br/> %</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ownership <br/> in Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equity <br/> %</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ownership <br/> in Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equity <br/> %</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ownership <br/> in Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equity <br/> %</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of Public Shares<sup>(5)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">7,590,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">39.9</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">5,865,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">33.9</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">2,415,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">17.4</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">690,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">5.7</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insiders&#8217; Existing Shares<sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,302,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,302,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,302,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,302,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Existing Qianzhi Shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,646,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,646,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49.9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,646,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,646,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">71.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">PIPE Investors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total Shares Outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,039,026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,314,026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,864,026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,139,026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">For the three months ended June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pro Forma Net Income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(3,766,296</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(3,766,296</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(3,766,296</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(3,766,296</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Pro Forma Basic and Diluted Net Loss per Share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.21</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.24</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.30</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.35</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">For the twelve months ended March 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pro Forma Net Income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(4,136,044</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(4,136,044</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(4,136,044</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(4,136,044</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Pro Forma Basic and Diluted Net Loss per Share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.23</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.26</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.33</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.39</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross Cash Proceeds of Trust Account at $10.62 per Share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">73,284,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">54,965,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18,326,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Business Combination Marketing Agreement Fee Payable to the IPO Underwriter</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,415,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,415,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,415,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,415,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Percentage of Fee Payable to the IPO Underwriter in Gross Cash Proceeds of Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    No Redemption<sup>(1) </sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    25% Redemption<sup>(2) </sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    75% Redemption<sup>(3) </sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
<br/>
    Maximum <br/>
Redemption<sup>(4) </sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    Dilution Sources</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
    <br/> in Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    <br/> %</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
    <br/> in Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    <br/> %</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
    <br/> in Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    <br/> %</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
    <br/> in Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    <br/> %</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024
    Incentive Plan</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">951,951</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">865,701</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">693,201</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">606,951</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            scenario assumes that no Public Shares are redeemed by Public Shareholders.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            scenario assumes that 1,725,000 Public Shares are redeemed by Public Shareholders.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            scenario assumes that 5,175,000 Public Shares are redeemed by Public Shareholders.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            scenario assumes that 6,900,000 Public Shares are redeemed by Public Shareholders.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            an aggregate of 690,000 Bowen Ordinary Shares to be issued upon conversion of the outstanding
                                            Bowen Rights upon consummation of the Business Combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            an aggregate of 36,150 Bowen Ordinary Shares to be issued upon conversion of the Bowen Private
                                            Rights upon consummation of the Business Combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Marketing Agreement with the IPO Underwriter, Bowen will pay a fixed amount of $2,415,000 to the IPO Underwriter.
This fee is equal to 3.3%, 4.4% and 13.2% of the gross proceeds of the IPO assuming no redemption, 25% redemption and 75%
redemption, respectively. The number of Public Shares that are redeemed in connection with the Business Combination will not reduce this
fee payable to the IPO Underwriter. As a result, such fee will represent a greater percentage of dilution as the number of Public Shares
being redeemed increases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Insiders, Qianzhi and/or their directors, officers, advisors or respective affiliates, may purchase Public Shares from Public Shareholders
in privately negotiated transactions or in the open market prior to or following the completion of the Business Combination. If any purchases are made: (a) all purchases will be at a price no higher than the price offered through the redemption
process, (b) any shares so purchased will not be voted in favor of approving the Business Combination, (c) the purchasers will have waived
their redemption rights with respect to all Bowen Ordinary Shares owned by them, and (d) in connection with any such purchases prior to
the extraordinary general meeting, Bowen will file a current report on Form 8-K to disclose (i) the amount of securities purchased in
any such purchases, along with the purchase price; (ii) the purpose of any such purchases; (iii) the impact, if any, of any such purchases
on the likelihood that the Business Combination will be approved; (iv) the identities or the nature of the security holders (e.g., 5%
security holders) who sold their securities in any such purchases; and (v) the number of securities for which Bowen has received redemption
requests pursuant to its shareholders&#8217; redemption rights in connection with the Business Combination.
If such purchases are made, the public &#8220;float&#8221; of Public Shares (prior to the Closing) or the New Bowen Ordinary Shares (following
the Closing) and the number of beneficial holders of Bowen Ordinary Shares (prior to the Closing) or the New Bowen Ordinary Shares (following
the Closing) may be reduced, possibly making it difficult to obtain or maintain the quotation, listing or trading of such securities
on Nasdaq or another national securities exchange or reducing the liquidity of the trading market for such securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Did
                                            the Bowen Board obtain a third-party valuation or fairness opinion in determining whether
                                            or not to proceed with the Business Combination?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
                                            Bowen retained Newbridge Securities to evaluate the fairness, from a financial point of view,
                                            to the Public Shareholders of the Merger Consideration to be paid to the Qianzhi equityholders
                                            in the Merger.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 18, 2024, at a meeting of the Bowen Board held to evaluate the Business Combination, Newbridge Securities rendered to the Bowen
Board an oral opinion, which was confirmed by delivery of a written opinion dated January 18, 2024 (the &#8220;<span style="font-weight: normal"><i>Fairness
Opinion</i></span>&#8221;), to the effect that, as of that date and based on and subject to the assumptions made, procedures followed,
matters considered and qualifications and limitations on the review undertaken described in such opinion, (i) the Merger Consideration
payable to the Qianzhi equityholders in the Merger was fair from a financial point of view to Bowen and Bowen&#8217;s shareholders
and (ii) Qianzhi had an aggregate fair market value equal to at least eighty percent (80.0%) of the net assets held by Bowen in the
Trust Account (excluding deferred underwriting commissions and taxes payable on the interest earned on the Trust Account), as of the
date of the Business Combination Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
full text of the Fairness Opinion delivered to the Bowen Board, dated January 18, 2024, is attached as <i><span style="text-decoration: underline">Annex C</span></i> and incorporated
by reference into this proxy statement/prospectus in its entirety. The Fairness Opinion sets forth, among other things, the assumptions
made, procedures followed, matters considered and qualifications and limitations on the scope of the review undertaken by Newbridge Securities
in rendering the Fairness Opinion. All shareholders of Bowen are urged to, and should, read the Fairness Opinion carefully and in its
entirety. The Fairness Opinion was directed to the Bowen Board and addressed only the fairness from a financial point of view to the
Public Shareholders, as of the date of the Fairness Opinion, of the Merger Consideration to be paid by Bowen pursuant to the Business
Combination Agreement and that Qianzhi had an aggregate fair market value equal to at least 80% of the assets held by Bowen in the Trust
Account (net of taxes payable). The Fairness Opinion did not address any other aspect or implications of the Business Combination and
does not constitute an opinion, advice or recommendation as to how any shareholder of Bowen should vote at the Shareholder Meeting. In
addition, the Fairness Opinion did not in any manner address the prices at which the Bowen Ordinary shares would trade following the
consummation of the Business Combination or at any time. The summary of the Fairness Opinion set forth in this proxy solicitation/prospectus
statement is qualified in its entirety by reference to the full text of the Fairness Opinion attached as <i><span style="text-decoration: underline">Annex C</span></i> hereto.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, please see the section entitled &#8220;<i>Shareholder Proposal No. 1: The Business Combination Proposal &#8212; Opinion
of Newbridge Securities, Fairness Opinion Provider</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>By
                                            what date must Bowen complete a business combination?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
                                            is a special purpose acquisition company formed as a Cayman Islands exempted company for
                                            the purpose of effecting an initial business combination with one or more businesses. Bowen
                                            currently must consummate a business combination by October 14, 2024, or by January
                                            14, 2025 if Bowen extends the time to complete a business combination pursuant to the
                                            Existing Charter).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
                                            are the funds in the Trust Account currently being held?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Trust Account is located in the United States with Continental, acting as trustee. Since
                                            the IPO, the funds in the Trust Account have been invested only in U.S. &#8220;government
                                            securities,&#8221; within the meaning of Section 2(a)(16) of the Investment Company Act of
                                            1940, as amended (the &#8220;<span style="font-weight: normal"><i>Investment Company Act</i></span>&#8221;),
                                            having a maturity of 185 days or less or in money market funds meeting certain conditions
                                            under Rule 2a-7 promulgated under the Investment Company Act, which invest only in direct
                                            U.S. government treasury obligations, as determined by Bowen.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            happens to the funds deposited in the Trust Account after completion of the Business Combination?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
                                            completion of the Business Combination, the funds in the Trust Account will be used to pay
                                            holders of Public Shares who exercise redemption rights and to pay transaction expenses in
                                            an amount currently anticipated to be approximately $[X] million (including a $2.415 million
                                            business combination marketing agreement fee payable to the IPO Underwriter pursuant
                                            to a business combination marketing agreement between Bowen and the IPO Underwriter), with
                                            the balance being used for working capital of New Bowen. On [X], 2024, the most recent practicable
                                            date prior to the date of this proxy statement/prospectus, the redemption price per share
                                            would have been approximately $[X], based on the aggregate amount on deposit in the Trust
                                            Account of approximately $[X] as of [X], 2024 (including interest not previously released
                                            to Bowen but net of expected taxes payable), divided by the total number of then outstanding
                                            Public Shares. The redemption price per share may increase between [X], 2024 and the date
                                            that is two business days prior to the Shareholder Meeting due to any interest that accrues
                                            on the amount on deposit in the Trust Account prior to such date, although we expect the
                                            redemption price two business days prior to the Shareholder Meeting will be approximately
                                            the same as the amount set forth above. These funds will not be released until the earlier
                                            of the completion of a business combination or Bowen&#8217;s liquidation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            conditions must be satisfied to complete the Business Combination?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
                                            to the terms of the Business Combination Agreement, and subject to applicable law, the consummation
                                            of the Business Combination is subject to a number of conditions set forth in the Business
                                            Combination Agreement including, among others, receipt of the requisite shareholder approvals
                                            contemplated by this proxy statement/prospectus. For a summary of the conditions that must
                                            be satisfied or waived prior to completion of the Business Combination, see the section entitled
                                            &#8220;<i>Shareholder Proposal No. 1: The Business Combination Proposal &#8212; Business
                                            Combination Agreement &#8212; Conditions to Closing</i>.&#8221;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>When
                                            do you expect the Business Combination to be completed?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            is currently expected that the Business Combination will be completed in the second half
                                            of 2024. This timing depends, among other things, on the approval of the proposals to be
                                            presented at the Shareholder Meeting. However, such meeting could be adjourned if the Adjournment Proposal is adopted at the Shareholder Meeting and Bowen elects to adjourn the
                                            Shareholder Meeting to a later date or dates if Bowen and Qianzhi mutually determine that
                                            additional time is required to consummate the Business Combination.</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
                                                                                                                                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><b>Q:</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Why
                                            is Bowen proposing the Name Change Proposal?</b></p>
</td></tr>
                                                                                                                                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
                                                                                                                                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><b>A:</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant
                                            to the Business Combination Agreement, Bowen and Qianzhi have mutually determined that Bowen
                                            shall change its name to &#8220;Emerald, Inc.&#8221; In the judgment of Bowen&#8217;s board
                                            of directors, changing the name of Bowen is desirable to reflect the Business Combination
                                            with Qianzhi and the combined business going forward. For more information, see the section
                                            entitled &#8220;<i>Shareholder Proposal No. 2: The Name Change Proposal.</i>&#8221;</p>
</td></tr>
                                                                                                                                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
                                                                                                                                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><b>Q:</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Why
                                            is Bowen proposing the Capitalization Amendment Proposal?</b></p>
</td></tr>
                                                                                                                                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
                                                                                                                                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><b>A:</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Pursuant
                                            to the Business Combination Agreement, Bowen and Qianzhi have mutually determined that the
                                            authorized share capital of Bowen shall be changed to $25,200, both with effect from the
                                            consummation of the Business Combination. In the judgment of Bowen&#8217;s board of directors,
                                            increasing the authorized number of ordinary shares is desirable for New Bowen to have sufficient
                                            shares for the issuances to the holders of Qianzhi&#8217;s stock in the Merger, including
                                            the Earnout Shares, to have enough additional authorized shares for issuance in the PIPE
                                            Financing contemplated by the Merger Agreement, and to have and have enough additional authorized
                                            shares for financing its business, for acquiring other businesses, for forming strategic
                                            partnerships and alliances, for stock dividends and stock splits, and for the 2024 Incentive
                                            Plan and other compensatory purposes. For more information, see the section entitled &#8220;<i>Shareholder
                                            Proposal No. 3: The Capitalization Amendment Proposal.</i>&#8221;</td></tr>
                                                                                                                                </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Why
                                            is Bowen proposing the Charter Amendment Proposals?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Pursuant
                                            to the Business Combination Agreement, Bowen and Qianzhi have mutually determined to remove
                                            the provisions of the Existing Charter dividing the Bowen board of directors into classes.
                                            The consequential amendments to the Existing Charter resulting from this change contemplated
                                            by the Board Unification Proposal, along with those changes contemplated by the Name Change
                                            Proposal and Capitalization Amendment Proposal to the extent each approved by the Bowen shareholders,
                                            along with removal of the non-substantive non-governance provisions of the Existing Charter
                                            applicable to special purpose acquisition companies, will be reflected in the Proposed Charter
                                            to be adopted pursuant to the Proposed Charter Adoption Proposal. For more
                                            information, see the sections entitled &#8220;<i>Shareholder Proposal No. 4: The
                                            Board Unification Proposal</i>&#8221; and &#8220;<i>Shareholder Proposal No. 5: The Proposed
                                            Charter Adoption Proposal.</i>&#8221;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Why
                                            is Bowen proposing the Nasdaq Proposal?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
                                            to Nasdaq Listing Rule 5635(a)(1), when a Nasdaq-listed company proposes to issue securities
                                            in connection with the acquisition of the stock or assets of another company, shareholder
                                            approval is required if the shares have or will have upon issuance voting power equal to
                                            or in excess of 20% of the voting power outstanding before the issuance of securities or
                                            the number of shares to be issued is or will be equal to or in excess of 20% of the number
                                            of shares outstanding before the issuance of the shares. Additionally, under Nasdaq Listing
                                            Rule 5635(b), shareholder approval is required prior to the issuance of securities when the
                                            issuance or potential issuance will result in a change of control of the registrant. Because
                                            the number of Bowen Ordinary Shares to be issued in the Merger will exceed 20% of the outstanding
                                            number of Bowen Ordinary Shares prior to the Merger and will result in a change of control,
                                            shareholder approval is required under these rules.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the Nasdaq Proposal is not approved by the holders of Bowen Ordinary Shares, the Business Combination cannot be consummated.
In the event that the Nasdaq Proposal is approved by the holders of Bowen Ordinary Shares, but the Business Combination is not consummated,
Bowen will not issue Bowen Ordinary Shares. For more information, see the section entitled &#8220;<i>Shareholder Proposal No. 6:
The Nasdaq Proposal</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Why
                                            is Bowen proposing the Equity Incentive Plan Proposal?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            purpose of the 2024 Incentive Plan is to enable New Bowen to offer eligible employees, directors
                                            and consultants cash and stock-based incentive awards in order to attract, retain and reward
                                            these individuals and strengthen the mutuality of interests between them and New Bowen&#8217;s
                                            shareholders. For more information, see the section entitled &#8220;<i>Shareholder Proposal
                                            No. 7: The Equity Incentive Plan Proposal</i>.&#8221;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Why
                                            is Bowen proposing the Director Election Proposal?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Director Election Proposal will allow Bowen to satisfy its requirements under Nasdaq rules
                                            to hold a meeting at which shareholders can elect directors. The Director Election Proposal
                                            will also enable New Bowen to have the New Bowen Board comprised of the individuals Bowen
                                            and Qianzhi agreed to nominate for election to the New Bowen Board pursuant to the Business
                                            Combination Agreement. For more information, see the section entitled &#8220;<i>Shareholder
                                            Proposal No. 8: The Director Election Proposal</i>.&#8221;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Why
                                            is Bowen proposing the Adjournment Proposal?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
                                            Shareholders are also being asked to consider and vote upon the Adjournment Proposal to approve
                                            the adjournment of the Shareholder Meeting to a later date or dates if Bowen and Qianzhi
                                            determine that more time is necessary to consummate the Business Combination for any reason.
                                            For more information, see the section entitled &#8220;<i>Shareholder Proposal No. 9:
                                            The Adjournment Proposal</i>.&#8221;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>When
                                            and where will the Shareholder Meeting be held?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Shareholder Meeting will be held on [&#9679;], 2024, at [&#9679;] [a.m./p.m.], Eastern Time,
                                            as a virtual meeting, or at such other time, on such other date and at such other place to
                                            which the meeting may be postponed or adjourned. Only shareholders who hold Bowen Ordinary
                                            Shares at the close of business on the Record Date will be entitled to vote at the Shareholder
                                            Meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
can participate in the meeting, vote and submit questions via live webcast by visiting <i>https://www.cstproxy.com/bowenacquisition/[&#9679;]</i>.
Please see &#8220;<i>&#8212; How do I attend the virtual Shareholder Meeting?</i>&#8221; for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
                                            is entitled to vote at the Shareholder Meeting?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
                                            has fixed [&#9679;], 2024 as the Record Date. If you are a shareholder of Bowen at the close
                                            of business on the Record Date, you are entitled to vote on matters that come before the
                                            Shareholder Meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
                                            do I vote?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you were a holder of record of Bowen Ordinary Shares on the Record Date, you may vote with
                                            respect to the proposals electronically, or by completing, signing, dating and returning
                                            the enclosed proxy card in the postage-paid envelope provided.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting
by Mail</i></b>. By signing the proxy card and returning it in the enclosed prepaid and addressed envelope, you are authorizing the individuals
named on the proxy card to vote your shares at the Shareholder Meeting in the manner you indicate. You are encouraged to sign and return
the proxy card even if you plan to attend the Shareholder Meeting so that your shares will be voted if you are unable to attend the Shareholder
Meeting. If you receive more than one proxy card, it is an indication that your shares are held in multiple accounts. Please sign and
return all proxy cards to ensure that all of your shares are voted. Votes submitted by mail must be received by 5:00 p.m., Eastern Time,
on [&#9679;], 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting
Electronically</i></b>. You may attend and vote at the Shareholder Meeting by visiting <i>https://www.cstproxy.com/bowenacquisition/[&#9679;]
</i>and entering the control number found on your proxy card or notice included in the proxy materials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
who hold their investments through a broker, bank or other nominee should follow the directions provided by their broker, bank or other
nominee to vote their Bowen Ordinary Shares. For more information, see &#8220;<i>&#8212; If my shares are held in &#8216;street name,&#8217;
will my broker, bank or nominee automatically vote my shares for me?</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
                                            do I attend the virtual Shareholder Meeting?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you are a registered shareholder as of the Record Date, you will receive a proxy card from
                                            Continental, acting as transfer agent. The form contains instructions on how to attend the
                                            virtual Shareholder Meeting including the URL address, along with your control number. You
                                            will need your control number for access. If you do not have your control number, contact
                                            Continental at 917-262-2373, or email proxy@continentalstock.com.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
can pre-register to attend the virtual Shareholder Meeting starting [&#9679;], 2024, at 9:00 a.m., Eastern Time (two business days prior
to the meeting date). Enter the URL address into your browser <i>https://www.cstproxy.com/bowenacquisition/[&#9679;]</i>, enter your
control number, name and email address. Once you pre-register, you can vote or enter questions in the chat box. At the start of the Shareholder
Meeting, you will need to log in again using your control number and will also be prompted to enter your control number if you vote during
the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you do not have access to Internet, you can listen only to the meeting by dialing [&#9679;] (or [&#9679;] if you are located outside
the United States and Canada (standard rates apply))] and when prompted enter the pin number [&#9679;]#. Please note that you will not
be able to vote or ask questions at the Shareholder Meeting if you choose to participate telephonically.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
who hold their investments through a broker, bank or other nominee will need to contact Continental to receive a control number to attend
the virtual Shareholder Meeting. If you plan to vote at the Shareholder Meeting, you will need to have a legal proxy from your bank or
broker or, if you would like to join and not vote, Continental will issue you a guest control number with proof of ownership. In either
case you must contact Continental for specific instructions on how to receive the control number. Continental can be contacted at the
number or email address above. Please allow up to 72 hours prior to the meeting for processing your control number.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
                                            my shares are held in &#8220;street name,&#8221; will my broker, bank or nominee automatically
                                            vote my shares for me?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            your shares are held in &#8220;street name&#8221; in a stock brokerage account or by a broker,
                                            bank or other nominee, you must provide the record holder of your shares with instructions
                                            on how to vote your shares. Please follow the directions provided by your broker, bank or
                                            other nominee to submit a voting instruction card or otherwise communicate your voting instructions
                                            to your broker, bank or other nominee. Please note that you may not vote shares held in &#8220;street
                                            name&#8221; by returning a proxy card directly to Bowen or by voting online at the Shareholder
                                            Meeting unless you provide a &#8220;legal proxy,&#8221; which you must obtain from your broker,
                                            bank or other nominee.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the rules of the New York Stock Exchange, brokers who hold shares in &#8220;street name&#8221; for a beneficial owner of those shares
typically have the authority to vote in their discretion on &#8220;routine&#8221; proposals when they have not received instructions
from beneficial owners. However, brokers are not permitted to exercise their voting discretion with respect to the approval of matters
that Nasdaq determines to be &#8220;non-routine&#8221; without specific instructions from the beneficial owner. The Business Combination
Proposal, the Name Change Proposal, the Capitalization Amendment Proposal, the Charter Amendment Proposals, the Nasdaq Proposal,
the Equity Incentive Plan Proposal, the Director Election Proposal and the Adjournment Proposal are &#8220;non-routine&#8221;
matters and therefore, brokers are not permitted to exercise their voting discretion with respect to these proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold your shares of Bowen in &#8220;street name&#8221; and you do not instruct your broker, bank or other nominee on how to vote
your shares, your broker, bank or other nominee will not vote your shares on the Business Combination Proposal, the Name Change Proposal,
the Capitalization Amendment Proposal, the Charter Amendment Proposals, the Nasdaq Proposal, the Equity Incentive Plan Proposal and
the Director Election Proposal. Accordingly, your bank, broker, or other nominee can vote your shares on the Business Combination Proposal,
the Name Change Proposal, the Capitalization Amendment Proposal, the Charter Amendment Proposals, the Nasdaq Proposal, the Equity
Incentive Plan Proposal, the Director Election Proposal and the Adjournment Proposal at the Shareholder Meeting only if you provide instructions
on how to vote. You should instruct your broker to vote your shares as soon as possible in accordance with directions you provide. If
your broker does not vote, it will have no effect on the Business Combination Proposal, the Name Change Proposal, the Capitalization
Amendment Proposal, the Charter Amendment Proposals, the Nasdaq Proposal, the Equity Incentive Plan Proposal, the Director Election
Proposal or the Adjournment Proposal. However, if your broker does not vote, your shares will not be counted as present for
the purposes of establishing a quorum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            proposals must be passed in order for the Business Combination to be completed?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Business Combination will not be completed unless the Business Combination Proposal is approved.
                                            In addition, the Business Combination will not be completed unless the Name Change Proposal,
                                            the Capitalization Amendment Proposal, the Charter Amendment Proposals, the Nasdaq Proposal,
                                            the Equity Incentive Plan Proposal and the Director Election Proposal are approved, or the
                                            corresponding conditions set forth in the Business Combination Agreement are waived by the
                                            parties. If Bowen does not complete a Business Combination by the date required by the Existing
                                            Charter, Bowen is required to cease all operations except for the purpose of winding up,
                                            redeeming out of funds lawfully available therefor all then outstanding Public Shares, and
                                            dissolve and liquidate, subject in each case to Bowen&#8217;s obligations under the Cayman
                                            Companies Act to provide for claims of creditors and other requirements of applicable law.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
                                            does the Bowen Board recommend that I vote?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Bowen Board unanimously recommends that Bowen&#8217;s shareholders entitled to vote on the
                                            proposals vote as follows:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR&#8221;
                                            approval of the Business Combination Proposal;</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
                                                                                                           <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#8220;FOR&#8221;
                                            approval of the Name Change Proposal;</td></tr>
                                                                                                           <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
                                                                                                           <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#8220;FOR&#8221;
                                            approval of the Capitalization Amendment Proposal;</td></tr>
                                                                                                           </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR&#8221;
                                            approval of each of the Charter Amendment Proposals;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR&#8221;
                                            approval of the Nasdaq Proposal;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR&#8221;
                                            approval of the Equity Incentive Plan Proposal;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR&#8221;
                                            approval of the Director Election Proposal; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR&#8221;
                                            approval of the Adjournment Proposal, if presented.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
                                            many votes do I have?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
                                            Shareholders have one vote per each Bowen Ordinary Share held by them on the Record Date
                                            for each of the proposals to be voted upon.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
                                            are Bowen&#8217;s Sponsors?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen&#8217;s
                                                                                                                                                                   Sponsors are Bowen Holding, a Delaware limited liability company, and Createcharm, a British Virgin Islands company. The Sponsors
                                                                                                                                                                   are affiliated with the officers and directors of Bowen. The Sponsors collectively currently own an aggregate of 2,066,782 Bowen
                                                                                                                                                                   Ordinary Shares and 34,178 Bowen Rights (including the Bowen Ordinary Shares and Bowen Rights included in the Bowen Private Units
                                                                                                                                                                   purchased by Createcharm in connection with the IPO), consisting of 569,250 Founder Shares held by Bowen Holding LP,
                                                                                                                                                                   155,750 Founder Shares held by Createcharm and 341,782 Bowen Ordinary Shares and 34,178 Bowen Rights included in the Bowen Private
                                                                                                                                                                   Units purchased by Createcharm in connection with the IPO. Bowen&#8217;s Sponsors and their involvement with Bowen and interests in
                                                                                                                                                                   the Business Combination are described further in the section of this proxy statement/prospectus entitled, &#8220;<i>Information
                                                                                                                                                                   About Bowen &#8211; SPAC Sponsors</i> and their Affiliates&#8221;.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
                                            do the Sponsors and Bowen&#8217;s directors and officers intend to vote?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Insiders have agreed, subject to applicable securities laws, to vote any Bowen Ordinary Shares
                                            owned by them in favor of all of the proposals presented at the Shareholder Meeting. The
                                            Insiders also have agreed to waive their redemption rights with respect to any Bowen Ordinary
                                            Shares owned by them in connection with the Shareholder Meeting. On the Record Date, the
                                            Insiders beneficially owned and were entitled to vote an aggregate of 2,066,782 Bowen Ordinary
                                            Shares, representing approximately 22.2% of Bowen&#8217;s issued and outstanding Bowen Ordinary
                                            shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            interests do the Insiders, including Bowen&#8217;s officers and directors, have that are
                                            different than the Public Shareholders?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
                                            you consider the recommendation of the Bowen Board in favor of approval of the Business Combination
                                            Proposal, you should keep in mind that the Insiders, including Bowen&#8217;s directors and
                                            executive officers, have interests in such proposal that are different from, or in addition
                                            to, those of Public Shareholders generally. These interests include, among other things,
                                            the interests described below:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that the Sponsors and Bowen&#8217;s officers and directors have certain economic interests
                                            in the Business Combination including:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Sponsors paid an aggregate of $25,000 for 1,725,000 Founder Shares currently owned by the
                                            Sponsors, in which certain of Bowen&#8217;s directors and executive officers hold an indirect interest. The Insiders have agreed to waive their redemption rights with
                                            respect to their Founder Shares and any Public Shares they hold in connection with the Business
                                            Combination and to waive their rights to liquidating distributions from the Trust Account
                                            with respect to any Founder Shares held by them if the Business Combination is not approved
                                            and Bowen fails to complete a business combination within the required time period. Accordingly,
                                            the Founder Shares would be worthless if the Business Combination or another business combination
                                            is not consummated within the required time period because the holders thereof are not entitled
                                            to participate in any redemption or liquidation distribution with respect to such shares.
                                            Such securities may have a significantly higher value at the time of the Business Combination,
                                            and if unrestricted and freely tradable would be valued at approximately $[X] based upon
                                            the closing price of $[X] per Bowen Ordinary Share on Nasdaq on [X], 2024;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Createcharm paid an aggregate of $3,417,820</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                            for 341,782 Bowen Private Units. Such securities may have a higher value at the time of the
                                            Business Combination and, if unrestricted and freely tradable, would be valued at approximately
                                            $[X], based upon the closing price of $[X] per Public Unit on Nasdaq on [X], 2024;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Sponsors and Bowen&#8217;s officers and directors will lose their entire investment in Bowen
                                            and will not be reimbursed for any loans extended, fees due or out-of-pocket expenses incurred
                                            on Bowen&#8217;s behalf related to identifying, investigating, negotiating and completing
                                            an initial business combination if the Business Combination is not consummated within the
                                            required time period. As of the date of this proxy statement/prospectus, there is an aggregate
                                            principal amount of $[X] of outstanding loans payable to the SPAC Sponsors and $[X] in
                                            aggregate fees due and out-of-pocket expenses to be repaid by Bowen;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accordingly,
                                            based on the value of the Bowen securities invested in and the amount of the
                                            loans and unreimbursed expenses as set forth above, the aggregate amount that the SPAC
                                            Sponsors and Bowen&#8217;s officers and directors have at risk is $[3,442,820 ($3,434,570
                                            by  Createcharm and $8,250 by Bowen Holding)];</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            addition, the SPAC Sponsors and their affiliates can earn a positive rate of
                                            return on their investment, even if other Bowen shareholders experience a negative rate of
                                            return;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            Bowen entered into an agreement, commencing on the date its securities were first listed
                                            on Nasdaq and up to the earlier of the consummation of a business combination or its liquidation,
                                            to pay Bowen Holding LP a monthly fee of US$10,000 for office space, secretarial and administrative
                                            support;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that pursuant to the Business Combination Agreement, Bowen has the right to designate
                                            one director to the New Bowen Board post-Closing. Such director, in the future, may receive
                                            any cash fees, stock options or stock awards that the New Bowen Board determines to pay to
                                            its directors. Bowen has designated Jun Zhang to be a director on the New Bowen Board post-Closing;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that the Business Combination Agreement provides for the continued indemnification of
                                            Bowen&#8217;s existing directors and officers and requires New Bowen to purchase, at or prior
                                            to the Closing, and maintain in effect for a period of six years after the Closing, a &#8220;tail&#8221;
                                            policy providing directors&#8217; and officers&#8217; liability insurance coverage for certain
                                            Bowen directors and officers after the Business Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that if the Trust Account is liquidated, including in the event Bowen is unable to complete
                                            an initial business combination within the required time period, each of the Sponsors has
                                            agreed to indemnify Bowen to ensure that the proceeds in the Trust Account are not reduced
                                            below $10.10 per Public Share, or such lesser per share amount as is in the Trust Account,
                                            by the claims of prospective target businesses with which Bowen has entered into an acquisition
                                            agreement or claims of any third party for services rendered or products sold to Bowen, but
                                            only if such a vendor or target business has not executed a waiver of any and all rights
                                            to seek access to the Trust Account; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that if the Business Combination or another business combination is not consummated
                                            within the required time period, Bowen will cease all operations except for the purpose of
                                            winding up, redeeming 100% of the outstanding Public Shares for cash and, subject to the
                                            approval of its remaining shareholders and the Bowen Board, dissolving and liquidating.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
personal and financial interests of the Insiders as well as Bowen&#8217;s executive officers and directors may have influenced their
motivation in identifying and selecting Qianzhi as a business combination target, completing the Business Combination with Qianzhi and
influencing the operation of the business following the Business Combination. The existence of such financial and personal interests
may result results in conflicts of interest on the part of such executive officers, directors and Insiders between what he, she, or they
may believe is in the best interests of Bowen and what he, she, or they may believe is best for himself, herself, or themselves in determining
to recommend that shareholders vote for the proposals. In considering the recommendations of the Bowen Board to vote for the proposals,
its shareholders should consider these interests. See this section entitled &#8220;<i>Shareholder Proposal No. 1: The Business Combination
Proposal &#8212; Interests of Certain Persons in the Business Combination.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            are the material U.S. federal income tax consequences of the Business Combination?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
                                            Shareholders who do not exercise their redemption rights will retain their Bowen Ordinary
                                            Shares and will not receive any additional Bowen Ordinary Shares or other consideration in
                                            the Merger. As a result, there will be no material U.S. federal income tax consequences as
                                            a result of the Merger to the current holders of Bowen Ordinary Shares, regardless of whether
                                            the Merger qualifies as a &#8220;reorganization&#8221; within the meaning of Section 368(a)
                                            of the Code. Furthermore, although the Merger should qualify as a &#8220;reorganization&#8221;
                                            within the meaning of Section 368(a) of the Code, and the parties to the Merger Agreement
                                            intend to report the Merger consistent with such qualification, such treatment is not a condition
                                            to completion of the Merger. If the Business Combination so qualifies, no gain or loss
                                            should be recognized by U.S. Holders as a result of the Business Combination. If the Business
                                            Combination does not so qualify as a reorganization within the meaning of Section 368(a)
                                            of the Code, it will be treated as a taxable stock sale. See the section entitled &#8220;<i>Material
                                            United States Federal Income Tax Considerations &#8212; U.S. Federal Income Taxation of U.S.
                                            Holders &#8212; Material U.S. Federal Income Tax Effects of the Business Combination</i>.&#8221;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            constitutes a quorum?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            quorum of our shareholders is necessary to hold a valid meeting. The presence, in person
                                            virtually or by proxy, of shareholders holding a majority of the Bowen Ordinary Shares entitled
                                            to vote at the Shareholder Meeting constitutes a quorum at the Shareholder Meeting. Abstentions
                                            will be considered present for the purposes of establishing a quorum. The Sponsors, who
                                            beneficially own approximately 22.2% of the issued and outstanding Bowen Ordinary Shares
                                            as of the Record Date, will count towards this quorum. In the absence of a quorum, Bowen&#8217;s
                                            directors have the power to adjourn the Shareholder Meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            vote is required to approve the proposals presented at the Shareholder Meeting?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            approval of each of the Name Change Proposal, the Capitalization Amendment Proposal and
                                            the Charter Amendment Proposals requires a special resolution under Cayman Islands
                                            law, being the affirmative vote of the holders of at least two-thirds (2/3) of the Bowen
                                            Ordinary Shares represented in person virtually or by proxy and entitled to vote thereon
                                            and who vote at the Shareholder Meeting at which a quorum is present. The approval of each
                                            of the other proposals requires an ordinary resolution, being the
                                            affirmative vote of the holders of a majority of the Bowen Ordinary Shares represented in
                                            person virtually or by proxy and entitled to vote thereon and who vote at the Shareholder
                                            Meeting at which a quorum is present. The Sponsors and the Insiders have agreed, subject to applicable securities
laws, to vote any ordinary shares owned by them in favor of the Business Combination Proposal. This is unlike some other similarly structured
transactions where the insiders vote in accordance with the public holders and therefore a majority of unaffiliated shareholders would
be required to approve a proposed transaction. Because the Sponsors and Insiders vote in favor of the Business Combination Proposal, the
transaction is not structured such that the vote of a majority of unaffiliated shareholders is required to approve the Business Combination
Proposal.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            if I do not want to vote &#8220;FOR&#8221; any of the proposals?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you do not want any of the proposals to be approved, you should vote &#8220;AGAINST&#8221;
                                            such proposal.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you attend the Shareholder Meeting in person virtually or by proxy, you may vote &#8220;AGAINST&#8221; the proposals and your Bowen Ordinary
Shares will be counted for the purposes of determining whether the proposals (as the case may be) are approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
if you fail to attend the Shareholder Meeting in person virtually or by proxy, or if you do attend the Shareholder Meeting in person
virtually or by proxy but you abstain or otherwise fail to vote at the Shareholder Meeting (including as a result of a broker non-vote),
your Bowen Ordinary Shares will not be counted for the purposes of determining whether any proposal is approved. Accordingly, your abstention
or failure to vote (including as a result of a broker non-vote) will have no effect on the outcome of such proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Adjournment Proposal only will be put forth for a vote if Bowen and Qianzhi mutually determine that additional time is required
to consummate the Business Combination for any reason.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            happens if the Business Combination is not consummated?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Business Combination or another initial business combination is not completed within
                                            the required time period provided for in the Existing Charter, then as contemplated by and
                                            in accordance with the Existing Charter, Bowen will: (i) cease all operations except for
                                            the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten
                                            business days thereafter subject to lawfully available funds therefor, redeem 100% of the
                                            Public Shares in consideration of a per-share price, payable in cash, equal to the quotient
                                            obtained by dividing (A) the aggregate amount then on deposit in the Trust Account, including
                                            interest not previously released to Bowen to pay its taxes (less up to $100,000 of such net
                                            interest to pay dissolution expenses), by (B) the total number of then outstanding Public
                                            Shares, which redemption will completely extinguish rights of the Public Shareholders (including
                                            the right to receive further liquidating distributions, if any), subject to applicable law
                                            and (iii) as promptly as reasonably possible following such redemption, subject to the approval
                                            of the remaining shareholders and the Bowen Board in accordance with applicable law, dissolve
                                            and liquidate, subject in each case to Bowen&#8217;s obligations under the Cayman Companies
                                            Act to provide for claims of creditors and other requirements of applicable law.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors waived their right to participate in any liquidation distribution with respect to the 1,725,000 Founder Shares and the 312,000
Bowen Private Shares owned by them. There will be no distribution from the Trust Account with respect to the Bowen Rights, which will
expire worthless in the event Bowen dissolves and liquidates the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>May
                                            I change my vote after I have mailed my signed proxy card?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
                                            Shareholders of record may send a later-dated, signed proxy card to Bowen Acquisition Corp.
                                            at 420 Lexington Avenue, Room 2446, New York, New York 10170, so that it is received by Bowen
                                            prior to the vote at the Shareholder Meeting (which is scheduled to take place on [&#9679;],
                                            2024) or attend the virtual Shareholder Meeting and vote electronically. Shareholders also
                                            may revoke their proxy by sending a notice of revocation to Bowen&#8217;s Chief Executive
                                            Officer, which must be received by Bowen&#8217;s Chief Executive Officer prior to the vote
                                            at the Shareholder Meeting. However, if your shares are held in &#8220;street name&#8221;
                                            by your broker, bank or another nominee, you must contact your broker, bank or other nominee
                                            to change your vote.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
                                            are votes counted?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Votes
                                            will be counted by the inspector of election appointed for the Shareholder Meeting, who will
                                            separately count &#8220;FOR&#8221; and &#8220;AGAINST&#8221; votes, abstentions and broker
                                            non-votes, if any. Shareholders who attend the Shareholder Meeting, either in person virtually
                                            or by proxy, will be counted (and the number of Bowen Ordinary Shares held by such shareholders
                                            will be counted) for the purposes of determining whether a quorum is present at the Shareholder
                                            Meeting. The presence, in person virtually or by proxy, of shareholders holding a majority
                                            of the Bowen Ordinary Shares entitled to vote at the Shareholder Meeting constitutes a quorum
                                            at the Shareholder Meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
                                            I am not going to attend the Shareholder Meeting, should I return my proxy card instead?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
                                            Whether you plan to attend the Shareholder Meeting virtually or not, please read the enclosed
                                            proxy statement/prospectus carefully, and vote your shares by completing, signing, dating
                                            and returning the enclosed proxy card in the postage-paid envelope provided.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            will happen if I return my proxy card without indicating how to vote?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you sign and return your proxy card without indicating how to vote on any particular proposal,
                                            the Ordinary Shares represented by your proxy will be voted in favor of each proposal. Proxy
                                            cards that are returned without a signature will not be counted as present at the Meeting
                                            and cannot be voted.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            happens if I sell my shares before the Shareholder Meeting?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Record Date for the Shareholder Meeting is earlier than the date of the Shareholder Meeting,
                                            as well as the date that the Business Combination is expected to be consummated. If you transfer
                                            your Bowen Ordinary Shares after the Record Date, but before the Shareholder Meeting, unless
                                            the transferee obtains from you a proxy to vote those shares, you would retain your right
                                            to vote at the Shareholder Meeting, but will transfer ownership of the shares and will not
                                            hold an interest in Bowen after the Business Combination is consummated.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Are
                                            there risks associated with the Business Combination that I should consider in deciding how
                                            to vote?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
                                            There are a number of risks related to the Business Combination and other transactions contemplated
                                            by the Business Combination Agreement, that are discussed in this proxy statement/prospectus.
                                            Please read with particular care the detailed description of the risks described in &#8220;<i>Risk
                                            Factors</i>&#8221; beginning on page 47 of this proxy statement/prospectus.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
                                            I am a holder of Bowen Ordinary Shares, do I have appraisal rights if I object to the Business
                                            Combination Proposal?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.
                                            There are no appraisal rights available to Bowen&#8217;s shareholders in connection with
                                            the Business Combination Proposal. However, as described herein, holders of Public Shares
                                            may exercise redemption rights in connection with the Business Combination Proposal.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
                                            do I exercise my redemption rights?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you are a holder of Public Shares and wish to exercise your right to have your Public Shares
                                            redeemed in connection with the Business Combination Proposal, you must:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prior
                                            to 5:00 p.m., Eastern Time, on [&#9679;], 2024 (two business days prior to the initially
                                            scheduled vote at the Shareholder Meeting) submit a written request to Continental, acting
                                            as transfer agent, that Bowen redeem all or a portion of your Public Shares for cash; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">deliver
                                            your Public Shares to Continental, physically or electronically through DTC no later than
                                            two business days prior to the Shareholder Meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
address of Continental is listed under the question &#8220;&#8212; <i>Who can help answer my questions?</i>&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Bowen Units must elect to separate the underlying Public Shares and Public Rights prior to exercising redemption rights with respect
to the Public Shares. If holders hold their Bowen Units in an account at a brokerage firm or bank, holders must notify their broker or
bank that they elect to separate the Bowen Units into the underlying Public Shares and Public Rights, or if a holder holds Bowen Units
registered in its own name, the holder must contact Continental directly and instruct it to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination Proposal, any holder of Public Shares will be entitled to request that their Public Shares be
redeemed for a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of
two business days prior to the Shareholder Meeting, including interest earned on the funds held in the Trust Account and not previously
released to Bowen to pay its taxes (which interest shall be net of taxes payable), divided by the number of then-outstanding Public Shares.
As of [X], 2024, this would have amounted to approximately $[X] per Public Share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
the proceeds deposited in the Trust Account could become subject to the claims of our creditors, if any, which have priority over the
redemption rights of Public Shareholders. Therefore, the per share distribution from the Trust Account in such a situation may be less
than originally anticipated due to such claims. We anticipate that the funds to be distributed to Public Shareholders electing to redeem
their Public Shares will be distributed promptly after the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
request for redemption, once made by a holder of Public Shares, may be withdrawn at any time until the deadline for exercising redemption
requests. If you tender or deliver your shares for redemption to Continental, acting as transfer agent, and later decide prior to the
deadline for exercising redemption requests not to elect redemption, you may request that Bowen instruct Continental to return the shares
(physically or electronically). You may make such request by contacting Continental at the phone number or address listed at the end
of this section. We will be required to honor such request only if made prior to the deadline for exercising redemption requests (although
the Bowen Board may agree to honor such requests after such deadline in its sole discretion).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
request for redemption will be honored unless the holder&#8217;s shares have been tendered or delivered (either physically or electronically)
to Continental by 5:00 p.m., Eastern Time, on [&#9679;], 2024 (two business days prior to the initially scheduled date of the Shareholder
Meeting).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a holder of Public Shares properly makes a request for redemption and the Public Shares are tendered or delivered as described above,
then, Bowen will, subject to the availability of lawful funds and consummation of the Business Combination, redeem Public Shares for
a pro rata portion of funds deposited in the Trust Account, calculated as of two business days prior to the Shareholder Meeting. If you
are a holder of Public Shares and you exercise your redemption rights, it will not result in the loss of any Public Rights that you may
hold.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Shareholder Meeting is abandoned for any reason, then holders of Public Shares shall not have the right to redeem their Public Shares
at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Am
                                            I required to vote against the Business Combination Proposal in order to have my Ordinary
                                            Shares redeemed?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.
                                            You are not required to vote against the Business Combination Proposal, or to vote at all,
                                            in order to have the right to demand that Bowen redeem your Ordinary Shares for cash equal
                                            to your pro rata share of the aggregate amount then on deposit in the Trust Account (including
                                            interest earned on their pro rata portion of the Trust Account, net of taxes payable). If
                                            the Business Combination is not completed, holders of Bowen Ordinary Shares electing to exercise
                                            their redemption rights will not be entitled to receive such payments and their Ordinary
                                            Shares will be returned to them.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
                                            I am a holder of Bowen Units, can I exercise redemption rights with respect to my Bowen Units?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.
                                            Holders of issued and outstanding Bowen Units must elect to separate the Bowen Units into
                                            the underlying Public Shares and Public Rights prior to exercising redemption rights with
                                            respect to the Public Shares. If you hold your Bowen Units in an account at a brokerage firm
                                            or bank, you must notify your broker or bank that you elect to separate the Bowen Units into
                                            the underlying Public Shares and Public Rights or, if you hold Bowen Units registered in
                                            your own name, you must contact Continental, as transfer agent, directly and instruct them
                                            to do so. You are required to cause your Public Shares to be separated and delivered to Continental
                                            by 5:00 p.m., Eastern Time, on [&#9679;], 2024 (two business days before the Shareholder
                                            Meeting) in order to exercise your redemption right with respect to your Public Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            are the U.S. federal income tax consequences of exercising my redemption rights?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. federal income tax consequences of exercising redemption rights depend on a holder&#8217;s particular facts and circumstances. See
the section entitled &#8220;&#8212;Material United States Federal Income Tax Considerations &#8212; U.S. Federal Income Tax Consequences
to U.S. Holders of Bowen Securities of Exercising Redemption Rights.&#8221; You are urged to consult your tax advisor regarding the tax
consequences of exercising your redemption rights.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            should I do if I receive more than one set of voting materials for the Shareholder Meeting?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            may receive more than one set of voting materials for the Shareholder Meeting, including
                                            multiple copies of this proxy statement/prospectus and multiple proxy cards or voting instruction
                                            cards. For example, if you hold your shares in more than one brokerage account, you will
                                            receive a separate voting instruction card for each brokerage account in which you hold shares.
                                            If you are a holder of record and your shares are registered in more than one name, you will
                                            receive more than one proxy card. Please complete, sign, date and return each proxy card
                                            and voting instruction card that you receive, or follow the directions to submit your proxy
                                            or voting instructions online, in order to cast your vote with respect to all of your shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
                                            will solicit and pay the cost of soliciting proxies for the Shareholder Meeting?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
                                            will pay the cost of soliciting proxies for the Shareholder Meeting. Bowen has engaged Laurel
                                            Hill Advisory Group to assist in the solicitation of proxies for the Shareholder Meeting
                                            and will pay Laurel Hill Advisory Group a fee for such services. Bowen will also reimburse
                                            banks, brokers and other custodians, nominees and fiduciaries representing beneficial owners
                                            of Public Shares for their expenses in forwarding soliciting materials to beneficial owners
                                            of Public Shares and in obtaining voting instructions from those owners. The directors, officers
                                            and employees of Bowen may also solicit proxies by telephone, by facsimile, by mail or on
                                            the Internet, but they will not be paid any additional amounts for soliciting proxies.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            do I need to do now?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            are urged to read carefully and consider the information contained in this proxy statement/prospectus
                                            and to consider how the Business Combination Proposal, the Charter Amendment Proposals, the
                                            Nasdaq Proposal, the Equity Incentive Plan Proposal, the Director Election Proposal and the Adjournment Proposal will affect you as a shareholder. You should then vote as
                                            soon as possible in accordance with the instructions provided in this proxy statement/prospectus
                                            and on the enclosed proxy card or, if you hold your shares through a brokerage firm, bank
                                            or other nominee, on the voting instruction form provided by the broker, bank or nominee,
                                            and determine if you desire to exercise redemption rights in connection with the Business
                                            Combination Proposal.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
                                            can help answer my questions?</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you have questions about the proposals or if you need additional copies of this proxy statement
                                            or the enclosed proxy card you should contact:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laurel
Hill Advisory Group</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ADDRESS]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
also may obtain additional information about Bowen from documents filed with the SEC by following the instructions in the section entitled
&#8220;<i>&#8212; Where You Can Find More Information.</i>&#8221; If you are a holder of Public Shares and you intend to seek redemption
of your shares, you will need to tender or deliver your Public Shares (and share certificates (if any) and other redemption forms) (either
physically or electronically) to Continental, acting as transfer agent, at the address below prior to 5:00 p.m., Eastern Time, on [&#9679;],
2024 (two business days prior to the date of the Shareholder Meeting). If you have questions regarding the certification of your position
tendering or delivery of your shares, please contact:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continental
Stock Transfer &amp; Trust Company<br/>
1 State Street Plaza, 30<sup>th</sup> Floor<br/>
New York, New York 10004<br/>
Attn: SPAC Redemption Team<br/>
E-mail: spacredemptions@continentalstock.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_006"></span>SUMMARY
OF THE PROXY STATEMENT/PROSPECTUS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary highlights selected information from this proxy statement/prospectus and may not contain all of the information that is important
to you. To better understand the Proposals to be submitted for a vote at the Shareholder Meeting, whether or not you plan to attend such
meeting, you should read this entire document carefully, including the Business Combination Agreement, attached as <i><span style="text-decoration: underline">Annex A</span></i>
to this proxy statement/prospectus. The Business Combination Agreement is the legal document that governs the Business Combination and
the other transactions that will be undertaken in connection therewith. The Business Combination Agreement is also described in detail
in this proxy statement/prospectus in the section entitled &#8220;<i>The Business Combination Agreement</i>.&#8221; This proxy statement/prospectus
also includes forward-looking statements that involve risks and uncertainties. See &#8220;<i>Cautionary Statement Regarding Forward-Looking
Statements</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties
to the Business Combination</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
is a blank check company incorporated on February 17, 2023, as a Cayman Islands exempted company for the purpose of effecting a merger,
stock exchange, asset acquisition, stock purchase, reorganization or similar business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 27, 2023, Bowen Holding, one of the Sponsors, acquired an aggregate of 1,725,000 Bowen Ordinary Shares for an aggregate
purchase price of $25,000. Thereafter, it transferred an aggregate of 1,155,750 Bowen Ordinary Shares to Createcharm, Bowen&#8217;s
other Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 14, 2023, Bowen consummated the IPO of 6,000,000 of its Bowen Units. Each Unit consists of one Bowen Ordinary Share and one Right,
each Right entitling the holder thereof to receive one-tenth of one Bowen Ordinary Share upon the completion of an initial business combination.
The Public Units were sold at an offering price of $10.00 per Public Unit, generating gross proceeds of $60,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the consummation of the IPO, Bowen consummated the private placement of 330,000 Bowen Private Units at a price of $10.00 per Bowen
Private Unit, generating total proceeds of $3,300,000. The Bowen Private Units were purchased by Createcharm (312,000 Bowen Private
Units) and the IPO Underwriter (18,000 Bowen Private Units). The Bowen Private Units are identical to the Bowen Units included in the Public Units sold
in the IPO. The purchasers of the Bowen Private Units have agreed not to transfer, assign or sell any of the Private Placement Units
or Ordinary Shares or Rights underlying the Bowen Private Units (except to certain transferees) until after the completion of the initial
Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2023, the underwriters exercised their over-allotment option in full to purchase an additional 900,000 Bowen Private Units.
As a result, on July 18, 2023, Bowen sold an additional 900,000 Bowen Private Units at $10.00 per Unit, generating gross proceeds of
$9,000,000. In connection with this sale, Createcharm and the IPO Underwriter also purchased an additional 31,500 Bowen Private
Units, with Createcharm having purchased 29,782 of the additional Bowen Private
Units and the IPO Underwriter having purchased 1,718 of the additional Bowen Private Units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Units, Bowen Ordinary Shares and Bowen Rights are currently listed on Nasdaq under the symbols &#8220;BOWNU,&#8221; &#8220;BOWN,&#8221;
and &#8220;BOWNR,&#8221; respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen&#8217;s
executive offices are located at 420 Lexington Ave, Suite 2446, New York, NY 10170, and its telephone number is (203) 998-5540.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Merger Sub</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Merger Sub is a wholly-owned subsidiary of Bowen formed solely for the purpose of effectuating the Merger. Merger Sub was incorporated
under the laws of the Cayman Islands on November 20, 2023. Merger Sub does not own any material assets and does not operate any business.
After the consummation of the business combination, Merger Sub will cease to exist as a separate legal entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mailing address of Merger Sub is 420 Lexington Ave, Suite 2446, New York, NY 10170, and its telephone number is (203) 998-5540.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NewCo
and Qianzhi</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
BioTechnology Co., Ltd. (referred to as &#8220;Qianzhi&#8221; in this proxy statement/prospectus) is a corporation established under
the laws of the PRC. Qianzhi is based in Shenzhen, China, and is a health and wellness focused biotech company, an early adopter
and developer of plant-based and ozonated products for antibacterial, skincare, gynecological and andrological applications, and provider
of prepackaged food and beverage products. Qianzhi is a wholly owned subsidiary of Qianzhi Group Holdings (Cayman) Limited, a newly
formed company established under the laws of the Cayman Islands (referred to as &#8220;NewCo&#8221; in this proxy statement/prospectus).
NewCo was formed to consummate the Business Combination. Following the consummation of the Business Combination, Merger Sub will have
merged with and into NewCo, with NewCo surviving the merger as a direct wholly-owned subsidiary of Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi&#8217;s
revenue for the three months ended June 30, 2024 was $1,665,658, with net cash flows used in operating activities of $2,351,758, compared
to $751,246 of revenue and $1,903,210 of net cash flows used in operating activities for the three months ended June 30, 2023. Qianzhi
had a net loss of $525,256 and $943,452 for the three months ended June 30, 2024 and 2023, respectively.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Qianzhi&#8217;s revenue for the fiscal year ended March 31, 2024 was $7,030,989, with net cash flows generated from operating activities
of $1,710,820, compared to $10,108,557 of revenue and $3,777,804 of net cash flows used in operating activities for the fiscal year ended
March 31, 2023. Qianzhi had a net loss of $698,174 and a net income of $3,591,998 for the fiscal years ended March 31, 2024 and 2023,
respectively. For additional information regarding Qianzhi, see the section of this proxy statement/prospectus entitled &#8220;<i>Business
of Qianzhi</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
headquarters of Qianzhi and NewCo are located at 1705, Block B, KK 100 Building, 5016 East Shennan Road, Luohu District, Shenzhen,
Guangdong Province, 518000 People&#8217;s Republic of China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Organizational
Structure of NewCo and Qianzhi</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
Group Holding (Cayman) Limited (&#8220;NewCo&#8221;), is a holding company that operates through its subsidiaries located in the People&#8217;s
Republic of China (&#8220;PRC&#8221;). NewCo was incorporated under the laws of the Cayman Islands on August 14, 2023 as an exempted
company with limited liability. Qianzhi Group owns 100% of the equity interests of Qianzhi Investment Holding Co., Ltd (&#8220;Qianzhi
BVI&#8221;), an entity incorporated on August 31, 2023 in accordance with the laws and regulations in the British Virgin Islands. Qianzhi
BVI owns 100% of the equity interests of Hong Kong Qianzhi Investment Holding Co., Ltd (&#8220;Qianzhi HK&#8221;), an entity incorporated
on September 27, 2023 in accordance with the laws and regulations in Hong Kong. Qianzhi HK owns 100% of the equity interests of Shenzhen
Shian Biotechnology Co., Ltd. (&#8220;Shenzhen Shian&#8221;), an entity formed on November 23, 2023, as a Wholly Foreign-Owned Enterprise
(&#8220;WFOE&#8221;) in the PRC. NewCo, Qianzhi BVI, Qianzhi HK and Shenzhen Shian are currently not engaging in any active business
operations and are acting as holding companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the reorganization described below, Ms. Xiaoqin Lin, the current chairman of the board of directors and the chief executive officer
of NewCo, was the controlling shareholder of Shenzhen Qianzhi Biotechnology Co., Ltd. (&#8220;Qianzhi&#8221;), an entity incorporated
on March 20, 2007 in accordance with PRC laws. Qianzhi owns 100% of the equity interests of the following subsidiaries: (1) Hubei Qianzhi
Biotechnology Co., Ltd. (&#8220;Hubei Qianzhi&#8221;), which was incorporated on February 20, 2019 in Ezhou City, Hubei Province in accordance
with PRC laws; (2) Shenzhen Qianzhi Health Management Co., Ltd. (&#8220;Qianzhi Health&#8221;), which was incorporated on May 5, 2019
in accordance with PRC laws; (3) Jiangxi Qianzhi Biotechnology Co., Ltd. (&#8220;Jiangxi Qianzhi&#8221;), which was incorporated on June
12, 2019 in Jiujiang City, Jiangxi Province in accordance with PRC laws, and (4) Shenzhen Qianzhi Biotech Co., Ltd. (&#8220;Qianzhi Biotech&#8221;),
which was incorporated on July 2, 2019 in accordance with PRC laws. Qianzhi, together with its subsidiaries are collectively referred
to as the &#8220;Qianzhi Operating Companies&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reorganization of NewCo&#8217;s legal structure (the &#8220;Reorganization&#8221;) was completed on December 27, 2023. The reorganization
involved the incorporation of NewCo, Qianzhi BVI, Qianzhi HK and Shenzhen Shian, and the transfer of the 100% equity interest of Qianzhi
to Shenzhen Shian. Consequently, NewCo, through its subsidiaries Qianzhi BVI and Qianzhi HK, directly controls Shenzhen Shian and Qianzhi,
and became the ultimate holding company of all other entities mentioned above. The business purpose of the Reorganization was to establish
NewCo as a Cayman-domiciled entity and enable it to achieve control over Qianzhi and its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 27, 2023, Qianzhi passed a resolution at a shareholders&#8217; meeting and agreed to increase its registered capital by RMB 2.412
million through an investment from Home Universe Investment Holdings Co., Limited, an unaffiliated investor (&#8220;Home Universe&#8221;).
On such date, Qianzhi and its shareholders signed amended Articles of Association and on July 13, 2023, Home Universe, Qianzhi and its
21 shareholders entered into a Capital Increase Agreement. Under this agreement, after the completion of the capital increase, Home Universe
held 1.96% of the equity interests of Qianzhi. As Home Universe is an entity informed in Hong-Kong, Qianzhi was changed from a domestic
enterprise to a Sino-foreign joint venture company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter,
on December 20, 2023, Qianzhi, its shareholders, Shenzhen Shian, and Home Universe entered into a Supplementary Agreement to the Capital
Increase Agreement. Since Home Universe was unable to contribute the capital increase amount of RMB 2.412 million to Qianzhi in accordance
with the terms of the Capital Increase Agreement, nor was it successful in introducing any third-party investor for Qianzhi before October
31, 2023, Home Universe was required to transfer the 1.96% of the equity interests of Qianzhi that it held to Shenzhen Shian, which fulfilled
the registered capital contribution obligation. On the same day, Qianzhi passed a resolution at the shareholders&#8217; meeting and all
of its shareholders agreed to transfer their equity interests held in Qianzhi to Shenzhen Shian. Shenzhen Shian entered into an Equity
Transfer Agreement with Home Universe and Qianzhi&#8217;s shareholders and acquired 100% of the equity interests of Qianzhi. On the same
day, Shenzhen Shian executed the amended Articles of Association of Qianzhi. On December 27, 2023, the Shenzhen Market Supervision Administration
approved Qianzhi&#8217;s business change registration.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reorganization has been accounted for as a recapitalization among entities under common control since the same controlling shareholders
controlled all these entities before and after the Reorganization. The consolidation of NewCo and its subsidiaries has been accounted
for at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the
first period presented in the accompanying consolidated financial statements. Results of operations for the periods presented comprise
those of the previously separate entities combined from the beginning of the period to the end of the period, eliminating the effects
of intra-entity transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following diagram illustrates Qianzhi&#8217;s corporate structure, including the direct owners of New Bowen and New Bowen&#8217;s
operating subsidiaries, as of the date of this proxy statement/prospectus:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="picture1.jpg" alt=""/>&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
Combination Agreement</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section describes the material provisions of the Business Combination Agreement but does not purport to describe all of the terms of
the Business Combination Agreement. This summary is qualified in its entirety by reference to the complete text of the Business Combination
Agreement, a copy of which is attached as <i><span style="text-decoration: underline">Annex A</span></i> hereto and which is incorporated herein by reference. You and other interested
readers are urged to read the Business Combination Agreement, carefully and in its entirety (and, if appropriate, with the advice of
financial and legal counsel), because it is the primary legal document that governs the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
Description of the Business Combination Agreement</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement contemplates that, at the Closing, upon the terms and subject to the conditions of the Business Combination
Agreement and in accordance with the Cayman Companies Act, Merger Sub will merge with and into NewCo, with NewCo being the surviving
company of the Merger and becoming a wholly-owned subsidiary of Bowen. Consistent with the Business Combination Agreement and in preparation
for the Business Combination, Qianzhi completed the Restructuring, in which it became a wholly owned subsidiary of NewCo by the issuance
of NewCo Ordinary Shares to the former holders of Qianzhi ordinary shares in exchange for such Qianzhi ordinary shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consideration</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
of Company Securities</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, at the Effective Time, all of NewCo Ordinary Shares issued and outstanding immediately prior to
the Effective Time other than (i) NewCo Ordinary Shares held by the parties to the Business Combination Agreement or their respective
wholly owned subsidiaries and (ii) those NewCo Ordinary Shares owned by the holders of NewCo Ordinary Shares who have validly exercised
and not effectively withdrawn or lost their rights to dissent from the Merger pursuant to the Cayman Companies Act, will be automatically
converted into the right to receive an aggregate of (a) 7,246,377 Merger Shares, a portion of which shall be deposited in escrow to provide
for indemnification in accordance with the Business Combination Agreement, and (b) the right to receive earnout consideration of up to
an aggregate of 1,400,000 Earnout Shares, as described further below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
Consideration</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the Merger Shares, the holders of NewCo Ordinary Shares have the contingent right to receive an aggregate of 1,400,000 Earnout
Shares as earnout consideration. The Earnout Shares will be issued if and to the extent certain net income milestones are achieved by
New Bowen and its subsidiaries during the fiscal years ended March 31, 2025 and 2026. In addition, the holders of NewCo Ordinary Shares
will be entitled to receive the Earnout Shares in the event there occurs any transaction resulting in a change of control during the
period of time that the Earnout Shares are earnable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representations
and Warranties</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement contains representations and warranties of Qianzhi and NewCo relating to, among other things, organization
and qualification; subsidiaries; capitalization; authority relative to the Business Combination Agreement; there being no conflict between
Qianzhi&#8217;s charter documents and other legal requirements and the Transactions and requiring only certain governmental consents;
compliance with applicable legal requirements; financial statements; having no undisclosed liabilities; the absence of certain changes
or events; there being no claims, suits, actions, complaints, demands or other proceedings pending or, to the knowledge of Qianzhi, threatened
against Qianzhi before any governmental entity; employee benefit plans; labor matters; business activities; title to property; taxes;
environmental matters; brokers; third-party expenses; intellectual property; agreements, contracts and commitments; governmental actions/filings;
interested party transactions; top customers and top suppliers; and board approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement contains representations and warranties of Bowen and Merger Sub relating to, among other things, organization
and qualification; subsidiaries; capitalization; authority relative to the Business Combination Agreement; there being no conflict between
Bowen&#8217;s charter documents and other legal requirements and the Transactions and requiring only certain governmental consents; Bowen
SEC reports and financial statements; having no undisclosed liabilities; the absence of certain changes or events; litigation; employee
benefit plans; labor matters; business activities; title to property; taxes; environmental matters; brokers; intellectual property; agreements,
contracts and commitments; insurance; interested party transactions; Nasdaq listing; board approval; and the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Covenants</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement includes customary affirmative and negative covenants of the parties with respect to business operations
prior to consummation of the Transactions. The parties also agreed to abide by certain exclusivity provisions, to use reasonable best
efforts to consummate the Merger, and to provide insurance for Bowen&#8217;s and Qianzhi&#8217;s directors and officers and indemnification
for Bowen&#8217;s directors and officers after the Closing. The Business Combination Agreement also contains additional covenants of
the parties, including, among others: (i) Bowen and Qianzhi will cooperate in the preparation and filing of the Registration Statement
of which this proxy statement/prospectus forms a part for the offer and sale of Bowen Ordinary Shares issuable pursuant to the Business
Combination Agreement; (ii) Qianzhi and NewCo will use reasonable best efforts to solicit and obtain the approval (the &#8220;<span style="font-weight: normal"><i>NewCo
Shareholder Approval</i></span>&#8221;) of the Merger and Transactions, by the requisite number of holders of NewCo Ordinary Shares,
as promptly as practicable following the date hereof; (iii) Bowen will adopt an incentive equity plan to be effective following the Closing;
(iv) Bowen will use commercially reasonable efforts to ensure that the Bowen Ordinary Shares, the Bowen Rights and the Bowen Units continue
to be listed on Nasdaq until the Closing, and Bowen will use commercially reasonable best efforts to cause the Bowen Ordinary Shares
to be listed on Nasdaq following the Closing; (v) certain employees of Qianzhi will execute employment agreements and noncompete agreements
in form to be mutually agreed upon; and (vi) , Bowen and Qianzhi will use commercially reasonable efforts to solicit the PIPE Investors
to enter into the PIPE Agreements (as defined below) with Bowen, on terms approved by Qianzhi (such approval not to be unreasonably withheld,
conditioned or delayed), pursuant to which the PIPE Investors consummate the PIPE Financing by purchasing, concurrently with the Closing,
equity or equity-linked securities of Bowen in an aggregate amount of $5.0 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions
to Closing</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mutual
Conditions</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consummation of the Merger and the other transactions contemplated by the Business Combination Agreement is conditioned upon the following,
among other things: (i) the Bowen Shareholder Approval and the NewCo Shareholder Approval having been received by Bowen and NewCo, respectively;
(ii) the approval for listing on Nasdaq of Bowen Ordinary Shares to be issued in connection with the Transactions, subject, if applicable,
to official notice of issuance thereof and the requirement to have a sufficient number of round lot holders; (iii) the Registration Statement
having become effective in accordance with the provisions of the Securities Act, no stop order having been issued by the SEC that remains
in effect with respect to the Registration Statement, and no proceeding seeking such a stop order having been threatened or initiated
by the SEC which remains pending; (iv) approval by the CFIUS of the Merger and other Transactions having been obtained and being in full
force and effect; (v) all required waiting periods under the HSR Act, if any, having expired or been terminated; (vi) approval of all
necessary filings with the China Securities Regulatory Commission (&#8220;<span style="font-weight: normal"><i>CSRC</i></span>&#8221;)
having been obtained and being in full force and effect; (vii) Bowen having at least $5,000,001 of net tangible assets (after giving
effect to redemptions by Bowen&#8217;s public shareholders) immediately prior to or upon the Closing; and (viii) holders of less than
5% of the NewCo Ordinary Shares issued and outstanding immediately prior to the Closing having exercised their right to dissent, and
not effectively withdrawn their dissent or lost their right to dissent, from the Merger pursuant to section 238 of the Cayman Companies
Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
Conditions to Bowen&#8217;s Obligations</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of Bowen and Merger Sub to consummate the Transactions are also conditioned upon, among other things: (i) the accuracy of
the representations and warranties of Qianzhi and NewCo; (ii) performance in all material respects of the agreements and covenants of
Qianzhi required by the Business Combination Agreement to be performed on or prior to the Closing; (iii) no action, suit or proceeding
being pending or threatened before any governmental entity which would prevent consummation of any of the Transactions, cause any of
the Transactions to be rescinded following consummation, or affect materially and adversely the right of the Surviving Company to own,
operate or control any of the assets and operations of Qianzhi following the Merger, and no order, judgment, decree, stipulation or injunction
to any such effect being in effect; (iv) certain employees of Qianzhi having executed employment agreements and Non-Competition Agreements
with Bowen; (v) the PIPE Financing being fully ready for consummation concurrently with the Closing; and (vi) all outstanding material
indebtedness owed to Qianzhi or its subsidiaries by affiliates or officers, directors, or employees thereof or by any other Person designated
by Qianzhi who will become an officer, director, or employee of Bowen upon the Closing having been repaid in full; all outstanding material
guaranties and similar arrangements pursuant to which Qianzhi or any of its subsidiaries has guaranteed the payment or performance of
any obligations of any such affiliate or officer, director, or employee, or other Person, to a third party having been terminated; and
no affiliate of Qianzhi owning any direct equity interests in any company that utilizes in its name or otherwise &#8220;Qianzhi&#8221;
or any derivative thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
Conditions to Qianzhi&#8217;s and NewCo&#8217;s Obligations</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of Qianzhi and NewCo to consummate the Transactions are also conditioned upon, among other things: (i) the accuracy of the
representations and warranties of Bowen and Merger Sub; (ii) performance in all material respects of the covenants of Bowen and Merger
Sub required by the Business Combination Agreement to be performed on or prior to the Closing; (iii) no action, suit or proceeding being
pending or threatened before any governmental entity which would prevent consummation of any of the Transactions, would cause any of
the Transactions to be rescinded following consummation or would affect materially and adversely or otherwise encumber the title of the
Bowen Ordinary Shares to be issued by Bowen in connection with the Merger, and no order, judgment, decree, stipulation or injunction
to any such effect being in effect; and (iv) the 2024 Incentive Plan having been adopted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the indemnification provisions of the Business Combination Agreement, Bowen, NewCo and Qianzhi, and their respective representatives,
successors and permitted assigns, will be indemnified, defended and held harmless by NewCo shareholders, jointly and severally to the
extent of the Escrow Shares, and thereafter severally but not jointly, from and against all Losses (as defined below) asserted against,
resulting to, imposed upon, or incurred by any indemnitee by reason of, arising out of or resulting from (i) the actual or alleged inaccuracy
or breach of any representation or warranty of Qianzhi or NewCo contained in or made pursuant to the Business Combination Agreement,
or contained in or made pursuant to any certificate delivered by Qianzhi or NewCo to Bowen pursuant to the Business Combination Agreement
in connection with the Closing; or (ii) the non-fulfillment or breach of any covenant or agreement of Qianzhi or NewCo contained in the
Business Combination Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
representations and warranties of Qianzhi and NewCo shall survive the Closing until the date that is two years after the Closing Date,
except that the representations and warranties relating to organization and qualification, subsidiaries, capitalization, authority relative
to the Business Combination Agreement, employee benefit plans, taxes, environmental matters, brokers and intellectual property (the &#8220;<span style="font-weight: normal"><i>Specified
Representations</i></span>&#8221;) shall survive until the expiration of the applicable statute of limitations. No amount shall be payable
under the foregoing provisions unless and until the aggregate amount of all indemnifiable Losses otherwise payable exceeds $3,750,000,
in which event NewCo shareholders shall be required to pay or be liable for all such indemnifiable Losses from the first dollar (except
that this limitation will not apply to indemnifiable Losses arising out of an actual or alleged breach of the Specified Representations).
The aggregate liability of NewCo shareholders for Losses shall not in any event exceed $18,750,000 (and no Company Shareholder shall
be liable for more than its pro rata share of the Losses, based on the same proportions as the total Merger Shares are allocated among
them).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement may be terminated at any time prior to the Closing as follows: (i) by mutual written consent of Bowen
and Qianzhi; (ii) by either Bowen or Qianzhi, if the Effective Time has not occurred on or before December 31, 2024; <i>provided </i>that
this termination right is not available to a party that is in breach or violation of the Business Combination Agreement and such breach
or violation is the primary cause of the failure to close by such date; (iii) by either Bowen or Qianzhi, if a governmental entity shall
have issued an order, decree, judgment or ruling or taken any other action, in any case having the effect of permanently restraining,
enjoining or otherwise prohibiting the Merger, which order, decree, ruling or other action is final and nonappealable; (iv) by either
Bowen or Company, if the other party has breached any of its covenants or representations and warranties, or any representation or warranty
has become untrue, such that the terminating party&#8217;s closing conditions would not be satisfied (subject to a thirty-day cure period,
if such breach is curable), provided that this termination right is not available to a party that is in breach of the Business Combination
Agreement such that the other party&#8217;s closing conditions would not be satisfied; (v) by either Bowen or Qianzhi, if the Bowen Shareholder
Approval is not obtained; (vi) by Bowen, if Qianzhi Stockholder Approval is not obtained by the requisite vote under the Cayman Companies
Act and NewCo&#8217;s charter documents within one (1) Business Day after the Shareholder Meeting; (vii) by Bowen, in the event that
CFIUS notifies the parties in writing that CFIUS has recommended or intends to recommend in a report that the Transactions be prohibited;
or (viii) by either Bowen or Qianzhi, if the approval of all necessary filings with the CSRC has not been obtained and is not in full
force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PIPE
Financing</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, the parties agreed that Bowen and Qianzhi shall use commercially reasonable efforts to solicit
PIPE Investors to enter into subscription agreements with Bowen (as amended or modified from time to time, collectively, the &#8220;<span style="font-weight: normal"><i>PIPE
Agreements</i></span>&#8221;), on terms approved by Qianzhi (such approval not to be unreasonably withheld, conditioned or delayed),
pursuant to which, among other things, each PIPE Investor shall agree to subscribe for and purchase from Bowen, and Bowen shall agree
to issue and sell to each such PIPE Investor, on the Closing Date concurrent with the Closing, the number or amount of Bowen Ordinary
Shares or other equity or equity-linked securities of Bowen set forth in the applicable PIPE Agreement, in exchange for the purchase
price set forth therein, in an aggregate amount of $5,000,000. Simultaneous with entering into the PIPE Agreements, the PIPE Investors
shall enter into a registration rights agreement with Bowen, on terms approved by Qianzhi (such approval not to be unreasonably withheld,
conditioned or delayed), pursuant to which, among other things, Bowen shall grant the PIPE Investors demand and piggyback registration
rights relating to the Bowen Ordinary Shares issuable pursuant to the PIPE Agreements or underlying the Bowen Ordinary Shares or other
equity or equity-linked securities issued pursuant to the PIPE Agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
Agreements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrently
with the execution of the Business Combination Agreement, Bowen, Qianzhi and certain NewCo shareholders entered into Voting and Support
Agreements (each, a &#8220;<span style="font-weight: normal"><i>Voting Agreement</i></span>&#8221;), pursuant to which, among other things,
each such NewCo shareholder agreed, with respect to all NewCo Ordinary Shares received by such NewCo Shareholder in the Restructuring,
to vote in favor of, or consent in writing to, the adoption of the Business Combination Agreement and the approval of the transactions
contemplated thereby, including the Merger, in order to effect the required NewCo shareholder approval. Such vote or consent shall occur
as soon as practicable as following the date of this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Shareholder Proposals</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
1 &#8211; The Business Combination Proposal</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in this proxy statement/prospectus, Bowen is asking its shareholders to approve the Business Combination Agreement and the
transactions contemplated thereby, including the Business Combination pursuant to which Merger Sub will merge with and into NewCo, with
NewCo being the surviving company of such Merger and becoming a wholly-owned subsidiary of Bowen. Bowen shareholders should carefully
read this proxy statement/prospectus in its entirety for more detailed information concerning the Business Combination Agreement, which
is attached as <i><span style="text-decoration: underline">Annex A</span></i> to this proxy statement/prospectus. Please see the section entitled the &#8220;<i>Shareholder Proposal
No. 1: The Business Combination Proposal &#8212; The Business Combination Agreement</i>&#8221; for additional information and a summary
of the material terms of the Business Combination Agreement. You are urged to read the Business Combination Agreement in its entirety
before voting on this proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consideration to be paid to the NewCo shareholders in connection with the Business Combination will be in Bowen Ordinary Shares and is
based on an enterprise value of $75 million of Qianzhi. Pursuant to the Business Combination Agreement, at the Effective Time, all of
the NewCo Ordinary Shares issued and outstanding immediately prior to the Effective Time other than (i) NewCo Ordinary Shares held by
Bowen or Qianzhi or their respective wholly owned subsidiaries and (ii) those NewCo Ordinary Shares owned by the holders of NewCo
Ordinary Shares who have validly exercised and not effectively withdrawn or lost their rights to dissent from the Merger pursuant to
the Cayman Companies Act, will be automatically converted into the right to receive an aggregate of (a) 7,246,377 Bowen Ordinary Shares,
a portion of which shall be deposited in escrow to provide for indemnification in accordance with the Business Combination Agreement,
and (b) the right to receive earnout consideration of up to an aggregate of 1,400,000 Earnout Shares. Please see the section entitled
&#8220;<i>Shareholder Proposal No. 1: The Business Combination Proposal</i>&#8221; for additional detail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
2 &#8211; The Name Change Proposal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in this proxy statement/prospectus, Bowen is asking its shareholders to approve, subject to the proposed name conforming with
Section 30 of the Companies Act (Revised) of the Cayman Islands, to approve the change of name of Bowen from Bowen Acquisition Corp to
&#8220;Emerald, Inc.&#8221;, effective from the Effective Time. Please see the section entitled &#8220;<i>Shareholder Proposal No. 2:
The Name Change Proposal</i>&#8221; for additional detail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
3 &#8211; The Capitalization Amendment Proposal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in this proxy statement/prospectus, Bowen is asking its shareholders to approve the increase of the authorized share capital
of Bowen from US$20,200, divided into 2,000,000 Preferred Shares of par value US$0.0001 each and 200,000,000 Ordinary Shares of par value
US$0.0001 each, to US$25,200, divided into 2,000,000 Preferred Shares of par value US$0.0001 each and 250,000,000 Ordinary Shares of
par value US$0.0001 each, by the creation of 50,000,000 additional Ordinary Shares of par value US$0.0001 each. Please see the section
entitled &#8220;<i>Shareholder Proposal No. 3: The Capitalization Amendment Proposal</i>&#8221; for additional detail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposals
4 and 5</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> &#8211; The Charter Amendment Proposals</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in this proxy statement/prospectus, the Existing Charter contains various provisions that will not be applicable following
consummation of the Business Combination, including certain provisions related to Bowen&#8217;s status as a blank check company. Bowen
is asking its shareholders to approve separate proposals to approve amendments to the Existing Charter to: (a) remove the provisions
dividing the Bowen Board into classes (Proposal. No. 4: The Board Unification Proposal); and (b) approve and adopt the Proposed
Charter to reflect the changes proposed in Proposals 2 through 4 to the extent approved by the Bowen shareholders and remove the
various non-substantive, non-governance provisions applicable only to special purpose acquisition companies that will no longer
be applicable to Bowen after the consummation of the Business Combination (Proposal. No. 5: The Proposed Charter Adoption Proposal).
A copy of the Proposed Charter effectuating the foregoing amendments, assuming their approval for purposes of illustration, is attached
to this proxy statement/prospectus as <i><span style="text-decoration: underline">Annex D</span></i>. For more information, see the sections entitled &#8220;<i>Shareholder
Proposal No. 4: The Board Unification Proposal</i>&#8221; and &#8220;<i>Shareholder Proposal No. 5: The Proposed Charter Adoption Proposal.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
6 &#8211; The Nasdaq Proposal</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in this proxy statement/prospectus, Bowen is asking its shareholders to approve for the purposes of complying with the applicable
provisions of Nasdaq Listing Rule 5635(a) and (b), the issuance of Bowen Ordinary Shares in connection with the Merger, to the extent
such issuance would require a shareholder vote under Nasdaq Listing Rule 5635(a) and (b). Please see the section entitled &#8220;<i>Shareholder
Proposal No. 6: The Nasdaq Proposal</i>&#8221; for additional detail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
7 &#8211; The Equity Incentive Plan Proposal</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in this proxy statement/prospectus, Bowen is asking its shareholders to approve and adopt the 2024 Incentive Plan. An aggregate
number of Bowen Ordinary Shares equal to 5% of the Bowen Ordinary Shares outstanding immediately following the Closing, subject to adjustment
as provided for in the 2024 Incentive Plan, will be reserved for issuance under the 2024 Incentive Plan. The Bowen Board approved the
2024 Incentive Plan on [&#9679;], subject to approval by Bowen&#8217;s shareholders at the Shareholder Meeting. If approved by the shareholders,
the effective date of the 2024 Incentive Plan will be the Closing Date. If approved by the shareholders, the 2024 Incentive Plan will
be administered by the New Bowen Board or by the compensation committee of the New Bowen Board, which will have the authority to make
awards under the 2024 Incentive Plan. A copy of the 2024 Incentive Plan is attached as <i><span style="text-decoration: underline">Annex B</span></i> to this proxy statement/prospectus.
Please see the section entitled &#8220;<i>Shareholder Proposal No. 7: The Equity Incentive Plan Proposal</i>&#8221; for additional
detail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
8 &#8211; The Director Election Proposal</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in this proxy statement/prospectus, Bowen is asking its shareholders to elect five (5) individuals to serve on the board of
directors of New Bowen upon consummation of the Business Combination. Please see the section entitled &#8220;<i>Shareholder Proposal
No. 8: The Director Election Proposal</i>&#8221; for additional detail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
9 &#8211; The Adjournment Proposal</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in this proxy statement/prospectus, Bowen is asking its shareholders to approve the adjournment of the Shareholder Meeting
to a later date or dates, if necessary, if Bowen and Qianzhi mutually determine that additional time is required to consummate the Business
Combination. Please see the section entitled &#8220;<i>Shareholder Proposal No. 9: The Adjournment Proposal</i>&#8221;
for additional detail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Board&#8217;s Reasons for Approval of the Business Combination</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Board, in evaluating the Business Combination, consulted with Bowen&#8217;s management team and its financial and legal advisors.
In reaching its resolution (a) that the Business Combination Agreement and the transactions contemplated thereby, including the Business
Combination, are advisable and in the best interests of Bowen and (b) to recommend that the Bowen Shareholders adopt the Business Combination
Agreement and the transactions contemplated thereby, including the Business Combination, the Bowen Board (i) consulted with Bowen&#8217;s
legal and financial advisors in connection with its evaluation of the Business Combination Agreement and the Business Combination, (ii)
reviewed the results of due diligence conducted by Bowen&#8217;s management team, together with its legal and financial advisors and
(iii) considered a range of factors, including, but not limited to, the factors discussed below. In light of the number and wide variety
of factors considered in connection with its evaluation of the Business Combination, the Bowen Board did not consider it practicable
to, and did not attempt to, quantify or otherwise assign relative weights to the specific factors that it considered in reaching its
determination and supporting its decision. The Bowen Board viewed its decision as being based on all of the information available and
the factors presented to and considered by it. In addition, individual directors may have given different weight to different factors.
In approving the Business Combination, the Bowen Board determined to obtain a fairness opinion. In addition, the officers and directors
of Bowen have substantial experience with mergers and acquisitions and in evaluating the operating and financial merits of companies
from a wide range of industries and concluded that their experience and background, together with experience and sector expertise of
Bowen&#8217;s advisors, enabled them to make the necessary analyses and determinations regarding the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Board considered a number of factors pertaining to the Business Combination as generally supporting its decision to enter into
the Business Combination Agreement and the transactions contemplated thereby, including, but not limited to, the following material factors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expanding
                                            Growth Industry</i>. Qianzhi is a health and wellness focused biotech company and an early
                                            adopter and developer of plant-based and ozonated products for antibacterial, skincare, gynecological
                                            and andrological applications. Based on the due diligence performed by the Bowen Board and
                                            its advisors on Qianzhi and its industry, including an assessment of mergers and acquisitions
                                            activity for companies in the industry in which Qianzhi operates, the Bowen Board believes
                                            Qianzhi represents an attractive opportunity for Bowen and its shareholders;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reasonableness
                                            of the aggregate consideration to be paid to Qianzhi&#8217;s shareholders under the Business
                                            Combination Agreement.</i> Following a review of the financial data provided to Bowen, including
                                            certain audited and unaudited financial information and models regarding Qianzhi (including,
                                            where applicable, the assumptions underlying such unaudited financial information and models)
                                            and Bowen&#8217;s due diligence review of Qianzhi&#8217;s business, the Bowen Board determined
                                            that the consideration to be paid to the Qianzhi shareholders was reasonable in light of
                                            such data and financial information;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Structure
    and timing of the Business Combination and PIPE Financing.</i> As contemplated by the Business Combination Agreement, the structure
    and timing of both the Business Combination and potential PIPE financing are consistent with common practice in initial business
    combination transactions consummated by special purpose acquisition companies. As a result, the Bowen board was able to compare the
    terms of the Business Combination against those of similar business combinations considered by Bowen&#8217;s management during the
    negotiation of the Business Combination Agreement. In addition to its consistency with common practice, the timing for the consummation
    of the Business Combination provided for in the Business Combination Agreement, effectively as soon as reasonably practicable following
    the execution of the Business Combination Agreement, was determined and agreed by the parties in light of (i) general business considerations
    weighing in favor of consummating the transaction promptly so that neither Bowen nor Qianzhi had to operate for longer than necessary
    under the burden of uncertainty and (ii) the deadline for Bowen to complete an initial business combination pursuant to the Existing
    Charter.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Due
                                            Diligence</i>. The Bowen Board reviewed and discussed in detail the results of the due diligence
                                            examination of Qianzhi conducted by Bowen&#8217;s management team and Bowen&#8217;s financial,
                                            legal and regulatory advisors, including extensive telephonic and in-person meetings with
                                            the management team and advisors of Qianzhi regarding Qianzhi&#8217;s business plan, operations,
                                            prospects and forecasts including historical growth trends and market share information as
                                            well as end-market size and growth projections, evaluation analyses with respect to the Business
                                            Combination, review of material contracts, Qianzhi&#8217;s audited and unaudited financial
                                            statements and other material matters, as well as general financial, technical, legal, intellectual
                                            property, regulatory, tax and accounting due diligence;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
                                            Condition</i>. The Bowen Board also considered factors such as Qianzhi&#8217;s historical
                                            financial results, outlook, financial plan, and debt structure. In considering these factors,
                                            the Bowen Board reviewed Qianzhi&#8217;s historical growth and its current prospects for
                                            growth if Qianzhi achieves its business plan and various historical and current balance sheet
                                            items of Qianzhi;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Experienced
                                            Management</i>. Qianzhi has a strong management team with significant operating experience.
                                            The senior management of Qianzhi intends to remain with Qianzhi in the capacity of officers
                                            and/or directors, and the Bowen Board believes that the retention of such members of senior
                                            management will provide helpful continuity in advancing Qianzhi&#8217;s strategic and growth
                                            goals;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
                                            Alternatives</i>. The Bowen Board believes, after a thorough review of other business combination
                                            opportunities reasonably available to Bowen, that the proposed Business Combination represents
                                            the best potential business combination for Bowen and the most attractive opportunity based
                                            upon the process utilized to evaluate and assess other potential acquisition targets;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Negotiated
                                            Transaction</i>. The Bowen Board considered the terms and conditions of the Transaction Agreements
                                            and the transactions contemplated thereby, each party&#8217;s representations, warranties
                                            and covenants, the indemnification obligations of Qianzhi&#8217;s equityholders, the
                                            conditions to each party&#8217;s obligation to consummate the Business Combination and the
                                            termination provisions, as well as the strong commitment by both Bowen and Qianzhi to complete
                                            the Business Combination.; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fairness
                                            Opinion</i>. The Bowen Board considered Newbridge Securities&#8217; fairness opinion, in
                                            which Newbridge Securities opined that the Business Combination is &#8220;fair&#8221; to
                                            the shareholders of Bowen from a financial perspective.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Board also considered a variety of uncertainties and risks and other potentially negative factors concerning the Business Combination
including, but not limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Business
                                            Plan May Not Be Achieved</i>. The risk that Qianzhi may not be able to execute on its business
                                            plan;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
                                            Risk</i>. The potential that a significant number of Public Shareholders elect to redeem
                                            their Public Shares prior to the consummation of the Business Combination and pursuant to
                                            the Existing Charter, which would potentially make the Business Combination more difficult
                                            to complete. However, even in the event that a significant number of Public Shareholders
                                            elect to redeem their shares, this redemption would not necessarily prevent the consummation
                                            of the Business Combination, because there is no minimum cash closing condition;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Regulatory
                                            Affairs</i>. The Bowen Board considered the impact of the review of the Business Combination
                                            by various regulatory agencies, including those in the PRC;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Closing
                                            Conditions</i>. The potential risks and costs associated with the Business Combination failing
                                            to be consummated in a timely manner or that Closing might not occur despite the reasonable
                                            best efforts of the parties. The completion of the Business Combination is conditioned on
                                            the satisfaction of certain Closing conditions that are not within Bowen&#8217;s control,
                                            including the receipt of certain required regulatory approvals;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Litigation
                                            Related to the Business Combination</i>. The possibility of litigation challenging the Business
                                            Combination or that an adverse judgment granting permanent injunctive relief could indefinitely
                                            enjoin consummation of the Business Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Listing
                                            Risks</i>. The challenges associated with preparing Qianzhi for the applicable disclosure
                                            and listing requirements to which Qianzhi will be subject as a publicly traded company in
                                            the United States;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Benefits
                                            May Not Be Achieved</i>. The risks that the potential benefits of the Business Combination
                                            may not be fully achieved or may not be achieved within the expected timeframe;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Market
                                            Volatility.</i> The possibility that the market for Bowen Ordinary Shares experiences volatility
                                            and disruptions, causing deal disruption;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation
                                            of Bowen</i>. The risks and costs to Bowen if the Business Combination is not completed,
                                            including the risk of diverting management focus and resources from other business combination
                                            opportunities, which could result in Bowen being unable to effect a business combination
                                            within the required time period provided for in the Existing Charter;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
                                            and Independent Committees</i>. The risk that, assuming approval of the Director Election
                                            Proposal, the New Bowen Board and independent committees thereof do not possess adequate
                                            skill set within the context of Qianzhi operating as a public company;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interests
                                            of Certain Persons.</i> The Sponsors and Bowen&#8217;s officers and directors have interests
                                            in the Business Combination that are different from or in addition to (and which may conflict
                                            with) the interests of the Public Shareholders (see &#8220;<i>&#8212; Interests of Certain
                                            Persons in the Business Combination</i>&#8221;);</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fees
                                            and Expenses</i>. The fees and expenses associated with completing the Business Combination;
                                            and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
                                            Risk Factors</i>. Various other risk factors associated with the business of Qianzhi, as
                                            described in the section entitled &#8220;<i>Risk Factors</i>&#8221; appearing elsewhere in
                                            this proxy statement/prospectus.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Board concluded, in its business judgment, that the potential benefits that it expects Bowen and its shareholders to achieve as
a result of the Business Combination outweigh the potentially negative and other factors associated with the Business Combination. Accordingly,
the Bowen Board determined that the Business Combination and the transactions contemplated by the Business Combination Agreement (including
the Merger) are fair and advisable to, and in the best interests of, Bowen and its shareholders. The above discussion of the material
factors considered by the Bowen Board is not intended to be exhaustive but does set forth the principal factors considered by the Bowen
Board. This explanation of Bowen&#8217;s reasons for the Business Combination and all other information presented in this section is
forward-looking in nature and, therefore, should be read in light of the factors discussed under &#8220;<i>Cautionary Note Regarding
Forward-Looking Statements</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date,
Time and Place of the Shareholder Meeting</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shareholder Meeting will be held on [&#9679;], 2024, at [&#9679;] [a.m./p.m.], Eastern Time, via a virtual meeting, or at such other
time, on such other date and at such place to which the meeting may be postponed or adjourned.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may attend the Shareholder Meeting and vote your shares electronically during the Shareholder Meeting via live audio webcast by visiting
<i>www.cstproxy.com/bowenacquisition/[&#9679;]</i>. You will need the control number that is printed on your proxy card to enter the
Shareholder Meeting. Bowen recommends that you log in at least 15 minutes before the meeting to ensure you are logged in when the Shareholder
Meeting starts. Please note that you will not be able to attend the Shareholder Meeting in person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold your Bowen Ordinary Shares through a bank or broker, you will need to contact Continental, Bowen&#8217;s transfer agent, to
receive a control number. If you plan to vote at the Shareholder Meeting, you will need to have a legal proxy from your bank or broker,
or if you would like to join and not vote, Continental can issue you a guest control number with proof of ownership. Either way you must
contact the Continental for specific instructions on how to receive the control number. Continental can be contacted at the number or
email address below. Please allow up to 72 hours prior to the meeting for processing your control number.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
can pre-register to attend the virtual Shareholder Meeting starting [&#9679;], 2024 at 9:00 a.m., Eastern Time (two business days prior
to the meeting date). Enter the following URL address into your browser <i>www.cstproxy.com/bowenacquisition/[&#9679;]</i>, enter your
control number, name and email address. Once you pre-register you can vote or enter questions in the chat box. At the start of the Shareholder
Meeting, you will need to log in again using your control number and will also be prompted to enter your control number if you want to
vote during the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you do not have access to the internet, you can listen only to the Shareholder Meeting by dialing [&#9679;] (or [&#9679;] if you are
located outside of the United States and Canada (standard rates apply)) and when prompted enter the pin number [&#9679;]#. Please note
you will not be able to vote or enter questions during the Shareholder Meeting if you choose to participate telephonically.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
Power; Record Date</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Board has fixed the close of business on [&#9679;], 2024 as the Record Date for determining Bowen shareholders entitled to notice
of and to attend and vote at the Shareholder Meeting. As of the close of business on the Record Date, there were 9,166,500 Bowen Ordinary
Shares outstanding and entitled to vote. Each Bowen Ordinary Share is entitled to one vote per share at the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Insiders have agreed, subject to applicable securities laws, to vote any Bowen Ordinary Shares owned by them in favor of the proposals
presented at the Shareholder Meeting. As of the date of this proxy statement/prospectus, the Insiders own approximately 22.2% of the
total outstanding Bowen Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quorum
and Vote for Bowen Shareholders</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
quorum of our shareholders is necessary to hold a valid meeting. Pursuant to the Existing Charter, the presence, in person virtually
or by proxy, of shareholders holding a majority of the Bowen Ordinary Shares entitled to vote at the Shareholder Meeting constitutes
a quorum at the Shareholder Meeting. Abstentions will be considered present for the purposes of establishing a quorum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of each of the Name Change Proposal, Capitalization Amendment Proposal, Board Unification Proposal and Proposed Charter
Adoption Proposal requires a special resolution under Cayman Islands law, being the affirmative vote of the holders of at least two-thirds
(2/3) of the Bowen Ordinary Shares represented in person virtually or by proxy and entitled to vote thereon and who vote at the Shareholder
Meeting at which a quorum is present. The approval of each of the other proposals require an ordinary resolution under Cayman Islands
law, being the affirmative vote of the holders of a majority of the Bowen Ordinary Shares represented in person virtually or by proxy
and entitled to vote thereon and who vote at the Shareholder Meeting at which a quorum is present. The Sponsors and the Insiders have agreed, subject to applicable securities
laws, to vote any ordinary shares owned by them in favor of the Business Combination Proposal. This is unlike some other similarly structured
transactions where the insiders vote in accordance with the public holders and therefore a majority of unaffiliated shareholders would
be required to approve a proposed transaction. Because the Sponsors and Insiders vote in favor of the Business Combination Proposal, the
transaction is not structured such that the vote of a majority of unaffiliated shareholders is required to approve the Business Combination
Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption
Rights</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Existing Charter, a holder of Public Shares may demand that Bowen redeem such shares for a pro rata portion of the Trust Account
if the Business Combination is consummated; provided that Bowen may not consummate the Business Combination if it has less than $5,000,001
of net tangible assets immediately prior to or upon consummation of the Business Combination. Holders of Public Shares will be entitled
to receive cash for these shares only if they deliver their shares to the Transfer Agent no later than two (2) business days prior to
the Shareholder Meeting. Holders of Public Shares do not need to vote for or against, or even vote at all on, the Business Combination
Proposal, and do not need to be holders of such Public Shares as of the record date, in order to exercise redemption rights. If the Business
Combination is not consummated, these shares will not be redeemed for cash. If a holder of Public Shares properly demands redemption,
delivers his, her, or its shares to the Transfer Agent as described above, and the Business Combination is consummated, Bowen will redeem
each Public Share for a full pro rata portion of the Trust Account, calculated as of two (2) business days prior to the anticipated consummation
of the Business Combination. It is anticipated that this would amount to approximately $[&#9679;] per share. If a holder of Public Shares
exercises its redemption rights, then it will be exchanging its Bowen Ordinary Shares for cash and will no longer own the shares. See
the section of this proxy statement/prospectus titled &#8220;<i>Shareholder Meeting &#8212; Redemption Rights</i>&#8221; for a detailed
description of the procedures to be followed if you wish to redeem your shares for cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Rights will not have redemption rights with respect to such Rights. However, holders of Rights will retain their Rights even if they
exercise redemption rights with respect to their Public Shares. Accordingly, they may sell their Rights freely in the open market. However,
Bowen cannot assure the holders of Rights that they will be able to sell their Rights in the open market as there may not be sufficient
liquidity in such securities when holders of Rights wish to sell their Rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appraisal
Rights</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no appraisal rights available to Bowen&#8217;s shareholders in connection with the Business Combination. However, holders of Public
Shares may elect to have their shares redeemed in connection with the adoption of the Business Combination Proposal, as described under
&#8220;<i>Redemption Rights</i>&#8221; above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
Solicitation</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
is soliciting proxies on behalf of the Bowen Board. This proxy solicitation is being made by mail, but also may be made by telephone
or in person. Bowen has engaged Laurel Hill Advisory Group to assist in the solicitation of proxies for the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a shareholder of Bowen grants a proxy, such shareholder may still revoke such proxy by attending the Shareholder Meeting and voting electronically.
A shareholder of Bowen may also change its vote by sending another proxy card with a later date, as described in the section entitled
&#8220;<i>Shareholder Meeting &#8212; Revoking Your Proxy</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interests
of Bowen&#8217;s Directors and Officers and Others in the Business Combination</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
you consider the recommendation of the Bowen Board in favor of approval of the Business Combination Proposal, you should keep in mind
that the Insiders, including Bowen&#8217;s directors and executive officers, have interests in such proposal that are different from,
or in addition to, those of Public Shareholders generally. These interests include, among other things, the interests described below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that the Sponsors and Bowen&#8217;s officers and directors have certain economic interests
                                            in the Business Combination including:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Sponsors paid an aggregate of $25,000 for 1,725,000 Founder Shares currently owned by the
                                            Sponsors, in which certain of Bowen&#8217;s directors and executive officers hold an indirect interest. The Insiders have agreed to waive their redemption rights with
                                            respect to their Founder Shares and any Public Shares they hold in connection with the Business
                                            Combination and their rights to liquidating distributions from the Trust Account with respect
                                            to any Founder Shares held by them if the Business Combination is not approved and Bowen
                                            fails to complete a business combination within the required time period. Accordingly, the
                                            Founder Shares would be worthless if the Business Combination or another business combination
                                            is not consummated within the required time period because the holders thereof are not entitled
                                            to participate in any redemption or liquidation distribution with respect to such shares.
                                            Such securities may have a significantly higher value at the time of the Business Combination,
                                            and if unrestricted and freely tradable would be valued at approximately $[X] based upon
                                            the closing price of $[X] per Bowen Ordinary Share on Nasdaq on [X], 2024;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Createcharm paid an aggregate of $3,417,820</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                            for 341,782 Bowen Private Units. Such securities may have a higher value at the time of the
                                            Business Combination and, if unrestricted and freely tradable, would be valued at approximately
                                            $[X], based upon the closing price of $[X] per Public Unit on Nasdaq on [X], 2024;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Sponsors and Bowen&#8217;s officers and directors will lose their entire investment in Bowen
                                            and will not be reimbursed for any loans extended, fees due or out-of-pocket expenses incurred
                                            on Bowen&#8217;s behalf related to identifying, investigating, negotiating and completing
                                            an initial business combination if the Business Combination is not consummated within the
                                            required time period. As of the date of this proxy statement/prospectus, there is an aggregate
                                            principal amount of $[X] of outstanding loans payable to the SPAC Sponsors and $[X] in
                                            aggregate fees due and out-of-pocket expenses to be repaid by Bowen;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accordingly,
                                            based on the value of the Bowen securities invested in and the amount of the
                                            loans and unreimbursed expenses as set forth above, the aggregate amount that the SPAC
                                            Sponsors and Bowen&#8217;s officers and directors have at risk is $[3,442,820 ($3,434,570
                                            by Createcharm and $8,250 by Bowen Holding)];</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            addition, the SPAC Sponsors and their affiliates can earn a positive rate of
                                            return on their investment, even if other Bowen shareholders experience a negative rate of
                                            return;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            Bowen entered into an agreement, commencing on the date its securities were first listed
                                            on Nasdaq and up to the earlier of the consummation of a business combination or its liquidation,
                                            to pay Bowen Holding LP a monthly fee of US$10,000 for office space, secretarial and administrative
                                            support;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that pursuant to the Business Combination Agreement, Bowen has the right to designate
                                            one director to the New Bowen Board post-Closing. Such director, in the future, may receive
                                            any cash fees, stock options or stock awards that the New Bowen Board determines to pay to
                                            its directors. Bowen has designated Jun Zhang to be a director on the New Bowen Board post-Closing;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that the Business Combination Agreement provides for the continued indemnification of
                                            Bowen&#8217;s existing directors and officers and requires New Bowen to purchase, at or prior
                                            to the Closing, and maintain in effect for a period of six years after the Closing, a &#8220;tail&#8221;
                                            policy providing directors&#8217; and officers&#8217; liability insurance coverage for certain
                                            Bowen directors and officers after the Business Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that if the Trust Account is liquidated, including in the event Bowen is unable to complete
                                            an initial business combination within the required time period, each of the Sponsors has
                                            agreed to indemnify Bowen to ensure that the proceeds in the Trust Account are not reduced
                                            below $10.10 per Public Share, or such lesser per share amount as is in the Trust Account,
                                            by the claims of prospective target businesses with which Bowen has entered into an acquisition
                                            agreement or claims of any third party for services rendered or products sold to Bowen, but
                                            only if such a vendor or target business has not executed a waiver of any and all rights
                                            to seek access to the Trust Account; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that if the Business Combination or another business combination is not consummated
                                            within the required time period, Bowen will cease all operations except for the purpose of
                                            winding up, redeeming 100% of the outstanding Public Shares for cash and, subject to the
                                            approval of its remaining shareholders and the Bowen Board, dissolving and liquidating.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
personal and financial interests of the Insiders as well as Bowen&#8217;s executive officers and directors may have influenced their
motivation in identifying and selecting Qianzhi as a business combination target, completing the Business Combination with Qianzhi and
influencing the operation of the business following the Business Combination. The existence of such financial and personal interests
may result results in conflicts of interest on the part of such executive officers, directors and Insiders between what he, she, or they
may believe is in the best interests of Bowen and what he, she, or they may believe is best for himself, herself, or themselves in determining
to recommend that shareholders vote for the proposals. In considering the recommendations of the Bowen Board to vote for the proposals,
its shareholders should consider these interests. See this section entitled &#8220;<i>Shareholder Proposal No. 1: The Business Combination
Proposal &#8212; Interests of Certain Persons in the Business Combination.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommendation
of the Bowen Board</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Board has determined that the Business Combination, on the terms and conditions set forth in the Business Combination Agreement,
is advisable and in the best interests of Bowen and its shareholders and has directed that the proposals set forth in this proxy statement/prospectus
be submitted to its shareholders for approval at the Shareholder Meeting on the date and at the time and place set forth in this proxy
statement/prospectus. The Bowen Board recommends that Bowen&#8217;s shareholders vote &#8220;FOR&#8221; the Business Combination Proposal,
&#8220;FOR&#8221; each of the Charter Amendment Proposals, &#8220;FOR&#8221; the Nasdaq Proposal, &#8220;FOR&#8221; the Equity Incentive
Plan Proposal, &#8220;FOR&#8221; the election of directors set forth in the Director Election Proposal and &#8220;FOR&#8221; the Adjournment Proposal (if necessary). See the section entitled &#8220;<i>Shareholder Proposal No. 1: The Business Combination Proposal
&#8212; Recommendation of the Bowen Board and Reasons for the Business Combination</i>&#8221; for additional information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen&#8217;s
directors and officers may have financial interests in the Business Combination that are different from, or in addition to, their interests
as shareholders of Bowen and the interests of shareholders of Bowen generally. The existence of financial and personal interests of one
or more of Bowen&#8217;s directors may result in a conflict of interest on the part of such director(s) between what they may believe
is in the best interests of Bowen and its shareholders and what they may believe is best for themselves in determining to recommend that
shareholders vote for the proposals. See the section entitled &#8220;<i>Shareholder Proposal No. 1: The Business Combination Proposal
&#8212; Interests of Certain Persons in the Business Combination</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anticipated
Accounting Treatment</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is anticipated that the Business Combination will be accounted for as a reverse recapitalization in accordance with GAAP. Under this
method of accounting, Bowen is expected to be treated as the &#8220;acquired&#8221; company for financial reporting purposes. Accordingly,
for accounting purposes, the financial statements of New Bowen will represent a continuation of the financial statements of Qianzhi with
the Transactions treated as the equivalent of Qianzhi issuing shares for the net assets of Bowen, accompanied by a recapitalization.
The net assets of Bowen will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to
the Business Combination will be those of Qianzhi in future reports of New Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory
Matters</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination is not subject to any additional federal or state regulatory requirement or approval, except for (i) filings with
the Cayman Islands necessary to effectuate the Business Combination, (ii) filings of solicitation materials required pursuant to Rule
14a-12 of the Exchange Act [and (iii) filings required to be made with the CSRC and CFIUS].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
and Uncertainties Relating to Doing Business in China</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
faces various risks and uncertainties related to doing business in mainland China. Qianzhi&#8217;s business operations are primarily
conducted in mainland China, and it is subject to complex and evolving laws and regulations in mainland China. For example, it faces
risks associated with regulatory approvals on offshore offerings, antimonopoly regulatory actions, and oversight on cybersecurity and
data privacy, which may impact its ability to conduct certain businesses, accept foreign investments, or list on a United States stock
exchange. These risks could result in a material adverse change in its operations and the value of New Bowen&#8217;s securities, significantly
limit or completely hinder its ability to continue to offer securities to investors, or cause the value of such securities to significantly
decline. For a detailed description of risks related to doing business in China, please refer to risks disclosed under &#8220;<i>Risk
Factors&#8201;&#8212;&#8201;Risks Relating to Doing Business in China</i>.&#8221; </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC
government has significant authority in regulating New Bowen&#8217;s operations and may influence its operations. It may exert more oversight
and control over offerings conducted overseas by, and/or foreign investment in, China-based issuers, which could significantly limit
or completely hinder New Bowen&#8217;s ability to offer or continue to offer securities to investors. Implementation of industry-wide
regulations in this nature may cause the value of such securities to significantly decline. For more details, see &#8220;<i>Risk Factors&#8201;&#8212;&#8201;Risks
Relating to Doing Business in China&#8201;&#8212;&#8201;Failure to meet the PRC government&#8217;s complex regulatory requirements
on and significant oversight over our business operation could result in a material adverse change in our operations and the value of
our securities</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
and uncertainties arising from the legal system of mainland China, including risks and uncertainties regarding the interpretation and
enforcement of laws and quickly evolving rules and regulations in mainland China, could result in a material adverse change in New Bowen&#8217;s
operations and the value of its securities. For more details, see &#8220;<i>Risk Factors&#8201;&#8212;&#8201;Risks Relating to Doing
Business in China&#8201;&#8212;&#8201;Uncertainties with respect to the legal system and changes in laws and regulations in mainland
China could adversely affect us.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Holding Foreign Companies Accountable Act</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the HFCAA, if the SEC determines that we have filed audit reports issued by a registered public accounting firm that has not been
subject to inspections by the PCAOB for two consecutive years, the SEC will prohibit our securities from being traded on a national
securities exchange or in the over-the-counter trading market in the United States. On December 16, 2021, the PCAOB issued a report
to notify the SEC of its determination that the PCAOB was unable to inspect or investigate completely registered public accounting
firms headquartered in mainland China and Hong Kong. On December 15, 2022, the PCAOB issued a report that vacated its December 16,
2021 determination and removed mainland China and Hong Kong from the list of jurisdictions where it is unable to inspect or
investigate completely registered public accounting firms. Qianzhi&#8217;s auditor is, and New Bowen&#8217;s auditor will be,
headquartered in Rowland Heights, California and is and will be subject to PCAOB inspections to assess its compliance with the
applicable professional standards. The PCAOB currently has access to inspect the working papers of Qianzhi&#8217;s auditor and such auditor was not subject to the determinations announced by the PCAOB on December 16, 2021. Each year, the PCAOB will
determine whether it can inspect and investigate completely audit firms in mainland China and Hong Kong, among other jurisdictions.
If the PCAOB determines in the future that it no longer has full access to inspect and investigate completely accounting firms in
mainland China and New Bowen uses an accounting firm headquartered in one of these jurisdictions to issue an audit report on its
financial statements filed with the SEC, New Bowen would be identified as a Commission-Identified Issuer following the filing of the
annual report for the relevant fiscal year. In accordance with the HFCAA, New Bowen&#8217;s securities would be prohibited from
being traded on a national securities exchange or in the over-the-counter trading market in the United States if it is identified as
a Commission-Identified Issuer for two consecutive years in the future. If New Bowen&#8217;s securities are prohibited from trading
in the United States, there is no certainty that it will be able to list on a non-U.S. exchange or that a market for its securities
will develop outside of the United States. In the event of such prohibition, the Nasdaq may determine to delist our securities. The
delisting of New Bowen&#8217;s securities, or the threat of their being delisted, may materially and adversely affect the value of
your investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"></p>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Permissions
Required from the PRC Authorities for New Bowen&#8217;s Operations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Qianzhi conducts, and <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen will conduct, its business in mainland China primarily through its PRC subsidiaries. Its operations in mainland China are governed
by laws and regulations of mainland China. Many aspects of Qianzhi&#8217;s business depend on obtaining and maintaining licenses, approvals,
permits or qualifications from PRC regulators. Obtaining such approvals, licenses, permits or qualifications depends on Qianzhi&#8217;s
or New Bowen&#8217;s compliance with regulatory requirements, as applicable. PRC regulatory authorities also have relatively broad discretion
to grant, renew and revoke licenses and approvals and to implement laws and regulations. Based on the legal advice of our PRC legal
counsel, Jingsh &amp; H Y Leung and the PRC laws and regulations currently in effect, and subject to different interpretations of these
laws and regulations that may be adopted by PRC authorities, as of the date of this proxy statement/prospectus, Qianzhi&#8217;s PRC
subsidiaries have obtained all of the licenses and approvals necessary to operate in China. As of the date of this proxy statement/prospectus,
none of the applications by Qianzhi or its subsidiaries for licenses or permits have been denied by the relevant governmental agency
or authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">However,
licensing requirements in China are constantly evolving, and New Bowen and the PRC subsidiaries may be subject to more stringent
regulatory requirements due to changes in the political or economic policies in the relevant jurisdictions. We cannot assure you
that the PRC subsidiaries will be able to satisfy such regulatory requirements, and as a result, the PRC subsidiaries may be unable
to retain, obtain or renew relevant licenses, permits or approvals in the future.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore, the government authorities may subsequently require the PRC subsidiaries and the affiliated entities
to obtain additional licenses, permits and approvals.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
If (i) Qianzhi (or New Bowen) does not receive or maintain any required permissions or approvals, (ii) Qianzhi (or New Bowen) inadvertently
concluded that certain permissions or approvals have been acquired or are not required, or (iii) applicable laws, regulations or interpretations
thereof change and Qianzhi (or New Bowen) becomes subject to the requirement of additional permissions or approvals in the future, there
is no assurance that such permissions or approvals will be able to be obtained in a timely manner, or at all, and such approvals may
be rescinded even if obtained. Any such circumstance could subject Qianzhi (or New Bowen) to sanctions imposed by the PRC regulatory
authorities, which could include fines and penalties, proceedings against it, and other forms of sanctions, and Qianzhi&#8217;s (or New
Bowen&#8217;s) business, financial condition and results of operations may be materially and adversely affected. For more detailed information,
see &#8220;<i>Risk Factors&#8201;&#8212;&#8201;Risks Relating to Doing Business in China&#8201;&#8212;&#8201;Uncertainties with respect
to the legal system and changes in laws and regulations in mainland China could adversely affect us.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the PRC government has recently sought to exert more oversight and control over offerings that are conducted overseas and/or
foreign investment in China-based issuers. The PRC subsidiaries and the affiliated entities may also experience adverse publicity
arising from such non-compliance with government regulations that negatively impact us. For more detailed information, see &#8220;<i>Risk
Factors&#8201;&#8212;&#8201;Risks Relating to Doing Business in China&#8201;&#8212;&#8201;The approval of and filing with the CSRC
or other PRC government authorities is required in connection with this Business Combination of our listing under laws of mainland China.
However, we cannot predict whether or when we will be able to obtain such approval or complete such filing, and even if we obtain such
approval, it could be rescinded. Any failure to or delay in obtaining such approval or complying with such filing requirements in relation
to offering, or a rescission of such approval, could subject us to sanctions imposed by the CSRC or other PRC government authorities.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
and Asset Flows through New Bowen&#8217;s Organization</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen is a holding company with no operations of its own. Qianzhi currently conducts its operations through its subsidiaries in
China. As a result, following consummation of the Business Combination, New Bowen&#8217;s ability to pay dividends to the
shareholders and to service any debt it may incur may depend upon dividends paid by its subsidiaries. If any of its subsidiaries
incurs debt on its own behalf in the future, the instruments governing such debt may restrict its ability to pay dividends to New
Bowen. In addition, its PRC subsidiaries are permitted to pay dividends to New Bowen only out of their accumulated after-tax-profits
upon satisfaction of relevant statutory conditions and procedures, if any, as determined in accordance with PRC accounting standards
and regulations. Further, its PRC subsidiaries are required to make appropriations to certain statutory reserve funds or may make
appropriations to certain discretionary funds, which are not distributable as cash dividends except in the event of a solvent
liquidation of the companies. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen&#8217;s board of directors will have complete discretion on whether to distribute dividends subject to its memorandum and
articles of association and certain restrictions under Cayman Islands law. Under Cayman Islands law, a Cayman Islands company may
pay a dividend out of either profit or its share premium account, provided that in no circumstances may a dividend be paid out of
the share premium account if this would result in the company being unable to pay its debts as they fall due in the ordinary course
of business. The decision to distribute dividends will be based on several factors, including New Bowen&#8217;s financial
performance, growth prospects, and liquidity requirements. To date, Qianzhi has not declared or paid any dividend to its
shareholders. It is expected that New Bowen will retain most, if not all, of its available funds and any future earnings after the
Business Combination to fund the development and growth of its business. As a result, it is not expected that New Bowen will pay any
cash dividends in the foreseeable future. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"></p>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
laws and regulations of mainland China, Qianzhi&#8217;s PRC subsidiaries are subject to certain restrictions with respect to paying
dividends or otherwise transferring any of their net assets to Qianzhi. Remittance of dividends by a wholly foreign-owned enterprise
out of mainland China is also subject to examination by the banks designated by State Administration of Foreign Exchange, or SAFE. The
amounts restricted include the paid-in capital and the statutory reserve funds of its PRC subsidiaries. Furthermore, cash transfers from
Qianzhi&#8217;s PRC subsidiaries to entities outside of mainland China are subject to PRC governmental control on currency conversion.
As a result, the funds in its PRC subsidiaries in mainland China may not be available to fund operations or for other use outside of
mainland China due to interventions in, or the imposition of restrictions and limitations on, the ability of the holding company, or
its subsidiaries by the PRC government on such currency conversion. see &#8220;<i>Risk Factors&#8212;Risks Relating to Doing Business
in the PRC&#8212;We rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing requirements
we may have, and any limitation on the ability of our PRC subsidiaries to make payments to us could have a material and adverse effect
on our ability to conduct our business,&#8221;</i> and <i>&#8220;Risk Factors&#8212;Risks Relating to Doing Business in the PRC&#8212;PRC
regulations of loans and direct investment by offshore holding companies to PRC entities may delay or prevent us from using the proceeds
of our offshore financing to make loans or additional capital contributions to our PRC subsidiary, which could materially and adversely
affect our liquidity and our ability to fund and expand our business,&#8221; and </i>&#8220;<i>Risk Factors&#8201;&#8212;&#8201;Risks
Relating to Doing Business in China&#8201;&#8212; Restrictions on the remittance of Renminbi into and out of China and governmental
control of currency conversion may limit our ability to pay dividends and other obligations and affect the value of your investment.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
laws of mainland China, Qianzhi may provide funding to its PRC subsidiaries only through capital contributions or loans, subject to
satisfaction of applicable government registration that it is not able to make direct capital contribution. Qianzhi has established
cash management policies to direct how funds are transferred among Qianzhi and its subsidiaries to ensure the efficient and compliant
handling of funds. These policies dictate that each cash transfer shall (i) go through approval processes, ensuring that only authorized
personnel are involved in the transaction, (ii) be properly recorded, facilitating audits and financial reviews, and (iii) be in compliance
with all applicable laws and regulations, including anti-money laundering and know-your-customer requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Permission,
Review and Filing Required from the Authorities in Mainland China Relating to the Transactions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC government has recently sought to exert more control and impose more restrictions on China-based companies raising capital offshore
and such efforts may continue or intensify in the future. On July 6, 2021, the relevant PRC authorities promulgated the Opinions on Severely
Cracking Down on Illegal Securities Activities According to Law, which emphasized the need to strengthen the supervision over overseas
listings by mainland China-based companies. Effective measures, such as promoting the establishment of relevant regulatory systems, are
to be taken to deal with the risks and incidents of mainland China-based overseas-listed companies, cybersecurity and data privacy protection
requirements and similar matters. The revised Measures for Cybersecurity Review issued by Cyberspace Administration of China (the &#8220;CAC&#8221;)
and several other administrations on December 28, 2021 (which took effect on February 15, 2022) also requires that, in addition to critical
information infrastructure operators purchasing network products or services that affect or may affect national security, any &#8220;online
platform operator&#8221; carrying out data processing activities that affect or may affect national security should also be subject to
a cybersecurity review, and any &#8220;online platform operator&#8221; possessing personal information of more than one million users
must apply for a cybersecurity review before its listing overseas. In the event a member of the cybersecurity review working mechanism
is in the opinion that any network product or service or any data processing activity affects or may affect national security, the Office
of Cybersecurity Review shall report the same to the Central Cyberspace Affairs Commission for its approval under applicable procedures
and then conduct cybersecurity review in accordance with the revised Measures for Cybersecurity Review. In addition, on November 14,
2021, the CAC released the Regulations on Network Data Security (Draft for Comments), which clarified that data processors refer to individuals
or organizations that autonomously determine the purpose and the manner of processing data, and if a data processor that processes personal
data of more than one million users intends to list overseas, it must apply for a cybersecurity review. In addition, data processors
that are listed overseas must carry out an annual data security assessment. Nonetheless, there remain substantial uncertainties with
respect to the interpretation and implementation of these rules and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"></p>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
according to the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies, or the Overseas Listing
Trial Measures, and five supporting guidelines, issued by the China Securities Regulatory Commission, or the &#8220;CSRC,&#8221; on February
17, 2023, collectively the Overseas Listing Filing Rules, if a PRC domestic company intends to complete a direct or indirect overseas
(i) initial public offering and listing, or (ii) listing of its assets through a single or multiple acquisitions, share swaps, shares
transfers or other means, the issuer (if the issuer is a PRC domestic company) or its designated major PRC domestic operating entity
(if the issuer is an offshore holding company), in each applicable event, the reporting entity, shall complete the filing procedures
with the CSRC within three business days after the issuer submits its application documents relating to the initial public offering and/or
listing or after the first public announcement of the relevant transaction (if the submission of relevant application documents is not
required). According to the Overseas Listing Filing Rules and a set of Q&amp;A published on the CSRC&#8217;s official website in connection
with the release of the Overseas Listing Filing Rules, if it is explicitly required (in the form of institutional rules) by any regulatory
authority having jurisdiction over the relevant industry and field that regulatory procedures should be performed prior to the overseas
listing of a PRC domestic company, such company must obtain the regulatory opinion, approval and other documents from and complete any
required filing with such competent authority before submitting a CSRC filing. The reporting entity shall make a timely report to the
CSRC and update its CSRC filing within three business days after the occurrence of any of the following material events, if any of them
occurs after obtaining its CSRC filing and before the completion of the offering and/or listing: (i) any material change to principal
business, licenses or qualifications of the issuer; (ii) a change of control of the issuer or any material change to equity structure
of the issuer; and (iii) any material change to the offering and listing plan. Once listed overseas, the reporting entity will be further
required to report the occurrence of any of the following material events within three business days after the occurrence and announcement
thereof to the CSRC: (i) a change of control of the issuer; (ii) the investigation, sanction or other measures undertaken by any foreign
securities regulatory agencies or relevant competent authorities in respect of the issuer; (iii) change of the listing status or transfer
of the listing board; and (iv) the voluntary or mandatory delisting of the issuer. In addition, the completion of any overseas follow-on
offerings by an issuer in the same overseas market where it has completed its public offering and listing would necessitate a filing
with the CSRC within three business days thereafter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Overseas Listing Filing Rules came into effect on March 31, 2023 and there remain substantial uncertainties with respect to its interpretation
and implementation. Based on the Notice on Administration for the Filing of Overseas Offering and Listing by Domestic Companies published
by the CSRC on February 17, 2023, or the Notice on the Overseas Listing Filing, and the set of Q&amp;A published on the CSRC&#8217;s
official website, which are in connection with the release of the Overseas Listing Filing Rules, the CSRC clarifies that (i) on or prior
to the effective date of the Overseas Listing Filing Rules, domestic companies that have already submitted valid applications for overseas
offering and listing but have not obtained approval from overseas regulatory authorities or stock exchanges may reasonably arrange the
timing for submitting their filing applications with the CSRC, and must complete the filing before the completion of their overseas offering
and listing; (ii) a transition period until September 30, 2023 will be granted to domestic companies which have already obtained the
approval from overseas regulatory authorities or stock exchanges but have not completed the indirect overseas listing prior to the effective
date of the Overseas Listing Filing Rules; if domestic companies fail to complete the overseas listing prior to September 30, 2023, they
shall file with the CSRC according to the requirements. Based on the Overseas Listing Filing Rules, the Notice on the Overseas Listing
Filing and the set of Q&amp;A published on the CSRC&#8217;s official website, New Bowen is required to complete the filing procedures
with the CSRC in connection with this Business Combination as required by the Overseas Listing Filing Rules prior to the listing of its
securities on Nasdaq. New Bowen has not yet submitted a filing with the CSRC with respect to the Business Combination. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement/prospectus, Qianzhi has not been involved in any investigations on cybersecurity review initiated
by the CAC and it has not received any official inquiry, notice, warning, or sanctions regarding cybersecurity and overseas listing from
the CAC, CSRC or any other PRC authorities. Based on the opinion of Qianzhi&#8217;s mainland China legal counsel, Jingsh &amp; H Y
Leung, Qianzhi believes that, as of the date of this proxy statement/prospectus, the completion of the Business Combination does
not require the application or completion of any cybersecurity review from PRC governmental authorities, including the CAC. However,
given (i) the uncertainties with respect to the enactment, implementation, and interpretation of the Overseas Listing Filing Rules and
laws and regulations relating to data security, privacy, and cybersecurity; and (ii) that the PRC government authorities have significant
discretion in interpreting and implementing statutory provisions in general, it cannot be assured that the relevant PRC government authorities
will not take a contrary position or adopt different interpretations, or that there will not be changes in the regulatory landscape..</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"></p>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
(i) the parties do not receive or maintain any required permission, or fail to complete any required review or filing, (ii) the
parties inadvertently conclude that such permission, review or filing is not required, or (iii) applicable laws, regulations, or
interpretations change such that it becomes mandatory for the parties to obtain any permission, review or filing in the future, the
parties may have to expend significant time and costs to comply with these requirements. If the parties are unable to do so, on
commercially reasonable terms, in a timely manner or otherwise, they may become subject to sanctions imposed by the PRC regulatory
authorities, which could include fines and penalties, proceedings against it, and other forms of sanctions, and the parties&#8217;
ability to conduct business, invest into China as foreign investments or accept foreign investments, complete the Business
Combination, or list on a U.S. or other overseas exchange may be restricted, and its business, reputation, financial condition, and
results of operations may be materially and adversely affected. Further, Qianzhi&#8217;s ability to offer or continue to offer
securities to investors may be significantly limited or completely hindered, and the value of New Bowen&#8217;s securities may
significantly decline. For more detailed information, see &#8220;<i>Risk Factors&#8201;&#8212;&#8201;Risks Relating to Doing
Business in China&#8201;&#8212;&#8201;&#8221;We conduct our business in a highly regulated environment and are subject to
extensive regulations in China which affect our operations, and which could result in material changes in our operations and the
value of our ordinary shares,&#8221; </i>and &#8220;&#8212; <i>The approval of and filing with the CSRC or other PRC government
authorities is required in connection with this Business Combination of our listing under laws of mainland China. However, we cannot
predict whether or when we will be able to obtain such approval or complete such filing, and even if we obtain such approval, it
could be rescinded. Any failure to or delay in obtaining such approval or complying with such filing requirements in relation to
offering, or a rescission of such approval, could subject us to sanctions imposed by the CSRC or other PRC government
authorities.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Emerging
Growth Company</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Business Combination, New Bowen will be, an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act,
as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;<span style="font-weight: normal"><i>JOBS Act</i></span>&#8221;).
As such, it will be eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other
public companies that are not &#8220;emerging growth companies&#8221; including, but not limited to, not being required to comply with
the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the &#8220;<span style="font-weight: normal"><i>Sarbanes-Oxley
Act</i></span>&#8221;), reduced disclosure obligations regarding executive compensation in their periodic reports and proxy statements,
and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any
golden parachute payments not previously approved. If some investors find the combined company&#8217;s securities less attractive as
a result, there may be a less active trading market for the combined company&#8217;s securities and the prices of the combined company&#8217;s
securities may be more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
JOBS Act also provides that an emerging growth company does not need to comply with any new or revised financial accounting standards
until such date that a private company is otherwise required to comply with such new or revised accounting standards. Pursuant to the
JOBS Act, the combined company has elected to take advantage of the benefits of this extended transition period for complying with new
or revised accounting standards as required when they are adopted for public companies. As a result, the combined company&#8217;s operating
results and financial statements may not be comparable to the operating results and financial statements of other companies who have
adopted the new or revised accounting standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
combined company will remain an emerging growth company until the earlier of: (i) the last day of the fiscal year (a) following the fifth
anniversary of the IPO, (b) in which it has total annual gross revenue of at least US$1.235 billion, or (c) in which the combined company
is deemed to be a large accelerated filer, which means the market value of the combined company&#8217;s common equity that is held by
non-affiliates exceeds US$700 million as of the last business day of its most recently completed second fiscal quarter; and (ii) the
date on which the combined company has issued more than US$1.00 billion in non-convertible debt securities during the prior three-year
period. References herein to &#8220;emerging growth company&#8221; have the meaning associated with it in the JOBS Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign
Private Issuer</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen believes it will qualify as a foreign private issuer under the Exchange Act at the first measurement period following the consummation
of the Business Combination. As a result, New Bowen anticipates that it will be permitted to follow the corporate governance practices
of its home country, the Cayman Islands, in lieu of the corporate governance standards of Nasdaq applicable to U.S. domestic companies.
For example, it will not be required to have a majority of the board consisting of independent directors nor have a compensation committee
or a nominating and corporate governance committee consisting entirely of independent directors. As a result, New Bowen&#8217;s shareholders
may not have the same protection afforded to shareholders of U.S. domestic companies that are subject to Nasdaq corporate governance
requirements. Foreign private issuers are also subject to reduced disclosure requirements and are exempt from certain provisions of the
U.S. securities rules and regulations applicable to U.S. domestic issuers such as the rules regulating solicitation of proxies and certain
insider reporting and short-swing profit rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Controlled
Company</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
consummation of the Business Combination, the former NewCo equityholders will beneficially own approximately 46.7% of the combined voting
power of New Bowen Ordinary Shares and NewCo&#8217;s majority equityholder will beneficially own approximately 36.4% of the combined
voting power of New Bowen Ordinary Shares, assuming no redemptions by the Public Shareholders of Bowen&#8217;s Public Shares, a total
of 690,000 Bowen Ordinary Shares are issued upon the conversion of the Bowen Rights, the Earnout Shares have been issued, and excluding
the effect of the issuance of securities in proposed PIPE Financing. However, assuming the maximum number of redemptions by the Public
Shareholders of Bowen&#8217;s Public Shares (and the other assumptions remain accurate), NewCo&#8217;s majority equityholder would beneficially
own 58% of the combined voting power of New Bowen Ordinary Shares and in such an event, New Bowen would be a &#8220;controlled company&#8221;
as defined in the corporate governance rules of Nasdaq. For so long as New Bowen is as a controlled company under that definition, it
would be permitted to elect to rely on certain exemptions from the Nasdaq corporate governance rules, including the requirements that
(i) a majority of the board of directors consists of independent directors; (ii) its board of directors have a compensation committee
that is composed entirely of independent directors with a written charter addressing the committee&#8217;s purpose and responsibilities
and (iii) its board of directors have a nominating and corporate governance committee that is composed entirely of independent directors
with a written charter addressing the committee&#8217;s purpose and responsibilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, the investors may not have the same protection afforded to shareholders of companies that are subject to these corporate governance
requirements. New Bowen&#8217;s status as a controlled company could cause its securities to look less attractive to certain investors
or otherwise harm the trading price. Please see &#8220;<i>Risk Factors &#8212; If New Bowen meets the definition of a &#8220;controlled
company&#8221; under the rules of the Nasdaq Listing Rule, it may choose to exempt from certain corporate governance requirements that
could have an adverse effect on the public shareholders.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material
U.S. Federal Income Tax Considerations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a description of material U.S. federal income tax consequences of the Business Combination, the exercise of redemption rights in respect
of Bowen Ordinary Shares and the ownership and disposition of Bowen Ordinary Shares, please see &#8220;<i>Material Tax Considerations&#8201;&#8212;&#8201;Material
U.S. Federal Income Tax Considerations to U.S. Holders</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary
Risk Factors</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Business Combination, Qianzhi and Bowen are subject to numerous risks and uncertainties. You should carefully consider these and the
other risks set forth in the section entitled &#8220;Risk Factors&#8221; of this proxy statement/prospectus. Such risks include, but
are not limited to:</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Relating to Qianzhi&#8217;s Business and Industry</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">If
                                            our products fail to meet the demands of our customers or to reflect the latest developments
                                            in the personal hygiene and disinfection products market, we may be unable to retain existing
                                            customers or attract new customers, and our business, financial condition and results of
                                            operations may be materially and adversely affected.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            significant portion of our revenue is concentrated with a small number of customers and we
                                            could be seriously harmed if these customers significantly reduced the volume of business
                                            they conduct, or cease doing business, with us.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                            may be unable to maintain our relationships with our customers and we may fail to engage
                                            new customers.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                            may be compelled to undertake product recalls or other actions, which could adversely affect
                                            our brand image, financial condition, results of operations, and growth prospects.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
                                            revenues and financial results may be adversely affected by an economic slowdown on a global
                                            scale or in any jurisdictions in which we operate. </span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Heightened
                                            tensions in international relations may adversely impact our business, financial condition,
                                            and results of operations.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                            face intense competition in the personal hygiene and disinfection products industry from
                                            numerous competitors.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                            are subject to cost overruns and delays, regulatory requirements, and miscalculations in
                                            capacity needs with respect to our expansion projects and our manufacturing facilities, as
                                            well as disruptions to our manufacturing facilities and those of our contract manufacturers
                                            and other suppliers.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
                                            facilities and operations may require continuous and substantial investment and upgrading.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                            have a limited operating history and our ability to successfully commercialize products of
                                            high quality and appeal to customers at scale is unproven and still evolving.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may experience net losses and may not sustain profitability in the future.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            rely on third-party suppliers and distributors for many of the materials utilized in our
                                            products and they may not continue to produce products or provide services that are consistent
                                            with our standards or applicable regulatory requirements, which could harm our brand, cause
                                            consumer dissatisfaction, and require us to find alternative suppliers of our products.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
                                            success depends on the continuing efforts of our senior management team and other key employees.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">If
                                            we fail to maintain an effective system of internal control over financial reporting, we
                                            may be unable to accurately report our financial results or prevent fraud, and investor confidence
                                            in our company and the market price of our securities may be adversely affected.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Failure
                                            or security breach of our information technology systems may disrupt our operations.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
                                            joint statements by the SEC and the PCAOB, rule changes by Nasdaq, and the Holding Foreign
                                            Companies Accountable Act passed by the U.S. Senate all call for additional and more stringent
                                            criteria to be applied to emerging market companies upon assessing the qualification of their
                                            auditors, especially the non-U.S. auditors who are not inspected by the PCAOB. These developments
                                            could add uncertainties to our operations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Forecasts
                                            and projections of our operating and financial results relies in large part upon assumptions
                                            and analyses developed by our management. If these assumptions or analyses prove to be incorrect,
                                            our actual operating results may be materially different from those forecasted or projected.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
                                            business plans require a significant amount of capital. In addition, our future capital needs
                                            may require us to obtain additional equity or debt financing that may dilute our shareholders
                                            or introduce covenants that may restrict our operations or our ability to pay dividends.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            future growth is dependent on the demand for, and upon consumers&#8217; willingness to adopt
                                            personal hygiene products and disinfectants, which is associated with consumers&#8217; demand
                                            for personal hygiene products and disinfectants, and adoption of new personal hygiene products
                                            and disinfectants.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Relating to Doing Business in the PRC</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Failure
                                            to meet the PRC government&#8217;s complex regulatory requirements on and significant oversight
                                            over our business operation could result in a material adverse change in our operations and
                                            the value of our securities.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The
                                            approval of and filing with the CSRC or other PRC government authorities is required in connection
                                            with this Business Combination of our listing under laws of mainland China. However, we cannot
                                            predict whether or when we will be able to obtain such approval or complete such filing,
                                            and even if we obtain such approval, it could be rescinded. Any failure to or delay in obtaining
                                            such approval or complying with such filing requirements in relation to offering, or a rescission
                                            of such approval, could subject us to sanctions imposed by the CSRC or other PRC government
                                            authorities.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Additional
                                            Regulations under PRC Law Relating to Data Security and Confidentiality and Archives Management
                                            may subject us to additional compliance requirements in the future.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">PRC
                                            regulations of loans and direct investment by offshore holding companies to PRC entities
                                            may delay or prevent us from using the proceeds of our offshore financing to make loans or
                                            additional capital contributions to our PRC subsidiary, which could materially and adversely
                                            affect our liquidity and our ability to fund and expand our business.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Chinese
                                            regulatory authorities could disallow our holding company structure, which may result in
                                            a material change in our operations and/or a material change in the value of New Bowen&#8217;s
                                            securities, including that it could cause the value of such securities to significantly decline.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                            may be materially adversely affected if our shareholders and beneficial owners who are PRC
                                            entities fail to comply with the PRC overseas investment regulations.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund
                                            any cash and financing requirements we may have, and any limitation on the ability of our
                                            PRC subsidiaries to make payments to us could have a material and adverse effect on our ability
                                            to conduct our business.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Relating to Intellectual Property, Information Technology and Legal Proceedings</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                            may be subject to intellectual property infringement claims, which may be expensive to defend
                                            and may disrupt our business and operations.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">As
                                            our patents may expire and may not be extended, our patent applications may not be granted,
                                            and our patent rights may be contested, circumvented, invalidated, or limited in scope, our
                                            patent rights may not protect us effectively. In particular, we may not be able to prevent
                                            others from developing or exploiting competing technologies, which could materially and adversely
                                            affect our business, financial condition, and results of operations.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">If
                                            our trademarks and trade names are not adequately protected, then we may not be able to build
                                            name recognition in our markets of interest and our business may be adversely affected.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                            depend on information technology to conduct our business. Any significant disruptions to
                                            our information technology systems or facilities, or those of third parties with which we
                                            do business, such as disruptions caused by cyber-attacks, could adversely impact our business.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">You
                                            may experience difficulties in effecting service of legal process, enforcing foreign judgments
                                            or bringing actions in China against us or our management named in the prospectus based on
                                            foreign laws. It may also be difficult for you or overseas regulators to conduct investigations
                                            or collect evidence within China.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif"><b><i>Risks
Relating to Being a Public Company and New Bowen&#8217;s Shares</i></b><i> </i></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">A market for New Bowen&#8217;s Shares may not develop, which would adversely affect the liquidity and price of New
Bowen&#8217;s Shares.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Our issuance of additional shares in connection with financings, acquisitions, investments, our equity incentive
plans or otherwise will dilute all other shareholders.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">New
                                            Bowen may be unable to maintain the listing of its securities on the Nasdaq Global Market
                                            in the future.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">You
                                            may face difficulties in protecting your interests, and your ability to protect your rights
                                            through U.S. courts may be limited, because New Bowen is incorporated under the laws of the
                                            Cayman Islands, and will conduct its operations, and its directors and executive officers
                                            reside, outside of the United States.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p>



<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif"></span></p>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            unaudited pro forma financial information included elsewhere in this proxy statement may
                                            not be indicative of what New Bowen&#8217;s actual financial position or results of operations
                                            would have been.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks
Related to Bowen Before the Business Combination, the Business Combination and Redemptions</i></span></p>



<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Bowen&#8217;s
                                            officers and directors have interests in the Business Combination that are different from
                                            those of Public Shareholders.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                            may become involved in litigation, including securities class action litigation relating
                                            to the proposed Business Combination that may materially adversely affect us.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Public
                                            Stockholders who wish to redeem their Public Shares for a pro rata portion of the Trust Account
                                            must comply with specific requirements for redemption that may make it more difficult for
                                            them to exercise their redemption rights prior to the deadline. If shareholders fail to comply
                                            with the redemption requirements specified in this proxy statement/prospectus, they will
                                            not be entitled to redeem their Public Shares for a pro rata portion of the funds held in
                                            the Trust Account.</span></td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
additional detail on these and other risks, see &#8220;Risk Factors&#8221; starting on page 47 of this proxy
statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_007"></span>SUMMARY
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary unaudited pro forma condensed combined financial information (the &#8220;Summary Pro Forma Information&#8221;) of Bowen
and Qianzhi, gives effect to the transactions contemplated by the Business Combination and related transactions. The following unaudited
pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X as amended by the
final rule, Release No. 33-10786 &#8220;Amendments to Financial Disclosures about Acquired and Disposed Businesses.&#8221; The unaudited
pro forma condensed combined financial statements are based on the Bowen historical financial statements and Qianzhi historical financial
statements as adjusted to give effect to the Business Combination and related transactions (collectively, the &#8220;Transactions&#8221;).
The unaudited pro forma condensed combined balance sheet gives pro forma effect to the Transactions as if they had been consummated on
June 30, 2024. The unaudited pro forma condensed combined statement of operations for the <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">three
months ended June 30, 2024 gives effect to the Transactions as if they had occurred on April 1, 2024, the beginning of the earliest period
presented.</span> The unaudited pro forma condensed combined statement of operations for the twelve months ended March 31,
2024 gives effect to the Transactions as if they had occurred on April 1, 2023, the beginning of the earliest period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Summary Pro Forma Information has been derived from, and should be read in conjunction with, the more detailed unaudited pro forma condensed
combined financial information included in the section titled &#8220;<i>Unaudited Pro Forma Condensed Combined Financial Statements</i>&#8221;
in this proxy statement/prospectus and the accompanying notes thereto. The unaudited pro forma condensed combined financial information
is based upon, and should be read in conjunction with, the historical financial statements and related notes of Bowen and Qianzhi for
the applicable periods included in this proxy statement/prospectus. The Summary Pro Forma Information has been presented for informational
purposes only and is not necessarily indicative of what the combined company&#8217;s financial position or results of operations actually
would have been had the Business Combination and related transactions been completed as of the dates indicated. In addition, the Summary
Pro Forma Information does not purport to project the future financial position or operating results of the combined company&#8217;s
following the reverse recapitalization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial information has been prepared using the assumptions below with respect to the potential
redemption into cash of Bowen ordinary shares:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scenario
                                            1&#8201;&#8212;&#8201;Assuming No Redemptions:</b> This presentation assumes that no Public
                                            Shareholder exercises redemption rights with respect to their Public Shares for a pro rata
                                            share of the funds in the Trust Account.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scenario
                                            2&#8201;&#8212;&#8201;Assuming 25% Redemptions:</b>&#8201;This presentation assumes that
                                            Public Shareholders holding 1,725,000 Public Shares will exercise their redemption rights
                                            for $18,319,500 of funds in the Trust Account. This redemption scenario assumes for
                                            illustrative purposes that there will be $54,965,200 left in the Trust Account assuming
                                            Public Shareholders exercise their redemption rights with respect to 1,725,000 Public Shares.
                                            </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scenario
                                            3&#8201;&#8212;&#8201;Assuming 75% Redemptions:</b>&#8201;This presentation assumes that
                                            Public Shareholders holding 5,175,000 Public Shares will exercise their redemption rights
                                            for $54,958,500 of funds in the Trust Account. This redemption scenario assumes for
                                            illustrative purposes that there will be $18,326,200 left in the Trust Account assuming
                                            Public Shareholders exercise their redemption rights with respect to 5,175,000 Public Shares.
                                            </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scenario
                                            4&#8201;&#8212;&#8201;Assuming Maximum Redemptions:</b>&#8201;This presentation assumes
                                            that Public Shareholders holding 6,900,000 Public Shares will exercise their redemption rights
                                            for $73,284,700 of funds in the Trust Account. The maximum redemption scenario assumes
                                            for illustrative purposes that there will be no funds left in the Trust Account assuming
                                            all Public Shareholders exercise their redemption rights with respect to all of the Public
                                            Shares. </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -24pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center">Pro Forma Combined</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Scenario 1<br/> Assuming No Redemptions</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Scenario 2<br/> Assuming 25% Redemptions</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Scenario 3<br/> Assuming 75% Redemptions</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Scenario 4<br/> Assuming Maximum Redemptions*</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><b>Summary Unaudited Pro Forma Condensed Combined Statement of Profit or Loss Data for the <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
    Months Ended June 30, 2024</span></b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left">Profit for the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(3,766,296</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(3,766,296</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(3,766,296</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(3,766,296</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Pro forma basic and diluted net loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.21</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.24</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.30</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.35</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Summary Unaudited Pro Forma Condensed Combined Statement of Profit or Loss Data for the Twelve Months Ended March 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Profit for the period</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right">(4,136,044</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right">(4,136,044</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right">(4,136,044</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right">(4,136,044</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pro forma basic and diluted net loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.23</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.26</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.3<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.39</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Summary Unaudited Pro Forma Condensed Combined Balance Sheet Data as of June 30,
    2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,311,847</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,992,347</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,353,347</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,027,147</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,625,058</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,625,058</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,625,058</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,625,058</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    equity</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79,686,789</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61,367,289</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,728,289</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,402,089</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
In maximum redemption scenario, with the issuance of securities in the proposed PIPE Financing of $5.0 million, Qianzhi will be
in compliance with the net tangible assets requirement of Nasdaq. Without PIPE financing, the Company&#8217;s failure to maintain compliance
with the net tangible assets requirement will result in termination of the Merger.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_008"></span>COMPARATIVE
PER SHARE DATA</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set forth per share data for Qianzhi and Bowen, on a stand-alone basis and on an unaudited pro forma combined basis,
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">historical per share information of Bowen for the <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">three
months ended June 30, 2024;</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">historical
    per share information of Qianzhi for the three months ended June 30, 2024;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">historical
    per share information of Bowen for the twelve months ended March 31, 2024;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">historical
    per share information of Qianzhi for the year ended March 31, 2024; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unaudited
    pro forma per share information of New Bowen for the <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">three months ended June 30, 2024 and
for</span> the twelve months ended March 31, 2024, after giving effect to the Business
    Combination, assuming four redemption scenarios as follows:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scenario
    1&#8201;&#8212;&#8201;Assuming No Redemptions:</b> This presentation assumes that no Public Shareholder exercises redemption rights
    with respect to their Public Shares for a pro rata share of the funds in the Trust Account.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scenario
    2&#8201;&#8212;&#8201;Assuming 25% Redemptions:</b>&#8201;This presentation assumes that Public Shareholders holding 1,725,000
    Public Shares will exercise their redemption rights for $18,319,500 of funds in the Trust Account. This redemption scenario
    assumes for illustrative purposes that there will be $54,965,200 left in the Trust Account assuming Public Shareholders exercise
    their redemption rights with respect to 1,725,000 Public Shares. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scenario
    3&#8201;&#8212;&#8201;Assuming 75% Redemptions:</b>&#8201;This presentation assumes that Public Shareholders holding 5,175,000
    Public Shares will exercise their redemption rights for $54,958,500 of funds in the Trust Account. This redemption scenario
    assumes for illustrative purposes that there will be $18,326,200 left in the Trust Account assuming Public Shareholders exercise
    their redemption rights with respect to 5,175,000 Public Shares. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scenario
    4&#8201;&#8212;&#8201;Assuming Maximum Redemptions:</b>&#8201;This presentation assumes that Public Shareholders holding 6,900,000
    Public Shares will exercise their redemption rights for $73,284,700 of funds in the Trust Account. The maximum redemption
    scenario assumes for illustrative purposes that there will be no funds left in the Trust Account assuming all Public Shareholders
    exercise their redemption rights with respect to all of the Public Shares.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma book value information reflects the Business Combination as if it had occurred on June 30, 2024. The weighted average
shares outstanding and net earnings per share information for the three months ended June 30, 2024 reflect the Business Combination
as if it had occurred on April 1, 2024. The weighted average shares outstanding and net earnings per share information for
the twelve months ended March 31, 2024 reflect the Business Combination as if it had occurred on April 1, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
information is only a summary and should be read in conjunction with the historical financial statements of Bowen and Qianzhi
and related notes included elsewhere in this proxy statement/prospectus. The unaudited pro forma combined per share information of Qianzhi
and Bowen is derived from, and should be read in conjunction with, the unaudited pro forma condensed combined financial statements and
related notes included elsewhere in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma combined net income per share information below does not purport to represent the net loss per share which would
have occurred had the companies been combined during the periods presented, nor earnings per share for any future date or period. The
unaudited pro forma combined book value per share information below does not purport to represent what the value of Qianzhi and Bowen
would have been had the companies been combined during the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
    Forma Combined</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scenario
    1<br/> Assuming No Redemptions</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scenario
    2<br/> Assuming 25% Redemptions</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scenario
    3<br/> Assuming 75% Redemptions</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scenario
    4<br/> Assuming Maximum Redemptions</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Book value per share as of June
    30, 2024</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.06</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88.15</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.54</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.78</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.53</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>F<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or the three months ended June 30,
2024</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average shares outstanding, common stock subject to possible redemption</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,900,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net income per share, common stock subject to redemption</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.12</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average shares
    outstanding, common stock, non-redeemable</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,266,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net income per share, common stock, non-redeemable</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.01</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: DengXian"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted
    weighted average of ordinary shares outstanding</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted loss per share</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10.51</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted
    pro forma weighted average shares outstanding</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: DengXian; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-family: DengXian; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,639,026</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,914,026</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,464,026</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,739,026</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted pro forma net loss per share</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.21</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.24</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.30</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.35</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%"><span style="font-size: 10pt"><b>For the twelve months ended March 31, 2024</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">Weighted average shares outstanding, common stock subject to possible redemption</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">4,929,508</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">Basic and diluted net income per share, common stock subject to redemption</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><span style="font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">0.95</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">Weighted average shares outstanding, common stock, non-redeemable</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">2,163,434</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">Basic and diluted net income per share, common stock, non-redeemable</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><span style="font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">(1.12</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">Basic and diluted weighted average of ordinary shares outstanding</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">50,000</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">Basic and diluted loss per share</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><span style="font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">(13.96</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">Basic and diluted pro forma weighted average shares outstanding</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">17,639,026</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">15,914,026</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">12,464,026</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">10,739,026</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">Basic and diluted pro forma net loss per share</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><span style="font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">(0.23</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><span style="font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">(0.26</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><span style="font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">(0.33</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><span style="font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">(0.39</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_009"></span>TICKER
SYMBOLS AND DIVIDEND INFORMATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
Information</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Units, Public Shares and Public Rights are currently listed on Nasdaq under the symbols &#8220;BOWNU,&#8221; &#8220;BOWN&#8221;
and &#8220;BOWNR,&#8221; respectively. Immediately prior to the Effective Time, the Bowen Units will automatically separate into their
component securities and, as a result, will no longer trade as an independent security. Upon the Closing, the New Bowen Ordinary Shares
are expected to be listed on Nasdaq under the symbol &#8220;MERA&#8221;. The Bowen Rights will automatically convert into Bowen
Ordinary Shares in accordance with their terms upon consummation of the Business Combination and no longer trade.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing price of the Bowen Units, the Public Shares and the Public Rights on January 17, 2024, the last trading day before announcement
of the execution of the Business Combination Agreement, was $10.43, $10.36 and $0.15, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of the Bowen Units, Public Shares and Public Rights should obtain current market quotations for their securities. The market price of
these securities could vary at any time before the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of [&#9679;], 2024, the Record Date, there was [&#9679;] holder of record of Bowen Units, [&#9679;] holders of record of shares of Ordinary
Shares and [&#9679;] holders of record of Bowen Warrants. The number of holders of record does not include a substantially greater number
of &#8220;street name&#8221; holders or beneficial holders whose Bowen Units, Ordinary Shares and Public Rights are held of record by
banks, brokers and other financial institutions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
has not paid any cash dividends to date and does not intend to pay cash dividends prior to the completion of the Business Combination.
Assuming the Business Combination is consummated, the payment of cash dividends in the future will be dependent, among other things,
upon New Bowen&#8217;s revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of
the Business Combination as well as compliance with the Proposed Charter and the Cayman Companies Act. The ability of New Bowen to declare
dividends may also be limited by the terms of financing or other agreements entered into by New Bowen from time to time, as well as any
foreign regulations that may restrict the payment of dividends in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
Information</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Qianzhi
is a privately-held corporation and none of its securities are publicly traded. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Ordinary Shares</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of [&#9679;], 2024, the Record Date, there were [&#9679;] holders of record of Shares of Qianzhi.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">There
is no public market for Qianzhi&#8217;s equity securities. Qianzhi has not paid any cash dividends on its stock to date and does not
intend to pay cash dividends prior to the completion of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Following
completion of the Business Combination, New Bowen&#8217;s Board of Directors will consider whether or not to institute a dividend policy.
It is presently intended that New Bowen retain its earnings for use in business operations and accordingly, we do not anticipate New
Bowen&#8217;s Board of Directors declaring any dividends in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_010"></span>RISK
FACTORS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should carefully consider all the following risk factors, together with all of the other information in this proxy statement/prospectus,
including the financial information, before deciding how to vote or instruct your vote to be cast to approve the Proposals described
in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
value of your investment following the completion of the Business Combination will be subject to significant risks affecting, among other
things, New Bowen&#8217;s and Qianzhi&#8217;s business, financial condition and results of operations. If any of the events described
below occur, New Bowen&#8217;s post-Business Combination business and financial results could be adversely affected in material respects.
This could result in a decline, which may be significant, in the trading price of New Bowen&#8217;s securities and you therefore may
lose all or part of your investment. The risk factors described below are not necessarily exhaustive and are based on certain assumptions
made by New Bowen and Qianzhi, which later may prove to be incorrect or incomplete. New Bowen and Qianzhi may face additional risks and
uncertainties that are not presently known to them, or that are currently deemed immaterial, but which may also ultimately have an adverse
effect on any such party or on the Business Combination. Therefore, you are encouraged to perform your own investigation with respect
to the businesses of New Bowen and Qianzhi.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this section, &#8220;<span style="font-weight: normal"><i>Qianzhi</i></span>,&#8221; &#8220;<span style="font-weight: normal"><i>we</i></span>,&#8221;
&#8220;<span style="font-weight: normal"><i>us</i></span>&#8221; or &#8220;<span style="font-weight: normal"><i>our</i></span>&#8221;
refer to Qianzhi and its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Related to Qianzhi&#8217;s Business and New Bowen After the Business Combination</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Risks
Relating to Qianzhi&#8217;s Business and Industry</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our products fail to meet the demands of our customers or to reflect the latest developments in the personal hygiene and disinfection
products market, we may be unable to retain existing customers or attract new customers, and our business, financial condition and results
of operations may be materially and adversely affected.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
personal hygiene and disinfection products market is characterized by rapid technological development and continual introduction of new
models. As a specialized manufacturer of hygiene and disinfection products, our future success depends largely on (i) our ability to
continually update and launch new products that can be used in updated or new product offerings from time to time, (ii) the number of
customers using our products and (iii) the price that they are willing to pay for our products. If our products fail to meet customer
demands in terms of product quality and functionality or to respond to the latest developments in the personal hygiene and disinfection
products market, we may not be able to maintain our existing customer base or attract new customers. In addition, we may not be able
to maintain the current selling prices of our products. Some factors that may affect our ability to meet customer demands and to attract
customers include: our ability to (i) develop or acquire the necessary technical know-how to design and manufacture new products and
enhance or adapt existing products to respond to changes in market trends and customer demands, (ii) manage our growth while maintaining
the consistency of our product quality, and (iii) promote our products to a broader base of prospective customers. If we are unable to
retain existing customers and continue to attract new customers to use our products and to increase their spending with us, our business,
financial condition and results of operations may be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
products and product line extensions may not gain widespread customer acceptance, may be otherwise discontinued, or cause sales of existing
products to decline.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future performance and growth depend on our ability to successfully identify, develop and introduce new products, product line
extensions and products in adjacent categories to our current products, and anticipate changes in consumer preferences. In
addition, largely due to consumer preferences and market dynamics affecting some of our skincare products, we believe it is
necessary to periodically refresh our product line to sustain brand awareness by adjusting our skincare products to include
additional attributes and/or enhancing our packaging. Accordingly, we believe it is important to frequently and timely introduce
innovative new product features and packaging to the marketplace. Additionally, we base our purchasing decisions for prepackaged
food products on our assessment of customer preferences and if we do not accurately make such decisions, we may not be able to
resell such products. The successful development and introduction of new products involves substantial research, development,
marketing and promotional expenditures, which we may be unable to recover if the new products do not gain widespread market
acceptance. New product development and marketing efforts, including efforts to enter markets or product categories in which we have
limited or no prior experience, have inherent risks. These risks include product development or launch delays, competitor actions,
regulatory approval hurdles and the failure of new products and line extensions to achieve anticipated levels of market acceptance.
In addition, sales generated by new products could result in an associated decline in sales of existing products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
year, we seek to introduce new products across the majority of our brands. However, there is no assurance that our new products
will be able to gain or maintain widespread acceptance. Success in launching new products is also dependent on our ability to deliver
effective and efficient marketing in an evolving media landscape (including digital), which is subject to dynamic and increasingly restrictive
privacy requirements. If product introductions are not successful, costs associated with these efforts may not be fully recouped and
our net earnings or margins could be adversely affected. From time to time, we may need to discontinue certain products and product lines,
which can result in returns from customers, asset write-offs and shutdown costs. We may suffer similar adverse consequences in the future
to the extent we discontinue products that do not meet retailer or consumer expectations or no longer satisfy consumer demand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on the policies of our key retailer customers.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Larger
and increasingly consolidated retailers have growing influence, and have sought to obtain lower pricing, special packaging inventory
practices, logistics or other changes to the customer-supplier relationship as a result of this influence. To the extent we provide concessions
or better trade terms to those customers, our profit margins are reduced. Further, if we are unable to effectively respond to the demands
of our customers, these customers could reduce their purchases of our products and increase their purchases of products from competitors.
Reductions in inventory by our customers, including as a result of consolidation in the retail industry, or these customers managing
their working capital requirements, could result in reduced orders for our products and adversely affect our results of operations and
cash flows for financial periods affected by such reductions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Protracted
unfavorable market conditions may cause many of our customers to more critically analyze the number of brands they sell, and reduce or
discontinue certain of our product lines, particularly those products that were not number one or two in their category.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, private label and retail-branded products sold by retail trade chains are typically sold at lower prices than branded products.
As consumers look for opportunities to decrease discretionary spending, our customers may discontinue or reduce distribution of some
of our products to encourage those consumers to purchase the customers&#8217; less expensive and, in some cases, more profitable services
or private label and retail-branded products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A
significant portion of our revenue is concentrated with a small number of customers and we could be seriously harmed if these customers
significantly reduced the volume of business they conduct, or cease doing business, with us.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
major customers are cosmetics retailers, beauty salons and health care centers. For the three months ended June 30, 2024, one customer
accounted for 12.0% of our total revenue. For the three months ended June 30, 2023, three customers accounted for 33.2%, 23.1% and 22.8%
of our total revenue, respectively. For the fiscal years ended March 31, 2024 and 2023, one customer accounted for 11.5% and 11.2%,
respectively, of our total revenue. Further, our <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">top 10 customers aggregately accounted
for 55.4% and 100.0% of the total revenue for the three months ended June 30, 2024 and 2023, respectively. O</span>ur top 10 customers aggregately accounted for 42.6% and 35.3% of the total revenue
for the years ended March 31, 2024 and 2023, respectively. Our dependence on a small number of larger customers could expose us to the
risk of substantial losses if a single large customer stops purchasing our products, purchases fewer of our products or goes out of business
and we cannot find substitute customers on equivalent terms. If any of our significant customers reduces the quantity of the products
they purchase from us or stops purchasing from us, our net revenues would be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be unable to maintain our relationships with our customers and we may fail to engage new customers.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we have multiple long-term sales agreements with certain of our customers, such agreements do not require our customers to purchase firm
quantities of our products and our customers must make discrete sales orders for us to generate sales revenues under these agreements.
We may not be able to obtain new purchases with our customers as they may choose to enter into arrangements with our competitors, who
may offer them access to a stronger product portfolio or more favorable economic terms. Accordingly, our customers could reduce their
purchasing levels or cease buying products from us at any time and for any reason. If we lose a significant customer or if sales of our
products to a significant customer materially decrease, it could have a material adverse effect on our business, financial condition
and results of operations. In addition, there can be no assurance that we would be able to develop new relationships with additional
customers, in order to expand our sales network.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have grown rapidly and expect to continue to expand our business in the future. If we fail to manage our growth or execute our growth
strategies, our business and results of operations may be materially and adversely affected.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the past few years, we experienced steady growth. Going forward, we expect to continue to expand our business and geographic coverage.
We may not succeed in executing our growth strategies due to a number of factors, such as:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may fail to develop products which respond to market changes and meet customers&#8217; demands
                                            and other factors;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may not be successful to effectively market our products in new markets or promote new products
                                            in existing markets; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may fail to achieve the benefits we expect from our expansion.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we fail to successfully execute our growth strategies, our business, financial performance and prospects may be materially and adversely
affected. In addition, our past performance and is not necessarily indicative of our financial condition, results of operations and changes
in liquidity and capital resources in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to maintain or increase the selling prices of our products.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
results of operations are affected by the pricing of our products. For ODM products and white-label products, we generally price our
products on the basis of a cost-plus calculation of the costs involved in manufacturing, and with reference to the prevailing market
prices. For new ODM products, we generally review and adjust our price list every month. Our ability to offer competitive prices and
launch new products and technologies quickly after the original-brand products and technologies are being released are critical factors,
among other factors, in securing orders from our customers. We are generally able to maintain current pricing strategies for our products
as a result of our localized operation and ancillary services provided to customers including drop ship service, private labeling and
customized packing services. We generally set our retail price based on our base selling prices, marketing expenses, fees paid to joint
distributors, different brand positioning and prices of competing products. If for any reason market perception of us should change
for the worse, we may not be able to maintain or increase the selling prices of our products, which would have a material and adverse
effect on our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
raw material purchase prices are subject to fluctuation, and we could face shortage in supply of our raw materials.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cost of inventory sold mainly consist of the raw materials used in our production. Our cost of inventory sold accounted for approximately
5% of our total cost of sales for the fiscal years ended March 31, 2024 and 2023. Depending on the market supply and demand
conditions, prices of our raw materials fluctuate and are influenced by the economic growth in the PRC, the prevailing prices of the
global market and the availability of such raw materials, all of which are beyond our control. A significant volatility in the price
levels of our raw materials could increase our cost of sales and adversely affect our profit margin. We have not hedged against changes
in commodity prices, and we do not intend to enter into such hedges in the future. We expect that our raw materials prices will continue
to fluctuate and be affected by the factors stated above in the future. As such, an increase in the prices of our raw materials, inability
to pass on or delay in passing on any increase in our costs of raw materials to our consumers or inability to identify and source from
alternative suppliers may have a significant impact on our profit margin and our profitability. We do not have long-term contractual
arrangements with our third-party suppliers. If all or a significant number of our suppliers for any particular raw material and/or packaging
material are unable or unwilling to meet our production requirements, or if we are unable to obtain raw materials in quantities and of
the quality we require at commercially reasonable prices, our production volume, product quality or profitability may deteriorate and
we could suffer shortages or significant cost increases which in turn may have a material adverse impact on our business, financial condition
and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
interruption in the normal operations of our warehouses may have an adverse impact on our ability to fulfill orders from our customers
and business operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to fulfill customer orders on a timely basis is critical to our business operations and depends on the smooth operation of our
warehouses. If we do not operate our warehouses well, it could result in delay in fulfilling customer orders, excess or insufficient
fulfillment capacity, an increase in costs, decrease in gross profit margin, or harm our reputation and relationships with our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our warehouses may be vulnerable to damage caused by fire, floods, power outages, telecommunication failures, break-ins, earthquakes,
human error and other events. Our warehouse management system could also be subject to errors or flaws, which could adversely impact
the normal operation of our warehouses and our ability to record inventory or fulfill orders on an accurate and efficient manner. Any
occurrence of the foregoing risks could have a material adverse impact on our business, financial conditions and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be compelled to undertake product recalls or other actions, which could adversely affect our brand image, financial condition, results
of operations, and growth prospects.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement/prospectus, no products sold or distributed by us have been recalled. If our products are subject
to recalls in the future, we may be subject to adverse publicity, damage to our brand, and liability for costs. In the future, we may
at various times, voluntarily or involuntarily, initiate a recall if any of our products, including any systems or parts sourced from
our suppliers, prove to be defective or noncompliant with applicable laws and regulations. Such recalls, whether voluntary or involuntary,
could involve significant expense and could adversely affect our brand image in our target markets, as well as our business, financial
condition, results of operations, and growth prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenues and financial results may be adversely affected by an economic slowdown on a global scale or in any jurisdictions in which we
operate.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
success of our business ultimately depends on consumer spending. Our revenues and financial results are impacted to a significant extent
by economic conditions globally and in any jurisdictions we operate. The global macroeconomic environment is facing numerous challenges.
Any slowdown could significantly reduce domestic commerce in jurisdictions we operate, including through the hygiene and disinfection
products market generally and through us. In addition, there is considerable uncertainty over the long-term effects of the expansionary
monetary and fiscal policies adopted by the central banks and financial authorities of some of the world&#8217;s leading economies, including
the United States and China. The conflicts in Ukraine and the imposition of broad economic sanctions on Russia could raise energy prices
and disrupt global markets. Unrest, terrorist threats and the potential for war in the Middle East and elsewhere may increase market
volatility across the globe. There have also been concerns about the relationship between China and other countries, including the surrounding
Asian countries, which may potentially have economic effects. In particular, there is significant uncertainty about the future relationship
between the United States and China with respect to trade policies, treaties, government regulations, and tariffs. Economic conditions
in jurisdictions we operate may be sensitive to global economic conditions, as well as changes in domestic economic and political policies
and the expected or perceived overall economic growth rate in specific jurisdiction. Any severe or prolonged economic slowdown globally
and in any jurisdictions, we operate may materially and adversely affect our business, results of operations, and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
continued change in the retail environment and changing consumer preferences could cause our sales to decline.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
increasing industry shifts to e-commerce, sales of our products and services remain highest in the traditional mass merchandiser and
retail stores. However, alternative retail channels, including direct to consumer, e-commerce retailers, hard discounters, subscription
services and buying clubs, have become more prevalent and the volume of consumer products that are sold through such alternative retail
channels is continuing to increase. In addition, a growing number of alternative sales channels and business models, such as niche brands,
native online brands, private label and store brands, direct-to-consumer brands and channels and discounter channels, have emerged in
the markets we serve. In particular, the growing presence of, and increasing sales through, e-commerce retailers have affected, and may
continue to affect, consumer behavior or preferences (as consumers increasingly shop online and via mobile and social applications) and
market dynamics, including any pricing pressures for consumer goods as retailers face added costs to build their e-commerce capacity.
Further, consumer preferences continue to evolve due to a number of factors, including fragmentation of the consumer market and changes
in consumer demographics, including the aging of the general population and the emergence of Millennials and Generation Z who have different
spending, consumption and purchasing habits; evolving consumer concerns or perceptions regarding ESG practices of manufacturers, including,
packaging materials, such as plastic packaging, and their environmental impact; greenhouse gas emissions; waste disposal practices; a
growing demand for natural or organic products and ingredients; changing consumer sentiment toward non-local products or sources among
different demographic groups; evolving consumer concerns or perceptions regarding the effects of ingredients or substances present in
certain consumer products; reduced brand loyalty; and concerns regarding human capital practices, including DEI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
significant changes in consumer preferences or behavior could materially and negatively impact demand for our products and services and,
in turn, our net sales and results of operations. Consumer preferences are also influenced by the perception of our brand images or those
of our products, the success of advertising and marketing campaigns, our ability to engage with consumers in the manner they prefer,
including through the use of digital media or assets, and the perception of our advertising content, use of social media and extent of
engagement in political and social issues. If we are not successful in adapting to changing consumer preferences and market dynamics
or expanding sales through alternative retail channels, our business, financial condition and results of operations may be negatively
impacted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Heightened
tensions in international relations may adversely impact our business, financial condition, and results of operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recently
there have been heightened tensions in international relations, particularly between the United States and China and the conflict between
Russia and Ukraine. These tensions have affected both diplomatic and economic ties. Heightened tensions could reduce levels of trade,
investments, technological exchanges, and other economic activities among major economies. Sanctions may create supply constraints and
drive inflation. The existing tensions and any further deterioration in international relations may have a negative impact on the general,
economic, political, and social conditions and adversely impact our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. government has made statements and taken certain actions that may lead to changes in U.S. and international trade policies towards
China. In January 2020, the &#8220;Phase One&#8221; agreement was signed between the United States and China on trade matters. However,
it remains unclear what additional actions, if any, will be taken by the U.S. or other governments with respect to international trade
agreements, the imposition of tariffs on goods imported into the United States, tax policy related to international commerce, or other
trade matters. Any unfavorable government policies on international trade, such as capital controls or tariffs, may affect the demand
for our products and services, impact the competitive position of our products and services or prevent us from selling products in certain
countries. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Likewise,
we are monitoring policies in the United States that are aimed at restricting U.S. persons from investing in or supplying certain Chinese
companies. The United States and various foreign governments have imposed controls, license requirements and restrictions on the import
or export of technologies and products (or voiced the intention to do so). For instance the U.S. government may potentially impose a
ban prohibiting U.S. persons from making investments in or engaging in transactions with certain Chinese companies. Chinese companies
may have to limit and reduce their research and development and other business activities, or cease conducting transactions with parties,
in the United States and other countries that impose export controls or other restrictions. Like other Chinese companies, our business,
financial condition and results of operations could be adversely affected as a result.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
conflict between Russia and Ukraine has, and is likely to continue to, generate uncertain geopolitical conditions, sanctions, and other
potential impacts on the global economic activities. While we do not have substantial operations in these areas or any direct suppliers
(i.e., Tier 1 supplier) from these areas, there is no guarantee that these geopolitical tensions will not cause reduce levels of trade,
investments and technological exchanges, or result in disruption to our global economic activities and supply chains, which in turn may
have an adverse impact on our business and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face intense competition in the personal hygiene and disinfection products industry from numerous competitors.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face intense competition in the markets in which we operate and many of our competitors may have substantially greater financial resources,
product development capabilities or better products quality than we have and may be able to respond more effectively to changing business
and economic conditions than we can. They may leverage their financial strength to improve their production and marketing capabilities,
diversify their product portfolio, develop effective substitutes for our products, locate their production facilities in strategic locations
and recruit experienced management personnel. Competition in these markets is based on the introduction of new products, pricing of products,
quality of products and packaging, brand awareness, perceived value and quality, innovation, in-store presence and visibility, promotional
activities, advertising, editorials, and other activities. We must compete with a high volume of new product introductions and existing
products by diverse companies across several different distribution channels.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
competitors may attempt to gain market share by offering products at prices at or below the prices at which our products are typically
offered, including through the use of large percentage discounts and &#8220;buy one and get one free&#8221; offers. Competitive pricing
may require us to reduce our prices, which would decrease our profitability or result in lost sales. Our competitors, many of whom have
greater resources than we do, may be better able to withstand these price reductions and lost sales. We cannot assure you that we will
be able to react to and match the business development of our competitors in a timely manner or at all. We also cannot assure you that
our competitors will not actively engage in activities designed to undermine our brands and product quality or to influence consumer
confidence in our products. In addition, new competitors may seek to enter or expand into our industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is difficult for us to predict the timing and scale of our competitors&#8217; activities in these areas or whether new competitors will
emerge. Our ability to compete also depends on the continued strength of our brand and products, the success of our marketing, innovation
and execution strategies, the continued diversity of our product offerings, the successful management of new product introductions and
innovations, strong operational execution, including in order fulfillment, and our success in entering new markets and expanding our
business in existing geographies. If we are unable to compete effectively with our competitors or if we fail to remain competitive, it
could materially and adversely affect our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to cost overruns and delays, regulatory requirements, and miscalculations in capacity needs with respect to our expansion
projects and our manufacturing facilities, as well as disruptions to our manufacturing facilities and those of our contract manufacturers
and other suppliers.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we initiate planned and unplanned expansion projects with respect to our facilities and those of our contract manufacturers
and other suppliers which are subject to risks of, and we have from time to time experienced, delay or cost overruns resulting from numerous
factors, including the following: shortages of equipment, materials or skilled labor; work stoppages; unscheduled delays in the delivery
of ordered materials and equipment; unanticipated cost increases; difficulties in obtaining necessary permits or in meeting permit conditions;
difficulties in meeting regulatory or quality requirements or obtaining regulatory approvals; availability of suppliers to certify equipment
for existing and enhanced regulations; design and engineering problems; failure or delay of third party service providers; and civil
unrest, labor disputes, natural disasters and pandemics. If we were to experience delays or cost overruns in the future it could result
in product allocation and retailer frustration, the loss of a significant customer or customers and the material decrease of the sales
of one or more of our products. In addition, we could miscalculate our anticipated capacity needs in any of our categories, including
as a result of meeting the anticipated demand of our customers, or expansion into new product lines or into new markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the supply of our products depends on the uninterrupted efficient operation of our manufacturing facilities and those of our contract
manufacturers and other suppliers and our ability to meet customer service levels. The manufacturing of certain of our products is concentrated
in one or more of our plants, contract manufacturers or other suppliers, with limited alternate qualified facilities available. Many
of our manufacturing processes and those of our contract manufacturers and other suppliers are complex and present difficult technical
challenges to obtain the manufacturing yields necessary to operate profitably and may require complex and specialized equipment which
can be expensive to repair or replace with required lead times of up to a year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
event that disrupts or otherwise negatively impacts manufacturing facilities, manufacturing systems or equipment, or contract manufacturers
or other suppliers could result in the delivery of inferior products or our ability to meet customer requirements or service levels.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may experience delays or interruptions in the shipments of our products due to factors outside of our control, and such delays or interruptions
could lead to lost revenue and customer satisfaction.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on third-party shipping companies and their services to transport our products to our warehouses and customers. Such services could
become disrupted by adverse weather conditions, natural disasters, ground logistics issues, and other interruptions. Any delays in shipping
services could result in untimely delivery of our products or provision of our services to our customers. If we are unable to deliver
our products or provide our services in a timely manner, our revenues could be negatively impacted and our reputation with our customers
could suffer, resulting in materially adverse impact to our business operations, financial position, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
performance depends on favorable labor relations with our employees. Any deterioration in these relations or a shortage of labor or a
rise in labor costs may have an adverse effect on our operating results.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
manufacturing process is labor intensive and relies heavily on know-how and experience of our employees. As result, we rely on a significant
number of skilled workers and other personnel to support our product development and manufacturing processes. Our success is dependent
on our ability to hire, train, retain and motivate our employees. If our employees are not satisfied with what we offer, such as remuneration
package or working environment, we may not be able to retain them, or to replace them with personnel of appropriate skill set at comparable
costs. In such event or in the event that the regions near our production facilities do not have a sufficiently sizable labor force,
we may need to expend additional resources to attract and recruit suitable employees. Favorable labor relations are essential to our
performance, and any material increase in our labor costs may have an adverse effect on our results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current insurance policies do not provide adequate levels of coverage against claims we may incur, and in the case
of an uninsured or underinsured claim we would be required to bear the costs of repair and recovery and/or potential liability for a
wide variety of perils to which our business is exposed.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain various insurance policies to safeguard against certain risks and unexpected events, including product liability insurance for
our product lines as well as certain of the pre-packaged foods we purchase from other suppliers. However, we do not have general liability
insurance coverage which covers all risks of physical loss, destruction or damage to our production facilities, the inventory of our
products and our fixed assets for our other subsidiaries, nor do we maintain property insurance, business disruption insurance or cyber-security
insurance or insurance against breaches or loss of data or personal private information of our customers. Accordingly, our insurance
coverage is insufficient to protect us against various types of losses that we may incur in operating our business. Further, there are
certain types of losses, such as losses from war, acts of terrorism, outbreak of diseases, earthquakes, typhoons, flooding and other
natural disasters, for which we cannot obtain insurance at a reasonable cost or at all. See &#8220;<i>INFORMATION ABOUT NEWCO AND QIANZHI
&#8211; Insurance</i>&#8221;. If we experience events for which we are not insured, we would incur the resulting financial losses, and
such losses may be substantial, particularly if our products and services are found to cause widespread injury, illness or death. Moreover,
our insurance policies may include financial limits with respect to the losses from events for which we are insured. The absence of insurance
protection places our company at risk of incurring substantial costs and expenses for repair, recovery, and potential legal liabilities
in the event of unforeseen events. If we experience uninsured losses or losses in excess of our insurance coverage, it could materially
and adversely affect our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is dependent on the continuous operation of our production facilities.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
major production facility is located in Ezhou of Hubei Province in the PRC. Our facilities are subject to operational risks, such as
the breakdown or failure of our major equipment, power supply or maintenance, performance below expected levels of output or efficiency,
obsolescence, labor disputes, natural disasters, industrial accidents and the need to comply with the directives of relevant government
authorities. Where events that limit our ability to operate our facilities occur, we may need to incur substantial additional expenses
to repair or replace the damaged equipment or facilities. The temporary closing down of our production facilities would severely affect
our daily production and business operation. If our production facilities were to be temporarily closed down, our ability to manufacture
and supply products and ability to meet delivery obligations to our customers would be significantly disrupted, and our relationships
with our customers could be damaged, which could materially and adversely affect our business, financial condition and results of operations.
In order to conduct maintenance, statutory inspections and testing, we may carry out planned shutdowns from time to time. We may also
shut down production lines from time to time to allow for capacity expansion and equipment upgrades. Although we take precautions to
minimize the risk of any significant operational problems at our facilities, our business, financial condition and results of operations
may be adversely affected by any disruption of operations at our facilities, whether caused by any of the factors mentioned above or
otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
facilities and operations may require continuous and substantial investment and upgrading.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have continued to invest and upgrade our production facilities to improve our production capabilities, increase our production lines,
enhance the quality of our products, and increase the automation and cost-effectiveness of our products. Our research and development
team develops new products and optimizes our existing products, and we require substantial investment and upgrading to apply these research
results and to expand our production capacity and enhance our automation processes. If our investment and upgrading costs are higher
than anticipated, or our business does not develop as anticipated to appropriately utilize new or upgraded facilities, our costs and
financial performance could be negatively affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
production facilities may be unable to maintain efficiency, encounter problems in ramping up production or otherwise have difficulty
meeting our production requirements.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future growth will depend upon our ability to maintain efficient operations at our existing facilities and our ability to expand our
facility as needed. The current utilization of our factory and warehouse at Ezhou City, Hubei Province has been steadily increasing and
is already close to full capacity. During the fiscal years ended March 31, 2024 and 2023, we increased our production capacity
by installing additional production lines in our existing factory and implementing automation to our existing production lines. In order
to meet our customers&#8217; demands and advancements in technology, we maintain our production facilities on a regular basis. If we
are unable to maintain our production facilities&#8217; efficiency, we may be unable to fulfill our purchase orders in a timely manner,
or at all. This could have a negative impact on our business and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a limited operating history and our ability to successfully commercialize products of high quality and appeal to customers at scale
is unproven and still evolving.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current business structure is the product of a reorganization of multiple operating businesses that occurred in 2023. Qianzhi was founded
in 2007 but our other operating subsidiaries were incorporated in 2019. Accordingly, there is limited historical basis for making judgments
on the demand for our products and services or our ability to develop and commercialize products, or our profitability in the future.
It is difficult to predict our future revenues and appropriately budget for our expenses, and we may have limited insight into trends
that may emerge and affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sustainability of our business depends, in large part, on our ability to timely execute our plan to develop, market and distribute high
quality products that appeal to customers. Due to our limited operating experience, we cannot assure you that we will be able to achieve
our targeted production volumes \on a timely basis, or at all. Our ability to achieve our targeted production volume are and will be
subject to risks, including with respect to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                            in product development</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lack
                                            of necessary funding;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                            or disruptions in our supply chain;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">quality
                                            control deficiencies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
                                            to adapt to changing market conditions and manage growth effectively;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">noncompliance
                                            with environmental, workplace safety, and relevant regulations; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cost
                                            overruns.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
we rely on third-party suppliers for the provision of many of the materials used in our products. To the extent our suppliers experience
any difficulties in providing us with or developing necessary materials, we could experience delays distributing products. Any delay
in the development and distribution of our products or provision of our services could subject us to customer complaints and materially
and adversely affect our reputation, demand for our products, and our growth prospects. Any of the foregoing could materially and adversely
affect our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may experience net losses and may not sustain profitability in the future.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot ensure that we will obtain sufficient levels of sales to sustain our growth or maintain profitability in the future. We also expect
our costs and expenses to increase in future periods, which could negatively affect our future results of operations if our revenue does
not increase accordingly. In particular, Qianzhi intends to continue to incrementally expand its sales and marketing efforts to drive
growth. We also expect to incur additional costs as we introduce new products to the market. Qianzhi will also face increased compliance
costs associated with growth, the expansion of its customer base and being a public company. Our efforts to grow our business may be
costlier than expected, and we may not be able to increase our revenue enough to offset our increased operating expenses. Qianzhi may
incur significant losses in the future for a number of reasons, including the other risks described herein, and unforeseen expenses,
difficulties, complications and delays, and other unknown events. If we are unable to sustain profitability, the value of our business
and ordinary shares may significantly decrease.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may require additional liquidity to implement our growth plans and are evaluating strategies to ensure we have access to the required
funding for future operations. These strategies may include, but are not limited to: (a) external financing in conjunction with the Business
Combination, obtaining additional loans from banks or related parties, and raising external capital, though there is no assurance that
we will be successful in obtaining such additional liquidity on terms acceptable to us, if at all; or failing that, (b) a business plan
to increase revenue and control operating costs and expenses to generate adequate positive operating cash flows and optimize operational
efficiency to improve our cash flow from operation. The feasibility of such plans are contingent upon many factors out of our control,
and are difficult to predict. We may seek additional equity or debt financing in the future to satisfy capital requirements, respond
to adverse developments or changes in our circumstances or unforeseen events or conditions, or fund organic or inorganic growth. We cannot
assure you that financing will be available in amounts or on terms acceptable to us, if at all. In the event that additional financing
is required from third party sources, we may not be able to raise it on acceptable terms or at all, and there could be potential significant
negative impact on our ability to continue its operations. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pressure on us to generate positive cash flow may be further exacerbated by our contractual obligations, including capital commitments,
operating lease commitments, borrowings, and debts. We expect to continue to invest in the design and testing of new products and research
and development to further expand our business. These investments may not result in revenue increases or positive net cash flow on a
timely basis, or at all. We may not generate sufficient revenues and may incur substantial losses for a number of reasons, including
lack of demand for our products, increasing competition, and other risks discussed herein, and we may incur unforeseen expenses, or encounter
difficulties, complications, or delays in deriving revenues or achieving profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
rely on third-party suppliers and distributors for many of the materials utilized in our products and they may not continue to produce
products or provide services that are consistent with our standards or applicable regulatory requirements, which could harm our brand,
cause consumer dissatisfaction, and require us to find alternative suppliers of our products.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
use multiple third-party suppliers to source many of the raw materials used in our products, the cosmetics used in our SDRA product line,
packaging for our products, and the pre-packaged food and beverage products we sell to certain customers. Our success depends upon our ability to enter into new supplier agreements and maintain our relationships
with suppliers who are critical and necessary to the output and production of our products. We rely on suppliers to provide key ingredients
for our products. While we try to obtain supplies from multiple sources whenever possible, we may need to purchase our supplies from
a single source, which exposes us to the risk of delivery failure. The ability of these third parties to supply and manufacture our products
may be affected by competing orders placed by other customers and the demands of those customers. If we experience significant increases
in demand or need to replace a significant number of existing suppliers, there can be no assurance that additional supply capacity will
be available when required on terms that are acceptable to us, or at all, or that any supplier will allocate sufficient capacity to us
in order to meet our requirements. Agreements may also contain pricing provisions that are subject to adjustment based on changes in
market prices of key commodities. Substantial increases in the prices for such materials, whether due to supply chain or logistics issues
or due to inflation, would increase our operating costs and could reduce our margins if it cannot recoup the increased costs. Any attempts
to increase the announced or expected prices of our products in response to increased costs could be viewed negatively by our customers
or potential customers and could adversely affect our business, prospects, financial condition, and results of operations. Furthermore,
qualifying alternate suppliers or developing our own replacements may be time consuming and costly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, quality control problems, such as the use of ingredients and delivery of products that do not meet our quality control standards
and specifications or comply with applicable laws or regulations, could harm our business. These quality control problems could result
in regulatory action, such as products of inferior quality or product stock outages or shortages, harming our sales and creating inventory
write-downs for unusable products. We are also subject to the risk of supply chain disruptions. Any disruption in the supply of materials
and ingredients, could temporarily disrupt production of our products until an alternative supplier is fully qualified by us or is otherwise
able to supply us the required material. There can be no assurance that our business, financial condition, and results of operations
will not be materially and adversely affected by future supply chain disruptions. There can be no assurance that we would be able to
successfully retain alternative suppliers or supplies on a timely basis, on acceptable terms or at all. Changes in business conditions,
force majeure, governmental changes, and other factors beyond our control or which we do not presently anticipate, could also affect
our suppliers&#8217; ability to deliver raw materials or finished goods to us on a timely basis. Any of the foregoing could materially
and adversely affect our results of operations, financial condition, and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplier
agreements may have provisions where such agreements can be terminated in various circumstances, including potentially without cause.
If the suppliers become unable to provide, or experience delays in, providing necessary supplies, or if the supplier agreements we have
in place are terminated, it may be difficult to find replacement materials. Changes in business conditions, pandemics, governmental changes,
and other factors beyond our control or that we do not presently anticipate could affect our ability to receive components or technology
from our suppliers. We have also outsourced significant portions of our distribution process to third-party service providers. The failure
of one or more of these entities to provide the expected services on a timely basis, or at all, or at the prices we expect, or the costs
and disruption incurred in changing these outsourced functions to being performed under our management and direct control or that of
a third-party, may have a material adverse effect on our business, financial condition and results of operations. Upon expiration of
these existing agreements, we may not be able to renegotiate the terms on a commercially reasonable basis, or at all. Further, our third-party
suppliers and distributors may:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
    economic or business interests or goals that are inconsistent with ours;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">take actions contrary to our instructions, requests, policies or objectives;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be unable or unwilling to fulfill their obligations under relevant purchase orders, including obligations to meet our production deadlines, quality standards, pricing guidelines and product specifications, and to comply with applicable regulations, including those regarding the safety and quality of products and ingredients;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">have financial difficulties;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">encounter raw material or labor shortages;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">encounter increases in raw material or labor costs which may affect our procurement costs;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">engage in activities or employ practices that may harm our reputation; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">work with, be acquired by, or come under control of, our competitors.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
occurrence of any of these events, alone or together, or the termination of any agreements with our suppliers, could have a material
adverse effect on our business, financial condition and results of operations. In addition, such problems may require us to find new
third-party suppliers or distributors, and there can be no assurance that we would be successful in finding third-party suppliers or
distributors meeting our standards of innovation and quality. The management and oversight of the engagement and activities of our third-party
suppliers and distributors requires substantial time, effort and expense of our employees, and we may be unable to successfully manage
and oversee the activities of our third-party suppliers and distributors. If we experience any supply chain disruptions caused by our
inability to locate suitable third-party suppliers, or if our raw material suppliers experience problems with product quality or disruptions
or delays in the manufacturing process or delivery of the finished products or the raw materials or components used to make such products,
our business, financial condition and results of operations could be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be unable to adequately control the costs associated with our operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have devoted significant capital to developing and growing our business, including developing our product line and expanding our marketing,
sales and distribution network. We expect to further incur significant costs that will impact our profitability, including research and
development expenses as we roll out new products, expand production, selling and distribution expenses as we continue to build our brand
and market our products, and additional costs associated with being a public company. Furthermore, currency fluctuations, tariffs or
shortages and other economic or political conditions may result in significant increases in freight charges and raw material costs. Our
ability to become profitable in the future will not only depend on our ability to successfully market our products but also to control
our costs. If we are unable to develop, market, sell, and distribute our products, or if the manufacturing of our products could not
be conducted in a cost-efficient manner, our margins, profitability, and prospects would be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
results of operations may vary significantly from period to period due to fluctuations in our operating costs.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
results of operations may vary significantly from period to period due to many factors, including our operating costs, which we anticipate
will increase significantly in future periods as we, among other things, design and develop new products and improvements to our existing
products, build and equip new manufacturing facilities and/or seek to expand our manufacturing capacity through third parties, increase
our sales and marketing activities, and increase our general and administrative functions to support our growing operations. As a result
of these factors, we believe that period-to-period comparisons of our results of operations may not necessarily be meaningful and that
these comparisons cannot be relied upon as indicators of future performance. Moreover, our results of operations may not meet expectations
of equity research analysts or investors. If this occurs, the trading price of our securities could fall substantially either suddenly
or over time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we operate our offices and warehouses on leased properties, we may not be able to control rental cost, quality, maintenance and management
of these offices and warehouses, nor can we ensure we will be able to renew or find suitable premises to replace our existing offices
and warehouses in the event our landlords refuse to renew the relevant lease agreements upon their expiration.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
lease the premises used as offices in Shenzhen, Guangdong Province in the PRC and from an independent third party. We also lease premises
used as factory and warehouses in Ezhou City, Hubei Province. See &#8220;<span style="font-weight: normal"><i>Business &#8212; Facilities&#8221;.
</i></span>Such premises and facilities were developed and/or maintained by our landlords. Accordingly, we are not in a position
to effectively control the quality, maintenance and management of such premises and facilities. In the event the quality of the premises
and facilities deteriorates, or if any or all of our landlords fail to properly maintain and renovate such premises or facilities in
a timely manner, or if we are unable to successfully extend or renew our leases upon expiration of the current term on commercially reasonable
terms or at all, we may be forced to relocate our branches, or the rental costs may increase significantly. We compete with many other
businesses for sites in certain prime locations, and some landlords may have entered into long-term leases with our competitors for these
locations. As a result, we may not be able to find desirable alternative locations without incurring significant time and financial costs.
If this occurs, our operations may be disrupted and our results of operations could be materially and adversely affected. We also lease
premises for research and development and offices. We cannot assure you that we would be able to renew the relevant lease agreements
without substantial additional costs or increases in the rental cost payable by us. If a lease agreement is renewed at a rent substantially
higher than the current rate, or currently existing favorable terms granted by the lessor are not extended, our business and results
of operations may be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we did not register all of our lease agreements in the PRC with the relevant government authorities and presently one lease
agreement is unregistered. Under the relevant PRC laws and regulations, we may be required to register and file with the relevant government
authority executed leases. While the lack of registration will not affect the validity and enforceability of the lease agreements, a
fine ranging from RMB1,000 to RMB10,000 may be imposed on the parties for each non-registered lease, in cases where the parties did not
observe orders issued by relevant government authorities requiring the parties to file for registration in a specific period of time.
We may be subject to an aggregate maximum penalty of RMB10,000 for the unregistered lease agreement in the PRC. We may incur additional
expenses if any fines are imposed upon us, which may adversely affect our business and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends on the continuing efforts of our senior management team and other key employees.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
depend on the continued contributions of our senior management team members and other key employees, including, in particular, our current chief executive officer and chairperson of our board of directors. Our future success also depends on our other key
personnel, including financial, sales and marketing and research and development staff. Our success will also depend on our ability to
attract and retain qualified personnel to manage our existing operations as well as our future growth. We may not be able to successfully
attract, recruit, or retain key personnel, and this could adversely impact our financial condition, operating results, and business prospects.
There is no assurance that these key personnel will not voluntarily terminate their employment with us and we do not carry, and do not
intend to procure, key person insurance on any of our senior management team. If any of our senior executives or key personnel leaves
us and we fail to effectively manage a transition to new personnel in the future, or if we fail to attract and retain qualified and experienced
professionals on acceptable terms, our business, financial condition and results of operations could be adversely affected. Moreover,
if any member of our senior management team or any of our other key personnel joins a competitor or forms a competing company, we may
lose customers, key professionals and sales staff members. All our executive officers and many key personnel are subject to the duty
of confidentiality and non-competition restrictions. However, if any disputes arise between any of our senior executives or key personnel
and us, there are uncertainties regarding whether we will be able to successfully pursue legal actions against these individuals because
of the uncertainties of China&#8217;s legal systems and complexities of legal systems of foreign jurisdictions. Moreover, even if we
succeed before a court of law, the compensation we would receive is unlikely to be sufficient to mitigate the negative impact on our
business and future operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are or may be subject to risks associated with strategic alliances or acquisitions.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into and may in the future enter into strategic alliances, including joint ventures or minority equity investments, with
various third parties to further our business purpose from time to time. These alliances could subject us to a number of risks, including
risks associated with sharing proprietary information, non-performance by third parties, and increases in expenses in integrating and
realizing synergies, any of which may materially and adversely affect our business. We may have limited ability to monitor or control
the actions of these third parties and, to the extent any of these third parties suffers negative publicity or harm to their reputation
from events relating to their businesses, we may also suffer negative publicity or harm to our reputation by virtue of our association
with any such third party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
acquisitions may have an adverse effect on our ability to manage our business.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
appropriate opportunities arise, we may acquire additional assets, products, technologies, or businesses that are complementary to our
existing business. Future acquisitions may expose us to potential risks, including risks associated with the integration of new operations,
services, and personnel, the diversion of resources from our existing businesses, failure to achieve expected growth by the acquired
businesses, and the inability to generate sufficient revenue to offset the costs and expenses of acquisitions, or the potential loss
of or harm to relationships with both employees and customers resulting from their integration of new businesses. In addition, we may
be unable to identify appropriate acquisition or strategic investment targets when it is necessary or desirable to make such acquisition
or investment to remain competitive or to expand our business. Even if we identify an appropriate acquisition or investment target, we
may face challenges in successfully negotiating favorable terms of the acquisition or investment and financing the proposed transaction.
We may need to raise additional debt funding or sell additional equity securities to make such acquisitions. The raising of additional
debt funding by us, if required, would result in increased debt service obligations and could result in additional operating and financing
covenants, or liens on our assets, that would restrict our operations. The sale of additional equity securities could result in additional
dilution to our shareholders. In addition, future acquisitions may require us to obtain shareholder approval and we may have to obtain
approvals and clearances from relevant government authorities for such acquisitions in order to comply with any applicable laws and regulations
of mainland China, which could result in increasing delay and costs, and may derail our business strategy if we fail to do so. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
acquisitions and the subsequent integration of new assets and businesses into our own require significant attention from our management
and could result in a diversion of resources from our existing business, which in turn could have an adverse effect on our operations.
Acquired assets or businesses may not generate the synergies or financial results we expect. Acquisitions could result in the occurrence
of significant goodwill impairment charges, amortization expenses for other intangible assets, and exposure to potential unknown liabilities
of the acquired business. Any acquired business may be involved in legal proceedings originating from historical periods prior to the
acquisition, and we may not be fully indemnified, or at all, for any damage to us resulting from such legal proceedings, which could
materially and adversely affect our financial position and results of operations. If any one or more of the aforementioned risks associated
with acquisitions or investments materialize, the acquisitions or investments may not be beneficial to us, which in turn may materially
and adversely affect our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we fail to maintain an effective system of internal control over financial reporting, we may be unable to accurately report our financial
results or prevent fraud, and investor confidence in our company and the market price of our securities may be adversely affected.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the consummation of the Business Combination, we had been a private company with limited accounting personnel and other resources
with which to address our internal controls over financial reporting. Our failure to discover and address any material weaknesses or
significant deficiencies in our system of internal controls over financial reporting could result in inaccuracies in our financial statements
and impair our ability to comply with applicable financial reporting requirements and related regulatory filings on a timely basis. Moreover,
ineffective internal control over financial reporting could significantly hinder our ability to prevent fraud.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of the Business Combination, we will become subject to the Sarbanes-Oxley Act of 2002. Section 404 of the Sarbanes-Oxley
Act, or Section 404, will require that we include a report from management on the effectiveness of our internal control over financial
reporting in our annual report beginning with our first annual report following the consummation of the Business Combination. In addition,
once we cease to be an &#8220;emerging growth company&#8221; as such term is defined in the JOBS Act, our independent registered public
accounting firm must attest to and report on the effectiveness of our internal control over financial reporting. Our management may conclude
that our internal control over financial reporting is not effective. Moreover, even if our management concludes that our internal control
over financial reporting is effective, our independent registered public accounting firm, after conducting its own independent testing,
may issue a report that is qualified if it is not satisfied with our internal controls or the level at which our controls are documented,
designed, operated or reviewed, or if it interprets the relevant requirements differently from us. In addition, after we become a public
company, our reporting obligations may place a significant strain on our management, operational and financial resources and systems
for the foreseeable future. We may be unable to timely complete our evaluation testing and any required remediation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the course of documenting and testing our internal control procedures, in order to satisfy the requirements of Section 404, we may identify
weaknesses and deficiencies in our internal control over financial reporting. In addition, if we fail to maintain the adequacy of our
internal control over financial reporting, as these standards are modified, supplemented or amended from time to time, we may not be
able to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with Section 404.
If we fail to achieve and maintain an effective internal control environment, we could suffer material misstatements in our financial
statements and fail to meet our reporting obligations, which would likely cause investors to lose confidence in our reported financial
information. This could in turn limit our access to capital markets, harm our results of operations, and lead to a decline in the trading
price of our securities. Additionally, ineffective internal control over financial reporting could expose us to increased risk of fraud
or misuse of corporate assets and subject us to potential delisting from the stock exchange on which we list, regulatory investigations,
and civil or criminal sanctions. We may also be required to restate our financial statements from prior periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure
or security breach of our information technology systems may disrupt our operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
increasingly rely on information technology systems to process, transmit and store information in relation to our operations. For example,
all of our production facilities, production processes and inventory management systems utilize information technology to maximize efficiencies
and minimize costs. Our information technology systems may be vulnerable to interruption due to a variety of events beyond our control,
including but not limited to, natural disasters, telecommunications failures, computer viruses, hacking and other security issues. Any
such interruption to our information technology systems could disrupt our operations and negatively impact our production capacity and
ability to fulfill sales orders, which could have an adverse effect on our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-compliance
with existing and future health, safety and environmental policies, laws, rules and regulations may lead to imposition of fines, penalties
and other liabilities and our compliance costs may increase if health, safety or environmental protection laws become more onerous.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations are subject to the health, safety and environmental policies, laws, rules and regulations of each local jurisdiction where
we operate. For instance, applicable PRC laws and regulations, among other things, require manufacturers to ensure that the production
plants and facilities meet the requirements of the relevant production safety laws, regulations and standards, conduct an environmental
impact assessment before engaging in new construction projects, receive approval and pass environmental acceptance check before the commencement
of production, pay fees in connection with activities that discharge waste materials, properly manage and dispose of hazardous substances,
and impose fines and other penalties on activities that threaten or contaminate the environment. Currently, all of our production facilities
are located in the PRC, but we may still be required to comply with environmental laws in relation to waste discharge of countries where
we operate our warehouses. For instance, in European Union countries, we may be subject to stricter environmental laws and regulations,
including specific requirements regarding methods and location for waste discharge and disposal of hazardous substances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
violation of applicable health, safety and environmental policies, laws, rules or regulations may result in orders of corrections, fines,
shutdown of production and obligation to take corrective measures. In addition, any violation which is criminal in nature may result
in criminal sanctions. Moreover, violations of health, safety and environmental policies, laws, rules and regulations or other related
incidents may result in our liabilities to third parties. Consequently, any non-compliance incidents could materially and adversely affect
our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
there can be no assurance that any local government will not change existing laws or adopt more stringent practices as to the enforcement
of health, safety and environmental regulations. Due to the uncertainty of regulatory developments and interpretation of laws and regulations,
and the amount of related expenditures we may need to incur beyond those currently anticipated, we also cannot assure you that we will
be in full compliance with the health, safety and environmental regulations at all times. If such costs become prohibitively expensive,
we may be forced to adjust, limit or cease certain aspects of our business operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
joint statements by the SEC and the PCAOB, rule changes by Nasdaq, and the Holding Foreign Companies Accountable Act passed by the U.S.
Senate all call for additional and more stringent criteria to be applied to emerging market companies upon assessing the qualification
of their auditors, especially the non-U.S. auditors who are not inspected by the PCAOB. These developments could add uncertainties to
our operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 21, 2020, SEC Chairman Jay Clayton and PCAOB Chairman William D. Duhnke III, along with other senior SEC staff, released a joint
statement highlighting the risks associated with investing in companies based in or have substantial operations in emerging markets including
China. The joint statement emphasized the risks associated with lack of access for the PCAOB to inspect auditors and audit work papers
in China and higher risks of fraud in emerging markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 18, 2020, Nasdaq filed three proposals with the SEC to (i) apply minimum offering size requirement for companies primarily operating
in &#8220;Restrictive Market&#8221;, (ii) adopt a new requirement relating to the qualification of management or board of director for
Restrictive Market companies, and (iii) apply additional and more stringent criteria to an applicant or listed company based on the qualifications
of the company&#8217;s auditors. On October 4, 2021, the SEC approved Nasdaq&#8217;s revised proposal for the rule changes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 20, 2020, the Senate passed the Holding Foreign Companies Accountable Act requiring a foreign company to certify it is not owned
or manipulated by a foreign government if the PCAOB is unable to audit specified reports because the company uses a foreign auditor not
subject to PCAOB inspection. If the PCAOB is unable to inspect the company&#8217;s auditors for three consecutive years, the issuer&#8217;s
securities are prohibited to trade on a national exchange. On December 2, 2020, the U.S. House of Representatives approved the HFCA Act.
On December 18, 2020, the HFCA Act was signed into law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 24, 2021, the SEC adopted interim final rules relating to the implementation of certain disclosure and documentation requirements
of the Holding Foreign Companies Accountable Act. We will be required to comply with these rules if the SEC identifies us as having a
&#8220;non-inspection&#8221; year under a process to be subsequently established by the SEC. The SEC is assessing how to implement other
requirements of the Holding Foreign Companies Accountable Act, including the listing and trading prohibition requirements described above.
In May 2021, the PCAOB issued for public comment a proposed rule related to the PCAOB&#8217;s responsibilities under the Holding Foreign
Companies Accountable Act, which, according to the PCAOB, would establish a framework for the PCAOB to use when determining, as contemplated
under the Holding Foreign Companies Accountable Act, whether the PCAOB is unable to inspect or investigate completely registered public
accounting firms located in a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction. The proposed
rule was adopted by the PCAOB in September 2021, pending the final approval of the SEC to become effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act, and on December 29, 2022, the Consolidated
Appropriations Act was signed into law by President Biden, which contained, among other things, an identical provision to the Accelerating
Holding Foreign Companies Accountable Act and amended the HFCA Act by requiring the SEC to prohibit an issuer&#8217;s securities from
trading on any U.S. stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years instead of three, thus
reducing the time period for triggering the delisting of New Bowen and the prohibition of trading in its securities if the PCAOB is unable
to inspect its accounting firm at such future time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 22, 2021, the PCAOB adopted a final rule implementing the HFCA Act, which provides a framework for the PCAOB to use when determining,
as contemplated under the HFCA Act, whether the board of directors of a company is unable to inspect or investigate completely registered
public accounting firms located in a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 2, 2021, the SEC adopted amendments to finalize rules implementing the submission and disclosure requirements in the HFCA Act,
which became effective on January 10, 2022. The rules apply to registrants that the SEC identifies as having filed an annual report with
an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that the PCAOB is unable
to inspect or investigate completely because of a position taken by an authority in foreign jurisdictions. For example, on December 16,
2021, the PCAOB issued a report on its determinations that it is unable to inspect or investigate completely PCAOB-registered public
accounting firms headquartered in mainland China and in Hong Kong, because of positions taken by PRC authorities in those jurisdictions.
The Board made these determinations pursuant to PCAOB Rule 6100, which provides a framework for how the PCAOB fulfills its responsibilities
under the HFCA Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
lack of access to the PCAOB inspection in China prevents the PCAOB from fully evaluating audits and quality control procedures of the
auditors based in China. As a result, investors may be deprived of the benefits of such PCAOB inspections. The inability of the PCAOB
to conduct inspections of auditors in China makes it more difficult to evaluate the effectiveness of these accounting firm&#8217;s audit
procedures or quality control procedures as compared to auditors outside of China that are subject to the PCAOB inspections, which could
cause existing and potential investors in our Ordinary Shares to lose confidence in our audit procedures and reported financial information
and the quality of its financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
auditor, Simon &amp; Edward, LLP, the independent registered public accounting firm that issues the audit report included elsewhere in
this proxy statement/prospectus, as an auditor of companies that are traded publicly in the United States and a firm registered with
the PCAOB, is subject to laws in the United States pursuant to which the PCAOB conducts regular inspections to assess its compliance
with the applicable professional standards. Our auditor is headquartered in Rowland Heights, California, and it is subject to PCAOB inspections
to assess its compliance with the applicable professional standards. The PCAOB currently has access to inspect the working papers of
our auditor and our auditor is not subject to the determinations announced by the PCAOB on December 16, 2021. However, the recent developments
would add uncertainties to the closing of Business Combination and there is no assurance whether Nasdaq or regulatory authorities would
apply additional and more stringent criteria us since we are an emerging growth company and our operations are conducted in China. Furthermore,
if the PCAOB is unable to inspect our accounting firm in the future, the HFCA Act, which requires that the PCAOB be permitted to inspect
an issuer&#8217;s public accounting firm within two years, as amended, will prohibit trading in its securities, and, as a result, an
exchange may determine to delist our securities and trading in such securities could be prohibited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 26, 2022, the CSRC, the MOF, and the PCAOB signed the Protocol, governing inspections and investigations of accounting firms based
in mainland China and Hong Kong, taking the first step toward opening access for the PCAOB to inspect and investigate registered public
accounting firms headquartered in mainland China and Hong Kong. Pursuant to the fact sheet with respect to the Protocol disclosed by
the SEC, the PCAOB shall have independent discretion to select any issuer audits for inspection or investigation and has the unfettered
ability to transfer information to the SEC. On December 15, 2022, the PCAOB Board determined that the PCAOB was able to secure complete
access to inspect and investigate registered public accounting firms headquartered in mainland China and Hong Kong and voted to vacate
its previous determinations to the contrary. However, should PRC authorities obstruct or otherwise fail to facilitate the PCAOB&#8217;s
access in the future, the PCAOB Board will consider the need to issue a new determination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
because we have substantial operations within the PRC, the audit workpapers prepared by our independent registered public accounting
firm for auditing us might not be inspected by the PCAOB without the approval of the Chinese authorities. If the lack of access to the
PCAOB inspection in China prevents the PCAOB from fully evaluating audits and quality control procedures of the auditors based in China,
our investors would be deprived of the benefits of such PCAOB inspections. Such inability of the PCAOB to conduct inspections of auditors
in China could cause existing and potential investors in our stock to lose confidence in our audit procedures and reported financial
information and the quality of our financial statements. Furthermore, the Holding Foreign Companies Accountable Act, which requires that
the PCAOB be permitted to inspect the issuer&#8217;s public accounting firm within three years, may result in the delisting of our Company
in the future if the PCAOB is unable to inspect our accounting firm at such future time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC may propose additional rules or guidance that could impact us if our auditor is not subject to PCAOB inspection. For example, on
August 6, 2020, the President&#8217;s Working Group on Financial Markets, or the PWG, issued the Report on Protecting United States Investors
from Significant Risks from Chinese Companies to the then President of the United States. This report recommended that the SEC implement
five recommendations to address companies from jurisdictions that do not provide the PCAOB with sufficient access to fulfil its statutory
mandate. Some of the concepts of these recommendations were implemented with the enactment of the Holding Foreign Companies Accountable
Act. However, some of the recommendations were more stringent than the Holding Foreign Companies Accountable Act. For example, if a company
was not subject to PCAOB inspection, the report recommended that the transition period before a company would be delisted would end on
January 1, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has announced that the SEC staff is preparing a consolidated proposal for the rules regarding the implementation of the Holding Foreign
Companies Accountable Act and to address the recommendations in the PWG report. It is unclear when the SEC will complete its rulemaking
and when such rules will become effective and what, if any, of the PWG recommendations will be adopted. The SEC has also announced amendments
to various annual report forms to accommodate the certification and disclosure requirements of the Holding Foreign Companies Accountable
Act. There could be additional regulatory or legislative requirements or guidance that could impact us if our auditor is not subject
to PCAOB inspection. The implications of this possible regulation or guidance in addition to the requirements of the Holding Foreign
Companies Accountable Act are uncertain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
for whatever reason the PCAOB is unable to conduct full inspections of our auditor, such uncertainty could cause the market price of
our ordinary shares to be materially and adversely affected, and our securities could be delisted or prohibited from being traded &#8220;over-the-counter&#8221;.
If our securities were unable to be listed on another securities exchange by then, such a delisting or prohibition from trading would
substantially impair your ability to sell or purchase our ordinary shares when you wish to do so, and the risk and uncertainty associated
with a potential delisting would have a negative impact on the price of our ordinary shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face risks related to natural disasters, health epidemics, and other outbreaks of disease, which could significantly disrupt our operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business could be adversely affected by natural disasters, health epidemics, and other outbreaks of disease. For example, the COVID-19
pandemic endangered the health of many people and significantly disrupted travel and economic activities both in China and across the
world. Our production facilities experienced temporary closures or work suspension from January 31, 2020 to February 10, 2020. The COVID-19
pandemic also negatively affected our supply chain. In 2020, many of our suppliers and customers also closed down their factories or
offices temporarily due to COVID-19. Delivery of our products was affected from time to time due to restrictions on transportation. As
a result, our business, financial condition and results of operations have been adversely affected. In recent years, there have been
other outbreaks of epidemics in China and globally. Our operations could be disrupted if one of our employees is suspected of having
H1N1 flu, avian flu, or another epidemic, since it could require our employees to be quarantined and/or our offices to be disinfected.
In addition, our results of operations could be adversely affected to the extent that the outbreak harms the PRC economy in general.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also vulnerable to natural disasters and other calamities. Any future outbreaks of disease, extreme unexpected bad weather or natural
disasters would adversely affect our business operations. If there is a recurrence of an outbreak of certain contagious diseases or natural
disasters, our production facilities may be temporarily closed, and our operations may be suspended. Government advice regarding, or
restrictions on, holding offline events, in the event of an outbreak of any contagious disease or occurrence of natural disasters may
have a material adverse effect on our business and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>You
should be aware that uncertainties are inherent in prospective financial projections of any kind, and such uncertainties increase with
the passage of time. None of Bowen or Qianzhi or any of their respective affiliates, advisors, officers, directors, or representatives
has made or makes any representation or can give any assurance to any Bowen shareholders, or any other person, regarding the ultimate
performance of Qianzhi compared to the information set forth under &#8220;The Business Combination Proposal&#160;&#8212; Unaudited Prospective
Financial Information of Qianzhi&#8221; or that any such results will be achieved.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
inclusion of Qianzhi&#8217;s projections relating to its business in this proxy statement/prospectus should not be regarded as an indication
that Bowen, Qianzhi or their respective advisors or other representatives considered or consider the projections to be necessarily predictive
of actual future performance or events, and the projections set forth under &#8220;<i>The Business Combination Proposal</i>&#160;<i>&#8212;</i>&#160;<i>Unaudited
Prospective Financial Information of Qianzhi</i>&#8221; should not be relied upon as such.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
projections that were prepared by management of Qianzhi speak as of
the date that such projections were made. Neither the independent registered public accounting firm of Bowen or Qianzhi, nor any
other independent accountants has audited, reviewed, compiled, examined or performed any procedures with respect to the accompanying
unaudited prospective financial information for the purpose of its inclusion herein, and accordingly, neither the independent
registered public accounting firm of Bowen or Qianzhi, nor any other independent accountant expresses an opinion or provides any
form of assurance with respect thereto for the purpose of this proxy statement/prospectus. Due to inherent uncertainties in
financial projections of any kind, shareholders are cautioned not to place undue reliance, if any, on the projections. For example,
Qianzhi&#8217;s operating results for fiscal 2024 did not achieve its projected results for such period due to the post-pandemic
slowdown experienced in the Chinese economy, which adversely impacted the purchasing power of our customers and reduced overall
product demand for our ozone sterilization and cosmetic products, and the negative impact on Qianzhi&#8217;s sales of hypochlorite
disinfection products resulting from the decision of the Chinese government to lift its zero-COVID policy. The economic and business
factors that resulted in Qianzhi not achieving its forecasted results for its 2024 fiscal year may persist longer than anticipated
and may continue to adversely impact Qianzhi&#8217;s ability to increase its revenues and improve its financial performance.
Accordingly, Qianzhi&#8217;s actual results for future forecasted periods may continue to be materially different than its
projections and shareholders are strongly cautioned not to place undue reliance, if any, on the projections, and
not to rely on these projections in making any decision regarding the Business Combination<span style="background-color: white">.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forecasts
and projections of our operating and financial results relies in large part upon assumptions and analyses developed by our management.
If these assumptions or analyses prove to be incorrect, our actual operating results may be materially different from those forecasted
or projected.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
forecasts and projections of future operating results rely in large part upon assumptions and analyses developed by our management
and reflects current estimates of future performance, any or all of which may not prove to be correct or accurate. If these
assumptions, analyses or estimates prove to be incorrect or inaccurate, our actual operating results may differ materially and
adversely from those forecasted or projected. We believe that the assumptions in the forecasts and projections were reasonable at
the time such information was prepared, given the information we had at the time, and believe they remain reasonable. In particular,
the prospective financial information was prepared by our management based on estimates and assumptions believed to be reasonable
with respect to the expected future financial performance of Qianzhi, which do not take into account any circumstances or
events occurring thereafter. </span>However, Qianzhi&#8217;s fiscal 2024 operating results did not achieve its forecast for such
period for the reasons described above. The foregoing factors may continue to adversely impact Qianzhi&#8217;s ability to increase
its revenues and improve its financial performance. Accordingly, Qianzhi&#8217;s actual results for future forecasted periods may
continue to be materially different than its projections and shareholders are strongly cautioned not to place undue reliance, if
any, on the projections, and not to rely on these projections in making any decision regarding the Business
Combination<span style="background-color: white">.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi&#8217;s </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prospective
financial information incorporates certain financial and operational assumptions that are inherently uncertain and may be beyond the
control of our management, including, but not limited to, future industry performance, general business, economic, market and
financial conditions, and matters specific to our business. In addition, such projections incorporate assumptions relating to (a)
sales volumes, average selling prices and revenues, which could be significantly impacted by economic events and consumer demand for
our products; (b) our expectation to sell internationally, which could be impacted by trade policies, regulatory constraints and
other factors; (c) our ability to maintain the strength of our brand; (d) our ability to manage costs of raw material and certain
components and the associated manufacturing costs of our products; (e) projected growth in the hygiene and disinfect products
market; and (f) our ability to satisfy delivery of our products, and introduce new products, on the timeline and at the quantities
planned. Additionally, Qianzhi&#8217;s management also assumes that it will be able to leverage a broad range of functional
attributes of its products to develop additional industry applications and intends to implement a multi-pronged marketing approach
in order to develop new customer bases and sales channels.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
the assumptions that underlie the prospective financial information are preliminary and there can be no assurance that our actual results
will be in line with our expectations. The prospective financial information covers multiple years and such financial projections, by
their nature, become subject to greater uncertainty with each succeeding year. In addition, whether actual operating and financial results
and business developments will be consistent with our expectations and assumptions as reflected in the forecast depends on a number of
factors, many of which are outside our control, including, but not limited to those stated elsewhere in this &#8220;<i>Risk Factors</i>&#8221;
section and the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            we can obtain sufficient capital to sustain and grow our business;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to manage growth;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            we can manage relationships with key suppliers;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to obtain necessary regulatory approvals;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">market
                                            demand for our products;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            timing and cost of new and existing marketing and promotional efforts;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">competition,
                                            including established and future competitors;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to retain existing key management, to integrate recent hires and to attract, retain
                                            and motivate qualified personnel;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            overall economy strength and stability globally and in jurisdictions we operate;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory,
                                            legislative, and political changes; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consumer
                                            spending habits.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forecasts and projections also reflect assumptions as to certain business decisions that are subject to change. The forecasts and projections
were not prepared with a view toward public disclosure or with a view toward complying with the guidelines of the SEC, or the guidelines
established by the American Institute of Certified Public Accountants with respect to the forecasts and projections, but, in the view
of our management, was prepared on a reasonable basis, reflects the best currently available estimates and judgments, and presents, to
the best of management&#8217;s knowledge and belief, the expected course of action and the expected future financial performance of Qianzhi.
However, such information is not historical fact, should not be seen as guidance or relied upon as being necessarily indicative of
future results. Neither our independent auditors, nor any other independent accountants, have compiled, examined or performed any procedures
with respect to the projections and forecasts, nor have they expressed any opinion or any other form of assurance on such information
or its achievability, and assume no responsibility for, and disclaim any association with, the forecasts and projections.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unfavorable
changes in any of these or other factors, most of which are beyond our control, could turn out to be different than those anticipated,
materially and adversely affect our business, prospects, financial results, and results of operations, and have an adverse impact on
the market price of Qianzhi&#8217;s ordinary shares or the financial position of the post-Business Combination entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of our product orders may be cancelled by customers despite their deposit payment and online confirmation.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
customers may cancel their orders for many reasons outside of our control, and we have experienced cancellation of orders in the past.
In addition, customers may terminate their orders even after such orders are deemed automatically confirmed. The time lag between reservation
to delivery could also impact customer decisions on whether to ultimately make a purchase, due to potential changes in preferences, competitive
developments, and other factors. If we encounter delays in the deliveries of products, a significant number of orders may be cancelled.
As a result, we cannot assure you that orders will not be cancelled or that such orders will ultimately result in the final purchase,
delivery, and sale of the products. Such cancellations could harm our business, brand image, financial condition, results of operations,
and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
sales depend in part on our ability to establish and maintain confidence in our business prospects among consumers, analysts and others
within our industry.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consumers
may be less likely to purchase our products if they do not believe that our business will succeed or that our operations, including customer
support operations, will continue for many years. Similarly, suppliers and other third parties will be less likely to invest time and
resources in developing business relationships with us if they are not convinced that our business will succeed. Accordingly, to build,
maintain and grow our business, we must establish and maintain confidence among customers, suppliers, analysts and other parties with
respect to our liquidity and business prospects. Maintaining such confidence may be particularly difficult as a result of many factors,
including our limited operating history, others&#8217; unfamiliarity with our products, uncertainty regarding the future of hygiene and
disinfection products, any delays in scaling production, distribution to meet demand, competition and our production and sales performance
compared with market expectations. Many of these factors are largely outside of our control, and any negative perceptions about our business
prospects, even if exaggerated or unfounded, would likely harm our business and make it more difficult to raise additional capital in
the future. In addition, a significant number of new companies have recently entered the hygiene and disinfection products industry.
If these new entrants or other manufacturers of hygiene and disinfection products go out of business, produce those that do not perform
as expected or otherwise fail to meet expectations, such failures may have the effect of increasing scrutiny of others in the industry,
including us, and further challenging customer, supplier and analyst confidence in our business prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we fail to manage our growth effectively, we may not be able to market and sell our products successfully.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have expanded our operations, and as we ramp up our production, significant expansion will be required, especially in connection with
potential increases in sales, expansion of our retail, distribution network, and marketing different models of hygiene and disinfection
products. Our future operating results depend to a large extent on our ability to manage this expansion and growth successfully. Risks
that we face in undertaking this expansion include, among others:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">managing
                                            our supply chain to support fast business growth;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintaining
                                            our strategic partnerships to manufacture our products;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">managing
                                            a larger organization with a greater number of employees in different divisions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">controlling
                                            expenses and investments in anticipation of expanded operations;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
                                            or expanding design, sales, and services;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">implementing
                                            and enhancing administrative infrastructure, systems, and processes; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">addressing
                                            new markets and potentially unforeseen challenges as they arise.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
failure to manage our growth effectively could materially and adversely affect our business, financial condition, results of operations,
and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business plans require a significant amount of capital. In addition, our future capital needs may require us to obtain additional equity
or debt financing that may dilute our shareholders or introduce covenants that may restrict our operations or our ability to pay dividends.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will need significant capital to, among other things, conduct research and development, expand our production capacity, and roll out
our sales and distribution networks. As we ramp up our production capacity and operations, we may also require significant capital to
maintain our property, facility, and equipment and such costs may be greater than what we currently anticipate. We expect that our level
of capital expenditures will be significantly affected by consumer demand for our products. The fact that we have a limited operating
history means we have limited historical data on the demand for our products. As a result, our future capital requirements may be uncertain
and actual capital requirements may be significantly different from what we currently anticipate. We may need to seek equity or debt
financing to finance a portion of our capital expenditures. Such financing might not be available to us in a timely manner or on terms
that are acceptable, or at all. If we cannot obtain sufficient capital on acceptable terms, our business, financial condition, and prospects
may be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to obtain the necessary financing to carry out our business plan is subject to a number of factors, including general market
conditions and investor acceptance of our business plan. These factors may make the timing, amount, terms and conditions of such financing
unattractive or unavailable to us. If we are unable to raise sufficient funds, we may need to significantly reduce our spending, delay
or cancel our planned investment or expansion activities, or substantially change our corporate structure. We might not be able to obtain
any funding or service any of the debts we incurred, and we might not have sufficient resources to conduct our business as projected,
both of which could mean that we would be forced to curtail or discontinue our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our future capital needs and other business reasons could require us to issue additional equity or debt securities or obtain
a credit facility. The issuance of additional equity or equity-linked securities could dilute our shareholders. The incurrence of indebtedness
would result in an increase in debt service obligations and could result in operating and financing covenants that would restrict our
operations or our ability to pay dividends to our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our suppliers fail to use ethical business practices and comply with applicable laws and regulations, our brand image could be harmed
due to negative publicity.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
core values, which include developing high quality personal hygiene and disinfection products while operating with integrity, are an
important component of our brand image, which makes our reputation sensitive to allegations of unethical business practices. We do not
control our independent suppliers or their business practices. Accordingly, we cannot guarantee their compliance with ethical business
practices, such as environmental responsibility, fair wage practices, and compliance with child labor laws, among others. A lack of demonstrated
compliance could lead us to seek alternative suppliers, which could increase our costs and result in delayed delivery of our products,
product shortages or other disruptions of our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Violation
of labor or other laws by our suppliers or the divergence of an independent supplier&#8217;s labor or other practices from those generally
accepted as ethical in the markets in which we do business could also attract negative publicity for us and our brand. This could diminish
the value of our brand image and reduce demand for our products. If we, or other manufacturers in our industry, encounter similar problems
in the future, it could harm our brand image, business, prospects, results of operations, and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
future growth is dependent on the demand for, and upon consumers&#8217; willingness to adopt, personal hygiene products and disinfectants,
which is associated with consumers&#8217; demand for personal hygiene products and disinfectants, and adoption of new personal hygiene
products and disinfectants.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Demand
for personal hygiene products and disinfectants depends to a large extent on general, economic, political and social conditions in a
given market and the introduction of new products. As our business grows, economic conditions and trends will impact our business, prospects,
and operating results. A weak or uncertain macroeconomic environment, high or increasing inflation (including in relation to energy prices)
and interest rates, stagnant or declining wages and restrictive lending policies may reduce consumers&#8217; net purchasing power and
lead existing and potential customers to refrain from purchasing a new product. Demand for our products may also be affected by factors
directly impacting the price of hygiene products and disinfectants or the cost of purchasing such products, such as sales incentives,
prices of raw materials and parts and components, and cost of governmental regulations, and taxes. Volatility in demand may lead to lower
product sales, which may result in further downward price pressure and adversely affect our business, prospects, financial condition
and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future growth also depends on consumers&#8217; demand for our products. The economic environment and macroeconomic conditions influence
levels of disposable income and consumer spending, thereby impacting demand for personal hygiene products and disinfectants, and defer
a purchase further or to purchase a more affordable product with fewer optional features at a lower price. Further, a weak or uncertain
economic environment, especially when combined with low consumer confidence, may disproportionately reduce demand for personal hygiene
products and disinfectants, due to the discretionary nature of such purchases. A decrease in potential customers&#8217; disposable income
or their financial flexibility, and an increase in consumer concerns can therefore generally have a negative impact on demand for our
products. If the market for products does not develop as we expect or develops more slowly than we expect, our business, prospects, financial
condition, and operating results will be affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
retain certain information about our customers, which may subject us to complex and evolving laws and regulations regarding cybersecurity,
privacy, data protection and information security in various jurisdictions we operate.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
use electronic systems to log, with necessary permission, certain information about customer&#8217;s use of our products in order to
aid us in diagnostics and maintenance, as well as to help us optimize the experiences of our customers with our products. Our customers
may object to the use of this data, which may harm our business. We have adopted strict information security policies and deployed advanced
security measures, including, among others, advanced encryption technologies, to comply with the requirements of the complex and evolving
laws and regulations regarding cybersecurity, privacy, data protection and information security in various jurisdictions we operate,
as well as to prevent data loss and other security breaches. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonetheless,
information stored on our systems may be targeted in cyber-attacks, including computer viruses, worms, phishing attacks, malicious software
programs, and other information security breaches, which could result in the unauthorized release, gathering, monitoring, misuse, loss,
or destruction of such information. If cybercriminals are able to circumvent our security measures, or if we are unable to detect and
prevent an intrusion into our systems, data stored with us may be compromised and susceptible to unauthorized access, use, disclosure,
disruption, modification, or destruction, which could subject us to liabilities, fines and other penalties. Additionally, if any of our
employees access, convert, or misuse any sensitive information, we could be liable for damages, and our business reputation could be
materially harmed. Because the techniques used to obtain unauthorized access or to sabotage systems change frequently, we may not be
able to anticipate these techniques and implement adequate preventative or protective measures. Furthermore, information stored by our
contractors, consultants, and collaborators also may be vulnerable to cyber-attacks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to our data collection practices, products, services and technologies, we are subject to or affected by a number of laws and regulations
in jurisdictions we operate, as well as contractual obligations and industry standards, that impose certain obligations and restrictions
with respect to data privacy and security and govern our collection, storage, retention, protection, use, processing, transmission, sharing
and disclosure of personal information including that of our employees, customers and other third parties with whom we conducts business.
These laws, regulations and standards may be interpreted and applied differently over time and from jurisdiction to jurisdiction, and
it is possible that they will be interpreted and applied in ways that may have a material and adverse impact on our business, financial
condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global data protection landscape is rapidly evolving, and implementation standards and enforcement practices are likely to remain uncertain
for the foreseeable future. We may not be able to monitor and react to all developments in a timely manner. For example, the European
Union adopted the General Data Protection Regulation (&#8220;<span style="font-weight: normal"><i>GDPR</i></span>&#8221;), which became
effective on May 25, 2018. United Kingdom adopted the GDPR as retained EU law at the end of the Brexit transition period, and a UK-specific
General Data Protection Regulation (&#8220;<span style="font-weight: normal"><i>UK GDPR</i></span>&#8221;) which is based on the EU GDPR
came into force from January 1, 2021. In the United States, there is no overarching generally applicable federal law in the US that governs
personal data. Instead, more narrow and specific federal laws apply to the processing or other use or treatment of certain types of personal
data, and US Federal Trade Commission may bring enforcement actions against companies that engage in processing of personal data in a
manner that constitutes an unfair or deceptive trade practice. In addition, the overwhelming majority of states have enacted laws related
to data privacy. For instance, California adopted the California Consumer Privacy Act of 2018 (&#8220;<span style="font-weight: normal"><i>CCPA</i></span>&#8221;),
which became effective in January 2020. Other jurisdictions have begun to propose similar laws. Failure to comply with applicable cybersecurity,
privacy, data protection and information security laws or regulations or to secure personal information could result in investigations,
enforcement actions and other proceedings against us, which could result in substantial fines, damages and other liability as well as
damage to our reputation and credibility, which could have a negative impact on revenues and profits. For more risks relating to laws
and regulations of mainland China regarding cybersecurity, privacy, data protection and information security, see <i>&#8220;INFORMATION
ABOUT NEWCO AND QIANZHI &#8212; Government Regulation &#8211; Regulations on Cyber Security and Privacy Protection.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance
with applicable cybersecurity, privacy, data protection and information security laws and regulations is a rigorous and time-intensive
process, and we may be required to put in place additional mechanisms to comply with such laws and regulations, which could cause us
to incur substantial costs or require us to change our business practices, including our data practices, in a manner adverse to our business.
In addition, changes in existing laws or regulations or adoption of new laws and regulations in these fields, particularly any new or
amended laws or regulations that require enhanced protection for certain types of data or new obligations with regard to data retention,
transfer or disclosure, could greatly increase our cost in providing our service offerings, require significant changes to our operations
or even prevent us from providing certain service offerings in jurisdictions in which we currently operate or in which we may operate
in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
generally comply with industry standards and are subject to the terms of our own privacy policies. We have incurred, and will continue
to incur, significant expenses in an effort to comply with privacy, data protection and information security standards and protocols
imposed by laws, regulations, and industry standards in jurisdictions we operate, or contractual obligations. Nonetheless, certain emerging
laws and regulations in these fields are still subject to a high degree of uncertainty as to their interpretation and application.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
our efforts to comply with applicable laws, regulations and other obligations relating to cybersecurity, privacy, data protection and
information security, it is possible that our practices, offerings, services or platform could fail to meet all of the requirements imposed
on us by such laws, regulations or obligations, which may in turn result in the suspension of our app and thus restrict our use of such
information, and hinder our ability to acquire new customers or market to existing customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot assure you that we will be able to comply with such laws and regulations regarding cybersecurity, privacy, data protection and
information security in all respects and any failure or perceived failure to comply with the same may result in inquiries or other proceedings
being instituted against, or other actions, decisions or sanctions being imposed on us by governmental authorities, users, consumers
or other parties. Any of the foregoing could cause us to lose customers and business partners and have a material adverse effect on our
operations, revenues and profits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be subject to anti-corruption, anti-bribery, anti-money laundering and similar laws, and noncompliance with such laws can subject
us to administrative, civil, and criminal penalties, collateral consequences, remedial measures, and legal expenses, all of which could
adversely affect our business, results of operations, financial condition, and reputation.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be subject to anti-corruption, anti-bribery, anti-money laundering and similar laws and regulations in various jurisdictions in which
we conduct activities, including the U.S. Foreign Corrupt Practices Act, or FCPA, and other anti-corruption laws and regulations. The
FCPA prohibits us and our officers, directors, employees, and business partners acting on our behalf, including agents, from corruptly
offering, promising, authorizing, or providing anything of value to a &#8220;foreign official&#8221; for the purposes of influencing
official decisions or obtaining or retaining business or otherwise obtaining favorable treatment. The FCPA also requires companies to
make and keep books, records, and accounts that accurately reflect transactions and dispositions of assets and to maintain a system of
adequate internal accounting controls. A violation of these laws or regulations could adversely affect our business, reputation, financial
condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have direct or indirect interactions with officials and employees of government agencies and state-owned affiliated entities in the ordinary
course of business. We also have business collaborations with government agencies and state-owned affiliated entities. These interactions
subject us to an increasing level of compliance-related concerns. We are in the process of implementing policies and procedures designed
to ensure compliance by us and our directors, officers, employees, consultants, agents, and business partners with applicable anti-corruption,
anti-bribery, anti-money laundering, financial and economic sanctions, and similar laws and regulations. However, our policies and procedures
may not be sufficient and our directors, officers, employees, consultants, agents, and business partners could engage in improper conduct
for which we may be held accountable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-compliance
with anti-corruption, anti-bribery, anti-money laundering or similar laws could subject us to whistleblower complaints, adverse media
coverage, investigations, and severe administrative, civil and criminal sanctions, collateral consequences, remedial measures, and legal
expenses, all of which could materially and adversely affect our business, reputation, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Risks
Relating to Doing Business in the PRC</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure
to meet the PRC government&#8217;s complex regulatory requirements on and significant oversight over our business operation could result
in a material adverse change in our operations and the value of our securities.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
facilities are located in the PRC and we may be subject to various governmental and regulatory requirements where we operate, including
through various local and municipal agencies and government sub-divisions. The PRC government has significant authority to influence
and intervene in the China operations of an offshore holding company, such as New Bowen. Accordingly, our business, financial condition,
results of operations and prospects may be influenced to a significant degree by political, economic and social conditions in China generally.
The Chinese economy differs from the economies of most of the developed countries in many respects, including the level of government
involvement, level of development, growth rate, control of foreign exchange and allocation of resources. Although the Chinese government
has implemented measures emphasizing the utilization of market forces for economic reform, the divestment of state ownership of productive
assets, and the establishment of improved corporate governance in business enterprises, a substantial portion of productive assets in
China is still owned by the government. In addition, the Chinese government continues to play a significant role in regulating industry
development by imposing industrial policies. The Chinese government also exercises significant control over China&#8217;s economic growth
through allocating resources, controlling payment of foreign currency-denominated obligations, setting monetary policy, and providing
preferential treatment to particular industries or companies. Furthermore, certain administrative measures in regulating (i) our operations
and (ii) offerings conducted overseas by, and foreign investment in, China-based issuers, could significantly limit or completely hinder
our ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
the Chinese government exercises substantial control over many sectors of the Chinese economy through regulation and state ownership.
Our ability to operate in China may be significantly impacted by changes in its laws and regulations, including those relating to securities
regulation, data protection, cybersecurity, taxation, foreign investment limits, mergers and acquisitions and other matters. The PRC
central or local governments may impose new, stricter regulations or interpretations of existing regulations that would require additional
expenditures and efforts on our part to ensure our compliance with such regulations or interpretations. As such, we may be subject to
various government and regulatory requirements in the provinces in which we operate in China and could be subject to regulation by various
political and regulatory entities, including various local and municipal agencies and government sub-divisions. We may incur increased
costs necessary to comply with existing and newly adopted laws and regulations or penalties for any failure to comply. If the Chinese
government seeks to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based
issuers, any such action could significantly limit or completely hinder our ability to offer or continue to offer securities to investors
and cause the value of such securities to significantly decline or be worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chinese economy has experienced significant growth over the past decades, growth has been uneven, both geographically and among various
sectors of the economy. The Chinese government has implemented various measures to generate economic growth and strategically allocate
resources. Some of these measures may benefit the overall Chinese economy but may have a negative effect on us. Any slowdown in the Chinese
economy may reduce the demand for our products and materially and adversely affect our business and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uncertainties
with respect to the legal system and changes in laws and regulations in mainland China could adversely affect us.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conduct our business primarily through our mainland China subsidiaries. Our operations in mainland China are governed by laws and regulations
of mainland China. Our mainland China subsidiaries are subject to laws and regulations applicable to foreign investment in mainland China.
The legal system of mainland China is a civil law system based on written statutes. Unlike the common law system, prior court decisions
under the civil law system may be cited for reference but have limited precedential value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
laws and regulations of mainland China have significantly enhanced the protections afforded to various forms of foreign investments in
mainland China for the past decades. However, because certain recently enacted laws and regulations are relatively new, and because of
the limited volume of published decisions and their nonbinding nature, the interpretation and enforcement of these laws and regulations
involve uncertainties. Furthermore, the legal system of mainland China is based in part on government policies, some of which are not
published or not published on a timely basis, and can change quickly with little advance notice. As a result, we may not be aware of
our potential violation of such policies and rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC government has complex regulatory requirements on the conduct of our business and it has recently promulgated certain regulations
and rules to exert more oversight over offerings that are conducted overseas and/or foreign investment in mainland China-based issuers.
Such action could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and cause
the value of such securities to significantly decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC government has also recently published new policies that significantly affect certain industries and there is no assurance that it
will not in the future release regulations or policies that could adversely affect our business, financial condition, and results of
operations. Furthermore, if China adopts more stringent standards with respect to certain areas such as corporate social responsibilities
or environmental protection, we may incur increased compliance costs or become subject to additional restrictions in their operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Additional
disclosure requirements may be adopted by, and regulatory scrutiny from, the SEC in response to risks related to companies with substantial
operations in China, which could increase our compliance costs, subject us to additional disclosure requirements, and/or suspend or terminate
our future securities offerings, making capital-raising more difficult.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2021, in response to the recent regulatory developments in China and actions adopted by the PRC government, the Chairman of
the SEC issued a statement asking the SEC staff to seek additional disclosures from offshore issuers associated with China-based operating
companies before their registration statements will be declared effective. As such, the offering of our securities may be subject to
additional disclosure requirements and review that the SEC or other regulatory authorities in the United States may adopt for companies
with China-based operations, which could increase our compliance costs, subject us to additional disclosure requirements, and/or suspend
or terminate our future securities offerings, making capital-raising more difficult.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conduct our business in a highly regulated environment and are subject to extensive regulations in China which affect our operations,
and which could result in material changes in our operations and the value of our ordinary shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate in a highly regulated environment. In particular, our manufacturing and other operations are subject to extensive regulations
in China, including but not limited to regulations relating to personal hygiene and disinfection products, regulations on compulsory
product certification, regulations on the recall of defective products, and regulations on product liability and consumer protection.
Several PRC regulatory authorities oversee different aspects of our operations , including but not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">compulsory
                                            product certification;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
                                            liabilities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">environmental
                                            protection system; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">work
                                            safety and occupational health requirements.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required to obtain a wide range of government approvals, licenses, permits, and registrations in connection with our operations as
well as to follow multiple mandatory standards or norms in our manufacturing and our products. However, the interpretation of these regulations
may change and new regulations may come into effect, which could disrupt or restrict our operations, reduce our competitiveness, or result
in substantial compliance costs. Certain filings with government agencies must be made. As we are expanding our sales and distribution
network and setting up additional retail stores in China, we cannot assure you that we will be able to complete such filings in a timely
manner. If any of our current or future branches fails to make the necessary filings, such branch may be subject to orders to promptly
rectify the non-compliance or fines up to RMB10,000. We cannot assure you that we have satisfied or will continue to satisfy all of the
laws, rules, and regulations in a timely manner or at all. In addition, the PRC government imposes foreign ownership restriction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
government actions in the future, including any decision to intervene or influence our operations at any time or to exert control over
an offering of securities conducted overseas and/or foreign investment in China-based issuers, may cause us to make material changes
to our operations, may limit or completely hinder our ability to offer or continue to offer securities to investors, and/or may cause
the value of such securities to significantly decline or be worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of and filing with the CSRC or other PRC government authorities is required in connection with this Business Combination of
our listing under laws of mainland China. However, we cannot predict whether or when we will be able to obtain such approval or complete
such filing, and even if we obtain such approval, it could be rescinded. Any failure to or delay in obtaining such approval or complying
with such filing requirements in relation to offering, or a rescission of such approval, could subject us to sanctions imposed by the
CSRC or other PRC government authorities.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Regulations on Mergers and Acquisitions of Domestic Companies by Foreign Investors, or the M&amp;A Rules, adopted by six different PRC
regulatory authorities in 2006 and amended in 2009, purports to require offshore special purpose vehicles that are controlled by PRC
companies or individuals and that have been formed for the purpose of seeking a public listing on an overseas stock exchange through
acquisitions of PRC domestic companies or assets to obtain an approval of the China Securities Regulatory Commission, or the CSRC, prior
to publicly listing their securities on an overseas stock exchange. The interpretation and application of the regulations remain unclear,
and our offshore offerings may ultimately require approval from the CSRC. If CSRC approval is required, it is uncertain whether we are
able to and how long it will take for us to obtain such approval, and, even if we obtain such CSRC approval, the approval could be rescinded.
Any failure to obtain or any delay in obtaining CSRC approval for our listing, or a rescission of such approval may subject us to sanctions
imposed by the CSRC or other PRC regulatory authorities, which could include fines and penalties on our operations in China, restrictions
or limitations on our ability to pay dividends outside of China, and other forms of sanctions that may materially and adversely affect
our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the PRC government has recently sought to exert more oversight and control over offerings that are conducted overseas or foreign investment
in China-based issuers. The Opinions (defined below), among others, emphasizes the need to strengthen cross-border regulatory cooperation
and the administration and supervision of China-based issuers, and to establish a comprehensive regulatory system for the application
of PRC capital market laws and regulations outside China. On February 17, 2023, the CSRC promulgated the Trial Administrative Measures
of Overseas Securities Offering and Listing by Domestic Companies, or the Overseas Listing Filing Rules, which became effective on March
31, 2023. According to the Overseas Listing Filing Rules, the offering or listing of shares, depository receipts, convertible corporate
bonds, or other equity-like securities by a PRC domestic company in an overseas stock market, whether directly or indirectly through
an offshore holding company, should be filed with the CSRC. If a PRC domestic company intends to complete a direct or indirect overseas
(i) initial public offering and listing, or (ii) listing of shares in the name of an overseas enterprise on the basis of the equity,
assets, income or other similar rights of the relevant PRC domestic company through a single or multiple acquisitions, share swaps, shares
transfers or other means, the issuer (if the issuer is a PRC domestic company) or its designated major PRC domestic operating entity
(if the issuer is an offshore holding company), in each applicable event, the reporting entity, shall complete the filing procedures
with the CSRC within three business days after the issuer submits its application documents relating to the initial public offering and/or
listing or after the first public announcement of the relevant transaction (if the submission of relevant application documents is not
required). The determination of whether any offering or listing is &#8220;indirect&#8221; will be made on a &#8220;substance over form&#8221;
basis. An offering or listing of an issuer will be considered as an overseas indirect offering or listing by PRC domestic companies if
both of the following conditions are met with respect to such issuer: (i) the revenues, profit, total assets, or net assets of PRC domestic
companies in the most recent fiscal year constitute more than 50% of the relevant line item in the issuer&#8217;s audited consolidated
and combined financial statements for that year; and (ii) the majority of the senior management personnel responsible for its business
operations and management are PRC citizens or have their ordinary residence in China, or if its main place of business is in China or
if its business operation is primarily conducted in China. In addition, according to the Overseas Listing Filing Rules and a set of Q&amp;A
published on the CSRC&#8217;s official website in connection with the release of the Overseas Listing Filing Rules, if it is explicitly
required (in the form of institutional rules) by any regulatory authority having jurisdiction over the relevant industry and field that
regulatory procedures should be performed prior to the overseas listing of a PRC domestic company, such company must obtain the regulatory
opinion, approval and other documents from and complete any required filing with such competent authority before submitting a CSRC filing.
The reporting entity shall make a timely report to the CSRC and update its CSRC filing within three business days after the occurrence
of any of the following material events, if any of them occurs after obtaining its CSRC filing and before the completion of the offering
and/or listing: (i) any material change to principal business, licenses or qualifications of the issuer; (ii) a change of control of
the issuer or any material change to equity structure of the issuer; and (iii) any material change to the offering and listing plan.
Once listed overseas, the reporting entity will be further required to report the occurrence of any of the following material events
within three business days after the occurrence and announcement thereof to the CSRC: (i) a change of control of the issuer; (ii) the
investigation, sanction or other measures undertaken by any foreign securities regulatory agencies or relevant competent authorities
in respect of the issuer; (iii) change of the listing status or transfer of the listing board; and (iv) the voluntary or mandatory delisting
of the issuer. In addition, the completion of any overseas follow-on offerings by an issuer in the same overseas market where it has
completed its public offering and listing would necessitate a filing with the CSRC within three business days thereafter. Failure to
comply with the applicable filing requirements may result in fines being imposed on the relevant PRC domestic companies and their controlling
shareholders and other responsible person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the Overseas Listing Filing Rules, the Notice on Administration for the Filing of Overseas Offering and Listing by Domestic Companies
published by the CSRC on February 17, 2023, or the Notice on the Overseas Listing Filing, and the set of Q&amp;A published on the CSRC&#8217;s
official website, we are required to complete the filing procedures with the CSRC in connection with this Business Combination as required
by the Overseas Listing Filing Rules prior to the listing of its securities on Nasdaq. As of the date of this proxy statement/prospectus,
we have not completed the filing procedures with the CSRC. We cannot assure you that we can complete the filing procedures in a timely
manner or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
Regulations under PRC Law Relating to Data Security and Confidentiality and Archives Management may subject us to additional compliance
requirements in the future.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recently,
the General Office of the Central Committee of the Communist Party of China and the General Office of the State Council of the PRC (the
&#8220;<span style="font-weight: normal"><i>State Council</i></span>&#8221;) jointly issued the Opinions on Severely Cracking Down on
Illegal Securities Activities According to Law, or the Opinions, which were made available to the public on July 6, 2021. The Opinions
emphasized the need to strengthen the administration over illegal securities activities, and the need to strengthen the supervision over
overseas listings by Chinese companies. The Opinions proposed to take effective measures, such as promoting the construction of relevant
regulatory systems, to deal with the risks and incidents facing China-based overseas-listed companies and the demand for cybersecurity
and data privacy protection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24, 2023, the CSRC and several other administrations jointly released the revised Provisions on Strengthening Confidentiality
and Archiving Administration of Overseas Securities Offering and Listing by Domestic Companies, or the Archives Rules, which came into
effect on March 31, 2023. The Archives Rules apply to both overseas direct offerings and overseas indirect offerings. The Archives Rules
provides that, among other things, (i) in relation to the overseas listing activities of PRC domestic enterprises, the PRC domestic enterprises
are required to strictly comply with the relevant requirements on confidentiality and archives management, establish a sound confidentiality
and archives system, and take necessary measures to discharge their confidentiality and archives management responsibilities; (ii) if
a PRC domestic enterprise is required to publicly disclose or provide to any securities companies or other securities service providers
or overseas regulators or individuals, any materials that contain state secrets or government work secrets (where there is ambiguity
or dispute on whether it is state secret or government work secret, a request shall be submitted to the competent government authority
for determination), during the course of its overseas offering or listing, the PRC domestic enterprise shall apply for approval from
competent authorities and file with the secrecy administrative department at the same level; and (iii) working papers produced in China
by securities companies and other securities service institutions, who provide such PRC domestic enterprises with securities services
during their overseas issuance and listing, should be stored in the PRC, and the transmission of any such working papers to recipients
outside China must be approved following the applicable PRC regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
failure or perceived failure by PRC domestic companies to comply with the above confidentiality and archives administration requirements
under the revised Provisions and other PRC laws and regulations may result in the relevant entities being held legally liable by competent
authorities, and referred to the judicial organ to be investigated for criminal liability if suspected of committing a crime.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
greater oversight by the CAC over data security, particularly for companies seeking to list on a foreign exchange, could adversely impact
our business.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2021, the Cyberspace Administration of China, or the CAC and several other administrations jointly issued the revised Measures
for Cybersecurity Review, or the Revised Review Measures, which became effective and replaced the existing Measures for Cybersecurity
Review on February 15, 2022. According to the Revised Review Measures, if an &#8220;online platform operator&#8221; that is in possession
of personal data of more than one million users intends to list in a foreign country, it must apply for a cybersecurity review. Based
on a set of Q&amp;A published on the official website of the CAC in connection with the issuance of the Revised Review Measures, an official
of the CAC indicated that an online platform operator should apply for a cybersecurity review prior to the submission of its listing
application with non-PRC securities regulators. After the receipt of all required application materials, the authorities must determine,
within ten business days thereafter, whether a cybersecurity review will be initiated, and issue a written notice to the relevant applicant
of its determination. If a review is initiated and the authorities conclude after such review that the listing will affect national security,
the listing of the relevant applicant will be prohibited. Given the recency of the issuance of the Revised Review Measures, there is
a general lack of guidance and substantial uncertainties exist with respect to its interpretation and implementation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2021, 13 governmental departments of the PRC, including the CAC, jointly promulgated the Cybersecurity Review Measures,
which became effective on February 15, 2022. The Cybersecurity Review Measures provide that, in addition to critical information infrastructure
operators (the &#8220;<span style="font-weight: normal"><i>CIIOs</i></span>&#8221;) that intend to purchase Internet products and services,
net platform operators engaging in data processing activities that affect or may affect national security must be subject to cybersecurity
review by the Cybersecurity Review Office of the PRC. According to the Cybersecurity Review Measures, a cybersecurity review assesses
potential national security risks that may be brought about by any procurement, data processing, or overseas listing. The Cybersecurity
Review Measures require that an online platform operator which possesses the personal information of at least one million users must
apply for a cybersecurity review by the CAC if it intends to be listed in foreign countries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the PRC Cybersecurity Law requires companies to implement certain organizational, technical and administrative measures and other necessary
measures to ensure the security of their networks and data stored on their networks. Specifically, the Cybersecurity Law provides that
China adopts a multi-level protection scheme (&#8220;MLPS&#8221;), under which network operators are required to perform obligations
of security protection to ensure that the network is free from interference, disruption or unauthorized access, and prevent network data
from being disclosed, stolen or tampered. Under the MLPS, entities operating information systems must have a thorough assessment of the
risks and the conditions of their information and network systems to determine the level to which the entity&#8217;s information and
network systems belong-from the lowest Level 1 to the highest Level 5 pursuant to a series of national standards on the grading and implementation
of the classified protection of cybersecurity. The grading result will determine the set of security protection obligations that entities
must comply with. Entities classified as Level 2 or above should report the grade to the relevant government authority for examination
and approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 14, 2021, the CAC released the Regulations on Network Data Security Management (draft for public comments), which provide that
if a data processor that processes personal data of more than one million users intends to list in a foreign country, it must apply for
a cybersecurity review. Pending the finalization, adoption, enforcement and interpretation of these new measures and regulations, we
cannot rule out the possibility that the measures and regulations may be enacted, interpreted or implemented in ways that will negatively
affect us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC Data Security Law, which was promulgated by the Standing Committee of the National People&#8217;s Congress, or the SCNPC, on June
10, 2021 and took effect on September 1, 2021, imposes data security and privacy obligations on entities and individuals carrying out
data activities. Further, the PRC Data Security Law introduces a data classification and hierarchical protection system based on the
importance of data in economic and social development, and the degree of harm it will cause to national security, public interests, or
legitimate rights and interests of individuals or organizations when such data is tampered with, destroyed, leaked, illegally acquired
or used. The PRC Data Security Law also provides for a national security review procedure for data activities that may affect national
security and imposes export restrictions on certain data an information. On July 30, 2021, the State Council promulgated the Regulations
on the Protection of the Security of Critical Information Infrastructure, or the Regulations, which took effect on September 1, 2021.
The Regulations supplement and specify the provisions on the security of critical information infrastructure as stated in the Cybersecurity
Review Measures. The Regulations provide, among others, that protection department of certain industry or sector shall notify the operator
of the critical information infrastructure in time after the identification of certain critical information infrastructure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 20, 2021, the SCNPC promulgated the Personal Information Protection Law of the PRC, or the Personal Information Protection Law,
which took effect on November 1, 2021. As the first systematic and comprehensive law specifically for the protection of personal information
in the PRC, the Personal Information Protection Law provides, among others, that (i) an individual&#8217;s consent shall be obtained
to use sensitive personal information, such as biometric characteristics and individual location tracking, (ii) personal information
operators using sensitive personal information shall notify individuals of the necessity of such use and impact on the individual&#8217;s
rights, and (iii) where personal information operators reject an individual&#8217;s request to exercise his or her rights, the individual
may file a lawsuit with a People&#8217;s Court.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement/prospectus, we have not received any notice from any authorities identifying us as a critical
information infrastructure operator or requiring us to go through cybersecurity review or network data security review by the CAC.
As confirmed by our PRC counsel, Jingsh &amp; H Y Leung, our operations and listing are not expected to be affected by, or subject
to, cybersecurity review by the CAC under the Cybersecurity Review Measures, given that we are not (i) a network platform operator
engaging in data processing activities that affect or may affect national security; (ii) a critical information infrastructure
operator purchasing cyber products or services that affect or may affect national security; or (iii) a network platform operator
with personal information data of more than one million users. There remains uncertainty, however, as to how the Cybersecurity
Review Measures and the Security Administration Draft will be interpreted or implemented and whether the PRC regulatory agencies,
including the CAC, may adopt new laws, regulations, rules, or detailed implementation and interpretation related to the
Cybersecurity Review Measures and the Security Administration Draft. If any such new laws, regulations, rules, or implementation and
interpretation come into effect, we expect to take all reasonable measures and actions to comply and to minimize the adverse effect
of such laws on it. We cannot guarantee, however, that we will not be subject to cybersecurity review and network data security
review in the future. During such reviews, we may be required to suspend our operations or experience other disruptions to their
operations. Cybersecurity review and network data security review could also result in negative publicity with respect to us and
diversion of our managerial and financial resources, which could materially and adversely affect its business, financial conditions,
and results of operations.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
If (i) we do not receive or maintain any required permission, or fail to complete any required review or filing, (ii) we inadvertently
conclude that such permission, review or filing is not required, or (iii) applicable laws, regulations, or interpretations change such
that it becomes mandatory for us to obtain any permission, review or filing in the future, we may have to expend significant time and
costs to comply with these requirements. If we are unable to do so, on commercially reasonable terms, in a timely manner or otherwise,
we may become subject to sanctions imposed by the PRC regulatory authorities, which could include fines and penalties, proceedings against
us, and other forms of sanctions, and our ability to conduct our business, complete the Business Combination, or list on a U.S. or other
overseas exchange may be restricted, and our business, reputation, financial condition, and results of operations may be materially and
adversely affected. Further, New Bowen&#8217;s ability to offer or continue to offer securities to investors may be significantly limited
or completely hindered, and the value of its securities may significantly decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is uncertain whether we can, or how long it will take us to, obtain such approval or complete such filing procedures and any such approval
could be rescinded. Any failure to obtain or delay in obtaining clearance of such approval or completing such filing procedures for this
Business Combination or our listing, or a rescission of any such approval if obtained by us, would subject us to regulatory actions or
other sanctions by the CSRC, CAC or other PRC regulatory authorities for failure to seek required governmental authorization in respect
of the same. These governmental authorities may impose fines, restrictions and penalties on our operations in China, such as revocation
of our licenses or shutting down part or all of our operations, limit our ability to pay dividends outside of China, limit our operating
privileges in China or take other actions that could have a material adverse effect on our business, financial condition, results of
operations and prospects, as well as the trading price of our securities. The PRC governmental authorities may also take actions requiring
us, or making it advisable for us, to suspend this Business Combination or our listing before settlement and delivery. Consequently,
if you engage in market trading or other activities in anticipation of and prior to settlement and delivery, you do so at the risk that
settlement and delivery may not occur. All of these could have a material adverse effect on the trading price of our securities and could
significantly limit or completely hinder our ability and the ability of any holder of our securities to offer or continue to offer such
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC
regulations of loans and direct investment by offshore holding companies to PRC entities may delay or prevent us from using the proceeds
of our offshore financing to make loans or additional capital contributions to our PRC subsidiary, which could materially and adversely
affect our liquidity and our ability to fund and expand our business.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may transfer funds to our PRC subsidiary or finance our PRC subsidiary by means of shareholders&#8217; loans or capital contributions
after completion of this offering. Any loans to our PRC subsidiary, which are foreign-invested enterprises, cannot exceed a statutory
limit, and shall be filed with the State Administration of Foreign Exchange, or SAFE, or its local counterparts. Furthermore, any capital
contributions we make to our PRC subsidiary shall be registered with the PRC State Administration for Market Regulation or its local
counterparts and filed with the Ministry of Commerce (&#8220;<span style="font-weight: normal"><i>MOFCOM</i></span>&#8221;) or its local
counterparts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 30, 2015, SAFE promulgated the Circular on Reforming the Administration Measures on Conversion of Foreign Exchange Registered Capital
of Foreign-invested Enterprises, or SAFE Circular 19. SAFE Circular 19, however, allows foreign invested enterprises in China to use
their registered capital settled in RMB converted from foreign currencies to make equity investments, but the registered capital of a
foreign invested company settled in RMB converted from foreign currencies remains not allowed to be used, among other things, for investment
in the security markets, or offering entrustment loans, unless otherwise regulated by other laws and regulations. On June 9, 2016, SAFE
further issued the Circular of the State Administration of Foreign Exchange on Reforming and Regulating Policies on the Control over
Foreign Exchange Settlement of Capital Accounts, or SAFE Circular 16, which, among other things, amended certain provisions of Circular
19. According to SAFE Circular 19 and SAFE Circular 16, the flow and use of the RMB capital converted from foreign currency-denominated
registered capital of a foreign invested company is regulated such that Renminbi capital may not be used for purposes beyond its business
scope or to provide loans to non-affiliates unless otherwise permitted under its business scope. On October 23, 2019, SAFE promulgated
the Circular of the State Administration of Foreign Exchange on Further Promoting the Facilitation of Cross-Border Trade and Investment,
or SAFE Circular 28, which removes the restrictions on domestic equity investments by non-investment foreign-invested enterprises with
their capital funds, provided that certain conditions are met. The applicable foreign exchange circulars and rules may limit our ability
to transfer the net proceeds from this offering and the concurrent private placements to our PRC subsidiary and convert the net proceeds
into RMB, which may adversely affect our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restrictions
on the remittance of Renminbi into and out of China and governmental control of currency conversion may limit our ability to pay dividends
and other obligations and affect the value of your investment.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC government imposes controls on the convertibility of Renminbi into foreign currencies and the remittance of currency out of China.
We receive substantially all of our revenue in Renminbi. Under our current corporate structure, our income is primarily derived from
dividend payments from our PRC subsidiary. Shortages in the availability of foreign currency may restrict the ability of our PRC subsidiary
to remit sufficient foreign currency to pay dividends or other payments to us, or otherwise satisfy their foreign currency denominated
obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
existing PRC foreign exchange regulations, payments of current account items, including profit distributions, interest payments, and
trade and service-related foreign exchange transactions, can be made in foreign currencies without prior SAFE approval by complying with
certain procedural requirements. However, approval from or registration or filings with competent government authorities is required
where Renminbi is to be converted into foreign currency and remitted out of China to pay capital expenses such as the repayment of loans
denominated in foreign currencies. Pursuant to SAFE Circular 19, a foreign-invested enterprise may convert up to 100% of the foreign
currency in its capital account into Renminbi on a discretionary basis according to the actual needs. The SAFE Circular 16 provides for
an integrated standard for conversion of foreign exchange under capital account items on a discretionary basis, which applies to all
enterprises registered in China. In addition, SAFE Circular 16 has narrowed the scope of purposes for which an enterprise must not use
the Renminbi funds so converted, which include, among others, (i) payment for expenditure beyond its business scope or otherwise as prohibited
by the applicable laws and regulations, (ii) investment in securities or other financial products other than banks&#8217; principal-secured
products, (iii) provision of loans to non-affiliated enterprises, except where it is expressly permitted in the business scope of the
enterprise, and (iv) construction or purchase of non-self-used real properties, except for real estate developers. The PRC government
may at its discretion further restrict access to foreign currencies for current account transactions or capital account transactions
in the future. If the foreign exchange control system prevents us from obtaining sufficient foreign currencies to satisfy our foreign
currency needs, we may not be able to pay dividends in foreign currencies to our shareholders. Further, there is no assurance that new
regulations will not be promulgated in the future that would have the effect of further restricting the remittance of Renminbi into or
out of China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fluctuations
in exchange rates could result in foreign currency exchange losses.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
value of Renminbi against the U.S. dollar and other currencies fluctuates, is subject to changes resulting from the PRC government&#8217;s
policies and depends to a large extent on domestic and international economic and political developments as well as supply and demand
in local markets. In July 2005, the PRC government changed its decades-old policy of pegging the value of Renminbi to the U.S. dollar,
and Renminbi appreciated more than 20% against the U.S. dollar over the following three years. Between July 2008 and June 2010, this
appreciation halted and the exchange rate between Renminbi and the U.S. dollar remained within a narrow band. Since June 2010, Renminbi
has fluctuated against the U.S. dollar, at times significantly and unpredictably. With the development of the foreign exchange market
and progress towards interest rate liberalization and Renminbi internationalization, the PRC government may in the future announce further
changes to the exchange rate system and we cannot assure you that Renminbi will not appreciate or depreciate significantly in value against
the U.S. dollar in the future. It is difficult to predict how market forces or PRC, or U.S. government policy may impact the exchange
rate between Renminbi and the U.S. dollar in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
depreciation of the Renminbi may adversely affect the value of, and any dividends payable on, our ordinary shares in foreign currency.
In addition, there are limited instruments available for us to reduce our foreign currency risk exposure at reasonable costs. All of
these factors could materially and adversely affect our business, financial condition, results of operations, and prospects, and could
reduce the value of, and dividends payable on, our ordinary shares in foreign currency terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
enforcement of the PRC Labor Contract Law and other labor-related regulations in the PRC may adversely affect our business and results
of operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SCNPC enacted the Labor Contract Law in 2008 and amended it on December 28, 2012. The Labor Contract Law introduced specific provisions
related to fixed-term employment contracts, part-time employment, probationary periods, consultation with labor unions and employee assemblies,
employment without a written contract, dismissal of employees, severance, and collective bargaining to enhance previous PRC labor laws.
Under the Labor Contract Law, an employer is obligated to sign an unlimited-term labor contract with any employee who has worked for
the employer for ten consecutive years. Further, if an employee requests or agrees to renew a fixed-term employment agreement that has
already been entered into twice consecutively, the resulting contract, with certain exceptions, must have an unlimited term, subject
to certain exceptions. With certain exceptions, an employer must pay severance to an employee where a labor contract is terminated or
expires. In addition, the PRC governmental authorities have continued to introduce various new labor-related regulations since the effectiveness
of the Labor Contract Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the PRC Social Insurance Law and the Administrative Measures on Housing Fund, employees are required to participate in pension insurance,
work-related injury insurance, medical insurance, unemployment insurance, maternity insurance, and housing funds and employers are required,
together with their employees or separately, to pay the social insurance premiums and housing funds for their employees. If we fail to
make adequate social insurance and housing fund contributions, we may be subject to fines and legal sanctions, and our business, financial
conditions and results of operations may be adversely affected. During the fiscal years ended March 31, 2024 and 2023 we
did not make adequate contributions to the social insurance and/or housing fund for certain employees as they voluntarily waived our
contributions. See &#8220;<i>INFORMATION ABOUT NEWCO AND QIANZHI &#8212; Government Regulation &#8211; Regulations Related to Employment
and Social Welfare</i>.&#8221; We received confirmations from the corporate credit report issued by Credit China (Guangdong) that
we were not subject to any penalty for failing to make full contributions to the social insurance fund and housing fund during the fiscal
years ended March 31, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
laws designed to enhance labor protection tend to increase our labor costs. In addition, as the interpretation and implementation of
these regulations are still evolving, our employment practices may not be at all times be deemed in compliance with the regulations.
As a result, we could be subject to penalties or incur significant liabilities in connection with labor disputes or investigations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">China&#8217;s
M&amp;A Rules and certain other regulations establish more complex procedures for certain acquisitions of PRC companies by foreign investors,
which could make it more difficult for us to pursue growth through acquisitions in China.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
number of PRC laws and regulations, including the M&amp;A Rules, the Anti-monopoly Law promulgated by the Standing Committee of the National
People&#8217;s Congress in August 2007 and amended in June 2022, the Rules of Ministry of Commerce on Implementation of Security Review
System of Mergers and Acquisitions of Domestic Enterprises by Foreign Investors promulgated by the Ministry of Commerce in August 2011,
and the Measures for the Security Review of Foreign Investment promulgated by the National Development and Reform Commission of the PRC,
or NDRC and the Ministry of Commerce in December 2020 have established procedures and requirements that are expected to make merger and
acquisition activities in China by foreign investors more time-consuming and complex. These include requirements in some instances that
the approval from the Ministry of Commerce be obtained in circumstances where overseas companies established or controlled by PRC enterprises
or residents acquire affiliated domestic companies. PRC laws and regulations also require certain merger and acquisition transactions
involving an industry that implicates national security to be subject to merger control review or security review.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future, we may further grow our business by acquiring complementary businesses. Complying with the requirements of the relevant rules
to complete such transactions could be time-consuming, and any required approval processes, including obtaining approval from the Ministry
of Commerce or its local counterparts may delay or inhibit our ability to complete such transactions which could affect our ability to
expand our business or maintain or expand our market share through future acquisitions would as such be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
may be difficult for overseas regulators to conduct investigations or collect evidence within China.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
claims or regulatory investigations that are common in the United States generally are difficult to pursue as a matter of law or practicality
in China. For example, in China, there are significant legal and other obstacles to providing information needed for regulatory investigations
or litigation initiated outside China. Although the authorities in China may establish a regulatory cooperation mechanism with the securities
regulatory authorities of another country or region to implement cross-border supervision and administration, such cooperation with the
securities regulatory authorities in the Unities States may not be efficient in the absence of mutual and practical cooperation mechanism.
Furthermore, according to Article 177 of the PRC Securities Law, or Article 177, which became effective in March 2020, no overseas securities
regulator is allowed to directly conduct investigations or evidence collection activities within the territory of the PRC. While detailed
interpretation of or implementation rules under Article 177 have yet to be promulgated, the inability for an overseas securities regulator
to directly conduct investigations or evidence collection activities within China may further increase difficulties faced by you in protecting
your interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chinese
regulatory authorities could disallow our holding company structure, which may result in a material change in our operations and/or a
material change in the value of New Bowen&#8217;s securities, including that it could cause the value of such securities to significantly
decline.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the consummation of the Business Combination, New Bowen will directly hold the equity of Qianzhi. Although the PRC government has an
increasingly open attitude towards absorbing foreign investment in general, it still implements the Special Administrative Measures for
Access of Foreign Investments (the &#8220;<span style="font-weight: normal"><i>Negative List</i></span>&#8221;). Under the Negative List,
the foreign invested enterprise would not be allowed to make investments in prohibited industries set out in the &#8220;Negative List&#8221;
while a foreign invested enterprise must satisfy certain conditions stipulated in the &#8220;negative list&#8221; for investment in restricted
industries. As of the date of this proxy statement/prospectus, none of our PRC subsidiaries or affiliates are currently subject to foreign
investment restrictions as set forth in the presently effective Special Administrative Measures for Entry of Foreign Investment (Negative
List) (2021 Version), or the 2021 Negative List. If any part of our business operations falls within the scope of the &#8220;Negative
List&#8221; or if the interpretation and implementation of the 2019 PRC Foreign Investment Law and any future &#8220;Negative List&#8221;
mandates further actions, such as market entry clearance granted by the PRC Ministry of Commerce, we face uncertainties as to whether
such clearance can be obtained in a timely manner, or at all. We cannot assure you that the relevant governmental authorities will not
interpret or implement the 2019 PRC Foreign Investment Law in the future in a way that will materially impact the viability of our current
corporate governance and business operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 4, 2014, SAFE issued the SAFE Circular 37, which requires PRC residents, including PRC individuals and institutions, to register
with SAFE or its local branches in connection with their direct establishment or indirect control of an offshore special purpose vehicle,
for the purpose of overseas investment and financing, with such PRC residents&#8217; legally owned assets or equity interests in domestic
enterprises or offshore assets or interests. In addition, such PRC residents must update their foreign exchange registrations with SAFE
or its local branches when the offshore special purpose vehicles in which such residents directly hold equity interests undergo material
events relating to any changes of basic information (including changes of such PRC individual shareholders, names, and operation terms),
increases or decreases in investment amount, share transfers or exchanges, or mergers or divisions. As of the date of this proxy statement/prospectus,
all of our shareholders have completed SAFE Circular 37 Registration and are in compliance. We will attempt to comply and ensure that, following
the consummation of the Business Combination, shareholders who are subject to these rules comply with the relevant requirements. However,
New Bowen and Qianzhi may not be fully informed of the identities of all their shareholders or beneficial owners who are PRC residents,
and therefore, may not be able to identify all their shareholders or beneficial owners who are PRC residents to ensure their compliance
with the SAFE Circular 37 or other related rules. In addition, there is no assurance that all such shareholders and beneficial owners
who are PRC residents will comply with a request to make, obtain, or update any applicable registrations or comply with other requirements
required by the SAFE Circular 37 or other related rules in a timely manner. Even if such shareholders and beneficial owners who are PRC
residents comply with such request, there is no assurance that they will successfully obtain or update any registration required by the
SAFE Circular 37 or other related rules in a timely manner. Failure to comply with the registration procedures set forth in the SAFE
Circular 37 may result in restrictions on foreign exchange activities of the relevant onshore company, including the payment of dividends
and other distributions to its offshore parent or affiliate, the capital inflow from the offshore entities, and settlement of foreign
exchange capital, and may also subject relevant onshore company or PRC residents to penalties under foreign exchange administration regulations
of mainland China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
if future laws, administrative regulations, or provisions mandate further actions to be taken by New Bowen or Qianzhi with respect to
their existing corporate structure, New Bowen may face substantial uncertainties as to whether it can complete such actions in a timely
manner, or at all. Failure to take timely and appropriate measures to cope with any of these or similar regulatory compliance challenges
could materially and adversely affect New Bowen&#8217;s corporate structure, resulting in a material change in its operations and/or
a material change in the value of New Bowen&#8217;s Ordinary Shares, including that it could cause the value of New Bowen&#8217;s Ordinary
Shares to significantly decline or become worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be materially adversely affected if our shareholders and beneficial owners who are PRC entities fail to comply with the PRC overseas
investment regulations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 26, 2017, the NDRC promulgated the Administrative Measures on Overseas Investments, which took effect as of March 1, 2018. According
to this regulation, non-sensitive overseas investment projects are subject to record-filing requirements with the local branch of the
NDRC. On September 6, 2014, the Ministry of Commerce promulgated the Administrative Measures on Overseas Investments, which took effect
as of October 6, 2014. According to this regulation, overseas investments of PRC enterprises that involve non-sensitive countries and
regions and non-sensitive industries are subject to record-filing requirements with a local branch of Ministry of Commerce. According
to the Circular of the State Administration of Foreign Exchange on Issuing the Regulations on Foreign Exchange Administration of the
Overseas Direct Investment of Domestic Institutions, which was promulgated by SAFE on July 13, 2009, and took effect on August 1, 2009,
PRC enterprises must register for overseas direct investment with a local SAFE branch. The shareholders or beneficial owners who are
PRC entities are required to be in compliance with the related overseas investment regulations. If they fail to complete the filings
or registrations required by overseas direct investment regulations, the relevant authority may order them to suspend or cease the implementation
of such investment and make corrections within a specified time. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
failure to comply with PRC regulations regarding the registration requirements for employee stock incentive plans may subject the PRC
plan participants or us to fines and other legal or administrative sanctions.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2012, SAFE promulgated the Notices on Issues Concerning the Foreign Exchange Administration for Domestic Individuals Participating
in Stock Incentive Plan of Overseas Publicly Listed Company, replacing earlier rules promulgated in 2007. Pursuant to these rules, PRC
citizens and non-PRC citizens who reside in China for a continuous period of not less than one year who participate in any stock incentive
plan of an overseas publicly listed company, subject to a few exceptions, are required to register with SAFE through a domestic qualified
agent, which could be the PRC subsidiaries of such overseas-listed company, and complete certain other procedures. We and our executive
officers and other employees who are PRC citizens or who reside in China for a continuous period of not less than one year and who have
been granted options will be subject to these regulations when our company becomes an overseas-listed company upon the completion of
this offering. Failure to complete SAFE registrations may subject them to fines and may also limit our ability to contribute additional
capital into our PRC subsidiary and limit our PRC subsidiary&#8217;s ability to distribute dividends to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of relevant PRC regulatory authorities and compliance procedures may be required in connection with this Business Combination,
and, if required, we cannot predict whether we will be able to obtain such approval.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recently,
the General Office of the Central Committee of the Communist Party of China and the General Office of the State Council jointly issued
the Opinions on Severe and Lawful Crackdown on Illegal Securities Activities, which was available to the public on July 6, 2021. These
opinions emphasized the need to strengthen the administration over illegal securities activities and the supervision on overseas listings
by China-based companies. These opinions proposed to take effective measures, such as promoting the construction of relevant regulatory
systems, to deal with the risks and incidents facing China-based overseas-listed companies and the demand for cybersecurity and data
privacy protection. Moreover, on December 28, 2021, the CAC and other relevant PRC governmental authorities jointly promulgated the Cybersecurity
Review Measures which took effect on February 15, 2022, and replaced the original Cybersecurity Review Measures promulgated on April
13, 2020. In accordance with the Cybersecurity Review Measures, network platform operators holding more than one million users/users&#8217;
individual information shall be subject to cybersecurity review before listing abroad.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 14, 2021, the National Internet Information Office issued the &#8220;Regulations on Network Data Security Management (Draft
for Solicitation of Comments),&#8221; or the Draft for Comment. The Draft for Comment requests data processors, Internet platform operators
and large-scale network operators to comply with the obligation of cybersecurity protection when carrying out data processing activities.
A data processor identified in the Draft for Comment refers to an individual and an organization that independently decides the processing
purpose and method in data processing activities. In accordance with the Draft for Comment, an Internet platform operator refers to a
data processor that provides users with Internet platform services such as information release, social interaction, transaction, payment,
audio-visual and so on, while large-scale Internet platform operators refer to those who have more than 50 million users, handle a large
amount of personal information and important data, and have strong social mobilization ability and market dominance. Meanwhile, the Draft
for Comment also provides that if data processors handling personal information of more than one million people intend to become listed
overseas, they shall abide by the relevant regulations and apply for cybersecurity review. In the opinion of Jingsh &amp; H Y Leung,
our business operations do not currently involve data processing and therefore do not fall under the definition of &#8220;data processors.&#8221;
We also do not fall under the definition of Internet platform operator and large-scale network operator. Jingsh &amp; H Y Leung has advised
us that we are not required to conduct cybersecurity review even after the Draft for Comment coming into effectiveness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
there remain uncertainties as to when the final measures will be issued and take effect, how they will be enacted, interpreted or implemented,
and whether they will affect us. If we inadvertently conclude that the Cybersecurity Review Measures do not apply to us, or applicable
laws, regulations, or interpretations change and it is determined in the future that Cybersecurity Review Measures become applicable
to us, we may be subject to review when conducting data processing activities and may face challenges in addressing its requirements
and make necessary changes to our internal policies and practices. We may incur substantial costs in complying with the Cybersecurity
Review Measures, which could result in material adverse changes in our business operations and financial position. If we are not able
to fully comply with the Cybersecurity Review Measures, our ability to offer or continue to offer securities to investors may be significantly
limited or completely hindered, and our securities may significantly decline in value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the aforementioned policies evolve and any related implementation rules are enacted, we may be subject to additional compliance requirement
in the future. As these opinions were recently issued, official guidance and interpretation of the opinions remain unclear in several
respects at this time. Therefore, we cannot assure you that we will remain fully compliant with all new regulatory requirements of these
opinions or any future implementation rules on a timely basis, or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the PRC Enterprise Income Tax Law, New Bowen may be classified as a PRC &#8220;resident enterprise&#8221; for PRC enterprise income tax
purposes. Such classification would likely result in unfavorable tax consequences to New Bowen and its non-PRC shareholders and have
a material adverse effect on its results of operations and the value of your investment.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the PRC Enterprise Income Tax Law (the &#8220;<span style="font-weight: normal"><i>EIT Law</i></span>&#8221;), which became effective
in January 2008, an enterprise established outside the PRC with &#8220;de facto management bodies&#8221; within the PRC is considered
a &#8220;resident enterprise&#8221; for PRC enterprise income tax purposes and is generally subject to a uniform 25% enterprise income
tax rate on its worldwide income. Under the implementation rules to the EIT Law, a &#8220;de facto management body&#8221; is defined
as a body that has material and overall management and control over the manufacturing and business operations, personnel and human resources,
finances, and properties of an enterprise. In April 2009, the State Administration of Taxation (the &#8220;<span style="font-weight: normal"><i>SAT</i></span>&#8221;)
issued the Circular on Issues Concerning the Identification of Chinese-Controlled Overseas Registered Enterprises as Resident Enterprises
in Accordance with the Actual Standards of Organizational Management, or &#8220;<span style="font-weight: normal"><i>SAT Circular 82</i></span>,&#8221;
which was amended in December 2017. SAT Circular 82 specifies that certain offshore incorporated enterprises controlled by PRC enterprises
or PRC enterprise groups will be classified as PRC resident enterprises if the following are located or resident in the PRC: senior management
personnel and departments that are responsible for daily production, operation, and management; financial and personnel decision-making
bodies; key properties, accounting books, company seal, and minutes of board meetings and shareholders&#8217; meetings; and half or more
of the senior management or directors having voting rights. In addition to SAT Circular 82, the SAT issued the Measures for the Administration
of Enterprise Income Tax of Chinese-Controlled Overseas Registered Enterprises as Resident Enterprises (for Trial Implementation), or
&#8220;<span style="font-weight: normal"><i>SAT Bulletin 45</i></span>,&#8221; which took effect in September 2011 and was amended in
April 2015, to provide more guidance on the implementation of SAT Circular 82 and clarify the reporting and filing obligations of such
&#8220;Chinese-controlled offshore incorporated resident enterprises.&#8221; SAT Bulletin 45 provides procedures and administrative details
for the determination of resident status and administration on post-determination matters. Although both SAT Circular 82 and SAT Bulletin
45 only apply to offshore enterprises controlled by PRC enterprises or PRC enterprise groups, not those controlled by PRC individuals
or foreign individuals, the determining criteria set forth in SAT Circular 82 and SAT Bulletin 45 may reflect the SAT&#8217;s general
position on how the &#8220;de facto management body&#8221; test should be applied in determining the tax resident status of offshore
enterprises, regardless of whether they are controlled by PRC enterprises, PRC enterprise groups, or by PRC or foreign individuals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the PRC tax authorities determine that the actual management body of New Bowen is within the territory of China, it may be deemed to
be a PRC resident enterprise for PRC enterprise income tax purposes and a number of unfavorable PRC tax consequences could follow. First,
New Bowen will be subject to the uniform 25% enterprise income tax on its worldwide income, which could materially reduce its net income.
In addition, New Bowen will also be subject to PRC enterprise income tax reporting obligations. Finally, dividends payable by New Bowen
to its investors and gains on the sale of its shares may become subject to PRC withholding tax, at a rate of 10% in the case of non-PRC
enterprises or 20% in the case of non-PRC individuals (in each case, subject to the provisions of any applicable tax treaty), if such
gains are deemed to be from PRC sources. It is unclear whether non-PRC shareholders of New Bowen would be able to claim the benefits
of any tax treaties between their country of tax residence and the PRC in the event that itis treated as a PRC resident enterprise. Any
such tax may reduce the returns on your investment in New Bowen Ordinary Shares. Although up to the date of this proxy statement/prospectus,
neither New Bowen or Qianzhi has been notified or informed by the PRC tax authorities that they have been deemed to be resident enterprises
for the purpose of the EIT Law, there is no assurance that they will not be deemed to be resident enterprises in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uncertainties
with respect to the interpretation and implementation of the PRC Foreign Investment Law and Implementation Regulations may affect our
corporate governance.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 1, 2020, the PRC Foreign Investment Law (the &#8220;<span style="font-weight: normal"><i>Foreign Investment Law</i></span>&#8221;)
and the Regulations for Implementation of the Foreign Investment Law (the &#8220;<span style="font-weight: normal"><i>Implementation
Regulations</i></span>&#8221;), came into effect and replaced the trio of prior laws regulating foreign investment in China, namely,
the Sino-foreign Equity Joint Venture Enterprise Law, the Sino-foreign Cooperative Joint Venture Enterprise Law, and the Wholly Foreign-invested
Enterprise Law, together with their implementation rules. Since the Foreign Investment Law and the Implementation Regulations are relatively
new, uncertainties still exist in relation to its interpretation and implementation. The Foreign Investment Law and the Implementation
Regulations may affect our relevant corporate governance practices and increase our compliance costs. For instance, the Foreign Investment
Law and the Implementation Regulations require that foreign-invested enterprises established before the Foreign Investment Law became
effective have five years to complete the necessary adjustments to their organization form, governance structure, and other required
matters to comply with the PRC Company Law, the Partnership Enterprise Law, and other laws. The PRC Company Law significantly differs
from the Sino-foreign Equity Joint Venture Enterprise Law and the Sino-foreign Cooperative Joint Venture Enterprise Law. These differences
include, but are not limited to, an enterprise&#8217;s highest authority, minimum number of directors, quorum, term of directors, voting
mechanisms, profit distributions and equity transfer restrictions. According to the Implementation Regulations, the provisions regarding
equity interest transfer and distribution of profits or remaining assets may remain the same as previously provided in the contracts
among the joint venture parties of a foreign-invested enterprise. Uncertainties still exist with respect to the specific adjustments
foreign-invested enterprises must make. The local branch of the State Administration for Market Regulation of the PRC (the &#8220;<span style="font-weight: normal"><i>SAMR</i></span>&#8221;)
may, at its discretion, require us to make necessary adjustments to our articles of association and other filing documents to comply
with the PRC Company Law and the Partnership Enterprise Law, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Foreign Investment Law and the Implementation Regulations impose information reporting requirements on foreign investors
and foreign-invested enterprises. Any foreign investors or foreign-invested enterprises found to be non-compliant with these reporting
obligations may be subject to fines or administrative liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face uncertainties with respect to indirect transfer of equity interests in PRC resident enterprises by their non-PRC holding companies.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face uncertainties regarding the reporting on and consequences of previous private equity financing transactions involving the transfer
and exchange of shares in our company by non-resident investors. In February 2015, the State Administration of Taxation issued the Bulletin
on Issues of Enterprise Income Tax on Indirect Transfers of Assets by Non-PRC Resident Enterprises or Bulletin 7. Pursuant to Bulletin
7, an &#8220;indirect transfer&#8221; of PRC assets, including a transfer of equity interests in an unlisted non-PRC holding company
of a PRC resident enterprise, by non-PRC resident enterprises may be re-characterized and treated as a direct transfer of the underlying
PRC assets, if such arrangement does not have a reasonable commercial purpose and was established for the purpose of avoiding payment
of PRC enterprise income tax. As a result, gains derived from such indirect transfer may be subject to PRC enterprise income tax, and
the transferee or other person who is obligated to pay for the transfer is obligated to withhold the applicable taxes, currently at a
rate of 10% for the transfer of equity interests in a PRC resident enterprise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 17, 2017, the State Administration of Taxation issued the Announcement of the State Administration of Taxation on Issues Concerning
the Withholding of Non-resident Enterprise Income Tax at Source, or Bulletin 37, which came into effect on December 1, 2017. Bulletin
37 further clarifies the practice and procedure of the withholding of nonresident enterprise income tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face uncertainties on the reporting and consequences of past or future private equity financing transactions, share exchanges or other
transactions involving the transfer of shares in our company by investors that are non-PRC resident enterprises. The PRC tax authorities
may pursue such non-resident enterprises with respect to a filing or the transferees with respect to withholding obligation and request
our PRC subsidiaries to assist in the filing. As a result, we and non-resident enterprises in such transactions may become at risk of
being subject to filing obligations or being taxed under Bulletin 7 and Bulletin 37, and may be required to expend valuable resources
to comply with them or to establish that we and our non-resident enterprises should not be taxed under these regulations, which may have
a material adverse effect on our financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC tax authorities have the discretion under Bulletin 7 to make adjustments to the taxable capital gains based on the difference between
the fair value of the taxable assets transferred and the cost of investment. If the PRC tax authorities make adjustments to the taxable
income of the transactions under Bulletin 7, our income tax costs associated with such transactions will be increased, which may have
an adverse effect on our financial condition and results of operations. We cannot assure you that the PRC tax authorities will not, at
their discretion, adjust any capital gains and impose tax return filing obligations on us or require us to provide assistance to them
for the investigation of any transactions we were involved in. Heightened scrutiny over acquisition transactions by the PRC tax authorities
may have a negative impact on potential acquisitions we may pursue in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing requirements we may have,
and any limitation on the ability of our PRC subsidiaries to make payments to us could have a material and adverse effect on our ability
to conduct our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a holding company and we may rely on dividends and other distributions on equity paid by our PRC subsidiaries for our cash and financing
requirements, including the funds necessary to pay dividends and other cash distributions to our shareholders and service any debt we
may incur. Current regulations of mainland China permit our PRC subsidiaries to pay dividends to us only out of their accumulated after-tax
profits upon satisfaction of relevant statutory conditions and procedures, if any, determined in accordance with Chinese accounting standards
and regulations. In addition, each of our PRC subsidiaries is required to set aside at least 10% of its after-tax profits each year,
if any, to fund certain reserve funds until the total amount set aside reached 50% of its registered capital. Furthermore, if our PRC
subsidiaries incur debt on their own behalf in the future, the instruments governing the debt may restrict their ability to pay dividends
or make other payments to us, which may restrict our ability to satisfy our liquidity requirements. Due to these restrictions and additional
restrictions that may be imposed under new PRC laws and regulations that may come into effect in the future, cash and/or non-cash assets
held by our PRC subsidiaries may not be available to fund our foreign currency needs or any foreign operations that we may have in the
future or for other uses outside of the PRC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Risks
Relating to Intellectual Property, Information Technology and Legal Proceedings</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be subject to intellectual property infringement claims, which may be expensive to defend and may disrupt our business and operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot be certain that our operations or any aspects of our business have not or will not infringe upon or otherwise violate trademarks,
patents, copyrights, know-how or other intellectual property rights held by third parties. From time to time in the future, we may be
subject to legal proceedings, claims or penalties relating to the intellectual property rights of others. In addition, there may be third-party
trademarks, patents, copyrights, know-how or other intellectual property rights that are infringed by our products or other aspects of
our business without our awareness. Holders of such intellectual property rights may seek to enforce such intellectual property rights
against us in China, the United States or other jurisdictions. If any third-party infringement claims are brought against us, we may
be forced to divert management&#8217;s time and other resources from our business and operations to defend against these claims, regardless
of their merits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the application and interpretation of China&#8217;s intellectual property right laws and the procedures and standards for granting trademarks,
patents, copyrights, know-how or other intellectual property rights in China are still evolving and are uncertain, and we cannot assure
you that PRC courts or regulatory authorities would agree with our analysis. If we were found to have violated the intellectual property
rights of others, we may be subject to liability and penalties for our infringement activities or may be prohibited from using such intellectual
property, and we may incur licensing fees or be forced to develop alternatives of our own. As a result, our business and results of operations
may be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to prevent others from making unauthorized use of our intellectual property, which could harm our business and competitive
position.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
regard our software registrations, trademarks, domain names, know-how, proprietary technologies and similar intellectual property as
critical to our success, and we rely on a combination of intellectual property laws and contractual arrangements, including confidentiality
and non-compete agreements with our employees and others, to protect our proprietary rights. Despite these measures, any of our intellectual
property rights could be challenged, invalidated, circumvented or misappropriated, or such intellectual property may not be sufficient
to provide us with competitive advantages. For example, we regularly file applications to register our trademarks in China, but these
applications may not be timely or successful and may be challenged by third parties. As China has adopted a &#8220;first to file&#8221;
trademark registration system and there are trademarks similar to ours which have been registered in the same categories, we may not
be able to successfully register our trademarks in such categories and may be exposed to the risk that we are held to be infringing third-party
trademark rights. Moreover, for our trademarks unregistered in China, we may not be able to prevent a third-party from using our brand.
There are others using trademarks similar to our trademarks. We believe our trademarks are vital to our business. We are in the process
of filing cancellation requests for certain incumbent trademarks held by third parties on the basis of lack of sufficient usage. However,
we cannot assure you that such requests would be successful, or that we can successfully register our trademarks at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any third-party brings trademark infringement against us in connection with our use of any of the unregistered trademarks, we may face
civil and administrative liabilities under the PRC Trademark Law. We may also be ordered to abandon any product alleged or held to infringe
upon third parties&#8217; legal interests or redesign our products or processes to avoid assertion of infringement and compensate for
losses of such third parties up to RMB5 million and may be ordered to eliminate any negative impact. In addition, we may be subject to
various administrative liabilities including, among others, imposition of fines with a maximum of five times of illegal turnover if such
illegal turnover exceeds RMB50,000, or RMB250,000 if such illegal turnover is less than RMB50,000. Any of these liabilities may disrupt
our business operations and materially and adversely affect our reputation, financial condition and operating results. Even if we are
successful in defending against such claims, legal proceedings could result in substantial costs and be a distraction to our management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meanwhile,
intellectual property protection is still a developing legal sector in China. We cannot predict the effect of future developments in
this legal sector, including the promulgation of new laws and changes to existing laws or the interpretation thereof. As a result, we
may not be able to adequately protect our intellectual property rights, which could adversely affect our turnover and competitive position.
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is often difficult to maintain and enforce intellectual property rights in China. Statutory laws and regulations are subject to judicial
interpretation and enforcement and may not be applied consistently due to the lack of clear guidance on statutory interpretation. Confidentiality
and non-compete agreements may be breached by counterparties, and there may not be adequate remedies available to us for any such breach.
Accordingly, we may not be able to effectively protect our intellectual property rights or to enforce our contractual rights in China.
Preventing any unauthorized use of our intellectual property is difficult and costly and the steps we take may be inadequate to prevent
the misappropriation of our intellectual property. In the event that we resort to litigation to enforce our intellectual property rights,
such litigation could result in substantial costs and a diversion of our managerial and financial resources. We can provide no assurance
that we will prevail in such litigation. In addition, our trade secrets may be leaked or otherwise become available to, or be independently
discovered by, our competitors. To the extent that our employees or consultants use intellectual property owned by others in their work
for us, disputes may arise as to the rights in related know-how and inventions. Any failure in protecting or enforcing our intellectual
property rights could have a material adverse effect on our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to adequately obtain or maintain our proprietary and intellectual property rights in our data or technology.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot guarantee our employees, consultants, or other parties will comply with confidentiality, non-disclosure, or invention assignment
agreements or that such agreements will otherwise be effective in controlling access to and distribution of our products, or certain
aspects of our products, and proprietary information. Additionally, we may be subject to claims from third parties challenging our ownership
interest in or inventorship of intellectual property we regard as our own, for example, claims alleging that our agreements with employees
or consultants obligating them to assign intellectual property to us are ineffective or in conflict with prior or competing contractual
obligations to assign inventions to another employer, to a former employer, or to another person or entity. We rely on work-for-hire
provisions to effectuate our ownership of intellectual property created by our employees; however, certain types of intellectual property
could require separate documentation to validly assign ownership to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
our patents may expire and may not be extended, our patent applications may not be granted, and our patent rights may be contested, circumvented,
invalidated, or limited in scope, our patent rights may not protect us effectively. In particular, we may not be able to prevent others
from developing or exploiting competing technologies, which could materially and adversely affect our business, financial condition,
and results of operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement/prospectus, we had 31 registered patents in mainland China, 63 registered trademarks and registered
copyrights to 4 software programs. Even if our patent applications are granted and we are issued patents accordingly, it is still uncertain
whether these patents will be contested, circumvented, or invalidated in the future. In addition, the rights granted under any issued
patents may not provide us with meaningful protection or competitive advantages. These legal measures afford only limited protection,
and competitors or others may gain access to or use our intellectual property and proprietary information. The claims under any patents
may not be broad enough to prevent others from developing technologies that are similar or that achieve results similar to ours. It is
also possible that the intellectual property rights of others could bar us from licensing and exploiting our patents. Numerous patents
and pending patent applications owned by others exist in the fields where we have developed and are developing our products. These patents
and patent applications might have priority over our patent applications and could subject our patent applications to invalidation. Finally,
in addition to those who may claim priority, any of our existing patents or pending patent applications may also be challenged by others
on the basis that they are otherwise invalid or unenforceable. Our success depends in part on our ability to obtain, maintain, expand,
enforce, and defend the scope of our intellectual property. The patent prosecution process is expensive and time-consuming, and we may
not be able to file, prosecute, maintain, enforce or license all necessary or desirable patents or patent applications at a reasonable
cost, in a timely manner, or in all jurisdictions where protection may be commercially advantageous, or we may not be able to protect
our proprietary rights at all. Any failure to obtain or maintain patent and other intellectual property protection with respect to our
products could harm our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to patented products and technologies, we rely on our unpatented proprietary products and technologies, trade secrets, processes,
and know-how.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on proprietary information, such as trade secrets, know-how, and confidential information, to protect intellectual property that
may not be patentable, or that we believe is best protected by means that do not require public disclosure. We generally seek to protect
this proprietary information by entering into confidentiality agreements, or consulting, services, or employment agreements that contain
non-disclosure and non-use provisions with our employees, consultants, contractors, scientific advisors, and third parties. However,
we cannot guarantee that we have entered into such agreements with every party that has or may have had access to our trade secrets or
proprietary information and, even if entered into, these agreements may be breached or may otherwise fail to prevent disclosure, third-party
infringement or misappropriation of our proprietary information, may be limited as to their term and may not provide an adequate remedy
in the event of unauthorized disclosure or use of proprietary information. We have limited control over the protection of trade secrets
used by our third-party manufacturers and suppliers and could lose future trade secret protection if any unauthorized disclosure of such
information occurs. In addition, our proprietary information may otherwise become known or be independently developed by our competitors
or other third parties. To the extent that our employees, consultants, contractors, and other third parties use intellectual property
owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions. Costly and
time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain
protection for our proprietary information could adversely affect our competitive business position. Furthermore, laws regarding trade
secret rights in certain markets where we operate may afford little or no protection to our trade secrets. If any of our trade secrets
were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them
from using that trade secret to compete with us. If any of our trade secrets were to be disclosed, whether lawfully or otherwise, to
or independently developed by a competitor or other third party, it could have a material adverse effect on our business, operating results,
and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also rely on physical and electronic security measures to protect our proprietary information, but we cannot guarantee that these security
measures provide adequate protection for such proprietary information or will never be breached. There is a risk that third parties may
obtain unauthorized access to and improperly utilize or disclose our proprietary information, which would harm our competitive advantages.
We may not be able to detect or prevent the unauthorized access to or use of our information by third parties, and we may not be able
to take appropriate and timely steps to mitigate the damages, or the damages may not be capable of being mitigated or remedied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
others may independently discover our trade secrets and proprietary information. If any of our trade secrets were to be lawfully obtained
or independently developed by a competitor or other third party, we would have no right to prevent them, or those to whom they communicate
it, from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently
developed by a competitor or other third party, our competitive position would be materially and adversely harmed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest
and our business may be adversely affected.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
registered or unregistered trademarks or trade names may be challenged, infringed, diluted, circumvented or declared generic or determined
to be infringing, misappropriating, or violating other marks. We may not be able to protect our rights to these trademarks and trade
names, which we need to build name recognition among potential partners or customers in the markets of interest. During trademark registration
proceedings, we may receive rejections of our applications. Although we are given an opportunity to respond to such rejections, we may
be unable to overcome them. In the event that our trademarks are successfully challenged, we could be forced to rebrand our products,
which could result in loss of brand recognition, and could require us to devote resources to advertising and marketing new brands. In
addition, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks.
Opposition or cancellation proceedings may be filed against our trademarks, which may not survive such proceedings. Furthermore, in many
countries, owning and maintaining a trademark registration may not provide an adequate defense against a subsequent infringement claim
asserted by the owner of a senior trademark. Some trademarks are used elsewhere in the world and are not registered in China. If we inadvertently
use these trademarks in China, we might be subject to litigation or claims, which could result in substantial costs, negative publicity,
and diversion of resources and management attention.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to obtain, protect or enforce our rights to these trademarks and trade names, which we need to build name recognition
among potential partners or customers in our markets of interest. At times, competitors or other third parties may adopt trade names
or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition,
there could be potential trade name or trademark infringement, misappropriation, dilution, or other claims brought by owners of other
registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Our efforts
to obtain, enforce or protect our proprietary rights related to trademarks, trade names, domain name or other intellectual property may
be ineffective and could result in substantial costs and diversion of resources and could adversely affect our business, financial condition,
results of operations, and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
depend on information technology to conduct our business. Any significant disruptions to our information technology systems or facilities,
or those of third parties with which we do business, such as disruptions caused by cyber-attacks, could adversely impact our business.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to keep our business operating effectively depends on the functional and efficient operation of information technology systems
and facilities, both internally and externally. We rely on these systems to, among other things, make a variety of day-to-day business
decisions as well as to record and process transactions, billings, payments, inventory, and other data, in many currencies, on a daily
basis, and across numerous and diverse markets and jurisdictions. Our systems, as well as those of our customers, suppliers, partners,
and service providers, also contain sensitive confidential information or intellectual property and are susceptible to interruptions,
including those caused by systems failures, cyber-attacks, and other natural or man-made incidents or disasters, which may be prolonged
or go undetected. Cyber-attacks, both domestically and abroad, are increasing in their frequency, sophistication, and intensity, and
have become increasingly difficult to detect. Although we have and continue to take precautions to prevent, detect, and mitigate such
events, a significant or large-scale interruption of our information technology systems or facilities could adversely affect our ability
to manage and keep our operations running efficiently and effectively, and could result in significant costs, fines or litigation. Furthermore,
because the techniques used to obtain unauthorized access to, or to sabotage, systems change frequently and often are not recognized
until launched against a target, we may be unable to anticipate these techniques or implement adequate preventative measures. We may
also experience security breaches that may remain undetected for an extended period. Even if identified, we may be unable to adequately
investigate or remediate incidents or breaches due to attackers increasingly using tools and techniques that are designed to circumvent
controls, to avoid detection, and to remove or obfuscate forensic evidence. While we strive to maintain reasonable preventative and data
security controls, it is not possible to prevent all cybersecurity threats to our information technology systems and information and
those of our third-party service providers, over which we exert less control. An incident that results in a wider or sustained disruption
to our business or products could have a material adverse effect on our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may increasingly be the target of cyber threats, including computer viruses or breaches due to misconduct of employees, contractors,
or others who have access to our networks and systems, or those of third parties with which we do business. Although we have designed
and implemented security measures to prevent and detect such unauthorized access or cyber threats from occurring, we cannot assure you
that vulnerabilities will not be identified in the future, or that our security efforts will be successful. Any unauthorized access to
our components could adversely affect our brand and harm our business, prospects, financial condition, and operating results. Further,
maintaining and updating these systems may require significant costs and often involves implementation, integration, and security risks,
including risks that we may not adequately anticipate the market or technological trends or that we may experience unexpected challenges
that could cause financial, reputational, and operational harm. However, failing to properly respond to and invest in information technology
advancements may limit our ability to attract and retain customers, prevent us from offering similar products as those offered by our
competitors or inhibit our ability to meet regulatory or other requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, we have not experienced a system failure, cyber-attack or security breach that has resulted in a material interruption in our operations
or material adverse effect on our financial condition. While we continuously seek to expand and improve our information technology systems
and maintain adequate disclosure controls and procedures, we cannot assure you that such measures will prevent interruptions or security
breaches that could adversely affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may fail to maintain an effective quality control system and may be subject to claims by our customers in respect of product quality
and compliance with relevant health and safety standards.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
quality of our products is vital to the success of our business in the industry. Our quality control depends significantly on the effectiveness
of our quality control system, which, in turn, depends on a number of factors, including the design of the products, the machines and
equipment used, quality of our staff and related training programs and our ability to ensure that our employees adhere to our quality
control policies and guidelines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may at times be involved in litigation or other legal proceedings during our ordinary course of business related to, among other things,
product or other types of liability, labor disputes or contractual disputes that could have a material and adverse effect on our financial
condition. If we become involved in any litigation or other legal proceedings in the future, the outcome of such proceedings could be
uncertain and could result in settlements or outcomes which negatively impact our reputation and our financial condition. In addition,
any litigation or legal proceedings could incur substantial legal expenses as well as significant time and attention of our management,
diverting their attention from our business and operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal years ended March 31, 2024 and 2023, there were no material product recalls, product returns, product liability
claims or customer complaints that adversely affected our business. There can be no assurance that our quality control system will continue
to be effective. Any significant failure in or deterioration of the efficacy of our quality control system could damage our product quality
and have an adverse effect on our reputation in the market among our existing or prospective customers. It will, in turn, lead to reduced
orders or loss of customers in the future, thus severely harming our business, financial condition, results of operations and prospects.
The end-users of our products may have the right to bring an action under the law of the PRC and relevant jurisdictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no assurance that we would not be named as a defendant in a lawsuit or proceedings brought by end consumers in the future in respect
of our products in the event that our products are found to be harmful for or detrimental to human health, resulting in illnesses or
deaths of any persons. A successful claim against us in respect of our products or a material recall of our products may result in (i)
significant financial costs to be incurred and management efforts to be spent in defending against such claim or other adverse allegations
or rectifying such defects or making payment for damages; (ii) deterioration of our brand and corporate image; and (iii) material adverse
effect on our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
litigation and negative publicity surrounding China-based companies listed in the United States may negatively impact the trading price
of our ordinary shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that recent litigation and negative publicity surrounding companies with operations in China that are listed in the United States
have negatively impacted stock prices of these companies. Certain politicians in the United States have publicly warned investors to
shun China-based companies listed in the United States. The SEC and the Public Company Accounting Oversight Board (United States), or
the PCAOB, also issued a joint statement on April 21, 2020, reiterating the disclosure, financial reporting and other risks involved
in the investments in companies that are based in emerging markets, and the limited remedies thereof. Furthermore, various equity-based
research organizations have recently published reports on China-based companies after examining their corporate governance practices,
related party transactions, sales practices and financial statements, and these reports have led to special investigations and listing
suspensions on U.S. national exchanges. Many of these companies are subject to shareholder lawsuits and SEC enforcement actions and are
conducting internal and external investigations into the allegations. It is not clear what effect this sector-wide scrutiny, criticism,
and negative publicity will have on New Bowen, its business, and the price of New Bowen Ordinary Shares. If New Bowen becomes the subject
of any unfavorable allegations, whether such allegations are proven to be true or untrue, it will have to expend significant resources
to investigate such allegations and/or defend itself. This situation will be costly and time consuming and could distract New Bowen&#8217;s
management from developing its business. If such allegations are not proven to be groundless, New Bowen and its business operations will
be severely affected and you could sustain a significant decline in the value of its Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may experience difficulties in effecting service of legal process, enforcing foreign judgments or bringing actions in China against us
or our management named in the prospectus based on foreign laws. It may also be difficult for you or overseas regulators to conduct investigations
or collect evidence within China.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen is an exempted entity incorporated under the laws of the Cayman Islands and Qianzhi is an entity incorporated under the laws of
the PRC. In addition, all of our assets are located in China and most of our senior executive officers and directors reside within China
for a significant portion of the time. As a result, it may be difficult for you to effect service of process upon us or those persons
inside mainland China. It may also be difficult for you to enforce in U.S. courts judgments obtained in U.S. courts based on the civil
liability provisions of the U.S. federal securities laws against us and our officers and directors as none of them currently resides
in the United States or has substantial assets located in the United States. In addition, there is uncertainty as to whether the courts
of the PRC would recognize or enforce judgments of U.S. courts against us, or such persons predicated upon the civil liability provisions
of the securities laws of the United States or any state.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recognition and enforcement of foreign judgments are provided for under the PRC Civil Procedures Law. PRC courts may recognize and enforce
foreign judgments in accordance with the requirements of the PRC Civil Procedures Law based either on treaties between China and the
country where the judgment is made or on principles of reciprocity between jurisdictions. China does not have any treaties or other forms
of written arrangement with the United States that provide for the reciprocal recognition and enforcement of foreign judgments. In addition,
according to the PRC Civil Procedures Law, the PRC courts will not enforce a foreign judgment against us or our directors and officers
if they decide that the judgment violates the basic principles of PRC laws or national sovereignty, security or public interest. As a
result, it is uncertain whether and on what basis a PRC court would enforce a judgment rendered by a court in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may become subject to product liability claims, which could harm our financial condition and liquidity if we are not able to successfully
defend or insure against such claims.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may become subject to product liability claims, which could harm our business, financial condition, results of operations, and prospects.
The personal hygiene and disinfection products industry experiences significant product liability claims and we face inherent risk of
exposure to claims in the event our products do not perform as expected or malfunction resulting in property damage, personal injury,
or death. Our risks in this area are particularly pronounced given we have limited field experience in the operation of our products.
A successful product liability claim against us could require us to pay substantial monetary compensation. Moreover, a product liability
claim could generate substantial negative publicity about our products, services and business and inhibit or prevent commercialization
of our future products, which would materially and adversely affect our brand, business, prospects, and results of operations. Our insurance
coverage might not be sufficient to cover all potential product liability claims. Any lawsuit seeking significant monetary damages may
materially and adversely affect our reputation, business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be subject to legal proceedings in the ordinary course of our business. If the outcomes of such proceedings are adverse to us, it
could have a material adverse effect on our business, results of operations, and financial condition.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be subject to legal proceedings from time to time in the ordinary course of our business, which could have a material adverse effect
on our business, results of operations, and financial condition. Claims arising out of actual or alleged violations of law could be asserted
against us by our customers, our competitors, governmental entities in civil or criminal investigations and proceedings, or other entities.
These claims could be asserted under a variety of laws, including but not limited to product liability laws, consumer protection laws,
intellectual property laws, labor and employment laws, securities laws, tort laws, contract laws, property laws, data compliance laws,
and employee benefit laws. There is no guarantee that we will be successful in defending ourselves in legal and administrative actions
or in asserting our rights under various laws. Even if we are successful in our attempt to defend ourselves in legal and administrative
actions or to assert our rights under various laws, enforcing our rights against the various parties involved may be expensive, time-consuming,
and ultimately futile. Such actions could also expose us to negative publicity and to substantial monetary damages and legal defense
costs, injunctive relief, and criminal, civil, and administrative fines and penalties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Relating to Being a Public Company and New Bowen&#8217;s Shares</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going
public through a merger rather than an underwritten offering presents risks to unaffiliated investors. Subsequent to our completion of
the business combination, we may be required to take write-downs or write-offs, restructuring and impairment or other charges that could
negatively affect our financial condition, results of operations and stock price, which could cause you to lose some or all of your investment.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going
public through a merger rather than an underwritten offering, as Qianzhi is seeking to do, presents risks to unaffiliated investors.
Such risks include the absence of a due diligence investigation conducted by an underwriter that might be subject to liability for any
material misstatements or omissions in a registration statement. We cannot assure you that due diligence conducted in connection with
this business combination has identified all material issues that may be present in Qianzhi&#8217;s business prior to the completion
of the Business Combination during the course of due diligence, that it would be possible to uncover all material issues through a customary
amount of due diligence, or that factors outside of Qianzhi&#8217;s control will not later arise. As a result of these factors, New Bowen
may be forced to later write-down or write-off assets, restructure our operations, or incur impairment or other charges that could result
in New Bowen reporting losses. Even if the due diligence investigation successfully identifies certain risks, unexpected risks may arise
and previously known risks may materialize in a manner not consistent with the preliminary risk analysis. Even though these charges may
be non-cash items and not have an immediate impact on New Bowen&#8217;s liquidity, the fact that it reports charges of this nature could
contribute to negative market perceptions about the post-combination company or its securities. In addition, charges of this nature may
cause New Bowen to violate net worth or other covenants to which it may be subject as a result of assuming pre-existing debt held by
a target business or by virtue of obtaining debt financing thereafter. Accordingly, any shareholders who choose to remain shareholders
following the Business Combination could suffer a reduction in the value of their securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
securities or industry analysts do not publish research, publish inaccurate or unfavorable research or cease publishing research about
New Bowen, the price for our shares and the trading volume could decline significantly.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for New Bowen&#8217;s shares will depend, in part, on the research and reports that securities or industry analysts publish
about New Bowen or its business. We may be unable to sustain coverage by well-regarded securities and industry analysts. If either none
or only a limited number of securities or industry analysts maintain coverage of New Bowen, or if these securities or industry analysts
are not widely respected within the general investment community, the demand for New Bowen&#8217;s shares could decrease, which might
cause the price for New Bowen&#8217;s shares and the trading volume to decline significantly. In the event that New Bowen obtains securities
or industry analyst coverage, if one or more of the analysts who cover New Bowen downgrade their assessment of New Bowen or publish inaccurate
or unfavorable research about our business, the market price and liquidity for New Bowen&#8217;s shares could be negatively impacted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
market for New Bowen&#8217;s Shares may not develop, which would adversely affect the liquidity and price of New Bowen&#8217;s Shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
active trading market for New Bowen&#8217;s shares may never develop or, if developed, may not be sustained. You may be unable to sell
your New Bowen&#8217;s shares unless a market can be established and sustained. This risk will be exacerbated if there is a high level
of redemptions of Bowen&#8217;s Public Shares in connection with the Closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading prices of New Bowen&#8217;s shares may be volatile and may fluctuate due to a variety of factors, some of which are beyond our
control, including, but not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
                                            or anticipated fluctuations in our financial condition or results of operations;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">variance
                                            in our financial performance from expectations of securities analysts;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in our projected operating and financial results;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in laws and regulations affecting our business, our customers, suppliers, or our industry;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            of new products and expansions by us or our competitors;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to continue to innovate and bring products to market in a timely manner;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            involvement in actual or potential litigation or regulatory investigations;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">negative
                                            publicity about us, our products or our industry;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in our senior management or key personnel;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            of new investments, acquisitions, strategic partnerships, or joint ventures by us or our
                                            competitors;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
                                            of our securities by us or our shareholders or, as well as the anticipation of lockup releases;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            operating results failing to meet the expectation of securities analysts or investors in
                                            a particular period;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in the post-combination company&#8217;s capital structure, such as future issuances of securities
                                            or the incurrence of additional debt;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            volume of Ordinary Shares available for public sale;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                                            economic, political, regulatory, industry, and market conditions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">natural
                                            disasters or major catastrophic events; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
                                            events or factors, including those resulting from war, incidents of terrorism, natural disasters,
                                            pandemics or responses to these events.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
and other factors may cause the market price and demand for New Bowen&#8217;s shares to fluctuate substantially, which may limit or prevent
investors from readily selling their shares and may otherwise negatively affect the liquidity of New Bowen&#8217;s shares. Fluctuations
may be even more pronounced in the trading market for New Bowen&#8217;s shares shortly following the Business Combination. Following
periods of such volatility in the market price of a company&#8217;s securities, securities class action litigation has often been brought
against that company. Because of the potential volatility of New Bowen&#8217;s shares, New Bowen may become the target of securities
litigation in the future. Securities litigation could result in substantial costs and divert management&#8217;s attention and resources
from its business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Business Combination&#8217;s benefits do not meet the expectations of investors or securities analysts, the market price of New Bowen&#8217;s
securities may decline.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the benefits of the Business Combination do not meet the expectations of investors or securities analysts, the market price of New Bowen&#8217;s
securities may decline. In addition, following the Business Combination, fluctuations in the price of New Bowen&#8217;s securities could
contribute to the loss of all or part of your investment. Prior to the Business Combination, there has not been a public market for Qianzhi&#8217;s
securities. Accordingly, the valuation ascribed to Qianzhi&#8217;s Ordinary Shares in the Business Combination may not be indicative
of the actual price that will prevail in the trading market following the Business Combination. If an active market for New Bowen&#8217;s
securities develops and continues, the trading price of its securities following the Business Combination could be volatile and subject
to wide fluctuations in response to various factors, some of which are beyond its control. New Bowen/s securities may trade at prices
significantly below the price you paid for them. In such circumstances, the trading price of New Bowen&#8217;s securities may not recover
and may experience a further decline, which could have a material adverse effect on your investment in our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broad
market and industry factors may materially harm the market price of our securities irrespective of New Bowen&#8217;s operating performance.
The stock market in general and Nasdaq have experienced price and volume fluctuations that have often been unrelated or disproportionate
to the operating performance of the particular companies affected. The trading prices and valuations of these stocks, and of New Bowen&#8217;s
securities, may not be predictable. A loss of investor confidence in the market for the stocks of other companies that investors perceive
to be similar to the post-combination company could depress New Bowen&#8217;s stock price regardless of its business, prospects, financial
conditions or results of operations. A decline in the market price of New Bowen&#8217;s securities also could adversely affect its ability
to obtain additional financing in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
issuance of additional shares in connection with financings, acquisitions, investments, our equity incentive plans or otherwise will
dilute all other shareholders.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for the PIPE Financing which we expect to complete contemporaneously with the closing of the Business Combination, we do not</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
expect to issue additional share capital in the near future that will result in dilution to all other shareholders. However,
we expect to grant equity awards to key employees under our equity incentive plans. In addition, we may decide it is in our best
interest to raise capital through equity financings in the future. Also, as part of our business strategy, we may acquire
or make investments in companies, solutions or technologies and issue equity securities to pay for any such acquisition or investment.
Any such issuances of additional share capital may cause shareholders to experience significant dilution of their ownership interests
and the per share value of New Bowen&#8217;s shares to decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Future
resales of our outstanding securities, including the registration of securities for resale under the Registration Rights Agreement, may
cause the market price of our securities to drop significantly, even if our business is doing well.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen will have17,139,026 ordinary shares outstanding immediately following the consummation of the Business Combination (assuming that
no ordinary shares are redeemed by Bowen&#8217;s public shareholders) and excluding the Earnout Shares and any ordinary shares issued
in connection with the PIPE Financing. Accordingly, there may be a large number of ordinary shares of New Bowen sold in the market following
the consummation of the Business Combination, or shortly thereafter. The sale or possibility of sale of these securities could have the
effect of increasing the volatility in our share price or putting significant downward pressure on the price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
requirements of being a public company may strain our resources, divert our management&#8217;s attention and affect our ability to attract
and retain qualified board members.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will be subject to the reporting requirements of the Securities Exchange Act of 1934, the Sarbanes-Oxley Act, the Dodd-Frank Act, Nasdaq
listing requirements and other applicable securities rules and regulations. As such, we will incur additional legal, accounting and other
expenses following completion of the Business Combination. These expenses may increase even more if we no longer qualify as an &#8220;emerging
growth company,&#8221; as defined in Section 2(a) of the Securities Act. The Exchange Act requires, among other things, that we file
annual and current reports with respect to our business and operating results. The Sarbanes-Oxley Act requires, among other things, that
we maintain effective disclosure controls and procedures and internal control over financial reporting. We may need to hire more employees
post-Business Combination or engage outside consultants to comply with these requirements, which will increase our post-Business Combination
costs and expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changing
laws, regulations and standards relating to corporate governance and public disclosure are creating uncertainty for public companies,
increasing legal and financial compliance costs and making some activities more time-consuming. These laws, regulations and standards
are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice
may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding
compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We expect these laws and
regulations to increase our legal and financial compliance costs after the Business Combination and to render some activities more time-consuming
and costly, although we are currently unable to estimate these costs with any degree of certainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
members of our management team have limited experience managing a publicly traded company, interacting with public company investors
and complying with the increasingly complex laws pertaining to public companies. Our management team may not successfully or efficiently
manage the transition to being a public company subject to significant regulatory oversight and reporting obligations under the federal
securities laws and regulations and the continuous scrutiny of securities analysts and investors. The need to establish the corporate
infrastructure demanded of a public company may divert management&#8217;s attention from implementing its growth strategy, which could
prevent us from improving our business, financial condition and results of operations. Furthermore, we expect these rules and regulations
to make it more difficult and more expensive for us to obtain director and officer liability insurance, and consequently we may be required
to incur substantial costs to maintain the same or similar coverage. These additional obligations could have a material adverse effect
on our business, financial condition, results of operations and prospects. These factors could also make it more difficult for us to
attract and retain qualified members of our board of directors, particularly to serve on our audit committee, and qualified executive
officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of disclosure of information in this proxy statement/prospectus and in filings required of a public company, our business and
financial condition will become more visible, which we believe may result in threatened or actual litigation, including by competitors
and other third parties. If such claims are successful, our business and operating results could be adversely affected, and, even if
the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve them,
could cause an adverse effect on our business, financial condition, results of operations, prospects and reputation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will be an &#8220;emerging growth company,&#8221; and it cannot be certain if the reduced SEC reporting requirements applicable to emerging
growth companies will make New Bowen&#8217;s Shares less attractive to investors, which could have a material and adverse effect on us,
including our growth prospects.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of the Business Combination, we will be an &#8220;emerging growth company&#8221; as defined in the JOBS Act. We will remain
an &#8220;emerging growth company&#8221; until the earliest to occur of (i) the last day of the fiscal year (a) following the fifth anniversary
of the closing of the Business Combination, (b) in which we have total annual gross revenue of at least US$1.235 billion or (c) in which
we are deemed to be a large accelerated filer, which means the market value of New Bowen shares held by non-affiliates exceeds US$700
million as of the last business day of our prior second fiscal quarter, and (ii) the date on which we issued more than US$1.0 billion
in non-convertible debt during the prior three-year period. We intend to take advantage of exemptions from various reporting requirements
that are applicable to most other public companies, including, but not limited to, an exemption from the provisions of Section 404(b)
of the Sarbanes-Oxley Act requiring that our independent registered public accounting firm provide an attestation report on the effectiveness
of our internal control over financial reporting and reduced disclosure obligations regarding executive compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Section 102(b)(1) of the JOBS Act exempts &#8220;emerging growth companies&#8221; from being required to comply with new or
revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement
declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply
with the requirements that apply to non-emerging growth companies, but any such election to opt out is irrevocable. We have elected not
to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application
dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of our financial statements with certain other public companies difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to qualify as a foreign private issuer within the meaning of the rules under the Exchange Act following consummation of the Business
Combination, and as such we are exempt from certain provisions applicable to United States domestic public companies.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we believe we will qualify as a foreign private issuer under the Exchange Act at the first measurement date following the consummation
of the Business Combination, we expect to become exempt from certain provisions of the securities rules and regulations in the United
States that are applicable to U.S. domestic issuers, including: (i) the rules under the Exchange Act requiring the filing of quarterly
reports on Form 10-Q or current reports on Form 8-K with the SEC; (ii) the sections of the Exchange Act regulating the solicitation of
proxies, consents, or authorizations in respect of a security registered under the Exchange Act; (iii) the sections of the Exchange Act
requiring insiders to file public reports of their share ownership and trading activities and liability for insiders who profit from
trades made in a short period of time; and (iv) the selective disclosure rules by issuers of material nonpublic information under Regulation
FD.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
we are able to qualify as a foreign private issuer, we will be required to file an annual report on Form 20-F within four months of the
end of each fiscal year. In addition, under Nasdaq rules, we will be required to submit on a Form 6-K an interim balance sheet and income
statement as of the end of our second quarter, no later than six months following the end of our second quarter. Press releases relating
to financial results and material events will also be furnished to the SEC on Form 6-K. However, the information we are required to file
with or furnish to the SEC will be less extensive and less timely compared to that required to be filed with the SEC by U.S. domestic
issuers. Accordingly, after the Business Combination, if you continue to hold our securities, you may receive less or different information
about us than you currently receive about Bowen or that you would receive about a U.S. domestic public company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
could lose our status as a foreign private issuer under current SEC rules and regulations if more than 50% of our outstanding voting
securities become directly or indirectly held of record by U.S. holders and any one of the following is true: (i) the majority of our
directors or executive officers are U.S. citizens or residents; (ii) more than 50% of our assets are located in the United States; or
(iii) our business is administered principally in the United States. If we lose our status as a foreign private issuer in the future,
we will no longer be exempt from the rules described above and, among other things, will be required to file periodic reports and annual
and quarterly financial statements as if we were a company incorporated in the United States. If this were to happen, we would likely
incur substantial costs in fulfilling these additional regulatory requirements, and members of our management would likely have to divert
time and resources from other responsibilities to ensuring these additional regulatory requirements are fulfilled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
New Bowen meets the definition of a &#8220;controlled company&#8221; under the rules of the Nasdaq Listing Rule, it may choose to exempt
from certain corporate governance requirements that could have an adverse effect on the public shareholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
consummation of the Business Combination, the former NewCo equityholders will beneficially own approximately 46.7% of the combined voting
power of New Bowen Ordinary Shares and NewCo&#8217;s majority equityholder will beneficially own approximately 36.4% of the combined
voting power of New Bowen Ordinary Shares, assuming no redemptions by the Public Shareholders of Bowen&#8217;s Public Shares, a total
of 690,000 Bowen Ordinary Shares are issued upon the conversion of the Bowen Rights, the Earnout Shares have been issued, and excluding
the effect of the issuance of securities in proposed PIPE Financing. However, assuming the maximum number of redemptions by the Public
Shareholders of Bowen&#8217;s Public Shares (and the other assumptions remain accurate), NewCo&#8217;s majority equityholder would beneficially
own 58% of the combined voting power of New Bowen Ordinary Shares and in such an event, New Bowen would be a &#8220;controlled company&#8221;
as defined in the corporate governance rules of Nasdaq. For so long as New Bowen is as a controlled company under that definition, it
would be permitted to elect to rely on certain exemptions from the Nasdaq corporate governance rules, including the requirements that
(i) a majority of the board of directors consists of independent directors; (ii) its board of directors have a compensation committee
that is composed entirely of independent directors with a written charter addressing the committee&#8217;s purpose and responsibilities
and (iii) its board of directors have a nominating and corporate governance committee that is composed entirely of independent directors
with a written charter addressing the committee&#8217;s purpose and responsibilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, the investors may not have the same protection afforded to shareholders of companies that are subject to these corporate governance
requirements. New Bowen&#8217;s status as a controlled company could cause its securities to look less attractive to certain investors
or otherwise harm the trading price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a &#8220;smaller reporting company&#8221; we are permitted to provide less disclosure than larger public companies which may make our
common stock less attractive to investors.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
is currently a &#8220;smaller reporting company,&#8221; as defined by Rule 12b-2 of the Exchange Act and New Bowen will continue to be
one immediately after the Business Combination. As a smaller reporting company, it is eligible to take advantage of certain exemptions
from various reporting requirements applicable to other public companies. Consequently, it may be more challenging for investors to analyze
our results of operations and financial prospects which may result in less investor confidence. Investors may find our Ordinary Shares
less attractive as a result of our smaller reporting company status. If some investors find our Ordinary Shares less attractive, there
may be a less active trading market for our Ordinary Shares and our share price may be more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred and expect to incur significant costs associated with the Business Combination. Whether or not the Business Combination
is completed, the incurrence of these costs will reduce the amount of cash available to be used for other corporate purposes by New Bowen
and Qianzhi.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to incur significant costs associated with the Business Combination. We will only pay some of these expenses if the Business Combination
occurs, such as the fee to the underwriter of Bowen&#8217;s IPO. Other fees and expenses, including legal fees, independent auditor fees,
fees to our solicitation agent, and expenses incurred in connection with the proxy solicitation for the special meeting will be incurred
regardless of whether the Business Combination occurs. These expenses will reduce the amount of cash available to be used for other corporate
purposes by New Bowen and Qianzhi whether or not the Business Combination is completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that a significant number of Bowen&#8217;s Ordinary Shares are redeemed, its stock may become less liquid following the Business
Combination.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a significant number of Bowen&#8217;s Ordinary Shares are redeemed, New Bowen, following the Business Combination, may be left with a
significantly smaller number of outstanding shares. As a result, trading in the shares of the surviving company following the Business
Combination may be limited and your ability to sell your shares in the market could be adversely affected. The Nasdaq Global Market may
delist the Ordinary Shares on its exchange, which could limit investors&#8217; ability to make transactions in New Bowen&#8217;s securities
and subject New Bowen to additional trading restrictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may fail to realize any or all of the anticipated benefits of the Business Combination.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
success of the Business Combination will depend, in part, on New Bowen&#8217;s ability to successfully manage and deploy the cash received
upon the consummation of the Business Combination. Although it intends to use the cash received upon the consummation of the Business
Combination for the continued development of its product candidates, there can be no assurance that it will be able to achieve our intended
objectives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen may be unable to maintain the listing of its securities on the Nasdaq Global Market in the future.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
New Bowen is unable to continue to meet the listing requirements of the Nasdaq Global Market, New Bowen&#8217;s securities could be delisted
from trading on Nasdaq. If its securities are delisted, New Bowen could face significant material adverse consequences, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            limited availability of market quotations for its securities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
                                            liquidity with respect to its securities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            determination that its shares are a &#8220;penny stock,&#8221; which will require brokers
                                            trading in its securities to adhere to more stringent rules, possibly resulting in a reduced
                                            level of trading activity in the secondary trading market for its securities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            limited amount of news and analyst coverage for the post-transaction company; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            decreased ability to issue additional securities or obtain additional financing in the future.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a company incorporated in the Cayman Islands, we are permitted to adopt certain home country practices in relation to corporate governance
matters that differ significantly from Nasdaq corporate governance listing standards applicable to domestic U.S. companies; these practices
may afford less protection to shareholders than they would enjoy if we complied fully with Nasdaq corporate governance listing standards.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen is an exempted company incorporated in the Cayman Islands, and as such, we believe New Bowen will qualify as a foreign private
issuer under the Exchange Act at the first measurement date following the consummation of the Business Combination. Nasdaq listing rules
include an exemption for foreign private issuers that allows them to follow the corporate governance practices of their home countries,
in lieu of certain of the corporate governance requirements imposed by Nasdaq on domestic U.S. companies. Corporate governance practices
in the Cayman Islands, which is New Bowen&#8217;s home country, may differ significantly from Nasdaq corporate governance requirements
applicable to domestic U.S. companies. For example, as a foreign private issuer, New Bowen will be permitted to rely on home country
practice in lieu of, and will be exempt from, the Nasdaq requirement (i) that a majority of our board of directors must be independent
directors; (ii) that director nominees must be selected or recommended solely by independent directors; (iii) that the compensation committee
must be comprised solely of independent directors; and (iv) that an audit committee be comprised of at least three members under Nasdaq
Rule 5605(c)(2)(A). New Bowen may rely on the exemption available to foreign private issuers with respect to any or all of the foregoing
requirements. As a result, you may not be provided with the benefits of certain corporate governance requirements of Nasdaq applicable
to domestic U.S. companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may face difficulties in protecting your interests, and your ability to protect your rights through U.S. courts may be limited, because
New Bowen is incorporated under the laws of the Cayman Islands, and will conduct its operations, and its directors and executive officers
reside, outside of the United States.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen is an exempted company limited by shares incorporated under the laws of the Cayman Islands and, following the Business Combination,
will conduct its operations through its consolidated subsidiaries in China. Further, all of its assets are located outside the United
States. All of its officers and directors reside outside the United States and the assets of those persons are located outside of the
United States. As a result, it may be difficult for investors to effect service of process within the United States upon New Bowen&#8217;s
directors or officers, or to enforce judgments obtained in the United States courts against its directors or officers. For more information
regarding the relevant laws of the Cayman Islands and China, see &#8220;<i>Enforceability of Civil Liability</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Business Combination, New Bowen&#8217;s corporate affairs will be governed by the Proposed Charter, the Cayman Islands Companies
Act and the common law of the Cayman Islands. The rights of New Bowen&#8217;s shareholders to take action against our directors, actions
by minority shareholders and the fiduciary duties of its directors to us under Cayman Islands law are to a large extent governed by the
common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from comparatively limited judicial precedent
in the Cayman Islands as well as from the common law of England, the decisions of whose courts are of persuasive authority, but are not
binding, on a court in the Cayman Islands. The rights of New Bowen&#8217;s shareholders and the fiduciary duties of its directors under
Cayman Islands law are different from what they would be under statutes or judicial precedent in some jurisdictions in the United States.
In particular, the Cayman Islands has a different body of securities laws than the United States and some U.S. states, such as Delaware,
may have more fully developed and judicially interpreted bodies of corporate law than the Cayman Islands. In addition, shareholders of
Cayman Islands companies may not have standing to initiate a shareholder derivative action in a federal court of the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
of Cayman Islands exempted companies like us have no general rights under Cayman Islands law to inspect corporate records (other than
the memorandum and articles of association, special resolutions, and the register of mortgages and charges, of such companies) or to
obtain copies of lists of shareholders of these companies. New Bowen&#8217;s directors have discretion under its post-offering articles
of association that will become effective immediately prior to completion of the Business Combination to determine whether or not, and
under what conditions, our corporate records may be inspected by our shareholders, but are not obliged to make them available to its
shareholders. This may make it more difficult for you to obtain the information needed to establish any facts necessary for a shareholder
motion or to solicit proxies from other shareholders in connection with a proxy contest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
corporate governance practices in the Cayman Islands, which is New Bowen&#8217;s home country, differ significantly from requirements
for companies incorporated in other jurisdictions such as the United States. If New Bowen chooses to follow home country practice in
the future, its shareholders may be afforded less protection than they otherwise would under rules and regulations applicable to U.S.
domestic issuers. As a result of all of the above, its public shareholders may have more difficulty in protecting their interests in
the face of actions taken by management, members of the board of directors or controlling shareholders than they would as public shareholders
of a company incorporated in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is not expected that we will pay dividends in the foreseeable future after the Business Combination.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is expected that New Bowen will retain most, if not all, of its available funds and any future earnings after the Business Combination
to fund the development and growth of its business. As a result, it is not expected that New Bowen will pay any cash dividends in the
foreseeable future. Following completion of the Business Combination, the New Bowen board of directors will have discretion as to whether
to distribute dividends. Even if the board of directors decides to declare and pay dividends, the timing, amount and form of future dividends,
if any, will depend on the future results of operations and cash flow, capital requirements and surplus, the amount of distributions,
if any, received by us from subsidiaries, our financial condition, contractual restrictions and other factors deemed relevant by the
board of directors. Accordingly, you may need to rely on sales of New Bowen&#8217;s shares after price appreciation, which may never
occur, as the only way to realize any future gains on your investment. There is no guarantee that the New Bowen shares will appreciate
in value after the Business Combination or that the market price of the New Bowen shares will not decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
management team has limited experience managing a public company.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
of the members of our management team have limited or no experience in managing a publicly traded company, interacting with public company
investors, and complying with the increasingly complex laws and regulations pertaining to public companies. Our management team may not
successfully or efficiently manage our transition to being a public company subject to significant regulatory oversight and reporting
obligations under the federal securities laws and the continuous scrutiny of securities analysts and investors. These new obligations
and constituents will require significant attention from our senior management and may divert their attention away from the day-to-day
management of our business, which could adversely affect our business, financial condition, and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be adversely affected by the effects of inflation and a potential recession.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
inflation has not materially affected our business or the results of our operations, global</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
inflation may affect our liquidity, business, financial condition, and results of operations by increasing our overall cost structure,
particularly if we are unable to increase the prices we charge for our products. The existence of inflation in the economy may result
in higher interest rates and capital costs, increased costs of labor, weakening exchange rates and other similar effects. As a result
of inflation, we may experience cost increases. In addition, poor economic and market conditions, including a potential recession, may
negatively impact the research and development investments and consumer spending levels and willingness, which would adversely affect
our operating income and results of operations. If we are unable to take effective measures in a timely manner to mitigate the impact
of  inflation as well as a potential recession, our business, financial condition, and results of operations could be adversely affected.
In order to mitigate the potential adverse impact of inflation on our business and results of operations, we plan to continue to improve
our operating efficiency, further strengthen our bargaining power with our suppliers, and introduce new products with higher profit margin.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
decline in general economic conditions or a disruption of financial markets may affect the discretionary income of consumers, which in
turn could adversely affect our profitability.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations and profitability are directly or indirectly affected by general economic conditions and, in particular, conditions that have
a direct impact on the demand for entertainment and leisure activities. A decline in general economic conditions could reduce the level
of discretionary income that players have to spend on our products, which could negatively impact our revenue. The revenue generated
from a particular product or product line could be affected directly by declines in consumer spending more broadly, resulting in a reduction
in revenue we receive through various income-sharing and/or profit-sharing arrangements. In addition, adverse economic conditions, including
volatility and disruptions in financial markets, may also affect other shareholders or investors in this arena, thereby potentially affecting
their ability to cooperate with us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
unaudited pro forma financial information included elsewhere in this proxy statement may not be indicative of what New Bowen&#8217;s
actual financial position or results of operations would have been.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
and Qianzhi currently operate as separate companies and have had no prior history as a combined entity, and Bowen&#8217;s and Qianzhi&#8217;s
operations have not previously been managed on a combined basis. The pro forma financial information included in this proxy statement/prospectus
is presented for informational purposes only and is not necessarily indicative of the financial position or results of operations that
would have actually occurred had the Business Combination been completed at or as of the dates indicated, nor is it indicative of the
future operating results or financial position of New Bowen. The pro forma statement of operations does not reflect future nonrecurring
charges resulting from the Business Combination. The unaudited pro forma financial information does not reflect future events that may
occur after the Business Combination and does not consider potential impacts of future market conditions on revenues or expenses. The
pro forma financial information included in the section entitled &#8220;<i>Unaudited Pro Forma Condensed Combined Financial Information</i>&#8221;
has been derived from Bowen&#8217;s and Qianzhi&#8217;s historical financial statements and certain adjustments and assumptions have
been made regarding Qianzhi after giving effect to the Business Combination. There may be differences between estimates in the pro forma
financial information and the final acquisition accounting, which could result in material differences from the pro forma information
presented in this proxy statement in respect of the estimated financial position and results of operations of Qianzhi. In addition, the
assumptions used in preparing the pro forma financial information may not prove to be accurate and other factors may affect Qianzhi&#8217;s
financial condition or results of operations following the closing. Any potential decline in Qianzhi&#8217;s financial condition or results
of operations may cause significant variations in the stock price of New Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Related to Bowen Before the Business Combination, the Business Combination and Redemptions</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
third parties bring claims against us, the proceeds held in the Trust Account could be reduced and the per-share redemption amount received
by shareholders may be less than $[__] per share.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
placing of funds in the Trust Account may not protect those funds from third-party claims against us. Although we will seek to have all
vendors, service providers, prospective target businesses or other entities with which we do business execute agreements with us waiving
any right, title, interest or claim of any kind in or to any monies held in the Trust Account for the benefit of our Public Shareholders,
such parties may not execute such agreements, or even if they execute such agreements they may not be prevented from bringing claims
against the Trust Account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar
claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim
against our assets, including the funds held in the Trust Account. Making such a request of potential target businesses may make our
acquisition proposal less attractive to them and, to the extent prospective target businesses refuse to execute such a waiver, it may
limit the field of potential target businesses that we might pursue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
redemption of our Public Shares, if we are unable to complete our initial business combination within the prescribed timeframe, or upon
the exercise of a redemption right in connection with our initial business combination, we will be required to provide for payment of
claims of creditors that were not waived that may be brought against us within the ten years following redemption. Accordingly, the per-share
redemption amount received by Public Shareholders could be less than the $[___] per share initially held in the Trust Account, due to
claims of such creditors. Our Sponsors have agreed that they will be liable to us if and to the extent any claims by a vendor for services
rendered or products sold to us, or a prospective target business with which we have discussed entering into a transaction agreement,
reduce the amount of funds in the Trust Account to below (i) $[___] per public share or (ii) such lesser amount per public share held
in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each
case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party
who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under our indemnity of the
underwriters of our Initial Public Offering against certain liabilities, including liabilities under the Securities Act. Moreover, in
the event that an executed waiver is deemed to be unenforceable against a third party, then our Sponsors will not be responsible to the
extent of any liability for such third-party claims. We have not independently verified whether our Sponsors have sufficient funds to
satisfy their indemnity obligations and believe that our Sponsors&#8217; only assets are securities of our company. We have not asked
our Sponsors to reserve for such indemnification obligations. Therefore, we believe it is unlikely that our Sponsors would be able to
satisfy those obligations. As a result, if any such claims were successfully made against the Trust Account, the funds available for
our initial business combination and redemptions could be reduced to less than $[___] per public share. In such event, we may not be
able to complete our initial business combination, and you would receive such lesser amount per share in connection with any redemption
of your Public Shares. None of our officers or directors are required to indemnify us for claims by third parties including, without
limitation, claims by vendors and prospective target businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Sponsors and the Insiders have agreed to vote their shares in favor of the Business Combination, regardless of how the Public Shareholders
vote.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Sponsors and the Insiders have agreed, subject to applicable securities laws, to vote any ordinary shares owned by them in favor of
the Business Combination Proposal. This is unlike some other similarly structured transactions where the insiders vote in accordance with the public holders
and therefore a majority of unaffiliated shareholders would be required to approve a proposed transaction. Because the Sponsors and Insiders
vote in favor of the Business Combination Proposal, the transaction is not structured such that the vote of a majority of unaffiliated
shareholders is required to approve the Business Combination Proposal. As of the date of this proxy statement/prospectus, the Sponsors and the Insiders own
ordinary shares equal to approximately 22.5% of Bowen&#8217;s issued and outstanding ordinary shares. Accordingly, it is more likely
that the necessary shareholder approval will be received for the Business Combination than would be the case if the Sponsors and the
Insiders agreed to vote any ordinary shares owned by them in accordance with the majority of the shares represented at the
extraordinary general meeting by the public shareholders.</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
independent directors may decide not to enforce the indemnification obligations of our Sponsors, resulting in a reduction in the amount
of funds in the Trust Account available for distribution to our Public Shareholders.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the proceeds in the Trust Account are reduced below the lesser of (i) $10.10 per public share or (ii) such lesser amount
per share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust
assets, in each case net of the interest which may be withdrawn to pay taxes, and our Sponsors assert that they are unable to satisfy
their obligations or that they have no indemnification obligations related to a particular claim, our independent directors would determine
whether to take legal action against our Sponsors to enforce their indemnification obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we currently expect that our independent directors would take legal action on our behalf against our Sponsors to enforce their indemnification
obligations to us, it is possible that our independent directors in exercising their business judgment may choose not to do so. For example,
they may determine that the cost of such legal action is too high relative to the amount recoverable or that a favorable outcome is not
likely. If our independent directors choose not to enforce these indemnification obligations, the amount of funds in the Trust Account
available for distribution to our Public Shareholders may be reduced below $10.10 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
after we distribute the proceeds in the Trust Account to our Public Shareholders, we file a bankruptcy petition or an involuntary bankruptcy
petition is filed against us that is not dismissed, a bankruptcy court may seek to recover such proceeds, and we and our board may be
exposed to claims of punitive damages.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
after we distribute the proceeds in the Trust Account to our Public Shareholders, we file a bankruptcy petition or an involuntary bankruptcy
petition is filed against us that is not dismissed, any distributions received by shareholders could be viewed under applicable debtor/creditor
and/or bankruptcy laws as either a &#8220;preferential transfer&#8221; or a &#8220;fraudulent conveyance.&#8221; As a result, a bankruptcy
court could seek to recover all amounts received by our shareholders. In addition, our board of directors may be viewed as having breached
its fiduciary duty to our creditors and/or having acted in bad faith, thereby exposing itself and us to claims of punitive damages, by
paying Public Shareholders from the Trust Account prior to addressing the claims of creditors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
before distributing the proceeds in the Trust Account to our Public Shareholders, we file a bankruptcy petition or an involuntary bankruptcy
petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our
shareholders and the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be
reduced.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
before distributing the proceeds in the Trust Account to our Public Shareholders, we file a bankruptcy petition or an involuntary bankruptcy
petition is filed against us that is not dismissed, the proceeds held in the Trust Account could be subject to applicable bankruptcy
law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our shareholders.
To the extent any bankruptcy claims deplete the Trust Account, the per-share amount that would otherwise be received by our shareholders
in connection with our liquidation may be reduced.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
shareholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption
of their shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are forced to enter into an insolvent liquidation, any distributions received by shareholders could be viewed as an unlawful payment
if it was proved that immediately following the date on which the distribution was made, we were unable to pay our debts as they fall
due in the ordinary course of business. As a result, a liquidator could seek to recover some or all amounts received by our shareholders.
Furthermore, our directors may be viewed as having breached their fiduciary duties to us or our creditors and/or may have acted in bad
faith, thereby exposing themselves and our company to claims, by paying Public Shareholders from the Trust Account prior to addressing
the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons. We and our directors and
officers who knowingly and willfully authorized or permitted any distribution to be paid out of our share premium account while we were
unable to pay our debts as they fall due in the ordinary course of business would be guilty of an offence and may be liable for a fine
of approximately $18,000 and imprisonment for five years in the Cayman Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
of companies formed through mergers with SPACs such as New Bowen may experience a material decline in price relative to the share price
of the SPACs prior to the merger.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
issued Bowen Ordinary Shares as part of units for $10.00 per unit upon the closing of its initial public offering. As with other SPACs,
the $10.00 per share price of Bowen reflected each Bowen Ordinary Share having a one-time right to redeem such share for a pro rata portion
of the proceeds held in the Trust Account. Following Closing, the outstanding Bowen Ordinary Shares will no longer have any such redemption
right and may be dependent upon the fundamental value of New Bowen, as well as other relevant factors such as market conditions and trading
multiples, and the securities of other companies formed through mergers with SPACs in recent years may be significantly less than $10.00
per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen&#8217;s
officers and directors have interests in the Business Combination that are different from those of Public Shareholders.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
you consider the recommendation of the Bowen Board in favor of approval of the Business Combination Proposal, you should keep in mind
that the Insiders, including Bowen&#8217;s executive officers and directors, have interests in such proposal that are different from,
or in addition to, those of Public Shareholders generally. These interests include that the Insiders will lose their entire investment
in Bowen if an initial business combination is not completed (other than with respect to Public Shares they may acquire in the future),
and that the Insiders will benefit from the completion of a business combination and may be incentivized to complete a business combination,
even if it is with a less favorable target company or on less favorable terms to shareholders, rather than liquidate Bowen. Further,
the personal and financial interests of the Sponsors, as well as Bowen&#8217;s executive officers and directors may have influenced their
motivation in identifying and selecting Qianzhi as a business combination target and completing the Business Combination with Qianzhi.
In considering the recommendations of the Bowen Board to vote for the proposals, Public Shareholders should consider these interests
as well as, among other things, the interests described below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that the Sponsors and Bowen&#8217;s officers and directors have certain economic interests
                                            in the Business Combination including:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Sponsors paid an aggregate of $25,000 for 1,725,000 Founder Shares currently owned by the
                                            Sponsors, in which certain of Bowen&#8217;s directors and executive officers hold an indirect interest. The Insiders have agreed to waive their redemption rights with
                                            respect to their Founder Shares and any Public Shares they hold in connection with the Business
                                            Combination and their rights to liquidating distributions from the Trust Account with respect
                                            to any Founder Shares held by them if the Business Combination is not approved and Bowen
                                            fails to complete a business combination within the required time period. Accordingly, the
                                            Founder Shares would be worthless if the Business Combination or another business combination
                                            is not consummated within the required time period because the holders thereof are not entitled
                                            to participate in any redemption or liquidation distribution with respect to such shares.
                                            Such securities may have a significantly higher value at the time of the Business Combination,
                                            and if unrestricted and freely tradable would be valued at approximately $[X] based upon
                                            the closing price of $[X] per Bowen Ordinary Share on Nasdaq on [X], 2024;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Createcharm paid an aggregate of $3,417,820</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                            for 341,782 Bowen Private Units. Such securities may have a higher value at the time of the
                                            Business Combination and, if unrestricted and freely tradable, would be valued at approximately
                                            $[X], based upon the closing price of $[X] per Public Unit on Nasdaq on [X], 2024;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Sponsors and Bowen&#8217;s officers and directors will lose their entire investment in Bowen
                                            and will not be reimbursed for any loans extended, fees due or out-of-pocket expenses incurred
                                            on Bowen&#8217;s behalf related to identifying, investigating, negotiating and completing
                                            an initial business combination if the Business Combination is not consummated within the
                                            required time period. As of the date of this proxy statement/prospectus, there is an aggregate
                                            principal amount of $[X] of outstanding loans payable to the SPAC Sponsors and $[X]
                                            in aggregate fees due and out-of-pocket expenses to be repaid by Bowen;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accordingly,
                                            based on the value of the Bowen securities invested in and the amount of the
                                            loans and unreimbursed expenses as set forth above, the aggregate amount that the SPAC
                                            Sponsors and Bowen&#8217;s officers and directors have at risk is $[3,442,820 ($3,434,570 b y Createcharm and $8,250 by Bowen Holding)];</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            addition, the SPAC Sponsors and their affiliates can earn a positive rate of
                                            return on their investment, even if other Bowen shareholders experience a negative rate of
                                            return;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            Bowen entered into an agreement, commencing on the date its securities were first listed
                                            on Nasdaq and up to the earlier of the consummation of a business combination or its liquidation,
                                            to pay Bowen Holding LP a monthly fee of US$10,000 for office space, secretarial and administrative
                                            support;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that pursuant to the Business Combination Agreement, Bowen has the right to designate
                                            one director to the New Bowen Board post-Closing. Such director, in the future, may receive
                                            any cash fees, stock options or stock awards that the New Bowen Board determines to pay to
                                            its directors. Bowen has designated Jun Zhang to be a director on the New Bowen Board post-Closing;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that the Business Combination Agreement provides for the continued indemnification of
                                            Bowen&#8217;s existing directors and officers and requires New Bowen to purchase, at or prior
                                            to the Closing, and maintain in effect for a period of six years after the Closing, a &#8220;tail&#8221;
                                            policy providing directors&#8217; and officers&#8217; liability insurance coverage for certain
                                            Bowen directors and officers after the Business Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that if the Trust Account is liquidated, including in the event Bowen is unable to complete
                                            an initial business combination within the required time period, each of the Sponsors has
                                            agreed to indemnify Bowen to ensure that the proceeds in the Trust Account are not reduced
                                            below $10.10 per Public Share, or such lesser per share amount as is in the Trust Account,
                                            by the claims of prospective target businesses with which Bowen has entered into an acquisition
                                            agreement or claims of any third party for services rendered or products sold to Bowen, but
                                            only if such a vendor or target business has not executed a waiver of any and all rights
                                            to seek access to the Trust Account; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that if the Business Combination or another business combination is not consummated
                                            within the required time period, Bowen will cease all operations except for the purpose of
                                            winding up, redeeming 100% of the outstanding Public Shares for cash and, subject to the
                                            approval of its remaining shareholders and the Bowen Board, dissolving and liquidating.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
personal and financial interests of the Insiders as well as Bowen&#8217;s executive officers and directors may have influenced their
motivation in identifying and selecting Qianzhi as a business combination target, completing the Business Combination with Qianzhi and
influencing the operation of the business following the Business Combination. The existence of such financial and personal interests
may result results in conflicts of interest on the part of such executive officers, directors and Insiders between what he, she, or they
may believe is in the best interests of Bowen and what he, she, or they may believe is best for himself, herself, or themselves in determining
to recommend that shareholders vote for the proposals. In considering the recommendations of the Bowen Board to vote for the proposals,
its shareholders should consider these interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors and Bowen&#8217;s directors, officers, advisors and their affiliates may elect to purchase Public Shares prior to the consummation
of the Business Combination, which may result it being more likely that we can consummate the Business Combination and reduce the public
&#8220;float&#8221; of our Public Share.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time at or prior to the Business Combination, during a period when they are not then aware of any material nonpublic information
regarding us or our securities, the Sponsors and Bowen&#8217;s directors, officers, advisors or respective affiliates may purchase Public
Shares from institutional and other investors who vote, or indicate an intention to vote, against any of the proposals presented at the
Shareholder Meeting, or execute agreements to purchase such shares from such investors in the future, or they may enter into transactions
with such investors and others to provide them with incentives to acquire Public Shares or vote their Public Shares in favor of the proposals
presented at the Shareholder Meeting. Such a purchase may include a contractual acknowledgement that such shareholder, although still
the record holder of our shares, is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption rights.
In the event that the Sponsors or Bowen&#8217;s directors, officers, advisors or respective affiliates purchase Public Shares in privately
negotiated transactions from Public Shareholders who have already elected to exercise their redemption rights, such selling shareholder
would be required to revoke their prior elections to redeem their Public Shares. The purpose of such share purchases and other transactions
would be to decrease the number of shares that have been or may be submitted for redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entering
into any such arrangements may have a depressive effect on the market price of Bowen Ordinary Shares. For example, as a result of these
arrangements, an investor or holder may have the ability to effectively purchase shares at a price lower than market and may therefore
be more likely to sell the shares he or she owns, either at or prior to the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement/prospectus, there have been no such discussions and no agreements to such effect have been entered
into with any such investor or holder. If such transactions are effected, the consequence could be to cause the Business Combination
to be consummated in circumstances where such consummation could not otherwise occur. We will file or submit a Form 8-K to disclose any
material arrangements entered into or significant purchases made by any of the aforementioned persons that would affect the vote on the
proposals to be put to the Shareholder Meeting or the redemption threshold. Any such report will include descriptions of any arrangements
entered into or significant purchases by any of the aforementioned persons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any shares were so purchased, the purchaser would not vote any such shares in favor of approval of the Business Combination Proposal.
Additionally, the purchaser would waive any redemption rights with respect to any securities so purchased.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
purchases by the Sponsors and Bowen&#8217;s officers and directors and/or their respective affiliates who are affiliated purchasers under
Rule 10b-18 under the Exchange Act will only be made to the extent such purchases are able to be made in compliance with Rule 10b-18,
which is a safe harbor from liability for manipulation under Section 9(a)(2) and Rule 10b-5 of the Exchange Act. Rule 10b-18 has certain
technical requirements that must be complied with in order for the safe harbor to be available to the purchaser. The Sponsors and Bowen&#8217;s
officers and directors and/or their respective affiliates will not make purchases of shares if the purchases would violate Section 9(a)(2)
or Rule 10b-5 of the Exchange Act. Any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the
extent such purchasers are subject to such reporting requirements. Additionally, in the event the Sponsors or our directors, officers,
advisors or their affiliates were to purchase Public Shares from Public Shareholders, such purchases would be structured in compliance
with the requirements of Rule 14e-5 under the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Closing Date, the trading price per share value of Bowen Ordinary Shares may be less than the per share value of the Trust Account.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the parties to the Business Combination agreed the consideration to be provided to NewCo shareholders was valued at a price equal to
the per share amount in the Trust Account at the time of the execution of the Business Combination Agreement, the cash backed value per
Bowen Ordinary Share following the Business Combination may be substantially less than such per share price. Accordingly, Public Shareholders
who do not exercise redemption rights will hold Bowen Ordinary Shares that will have a value to them ascribed by their trading price
as of two business days prior to the Shareholder Meeting, which may be substantially less than the amount they would have received upon
exercise of redemption rights. In particular, the shares of most companies that are the result of a recently completed business combinations
between a SPAC and an operating company have traded at prices substantially below $10.00 per share. As such, Public Shareholders who
do not exercise redemptions right may hold securities that never obtain a value equal to or exceeding the current per share value of
the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reports
published by analysts, including projections in those reports that differ from our actual results, as well as the failure of research
analysts to publish reports on us, could adversely affect the price and trading volume of our commons stock.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
research analysts may establish and publish their own periodic projections for New Bowen following consummation of the Business Combination.
New Bowen does not control these analysts or the content and opinions included in their reports. Projections included in these reports
may vary widely and may not accurately predict the results we actually achieve. Our share price may decline if our actual results do
not match the projections of these securities research analysts. Similarly, if one or more of the analysts who write reports on us downgrades
the Bowen Ordinary Shares or publishes inaccurate or unfavorable research about our business, our share price could decline. If one or
more of these analysts ceases coverage of us or fails to publish reports on us regularly, our share price or trading volume could decline.
While we expect research analyst coverage following consummation of the Business Combination, if no analysts commence coverage of us,
the market price and volume for Bowen Ordinary Shares could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may become involved in litigation, including securities class action litigation relating to the proposed Business Combination that may
materially adversely affect us.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may become involved in various legal proceedings relating to the proposed Business Combination. Such matters can be
time-consuming, divert management&#8217;s attention and resources, cause us to incur significant expenses or liability or require us
to change our business practices. Because of the potential risks, expenses and uncertainties of litigation, we may, from time to time,
settle disputes, even where we believe that we have meritorious claims or defenses. Because litigation is inherently unpredictable, we
cannot assure you that the results of any of these actions will not have a material adverse effect on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Business Combination, the share price of the Bowen Ordinary Shares may be volatile and, in the past, companies that have experienced
volatility in the market price of their stock have been subject to securities litigation, including class action litigation. Additionally,
New Bowen may be the target of this type of litigation in the future. Litigation of this type could result in substantial costs and diversion
of management&#8217;s attention and resources, which could have a material adverse effect on New Bowen&#8217;s business, financial condition,
and results of operations. Any adverse determination in litigation could also subject New Bowen to significant liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fairness opinion delivered by Newbridge Securities to the Bowen Board will not reflect changes, circumstances, developments or events
that may have occurred or may occur (or information that may become, or may have become, available) after the date of the opinion.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinion delivered by Newbridge Securities, Bowen&#8217;s financial advisor, to the Bowen Board addresses the fairness of the consideration
in the Business Combination from a financial point of view to the Bowen Board. The Bowen Board has not obtained an updated fairness opinion
as of the date of this proxy statement/prospectus and Bowen does not expect to receive an updated fairness opinion prior to the Closing.
Changes in the operations and prospects of Qianzhi, general market and economic conditions and other factors that may be beyond their
control, and on which the fairness opinion was based, may alter the value of Qianzhi or the prices of Bowen Ordinary Shares by the time
the Business Combination is completed. The opinion did not speak as of the time the transaction will be completed or as of any date other
than the date of such opinion. The Bowen Board&#8217;s recommendation that Bowen&#8217;s shareholders vote &#8220;FOR&#8221; approval
of the Business Combination Proposal, however, is made as of the date of this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Shareholders who wish to redeem their Public Shares for a pro rata portion of the Trust Account must comply with specific requirements
for redemption that may make it more difficult for them to exercise their redemption rights prior to the deadline. If shareholders fail
to comply with the redemption requirements specified in this proxy statement/prospectus, they will not be entitled to redeem their Public
Shares for a pro rata portion of the funds held in the Trust Account.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Public Shareholder will be entitled to receive cash for any Public Shares to be redeemed only if such Public Shareholder: (i) holds Public
Shares; (ii) submits a written request to the Transfer Agent in which it requests that Bowen redeem all or a portion of its Public Shares
for cash,; and (iii) delivers its Public Shares to the Transfer Agent, physically or electronically through DTC. Holders must complete
the procedures for electing to redeem their Public Shares in the manner described above prior to 5:00 p.m., Eastern Time, on [&#9679;],
2024 (two business days before the Shareholder Meeting) in order for their shares to be redeemed. In order to obtain a physical share
certificate, a shareholder&#8217;s broker and/or clearing broker, DTC and the Transfer Agent will need to act to facilitate this request.
It is Bowen&#8217;s understanding that shareholders should generally allot at least two weeks to obtain physical certificates from the
transfer agent. However, because Bowen does not have any control over this process or over DTC, it may take significantly longer than
two weeks to obtain a physical stock certificate. If it takes longer than anticipated to obtain a physical certificate, Public Shareholders
who wish to redeem their Public Shares may be unable to obtain physical certificates by the deadline for exercising their redemption
rights and thus will be unable to redeem their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Business Combination is consummated, and if a Public Shareholder properly exercises its right to redeem all or a portion of the Public
Shares that it holds and timely delivers its shares to the Transfer Agent, Bowen will redeem such Public Shares for a per-share price,
payable in cash, equal to the pro rata portion of the Trust Account, calculated as of two business days prior to the consummation of
the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a Public Shareholder fails to receive notice of its right to redeem Public Shares in connection with the Business Combination or fails
to comply with the procedures for tendering its shares, such shares may not be redeemed.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
despite Bowen&#8217;s compliance with the proxy rules, a Public Shareholder fails to receive Bowen&#8217;s proxy materials, such Public
Shareholder may not become aware of the opportunity to redeem his, her or its Public Shares. In addition, the proxy materials that Bowen
is furnishing to holders of Public Shares in connection with the Business Combination describes the various procedures that must be complied
with in order to validly redeem Public Shares. In the event that a Public Shareholder fails to comply with these procedures, its Public
Shares may not be redeemed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
does not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete
the Business Combination even if a substantial majority of Bowen&#8217;s shareholders do not support it.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
does not have a specified maximum redemption threshold. As a result, Bowen may be able to complete the Business Combination even though
a substantial portion of Public Shareholders do not agree with the transaction and have redeemed their shares or have entered into privately
negotiated agreements to sell their shares. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you or a &#8220;group&#8221; of shareholders of which you are a part are deemed to hold an aggregate of more than 15% of the Public Shares,
you (or, if a member of such a group, all of the members of such group in the aggregate) will lose the ability to redeem all such shares
in excess of 15% of the Public Shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Public Shareholder, together with any of his, her or its affiliates or any other person with whom it is acting in concert or as a &#8220;group&#8221;
(as defined under Section 13 of the Exchange Act), will be restricted from redeeming in the aggregate his, her or its shares or, if part
of such a group, the group&#8217;s shares, in excess of 15% of the Public Shares. In order to determine whether a shareholder is acting
in concert or as a group with another shareholder, Bowen will require each Public Shareholder seeking to exercise redemption rights to
certify to Bowen whether such shareholder is acting in concert or as a group with any other shareholder. Such certifications, together
with other public information relating to stock ownership available to Bowen at that time, such as Section 13D, Section 13G and Section
16 filings under the Exchange Act, will be the sole basis on which Bowen makes the above-referenced determination. Your inability to
redeem any such excess Bowen Ordinary Shares will reduce your influence over Bowen&#8217;s ability to consummate the Business Combination
and you could suffer a material loss on your investment in Bowen if you sell such excess shares in open market transactions. Additionally,
you will not receive redemption distributions with respect to such excess shares if Bowen consummates the Business Combination. As a
result, you will continue to hold that number of shares aggregating to more than 15% of the Public Shares and, in order to dispose of
such excess shares, would be required to sell your shares in open market transactions, potentially at a loss. Bowen cannot assure you
that the value of such excess shares will appreciate over time following the Business Combination or that the market price of the Public
Shares will exceed the per-share redemption price. Notwithstanding the foregoing, shareholders may challenge Bowen&#8217;s determination
as to whether a shareholder is acting in concert or as a group with another shareholder in a court of competent jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no guarantee that a shareholder&#8217;s decision whether to redeem its shares for a pro rata portion of the Trust Account will put
the shareholder in a better future economic position.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
can give no assurance as to the price at which a shareholder may be able to sell its Public Shares in the future following the completion
of the Business Combination or any alternative business combination. Certain events following the consummation of any initial business
combination, including the Business Combination, may cause an increase in Bowen&#8217;s share price, and may result in a lower value
realized now than a shareholder of Bowen might realize in the future had the shareholder not redeemed its shares. Similarly, if a shareholder
does not redeem its shares, the shareholder will bear the risk of ownership of Public Shares after the consummation of any initial business
combination, and there can be no assurance that a stockholder can sell its shares in the future for a greater amount than the redemption
price set forth in this proxy statement/prospectus. A shareholder should consult the shareholder&#8217;s own financial advisor for assistance
on how this may affect his, her or its individual situation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Bowen&#8217;s
Public Shareholders will experience immediate dilution as a consequence of the issuance of Bowen&#8217;s ordinary shares as consideration
in the Business Combination and the PIPE Financing. Having a minority share position may reduce the influence that the current Public
Shareholders have on the management of New Bowen.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen&#8217;s
Public Shareholders will experience immediate dilution as a consequence of the issuance of the ordinary shares as consideration in the
Business Combination and the PIPE Financing. Having a minority share position may reduce the influence that current Public Shareholders
have on the management of New Bowen. It is anticipated that upon completion of the Business Combination and assuming minimum redemptions
by the Public Shareholders, Bowen&#8217;s Public Shareholders will retain an ownership interest of approximately [&#160;&#160;&#160;&#160;&#160; ] % of New Bowen,
the Sponsors and other Insiders will retain an ownership interest of approximately [ &#160;&#160;&#160;]% of New Bowen (excluding the PIPE Financing),
and the Qianzhi shareholders will own approximately [&#160;&#160;&#160;&#160; ]% (excluding the 1,400,000 Earnout Shares) of New Bowen. These levels of ownership
interest: (a) include the impact of the shares issuable upon conversion of the Bowen Rights, (b) assume that no additional public shareholder
exercises redemption rights with respect to its shares for a pro rata portion of the funds in the Trust Account, and (c) assume that
no shares are issued pursuant to the 2024 Incentive Plan. If the actual facts are different from these assumptions (which they are likely
to be), the percentage ownership retained by the Bowen shareholders will be different. See &#8220;Unaudited Pro Forma Condensed Combined
Financial Information.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tables below show the anticipated ownership of New Bowen upon completion of the Business Combination, along with other potential sources
of dilution. The tables show the potential impact of redemptions on the share ownership by non-redeeming shareholders in (i) a no redemption
scenario, (ii) 25% redemption scenario, (iii) 75% redemption scenario, and (iv) 100% redemption scenario. The levels of ownership presented
in the tables below assume that 500,000 shares in connection with the PIPE Financing and 1,400,000 Earnout Shares have been issued. The information in the tables below has been rounded to the nearest whole number or the nearest decimal. Therefore, the
sum of the numbers in a column may not conform exactly to the total figure given for that column in the below table. In addition, certain
percentages presented in the tables below reflect calculations based upon the underlying information prior to rounding and, accordingly,
may not conform exactly to the percentages that would be derived if the relevant calculations were based upon the rounded numbers or
may not sum due to rounding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    No Redemption<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    25% Redemption<sup>(2)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    75% Redemption<sup>(3)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    <br/>
Maximum <br/>
Redemption<sup>(4)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif">Shareholders</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ownership <br/> in Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Equity <br/> %</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ownership <br/> in Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Equity <br/> %</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ownership <br/> in Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Equity <br/> %</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ownership <br/> in Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Equity <br/> %</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of Public Shares<sup>(5)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">7,590,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">39.9</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">5,865,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">33.9</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">2,415,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">17.4</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">690,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">5.7</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insiders&#8217; Existing
    Shares<sup>(6)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,302,650</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12.1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,302,650</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">13.3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,302,650</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">16.6</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,302,650</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Existing Qianzhi shareholders</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,646,376</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">45.4</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,646,376</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">49.9</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,646,376</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">62.4</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,646,376</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">71.2</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">PIPE Investors</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2.6</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><p style="margin: 0">%</p></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2.9</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><p style="margin: 0">%</p></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3.6</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><p style="margin: 0">%</p></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4.1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><p style="margin: 0">%</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Total Shares Outstanding</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19,039,026</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">100.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">17,314,026</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">100.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">13,864,026</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">100.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,139,026</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">100.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    No Redemption<sup>(1) </sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    25% Redemption<sup>(2) </sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    75% Redemption<sup>(3) </sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    <br/>
    Maximum<br/>
 Redemption<sup>(4) </sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif">Additional Dilution Sources</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ownership <br/> in Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Equity <br/> %</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ownership <br/> in Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Equity <br/> %</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ownership <br/> in Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Equity <br/> %</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ownership <br/> in Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Equity <br/> %</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left">2024 Incentive Plan</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">951,951</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">4.8</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">865,701</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">4.8</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">693,201</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">4.8</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">606,951</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">4.8</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"></p>

<!-- Field: Rule-Page --><div style="font: 10pt Times New Roman, Times, Serif; width: 25%"><div style="border-top: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            scenario assumes that no Public Shares are redeemed by Public Shareholders.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            scenario assumes that 1,725,000 Public Shares are redeemed by Public Shareholders.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            scenario assumes that 5,175,000 Public Shares are redeemed by Public Shareholders.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            scenario assumes that 6,900,000 Public Shares are redeemed by Public Shareholders.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            an aggregate of 690,000 Bowen Ordinary Shares to be issued upon conversion of the outstanding
                                            Bowen Rights upon consummation of the Business Combination.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            an aggregate of 36,150 Bowen Ordinary Shares to be issued upon conversion of the Bowen Private
                                            Rights upon consummation of the Business Combination.</span></td></tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of additional ordinary shares will significantly dilute the equity interests of existing holders of Bowen securities and may
adversely affect prevailing market prices for our Public Shares and Public Rights. Having a minority ownership interest in New Bowen
may reduce the influence that the Public Shareholders have on the management of New Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
Bowen is deemed to be an investment company for purposes of the Investment Company Act, it could be forced to liquidate and investors
in Bowen would not be able to participate in any benefits of owning shares in New Bowen, including the potential appreciation of New
Bowen&#8217;s shares following the Business combination and Bowen&#8217;s rights would expire worthless.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is possible that a claim could be made that Bowen has been operating as an unregistered investment company. It is also possible that
the investment of funds from Bowen&#8217;s IPO and simultaneous private placement of units during Bowen&#8217;s life as a blank check
company, and the earning and use of interest from such investment, could increase the likelihood of Bowen being found to have been operating
as an unregistered investment company more than if Bowen sought to potentially mitigate this risk by holding such funds as cash. Furthermore,
the longer the funds are invested in United States &#8220;government securities&#8221; within the meaning of Section 2(a)(16) of the
Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated
under the Investment Company Act which invest only in direct U.S. government treasury obligations, the greater the risk could be that
Bowen is considered an investment company. If Bowen is deemed to be an investment company for purposes of the Investment Company Act
and found to have been operating as an unregistered investment company, Bowen may not be able to consummate the Business Combination
and may be required to change its operations, wind down its operations or register as an investment company under the Investment Company
Act. If Bowen is forced to liquidate as a result of the foregoing, investors in Bowen would not be able to participate in any benefits
of owning shares in New Bowen, including the potential appreciation of the New Bowen shares following the Business Combination and Bowen&#8217;s
rights would expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Bowen&#8217;s
ability to complete the Business Combination may be impacted by the fact that certain of the Sponsors&#8217; limited partners are non-U.S.
persons and a majority of Bowen&#8217;s and Qianzhi&#8217;s executive officers and directors are located in, or have significant ties
to, China. This may make it harder for Bowen to complete the Business Combination with Qianzhi.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen&#8217;s
Chairwoman of the Board, Na Gai, and one of Bowen&#8217;s directors, Jun Zhang, each of whom are limited partners of one of the Sponsors,
are non-U.S. persons. In addition, a majority of Bowen&#8217;s and each of Qianzhi&#8217;s directors and executive officers are
located in, or have significant ties to, China. As a result, this may make it harder for us to complete the Business Combination with
Qianzhi if the Business Combination is determined to be subject to U.S. foreign investment regulations and review by a U.S. government
entity. The Committee on Foreign Investment in the United States (&#8220;CFIUS&#8221;) is an interagency committee authorized to review
certain transactions involving foreign investment in the United States by foreign persons in order to determine the effect of such transactions
on the national security of the United States. The scope of CFIUS was expanded by the Foreign Investment Risk Review Modernization Act
of 2018 (&#8220;FIRRMA&#8221;) to include certain non-passive, non-controlling investments in sensitive U.S. businesses and certain acquisitions
of real estate even with no underlying U.S. business. FIRRMA and subsequent implementing regulations that are now in force also subject
certain categories of investments to mandatory filings. If the Business Combination with Qianzhi falls within the scope of foreign ownership
restrictions, we may be unable to consummate the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if the Business Combination falls within CFIUS&#8217;s jurisdiction, the parties may be required to make a mandatory filing,
determine to submit a voluntary notice to CFIUS, or proceed with the Business Combination without notifying CFIUS and then bear the risk
of CFIUS intervention, before or after closing the Business Combination. CFIUS may decide to block or delay the Business Combination
or impose conditions to mitigate national security concerns with respect to such Business Combination if the parties proceeded without
first obtaining CFIUS clearance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foreign ownership limitations, and the potential impact of CFIUS, may limit the attractiveness of the Business Combination. Moreover,
the process of government review, whether by CFIUS or otherwise, could be lengthy. Failure to obtain any required approvals within the
requisite time period may prevent the parties from completing the Business Combination and require Bowen to liquidate. If Bowen liquidates,
Bowen&#8217;s rights will expire worthless and Public Shareholders may lose the potential investment opportunity in New Bowen and the
opportunity of realizing future gains on the securities of New Bowen through any price appreciation in the combined company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_011"></span>MEETING
OF BOWEN SHAREHOLDERS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
is furnishing this proxy statement/prospectus to its shareholders as part of the solicitation of proxies by the Bowen Board for use at
the Shareholder Meeting to be held on [&#9679;], 2024 and at any adjournment or postponement thereof. This proxy statement/prospectus
provides Bowen shareholders with information they need to know to be able to vote or direct their vote to be cast at the Shareholder
Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date,
Time and Place of the Shareholder Meeting</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shareholder Meeting will be held on [&#9679;], 2024, at [&#9679;] [a.m./p.m.], Eastern Time, via a virtual meeting, or at such other
time, on such other date and at such place to which the meeting may be postponed or adjourned.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
or about [&#9679;], 2024, Bowen commenced mailing this proxy statement/prospectus and the enclosed form of proxy to its shareholders
entitled to vote at the Shareholder Meeting. You may attend the Shareholder Meeting and vote your shares electronically during the Shareholder
Meeting via live audio webcast by visiting <i>www.cstproxy.com/bowenacquisition/[&#9679;]</i>. You will need the control number that
is printed on your proxy card to enter the Shareholder Meeting. Bowen recommends that you log in at least 15 minutes before the meeting
to ensure you are logged in when the Shareholder Meeting starts. Please note that you will not be able to attend the Shareholder Meeting
in person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold your Bowen Ordinary Shares through a bank or broker, you will need to contact Continental, Bowen&#8217;s transfer agent, to
receive a control number. If you plan to vote at the Shareholder Meeting, you will need to have a legal proxy from your bank or broker,
or if you would like to join and not vote, Continental can issue you a guest control number with proof of ownership. Either way you must
contact the Continental for specific instructions on how to receive the control number. Continental can be contacted at the number or
email address below. Please allow up to 72 hours prior to the meeting for processing your control number.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
can pre-register to attend the virtual Shareholder Meeting starting [&#9679;], 2024 at 9:00 a.m., Eastern Time (two business days prior
to the meeting date). Enter the following URL address into your browser <i>www.cstproxy.com/bowenacquisition/[&#9679;]</i>, enter your
control number, name and email address. Once you pre-register you can vote or enter questions in the chat box. At the start of the Shareholder
Meeting, you will need to log in again using your control number and will also be prompted to enter your control number if you want to
vote during the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you do not have access to the internet, you can listen only to the Shareholder Meeting by dialing [&#9679;] (or [&#9679;] if you are
located outside of the United States and Canada (standard rates apply)) and when prompted enter the pin number [&#9679;]#. Please note
you will not be able to vote or enter questions during the Shareholder Meeting if you choose to participate telephonically.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose
of the Shareholder Meeting</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Shareholder Meeting, Bowen shareholders are being asked to vote on the following proposals:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Business Combination Proposal;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the
                                            Name Change Proposal;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the
                                            Capitalization Amendment Proposal;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Charter Amendment Proposals;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Nasdaq Proposal;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Equity Incentive Plan Proposal;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Director Election Proposal; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Adjournment Proposal (if necessary).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Name Change Proposal, the Capitalization Proposal, the Charter Amendment Proposals, the Nasdaq Proposal, the Equity Incentive
Plan Proposal and the Director Election Proposal is conditioned on the approval and adoption of the Condition Precedent Proposal. The Adjournment Proposal is not conditioned upon the approval of any other proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record
Date; Who is Entitled to Vote</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Board has fixed the close of business on [&#9679;], 2024 as the Record Date for determining Bowen shareholders entitled to notice
of and to attend and vote at the Shareholder Meeting. As of the close of business on the Record Date, there were 9,166,500 Bowen Ordinary
Shares outstanding and entitled to vote. Each Bowen Ordinary Share is entitled to one vote per share at the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Insiders have agreed, subject to applicable securities laws, to vote any Bowen Ordinary Shares owned by them in favor of the proposals
presented at the Shareholder Meeting. As of the date of this proxy statement/prospectus, the Insiders own approximately 22.2% of the
total outstanding Bowen Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quorum
and Required Vote for Proposals for the Shareholder Meeting</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
quorum of Bowen shareholders is necessary to hold a valid meeting. A quorum will be present at the Shareholder Meeting if a majority
of the voting power of all outstanding Bowen Ordinary Shares entitled to vote as of the Record Date at the Shareholder Meeting is represented
at the Shareholder Meeting virtually or by proxy. Abstentions will be counted as present for the purpose of determining a quorum. The
Insiders, which currently hold approximately 22.2% of the issued and outstanding Bowen Ordinary Shares, will count towards this quorum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of each of the Name Change Proposal, the Capitalization Amendment Proposal and the Charter Amendment Proposals
requires a special resolution under Cayman Islands law, being the affirmative vote of the holders of at least two-thirds (2/3) of the
Bowen Ordinary Shares represented in person virtually or by proxy and entitled to vote thereon and who vote at the Shareholder Meeting
at which a quorum is present. The approval of each of the other proposals require an ordinary resolution under Cayman Islands law, being
the affirmative vote of the holders of a majority of the Bowen Ordinary Shares represented in person virtually or by proxy and entitled
to vote thereon and who vote at the Shareholder Meeting at which a quorum is present.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abstentions
and Broker Non-Votes</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abstentions
are considered present for the purposes of establishing a quorum and will have no effect on the approval of any of the Business Combination
Proposal, the Charter Amendment Proposals, the Nasdaq Proposal, the Equity Incentive Plan Proposal, the Director Election Proposal or
the Adjournment Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Nasdaq rules, if a shareholder holds their shares in &#8220;street&#8221; name through a bank, broker or other nominee and the shareholder
does not instruct their broker, bank or other nominee how to vote their shares on a proposal, the broker, bank or other nominee has the
authority to vote the shares in its discretion on certain &#8220;routine&#8221; matters. However, banks, brokers and other nominees are
not authorized to exercise their voting discretion on any &#8220;non-routine&#8221; matters. This can result in a &#8220;broker non-vote,&#8221;
which occurs on a proposal when (i) a bank, broker or other nominee has discretionary authority to vote on one or more &#8220;routine&#8221;
proposals to be voted on at a meeting of shareholders or has received instructions as to how to vote on some but not all of the &#8220;non-routine&#8221;
proposals, (ii) there are one or more &#8220;non-routine&#8221; proposals to be voted on at the meeting for which the bank, broker or
other nominee does not have authority to vote without instructions from the beneficial owner of the shares and (iii) the beneficial owner
fails to provide the bank, broker or other nominee with voting instructions on a &#8220;non-routine&#8221; matter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that all of the proposals to be voted on at the Shareholder Meeting will be considered non-routine matters. As a result, if you
hold your shares in street name, your bank, brokerage firm or other nominee cannot vote your shares on any of the proposals to be voted
on at the Shareholder Meeting without your instruction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
all of the proposals to be voted on at the Shareholder Meeting are &#8220;non-routine&#8221; matters, banks, brokers and other nominees
will not have authority to vote on any proposals unless instructed, so Bowen does not expect there to be any broker non-votes at the
Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommendation
of the Bowen Board</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Board has determined that the Business Combination, on the terms and conditions set forth in the Business Combination Agreement,
is advisable and in the best interests of Bowen and its shareholders and has directed that the proposals set forth in this proxy statement/prospectus
be submitted to its shareholders for approval at the Shareholder Meeting on the date and at the time and place set forth in this proxy
statement/prospectus. The Bowen Board recommends that Bowen&#8217;s shareholders vote &#8220;FOR&#8221; the Business Combination Proposal,
&#8220;FOR&#8221; each of the Charter Amendment Proposals, &#8220;FOR&#8221; the Nasdaq Proposal, &#8220;FOR&#8221; the Equity Incentive
Plan Proposal, &#8220;FOR&#8221; each of the nominees to be elected pursuant to the Director Election Proposal and &#8220;FOR&#8221;
the Adjournment Proposal (if necessary). See the section entitled &#8220;<i>Shareholder Proposal No. 1: The Business Combination
Proposal &#8212; Recommendation of the Bowen Board and Reasons for the Business Combination</i>&#8221; for additional information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen&#8217;s
directors and officers may have financial interests in the Business Combination that are different from, or in addition to, their interests
as shareholders of Bowen and the interests of shareholders of Bowen generally. The existence of financial and personal interests of one
or more of Bowen&#8217;s directors may result in a conflict of interest on the part of such director(s) between what they may believe
is in the best interests of Bowen and its shareholders and what they may believe is best for themselves in determining to recommend that
shareholders vote for the proposals. See the section entitled &#8220;<i>Shareholder Proposal No. 1: The Business Combination Proposal
&#8212; Interests of Certain Persons in the Business Combination</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
Your Shares</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you were a holder of record of Public Shares as of the close of business on [&#9679;], 2024, the Record Date for the Shareholder Meeting,
you may vote with respect to the proposals electronically, or by completing, signing, dating and returning the enclosed proxy card in
the postage-paid envelope provided. Your proxy card shows the number of Public Shares that you own. If your shares are held in &#8220;street
name&#8221; or are in a margin or similar account, you should contact your broker to ensure that votes related to the shares you beneficially
own are properly counted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are two ways to vote your Public Shares at the Shareholder Meeting:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting
                                            by Mail. </b>By signing the proxy card and returning it in the enclosed prepaid and addressed
                                            envelope, you are authorizing the individuals named on the proxy card to vote your shares
                                            at the Shareholder Meeting in the manner you indicate. You are encouraged to sign and return
                                            the proxy card even if you plan to attend the Shareholder Meeting so that your shares will
                                            be voted if you are unable to attend the Shareholder Meeting. If you receive more than one
                                            proxy card, it is an indication that your shares are held in multiple accounts. Please sign
                                            and return all proxy cards to ensure that all of your shares are voted. Votes submitted by
                                            mail must be received by 5:00 p.m., Eastern Time, on [&#9679;], 2024.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting
                                            Electronically. </b>You may attend, vote and examine the list of shareholders entitled to
                                            vote at the Shareholder Meeting by visiting the website listed on your proxy card or voting
                                            instruction form and entering the control number found on your proxy card, voting instruction
                                            form or notice included in the proxy materials.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revoking
Your Proxy</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you give a proxy, you may revoke it at any time before the Shareholder Meeting or at the Shareholder Meeting by doing any one of the
following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                            may send another proxy card with a later date;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                            may notify Bowen&#8217;s Chief Executive Officer in writing to Bowen Acquisition Corp, 420
                                            Lexington Avenue, Suite 2446, New York, NY 10170, before the Shareholder Meeting that you
                                            have revoked your proxy; or</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                            may attend the Shareholder Meeting and vote electronically, as indicated above.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
of Sponsors, Directors and Officers</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a letter agreement with Bowen, the Insiders have agreed, subject to applicable securities laws, to vote any Bowen Ordinary Shares
owned by them in favor of the proposals presented at the Shareholder Meeting, and have agreed to waive their redemption rights with respect
to any Bowen Ordinary Shares owned by them in connection with the Shareholder Meeting. In addition, the IPO Underwriter has agreed to
waive its redemption rights with respect to the Bowen Representative Shares and Bowen Private Shares held by it. No person was paid
any consideration in exchange for these waivers. The Bowen Founder Shares, the Bowen Representative Shares and the Bowen Private
Shares will be excluded from the pro rata calculation used to determine the per-share redemption price. As of the date of this proxy
statement/prospectus, the Sponsors own approximately 22.2% of the issued and outstanding Bowen Ordinary Shares and Bowen&#8217;s officers
and directors do not own any Bowen Ordinary Shares (excluding any securities indirectly owned by officers or directors as a result of
his or her membership interest in the Sponsors).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Additional Matters May Be Presented at the Shareholder Meeting</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shareholder Meeting has been called only to consider the approval of the Business Combination Proposal, the Charter Amendment Proposals,
the Nasdaq Proposal, the Equity Incentive Plan Proposal, the Director Election Proposal and the Adjournment Proposal (if
necessary). Under the Existing Charter, no other matters may be considered at the Shareholder Meeting if they are not included in this
proxy statement/prospectus, which serves as the notice of the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Who
Can Answer Your Questions about Voting Your Shares?</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a Bowen shareholder and have any questions about how to vote or direct a vote in respect of your Bowen Ordinary Shares, you may
call Laurel Hill Advisory Group, our proxy solicitor, by calling [X], or banks and brokers can call [X], or by emailing [X].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption
Rights</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Existing Charter, holders of Public Shares may seek to redeem, out of funds legally available therefor, their shares for cash,
regardless of whether they vote for or against, or whether they do not vote at all on, the Business Combination Proposal. Any shareholder
holding Public Shares may demand that Bowen redeem such shares for a full pro rata portion of the Trust Account (which, for illustrative
purposes, was approximately $[X] per share of Public Shares as of [X], 2024, the most recent practicable date prior to the date of this
proxy statement/prospectus), calculated as of two business days prior to the consummation of the Business Combination, including interest
earned on the funds held in the Trust Account and not previously released to Bowen to pay its taxes (which interest shall be net of taxes
payable). If a holder properly seeks redemption as described in this section and the Business Combination is consummated, Bowen will,
subject to funds being legally available therefor, redeem these shares for a pro rata portion of funds deposited in the Trust Account
and the holder will no longer own these shares following the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a Public Shareholder, you will be entitled to receive cash for any Public Shares to be redeemed only if you:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
                                            hold Public Shares directly or (b) hold Public Shares through Bowen Units and elect to separate
                                            your Bowen Units into the underlying Public Shares and Public Rights prior to exercising
                                            your redemption rights with respect to the Public Shares;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">submit
                                            a written request to Continental, Bowen&#8217;s transfer agent, in which you request that
                                            Bowen redeem all or a portion of your Public Shares for cash; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">deliver
                                            your Public Shares (and share certificates (if any)) to Continental, Bowen&#8217;s transfer
                                            agent, physically or electronically through DTC.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Public Shareholder must complete the procedures for electing to redeem its Public Shares in the manner described above prior to 5:00
p.m., Eastern Time, on [&#9679;], 2024 (two business days before the initially scheduled date of the Shareholder Meeting), in order for
its shares to be redeemed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
redemption rights include the requirement that a holder must identify itself in writing as a beneficial holder and provide its legal
name, phone number and address to Continental in order to validly redeem its shares. If the Business Combination is not consummated,
the Public Shares will be returned to the respective holder, broker or bank.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold your shares in &#8220;street name,&#8221; you will have to coordinate with your broker to have your shares certificated or delivered
electronically. Public Shares that have not been tendered (either physically or electronically) in accordance with these procedures will
not be redeemed for cash. There is a nominal cost associated with this tendering process and the act of certificating the shares or tendering/delivering
them through DTC&#8217;s DWAC system. Continental will typically charge the tendering broker a fee and it would be up to the broker whether
or not to pass this cost on to the redeeming shareholder. In the event the proposed Business Combination is not consummated, this may
result in an additional cost to shareholders for the return of their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
request for redemption, once made by a Public Shareholder, may be withdrawn at any time until the deadline for exercising redemption
requests. If you tender or deliver your shares for redemption to Continental, acting as transfer agent, and later decide prior to the
deadline for exercising redemption requests not to elect redemption, you may request that Bowen instruct Continental to return the shares
(physically or electronically). You may make such request by contacting Continental at the phone number or address listed at the end
of this section. Bowen will be required to honor such request only if made prior to the deadline for exercising redemption requests (although
the Bowen Board may agree to honor such requests after such deadline in its sole discretion).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a Public Shareholder, together with any affiliate of such Public Shareholder or any other person with whom such Public
Shareholder is acting in concert or as a &#8220;group&#8221; (as defined in Section 13(d)(3) of the Exchange Act), will be restricted
from redeeming its Public Shares with respect to more than an aggregate of 15% of the Public Shares, without our prior consent. Accordingly,
if a Public Shareholder, alone or acting in concert or as a group, seeks to redeem more than 15% of the outstanding Public Shares, then
any such shares in excess of that 15% limit would not be redeemed for cash, without our prior consent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Business Combination is not approved or completed for any reason, then the Public Shareholders who elected to exercise their redemption
rights will not be entitled to redeem their shares for a full pro rata portion of the Trust Account, as applicable. In such case, Bowen
will promptly return any shares (and share certificates (if any)) tendered or delivered by Public Shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen&#8217;s
transfer agent can be contacted at the following address:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continental
Stock Transfer &amp; Trust Company<br/>
1 State Street Plaza, 30<sup>th</sup> Floor<br/>
New York, New York 10004<br/>
Attn: SPAC Redemption Team<br/>
E-mail: spacredemptions@continentalstock.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Insiders have waived their redemption rights with respect to their Bowen Ordinary Shares in connection with the shareholder vote to approve
the Business Combination. Accordingly, such shares will be excluded from the pro rata calculation used to determine the per-share redemption
price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing price of Public Shares on [X], 2024, the most recent practicable date prior to the date of this proxy statement/prospectus, was
$[X] per share. The cash held in the Trust Account on such date was approximately $[X] (including interest not previously released to
Bowen to pay its taxes) (approximately $[X] per share of Public Shares). Prior to exercising redemption rights, shareholders should verify
the market price of Public Shares as they may receive higher proceeds from the sale of their Public Shares in the public market than
from exercising their redemption rights if the market price per share is higher than the redemption price. Bowen cannot assure its shareholders
that they will be able to sell their Public Shares in the open market, even if the market price per share is higher than the redemption
price stated above, as there may not be sufficient liquidity in its securities when its shareholders wish to sell their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a holder of Public Shares exercises his, her or its redemption rights, then he, she or it will be exchanging its Public Shares for cash
and will no longer own those shares. You will be entitled to receive cash for these shares only if you properly demand redemption by
tendering or delivering your Public Shares (and share certificates (if any) and other redemption forms) (either physically or electronically)
to Bowen&#8217;s transfer agent as described above and the Business Combination is consummated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a discussion of certain material United States federal income tax considerations for shareholders with respect to the exercise of these
redemption rights, see &#8220;<i>Material United States Federal Income Tax Considerations &#8212; U.S. Federal Income Tax Consequences
to U.S. Holders of Exercising Redemption Rights</i>.&#8221; The consequences of a redemption to any particular shareholder will depend
on that shareholder&#8217;s particular facts and circumstances. Accordingly, you are urged to consult your tax advisor to determine your
tax consequences from the exercise of your redemption rights, including the applicability and effect of U.S. federal, state, local and
non-U.S. income and other tax laws in light of your particular circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appraisal
Rights</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no appraisal rights available to Bowen&#8217;s shareholders in connection with the Business Combination. However, holders of Public
Shares may elect to have their shares redeemed in connection with the adoption of the Business Combination Proposal, as described under
&#8220;<i>Redemption Rights</i>&#8221; above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
Solicitation Costs</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
is soliciting proxies on behalf of the Bowen Board. This proxy solicitation is being made by mail, but also may be made by telephone
or in person. Bowen has engaged Laurel Hill Advisory Group to assist in the solicitation of proxies for the Shareholder Meeting. Bowen
and its directors, officers and employees may also solicit proxies in person. Bowen will ask banks, brokers and other institutions, nominees
and fiduciaries to forward this proxy statement/prospectus and the related proxy materials to their principals and to obtain their authority
to execute proxies and voting instructions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
will bear the entire cost of the proxy solicitation, including the preparation, assembly, printing, mailing and distribution of this
proxy statement/prospectus and the related proxy materials. Bowen will pay Laurel Hill Advisory Group a fee of $[X], plus disbursements,
reimburse Laurel Hill Advisory Group for its reasonable out-of-pocket expenses and indemnify Laurel Hill Advisory Group and its affiliates
against certain claims, liabilities, losses, damages and expenses for its services as Bowen&#8217;s proxy solicitor. Bowen will reimburse
brokerage firms and other custodians for their reasonable out-of-pocket expenses for forwarding this proxy statement and the related
proxy materials to Bowen shareholders. Directors, officers and employees of Bowen who solicit proxies will not be paid any additional
compensation for soliciting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insider
Ownership of Bowen Ordinary Shares</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the Record Date for the Shareholder Meeting, the Insiders owned of record and were entitled to vote 2,066,782 Bowen Ordinary Shares.
Such shares currently constitute approximately 22.2% of the outstanding Bowen Ordinary Shares. The Insiders have agreed, subject to applicable
securities laws, to vote any Bowen Ordinary Shares owned by them in favor of the proposals presented at the Shareholder Meeting, and
have agreed to waive their redemption rights with respect to any Bowen Ordinary Shares owned by them in connection with this Shareholder
Meeting. In addition, the IPO Underwriter has agreed to waive its redemption rights with respect to the Bowen Representative Shares and
Bowen Private Shares held by it. No person was paid any consideration in exchange for these waivers. The Bowen Founder Shares,
the Bowen Representative Shares and the Bowen Private Shares will be excluded from the pro rata calculation used to determine the per-share
redemption price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential
Purchases of Public Shares</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time at or prior to the Business Combination, during a period when they are not then aware of any material nonpublic information
regarding us or our securities, the Insiders, Bowen, Qianzhi and/or their respective directors, officers, advisors or respective affiliates
may purchase Public Shares from institutional and other investors who vote, or indicate an intention to vote, against any of the proposals
presented at the Shareholder Meeting, or execute agreements to purchase such shares from such investors in the future, or they may enter
into transactions with such investors and others to provide them with incentives to acquire Public Shares or vote their Public Shares
in favor of the proposals presented at the Shareholder Meeting. Such a purchase may include a contractual acknowledgement that such shareholder,
although still the record holder of our shares, is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption
rights. In the event that the Insiders, Bowen, Qianzhi and/or their respective directors, officers, advisors or respective affiliates
purchase Public Shares in privately negotiated transactions from Public Shareholders who have already elected to exercise their redemption
rights, such selling shareholder would be required to revoke their prior elections to redeem their Public Shares. The purpose of such
share purchases and other transactions would be to decrease the number of shares that have been or may be submitted for redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entering
into any such arrangements may have a depressive effect on the market price of Bowen Ordinary Shares. For example, as a result of these
arrangements, an investor or holder may have the ability to effectively purchase shares at a price lower than market and may therefore
be more likely to sell the shares he or she owns, either at or prior to the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement/prospectus, there have been no such discussions and no agreements to such effect have been entered
into with any such investor or holder. If such transactions are effected, the consequence could be to cause the Business Combination
to be consummated in circumstances where such consummation could not otherwise occur. We will file or submit a Form 8-K to disclose any
material arrangements entered into or significant purchases made by any of the aforementioned persons that would affect the vote on the
proposals to be put to the Shareholder Meeting or the redemption threshold. Any such report will include descriptions of any arrangements
entered into or significant purchases by any of the aforementioned persons including (i) the amount of securities purchased in any
such purchases, along with the purchase price; (ii) the purpose of any such purchases; (iii) the impact, if any, of any such purchases
on the likelihood that the Business Combination will be approved; (iv) the identities or the nature of the security holders (e.g., 5%
security holders) who sold their securities in any such purchases; and (v) the number of securities for which Bowen has received redemption
requests pursuant to its shareholders&#8217; redemption rights in connection with the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any shares were so purchased, the purchaser would not vote any such shares in favor of approval of the Business Combination Proposal.
Additionally, the purchaser would waive any redemption rights with respect to any securities so purchased.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
purchases by the Sponsors and Bowen&#8217;s officers and directors and/or their respective affiliates who are affiliated purchasers under
Rule 10b-18 under the Exchange Act will only be made to the extent such purchases are able to be made in compliance with Rule 10b-18,
which is a safe harbor from liability for manipulation under Section 9(a)(2) and Rule 10b-5 of the Exchange Act. Rule 10b-18 has certain
technical requirements that must be complied with in order for the safe harbor to be available to the purchaser. The Sponsors and Bowen&#8217;s
officers and directors and/or their respective affiliates will not make purchases of shares if the purchases would violate Section 9(a)(2)
or Rule 10b-5 of the Exchange Act. Any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the
extent such purchasers are subject to such reporting requirements. Additionally, in the event the Sponsors or Bowen&#8217;s directors,
officers, advisors or their affiliates were to purchase Public Shares from Public Shareholders, such purchases would be structured in
compliance with the requirements of Rule 14e-5 under the Exchange Act.<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_012"></span>PROPOSAL
1: THE BUSINESS COMBINATION PROPOSAL</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overview</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
is asking its shareholders to approve the Business Combination Agreement and the transactions contemplated thereby, including the
Merger pursuant to which Merger Sub will merge with and into NewCo, with NewCo being the surviving company of the Merger and
becoming a wholly-owned subsidiary of Bowen. The structure of the Business Combination is a reverse triangular merger which is
customary for special purpose acquisition company business combinations. The contemplated timing of the Business Combination, for it
to essentially be consummated as soon as reasonably practicable, was determined by the parties in light of (i) general business
considerations weighing in favor of consummating the transaction promptly so that neither Bowen nor Qianzhi had to operate for
longer than necessary under the burden of uncertainty and (ii) the deadline for Bowen to complete an initial business combination
pursuant to the Existing Charter. Bowen shareholders should carefully read this proxy statement/prospectus in its entirety for
more detailed information concerning the Business Combination Agreement, which is attached as <i><span style="text-decoration: underline">Annex A</span></i> to this proxy
statement/prospectus. Please see the section entitled the &#8220;<i>&#8212; The Business Combination Agreement</i>&#8221; for
additional information and a summary of certain terms of the Business Combination Agreement. You are urged to read the Business
Combination Agreement in its entirety before voting on this proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we are holding an extraordinary general meeting of shareholders to vote on the Business Combination, we may consummate the Business
Combination only if the Business Combination Proposal is approved by a majority of the votes cast (in person virtually or by proxy)
by the holders of a majority of the Bowen ordinary shares entitled to vote at the Shareholder Meeting. However, because the
Sponsors and Insiders have agreed to vote their shares in favor of the Business Combination Proposal (and therefore are not required to vote in accordance with the majority of unaffiliated shareholders), the transaction is not
structured such that the vote of a majority of unaffiliated shareholders is required to approve the Business Combination
Proposal. Under the Business Combination Agreement, the approval of the Business Combination Proposal is a condition to the
consummation of the Business Combination. If the Business Combination Proposal is not approved by Bowen&#8217;s shareholders, the
Business Combination will not be consummated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
Combination Agreement</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section describes the material provisions of the Business Combination Agreement but does not purport to describe all of the terms of
the Business Combination Agreement. This summary is qualified in its entirety by reference to the complete text of the Business Combination
Agreement, a copy of which is attached as <i><span style="text-decoration: underline">Annex A</span></i> hereto and which is incorporated herein by reference. You and other interested
readers are urged to read the Business Combination Agreement, carefully and in its entirety (and, if appropriate, with the advice of
financial and legal counsel), because it is the primary legal document that governs the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement contains representations, warranties and covenants that the parties thereto made to each other as of the
date of the Business Combination Agreement or other specific dates. The assertions embodied in those representations, warranties and
covenants were made for purposes of the contract among the parties to the Business Combination Agreement and are subject to important
qualifications and limitations agreed to in connection with negotiating the Business Combination Agreement, including by the underlying
disclosure schedules of both Bowen and Qianzhi and its subsidiaries, which are not filed publicly and are subject to a contractual standard
of materiality different from that generally applicable to shareholders and were used for the purpose of allocating risk among the parties
to the Business Combination Agreement rather than establishing matters as facts. We do not believe that the disclosure schedules contain
information that is material to an investment decision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the representations and warranties of the parties to the Business Combination Agreement may or may not have been accurate as of any specific
date and do not purport to be accurate as of the date of this proxy statement/prospectus. Accordingly, no person or entity should rely
on the representations and warranties in the Business Combination Agreement or the summaries thereof in this proxy statement/prospectus
as characterizations about the actual state of facts of the parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement and the transactions contemplated thereby have been unanimously approved by the boards of directors of
Bowen and Qianzhi and are expected to be consummated as soon as possible following the Shareholder Meeting should the requisite vote
be obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
Description of the Business Combination Agreement</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement contemplates that, at the Closing, upon the terms and subject to the conditions of the Business Combination
Agreement and in accordance with the Cayman Companies Act, Merger Sub will merge with and into NewCo, with NewCo being the surviving
company of the Merger and becoming a wholly-owned subsidiary of Bowen. Consistent with the Business Combination Agreement and in preparation
for the Business Combination, Qianzhi completed the Restructuring, in which it became a wholly owned subsidiary of NewCo by the issuance
of NewCo Ordinary Shares to the former holders of Qianzhi ordinary shares in exchange for such Qianzhi ordinary shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consideration</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
of Company Securities</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, at the Effective Time, all of NewCo Ordinary Shares issued and outstanding immediately prior to
the Effective Time other than (i) NewCo Ordinary Shares held by the parties to the Business Combination Agreement or their respective
wholly owned subsidiaries and (ii) those NewCo Ordinary Shares owned by the holders of NewCo Ordinary Shares who have validly exercised
and not effectively withdrawn or lost their rights to dissent from the Merger pursuant to the Cayman Companies Act, will be automatically
converted into the right to receive an aggregate of (a) 7,246,377 Merger Shares, a portion of which shall be deposited in escrow to provide
for indemnification in accordance with the Business Combination Agreement, and (b) the right to receive earnout consideration of up to
an aggregate of 1,400,000 Earnout Shares, as described further below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
Consideration</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the Merger Shares, the holders of NewCo Ordinary Shares have the contingent right to receive an aggregate of 1,400,000 Earnout
Shares as earnout consideration. The Earnout Shares will be issued if and to the extent certain net income milestones are achieved by
New Bowen and its subsidiaries during the fiscal years ended March 31, 2025 and 2026. In addition, the holders of NewCo Ordinary Shares
will be entitled to receive the Earnout Shares in the event there occurs any transaction resulting in a change of control during the
period of time that the Earnout Shares are earnable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representations
and Warranties</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement contains representations and warranties of Qianzhi and NewCo relating to, among other things, organization
and qualification; subsidiaries; capitalization; authority relative to the Business Combination Agreement; there being no conflict between
Qianzhi&#8217;s charter documents and other legal requirements and the Transactions and requiring only certain governmental consents;
compliance with applicable legal requirements; financial statements; having no undisclosed liabilities; the absence of certain changes
or events; there being no claims, suits, actions, complaints, demands or other proceedings pending or, to the knowledge of Qianzhi, threatened
against Qianzhi before any governmental entity; employee benefit plans; labor matters; business activities; title to property; taxes;
environmental matters; brokers; third-party expenses; intellectual property; agreements, contracts and commitments; governmental actions/filings;
interested party transactions; top customers and top suppliers; and board approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement contains representations and warranties of Bowen and Merger Sub relating to, among other things, organization
and qualification; subsidiaries; capitalization; authority relative to the Business Combination Agreement; there being no conflict between
Bowen&#8217;s charter documents and other legal requirements and the Transactions and requiring only certain governmental consents; Bowen
SEC reports and financial statements; having no undisclosed liabilities; the absence of certain changes or events; litigation; employee
benefit plans; labor matters; business activities; title to property; taxes; environmental matters; brokers; intellectual property; agreements,
contracts and commitments; insurance; interested party transactions; Nasdaq listing; board approval; and the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Survival</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described further under &#8220;<i>Indemnification</i>&#8221; below, the representations and warranties of Qianzhi and NewCo will survive
the Closing for a period of two years, except that the Specified Representations (as defined below) will survive until the expiration
of the applicable statute of limitations. The representations and warranties of Bowen will not survive the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Covenants</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement includes customary affirmative and negative covenants of the parties with respect to business operations
prior to consummation of the Transactions. The parties also agreed to abide by certain exclusivity provisions, to use reasonable best
efforts to consummate the Merger, and to provide insurance for Bowen&#8217;s and Qianzhi&#8217;s directors and officers and indemnification
for Bowen&#8217;s directors and officers after the Closing. The Business Combination Agreement also contains additional covenants of
the parties, including, among others:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
                                            and Qianzhi will cooperate in the preparation and filing of the Registration Statement of
                                            which this proxy statement/prospectus forms a part for the offer and sale of Bowen Ordinary
                                            Shares issuable pursuant to the Business Combination Agreement.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
                                            and NewCo will use reasonable best efforts to solicit and obtain the approval (the &#8220;<span style="font-weight: normal"><i>NewCo
                                            Shareholder Approval</i></span>&#8221;) of the Merger and Transactions, by the requisite
                                            number of holders of NewCo Ordinary Shares, as promptly as practicable following the date
                                            hereof.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
                                            will adopt an incentive equity plan to be effective following the Closing.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
                                            will use commercially reasonable efforts to ensure (i) the Bowen Ordinary Shares, (ii) the
                                            Bowen Rights and (iii) the Bowen Units continue to be listed on Nasdaq until the Closing,
                                            and Bowen will use commercially reasonable best efforts to cause the Bowen Ordinary Shares
                                            to be listed on Nasdaq following the Closing.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
                                            to Closing, certain employees of Qianzhi will execute employment agreements and noncompete
                                            agreements in form to be mutually agreed upon (each a &#8220;<span style="font-weight: normal"><i>Non-Competition
                                            Agreement</i></span>&#8221;).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
                                            as soon as practicable, Bowen and Qianzhi will use commercially reasonable efforts to solicit
                                            the PIPE Investors to enter into the PIPE Agreements (as defined below) with Bowen, on terms
                                            approved by Qianzhi (such approval not to be unreasonably withheld, conditioned or delayed),
                                            pursuant to which the PIPE Investors consummate the PIPE Financing by purchasing, concurrently
                                            with the Closing, equity or equity-linked securities of Bowen in an aggregate amount of $5.0
                                            million.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions
to Closing</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mutual
Conditions</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consummation of the Merger and the other transactions contemplated by the Business Combination Agreement is conditioned upon the following,
among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Bowen Shareholder Approval and the NewCo Shareholder Approval having been received by Bowen
                                            and NewCo, respectively;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            approval for listing on Nasdaq of Bowen Ordinary Shares to be issued in connection with the
                                            Transactions, subject, if applicable, to official notice of issuance thereof and the requirement
                                            to have a sufficient number of round lot holders;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Registration Statement having become effective in accordance with the provisions of the Securities
                                            Act, no stop order having been issued by the SEC that remains in effect with respect to the
                                            Registration Statement, and no proceeding seeking such a stop order having been threatened
                                            or initiated by the SEC which remains pending;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
                                            by the CFIUS of the Merger and other Transactions having been obtained and being in full
                                            force and effect;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            required waiting periods under the HSR Act, if any, having expired or been terminated;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
                                            of all necessary filings with the China Securities Regulatory Commission (&#8220;<span style="font-weight: normal"><i>CSRC</i></span>&#8221;)
                                            having been obtained and being in full force and effect;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
                                            having at least $5,000,001 of net tangible assets (after giving effect to redemptions by
                                            Bowen&#8217;s public shareholders) immediately prior to or upon the Closing; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
                                            of less than 5% of the NewCo Ordinary Shares issued and outstanding immediately prior to
                                            the Closing having exercised their right to dissent, and not effectively withdrawn their
                                            dissent or lost their right to dissent, from the Merger pursuant to section 238 of the Cayman
                                            Companies Act.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
Conditions to Bowen&#8217;s Obligations</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of Bowen and Merger Sub to consummate the Transactions are also conditioned upon, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            accuracy of the representations and warranties of Qianzhi and NewCo;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
                                            in all material respects of the agreements and covenants of Qianzhi required by the Business
                                            Combination Agreement to be performed on or prior to the Closing;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            action, suit or proceeding being pending or threatened before any governmental entity which
                                            would (i) prevent consummation of any of the Transactions, (ii) cause any of the Transactions
                                            to be rescinded following consummation, or (iii) affect materially and adversely the right
                                            of the Surviving Company to own, operate or control any of the assets and operations of Qianzhi
                                            following the Merger, and no order, judgment, decree, stipulation or injunction to any such
                                            effect being in effect;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
                                            employees of Qianzhi having executed employment agreements and Non-Competition Agreements
                                            with Bowen;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            PIPE Financing being fully ready for consummation concurrently with the Closing; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            outstanding material indebtedness owed to Qianzhi or its subsidiaries by affiliates or officers,
                                            directors, or employees thereof or by any other Person designated by Qianzhi who will become
                                            an officer, director, or employee of Bowen upon the Closing having been repaid in full; all
                                            outstanding material guaranties and similar arrangements pursuant to which Qianzhi or any
                                            of its subsidiaries has guaranteed the payment or performance of any obligations of any such
                                            affiliate or officer, director, or employee, or other Person, to a third party having been
                                            terminated; and no affiliate of Qianzhi owning any direct equity interests in any company
                                            that utilizes in its name or otherwise &#8220;Qianzhi&#8221; or any derivative thereof.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
Conditions to Qianzhi&#8217;s and NewCo&#8217;s Obligations</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of Qianzhi and NewCo to consummate the Transactions are also conditioned upon, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            accuracy of the representations and warranties of Bowen and Merger Sub;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
                                            in all material respects of the covenants of Bowen and Merger Sub required by the Business
                                            Combination Agreement to be performed on or prior to the Closing;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            action, suit or proceeding being pending or threatened before any governmental entity which
                                            (i) would prevent consummation of any of the Transactions, (ii) would cause any of the Transactions
                                            to be rescinded following consummation or (iii) would affect materially and adversely or
                                            otherwise encumber the title of the Bowen Ordinary Shares to be issued by Bowen in connection
                                            with the Merger, and no order, judgment, decree, stipulation or injunction to any such effect
                                            being in effect; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            2024 Incentive Plan having been adopted.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the indemnification provisions of the Business Combination Agreement, Bowen, NewCo and Qianzhi, and their respective representatives,
successors and permitted assigns, will be indemnified, defended and held harmless by NewCo shareholders, jointly and severally to the
extent of the Escrow Shares, and thereafter severally but not jointly, from and against all Losses (as defined below) asserted against,
resulting to, imposed upon, or incurred by any indemnitee by reason of, arising out of or resulting from (i) the actual or alleged inaccuracy
or breach of any representation or warranty of Qianzhi or NewCo contained in or made pursuant to the Business Combination Agreement,
or contained in or made pursuant to any certificate delivered by Qianzhi or NewCo to Bowen pursuant to the Business Combination Agreement
in connection with the Closing; or (ii) the non-fulfillment or breach of any covenant or agreement of Qianzhi or NewCo contained in the
Business Combination Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used above, the term &#8220;<span style="font-weight: normal"><i>Losses</i></span>&#8221; includes all losses, liabilities, damages,
judgments, awards, orders, penalties, settlements, costs and expenses (including, without limitation, interest, penalties, court costs
and reasonable legal fees and expenses), including those arising from any demands, claims, suits, actions, costs of investigation, notices
of violation or noncompliance, causes of action, proceedings and assessments, whether or not made by third parties or whether or not
ultimately determined to be valid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
representations and warranties of Qianzhi and NewCo shall survive the Closing until the date that is two years after the Closing Date,
except that the representations and warranties relating to organization and qualification, subsidiaries, capitalization, authority relative
to the Business Combination Agreement, employee benefit plans, taxes, environmental matters, brokers and intellectual property (the &#8220;<span style="font-weight: normal"><i>Specified
Representations</i></span>&#8221;) shall survive until the expiration of the applicable statute of limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
amount shall be payable under the foregoing provisions unless and until the aggregate amount of all indemnifiable Losses otherwise payable
exceeds $3,750,000, in which event NewCo shareholders shall be required to pay or be liable for all such indemnifiable Losses from the
first dollar (except that this limitation will not apply to indemnifiable Losses arising out of an actual or alleged breach of the Specified
Representations). The aggregate liability of NewCo shareholders for Losses shall not in any event exceed $18,750,000 (and no Company
Shareholder shall be liable for more than its pro rata share of the Losses, based on the same proportions as the total Merger Shares
are allocated among them).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement may be terminated at any time prior to the Closing as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            mutual written consent of Bowen and Qianzhi;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            either Bowen or Qianzhi, if the Effective Time has not occurred on or before December 31,
                                            2024; <i>provided </i>that this termination right is not available to a party that is in
                                            breach or violation of the Business Combination Agreement and such breach or violation is
                                            the primary cause of the failure to close by such date;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            either Bowen or Qianzhi, if a governmental entity shall have issued an order, decree, judgment
                                            or ruling or taken any other action, in any case having the effect of permanently restraining,
                                            enjoining or otherwise prohibiting the Merger, which order, decree, ruling or other action
                                            is final and nonappealable;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            either Bowen or Company, if the other party has breached any of its covenants or representations
                                            and warranties, or any representation or warranty has become untrue, such that the terminating
                                            party&#8217;s closing conditions would not be satisfied (subject to a thirty-day cure period,
                                            if such breach is curable), provided that this termination right is not available to a party
                                            that is in breach of the Business Combination Agreement such that the other party&#8217;s
                                            closing conditions would not be satisfied;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            either Bowen or Qianzhi, if the Bowen Shareholder Approval is not obtained;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            Bowen, if Qianzhi Stockholder Approval is not obtained by the requisite vote under the Cayman
                                            Companies Act and NewCo&#8217;s charter documents within one (1) Business Day after the Shareholder
                                            Meeting;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            Bowen, in the event that CFIUS notifies the parties in writing that CFIUS has recommended
                                            or intends to recommend in a report that the Transactions be prohibited; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            either Bowen or Qianzhi, if the approval of all necessary filings with the CSRC has not been
                                            obtained and is not in full force and effect.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
termination of the Business Combination Agreement, the Business Combination Agreement will become void (with certain customary exceptions),
except that the parties shall not be relieved of liability for any willful breach of the Business Combination Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees
and Expenses</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
fees and expenses incurred in connection with the Business Combination Agreement and the other transactions contemplated by the Business
Combination Agreement will be paid for by Qianzhi.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waivers</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Either
Bowen or Qianzhi may extend the time for performance of any obligation of any other Party, waive any inaccuracies in the representations
and warranties of any other Party contained in the Business Combination Agreement or in any document delivered pursuant to the Business
Combination Agreement, and waive compliance with any agreements of any other party or any condition to its own obligations contained
in the Business Combination Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing
Law</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement shall be governed by and construed in accordance with the internal law of the State of New York regardless
of the law that might otherwise govern under applicable principles of conflicts of law thereof. Notwithstanding the foregoing, the Merger
and the exercise of appraisal and dissenters&#8217; rights under the Cayman Companies Act, the fiduciary or other duties of the board
of directors of Bowen, Merger Sub, NewCo and Qianzhi with respect to the Merger shall in each case be construed, performed and enforced
in accordance with the laws of the Cayman Islands, in respect of which each of the Parties irrevocably submitted to the non-exclusive
jurisdiction of the courts of the Cayman Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third-Party
PIPE Financing</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, the Parties agreed that Bowen and Qianzhi shall use commercially reasonable efforts to solicit
PIPE Investors to enter into subscription agreements with Bowen (as amended or modified from time to time, collectively, the &#8220;<span style="font-weight: normal"><i>PIPE
Agreements</i></span>&#8221;), on terms approved by Qianzhi (such approval not to be unreasonably withheld, conditioned or delayed),
pursuant to which, among other things, each PIPE Investor shall agree to subscribe for and purchase from Bowen, and Bowen shall agree
to issue and sell to each such PIPE Investor, on the Closing Date concurrent with the Closing, the number or amount of Bowen Ordinary
Shares or other equity or equity-linked securities of Bowen set forth in the applicable PIPE Agreement, in exchange for the purchase
price set forth therein, in an aggregate amount of $5,000,0000. The timing and structure of the PIPE Financing are customary for similar financings entered into in connection with
initial business combination transactions of special purpose acquisition companies. Simultaneous with entering into the PIPE Agreements, the PIPE
Investors shall enter into a registration rights agreement with Bowen (as amended or modified from time to time, the &#8220;<span style="font-weight: normal"><i>PIPE
Registration Rights Agreement</i></span>&#8221;), on terms approved by Qianzhi (such approval not to be unreasonably withheld, conditioned
or delayed), pursuant to which, among other things, Bowen shall grant the PIPE Investors demand and piggyback registration rights relating
to the Bowen Ordinary Shares issuable pursuant to the PIPE Agreements or underlying the Bowen Ordinary Shares or other equity or equity-linked
securities issued pursuant to the PIPE Agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
shall reasonably cooperate in soliciting the PIPE Investors, obtaining the PIPE Financing and preparing the PIPE Agreements and PIPE
Registration Rights Agreement by, in a timely manner, (i) providing such information and assistance as Bowen may reasonably request,
(ii) granting such access to potential PIPE Investors and their representatives as may reasonably be necessary for their due diligence,
and (iii) causing its and its subsidiaries&#8217; respective senior management teams to participate in a reasonable number of meetings,
presentations, road shows, drafting sessions, due diligence sessions with respect to the PIPE Financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
shall use commercially reasonable efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary,
proper or advisable to cause the PIPE Financing to be consummated on the terms set forth in the PIPE Agreements, including using its
commercially reasonable efforts to (i) maintain in full force and effect the PIPE Agreements in accordance with the terms thereof, (ii)
satisfy on a timely basis all conditions to obtaining the PIPE Financing set forth in the PIPE Agreements that are applicable to the
Bowen or any of its Subsidiaries and within the control of Bowen or any of its subsidiaries, (iii) cause the PIPE Investors to fund the
PIPE Financing concurrently with or prior to the Closing, (iv) comply on a timely basis with the Bowen&#8217;s obligations under the
PIPE Agreements, and (v) enforce Bowen&#8217;s rights under the PIPE Agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
Statement and Proxy Statement</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties made customary covenants regarding the Registration Statement, including to file with the Registration Statement in connection
with the registration under the Securities Act of Bowen Ordinary Shares to be issued under the Business Combination Agreement to the
NewCo equityholders. The Registration Statement is required to contain Bowen&#8217;s proxy statement to solicit proxies from Bowen shareholders
to approve, among other things, the Business Combination Proposal and the other matters described herein. Accordingly, this document
serves as both a prospectus and proxy statement for Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related
Agreements</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
Agreements</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrently
with the execution of the Business Combination Agreement, Bowen, Qianzhi and certain NewCo shareholders entered into Voting and Support
Agreements (each, a &#8220;<span style="font-weight: normal"><i>Voting Agreement</i></span>&#8221;), pursuant to which, among other things,
each such NewCo shareholder agreed, with respect to all NewCo Ordinary Shares received by such NewCo Shareholder in the Restructuring,
to vote in favor of, or consent in writing to, the adoption of the Business Combination Agreement and the approval of the transactions
contemplated thereby, including the Merger, in order to effect the required NewCo shareholder approval. Such vote or consent shall occur
as soon as practicable as following the date of this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interests
of Bowen&#8217;s Directors and Officers in the Business Combination</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
you consider the recommendation of the Bowen Board in favor of approval of the Business Combination Proposal, you should keep in mind
that the Insiders, including Bowen&#8217;s executive officers and directors, have interests in such proposal that are different from,
or in addition to, those of Public Shareholders generally. These interests include that the Insiders will lose their entire investment
in Bowen if an initial business combination is not completed (other than with respect to Public Shares they may acquire in the future),
and that the Insiders will benefit from the completion of a business combination and may be incentivized to complete a business combination,
even if it is with a less favorable target company or on less favorable terms to shareholders, rather than liquidate Bowen. Further,
the personal and financial interests of the Sponsors, as well as Bowen&#8217;s executive officers and directors may have influenced their
motivation in identifying and selecting Qianzhi as a business combination target and completing the Business Combination with Qianzhi.
In considering the recommendations of the Bowen Board to vote for the proposals, Public Shareholders should consider these interests
as well as, among other things, the interests described below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that the Sponsors and Bowen&#8217;s officers and directors have certain economic interests
                                            in the Business Combination including:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Sponsors paid an aggregate of $25,000 for 1,725,000 Founder Shares currently owned by the
                                            Sponsors, in which certain of Bowen&#8217;s directors and executive officers hold an indirect interest. The Insiders have agreed to waive their redemption rights with
                                            respect to their Founder Shares and any Public Shares they hold in connection with the Business
                                            Combination and their rights to liquidating distributions from the Trust Account with respect
                                            to any Founder Shares held by them if the Business Combination is not approved and Bowen
                                            fails to complete a business combination within the required time period. Accordingly, the
                                            Founder Shares would be worthless if the Business Combination or another business combination
                                            is not consummated within the required time period because the holders thereof are not entitled
                                            to participate in any redemption or liquidation distribution with respect to such shares.
                                            Such securities may have a significantly higher value at the time of the Business Combination,
                                            and if unrestricted and freely tradable would be valued at approximately $[X] based upon
                                            the closing price of $[X] per Bowen Ordinary Share on Nasdaq on [X], 2024;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Createcharm paid an aggregate of $3,417,820</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                            for 341,782 Bowen Private Units. Such securities may have a higher value at the time of the
                                            Business Combination and, if unrestricted and freely tradable, would be valued at approximately
                                            $[X], based upon the closing price of $[X] per Public Unit on Nasdaq on [X], 2024;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Sponsors and Bowen&#8217;s officers and directors will lose their entire investment in Bowen
                                            and will not be reimbursed for any loans extended, fees due or out-of-pocket expenses incurred
                                            on Bowen&#8217;s behalf related to identifying, investigating, negotiating and completing
                                            an initial business combination if the Business Combination is not consummated within the
                                            required time period. As of the date of this proxy statement/prospectus, there is an aggregate
                                            principal amount of $[X] of outstanding loans payable to the SPAC Sponsors and $[X]
                                            in aggregate fees due and out-of-pocket expenses to be repaid by Bowen;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accordingly,
                                            based on the value of the Bowen securities invested in and the amount of the
                                            loans and unreimbursed expenses as set forth above, the aggregate amount that the SPAC
                                            Sponsors and Bowen&#8217;s officers and directors have at risk is $[3,442,820 ($3,434,570
                                            by Createcharm and $8,250 by Bowen Holding)];</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9675;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            addition, the SPAC Sponsors and their affiliates can earn a positive rate of
                                            return on their investment, even if other Bowen shareholders experience a negative rate of
                                            return;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            Bowen entered into an agreement, commencing on the date its securities were first listed
                                            on Nasdaq and up to the earlier of the consummation of a business combination or its liquidation,
                                            to pay Bowen Holding LP a monthly fee of US$10,000 for office space, secretarial and administrative
                                            support;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that pursuant to the Business Combination Agreement, Bowen has the right to designate
                                            one director to the New Bowen Board post-Closing. Such director, in the future, may receive
                                            any cash fees, stock options or stock awards that the New Bowen Board determines to pay to
                                            its directors. Bowen has designated Jun Zhang to be a director on the New Bowen Board post-Closing;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that the Business Combination Agreement provides for the continued indemnification of
                                            Bowen&#8217;s existing directors and officers and requires New Bowen to purchase, at or prior
                                            to the Closing, and maintain in effect for a period of six years after the Closing, a &#8220;tail&#8221;
                                            policy providing directors&#8217; and officers&#8217; liability insurance coverage for certain
                                            Bowen directors and officers after the Business Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that if the Trust Account is liquidated, including in the event Bowen is unable to complete
                                            an initial business combination within the required time period, each of the
                                            Sponsors has agreed to indemnify Bowen to ensure that the proceeds in the Trust Account are
                                            not reduced below $10.10 per Public Share, or such lesser per share amount as is in the Trust
                                            Account, by the claims of prospective target businesses with which Bowen has entered into
                                            an acquisition agreement or claims of any third party for services rendered or products sold
                                            to Bowen, but only if such a vendor or target business has not executed a waiver of any and
                                            all rights to seek access to the Trust Account; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that if the Business Combination or another business combination is not consummated
                                            within the required time period, Bowen will cease all operations except for the purpose of
                                            winding up, redeeming 100% of the outstanding Public Shares for cash and, subject to the
                                            approval of its remaining shareholders and the Bowen Board, dissolving and liquidating.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
personal and financial interests of the Insiders as well as Bowen&#8217;s executive officers and directors may have influenced their
motivation in identifying and selecting Qianzhi as a business combination target, completing the Business Combination with Qianzhi and
influencing the operation of the business following the Business Combination. The existence of such financial and personal interests
may result results in conflicts of interest on the part of such executive officers, directors and Insiders between what he, she, or they
may believe is in the best interests of Bowen and what he, she, or they may believe is best for himself, herself, or themselves in determining
to recommend that shareholders vote for the proposals. In considering the recommendations of the Bowen Board to vote for the proposals,
its shareholders should consider these interests. See this section entitled &#8220;<i>Shareholder Proposal No. 1: The Business Combination
Proposal &#8212; Interests of Certain Persons in the Business Combination.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Material
Effects of the Business Combination and potential PIPE Financing</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following material benefits and detriments from the Business Combination and PIPE Financing are expected to affect (i) Bowen and its
affiliates, (ii) the SPAC Sponsors and their affiliates, (iii) Qianzhi and its affiliates, and (iv) the Public Shareholders. This information
is provided pursuant to Item 1605(c) of Regulation S-K, as promulgated under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Bowen
and its affiliates</i>. For Bowen, the Business Combination represents the opportunity to complete the purpose for which it was
formed. The only potential detriment to Bowen of the Business Combination is the opportunity cost&#8212;that by consummating the
Business Combination, Bowen is foregoing the opportunity to consummate a business combination transaction with another entity that
theoretically could be of greater value to Bowen than Qianzhi. However, Bowen&#8217;s board considered the benefits of the
transaction with Qianzhi and determined such transaction was the best transaction available to it at such time. The potential PIPE
Financing benefits New Bowen by providing it with additional capital that could fund operations and growth following the
Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>SPAC
Sponsors and their affiliates.</i> For the SPAC Sponsors, the principal material benefit represented by the Business Combination is
that unless the Business Combination (or another initial business combination transaction) is consummated by Bowen prior to the
deadline pursuant to the Existing Chater, the SPAC Sponsors will lose their entire $3,442,820 investment in Bowen ($3,434,570 by
Createcharm, including $16,750 paid to Bowen Holding in exchange for Founder Shares, and $8,250 by Bowen Holding), which such
investment is described in greater detail in the section of this proxy statement/prospectus entitled &#8220;<i>Information about
Bowen &#8211; SPAC Sponsors and their affiliates</i>&#8221;. The potential PIPE Financing benefits New Bowen by providing it with
additional capital that could fund operations and growth, and thereby potentially further increasing the value of the SPAC
Sponsors&#8217; New Bowen holdings and their return on investment following the Business Combination. The potential detriment of the
PIPE Financing to the SPAC Sponsors and their affiliates is that the up to 500,000 New Bowen Ordinary Shares that may be issued to
the investors in the PIPE Financing would dilute the ownership percentage of the SPAC Sponsors by between approximately 0.35%
(assuming no redemption of Bowen Ordinary Shares by Public Shareholders) and approximately 0.96% (assuming redemption of 100% of the
Bowen Ordinary Shares held by the Public Shareholders). The SPAC Sponsors&#8217; and TenX Global Capital LP
(&#8220;<i>TenX</i>&#8221;), are not expected to experience any material benefits from the Business Combination other than as a
limited partner with a substantial economic interest in Bowen Holding, as described further in the section of this proxy
statement/prospectus entitled &#8220;<i>Information about Bowen &#8211; SPAC Sponsors and their affiliates</i>&#8221;, and the only
potential material detriment is the possibility that New Bowen will not continue to engage TenX for services as described further in
the section of this proxy statement/prospectus entitled &#8220;<i>Information about Bowen &#8211; SPAC Sponsors and their
Affiliates</i>&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Qianzhi
and its affiliates</i>. For Qianzhi and its affiliates, the Business Combination represents the opportunity to become a publicly
traded company, with all the attendant benefits thereof including increased access to capital from the public markets. For
Qianzhi&#8217;s affiliates, the tradability of their New Bowen Ordinary Shares is expected to make their holdings more liquid. The
potential detriments to Qianzhi and its affiliates are the increased costs and difficulty of operating as a public company and the
dilution of their ownership stake in Qianzhi&#8217;s business of between approximately 29.2% (assuming redemption of 100% of the
Bowen Ordinary Shares held by the Public Shareholders) and approximately 57.7% (assuming no redemption of Bowen Ordinary Shares by
Public Shareholders), from 100% of Qianzhi prior to the Business Combination to between approximately 70.8% (assuming redemption of
100% of the Bowen Ordinary Shares held by the Public Shareholders) and approximately 42.3% (assuming no redemption of Bowen Ordinary
Shares by Public Shareholders) of New Bowen, not including any Bowen Ordinary Shares that could be issued pursuant to the potential
PIPE Financing. The potential PIPE Financing benefits New Bowen by providing it with additional capital that could fund
Qianzhi&#8217;s operations and growth following the Business Combination, and thereby increase the value of Qianzhi and its
affiliates&#8217; holdings and their return on investment in Qianzhi. The potential detriment of the PIPE Financing to Qianzhi and
its affiliates is that the up to 500,000 New Bowen Ordinary Shares that may be issued to the investors in the PIPE Financing would
dilute the ownership percentage of the current Qianzhi shareholders following the Business Combination by between approximately 1.2%
(assuming no redemption of Bowen Ordinary Shares by Public Shareholders) and approximately 3.3% (assuming redemption of 100% of the
Bowen Ordinary Shares held by the Public Shareholders).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Public
Shareholders</i>. For the Public Shareholders of Bowen, the Business Combination represents the opportunity to share in the growth of
a company such as Qianzhi that was chosen by the management of Bowen as an acquisition target in an initial business combination (which
was Bowen&#8217;s original purpose). Unlike the Bowen Insiders, if an initial business combination was not consummated by Bowen within
the required time period, the Public Shareholders would receive a pro-rata portion of the trust account, equivalent to their initial
investment plus interest. Like the Bowen Insiders, however, the Bowen Rights held by the Public Shareholders would expire worthless if
no business combination such as the Business Combination is completed by the deadline. The primary potential detriment to the Public
Shareholders of the Business Combination is the dilution of their ownership stake in the combined business of between approximately 30.7%
(assuming no redemption of Bowen Ordinary Shares by Public Shareholders) and approximately 68.3% (assuming redemption of 100% of the
Bowen Ordinary Shares held by the Public Shareholders), from approximately 75% of Bowen prior to the Business Combination to between
approximately 44.3% (assuming no redemption of Bowen Ordinary Shares by Public Shareholders) and approximately 6.7% (assuming redemption
of 100% of the Bowen Ordinary Shares held by the Public Shareholders) of New Bowen, not including any Bowen Ordinary Shares that could
be issued pursuant to the potential PIPE Financing. The potential PIPE Financing benefits New Bowen by providing it with additional
capital that could fund New Bowen&#8217;s operations and growth following the Business Combination, and thereby increase the value of
New Bowen and the Public Shareholders&#8217; holdings and their return on investment in Bowen. The potential detriment of the PIPE
Financing to the Public Shareholders is that the up to 500,000 New Bowen Ordinary Shares that may be issued to the investors in the PIPE
Financing would dilute the ownership percentage of the current Bowen shareholders following the Business Combination by between approximately
0.3% (assuming redemption of 100% of the Bowen Ordinary Shares held by the Public Shareholders) and approximately 1.3% (assuming no redemption
of Bowen Ordinary Shares by Public Shareholders).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Bowen
                                            Officer and Director Fiduciary Duties and Contractual Obligations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In addition to the foregoing,
Bowen&#8217;s officers and directors had fiduciary or contractual obligations to other entities, as listed below, while Bowen was seeking
to locate a target business for a business combination. Accordingly, if any of Bowen&#8217;s officers or directors had become aware of
a business combination opportunity which was suitable for an entity to which he or she had then-current fiduciary or contractual obligations,
such officer or director would have been entitled to honor his or her fiduciary or contractual obligations to present such business combination
opportunity to such entity prior to Bowen and might have only decided to present it to Bowen if such entity rejected the opportunity,
and consummating the same would not violate any restrictive covenants to which such officers and directors were subject. Bowen&#8217;s
Charter provides that to the fullest extent permitted by applicable law: (i) no individual serving as a director or an officer shall
have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or
similar business activities or lines of business as Bowen; and (ii) Bowen renounces any interest or expectancy in, or in being offered
an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any director or officer,
on the one hand, and Bowen, on the other. Bowen does not believe, however, that the fiduciary duties or contractual obligations of its
officers or directors has materially affected or will materially affect its ability to complete the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Below is a table summarizing
the entities to which our executive officers and directors currently have fiduciary duties or contractual obligations:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Officer
    or Director</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entity</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entity&#8217;s
    Business</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Affiliation</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Na
    Gai</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shenzhen
    Guoxing Capital Co., Ltd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset
    management and investment company based in China</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    (Executive President)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Flag
    Ship Acquisition Corp.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Blank
    check company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiangang
    Luo</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cleantech
    Global Limited</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    consulting firm</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Employee]
    (Manager)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prime
    Science &amp; Technology, Inc.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer/software
    consulting and IT outsourcing</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    (President)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PNE
    Limited Partner LLC and Luo Long General Partner LLC</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special
    purpose vehicles for investing in Princeton NuEnergy, a US based cleantech company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    (President)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jing
    Lu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">China
    Bridge Capital International Inc.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PE/VC
    investment advisory company specializing in innovative technologies</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officer
    (Chief Operating Officer)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Keyarch
    Acquisition Corporation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Blank
    check company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officer
    (Chief Financial Officer)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrence
    Leighton&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bentley
    Associates</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boutique
    investment bank</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing
    Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wei
    Li</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hyatt
    Capital Management</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private
    investment fund and financial services </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officer
    (Chief Executive Officer)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jun
    Zhang</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mazars
    (Shenzhen Branch)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit,
    accountancy, advisory, tax and legal services</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Partner and Associate Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shenzhen
    Zhonghuan Certified Public Accountants Co., Ltd</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
    services</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    (Chairman)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Background
of the Business Combination</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Acquisition Corp is a Cayman Islands exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition,
share purchase, reorganization or similar business combination with one or more businesses. Bowen&#8217;s search for a target business
was not limited to any industry or geographic region but Bowen primarily focused its search for target businesses in Asia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 11, 2023, Bowen completed its initial public offering of 6,000,000 units at a price of $10.00 per unit, generating gross proceeds
to Bowen of $60,000,000. On July 17, 2023, the underwriters exercised their over-allotment option in full to purchase an additional 900,000
Units. As a result, on July 18, 2023, Bowen sold an additional 900,000 Units at $10.00 per Unit, generating gross proceeds of
$9,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the consummation of the IPO, neither Bowen nor anyone on its behalf engaged in any substantive discussions, directly or indirectly,
with any target business with respect to a business combination with Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the completing its IPO, Bowen utilized the operating experience and entrepreneurial expertise of its officers and directors to identify
potential business combination targets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
utilized the following general criteria in evaluating candidates for an initial business combination:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Growth
                                            Potential</i> - Bowen sought to acquire one or more businesses that had the potential for
                                            significant revenue and earnings growth through a combination of both existing and new product
                                            development, increased production capacity, expense reduction and synergistic follow-on acquisitions
                                            resulting in increased operating leverage. Bowen also sought to acquire one or more businesses
                                            that had the potential to generate strong, stable and increasing free cash flow, particularly
                                            businesses with predictable revenue streams and definable low working capital and capital
                                            expenditure requirements.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Strong
                                            management team that can create significant value for target business</i> - Bowen sought
                                            to identify companies with strong and experienced management teams that would complement
                                            the operating and investment abilities of Bowen&#8217;s management team.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Benefit
                                            of Being a Public Company</i> - Bowen sought to acquire a business or businesses that it
                                            believed would benefit from being publicly traded and which could effectively utilize access
                                            to broader sources of capital and a public profile that are associated with being a publicly
                                            traded company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the completion of the IPO, Bowen considered numerous potential target businesses with the objective of consummating its initial business
combination. Bowen&#8217;s initial target exploration focused on certain targets with whom Bowen&#8217;s officers, directors and Sponsors
were already familiar through their networks and investment activities, and who could satisfy some or all the key criteria for a business
combination target described above. As Bowen&#8217;s search progressed, the list of potential business combination partners was refined
to exclude potential partners who did not meet all or most of the key criteria or who Bowen&#8217;s management believed were unlikely
to consider a business combination with Bowen. The list of potential business combination partners was also expanded to include potential
partners introduced to Bowen by third party investors, investment banks, private equity firms, consulting firms, legal and accounting
firms and inbound inquiries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the process that ultimately led to Bowen selecting Qianzhi as its business combination partner, representatives of Bowen contacted, and
were contacted by, a number of individuals and entities with respect to business combination opportunities and engaged in discussions
with several possible target businesses regarding potential transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
that period, Bowen reviewed approximately 20 targets in its search, and made contact with representatives of six such potential
business combination targets to engage in more detailed discussions regarding a potential business combination transaction.
Non-disclosure agreements were signed with five of such potential targets, the terms of each of which were customary and did not
contain standstill obligations. Thereafter, Bowen reviewed detailed financial and business information and conducted preliminary due
diligence on four of the potential targets, including Qianzhi (Bowen did not engage with the fifth target because such target
failed to deliver any of the information Bowen requested in order to perform a proper analysis of such target). Ultimately,
without foreclosing the possibility of a future business combination involving these potential targets, Bowen decided to engage in
discussions with the potential initial business combination targets other than Qianzhi in a less active fashion, because (i) such
other potential targets pursued an alternative transaction or strategy, (ii) Bowen did not meet such potential targets&#8217;
valuation expectations and/or (iii) such targets did not meet one or more of Bowen&#8217;s acquisition criteria described above and
Bowen determined that such targets would not have been advantageous to Bowen and its shareholders. Furthermore, Bowen concluded that
a business combination transaction with Qianzhi aligned the best with Bowen&#8217;s acquisition criteria and, among other things,
Qianzhi was receptive to a valuation and consideration structure that would be advantageous to Bowen and its
shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below
is a summary of the three potential combination targets other than Qianzhi on which Bowen conducted preliminary due diligence but decided
not to proceed with an indication of interest or letter of intent:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Candidate
                                            A was a China-based industrial intelligent equipment producer. On August 2, 2023, Bowen was
                                            first introduced to Candidate A through Bowen&#8217;s CEO, Jiangang Luo. On the same date,
                                            Bowen received a copy of Candidate A&#8217;s investor presentation and detailed financial
                                            information. On August 5, 2023, Bowen&#8217;s management, including CEO, Jiangang Luo, and
                                            CFO, Jing Lu, had an introductory videoconference with Candidate A&#8217;s management, including
                                            its Chairman and CEO, to discuss its business operations and combination potentials. On August
                                            8, 2023, Bowen and Candidate A executed a confidentiality agreement. On August 11, 2023,
                                            Bowen sent a preliminary due diligence list to Candidate A to complement the on-going due
                                            diligence process. Candidate A did not provide the requested information, and therefore,
                                            Bowen ceased further discussions with Candidate A.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Candidate
                                            B was a China-based integrated medical service provider. On August 10, 2023, Bowen was first
                                            introduced to Candidate B through Bowen&#8217;s CEO, Jiangang Luo, and received a copy of
                                            Candidate B&#8217;s investor presentation. On August 15, 2023, Bowen and Candidate B executed
                                            a confidentiality agreement. On September 23, 2023, Bowen sent a preliminary due diligence
                                            list to Candidate B. Before the receipt of the due diligence materials and commencing of
                                            due diligence process on September 14, 2023, Bowen maintained an ongoing email conversation
                                            with Candidate B regarding the de-SPAC process. Bowen&#8217;s management ultimately
                                            concluded that Company B lacked public company-readiness due to the absence of a PCAOB
                                            audit plan or committed timeline. As a result, Bowen ceased further discussions with
                                            Candidate B.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Candidate
                                            C was a Korean-based company that provided AI-based disaster prevention and response systems.
                                            On October 19, 2023, the financial advisor of Candidate C introduced Candidate C to Bowen.
                                            After an initial call between a representative of Bowen and the financial advisor of Candidate
                                            C on October 24, 2023, Bowen and Candidate C executed a confidentiality agreement on October
                                            25, 2023. On October 31, 2023, Bowen sent a preliminary due diligence list to Candidate C.
                                            On November 12, 2023, Bowen commenced its due diligence process after the receipt of due
                                            diligence materials. On November 22, 2023, Bowen&#8217;s management including CEO, Jiangang
                                            Luo, and CFO, Jing Lu, held an introductory videoconference with the financial advisor of
                                            Candidate C. At the meeting, Bowen&#8217;s management learned that Candidate C was exploring
                                            and leaning towards alternative options for listing, such as an initial public
                                            offering. Even though Bowen determined Candidate C would be a viable candidate for a
                                            business combination, the indecision regarding Candidate C&#8217;s listing strategy presented
                                            considerable uncertainty and risks from Bowen&#8217;s perspective. Given the concurrent advancements
                                            in discussions with Qianzhi, Bowen ceased further discussions with Candidate C.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
was made aware of Qianzhi through its director&#8217;s network in September 2023. The following is a summary of the negotiations that
ensued:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On September 19, 2023, Jun Zhang, an independent director
                                                                                                                                                                                                                                          and audit committee chair of Bowen, introduced Qianzhi to the Bowen board and Bowen&#8217;s management. Mr. Zhang and Liangwen
                                                                                                                                                                                                                                          Wang, Chief Financial Officer of Qianzi since June 2018, first met each other in April 2017 at an accounting and tax seminar and
                                                                                                                                                                                                                                          have remained in contact since then. In July 2023, Mr. Zhang and Mr. Wang met at a social occasion. At this event, Mr. Wang learned
                                                                                                                                                                                                                                          of Mr. Zhang&#8217;s affiliation with Bowen and that Bowen had recently completed its IPO and was looking for potential targets with
                                                                                                                                                                                                                                          which to complete a business combination transaction. Mr. Wang indicated to Mr. Zhang that Qianzhi was actively exploring a stock
                                                                                                                                                                                                                                          listing on a senior stock exchange. As a result of this meeting, Mr. Zhang and Mr. Wang expressed interest in further discussions
                                                                                                                                                                                                                                          regarding the two companies.  Mr. Zhang then informed the Bowen board of Qianzhi and the board determined to express the
                                                                                                                                                                                                                                          following deal points to Qianzhi: (i) there would be no requirement on the part of Bowen to have a minimum amount of cash at
                                                                                                                                                                                                                                          closing to consummate the business combination, (ii) there would be no requirement to surrender or forfeit any founder
                                                                                                                                                                                                                                          shares held by the Bowen Sponsors upon consummation of the business combination and (iii) Qianzhi would need to
                                                                                                                                                                                                                                          be willing to pay for costs associated with extending the time Bowen had to consummate a business combination (if necessary) and other
                                                                                                                                                                                                                                          transactional expenses incurred by Bowen during the business combination process. Subsequently, Mr. Zhang conveyed the
                                                                                                                                                                                                                                          above terms to Qianzhi and learned that Qianzhi was amenable to such terms and was interested in proceeding further with a proposed
                                                                                                                                                                                                                                          transaction.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            September 22, 2023, Bowen and Qianzhi executed a confidentiality agreement to facilitate
                                            further discussion. On the same date, Bowen sent a preliminary due diligence request list
                                            to Qianzhi.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            September 25, 2023, Bowen&#8217;s team had a videoconference meeting with Qianzhi&#8217;s
                                            management and Qianzhi&#8217;s US counsel (Becker &amp; Poliakoff), Qianzhi&#8217;s PRC counsel
                                            (Jingsh &amp; HY Leung), Qianzhi&#8217;s auditor (Simon &amp; Edward, LLP), and Qianzhi&#8217;s
                                            external industry report provider (Frost &amp; Sullivan), in which they discussed the timeline
                                            for the potential business combination. All parties agreed to a weekly video conference call
                                            to discuss the due diligence process and related negotiation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            September 28, 2023, Bowen received the preliminary due diligence materials from Qianzhi.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            September 30, 2023, on behalf of Bowen, Mr. Zhang sent to Qianzhi&#8217;s management a draft
                                            non-binding letter of intent for the proposed business combination for review, which included
                                            a proposed transaction structure and a range of pre-money equity value for Qianzhi of
                                            between $60 million and $80 million. The pre-money equity value of Qianzhi was based
                                            on Qianzhi&#8217;s historical financial statements for the years ended March 31, 2023
                                            and 2022 and an earnings projection for the next five years which had been provided by Qianzhi
                                            to Bowen. The value also was based on preliminary P/E multiples using a comparable
                                            companies analysis performed by Bowen, as set forth in the table below. The comparable
                                            companies utilized by Bowen in performing its analysis were largely consistent with the companies
                                            utilized by Newbridge in preparing its opinion for the Bowen board as described below, although
                                            Newbridge&#8217;s analysis was more expansive and therefore contained several different comparable
                                            companies than Bowen&#8217;s analysis. Due to the fact that the comparable companies were
                                            significantly larger than Qianzhi, valuation discounts of between 30% and 10% were also applied
                                            to the median P/E multiples of the comparable companies for a more conservative analysis.
                                            The letter of intent also contemplated earnout consideration payable to Qianzhi&#8217;s
                                            shareholders equal to an aggregate of 20% of the pre-money equity value of Qianzhi with net
                                            income targets for FY2025 and FY2026 based on Qianzhi&#8217;s own financial projections.
                                            The earnout was consistent on an aggregate basis with Bowen&#8217;s evaluation of Qianzhi&#8217;s
                                            business, which was based on Bowen management&#8217;s analysis of comparable companies in
                                            the health and wellness focused biotech sector, Qianzhi&#8217;s business plan and other materials
                                            provided by Qianzhi&#8217;s management. On the same day, Mr. Zhang discussed the key terms
                                            of the draft letter of intent with Qianzhi&#8217;s management, which included Bowen and
                                            Qianzhi to use their best efforts to obtain an equity financing in connection with the Business
                                            Combination in an amount of not less than 5% of the transaction consideration to be paid
                                            for Qianzhi. As a result of such conversations, on October 1, 2023, Mr. Zhang sent a
                                            revised letter of intent to Qianzhi for review with substantially similar terms as Bowen&#8217;s
                                            initial draft. There were no substantive discussions regarding the continuing employment
                                            or involvement of any persons affiliated with Bowen prior to the Business Combination, any
                                            formal or informal commitment to retain any financial advisors after the Business Combination
                                            and any pre-existing relationships between Bowen&#8217;s sponsors and additional investors
                                            other than customary discussions regarding whether any independent directors of Bowen should
                                            remain on the board of the combined company following the Business Combination. It was ultimately
                                            determined that Jun Zhang, an independent director of Bowen, would remain a director following
                                            consummation of the Business Combination.</span></p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comparable
    Companies</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/28/2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    Multiples</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P/E</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Name</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Symbol</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022E</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 62%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIFEVANTAGE
    CORPORATION</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LFVN</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNITED-GUARDIAN,
    INC.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UG</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHURCH
    &amp; DWIGHT CO.INC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHD</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FITLIFE
    BRANDS, INC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FTLF</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KIMBERLY-CLARK
    CORP</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KMB</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE CLOROX COMPANY</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLX</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MEDIAN</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.8</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            October 2, 2023, Bowen, Qianzhi, and Jingsh &amp; HY Leung held a conference call
                                            to discuss the potential transaction timeline and the drafting progress of the Business Combination
                                            Agreement and related documents.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            October 16, 2023, Bowen, Qianzhi, Jingsh &amp; HY Leung, Becker &amp; Poliakoff and Frost
                                            &amp; Sullivan held a conference call to discuss the progress of the Business Combination
                                            Agreement and the progress of the audit of Qianzhi&#8217;s financial statements, the CSRC
                                            filing, industry reports and structuring of the transaction.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            October 17, 2023, Bowen and Qianzhi executed a non-binding letter of intent. The material
                                            terms of the non-binding letter of intent included: (i) transaction
                                            consideration based on a total equity value of Qianzhi in the range of $60 and 80 million,
                                            subject to completion of a PCAOB audit of Qianzhi&#8217;s financial statements and other
                                            customary adjustments and earnouts; (ii) all shares to be issued in the transaction would
                                            be subject to the same lock up terms of Bowen&#8217;s Sponsors; (iii) customary non-competition
                                            and non-solicitation provsions to be agreed by executives and significant stockholders of
                                            Qianzhi; (iv) the surviving company would create a new equity incentive plan with award pool
                                            equal to 5% of the combined company&#8217;s outstanding stock immediately after the Closing;
                                            (v) the board of the combined company to be comprised of two independent members nominated
                                            by Bowen and three members by Qianzhi; (vi) Qianzhi to complete the PCAOB audit no later
                                            than November 15, 2023; (vii) unilateral exclusivity for 120 days applied to Qianzhi; and(viii)
                                            PIPE financing for the transaction equal to 5% of the transaction consideration.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            October 19, 2023, Bowen engaged Han Kun Law Offices (&#8220;Han Kun&#8221;) to advise it
                                            on matters of PRC law and to conduct PRC legal due diligence in connection with the proposed
                                            Business Combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            October 23, 2023, during the weekly conference call, both Bowen and Qianzhi noted that US
                                            legal counsels had been engaged in matters related to the business combination and would
                                            be included in future discussions. The discussions also covered due diligence process on
                                            Qianzhi and Qianzhi&#8217;s audit status.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            the same date, Bowen introduced by email Han Kun to Qianzhi and Becker &amp; Poliakoff to
                                            discuss the legal due diligence process in China.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            October 24, 2023, Bowen introduced by email Graubard Miller, Bowen&#8217;s U.S. legal counsel,
                                            to Becker &amp; Poliakoff to help prepare documentation for the proposed Business Combination
                                            and this proxy statement/prospectus.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            October 30, 2023, all parties participated in the weekly conference call, during which all
                                            parties provided progress updates on the drafting status of the Business Combination Agreement
                                            and legal due diligence. During the call, Bowen, Qianzhi and their respective counsels
                                            discussed the transaction structure and key terms and items, including the contemplated plan
                                            of reorganization, valuation, earnouts, the need to engage a qualified independent firm to
                                            render a fairness opinion, the timeline in consideration of completing the necessary financial
                                            statements of both Bowen and Qianzhi, the preparation and timing of submitting the necessary
                                            filings with the CSRC, and the potential PIPE financing.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            November 6, 2023, during the weekly all parties&#8217; conference call, updates were shared
                                            regarding the preparation activities for the proposed Business Combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            November 13, 2023, the weekly all parties&#8217; conference call focused on providing updates
                                            on the progress and timelines concerning Qianzhi&#8217;s overseas structure, the drafting
                                            of the Business Combination Agreement and related disclosure schedules, and the completion
                                            of legal due diligence.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            November 15, 2023, Bowen engaged Newbridge Securities to perform a valuation analysis and
                                            evaluate the fairness of the proposed Business Combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            November 20, 2023, a first draft of the Business Combination Agreement was sent from Graubard
                                            Miller to Becker &amp; Poliakoff, Jingsh &amp; HY Leung, and Han Kun. Subsequently, the parties
                                            exchanged numerous revised versions and modifications of the Business Combination Agreement, including (i) director nominees to serve on the board of the
combined company, (ii) executives to be subject to non-competition agreements, (iii) terms of the earnout consideration and PIPE financing
proposed by Bowen accepted by Qianzhi and (iv) a right on the part of Qianzhi to terminate the Business Combination Agreement if the
CSRC did not approve the transaction.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            the same date, the weekly all parties&#8217; conference call focused on the drafting process
                                            of the Business Combination Agreement and due diligence procedures. The discussion further
                                            covered the valuation analysis and Qianzhi&#8217;s overseas structure, alongside various
                                            ancillary topics.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            November 27, 2023, the weekly all parties&#8217; conference call focused on the status of
                                            the drafting of the Business Combination Agreement alongside various ancillary matters.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            December 5, 2023, the weekly all parties&#8217; conference call focused on advancing the
                                            draft of the Business Combination Agreement and exchanging updates on the audit of Qianzhi&#8217;s
                                            financial statements. Additionally, Bowen requested that Qianzhi prepare an English version
                                            of the investor presentation that could be used in connection with the proposed transaction.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            December 7, 2023, Bowen discussed with Qianzhi; (i) the industry trends; (ii) competitive
                                            landscape; (iii) Qianzhi&#8217;s product categories; (iv) customer bases in each category
                                            and potential risk of loss of clients, especially the possibility of tapering demand of its
                                            sterilization and disinfection products following the end of the Covid-19 pandemic; and (v)
                                            Qianzhi&#8217;s assumptions underlying Qianzhi&#8217;s financial projections. Qianzhi admitted
                                            the potential decline of demand from its customers after the Covid-19 pandemic while remaining
                                            optimistic about its business expansion initiatives, such as bringing new products to the
                                            market, penetrating online market, and developing new marketing channels to offset and surpass
                                            such potential decline in customer demand in the middle and long term. As a result of the foregoing discussion, Qianzhi indicated it would agree to certain performance based targets for
FY2025 and FY2026 which would be based on projected net income for each year.</span></td></tr>

</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            December 11, 2023, the weekly all parties&#8217; conference call focused on the discussion
                                            of the Business Combination Agreement and related ancillary agreements. Bowen also provided
                                            an update on its discussions with Newbridge regarding Qianzhi&#8217;s valuation and the Newbridge
                                            opinion. The parties&#8217; discussions further covered other ancillary matters.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            December 18, 2023, the weekly all parties&#8217; conference call focused on the status of
                                            the Business Combination Agreement and outlined the timeline of various ancillary items,
                                            including legal due diligence, the Newbridge valuation report, Qianzhi&#8217;s overseas restructuring
                                            and the filing with the China Securities Regulatory Commission (&#8220;CSRC&#8221;).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            December 20, 2023, Han Kun sent the draft Legal Due Diligence Key Issues List for Bowen&#8217;s
                                            review.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    December 20, 2023, Qianzhi, its shareholders, Shenzhen Shian, and Home Universe, an unaffiliated third party, entered into a Supplementary Agreement to the Capital
    Increase Agreement with Home Universe, which was originally entered into on July 13, 2023. The Capital Increase Agreement provided for
Home Universe to acquire 1.96% of Qianzhi&#8217;s equity interests in consideration of a capital investment. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
had previously passed a resolution at a shareholders&#8217; meeting and agreed to increase its registered capital by RMB 2.412 million
to allow for this investment by Home Universe. However, </span> Home Universe was unable to contribute the capital increase amount of RMB 2.412 million on time, nor was it
    successful in introducing any third-party investor for Qianzhi before October 31, 2023. Accordingly, all parties agreed that Home
    Universe shall transfer the 1.96% of equity interest of Qianzhi it held to Shenzhen Shian and Shenzhen Shian will fulfil the registered
    capital contribution obligation. On the same day, Qianzhi passed a resolution at the shareholders&#8217; meeting and all shareholders
    agreed to transfer their equity interests held in Qianzhi to Shenzhen Shian. Shenzhen Shian then entered into an Equity Transfer
    Agreement with Home Universe and Qianzhi&#8217;s shareholders and acquired 100% of the equity interests of Qianzhi. On the same day,
    Shenzhen Shian executed amended Articles of Association of Qianzhi. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    December 27, 2023, the Shenzhen Market Supervision Administration approved Qianzhi&#8217;s business change registration and the reorganization
    of Qianzhi&#8217;s legal structure was completed. As described in greater detail earlier under <i>&#8220;SUMMARY OF THE PROXY STATEMENT/PROSPECTUS
    - Parties to the Business Combination - Organizational Structure of NewCo and Qianzhi&#8221; </i>on page 22, of this proxy statement/prospectus,
    the reorganization involved the incorporation of NewCo, Qianzhi BVI, Qianzhi HK and Shenzhen Shian, and the transfer of 100% of the
    equity interests of Qianzhi to Shenzhen Shian.&#160;&#160;This reorganization resulted in NewCo, through its directly-owned subsidiaries,
    becoming the ultimate holding company of Qianzhi and its affiliated operating companies.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            December 21, 2023, Han Kun updated and sent the final Legal Due Diligence Key Issues List.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            December 22, 2023, Bowen and Han Kun held a telephonic conference call to discuss the Legal
                                            Due Diligence Key Issues List.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            December 25, 2023, Bowen proposed an equity valuation of $75 million based on updated financial
                                            statements reviewed by Qianzhi&#8217;s auditors and also updated valuation multiples of the
                                            Household Good Chemical industry.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            December 29, 2023, Qianzhi, through its US legal counsel, agreed to the proposed $75 million
                                            equity valuation.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 1, 2024, the weekly all parties&#8217; conference call focused on discussions regarding
                                            the Business Combination Agreement and disclosure schedules. Jingsh &amp; HY Leung
                                            also indicated that Qianzi&#8217;s restructuring process had not yet been fully completed,
                                            prompting a discussion among all parties on the need to expedite the timelines. Additionally,
                                            the conversations addressed the planned timeline for signing the Business Combination Agreement
                                            and other related transaction documents.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 5, 2024, the Bowen Board, other than Ms. Wei Li, met by conference call to discuss
                                            the Business Combination Agreement, with Bowen management and Newbridge Securities participating.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 10, 2024, Bowen, Qianzhi, and their respective counsel held a conference call to
                                            address all remaining issues regarding the Business Combination Agreement.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 18, 2024, the Bowen Board, other than Ms. Wei Li, met by conference call to discuss
                                            and evaluate the proposed transaction, with Bowen management and Newbridge Securities participating.
                                            Newbridge Securities presented the final fairness opinion and explained the factors underlying
                                            its conclusion that the proposed Merger Consideration, was fair, from a financial point of
                                            view, to the Bowen shareholders. Thereafter, the Bowen Board unanimously approved the proposed
                                            Business Combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            the same date, the Business Combination Agreement and other related transaction agreements
                                            were signed. In addition, on January 18, 2024, Bowen and Qianzhi issued a press release announcing
                                            the signing of the Business Combination Agreement. Thereafter, on January 24, 2024, Bowen
                                            filed a Current Report on Form 8-K announcing the execution of the Business Combination Agreement
                                            and disclosing the material terms of the Business Combination Agreement, and the agreements
                                            ancillary thereto, in detail.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommendation
of the Bowen Board and Reasons for the Business Combination</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Board, in evaluating the Business Combination, consulted with Bowen&#8217;s management team and its financial and legal advisors.
In reaching its resolution (a) that the Business Combination Agreement and the transactions contemplated thereby, including the Business
Combination, are advisable and in the best interests of Bowen and its shareholders and (b) to recommend that the Bowen shareholders adopt
the Business Combination Agreement and the transactions contemplated thereby, including the Business Combination, the Bowen Board (i)
consulted with Bowen&#8217;s legal and financial advisors in connection with its evaluation of the Business Combination Agreement and
the Business Combination, (ii) reviewed the results of due diligence conducted by Bowen&#8217;s management team, together with its legal
and financial advisors and (iii) considered a range of factors, including, but not limited to, the factors discussed below. In light
of the number and wide variety of factors considered in connection with its evaluation of the Business Combination, the Bowen Board did
not consider it practicable to, and did not attempt to, quantify or otherwise assign relative weights to the specific factors that it
considered in reaching its determination and supporting its decision. The Bowen Board viewed its decision as being based on all of the
information available and the factors presented to and considered by it. In addition, individual directors may have given different weight
to different factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
approving the Business Combination, the Bowen Board determined to obtain a fairness opinion. In addition, the officers and directors
of Bowen have substantial experience with mergers and acquisitions and in evaluating the operating and financial merits of companies
from a wide range of industries and concluded that their experience and background, together with experience and sector expertise of
Bowen&#8217;s advisors, enabled them to make the necessary analyses and determinations regarding the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Board considered a number of factors pertaining to the Business Combination as generally supporting its decision to enter into
the Business Combination Agreement and the transactions contemplated thereby, including, but not limited to, the following material factors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expanding
                                            Growth Industry</i>. Qianzhi is a health and wellness focused biotech company and an early
                                            adopter and developer of plant-based and ozonated products for antibacterial, skincare, gynecological
                                            and andrological applications. Based on the due diligence performed by the Bowen Board and
                                            its advisors on Qianzhi and its industry, including an assessment of mergers and acquisitions
                                            activity for companies in the industry in which Qianzhi operates, the Bowen Board believes
                                            Qianzhi represents an attractive opportunity for Bowen and its shareholders;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reasonableness
                                            of the aggregate consideration to be paid to Qianzhi&#8217;s shareholders under the Business
                                            Combination Agreement.</i> Following a review of the financial data provided to Bowen, including
                                            certain audited and unaudited financial information and models regarding Qianzhi (including,
                                            where applicable, the assumptions underlying such unaudited financial information and models)
                                            and Bowen&#8217;s due diligence review of Qianzhi&#8217;s business, the Bowen Board determined
                                            that the consideration to be paid to the Qianzhi shareholders was reasonable in light of
                                            such data and financial information;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Due
                                            Diligence</i>. The Bowen Board reviewed and discussed in detail the results of the due diligence
                                            examination of Qianzhi conducted by Bowen&#8217;s management team and Bowen&#8217;s financial,
                                            legal and regulatory advisors, including extensive telephonic and in-person meetings with
                                            the management team and advisors of Qianzhi regarding Qianzhi&#8217;s business plan, operations,
                                            prospects and forecasts including historical growth trends and market share information as
                                            well as end-market size and growth projection, evaluation analyses with respect to the Business
                                            Combination, review of material contracts, Qianzhi&#8217;s audited and unaudited financial
                                            statements and other material matters as well as general financial, technical, legal, intellectual
                                            property, regulatory, tax and accounting due diligence;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
                                            Condition</i>. The Bowen Board also considered factors such as Qianzhi&#8217;s historical
                                            financial results, outlook, financial plan, and debt structure. In considering these factors,
                                            the Bowen Board reviewed Qianzhi&#8217;s historical growth and its current prospects for
                                            growth if Qianzhi achieves its business plan and various historical and current balance sheet
                                            items of Qianzhi;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Experienced
                                            Management</i>. Qianzhi has a strong management team with significant operating experience.
                                            The senior management of Qianzhi intends to remain with Qianzhi in the capacity of officers
                                            and/or directors, and the Bowen Board believes that the retention of such members of senior
                                            management will provide helpful continuity in advancing Qianzhi&#8217;s strategic and growth
                                            goals;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 132; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
                                            Alternatives</i>. The Bowen Board believes, after a thorough review of other business combination
                                            opportunities reasonably available to Bowen, that the proposed Business Combination represents
                                            the best potential business combination for Bowen and the most attractive opportunity based
                                            upon the process utilized to evaluate and assess other potential acquisition targets;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Negotiated
                                            Transaction</i>. The Bowen Board considered the terms and conditions of the Transaction Agreements
                                            and the transactions contemplated thereby, each party&#8217;s representations, warranties
                                            and covenants, the conditions to each party&#8217;s obligation to consummate the Business
                                            Combination and the termination provisions, as well as the strong commitment by both Bowen
                                            and Qianzhi to complete the Business Combination; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fairness
                                            Opinion</i>. The Bowen Board considered Newbridge Securities&#8217; fairness opinion, in
                                            which Newbridge Securities opined that the Business Combination is &#8220;fair&#8221; to
                                            the shareholders of Bowen from a financial perspective.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Board also considered a variety of uncertainties and risks and other potentially negative factors concerning the Business Combination
including, but not limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Business
                                            Plan May Not Be Achieved</i>. The risk that Qianzhi may not be able to execute on its business
                                            plan;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
                                            Risk</i>. The potential that a significant number of Public Shareholders elect to redeem
                                            their Public Shares prior to the consummation of the Business Combination and pursuant to
                                            the Existing Charter, which would potentially make the Business Combination more difficult
                                            to complete. However, even in the event that a significant number of Public Shareholders
                                            elect to redeem their shares, this redemption would not prevent the consummation of the Business
                                            Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Regulatory
                                            Affairs</i>. The Bowen Board considered the impact of the review of the Business Combination
                                            by various regulatory agencies, including those in the PRC;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Closing
                                            Conditions</i>. The potential risks and costs associated with the Business Combination failing
                                            to be consummated in a timely manner or that Closing might not occur despite the reasonable
                                            best efforts of the parties. The completion of the Business Combination is conditioned on
                                            the satisfaction of certain Closing conditions that are not within Bowen&#8217;s control,
                                            including the receipt of certain required regulatory approvals;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Litigation
                                            Related to the Business Combination</i>. The possibility of litigation challenging the Business
                                            Combination or that an adverse judgment granting permanent injunctive relief could indefinitely
                                            enjoin consummation of the Business Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Listing
                                            Risks</i>. The challenges associated with preparing Qianzhi for the applicable disclosure
                                            and listing requirements to which Qianzhi will be subject as a publicly traded company in
                                            the United States;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Benefits
                                            May Not Be Achieved</i>. The risks that the potential benefits of the Business Combination
                                            may not be fully achieved or may not be achieved within the expected timeframe;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Market
                                            Volatility.</i> The possibility that the market for Bowen Ordinary Shares experiences volatility
                                            and disruptions, causing deal disruption;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation
                                            of Bowen</i>. The risks and costs to Bowen if the Business Combination is not completed,
                                            including the risk of diverting management focus and resources from other business combination
                                            opportunities, which could result in Bowen being unable to effect a business combination
                                            within the required time period;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
                                            and Independent Committees</i>. The risk that, assuming approval of the Director Election
                                            Proposal, the New Bowen Board and independent committees thereof do not possess adequate
                                            skill set within the context of Qianzhi operating as a public company;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interests
                                            of Certain Persons.</i> The Sponsors and Bowen&#8217;s officers and directors have interests
                                            in the Business Combination that are different from or in addition to (and which may conflict
                                            with) the interests of the Public Shareholders (see &#8220;<i>&#8212; Interests of Certain
                                            Persons in the Business Combination</i>&#8221;);</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fees
                                            and Expenses</i>. The fees and expenses associated with completing the Business Combination;
                                            and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
                                            Risk Factors</i>. Various other risk factors associated with the business of Qianzhi, as
                                            described in the section entitled &#8220;<i>Risk Factors</i>&#8221; appearing elsewhere in
                                            this proxy statement/prospectus.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 133; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Board concluded, in its business judgment, that the potential benefits that it expects Bowen and its shareholders to achieve as
a result of the Business Combination outweigh the potentially negative and other factors associated with the Business Combination. Accordingly,
the Bowen Board determined that the Business Combination and the transactions contemplated by the Business Combination Agreement (including
the Merger) are fair and advisable to, and in the best interests of, Bowen and its shareholders. The independent directors on the
Bowen Board did not retain an unaffiliated representative to act solely on behalf of unaffiliated security holders for purposes of negotiating
the terms of the Business Combination and/or preparing a report concerning the approval of the Business Combination. The above discussion
of the material factors considered by the Bowen Board is not intended to be exhaustive but does set forth the principal factors considered
by the Bowen Board. This explanation of Bowen&#8217;s reasons for the Business Combination and all other information presented in this
section is forward-looking in nature and, therefore, should be read in light of the factors discussed under &#8220;<i>Cautionary Note
Regarding Forward-Looking Statements</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
of Newbridge Securities, Fairness Opinion Provider</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
retained Newbridge to act as its financial advisor in connection with the Business Combination. Newbridge, as part of its investment
banking business, is continually engaged in the valuation of businesses and their securities in connection with mergers and acquisitions,
negotiated underwritings, secondary distributions of listed and unlisted securities, private placements and valuations for estate, corporate
and other purposes. Bowen selected Newbridge to act as its financial advisor in connection with the Business Combination on the basis
of Newbridge&#8217;s experience in similar transactions and its reputation in the investment community.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 18, 2024, at a meeting of the Bowen board held to evaluate the Business Combination, Newbridge delivered to the Bowen board an
oral opinion, which was confirmed by delivery of a written opinion, dated January 18, 2024, to the effect that, as of the date of the
opinion and based on and subject to various assumptions and limitations described in its written opinion, the Merger Consideration to
be paid to the stockholders of Qianzhi, is fair, from a financial point of view, to Bowen&#8217;s shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of Newbridge&#8217;s written opinion to the Bowen board, which describes, among other things, the assumptions made, procedures
followed, factors considered and limitations on the review undertaken, is attached as <i><span style="text-decoration: underline">Annex C</span></i> hereto and is incorporated
by reference herein in its entirety. The following summary of Newbridge&#8217;s opinion is qualified in its entirety by reference to
the full text of the opinion. Newbridge delivered its opinion to the Bowen board for the benefit and use of the Bowen board (in its capacity
as such) in connection with and for the purposes of its evaluation of the Business Combination from a financial point of view. Newbridge&#8217;s
opinion also does not address the relative merits of the Business Combination as compared to any alternative business strategies or transactions
that might exist for Bowen, or the underlying business decision of Bowen whether to proceed with those business strategies or transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with rendering its opinion, Newbridge, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">considered
    its assessment of general economic, market and financial conditions as well as its experience in connection with similar transactions,
    and business and securities valuations generally;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewed
    a draft of the Business Combination Agreement, dated January 18, 2024;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewed
    Bowen&#8217;s publicly available historical financial results, as well as certain publicly available information concerning the trading
    of, and the trading market for, the Bowen Ordinary Shares since its IPO;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewed
    publicly available financial information of Bowen filed with the U.S. Securities &amp; Exchange Commission, including its Form 10-Qs
    and certain reports on material events filed on Forms 8-K between July 14, 2023, and January 18, 2024;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">conducted
    discussions with Qianzhi&#8217;s management team to better understand Qianzhi&#8217;s recent business history, and near-term financials;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewed
    a financial model of Qianzhi with historical and future financial projections (including potential revenue growth, net income and
    net income margins) provided by Qianzhi&#8217;s management team;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">performed
    a public company comparable analysis of similar companies to Qianzhi that trade on senior U.S. stock exchanges (NYSE American / NASDAQ
    / NYSE), and operate in the &#8220;Household Goods Chemicals&#8221; sector, to derive certain forward Price-to-Earnings (P/E) multiples;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">performed
    an M&amp;A transaction comparable analysis of similar companies to Qianzhi that operate in the &#8220;Household Goods Chemicals&#8221;
    sector, to derive certain enterprise value / net income multiples.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In conducting its review and
arriving at its opinion, Newbridge did not independently verify any of the foregoing information and Newbridge assumed and relied upon
such information being accurate and complete in all material respects, and Newbridge further relied upon the assurances of management
of Bowen that they are not aware of any facts that would make any of the information reviewed by Newbridge inaccurate, incomplete or
misleading in any material respect. In addition, Newbridge has not assumed any responsibility for any independent valuation or appraisal
of the assets or liabilities, including any ongoing litigation and administrative investigations, if any, of Qianzhi, nor has Newbridge
been furnished with any such valuation or appraisal. In addition, Newbridge has not assumed any obligation to conduct, nor has it conducted,
any physical inspection of the properties or facilities of Qianzhi.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 134; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of Newbridge&#8217;s opinion was approved by an authorized internal committee of Newbridge. Newbridge&#8217;s opinion is necessarily
based on economic, market and other conditions as they exist and can be evaluated on, and the information made available to it on, the
date thereof. Newbridge expressed no opinion as to the underlying valuation, future performance or long-term viability of Bowen and its
successors. Further, Newbridge expressed no opinion as to what the value of the Bowen Ordinary Shares actually will be when the Business
Combination is consummated or the prices at which Bowen Ordinary Shares will trade at any time. It should be understood that, although
subsequent developments may affect Newbridge&#8217;s opinion, Newbridge does not have any obligation to update, revise or reaffirm its
opinion and has expressly disclaimed any responsibility to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following represents a brief summary of the material financial analyses reviewed by the Bowen board and performed by Newbridge in connection
with its opinion. The financial analyses summarized below include information presented in tabular format. In order to fully understand
the financial analyses performed by Newbridge, the tables must be read together with the text of each summary. The tables alone do not
constitute a complete description of the financial analyses performed by Newbridge. Considering the data set forth in the tables below
without considering the full narrative description of the financial analyses, including the methodologies and assumptions underlying
the analyses, could create a misleading or incomplete view of the financial analyses performed by Newbridge.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Financial
Analyses.</span> Newbridge employed two methods to analyze the range of values of Qianzhi &#8211; a comparable public company
analysis and a comparable precedent M&amp;A transaction analysis. Newbridge did not exclude any companies or transactions that it believed
met the respective selection criteria described below for each analysis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Comparable
Public Company Analysis</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
calculate the implied equity value of the operating business, Newbridge first obtained the average 2023 and 2024E Price-to-Earnings
multiples from a total of seven (7) comparable public companies identified by Newbridge that most resembled Qianzhi&#8217;s
business, and applied to the midpoint of Qianzhi&#8217;s 2023 and 2024E Net Income. The public company comparables were selected
using the following criteria: (i) listed on a major Stock Exchange in the United States, (ii) in the &#8220;Household Goods
Chemicals&#8221; sector, and (iii) had forecasted Earnings-per-Share data for 2024. In determining which companies were
appropriate for the comparable public company analysis, Newbridge sought to include companies that had similar characteristics as
Qianzhi, primarily similar business models. Accordingly, the public comparable dataset presented have a similar business model, in
that they sell household goods chemicals for the purposes of cleaning or cosmetics and trade on a major US exchange (the NYSE).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market capitalizations of the public comparable dataset chosen by Newbridge (which ranged from a low of $10.7 billion to a high
of $353.4 billion) was significantly higher than the Merger Consideration being paid to Qianzhi of $75 million. The public companies
in the dataset also had a much more extensive history of operations, and significantly higher 2023 revenues (of between a low of $5.5
billion to a high of $81.5 billion) than that of Quanzhi, which had revenues for 2023 of $10.1 million. While the history of operations,
size of the market capitalization, and sales of the public companies in the dataset are all much higher than that of Quanzhi, Newbridge
concluded that the companies chosen had several key characteristics in common with Quanzhi that made them appropriate
public companies to compare Qianzhi to, including that they had a U.S. national securities exchange listing, had a similar business model,
and the fact that there were no other similar companies with smaller equity values and sales to compare Qianzhi to.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
average of the 2023 (25.5x) and 2024E (23.4x) P/E multiples was 24.4x and was then multiplied by the midpoint of the 2023 ($3.6M) and
2024E ($4.4M) Net Income of Qianzhi of $4.0M, to derive an Enterprise Value of $97.1M. The Net Debt (of +$4.9M) was added to the Enterprise
Value to obtain an Implied Equity Value using this analysis of $101.8M.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below summarizes certain observed historical and projected financial performance and trading multiples of the selected public companies
were sourced from S&amp;P Capital IQ data as of January 17, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Household
    Goods Chemicals</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/17/2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    Sheet</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
    Statement</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    Multiples</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enterprise</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P/E</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P/E</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Name</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Symbol</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Value</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023E</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024E</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023E</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024E</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Procter &amp; Gamble Company</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NYSE:PG</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">149.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">353,391.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">379,621.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colgate-Palmolive
    Company</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NYSE:CL</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,660.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,426.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Est&#233;e Lauder Companies Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NYSE:EL</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">126.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,188.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,431.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kimberly-Clark
    Corporation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NYSE:KMB</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,674.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,957.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Church
    &amp; Dwight Co., Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NYSE:CHD</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,317.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,579.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Clorox Company</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NYSE:CLX</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">144.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,885.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,824.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coty
    Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NYSE:COTY</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,753.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,741.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
    in millions, except per share data)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MEDIAN</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 135; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Comparable
Precedent M&amp;A Transaction Analysis</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Newbridge
analyzed the last three years (since January 2021) of M&amp;A transaction data to find similar transactions where the targets being acquired
most resembled Qianzhi. The universe of transactions where there were similarities to Qianzhi, and where financial data was recorded
for the transaction value was generally limited, as is usually the case versus Public Comparables. The criteria used for the selected
transactions were those in which the targets most resembled Qianzhi, and included (i) targets with business models in the &#8220;Household
Goods Chemicals&#8221; sector, (ii) transactions that occurred with companies&#8217; headquarters in the United States, Latin American,
Europe or Asia/Pacific, and (iii) where the identified the Enterprise Value /Net Income multiple was known.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
average transaction value of the transactions chosen for the M&amp;A Transaction dataset (which ranged from a low of $9.2 million
to a high of $4.7 billion, and had an average of approximately $1.1 billion) was significantly higher than the Merger Consideration being
paid to Qianzhi of $75 million. However, Newbridge concluded that the transactions chosen had several key characteristics
in common with Quanzhi that made them the right transaction set to use, including that they had a similar business model, and the absence
of other similar companies with smaller transaction values.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
M&amp;A dataset for the Household Goods Chemicals sector in that time frame had an average Enterprise Value / Net Income multiple of
20.4x and then multiplied by the midpoint of the 2023 and 2024E Net Income of Qianzhi of $4.0M, to derive an Enterprise Value of $81.1M.
The Net Debt (of +$4.9M) was added to the Enterprise Value to obtain an Implied Equity Value using this analysis of $85.8M.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below summarizes the Comparable Precedent M&amp;A Transaction data set, and was sourced from S&amp;P Capital IQ data as of January
17, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="8" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: normal 10pt Times New Roman, Times, Serif">M&amp;A
    Comparables Analysis (2021 - Present) |Household Goods Chemicals</span></td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">M&amp;A
    Closed Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Headquarters</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Target/Issuer</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
    Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enterprise
    Value / Net Income</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyers/Investors</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/11/2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asia/Pacific</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PSC
    Corporation Ltd. (SGX:DM0)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/09/2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Europe</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chrisal
    NV</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HeiQ
    Plc (LSE:HEIQ)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/31/2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Latin
    America</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Productos
    Familia S.A.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">706.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Essity
    AB (publ) (OM:ESSITY B)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/08/2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asia/Pacific</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PT
    Victoria Care Indonesia Tbk (IDX:VICI)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KV
    Asia Capital Pte. Ltd.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/10/2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asia/Pacific</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Essity
    AustralAsia</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">511.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Essity
    Group Holding BV</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/05/2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diversey
    Holdings, Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,721.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solenis
    LLC</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/19/2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asia/Pacific</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lifestyle
    International Holdings Limited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">240.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/01/2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Europe</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HEMA
    B.V.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,431.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mississippi
    Ventures</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Newbridge
always tries to include at least two valuation methodologies in its fairness opinions and never relies on just one methodology. Although many of the transactions identified involved companies significantly larger than Qianzhi, Newbridge believes the M&amp;A
transaction analysis is a helpful methodology to build out another valuation datapoint. However, this methodology has certain
limitations (in comparison to the public comparables analysis), such as having to exclude certain transactions that might otherwise
be relevant because they did not include the EV/Net Income data, and therefore cannot be used in this analysis. Additionally,
because this methodology analyzes transactions over a 2-3 year period historically, this often spans different market conditions,
whereas the public comparables analysis examines companies using real-time public market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Miscellaneous</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion set forth above is a summary of the material financial analyses presented by Newbridge to the Bowen board in connection with
its opinion and is not a comprehensive description of all analyses undertaken by Newbridge in connection with its opinion. The preparation
of a financial opinion is a complex analytical process involving various determinations as to the most appropriate and relevant methods
of financial analysis and the application of those methods to the particular circumstances and, therefore, a financial opinion is not
readily susceptible to partial analysis or summary description. Newbridge believes that its analyses summarized above must be considered
as a whole. Newbridge further believes that selecting portions of its analyses and the factors considered, or focusing on information
presented in tabular format, without considering all analyses and factors or the narrative description of the analyses, could create
a misleading or incomplete view of the processes underlying Newbridge&#8217;s analyses and opinion. The fact that any specific analysis
has been referred to in the summary above is not meant to indicate that such analysis was given greater weight than any other analysis
referred to in the summary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
performing its analyses, Newbridge considered industry performance, general business and economic conditions and other matters, many
of which are beyond the control of Bowen. The estimates of the future performance of Bowen in or underlying Newbridge&#8217;s analyses
are not necessarily indicative of actual values or actual future results, which may be significantly more or less favorable than those
estimates or those suggested by Newbridge&#8217;s analyses. The analyses do not purport to be appraisals or to reflect the prices at
which a company might actually be sold or the prices at which any securities have traded or may trade at any time in the future. Accordingly,
the estimates used in, and the ranges of valuations resulting from, any particular analysis described above are inherently subject to
substantial uncertainty and should not be taken to be Newbridge&#8217;s view of the actual values of the Bowen Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 136; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Conclusion</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
values derived from the different analyses that Newbridge used show a range between $85.8M to $101.8M. The Merger Consideration to be
paid by Bowen of $75.0M is below the midpoint of the valuation ranges of the financial analyses described above. In coming to this
conclusion, Newbridge did not take into account any earnout consideration that might be paid by Bowen in the Business Combination. Because
the earnout consideration was &#8220;conditional&#8221; based upon metrics that have not yet been achieved, and may never be achieved,
Newbridge does not believe it is appropriate to consider such conditional consideration in arriving at the valuation of Qianzhi.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on its analysis, it is Newbridge&#8217;s opinion that, (i) the Merger Consideration is fair, from a financial point of view, to Bowen
and Bowen&#8217;s shareholders and (ii) Qianzhi has an aggregate fair market value equal to at least 80% of the net assets held
in the Trust Account (excluding deferred underwriting fees and taxes payable on the income earned on the Trust Account).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
type and amount of consideration payable in the Business Combination was determined through negotiations between Bowen and Qianzhi, and
was approved by the Bowen board. The decision to enter into the Business Combination Agreement was solely that of the Bowen board. As
described above, Newbridge&#8217;s opinion and analyses was only one of many factors considered by the Bowen board in its evaluation
of the Business Combination and should not be viewed as determinative of the views of Bowen or Qianzhi&#8217;s management with respect
to the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fees
and Expenses</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
compensation for Newbridge&#8217;s services in connection with the rendering of its Opinion to the Bowen board, Bowen agreed to pay Newbridge
a fee of $150,000. $50,000 of the fee was paid as a retainer, $50,000 was paid upon delivery of the Opinion, and the remaining $50,000
is payable upon consummation of the Business Combination. No portion of Newbridge&#8217;s fee is refundable or contingent upon the conclusion
reached in the Opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unaudited Prospective Financial Information of Qianzhi</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of evaluating Qianzhi&#8217;s financial condition and whether to proceed with the Business Combination, Bowen was provided with
documents from Qianzhi, including projections for the fiscal years ending March 31, 2024 through March 31, 2028, copies of material
contracts, and summaries of various industry analysis and trends. Additionally, the Bowen Board reviewed and discussed with its financial
advisor its analysis in rendering the fairness opinion described in the proxy statement/prospectus. In rendering its opinion on the fairness
of the transaction, Bowen&#8217;s financial advisor, Newbridge Securities, reviewed the financial projections provided by Qianzhi.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
Bowen nor Qianzhi as a matter of course makes public projections as to future sales, earnings, or other results. However, Qianzhi management
prepared the prospective financial information set forth below (the &#8220;<span style="font-weight: normal"><i>Qianzhi Management Projections</i></span>&#8221;)
to present to the Bowen Board in connection with its consideration of the potential Business Combination. <span style="background-color: white">As
discussed in greater detail herein, the financial projections prepared by Qianzhi are based, in part, on assumptions regarding its ability
to growth into new customer bases and derive revenues from new product applications. Accordingly, such projections may be of limited,
if any, usefulness to investors, in evaluating the Business Combination and</span> shareholders are strongly cautioned not to place undue
reliance, if any, on the Qianzhi Management Projections and not to rely on such projections in making any decision regarding the Business
Combination<span style="background-color: white">. However, Bowen is including these financial projections in this proxy statement/prospectus
as such projections were considered by Bowen&#8217;s Board in approving the Business Combination and recommending it to its shareholders
and its financial advisor, based its fairness opinion, in part, upon such information.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
management prepared such financial information based on their judgment and assumptions regarding the future financial performance of
Qianzhi. Bowen is including the Qianzhi Management Projections solely because that information was made available to the Bowen Board
and financial advisor in connection with the evaluation of the Business Combination. The Qianzhi Management Projections are being provided
for information purposes only and are not and should not be viewed as public guidance regarding the future performance of Qianzhi. The
inclusion of the below information should not be regarded as an indication that Bowen, Qianzhi, their respective boards of directors,
or their respective affiliates, advisors or other representatives consider such financial projections to be necessarily predictive of
actual future results. Furthermore, the Qianzhi Management Projections do not take into account any circumstances or events occurring
after the date they were prepared. You should review the financial statements of Qianzhi included in this proxy statement/prospectus,
as well as the financial information in this proxy statement/prospectus and to not rely on any single financial measure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Qianzhi Management Projections are not fact and should not be relied upon as being necessarily indicative of future results. Due to inherent
uncertainties in financial projections of any kind, shareholders are strongly cautioned not to place undue reliance, if any, on the projections
and not to rely on the Qianzhi Management Projections in making any decision regarding the Business Combination. There undoubtedly will
be differences between actual and projected results, and the differences may be material. The Qianzhi Management Projections cover
a period of five fiscal years and the risk that these uncertainties and contingencies could cause the assumptions to fail to be reflective
of actual results is further increased by the length of time over which these assumptions apply. The failure to achieve assumptions and
projections in early periods could have a compounding effect on the projections shown for the later periods. Thus, any such failure of
an assumption or projection to be reflective of actual results in an early period could have a greater effect on the projected results
failing to be reflective of actual events in later periods. The Qianzhi Management Projections cover a period of five fiscal years
ending with March 31, 2028 and were based on sales data from the fiscal years ended March 31, 2022 and 2023, its future business direction,
product outlook and development of new sales channels and customers. The Qianzhi Management Projections are subject to the inherent uncertainties
and limitations that can affect long-term projected financial results, and particularly, for Qianzhi, whether it can achieve its anticipated
number of new sales channels and new customers. Accordingly, the usefulness of the Qianzhi Management Projections is limited and shareholders
are strongly cautioned not to place undue reliance, if any, on the Qianzhi Management Projections, and not to rely on these projections
in making any decision regarding the Business Combination<span style="background-color: white">.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to Qianzhi&#8217;s fiscal 2024 operating results falling short of the forecast, Qianzhi attributes this to two main factors. Qianzhi
believes that the primary reason was the decreased demand for its hypochlorous acid disinfectant products due to the lifting of pandemic
controls in China. In the 2023 fiscal year, the total sales of disinfectant amounted to $1,658,800, whereas in the 2024 fiscal year,
it was $248,700, a decrease of $1,400,100 or 85%. In addition, Qianzhi believes that the post-pandemic slowdown experienced in the Chinese
economy adversely impacted the purchasing power of its customers and reduced overall product demand for its ozone sterilization and cosmetic
products. As many of Qianzhi&#8217;s sales staff spent a considerable amount of time working remotely, Qianzhi relied mainly on existing
customers without being able to develop new sales channels or customers. Consequently, its core ozone sterilization products, experienced
a decrease in total sales from $5,570,600 in the 2023 fiscal year to $3,694,900 in the 2024 fiscal year, a reduction of $1,875,800 or
33.7%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi,
however, believes that the period from fiscal 2025 through 2028 remains in line with the projections and that the growth rate
implied by the projected revenues will be achieved through its ability to introduce new products, expand into new sales
channels and develop additional product application scenarios. For instance, Qianzhi is currently planning to introduce
three (3) new products to the market during 2025. These new products are ozone-based pastes with anti-bacterial properties and have
been developed based on Qianzhi&#8217;s proprietary rights using traditional Chinese medical ingredients (Cnidii Fructus extract and
Sophorae Flavescentis Radix extract) that seek to alleviate certain chronic diseases, such as arthritis and skin
inflammation.&#160;Each of these products have been tested by third-party product testing companies and Qianzhi has made the
appropriate regulatory filings with the relevant government authorities. In addition, Qianzhi is developing marketing and sales
channels for its existing and new products in order to maximize the revenues that such products may generate and as described below
in greater detail, has entered into cooperation agreements with five customers in order to begin exploiting the commercial
potential of these products. Accordingly, Qianzhi&#8217;s financial forecasts assume additional revenues from these new
products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In addition, <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi&#8217;s
core products, the ozone sterilization products and hypochlorous acid disinfectant series, have mainly been sold to beauty salons and
individual households for home disinfection. However, Qianzhi believes that it will be able to expand its sales channels by seeking to
market the functional attributes of its products for additional industry applications. As an example, Qianzhi believes that hypochlorous
acid disinfectants may also be able to be used for washing produce, pet disinfection, sterilization in aquatic and livestock product
factories, and disinfection in kitchens, restaurants, agriculture, forestry, animal husbandry, fishing, laboratories, pharmaceutical
factories, nursing homes, hospitals, schools, kindergartens, hotels, and other environments. Qianzhi believes that the benefits of its
products are significant and that there is a significant market space for growth and for it to achieve the projected operating results
for the fiscal 2025 &#8211; 2028 periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
exploit this growth potential, Qianzhi intends to implement a multi-pronged marketing approach, including: serving its existing
customer base; conducting full-scale marketing through e-commerce and live streaming platforms; forming chain service agencies,
providing products, technology, and service guidance at communities nationwide; and establishing an agency model to connect products
and services with various institutional settings such as hospitals, health care and medical facilities, schools, hotels, elder-care
facilities, and elderly health service platforms. Consistent with these efforts, Qianzhi has recently entered into product
purchase agreements and cooperation agreements for its products. For its ozone-based antibacterial, personal care, and disinfectant
products, Qianzhi has entered into purchase agreements with three customers, including a supply chain management company, a hospital
and a kindergarten. Under each of these agreements, the customers will issue purchase orders for the products at agreed upon price
and quantity terms. Additionally, to enhance its market reach for its disinfectant products, including its new products described
earlier, Qianzhi has established cooperation relationship with five companies, including a dental clinic, a child day-care center, a
trading company and two hotels. These agreements, which have an initial two-year term, provide that the parties shall develop
strategic relationships pursuant to which Qianzhi&#8217;s customers will commit to procuring its products. As a result, Qianzhi anticipates these agreements will lead to future sales for the company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
is continuing to actively pursue negotiations with additional potential sales and marketing partners to further exploit these new
product applications and sales channels. However, the economic and business factors that resulted in Qianzhi not achieving its
forecasted results for its 2024 fiscal year may persist longer than anticipated and may continue to adversely impact Qianzhi&#8217;s
ability to increase its revenues and improve its financial performance. Accordingly, Qianzhi&#8217;s actual results may continue to
be materially different than its projections and shareholders are strongly cautioned not to place undue reliance, if any, on the
Qianzhi Management Projections, and not to rely on these projections in making any decision regarding the Business Combination<span style="background-color: white">.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 137; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
presented in this proxy statement/prospectus with numeric specificity, the Qianzhi Management Projections are forward-looking statements
that are inherently subject to significant uncertainties, reflect numerous estimates and assumptions with respect to general business,
economic, industry, regulatory, market and financial conditions and trends and other future events, as well as matters specific to Qianzhi&#8217;s
business, all of which are difficult to predict and many of which are beyond Qianzhi&#8217;s control. The various risks and uncertainties
include risks set forth in the sections entitled &#8220;<i>Risk Factors</i>,&#8221; &#8220;<i>Qianzhi Management&#8217;s Discussion and
Analysis of Financial Condition and Results of Operations</i>&#8221; and &#8220;<i>Forward-Looking Statements</i>.&#8221; As a result,
there can be no assurance that the projected results will be realized or that actual results will not be significantly higher or lower
than projected. Further, the inclusion of financial projections in this proxy statement should not be regarded as an indication that
Qianzhi, Bowen, their respective boards of directors, or their respective affiliates, advisors or other representatives considered, or
now consider, such financial projections necessarily to be predictive of actual future results or to support or fail to support your
decision whether to vote for or against the Business Combination. You are cautioned that the projections solely represent Qianzhi&#8217;s
best efforts in predicting future operating results and must be considered in that light. As a result, in making a decision regarding
the Business Combination, please understand that the projections may be materially different than actual results. These Qianzhi Management
Projections are subjective in many respects and thus are susceptible to multiple interpretations and periodic revisions based on actual
experience and business developments. Qianzhi believes the assumptions in the prospective financial information were reasonable at the
time the financial information was prepared, given the information Qianzhi had at the time. However, with the passage of time, additional
events may transpire which could affect the reasonableness of the basis of the projections. Although Qianzhi did not achieve
the projected financial results for its fiscal year ended March 31, 2024, as of the date of this proxy statement/prospectus, Qianzhi believes that the period from fiscal 2025 through 2028 remains in line with the projections and that the
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumptions supporting its forecast are reasonable as of such
date</span>.
Important factors that may affect actual results and cause the results reflected in the prospective financial information not to be achieved
include, among other things, risks and uncertainties relating to Qianzhi&#8217;s business, industry performance, the regulatory environment,
and general business and economic conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Qianzhi Management Projections were not prepared with a view towards public disclosure or compliance with the published guidelines of
the SEC or the guidelines established by the American Institute of Certified Public Accountants for preparation and presentation of prospective
financial information. The Qianzhi Management Projections were prepared solely for internal use, and capital budgeting and other management
purposes, and are subjective in many respects and therefore susceptible to varying interpretations and the need for periodic revision
based on actual experience and business developments, and were not intended for third-party use, including by investors or equity or
debt holders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Qianzhi Management Projections were requested by, and disclosed to, Bowen for use as a component in its overall evaluation of Qianzhi.
The Bowen Board considered and relied upon such Qianzhi Management Projections in determining the valuation for Qianzhi in the Business
Combination. Bowen first had access to the Qianzhi Management Projections on September 28, 2023. Although
Bowen, its financial advisor, and their respective representatives discussed the Qianzhi Management Projections with Qianzhi&#8217;s
representatives in detail, neither Bowen nor its representatives or advisors made or required any adjustments to Qianzhi&#8217;s financial
data. Qianzhi subsequently finalized the Qianzhi Management Projections on October 10, 2023. For further details about financial
analysis undertaken by the Bowen Board and Bowen&#8217;s management in reliance upon the Qianzhi Management Projections, see &#8220;<i>Reasons
for Bowen&#8217;s Board of Directors&#8217; Approval of the Business Combination.</i>&#8221; Neither Qianzhi&#8217;s management nor any
of its representatives has made or makes any representation to any person regarding the ultimate performance of Qianzhi compared to the
information contained in the Qianzhi Management Projections or that the financial and operating results included therein will be achieved.
Further neither Qianzhi nor any of its officers, directors, affiliates or representatives intends to or undertakes any obligation to
update or otherwise revise the Qianzhi Management Projections to reflect circumstances existing after the Qianzhi Management Projections
were finalized or to reflect the occurrence of future events in the event that any or all of the assumptions underlying the Qianzhi Management
Projections are shown to be in error. New Bowen does not intend to reference these projections in its future periodic reports filed under
the Exchange Act. The financial projections are included in this proxy statement/prospectus solely for informational purposes and not
to induce any Bowen shareholders to vote in favor of any of the proposals at the extraordinary general meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
Qianzhi&#8217;s independent auditors, nor any other independent accountants, have compiled, examined or performed any procedures with
respect to the prospective financial information contained herein, nor have they expressed any opinion or any other form of assurance
on such information or its achievability, and assume no responsibility for, and disclaim any association with, the prospective financial
information. The audit reports included in this proxy statement/prospectus relate to historical financial information. They do not extend
to the prospective financial information and should not be read to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXCEPT
AS REQUIRED BY APPLICABLE SECURITIES LAWS, QIANZHI DOES NOT INTEND TO MAKE PUBLICLY AVAILABLE ANY UPDATE OR OTHER REVISION TO THE QIANZHI
MANAGEMENT PROJECTIONS. THE QIANZHI MANAGEMENT PROJECTIONS DO NOT TAKE INTO ACCOUNT ANY CIRCUMSTANCES OR EVENTS OCCURRING AFTER THE DATE
THAT INFORMATION WAS PREPARED. READERS OF THIS PROXY STATEMENT/PROSPECTUS ARE STRONGLY CAUTIONED NOT TO PLACE UNDUE RELIANCE, IF ANY,
ON THE UNAUDITED QIANZHI MANAGEMENT PROJECTIONS SET FORTH BELOW AND NOT TO RELY ON SUCH FINANCIAL INFORMATION IN MAKING A DECISION REGARDING
THE BUSINESS COMBINATION PROPOSAL, AS SUCH FINANCIAL INFORMATION MAY BE MATERIALLY DIFFERENT THAN ACTUAL RESULTS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>


<!-- Field: Page; Sequence: 138; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Qianzhi Management Projections are unaudited, based upon estimated results of Qianzhi management and do not include the impact of the
accounting for the Business Combination or other impacts from the consummation of the Business Combination. The  Qianzhi
Management Projections are summarized below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>In
light of the foregoing factors and the uncertainties inherent in these projections, shareholders of Bowen are strongly cautioned not
to place undue reliance, if any, on these projections, and not to rely on these projections in making any decision regarding the Business
Combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
material projections provided by Qianzhi&#8217;s management team to Bowen are summarized in the table below with specific assumptions
immediately following the table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Projected
Financial Metrics ($ in thousands)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Fiscal Year End March 31,</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022 (Actual)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023 (Actual)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024 </td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2027</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2028</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; font-weight: bold">Revenue</td><td style="width: 2%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 5%; font-style: italic; text-align: right">6,737</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 2%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 5%; font-style: italic; text-align: right">10,109</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 2%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 5%; font-style: italic; text-align: right">16,409</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 2%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 5%; font-style: italic; text-align: right">28,093</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 2%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 5%; font-style: italic; text-align: right">50,879</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 2%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 5%; font-style: italic; text-align: right">97,300</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 2%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 5%; font-style: italic; text-align: right">195,620</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Cost of revenue</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">4,785</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">4,671</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">7,583</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">12,982</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">23,512</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">44,964</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">90,398</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Business taxes</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">&#8212;</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">&#8212;</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">-</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">-</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">-</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">-</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">-</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">General expenses</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">41</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">108</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">175</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">300</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">544</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">1,040</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">2,091</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Administration expenses</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">1,531</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">1,599</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">2,595</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">4,442</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">8,046</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">15,386</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">30,934</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">R&amp;D expenses</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">47</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">45</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">72</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">124</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">224</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">429</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">862</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Interest expenses</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">(2</td><td style="font-style: italic; text-align: left">)</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">(1</td><td style="font-style: italic; text-align: left">)</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">174</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">185</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">192</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">238</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">284</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Operating Income</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">336</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">3,688</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">5,809</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">10,059</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">18,361</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">35,243</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">71,051</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Non-operating income</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">64</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">75</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">&#8212;</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">&#8212;</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">&#8212;</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">&#8212;</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">&#8212;</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Non-operating expenses</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">&#8212;</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">8</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">&#8212;</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">&#8212;</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">&#8212;</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">&#8212;</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">&#8212;</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Net income before taxes</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">400</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">3,755</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">5,809</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">10,059</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">18,361</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">35,243</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">71,051</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Income taxes</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">19</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">163</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">1,452</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">2,515</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">4,590</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">8,811</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">17,763</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Net Income</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">381</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">3,591</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">4,357</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">7,545</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">13,771</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">26,432</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">53,288</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above financial metrics were included in Qianzhi&#8217;s projections that were provided to Newbridge Securities solely for purpose of
rendering its fairness opinion, which opinion is materially related to the Business Combination. Further, the projections are disclosed
in this proxy statement/prospectus in order to comply with Item 1015 of Regulation M-A regarding disclosure of Newbridge Securities&#8217;
analyses or substantive work. Accordingly, consistent with SEC guidance, the metrics provided to Newbridge Securities for purpose of
rendering its fairness opinion are not deemed to be non-GAAP financial measures requiring reconciliation to GAAP and/or other additional
disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
as mentioned above, Qianzhi did not achieve the projected financial results for its fiscal year ended March 31, 2024 and generated revenues
of $7,030,989 while incurring an operating loss of $44<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span>,701 and net loss of $698,174. Qianzhi attributes these results to the post-pandemic
slowdown experienced in the Chinese economy, which adversely impacted the purchasing power of our customers and reduced overall product
demand for our ozone sterilization and cosmetic products. In addition, revenues from sales of our hypochlorite disinfection products
were adversely impacted by the decision of the Chines government to lift its zero-COVID policy, which resulted in depressed sales for
this product line. These factors resulted in reduced sales revenue and our operating loss for fiscal 2024.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 139; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->126<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
and Basis for the Projected Financial Metrics Table</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Qianzhi Management Projections reflect numerous material estimates and assumptions made by Qianzhi management and believed to be reasonable
with respect to expected future financial performance. Generally, Qianzhi&#8217;s projected revenue is based on a variety of operational
assumptions, including, the timing of development and commercialization of its products, population size and growth, level of product
awareness with customers, and pricing mix. Further, projected gross profit is driven by the projected revenue and corresponding costs
related to the delivery of its products, including related overhead costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the preparation of the unaudited prospective financial information, Qianzhi&#8217;s management team considered various
material assumptions, including but not limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
                                            relating to future product development and product launch timelines;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
                                            relating to sales and marketing performance, marketing channels, investment levels and sales
                                            and marketing effectiveness based on industry trends;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
    related to obtaining operating funds include historical sales, sales growth rate, development of new sales channels, and acquisition
    of new customers;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
                                            relating to time and cost to acquire customers, including conversion rate from lead funnel
                                            for various sub-verticals and onboarding timeline;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
                                            relating to access to continuous working capital;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
                                            relating to the ability to grow customer base, customer retention, purchase volume and recurring
                                            purchases;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
                                            relating to regulatory requirements for current and future products, including government permissions for new products entering the market;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                            important assumptions affecting profitability projections include maintaining pricing,
                                            maintaining or reducing cost of goods sold and maintaining or increasing gross margin,
                                            which are based on Qianzhi&#8217;s existing products being mature products and that sales
                                            prices and cost of goods sold are not expected to fluctuate significantly;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Assumptions concerning profit forecasts include
    sales volume, sales pricing, gross margin, sales costs, expense levels, and tax levels;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
                                            relating to strategic partnerships for research and development, and sales and marketing
                                            across various sub-verticals;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
                                            relating to key hires including sales and marketing hires and operating costs;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
                                            relating to estimated timing of Closing the Business Combination and receiving the estimated
                                            net proceeds of the Business Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
                                            relating to third-party forecasts for industry growth and growth of comparable companies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
                                            size based on third-party data;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
                                            relating to the continued growth of the relevant customer markets include <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi&#8217;s business plans,
marketing plans, customer repurchase rate, average order value, and development trends in the ozone products industry</span>; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumption
                                            that there will not be any material liabilities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following provides more specificity or detail relative to  the above assumptions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            global economics remains stable, particularly in the PRC market, which will likely enhance
                                            customers&#8217; willingness to pay;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            demographics of the Qianzhi&#8217;s target customer base remain solid and are expected to
                                            increase steadily, thereby expanding the number of potential customers;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
                                            will be able to continuously expand into new, high-quality market channels to find new customers
                                            and improve the efficiency of user acquisition;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
                                            will be able to continually iterate its data systems to ensure the accuracy and efficiency
                                            of business decisions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
                                            will be able to develop new products and establish collaborations with potential partners;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
                                            will be able to explore market insights to identify new and expandable product markets;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
                                            will be able to attract or retain the experienced management team and qualified personnel
                                            or find suitable or comparable replacements on a timely basis; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">future
                                            legislative or regulatory changes would not have a material adverse effect on Qianzhi&#8217;s
                                            business, results of operations, and financial condition.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 140; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->127<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi&#8217;s
forecasts are based on the models that Qianzhi uses for its operating plans. Calculations are made based on historical sales data, which
it adjusts based on estimates of future performance of certain key measures, such as the retention rate, payment rate, and promotion
budget. In addition, in its forecasts, Qianzhi has also assumed significantly increased sales during each of the fiscal years ended
March 31, 2025 through March 31, 2028. If Qianzhi is not successful in developing new customers, sales channels and product applications,
it will not be able to achieve the projected financial results. In light of these assumptions, the Qianzhi Management Projections may
not be useful to shareholders and shareholders are strongly cautioned not to place undue reliance, if any, on the Qianzhi Management
Projections, and not to rely on these projections in making any decision regarding the Business Combination<span style="background-color: white">.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
calculating the revenue forecasts, Qianzhi considered that all of its products, excluding newly introduced products, are in the
mature stage, which is characterized by stable sales rates and market share, while marketing and promotional expenses would gradually
decrease, and cost of goods sold would remain relatively stable. As discussed in detail above, this forecast assumes no significant changes
in the overall market environment, stable promotional prices, and the ability of mature products to maintain stable retention and payments,
the ability of products in the growth and development stages to meet the projected improvements, and Qianzhi&#8217;s ability to introduce
new products effectively and move them from development to promotion. As a result, the projected growth rates hinge on several critical
factors and contingencies, including (i) whether increasing competition in the market could adversely affect Qianzhi&#8217;s market share
and revenue potential; (ii) whether changes in customer spending habits or economic conditions may affect their willingness to make purchases,
and therefore affect revenue; (iii) whether product developers can consistently provide compelling products; (iv) whether Qianzhi&#8217;s
marketing campaigns, and other promotional strategies are as effective as expected; and (v) whether future legislative or regulatory
changes may have a material adverse effect on Qianzhi&#8217;s business, results of operations, and financial condition. Although, sales
of our products decreased in fiscal 2024, management believes that such results were due to (i) the post-pandemic slowdown experienced
in the Chinese economy, which adversely impacted the purchasing power of our customers and reduced overall product demand for our ozone
sterilization and cosmetic products, and (ii) with respect to our hypochlorite disinfection products, the decision by the Chinese government
to lift its zero-COVID policy, which resulted in depressed sales for this product line. These factors resulted in reduced sales revenue
and our operating loss for fiscal 2024. However, Qianzhi&#8217;s management believes that as the Chinese economy continues to adjust
to the post-COVID environment and the Company implements new sales channels and develops new markets for its products, it&#8217;s operating
results will improve in future periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Qianzhi Management Projections reflect the consistent application of the accounting policies of Qianzhi and should be read in conjunction
with the accounting policies included in footnotes to the accompanying historical consolidated financial statements of Qianzhi included
in this proxy statement/prospectus. There will be differences between actual and projected results, and actual results may be materially
greater or materially less than those contained in the Qianzhi Management Projections. The inclusion of the Qianzhi Management Projections
in this proxy statement/prospectus should not be regarded as an indication that Qianzhi or its representatives considered or currently
consider the projections to be a reliable prediction of future events, and readers of this proxy statement/prospectus are cautioned not
to place undue reliance on these projections.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Qianzhi Management Projections are the responsibility of Qianzhi management. Neither Qianzhi&#8217;s independent auditors, nor any other
independent accountants have examined, compiled, or otherwise performed procedures with respect to the accompanying prospective financial
information presented herein and, accordingly, expresses no opinion or any other form of assurance on such information or its achievability,
and assume no responsibility for, and disclaim any association with the prospective financial information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discussion
of Qianzhi Management Projections</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi&#8217;s
revenue is mainly generated from the sale of plant-based and ozonated products for antibacterial, skincare, gynecological and andrological
applications. The majority of Qianzhi&#8217;s products are ozonated, oil-based and infused with formulated herbal ingredients. Qianzh&#8217;s
other proprietary products include ozonated disinfectant products produced by ambient temperature ozone curing technology. Qianzhi sells
its products directly through its professional sales team and distributes its products through various distribution channels.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 141; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->128<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
costs and expenses mainly consist of product development, manufacturing expenses commission costs to be paid to promotion channels, selling
expenses, administrative expenses, as well as research and development expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Satisfaction
of 80% Test</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is a requirement under the Existing Charter that any business acquired by Bowen have a fair market value equal to at least 80% of the
balance of the funds in the Trust Account (excluding deferred underwriting discounts and commissions and taxes payable on the interest
earned on the Trust Account) at the time of the execution of a definitive agreement for an initial business combination. As of January
18, 2024, the date of the execution of the Business Combination Agreement, the balance of the funds in the Trust Account (excluding deferred
underwriting discounts and commissions and taxes payable on the interest earned on the Trust Account) was approximately $71.6 million,
and 80% thereof represents approximately $57.3 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
reaching its conclusion that the Business Combination meets the 80% fair market value test, the Bowen Board believed that
the financial skills and background of its members qualified it to conclude that the acquisition of Qianzhi and its subsidiaries
met this requirement. In addition, the Bowen Board also considered the opinion provided by Newbridge Securities to the effect that,
as of the date of such opinion and based upon and subject to the assumptions made, procedures followed, matters considered and limitations
and qualifications set forth therein, Qianzhi had a fair market value equal to at least 80% of the net assets of the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption
Rights</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Existing Charter, holders of Public Shares may seek to redeem their shares for cash, regardless of whether they vote &#8220;FOR&#8221;
or &#8220;AGAINST,&#8221; or do not vote at all on, the Business Combination Proposal. Any Bowen Public Shareholder holding Public Shares
as of the Record Date may demand that Bowen redeem such shares for a pro rata portion of the Trust Account (which, for illustrative purposes,
was approximately $[X] per share as of [X], 2024, the most recent practicable date prior to the date of this proxy statement/prospectus),
calculated as of two business days prior to the anticipated consummation of the Business Combination, including interest earned on the
funds held in the Trust Account and not previously released to Bowen to pay its taxes (which interest shall be net of taxes payable).
If a holder properly seeks redemption and the Business Consummation is consummated, Bowen will, subject to funds being legally available
therefor, redeem these shares for a pro rata portion of funds deposited in the Trust Account and the holder will no longer own these
shares following the Business Combination. Please see the section entitled &#8220;<i>Special Meeting of Bowen Shareholders &#8212; Redemption
Rights.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material
U.S. Federal Income Tax Consequences</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a detailed discussion of material tax consequences of the Business Combination to the holders of Bowen Ordinary Shares, see the section
entitled &#8220;<i>Material United States Federal Income Tax Considerations</i>&#8221; in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anticipated
Accounting Treatment</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is anticipated that the Business Combination will be accounted for as a reverse recapitalization in accordance with GAAP. Under this
method of accounting, Bowen is expected to be treated as the &#8220;acquired&#8221; company for financial reporting purposes. Accordingly,
for accounting purposes, the financial statements of New Bowen will represent a continuation of the financial statements of Qianzhi with
the Transactions treated as the equivalent of Qianzhi issuing shares for the net assets of Bowen, accompanied by a recapitalization.
The net assets of Bowen will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to
the Business Combination will be those of Qianzhi in future reports of New Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory
Matters</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination is not subject to any additional federal or state regulatory requirement or approval, except for (i) filings with
the Cayman Islands necessary to effectuate the Business Combination, and (ii) filings of solicitation materials required pursuant to
Rule 14a-12 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appraisal
Rights</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
shareholders do not have appraisal rights in connection with the Business Combination under the Cayman Companies Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 142; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->129<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resolution
to be Voted Upon</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#8220;RESOLVED, as an ordinary
resolution, that the Business Combination Agreement dated January 18, 2024 (as it may be amended and/or restated from time to time, the
&#8220;<i>Business Combination Agreement</i>&#8221;), by and among Bowen Acquisition Corp., an exempted company with limited liability
incorporated under the laws of the Cayman Islands (&#8220;<i>Bowen</i>&#8221;), Bowen Merger Sub, a Cayman Islands exempted company and
a wholly owned subsidiary of Bowen (&#8220;<i>Merger Sub</i>&#8221;), Shenzhen Qianzhi BioTechnology Co. Ltd., a company incorporated
in the People&#8217;s Republic of China and a wholly owned subsidiary of NewCo (as defined below) (the &#8220;<i>Company</i>&#8221; or
&#8220;<i>Qianzhi</i>&#8221;), and Qianzhi Group Holding (Cayman) Limited, a newly formed Cayman Islands company (&#8220;<i>NewCo</i>&#8221;),
a copy of which are attached to the accompanying proxy statement/prospectus as <span style="text-decoration: underline">Annex A</span>, and all transactions contemplated
thereunder, including without limitation, the merger between the Merger Sub and NewCo, be and each is hereby approved, ratified,
confirmed and adopted (as applicable) in all respects.&#8221;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required
Vote</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the Business Combination Proposal requires an ordinary resolution under Cayman Islands law, being the affirmative vote of
the holders of a majority of the Bowen Ordinary Shares represented in person virtually or by proxy and entitled to vote thereon and who
vote at the Shareholder Meeting at which a quorum is present. Abstentions will be considered present for the purposes of establishing
a quorum but will not constitute votes cast at the Shareholder Meeting and therefore will have no effect on the approval of the Business
Combination Proposal. Broker non-votes, if any, will also have no effect on the approval of the Business Combination Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommendation
of the Bowen Board</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOWEN BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS VOTE &#8220;FOR&#8221;<br/>
THE APPROVAL OF THE BUSINESS COMBINATION PROPOSAL.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
existence of financial and personal interests of Bowen&#8217;s directors may result in a conflict of interest on the part of one or more
of the directors between what he, she or they may believe is in the best interests of Bowen and its shareholders and what he, she or
they may believe is best for himself, herself or themselves in determining to recommend that shareholders vote for the proposals. In
addition, Bowen&#8217;s Officers may have interests in the Business Combination Proposal that may conflict with your interests as a shareholder.
See the section entitled &#8220;&#8212; <i>Interests of Certain Persons in the Business Combination</i>&#8221; for further discussion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 143; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->130<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="al_001"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
2: THE NAME CHANGE PROPOSAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Name Change Proposal asks shareholders of Bowen to approve, subject to the proposed name conforming with section 30 of the Companies
Act (Revised) of the Cayman Islands, to approve the change of name of Bowen from Bowen Acquisition Corp to &#8220;Emerald, Inc.&#8221;,
effective from the Effective Time. In the judgment of Bowen&#8217;s board of directors, changing the name of the new public entity is
desirable to reflect the Business Combination with Qianzhi and the combined business going forward.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resolution
to be Voted Upon</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
as a special resolution, that subject to the proposed name conforming with section 30 of the Companies Act (Revised) of the Cayman Islands,
the name of Bowen be changed to &#8216;Emerald, Inc.&#8221;, effective from the effective time of the Merger&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Required
Vote</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Name Change Proposal must be approved by special resolution under the Cayman Islands law, being the affirmative vote by the holders of
not less than two-thirds of the Bowen Ordinary Shares present in person virtually or represented by proxy (or in the case of a shareholder
being a corporation, by its duly authorized representative) who, being entitled to vote at the Shareholder Meeting at which a quorum
is present, vote. Abstentions will be considered present for the purposes of establishing a quorum but will not constitute votes cast
at the Shareholder Meeting and therefore will have no effect on the approval of the Name Change Proposal. Broker non-votes, if any, will
also have no effect on the approval of the Name Change Proposal. If the Condition Precedent Proposal is not approved, the Name Change
Proposal will not be presented at the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Bowen Board</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN&#8217;S
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE BOWEN SHAREHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE NAME CHANGE PROPOSAL,
IF PRESENTED.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 144; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->131<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="al_002"></span>PROPOSAL
3: THE CAPITALIZATION AMENDMENT PROPOSAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Capitalization Amendment Proposal asks shareholders of Bowen to approve the increase of the authorized share capital of Bowen from US$20,200,
divided into 2,000,000 Preferred Shares of par value US$0.0001 each and 200,000,000 Ordinary Shares of par value US$0.0001 each, to US$25,200,
divided into 2,000,000 Preferred Shares of par value US$0.0001 each and 250,000,000 Ordinary Shares of par value US$0.0001 each, by the
creation of 50,000,000 additional Ordinary Shares of par value US$0.0001 each. In the judgment of Bowen&#8217;s board of directors, increasing
the authorized number of ordinary shares is desirable for New Bowen to have sufficient shares for the issuances to the holders of Qianzhi&#8217;s
stock in the Merger, including the Earnout Shares, to have enough additional authorized shares for issuance in the PIPE Financing contemplated
by the Merger Agreement, and to have and have enough additional authorized shares for financing its business, for acquiring other businesses,
for forming strategic partnerships and alliances, for stock dividends and stock splits, and for the 2024 Incentive Plan and other compensatory
purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resolution
to be Voted Upon</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
as a special resolution, that the increase of the authorized share capital of Bowen from US$20,200, divided into 2,000,000 Preferred
Shares of par value US$0.0001 each and 200,000,000 Ordinary Shares of par value US$0.0001 each, to US$25,200, divided into 2,000,000
Preferred Shares of par value US$0.0001 each and 250,000,000 Ordinary Shares of par value US$0.0001 each, by the creation of 50,000,000
additional Ordinary Shares of par value US$0.0001 each be approved and authorized in all respects.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Required
Vote</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Capitalization Amendment Proposal must be approved by special resolution under the Cayman Islands law, being the affirmative vote by
the holders of not less than two-thirds of the Bowen Ordinary Shares present in person virtually or represented by proxy (or in the case
of a shareholder being a corporation, by its duly authorized representative) who, being entitled to vote at the Shareholder Meeting at
which a quorum is present, vote. Abstentions will be considered present for the purposes of establishing a quorum but will not constitute
votes cast at the Shareholder Meeting and therefore will have no effect on the approval of the Capitalization Amendment Proposal. Broker
non-votes, if any, will also have no effect on the approval of the Capitalization Amendment Proposal. If the Condition Precedent Proposal
is not approved, the Capitalization Amendment Proposal will not be presented at the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Bowen Board</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN&#8217;S
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE BOWEN SHAREHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE CAPITALIZATION AMENDMENT
PROPOSAL, IF PRESENTED.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 145; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->132<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_013"></span>PROPOSALS
4 AND 5:</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> THE CHARTER AMENDMENT PROPOSALS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, Bowen is requesting that its shareholders consider and vote upon and approve, separate and
apart from their consideration and vote upon the Business Combination Proposal, proposals to amend the Existing Charter and
adopt the Proposed Charter</span>, substantially in the form attached to this proxy statement/prospectus as <i><span style="text-decoration: underline">Annex D</span></i>,
to be effective upon the consummation of the Business Combination, as described further below. Approval of the Charter Amendment
Proposals is a condition to the parties&#8217; obligations to consummate the Business Combination, such that, if the Charter
Amendment Proposals are not approved, the Business Combination may not be consummated, unless the corresponding condition in the Business
Combination Agreement is waived by the parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Charter Amendment Proposals are conditioned on the approval of the Business Combination Proposal. Therefore, if the Business Combination
Proposal is not approved, then the Charter Amendment Proposal will have no effect, even if approved by Bowen&#8217;s shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Proposal
No. 4, the BOARD UNIFICATION Proposal</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, if
approved, will remove the provisions of the Existing Charter dividing the Bowen Board into multiple classes, as described more particularly
below. In the judgment of Bowen&#8217;s board of directors, removing the provisions dividing the Bowen Board into three classes is desirable
as it improves New Bowen&#8217;s corporate governance profile by enhancing the directors&#8217; accountability to shareholders and is
in the best interests of New Bowen&#8217;s shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Board Unification Proposal is approved, Article 16.4 of the Existing Charter shall be deleted in its entirety and replaced with the
following new Article 16.4:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;16.4
Each director holds office for the term fixed by the Ordinary Resolution or fixed by the resolution of the directors appointing such
director, as applicable, but such term shall not exceed two years.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resolution
to be Voted Upon</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
as an ordinary resolution, that the provisions of Bowen&#8217;s Amended and Restated Memorandum and Articles of Association dividing
the Bowen Board into classes be removed.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Required
Vote</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the Board Unification Proposal requires a special resolution under Cayman Islands law, being the affirmative vote of the
holders of at least two-thirds (2/3) of the Bowen Ordinary Shares represented in person virtually or by proxy and entitled to vote thereon
and who vote at the Shareholder Meeting at which a quorum is present. Abstentions will be considered present for the purposes of establishing
a quorum but will not constitute votes cast at the Shareholder Meeting and therefore will have no effect on the approval of the Board
Unification Proposal. Broker non-votes, if any, will also have no effect on the approval of the Board Unification Proposal. If the Condition
Precedent Proposal is not approved, the Board Unification Proposal will not be presented at the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Bowen Board</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN&#8217;S
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE BOWEN SHAREHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE BOARD UNIFICATION PROPOSAL,
IF PRESENTED.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Proposal
No. 5, the PROPOSED CHARTER ADOPTION Proposal</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
if approved, the Proposed Charter, substantially in the form attached to this proxy statement/prospectus as <i><span style="text-decoration: underline">Annex D</span></i>, to
be effective upon the Effective Time, reflecting, among other things, the consequential amendments resulting from the Name Change Proposal
(if the Name Change Proposal has been approved), the Capitalization Amendment Proposal (if the Capitalization Amendment Proposal has
been approved), the Board Unification Proposal (if the Board Unification Proposal has been approved) and the removal of the various non-substantive,
non-governance provisions applicable only to special purpose acquisition companies that will no longer be applicable to Bowen after the
consummation of the Business Combination, will be approved and adopted.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Proposed Charter Adoption Proposal is approved, the key changes to the</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
provisions of the Existing Charter that will be made in the Proposed Charter will be as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
                                            approval of the Name Change Proposal, all references to the name of Bowen shall be changed
                                            from &#8220;Bowen Acquisition Corp&#8221; to &#8220;Emerald, Inc.&#8221;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
                                            approval of the Capitalization Amendment Proposal, the authorized share capital of Bowen
                                            as set out in the memorandum shall be changed to US$25,200 divided into 2,000,000 Preferred
                                            Shares of par value US$0.0001 each and 250,000,000 Ordinary Shares of par value US$0.0001
                                            each.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
                                            13.1 shall be deleted in its entirety and replaced with the following new Article 13.1:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;13.1
Save as provided in the following Article, no business shall be transacted at any meeting unless a quorum is present in person (including
virtually) or by proxy at the meeting. One or more Members who together hold not less than one-third of the Shares entitled to vote at
such meeting being individuals present in person (including virtually) or by proxy or if a corporation or other non-natural person by
its duly authorised representative or proxy shall be a quorum.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
                                            13.9 shall be deleted in its entirety and replaced with the following new Article 13.9:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;13.9
If, prior to a general meeting, a notice is issued in respect of such general meeting and the directors, in their absolute discretion,
consider that it is impractical or undesirable for any reason to hold that general meeting at the place, the day and the hour specified
in the notice calling such general meeting, the directors may postpone the general meeting to another place, day and/or hour provided
that notice of the place, the day and the hour of the rearranged general meeting is promptly given to all Members. No business shall
be transacted at any postponed meeting other than the business specified in the notice of the original meeting.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Assuming
                                            approval of the Board Unification Proposal, <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
                                            16.4 shall be deleted in its entirety and replaced with the following new Article 16.4:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;16.4
Each director holds office for the term fixed by the Ordinary Resolution or fixed by the resolution of the directors appointing such
director, as applicable, but such term shall not exceed two years.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 146; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->133<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
                                            16.5 shall be deleted in its entirety and replaced with the following new Article 16.5:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;16.5
The Company may by Ordinary Resolution appoint any person to be a director or may by Ordinary Resolution remove any director.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
                                            17.1 shall be deleted in its entirety and replaced with the following new Article 17.1:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;17.1
Any director may appoint any other person, including another director, to act in his place as an alternate director. No appointment
shall take effect until the director has given notice of the appointment to the other directors. Such notice must be given to each
other director by either of the following methods:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
by notice in writing in accordance with the notice provisions;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
if the other director has an email address, by emailing to that address a scanned copy of the notice as a PDF attachment (the PDF
version being deemed to be the notice unless Article 32.7 applies), in which event notice shall be taken to be given on the date of
receipt by the recipient in readable form. For the avoidance of doubt, the same email may be sent to the email address of more than
one director (and to the email address of the Company pursuant to Article 17.4(c)). &#8220;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
                                            18.10 shall be deleted in its entirety and replaced with the following new Article 18.10:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;18.10
The remuneration to be paid to the directors, if any, shall be such remuneration as the directors shall determine. The directors
shall also be entitled to be paid all out of pocket expenses properly incurred by them in connection with activities on behalf of the
Company.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            full Article 37 which relates to business combination shall be deleted in its entirety and
                                            the corresponding definitions in Section 1.1 which are obsolete following deletion of Article
                                            37 shall also be deleted.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the judgment of Bowen&#8217;s board of directors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">removing
                                            the provisions dividing the Board into three classes is desirable as it improves New Bowen&#8217;s
                                            corporate governance profile by enhancing the directors&#8217; accountability to shareholders
                                            and is in the best interests of New Bowen&#8217;s shareholders; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">removing
                                            the various provisions applicable only to special purpose acquisition companies is desirable
                                            because such provisions will no longer be applicable after the consummation of the Business
                                            Combination and will serve no further purpose.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Proposed Charter Adoption Proposal is approved, the Proposed Charter will be adopted and the Existing Charter will
be deleted in its entirety and replaced by the Proposed Charter so that a single document exists that fully states the provisions
that constitute the memorandum and articles of association of Bowen, effective upon the Effective Time. If and to the extent any
of the Name Change Proposal, the Capitalization Amendment Proposal or the Board Unification Proposal is not approved
by Bowen shareholders, the changes to the Existing Charter that would be reflected in the Proposed Charter as contemplated
thereby and described above will not be reflected in the Proposed Charter that becomes effective upon the Effective Time.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the Proposed Charter, as it will be in effect assuming consummation of the Merger and approval of the Proposed Charter Adoption
Proposal, is attached hereto as <i><span style="text-decoration: underline">Annex D</span></i>. Additionally, the text of the Proposed Charter, assuming approval of the
Proposed Charter Adoption Proposal and, with respect to certain sections of the Proposed Charter as described above, the Name Change
Proposal, the Capitalization Amendment Proposal and the Board Unification Proposal, is set forth in <i><span style="text-decoration: underline">Annex D</span></i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resolution
to be Voted Upon</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
as a special resolution, that the amendment and restatement of the existing memorandum and articles of association of Bowen, including
without limitation, the consequential changes resulting from the Name Change Proposal (if approved), the Capitalization Amendment Proposal
(if approved) and the Board Unification Proposal (if approved) and the removal of non-substantive, non-governance provisions applicable
only to special purpose acquisition companies that will no longer be applicable to Bowen after the consummation of the Business Combination,
by deletion in their entirety and substitution in their place by the proposed second amended and restated memorandum and articles of
association of New Bowen, the substantial form of which is attached the accompanying proxy statement as <i>Annex D, </i>with effect upon
the Effective Time, be approved and authorized in all respects.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Required
Vote</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The approval of the Proposed
Charter Adoption Proposal requires a special resolution under Cayman Islands law, being the affirmative vote of the
holders of at least two-thirds (2/3) of the Bowen Ordinary Shares represented in person virtually or by proxy and
entitled to vote thereon and who vote at the Shareholder Meeting at which a quorum is present. Abstentions will be considered
present for the purposes of establishing a quorum but will not constitute votes cast at the Shareholder Meeting and therefore will have
no effect on the approval of the Proposed Charter Adoption Proposal. Broker non-votes, if any, will also have no effect
on the approval of the Proposed Charter Adoption Proposal. If the Condition Precedent Proposal is not approved, the Proposed Charter
Adoption Proposal will not be presented at the Shareholder Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of the Bowen Board</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN&#8217;S
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE BOWEN SHAREHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE PROPOSED CHARTER ADOPTION
PROPOSAL, IF PRESENTED.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 147; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->134<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_014"></span>PROPOSAL
6: THE NASDAQ PROPOSAL</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overview</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nasdaq Proposal asks shareholders of Bowen to approve, for the purposes of complying with the applicable provisions of Nasdaq Listing
Rule 5635(a) and (b), the issuance of Bowen Ordinary Shares in connection with the Merger, to the extent such issuance would require
a shareholder vote under Nasdaq Listing Rule 5635(a) and (b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reasons
for the Approval for Purposes of Nasdaq Listing Rule 5635</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Nasdaq Listing Rule 5635(a)(1), shareholder approval is required prior to the issuance of Ordinary Shares, or of securities convertible
into or exercisable for Ordinary Shares, in connection with the acquisition of another company if such securities are not issued in a
public offering for cash and (i) the Ordinary Shares has, or will have upon issuance, voting power equal to or in excess of 20% of the
voting power outstanding before the issuance of such securities (or securities convertible into or exercisable for Ordinary Shares);
or (ii) the number of shares of Ordinary Shares to be issued is or will be equal to or in excess of 20% of the number of shares of Ordinary
Shares outstanding before the issuance of the stock or securities. Additionally, under Nasdaq Listing Rule 5635(b), shareholder approval
is required prior to the issuance of securities when the issuance or potential issuance will result in a change of control of the registrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Business Combination, Bowen has 9,166,500 Ordinary Shares outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, we anticipate that we will issue to the shareholders of Qianzhi as Merger Consideration upon Closing
of the Business Combination an aggregate of approximately 7,246,377 Ordinary Shares, plus the contingent right to receive up to 1,400,000
Earnout Shares. See &#8220;<i>The Business Combination Proposal &#8212; The Merger Agreement</i>.&#8221; Because the number of Bowen
Ordinary Shares we anticipate issuing in the Business Combination (1) will constitute more than 20% of the outstanding Bowen Ordinary
Shares and more than 20% of outstanding voting power prior to such issuance and (2) will result in a change of control of Bowen, we are
required to obtain shareholder approval of such issuances pursuant to Nasdaq Listing Rules 5635(a) and (b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is a condition to the consummation of the Business Combination that Bowen&#8217;s Ordinary Shares remain listed on Nasdaq. If this proposal
is not approved by the holders of Bowen Ordinary Shares, the Business Combination cannot be consummated unless the applicable condition
in the Business Combination Agreement is waived by the parties. If this proposal is approved by holders of Bowen Ordinary Shares, but
the Business Combination Agreement is not consummated, Bowen will not issue such Bowen Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resolution
to be Voted Upon</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
as an ordinary resolution, that the issuance of up to [X] ordinary shares in connection with the Business Combination be approved and
adopted in all respects.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required
Vote</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of Nasdaq Proposal requires an ordinary resolution, being the affirmative vote of the holders of a
majority of the Bowen Ordinary Shares represented in person virtually or by proxy and entitled to vote thereon and who vote at the Shareholder
Meeting at which a quorum is present. Abstentions will be considered present for the purposes of establishing a quorum but will
not constitute votes cast at the Shareholder Meeting and therefore will have no effect on the approval of the Nasdaq Proposal. Broker
non-votes, if any, will also have no effect on the approval of the Nasdaq Proposal. If the Condition Precedent Proposal is not approved,
the Nasdaq Proposal will not be presented at the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommendation
of the Bowen Board</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOWEN BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE NASDAQ PROPOSAL, IF PRESENTED.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
existence of financial and personal interests of Bowen&#8217;s directors may result in a conflict of interest on the part of one or more
of the directors between what he, she or they may believe is in the best interests of Bowen and its shareholders and what he, she or
they may believe is best for himself, herself or themselves in determining to recommend that shareholders vote for the proposals. In
addition, Bowen&#8217;s officers may have interests in the Business Combination Proposal that may conflict with your interests as a shareholder.
See the section entitled &#8220;<i>Proposal 1: The Business Combination Proposal &#8212; Interests of Certain Persons in the Business
Combination</i>&#8221; for further discussion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 148; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->135<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_015"></span>PROPOSAL
7: THE INCENTIVE PLAN PROPOSAL</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Equity Incentive Plan Proposal asks shareholders of Bowen to approve and adopt the 2024 Incentive Plan. An aggregate number of Bowen
Ordinary Shares equal to 5% of the Bowen Ordinary Shares outstanding immediately following the Closing will be reserved for issuance
under the 2024 Incentive Plan. The Bowen Board approved the 2024 Incentive Plan on [&#9679;], subject to approval by Bowen&#8217;s shareholders
at the Shareholder Meeting. If approved by the shareholders, the effective date of the 2024 Incentive Plan will be the Closing Date.
The 2024 Incentive Plan is described in more detail below. A copy of the 2024 Incentive Plan is attached as Annex B to this proxy statement/prospectus.
If approved by the shareholders, the 2024 Incentive Plan will be administered by the New Bowen Board or by the compensation committee
of the New Bowen Board, which will have the authority to make awards under the 2024 Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
careful consideration, the Bowen Board believes that approving the 2024 Incentive Plan is in the best interests of Bowen and its shareholders.
The general purpose of the 2024 Incentive Plan is to attract and retain employees, directors and consultants who contribute to New Bowen&#8217;s
success by their ability, ingenuity and industry, and to enable such persons to participate in the long-term success and growth of New
Bowen. If approved, the 2024 Incentive Plan will enable New Bowen to provide share-based incentives that align the interests of employees,
directors and consultants with those of the shareholders of New Bowen by motivating such persons to achieve long-term results and rewarding
them for their achievements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terms
of the 2024 Incentive Plan</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of the principal terms of the 2024 Incentive Plan is qualified in its entirety by the full text of the 2024 Incentive
Plan, a copy of which is attached as <i><span style="text-decoration: underline">Annex B</span></i> to this proxy statement/prospectus. You may also obtain, free of charge, a
copy of the 2024 Incentive Plan by writing to Bowen at 420 Lexington Avenue, Suite 2446, New York, New York 10170.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administration.
</i></b>The New Bowen Board or one or more committees appointed by the New Bowen Board will administer the 2024 Incentive Plan. For this
purpose, the New Bowen Board will delegate general administrative authority for the 2024 Incentive Plan to the compensation committee
of the New Bowen Board. The appropriate acting body, whether the New Bowen Board, the compensation committee of the New Bowen Board or
another committee appointed by the New Bowen Board, is referred to in this summary as the &#8220;<span style="font-weight: normal"><i>Administrator</i></span>&#8221;.
The Administrator may also delegate to one or more persons the right to act on its behalf in such matters as authorized by the Administrator.
The Administrator determines which eligible individuals shall be granted awards under the plan, provided that any award granted to a
member of the compensation committee of the New Bowen Board shall be subject to the approval or ratification of the New Bowen Board.
Along with other authority granted to the Administrator under the 2024 Incentive Plan, the Administrator may (i) select recipients of
awards, (ii) determine the number of shares subject to awards, (iii) approve form award agreements, (iv) determine the terms and conditions
of awards, and (v) allow participants to satisfy withholding tax obligations through a reduction of shares. The Administrator may not,
however, effectuate a repricing or exchange of outstanding stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Authorized
Shares; Lapsed Awards. </i></b>An aggregate number of New Bowen Ordinary Shares equal to 5% of the shares of New Bowen Ordinary Shares
outstanding immediately following the Closing is the maximum number of shares of New Bowen Ordinary Shares that may be issued or transferred
pursuant to awards under the 2024 Incentive Plan. On the first day of each fiscal year of New Bowen during the term of the 2024 Incentive
Plan commencing on the first year following the Closing, the number of New Bowen Ordinary Shares that may be issued under the 2024 Incentive
Plan will automatically increase by a number of New Bowen Ordinary Shares such that the number of shares that may be issued under the
2024 Incentive Plan shall equal 5% of the New Bowen Ordinary Shares outstanding as of the last day of the preceding fiscal
year. If any outstanding award under the 2024 Incentive Plan expires, is forfeited or is cancelled, in whole or in part, then the number
of shares subject to the 2024 Incentive Plan shall be increased by the portion of such awards so forfeited, expired or cancelled and
such forfeited, expired or cancelled shares may again be awarded under the 2024 Incentive Plan. Shares tendered in payment of the exercise
price or withholding taxes with respect to an award shall not become, or again be, available for awards under the 2024 Incentive Plan.
The grant of awards that may not be satisfied by issuance of shares shall not count against the maximum number of shares of Ordinary
Shares subject to the 2024 Incentive Plan; however, shares attributable to awards that may be satisfied either by the issuance of shares
or by cash or other consideration shall be counted against the maximum number of shares of Ordinary Shares that may be issued under the
2024 Incentive Plan. If New Bowen Ordinary Shares issued in connection with any award granted under the 2024 Incentive Plan shall be
repurchased by New Bowen, in whole or in part, then the number of New Bowen Ordinary Shares subject to the 2024 Incentive Plan shall
not be increased by that portion of the shares repurchased by New Bowen, and such repurchased shares may not again be awarded pursuant
to the provisions of the 2024 Incentive Plan. Additionally, the aggregate number of New Bowen Ordinary Shares that may be issued or used
with respect to any ISO (defined below) shall not exceed the number of shares reserved for issuance under the plan (subject to adjustment
as provided for in the 2024 Incentive Plan).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 149; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->136<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Eligibility.
</i></b>Individuals eligible to receive awards under the 2024 Incentive Plan include New Bowen&#8217;s employees, directors and consultants.
Approximately [&#9679;] employees, [&#9679;] directors and [&#9679;] consultants will be eligible to participate in the 2024 Incentive
Plan, if approved, as of the Closing Date. The Administrator determines from time to time the participants to whom awards will be granted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Incentive
Awards. </i></b>The 2024 Incentive Plan authorizes stock options, stock appreciation rights (&#8220;<span style="font-weight: normal"><i>SARs</i></span>&#8221;),
restricted stock, restricted stock units, as well as other awards (described in the 2024 Incentive Plan) that are responsive to changing
developments in management compensation. The 2024 Incentive Plan retains the flexibility to offer competitive incentives and to tailor
benefits to specific needs and circumstances. Any award may be paid or settled in cash. An option or SAR will expire, or other award
will vest, in accordance with the schedule set forth in the applicable award agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Option. </i>A stock option is the right to purchase shares of Ordinary Shares at a future date at a specified price per share generally
equal to, but not less than, the fair market value of a share on the date of grant. An option may either be an Incentive Stock Option
(&#8220;<span style="font-weight: normal"><i>ISO</i></span>&#8221;) or a non-qualified stock option. ISO benefits are taxed differently
from non-qualified stock options, as described under &#8220;<i>Federal Income Tax Treatment of Awards under the 2024 Incentive Plan</i>,&#8221;
below. ISOs also are subject to more restrictive terms and are limited in amount by the Code and the 2024 Incentive Plan. Full payment
for shares purchased on the exercise of any option must be made at the time of such exercise in a manner approved by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>SARs.
</i>A SAR is the right to receive payment of an amount equal to the excess of the fair market value of a share of Ordinary Shares on
the date of exercise of the SAR over the base price of the SAR. The base price will be established by the Administrator at the time of
grant of the SAR, but will not be less than the fair market value of a New Bowen Ordinary Share on the date of grant. SARs may be granted
in connection with other awards or independently.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
Stock. </i>A restricted stock award is typically for a fixed number of New Bowen Ordinary Shares, subject to restrictions. The Administrator
specifies the price, if any, the participant must pay for such shares, the duration of the restriction period and the conditions under
which the shares may be forfeited. The Administrator may waive any restriction period and any other conditions under appropriate circumstances
(such as death or disability). Generally, during the restriction period, the participant will have all of the rights of a shareholder
with respect to the shares of restricted stock, including the right to vote the shares of restricted stock and to receive dividends,
provided that any such dividends will be subject to the same restrictions and other conditions as the restricted shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
Stock Units. </i>Restricted stock units represent unfunded, unsecured rights to receive New Bowen Ordinary Shares or cash equal to the
fair market value of New Bowen Ordinary Shares, or any combination thereof, as provided in the applicable award agreement. Prior to the
settlement of an award of restricted stock units and the receipt of shares, if any, the participant will not have any rights as a shareholder
with respect to such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Awards. </i>The Administrator may also grant other forms of awards based upon, payable in or otherwise related to, in whole or in part,
New Bowen Ordinary Shares, if the Administrator, in its sole discretion, determines that such other form of award is consistent with
the purposes of the 2024 Incentive Plan. The terms and conditions of any such other form of award will be set forth in an applicable
award agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transfer
Restrictions. </i></b>Subject to certain exceptions, awards under the 2024 Incentive Plan are not transferable by the recipient other
than by will or the laws of descent and distribution and are generally exercisable during the recipient&#8217;s lifetime only by him
or her.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Adjustments
or Changes in Capitalization. </i></b>In the event of any change in the outstanding New Bowen Ordinary Shares by reason of a merger,
consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, stock split,
liquidating dividend, combination of shares, exchange of shares, change in corporate structure or other similar corporate transaction
not involving the receipt of consideration by New Bowen, the aggregate number of New Bowen Ordinary Shares available under the 2024 Incentive
Plan or subject to outstanding awards (including the exercise price of any awards) will be adjusted as the Administrator deems necessary
or appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 150; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->137<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Control. </i></b>Upon a change in control of New Bowen, unless the Administrator determines otherwise, the vesting of all outstanding
awards under the 2024 Incentive Plan will fully accelerate, and in the case of options or stock appreciation rights, will become immediately
exercisable. Upon a change in control where New Bowen is not the surviving company (or survives only as a subsidiary), unless the Administrator
determines otherwise, all outstanding stock options and SARs that are not exercised will be assumed, or replaced with comparable options
or rights, by the surviving company. Alternatively, the Administrator may also (i) require participants to surrender their outstanding
stock options and SARs in exchange for payment by New Bowen in cash or Ordinary Shares in an amount equal to the amount by which the
then fair market value of the New Bowen Ordinary Shares subject to unexercised stock options and SARs exceeds the exercise price of the
stock options or fair market value of the SARs on the award date, as applicable or (ii) after giving participants an opportunity to exercise
outstanding stock options and SARs, terminate any or all unexercised stock options and SARs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
change in control is defined to include (i) the sale of all or substantially all of New Bowen&#8217;s assets, (ii) the acquisition of
beneficial ownership by any person or entity, directly or indirectly, of securities representing 50% or more of the total number of votes
that may be cast for the election of directors of New Bowen, (iii) certain changes in the majority of the New Bowen Board and (iv) the
consummation of certain mergers or consolidations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Amendments
to and Termination of the 2024 Incentive Plan. </i></b>The New Bowen Board may amend the 2024 Incentive Plan at any time and in any manner
without the consent of the shareholders, except that no amendment may be made to the 2024 Incentive Plan without shareholder approval
that would (i) expand the types of awards available under the 2024 Incentive Plan or otherwise materially revise the 2024 Incentive Plan
or (ii) increase the number of shares reserved for issuance under the 2024 Incentive Plan, modify the eligible individuals under the
2024 Incentive Plan or change the identity of the granting company. Generally speaking, outstanding awards may be amended, except that
no amendment to the 2024 Incentive Plan or to any outstanding awards may be made that would impair the rights of any participant with
respect to such outstanding award issued to such participant, without the consent of the participant. In addition, amendments to outstanding
awards may not effectuate a repricing or exchange of outstanding stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
New Bowen Board may suspend or terminate the 2024 Incentive Plan at any time, provided that termination of the 2024 Incentive Plan will
not impair or affect any award previously granted. Unless earlier terminated by New Bowen&#8217;s Board, the 2024 Incentive Plan will
automatically terminate on the tenth anniversary of the date it is approved by shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Clawback
and Recoupment. </i></b>New Bowen may cancel any award, require the participant to reimburse any or all amounts paid pursuant to an award
or under the terms of the 2024 Incentive Plan and effect any other right of recoupment in accordance with any New Bowen policies that
may be adopted from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal
Income Tax Treatment of Awards under the 2024 Incentive Plan</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal
income tax consequences relating to awards under the 2024 Incentive Plan are summarized in the following discussion. This summary is
not intended to be exhaustive and, among other considerations, does not describe the deferred compensation provisions of Section 409A
of the Code to the extent an award is subject to and does not satisfy those rules, nor does it describe state, local or international
tax consequences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
non-qualified stock options, New Bowen is generally entitled to deduct, subject to Code limitations (and the optionee recognizes
taxable income in), an amount equal to the difference between the option exercise price and the fair market value of the shares at
the time of exercise. For ISOs, New Bowen is generally not entitled to a deduction, nor does the participant recognize income at the
time of exercise. The current U.S. federal income tax consequences of other awards authorized under the 2024 Incentive Plan
generally follow certain basic patterns: SARs are taxed and deductible in substantially the same manner as non-qualified stock
options; nontransferable restricted stock subject to a substantial risk of forfeiture results in income recognition equal to the
excess of the fair market value over the price paid (if any) only at the time the restrictions lapse (unless the recipient elects to
accelerate recognition as of the date of grant); bonuses are generally subject to tax at the time of payment; cash-based awards are
generally subject to tax </span>at the time of payment; and compensation otherwise effectively deferred is taxed when paid. New
Bowen will generally have a corresponding deduction at the time the participant recognizes income, subject to Code limitations.
However, as discussed above, for those awards subject to ISO treatment, New Bowen would generally have no corresponding compensation
deduction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 151; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->138<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an award is accelerated under the 2024 Incentive Plan in connection with a change in control (as this term is used under the Code), New
Bowen may not be permitted to deduct the portion of the compensation attributable to the acceleration (&#8220;<span style="font-weight: normal"><i>Parachute
Payments</i></span>&#8221;) if it exceeds certain threshold limits under the Code (and certain related excise taxes may be triggered).
Furthermore, Section 162(m) of the Code denies deductions to publicly held corporations for compensation paid to certain senior executives
that exceeds $1 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Plan Benefits</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awards
are subject to the discretion of the Administrator. Therefore, it is not possible to determine the benefits that will be received in
the future by participants in the 2024 Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
Registration</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the consummation of the Business Combination, when permitted by SEC rules, New Bowen intends to file with the SEC a registration statement
on Form S-8 covering the shares of New Bowen Ordinary Shares issuable under the 2024 Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resolution
to be Voted Upon</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
as an ordinary resolution, that the 2024 Incentive Plan is hereby authorized and approved, to be effective immediately upon the consummation
of the Business Combination.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required
Vote</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the Equity Incentive Plan Proposal requires an ordinary resolution, being the affirmative vote of
at least a majority of the votes cast by the holders of the issued and outstanding Bowen Ordinary Shares who are present in person virtually
or represented by proxy and entitled to vote thereon and who vote at the Shareholder Meeting at which a quorum is present. Abstentions
will be considered present for the purposes of establishing a quorum but will not constitute votes cast at the Shareholder Meeting and
therefore will have no effect on the approval of the Equity Incentive Plan Proposal. Broker non-votes, if any, will also have no effect
on the approval of the Equity Incentive Plan Proposal. If the Condition Precedent Proposal is not approved, the Equity Incentive Plan
Proposal will not be presented at the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommendation
of the Bowen Board</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOWEN BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE EQUITY INCENTIVE PLAN PROPOSAL, IF PRESENTED.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
existence of financial and personal interests of Bowen&#8217;s directors may result in a conflict of interest on the part of one or more
of the directors between what he, she or they may believe is in the best interests of Bowen and its shareholders and what he, she or
they may believe is best for himself, herself or themselves in determining to recommend that shareholders vote for the proposals. In
addition, Bowen&#8217;s Officers may have interests in the Business Combination Proposal that may conflict with your interests as a shareholder.
See the section entitled &#8220;<i>Shareholder Proposal No. 1: The Business Combination Proposal &#8212; Interests of Certain Persons
in the Business Combination</i>&#8221; for further discussion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 152; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->139<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_016"></span>PROPOSAL
8: THE DIRECTOR ELECTION PROPOSAL</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election
of Directors</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, the parties agreed to take all necessary action so that effective at the Closing, the Bowen Board
will consist of five (5) individuals, a majority of whom will be independent in accordance with Nasdaq requirements. Of the five directors
to be nominated for election at the Shareholder Meeting, under the Business Combination Agreement, four are to be designated by Qianzhi
and the remaining director is to be designated by Bowen. The individuals designated by Qianzhi are Dajun Wang, Wei Liang, Wen He, and Zhenning He. Bowen has designated Jun Zhang.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Shareholder Meeting, all five directors will be nominated by management for election to New Bowen&#8217;s board of directors, effective
upon the consummation of the Merger. Information regarding each nominee is set forth below in the section titled &#8220;<i>Directors
and Executive Officers of New Bowen after the Business Combination</i>.&#8221; [Unless authority is withheld or the shares are subject
to a broker non-vote, the proxies solicited by the Bowen Board will be voted &#8220;FOR&#8221; the election of these nominees.]<sup>2
</sup>In case any of the nominees becomes unavailable for election to the board of directors, an event that is not anticipated, the persons
named as proxies, or their substitutes, will have full discretion and authority to vote or refrain from voting for any other candidate
in accordance with their judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
consummation of the Business Combination, the election of directors of New Bowen will be governed by the Proposed Charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resolution
to be Voted Upon</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
as an ordinary resolution of the holders of the Ordinary Shares, that, effective as of the consummation of the Business Combination,
Dajun Wang, Wei Liang, Wen He, Zhenning He, and Jun Zhang be elected to serve on the board of directors until their respective successors
are duly elected and qualified.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required
Vote</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
election of directors requires an ordinary resolution under Cayman Islands law, the affirmative vote of the holders of a majority of
the Bowen Ordinary Shares present (in person virtually or by proxy or, if a corporation or other non-natural person, by its duly authorized
representative) who, being entitled to vote on such proposal at the Shareholder Meeting at which a quorum is present, vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abstentions
will be considered present for the purposes of establishing a quorum but will not constitute votes cast at the Shareholder Meeting and
therefore will have no effect on the approval of the Director Election Proposal. Broker non-votes, if any, will also have no effect on
the approval of the Director Election Proposal. If the Condition Precedent Proposal is not approved, the Director Election Proposal will
not be presented at the Shareholder Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommendation
of the Bowen Board</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN&#8217;S
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT ITS SHAREHOLDERS VOTE &#8220;FOR&#8221; EACH OF THE NOMINEES LISTED IN THIS PROXY STATEMENT/PROSPECTUS,
IF PRESENTED.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="font: 10pt Times New Roman, Times, Serif; width: 25%"><div style="border-top: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>2
</sup>NTD (from GM): Cayman counsel, is this correct? Isn&#8217;t this an ordinary resolution like any other? This language reads like
it is from the Delaware standard, where voting is by a plurality and you either vote &#8220;FOR&#8221; or &#8220;WITHHOLD AUTHORITY&#8221;.
For a Cayman company, don&#8217;t you vote &#8220;FOR,&#8221; &#8220;AGAINST&#8221; or &#8220;ABSTAIN&#8221;, like any other resolution?</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 153; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->140<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_017"></span>PROPOSAL
9: THE ADJOURNMENT PROPOSAL</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Adjournment Proposal allows Bowen&#8217;s Board to submit a proposal to adjourn the Shareholder Meeting to a later date or dates,
if necessary, if Bowen and Qianzhi determine additional time is necessary to consummate the Business Combination. In no event will Bowen
solicit proxies to adjourn the Shareholder Meeting beyond the date by which it may properly do so under the Existing Charter and the
Companies Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose
of the Adjournment Proposal</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Adjournment Proposal is to provide more time if the parties determine such additional time is necessary to consummate
the Business Combination, for instance, if the parties determined that too many holders of Public Shares were seeking redemption at the
Shareholder Meeting or to permit further solicitation of proxies in the event, based on the tabulated votes, there are not sufficient
votes at the time of the Shareholder Meeting to approve the Business Combination Proposal, the Charter Amendment Proposals, the Nasdaq
Proposal, the Equity Incentive Plan Proposal or the Director Election Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consequences
if the Adjournment Proposal is not Approved</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an Adjournment Proposal is presented to the Shareholder Meeting and is not approved by the Bowen shareholders, Bowen&#8217;s Board
may not be able to adjourn the Shareholder Meeting to a later date if necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resolution
to be Voted Upon</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full text of the resolution to be passed is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
as an ordinary resolution, that there are insufficient proxies received at the time of the Meeting to authorize and approve the other
Proposals at the Meeting, the chairman of the Meeting be instructed to adjourn the Meeting in order to allow Golden Star to solicit additional
proxies in favor of the approval of the other Proposals.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required
Vote</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Adjournment Proposal will not be submitted if the Business Combination Proposal is approved. Adoption of the Adjournment
Proposal is not conditioned upon the adoption of any of the other proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
of the Adjournment Proposal will require an ordinary resolution under Cayman Islands law, being the affirmative vote of the
holders of a majority of the Bowen Ordinary Shares present (in person virtually or by proxy or, if a corporation or other non-natural
person, by its duly authorized representative) who, being entitled to vote on such proposal at the Shareholder Meeting at which a quorum
is present, vote. Abstentions will be considered present for the purposes of establishing a quorum but will not constitute votes cast
at the Shareholder Meeting and therefore will have no effect on the approval of the Adjournment Proposal. Broker non-votes,
if any, will also have no effect on the approval of the Adjournment Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOWEN BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT BOWEN SHAREHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE ADJOURNMENT PROPOSAL,
IF PRESENTED.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 154; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->141<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_018"></span>UNAUDITED
PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Introduction</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following unaudited pro forma condensed combined balance sheet as of June 30, 2024, the unaudited pro forma condensed combined
statements of operations for the three months ended June 30, 2024 and for the twelve months ended March 31, 2024 present the combination of the financial information of Bowen and Qianzhi after giving effect
to the Business Combination and related adjustments described in the accompanying notes. Bowen and Qianzhi are referred to herein, subsequent
to the Business Combination, as the post-combination company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined balance sheet combines the unaudited balance sheet of Qianzhi as of June 30, 2024,
with the unaudited consolidated balance sheet of Bowen as of June 30, 2024, giving effect to the Business Combination as if it
had been consummated on June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited pro forma condensed combined statements of operations for the <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">three
months ended June 30, 2024 combines the unaudited statement of operations of Qianzhi for three months ended June 30, 2024, with the unaudited
statement of operations for three months ended June 30, 2024 of Bowen, giving effect to the Business Combination as if it had occurred
on April 1, 2024, the beginning of the earliest period presented.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined statements of operations for the twelve months ended March 31, 2024 combines the audited statement
of operations of Qianzhi for the year ended March 31, 2024, with the unaudited statement of operations for twelve months ended March
31, 2024 of Bowen (see Note 5 for the detail breakdown of the unaudited statement of operations between April 1, 2023, and December
31, 2023 and between January 1, 2024, and March 31, 2024), giving effect to the Business Combination as if it had occurred on April
1, 2023, the beginning of the earliest period presented.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial information is based on and should be read in conjunction with the consolidated financial
statements of Bowen and Qianzhi and the notes thereto, as well as the disclosures contained in the section entitled &#8220;Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial information has been presented for illustrative purposes only and does not necessarily
reflect what the post-combination company&#8217;s financial condition or results of operations would have been had the Business Combination
occurred on the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
the unaudited pro forma condensed combined financial information also may not be useful in predicting the future financial condition
and results of operations of the post-combination company. The actual financial position and results of operations may differ significantly
from the pro forma amounts reflected herein due to a variety of factors. The unaudited pro forma adjustments represent management&#8217;s
estimates based on information available as of the date of these unaudited pro forma condensed combined financial statements and are
subject to change as additional information becomes available and analyses are performed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
of the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 18, 2024, Bowen entered into an Agreement and Plan of Reorganization (the &#8220;Business Combination Agreement&#8221;), by
and among Bowen, Bowen Merger Sub, a Cayman Islands exempted company and a wholly owned subsidiary of Bowen (&#8220;Merger
Sub&#8221;), Shenzhen Qianzhi BioTechnology Co. Ltd., a company incorporated in the People&#8217;s Republic of China and a wholly
owned subsidiary of NewCo (as defined below) (&#8220;Qianzhi&#8221;), and Qianzhi Group Holding (Cayman) Limited, a newly formed
Cayman Islands company (&#8220;NewCo&#8221;). The Business Combination Agreement and the transactions contemplated thereby (the
&#8220;Business Combination&#8221; or the &#8220;Transactions&#8221;) were approved by the boards of directors of Bowen (the
&#8220;Bowen Board&#8221;), Merger Sub, Qianzhi and NewCo. The Business Combination Agreement contemplates that, at the closing of
the Business Combination (the &#8220;Closing&#8221;), upon the terms and subject to the conditions of the Business Combination
Agreement and in accordance with the Companies Act (Revised) of the Cayman Islands, as amended (the &#8220;Cayman Companies
Act&#8221;), Merger Sub will merge with and into NewCo (the &#8220;Merger&#8221;), with NewCo being the surviving company of the
Merger (&#8220;Surviving Company&#8221;) and becoming a wholly owned subsidiary of Bowen. As used in this proxy
statement/prospectus, &#8220;New Bowen&#8221; refers to Bowen after giving effect to the consummation of the Business
Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the Business Combination Agreement, the parties are using commercially reasonable efforts to solicit investors (the &#8220;PIPE
Investors&#8221;) to enter into subscription agreements with Bowen, on terms approved by Qianzhi, pursuant to which the PIPE Investors
will purchase, concurrently with the closing of the Merger, equity or equity-linked securities of Bowen in an aggregate amount of $5.0
million (the &#8220;PIPE Financing&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 155; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->142<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, at the effective time of the Merger (the &#8220;Effective Time&#8221;), all of the NewCo Ordinary
Shares issued and outstanding immediately prior to the Effective Time other than (i) NewCo Ordinary Shares held by Bowen or Qianzhi
or their respective wholly owned subsidiaries and (ii) those NewCo Ordinary Shares owned by the holders of NewCo Ordinary Shares
who have validly exercised and not effectively withdrawn or lost their rights to dissent from the Merger pursuant to the Cayman Companies
Act, will be automatically converted into the right to receive an aggregate of (a) 7,246,377 ordinary shares of Bowen (&#8220;Bowen Ordinary
Shares&#8221;), a portion of which shall be deposited in escrow to provide for indemnification in accordance with the Business Combination
Agreement (the &#8220;Merger Shares&#8221;), and (b) the contingent right to receive earnout consideration of up to an aggregate
of 1,400,000 Bowen Ordinary Shares (the &#8220;Earnout Shares&#8221;). The Earnout Shares will be issued if and to the extent certain
net income milestones are achieved by New Bowen and its subsidiaries during the fiscal years ended March 31, 2025 and 2026. The Merger Shares and Earnout Shares will be referred to herein collectively as the &#8220;Merger Consideration.&#8221; </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consummation of the Merger and the other transactions contemplated by the Business Combination Agreement requires that Bowen having at
least $5,000,001 of net tangible assets (after giving effect to redemptions by Bowen&#8217;s public shareholders) immediately prior to
or upon the Closing. In the maximum redemption scenario, when 6,900,000 Bowen Public Shares are redeemed, net tangible assets of Bowen
will be less than $5,000,001, however, with the issuance of securities in the proposed PIPE Financing of $5.0 million, Bowen will be
in compliance with the net tangible assets requirement of Nasdaq. Without the PIPE financing, Bowen&#8217;s failure to maintain compliance
with the net tangible assets requirement will result in termination of the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is a calculation, on a per Bowen Ordinary Share basis, of the estimated net cash to be received by New Bowen from the Trust
Account in a no redemption scenario, 25% redemption scenario, 75% redemption scenario, and the maximum redemption scenario. Such calculations
are based upon (i) cash held in the Trust Account as of June 30, 2024 of approximately $10.62 per Public Share (rounded
to the nearest cent) and (ii) estimated transaction expenses of $3,145,944. The total number of shares outstanding in the table
below gives effect to the issuance of Merger Shares and the conversion of the Bowen Rights into Bowen Ordinary Shares upon consummation
of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    <br/> No <br/> Redemption<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    <br/> 25% <br/> Redemption<sup>(2)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    <br/> 75% <br/> Redemption<sup>(3)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
Maximum    <br/> Redemption<sup>(4)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Bowen Ordinary Shares Not Redeemed</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">6,900,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">5,175,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">1,725,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gross Cash Proceeds of Trust Account at $10.62 per Share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">73,284,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">54,965,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18,326,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Estimated Transaction Expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,145,944</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,145,944</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,145,944</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,145,944</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Shares Outstanding&#160;<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,039,026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,314,026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,864,026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,139,026</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Net Cash per Share of Bowen Ordinary Shares Outstanding</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3.68</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.99</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.09</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A*</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    is less than zero.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    scenario assumes that no Public Shares are redeemed by Public Shareholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    scenario assumes that 1,725,000 Public Shares are redeemed by Public Shareholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    scenario assumes that 5,175,000 Public Shares are redeemed by Public Shareholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    scenario assumes that 6,900,000 Public Shares are redeemed by Public Shareholders.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) an aggregate of 690,000 Bowen Ordinary Shares to be issued upon conversion of the outstanding Bowen Rights upon consummation
    of the Business Combination; (ii) an aggregate of 36,150 Bowen Ordinary Shares to be issued upon conversion of the Bowen Private
    Rights upon consummation of the Business Combination; (iii) an aggregate of 500,000 Bowen Ordinary Shares to be issued in <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
PIPE Financing; and (iv) an aggregate of 1,400,000 Earnout Shares</span>.</span></td></tr>
  </table>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anticipated
Accounting Treatment</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the legal form of the Business Combination pursuant to the Business Combination Agreement, the Business Combination will be accounted
as recapitalization. Under this method of accounting, Bowen will be treated as the &#8220;acquired&#8221; company and Qianzhi will be
treated as the acquirer for financial statement reporting purposes. Qianzhi has been determined to be the accounting acquirer based on
evaluation of the following facts and circumstances:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi&#8217;s
                                            shareholders will have the largest voting interest in the post-combination company under
                                            the no redemption, 25% redemption, 75% redemption and 100% redemption scenarios;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi&#8217;s
                                            shareholders will have the ability to nominate at least a majority of the members of the
                                            board of directors of the combined entity;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi&#8217;s
                                            senior management is the senior management of the post-combination company;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
                                            is the larger entity, in terms of substantive operations and employee base.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 22pt; text-align: justify; text-indent: -22pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
of Pro Forma Presentation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
noted above, the unaudited pro forma condensed combined financial information contained herein assumes that Bowen&#8217;s shareholders
approve the proposed Business Combination. Bowen cannot predict how many of the Bowen Public Shareholders will exercise their right to
have their Bowen Public Shares redeemed for cash. As a result, Qianzhi has elected to provide the unaudited pro forma condensed combined
financial information under four different redemption scenarios, which produce different allocations of total Qianzhi equity between
holders of Qianzhi Ordinary Shares. The actual results will likely be within the parameters described by the four scenarios, however,
there can be no assurance regarding which scenario will be closest to the actual results. Under all scenarios, Qianzhi is considered
to be the accounting acquirer. The following table sets forth summary historical comparative share information for Bowen and Qianzhi
and unaudited pro forma condensed combined per share information of the combined company after giving effect to the Business Combination,
assuming four redemption scenarios as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
                                            No Redemptions: This presentation assumes that no Bowen Public Shareholders elect to have
                                            their Bowen Public Shares redeemed for cash in connection with the Business Combination as
                                            permitted by the Bowen Articles and there are no Dissenting Bowen Shares.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
                                            25% Redemptions: This presentation assumes that 1,725,000 Bowen Public Shares are redeemed
                                            for aggregate redemption payments of $18,319,500, assuming a $10.62 per share
                                            Redemption Price and based on funds in the trust account as of June 30, 2024.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
                                            75% Redemptions: This presentation assumes that 5,175,000 Bowen Public Shares are redeemed
                                            for aggregate redemption payments of $54,958,500, assuming a $10.62 per share
                                            Redemption Price and based on funds in the trust account as of June 30, 2024.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
                                            maximum Redemptions: This presentation assumes that 6,900,000 Bowen Public Shares are redeemed
                                            for aggregate redemption payments of $73,284,700, assuming a $10.62 per share
                                            Redemption Price and based on funds in the trust account as of June 30, 2024.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt">The pro forma shares of the combined Company
common stock issued and outstanding immediately after the Merger under the four redemption scenarios are as below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="30" style="border-bottom: Black 1.5pt solid; text-align: center">Pro Forma Combined</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">Scenario 1</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">Scenario 2</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">Scenario 3</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">Scenario 4</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Assuming No Redemptions</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Assuming 25% Redemptions</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Assuming 75% Redemptions</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Assuming Maximum Redemptions</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">Bowen public stockholders</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">7,590,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">39.9</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">5,865,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">33.9</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">2,415,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">17.4</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">690,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">5.7</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Bowen Initial Stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,302,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,302,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,302,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,302,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Qianzhi shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,646,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45.4</td><td style="text-align: left"><p style="margin: 0">%</p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,646,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49.9</td><td style="text-align: left"><p style="margin: 0">%</p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,646,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62.4</td><td style="text-align: left"><p style="margin: 0">%</p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,646,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">71.2</td><td style="text-align: left"><p style="margin: 0">%</p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">PIPE Investors</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">500,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.6</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">500,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.9</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">500,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3.6</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">500,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4.1</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Pro forma ordinary shares issued and outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,039,026</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">17,314,026</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,864,026</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,139,026</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -22pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 22pt; text-align: justify; text-indent: -22pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 156; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->143<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
PRO FORMA CONDENSED COMBINED BALANCE SHEET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AS
OF June 30, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="8" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Scenario
    1<br/>
    Assuming No Redemptions</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="8" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Scenario
    2<br/>
    Assuming 25% Redemptions</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="8" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Scenario
    3<br/>
    Assuming 75% Redemptions</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="8" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Scenario
    4<br/>
    Assuming Maximum Redemptions *</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(A)
    <br/>
    Bowen</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(B)
    <br/>
    Qianzhi</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Transaction
    Accounting Adjustments</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Note</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Pro
    forma Balance Sheet</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Transaction
    Accounting Adjustments</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Note</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Pro
    forma Balance Sheet</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Transaction
    Accounting Adjustments</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Note</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Pro
    forma Balance Sheet</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Transaction
    Accounting Adjustments</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Note</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Pro
    forma Balance Sheet</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>ASSETS</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current
    assets:</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cash</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">272,630</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,497,989</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">77,719,645</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">59,400,145</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">22,761,145</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,434,945</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(18,319,500</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(54,958,500</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,000,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,000,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,000,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,000,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(9)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(9)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(9)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(9)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Accounts
    receivables</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19,133</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19,133</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19,133</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19,133</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19,133</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Account
    receivables &#8211; related parties</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74,643</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74,643</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74,643</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74,643</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74,643</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Inventories</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">306,961</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">306,961</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">306,961</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">306,961</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">306,961</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Advance
    to suppliers</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">220,198</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">220,198</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">220,198</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">220,198</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">220,198</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other
    receivables &#8211; related parties</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">912,052</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">912,052</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">912,052</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">912,052</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">912,052</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other
    current assets</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">87,408</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">289,266</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">376,674</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">376,674</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">376,674</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">376,674</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total
    current assets</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">360,038</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,320,242</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74,949,026</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">79,629,306</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">56,629,526</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">61,309,806</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19,990,526</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">24,670,806</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,664,326</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6,344,606</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investments
    held in trust account</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Property
    and equipment, net</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">514,947</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">514,947</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">514,947</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">514,947</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">514,947</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Right-of-use
    lease assets, net</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">540,702</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">540,702</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">540,702</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">540,702</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">540,702</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Deposit
    and other assets</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">626,892</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">626,892</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">626,892</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">626,892</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">626,892</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total
    non-current assets</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,682,541</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,682,541</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,682,541</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,682,541</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,682,541</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#12288;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>TOTAL
    ASSETS</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73,644,738</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6,002,783</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,664,326</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">81,311,847</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16,655,174</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">62,992,347</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(53,294,174</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">26,353,347</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(71,620,374</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">8,027,147</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>LIABILITIES
    AND EQUITY</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>CURRENT
    LIABILITIES</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Short-term
    loans</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">110,084</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">110,084</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">110,084</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">110,084</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">110,084</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Accounts
    payable</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,692</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,692</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,692</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,692</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,692</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Contract
    liabilities</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">234,876</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">234,876</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">234,876</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">234,876</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">234,876</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Taxes
    payable</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">435,407</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">435,407</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">435,407</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">435,407</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">435,407</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other
    payables</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">89,682</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">89,682</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">89,682</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">89,682</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">89,682</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other
    payables &#8211; related parties</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">39,115</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">39,115</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">39,115</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">39,115</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">39,115</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Accrued
    offering costs and expenses</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Accrued
    expenses - related party</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">30,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">30,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">30,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">30,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">30,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other
    current liabilities</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">166,406</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">166,406</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">166,406</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">166,406</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">166,406</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Operating
    lease liability, current</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">214,596</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">214,596</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">214,596</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">214,596</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">214,596</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>TOTAL
    CURRENT LIABILITIES</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">219,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,295,858</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,325,858</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,325,858</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,325,858</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,325,858</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Operating
    lease liability, noncurrent</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">299,200</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">299,200</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">299,200</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">299,200</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">299,200</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>TOTAL
    LIABILITIES</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">219,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,595,058</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,625,058</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,625,058</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,625,058</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(189,730</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,625,058</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Commitments</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Ordinary
    shares subject to possible redemption, 6,900,000 at redemption value of $10.62</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73,284,700</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>EQUITY</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Ordinary
    shares</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">227</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">763</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,904</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">590</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,731</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">245</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,386</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,214</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(50,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(50,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(50,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(50,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">724</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">724</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">724</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">724</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">140</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">140</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">140</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">140</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Additional
    paid in capital</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,034,392</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">140,081</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">78,361,552</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">140,081</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">60,042,225</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">140,081</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">23,403,570</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">140,081</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,077,542</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(724</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(724</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(724</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(724</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(140</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(140</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(140</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(140</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73,283,937</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">54,964,610</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">18,325,955</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,999,950</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,999,950</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,999,950</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,999,950</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(9)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(9)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(9)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(9)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Statutory
    reserve</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">461,228</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">461,228</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">461,228</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">461,228</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">461,228</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Retained
    earnings</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">140,081</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,434,528</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(140,081</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,434,528</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(140,081</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,434,528</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(140,081</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,434,528</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(140,081</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,434,528</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Accumulated
    other comprehensive loss</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(572,423</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(572,423</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(572,423</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(572,423</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(572,423</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>TOTAL
    SHAREHOLDERS&#8217; EQUITY</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">140,308</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,407,725</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">75,138,756</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">79,686,789</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">56,819,256</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">61,367,289</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">20,180,256</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">24,728,289</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,854,056</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6,402,089</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>TOTAL
    LIABILITIES AND EQUITY</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73,644,738</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6,002,783</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,664,326</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">81,311,847</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16,655,174</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">62,992,347</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(53,294,174</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">26,353,347</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(71,620,374</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">8,027,147</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  </table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Refer to the accompanying notes to the unaudited
pro forma financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(A) Derived from the unaudited balance sheet of Bowen
as of June 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(B) Derived from the unaudited balance sheet
of Qianzhi as of June 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">* In the maximum redemption scenario, net tangible
assets of Bowen will be less than $5,000,001, however, with the issuance of securities in the proposed PIPE Financing of $5.0 million,
Bowen will be in compliance with the net tangible assets requirement of Nasdaq. Without the PIPE financing, Bowen&#8217;s failure to maintain
compliance with the net tangible assets requirement will result in termination of the Merger.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 157; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->144<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE MONTHS ENDED JUNE 30, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="8" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Scenario
    1 <br/>
    Assuming No Redemptions</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="8" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Scenario
    2<br/>
    Assuming 25% Redemptions</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="8" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Scenario
    3<br/>
    Assuming 75% Redemptions</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="8" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Scenario
    4<br/>
    Assuming Maximum Redemptions</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(A)
    <br/>
    Bowen</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(B)
    <br/>
    Qianzhi</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Transaction
    Accounting Adjustments</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Note</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Pro
    forma Income statement</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Transaction
    Accounting Adjustments</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Note</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Pro
    forma Income statement</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Transaction
    Accounting Adjustments</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Note</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Pro
    forma Income statement</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Transaction
    Accounting Adjustments</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Note</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Pro
    forma Income statement</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Revenue,
    net</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,665,658</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,665,658</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,665,658</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,665,658</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,665,658</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cost
    of revenue</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(123,621</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(123,621</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(123,621</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(123,621</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(123,621</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Promotion
    cost</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(561,675</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(561,675</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(561,675</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(561,675</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(561,675</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Gross
    profit</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">980,362</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">980,362</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">980,362</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">980,362</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">980,362</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Operating
    expenses</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Selling
    and marketing</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(528,211</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(528,211</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(528,211</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(528,211</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(528,211</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">General
    and administrative</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(125,096</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(917,199</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(i)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,158,239</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(i)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,158,239</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(i)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,158,239</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(i)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,158,239</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#12288;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">30,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(ii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">30,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(ii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">30,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(ii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">30,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(ii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Research
    and development</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16,464</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16,464</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16,464</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16,464</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16,464</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Total
    operating expenses</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(125,096</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,461,874</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,115,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,702,914</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,115,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,702,914</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,115,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,702,914</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,115,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,702,914</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>INCOME
    FROM OPERATIONS</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(125,096</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(481,512</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,115,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,722,552</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,115,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,722,552</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,115,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,722,552</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,115,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,722,552</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>OTHER
    INCOME(EXPENSES)</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest
    income</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">941,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">959</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(941,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(iii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">959</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(941,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(iii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">959</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(941,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(iii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">959</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(941,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(iii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">959</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest
    expense</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(821</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(821</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(821</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(821</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(821</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Government
    subsidies</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">9,512</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">9,512</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">9,512</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">9,512</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">9,512</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other
    loss, net</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(36,929</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(36,929</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(36,929</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(36,929</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(36,929</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Total
    other income (expense), net</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">941,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(27,279</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(941,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(27,279</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(941,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(27,279</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(941,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(27,279</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(941,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(27,279</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income
    (loss) before income tax provision</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">816,754</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(508,791</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,057,794</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,749,831</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,057,794</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,749,831</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,057,794</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,749,831</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,057,794</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,749,831</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#12288;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#12288;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#12288;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#12288;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income
    tax provision</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16,465</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16,465</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16,465</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16,465</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16,465</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#12288;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#12288;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#12288;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#12288;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Net
    income (loss)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">816,754</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(525,256</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,057,794</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,766,296</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,057,794</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,766,296</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,057,794</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,766,296</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,057,794</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,766,296</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Weighted
    average shares outstanding, common stock subject to possible redemption</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6,900,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Basic
    and diluted net income per share, common stock subject to redemption</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.12</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Weighted
    average shares outstanding, common stock, non-redeemable</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,266,500</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Basic
    and diluted net income per share, common stock, non-redeemable</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0,01</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Basic
    and diluted weighted average of ordinary shares outstanding</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Basic
    and diluted loss per share</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(10.51</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Basic
    and diluted pro forma weighted average shares outstanding</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17,639,026</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,914,026</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12,464,026</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10,739,026</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Basic
    and diluted pro forma net loss per share</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.21</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.24</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.30</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.35</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Excluding Earnout Shares (see Note 4).</span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to the accompanying notes to the unaudited pro forma financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 158; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->145<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE TWELVE MONTHS ENDED MARCH 31, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="8" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Scenario
                                            1</span></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Assuming
    No Redemptions</span></p></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="8" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Scenario
    2<br/>
    Assuming 25% Redemptions</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="8" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Scenario
    3<br/>
    Assuming 75% Redemptions</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="8" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Scenario
    4<br/>
    Assuming Maximum Redemptions</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="4" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(A)</span></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Bowen</span></p></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(B)</span></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;Qianzhi</span></p></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Transaction
    Accounting Adjustments</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Note</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Pro
    forma Income statement</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Transaction
    Accounting Adjustments</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Note</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Pro
    forma Income statement</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Transaction
    Accounting Adjustments</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Note</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Pro
    forma Income statement</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Transaction
    Accounting Adjustments</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Note</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Pro
    forma Income statement</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Revenue,
    net</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7,030,989</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7,030,989</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7,030,989</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7,030,989</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7,030,989</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cost
    of revenue</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(569,368</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(569,368</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(569,368</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(569,368</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(569,368</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Promotion
    cost</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,481,225</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,481,225</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,481,225</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,481,225</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,481,225</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Gross
    profit</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,980,396</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,980,396</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,980,396</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,980,396</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,980,396</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Operating
    expenses</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Selling
    and marketing</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(44,159</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(44,159</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(44,159</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(44,159</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(44,159</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">General
    and administrative</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(378,593</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,318,060</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(i)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7,755,930</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(i)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7,755,930</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(i)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7,755,930</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,145,944</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(i)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7,755,930</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">86,667</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(ii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">86,667</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(ii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">86,667</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(ii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">86,667</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(ii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Research
    and development</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(59,878</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(59,878</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(59,878</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(59,878</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(59,878</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Total
    operating expenses</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(378,593</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,422,097</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,059,277</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7,859,967</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,059,277</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7,859,967</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,059,277</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7,859,967</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,059,277</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7,859,967</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>INCOME
    FROM OPERATIONS</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(378,593</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(441,701</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,059,277</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,879,571</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,059,277</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,879,571</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,059,277</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,879,571</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,059,277</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,879,571</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>OTHER
    INCOME(EXPENSES)</b></span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest
    income</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,652,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,246</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,652,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(iii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,246</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,652,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(iii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,246</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,652,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(iii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,246</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,652,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(iii)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,246</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest
    expense</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,088</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,088</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,088</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,088</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,088</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Government
    subsidies</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74,716</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74,716</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74,716</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74,716</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74,716</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other
    income, net</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">21,128</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">21,128</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">21,128</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">21,128</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">21,128</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Total
    other income, net</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,652,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">96,002</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,652,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">96,002</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,652,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">96,002</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,652,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">96,002</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,652,850</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">96,002</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income
    (loss) before income tax provision</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,274,257</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(345,699</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,712,127</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,783,569</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,712,127</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,783,569</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,712,127</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,783,569</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,712,127</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,783,569</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income
    tax provision</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(352,475</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(352,475</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(352,475</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(352,475</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(352,475</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Net
    income (loss)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,274,257</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(698,174</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,712,127</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,136,044</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,712,127</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,136,044</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,712,127</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,136,044</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,712,127</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,136,044</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Weighted
    average shares outstanding, common stock subject to possible redemption</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,929,508</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Basic
    and diluted net income per share, common stock subject to redemption</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.95</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Weighted
    average shares outstanding, common stock, non-redeemable</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,163,434</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Basic
    and diluted net income per share, common stock, non-redeemable</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.12</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Basic
    and diluted weighted average of ordinary shares outstanding</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50,000</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Basic
    and diluted loss per share</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(13.96</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Basic
    and diluted pro forma weighted average shares outstanding *</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17,639,026</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,914,026</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12,464,026</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10,739,026</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Basic
    and diluted pro forma net loss per share</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.23</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.26</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.33</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.39</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Excluding Earnout Shares (see Note 4).</span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to the accompanying notes to the unaudited pro forma financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
Unaudited historical statement of operations of Bowen for the twelve months ended March 31, 2024 (see Note 5).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
Derived from the audited statement of operations of Qianzhi for the year ended March 31, 2024.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 159; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->146<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
1&#8212;Basis of Presentation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial information is based on Bowen&#8217;s unaudited historical financial statements and
Qianzhi&#8217;s unaudited historical consolidated financial statements as adjusted to give effect to the Business Combination
and Material Events. The unaudited pro forma condensed combined balance sheet gives effect to the Business Combination and Material Events
as if they had occurred on June 30, 2024. The unaudited pro forma condensed combined statement of operations for the t<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">hree
months ended June 30, 2024 gives effect to the Business Combination and Material Events as if they had occurred on April 1, 2024. </span> The unaudited pro forma condensed combined statement of operations for the
twelve months ended March 31, 2024 gives effect to the Business Combination and Material Events as if they had occurred on April 1, 2023.
Bowen&#8217;s results for its twelve months ended March 31, 2024 are derived by adding the results of the three months ended March 31,
2024, to its statement of operations for the year ended December 31, 2023, and subtracting the results of the three months ended March
31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial information should be read in conjunction with:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            accompanying notes to the unaudited pro forma condensed combined financial information;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the audited historical statement of operations of Bowen for the year ended December 31, 2023;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the
                                            unaudited historical financial statements of Bowen as of June 30, 2024 and for the
                                            three months ended June 30, 2024 and March 31, 2024;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            audited historical financial statements of Qianzhi as of March 31, 2024 and for the year
                                            ended March 31, 2024;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the unaudited historical financial statements of Qianzhi as of <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
30, 2024 and for the three months ended June 30, 2024 and the related notes thereto, included elsewhere in this proxy statement/prospectus;
and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            sections entitled &#8220;The Business Combination Agreement,&#8221; &#8220;Related Agreements
                                            &#8211; Subscription Agreements,&#8221; &#8220;Bowen&#8217;s Management&#8217;s Discussion
                                            and Analysis of Financial Condition and Results of Operations,&#8221; &#8220;Qianzhi&#8217;s
                                            Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221;
                                            and other financial information relating to Bowen and Qianzhi included elsewhere in this
                                            proxy statement/prospectus.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 22pt; text-align: justify; text-indent: -22pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial information below presents four redemption scenarios as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
                                            No Redemptions: This presentation assumes that no Bowen Public Shareholders elect to have
                                            their Bowen Public Shares redeemed for cash in connection with the Business Combination as
                                            permitted by the Bowen Articles and there are no Dissenting Bowen Shares.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
                                            25% Redemptions: This presentation assumes that 1,725,000 Bowen Public Shares are redeemed
                                            for aggregate redemption payments of $18,319,500, assuming a $10.62 per share
                                            Redemption Price and based on funds in the trust account as of June 30, 2024.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
                                            75% Redemptions: This presentation assumes that 5,175,000 Bowen Public Shares are redeemed
                                            for aggregate redemption payments of $54,958,500, assuming a $10.62 per share
                                            Redemption Price and based on funds in the trust account as of June 30, 2024.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
                                            maximum Redemptions: This presentation assumes that 6,900,000 Bowen Public Shares are redeemed
                                            for aggregate redemption payments of $73,284,700, assuming a $10.62 per share
                                            Redemption Price and based on funds in the trust account as of June 30, 2024.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 22pt; text-align: justify; text-indent: -22pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2&#8212;Accounting Policies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of the Business Combination, management will perform a comprehensive review of the two entities&#8217; accounting policies.
As a result of the review, management may identify differences between the accounting policies of the two entities which, when conformed,
could have a material impact on the financial statements of the post-combination company. Based on its initial analysis, management did
not identify any differences that would have a material impact on the unaudited pro forma condensed combined financial information. As
a result, the unaudited pro forma condensed combined financial information does not assume any differences in accounting policies.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3&#8212;Adjustments to Unaudited Pro Forma Condensed Combined Financial Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma adjustments included in the unaudited pro forma condensed combined balance sheet as of June 30, 2024 and in the unaudited
pro forma condensed combined statements of operations for the three months ended June 30, 2024 and for the twelve months ended March 31, 2024 are based on preliminary estimates.
The final amounts recorded may differ from the information presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Adjustments
to Unaudited Pro Forma Condensed Combined Balance Sheet</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma adjustments included in the unaudited pro forma condensed combined balance sheet as of June 30, 2024 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            the transfer of cash held in trust account to cash;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
                                            the settlement of accrued offering costs and expenses that become due and payable upon consummation
                                            of the merger;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
                                            the elimination of Bowen&#8217;s historical retained earnings;</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
                                                                                                                           <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">(4)</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Reflects
                                            the elimination of 50,000 NewCo Ordinary Shares, par value $1.00;</td></tr>
                                                                                                                           </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
                                            the conversion of NewCo Ordinary Share to 7,246,377 ordinary shares, par value $0.0001;</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
                                                                                                                                                    <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">(6)</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Reflects the issuance of <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,400,000 earnout
shares as earnout consideration and deemed to be as equity instruments in accordance with ASC 805 and ASC 815. The holders of NewCo Ordinary
Shares will be entitled to receive the Earnout Shares in the event there occurs any transaction resulting in a change of control during
the period of time that the Earnout Shares are earnable;</span></td></tr>
                                                                                                                                                    </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            Scenario 1, reflects the reclassification of 6,900,000 ordinary shares subject to possible
                                            redemption to permanent equity at $0.0001 par value with no redemptions. In Scenario 2, which
                                            assumes the same facts as described in Items 1 through 5 above, but also assumes 1,725,000
                                            shares, which is 25% of Bowen redeemable shares, are redeemed for cash by Bowen shareholders,
                                            at a redemption price of $10.62 per share. In Scenario 3, which assumes the same facts
                                            as described in Items 1 through 5 above, but also assumes 5,175,000 shares, which is 75%
                                            of Bowen redeemable shares, are redeemed for cash by Bowen shareholders, at a redemption
                                            price of $10.62 per share. In Scenario 4, which assumes the same facts as described
                                            in Items 1 through 5 above, but also assumes the maximum number of 6,900,000 shares are redeemed
                                            for cash by Bowen shareholders, at a redemption price of $10.62 per share;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
                                            the issuance of 500,000 Bowen Ordinary Shares to certain investors for an aggregate of $5.0
                                            million in the PIPE Financing, par value $0.0001 per share for a purchase price of $10.00
                                            per share; and</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
                                                      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects the payment of transaction expenses of $3.15 million (including
a $2.415 million business combination marketing agreement fee payable to the IPO Underwriter, as well as legal, financial advisory, accounting,
auditing and other professional fees) upon consummation of the Business Combination. As part of the Business Combination, $3.15 million
will offset to additional-paid-in capital.</span></td></tr>
                                                      </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 160; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->147<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Statements
of Operations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma adjustment included in the unaudited pro forma condensed combined statements of operations for the three months ended June 30, 2024 and for the twelve months ended
March 31, 2024 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Reflects preliminary estimated of transaction expenses of $3.15 million (including a $2.415 million business combination marketing
agreement fee payable to the IPO Underwriter, as well as legal, financial advisory, accounting, auditing and other professional fees)
upon consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(ii) Represents an adjustment to reverse the related
party administrative expense, as the services will cease upon closing of the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an adjustment to eliminate interest earned
on marketable securities held in Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4&#8212;Net Loss per Share</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss per share was calculated using the historical weighted average shares outstanding, and the issuance of additional shares in connection
with the Business Combination, assuming the shares were outstanding since April 1, 2023. As the Business Combination and related
transactions are being reflected as if they had occurred at the beginning of the period presented, the calculation of weighted average
shares outstanding for basic and diluted net loss per share assumes that the shares issuable in the Business Combination have been outstanding
for the entirety of the period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Earnout Shares will be issued if and to the extent certain net income milestones are achieved by New Bowen and its subsidiaries during
the fiscal years ended March 31, 2025 and 2026. Contingently issuable shares should be included in basic EPS only when there is no circumstance
under which those shares would not be issued and basic EPS should not be restated for changed circumstances. Therefore, the Earnout Shares
are not included in basic pro forma shares outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial information has been prepared to present four alternative scenarios with respect to
redemption of ordinary shares by Public Shareholders at the time of the Business Combination for the three months ended June 30, 2024 and for the twelve months ended March
31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center">Pro Forma Combined</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Scenario 1<br/> Assuming No Redemptions</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Scenario 2<br/> Assuming 25% Redemptions</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Scenario 3<br/> Assuming 75% Redemptions</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Scenario 4<br/> Assuming Maximum Redemptions</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">For the three months ended June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left">Pro forma net income</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(3,766,296</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(3,766,296</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(3,766,296</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(3,766,296</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Pro forma basic and diluted net loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.21</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.24</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.30</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.35</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">For the twelve months ended March 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pro forma net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,136,044</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(4,136,044</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(4,136,044</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(4,136,044</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Pro forma basic and diluted net loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.23</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.26</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.33</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.39</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Number of ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Bowen public stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,590,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,865,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,415,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">690,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Bowen Initial Stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,302,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,302,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,302,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,302,650</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Qianzhi shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,246,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,246,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,246,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,246,376</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">PIPE Investors</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">500,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">500,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">500,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">500,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Pro forma weighted-average shares outstanding&#8212;basic and diluted</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,639,026</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,914,026</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,464,026</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,739,026</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Antidilutive shares not included in the computation of diluted net loss per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024 Incentive Plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">951,951</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">865,701</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">693,201</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">606,951</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Earnout Shares</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,400,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,400,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,400,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,400,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total antidilutive shares</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,351,951</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,265,701</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,093,201</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,006,951</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5 &#8211; The table below is the breakdown of unaudited historical statement of operations of Bowen for the twelve months ended March
31, 2024:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Bowen Historical (Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">April 1, 2023 <br/>
    to December 31,<br/>
    2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">January 1, 2024<br/>
    to March<br/>
    31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Combined</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 1.5pt">Formation and operating costs</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">241,463</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">137,130</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">378,593</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(241,463</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(137,130</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(378,593</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other Income:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Interest earned on investments held in trust account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,729,358</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">923,492</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,652,850</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,729,358</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">923,492</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,652,850</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net income</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,487,895</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">786,362</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,274,257</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 161; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->148<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_019"></span>
MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Federal Income Tax Considerations</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion is a summary of U.S. federal income tax considerations for U.S. Holders and Non-U.S. Holders (each as defined
below, and together, &#8220;<span style="font-weight: normal"><i>holders</i></span>&#8221;) of (i) the exercise of redemption rights
by U.S. Holders (as defined below) of Bowen Ordinary Shares, and (ii) the ownership and disposition of New Bowen Ordinary Shares after
the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section applies only to holders that hold Bowen securities, or as applicable, Qianzhi securities and, after the completion of the Business
Combination, New Bowen securities, as &#8220;capital assets&#8221; within the meaning of Section 1221 of the Code (generally, property
held for investment). This discussion does not discuss all aspects of U.S. federal income taxation that may be relevant to holders in
light of their particular circumstances or status including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">financial
                                            institutions or financial services entities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">broker-dealers;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">taxpayers
                                            that are subject to the mark-to-market accounting rules;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt
                                            entities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">governments
                                            or agencies or instrumentalities thereof;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">insurance
                                            companies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated
                                            investment companies or real estate investment trusts;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expatriates
                                            or former long-term residents of the United States;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            that actually or constructively own five percent or more of our voting shares or five percent
                                            or more of the total value of all classes of our shares, or following the Business Combination,
                                            will own five percent or more of the shares of New Bowen, by vote or value;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            that acquired our securities pursuant to an exercise of employee share options, in connection
                                            with employee share incentive plans or otherwise as compensation;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            that hold our securities as part of a straddle, constructive sale, hedging, conversion or
                                            other integrated or similar transaction;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            whose functional currency is not the U.S. dollar;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">controlled
                                            foreign corporations; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">passive
                                            foreign investment companies.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to the consequences of ownership and disposition of New Bowen Ordinary Shares, this discussion is limited to U.S. Holders that
will acquire such New Bowen Shares by virtue of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion is based on the Code, proposed, temporary and final Treasury regulations promulgated under the Code, and judicial and administrative
interpretations thereof, all as of the date hereof. The foregoing is subject to change, which change could apply retroactively and could
affect the tax considerations described herein. This discussion does not address U.S. federal taxes other than those pertaining to U.S.
federal income taxation (such as estate or gift taxes, the alternative minimum tax or the Medicare tax on investment income), nor does
it address any aspects of U.S. state or local or Non-U.S. taxation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not and do not intend to seek any rulings from the Internal Revenue Service (&#8220;<span style="font-weight: normal"><i>IRS</i></span>&#8221;)
regarding the Business Combination or any other related matters. There can be no assurance that the IRS will not take positions inconsistent
with the considerations discussed below or that any such positions would not be sustained by a court.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this proxy statement/prospectus, the term &#8220;<span style="font-weight: normal"><i>U.S. Holder</i></span>&#8221; means a beneficial
owner of Bowen securities or Qianzhi securities, as applicable, and after the Business Combination, New Bowen securities received in
the Business Combination, who or that is, for U.S. federal income tax purposes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            individual who is a citizen or resident of the United States;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 162; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->149<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            corporation (or other entity that is treated as a corporation for U.S. federal income tax
                                            purposes) that is created or organized (or treated as created or organized) in or under the
                                            laws of the United States or any state thereof or the District of Columbia;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            estate whose income is subject to U.S. federal income tax regardless of its source; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            trust if (i) a U.S. court can exercise primary supervision over the administration of such
                                            trust and one or more U.S. persons have the authority to control all substantial decisions
                                            of the trust or (ii) it has a valid election in place to be treated as a U.S. person for
                                            U.S. federal income tax purposes.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
&#8220;<span style="font-weight: normal"><i>Non-U.S. Holder</i></span>&#8221; means a beneficial owner of Bowen securities or Qianzhi
securities, and, after the Business Combination, New Bowen securities received in the Business Combination, that is, for U.S. federal
income tax purposes, an individual, corporation, estate or trust that is not a U.S. Holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion does not consider the tax treatment of partnerships or other pass-through entities or persons who hold our securities through
such entities. If a partnership (or any entity or arrangement so characterized for U.S. federal income tax purposes) holds Bowen securities
or Qianzhi securities, the U.S. federal income tax treatment of such partnership and a person treated as a partner of such partnership
will generally depend on the status of the partner and the activities of the partnership. A holder that is a partnership and the partners
in such partnership should consult their own tax advisors with regard to the U.S. federal income tax consequences of the transactions
described herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SUMMARY DOES NOT PURPORT TO BE A COMPREHENSIVE ANALYSIS OR DESCRIPTION OF ALL POTENTIAL U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE BUSINESS
COMBINATION, OWNERSHIP AND DISPOSITION OF NEW BOWEN SECURITIES AND THE EXERCISE OF REDEMPTION RIGHTS. IN ADDITION, THE U.S. FEDERAL INCOME
TAX TREATMENT OF THE BENEFICIAL OWNERS OF BOWEN SECURITIES, QIANZHI SECURITIES OR NEW BOWEN SECURITIES MAY BE AFFECTED BY MATTERS NOT
DISCUSSED HEREIN AND DEPENDS IN SOME INSTANCES ON DETERMINATIONS OF FACT AND INTERPRETATIONS OF COMPLEX PROVISIONS OF U.S. FEDERAL INCOME
TAX LAW FOR WHICH NO CLEAR PRECEDENT OR AUTHORITY MAY BE AVAILABLE. HOLDERS OF BOWEN SECURITIES OR QIANZHI SECURITIES SHOULD CONSULT
WITH THEIR TAX ADVISORS REGARDING THE PARTICULAR TAX CONSEQUENCES TO THEM OF THE BUSINESS COMBINATION AND OF THE OWNERSHIP AND DISPOSITION
OF NEW BOWEN SECURITIES AFTER THE BUSINESS COMBINATION, INCLUDING THE APPLICABILITY AND EFFECTS OF U.S. FEDERAL, STATE, LOCAL, AND OTHER
TAX LAWS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Federal Income Taxation of U.S. Holders</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material
U.S. Federal Income Tax Consequences of Exercising Redemption Rights</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that a U.S. Holder of Bowen Ordinary Shares elects to exercise its redemption rights pursuant to the redemption provisions
described in this proxy statement/prospectus, the treatment of the redemption for U.S. federal income tax purposes will generally depend
on whether the redemption qualifies as a sale under Section 302 of the Code or as a distribution, the consequences of which will be impacted
by the PFIC rules, as discussed below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to such PFIC rules, the U.S. federal income tax consequences to a U.S. Holder of Bowen Ordinary Shares that exercises its redemption
rights to receive cash from the trust account in exchange for all or a portion of its Bowen Ordinary Shares will depend on whether the
redemption qualifies as a sale of such shares redeemed under Section 302 of the Code or is treated as a distribution under Section 301
of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
redemption of Bowen Ordinary Shares will generally qualify as a sale of such shares redeemed if such redemption (i) is &#8220;substantially
disproportionate&#8221; with respect to the redeeming U.S. Holder, (ii) results in a &#8220;complete termination&#8221; of such U.S.
Holder&#8217;s interest in us or (iii) is &#8220;not essentially equivalent to a dividend&#8221; with respect to such U.S. Holder. These
tests are explained more fully below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of such tests, a U.S. Holder takes into account not only Bowen Ordinary Shares actually owned by such U.S. Holder, but also
Bowen Ordinary Shares that are constructively owned by such U.S. Holder. A redeeming U.S. Holder may constructively own, in addition
to Bowen Ordinary Shares owned directly, Bowen Ordinary Shares owned by certain related individuals and entities in which such U.S. Holder
has an interest or that have an interest in such U.S. Holder, as well as any Bowen Ordinary Shares such U.S. Holder has a right to acquire
by exercise of an option, which would generally include Bowen Ordinary Shares which could be acquired pursuant to the rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 163; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->150<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
redemption of Bowen Ordinary Shares will generally be &#8220;substantially disproportionate&#8221; with respect to a redeeming U.S. Holder
if the percentage of our outstanding voting shares that such U.S. Holder actually or constructively owns immediately after the redemption
is less than 80 percent of the percentage of our outstanding voting shares that such U.S. Holder actually or constructively owned immediately
before the redemption. Prior to the Business Combination, the Bowen Ordinary Shares may not be treated as voting shares for this purpose
and, consequently, this substantially disproportionate test may not be applicable. There will be a complete termination of such U.S.
Holder&#8217;s interest if either (i) all of the Bowen Ordinary Shares actually or constructively owned by such U.S. Holder are redeemed
or (ii) all of the Bowen Ordinary Shares actually owned by such U.S. Holder are redeemed and such U.S. Holder is eligible to waive, and
effectively waives in accordance with specific rules, the attribution of any Bowen securities owned by certain family members and such
U.S. Holder does not constructively own any other shares of us. The redemption of Bowen Ordinary Shares will not be essentially equivalent
to a dividend if it results in a &#8220;meaningful reduction&#8221; of such U.S. Holder&#8217;s proportionate interest in us. Whether
the redemption will result in a meaningful reduction in such U.S. Holder&#8217;s proportionate interest will depend on the particular
facts and circumstances applicable to it. The IRS has indicated in a published ruling that even a small reduction in the proportionate
interest of a small minority shareholder in a publicly held corporation who exercises no control over corporate affairs may constitute
such a &#8220;meaningful reduction.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption
Treated as a Sale of Bowen Ordinary Shares Under Section 302 of the Code</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the above tests is satisfied, the redemption will generally be treated as sale of a U.S. Holder&#8217;s Bowen Ordinary Shares.
Subject to the PFIC rules discussed below, a U.S. Holder treated as selling Bowen Ordinary Shares will generally recognize capital gain
or loss. The amount of gain or loss recognized will generally be equal to the difference between (i) the sum of the amount of cash and
the fair market value of any property received in such sale and (ii) the U.S. Holder&#8217;s adjusted tax basis in the shares disposed
of.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
tax law currently in effect, long-term capital gains recognized by non-corporate U.S. Holders are generally subject to U.S. federal income
tax at a preferential rate of tax. Capital gain or loss will be long-term capital gain or loss if the U.S. Holder&#8217;s holding period
for the relevant securities exceeds one year. However, it is unclear whether the redemption rights with respect to the Bowen Ordinary
Shares may prevent the holding period for such shares from commencing prior to the termination of such rights. The deductibility of capital
losses is subject to limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption
Treated as a Distribution Under Section 301 of the Code</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
none of the above tests is satisfied, a redemption will be treated as a distribution under Section 301 of the Code with respect to Bowen
Ordinary Shares. Such distribution will generally be treated as a dividend for U.S. federal income tax purposes to the extent the distribution
is paid out of Bowen&#8217;s current or accumulated earnings and profits (as determined under U.S. federal income tax principles). Distributions
in excess of any such earnings and profits will generally be applied against and reduce the U.S. Holder&#8217;s basis in its other Bowen
securities (but not below zero) and, to the extent in excess of such basis, will be treated as capital gain from the sale or exchange
of such redeemed shares. After the application of those rules, any remaining tax basis a U.S. Holder has in the redeemed Bowen Ordinary
Shares will be added to the adjusted tax basis in such holder&#8217;s remaining Bowen securities. If there are no remaining Bowen securities,
a U.S. Holder should consult its tax advisors as to the allocation of any remaining basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
dividend will not be eligible for the dividends received deduction allowed to corporations in respect of dividends received from U.S.
corporations. If Bowen is, or was in its preceding taxable year, a PFIC (as discussed below under &#8220;<span style="font-weight: normal"><i>PFIC
Considerations</i></span>&#8221;), dividends received by certain non-corporate U.S. Holders (including individuals) generally would not
constitute &#8220;qualified dividend income&#8221; and thus would not be eligible to be taxed at the applicable preferential capital
gains rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 164; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->151<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALL
U.S. HOLDERS SHOULD CONSULT THEIR TAX ADVISORS AS TO THE TAX CONSEQUENCES TO THEM OF A REDEMPTION OF ALL OR A PORTION OF THEIR BOWEN
ORDINARY SHARES PURSUANT TO AN EXERCISE OF REDEMPTION RIGHTS, INCLUDING THE APPLICATION OF THE PFIC RULES.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material
U.S. Federal Income Tax Effects of the Business Combination</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Bowen Ordinary Shares (whether or not U.S. Holders, and, in each case, as described below, whether or not Bowen or New Bowen are treated
as a PFIC for U.S. federal income tax purposes or the Business Combination qualifies as a Reorganization) will not recognize gain
or loss for U.S. federal income tax purposes in the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination is intended to qualify as a &#8220;reorganization&#8221; within the meaning of Section 368 of the Code, and the
parties to the Business Combination Agreement have agreed to report the Business Combination in a manner consistent with such tax treatment
to the extent permitted under applicable law. There are many requirements that must be satisfied in order for the Business Combination
to qualify as a reorganization under Section 368(a) of the Code, some of which are based upon factual determinations, and others which
are fundamental to corporate reorganizations. No ruling has been requested, nor is one intended to be requested, from the IRS as to the
U.S. federal income tax consequences of the Business Combination. Consequently, no assurance can be given that the IRS will not assert,
or that a court would not sustain, a position contrary to any of those set forth below. Accordingly, each U.S. Holder is urged to consult
its tax advisor with respect to the particular tax consequence of the Business Combination to such U.S. Holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Business Combination is treated as a reorganization within the meaning of Section 368(a) of the Code and/or a transaction governed
by Section 351 of the Code, none of Bowen, New Bowen, nor Qianzhi should recognize gain or loss as a result of the Business Combination
and the U.S. Holders of Bowen Ordinary Shares or Qianzhi ordinary shares should not recognize gain or loss for U.S. federal income tax
purposes in the Business Combination. If the Business Combination does not qualify as a reorganization within the meaning of Section
368 of the Code and does not otherwise qualify for tax-free treatment under Section 351 of the Code, it will be treated as a taxable
stock sale.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> If the Business Combination does not
qualify as a &#8220;reorganization&#8221; within the meaning of Section 368 of the Code, holders of Qianzhi shares may recognize
gain or loss for U.S. federal income tax purposes.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material
U.S. Federal Income Tax Effects of Ownership and Disposition of New Bowen Ordinary Shares</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion is a summary of certain material U.S. federal income tax consequences of the ownership and disposition of New Bowen
Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxation
of Distributions with respect to New Bowen Ordinary Shares</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the PFIC rules described below under &#8220;<i>Passive Foreign Investment Company Rules</i>,&#8221; the U.S. federal income tax consequences
to a U.S. Holder of New Bowen Ordinary Shares who receives any distribution paid on the New Bowen Ordinary Shares generally will correspond
to the U.S. federal income tax consequences to a U.S. Holder of Bowen Ordinary Shares who is treated as receiving a distribution from
paid on the Bowen Ordinary Shares, if such U.S. Holder&#8217;s redemption of ordinary shares does not qualify as a sale of ordinary shares,
as discussed above in &#8220;&#8212;<i>U.S. Federal Income Tax Consequences to U.S. Holders of Bowen Securities of Exercising Redemption
Rights</i>&#8212;<i>Redemption Treated as a Distribution Under Section 301 of the Code</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
or Loss on Sale, Taxable Exchange or Other Taxable Disposition of New Bowen Ordinary Shares</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the PFIC rules described below under &#8220;<i>&#8212;Passive Foreign Investment Company Rules</i>,&#8221; the U.S. federal income
tax consequences to a U.S. Holder of New Bowen Ordinary Shares on the sale or other taxable disposition of the New Bowen Ordinary Shares
will generally correspond to the U.S. federal income tax consequences to a U.S. Holder of Bowen Ordinary Shares redeeming their Bowen
Ordinary Shares, if their redemption of Bowen Ordinary Shares qualifies as a sale of Bowen Ordinary Shares, as discussed above in &#8220;<i>&#8212;U.S.
Federal Income Tax Consequences to U.S. Holders of Bowen Securities of Exercising Redemption Rights&#8212;Redemption Treated as a Sale
of Bowen Ordinary Shares Under Section 302 of the Code</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Passive
Foreign Investment Company Rules</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
treatment of U.S. Holders could be materially different from that described above if Bowen or New Bowen is or was treated as a PFIC for
U.S. federal income tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
non-U.S. corporation is a PFIC for U.S. federal income tax purposes for any taxable year in which (i) 50% or more of the value of its
assets (generally determined on the basis of a weighted quarterly average) consists of assets, including its pro rata share of the assets
of any corporation in which it is considered to own at least 25% of the shares by value, that produce, or are held for the production
of, passive income, or (ii) 75% or more of its gross income, including its pro rata share of the gross income of any corporation in which
it is considered to own at least 25% of the shares by value, consists of passive income. Passive income generally includes dividends,
interest, rents and royalties (other than rents or royalties derived from the active conduct of a trade or business) and gains from the
disposition of passive assets. Cash and cash equivalents are generally passive assets. The value of goodwill will generally be treated
as an active or passive asset based on the nature of the income produced in the activity to which the goodwill is attributable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 165; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->152<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the start-up exception, a corporation will not be a PFIC for the first taxable year the corporation has gross income (the &#8220;<span style="font-weight: normal"><i>start-up
year</i></span>&#8221;), if (1) no predecessor of the corporation was a PFIC, (2) it is established to the satisfaction of the IRS that
the corporation will not be a PFIC for either of the first two taxable years following the start-up year, and (3) the corporation is
not in fact a PFIC for either of those years (the &#8220;<span style="font-weight: normal"><i>start-up exception</i></span>&#8221;).
PFIC status for any taxable year is a factual annual determination that can be made only after the end of that year and will depend on
the composition of New Bowen&#8217;s income and assets and the value of its assets from time to time and, for the taxable year in which
the Business Combination occurs, the composition of the income and assets, and the value of the assets, of Bowen, its predecessor
for this purpose. The value of New Bowen&#8217;s assets includes the value of its goodwill and other intangible assets not shown on its
financial statements, which may be determined, in large part, by reference to the market price of the New Bowen Ordinary Shares from
time to time, which is subject to change and may be volatile. Accordingly, there is a risk that New Bowen may be a PFIC for its current
or any future taxable year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Bowen is or was a PFIC for any taxable year during the holding period of a U.S. Holder in its Bowen Ordinary Shares, then, New Bowen
will also be treated as a PFIC as to such U.S. Holder with respect to New Bowen Shares received in exchange for Bowen Ordinary Shares
pursuant to the Business Combination, even if New Bowen does not meet the test for PFIC status in its own right, unless the U.S. Holder
made an applicable PFIC election (or elections). In addition, if this rule were to apply, such U.S. Holder would be treated for purposes
of the PFIC rules as if such U.S. Holder held such New Bowen Shares (treated as shares of a PFIC as to such holder) for a period that
includes such holder&#8217;s holding period for the Bowen Ordinary Shares exchanged therefor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
New Bowen is a PFIC or is treated as a PFIC with respect to a U.S. Holder, such U.S. Holder generally will be subject to special and
adverse rules with respect to (i) any gain recognized by the U.S. Holder on the sale or other disposition of its New Bowen Shares and
(ii) any &#8220;excess distribution&#8221; made to the U.S. Holder (generally, any distributions to such U.S. Holder during a taxable
year of the U.S. Holder to the extent greater than 125% of the average annual distributions received by such U.S. Holder in respect of
the New Bowen Shares during the three preceding taxable years of such U.S. Holder or, if shorter, such U.S. Holder&#8217;s holding period
for the New Bowen Shares).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
these rules (the &#8220;<span style="font-weight: normal"><i>interest charge rules</i></span>&#8221;):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            U.S. Holder&#8217;s gain or excess distribution will be allocated ratably over the U.S. Holder&#8217;s
                                            holding period for the New Bowen Ordinary Shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            amount allocated to the U.S. Holder&#8217;s taxable year in which the U.S. Holder recognized
                                            the gain or received the excess distribution, or to the period in the U.S. Holder&#8217;s
                                            holding period before the first day of New Bowen&#8217;s first taxable year in which New
                                            Bowen is a PFIC, will be taxed as ordinary income;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            amount allocated to other taxable years (or portions thereof) of the U.S. Holder and included
                                            in the U.S. Holder&#8217;s holding period will be taxed at the highest tax rate in effect
                                            for that year and applicable to the U.S. Holder; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            additional tax equal to the interest charge generally applicable to underpayments of tax
                                            will be imposed on the U.S. Holder with respect to the tax attributable to each taxable year
                                            described in the preceding bullet of the U.S. Holder.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PFIC
Elections</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, if New Bowen is a PFIC, a U.S. Holder may avoid the adverse PFIC tax consequences under the interest charge rules described
above in respect of New Bowen Ordinary Shares (a) by making or having made a qualified electing fund (&#8220;<span style="font-weight: normal"><i>QEF</i></span>&#8221;)
election or a mark-to-market election for the first taxable year for which New Bowen (or Bowen) is or was a PFIC and in which such U.S.
Holder held (or was deemed to hold) such New Bowen (or Bowen) Shares and maintain such election or (b) by making and maintaining a QEF
election along with an applicable purging election (collectively, the &#8220;<span style="font-weight: normal"><i>PFIC Elections</i></span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QEF
and Purging Elections</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of making and maintaining a timely and valid QEF election (if eligible to do so), a U.S. Holder of New Bowen Ordinary Shares
must include in income such U.S. Holder&#8217;s pro rata share of New Bowen&#8217;s net capital gains (as long-term capital gain) and
other earnings and profits (as ordinary income), on a current basis, whether or not distributed. A U.S. Holder generally may make a separate
election to defer the payment of taxes on undistributed income inclusions under the QEF rules, but if deferred, any such taxes will be
subject to an interest charge. A subsequent distribution of such earnings and profits that were previously included in income should
generally not be taxable as a dividend to such U.S. Holder. The tax basis of a U.S. Holder&#8217;s shares in a PFIC with respect to which
a QEF election has been made will be increased by amounts that are included in income and decreased by amounts distributed but not taxed
as dividends, under the above rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 166; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->153<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the absence of a purging election, a U.S. Holder would be treated for purposes of the interest charge rules as if the U.S. Holder held
such New Bowen Shares for a period that includes a period when the QEF election was not in effect, including such U.S. Holder&#8217;s
holding period for the Bowen securities exchanged therefor, respectively. U.S. Holders are urged to consult their tax advisors regarding
the application of the purging elections rules to their particular circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
QEF election is made on a shareholder-by-shareholder basis, and once made, can be revoked only with the consent of the IRS. A U.S. Holder
generally makes a QEF election by attaching a completed IRS Form 8621 (Information Return by a Shareholder of a Passive Foreign Investment
Company or Qualified Electing Fund), including the information provided in a PFIC Annual Information Statement from Bowen or New Bowen,
as the case may be, to a timely filed U.S. federal income tax return for the tax year to which the election relates. In the event that
New Bowen determines after the completion of the Business Combination that New Bowen is a PFIC for U.S. federal income tax purposes for
any taxable year, New Bowen will, upon request of a holder of New Bowen Ordinary Shares, make reasonable best efforts to provide a PFIC
Annual Information Statement to such holder. Retroactive QEF elections generally may be made only by filing a protective statement with
such federal income tax return and if certain other conditions are met or with the consent of the IRS. U.S. Holders are urged to consult
their tax advisors regarding the availability and tax consequences of a retroactive QEF election under their particular circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark-to-Market
Election</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an alternative to a QEF election, if a U.S. Holder owns shares in a company that is a PFIC and the shares are &#8220;regularly traded&#8221;
on a &#8220;qualified exchange,&#8221; such U.S. Holder could make a mark-to-market election that would result in tax treatment different
from that under the interest charge rules described above. The Bowen Ordinary Shares and New Bowen Ordinary Shares will be treated as
regularly traded for any calendar year in which more than a de minimis quantity of the Bowen Ordinary Shares or New Bowen Ordinary Shares,
as applicable, are traded on a qualified exchange on at least 15 days during each calendar quarter. Nasdaq, where the Bowen Shares are
listed and the New Bowen Ordinary Shares are expected to be listed, is a qualified exchange for this purpose.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
electing U.S. Holder generally will include for each of its taxable years as ordinary income the excess, if any, of the fair market value
of its New Bowen Shares at the end of such year over its adjusted basis in its New Bowen Ordinary Shares. The U.S. Holder also will recognize
an ordinary loss in respect of the excess, if any, of its adjusted basis of its New Bowen Ordinary Shares over the fair market value
of its New Bowen Ordinary Shares at the end of its taxable year (but only to the extent of the net amount of previously included in income
as a result of the mark-to-market election). The U.S. Holder&#8217;s basis in its New Bowen Ordinary Shares will be adjusted to reflect
any such income or loss amounts. Any gain recognized on a sale or other taxable disposition of its New Bowen Ordinary Shares will be
treated as ordinary income, and any loss will be treated as an ordinary loss (but only to the extent of the net amount previously included
in income as a result of the mark-to-market election, with any excess treated as a capital loss). If a U.S. Holder makes the mark-to-market
election, distributions paid on New Bowen Ordinary Shares will be treated as discussed under &#8220;<i>U.S. Federal Income Tax Consequences
of Ownership and Disposition of New Bowen Ordinary Shares&#8212; Taxation of Distributions with respect to New Bowen Ordinary Shares</i>&#8221;
above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
made, a mark-to-market election will be effective for the taxable year for which the election is made and for all subsequent taxable
years in which New Bowen is a PFIC, unless the New Bowen Ordinary Shares cease to qualify as &#8220;regularly traded&#8221; on a &#8220;qualified
exchange&#8221; for purposes of the PFIC rules or the IRS consents to the revocation of the election. U.S. Holders are urged to consult
their tax advisors regarding the availability and tax consequences of a mark-to-market election with respect to New Bowen Ordinary Shares
under their particular circumstances (including the possible recognition of income or gain under the PFIC interest charge rules in the
case that the mark-to-market election is not made for the first taxable year in which the U.S. Holders own (or are treated as owning)
the New Bowen Ordinary Shares).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 167; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->154<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
PFIC Rules</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
New Bowen is a PFIC and, at any time, has a non-U.S. subsidiary that is a PFIC, a U.S. Holder generally would be deemed to own a proportionate
amount of the shares of such lower-tier PFIC and generally could incur liability for the deferred tax and interest charge under the interest
charge rules described above if New Bowen receives an excess distribution from, or disposes of all or part of its interest in, the lower-tier
PFIC, or the U.S. Holder otherwise was deemed to have disposed of an interest in the lower-tier PFIC, in each case as if the U.S. Holder
held such shares directly, even though the U.S. Holder will not receive any proceeds of that distribution or disposition. A mark-to-market
election cannot be made with respect to a lower-tier PFIC. U.S. Holders are urged to consult their tax advisors regarding the tax issues
raised by lower-tier PFICs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder that owns (or is deemed to own) shares in a PFIC during any taxable year of the U.S. Holder may have to file an IRS Form
8621 (whether or not a QEF or mark-to-market election is made) and to provide such other information as may be required by the U.S. Treasury
Department. Failure to do so, if required, will extend the statute of limitations applicable to such U.S. Holder until such required
information is furnished to the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
RULES DEALING WITH PFICS ARE VERY COMPLEX AND ARE IMPACTED BY VARIOUS FACTORS IN ADDITION TO THOSE DESCRIBED ABOVE. ALL U.S. HOLDERS
ARE URGED TO CONSULT THEIR TAX ADVISORS REGARDING THE CONSEQUENCES TO THEM OF THE PFIC RULES, INCLUDING, WITHOUT LIMITATION, WHETHER
A QEF ELECTION (OR A QEF ELECTION ALONG WITH A PURGING ELECTION), A MARK-TO-MARKET ELECTION, OR ANY OTHER ELECTION IS AVAILABLE AND THE
CONSEQUENCES TO THEM OF ANY SUCH ELECTION, THE APPLICATION OF THE PFIC RULES TO WARRANTS, AND THE IMPACT OF ANY PROPOSED OR FINAL PFIC
TREASURY REGULATIONS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Federal Income Taxation of Non-U.S. Holders</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Non-U.S. Holder generally will not be subject to U.S. federal income tax or withholding tax on distributions received with respect to
New Bowen Ordinary Shares if the Non-U.S. Holder is not engaged in a U.S. trade or business. If the Non-U.S. Holder is engaged in a U.S.
trade or business, our distributions will be subject to U.S. federal income tax to the extent they constitute income effectively connected
with the Non-U.S. Holder&#8217;s U.S. trade or business (and a corporate Non-U.S. Holder may also be subject to U.S. federal branch profits
tax). However, distributions paid to a Non-U.S. Holder who is engaged in a trade or business may be exempt from taxation under an income
tax treaty if the income arising from the distribution is not attributable to a U.S. permanent establishment maintained by the Non-U.S.
Holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale,
Exchange or other Disposition of New Bowen Shares</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, a Non-U.S. Holder will not be subject to U.S. federal income tax or withholding tax on any gain resulting from the disposition
of New Bowen Ordinary Shares provided the Non-U.S. Holder is not engaged in a U.S. trade or business. A Non-U.S. Holder that is engaged
in a U.S. trade or business will be subject to U.S. federal income tax in the event the gain from the disposition of New Bowen Ordinary
Shares is effectively connected with the conduct of such U.S. trade or business (provided, in the case of a Non-U.S. Holder entitled
to the benefits of an income tax treaty with the United States, such gain also is attributable to a U.S. permanent establishment). However,
even if not engaged in a U.S. trade or business, individual Non-U.S. Holders may be subject to tax on gain resulting from the disposition
of New Bowen Ordinary Shares if they are present in the United States for 183 days or more during the taxable year of the disposition
and meet certain other requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
Reporting and Backup Withholding</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
payments (including constructive dividends) with respect to New Bowen Shares and proceeds from the sale, exchange or redemption of Bowen
Securities may be subject to information reporting to the IRS and possible United States backup withholding. Backup withholding (currently
at a rate of 24 percent) will not apply, however, to a U.S. Holder who furnishes a correct taxpayer identification number (generally
on an IRS Form W-9 provided to the relevant paying agent) and makes other required certifications, or who is otherwise exempt from backup
withholding and establishes such exempt status if required to do so. Any amounts withheld under the backup withholding rules may be allowed
as a refund or credit against a holder&#8217;s U.S. federal income tax liability, if any, provided the required information is timely
furnished to the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, certain U.S. Holders (and to the extent specified in applicable Treasury Regulations, certain individual Non-U.S. Holders)
holding specified foreign financial assets with an aggregate value in excess of the applicable dollar thresholds are required to report
information to the IRS relating to New Bowen Shares or the non-U.S. financial accounts through which they are held, subject to certain
exceptions (including an exception for New Bowen Shares held in accounts maintained by U.S. financial institutions), by attaching a complete
IRS Form 8938 (Statement of Specified Foreign Financial Assets) with their tax return for each year in which they hold New Bowen Shares.
Additionally, in the event an individual U.S. Holder (and to the extent specified in applicable Treasury Regulations, an individual Non-U.S.
Holder or a U.S. entity) that is required to file IRS Form 8938 does not file such form, the statute of limitations on the assessment
of U.S. federal income taxes of such holder for the related tax year may not close until three years after the date that the required
information is filed. U.S. Holders (including U.S. entities) and Non-U.S. Holders should consult their own tax advisors regarding their
reporting obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 168; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->155<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_020"></span>INFORMATION
ABOUT BOWEN</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>References
in this section to &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; the &#8220;Company,&#8221; or &#8220;Bowen&#8221; are to Bowen
Acquisition Corp.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
is a Cayman Islands exempted company formed for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase,
reorganization, or similar business combination with one or more businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 27, 2023, Bowen Holding LP, one of the Sponsors, acquired an aggregate of 1,725,000 Bowen Ordinary Shares for an aggregate
purchase price of $25,000. Thereafter, it transferred an aggregate of 1,155,750 Bowen Ordinary Shares to Createcharm Holdings Ltd, Bowen&#8217;s
other Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IPO
and Private Placement</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 14, 2023, Bowen consummated the IPO of 6,000,000 Bowen Units. Each Bowen Unit consists of one Bowen Ordinary Share and one Right,
each Right entitling the holder thereof to receive one-tenth of one Bowen Ordinary Share upon the completion of an initial business combination.
The Public Units were sold at an offering price of $10.00 per Public Unit, generating gross proceeds of $60,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the consummation of the IPO, Bowen consummated the private placement of 330,000 Bowen Private Units at a price of $10.00 per Bowen
Private Unit, generating total proceeds of $3,300,000. The Bowen Private Units were purchased by Createcharm (312,000 Bowen Private
Units) and the IPO Underwriter (18,000 Bowen Private Units). The Bowen Private Units are identical to the Public Units sold in the IPO. The purchasers
of the Bowen Private Units have agreed not to transfer, assign or sell any of the Bowen Private Units or Bowen Ordinary Shares or Bowen
Rights underlying the Bowen Private Units (except to certain transferees) until after the completion of the initial Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2023, the underwriters exercised their over-allotment option in full to purchase an additional 900,000 Bowen Private Units.
As a result, on July 18, 2023, Bowen sold an additional 900,000 Bowen Private Units at $10.00 per Unit, generating gross proceeds of
$9,000,000. In connection with this sale, the Sponsors and EBC also purchased an additional 31,500 Bowen Private Units, with Createcharm having purchased 29,782 of the additional Bowen Private
Units and the IPO Underwriter having purchased 1,718 of the additional Bowen Private Units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Units, Bowen Ordinary Shares and Bowen Rights are currently listed on Nasdaq under the symbols &#8220;BOWNU,&#8221; &#8220;BOWN,&#8221;
and &#8220;BOWNR,&#8221; respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of [&#9679;], 2024, the Record Date, there was [&#9679;] holder of record of Bowen Units, [&#9679;] holders of record of Bowen Ordinary
Shares, and [&#9679;] holders of record of Bowen Rights. The number of holders of record does not include a substantially greater number
of &#8220;street name&#8221; holders or beneficial holders whose Bowen Units, Bowen Ordinary Shares and Bowen Rights are held of record
by banks, brokers and other financial institutions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
Policy</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
has not paid any cash dividends on the Bowen Ordinary Shares to date and does not intend to pay cash dividends prior to the completion
of the Business Combination. The payment of cash dividends in the future will be dependent upon New Bowen&#8217;s revenues and earnings,
if any, capital requirements and general financial condition subsequent to completion of the Business Combination. The payment of any
cash dividends subsequent to the Business Combination will be within the discretion of New Bowen&#8217;s board of directors at such time.
New Bowen&#8217;s ability to declare dividends may also be limited by restrictive covenants pursuant to any debt financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
Proceeds Held in Trust</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the closing of the IPO and simultaneous private placement, approximately $69,690,000 of the net proceeds of the sale of the Bowen Units
in the IPO and the sale of the Bowen Private Units was placed in the Trust Account. The funds in the Trust Account are invested in U.S.
treasuries or United States bonds having a maturity of 185 days or less or money market funds meeting the applicable conditions of Rule
2a-7 under the Investment Company Act of 1940, as amended. As of the Record Date, Bowen held approximately $[&#9679;] million in the
Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described in the prospectus for Bowen&#8217;s IPO and in the section of this proxy statement/prospectus titled &#8220;<i>Bowen&#8217;s
Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</i>&#8221; below, these proceeds will not
be released until the earlier of the completion of an initial business combination and Bowen&#8217;s redemption of 100% of the outstanding
Public Shares upon its failure to consummate a business combination within the required time period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 169; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->156<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
Market Value of Target Business</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
target business or businesses that Bowen acquires must collectively have a fair market value equal to at least 80% of the balance of
the funds in the Trust Account (excluding taxes payable on the income earned on the Trust Account) at the time of the execution of a
definitive agreement for its initial business combination. As described elsewhere in this proxy statement/prospectus, Bowen&#8217;s board
of directors determined that this test was met in connection with the proposed Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
Approval of Business Combination</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Existing Charter, Bowen is seeking shareholder approval of the Business Combination at a meeting called for such purpose at which
public shareholders may seek to redeem their Public Shares, regardless of whether they vote for or against the proposed Business Combination
or are holders of record on the record date established for such vote, subject to the limitations described in the prospectus for the
IPO. Accordingly, in connection with the Business Combination, public shareholders may seek to redeem their Public Shares in accordance
with the procedures set forth in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption
of Public Shares and Liquidation if no Initial Business Combination</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
currently has only until October 14, 2024, or January 14, 2025 if it decides to extend the period of time to consummate
an initial business combination, to complete its initial business combination. If Bowen is unable to complete an initial business
combination within such time period and such date is not extended by the Bowen shareholders, Bowen will: (i) cease all operations except
for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public
shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest
earned on the funds held in the trust account and not previously released to us to pay our taxes (less up to $100,000 of interest to
pay liquidation and dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely
extinguish public shareholders&#8217; rights as shareholders (including the right to receive further liquidating distributions, if any),
subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining
shareholders and our board of directors, dissolve and liquidate, subject in each case to our obligations under Cayman Islands law to
provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions
with respect to our rights, which will expire worthless if we fail to complete our initial business combination within the 18-month time
period. Our Existing Charter provides that, if we wind up for any other reason prior to the consummation of our initial business combination,
we will follow the foregoing procedures with respect to the liquidation of the trust account as promptly as reasonably possible but not
more than 10 business days thereafter, subject to applicable Cayman Islands law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors have waived their rights to liquidating distributions from the trust account with respect to any Founder Shares and Bowen Private
Shares held by them if we fail to complete our initial business combination within the time period set forth in the Existing Charter. However, if our initial shareholders acquire public shares after the IPO,
they will be entitled to liquidating distributions from the trust account with respect to such public shares if we fail to complete our
initial business combination within the allotted 15-month time period (or 18-month time period, as applicable).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors have agreed, pursuant to a letter agreement with Bowen, that they will not propose any amendment to our amended and restated
memorandum and articles of association (i) that would modify the substance or timing of our obligation to allow redemption in connection
with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within
the time period set forth in the Existing Charter, or (ii) with respect to any
other material provision relating to shareholders&#8217; rights or pre-initial business combination activity, unless we provide our public
shareholders with the opportunity to redeem their ordinary shares upon approval of any such amendment at a per-share price, payable in
cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account
and not previously released to us to pay our taxes divided by the number of then outstanding public shares. However, we will only redeem
our public shares so long as (after such redemption) our net tangible assets will be at least $5,000,001 either immediately prior to
or upon consummation of our initial business combination and after payment of underwriters&#8217; fees and commissions (so that we are
not subject to the SEC&#8217;s &#8220;penny stock&#8221; rules). If this optional redemption right is exercised with respect to an excessive
number of public shares such that we cannot satisfy the net tangible asset requirement (described above) we would not proceed with the
amendment or the related redemption of our public shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 170; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->157<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that all costs and expenses associated with implementing our plan of liquidation and dissolution, as well as payments to any creditors,
will be funded from amounts held outside the trust account, although we cannot assure you that there will be sufficient funds for such
purpose. However, if those funds are not sufficient to cover the costs and expenses associated with implementing our plan of liquidation
and dissolution, to the extent that there is any interest accrued in the trust account not required to pay taxes on interest income earned
on the trust account balance, we may request the trustee to release to us an additional amount of up to $100,000 of such accrued interest
to pay those costs and expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we were to expend all of the net proceeds of the IPO and the sale of the Bowen Private Units, other than the proceeds deposited in the
trust account, and without taking into account interest, if any, earned on the trust account, the per-share redemption amount received
by shareholders upon our dissolution would be approximately $10.10. The proceeds deposited in the trust account could, however, become
subject to the claims of our creditors which would have higher priority than the claims of our public shareholders. We cannot assure
you that the actual per-share redemption amount received by shareholders will not be substantially less than $10.10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we will seek to have all vendors, service providers, prospective target businesses or other entities with which we do business execute
agreements with us waiving any right, title, interest and claim of any kind in or to any monies held in the trust account for the benefit
of our public shareholders, there is no guarantee that they will execute such agreements or even if they execute such agreements that
they would be prevented from bringing claims against the trust account including but not limited to fraudulent inducement, breach of
fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order
to gain an advantage with respect to a claim against our assets, including the funds held in the trust account. If any third party refuses
to execute an agreement waiving such claims to the monies held in the trust account, our management will perform an analysis of the alternatives
available to it and will only enter into an agreement with a third party that has not executed a waiver if management believes that such
third party&#8217;s engagement would be significantly more beneficial to us than any alternative. Examples of possible instances where
we may engage a third party that refuses to execute a waiver include the engagement of a third-party consultant whose particular expertise
or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver
or in cases where management is unable to find a service provider willing to execute a waiver.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
sponsors have agreed that they will be liable to us if and to the extent any claims by a third party for services rendered or products
sold to us, or a prospective target business with which we have discussed entering into a transaction agreement, reduce the amount of
funds in the trust account to below (i) $10.10 per public share or (ii) such lesser amount per public share held in the trust account
as of the date of the liquidation of the trust account, due to reductions in value of the trust assets, in each case net of the amount
of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights
to seek access to the trust account and except as to any claims under our indemnity of the underwriters of the IPO against certain liabilities,
including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party,
then our sponsors will not be responsible to the extent of any liability for such third party claims We have not independently verified
whether our sponsors have sufficient funds to satisfy their indemnity obligations and believe that our sponsors&#8217; only assets are
securities of our company. We have not asked our sponsors to reserve for such indemnification obligations. Therefore, we believe it is
unlikely that our sponsors would be able to satisfy those obligations. As a result, if any such claims were successfully made against
the trust account, the funds available for our initial business combination and redemptions could be reduced to less than $10.10 per
public share. In such event, we may not be able to complete our initial business combination, and you would receive such lesser amount
per share in connection with any redemption of your public shares. None of our officers or directors are required to indemnify us for
claims by third parties including, without limitation, claims by vendors and prospective target businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the proceeds in the trust account are reduced below (i) $10.10 per public share or (ii) such lesser amount per public
share held in the trust account as of the date of the liquidation of the trust account, due to reductions in value of the trust assets,
in each case net of the amount of interest which may be withdrawn to pay taxes, and our sponsors assert that they are unable to satisfy
their indemnification obligations or that they have no indemnification obligations related to a particular claim, our independent directors
would determine whether to take legal action against our sponsors to enforce such indemnification obligations. While we currently expect
that our independent directors would take legal action on our behalf against our sponsors to enforce their indemnification obligations
to us, it is possible that our independent directors in exercising their business judgment may choose not to do so if, for example, the
cost of such legal action is deemed by the independent directors to be too high relative to the amount recoverable or if the independent
directors determine that a favorable outcome is not likely.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In the event that we liquidate
and it is subsequently determined that the reserve for claims and liabilities is insufficient, shareholders who received funds from our
trust account could be liable for claims made by creditors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">If we file a bankruptcy petition
or an involuntary bankruptcy petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject
to applicable bankruptcy law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over
the claims of our shareholders. To the extent any bankruptcy claims deplete the trust account, we cannot assure you we will be able to
return $10.10 per share to our public shareholders. Additionally, if we file a bankruptcy petition or an involuntary bankruptcy petition
is filed against us that is not dismissed, any distributions received by shareholders could be viewed under applicable debtor/creditor
and/or bankruptcy laws as either a &#8220;preferential transfer&#8221; or a &#8220;fraudulent conveyance.&#8221; As a result, a bankruptcy
court could seek to recover some or all amounts received by our shareholders. Furthermore, our board of directors may be viewed as having
breached its fiduciary duty to our creditors and/or may have acted in bad faith, thereby exposing itself and our company to claims of
punitive damages, by paying public shareholders from the trust account prior to addressing the claims of creditors. We cannot assure you
that claims will not be brought against us for these reasons.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Our public shareholders will
be entitled to receive funds from the trust account only (i) in the event of the redemption of our public shares if we do not complete
our initial business combination within the time period set forth in the Existing Charter, (ii) in connection with a shareholder vote
to amend our amended and restated memorandum and articles of association that would affect the substance or timing of our obligation to
provide for the redemption of our public shares in connection with an initial business combination or to redeem 100% of our public shares
if we have not consummated an initial business combination within the time period set forth in the Existing Charter or (iii) if they redeem
their respective shares for cash upon the completion of the initial business combination. In no other circumstances will a shareholder
have any right or interest of any kind to or in the trust account. In the event we seek shareholder approval in connection with our initial
business combination, a shareholder&#8217;s voting in connection with the business combination alone will not result in a shareholder&#8217;s
redeeming its shares to us for an applicable pro rata share of the trust account. Such shareholder must have also exercised its redemption
rights described above. These provisions of our amended and restated memorandum and articles of association, like all provisions of our
amended and restated memorandum and articles of association, may be amended with a shareholder vote.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Facilities</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt">Bowen maintains its principal executive
offices at 420 Lexington Avenue, Suite 2446, New York, New York 10170 and its telephone number is (203) 998-5540. Bowen has access to
such office space as part of the administrative services Bowen receives from Bowen Holding LP in exchange for $10,000 per month. Bowen
considers its current office space, combined with the other office space otherwise available to Bowen&#8217;s executive officers and directors,
adequate for its current operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>SPAC Sponsors and their Affiliates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Bowen has two &#8220;SPAC sponsors&#8221;
as such term is defined in Item 1603(1) of Regulation S-K, as promulgated under the Securities Act, Createcharm and Bowen Holding, and
Bowen Holding has one affiliate, TenX. Each is described in further detail below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Bowen Holding</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Bowen Holding is a
Delaware limited liability company formed by Dahe Zhang, a seasoned executive and sponsor of several SPACs. He has served as Chief
Financial Officer and Executive Director of TenX Keane Acquisition, a blank check company (Nasdaq: TENK), since March 2021. In
August 2024, TenX Keane successfully completed a business combination with Cituis Pharmaceuticals, Inc (Nasdaq: CTOR)&#8217;s
subsidiary, Citius Oncology, Inc., a late-stage pharmaceutical company focused on developing and commercializing targeted oncology
therapies. Mr. Zhang has over 20 years of experience in financial services and previously served as Chief Financial Officer and
executive director of China XD Plastics Company Limited from 2009 to 2021. Bowen Holding was formed for the sole purpose of
sponsoring Bowen. Prior to its involvement with Bowen, Bowen Holding did not have any operations. Other than the experience and
involvement of Mr. Zhang, and Bowen Holding&#8217;s affiliate TenX, Bowen Holding does not have any further experience organizing or
managing special purpose acquisition companies and is not and never has been involved with other special purpose acquisition
companies. Each of the following directors and officers is a limited partner in Bowen Holding, having the following shares of its
economic profits: Jiangang Luo, Bowen&#8217;s Chief Executive Officer (15.2%); Jing Lu, Bowen&#8217;s Chief Financial Officer
(12.1%); Lawrence Leighton, a director on Bowen&#8217;s board of directors (4.5%); and Wei Li, a director on Bowen&#8217;s board of
directors (4.5%). The other persons with a direct interest in Bowen Holding and thereby an indirect interest in Bowen are: TenX
(60.6%) and Fengfei Zhang (3.0%). Bowen Holding&#8217;s general partner is Bowen Management, LLC, of which Mr. Zhang is
manager.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Bowen Holding, along with
Createcharm, was responsible for organizing, directing and managing the business and affairs of Bowen from its incorporation until consummation
of its initial public offering. Bowen Holding&#8217;s activities included identifying and negotiating terms with the representative of
the underwriters in Bowen&#8217;s IPO, other third-party service providers such as Bowen&#8217;s auditors and legal counsel, and Bowen&#8217;s
original directors and officers. Since the IPO, Bowen Holding has assisted Bowen&#8217;s management in identifying and negotiating terms
with Qianzhi. Bowen Holding has had no operations outside of the responsibilities described above that it had and fulfilled to Bowen.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 27, 2023, Bowen
Holding acquired an aggregate of 1,725,000 Founder Shares for an aggregate purchase price of $25,000. Thereafter, it transferred an aggregate
of 1,155,750 Founder Shares to Createcharm for the same price per share it initially paid. It currently holds 569,250 shares and is expected
to hold the same number as of the closing and immediately following the closing of the Business Combination.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 171; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->158<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Therefore,
Bowen Holding can earn a positive rate of return on its investment even if other Bowen shareholders experience a negative rate of return.
The New Bowen Ordinary Shares to be held by Bowen Holding following the Business Combination will be identical to the New Bowen Ordinary
Shares to be held by Bowen&#8217;s Public Shareholders. Pursuant to the SEC&#8217;s rules, these New Bowen Ordinary Shares may be considered
&#8220;compensation&#8221; awarded to or earned by Bowen Holding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the above, in connection with Bowen Holding&#8217;s sponsorship and management of Bowen:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
                                            to an administrative services agreement between Bowen and Bowen Holding entered into in connection
                                            with the IPO, Bowen Holding has been allowed to charge Bowen an allocable share of its overhead,
                                            up to $10,000&#160;per month, until to the close of the Business Combination, to compensate
                                            it for Bowen&#8217;s use of its office, utilities and personnel. As of August 31, 2024, Bowen
                                            has incurred $136,667 with $90,000 paid to Bowen Holding for these services; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            February 27, 2023, Bowen Holding issued an unsecured promissory note to Bowen, pursuant to
                                            which Bowen could borrow up to an aggregate principal amount of $300,000. The note was non-interest
                                            bearing and payable on the earlier of (i) December 31, 2023, or (ii) the consummation of
                                            the IPO. The note expired without any amount ever being lent thereunder.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            connection with the IPO, Bowen Holding agreed that if the Trust Account is liquidated, including
                                            in the event Bowen is unable to complete an initial business combination within the required
                                            time period, Bowen Holding would to indemnify Bowen to ensure that the proceeds in the Trust
                                            Account are not reduced below $10.10 per Public Share, or such lesser per share amount as
                                            is in the Trust Account, by the claims of prospective target businesses with which Bowen
                                            has entered into an acquisition agreement or claims of any third party for services rendered
                                            or products sold to Bowen, but only if such a vendor or target business has not executed
                                            a waiver of any and all rights to seek access to the Trust Account.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restrictions
on sale by Bowen Holding of Bowen and New Bowen securities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Source
    of Restriction</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Term
    of Restriction</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Letter
    Agreement, dated July 11, 2023, by and among Bowen and Createcharm, among others</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to the limited exceptions described further below, the Founder Shares were placed in escrow in connection with the closing of the
    IPO and may not be transferred until six months after the date of the consummation of an initial business combination by Bowen such
    as the Business Combination, or earlier, if, subsequent to such an initial business combination, Bowen consummates a subsequent liquidation,
    merger, stock exchange or other similar transaction which results in all Bowen shareholders having the right to exchange their shares
    for cash, securities or other property.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with Createcharm&#8217;s sponsorship and management of Bowen, concurrently with the pricing of Bowen&#8217;s IPO, Bowen
and its initial shareholders including Bowen Holding, among others, entered into a the letter agreement, dated July 11, 2023,
pursuant to which Bowen Holding agreed that its Founder Shares were to be placed in escrow in connection with the closing of the IPO
and may not be transferred until six months after the date of the consummation of an initial business combination by Bowen, such as
the Business Combination, or earlier, if, subsequent to such an initial business combination, Bowen consummates a subsequent
liquidation, merger, stock exchange or other similar transaction which results in all Bowen shareholders having the right to
exchange their shares for cash, securities or other property. Pursuant to this letter agreement, Bowen Holding agreed it may not
seek redemption of its Founder Shares. Therefore, if Bowen does not consummate an initial business combination such as the Business
Combination prior to the deadline for it to pursuant to the Existing Charter, as may be amended, Bowen Holding&#8217;s Founder
Shares will have no value. Finally, pursuant to this letter agreement, Bowen Holding agreed (a) that if Bowen were to seek
shareholder approval of a proposed initial business combination such as the Business Combination, then Bowen Holding shall, subject to
all applicable securities laws, vote any Bowen Ordinary Shares owned by it in favor of such proposed business combination, and (b)
that if Bowen seeks to consummate a proposed business combination by engaging in a tender offer, Bowen Holding would not sell or
tender any Bowen Ordinary Shares owned by it in connection therewith.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Bowen
Holding affiliate &#8211; TenX </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TenX
is an affiliate of Bowen Holding on the basis of TenX being a limited partner of Bowen Holding with a 60.6% economic interest. TenX
has experience organizing or managing special purpose acquisition companies, including acting as an affiliate of the sponsor of
AlphaTime Acquisition Corp, AlphaVest Acquisition Corp and Bayview Acquisition Corp. Aside from its limited partnership interest in
Bowen Holding LP, TenX has been involved with Bowen as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            February 20, 2023, Bowen engaged TenX to provide Bowen with consulting and advisory services
                                            in connection with, among other things, (i) preparing certain of Bowen&#8217;s consolidated
                                            financial statements and other financial-related disclosures at a fixed price of $20,000
                                            and (ii) assisting Bowen with the preparation of, and the accounting relating to, Bowen&#8217;s
                                            quarterly and annual reports to be filed with the Securities and Exchange Commission, at
                                            a price of $5,250 per quarter commencing on the month following the consummation of the IPO.
                                            As of August 31, 2024, Bowen has incurred $46,250 with $41,000 paid to TenX for these services.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Createcharm</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Createcharm
is a British Virgin Islands company, formed by Na Gai, Bowen&#8217;s chief executive officer and chairperson of the board, to leverage
her extensive experience investing in and acquiring businesses. Ms. Gai has approximately 10 years of investing experience and has served
as the executive president for Shenzhen Guoxing Capital Co., Ltd., an asset management and investment company based in China, since September
2015. She also served as a partner of Hunan Zhongsheng Hongcheng Investment Management Partnership (LP), a private equity investment
company based in China, from February to May 2017. Prior to its involvement with Bowen, Createcharm did not have any experience organizing
or managing special purpose acquisition companies and is not and never has been involved with other special purpose acquisition companies.
Ms. Gai is Createcharm&#8217;s sole stockholder, officer and director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Createcharm,
along with Bowen Holding, was responsible for organizing, directing and managing the business and affairs Bowen from its incorporation
through its initial public offering. Createcharm&#8217;s activities included identifying and negotiating terms with the representative
of the underwriters in Bowen&#8217;s IPO, other third-party service providers such as Bowen&#8217;s auditors and legal counsel, and Bowen&#8217;s
original directors and officers. Since the IPO, Createcharm has assisted Bowen&#8217;s management in identifying and negotiating terms
with Qianzhi.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to Bowen&#8217;s IPO, Bowen Holding transferred an aggregate of 1,155,750 Founder Shares to Createcharm for the same price per share
it initially paid. Since that time, Createcharm has been Bowen&#8217;s largest shareholder. Along with Bowen Holding, Createcharm nominated
each current officer and director of Bowen and assisted Bowen&#8217;s management in preparing for and consummating the IPO. It also assisted
Bowen&#8217;s management in identifying and negotiating terms with Qianzhi. In Bowen&#8217;s IPO and simultaneous private placement,
Createcharm purchased 341,782 Private Placement Units, including in connection with the exercise by the underwriter of the IPO of its
overallotment option. Each Private Placement Unit is comprised of one Bowen Ordinary Share and one Bowen Right, each Bowen Right to be
converted automatically into 1/10 (one-tenth) of one Bowen Ordinary Share upon consummation by Bowen of an initial business combination.
Createcharm paid a purchase price of $10.00 per Private Placement Unit, which is identical to the purchase price paid for the Bowen Units
sold in the IPO, and the Private Placement Units are substantially similar to the Bowen Units sold in the IPO. Given these holdings,
as of the consummation of the Business Combination, Createcharm will hold 1,531,710 New Bowen Ordinary Shares, comprised of the 1,497,532
Bowen Ordinary Shares it currently holds and 34,178 New Bowen Ordinary Shares to be received in respect of its Bowen Rights, and will
have paid an aggregate of $3,434,750 for such 1,531,710 shares, or approximately $2.24 per share. Therefore, Createcharm can earn a positive
rate of return on its investment even if other Bowen shareholders experience a negative rate of return. The New Bowen Ordinary Shares
to be held by Createcharm following the Business Combination will be identical to the New Bowen Ordinary Shares to be received by Bowen&#8217;s
Public Shareholders. Pursuant to the SEC&#8217;s rules, these New Bowen Ordinary Shares and the Founder Shares and Bowen Rights that
preceded them may be considered &#8220;compensation&#8221; awarded to or earned by Createcharm.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the above, in connection with Createcharm&#8217;s sponsorship and management of Bowen:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Createcharm
                                            paid $151,318 of Bowen&#8217;s expenses related to its IPO, all of which was fully repaid
                                            upon closing of the IPO on July 14, 2023 out of the offering proceeds held outside the Trust
                                            Account. </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            connection with the IPO, Createcharm agreed that if the Trust Account is liquidated, including
                                            in the event Bowen is unable to complete an initial business combination within the required
                                            time period, Createcharm would to indemnify Bowen to ensure that the proceeds in the Trust
                                            Account are not reduced below $10.10 per Public Share, or such lesser per share amount as
                                            is in the Trust Account, by the claims of prospective target businesses with which Bowen
                                            has entered into an acquisition agreement or claims of any third party for services rendered
                                            or products sold to Bowen, but only if such a vendor or target business has not executed
                                            a waiver of any and all rights to seek access to the Trust Account.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 172; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->159<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restrictions
on sale by Createcharm of Bowen and New Bowen securities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Source
    of Restriction</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Term
    of Restriction</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Letter
    Agreement, dated July 11, 2023, by and among Bowen and Createcharm, among others</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to the limited exceptions described further below</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Founder Shares were placed in escrow in connection with the closing of the IPO and may not be transferred until six months after
    the date of the consummation of an initial business combination by Bowen such as the Business Combination, or earlier, if, subsequent
    to such an initial business combination, Bowen consummates a subsequent liquidation, merger, stock exchange or other similar transaction
    which results in all Bowen shareholders having the right to exchange their shares for cash, securities or other property; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Private Placement Units (and Bowen Ordinary Shares underlying the Private Placement Units), may not be transferred until the completion
    of an initial business combination by Bowen such as the Business Combination.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with Createcharm&#8217;s sponsorship and management of Bowen, concurrently with the pricing of Bowen&#8217;s IPO, Bowen and
its initial shareholders including Createcharm, among others, entered into a the letter agreement, dated July 11, 2023, pursuant to which
Createcharm agreed (A) that its Founder Shares were to be placed in escrow in connection with the closing of the IPO and may not be transferred
until six months after the date of the consummation of an initial business combination by Bowen, such as the Business Combination, or
earlier, if, subsequent to such an initial business combination, Bowen consummates a subsequent liquidation, merger, stock exchange or
other similar transaction which results in all Bowen shareholders having the right to exchange their shares for cash, securities or other
property; and (B) the Private Placement Units (and Bowen Ordinary Shares underlying the Private Placement Units) to be purchased by Createcharm
in the Private Placement that was consummated concurrently with the closing of the IPO, may not be transferred until the completion of
an initial business combination by Bowen such as the Business Combination. Pursuant to this letter agreement, Createcharm agreed it may
not seek redemption of its Founder Shares or the Bowen Ordinary Shares in its Private Placement Units. Therefore, if Bowen does not consummate
an initial business combination such as Business Combination prior to the deadline for it to pursuant to the Existing Charter, as may
be amended, Createcharm&#8217;s Bowen securities will all expire worthless. Finally, pursuant to this letter agreement, Createcharm agreed
(a) that if Bowen were to seek shareholder approval of a proposed initial business combination such as the Business Combination, then
Createcharm shall, subject to all applicable securities laws, vote any Bowen Ordinary Shares owned by it in favor of such proposed business combination, and (b) that if Bowen seeks
to consummate a proposed business combination by engaging in a tender offer, Createcharm would not sell or tender any Bowen Ordinary
Shares owned by it in connection therewith.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Employees</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt">Bowen has three executive officers.
These individuals are not obligated to devote any specific number of hours to Bowen&#8217;s matters, but they intend to devote as much
time as they deem necessary to Bowen&#8217;s affairs until it has completed an initial business combination. The amount of time they will
devote in any time period will vary based on whether a target business has been selected for Bowen&#8217;s initial business combination
and the stage of the initial business combination process Bowen is in. Bowen does not have, and does not intend to have, any full-time
employees prior to the consummation of a business combination.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors,
Executive Officers and Corporate Governance</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen&#8217;s
directors and executive officers are as follows:</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">Name</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Age</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Position</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: justify">Na Gai</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center">36</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: justify">Chairwoman of the Board of Directors</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Jiangang Luo</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">54</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Chief Executive Officer</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Jing Lu</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">58</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Chief Financial Officer</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Lawrence Leighton</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">88</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Director</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Wei Li</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">44</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Director</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Jun Zhang</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">60</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Director</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Na
Gai</i></b>, our Chairwoman, has served as the executive president for Shenzhen Guoxing Capital Co., Ltd., an asset management and investment
company based in China, since September 2015. Ms. Gai also served as a partner of Hunan Zhongsheng Hongcheng Investment Management Partnership
(LP), a private equity investment company based in China, from February to May 2017. Since October 2021, she has also served as an independent
director for Flag Ship Acquisition Corp., a blank check company like our company, that is seeking to consummate its initial public offering.
Ms. Gai received a bachelor degree of Business Administration from The Open University of China and an accounting diploma from Changsha
University of Science &amp; Technology. Ms. Gai was also certified as AFP Financial planner in August 2017. Ms. Gai is a Chinese citizen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Jiangang
Luo</i></b>, our Chief Executive Officer, has been the manager of Cleantech Global Limited, an investment consulting firm, since 2014,
and the president of Prime Science &amp; Technology, Inc., a computer/software consulting and IT outsourcing company, since 2006. Since
2021, he has also been the president of PNE Limited Partner LLC and Luo &amp; Long General Partner LLC, which are special purpose vehicles
that were established for the sole purpose of investing in Princeton NuEnergy, a US based cleantech company. From 2011 to 2016, he served
as managing partner of Faith Asset Management LLC, a global investment firm focused on the clean energy sector. From 2000 to 2006, he
worked for Oracle as a Principal Consultant. Before 2000, he worked as a senior information system professional in various Fortune 500
companies including China Resources Group and Liz Claiborne. Mr. Luo also served as an executive for many non-profit organizations such
as Chairman of the Tsinghua Alumni Association in New York and President of New Jersey Chinese Computer Professionals Society. Mr. Luo
is a member of Tsinghua Entrepreneur &amp; Elite Club. He has invested in many cleantech/fintech companies over the last 10 years. Mr.
Luo received degrees in Applied Mathematics and Computer Science from Tsinghua University, a Computer Science Masters degree from New
Jersey Institute of Technology and a masters degree in Computational Mathematics from Tsinghua University. Mr. Luo is a US citizen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dr.
Jing Lu</i></b>, our Chief Financial Officer, has more than 20 years of experience in the financial service industry. Dr. Lu has served
as a Managing Director and then Chief Operating Officer of China Bridge Capital International Inc., a PE/VC investment advisory company
specialized in innovative technologies from 2017 to 2019 and since March 2021. She has also served as Chief Financial Officer of Keyarch
Acquisition Corporation, a blank check company similar to our company, since March 2021. She also served as Chief Investment Officer
for the New Hope Fertility Center (NHFC) from 2019 to 2021, sourcing and managing PE investments, bank loans and government PPP loans.
Prior to China Bridge Capital, Dr. Lu was President of ACE AV Consulting Inc. from 2005 to 2017. Dr. Lu was an Executive Director at
CIBC World Markets in 2001 working on corporate securities. Between 1998 and 2001, Dr. Lu worked at the Federal Reserve Bank of New York
as a bank regulator and supervisor, working on Basel Capital Accords as well as examining banks&#8217; implementation of the Basel Accords.
Before moving to New York, Dr. Lu was a professor of economics at York University in Canada for four years, specializing her teaching
and research in Macroeconomics, Institutional Economics, and Econometrics. Dr. Lu received a Ph.D. and M.A. in Economics from Western
University in Canada, a Graduate Certificate in Economics from the People&#8217;s University in China, and a B.A in World Economy from
Fudan University in China. Dr. Lu is a U.S. citizen and resident of the State of New York.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lawrence
Leighton</i></b>, one of our directors, is a seasoned international investment banker with approximately 50 years of experience. He
has worked with many major international companies throughout his career, including Pernod Ricard SA (ENXTPA: RI) and Verizon
Communications Inc. (NYSE: VZ). Mr. Leighton has served as a Managing Director of Bentley Associates, a boutique investment bank,
since 1997. In 1989, he became President and Chief Executive Officer of UI USA, the US subsidiary of Union d&#8217;&#200;tudes et
d&#8217;Investissements, the merchant banking arm of Credit Agric&#244;le, the largest bank in France. From 1982 to 1989, Mr.
Leighton served as a Managing Director of Chase Bank. Previously, he was a Limited Partner at Bear, Stearns &amp; Co., focusing on
international mergers and acquisitions. Starting in 1974, he was with Norton Simon as the Director of Strategic Planning/Mergers
&amp; Acquisitions. Before Norton Simon, Mr. Leighton was with Clark, Dodge &amp; Co. where he became Co-Head of the Corporate
Finance Department. He has been a member of the board of directors of Bon Natural Life Limited, a natural products and ingredients
business, since June 2021. Mr. Leighton received a B.S.E. degree from Princeton University and an M.B.A. from Harvard Business
School. Mr. Leighton is a U.S. Citizen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 173; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->160<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Wei
Li</i></b>, one of our directors, is the co-founder and has served as CEO of Hyatt Capital Management, a private investment fund and
financial service company dedicated to impact investing in the Asian pacific area, since 2018. Previously, Ms. Li served as Managing
Director and Head of Structured Finance at China Renaissance (HK.1911), a leading boutique investment bank in Hong Kong, Shanghai and
Beijing (where she was based during her time there), from 2016 to 2018. She was Executive Director &amp; Head of Private Credit Investment
at CITIC Securities (SH.600030), an investment bank, from 2011 to 2016. Ms. Li received a M. Phil degree in Land Economy from University
of Cambridge and is a Ph.D candidate from University of Rochester. Ms. Li is a CFA charter-holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Jun
Zhang</i></b>, one of our directors, has served as Senior Partner and Associate Director at Mazars (Shenzhen Branch) since 2000. Mr.
Zhang&#8217;s biography is set forth below under the section titled &#8220;<i>Directors and Officers of New Bowen After the Business
Combination</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms
of office. Our board of directors is authorized to appoint persons to the offices set forth in our amended and restated memorandum and
articles of association as it deems appropriate. Our amended and restated memorandum and articles of association provide that our officers
may consist of one or more Chairmen of the Board, one or more Chief Executive Officers, a President, a Chief Financial Officer, Vice
Presidents, Secretary, Treasurer, Assistant Secretary, and such other offices as may be determined by the board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Other than as described above, Bowen&#8217;s SPAC Sponsors, their affiliates and promoters do not have any material
roles or responsibilities in directing and managing Bowen&#8217;s activities.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
Independence</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ
listing standards require that a majority of our board of directors be independent, subject to certain phase-in provisions. An &#8220;independent
director&#8221; is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual
having a relationship which in the opinion of the company&#8217;s board of directors, would interfere with the director&#8217;s exercise
of independent judgment in carrying out the responsibilities of a director. Our board of directors has determined that each of Lawrence
Leighton, Wei Li and Jun Zhang are &#8220;independent directors&#8221; as defined in the NASDAQ listing standards and applicable SEC
rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
Officer and Director Compensation</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
executive officer has received any cash compensation for services rendered to Bowen. From the IPO to the acquisition of a target business
or Bowen&#8217;s liquidation of the trust account, Bowen pays Bowen Holding LP $10,000 per
month for providing Bowen with office space and certain office and secretarial services. However, this arrangement is solely for Bowen&#8217;s
benefit and is not intended to provide Bowen&#8217;s officers or directors compensation in lieu of a salary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not party to any agreements with Bowen&#8217;s officers and directors that provide for benefits upon termination of employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
Committee</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with its IPO, Bowen established an audit committee of the board of directors. Lawrence Leighton, Wei Li and Jun Zhang are
the members of the audit committee, each of whom is an independent director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
member of the audit committee is financially literate, and Bowen&#8217;s board of directors has determined that Jun Zhang qualifies as
an &#8220;audit committee financial expert&#8221; as defined in applicable SEC rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Responsibilities
of the audit committee include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            appointment, compensation, retention, replacement, and oversight of the work of the independent
                                            registered public accounting firm and any other independent registered public accounting
                                            firm engaged by Bowen;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pre-approving
                                            all audit and non-audit services to be provided by the independent registered public accounting
                                            firm or any other registered public accounting firm engaged by Bowen, and establishing pre-approval
                                            policies and procedures;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 174; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->161<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and discussing with the independent registered public accounting firm all relationships the
                                            auditors have with Bowen in order to evaluate their continued independence;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">setting
                                            clear hiring policies for employees or former employees of the independent registered public
                                            accounting firm;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">setting
                                            clear policies for audit partner rotation in compliance with applicable laws and regulations;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining
                                            and reviewing a report, at least annually, from the independent registered public accounting
                                            firm describing the independent auditor&#8217;s internal quality-control procedures and (ii)
                                            any material issues raised by the most recent internal quality-control review, or peer review,
                                            of the audit firm, or by any inquiry or investigation by governmental or professional authorities,
                                            within, the preceding five years respecting one or more independent audits carried out by
                                            the firm and any steps taken to deal with such issues;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving any related party transaction required to be disclosed pursuant to Item 404
                                            of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            with management, the independent registered public accounting firm, and Bowen&#8217;s legal
                                            advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence
                                            with regulators or government agencies and any employee complaints or published reports that
                                            raise material issues regarding Bowen&#8217;s financial statements or accounting policies
                                            and any significant changes in accounting standards or rules promulgated by the Financial
                                            Accounting Standards Board, the SEC or other regulatory authorities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
Committee</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with its IPO, Bowen established a compensation committee of the board of directors. The members of Bowen&#8217;s Compensation
Committee are Lawrence Leighton, Wei Li and Jun Zhang. Bowen also adopted a compensation committee charter, which details the principal
functions of the compensation committee, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving on an annual basis the corporate goals and objectives relevant to Bowen&#8217;s
                                            Chief Executive Officer&#8217;s compensation, evaluating the Chief Executive Officer&#8217;s
                                            performance in light of such goals and objectives and determining and approving the remuneration
                                            (if any) of the Chief Executive Officer based on such evaluation;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving the compensation of all of Bowen&#8217;s other officers;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            Bowen&#8217;s executive compensation policies and plans;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">implementing
                                            and administering Bowen&#8217;s incentive compensation equity-based remuneration plans;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assisting
                                            management in complying with Bowen&#8217;s proxy statement and annual report disclosure requirements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving
                                            all special perquisites, special cash payments and other special compensation and benefit
                                            arrangements for Bowen&#8217;s officers and employees;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">producing
                                            a report on executive compensation to be included in Bowen&#8217;s annual proxy statement;
                                            and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing,
                                            evaluating and recommending changes, if appropriate, to the remuneration for directors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant,
legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such
adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the
compensation committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
Nominations</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
does not have a standing nominating committee. In accordance with Rule 5605(e)(2) of the NASDAQ Rules, a majority of the independent
directors may recommend a director nominee for selection by the board of directors. The board of directors believes that the independent
directors can satisfactorily carry out the responsibility of properly selecting or approving director nominees without the formation
of a standing nominating committee. As there is no standing nominating committee, we do not have a nominating committee charter in place.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors will also consider director candidates recommended for nomination by our shareholders during such times as they are
seeking proposed nominees to stand for election at the next annual meeting of shareholders (or, if applicable, a special meeting of shareholders).
Our shareholders that wish to nominate a director for election to our board of directors should follow the procedures set forth in our
amended and restated memorandum and articles of association.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess.
In general, in identifying and evaluating nominees for director, our board of directors considers educational background, diversity of
professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent
the best interests of our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code
of Conduct and Ethics</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
has adopted a code of conduct and ethics applicable to its directors, officers and employees in accordance with applicable federal securities
laws. Copies of Bowen&#8217;s Code of Ethics and audit committee charter were filed as exhibits to the IPO registration statement. You
may review these documents by accessing Bowen&#8217;s public filings at the SEC&#8217;s web site at <i>www.sec.gov</i>. In addition,
Bowen will provide a copy of the Code of Ethics without charge upon request. Bowen will disclose any amendments to or waivers of certain
provisions of its Code of Ethics in a Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 175; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->162<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_021"></span>BOWEN&#8217;S
MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>References
in this section to &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221; refer to Bowen Acquisition Corp. References to our &#8220;management&#8221;
or our &#8220;management team&#8221; refer to our officers and directors.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussion and analysis should be read in conjunction with the financial statements and related notes included elsewhere in
this proxy statement/prospectus. This discussion includes forward-looking statements within the meaning of Section 27A of the Securities
Act and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about
future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may
cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels
of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking
statements by terminology such as &#8220;may,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221;
&#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; or the negative
of such terms or other similar expressions. Such statements include, but are not limited to, possible business combinations and the financing
thereof, and related matters, as well as all other statements other than statements of historical fact included in this proxy statement/prospectus.
Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overview</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
is a blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share
exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Results
of Operations</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have neither engaged in any operations nor generated any revenues to date. Our only activities since inception through June 30, 2024
<span style="background-color: white">were organizational activities, those necessary to prepare for the IPO described below and identifying
a target company for our initial Business Combination. We do not expect to generate any operating revenues until after the completion
of our initial Business Combination. We expect to generate non-operating income in the form of interest income on marketable securities
held after the IPO. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting,
accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business
Combination.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended June 30, 2024, we had a net income of $816,754, which consists of loss of $125,096 derived from formation and
operating costs offset by income earned on Trust Account of $941,850.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the six months ended June 30, 2024, we had a net income of $1,603,116, which consists of loss of $262,226 derived from formation and
operating costs offset by income earned on Trust Account of $1,865,342.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended June 30, 2023, we had a net income of $0.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the period from February 17, 2023 (inception) through June 30, 2023, we had a net loss of $3,105, which consists of loss of $3,105 derived
from formation and operating costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity,
Capital Resources and Going Concern</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 14, 2023, we consummated our IPO of Units, at $10.00 per Unit, generating gross proceeds of $60,000,000. Simultaneously with the
closing of our IPO, we consummated the sale of 330,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private
placement to the Sponsors, generating total gross proceeds of $3,300,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2023, the underwriters exercised the over-allotment option in full to purchase 900,000 Units. As a result, on July 18, 2023,
we sold an additional 900,000 Units at $10.00 per Unit, generating gross proceeds of $9,000,000. Simultaneously with the closing of the
full exercise of the over-allotment option, we completed the private sale of an aggregate of 31,500 Private Placement Units, at a purchase
price of $10.00 per Private Placement Unit, generating gross proceeds of $315,000. Transaction costs amounted to $3,243,898 consisting
of $1,725,000 of cash underwriting fees and $1,518,898 of other offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the IPO and the sale of over-allotment units, an amount of $69,690,000 ($10.10 per Unit) from the net proceeds of the
sale of the Units in the IPO and the Private Placement was placed in a trust account. The funds held in the Trust Account may be invested
in U.S. government securities with a maturity of 185 days or less. We intend to use substantially all of the funds held in the trust
account, including any amounts representing interest earned on the trust account, to complete our initial business combination. To the
extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the
remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses,
make other acquisitions and pursue our growth strategies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 176; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->163<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the completion of our initial business combination, we have available to us the approximately $700,000 of proceeds held outside the
trust account. We will use these funds primarily to identify and evaluate target businesses, perform business due diligence on prospective
target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives
or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a business
combination, and to pay taxes to the extent the interest earned on the trust account is not sufficient to pay our taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not believe we will need to raise additional funds following this offering in order to meet the expenditures required for operating
our business. However, if our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating
an initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate
our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to complete our initial
business combination or because we become obligated to redeem a significant number of our public shares upon completion of our initial
business combination, in which case we may issue additional securities or incur debt in connection with such business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, we had cash of $272,630 and a working capital of $95,109 (excluding $45,199 due from Shenzhen Qianzhi). The Company
has incurred and expects to continue to incur significant professional costs to remain as a public traded company and to incur transaction
costs in pursuit of a Business Combination. In connection with the Company&#8217;s assessment of going concern considerations in accordance
with Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to
Continue as a Going Concern,&#8221; management believes that these conditions raise substantial doubt about the Company&#8217;s ability
to continue as a going concern. In addition, if the Company is unable to complete a Business Combination within the Combination Period
and such period is not extended, there will be a liquidation and subsequent dissolution. As a result, management has determined that
such additional condition also raises substantial doubt about the Company&#8217;s ability to continue as a going concern. The consolidated
financial statement does not include any adjustments that might result from the outcome of the uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to Financial Statement Note 5 - Related Parties.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
Contractual Obligations</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities reflected on our balance
sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
Rights</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares, IPO Underwriter shares, and Bowen Private Units will be entitled to registration rights pursuant to a
registration rights agreement dated July 11, 2023 requiring Bowen to register such securities for resale. Subject to certain limitations
set forth in such agreement, the holders of these securities will be entitled to make up to three demands, excluding short form registration
demands, that Bowen register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights
with respect to registration statements filed subsequent to completion of a Business Combination and rights to require Bowen to
register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides
that Bowen will not be required to effect or permit any registration or cause any registration statement to become effective until
the securities covered thereby are released from their lock-up restrictions. Bowen will bear the expenses incurred in connection
with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
Combination Marketing Agreement</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have engaged EBC as an advisor in connection with its Business Combination to assist in holding meetings with Bowen shareholders
to discuss the potential Business Combination and the target business&#8217; attributes, introduce Bowen to potential investors
that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and
public filings in connection with the Business Combination. Bowen will pay EBC a service fee for such services upon the consummation
of its initial Business Combination in an amount equal to 3.5% of the gross proceeds of the IPO. In addition, Bowen will pay EBC
a service fee in an amount equal to 1.0% of the total consideration payable in the initial Business Combination if it introduces Bowen
to the target business with whom it completes an initial Business Combination and the amount will be payable in cash and is due at
the closing date of the initial Business Combination. The additional 1.0% fee is not payable in connection with the Business Combination
with Qianzhi.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical
Accounting Estimates</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United
States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure
of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual
results could materially differ from those estimates. We have not identified any critical accounting policies or estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
Accounting Standards</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on our financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 177; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->164<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_022"></span>INFORMATION
ABOUT NEWCO AND QIANZHI</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unless
the context otherwise requires, references in this &#8220;Business of Qianzhi&#8221; section to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221;
and similar first-person references are intended to mean the business and operations of Qianzhi and its consolidated subsidiaries taken
as a whole prior to the Business Combination and New Bowen and its consolidated subsidiaries taken as a whole following the Business
Combination. References to Qianzhi&#8217;s operating subsidiaries are included with respect to the business and operations strictly concerning
such subsidiaries. The discussion of Qianzhi&#8217;s business and the markets in which it competes below is qualified by, and should
be read in conjunction with, the discussion of the risks related to Qianzhi&#8217;s business and industry detailed elsewhere in this
proxy statement/prospectus.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are a health and wellness focused biotech company
and an early adopter and developer of plant-based and ozonated products for antibacterial, skincare, gynecological and andrological applications.
The majority of our products are ozonated, oil-based and infused with formulated herbal ingredients. Our other proprietary products include
ozonated disinfectant products produced by ambient temperature ozone curing technology. According to Frost &amp; Sullivan, in comparison
to traditional disinfectants, ozonated disinfectants products generally have more advanced product functionalities and advantages, including:
(1) product safety, as ozonated disinfectants do not leave harm residues; (2) eco-friendly features, since ozone breaks down into oxygen,
leaving no harmful byproducts, which further reduces environmental pollution; and (3) improved efficiency in killing bacteria, viruses,
and other pathogens at lower concentrations than traditional disinfectants. Our operations span the entire value chain of personal
care and disinfection products, from R&amp;D, production, to sales and marketing.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have three major brands and product series: &#8220;Qianzhi Yang&#174;&#8221; (ozone-based personal care products), &#8220;SDRA
Care Cosmetics&#8221; (cosmetics) and &#8220;Zone Clean Disinfectant Series&#8221; (disinfection products). For applications in sanitization
and disinfection, we leverage ozone for its unique sterilization properties&#8212;efficiency, broad spectrum, rapidity and an absence
of secondary pollution, and employ technology that supports the solidification of ozone molecules into plant-based oils (unsaturated
fatty acids, or UFA). in order to improve its efficacy Through dedicated research and development, we have secured several patents to successfully launch
our proprietary brand, Qianzhi Yang&#174;, along with a series of products under the brand name of &#8220;Xiao&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are highly focused on research,
development, production and sales of these products. Based on our long-term sales strategy and market demand research, we have found
that our target clientele can extend beyond our direct customers, such as beauty salons and trading companies. For instance, beauty
salons often conduct promotional activities such as providing customers with goods of certain value as promotional gifts to improve
their customer experience and encourage additional sales. Therefore, as an ancillary promotional arrangement for these customers, we
also provide pre-packaged food sales as part of our customer support. These products mainly include fast-moving consumer goods such
as rice, red wine, tea, drinking water, and milk that can be used for personal use or as gifts among relatives and friends. Hence,
we define them as ancillary products derived from our main products and call them the pre-packaged food series. These products are
all acquired from various third-party suppliers that we contract with from time to time and are not part of the research and
development function of our business operations. In addition, we adjust the variety of these products based on market changes,
customer demands and seasonality. Based on the customers&#8217; consumption habits and demands, any such ancillary product is
usually sold only for a limited period and may be discontinued at any time. Further, we might introduce a new product for sale based
on market feedback. Because we adjust these products based on changes in consumers&#8217; consumption habits, and each has
relatively short sales cycles, we do not consider these products as integral to our overall business operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the COVID-19 outbreak, we have significantly enhanced
our production capacity and supply chain efficiencies. These advances allow us to serve as a key provider of essential infection
prevention and control materials. Utilizing advanced equipment and processes, we have optimized our research and development efforts
to create the Zone Clean&#174; brand series of non-electrolytic hypochlorite disinfectants and are able to support the distribution of
large quantities of professional-grade disinfectants to medical institutions and home disinfectants to the public. Currently, our facility
in the Ezhou Economic Development Zone of Hubei Province currently maintains an average production capacity of 7.5 tons of semi-finished
stock solutions and 4,000 bottles of finished products per hour.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
prioritize the quality and efficacy of our products. Our rigorous production process, advanced supply chain, skilled and experienced
teams, and robust research and development initiatives enable us to offer an array of high-quality health products and services. We are
working continuously to innovate and expand our offerings to provide safer, and more reliable products to help our consumers enjoy a
healthier life. Our unwavering consumer-centric commitment drives us towards our vision of &#8220;Keeping Humans Away from Antibiotics&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue for the fiscal year ended March 31, 2024 was $7.0 million, with net cash flows generated from operating activities
of $1.7 million, compared to $10.1 million of revenue and $3.8 million of net cash flows used in operating activities
for the fiscal year ended March 31, 2023. We had a net loss of $0.7 million and a net income of $3.6 million for
the fiscal years ended March 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competitive
Strengths</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe our major competitive advantages are the keys to maintaining steady growth. We believe the following competitive strengths are
essential for our success and differentiate us from our competitors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 178; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->165<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Intellectual
Property and Research and Development:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a strong track record of successful research and development efforts, which has led to 31 patents granted to our company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
develop high-quality products, we have invested a significant amount of human, material and financial resources in experimentation and
improvements. Our research and development team has significant professional and technical knowledge and hands-on experience and is committed
to improving the efficacy, safety and quality of our products.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In order to improve our competitive position, we
have established commercial relationships with a number of organizations and research institutions in China and abroad to jointly develop
new products and promote new technologies. These organizations and research institutions provide services in the nature of project
consulting. Generally, our agreements with these third parties are for a fixed term and can be terminated based on customary commercial
reasons and we have entered into these relationships in the ordinary course of our business. We believe that these relationships
enable us to integrate resources, share information, improve product technology, lower production costs, and enhance market competitiveness.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future, we intend to remain committed to our technological research and development efforts and pursue innovation. We will focus
on improving the efficacy and quality of our products and optimizing our product production processes in order to offer customers better quality products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Product
Quality and Efficient Production Processes:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are committed to maintaining the highest standard of product quality and efficient production processes. Unlike many other industry competitors
which rely heavily on outsourcing, we own and control the production process of our core technologies to protect our business
secrets and strengthen our technology and production capabilities. This strategic approach reduces our dependence on suppliers and contractors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
entire process of producing our core products, Qianzhi Yang&#174; and Zone Clean&#174;, is handled by our wholly-owned subsidiary,
Hubei Qianzhi Biotechnology Co., Ltd. Our laboratory and production facilities are located in Ezhou, Hubei Province. By keeping control
over our core processes, we have high degree of confidence in the stability of our production processes and the consistent safety and
quality of the products we deliver.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a customized solution for procuring packaging materials and raw materials based on product needs. Furthermore, the core
components of our products are all produced on self-built and optimized production lines in strict accordance with high-quality standards.
All our products are subject to self-testing and quality testing by nationally recognized third-party professional testing organizations
such as CAS Testing and Pulyn Testing, in order to ensure consistent product quality. In addition, we continuously invest in our
R&amp;D function and maintain a close collaboration between our R&amp;D and production teams, so that we can ensure that our products
meet industry standards and customer expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ingredient
Quality and Product Utility:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meticulously
designed to adequately satisfy consumer needs and take user-friendliness into account, our Qianzhi Yang&#174; series of products are produced
in gel and oil-based forms based on different use scenarios and anatomical needs. Our product design takes into consideration the
different physiological structures of men and women. As a result, in our private care kit, we have adopted new disposable drug applicators
to provide consumers with more convenience and comfort.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meanwhile,
we also fully consider the sensitivity of different parts of the human body. We specifically design an appropriate range of ozone (O3)
content (1.24% to 1.52%) for products designed for the body surface, and a slightly higher range of ozone (O3) content (1.34% to 1.64%)
for products used for intimate care. In this way, we ensure that our products can safely and efficiently eliminate harmful bacteria such
as Staphylococcus aureus, Escherichia coli and Candida albicans, and avoid harming the healthy bacteria to provide safe and effective
private care.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we tailor the product offering mix of our Zone Clean&#174; Hypochlorite Disinfectant product series for different use scenarios
and functions. We offer a diverse range of product sizes, including portable packs of 50ml and 80ml, family packs of 500ml and 1L, and
volume packs of 5L and 25L volume packs to meet different consumers&#8217; needs. We have also adopted user-friendly and metal-free nozzle
designs to ensure product efficacy and improve consumer experience with more convenient and efficient application.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 179; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->166<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
Brand Value:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
brands, including Qianzhi Yang, Zone Clean, and SDRA, have established strong recognition among our customer base and play a pivotal
role in our sales and marketing strategies. At the 14th International Brand Festival Asia in 2019 organized by Asiabrand in Hong
Kong, we were awarded a brand valuation certificate by Asiabrand, estimating that our brand value reached 150 million RMB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
brand is the hallmark of our consumer-centric expertise and innovation in biotechnology. As a company specializing in biotechnology
research, development, and application, we are committed to providing healthier, safer and more convenient products and services. Meanwhile,
we also actively engage in social responsibility initiatives to promote sustainable development. Moving forward, we will focus on upholding
our vision of &#8220;Keeping Humans Away from Antibiotics&#8221;, improving our brand value, sustaining our competitive edge, and creating
more value for society.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
operating in the beauty and skin care, intimate care, and cleansing and disinfection industries face intense competition. We expect the
competition to increase and intensify.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
this stage, our main competitors are large and well-known companies in the pharmaceutical, cosmetic, medical equipment and healthcare
sectors. We face and will continue to face intense competition. Many of these competitors are better known in the industry, have stronger
research and development and marketing capabilities, and possess more diversified distribution channels and financial resources. This
is likely to enable them to develop or have developed products that can compete with or be technologically superior to our products.
As we enter new markets, we seek to further consolidate our existing market share and to adopt a market penetration strategy with new
products to increase our existing market share and expand distribution channels.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the intimate care market, our major competitive products include JieErYin Lotion, FuYanJie Plant Herbal Lotion, Metronidazole and Chlorhexidine
Lotion, FuFangHuangSongXiYe, ChuShiZhiYangXiYe, HongHeFuJieXiYe, PiFuKangXiYe, QingBaiJieShenXiYe, HuangKuXiYe and Kubo Zhiyang Xiye,
many of which are OTC products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the cleansing and disinfection market, we face competition not only from well-known brands such as Dettol, Colgate and Liby, but also
from similar products such as SMAM, Abajo and Spene.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the skin care industry, we face competition from many well-known domestic and
foreign competitors such as the Est&#233;e Lauder Companies, Shiseido, Procter &amp; Gamble and L&#8217;Or&#233;al.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
History and Structure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
diagram below illustrates our corporate structure, including the direct owners of New Bowen and New Bowen&#8217;s operating subsidiaries,
as of the date of this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 180; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->167<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="picture1.jpg" alt=""/>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
Group Holding (Cayman) Ltd. is an exempted company incorporated on August 14, 2023 under the laws of the Cayman Islands. Qianzhi Group
Holding (Cayman) Ltd. is the sole-owner of Qianzhi BVI, which was formed on August 31, 2023 under the laws of the British Virgin Island
and owns 100% of the of the equity of Qianzhi HK, which was established on September 27, 2023 in accordance with the laws of Hong Kong,
China. Shenzhen Shian Biotechnology Co., Ltd, a wholly-owned subsidiary of Qianzhi HK, is a wholly foreign-owned enterprise (&#8220;WFOE&#8221;)
established on November 23, 2023 in accordance with the laws of the People&#8217;s Republic of China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shenzhen
Qianzhi Biotechnology Co., Ltd (&#8220;Qianzhi&#8221;), the main domestic operating entity of Qianzhi Group (Cayman), is a limited liability
company established in Shenzhen, Guangdong Province on March 20, 2007 in accordance with the laws of the People&#8217;s Republic of China.
In 2021, it developed and launched Zone Clean&#174; Hypochlorite Disinfectant product series. Qianzhi currently owns four wholly-owned
subsidiaries:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shenzhen
                                            Qianzhi Biotech Co., Ltd, a limited liability company, established in Shenzhen, Guangdong
                                            Province on July 2, 2019 in accordance with the laws of the People&#8217;s Republic of China;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shenhzen
                                            Qianzhi Health Management Co., Ltd, a limited liability company established in Shenzhen,
                                            Guangdong Province on May 5, 2019 in accordance with the laws of the People&#8217;s Republic
                                            of China;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hubei
                                            Qianzhi Biotechnology Co., Ltd, a limited liability company established in Ezhou, Hubei Province
                                            in accordance with the laws of the People&#8217;s Republic of China; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiangxi
                                            Qianzhi Biotechnology Co., Ltd, a limited liability company established on June 12, 2019
                                            in accordance with the laws of the People&#8217;s Republic of China.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Model and Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We sell self-produced or purchased products
through our sales channels to beauty salons, personal care product dealers and others.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aside
from our planned product pipeline, we have tailored marketing strategies specifically for new products. We aim to attract younger
consumers with targeted product and packaging designs, change our traditional sales model, and align our sales and promotion efforts
with an updated marketing mix, including e-commerce, influencer collaboration and social media. For healthcare equipment and products
to be developed, we intend to enhance communications and partnerships with industry experts and other organizations and establish
a medical sales channel plan in anticipation of the upcoming products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 181; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->168<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
recent years the domestic intimate care market is growing and represents an opportunity for expansion. We see potential in expanding
in this market through attracting more consumers, diversifying our product portfolio, and driving innovation in this market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have a high degree of confidence in achieving
success in this market while maintaining our existing market share for beauty and skincare products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Products</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Existing
Products</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed above, our three major brands are &#8220;Qianzhi Yang&#8221;, &#8220;SDRA&#8221; and &#8220;Zone Clean&#8221;. These brands
form our three product series: &#8220;Qianzhi Yang Intimate Care Series&#8221; (ozone-based intimate care products), &#8220;SDRA Care
Cosmetics&#8221; (cosmetics) and &#8220;Zone Clean Hypochlorite Disinfectant Series&#8221; (disinfection products), respectively. In
addition, we also sell prepackaged food and beverage products as an ancillary promotional arrangement to our beauty salon customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Qianzhi
Yang</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our main brand, Qianzhi Yang&#174;, we have developed a variety of intimate care products in either oil or cream forms catering to different
ages and consumer needs, including Qianzhi Yang For Men, which targets intimate care for men over 40; Qianzhi Yang For Women, which targets
intimate care for women over 40, Qianzhi Yang For Daily, for repairing inflammation of surface skin for all ages; Yi Zu Yi Pin., for
repairing inflammation of the feet inflammation; Ta Yu, which targets intimate care for women aged 20 to 35; and Ta Lv, which targets
intimate care for men aged 20 to 35. Our intimate care product series achieves efficacy mainly by leveraging ozone for its sterilization
and disinfection properties. Ozone can react with cell membranes, attack the components of the cell membrane, then disrupt lipoproteins
and lipopolysaccharides within the cell membrane to change the permeability of the cell membrane leading to cell lysis and death, which
can effectively treat body surface inflammation and provide intimate care in daily life. By changing the permeability of the cell membrane,
ozone molecules can also inhibit microbial growth and reproduction to effectively prevent and treat infections.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="forms-4_014.jpg" alt=""/>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 182; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->169<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="text-decoration: underline">SDRA&#174; Care Cosmetics</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SDRA&#174;
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Care Cosmetics is a mature skincare product series
purchased from third parties. This product series includes products such as:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SDRA
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nectar
                                            Nourishing Essential Oil</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SDRA
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hydrating
                                            and Moisturizing Mask</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SDRA
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Botanical
                                            Essence Toner</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SDRA
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moisturizing
                                            Lotion</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SDRA
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Protective
                                            Cream</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SDRA
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Botanical
                                            Hydrating Serum, and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SDRA
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Silky
                                            Softening Cleanser.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
we are also actively preparing for self-production, including applying for relevant production qualifications and building a cosmetic
production line.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="forms-4_004.jpg" alt="" style="width: 650px"/>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Zone
Clean&#174; Hypochlorite Disinfectant Series</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
non-electrolytic hypochlorous acid as its main ingredient (having a PH of 4.6 to 6.6 with available chlorine content of 130 to 176),
our Zone Clean&#174; Hypochlorite Disinfectant Series is largely used in the disinfection of home, public spaces (e.g. hospitals
and hotels), fruits, vegetables, tableware and pet areas. These products use food-grade sodium hypochlorite and food-grade hydrochloric
acid as raw materials. We employ highly sensitive sensor CPU-controlled microcircuits and precision micro-pumps to produce this series
through the principle of jet flow phase interface reaction to ensure the stability of the main ingredients: NaCl, HClO and purified
water. We adopt mixed electrolysis of hypochlorous acid to produce these products, so that they do not contain charged
ions and has enhanced stability, weak odor, a shelf-life of 12 months, and with sterilizing power approximately three times higher than
disinfectants using traditional electrolysis. Unlike this series, disinfectants using traditional electrolysis of hypochlorous acid usually
have a shelf life of approximately 3 months because they contain charged ions which lead to greater instability, decomposition and evaporation.
We tailor this product offering mix to catering to different use needs. We offer a diverse range of product sizes, including portable
packs of 50ml and 80ml, family packs of 500ml and 1L, and volume packs of 5L and 25L.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 183; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->170<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_005.jpg" alt=""/>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Product Testing</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">As described below
in greater detail, our hygiene and disinfection </span><span style="font-size: 9.5pt">products are subject to regulation by one or more
regulatory agencies in the PRC, including the National Health Commission and the Ministry of Health, which have adopted numerous regulations
that govern how we can market, sell and distribute these products. See &#8220;<i>INFORMATION ABOUT NEWCO AND QIANZHI &#8211; Governmental
Regulations &#8211; PRC Laws and Regulations</i>&#8221;. </span><span style="font-size: 10pt">Before we can commercialize our hygiene
products, we must be able to substantiate the efficacy and safety of these products consistent with applicable regulatory requirements.
Pursuant to the requirements of the Infectious Disease Prevention and Control Law of the PRC, the Disinfection Management Measures, and
the Regulations on Hygiene and Safety Evaluation of Disinfection Products, prior to commercial introduction of covered products, the party responsible for the product must file a qualified hygiene and safety evaluation report with the appropriate provincial health administrative
department, which conducts a formal review of the health and safety evaluation report. </span><span style="font-size: 9.5pt">Presently,
</span><span style="font-size: 10pt">Qianzhi has eight (8) hygiene and disinfection products, all of which are filed with the National
Disinfection Product Online Platform.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To demonstrate compliance, we contract with third-party
certification firms to assess the efficacy of these products. For products in the Qianzhi Yang<sup>&#174;</sup> Private Care Series, testing
and certification is performed by CAS Testing Technical Services (Guangzhou) Co., Ltd. or Hubei Pulyn Standards Technical Services Co.,
Ltd., which conduct an array of assessments on the bactericidal effect of these products on a number of bacteria, including Candida albicans,
Escherichia coli, and staphylococcus. Similarly, for our Zone Clean<sup>&#174;</sup> hypochlorous acid disinfectant product line, testing
and certification is performed by Hubei Pulyn Standards Technical Services Co., Ltd., which performed an array of assessments on the
bactericidal effect and safety of these products. The testing is designed to assess the efficacy and safety of these products and compliance
with the regulatory standards under applicable PRC regulations. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
products in our Qianzhi Yang<sup>&#174;</sup> Private Care Series and our Zone Clean&#174; Hypochlorite Disinfectant Series satisfy all
applicable regulatory standards with a demonstrated bactericidal effect between 90 and 99%. The products in our Qianzhi Yang&#174;
Private Care Series and our Zone Clean&#174; Hypochlorite Disinfectant Series satisfy the Technical Standard For Disinfection published
by Ministry of Health of the PRC and Hygienic Standard for Disposable Sanitary Products published by General Administration of Quality
Supervision, Inspection and Quarantine of the PRC. Please see the discussion under <i>&#8220;INFORMATION ABOUT NEWCO AND QIANZHI &#8211;
Governmental Regulations &#8211; PRC Laws and Regulations</i>&#8221; for additional details regarding the government regulations that
apply to our products.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to our SDRA&#174; Care Cosmetics product line, we purchase these products from a third party supplier which manufactures the
product and is responsible for ensuring that the products are manufactured in accordance with all relevant laws and regulations. In selecting
the suppliers and manufacturers that we contract with, we inspect their licenses, qualifications and quality control processes to ensure
that their products are compliant with applicable laws and regulations. We have entered into a purchase agreement with Guangzhou Ruixi
Biochemical Technology Co., Ltd (&#8220;Ruixi&#8221;) pursuant to which we purchase our SDRA products. Under this agreement, Ruixi is
responsible for ensuring that the products comply with relevant laws and regulations, and we have inspection rights. Ruixi holds a Cosmetic
Production License issued by Guangdong Provincial Medical Products Administration and all SDRA products are filed with the PRC National
Medical Products Administration, which regulates various aspects of the manufacturing and commercialization of cosmetic products, including
the ingredients used, results/rates after latest inspection and supervision, and product labeling and packaging to ensure that the functions
and specifications of the product claimed by the manufacturer are reasonable and in compliance with applicable regulations.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Product
Pipeline</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to be ready for potentially intensified competition and maintain our industry position, we plan to make significant additional
investments in the near future to add new types and features to our existing product offerings, primarily focusing on providing products
tailored for women. With the rapid technological development related to women&#8217;s health in recent years, in particular the preventing
and treatment of HPV, we hope to leverage our legacy products and technologies to create a new range of products supporting the daily
health of female consumers. We will spend most of R&amp;D expenses mentioned in &#8220;Use of Proceeds&#8221; on initial
market research and development of these products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Prepackaged Food Products</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based on our market demand research, as an ancillary
promotional arrangement for certain of our customers, we also provide pre-packaged food sales as part of our customer support. These
products mainly include fast-moving consumer goods such as rice, red wine, tea, drinking water, and milk. These products are all acquired
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">from various third-party suppliers that we contract with from
time to time and are not part of the research and development function of our business operations. In addition, we adjust the variety
of these products based on market changes, customer demands and seasonality. As we adjust these products based on changes in consumers&#8217;
consumption habits, and each has relatively short sales cycles, we do not consider these products as integral to our overall business
operations.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Suppliers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
main raw materials that we procure include olive oil, sodium hypochlorite, soybean oil and ozone antibacterial oil. Other raw materials
such as dosing devices and packaging bottles are finished products purchased from third parties. Our purchasing department manages the
procurement of raw materials, end products, supplies, packaging materials, and other items in strict accordance with our supplier management
system and procurement process to meet other departments&#8217; needs. To ensure product quality, it also annually evaluates our suppliers
and forms a list of qualified suppliers. The key suppliers we have had strong partnership with over the years include Shenzhen Bona Pharma
Technology Co., Ltd., Shanghai Syntec Additive Limited, and Sunkiss (Shanghai) Biotechnology Co., Ltd.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 184; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->171<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following chart briefly illustrates our procurement process:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_006.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is dedicated to maintaining the gold standard in
its products, continuous R&amp;D and efficient production process. Unlike many other competitors heavily relying on outsourcing, it controls
the production process involving its core technologies to protect its trade secrets and reduce its dependence on contractors. The entire
process of producing its ozone-based and disinfectant products is handled by Hubei Qianzhi Biotechnology Co., Ltd., its wholly-owned
subsidiary. This approach enables Qianzhi to have a high degree of confidence in ensuring stable production processes and delivering
its products with consistent quality. The core components of its products are all produced on its production lines, following strict
production standards, except for packaging materials and purchased raw materials, for which it adopts a customized solution to purchasing
purely based on product needs. Its products are subject to self-testing and testing by nationally recognized third-party testing agencies
such as CAS TESTING and PULYN to ensure its consistency in product quality. In addition, Qianzhi continuously invests in
R&amp;D to maintain its leadership in technologies and meet customer expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As mentioned above, we also offer our beauty salon
customers the opportunity to purchase pre-packaged food and beverage products that we source from various third-party commercial suppliers
such as wholesalers or trading firms.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Customers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
Biotech operates in the business-to-business and business-to-consumer models. Our chairwoman, Ms. Xiaoqin Lin, has been in the beauty
industry for over 20 years, and has a strong understanding of the needs of downstream market customers such as beauty salons and personal
care product dealers. Qianzhi&#8217;s management and marketing teams possess significant experience in the beauty industry and
have targeted a wide pool of high-quality customers with whom we are working to develop long-term relationships. In addition to providing
high-quality products to downstream customers, we also train them on the products and provide after-sales services to assist in their
end-user sales efforts and enhance customer satisfaction and loyalty. Our sales department also holds regular sales training sessions
so that our customers with unsatisfactory sales performance can improve their outcomes. Meanwhile, we have put in place strict mechanisms
to disqualify and terminate our relationships with any downstream customers who make false advertising claims about our products,
exaggerate their efficacy, or impair our image or brands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 185; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->172<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2024, approximately 90% of our revenue was derived from sales in Guangdong Province, China, and 10% was derived
from sales in Fujian Province and other provinces of China. Female consumers accounted for 80.75% of our Qianzhi Yang&#174; product
series, with male consumers accounting for 19.25%. Most consumers purchasing our skincare products were female users, generally
between 40 and 65.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Research
and Development</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hubei
Qianzhi, our main production base, has entered into a cooperation agreement with Professor Hong Jiang and his team from Wuhan University
to create a core R&amp;D team headed by Professor Jiang and comprised of over 20 members who have strong expertise, industry experience
and practical abilities. &#160;This R&amp;D team has been working closely to explore new technologies and create strong technical barriers
to our competitors for our products. In the future, Professor Jiang is expected to provide additional technical support and guidance
for research and development of our new products. Professor Jiang Hong is an associate professor at the School of Basic Medical
Science, Wuhan University, a researcher of the Key Laboratory of Pesticide Development and Application Technology of the Ministry of
Agriculture, a member of the Society for Vector Biology and Control, the Chinese Preventive Medicine Association, and an expert on prevention
and control of small animals for the National Oncomelania and Schistosoma Preservation Base/Human Parasite Depository.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Opportunities; Use of Proceeds</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the economy has recovered from the COVID-19 pandemic and continued to grow, public health and hygiene awareness has increased, and we
believe that consumers have a greater concern about disease prevention than before. As a company providing health and hygiene products
to the public, we will strive to seize new opportunities to offer safer and more effective health and hygiene disinfection products to
more consumers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To enable us to develop new market penetration strategies
and open new markets for our products, we intend to use a portion of the proceeds we receive from this Business Combination
for business expansion and market development purposes, including analyzing new potential markets for our products and further researching
consumer behaviors to expand our potential customer base. This may include efforts to introduce our products into foreign markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">operates in the personal care industry which is
highly competitive and growing in China. The development and commercialization of personal care products is facing intense competition,
and the personal care industry features rapid technological changes, fierce competition, and intellectual property protection. In addition,
consumer interest in natural and environmentally friendly cosmetics is also increasing. As a result, we intend to use a portion of the
proceeds we receive from this Business Combination for the purpose of research and development of new products, to adapt to market changes
and develop more new market-oriented products by upgrading existing products (e.g. developing aqueous ozone-based products and valuing
feedback across sales channels).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 186; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->173<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Manufacturing
and Supply Chain</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
produce most of the products that we sell to our customers. Ozone-based and disinfectant products are mainly produced by Hubei Qianzhi
using leased plants and its own production equipment and technical processes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_007.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
present, Hubei Qianzhi, our wholly-owned subsidiary, has a production plant of nearly 1,000m<sup>2</sup> located in Ezhou, Hubei Providence.
The plant has a class 10,000 clean laboratory of 500m<sup>2 </sup>and more than 30 sets of state-of-the-art production equipment that
enable us to carry out high-precision and efficient manufacturing operations. All research, development, and experimental activities
are carried out in our laboratory environment that is optimized for quality and equipped with state-of-the-art cleaning facilities. Hubei
Qianzhi has also obtained the Hygiene License for Disinfectants Manufacturers from the Health Commission of Hubei Province, and all disinfectants
we produce have been filed on appropriate national platforms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
produce our products according to the following process:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_008.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 187; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->174<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are able to effectively manage our supply chain to ensure stability in the supply of raw materials and quality control in producing our
products, while reducing costs and improving operational efficiency. We have also established long-term relationships with cosmetics
manufacturers and plan to build our own cosmetic production lines to have a higher degree of quality control and continuously offer our
products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Distribution
Model and Marketing Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
China, we mainly adopt business-to-business and business-to-consumer distribution models. For the business-to-business market, our key
customers are companies, social organizations, schools, medical institutions, beauty salons, and government authorities. We have a professional
and experienced sales team for this market. Currently, we provide customized hygiene and health solutions and a range of health and wellness
products produced on demand for our business-to-business customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
started our business-to-consumer business as an effort to diversify in response to the economic downturn following the COVID-19 outbreak
in 2019. In addition, we are exploring various retail models and are seeking to sell our products on Taobao, Jingdong, Pinduoduo,
Douyin and other mainstream e-commerce platforms in China because their large user base and extensive coverage enable us to expand our
sales channels and enhance our brand awareness. Currently, we provide guidance and services to business-to-consumer customers for selection,
purchase and use of our products, and offer offline customers more customized product mixes tailoring to their situations and needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have conducted thorough research and analysis to understand consumer needs and purchasing behaviors for our retail model. Specifically,
we plan to increase our marketing budget and strengthen our marketing and sales efforts to consolidate our existing business-to-business
customer base, and identify and attract new business-to-consumer customers. We seek to enhance our brand visibility by increasing domestic
and international media exposure and collaborating with influencers. We also plan to work continuously to refine product designs and
functions to improve user experience and satisfaction. These efforts are expected to enable us to expand our market share and increase
our brand awareness and user loyalty. We will also focus on optimizing our marketing strategies and enhance product stickiness to expand
our sales channels and retain more consumers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
we are in the process of implementing business plans to develop new sales channels and product application scenarios in order to realize
our growth targets. For instance, we believe that we will be able to expand industry applications for our ozone sterilization and hypochlorous
acid disinfectant products due to the broad range of functional attributes that both product lines possess. For example. Due to the diversity
of disinfection targets and the complexity of environments, hypochlorous acid disinfectants can be used for washing produce, pet disinfection,
sterilization in aquatic and livestock product factories, and disinfection in kitchens, restaurants, agriculture, forestry, animal husbandry,
fishing, laboratories, pharmaceutical factories, nursing homes, hospitals, schools, kindergartens, hotels, and other environments. We
intend to implement a multi-pronged marketing approach, including: serving our existing customer base; conducting full-scale marketing
through e-commerce and live streaming platforms; forming chain service agencies, providing products, technology, and service guidance
at communities nationwide; and establishing an agency model to connect products and services with various institutional settings such
as hospitals, health care and medical facilities, schools, hotels, elder-care facilities, and elderly health service platforms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The customers for the pre-packaged food and beverage
products we sell are beauty salons that also purchase our core product lines or the customers of those salons. The pre-packaged food
and beverage products are sourced from various third-party suppliers. The specific pre-packaged food and beverage products that we sell
change from time to time based on market trends, seasonality and the assessment of the interests of potential customers.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intellectual
Property</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
regard our patents, trademarks, service marks, domain names, trade secrets, and similar intellectual property as critical to our
success. We rely on a combination of patent, copyright and trademark law, and confidentiality and non-disclosure agreements to
protect our intellectual property rights. We also regularly monitor any infringement or misappropriation of our intellectual property
rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement/prospectus, we have registered in the PRC:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65
    trademarks, including 4 pending trademarks;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31
    patented technologies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4
    software copyrights.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Of our patented technologies, 19 relate to our
&#8220;Qianzhi Yang Intimate Care Series&#8221; (ozone-based intimate care products) and 11 relate to our &#8220;Zone Clean Hypochlorite
Disinfectant Series&#8221; (disinfection products). The remaining patent relates to a product under development which we anticipate launching
during the fiscal year ending March 31, 2026. We own all of the foregoing patented technologies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">According to <i>Patent Law of the People&#8217;s Republic
of China</i>, the term of patent rights for inventions is twenty years, the term of patent rights for utility models is ten years, and
the term of patent rights for designs is fifteen years, all commencing from the filing date. As of the date of this proxy statement/prospectus,
Qianzhi owns 27 patent rights for utility models, which will expire between 2030 and 2032; 3 patent rights for designs, which will expire
in 2037; and 1 patent right for an invention, which will expire in 2039.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A detailed summary of the various patent rights
we hold is set forth below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="9" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Patents</span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; width: 2%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related
    Product</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; width: 2%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent
    Type</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; width: 2%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font: 10pt Times New Roman, Times, Serif; width: 16%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
                                            Term</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Since
    Filing)</span></p></td>
    <td style="text-align: left; padding-bottom: 1.5pt; width: 2%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiration
    Date</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Invention
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep-29-2039</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov-09-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov-09-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disinfection
    Product</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov-09-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disinfection
    Product</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov-09-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disinfection
    Product</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov-09-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disinfection
    Product</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov-09-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disinfection
    Product</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov-09-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep-14-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep-14-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep-14-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disinfection
    Product</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep-14-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep-24-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep-24-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep-24-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disinfection
    Product</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aug-08-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disinfection
    Product</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jul-06-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disinfection
    Product</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jul-14-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jul-31-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov-12-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep-26-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep-26-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep-13-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep-13-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oct-22-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aug-29-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dec-30-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disinfection
    Product</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utility
    Model</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mar-01-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Design</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov-09-2037</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Design</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov-09-2037</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ozone-Based
    Personal Care</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Design</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15
    years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov-09-2037</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are committed to developing and protecting our intellectual property and filing patent applications to protect our technologies. We have
adopted internal methods to strengthen the protection of our trade secrets and other intangible assets. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Facilities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal administrative office is located at 17 Floor, Tower B, Jingji 100, Luohu District, Shenzhen City, covering an area of approximately
700m<sup>2</sup> with a lease term from May 2023 to September 2026. The total monthly rental is RMB118,548. This space is mainly used
by us as our administration, marketing and sales department headquarters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 188; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->175<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
medical grade production laboratory is located at No. 71, Fanchuan Avenue, Economic Development Zone, Ezhou City, Hubei Province.
The laboratory and the manufacturing workshop cover an area of over 1,000 m<sup>2</sup> and houses our product research and development
department, production lines, and administrative office for our employees in Hubei.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets out the details of our leased properties:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Company</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Address</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Area/m<sup>2</sup></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Term</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Monthly Rental/&#165; Yuan</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; width: 27%; text-align: left">Shenzhen Qianzhi Biotechnology Co., Ltd</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; width: 21%; text-align: left">1705, 17 Floor, Tower B, Jingji 100, Luohu District, Shenzhen City,</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right">177.75</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023/9/1-2026/8/31</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">31,995</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left">Shenzhen Qianzhi Health Management Co., Ltd.Qianzhi Health</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left">1703, 17 Floor, Tower B, Jingji 100, Luohu District, Shenzhen City,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">171.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023/9/1-2026/8/31</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">30,790</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left">Shenzhen Qianzhi Biotech Co.,Ltd.</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left">1701, 17 Floor, Tower B, Jingji 100, Luohu District, Shenzhen City,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">309.79</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023/8/1-2026/7/31</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">55,762</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left">Hubei Qianzhi Biotechnology Co., Ltd</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left">No. 71, Fanchuan Avenue, Economic
    Development Zone, Ezhou City, Hubei Province</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">879</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019/5/1-2025/12/31</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">18,898</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the facilities that we currently lease are adequate to meet our needs for the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees
and Management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have established a team specialized in production and research and development, a team responsible for operation and management, and
a sales team.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
production and research and development team consists of a group of technical experts who are well versed in a variety of advanced technologies
and innovative methodologies, and work to drive product upgrades and research and development innovations. The operation and management
team consists of individuals with management experience in well-known companies both domestically and abroad, who have experience and
ability in marketing operations, project management and customer service. The team is committed to refining Qianzhi&#8217;s operational
processes, improving its efficiency and ensuring that Qianzhi&#8217;s business development keeps abreast with market demand. Our
sales team consists of sales professions with proficient sales skills and extensive customer networks, who are able to effectively promote
our products and establish long-term and stable partnerships with our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement/prospectus, we have 38 full-time employees at the following companies:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">Company:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">Number</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify">Qianzhi Biotechnology</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">10</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Hubei Qianzhi</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">16</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Jiangxi Qianzhi</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Qianzhi Bio-tech</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Qianzhi Health</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">38</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide our employees with fringe benefits including, among others, team building activities, holiday leaves, care giving and knowledge
training. We also make contributions to the social insurances and housing fund (&#8220;Five Social Insurances and One Housing
Fund&#8221;) for all employees in accordance with the laws, and hold regular training on industry regulations and personal health and
safety of employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 189; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->176<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
employees have not formed any labor union or association. We arrange in-house training from time to time to enhance our employees&#8217;
skills required in their corresponding positions. Our success depends on our ability to attract, retain and motivate qualified employees.
We strive to provide our employees with competitive compensation packages, humane management solutions and a positive, energetic and creative work environment. We believe that a good working relationship with the employees will be the foundation
for the sustainable development of a responsible company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Insurance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required by regulations in the PRC, we participate in various employee social security plans that are organised by municipal and provincial
governments for our full-time employees, including pension, unemployment insurance, childbirth insurance, work-related injury insurance,
medical insurance, and housing insurance. We are required under PRC laws to make contributions from time to time to employee benefit
plans for our full-time employees at specified percentages of the salaries, bonuses, and certain allowances of such employees, up to
a maximum amount specified by the local governments in China. We have made adequate social security and housing fund contributions for
all employees. We also have joined commercial insurance plan for our employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, we maintain various insurance policies
to safeguard against certain risks and unexpected events, including product liability insurance for our product lines as well as certain
of the pre-packaged foods we purchase from other suppliers. However, we do not have general liability insurance coverage which covers
all risks of physical loss, destruction or damage to our production facilities, the inventory of our products and our fixed assets for
our other subsidiaries, nor do we maintain property insurance, business disruption insurance or cyber-security insurance or insurance
against breaches or loss of data or personal private information of users of our games. Accordingly, our insurance coverage is insufficient
to protect us against various types of losses that we may incur in operating our business. Further, there are certain types of losses,
such as losses from war, acts of terrorism, outbreak of diseases, earthquakes, typhoons, flooding and other natural disasters, for which
we cannot obtain insurance at a reasonable cost or at all.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Seasonality</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is not subject to seasonality except with respect to the composition of the pre-packaged food and beverage products that
we provide to our beauty salon customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may become a party to various legal or administrative proceedings arising in the ordinary course of our business, including
actions with respect to intellectual property infringement, violation of third-party licenses or other rights, breach of contract, and
labor and employment claims. We are currently not a party to, and we are not aware of any threat of, any legal or administrative proceedings
that, in the opinion of our management, are likely to have any material and adverse effect on our business, financial condition, cash
flow, or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Industry
Background and Market Trends</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unless
otherwise noted, all the information and data presented in this section have been derived from the industry report of Frost &amp; Sullivan
commissioned by Qianzhi in February 2024, entitled &#8220;The Independent Industry Research of China Hygiene, Disinfection and Beauty
Product Market&#8221; (the &#8220;Frost &amp; Sullivan Report&#8221;). Frost &amp; Sullivan has advised that the statistical and graphical
information contained herein is drawn from its database and other sources. The following discussion contains projections for future growth,
which may not occur at the rates that are projected or at all.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(1)
Hygiene and Disinfection Products</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the annual Statistical Bulletin on Hygiene and Health Development released by the Chinese National Health Commission, cash expenditures
on personal hygiene in China has increased from RMB1.51 trillion in 2017 to RMB2.29 trillion in 2022, with a compound annual growth rate
of 8.7%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the annual Statistical Communique on National Economic and Social Development released by the National Bureau of Statistics, per capita
consumption expenditure in China increased from RMB18.32 thousand in 2017 to RMB24.54 thousand in 2022, with a compound annual growth
rate of 6.0%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 190; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->177<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_009.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Source:
National Health Commission, National Bureau of Statistics, Frost &amp; Sullivan)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Covid-19 pandemic caused many people to realize that good hygiene habits and effective disinfection measures are important for preventing
diseases. This has led to the development of the hygiene and disinfection market. In addition, the outbreak of the pandemic has also
enhanced consumers&#8217; awareness of hygiene and disinfection products available to them, stimulating the demand for such products
and promoting the rapid development of the market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(2)
Personal Hygiene Products</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the previously defined market segments upon difference in personal hygiene product usage&#160;, hygiene products for personal care
can be categorized into three general categories: basic personal hygiene products (which include products such as soaps, hand sanitizers,
bath &amp; shower products, face and body care products), intimate hygiene products and other hygiene products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to Frost &amp; Sullivan, the personal hygiene market size was valued at RMB 428.9 billion in 2018, which increased to RMB 635.6 billion
by 2022. The noticeable market growth was attributed to the increasing recognition of the significance of personal hygiene in prevention
of disease and preserving health, as well as the rise of e-commerce which has facilitated consumers&#8217; access to a wide variety of
products, including imported items. Furthermore, the pandemic also contributed to the increased awareness towards personal care and hygiene.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
such, the growth of personal hygiene product market is anticipated to continue with an expected increased market size of RMB 951.1 billion
in 2027 at a CAGR of 8.3% according to Frost &amp; Sullivan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 191; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->178<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_010.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Source:
Frost &amp;Sullivan)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(3)
Daily Disinfectants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market size of daily disinfectants in China has more than doubled from 2018 to 2022, increasing from RMB1.07 billion in 2018 to RMB2.68
billion in 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daily
disinfectants mainly include hypochlorous acid disinfectants, 75% alcohol disinfectants, and 84 disinfectants. Compared with other daily
disinfectants, hypochlorous acid disinfectants have several advantages, such as no alcohol, non-irritating odor, relatively low concentration,
low corrosiveness, low toxicity to humans, high disinfection efficiency, high safety, and a wide range of applications. After the outbreak
of COVID-19, the awareness of disinfectants has improved significantly, and the demand for hypochlorous acid disinfectants has increased
rapidly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future, the market size of daily disinfectants is expected to expand, reaching RMB3.77 billion in 2027. As an efficient, safe, and
environmentally friendly disinfectant, we believe that hypochlorous acid disinfectant holds certain market potential. With ongoing technological
advancement, the stability and convenience of hypochlorous acid disinfectant are expected to improve, promoting further uses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 192; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->179<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="forms-4_011.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Source:
Frost &amp; Sullivan)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(4)
Hygiene and Disinfection Products and Female Hygiene Market</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>a.
Expanding Market Scale</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the improvement of living standards in the PRC, the enhancement of health awareness, and the impact of COVID-19, demand for hygiene and
disinfection products has grown. With the further improvement of health awareness and increased attention on disease prevention, the
penetration rate of hygiene and disinfection products is expected to continue to increase. In addition to uses in family life, it is
anticipated that use of these products will be expanded to a wider range of fields. For instance, schools, supermarkets, sports and entertainment
venues, and other public places are anticipated to introduce hygiene and disinfection products to ensure public hygiene. As a result,
the market size of the hygiene and disinfection products is expected to continue to expand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>b.
Personalized and Diversified Products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
demand for hygiene and disinfection products tends to be personalized and customized. People are willing to use hygiene and disinfection
products which can match their specific needs. Since the preferences of individuals are different, personalized products can better meet
the diversified needs of consumers, promoting the innovation and diversity of the market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future, manufacturers of hygiene and disinfection products will be expected not only to provide general products but also
to launch products with different specifications, different functions, and different materials to meet consumers&#8217; needs.
For example, hygiene and disinfection products like hygienic ozone products and hypochlorous acid disinfectants will have more types
and application scenarios to meet the specific needs and preferences of various consumers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 193; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->180<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>c.
Potential in the Female Market</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affected
by physiological factors, women are more likely to face hygiene issues, especially intimate hygiene problems, such as vaginitis, cervical
erosion, HPV, etc. As education levels, income levels, and economic autonomy of females increase, women are placing greater emphasis
on personal hygiene and life quality.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the past, female health awareness was mostly &#8220;treating diseases&#8221;, suggesting they would take corresponding measures only
when issues arose. However, we have seen a gradual shift in awareness towards &#8220;disease-free prevention&#8221;, that is, paying
more attention to health maintenance and disease prevention. This change has promoted the development of the female hygiene and disinfection
market. Female consumers are becoming more inclined to buy safe and efficient hygiene and disinfection products to meet their needs for
personal hygiene.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(5)
Cosmetic and Skincare Products</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beauty
products can be simply categorized as makeup products and skin care products. In recent years, driven by factors such as increases in
income levels, growth of the beauty economy, and innovation in sales channels, the market size of China&#8217;s cosmetic and skincare
products has expanded. From 2018 to 2022, the market size of cosmetic and skincare products in China increased from RMB260.6 billion
to RMB406.6 billion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
per capita disposable income continues to grow, the penetration rate of cosmetic and skincare products in lower-tier cities is expected
to increase. Changes in aesthetic consciousness have also led to increased attention by men on makeup and skincare. Further, as cosmetic
skills continue to improve, consumers are increasingly pursuing the sophistication of makeup, and their demand for cosmetic and skincare
products has become more refined, giving rise to more subcategories. In addition, the innovation of marketing channels for cosmetic and
skincare brands is also expected to promote the development of the market. Emerging channels such as e-commerce, live streaming and new
beauty collection stores can provide brands with more opportunities to interact with consumers and promote products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on these factors, the market size of China&#8217;s cosmetic and skincare products is expected to expand to RMB580.0 billion in 2027.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<img src="forms-4_012.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Source:
Frost &amp; Sullivan)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 194; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->181<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(6)
The Hygienic Ozone Products Market Trend</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>a.
The Increase Penetration Rate of Ozone Anti-Microbial</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the strength of antibiotic properties, hygienic ozone products can be divided into ozone bacteriostats and ozone antimicrobials. Ozone
antibacterial agents can inhibit or hinder bacterial growth and reproduction and its activity; however, their ability to remove bacteria
is weak. Ozone bacteriostats can kill bacteria or inhibit bacterial growth and reproduction and their activity with a strong
ability to remove bacteria.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
present, companies with strong technical capabilities in the industry mainly produce antimicrobials, while companies with relatively
weaker technical capabilities primarily focus on producing bacteriostats. In the future, with the increasing demand for hygiene and health
products and the overall improvement in industry-wide technical capabilities, the penetration of ozone antimicrobials is expected to
expand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>b.
Variety in Product Types and Extensive Application Scenarios</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to different product dosage forms, hygienic ozone products can be divided into oil products, gel products, and water products. At present,
the main products are mostly ozone oil (oil products) and ozone gel. For instance, vegetable oil usually serves as a base to produce
oxidation products with antibacterial effects through the reaction of ozone and unsaturated fatty acids in vegetable oil. Oil and gel
products are mostly smeared and cannot be sprayed, which limits their applications to a certain extent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the development of newer technologies, some companies are actively developing more stable and convenient dosage forms, such as solid
particles, powders, and water agents to adapt to the developing market. The development of dosage forms can extend the use range and
application scenarios of hygienic ozone products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>c.
Common Distribution Channels of Hygiene Ozone Product</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
present, hygienic ozone products are mostly used for bacteriostat and antimicrobials of skin mucous membranes and intimate areas. The
main distribution channels include private clinics and beauty salons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the introduction of new products, the application of ozone products is likely to be more diversified, so as to broaden its distribution
channels. For example, new ozone products such as ozone disinfectant spray, which is being researched, are portable, easy to use and
can be conveniently deployed in various environments such as homes, offices, and public transportation. These products can be distributed
through multiple channels such as e-commerce, daily retail stores, and pharmacies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governmental
Regulations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PRC
Laws and Regulations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we conduct our operations through our subsidiaries in the PRC, with our operations team, management, and facilities located in mainland
China, we are subject to the laws and regulations of the PRC, including intellectual property, employment, social welfare, insurance,
and taxation regulations. Below is a summary of the major PRC laws, rules, and regulations applicable to our current business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">PRC
Regulation of Health Care Products</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
recent years, the National Health Commission and other related departments have issued a series of policies to support and standardize
the development of the hygiene and disinfection industry, promoting the development of the market. These policies have put forward the
requirements for product quality and safety standards, encouraging industrial innovation and technology research and promoting the hygiene
and disinfection market to develop in a healthier and more efficient way. The following is a summary of the PRC rules and regulations
applicable to our products, including our Qianzhi Yang&#174; Private Care Series (Ozone-based products) and our Zone Clean&#174; Hypochlorite
Disinfectant Series.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 195; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->182<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2009, the Ministry of Health released the Regulations on Application and Acceptance of Hygiene License for Disinfectants Manufacturers
and Disinfection Service Institutions, which states that disinfectants manufacturers shall obtain a hygiene license issued by the provincial
health administrative department in their locality before engaging in the production of disinfectants. Disinfection service institutions
shall obtain a hygiene license issued by the provincial health administrative department in their location before carrying out disinfection
services. Disinfectants manufacturers should submit specified documents when applying for a hygiene license.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2002, the Ministry of Health released the <i>Catalogue of Disinfectants</i> classified disinfectants in detail, including: Disinfectants
and disinfection equipment, Hygiene products and Disposable medical supplies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2005, the Ministry of Health released the <i>Notice of the Ministry of Health on Adjusting the Supervision and Licensing Scope of Disinfectants</i>,
which states that products specifically intended for disinfection or antimicrobial purposes on human feet, eyes, nails, underarms, scalp,
hair, nasal mucosa, and other specific areas will no longer be accepted, approved, or regulated as disinfectants. Skin and mucous membrane
disinfectants, antimicrobial and bacteriostat must not claim to have disinfection or antimicrobial effects on specific areas such as
human feet, eyes, nails, underarms, scalp, hair, nasal mucosa, and others.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
in 2005, the Ministry of Health released the <i>Management Standards of Disinfectants Label Instructions</i>, which stated that antimicrobial
and bacteriostat are prohibited from labeling the contents of high-efficiency, non-toxic, disinfectants, sterilization, antibacterial,
anti-inflammatory, disease treatment, reduction or relief on disease symptoms, prevention of sexual diseases, spermicide, contraception,
antibiotics, hormones, and other prohibited contents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2006, the Ministry of Health released the Regulations on the Acceptance of Health Administrative Licensing Applications for Disinfectants
and disinfection equipment by the Ministry of Health. It states that the application and acceptance of disinfectants and disinfection
equipment shall strictly follow the provisions of the Hygiene Administrative Licensing Procedure of Health Related Products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2009, the Ministry of Health released the <i>Notice of the Ministry of Health on Carrying out the Special Action to Rectify the Illegal
Affairs of Disinfectants</i>. It states that supervision and inspection should be carried out strictly on the manufactures in accordance
with the <i>Hygienic Standards for Disinfectants Manufacturers</i>. NHC will focus on checking whether the raw materials are consistent
with the formula ingredients and registrations and whether the raw material warehouse has substances and ingredients prohibited by the
Ministry of Health.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
in 2009, the Ministry of Health released the <i>Hygienic Standards for Disinfectants Manufacturers</i>. It states that disinfectants
manufacturers need to meet relevant requirements in terms of factory environment, factory layout, factory sanitation, equipment, materials
and warehousing, personnel, etc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the Ministry of Health released the <i>Hygiene Licensing Provisions for Disinfectants Manufacturers</i>. It states that the organizations
and individuals engaged in the production and repackaging of disinfectants in China must apply for the Hygiene License of Disinfectants
Manufacturers in accordance with these provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2014, the National Health and Family Planning Commission released the <i>Regulations on Health and Safety Evaluation of Disinfectants</i>.
It states that the product standards for disinfectants, antimicrobial, and bacteriostat should include hygienic quality requirements
for raw materials (e.g. grade and purity), technical requirements (e.g. sensory indicators, physicochemical indicators, microbiological
indicators, microbiocidal indicators) and inspection methods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2014, the National Health and Family Planning Commission released the <i>Hygienic Supervision Standards for Disinfectants</i>. It states
that conduct classification management for disinfectants according to the usage and the risk level. The first type is disinfectants with
high risk that require strict management to ensure safety and effectiveness. The second type is disinfectants that have moderate risk
and require strengthened management to ensure safety and effectiveness. The third type is hygiene products (except antimicrobial and
bacteriostat) with a lower level of risk and the safety and effectiveness can be ensured by implementing routine management. When the
same disinfectant involves different categories, it should be managed according to the higher risk category.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 196; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->183<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
National Health and Family Planning Commission released the Notice of the National Health and Family Planning Commission on Further Strengthening
the Supervision of Disinfectants During and After the Event in 2015. It states that each region should further strengthen the in-process
and post-supervision of disinfectants, promote daily supervision and inspection, random sampling, notification, credit management
and other methods, highlight problem orientation and risk management, and formulate annual supervision and inspection plans for the prominent
problems and weak links in disinfectants supervision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2015, the National Health and Family Planning Commission released the Notice of the National Health and Family Planning Commission on
Serious Investigation and Punishment of Illegal Activities such as Exaggerated Propaganda of Antimicrobial and Bacteriostat. It states
that each region should severely crack down on the illegal and exaggerated promotion of antimicrobial and bacteriostat, and strictly
enforce illegal and non-compliant enterprises. Strengthen the construction of credit system for disinfectants manufacturers, establish
a system for listing bad records of these enterprises, and legally disclose information on unqualified products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2017, the National Health Commission released the Disinfectants Management Measures. It states that related enterprises should carry
out health safety assessments in accordance with relevant provisions and meet the requirements of hygiene standards and hygiene norms.
When the product is launched, the health safety evaluation report should be submitted to the provincial health and family planning administrations
for a record, and the record shall provide materials in accordance with the provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2018, the National Health Commission released the <i>Notice of the National Health Commission on the Launch of the National Disinfectants
Online Filing Information Service Platform</i>. It states that the National Information Service Platform will be launched and put into
operation on October 8, 2018. Its main purpose is to provide online filing services for health and safety evaluation of disinfectants
for disinfection product responsibility units, and to provide standardized and unified information services for social supervision and
information inquiry, social credit system construction, and supervision agencies to carry out in-process and post event supervision and
law enforcement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
same year, the National Health Commission released the <i>Technical Requirements for Hygienic Safety Evaluation of disinfectants</i>
in 2018. It states that the proposed comprehensive evaluation of the effectiveness and health safety of disinfectants, including product
labels, instructions, inspection reports, enterprise standards or quality standards and health license.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2019, the National Health Commission released the Letter of the National Health Commission on Public Solicitation of the List of effective
ingredients of Antimicrobial and Bacteriostat (draft for comments) again. It states that for effective ingredients of antimicrobial and
bacteriostat not yet included in the list, disinfectants manufacturers meeting the following requirements may submit applications to
the Disinfection Professional Standards Committee. Upon assessment and validation of the safety and efficacy, these ingredients can be
added as supplementary additions to the list.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2019, the National Health Commission released the <i>Notice of the National Health Commission on Further Strengthening the Supervision
of Disinfectants.</i> It states that provincial health administrations should effectively enhance service awareness, improve the examination
and approval process of disinfectant manufacturers, and constantly improve the approval efficiency and quality. Besides, they should
audit disinfectant manufacturers strictly in accordance with related regulations, such as <i>Health Licensing Provisions of Disinfectant
Manufactures</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the Food Safety Laws of the People&#8217;s Republic of China (2021 Amendment), &#8220;Prepackaged Food&#8221; refers to food which is packed
or made in packing materials or containers in a predetermined fixed quantity. Any companies conduct the selling of prepacked food must
obtain filing certificates from the food safety authorities. Qianzhi and its subsidiaries have all acquired relevant filing certificates.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2022, the National Health Commission released the Notice of the National Health Commission on Further Strengthening the Supervision and
Administration of Antimicrobial and Bacteriostat. It states that all units should fully recognize the importance of supervision and management
of antimicrobial and bacteriostat, consider it as a vital aspect of safeguarding public health, ensure meticulous and effective implementation
of supervision and management of antibacterial agents, etc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">PRC
Regulations Related to Companies and Foreign Investment</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
establishment, operation, and management of corporate entities in China are governed by the PRC Company Law, which was promulgated on
December 29, 1993 and last amended with immediate effect on October 26, 2018. Under the PRC Company Law, companies are generally classified
into two categories: limited liability companies and limited companies by shares. The Company Law also applies to foreign-invested limited
liability companies and companies limited by shares. According to the Company Law, the provisions otherwise prescribed by the laws on
foreign investment shall prevail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 197; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->184<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Market Entrance Rules for Foreign Investment</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
entrance for investment activities in mainland China by foreign investors is mainly governed by the Guidance Catalogue of Encouraged
Industries for Foreign Investment (2020 Version), or the Catalogue, which was promulgated by the Ministry of Commerce, or the MOFCOM,
and the National Development and Reform Commission, or the NDRC, on December 27, 2020, and became effective on January 27, 2021, and
the Special Administrative Measures (Negative List) for the Entrance of Foreign Investment (2021 Version), or the Negative List, which
was promulgated by the MOFCOM and the NDRC on December 27, 2021 and became effective on January 1, 2022. The Catalogue lists the encouraged
industries for foreign investment, and the Negative List identifies the prohibited and restricted industries for foreign investment.
If the investment falls within an &#8220;encouraged&#8221; category in the Catalogue, such foreign investment can be conducted through
the establishment of a wholly foreign-owned enterprise. If the investment falls within the &#8220;restricted&#8221; category on the Negative
List, such foreign investment may be conducted through the establishment of a joint venture enterprise, with varying minimum shareholdings
for the mainland China party, depending on the particular industry. If the investment falls within a &#8220;prohibited&#8221; category
on the Negative List, no foreign investment of any kind is allowed. Any investment that occurs within an industry not falling into any
of three categories mentioned above is classified as a permitted industry for foreign investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Foreign Investment Law</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 15, 2019, the National People&#8217;s Congress approved the Foreign Investment Law (the &#8220;Foreign Investment Law&#8221;),
which took effect on January 1, 2020 and replaced the three governing laws on foreign investments in mainland China, namely, the PRC
Sino-foreign Equity Joint Ventures Law, the PRC Sino-foreign Cooperative Enterprises Law and the PRC Wholly Foreign-owned Enterprises
Law, together with their implementation rules and ancillary regulations. The Regulations for the Implementation of the Foreign Investment
Law, which were promulgated by the State Council on December 26, 2019, and became effective on January 1, 2020, further clarified and
elaborated the relevant provisions of the Foreign Investment Law. According to the Foreign Investment Law and the Implementation Regulations
for the Foreign Investment Law, foreign investment refers to any investment activity directly or indirectly carried out by foreign natural
persons, enterprises, or other organizations (the &#8220;foreign investors&#8221;) within the territory of the PRC, including the following
circumstances: (i) a foreign investor establishes a foreign-funded enterprise within the territory of the PRC, either alone or together
with any other investor; (ii) a foreign investor acquires shares, equities, property shares, or any other similar rights and interests
of a PRC enterprise; (iii) a foreign investor invests in any new project within the territory of the PRC, either alone or together with
any other investors; or (iv) a foreign investor invests in any other way as stipulated under the laws or administrative regulations or
provided by the State Council. The Foreign Investment Law and its Implementation Rules embody an expected PRC regulatory trend to rationalize
its foreign investment regulatory regime in line with prevailing international practice and the legislative efforts to unify the corporate
legal requirements for both foreign and domestic invested enterprises in mainland China, and establish the basic framework for the access
of, and the promotion, protection and administration of foreign investments in view of investment protection and fair competition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Foreign Investment Law grants national treatment to foreign invested enterprises, or FIEs, except for those FIEs that operate in industries
deemed to be either &#8220;restricted&#8221; or &#8220;prohibited&#8221; in the Negative List. The Foreign Investment Law provides that
FIEs operating in foreign restricted industries will require market entry clearance and other approvals from relevant PRC authorities.
If a foreign investor is found to invest in any prohibited industry as stipulated in the Negative List, such foreign investor may be
required to, among other things, cease its investment activities, dispose of its equity interests or assets within a prescribed time
limit or have its income confiscated. If the investment activity of a foreign investor is in breach of any special administrative measure
for restrictive access provided for in the Negative List, the relevant competent department shall order the foreign investor to make
corrections within a prescribed time limit and take necessary measures to meet the requirements of the special administrative measure
for restrictive access. Moreover, legal liability may be imposed if foreign investors were found to be in violation with the provisions
for the access of foreign investment under the Negative List.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 198; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->185<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Foreign Investment Law also provides several protective rules and principles for foreign investors and their investments
in mainland China, including, among others, that a foreign investor may freely transfer into or out of mainland China, in Renminbi or
a foreign currency, its contributions, profits, capital gains, income from disposition of assets, royalties of intellectual property
rights, indemnity or compensation lawfully acquired, and income from liquidation, among others, within mainland China; local governments
shall abide by their commitments to foreign investors; governments at all levels and their departments shall enact local normative documents
concerning foreign investment in compliance with laws and regulations and shall not impair legitimate rights and interests, impose additional
obligations onto FIEs, set market access restrictions and exit conditions, or intervene with the normal production and operation activities
of FIEs; except for special circumstances in which case statutory procedures shall be followed and fair and reasonable compensation shall
be made in a timely manner, expropriation or requisition of the investment of foreign investors is prohibited; and mandatory technology
transfer is prohibited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the Foreign Investment Law provides that FIEs established according to the previous PRC Sino-foreign Equity Joint Ventures Law, the PRC
Sino-foreign Cooperative Enterprises Law and the PRC Wholly Foreign-owned Enterprises Law before the Foreign Investment Law was enacted
may maintain their structure and corporate governance within five years commencing from January 1, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 30, 2019, the MOFCOM and the State Administration for Market Regulation (formerly known as the State Administration for Industry
and Commerce) jointly promulgated the Measures for Reporting of Foreign Investment Information, or the Foreign Investment Reporting Measures,
which came into effect on January 1, 2020 and replaced the Interim Administrative Measures for the Record-filing of the Establishment
and Modification of Foreign-invested Enterprises. The Foreign Investment Reporting Measures establish an online reporting system for
foreign investment instead of the previous requirement of the MOFCOM filing and/or approval procedures. Pursuant to the Foreign Investment
Reporting Measures, for foreign investment carried out directly or indirectly within mainland China, foreign investors or FIEs shall
submit investment information for establishments, modifications and dissolution and annual reports of the FIEs through the online reporting
system.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 19, 2020, the NDRC and the MOFCOM promulgated the Measures for Security Review of Foreign Investment, which became effective
on January 18, 2021, pursuant to which, security review shall be conducted if foreign investments affecting or likely to affect national
security. The Foreign Investment Security Review Mechanism in charge of organization, coordination and guidance of foreign investment
security review is thereunder established. A working mechanism office shall be established under the NDRC and led by the NDRC and the
MOFCOM to undertake routine work on the security review of foreign investment. According to the Measures for Security Review of Foreign
Investment, foreign investment activities falling within the scope such as important cultural products and services, important information
technologies and Internet products and services, important financial services, key technologies and other important fields that concern
national security while obtaining the ultimate control over the enterprise invested in, a foreign investor or a party concerned in the
PRC shall take the initiative to make a declaration to the working mechanism office prior to making the investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">PRC
Regulations on Foreign Exchange</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
Administration of Foreign Exchange</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the PRC Foreign Exchange Administrative Regulations promulgated on January 29, 1996 and last amended on August 5, 2008, and various regulations
issued by the State Administration of Foreign Exchange of the PRC, or SAFE, and other relevant PRC government authorities, Renminbi is
convertible into other currencies for current account items, such as trade-related receipts and payments and payment of interest and
dividends. The conversion of Renminbi into other currencies and remittance of the converted foreign currencies outside China for capital
account items, such as direct equity investments, loans, and repatriation of investment, requires prior approval from the SAFE or its
local branch.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
for transactions that take place in China must be made in Renminbi. Unless otherwise approved, PRC domestic companies may not repatriate
payments denominated in foreign currencies received from abroad or retain the same abroad. Foreign-invested enterprises may retain foreign
currencies under the current account with designated foreign exchange banks subject to a limit set by the SAFE or its local branch. Foreign
currencies under the current account may be either retained or sold to a financial institution engaged in the settlement and sale of
foreign currencies pursuant to the relevant SAFE rules and regulations. For foreign currencies under the capital account, approval by
the SAFE is generally required for the retention or sale of such foreign currencies to a financial institution engaged in settlement
and sale of foreign currencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 199; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->186<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Circular on Further Improving and Adjusting Foreign Exchange Administration Policies for Direct Investment promulgated by the
SAFE on November 19, 2012 and last amended on December 30, 2019, or the SAFE Circular 59, approval of the SAFE is not required for opening
a foreign exchange account and depositing foreign currencies into the accounts relating to direct investments. The SAFE Circular 59 also
simplifies foreign exchange-related registration required for foreign investors to acquire the equity interest in PRC domestic companies
and further improves the administration of foreign exchange settlement for foreign-invested enterprises. The Circular on Further Simplifying
and Improving the Foreign Exchange Administration Policies for Direct Investment promulgated by the SAFE and effective on June 1, 2015
and last amended on December 30, 2019, or the SAFE Circular 13, cancels the administrative approvals of foreign exchange registration
of direct domestic investment and direct overseas investment, and simplifies the procedure for foreign exchange-related registration.
Pursuant to the SAFE Circular 13, investors must register with banks for direct domestic investment and direct overseas investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to SAFE Circular 19 which became effective on June 1, 2015 and was last amended on December 30, 2019, a foreign-invested enterprise may,
according to its actual business needs, settle with a bank the portion of the foreign exchange capital in its capital account for which
the relevant foreign exchange administration has confirmed monetary capital contribution rights and interests (or for which the bank
has registered the injection of the monetary capital contribution into the account). Pursuant to SAFE Circular 19, for the time being,
foreign-invested enterprises are allowed to settle 100% of their foreign exchange capital on a discretionary basis; a foreign-invested
enterprise must truthfully use its capital for its own operating purposes within the scope of business; and where an ordinary foreign-invested
enterprise makes domestic equity investment with the amount of foreign exchanges settled, the foreign-invested enterprise must first
go through domestic re-investment registration and open a corresponding account for foreign exchange settlement, pending payment with
the foreign exchange administration or the bank at the place where it is registered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SAFE Circular 16, promulgated by the SAFE and effective on June 9, 2016, stipulates that PRC domestic companies may also convert their
foreign debts denominated in foreign currencies into Renminbi on a self-discretionary basis. The SAFE Circular 16 also provides an integrated
standard for conversion of foreign exchange under capital account items (including foreign exchange capital and foreign debts) on a self-discretionary
basis, which applies to all PRC domestic companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the PRC Market Entities Registration Administrative Regulations promulgated by the State Council on July 27, 2021 and effective on
March 1, 2022, and other laws and regulations governing foreign-invested enterprises and company registrations, the establishment of
a foreign-invested enterprise and any capital increase and other major changes in a foreign-invested enterprise must be registered with
the SAMR or its local counterparts, and must be filed via the foreign investment comprehensive administrative system, if such foreign-invested
enterprise does not involve special market-entry administrative measures prescribed by the PRC government.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 23, 2019, the SAFE issued the Circular on Further Promoting Cross-Border Trade and Investment Facilitation. This circular allows
foreign-invested enterprises whose approved business scopes do not contain equity investment to use their capital obtained from foreign
exchange settlement to make domestic equity investment as long as the investment is real and complies with the foreign investment-related
laws and regulations. In addition, this circular stipulates that qualified enterprises in certain pilot areas may use their capital income
from registered capital, foreign debt, and overseas listing, for the purpose of domestic payments without providing authenticity certifications
to the relevant banks in advance for those domestic payments. Payments for transactions that take place in China must be made in Renminbi.
Income denominated in foreign currencies received by PRC domestic companies may be repatriated into China or retained outside of China
in accordance with requirements and terms specified by the SAFE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 200; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->187<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the foreign exchange laws and regulations, when setting up a new foreign-invested enterprise, the foreign-invested enterprise must
register with a bank located at its place of registration after obtaining its business license, and if there is any change in capital
or other changes relating to the basic information of the foreign-invested enterprise, including any increase in its registered capital
or total investment, the foreign-invested enterprise must register such changes with the bank located at its place of registration after
obtaining approval from or completing the filing with competent authorities. Pursuant to the relevant foreign exchange laws and regulations,
the above-mentioned foreign exchange registration with the banks will typically take less than four weeks upon the acceptance of the
registration application.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loans
by Foreign Companies to Their PRC Subsidiaries</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
loan made by foreign investors as shareholders in a foreign-invested enterprise is considered foreign debt in China and is regulated
by various laws and regulations, including the PRC Regulation on Foreign Exchange Administration, the Interim Provisions on the Management
of Foreign Debts, the Statistical Monitoring of Foreign Debt Tentative Provisions, and the Administrative Measures for Registration of
Foreign Debt. Under these rules and regulations, a shareholder loan in the form of foreign debt made to a PRC entity does not require
the prior approval of SAFE. However, such foreign debt must be registered with and recorded by SAFE or its local branches within fifteen
business days after the entering of the foreign debt contract. Pursuant to these rules and regulations, the balance of the foreign debts
of a foreign-invested enterprise cannot exceed the difference between the total investment and the registered capital of the foreign-invested
enterprise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 12, 2017, the PBOC promulgated the Notice of the People&#8217;s Bank of China on Matters concerning the Macro-Prudential Management
of Full-Covered Cross-Border Financing, or PBOC Notice No. 9. Pursuant to PBOC Notice No. 9, within a transition period of one year from
January 12, 2017, foreign-invested enterprises may adopt the currently valid foreign debt management mechanism, or the mechanism as provided
in PBOC Notice No. 9 at their own discretions. PBOC Notice No. 9 provides that enterprises may conduct independent cross-border financing
in Renminbi or foreign currencies as required. Pursuant to PBOC Notice No. 9, the outstanding cross-border financing of an enterprise
(the outstanding balance drawn, here and below) will be calculated using a risk-weighted approach and cannot exceed certain specified
upper limits. PBOC Notice No. 9 further provides that the upper limit of risk-weighted outstanding cross-border financing for enterprises
is 200% of its net assets, or the Net Asset Limits. Enterprises must file with SAFE in its capital item information system after entering
into the relevant cross-border financing contracts and prior to three business days before drawing any money from the foreign debts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Offshore
Investment by PRC Residents</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Circular on Issues Concerning the Foreign Exchange Administration over the Overseas Investment and Financing and Round-Trip Investment
by Domestic Residents via Special Purpose Vehicles issued by the SAFE and effective on July 4, 2014, or SAFE Circular 37, PRC residents
are required to register with local branches of the SAFE in connection with their direct or indirect offshore investment in overseas
special purpose vehicles directly established or indirectly controlled by PRC residents for offshore investment and financing with their
legally owned assets or interests in PRC domestic companies, or their legally owned offshore assets or interests. Such PRC residents
are also required to amend their registrations with the SAFE when there is a change to the basic information of the special purpose vehicles,
such as changes of an individual PRC resident, the name or operating period of the special purpose vehicles, or when there is a significant
change to the special purpose vehicles, such as changes of the individual PRC residents&#8217; increase or decrease of the capital contribution
in the special purpose vehicles, or any share transfer or exchange, merger, or division of the special purpose vehicles. At the same
time, the SAFE issued the Operation Guidance for Issues Concerning Foreign Exchange Administration over Round-Trip Investment regarding
the procedures for SAFE registration under the SAFE Circular 37, which took effect on July 4, 2014, as an attachment to the SAFE Circular
37.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the SAFE Circular 13, PRC residents may register with qualified banks instead of the SAFE in connection with their establishment or control
of an offshore entity established for the purpose of overseas direct investment. The SAFE and its branches will implement indirect supervision
over foreign exchange registration of direct investment via the banks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure
to comply with the registration procedures set forth in the SAFE Circular 37 may result in restrictions on foreign exchange activities
of the relevant onshore company, including the payment of dividends and other distributions to its offshore parent or affiliate, the
capital inflow from the offshore entities, and settlement of foreign exchange capital, and may also subject relevant onshore company
or PRC residents to penalties under foreign exchange administration regulations of mainland China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 201; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->188<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Regulations
on Outbound Direct Investment</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 26, 2017, the NDRC promulgated the Administrative Measures on Overseas Investments of Enterprises, or NDRC Order No. 11, which
took effect on March 1, 2018. According to NDRC Order No. 11, non-sensitive overseas investment projects are required to make record
filings with the NDRC or its local branch. On September 6, 2014, MOFCOM promulgated the Administrative Measures on Overseas Investments,
which took effect on October 6, 2014. According to such regulation, overseas investments of PRC enterprises that involve non-sensitive
countries and regions and non-sensitive industries must make record filings with the MOFCOM or its local branch. The Notice of the State
Administration of Foreign Exchange on Further Improving and Adjusting Foreign Exchange Administration Policies for Direct Investment
was issued by SAFE on November 19, 2012 and last amended on December 30, 2019, under which PRC enterprises must register for overseas
direct investment with local banks. The shareholders or beneficial owners who are PRC entities are required to be in compliance with
the related overseas investment regulations. If they fail to complete the filings or registrations required by overseas direct investment
regulations, the relevant authority may order them to suspend or cease the implementation of such investment and make corrections within
a specified time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Regulations
on Dividend Distribution</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal laws and regulations regulating the distribution of dividends by foreign-invested enterprises in mainland China include the
PRC Company Law, as amended in 2004, 2005, 2013, and 2018, and the 2019 PRC Foreign Investment Law and its Implementation Regulations.
According to the regulatory mechanism provided by the above-mentioned laws, a foreign-invested enterprise in mainland China may only
pay dividends out of accumulated profits (if any) determined in accordance with PRC accounting standards and regulations. The PRC companies
(including foreign-invested enterprises) are required to draw at least 10% of their after-tax profits into the statutory reserve fund
until the relevant reserve fund reaches 50% of their registered capital, except as otherwise provided by the laws on foreign investment;
and no profit shall be distributed before making up any loss in the previous fiscal year. Retained profits for previous fiscal years
may be distributed together with distributable profits for the current fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">PRC
Regulations relating to Taxation</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Enterprise
Income Tax</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the EIT Law promulgated by the SCNPC on March 16, 2007, which became effective January 1, 2008 and was last amended on December 29,
2018, enterprises shall be classified into resident enterprises and non-resident enterprises. The income tax rate for resident enterprises
is 25%, while the income tax rate for non-resident enterprises is 20%. According to the EIT Law and the Implementation Regulations for
the Enterprise Income Tax Law of the PRC (the &#8220;Implementation Regulations for EIT Law&#8221;) issued by the State Council on December
6, 2007, which became effective January 1, 2008 and were last amended on April 23, 2019, enterprise income tax shall be payable by a
resident enterprise for the income derived from or accruing in or outside the PRC. Enterprise income tax shall be payable by a non-resident
enterprise with office or premises within the territory of the PRC for the income derived from or accruing in the PRC by its office or
premises, and the income derived from or accruing outside the PRC for which its office or premises has a de facto relationship. Where
the non-resident enterprise has no office or premises within the territory of the PRC or the income derived or accrued has no de facto
relationship with its office or premises, enterprise income tax shall be payable by the non-resident enterprise for the income derived
from or accruing in the PRC at a reduced rate of 10%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Value-Added
Tax</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the PRC Provisional Regulations on Value-Added Tax last amended on November 19, 2017 and its implementation rules last amended on
October 28, 2011, unless stipulated otherwise, taxpayers who sell goods, labor services, or tangible personal property leasing services,
or import goods will be subject to a 17% tax rate; taxpayers who sell transport services, postal services, basic telecommunications services,
construction services, or real property leasing services, sell real property or transfer land use rights will be subject to an 11% tax
rate; and taxpayers who sell services or intangible assets will be subject to a 6% tax rate. On November 19, 2017, the State Council
promulgated the Decisions on Abolishing the PRC Provisional Regulations on Business Tax and Amending the PRC Provisional Regulations
on Value-Added Tax, pursuant to which all enterprises and persons engaged in the sale of goods, provision of processing, repairing, and
replacement services, sales of services, intangible assets, and real property, and the importation of goods into the territory of mainland
China are VAT taxpayers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 202; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->189<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the Announcement on Relevant Policies for Deepening Value-Added Tax Reform effective on April 1, 2019, the generally applicable value-added
tax rates are simplified as 13%, 9%, 6%, and 0%, and the value-added tax rate applicable to small-scale taxpayers is 3%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividend
Withholding Tax</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC Enterprise Income Tax Law stipulates that an income tax rate of 10% applies to dividends declared to non-PRC resident investors that
do not have an establishment or place of business in China, or that have such establishment or place of business but the relevant income
is not effectively connected with the establishment or place of business, to the extent that such dividends are derived from sources
within China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Arrangement between Mainland China and the Hong Kong Special Administrative Region for the Avoidance of Double Taxation and Tax
Evasion on Income and other applicable laws of mainland China, if a Hong Kong resident enterprise is determined by the competent tax
authority to have satisfied the relevant conditions and requirements, the 10% withholding tax rate on the dividends received by the Hong
Kong resident enterprise from a PRC resident enterprise may be reduced to 5%. According to the Circular on Several Questions Regarding
the Beneficial Owner in Tax Treaties, which was issued by the SAT on February 3, 2018 and took effect on April 1, 2018, when determining
an applicant&#8217;s status as the beneficial owner regarding tax treatments in connection with dividends, interest, or royalties in
the tax treaties, several factors are considered, including whether the applicant is obligated to pay over 50% of the income in twelve
months to residents in a third country or region, whether the business operated by the applicant constitutes the actual business activities,
and whether the counterparty country or region to the tax treaties does not levy any tax or grant any tax exemption on relevant incomes
or levies tax at an extremely low rate, and such factors will be analyzed according to the actual circumstances of the specific cases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
on Indirect Transfer</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Circular 7 issued by the SAT on February 3, 2015 and last amended on December 29, 2017, an indirect transfer of assets, including
equity interest in a PRC resident enterprise, by non-PRC resident enterprises may be recharacterized and treated as a direct transfer
of PRC taxable assets, if such arrangement does not have a reasonable commercial purpose and was established for the purpose of avoiding
payment of PRC enterprise income tax. As a result, gains derived from such indirect transfer may be subject to PRC enterprise income
tax. When determining whether there is a reasonable commercial purpose of the transaction arrangement, several factors are considered,
including whether the main value of the equity interest of the relevant offshore enterprise derives directly or indirectly from PRC taxable
assets, whether the assets of the relevant offshore enterprise mainly consists of direct or indirect investment in China or if its income
is mainly derived from China, and whether the offshore enterprise and its subsidiaries directly or indirectly holding PRC taxable assets
have a real commercial nature that is evidenced by their actual function and risk exposure. The Circular 7 does not apply to sales of
shares by investors through a public stock exchange where such shares were acquired on a public stock exchange. On October 17, 2017,
the SAT issued the Circular 37, which was amended by the Announcement of the State Administration of Taxation on the Revision to Certain
Taxation Regulatory Documents issued by the SAT on June 15, 2018. The Circular 37 further elaborates the relevant implementing rules
regarding the calculation, reporting, and payment obligations of the withholding tax by non-PRC resident enterprises. Nevertheless, there
remain uncertainties as to the interpretation and application of the Circular 7. The Circular 7 may be determined by the tax authorities
to be applicable to our offshore transactions or sale of our shares or those of our offshore subsidiaries where non-PRC resident enterprises,
being the transferors, were involved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 203; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->190<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Regulations
on Mergers and Acquisitions and Overseas Listing</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 8, 2006, six PRC governmental and regulatory authorities, including MOFCOM and CSRC, promulgated the Regulations on Mergers and
Acquisitions of Domestic Companies by Foreign Investors, or the M&amp;A Rules, effective as of September 8, 2006 and later revised on
June 22, 2009, which governs the mergers and acquisitions of domestic enterprises by foreign investors. The M&amp;A Rules, among other
things, requires that if an overseas company established or controlled by PRC companies or individuals intends to acquire equity interests
or assets of any other PRC domestic company affiliated with such PRC companies or individuals, such acquisition must be submitted to
MOFCOM for approval. The M&amp;A Rules also requires that an offshore special purpose vehicle formed for overseas listing purposes and
controlled directly or indirectly by the PRC individuals or companies shall obtain the approval of the CSRC prior to overseas listing
and trading of such special purpose vehicle&#8217;s securities on an overseas stock exchange. After the 2019 PRC Foreign Investment Law
and its Implementation Regulations became effective on January 1, 2020, the provisions of the M&amp;A Rules remain effective to the extent
they are not inconsistent with the 2019 PRC Foreign Investment Law and its Implementation Regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 17, 2023, the CSRC promulgated the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies,
or the Overseas Listing Trial Measures, and five supporting guidelines, collectively the Overseas Listing Filing Rules, which became
effective on March 31, 2023. According to the Overseas Listing Filing Rules, the offering or listing of shares, depository receipts,
convertible corporate bonds, or other equity-like securities by a PRC domestic company in an overseas stock market, whether directly
or indirectly through an offshore holding company, should be filed with the CSRC. The determination of whether any offering or listing
is &#8220;indirect&#8221; will be made on a &#8220;substance over form&#8221; basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Overseas Listing Filing Rules, the reporting entity shall submit filing materials including but not limited to a report to the CSRC
within three business days after submitting listing applications to an overseas stock market. Once listed overseas, the reporting entity
will be further required to report the occurrence of any of the following material events within three business days after the occurrence
and announcement thereof to the CSRC: (i) a change of control of the issuer; (ii) the investigation, sanction or other measures undertaken
by any foreign securities regulatory agencies or relevant competent authorities in respect of the issuer; (iii) change of the listing
status or transfer of the listing board; and (iv) the voluntary or mandatory delisting of the issuer. In addition, the completion of
any overseas follow-on offerings by an issuer in the same overseas market where it has completed its public offering and listing would
necessitate a filing with the CSRC within three business days thereafter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CSRC also published the Notice on Administration for the Filing of Overseas Offering and Listing by Domestic Companies on February 17,
2023, or the Notice on the Overseas Listing Filing and the set of Q&amp;A published on the CSRC&#8217;s official website, which are in
connection with the release of the Overseas Listing Filing Rules. The CSRC clarifies that (i) on or prior to the effective date of the
Overseas Listing Filing Rules, domestic companies that have already submitted valid applications for overseas offering and listing but
have not obtained approval from overseas regulatory authorities or stock exchanges may reasonably arrange the timing for submitting their
filing applications with the CSRC, and must complete the filing before the completion of their overseas offering and listing; (ii) a
transition period will be granted to domestic companies until September 30, 2023, which, prior to the effective date of the Overseas
Listing Filing Rules, have already obtained the approval from overseas regulatory authorities or stock exchanges, but have not completed
the indirect overseas listing; if domestic companies fail to complete the overseas listing prior to September 30, 2023, they shall file
with the CSRC according to the requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the Overseas Listing Filing Rules, PRC domestic companies are primarily responsible for compliance with the rules. Violation of the
Overseas Listing Filing Rules or the completion of an overseas listing in breach of the Overseas Listing Filing Rules may result in a
warning and a fine ranging from RMB1,000,000 to RMB10,000,000. Furthermore, the directly responsible supervisors and other directly liable
persons of the relevant PRC domestic companies may be subject to warning and a fine ranging from RMB500,000 to RMB5,000,000, and the
controlling shareholders and actual controllers of the relevant PRC domestic companies may be subject to a fine ranging from RMB1,000,000
to RMB10,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24, 2023, the CSRC issued Provisions on Strengthening Confidentiality and Archiving Administration of Overseas Securities Offering
and Listing by Domestic Companies, or the Archives Rules, which became effective on March 31, 2023 and specify that during the overseas
issuance of securities and listing activities of domestic enterprises, domestic enterprises and securities companies and securities service
institutions that provide relevant securities services shall, by strictly abiding by the relevant laws and regulations of mainland China
and the requirements therein, establish sound confidentiality and file work systems, take necessary measures to implement confidentiality
and file management responsibilities, and shall not leak national secrets and undermine national and public interests. Files such as
the work manuscripts generated in the PRC by securities companies and securities service institutions that provide relevant securities
services for overseas issuance and listing of securities by domestic enterprises shall be kept in the PRC. The transmission of any such
working papers to recipients outside China must be approved in accordance with the applicable PRC regulations. Where files or copies
thereof need to be transferred outside of the PRC, it shall be subject to the approval procedures in accordance with relevant regulations
of mainland China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 204; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->191<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">PRC
Regulations Related to Leasing</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Law on Administration of Urban Real Estate of the PRC, which was promulgated by the SCNPC on July 5, 1994, was last amended on
August 26, 2019, and became effective on January 1, 2020, the lessor and lessee are required to enter into a written lease contract when
leasing premises, which contains such provisions as the lease term, the use of the premises, the rental and repair liability, and other
rights and obligations. Both the lessor and lessee are required to register the lease with the real estate administration department.
If the lessor and lessee fail to go through the registration procedures, both lessor and lessee may be subject to fines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the PRC Civil Code, the lessee may sublease leased premises to a third party, subject to the consent of the lessor. Where a lessee
subleases the premises, the lease contract between the lessee and the lessor remains valid. The lessor is entitled to terminate the lease
if the lessee subleases the premises without the consent of the lessor. In addition, if the lessor transfers the premises, the lease
contract between the lessee and the lessor will remain valid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 1, 2010, the Ministry of Housing and Urban-Rural Development promulgated the Administrative Measures for Leasing of Commodity
Housing, which became effective February 1, 2011. According to such measures, the lessor and lease are required to enter into lease contracts
which should generally contain specified provisions, and lease contracts should be registered with the relevant construction or property
authorities at the municipal or county level within 30 days after the conclusion of lease contracts. If a lease contract is extended
or terminated or if there is any change to the registered items, the lessor and the lease are required to effect alteration registration,
extension of registration, or deregistration with the original relevant construction or property authorities within 30 days after the
occurrence of such extension, termination, or alteration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Regulations
on Product Liability and Consumer Protection</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 28, 2020, the National People&#8217;s Congress approved the PRC Civil Code, which took effect on January 1, 2021. According to the
Civil Code, if defective products are identified after they have been put into circulation, their manufacturers or sellers must timely
take remedial measures such as warning announcement and product recall. If damage arises from a defective product, the aggrieved party
may seek compensation from either the manufacturer or the seller of the product. If the defect is caused by the seller, the manufacturer
will be entitled to seek indemnification from the seller upon compensation of the aggrieved party. If the products are manufactured or
sold with known defects causing deaths or severe health issues, punitive damages may be claimed in addition to compensatory damages.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the PRC Product Quality Law last amended on December 29, 2018, a manufacturer is prohibited from making or selling products that do
not meet applicable standards and requirements for safeguarding human health and ensuring human and property safety. Products must be
free from unreasonable dangers threatening human and property safety. Where a defective product causes physical injury to a person or
property damage, the aggrieved party may claim compensation against the manufacturer or the seller of the product. Manufacturers and
sellers of non-compliant products may be ordered to cease the manufacture or sale of the products and could be subject to confiscation
of the products or fines. Income from sales in contravention of such standards or requirements may also be confiscated, and in severe
cases, the business license may be revoked.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to a variety of consumer protection laws, including the PRC Consumer Rights and Interests Protection Law, which was
amended in 2013 and took effect on March 15, 2014. This law imposes stringent requirements and obligations on business operators. For
example, business operators should guarantee that the products and services they provide satisfy the requirements for personal or property
safety, and provide consumers with authentic information about the quality, function, usage, and term of validity of the products or
services. Failure to comply with these consumer protection laws could subject us to administrative sanctions, such as the issuance of
a warning, confiscation of illegal income, imposition of fines, an order to cease business operations, or revocation of business licenses,
as well as potential civil or criminal liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 205; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->192<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">PRC
Regulations Related to Intellectual Property</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Copyright</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copyright
is protected by (i) the Copyright Law of the PRC, promulgated by The Standing Committee of the National People&#8217;s Congress (the
&#8220;SCNPC&#8221;) on September 7, 1990, last amended on November 11, 2020, and effective from June 1, 2021, and (ii) the Implementation
Regulations of the Copyright Law of PRC, issued by the State Council on August 2, 2002 and last amended on January 30, 2013, which provided
provisions on the classification of works and the obtaining and protection of copyright and the related rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Computer Software Copyright Registration Measures, promulgated by the National Copyright Administration (the &#8220;NCA&#8221;) on February
20, 2002, regulate registrations of software copyright and exclusive licensing contracts for software copyright and transfer contracts.
The NCA is the competent authority for the nationwide administration of software copyright registration, and the PRC Copyright Protection
Center is designated as the software registration authority. The PRC Copyright Protection Center shall grant registration certificates
to the Computer Software Copyrights applicants, which conform to the provisions of both the Computer Software Copyright Registration
Measures and the Computer Software Protection Regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trademark</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to (i) the Trademark Law of the PRC, promulgated by the SCNPC on August 23, 1982, last amended on April 23, 2019, and effective from
November 1, 2019 and (ii) the Implementation Regulations of the Trademark Law of the PRC, which were promulgated by the State Council
on August 3, 2002, became effective on September 15, 2002, and were most recently amended on April 29, 2014, the validity period of registered
trademarks is 10 years, commencing from the date of registration approval. A trademark registrant who intends to continue using the registered
trademark upon the expiry of its validity period shall go through the formalities of renewal within 12 months before the expiry according
to the relevant provisions. Registrants may be granted a grace period of six months if they fail to do so. The validity period of each
renewal is 10 years, commencing from the day after the expiry date of the last validity period of the registered trademark. The trademark
registration will be canceled if the renewal procedures are not completed within the grace period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Patent</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents
are protected by (i) the PRC Patent Law, which was promulgated on March 12, 1984, was last amended on October 17, 2020, and became effective
from June 1, 2021, and (ii) the Implementation Rules for the Patent Law of the PRC, which were promulgated by the State Council on June
15, 2001 and last amended on January 9, 2010. A patentable invention or utility model must meet three conditions: novelty, inventiveness,
and practical applicability. Patents cannot be granted for scientific discoveries, rules and methods for intellectual activities, methods
used to diagnose or treat diseases, animal and plant breeds, or substances obtained by means of nuclear transformation. The Patent Office
under the National Intellectual Property Administration is responsible for receiving, examining, and approving patent applications. Except
under certain specific circumstances provided by law, any third-party user must obtain consent or a proper license from the patent owner
to use the patent, otherwise the use will constitute an infringement of the rights of the patent holder. Patents are divided into three
types, namely &#8220;inventions,&#8221; &#8220;utility models,&#8221; and &#8220;designs.&#8221; An invention patent is valid for 20
years, a design patent is valid for 15 years, and a utility model patent is valid for 10 years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Domain
Names</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domain
names are protected by (i) the Administrative Measures of Internet Domain Names, issued by the Ministry of Industry and Information Technology
(the &#8220;MIIT&#8221;) on August 24, 2017 and effective from November 1, 2017, and (ii) the Implementing Rules on Registration of China
Country Code Top-level Domain Names, issued by China Internet Network Information Center on June 18, 2019 and effective therefrom. The
MIIT is the regulatory body responsible for the administration of PRC internet domain names. The China Internet Network Information Center
is responsible for the administration of registration of China country code top-level domain names. Domain name registrations are processed
by the domain name registration service agencies established pursuant to the relevant provisions. The applicants become domain name holders
upon successful registration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 206; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->193<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trade
Secrets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the PRC Anti-Unfair Competition Law promulgated by the SCNPC on September 2, 1993 and last amended on April 23, 2019, a &#8220;trade
secret&#8221; refers to technical and business information that is unknown to the public, may create business interests or profits for
its legal owners or holders, and is maintained as a secret by its legal owners or holders. Under the Anti-Unfair Competition Law, business
operators are prohibited from infringing others&#8217; trade secrets by: (i) obtaining the trade secrets from the legal owners or holders
by any unfair methods such as theft, bribery, fraud, coercion, electronic intrusion, or any other illicit means; (ii) disclosing, using,
or permitting others to use the trade secrets obtained illegally under item (i) above; (iii) disclosing, using, or permitting others
to use the trade secrets in violation of any contractual agreements or any requirements of the legal owners or holders to keep such trade
secrets confidential; or (iv) instigating, inducing, or assisting others to violate a confidentiality obligation or to violate a rights
holder&#8217;s requirements on keeping the confidentiality of trade secrets, disclosing, using, or permitting others to use the trade
secrets of the rights holder. If a third party knows or should have known the above-mentioned illegal conduct but nevertheless obtains,
uses, or discloses trade secrets of others, the third party may be deemed to have misappropriated the others&#8217; trade secrets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
operators who violate the provisions of the Anti-Unfair Competition Law and cause others to suffer damages shall bear civil liability,
and where the legitimate rights and interests of a business operator are harmed by unfair competition, the business operator may file
a lawsuit with a People&#8217;s Court. The amount of compensation for a business operator who suffer damages due to unfair competition
shall be determined on the basis of the actual losses suffered as a result of the infringement; where it is difficult to ascertain the
actual losses, the amount of compensation shall be determined in accordance with the benefits gained by the infringing party from the
infringement. If a business operator maliciously commits an act of infringing trade secrets and the case is serious, the amount of compensation
may be determined at not less than one time and not more than five times the amount determined in accordance with the foregoing method.
The amount of compensation shall also include reasonable expenses paid by the business operator to stop the infringement. If it is difficult
to ascertain the actual losses suffered or benefits gained, the People&#8217;s Court shall, in consideration of the extent of the infringement,
award compensation of less than RMB5,000,000 to the rights holder. Additionally, government authorities shall stop any illegal activities
which infringe upon trade secrets and confiscate the illegal income from the infringing parties, and impose a fine between RMB100,000
to RMB1,000,000 (or where the circumstances are serious, between RMB500,000 to RMB5,000,000).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the PRC Criminal Law promulgated by the National People&#8217;s Congress on July 1, 1979 and last amended on December 26, 2020, anyone
that commits any of the following acts of trade secrets infringement, if the circumstances are serious, shall be sentenced to a fixed-term
imprisonment of not more than 3 years and/or shall be fined; if the circumstances are especially serious, the infringing party shall
be sentenced to a fixed-term imprisonment of not less than 3 years but not more than 10 years and shall be subject to fines: (i) obtaining
trade secrets from their legal owners or holders through unfair methods such as theft, bribery, fraud, coercion, electronic intrusion,
or any other illicit means; (ii) disclosing, using, or permitting others to use trade secrets obtained illegally under item (i) above;
(iii) disclosing, using, or permitting others to use trade secrets in violation of any contractual agreements or any requirements of
the legal owners or holders to keep such trade secrets confidential. Any person who has knowledge of the circumstances referred to above
but nevertheless obtains, discloses, uses or allows others to use such trade secrets shall be deemed to have infringed upon trade secrets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 207; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->194<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">PRC
Regulations Related to Employment and Social Welfare</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Labor Contract Law</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the PRC Labor Law, promulgated on July 5, 1994 and last amended on December 29, 2018, enterprises and institutions shall establish
and improve their system of workplace safety and sanitation, strictly abide by state rules and standards on workplace safety, and educate
laborers in labor safety and sanitation in China. Labor safety and sanitation facilities shall comply with national standards. Enterprises
and institutions shall provide laborers with safe workplace and sanitation conditions that are in compliance with state stipulations
and the relevant articles of labor protection. The PRC Labor Contract Law, which was implemented on January 1, 2008 and amended on December
28, 2012, primarily governs the rights and duties of employees and employers, including the establishment, performance, and termination
of labor contracts. Pursuant to the PRC Labor Contract Law, labor contracts shall be concluded in writing if labor relationships are
to be or have been established between enterprises or institutions and the laborers. Enterprises and institutions are prohibited from
forcing laborers to work beyond the stipulated work time limit, and employers shall pay laborers for overtime work in accordance with
relevant laws and regulations. In addition, labor wages shall not be lower than local standards on minimum wages and shall be paid to
laborers in a timely manner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Social
Insurance and Housing Fund</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to (i) the Regulation of Insurance for Labor Injury, enacted on January 1, 2004 and amended on December 20, 2010, (ii) the Provisional
Measures for Maternity Insurance of Employees of Corporations implemented on January 1, 1995, (iii) the Decisions on the Establishment
of a Unified Program for Basic Old-Aged Pension Insurance for Employees of Corporations of the State Council issued on July 16, 1997,
(iv) the Decisions on the Establishment of the Medical Insurance Program for Urban Workers of the State Council promulgated on December
14, 1998, (v) the Unemployment Insurance Measures promulgated on January 22, 1999, and (vi) the Social Insurance Law of the PRC, implemented
on July 1, 2011 and amended on December 29, 2018, enterprises are obliged to provide their employees in China with welfare schemes covering
pension insurance, unemployment insurance, maternity insurance, labor injury insurance, and medical insurance. These payments are made
to local administrative authorities and any employer that fails to contribute may be fined and ordered to make up within a prescribed
time limit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the Regulations on the Management of Housing Provident Funds, which was promulgated by the State Council on April 3,
1999 and last amended on March 24, 2019, enterprises must register at the competent managing center for housing provident funds and upon
the examination by such managing center of housing provident funds, these enterprises are required to complete procedures for opening
an account at the relevant bank for the deposit of employees&#8217; housing provident funds. Enterprises are also required to pay and
deposit housing provident funds on behalf of their employees in full and in a timely manner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Regulations
on Cyber Security and Privacy Protection</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Internet
Information and Data Security</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the PRC Cybersecurity Law issued by the SCNPC on November 7, 2016 and implemented on June 1, 2017, the state shall implement the multi-level
protection scheme for network cybersecurity. Network operators shall, according to the requirements of laws and requirements as well
as the mandatory requirements of national and industry standard, develop internal security management mechanisms, take technical measures
and other necessary measures to ensure network security and stable operation. Under the Cybersecurity Law of PRC, where network operators
provide network access and domain registration services for users, handle network access formalities for fixed-line or mobile phone users,
or provide users with information release services, instant messaging services and other services, they shall require users to provide
true identity information, or otherwise, the network operators shall not provide them with relevant services. The PRC Cybersecurity Law
also specifies that the network operators shall provide technical support and assistance to public security organs and state security
organs for safeguarding national security and crime investigation activities. Network operators in violation of the provisions of this
law may be subject to penalties, such as being ordered to make rectifications, given warnings or fines, confiscated of unlawful gains,
ordered to a temporary suspension of operations, a suspension of business for corrections, closing down of websites, revocation of relevant
operations permits, etc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 208; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->195<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the PRC Data Security Law passed by the SCNPC on June 10, 2021 and implemented on September 1, 2021, the state establishes a classified
and tiered system for data protection. When conducting data processing activities, one shall comply with laws and regulations, establish
a sound, full-range data security and management system, organize and conduct data security education and training as well as take corresponding
technical measures and other necessary measures to protect data safety. The use of the internet and other information networks to carry
out data processing activities shall, on the basis of the multi-level protection scheme for network cybersecurity, fulfil the obligations
of data security protection. The handlers of important data shall, in accordance with relevant provisions, carry out risk assessment
on their data processing activities on a regular basis and submit risk assessment reports to the relevant competent authorities. Relevant
organizations and individuals shall cooperate with public security departments or state security organs in obtaining data for the purpose
of safeguarding state security or investigating crimes according to law. Those who fail to fulfil the obligations of data security protection
and provide important data abroad in violation of the law will be ordered to correct, warned, fined, suspended with their business or
suspended for rectification, or revoked of relevant business licenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the Opinions on Severely Cracking Down on Illegal Securities Activities According to Law, or the Opinions, jointly issued by the General
Office of the CPC Central Committee and the General Office of the State Council on July 6, 2021, China will strengthen the standard review
in data security, cross-border data flow and confidential information management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 8, 2022, the MIIT issued the Administrative Measures for Data Security in the Field of Industry and Information Technology,
or the Data Security Measures in the IT Field, which took effect on January 1, 2023. Data Security Measures in the IT Field provide that
all businesses which handle industrial and telecoms data in China are required to categorize such information into &#8220;general,&#8221;
&#8220;important&#8221; and &#8220;core&#8221; and businesses processing &#8220;important&#8221; and &#8220;core&#8221; data shall comply
with certain filing and reporting obligations. Industrial data refer to data produced and collected in the course of research and development
design, manufacturing, operation and management, operating and maintenance, and platform operation in various sectors and fields of industry.
Telecoms data refer to the data generated and collected in the course of telecommunications business operations. In accordance with the
Data Security Measures in the IT Field, the industrial and telecommunication data handlers shall classify data firstly based on the data&#8217;s
category and then based on its security level on a regular basis, to classify and identify data based on the industry requirements, business
needs, data sources and purposes and other factors, and to make a data classification list. In addition, the industrial and telecommunication
data handlers shall establish and improve a sound data classification management system, take measures to protect data based on the levels,
carryout key protection of critical data, implement stricter management and protection of core data on the basis of critical data protection,
and implement the protection with the highest level of requirement if different levels of data are processed at the same time. The Data
Security Measures in the IT Field also impose certain obligations on industrial and telecommunication data handlers in relation to, among
others, implementation of data security work system, administration of key management, data collection, data storage, data usage, data
transmission, provision of data, publicity of data, data destruction, safety audit and emergency plans, etc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Administrative Provisions on Security Vulnerability of Network Products (Provisions) was jointly promulgated by the MIIT, the CAC and
the MPC on July 12, 2021 and became effective on September 1, 2021. Network product providers, network operators as well as organizations
or individuals engaging in the discovery, collection, release and other activities of network product security vulnerability are subject
to the Provisions and shall establish channels to receive information of security vulnerability of their respective network products
and shall examine and fix such security vulnerability in a timely manner. In response to the Cybersecurity Law, network product providers
are required to report relevant information of security vulnerability of network products with the MIIT within two days and to provide
technical support for network product users. Network operators shall take measures to examine and fix security vulnerability after discovering
or acknowledging that their networks, information systems or equipment have security loopholes. According to the Provisions, the breaching
parties may be subject to monetary fine as regulated in accordance with the Cybersecurity Law. Since the Provisions is relatively new,
uncertainties still exist in relation to its interpretation and implementation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the Regulations of Security Protection for Critical Information Infrastructure, or the CII Protection Regulations, issued by the State
Council on July 30, 2021 and implemented on September 1, 2021, critical information infrastructure means network facilities and information
systems in important industries and fields&#8201;&#8212;&#8201;such as public communication and information services, energy, transportation,
irrigation, finance, public services, e-government, and science and technology industries for national defense&#8201;&#8212;&#8201;that
may seriously endanger national security, national economy and people&#8217;s livelihood, and public interests in the event that they
are damaged or lose their functions or their data are leaked. The Regulations emphasize that no individual or organization may engage
in any activity of illegally hacking into, interfering with, or damaging any critical information infrastructure or endanger the critical
information infrastructure security.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 209; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->196<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2020, the Measures for Cybersecurity Review was jointly promulgated by the CAC, the NDRC, the MIIT, the MPC, the Ministry of
State Security, the MOF, the MOFCOM, the People&#8217;s Bank of China, or the PBOC, the SAMR, the National Radio and Television Administration,
the National Administration of State Secrets Protection and the State Cryptography Administration, revised on December 28, 2021 by the
aforementioned departments and the CSRC, and the Revised Measures for Cybersecurity Review was formally implemented on February 15, 2022.
According to the Revised Measures for Cybersecurity Review, operators of online platforms with personal information of more than one
million users must file a cybersecurity review with the Cybersecurity Review Office when they pursue listing in a foreign country. In
the meantime, the governmental authorities have the discretion to initiate a cybersecurity review on any data processing activity if
they deem such a data processing activity affects or may affect national security. The specific implementation rules on cybersecurity
review are subject to further clarification by subsequent regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 7, 2022, the CAC issued the Measures for the Security Assessment of Cross-border Data Transfer, effective and implemented on September
1, 2022. The Measures for the Security Assessment of Cross-border Data Transfer applies to the security assessment conducted by data
handlers where they provide overseas parties with important data and personal information collected and generated during the operation
in the PRC. Based on the Measures for the Security Assessment of Cross-border Data Transfer, data handlers shall apply for the security
assessment of data cross-border transfer to the national cyberspace administration through the provincial cyberspace administration in
the place where they operate if they provide data outside China and fall into one of the following conditions: a data handler shall apply
to competent authorities for security assessment prior to transferring any data abroad if the transfer involves (i) important data; (ii)
personal information transferred overseas by a CIIO and a data handler that has processed personal information of more than one million
individuals; (iii) personal information transferred overseas by a data handler who has already provided personal information of 100,000
persons or sensitive personal information of 10,000 persons overseas since January 1 of the previous year; or (iv) other circumstances
as requested by the CAC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 14, 2021, the CAC issued the Regulations on Network Data Security Management (draft for public comments), data handlers who
carry out the following activities, according to relevant regulations in China, shall apply for cybersecurity review: (i) the merger,
reorganization or division of internet platform operators that have gathered a large amount of data resources related to national security,
economic development and public interests, which affects or may affect national security; (ii) the data handlers who process personal
information of at least one million users apply for listing in a foreign country; (iii) the data handlers&#8217; listing in Hong Kong
affects or may affect national security; (iv) other data processing activities that affect or may affect national security. Large internet
platform operators who set up headquarters or operation centers or research and development centers overseas shall report to the national
cyberspace administration and the competent authorities. As of the date of this proxy statement/prospectus, the Regulations have not
been formally adopted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Personal
Privacy Protection</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Several Provisions on Regulating the Market Order of Internet Information Services issued by the MIIT on December 29, 2011 and effective
on March 15, 2012, the Decision on Strengthening the Protection of Online Information issued by the SCNPC and implemented on December
28, 2012, the Order for the Protection of Telecommunications and Internet User Personal Information issued by the MIIT and implemented
on July 16, 2013, and the Cybersecurity Law of the PRC issued by the SCNPC on November 7, 2016 and implemented on June 1, 2017, any collection
and use of a user&#8217;s personal information must be legal, rational and necessary, and the user should be clearly notified the purposes,
methods and scopes of collecting and using information, channels for enquiring and correcting information, and the consequence of refusal
to provide information. An internet information service provider shall be prohibited from divulging, tampering or destroying any personal
information, or selling or providing such information to other parties. Any violation of these laws and regulations may subject to warnings,
fines, confiscation of illegal gains, revocation of licenses, cancelation of filings, closedown of websites or even criminal liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 210; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->197<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Methods of Identifying Illegal Acts of Apps to Collect and Use Personal Information jointly promulgated and implemented by the CAC, the
MIIT, the MPC and the SAMR on November 28, 2019 clarifies specific circumstances of illegal collection of information, including &#8220;failing
to publish the rules on the collection and use of personal information&#8221;, &#8220;failing to explicitly explain the purposes, methods
and scope of the collection and use of personal information&#8221;, &#8220;collecting and using personal information without the users&#8217;
consent&#8221;, &#8220;collecting personal information unrelated to the services it provides and beyond necessary principle&#8221;, &#8220;providing
personal information to others without the users&#8217; consent&#8221;, and &#8220;failing to provide the function of deleting or correcting
the personal information according to the laws&#8221; or &#8220;failing to publish information such as ways of filing complaints and
reports&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the PRC Civil Code adopted by the National People&#8217;s Congress on May 28, 2020 and implemented on January 1, 2021, the personal
information of natural persons is protected by law. Any organization or individual must legally obtain the relevant personal information
of others and must ensure the security of the relevant information, and must not illegally collect, use, process or disseminate the personal
information of others, nor illegally trade, provide or disclose the personal information of others.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the Personal Information Protection Law of the PRC adopted by the SCNPC on August 20, 2021 and implemented from November 1, 2021,
the personal information of natural persons shall be protected by law. As the first systematic and comprehensive law specifically for
the protection of personal information in the PRC, the Personal Information Protection Law provides, among others, that (i) an individual&#8217;s
separate consent shall be obtained before operation of such individual&#8217;s sensitive personal information, e.g., biometric characteristics
and individual location tracking, (ii) personal information operators operating sensitive personal information shall notify individuals
of the necessity of such operations and the influence on the individuals&#8217; rights, (iii) if personal information operators reject
individuals&#8217; requests to exercise their rights, individuals may file a lawsuit with a People&#8217;s Court.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SAMR issued the Standard of Information Security Technology Personal Information Security Specification (2017 edition), which took effect
in May 2018, and the Standard of Information Security Technology Personal Information Security Specification (2020 edition), which took
effect in October 2020. Pursuant to these standards, any entity or person who has the authority or right to determine the purposes for
and methods of using or processing personal information are seen as a personal data controller. Such personal data controller is required
to collect information in accordance with applicable laws, and prior to collecting such data, the information provider&#8217;s consent
is required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Regulations
on Environmental Protection</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the PRC Environmental Protection Law promulgated by the SCNPC on December 26, 1989, last amended on April 24, 2014 and implemented
from January 1, 2015, any entity which discharges or will discharge pollutants during the course of operations or other activities must
implement effective environmental protection safeguards and procedures to control and properly treat waste gas, waste water, waste residue,
dust, malodorous gases, radioactive substances, noise, vibrations, electromagnetic radiation and other hazards produced during such activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 211; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->198<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span>&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_023"></span>QIANZHI&#8217;S
MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial
statements and the related notes included elsewhere in this filing. This discussion contains forward-looking statements reflecting our
current expectations that involve risks and uncertainties. Actual results and the timing of events could differ materially from those
discussed in our forward-looking statements as a result of many factors, including those set forth under &#8220;Risk Factors&#8221; and
elsewhere in this filing.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>References
in this section to &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; or the &#8220;Company,&#8221; are to Qianzhi.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a health and wellness focused biotech company and an early adopter and developer of plant-based and ozonated products for antibacterial,
skincare, gynecological and andrological applications. The majority of our products are ozonated, oil-based and infused with formulated
herbal ingredients. our other proprietary products include ozonated disinfectant products produced by ambient temperature ozone curing
technology. We believe that our ozonated disinfectants are safer, more environmentally friendly and more efficient, as compared to traditional
alcohol, chlorine or phenol-based disinfectants. Our operations span the entire value chain of personal care and disinfection products,
from R&amp;D, production, to sales and marketing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposed
Business Combination with Bowen</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 18, 2024, Bowen, Bowen Merger Sub, a wholly owned subsidiary of Bowen, Qianzhi, which became a wholly-owned subsidiary of NewCo
upon the closing of the Restructuring, and NewCo entered into the Business Combination Agreement. The Business Combination Agreement
contemplates that, at the closing of the Business Combination, upon the terms and subject to the conditions of the Business Combination
Agreement, Merger Sub will merge with and into NewCo, with NewCo being the surviving company of the Merger and becoming a wholly owned
subsidiary of Bowen. In preparation for the Transactions, Qianzhi completed the Restructuring in which it became a wholly owned subsidiary
of NewCo by the issuance of ordinary shares of NewCo to the former holders of ordinary shares of the Qianzhi in exchange for such ordinary
shares of Qianzhi.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is anticipated that the Business Combination will be accounted for as a reverse recapitalization in accordance with GAAP. Under this
method of accounting, Bowen is expected to be treated as the &#8220;acquired&#8221; company for financial reporting purposes. Accordingly,
for accounting purposes, the financial statements of New Bowen will represent a continuation of the financial statements of Qianzhi with
the Transactions treated as the equivalent of Qianzhi issuing shares for the net assets of Bowen, accompanied by a recapitalization.
The net assets of Bowen will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to
the Business Combination will be those of Qianzhi in future reports of New Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
Factors that Affect Our Results of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe the following key factors may affect our financial condition and results of operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Ability to Retain Existing Customers or Attract Additional Customers and Increase the Spending Per Customer</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
major customers are cosmetics retailers, beauty salons and health care centers. For the three months ended June 30, 2024, two
customers accounted for 17.4% and 10.5% of our total revenue, respectively. For the three months ended June 30, 2023, three
customers accounted for 33.2%, 23.1% and 22.8% of our total revenue, respectively. For the year ended March 31, 2024 and 2023,
one customer accounted for 11.5% and 11.2% of our total revenue, respectively. Our top 10 customers aggregately accounted for
79.9% and 100.0% of the total revenue for the three months ended June 30, 2024 and 2023, respectively. Our top 10 customers
aggregately accounted for 42.6% and 35.3% of the total revenue for the years ended March 31, 2024 and 2023, respectively. Our
dependence on a small number of larger customers could expose us to the risk of substantial losses if a single large customer stops
purchasing our products, purchases fewer of our products or goes out of business and we cannot find substitute customers on
equivalent terms. If any of our significant customers reduces the quantity of the products they purchase from us or stops purchasing
from us, our net revenues would be materially and adversely affected. Therefore, the success of our business in the future depends
on our effective marketing efforts to expand our distribution network. The success of expansion will depend upon many factors,
including our ability to form relationships with, and manage an increasing number of, customers base and optimize our distribution
network. If our marketing efforts fail to convince customers to accept our products, we may find it difficult to maintain the
existing level of sales or to increase such sales. Should this happen, our net revenues would decline and our growth prospects would
be severely impaired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"></p>

<!-- Field: Page; Sequence: 212; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->199<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Ability to Increase Awareness of Our Brands and Develop Customer Loyalty</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
brands, such as &#8220;Qian Zhi Yang&#8221;, &#8220;SDRA&#8221; and &#8220;Zone Clean&#8221;, are well-recognized among our clients.
Our brands are integral to our sales and marketing efforts. We believe that maintaining and enhancing our brand name recognition in a
cost-effective manner is critical to achieving widespread acceptance of our current and future products and is an important element in
our effort to increase our customer base. Successful promotion of our brand names will depend largely on our marketing efforts and ability
to provide reliable and quality products at competitive prices. Brand promotion activities may not necessarily yield increased revenue,
and even if they do, any increased revenue may not offset the expenses we will incur in marketing activities. If we fail to successfully
promote and maintain our brand, or if we incur substantial expenses in an unsuccessful attempt to promote and maintain our brand, we
may fail to attract new customers or retain our existing customers, in which case our business, operating results and financial condition,
would be materially adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Ability to Compete Successfully</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
personal hygiene and disinfectant industry in China is highly competitive and constantly evolving. The development and commercialization
of new hygiene and disinfectant products is highly competitive, and the industry currently is characterized by rapidly changing technologies,
significant competition and a strong emphasis on intellectual property. We will face competition with respect to our current and future
hygiene and disinfectant product candidates from major cosmetics companies in China. The increase in consumers&#8217; demand for health
and beauty products has resulted in rapid commercialization in hygiene and disinfectant products, which has increasingly attracted the
attention of some large-scale companies. Some of our current or potential competitors may have significantly greater financial resources
and expertise in research and development, manufacturing, and marketing than we do, which could result in our competitors establishing
a strong market position before our new products are able to enter the market. Additionally, technologies developed by our competitors
may render our product candidates uneconomical or obsolete. If we do not compete effectively, our operating results could be harmed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Government
policies may impact our business and operating results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
recent years, the impact of government policies on our business has not been unfavorable. However, our business and operating results
will be affected by the overall economic growth and government policies in the PRC, and our products are currently eligible for certain
favorable government tax and other incentives. Although we will seek to adjust as required if and when government policies change, unfavorable
changes in government policies and incentives could affect the demand for our products and could materially and adversely affect our
results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
Financial Performance Indicators</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
assessing our financial performance, we consider a variety of financial performance measures, including growth in net revenue and gross
profit, our ability to control costs and operating expenses to improve our operating efficiency and net income. Our review of these indicators
facilitates timely evaluation of the performance of our business and effective communication of results and key decisions, allowing our
business to respond promptly to competitive market conditions and different demands and preferences from our customers. The key measures
that we use to evaluate the performance of our business are set forth below and are discussed in greater details under &#8220;<i>Results
of Operations</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue is reported net of all value added taxes (&#8220;<i>VAT</i>&#8221;). Our products are sold with no right of return and we do
not customarily provide credits or sales incentive to customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
sell our products to our customers in five broad product categories: ozone sterilization products, hypochlorite disinfection products,
cosmetic products, prepackaged food products, and other products, which accounted for </span>55.7%, 4.4%, 16.4%, 23.2% and 0.3%, respectively,
of our total revenue for the three months ended June 30, 2024, and 46.8%, 2.2%, 27.0%, 11.3% and 12.7%, respectively, of our total revenue
for the three months ended June 30, 2023. Sales volumes of our ozone sterilization products, hypochlorite disinfection products and cosmetic
products increased by 163.4%, 353.8% and 38.9%, respectively, in the three months ended June 30, 2024 as compared to the three months
ended June 30, 2023 due to increased customer demand. During this period, revenue from sales of prepackaged food products increased by
355.2%, but revenue from sales of other products decreased by 94.3% due to changes in customer preferences. As a result, our total revenue
increased by 121.7% for three months ended June 30, 2024 as compared to three months ended June 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">Our ozone sterilization
products, hypochlorite disinfection products, cosmetic products, prepackaged food and other products accounted for <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52.6%,
3.5%, 11.1%, 29.2% and 3.6%, respectively, of our total revenue for the year ended March 31, 2024, and 55.1%, 16.4%, 8.4%, 11.2% and
8.9%, respectively, of our total revenue for the year ended March 31, 2023. Sales volumes of our ozone sterilization products, hypochlorite
disinfection products and cosmetic products decreased by 29.1%, 84.2% and 2.4%, respectively, for the year ended March 31, 2024 as compared
to the year ended March 31, 2023 due to decreased customer demand. During this period, revenue from sales of prepackaged food products
increased by 80.5%, but revenue from sales of other products decreased by 71.5% due to changes in customer preferences. As a result,
our total revenue decreased by 30.4% for the year ended March 31, 2024 as compared to the year ended March 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 213; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->200<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Gross
Profit and Gross Margin</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
profit is equal to net revenue minus cost of revenue. Cost of revenue consists primarily of the costs of finished goods manufactured
and/or the procurement cost of third-party products, freight charges, depreciation of property and machinery and warehousing expenses.
Cost of revenue also includes incremental costs of obtaining sales contracts, which are mainly promotional costs paid to organizers of
our sales campaigns in an amount in-line with sales revenues realized from those sales campaigns. Cost of revenue generally changes as
our production costs change, as these are affected by factors including the market price of raw materials, labor productivity, the purchase
cost of third-party products and promotional costs. Our cost of revenues accounted for 41.1% and 87.5% of our total revenue for the
three months ended June 30, 2024 and 2023, respectively.  Our cost of revenues accounted for 43.4% and 46.2% of our total revenue
for the fiscal year 2024 and 2023, respectively. We expect our cost of revenues to increase as we further expand our operations in the
foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our gross margin was 58.9% for the three months ended June 30, 2024, an
increase by 46.4% from gross margin of 12.5% for the three months
ended June 30, 2023.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Our gross margin was 56.6%
for the year ended March 31, 2024, an increase by 2.8% from gross margin of 53.8% in fiscal year 2023. Our gross margin is impacted by
promotional costs, product mix, as some products provide higher gross margins, and prices of our products. These factors led to the increases
in our costs of revenue and gross profit and gross margin for the respective periods. See detailed discussion under &#8220;<i>Results
of Operations</i>&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operating expenses consist of selling expenses, general and administrative expenses and research and development expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
expenses represents primarily costs of payroll and benefits costs for sales team, business travel and meals expenses, as well as marketing
expenses. Our selling expenses accounted for 31.7% and 1.2% of our total revenue for the three months ended June 30, 2024 and 2023,
respectively.  Our selling expenses accounted for 0.6% and 1.1% of our total revenue for the years ended March 31, 2024 and 2023,
respectively. We expect our overall selling expenses, including but not limited to, salaries and travel expenses, to increase in the
foreseeable future in connection with the growth of our business, especially as we seek to expand our business and promote our products
to customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
general and administrative expenses represent primarily payroll and benefits costs for administrative employees, rent and operating costs
of office premises, depreciation and amortization of office facilities, professional fees and other administrative expenses. General
and administrative expenses were 55.1% and 135.6% of our revenue for the three months ended June 30, 2024 and 2023, respectively.
 General and administrative expenses were 60.7% and 15.8% of our revenue for the years ended March 31, 2024 and 2023, respectively. We
expect our general and administrative expenses, including, but not limited to, salaries and business consulting expenses, to continue
to increase in the foreseeable future, as we plan to hire additional personnel and incur additional expenses in connection with the expansion
of our business operations. We expect our professional fees for legal, audit, and advisory services to increase as we become a public
company upon the completion of this business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and development expenses primarily consist of employee costs, material costs related to execution of studies, depreciation of
equipment used in the research and development activities, and research and development expenses. Research and development expenses
were 1.0% of our revenue for the three months ended June 30, 2024 and 2023. Research and development expenses were 0.9% and 0.4%
of our revenue for the years ended March 31, 2024 and 2023, respectively. As we continue to develop new products and diversify our product
offerings to satisfy customer demand, we expect our research and development expenses to continue to increase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth a summary of our consolidated results of operations for the periods presented, both in absolute amount and
as a percentage of our total operating revenue for the years presented. This information should be read together with our consolidated
financial statements and related notes included elsewhere in this proxy statement/prospectus. The results of operations in any period are not necessarily
indicative of our future trends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 214; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->201<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Comparison
of Results of Operations for the Three Months Ended June 30, 2024 and 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth a summary of our consolidated results of operations for the periods presented, both in absolute amount and
as a percentage of our total operating revenue for the periods presented. This information should be read together with our unaudited
condensed consolidated financial statements and related notes included elsewhere in this filling. The results of operations in any period
are not necessarily indicative of our future trends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June
    30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Variance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#12288;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#12288;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#12288;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#12288;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#12288;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#12288;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold">REVENUE</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">1,665,658</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">100.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">751,246</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">100.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">914,412</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">121.7</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Cost of revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(123,621</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7.4</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(124,499</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(16.6</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">878</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.7</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Promotion cost</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(561,675</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(33.7</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(532,560</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(70.9</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(29,115</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5.5</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">GROSS PROFIT</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">980,362</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">58.9</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">94,187</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12.5</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">886,175</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">940.9</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">OPERATING EXPENSES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Selling expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">528,211</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,767</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">519,444</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,925.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">917,199</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,019,034</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">135.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(101,835</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10.0</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,464</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,475</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,989</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">120.3</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,461,874</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">87.8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,035,276</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">137.8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">426,598</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">41.2</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">(LOSS) INCOME FROM OPERATIONS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(481,512</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28.9</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(941,089</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(125.3</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">459,577</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(48.8</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">OTHER INCOME (EXPENSE)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest income, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">138</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">254</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(116</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45.7</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Government subsidies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,512</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,289</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,777</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(57.3</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other income (expenses), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(36,929</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2.2</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18,769</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2.5</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18,160</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">96.8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other income, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(27,279</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1.6</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,774</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.5</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(31,053</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(822.8</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">(LOSS) INCOME BEFORE INCOME TAX PROVISION</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(508,791</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(30.5</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(937,315</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(124.8</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">428,524</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45.7</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">PROVISION FOR INCOME TAXES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,465</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,137</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,328</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">168.3</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">NET (LOSS) INCOME</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(525,256</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(31.5</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(943,452</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(125.6</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">418,196</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(44.3</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenues</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently sell our products to our customers in five broad product categories: ozone sterilization products, hypochlorite disinfection
products, cosmetic products, prepackaged food and other products. Our total revenues increased by $914,412, or 121.7%, to $1,665,658
for the three months ended June 30, 2024 from $751,246 for the three months ended June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify; text-indent: 22.5pt"></p>

<!-- Field: Page; Sequence: 215; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->202<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the breakdown of our revenue for the three months ended June 30, 2024 and 2023, respectively:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June
    30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Sales of self-manufactured products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 43%; text-align: left">Revenue from sales of ozone sterilization products</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">926,955</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">351,497</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">575,458</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">163.7</td><td style="width: 2%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Revenue from sales of hypochlorite disinfection products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73,053</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,896</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,157</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">332.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Sales of third-party products purchased</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Revenue from sales of cosmetic products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">273,759</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">202,521</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">71,238</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Revenue from sales of prepackaged food</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">386,484</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">84,902</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">301,582</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">355.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Revenue from sales of other products</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,407</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">95,430</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(90,023</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(94.3</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,665,658</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">751,246</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">914,412</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">121.7</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
from sales of ozone sterilization products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ozone sterilization products primarily consist of ozone oil used in intimate care products for both female and male customers, as well
as cosmetic products with antibiosis and anti-inflammatory effects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
from sales of our ozone sterilization products increased by 163.7% or $575,458 to $926,955 for the three months ended June 30, 2024
from $351,497 for the three months ended June 30, 2023. This increase was mainly attributable to a 163.4% increase in sales volume
of our ozone sterilization products from 1,614 cases for the three months ended June 30, 2023 to 4,252 cases for the three months
ended June 30, 2024. The increase in revenues was attributable to the recovery of the Chinese economy from the post-pandemic
slowdown as demand for our ozone sterilization products increased during the three months ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
from sales of hypochlorite disinfection products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
hypochlorite disinfection products primarily consist of disinfectants containing HCIO, which is widely used for disinfecting of home
environments, public areas such as hospitals and hotels, fruit and vegetables, tableware and pet environments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
from sales of our hypochlorite disinfection products increased by 332.4% or $56,157 to $73,053 for the three months ended June 30,
2024 from $16,896 for the three months ended June 30, 2023. This increase was mainly attributable to a 353.8% increase in sales
volume of our hypochlorite disinfection products from 1,555 bottles for the three months ended June 30, 2023 to 7,056 bottles for
the three months ended June 30, 2024 due to an increase in customer demand for its highly efficient disinfecting effect against the
COVID-19 virus. The average selling price of our hypochlorite disinfection products decreased slightly by 2.2% due to changes in
product mix. We also experienced a 2.6% negative impact from fluctuations in foreign currency exchange rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
from sales of cosmetic products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cosmetic products primarily consist of our SDRA skin care products, which contain amino acids and natural plants essences with
moisturizing effects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
from sales of our cosmetic products increased by 35.2% or $71,238 to $273,759 for the three months ended June 30, 2024 from $202,521
for the three months ended June 30, 2023. This increase was attributable to a 38.9% increase in sales volume of our cosmetic products
from 1,890 bottles for the three months ended June 30, 2023 to 2,626 bottles for the three months ended June 30, 2024 due to an increase
in customer demand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
from sales of prepackaged food</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
prepackaged food products primarily consist of tea, drinking water, milk, edible oils, rice and wine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
from sales of our prepackaged foods increased by 355.2% or $301,582 to $386,484 for the three months ended June 30, 2024 from $84,902
for the three months ended June 30, 2023. This increase was mainly attributable to increases in revenue from sales of wine and drinking
water of $277,493 and $53,670, respectively, and partially offset by a decrease in sales of rice of $42,474 due to changes in customer
preferences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 216; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->203<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
from sales of other products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
other products primarily consist of jewels and household products, such as, underclothes, health care products, watches and laundry detergent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
from sales of our other products decreased by 94.3% or $90,023 to $5,407 for the three months ended June 30, 2024 from $95,430 for the
three months ended June 30, 2023 due to a decrease in customer demand of third-party health care products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost
of Revenues</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenues consists primarily of the costs of finished goods manufactured and/or procurement cost of third-party products, freight charges,
depreciation of property and machinery and warehousing expenses. Cost of revenues also includes incremental costs of obtaining sales
contracts, which are mainly promotional cost paid to organizers of our sales campaigns in an amount in-line with the sales revenues realized
from those sales campaigns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our cost of revenues decreased by $878, or 0.7%, from $124,499 for the
three months ended June 30, 2023 to $123,621 in the same period of 2024. Our cost of revenues accounted for 7.4% and 16.6% of our total
revenue for the three months ended June 30, 2024 and 2023, respectively. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June
    30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Sales of self-manufactured products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 43%; text-align: left">Cost of revenues &#8211; ozone sterilization products</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">30,737</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">54,682</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(23,945</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">(43.8</td><td style="width: 2%; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cost of revenues &#8211; hypochlorite disinfection products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,127</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,321</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,806</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">214.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Sales of third-party products purchased</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cost of revenues &#8211; cosmetic products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,458</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,363</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,095</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cost of revenues &#8211; prepackaged food</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,460</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,062</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,398</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">131.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Cost of revenues &#8211; other products</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">839</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,071</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(23,232</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(96.5</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total cost of revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">123,621</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">124,499</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(878</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.7</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of revenue from sales of ozone sterilization products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
43.8% decrease in the cost of revenues for our ozone sterilization products from $54,682 for the three months ended June 30, 2023 to
$30,737 for the three months ended June 30, 2024 was mainly attributable to the following: (i) a 37.8% decrease in the unit cost of
our ozone sterilization products due to improved productivity and decreased depreciation cost as part of our production equipment
reached their expected useful life and depreciation cost decreased by $12,313; (ii) we perform physical stocktaking on a quarterly
basis and wrote-off obsolete ozone sterilization inventories to the cost of revenue account in the amount of $2,180 and $36,794
during the three months ended June 30, 2024 and 2023, respectively; and partially offset by (iii) a 163.4% increase in sales volume
of our ozone sterilization products from 1,614 cases for the three months ended June 30, 2023 to 4,252 cases for the three months
ended June 30, 2024 resulting from increase in customer demand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of revenue from sales of hypochlorite disinfection products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 214.0% increase in the cost of revenues for our hypochlorite disinfection
products from $8,321 for the three months ended June 30, 2023 to $26,127 for the three months ended June 30, 2024 was mainly attributable
to the following: (i) a 353.8% increase in sales volume of our hypochlorite disinfection products from 1,555 bottles for the three months
ended June 30, 2023 to 7,056 bottles for the three months ended June 30, 2024 resulting from an increase in customer demand; and partially
offset by (ii) a decrease of 29.0% in unit cost of our hypochlorite disinfection products due to improved productivity and decreased depreciation cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of revenue from sales of cosmetic products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">Cost of revenues for our
cosmetic products increased by 12.1% from $17,363 for the three months ended June 30, 2023 to $19,458 for the three months ended June
30, 2024, mainly attributable to the following: (i) a 38.9% increase in sales volume of our cosmetic products; and partially offset by
(ii) a decrease of 17.2% in the unit cost of our cosmetic products due to improved productivity and cost reductions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify; text-indent: 22.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify; text-indent: 22.5pt"></p>

<!-- Field: Page; Sequence: 217; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->204<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of revenue from sales of prepackaged food</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 131.6% increase in the cost of revenues for our prepackaged food from
$20,062 for the three months ended June 30, 2023 to $46,460 for the three months ended June 30, 2024 was mainly attributable to an increase
in the cost of revenue from sales of wine of $21,399, and partially offset by a decrease in the cost of revenue from sales of rice of
$9,129. We changed our sale strategy to promote sales of <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">wine
which have a higher gross margin, which helped to improve our profitability during the three months ended June 30, 2024.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of revenue from sales of other products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
experienced a 96.5% decrease in the cost of revenues for our other products from $24,071 for the three months ended June 30, 2023 to
$839 for the three months ended June 30, 2024 due to a decrease in customer demand of third-party health care
products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promotion
cost</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June
    30,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Promotion cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">561,675</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">532,560</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">29,115</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">5.5</td><td style="width: 1%; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
promotion costs for the three months ended June 30, 2024 increased by $29,115, or 5.5% to $561,675, from $532,560 in the same period
of 2023 due to increased revenue, as described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross
Profit</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our gross profit for the three months ended June 30, 2024 increased by
$886,175, or 940.9% to $980,362, from $94,187 in the same period of 2023, mainly due to increases in the sales volume of our products
as discussed above. Our gross margin increased by 46.4% from 12.5% for the three months ended June 30, 2023 to 58.9% in the same period
of 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the breakdown of our operating expenses for the three months ended June 30, 2024 and 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June
    30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Variance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of<br/> revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of<br/> revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 39%; font-weight: bold; text-align: left">Total revenue</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right">1,665,658</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 6%; font-weight: bold; text-align: right">100.0</td><td style="width: 1%; font-weight: bold; text-align: left">%</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right">751,246</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 6%; font-weight: bold; text-align: right">100.0</td><td style="width: 1%; font-weight: bold; text-align: left">%</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right">914,412</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 6%; font-weight: bold; text-align: right">121.7</td><td style="width: 2%; font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Selling expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">528,211</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,767</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">519,444</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,925.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">917,199</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,019,034</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">135.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(101,835</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10.0</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,464</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,475</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,989</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">120.3</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total operating expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,461,874</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">87.8</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,035,276</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">137.8</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">426,598</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">41.2</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 218; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->205<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Selling
expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
selling expenses represents primarily costs of payroll and benefits costs for sales employees, business travel and meals expenses, as
well as marketing expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June
    30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Variance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Salary and employee benefit expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">5,373</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">1.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">4,279</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">48.8</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">1,094</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">25.6</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">512,634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">97.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,466</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">510,168</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,688.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Entertainment and business travel expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,603</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,397</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">461.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other selling expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,204</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.2</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">419</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4.8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">785</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">187.4</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total selling expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">528,211</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,767</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">519,444</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,925.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
selling expenses increased by $519,444, from $8,767 for the three months ended June 30, 2023 to $528,211 in the same period of 2024,
primarily attributable to (i) an increase in marketing expenses of $510,168 as we provided training and incentives to our major
clients to promote sales during the three months ended June 30, 2024; and (ii) an increase in entertainment and business travel
expenses of $7,397 due to more business travel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
and administrative expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
general and administrative expenses primarily represents payroll and benefits costs for administrative employees, rent and
operating costs for our office premises, depreciation and amortization of office facilities, professional fees and other administrative
expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June
    30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Variance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 39%; text-align: left">Salary and employee benefit expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">127,580</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">13.9</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">131,985</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">13.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(4,405</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(3.3</td><td style="width: 2%; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,809</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,960</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,849</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Office supply and maintenance fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,893</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,874</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,981</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(50.1</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Office rent and utility expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54,394</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,387</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,993</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.5</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Transportation, business travel and meals expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,377</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,685</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,692</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">59.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Professional service fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">642,643</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">741,079</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(98,436</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13.3</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other general and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,503</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.4</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,064</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.2</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,439</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">69.7</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total general and administrative</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">917,199</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,019,034</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(101,835</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10.0</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
general and administrative expenses decreased by $101,835 or 10.0% from $1,019,034 for the three months ended June 30, 2023 to $917,199
for the same period of 2024, primarily attributable to (i) a decrease in professional service fees by $98,436 for the three months ended
June 30, 2024 as compared to the same period of 2023, which was primarily due to decreased legal and financial consulting fees in connection
with our intended business combination; (ii) decreases in office supply and maintenance fees of $21,981 for the three months ended June
30, 2024 as compared to the same period for 2023 due to cost savings; partially offset by (iii) an increase in transportation, business
travel and meals expense of $14,692 for the three months ended June 30, 2024 as compared to the same period of 2023, as we incurred
more client entertainment expenses during the three months ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and development expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and development expenses primarily consist of employee costs, material costs related to execution of studies, depreciation of
equipment used in the research and development activities and research and development service expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June
    30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Variance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 39%; text-align: left">Salary and employee benefit expenses to R&amp;D staff</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">10,566</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">64.2</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">7,381</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">98.7</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">3,185</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">43.2</td><td style="width: 2%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Materials used in R&amp;D activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,100.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Depreciation of R&amp;D equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(100.0</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">R&amp;D service expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,850</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">35.5</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">77</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,773</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,497.4</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total R&amp;D expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,464</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,475</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,989</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">120.3</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses increased by $8,989, or 120.3%, from $7,475 for the three months ended June 30, 2023 to $16,464 for the same
period of 2024, primarily attributable to the increase in research and development expenses of $5,773 for increased patent application
fees during the three months ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 219; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->206<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Income (expenses), Net</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
other income (expenses) includes interest income generated from our bank deposits, interest expenses incurred on our bank borrowings,
government subsidy income, and loss from disposal of equipment. Total other expenses, net was $27,279 for the three months ended June
30, 2024, compared to total other income, net of $3,774 for the three months ended June 30, 2023, due to the following reasons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income, net, decreased by $116 for the three months ended June 30, 2024 as compared to the same period of 2023, due to decrease in interest
income on our bank balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
subsidies received in the form of a grant and recognized as other operating income totaled $9,512 and $22,289 for the three months ended
June 30, 2024 and 2023, respectively. Government subsidy income primarily relates to cash awarded by government agencies to local companies
to promote entrepreneurship, stimulate local economies and ameliorate the impact of the COVID-19 pandemic. Such awards were granted on
a case-by-case basis by various local government entities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Provision
for Income Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
provision for income taxes was $16,465 for the three months ended June 30, 2024, an increase of $10,328 from $6,137 for the same period
of 2023 due to our increased taxable income of PRC subsidiaries. Our holding company incorporated in the Cayman Islands, our wholly-owned
subsidiary, Qianzhi BVI and Qianzhi HK are not subject to PRC income tax, and their expenses are not deductible from PRC taxable income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
income (loss)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the foregoing, our net loss was $525,256 for the three months ended June 30, 2024, compared to net loss of $943,452 for the
same period of 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Comparison
of Results of Operations for the Years Ended March 31, 2024 and 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth a summary of our consolidated results of operations for the periods presented, both in absolute amount and
as a percentage of our total operating revenue for the periods presented. This information should be read together with our consolidated
financial statements and related notes included elsewhere in this filling. The results of operations in any period are not necessarily
indicative of our future trends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Years Ended March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Variance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#12288;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#12288;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#12288;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#12288;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#12288;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#12288;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold">REVENUE</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">7,030,989</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">100.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">10,108,557</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">100.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(3,077,568</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(30.4</td><td style="width: 1%; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">COST OF REVENUE</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(569,368</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8.1</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,920,164</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19.0</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,350,796</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(70.3</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Promotion cost</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,481,225</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(35.3</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,751,155</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(27.2</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">269,930</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9.8</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">GROSS PROFIT</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,980,396</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">56.6</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,437,238</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">53.8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,456,842</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(26.8</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">OPERATING EXPENSES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Selling expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,159</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">108,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(63,881</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(59.1</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,318,060</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,598,512</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,719,548</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">170.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">59,878</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.9</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">44,527</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.4</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,351</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">34.5</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,422,097</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">62.9</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,751,079</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17.3</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,671,018</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">152.5</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">(LOSS) INCOME FROM OPERATIONS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(441,701</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6.3</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,686,159</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">36.5</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,127,860</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(112.0</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">OTHER INCOME (EXPENSE)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest income, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">158</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,379</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,221</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(88.5</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Government subsidies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74,716</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69,573</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,143</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other income (expenses), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,128</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.3</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,296</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.0</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23,424</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,020.2</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other income, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">96,002</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.4</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">68,656</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.7</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">27,346</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">39.8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">(LOSS) INCOME BEFORE INCOME TAX PROVISION</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(345,699</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.9</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,754,815</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,100,514</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(109.2</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">PROVISION FOR INCOME TAXES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">352,475</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">162,817</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.6</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">189,658</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">116.5</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">NET (LOSS) INCOME</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(698,174</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(9.9</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,591,998</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">35.5</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,290,172</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(119.4</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenues</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently sell our products to our customers in five broad product categories: ozone sterilization products, hypochlorite disinfection
products, cosmetic products, prepackaged food and other products. Our total revenues decreased by $3,077,568, or 30.4%, to $7,030,989
for the year ended March 31, 2024 from $10,108,557 for the year ended March 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the breakdown of our revenue for the years ended March 31, 2024 and 2023, respectively:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Years Ended March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Sales of self-manufactured products</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 39%; text-align: left">Revenue from sales of ozone sterilization products</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,694,858</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">5,570,618</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(1,875,760</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">(33.7</td><td style="width: 2%; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Revenue from sales of hypochlorite disinfection products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">248,707</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,658,808</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,410,101</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(85.0</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Sales of third-party products purchased</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Revenue from sales of cosmetic products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">780,899</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">844,812</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(63,913</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7.6</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Revenue from sales of prepackaged food</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,050,572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,136,197</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">914,375</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Revenue from sales of other products</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">255,953</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">898,122</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(642,169</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(71.5</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,030,989</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,108,557</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,077,568</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(30.4</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 220; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->207<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
from sales of ozone sterilization products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ozone sterilization products primarily consist of ozone oil used in intimate care products for both female and male customers, as well
as cosmetic products with antibiosis and anti-inflammatory effects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
from sales of our ozone sterilization products decreased by 33.7% or $1,875,760 to $3,694,858 for the year ended March 31, 2024 from
$5,570,618 for the year ended March 31, 2023. This decrease was attributable to the following: (i) a 29.1% decrease in sales volume of
our ozone sterilization products from 24,155 cases for the year ended March 31, 2023 to 17,115 cases for the year ended March 31, 2024
due to a decrease in customer demand. T<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">he post-pandemic slowdown experienced
in the Chinese economy adversely impacted the purchasing power of our customers and reduced overall product demand for our ozone sterilization
products</span>; and (ii) a 6.7%
negative impact from fluctuations in foreign currency exchange rates, as the average exchange rate used in converting RMB into USD changed
from US$1 to RMB 6.6035 in for the year ended March 31, 2023 to US$1 to RMB 7.0440 in the same period of 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
from sales of hypochlorite disinfection products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
hypochlorite disinfection products primarily consist of disinfectants containing HCIO, which is widely used for disinfecting of home
environments, public areas such as hospitals and hotels, fruit and vegetables, tableware and pet environments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
from sales of our hypochlorite disinfection products decreased by 85.0% or $1,410,101 to $248,707 for the year ended March 31, 2024 from
$1,658,808 for the year ended March 31, 2023. This decrease was mainly attributable to the following: (i) a 84.2% decrease in sales volume
of our hypochlorite disinfection products from 144,253 bottles for the year ended March 31, 2023 to 22,842 bottles for the year ended March
31, 2024. In response to the COVID-19 outbreak, China&#8217;s National Health Commission recommended the use of hypochlorite disinfection
for its highly efficient disinfecting effect against the COVID-19 virus, and there was a strong demand for our hypochlorite disinfection
products during the year ended March 31, 2023. However, as the Chinese government lifted its zero-COVID policy and reduced public health
measures in public areas after December 2022, sales demand for our hypochlorite disinfection products decreased significantly during
the year ended March 31, 2024; and (ii) a 6.7% negative impact from fluctuations in foreign currency exchange rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
from sales of cosmetic products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cosmetic products primarily consist of our SDRA skin care products, which contain amino acids and natural plants essences with
moisturizing effects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
from sales of our cosmetic products decreased by 7.6% or $63,912 to $780,899 for the year ended March 31, 2024 from $844,812 for the
year ended March 31, 2023. This decrease was attributable to an 2.4% decrease in sales volume of our cosmetic products from 7,476 bottles
for the year ended March 31, 2023 to 7,297 bottles for the year ended March 31, 2024 due to a decrease in customer demand. The slowdown
in the broader economy caused by the COVID-19 pandemic led to a decline in customers&#8217; spending power, and our sales of cosmetic
products decreased accordingly. We also experienced a 6.7% negative impact from fluctuations in foreign currency exchange rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
from sales of prepackaged food</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
prepackaged food products primarily consist of tea, drinking water, milk, edible oils, rice and wine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
from sales of our prepackaged foods increased by 80.5% or $914,375 to $2,050,572 for the year ended March 31, 2024 from $1,136,197 for
the year ended March 31, 2023. This increase was mainly attributable to increases in revenue from sales of wine, drinking water and rice
of $826,958, $255,674 and $242,078, respectively, and partially offset by a decrease in sales of edible oils of $228,088 due to changes
in customer preferences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
from sales of other products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
other products primarily consist of jewels and household products, such as, underclothes, health care products, watches and laundry detergent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
from sales of our other products decreased by 71.5% or $642,169 to $255,953 for the year ended March 31, 2024 from $898,122 for the year
ended March 31, 2023. This decrease was mainly attributable to the decrease in revenue from sales of jewels, underwear and laundry detergent
of $296,699, $202,360 and $115,858, respectively due to decrease in customer demand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 221; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->208<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost
of Revenues</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenues consists primarily of the costs of finished goods manufactured and/or procurement cost of third-party products, freight charges,
depreciation of property and machinery and warehousing expenses. Cost of revenues also includes incremental costs of obtaining sales
contracts, which are mainly promotional cost paid to organizers of our sales campaigns in an amount in-line with the sales revenues realized
from those sales campaigns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cost of revenues decreased by $1,350,796, or 70.3%, from $1,920,164 for the year ended March 31, 2023 to $569,368 in the same period
of 2024. Our cost of revenues accounted for 8.1% and 19.0% of our total revenue for the year ended March 31, 2024 and 2023, respectively.
The decrease in our cost of revenues was due to the following reasons:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Years Ended March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Sales of self-manufactured products</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 39%; text-align: left">Cost of revenues &#8211; ozone sterilization products</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">264,455</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">619,954</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(355,499</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">(57.3</td><td style="width: 2%; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cost of revenues &#8211; hypochlorite disinfection products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,395</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">339,585</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(289,190</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(85.2</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Sales of third-party products purchased</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cost of revenues &#8211; cosmetic products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,241</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,908</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(60,667</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(40.2</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cost of revenues &#8211; prepackaged food</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">113,332</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">489,239</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(375,907</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(76.8</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Cost of revenues &#8211; other products</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">50,945</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">320,478</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(269,533</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(84.1</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total cost of revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">569,368</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,920,164</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,350,796</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(70.3</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of revenue from sales of ozone sterilization products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
57.3% decrease in the cost of revenues for our ozone sterilization products from $619,954 for the year ended March 31, 2023 to $264,455
for the year ended March 31, 2024 was mainly attributable to the following: (i) a 35.8% decrease in the unit cost of our ozone sterilization
products due to improved productivity and cost reductions; (ii) a 29.1% decrease in sales volume of our ozone sterilization products
from 24,155 cases for the year ended March 31, 2023 to 22,842 cases for the year ended March 31, 2024 resulting from a decrease in customer
demand; and (iii) a 6.7% negative impact from fluctuations in foreign currency exchange rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of revenue from sales of hypochlorite disinfection products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
85.2% decrease in the cost of revenues for our hypochlorite disinfection products from $339,585 for the year ended March 31, 2023 to
$50,395 for the year ended March 31, 2024 was mainly attributable to the following: (i) a 84.2% decrease in sales volume of our hypochlorite
disinfection products from 144,253 bottles for the year ended March 31, 2023 to 22,842 bottles for the year ended March 31, 2024.
This decrease was caused by the changes in the public health measures required by the Chinese government in response to the COVID-19
outbreak, as the reduction in public health mandates and &#8220;zero-COVID&#8221; policy after December 2022 resulted in a significant
decrease in the demand for our hypochlorite disinfection products during the year ended March 31, 2024; and (ii) a 6.7% negative impact
from fluctuations in foreign currency exchange rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of revenue from sales of cosmetic products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
40.2% decrease in the cost of revenues for our cosmetic products from $150,908 for the year ended March 31, 2023 to $90,241 for the year
ended March 31, 2024 was mainly attributable to the following: (i) a decrease of 34.6% in the weighted-average unit cost for this product
category mainly due to improvements in productivity and cost reductions; (ii) a 6.7% negative impact from fluctuations in
foreign currency exchange rates; and (iii) a 2.4% decrease in sales volume of our cosmetic products from 7,476 bottles for the year ended
March 31, 2023 to 7,297 bottles for the year ended March 31, 2024 due to decreased customer demand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of revenue from sales of prepackaged food</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
76.8% decrease in the cost of revenues for our prepackaged food from $489,239 for the year ended March 31, 2023 to $113,332 for the year
ended March 31, 2024 was mainly attributable to a decrease in the cost of revenue from sales of tea, edible oils, wine and drinking water
of $157,195, $88,622, $49,587 and $45,541, respectively, due to decreases in customer demand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"></p>

<!-- Field: Page; Sequence: 222; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->209<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of revenue from sales of other products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
experienced a 84.1% decrease in the cost of revenues for our other products from $320,478 for the year ended March 31, 2023 to $50,945
for the year ended March 31, 2024. This decrease was mainly attributable to a decrease in cost of revenues from sales of jewels, underwear
and laundry detergent of $112,128, $86,745 and $46,420, respectively, due to changes in customer preferences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promotion
cost</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Years Ended March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 39%; text-align: left">Promotion cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">2,481,225</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">2,751,155</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(269,930</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">(9.8</td><td style="width: 2%; text-align: left">)%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
promotion costs for the year ended March 31, 2024 decreased by $269,930, or 9.8% to $2,481,225, from $2,751,155 in the same period of
2023 due to decreased revenue, as described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross
Profit</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
gross profit for the year ended March 31, 2024 decreased by $1,456,842, or 26.8% to $3,980,396, from $5,437,238 in the same period of
2023, mainly due to decreases in the sales volume of our products as discussed above. Our gross margin increased by 2.8% from 53.8% for
the year ended March 31, 2023 to 56.6% in the same period of 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the breakdown of our operating expenses for the years ended March 31, 2024 and 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Years Ended March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Variance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of<br/> revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of<br/> revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold; text-align: left">Total revenue</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right">7,030,989</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 6%; font-weight: bold; text-align: right">100.0</td><td style="width: 1%; font-weight: bold; text-align: left">%</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right">10,108,557</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 6%; font-weight: bold; text-align: right">100.0</td><td style="width: 1%; font-weight: bold; text-align: left">%</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right">(3,077,568</td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 6%; font-weight: bold; text-align: right">(30.4</td><td style="width: 1%; font-weight: bold; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Selling expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,159</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">108,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(63,881</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(59.1</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,318,060</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,598,512</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,719,548</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">170.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">59,878</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.9</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">44,527</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.4</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,351</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">34.5</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total operating expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,422,097</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">62.9</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,751,079</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">17.3</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,671,018</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">152.5</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 223; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->210<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Selling
expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
selling expenses represents primarily costs of payroll and benefits costs for sales employees, business travel and meals expenses,
as well as marketing expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Years Ended March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Variance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Salary and employee benefit expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">16,048</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">36.3</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">17,093</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">15.8</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(1,045</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(6.1</td><td style="width: 1%; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,579</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,768</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(36,189</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(79.1</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Entertainment and business travel expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,294</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,220</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(27,926</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(71.2</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other selling expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,238</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16.4</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,959</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5.5</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,279</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21.5</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total selling expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">44,159</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">108,040</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(63,881</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(59.1</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
selling expenses decreased by $63,881, or 59.1%, from $108,040 for the year ended March 31, 2023 to $44,159 in the same period of 2024,
primarily attributable to (i) a decrease in marketing expenses of $36,189 as we held more promotional activities to introduce our new
products during the year ended March 31, 2023; and (ii) a decrease in entertainment and business travel expenses of $27,926 due to the
associated cost savings for business travel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
and administrative expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
general and administrative expenses represent primarily payroll and benefits costs for administrative employees, rent and operating costs
of office premises, depreciation and amortization of office facilities, professional fees and other administrative expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Years Ended March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Variance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Salary and employee benefit expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">678,658</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">15.9</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">667,703</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">41.8</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">10,955</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">1.6</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">99,058</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">91,737</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,321</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Office supply and maintenance fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">119,097</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,899</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">123.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Office rent and utility expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">280,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">246,372</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,928</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.8</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Transportation, business travel and meals expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">237,886</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54,658</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">183,228</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">335.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Professional service fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,898,739</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">67.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">300,473</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,5<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span>,266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">864.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exhibition fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">151,149</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(151,149</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(100.0</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other general and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,322</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.1</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">33,221</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.1</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28,899</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(87.0</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total general and administrative</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,318,060</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,598,512</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,719,548</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">170.1</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
general and administrative expenses increased by $2,71<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span>,548 or 170.1% from $1,598,512 for the year ended March 31, 2023 to $4,31<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span>,060
for the same period of 2024, primarily attributable to (i) an increase in professional service fees by $2,5<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span>,266 for the year ended
March 31, 2024 as compared to the same period of 2023, which was primarily due to increased legal and financial consulting fees in connection
with our intended business combination; (ii) increases in transportation, business travel and meals expense of $183,228 for the year
ended March 31, 2024 as compared to the same period for 2023 due to travel and meals expense of professional service teams; partially
offset by (iii) a decrease in exhibition fees of $151,149 for the year ended March 31, 2024 as compared to the same period of 2023, as
we did not incur comparable expenses for the year ended March 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 224; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->211<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and development expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and development expenses primarily consist of employee costs, material costs related to execution of studies, depreciation of
equipment used in the research and development activities and research and development service expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Years Ended March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Variance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Salary and employee benefit expenses to R&amp;D staff</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">35,444</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">59.2</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">32,099</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">72.1</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">3,345</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">10.4</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Materials used in R&amp;D activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">247</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">294</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(47</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15.9</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Depreciation of R&amp;D equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,653</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,640</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(99.5</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">R&amp;D service expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,174</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">40.4</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,481</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21.3</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,693</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">155.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total R&amp;D expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">59,878</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">44,527</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,351</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">34.5</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses increased by $15,351, or 34.5%, from $34,627 for the year ended March 31, 2023 to $59,878 for the same period
of 2024, primarily attributable to the increase in research and development expenses of $14,693 for increased patent application fees
during the year ended March 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Income, Net</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
other income (expenses) includes interest income generated from our bank deposits, interest expenses incurred on our bank borrowings,
government subsidy income, and loss from the disposal of a subsidiary. Total other income, net, increased by $27,346 or 39.8%, from $68,656
for the year ended March 31, 2023 to $96,002 for the same period of 2024, due to the following reasons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income, net, decreased by $1,221 for the year ended March 31, 2024 as compared to the same period of 2023, due to an increase in interest
expenses on our bank borrowings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
subsidies received in the form of a grant and recognized as other operating income totaled $74,716 and $69,573 for the years ended March
31, 2024 and 2023, respectively. Government subsidy income primarily relates to cash awarded by government agencies to local companies
to promote entrepreneurship, stimulate local economies and ameliorate the impact of the COVID-19 pandemic. Such awards were granted on
a case-by-case basis by various local government entities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Provision
for Income Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
provision for income taxes was $352,475 for the year ended March 31, 2024, an increase of $189,658 from $162,817 for the same period
of 2023 due to our increased taxable income of PRC subsidiaries. Under the Enterprise Income Tax (&#8220;EIT&#8221;) Law of PRC, domestic
enterprises and Foreign Investment Enterprises (&#8220;FIEs&#8221;) are usually subject to a unified 25% enterprise income tax rate while
preferential tax rates, tax holidays and tax exemptions may be granted on a case-by-case basis. However, our subsidiaries Qianzhi Biotechnology,
Jiangxi Qianzhi, Qianzhi Biotech and Qianzhi Health are incorporated in the PRC and were qualified as small-scale, minimal profit enterprises
for the years ended March 31, 2024 and 2023. Based on the EIT Law of PRC, and according to the Announcement on Issues Related to the
Implementation of Inclusive Income Tax Reduction and Exemption Policy for Small and Low Profit Enterprises issued by the State Administration
of Taxation, from January 1, 2022 to December 31, 2024, once an enterprise meets certain requirements and is identified as a small-scale
minimal profit enterprise, its taxable income is entitled to a reduced income tax rate ranging from 2.5% to 5% depending on the amount
and period of taxable income. Our holding company incorporated in the Cayman Islands, our wholly-owned subsidiary, Qianzhi BVI and Qianzhi
HK are not subject to PRC income tax, and their expenses are not deductible from PRC taxable income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 22.5pt"></p>

<!-- Field: Page; Sequence: 225; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->212<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
income (loss)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the foregoing, our net loss was $698,174 for the years ended March 31, 2024, compared to net income of $3,591,998 for the
same period of 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, we have financed our operations primarily through cash flows from operations, shareholders&#8217; contributions and bank loans
when necessary. We plan to support our future operations primarily from cash flows provided by operating activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, we had $2,497,989 in cash as compared to $4,832,079 as of March 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, our inventory balance amounted to $306,961, primarily consisting of finished products and raw materials,
which we believe are able to be sold quickly based on the analysis of the current trends in demand for our products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, we had a short-term bank loan of $110,084 from Bank of China for working capital purposes. We expect
that we will be able to renew all of the existing bank loans upon their maturity based on past experiences and our outstanding credit
history.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, our working capital balance was $3,024,384. In assessing our liquidity, management monitors and analyzes
our cash on-hand, our ability to generate sufficient revenue in the future, and our contractual obligations. We believe that our current
cash, cash flows provided by operating activities and borrowings from banks will be sufficient to meet our working capital needs for
at least 12 months from the date of this report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth summary of our cash flows for the periods indicated:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center">For the Three Months Ended<br/> June
    30,</td><td style="padding-bottom: 1.5pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center">For the Years Ended<br/> March 31,</td><td style="padding-bottom: 1.5pt; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; font-size: 10pt; text-align: left">Net cash (used in) provided by operating activities</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(2,351,758</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(1,903,210</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">1,710,820</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">3,777,804</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Net cash used in investing activities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(567</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(365,417</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(172,340</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Net cash provided by (used in) financing activities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">41,415</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(28,331</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(99,376</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">100,360</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Effect of exchange rate change on cash and cash equivalents</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(23,747</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(180,489</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(250,894</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(172,804</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Net (decrease) increase in cash</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(2,334,090</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(2,112,597</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">995,133</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,533,020</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Cash, beginning of year</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">4,832,079</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">3,836,946</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">3,836,946</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">303,926</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Cash, end of year</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,497,989</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,724,349</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,832,079</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,836,946</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Net cash used in
operating activities was $2,351,758 for the three months ended June 30, 2024, which was primarily attributable to (i) net loss of
$525,256 for the three months ended June 30, 2024; (ii) an increase of $1,253,358 in other receivables &#8211; related parties, as
we advanced funds to Shenzhen Yelin for its general working capital needs, and to Ms. Xiaoqin Lin for payment of
combination expenses; and (iii) a decrease of $517,851 in accounts payable, as we paid promotion costs accrued in March 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Net cash used in operating
activities was $1,903,210 for the three months ended June 30, 2023, which was primarily attributable to (i) net loss of $943,452 for
the three months ended June 30, 2024; (ii) a decrease of $1,870,734 in other receivables &#8211; related parties, as we as we collected
other receivables from related parties; (iii) an increase of $1,775,436 in other current assets due to prepaid expenses
in connection with our intended business combination;
(iv) a decrease
of $613,468 in accounts payables, as we paid promotion costs accrued in March 2023; and (v) a decrease of $463,629 in contract liabilities
resulting from product deliveries to customers to satisfy contractual obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by operating activities was $1,710,820 for the year ended March 31, 2024, which was primarily attributable to (i) net loss
of $698,174 for the year ended March 31, 2024; (ii) a decrease of $1,764,877 in other receivables &#8211; related parties, as we collected
other receivables from related parties and we do not intend to make additional cash advances to related parties in the future; (iii)
a decrease of $853,357 in account receivables &#8211; related parties, as we collected account receivables from related parties; and
(iv) an increase of $348,946 in other current assets due to prepaid expenses in connection with our intended
business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by operating activities was $3,777,804 for the year ended March 31, 2023, which was primarily attributable to (i) net income
of $3,591,998 for the year ended March 31, 2023; (ii) an increase of $1,520,855 in other receivables &#8211; related parties,
as we collected all these receivables from related parties and we do not intend to make additional cash advances to related parties
in the future; (iii) an increase of $617,771 in accounts payable due to an increase in accrued promotion expenses payable to the organizer
of our promotion campaigns in March 2023; (iv) a decrease of $450,465 in deposit and other assets made to a supplier to ensure timely
supply of our prepackaged food products; (v) a decrease of $424,018 in loans to related parties due to repayment of loans from the following
related parties - Ms. Xiaoqin Lin and Mr. Liangwen Wang; and (vi) an increase of $359,758 in taxes payable due to accrued and unpaid
value added taxes payable and income taxes payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 226; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->213<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investing
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">Net cash used in investing
activities was $Nil for three months ended June 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">Net cash used in investing
activities amounted to $567 for the three months ended June 30, 2023, and primarily included the purchase of fixed assets in the same
amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in investing activities amounted to $365,417 and $172,340 for the years ended March 31, 2024 and 2023, respectively,
and primarily included the purchase of fixed assets in the same amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financing
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">Net cash provided by financing
activities amounted to $41,415 for the three months ended June 30, 2024, attributable to proceeds of RMB 300,000 from short-term bank
loans borrowed from Bank of China.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">Net cash used in financing
activities amounted to $28,331 for the three months ended June 30, 2023, attributable to repayment of short-term bank loans of the same
amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in financing activities amounted to $99,376 for the year ended March 31, 2024, which was attributable to proceeds from short-term
bank loans of $70,982, as well as the repayment of short-term bank loans of $141,965 and long-term bank loans of $28,393, respectively.
During the year ended March 31, 2024, our subsidiary Hubei Qianzhi repaid a RMB 1 million loan to the Bank of China upon maturity, renewed
the loan agreement to borrow another RMB 1 million for one year with a maturity date of December 5, 2024, and our subsidiary, Qianzhi
Health repaid a RMB 200,000 loan to Shenzhen Qianhai WeBank Co., Ltd.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities amounted to $100,360 for the year ended March 31, 2023, attributable to (i) proceeds from short-term
bank loans of $151,435 and long-term bank loans of $30,287, as well as the repayment of short-term bank loans of $60,574. During fiscal
year 2023, our subsidiary Hubei Qianzhi repaid a RMB 400,000 loan to the Bank of China upon maturity, renewed the loan agreement to borrow
RMB 1 million for an additional one year with a maturity date on August 17, 2023, and our subsidiary, Qianzhi Health borrowed RMB 200,000
from Shenzhen Qianhai WeBank Co., Ltd; (ii) payment for the acquisition of a non-controlling interest in the amount of $106,004. On December
5, 2022, Qianzhi Biotechnology acquired a 49% ownership interest from the minority shareholder of Hubei Qianzhi for RMB 700,000; and
(iv) proceeds from shareholders&#8217; contribution of RMB 600,000 million (equivalent to US$85,216).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commitments
and Contingencies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we are a party to various legal actions arising in the ordinary course of business. We accrue costs associated with these
matters when they become probable and the amount can be reasonably estimated. Legal costs incurred in connection with loss contingencies
are expensed as incurred. For the years ended March 31, 2024 and 2023, we did not have any material legal claims or litigation that,
individually or in aggregate, could have a material adverse impact on our consolidated financial position, results of operations and
cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, we had the following contractual obligations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Payment Due by Period</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic">Contractual Obligations</td><td style="font-style: italic; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: right">Total</td><td style="padding-bottom: 1.5pt; font-style: italic">&#160;</td><td style="font-style: italic; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: right">Less than 1 year</td><td style="padding-bottom: 1.5pt; font-style: italic">&#160;</td><td style="font-style: italic; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: right">1-2 years</td><td style="padding-bottom: 1.5pt; font-style: italic">&#160;</td><td style="font-style: italic; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: right">2-3 years</td><td style="padding-bottom: 1.5pt; font-style: italic">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 44%; text-align: left">(1) Debt Obligations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">110,084</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">110,084</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">(2) Operating Lease Obligations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">513,796</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">214,596</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">299,200</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">623,880</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">324,680</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">299,200</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of June 30, 2024, we had a total of $110,084 in short-term loans from Bank of China (see Footnote 9 &#8211; Debt, for
    details).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    lease a factory and storehouse in Ezhou City, Hubei Province of China, and office spaces in Shenzhen City, Guangdong Province of
    China, with terms ranging from 20 months to 8 years (see Footnote 1<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span>
    &#8211; Operating lease, for details).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 227; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->214<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trend
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as disclosed elsewhere in this proxy statement/prospectus, we are not aware of any trends, uncertainties, demands, commitments,
or events that are reasonably likely to have a material effect on our net revenues, income from continuing operations, profitability,
liquidity or capital resources, or that would cause reported financial information not necessarily to be indicative of future operating
results or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inflation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inflation
does not materially affect our business or the results of our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Seasonality</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seasonality
does not materially affect our business or the results of our operations except with respect to the composition of the pre-packaged food and beverage products that we provide to our beauty
salon customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Policies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements. These
financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions that affect the reported
amounts of our assets and liabilities and revenues and expenses, to disclose contingent assets and liabilities on the date of the consolidated
financial statements, and to disclose the reported amounts of revenues and expenses incurred during the financial reporting period. The
most significant estimates and assumptions include the valuation of accounts receivable and inventories, useful lives of property, plant
and equipment and intangible assets, the recoverability of long-lived assets, provision necessary for contingent liabilities, and revenue
recognition. We continue to evaluate these estimates and assumptions that we believe to be reasonable under the circumstances. We rely
on these evaluations as the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent
from other sources. Since the use of estimates is an integral component of the financial reporting process, actual results could differ
from those estimates. Some of our accounting policies require higher degrees of judgment than others in their application. We believe
critical accounting policies as disclosed in this proxy statement/prospectus reflect the more significant judgments and estimates used
in preparation of our consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Risks
and Uncertainties</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
main operation is located in the PRC. Accordingly, our business, financial condition, and results of operations may be influenced by
political, economic, and legal environments in the PRC, as well as by the general state of the PRC economy. Our results may be adversely
affected by changes in the political, regulatory and social conditions in the PRC. Although we have not experienced losses from these
situations and believes that we are in compliance with existing laws and regulations including our organization and structure, this may
not be indicative of future results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
development and commercialization of hygiene and disinfectant products is highly competitive, and the industry currently is characterized
by rapidly changing technologies, significant competition and a strong emphasis on intellectual property. We may face competition with
respect to our current and future hygiene and disinfectant product candidates from major cosmetics companies in China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business, financial condition and results of operations may also be negatively impacted by risks related to natural disasters, extreme
weather conditions, health epidemics and other catastrophic incidents, which could significantly disrupt our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following critical accounting policies rely upon assumptions and estimates and were used in the preparation of our consolidated financial
statements:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"></p>

<!-- Field: Page; Sequence: 228; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->215<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Uses
of estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing the consolidated financial statements in conformity with accounting
principles generally accepted in the United States of America (&#8220;US GAAP&#8221;), we make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements,
and the reported amounts of revenues and expenses during the reporting periods. These estimates are based on information as of the date
of the consolidated financial statements. Significant estimates required to be made include, but are not limited to, the estimated current
credit losses on financial assets, realizability of advance to suppliers, inventory valuations, useful lives of property and equipment,
the recoverability of long-lived assets, revenue recognition and realization of deferred tax assets. Actual results could differ from
those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Cash</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
includes currency on hand and deposits held by banks that can be added or withdrawn without limitation. We maintain cash with financial
institutes, such as banks, in the PRC. In China, a depositor has up to RMB500,000 insured by the People&#8217;s Bank of China Financial
Stability Bureau (&#8220;FSD&#8221;). As of June 30, 2024 and March 31, 2024, $656,464 and $2,961,187 of our cash
held by financial institutions was uninsured, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Accounts
receivable</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivables are presented net of allowance for doubtful accounts. We use the current expected credit losses model to determine credit-related
impairment losses for financial instruments held at amortized cost and to estimate these expected credit losses over the life of an exposure
(or pool of exposures). The estimate of expected credit losses considers both historical and current information, reasonable and supportable
forecasts, as well as estimates of prepayments. The estimated credit losses and subsequent adjustment to such loss estimates are recorded
through an allowance account which is deducted from the amortized cost of the financial instrument, with the offset recorded in current
earnings. Delinquent account balances are written-off against the allowance for doubtful accounts after management has determined that
the collection is not probable. As of June 30, 2024 and March 31, 2024, there was no allowance recorded as we determined that
all of the accounts receivable are fully collectible.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Advances
to suppliers</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
to suppliers represent prepayments made to ensure continuous high-quality supplies and favorable purchase prices of third-party products
and raw materials. These advances are directly related to the purchases of third-party products and raw materials used to fulfill sales
orders. We are required from time to time to make cash advances when placing our purchase orders. These advances are settled upon suppliers
delivering third-party products and raw materials to us when the transfer of ownership occurs. We review our advances to suppliers on
a periodic basis and make general and specific allowances when there is doubt as to the ability of a supplier to provide supplies to
us or refund an advance. As of June 30, 2024 and March 31, 2024, no allowance for advances to suppliers was deemed necessary,
as we believe that all advances to suppliers are fully realizable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Inventories</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
are stated at lower of cost or net realizable value using weighted average method. Costs include the cost of raw materials, freight,
direct labor and related production overhead, as well as procurement cost of third-party products. Any excess of the cost over the net
realizable value of each item of inventories is recognized as a provision for diminution in the value of inventories. Net realizable
value is the estimated selling price in the normal course of business less any costs to complete and sell products. We evaluate inventories
on a quarterly basis for its net realizable value adjustments, and reduces the carrying value of those inventories that are obsolete
or in excess of the forecasted usage to their estimated net realizable value based on various factors including aging, expiration dates,
as applicable, taking into consideration historical and expected future product sales. We perform physical stocktaking quarterly and
write-off obsolete inventories to the cost of revenue account. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 229; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->216<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Fair
value of financial instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The
hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of
inputs used to measure fair value are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1&#8201;&#8212;&#8201;inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in
    active markets.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2&#8201;&#8212;&#8201;inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets,
    quoted market prices for identical or similar assets in markets that are not active, inputs other than quoted prices that are observable
    and inputs derived from or corroborated by observable market data.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3&#8201;&#8212;&#8201;inputs to the valuation methodology are unobservable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise disclosed, the fair value of our financial instruments, including cash, accounts receivable, inventories, advances to suppliers,
other receivables &#8211; related parties, other current assets, short-term bank loans, accounts payable, other payables &#8211; related
parties, taxes payable, unearned revenue, other current liabilities, approximate the fair value of the respective assets and liabilities
as of March 31, 2024 and 2023 based upon the short-term nature of the assets and liabilities. The fair value of operating lease liabilities
approximates their recorded values as their stated interest rates approximate the rates currently available in the market we could obtain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Revenue
recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
determine revenue recognition for contracts with customers, we performs the following five steps : (i) identify the contract(s) with
the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration
to the extent that it is probable that a significant future reversal will <i>not</i> occur, (iv) allocate the transaction price to the
respective performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy the performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
enter sales contracts with various individuals and/or companies. Pursuant to sales contracts entered, we are to provide the required
hygiene and disinfectant or other products to our customers without a right of return. Most customers are required to make full advance
payment to us upon signing the contract, and send the purchase order within ten days. We deliver the ordered hygiene and disinfectant
or other products within seven days after receiving of purchase order and advance payment, and the delivery expense is borne by the customers.
The customer shall inspect the quantity and quality of the products received timely and notify any noncompliance to us on the day of
receipt, and no return will be grant after customers&#8217; acceptances. We may grant certain sales returns from time to time exclusively
under management&#8217;s discretion, which results 1% of total sales reserved for the potential sales return based on historical experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
recognize revenue when we transfer our goods and services to customers in an amount that reflects the consideration to which we expect
to be entitled in such exchange. We account for revenue generated from sales of our products on a gross basis, as we are acting as a
principal in these transactions, are subject to inventory risk, have latitude in establishing prices, and is responsible for fulfilling
the promise to provide customers the specified goods over which we have control and the ability to direct the use of the goods to obtain
substantially all the benefits. All of our contracts have one single performance obligation, namely, the promise to transfer the individual
goods to customers, and there is no separately identifiable other promise in the contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue is recognized at a point in time when title and risk of loss passes and customers inspect and accept the goods, which generally
occurs at day of delivery. Revenue is reported net of after sales discount and return reserve and all value added taxes (&#8220;VAT&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
pay promotional costs to the organizer of our sales campaigns which is in line with revenue and would not have incurred if the
contract had not been obtained. We determined the promotional costs as incremental costs of obtaining a contract and apply a
practical expedient to expense costs when incurred when the amortization period of the asset that the entity otherwise would have
recognized is one year or less. We do not incur significant additional costs to secure contracts with customers, except for promotional expenses, that are expected to
provide benefits lasting longer than one year, which must be recognized as assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"></p>

<!-- Field: Page; Sequence: 230; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->217<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Contract
Liabilities</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
contract liabilities primarily relate to unsatisfied performance obligations when payments have been received from customers before our
products are delivered. Costs of fulfilling customers&#8217; purchase orders, such as shipping, handling and delivery, which occur prior
to the transfer of control, are recognized in selling, general and administrative expense when incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Cost
of revenue</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenue consists primarily of the costs of finished goods manufactured and/or procurement cost of third-party products, freight charges,
depreciation of property and machinery and warehousing expenses. Cost of revenue also includes incremental costs of obtaining sales contract,
which are mainly promotion cost paid to organizers of our sales campaigns in the amount in-line with sales revenue realized at those
sales campaigns. We use practical expedients to expense the incremental costs when incurred on the same period sales revenue is realized
even though the service agreement is executed within one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Research
and development expenses</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expense all internal research and development costs as incurred, which primarily comprise employee costs, material costs related to execution
of studies, depreciation of equipment used in the research and development activities and research and development service expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Selling,
General and Administrative Expenses</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
expenses represents primarily costs of payroll and benefits costs for sales teams, business travel and meals expenses, as well as marketing
expenses. General and administrative expenses represent primarily payroll and benefits costs for administrative employees, rent and operating
costs of office premises, depreciation and amortization of office facilities, professional fees and other administrative expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Government
subsidies</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
subsidy income primarily relates to government cash awards to local companies to promote entrepreneurship, stimulate local economies
and overcome the COVID-19 outbreak. Such awards are granted on a case-by-case basis by local government entities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
recognize government subsidies as other operating income upon receipt if the subsidies are not subject to any past or future conditions,
there are no performance conditions or conditions of use, and not subject to future refunds. For certain government subsidies provided
to us during the COVID-19 epidemic depending on the actual use of our warehouse, the amount received was recognized as other income over
the contract term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Segment
Reporting</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
use the management approach in determining reportable operating segments. The management approach considers the internal reporting used
by our chief operating decision maker for making operating decisions about the allocation of resources of the segment and the assessment
of its performance in determining our reportable operating segments. Management has determined that we have one operating segment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"></p>

<!-- Field: Page; Sequence: 231; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->218<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Income
taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for current income taxes in accordance with the laws of the relevant tax authorities. Deferred income taxes are recognized when
temporary differences exist between the tax bases of assets and liabilities and their reported amounts in the consolidated financial
statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years
in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a
change in tax rates is recognized in income in the period including the enactment date. Valuation allowances are established, when necessary,
to reduce deferred tax assets to the amount expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
uncertain tax position is recognized only if it is &#8220;more likely than not&#8221; that the tax position would be sustained in a tax
examination. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination.
For tax positions not meeting the &#8220;more likely than not&#8221; test, no tax benefit is recorded. Penalties and interest incurred
related to underpayment of income tax are classified as income tax expense in the period incurred. No significant penalties or interest
relating to income taxes have been incurred during the years ended March 31, 2024 and 2023. We do not believe there was any uncertain
tax provision at June 30, 2024 and March 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
subsidiaries in China are subject to the income tax laws of the PRC. No significant income was generated outside the PRC for the three
months ended June 30, 2024 and 2023, and for the years ended March 31, 2024 and 2023. As of June 30, 2024 and March 31, 2024, all of the tax returns of our PRC subsidiaries remain open for statutory examination by PRC tax authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Value
added tax (&#8220;VAT&#8221;)</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
revenue represents the invoiced value of goods, net of VAT. The VAT is based on gross sales price and VAT rates range up to 13%, depending
on the type of products sold. The VAT may be offset by VAT paid by us on raw materials and other materials included in the cost of producing
or acquiring our finished products. We record a VAT payable or receivable net of payments in the accompanying consolidated financial
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Earnings
per Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
compute earnings per share (&#8220;EPS&#8221;) in accordance with ASC 260, &#8220;Earnings per Share&#8221; (&#8220;ASC 260&#8221;).
ASC 260 requires companies with complex capital structures to present basic and diluted EPS. Basic EPS is measured as net income divided
by the weighted average common shares outstanding for the period. Diluted presents the dilutive effect on a per share basis of potential
common shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented,
or issuance date, if later. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or
decrease loss per share) are excluded from the calculation of diluted EPS. For the three months ended June 30, 2024 and 2023, and
for the years ended March 31, 2024 and 2023, there were no dilutive shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Recently
Issued Accounting Pronouncements Not Yet Adopted</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consider the applicability and impact of all accounting standards updates (&#8220;ASUs&#8221;). Management periodically reviews new accounting
standards that are issued. Under the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), we meet the
definition of an emerging growth company, or EGC, and has elected the extended transition period for complying with new or revised accounting
standards, which delays the adoption of these accounting standards until they would apply to private companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 232; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->219<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amended
guidance requires incremental reportable segment disclosures, primarily about significant segment expenses. The amendments also require
entities with a single reportable segment to provide all disclosures required by these amendments, and all existing segment disclosures.
The amendments will be applied retrospectively to all prior periods presented in the financial statements and is effective for fiscal
years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024, with early adoption permitted.
We are currently in the process of evaluating the impact this amended guidance may have on the footnotes to our consolidated financial
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amended guidance enhances
income tax disclosures primarily related to the effective tax rate reconciliation and income taxes paid information. This guidance requires
disclosure of specific categories in the effective tax rate reconciliation and further information on reconciling items meeting a quantitative
threshold. In addition, the amended guidance requires disaggregating income taxes paid (net of refunds received) by federal, state, and
foreign taxes. It also requires disaggregating individual jurisdictions in which income taxes paid (net of refunds received) is equal
to or greater than 5 percent of total income taxes paid (net of refunds received). The amended guidance is effective for fiscal years
beginning after December 15, 2024. The guidance can be applied either prospectively or retrospectively. We are currently in the process
of evaluating the impact this amended guidance may have on the footnotes to our consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
accounting standards that have been issued by FASB that do not require adoption until a future date are not expected to have a material
impact on the consolidated financial statements upon adoption. We do not discuss recent standards that are not anticipated to have an
impact on or are unrelated to our consolidated financial condition, results of operations, cash flows or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Off-Balance
Sheet Financing Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of June 30, 2024. We do
not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as
variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have
not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments
of other entities, or purchased any non-financial assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Internal
Controls and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
is not currently required to comply with the SEC&#8217;s rules implementing Section 404 of the Sarbanes-Oxley Act and is therefore not
required to make a formal assessment of the effectiveness of our internal control over financial reporting for that purpose. Upon the
consummation of the Business Combination and the Company becoming a public company, we will be required to comply with the SEC&#8217;s
rules implementing Section 302 of the Sarbanes-Oxley Act, which will require our management to certify financial and other information
in our quarterly and annual reports and provide an annual management report on the effectiveness of our internal control over financial
reporting. Every year subsequently, on the last day of its second fiscal quarter, the Company will determine its market capitalization
held by non-affiliate holders. Should its market cap exceed $700 million, it will become subject to the provisions and requirements under
Section 404(b) of the Sarbanes-Oxley Act, which will require the Company to undergo audits of its internal controls over financial reporting
as part of its yearly financial statement audits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Emerging
Growth Company Status</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
expects to be an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, following completion of the Business Combination.
Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment
of the JOBS Act until such time as those standards apply to private companies. Qianzhi expects to elect to use this extended transition
period to enable it to comply with new or revised accounting standards that have different effective dates for public and private companies
until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the
extended transition period provided in the JOBS Act. As a result, Qianzhi&#8217;s financial statements may not be comparable to companies
that comply with new or revised accounting pronouncements as of public company effective dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantitative
and Qualitative Disclosures About Market Risk</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a &#8220;smaller reporting company&#8221; as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and pursuant to
Item 305 of Regulation S-K, Qianzhi is not required to disclose information under this section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 233; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->220<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_024"></span>DIRECTORS
AND EXECUTIVE OFFICERS OF NEW BOWEN<br/>
AFTER THE BUSINESS COMBINATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
about Directors Expected to be Appointed to the Board Upon the Closing of the Business Combination</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of the Business Combination, New Bowen&#8217;s Board will be comprised of five members, four of whom are to be designated
by Qianzhi and one of whom will be designated by Bowen. Each such designee will meet the director qualification and eligibility criteria
of the Nominating and Corporate Governance Committee of New Bowen. Each of Bowen&#8217;s incumbent directors other than Jun Zhang will
resign from our Board upon Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
Officers and Directors</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following persons are anticipated to be the executive officers and directors of Bowen, which will be renamed &#8220;Emerald, Inc.&#8221;
following the Business Combination:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Executive
    Officers</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dajun
    Wang</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liangwen
    Wang</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Directors</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dajun
    Wang</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wei
    Liang</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wen
    He</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhenning
    He</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jun
    Zhang</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
biographies of the above-identified individuals are set forth below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dajun
Wang &#8212; Chief Executive Officer and Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Wang will be the Chief Executive Officer and a member of the Board of Directors of New Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Wang&#8217;s significant business, executive and professional experience
make him well qualified to serve on the New Bowen Board. Mr. Wang has been shortlisted as a Foreign High-End Talents (Category A) in
China. Mr. Wang has also served as a partner at Shenzhen Efung Investment Management Limited Partnership Enterprise, a bio-tech investment
company, since 2022 and a senior partner at Fern Win Capital (China) Co., Ltd., a financial investment company, since 2022. From 2021
to 2022, Mr. Wang served as director at Shenzhen Letu Investment Fund Co., Ltd., a biotech investment company. From 2018 to 2020, Mr.
Wang served as executive director and chief financial consultant at Northeast Asia Innovation Financial Asset Trading Center and China
Enterprise Development Research Institute Ltd., a provider of equity investment and financial consulting services. From 2012 to 2018,
Mr. Wang co-founded and served as a partner at Bona Capital and Fengxiang International Capital, investment consulting firms.
Mr. Wang also co-founded Leinisen Pharmaceutical and Baoqiang Pharmaceutical in 2006 and 2007, respectively. From 2005 to 2006, Mr. Wang served as Vice
President at Deutsche Bank and from 2000 to 2005, Mr. Wang served as senior analyst at Goldman Sachs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Wang holds a PhD degree in Molecular Medical Genetics from University of Toronto, a MBA degree in International Finance from International
University of Japan, a Master degree in Research Molecular Bioscience from Chinese Academy of Sciences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liangwen
Wang &#8212; Chief Financial Officer</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Wang will be the Chief Financial Officer and a member of the Board of Directors for New Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since June 2021, Mr. Wang has served as
the Chief Financial Officer of Qianzhi, having joined Qianzhi in June 2018. At Qianzhi, Mr. Wang is responsible for the comprehensive
financial accounting and management of Qianzhi, where he supervises the implementation of Qianzhi&#8217;s strategic goals and oversees
its overall financial planning and internal control over financial reporting. Prior to that, he served as the internal audit manager
at Shenzhen Hongtai Group Holding Co., Ltd from 2013 to 2018. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 234; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->221<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Wang holds an Associate degree in Accounting from Hainan College of Vocation and Technique. Mr. Wang also holds The Audit Professional
Qualification (Intermediate Level) Certificate and Intermediate Accounting Certificate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wei
Liang &#8212; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Liang will be a member of the Board of Directors for New Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Liang&#8217;s significant business and professional expertise and experience make him well qualified to serve on the New Bowen Board.
Mr. Liang joined Qianzhi in January 2021 and he has served as the marketing executive director at Shenzhen Qianzhi Bio-Tech Co., Ltd.
since such time. Mr. Liang oversees the administration, strategic planning and marketing activities of Qianzhi and has spearheaded its
brand influences through his rich experiences in the marketing area.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
1995 to 2013, Mr. Liang served as purchasing manager at Shenzhen Suibao Department Store Co., Ltd., a Hong Kong Exchange listed department
store founded in 1996, which is one of the earliest and largest retail enterprises in China, where he was responsible for the overall
procurement process, business negotiations and the supply chain management. In January 2014, Mr. Liang founded VisionEase, an optical
business where he acted as a sole trader. In 2016, Mr. Liang changed the name of VisionEase to Dazhou Vision Technology (Shenzhen) Co.,
Ltd and expanded its business to provide professional eye protection for teenagers and be a source of publicized eyesight protection
events. Mr. Liang served as the general manager of Dazhou from that point until December 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Liang holds an Associate degree in Marketing from Nankai University. Mr. Liang has also obtained the Certificate of National Senior Optometrist
in 2014.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wen
He &#8212; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
He will be a member of the Board of Directors for New Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
He&#8217;s significant business and professional expertise and experience make him well qualified to serve on the New Bowen Board. Mr.
He has served as Executive Chairman of Guangdong Hong Kong Macao Greater Bay Area Business Federation and Founding, an organization that
promotes and coordinates economic and regional cooperation for the companies registered in Guangdong, Hong Kong and Macao, since 2021.
Since 2022, Mr. He has also served as chairman of Sipaike (Shenzhen) Digital Technology Co., Ltd, an enterprise management and investment
consulting firm. From 2021 to February 2024, Mr. He served as the Chief Executive Officer of Qianhai Wutong Innovation Financial Technology
Co., Ltd., a venture capital and equity investment company in Shenzhen. Mr. He has also served as the Chief Executive Officer of Mulan
King Holding Inc., a financial consulting firm. From 2002 to 2007, Mr. He served as the Vice President of Shenzhen Longmai Information
Co., Ltd. and the independent director of China Oil Gangran Energy Group Holdings Limited (08132.HK) from 2019 to 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
He holds a MBA degree from Columbia Southern University in 2005 and a BA degree in Chinese and Literature from Hunan Normal University.
Mr. He also hold Project Management Professional Certificate and ICAA Certificate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhenning
He &#8212; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
He will be a member of the Board of Directors for New Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
He&#8217;s significant business and professional expertise and experience make him well qualified to serve on the New Bowen Board. From
June 2020 through May 2023, Mr. He has served as General Manager Assistant at Waton Securities International Limited, a securities firm,
where he was in charge of the new media operating segment and focused the firm&#8217;s brand influences and enhanced the quality of online
services and products. From May 2023 to July 2023, Mr. He held an internship with the Public Relations Department of Herm&#232;s
where he was responsible for the preparation of showrooms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
He holds a MA degree in Media from University of Westminster and a BS degree in Accounting from Pennsylvania State University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 235; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->222<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jun
Zhang &#8212; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Zhang will be a member of the Board of Directors for New Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Zhang has served on the Board of Directors of Bowen since July 2023.
Mr. Zhang has served as Senior Partner and Associate Director at Mazars (Shenzhen Branch) since 2000. Mr. Zhang also founded Shenzhen
Zhonghuan Certified Public Accountants Co., Ltd, an accounting firm, in 2009 and has served as Chairman since its founding. From 1994
to 2000, he served as Partner and Associate Director at Shenzhen Wenwu Accounting Firm. From 1989 to 1994, he was the Senior Manager
at Shenzhen Shekou Zhonghua Accounting Firm. He served as Project Manager at Wuhan Accounting Firm of Wuhan Finance Bureau from 1986
to 1989. Mr. Zhang received a Master&#8217;s degree in Management from Zhongnan University of Economics and Law and Bachelor&#8217;s
degree in Financial Accounting from Jianghan University. He is a CPA in China. Mr. Zhang is a Chinese citizen. Mr. Zhang&#8217;s business
experience, contacts and relationships make him well qualified to serve on the New Bowen Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Family
Relationships</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are not expected to be any family relationships between New Bowen&#8217;s Board and any of its executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
of Directors</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the completion of the Business Combination, the New Bowen Board will be increased to five directors. At each succeeding annual general
meeting of New Bowen, all the directors of New Bowen shall be elected for a term of one year. Under the terms of the Proposed Charter, there will be no limit on the number of terms a director
may serve on the New Bowen Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
Independence</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
listing rules require that a majority of the board of directors of a company listed on Nasdaq be composed of &#8220;independent directors,&#8221;
which is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having
a relationship, which, in the opinion of the company&#8217;s board of directors, would interfere with the director&#8217;s exercise of
independent judgment in carrying out the responsibilities of a director. New Bowen&#8217;s Board has determined that, upon the consummation
of the Business Combination, each of Wen He, Zhenning He, and Jun Zhang will be an independent director under the Nasdaq listing rules
and Rule 10A-3 of the Exchange Act. In making these determinations, New Bowen&#8217;s Board considered the current and prior relationships
that each non-employee director has with Qiangzhi and will have with New Bowen and all other facts and circumstances New Bowen&#8217;s
Board deemed relevant in determining independence, including the beneficial ownership of New Bowen Common Stock by each non-employee
director, and the transactions involving them described in the section titled &#8220;<i>Certain Relationships and Related Transactions</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Committees
of the Board of Directors</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
standing committees of New Bowen&#8217;s Board will consist of an Audit Committee, a Compensation Committee, and a Nominating and Corporate
Governance Committee. The expected composition of each committee following the Business Combination is set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
Committee</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee has been established in accordance with Section 3(a)(58)(A) of the Exchange Act and following the Business Combination
will consist of Mr. Wen He, Mr. Zhenning He, and Mr. Jun Zhang, each of whom are independent directors and are &#8220;financially literate&#8221;
as defined under the Nasdaq listing standards. Mr. Jun Zhang will serve as chairman of the Audit Committee. New Bowen&#8217;s Board has
determined that Mr. Zhang qualifies as an &#8220;audit committee financial expert,&#8221; as defined under rules and regulations of the
SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee&#8217;s duties will be set forth in our Audit Committee Charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
Committee</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Business Combination, our Compensation Committee will consist of Mr. Wen He, Mr. Zhenning He, and Mr. Jun Zhang, each of whom is
an independent director. Mr. Wen He will serve as chairman of the Compensation Committee. The functions of the Compensation Committee
will be set forth in a Compensation Committee Charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 236; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->223<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating
and Corporate Governance Committee</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Business Combination, our Nominating and Corporate Governance Committee will consist of Mr. Wen He, Mr. Zhenning He, and Mr. Jun
Zhang, each of whom is an independent director under Nasdaq&#8217;s listing standards. Mr. Zhenning He will serve as the chair of the
Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee is responsible for overseeing the selection
of persons to be nominated to serve on New Bowen&#8217;s Board. The Nominating and Corporate Governance Committee considers persons identified
by its members, management, stockholders, investment bankers and others.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
guidelines for selecting nominees, will be specified in the Nominating and Corporate Governance Committee Charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code
of Business Conduct and Ethics</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the consummation of the Business Combination, we will adopt a new Code of Business Conduct and Ethics for our directors, officers, employees
and certain affiliates following the Business Combination in accordance with applicable federal securities laws, a copy of which will
be available on New Bowen&#8217;s website at https://[&#9679;]. New Bowen will make a printed copy of the Code of Business Conduct and
Ethics available to any stockholder who so requests. Following the Business Combination, requests for a printed copy may be directed
to our Chief Executive Officer, Dajun Wang at [X].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we amend or grant a waiver of one or more of the provisions of our Code of Business Conduct and Ethics, we intend to satisfy the requirements
under Item 5.05 of Form 8-K regarding the disclosure of amendments to or waivers from provisions of our Code of Business Conduct and
Ethics that apply to our principal executive officer, principal financial officer and principal accounting officer by posting the required
information on New Bowen&#8217;s website at https://[&#9679;]. The information on this website is not part of this proxy statement/prospectus.<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 237; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->224<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_025"></span>EXECUTIVE
OFFICER AND DIRECTOR COMPENSATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
Officer and Director Compensation of Bowen</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
executive officer or director of Bowen has received any compensation for services rendered to Bowen. No compensation or fees of any kind,
including finders, consulting or other similar fees, will be paid to any of Bowen&#8217;s existing shareholders, including its officers
and directors, or any of their respective affiliates, prior to, or for any services they render in order to effectuate, the consummation
of the Merger. Since its formation, Bowen has not granted any share options or share appreciation rights or any other awards under long-term
incentive plans to any of its executive officers or directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, Bowen Holding LP, one of the Sponsors, makes available to Bowen certain general and administrative services, including
office space, utilities and administrative support, as Bowen may require from time to time. Bowen has agreed to pay $10,000 per month
for these services. Additionally, Bowen pays TenX Global Capital, a member of Bowen Holding LP, to provide Bowen with consulting and
advisory services in connection with, among other things, assisting Bowen with the preparation of, and the accounting relating to, quarterly
and annual reports to be filed with the Securities and Exchange Commission at a price of $5,250 per quarter. Additionally, Bowen&#8217;s
directors and executive officers are reimbursed for any out-of-pocket expenses incurred in connection with activities on Bowen&#8217;s
behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. There is no limit
on the amount of these out-of-pocket expenses and there will be no review of the reasonableness of the expenses by anyone other than
Bowen&#8217;s board of directors, which includes persons who may seek reimbursement, or a court of competent jurisdiction if such reimbursement
is challenged. Because of the foregoing, Bowen generally does not have the benefit of independent directors examining the propriety of
expenses incurred on its behalf and subject to reimbursement. As of [X], 2024, an aggregate of approximately $[X] has been incurred and
unpaid for such expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
Officer and Director Compensation of Qianzhi</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Throughout
this section, unless otherwise noted, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and similar terms refer to Qianzhi prior
to the consummation of the Business Combination.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
achieve Qianzhi&#8217;s goals, Qianzhi has designed its compensation and benefits program to attract, retain, incentivize and reward
deeply talented and qualified executives who share its philosophy and desire to work towards achieving its goals. Qianzhi believes its
compensation program should promote the success of Qianzhi and align executive incentives with the long-term interests of its stockholders.
Qianzhi&#8217;s current compensation arrangements are as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Qianzhi Board determines compensation of Qianzhi&#8217;s executive officers. For the year ended March 31, 2024, our named executive
officers are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xiaoqin
                                            Lin, Chief Executive Officer.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liangwen
                                            Wang, Chief Financial Officer.</span></td></tr>
                                                                                           </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Xiaoqin Lin &#8212; Chief Executive Officer</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Ms. Lin currently serves
as our Chairperson and Chief Executive Officer and has held executive positions with Qianzhi since April 2011. Since April 2011, she
served as the Executive Director of Qianzhi, which is the Chief Executive Officer position of the company. From December 2018 to
August 2021 and again since August 2022, she has served as the chairperson of Qianzhi and served as a director of Qianzhi from August
2021 to August 2022. From November 2023 to present, she also served as the Supervisor of Shenzhen Shian and has acted as the
Director of NewCo since its formation in August 2023. Ms. Lin is 47 years old.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liangwen
Wang &#8212; Chief Financial Officer</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
see &#8220;<i>Directors and Executive Officers of New Bowen After the Business Combination - Information about Directors Expected to
be Appointed to the Board Upon the Closing of the Business Combination&#8221; </i>for the professional profile of Mr. Liangwen Wang.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section provides an overview of Qianzhi&#8217;s executive compensation arrangements with its named executive officers, including
a narrative description of the material factors necessary to understand the information disclosed in the summary compensation table below. Actual compensation programs adopted following the completion of the Business
Combination may differ materially from the currently planned programs summarized in this discussion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>


<!-- Field: Page; Sequence: 238; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->225<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary
Compensation Table for Fiscal Year 2024</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information concerning the compensation of the named executive officers for the fiscal years ended March 31,
2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
                                            and Position<sup>(1)</sup></b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Fiscal<br/> Year</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Salary<br/> ($)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Bonus<br/> ($)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Stock<br/> Awards<br/> ($)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option<br/> Awards<br/> ($)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">All Other<br/> Compensation<br/>
    ($)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total<br/> ($)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: left">Xiaoqin Lin, Chief Executive Officer</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: center">202<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">51,426.00</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">20,570.40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">71,996.40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">202<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">51,426.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">20,570.40</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">71,996.40</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Liangwen Wang, Chief Financial Officer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">202<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">25,713.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#8194;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19,999.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">45,712.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">202<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">25,713.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">25,713.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">All
                                            U.S. dollar amounts in the above table were converted from Renminbi at an exchange rate of
                                            0.14285 RMB to $1.00.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Narrative
Disclosure to Summary Compensation Table</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
Agreements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
has entered into employment agreements with its named executive officers and certain other key employees which governs the terms
of their continuing employment with Qianzhi.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
Agreements with Current Executive Officers</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of Qianzhi&#8217;s named executive officers is party to an employment agreement with Qianzhi. Under this agreement, the employment of
the each of our named executive officers is for a fixed term of three (3) years. The employment agreement with our Chief Executive Officer
expires December 31, 2024 and the employment agreement with our Chief Financial Officer expires June 19, 2027. Each of these employment
agreements may be terminated for cause at any time and without advance notice or compensation for certain acts, such as violation of
company policies, conviction of crime, continued failure to satisfactorily perform agreed duties, or misconduct or dishonest act to our
detriment. The employment of each named executive officer may also be terminated without cause upon 30-day advance written notice. Each
of the named executive officers may resign at any time with 30-day advance written notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
employment agreements provides for a base salary payable to the executive officer in accordance with the above table.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
In addition, each named executive officer is entitled to pension insurance, medical insurance, unemployment insurance, work-related injury
insurance, maternity insurance and housing provident fund in accordance with PRC law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the named executive officers have agreed to hold, both during and after the termination or expiry of their respective employment agreement,
in strict confidence and not to use, except as required in the performance of his or her duties in connection with the employment or
pursuant to applicable law, any confidential information of Qianzhi or trade secrets, any confidential information or trade secrets of
Qianzhi&#8217;s customers or prospective customers, or the confidential or proprietary information of any third party received by Qianzhi
and for which Qianzhi has confidential obligations. Both named executive officers have also agreed to disclose in confidence to Qianzhi
all inventions, designs, and trade secrets which they conceive, develop, or reduce to practice during the employment with Qianzhi and
to assign all rights, title, and interest in them to Qianzhi, and assist Qianzhi in obtaining and enforcing patents, copyrights, and
other legal rights for these inventions, designs, and trade secrets. In addition, each of the named executive officers have agreed to
be bound by non-competition and non-solicitation restrictions during the term of his or her employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
Equity Awards At 2024 Fiscal Year End</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2024, none of our named executive officers held any equity awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officer
Compensation Following the Business Combination</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
policies of New Bowen with respect to the compensation of its executive officers following the Business Combination are expected to be
administered by the board of directors of New Bowen in consultation with its compensation committee and governed by employment agreements
to be entered into with such officers individually. New Bowen may also rely on data and analyses from third parties, such as compensation
consultants, in connection with its compensation programs. New Bowen intends to design and implement programs to provide for compensation
that is sufficient to attract, motivate and retain executives of New Bowen and potentially other individuals and to establish an appropriate
relationship between executive compensation and the creation of stockholder value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 239; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->226<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-Closing
Executive Officer Employment Letters</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination, New Bowen will enter into employment agreements on terms to be negotiated with
Dajun Wang and Liangwen Wang, who will be the only executive officers of New Bowen following the closing of the Business Combination.
Qianzhi expects to extend standard employment letters to certain other individuals who it expects will likely occupy senior managerial
roles within New Bowen following the closing of the Business Combination, but such individuals are not presently expected to be appointed
as executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024
Incentive Plan</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen expects to adopt the 2024 Incentive Plan in connection with the Business Combination. For more information about the 2024 Incentive
Plan, please see the section titled &#8220;<i>Proposal 4: The Stock Plan Proposal</i>&#8221; for the material terms of the 2024 Incentive
Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
Compensation</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Business Combination, Qianzhi has not adopted a formal policy or plan to compensate its directors. Current members of the Board
of Qianzhi have not received additional compensation for their service as members of the Qianzhi Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors of New Bowen expects to adopt a nonemployee director compensation program (the &#8220;<span style="font-weight: normal"><i>Director
Compensation Policy</i></span>&#8221;), which will become effective in connection with the completion of the Business Combination. The
Director Compensation Policy will be designed to align compensation with New Bowen&#8217;s business objectives and the creation of stockholder
value, while enabling New Bowen to attract, retain, incentivize and reward non-employee directors who contribute to the long-term success
of New Bowen. The Director Compensation Policy is expected to provide for an annual cash retainer for all non-employee directors, in
addition to equity grants determined by the compensation committee and reimbursement for reasonable expenses incurred in connection with
attending board and committee meetings. The board of New Bowen expects to review non-employee director compensation periodically to ensure
that non-employee director compensation remains competitive such that New Bowen is able to recruit and retain qualified non-employee
directors. The amount and form of such compensation has not yet been determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 240; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->227<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_026"></span>CERTAIN
RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Related Party Transactions</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 27, 2023, Bowen Holding LP, one of the Sponsors, of which each of Jiangang Luo, Jing Lu, Lawrence Leighton, Wei Li
and Jun Zhang, officers and directors of Bowen, along with TenX and Fengfei Zhang, is a limited partner, acquired an
aggregate of 1,725,000 Founder Shares for an aggregate purchase price of $25,000. Thereafter, Bowen Holding LP transferred an
aggregate of 1,155,750 Founder Shares to Createcharm Holdings Ltd, the other Sponsor which is controlled by Na Gai, Bowen&#8217;s
Chairwoman of the Board. Prior to the initial investment in Bowen of $25,000 by the Sponsors, Bowen had no assets, tangible or
intangible. The number of Founder Shares issued was determined based on the expectation that such Founder Shares would represent 20%
of the outstanding shares upon completion of the IPO (excluding the Bowen Private Shares and IPO Underwriter Shares).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the consummation of the IPO, Bowen consummated the private placement of 330,000 Bowen Private Units at a price of $10.00 per Bowen
Private Unit, generating total proceeds of $3,300,000. The Bowen Private Units were purchased by Createcharm Holdings Ltd (312,000
Bowen Private Units) and the IPO Underwriter (18,000 Bowen Private Units). The Bowen Private Units are identical to the Bowen Units included in the Public
Units sold in the IPO. The purchasers of the Bowen Private Units have agreed not to transfer, assign or sell any of the Private Placement
Units or Ordinary Shares or Rights underlying the Bowen Private Units (except to certain transferees) until after the completion of the
initial Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 18, 2023, Createcharm Holdings Ltd and the IPO Underwriter purchased an additional 31,500 Bowen Private Units, with Createcharm having purchased 29,782 of the additional Bowen Private Units and the IPO Underwriter having purchased
1,718 of the additional Bowen Private Units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth herein, no compensation of any kind, including finder&#8217;s and consulting fees, will be paid to Bowen&#8217;s
initial shareholders, existing officers, directors and advisors, or any of their respective affiliates, for services rendered prior to
or in connection with the completion of an initial business combination. However, these individuals will be reimbursed for any out-of-pocket
expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence
on suitable business combinations. Bowen&#8217;s audit committee will review on a quarterly basis all payments that were made
to the initial shareholders or their affiliates and will determine which expenses and the amount of expenses that will be reimbursed.
There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on Bowen&#8217;s
behalf.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Holding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> agreed to loan Bowen up to $300,000 to be
used for a portion of the expenses of the IPO. These loans were non-interest bearing, unsecured and were due at the earlier of December
31, 2023, the closing of the IPO or Bowen&#8217;s determination not to proceed with the IPO. No loans were ever extended under such agreement. Createcharm paid $151,318 on behalf of Bowen for expenses related
to the IPO, all of which was fully repaid upon closing of the IPO on July 14, 2023 out of the offering proceeds not held in trust account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Holding LP has agreed that, commencing on the effective date of the prospectus for the IPO through the earlier of Bowen&#8217;s
consummation of an initial business combination or the liquidation of the trust account, it will make available to Bowen certain
general and administrative services, including office space, utilities and administrative support, as Bowen may require from time to
time. Bowen agreed to pay $10,000 per month for these services upon demand by Bowen Holding LP. Bowen believes, based on
rents and fees for similar services, that these fees are at least as favorable as Bowen could have obtained from an unaffiliated
person. As of August 31, 2024, Bowen has incurred $136,667 with $90,000 paid to Bowen Holding LP for these
services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 20, 2023, Bowen engaged TenX, which is wholly owned by Jiayu Li and is a member of Bowen Holding, to provide Bowen
with consulting and advisory services in connection with, among other things, (i) preparing certain of Bowen&#8217;s consolidated
financial statements and other financial-related disclosures at a fixed price of $20,000 and (ii) assisting Bowen with the
preparation of, and the accounting relating to, Bowen&#8217;s quarterly and annual reports to be filed with the Securities and
Exchange Commission at a price of $5,250 per quarter commencing on the month following the consummation of the IPO. As of August
31, 2024, Bowen has incurred $46,250 with $41,000 paid to TenX for these services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In addition, in order to finance
transaction costs in connection with an intended initial business combination, Bowen&#8217;s initial shareholders, officers, directors
or their affiliates may, but are not obligated to, loan Bowen funds on a non-interest bearing basis as may be required. If Bowen completes
an initial business combination, Bowen would repay such loaned amounts. In the event that the initial business combination does not close,
Bowen may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from the trust
account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into working capital units at $10.00 per
unit at the option of the lender. The working capital units would be identical to the private units sold in the private placement. Except
as set forth above, the terms of such loans have not been determined and no written agreements exist with respect to such loans. Bowen
does not expect to seek loans from parties other than Bowen&#8217;s initial shareholders, officers, directors or their affiliates as
Bowen does not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access
to funds in our trust account, but if Bowen does, it will request such lender to provide a waiver against any and all rights to seek
access to funds in the trust account. As of the filing date, Bowen has not received any such loans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 241; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->228<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NewCo
and Qianzhi Related Party Transactions</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets forth the related parties of Qianzhi and their relationships with Qianzhi:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship
    with the Company</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Xiaoqin Lin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&#8217;s controlling shareholder, Chief Executive Officer and chairman of the Company&#8217;s Board of Directors</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Liangwen Wang</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Yuetao Lin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    and Senior Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Xiaoling Yuan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Juxiang Hu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    and Senior Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Yanmin Liu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Yajun Sun</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Liangming Hu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Lizhong Ge</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Husband
    of Ms. Xiaoqin Lin</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shenzhen
    Yelin Network Technology Co., Ltd (&#8220;Shenzhen Yelin&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    common control of Ms. Xiaoqin Lin, whose ownership were disposed on January 4, 2023. Ms. Xiaoqin Lin has significant influence over Shenzhen Yelin after the disposal. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales transactions and accounts receivables &#8211; related
parties</i></span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 21.3pt">The Company sold its self-produced
products to Shenzhen Yelin in the amounts of $74,593 and $74,728 during the three months ended June 30, 2024 and 2023 with accounts receivable
balances of $74,643 as of June 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 21.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 21.3pt">The Company sold its
self-produced products to Ms. Yuetao Lin and Ms. Xiaoling Yuan in the amounts of $12,215 and $17,101, respectively, during the three
months ended June 30, 2024, and the accounts receivable balance from these individuals as of June 30, 2024 was $Nil. There were no
sales transactions with these individuals during the three months ended June 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt">The Company sold
its self-produced products to Shenzhen Yelin in the amounts of $234,593 and $51,546 during the years ended March 31, 2024 and 2023 with
accounts receivable balances of $Nil and $875,276 as of March 31, 2024 and 2023, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt">The Company sold
its self-produced products to Ms. Juxiang Hu, Ms. Yuetao Lin and Ms. Xiaoling Yuan in the amounts of $62,804, $62,799 and $62,809, respectively
during the year ended March 31, 2024, and accounts receivable balance with these individuals as of March 31, 2024 was $Nil. There were
no sales transactions with these individuals during the year ended March 31, 2023, and accounts receivable balance with these individuals
as of March 31, 2023 was $Nil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 242; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->229<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<i>Other receivables &#8211; related parties</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company advanced funds to Shenzhen Yelin for general working capital needs of Shenzhen Yelin, to Ms. Xiaoqin Lin for payment of combination
expenses of the Company, to officers as petty cash to cover minor expenses of the Company, and advanced salaries to employees for their
personal use. Such advance was non-interest bearing and due on demand. The other receivables due from related parties as of June 30,
2024 and March 31, 2024 were as followings:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nature</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2024</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    31, 2024</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shenzhen
    Yelin</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
    funds to Shenzhen Yelin for its general working capital needs</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">506,877</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Xiaoqin Lin</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
    funds for payment of business combination expenses of the Company*</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">283,106</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Yanmin Liu</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
    salary to employees for their personal use</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,521</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,700</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Yajun Sun</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
    salary to employees for their personal use</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,444</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,174</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Juxiang Hu</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Petty
    cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,104</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,212</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
    salary to employees for their personal use</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    other receivables &#8211; related parties</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">912,052</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,086</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">(*) The amount due from
Ms. Xiaoqin Lin had been fully collected back on <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
4, 2024 </span> and the Company does not intend to make additional cash advances to related parties going forward.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The other receivables due from related
parties as of March 31, 2024 and 2023 were as followings:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 18%; text-align: justify">Shenzhen Yelin</td><td style="width: 2%">&#160;</td>
    <td style="width: 44%; text-align: justify">Advanced funds to Shenzhen Yelin for its general working capital needs</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,768,718</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Ms. Yanmin Liu</td><td>&#160;</td>
    <td style="text-align: justify">Advanced salary to employees for their personal use</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Ms. Yajun Sun</td><td>&#160;</td>
    <td style="text-align: justify">Advanced salary to employees for their personal use</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,174</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,672</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Ms. Juxiang Hu</td><td>&#160;</td>
    <td style="text-align: justify">Petty cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,212</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 1.5pt">Advanced salary to employees for their personal use</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,166</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total other receivables &#8211; related parties</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68,086</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,809,556</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans to related parties</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 87%; margin-left: 0.25in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: justify">Mr. Liangwen Wang</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(1</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">29,122</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 1, 2023, Mr. Liangwen Wang borrowed RMB 200,000 (equivalent to US$29,122) from Qianzhi
                                            for a term of twenty-four months, with maturity date on December 23, 2024 and interest
                                            rate of 9.9792% per annum. The loan was fully repaid on September 28, 2023.</span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other payables &#8211; related parties</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 21.3pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">balance of other payables &#8211; related parties
were comprised of the Company&#8217;s advances from Ms. Xiaoqin Lin used for working capital during the Company&#8217;s normal course
of business, and payment of expenses made by related parties on behalf of the Company. Such advance was non-interest bearing and due
on demand. The other payables due to related parties as of June 30, 2024 and March 31, 2024 were as followings:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">As of</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Name</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">June 30, 2024</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31, 2024</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: center">(Unaudited)</td><td style="font-size: 10pt">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; font-size: 10pt; text-align: justify">Ms. Xiaoqin Lin</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 16%; font-size: 10pt; text-align: right">-</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 16%; font-size: 10pt; text-align: right">276,533</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: justify">Mr. Liangming Hu</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">39,056</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">38,991</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: justify">Others</td><td style="font-size: 10pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">59</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">55</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; text-align: justify">Total other payables &#8211; related parties</td><td style="font-size: 10pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">39,115</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">315,579</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 21.3pt; margin-bottom: 0pt">The other payables
due to related parties as of March 31, 2024 and 2023 were as followings:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Ms. Xiaoqin Lin</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">276,533</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">36,099</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Mr. Liangming Hu</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38,991</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,771</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Mr. Lizhong Ge</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,026</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">55</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,758</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total other payables &#8211; related parties</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">315,579</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">105,654</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 21.3pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 21.3pt">During the year ended March
31, 2024, Ms. Xiaoqin Lin, the Company&#8217;s Chief Executive Officer, paid for certain expenses on behalf of the Company. On March
31, 2024, the Company, Ms. Lin and Shenzhen Yelin, a company affiliated with Ms. Lin, entered into an agreement whereby Shenzhen Yelin
collected cash in the amount of $1,174,118 for products sold by the Company to third parties and in turn delivered such cash to Ms. Lin
as repayment for the same amount advanced by Ms. Lin for such expenses.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 21.3pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan guarantee provided by related parties</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with Qianzhi&#8217;s long-term loans borrowed from Webank Co., Ltd., Qianzhi&#8217;s CFO, Mr. Liangwen Wang
provided a personal loan guarantee without additional compensation.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 243; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->230<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related
Person Transactions Following the Business Combination</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is not anticipated that the board of directors of New Bowen will adopt a formal written related person transactions policy following
consummation of the Business Combination. However, New Bowen&#8217;s audit committee will be tasked with the identification, review,
consideration and oversight of related person transactions. For these purposes, a related person transaction is a transaction, arrangement
or relationship (or any series of similar transactions, arrangements or relationships) in which New Bowen or any of its subsidiaries
are participants involving an amount that exceeds $120,000, in which any related person has a material interest. A related person is
any executive officer, director, nominee to become a director or a holder of more than 5% of any class of New Bowen&#8217;s voting securities,
including any of their immediate family members and affiliates, including entities owned or controlled by such persons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
involving compensation for services provided to New Bowen or any of its subsidiaries as an employee, consultant or director would not
be considered related person transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is anticipated that the related person in question or, in the case of transactions with a holder of more than 5% of any class of New
Bowen&#8217;s voting securities, an officer with knowledge of a proposed transaction, will be required to present information regarding
the proposed related person transaction to New Bowen&#8217;s audit committee (or to another independent body of the board of directors
of New Bowen) for review. To identify related person transactions in advance, New Bowen expects to rely on information supplied by its
executive officers, directors and certain significant shareholders. In considering related person transactions, New Bowen&#8217;s audit
committee is expected to take into account the relevant available facts and circumstances, which may include, but are not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risks, costs, and benefits to New Bowen;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact on a director&#8217;s independence in the event the related person is a director, immediate family member of a director or
    an entity with which a director is affiliated;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    terms of the transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    availability of other sources for comparable services or products; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    terms available to or from, as the case may be, unrelated third parties.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen&#8217;s audit committee will approve only those transactions that it determines are fair to New Bowen and in its best interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 244; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->231<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_027"></span>BENEFICIAL
OWNERSHIP OF SECURITIES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding the beneficial ownership of Bowen Ordinary Shares as of [X], and the expected beneficial
ownership of New Bowen Ordinary Shares as of immediately after the Business Combination, by:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person who is known to be the beneficial owner of more than 5% of the Bowen Ordinary Shares and each person who is expected to be
    the beneficial owner of more than 5% of the New Bowen Ordinary Shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    executive officer and director of Bowen pre-Business Combination and each expected executive officer and director of New Bowen post-Business
    Combination; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    executive officers and directors of Bowen pre-Business Combination, as a group, and all the expected executive officers and directors
    of New Bowen post-Business Combination, as a group.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security
if he, she or it possesses sole or shared voting or investment power over that security, including options, rights and convertible notes
that are currently exercisable or exercisable within 60 days. The Bowen Ordinary Shares issuable upon conversion of the Bowen Rights
are included in a holder&#8217;s beneficial ownership of New Bowen Ordinary Shares post-Business Combination, as they would be converted
into New Bowen Ordinary Shares upon consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
beneficial ownership of Bowen Ordinary Shares pre-Business Combination is based on [X] Bowen Ordinary Shares issued and outstanding as
of [X] (including those shares held as a constituent part of Bowen Units). The expected beneficial ownership of New Bowen Ordinary Shares
assumes two scenarios:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>assuming
    no redemptions</i>: this presentation assumes that no Bowen public shareholders exercise right to have their public shares converted
    into pro rata share of the trust account; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>assuming
    maximum redemptions</i>: this presentation assumes that all public shareholders exercise redemption rights with respect to their
    public shares.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above does not take into account any New Bowen Ordinary Shares that may be issued in the PIPE Financing. In addition, <span style="background-color: white">the
beneficial ownership calculations set forth in the below table on a post-Business Combination basis includes an aggregate of 724,637
ordinary shares of New Bowen that will be held in escrow. However, such calculations do not include the 1,400,000 Earnout Shares which
may be issued to the former shareholders of Qianzhi as such ordinary shares may only be issued based on the achievement of certain milestones
which will not occur within 60 days of the Record Date.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the foregoing assumptions, Bowen estimates that there would be [X] New Bowen Ordinary Shares issued and outstanding immediately following
the consummation of the Business Combination in the &#8220;no redemption&#8221; scenario, and [X] New Bowen Ordinary Shares issued and
outstanding immediately following the consummation of the Business Combination in the &#8220;maximum redemption&#8221; scenario. If the
actual facts are different from the foregoing assumptions, ownership figures in New Bowen and the columns under Post-Business Combination
in the table that follows will be different.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated and subject to applicable community property and similar laws, Bowen believes that all persons named in the table
below have sole voting and investment power with respect to the voting securities beneficially owned by them.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 245; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->232<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-Business
    Combination</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior
                                            to the</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transactions</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No
                                            Redemption</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Maximum
                                            Redemption</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
                                            and Address of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beneficial
                                            Owners(1)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(#)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pct.<br/>
    (%)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of<br/>
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b><br/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(#)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pct.<br/>
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(%)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of<br/>
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares<br/>
         </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(#)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pct.<br/>
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(%)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Officers and Directors of Bowen:</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Na
    Gai(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">1,497,532</p><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">16.3</p><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,531,710</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,531,710</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Jiangang Luo(3)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Jing Lu(3)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Lawrence Leighton(3)</p></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Wei Li(3)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Jun Zhang(3)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Directors and Executive Officers as a group (6 Individuals) (4)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,497,532</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,531,710</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,531,710</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Officers and Directors of NewCo:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dajun
    Wang</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wei
    Liang</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wen
    He</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhenning
    He</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jun
    Zhang(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liangwen
    Wang(8)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">72,029</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">*</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">72,029</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">*</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Directors and Executive Officers as a group (6 Individuals)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greater
    than 5% Holders:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lin
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xiaoqin Investment Holding Co., Ltd.(7)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,661,015</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,661,015</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Createcharm Holdings Ltd(5)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,497,532</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">16.3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,531,710</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">__</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,531,710</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">__</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Bowen Holding LP(6)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">569,250</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6.2</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">569,250</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">__</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">569,250</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">__</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<!-- Field: Rule-Page --><div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 25%; margin-bottom: 0pt"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than 1%.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
    otherwise noted, the business address of each of the following entities or individuals under the caption &#8220;<i>Executive Officers
    and Directors of Bowen</i>&#8221; is c/o Bowen Acquisition Corp, 420 Lexington Avenue, Room 2446, New York NY 10170. Unless otherwise
    noted, the business address of each of the following entities or individuals under the caption &#8220;<i>Executive Officers and Directors
    of NewCo</i>&#8221; is Water&#8217;s Edge Building, 4<sup>th</sup> Floor, Meridian Plaza, Road Town, Tortola VG1110, British Virgin
    Islands.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Createcharm
                                            Holdings Ltd is the record holder of the shares reported herein. Na Gai is the sole director
                                            and shareholder of Createcharm Holdings Ltd. As a result, she exercises sole voting and dispositive
                                            power over the shares and accordingly is deemed to be the beneficial owner of such shares.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does
    not include any shares indirectly owned by this individual as a result of his or her partnership interest in Bowen Holding LP as
    such individual does not exercise voting or dispositive power over such shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            shares held by Createcharm Holdings Ltd. of which Na Gai controls and has voting and dispositive
                                            power over such shares.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                            Does not include any shares indirectly owned by each of Jiangang Luo, Jing Lu, Lawrence Leighton,
                                            Wei Li and Jun Zhang, as a result of each holding a partnership interest in Bowen Holding
                                            LP as none of them exercise voting or dispositive power over such shares.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Na
    Gai is the sole director and shareholder of Createcharm Holdings Ltd. As a result, she exercises sole voting and dispositive power
    over susch shares and accordingly is deemed to be the beneficial owner of such shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
    Management LLC is the managing member of Bowen Holding LP and Dahe Zhang is the manager of Bowen Management LLC. As a result,
    Dahe Zhang exercises voting and dispositive power over the shares held by Bowen Holding LP and accordingly is deemed to be the
    beneficial owner of such shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    address of the shareholder is Water&#8217;s Edge Building, 4<sup>th</sup> Floor, Meridian Plaza, Road Town, Tortola VG1110, British
    Virgin Islands. Xiaoqin Lin is the beneficial owner of such shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    shares beneficially owned by Liangwen Wang are registered in the name of Wang Liangwen Investment Holding Co. Ltd. The address of
    the shareholder is Water&#8217;s Edge Building, 4<sup>th</sup> Floor, Meridian Plaza, Road Town, Tortola VG1110, British Virgin Islands.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time at or prior to the Business Combination, during a period when they are not then aware of any material nonpublic information
regarding us or our securities, the Insiders, Bowen, Qianzhi and/or their respective directors, officers, advisors or respective affiliates
may purchase Public Shares from institutional and other investors who vote, or indicate an intention to vote, against any of the proposals
presented at the Shareholder Meeting, or execute agreements to purchase such shares from such investors in the future, or they may enter
into transactions with such investors and others to provide them with incentives to acquire Public Shares or vote their Public Shares
in favor of the proposals presented at the Shareholder Meeting. Such a purchase may include a contractual acknowledgement that such shareholder,
although still the record holder of our shares, is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption
rights. In the event that the Insiders, Bowen, Qianzhi and/or their respective directors, officers, advisors or respective affiliates
purchase Public Shares in privately negotiated transactions from Public Shareholders who have already elected to exercise their redemption
rights, such selling shareholder would be required to revoke their prior elections to redeem their Public Shares. The purpose of such
share purchases and other transactions would be to decrease the number of shares that have been or may be submitted for redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entering
into any such arrangements may have a depressive effect on the market price of Bowen Ordinary Shares. For example, as a result of these
arrangements, an investor or holder may have the ability to effectively purchase shares at a price lower than market and may therefore
be more likely to sell the shares he or she owns, either at or prior to the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement/prospectus, there have been no such discussions and no agreements to such effect have been entered
into with any such investor or holder. If such transactions are effected, the consequence could be to cause the Business Combination
to be consummated in circumstances where such consummation could not otherwise occur. We will file or submit a Form 8-K to disclose any
material arrangements entered into or significant purchases made by any of the aforementioned persons that would affect the vote on the
proposals to be put to the Shareholder Meeting or the redemption threshold. Any such report will include descriptions of any arrangements
entered into or significant purchases by any of the aforementioned persons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any shares were so purchased, the purchaser would not vote any such shares in favor of approval of the Business Combination Proposal.
Additionally, the purchaser would waive any redemption rights with respect to any securities so purchased.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
purchases by the Sponsors and Bowen&#8217;s officers and directors and/or their respective affiliates who are affiliated purchasers under
Rule 10b-18 under the Exchange Act will only be made to the extent such purchases are able to be made in compliance with Rule 10b-18,
which is a safe harbor from liability for manipulation under Section 9(a)(2) and Rule 10b-5 of the Exchange Act. Rule 10b-18 has certain
technical requirements that must be complied with in order for the safe harbor to be available to the purchaser. The Sponsors and Bowen&#8217;s
officers and directors and/or their respective affiliates will not make purchases of shares if the purchases would violate Section 9(a)(2)
or Rule 10b-5 of the Exchange Act. Any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the
extent such purchasers are subject to such reporting requirements. Additionally, in the event the Sponsors or Bowen&#8217;s directors,
officers, advisors or their affiliates were to purchase Public Shares from Public Shareholders, such purchases would be structured in
compliance with the requirements of Rule 14e-5 under the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 246; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->233<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_028"></span>DESCRIPTION
OF SECURITIES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description of the material terms of the securities of New Bowen includes a summary of specified provisions of the Proposed
Charter that will be in effect on the Closing Date and immediately prior to the Effective Time. This description is qualified by reference
to the Proposed Charter, the form of which is attached hereto as <i>Annex D</i>. In this section, the terms &#8220;we&#8221;, &#8220;our&#8221;
or &#8220;us&#8221; refer to New Bowen following the consummation of the Business Combination, and all capitalized terms used in this
section are as defined in the Proposed Charter, unless elsewhere defined herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen is a Cayman Islands exempted company with limited liability and immediately following the consummation of the Business Combination
its affairs will be governed by the Proposed Charter, the Cayman Islands Companies Act, and the common law of the Cayman Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
adoption and approval of the Capitalization Amendment Proposal, New Bowen&#8217;s authorized share capital will consist of US$[25,200]
divided into (i) [250,000,000] Ordinary Shares of US$0.0001 par value each, and (ii) [2,000,000] preferred shares of US$0.0001 par value
each. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Proposed Charter will become effective on the Closing Date and immediately prior to the Effective Time. The following are summaries of
material provisions of the Proposed Charter and the Cayman Islands Companies Act insofar as they relate to the material terms of the
New Bowen Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ordinary
Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of New Bowen&#8217;s issued and outstanding ordinary shares are fully paid and non-assessable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen&#8217;s shareholders who are non-residents of the Cayman Islands may freely hold and vote their ordinary shares. The Proposed Charter
prohibits New Bowen from issuing bearer shares and all New Bowen Ordinary Shares will be issued in registered form, which will be deemed
issued when registered in New Bowen&#8217;s register of members. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen will maintain a register of its members and a shareholder will only be entitled to a share certificate if the board of directors
of New Bowen resolves that share certificates be issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividends</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of New Bowen Ordinary Shares are entitled to receive such dividends as may be declared by the board of directors subject to the
Proposed Charter and the Cayman Islands Companies Act. In addition, New Bowen shareholders may by ordinary resolution declare a dividend,
but no dividend may exceed the amount recommended by the board of directors. Under Cayman Islands law, dividends may be paid only out
of funds which are lawfully available for that purpose. No dividend may be declared and paid unless the board of directors determines
that New Bowen has funds lawfully available for such purpose and that, immediately after the payment out of the share premium account,
New Bowen will be able to pay its debts as they fall due in the ordinary course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
at any meeting of shareholders will be decided by poll and not by way of a show of hands. A poll shall be taken in such manner as the
chairperson of the meeting directs, and the result of the poll shall be deemed to be the resolution of the meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Every
shareholder present at a meeting of shareholders shall have one vote for each share of which he is the holder, unless any Share carries
special voting rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 247; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->234<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
proposals submitted at a meeting shall be decided by an ordinary resolution except where a greater majority is required by the Proposed
Charter or by the Cayman Islands Companies Act. In the case of an equality of votes, the chairperson of the meeting shall be entitled
to a second or casting vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
ordinary resolution to be passed by the shareholders will require a simple majority of votes cast, while a special resolution will require
not less than two-thirds of votes cast, by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed,
by proxy or, in the case of corporations, by their duly authorized representatives, at a general or extraordinary meeting of New Bowen
held in accordance with the Proposed Charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transfer
of Ordinary Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the restrictions contained in the Proposed Charter, the rules or regulations of any stock exchange on which the New Bowen Ordinary
Shares are then listed and any relevant securities laws, New Bowen shareholders may freely transfer all or any of their New Bowen Ordinary
Shares by an instrument of transfer in any usual or common form or in a form prescribed by such stock exchange or in any other form approved
by the board of directors of New Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
the shares in question are not listed on or subject to the rules of a stock exchange, but subject to any rights and restrictions for
the time being attached to any share, the directors of New Bowen may decline to register any transfer of any share which is not fully
paid up or on which New Bowen has a lien. The New Bowen directors may also decline to register any transfer of a share if such transfer
would breach or cause a breach of: (i) the rules of any applicable stock exchange; or (ii) applicable law or regulation. The directors
may also decline to register any transfer of any share unless:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    instrument of transfer is lodged with New Bowen, or the designated transfer agent or share registrar, accompanied by the certificate
    for the shares to which it relates (if any) and such other evidence as the board of directors of New Bowen may reasonably require
    to show the right of the transferor to make the transfer;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    instrument of transfer is in respect of only one class of shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    instrument of transfer is properly stamped, if required;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    the case of a transfer to joint holders, the number of joint holders to whom the share is to be transferred does not exceed four;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    shares transferred are fully paid up and free of any lien in favor of New Bowen; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    fee of such maximum sum as the applicable stock exchange may determine to be payable, or such lesser sum as the board of directors
    of New Bowen may from time to time require, is paid to New Bowen in respect thereof.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the board of directors of New Bowen refuses to register a transfer of any such shares not listed on or subject to the rules of a stock
exchange, they shall, within one month after the date on which the instrument of transfer was lodged, send to each of the transferor
and the transferee notice of such refusal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
New Bowen is wound up, the shareholders may, subject to the Proposed Charter and any other sanction required by the Cayman Companies
Act, pass a special resolution allowing the liquidator to do either or both of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    divide in specie among the shareholders the whole or any part of New Bowen&#8217;s assets and, for that purpose, to value any assets
    and to determine how the division shall be carried out as between the shareholders or different classes of shareholders; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    vest the whole or any part of the assets in trustees for the benefit of shareholders and those liable to contribute to the winding
    up.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 248; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->235<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
directors have the authority to present a petition for our winding up to the Grand Court of the Cayman Islands on our behalf without
the sanction of a resolution passed at a general meeting. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen is a Cayman Islands exempted company incorporated with limited liability, and under the Cayman Islands Companies Act, the liability
of New Bowen&#8217;s members is limited to the amount, if any, unpaid on the shares respectively held by them. The Proposed Charter contains
a declaration that the liability of our members is so limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Calls
on Ordinary Shares and Forfeiture of Ordinary Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors of New Bowen may from time to time make calls upon shareholders for any amounts unpaid on their New Bowen Ordinary
Shares. The New Bowen Ordinary Shares that have been called upon and remain unpaid are, after a notice period, subject to forfeiture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Redemption
of Ordinary Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the provisions of the Cayman Islands Companies Act, New Bowen may issue shares that are to be redeemed or are liable to be redeemed
at the option of the shareholder or New Bowen. The redemption of such shares will be effected in such manner and upon such other terms
as New Bowen may, by the board of directors of New Bowen determine before the issue of such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Variations
of Rights of Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
at any time the share capital of New Bowen is divided into different classes of shares, all or any of the rights attached to any class
(unless otherwise provided by the terms of issue of the shares of that class) may only be materially and adversely varied with the consent
in writing of the holders of at least two-thirds (2/3) of the issued shares of that class, or with the sanction of a special resolution
passed by a majority of not less than two-thirds of the votes cast at a separate meeting of the holders of the shares of that class where
at least one-third (1/3) of the issued shares of that class are present (provided that if at any adjourned meeting of such holders a
quorum as above defined is not present, those shareholders who are present shall form a quorum). </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
Meetings of Shareholders</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen may (but shall not be obliged to, unless required by the applicable rules of an applicable stock exchange or by applicable law)
in each year hold an annual general meeting. The annual general meeting shall be held at such time and place as the board of directors
of New Bowen may determine. At least seven (7) calendar days&#8217; notice shall be given for any general meeting. The chairperson of
the board of directors or the board of directors of New Bowen as a whole may call extraordinary general meetings. Additionally, the board
of directors of New Bowen must convene an extraordinary general meeting upon the requisition of shareholders holding at least [ten per
cent (10%)] of the rights to vote attaching to all issued and outstanding shares of New Bowen that as at the date of the deposit of the
requisition shares carry the right to vote at general meetings of New Bowen. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Inspection
of Books and Records</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our ordinary shares will have no general right under the Cayman Companies Act to inspect or obtain copies of our register of members
or our corporate records.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 249; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->236<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in Share Capital</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the Cayman Companies Act, New Bowen may from time to time by ordinary resolution:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase
    the share capital by new shares of the amount fixed by that ordinary resolution and with the attached rights, priorities and privileges
    set out in that ordinary resolution;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consolidate
    and divide all or any share capital into shares of a larger amount than existing shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sub-divide
    its existing shares or any of them into shares of a smaller amount; provided that in the subdivision the proportion between the amount
    paid and the amount, if any, unpaid on each reduced share will be the same as it was in case of the share from which the reduced
    share is derived; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cancel
    any shares that at the date of the passing of that ordinary resolution have not been taken or agreed to be taken by any person and
    diminish the amount of its share capital by the amount of the shares so cancelled or, in the case of shares without nominal par value,
    diminish the number of shares into which our capital is divided.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the Cayman Companies Act and to any rights for the time being conferred on the shareholders holding a particular class of shares,
New Bowen may by special resolution reduce its share capital in any way. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Anti-Takeover
Provisions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
provisions of the Proposed Charter may discourage, delay or prevent a change of control of New Bowen or management that shareholders
may consider favorable, including provisions that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorize
    New Bowen&#8217;s board of directors to issue preferred shares in one or more series and to designate the price, rights, preferences,
    privileges and restrictions of such preferred shares without any further vote or action by New Bowen shareholders; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limit
    the ability of shareholders to requisition and convene general meetings of shareholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen&#8217;s Proposed Charter requires an ordinary resolution to remove any director and requires a special resolution to amend the
Proposed Charter. These provisions of New Bowen&#8217;s Proposed Charter and Cayman Islands law could delay the ability of shareholders
to change the membership of a majority of its board, force shareholder action to be taken at an annual meeting or an extraordinary general
meeting called by the New Bowen board or on the requisition of the holders of shares carrying at least 10% of the rights to vote at a
shareholder meeting of New Bowen, and in turn delay the ability of shareholders to force consideration of a proposal or take action.
However, under Cayman Islands law, New Bowen&#8217;s directors may only exercise the rights and powers granted to them under the Proposed
Charter for a proper purpose and for what they believe in good faith to be in the best interests of Proposed Charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exempted
Company</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen is an exempted company with limited liability incorporated under the laws of Cayman Islands. A Cayman Islands exempted company:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
    a company that conducts its business mainly outside the Cayman Islands;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
    prohibited from trading in the Cayman Islands with any person, firm or corporation except in furtherance of the business of the exempted
    company carried on outside the Cayman Islands (and for this purpose can effect and conclude contracts in the Cayman Islands and exercise
    in the Cayman Islands all of its powers necessary for the carrying on of its business outside the Cayman Islands);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
                                            not have to file an annual return of its shareholders with the Registrar of Companies of
                                            the Cayman Islands;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
    not have to make its register of members open to inspection by shareholders of that company;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
    not have to hold an annual general meeting;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    obtain an undertaking against the imposition of any future taxation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    register as a limited duration company; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    register as a segregated portfolio company.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 250; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->237<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="bs_029"></span>ENFORCEABILITY
OF CIVIL LIABILITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen is incorporated under the laws of the Cayman Islands. Service of process upon New Bowen and upon its directors and officers named
in this proxy statement/prospectus, may be difficult to obtain within the United States. Furthermore, because substantially all New Bowen&#8217;s
assets are located outside the United States, any judgment obtained in the United States against New Bowen may not be collectible within
the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen has been advised by its Cayman Islands legal counsel that there is uncertainty as to whether the courts of the Cayman Islands would
(i) recognize or enforce judgments of U.S. courts predicated upon the civil liability provisions of the federal securities laws of the
United States or the securities laws of any state in the United States, or (ii) entertain original actions brought in the Cayman Islands
that are predicated upon the federal securities laws of the United States or the securities laws of any state in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen has also been advised by its Cayman Islands legal counsel that although there is no statutory enforcement in the Cayman Islands
of judgments obtained in the federal or state courts of the United States (and the Cayman Islands are not a party to any treaties for
the reciprocal enforcement or recognition of such judgments), a judgment obtained in such jurisdiction will be recognized and enforced
in the courts of the Cayman Islands at common law, without any re-examination of the merits of the underlying dispute, by an action commenced
on the foreign judgment debt in the Grand Court of the Cayman Islands; provided that such judgment (i) is given by a foreign court of
competent jurisdiction, (ii) imposes on the judgment debtor a liability to pay a liquidated sum for which the judgment has been given,
(iii) is final, (iv) is not in the nature of taxes, a fine, or a penalty, and (v) was not obtained in a manner and is not of a kind the
enforcement of which is contrary to natural justice or the public policy of the Cayman Islands. However, the Cayman Islands are unlikely
to enforce a judgment obtained from U.S. courts under civil liability provisions of U.S. securities laws if such judgment is determined
by the courts of the Cayman Islands to give rise to obligations to make payments that are penal or punitive in nature. A Cayman Islands
court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, New Bowen has been advised by its PRC legal counsel that there is uncertainty as to whether courts in mainland China would
(i) recognize or enforce judgments of U.S. courts predicated upon the civil liability provisions of the securities laws of the United
States or any state in the United States, or (ii) entertain original actions brought in mainland China predicated upon the securities
laws of the United States or any state in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Bowen has also been advised by its PRC legal counsel that the recognition and enforcement of foreign judgments are provided for under
the PRC Civil Procedures Law. Courts in mainland China may recognize and enforce foreign judgments in accordance with the requirements,
public policy considerations and conditions set forth in applicable provisions of the laws in mainland China relating to the enforcement
of civil liability, including the PRC Civil Procedures Law, based either on treaties between mainland China and the country where the
judgment is made or on principles of reciprocity between jurisdictions. There exists no treaty or other forms of reciprocity between
mainland China and the United States or the Cayman Islands governing the recognition and enforcement of foreign judgments as of the date
of this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, according to the PRC Civil Procedures Law, courts in mainland China will not enforce a foreign judgment if they decide that
the judgment violates the basic principles of the law in mainland China or national sovereignty, security or public interest. As a result,
it is uncertain whether and on what basis a court in mainland China would enforce a judgment rendered by a court in the United States
or the Cayman Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 251; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->238<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="bs_030"></span>SHARES
ELIGIBLE FOR FUTURE SALE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
will issue 8,646,377 ordinary shares of New Bowen to existing equityholders of Qianzhi in connection with the Business Combination, including
the Earnout Shares. All of the ordinary shares of New Bowen issued in connection with the Business Combination are expected to be freely
transferable by persons other than by Qiznahi&#8217;s &#8220;affiliates&#8221; without restriction or further registration under the
Securities Act, subject to any lock-up or other contractual restrictions. Sales of substantial amounts of the New Bowen ordinary shares
in the public market could adversely affect prevailing market prices of the New Bowen ordinary shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lock-up
Provisions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors and Insider have agreed not to transfer, assign or sell any of the Founder Shares until six months after the completion of Bowen&#8217;s
initial business combination and have agreed not to transfer any Private Units (or underlying securities) until the consummation of Bowen&#8217;s
initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares, IPO Underwriter shares, and Bowen Private Units are entitled to registration rights pursuant to a registration
rights agreement dated July 11, 2023 requiring the New Bowen to register such securities for resale. Subject to certain limitations set
forth in such agreement, the holders of these securities will be entitled to make up to three demands, excluding short form registration
demands, that New Bowen register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights
with respect to registration statements filed subsequent to completion of a Business Combination and rights to require New Bowen to register
for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that New
Bowen will not be required to effect or permit any registration or cause any registration statement to become effective until the securities
covered thereby are released from their lock-up restrictions. New Bowen will bear the expenses incurred in connection with the filing
of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restrictions
on the Use of Rule 144 by Shell Companies or Former Shell Companies</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
144 is not available for the resale of securities initially issued by shell companies (other than business combination related shell
companies) or issuers that have been at any time previously a shell company. However, Rule 144 also includes an important exception to
this prohibition if the following conditions are met:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    issuer of the securities that was formerly a shell company has ceased to be a shell company;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding
    12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC, which is expected to
    be filed promptly after completion of the Business Combination, reflecting its status as an entity that is not a shell company.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement/prospectus, there are 9,166,500 Bowen Ordinary Shares outstanding. Of these shares, 6,900,000 shares
sold in the initial public offering of Bowen are freely tradable without restriction or further registration under the Securities Act,
except for any shares purchased by one of our affiliates within the meaning of Rule 144 under the Securities Act. All of the remaining
2,266,500 shares owned collectively by the Sponsors and the IPO Underwriter are restricted securities
under Rule 144, in that they were issued in private transactions not involving a public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement/prospectus, there are a total of 726,150 Bowen Rights outstanding, consisting of 690,000 Public Rights
and 36,150 Private Rights. Each Bowen Right is convertible into 1/10<sup>th</sup> of one ordinary share upon the consummation of the
Business Combination, in accordance with the terms of the Rights Agreement. The Public Rights and are freely tradable, except for any
Public Rights purchased by one of our affiliates within the meaning of Rule 144 under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 252; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->239<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_031"></span>APPRAISAL
RIGHTS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Bowen Ordinary Shares are not entitled to appraisal rights in connection with the Business Combination under the Companies Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_032"></span>HOUSEHOLDING
INFORMATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
Bowen has received contrary instructions, Bowen may send a single copy of this proxy statement/prospectus to any household at which two
or more shareholders reside if Bowen believes the shareholders are members of the same family. This process, known as &#8220;householding&#8221;,
reduces the volume of duplicate information received at any one household and helps to reduce Bowen&#8217;s expenses. However, if shareholders
prefer to receive multiple sets of Bowen&#8217;s disclosure documents at the same address this year or in future years, the shareholders
should follow the instructions described below. Similarly, if an address is shared with another shareholder and together both of the
shareholders would like to receive only a single set of Bowen&#8217;s disclosure documents, the shareholders should follow these instructions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    the shares are registered in the name of the shareholders, the shareholders should contact Bowen at its offices at Bowen Acquisition
    Corp, 420 Lexington Avenue, Suite 2446, New York, NY 10170, to inform Bowen of his or her request; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    a bank, broker or other nominee holds the stock, the shareholders should contact the bank, broker or other nominee directly.</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_033"></span>TRANSFER
AGENT AND REGISTRAR</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent for shares of New Bowen Ordinary Shares upon closing of the Business Combination will be Continental Stock Transfer &amp;
Trust Company, 1 State Street, 30th Floor, New York, New York 10004.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_034"></span>SUBMISSION
OF PROPOSALS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bowen Board knows of no matter other than those described herein that will be presented for consideration at the Shareholder Meeting.
However, should any other matters properly come before the Shareholder Meeting or any adjournments or postponements thereof, it is the
intention of the person(s) named in the accompanying proxy to vote in accordance with their best judgment in the interests of Bowen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_035"></span>FUTURE
PROPOSALS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Business Combination is consummated and New Bowen holds a 2024 annual general meeting of shareholders, it will provide notice of
or otherwise publicly disclose the date on which the 2024 annual meeting will be held. Following completion of the Business Combination,
New Bowen is expected to qualify as a &#8220;foreign private issuer&#8221; under the rules and regulations of the SEC. As a foreign private
issuer, New Bowen expects to be exempt from certain rules under the Exchange Act that would otherwise apply if it were a company incorporated
in the United States or did not meet the other conditions to qualify as a foreign private issuer, including the requirement to file proxy
solicitation materials on Schedule 14A in connection with annual or special meetings of its security holders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_036"></span>WHERE
YOU CAN FIND MORE INFORMATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
files reports, proxy statements and other information with the SEC as required by the Exchange Act. You may access information filed
on Bowen at the SEC website, which contains reports, proxy statements and other information, at: <i>www.sec.gov.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement/prospectus is available without charge to Bowen&#8217;s shareholders upon written or oral request. If you would like
additional copies of this proxy statement/prospectus or if you have questions about the Business Combination or the proposals to be presented
at the Shareholder Meeting, you should contact Bowen in writing at Bowen Acquisition Corp, 420 Lexington Avenue, Suite 2446, New York,
NY 10170, or by telephone at (203) 998-5540.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you have questions about the proposals or this proxy statement/prospectus, would like additional copies of this proxy statement/prospectus,
or need to obtain proxy cards or other information related to the proxy solicitation, please contact Laurel Hill Advisory Group, Bowen&#8217;s
proxy solicitor, by calling [X] (toll-free), or banks and brokers can call [X], or by emailing [X]. You will not be charged for any of
the documents that you request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 253; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->240<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
obtain timely delivery of the documents, you must request them no later than five business days before the date of the meeting, or no
later than [&#9679;], 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
and statements contained in this proxy statement/prospectus or any annex to this proxy statement/prospectus are qualified in all respects
by reference to the copy of the relevant contract or other annex filed as an exhibit to this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
information contained in this document relating to Bowen has been supplied by Bowen and all such information relating to NewCo and Qianzhi
has been supplied by Qianzhi. Information provided by Bowen or Qianzhi does not constitute any representation, estimate or projection
of the other.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document is a proxy statement/prospectus of Bowen for the Shareholder Meeting. Bowen has not authorized anyone to give any information
or make any representation about the Business Combination, Bowen or Qianzhi that is different from, or in addition to, that contained
in this proxy statement/prospectus. Therefore, if anyone does give you information of this sort, you should not rely on it. The information
contained in this proxy statement/prospectus speaks only as of the date of this document unless the information specifically indicates
that another date applies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_037"></span>LEGAL
MATTERS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ogier,
Cayman Islands will pass upon the validity of the Bowen Ordinary Shares to be issued in connection with the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_038"></span>EXPERTS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements of Bowen Acquisition Corp as of December 31, 2023 and for the period from February 17, 2023 (inception) to December
31, 2023 included in this proxy statement/prospectus have been audited by UHY LLP, an independent registered public accounting firm,
as set forth in their report appearing elsewhere herein, and included in reliance upon such report given on the authority of such firm
as experts in accounting and auditing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements of Qianzhi Group Holding (Cayman) Limited as of March 31, 2024 and 2023 and for the years
then ended have been audited by Simon &amp; Edward, LLP, an independent registered public accounting firm, as set forth in their report
appearing elsewhere herein. Such consolidated financial statements have been so included in reliance upon such report given on the authority
of such firm as experts in accounting and auditing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_039"></span>SHAREHOLDER
COMMUNICATIONS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
and interested parties may communicate with the Bowen Board, any committee chairperson or the non-management directors as a group by
writing to the board or committee chairperson in care of Bowen Acquisition Corp, 420 Lexington Avenue, Suite 2446, New York, NY 10170,
Attention: Corporate Secretary. Following the Business Combination, such communications should be sent in care of New Bowen, 1705, Block
B, KK 100 Building, 5016 East Shennan Road, Luohu District, Shenzhen, Guangdong Province, 518000 People&#8217;s
Republic of China, Attention: Corporate Secretary. Each communication will be forwarded, depending on the subject matter, to the Bowen
Board, the New Bowen Board, the appropriate committee chairperson or all non-management directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 254; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->241<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_040"></span>INDEX
TO FINANCIAL STATEMENTS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_001">Condensed
    Consolidated Balance Sheets as of June 30, 2024 (Unaudited) and March 31, 2024</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_002">Unaudited
    Condensed Consolidated Statements of Operation and Comprehensive (Loss) Income for the Three Months Ended June
30, 2024 and 2023</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</span>3</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_003">Unaudited
    Condensed Consolidated Statements of Changes in Shareholders&#8217; Equity for the Three Months Ended June 30, 2024 and 2023</a> </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</span>4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_004">Unaudited
    Condensed Consolidated Statements of Cash Flows for the Three Months Ended June 30, 2024 and 2023</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</span>5</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_005">Notes to Unaudited Condensed Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</span>6</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 255; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ak_001"></span><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March
    31, 2024</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">(Unaudited)</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: -30pt; font-weight: bold; text-align: center">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">CURRENT ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify; padding-left: 10pt">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,497,989</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">4,832,079</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt">Prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 10pt">Accounts receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,133</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,871</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt">Account receivables &#8211; related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74,643</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 10pt">Inventories, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">306,961</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">361,311</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt">Advances to suppliers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">220,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197,576</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 10pt">Other receivables &#8211; related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">912,052</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">68,086</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt">Loans to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">289,266</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">449,085</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">TOTAL CURRENT ASSETS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,320,242</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,930,008</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
held in trust account</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 10pt">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">514,947</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">553,059</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt">Right-of-use lease assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">540,702</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">599,088</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Deposit and other assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">626,892</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">630,975</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Total non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">TOTAL ASSETS</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,002,783</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,713,130</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: center">LIABILITIES AND EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">CURRENT LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt">Short-term loans</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">110,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">69,249</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt">Current portion of long-term loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 10pt">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,692</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">525,266</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt">Contract liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">234,876</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">372,295</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 10pt">Taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">435,407</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">507,071</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt">Other payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">89,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">156,159</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 10pt">Other payables &#8211; related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">315,579</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt">Other current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">166,406</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">229,340</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Operating lease liability, current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">214,596</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">213,490</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-left: 10pt">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-left: 10pt">TOTAL CURRENT LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,295,858</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,388,449</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Long-term loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Operating lease liability, noncurrent</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">299,200</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">354,178</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">TOTAL LIABILITIES</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,595,058</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,742,627</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">COMMITMENTS AND CONTINGENCIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Ordinary shares subject to possible redemption (6,900,000 shares at $10.35 per share)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Ordinary shares, $1.00 par value, 50,000 shares authorized, 50,000 shares issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Preferred shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt">Additional paid in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,034,392</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,034,392</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 10pt">Statutory reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">461,228</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">461,228</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt">Retained earnings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,434,528</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,959,784</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Accumulated other comprehensive loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(572,423</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(534,901</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">TOTAL SHAREHOLDERS&#8217; EQUITY</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,407,725</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,970,503</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">TOTAL LIABILITIES AND EQUITY</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,002,783</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,713,130</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 256; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ak_002"></span><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATION AND COMPREHENSIVE (LOSS) INCOME</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June
    30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; font-weight: bold; text-align: left">REVENUE, NET</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,665,658</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">751,246</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Cost of revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(123,621</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(124,499</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Promotion cost</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(561,675</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(532,560</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">GROSS PROFIT</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">980,362</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">94,187</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">OPERATING EXPENSES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Selling and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">528,211</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,767</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">917,199</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,019,034</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,464</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,475</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,461,874</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,035,276</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">LOSS FROM OPERATIONS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(481,512</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(941,089</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">OTHER INCOME (EXPENSES)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">959</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,767</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(821</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,513</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Government subsidies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,512</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,289</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Interest earned on investments held in trust account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(36,929</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18,769</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other (loss) income, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(27,279</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,774</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">LOSS BEFORE INCOME TAX PROVISION</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(508,791</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(937,315</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">INCOME TAX PROVISION</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(16,465</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,137</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">NET LOSS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(525,256</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(943,452</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">OTHER COMPREHENSIVE INCOME</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total foreign currency translation adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(37,522</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(306,056</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">COMPREHENSIVE LOSS</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(562,778</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,249,508</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">LOSS PER SHARE</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10.51</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(18.87</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">50,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">50,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; display: none; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excludes
    an aggregate of up to 225,000 ordinary shares subject to forfeiture depending on the extent to which the over-allotment option is
    exercised by the underwriters (see Notes 5 and 7). On July 17, 2023, the underwriters fully exercised the over-allotment option.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white">&#160;</p>

<!-- Field: Page; Sequence: 257; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ak_003"></span><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE MONTHS ENDED JUNE 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">reserve</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">earnings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">loss</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Additional paid-in</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Statutory</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Retained</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated
                                            other comprehensive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">reserve</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">earnings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">loss</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; width: 37%">Balance at March 31, 2023</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 5%; font-weight: bold; text-align: right">50,000</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">50,000</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">3,034,392</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">341,044</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">2,778,142</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">(204,749</td><td style="width: 1%; font-weight: bold; text-align: left">)<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="width: 2%; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">5,998,829</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(943,452</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(943,452</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency translation adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(306,056</td><td style="padding-bottom: 1.5pt; text-align: left">)<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(306,056</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at June 30, 2023</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">50,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">50,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,034,392</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">341,044</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,834,690</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(510,805</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,749,321</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Additional paid-in</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Statutory</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Retained</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated
                                            other comprehensive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">reserve</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">earnings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">loss</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; width: 37%">Balance at March 31, 2024</td><td style="font-weight: bold; width: 2%">&#160;</td>
    <td style="font-weight: bold; text-align: left; width: 1%">&#160;</td><td style="font-weight: bold; text-align: right; width: 5%">50,000</td><td style="font-weight: bold; text-align: left; width: 1%">&#160;</td><td style="font-weight: bold; width: 2%">&#160;</td>
    <td style="font-weight: bold; text-align: left; width: 1%">$</td><td style="font-weight: bold; text-align: right; width: 5%">50,000</td><td style="font-weight: bold; text-align: left; width: 1%">&#160;</td><td style="font-weight: bold; width: 2%">&#160;</td>
    <td style="font-weight: bold; text-align: left; width: 1%">$</td><td style="font-weight: bold; text-align: right; width: 5%">3,034,392</td><td style="font-weight: bold; text-align: left; width: 1%">&#160;</td><td style="font-weight: bold; width: 2%">&#160;</td>
    <td style="font-weight: bold; text-align: left; width: 1%">$</td><td style="font-weight: bold; text-align: right; width: 5%">461,228</td><td style="font-weight: bold; text-align: left; width: 1%">&#160;</td><td style="font-weight: bold; width: 2%">&#160;</td>
    <td style="font-weight: bold; text-align: left; width: 1%">$</td><td style="font-weight: bold; text-align: right; width: 5%">1,959,784</td><td style="font-weight: bold; text-align: left; width: 1%">&#160;</td><td style="font-weight: bold; width: 2%">&#160;</td>
    <td style="font-weight: bold; text-align: left; width: 1%">$</td><td style="font-weight: bold; text-align: right; width: 5%">(534,901</td><td style="font-weight: bold; text-align: left; width: 1%">)</td><td style="font-weight: bold; width: 2%"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font-weight: bold; text-align: left; width: 1%">$</td><td style="font-weight: bold; text-align: right; width: 5%">4,970,503</td><td style="font-weight: bold; text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(525,256</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(525,256</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency translation adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(37,522</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(37,522</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at June 30, 2024</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">50,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">50,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,034,392</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">461,228</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,434,528</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(572,423</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,407,725</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 258; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ak_004"></span><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June
    30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(525,256</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(943,452</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Adjustments to reconcile net loss to cash used in operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,655</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,654</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Amortization of operating lease right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54,696</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,907</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Interest reinvested held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Reserve for sales return</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Disposal and acquiring of noncontrolling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Loss on disposal of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Accounts receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,605</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,147</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Account receivables &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(74,884</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(366,713</td><td style="text-align: left">)</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accrued offering costs and expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accrued expenses - related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Prepaid Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,186</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,465</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Advance to suppliers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">370,187</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">47,244</p></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Other receivables &#8211; related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,253,358</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,870,734</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Loans to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,331</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(235,042</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,775,436</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Deposit and other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,417</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(517,851</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(613,468</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Contract liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(135,452</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(463,629</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(68,613</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(307,799</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Other payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(65,680</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,370</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Other payables &#8211; related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">122,253</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">457,166</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(50,371</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(59,037</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(61,844</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,111</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,351,758</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,903,210</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Purchase of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(567</td><td style="text-align: left">)</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Investments of cash into Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(567</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Proceeds from short-term loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,415</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Proceeds from long-term loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Repayment of short-term loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Repayment of long-term loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,331</td><td style="text-align: left">)</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Proceeds from shareholders&#8217; contribution</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Payment for acquisition of noncontrolling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Proceeds from issuance of founder shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Proceeds from sale of ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Proceeds from Private Placement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Payments of underwriter&#8217;s discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Payments to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Payment of offering costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash provided by (used in) financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">41,415</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28,331</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Effect of changes of foreign exchange rates on cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(23,747</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(180,489</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Net decrease in cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,334,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,112,597</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cash, beginning of year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,832,079</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,836,946</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash, end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,497,989</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,724,349</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Supplemental disclosure of cash flow information</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Cash paid for interest expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">821</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Cash paid for income tax</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">97,477</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">49,416</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 259; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_005"></span>NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE
1. ORGANIZATION AND BUSINESS DESCRIPTION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Business</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
Group Holding (Cayman) Limited (&#8220;NewCo&#8221; or the &#8220;Company&#8221;), through its subsidiaries located in the People&#8217;s
Republic of China (&#8220;PRC&#8221;), is a health and wellness focused biotech company and an early adopter and developer of plant-based
and ozonated products for antibacterial, skincare, gynecological and andrological applications.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Organizations</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NewCo
was incorporated under the laws of the Cayman Islands on August 14, 2023 as an exempt company with limited liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NewCo
owns 100% equity interest of Qianzhi Investment Holding Co., Ltd (&#8220;Qianzhi BVI&#8221;), an entity incorporated on August 31, 2023
in accordance with the laws and regulations in the British Virgin Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
BVI owns 100% equity interest of Hong Kong Qianzhi Investment Holding Co., Ltd (&#8220;Qianzhi HK&#8221;), an entity incorporated on
September 27, 2023 in accordance with the laws and regulations in Hong Kong.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
HK owns 100% equity interest of Shenzhen Shian Biotechnology Co., Ltd. (&#8220;Shenzhen Shian&#8221;), an entity formed on November 23,
2023, as a Wholly Foreign-Owned Enterprise (&#8220;WFOE&#8221;) in the People&#8217;s Republic of China (&#8220;PRC&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NewCo,
Qianzhi BVI, Qianzhi HK and Shenzhen Shian are currently not engaging in any active business operations and merely acting as holding
companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the reorganization described below, Ms. Xiaoqin Lin, the chairman of the board of directors and the chief executive officer of the
Company, was the controlling shareholder of Shenzhen Qianzhi Biotechnology Co., Ltd. (&#8220;Qianzhi Biotechnology&#8221;), an entity
incorporated on March 20, 2007 in accordance with PRC laws. Qianzhi Biotechnology owns 100% of the equity interests of the following
subsidiaries: (1) Hubei Qianzhi Biotechnology Co., Ltd. (&#8220;Hubei Qianzhi&#8221;) was incorporated on February 20, 2019 in Ezhou
City, Hubei Province in accordance with PRC laws; (2) Shenzhen Qianzhi Health Management Co., Ltd. (&#8220;Qianzhi Health&#8221;) was
incorporated on May 5, 2019 in accordance with PRC laws; (3) Jiangxi Qianzhi Biotechnology Co., Ltd. (&#8220;Jiangxi Qianzhi&#8221;)
was incorporated on June 12, 2019 in Jiujiang City, Jiangxi Province in accordance with PRC laws, and (4) Shenzhen Qianzhi Biotech Co.,
Ltd. (&#8220;Qianzhi Biotech&#8221;) was incorporated on July 2, 2019 in accordance with PRC laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Qianzhi Biotechnology also owns 51% equity interest in Zhishang Zhimei (Shenzhen) Brand Planning Consulting Co., Ltd. (&#8220;Zhishang
Zhimei&#8221;), an entity incorporated on August 13, 2019 and deregistered on October 12, 2022 in accordance with PRC laws. As Zhishang
Zhimei had no operating activity and no material assets, the deregister of Zhishang Zhimei did not constitute discontinued operation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
Biotechnology, together with its subsidiaries are collectively referred to as the &#8220;Qianzhi Operating Companies&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reorganization</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reorganization of legal structure (&#8220;Reorganization&#8221;) was completed on December 27, 2023. The reorganization involved the
incorporation of NewCo, Qianzhi BVI, Qianzhi HK and Shenzhen Shian, and the transfer of the 100% equity interest of Qianzhi Biotechnology
to Shenzhen Shian. Consequently, NewCo, through its subsidiaries Qianzhi BVI and Qianzhi HK, directly controls Shenzhen Shian and Qianzhi
Biotechnology, and became the ultimate holding company of all other entities mentioned above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 260; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reorganization has been accounted for as a recapitalization among entities under common control since the same controlling shareholders
controlled all these entities before and after the Reorganization. The consolidation of the Company and its subsidiaries has been accounted
for at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the
first period presented in the accompanying unaudited condensed consolidated financial statements. Results of operations for the periods
presented comprise those of the previously separate entities combined from the beginning of the period to the end of the period, eliminating
the effects of intra-entity transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the completion of the Reorganization, the Company has subsidiaries in countries and jurisdictions in the PRC, and Hong Kong. Details
of the subsidiaries of the Company as of June 30, 2024 were set out below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="display: none">SUMMARY OF THE SUBSIDIARIES OF THE COMPANY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Name of Entity</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date of Incorporation</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place of Incorporation</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal Activities</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">NewCo</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
                                            14, 2023</span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">Cayman Islands</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent,
                                            100%</span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">Investment holding</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; width: 19%; text-align: left">Qianzhi BVI</td><td style="text-align: center; width: 2%; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; width: 1%; text-align: center">&#160;</td><td style="vertical-align: top; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
                                            31, 2023</span></td><td style="vertical-align: top; width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 2%; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; width: 14%; text-align: center">British Virgin Islands</td><td style="text-align: center; width: 2%; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; width: 1%; text-align: center">&#160;</td><td style="vertical-align: top; width: 14%; text-align: center">100%</td><td style="vertical-align: top; width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 2%; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; width: 25%; text-align: center">Investment holding</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left">Qianzhi HK</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
                                            27, 2023</span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">Hong Kong</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center">100%</td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">Investment holding</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left">Shenzhen Shian</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
                                            23, 2023</span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">PRC</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center">100%</td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">WFOE, Investment holding</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-weight: bold; text-align: left">Qianzhi Operating Companies:</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left">Qianzhi Biotechnology</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
                                            20, 2007</span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">PRC</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center">100%</td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">General administration and sales of the Company&#8217;s products to customers</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left">Hubei Qianzhi</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
                                            20, 2019</span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;PRC</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center">100%</td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">Research, development and manufacturing of product</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left">Qianzhi Health</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
                                            5, 2019</span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;PRC</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center">100%</td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">Sales of product</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left">Jiangxi Qianzhi</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
                                            12, 2019</span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;PRC</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center">100%</td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">Sales of product</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left">Qianzhi Biotech</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
                                            2, 2019</span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;PRC</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center">100%</td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">Sales of product</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE
2 &#8212; <span>LIQUIDITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company&#8217;s </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unaudited condensed <span style="background-color: white">consolidated
financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of
liabilities and commitments in the normal course of business. The Company incurred net loss of $<span style="background-color: white">525,256</span>, and cash used in operating activities
was $2,489,807 for the three months ended June 30, 2024. As of June 30, 2024, the Company has a working capital of $2,886,779.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
assessing its liquidity, management monitors and analyzes the Company&#8217;s cash, its ability to generate sufficient revenue
sources in the future, and its contractual obligations. As of June 30, 2024, the Company had cash of $2,360,384 and outstanding bank
loan of $110,084. The Company believes that its current cash, cash from sales growth, repayment of receivables from related parties
and borrowings from banks will be sufficient to meet its working capital needs for at least 12 months from the date of this
report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Basis
of Presentation and Principles of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally
accepted in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information pursuant to the rules and regulations
of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Accordingly, they do not include all of the information and footnotes
required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements should be read in
conjunction with the Company&#8217;s consolidated financial statements and the notes thereto for the year ended March 31, 2024 included
in the Form S-4. Operating results for the three months ended June 30, 2024 are not necessarily indicative of the
results that may be expected for the fiscal year ending March 31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Reclassifications</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
amounts on the prior-years&#8217; consolidated balance sheets, consolidated statements of operations and cash flows were reclassified
to conform to current-year presentation, with no effect on ending stockholders&#8217; equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Uses
of estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
preparing the unaudited condensed consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited
condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. These estimates
are based on information as of the date of the unaudited condensed consolidated financial statements. Significant estimates required
to be made by management include, but are not limited to, the estimated current credit losses on financial assets, realizability of advances
to suppliers, inventory valuations, useful lives of property and equipment, the recoverability of long-lived assets, revenue recognition
and realization of deferred tax assets. Actual results could differ from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 261; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Risks
and Uncertainties</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
main operation of the Company is located in the PRC. Accordingly, the Company&#8217;s business, financial condition, and results of operations
may be influenced by political, economic, and legal environments in the PRC, as well as by the general state of the PRC economy. The
Company&#8217;s results may be adversely affected by changes in the political, regulatory and social conditions in the PRC. Although
the Company has not experienced losses from these situations and believes that it is in compliance with existing laws and regulations
including its organization and structure disclosed in Note 1, this may not be indicative of future results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
development and commercialization of personal hygiene and disinfectant products is highly competitive, and the industry currently is
characterized by rapidly changing technologies, significant competition and a strong emphasis on intellectual property. The Company may
face competition with respect to its current and future personal hygiene and disinfectant product candidates from major personal care
companies in China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s business, financial condition and results of operations may also be negatively impacted by risks related to natural disasters,
extreme weather conditions, health epidemics and other catastrophic incidents, which could significantly disrupt the Company&#8217;s
operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Cash</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
includes currency on hand and deposits held by banks that can be added or withdrawn without limitation. The Company maintains cash with
financial institutes, such as banks, in the PRC. In China, a depositor has up to RMB500,000 insured by the People&#8217;s Bank of China
Financial Stability Bureau (&#8220;FSD&#8221;). As of June 30, 2024 and March 31, 2024, $656,464 and $2,961,187 of the Company&#8217;s
cash held by financial institutions were uninsured, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Accounts
receivable</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivables are presented net of allowance for doubtful accounts. The Company uses the current expected credit losses model to determine
credit-related impairment losses for financial instruments held at amortized cost and to estimate these expected credit losses over the
life of an exposure (or pool of exposures). The estimate of expected credit losses considers both historical and current information,
reasonable and supportable forecasts, as well as estimates of prepayments. The estimated credit losses and subsequent adjustment to such
loss estimates are recorded through an allowance account which is deducted from the amortized cost of the financial instrument, with
the offset recorded in current earnings. Delinquent account balances are written-off against the allowance for doubtful accounts after
management has determined that the collection is not probable. As of June 30, 2024 and March 31, 2024, there was no allowance recorded
as the Company determined that all of the accounts receivable are fully collectible.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Advances
to suppliers</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
to suppliers mainly represent prepayments made to ensure continuous high-quality supplies and favorable purchase prices of third-party
products and raw materials. These advances are directly related to the purchases of third-party products and raw materials used to fulfill
sales orders. The Company is required from time to time to make cash advances when placing its purchase orders. These advances are settled
upon suppliers delivering third-party products and raw materials to the Company when the transfer of ownership occurs. The Company reviews
its advances to suppliers on a periodic basis and makes general and specific allowances when there is doubt as to the ability of a supplier
to provide supplies to the Company or refund an advance. As of June 30, 2024 and March 31, 2024, no allowance for advances to suppliers
was deemed necessary, as the Company believes that all advances to suppliers are fully realizable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Inventories, net</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
are stated at lower of cost or net realizable value using weighted average method. Costs include the cost of raw materials, freight,
direct labor and related production overhead, as well as procurement cost of third-party products. Any excess of the cost over the net
realizable value of each item of inventories is recognized as a provision for diminution in the value of inventories. Net realizable
value is the estimated selling price in the normal course of business less any costs to complete and sell products. The Company evaluates
inventories on a quarterly basis for its net realizable value adjustments, and reduces the carrying value of those inventories that are
obsolete or in excess of the forecasted usage to their estimated net realizable value based on various factors including aging, expiration
dates, as applicable, taking into consideration historical and expected future product sales. The Company performs physical stocktaking
quarterly and writes off obsolete inventories to the cost of revenue account. Obsolete inventories in the amount of $2,354 and $54,079
were written-off during the three months ended June 30, 2024 and 2023, respectively. As of June 30, 2024 and March 31, 2024, the company
has no slow-moving, obsolete, or damaged inventories and thus no inventory reserve deemed necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 262; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Fair
value of financial instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The
hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of
inputs used to measure fair value are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1&#8201;&#8212;&#8201;inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in
    active markets.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2&#8201;&#8212;&#8201;inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets,
    quoted market prices for identical or similar assets in markets that are not active, inputs other than quoted prices that are observable
    and inputs derived from or corroborated by observable market data.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3&#8201;&#8212;&#8201;inputs to the valuation methodology are unobservable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise disclosed, the fair value of the Company&#8217;s financial instruments, including cash, accounts receivable, inventories, advances
to suppliers, other receivables &#8211; related parties, other current assets, short-term bank loans, accounts payable, other payables
&#8211; related parties, taxes payable, contract liabilities, other current liabilities, approximate the fair value of the respective
assets and liabilities as of June 30, 2024 and March 31, 2024 based upon the short-term nature of the assets and liabilities. The fair
value of operating lease liabilities approximates their recorded values as their stated interest rates approximate the rates currently
available in the market the Company could obtain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Property
and equipment, net</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization of property and equipment
is provided using the straight-line method over their expected useful lives, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT EXPECTED USEFUL LIVES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    life</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery
    and equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1&#8211;10
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    equipment and furniture</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2&#8211;5
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Automobiles</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2&#8211;4
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    improvement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shorter
    of remaining lease term or 5 years</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures
for maintenance and repairs, which do not materially extend the useful lives of the assets, are charged to expense as incurred. Expenditures
for major renewals and betterments which substantially extend the useful life of assets are capitalized. The cost and related accumulated
depreciation of assets retired or sold are removed from the respective accounts, and any gain or loss is recognized in the unaudited
condensed consolidated statements of income and other comprehensive income in other income or expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Impairment
of long-lived Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets, such as property and equipment and intangible assets, are reviewed for impairment when events or changes in circumstances indicate
that the carrying value of such assets may not be recoverable. Recoverability of a long-lived asset or asset group to be held and used
is measured by a comparison of the carrying amount of an asset or asset group to the estimated undiscounted future cash flows expected
to be generated by the asset or asset group. If the carrying value of an asset or asset group exceeds its estimated undiscounted future
cash flows, an impairment charge is recognized by the amount that the carrying value exceeds the estimated fair value of the asset or
asset group. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values
and third-party independent appraisals, as considered necessary. Assets to be disposed are reported at the lower of carrying amount or
fair value less costs to sell, and are no longer depreciated. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 263; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Revenue
recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
determine revenue recognition for contracts with customers, the Company performs the following five steps : (i) identify the contract(s)
with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable
consideration to the extent that it is probable that a significant future reversal will <i>not</i> occur, (iv) allocate the transaction
price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance
obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered sales contracts with various individuals and/or companies. Pursuant to sales contracts entered, the Company is to provide
the required personal care or other products to its customers without a right of return. Most customers are required to make full advance
payment to the Company upon signing the contract, and send the purchase order within ten days. The Company shall deliver the ordered
personal care or other products within seven days after receiving of purchase order and advance payment, and the delivery expense is
borne by the customers. The customer shall inspect the quantity and quality of the products received timely and notify any noncompliance
to the Company on the day of receipt, and no return will be grant after customers&#8217; acceptances. The Company may grant certain sales
returns from time to time exclusively under management&#8217;s discretion, which results 1% of total sales reserved for the potential
sales return based on historical experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when it transfers its goods and services to customers in an amount that reflects the consideration to which
the Company expects to be entitled in such exchange. The Company accounts for revenue generated from sales of its products on a gross
basis, as the Company is acting as a principal in these transactions, is subject to inventory risk, has latitude in establishing prices,
and is responsible for fulfilling the promise to provide customers the specified goods, which the Company has control of the goods and
has the ability to direct the use of goods to obtain substantially all the benefits. All of the Company&#8217;s contracts have one single
performance obligation, namely, the promise is to transfer the individual goods to customers, and there is no separately identifiable
other promise in the contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s revenue is recognized at a point in time when title and risk of loss passes and customers inspect and accept the goods,
which generally occurs at day of delivery. Revenue is reported net of after sales discount and return reserve and all value added taxes
(&#8220;VAT&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company pays promotional costs to the organizer of the Company&#8217;s sales campaigns which is in line with revenue and would not have
incurred if the contract had not been obtained. The Company determined the promotional costs as incremental costs of obtaining a contract
and applies a practical expedient to expense costs when incurred when the amortization period of the asset that the entity otherwise
would have recognized is one year or less. The Company does not incur significant additional costs to secure contracts with customers,
except for promotional expenses, that are expected to provide benefits lasting longer than one year, which must be recognized as assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Disaggregation
of revenue</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company disaggregates its revenue from contracts by product types, as the Company believes it best depicts how the nature, amount, timing
and uncertainty of the revenue and cash flows are affected by economic factors. The following table identifies the disaggregation of
its revenue for the three months ended June 30, 2024 and 2023, respectively:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the Three Months Ended June 30,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sales
    of self-manufactured products</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
    from sales of ozone sterilization products</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">926,955</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">351,497</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
    from sales of hypochlorite disinfection products</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,053</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,896</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sales
    of third-party products purchased</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
    from sales of cosmetic products</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">273,759</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">202,521</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
    from sales of prepackaged food</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">386,484</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,902</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
    from sales of other products</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,407</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,430</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    revenue, net</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,665,658</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">751,246</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 264; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Contract
Liabilities</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contract liabilities primarily relate to unsatisfied performance obligations when payments have been received from customers
before the Company&#8217;s products are delivered. Costs of fulfilling customers&#8217; purchase orders, such as shipping, handling and
delivery, which occur prior to the transfer of control, are recognized in selling, general and administrative expense when incurred.
Contract liabilities amounted to $234,876 and $372,295 as of June 30, 2024 and March 31, 2024, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Cost
of revenue</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenue consists primarily of the costs of finished goods manufactured and/or procurement cost of third-party products, freight charges,
depreciation of property and machinery and warehousing expenses. Cost of revenue also includes incremental costs of obtaining sales contract,
which are mainly promotion cost paid to organizers of the Company&#8217;s sales campaigns in the amount in-line with sales revenue realized
at those sales campaigns. The Company uses practical expedient to expense the incremental costs when incurred on the same period sales
revenue realized even though the service agreement executed within one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Research
and development expenses</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expenses all internal research and development costs as incurred, which primarily comprise employee costs, material costs related
to execution of studies, depreciation of equipment used in the research and development activities and research and development service
expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Selling,
General and Administrative Expenses</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
expenses represents primarily costs of payroll and benefits costs for sales team, business travel and meals expenses, as well as marketing
expenses. General and administrative expenses represent primarily payroll and benefits costs for administrative employees, rent and operating
costs of office premises, depreciation and amortization of office facilities, professional fees and other administrative expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Government
subsidies</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
subsidy income primarily relate to government&#8217;s cash award to local companies to promote entrepreneurship, stimulate local economies
and overcome COVID-19 outbreak. Such awards are granted on a case-by-case basis by local government.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes government subsidies as other operating income upon receipt if the subsidies are not subject to any past or future
conditions, there are no performance conditions or conditions of use, and not subject to future refunds. For certain government subsidies
provided to the Company during the COVID-19 epidemic depending on the actual use of the Company&#8217;s warehouse, the amount received
was recognized as other income over the contract term. Government subsidies recognized as other operating income totaled $9,512 and $22,289
for the three months ended June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Segment
Reporting</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the management approach in determining reportable operating segments. The management approach considers the internal reporting
used by the Company&#8217;s chief operating decision maker for making operating decisions about the allocation of resources of the segment
and the assessment of its performance in determining the Company&#8217;s reportable operating segments. Management has determined that
the Company has one operating segment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 265; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Income
taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for current income taxes in accordance with the laws of the relevant tax authorities. Deferred income taxes are recognized
when temporary differences exist between the tax bases of assets and liabilities and their reported amounts in the unaudited condensed
consolidated financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in tax rates is recognized in income in the period including the enactment date. Valuation allowances are established,
when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
uncertain tax position is recognized only if it is &#8220;more likely than not&#8221; that the tax position would be sustained in a tax
examination. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination.
For tax positions not meeting the &#8220;more likely than not&#8221; test, no tax benefit is recorded. Penalties and interest incurred
related to underpayment of income tax are classified as income tax expense in the period incurred. No significant penalties or interest
relating to income taxes have been incurred during the three months ended June 30, 2024 and 2023. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s subsidiaries in China are subject to the income tax laws of the PRC. No significant income was generated outside the
PRC for the three months ended June 30, 2024 and 2023. As of June 30, 2024 and March 31, 2024, all of the Company&#8217;s tax returns
of its PRC subsidiaries remain open for statutory examination by PRC tax authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Value
added tax (&#8220;VAT&#8221;)</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
revenue represents the invoiced value of goods, net of VAT. The VAT is based on gross sales price and VAT rates range up to 13%, depending
on the type of products sold. The VAT may be offset by VAT paid by the Company on raw materials and other materials included in the cost
of producing or acquiring its finished products. The Company recorded a VAT payable or receivable net of payments in the accompanying
unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Earnings
per Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company computes earnings per share (&#8220;EPS&#8221;) in accordance with ASC 260, &#8220;Earnings per Share&#8221; (&#8220;ASC 260&#8221;).
ASC 260 requires companies with complex capital structures to present basic and diluted EPS. Basic EPS is measured as net income divided
by the weighted average common shares outstanding for the period. Diluted presents the dilutive effect on a per share basis of potential
common shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented,
or issuance date, if later. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or
decrease loss per share) are excluded from the calculation of diluted EPS. For the three months ended June 30, 2024 and 2023, there were
no dilutive shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Foreign
Currency Translation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency and the reporting currency of NewCo and Qianzhi BVI is the U.S Dollar (&#8220;US$&#8221;). Qianzhi HK uses Hong Kong
dollar (&#8220;HK$&#8221;) as its functional currency. The Company operates its business through its subsidiaries in the PRC as of June
30, 2024. The functional currency of the Company&#8217;s subsidiaries is the Chinese Yuan (&#8220;RMB&#8221;). The Company&#8217;s unaudited
condensed consolidated financial statements have been translated into US$.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities accounts are translated using the exchange rate at each reporting period end date. Equity accounts are translated at
historical rates. Income and expense accounts are translated at the average rate of exchange during the reporting period. The resulting
translation adjustments are reported under other comprehensive income. Gains and losses resulting from the translations of foreign currency
transactions and balances are reflected in the results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 266; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
RMB is not freely convertible into foreign currency and all foreign exchange transactions must take place through authorized institutions.
No representation is made that the RMB amounts could have been, or could be, converted into US$ at the rates used in translation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table outlines the currency exchange rates that were used in creating the unaudited condensed consolidated financial statements:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="display: none">SCHEDULE OF FOREIGN EXCHANGE RATE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 90%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June
    30, 2024</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June
    30, 2023</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March
    31, 2024</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Period-end
    spot rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$1=RMB7.2672</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$1=RMB7.2513</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$1=RMB7.2203</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
    rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$1=RMB7.2438</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$1=RMB7.0595</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$1=RMB7.0440</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Comprehensive
income</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
income consists of two components, net income and other comprehensive income (loss). The foreign currency translation gain or loss resulting
from translation of the financial statements expressed in RMB or HK$ to US$ is reported in other comprehensive income (loss) in the unaudited
condensed consolidated statements of income and comprehensive income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Statement
of Cash Flows</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 230, &#8220;Statement of Cash Flows&#8221;, cash flows from the Company&#8217;s operations are formulated based upon
the local currencies. As a result, amounts related to assets and liabilities reported on the unaudited condensed consolidated statements
of cash flows will not necessarily agree with changes in the corresponding balances on the unaudited condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Related
parties</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties
are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant
influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject
to common control or significant influence, such as a family member or relative, shareholder, or a related corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Employee
Defined Contribution Plan</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s subsidiaries in the PRC participate in a government-mandated multi-employer defined contribution plan pursuant to which
pension, work-related injury benefits, maternity insurance, medical insurance, unemployment benefit and housing fund are provided to
eligible full-time employees. The relevant labor regulations require the Company&#8217;s subsidiaries in the PRC to pay the local labor
and social welfare authorities monthly contributions based on the applicable benchmarks and rates stipulated by the local government.
The contributions to the plan are expensed as incurred. Employee social security included as expenses in the accompanying unaudited condensed
consolidated statements of income and comprehensive income amounted to $24,234 and $24,711 for the three months ended June 30, 2024 and
2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Lease</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2021, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2016-02. Under this guidance, the Company determines
if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets,
operating lease liability, and operating lease liability, noncurrent in the Company&#8217;s consolidated balance sheets. ROU assets represent
the Company&#8217;s right to use an underlying asset for the lease term, and lease liabilities represent the Company&#8217;s obligation
to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on
the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate
the lease when it is reasonably certain that it will exercise that option, if any. As the Company&#8217;s leases do not provide an implicit
rate, the Company used an incremental borrowing rate based on the information available at commencement date in determining the present
value of lease payments. The Company has elected to adopt the following lease policies in conjunction with the adoption of ASU 2016-02:
(i) for leases that have lease terms of 12 months or less and does not include a purchase option that is reasonably certain to exercise,
the Company elected not to apply ASC 842 recognition requirements; and (ii) the Company elected to apply the package of practical expedients
for existing arrangements entered into prior to April 1, 2021 to not reassess (a) whether an arrangement is or contains a lease, (b)
the lease classification applied to existing leases, and(c) initial direct costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 267; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Recent
Accounting Standard Adopted</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASC Update No. 2016-13, (Topic 326), Financial Instruments &#8211; Credit Losses: Measurement of Credit Losses
on Financial Instruments. This ASC update introduces new guidance for the accounting for credit losses on financial instruments within
its scope. A new model, referred to as the current expected credit losses model, requires an entity to determine credit-related impairment
losses for financial instruments held at amortized cost and to estimate these expected credit losses over the life of an exposure (or
pool of exposures). The estimate of expected credit losses should consider both historical and current information, reasonable and supportable
forecasts, as well as estimates of prepayments. The estimated credit losses and subsequent adjustment to such loss estimates will be
recorded through an allowance account which is deducted from the amortized cost of the financial instrument, with the offset recorded
in current earnings. ASC No. 2016-13 also modifies the impairment model for available-for-sale debt securities. The new model will require
an estimate of expected credit losses only when the fair value is below the amortized cost of the asset, thus the length of time the
fair value of an available-for-sale debt security has been below the amortized cost will no longer affect the determination of whether
a credit loss exists. In addition, credit losses on available-for-sale debt securities will be limited to the difference between the
security&#8217;s amortized cost basis and its fair value. The updated guidance is effective for all entities other than public companies&#8217;
fiscal years beginning after December 15, 2022. The Company has adopted this accounting standard, effective April 1, 2023. Management
assessed the adoption of this standard on the effective date and concluded that the adoption did not have a material effect on the Company&#8217;s
financial condition, results of operations, and cash flows during the three months ended June 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes, as part of its Simplification Initiative to
reduce the cost and complexity in accounting for income taxes. This standard removes certain exceptions related to the approach for intra
period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities
for outside basis differences. It also amends other aspects of the guidance to help simplify and promote consistent application of GAAP.
The amendments in these ASUs are effective for the Company&#8217;s fiscal years, and interim periods within those fiscal years beginning
March 31, 2024. The Company has adopted this accounting standard, effective April 1, 2024. Management assessed the adoption of this standard
on the effective date and concluded that the adoption did not have a material effect on the Company&#8217;s financial condition, results
of operations, and cash flows during the three months ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the FASB issued ASU No. 2021-08, &#8220;Business Combinations (Topic 805): Accounting for Contract Assets and Contract
Liabilities from Contracts with Customers&#8221; (&#8220;ASU 2021-08&#8221;). This ASU requires entities to apply Topic 606 to recognize
and measure contract assets and contract liabilities in a business combination. The amendments improve comparability after the business
combination by providing consistent recognition and measurement guidance for revenue contracts with customers acquired in a business
combination and revenue contracts with customers not acquired in a business combination. The amendments are effective for the Company
beginning after December 15, 2023, and are applied prospectively to business combinations that occur after the effective date. The Company
has adopted this accounting standard, effective April 1, 2024. Management assessed the adoption of this standard on the effective date
and concluded that the adoption did not have a material effect on the Company&#8217;s financial condition, results of operations, and
cash flows during the three months ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Recently
Issued Accounting Pronouncements Not Yet Adopted</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers the applicability and impact of all accounting standards updates (&#8220;ASUs&#8221;). Management periodically reviews
new accounting standards that are issued. Under the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;),
the Company meets the definition of an emerging growth company, or EGC, and has elected the extended transition period for complying
with new or revised accounting standards, which delays the adoption of these accounting standards until they would apply to private companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amended
guidance requires incremental reportable segment disclosures, primarily about significant segment expenses. The amendments also require
entities with a single reportable segment to provide all disclosures required by these amendments, and all existing segment disclosures.
The amendments will be applied retrospectively to all prior periods presented in the financial statements and is effective for fiscal
years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024, with early adoption permitted.
The Company is currently in the process of evaluating the impact this amended guidance may have on the footnotes to its consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 268; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amended guidance enhances
income tax disclosures primarily related to the effective tax rate reconciliation and income taxes paid information. This guidance requires
disclosure of specific categories in the effective tax rate reconciliation and further information on reconciling items meeting a quantitative
threshold. In addition, the amended guidance requires disaggregating income taxes paid (net of refunds received) by federal, state, and
foreign taxes. It also requires disaggregating individual jurisdictions in which income taxes paid (net of refunds received) is equal
to or greater than 5 percent of total income taxes paid (net of refunds received). The amended guidance is effective for fiscal years
beginning after December 15, 2024. The guidance can be applied either prospectively or retrospectively. The Company is currently in the
process of evaluating the impact this amended guidance may have on the footnotes to its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
accounting standards that have been issued by FASB that do not require adoption until a future date are not expected to have a material
impact on the consolidated financial statements upon adoption. The Company does not discuss recent standards that are not anticipated
to have an impact on or are unrelated to its consolidated financial condition, results of operations, cash flows or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 &#8212; ACCOUNTS RECEIVABLE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable, net, consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">19,133</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">21,871</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Accounts receivable &#8211; related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74,643</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less: allowance for doubtful accounts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Accounts receivable, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">93,776</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,871</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024 and March 31, 2024, the Company determined that all of the accounts receivable are fully collectible.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 &#8212; INVENTORIES, NET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
consisted of raw materials, finished goods, third-party products and low value consumables, and are stated at the lower of cost or net
realizable value. As of June 30, 2024 and March 31, 2024, inventories consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="display: none">SCHEDULE OF INVENTORIES, NET</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(Unaudited)</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Raw materials</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">153,504</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">165,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Self-produced finished goods</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73,725</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82,462</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: justify">External purchased finished goods</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">79,732</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">113,349</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Total inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">306,961</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">361,311</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Inventory valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total inventory, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">306,961</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">361,311</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company performs physical stocktaking periodically and writes off obsolete inventories to the cost of revenue whenever they are identified.
Obsolete inventories in the amounts of $2,354 and $54,079 were written-off during the three months ended June 30, 2024 and 2023, respectively.
As of June 30, 2024 and March 31, 2024, the company has no slow-moving, obsolete, or damaged inventories and thus no inventory reserve
deemed necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 269; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8212; ADVANCES TO SUPPLIERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required from time to time to make cash advances when placing its purchase orders. These advances are settled upon suppliers
delivering third-party products and raw materials to the Company when the transfer of ownership occurs. As of June 30, 2024 and March
31, 2024, advances to suppliers consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF ADVANCES TO SUPPLIERS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    of</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June
    30, 2024</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March
    31, 2024</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
    to suppliers to purchase third-party products (1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;720,213    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">724,781</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
    to suppliers for raw materials</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;5,408
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,776</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;77,076</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,302</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    advances to suppliers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;802,697    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">783,859</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    allowance for doubtful accounts</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
    to suppliers, net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;802,697
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">783,859</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    noncurrent portion of advances to suppliers (1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(582,499</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(586,283</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    portion of advances to suppliers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;220,198
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,576</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The noncurrent
    portion of advances to suppliers reflected the long-term advances to one supplier of prepackaged food products, which is reported
    under &#8220;Deposit and other assets&#8221;. The amount of noncurrent portion of advances to suppliers as of June 30, 2024 is expected
    to be fully realized by December 2025.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024 and March 31, 2024, the Company determined that all of the advances to suppliers are realizable in the future periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8212; PROPERTY AND EQUIPMENT, NET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment, net, consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(Unaudited)</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Machinery and equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">347,914</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">350,174</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Office equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53,218</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53,564</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Automobiles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">548,225</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">551,786</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Furniture</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,098</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,189</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Leasehold improvement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">38,235</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">38,483</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,001,690</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,008,196</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less: accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(486,743</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(455,137</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">514,947</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">553,059</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the equipment used for manufacturing, the depreciation expense is included as part of manufacturing overhead, while the equipment used
for general administrative are included in selling, general and administrative expense on the statements of operations. For the three
months ended June 30, 2024 and 2023, the total depreciation and amortization expenses were $34,655 and $29,654, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8212; CONTRACT LIABILITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contract liabilities primarily relate to unsatisfied performance obligations when payments have been received from customers
before the Company&#8217;s products are delivered. Costs of fulfilling customers&#8217; purchase orders, such as shipping, handling and
delivery, which occur prior to the transfer of control, are recognized in selling, general and administrative expense when incurred.
Contract liabilities amounted to $234,876 and $372,295 as of June 30, 2024 and March 31, 2024, respectively. As of the reporting date,
approximately $36,231 or 15.4%, of the June 30, 2024 contract liabilities had been recognized as revenue, and the remaining balance is
expected to be recognized by December, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 270; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8212; DEBTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company borrowed funds from PRC banks and other financial institutions as working capitals. As of June 30, 2024 and March 31, 2024,
the Company&#8217;s debts consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Short-term
loans:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF SHORT TERM DEBT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(Unaudited)</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Short-term bank loans:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Loans from Bank of China:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: justify; padding-bottom: 1.5pt">Maturity date on December 5, 2024, interest rate 3.77% per
    annum</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">&#160;</td><td style="vertical-align: middle; padding-bottom: 1.5pt; width: 6%; text-align: center"><p style="margin-top: 0; margin-bottom: 0">(1)</p></td><td style="vertical-align: middle; width: 1%; padding-bottom: 1.5pt; text-align: center"/><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">110,084</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">69,249</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total short-term loans</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">110,084</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">69,249</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    December 6, 2023, Hubei Qianzhi obtained a line of credit from Bank of China to borrow up to RMB 1,000,000 (equivalent to $137,605)
    loans as working capital for one year, with interest rate of 3.77% per annum and maturity date on December 5, 2024. The Company withdrawn
    RMB 300,000 (equivalent to $41,281), RMB 200,000 (equivalent to $27,521) and RMB 300,000 (equivalent to $41,281) on December 11,
    2023, January 24, 2024 and May 16, 2024, respectively. There was no guarantee requirement for this loan, and $821 interest expenses
    were recorded for the three months ended June 30, 2024.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 271; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8212; RELATED PARTY TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Nature of relationships with related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEUDLE
OF NATURE OF RELATIONSHIPS WITH RELATED PARTIES</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 48%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship
    with the Company</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Xiaoqin Lin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&#8217;s controlling shareholder, Chief Executive Officer and chairman of the Company&#8217;s Board of Directors</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Liangwen Wang</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Yuetao Lin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    and Senior Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Xiaoling Yuan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Juxiang Hu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    and Senior Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Yanmin Liu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Yajun Sun</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Liangming Hu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shenzhen
    Yelin Network Technology Co., Ltd (&#8220;Shenzhen Yelin&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    common control of Ms. Xiaoqin Lin, whose ownership were disposed on January 4, 2023. Ms. Xiaoqin Lin has significant influence over
    Shenzhen Yelin after the disposal. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Sales transactions and accounts receivables &#8211; related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company sold its self-produced products to Shenzhen Yelin in the amounts of $74,593 and $74,728 during the three months ended June 30,
2024 and 2023 with accounts receivable balances of $74,643 as of June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company sold its self-produced products to Ms. Yuetao Lin and Ms. Xiaoling Yuan in the amounts of $12,215 and $17,101, respectively,
during the three months ended June 30, 2024, and the accounts receivable balances due from these individuals as of June 30, 2024 was
$Nil. There were no sales transactions with these individuals during the three months ended June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Other receivables &#8211; related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company advanced funds to Shenzhen Yelin for general working capital needs of Shenzhen Yelin, to Ms. Xiaoqin Lin for payment of combination
expenses of the Company, to officers as petty cash to cover minor expenses of the Company, and advanced salaries to employees for their
personal use. Such advance was non-interest bearing and due on demand. The other receivables due from related parties as of June 30,
2024 and March 31, 2024 were as followings:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF OTHER RECEIVABLES RELATED PARTIES</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    of</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June
    30, 2024</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March
    31, 2024</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 27%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shenzhen
    Yelin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
    funds to Shenzhen Yelin for its general working capital needs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">506,877</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Xiaoqin Lin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
    funds for payment of business combination expenses of the Company*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">283,106</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Yanmin Liu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
    salary to employees for their personal use</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,521</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,700</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Yajun Sun</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
    salary to employees for their personal use</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,444</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,174</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Juxiang Hu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Petty
    cash</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,212</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
    salary to employees for their personal use</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    other receivables &#8211; related parties</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">912,052</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,086</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            amount due from Ms. Xiaoqin Lin was paid back on September 4, 2024 and the
                                            Company does not intend to make additional cash advance to related parties going
                                            forward.</span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 272; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Other payables &#8211; related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
balance of other payables &#8211; related parties were comprised of the Company&#8217;s advances from Ms. Xiaoqin Lin used for working
capital during the Company&#8217;s normal course of business, and payment of expenses made by related parties on behalf of the Company.
Such advance was non-interest bearing and due on demand. The other payables due to related parties as of June 30, 2024 and March 31,
2024 were as followings:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF OTHER PAYABLES RELATED PARTIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(Unaudited)</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Ms. Xiaoqin Lin</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">-&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">276,533</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Mr. Liangming Hu</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,056</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38,991</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">59</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">55</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total other payables &#8211; related parties</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">39,115</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">315,579</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended March 31, 2024, Ms. Xiaoqin Lin, the Company&#8217;s Chief Executive Officer, paid for certain expenses on behalf of the
Company. On March 31, 2024, the Company, Ms. Lin and Shenzhen Yelin, a company affiliated with Ms. Lin, entered into an agreement whereby
Shenzhen Yelin collected cash in the amount of $1,174,118 for products sold by the Company to third parties and in turn delivered such
cash to Ms. Lin as repayment for the same amount advanced by Ms. Lin for such expenses.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 &#8212; TAXES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Corporate Income Taxes (&#8220;CIT&#8221;)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Cayman
Islands and British Virgin Islands (&#8220;BVI&#8221;)</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is incorporated in the Cayman Islands and its wholly-own subsidiary, Qianzhi BVI is incorporated in BVI. Under the current tax
laws of the Cayman Islands and the BVI, these entities are not subject to taxes on their income or capital gains. In addition, dividend
payments are not subject to withholdings tax in the Cayman Islands and the BVI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Hong
Kong</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
HK is incorporated in Hong Kong and is subject to profit taxes in Hong Kong at a rate of 16.5%. However, Qianzhi HK did not generate
any assessable profits derived from Hong Kong sources for the three months ended June 30, 2024 and 2023, and accordingly no provision
for Hong Kong profits tax has been made in these periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">PRC</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Enterprise Income Tax (&#8220;EIT&#8221;) Law of PRC, domestic enterprises and Foreign Investment Enterprises (&#8220;FIEs&#8221;)
are usually subject to a unified 25% enterprise income tax rate while preferential tax rates, tax holidays and even tax exemption may
be granted on a case-by-case basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s wholly owned subsidiaries - Shenzhen Qianzhi, Jiangxi Qianzhi, Qianzhi Biotech and Qianzhi Health are incorporated in
the PRC and qualified as small-scaled minimal profit enterprises for the three months ended June 30, 2024 and 2023. Based on the EIT
Law of PRC, and according to the Announcement on Issues Related to the Implementation of Inclusive Income Tax Reduction and Exemption
Policy for Small and Low Profit Enterprises issued by the State Administration of Taxation, from January 1, 2022 to December 31, 2024,
once an enterprise meets certain requirements and is identified as a small-scale minimal profit enterprise, its taxable income is entitled
to a reduced income tax rate ranging from 2.5% to 5% depending on the amount and period of taxable income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 273; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIT
grants preferential tax treatment to High and New Technology Enterprises (&#8220;HNTEs&#8221;). Under this preferential tax treatment,
HNTEs are entitled to an income tax rate of 15%, subject to a requirement that they re-apply for their HNTE status every three years.
Hubei Qianzhi, one of the Company&#8217;s main operating subsidiaries in the PRC, was approved as a HNTE and is entitled to a reduced
income tax rate of 15% beginning November 2022 with a term of three years. Although Hubei Qianzhi was approved as a HNTE and enjoying
a 15% reduced income tax rate, it incurred accumulated loss as of June 30, 2024, with no impact of the tax holidays on PRC corporate
income taxes for the three months ended June 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the income tax provision are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF INCOME TAX PROVISION</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June
    30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(Unaudited)</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(Unaudited)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Current tax provision:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Cayman and BVI</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Hong Kong</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: justify; padding-bottom: 1.5pt">PRC</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">16,465</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">6,137</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 10pt">Sub-total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,465</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,137</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 10pt">Current tax provision</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,465</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,137</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Deferred tax provision:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Cayman and BVI</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Hong Kong</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">PRC</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Sub-total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Deferred tax provision</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total income tax provision</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,465</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,137</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reconciles the China statutory rates to the Company&#8217;s effective tax rates for the three months ended June 30, 2024
and 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF EFFECTIVE TAX RATES</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June
    30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(Unaudited)</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(Unaudited)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">PRC statutory income tax rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">25.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">25.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Effect of PRC preferential tax rate and tax exemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9.1</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18.0</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Research and development tax credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Non-deductible expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.0</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.4</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Change in valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(73.6</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9.3</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Non-PRC entities not subject to PRC income tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">51.3</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.6</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3.2</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.7</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company continually evaluates expiring statutes of limitations, audits, proposed settlements, changes in tax law and new authoritative
rulings. As of June 30, 2024, all of the Company&#8217;s tax returns of its PRC subsidiaries remain open for statutory examination by
PRC tax authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are composed of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(Unaudited)</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Deferred tax assets derived from net operating loss (&#8220;NOL&#8221;) carry forwards
    and deferred revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">54,095</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">32,169</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less: valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(54,095</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(32,169</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total deferred tax assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company periodically evaluates the likelihood of the realization of deferred tax assets, and reduces the carrying amount of the deferred
tax assets by a valuation allowance to the extent it believes a portion will not be realized. Management considers new evidence, both
positive and negative, that could affect the Company&#8217;s future realization of deferred tax assets including its recent cumulative
earnings experience, expectation of future income, the carry forward periods available for tax reporting purposes and other relevant
factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 274; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Taxes payable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes
payable consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF TAXES PAYABLE</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(Unaudited)</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Income tax payable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">366,006</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">349,282</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Value added tax payable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,096</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">144,858</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Other taxes payable</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,305</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,931</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total taxes payable</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">435,407</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">507,071</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12 - OPERATING LEASE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases factory and storehouse in Ezhou City, Hubei Province of China, and office spaces in Shenzhen City, Guangdong Province
of China, with terms ranging from 20 months to eight years. The Company considers those renewal or termination options that are reasonably
certain to be exercised in the determination of the lease term and initial measurement of ROU assets and lease liabilities. Leases with
initial term of 12 months or less are not recorded on the balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines whether a contract is or contains a lease at inception of the contract and whether that lease meets the classification
criteria of a finance or operating lease. When available, the Company uses the rate implicit in the lease to discount lease payments
to present value; however, most of the Company&#8217;s leases do not provide a readily determinable implicit rate. Therefore, the Company
discounts lease payments based on an estimate of its incremental borrowing rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below presents the operating lease related assets and liabilities recorded on the balance sheets:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF OPERATING LEASE RELATED ASSETS AND LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"/><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(Unaudited)</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Operating lease assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: justify; padding-bottom: 1.5pt">Operating lease right of use assets</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">540,702</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">599,088</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Total operating lease assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">540,702</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">599,088</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#12288;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#12288;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#12288;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Operating lease obligations:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Current operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">214,596</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">213,490</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Noncurrent operating lease liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">299,200</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">354,178</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Total operating lease obligations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">513,796</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">567,668</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average remaining lease term and the weighted-average discount rate of leases are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF WEIGHTED AVERAGE REMAINING LEASE TERM AND DISCOUNT</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 81%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average
    remaining lease term</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5
    years</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average
    discount rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.77</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the maturity of operating lease liabilities as of June 30, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF MATURITY OF OPERATING LEASE LIABILITIES</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Twelve
    months ending June 30,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 81%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;234,511
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;239,140
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;58,304
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2028</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;13,273
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    lease payments</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">545,228
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    imputed interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(31,431</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    lease liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">513,796
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 275; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13 &#8212; SHAREHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ordinary
Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NewCo
was incorporated under the laws of the Cayman Islands on August 14, 2023. The authorized number of ordinary shares was 50,000 shares
with par value of US$1.00 per share and 50,000 shares were issued (see Note 1).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Statutory
reserve and restricted net assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relevant
PRC laws and regulations restrict the Company&#8217;s PRC subsidiaries from transferring a portion of their net assets, equivalent to
their statutory reserves and their share capital, to the Company in the form of loans, advances or cash dividends. Only PRC entities&#8217;
accumulated profits may be distributed as dividends to the Company without the consent of a third party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to make appropriations to certain reserve funds, comprising the statutory surplus reserve and the discretionary surplus
reserve, based on after-tax net income determined in accordance with generally accepted accounting principles of the PRC (&#8220;PRC
GAAP&#8221;). Appropriations to the statutory surplus reserve are required to be at least 10% of the after-tax net income determined
in accordance with PRC GAAP until the reserve is equal to 50% of the entity&#8217;s registered capital. Appropriations to the discretionary
surplus reserve are made at the discretion of the Board of Directors. The statutory reserve may be applied against prior year losses,
if any, and may be used for general business expansion and production or increase in registered capital, but are not distributable as
cash dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
payment of dividends by entities organized in China is subject to limitations, procedures and formalities. Regulations in the PRC currently
permit payment of dividends only out of accumulated profits as determined in accordance with accounting standards and regulations in
China. The results of operations reflected in the unaudited condensed consolidated financial statements prepared in accordance with U.S
GAAP differ from those in the statutory financial statements of its subsidiaries. Remittance of dividends by a wholly foreign-owned company
out of China is subject to examination by the banks designated by State Administration of Foreign Exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
light of the foregoing restrictions, the Company&#8217;s subsidiaries are restricted in their ability to transfer their net assets to
the Company. Foreign exchange and other regulations in the PRC may further restrict its subsidiaries from transferring funds to the Company
in the form of dividends, loans and advances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024 and March 31, 2024, the restricted amounts as determined pursuant to PRC statutory laws totaled $461,228, and total
restricted net assets amounted to $3,545,620.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14 &#8212; CONCENTRATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
majority of the Company&#8217;s revenue and expense transactions are denominated in RMB and a significant portion of the Company and
its subsidiaries&#8217; assets and liabilities are denominated in RMB. RMB is not freely convertible into foreign currencies. In the
PRC, certain foreign exchange transactions are required by law to be transacted only by authorized financial institutions at exchange
rates set by the People&#8217;s Bank of China (&#8220;PBOC&#8221;). Remittances in currencies other than RMB by the Company in China
must be processed through the PBOC or other China foreign exchange regulatory bodies which require certain supporting documentation in
order to affect the remittance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains cash with financial institutes, such as banks, in the PRC. Should any bank holding cash become insolvent, or if the
Company is otherwise unable to withdraw funds, the Company would lose the cash with that bank; however, the Company has not experienced
any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank accounts. In China, a depositor
has up to RMB500,000 insured by the People&#8217;s Bank of China Financial Stability Bureau (&#8220;FSD&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 276; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to significant concentrations of credit risk are cash and cash equivalents and accounts
receivable. As of June 30, 2024 and March 31, 2024, $656,464 and $2,961,187 of the Company&#8217;s cash held by financial institutions
were uninsured, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended June 30, 2024 and 2023, the Company&#8217;s substantial assets were located in the PRC and the Company&#8217;s
substantial revenues were derived from its subsidiaries located in the PRC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended June 30, 2024, one customer accounted for 12.0% of the Company&#8217;s total revenue, and its account receivable
balances was $Nil as of June 30, 2024. For the three months ended June 30, 2023, three customers accounted for 33.2%, 23.1% and 22.8%
of the Company&#8217;s total revenue, respectively, and their account receivable balances were Nil as of June 30, 2023. The Company&#8217;s
top 10 customers aggregately accounted for 55.4% and 100.0% of the total revenue for the three months ended June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of one of the Company&#8217;s major products, ozone sterilization product, accounted for 55.7% and 46.8% of the Company&#8217;s total
revenue for the three months ended June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, two customers accounted for 44.3% and 14.6% of the total accounts receivable balance, respectively. As of March 31,
2024, two customers accounted for 17.0% and 11.6% of the total accounts receivable balance, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, one supplier accounted for 89.7% of the total advances to supplier balance. As of March 31, 2024, one supplier accounted
for 92.5% of the total advances to supplier balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended June 30, 2024, four suppliers accounted for 39.8%, 15.6%, 15.0% and 14.5% of the total purchases, respectively.
For the three months ended June 30, 2023, two suppliers accounted for 57.2% and 19.6% of the total purchases, respectively. The Company&#8217;s
top 10 supplier aggregately accounted for 98.5% and 99.4% of the total purchases for the three months ended June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15 &#8212; COMMITMENTS AND CONTINGENCIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company is a party to various legal actions arising in the ordinary course of business. The Company accrues costs associated
with these matters when they become probable and the amount can be reasonably estimated. Legal costs incurred in connection with loss
contingencies are expensed as incurred. For the three months ended June 30, 2024 and 2023, the Company did not have any material legal
claims or litigation that, individually or in aggregate, could have a material adverse impact on the Company&#8217;s consolidated financial
position, results of operations and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company lease factory and storehouse in Ezhou City, Hubei Province of China, and office spaces in Shenzhen City, Guangdong Province of
China, with terms ranging from 20 months to eight years. (see Footnote 12 &#8211; Operating lease, for details)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
16- SUBSEQUENT EVENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has assessed all subsequent events through September 10, 2024 which is the date that these unaudited condensed consolidated financial
statements are issued and there are no further material subsequent events that require disclosure in these unaudited condensed consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
17&#8212; CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Rule 12-04(a), 5-04(c) and 4-08(e)(3) of Regulation S-X, the condensed financial information of the parent company
shall be filed when the restricted net assets of consolidated subsidiaries exceed 25 percent of consolidated net assets as of the end
of the most recently completed fiscal year. The Company performed a test on the restricted net assets of consolidated subsidiaries in
accordance with such requirement and concluded that it was applicable to the Company as the restricted net assets of the Company&#8217;s
subsidiaries exceeded 25% of the consolidated net assets of the Company. Therefore, the condensed financial statements for the parent
company are included herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 277; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the above test, restricted net assets of consolidated subsidiaries shall mean that amount of the Company&#8217;s proportionate
share of net assets of consolidated subsidiaries (after intercompany eliminations) which as of the end of the most recent fiscal year
may not be transferred to the parent company by subsidiaries in the form of loans, advances or cash dividends without the consent of
a third party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
condensed financial information of the parent company has been prepared using the same accounting policies as set out in the Company&#8217;s
unaudited condensed consolidated financial statements except that the parent company used the equity method to account for investment
in its subsidiaries. Such investment is presented on the condensed balance sheets as &#8220;Investment in subsidiaries&#8221; and the
respective profit or loss as &#8220;Equity in earnings of subsidiaries&#8221; on the condensed statements of income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
footnote disclosures contain supplemental information relating to the operations of the Company and, as such, these statements should
be read in conjunction with the notes to the unaudited condensed consolidated financial statements of the Company. Certain information
and footnote disclosures normally included in financial statements prepared in accordance with U.S GAAP have been condensed or omitted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not pay any dividend for the periods presented. As of June 30, 2024 and March 31, 2024, there were no material contingencies,
significant provisions for long-term obligations, or guarantees of the Company, except for those which have been separately disclosed
in the unaudited condensed consolidated financial statements, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PARENT
COMPANY BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="display: none">SCHEDULE
OF CONDENSED CONSOLIDATED FINANCIAL STATEMENT</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(Unaudited)</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">CURRENT ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: justify">Prepayment for IPO expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">127,974</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">394,161</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">NON-CURRENT ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Investment in subsidiaries</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,140,898</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,221,436</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">TOTAL ASSETS</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,268,872</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,615,597</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">CURRENT LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Other payables &#8211; related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,475,368</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,199,315</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Due to subsidiaries</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,385,779</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,385,779</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">60,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">TOTAL CURRENT LIABILITIES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,861,147</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,645,094</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">COMMITMENTS AND CONTINGENCIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">SHAREHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt">Ordinary shares, $1.00 par value, 50,000 shares authorized, 50,000 shares
    issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 10pt">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,034,392</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,034,392</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt">Retained earnings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,895,756</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,421,012</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Accumulated other comprehensive loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(572,423</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(534,901</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">TOTAL SHAREHOLDERS&#8217; EQUITY</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,407,725</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,970,503</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,268,872</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,615,597</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 278; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PARENT
COMPANY STATEMENTS OF COMPREHENSIVE INCOME</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June
    30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Operating costs and expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: justify; padding-left: 10pt">General and administrative expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(482,240</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(679,208</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Equity in earnings of subsidiaries</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(43,016</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(264,244</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">NET LOSS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(525,256</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(943,452</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Foreign currency translation adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(37,522</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(306,056</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">COMPREHENSIVE LOSS ATTRIBUTABLE TO THE COMPANY</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(562,778</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,249,508</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 279; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PARENT
COMPANY STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June
    30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">CASH FLOWS FROM OPERATING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: justify">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(525,256</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(943,452</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify">Adjustments to reconcile net cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: justify">Equity in earnings of subsidiaries</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,016</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">264,244</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: justify">Prepayment for IPO expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266,187</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,058,329</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: justify">Other payables &#8211; related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">276,053</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">492,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: justify; padding-bottom: 1.5pt">Due to subsidiaries</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">1,245,537</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: justify; padding-bottom: 1.5pt">Other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(60,000</p></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">-</p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Net cash provided by operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">CHANGES IN CASH</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">CASH, beginning of period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">CASH, end of period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<!-- Field: Page; Sequence: 280; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#F1_007">Report of Independent Registered Public Accounting Firm</a> (PCAOB ID: 2485)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b><a href="#ap_001">Consolidated Balance Sheets as of
    March 31, 2024 and 2023</a></b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b><a href="#ap_002">Consolidated Statements of Operation
    and Comprehensive (Loss) Income for the Years Ended March 31, 2024 and 2023</a></b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-31<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b><a href="#ap_003">Consolidated Statements of Changes
    in Shareholders&#8217; Equity for the Years Ended March 31, 2024 and 2023</a></b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-32<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b><a href="#ap_004">Consolidated Statements of Cash Flows
    for the Years Ended March 31, 2024 and 2023</a></b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-33<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#ap_005">Notes to Consolidated Financial Statements</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-34</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 281; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; width: 72%"><span id="F1_007"></span>&#160;<img src="forms-4_013.jpg" alt=""/></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
                           <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>17506 Colima Road Suite #101</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Rowland Heights, CA 91748</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Tel: +1 (626) 581-0818</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Fax: +1 (626) 581-0809</b></p></td>
  </tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Report
of Independent Registered Public Accounting Firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
and Board of Directors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
Group Holding (Cayman) Limited</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of Qianzhi Group Holding (Cayman) Limited and subsidiaries (the &#8220;Company&#8221;)
as of March 31, 2024 and 2023, the related consolidated statements of income and comprehensive income, changes in stockholders&#8217;
equity, and cash flows for each of the two years in the period ended March 31, 2024, and the related notes to the consolidated
financial statements. In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position
of the Company as of March 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two
years in the period ended March 31, 2024<b>,</b> in conformity with accounting principles generally accepted in the United States
of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion
on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with
the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to
the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange
Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing
an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Audit Matter</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that
was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material
to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication
of critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are
not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or
disclosures to which it relates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 282; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Relationship and Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 10 to the consolidated financial statements, management disclosed that one entity under common control of the
Company&#8217;s chief executive officer was not only a customer but also a debtor during the same period of time. In addition, the Company
has also incurred miscellaneous transactions with multiple officers or senior management personnel during the years ended March 31, 2024
and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
identified the evaluation of the Company&#8217;s identification of related parties and related party transactions as a critical audit
matter. This required a high degree of auditor judgment and an increased extent of effort when performing audit procedures to evaluate
the reasonableness of management&#8217;s procedures performed to identify related parties and related party transactions of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary procedures we performed to address this critical audit matter included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Wingdings">&#216;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inquired
    and performed walkthrough about internal controls over the Company&#8217;s related party process, including controls related to the
    identification of significant non-routine related party transactions with the entities.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Wingdings">&#216;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Read
    new agreements and contracts entered into with the related entities.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Wingdings">&#216;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inquired
    of executive officers, key members of the Company, and the Board of Directors regarding related party transactions with the entities.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Wingdings">&#216;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Received
    confirmations from related parties and compared responses to the Company&#8217;s records.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Wingdings">&#216;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performed
    the following procedures to identify information related to potential additional transactions between the Company and related parties
    that may also include third parties:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Read
    external news for information related to transactions between the Company and the entities.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inspect
    the Company&#8217;s minutes from meetings of the Board of Directors.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Perform
    information search on third party websites about the Company and the entities for new relationships possibly undisclosed.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Wingdings">&#216;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluate
    the overall sufficiency of audit evidence over the identification of significant non-routine related party transactions with the
    entities along with its subsequent movements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Simon &amp; Edward, LLP</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rowland
Heights, California</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
19,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 283; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ap_001"></span>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">ASSETS</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">CURRENT ASSETS</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: justify">Cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">4,832,079</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">3,836,946</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Accounts receivables</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">21,871</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">42,081</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Account receivables &#8211; related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">875,276</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Inventories, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">361,311</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">454,582</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Advances to suppliers</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">197,576</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">480,213</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Other receivables &#8211; related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">68,086</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,809,556</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Loans to related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">29,122</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Other current assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">449,085</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">107,861</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">TOTAL CURRENT ASSETS</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,930,008</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,635,637</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Property and equipment, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">553,059</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">304,191</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Right-of-use lease assets, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">599,088</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">263,789</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Deposit and other assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">630,975</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">449,372</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">TOTAL ASSETS</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,713,130</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">8,652,989</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">LIABILITIES AND EQUITY</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">CURRENT LIABILITIES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Short-term loans</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">69,249</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">145,611</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Current portion of long-term loans</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">16,641</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">525,266</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">753,300</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Contract liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">372,295</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">706,974</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Taxes payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">507,071</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">350,195</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Other payables</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">156,159</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">123,832</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Other payables &#8211; related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">315,579</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">105,654</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">229,340</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">185,042</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Operating lease liability, current</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">213,490</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">132,981</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">TOTAL CURRENT LIABILITIES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,388,449</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,520,230</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; text-align: justify">Long-term loans</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,481</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Operating lease liability, noncurrent</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">354,178</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">121,449</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">TOTAL LIABILITIES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,742,627</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,654,160</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">COMMITMENTS AND CONTINGENCIES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">EQUITY</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Ordinary shares, $1.00 par value, 50,000 shares authorized, 50,000 shares issued and outstanding</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Additional paid in capital</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,034,392</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,034,392</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Statutory reserve</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">461,228</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">341,044</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Retained earnings</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,959,784</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,778,142</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Accumulated other comprehensive loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(534,901</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(204,749</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">TOTAL SHAREHOLDERS&#8217; EQUITY</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,970,503</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,998,829</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">TOTAL LIABILITIES AND EQUITY</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,713,130</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">8,725,225</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 284; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ap_002"></span>CONSOLIDATED
STATEMENTS OF OPERATION AND COMPREHENSIVE (LOSS) INCOME</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">REVENUE, NET</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">7,030,989</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">10,108,557</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Cost of revenue</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(569,368</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,920,164</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Promotion cost</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,481,225</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,751,155</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">GROSS PROFIT</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-style: normal; font-weight: normal">3,980,396</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,437,238</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">OPERATING EXPENSES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Selling and marketing</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">44,159</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">108,040</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">General and administrative</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,318,060</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,598,512</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Research and development</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">59,878</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">44,527</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total operating expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,422,097</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,751,079</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">(LOSS) INCOME FROM OPERATIONS</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(441,701</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,686,159</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">OTHER INCOME (EXPENSES)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest income</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,246</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,314</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest expense</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(3,088</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(3,935</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Government subsidies</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">74,716</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">69,573</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Other income (expense), net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">21,128</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,296</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total other income, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">96,002</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">68,656</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">(LOSS) INCOME BEFORE INCOME TAX PROVISION</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(345,699</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,754,815</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">INCOME TAX PROVISION</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(352,475</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(162,817</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">NET (LOSS) INCOME</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(698,174</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,591,998</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">OTHER COMPREHENSIVE INCOME</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total foreign currency translation adjustment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(330,152</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(352,103</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">COMPREHENSIVE (LOSS) INCOME</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,028,326</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,239,895</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif">EARNINGS PER SHARE</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Basic and diluted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(13.96</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">71.84</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Basic and diluted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 285; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ap_003"></span>CONSOLIDATED
STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED MARCH 31, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Common shares</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Additional paid-in</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Statutory</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Retained</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated
                                            other comprehensive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>income</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total shareholders&#8217;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>controlling</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">capital</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">reserve</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">earnings</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(loss)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">equity</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">interest</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">equity</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 28%">Balance at April 1, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 4%; text-align: right">50,000</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 4%; text-align: right">50,000</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 4%; text-align: right">2,949,176</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 4%; text-align: right">81,648</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 4%; text-align: right">(490,879</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 4%; text-align: right">147,354</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 4%; text-align: right">2,737,299</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 4%; text-align: right">42,079</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 4%; text-align: right">2,779,378</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Capital injection</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">85,216</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">85,216</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">85,216</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Acquisition of noncontrolling interest</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(63,581</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(63,581</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(36,027</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(99,608</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Disposal of a subsidiary</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,052</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,052</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Appropriation to statutory reserve</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">259,396</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(259,396</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net income</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,591,998</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,591,998</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,591,998</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net income (loss)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,591,998</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,591,998</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,591,998</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Foreign currency translation adjustment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(352,103</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(352,103</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(352,103</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif">Balance at March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">50,000</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">50,000</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">3,034,392</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">341,044</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">2,778,142</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(204,749</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,998,829</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,998,829</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif">Balance</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">50,000</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">50,000</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">3,034,392</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">341,044</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">2,778,142</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(204,749</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,998,829</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,998,829</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Appropriation to statutory reserve</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">120,184</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(120,184</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(698,174</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(698,174</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(698,174</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net income (loss)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(698,174</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(698,174</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(698,174</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Foreign currency translation adjustment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(330,152</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(330,152</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(330,152</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif">Balance at March 31, 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">50,000</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">50,000</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">3,034,392</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">461,228</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,959,784</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(534,901</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">4,970,503</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">4,970,503</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif">Balance</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">50,000</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">50,000</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">3,034,392</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">461,228</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,959,784</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(534,901</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">4,970,503</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">4,970,503</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 286; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ap_004"></span>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash flows from operating activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left">Net (loss) income</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(698,174</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">3,591,998</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Adjustments to reconcile net (loss) income to cash   provided by operating
    activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Depreciation and amortization</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">133,083</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">157,487</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Amortization of operating lease right-of-use assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">284,615</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">128,762</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Reserve for sales return</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">101,743</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Disposal and acquiring of noncontrolling interest</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6,546</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Loss on disposal of property and equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(36,629</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,872</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Changes in operating assets and liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Accounts receivables</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">18,609</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(30,018</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Account receivables &#8211; related party</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">853,357</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(51,546</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt">Inventories</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">72,843</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">165,128</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Advance to suppliers</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">265,666</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(353,939</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Other receivables &#8211; related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,764,877</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,520,855</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Loans to related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">28,393</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">424,018</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Other current assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(348,946</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">77,456</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Deposit and other assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(205,002</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">450,465</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(196,023</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">617,771</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Contract liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(307,657</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(148,430</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Taxes payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">176,972</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">359,758</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Other payables</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">39,335</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">34,345</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Other payables &#8211; related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">225,648</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">37,488</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Operating lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(307,696</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(151,525</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(52,451</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(131,720</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; text-align: left">Net cash provided by operating activities</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-style: normal; font-weight: normal">1,710,820</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,777,804</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash flows from investing activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Purchase of property and equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(365,417</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(172,340</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net cash used in investing activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(365,417</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(172,340</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash flows from financing activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Proceeds from short-term loans</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">70,982</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">151,435</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Proceeds from long-term loans</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">30,287</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Repayment of short-term loans</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(141,965</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(60,574</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Repayment of long-term loans</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(28,393</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Proceeds from shareholders&#8217; contribution</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">85,216</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Payment for acquisition of noncontrolling interest</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(106,004</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net cash (used in) provided by financing activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(99,376</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100,360</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Effect of changes of foreign exchange rates on cash</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(250,894</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(172,804</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Net increase in cash</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">995,133</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,533,020</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash, beginning of year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,836,946</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">303,926</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash, end of year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,832,079</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,836,946</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Supplemental disclosure of cash flow information</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Cash paid for interest expense</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,088</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,255</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Cash paid for income tax</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">104,732</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">67,600</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 287; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ap_005"></span>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE
1. ORGANIZATION AND BUSINESS DESCRIPTION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Business</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
Group Holding (Cayman) Limited (&#8220;NewCo&#8221; or the &#8220;Company&#8221;), through its subsidiaries located in the People&#8217;s
Republic of China (&#8220;PRC&#8221;), is a health and wellness focused biotech company and an early adopter and developer of plant-based
and ozonated products for antibacterial, skincare, gynecological and andrological applications.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Organizations</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NewCo
was incorporated under the laws of the Cayman Islands on August 14, 2023 as an exempted company with limited liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NewCo
owns 100% equity interest of Qianzhi Investment Holding Co., Ltd (&#8220;Qianzhi BVI&#8221;), an entity incorporated on August 31, 2023
in accordance with the laws and regulations in the British Virgin Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
BVI owns 100% equity interest of Hong Kong Qianzhi Investment Holding Co., Ltd (&#8220;Qianzhi HK&#8221;), an entity incorporated on
September 27, 2023 in accordance with the laws and regulations in Hong Kong.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
HK owns 100% equity interest of Shenzhen Shian Biotechnology Co., Ltd. (&#8220;Shenzhen Shian&#8221;), an entity formed on November 23,
2023, as a Wholly Foreign-Owned Enterprise (&#8220;WFOE&#8221;) in the People&#8217;s Republic of China (&#8220;PRC&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NewCo,
Qianzhi BVI, Qianzhi HK and Shenzhen Shian are currently not engaging in any active business operations and merely acting as holding
companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the reorganization described below, Ms. Xiaoqin Lin, the chairman of the board of directors and the chief executive officer of the
Company, was the controlling shareholder of Shenzhen Qianzhi Biotechnology Co., Ltd. (&#8220;Qianzhi Biotechnology&#8221;), an entity
incorporated on March 20, 2007 in accordance with PRC laws. Qianzhi Biotechnology owns 100% of the equity interests of the following
subsidiaries: (1) Hubei Qianzhi Biotechnology Co., Ltd. (&#8220;Hubei Qianzhi&#8221;) was incorporated on February 20, 2019 in Ezhou
City, Hubei Province in accordance with PRC laws; (2) Shenzhen Qianzhi Health Management Co., Ltd. (&#8220;Qianzhi Health&#8221;) was
incorporated on May 5, 2019 in accordance with PRC laws; (3) Jiangxi Qianzhi Biotechnology Co., Ltd. (&#8220;Jiangxi Qianzhi&#8221;)
was incorporated on June 12, 2019 in Jiujiang City, Jiangxi Province in accordance with PRC laws, and (4) Shenzhen Qianzhi Biotech Co.,
Ltd. (&#8220;Qianzhi Biotech&#8221;) was incorporated on July 2, 2019 in accordance with PRC laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Qianzhi Biotechnology also owns 51% equity interest in Zhishang Zhimei (Shenzhen) Brand Planning Consulting Co., Ltd. (&#8220;Zhishang
Zhimei&#8221;), an entity incorporated on August 13, 2019 and deregistered on October 12, 2022 in accordance with PRC laws. As Zhishang
Zhimei had no operating activity and no material assets, the deregister of Zhishang Zhimei did not constitute discontinued operation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
Biotechnology, together with its subsidiaries are collectively referred to as the &#8220;Qianzhi Operating Companies&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reorganization</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reorganization of legal structure (&#8220;Reorganization&#8221;) was completed on December 27, 2023. The reorganization involved the
incorporation of NewCo, Qianzhi BVI, Qianzhi HK and Shenzhen Shian, and the transfer of the 100% equity interest of Qianzhi Biotechnology
to Shenzhen Shian. Consequently, NewCo, through its subsidiaries Qianzhi BVI and Qianzhi HK, directly controls Shenzhen Shian and Qianzhi
Biotechnology, and became the ultimate holding company of all other entities mentioned above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 288; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reorganization has been accounted for as a recapitalization among entities under common control since the same controlling shareholders
controlled all these entities before and after the Reorganization. The consolidation of the Company and its subsidiaries has been accounted
for at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the
first period presented in the accompanying consolidated financial statements. Results of operations for the periods presented comprise
those of the previously separate entities combined from the beginning of the period to the end of the period, eliminating the effects
of intra-entity transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the completion of the Reorganization, the Company has subsidiaries in countries and jurisdictions in the PRC, and Hong Kong. Details
of the subsidiaries of the Company as of March 31, 2024 were set out below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none">SUMMARY OF THE SUBSIDIARIES OF THE COMPANY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of Entity</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
                                            of</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place of Incorporation</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%
                                            of </b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal
    Activities</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NewCo</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    14, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
    Islands</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent,
    100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    holding</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
    BVI</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    31, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">British
    Virgin Islands</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    holding</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
    HK</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    27, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    holding</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shenzhen
    Shian</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    23, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WFOE,
    Investment holding</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Qianzhi
    Operating Companies:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
    Biotechnology</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    20, 2007</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    administration and sales of the Company&#8217;s products to customers</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hubei
    Qianzhi</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    20, 2019</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;PRC</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research,
    development and manufacturing of product</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
    Health</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    5, 2019</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;PRC</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
    of product</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiangxi
    Qianzhi</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    12, 2019</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;PRC</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
    of product</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
    Biotech</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    2, 2019</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;PRC</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
    of product</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE
2 &#8212; LIQUIDITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company&#8217;s consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of
assets and the settlement of liabilities and commitments in the normal course of business. The Company incurred net loss of $698,174,
and cash provided by operating activities was $1,710,820 for the year ended March 31, 2024. As of March 31, 2024, the Company has a working
capital of $3,541,559. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
assessing its liquidity, management monitors and analyzes the Company&#8217;s cash, its ability to generate sufficient revenue sources
in the future, and its contractual obligations. As of March 31, 2024, the Company had cash of $4,832,079 and outstanding bank loan of
$69,249. The Company believes that its current cash, cash flows provided by operating activities and borrowings from banks will be sufficient
to meet its working capital needs for at least 12 months from the date of this report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Basis
of Presentation and Principles of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (&#8220;U.S. GAAP&#8221;) and pursuant to the rules and regulations of the Securities and Exchange Commission
(&#8220;SEC&#8221;). The accompanying consolidated financial statements include the financial statements of the Company, and its wholly
owned subsidiaries. All inter-company balances and transactions are eliminated upon consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span style="text-decoration: underline">Reclassifications</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Certain amounts on the
prior-years&#8217; consolidated balance sheets, consolidated statements of operations and cash flows were reclassified to conform to
current-year presentation, with no effect on ending stockholders&#8217; equity.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Uses
of estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
preparing the consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements, and the reported amounts of revenues and expenses during the reporting periods. These estimates are based on
information as of the date of the consolidated financial statements. Significant estimates required to be made by management
include, but are not limited to, the estimated current credit losses on financial assets, realizability of advances to suppliers, inventory valuations, useful lives of property and equipment, the
recoverability of long-lived assets, revenue recognition and realization of deferred
tax assets. Actual results could differ from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 289; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Risks
and Uncertainties</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
main operation of the Company is located in the PRC. Accordingly, the Company&#8217;s business, financial condition, and results of operations
may be influenced by political, economic, and legal environments in the PRC, as well as by the general state of the PRC economy. The
Company&#8217;s results may be adversely affected by changes in the political, regulatory and social conditions in the PRC. Although
the Company has not experienced losses from these situations and believes that it is in compliance with existing laws and regulations
including its organization and structure disclosed in Note 1, this may not be indicative of future results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
development and commercialization of personal hygiene and disinfectant products is highly competitive, and the industry currently is
characterized by rapidly changing technologies, significant competition and a strong emphasis on intellectual property. The Company may
face competition with respect to its current and future personal hygiene and disinfectant product candidates from major personal care
companies in China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s business, financial condition and results of operations may also be negatively impacted by risks related to natural disasters,
extreme weather conditions, health epidemics and other catastrophic incidents, which could significantly disrupt the Company&#8217;s
operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Cash</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
includes currency on hand and deposits held by banks that can be added or withdrawn without limitation. The Company maintains cash with
financial institutes, such as banks, in the PRC. In China, a depositor has up to RMB500,000 insured by the People&#8217;s Bank of China
Financial Stability Bureau (&#8220;FSD&#8221;). As of March 31, 2024 and 2023, $2,961,187 and $1,986,923 of the Company&#8217;s cash
held by financial institutions were uninsured, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Accounts
receivable</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivables are presented net of allowance for doubtful accounts. The Company uses the current expected credit losses model to determine
credit-related impairment losses for financial instruments held at amortized cost and to estimate these expected credit losses over the
life of an exposure (or pool of exposures). The estimate of expected credit losses considers both historical and current information,
reasonable and supportable forecasts, as well as estimates of prepayments. The estimated credit losses and subsequent adjustment to such
loss estimates are recorded through an allowance account which is deducted from the amortized cost of the financial instrument, with
the offset recorded in current earnings. Delinquent account balances are written-off against the allowance for doubtful accounts after
management has determined that the collection is not probable. As of March 31, 2024 and 2023, there was no allowance recorded as the
Company determined that all of the accounts receivable are fully collectible.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Advances
to suppliers</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
to suppliers mainly represent prepayments made to ensure continuous high-quality supplies and favorable purchase prices of third-party
products and raw materials. These advances are directly related to the purchases of third-party products and raw materials used to fulfill
sales orders. The Company is required from time to time to make cash advances when placing its purchase orders. These advances are settled
upon suppliers delivering third-party products and raw materials to the Company when the transfer of ownership occurs. The Company reviews
its advances to suppliers on a periodic basis and makes general and specific allowances when there is doubt as to the ability of a supplier
to provide supplies to the Company or refund an advance. As of March 31, 2024 and 2023, no allowance for advances to suppliers was deemed
necessary, as the Company believes that all advances to suppliers are fully realizable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Inventories</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
are stated at lower of cost or net realizable value using weighted average method. Costs include the cost of raw materials, freight,
direct labor and related production overhead, as well as procurement cost of third-party products. Any excess of the cost over the net
realizable value of each item of inventories is recognized as a provision for diminution in the value of inventories. Net realizable
value is the estimated selling price in the normal course of business less any costs to complete and sell products. The Company evaluates
inventories on a quarterly basis for its net realizable value adjustments, and reduces the carrying value of those inventories that are
obsolete or in excess of the forecasted usage to their estimated net realizable value based on various factors including aging, expiration
dates, as applicable, taking into consideration historical and expected future product sales. The Company performs physical stocktaking
quarterly and writes off obsolete inventories to the cost of revenue account. Obsolete inventories in the amount of $16,609 and $21,982 were written-off during the years ended March 31, 2024 and 2023, respectively.
As of March 31, 2024 and 2023, the company has no slow-moving, obsolete, or damaged inventories and thus no inventory reserve deemed necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 290; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Fair
value of financial instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The
hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of
inputs used to measure fair value are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1&#8201;&#8212;&#8201;inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in
    active markets.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2&#8201;&#8212;&#8201;inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets,
    quoted market prices for identical or similar assets in markets that are not active, inputs other than quoted prices that are observable
    and inputs derived from or corroborated by observable market data.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3&#8201;&#8212;&#8201;inputs to the valuation methodology are unobservable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise disclosed, the fair value of the Company&#8217;s financial instruments, including cash, accounts receivable, inventories,
advances to suppliers, other receivables &#8211; related parties, other current assets, short-term bank loans, accounts payable,
other payables &#8211; related parties, taxes payable, contract liabilities, other current liabilities, approximate
the fair value of the respective assets and liabilities as of March 31, 2024 and 2023 based upon the short-term nature of the assets
and liabilities. The fair value of operating lease liabilities approximates their recorded values as their stated interest rates
approximate the rates currently available in the market the Company could obtain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Property
and equipment, net</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization of property and equipment
is provided using the straight-line method over their expected useful lives, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT EXPECTED USEFUL LIVES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    life</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery
    and equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1&#8211;10
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    equipment and furniture</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2&#8211;5
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Automobiles</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2&#8211;4
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    improvement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shorter
    of remaining lease term or 5 years</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures
for maintenance and repairs, which do not materially extend the useful lives of the assets, are charged to expense as incurred. Expenditures
for major renewals and betterments which substantially extend the useful life of assets are capitalized. The cost and related accumulated
depreciation of assets retired or sold are removed from the respective accounts, and any gain or loss is recognized in the consolidated
statements of income and other comprehensive income in other income or expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Impairment
of long-lived Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets, such as property and equipment and intangible assets, are reviewed for impairment when events or changes in circumstances indicate
that the carrying value of such assets may not be recoverable. Recoverability of a long-lived asset or asset group to be held and used
is measured by a comparison of the carrying amount of an asset or asset group to the estimated undiscounted future cash flows expected
to be generated by the asset or asset group. If the carrying value of an asset or asset group exceeds its estimated undiscounted future
cash flows, an impairment charge is recognized by the amount that the carrying value exceeds the estimated fair value of the asset or
asset group. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values
and third-party independent appraisals, as considered necessary. Assets to be disposed are reported at the lower of carrying amount or
fair value less costs to sell, and are no longer depreciated. No impairment of long-lived assets was recognized as of March 31, 2024
and 2023 based on the management&#8217;s assessment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 291; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Revenue
recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
determine revenue recognition for contracts with customers, the Company performs the following five steps : (i) identify the contract(s)
with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable
consideration to the extent that it is probable that a significant future reversal will <i>not</i> occur, (iv) allocate the transaction
price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance
obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered sales contracts with various individuals and/or companies. Pursuant to sales contracts entered, the Company is to provide
the required personal care or other products to its customers without a right of return. Most customers are required to make full advance
payment to the Company upon signing the contract, and send the purchase order within ten days. The Company shall deliver the ordered
personal care or other products within seven days after receiving of purchase order and advance payment, and the delivery expense is
borne by the customers. The customer shall inspect the quantity and quality of the products received timely and notify any noncompliance
to the Company on the day of receipt, and no return will be grant after customers&#8217; acceptances. The Company may grant certain sales
returns from time to time exclusively under management&#8217;s discretion, which results 1% of total sales reserved for the potential
sales return based on historical experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when it transfers its goods and services to customers in an amount that reflects the consideration to which
the Company expects to be entitled in such exchange. The Company accounts for revenue generated from sales of its products on a gross
basis, as the Company is acting as a principal in these transactions, is subject to inventory risk, has latitude in establishing prices,
and is responsible for fulfilling the promise to provide customers the specified goods, which the Company has control of the goods and
has the ability to direct the use of goods to obtain substantially all the benefits. All of the Company&#8217;s contracts have one single
performance obligation, namely, the promise is to transfer the individual goods to customers, and there is no separately identifiable
other promise in the contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s revenue is recognized at a point in time when title and risk of loss passes and customers inspect and accept the goods,
which generally occurs at day of delivery. Revenue is reported net of after sales discount and return reserve and all value added taxes
(&#8220;VAT&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company pays promotional costs to the organizer of the Company&#8217;s sales campaigns which is in line with revenue and would not
have incurred if the contract had not been obtained. The Company determined the promotional costs as incremental costs of obtaining
a contract and applies a practical expedient to expense costs when incurred when the amortization period of the asset that the
entity otherwise would have recognized is one year or less. The Company does not incur significant additional costs to secure contracts with customers, except for promotional expenses, that are
expected to provide benefits lasting longer than one year, which must be recognized as assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Disaggregation
of revenue</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company disaggregates its revenue from contracts by product types, as the Company believes it best depicts how the nature, amount, timing
and uncertainty of the revenue and cash flows are affected by economic factors. The following table identifies the disaggregation of
its revenue for the years ended March 31, 2024 and 2023, respectively:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif">Sales of self-manufactured products</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Revenue from sales of ozone sterilization products</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">3,694,858</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">5,570,618</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Revenue from sales of hypochlorite disinfection products</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">248,707</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,658,808</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Sales of third-party products purchased</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Revenue from sales of cosmetic products</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">780,899</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">844,812</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Revenue from sales of prepackaged food</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,050,572</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,136,197</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Revenue from sales of other products</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">255,953</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">898,122</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Total revenue, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,030,989</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">10,108,557</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 292; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Contract
Liabilities</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contract liabilities primarily relate to unsatisfied performance obligations when payments have been received from customers
before the Company&#8217;s products are delivered. Costs of fulfilling customers&#8217; purchase orders, such as shipping, handling and
delivery, which occur prior to the transfer of control, are recognized in selling, general and administrative expense when incurred.
Contract liabilities amounted to $372,295 and $706,974 as of March 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Cost
of revenue</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenue consists primarily of the costs of finished goods manufactured and/or procurement cost of third-party products, freight charges,
depreciation of property and machinery and warehousing expenses. Cost of revenue also includes incremental costs of obtaining sales contract,
which are mainly promotion cost paid to organizers of the Company&#8217;s sales campaigns in the amount in-line with sales revenue realized
at those sales campaigns. The Company uses practical expedient to expense the incremental costs when incurred on the same period sales
revenue realized even though the service agreement executed within one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Research
and development expenses</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expenses all internal research and development costs as incurred, which primarily comprise employee costs, material costs related
to execution of studies, depreciation of equipment used in the research and development activities and research and development service
expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Selling,
General and Administrative Expenses</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
expenses represents primarily costs of payroll and benefits costs for sales team, business travel and meals expenses, as well as marketing
expenses. General and administrative expenses represent primarily payroll and benefits costs for administrative employees, rent and operating
costs of office premises, depreciation and amortization of office facilities, professional fees and other administrative expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Government
subsidies</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
subsidy income primarily relate to government&#8217;s cash award to local companies to promote entrepreneurship, stimulate local economies
and overcome COVID-19 outbreak. Such awards are granted on a case-by-case basis by local government.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes government subsidies as other operating income upon receipt if the subsidies are not subject to any past or future
conditions, there are no performance conditions or conditions of use, and not subject to future refunds. For certain government subsidies
provided to the Company during the COVID-19 epidemic depending on the actual use of the Company&#8217;s warehouse, the amount received
was recognized as other income over the contract term. Government subsidies recognized as other operating income totaled $74,716 and
$69,573 for the years ended March 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Segment
Reporting</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the management approach in determining reportable operating segments. The management approach considers the internal reporting
used by the Company&#8217;s chief operating decision maker for making operating decisions about the allocation of resources of the segment
and the assessment of its performance in determining the Company&#8217;s reportable operating segments. Management has determined that
the Company has one operating segment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 293; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Income
taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for current income taxes in accordance with the laws of the relevant tax authorities. Deferred income taxes are recognized
when temporary differences exist between the tax bases of assets and liabilities and their reported amounts in the consolidated financial
statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years
in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a
change in tax rates is recognized in income in the period including the enactment date. Valuation allowances are established, when necessary,
to reduce deferred tax assets to the amount expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
uncertain tax position is recognized only if it is &#8220;more likely than not&#8221; that the tax position would be sustained in a tax
examination. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination.
For tax positions not meeting the &#8220;more likely than not&#8221; test, no tax benefit is recorded. Penalties and interest incurred
related to underpayment of income tax are classified as income tax expense in the period incurred. No significant penalties or interest
relating to income taxes have been incurred during the years ended March 31, 2024 and 2023. The Company does not believe there was any
uncertain tax provision at March 31, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s subsidiaries in China are subject to the income tax laws of the PRC. No significant income was generated outside the
PRC for the years ended March 31, 2024 and 2023. As of March 31, 2024 and 2023, all of the Company&#8217;s tax returns of its PRC subsidiaries
remain open for statutory examination by PRC tax authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Value
added tax (&#8220;VAT&#8221;)</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
revenue represents the invoiced value of goods, net of VAT. The VAT is based on gross sales price and VAT rates range up to 13%, depending
on the type of products sold. The VAT may be offset by VAT paid by the Company on raw materials and other materials included in the cost
of producing or acquiring its finished products. The Company recorded a VAT payable or receivable net of payments in the accompanying
consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Earnings
per Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company computes earnings per share (&#8220;EPS&#8221;) in accordance with ASC 260, &#8220;Earnings per Share&#8221; (&#8220;ASC 260&#8221;).
ASC 260 requires companies with complex capital structures to present basic and diluted EPS. Basic EPS is measured as net income divided
by the weighted average common shares outstanding for the period. Diluted presents the dilutive effect on a per share basis of potential
common shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented,
or issuance date, if later. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or
decrease loss per share) are excluded from the calculation of diluted EPS. For the years ended March 31, 2024 and 2023, there were no
dilutive shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Foreign
Currency Translation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency and the reporting currency of NewCo and Qianzhi BVI is the U.S Dollar (&#8220;US$&#8221;). Qianzhi HK uses Hong Kong
dollar (&#8220;HK$&#8221;) as its functional currency. The Company operates its business through its subsidiaries in the PRC as of March
31, 2024. The functional currency of the Company&#8217;s subsidiaries is the Chinese Yuan (&#8220;RMB&#8221;). The Company&#8217;s consolidated
financial statements have been translated into US$.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities accounts are translated using the exchange rate at each reporting period end date. Equity accounts are translated at
historical rates. Income and expense accounts are translated at the average rate of exchange during the reporting period. The resulting
translation adjustments are reported under other comprehensive income. Gains and losses resulting from the translations of foreign currency
transactions and balances are reflected in the results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 294; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
RMB is not freely convertible into foreign currency and all foreign exchange transactions must take place through authorized institutions.
No representation is made that the RMB amounts could have been, or could be, converted into US$ at the rates used in translation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table outlines the currency exchange rates that were used in creating the consolidated financial statements:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none">SCHEDULE OF FOREIGN EXCHANGE RATE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March
                                            31, 2024</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March
                                            31, 2023</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Period-end spot rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$1=RMB7.2203</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$1=RMB6.8676</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Average rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$1=RMB7.0440</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$1=RMB6.6035</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Comprehensive
income</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
income consists of two components, net income and other comprehensive income (loss). The foreign currency translation gain or loss resulting
from translation of the financial statements expressed in RMB or HK$ to US$ is reported in other comprehensive income (loss) in the consolidated
statements of income and comprehensive income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Statement
of Cash Flows</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 230, &#8220;Statement of Cash Flows&#8221;, cash flows from the Company&#8217;s operations are formulated based upon
the local currencies. As a result, amounts related to assets and liabilities reported on the consolidated statements of cash flows will
not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Related
parties</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties
are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant
influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject
to common control or significant influence, such as a family member or relative, shareholder, or a related corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Employee
Defined Contribution Plan</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s subsidiaries in the PRC participate in a government-mandated multi-employer defined contribution plan pursuant to which
pension, work-related injury benefits, maternity insurance, medical insurance, unemployment benefit and housing fund are provided to
eligible full-time employees. The relevant labor regulations require the Company&#8217;s subsidiaries in the PRC to pay the local labor
and social welfare authorities monthly contributions based on the applicable benchmarks and rates stipulated by the local government.
The contributions to the plan are expensed as incurred. Employee social security included as expenses in the accompanying consolidated
statements of income and comprehensive income amounted to $97,854 and $86,826 for the years ended March 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Lease</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2021, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2016-02. Under this guidance, the Company determines
if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets,
operating lease liability, and operating lease liability, noncurrent in the Company&#8217;s consolidated balance sheets. ROU assets represent
the Company&#8217;s right to use an underlying asset for the lease term, and lease liabilities represent the Company&#8217;s obligation
to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on
the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate
the lease when it is reasonably certain that it will exercise that option, if any. As the Company&#8217;s leases do not provide an implicit
rate, the Company used an incremental borrowing rate based on the information available at commencement date in determining the present
value of lease payments. The Company has elected to adopt the following lease policies in conjunction with the adoption of ASU 2016-02:
(i) for leases that have lease terms of 12 months or less and does not include a purchase option that is reasonably certain to exercise,
the Company elected not to apply ASC 842 recognition requirements; and (ii) the Company elected to apply the package of practical expedients
for existing arrangements entered into prior to April 1, 2021 to not reassess (a) whether an arrangement is or contains a lease, (b)
the lease classification applied to existing leases, and(c) initial direct costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 295; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Recent
Accounting Standard Adopted</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASC Update No. 2016-13, (Topic 326), Financial Instruments &#8211; Credit Losses: Measurement of Credit Losses
on Financial Instruments. This ASC update introduces new guidance for the accounting for credit losses on financial instruments within
its scope. A new model, referred to as the current expected credit losses model, requires an entity to determine credit-related impairment
losses for financial instruments held at amortized cost and to estimate these expected credit losses over the life of an exposure (or
pool of exposures). The estimate of expected credit losses should consider both historical and current information, reasonable and supportable
forecasts, as well as estimates of prepayments. The estimated credit losses and subsequent adjustment to such loss estimates will be
recorded through an allowance account which is deducted from the amortized cost of the financial instrument, with the offset recorded
in current earnings. ASC No. 2016-13 also modifies the impairment model for available-for-sale debt securities. The new model will require
an estimate of expected credit losses only when the fair value is below the amortized cost of the asset, thus the length of time the
fair value of an available-for-sale debt security has been below the amortized cost will no longer affect the determination of whether
a credit loss exists. In addition, credit losses on available-for-sale debt securities will be limited to the difference between the
security&#8217;s amortized cost basis and its fair value. The updated guidance is effective for all entities other than public companies&#8217;
fiscal years beginning after December 15, 2022. The Company has adopted this accounting standard, effective April 1, 2023. Management
assessed the adoption of this standard on the effective date and concluded that the adoption did not have a material effect on the Company&#8217;s
financial condition, results of operations, and cash flows during the year ended March 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Recently
Issued Accounting Pronouncements Not Yet Adopted</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers the applicability and impact of all accounting standards updates (&#8220;ASUs&#8221;). Management periodically reviews
new accounting standards that are issued. Under the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;),
the Company meets the definition of an emerging growth company, or EGC, and has elected the extended transition period for complying
with new or revised accounting standards, which delays the adoption of these accounting standards until they would apply to private companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes, as part of its Simplification Initiative to
reduce the cost and complexity in accounting for income taxes. This standard removes certain exceptions related to the approach for intra
period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities
for outside basis differences. It also amends other aspects of the guidance to help simplify and promote consistent application of GAAP.
The amendments in these ASUs are effective for the Company&#8217;s fiscal years, and interim periods within those fiscal years beginning
March 31, 2024. The Company does not expect to early adopt this guidance and is in the process of evaluating the impact of adoption of
this guidance on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the FASB issued ASU No. 2021-08, &#8220;Business Combinations (Topic 805): Accounting for Contract Assets and Contract
Liabilities from Contracts with Customers&#8221; (&#8220;ASU 2021-08&#8221;). This ASU requires entities to apply Topic 606 to recognize
and measure contract assets and contract liabilities in a business combination. The amendments improve comparability after the business
combination by providing consistent recognition and measurement guidance for revenue contracts with customers acquired in a business
combination and revenue contracts with customers not acquired in a business combination. The amendments are effective for the Company
beginning after December 15, 2023, and are applied prospectively to business combinations that occur after the effective date. The Company
does not expect the adoption of ASU 2021-04 will have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amended
guidance requires incremental reportable segment disclosures, primarily about significant segment expenses. The amendments also require
entities with a single reportable segment to provide all disclosures required by these amendments, and all existing segment disclosures.
The amendments will be applied retrospectively to all prior periods presented in the financial statements and is effective for fiscal
years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024, with early adoption permitted.
The Company is currently in the process of evaluating the impact this amended guidance may have on the footnotes to its consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 296; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amended guidance enhances
income tax disclosures primarily related to the effective tax rate reconciliation and income taxes paid information. This guidance requires
disclosure of specific categories in the effective tax rate reconciliation and further information on reconciling items meeting a quantitative
threshold. In addition, the amended guidance requires disaggregating income taxes paid (net of refunds received) by federal, state, and
foreign taxes. It also requires disaggregating individual jurisdictions in which income taxes paid (net of refunds received) is equal
to or greater than 5 percent of total income taxes paid (net of refunds received). The amended guidance is effective for fiscal years
beginning after December 15, 2024. The guidance can be applied either prospectively or retrospectively. The Company is currently in the
process of evaluating the impact this amended guidance may have on the footnotes to its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
accounting standards that have been issued by FASB that do not require adoption until a future date are not expected to have a material
impact on the consolidated financial statements upon adoption. The Company does not discuss recent standards that are not anticipated
to have an impact on or are unrelated to its consolidated financial condition, results of operations, cash flows or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 &#8212; ACCOUNTS RECEIVABLE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable, net, consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">21,871</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">42,081</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Accounts receivable &#8211; related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">875,276</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Less: allowance for doubtful accounts</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Accounts receivable, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">21,871</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">917,357</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2024 and 2023, the Company determined that all of the accounts receivable are fully collectible.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 &#8212; INVENTORIES, NET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
consisted of raw materials, finished goods, third-party products and low value consumables, and are stated at the lower of cost or net
realizable value. As of March 31, 2024 and 2023, inventories consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none">SCHEDULE OF INVENTORIES, NET</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Raw materials</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">165,500</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">228,867</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Self-produced finished goods</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">82,462</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">129,060</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">External purchased finished goods</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">113,349</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">95,954</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Low value consumables</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">701</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total inventory</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">361,311</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">454,582</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Inventory valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total inventory, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">361,311</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">454,582</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company performs physical stocktaking periodically and writes off obsolete inventories to the cost of revenue whenever they are identified.
Obsolete inventories in the amount of $16,609 and $21,982 were written-off during the years ended March 31, 2024 and 2023, respectively.
As of March 31, 2024 and 2023, the company has no slow-moving, obsolete, or damaged inventories and thus no inventory reserve deemed
necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 297; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8212; ADVANCES TO SUPPLIERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required from time to time to make cash advances when placing its purchase orders. These advances are settled upon suppliers
delivering third-party products and raw materials to the Company when the transfer of ownership occurs. As of March 31, 2024 and 2023,
advances to suppliers consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF ADVANCES TO SUPPLIERS</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Advances to suppliers to purchase third-party
    products (1)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">724,781</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">824,684</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Advances to suppliers for raw materials</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,776</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">87,791</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Others</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">50,302</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">13,833</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total advances to suppliers</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">783,859</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">926,308</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Less: allowance for doubtful accounts</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Advances to suppliers, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">783,859</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">926,308</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Less: noncurrent portion of advances to suppliers (1)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(586,283</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(446,095</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Current portion of advances to suppliers</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">197,576</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">480,213</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in">(1)</td>
  <td style="text-align: justify">Noncurrent portion of advances to suppliers reflected the long-term advances to one supplier of prepackaged food products, which is reported under &#8220;Deposit and other assets&#8221;. The amount
of noncurrent portion of advances to suppliers as of March 31, 2024 is expected to be fully realized by December 2025.</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2024 and 2023, the Company determined that all of the advances to suppliers are realizable in the future periods.</span></p>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8212; PROPERTY AND EQUIPMENT, NET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment, net, consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As
    of March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Machinery and equipment</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">350,174</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">367,576</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Office equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">53,564</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">56,315</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Automobiles</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">551,786</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">274,340</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Furniture</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14,189</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14,917</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Leasehold improvement</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">38,483</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">40,460</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Subtotal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,008,196</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">753,608</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Property and equipment, gross</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,008,196</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">753,608</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Less: accumulated depreciation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(455,137</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(449,417</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Property and equipment, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">553,059</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">304,191</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the equipment used for manufacturing, the depreciation expense is included as part of manufacturing overhead, while the equipment used
for general administrative are included in selling, general and administrative expense on the statements of operations. For the years
ended March 31, 2024 and 2023, the total depreciation and amortization expenses were $133,083 and $157,487, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8212; CONTRACT LIABILITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contract liabilities primarily relate to unsatisfied performance obligations when payments have been received from customers
before the Company&#8217;s products are delivered. Costs of fulfilling customers&#8217; purchase orders, such as shipping, handling and
delivery, which occur prior to the transfer of control, are recognized in selling, general and administrative expense when incurred.
Contract liabilities amounted to $372,295 and $706,974 as of March 31, 2024 and 2023, respectively. As of the reporting date, approximately
$183,990 or 49.4%, of the March 31, 2024 contract liabilities had been recognized as revenue, and the remaining balance is expected
to be recognized by September, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 298; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8212; <span>DEBT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;DEBTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company borrowed from PRC banks and other financial institutions as working capitals. As of March 31, 2024 and 2023, the Company&#8217;s
debts consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Short-term loans:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF SHORT TERM DEBT</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Note</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Note</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">Short-term bank loans:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Loans from Bank of China:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: justify">Maturity date on August 17, 2023, interest rate 4.18% per annum</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">(1)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">145,611</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Maturity date on December 5, 2024, interest rate 3.77% per annum</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">(2)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">69,249</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">Total short-term loans</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">69,249</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">145,611</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    August 18, 2022, Hubei Qianzhi obtained a line of credit from Bank of China to borrow up to RMB 1 million (equivalent to $145,611)
    loans as working capital for one year, with the maturity date on August 17, 2023. The Company withdrawn RMB 300,000 (equivalent to
    $43,683) on September 6, 2022 and RMB 700,000 (equivalent to $101,928) on December 15, 2022, respectively. There was no guarantee
    requirement for this loan. The loan was fully repaid upon maturity, and $2,468 and $2,215 interest expenses were recorded for the
    years ended March 31, 2024 and 2023.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    December 6, 2023, Hubei Qianzhi obtained another line of credit from Bank of China to borrow up to RMB 1,000,000 (equivalent to $138,498)
    loans as working capital for one year, with interest rate of 3.77% per annum and maturity date on December 5, 2024. The Company withdrawn
    RMB 300,000 (equivalent to $41,549) and RMB 200,000 (equivalent to $27,700) on December 11, 2023 and January 24, 2024, respectively.
    There was no guarantee requirement for this loan, and $620 interest expenses were recorded for the year ended March 31, 2024.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Long-term loans:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF LONG TERM LOANS</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Note</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Note</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">Long-term bank loans:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Loans from Webank Co., Ltd.:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: justify">Maturity date on December 23, 2024, interest rate 9.9792% per annum</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">(3)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">29,122</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Less: current portion of long-term loans</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(16,641</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">Total long-term loans</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">12,481</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2023,
the Company&#8217;s subsidiary, Qianzhi Health entered into a loan agreement with Shenzhen Qianhai WeBank Co., Ltd, to borrow RMB 200,000
(equivalent to US$29,122) as working capital for 24 months, with maturity date on December 23, 2024 and interest rate of 9.9792% per
annum. The Company&#8217;s CFO, Mr. Liangwen Wang provided personal guarantee to this loan. The loan was fully repaid on September 28,
2023.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 299; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8212; RELATED PARTY TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Nature of relationships with related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEUDLE
OF NATURE OF RELATIONSHIPS WITH RELATED PARTIES</span></span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship
    with the Company</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Xiaoqin Lin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&#8217;s controlling shareholder, Chief Executive Officer and chairman of the Company&#8217;s Board of Directors</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Liangwen Wang</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Yuetao Lin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    and Senior Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Xiaoling Yuan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Juxiang Hu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    and Senior Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Yanmin Liu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Yajun Sun</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Liangming Hu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Management of the Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Lizhong Ge</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Husband
    of Ms. Xiaoqin Lin</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shenzhen
    Yelin Network Technology Co., Ltd (&#8220;Shenzhen Yelin&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    common control of Ms. Xiaoqin Lin, whose ownership were disposed on January 4, 2023. Ms. Xiaoqin Lin has significant influence over Shenzhen Yelin after the disposal. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Sales transactions and accounts receivables &#8211; related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company sold its self-produced products to Shenzhen Yelin in the amounts of $234,593 and $51,546 during the years ended March 31, 2024
and 2023 with accounts receivable balances of $Nil and $875,276 as of March 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company sold its self-produced products to Ms. Juxiang Hu, Ms. Yuetao Lin and Ms. Xiaoling Yuan in the amounts of $62,804, $62,799 and
$62,809, respectively during the year ended March 31, 2024, and accounts receivable balance with these individuals as of March 31, 2024
was $Nil. There were no sales transactions with these individuals during the year ended March 31, 2023, and accounts receivable balance
with these individuals as of March 31, 2023 was $Nil.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Other receivables &#8211; related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company advanced funds to Shenzhen Yelin for general working capital needs of Shenzhen Yelin, to officers as petty cash to cover minor
expenses of the Company, and advanced salaries to employees for their personal use. Such advance was non-interest bearing and due on
demand. The other receivables due from related parties as of March 31, 2024 and 2023 were as followings:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF OTHER RECEIVABLES RELATED PARTIES</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Name</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Nature</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: justify">Shenzhen Yelin</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: justify">Advanced funds to Shenzhen Yelin for its general working capital needs</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">1,768,718</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Ms. Yanmin Liu</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Advanced salary to employees for their personal use</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">27,700</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Ms. Yajun Sun</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Advanced salary to employees for their personal use</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">17,174</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">20,672</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Ms. Juxiang Hu</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Petty cash</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">23,212</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Others</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Advanced salary to employees for their personal use</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">20,166</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Total other receivables &#8211; related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">68,086</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,809,556</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Loans to related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF LOANS TO   RELATED PARTIES</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Name</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Note</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Name</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Note</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: justify">Mr. Liangwen Wang</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">(1)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">29,122</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Loans to related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">(1)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">29,122</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 1, 2023, Mr. Liangwen Wang borrowed RMB 200,000 (equivalent to US$29,122) from the Company for a term of twenty-four months,
    with maturity date on December 23, 2024 and interest rate of 9.9792% per annum. The loan was fully repaid on September 28, 2023.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 300; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(e)
Other payables &#8211; related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">balance of other payables &#8211; related parties
were comprised of the Company&#8217;s advances from Ms. Xiaoqin Lin used for working capital during the Company&#8217;s normal course
of business, and payment of expenses made by related parties on behalf of the Company. Such advance was non-interest bearing and due
on demand. The other payables due to related parties as of March 31, 2024 and 2023 were as followings:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF OTHER PAYABLES RELATED PARTIES</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Name</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Name</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Ms. Xiaoqin Lin</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">276,533</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">36,099</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Mr. Liangming Hu</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">38,991</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">40,771</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Mr. Lizhong Ge</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">24,026</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Others</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">55</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,758</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">Total other payables &#8211; related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">315,579</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">105,654</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Qianzhi Biotechnology, Shenzhen Yelin and Ms. Xiaoqin
Lin entered into an agreement that Shenzhen Yelin collected cash in the amount of $1,027,129 for products sold by Qianzhi Biotechnology,
and made reimbursement of the same amount to Ms. Xiaoqin Lin for her payment of business combination expenses on behalf of the
Company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(f)
Loan guarantee provided by related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Company&#8217;s long-term loans borrowed from Webank Co., Ltd., the Company&#8217;s CFO, Mr. Liangwen Wang provided
personal loan guarantee without additional compensation (see Note 9).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 &#8212; TAXES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Corporate Income Taxes (&#8220;CIT&#8221;)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Cayman
Islands and British Virgin Islands (&#8220;BVI&#8221;)</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is incorporated in the Cayman Islands and its wholly-own subsidiary, Qianzhi BVI is incorporated in BVI. Under the current tax
laws of the Cayman Islands and the BVI, these entities are not subject to taxes on their income or capital gains. In addition, dividend
payments are not subject to withholdings tax in the Cayman Islands and the BVI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Hong
Kong</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
HK is incorporated in Hong Kong and is subject to profit taxes in Hong Kong at a rate of 16.5%. However, Qianzhi HK did not generate
any assessable profits derived from Hong Kong sources for the years ended March 31, 2024 and 2023, and accordingly no provision for Hong
Kong profits tax has been made in these periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">PRC</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Enterprise Income Tax (&#8220;EIT&#8221;) Law of PRC, domestic enterprises and Foreign Investment Enterprises (&#8220;FIEs&#8221;)
are usually subject to a unified 25% enterprise income tax rate while preferential tax rates, tax holidays and even tax exemption may
be granted on a case-by-case basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s wholly owned subsidiaries - Shenzhen Qianzhi, Jiangxi Qianzhi, Qianzhi Biotech and Qianzhi Health are incorporated in
the PRC and qualified as small-scaled minimal profit enterprises for the years ended March 31, 2024 and 2023. Based on the EIT Law of
PRC, and according to the Announcement on Issues Related to the Implementation of Inclusive Income Tax Reduction and Exemption Policy
for Small and Low Profit Enterprises issued by the State Administration of Taxation, from January 1, 2022 to December 31, 2024, once
an enterprise meets certain requirements and is identified as a small-scale minimal profit enterprise, its taxable income is entitled
to a reduced income tax rate ranging from 2.5% to 5% depending on the amount and period of taxable income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 301; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIT
grants preferential tax treatment to High and New Technology Enterprises (&#8220;HNTEs&#8221;). Under this preferential tax treatment,
HNTEs are entitled to an income tax rate of 15%, subject to a requirement that they re-apply for their HNTE status every three years.
Hubei Qianzhi, one of the Company&#8217;s main operating subsidiaries in the PRC, was approved as a HNTE and is entitled to a reduced
income tax rate of 15% beginning November 2022 with a term of three years. Although Hubei Qianzhi was approved as a HNTE and enjoying
a 15% reduced income tax rate, it incurred accumulated loss as of March 31, 2024, with no impact of the tax holidays on PRC corporate
income taxes for the years ended March 31, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the income tax provision (benefit) are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF INCOME TAX PROVISION</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Current tax provision:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Cayman and BVI</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Hong Kong</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">PRC</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">352,475</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">162,817</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Sub-total</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">352,475</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">162,817</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Current tax provision</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">352,475</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">162,817</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Deferred tax provision (benefit):</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Cayman and BVI</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Hong Kong</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">PRC</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Sub-total</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Deferred tax provision</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total income tax provision</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">352,475</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">162,817</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reconciles the China statutory rates to the Company&#8217;s effective tax rates for the years ended March 31, 2024 and
2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF EFFECTIVE TAX RATES</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">PRC statutory income tax rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">25.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">25.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Effect of PRC preferential tax rate and tax exemption</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6.3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(21.2</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Research and development tax credit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(0.5</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(0.2</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.5</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Tax effect of the non-profit subsidiaries</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(0.4</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Other PRC effect</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1.3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Non-PRC entities not subject to PRC income tax</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(120.5</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Effective tax rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(102.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4.2</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company continually evaluates expiring statutes of limitations, audits, proposed settlements, changes in tax law and new authoritative
rulings. As of March 31, 2024, all of the Company&#8217;s tax returns of its PRC subsidiaries remain open for statutory examination by
PRC tax authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are composed of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Deferred tax assets derived from net operating loss (&#8220;NOL&#8221;) carry forwards
    and deferred revenue</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">32,169</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">74,523</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Less: valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(32,169</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(74,523</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total deferred tax assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company periodically evaluates the likelihood of the realization of deferred tax assets, and reduces the carrying amount of the deferred
tax assets by a valuation allowance to the extent it believes a portion will not be realized. Management considers new evidence, both
positive and negative, that could affect the Company&#8217;s future realization of deferred tax assets including its recent cumulative
earnings experience, expectation of future income, the carry forward periods available for tax reporting purposes and other relevant
factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 302; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Taxes payable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes
payable consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF TAXES PAYABLE</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Income tax payable</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">349,282</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">78,450</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Value added tax payable, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">144,858</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">254,161</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Other taxes payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,931</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">17,584</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total taxes payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">507,071</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">350,195</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>
<!-- Field: Split-Segment; Name: 002 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12 - OPERATING LEASE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases factory and storehouse in Ezhou City, Hubei Province of China, and office spaces in Shenzhen City, Guangdong Province
of China, with terms ranging from 20 months to eight years. The Company considers those renewal or termination options that are reasonably
certain to be exercised in the determination of the lease term and initial measurement of ROU assets and lease liabilities. Leases with
initial term of 12 months or less are not recorded on the balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines whether a contract is or contains a lease at inception of the contract and whether that lease meets the classification
criteria of a finance or operating lease. When available, the Company uses the rate implicit in the lease to discount lease payments
to present value; however, most of the Company&#8217;s leases do not provide a readily determinable implicit rate. Therefore, the Company
discounts lease payments based on an estimate of its incremental borrowing rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below presents the operating lease related assets and liabilities recorded on the balance sheets:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF OPERATING LEASE RELATED ASSETS AND LIABILITIES</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Operating lease assets:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Operating lease right of use assets</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">599,088</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">263,789</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total operating lease assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">599,088</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">263,789</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#12288;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#12288;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#12288;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Operating lease obligations:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Current operating lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">213,490</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">132,981</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Noncurrent operating lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">354,178</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">121,449</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total operating lease obligations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">567,668</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">254,430</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average remaining lease term and the weighted-average discount rate of leases are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;SCHEDULE
OF WEIGHTED AVERAGE REMAINING LEASE TERM AND DISCOUNT</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2024</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify">Weighted-average remaining lease term</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7
                                            years</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Weighted-average discount rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4.77</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the maturity of operating lease liabilities as of March 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">SCHEDULE
OF MATURITY OF OPERATING LEASE LIABILITIES</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: justify">Years ending March 31,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">US$</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify">2025</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">236,035</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">2026</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">244,100</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">2027</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">105,593</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">2028</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">20,038</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total lease payments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">605,766</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Less: imputed interest</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(38,098</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">567,668</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 303; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13 &#8212; SHAREHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ordinary
Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NewCo
was incorporated under the laws of the Cayman Islands on August 14, 2023. The authorized number of ordinary shares was 50,000 shares
with par value of US$1.00 per share and 50,000 shares were issued (see Note 1).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Statutory
reserve and restricted net assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relevant
PRC laws and regulations restrict the Company&#8217;s PRC subsidiaries from transferring a portion of their net assets, equivalent to
their statutory reserves and their share capital, to the Company in the form of loans, advances or cash dividends. Only PRC entities&#8217;
accumulated profits may be distributed as dividends to the Company without the consent of a third party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to make appropriations to certain reserve funds, comprising the statutory surplus reserve and the discretionary surplus
reserve, based on after-tax net income determined in accordance with generally accepted accounting principles of the PRC (&#8220;PRC
GAAP&#8221;). Appropriations to the statutory surplus reserve are required to be at least 10% of the after-tax net income determined
in accordance with PRC GAAP until the reserve is equal to 50% of the entity&#8217;s registered capital. Appropriations to the discretionary
surplus reserve are made at the discretion of the Board of Directors. The statutory reserve may be applied against prior year losses,
if any, and may be used for general business expansion and production or increase in registered capital, but are not distributable as
cash dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
payment of dividends by entities organized in China is subject to limitations, procedures and formalities. Regulations in the PRC currently
permit payment of dividends only out of accumulated profits as determined in accordance with accounting standards and regulations in
China. The results of operations reflected in the consolidated financial statements prepared in accordance with U.S GAAP differ from
those in the statutory financial statements of its subsidiaries. Remittance of dividends by a wholly foreign-owned company out of China
is subject to examination by the banks designated by State Administration of Foreign Exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
light of the foregoing restrictions, the Company&#8217;s subsidiaries are restricted in their ability to transfer their net assets to
the Company. Foreign exchange and other regulations in the PRC may further restrict its subsidiaries from transferring funds to the Company
in the form of dividends, loans and advances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2024 and 2023, the restricted amounts as determined pursuant to PRC statutory laws totaled $461,228 and $341,044, respectively,
and total restricted net assets amounted to $3,545,620 and $3,425,436, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14 &#8212; CONCENTRATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
majority of the Company&#8217;s revenue and expense transactions are denominated in RMB and a significant portion of the Company and
its subsidiaries&#8217; assets and liabilities are denominated in RMB. RMB is not freely convertible into foreign currencies. In the
PRC, certain foreign exchange transactions are required by law to be transacted only by authorized financial institutions at exchange
rates set by the People&#8217;s Bank of China (&#8220;PBOC&#8221;). Remittances in currencies other than RMB by the Company in China
must be processed through the PBOC or other China foreign exchange regulatory bodies which require certain supporting documentation in
order to affect the remittance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains cash with financial institutes, such as banks, in the PRC. Should any bank holding cash become insolvent, or if the
Company is otherwise unable to withdraw funds, the Company would lose the cash with that bank; however, the Company has not experienced
any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank accounts. In China, a depositor
has up to RMB500,000 insured by the People&#8217;s Bank of China Financial Stability Bureau (&#8220;FSD&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 304; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to significant concentrations of credit risk are cash and cash equivalents and accounts
receivable. As of March 31, 2024 and 2023, $2,961,187 and $1,986,923 of the Company&#8217;s cash held by financial
institutions were uninsured, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended March 31, 2024 and 2023, the Company&#8217;s substantial assets were located in the PRC and the Company&#8217;s substantial
revenues were derived from its subsidiaries located in the PRC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended March 31, 2024, one customer accounted for 11.5% of the Company&#8217;s total revenue, and its account receivable balance
was $Nil as of March 31, 2024. For the year ended March 31, 2023, one customer accounted for 11.2% of the Company&#8217;s total revenue,
and its account receivable balance was Nil as of March 31, 2023. The Company&#8217;s top 10 customers aggregately accounted for 42.6%
and 35.3% of the total revenue for the years ended March 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of one of the Company&#8217;s major products, ozone sterilization product, accounted for 52.6% and 55.1% of the Company&#8217;s total
revenue for the years ended March 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2024, two customers accounted for 17.0% and 11.6% of the total accounts receivable balance, respectively. As of March 31,
2023, four customers accounted for 25.7%, 18.7%, 14.3%, and 13.1% of the total accounts receivable balance, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2024, one supplier accounted for 92.5% of the total advances to supplier balance. As of March 31, 2023, one supplier accounted
for 78.8% of the total advances to supplier balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended March 31, 2024, four suppliers accounted for 20.9%, 16.4%, 15.2% and 11.5% of the total purchases, respectively. For the
year ended March 31, 2023, one supplier accounted for 15.6% of the total purchases. The Company&#8217;s top 10 supplier aggregately accounted
for 90.8% and 60.7% of the total purchases for the years ended March 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15 &#8212; COMMITMENTS AND CONTINGENCIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company is a party to various legal actions arising in the ordinary course of business. The Company accrues costs associated
with these matters when they become probable and the amount can be reasonably estimated. Legal costs incurred in connection with loss
contingencies are expensed as incurred. For the years ended March 31, 2024 and 2023, the Company did not have any material legal claims
or litigation that, individually or in aggregate, could have a material adverse impact on the Company&#8217;s consolidated financial
position, results of operations and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company lease factory and storehouse in Ezhou City, Hubei Province of China, and office spaces in Shenzhen City, Guangdong Province of
China, with terms ranging from 20 months to eight years. (see Footnote 12 &#8211; Operating lease, for details)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span>&#8212; CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Rule 12-04(a), 5-04(c) and 4-08(e)(3) of Regulation S-X, the condensed financial information of the parent company
shall be filed when the restricted net assets of consolidated subsidiaries exceed 25 percent of consolidated net assets as of the end
of the most recently completed fiscal year. The Company performed a test on the restricted net assets of consolidated subsidiaries in
accordance with such requirement and concluded that it was applicable to the Company as the restricted net assets of the Company&#8217;s
subsidiaries exceeded 25% of the consolidated net assets of the Company. Therefore, the condensed financial statements for the parent
company are included herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 305; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the above test, restricted net assets of consolidated subsidiaries shall mean that amount of the Company&#8217;s proportionate
share of net assets of consolidated subsidiaries (after intercompany eliminations) which as of the end of the most recent fiscal year
may not be transferred to the parent company by subsidiaries in the form of loans, advances or cash dividends without the consent of
a third party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
condensed financial information of the parent company has been prepared using the same accounting policies as set out in the Company&#8217;s
condensed consolidated financial statements except that the parent company used the equity method to account for investment in its subsidiaries.
Such investment is presented on the condensed balance sheets as &#8220;Investment in subsidiaries&#8221; and the respective profit or
loss as &#8220;Equity in earnings of subsidiaries&#8221; on the condensed statements of income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
footnote disclosures contain supplemental information relating to the operations of the Company and, as such, these statements should
be read in conjunction with the notes to the consolidated financial statements of the Company. Certain information and footnote disclosures
normally included in financial statements prepared in accordance with U.S GAAP have been condensed or omitted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not pay any dividend for the periods presented. As of March 31, 2024 and 2023, there were no material contingencies, significant
provisions for long-term obligations, or guarantees of the Company, except for those which have been separately disclosed in the consolidated
financial statements, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PARENT
COMPANY BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="display: none">SCHEDULE
OF CONDENSED CONSOLIDATED FINANCIAL STATEMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">ASSETS</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">CURRENT ASSETS</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Prepayment for IPO expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">394,161</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">NON-CURRENT ASSETS</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Investment in subsidiaries</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,221,436</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,998,829</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">TOTAL ASSETS</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,615,597</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,998,829</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">CURRENT LIABILITIES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Other payables &#8211; related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,199,315</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Due to subsidiaries</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,385,779</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">60,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">TOTAL CURRENT LIABILITIES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,645,094</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">COMMITMENTS AND CONTINGENCIES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">SHAREHOLDERS&#8217; EQUITY</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Ordinary shares, $1.00 par value, 50,000 shares authorized, 50,000 shares
    issued and outstanding</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Additional paid-in capital</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,034,392</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,034,392</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Retained earnings</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,421,012</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,119,186</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Accumulated other comprehensive loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(534,901</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(204,749</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">TOTAL SHAREHOLDERS&#8217; EQUITY</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,970,503</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,998,829</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,615,597</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,998,829</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 306; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PARENT
COMPANY STATEMENTS OF COMPREHENSIVE INCOME</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Operating costs and expenses:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: justify">General and administrative expenses</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(2,250,933</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Equity in earnings of subsidiaries</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,552,759</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,591,998</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">NET (LOSS) INCOME</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(698,174</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,591,998</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Foreign currency translation adjustment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(330,152</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(352,103</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO THE COMPANY</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,028,326</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,239,895</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 307; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PARENT
COMPANY STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended March 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">CASH FLOWS FROM OPERATING ACTIVITIES:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: justify">Net (loss) income</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(698,174</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">3,591,998</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify">Adjustments to reconcile net cash flows from operating activities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: justify">Equity in earnings of subsidiaries</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,552,759</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(3,591,998</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify">Changes in operating assets and liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: justify">Prepayment for IPO expense</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(394,161</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: justify">Other payables &#8211; related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,199,315</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: justify">Due to subsidiaries</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,385,779</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: justify">Other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">60,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Net cash provided by operating activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">CHANGES IN CASH</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">CASH, beginning of period</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">CASH, end of period</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 308; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INDEX
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="#a_003">Consolidated Balance Sheets as of June 30, 2024 (Unaudited) and December 31, 2023 (Audited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in">F-56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="#a_004">Consolidated Statements of Operations (Unaudited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">F-57</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="#a_005">Consolidated Statements of Changes in Shareholders&#8217; Equity (Unaudited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">F-58</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="#a_006">Consolidated Statements of Cash Flows (Unaudited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">F-59</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="#vi_001">Unaudited Notes to the Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: -10pt; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">F-60</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 309; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p id="xdx_041_c20240101__20240630_zddts7rgZNVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_304_111_zTloOLPfslre" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240630_zC16lfbPaY5l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20231231_zSaFvVgTKUIi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsAbstract_iB_ziDansqmGCP4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrentAbstract_i01B_z25yl22C8Dn3" style="display: none; vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current assets:</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--Cash_i01I_maACzEoK_zno424H3yF9c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2024-06-30" id="Fact000040" format="ixt:numdotdecimal" decimals="0" unitRef="USD">272,630</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-12-31" id="Fact000041" format="ixt:numdotdecimal" decimals="0" unitRef="USD">426,913</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PrepaidExpenseCurrent_i01I_maACzEoK_zhSY0meK2KL4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2024-06-30" id="Fact000043" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,209</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2023-12-31" id="Fact000044" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,481</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherReceivablesNetCurrent_i01I_maACzEoK_zv27HiDA6Pzh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other receivable (Note 6)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2024-06-30" id="Fact000046" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,199</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0047">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AssetsCurrent_i01TI_mtACzEoK_maAzRRr_zEwvKuIymQx5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Total Current Assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-06-30" id="Fact000049" format="ixt:numdotdecimal" decimals="0" unitRef="USD">360,038</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31" id="Fact000050" format="ixt:numdotdecimal" decimals="0" unitRef="USD">506,394</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsHeldInTrustNoncurrent_i01I_maAzRRr_zZWKrMsJEAz9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Investment held in Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2024-06-30" id="Fact000052" format="ixt:numdotdecimal" decimals="0" unitRef="USD">73,284,700</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-12-31" id="Fact000053" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,419,358</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AssetsNoncurrent_i01TI_mtANzyez_maAzROw_zyUcNyNYk3m1" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2023-12-31" id="Fact000056" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,419,358</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--Assets_i01TI_mtAzRRr_znWhM5qv44s4" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-06-30" id="Fact000058" format="ixt:numdotdecimal" decimals="0" unitRef="USD">73,644,738</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31" id="Fact000059" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,925,752</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z2Z3d1LPcwaf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesCurrentAbstract_i01B_zt38d4wAaHYa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AccruedLiabilitiesCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_maLCzzgc_zfgUMSFyrKag" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued offering costs and expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-06-30_us-gaap_NonrelatedPartyMember" id="Fact000067" format="ixt:numdotdecimal" decimals="0" unitRef="USD">189,730</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember" id="Fact000068" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,610</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AccruedLiabilitiesCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzzgc_zX6Psp2zC113" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued expenses - related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember" id="Fact000070" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="Fact000071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,250</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzzgc_zSQttJU1ZcSa" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued expenses </td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember" id="Fact000073" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="Fact000074" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,250</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--LiabilitiesCurrent_i02TI_mtLCzzgc_maLzov1_zp64xlwWt8d8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Current Liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000076" format="ixt:numdotdecimal" decimals="0" unitRef="USD">219,730</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000077" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,860</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Liabilities_i01TI_mtLzov1_maLASEzVp5_zkhCVPBnTlJl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-06-30" id="Fact000079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">219,730</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31" id="Fact000080" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,860</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzVp5_zygrNSmEEuN1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Commitments and contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0082">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0083">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i01I_maLASEzVp5_zDk19Eu2elzg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Ordinary shares subject to possible redemption, <span id="xdx_90C_ecustom--OrdinarySharesSubjectToRedemption_iI_c20240630_zBjGmq3SjFWf" title="Ordinary shares subject to redemption"><span id="xdx_905_ecustom--OrdinarySharesSubjectToRedemption_iI_c20231231_z9ZUk04mVW08" title="Ordinary shares subject to redemption"><ix:nonFraction name="BOWN:OrdinarySharesSubjectToRedemption" contextRef="AsOf2024-06-30" id="Fact000088" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="BOWN:OrdinarySharesSubjectToRedemption" contextRef="AsOf2023-12-31" id="Fact000090" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></ix:nonFraction></span></span> shares at redemption value of $<span id="xdx_90A_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_c20240630_zHgIPDGCMSw8" title="Ordinary shares redemption value per share"><span title="Ordinary shares subject to redemption par value"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2024-06-30" id="Fact000092" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.62</ix:nonFraction></span></span> and $<span id="xdx_901_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_c20231231_zZAhOWOrf3Bi" title="Ordinary shares redemption value per share"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000094" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.35</ix:nonFraction></span> per share as of June 30, 2024 and December 31, 2023, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2024-06-30" id="Fact000085" format="ixt:numdotdecimal" decimals="0" unitRef="USD">73,284,700</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31" id="Fact000086" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,419,358</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquityAbstract_i01B_zeN04kPe4LN9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Shareholders&#8217; Equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--PreferredStockValue_i02I_maSEzPmX_zC66qN808UEl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Preferred shares, $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240630_zIIkTYz937y5" title="Preferred stock, par value"><span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zLshupfGms16" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30" id="Fact000102" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000104" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240630_zlUDzbN1gDH8" title="Preferred stock, shares authorized"><span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_ziLRJMX4HZX7" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-06-30" id="Fact000106" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000108" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_dn_c20240630_zNJ1JElEjOS7" title="Preferred stock, shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_dn_c20231231_zcYr4CRwI3L4" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20240630_zXgENcist2f" title="Preferred stock, shares outstanding"><span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20231231_zEzjTrqdN07j" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-06-30" id="Fact000110" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000112" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-06-30" id="Fact000114" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000116" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0099">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0100">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CommonStockValue_i02I_maSEzPmX_znlRu6C3adWb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ordinary shares, $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240630_zp0NjmYVIfM" title="Ordinary stock, par value"><span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231231_zy3oJZgS6eta" title="Ordinary stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30" id="Fact000121" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000123" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240630_zCognAr79po2" title="Ordinary stock, shares authorized"><span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zozH6Sw19MEl" title="Ordinary stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-06-30" id="Fact000125" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000127" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_pid_c20240630_zcd1dbDvrRlg" title="Ordinary stock, shares issued"><span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zVKCC1IHHO9f" title="Ordinary stock, shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240630_zIkC2ZeXnDWb" title="Ordinary stock, shares outstanding"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zZeOLUJRC0Vd" title="Ordinary stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-06-30" id="Fact000129" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000131" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30" id="Fact000133" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000135" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding (excluding <span id="xdx_904_ecustom--OrdinarySharesSubjectToRedemption_iI_pid_c20240630_zWUPbCjIcn79" title="Ordinary shares subject to redemption"><span id="xdx_900_ecustom--OrdinarySharesSubjectToRedemption_iI_pid_c20231231_zNZC1ypYxj1" title="Ordinary shares subject to redemption"><ix:nonFraction name="BOWN:OrdinarySharesSubjectToRedemption" contextRef="AsOf2024-06-30" id="Fact000137" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="BOWN:OrdinarySharesSubjectToRedemption" contextRef="AsOf2023-12-31" id="Fact000139" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></ix:nonFraction></span></span> shares subject to redemption on June 30, 2024 and December 31, 2023, respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-06-30" id="Fact000118" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31" id="Fact000119" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AdditionalPaidInCapital_i02I_maSEzPmX_zH77fUR2LN4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0141">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0142">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCzMJv_maSEzPmX_zhcRBQCzQekj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Retained earnings</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-06-30" id="Fact000144" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,081</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31" id="Fact000145" format="ixt:numdotdecimal" decimals="0" unitRef="USD">402,307</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockholdersEquity_i02TI_mtSEzPmX_maLASEzVp5_zY3jwWZo9c1a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Shareholders&#8217; Equity</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000147" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,308</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000148" format="ixt:numdotdecimal" decimals="0" unitRef="USD">402,534</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzVp5_zPrIhE3oQcIb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">T<b>otal Liabilities and Shareholders&#8217; Equity</b></span></td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000150" format="ixt:numdotdecimal" decimals="0" unitRef="USD">73,644,738</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000151" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,925,752</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 310; Options: NewSection; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_004"></span>CONSOLIDATED
STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_113_zRL5P8qVMSd6" summary="xdx: Statement - Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240401__20240630_z77dAHzbUPx9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230401__20230630_zUh1fnCUdwoe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20240101__20240630_za0ZEiCfNtA4">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230217__20230630_zqeskDUfSG98">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended<br/>
June 30, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Period from <br/>
February 17, 2023 (Inception) Through <br/>
June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_msCzPB4_z9Gc3tRk99Ef" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left; padding-bottom: 1.5pt">Formation and operating costs</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2024-04-012024-06-30" id="Fact000153" format="ixt:numdotdecimal" decimals="0" unitRef="USD">125,096</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0154">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2024-01-01to2024-06-30" id="Fact000155" format="ixt:numdotdecimal" decimals="0" unitRef="USD">262,226</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-02-172023-06-30" id="Fact000156" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,105</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OperatingIncomeLoss_iT_mtCzPB4_maCzGNF_zDD5ksY8Rjm8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-04-012024-06-30" id="Fact000158" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">125,096</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0159">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-01-01to2024-06-30" id="Fact000160" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">262,226</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-02-172023-06-30" id="Fact000161" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherNonoperatingIncomeExpenseAbstract_iB_zBdmldjyll74" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other Income:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeLossFromEquityMethodInvestments_i01_maCzxOo_zIDi70hB0ifg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Interest earned on investments held in trust account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2024-04-012024-06-30" id="Fact000168" format="ixt:numdotdecimal" decimals="0" unitRef="USD">941,850</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0169">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2024-01-01to2024-06-30" id="Fact000170" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,865,342</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0171">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherNonoperatingIncomeExpense_i01T_mtCzxOo_maCzGNF_zrB5dQ2O0Zx9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2024-04-012024-06-30" id="Fact000173" format="ixt:numdotdecimal" decimals="0" unitRef="USD">941,850</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0174">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2024-01-01to2024-06-30" id="Fact000175" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,865,342</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0176">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLoss_iT_mtCzGNF_zkNxCP8c5qc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30" id="Fact000178" format="ixt:numdotdecimal" decimals="0" unitRef="USD">816,754</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0179">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-06-30" id="Fact000180" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,603,116</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-06-30" id="Fact000181" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted average common stock outstanding, common stock subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zapOqR6iTlBf" title="Basic weighted average ordinary shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zEjLux9z25af" title="Diluted weighted average ordinary shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-04-012024-06-30_custom_RedeemableOrdinarySharesMember" id="Fact000183" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-04-012024-06-30_custom_RedeemableOrdinarySharesMember" id="Fact000185" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zdNzV0XKUfli" title="Basic weighted average ordinary shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zlSRJnwEamef" title="Diluted weighted average ordinary shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span style="-sec-ix-hidden: xdx2ixbrl0187"><span style="-sec-ix-hidden: xdx2ixbrl0189">-</span></span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_z4l4tKiZEVy7" title="Basic weighted average ordinary shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_z25Zi6rynFo7" title="Diluted weighted average ordinary shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-012024-06-30_custom_RedeemableOrdinarySharesMember" id="Fact000191" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-012024-06-30_custom_RedeemableOrdinarySharesMember" id="Fact000193" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zNHG1pyKUAZ1" title="Basic weighted average ordinary shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zBuqvKoFKYsi" title="Diluted weighted average ordinary shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span style="-sec-ix-hidden: xdx2ixbrl0195"><span style="-sec-ix-hidden: xdx2ixbrl0197">-</span></span></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Basic and diluted net income per share, common stock subject to redemption</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span id="xdx_90F_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_z3Fffxbga0Yj" title="Basic net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zFgFelWQhs91" title="Diluted net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-04-012024-06-30_custom_RedeemableOrdinarySharesMember" id="Fact000199" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-04-012024-06-30_custom_RedeemableOrdinarySharesMember" id="Fact000201" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.12</ix:nonFraction></ix:nonFraction></span></span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span id="xdx_904_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zhVeSU9WDoq3" title="Basic net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zN0zyHFxHZY3" title="Diluted net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span style="-sec-ix-hidden: xdx2ixbrl0203"><span style="-sec-ix-hidden: xdx2ixbrl0205">-</span></span></span></span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span id="xdx_901_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zTST5heLK6ka" title="Basic net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_904_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zaUSCYdqEwP4" title="Diluted net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-01-012024-06-30_custom_RedeemableOrdinarySharesMember" id="Fact000207" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-012024-06-30_custom_RedeemableOrdinarySharesMember" id="Fact000209" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.24</ix:nonFraction></ix:nonFraction></span></span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span id="xdx_907_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zQvB4cQl6Zhl" title="Basic net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zGJJLUQif1Kh" title="Diluted net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span style="-sec-ix-hidden: xdx2ixbrl0211"><span style="-sec-ix-hidden: xdx2ixbrl0213">-</span></span></span></span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average common stock outstanding, common stock, non-redeemable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_zHoSLeBeoJy7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-04-012024-06-30_custom_NonRedeemableOrdinarySharesMember" id="Fact000214" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_fKDEp_zIpFhYhrPxN1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-04-012023-06-30_custom_NonRedeemableOrdinarySharesMember" id="Fact000215" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,680,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_z4mOOLQD0aTb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-012024-06-30_custom_NonRedeemableOrdinarySharesMember" id="Fact000216" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_fKDEp_zvDndY7N49Gi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-02-172023-06-30_custom_NonRedeemableOrdinarySharesMember" id="Fact000217" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,656,774</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Basic and diluted net loss per share, common stock, non-redeemable</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span id="xdx_903_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_zpA66AxquYEi" title="Basic net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_zL3eTorLGp3f" title="Diluted net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-04-012024-06-30_custom_NonRedeemableOrdinarySharesMember" id="Fact000219" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-04-012024-06-30_custom_NonRedeemableOrdinarySharesMember" id="Fact000221" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span id="xdx_90F_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_zUjsaoyWl7L" title="Basic net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_zibk3NXgd3B3" title="Diluted net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span style="-sec-ix-hidden: xdx2ixbrl0223"><span style="-sec-ix-hidden: xdx2ixbrl0225">-</span></span></span></span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_zX1G4uYe3S67" title="Basic net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_901_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_zHYQgNbF22Hg" title="Diluted net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-01-012024-06-30_custom_NonRedeemableOrdinarySharesMember" id="Fact000227" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-012024-06-30_custom_NonRedeemableOrdinarySharesMember" id="Fact000229" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.03</ix:nonFraction></ix:nonFraction></span></span></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span id="xdx_909_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_zsb0w8FfNdO7" title="Basic net income (loss) per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_904_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_zyIMmIAu2HD" title="Diluted net income (loss) per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-02-172023-06-30_custom_NonRedeemableOrdinarySharesMember" id="Fact000231" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-02-172023-06-30_custom_NonRedeemableOrdinarySharesMember" id="Fact000233" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.002</ix:nonFraction></ix:nonFraction></span></span></td><td style="font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0A_z6yFp5zIufN8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1E_zJj8GglxKa9i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000234" xml:lang="en-US">Excludes
    an aggregate of up to <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230401__20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zUCnGgKbTQq4" title="Ordinary shares subject to forfeiture"><span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230217__20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zGqdNySigYo3" title="Ordinary shares subject to forfeiture"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-04-012023-06-30_srt_MaximumMember_us-gaap_OverAllotmentOptionMember" id="Fact000236" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-02-172023-06-30_srt_MaximumMember_us-gaap_OverAllotmentOptionMember" id="Fact000238" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225,000</ix:nonFraction></ix:nonFraction></span></span> ordinary shares subject to forfeiture depending on the extent to which the over-allotment option is
    exercised by the underwriters (see Notes 5 and 7). On July 17, 2023, the underwriters fully exercised the over-allotment option.</ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 311; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>CONSOLIDATED
STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THREE AND SIX MONTHS ENDED JUNE 30, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_114_zzRpkz2Qmf32" summary="xdx: Statement - Consolidated Statements of Changes in Shareholders' Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zs7Q9ZI7i4U1" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zmLSjRPFjfoc" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BD_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zl4CzKuqZm5g" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B9_z0MzumyPqf59" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ordinary Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid-in</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Retained</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholders&#8217; </b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Earnings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equity</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_437_c20240101__20240331_eus-gaap--StockholdersEquity_iS_zsfMJEoIW9Sh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; font-weight: bold">Balance as of January 1, 2024</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_pid_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zHA7KeZuMpf8" title="Balance, shares" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000245" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000240" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0241">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact000242" format="ixt:numdotdecimal" decimals="0" unitRef="USD">402,307</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000243" format="ixt:numdotdecimal" decimals="0" unitRef="USD">402,534</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount_zsOH9fz8mA95" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0247">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0248">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="Fact000249" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">923,492</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" contextRef="From2024-01-012024-03-31" id="Fact000250" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">923,492</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zVIDJhCrlPKh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Net income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0252">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0253">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="Fact000254" format="ixt:numdotdecimal" decimals="0" unitRef="USD">786,362</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31" id="Fact000255" format="ixt:numdotdecimal" decimals="0" unitRef="USD">786,362</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20240401__20240630_eus-gaap--StockholdersEquity_iS_zcIWbJW22Sdk" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance as of March 31, 2024</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20240401__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zpbrqakhoLu" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-03-31_us-gaap_CommonStockMember" id="Fact000262" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_CommonStockMember" id="Fact000257" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0258">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember" id="Fact000259" format="ixt:numdotdecimal" decimals="0" unitRef="USD">265,177</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31" id="Fact000260" format="ixt:numdotdecimal" decimals="0" unitRef="USD">265,404</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount_zuNYrvn57ICi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0264">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0265">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember" id="Fact000266" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">941,850</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" contextRef="From2024-04-012024-06-30" id="Fact000267" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">941,850</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_zDxqo6uucmhb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0269">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0270">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember" id="Fact000271" format="ixt:numdotdecimal" decimals="0" unitRef="USD">816,754</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30" id="Fact000272" format="ixt:numdotdecimal" decimals="0" unitRef="USD">816,754</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20240401__20240630_eus-gaap--StockholdersEquity_iE_zyVTYljXb609" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance as of June 30, 2024</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20240401__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zHPj2Q96v2Be" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000279" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000274" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0275">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact000276" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,081</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000277" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,308</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE MONTHS ENDED JUNE 30, 2023 AND THE PERIOD FROM FEBURARY 17, 2023 (INCEPTION) THROUGH JUNE 30, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ordinary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid-in</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholders&#8217; </b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equity</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_438_c20230217__20230331_eus-gaap--StockholdersEquity_iS_zkezdcqwoENe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance as of February 17, 2023 (inception)</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20230217__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zlHNBEbJ8uO5" title="Balance, shares" style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0286">-</span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: justify">$</td>
    <td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0281">-</span></td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0282">-</span></td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: justify">$</td>
    <td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0283">-</span></td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0284">-</span></td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--StockIssuedDuringPeriodValueOther_z3xOzzYL1XWe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Ordinary shares issued to Sponsor</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230217__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_z0n6TvBDzFHg" title="Ordinary shares issued to Sponsor, shares" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2023-02-172023-03-31_us-gaap_CommonStockMember" id="Fact000293" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,725,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-02-172023-03-31_us-gaap_CommonStockMember" id="Fact000288" format="ixt:numdotdecimal" decimals="0" unitRef="USD">173</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-02-172023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000289" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,827</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0290">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-02-172023-03-31" id="Fact000291" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zRSsPOEO87W6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Ordinary shares issued to underwriter</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230217__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zhwjQKev8fGi" title="Ordinary shares issued to underwriter, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-172023-03-31_us-gaap_CommonStockMember" id="Fact000300" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-02-172023-03-31_us-gaap_CommonStockMember" id="Fact000295" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-02-172023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000296" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,015,982</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0297">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-02-172023-03-31" id="Fact000298" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,016,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zxbiit7c2TL3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0302">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0303">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-03-31_us-gaap_RetainedEarningsMember" id="Fact000304" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-03-31" id="Fact000305" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLoss_zK3RiwX12mAd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net income (loss)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0307">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0308">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-03-31_us-gaap_RetainedEarningsMember" id="Fact000309" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-03-31" id="Fact000310" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43F_c20230401__20230630_eus-gaap--StockholdersEquity_iS_zESJOmOXK0u5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance as of March 31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230401__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zfX7UvR6I4Ui" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact000317" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,905,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact000312" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000313" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,040,809</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember" id="Fact000314" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" id="Fact000315" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,037,895</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_437_c20230401__20230630_eus-gaap--StockholdersEquity_iS_zvn1zKtWnqx1" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_pid_c20230401__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zByomNTtSeY4" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact000324" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,905,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact000319" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000320" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,040,809</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember" id="Fact000321" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" id="Fact000322" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,037,895</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20230401__20230630_eus-gaap--StockholdersEquity_iE_zNKrJJnCvrVl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance as of June 30, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20230401__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zN2LaeMo00ka" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000331" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,905,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000326" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000327" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,040,809</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact000328" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" id="Fact000329" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,037,895</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43F_c20230401__20230630_eus-gaap--StockholdersEquity_iE_zsbjbGh5RAuj" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iE_pid_c20230401__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zN6VaKXGCYY3" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000338" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,905,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000333" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000334" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,040,809</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact000335" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" id="Fact000336" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,037,895</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 312; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_112_zprZRYAGup2g" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20240101__20240630_zFV1hAT36ub" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Six<br/> Months Ended<br/> June 30, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230217__20230630_zFsGGCeLYdr5" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 4.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Period from<br/> February 17, 2023<br/> (Inception) Through</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 4.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_z2RMxPYSnkvl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_i01_maNCPBUzRpw_zH6Iq5TEMW83" style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: left">Net income (loss)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-06-30" id="Fact000343" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,603,116</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-06-30" id="Fact000344" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_z6rB5K28DCq5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net income (loss) to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromEquityMethodInvestments_i02N_di_msNCPBUzRpw_zXk0iHTEMGw" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Income earned on investment held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2024-01-01to2024-06-30" id="Fact000349" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,865,342</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0350">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zzNM4cTbfS6a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Changes in current assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--IncreaseDecreaseInAccruedOfferingCostsAndExpenses_i03_maNCPBUzRpw_z04taCoc7r27" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Accrued offering costs and expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:IncreaseDecreaseInAccruedOfferingCostsAndExpenses" contextRef="From2024-01-01to2024-06-30" id="Fact000355" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,143</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:IncreaseDecreaseInAccruedOfferingCostsAndExpenses" contextRef="From2023-02-172023-06-30" id="Fact000356" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,105</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i03_maNCPBUzRpw_zQOyKTliVNOb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Accrued expenses - related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2024-01-01to2024-06-30" id="Fact000358" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,750</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0359">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInPrepaidExpense_i03N_di_msNCPBUzRpw_zHruuhc7aaqj" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 10pt">Prepaid Expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2024-01-01to2024-06-30" id="Fact000361" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">34,050</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0362">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCz2Gm_mtNCPBUzRpw_zbtcVHHVCJWc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-01-01to2024-06-30" id="Fact000364" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">154,283</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0365">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zu6fCUJnsC2h" style="display: none; vertical-align: bottom; background-color: White">
    <td>Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PaymentsToAcquireOtherInvestments_i01N_di_msCzCFL_zN6bqNE34E3i" style="display: none; vertical-align: bottom; background-color: White">
    <td>Investments of cash into Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCzCFL_maCz2Gm_zKJBQCzdtvy6" style="display: none; vertical-align: bottom; background-color: White">
    <td>Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zKegCI9kunAg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--ProceedsFromIssuanceOfFounderShares_i01_maCzrqf_ziv7tbZmERa1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Proceeds from issuance of EBC founder shares</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0379">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="BOWN:ProceedsFromIssuanceOfFounderShares" contextRef="From2023-02-172023-06-30" id="Fact000380" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,520</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maCzrqf_zRsgBnC1rbq5" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Proceeds from sale of ordinary shares</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_i01_maCzrqf_zS7ayfaC4ZXf" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Proceeds from Private Placement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--PaymentsOfUnderwritersDiscount_i01N_di_msCzrqf_zaH0eBk4BCb8" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Payments of underwriter&#8217;s discount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RepaymentsOfRelatedPartyDebt_i01N_di_msCzrqf_zPx7Oy9facte" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Payments to related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--PaymentOfOfferingCosts_i01N_di_msCzrqf_zwxvz1iWdWce" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Payment of offering costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzrqf_maCz2Gm_zf6Wmnj8fZAb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0397">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-02-172023-06-30" id="Fact000398" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,520</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCz2Gm_zMhoxjPXSycc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net change in cash</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2024-01-01to2024-06-30" id="Fact000400" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">154,283</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-02-172023-06-30" id="Fact000401" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,520</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_ziP1Y8d18Aoe" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cash at beginning of period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-12-31" id="Fact000403" format="ixt:numdotdecimal" decimals="0" unitRef="USD">426,913</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0404">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_z4fw5HszG7Nj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash at the end of period</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-06-30" id="Fact000406" format="ixt:numdotdecimal" decimals="0" unitRef="USD">272,630</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000407" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,520</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_ztbCzPOKUGIa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental disclosure of noncash financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_i01_zwxzYeJtP1Wh" style="display: none; vertical-align: bottom; background-color: White">
    <td>Offering costs paid by Sponsor in exchange for issuance of ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--NonCashOfferingCostsChargedToAdditionalPaidinCapital_i01_zpXCYoSU7OLa" style="display: none; vertical-align: bottom; background-color: White">
    <td>Offering costs charged to Additional Paid-in Capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ReclassificationOfOrdinarySharesSubjectToRedemption_i01_z9mGlqW7fkrg" style="display: none; vertical-align: bottom; background-color: White">
    <td>Reclassification of ordinary shares subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_i01_zPvrVUwKSaP9" style="display: none; vertical-align: bottom; background-color: White">
    <td>Allocation of offering costs to ordinary shares subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption_i01_zfAfQzmqPnri" style="display: none; vertical-align: bottom; background-color: White">
    <td>Remeasurement adjustment on ordinary shares subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_i01_zX0uLe50NUxh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-01-01to2024-06-30" id="Fact000427" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,865,342</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0428">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredOfferingCostsPaidByRelatedParty_i01_zXyV9DO3WP3e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Offering costs paid by related party</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0430">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:DeferredOfferingCostsPaidByRelatedParty" contextRef="From2023-02-172023-06-30" id="Fact000431" format="ixt:numdotdecimal" decimals="0" unitRef="USD">144,108</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--PrepaidExpensesPaidByRelatedParty_i01_zrxw2w7WPQDh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Prepaid expenses paid by related party</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0433">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:PrepaidExpensesPaidByRelatedParty" contextRef="From2023-02-172023-06-30" id="Fact000434" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,600</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--NoncashOfferingCostsAdjustedFromPrepaidExpenses_i01_zMnWmBkW2TX7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Offering costs adjusted from prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0436">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:NoncashOfferingCostsAdjustedFromPrepaidExpenses" contextRef="From2023-02-172023-06-30" id="Fact000437" format="ixt:numdotdecimal" decimals="0" unitRef="USD">639</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--DeferredOfferingCostsIncludedInAccruedExpenses_i01_z3TQhwigPqUj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Offering costs included in accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0439">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:DeferredOfferingCostsIncludedInAccruedExpenses" contextRef="From2023-02-172023-06-30" id="Fact000440" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,505</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_i01_zD8QDmdRW4Yg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Offering costs paid by Sponsor in exchange for issuance of ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0442">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" contextRef="From2023-02-172023-06-30" id="Fact000443" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--OfferingCostsChargedToAPICFounderShares_i01_zGW3im09HwLl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Offering costs charged to APIC &#8211; EBC founder shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0445">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:OfferingCostsChargedToAPICFounderShares" contextRef="From2023-02-172023-06-30" id="Fact000446" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,013,480</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 313; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p id="xdx_040_c20240101__20240630_zXzRohuloMde" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="vi_001"></span>BOWEN
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
<span style="text-transform: uppercase"><span id="a_007"></span>NOTES TO THE FINANCIAL STATEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000448" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_80F_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zB2oomZDbBha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8212; <span id="xdx_82B_zG09NjEIsedf">ORGANIZATION AND BUSINESS OPERATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organizational
and General</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Acquisition Corp (the &#8220;Company&#8221;) was incorporated in the Cayman Islands on February 17, 2023. The Company was formed for
the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination
with one or more businesses (the &#8220;Business Combination&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early
stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth
companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s sponsors are Createcharm Holdings Ltd., a British Virgin Islands company, and Bowen Holding LP, a Delaware limited partnership
(the &#8220;Sponsors&#8221;). As of June 30, 2024, the Company had not commenced any operations. All activities for the period from February
17, 2023 (inception) through June 30, 2024 relate to the Company&#8217;s formation, the initial public offering (&#8220;IPO&#8221;)
and initial business combination, which is described below. The Company will not generate any operating revenues until after the completion
of an initial Business Combination, at the earliest. The Company is generating non-operating income in the form of interest income from
the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s IPO (the &#8220;Registration Statement&#8221;) was declared effective on July 11, 2023.
On July 14, 2023, the Company consummated the IPO of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zXkIXqVCmuq9" title="Stock issued during period shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-142023-07-14_us-gaap_IPOMember" id="Fact000450" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></span> of its units (&#8220;Public Units&#8221;). Each Public Unit consists of
one ordinary share, $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z6ca4ejeCCl5" title="Ordinary shares, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-07-14_us-gaap_IPOMember" id="Fact000452" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> par value (&#8220;Ordinary Shares&#8221;), of the Company and one right (&#8220;Rights&#8221;), each Right
entitling the holder thereof to receive one-tenth of one ordinary share upon the completion of the Company&#8217;s initial business combination.
The Public Units were sold at an offering price of $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zF5aCDIpxIue" title="Sale of stock, par share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-07-14_us-gaap_IPOMember" id="Fact000454" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit, generating gross proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z72vmFIlHsx4" title="Proceeds from issuance of IPO"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-07-142023-07-14_us-gaap_IPOMember" id="Fact000456" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">60,000,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the consummation of the IPO, the Company consummated the private placement (&#8220;Private Placement&#8221;) of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zhrlXbAF2FXb" title="Stock issued during period shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember" id="Fact000458" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">330,000</ix:nonFraction></span> units (&#8220;Private
Placement Units&#8221;) at a price of $<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zM0dBaFGobXf" title="Price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-07-14_us-gaap_PrivatePlacementMember" id="Fact000460" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Private Placement Unit, generating total proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zxVLExIfYjwe" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember" id="Fact000462" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">3,300,000</ix:nonFraction></span>. The Private Placement
Units were purchased by Createcharm Holdings Ltd, one of the Company&#8217;s sponsors, and EarlyBirdCapital, Inc. (&#8220;EBC&#8221;),
the representative of the underwriters in the IPO. The Private Placement Units are identical to the Units included in the Public Units
sold in the IPO. The purchasers of the Private Placement Units have agreed not to transfer, assign or sell any of the Private Placement
Units or Ordinary Shares or Rights underlying the Private Placement Units (except to certain transferees) until after the completion
of the Company&#8217;s initial Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2023, the underwriters exercised their over-allotment option in full to purchase an additional <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230717__20230717__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zyjl9lYzFfma" title="Stock issued during period shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-172023-07-17_us-gaap_OverAllotmentOptionMember" id="Fact000464" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> Units. As a result, on
July 18, 2023, the Company sold an additional <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zRUXFuEHgEWe" title="Number of units sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember" id="Fact000466" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> Units at $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zR0RnGh00WH3" title="Sale of stock price per unit"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-07-18_us-gaap_OverAllotmentOptionMember" id="Fact000468" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit, generating gross proceeds of $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zkKjR6O89hX4" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember" id="Fact000470" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,000,000</ix:nonFraction></span>. In connection
with this sale, Createcharm Holdings Ltd. and EBC also purchased an additional <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zv3df78rOIn3" title="Number of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-182023-07-18_us-gaap_PrivatePlacementMember" id="Fact000472" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,500</ix:nonFraction></span> Private Placement Units from the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of July 18, 2023, transaction costs amounted to $<span id="xdx_90D_eus-gaap--PaymentsOfStockIssuanceCosts_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zVlleXFyNmz3" title="Transaction costs"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2023-07-182023-07-18_us-gaap_IPOMember" id="Fact000474" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,318,898</ix:nonFraction></span> consisting of $<span id="xdx_907_eus-gaap--PaymentsForUnderwritingExpense_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zL7glKeIRxJh" title="Cash underwriting fees"><ix:nonFraction name="us-gaap:PaymentsForUnderwritingExpense" contextRef="From2023-07-182023-07-18_us-gaap_IPOMember" id="Fact000476" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,725,000</ix:nonFraction></span> of cash underwriting fees and $<span id="xdx_90A_ecustom--OtherOfferingCosts_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5S3xmFQghrj" title="Other offering costs"><ix:nonFraction name="BOWN:OtherOfferingCosts" contextRef="From2023-07-182023-07-18_us-gaap_IPOMember" id="Fact000478" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,593,898</ix:nonFraction></span> of other
offering costs. These costs were charged to additional paid-in capital or accumulated deficit to the extent additional paid-in capital
is fully depleted upon completion of the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will have until 15 months from the closing of the IPO (or up to 18 months, if the Company extends the time to complete a Business
Combination as permitted in its Amended and Restated Memorandum and Articles of Association) to consummate a Business Combination (the
&#8220;Combination Period&#8221;). However, if the Company has not completed a Business Combination within the Combination Period and
shareholders have not otherwise amended the Amended and Restated Memorandum and Articles of Association to extend this period, the Company
will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business
days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit
in the Trust Account, including interest earned and not previously released to us to pay the Company&#8217;s taxes, if any (less certain
amount of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption
will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating
distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s
remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject to the Company&#8217;s obligations under Cayman
Islands law to provide for claims of creditors and the requirements of other applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 20, 2023, a wholly-owned subsidiary of the Company, Bowen Merger Sub (&#8220;Merger Sub&#8221;) was formed for the purpose of
entering into a business combination agreement. See &#8220;Proposed Business Combination&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposed
Business Combination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 18, 2024, the Company entered into an Agreement and Plan of Reorganization (the &#8220;Agreement&#8221;) with (i) Bowen Merger
Sub, a Cayman Islands exempted company and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), (ii) Shenzhen Qianzhi
BioTechnology Co. Ltd., a company incorporated in the People&#8217;s Republic of China and a wholly owned subsidiary of NewCo (as defined
below) (&#8220;Shenzhen Qianzhi&#8221;), and (iii) <span style="background-color: white">Qianzhi Group Holding (Cayman) Limited, a newly
formed Cayman Islands company (&#8220;<span style="text-decoration: underline">NewCo</span>,&#8221; and collectively with the Company, Merger Sub and Shenzhen Qianzhi, the &#8220;<span style="text-decoration: underline">Parties</span>&#8221;,
each a &#8220;<span style="text-decoration: underline">Party</span>&#8221;).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Agreement, at the closing of the business combination, Merger Sub will merge with and into NewCo (the &#8220;<span style="text-decoration: underline">Merger</span>&#8221;),
with NewCo being the surviving company of the Merger (&#8220;<span style="text-decoration: underline">Surviving Company</span>&#8221;) and becoming a wholly owned subsidiary
of the Company. In the Merger, the holders (the &#8220;NewCo Shareholders&#8221;) of the ordinary shares of NewCo (&#8220;NewCo Ordinary
Shares&#8221;) will receive ordinary shares of the Company (&#8220;Parent Ordinary Shares&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Agreement, at the effective time of the Merger (the &#8220;Effective Time&#8221;), all of NewCo Ordinary Shares issued and outstanding
immediately prior to the Effective Time will be automatically converted into the right to receive an aggregate of (a) <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240118__20240118__us-gaap--StatementEquityComponentsAxis__custom--MergerSharesMember__us-gaap--TypeOfArrangementAxis__custom--AgreementMember_zsC8X59Cpna1" title="Number of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-182024-01-18_custom_MergerSharesMember_custom_AgreementMember" id="Fact000480" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,246,377</ix:nonFraction></span> Parent
Ordinary Shares (the &#8220;Merger Shares&#8221;), and (b) the right to receive earnout consideration of up to an aggregate of <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240118__20240118__us-gaap--StatementEquityComponentsAxis__custom--EarnoutSharesMember__us-gaap--TypeOfArrangementAxis__custom--AgreementMember__srt--RangeAxis__srt--MaximumMember_zRFpl16lJ2Sk" title="Number of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-182024-01-18_custom_EarnoutSharesMember_custom_AgreementMember_srt_MaximumMember" id="Fact000482" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,400,000</ix:nonFraction></span>
Parent Ordinary Shares (the &#8220;Earnout Shares&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going
Concern Consideration</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, the Company had cash of $<span id="xdx_906_eus-gaap--Cash_iI_c20240630_z1nK0Gly7TI3" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2024-06-30" id="Fact000484" format="ixt:numdotdecimal" decimals="0" unitRef="USD">272,630</ix:nonFraction></span> and a working capital of $<span id="xdx_908_ecustom--WorkingCapitalDeficit_iI_c20240630_zvWgVVhBHkVg" title="Working capital"><ix:nonFraction name="BOWN:WorkingCapitalDeficit" contextRef="AsOf2024-06-30" id="Fact000486" format="ixt:numdotdecimal" decimals="0" unitRef="USD">95,109</ix:nonFraction></span> (excluding $<span id="xdx_903_eus-gaap--OtherReceivablesNetCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShenzhenQianzhiMember_zvn2MGHDrVEf" title="Due from related parties"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2024-06-30_custom_ShenzhenQianzhiMember" id="Fact000488" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,199</ix:nonFraction></span> due from Shenzhen Qianzhi). The
Company has incurred and expects to continue to incur significant professional costs to remain as a public traded company and to incur
transaction costs in pursuit of a Business Combination. In connection with the Company&#8217;s assessment of going concern considerations
in accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s
Ability to Continue as a Going Concern,&#8221; management believes that these conditions raise substantial doubt about the Company&#8217;s
ability to continue as a going concern. In addition, if the Company is unable to complete a Business Combination within the Combination
Period and such period is not extended, there will be a liquidation and subsequent dissolution. As a result, management has determined
that such additional condition also raises substantial doubt about the Company&#8217;s ability to continue as a going concern. The consolidated
financial statement does not include any adjustments that might result from the outcome of the uncertainty.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 314; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000490" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zg1xV1GwNg0d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8212; <span id="xdx_82F_zA83al8Onr2a">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000492" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zDGTG5XmeChh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zUxqRnHjUOqj">Basis
of Presentation and Principles of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;US GAAP&#8221;) for interim financial information and in accordance with the instructions to
Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the unaudited financial statements reflect all adjustments, which
include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The
interim results for the period ended June 30, 2024 are not necessarily indicative of the results that may be expected through December
31, 2024. All intercompany accounts and transactions are eliminated upon consolidation. The information included in this Form 10-Q should
be read in conjunction with information included in the Company&#8217;s annual report on Form 10-K for the year ended December 31, 2023,
filed with the Securities and Exchange Commission on March 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000494" name="BOWN:EmergingGrowthCompanyPolicyTextBlock"><p id="xdx_84D_ecustom--EmergingGrowthCompanyPolicyTextBlock_zSmJyp9e1Gmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_ztfXEU3hhLC5">Emerging
Growth Company</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000496" name="us-gaap:UseOfEstimates"><p id="xdx_84B_eus-gaap--UseOfEstimates_zd8txaf1Tr45" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_ziK8M0jpATv7">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the consolidated financial statement in conformity with US GAAP requires the Company&#8217;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000498" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zipcGUzRtCtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zNGkI8nRUxtd">Cash
and cash equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had a cash balance of $<span id="xdx_902_eus-gaap--Cash_iI_pp0p0_c20240630_zAlO8iPeSzX7" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2024-06-30" id="Fact000500" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">272,630</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20231231_zmztkBWTdqn5" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-12-31" id="Fact000502" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">426,913</ix:nonFraction></span> as of June 30, 2024 and December 31, 2023, respectively. The Company had <span id="xdx_909_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240630_z2CKN0fZxdza" title="Cash equivalents"><span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zkEELsKcwKJ" title="Cash equivalents"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2024-06-30" id="Fact000504" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact000506" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> cash
equivalents as of June 30, 2024 and December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000508" name="us-gaap:InvestmentPolicyTextBlock"><p id="xdx_84D_eus-gaap--InvestmentPolicyTextBlock_zL5lotToLD14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zgn1LlvFy8Aj">Investments
Held in Trust Account</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s portfolio of investments held in the Trust Account is comprised of investments only in U.S. government securities with
a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which
invest only in direct U.S. government treasury obligations. The Company&#8217;s investments held in the Trust Account are classified
as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains
and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable
securities held in Trust Account in the accompanying statements of operations. The estimated fair value of investments held in the Trust
Account is determined using available market information. As of June 30, 2024 and December 31, 2023, the Trust Account had balance of
$<span id="xdx_907_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20240630_zTCSUZQOVlMi" title="Trust account balance"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2024-06-30" id="Fact000510" format="ixt:numdotdecimal" decimals="0" unitRef="USD">73,284,700</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231_zqPrkszMnHZc" title="Trust account balance"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-12-31" id="Fact000512" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,419,358</ix:nonFraction></span>, respectively. The interest and dividend income earned from the Trust Account totaled $<span id="xdx_90B_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_pp0p0_c20240401__20240630_zsiiM69cBkFd" title="Interests earned from trust account"><ix:nonFraction name="BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount" contextRef="From2024-04-012024-06-30" id="Fact000514" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">941,850</ix:nonFraction></span> and $<span id="xdx_901_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_pp0p0_c20240101__20240630_zXYhRnbC0yXk" title="Interest and dividend income earned from trust account"><ix:nonFraction name="BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount" contextRef="From2024-01-01to2024-06-30" id="Fact000516" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,865,342</ix:nonFraction></span>
for three and six months ended June 30, 2024, respectively, which were fully reinvested into the Trust Account as earned and unrealized
gain on investments and therefore presented as an adjustment to the operating activities in the Consolidated Statements of Cash Flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000518" name="BOWN:OfferingCostsPolicyTextBlock"><p id="xdx_84F_ecustom--OfferingCostsPolicyTextBlock_zJohv5TrH4Le" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zDoEB7BkwZVg">Offering
Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
costs consist of legal and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that
are directly related to the IPO and that were charged to shareholders&#8217; equity upon the completion of the IPO on July 14, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000520" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_z71YEBUcSXue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zhUqkdxrCMji">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;<i>Income Taxes</i>.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 315; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were <span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20240630_zbzapixzmQ0k" title="Unrecognized tax benefits"><span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zSaQfj8d9C6d" title="Unrecognized tax benefits"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2024-06-30" id="Fact000522" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2023-12-31" id="Fact000524" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> unrecognized tax benefits and <span id="xdx_901_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20240630_zcLDqJZK7E8c" title="Interest and penalties accrued"><span id="xdx_900_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20231231_z7FZkptnHQR8" title="Interest and penalties accrued"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" contextRef="AsOf2024-06-30" id="Fact000526" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" contextRef="AsOf2023-12-31" id="Fact000528" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> amounts accrued for interest and penalties as of June 30, 2024
and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals,
or material deviation from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax
regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#8217;s
consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000530" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zlFO4bhF6Kk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zHGM35ZCbFJk">Net
Income (Loss) per Ordinary Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include
a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income
per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company
first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed
income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss)
ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement
of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public
shareholders. As of June 30, 2024 and 2023, the Company did not have any dilutive securities and other contracts that could, potentially,
be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per
share is the same as basic income (loss) per share for the period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net income (loss) per share presented in the statements of operations is based on the following:</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000532" name="srt:ScheduleOfCondensedIncomeStatementTableTextBlock"><p id="xdx_89F_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zFiYCcWKe56f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zZaHA01dQnV4" style="display: none">SCHEDULE
OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_492_20240401__20240630_zEPV8mzuxNO8" style="font-weight: bold; text-align: center"><b>2024</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_491_20230401__20230630_zgwKQxKgn7vh" style="font-weight: bold; text-align: center"><b>2023</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_49B_20240101__20240630_zNbVNk9ZmBQe" style="text-align: center"><b>June 30,<br/>
    2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_494_20230217__20230630_zcd2NavKx0ld" style="text-align: center"><b>June 30, <br/>
    2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Three Months Ended June 30,</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>Six Months Ended</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>For the Period from February 17, 2023 through</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2024</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2023</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>June 30,<br/>
    2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>June 30, <br/>
    2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_maNLIAOz10T_zbrmeHprLolh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Net income (loss)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30" id="Fact000534" format="ixt:numdotdecimal" decimals="0" unitRef="USD">816,754</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0535">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-06-30" id="Fact000536" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,603,116</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-06-30" id="Fact000537" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_401_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz10T_zAbKlpGMN215" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accretion of temporary equity into redemption value (interest earned)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:AccretionOfTemporaryEquityIntoRedemptionValue" contextRef="From2024-04-012024-06-30" id="Fact000539" format="ixt:numdotdecimal" decimals="0" unitRef="USD">941,850</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0540">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:AccretionOfTemporaryEquityIntoRedemptionValue" contextRef="From2024-01-01to2024-06-30" id="Fact000541" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,865,342</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0542">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--NetLossIncludingAccretionOfEquityIntoRedemptionValue_iT_mtNLIAOz10T_zuPmzF721cVd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss including accretion of equity into redemption value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="BOWN:NetLossIncludingAccretionOfEquityIntoRedemptionValue" contextRef="From2024-04-012024-06-30" id="Fact000544" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">125,096</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="BOWN:NetLossIncludingAccretionOfEquityIntoRedemptionValue" contextRef="From2024-01-01to2024-06-30" id="Fact000546" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">262,226</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="BOWN:NetLossIncludingAccretionOfEquityIntoRedemptionValue" contextRef="From2023-02-172023-06-30" id="Fact000547" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zsq1envgUrs1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000549" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zNJHbGlybjOl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_z4YUe7BJfSVk" style="display: none">SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED</span></span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSBy0peTNeqd" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zHFJtctmQ7Af" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_493_20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zrGeGu54Bja" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrUDxN5tolnh" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_499_20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zoS3vQSHFBhl" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_499_20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCvvcjVvYjp1" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zN0D5o5bki2k" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zco4vS2BZfp7" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Three Months Ended<br/>
 June 30, 2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Six Months Ended &#160;<br/>
June 30, 2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Three Months Ended <br/>
June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the Period from <br/>
February 17, 2023 through <br/>
June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Particulars</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and
    diluted net income/(loss) per share:</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average shares outstanding</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRlmacH7Veaj" title="Weighted-average shares outstanding - basic"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z7aUZCzHX6wh" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember" id="Fact000551" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember" id="Fact000553" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zOQnfAKWBQC4" title="Weighted-average shares outstanding - basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zw7LQikX1Owc" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000555" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000557" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zlAbDpzpBcE5" title="Weighted-average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zwdZB8aavyb4" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember" id="Fact000559" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember" id="Fact000561" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z4xwsqmQRZs5" title="Weighted-average shares outstanding - basic"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqoTpOOCEHOh" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000563" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000565" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zvYEr2B32Nu2" title="Weighted-average shares outstanding - basic"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zADwgPj1Bpz9" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0567"><span style="-sec-ix-hidden: xdx2ixbrl0569">-</span></span></span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFN1VzmKwYAa" title="Weighted-average shares outstanding - basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFBwNIxZYrE8" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember" id="Fact000571" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember" id="Fact000573" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,680,000</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; font-size: 11pt; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zfVl1CLuVOr" title="Weighted-average shares outstanding - basic"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_znOvNmn9lYB4" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0575"><span style="-sec-ix-hidden: xdx2ixbrl0577">-</span></span></span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYEWjo6tCvF5" title="Weighted-average shares outstanding - basic"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zuALVTokWFIa" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember" id="Fact000579" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember" id="Fact000581" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,656,774</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership percentage</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--OwnershipPercentage_pid_dp_uPure_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRX0VSo5MI3e" title="Ownership percentage"><ix:nonFraction name="BOWN:OwnershipPercentage" contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember" id="Fact000583" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--OwnershipPercentage_pid_dp_uPure_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zI77K3HjvqZd" title="Ownership percentage"><ix:nonFraction name="BOWN:OwnershipPercentage" contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000585" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zcTLuYDNbyS5" title="Ownership percentage"><ix:nonFraction name="BOWN:OwnershipPercentage" contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember" id="Fact000587" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zq3nXiuDFsM3" title="Ownership percentage"><ix:nonFraction name="BOWN:OwnershipPercentage" contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000589" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zz6QDtUW3A9l" title="Ownership percentage"><span style="-sec-ix-hidden: xdx2ixbrl0591">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zd3pzYuFsn3k" title="Ownership percentage"><ix:nonFraction name="BOWN:OwnershipPercentage" contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember" id="Fact000593" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zzQDZ6b20zb" title="Ownership percentage"><span style="-sec-ix-hidden: xdx2ixbrl0595">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFLbzzGvCPba" title="Ownership percentage"><ix:nonFraction name="BOWN:OwnershipPercentage" contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember" id="Fact000597" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerators:</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zshkQfUYiUi6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of net loss including
    accretion of temporary equity</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity" contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember" id="Fact000599" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">94,165</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity" contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000600" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">30,931</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity" contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember" id="Fact000601" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">197,388</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity" contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000602" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">64,838</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0603">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0604">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0605">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity" contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember" id="Fact000606" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_402_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_z6JeXvyniSQ4" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    earned on investment held in trust account</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount" contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember" id="Fact000608" format="ixt:numdotdecimal" decimals="0" unitRef="USD">941,850</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0609">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount" contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember" id="Fact000610" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,865,342</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0611">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0612">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0613">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0614">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0615">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_znOk6211LrT4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of net income/(loss)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember" id="Fact000617" format="ixt:numdotdecimal" decimals="0" unitRef="USD">847,685</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000618" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">30,931</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember" id="Fact000619" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,667,954</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000620" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">64,838</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0621">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0622">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0623">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember" id="Fact000624" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,105</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominators:</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average shares
    outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQzV0IDvSyj2" title="Weighted average shares outstanding - basic"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zOT1zbMGB639" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember" id="Fact000626" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember" id="Fact000628" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_ze0K9wVa10dd" title="Weighted average shares outstanding - basic"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zcDkDRb7KoM2" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000630" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000632" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zYvu0Nr3kbJf" title="Weighted average shares outstanding - basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zGimqSbrnS3g" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember" id="Fact000634" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember" id="Fact000636" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMUgytbR5TI3" title="Weighted average shares outstanding - basic"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zC3p20bgWXld" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000638" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000640" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zyptN8z7J0zk" title="Weighted average shares outstanding - basic"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zC95eqOTAu9k" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0642"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></span></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zbyRYDgivH3e" title="Weighted average shares outstanding - basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zXbDy5TMdmMb" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember" id="Fact000646" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember" id="Fact000648" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,680,000</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTdaJvG0QYge" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z9t6Q9aH3u9i" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0650"><span style="-sec-ix-hidden: xdx2ixbrl0652">-</span></span></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z34tVg8XqKUi" title="Weighted-average shares outstanding - basic"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYR4raUHLa09" title="Weighted-average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember" id="Fact000654" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember" id="Fact000656" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,656,774</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net income/(loss) per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z34oXUuyBQ39" title="Basic net income/(loss) per share"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zvLOYwYGlhe1" title="Diluted net income/(loss) per share"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember" id="Fact000658" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember" id="Fact000660" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.12</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zuL9mXv5DD1l" title="Basic net income/(loss) per share"><span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrvsnXUJxtbj" title="Diluted net income/(loss) per share">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000662" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000664" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQpX6slT0dG2" title="Basic net income/(loss) per share"><span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zG7Oo29qJ0Wc" title="Diluted net income/(loss) per share"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember" id="Fact000666" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember" id="Fact000668" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.24</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zJDyTrubNsA" title="Basic net income/(loss) per share"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zzlN34jafbG5" title="Diluted net income/(loss) per share">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000670" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember" id="Fact000672" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.03</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zg0u4HGHo3va" title="Basic net income/(loss) per share"><span id="xdx_904_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zdFuSn87WLE2" title="Diluted net income/(loss) per share"><span style="-sec-ix-hidden: xdx2ixbrl0674"><span style="-sec-ix-hidden: xdx2ixbrl0676">-</span></span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zhEKTZF2Z2Pd" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zsHEHZzJIhbc" title="Diluted net income/(loss) per share"><span style="-sec-ix-hidden: xdx2ixbrl0678"><span style="-sec-ix-hidden: xdx2ixbrl0680">-</span></span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z6KC1AJBXhJc" title="Basic net income/(loss) per share"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zA2v4GYzuEPk" title="Diluted net income/(loss) per share"><span style="-sec-ix-hidden: xdx2ixbrl0682"><span style="-sec-ix-hidden: xdx2ixbrl0684">-</span></span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_za6AczHeao4j" title="Basic net income/(loss) per share"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zKdoRSOAcBi4" title="Diluted net income/(loss) per share">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember" id="Fact000686" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember" id="Fact000688" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.002</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p></ix:nonNumeric><p id="xdx_8AE_z9AwGfR5raC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000690" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_z3lZhr9911K6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zPYpyu6KgvTj">Concentration
of Credit Risk</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_c20240630_z3L1nYZwLMTb" title="Cash FDIC insured amount"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2024-06-30" id="Fact000692" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span>. The Company has not experienced losses on these accounts
and management believes the Company is not exposed to significant risks on such accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 316; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000694" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zcJebipTI21i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_z7zkLhnilQEl">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;<i>Fair Value
Measurement</i>,&#8221; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000696" name="us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"><p id="xdx_84D_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zVKEDCaCr3jb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zRwInfBS5jUe">Ordinary
Shares Subject to Possible Redemption</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Ordinary shares subject to mandatory redemption (if
any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary
shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, ordinary shares
are classified as shareholders&#8217; equity. The Company&#8217;s ordinary shares features certain redemption rights that are considered
to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject
to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#8217; equity section of the
Company&#8217;s balance sheet. <span style="background-color: white">The Company recognizes changes in redemption value immediately as
they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.
Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital
and accumulated deficit.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000698" name="BOWN:ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock"><p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zGAuRR7PPSeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2023 and June 30, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are
reconciled in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zpc5XAu9ccQg" style="display: none">SCHEDULE
OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 84%; text-align: left">Public offering proceeds</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPTO3JbwgL46" title="Public offering proceeds" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-01-012023-12-31_us-gaap_IPOMember" id="Fact000700" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zC2iWnioAnWf" title="Proceeds allocated to public rights" style="text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2023-01-012023-12-31_us-gaap_IPOMember" id="Fact000702" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,272,724</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3GYLMyaZGMg" title="Allocation of offering costs related to redeemable shares" style="text-align: right">(<ix:nonFraction name="us-gaap:OfferingCostsPartnershipInterests" contextRef="AsOf2023-12-31_us-gaap_IPOMember" id="Fact000704" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,925,140</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3ebkpA4pQAi" title="Accretion of carrying value to redemption value" style="text-align: right"><ix:nonFraction name="BOWN:AccretionOfCarryingValueToRedemptionValue" contextRef="From2023-01-012023-12-31_us-gaap_IPOMember" id="Fact000706" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,797,864</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ordinary shares subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20230101__20231231_zMmdN8mzOY43" title="Ordinary shares subject to possible redemption" style="text-align: right"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" contextRef="AsOf2022-12-31" id="Fact000708" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic">Over-allotment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Over-allotment proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ProceedsFromOtherEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zhdg83vT3Rme" title="Over-allotment proceeds" style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2023-01-012023-12-31_us-gaap_OverAllotmentOptionMember" id="Fact000710" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z6J18rD4Rk1b" title="Proceeds allocated to Public Rights" style="text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2023-01-012023-12-31_us-gaap_OverAllotmentOptionMember" id="Fact000712" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">490,909</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zojTNcHsWDO" title="Allocation of offering costs related to redeemable shares" style="text-align: right">(<ix:nonFraction name="us-gaap:OfferingCostsPartnershipInterests" contextRef="AsOf2023-12-31_us-gaap_OverAllotmentOptionMember" id="Fact000714" format="ixt:numdotdecimal" decimals="0" unitRef="USD">212,727</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zHWQ4CTJT1de" title="Accretion of carrying value to redemption value" style="text-align: right"><ix:nonFraction name="BOWN:AccretionOfCarryingValueToRedemptionValue" contextRef="From2023-01-012023-12-31_us-gaap_OverAllotmentOptionMember" id="Fact000716" format="ixt:numdotdecimal" decimals="0" unitRef="USD">793,636</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zim6byzjMXwh" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2023-01-012023-12-31_us-gaap_OverAllotmentOptionMember" id="Fact000718" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,729,358</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Ordinary shares subject to possible redemption, December 31, 2023</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20240101__20240630_z6P1opG3tZBi" title="Ordinary shares subject to possible redemption" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" contextRef="AsOf2023-12-31" id="Fact000720" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,419,358</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">Plus:</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td><td title="Ordinary shares subject to possible redemption" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">Subsequent
    measurement of ordinary shares subject to possible redemption (income earned on trust account)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td><td title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)" id="xdx_984_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20240101__20240630_zGjItKI6Dbd7" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: normal 10pt Times New Roman, Times, Serif"><ix:nonFraction name="BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-01-01to2024-06-30" id="Fact000722" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,865,342</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>Ordinary
    shares subject to possible redemption, June 30, 2024</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>$</b></span></td><td title="Ordinary shares subject to possible redemption" id="xdx_986_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iE_c20240101__20240630_zwYfAIm1ZNUh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: normal 10pt Times New Roman, Times, Serif"><b><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" contextRef="AsOf2024-06-30" id="Fact000724" format="ixt:numdotdecimal" decimals="0" unitRef="USD">73,284,700</ix:nonFraction></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_z6s9ZdWbnonf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000726" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zvlTHZ2lITda" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zCZJ7hRWs7j2">Recent
Accounting Standards</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#8217;s consolidated financial statements.</span></p>

</ix:nonNumeric><p id="xdx_854_zffhMR6q4hoi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Correction
of an Error</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
preparing the Company&#8217;s Form 10-Q for the quarterly period ended June 30, 2024, the Company identified an omission in the disclosure
of the non-cash item in the Cash Flow Statement related with the offering cost charged to APIC for the EBC founder shares in its historical
filing for the quarter ended June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with SEC Staff Accounting Bulletin No. 99, &#8220;Materiality,&#8221; and SEC Staff Accounting Bulletin No. 108, &#8220;Considering
the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements;&#8221; the Company evaluated
the error and has determined that the omission of non-cash item in the interim period of six months in 2023 does not have any impact
on the consolidated financial statements in the full year of 2023 and 2024. Accordingly, the Company has corrected such immaterial error
by adjusting its statement of cash flows for the period from February 17, 2023 (inception) through June 30, 2023 related to the supplemental
disclosure of noncash financing activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following analysis provides a comparison of the supplemental disclosure of noncash financing activities as reported on the Form 10-Q
for the quarter ended June 30, 2023, and the final revised disclosure to correct the error:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000728" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zrIeFQGHFK63" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B2_zalQH45DorYe" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SUPPLEMENTAL
DISCLOSURE OF NONCASH FINANCING ACTIVITIES</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20230401__20230630_zDUmkvO9Pav2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As reported on Form 10-Q for the quarter ended June 30, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20240401__20240630_zTiJTaglAq4j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As revised on<br/>
Form 10-Q</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental disclosure of noncash financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--NoncashOfferingCostsPaidByRelatedParty_zILkhYJtkzLb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Offering costs paid by related party</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="BOWN:NoncashOfferingCostsPaidByRelatedParty" contextRef="From2023-04-012023-06-30" id="Fact000730" format="ixt:numdotdecimal" decimals="0" unitRef="USD">144,108</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="BOWN:NoncashOfferingCostsPaidByRelatedParty" contextRef="From2024-04-012024-06-30" id="Fact000731" format="ixt:numdotdecimal" decimals="0" unitRef="USD">144,108</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--NoncashPrepaidExpensesPaidByRelatedParty_zpSTUAqjtyp1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid expenses paid by related party</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:NoncashPrepaidExpensesPaidByRelatedParty" contextRef="From2023-04-012023-06-30" id="Fact000733" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:NoncashPrepaidExpensesPaidByRelatedParty" contextRef="From2024-04-012024-06-30" id="Fact000734" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,600</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--NoncashOfferingCostsAdjustedFromPrepaidExpenses_zA7wCbaY8zRg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Offering costs adjusted from prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:NoncashOfferingCostsAdjustedFromPrepaidExpenses" contextRef="From2023-04-012023-06-30" id="Fact000736" format="ixt:numdotdecimal" decimals="0" unitRef="USD">639</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:NoncashOfferingCostsAdjustedFromPrepaidExpenses" contextRef="From2024-04-012024-06-30" id="Fact000737" format="ixt:numdotdecimal" decimals="0" unitRef="USD">639</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--NoncashOfferingCostsIncludedInAccruedExpenses_zzWV27yzB3p4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Offering costs included in accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:NoncashOfferingCostsIncludedInAccruedExpenses" contextRef="From2023-04-012023-06-30" id="Fact000739" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,505</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:NoncashOfferingCostsIncludedInAccruedExpenses" contextRef="From2024-04-012024-06-30" id="Fact000740" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,505</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_zyq3q4cuHGo6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Offering costs paid by Sponsor in exchange for issuance of ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" contextRef="From2023-04-012023-06-30" id="Fact000742" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" contextRef="From2024-04-012024-06-30" id="Fact000743" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--NonCashOfferingCostsChargedToAdditionalPaidinCapital_zEU2RD3p88W7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Offering costs charged to APIC &#8211; EBC founder shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0745">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:NonCashOfferingCostsChargedToAdditionalPaidinCapital" contextRef="From2024-04-012024-06-30" id="Fact000746" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,013,480</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr></table>


</ix:nonNumeric><p id="xdx_8A8_zGyc7i1BEQZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000748" name="BOWN:InitialPublicOfferingTextBlock"><p id="xdx_80C_ecustom--InitialPublicOfferingTextBlock_zQN4fgvRk3Fg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8212; <span id="xdx_82C_zvmZL6zwQNOj">INITIAL PUBLIC OFFERING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 14, 2023, the Company sold <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ziNBSwTUyVal" title="Stock issued during period shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-142023-07-14_us-gaap_IPOMember" id="Fact000750" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></span> Units at a price of $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zAIhRA4mUEN7" title="Sale of stock, par share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-07-14_us-gaap_IPOMember" id="Fact000752" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit. <span id="xdx_905_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zSh5Bk8iblQ4" title="Units related to initial public offering description"><ix:nonNumeric contextRef="From2023-07-142023-07-14_us-gaap_IPOMember" id="Fact000754" name="us-gaap:SaleOfStockDescriptionOfTransaction">Each Unit consists of one ordinary share and one right
to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company&#8217;s initial Business Combination. Ten Public
Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares
will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional
shares underlying the rights</ix:nonNumeric></span>. The Company also granted the underwriters a 45-day option to purchase up to an additional <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_z9RlZCZnFcSc" title="Stock issued during the period, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-07-142023-07-14_us-gaap_OverAllotmentOptionMember_srt_MaximumMember" id="Fact000756" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> units
to cover over-allotments. The over-allotment was subsequently fully exercised on July 17, 2023. See Note 1 for further details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000758" name="BOWN:PrivatePlacementsTextBlock"><p id="xdx_808_ecustom--PrivatePlacementsTextBlock_zSuAeT4mq32e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 &#8212; <span id="xdx_826_zkjgIAqZ1Sxf">PRIVATE PLACEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors and EBC had agreed to purchase an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zMXlx0qQXuGa" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember" id="Fact000760" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">330,000</ix:nonFraction></span> Private Placement Units (<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorsMember_z8uyaXrHNnPb" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember_custom_SponsorsMember" id="Fact000762" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">312,000</ix:nonFraction></span> Private Placement Units to be purchased
by the Sponsors and <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--EBCMember_zy0I1mPXndQ1" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember_custom_EBCMember" id="Fact000764" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,000</ix:nonFraction></span> Private Placement Units to be purchased by EBC or its designees), or <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_z75nPHOfjBYl" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember_custom_UnderwritersMember" id="Fact000766" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">361,500</ix:nonFraction></span> Private Placement Units if the
underwriters&#8217; over-allotment is exercised in full, at a price of $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zdJXxhSitFPf" title="Unit exercise price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-07-14_us-gaap_PrivatePlacementMember" id="Fact000768" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Private Placement Unit ($<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zoojZRuJhkyk" title="Value of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember" id="Fact000770" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,300,000</ix:nonFraction></span>, or an aggregate
of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zHmhlGb5hN3f" title="Value of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember_custom_UnderwritersMember" id="Fact000772" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,615,000</ix:nonFraction></span> if the underwriters&#8217; over-allotment is exercised in full) from the Company in a private placement that will occur
simultaneously with the closing of the Initial Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the IPO on July 14, 2023, the Company consummated the private sale of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zPvRTKkuTfjj" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember" id="Fact000774" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">330,000</ix:nonFraction></span> Private Placement Units. <span id="xdx_903_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z8nQtTj8eqre" title="Units related to private placement description"><ix:nonNumeric contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember" id="Fact000776" name="us-gaap:SaleOfStockDescriptionOfTransaction">Each
Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the
consummation of the Company&#8217;s initial Business Combination.</ix:nonNumeric></span> The proceeds from the sale of the Private Placement Units were
added to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the
Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the
redemption of the Public Shares (subject to the requirements of applicable law). The Private Placement Units (including the
underlying securities) will not be transferable, assignable, or salable until the completion of a Business Combination, subject to
certain exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2023, the underwriters exercised the over-allotment option in full. See Note 1 for more details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 317; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000778" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z3GywOdgSHI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 &#8212; <span id="xdx_82A_zaXgTC9OiXe4">RELATED PARTIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Founder
Shares and EBC Founder Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 27, 2023, the Sponsors received <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zglblFNDvW7d" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-272023-02-27_custom_SponsorsMember" id="Fact000780" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,725,000</ix:nonFraction></span> of the Company&#8217;s ordinary shares (&#8220;Founder Shares&#8221;) in exchange
for $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zkZoz5c7plq9" title="Sponsors received ordinary shares, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-02-272023-02-27_custom_SponsorsMember" id="Fact000782" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span> paid for offering costs borne by the Sponsors. Up to <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zVcODg9xyeBc" title="Number of shares subject to forfeiture"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-02-272023-02-27_custom_SponsorsMember_us-gaap_OverAllotmentOptionMember" id="Fact000784" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225,000</ix:nonFraction></span> of such Founder Shares were subject to forfeiture to the extent
that the underwriters&#8217; over-allotment was not exercised in full. On July 17, 2023, the underwriters exercised their over-allotment option in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 15, 2023, the Company issued to EBC <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zVWcQHN6JEha" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-03-152023-03-15_custom_EBCMember" id="Fact000786" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></span> ordinary shares (&#8220;EBC founder shares&#8221;) for a purchase price of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zp3zDrlFqLY4" title="Ordinary share price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-03-15_custom_EBCMember" id="Fact000788" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.014</ix:nonFraction></span> per
share and an aggregate purchase price of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zOcA9RsGMA3h" title="Value of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-03-152023-03-15_custom_EBCMember" id="Fact000790" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">2,520</ix:nonFraction></span>. The EBC founder shares are deemed to be underwriters&#8217; compensation by FINRA pursuant
to Rule 5110 of the FINRA Manual. The Company estimated the fair value of the EBC founder shares to be approximately $<span id="xdx_908_eus-gaap--DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zYPoSV8plTk1" title="Fair value of shares issued"><ix:nonFraction name="us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" contextRef="From2023-03-152023-03-15_custom_EBCMember" id="Fact000792" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,016,000</ix:nonFraction></span> or $<span id="xdx_90E_eus-gaap--SharePrice_iI_pid_c20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zaU5F0wQ6GYd" title="Fair value of ordinary per share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-03-15_custom_EBCMember" id="Fact000794" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.65</ix:nonFraction>
</span>per share using the Black-Scholes option pricing model. The Company accounted for the difference between the par value and fair value
of the shares as offering cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000796" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_89D_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zOCn0l1Ycqmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair
value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zJYUcGy76vr" style="display: none">SCHEDULE
OF ASSUMPTIONS TO ESTIMATE FAIR VALUE</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 84%; text-align: left">Time to expiration</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90F_ecustom--EquitySecuritiesFvNiTerm_dtY_c20230315__20230315_zLaPy9wr7i8a" title="Time to expiration"><ix:nonNumeric contextRef="From2023-03-152023-03-15" format="ixt-sec:duryear" id="Fact000798" name="BOWN:EquitySecuritiesFvNiTerm">1.84</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_ziZuy1TovcP6" title="Risk-free rate"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiMeasurementInput" contextRef="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="Fact000800" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zh5axFQLqyh7" title="Risk-free rate"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiMeasurementInput" contextRef="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputPriceVolatilityMember" id="Fact000802" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">5.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zgEwwIudNqN1" title="Risk-free rate"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiMeasurementInput" contextRef="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputExpectedDividendRateMember" id="Fact000804" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Probability of completion of business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember_zRD7Tcv0CwE5" title="Founder shares measurement input"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiMeasurementInput" contextRef="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_custom_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember" id="Fact000806" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">60.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zjmPdDVpjt96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur
of: (A) six months after the completion of the initial Business Combination and (B) the date on which the Company completes a liquidation,
merger, share exchange, reorganization or other similar transaction after an initial Business Combination that results in all of the
Company&#8217;s public shareholders having the right to exchange their ordinary shares for cash, securities or other property. EBC has
also agreed, subject to exceptions, that the EBC founder shares cannot be sold, transferred or assigned, until the consummation of an
initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Promissory
Note&#8201;&#8212;&#8201;Related Party</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 27, 2023, the Sponsors issued an unsecured promissory note to the Company (the &#8220;Promissory Note&#8221;), pursuant to which
the Company may borrow up to an aggregate principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20230227__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorsMember_z6PXcjJFr5V7" title="Promissory note aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-02-27_custom_PromissoryNoteMember_custom_SponsorsMember" id="Fact000808" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span>. The Promissory Note was non-interest bearing and payable on the
earlier of (i) December 31, 2023, or (ii) the consummation of the IPO. The Promissory Note expired on <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20230227__20230227__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorsMember_zBMTlxby19xa" title="Promissory note maturity date"><ix:nonNumeric contextRef="From2023-02-272023-02-27_custom_PromissoryNoteMember_custom_SponsorsMember" format="ixt:datemonthdayyearen" id="Fact000810" name="us-gaap:DebtInstrumentMaturityDate">July 14, 2023</ix:nonNumeric></span>. As of June 30, 2024
and December 31, 2023, there were <span id="xdx_902_eus-gaap--NotesPayable_iI_do_c20240630__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember_zMGyFeQuVqGa" title="Notes outstanding amount"><span id="xdx_902_eus-gaap--NotesPayable_iI_do_c20231231__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember_zGFILMtmypLk" title="Notes outstanding amount"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-06-30_custom_PromissoryNoteMember" id="Fact000812" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2023-12-31_custom_PromissoryNoteMember" id="Fact000814" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> amounts outstanding under the Promissory Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriting
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company granted the underwriters a 45-day option from the date of IPO to purchase up to <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zvvNXvDisHv5" title="Stock issued during the period, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-07-142023-07-14_us-gaap_OverAllotmentOptionMember_srt_MaximumMember" id="Fact000816" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> additional Units to cover over-allotments,
at the IPO price less the underwriting discounts and commissions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters were entitled to a cash underwriting discount of $<span id="xdx_90E_ecustom--CashUnderwritingDiscountPerUnit_pid_c20240101__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zFo1GPhiffRg" title="Cash underwriting discount per unit"><ix:nonFraction name="BOWN:CashUnderwritingDiscountPerUnit" contextRef="From2024-01-012024-06-30_us-gaap_OverAllotmentOptionMember" id="Fact000818" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.25</ix:nonFraction></span> per Unit, or $<span id="xdx_90C_ecustom--CashUnderwritingDiscount_pid_c20240101__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zGRUy9PNOYw7" title="Aggregate cash underwriting discount"><ix:nonFraction name="BOWN:CashUnderwritingDiscount" contextRef="From2024-01-012024-06-30_us-gaap_OverAllotmentOptionMember" id="Fact000820" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">1,500,000</ix:nonFraction></span> in the aggregate (or $<span id="xdx_90C_eus-gaap--PaymentsForUnderwritingExpense_pid_c20240101__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zQtc3S5fKzq5" title="Payments for underwriting expense"><ix:nonFraction name="us-gaap:PaymentsForUnderwritingExpense" contextRef="From2024-01-012024-06-30_us-gaap_OverAllotmentOptionMember" id="Fact000822" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">1,725,000</ix:nonFraction></span> in the aggregate
if the underwriters&#8217; over-allotment option is exercised in full), payable upon the closing of the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2023, the underwriters exercised the over-allotment option in full to purchase <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230717__20230717__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zXGXoLPdIJE" title="Number of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-172023-07-17_us-gaap_OverAllotmentOptionMember" id="Fact000824" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> Units. As a result, on July 18, 2023,
the Company sold an additional <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zaMFNVboA7p6" title="Number of units sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember" id="Fact000826" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> Units at $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zYUYa8VCiJ1l" title="Sale of stock price per unit"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-07-18_us-gaap_OverAllotmentOptionMember" id="Fact000828" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit, generating gross proceeds to the Company of $<span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_ziu6bwz3pv3d" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember" id="Fact000830" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,000,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Due
to Related Party</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors paid certain formation, operating or offering costs on behalf of the Company. These amounts were due on demand and non-interest
bearing. As of June 30, 2024, the Sponsors had paid $<span id="xdx_901_eus-gaap--OtherLiabilitiesCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zh40yas4j7Jl" title="Due to related party"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-06-30_custom_SponsorsMember_us-gaap_IPOMember" id="Fact000832" format="ixt:numdotdecimal" decimals="0" unitRef="USD">151,318</ix:nonFraction></span> on behalf of the Company for expenses related to IPO, which was fully repaid
upon closing of the IPO on July 14, 2023 out of the offering proceeds held in trust account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024 and December 31, 2023, the total accrued expenses due to related parties was $<span id="xdx_902_eus-gaap--AccruedLiabilitiesCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHgUxc2wuXme" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember" id="Fact000834" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z4AFaZSrMok2" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="Fact000836" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,250</ix:nonFraction></span>, respectively. See
following paragraphs for details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Initial
Accounting Service Fee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has engaged TenX Global Capital, a related party of the Company, to assist in the preparation of financial statements and other
accounting consulting services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
initial accounting service fee was only related with the initial accounting preparation which was incurred in the period from February
17, 2023 (inception) to March 31, 2023 with total amount of $<span id="xdx_90B_eus-gaap--ProfessionalFees_c20230217__20230331__dei--LegalEntityAxis__custom--TenXGlobalCapitalMember_zRvuXhchtJ5l" title="Accounting service fee"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-02-172023-03-31_custom_TenXGlobalCapitalMember" id="Fact000838" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></span>. There was no such cost in the subsequent periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Accounting
Service Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has engaged TenX Global Capital, a related party of the Company, to assist in preparing quarterly and annual financial statements
commencing following the consummation of the IPO. The Company has agreed to pay for these services at a fixed quarterly rate of $<span id="xdx_908_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20230714__20230714__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zOX2X97FTQb3" title="Accounting service fee payable per quarter"><ix:nonFraction name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="From2023-07-142023-07-14_custom_AccountingServiceAgreementMember" id="Fact000840" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,250</ix:nonFraction></span>
each quarter. For three months ended June 30, 2024 and 2023, a service fee of $<span id="xdx_905_eus-gaap--ProfessionalFees_c20240401__20240630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_z2a0wkbhHnch" title="Accrued liabilities"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2024-04-012024-06-30_custom_AccountingServiceAgreementMember" id="Fact000842" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,250</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--ProfessionalFees_c20230401__20230630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_z4qlek3Fzw52" title="Accrued liabilities"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-04-012023-06-30_custom_AccountingServiceAgreementMember" id="Fact000844" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> has been accrued and paid for these services.
For six months ended June 30, 2024 and during the period from February 17, 2023 (inception) through June 30, 2023, service fee of $<span id="xdx_90E_eus-gaap--ProfessionalFees_c20240101__20240630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zByW5qAe5wb3" title="Service fee"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2024-01-012024-06-30_custom_AccountingServiceAgreementMember" id="Fact000846" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,500</ix:nonFraction></span>
and $<span id="xdx_909_eus-gaap--ProfessionalFees_c20230217__20230630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_z1LzqKOYjc84" title="Accounting service fee"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-02-172023-06-30_custom_AccountingServiceAgreementMember" id="Fact000848" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> have been incurred for these services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administration
Fee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
on the effectiveness of the Registration Statement on July 11, 2023, an affiliate of the Sponsors will be allowed to charge the
Company an allocable share of its overhead, up to $<span id="xdx_90C_eus-gaap--AffiliateCosts_c20230711__20230711__srt--TitleOfIndividualAxis__custom--SponsorsMember__srt--RangeAxis__srt--MaximumMember_ztqYf0fhDEJa" title="Affiliate costs per month"><ix:nonFraction name="us-gaap:AffiliateCosts" contextRef="From2023-07-112023-07-11_custom_SponsorsMember_srt_MaximumMember" id="Fact000850" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></span>
per month, until to the close of the Business Combination, to compensate it for the Company&#8217;s use of its office, utilities and
personnel. Administration fee of $<span id="xdx_90E_eus-gaap--AdministrativeFeesExpense_c20240401__20240630_zoRz0cYYRfOe" title="Administrative fee"><ix:nonFraction name="us-gaap:AdministrativeFeesExpense" contextRef="From2024-04-012024-06-30" id="Fact000852" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></span>
and $<span id="xdx_909_eus-gaap--AdministrativeFeesExpense_c20240101__20240630_ziyK2jc0nw98" title="Administrative fee"><ix:nonFraction name="us-gaap:AdministrativeFeesExpense" contextRef="From2024-01-01to2024-06-30" id="Fact000854" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction></span>
were incurred as &#8220;accrued expenses &#8211; related parties&#8221; for the three and six months ended June 30, 2024,
respectively. For the period from February 17, 2023 (inception) through June 30, 2023, the Company did <span id="xdx_90F_eus-gaap--AdministrativeFeesExpense_do_c20230217__20230630_zRb1uQYvrZEk" title="Administration fee"><ix:nonFraction name="us-gaap:AdministrativeFeesExpense" contextRef="From2023-02-172023-06-30" id="Fact000856" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span>t
incur any fees for these services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000858" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zyLIYCmATNUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8212;<span id="xdx_823_zKJ1iHLnOPih"> COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares, EBC founder shares, Private Placement Units will be entitled to registration rights pursuant to a registration
rights agreement dated on the effectiveness of the Registration Statement on July 11, 2023 requiring the Company to register such securities
for resale. Subject to certain limitations set forth in such agreement, the holders of these securities will be entitled to make up to
three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain
&#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to completion of a Business Combination
and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the
registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration
statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear
the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 318; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination Marketing Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has engaged EBC as an advisor in connection with its Business Combination to assist in holding meetings with the Company stockholders
to discuss the potential Business Combination and the target business&#8217; attributes, introduce the Company to potential investors
that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and
public filings in connection with the Business Combination. The Company will pay EBC a service fee for such services upon the consummation
of its initial Business Combination in an amount of $<span id="xdx_90E_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20240101__20240630__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_z8kVxINh0KM2" title="Service fee"><ix:nonFraction name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" contextRef="From2024-01-012024-06-30_custom_BusinessCombinationMarketingAgreementMember" id="Fact000860" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,415,000</ix:nonFraction></span>, equal to<span id="xdx_90C_ecustom--PercentageOfGrossProceedsOfInitialPublicOffering_iI_pid_dp_uPure_c20240630__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_zyk8isjetBP6" title="Percentage of gross proceeds of initial public offering"> <ix:nonFraction name="BOWN:PercentageOfGrossProceedsOfInitialPublicOffering" contextRef="AsOf2024-06-30_custom_BusinessCombinationMarketingAgreementMember" id="Fact000862" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.5</ix:nonFraction></span>% of the gross proceeds of the IPO. In addition, the Company
will pay EBC a service fee in an amount equal to <span id="xdx_90A_ecustom--PercentageOfServiceFeeOfTotalConsiderationPayable_iI_pid_dp_uPure_c20240630__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_z2VYbFe6dlTh" title="Percentage of service fee of total consideration payable"><ix:nonFraction name="BOWN:PercentageOfServiceFeeOfTotalConsiderationPayable" contextRef="AsOf2024-06-30_custom_BusinessCombinationMarketingAgreementMember" id="Fact000864" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.0</ix:nonFraction></span>% of the total consideration payable in the initial Business Combination if it introduces
the Company to the target business with whom it completes an initial Business Combination and the amount will be payable in cash and
is due at the closing date of the initial Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Business
Combination Transaction Cost</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company has engaged several service providers including legal and valuation services, specifically for business combination between
the Company and Shenzhen Qianzhi BioTechnology Co. Ltd. (&#8220;Qianzhi&#8221;). Per the agreed terms, Qianzhi agreed to be
responsible for all expenses incurred by the Company in connection with business combination. During the three months ended June 30,
2024, $<span id="xdx_903_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20240401__20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zNbVaVR6mQbd" title="Business combination related cost incurred"><ix:nonFraction name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" contextRef="From2024-04-012024-06-30_custom_QianzhiMember" id="Fact000866" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,199</ix:nonFraction></span>
of business combination related cost has been incurred which $<span id="xdx_909_ecustom--BusinessCombinationAcquisitionRelatedCostsReimbursed_c20240401__20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zn5QdfCt14gi" title="Business combination related cost reimbursed"><ix:nonFraction name="BOWN:BusinessCombinationAcquisitionRelatedCostsReimbursed" contextRef="From2024-04-012024-06-30_custom_QianzhiMember" id="Fact000868" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span>
was reimbursed by Qianzhi. During the six months ended June 30, 2024, $<span id="xdx_90C_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20240101__20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zTnFCog0Y3k8" title="Business combination related cost"><ix:nonFraction name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" contextRef="From2024-01-012024-06-30_custom_QianzhiMember" id="Fact000870" format="ixt:numdotdecimal" decimals="0" unitRef="USD">252,002</ix:nonFraction></span>
of business combination related cost has been incurred which $<span id="xdx_904_ecustom--BusinessCombinationAcquisitionRelatedCostsReimbursed_c20240101__20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zF0rcg51FBh9" title="Business combination related cost reimbursed"><ix:nonFraction name="BOWN:BusinessCombinationAcquisitionRelatedCostsReimbursed" contextRef="From2024-01-012024-06-30_custom_QianzhiMember" id="Fact000872" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206,803</ix:nonFraction></span>
was reimbursed by Qianzhi. This activity has been recorded net in accompanying financial statements. As of June 30, 2024, the
receivable from Qianzhi and accrued to service providers was $<span id="xdx_906_eus-gaap--OtherReceivablesNetCurrent_iI_c20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zT1W5C1zhSL6" title="Other receivables"><span id="xdx_902_ecustom--BusinessCombinationAcquisitionRelatedCostsReimbursed_c20240731__20240731__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXqmxgAxwRZh" title="Business combination related cost reimbursed"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2024-06-30_custom_QianzhiMember" id="Fact000874" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="BOWN:BusinessCombinationAcquisitionRelatedCostsReimbursed" contextRef="From2024-07-312024-07-31_custom_QianzhiMember_us-gaap_SubsequentEventMember" id="Fact000876" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,199</ix:nonFraction></ix:nonFraction></span></span>. On July 31, 2024, the outstanding amount was paid off by Qianzhi.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000878" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_806_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zeIgVsuanBU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8212; <span id="xdx_828_zgUlCuCAyM4j">SHAREHOLDERS&#8217; EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Shares</i></b> &#8212; The Company is authorized to issue <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240630_zyR5QrsW2Eb5" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-06-30" id="Fact000880" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span> preferred shares with a par value of $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240630_zEBeCxRsxLN5" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30" id="Fact000882" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share with such
designations, voting and other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.
As of June 30, 2024 and December 31, 2023, there were <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_do_c20240630_zMfFFe5S887j" title="Preferred stock, shares issued"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240630_zYqfeMLFear6" title="Preferred stock, shares outstanding"><span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_z09AC5Dpm2L" title="Preferred stock, shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_zLXarCeMPJy7" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-06-30" id="Fact000884" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-06-30" id="Fact000886" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000888" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000890" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> preferred shares issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ordinary
Shares</i></b> &#8212; The Company is authorized to issue <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240630_zfUpVDR31W4a" title="Ordinary stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-06-30" id="Fact000892" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></span> ordinary shares with a par value of $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240630_zfJvfrxZNPde" title="Ordinary stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30" id="Fact000894" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction> </span>per share. <span id="xdx_909_eus-gaap--CommonStockVotingRights_c20240101__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4o5zkecJ5da" title="Ordinary stock, voting rights"><ix:nonNumeric contextRef="From2024-01-012024-06-30_us-gaap_CommonStockMember" id="Fact000896" name="us-gaap:CommonStockVotingRights">Holders
of ordinary shares are entitled to one vote for each share</ix:nonNumeric></span>. On February 27, 2023, the Sponsors received <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zimQWWaQ0bua" title="Issuance of ordinary shares to Sponsor, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-272023-02-27_custom_SponsorsMember" id="Fact000898" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,725,000</ix:nonFraction></span> of the Founder Shares
in exchange for $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zJ60AhrGcQQd" title="Issuance of ordinary shares to Sponsor, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-02-272023-02-27_custom_SponsorsMember" id="Fact000900" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span> paid for offering costs borne by the Sponsors, of which an aggregate of up to <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zv71jJBVmkbd" title="Number of shares subject to forfeiture"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-02-272023-02-27_custom_SponsorsMember_us-gaap_OverAllotmentOptionMember" id="Fact000902" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225,000</ix:nonFraction></span> of such Founder Shares
were subject to forfeiture to the extent that the underwriters&#8217; over-allotment was not exercised in full or in part, so that the
number of Founder Shares will equal 20% of the Company&#8217;s issued and outstanding ordinary shares after the IPO (excluding shares
underlying the Private Placement Units). No ordinary shares are subject to forfeiture since the over-allotment was fully exercised on
July 17, 2023. As of June 30, 2024 and December 31, 2023, there were <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_pid_c20240630_zne4WSgLqDCf" title="Ordinary shares issued"><span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240630_zK99cXm3ZeR6" title="Ordinary shares outstanding"><span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_z41EvWA6EZCe" title="Ordinary stock, shares issued"><span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zYds4ElMB4K2" title="Ordinary stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-06-30" id="Fact000904" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30" id="Fact000906" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000908" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000910" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> ordinary shares issued and outstanding (excluding <span id="xdx_90D_ecustom--OrdinarySharesSubjectToRedemption_iI_c20240630_zTDTCDdxX3we" title="Ordinary shares subject to redemption"><ix:nonFraction name="BOWN:OrdinarySharesSubjectToRedemption" contextRef="AsOf2024-06-30" id="Fact000912" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></span>
shares subject to possible redemption).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rights
</i></b>&#8212; Except in cases where the Company is not the surviving company in a business combination, <span id="xdx_901_eus-gaap--CommonStockVotingRights_c20240101__20240630_zS2WDoWWNPpl" title="Ordinary stock, voting rights"><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" id="Fact000914" name="us-gaap:CommonStockVotingRights">each holder of a right will
automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination</ix:nonNumeric></span>. The Company will
not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole
share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company is not the surviving
company upon completion of the initial Business Combination, each holder of a right will be required to affirmatively convert his, her
or its rights in order to receive the one-tenth (1/10) of one ordinary share underlying each right upon consummation of the business
combination. If the Company is unable to complete the initial Business Combination within the required time period and the Company will
redeem the public shares for the funds held in the trust account, holders of rights will not receive any of such funds for their rights
and the rights will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000916" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_807_eus-gaap--FairValueDisclosuresTextBlock_zglg1BNMSnDb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8212;<span id="xdx_82D_zBPu0g79U7mj"> Fair Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which
transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets
or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000918" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock"><p id="xdx_892_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zHevNpAQnl41" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis at June 30,
2024 and December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair
value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zrl4VqYdy7I6" style="display: none">SCHEDULE
OF MEASURED FAIR VALUE ON RECURRING BASIS</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Date</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Trading Securities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2024</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 45%; text-align: left">Marketable securities held in the trust account</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zbjEgAq8OH5k" title="Marketable securities held in the trust account" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact000920" format="ixt:numdotdecimal" decimals="0" unitRef="USD">73,284,700</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Marketable securities held in the trust account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zD90qliMI9ii" title="Marketable securities held in the trust account" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member" id="Fact000922" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,419,358</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>




</ix:nonNumeric><p id="xdx_8AD_zH3p57bs5Deg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-06-30" escape="true" id="Fact000924" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zicSOEJTmSq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8212;<span id="xdx_829_zB00o4Dzkw19"> SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were available to be issued. Based upon this review, the Company identified the following subsequent event that would have required adjustment
or disclosure in the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On July 31, 2024, $<span id="xdx_909_ecustom--BusinessCombinationAcquisitionRelatedCostsReimbursed_c20240731__20240731__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zBdO0ERmmxf1" title="Business combination related cost reimbursed"><ix:nonFraction name="BOWN:BusinessCombinationAcquisitionRelatedCostsReimbursed" contextRef="From2024-07-312024-07-31_custom_QianzhiMember_us-gaap_SubsequentEventMember" id="Fact000926" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,199</ix:nonFraction></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">of
business combination related cost was reimbursed by Qianzhi.</span></p>
</ix:nonNumeric><p id="xdx_81D_zzyo6fnAeIIf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 319; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INDEX
TO THE FINANCIAL STATEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.75in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#am_025">Report of Independent Registered Public Accounting Firm</a> (PCAOB #1195) </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-67</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Statements:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#am_026">Consolidated
    Balance Sheet</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-68</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#am_027">Consolidated
    Statement of Operations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-69</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#am_028">Consolidated
    Statement of Changes in Stockholders&#8217; Equity</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-70</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#am_029">Consolidated
    Statement of Cash Flows</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-71</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#am_030">Notes to Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: -10pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-72
    to F-80</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 320; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="am_025"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Board of Directors and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
of Bowen Acquisition Corp and Subsidiary </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
on the Financial Statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of Bowen Acquisition Corp and its wholly owned subsidiary (the &#8220;Company&#8221;)
as of December 31, 2023, and the related consolidated statements of operations, changes in shareholders&#8217; equity, and cash flows
for the period from February 17, 2023 (inception) to December 31, 2023, and the related notes (collectively referred to as the &#8220;financial
statements&#8221;). In our opinion, the financial statements presents fairly, in all material respects, the financial position of the
Company as of December 31, 2023, and the results of its operations and its cash flows for the period from February 17, 2023 (inception)
to December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantial
Doubt about the Company&#8217;s Ability to Continue as a Going Concern</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared to assume the Company will continue as a going concern. As discussed in Note 1 to
the financial statements, the Company has no revenue, and incurred and expects to continue to incur significant professional costs to
remain as a publicly traded company and to incur significant transaction costs in the pursuit of the consummation of a business combination.
The Company&#8217;s cash and working capital as of December 31, 2023, are not sufficient to complete its planned activities for the upcoming
year. These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s evaluation
of the events and conditions and management&#8217;s plans regarding these matters are also described in Note 1 to the financial statements.
The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our opinion is not modified
with respect to that matter.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
for Opinion</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit,
we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides
a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    UHY LLP</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have served as the Company&#8217;s auditor since 2023.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, New York</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    29, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>


<!-- Field: Page; Sequence: 321; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="am_026">CONSOLIDATED </span>BALANCE
SHEET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" id="xdx_301_111_zDrvIvacRTQj" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20231231_zdDvjOQYODZ1" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsAbstract_iB_zIAaDdXMQ8o3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ASSETS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrentAbstract_i01B_zM4xQFuhVmGa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current assets:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--Cash_i02I_maACzEoK_z3eQVdMjMiPg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-12-31" id="Fact000932" format="ixt:numdotdecimal" decimals="0" unitRef="USD">426,913</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--PrepaidExpenseCurrent_i02I_maACzEoK_zhN1D4SRQ0ld" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
    expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2023-12-31" id="Fact000934" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,481</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrent_i02TI_mtACzEoK_maAzROw_zY23FYZgG8Pj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current assets</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31" id="Fact000936" format="ixt:numdotdecimal" decimals="0" unitRef="USD">506,394</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AssetsHeldInTrustNoncurrent_i01I_maANzyez_zRZyy1gNc9Yh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
held in trust account</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-12-31" id="Fact000938" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,419,358</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AssetsNoncurrent_i01TI_mtANzyez_maAzROw_zEbacREJKCMb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total non-current assets</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2023-12-31" id="Fact000940" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,419,358</ix:nonFraction></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--Assets_i01TI_mtAzROw_zjnAFDTBGgbc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Assets</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31" id="Fact000942" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,925,752</ix:nonFraction></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z4aJXVvuyzCf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LIABILITIES AND SHAREHOLDERS&#8217;
    EQUITY</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesCurrentAbstract_i01B_zNFPWslSn7de" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Liabilities:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zbNhmZXk3MHj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued offering costs
    and expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember" id="Fact000948" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,610</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHWpPwlVJNQg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    expenses &#8211; related party</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="Fact000950" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,250</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedLiabilitiesCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCziw4_zjIKb78Hy3lc" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="Fact000952" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,250</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--LiabilitiesCurrent_i02TI_mtLCziw4_maLASEzhhN_zJxOTaWa52P4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Current Liabilities</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000954" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,860</ix:nonFraction></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzhhN_zHG1I0vHhIC1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commitments and contingencies</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span>&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i01I_maLASEzhhN_zzBZDm79S9r3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
    shares subject to possible redemption (<span id="xdx_901_ecustom--OrdinarySharesSubjectToRedemption_iI_c20231231_zibIPqSaQv61" title="Ordinary shares subject to redemption"><ix:nonFraction name="BOWN:OrdinarySharesSubjectToRedemption" contextRef="AsOf2023-12-31" id="Fact000960" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></span> shares at $<span id="xdx_906_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_c20231231_zCcHJLooWBV4" title="Ordinary shares subject to redemption par value"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000962" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.35</ix:nonFraction></span> per share)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31" id="Fact000958" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,419,358</ix:nonFraction></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquityAbstract_i01B_z3U5Qqyl5mcg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholders&#8217;
    Equity:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--PreferredStockValue_i02I_maSEzPmX_zkSInJAVumGe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred shares, $<span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zfBvR0NDNkRb" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000968" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>
    par value; <span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zCnjbfjnaKO" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000970" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span> shares authorized; <span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_pid_dn_c20231231_zGswYDzioEV8" title="Preferred stock, shares issued"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_dn_c20231231_zBpRwy4pig9a" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000972" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000974" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></span></span> issued and outstanding</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--CommonStockValue_i02I_maSEzPmX_zB8WU8DWMW8i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares, $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zjhtTHEKzESe" title="Ordinary shares, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000978" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>
    par value; <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zTurkVnJCt07" title="Ordinary stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000980" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></span> shares authorized; <span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zrgmdSIyURdk" title="Ordinary stock, shares issued"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_z4JFf0JVqnX3" title="Ordinary stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000982" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000984" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31" id="Fact000976" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AdditionalPaidInCapital_i02I_maSEzPmX_zJvm0tQMwuZe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional paid-in capital</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0986">-</span> </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCzMJv_maSEzPmX_zOeaJaEtqLF" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retained
    Earnings</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31" id="Fact000988" format="ixt:numdotdecimal" decimals="0" unitRef="USD">402,307</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--StockholdersEquity_i02TI_mtSEzPmX_maLASEzhhN_zWtunGTThure" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Shareholders&#8217; Equity</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000990" format="ixt:numdotdecimal" decimals="0" unitRef="USD">402,534</ix:nonFraction></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzhhN_zMNUD79JtWC6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">T<b>otal
    Liabilities and Shareholders&#8217; Equity</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000992" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,925,752</ix:nonFraction></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 322; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="am_027"></span>CONSOLIDATED
STATEMENT OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_113_zMtYBHcXayJi" summary="xdx: Statement - Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230217__20231231_zizTcSQz2JE8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">FOR THE PERIOD<br/> FROM</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">FEBRUARY 17, 2023 (INCEPTION) THROUGH<br/> DECEMBER 31, 2023</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingCostsAndExpenses_msCzPB4_zvnUNM4n3J6k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left; padding-bottom: 1.5pt">Formation and operating costs</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 18%; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-02-172023-12-31" id="Fact000994" format="ixt:numdotdecimal" decimals="0" unitRef="USD">244,568</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OperatingIncomeLoss_iT_mtCzPB4_maCzGNF_zQUAyfgCsCX9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-02-172023-12-31" id="Fact000996" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">244,568</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherNonoperatingIncomeExpenseAbstract_iB_zpyRz8o1YlK8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromEquityMethodInvestments_i01_maCzxOo_zdNzeEDn5Nm2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Interest  earned on investments held in trust account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2023-02-172023-12-31" id="Fact001000" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,729,358</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherNonoperatingIncomeExpense_i01T_mtCzxOo_maCzGNF_zHvFfVVAUiF3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-02-172023-12-31" id="Fact001002" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,729,358</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLoss_iT_mtCzGNF_zKMH9fcpAfxe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net income</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-12-31" id="Fact001004" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,484,790</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and diluted weighted average ordinary shares outstanding, redeemable ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zGH0WSGtRtbj" title="Basic weighted average ordinary shares outstanding, redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zUsgtr6Uczu" title="Diluted weighted average ordinary shares outstanding, redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-02-172023-12-31_custom_RedeemableOrdinarySharesMember" id="Fact001006" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-02-172023-12-31_custom_RedeemableOrdinarySharesMember" id="Fact001008" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,819,156</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic and diluted net income per share, redeemable ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_909_eus-gaap--EarningsPerShareBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zLUMC7CHGaw4" title="Basic net income per share, redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zm1QEXXEYZ45" title="Diluted net income per share, redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-02-172023-12-31_custom_RedeemableOrdinarySharesMember" id="Fact001010" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-02-172023-12-31_custom_RedeemableOrdinarySharesMember" id="Fact001012" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.12</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and diluted weighted average ordinary shares outstanding, non-redeemable ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_z3I1oVUZ8Gpf" title="Basic weighted average ordinary shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_zUeavtIDElyh" title="Diluted weighted average ordinary shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-02-172023-12-31_custom_NonRedeemableOrdinarySharesMember" id="Fact001014" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-02-172023-12-31_custom_NonRedeemableOrdinarySharesMember" id="Fact001016" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,095,943</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic and diluted net loss per share, non-redeemable ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_907_eus-gaap--EarningsPerShareBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_zWF1EDxzYcX8" title="Basic net loss per share, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinarySharesMember_zORhNR1Iapda" title="Diluted net loss per share, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-02-172023-12-31_custom_NonRedeemableOrdinarySharesMember" id="Fact001018" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-02-172023-12-31_custom_NonRedeemableOrdinarySharesMember" id="Fact001020" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.32</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 323; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="am_028"></span>CONSOLIDATED
STATEMENT OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30E_114_zKzjAGGqOWHe" summary="xdx: Statement - Consolidated Statements of Changes in Shareholders' Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zeywLmwVtF6i" style="display: none; text-align: center">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_z20D3vxJPNGg" style="display: none; text-align: center">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none; font-weight: bold">&#160;</td>
    <td style="display: none; font-weight: bold; text-align: left">&#160;</td><td id="xdx_4BD_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zCa5bD8DYxBg" style="display: none; font-weight: bold; text-align: center">&#160;</td><td style="display: none; font-weight: bold; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td id="xdx_4B9_zDqOQHo9kd84" style="display: none; text-align: center">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ordinary
                                                                                 Shares</b></span></p></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid-in</b></span></p></td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Retained Earnings (Accumulated</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholders&#8217;</b></span></p></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Capital</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equity</td><td style="font-weight: bold">&#160;</td></tr>
<tr id="xdx_436_c20230217__20231231_eus-gaap--StockholdersEquity_iS_zJwMYNRgSlFk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Balance on February 17, 2023 (inception)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Issuance of ordinary shares to Sponsor, shares" style="text-align: right"><p id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230217__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zGb9w5l3zfB8" title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1027">-</span></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1022">-</span></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1023">-</span></p></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-style: normal; font-weight: normal; text-align: left">$</td><td style="font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1024">-</span></p></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1025">-</span></p></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_432_c20230217__20231231_eus-gaap--StockholdersEquity_iS_zkA8eWDZ3e65" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; font-weight: bold">Balance</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230217__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zREB0hgN291" title="Balance, shares" style="display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1034">-</span></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">$</td><td style="display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1029">-</span></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">$</td><td style="display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1030">-</span></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">$</td><td style="display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1031">-</span></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">$</td><td style="display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1032">-</span></td><td style="display: none; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zmHJ4sUjhd6a" style="vertical-align: bottom; background-color: White">
    <td style="width: 35%; text-align: left">Issuance of ordinary shares to Sponsors</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230217__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zLJa2ImInKPb" title="Issuance of ordinary shares to Sponsor, shares" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001041" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,725,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001036" format="ixt:numdotdecimal" decimals="0" unitRef="USD">173</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001037" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,827</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1038">-</span></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-02-172023-12-31" id="Fact001039" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueToUnderwriter_zgcINGV5TrJ9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of ordinary shares to Underwriter</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesToUnderwriter_pid_c20230217__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_z3mzyVJ7U2I4" title="Issuance of ordinary shares to Underwriter, shares" style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodSharesToUnderwriter" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001048" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueToUnderwriter" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001043" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueToUnderwriter" contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001044" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,015,982</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1045">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueToUnderwriter" contextRef="From2023-02-172023-12-31" id="Fact001046" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,016,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits_zg7RzG4bsjva" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from sale of public units</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits_c20230217__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBgg26dsk88" title="Proceeds from sale of public units, shares" style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001055" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001050" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits" contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001051" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,999,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1052">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits" contextRef="From2023-02-172023-12-31" id="Fact001053" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--StockIssuedDuringPeriodValueProceedsFromOverallotment_zAJxy31JgqO2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from over-allotment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesProceedsFromOverallotment_c20230217__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3IurCvya1d6" title="Proceeds from over-allotment, shares" style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodSharesProceedsFromOverallotment" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001062" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueProceedsFromOverallotment" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001057" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueProceedsFromOverallotment" contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001058" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,999,910</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1059">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueProceedsFromOverallotment" contextRef="From2023-02-172023-12-31" id="Fact001060" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--StockIssuedDuringPeriodValueSaleOfPrivateUnits_zsiGMS9ts8ef" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sale of Private Units</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--StockIssuedDuringPeriodSharesSaleOfPrivateUnits_c20230217__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1DhAOAZkxBj" title="Sale of Private Units, shares" style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodSharesSaleOfPrivateUnits" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001069" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">330,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueSaleOfPrivateUnits" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001064" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueSaleOfPrivateUnits" contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001065" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,299,967</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1066">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueSaleOfPrivateUnits" contextRef="From2023-02-172023-12-31" id="Fact001067" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,300,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits_z37OmjJu3zce" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Over-allotment of Private Units</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits_c20230217__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9q4dpQ7HQn1" title="Over-allotment of Private Units, shares" style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001076" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits" contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001072" format="ixt:numdotdecimal" decimals="0" unitRef="USD">314,997</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1073">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits" contextRef="From2023-02-172023-12-31" id="Fact001074" format="ixt:numdotdecimal" decimals="0" unitRef="USD">315,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits_zE1CCoZFXg2e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Underwriter&#8217;s commission on sale of Public Units</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1078">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits" contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001079" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,500,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1080">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits" contextRef="From2023-02-172023-12-31" id="Fact001081" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,500,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment_z8JrX7q1Qe6l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Underwriter&#8217;s commission on Over-allotment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1083">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment" contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001084" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">225,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1085">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment" contextRef="From2023-02-172023-12-31" id="Fact001086" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">225,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts_zv9GycfHlEZe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts" contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001089" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,593,898</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1090">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts" contextRef="From2023-02-172023-12-31" id="Fact001091" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,593,898</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueOther_zJ4bKaHR5NH7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesOther_c20230217__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFQCEOHRBqh2" title="Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001098" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001093" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">690</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001094" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">65,235,677</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1095">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-02-172023-12-31" id="Fact001096" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">65,236,367</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_zxhFwYzqpiH8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs to ordinary shares subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1100">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001101" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,137,867</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1102">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" contextRef="From2023-02-172023-12-31" id="Fact001103" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,137,867</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock_zdrKdRqRhnJe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Deduction for increase of carrying value of redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001106" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,591,500</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1107">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" contextRef="From2023-02-172023-12-31" id="Fact001108" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,591,500</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--AdjustmentsToAdditionalPaidInCapitalOther_z9mosN3u6Wjf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1110">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001111" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">646,875</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember" id="Fact001112" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,082,483</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" contextRef="From2023-02-172023-12-31" id="Fact001113" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,729,358</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_zAkZk1cAawt5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1116">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember" id="Fact001117" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,484,790</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-12-31" id="Fact001118" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,484,790</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20230217__20231231_eus-gaap--StockholdersEquity_iE_z6BzND5My7Gd" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance as of December 31, 2023</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20230217__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zBey4fyr4EK3" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact001125" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact001120" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1121">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact001122" format="ixt:numdotdecimal" decimals="0" unitRef="USD">402,307</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact001123" format="ixt:numdotdecimal" decimals="0" unitRef="USD">402,534</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20230217__20231231_eus-gaap--StockholdersEquity_iE_zX1ewhskc1A3" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; font-weight: bold; padding-bottom: 2.5pt">Balance</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20230217__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zUxugRkfIqb" title="Balance, shares" style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact001132" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact001127" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1128">-</span></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact001129" format="ixt:numdotdecimal" decimals="0" unitRef="USD">402,307</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact001130" format="ixt:numdotdecimal" decimals="0" unitRef="USD">402,534</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 324; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="am_029"></span>CONSOLIDATED
STATEMENT OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_112_zfAUH40f7Zr" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230217__20231231_ziJwtLVMIQee" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Period from February 17, 2023 (Inception) Through</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zx6UmyEahuf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_i01_maNCPBUzRpw_zschyXQvw7H" style="vertical-align: bottom; background-color: White">
    <td style="width: 78%; text-align: left">Net income</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-12-31" id="Fact001136" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,484,790</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zYTwx4XEKL2e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustment to reconcile net loss to net cash used in operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromEquityMethodInvestments_i02N_di_msNCPBUzRpw_zU7FQCbJAPij" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Interest reinvested held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2023-02-172023-12-31" id="Fact001140" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,729,358</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--IncreaseDecreaseInAccruedOfferingCostsAndExpenses_i02_maNCPBUzRpw_zXpbaAEM4xda" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Accrued offering costs and expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:IncreaseDecreaseInAccruedOfferingCostsAndExpenses" contextRef="From2023-02-172023-12-31" id="Fact001142" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,714</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i02_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maNCPBUzRpw_zEcZwuLKqVVk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Accrued expenses &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2023-02-172023-12-31_us-gaap_RelatedPartyMember" id="Fact001144" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,250</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInPrepaidExpense_i02N_di_msNCPBUzRpw_zlO3kZ4RUuGk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prepaid expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2023-02-172023-12-31" id="Fact001146" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,481</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i02T_maCz2Gm_mtNCPBUzRpw_zRcHMRCy17X" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-02-172023-12-31" id="Fact001148" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">292,085</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_ztwI6HHiact" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PaymentsToAcquireOtherInvestments_i01N_di_msCzCFL_z8QklhWvcb42" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Investments of cash into Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireOtherInvestments" contextRef="From2023-02-172023-12-31" id="Fact001152" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,690,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCzCFL_maCz2Gm_z5TbJCpA7Fd" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-02-172023-12-31" id="Fact001154" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">69,690,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zu54QAlozu23" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--ProceedsFromIssuanceOfFounderShares_i01_maCzrqf_zln3vT0CBqe1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuance of founder shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:ProceedsFromIssuanceOfFounderShares" contextRef="From2023-02-172023-12-31" id="Fact001158" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,520</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maCzrqf_zBiss3oHt70l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from sale of ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-02-172023-12-31" id="Fact001160" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_i01_maCzrqf_znBbtcFhDKM" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from Private Placement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2023-02-172023-12-31" id="Fact001162" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,615,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--PaymentsOfUnderwritersDiscount_i01N_di_msCzrqf_zlecQ8oGVdE1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payments of underwriter&#8217;s discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:PaymentsOfUnderwritersDiscount" contextRef="From2023-02-172023-12-31" id="Fact001164" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,725,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--RepaymentsOfRelatedPartyDebt_i01N_di_msCzrqf_zItqqbDXUK0c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payments to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2023-02-172023-12-31" id="Fact001166" format="ixt:numdotdecimal" decimals="0" unitRef="USD">151,318</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_ecustom--PaymentOfOfferingCosts_i01N_di_msCzrqf_zrym0RUQRuk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Payment of offering costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="BOWN:PaymentOfOfferingCosts" contextRef="From2023-02-172023-12-31" id="Fact001168" format="ixt:numdotdecimal" decimals="0" unitRef="USD">332,204</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzrqf_maCz2Gm_zDpeqU1T9se6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-02-172023-12-31" id="Fact001170" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,408,998</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCz2Gm_z2plUvBz3si3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net change in cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-02-172023-12-31" id="Fact001172" format="ixt:numdotdecimal" decimals="0" unitRef="USD">426,913</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zM38y2csn2Mj" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cash at beginning of period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1174">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_zFMfPpMaqmM4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash at the end of period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-12-31" id="Fact001176" format="ixt:numdotdecimal" decimals="0" unitRef="USD">426,913</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zNxFkuLBEMEl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental disclosure of noncash financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_i01_z5OjarMgwgli" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Offering costs paid by Sponsor in exchange for issuance of ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" contextRef="From2023-02-172023-12-31" id="Fact001180" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--NoncashOfferingCostsAdjustedFromPrepaidExpenses_i01_z6FjIYUVQEQf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Offering costs adjusted from prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:NoncashOfferingCostsAdjustedFromPrepaidExpenses" contextRef="From2023-02-172023-12-31" id="Fact001182" format="ixt:numdotdecimal" decimals="0" unitRef="USD">894</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--NonCashOfferingCostsChargedToAdditionalPaidinCapital_i01_z4OJEDXGYr9d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Offering costs charged to Additional Paid-in Capital</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:NonCashOfferingCostsChargedToAdditionalPaidinCapital" contextRef="From2023-02-172023-12-31" id="Fact001184" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,593,898</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ReclassificationOfOrdinarySharesSubjectToRedemption_i01_zRm75QXeafWa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Reclassification of ordinary shares subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:ReclassificationOfOrdinarySharesSubjectToRedemption" contextRef="From2023-02-172023-12-31" id="Fact001186" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,236,367</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_i01_zMGGnPgwM3M6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Allocation of offering costs to ordinary shares subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" contextRef="From2023-02-172023-12-31" id="Fact001188" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,137,868</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption_i01_zIqS9fKHe8q6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Remeasurement adjustment on ordinary shares subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption" contextRef="From2023-02-172023-12-31" id="Fact001190" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,591,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_i01_zOaVAzhJvxi8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Subsequent measurement of ordinary shares subject to possible redemption (income earned on Trust Account)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2023-02-172023-12-31" id="Fact001192" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,729,358</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 325; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p id="xdx_04C_c20230217__20231231_z4JcDBLv442d" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="am_030"></span>NOTES
TO <span style="text-transform: uppercase">CONSOLIDATED </span> FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001194" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_80D_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z9rOULZoOjsf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8212;<span id="xdx_82B_zqUp5u4n4yzg">ORGANIZATION AND BUSINESS OPERATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organizational
and General</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Acquisition Corp (the &#8220;Company&#8221;) was incorporated in the Cayman Islands on February 17, 2023. The Company was formed for
the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination
with one or more businesses (the &#8220;Business Combination&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early
stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth
companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s sponsors are Createcharm Holdings Ltd., a British Virgin Islands company, and Bowen Holding LP, a Delaware limited partnership
(the &#8220;Sponsors&#8221;). As of December 31, 2023, the Company had not commenced any operations. All activity for the period from
February 17, 2023 (inception) through December 31, 2023 relates to the Company&#8217;s formation and the initial public offering (&#8220;IPO&#8221;)
described below, and following the IPO, the search for a target to consummate a Business Combination<span style="background-color: white">.
</span>The Company will not generate any operating revenues until after the completion of an initial Business Combination, at the earliest.
The Company  generated non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has
selected December 31 as its fiscal year end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s IPO (the &#8220;Registration Statement&#8221;) was declared effective on July 11, 2023.
On July 14, 2023, the Company consummated the IPO of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5QAUuQbyZU1" title="Stock issued during period shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-142023-07-14_us-gaap_IPOMember" id="Fact001196" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></span> of its units (&#8220;Public Units&#8221;). Each Public Unit consists of
one ordinary share, $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ztoRUlt3J7N4" title="Ordinary shares, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-07-14_us-gaap_IPOMember" id="Fact001198" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> par value (&#8220;Ordinary Shares&#8221;), of the Company and one right (&#8220;Rights&#8221;), each Right
entitling the holder thereof to receive one-tenth of one ordinary share upon the completion of the Company&#8217;s initial business combination.
The Public Units were sold at an offering price of $<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zeBeRm19B9rk" title="Sale of stock, par share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-07-14_us-gaap_IPOMember" id="Fact001200" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit, generating gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zOlW8wvtVtCg" title="Proceeds from issuance of IPO"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-07-142023-07-14_us-gaap_IPOMember" id="Fact001202" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">60,000,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the consummation of the IPO, the Company consummated the private placement (&#8220;Private Placement&#8221;) of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zGIgiOqmJhAa" title="Stock issued during period shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember" id="Fact001204" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">330,000</ix:nonFraction></span> units (&#8220;Private
Placement Units&#8221;) at a price of $<span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcaS3eP1Lyq7" title="Price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-07-14_us-gaap_PrivatePlacementMember" id="Fact001206" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Private Placement Unit, generating total proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zjlY2IK9ruif" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember" id="Fact001208" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">3,300,000</ix:nonFraction></span>. The Private Placement
Units were purchased by Createcharm Holdings Ltd, one of the Company&#8217;s sponsors, and EarlyBirdCapital, Inc. (&#8220;EBC&#8221;),
the representative of the underwriters in the IPO. The Private Placement Units are identical to the Units included in the Public Units
sold in the IPO. The purchasers of the Private Placement Units have agreed not to transfer, assign or sell any of the Private Placement
Units or Ordinary Shares or Rights underlying the Private Placement Units (except to certain transferees) until after the completion
of the Company&#8217;s initial Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2023, the underwriters exercised their over-allotment option in full to purchase an additional <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230717__20230717__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zwhRT3WDbwzf" title="Stock issued during period shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-172023-07-17_us-gaap_OverAllotmentOptionMember" id="Fact001210" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> Units. As a result, on
July 18, 2023, the Company sold an additional <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zi0tGcTmtfS9" title="Number of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember" id="Fact001212" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> Units at $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zFkSr01l5ss" title="Price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-07-18_us-gaap_OverAllotmentOptionMember" id="Fact001214" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit, generating gross proceeds of $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zfMFXSC7Ll66" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember" id="Fact001216" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">9,000,000</ix:nonFraction></span>. In connection
with this sale, Createcharm Holdings Ltd and EBC also purchased an additional <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_znLDoLu55dm1" title="Number of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-182023-07-18_us-gaap_PrivatePlacementMember" id="Fact001218" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,500</ix:nonFraction></span> Private Placement Units from the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of July 18, 2023, transaction costs amounted to $<span id="xdx_909_eus-gaap--PaymentsOfStockIssuanceCosts_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zNXiZIVGlbv9" title="Transaction cost"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2023-07-182023-07-18_us-gaap_IPOMember" id="Fact001220" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,318,898</ix:nonFraction></span> consisting of $<span id="xdx_907_eus-gaap--PaymentsForUnderwritingExpense_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zKrDfouXZQWc" title="Payments for underwriting expense"><ix:nonFraction name="us-gaap:PaymentsForUnderwritingExpense" contextRef="From2023-07-182023-07-18_us-gaap_IPOMember" id="Fact001222" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,725,000</ix:nonFraction></span> of cash underwriting fees and $<span id="xdx_905_ecustom--OtherOfferingCosts_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zbK04C5WaBJb" title="Other offering costs"><ix:nonFraction name="BOWN:OtherOfferingCosts" contextRef="From2023-07-182023-07-18_us-gaap_IPOMember" id="Fact001224" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">1,593,898</ix:nonFraction></span> of other
offering costs. These costs were charged to additional paid-in capital or accumulated deficit to the extent additional paid-in capital
is fully depleted upon completion of the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will have until 15 months from the closing of the IPO (or up to 18 months, if the Company extends the time to complete a Business
Combination as permitted in its Amended and Restated Memorandum and Articles of Association) to consummate a Business Combination (the
&#8220;Combination Period&#8221;). Sponsors or their affiliated or designees, upon five days&#8217; advance
notice prior to the deadline, must deposit into the Trust Account $<span id="xdx_907_eus-gaap--Deposits_iI_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z8G19rfIEFUg" title="Deposits"><ix:nonFraction name="us-gaap:Deposits" contextRef="AsOf2023-07-18_us-gaap_IPOMember" id="Fact001226" format="ixt:numdotdecimal" decimals="0" unitRef="USD">690,000</ix:nonFraction></span> (or $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z2E1789Uvww" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-07-18_us-gaap_IPOMember" id="Fact001228" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></span> per share) for the extension, on or prior to the
date of the deadline. However, if the Company has not completed a Business Combination within the Combination Period and
shareholders have not otherwise amended the Amended and Restated Memorandum and Articles of Association to extend this period, the Company
will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business
days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit
in the Trust Account, including interest earned and not previously released to us to pay the Company&#8217;s taxes, if any (less certain
amount of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption
will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating
distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s
remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject to the Company&#8217;s obligations under Cayman
Islands law to provide for claims of creditors and the requirements of other applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On November 20, 2023, a wholly-owned
subsidiary of the Company, Bowen Merger Sub (&#8220;Merger Sub&#8221;) was formed for the purpose of entering into a business combination
agreement. See subsequent events disclosure below.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 326; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Going
Concern Consideration</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of December 31, 2023, the Company had cash of $<span id="xdx_90C_eus-gaap--Cash_iI_c20231231_zHxvsMCLVSn2" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-12-31" id="Fact001230" format="ixt:numdotdecimal" decimals="0" unitRef="USD">426,913</ix:nonFraction></span>
and working capital of $<span id="xdx_900_ecustom--WorkingCapitalDeficit_iI_c20231231_zaEtvKWjiU4h" title="Working capital deficit"><ix:nonFraction name="BOWN:WorkingCapitalDeficit" contextRef="AsOf2023-12-31" id="Fact001232" format="ixt:numdotdecimal" decimals="0" unitRef="USD">402,534</ix:nonFraction></span>.
The Company has incurred and expects to continue to incur significant professional costs to remain as a public<span style="background-color: white">ly</span>
traded company and to incur transaction costs in pursuit of a Business Combination. In connection with the Company&#8217;s
assessment of going concern considerations in accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2014-15,
&#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; management believes that
these conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. In addition, if the
Company is unable to complete a Business Combination within the Combination Period and such period is not extended, there will be a
liquidation and subsequent dissolution. As a result, management has determined that such additional condition also raises
substantial doubt about the Company&#8217;s ability to continue as a going concern. The <span style="background-color: white">consolidated </span>
financial statements do not include any adjustments that might result from the outcome of the uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001234" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zF6w2MMGASE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE
2 &#8212; <span id="xdx_826_zPhBxTWT60bc">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001236" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zHmSXfLEBGWa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_866_zwgilH11G9z2">Basis
of Presentation and Principles of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary and are presented
in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;)
and pursuant to the rules and regulations of the SEC. All intercompany accounts and transactions are eliminated upon consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001238" name="BOWN:EmergingGrowthCompanyPolicyTextBlock"><p id="xdx_84A_ecustom--EmergingGrowthCompanyPolicyTextBlock_zWKlwfrQmYzd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_866_zfYOuyVDRYsl">Emerging
Growth Company</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 327; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001240" name="us-gaap:UseOfEstimates"><p id="xdx_840_eus-gaap--UseOfEstimates_zCA91RayHq8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zHOe49ZxvDKe">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the financial statement in conformity with US GAAP requires the Company&#8217;s management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001242" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zmfCyCJVr811" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_86B_zAwsvaka99Lf">Cash
and cash equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash
equivalents. The Company had a cash balance of $<span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20231231_zFK1kspiUhB5" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-12-31" id="Fact001244" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">426,913</ix:nonFraction></span>
as of December 31, 2023. The Company had <span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_znrFr9kvJLR2" title="Cash equivalents"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact001246" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> cash equivalents as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001248" name="us-gaap:InvestmentPolicyTextBlock"><p id="xdx_84F_eus-gaap--InvestmentPolicyTextBlock_zqRWTWIBXBQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_866_zJ3NmQZbipc9">Investments
Held in Trust Account</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company&#8217;s portfolio of investments held in the trust account is comprised of investments only in U.S. government securities
with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company
Act which invest only in direct U.S. government treasury obligations. The Company classified its investments in treasury securities
as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period.
Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on
marketable securities held in trust account in the accompanying statements of operations. The estimated fair value of investments
held in the trust account is determined using available market information. As of December 31, 2023, the trust account had cash
balance of $<span id="xdx_90E_eus-gaap--AssetsHeldInTrust_iI_c20231231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashMember_zOzfr1rK79ag" title="Trust account, cash balance"><ix:nonFraction name="us-gaap:AssetsHeldInTrust" contextRef="AsOf2023-12-31_us-gaap_CashMember" id="Fact001250" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,208</ix:nonFraction></span> together with U.S. Treasury Bills of $<span id="xdx_905_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zZqLbbU6cr9a" title="Trust account, cash balance, with U.S. treasury bills"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-12-31_us-gaap_USTreasurySecuritiesMember" id="Fact001252" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,411,150</ix:nonFraction></span> which subsequently matured on January 11, 2024. And the total balance was reinvested in the money market
fund thereafter.
The interests earned from the trust account totaled $<span id="xdx_906_ecustom--InterestsEarnedFromTrustAccount_pp0p0_c20230217__20231231_zWbX4N8uaJVj" title="Interests earned from trust account"><ix:nonFraction name="BOWN:InterestsEarnedFromTrustAccount" contextRef="From2023-02-172023-12-31" id="Fact001254" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,729,358</ix:nonFraction></span>
for the period from February 17, 2023 (inception) through December 31, 2023, which were fully reinvested into the trust account as
earned and unrealized gain on investments and therefore presented as an adjustment to the operating activities in the Statement of
Cash Flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001256" name="BOWN:OfferingCostsPolicyTextBlock"><p id="xdx_841_ecustom--OfferingCostsPolicyTextBlock_zTKkNdQFKHJk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zamlBjzlDZ2b">Offering
Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
costs consist of legal, accounting, and other costs (including underwriting discounts and commissions) incurred through the balance sheet
date that are directly related to the IPO and that were charged to shareholders&#8217; equity upon the completion of the IPO on July
14, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001258" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zGDLIhZAEBn4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_861_zjwJMGXFhF8i">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;<i>Income Taxes</i>.&#8221;
Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the <span style="background-color: white">consolidated </span>
financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and
liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is
recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce
deferred tax assets to the amount expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were <span id="xdx_90B_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zsYWbZ380F1h" title="Unrecognized tax benefits"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2023-12-31" id="Fact001260" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> unrecognized tax benefits and <span id="xdx_90F_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20231231_zSsfZpwbEj33" title="Accrued for interest and penalties"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" contextRef="AsOf2023-12-31" id="Fact001262" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> amounts accrued for interest and penalties as of December 31, 2023.
The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation
from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 328; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax
regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#8217;s
consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001264" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_841_eus-gaap--EarningsPerSharePolicyTextBlock_zHgK6ZKKHid" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_86A_z0ppd2hs22Oa">Net
Income (Loss) per Ordinary Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><br/>
The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include
a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income
per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company
first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed
income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss)
ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement
of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public
shareholders. As of December 31, 2023, the Company did not have any dilutive securities and other contracts that could, potentially,
be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per
share is the same as basic income (loss) per share for the period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
net income (loss) per share presented in the statements of operations is based on the following:</span></p>

<ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001266" name="srt:ScheduleOfCondensedIncomeStatementTableTextBlock"><p id="xdx_89A_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_z5fqU2qlhri2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_zHiJwUlqeU1k" style="display: none">SCHEDULE
OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230217__20231231_zbKQnV15xwDe" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Period from February 17, 2023 (Inception) Through</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_maNLIAOz10T_zOJii0vLKohb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left">Net income</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-02-172023-12-31" id="Fact001268" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,484,790</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--InterestEarnedOnInvestmentHeldInTrustAccount_iN_di_msNLIAOz10T_zo7AJGrk1xXi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest earned on investment held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:InterestEarnedOnInvestmentHeldInTrustAccount" contextRef="From2023-02-172023-12-31" id="Fact001270" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,729,358</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz10T_zAg74kxuxLM" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of temporary equity into redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="BOWN:AccretionOfTemporaryEquityIntoRedemptionValue" contextRef="From2023-02-172023-12-31" id="Fact001272" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,591,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--NetLossIncludingAccretionOfCommonStockToRedemptionValue_iT_mtNLIAOz10T_zKdGwxjFuO41" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss including accretion of common stock to redemption value</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="BOWN:NetLossIncludingAccretionOfCommonStockToRedemptionValue" contextRef="From2023-02-172023-12-31" id="Fact001274" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,836,068</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zYKcI8lxkzp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001276" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zcpFV3BsqmD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BF_zMFGGaplzlue">SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSbd0Fp6rMFl" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zGAERQ6dGDUi" style="font-weight: bold; text-align: center">Non-Redeemable</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Period from February 17, 2023 (Inception) Through</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Non-Redeemable</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Particulars</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic and diluted net income/(loss) per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%">Weighted-average shares outstanding</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zU6CljOH48ac" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zFYq4I4GQtSh" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember" id="Fact001278" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember" id="Fact001280" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,819,156</ix:nonFraction></ix:nonFraction></span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zNfgYAWx4Gr9" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCzo2RWqf9bk" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember" id="Fact001282" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember" id="Fact001284" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,095,943</ix:nonFraction></ix:nonFraction></span></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ownership percentage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zECPHfL2glR8" title="Ownership percentage"><ix:nonFraction name="BOWN:OwnershipPercentage" contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember" id="Fact001286" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">65</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zsjNSrA2WIZc" title="Ownership percentage"><ix:nonFraction name="BOWN:OwnershipPercentage" contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember" id="Fact001288" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">35</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Numerators:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zVCdrxP2wiac" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Allocation of net loss including accretion of temporary equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity" contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember" id="Fact001290" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,059,453</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity" contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember" id="Fact001291" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,776,615</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--IncomeEarnedOnTrustAccount_iN_di_zAHwZN6mpoR2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income earned on Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="BOWN:IncomeEarnedOnTrustAccount" contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember" id="Fact001293" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,729,358</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1294">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_zDB0ptiEw1dk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of temporary equity to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="BOWN:AccretionOfTemporaryEquityIntoRedemptionValue" contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember" id="Fact001296" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,591,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1297">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--AllocationOfNetIncomeloss_zq0KsXBOf1Ke" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Allocation of net income/(loss)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="BOWN:AllocationOfNetIncomeloss" contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember" id="Fact001299" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,261,405</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="BOWN:AllocationOfNetIncomeloss" contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember" id="Fact001300" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,776,615</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Denominators:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted-average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRIL4Yi3jFe8" title="Weighted average shares outstanding - basic"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTMeIKfe5D67" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember" id="Fact001302" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember" id="Fact001304" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,819,156</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zZ4GwgKssWo7" title="Weighted average shares outstanding - basic"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqU9AdEZFfK1" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember" id="Fact001306" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember" id="Fact001308" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,095,943</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income/(loss) per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zftFIOmZjSkl" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zVuMWGvFHwTb" title="Diluted net income/(loss) per share"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember" id="Fact001310" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember" id="Fact001312" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.12</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zHHmNNLje0E9" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zg1zZTQ3WBvh" title="Diluted net income/(loss) per share">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember" id="Fact001314" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember" id="Fact001316" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.32</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zWjFEaPV48a9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 329; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001318" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z2d9dRUEHMr8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zOFadp8Mtut6">Concentration
of Credit Risk</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zMylsduoDCS4" title="Cash, FDIC insured amount"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2023-12-31" id="Fact001320" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span>. The Company has not experienced losses on these accounts
and management believes the Company is not exposed to significant risks on such accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001322" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zeMFmxxmd9tb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zpDX0PpSV6R5">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;<i>Fair Value
Measurement</i>,&#8221; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001324" name="us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"><p id="xdx_847_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_z1WqK5dF6HTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zyQLC8aa7lud">Ordinary
Shares Subject to Possible Redemption</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Ordinary shares subject to mandatory redemption (if
any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary
shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, ordinary shares
are classified as shareholders&#8217; equity. The Company&#8217;s ordinary shares features certain redemption rights that are considered
to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject
to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#8217; equity section of the
Company&#8217;s balance sheet. <span style="background-color: white">The Company recognizes changes in redemption value immediately as
they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.
Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital
and accumulated deficit.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001326" name="BOWN:ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock"><p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zd2wBE9lAYs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">At
December 31, 2023, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BF_zpu6m2fUs7rj" style="display: none">SCHEDULE
OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left">Public offering proceeds</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231_za2ZKsoTet4c" title="Public offering proceeds" style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-02-172023-12-31" id="Fact001328" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230217__20231231_zYj5oSuFxqL7" title="Proceeds allocated to public rights" style="text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-02-172023-12-31" id="Fact001330" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,272,724</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231_zFJ7buaNy8O7" title="Allocation of offering costs related to redeemable shares" style="text-align: right">(<ix:nonFraction name="us-gaap:OfferingCostsPartnershipInterests" contextRef="AsOf2023-12-31" id="Fact001332" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,925,140</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230217__20231231_zW9JCGlmekni" title="Accretion of carrying value to redemption value" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="BOWN:AccretionOfCarryingValueToRedemptionValue" contextRef="From2023-02-172023-12-31" id="Fact001334" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,797,864</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ordinary shares subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20230217__20231231_zgqwa1e5dh05" title="Gross proceeds" style="text-align: right"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" contextRef="AsOf2023-02-16" id="Fact001336" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic">Over-allotment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Over-allotment proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ProceedsFromLegalSettlements_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zfFMrSFQSlFi" title="Over-allotment proceeds" style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromLegalSettlements" contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember" id="Fact001338" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zYxgPuaVAyvk" title="Proceeds allocated to Public Rights" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember" id="Fact001340" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">490,909</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_znuXsHmUR8Gk" title="Allocation of offering costs related to redeemable shares" style="text-align: right">(<ix:nonFraction name="us-gaap:OfferingCostsPartnershipInterests" contextRef="AsOf2023-12-31_us-gaap_OverAllotmentOptionMember" id="Fact001342" format="ixt:numdotdecimal" decimals="0" unitRef="USD">212,727</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zcZb6OK0dWm9" title="Accretion of carrying value to redemption value" style="text-align: right"><ix:nonFraction name="BOWN:AccretionOfCarryingValueToRedemptionValue" contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember" id="Fact001344" format="ixt:numdotdecimal" decimals="0" unitRef="USD">793,636</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zeDGC1VR9Hp5" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember" id="Fact001346" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,729,358</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Ordinary shares subject to possible redemption</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zgIlv0x3m5Tl" title="Ordinary shares subject to possible redemption" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" contextRef="AsOf2023-12-31_us-gaap_OverAllotmentOptionMember" id="Fact001348" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,419,358</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zxvw1Qtx8jLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001350" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z2k0Bblpjmqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zNLZGX6jgbxd">Recent
Accounting Standards</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#8217;s consolidated financial statements.</span></p>

</ix:nonNumeric><p id="xdx_856_z0JNTepPBrP2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 330; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001352" name="BOWN:InitialPublicOfferingTextBlock"><p id="xdx_805_ecustom--InitialPublicOfferingTextBlock_zHDaCE2xECgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE
3 &#8212; <span id="xdx_822_z93dWclkbSi4">INITIAL PUBLIC OFFERING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
July 14, 2023, the Company sold <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z70KqMXJ81qd" title="Stock issued during period shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-142023-07-14_us-gaap_IPOMember" id="Fact001354" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></span> Units at a price of $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zjzkwGZXp3Hh" title="Sale of stock, par share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-07-14_us-gaap_IPOMember" id="Fact001356" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit. <span id="xdx_903_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zkBlcL0EsE5e" title="Stock holders equity related to initial public offering description"><ix:nonNumeric contextRef="From2023-07-142023-07-14_us-gaap_IPOMember" id="Fact001358" name="us-gaap:SaleOfStockDescriptionOfTransaction">Each Unit consists of one ordinary share and one right
to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company&#8217;s initial Business Combination. Ten Public
Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares
will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional
shares underlying the rights</ix:nonNumeric></span>. The Company also granted the underwriters a 45-day option to purchase up to an additional <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z7DTOAlYEYM5" title="Stock issued during the period, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-07-142023-07-14_us-gaap_OverAllotmentOptionMember" id="Fact001360" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> units
to cover over-allotments. The over-allotment was subsequently fully exercised on July 17, 2023. See Note 1 for further details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001362" name="BOWN:PrivatePlacementsTextBlock"><p id="xdx_808_ecustom--PrivatePlacementsTextBlock_z6RicVGoIEY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE
4 &#8212; <span id="xdx_82A_z3OdyWOSDWga">PRIVATE PLACEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Sponsors and EBC have agreed to purchase an aggregate of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zGzG654MNrnb" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember" id="Fact001364" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">330,000</ix:nonFraction></span> Private Placement Units (<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorsMember_z41JzLzYhRC5" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_SponsorsMember" id="Fact001366" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">312,000</ix:nonFraction></span> Private Placement Units to be purchased
by the Sponsors and <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--EBCMember_z9ap4lEPiFsj" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_EBCMember" id="Fact001368" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,000</ix:nonFraction></span> Private Placement Units to be purchased by EBC or its designees), or <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zF3PYUh11omc" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_UnderwritersMember" id="Fact001370" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">361,500</ix:nonFraction></span> Private Placement Units if the
underwriters&#8217; over-allotment is exercised in full, at a price of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zDhaSGaytAxe" title="Private placement units of underwriters over-allotment per share price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember_custom_UnderwritersMember" id="Fact001372" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Private Placement Unit ($<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcVkGIuQPWNh" title="Value of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember" id="Fact001374" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,300,000</ix:nonFraction></span>, or an aggregate
of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zAF9PtaDHstf" title="Value of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_UnderwritersMember" id="Fact001376" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,615,000</ix:nonFraction></span> if the underwriters&#8217; over-allotment is exercised in full) from the Company in a private placement that will occur
simultaneously with the closing of the Initial Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Simultaneously with and soon after the closing of
the IPO, the Sponsors and EBC purchased an aggregate of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zn6CdMyaY08b" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_UnderwritersMember" id="Fact001378" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">361,500</ix:nonFraction></span> Private Placement Units ($<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zuiz5k7UbKcc" title="Value of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_UnderwritersMember" id="Fact001380" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,615,000</ix:nonFraction></span>), including exercise of over-allotment
option. Each Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon
the consummation of the Company&#8217;s initial Business Combination. The proceeds from the sale of the Private Placement Units were added
to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination
Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the
Public Shares (subject to the requirements of applicable law). The Private Placement Units (including the underlying securities) will
not be transferable, assignable, or saleable until the completion of a Business Combination, subject to certain exceptions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
July 17, 2023, the underwriters exercised the over-allotment option in full. See Note 1 for more details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001382" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zQXb3zCQnIz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE
5 &#8212; <span id="xdx_821_zWvrpnCnpcQ9">RELATED PARTIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Founder
Shares and EBC Founder Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
February 27, 2023, the Sponsors received <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zCIr7Y2Pgur6" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-272023-02-27_custom_SponsorsMember" id="Fact001384" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,725,000</ix:nonFraction></span> of the Company&#8217;s ordinary shares (&#8220;Founder Shares&#8221;) in exchange
for $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zAr2KHkDuVQ" title="Sponsors received ordinary shares, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-02-272023-02-27_custom_SponsorsMember" id="Fact001386" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span> paid for offering costs borne by the Sponsors. Up to <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zr1jFfUVVRJf" title="Number of shares subject to forfeiture"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-02-272023-02-27_custom_SponsorsMember_us-gaap_OverAllotmentOptionMember" id="Fact001388" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225,000</ix:nonFraction></span> of such Founder Shares were subject to forfeiture to the extent
that the underwriters&#8217; over-allotment was not exercised in full (See Note 7).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 15, 2023, the Company issued to EBC <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zMUErzboSoLf" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-03-152023-03-15_custom_EBCMember" id="Fact001390" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></span> ordinary shares (&#8220;EBC founder shares&#8221;) for a purchase price of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zjkuABniQ4Zh" title="Ordinary share price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-03-15_custom_EBCMember" id="Fact001392" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.014</ix:nonFraction></span> per
share and an aggregate purchase price of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zwQh6yIRA2u7" title="Value of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-03-152023-03-15_custom_EBCMember" id="Fact001394" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">2,520</ix:nonFraction></span>. The EBC founder shares are deemed to be underwriters&#8217; compensation by FINRA pursuant
to Rule 5110 of the FINRA Manual. The Company estimated the fair value of the EBC founder shares to be approximately $<span id="xdx_900_eus-gaap--DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zCwAnFuddb2" title="Fair value of shares issued"><ix:nonFraction name="us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" contextRef="From2023-03-152023-03-15_custom_EBCMember" id="Fact001396" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,016,000</ix:nonFraction></span> or $<span id="xdx_90E_eus-gaap--SharePrice_iI_pid_c20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zQ7ZMcax1Dt7" title="Fair value of ordinary per share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-03-15_custom_EBCMember" id="Fact001398" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.65</ix:nonFraction></span>
per share using the Black-Scholes option pricing model. The Company accounted for the difference between the par value and fair value
of the shares as offering cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001400" name="BOWN:ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock"><p id="xdx_898_ecustom--ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock_zmfEjAVBnFBg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair
value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zG9F7VFpDzH4" style="display: none">SCHEDULE
FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left">Time to expiration</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0VXkd1AhY94" title="Time to expiration"><ix:nonNumeric contextRef="From2023-03-152023-03-15_us-gaap_FairValueInputsLevel3Member" format="ixt-sec:duryear" id="Fact001402" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">1.84</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAKlvigTYDI8" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-03-152023-03-15_us-gaap_FairValueInputsLevel3Member" id="Fact001404" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_znAtmI8QBi6f" title="Volatility rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-03-152023-03-15_us-gaap_FairValueInputsLevel3Member" id="Fact001406" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWmPu4yISRsa" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-03-152023-03-15_us-gaap_FairValueInputsLevel3Member" id="Fact001408" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected likelihood of a successful business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--ExpectedLikelihoodSuccessfulBusinessCombination_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zDmVhFcRiIid" title="Expected likelihood of a successful business combination, percentage"><ix:nonFraction name="BOWN:ExpectedLikelihoodSuccessfulBusinessCombination" contextRef="From2023-03-152023-03-15_us-gaap_FairValueInputsLevel3Member" id="Fact001410" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zfiEO9D8VNCc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur
of: (A) six months after the completion of the initial Business Combination and (B) the date on which the Company completes a liquidation,
merger, share exchange, reorganization or other similar transaction after an initial Business Combination that results in all of the
Company&#8217;s public shareholders having the right to exchange their ordinary shares for cash, securities or other property. EBC has
also agreed, subject to exceptions, that the EBC founder shares cannot be sold, transferred or assigned, until the consummation of an
initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 331; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Promissory
Note&#8201;&#8212;&#8201;Related Party</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 27, 2023, the Sponsors issued an unsecured promissory note to the Company (the &#8220;Promissory Note&#8221;), pursuant to which
the Company may borrow up to an aggregate principal amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230227__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zLzIAFDWTmPh" title="Promissory note aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-02-27_custom_PromissoryNoteMember_us-gaap_RelatedPartyMember" id="Fact001412" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span>. The Promissory Note was non-interest bearing and payable on the
earlier of (i) December 31, 2023, or (ii) the consummation of the IPO. The Promissory Note expired on July 14, 2023. As of December 31,
2023, there were no amounts outstanding under the Promissory Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriting
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company granted the underwriters a 45-day option from the date of IPO to purchase up to <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zRyZzePx7WJ9" title="Stock issued during the period, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember_srt_MaximumMember" id="Fact001414" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> additional Units to cover over-allotments,
at the IPO price less the underwriting discounts and commissions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters were entitled to a cash underwriting discount of $<span id="xdx_907_ecustom--CashUnderwritingDiscountPerUnit_pid_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zMYmFuKKNyXd" title="Cash underwriting discount per unit"><ix:nonFraction name="BOWN:CashUnderwritingDiscountPerUnit" contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember" id="Fact001416" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.25</ix:nonFraction></span> per Unit, or $<span id="xdx_90A_ecustom--CashUnderwritingDiscount_pid_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z8k88KDa3uE7" title="Aggregate cash underwriting discount"><ix:nonFraction name="BOWN:CashUnderwritingDiscount" contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember" id="Fact001418" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">1,500,000</ix:nonFraction></span> in the aggregate (or $<span id="xdx_90F_eus-gaap--PaymentsForUnderwritingExpense_pid_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z3tJwdw31Mhd" title="Payments for underwriting expense"><ix:nonFraction name="us-gaap:PaymentsForUnderwritingExpense" contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember" id="Fact001420" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">1,725,000</ix:nonFraction></span> in the aggregate
if the underwriters&#8217; over-allotment option is exercised in full), payable upon the closing of the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2023, the underwriters exercised the over-allotment option in full to purchase <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230717__20230717__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zpp2EAKNx8Ie" title="Stock issued during the period, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-07-172023-07-17_us-gaap_OverAllotmentOptionMember" id="Fact001422" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> Units. As a result, on July 18, 2023,
the Company sold an additional <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zQhAMBESvvie" title="Stock issued during the period, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember" id="Fact001424" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> Units at $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zZkiQYbsTnza" title="Price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-07-18_us-gaap_OverAllotmentOptionMember" id="Fact001426" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit, generating gross proceeds to the Company of $<span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z0IlAoK699Cj" title="Gross proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember" id="Fact001428" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,000,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i>Accrued Expenses <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to Related Party</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors paid certain formation, operating or offering costs on behalf of the Company. These amounts were due on demand and non-interest
bearing. As of December 31, 2023, the Sponsors had paid $<span id="xdx_902_eus-gaap--RepaymentsOfRelatedPartyDebt_c20230217__20231231_z2pzuxMiLAL1" title="Related party debt"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2023-02-172023-12-31" id="Fact001430" format="ixt:numdotdecimal" decimals="0" unitRef="USD">151,318</ix:nonFraction></span> on behalf of the Company for expenses related to IPO, which was fully
repaid upon closing of the IPO on July 14, 2023 out of the offering proceeds held in trust account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the total accrued expenses due to related parties was $<span id="xdx_901_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zdH8fz41AjNb" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="Fact001432" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,250</ix:nonFraction></span>, which include $<span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zlZpdlDUxZc8" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001434" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000</ix:nonFraction></span> payable for administration
fee and $<span id="xdx_905_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--IncomeStatementLocationAxis__custom--AccountingServicesExpenseMember_zB6Ukb3G5L25" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember_custom_AccountingServicesExpenseMember" id="Fact001436" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,250</ix:nonFraction></span> payable for accounting service fee. See following paragraphs for details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Initial
Accounting Service Fee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has engaged TenX Global Capital, a related party of the Company, to assist in the preparation of consolidated financial
statements and other accounting consulting services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period from February 17, 2023 (inception) through December 31, 2023, a service fee of $<span id="xdx_901_eus-gaap--ProfessionalFees_c20230217__20231231__dei--LegalEntityAxis__custom--TenXGlobalCapitalMember_zZlGfEKPQcTk" title="Service fee"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-02-172023-12-31_custom_TenXGlobalCapitalMember" id="Fact001438" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000</ix:nonFraction></span> of offering costs have been incurred
for these services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Accounting
Service Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has engaged TenX Global Capital, a related party of the Company, to assist in preparing quarterly and annual financial statements
commencing following the consummation of the IPO. The Company has agreed to pay for these services at a fixed quarterly rate of $<span id="xdx_90C_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20230217__20231231__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zY2C0ZoW5wz5" title="Payment for services"><ix:nonFraction name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="From2023-02-172023-12-31_custom_AccountingServiceAgreementMember" id="Fact001440" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,250</ix:nonFraction></span>
each quarter. As of December 31, 2023, a service fee of $<span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_z0a3avIHDclj" title="Accrued liabilities"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_AccountingServiceAgreementMember" id="Fact001442" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,500</ix:nonFraction></span> has been accrued with $<span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrent_iI_c20230630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zkcPy0KNJbw" title="Accrued liabilities"><span id="xdx_908_eus-gaap--AccruedLiabilitiesCurrent_iI_c20230930__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zlbmcucShdHk" title="Accrued liabilities"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-06-30_custom_AccountingServiceAgreementMember" id="Fact001444" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-09-30_custom_AccountingServiceAgreementMember" id="Fact001446" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,250</ix:nonFraction></ix:nonFraction></span></span> paid for the second and third quarter accounting
service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administration
Fee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
on the effectiveness of the Registration Statement on July 11, 2023, an affiliate of the Sponsors will be allowed to charge the Company
an allocable share of its overhead, up to $<span id="xdx_90A_eus-gaap--AffiliateCosts_c20230711__20230711__srt--TitleOfIndividualAxis__custom--SponsorsMember__srt--RangeAxis__srt--MaximumMember_zmzVt8HJElkh" title="Affiliate costs"><ix:nonFraction name="us-gaap:AffiliateCosts" contextRef="From2023-07-112023-07-11_custom_SponsorsMember_srt_MaximumMember" id="Fact001448" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></span> per month, until to the close of the Business Combination, to compensate it for the
Company&#8217;s use of its office, utilities and personnel. An administration fee of $<span id="xdx_90E_eus-gaap--AdministrativeFeesExpense_c20230217__20231231_zYQyOU6H0wik" title="Administrative fee"><ix:nonFraction name="us-gaap:AdministrativeFeesExpense" contextRef="From2023-02-172023-12-31" id="Fact001450" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,667</ix:nonFraction></span> was recorded with $<span id="xdx_90C_eus-gaap--PaymentForAdministrativeFees_c20230217__20231231_zP0trXX3c145" title="Administrative fees paid"><ix:nonFraction name="us-gaap:PaymentForAdministrativeFees" contextRef="From2023-02-172023-12-31" id="Fact001452" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,667</ix:nonFraction></span> paid for the period
from February 17, 2023 (inception) through December 31, 2023. The unpaid amount as of December 31, 2023 was $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zVcmXvdbCOlb" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001454" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 332; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001456" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zDW4iBFCPjua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8212; <span id="xdx_82F_zWCny5HvGM6g">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares, EBC founder shares, Private Placement Units will be entitled to registration rights pursuant to a registration
rights agreement dated on the effectiveness of the Registration Statement on July 11, 2023 requiring the Company to register such securities
for resale. Subject to certain limitations set forth in such agreement, the holders of these securities will be entitled to make up to
three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain
&#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to completion of a Business Combination
and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the
registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration
statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear
the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination Marketing Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has engaged EBC as an advisor in connection with its Business Combination to assist in holding meetings with the Company stockholders
to discuss the potential Business Combination and the target business&#8217; attributes, introduce the Company to potential investors
that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and
public filings in connection with the Business Combination. The Company will pay EBC a service fee for such services upon the consummation
of its initial Business Combination in an amount of $<span id="xdx_90D_ecustom--ServiceFee_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_zGCuHHR5bgnd" title="Service fee"><ix:nonFraction name="BOWN:ServiceFee" contextRef="AsOf2023-12-31_custom_BusinessCombinationMarketingAgreementMember" id="Fact001458" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,415,000</ix:nonFraction></span>, equal to <span id="xdx_903_ecustom--PercentageOfGrossProceedsOfInitialPublicOffering_iI_pid_dp_uPure_c20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_zwsYgwylXRvg" title="Percentage of gross proceeds of initial public offering"><ix:nonFraction name="BOWN:PercentageOfGrossProceedsOfInitialPublicOffering" contextRef="AsOf2023-12-31_custom_BusinessCombinationMarketingAgreementMember" id="Fact001460" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.5</ix:nonFraction></span>% of the gross proceeds of the IPO. In addition, the Company
will pay EBC a service fee in an amount equal to <span id="xdx_90C_ecustom--PercentageOfServiceFeeOfTotalConsiderationPayable_iI_pid_dp_uPure_c20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_z1MHaUYqhHte" title="Percentage of service fee of total consideration payable"><ix:nonFraction name="BOWN:PercentageOfServiceFeeOfTotalConsiderationPayable" contextRef="AsOf2023-12-31_custom_BusinessCombinationMarketingAgreementMember" id="Fact001462" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.0</ix:nonFraction></span>% of the total consideration payable in the initial Business Combination if it introduces
the Company to the target business with whom it completes an initial Business Combination and the amount will be payable in cash and
is due at the closing date of the initial Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Business Combination Transaction Cost</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has engaged several service
providers including legal and valuation services, specifically for business combination between the Company and Shenzhen Qianzhi
BioTechnology Co. Ltd. (&#8220;Qianzhi&#8221;). Per the agreed terms, Qianzhi agreed to be responsible for all expenses incurred by
the Company in connection with business combination. During the year of 2023, $<span id="xdx_90A_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20230217__20231231_zhFSJN0oMyzj" title="Business combination related cost"><ix:nonFraction name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" contextRef="From2023-02-172023-12-31" id="Fact001464" format="ixt:numdotdecimal" decimals="0" unitRef="USD">181,022</ix:nonFraction></span>
of business combination related cost has been incurred and reimbursed by Qianzhi and approximately <span id="xdx_909_eus-gaap--AccountsPayableCurrent_iI_c20231231_zzlObPMfAG48" title="Commited for future expenses">$<ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-12-31" id="Fact001466" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,000</ix:nonFraction></span>
is committed for future services as of December 31, 2023. This activity has been recorded net in accompanying financial
statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001468" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_806_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zxzDqZ7DJ07a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8212; <span id="xdx_822_z0FvqJdQcbBj">SHAREHOLDERS&#8217; EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Shares</i></b> &#8212; The Company is authorized to issue <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zLLMAE4iHR01" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact001470" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span> preferred shares with a par value of $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zQN4FecLJtH" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact001472" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share with such
designations, <span id="xdx_90C_eus-gaap--PreferredStockVotingRights_c20230217__20231231_zkZ7SrAVjtb3" title="Preferred stock voting rights"><ix:nonNumeric contextRef="From2023-02-172023-12-31" id="Fact001474" name="us-gaap:PreferredStockVotingRights">voting and other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.</ix:nonNumeric></span>
As of December 31, 2023, there were <span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_z8Ity03v6p7d" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_zOAsmf68SbH7" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact001476" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact001478" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></span></span> preferred shares issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ordinary
Shares</i></b> &#8212; The Company is authorized to issue <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zWizlRhR6Eue" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact001480" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></span> ordinary shares with a par value of $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zTVpTrwnUc3a" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact001482" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share. <span id="xdx_904_eus-gaap--CommonStockVotingRights_c20230217__20231231_z9JBDOFQkyL3" title="Common stock voting rights"><ix:nonNumeric contextRef="From2023-02-172023-12-31" id="Fact001484" name="us-gaap:CommonStockVotingRights">Holders
of ordinary shares are entitled to one vote for each share.</ix:nonNumeric></span> On February 27, 2023, the Sponsors received <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zuujyD6O0fd9" title="Issuance of ordinary shares to Sponsor, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-272023-02-27_custom_SponsorsMember" id="Fact001486" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,725,000</ix:nonFraction></span> of the Founder Shares
in exchange for $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zKcPZ1vI09rd" title="Issuance of ordinary shares to Sponsor, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-02-272023-02-27_custom_SponsorsMember" id="Fact001488" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span> paid for offering costs borne by the Sponsors, of which an aggregate of up to <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z4EUK7diXbe9" title="Number of shares subject to forfeiture"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-02-272023-02-27_custom_SponsorsMember_us-gaap_OverAllotmentOptionMember" id="Fact001490" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225,000</ix:nonFraction></span> of such Founder Shares
were subject to forfeiture to the extent that the underwriters&#8217; over-allotment was not exercised in full or in part, so that the
number of Founder Shares will equal 20% of the Company&#8217;s issued and outstanding ordinary shares after the IPO (excluding shares
underlying the Private Placement Units). No ordinary shares are subject to forfeiture since the over-allotment was fully exercised on
July 17, 2023. As of December 31, 2023, there were <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zQC5NH2oeJ7j" title="Ordinary shares issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zvJxokkXZFGl" title="Ordinary shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact001492" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact001494" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,266,500</ix:nonFraction></ix:nonFraction></span></span> ordinary shares issued and outstanding (excluding <span id="xdx_90D_ecustom--OrdinarySharesSubjectToRedemption_iI_c20231231_zWpy2SOMaTy9" title="Ordinary shares subject to redemption"><ix:nonFraction name="BOWN:OrdinarySharesSubjectToRedemption" contextRef="AsOf2023-12-31" id="Fact001496" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></span> shares subject
to possible redemption).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rights
</i></b>&#8212; Except in cases where the Company is not the surviving company in a business combination, <span id="xdx_909_eus-gaap--CommonStockVotingRights_c20230217__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zh7bguN3OHx6" title="Common stock voting rights"><ix:nonNumeric contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember" id="Fact001498" name="us-gaap:CommonStockVotingRights">each holder of a right will
automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination.</ix:nonNumeric></span> The Company will
not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole
share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company is not the surviving
company upon completion of the initial Business Combination, each holder of a right will be required to affirmatively convert his, her
or its rights in order to receive the one-tenth (1/10) of one ordinary share underlying each right upon consummation of the business
combination. If the Company is unable to complete the initial Business Combination within the required time period and the Company will
redeem the public shares for the funds held in the trust account, holders of rights will not receive any of such funds for their rights
and the rights will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 333; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001500" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_807_eus-gaap--FairValueDisclosuresTextBlock_znVM2BK1Thll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8212; <span id="xdx_826_z0bbJURugr27">Fair Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which
transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets
or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
significant assumptions which the Company used to value the EBC Founder Shares are referred to Note 5. The following table presents
information about the Company&#8217;s assets that are measured at fair value on a recurring basis at December 31, 2023 and indicates
the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.</span></p>

<ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001502" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock"><p id="xdx_894_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z6NnfmmBvQmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BF_zSlcIVF1yKE1" style="display: none">SCHEDULE
OF MEASURED FAIR VALUE ON RECURRING BASIS</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_491_20231231_zoAXwkwUOHz2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49E_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zwEAR7ev2ltj" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49E_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_ziheDFnDL1pl" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_495_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zeYDvkFcb7vc" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prices in</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Active</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Markets</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level
    1)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level
    2)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level
    3)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsHeldInTrustNoncurrent_iI_zO45lkmG0Kef" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment held in trust account</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-12-31" id="Fact001504" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,419,358</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member" id="Fact001505" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,419,358</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="-sec-ix-hidden: xdx2ixbrl1506">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1507">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_zbyOkNUMQ2mi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-02-172023-12-31" escape="true" id="Fact001509" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zEoeOS28HpNb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8212; <span id="xdx_824_zMsFDRBzlrP6">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated
financial statements were issued. Based on the review, management identified the following subsequent event that is required
disclosure in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 18, 2024, the Company entered into an Agreement and Plan of Reorganization (the &#8220;Agreement&#8221;) with (i) Bowen Merger
Sub, a Cayman Islands exempted company and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), (ii) Shenzhen Qianzhi
BioTechnology Co. Ltd., a company incorporated in the People&#8217;s Republic of China and a wholly owned subsidiary of NewCo (as defined
below) (&#8220;Shenzhen Qianzhi&#8221;), and (iii) <span style="background-color: white">Qianzhi Group Holding (Cayman) Limited, a newly
formed Cayman Islands company (&#8220;<span style="text-decoration: underline">NewCo</span>,&#8221; and collectively with the Company, Merger Sub and Shenzhen Qianzhi, the &#8220;<span style="text-decoration: underline">Parties</span>&#8221;,
each a &#8220;<span style="text-decoration: underline">Party</span>&#8221;).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Agreement, at the closing of the business combination, Merger Sub will merge with and into NewCo (the &#8220;<span style="text-decoration: underline">Merger</span>&#8221;),
with NewCo being the surviving company of the Merger (&#8220;<span style="text-decoration: underline">Surviving Company</span>&#8221;) and becoming a wholly owned subsidiary
of the Company. In the Merger, the holders (the &#8220;NewCo Shareholders&#8221;) of the ordinary shares of NewCo (&#8220;NewCo Ordinary
Shares&#8221;) will receive ordinary shares of the Company (&#8220;Parent Ordinary Shares&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Agreement, at the effective time of the Merger (the &#8220;Effective Time&#8221;), all of NewCo Ordinary Shares issued and outstanding
immediately prior to the Effective Time will be automatically converted into the right to receive an aggregate of (a) <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240118__20240118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--MergerSharesMember__us-gaap--TypeOfArrangementAxis__custom--AgreementMember_zdnqll8HqLSg" title="Number of parent ordinary shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-182024-01-18_us-gaap_SubsequentEventMember_custom_MergerSharesMember_custom_AgreementMember" id="Fact001511" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,246,377</ix:nonFraction></span> Parent
Ordinary Shares (the &#8220;Merger Shares&#8221;), and (b) the right to receive earnout consideration of up to an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240118__20240118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--EarnoutSharesMember__us-gaap--TypeOfArrangementAxis__custom--AgreementMember__srt--RangeAxis__srt--MaximumMember_zcVhP7HKEhTa" title="Number of parent ordinary shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-182024-01-18_us-gaap_SubsequentEventMember_custom_EarnoutSharesMember_custom_AgreementMember_srt_MaximumMember" id="Fact001513" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,400,000</ix:nonFraction></span>
Parent Ordinary Shares (the &#8220;Earnout Shares&#8221;).</span></p>

</ix:nonNumeric><p id="xdx_81A_zWxOkHg6Gukc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#160;</span></p>


<!-- Field: Page; Sequence: 334; Value: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_041"></span>ANNEX
A &#8211; AGREEMENT AND PLAN OF REORGANIZATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font: normal 10pt Times New Roman, Times, Serif">EXECUTION
VERSION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGREEMENT
AND PLAN OF REORGANIZATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BY
AND AMONG</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN
ACQUISITION CORP,</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN
MERGER SUB,</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHENZHEN
QIANZHI BIOTECHNOLOGY CO., LTD</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AND</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QIANZHI
GROUP HOLDING (CAYMAN) LIMITED</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DATED
AS OF JANUARY 18, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 335; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
OF CONTENTS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
MERGER</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Merger</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    Time; Closing</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of the Merger</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing
    Documents</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    on Securities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger
    Consideration Exchange Procedures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lost,
    Stolen or Destroyed Certificates</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    Consequences</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taking
    of Necessary Action; Further Action</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Escrow</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Committee
    and Representative</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appraisal
    and Dissenter&#8217;s Rights</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
AND WARRANTIES REGARDING THE COMPANY AND NEWCO</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organization
    and Qualification</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority
    Relative to this Agreement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Conflict; Required Filings and Consents</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Statements</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Undisclosed Liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence
    of Certain Changes or Events</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Litigation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    Benefit Plans</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Labor
    Matters</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
    Activities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    to Property</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental
    Matters</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers;
    Third Party Expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
    Property</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreements,
    Contracts and Commitments</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental
    Actions/Filings</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.22</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interested
    Party Transactions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.23</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Top
    Customers and Top Suppliers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.24</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
    Approval</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 336 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.25</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Additional Representations and Warranties</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.26</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Investigation; No Reliance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Survival
    of Representations, Warranties, Covenants and Agreements</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
AND WARRANTIES OF PARENT AND MERGER SUB</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organization
    and Qualification</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority
    Relative to this Agreement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Conflict; Required Filings and Consents</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent
    SEC Reports and Financial Statements</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Undisclosed Liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence
    of Certain Changes or Events</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Litigation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    Benefit Plans</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Labor
    Matters</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
    Activities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    to Property</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental
    Matters</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
    Property</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreements,
    Contracts and Commitments</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interested
    Party Transactions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.22</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
    Listing</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.23</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
    Approval</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.24</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trust
    Fund</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.25</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Additional Representations and Warranties</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.26</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Investigation; No Reliance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.27</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Survival
    of Representations, Warranties, Covenants and Agreements</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDUCT
PRIOR TO THE EFFECTIVE TIME</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct
    of Business by the Company and NewCo and Parent and Merger Sub</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADDITIONAL
AGREEMENTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
    Statement and Proxy Statement; Special Meeting</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
    and Officers of Parent and the Company After Merger</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Actions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required
    Information</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 337 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidentiality;
    Access to Information</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    Disclosure</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercially
    Reasonable Best Efforts</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Securities Transactions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Claim Against Trust Fund</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
    of Certain Matters</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
    Listing</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Solicitation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter
    Protections; Directors&#8217; and Officers&#8217; Liability Insurance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insider
    Loans</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    Financial Information</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access
    to Financial Information</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent
    Borrowings</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trust
    Fund Disbursement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
    Agreements</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncompete
    Agreement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PIPE
    Financing</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.22</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NewCo
    Shareholder Approval</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.23</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees
    and Expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VI</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDITIONS
TO THE TRANSACTION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions
    to Obligations of Each Party to Effect the Merger</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    Conditions to Obligations of the Company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    Conditions to the Obligations of Parent and Merger Sub</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VII</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INDEMNIFICATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification
    of Parent Indemnitees</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification
    of Third-Party Claims</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification
    of Direct Claims</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance
    Effect</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limitations
    on Indemnification</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusive
    Remedy</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustment
    to Merger Consideration</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representative
    Capacities; Application of Escrow</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VIII</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TERMINATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    of Termination; Effect of Termination</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 338 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IX</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFINED
TERMS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defined
    Terms</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
X</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GENERAL
PROVISIONS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interpretation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counterparts;
    Electronic Delivery</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entire
    Agreement; Third Party Beneficiaries</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Remedies; Specific Performance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing
    Law</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    to Jurisdiction; WAIVER OF JURY TRIAL</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rules
    of Construction</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assignment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extension;
    Waiver</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
    Schedules</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 339 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGREEMENT
AND PLAN OF REORGANIZATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
AGREEMENT AND PLAN OF REORGANIZATION is made and entered into as of January 18, 2024, by and among Bowen Acquisition Corp, a Cayman Islands
exempted company (&#8220;<span style="text-decoration: underline">Parent</span>&#8221;), Bowen Merger Sub, a Cayman Islands exempted company and a wholly-owned subsidiary of
Parent (&#8220;<span style="text-decoration: underline">Merger Sub</span>&#8221;), Shenzhen Qianzhi BioTech Company Limited, a company incorporated in the People&#8217;s Republic
of China (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;), and Qianzhi Group Holding (Cayman) Limited, an exempted company incorporated with limited
liability in the Cayman Islands (&#8220;<span style="text-decoration: underline">NewCo</span>,&#8221; and together with Parent, Merger Sub and the Company, the &#8220;<span style="text-decoration: underline">Parties,</span>&#8221;
and each of Parent, Merger Sub, the Company and Newco individually, a &#8220;<span style="text-decoration: underline">Party</span>&#8221;). As used herein, (i) the term &#8220;<span style="text-decoration: underline">Agreement</span>&#8221;
refers to this Agreement and Plan of Reorganization, as the same may be amended from time to time, and all schedules hereto (including
the Company Schedule and the Parent Schedule, as defined in the preambles to <span style="text-decoration: underline">ARTICLE II</span> and <span style="text-decoration: underline">ARTICLE III</span> hereof, respectively),
and (ii) unless the context clearly otherwise indicates, the term &#8220;<span style="text-decoration: underline">Company</span>&#8221; refers to the Company and its Subsidiaries
(as defined in <span style="text-decoration: underline">Section 10.2(m)</span>), prior to the Restructuring (as defined in the Recitals), and refers to NewCo and its Subsidiaries,
including the Company, after the Restructuring.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
Parent is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange,
asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
Merger Sub is a newly incorporated, direct, wholly-owned subsidiary of Parent and was formed for the sole purpose of effecting the Merger
(as defined below).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Company is a company incorporated in the People&#8217;s Republic of China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
Prior to the execution of this Agreement, the Company completed a restructuring (the &#8220;<span style="text-decoration: underline">Restructuring</span>&#8221;), pursuant to
which the Company became an indirect wholly-owned subsidiary of NewCo, and the holders of all the Equity Securities of the Company issued
and outstanding immediately prior to the effective time of the Restructuring became the holders of all NewCo Ordinary Shares (as defined
in <span style="text-decoration: underline">Section 2.3(a)</span>) issued and outstanding immediately after the effective time of the Restructuring. The term &#8220;<span style="text-decoration: underline">NewCo
Shareholders</span>&#8221; refers to the holders of the Equity Securities of the Company, prior to the Restructuring, and the holders of
the NewCo Ordinary Shares, after the Restructuring.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.
Upon the terms and subject to the conditions of this Agreement and in accordance with the Companies Act (Revised) of the Cayman Islands,
as amended (the &#8220;<span style="text-decoration: underline">Cayman Companies Act</span>&#8221;), the Parties intend to enter into a business combination transaction by which
Merger Sub will merge with and into NewCo, with NewCo being the surviving company of the Merger (&#8220;<span style="text-decoration: underline">Surviving Company</span>&#8221;)
and becoming a wholly-owned subsidiary of Parent, and in exchange the NewCo Shareholders will receive ordinary shares of Parent as provided
by this Agreement (the &#8220;<span style="text-decoration: underline">Merger</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 340 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.
The boards of directors of each of Parent, Merger Sub, the Company and NewCo have determined that the Merger is fair to, and in the best
interests of, their respective companies and their respective shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.
Concurrently with the execution of this Agreement, Parent, the Company and certain shareholders of the Company have entered into Voting
and Support Agreements, in the form attached hereto as <span style="text-decoration: underline">Exhibit A</span> (each, a &#8220;<span style="text-decoration: underline">Voting Agreement</span>&#8221;), pursuant to
which, among other things, each such shareholder has agreed, with respect to all NewCo Ordinary Shares received by such shareholder in
the Restructuring, to vote in favor of, or consent in writing to, the adoption of this Agreement and the approval of the Transactions,
including the Merger (the &#8220;<span style="text-decoration: underline">NewCo Shareholder Approval</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.
The parties intend, by executing this Agreement, to adopt a plan of reorganization within the meaning of Section 368 of the Internal
Revenue Code of 1986, as amended (the &#8220;<span style="text-decoration: underline">Code</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the covenants, promises and representations set forth herein, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows (defined terms used in this Agreement are
listed alphabetically in <span style="text-decoration: underline">ARTICLE IX</span>, together with the Section and, if applicable, paragraph number in which the definition of
each such term is located):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
MERGER</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<span style="text-decoration: underline">The Merger</span>. At the Effective Time (as defined in <span style="text-decoration: underline">Section 1.2</span>) and subject to and upon the terms and conditions of this
Agreement and the applicable provisions of the Cayman Companies Act, NewCo shall be merged with Merger Sub, the separate corporate existence
of Merger Sub shall cease and NewCo shall continue as the Surviving Company after the Merger and as a wholly-owned subsidiary of Parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
<span style="text-decoration: underline">Effective Time; Closing</span>. Subject to the conditions of this Agreement, as soon as practicable on or after the Closing Date (as
hereinafter defined), the parties hereto shall execute a plan of merger (and any other documents required by the Cayman Companies Act
to consummate the Merger) (the &#8220;<span style="text-decoration: underline">Plan of Merger</span>&#8221;) in form and substance reasonably acceptable to the Parties, and the
Parties shall cause the Merger to be consummated by registering the Plan of Merger with the Cayman Registrar in accordance with the provisions
of the Cayman Companies Act. The Merger shall become effective on the date that the Plan of Merger is registered by the Cayman Registrar
in accordance with the Cayman Companies Act or such later time as specified in the Plan of Merger (the &#8220;<span style="text-decoration: underline">Effective Time</span>&#8221;).
Unless this Agreement shall have been terminated pursuant to <span style="text-decoration: underline">Section 8.1</span>, the consummation of the Transactions (the &#8220;<span style="text-decoration: underline">Closing</span>&#8221;),
other than the filing of the Plan of Merger, shall take place at the offices of Graubard Miller, counsel to Parent, 405 Lexington Avenue,
New York, New York 10174-1901 at a time and date to be specified by the parties, which shall be no later than the third (3<sup>rd</sup>)
Business Day after the satisfaction or waiver of the conditions set forth in <span style="text-decoration: underline">ARTICLE IV</span>, or at such other time, date and location
as the parties hereto agree in writing (the &#8220;<span style="text-decoration: underline">Closing Date</span>&#8221;). Closing signatures may be transmitted by facsimile or
by email pdf files. For purposes of this Agreement, &#8220;Business Day&#8221; shall mean any day other than a Saturday or Sunday or
any day on which banks located in the Cayman Islands and New York, NY are authorized or required to be closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 341; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
<span style="text-decoration: underline">Effect of the Merger</span>. At the Effective Time, the effect of the Merger shall be as provided in this Agreement, the Plan of Merger
and the Cayman Companies Act. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time all the rights,
the property of every description including causes of action, and the business, undertaking, goodwill, benefits, immunities, and privileges
of each of NewCo and Merger Sub shall vest in Surviving Company, and all the mortgages, charges or security interests, and all contracts,
obligations, claims, debts and liabilities of each of NewCo and Merger Sub shall become the mortgages, charges, or security interests,
and all contracts, obligations, claims, debts and liabilities of Surviving Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4
<span style="text-decoration: underline">Governing Documents</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
At the Effective Time, the memorandum and articles of association of Merger Sub shall become the memorandum and articles of association
of Surviving Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On the Closing Date, Parent shall cause its memorandum and articles of association to be amended and restated in such form as shall be
mutually agreed upon between the Company and Parent (the &#8220;<span style="text-decoration: underline">A&amp;R Memorandum and Articles of Association</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5
<span style="text-decoration: underline">Effect on Securities</span>. Subject to the terms and conditions of this Agreement, at the Effective Time, by virtue of the Merger and
this Agreement and without any further action on the part of Merger Sub or NewCo, or the holders of any of the securities of Parent,
Merger Sub, the Company or NewCo, the following shall occur:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Conversion of NewCo Ordinary Shares</span>. Other than any shares to be canceled pursuant to <span style="text-decoration: underline">Section 1.5(e)</span> and the Dissenting
Shares, all of NewCo Ordinary Shares issued and outstanding immediately prior to the Effective Time will be automatically converted,
at the Effective Time, into the right to receive an aggregate of (i) 7,246,377 ordinary shares, par value $0.0001, of Parent (&#8220;<span style="text-decoration: underline">Parent
Ordinary Shares</span>&#8221;), a portion of which shall be deposited in escrow in accordance with <span style="text-decoration: underline">Section 1.10</span> (the &#8220;<span style="text-decoration: underline">Merger
Shares</span>&#8221;), and (ii) the right to receive an aggregate of 1,400,000 Parent Ordinary Shares in accordance with <span style="text-decoration: underline">Section 1.12
</span>(the &#8220;<span style="text-decoration: underline">Earnout Shares</span>&#8221;). The Merger Shares and Earnout Shares shall be referred to herein collectively as the &#8220;<span style="text-decoration: underline">Merger
Consideration</span>.&#8221; The Merger Consideration shall be paid to the NewCo Shareholders in the respective amounts set forth on <span style="text-decoration: underline">Schedule
A</span> hereto. The Earnout Shares that may be issuable if earned shall be in addition to the Merger Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Shares of Merger Sub</span>. Each ordinary share, par value $1.00 per share, of Merger Sub (collectively, the &#8220;<span style="text-decoration: underline">Merger Sub Ordinary
Shares</span>&#8221;) issued and outstanding immediately prior to the Effective Time shall be converted into one validly issued, fully paid
and nonassessable ordinary share, as the case may be, of the Surviving Company. After the Effective Time, each certificate evidencing
ownership of Merger Sub Ordinary Shares shall evidence ownership of the corresponding ordinary shares of the Surviving Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 342; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Adjustments to Exchange Ratios</span>. The amount of Merger Consideration to be issued or paid at Closing shall be equitably adjusted
to reflect appropriately the effect of any share split, reverse share split, share dividend (including any dividend or distribution of
securities convertible into Parent Ordinary Shares or NewCo Ordinary Shares), extraordinary cash dividends, reorganization, recapitalization,
reclassification, combination, exchange of shares or other like change with respect to Parent Ordinary shares or NewCo Ordinary Shares
occurring on or after the date hereof and prior to the Effective Time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">Fractional Shares</span>. No fraction of a Parent Ordinary Share will be issued by virtue of the Merger, and each holder of NewCo Ordinary
Shares who would otherwise be entitled to a fraction of a Parent Ordinary Share (after aggregating all fractional Parent Ordinary Shares
that otherwise would be received by such holder) shall, upon compliance with <span style="text-decoration: underline">Section 1.6</span>, receive from Parent, in lieu of such
fractional share, one (1) Parent Ordinary Share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<span style="text-decoration: underline">Cancellation of Treasury and Parent-Owned Stock</span>. Each NewCo Ordinary Share held by Parent, the Company or NewCo or any direct
or indirect wholly-owned subsidiary of Parent, the Company or NewCo immediately prior to the Effective Time shall be canceled and extinguished
without any conversion or payment in respect thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6
<span style="text-decoration: underline">Merger Consideration Exchange Procedures</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Exchange Procedures</span>. At or prior to the Closing, each NewCo Shareholder shall (i) deliver the certificates evidencing their right
to NewCo Ordinary Shares (the &#8220;<span style="text-decoration: underline">NewCo Certificates</span>&#8221;), if any, to Parent for cancellation, or in the case of a lost,
stolen or destroyed NewCo Certificate, will deliver to Parent an affidavit (and indemnity if required) in the manner provided in <span style="text-decoration: underline">Section
1.7</span>, and (ii) deliver a duly completed and executed letter of transmittal to Parent, in a form to be mutually agreed upon between
Parent and the Company (&#8220;<span style="text-decoration: underline">Letter of Transmittal</span>&#8221;), and shall receive in exchange therefor the Merger Shares to which
such NewCo Shareholder is entitled pursuant to <span style="text-decoration: underline">Section 1.5</span>, in book-entry form (unless certificates representing Merger Shares
are otherwise requested by such NewCo Shareholder), and the NewCo Certificates, if any, shall forthwith be cancelled. The Letter of Transmittal
shall be in customary form and shall provide that (w) the NewCo Shareholder consents to the appointment of the Representative as set
forth in <span style="text-decoration: underline">Section 1.11(b)</span>, (x) the NewCo Shareholder acknowledges and agrees to the indemnification obligations set forth in <span style="text-decoration: underline">ARTICLE
VII</span> and the terms and conditions of the Escrow Agreement, (y) the NewCo Shareholder agrees to a general release and waiver of claims
in favor of the Company and NewCo and their Subsidiaries, subject to certain exceptions, and (z) the NewCo Shareholder agrees that it
may not, subject to certain exceptions, Transfer the Merger Shares until the earlier of (1) the six-month anniversary of the Closing
Date and (2) the date on which subsequent to the Merger, Parent consummates a liquidation, merger, share exchange or other similar transaction
which results in all of Parent&#8217;s shareholders having the right to exchange their Parent Ordinary Shares for cash, securities or
other property. To the extent that a NewCo Shareholder has not delivered the NewCo Certificates, if any, and a duly completed and executed
Letter of Transmittal at or prior to the Closing, such NewCo Shareholder shall deliver such items to Parent promptly following the Closing.
The delivery to Parent of the NewCo Certificates, if any, and a duly completed and executed Letter of Transmittal shall be a condition
to the receipt by each NewCo Shareholder of the Merger Consideration to which such NewCo Shareholder is entitled pursuant to <span style="text-decoration: underline">Section
1.5</span>. The Merger Shares shall be issued only in the name of the registered holder of the NewCo Ordinary Shares exchanged therefor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 343; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Distributions With Respect to Unexchanged NewCo Ordinary Shares</span>. No dividends or other distributions declared or made after the
date of this Agreement with respect to Parent Ordinary Shares with a record date after the Effective Time will be paid to any NewCo Shareholder
with respect to the Merger Consideration to which such NewCo Shareholder is entitled pursuant to <span style="text-decoration: underline">Section 1.5</span>, until such NewCo
Shareholder shall have delivered to Parent its NewCo Certificates, if any, and a duly executed and completed Letter of Transmittal. Subject
to applicable law, following delivery of any such NewCo Certificates and the Letter of Transmittal, Parent shall promptly deliver to
such NewCo Shareholder, without interest, the Merger Consideration into which such NewCo Ordinary Shares shall have been converted in
the Merger and the amount of any such dividends or other distributions with a record date after the Effective Time theretofore paid with
respect to such Merger Consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Required Withholding</span>. Parent shall be entitled to deduct and withhold (or cause to be deducted and withheld) from any consideration
payable or otherwise deliverable pursuant to this Agreement such amounts as are required to be deducted or withheld therefrom under the
Code or under any provision of state, local or foreign tax law. To the extent such amounts are so deducted or withheld consistent with
the terms of this <span style="text-decoration: underline">Section 1.6(c)</span>, such amounts shall be treated for all purposes under this Agreement as having been paid to the
Person to whom such amounts would otherwise have been paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">No Further Ownership Rights in NewCo Ordinary Shares</span>. All Parent Ordinary Shares issued in accordance with the terms hereof shall
be deemed to have been issued in full satisfaction of all rights pertaining to NewCo Ordinary Shares and there shall be no further registration
of transfers on the records of the Surviving Company of the NewCo Ordinary Shares that were outstanding immediately prior to the Effective
Time. At the Effective Time, each holder of NewCo Ordinary Shares shall cease to have any other rights in and to NewCo or the Surviving
Company, except the right to receive the Merger Consideration into which such NewCo Ordinary Shares shall have been converted in the
Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7
<span style="text-decoration: underline">Lost, Stolen or Destroyed Certificates</span>. In the event that any NewCo Certificates shall have been lost, stolen or destroyed, Parent
shall issue in exchange for such lost, stolen or destroyed NewCo Certificates, upon the making of an affidavit of that fact by the holder
thereof, the applicable Merger Consideration into which the NewCo Ordinary Shares formerly represented by such NewCo Certificates was
converted into and any dividends or distributions payable pursuant to <span style="text-decoration: underline">Section 1.6(b)</span>; <span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">however</span>, that, as
a condition precedent to the delivery of such Merger Consideration, the owner of such lost, stolen or destroyed NewCo Certificates shall
indemnify Parent against any claim that may be made against Parent or Surviving Company with respect to the NewCo Certificates alleged
to have been lost, stolen or destroyed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8
<span style="text-decoration: underline">Tax Consequences</span>. It is intended by the parties hereto that the Merger shall constitute reorganization within the meaning of Section
368 of the Code. The Parties hereto adopt this Agreement as a &#8220;plan of reorganization&#8221; within the meaning of Sections 1.368-2(g)
and 1.368-3(a) of the United States Income Tax Regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 344; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9
<span style="text-decoration: underline">Taking of Necessary Action; Further Action</span>. If, at any time after the Effective Time, any further action is necessary or desirable
to carry out the purposes of this Agreement and to vest Surviving Company with full right, title and possession to all assets, property,
rights, privileges, powers and franchises of NewCo and Merger Sub, the officers and directors of NewCo and Merger Sub will take all such
lawful and necessary action.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10
<span style="text-decoration: underline">Escrow</span>. As security for the indemnity obligations set forth in <span style="text-decoration: underline">ARTICLE VII</span>, at the Closing, the NewCo Shareholders receiving
Merger Shares shall deposit in escrow an aggregate of ten percent (10%) of the Merger Shares (the &#8220;<span style="text-decoration: underline">Escrow Shares</span>&#8221;)<b>,
</b>which shall be allocated among the NewCo Shareholders entitled to receive the same in the same proportions as the total Merger Shares
are allocated among them, all in accordance with the terms and conditions of the Escrow Agreement to be entered into at the Closing between
Parent, the Representative (as defined in <span style="text-decoration: underline">Section 1.11(b)</span>) and Continental Stock Transfer &amp; Trust Company (&#8220;<span style="text-decoration: underline">Continental</span>&#8221;),
as Escrow Agent, in the form annexed hereto as <span style="text-decoration: underline">Exhibit B</span> (the &#8220;<span style="text-decoration: underline">Escrow Agreement</span>&#8221;). The Escrow Agreement shall
provide that, on the date (the &#8220;<span style="text-decoration: underline">Escrow Termination Date</span>&#8221;) that is two (2) years after the Closing<b>,</b> the Escrow
Agent shall release the Escrow Shares, less that portion of the Escrow Shares applied in satisfaction of or reserved with respect to
indemnification claims made prior to such date, to the Persons entitled to receive them in the same proportions as originally deposited
into escrow. Any Escrow Shares held with respect to any unresolved claim for indemnification and not applied as indemnification with
respect to such claim upon its resolution shall be delivered to such Persons promptly upon such resolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11
<span style="text-decoration: underline">Committee and Representative</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Parent Committee</span>. Prior to the Closing, the Board of Directors of Parent shall appoint a committee (the &#8220;<span style="text-decoration: underline">Committee</span>&#8221;)
consisting of one or more of its then members to act on behalf of Parent and the Parent Indemnitees (as defined in <span style="text-decoration: underline">Section 7.1(a)</span>)
to take all necessary or appropriate actions under this Agreement and the Escrow Agreement after the Closing, including all decisions
in connection with the Earnout Shares and all decisions in connection with the indemnification obligations set forth in <span style="text-decoration: underline">ARTICLE VII</span>.
In the event of a vacancy in the Committee, the board of directors of Parent or, after the consummation of the Merger, a majority of
those Persons who served on Parent&#8217;s Board immediately prior to the Closing Date, shall appoint as a successor some other Person
who would qualify as an &#8220;independent&#8221; director of Parent and who has not had any relationship with the Company prior to the
Closing. Such committee is intended to be the &#8220;Committee&#8221; referred to in <span style="text-decoration: underline">ARTICLE VII</span> and the Escrow Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Representative</span>. Each NewCo Shareholder, in its Letter of Transmittal, shall designate and appoint Liangwen Wang, the Chief Financial
Officer of the Company (the &#8220;<span style="text-decoration: underline">Representative</span>&#8221;), as its agent and attorney-in-fact to represent the interests of the
NewCo Shareholders after the Closing for the purposes of this Agreement and the Escrow Agreement, including giving consents and approvals
hereunder and thereunder and making those determinations hereunder and thereunder that are specifically reserved to the Representative
by the terms hereof and thereof. If such Person ceases to serve in such capacity, for any reason, those members of the board of directors
of Parent who were members of the board of directors of the Company prior to the Closing shall appoint as successor a Person who was
a former director of the Company or such other Person as such members shall designate. Such Person or successor is intended to be the
&#8220;Representative&#8221; referred to in <span style="text-decoration: underline">ARTICLE VII</span> and the Escrow Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 345; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12
<span style="text-decoration: underline">Earnout</span>. The terms governing the Earnout Shares are set forth in <span style="text-decoration: underline">Schedule B</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13
<span style="text-decoration: underline">Appraisal and Dissenter&#8217;s Rights</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
NewCo Ordinary Shares (the &#8220;<span style="text-decoration: underline">Dissenting Shares</span>&#8221;) owned by the holders of NewCo Ordinary Shares who have validly exercised
and not effectively withdrawn or lost their rights to dissent from the Merger pursuant to section 238 of the Cayman Companies Act (the
&#8220;<span style="text-decoration: underline">Dissenting Shareholders</span>&#8221;) shall thereafter represent the right to receive only the payment resulting from the procedure
set forth in the Cayman Companies Act with respect to the Dissenting Shares owned by such Dissenting Shareholder, and shall not be entitled
to receive the Merger Consideration (which, for the avoidance of doubt, shall not be allocated to the other holders of NewCo Ordinary
Shares), unless and until such Dissenting Shareholder effectively withdraws its demand for, or loses its rights to, dissent from the
Merger pursuant to the Cayman Companies Act with respect to any Dissenting Shares. The Company and NewCo shall give Parent (i) prompt
notice of any notices of objection, notices of election to dissent, written demands for appraisal, demands for fair value, attempted
withdrawals of such demands, and any other instruments served pursuant to applicable Laws that are received by the Company relating to
any Dissenting Shareholder&#8217;s rights of dissent under the Cayman Companies Act and (ii) the opportunity to direct all negotiations
and proceedings with respect to demand for appraisal under the Cayman Companies Act. The Company and NewCo shall not, except with the
prior written consent of Parent, voluntarily make any payment with respect to any demands for appraisal, offer to settle or settle any
such demands or approve any withdrawal of any such demands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In the event that any written notices of objection to the Merger are served by the holders of NewCo Ordinary Shares pursuant to section
238(2) of the Cayman Companies Act, the Company and NewCo shall serve written notice of the authorization of this Agreement, the Plan
of Merger and the Merger on such Shareholders pursuant to section 238(4) of the Cayman Companies Act within twenty (20) days of obtaining
the NewCo Shareholder Approval, provided, that prior to serving any such notice, the Company and NewCo shall consult with Parent with
respect to such notice and shall afford Parent a reasonable opportunity to comment thereon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 346; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
AND WARRANTIES REGARDING THE COMPANY AND NEWCO</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the exceptions set forth in <span style="text-decoration: underline">Schedule 2</span> attached hereto (the &#8220;<span style="text-decoration: underline">Company Schedule</span>&#8221;), the Company and NewCo,
jointly and severally, hereby represent and warrant to, and covenant with, Parent and Merger Sub as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<span style="text-decoration: underline">Organization and Qualification</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the People&#8217;s Republic of
China and has the requisite corporate power and authority to own, lease and operate its assets and properties and to carry on its business
as it is now being or currently planned by the Company to be conducted. NewCo is an exempted company duly incorporated, validly existing
and in good standing under the laws of the Cayman Islands and has the requisite corporate power and authority to own, lease and operate
its assets and properties and to carry on its business as it is now being or currently planned by the Company to be conducted. Each of
the Company and NewCo is in possession of all franchises, grants, authorizations, licenses, permits, easements, consents, certificates,
approvals and orders (&#8220;<span style="text-decoration: underline">Approvals</span>&#8221;) necessary to own, lease and operate the properties it purports to own, operate
or lease and to carry on its business as it is now being or currently planned by the Company or NewCo to be, conducted, except where
the failure to have such Approvals would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect
on the Company. Complete and correct copies of the memorandum and articles of association or certificate of incorporation and bylaws
(such instruments or other comparable governing instruments with different names of an entity, collectively, the &#8220;<span style="text-decoration: underline">Charter Documents</span>&#8221;)
of the Company and NewCo, as amended and currently in effect, have been heretofore made available to Parent or Parent&#8217;s counsel.
The Company and NewCo are not and have not at any time been in default or violation of any term, condition or provision of their respective
Charter Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each of the Company and NewCo is duly qualified or licensed to do business as a foreign corporation and is in good standing in each jurisdiction
where the character of the properties owned, leased or operated by it or the nature of its activities makes such qualification or licensing
necessary, except for such failures to be so duly qualified or licensed and in good standing that would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect on the Company. Each jurisdiction in which the Company is so qualified or licensed
is listed in <span style="text-decoration: underline">Schedule 2.1(b)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The minute books of each of the Company and NewCo contain true, complete and accurate records of all meetings and consents in lieu of
meetings of its board of directors (and any committees thereof), similar governing bodies and shareholders. Copies of the minute books
of each the Company and NewCo have been heretofore made available to Parent or Parent&#8217;s counsel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<span style="text-decoration: underline">Subsidiaries</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Neither the Company nor NewCo has any direct or indirect Subsidiaries other than those listed in <span style="text-decoration: underline">Schedule 2.2</span> (the &#8220;<span style="text-decoration: underline">Company
Subsidiaries</span>&#8221;). Except as set forth in <span style="text-decoration: underline">Schedule 2.2</span>, the Company and NewCo own all of the issued and outstanding Equity
Securities of the respective Company Subsidiaries, free and clear of all Liens (as defined in <span style="text-decoration: underline">Section 10.2(h)</span>). Except for the
Company Subsidiaries, neither the Company nor NewCo owns, directly or indirectly, any ownership, equity, profits or voting interest in
any Person or has any agreement or commitment to purchase any such interest, and has not agreed and is not obligated to make nor is bound
by any written, oral or other agreement, contract, subcontract, lease, binding understanding, instrument, note, option, warranty, purchase
order, license, sublicense, insurance policy, benefit plan, commitment or undertaking of any nature, as of the date hereof or as may
hereafter be in effect under which it may become obligated to make, any future investment in or capital contribution to any other entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 347; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each Company Subsidiary that is a corporation is duly incorporated, validly existing and in good standing under the laws of its jurisdiction
of organization or formation (as listed in <span style="text-decoration: underline">Schedule 2.2</span>) and has the requisite corporate power and authority to own, lease and
operate its assets and properties and to carry on its business as it is now being or currently planned by the Company to be conducted.
Each Company Subsidiary that is a limited liability company is duly organized or formed, validly existing and in good standing under
the laws of its jurisdiction of organization or formation (as listed in <span style="text-decoration: underline">Schedule 2.2</span>) and has the requisite power and authority
to own, lease and operate its assets and properties and to carry on its business as it is now being or currently planned by the Company
to be conducted. Each Company Subsidiary is in possession of all Approvals necessary to own, lease and operate the properties it purports
to own, operate or lease and to carry on its business as it is now being or currently planned by the Company to be conducted, except
where the failure to have such Approvals could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect on the Company. Complete and correct copies of the Charter Documents of each Company Subsidiary, as amended and currently in effect,
have been heretofore delivered to Parent or Parent&#8217;s counsel. No Company Subsidiary is in violation of any of the provisions of
its Charter Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Each Company Subsidiary is duly qualified or licensed to do business as a foreign corporation or foreign limited liability company and
is in good standing in each jurisdiction where the character of the properties owned, leased or operated by it or the nature of its activities
makes such qualification or licensing necessary, except for such failures to be so duly qualified or licensed and in good standing that
could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company. Each jurisdiction
in which each Company Subsidiary is so qualified or licensed is listed in <span style="text-decoration: underline">Schedule 2.2</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The minute books of each Company Subsidiary contain true, complete and accurate records of all meetings and consents in lieu of meetings
of its board of directors (and any committees thereof), similar governing bodies and shareholders. Copies of the minute books of each
Company Subsidiary have been heretofore made available to Parent or Parent&#8217;s counsel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<span style="text-decoration: underline">Capitalization</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The registered capital of the Company is 20,502,000 RMB, all of which has been paid up as of the date of this Agreement in accordance
with applicable Legal Requirements and its Charter Documents. As of the date of this Agreement, all of the issued and outstanding Equity
Securities of the Company are owned beneficially and of record by NewCo or a wholly-owned Subsidiary of NewCo, free and clear of all
Liens. The authorized capital stock of NewCo consists of 50,000 ordinary shares (&#8220;<span style="text-decoration: underline">NewCo Ordinary Shares</span>&#8221;), of which
50,000 shares are issued and outstanding as of the date of this Agreement, all of which are validly issued, fully paid and nonassessable.
<span style="text-decoration: underline">Schedule 2.3(a)</span> contains a list of all of the holders of the NewCo Ordinary Shares as of the date of this Agreement, the number
of NewCo Ordinary Shares as of the date of this Agreement owned by each shareholder, and each shareholder&#8217;s residence address.
The NewCo Ordinary Shares are owned beneficially and of record by such shareholders, free and clear of all Liens. Other than (i) the
Equity Securities of the Company owned beneficially and of record by NewCo and (ii) the NewCo Ordinary Shares, neither the Company nor
NewCo has any Equity Securities authorized or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 348; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
As of the date of this Agreement, no Equity Securities of the Company or NewCo Ordinary Shares are reserved for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
All outstanding Equity Securities of the Company and NewCo Ordinary Shares have been, issued and granted in compliance with (x) all applicable
Legal Requirements and preemptive or similar rights, and (y) all requirements set forth in any applicable Company Contracts (as defined
in <span style="text-decoration: underline">Section 2.19</span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Except as set forth in <span style="text-decoration: underline">Schedule 2.3(d)</span> or as contemplated by this Agreement, there are no subscriptions, options, warrants, rights
(including preemptive rights), convertible, exchangeable or similar securities, or other plans, commitments or agreements of any character,
to which the Company or NewCo or any of their Subsidiaries is a party or by which the Company or NewCo or any of their Subsidiaries is
bound, obligating or providing for the Company or NewCo or any of their Subsidiaries to issue, deliver or sell, or cause to be issued,
delivered or sold any Equity Securities of the Company or NewCo or any of their Subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Except as set forth in <span style="text-decoration: underline">Schedule 2.3(e)</span> or as contemplated by this Agreement, there are no subscriptions, options, warrants, rights,
redeemable or similar securities, or other plans, commitments or agreements of any character, to which the Company or NewCo or any of
their Subsidiaries is a party or by which the Company or NewCo or any of their Subsidiaries is bound, obligating or providing for the
Company or NewCo or any of their Subsidiaries to repurchase, redeem or otherwise acquire, or cause the repurchase, redemption or acquisition
of, any Equity Securities of the Company or NewCo or any of their Subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Except as set forth in <span style="text-decoration: underline">Schedule 2.3(f)</span> or as contemplated by this Agreement, there are no registrations rights, and there is no
voting trust, proxy, rights plan, anti-takeover plan or other agreements or understandings, to which the Company or NewCo or any of their
Subsidiaries is a party or by which the Company or NewCo or any of their Subsidiaries is bound with respect to any Equity Securities
of the Company or NewCo or any of their respective Subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Except as provided for in this Agreement or as set forth in <span style="text-decoration: underline">Schedule 2.3(g)</span>, as a result of the consummation of the Transactions,
no Equity Securities of the Company or NewCo or any of their respective Subsidiaries are issuable and no rights in connection with any
such Equity Securities accelerate or otherwise become triggered (whether as to vesting, exercisability, convertibility or otherwise).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
No outstanding Equity Securities of the Company or NewCo Ordinary Shares are unvested or subjected to a repurchase option, risk of forfeiture
or other condition under any applicable agreement with the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 349; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
<span style="text-decoration: underline">Authority Relative to this Agreement</span>. The Company has full corporate power and authority to: (i) execute, deliver and perform
this Agreement, and each other Transaction Agreement that the Company has executed or delivered or is to execute or deliver pursuant
to this Agreement, and (ii) carry out the Company&#8217;s obligations hereunder and thereunder and, to consummate the Transactions (including
the Merger) and the transactions contemplated by the other Transaction Agreements. The execution and delivery of this Agreement by the
Company and the consummation by the Company of the Transactions (including the Merger) and the transactions contemplated by the other
Transaction Agreements have been duly and validly authorized by all necessary corporate action on the part of the Company (including
the approval by its board of directors and its shareholders as required by the Cayman Companies Act), and no other corporate proceedings
on the part of the Company are necessary to authorize this Agreement or to consummate the Transactions and the transactions contemplated
by the other Transaction Agreements, other than the NewCo Shareholder Approval. This Agreement has been duly and validly executed and
delivered by the Company and, assuming the due authorization, execution and delivery thereof by the other Parties hereto, constitutes
the legal and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as may be limited
by bankruptcy, insolvency, reorganization or other similar laws affecting the enforcement of creditors&#8217; rights generally and by
general principles of equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5
<span style="text-decoration: underline">No Conflict; Required Filings and Consents</span>. Except as set forth in <span style="text-decoration: underline">Schedule 2.5</span> hereto:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The execution and delivery of this Agreement by the Company do not, and the performance of this Agreement by the Company shall not, (i)
conflict with or violate the Company&#8217;s Charter Documents, (ii) conflict with or violate any Legal Requirements (as defined in <span style="text-decoration: underline">Section
10.2(g)</span>), (iii) result in any breach of or constitute a default (or an event that with notice or lapse of time or both would become
a default) under, or materially impair the Company&#8217;s rights or alter the rights or obligations of any third party under, or give
to others any rights of termination, amendment, acceleration or cancellation of, or result in the creation of a lien or encumbrance on
any of the properties or assets of the Company pursuant to, any Company Contracts or (iv) result in the triggering, acceleration or increase
of any payment to any Person pursuant to any Company Contract, including any &#8220;change in control&#8221; or similar provision of
any Company Contract, except, with respect to clauses (ii), (iii) or (iv), for any such conflicts, violations, breaches, defaults, triggerings,
accelerations, increases or other occurrences that would not, individually and in the aggregate, have a Material Adverse Effect on the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The execution and delivery of this Agreement by the Company does not, and the performance of its obligations hereunder will not, require
any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Entity or other third party (including,
without limitation, lenders and lessors), except (i) for applicable requirements, if any, of the Securities Act, the Exchange Act and
blue sky laws, and the rules and regulations thereunder, (ii) for the filing of the Plan of Merger, (iii) for the notification required
under Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the &#8220;<span style="text-decoration: underline">HSR Act</span>&#8221;), (iv) for the CFIUS Approval,
(v) for the consents, approvals, authorizations and permits, and the filings and notifications, that are described in <span style="text-decoration: underline">Schedule 2.5(b)</span>,
(vi) for the consents, approvals, authorizations and permits, and the filings and notifications, that have been obtained or made and
are in full force and effect, and (vii) where the failure to obtain such consents, approvals, authorizations or permits, or to make such
filings or notifications, would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on the
Company or, after the Closing, the Parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 350; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6
<span style="text-decoration: underline">Compliance</span>. The Company is in compliance with and not in violation of, and during the last three (3) years, has been in compliance
with and not in violation of, any Legal Requirements with respect to the conduct of its business, or the ownership or operation of its
business, except for failures to comply or violations which, individually or in the aggregate, have not had and are not reasonably likely
to have a Material Adverse Effect on the Company. Except as set forth in <span style="text-decoration: underline">Schedule 2.6</span>, no written notice of non-compliance with
or violation of any Legal Requirements has been received by the Company (and the Company has no Knowledge of any such notice having been
delivered to any other Person) during the last three (3) years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7
<span style="text-decoration: underline">Financial Statements</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company has made available to Parent true and complete copies of the audited consolidated financial statements (including any related
notes thereto) of the Company and its Subsidiaries for the fiscal years ended March 31, 2023 and 2022 (the &#8220;<span style="text-decoration: underline">Audited
Financial Statements</span>&#8221; or the &#8220;<span style="text-decoration: underline">Financial Statements</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Financial Statements have been (i) prepared from, and in accordance in all material respects, with, the books and records of the
Company as of the times and for the periods referred to therein, and (ii) prepared in accordance with U.S. GAAP (as defined below), consistently
applied during the periods involved (except as otherwise indicated in such statements). The Financials Statements fairly present in all
material respects the consolidated financial position of the Company and its Subsidiaries as of the respective dates thereof and the
consolidated results of the operations, changes in stockholders&#8217; equity and cash flows of the Company and its Subsidiaries for
the periods indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The books of account, minute books and transfer ledgers and other similar books and records of the Company and its Subsidiaries have
been maintained in accordance with good business practice, are complete and correct in all material respects and there have been no material
transactions that are required to be set forth therein and which have not been so set forth.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Except as otherwise noted in the Financial Statements, the accounts and notes receivable of the Company and its Subsidiaries reflected
in the Financial Statements: (i) arose from bona fide sales transactions in the ordinary course of business and are payable on ordinary
trade terms, (ii) are legal, valid and binding obligations of the respective debtors enforceable in accordance with their terms, except
as such may be limited by bankruptcy, insolvency, reorganization, or other similar laws affecting creditors&#8217; rights generally,
and by general equitable principles, (iii) are not subject to any valid set-off or counterclaim to which the Company has been notified
in writing as of the date hereof except to the extent set forth in such balance sheet contained therein, and (iv) are not the subject
of any actions or proceedings brought by or on behalf of the Company or any of its Subsidiaries as of the date hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 351; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The Company and its Subsidiaries have established and maintain systems of internal accounting controls that are designed to provide,
in all material respects, reasonable assurance that (i) all transactions are executed in accordance with management&#8217;s authorization
and (ii) all transactions are recorded as necessary to permit preparation of proper and accurate financial statements in accordance with
U.S. GAAP and to maintain accountability for the Company&#8217;s and its Subsidiaries&#8217; assets. As of the date of this Agreement,
the Company has not identified or been made aware of any, and to the Knowledge of the Company, there is no (i) &#8220;significant deficiency&#8221;
in the internal accounting controls of the Company, (ii) &#8220;material weakness&#8221; in the internal controls over financial reporting
of the Company, or (iii) fraud, whether or not material, that involves management or other employees of the Company who have a significant
role in the internal accounting controls of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Company&#8217;s auditor has at all required times since the date of enactment of the Sarbanes-Oxley Act been: (i) a registered public
accounting firm (as defined in Section 2(a)(12) of the Sarbanes-Oxley Act); (ii) &#8220;independent&#8221; with respect to the Company
within the meaning of Regulation S-X under the Exchange Act; and (iii) in compliance with subsections (g) through (l) of Section 10A
of the Exchange Act and the rules and regulations promulgated by the SEC and the Public Company Accounting Oversight Board thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
There are no outstanding loans or other extensions of credit made by the Company to any executive officer (as defined in Rule 3b-7 under
the Exchange Act) or director of the Company. The Company has not taken any action prohibited by Section 402 of the Sarbanes-Oxley Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Except as set forth in <span style="text-decoration: underline">Schedule 2.7(h)</span>, the Company has no indebtedness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8
<span style="text-decoration: underline">No Undisclosed Liabilities</span>. Except as set forth in <span style="text-decoration: underline">Schedule 2.8</span>, neither the Company nor any of the Company Subsidiaries
has any liabilities or obligations (absolute, accrued, contingent or otherwise) of a nature required to be reflected or reserved for
on a balance sheet prepared in accordance with IFRS or in the related notes thereto, except liabilities and obligations (i) reflected
or reserved for in the Financial Statements or disclosed in any notes thereto, (ii) incurred or arising under or in connection with the
Transactions, including expenses related thereto, or (iii) incurred or arising in the ordinary course of business consistent with past
practice since the date of the most recent balance sheet included in the Financial Statements, provided such liabilities and obligations,
individually or in the aggregate, would not have a Material Adverse Effect on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9
<span style="text-decoration: underline">Absence of Certain Changes or Events</span>. Except as contemplated by this Agreement, since the date of the most recent balance sheet
included in the Financial Statements, there has not been: (i) any Material Adverse Effect on the Company, (ii) any declaration, setting
aside or payment of any dividend on, or other distribution (whether in cash, capital stock or property) in respect of, any Equity Securities
of the Company, or any purchase, redemption or other acquisition by the Company of any Equity Securities of the Company or any other
securities of the Company or any options, warrants, calls or rights to acquire any such Equity Securities or other securities of the
Company, (iii) any split, combination or reclassification of any Equity Securities of the Company, (iv) any granting by the Company of
any increase in compensation or fringe benefits, except for normal increases of cash compensation in the ordinary course of business
consistent with past practice, or any payment by the Company of any bonus, except for bonuses made in the ordinary course of business
consistent with past practice, or any granting by the Company of any increase in severance or termination pay or any entry by the Company
into any currently effective employment, severance, termination or indemnification agreement or any agreement the benefits of which are
contingent or the terms of which are materially altered upon the occurrence of a transaction involving the Company of the nature contemplated
hereby, (v) entry by the Company into any licensing or other agreement with regard to the acquisition or disposition of any Intellectual
Property other than licenses in the ordinary course of business consistent with past practice or any amendment or consent with respect
to any licensing agreement filed or required to be filed by the Company with respect to any Governmental Entity, (vi) any material change
by the Company in its accounting methods, principles or practices, except as required by concurrent changes in IFRS, (vii) any change
in the auditors of the Company, (viii) any issuance of capital stock of the Company, or (ix) any revaluation by the Company of any of
its assets, including, without limitation, writing down the value of capitalized inventory or writing off notes or accounts receivable
or any sale of assets of the Company other than in the ordinary course of business consistent with past practice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 352; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10
<span style="text-decoration: underline">Litigation</span>. Except as disclosed in <span style="text-decoration: underline">Schedule 2.10</span>, there are no claims, suits, actions, complaints, demands or other proceedings
pending or, to the Knowledge of the Company, threatened against the Company before any Governmental Entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11
<span style="text-decoration: underline">Employee Benefit Plans</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Schedule 2.11(a)</span> lists all employee compensation, incentive, fringe or benefit plans, programs, policies, commitments or other
arrangements (whether or not set forth in a written document) covering any active or former employee, director or consultant of the Company,
or any trade or business (whether or not incorporated) which is under common control with the Company, with respect to which the Company
has liability (individually, a &#8220;<span style="text-decoration: underline">Plan</span>,&#8221; and, collectively, the &#8220;<span style="text-decoration: underline">Plans</span>&#8221;). All Plans have been maintained
and administered in all material respects in compliance with their respective terms and with the requirements prescribed by any and all
statutes, orders, rules and regulations which are applicable to such Plans, and all liabilities with respect to the Plans have been properly
reflected in the Financial Statements and the books and records of the Company. No suit, action or other litigation (excluding claims
for benefits incurred in the ordinary course of Plan activities) has been brought, or, to the Knowledge of the Company, is threatened,
against or with respect to any Plan. There are no audits, inquiries or proceedings pending or, to the Knowledge of the Company, threatened
by any governmental agency with respect to any Plan. All contributions, reserves or premium payments required to be made or accrued as
of the date hereof to the Plans have been timely made or accrued. The Company does not have any plan or commitment to establish any new
Plan, to modify any Plan (except to the extent required by law or to conform any such Plan to the requirements of any applicable law,
in each case as previously disclosed to Parent in writing, or as required by this Agreement), or to enter into any new Plan. Except as
disclosed in <span style="text-decoration: underline">Schedule 2.11(a)</span>, each Plan can be amended, terminated or otherwise discontinued after the Closing in accordance
with its terms, without liability to Parent or the Surviving Company (other than ordinary administration expenses and expenses for benefits
accrued but not yet paid).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Except as disclosed in <span style="text-decoration: underline">Schedule 2.11(b)</span>, neither the execution and delivery of this Agreement nor the consummation of the Transactions
will (i) result in any payment (including severance, unemployment compensation, golden parachute, bonus or otherwise) becoming due to
any shareholder, director, officer or employee of the Company under any Plan or otherwise, (ii) materially increase any benefits otherwise
payable under any Plan, or (iii) result in the acceleration of the time of payment or vesting of any such benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 353; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12
<span style="text-decoration: underline">Labor Matters</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Except as set forth on <span style="text-decoration: underline">Schedule 2.12</span>, the Company is not a party to any collective bargaining agreement or other labor union contract
applicable to persons employed by the Company nor does the Company know of any activities or proceedings of any labor union to organize
any such employees. There are no pending grievance or similar proceedings involving the Company and any of its employees subject to a
collective bargaining agreement or other labor union contract and there are no continuing obligations of the Company pursuant to the
resolution of any such proceeding that is no longer pending.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Except as provided for in the collective bargaining agreements and labor union contracts set forth on <span style="text-decoration: underline">Schedule 2.12</span>, each employee
and consultant of the Company is terminable &#8220;at will&#8221; subject to applicable notice periods as set forth by law or in the
employment agreement, but in any event not more than ninety (90) days, and there are no agreements or understandings between the Company
and any of its employees or consultants that their employment or services will be for any particular period. The Company is not aware
that any of its officers or key employees intends to terminate his or her employment with the Company. The Company is in compliance in
all material respects and, to the Company&#8217;s Knowledge, each of its employees and consultants is in compliance in all material respects,
with the terms of the respective employment and consulting agreements between the Company and such individuals. There are not, and there
have not been, any oral or informal arrangements, commitments or promises between the Company and any employees or consultants of the
Company that have not been documented as part of the formal written agreements between any such individuals and the Company that have
been made available to Parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company is in compliance, and during the last three (3) years has been in compliance, in all material respects with all Legal Requirements
applicable to its employees, respecting employment, employment practices, terms and conditions of employment and wages and hours and
is not liable for any arrears of wages or penalties with respect thereto. The Company&#8217;s obligations to provide statutory severance
pay to its employees are fully funded or accrued on the most recent Financial Statements and the Company has no Knowledge of any circumstance
that could give rise to any valid claim by a current or former employee for compensation on termination of employment (beyond the statutory
severance pay to which employees are entitled). All amounts that the Company is legally or contractually required either (x) to deduct
from its employees&#8217; salaries or to transfer to such employees&#8217; pension or provident, life insurance, incapacity insurance,
continuing education fund or other similar funds, or (y) to withhold from its employees&#8217; salaries and benefits and to pay to any
Governmental Entity as required by applicable Legal Requirements have, in each case, been duly deducted, transferred, withheld and paid,
and the Company does not have any outstanding obligation to make any such deduction, transfer, withholding or payment. There are no pending,
or to the Company&#8217;s Knowledge, threatened or reasonably anticipated, claims or actions against the Company by any employee in connection
with such employee&#8217;s employment or termination of employment by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
No employee or former employee of the Company is owed any wages, benefits or other compensation for past services (other than wages,
benefits and compensation accrued in the ordinary course of business consistent with past practice during the current pay period and
any accrued benefits for services, which by their terms or under applicable law, are payable in the future, such as accrued vacation,
recreation leave and severance pay).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 354; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.13
<span style="text-decoration: underline">Business Activities</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Except as disclosed in <span style="text-decoration: underline">Schedule 2.13</span>, there is no agreement, commitment, judgment, injunction, order or decree binding upon the
Company or its assets or to which the Company is a party which has or could reasonably be expected to have the effect of prohibiting
or materially impairing any business practice of the Company, any acquisition of property by the Company or the conduct of business by
the Company as currently conducted, other than such agreements, commitments, judgments, injunctions, orders and decrees that have not
had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
NewCo and its Subsidiaries were created for the purpose of facilitating the Restructuring and the Merger. Except as effected by the Restructuring,
NewCo and its Subsidiaries do not have any assets or properties of any kind, do not conduct and have never conducted any business, and
have and will have at the Closing no obligations or liabilities of any nature whatsoever, except for such obligations as are imposed
under this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
As of the date of this Agreement, the projections with respect to the Company that were delivered by or on behalf of the Company to Parent,
including any statement with respect to projected revenues, costs, expenses, and profits, a copy of which are attached as <span style="text-decoration: underline">Schedule
2.13(c)</span>, were prepared by the Company based on reasonable and appropriate assumptions for projections of such kind with respect to
the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14
<span style="text-decoration: underline">Title to Property</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All real property owned by the Company (including improvements and fixtures thereon, easements and rights of way) is shown or reflected
on the most recent balance sheet included in the Financial Statements. The Company has good, valid and marketable fee simple title to
such real property, and except as set forth in the Audited Financial Statements or in <span style="text-decoration: underline">Schedule 2.14(a)</span>, all such real property
is held free and clear of (i) all leases, licenses and other rights to occupy or use such real property and (ii) all Liens, rights of
way, easements, restrictions, exceptions, variances, reservations, covenants or other title defects or limitations of any kind, other
than Liens for taxes not yet due and payable and such Liens or other imperfections of title, if any, that do not, individually or in
the aggregate, materially detract from the value of or materially interfere with the present or contemplated use of such property in
the business of the Company. <span style="text-decoration: underline">Schedule 2.14(a)</span> also contains a list of all options or other contracts under which the Company has
a right to acquire or the obligation to sell any interest in real property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 355; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
All real property occupied, used or held for use by the Company (other than the real property owned by the Company), and all personal
property and other property and assets owned, used or held for use by the Company in connection with the business of the Company (the
&#8220;<span style="text-decoration: underline">Personal Property</span>&#8221;), are shown or reflected on the most recent balance sheet included in the Financial Statements,
other than property acquired on or after the date of the most recent balance sheet included in the Financial Statements in the ordinary
course of business consistent with past practice. The Company has good and marketable title to, or a valid and binding leasehold or license
interest in, all such real property and Personal Property, except as would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect on the Company. Except as set forth in the Audited Financial Statements or in <span style="text-decoration: underline">Schedule 2.14(a)</span>,
all such real property and Personal Property is held free and clear of all Liens, other than Liens that do not, individually or in the
aggregate, materially detract from the value of or materially interfere with the present or contemplated use of such property in the
business of the Company. <span style="text-decoration: underline">Schedule 2.14(b)</span> contains a list of all leases of real property and Personal Property held by the Company.
All such leases are in full force and effect and are enforceable in accordance with their terms, and there is not, under any of such
leases, any existing material default or event of default (or any event which with notice or lapse of time, or both, would constitute
a material default or event of default) of the Company or, to the Company&#8217;s Knowledge, any other Party, except as would not reasonably
be expected to have, individually or in the aggregate, a Material Adverse Effect on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company has good and marketable title to, or a valid and effective leasehold or license interest in, all material real property and
Personal Property required for the conduct of the business of the Company, as presently operated and as contemplated to be operated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15
<span style="text-decoration: underline">Taxes</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Definition of Taxes</span>. For the purposes of this Agreement, &#8220;<span style="text-decoration: underline">Tax</span>&#8221; or &#8220;<span style="text-decoration: underline">Taxes</span>&#8221; refers to any
and all federal, state, local and foreign taxes, including, without limitation, gross receipts, income, profits, sales, use, occupation,
value added, ad valorem, transfer, franchise, withholding, payroll, recapture, employment, excise and property taxes, assessments, governmental
charges and duties together with all interest, penalties and additions imposed with respect to any such amounts and any obligations under
any agreements or arrangements with any other Person with respect to any such amounts and including any liability of a predecessor entity
for any such amounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Tax Returns and Audits</span>. Except as set forth in <span style="text-decoration: underline">Schedule 2.15</span> hereto:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Company has timely filed all federal, state, local and foreign returns, estimates, information statements and reports relating to
Taxes (&#8220;<span style="text-decoration: underline">Returns</span>&#8221;) required to be filed by the Company with any Tax authority prior to the date hereof. All such Returns
are true, correct and complete. The Company has paid all Taxes due and payable with respect to such Returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
All Taxes that the Company is required by law to withhold or collect have been duly withheld or collected, and have been timely paid
over to the proper governmental authorities to the extent due and payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 356; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Company has not been delinquent in the payment of any Tax nor is there any Tax deficiency outstanding, proposed or assessed against
the Company, nor has the Company executed any unexpired waiver of any statute of limitations on or extending the period for the assessment
or collection of any Tax. The Company has complied with all Legal Requirements with respect to payments made to third parties and the
withholding of any payment of withheld Taxes and has timely withheld from employee wages and other payments and timely paid over in full
to the proper taxing authorities all amounts required to be so withheld and paid over for all periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
To the Knowledge of the Company, no audit or other examination of any Return of the Company by any Tax authority is presently in progress,
nor has the Company been notified of any request for such an audit or other examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
No adjustment relating to any Returns filed by the Company has been proposed in writing, formally or informally, by any Tax authority
to the Company or any representative thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
The Company has no liability for any unpaid Taxes which have not been accrued for or reserved on the Company&#8217;s balance sheets included
in the Financial Statements, whether asserted or unasserted, contingent or otherwise, other than any liability for unpaid Taxes that
may have accrued since the end of the most recent fiscal year in connection with the operation of the business of the Company in the
ordinary course.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.16
<span style="text-decoration: underline">Environmental Matters</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
For the purposes of this Agreement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&#8220;<span style="text-decoration: underline">Environmental Law</span>&#8221; means any federal, state, local or foreign law, regulation, order, decree, permit, authorization,
opinion, common law or agency requirement relating to: (A) the protection, investigation or restoration of the environment, health and
safety, or natural resources; (B) the handling, use, presence, disposal, release or threatened release of any Hazardous Substance or
(C) noise, odor, wetlands, pollution, contamination or any injury or threat of injury to persons or property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
&#8220;<span style="text-decoration: underline">Hazardous Substance</span>&#8221; means any substance that is: (i) listed, classified or regulated pursuant to any Environmental
Law; (ii) any petroleum product or by-product, asbestos-containing material, lead-containing paint or plumbing, polychlorinated biphenyls,
radioactive materials or radon; or (iii) any other substance which is the subject of regulatory action by any Governmental Entity pursuant
to any Environmental Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 357; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Except as disclosed in <span style="text-decoration: underline">Schedule 2.16(b)</span> hereto: (i) the Company has complied with all applicable Environmental Laws (as defined
below); (ii) the properties currently operated or being constructed by the Company (including soils, groundwater, surface water, air,
buildings or other structures) are not contaminated with any Hazardous Substances (as defined below); (iii) the properties formerly owned,
operated or constructed by the Company were not contaminated with Hazardous Substances during the period of ownership, operation or construction
by the Company or, to the Company&#8217;s Knowledge, during any prior period; (iv) the Company is not subject to liability for any Hazardous
Substance disposal or contamination on any third party or public property (whether above, on or below ground or in the atmosphere or
water); (v) the Company has not been associated with any release or threat of release of any Hazardous Substance; (vi) the Company has
not received any notice, demand, letter, claim or request for information alleging that the Company may be in violation of or liable
under any Environmental Law; and (vii) the Company is not subject to any orders, decrees, injunctions or other arrangements with any
Governmental Entity or subject to any indemnity or other agreement with any third party relating to liability under any Environmental
Law or relating to Hazardous Substances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Schedule 2.16(c)</span> sets forth all environmental studies and investigations completed or in process with respect to the Company and/or
the Company Subsidiaries or their respective properties, assets or operations, including all phase reports, that are known to the Company.
All such written reports and material documentation relating to any such study or investigation has been provided by the Company to Parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17
<span style="text-decoration: underline">Brokers; Third Party Expenses</span>. Except as set forth in <span style="text-decoration: underline">Schedule 2.17</span> hereto, the Company has not incurred, nor will it incur,
directly or indirectly, any liability for brokerage, finders&#8217; fees, agent&#8217;s commissions or any similar charges in connection
with this Agreement or the Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.18
<span style="text-decoration: underline">Intellectual Property</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
For the purposes of this Agreement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&#8220;<span style="text-decoration: underline">Company Intellectual Property</span>&#8221; shall mean any Intellectual Property that is or is purported to be owned by, or licensed
to, the Company, including software and software programs developed by or exclusively licensed to the Company (specifically excluding
any off the shelf or shrink-wrap software).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
&#8220;<span style="text-decoration: underline">Company Products</span>&#8221; means all current versions of products or service offerings of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
&#8220;<span style="text-decoration: underline">Company Registered Intellectual Property</span>&#8221; means all of the Registered Intellectual Property is or is purported to
be owned by, or filed in the name of, the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
&#8220;<span style="text-decoration: underline">Data Protection Requirements</span>&#8221; means (i) all applicable Laws pertaining to processing of Personal Data, data protection,
data privacy, data security, data breach notification, data localization or data transfers and (ii) to the extent relating to the processing
of Personal Data, data protection, data security, data breach notification, data localization, or data transfers, (a) the Company&#8217;s
policies and notices, (b) industry standards to which the Company purports to be bound (including the Payment Card Industry Data Security
Standard) and (c) Company Contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 358; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
&#8220;<span style="text-decoration: underline">Intellectual Property</span>&#8221; shall mean any or all of the following and all worldwide common law and statutory rights in,
arising out of, or associated therewith: (i) patents and applications therefor and all reissues, divisions, renewals, extensions, provisionals,
continuations and continuations-in-part thereof (&#8220;<span style="text-decoration: underline">Patents</span>&#8221;); (ii) inventions (whether patentable or not), invention
disclosures, improvements, trade secrets, proprietary information, know how, technology, technical data and customer lists, and all documentation
relating to any of the foregoing; (iii) copyrights, copyrights registrations and applications therefor, and all other rights corresponding
thereto throughout the world (&#8220;<span style="text-decoration: underline">Copyrights</span>&#8221;); (iv) software and software programs; (v) <span style="background-color: white">social
media handles,</span> domain names, uniform resource locators and other names and locators associated with the Internet; (vi) industrial
designs and any registrations and applications therefor; (vii) trade names, logos, common law trademarks and service marks, trademark
and service mark registrations and applications therefor (collectively, &#8220;<span style="text-decoration: underline">Trademarks</span>&#8221;); (viii) all databases and data
collections and all rights therein; (ix) all moral and economic rights of authors and inventors, however denominated, and (x) any similar
or equivalent rights to any of the foregoing (as applicable).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
&#8220;<span style="text-decoration: underline">IT Data</span>&#8221; shall mean all business information and data, including Personal Data (whether of employees, contractors,
consultants, customers, consumers, or other persons and whether in electronic or any other form or medium) that is accessed, collected,
used, stored, shared, distributed, transferred, disclosed, destroyed, disposed of or otherwise processed by any of the IT Systems or
otherwise in the course of the conduct of the business of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
&#8220;<span style="text-decoration: underline">IT Systems</span>&#8221; means all software, computer and information technology systems, servers, networks, databases, computer
hardware and equipment, information, records, communications equipment, telecommunications equipment, interfaces, platforms, and peripherals
that are owned, used or controlled by or for the business of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
&#8220;<span style="text-decoration: underline">Personal Data</span>&#8221; means any data or information (i) relating to an identified natural person (or information that, in
combination with other information, could reasonably allow the identification of a natural person), including demographic, health, behavioral,
biometric, financial, nonpublic, and geolocation information, IP addresses, employee information, and any other information defined as
&#8220;personal data,&#8221; &#8220;personal information,&#8221; &#8220;personally identifiable information,&#8221; or any similar term
under applicable Legal Requirements, or (ii) that identifies, relates to, describes, is reasonably capable of being associated with,
or could reasonably be linked, directly or indirectly, with a particular individual, household, or device.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
&#8220;<span style="text-decoration: underline">Registered Intellectual Property</span>&#8221; means all Intellectual Property that is the subject of an application, certificate,
filing, registration or other document issued, filed with, or recorded by any Governmental Entity or private registrar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Schedule 2.18</span> contains a description of all Intellectual Property of the Company. The Company owns or has a valid and enforceable
right to use all Intellectual Property required for the conduct of the business of the Company, as presently operated and as contemplated
to be operated. Except as disclosed in <span style="text-decoration: underline">Schedule 2.18</span>, no Company Intellectual Property or Company Product is subject to any material
proceeding or outstanding decree, order, judgment, contract, license, agreement or stipulation that restricts in any manner the use,
transfer or licensing thereof by the Company, or that may affect the validity, use or enforceability of such Company Intellectual Property
or Company Product, which would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 359; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Except as disclosed in <span style="text-decoration: underline">Schedule 2.18</span>, the Company has exclusive right, title, and interest in and to (i) all registered Patents,
Trademarks and Copyrights owned by it and used in connection with the operation or conduct of the business of the Company, including
the sale of any products or the provision of any services by the Company, and (ii) each other material item of Company Intellectual Property
owned by it, in each case, free and clear of any Liens (excluding non-exclusive licenses and related restrictions granted by it in the
ordinary course of business). All Persons who have participated in the invention, creation, authorship, or development of any material
Intellectual Property for or on behalf of the Company have executed and delivered to the Company, a valid and enforceable written agreement
(x) providing for the non-disclosure by such Person of any confidential information of or used by the Company and (y) providing for the
present assignment by such Person to the Company of all right, title, and interest in all Intellectual Property arising out of such Person&#8217;s
employment by, engagement by or contract with the Company, except where ownership of such Intellectual Property would vest in the Company
by operation of law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company rights in the Company Intellectual Property are valid, subsisting, and enforceable, except as would not reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect on the Company. The Company has in place commercially reasonable
measures to protect and maintain the confidentiality of any material trade secrets included in the Company Intellectual Property. To
the Knowledge of the Company, there has been no unauthorized access, use or disclosure of any such material trade secrets included in
the Company Intellectual Property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The conduct of the business of the Company, as presently operated and as contemplated to be operated, including the Company&#8217;s use
of any product, device or process, has not and does not infringe or misappropriate the Intellectual Property of any third party or constitute
unfair competition or trade practices under the laws of any jurisdiction, and the Company has not received any claims or threats from
third parties alleging any such infringement, misappropriation or unfair competition or trade practices. To the Knowledge of the Company,
no third party is infringing upon, misappropriating or otherwise violating any material Company Intellectual Property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The execution, delivery and performance by the Company of this Agreement and the other Transaction Agreements to which it is or will
be a party and the consummation by the Company of the Transactions will not result in the loss, termination or impairment of any right
of the Company in or to any material Intellectual Property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
The Company has in place commercially reasonable measures to protect the confidentiality, integrity, availability and security of the
IT Systems, and commercially reasonable back-up and disaster recovery procedures for the continued operation of their businesses in the
event of a failure of the IT Systems. The Company has used commercially reasonable efforts to prevent the introduction into the IT Systems,
any malware, ransomware, disabling codes or instructions, spyware, Trojan horses, worms, viruses or other software routines that would
permit or cause unauthorized access to, or disruption, impairment, disablement, or destruction of the IT Systems, and to the Knowledge
of the Company, the IT Systems do not contain any of the foregoing. The IT Systems have not suffered any critical failures, errors, breakdowns
or other adverse events that have caused any material disruption in the operation of the business of the Company. The IT Systems are
in good working order in all material respects and are sufficient in all material respects for the existing needs of the business of
the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 360; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
To the Knowledge of the Company, the Company and its Subsidiaries have not suffered any security breach or incident or any other event
resulting in any unauthorized or unlawful access, acquisition, exfiltration, manipulation, erasure, loss, use, disclosure or other processing
that compromised the confidentiality, integrity, availability or security of Personal Data or the IT Data or IT Systems, resulting in
any unauthorized or unlawful processing of Personal Data or the IT Data or IT Systems, or triggering any reporting requirement under
any breach notification Legal Requirement. To the Knowledge of the Company, no service provider (in the course of providing services
for or on behalf of the Company) has suffered any such security breach or incident or other event that would reasonably be expected,
individually or in the aggregate, to have a Material Adverse Effect on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Company is in material compliance, and for the last three (3) years has been in material compliance, with all applicable Data Protection
Requirements, including all such requirements regarding the collection, retention, storage, security, disclosure, transfer, disposal,
use, or other processing of Personal Data. There is no claim, suit, action, complaint, demand or other proceeding pending, or to the
Knowledge of the Company, threatened against the Company with respect to their collection, retention, storage, security, disclosure,
transfer, disposal, use, or other processing of any Personal Data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19
<span style="text-decoration: underline">Agreements, Contracts and Commitments</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Schedule 2.19</span> hereto sets forth a complete and accurate list of all Material Company Contracts (as defined below), specifying
the parties thereto. For purposes of this Agreement, (i) the term &#8220;<span style="text-decoration: underline">Company Contracts</span>&#8221; shall mean all contracts, agreements,
leases, mortgages, indentures, notes, bonds, licenses, permits, franchises, purchase orders, sales orders, and other understandings,
commitments and obligations (including, without limitation, outstanding offers and proposals) of any kind, whether written or oral, to
which the Company is a party or by or to which any of the properties or assets of the Company may be bound, subject or affected (including
without limitation notes or other instruments payable to the Company) and (ii) the term &#8220;<span style="text-decoration: underline">Material Company Contracts</span>&#8221;
shall mean (x) each Company Contract (A) providing for payments (present or future) to the Company in excess of $70,000.00 in the aggregate
or (B) under or in respect of which the Company presently has any liability or obligation of any nature whatsoever (absolute, contingent
or otherwise) in excess of $70,000.00, (y) each Company Contract that otherwise is or may be material to the businesses, operations,
assets, condition (financial or otherwise) or prospects of the Company, and (z) the limitations of subclause (x) and subclause (y) notwithstanding,
each of the following Company Contracts:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
any Company Contract with a Top Supplier or Top Customer;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 361; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
(x) any Company Contract relating to indebtedness having an outstanding principal amount, together with any undrawn commitments to fund
indebtedness under such Company Contract, in excess of $70,000.00 and (y) any outstanding letter of credit with commitments in excess
of $70,000.00;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
any guaranty, direct or indirect, by the Company of any indebtedness or other obligation of any third party (other than a Company Subsidiary)
in excess of $70,000.00, excluding endorsements made for collection in the ordinary course of business;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
any Company Contract for employment or for engagement of a consultant or independent contractor, or any similar Company Contract, with
any current officer or director, employee or other individual service provider of the Company that (i) provides for an annual base salary
or fee in excess of $70,000.00 or (ii) cannot be terminated upon thirty (30) days&#8217; notice or less without payment or liability;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
any Company Contract with any current or former officer or director, employee, or other individual service provider of the Company that
provides for change in control or transaction-based payments and/or benefits and triggered by the Merger;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
any Company Contract made other than in the ordinary course of business (x) providing for the grant of any preferential rights to purchase
or lease any asset of the Company or (y) providing for any right (exclusive or non-exclusive) to sell or distribute, or otherwise relating
to the sale or distribution of, any product or service of the Company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
any Company Contract for the acquisition or sale of any Person or any business unit thereof, by merger, consolidation, sale of assets
or otherwise, in each case, involving payments in excess of $70,000.00 and with respect to which there are any material ongoing obligations;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
any Company Contract which grants any Person a right of first refusal, right of first offer or similar right with respect to any material
properties, assets or businesses of the Company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
any joint venture, partnership or similar Company Contract (other than a Company Contract between wholly-owned Subsidiaries of the Company)
that is material to the Company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
any Company Contract under which the Company (x) is a licensee or otherwise receives any right with respect to any Intellectual Property
material to the Company or the operation of its business (excluding (A) non-exclusive click-wrap and shrink-wrap licenses and (B) non-exclusive
licenses for off-the-shelf software and other non-exclusive licenses of unmodified software that is commercially available to the public
generally, in each case with one-time or annual aggregate fees of less than $70,000.00), (y) is a licensor or otherwise grants to a third
party any rights to use any item of Intellectual Property, other than non-exclusive licenses or sublicenses granted to customers in the
ordinary course of business, or (z) is subject to any material restriction on the Company&#8217;s ability to use or exploit any Intellectual
Property;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 362; Options: NewSection; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
any obligation to register any Equity Securities or other securities of the Company with any Governmental Entity;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)
any obligation to make payments, contingent or otherwise, arising out of the prior acquisition of the business, all or substantially
all of the assets or stock of other Persons;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)
any collective bargaining agreement with any labor union;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)
any lease or similar arrangement for the use by the Company of real property or Personal Property where the annual lease payments are
greater than $70,000.00 (other than any lease of vehicles, office equipment or operating equipment made in the ordinary course of business);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv)
any Company Contract granting or purporting to grant, or otherwise in any way relating to, any mineral rights or any other interest (including,
without limitation, a leasehold interest) in real property;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi)
any Company Contract containing covenants of the Company (A) prohibiting or limiting the right of the Company to engage in or compete
with any Person in any line of business or (B) prohibiting or restricting the Company&#8217;s ability to conduct their business with
any Person in any geographic area, in each case, that currently has or would reasonably be expected to have a material and adverse effect
on the business, as currently operated, of the Company, in each case other than, for the avoidance of doubt, customary non-solicitation
and no-hire provisions entered into in the ordinary course of business;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvii)
any Company Contract that is a settlement, conciliation or similar agreement with any Governmental Entity or pursuant to which the Company
will have any material outstanding obligation after the date of this Agreement;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xviii)
(x) any mortgage, indenture, note, installment obligation or other instrument or agreement for or relating to any borrowing of money
by a Company Insider from the Company, or guarantee by the Company of any borrowing of money by a Company Insider from any Person, other
than in connection with the advancement of expenses to employees in the ordinary course of business, (y) any mortgage, indenture, note,
installment obligation or other instrument or agreement for or relating to any borrowing of money by the Company from a Company Insider,
or any guaranty by a Company Insider of any borrowing of money by the Company from any Person, other than in connection with the payment
of Company expenses (subject to reimbursement) in the ordinary course of business, and (z) any other Company Contract to which a Company
Insider, or any entity owned or controlled by a Company Insider, is a party; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 363; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xix)
any offer or proposal which, if accepted, would constitute any of the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each Material Company Contract was entered into at arms&#8217; length and in the ordinary course, is in full force and effect and, to
the Company&#8217;s Knowledge, is valid and binding upon and enforceable against each of the parties thereto, except insofar as enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217; rights generally
or by principles governing the availability of equitable remedies. To the Company&#8217;s Knowledge, no other party to a Material Company
Contract is the subject of a bankruptcy or insolvency proceeding. True, correct and complete copies of all Material Company Contracts
and all offers and proposals that, if accepted, would constitute Material Company Contracts (or written summaries in the case of oral
Material Company Contracts or offers or proposals) have been heretofore delivered to Parent or Parent&#8217;s counsel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Except as set forth in <span style="text-decoration: underline">Schedule 2.19,</span> neither the Company nor, to the best of the Company&#8217;s Knowledge, any other party thereto
is in breach of or in default under, and no event has occurred which with notice or lapse of time or both would become a breach of or
default under, any Company Contract, and no party to any Company Contract has given any written notice of any claim of any such breach,
default or event, which, individually or in the aggregate, are reasonably likely to have a Material Adverse Effect on the Company. Each
Material Company Contract that has not expired by its terms is in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20
<span style="text-decoration: underline">Insurance</span>. <span style="text-decoration: underline">Schedule 2.20</span> sets forth the Company&#8217;s insurance policies and fidelity and surety bonds covering the assets,
business, equipment, properties, operations, employees, officers and directors (collectively, the &#8220;<span style="text-decoration: underline">Insurance Policies</span>&#8221;).
The coverages provided by such Insurance Policies are adequate in amount and scope for the Company&#8217;s business and operations, including
any insurance required to be maintained by Company Contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21
<span style="text-decoration: underline">Governmental Actions/Filings</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
For purposes of this Agreement, &#8220;<span style="text-decoration: underline">Governmental Action/Filing</span>&#8221; shall mean any franchise, license, certificate of compliance,
authorization, consent, order, permit, approval, consent or other action of, or any filing, registration or qualification with, any Governmental
Entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Except as set forth in <span style="text-decoration: underline">Schedule 2.21(b)</span>, the Company has been granted and holds, and has made, all Governmental Actions/Filings
(including, without limitation, Governmental Actions/Filings required for emission or discharge of effluents and pollutants into the
air and the water) necessary to the conduct by the Company of its business (as presently conducted and as presently proposed to be conducted)
or used or held for use by the Company, and true, complete and correct copies of which have heretofore been delivered to Parent. Each
such Governmental Action/Filing is in full force and effect and, except as disclosed in <span style="text-decoration: underline">Schedule 2.21(b)</span>, will not expire prior
to December 31, 2025 and the Company is in substantial compliance with all of its obligations with respect thereto. No event has occurred
and is continuing which requires or permits, or after notice or lapse of time or both would require or permit, and consummation of the
Transactions and the transactions contemplated by the other Transaction Agreements will not require or permit (with or without notice
or lapse of time, or both), any modification or termination of any such Governmental Actions/Filings except such events which, either
individually or in the aggregate, would not have a Material Adverse Effect upon the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 364; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Except as set forth in <span style="text-decoration: underline">Schedule 2.21(c)</span>, no Governmental Action/Filing is necessary to be obtained, secured or made by the Company
to enable it to continue to conduct its businesses and operations and use its properties after the Closing in a manner which is consistent
with current practice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.22
<span style="text-decoration: underline">Interested Party Transactions</span>. Except as set forth in the <span style="text-decoration: underline">Schedule 2.22</span>, no Affiliate, employee, officer, director or shareholder
of the Company or a member of his or her immediate family, or any Affiliate of any of the foregoing (&#8220;<span style="text-decoration: underline">Interested Party</span>&#8221;),
is indebted to the Company, nor is the Company indebted (or committed to make loans or extend or guarantee credit) to any of such Persons,
other than (i) for payment of salary for services rendered, (ii) reimbursement for reasonable expenses incurred on behalf of the Company,
and (iii) for other employee benefits made generally available to all employees. Except as set forth in <span style="text-decoration: underline">Schedule 2.22</span>, to the
Company&#8217;s Knowledge, no Interested Party has any direct or indirect ownership or other financial interest in any Person with whom
the Company is affiliated or with whom the Company has a contractual or other business relationship, or in any Person that competes with
the Company, except that each Insider and members of their respective immediate families may own less than 5% of the outstanding stock
in publicly traded companies that may compete with the Company. Except as set forth in <span style="text-decoration: underline">Schedule 2.22</span>, to the Knowledge of the
Company, no Insider or Interested Party is, directly or indirectly, interested in any Material Company Contract (other than such contracts
as relate to any such Person&#8217;s ownership of capital stock or other securities of the Company or such Person&#8217;s employment
with the Company). All Company Contracts and transaction documents set forth in the Schedule 2.22 were entered into by the parties thereto
on an arm&#8217;s-length basis and have no Material Adverse Effect on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.23
<span style="text-decoration: underline">Top Customers and Top Suppliers</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Schedule 2.23(a)</span> sets forth a true, correct and complete list of the names of the top ten (10) customers by dollar sales volume
paid by such customers to the Company for the year ended December 31, 2022 (each, a &#8220;<span style="text-decoration: underline">Top Customer</span>&#8221;). None of the Top
Customers has (i) terminated or given written notice to the Company expressly stating its intention to terminate its relationship with
the Company, (ii) given written notice to the Company expressly stating that, following the date of this Agreement, it plans to reduce
substantially the quantity of products or services that it purchases from the Company, or (iii) given written notice to the Company expressly
stating that, following the date of this Agreement, it desires to renegotiate its Contract with the Company or the terms on which the
Company provides services to such Top Customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Schedule 2.23(b)</span> sets forth a true, correct and complete list of the names of the top ten (10) suppliers by dollar sales volume
paid by the Company to such supplier for the year ended December 31, 2022 (each, a &#8220;<span style="text-decoration: underline">Top Supplier</span>&#8221;). None of the Top
Suppliers has (i) terminated or given written notice to the Company expressly stating its intention to terminate its relationship with
the Company, (ii) given written notice to the Company expressly stating that, following the date of this Agreement, it plans to reduce
substantially the quantity of products or services that it provides to the Company, or (iii) given written notice to the Company expressly
stating that, following the date of this Agreement, that it desires to renegotiate its Contract with the Company or the terms on which
the Company receives services or products from such Top Supplier.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 365; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.24
<span style="text-decoration: underline">Board Approval</span>. The board of directors of the Company (including any required committee or subgroup thereof) has, as of the date
of this Agreement, duly approved this Agreement and the Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.25
<span style="text-decoration: underline">No Additional Representations and Warranties</span><span style="background-color: white">. Except as otherwise expressly provided in
this <span style="text-decoration: underline">ARTICLE II</span> (as modified by the Company Schedules) and in any Ancillary Agreement, neither the Company, any Company Subsidiary,
any of their respective Affiliates, nor any of their respective directors, officers, employees, stockholders, partners, members or representatives
has made, or is making, any other express or implied representation or warranty whatsoever with respect to the Company, its Affiliates,
and any matter relating to any of them, including their affairs, the condition, value or quality of their assets, liabilities, financial
condition or results of operations, or with respect to the accuracy or completeness of any other information made available to Parent,
its Affiliates or any of their respective representatives by, or on behalf of, Company, and any such representations or warranties are
expressly disclaimed. Without limiting the generality of the foregoing, except as expressly set forth in this Agreement, neither the
Company nor any other person on behalf of Company has made or makes, any representation or warranty, whether express or implied, with
respect to any projections, forecasts or estimates or budgets made available to Parent, its Affiliates or any of their respective representatives
of future revenues, future results of operations (or any component thereof), future cash flows or future financial condition (or any
component thereof) of the Company, whether or not included in any management presentation or in any other information made available
to Parent, its Affiliates or any of their respective representatives or any other person, and that any such representations or warranties
are expressly disclaimed.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.26
<span style="text-decoration: underline">Independent Investigation; No Reliance</span><span style="background-color: white">. Each of the Company and NewCo is a sophisticated
purchaser and has conducted its own independent investigation, verification, review and analysis of the business, operations, assets,
liabilities, results of operations, financial condition, technology and prospects of Parent and Merger Sub, which investigation, review
and analysis was conducted by the Company and NewCo together with expert advisors, including legal counsel, that they have engaged for
such purpose. The Company and NewCo and their representatives have been provided with full and complete access to the representatives,
properties, offices, plants and other facilities, books and records of Parent and Merger Sub and other information that they have requested
in connection with their investigation of Parent and Merger Sub and the Transactions. In entering into this Agreement, each of the Company
and NewCo acknowledges that it has relied solely upon the aforementioned investigation, review and analysis and the representations and
warranties of Parent and Merger Sub expressly set forth in <span style="text-decoration: underline">ARTICLE III</span> of this Agreement (as modified by the Parent Schedule).
Neither the Company nor NewCo is relying on any statement, representation or warranty, oral or written, express or implied, made by Parent
or Merger Sub or any of their respective representatives, except as expressly set forth in <span style="text-decoration: underline">ARTICLE III</span> (as modified by the Parent
Schedule)</span>. <span style="background-color: white">The Company and NewCo further acknowledges and agrees with the representations
and warranties of Parent and Merger Sub set forth in </span><span style="text-decoration: underline">Section 3.25</span><span style="background-color: white">.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 366; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27
<span style="text-decoration: underline">Survival of Representations, Warranties, Covenants and Agreements</span>. The representations, warranties, covenants and agreements of
the Company and NewCo set forth in this Agreement shall survive the Closing as set forth in <span style="text-decoration: underline">Section 7.5(a)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III<br/>
REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the exceptions set forth in <span style="text-decoration: underline">Schedule 3</span> attached hereto (the &#8220;<span style="text-decoration: underline">Parent Schedule</span>&#8221;), and except as set forth
in the Parent SEC Reports (as defined in <span style="text-decoration: underline">Section 3.7</span>), Parent and Merger Sub, jointly and severally, hereby represent and warrant
to, and covenants with, the Company and NewCo, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<span style="text-decoration: underline">Organization and Qualification</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Each of Parent and Merger Sub is an exempted company duly incorporated, validly existing and in good standing under the laws of the Cayman
Islands and has the requisite corporate power and authority to own, lease and operate its assets and properties and to carry on its business
as it is now being conducted. Each of Parent and Merger Sub is in possession of all Approvals necessary to own, lease and operate the
properties it purports to own, operate or lease and to carry on its business as it is now being conducted, except where the failure to
have such Approvals would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on Parent.
Complete and correct copies of the Charter Documents of each of Parent and Merger Sub, as amended and currently in effect, have been
heretofore delivered to the Company. Parent and Merger Sub are not and have not at any time been in default or violation of any term,
condition or provision of their respective Charter Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each of Parent and Merger Sub is duly qualified or licensed to do business as a foreign corporation and is in good standing, in each
jurisdiction where the character of the properties owned, leased or operated by it or the nature of its activities makes such qualification
or licensing necessary, except for such failures to be so duly qualified or licensed and in good standing that could not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect on Parent. Each jurisdiction in which Parent or Merger
Sub is so qualified or licensed is listed in <span style="text-decoration: underline">Schedule 3.1</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<span style="text-decoration: underline">Subsidiaries</span>. As of the Agreement Date, Parent has no, and has never had any, direct or indirect Subsidiaries, other than Merger
Sub, and Merger Sub has no, and has never had any, direct or indirect Subsidiaries. Parent owns all of the outstanding equity securities
of Merger Sub, free and clear of all Liens. Except for Parent&#8217;s ownership of Merger Sub, neither Parent nor Merger Sub owns, directly
or indirectly, any equity or voting interest in any Person or has any agreement or commitment to purchase any such interest, and has
not agreed and is not obligated to make nor is bound by any written or oral agreement, contract, subcontract, lease, binding understanding,
instrument, note, option, warranty, purchase order, license, sublicense, insurance policy, benefit plan, commitment or undertaking of
any nature, as of the Agreement Date or as may hereafter be in effect under which it may become obligated to make, any future investment
in or capital contribution to any other Person. Merger Sub does not have any assets or properties of any kind, does not now conduct and
has never conducted any business, and has and will have at the Closing no obligations or liabilities of any nature whatsoever, except
for such obligations as are imposed under this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 367; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<span style="text-decoration: underline">Capitalization</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The authorized share capital of Parent consists of (i) 200,000,000 Parent Ordinary Shares, of which 9,166,500 Parent Ordinary Shares
are issued and outstanding as of the date of this Agreement, all of which are validly issued, fully paid and nonassessable, and (ii)
2,000,000 preference shares, par value $0.0001 per share (&#8220;<span style="text-decoration: underline">Parent Preference Shares</span>&#8221;), of which no Parent Preference
Shares are issued or outstanding as of the date of this Agreement. The authorized share capital of Merger Sub consists of 1,000 Merger
Sub Ordinary Shares, of which 1,000 are issued and outstanding as of the date of this Agreement, all of which are validly issued, fully
paid and nonassessable. Other than Parent Ordinary Shares and Parent Preference Shares and the Merger Sub Ordinary Shares, neither Parent
nor Merger Sub has any Equity Securities authorized or outstanding. All of the issued and outstanding Merger Sub Ordinary Shares are
owned beneficially and of record by Parent, free and clear of all Liens.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
As of the date of this Agreement, 726,150 Parent Ordinary Shares are reserved for issuance upon exchange of the Parent&#8217;s outstanding
rights (&#8220;<span style="text-decoration: underline">Parent Rights</span>&#8221;), each of which entitles the holder thereof to receive one-tenth of one Parent Ordinary Share
upon the completion of an initial business combination by Parent. All Parent Ordinary Shares subject to issuance pursuant to the Parent
Rights, upon issuance on the terms and conditions specified in the instrument pursuant to which they are issuable, will be duly authorized,
validly issued, fully paid and nonassessable. Parent has heretofore delivered to the Company true, complete and accurate copies of the
Parent Rights, including any and all documents and agreements relating thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
All outstanding Parent Ordinary Shares and Parent Rights have been issued and granted in compliance with (x) all applicable Legal Requirements
and preemptive or similar rights, and (y) all requirements set forth in any applicable Parent Contracts (as defined in <span style="text-decoration: underline">Section 3.19</span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Except as set forth in <span style="text-decoration: underline">Schedule 3.3(d)</span> or as contemplated by this Agreement, there are no subscriptions, options, warrants, rights
(including preemptive rights), convertible, exchangeable or similar securities, or other plans, commitments or agreements of any character,
to which Parent or Merger Sub or any of their Subsidiaries is a party or by which Parent or Merger Sub or any of their Subsidiaries is
bound, obligating or providing for Parent or Merger Sub or any of their Subsidiaries to issue, deliver or sell, or cause to be issued,
delivered or sold any Equity Securities of Parent or Merger Sub or any of their Subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Except as set forth in <span style="text-decoration: underline">Schedule 3.3(e)</span> or as contemplated by this Agreement, there are no subscriptions, options, warrants, rights,
redeemable or similar securities, or other plans, commitments or agreements of any character, to which Parent or Merger Sub or any of
their Subsidiaries is a party or by which Parent or Merger Sub or any of their Subsidiaries is bound, obligating or providing for Parent
or Merger Sub or any of their Subsidiaries to repurchase, redeem or otherwise acquire, or cause the repurchase, redemption or acquisition
of, any Equity Securities of Parent or Merger Sub or any of their Subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 368; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Except as set forth in <span style="text-decoration: underline">Schedule 3.3(f)</span> or as contemplated by this Agreement, there are no registrations rights, and there is no
voting trust, proxy, rights plan, anti-takeover plan or other agreements or understandings, to which Parent or Merger Sub or any of their
Subsidiaries is a party or by which Parent or Merger Sub or any of their Subsidiaries is bound with respect to any Equity Securities
of the Parent or Merger Sub or any of their Subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Except as provided for in this Agreement or as set forth in <span style="text-decoration: underline">Schedule 3.3(g)</span>, as a result of the consummation of the Transactions,
no Equity Securities of Parent or Merger Sub or any of their Subsidiaries are issuable and no rights in connection with any such Equity
Securities accelerate or otherwise become triggered (whether as to vesting, exercisability, convertibility or otherwise).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
No outstanding Parent Ordinary Shares are unvested or subjected to a repurchase option, risk of forfeiture or other condition under any
applicable agreement with Parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The shares of Parent Ordinary Shares to be issued by Parent in connection with the Merger, upon issuance in accordance with the terms
of this Agreement, will be duly authorized and validly issued and such shares of Parent Ordinary Shares will be fully paid and nonassessable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
<span style="text-decoration: underline">Authority Relative to this Agreement</span>. Each of Parent and Merger Sub has full corporate power and authority to: (i) execute, deliver
and perform this Agreement, and each ancillary document that Parent or Merger Sub has executed or delivered or is to execute or deliver
pursuant to this Agreement, and (ii) carry out each of Parent&#8217;s and Merger Sub&#8217;s obligations hereunder and thereunder and,
to consummate the Transactions (including the Merger) and the transactions contemplated by the other Transaction Agreements. The execution
and delivery of this Agreement by Parent and Merger Sub and the consummation by Parent and Merger Sub of the Transactions (including
the Merger) and the transactions contemplated by the other Transaction Agreements (other than the authorization, filing and/or registration
of the Plan of Merger, the Name Change Amendment, the Capitalization Amendment, the change of directors of SPAC in accordance with Section
5.2 and the A&amp;R Memorandum and Articles of Association, as applicable) have been duly and validly authorized by all necessary corporate
action on the part of Parent and Merger Sub (including the approval by its board of directors),and no other corporate proceedings on
the part of Parent or Merger Sub are necessary to authorize this Agreement or to consummate the Transactions and the transactions contemplated
by the other Transaction Agreements, other than the Parent Shareholder Approval (as defined in <span style="text-decoration: underline">Section 5.1(a))</span>, the authorization,
filing and registration of the Plan of Merger, the Name Change Amendment, the Capitalization Amendment, the change of directors of the
Parent in accordance with Section 5.2 and the adoption of the A&amp;R Memorandum and Articles of Association, as applicable). This Agreement
has been duly and validly executed and delivered by Parent and Merger Sub and, assuming the due authorization, execution and delivery
thereof by the other Parties hereto, constitutes the legal and binding obligation of Parent and Merger Sub, enforceable against Parent
and Merger Sub in accordance with its terms, except as may be limited by bankruptcy, insolvency, reorganization or other similar laws
affecting the enforcement of creditors&#8217; rights generally and by general principles of equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 369; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5
<span style="text-decoration: underline">No Conflict; Required Filings and Consents</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The execution and delivery of this Agreement by each of Parent and Merger Sub does not, and the performance of this Agreement by Parent
and Merger Sub shall not: (i) conflict with or violate Parent&#8217;s or Merger Sub&#8217;s Charter Documents, as the case may be, (ii)
conflict with or violate any Legal Requirements, or (iii) result in any breach of or constitute a default (or an event that with notice
or lapse of time or both would become a default) under, or materially impair Parent&#8217;s or Merger Sub&#8217;s rights or alter the
rights or obligations of any third party under, or give to others any rights of termination, amendment, acceleration or cancellation
of, or result in the creation of a Lien on any of the properties or assets of Parent or Merger Sub pursuant to, any Parent Contracts,
except, with respect to clauses (ii) or (iii), for any such conflicts, violations, breaches, defaults or other occurrences that would
not, individually and in the aggregate, have a Material Adverse Effect on Parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The execution and delivery of this Agreement by Parent or Merger Sub does not, and the performance of its obligations hereunder will
not, require any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Entity, except (i)
for applicable requirements, if any, of the Securities Act, the Exchange Act, blue sky laws, and the rules and regulations thereunder,
(ii) for the qualification of Parent as a foreign corporation in those jurisdictions in which the business of the Company makes such
qualification necessary, (iii) for the filing of the Plan of Merger and other necessary documents to effect the Merger with the Cayman
Registrar, (iv) for the filing of the Name Change Amendment, the Capitalization Amendment, the A&amp;R Memorandum and Articles of Association,
together with the special resolutions passed by the Parent, with the Cayman Registrar, (v) for the notification required under the HSR
Act, (vi) for the CFIUS Approval, and (vii) where the failure to obtain such consents, approvals, authorizations or permits, or to make
such filings or notifications, would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect
on Parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6
<span style="text-decoration: underline">Compliance</span>. Parent and Merger Sub are in compliance with and not in violation of, and during the last three (3) years, have been
in compliance with and not in violation of, any Legal Requirements with respect to the conduct of their business, or the ownership or
operation of their business, except for failures to comply or violations which, individually or in the aggregate, have not had and are
not reasonably likely to have a Material Adverse Effect on Parent. Except as set forth in <span style="text-decoration: underline">Schedule 3.6</span>, no written notice of non-compliance
with any Legal Requirements has been received by Parent or Merger Sub (and Parent and Merger Sub have no Knowledge of any such notice
delivered to any other Person) during the last three (3) years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7
<span style="text-decoration: underline">Parent SEC Reports and Financial Statements</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Parent has timely filed all required registration statements, reports, schedules, forms, statements and other documents required
to be filed by it with the SEC since July 11, 2023 (collectively, as they have been amended since the time of their filing and including
all exhibits thereto, the &#8220;<span style="text-decoration: underline">Parent SEC Reports</span>&#8221;). None of the Parent SEC Reports, as of their respective dates (or
if amended or superseded by a filing prior to the date of this Agreement or the Closing Date, then on the date of such filing), contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 370; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The audited consolidated financial statements (including any related notes thereto) of Parent as of February 28, 2023, and the related
statements of operations, shareholders&#8217; equity, and cash flows for the period from February 17, 2023 (inception) through February
28, 2023 (the &#8220;<span style="text-decoration: underline">Parent Audited Financial Statements</span>&#8221;) and the unaudited consolidated financial statements (including
any related notes thereto) of Parent for the period ended September 30, 2023 (the &#8220;<span style="text-decoration: underline">Parent Unaudited Financial Statements</span>,&#8221;
and together with the Parent Audited Financial Statements, the &#8220;<span style="text-decoration: underline">Parent Financial Statements</span>&#8221;) are set forth in the
Parent SEC Reports.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Parent Financial Statements comply as to form in all material respects, and were prepared in accordance, with U.S. generally accepted
accounting principles (&#8220;<span style="text-decoration: underline">U.S. GAAP</span>&#8221;) applied on a consistent basis throughout the periods involved (except as otherwise
indicated in such statements and except that the Parent Unaudited Financial Statements may exclude the footnote disclosures and other
presentation items required for U.S. GAAP and may exclude normal and immaterial year-end adjustments). The Parent Financial Statements
fairly present in all material respects the financial position of Parent and its Subsidiaries as of the respective dates thereof and
the consolidated results of the operations, changes in stockholders&#8217; equity and cash flows of Parent and its Subsidiaries for the
periods indicated (except that the Parent Unaudited Financial Statements may exclude the footnote disclosures and other presentation
items required for U.S. GAAP and may exclude normal and immaterial year-end adjustments).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The books of account, minute books and transfer ledgers and other similar books and records of Parent and its Subsidiaries have been
maintained in accordance with good business practice, are complete and correct in all material respects and there have been no material
transactions that are required to be set forth therein and which have not been so set forth.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Except as otherwise noted in the Parent Financial Statements, the accounts and notes receivable of Parent and its Subsidiaries reflected
in the Parent Financial Statements: (i) arose from bona fide sales transactions in the ordinary course of business and are payable on
ordinary trade terms, (ii) are legal, valid and binding obligations of the respective debtors enforceable in accordance with their terms,
except as such may be limited by bankruptcy, insolvency, reorganization, or other similar laws affecting creditors&#8217; rights generally,
and by general equitable principles, (iii) are not subject to any valid set-off or counterclaim to which Parent has been notified in
writing as of the date hereof except to the extent set forth in such balance sheet contained therein, and (iv) are not the subject of
any actions or proceedings brought by or on behalf of Parent or any of its Subsidiaries as of the date hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Parent has established and maintains disclosure controls and procedures (as defined in Rule 13a-15 under the Exchange Act). Such disclosure
controls and procedures are designed to ensure that material information relating to Parent is made known to Parent&#8217;s principal
executive officer and its principal financial officer, particularly during the periods in which the periodic reports required under the
Exchange Act are being prepared. To Parent&#8217;s Knowledge, such disclosure controls and procedures are effective in timely alerting
Parent&#8217;s principal executive officer and principal financial officer to material information required to be included in Parent&#8217;s
periodic reports required under the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 371; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
There are no outstanding loans or other extensions of credit made by Parent to any executive officer (as defined in Rule 3b-7 under the
Exchange Act) or director of Parent. Parent has not taken any action prohibited by Section 402 of the Sarbanes-Oxley Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8
<span style="text-decoration: underline">No Undisclosed Liabilities</span>. Except as set forth in <span style="text-decoration: underline">Schedule 3.8</span>, neither Parent nor Merger Sub has any liabilities or obligations
(absolute, accrued, contingent or otherwise) of a nature required to be reflected or reserved for on a balance sheet prepared in accordance
with U.S. GAAP or in the related notes thereto, except liabilities and obligations (i) reflected or reserved for in the Parent Financial
Statements or disclosed in any notes thereto, (ii) incurred or arising under or in connection with the Transactions, including expenses
related thereto, or (iii) incurred or arising in the ordinary course of business consistent with past practice since the date of the
most recent balance sheet included in the Parent Financial Statements, provided such liabilities and obligations, individually or in
the aggregate, would not have a Material Adverse Effect on the Parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9
<span style="text-decoration: underline">Absence of Certain Changes or Events</span>. Except as set forth in Parent SEC Reports filed prior to the date of this Agreement, and
except as contemplated by this Agreement, since the date of the most recent balance sheet included in the Parent Financial Statement,
there has not been: (i) any Material Adverse Effect on Parent, (ii) any declaration, setting aside or payment of any dividend on, or
other distribution (whether in cash, stock or property) in respect of, any of Parent&#8217;s capital stock, or any purchase, redemption
or other acquisition by Parent of any of Parent&#8217;s capital stock or any other securities of Parent or any options, warrants, calls
or rights to acquire any such shares or other securities, (iii) any split, combination or reclassification of any of Parent&#8217;s capital
stock, (iv) any granting by Parent of any increase in compensation or fringe benefits, except for normal increases of cash compensation
in the ordinary course of business consistent with past practice, or any payment by Parent of any bonus, except for bonuses made in the
ordinary course of business consistent with past practice, or any granting by Parent of any increase in severance or termination pay
or any entry by Parent into any currently effective employment, severance, termination or indemnification agreement or any agreement
the benefits of which are contingent or the terms of which are materially altered upon the occurrence of a transaction involving Parent
of the nature contemplated hereby, (v) entry by Parent into any licensing or other agreement with regard to the acquisition or disposition
of any Intellectual Property other than licenses in the ordinary course of business consistent with past practice or any amendment or
consent with respect to any licensing agreement filed or required to be filed by Parent with respect to any Governmental Entity, (vi)
any material change by Parent in its accounting methods, principles or practices, except as required by concurrent changes in U.S. GAAP,
(vii) any change in the auditors of Parent, (viii) any issuance of capital stock of Parent, or (ix) any revaluation by Parent of any
of its assets, including, without limitation, writing down the value of capitalized inventory or writing off notes or accounts receivable
or any sale of assets of Parent other than in the ordinary course of business consistent with past practice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10
<span style="text-decoration: underline">Litigation</span>. There are no claims, suits, actions or proceedings pending or to Parent&#8217;s Knowledge, threatened against Parent
or Merger Sub, before any Governmental Entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 372; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11
<span style="text-decoration: underline">Employee Benefit Plans</span>. Neither Parent nor Merger Sub maintains, and has no liability under, any Plan, and neither the execution
and delivery of this Agreement nor the consummation of the Transactions will (i) result in any payment (including severance, unemployment
compensation, golden parachute, bonus, or otherwise) becoming due to any stockholder, director, or employee of Parent or Merger Sub,
or (ii) result in the acceleration of the time of payment or vesting of any such benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12
<span style="text-decoration: underline">Labor Matters</span>. Neither Parent nor Merger Sub is a party to any collective bargaining agreement or other labor union contract applicable
to persons employed by Parent or Merger Sub and neither Parent nor Merger Sub knows of any activities or proceedings of any labor union
to organize any such employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13
<span style="text-decoration: underline">Business Activities</span>. Since its organization, Parent has not conducted any business activities other than activities directed toward
the accomplishment of a business combination. Merger Sub was created for the purpose of facilitating the Merger and has not conducted
any prior business activities or incurred any liabilities, other than any such activities or liabilities incidental to consummating the
Merger. Except as set forth in the Parent Charter Documents, there is no agreement, commitment, exclusive license, judgment, injunction,
order, or decree binding upon Parent or Merger Sub or to which Parent or Merger Sub is a party which has or would reasonably be expected
to have the effect of prohibiting or materially impairing any business practice of Parent or Merger Sub, any acquisition of property
by Parent or Merger Sub, or the conduct of business by Parent or Merger Sub.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.14
<span style="text-decoration: underline">Title to Property</span>. Neither Parent nor Merger Sub owns or leases any real property or personal property. Except as set forth in
<span style="text-decoration: underline">Schedule 3.14</span>, as of the date of this Agreement, there are no options or other contracts under which Parent or Merger Sub has
a right or obligation to acquire or lease any interest in real property or personal property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.15
<span style="text-decoration: underline">Taxes</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Tax Returns and Audits</span>. Except as set forth in <span style="text-decoration: underline">Schedule 3.15</span>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Each of Parent and Merger Sub has timely filed all Returns required to be filed by Parent and Merger Sub with any Tax authority prior
to the date hereof. All such Returns are true, correct and complete. Parent and Merger Sub has paid all Taxes due with respect to such
Returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
All Taxes that Parent or Merger Sub is required by law to withhold or collect have been duly withheld or collected, and have been timely
paid over to the proper governmental authorities to the extent due and payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 373; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Neither Parent nor Merger Sub has been delinquent in the payment of any Tax that has not been accrued for in Parent&#8217;s books and
records of account for the period for which such Tax relates nor is there any Tax deficiency outstanding, proposed or assessed against
Parent, nor has Parent executed any unexpired waiver of any statute of limitations on or extending the period for the assessment or collection
of any Tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
To the Knowledge of Parent, no audit or other examination of any Return of Parent or Merger Sub by any Tax authority is presently in
progress, nor has Parent or Merger Sub been notified of any request for such an audit or other examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
No adjustment relating to any Returns filed by Parent or Merger Sub has been proposed in writing, formally or informally, by any Tax
authority to Parent or Merger Sub or any representative thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
Neither Parent nor Merger Sub has any liability for any unpaid Taxes which have not been accrued for or reserved on Parent&#8217;s balance
sheets included in the audited financial statements for the most recent fiscal year ended, whether asserted or unasserted, contingent
or otherwise, other than any liability for unpaid Taxes that may have accrued since the end of the most recent fiscal year in connection
with the operation of the business of Parent in the ordinary course of business, none of which is material to the business, results of
operations or financial condition of Parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16
<span style="text-decoration: underline">Environmental Matters</span>. Except for such matters that, individually or in the aggregate, would not reasonably be expected to result
in a material liability of Parent and Merger Sub, taken as a whole: (i) Parent and Merger Sub have complied in all material respects
with applicable Environmental Laws; (ii) none of Parent or Merger Sub or, the Knowledge of Parent, any third party, has caused any properties
currently owned, leased or operated by Parent and Merger Sub to be contaminated with any Hazardous Substances; (iii) the properties formerly
owned, leased or operated by Parent and Merger Sub were not contaminated with Hazardous Substances during the period of ownership, leasing
or operation by Parent or Merger Sub; (iv) as of the Agreement Date, neither Parent nor Merger Sub has received notice that it is potentially
liable for any Hazardous Substance disposal or contamination on any third party or public property (whether above, on, or below ground
or in the atmosphere or water); (v) as of the Agreement Date, neither Parent nor Merger Sub has received any written notice, demand,
letter, claim, or request for information alleging that Parent or Merger Sub may be in material violation of or have material liability
under any Environmental Law; and (vi) neither Parent nor Merger Sub is subject to any orders, decrees, injunctions, or other arrangements
with any Governmental Entity or subject to any contractual indemnity or other agreement with any third party relating to a material liability
under any Environmental Law, including in relation to Hazardous Substances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.17
<span style="text-decoration: underline">Brokers</span>. Except as set forth in <span style="text-decoration: underline">Schedule 3.17</span>, neither Parent nor Merger Sub has incurred, nor will either incur, directly
or indirectly, any liability for brokerage or finders&#8217; fees or agent&#8217;s commissions or any similar charges in connection with
this Agreement or any transaction contemplated hereby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.18
<span style="text-decoration: underline">Intellectual Property</span>. Neither Parent nor Merger Sub owns, licenses, or otherwise has any right, title or interest in any material
Intellectual Property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 374; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19
<span style="text-decoration: underline">Agreements, Contracts and Commitments</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Except as set forth in the Parent SEC Reports filed prior to the Agreement Date or as set forth on <span style="text-decoration: underline">Schedule 3.19</span>, other than confidentiality
and non-disclosure agreements, there are no contracts, agreements, leases, mortgages, indentures, notes, bonds, Liens, license, permit,
franchise, purchase orders, sales orders or other understandings, commitments or obligations (including without limitation outstanding
offers or proposals) of any kind, whether written or oral, to which Parent or Merger Sub is a party or by or to which any of the properties
or assets of Parent or Merger Sub may be bound, subject or affected, which may not be cancelled without penalty or liability by Parent
or Merger Sub on less than thirty (30) days&#8217; or less prior notice (&#8220;<span style="text-decoration: underline">Parent Contracts</span>&#8221;). All Parent Contracts
as of the Agreement Date are listed in <span style="text-decoration: underline">Schedule 3.19</span> other than those that are exhibits to the Parent SEC Reports.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Except as set forth in the Parent SEC Reports filed prior to the Agreement Date, each Parent Contract is in full force and effect, and,
to the Knowledge of Parent, is valid and binding upon and enforceable against each of the parties thereto, except insofar as enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, or similar laws affecting creditors&#8217; rights generally
or by principles governing the availability of equitable remedies. True, correct, and complete copies of all Parent Contracts (or written
summaries in the case of oral Parent Contracts) have been heretofore made available to the Company or Company counsel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Neither Parent or Merger Sub nor, to the Knowledge of Parent, any other party thereto is in breach of or in default under, and, to the
Knowledge of Parent, no event has occurred which with notice or lapse of time or both would become a breach of or default under, any
Parent Contract, and no party to any Parent Contract has given any written notice of any claim of any such breach, default or event,
which, individually or in the aggregate, are reasonably likely to have a Material Adverse Effect on Parent or Merger Sub. Each Parent
Contract that has not expired by its terms is in full force and effect, except where such failure to be in full force and effect is not
reasonably likely to have a Material Adverse Effect on Parent or Merger Sub.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.20
<span style="text-decoration: underline">Insurance</span>. Except for directors&#8217; and officers&#8217; liability insurance, neither Parent nor Merger Sub maintains any Insurance
Policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21
<span style="text-decoration: underline">Interested Party Transactions</span>. Except as set forth in the SEC Reports filed prior to the date of this Agreement, no employee,
officer, director, or stockholder of Parent or Merger Sub or a member of his or her immediate family is indebted to Parent or Merger
Sub, nor is Parent or Merger Sub indebted (or committed to make loans or extend or guarantee credit) to any of such Persons, other than
reimbursement for reasonable expenses incurred on behalf of Parent or Merger Sub. Except as set forth in the SEC Reports filed prior
to the date of this Agreement, to Parent&#8217;s Knowledge, no employee, officer, director, or stockholder or any member of his or her
immediate family is, directly or indirectly, interested in any material Parent Contract (other than such contracts as relate to the acquisition
of such stockholder&#8217;s ownership of capital stock or other securities of Parent).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.22
<span style="text-decoration: underline">Nasdaq Listing</span>. The Parent Ordinary Shares and Parent Rights are listed for trading on The Nasdaq Stock Market LLC (the &#8220;<span style="text-decoration: underline">Nasdaq</span>&#8221;).
There is no action or proceeding pending or, to Parent&#8217;s Knowledge, threatened against Parent by Nasdaq with respect to any intention
by such entity to prohibit or terminate the listing of Parent Ordinary Shares or Parent Rights on Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 375; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.23
<span style="text-decoration: underline">Board Approval</span>. The board of directors of each of Parent and Merger Sub has, as of the Agreement Date, unanimously (i) declared
the advisability of the Merger and approved this Agreement and the Transactions in accordance with the Charter Documents of Parent and
Merger Sub (except for the approval of the Plan of Merger, which shall be obtained prior to the execution of such Plan of Merger), (ii)
determined that the Merger is in the best interests of the shareholders of Parent and Merger Sub, and (iii) determined that the fair
market value of the Company is equal to at least 80% of the balance in the Trust Fund (net of amounts previously disbursed to management
for tax obligations and excluding the amount of deferred underwriting discounts held in trust). The sole shareholder of the Merger Sub
has approved and adopted this Agreement, the Merger and the Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.24
<span style="text-decoration: underline">Trust Fund</span>. As of the date of this Agreement, Parent has approximately $69,690,000 invested in United States Government securities
or money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act of 1940 in a trust account
administered by Continental (the &#8220;<span style="text-decoration: underline">Trust Fund</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.25
<span style="text-decoration: underline">No Additional Representations and Warranties</span><span style="background-color: white">. Except as otherwise expressly provided in
this <span style="text-decoration: underline">ARTICLE III</span></span> (<span style="background-color: white">as modified by the Parent Schedule) and in any Ancillary Agreement,
neither Parent, Merger Sub, any of their respective Affiliates, nor any of their respective directors, officers, employees, stockholders,
partners, members or representatives has made, or is making, any other express or implied representation or warranty whatsoever with
respect to Parent, Merger Sub, their respective Affiliates, and any matter relating to any of them, including their affairs, the condition,
value or quality of their assets, liabilities, financial condition or results of operations, or with respect to the accuracy or completeness
of any other information made available to the Company, its Affiliates or any of their respective representatives by, or on behalf of,
Parent or Merger Sub, and any such representations or warranties are expressly disclaimed. </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.26
<span style="text-decoration: underline">Independent Investigation; No Reliance</span>. <span style="background-color: white">Each of Parent and Merger Sub is a sophisticated
purchaser and has made its own independent investigation, review and analysis regarding the Company and the Company Subsidiaries and
the Transactions, which investigation, review and analysis were conducted by Parent and Merger Sub together with expert advisors, including
legal counsel, that they have engaged for such purpose. Parent, Merger Sub and their representatives have been provided with full and
complete access to the representatives, properties, offices, plants and other facilities, books and records of the Company and the Company
Subsidiaries and other information that they have requested in connection with their investigation of the Company and the Company Subsidiaries
and the Transactions. In entering into this Agreement, each of Parent and Merger Sub acknowledges that it has relied solely upon the
aforementioned investigation, review and analysis and the representations and warranties of the Company and NewCo expressly set forth
in <span style="text-decoration: underline">ARTICLE II</span> of this Agreement (as modified by the Company Schedule). Neither Parent nor Merger Sub is relying on any statement,
representation or warranty, oral or written, express or implied, made by the Company or NewCo or any of their respective representatives,
except as expressly set forth in <span style="text-decoration: underline">ARTICLE II</span></span> (<span style="background-color: white">as modified by the Company Schedule).
The Company and NewCo further acknowledges and agrees with the representations and warranties of Parent and Merger Sub set forth in </span><span style="text-decoration: underline">Section
2.25</span><span style="background-color: white">.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 376; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.27
<span style="text-decoration: underline">Non-Survival of Representations, Warranties, Covenants and Agreements</span>. The representations, warranties, covenants and agreements
of Parent and Merger Sub contained in or made pursuant to this Agreement, or contained in or made pursuant to any certificate or instrument
delivered by Parent or Merger Sub pursuant to this Agreement, shall terminate and expire at the Closing (and there shall be no liability
after the Closing in respect thereof), and, from and after the Closing, no action, suit or other proceeding, whether in contract or tort
or otherwise, whether at law or equity or otherwise, shall be brought and no recourse shall be had against or from any Person in respect
of such non-surviving representations, warranties, covenants and agreements, including for any misrepresentation or any breach of any
warranty, covenant, or other provision contained in or made pursuant to this Agreement, or contained in or made pursuant to any certificate
or instrument delivered by Parent or Merger Sub pursuant to this Agreement, or otherwise relating to the subject matter of this Agreement,
except for (a) those covenants and agreements contained herein that by their terms expressly apply in whole or in part after the Closing
and then only with respect to any breaches to the extent occurring after the Closing, including without limitation <span style="text-decoration: underline">Sections 5.5(a)
</span>(Confidentiality), <span style="text-decoration: underline">5.9</span> (No Claim Against Trust Fund), <span style="text-decoration: underline">5.23</span> (Fees and Expenses), and <span style="text-decoration: underline">ARTICLE X</span> (General Provisions).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV<br/>
CONDUCT PRIOR TO THE EFFECTIVE TIME</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<span style="text-decoration: underline">Conduct of Business by the Company and NewCo and Parent and Merger Sub</span>. During the period from the date of this Agreement and
continuing until the earlier of the termination of this Agreement pursuant to its terms or the Closing, each of the Company and NewCo,
on one hand, and Parent and Merger Sub, on the other hand, except to the extent that the other Party shall otherwise consent in writing
or as contemplated by this Agreement or as set forth in <span style="text-decoration: underline">Schedule 4.1</span>, shall (and shall cause their respective Subsidiaries to)
carry on its business in the usual, regular and ordinary course consistent with past practice, in substantially the same manner as heretofore
conducted and in compliance in all material respects with all applicable laws and, pay its debts and taxes when due subject to good faith
disputes over such debts or taxes, pay or perform other material obligations when due, and use its commercially reasonable best efforts
consistent with past practices and policies to (i) preserve substantially intact its present business organization, (ii) keep available
the services of its present key officers and employees and (iii) preserve its relationships with customers, suppliers, distributors,
licensors, licensees, and others with which it has significant business dealings. In addition, during the period from the date of this
Agreement and continuing until the earlier of the termination of this Agreement pursuant to its terms or the Closing, each of the Company
and NewCo, on one hand, and Parent and Merger Sub, on the other hand, except to the extent that the other shall otherwise consent in
writing or as contemplated by this Agreement or as set forth in <span style="text-decoration: underline">Schedule 4.1</span>, shall not (and hereby agree to cause their respective
Subsidiaries not to) do any of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
waive any share repurchase rights, accelerate, amend or (except as specifically provided for herein) change the period of exercisability
of options or restricted stock, or reprice options granted under any employee, consultant, director or other stock plans or authorize
cash payments in exchange for any options granted under any of such plans;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 377; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
grant any severance or termination pay to (i) any officer or (ii) any employee, except pursuant to applicable law, written agreements
outstanding, or policies existing on the date hereof and as previously or concurrently disclosed in writing or made available to the
other party, or adopt any new severance plan, or amend or modify or alter in any manner any severance plan, agreement or arrangement
existing on the date hereof;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
transfer or license to any person or otherwise extend, amend or modify any material rights to any Intellectual Property or enter into
grants to transfer or license to any person future patent rights, other than in the ordinary course of business consistent with past
practice provided that in no event shall the Company or Parent license on an exclusive basis or sell any Intellectual Property;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
declare, set aside or pay any dividends on or make any other distributions (whether in cash, Equity Securities or other property) in
respect of any of their Equity Securities, or split, combine or reclassify any of their Equity Securities, or issue or authorize the
issuance of any other securities in respect of, in lieu of or in substitution for, any of their Equity Securities;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
purchase, redeem or otherwise acquire, directly or indirectly, any Equity Securities of the Company or Parent;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
issue, deliver, sell, authorize, pledge or otherwise encumber any Equity Securities, or enter into other agreements or commitments of
any character obligating it to do any of the foregoing;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
amend its Charter Documents;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
acquire or agree to acquire by merging or consolidating with, or by purchasing any equity interest in or a portion of the assets of,
or by any other manner, any business or any corporation, partnership, association or other business organization or division thereof,
or otherwise acquire or agree to acquire any assets which are material, individually or in the aggregate, to the business of Parent or
the Company, as applicable, or enter into any joint ventures, strategic partnerships or alliances or other arrangements that provide
for exclusivity of territory or otherwise restrict such party&#8217;s ability to compete or to offer or sell any products or services.
For purposes of this paragraph, &#8220;material&#8221; includes the requirement that, as a result of such transaction, financial statements
of the acquired, merged or consolidated entity be included in the Registration Statement or Proxy Statement;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
sell, lease, license, encumber or otherwise dispose of any properties or assets, except (A) sales of inventory in the ordinary course
of business consistent with past practice, and (B) the sale, lease or disposition (other than through licensing) of property or assets
that are not material, individually or in the aggregate, to the business of such party;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
incur any indebtedness for borrowed money or guarantee any such indebtedness of another Person or Persons, issue or sell any debt securities
or options, warrants, calls or other rights to acquire any debt securities of Parent or the Company, as applicable, enter into any &#8220;keep
well&#8221; or other agreement to maintain any financial statement condition or enter into any arrangement having the economic effect
of any of the foregoing;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 378; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
adopt or amend any employee benefit plan, policy or arrangement, any employee stock purchase or employee stock option plan, or enter
into any employment contract or collective bargaining agreement (other than offer letters and letter agreements entered into in the ordinary
course of business consistent with past practice with employees who are terminable &#8220;at will&#8221;), pay any special bonus or special
remuneration to any director or employee, or increase the salaries or wage rates or fringe benefits (including rights to severance or
indemnification) of its directors, officers, employees or consultants, except in the ordinary course of business consistent with past
practice or to conform to the requirements of any applicable law;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
pay, discharge, settle or satisfy any claims, liabilities or obligations (absolute, accrued, asserted or unasserted, contingent or otherwise),
or litigation (whether or not commenced prior to the date of this Agreement), other than the payment, discharge, settlement or satisfaction,
in the ordinary course of business consistent with past practice or in accordance with their terms, of liabilities recognized or disclosed
in the most recent Financial Statements or Parent Financial Statements, as applicable, or incurred in the ordinary course of business
or in connection with the Transactions since the date of such financial statements, or waive the benefits of, agree to modify in any
manner, terminate, release any person from or knowingly fail to enforce any confidentiality or similar agreement to which the Company
is a party or of which the Company is a beneficiary or to which Parent is a party or of which Parent is a beneficiary, as applicable;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
except in the ordinary course of business consistent with past practice, modify, amend or terminate any Company Contract or Parent Contract,
as applicable, or waive, delay the exercise of, release or assign any material rights or claims thereunder;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
except as required by IFRS or U.S. GAAP, revalue any of its assets or make any change in accounting methods, principles or practice;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
except in the ordinary course of business consistent with past practice, incur or enter into any agreement, contract or commitment requiring
such party to pay in excess of $70,000.00 in any 12-month period;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
settle any litigation where the consideration given is other than monetary or to which an Insider is a party;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
make or rescind any Tax elections that, individually or in the aggregate, could be reasonably likely to adversely affect the Tax liability
or Tax attributes of such party, settle or compromise any income tax liability or, except as required by applicable law, change any method
of accounting for Tax purposes or prepare or file any Return in a manner inconsistent with past practice;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
form or establish any Subsidiary, except in the ordinary course of business consistent with past practice or as contemplated by this
Agreement;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
permit any Person to exercise any of its discretionary rights under any Plan to provide for the automatic acceleration of any outstanding
options, the termination of any outstanding repurchase rights or the termination of any cancellation rights issued pursuant to such plans;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 379; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
make capital expenditures except in accordance with prudent business and operational practices consistent with prior practice;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
make or omit to take any action which would be reasonably expected to have a Material Adverse Effect on such Party;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
enter into any transaction with or distribute or advance any assets or property to any of its officers, directors, partners, shareholders,
managers, members or other Affiliates other than the payment of salary and benefits and tax distributions in the ordinary course of business
consistent with past practice; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
agree in writing or otherwise agree, commit or resolve to take any of the actions described in <span style="text-decoration: underline">Section 4.1(a)</span> through <span style="text-decoration: underline">(v)</span>
above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V<br/>
ADDITIONAL AGREEMENTS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<span style="text-decoration: underline">Registration Statement and Proxy Statement; Special Meeting</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
As soon as is reasonably practicable after receipt by Parent from the Company of all financial and other information relating to the
Company and NewCo as Parent may reasonably request for its preparation, Parent shall prepare and file with the SEC under the Securities
Act, and with all other applicable regulatory bodies, a registration statement on Form S-4 with respect to the issuance of Parent Ordinary
Shares as part of the Merger Consideration in connection with the Merger (the &#8220;<span style="text-decoration: underline">Registration Statement</span>&#8221;), which shall
include proxy materials for the purpose of soliciting proxies from holders of Parent Ordinary Shares to vote in favor of (i) the adoption
of this Agreement and the approval of the Merger (the &#8220;<span style="text-decoration: underline">Merger Proposal</span>,&#8221; and the approval thereof, the &#8220;<span style="text-decoration: underline">Parent
Shareholder Approval</span>&#8221;), (ii) the change of the name of Parent to a name mutually agreed upon by the Parties with effect from
and after the Closing (the &#8220;<span style="text-decoration: underline">Name Change Amendment</span>&#8221;), (iii) the increase of the authorized number of Parent Ordinary
Shares to an amount mutually agreed with effect from and after the Closing (the &#8220;<span style="text-decoration: underline">Capitalization Amendment</span>&#8221;), (iv)
the adoption of the A&amp;R Memorandum and Articles of Association with effect from and after the Closing to, among other things, remove
all provisions applicable to blank check companies, (v) the adoption, effective from and after the Closing, of an equity incentive plan
(the &#8220;<span style="text-decoration: underline">Parent Plan</span>&#8221;), (vi) the election, effective from and after the Closing, of the Persons set forth in <span style="text-decoration: underline">Schedule
5.2</span> as directors of Parent, (vi) each other proposal that the SEC or Nasdaq (or the respective staff members thereof) indicates is
necessary in its comments to the Registration Statement or in correspondence related thereto, and (vii) the adjournment of the Special
Meeting if additional time is necessary to consummate the Transactions for any reason, at an extraordinary general meeting of holders
of Parent Ordinary Shares to be called and held for such purpose (the &#8220;<span style="text-decoration: underline">Special Meeting</span>&#8221;). The Parent Plan shall provide
that an aggregate of not more than five percent (5%) of the Parent Ordinary Shares to be outstanding as of the Closing shall be reserved
for issuance pursuant to the Parent Plan and shall be on such other terms and conditions as are mutually acceptable to the Parties. The
Company and NewCo shall furnish to Parent all information concerning the Company and NewCo as Parent may reasonably request in connection
with the preparation of the Registration Statement. The Company and its counsel shall be given an opportunity to review and comment on
the preliminary Registration Statement prior to its filing with the SEC. Parent, with the assistance of the Company and NewCo, shall
promptly respond to any SEC comments on the Registration Statement and shall otherwise use commercially reasonable best efforts to cause
the Registration Statement to be approved by the SEC as promptly as practicable. Parent shall also take any and all actions required
to satisfy the requirements of the Securities Act and the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 380; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
As soon as practicable following the approval of the Registration Statement by the SEC (the &#8220;<span style="text-decoration: underline">SEC Approval Date</span>&#8221;),
Parent shall distribute the proxy materials included therein (the &#8220;<span style="text-decoration: underline">Proxy Statement</span>&#8221;) to the holders of Parent Ordinary
Shares and, pursuant thereto, shall call the Special Meeting in accordance with the Cayman Companies Act, as amended, and, subject to
the other provisions of this Agreement, solicit proxies from such holders to vote in favor of the Merger Proposal and the other matters
presented to the shareholders of Parent for approval or adoption at the Special Meeting, including, without limitation, the matters described
in <span style="text-decoration: underline">Section 5.1(a)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Parent shall comply with all applicable provisions of and rules under the Exchange Act and all applicable provisions of the Cayman Companies
Act, as amended, and the Cayman Companies Act in the preparation, filing and distribution of the Proxy Statement, the solicitation of
proxies thereunder, and the calling and holding of the Special Meeting. Without limiting the foregoing, Parent shall ensure that the
Proxy Statement does not, as of the date on which it is first distributed to holders of Parent Ordinary Shares, and as of the date of
the Special Meeting, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements made, in light of the circumstances under which they were made, not misleading (provided that Parent shall not be responsible
for the accuracy or completeness of any information furnished by the Company or NewCo for inclusion in the Proxy Statement). The Company
represents and warrants that the information furnished by the Company and NewCo for inclusion in the Proxy Statement will not as of the
date on which the Proxy Statement (or any amendment or supplement thereto) is first distributed to holders of Parent Ordinary Shares
or at the time of the Special Meeting contain any statement which, at such time and in light of the circumstances under which it is made,
is false or misleading with respect to any material fact, or omits to state any material fact required to be stated therein or necessary
in order to make the statement therein not false or misleading.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Parent, acting through its board of directors, shall include in the Proxy Statement the recommendation of its board of directors that
the holders of Parent Ordinary shares vote in favor of the adoption of this Merger Proposal, and shall otherwise use commercially reasonable
best efforts to obtain the Parent Shareholder Approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<span style="text-decoration: underline">Directors and Officers of Parent and the Company After Merger</span>. The Parties shall take all necessary action so that the persons
listed in <span style="text-decoration: underline">Schedule 5.2</span> are elected to the positions of officers and directors of Parent and Surviving Company, as set forth therein,
to serve in such positions effective immediately after the Closing. If any Person listed in <span style="text-decoration: underline">Schedule 5.2</span> is unable to serve, the
Party appointing such Person as set forth in such schedule shall designate a successor; <span style="text-decoration: underline">provided</span>, that, if such designation is
to be made prior to the first annual general meeting of shareholders of Parent after the Closing, any successor to a Person designated
by Parent shall be made by the Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 381; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<span style="text-decoration: underline">Other Actions</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
As promptly as practicable after execution of this Agreement, Parent will prepare and file a Current Report on Form 8-K pursuant to the
Exchange Act to report the execution of this Agreement (&#8220;<span style="text-decoration: underline">Parent Signing Form 8-K</span>&#8221;), which the Company may review and
comment upon prior to filing. Any language included in the Parent Signing Form 8-K that reflects the Company&#8217;s comments, as well
as any text as to which the Company has not commented upon being given a reasonable opportunity to comment, shall, notwithstanding the
provisions of <span style="text-decoration: underline">Section 5.1(a)</span> and <span style="text-decoration: underline">Section 5.6</span>, be deemed to have been approved by the Company and may henceforth be used
by Parent in other filings made by it with the SEC and in other documents distributed by Parent in connection with the Transactions without
further review or consent of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Promptly after the execution of this Agreement, Parent and the Company shall issue a joint press release announcing the execution of
this Agreement (the &#8220;<span style="text-decoration: underline">Signing Press Release</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
At least five (5) days prior to Closing, Parent shall prepare a draft Current Report on Form 8-K announcing the Closing, together with,
or incorporating by reference, the financial statements prepared by the Company and its accountant, and such other information that may
be required to be disclosed with respect to the Merger in any report or form to be filed with the SEC (&#8220;<span style="text-decoration: underline">Closing Form 8-K</span>&#8221;),
which shall be in a form reasonably acceptable to the Company. Prior to Closing, Parent and the Company shall prepare a press release
announcing the consummation of the Merger hereunder (&#8220;<span style="text-decoration: underline">Closing Press Release</span>&#8221;). Concurrently with the Closing, Parent
shall distribute the Closing Press Release. Concurrently with the Closing, or as soon as practicable thereafter, Parent shall file the
Closing Form 8-K with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<span style="text-decoration: underline">Required Information</span>. In connection with the preparation of the Parent Signing Form 8-K, the Signing Press Release, the Registration
Statement, the Proxy Statement, the Closing Form 8-K and the Closing Press Release, or any other statement, filing notice or application
made by or on behalf of Parent, the Company and/or NewCo, or any of their respective Affiliates, to any Government Entity or other third
party in connection with Merger and the other Transactions, and for such other reasonable purposes, the Company and Parent each shall,
upon request by the other, furnish the other with all information concerning themselves, their respective Subsidiaries, Affiliates, directors,
officers and shareholders (including the directors and officers of Parent and NewCo to be elected or appointed effective as of the Closing
pursuant to <span style="text-decoration: underline">Section 5.2</span> hereof) and such other matters as may be reasonably necessary or advisable in connection with the Merger.
Each Party agrees that all such information provided shall, as of the date of such statement, filing or notice, be true and correct in
all material respects and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements contained therein, in light of the circumstances under which they were made, not misleading.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 382; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<span style="text-decoration: underline">Confidentiality; Access to Information</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Confidentiality</span>. Any confidentiality agreement previously executed by the parties shall be superseded in its entirety by the provisions
of this Agreement. Subject to the provisions of this Agreement, including <span style="text-decoration: underline">Sections 5.1</span>, <span style="text-decoration: underline">5.3</span>, <span style="text-decoration: underline">5.4</span> and <span style="text-decoration: underline">5.6</span>,
each Party agrees to maintain in confidence any non-public information received from the other party, and to use such non-public information
only for purposes of consummating the Transactions. Such confidentiality obligations will not apply to (i) information which was known
to the one party or their respective agents prior to receipt from the other party; (ii) information which is or becomes generally known
to the public; (iii) information acquired by a party or their respective agents from a third party who was not bound to an obligation
of confidentiality; and (iv) disclosure required by law or stock exchange or regulatory authority rule. In the event this Agreement is
terminated as provided in <span style="text-decoration: underline">ARTICLE VIII</span> hereof, each Party (i) will destroy or return or cause to be destroyed or returned to the
other all documents and other material obtained from the other in connection with the Merger contemplated hereby, and (ii) will use its
commercially reasonable best efforts to delete from its computer systems all documents and other material obtained from the other in
connection with the Merger contemplated hereby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Access to Information</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Company and NewCo will afford Parent and its financial advisors, accountants, counsel and other representatives reasonable access
during normal business hours, upon reasonable notice, to the properties, books, records and personnel of the Company (including the directors
and officers of the Company and NewCo, and the prospective directors and officers of Parent after the Closing, for the purposes of customary
background checks), NewCo and the Company Subsidiaries during the period prior to the Closing to obtain all information concerning the
business, including the status of business development efforts, properties, results of operations and personnel of the Company, NewCo
and the Company Subsidiaries, as Parent may reasonably request. No information or knowledge obtained by Parent in any investigation pursuant
to this <span style="text-decoration: underline">Section 5</span> will affect or be deemed to modify any representation or warranty contained herein or the conditions to the
obligations of the parties to consummate the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Parent will afford the Company and its financial advisors, underwriters, accountants, counsel and other representatives reasonable access
during normal business hours, upon reasonable notice, to the properties, books, records and personnel of Parent during the period prior
to the Closing to obtain all information concerning the business, including properties, results of operations and personnel of Parent,
as the Company may reasonably request. No information or knowledge obtained by the Company in any investigation pursuant to this <span style="text-decoration: underline">Section
5.6</span> will affect or be deemed to modify any representation or warranty contained herein or the conditions to the obligations of the
Parties to consummate the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 383; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<span style="text-decoration: underline">Public Disclosure</span>. From the date of this Agreement until Closing or the termination of this Agreement pursuant to <span style="text-decoration: underline">ARTICLE VIII</span>,
the Parties shall cooperate in good faith to jointly prepare all press releases and public announcements pertaining to this Agreement
and the transactions governed by it, and no Party shall issue or otherwise make any press release or public announcement, filing or communication
pertaining to this Agreement or the Transactions without the prior consent of Parent (in the case of the Company) or the Company (in
the case of Parent), except as required by any legal requirement or by the rules and regulations of, or pursuant to any agreement of
a stock exchange or trading system. No Party will unreasonably withhold, condition or delay approval with respect to any such press release
or public announcement, filing or communication. If any Party determines with the advice of counsel that it is required to make any press
release or public announcement, filing or communication pertaining to this Agreement or the Transactions, it shall, at a reasonable time
before making any public disclosure, consult with the other Party regarding such disclosure, seek such confidential treatment for such
terms or portions of this Agreement or the transaction as may be reasonably requested by the other Party and disclose only such information
as is legally compelled to be disclosed. Any language included in a press release or public announcement, filing or communication that
reflects the comments of the reviewing Party, as well as any text as to which the reviewing Party has not commented upon after being
given a reasonable opportunity to comment, shall be deemed to have been approved by the reviewing Party and may henceforth be used by
other Party in other press releases and public announcements, filings and communications, and in other documents distributed by the other
Party in connection with the Transactions, without further review or consent of the reviewing Party. This provision will not apply to
communications by any Party to its counsel, accountants and other professional advisors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<span style="text-decoration: underline">Commercially Reasonable Best Efforts</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Upon the terms and subject to the conditions set forth in this Agreement, each of the Parties agrees to use its commercially reasonable
best efforts to take, or cause to be taken, all actions, and to do, or cause to be done, and to assist and cooperate with the other Parties
in doing, all things necessary, proper or advisable to consummate and make effective, in the most expeditious manner practicable, the
Merger and the other Transactions, including using commercially reasonable best efforts to accomplish the following: (i) the taking of
all reasonable acts necessary to cause the conditions precedent set forth in <span style="text-decoration: underline">ARTICLE VI</span> to be satisfied, (ii) the obtaining of
all necessary actions, waivers, consents, approvals, orders and authorizations from Governmental Entities and the making of all necessary
registrations, declarations and filings (including registrations, declarations and filings with Governmental Entities, if any) and the
taking of all reasonable steps as may be necessary to avoid any suit, claim, action, investigation or proceeding by any Governmental
Entity, (iii) the obtaining of all consents, approvals or waivers from third parties required as a result of the Transactions, including
the consents referred to in <span style="text-decoration: underline">Schedule 2.5</span> of the Company Schedule, (iv) the defending of any suits, claims, actions, investigations
or proceedings, whether judicial or administrative, challenging this Agreement or the consummation of the Transactions, including seeking
to have any stay or temporary restraining order entered by any court or other Governmental Entity vacated or reversed, and (v) the execution
or delivery of any additional instruments reasonably necessary to consummate the Transactions and to fully carry out the purposes of
this Agreement. In connection with and without limiting the foregoing, Parent and its board of directors and the Company and its board
of directors shall, if any state takeover statute or similar statute or regulation is or becomes applicable to the Merger, this Agreement
or any of the Transactions, use its commercially reasonable best efforts to enable the Merger and the other Transactions to be consummated
as promptly as practicable on the terms contemplated by this Agreement. Notwithstanding anything herein to the contrary, nothing in this
Agreement shall be deemed to require Parent or the Company to agree to any divestiture by itself or any of its affiliates of shares of
capital stock or of any business, assets or property, or the imposition of any material limitation on the ability of any of them to conduct
their business or to own or exercise control of such assets, properties and stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 384; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Without limiting any of the foregoing, if required pursuant to the HSR Act, as promptly as practicable but in no event later than fifteen
(15) Business Days after the Agreement Date, Parent and the Company (i) shall each prepare and file the notification required of it thereunder
in connection with the Transactions, (ii) shall promptly and in good faith respond to all information requested of it by the Federal
Trade Commission and Department of Justice in connection with such notification and otherwise cooperate in good faith with each other
and such Governmental Entities, and (iii) shall each request early termination of any waiting period under the HSR Act. Parent and the
Company shall (1) promptly inform the other of any communication to or from the Federal Trade Commission, the Department of Justice or
any other Governmental Entity regarding the Transactions and permit counsel to the other Party an opportunity to review in advance, and
each Party shall consider in good faith the views of such counsel in connection with, any proposed written communications by such Party
to any Governmental Entity concerning the Transactions, (2) give the other prompt notice of the commencement of any action, suit, litigation,
arbitration, proceeding or investigation by or before any Governmental Entity with respect to such transactions, and (3) keep the other
reasonably informed as to the status of any such action, suit, litigation, arbitration, proceeding or investigation. Each Party agrees
to provide, to the extent permitted by the applicable Governmental Entity, the other Parties and their counsel the opportunity, on reasonable
advance notice, to participate in any substantive meetings or discussions, either in person or by telephone, between such Party and/or
any of its Affiliates, agents or advisors, on the one hand, and any Governmental Entity, on the other hand, concerning or in connection
with the Transactions; <span style="text-decoration: underline">provided</span>, no Party shall extend any waiting period or comparable period under the HSR Act or enter into
any agreement with any Governmental Entity without the written consent of the other Party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 385; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Without limiting any of the foregoing, if required pursuant to the DPA, each Party shall cooperate in good faith and use their commercially
reasonable efforts to: (i) as promptly as practicable prepare and submit to the Committee on Foreign Investment in the United States,
or any member agency thereof acting in its capacity as such (&#8220;<span style="text-decoration: underline">CFIUS</span>&#8221;), a declaration (the &#8220;<span style="text-decoration: underline">CFIUS Declaration</span>&#8221;)
concerning the Merger and the other Transactions in accordance with the Defense Production Act of 1950, as amended (50 U.S.C. &#167;
4565), and its implementing regulations located at 31 C.F.R. Parts 800, 802 (the &#8220;<span style="text-decoration: underline">DPA</span>&#8221;); (ii) after submitting the
CFIUS Declaration, as promptly as practicable respond (and cause its respective Affiliates to respond) to any request for additional
information, documents, or other materials from CFIUS no later than the time frame set forth in the DPA or within a longer time frame
approved by CFIUS in writing, provided that any Party, after consultation with each such other Party, may request in good faith an extension
of time pursuant to 31 C.F.R. &#167; 800.403(a)(3) to respond to CFIUS requests for follow-up information, provided that under no circumstance
may a party request any extension that would reasonably be expected to cause CFIUS to reject the CFIUS Declaration; and (iii) obtain
CFIUS Approval as promptly as practicable after the date hereof. Such commercially reasonable efforts shall include promptly after the
date hereof (1) participating (or directing its representatives to participate) in any informal pre-filing discussions with representatives
of CFIUS; (2) drafting, coordinating, and submitting the declaration to CFIUS, including by allowing each such other Party to have an
opportunity to review in advance and comment on drafts of filings and submissions, subject to redactions of information reasonably determined
by such other Party to be business confidential; (3) informing each such other Party of any communication received by such Party from,
or given by such Party to, CFIUS, by promptly providing copies to the other of any such written communications, except for any exhibits
to such communications providing the personal identifying information required by 31 C.F.R. &#167; 800.502(c)(5)(vi), any communications
that are otherwise requested by CFIUS to remain confidential from each such other Party or information reasonably determined by such
other Party to be business confidential; (4) permitting each other to review in advance any written or oral communication that any Party
gives to CFIUS, except for any communications that are requested by CFIUS to remain confidential from each such other Party or information
reasonably determined by such Party to be business confidential, and reasonably consulting with each other Party in advance of any meeting,
telephone call or conference with CFIUS, and to the extent not prohibited by CFIUS, giving each other Party the opportunity to attend
and participate in any telephonic conferences or in-person meetings with CFIUS; (5) preparing for and attending any meetings with CFIUS;
and (6) taking any other reasonably requested action in furtherance of CFIUS Approval. Notwithstanding the foregoing or anything to the
contrary contained in this Agreement, in the event that CFIUS notifies the Parties in writing that CFIUS has recommended or intends to
recommend in a report that the President prohibit the Transactions (a &#8220;<span style="text-decoration: underline">CFIUS Turndown</span>&#8221;), Parent may, in its discretion,
request a withdrawal of the CFIUS Declaration filed with CFIUS in connection with the CFIUS Approval, none of the Parties shall have
any further obligation to seek CFIUS Approval and this Agreement may be terminated in accordance with <span style="text-decoration: underline">Section 8.1</span>. &#8220;<span style="text-decoration: underline">CFIUS
Approval</span>&#8221; means, following the filing with CFIUS of a CFIUS Declaration, CFIUS issuing a written notification to the Parties
that (w) CFIUS has concluded that none of the Transactions is a &#8220;covered transaction&#8221; subject to review under the DPA; (x)
CFIUS has completed its assessment under the DPA of the Transactions in response to the CFIUS Declaration, determined that there are
no unresolved national security concerns with respect to the Transactions, and advised that all action under the DPA has concluded with
respect to the Transactions; (y) following CFIUS&#8217; review under the DPA of the Transactions in response to the CFIUS Declaration
and CFIUS&#8217; request for the Parties to file a formal joint voluntary notice (&#8220;<span style="text-decoration: underline">CFIUS Notice</span>&#8221;), CFIUS has completed
its review (or, if applicable, any investigation) under the DPA of the Transactions in response to the CFIUS Notice, determined that
there are no unresolved national security concerns with respect to the Transactions, and advised that all action under the DPA has concluded
with respect to the Transactions; or (z) CFIUS has sent a report to the President of the United States (the &#8220;<span style="text-decoration: underline">President</span>&#8221;)
requesting the President&#8217;s decision with respect to the CFIUS Declaration and the President has either (I) announced a decision
not to take any action to suspend, prohibit, or place any limitations on any of the Transactions or (II) the period under the DPA during
which the President may announce a decision to take action to suspend, prohibit or place any limitations on the Transactions shall have
expired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<span style="text-decoration: underline">No Securities Transactions</span>. Neither the Company, nor NewCo, nor any of their Affiliates, directly or indirectly, shall engage
in any transactions involving the securities of Parent prior to the time of the making of a public announcement of the Transactions.
The Company and NewCo shall use its best efforts to require each of its officers, directors and employees, and shall use commercially
reasonable best efforts to require each of its agents, advisors, contractors, associates, clients, customers and representatives, to
comply with the foregoing requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 386; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<span style="text-decoration: underline">No Claim Against Trust Fund</span>. Notwithstanding anything else in this Agreement, the Company and NewCo acknowledges that it has read
Parent&#8217;s final prospectus for its initial public offering dated July 11, 2023 (the &#8220;Final Prospectus&#8221;) and understands
that Parent has established the Trust Fund for the benefit of Parent&#8217;s public shareholders and that Parent may disburse monies
from the Trust Fund only (a) to Parent&#8217;s public shareholders in the event their Parent Ordinary Shares are redeemed for cash in
accordance with Parent&#8217;s Charter Documents, or (b) to Parent after, or concurrently with, the consummation of an initial business
combination, except with respect to interest earned on the Trust Fund that may be released to Parent to pay its tax obligations and except
for up to $100,000 of interest that may be released to Parent to pay liquidation and dissolution expenses. The Company and NewCo further
acknowledges that, if the Transactions are not, or, upon termination of this Agreement, another initial business combination is not,
consummated as required by Parent&#8217;s Charter Documents, Parent will be obligated to return to its shareholders the amounts being
held in the Trust Fund. Accordingly, the Company and NewCo, for themselves and their respective Subsidiaries, Affiliates, directors,
officers, employees, shareholders, representatives, advisors and all other associates and affiliates, hereby waive all rights, title,
interest or claim of any kind against Parent to collect from the Trust Fund any monies that may be owed to them by Parent for any reason
whatsoever, including but not limited to a breach of this Agreement by Parent or any negotiations, agreements or understandings with
Parent (whether in the past, present or future), and will not seek recourse against the Trust Fund at any time for any reason whatsoever.
This paragraph will survive this Agreement and will not expire and will not be altered in any way without the express written consent
of Parent and the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<span style="text-decoration: underline">Disclosure of Certain Matters</span>. Each of Parent and the Company will provide the others with prompt written notice of any event,
development or condition that (a) would cause any of such Party&#8217;s representations and warranties to become untrue or misleading
or which may affect its ability to consummate the Transactions, (b) had it existed or been known on the date hereof would have been required
to be disclosed under this Agreement, (c) gives such Party any reason to believe that any of the conditions set forth in <span style="text-decoration: underline">ARTICLE VI
</span>will not be satisfied, (d) is of a nature that is or may be materially adverse to the operations, prospects or condition (financial
or otherwise) of the Company, or (e) would require any amendment or supplement to the Registration Statement. The parties shall have
the obligation to supplement or amend the Company Schedules and Parent Schedules (the &#8220;<span style="text-decoration: underline">Disclosure Schedules</span>&#8221;) being
delivered concurrently with the execution of this Agreement with respect to any matter hereafter arising or discovered which, if existing
or known at the date of this Agreement, would have been required to be set forth or described in the Disclosure Schedules. The obligations
of the Parties to amend or supplement the Disclosure Schedules being delivered herewith shall terminate on the Closing Date. Notwithstanding
any such amendment or supplementation, for purposes of <span style="text-decoration: underline">ARTICLE VI</span>, <span style="text-decoration: underline">ARTICLE VII</span> and <span style="text-decoration: underline">ARTICLE VIII</span><b>, </b>the representations
and warranties of the Parties shall be made with reference to the Disclosure Schedules as they exist at the time of execution of this
Agreement, subject to such anticipated changes as are set forth in <span style="text-decoration: underline">Schedule 4.1</span> or otherwise expressly contemplated by this Agreement
or that are set forth in the Disclosure Schedules as they exist on the date of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 387; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<span style="text-decoration: underline">Nasdaq Listing</span>. From the date hereof through the Effective Time, the Parent shall use its commercially reasonable efforts to maintain
the listing of the Parent Ordinary Shares, Parent Units, and Parent Rights on Nasdaq and maintain all applicable initial and continuing
listing requirements of Nasdaq. The Parent shall prepare and submit to Nasdaq a listing application, if required under Nasdaq rules,
covering the shares of Parent Ordinary Shares issuable in the Merger, and shall use its commercially reasonable best efforts to cause
the shares of Parent Ordinary Shares issuable pursuant to the Transactions to be approved for listing on the Nasdaq, subject to official
notice of issuance, as promptly as practicable after the date of this Agreement, and in any event prior to the Effective Time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<span style="text-decoration: underline">No Solicitation</span>. During the period from the date of this Agreement and continuing until the earlier of the termination of this
Agreement pursuant to its terms or the Closing, other than as contemplated by this Agreement or with the express written consent of the
other Party, (a) the Company and NewCo will not, and will cause their respective Affiliates, employees, agents, officers, directors and
representatives not to, directly or indirectly, solicit or enter into discussions or transactions with, or encourage, or provide any
information to, any corporation, partnership or other entity or group (other than Parent and its designees) concerning any merger, sale
of ownership interests in the Company or NewCo (other than any purchases of equity securities by the Company or NewCo from employees
of the Company or the Company Subsidiaries or NewCo), sale of any portion of the assets of the Company or the Company Subsidiaries or
NewCo (other than immaterial assets sold in the ordinary course of business consistent with past practice), recapitalization, or similar
transaction involving the Company or NewCo (&#8220;<span style="text-decoration: underline">Company Competing Transaction</span>&#8221;), and (b) each of Parent and Merger Sub
will not, and will cause its respective controlled Affiliates, employees, agents, officers, directors and representatives not to, directly
or indirectly, solicit or enter into discussions or transactions with, or encourage, or provide any information to, any corporation,
partnership or other entity or group (other than the Company and its designees) concerning any merger, purchase of ownership interests
and/or assets, recapitalization or similar business combination transaction (&#8220;<span style="text-decoration: underline">Parent Competing Transaction</span>&#8221;). In addition,
(i) the Company and NewCo will, and will cause their respective Affiliates, employees, agents, officers, directors and representatives
to, immediately cease any and all existing discussions or negotiations with any Person conducted heretofore with respect to any Company
Competing Transaction, and (ii) each of Parent and Merger Sub will, and will cause its respective controlled Affiliates, employees, agents,
officers, directors and representatives to, immediately cease any and all existing discussions or negotiations with any Person conducted
heretofore with respect to any Parent Competing Transaction. The Company and NewCo will promptly (and in any event within two (2) Business
Days of receipt) notify Parent if either of them receives, or if any of their respective Affiliates, employees, agents, officers, directors
or representatives receives, any proposal, offer or submission with respect to a Company Competing Transaction after the date of this
Agreement. Notwithstanding the foregoing, the Company may respond to any such proposal, offer or submission by indicating only that the
Company is subject to this Agreement and is unable to provide any information related to the Company or the Company Subsidiaries or NewCo
or entertain any proposals or offers or engage in any negotiations or discussions concerning a Company Competing Transaction for as long
as this Agreement remains in effect. The Parties agree that the rights and remedies for noncompliance with this <span style="text-decoration: underline">Section 5.12</span> include
specific performance, it being acknowledged and agreed that any breach or threatened breach will cause irreparable injury to the non-breaching
party and that money damages would not provide an adequate remedy for such injury.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 388; Value: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<span style="text-decoration: underline">Charter Protections; Directors&#8217; and Officers&#8217; Liability Insurance</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All rights to indemnification for acts or omissions occurring through the Closing Date now existing in favor of the current directors
and officers of Parent as provided in the Charter Documents of Parent or in any indemnification agreements shall survive the Merger and
shall continue in full force and effect in accordance with their terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
For a period of six (6) years after the Closing Date, each of Parent and the Company shall cause to be maintained in effect the current
policies of directors&#8217; and officers&#8217; liability insurance maintained by Parent and the Company, respectively (or policies
of at least the same coverage and amounts containing terms and conditions which are no less advantageous), with respect to claims arising
from facts and events that occurred prior to the Closing Date. In the alternative, upon the Closing, Parent shall obtain a &#8220;tail&#8221;
insurance policy that provides coverage for at least a six-year period after the Closing Date, for the benefit of the current officers
and directors of Parent with respect to claims arising from acts, events or omissions that occurred at or prior to the Closing, including
with respect to the Transactions (the &#8220;<span style="text-decoration: underline">D&amp;O Tail Insurance</span>&#8221;), with coverage and amounts and containing terms and
conditions that are customary and prudent under the circumstances. The premium for such D&amp;O Tail Insurance shall be paid for by Parent.
Parent shall cause such D&amp;O Tail Insurance to be maintained in full force and effect, for its full term, and shall honor, and cause
its Subsidiaries and Affiliates to honor, all obligations thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
If Parent or any of its successors or assigns (i) consolidates with or merges into any other Person and shall not be the continuing or
surviving entity of such consolidation or merger, or (ii) transfers or conveys all or substantially all of its properties and assets
to any Person, then, in each such case, to the extent necessary, proper provision shall be made so that the successors and assigns of
Parent assume the obligations set forth in this <span style="text-decoration: underline">Section 5.13</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The provisions of this <span style="text-decoration: underline">Section 5.13</span> are intended to be for the benefit of, and shall be enforceable by, each Person who will have
been a director or officer of Parent for all periods ending on or before the Closing Date and may not be changed without the consent
of the Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<span style="text-decoration: underline">Insider Loans</span>. The Company and NewCo shall use their best efforts to cause each Insider of the Company, NewCo and the Company
Subsidiaries to, at or prior to Closing (i) repay to the Company, NewCo or the Company Subsidiary any loan by the Company, NewCo or the
Company Subsidiary to such Person and any other amount owed by such Person to the Company, NewCo or the Company Subsidiary; (ii) cause
any guaranty or similar arrangement pursuant to which the Company, NewCo or a Company Subsidiary has guaranteed the payment or performance
of any obligations of such Person to a third party to be terminated; and (iii) cease to own any direct equity interests in any Company
Subsidiary or in any other Person that utilizes the name &#8220;Qianzhi&#8221; or any derivative thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 389; Options: NewSection; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<span style="text-decoration: underline">Certain Financial Information</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Within fifteen (15) Business Days after the end of each month between the date hereof and the earlier of the Closing Date and the date
on which this Agreement is terminated, the Company shall deliver to Parent unaudited consolidated financial statements of the Company
for such month, including a balance sheet, statement of operations, statement of cash flows and statement of shareholders&#8217; equity,
that are certified as correct and complete by the Chief Executive Officer and Chief Financial Officer of the Company, prepared in accordance
with IFRS applied on a consistent basis to prior periods (except as may be indicated in the notes thereto) and fairly presenting in all
material respects the financial position of the Company at the date thereof and the results of its operations and cash flows for the
period indicated, except that such statements need not contain notes and may be subject to normal adjustments that are not expected to
have a Material Adverse Effect on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company will use commercially reasonable efforts to provide Parent with (i) the Company&#8217;s (or, as applicable, NewCo&#8217;s)
consolidated audited financial statements for each fiscal year ending on or after March 31, 2024 by the ninetieth (90<sup>th</sup>) calendar
day following the end of such fiscal year, (ii) the Company&#8217;s (or, as applicable, NewCo&#8217;s) consolidated interim financial
statements for the fiscal quarter ended December 31, 2023 by March 15, 2024, and (iii) the Company&#8217;s (or, as applicable, NewCo&#8217;s)
consolidated interim financial statements for each fiscal quarter ending on or after June 30, 2024 (other than a fiscal quarter ending
on the last day of a fiscal year) by the forty-fifth (45<sup>th</sup>) calendar day following the end of each such fiscal quarter. All
of the financial statements to be delivered pursuant to this &#8206;<span style="text-decoration: underline">Section 5.15(b)</span> (the &#8220;<span style="text-decoration: underline">Additional Financial Statements</span>&#8221;)
will be prepared under GAAP (except as may be indicated in the notes thereto) in accordance with requirements of the PCAOB for public
companies. The Additional Financial Statements will comply in all material respects with the applicable accounting requirements and with
the rules and regulations of the SEC, the Exchange Act and the Securities Act for financial statements required to be included in the
Registration Statement and Proxy Statement. The Additional Financial Statements will fairly present in all material respects the financial
position and results of operations of the Company (or, as applicable, NewCo) as of the date or for the periods indicated, except as otherwise
indicated in such statements and, in the case of interim financial statements, subject to the absence of footnotes and other presentation
items and for normal or immaterial year-end adjustments. The Company will use commercially reasonable efforts to promptly provide additional
Company financial information (including customary pro forma financial statements) reasonably requested by Parent for inclusion in the
Proxy Statement and any other filings, including on Form 8-K, to be made by Parent with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<span style="text-decoration: underline">Access to Financial Information</span>. The Company will, and will cause its auditors to, (a) continue to provide Parent and its advisors
full access to all of the Company&#8217;s financial information used in the preparation of its Financial Statements and Additional Financial
Statements and (b) cooperate fully with any reviews performed by Parent or its advisors of any such financial statements or information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<span style="text-decoration: underline">Parent Borrowings</span>. Through the Closing, Parent shall be allowed to borrow funds from its directors, officers and/or shareholders
to meet its reasonable capital requirements, with any such loans to be made only as reasonably required by the operation of Parent in
due course on a non-interest bearing basis and repayable at Closing (or convertible into securities of Parent at the Closing in accordance
with the terms of the promissory notes issued to evidence the borrowing, which such terms have been set forth in the Final Prospectus).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 390; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<span style="text-decoration: underline">Trust Fund Disbursement</span>. All liabilities of Parent due and owing or incurred at or prior to the Effective Time shall be paid from
the Trust Fund as and when due, as follows: first, all amounts payable to Parent shareholders electing conversion in connection with
their vote on the Merger; second, all Parent tax liabilities and deferred underwriting discounts and commissions; and third, all Parent
Transaction Expenses and other liabilities due and payable. Any remaining cash following the foregoing disbursements shall be transferred
to the Company and used for the Company Transaction Expenses due and payable and for Company working capital and general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<span style="text-decoration: underline">Employment Agreements</span>. Prior to the Closing Date, Parent and Wei Liang, Liangwen Wang, Juxiang Hu shall have executed employment
agreements to be effective as of the Effective Date in form to be mutually agreed upon (the &#8220;<span style="text-decoration: underline">Employment Agreements</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<span style="text-decoration: underline">Noncompete Agreement</span>. Prior to the Closing Date, Parent, the Company and Li Xiao, Yang Yang, Yuetao Lin shall have executed the
noncompete agreements in form to be mutually agreed upon (the &#8220;<span style="text-decoration: underline">Noncompete Agreements</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21
<span style="text-decoration: underline">PIPE Financing</span>. Commencing as soon as practicable after the date hereof, Parent and the Company shall use commercially reasonable
efforts to solicit investors (the &#8220;<span style="text-decoration: underline">PIPE Investors</span>&#8221;) to enter into subscription agreements with Parent (as amended
or modified from time to time, collectively, the &#8220;<span style="text-decoration: underline">Subscription Agreements</span>&#8221;), on terms approved by the Company (such
approval not to be unreasonably withheld, conditioned or delayed), pursuant to which, among other things, each PIPE Investor shall agree
to subscribe for and purchase from Parent, and Parent shall agree to issue and sell to each such PIPE Investor, on the Closing Date concurrent
with the Closing, the number or amount of Parent Ordinary Shares, Parent Preference Shares or other equity or equity-linked securities
of Parent set forth in the applicable Subscription Agreement, in exchange for the purchase price set forth therein, in an aggregate amount
of $5,000,000 (the financing contemplated by the Subscription Agreements, the &#8220;<span style="text-decoration: underline">PIPE Financing</span>&#8221;). Simultaneous with
entering into the Subscription Agreements, the PIPE Investors shall enter into a registration rights agreement with Parent (as amended
or modified from time to time, the &#8220;<span style="text-decoration: underline">Registration Rights Agreement</span>&#8221;), on terms approved by the Company (such approval
not to be unreasonably withheld, conditioned or delayed), pursuant to which, among other things, Parent shall grant the PIPE Investors
demand and piggyback registration rights relating to the Parent Ordinary Shares issuable pursuant to the Subscription Agreements or underlying
the Parent Preference Shares or other equity or equity-linked securities issued pursuant to the Subscription Agreements. The Company
shall reasonably cooperate in soliciting the PIPE Investors, obtaining the PIPE Financing and preparing the Subscription Agreements and
Registration Rights Agreement by, in a timely manner, (i) providing such information and assistance as Parent may reasonably request,
(ii) granting such access to potential PIPE Investors and their representatives as may reasonably be necessary for their due diligence,
and (iii) causing its and its Subsidiaries&#8217; respective senior management teams to participate in a reasonable number of meetings,
presentations, road shows, drafting sessions, due diligence sessions with respect to the PIPE Financing. The Parent shall use commercially
reasonable efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable
to cause the PIPE Financing to be consummated on the terms set forth in the Subscription Agreements, including using its commercially
reasonable efforts to (i) maintain in full force and effect the Subscription Agreements in accordance with the terms thereof, (ii) satisfy
on a timely basis all conditions to obtaining the PIPE Financing set forth in the Subscription Agreements that are applicable to the
Parent or any of its Subsidiaries and within the control of the Parent or any of its Subsidiaries, (iii) cause the PIPE Investors to
fund the PIPE Financing concurrently with or prior to the Closing, (iv) comply on a timely basis with the Parent&#8217;s obligations
under the Subscription Agreements, and (v) enforce the Parent&#8217;s rights under the Subscription Agreements. The net proceeds from
the PIPE shall be used, first, for all Parent tax liabilities and deferred underwriting discounts and commissions, and second, for all
Parent Transaction Expenses and other liabilities due and payable (in each case, to the extent not paid from the Trust Fund in accordance
with <span style="text-decoration: underline">Section 5.18)</span>. Any net proceeds following the foregoing uses shall be transferred to the Company and used for the Company
Transaction Expenses due and payable and for Company working capital and general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 391; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.22
<span style="text-decoration: underline">NewCo Shareholder Approval</span><span style="background-color: white">. As soon as practicable following the SEC Approval Date, NewCo
shall obtain the NewCo Shareholder Approval, without the need for calling a general meeting of NewCo&#8217;s shareholders, by obtaining
written consent to the adoption of this Agreement and approval of the </span>Transactions<span style="background-color: white">, including
the Merger, from the holders of the number of NewCo Ordinary Shares necessary in accordance with the Cayman Companies Act and NewCo&#8217;s
Charter Documents</span>; <span style="text-decoration: underline">provided</span><span style="background-color: white">, that consents with respect to the NewCo Shareholder
Approval will be solicited from all holders of NewCo Ordinary Shares. NewCo shall use its best efforts to cause the NewCo Shareholders
to (i) with respect to all of their NewCo Ordinary Shares, provide written consent to the adoption of this Agreement and approval of
the </span>Transactions<span style="background-color: white">, including the Merger, and vote in opposition to, and refrain from providing
written consent to, any and all other proposals that could reasonably be expected to delay or impair the ability of the Company to consummate
the Merger, and (ii) execute and deliver all related documentation and take such other action in support of the Merger as shall reasonably
be requested by NewCo in connection with the Merger.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.23
<span style="text-decoration: underline">Fees and Expenses</span>. All fees and expenses incurred by the Parties in connection with this Agreement and the Transactions shall
be paid by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VI</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDITIONS
TO THE TRANSACTION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
<span style="text-decoration: underline">Conditions to Obligations of Each Party to Effect the Merger</span>. The respective obligations of each Party to this Agreement to effect
the Merger shall be subject to the satisfaction at or prior to the Closing Date of the following conditions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Parent Shareholder Approval</span>. The Parent Shareholder Approval shall have been duly obtained by the requisite vote under the Cayman
Companies Act and Parent&#8217;s Charter Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">NewCo Shareholder Approval</span>. The NewCo Shareholder Approval shall have been duly obtained by the requisite vote under the Cayman
Companies Act and NewCo&#8217;s Charter Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Registration Statement</span>. The SEC shall have declared the Registration Statement effective, no stop order shall have been issued
by the SEC which remains in effect with respect to the Registration Statement, and no proceeding seeking such a stop order shall have
been threatened or initiated by the SEC which remains pending.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 392; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">Nasdaq Listing</span>. The listing of Parent Ordinary Shares comprising the Merger Consideration (includes the Merger Shares and Earnout
Shares) on Nasdaq shall have been approved, subject only to official notice of issuance and the requirement to have a sufficient number
of round lot holders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<span style="text-decoration: underline">HSR Act</span>. The applicable waiting period under the HSR Act in respect of the Merger shall have expired or been terminated, or it
shall have been determined and agreed by the Parties that no filing or waiting period under the HSR Act is required in respect of the
Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<span style="text-decoration: underline">CFIUS Approval</span>. CFIUS Approval shall have been obtained and be in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<span style="text-decoration: underline">CSRC Approval</span>. Approval of all necessary filings with China Securities Regulatory Commission (&#8220;<span style="text-decoration: underline">CSRC</span>&#8221;) shall
have been obtained and be in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<span style="text-decoration: underline">Parent Net Tangible Assets</span>. The Parent shall have at least $5,000,001 of net tangible assets (as determined in accordance with
Rule 3a51-1(g)(1) of the Exchange Act).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<span style="text-decoration: underline">Appraisal Rights</span>. Holders of less than five percent (5%) of the NewCo Ordinary Shares issued and outstanding immediately prior
to the Closing shall have exercised their right to dissent, and not effectively withdrawn their dissent or lost their right to dissent,
from the Merger pursuant to section 238 of the Cayman Companies Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
<span style="text-decoration: underline">Additional Conditions to Obligations of the Company</span>. The obligations of the Company to consummate and effect the Merger shall
be subject to the satisfaction at or prior to the Closing Date of each of the following conditions, any of which may be waived, in writing,
exclusively by the Company:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Representations and Warranties</span>. Each representation and warranty of Parent contained in <span style="text-decoration: underline">Sections 3.1</span> (Organization and
Qualification), <span style="text-decoration: underline">3.3</span> (Capitalization), <span style="text-decoration: underline">3.4</span> (Authority Relative to This Agreement) and <span style="text-decoration: underline">3.17</span> (Brokers) shall be true
and correct in all respects as of the date of this Agreement and, subject to the provisions of <span style="text-decoration: underline">Section 5.10</span>, on and as of the
Closing Date with the same force and effect as if made on the Closing Date (except those representations and warranties that address
matters only as of a specified date, the accuracy of which shall be determined as of that specified date in all respects). Each other
representation and warranty of Parent contained in this Agreement that is (i) subject to materiality, Material Adverse Effect or other
similar qualification, shall have been true and correct in all respects, or (ii) not subject to materiality, Material Adverse Effect
or other similar qualification, shall have been true and correct in all material respects, in each case as of the date of this Agreement
and, subject to the provisions of <span style="text-decoration: underline">Section 5.10</span>, on and as of the Closing Date with the same force and effect as if made on the
Closing Date (except those representations and warranties that address matters only as of a specified date, the accuracy of which shall
be determined as of that specified date). The Company shall have received a certificate with respect to the foregoing signed on behalf
of Parent by an authorized officer of Parent (&#8220;<span style="text-decoration: underline">Parent Closing Certificate</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 393; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Agreements and Covenants</span>. Parent and the Merger Sub shall have performed or complied with all agreements and covenants required
by this Agreement to be performed or complied with by them on or prior to the Closing Date, except to the extent that any failure to
perform or comply (other than a willful failure to perform or comply or failure to perform or comply with an agreement or covenant reasonably
within the control of Parent) does not, or is not reasonably expected to, constitute a Material Adverse Effect with respect to Parent,
and the Parent Closing Certificate shall include a provision to such effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">No Litigation</span>. No action, suit or proceeding shall be pending or threatened before any Governmental Entity which (i) would prevent
consummation of any of the Transactions, (ii) would cause any of the Transactions to be rescinded following consummation or (iii) would
affect materially and adversely or otherwise encumber the title of the Parent Ordinary Shares to be issued by Parent in connection with
the Merger, and no order, judgment, decree, stipulation or injunction to any such effect shall be in effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">Consents</span>. Parent shall have obtained the consents, waivers and approvals required to be obtained by Parent in connection with
the consummation of the Transactions, other than consents, waivers and approvals the absence of which, either alone or in the aggregate,
would not reasonably be expected to have a Material Adverse Effect on Parent, and the Parent Closing Certificate shall include a provision
to such effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<span style="text-decoration: underline">Parent Plan</span>. Prior to the Closing Date, the Parent Plan shall have been adopted in accordance with <span style="text-decoration: underline">Section 5.1</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<span style="text-decoration: underline">Other Deliveries</span>. At or prior to Closing, Parent shall have delivered to the Company (i) copies of resolutions and actions taken
by Parent&#8217;s board of directors and shareholders in connection with the approval of this Agreement and the Transactions, and (ii)
such other documents or certificates as shall reasonably be required by the Company and its counsel in order to consummate the Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<span style="text-decoration: underline">Resignations</span>. The persons listed in <span style="text-decoration: underline">Schedule 6.2(g)</span> shall have resigned from all of their positions and offices with Parent
and Merger Sub.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
<span style="text-decoration: underline">Additional Conditions to the Obligations of Parent and Merger Sub</span>. The obligations of Parent and Merger Sub to consummate and
effect the Merger shall be subject to the satisfaction at or prior to the Closing Date of each of the following conditions, any of which
may be waived, in writing, exclusively by Parent:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Representations and Warranties</span>. Each representation and warranty of the Company and NewCo contained in <span style="text-decoration: underline">Sections 2.1</span> (Organization
and Qualification), <span style="text-decoration: underline">2.3</span> (Capitalization), <span style="text-decoration: underline">2.4</span> (Authority Relative to This Agreement) and <span style="text-decoration: underline">2.17</span> (Brokers; Third-Party
Expenses) shall have been true and correct in all respects as of the date of this Agreement and, subject to the provisions of <span style="text-decoration: underline">Section
5.10</span>, on and as of the Closing Date with the same force and effect as if made on the Closing Date (except those representations and
warranties that address matters only as of a specified date, the accuracy of which shall be determined as of that specified date in all
respects). Each other representation and warranty of Parent contained in this Agreement that is (i) subject to materiality, Material
Adverse Effect or other similar qualification, shall have been true and correct in all respects, or (ii) not subject to materiality,
Material Adverse Effect or other similar qualification, shall have been true and correct in all material respects, in each case as of
the date of this Agreement and, subject to the provisions of <span style="text-decoration: underline">Section 5.10</span>, on and as of the Closing Date with the same force and
effect as if made on the Closing Date (except those representations and warranties that address matters only as of a specified date,
the accuracy of which shall be determined as of that specified date). Parent shall have received a certificate with respect to the foregoing
signed on behalf of the Company by an authorized officer of the Company (&#8220;<span style="text-decoration: underline">Company Closing Certificate</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 394; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Agreements and Covenants</span>. The Company and the NewCo Shareholders shall have performed or complied with all agreements and covenants
required by this Agreement to be performed or complied with by them at or prior to the Closing Date except to the extent that any failure
to perform or comply (other than a willful failure to perform or comply or failure to perform or comply with an agreement or covenant
reasonably within the control of the Company) does not, or is not reasonably expected to constitute a Material Adverse Effect on the
Company, and the Company Closing Certificate shall include a provision to such effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">No Litigation</span>. No action, suit or proceeding shall be pending or threatened before any Governmental Entity which would (i) prevent
consummation of any of the Transactions, (ii) cause any of the Transactions to be rescinded following consummation, or (iii) affect materially
and adversely the right of the Surviving Company to own, operate or control any of the assets and operations of the Company following
the Merger, and no order, judgment, decree, stipulation or injunction to any such effect shall be in effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">Consents</span>. The Company shall have obtained all consents, waivers, permits and approvals required to be obtained by the Company
in connection with the consummation of the Transactions, other than consents, waivers and approvals the absence of which, either alone
or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on the Company, and the Company Closing Certificate
shall include a provision to such effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<span style="text-decoration: underline">Material Adverse Effect</span>. No Material Adverse Effect with respect to the Company shall have occurred since the date of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<span style="text-decoration: underline">Employment Agreements.</span> The Employment Agreements shall have been executed and delivered by those Persons required by the terms
of this Agreement and shall all be in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<span style="text-decoration: underline">Noncompete Agreements. </span>The Noncompete Agreements shall have been executed and delivered by those Persons required by the terms
of this Agreement and shall all be in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<span style="text-decoration: underline">PIPE Financing</span>. The PIPE Financing shall have been consummated concurrently with the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 395; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<span style="text-decoration: underline">Other Deliveries</span>. At or prior to Closing, the Company shall have delivered to Parent: (i) copies of resolutions and actions taken
by the Company&#8217;s board of directors and Shareholders in connection with the approval of this Agreement and the Transactions, and
(ii) such other documents or certificates as shall reasonably be required by Parent and its counsel in order to consummate the Transactions,
including negative assurance letters from counsel to the Company as of the Closing in form and substance reasonably satisfactory to Parent
and &#8220;comfort letters&#8221; from the Company&#8217;s accounting firm pursuant to AU 634 of the Public Company Accounting Oversight
Board as of the effectiveness of the Registration Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<span style="text-decoration: underline">Derivative Securities</span>. Except as described in the Company Disclosure Schedules delivered on the date of this Agreement and for
securities issued in the PIPE Financing, there shall be outstanding no options, rights, warrants or other derivative securities entitling
the holders thereof to acquire any capital stock or other securities of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<span style="text-decoration: underline">Insider Loans; Equity Ownership in Subsidiaries</span>. (i) All outstanding indebtedness owed by the Insiders to the Company and the
Company Subsidiaries shall have been repaid in full, including the indebtedness and other obligations described on <span style="text-decoration: underline">Schedule 2.22</span>;
(ii) all outstanding guaranties and similar arrangements pursuant to which the Company or any Company Subsidiary has guaranteed the payment
or performance of any obligations of any of the Insiders to a third party shall have been terminated; and (iii) no Insider shall own
any direct equity interests in any Company Subsidiary or in any other Person that utilizes in its name &#8220;Qianzhi&#8221; or any derivative
thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VII</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INDEMNIFICATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
<span style="text-decoration: underline">Indemnification of Parent Indemnitees</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subject to the terms and conditions of this <span style="text-decoration: underline">ARTICLE VII</span> (including without limitation the limitations set forth in <span style="text-decoration: underline">Section
7.5</span>), Parent, the Surviving Company and the Company, and their respective representatives, successors and permitted assigns (the
&#8220;<span style="text-decoration: underline">Parent Indemnitees</span>&#8221;), shall be indemnified, defended and held harmless by the NewCo Shareholders, jointly and severally
to the extent of the Escrow Shares, and thereafter severally but not jointly, from and against all Losses asserted against, resulting
to, imposed upon, or incurred by any Parent Indemnitee by reason of, arising out of or resulting from:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the actual or alleged inaccuracy or breach of any representation or warranty of the Company or NewCo contained in or made pursuant to
this Agreement, or contained in or made pursuant to any certificate delivered by the Company or NewCo to Parent pursuant to this Agreement
in connection with the Closing; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the non-fulfillment or breach of any covenant or agreement of the Company or NewCo contained in this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
As used in this <span style="text-decoration: underline">ARTICLE VII</span>, the term &#8220;<span style="text-decoration: underline">Losses</span>&#8221; shall include all losses, liabilities, damages, judgments, awards,
orders, penalties, settlements, costs and expenses (including, without limitation, interest, penalties, court costs and reasonable legal
fees and expenses), including those arising from any demands, claims, suits, actions, costs of investigation, notices of violation or
noncompliance, causes of action, proceedings and assessments, whether or not made by third parties or whether or not ultimately determined
to be valid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 396; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
For all purposes of this <span style="text-decoration: underline">ARTICLE VII</span>, any representation or warranty contained in or made pursuant to this Agreement, or contained
or made pursuant to any certificate delivered by the Company or NewCo to Parent pursuant to this Agreement in connection with the Closing,
that is qualified by a term or terms such as &#8220;material,&#8221; &#8220;materially,&#8221; or &#8220;Material Adverse Effect&#8221;
shall be deemed made or given without such qualification and without giving effect to such words.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
No investigation or knowledge by the Parent Indemnitees or their representatives of a breach of a representation, warranty, covenant
or agreement of an Indemnifying Party shall affect the recourse available to the Parent Indemnitees under this <span style="text-decoration: underline">ARTICLE VII</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
<span style="text-decoration: underline">Indemnification of Third-Party Claims</span>. The indemnification obligations and liabilities under this <span style="text-decoration: underline">ARTICLE VII</span> with respect
to actions, proceedings, lawsuits, investigations, demands or other claims brought against the Parent Indemnitees by a Person other than
the Company (a &#8220;<span style="text-decoration: underline">Third-Party Claim</span>&#8221;) shall be subject to the following terms and conditions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Notice of Claim</span>. The Parent Indemnitees will give the Representative prompt written notice after receiving written notice of any
Third-Party Claim or discovering the liability, obligation or facts giving rise to such Third-Party Claim (a &#8220;<span style="text-decoration: underline">Notice of Claim</span>&#8221;),
which Notice of Third-Party Claim shall set forth (i) a brief description of the nature of the Third-Party Claim, (ii) the total amount
of the Loss or the anticipated potential Loss (including any costs or expenses which have been or may be reasonably incurred in connection
therewith), and (iii) whether such Loss may be covered (in whole or in part) under any insurance and the estimated amount of such Loss
which may be covered under such insurance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Defense</span>. The Representative shall have the right, at its option (subject to the limitations set forth in <span style="text-decoration: underline">Section 7.2(c)</span>),
by written notice to the Parent Indemnitees, to assume the defense of the Third-Party Claim as to which such Notice of Claim has been
given, and shall be entitled to appoint a recognized and reputable counsel reasonably acceptable to the Parent Indemnitees to be the
lead counsel in connection with such defense. In such event, the Parent Indemnitees shall have the right to participate in such defense
with their own counsel, but the fees and disbursements of counsel retained by the Parent Indemnitees shall not be indemnifiable Losses
hereunder. If the Representative is permitted and elects to assume such defense:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the Representative shall diligently and in good faith defend such Third-Party Claim and shall keep the Parent Indemnitees reasonably
informed of the status of such defense; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the Parent Indemnitees shall cooperate fully in all respects with the Representative in any such defense, compromise or settlement thereof,
including, without limitation, the selection of counsel, and the Parent Indemnitees shall make available to the Representative all pertinent
information and documents under their control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 397; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Limitations of Right to Assume Defense</span>. Anything in this Section 7.2 to the contrary notwithstanding:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Representative shall not be entitled to assume control of the defense of the Third-Party Claim, and the reasonable fees and expenses
of counsel retained by the Parent Indemnitees shall be indemnifiable Losses hereunder, if (i) the Third-Party Claim relates to or arises
in connection with any criminal proceeding, action, indictment, allegation or investigation; (ii) the Third-Party Claim seeks an injunction
or equitable relief against the Parent Indemnitees; (iii) there is a reasonable probability that a Third-Party Claim may materially and
adversely affect the Parent Indemnitees or their Subsidiaries other than as a result of money damages or other money payments; (iv) the
potential Loss arising from such Third-Party Claim would reasonably be expected to exceed the limitations set forth in <span style="text-decoration: underline">Section 7.5(c)</span>;
or (v) if in the reasonable opinion of counsel to the Parent Indemnitees, (x) there are legal defenses available to the Parent Indemnitee
that are different from or additional to those available to the NewCo Shareholders, or (y) there exists a conflict of interest between
the NewCo Shareholders and the Parent Indemnitees that cannot be waived.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
If the Representative is permitted and elects to assume the defense of a Third Party Claim, but fails to defend such Third Party Claim
actively and in good faith promptly after receiving a Notice of Claim, or at any time thereafter, the Parent Indemnitees will (upon further
written notice) have the right to undertake the defense, compromise or settlement of such Third Party Claim as it may determine in its
reasonable discretion, and the reasonable fees and expenses of counsel retained by the Parent Indemnitees shall be indemnifiable Losses
hereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Representative shall not, without the written consent of the Parent Indemnitees, settle or compromise any action or consent to the
entry of any judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">Other Limitations</span>. Failure to give prompt Notice of Claim or to provide copies of relevant available documents or to furnish relevant
available data shall not affect the Representative&#8217;s duty or obligations under this <span style="text-decoration: underline">ARTICLE VII</span>, except to the extent (and
only to the extent that) such failure shall have adversely affected the ability of the Representative to defend against or reduce its
liability or caused or increased such liability or otherwise caused the damages for which the Representative is obligated to be greater
than such damages would have been had the Parent Indemnitees given the Representative prompt notice hereunder. So long as the Representative
is defending any such action actively and in good faith, the Parent Indemnitees shall not settle such action.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3
<span style="text-decoration: underline">Indemnification of Direct Claims</span>. The Parent Indemnitees will give the Representative prompt written notice of any claim for indemnification
that is not a Third-Party Claim, which notice shall contain, to the extent applicable, the same information as a Notice of Claim for
a Third-Party Claim. The Representative will have a period of thirty (30) days after receipt of such notice to respond thereto. If the
Representative does not respond to such notice within such thirty (30) days, or responds within such thirty (30) days and rejects such
claim in whole or in part, the Parent Indemnitees will be free to pursue such remedies as may be available under this Agreement, the
Escrow Agreement or applicable Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 398; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4
<span style="text-decoration: underline">Insurance Effect</span>. To the extent that any Losses that are subject to indemnification pursuant to this <span style="text-decoration: underline">ARTICLE VII</span> are covered
by insurance paid for by the Company prior to the Closing, Parent shall use commercially reasonable best efforts to obtain the maximum
recovery under such insurance; <span style="text-decoration: underline">provided</span>, that Parent shall nevertheless be entitled to bring a claim for indemnification under
this <span style="text-decoration: underline">ARTICLE VII</span> in respect of such Losses and the time limitations set forth in <span style="text-decoration: underline">Section 7.5</span> hereof for bringing a claim
of indemnification under this Agreement shall be tolled during the pendency of such insurance claim. The existence of a claim by Parent
for monies from an insurer or against a third party in respect of any Loss shall not, however, delay any payment pursuant to the indemnification
provisions contained herein and otherwise determined to be due and owing by the NewCo Shareholders. If Parent has received the payment
required by this Agreement from the NewCo Shareholders (including by delivery of Escrow Shares) in respect of any Loss and later receives
proceeds from insurance or other amounts in respect of such Loss, then it shall pay to the Representative (for the benefit of the NewCo
Shareholders), as promptly as practicable after receipt, a sum equal to the amount of such proceeds from insurance or other amount received,
up to the aggregate amount of any payments received from the NewCo Shareholders pursuant to this Agreement in respect of such Loss. Parent
may pay such sum in Parent Ordinary Shares to the extent Parent Ordinary Shares were used in making the corresponding indemnification
payment from the NewCo Shareholders, and may deposit such Parent Ordinary Shares in escrow to the extent (x) Escrow Shares were used
in making the corresponding indemnification payment from the NewCo Shareholders, and (y) such Escrow Shares would have remained in escrow
at such time. Notwithstanding any other provisions of this Agreement, it is the intention of the Parties that no insurer or any other
third party shall be (i) entitled to a benefit it would not be entitled to receive in the absence of the foregoing indemnification provisions,
or (ii) relieved of the responsibility to pay any claims for which it is obligated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5
<span style="text-decoration: underline">Limitations on Indemnification</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Survival; Time Limitation</span>. The representations and warranties of the Company and NewCo in this Agreement or in any writing delivered
by the Company or NewCo to Parent in connection with this Agreement (including the certificate required to be delivered by the Company
pursuant to <span style="text-decoration: underline">Section 6.3(a)</span>) shall survive the Closing for the period that ends on the date that is two (2) years after the Closing
Date, except that claims for breaches of the representations and warranties in <span style="text-decoration: underline">Sections 2.1</span> (Organization and Qualification),
<span style="text-decoration: underline">2.2</span> (Subsidiaries), <span style="text-decoration: underline">2.3</span> (Capitalization), <span style="text-decoration: underline">2.4</span> (Authority Relative to this Agreement), <span style="text-decoration: underline">2.11</span> (Employee Benefit
Plans), <span style="text-decoration: underline">2.15</span> (Taxes), <span style="text-decoration: underline">2.16</span> (Environmental Matters), <span style="text-decoration: underline">2.17</span> (Brokers; Third Party Expenses) and <span style="text-decoration: underline">2.18</span> (Intellectual
Property) (the &#8220;<span style="text-decoration: underline">Specified Representations</span>&#8221;) shall survive until the expiration of the applicable statute of limitations
(the &#8220;<span style="text-decoration: underline">Survival Period</span>&#8221;). Any indemnification claim made by the Parent Indemnitees prior to the termination of the
applicable Survival Period shall be preserved despite the subsequent termination of such period and any claim set forth in a Notice of
Claim sent prior to the expiration of the applicable Survival Period shall survive until final resolution thereof. Except as set forth
in the immediately preceding sentence, no claim for indemnification under this <span style="text-decoration: underline">ARTICLE VII</span> shall be brought after the end of the
applicable Survival Period. The covenants and agreements of the Company and NewCo contained in this Agreement shall survive indefinitely.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 399; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Basket</span>. No amount shall be payable under <span style="text-decoration: underline">ARTICLE VII</span> unless and until the aggregate amount of all indemnifiable Losses
otherwise payable exceeds $3,750,000 (the &#8220;<span style="text-decoration: underline">Basket</span>&#8221;), in which event the NewCo Shareholders shall be required to pay
or be liable for all such indemnifiable Losses from the first dollar. Notwithstanding the foregoing sentence, the Basket shall not apply
to indemnifiable Losses arising out of or resulting from an actual or alleged breach of a Specified Representation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Aggregate Amount Limitation</span>. The aggregate liability of the NewCo Shareholders for Losses pursuant to <span style="text-decoration: underline">ARTICLE VII</span> shall
not in any event exceed $18,750,000 (and no NewCo Shareholder shall be liable for more than its pro rata share of the Losses, based on
the same proportions as the total Merger Shares are allocated among them).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6
<span style="text-decoration: underline">Payments</span>. Any indemnification obligation of the NewCo Shareholders under this <span style="text-decoration: underline">ARTICLE VII</span> will be settled through delivery
to the Parent Indemnitee of such number of Escrow Shares (which delivery shall be required to be made within five (5) Business Days after
the final determination of such obligation in accordance with this <span style="text-decoration: underline">ARTICLE VII</span> and the Escrow Agreement) as are equal in value
to the finally determined amount of indemnifiable Loss, or, if no Escrow Shares remain, at the election of the Representative, either
(i) through delivery to the Parent Indemnitees of such number of Merger Shares as are equal in value to any such shortfall, (ii) through
payment to the Parent Indemnitees of any such shortfall in cash, or (iii) through a combination of the foregoing. The value the Parent
Ordinary Shares shall be determined based on the dollar volume-weighted average price of the Parent Ordinary Shares on the principal
securities exchange or securities market on which such security is then traded during the fifteen (15) trading day period ending on the
Business Day prior to the date of the finally determined indemnifiable Loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7
<span style="text-decoration: underline">Exclusive Remedy</span>. Parent, on behalf of itself and the other Parent Indemnitees, hereby acknowledges and agrees that, from and
after the Closing, the sole remedy of the Parent Indemnitees with respect to any and all claims for money damages arising out of or relating
to this Agreement shall be pursuant and subject to the requirements of the indemnification provisions set forth in this <span style="text-decoration: underline">ARTICLE VII</span>.
Notwithstanding any of the foregoing, nothing contained in this <span style="text-decoration: underline">ARTICLE VII</span> shall in any way impair, modify or otherwise limit
the Parent Indemnitees right to bring any claim, demand or suit against the other Party based upon fraud, intentional misrepresentation
or willful misconduct.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.8
<span style="text-decoration: underline">Adjustment to Merger Consideration</span>. Amounts paid for indemnification under <span style="text-decoration: underline">ARTICLE VII</span> shall be deemed to be an adjustment
to the Merger Consideration, except as otherwise required by Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 400; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.9
<span style="text-decoration: underline">Representative Capacities; Application of Escrow</span>. The Parties acknowledge that the Representative&#8217;s obligations under this
<span style="text-decoration: underline">ARTICLE VII</span> are solely as a representative of the Company&#8217;s shareholders in the manner set forth in the Escrow Agreement
and that the Representative shall have no personal responsibility for any expenses incurred by him in such capacity. Out-of-pocket expenses
of the Representative for attorneys&#8217; fees and other costs, including the cost of assuming defense, compromise or settlement of
the Third-Party Claim pursuant to <span style="text-decoration: underline">Section 7.2(b)</span>, shall be borne in the first instance by Parent, which may make a claim for reimbursement
thereof as part of its Losses. The parties further acknowledge that all actions to be taken by Parent or the Parent Indemnitees pursuant
to this <span style="text-decoration: underline">ARTICLE VII</span> or the Escrow Agreement shall be taken on their behalf by the Committee. The Escrow Agent, pursuant to the
Escrow Agreement after the Closing, first shall apply the Escrow Shares, as appropriate, to satisfy claims for indemnification pursuant
to this <span style="text-decoration: underline">ARTICLE VII</span>. The Escrow Agent will hold any remaining portion of the Escrow Shares until final resolution of all claims
for indemnification submitted prior to the date that is two (2) years after the Closing. Notwithstanding anything to the contrary contained
herein, the Representative shall have no liability to Parent, the Company, NewCo or any NewCo Shareholder for any action taken or omitted
to be taken hereunder, unless such liability is determined by a judgment or a court of competent jurisdiction to have resulted from the
gross negligence, or willful misconduct of the Representative. Parent shall defend, indemnify and hold harmless the Representative for
all losses, damages, costs and expenses (including reasonable attorney&#8217;s fees and costs of investigation) arising out of or in
connection with, the performance by the Representative of its duties and obligations under this Agreement, unless such liability is determined
by a judgment or a court of competent jurisdiction to have resulted from the gross negligence, or willful misconduct of the Representative.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VIII</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TERMINATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1
<span style="text-decoration: underline">Termination</span>. This Agreement may be terminated at any time prior to the Closing:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
by mutual written agreement of Parent and the Company at any time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
by either Parent or the Company if the Merger shall not have been consummated by December 31, 2024; <span style="text-decoration: underline">provided</span>, however, that the
right to terminate this Agreement under this <span style="text-decoration: underline">Section 8.1(b)</span> shall not be available to any Party whose action or failure to act
has been a principal cause of or resulted in the failure of the Merger to occur on or before such date and such action or failure to
act constitutes a breach of this Agreement;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
by either Parent or the Company if a Governmental Entity shall have issued an order, decree, judgment or ruling or taken any other action,
in any case having the effect of permanently restraining, enjoining or otherwise prohibiting the Merger, which order, decree, ruling
or other action is final and nonappealable;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
by the Company, upon a breach of any representation, warranty, covenant or agreement on the part of Parent set forth in this Agreement,
or if any representation or warranty of Parent shall have become untrue, in either case such that the conditions set forth in <span style="text-decoration: underline">ARTICLE
VI</span> would not be satisfied as of the time of such breach or as of the time such representation or warranty shall have become untrue,
<span style="text-decoration: underline">provided</span>, that if such breach or inaccuracy is curable by Parent prior to the Closing Date, then the Company may not terminate
this Agreement under this <span style="text-decoration: underline">Section 8.1(d)</span> for thirty (30) days after delivery of written notice from the Company to Parent of such
breach, <span style="text-decoration: underline">provided</span> Parent continues to exercise commercially reasonable best efforts to cure such breach (it being understood that
the Company may not terminate this Agreement pursuant to this <span style="text-decoration: underline">Section 8.1(d)</span> if it shall have materially breached this Agreement
or if such breach by Parent is cured during such 30-day period);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 401; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
by Parent, upon a breach of any representation, warranty, covenant or agreement on the part of the Company or NewCo set forth in this
Agreement, or if any representation or warranty of the Company or NewCo shall have become untrue, in either case such that the conditions
set forth in <span style="text-decoration: underline">ARTICLE VI</span> would not be satisfied as of the time of such breach or as of the time such representation or warranty
shall have become untrue, provided, that if such breach or inaccuracy is curable by the Company or NewCo prior to the Closing Date, then
Parent may not terminate this Agreement under this <span style="text-decoration: underline">Section 8.1(e)</span> for thirty (30) days after delivery of written notice from Parent
to the Company of such breach, provided the Company and the NewCo Shareholders continue to exercise commercially reasonable best efforts
to cure such breach (it being understood that Parent may not terminate this Agreement pursuant to this <span style="text-decoration: underline">Section 8.1(e)</span> if it shall
have materially breached this Agreement or if such breach by the Company or a Shareholder is cured during such 30-day period);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
by either Parent or the Company, if the Parent Shareholder Approval is not obtained, by the requisite vote under the Cayman Companies
Act and Parent&#8217;s Charter Documents, at the Special Meeting (including any adjournments thereof);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
by Parent, if the Company Stockholder Approval is not obtained, by the requisite vote under the Cayman Companies Act and NewCo&#8217;s
Charter Documents, within one (1) Business Day after the Special Meeting;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
by Parent, if a CFIUS Turndown has occurred; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
by either the Parent or the Company if the approval of all necessary filings with the CSRC has not been obtained and be in full force
and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2
<span style="text-decoration: underline">Notice of Termination; Effect of Termination</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Any termination of this Agreement under <span style="text-decoration: underline">Section 8.1</span> above will be effective immediately upon (or, if the termination is pursuant
to <span style="text-decoration: underline">Section 8.1(d)</span> or <span style="text-decoration: underline">Section 8.1(e)</span> and the proviso therein is applicable, thirty (30) days after) the delivery of written
notice of the terminating party to the other Parties hereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In the event of the termination of this Agreement as provided in <span style="text-decoration: underline">Section 8.1</span>, this Agreement shall be of no further force or effect
and the Merger shall be abandoned, except for and subject to the following: (i) <span style="text-decoration: underline">Sections 5.5(a)</span> (Confidentiality), <span style="text-decoration: underline">5.9</span>
(No Claim Against Trust Fund), <span style="text-decoration: underline">5.23</span> (Fees and Expenses), <span style="text-decoration: underline">8.2</span> (Effect of Termination) and <span style="text-decoration: underline">ARTICLE X</span> (General Provisions)
shall survive the termination of this Agreement, and (ii) nothing herein shall relieve any Party from liability for any willful breach
of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 402; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IX</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFINED
TERMS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1
<span style="text-decoration: underline">Defined Terms</span>. Terms defined in this Agreement are organized alphabetically as follows, together with the Section and, where applicable,
paragraph, number in which definition of each such term is located:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 85%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;A&amp;R
    Memorandum and Articles of Association&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.4(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Additional
    Financial Statements&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.15(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Affiliate&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Agreement&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Approvals&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.1(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Audited
    Financial Statements&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.7(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Basket&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.5(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Business
    Day&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Capitalization
    Amendment&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.1(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Cayman
    Companies Act&#8221; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recital
    E</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;CFIUS&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.7(c)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;CFIUS
    Approval&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.7(c)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;CFIUS
    Declaration&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.7(c)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;CFIUS
    Notice&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.7(c)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;CFIUS
    Turndown&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.7(c)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Charter
    Documents&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.1(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Closing&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Closing
    Date&#8221; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Closing
    Form 8-K&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.3(c)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Closing
    Press Release&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.3(c)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Code&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recital
    H</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Committee&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.11(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Company&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Company
    Closing Certificate&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.3(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Company
    Competing Transaction&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.12</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Company
    Contracts&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.19(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Company
    Intellectual Property&#8221; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.18(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Company
    Products&#8221; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.18(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Company
    Registered Intellectual Property&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.18(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Company
    Schedule&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    II Preamble</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Company
    Subsidiaries&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.2(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Continental&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.10</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Copyrights&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.18(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;CSRC&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.1(g)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;D&amp;O
    Tail Insurance&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.13(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Data
    Protection Requirements&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.18(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Disclosure
    Schedules&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.10</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Dissenting
    Shares&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.13(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Dissenting
    Shareholders&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.13(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;DPA&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.7(c)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Page; Sequence: 403; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -4.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 85%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Earnout
    Shares&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.5(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Effective
    Time&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Employment
    Agreements&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.19</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Environmental
    Law&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.16(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Equity
    Securities&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Escrow
    Agreement&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.10</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Escrow
    Shares&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.10</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Escrow
    Termination Date</span>&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.10</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Exchange
    Act&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(c)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Final
    Prospectus&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Financial
    Statements&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.7(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Governmental
    Action/Filing&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.21(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Governmental
    Entity&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(d)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Hazardous
    Substance&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.16(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;HSR
    Act&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.5(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;IFRS&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.7(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Insider&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(e)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Insurance
    Policies&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.20</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Intellectual
    Property&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.18(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;IT
    Data&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.18(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;IT
    Systems&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.18(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Proxy
    Statement&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.1(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Knowledge&#8221;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(f)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Legal
    Requirements&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(g)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Letter
    of Transmittal&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.6(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Lien&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(h)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Losses&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.1(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Material
    Adverse Effect&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(i)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Material
    Company Contracts&#8221; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.19(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Merger&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recital
    E</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Merger
    Consideration&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.5(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Merger
    Proposal&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.1(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Merger
    Shares&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.5(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Merger
    Sub&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Merger
    Sub Ordinary Shares&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.5(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Name
    Change Amendment&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.1(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Nasdaq&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.22</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;NewCo&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;NewCo
    Certificates&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.6(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;NewCo
    Ordinary Shares&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.3(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;NewCo
    Shareholder Approval&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recital
    G</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;NewCo
    Shareholders&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recital
    D</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Noncompete
    Agreements&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.20</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Notice
    of Claim&#8221; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.2(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    Audited Financial Statements&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.7(b)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -4.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 404; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -4.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 85%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    Closing Certificate&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.2(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    Contracts&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.19(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    Competing Transaction&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.12</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    Financial Statements&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.7(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    Indemnitees&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.1(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    Ordinary Shares&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.5(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    Plan&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.1(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    Preference Shares&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.3(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    Rights&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.3(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    Schedule&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    III Preamble</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    SEC Reports&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.7(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    Signing Form 8-K&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.3(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    Shareholder Approval&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.1(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parent
    Unaudited Financial Statements,&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.7(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Parties&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Patents&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.18(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Person&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(j)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Personal
    Data&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.18(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Personal
    Property&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.14(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;PIPE
    Financing&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.21</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;PIPE
    Investors&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.21</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Plan&#8221;
    or &#8220;Plans&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.11(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Plan
    of Merger&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;President&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.7(c)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Proxy
    Statement&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.1(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Registered
    Intellectual Property&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.18(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Registration
    Rights Agreement&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.21</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Registration
    Statement&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.1(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Representative&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.11(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Restructuring&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recital
    D</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Returns&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.15(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;SEC&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(k)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;SEC
    Approval Date&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.1(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Securities
    Act&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(l)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Signing
    Press Release&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.3(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Special
    Meeting&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.1(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Specified
    Representations&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.5(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Stock&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(b)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Subscription
    Agreements&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.21</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Subsidiary&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(m)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Survival
    Period&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.5(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Surviving
    Company&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recital
    E</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Tax&#8221;
    or &#8220;Taxes&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.15(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Third-Party
    Claim&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Top
    Customer&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.23(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Top
    Supplier&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.23(b)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -4.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 405; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -4.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 85%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Trademarks&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.18(a)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Transaction
    Agreements&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(o)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Transaction
    Expenses&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(n)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Transactions&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(p)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Transfer&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(q)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Trust
    Fund&#8221; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.24</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;U.S.
    GAAP&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.7(c)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Voting
    Agreement&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recital
    G</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Voting
    Debt&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2(b)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
X</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GENERAL
PROVISIONS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1
<span style="text-decoration: underline">Notices</span>. All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally
or by commercial delivery service, or sent via telecopy or e-mail (receipt confirmed) to the Parties at the following mailing addresses
or telecopy numbers or e-mail addresses (or at such other mailing addresses or telecopy numbers or e-mail addresses for a Party as shall
be specified by like notice):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
to Parent or the Committee, to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse; margin-left: 1in">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
    Acquisition Corp</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">420
    Lexington Ave, Suite 2446 </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10170</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiangang
    Luo</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">jiangangluo@bowenspac.com</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse; margin-left: 1in">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Graubard
    Miller </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">405
    Lexington Ave, 44th Floor</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10174</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Alan Miller, Esq.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    M. Gallant, Esq.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric
    Schwartz, Esq.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dmiller@graubard.com</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">jgallant@graubard.com</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">eschwartz@graubard.com</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
to the Company, NewCo or the Representative, to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse; margin-left: 1in">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
    Group Holdings (Cayman) Limited</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1705,
    Block B, KK 100 Building</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5016
    East Shennan Road</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luoho
    District, Shenzhen</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guangdong
    Province, 51800</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peoples
    Republic of China</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xiaoqin
    Lin, Chief Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liangwen
    Wang, Chief Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">395644267@qq.com
    (Lin)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">275267023@qq.com
    (Wang)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 406; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse; margin-left: 1in">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Becker
    &amp; Poliakoff LLP</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45
    Broadway, 17<sup>th</sup> Floor</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10006</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chengying
    Xiu, Esq.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven
    L. Glauberman, Esq.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">jxiu@beckerlawyers.com</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sglauberman@beckerlawyers.com</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2
<span style="text-decoration: underline">Interpretation</span>. The definitions of the terms herein shall apply equally to the singular and plural forms of the terms defined.
Whenever the context shall require, any pronoun shall include the corresponding masculine, feminine and neuter forms. When a reference
is made in this Agreement to an Exhibit or Schedule, such reference shall be to an Exhibit or Schedule to this Agreement unless otherwise
indicated. When a reference is made in this Agreement to Sections or subsections, such reference shall be to a Section or subsection
of this Agreement. Unless otherwise indicated the words &#8220;include,&#8221; &#8220;includes&#8221; and &#8220;including&#8221; when
used herein shall be deemed in each case to be followed by the words &#8220;without limitation.&#8221; The table of contents and headings
contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.
When reference is made herein to &#8220;the business of&#8221; an entity, such reference shall be deemed to include the business of all
direct and indirect Subsidiaries of such entity. Reference to the Subsidiaries of an entity shall be deemed to include all direct and
indirect Subsidiaries of such entity. All monetary amounts set forth herein are referenced in United States dollars, unless otherwise
noted. For purposes of this Agreement, the following capitalized terms have the following meanings:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&#8220;<span style="text-decoration: underline">Affiliate</span>&#8221; shall mean, as applied to any Person, any other Person directly or indirectly controlling, controlled
by or under direct or indirect common control with, such Person. For purposes of this definition, &#8220;control&#8221; (including with
correlative meanings, the terms &#8220;controlling,&#8221; &#8220;controlled by&#8221; and &#8220;under common control with&#8221;),
as applied to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management
and policies of such Person, whether through the ownership of voting securities, by contract or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&#8220;<span style="text-decoration: underline">Equity Securities</span>&#8221; means, with respect to any Person, (i) any shares, shares of capital or capital stock, partnership,
membership, joint venture or similar interest, or other voting securities of, or other ownership interest in, such Person (&#8220;<span style="text-decoration: underline">Stock</span>&#8221;),
(ii) bonds, debentures, notes or other Indebtedness having the right to vote (or convertible or exchangeable into or exercisable for
securities having the right to vote) on any matters on which holders of Stock of such Person, in their capacity as such, would have the
right to vote (&#8220;<span style="text-decoration: underline">Voting Debt</span>&#8221;), (iii) any securities of such Person convertible into or exchangeable for Stock or Voting
Debt of such Person, (iv) any warrants, calls, subscriptions, options or other rights (including preemptive rights) to subscribe for,
purchase or acquire from such Person, or any other obligations of any character of such Person to issue, any Stock or Voting Debt of
such Person, or any securities of such Person convertible into or exchangeable for Stock or Voting Debt of such Person, or (v) any restricted
shares, stock appreciation rights, restricted units, performance units, contingent value rights, &#8220;phantom&#8221; stock or similar
securities, profit participation, equity-based awards, or rights issued by or with the approval of such Person that are derivative of,
or provide economic benefits based, directly or indirectly, on the value or price of, any Stock of such Person or any business, products
or assets of such Person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 407; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&#8220;<span style="text-decoration: underline">Exchange Act</span>&#8221; means the Securities Exchange Act of 1934, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&#8220;<span style="text-decoration: underline">Governmental Entity</span>&#8221; shall mean any United States or foreign federal, national, state, county, municipal, provincial,
or local government, any transnational or supranational government, any political subdivision of any of the foregoing, and any authority,
agency, commission, body, department or other instrumentality exercising executive, legislative, judicial, regulatory or administrative
functions of or pertaining to any such government or political subdivision thereof, including any self-regulatory or quasi-regulatory
authority, agency, commission, body, department or other instrumentality and any court, arbitral body or tribunal of competent jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&#8220;<span style="text-decoration: underline">Insider</span>&#8221; shall mean, with respect to any Person, any officer, director, employee, or holder of Equity Securities
of such Person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&#8220;<span style="text-decoration: underline">Knowledge</span>&#8221; shall mean actual knowledge or awareness, after due inquiry, as to a specified fact or event of a Person
that is an individual or of an executive officer or director of a Person that is a corporation or of a Person in a similar capacity of
an entity other than a corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&#8220;<span style="text-decoration: underline">Legal Requirements</span>&#8221; shall mean any federal, state, local, municipal, foreign or other law, statute, constitution,
principle of common law, resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted,
promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Entity and all requirements set forth
in applicable Company Contracts or Parent Contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&#8220;<span style="text-decoration: underline">Lien</span>&#8221; shall mean any mortgage, pledge, security interest, encumbrance, lien, restriction or charge of any kind (including,
without limitation, any conditional sale or other title retention agreement or lease in the nature thereof, any sale with recourse against
the seller or any Affiliate of the seller, any restriction on transfer, any option to purchase or sell, or any agreement to give any
security interest).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 408; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&#8220;<span style="text-decoration: underline">Material Adverse Effect</span>,&#8221; when used in connection with the Company or Parent, shall mean any change, event, occurrence,
effect or circumstance, individually or when aggregated with other <span style="background-color: white">changes, events, occurrences,
effects or circumstances</span>, that (i) has had or would reasonably be expected to have a materially adverse effect on the business,
financial condition, results of operations or prospects of such Party and its Subsidiaries, taken as a whole; or (ii) would prevent,
delay, impair or materially impede the ability of such Party to consummate the Merger; <span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">however</span>, that none of
the following, alone or in combination, shall be deemed, in and of itself, to constitute, or shall be taken into account in determining
whether there has been or will be, a Material Adverse Effect under clause (i) of this definition: (A) acts of war, sabotage, civil or
political unrest or terrorism, or any escalation or worsening of any such acts of war, sabotage, civil or political unrest or terrorism;
(B) earthquakes, hurricanes, wildfires, mudslides, tornados or other natural or man-made disasters, acts of God or other force majeure
events; (C) any pandemic (including COVID-19), epidemic, plague or other general outbreak of illness, including any actions taken by
a Governmental Entity in response thereto; (D) any proposal, enactment or change in interpretation of, or other change in, applicable
Legal Requirements or IFRS or U.S. GAAP (or equivalent accounting practice in any other jurisdiction); (E) general conditions in the
industries in which the Company or any of its Subsidiaries operate; (F) any change in interest rates or economic, political, business,
financial, commodity, currency or market conditions generally; (G) the failure, in and of itself, of the Company or any of its Subsidiaries
to meet any internal or published projections, forecasts, estimates or predictions in respect of revenue, earnings or other financial
or operating metrics before, on or after the date of this Agreement, or changes in the credit rating of the Company or any of its Subsidiaries,
provided that such projections, forecasts, estimates or predictions were based on reasonable and appropriate assumptions for projections,
forecasts, estimates or predictions of such kind (it being understood that the underlying facts giving rise or contributing to such failure
or change may be taken into account in determining whether there has been a Material Adverse Effect if otherwise contemplated by this
definition); (H) changes attributable to the public announcement or pendency of the transactions contemplated hereby or the performance
of this Agreement, including the impact thereof on relationships, contractual or otherwise, with customers, suppliers, licensors, distributors,
partners, providers and employees; or (I) any actions taken, or failures to take action, or such other changes or events, in each case,
by the Company or its Subsidiaries which Parent has requested or to which it has consented, in each case, expressly in writing or which
actions are expressly contemplated by this Agreement; <span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">however</span>, in the case of clauses (A) to (F) above, if any
such <span style="background-color: white">change, event, occurrence, effect or circumstance</span> has a disproportionate and adverse
effect on such Party and its Subsidiaries, taken as a whole, relative to other similarly situated businesses in the industries in which
such Party and its Subsidiaries operate, such change, event, occurrence, effect or circumstance may deemed to constitute, or may be taken
into account in determining whether there has been or will be, a Material Adverse Effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&#8220;<span style="text-decoration: underline">Person</span>&#8221; shall mean any individual, corporation (including any non-profit corporation), general partnership, limited
partnership, limited liability partnership, joint venture, estate, trust, company (including any limited liability company or joint stock
company), firm or other enterprise, association, organization, entity or Governmental Entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
&#8220;<span style="text-decoration: underline">SEC</span>&#8221; shall mean the United States Securities and Exchange Commission.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
&#8220;<span style="text-decoration: underline">Securities Act</span>&#8221; shall mean the Securities Act of 1933, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
&#8220;<span style="text-decoration: underline">Subsidiary</span>&#8221; means, with respect to a Person, (i) any corporation or other organization (including a limited liability
company or a partnership), whether incorporated or unincorporated, of which such Person, directly or indirectly, owns or controls shares,
stock or other securities or interests in such corporation or other organization having by their terms ordinary voting power to elect
a majority of the board of directors or others performing similar functions with respect to such corporation or other organization, or
of which such Person, directly or indirectly, is a general partner or managing member or acts in a similar management capacity, or (ii)
any joint venture or other entity in which such Person has a participation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 409; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
&#8220;<span style="text-decoration: underline">Transaction Expenses</span>&#8221; means, with regard to a Party, all fees and expenses of any of such Party incurred or payable
as of the Closing and not paid prior to the Closing (i) in connection with the consummation of the Transactions, including any amounts
payable to professionals (including investment bankers, brokers, finders, attorneys, accountants and other consultants and advisors)
retained by or on behalf of such Party and any extension costs of Parent, including additional contributions to the Trust Fund repayable
by Parent in connection with the Closing, (ii) any change in control bonus, transaction bonus, retention bonus, termination or severance
payment or payment relating to terminated options, warrants or other equity appreciation, phantom equity, profit participation or similar
rights, in any case, to be made to any current or former employee, independent contractor, director or officer of any Company Group member
at or after the Closing pursuant to any agreement to which any Company Group member is a party prior to the Closing which become payable
(including if subject to continued employment) as a result of the execution of this Agreement or the consummation of the Transactions,
and (iii) any sales, use, real property transfer, stamp, stock transfer or other similar transfer Taxes imposed on the Parent, Merger
Sub, NewCo or the Company in connection with the Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
&#8220;<span style="text-decoration: underline">Transaction Agreements</span>&#8221; means this Agreement, the Voting and Support Agreement, the Escrow Agreement, the Noncompete
Agreements, the Employment Agreements, the Subscription Agreements, the Registration Rights Agreement, and all the agreements, documents,
instruments and certificates entered into in connection herewith or therewith and any and all exhibits and schedules thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
&#8220;<span style="text-decoration: underline">Transactions</span>&#8221; means the transactions contemplated by this Agreement, including the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
&#8220;<span style="text-decoration: underline">Transfer</span>&#8221; shall mean to, directly or indirectly, whether in one transaction or a series of transactions and whether
by merger, consolidation, division, operation of law, or otherwise, (i) offer, sell, transfer, assign, pledge, encumber, hypothecate
or similarly dispose of, either voluntarily or involuntarily, or to enter into any contract, option or other arrangement or understanding
with respect to the sale, transfer, assignment, pledge, encumbrance, hypothecation or similar disposition of, any interest owned by a
Person or any interest (including a beneficial interest) in, or the ownership, control or possession of, any interest owned by a Person,
(ii) enter into any swap, hedging, short sale, or other arrangement that transfers to another, in whole or in part, any of the economic
consequences of ownership of any of Shares or securities convertible into or exercisable or exchangeable for Class A Common Stock, whether
any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (iii) publicly announce any intention
to effect any transaction specified in clause (i) or (ii).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3
<span style="text-decoration: underline">Counterparts; Electronic Delivery</span>. This Agreement and each other document executed in connection with the Transactions, and the
consummation thereof, may be executed in one or more counterparts, all of which shall be considered one and the same document and shall
become effective when one or more counterparts have been signed by each of the Parties and delivered to the other Party, it being understood
that all parties need not sign the same counterpart. Delivery by facsimile or electronic transmission to counsel for the other Party
of a counterpart executed by a Party shall be deemed to meet the requirements of the previous sentence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 410; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4
<span style="text-decoration: underline">Entire Agreement; Third Party Beneficiaries</span>. This Agreement and the documents and instruments and other agreements among the Parties
hereto as contemplated by or referred to herein, including the Exhibits and Schedules hereto (a) constitute the entire agreement among
the Parties with respect to the subject matter hereof and supersede all prior agreements and understandings, both written and oral, among
the parties with respect to the subject matter hereof, it being understood that the term sheet between Parent and the Company executed
on or about October 17, 2023 is hereby terminated in its entirety and shall be of no further force and effect (except to the extent expressly
stated to survive the execution of this Agreement and the consummation of the Transactions); and (b) are not intended to confer upon
any other person any rights or remedies hereunder (except as specifically provided in this Agreement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5
<span style="text-decoration: underline">Severability</span>. In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court
of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect
and the application of such provision to other persons or circumstances will be interpreted so as reasonably to effect the intent of
the Parties hereto. The Parties further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable
provision that will achieve, to the extent possible, the economic, business and other purposes of such void or unenforceable provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6
<span style="text-decoration: underline">Other Remedies; Specific Performance</span>. Except as otherwise provided herein, any and all remedies herein expressly conferred upon
a Party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such Party, and
the exercise by a Party of any one remedy will not preclude the exercise of any other remedy. The Parties hereto agree that irreparable
damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms
or were otherwise breached. It is accordingly agreed that the Parties shall be entitled to seek an injunction or injunctions to prevent
breaches of this Agreement and to enforce specifically the terms and provisions hereof in any court of the United States or any state
having jurisdiction, this being in addition to any other remedy to which they are entitled at law or in equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7
<span style="text-decoration: underline">Governing Law</span>. This Agreement shall be governed by and construed in accordance with the internal law of the State of New York
regardless of the law that might otherwise govern under applicable principles of conflicts of law thereof. Notwithstanding the foregoing,
the Merger and the exercise of appraisal and dissenters&#8217; rights under the Cayman Companies Act, the fiduciary or other duties of
the board of directors of Parent, Merger Sub, NewCo and Company with respect of the Merger, shall in each case be construed, performed
and enforced in accordance with the Laws of the Cayman Islands in respect of which each of the Parties hereto irrevocably submits it
to the non-exclusive jurisdiction of the courts of the Cayman Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 411; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8
<span style="text-decoration: underline">Consent to Jurisdiction; WAIVER OF JURY TRIAL</span>. Each of the Parties hereto irrevocably consents to the exclusive jurisdiction and
venue of the Supreme Court of the State of New York for the County of New York or in the United States District Court for the Southern
District of New York in connection with any matter arising under the Laws of the State of New York based upon or arising out of this
Agreement or the Transactions, agrees that process may be served upon them by sending notice in accordance with <span style="text-decoration: underline">Section 10.1</span> or
in any manner authorized by the laws of the State of New York for such persons, and waives and covenants not to assert or plead any objection
which they might otherwise have to such jurisdiction, venue and manner of service of process. Each Party hereto hereby agrees not to
commence any legal proceedings arising under the Laws of the State of New York relating to or arising out of this Agreement or the Transactions
in any jurisdiction or courts other than as provided herein. THE PARTIES HEREBY UNCONDITIONALLY AND IRREVOCABLY WAIVE (AND SHALL CAUSE
THEIR SUBSIDIARIES AND AFFILIATES TO WAIVE) THEIR RIGHT TO TRIAL BY JURY IN ANY JUDICIAL PROCEEDING IN ANY COURT RELATING TO ANY DISPUTE,
CONTROVERSY OR CLAIM ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS TRANSACTION AGREEMENTS (INCLUDING ANY SCHEDULE OR EXHIBIT
HERETO AND THERETO) OR THE BREACH, TERMINATION OR VALIDITY OF SUCH AGREEMENTS OR THE NEGOTIATION, EXECUTION OR PERFORMANCE OF SUCH AGREEMENTS.
NO PARTY TO THIS AGREEMENT SHALL SEEK A JURY TRIAL IN ANY LAWSUIT, PROCEEDING, COUNTERCLAIM OR ANY OTHER LITIGATION PROCEDURE BASED UPON,
OR ARISING OUT OF, THE TRANSACTOIN AGREEMENTS, THE MERGER, OR ANY RELATED INSTRUMENTS. NO PARTY WILL SEEK TO CONSOLIDATE ANY SUCH ACTION
IN WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT BE OR HAS NOT BEEN WAIVED. EACH PARTY TO THIS
AGREEMENT CERTIFIES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT OR INSTRUMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND
CERTIFICATIONS SET FORTH ABOVE IN THIS <span style="text-decoration: underline">SECTION 10.8</span>. NO PARTY OR REPRESENTATIVE OF ANY PARTY HAS IN ANY WAY AGREED WITH OR REPRESENTED
TO ANY OTHER PARTY THAT THE PROVISIONS OF THIS <span style="text-decoration: underline">SECTION 10.8</span> WILL NOT BE FULLY ENFORCED IN ALL INSTANCES.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9
<span style="text-decoration: underline">Rules of Construction</span>. The Parties hereto agree that they have been represented by counsel during the negotiation and execution
of this Agreement and, therefore, waive the application of any law, regulation, holding or rule of construction providing that ambiguities
in an agreement or other document will be construed against the Party drafting such agreement or document.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10
<span style="text-decoration: underline">Assignment</span>. No Party may assign either this Agreement or any of its rights, interests, or obligations hereunder without the prior
written approval of the other Parties; provided, however, that a Parent Shareholder may assign its rights and interests in connection
with estate planning purposes so long as such assignee assumes such Shareholder&#8217;s obligations hereunder. Subject to the first sentence
of this <span style="text-decoration: underline">Section 10.10</span>, this Agreement shall be binding upon and shall inure to the benefit of the Parties hereto and their respective
successors and permitted assigns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 412; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11
<span style="text-decoration: underline">Amendment</span>. This Agreement may be amended by the Parties hereto at any time by execution of an instrument in writing signed on
behalf of each of the Parties; <span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">however</span>, that after the Closing, any such amendment shall be approved in writing
by the Committee and the Representative.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12
<span style="text-decoration: underline">Extension; Waiver</span>. At any time prior to the Closing, any Party hereto may, to the extent legally allowed, (i) extend the time
for the performance of any of the obligations or other acts of the other Parties hereto, (ii) waive any inaccuracies in the representations
and warranties made to such Party contained herein or in any document delivered pursuant hereto, and (iii) waive compliance with any
of the agreements or conditions for the benefit of such Party contained herein. Any agreement on the part of a Party hereto to any such
extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of such Party. Delay in exercising
any right under this Agreement shall not constitute a waiver of such right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13
<span style="text-decoration: underline">Disclosure Schedules</span>. The information furnished in the Disclosure Schedules is arranged in sections corresponding to the Sections
of this Agreement, and the disclosures in any section of the Disclosure Schedules shall qualify (a) the corresponding Section of this
Agreement and (b) other Sections of this Agreement to the extent (notwithstanding the absence of a specific cross-reference), that it
is clear from a reasonable reading of the Disclosure Schedules and such other Sections of this Agreement that such disclosure is also
applicable to such other Sections of this Agreement. The Disclosure Schedules and the information and disclosures contained in such Schedules
are intended only to qualify and limit the representations and warranties of the parties contained in this Agreement and shall not be
deemed to expand in any way the scope of any such representation or warranty. The inclusion of any information in the Disclosure Schedules
shall not be deemed to be an admission or acknowledgment that such information is material or outside the ordinary course of business.
The inclusion of any fact or information in a Dislcosure Schedule is not intended to be construed as an admission or concession as to
the legal effect of any such fact or information in any proceeding between any party and any Person who is not a party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<i>Signature
Page Follows</i>]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 413; Value: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed as of the date first written above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BOWEN
    ACQUISITION CORP</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><i>/s/ Na Gai</i></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">Na Gai</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">Chairwoman</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BOWEN
    MERGER SUB</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><i>/s/ Na Gai</i></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">Na Gai</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">Sole Director</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHENZHEN
    QIANZHI BIOTECHNOLOGY CO., LTD</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><i>/s/ Juxiang Hu</i></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">Juxiang Hu</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">Legal Representative</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QIANZHI
    GROUP HOLDING (CAYMAN) LIMITED</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><i>/s/ Xiaoqin Lin</i></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">Xiaoqin Lin</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">Director</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>[Signature
Page to Agreement and Plan of Merger]</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 414 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_042"></span>ANNEX
B &#8211; 2024 EQUITY INCENTIVE PLAN</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EMERALD,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024
EQUITY INCENTIVE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<span style="text-decoration: underline">Purposes of the Plan</span>. The purposes of this Plan are to attract and retain the best available personnel, to provide additional
incentives to Employees, Directors and Consultants and to promote the success of the Company&#8217;s business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<span style="text-decoration: underline">Definitions</span>. The following definitions shall apply as used herein and in the individual Award Agreements except as defined otherwise
in an individual Award Agreement. In the event a term is separately defined in an individual Award Agreement, such definition shall supersede
the definition contained in this Section 2.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&#8220;<span style="text-decoration: underline">Administrator</span>&#8221; shall refer to the Board or the Committee, as applicable. The Administrator may delegate its duties
and powers under this 2024 Equity Incentive Plan in whole or in part to a person or a board committee designated by it in accordance
with Applicable Law and the M&amp;A.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&#8220;<span style="text-decoration: underline">Affiliate</span>&#8221; means (a) with respect to a Person, any other Person that, directly or indirectly, Controls, is Controlled
by or is under common Control with such Person; and (b) in the case of an individual, shall include his/her parents, spouse, children
(and their spouses, if any), siblings (and their spouses, if any), and other immediate family members, or any Person Controlled by any
of the aforesaid individuals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&#8220;<span style="text-decoration: underline">Applicable Laws</span>&#8221; means the legal requirements relating to the Plan and the Awards under applicable laws, regulations,
rules, federal securities laws, state corporate and securities laws, the rules of any applicable stock exchange or national market system,
the U.S. Code, and the laws, regulations, orders or rules of any jurisdiction applicable to the Awards granted to residents therein or
the Grantees receiving such Awards, including but not limited to the respective applicable laws of the People&#8217;s Republic of China
and of the Cayman Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&#8220;<span style="text-decoration: underline">Assumed</span>&#8221; means that pursuant to a Corporate Transaction either (i) the Award is expressly affirmed by the Company
or (ii) the contractual obligations represented by the Award are expressly assumed (and not simply by operation of law) by the successor
entity or its Parent in connection with the Corporate Transaction with appropriate adjustments to the number and type of securities of
the successor entity or its Parent subject to the Award and the exercise or purchase price thereof which at least preserves the compensation
element of the Award existing at the time of the Corporate Transaction as determined in accordance with the instruments evidencing the
agreement to assume the Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&#8220;<span style="text-decoration: underline">Award</span>&#8221; means, individually or collectively, the grant of an Option, SAR, Dividend Equivalent Right, Restricted Share,
Restricted Share Unit or other right or benefit under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&#8220;<span style="text-decoration: underline">Award Agreement</span>&#8221; means the written agreement evidencing the grant of an Award executed by the Company and the Grantee,
including any amendments thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&#8220;<span style="text-decoration: underline">Board</span>&#8221; means the board of directors of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&#8220;<span style="text-decoration: underline">Business Combination Agreement</span>&#8221; means the Business Combination Agreement dated January 18, 2024, by and among the
Company (formerly as Bowen Acquisition Corp), Bowen Merger Sub, Shenzhen Qianzhi Biotechnology Co., Ltd., and Qianzhi Group Holding (Cayman)
Limited, as amended, restated and/or supplemented from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 415; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&#8220;<span style="text-decoration: underline">Cause</span>&#8221; means, in the determination of the Administrator, the Grantee&#8217;s: (i) performance of any act or failure
to perform any act in bad faith and to the detriment of the Company or a Related Entity (economical or reputational), (ii) commitment
of an act of theft, embezzlement, fraud, or a breach of trust, (iii) breach of a fiduciary duty, or commission of a crime (other than
minor traffic violations or similar offenses), (iv) material violation of any Applicable Laws or securities laws, (v) any intentional
act in a manner detrimental to the reputation, business operation, assets, or market image of the Company or any Related Entity, (vi)
negligence in performing, or refusal to perform, any major duties to the Company or a Related Entity, or material violation of any code
of conduct, rules, regulations, or policies of the Company or a Related Entity, or (vii) any intentional misconduct or any breach of
any labor contract (employment agreement), non-disclosure obligation, non-competition obligation, non-solicitation obligation or other
agreement between the Grantee and the Company or a Related Entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&#8220;<span style="text-decoration: underline">Committee</span>&#8221; shall mean a compensation committee of the Board or another board committee designated by the Board to
administer this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
&#8220;<span style="text-decoration: underline">Company</span>&#8221; means Emerald, Inc. (formerly as Bowen Acquisition Corp), an exempted company incorporated with limited
liability under the laws of the Cayman Islands, or any successor corporation that adopts the Plan in connection with a Corporate Transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
&#8220;<span style="text-decoration: underline">Consultant</span>&#8221; means any person (other than an Employee or a Director, solely with respect to rendering services in
such person&#8217;s capacity as an Employee or Director) who is engaged by the Company or any Related Entity to render consulting or
advisory services to the Company or such Related Entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
&#8220;<span style="text-decoration: underline">Continuous Service</span>&#8221; means the provision of services to the Company or a Related Entity in any capacity of an Employee,
Director or Consultant that is not interrupted or terminated. In jurisdictions requiring notice in advance of an effective termination
as an Employee, Director or Consultant, Continuous Service shall be deemed terminated upon the actual cessation of providing services
to the Company or a Related Entity notwithstanding any required notice period that must be fulfilled before a termination as an Employee,
Director or Consultant can be effective under Applicable Laws. A Grantee&#8217;s Continuous Service shall be deemed to have terminated
either upon an actual termination of Continuous Service or upon the entity for which the Grantee provides services ceasing to be a Related
Entity. Continuous Service shall not be considered interrupted in the case of (i) any approved leave of absence, (ii) transfers among
the Company, any Related Entity, or any successor, in any capacity of Employee, Director or Consultant, or (iii) any change in status
as long as the individual remains in the service of the Company or a Related Entity in any capacity of Employee, Director or Consultant
(except as otherwise provided in the Award Agreement); provided that, in case any approved leave of absence is of a period longer than
thirty (30) days or a longer period set forth under the Award Agreement (the &#8220;<span style="text-decoration: underline">Long Leave</span>&#8221;), the Administrator may
at its sole discretion determine that the vesting schedule with respect to the Award granted to such Employee, Director or Consultant
shall be suspended during such Long Leave and resume upon the termination of the Long Leave, and shall be expended by the length of the
suspension. An approved leave of absence shall include sick leave, military leave, or any other authorized personal leave.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
&#8220;<span style="text-decoration: underline">Control</span>&#8221; of a given Person means the power or authority, whether exercised or not, to direct the business, management
and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; provided,
that such power or authority shall conclusively be presumed to exist upon possession of beneficial ownership or power to direct the vote
of more than fifty percent (50%) of the votes entitled to be cast at a meeting of the members or shareholders of such Person or power
to control the composition of a majority of the board of directors of such Person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 416; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
&#8220;<span style="text-decoration: underline">Corporate Transaction</span>&#8221; means (as determined by the Administrator acting reasonably) any of the following transactions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
a merger, amalgamation, consolidation or other business combination of the Company with or into any Person, in which the Company is not
the surviving entity, or any other transaction or series of transactions, as a result of which the shareholders of the Company immediately
prior to such transaction or series of transactions will cease to own a majority of the voting power of the surviving entity immediately
after consummation of such transaction or series of transactions, except for a transaction the principal purpose of which is to change
the state or country in which the Company is incorporated;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.4in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the sale, transfer, exclusive license or other disposition of all or substantially all of the assets of the Company and its Subsidiaries;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.4in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the complete liquidation or dissolution of the Company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.4in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
any reverse merger or series of related transactions culminating in a reverse merger (including, but not limited to, a tender offer followed
by a reverse merger) in which the Company is the surviving entity but (A) the Ordinary Shares outstanding immediately prior to such merger
are converted or exchanged by virtue of the merger into other property, whether in the form of securities, cash or otherwise, or (B)
in which securities possessing more than fifty percent (50%) of the total combined voting power of the Company&#8217;s outstanding securities
are transferred to a Person or Persons different from those who held such securities immediately prior to such merger or the initial
transaction culminating in such merger; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
the acquisition in a single or series of related transactions by any Person or related group of Persons (other than the Company or by
a Company-sponsored employee benefit plan) of beneficial ownership of securities possessing more than fifty percent (50%) of the total
combined voting power of the Company&#8217;s outstanding securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.4in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
&#8220;<span style="text-decoration: underline">Director</span>&#8221; means a member of the Board or the board of directors of any Related Entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
&#8220;<span style="text-decoration: underline">Disability</span>&#8221; means that a Grantee is unable to carry out the responsibilities and functions of the position held by
the Grantee by reason of any medically determinable physical or mental impairment for a period of not less than ninety (90) consecutive
days. A Grantee will not be considered to have incurred a Disability unless he or she furnishes proof of such impairment sufficient to
satisfy the Administrator in its reasonable discretion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
&#8220;<span style="text-decoration: underline">Dividend Equivalent Right</span>&#8221; means a right entitling the Grantee to compensation measured by dividends paid with respect
to Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
&#8220;<span style="text-decoration: underline">Employee</span>&#8221; means any person, including a Director, who is in the employment of the Company or any Related Entity,
subject to the control and direction of the Company or any Related Entity as to both the work to be performed and the manner and method
of performance. The payment of a Director&#8217;s fee to a Director or consulting fee to a Consultant by the Company or a Related Entity
shall not be sufficient to constitute &#8220;employment&#8221; by the Company or the Related Entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
&#8220;<span style="text-decoration: underline">Fair Market Value</span>&#8221; means, with respect to any property (including, without limitation, any Shares or other securities)
the fair market value of such property determined by such methods or procedures as shall be established from time to time by the Administrator;
provided, however, that with respect to any Shares, the Fair Market Value per Share shall be in no event be lower than the par value
of such Share, and,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 417; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
if the Shares of the Company are listed on any established stock exchange or a U.S. national market system, including without limitation
the New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market
of The Nasdaq Stock Market, its Fair Market Value will be the closing sale price for such stock (or the closing bid, if no sales were
reported) as quoted on such exchange or system on the day of determination, as reported in <i>The Wall Street Journal</i> or such other
source as the Administrator deems reliable. If the determination date for the Fair Market Value occurs on a non-Trading Day (i.e., a
weekend or holiday), the Fair Market Value will be such price on the immediately preceding Trading Day, unless otherwise determined by
the Administrator;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
if the Shares of the Company are regularly quoted by a recognized securities dealer but selling prices are not reported, or if the Shares
are quoted on the Over-the-Counter (OTC) market (including on the OTCQB, OTCBB or Pink Sheets), the Fair Market Value of a Share will
be the mean between the high bid and low asked prices for the Shares on the day of determination, as reported in <i>The Wall Street Journal</i>,
the OTC, or such other source as the Administrator deems reliable. If the determination date for the Fair Market Value occurs on a non-Trading
Day (i.e., a weekend or holiday), the Fair Market Value will be such price on the immediately preceding Trading Day, unless otherwise
determined by the Administrator; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
in the absence of an established market for the Shares, the Fair Market Value will be determined in good faith by the Administrator after
taking into account such factors as the Administrator shall deem appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
&#8220;<span style="text-decoration: underline">Fiscal Year</span>&#8221; means the fiscal year of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
&#8220;<span style="text-decoration: underline">Grantee</span>&#8221; means an Employee, Director, or Consultant who receives an Award under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
&#8220;<span style="text-decoration: underline">Incentive Stock Option</span>&#8221; shall mean a stock option granted pursuant to the Plan that by its terms qualifies and is
otherwise intended to qualify as an incentive stock option within the meaning of Section 422 of the U.S. Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
&#8220;<span style="text-decoration: underline">M&amp;A</span>&#8221; means the currently effective memorandum and articles of association of the Company, as amended from time
to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
&#8220;<span style="text-decoration: underline">Ordinary Share</span>&#8221; means the Company&#8217;s ordinary shares of a par value of US$0.0001 each.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
&#8220;<span style="text-decoration: underline">Option</span>&#8221; means an option to purchase Shares pursuant to an Award Agreement granted under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
&#8220;<span style="text-decoration: underline">Parent</span>&#8221; means any company (other than the Company) in an unbroken chain of companies ending with the Company, if
each of the companies (other than the Company) owns or Controls stock possessing 50% or more of the total combined voting power of all
classes of stock in one of the other companies in such chain. A company that attains the status of a Parent on a date after the adoption
of the Plan shall be considered a Parent commencing as of such date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 418; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
&#8220;<span style="text-decoration: underline">Person</span>&#8221; means any individual, corporation, partnership, limited partnership, limited liability company, firm, joint
venture, estate, trust, unincorporated organization, association, enterprise, institution, public benefit corporation, entity or governmental
or regulatory authority or other entity of any kind or nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
&#8220;<span style="text-decoration: underline">Plan</span>&#8221; means this 2024 Equity Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
Intentionally omitted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
&#8220;<span style="text-decoration: underline">Related Entity</span>&#8221; means any Parent or Subsidiary or Affiliate of the Company and any business, corporation, partnership,
limited liability company or other entity in which the Company or a Parent or a Subsidiary or an Affiliate of the Company holds a substantial
ownership interest, directly or indirectly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
&#8220;<span style="text-decoration: underline">Replaced</span>&#8221; means that pursuant to a Corporate Transaction the Award is replaced with a comparable share or stock award
or a cash incentive program of the Company, the successor entity (if applicable) or Parent of either of them which preserves the compensation
element of such Award existing at the time of the Corporate Transaction and provides for subsequent payout in accordance with the same
(or a more favorable) vesting schedule applicable to such Award. The determination of Award comparability shall be made by the Administrator
and its determination shall be final, binding and conclusive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
&#8220;<span style="text-decoration: underline">Restricted Share</span>&#8221; means a Share issued under the Plan to the Grantee for such consideration, if any, and subject
to such restrictions on transfer, rights of first refusal, repurchase provisions, forfeiture provisions, and other terms and conditions
as established by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
&#8220;<span style="text-decoration: underline">Restricted Share Units</span>&#8221; means an Award which may be earned in whole or in part upon the passage of time or the attainment
of performance criteria established by the Administrator and which may be settled for cash, Shares or other securities or a combination
of cash, Shares or other securities as established by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
&#8220;<span style="text-decoration: underline">SAR</span>&#8221; means a share appreciation right entitling the Grantee to Shares or cash compensation, as established by the
Administrator, measured by appreciation in the value of Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
&#8220;<span style="text-decoration: underline">Share</span>&#8221; means an Ordinary Share of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
&#8220;<span style="text-decoration: underline">Spin-off Transaction</span>&#8221; means a distribution by the Company to its shareholders of all or any portion of the securities
of any Subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
&#8220;<span style="text-decoration: underline">Subsidiary</span>&#8221; means with respect to a specific entity, (i) any entity (x) more than fifty percent (50%) of whose shares
or other interests entitled to vote in the election of directors or (y) more than a fifty percent (50%) interests in whose profits or
capital, are owned or Controlled directly or indirectly by the subject entity or through one (1) or more Subsidiaries of the subject
entity; (ii) any entity whose assets, or portions thereof, are consolidated with the net earnings of the subject entity and are recorded
on the books of the subject entity for financial reporting purposes in accordance with U.S. GAAP; or (iii) any entity with respect to
which the subject entity has the power to otherwise direct the business and policies of that entity directly or indirectly through another
Subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 419; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
&#8220;<span style="text-decoration: underline">Trading Day</span>&#8221; means a day that the primary stock exchange (or share exchange), national market system, or other trading
platform, as applicable, upon which the Shares are listed (or otherwise trades regularly, as determined by the Administrator, in its
sole discretion) is open for trading.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
&#8220;<span style="text-decoration: underline">U.S. Code</span>&#8221; means the U.S. Internal Revenue Code of 1986, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<span style="text-decoration: underline">Shares Subject to the Plan</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Shares to be issued pursuant to the Awards under this Plan shall be authorized, but unissued, or reacquired, Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Subject to adjustment upon changes in capitalization of the Company as provided in Section 13 and the automatic increase set forth in
Section 3(d), the maximum aggregate number of Shares that may be subject to Awards and sold under the Plan shall initially be [ ] Ordinary
Shares, which is equal to five percent (5%) of the aggregate number of Ordinary Shares issued and outstanding immediately after the Closing
(as defined in the Business Combination Agreement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Any Shares covered by an Award (or portion of an Award) which is forfeited, canceled or expires (whether voluntarily or involuntarily)
shall be deemed not to have been issued for purposes of determining the maximum aggregate number of Shares which may be issued under
the Plan. Shares that actually have been issued under the Plan pursuant to an Award shall not be returned to the Plan and shall not become
available for future issuance under the Plan, except that if unvested Shares are forfeited or repurchased by the Company, such Shares
shall become available for future grant under the Plan. Shares covered by an Award which are surrendered (i) in payment of the Award
exercise or purchase price or (ii) in satisfaction of tax withholding obligations incident to the exercise of an Award shall not be returned
to the Plan and shall not become available for future issuance under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Subject to adjustment upon changes in capitalization of the Company as provided in Section 13, the number of Shares available for issuance
under this Plan will automatically increase on the first day of each Fiscal Year beginning with the 2025 Fiscal Year, by a number of
Ordinary Shares such that the total number of Shares that may be issued under the Plan shall equal five percent (5%) of the aggregate
number of Ordinary Shares outstanding on the last day of the immediately preceding Fiscal Year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<span style="text-decoration: underline">Administration of the Plan</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Plan Administrator</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<span style="text-decoration: underline">Administration</span>. The Plan shall be administered by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<span style="text-decoration: underline">Administration Errors</span>. In the event an Award is granted in a manner inconsistent with the provisions of this subsection (a), such
Award shall be presumptively valid as of its grant date to the extent permitted by the Applicable Laws and approved by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Powers of the Administrator</span>. Subject to Applicable Laws and the provisions of the Plan (including any other powers given to the
Administrator hereunder), and except as otherwise provided by the Board, the Administrator shall have the authority, in its discretion:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
to select the Employees, Directors and Consultants to whom Awards may be granted from time to time hereunder;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
to determine whether and to what extent Awards are granted hereunder;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 420; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
to determine the type and the number of Awards to be granted, the number of Shares and the amount of consideration to be covered by each
Award granted hereunder;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
to approve forms of Award Agreements for use under the Plan, to amend terms of the Award Agreements;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
to determine or alter the terms and conditions of any Award granted hereunder (including without limitation the vesting schedule and
exercise price set forth in the Notice of Stock Option Award and the Award Agreements, any restrictions or limitations on the Award,
any schedule for lapse of forfeiture restrictions or restrictions on the exercisability of an Award, and accelerations or waivers thereof,
based in each case on such considerations as the Administrator in its sole discretion determines);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
to determine whether, to what extent, and under what circumstances Awards may be settled or exercised in cash, Shares, other securities,
other Awards, or other property, or canceled, forfeited or suspended, and the method or methods by which Awards may be settled, exercised,
canceled, forfeited or suspended and to determine whether, to what extent, and under what circumstances cash, Shares, other securities,
other Awards, other property, and other amounts payable with respect to an Award under this Plan shall be deferred either automatically
or at the election of the holder thereof or of the Administrator;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
to amend the terms of any outstanding Award granted under the Plan, provided that any amendment that would adversely affect the Grantee&#8217;s
rights under an outstanding Award in material aspects shall not be made without the Grantee&#8217;s written consent;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
to construe and interpret the terms of the Plan and Awards, including without limitation, any notice of award or Award Agreement, granted
pursuant to the Plan;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
to establish, prescribe, amend and rescind rules and terms of or relating to the Plan, including rules and terms relating to sub-plans
established for the purpose of satisfying applicable foreign laws or for qualifying for favorable tax treatment under applicable foreign
laws;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
to determine whether and to what extent Awards should continue being effective following a Corporate Transaction;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
to determine the Fair Market Value;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)
to execute on behalf of the Company any instrument required to effect the grant of an Award;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)
to require a Grantee to provide representation or evidence that any currency used to pay the exercise price of any Award was legally
acquired and taken out of the jurisdiction in which the Grantee resides in accordance with the Applicable Laws;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)
to correct any defect, omission or inconsistency in the Plan or any Award Agreement; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv)
to take such other action, not inconsistent with the terms of the Plan and the Applicable Laws, as the Administrator deems appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 421; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
All decisions of the Administrator shall be final, conclusive and binding upon all persons, including the Company, the shareholders of
the Company and the Grantees and their beneficiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">Indemnification</span>. In addition to such other rights of indemnification as they may have as members of the Board or Employees of
the Company or a Related Entity, members of the Board and any Employees of the Company or a Related Entity to whom authority to act for
the Board, the Administrator or the Company is delegated shall be defended and indemnified by the Company to the extent permitted by
Applicable Law and in the manner approved by the Administrator, on an after-tax basis, against all reasonable expenses, including attorneys&#8217;
fees, actually and necessarily incurred in connection with the defense of any claim, investigation, action, suit or proceeding, or in
connection with any appeal therein, to which they or any of them may be a party by reason of any action taken or failure to act under
or in connection with the Plan, or any Award granted hereunder, and against all amounts paid by them in settlement thereof (provided
such settlement is approved by the Company) or paid by them in satisfaction of a judgment in any such claim, investigation, action, suit
or proceeding, except in relation to matters as to which it shall be adjudged in such claim, investigation, action, suit or proceeding
that such Person is liable for gross negligence, bad faith or intentional misconduct; provided, however, that within thirty (30) days
after the institution of such claim, investigation, action, suit or proceeding, such Person shall offer to the Company, in writing, the
opportunity at the Company&#8217;s expense to defend the same.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<span style="text-decoration: underline">Eligibility</span>. Awards may be granted to Employees, Directors and Consultants. An Employee, Director or Consultant who has been granted
an Award may, if otherwise eligible, be granted additional Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<span style="text-decoration: underline">Terms and Conditions Applicable to Awards Generally</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Types of Awards</span>. The Administrator is authorized under the Plan to grant an Award to an Employee, Director or Consultant that
is not inconsistent with the provisions of the Plan and that by its terms involves or might involve the issuance of (i) Shares, (ii)
cash, or (iii) an Option, a SAR or similar right with a fixed or variable price which may be related to the Fair Market Value of the
Shares and with an exercise or conversion privilege related to the passage of time, the occurrence of one or more events, or the satisfaction
of performance criteria or other conditions. Such awards include, without limitation, Options, SARs, Restricted Shares, Restricted Share
Units, Dividend Equivalent Rights or other types of awards approved by the Administrator, and an Award may consist of one such security
or benefit, or two (2) or more of them in any combination or alternative. Awards shall be granted for no cash consideration or for such
minimal cash consideration as may be required by Applicable Laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Designation of Award</span>. All Awards shall be evidenced by an Award Agreement between the Company and each Grantee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Conditions of Award</span>. Subject to the terms of the Plan, the Administrator shall determine the provisions, terms, and conditions
of each Award including, but not limited to, the Award vesting schedule, repurchase provisions, rights of first refusal, forfeiture provisions,
form of payment (cash, Shares, or other consideration) upon settlement of the Award, payment contingencies, the extent to which any vesting
schedule or schedule for lapse of forfeiture or exercisability restrictions may be accelerated or waived, and satisfaction of any performance
criteria, while the identities of Grantees and the number of Shares to be covered by such Award shall be determined by the Administrator.
Each Award shall be subject to the terms of an Award Agreement approved by the Administrator. The performance criteria established by
the Administrator may be based on any one of, or combination of, the following: (i) increase in share price, (ii) earnings per share,
(iii) total shareholder return, (iv) operating margin, (v) gross margin, (vi) return on equity, (vii) return on assets, (viii) return
on investment, (ix) operating income, (x) net operating income, (xi) pre-tax profit, (xii) cash flow, (xiii) revenue, (xiv) expenses,
(xv) earnings before interest, taxes and depreciation, (xvi) economic value added and (xvii) market share. The performance criteria may
be applicable to the Company, Related Entities and/or any individual business units of the Company or any Related Entity. Partial achievement
of the specified criteria may result in a payment or vesting corresponding to the degree of achievement as specified in the Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 422; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">Acquisitions and Other Transactions</span>. The Administrator may issue Awards under the Plan in settlement, assumption or substitution
for, outstanding awards or obligations to grant future awards in connection with the Company or a Related Entity acquiring another entity,
an interest in another entity or an additional interest in a Related Entity whether by merger, share purchase, asset purchase or other
form of transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<span style="text-decoration: underline">Deferral of Award Payment</span>. The Administrator may establish one or more programs under the Plan to permit Grantees the opportunity
to elect to defer receipt of consideration upon exercise of an Award (other than an Award held by a U.S. taxpayer), satisfaction of performance
criteria, or other event that absent the election would entitle the Grantee to payment or receipt of Shares or other consideration under
an Award. The Administrator may establish the election procedures, the timing of such elections, the mechanisms for payments of, and
accrual of interest or other earnings, if any, on amounts, Shares or other consideration so deferred, and such other terms, conditions,
rules and procedures that the Administrator deems advisable for the administration of any such deferral program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<span style="text-decoration: underline">Separate Programs</span>. The Administrator may establish one or more separate programs under the Plan for the purpose of issuing particular
forms of Awards to one or more classes of Grantees on such terms and conditions as determined by the Administrator from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<span style="text-decoration: underline">Multiple Awards</span>. Awards may, in the discretion of the Administrator, be granted either alone or in addition to or in tandem with
any other Award or any award granted under any other plan of the Company. Awards granted in addition to or in tandem with other Awards,
or in addition to or in tandem with awards granted under any other plan of the Company, may be granted either at the same time as or
at a different time from the grant of such other Awards or awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<span style="text-decoration: underline">Term of Award</span>. The term of each Award shall be the term stated in the Award Agreement. Notwithstanding the foregoing, the specified
term of any Award shall not include any period for which the Grantee has elected to defer the receipt of the Shares or cash issuable
pursuant to the Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<span style="text-decoration: underline">Post-Termination Exercises</span>. The Administrator shall establish and set forth in each Award Agreement that evidences an Award whether
an Award shall continue to be exercisable, and the terms and conditions of such exercise, after the cessation of Grantee&#8217;s Continuous
Service, any of which provisions may be waived or modified by the Administrator at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<span style="text-decoration: underline">Transferability of Awards</span>. Unless the Board or the Administrator shall otherwise determine, no Award and no right under any such
Award, shall be assignable, alienable, saleable or transferable by a Grantee otherwise than by will or by the laws of descent and distribution;
provided, however, that, if so determined by the Administrator or the Board, a Grantee may, in the manner established by the Administrator,
designate a beneficiary or beneficiaries to exercise the rights of the Grantee, and to receive any property distributable, with respect
to any Award upon the death of the Grantee. Each Award, and each right under any Award, shall be exercisable during the Grantee&#8217;s
lifetime only by the Grantee or, if permissible under Applicable Laws and the applicable Award Agreement, by the Grantee&#8217;s guardian
or legal representative. No Award and no right under any such Award, may be pledged, charged, mortgaged, alienated, attached, or otherwise
encumbered, and any purported pledge, charge, mortgage, alienation, attachment or encumbrance thereof shall be void and unenforceable
against the Company. The provisions of this paragraph shall not apply to any Award which has been fully exercised, earned or paid, as
the case may be, and shall not preclude forfeiture of an Award in accordance with the terms hereof and of the applicable Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 423; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<span style="text-decoration: underline">Time of Granting Awards</span>. The date of grant of an Award shall for all purposes be the date on which the Administrator makes the
determination to grant such Award, or such other date as is determined by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<span style="text-decoration: underline">Award Exercise or Purchase Price, Consideration and Taxes</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Exercise or Purchase Price</span>. The exercise or purchase price, if any, for an Award shall be determined by the Administrator. Notwithstanding
the foregoing provisions of this Section 7(a), in the case of an Award issued pursuant to Section 6(d), above, the exercise or purchase
price for the Award shall be determined in accordance with the provisions of the relevant instrument evidencing the agreement to issue
such Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Consideration</span>. Subject to Applicable Laws, the consideration to be paid for the Shares to be issued upon exercise or purchase
of an Award including the method of payment, shall be determined by the Administrator, save that the consideration per Share shall in
any event be no less than the par value per such Share. In addition to any other types of consideration the Administrator may determine,
the Administrator is authorized to accept as consideration for Shares issued under the Plan the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
cash;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
check;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
to the extent permitted by the Administrator, surrender of Shares or delivery of a properly executed form of attestation of ownership
of Shares as the Administrator may require which have a Fair Market Value on the date of surrender or attestation equal to the aggregate
exercise price of the Shares as to which said Award shall be exercised;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
with respect to Options, payment through a broker-dealer sale and remittance procedure pursuant to which the Grantee (A) shall provide
written instructions to a Company designated brokerage firm to effect the immediate sale of some or all of the purchased Shares and remit
to the Company sufficient funds to cover the aggregate exercise price payable for the purchased Shares and (B) shall provide written
directives to the Company to deliver the certificates for the purchased Shares directly to such brokerage firm in order to complete the
sale transaction; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
any combination of the foregoing methods of payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Administrator may at any time or from time to time, by adoption of or by amendment to the standard forms of Award Agreement described
in Section 4(b)(iv), or by other means, grant Awards which do not permit all of the foregoing forms of consideration to be used in payment
for the Shares or which otherwise restrict one or more forms of consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 59pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 424; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Taxes</span>. No Shares shall be delivered under the Plan to any Grantee until such Grantee has made arrangements acceptable to the Administrator
for the satisfaction of any income and employment tax withholding obligations under Applicable Laws. The Company or any of its Related
Entities which is an employer of the Grantee shall have the authority and the right to deduct or withhold, or require a Grantee to remit
to the Company or its subsidiaries, an amount sufficient to satisfy all applicable taxes (including the Grantee&#8217;s payroll tax obligations)
required or permitted by Applicable Laws to be withheld with respect to any taxable event concerning a Grantee arising as a result of
the Plan. The Administrator may in its discretion and in satisfaction of the foregoing requirement allow a Grantee to elect to have the
Company withhold Shares otherwise issuable under an Award (or allow the return of Shares) having a Fair Market Value equal to the sum
required to be withheld. Notwithstanding any other provision of the Plan, the number of Shares which may be withheld with respect to
the issuance, vesting, exercise or payment of any Award (or which may be repurchased from the Grantee of such Award after such Shares
were acquired by the Grantee from the Company) in order to satisfy any income and payroll tax liabilities applicable to the Grantee with
respect to the issuance, vesting, exercise or payment of the Award shall, unless specifically approved by the Administrator, be limited
to the number of Shares which have a Fair Market Value on the date of withholding or repurchase equal to the aggregate amount of such
liabilities based on the minimum statutory withholding rates for the applicable income and payroll tax purposes that are applicable to
such supplemental taxable income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<span style="text-decoration: underline">Exercise of Award</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Procedure for Exercise</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Any Award granted hereunder shall be exercisable at such times and under such conditions as determined by the Administrator under the
terms of the Plan and specified in the Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
An Award shall be deemed to be exercised when written notice of such exercise has been given to the Company in accordance with the terms
of the Award by the Person entitled to exercise the Award and full payment for the Shares with respect to which the Award is exercised,
including, to the extent selected, use of the broker-dealer sale and remittance procedure to pay the purchase price as provided in Section
7(b)(iv).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">No Exercise in Violation of Applicable Law. </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, regardless of whether an Award has otherwise become exercisable, the Award shall not be exercised if the Administrator
(in its sole discretion) determines that an exercise would violate any Applicable Laws. Shares shall not be issued pursuant to the exercise
of an Award unless the exercise of such Award and the issuance and delivery of such Shares pursuant thereto shall comply with all Applicable
Laws (including all relevant filings, approvals and registrations (if any) required under the laws of People&#8217;s Republic of China
with respect to the exercise of such Award, including without limitation, those required with the PRC State Administration of Foreign
Exchange).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 59pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<span style="text-decoration: underline">Conditions Upon Issuance of Shares</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Shares shall not be issued pursuant to the exercise of an Award unless the exercise of such Award and the issuance and delivery of such
Shares pursuant thereto shall comply with all Applicable Laws, the M&amp;A and the relevant Award Agreement, and shall be further subject
to the approval of counsel for the Company with respect to such compliance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
As a condition to the exercise of an Award, the Company may require the Person exercising such Award to represent and warrant at the
time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute
such Shares if, in the opinion of counsel for the Company, such a representation is required by any Applicable Laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 425; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
As a condition to the exercise of an Award, the applicable Award Agreement may require the Grantee to grant a power of attorney to the
Board or any Person designated by the Board to exercise the voting rights with respect to the Shares and the Company may require the
Person exercising such Award to acknowledge and agree to be bound by the provisions of the currently effective M&amp;A and other documents
of the Company in relation to the Shares (if any, including any Investor Rights Agreement), as if the Grantee is a holder of Ordinary
Shares thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
All certificates for Shares or other securities delivered under this Plan pursuant to any Award or the exercise thereof shall be subject
to such stop transfer orders and other restrictions as the Administrator may deem advisable under this Plan or the rules, regulations,
and other requirements of the United States Securities and Exchange Commission, any stock exchange upon which such Shares or other securities
are then listed, and any Applicable Laws, and the Administrator may cause a legend or legends to be put on any such certificates to make
appropriate reference to such restrictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<span style="text-decoration: underline">Terms of Options</span>. The Administrator is hereby authorized to grant Options to Grantees with the following terms and conditions
and with such additional terms and conditions, in either case not inconsistent with the provisions of this Plan, as the Administrator
shall determine and set forth in the Award Agreement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The purchase price per Share under an Option shall be as determined by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The term of each Option shall be fixed by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Administrator shall determine the time or times at which an Option may be exercised in whole or in part, the vesting conditions applicable
to the Award, and the method or methods by which, and the form or forms, including, without limitation, cash, Shares, other Awards, or
other property, or any combination thereof, having a Fair Market Value on the exercise date equal to the relevant exercise price, in
which, payment of the exercise price with respect thereto may be made or deemed to have been made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
All Options shall be evidenced by an Award Agreement sent from or on behalf of the Administrator on behalf of the Company to the Grantee.
The Award Agreement shall include such additional provisions as may be specified by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Unless otherwise set forth in an Award Agreement, the termination or cessation of Continuous Service shall have the following effects
on Options granted to the Grantees:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<span style="text-decoration: underline">Dismissal for Cause</span>. If a Grantee&#8217;s employment by or service to the Company or a Related Entity is terminated by the Company
or Related Entity for Cause, the Grantee&#8217;s Options will immediately terminate upon such termination, whether or not the Option
is then vested and/or exercisable;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<span style="text-decoration: underline">Death or Disability</span>. If a Grantee&#8217;s employment by or service to the Company or a Related Entity terminates as a result of
the Grantee&#8217;s death or Disability:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
the Grantee (or his or her legal representative or beneficiary, in the case of the Grantee&#8217;s Disability or death, respectively),
will have the right to exercise the Grantee&#8217;s Options (or portion thereof) until the first anniversary of the date of the termination
of Grantee&#8217;s Continuous Service, to the extent that such Options were vested and exercisable on the date of the Grantee&#8217;s
termination of Continuous Service on account of death or Disability;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 426; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
the Options, to the extent not vested and exercisable on the date of the Grantee&#8217;s termination of Continuous Service, shall immediately
terminate for nil consideration upon the Grantee&#8217;s termination of Continuous Service on account of death or Disability; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
the Options, to the extent exercisable on the date of the Grantee&#8217;s termination of Continuous Service on account of death or Disability
and not exercised prior to the first anniversary of the date of the termination of Grantee&#8217;s Continuous Service, shall terminate
at the close of business on such first anniversary date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<span style="text-decoration: underline">Other Terminations of Continuous Service</span>. If a Grantee&#8217;s Continuous Service to the Company or a Related Entity terminates
for any reason other than a termination by the Company or a Related Entity for Cause or because of the Grantee&#8217;s death or Disability:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
the Grantee will have the right to exercise his or her Options (or portion thereof) until the ninetieth day following the date of the
Grantees termination or cessation of Continuous Service solely to the extent that such Options were vested and exercisable on the date
of the Grantee&#8217;s termination or cessation of Continuous Service;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
the Options, to the extent not vested and exercisable on the date of the Grantee&#8217;s termination or cessation of Continuous Service,
shall terminate immediately upon the Grantee termination or cessation of Continuous Service; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
the Options, to the extent exercisable on the date of the Grantee&#8217;s termination or cessation of Continuous Service and not exercised
prior to the close of business on the ninetieth day following the date of the Grantees termination or cessation of Continuous Service,
shall terminate at the close of business on the ninetieth day following the termination or cessation of Continuous Service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<span style="text-decoration: underline">Terms of Restricted Shares and Restricted Share Units</span>. The Administrator is hereby authorized to grant Awards of Restricted Shares
and Restricted Share Units to Grantees with the following terms and conditions and with such additional terms and conditions, in either
case not inconsistent with the provisions of this Plan, as the Administrator shall determine and set forth in the Award Agreement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Restricted Shares and Restricted Share Units shall be subject to such restrictions as the Administrator may impose (including, without
limitation, any limitation on the right to vote a Restricted Share or the right to receive any dividend or other right or property),
which restrictions may lapse separately or in combination at such time or times, in such installments or otherwise, as the Administrator
may deem appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any Restricted Share or Restricted Share Unit granted under this Plan may be evidenced in such manner as the Administrator may deem appropriate
including, without limitation, as set forth in an Award Agreement, book-entry registration or issuance of a share certificate or certificates,
creation of a new class of shares or amendment of the Memorandum and/or Articles of Association of the Company. Award Agreements shall
specify the period of restriction, the number of Restricted Shares or Restricted Share Units granted, the vesting schedule and such other
terms and conditions as the Administrator, in its sole discretion, may determine. In the event any share certificate is issued in respect
of Restricted Shares granted under this Plan, such certificate shall be registered in the name of the Grantee and shall bear an appropriate
legend referring to the terms, conditions, and restrictions applicable to such Restricted Share.<b>&#8239;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 427; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Issuance and Restrictions</span>. Restricted Shares shall be subject to such restrictions on transferability and other restrictions as
the Administrator may impose (including, without limitation, limitations on transfer, right of first refusal, repurchase provisions,
forfeiture provisions, the right to vote Restricted Shares or the right to receive dividends on the Restricted Share). These restrictions
may lapse separately or in combination at such times, pursuant to such circumstances, in such installments, or otherwise, as the Administrator
determines at the time of the grant of the Award or thereafter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">Form and Timing of Payment of Restricted Share Units</span>. At the time of grant, the Administrator may specify the date or dates on
which the Restricted Share Units shall become fully vested and nonforfeitable. Upon vesting, the Administrator, on behalf of the Company,
may pay Restricted Share Units in the form of cash, in Shares, or other forms of payment or in any combination of the foregoing, as specified
in the Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<span style="text-decoration: underline">Forfeiture/Repurchase</span>. Except as otherwise determined by the Committee at the time of the grant of the Award or thereafter, upon
termination or cessation of Continuous Service during the applicable restriction period, the unvested Restricted Shares and Restricted
Share Units and the Restricted Shares and Restricted Share Units that are at that time subject to restrictions shall be forfeited or
repurchased in accordance with the Award Agreement and Applicable Laws; <i>provided, however</i>, the Administrator may (a) provide in
any Award Agreement evidencing Restricted Shares or Restricted Share Units that restrictions or forfeiture and repurchase conditions
relating to Restricted Shares and Restricted Share Units will be waived in whole or in part in the event of terminations resulting from
specified causes, and (b) in other cases waive in whole or in part restrictions or forfeiture and repurchase conditions relating to Restricted
Shares and Restricted Share Units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<span style="text-decoration: underline">Certificates for Restricted Shares and Restricted Share Units</span>. Restricted Shares and Restricted Share Units granted pursuant to
the Plan may be evidenced in an Award Agreement in such form as the Administrator may determine. If certificates representing Restricted
Shares are issued and registered in the name of the Grantee, certificates must bear an appropriate legend referring to the terms, conditions,
and restrictions applicable to such Restricted Shares, and the Administrator may, at its discretion, retain physical possession of the
certificate until such time as all applicable restrictions lapse.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<span style="text-decoration: underline">Removal of Restrictions on Restricted Shares</span>. Except as otherwise provided in this Article 11, Restricted Shares granted under
the Plan shall be released from escrow as soon as practicable after the last day of the period of restriction. The Administrator, in
its discretion, may accelerate the time at which any restrictions shall lapse or be removed. After the restrictions have lapsed, the
Grantee shall be entitled to have any legend or legends removed from his or her Share certificate, and the Shares shall be freely transferable
by the Grantee, subject to applicable legal restrictions. The Administrator (in its discretion) may establish procedures regarding the
release of Shares from escrow and the removal of legends, as necessary or appropriate to minimize administrative burdens on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<span style="text-decoration: underline">Terms of Other Share-Based Awards</span>. The Administrator is hereby authorized to grant to Grantees such other Awards (including, without
limitation, share appreciation rights and rights to dividends and dividend equivalents) that are denominated or payable in, valued in
whole or in part by reference to, or otherwise based on or related to, Shares (including, without limitation, securities convertible
into Shares) as are deemed by the Administrator to be consistent with the purposes of this Plan, including Sections 6-9 hereof (as may
be appliable). Subject to the terms of this Plan, the Administrator shall determine the terms and conditions of such Awards. Shares or
other securities delivered pursuant to a purchase right granted under this Section 12 shall be purchased for such consideration, which
may be paid by such method or methods and in such form or forms, including, without limitation, cash, Shares, other securities, other
Awards, or other property, or any combination thereof, as the Administrator shall determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 428; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<span style="text-decoration: underline">Adjustments Upon Changes in Capitalization</span>. Subject to any required action by the shareholders of the Company, the number of Shares
covered by each outstanding Award, the number of Shares which have been authorized for issuance under the Plan but as to which no Awards
have yet been granted or which have been returned to the Plan, the exercise or purchase price of each such outstanding Award, the maximum
number of Shares with respect to which Awards may be granted to any Grantee in any Fiscal Year, as well as any other terms that the Administrator
determines require adjustment shall be proportionately adjusted for (i) any increase or decrease in the number of issued Shares resulting
from a share split, reverse share split, share dividend, combination or reclassification of the Shares, or similar transaction affecting
the Shares, (ii) any other increase or decrease in the number of issued Shares effected without receipt of consideration by the Company,
or (iii) as the Administrator may determine in its discretion, any other transaction with respect to Ordinary Shares including a corporate
merger, consolidation, acquisition of property or equity, separation (including a spin-off or other distribution of shares or property),
reorganization, liquidation (whether partial or complete) or any similar transaction; provided, however that conversion of any convertible
securities of the Company shall not be deemed to have been &#8220;effected without receipt of consideration.&#8221; Such adjustment shall
be made by the Administrator and its determination shall be final, binding and conclusive. Except as the Administrator determines, no
issuance by the Company of shares of any class, or securities convertible into shares of any class, shall affect, and no adjustment by
reason hereof shall be made with respect to, the number or price of Shares subject to an Award. In the event of a Spin-off Transaction,
the Administrator may in its discretion make such adjustments and take such other action as it deems appropriate with respect to outstanding
Awards under the Plan, including but not limited to: (i) adjustments to the number and kind of Shares, the exercise or purchase price
per Share and the vesting periods of outstanding Awards, (ii) prohibit the exercise of Awards during certain periods of time prior to
the consummation of a Spin-off Transaction, or (iii) the substitution, exchange or grant of Awards to purchase securities of the Subsidiary;
provided that the Administrator shall not be obligated to make any such adjustments or take any such action hereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<span style="text-decoration: underline">Corporate Transactions</span>. Except as may otherwise be provided in any Award Agreement, if the Committee anticipates the occurrence,
or upon the occurrence, of a Corporate Transaction, the Administrator may, in its sole discretion, provide for (i) any and all Awards
outstanding hereunder to terminate at a specific time in the future and shall give each Grantee the right to exercise the vested portion
of such Awards during a period of time as the Administrator may determine, or (ii) the purchase of any Award for an amount of cash, as
determined by the Administrator in good faith, which may equal to the amount that could have been attained upon the exercise of such
Award (and, for the avoidance of doubt, if as of such date the Administrator determines in good faith that no amount would have been
attained upon the exercise of such Award, then such Award may be terminated by the Company without payment), or (iii) the replacement
of such Award with other rights or property selected by the Administrator in its sole discretion or the assumption of or substitution
of such Award by the successor or surviving corporation, or a Parent or Subsidiary thereof, with appropriate adjustments as to the number
and kind of Shares and prices, which will preserve the rights under the affected Awards previously granted hereunder, or (iv) payment
of Award in cash based on the value of Shares on the date of the Corporate Transaction plus reasonable interest on the Award through
the date when such Award would otherwise be vested or have been paid in accordance with its original terms, if necessary to comply with
Section 409A of the U.S. Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<span style="text-decoration: underline">Effective Date and Term of Plan</span>. The Plan shall be effective upon the later to occur of (a) its adoption by the Board, (b) its
approval by the shareholders of the Company, and (c) the time as of immediately prior to the Effective Time (as defined in the Business
Combination Agreement) (the &#8220;<span style="text-decoration: underline">Effective Date</span>&#8221;). The Plan shall continue in effect for a term of ten (10) years after
the Effective Date, unless sooner terminated. No Award shall be granted under this Plan after the tenth anniversary of the Effective
Date. However, unless otherwise expressly provided in this Plan or in an applicable Award Agreement, any Award theretofore granted may
extend beyond such date, and the authority of the Administrator to amend, alter, adjust, suspend, discontinue, or terminate any such
Award, or to waive any conditions or rights under any such Award, and the authority of the Board to amend this Plan, shall extend beyond
such date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 429; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<span style="text-decoration: underline">Amendment, Suspension or Termination of the Plan</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Except to the extent prohibited by Applicable Laws and unless otherwise expressly provided in an Award Agreement or in this Plan, the
Administrator may amend, alter, suspend, discontinue or terminate this Plan, or any Award Agreement hereunder or any portion hereof or
thereof at any time; <i>provided, however</i>, that, no such amendment, alteration, suspension, discontinuation or termination shall
be made (y) to the extent required by Applicable Laws, without (i) shareholder approval with such legally mandated threshold for a resolution
of the shareholders of the Company, if such approval is necessary to comply with any tax or regulatory requirement for which or with
which the Administrator deems it necessary or desirable to qualify or comply or (ii) shareholder approval with such threshold for a resolution
of the shareholders of the Company in respect of such amendment, alteration, suspension, discontinuation or termination as provided in
the Company&#8217;s Memorandum and Articles of Association for any amendment to this Plan that increases the total number of Shares reserved
for the purposes of this Plan, and (z) with respect to any Award Agreement, the consent of the affected Grantee, if such action would
materially and adversely affect the rights of such Grantee under any outstanding Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Administrator may waive any conditions or rights under, amend any terms of, or amend, alter, suspend, discontinue or terminate, any
Award theretofore granted, prospectively or retroactively, without the consent of any relevant Grantee or holder or beneficiary of an
Award; <i>provided, however</i>, that no such action shall materially and adversely affect the rights of any affected Grantee or holder
or beneficiary under any Award theretofore granted under this Plan; and <i>provided further</i> that, except as provided in Section 13
hereof, no such action shall reduce the exercise price of any Option established at the time of grant thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Administrator shall be authorized to make adjustments in the terms and conditions of, and the criteria included in, Awards in recognition
of unusual or nonrecurring events; whenever the Administrator determines that such adjustments are appropriate in order to prevent dilution
or enlargement of the benefits or potential benefits intended to be made available under this Plan. Any provision of this Plan or any
Award Agreement to the contrary notwithstanding, with the affected Grantee&#8217;s consent, the Administrator may cause any Award granted
hereunder to be canceled in consideration of a cash payment or alternative Award made to the holder of such canceled Award equal in value
to the Fair Market Value of such canceled Award as of the time of the cancellation. The Administrator may correct any defect, supply
any omission, or reconcile any inconsistency in this Plan or any Award in the manner and to the extent it shall deem desirable to carry
this Plan into effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.
<span style="text-decoration: underline">Reservation of Shares</span>. The Company, during the term of the Plan, will at all times reserve and keep available such number of Shares
as shall be sufficient to satisfy the requirements of the Plan. The inability of the Company to obtain authority from any regulatory
body having jurisdiction, which authority is deemed by the Company&#8217;s counsel to be necessary to the lawful issuance and sale of
any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such
requisite authority shall not have been obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.
<span style="text-decoration: underline">No Effect on Terms of Employment/Consulting Relationship</span>. The Plan shall not confer upon any Grantee any right with respect to
the Grantee&#8217;s Continuous Service, nor shall it interfere in any way with his or her right or the right of the Company or any Related
Entity to terminate the Grantee&#8217;s Continuous Service at any time, with or without Cause, and with or without notice. The ability
of the Company or any Related Entity to terminate the employment of a Grantee who is employed at will is in no way affected by its determination
that the Grantee&#8217;s Continuous Service has been terminated for Cause for the purposes of this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 430; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.
<span style="text-decoration: underline">No Effect on Retirement and Other Benefit Plans</span>. Except as specifically provided in a retirement or other benefit plan of the
Company or a Related Entity, Awards shall not be deemed compensation for purposes of computing benefits or contributions under any retirement
plan of the Company or a Related Entity, and shall not affect any benefits under any other benefit plan of any kind or any benefit plan
subsequently instituted under which the availability or amount of benefits is related to level of compensation. The Plan is not a &#8220;Retirement
Plan&#8221; or &#8220;Welfare Plan&#8221; under the Employee Retirement Income Security Act of 1974, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.
<span style="text-decoration: underline">Vesting Schedule</span>. The Awards to be issued to any Grantee under the Plan shall be subject to the vesting schedule as specified
in the Award Agreement of such Grantee. The Administrator shall have the right to adjust the vesting schedule of the Awards granted to
any Grantees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.
<span style="text-decoration: underline">Unfunded Obligation</span>. Any amounts payable to Grantees pursuant to the Plan shall be unfunded and unsecured obligations for all
purposes. Neither the Company nor any Related Entity shall be required to segregate any monies from its general funds, or to create any
trusts, or establish any special accounts with respect to such obligations. The Company shall retain at all times beneficial ownership
of any investments, including trust investments, which the Company may make to fulfill its payment obligations hereunder. Any investments
or the creation or maintenance of any trust or any Grantee account shall not create or constitute a trust or fiduciary relationship between
the Administrator, the Company or any Related Entity and a Grantee, or otherwise create any vested or beneficial interest in any Grantee
or the Grantee&#8217;s creditors in any assets of the Company or a Related Entity. The Grantees shall have no claim against the Company
or any Related Entity for any changes in the value of any assets that may be invested or reinvested by the Company with respect to the
Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.
<span style="text-decoration: underline">Holding Company, Trustee, etc</span>. Notwithstanding anything to the contrary in this Plan, any Award Agreement, any notice of award
or the terms on which any Award is granted or vested, any underlying Share of the Awards may, at the Administrator&#8217;s own discretion,
be held by one or more holding companies or trustees or other nominees (collectively, the &#8220;<span style="text-decoration: underline">Trustees</span>&#8221;) as designated
by the Administrator for the Grantees, and the Plan may be implemented and administrated by the Administrator through the Trustees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.
<span style="text-decoration: underline">Entire Plan</span>. This Plan, the individual Award Agreements and notices of issuance of the Awards, together with all the exhibits
hereto and thereto, constitute and contain the entire stock incentive plan and understanding of the parties with respect to the subject
matter hereof and supersedes any and all prior negotiations, correspondence, agreements, understandings, memorandum, duties or obligations
between the parties respecting the subject matter hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.
<span style="text-decoration: underline">Construction</span>. Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation
of any provision of the Plan. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall
include the singular. Use of the term &#8220;or&#8221; is not intended to be exclusive, unless the context clearly requires otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.
<span style="text-decoration: underline">No Rights to Awards; Non-Uniform Treatment</span>. No employee, independent contractor, Grantee or other person shall have any claim
to be granted any Award under this Plan, and there is no obligation for uniformity of treatment of employees, independent contractors,
Grantees, or holders or beneficiaries of Awards under this Plan. The terms and conditions of Awards need not be the same with respect
to each recipient.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 431; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.
<span style="text-decoration: underline">No Fractional Shares</span>. No fractional Shares will be issued or delivered pursuant to the Plan. Except as otherwise provided in the
Plan or applicable Award Agreement, the Administrator will determine whether cash, additional Awards or other securities or property
will be issued or paid in lieu of fractional Shares or whether any fractional Shares should be rounded, forfeited or otherwise eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.
<span style="text-decoration: underline">Forfeiture Events</span>. The Administrator may specify in an Award Agreement that the Grantee&#8217;s rights, payments, and benefits
with respect to an Award will be subject to the reduction, cancellation, forfeiture, recoupment, reimbursement, or reacquisition upon
the occurrence of certain specified events, in addition to any otherwise applicable vesting or performance conditions of an Award. Such
events may include, without limitation, termination of such Grantee&#8217;s status as an Employee, Director and/or Consultant for Cause
or any specified action or inaction by the Grantee, whether before or after such termination of employment and/or other service, that
would constitute Cause for termination of such Grantee&#8217;s status as an Employee, Director and/or Consultant. Notwithstanding any
provisions to the contrary under this Plan, all Awards granted under the Plan will be subject to reduction, cancellation, forfeiture,
recoupment, reimbursement, or reacquisition under any clawback policy adopted by the Company and in effect as of the date of grant or
any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association
on which the Company&#8217;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection
Act or other Applicable Laws (the &#8220;<span style="text-decoration: underline">Clawback Policy</span>&#8221;). The Administrator may require the Grantee to forfeit, return
or reimburse the Company all or a portion of the Award and any amounts paid thereunder pursuant to the terms of the Clawback Policy or
as necessary or appropriate to comply with Applicable Laws, including without limitation any reacquisition right regarding previously
acquired Shares or other cash or property. Unless this Section 27 specifically is mentioned and waived in an Award Agreement or other
document, no recovery of compensation under a Clawback Policy or otherwise will constitute an event that triggers or contributes to any
right of the Grantee to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or similar term) under any agreement
with the Company or any Related Entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.
<span style="text-decoration: underline">Severability</span>. If any provision of this Plan or any Award is or becomes or is deemed to be invalid, illegal, or unenforceable in
any jurisdiction, or as to any person or Award, or would disqualify this Plan or any Award under any Applicable Laws, such provision
shall (to the fullest extent permitted by Applicable Laws) be construed or deemed amended to conform to Applicable Laws, or if it cannot
be so construed or deemed amended without, in the determination of the Administrator, materially altering the intent of this Plan or
the Award, such provision shall be stricken as to such jurisdiction, person or Award, and the remainder of this Plan and any such Award
shall remain in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.
<span style="text-decoration: underline">No Shareholders Rights</span>. No Award gives the Grantee any of the rights of a Shareholder of the Company unless and until Shares are
in fact issued to such Person in connection with such Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.
<span style="text-decoration: underline">Multiple Jurisdictions</span>. In order to assure the viability of Awards granted to Grantees employed in various jurisdictions, the
Administrator may, in its sole discretion, provide for such special terms as it may consider necessary or appropriate to accommodate
differences in local law, tax policy, or custom applicable in the jurisdiction in which the Grantee resides or is employed. Moreover,
the Administrator may approve such supplements to, amendments, restatements or alternative versions of this Plan as it may consider necessary
or appropriate for such purposes without thereby affecting the terms of this Plan as in effect for any other purpose. Notwithstanding
the foregoing, the Administrator may not take any actions hereunder, and no Awards shall be granted, that would violate any Applicable
Laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.
<span style="text-decoration: underline">Governing Law</span>. The Plan and all Award Agreements shall be governed by and construed in accordance with the laws of the Cayman
Islands, except that any principles or provisions of Cayman Islands law that would apply the law of another jurisdiction (other than
applicable provisions of U.S. Federal law) shall be disregarded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 432; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.
<span style="text-decoration: underline">Limitations Applicable to Section 16 Persons</span>. Notwithstanding any other provision of the Plan, the Plan, and any Award granted
or awarded to any Grantee who is then subject to Section 16&#8239;of the Exchange Act, shall be subject to any additional limitations
set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange
Act) that are requirements for the application of such exemptive rule. To the extent permitted by the Applicable Laws, the Plan and Awards
granted or awarded hereunder shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.
<span style="text-decoration: underline">Government and Other Regulations</span>. The obligation of the Company to make payment of awards in Shares or otherwise shall be subject
to all Applicable Laws, and to such approvals by government agencies as may be required. The Company shall be under no obligation to
register any of the Shares paid pursuant to the Plan under the Securities Act or any other similar law in any applicable jurisdiction.
If the Shares paid pursuant to the Plan may in certain circumstances be exempt from registration pursuant to the Securities Act or other
Applicable Laws, the Company may restrict the transfer of such Shares in such manner as it deems advisable to ensure the availability
of any such exemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.
<span style="text-decoration: underline">Section 409A</span>. To the extent that the Administrator determines that any Award granted under the Plan is or may become subject to
Section 409A of the U.S. Code, the Award Agreement evidencing such Award shall incorporate the terms and conditions required by Section
409A of the U.S. Code. To the extent applicable, the Plan and such Award Agreement shall be interpreted in accordance with Section 409A
of the U.S. Code and the&#8239;U.S. Department of Treasury regulations and other interpretative guidance issued thereunder, including
without limitation any such regulation or other guidance that may be issued after the Effective Date. Notwithstanding any provision of
the Plan to the contrary, in the event that following the Effective Date the Administrator determines that any Award may be subject to
Section 409A of the U.S. Code and related Department of Treasury guidance (including such Department of Treasury guidance as may be issued
after the Effective Date), the Administrator may adopt such amendments to the Plan and the applicable Award Agreement or adopt other
policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the
Administrator determines are necessary or appropriate to (a) exempt the Award from Section 409A of the U.S. Code and/or preserve the
intended tax treatment of the benefits provided with respect to the Award, or (b) comply with the requirements of Section 409A of the
U.S. Code and related&#8239;U.S. Department of Treasury guidance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">###</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 433; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_043"></span>ANNEX
C &#8211; FAIRNESS OPINION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Annex
C</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="annexc_001.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
18<sup>th</sup>, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">PRIVATE
&amp; CONFIDENTIAL</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Board of Directors of Bowen Acquisition Corp (NASDAQ:BOWN)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">420
Lexington Avenue, Suite 2446, New York, NY | 10170 | United States</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Newbridge
Securities Corporation (&#8220;Newbridge,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) understands that <span style="text-decoration: underline">Bowen Acquisition
Corp (NASDAQM:BOWN)</span>, a publicly traded blank check company incorporated as a Cayman Islands, exempted company (&#8220;BOWN&#8221;),
is considering a business combination with <span style="text-decoration: underline">Shenzhen Qianzhi Biotechnology Co., Ltd.</span>, a privately-held company incorporated as
a Cayman Islands, exempted company (the &#8220;Company&#8221; or &#8220;SQBCL&#8221;, and together with BOWN, collectively, the &#8220;Parties&#8221;)
pursuant to an Agreement and Plan of Reorganization among the Parties (the &#8220;Merger Agreement&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
                                            to the terms of the draft Merger Agreement, the Parties intend to effect a business combination
                                            transaction (the &#8220;Merger&#8221;) whereby (a) BOWN has formed a wholly-owned subsidiary,
                                            incorporated in the Cayman Islands (&#8220;Merger Sub&#8221;), which will merge with and
                                            into SQBCL, so that after the closing of the Merger, SQBCL will continue as the surviving
                                            entity and (b) BOWN shall acquire all of the issued and outstanding shares of SQBCL from
                                            the shareholders of SQBCL in exchange for BOWN Ordinary Shares (&#8220;BOWN Shares&#8221;)
                                            as a result of which SQBCL shall become a wholly-owned subsidiary of BOWN (the &#8220;Share
                                            Exchange&#8221; and together with the Merger and the other transactions contemplated by the
                                            Merger Agreement, the &#8220;Transactions&#8221;).</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            consideration for the acquired shares of SQBCL, the shareholders of SQBCL shall collectively
                                            be entitled to receive from BOWN, in the aggregate, 7,246,377 BOWN Ordinary Shares valued
                                            at approximately $10.35 per share, with an aggregate value equal to <span style="text-decoration: underline">Seventy-Five Million
                                            USD ($75,000,000)</span> (the &#8220;Merger Consideration&#8221;). A portion of the Merger Consideration
                                            shall be placed in escrow to cover certain post-Closing indemnification obligations of SQBCL.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            shareholders of SQBCL shall also have a contingent right to receive an aggregate of 1,400,000
                                            BOWN Ordinary Shares (the &#8220;Earnout Consideration&#8221;) through an equity earnout
                                            if certain net income -based milestones are achieved by BOWN and its subsidiaries during
                                            the years ending March 31, 2025, and 2026.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 35.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors of BOWN has retained Newbridge to render an opinion (the &#8220;Opinion&#8221;) as to whether, on the date of such
Opinion, (i) the Merger Consideration is fair, from a financial point of view, to BOWN and BOWN&#8217;s public stockholders and (ii)
the Company has an aggregate fair market value equal to at least eighty percent (80.0%) of the assets held by BOWN in its trust account
(the &#8220;Trust Account&#8221;) for the benefit of BOWN&#8217;s public stockholders (excluding taxes payable on the interest earned
on the Trust Account).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not been requested to opine to, and our Opinion does not in any manner address, the underlying business decision of BOWN to proceed
with the Transactions. In addition, we have not been requested to explore any alternatives to the Transactions. Further, our Opinion
does not address the relative merits of the Transactions as compared to any alternative business strategy that might exist for BOWN.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Newbridge,
as part of its investment banking business, is regularly engaged in the valuation of businesses and their securities in connection with
mergers and acquisitions, going private transactions, related-party transactions, negotiated underwritings, secondary distributions of
listed and unlisted securities, debt restructurings, private placements, related-party transactions, and valuations for corporate and
other purposes. We do not perform tax, accounting or legal services, nor do we render such advice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
Advisory Services offered through Newbridge Financial Services Group, Inc. an SEC Registered Investment Advisor</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1200
North Federal Highway, Suite 400, Boca Raton, FL 33432 | Telephone:&#160;561.395.1220 Fax: 561.229.1531</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>www.newbridgesecurities.com</i></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 434; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Newbridge
will receive a fee and reimbursement of its expenses for such services. In addition, BOWN has agreed to indemnify Newbridge for certain
liabilities arising out of its engagement, including the rendering of this Opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Newbridge
has not participated in, or provided advice with respect to, the pricing determination, structuring or negotiation of the Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the ordinary course of business, Newbridge, certain customer accounts held at Newbridge, and certain of our affiliates, as well as investment
funds in which we or our affiliates may have financial interests, may acquire, hold or sell, long or short positions, or trade or otherwise
effect transactions, in equity, debt, and other securities and financial instruments (including bank loans and other obligations) of,
or investments in, BOWN, and its successor entities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the review and analysis performed to render our Opinion, among other things, we have undertaken the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">considered
                                            our assessment of general economic, market and financial conditions as well as our experience
                                            in connection with similar transactions, and business and securities valuations generally;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewed
                                            a draft of the Merger Agreement, dated January 18<sup>th</sup>, 2024;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewed
                                            BOWN&#8217;s publicly available historical financial results, as well as certain publicly
                                            available information concerning the trading of, and the trading market for, the ordinary
                                            shares of BOWN since its initial public offering;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewed
                                            publicly available financial information of BOWN filed with the U.S. Securities &amp; Exchange
                                            Commission, including its Form 10-Qs and certain reports on material events filed on Forms
                                            8-K between July 14<sup>th</sup>, 2023, and January 18<sup>th</sup>, 2024;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">conducted
                                            discussions with SQBCL&#8217;s management team to better understand SQBCL&#8217;s recent
                                            business history, and near-term financials;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewed
                                            a financial model of SQBCL with historical and future financial projections (including potential
                                            revenue growth, net income and net income margins) provided by the Company&#8217;s management
                                            team;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">performed
                                            a public company comparable analysis of similar companies to SQBCL that trade on senior U.S.
                                            stock exchanges (NYSE American / NASDAQ / NYSE), and operate in the &#8220;Household Goods
                                            Chemicals&#8221; sector, to derive certain forward Price-to-Earnings (P/E) multiples; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">performed
                                            an M&amp;A transaction comparable analysis of similar companies to SQBCL that operate in
                                            the &#8220;Household Goods Chemicals&#8221; sector, to derive certain enterprise value /
                                            net income multiples.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
forming our Opinion, we have had full access to, and full cooperation from, the management teams of both BOWN and SQBCL to ask questions
and receive answers to those questions. Our Opinion is solely and necessarily based on economic, financial and market conditions as they
exist and can be evaluated as of the date hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with our review and analyses and in arriving at our Opinion, we have assumed and relied upon the accuracy and completeness
of the financial and other information provided to us or publicly available and have not attempted to verify independently any such information
(in accordance with reasonable industry practice).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
Advisory Services offered through Newbridge Financial Services Group, Inc. an SEC Registered Investment Advisor</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1200
North Federal Highway, Suite 400, Boca Raton, FL 33432 | Telephone:&#160;561.395.1220 Fax: 561.229.1531</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>www.newbridgesecurities.com</i></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 435 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to certain financial information, including financial analyses and projections, relating to the business and prospects of BOWN
and SQBCL provided to us, we have assumed that the financial information has been reasonably prepared on a basis reflecting reasonable
and good faith estimates and good faith judgments of the management teams of both BOWN and SQBCL as to the future financial performance
of the combined parties without and subsequent to a potential business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Opinion is solely for the use of the Board of Directors of BOWN, and is not to be publicly disclosed, used, excerpted, reproduced or
disseminated, quoted or referred to at any time, in any manner or for any purpose, without the prior written consent of Newbridge, except
that this Opinion may be reproduced in full in, and references to this Opinion and to Newbridge and its relationship with BOWN may be
included in, filings made by BOWN with the U.S. Securities and Exchange Commission and in any registration statement, prospectus, proxy
statement or similar disclosure document delivered to shareholders of BOWN.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have tried to apply objective measures of value in rendering our Opinion. You understand, however, that such a valuation necessarily
is based on some subjective interpretations of value. We understand that we are not obligated to review our Opinion due to events and
fluctuating economic conditions occurring subsequent to the date of this Opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 35.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon and subject to the foregoing, it is our Opinion that, as of the date hereof, (i) the Merger Consideration is fair, from a financial
point of view, to BOWN and BOWN&#8217;s public stockholders and (ii) the Company has an aggregate fair market value equal to at least
eighty percent (80.0%) of assets held in the Trust Account (excluding taxes payable on the income earned on the Trust Account).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Newbridge
    Securities Corporation</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><i>/</i></span><i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">s/
    Chad D. Champion</span></i></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chad
    D. Champion</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Managing Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Head
    of Equity Capital Markets &amp; Investment Banking</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
Advisory Services offered through Newbridge Financial Services Group, Inc. an SEC Registered Investment Advisor</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1200
North Federal Highway, Suite 400, Boca Raton, FL 33432 | Telephone:&#160;561.395.1220 Fax: 561.229.1531</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">www.newbridgesecurities.com</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 436 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_044"></span>ANNEX
D &#8211; PROPOSED CHARTER OF NEW BOWEN</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Companies Act (Revised)</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company Limited by Shares</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 40%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;
<span style="text-transform: uppercase"><b><br/>SECOND amended and restated</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>memorandum
of association<br/> OF<br/> Emerald, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 40%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adopted
by special resolution on [&#9679;] and effective on [&#9679;])</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><img src="annexd_001.jpg" alt="" style="width: 118px; height: 47px"/></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 437; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Companies
Act (Revised)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company
Limited by Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Second
Amended and Restated</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Memorandum
of Association</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EMERALD,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Adopted
by special resolution on [&#9679;] and effective on [&#9679;])</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            name of the Company is <b>EMERALD, INC.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company&#8217;s registered office will be situated at the office of Ogier Global (Cayman) Limited,
                                            89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands or at such other place in
                                            the Cayman Islands as the directors may at any time decide.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company&#8217;s objects are unrestricted. As provided by section 7(4) of the Companies Act (Revised),
                                            the Company has full power and authority to carry out any object not prohibited by any law
                                            of the Cayman Islands.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company has unrestricted corporate capacity. Without limitation to the foregoing, as provided
                                            by section 27 (2) of the Companies Act (Revised), the Company has and is capable of exercising
                                            all the functions of a natural person of full capacity irrespective of any question of corporate
                                            benefit.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
                                            in any of the preceding paragraphs permits the Company to carry on any of the following businesses
                                            without being duly licensed, namely:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            business of a bank or trust company without being licensed in that behalf under the Banks
                                            and Trust Companies Act (Revised); or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">insurance
                                            business from within the Cayman Islands or the business of an insurance manager, agent, sub-agent
                                            or broker without being licensed in that behalf under the Insurance Act (Revised);or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            business of company management without being licensed in that behalf under the Companies
                                            Management Act (Revised).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The
                                            Company will not trade in the Cayman Islands with any person, firm or corporation except
                                            in furtherance of its business carried on outside the Cayman Islands. Despite this, the Company
                                            may effect and conclude contracts in the Cayman Islands and exercise in the <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
Islands any of its powers necessary for the carrying on of its business outside the Cayman Islands.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 438 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company is a company limited by shares and accordingly the liability of each member is limited
                                            to the amount (if any) unpaid on that member&#8217;s shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            share capital of the Company is US$25,200 divided into 250,000,000 Ordinary Shares of US$0.0001
                                            par value each and 2,000,000 Preferred Shares of US$0.0001 par value each. Subject to the
                                            Companies Act (Revised) and the Company&#8217;s articles of association, the Company has power
                                            to do any one or more of the following:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">redeem
                                            or repurchase any of its shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase
                                            or reduce its capital;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issue
                                            any part of its capital (whether original, redeemed, increased or reduced):</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                            or without any preferential, deferred, qualified or special rights, privileges or conditions;
                                            or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                            to any limitations or restrictions</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 70.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
unless the condition of issue expressly declares otherwise, every issue of shares (whether declared to be ordinary, preference or otherwise)
is subject to this power; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 70.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">alter
                                            any of those rights, privileges, conditions, limitations or restrictions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company has power to register by way of continuation as a body corporate limited by shares
                                            under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the
                                            Cayman Islands.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 439 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Companies
Act (Revised)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company Limited By Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 40%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECOND
AMENDED AND RESTATED<br/> <span style="text-transform: uppercase">articles of association</span><br/> <span style="text-transform: uppercase">of</span><br/>
EMERALD, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 40%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Adopted
by special resolution passed on [&#9679;] and effective on [&#9679;])</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="annexd_001.jpg" alt="" style="width: 118px; height: 47px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 440 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contents</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1
    Definitions, interpretation and exclusion of Table A</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interpretation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusion
    of Table A Articles</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2
    Shares</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to issue Shares and options, with or without special rights</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to issue fraction of a Share</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to pay commissions and brokerage fees</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trusts
    not recognised</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security
    interests</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to vary class rights</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of new Share issue on existing class rights</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
    contributions without issue of further Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    bearer Shares or warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury
    Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
    attaching to Treasury Shares and related matters</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Register
    of Members</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    Return</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3
    Share certificates</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of share certificates</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renewal
    of lost or damaged share certificates</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4
    Lien on Shares</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nature
    and scope of lien</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    may sell Shares to satisfy lien</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority
    to execute instrument of transfer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consequences
    of sale of Shares to satisfy lien</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application
    of proceeds of sale</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5
    Calls on Shares and forfeiture</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to make calls and effect of calls</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time
    when call made</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liability
    of joint holders</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    on unpaid calls</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deemed
    calls</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to accept early payment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to make different arrangements at time of issue of Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    of default</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeiture
    or surrender of Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal
    of forfeited or surrendered Share and power to cancel forfeiture or surrender</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of forfeiture or surrender on former Member</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evidence
    of forfeiture or surrender</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
    of forfeited or surrendered Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6
    Transfer of Shares</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
    to transfer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to refuse registration for Shares not listed on a Designated Stock Exchange</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suspension
    of transfers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    may retain instrument of transfer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    of refusal to register</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<!-- Field: Page; Sequence: 441 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7
    Transmission of Shares</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons
    entitled on death of a Member</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
    of transfer of a Share following death or bankruptcy</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnity</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
    of person entitled to a Share following death or bankruptcy</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8
    Alteration of capital</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increasing,
    consolidating, converting, dividing and cancelling share capital</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dealing
    with fractions resulting from consolidation of Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reducing
    share capital</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9
    Redemption and purchase of own Shares</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to issue redeemable Shares and to purchase own Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to pay for redemption or purchase in cash or in specie</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of redemption or purchase of a Share</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10
    Meetings of Members</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    and extraordinary general meetings</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to call meetings</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Content
    of notice</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Period
    of notice</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons
    entitled to receive notice</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accidental
    omission to give notice or non-receipt of notice</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11
    Proceedings at meetings of Members</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quorum</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lack
    of quorum</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
    of a Director to attend and speak</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of technology</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjournment,
    postponement and cancellation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method
    of voting</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taking
    of a poll</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman&#8217;s
    casting vote</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    resolutions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sole-Member
    Company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12
    Voting rights of Members</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
    to vote</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
    of joint holders</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representation
    of corporate Members</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    with mental disorder</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Objections
    to admissibility of votes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of proxy</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">How
    and when proxy is to be delivered</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
    by proxy</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13
    Number of Directors</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14
    Appointment, disqualification and removal of Directors</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    age limit</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    shareholding qualification</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment
    of Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board&#8217;s
    power to appoint Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<!-- Field: Page; Sequence: 442 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Removal of Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resignation
    of Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination
    of the office of Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15
    Alternate Directors</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment
    and removal</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
    of alternate Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment
    ceases when the appointor ceases to be a Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Status
    of alternate Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Status
    of the Director making the appointment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16
    Powers of Directors</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Powers
    of Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
    below the minimum number</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointments
    to office</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions
    for employees</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of voting rights</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remuneration</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
    of information</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17
    Delegation of powers</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to delegate any of the Directors&#8217; powers to a committee</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Local
    boards</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to appoint an agent of the Company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to appoint an attorney or authorised signatory of the Company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
    Powers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    Governance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18
    Meetings of Directors</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulation
    of Directors&#8217; meetings</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calling
    meetings</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    of meetings</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Period
    of notice</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of technology</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quorum</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    or deputy to preside</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recording
    of dissent</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    resolutions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Validity
    of acts of Directors in spite of formal defect</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19
    Permissible Directors&#8217; interests and disclosure</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20
    Minutes</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>21
    Accounts and audit</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">45<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>22
    Record dates</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>23
    Dividends</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source
    of dividends</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declaration
    of dividends by Members</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    of interim dividends and declaration of final dividends by Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apportionment
    of dividends</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
    of set off</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<!-- Field: Page; Sequence: 443 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    Power to pay other than in cash</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">How
    payments may be made</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
    or other monies not to bear interest in absence of special rights</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
    unable to be paid or unclaimed</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>24
    Capitalisation of profits</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalisation
    of profits or of any share premium account or capital redemption reserve;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying
    an amount for the benefit of Members</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>25
    Share Premium Account</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
    to maintain share premium account</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debits
    to share premium account</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>26
    Seal</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    seal</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duplicate
    seal</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
    and how seal is to be used</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    no seal is adopted or used</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to allow non-manual signatures and facsimile printing of seal</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Validity
    of execution</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>27
    Indemnity</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Release</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>28
    Notices</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of notices</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Electronic
    communications</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons
    entitled to notices</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons
    authorised to give notices</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delivery
    of written notices</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint
    holders</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signatures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Giving
    notice to a deceased or bankrupt Member</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    of giving notices</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Saving
    provision</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>29
    Authentication of Electronic Records</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application
    of Articles</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authentication
    of documents sent by Members by Electronic means</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authentication
    of document sent by the Secretary or Officers of the Company by Electronic means</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manner
    of signing</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Saving
    provision</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30
    Transfer by way of continuation</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>31
    Winding up</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distribution
    of assets in specie</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    obligation to accept liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>32
    Amendment of Memorandum and Articles</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to change name or amend Memorandum</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to amend these Articles</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>33
    Mergers and Consolidations</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>34
    Certain Tax Filings</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 444 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
Act (Revised)</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
Limited by Shares</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second
Amended and Restated<br/>
Articles of Association</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EMERALD,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Adopted
by special resolution passed on [&#9679;] and effective on [&#9679;])</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Definitions,
                                            interpretation and exclusion of Table A</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.1</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>In
                                            these Articles, the following definitions apply:</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Act
</b>means the Companies Act (Revised) of the Cayman Islands, including any statutory modification or re-enactment thereof for the time
being in force;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Applicable
Law </b>means, with respect to any person, all provisions of laws, statutes, ordinances, rules, regulations, permits, certificates, judgments,
decisions, decrees or orders of any governmental authority applicable to such person;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Articles
</b>means, as appropriate:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">these
                                            articles of association as amended, restated, supplemented, and/or as otherwise modified
                                            from time to time: or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">two
                                            or more particular articles of these Articles;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
<b>Article</b> refers to a particular article of these Articles;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Auditors
</b>means the auditor or auditors for the time being of the Company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
</b>means the board of Directors from time to time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Day</b> means a day when banking institutions or trust companies in New York City or Grand Cayman, the Cayman Islands are open for the
transaction of normal banking business and for the avoidance of doubt, shall not include a Saturday, Sunday or public holiday in the
New York City or Cayman Islands;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cayman
Islands</b> means the British Overseas Territory of the Cayman Islands;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 445 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Clear
Days</b>, in relation to a period of notice, means that period of calendar days excluding:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            calendar day when the notice is given or deemed to be given; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            calendar day for which it is given or on which it is to take effect;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Clearing
House </b>means a clearing house recognised by the laws of the jurisdiction in which the Shares (or depositary receipts therefor) are
listed or quoted on a stock exchange or interdealer quotation system in such jurisdiction;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
</b>means Securities and Exchange Commission of the United States of America or other federal agency for the time being administering
the U.S. Securities Act;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company
</b>means the above-named company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Default
Rate</b> means ten per cent per annum;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Designated
Stock Exchanges</b> means the Nasdaq Global Market in the United States of America for so long as any class of the Company&#8217;s Shares
are there listed and any other stock exchange on which any class of the Company&#8217;s Shares are listed for trading;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Designated
Stock Exchange Rules</b> means the relevant code, rules and regulations, as amended, from time to time, applicable as a result of the
original and continued listing of any Shares on the Designated Stock Exchanges;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors
</b>means the directors for the time being of the Company and the expression Director shall be construed accordingly;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Electronic
</b>has the meaning given to that term in the Electronic Transactions Act (Revised) of the Cayman Islands;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Electronic
Communication Facilities </b>means video, video-conferencing, internet or online conferencing applications, telephone or tele-conferencing
and/or any other video-communications, internet or online conferencing application or telecommunications facilities by means of which
all persons participating in a meeting are capable of hearing and being heard by each other;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Electronic
Record</b> has the meaning given to that term in the Electronic Transactions Act (Revised) of the Cayman Islands;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Electronic
Signature</b> has the meaning given to that term in the Electronic Transactions Act (Revised) of the Cayman Islands;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fully
Paid Up</b> means:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            relation to a Share with par value, means that the par value for that Share and any premium
                                            payable in respect of the issue of that Share, has been fully paid or credited as paid in
                                            money or money&#8217;s worth; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 446 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            relation to a Share without par value, means that the agreed issue price for that Share has
                                            been fully paid or credited as paid in money or money&#8217;s worth;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>general
meeting</b> means a general meeting of the Company duly constituted in accordance with the Articles;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent
Director</b> means a Director who is an independent director as defined in the Designated Stock Exchange Rules as determined by the Board;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Member
</b>means any person or persons entered on the register of Members from time to time as the holder of a Share;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Memorandum
</b>means the memorandum of association of the Company as amended from time to time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>month
</b>means a calendar month;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Officer
</b>means a person appointed to hold an office in the Company including a Director, alternate Director or liquidator and excluding the
Secretary;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ordinary
Resolution</b> means a resolution of a general meeting passed by a simple majority of the votes cast by, or on behalf of, the Members
who (being entitled to do so) vote in person or by proxy or, in the case of corporations, by their duly authorised representatives, at
that meeting. The expression includes an unanimous written resolution;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ordinary
Share </b>means an ordinary share of US$0.0001 par value each in the capital of the Company, having the rights set out in these Articles;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Partly
Paid Up</b> means:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            relation to a Share with par value, that the par value for that Share and any premium payable
                                            in respect of the issue of that Share, has not been fully paid or credited as paid in money
                                            or money&#8217;s worth; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            relation to a Share without par value, means that the agreed issue price for that Share has
                                            not been fully paid or credited as paid in money or money&#8217;s worth;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Share</b> means a preferred share of US$0.0001 par value each in the capital of the Company, having the rights set out in these Articles;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Register
of Members</b> means the register of Members maintained in accordance with the Act and includes (except where otherwise stated) any branch
or duplicate or listed register of the Members;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Secretary
</b>means a person appointed to perform the duties of the secretary of the Company, including a joint, assistant or deputy secretary;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 447 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share
</b>means an Ordinary Share or a Preferred Share in share capital of the Company and the expression:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">includes
                                            stock (except where a distinction between shares and stock is expressed or implied); and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                            the context permits, also includes a fraction of a Share;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Special
Resolution</b> has the meaning given to that term in the Act, and the expression includes a written resolution passed in accordance with
the Act;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tax
Filing Authorised Person</b> means such person as any director shall designate from time to time, acting severally;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Treasury
Shares</b> means Shares held in treasury pursuant to the Act and Article 2.16;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
Securities Act</b> means the Securities Act of 1933 of the United States of America, as amended, or any similar federal statute and the
rules and regulations of the Commission thereunder, all as the same shall be in effect at the time; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Virtual
Meeting</b> means any general meeting at which the Members (and any other permitted participants of such meeting, including without limitation
the chairman of the meeting and any Directors) are permitted to attend and participate solely by means of Electronic Communication Facilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interpretation</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            the interpretation of these Articles, the following provisions apply unless the context otherwise
                                            requires:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            reference in these Articles to a statute is a reference to a statute of the Cayman Islands
                                            as known by its short title, and includes:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            statutory modification, amendment or re-enactment; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            subordinate legislation or regulations issued under that statute.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
limitation to the preceding sentence, a reference to a revised Act of the Cayman Islands is taken to be a reference to the revision of
that Act in force from time to time as amended from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 70.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Headings
                                            are inserted for convenience only and do not affect the interpretation of these Articles,
                                            unless there is ambiguity.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            a day on which any act, matter or thing is to be done under these Articles is not a Business
                                            Day, the act, matter or thing must be done on the next Business Day.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 448 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            word which denotes the singular also denotes the plural, a word which denotes the plural
                                            also denotes the singular, and a reference to any gender also denotes the other genders.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            reference to a <b>person</b> includes, as appropriate, a company, trust, partnership, joint
                                            venture, association, body corporate or government agency.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                            a word or phrase is given a defined meaning another part of speech or grammatical form in
                                            respect to that word or phrase has a corresponding meaning.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            references to time are to be calculated by reference to time in the place where the Company&#8217;s
                                            registered office is located.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            words <b>written</b> and <b>in writing</b> include all modes of representing or reproducing
                                            words in a visible form, but do not include an Electronic Record where the distinction between
                                            a document in writing and an Electronic Record is expressed or implied.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            words <b>including</b>, <b>include</b> and <b>in particular</b> or any similar expression
                                            are to be construed without limitation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            requirements as to execution or signature under the Articles including the execution of the
                                            Articles themselves can be satisfied in the form of an Electronic Signature.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            term &#8220;<b>holder</b>&#8221; in relation to a Share means a person whose name is entered
                                            in the Register of Members as the holder of such Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            term &#8220;<b>present</b>&#8221; means, in respect of any person attending a meeting, such
                                            person&#8217;s presence at a general meeting of Members (or any meeting of the holders of
                                            any class of Shares), which may be satisfied by means of such person or, if a corporation
                                            or other non-natural person, its duly authorized representative (or, in the case of any Member,
                                            a proxy which has been validly appointed by such Member in accordance with these Articles),
                                            being: (a) physically present at the meeting; or (b) in the case of any meeting at which
                                            Electronic Communication Facilities are permitted in accordance with these Articles, including
                                            any Virtual Meeting, connected by means of the use of such Electronic Communication Facilities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            headings in these Articles are intended for convenience only and shall not affect the interpretation
                                            of these Articles.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusion
of Table A Articles</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            regulations contained in Table A in the First Schedule of the Act and any other regulations
                                            contained in any statute or subordinate legislation are expressly excluded and do not apply
                                            to the Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 449 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to issue Shares and options, with or without special rights</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the provisions of the Act, the applicable Designated Stock Exchange Rules, the Memorandum
                                            (and to any direction that may be given by the Company in general meeting) and these Articles
                                            about the redemption and purchase of the Shares, and without prejudice to any rights attaching
                                            the Shares, the Directors have general and unconditional authority to allot (with or without
                                            confirming rights of renunciation), grant options over or otherwise deal with any unissued
                                            Shares to such persons, at such times and on such terms and conditions as they may decide.
                                            No Share may be issued at a discount except in accordance with the provisions of the Act.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                            limitation to the preceding Article, the Directors may so deal with the unissued Shares:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">either
                                            at a premium or at par; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                            or without preferred, deferred or other special rights or restrictions, whether in regard
                                            to dividend, voting, return of capital or otherwise.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company may issue rights, options, warrants or convertible securities or securities of similar
                                            nature conferring the right upon the holders thereof to subscribe for, purchase or receive
                                            any class of Shares or other securities in the Company at such times and on such terms and
                                            conditions as the Directors may decide.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
                                            any Preferred Shares of any series are issued, the Directors shall fix, by resolution or
                                            resolutions, the following provisions of such series:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            designation of such series and the number of Preferred Shares to constitute such series;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            the shares of such series shall have voting rights, in addition to any voting rights provided
                                            by Law, and, if so, the terms of such voting rights, which may be general or limited;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            dividends, if any, payable on such series, whether any such dividends shall be cumulative,
                                            and, if so, from what dates, the conditions and dates upon which such dividends shall be
                                            payable, the preference or relation which such dividends shall bear to the dividends payable
                                            on any Shares of any other class of Shares or any other series of Preferred Shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            the Preferred Shares or such series shall be subject to redemption by the Company, and, if
                                            so, the times, prices and other conditions of such redemption;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            amount or amounts payable upon Preferred Shares of such series upon, and the rights of the
                                            holders of such series in, a voluntary or involuntary liquidation, dissolution or winding
                                            up, or upon any distribution of the assets, of the Company;</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 450 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            the Preferred Shares of such series shall be subject to the operation of a retirement or
                                            sinking fund and, if so, the extent to and manner in which any such retirement or sinking
                                            fund shall be applied to the purchase or redemption of the Preferred Shares of such series
                                            for retirement or other corporate purposes and the terms and provisions relative to the operation
                                            of the retirement or sinking fund;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            the Preferred Shares of such series shall be convertible into, or exchangeable for, Shares
                                            of any other class of Shares or any other series of Preferred Shares or any other securities
                                            and, if so, the price or prices or the rate or rates of conversion or exchange and the method,
                                            if any, of adjusting the same, and any other terms and conditions of conversion or exchange;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            limitations and restrictions, if any, to be effective while any Preferred Shares or such
                                            series are outstanding upon the payment of dividends or the making of other distributions
                                            on, and upon the purchase, redemption or other acquisition by the Company of, the existing
                                            Shares or Shares of any other class of Shares or any other series of Preferred Shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            conditions or restrictions, if any, upon the creation of indebtedness of the Company or upon
                                            the issue of any additional Shares, including additional shares of such series or of any
                                            other class of Shares or any other series of Preferred Shares; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            other powers, preferences and relative, participating, optional and other special rights,
                                            and any qualifications, limitations and restrictions of any other class of Shares or any
                                            other series of Preferred Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to issue fraction of a Share</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the Act, the Company may issue fractions of a Share of any class. A fraction of a Share
                                            shall be subject to and carry the corresponding fraction of liabilities (whether with respect
                                            to calls or otherwise), limitations, preferences, privileges, qualifications, restrictions,
                                            rights and other attributes of a Share of that class of Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to pay commissions and brokerage fees</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company may pay a commission to any person in consideration of that person:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">subscribing
                                            or agreeing to subscribe, whether absolutely or conditionally; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">procuring
                                            or agreeing to procure subscriptions, whether absolute or conditional,</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
any Shares. That commission may be satisfied by the payment of cash or the allotment of Fully Paid Up or Partly Paid Up Shares or partly
in one way and partly in another.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company may employ a broker in the issue of its capital and pay him any proper commission
                                            or brokerage.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 451 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trusts
not recognised</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                            as required by Act:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                            person shall be recognised by the Company as holding any Share on any trust; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                            person other than the Member shall be recognised by the Company as having any right in a
                                            Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security
interests</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                            the preceding Article, the Company may (but shall not be obliged to) recognise a security
                                            interest of which it has actual notice over shares. The Company shall not be treated as having
                                            recognised any such security interest unless it has so agreed in writing with the secured
                                            party.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to vary class rights</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the share capital is divided into different classes of Shares then, unless the terms on which
                                            a class of Shares was issued state otherwise, the rights attaching to a class of Shares may
                                            only be varied if one of the following applies:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Members holding not less than two-thirds of the issued Shares of that class consent in writing
                                            to the variation; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            variation is made with the sanction of a Special Resolution passed at a separate general
                                            meeting of the Members holding the issued Shares of that class.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            the purpose of Article 2.10(b), all the provisions of these Articles relating to general
                                            meetings apply, mutatis mutandis, to every such separate meeting except that:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            necessary quorum shall be one or more persons holding, or representing by proxy, not less
                                            than one third of the issued Shares of the class; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            Member holding issued Shares of the class, present in person or by proxy or, in the case
                                            of a corporate Member, by its duly authorised representative, may demand a poll.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            the purposes of a separate class meeting, the Directors may treat two or more or all the
                                            classes of Shares as forming one class of Shares if the Directors consider that such classes
                                            of Shares
would be affected in the same way by the proposals under consideration, but in any other case shall treat them as separate classes of
Shares.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 452 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
of new Share issue on existing class rights</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.13</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            the terms on which a class of Shares was issued state otherwise, the rights conferred on
                                            the Member holding Shares of any class shall not be deemed to be varied by the creation or
                                            issue of further Shares ranking <i>pari passu</i> with the existing Shares of that class.
                                            For the avoidance of doubt, the creation, designation or issuance of any Preferred Shares
                                            with rights and privileges ranking in priority to any existing class of Shares pursuant to
                                            Article 2.4 including, without limitation, the creation of Preferred Shares with enhanced
                                            or weighted voting rights, shall not be deemed to be a variation of the rights of any existing
                                            class of Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
contributions without issue of further Shares</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
                                            the consent of a Member, the directors may accept a voluntary contribution to the capital
                                            of the Company from that Member without issuing Shares in consideration for that contribution.
                                            In that event, the contribution shall be dealt with in the following manner:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            shall be treated as if it were a share premium.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            the Member agrees otherwise:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the Member holds Shares in a single class of Shares, it shall be credited to the share premium
                                            account for that class of Shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the Member holds Shares of more than one class, it shall be credited rateably to the share
                                            premium accounts for those classes of Shares (in the proportion that the sum of the issue
                                            prices for each class of Shares that the Member holds bears to the total issue prices for
                                            all classes of Shares that the Member holds).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            shall be subject to the provisions of the Act and these Articles applicable to share premiums.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
bearer Shares or warrants</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company shall not issue Shares or warrants to bearers.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury
Shares</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
                                            that the Company purchases, redeems or acquires by way of surrender in accordance with the
                                            Act shall be held as Treasury Shares and not treated as cancelled if:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Directors so determine prior to the purchase, redemption or surrender of those shares; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            relevant provisions of the Memorandum and Articles and the Act are otherwise complied with.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
attaching to Treasury Shares and related matters</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            dividend may be declared or paid, and no other distribution (whether in cash or otherwise)
                                            of the Company&#8217;s assets (including any distribution of assets to Members on a winding
                                            up) may be made to the Company in respect of a Treasury Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 453 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company shall be entered in the register of Members as the holder of the Treasury Shares.
                                            However:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Company shall not be treated as a Member for any purpose and shall not exercise any right
                                            in respect of the Treasury Shares, and any purported exercise of such a right shall be void;
                                            and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            Treasury Share shall not be voted, directly or indirectly, at any meeting of the Company
                                            and shall not be counted in determining the total number of issued shares at any given time,
                                            whether for the purposes of these Articles or the Act.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
                                            in Article 2.18 prevents an allotment of Shares as Fully Paid Up bonus shares in respect
                                            of a Treasury Share and Shares allotted as Fully Paid Up bonus shares in respect of a Treasury
                                            Share shall be treated as Treasury Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury
                                            Shares may be disposed of by the Company in accordance with the Act and otherwise on such
                                            terms and conditions as the Directors determine.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Register
of Members</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors shall keep or cause to be kept a register of Members as required by the Act and
                                            may cause the Company to maintain one or more branch registers as contemplated by the Act,
                                            provided that where the Company is maintaining one or more branch registers, the Directors
                                            shall ensure that a duplicate of each branch register is kept with the Company&#8217;s principal
                                            register of Members and updated within such number of days of any amendment having been made
                                            to such branch register as may be required by the Act.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.22</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            title to Shares listed on a Designated Stock Exchange may be evidenced and transferred in
                                            accordance with the laws applicable to the rules and regulations of the Designated Stock
                                            Exchange and, for these purposes, the register of Members may be maintained in accordance
                                            with section 40B of the Act.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
Return</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors in each calendar year shall prepare or cause to be prepared an annual return and
                                            declaration setting forth the particulars required by the Act and shall deliver a copy thereof
                                            to the registrar of companies for the Cayman Islands.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 454 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share
                                            certificates</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
of share certificates</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Member shall only be entitled to a share certificate if the Directors resolve that share
                                            certificates shall be issued. Share certificates representing Shares, if any, shall be in
                                            such form as the Directors may determine. If the Directors resolve that share certificates
                                            shall be issued, upon being entered in the register of Members as the holder of a Share,
                                            the Directors may issue to any Member:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">without
                                            payment, one certificate for all the Shares of each class held by that Member (and, upon
                                            transferring a part of the Member&#8217;s holding of Shares of any class, to a certificate
                                            for the balance of that holding); and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                                            payment of such reasonable sum as the Directors may determine for every certificate after
                                            the first, several certificates each for one or more of that Member&#8217;s Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Every
                                            certificate shall specify the number, class and distinguishing numbers (if any) of the Shares
                                            to which it relates and whether they are Fully Paid Up or Partly Paid Up. A certificate may
                                            be executed under seal or executed in such other manner as the Directors determine.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Every
                                            certificate shall bear legends required under the applicable laws, including the U.S. Securities
                                            Act (to the extent applicable).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company shall not be bound to issue more than one certificate for Shares held jointly by
                                            several persons and delivery of a certificate for a Share to one joint holder shall be a
                                            sufficient delivery to all of them.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renewal
of lost or damaged share certificates</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            a share certificate is defaced, worn-out, lost or destroyed, it may be renewed on such terms
                                            (if any) as to:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">evidence;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">indemnity;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">payment
                                            of the expenses reasonably incurred by the Company in investigating the evidence; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">payment
                                            of a reasonable fee, if any for issuing a replacement share certificate,</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
the Directors may determine, and (in the case of defacement or wearing-out) on delivery to the Company of the old certificate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lien
                                            on Shares</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nature
and scope of lien</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company has a first and paramount lien on all Shares (whether Fully Paid Up or not) registered
                                            in the name of a Member (whether solely or jointly with others). The lien is for all monies
                                            payable to the Company by the Member or the Member&#8217;s estate:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">either
                                            alone or jointly with any other person, whether or not that other person is a Member; and</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 455 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            or not those monies are presently payable.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                            any time the Board may declare any Share to be wholly or partly exempt from the provisions
                                            of this Article.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
may sell Shares to satisfy lien</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company may sell any Shares over which it has a lien if all of the following conditions are
                                            met:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            sum in respect of which the lien exists is presently payable;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Company gives notice to the Member holding the Share (or to the person entitled to it in
                                            consequence of the death or bankruptcy of that Member) demanding payment and stating that
                                            if the notice is not complied with the Shares may be sold; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            sum is not paid within fourteen (14) Clear Days after that notice is deemed to be given under
                                            these Articles,</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
Shares to which this Article 4.3 applies shall be referred to as Lien Default Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Lien Default Shares may be sold in such manner as the Board determines.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            the maximum extent permitted by law, the Directors shall incur no personal liability to the
                                            Member concerned in respect of the sale.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority
to execute instrument of transfer</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            give effect to a sale, the Directors may authorise any person to execute an instrument of
                                            transfer of the Lien Default Shares sold to, or in accordance with the directions of, the
                                            purchaser.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            title of the transferee of the Lien Default Shares shall not be affected by any irregularity
                                            or invalidity in the proceedings in respect of the sale.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>




<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consequences
of sale of Shares to satisfy lien</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            a sale pursuant to the preceding Articles:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            name of the Member concerned shall be removed from the register of Members as the holder
                                            of those Lien Default Shares; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            person shall deliver to the Company for cancellation the certificate (if any) for those Lien
                                            Default Shares.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 456 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                            the provisions of Article 4.8, such person shall remain liable to the Company for all monies
                                            which, at the date of sale, were presently payable by him to the Company in respect of those
                                            Lien Default Shares. That person shall also be liable to pay interest on those monies from
                                            the date of sale until payment at the rate at which interest was payable before that sale
                                            or, failing that, at the Default Rate. The Board may waive payment wholly or in part or enforce
                                            payment without any allowance for the value of the Lien Default Shares at the time of sale
                                            or for any consideration received on their disposal.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application
of proceeds of sale</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            net proceeds of the sale, after payment of the costs, shall be applied in payment of so much
                                            of the sum for which the lien exists as is presently payable. Any residue shall be paid to
                                            the person whose Lien Default Shares have been sold:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            no certificate for the Lien Default Shares was issued, at the date of the sale; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            a certificate for the Lien Default Shares was issued, upon surrender to the Company of that
                                            certificate for cancellation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">but,
in either case, subject to the Company retaining a like lien for all sums not presently payable as existed on the Lien Default Shares
before the sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Calls
                                            on Shares and forfeiture</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to make calls and effect of calls</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the terms of allotment, the Board may make calls on the Members in respect of any monies
                                            unpaid on their Shares including any premium. The call may provide for payment to be by instalments.
                                            Subject to receiving at least 14 Clear Days&#8217; notice specifying when and where payment is
                                            to be made, each Member shall pay to the Company the amount called on his Shares as required
                                            by the notice.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
                                            receipt by the Company of any sum due under a call, that call may be revoked in whole or
                                            in part and payment of a call may be postponed in whole or in part. Where a call is to be
                                            paid in instalments, the Company may revoke the call in respect of all or any remaining instalments
                                            in whole or in part and may postpone payment of all or any of the remaining instalments in
                                            whole or in part.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Member on whom a call is made shall remain liable for that call notwithstanding the subsequent
                                            transfer of the Shares in respect of which the call was made. He shall not be liable for
                                            calls made after he is no longer registered as Member in respect of those Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time
when call made</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            call shall be deemed to have been made at the time when the resolution of the Directors authorising
                                            the call was passed.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 457 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liability
of joint holders</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Members
                                            registered as the joint holders of a Share shall be jointly and severally liable to pay all
                                            calls in respect of the Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
on unpaid calls</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            a call remains unpaid after it has become due and payable the person from whom it is due
                                            and payable shall pay interest on the amount unpaid from the day it became due and payable
                                            until it is paid:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                            the rate fixed by the terms of allotment of the Share or in the notice of the call; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            no rate is fixed, at the Default Rate.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Directors may waive payment of the interest wholly or in part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deemed
calls</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            amount payable in respect of a Share, whether on allotment or on a fixed date or otherwise,
                                            shall be deemed to be payable as a call. If the amount is not paid when due the provisions
                                            of these Articles shall apply as if the amount had become due and payable by virtue of a
                                            call.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to accept early payment</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company may accept from a Member the whole or a part of the amount remaining unpaid on Shares
                                            held by him although no part of that amount has been called up.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to make different arrangements at time of issue of Shares</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the terms of allotment, the Directors may make arrangements on the issue of Shares to
                                            distinguish between Members in the amounts and times of payment of calls on their Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
of default</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            a call remains unpaid after it has become due and payable the Directors may give to the person
                                            from whom it is due not less than 14 Clear Days&#8217; notice requiring payment of:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            amount unpaid;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            interest which may have accrued; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            expenses which have been incurred by the Company due to that person&#8217;s default.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            notice shall state the following:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the place where payment is to be made; and</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 458 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            warning that if the notice is not complied with the Shares in respect of which the call is
                                            made will be liable to be forfeited.</span></td></tr></table>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeiture
or surrender of Shares</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the notice given pursuant to Article 5.10 is not complied with, the Directors may, before
                                            the payment required by the notice has been received, resolve that any Share the subject
                                            of that notice be forfeited. The forfeiture shall include all dividends or other monies payable
                                            in respect of the forfeited Share and not paid before the forfeiture. Despite the foregoing,
                                            the Board may determine that any Share the subject of that notice be accepted by the Company
                                            as surrendered by the Member holding that Share in lieu of forfeiture.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal
of forfeited or surrendered Share and power to cancel forfeiture or surrender</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            forfeited or surrendered Share may be sold, re-allotted or otherwise disposed of on such
                                            terms and in such manner as the Board determine either to the former Member who held that
                                            Share or to any other person. The forfeiture or surrender may be cancelled on such terms
                                            as the Directors think fit at any time before a sale, re-allotment or other disposition.
                                            Where, for the purposes of its disposal, a forfeited or surrendered Share is to be transferred
                                            to any person, the Directors may authorise some person to execute an instrument of transfer
                                            of the Share to the transferee. The Directors may accept the surrender for no consideration
                                            of any Fully Paid Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
of forfeiture or surrender on former Member</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            forfeiture or surrender:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            name of the Member concerned shall be removed from the register of Members as the holder
                                            of those Shares and that person shall cease to be a Member in respect of those Shares; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            person shall surrender to the Company for cancellation the certificate (if any) for the forfeited
                                            or surrendered Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                                                                                                                                             Despite the forfeiture or surrender of his Shares, that person shall remain liable to the Company for all monies which at the date
                                                                                                                                                             of forfeiture or surrender were presently payable by him to the Company in respect of those Shares together with:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            expenses; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest
                                            from the date of forfeiture or surrender until payment:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 70.9pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 35.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                            the rate of which interest was payable on those monies before forfeiture; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 70.9pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 35.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            no interest was so payable, at the Default Rate.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Directors, however, may waive payment wholly or in part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 459 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evidence
of forfeiture or surrender</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            declaration, whether statutory or under oath, made by a Director or the Secretary shall be
                                            conclusive evidence of the following matters stated in it as against all persons claiming
                                            to be entitled to forfeited Shares:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            the person making the declaration is a Director or Secretary of the Company, and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            the particular Shares have been forfeited or surrendered on a particular date.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the execution of an instrument of transfer, if necessary, the declaration shall constitute good title to the Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
of forfeited or surrendered Shares</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            person to whom the forfeited or surrendered Shares are disposed of shall not be bound to
                                            see to the application of the consideration, if any, of those Shares nor shall his title
                                            to the Shares be affected by any irregularity in, or invalidity of the proceedings in respect
                                            of, the forfeiture, surrender or disposal of those Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
                                            of Shares</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
to transfer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the following Articles about the transfer of Shares, and provided that such transfer complies
                                            with applicable rules of the Designated Stock Exchange, the Commission and/or any other competent
                                            regulatory authority or otherwise under Applicable Law, a Member may freely transfer Shares
                                            to another person by completing an instrument of transfer in a common form or in a form prescribed
                                            by the Designated Stock Exchange, the Commission and/or any other competent regulatory authority
                                            or otherwise under Applicable Law, or in any other form approved by the Directors, executed:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                            the Shares are Fully Paid, by or on behalf of that Member; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                            the Shares are partly paid, by or on behalf of that Member and the transferee.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            transferor shall be deemed to remain the holder of a Share until the name of the transferee
                                            is entered into the Register of Members.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 460 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to refuse registration for Shares not listed on a Designated Stock Exchange</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                            the Shares of any class in question are not listed on or subject to the rules of any Designated
                                            Stock Exchange, the Directors may in their absolute discretion decline to register any transfer
                                            of such Shares which are not Fully Paid Up or on which the Company has a lien. The Directors
                                            may also, but are not required to, decline to register any transfer of any such Share unless:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            instrument of transfer is lodged with the Company, accompanied by the certificate (if any)
                                            for the Shares to which it relates and such other evidence as the Board may reasonably require
                                            to show the right of the transferor to make the transfer;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            instrument of transfer is in respect of only one class of Shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            instrument of transfer is properly stamped, if required;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of a transfer to joint holders, the number of joint holders to whom the Share is
                                            to be transferred does not exceed four;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Shares transferred are Fully Paid Up and free of any lien in favour of the Company; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            applicable fee of such maximum sum as the Designated Stock Exchanges may determine to be
                                            payable, or such lesser sum as the Board may from time to time require, related to the transfer
                                            is paid to the Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suspension
of transfers</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            registration of transfers may, on 14 days&#8217; notice being given by advertisement in such
                                            one or more newspapers or by electronic means, be suspended and the register of Members closed
                                            at such times and for such periods as the Directors may, in their absolute discretion, from
                                            time to time determine, provided always that such registration of transfer shall not be suspended
                                            nor the register of Members closed for more than 30 days in any year.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
may retain instrument of transfer</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            instruments of transfer that are registered shall be retained by the Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
of refusal to register</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Directors refuse to register a transfer of any Shares of any class not listed on a Designated
                                            Stock Exchange, they shall within one month after the date on which the instrument of transfer
                                            was lodged with the Company send to each of the transferor and the transferee notice of the
                                            refusal.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transmission
                                            of Shares</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons
entitled on death of a Member</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            a Member dies, the only persons recognised by the Company as having any title to the deceased
                                            Members&#8217; interest are the following:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                            the deceased Member was a joint holder, the survivor or survivors; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 461 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                            the deceased Member was a sole holder, that Member&#8217;s personal representative or representatives.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
                                            in these Articles shall release the deceased Member&#8217;s estate from any liability in
                                            respect of any Share, whether the deceased was a sole holder or a joint holder.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
of transfer of a Share following death or bankruptcy</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            person becoming entitled to a Share in consequence of the death or bankruptcy of a Member
                                            may elect to do either of the following:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            become the holder of the Share; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            transfer the Share to another person.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
                                            person must produce such evidence of his entitlement as the Directors may properly require.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the person elects to become the holder of the Share, he must give notice to the Company to
                                            that effect. For the purposes of these Articles, that notice shall be treated as though it
                                            were an executed instrument of transfer.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the person elects to transfer the Share to another person then:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the Share is Fully Paid Up, the transferor must execute an instrument of transfer; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the Share is nil or Partly Paid Up, the transferor and the transferee must execute an instrument
                                            of transfer.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            the Articles relating to the transfer of Shares shall apply to the notice or, as appropriate,
                                            the instrument of transfer.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnity</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            person registered as a Member by reason of the death or bankruptcy of another Member shall
                                            indemnify the Company and the Directors against any loss or damage suffered by the Company
                                            or the Directors as a result of that registration.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
of person entitled to a Share following death or bankruptcy</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            person becoming entitled to a Share by reason of the death or bankruptcy of a Member shall
                                            have the rights to which he would be entitled if he were registered as the holder of the
                                            Share. But, until he is registered as Member in respect of the Share, he shall not be entitled
                                            to attend or vote at any meeting of the Company or at any separate meeting of the holders
                                            of that class of Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 462 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Alteration
                                            of capital</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increasing,
consolidating, converting, dividing and cancelling share capital</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            the fullest extent permitted by the Act, the Company may by Ordinary Resolution do any of
                                            the following and amend its Memorandum for that purpose:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase
                                            its share capital by new Shares of the amount fixed by that Ordinary Resolution and with
                                            the attached rights, priorities and privileges set out in that Ordinary Resolution;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consolidate
                                            and divide all or any of its share capital into Shares of larger amount than its existing
                                            Shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">convert
                                            all or any of its Paid Up Shares into stock, and reconvert that stock into Paid Up Shares
                                            of any denomination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sub-divide
                                            its Shares or any of them into Shares of an amount smaller than that fixed by the Memorandum,
                                            so, however, that in the sub-division, the proportion between the amount paid and the amount,
                                            if any, unpaid on each reduced Share shall be the same as it was in case of the Share from
                                            which the reduced Share is derived; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cancel
                                            Shares which, at the date of the passing of that Ordinary Resolution, have not been taken
                                            or agreed to be taken by any person, and diminish the amount of its share capital by the
                                            amount of the Shares so cancelled or, in the case of Shares without nominal par value, diminish
                                            the number of Shares into which its capital is divided.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dealing
with fractions resulting from consolidation of Shares</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whenever,
                                            as a result of a consolidation of Shares, any Members would become entitled to fractions
                                            of a Share the Directors may on behalf of those Members deal with the fractions as it thinks
                                            fit, including (without limitation):</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">either
                                            round up or down the fraction to the nearest whole number, such rounding to be determined
                                            by the Directors acting in their sole discretion;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sell
                                            the Shares representing the fractions for the best price reasonably obtainable to any person
                                            (including, subject to the provisions of the Act, the Company); or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">distribute
                                            the net proceeds in due proportion among those Members.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            the purposes of Article 8.2, the Directors may authorise some person to execute an instrument
                                            of transfer of the Shares to, in accordance with the directions of, the purchaser. The transferee
                                            shall not be bound to see to the application of the purchase money nor shall the transferee&#8217;s
                                            title to the Shares be affected by any irregularity in, or invalidity of, the proceedings
                                            in respect of the sale.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 463 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reducing
share capital</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the Act and to any rights for the time being conferred on the Members holding a particular
                                            class of Shares, the Company may, by Special Resolution, reduce its share capital in any
                                            way.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemption
                                            and purchase of own Shares</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to issue redeemable Shares and to purchase own Shares</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the Act and to any rights for the time being conferred on the Members holding a particular
                                            class of Shares, and where applicable, the Designated Stock Exchange Rules, the rules and
                                            regulations of the Commission and/or any other competent regulatory authority or otherwise
                                            under Applicable Law, the Company may by its Directors:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issue
                                            Shares that are to be redeemed or liable to be redeemed, at the option of the Company or
                                            the Member holding those redeemable Shares, on the terms and in the manner its Directors
                                            determine before the issue of those Shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                            the consent by Special Resolution of the Members holding Shares of a particular class, vary
                                            the rights attaching to that class of Shares so as to provide that those Shares are to be
                                            redeemed or are liable to be redeemed at the option of the Company on the terms and in the
                                            manner which the Directors determine at the time of such variation; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchase
                                            all or any of its own Shares of any class including any redeemable Shares on the terms and
                                            in the manner which the Directors determine at the time of such purchase.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may make a payment in respect of the redemption or purchase of its own Shares in any manner authorised by the Act, including
out of any combination of the following: capital, its profits and the proceeds of a fresh issue of Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to pay for redemption or purchase in cash or in specie</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">When
                                            making a payment in respect of the redemption or purchase of Shares, the Directors may make
                                            the payment in cash or <i>in specie</i> (or partly in one and partly in the other) if so
                                            authorised by the terms of the allotment of those Shares or by the terms applying to those <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
in accordance with Article 9.1, or otherwise by agreement with the Member holding those Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 464 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
of redemption or purchase of a Share</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            the date of redemption or purchase of a Share:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Member holding that Share shall cease to be entitled to any rights in respect of the Share
                                            other than the right to receive:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            price for the Share; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            dividend declared in respect of the Share prior to the date of redemption or purchase;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Member&#8217;s name shall be removed from the register of Members with respect to the Share;
                                            and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Share shall be cancelled or held as a Treasury Share, as the Directors may determine.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            the purpose of Article 9.3, the date of redemption or purchase is the date when the Member&#8217;s
                                            name is removed from the register of Members with respect to the Shares the subject of the
                                            redemption or purchase.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Meetings
                                            of Members</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
and extraordinary general meetings</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company may, but shall not (unless required by the applicable Designated Stock Exchange Rules
                                            or by Applicable Law) be obligated to, in each year hold a general meeting as an annual general
                                            meeting, which, if held, shall be convened by the Board, in accordance with these Articles.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            general meetings other than annual general meetings shall be called extraordinary general
                                            meetings.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            agenda of the annual general meeting shall be set by the Directors and shall include the
                                            presentation of the Company&#8217;s annual accounts and the report of the Directors (if any).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to call meetings</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may call a general meeting at any time.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            there are insufficient Directors to constitute a quorum and the remaining Directors are unable
                                            to agree on the appointment of additional Directors, the Directors must call a general meeting
                                            for the purpose of appointing additional Directors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors must also call a general meeting if requisitioned in the manner set out in the
                                            next two Articles.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            requisition must be in writing and given by one or more Members who (together) hold at least
                                            [ten] per cent of the rights to vote at such general meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            requisition must also:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">specify
                                            the purpose of the meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 465 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            signed by or on behalf of each requisitioner (and for this purpose each joint holder shall
                                            be obliged to sign). The requisition may consist of several documents in like form signed
                                            by one or more of the requisitioners; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            delivered in accordance with the notice provisions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
                                            the Directors fail to call a general meeting within 21 Clear Days&#8217; from the date of
                                            receipt of a requisition, the requisitioners or any of them may call a general meeting within
                                            three months after the end of that period.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                            limitation to the foregoing, if there are insufficient Directors to constitute a quorum and
                                            the remaining Directors are unable to agree on the appointment of additional Directors, any
                                            one or more Members who together hold at least ten per cent of the rights to vote at a general
                                            meeting may call a general meeting for the purpose of considering the business specified
                                            in the notice of meeting which shall include as an item of business the appointment of additional
                                            Directors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Members
                                            seeking to bring business before the annual general meeting or to nominate candidates for
                                            election as Directors at the annual general meeting must deliver notice to the principal
                                            executive offices of the Company not later than the close of business on the 90th day nor
                                            earlier than the close of business on the 120th day prior to the scheduled date of the annual
                                            general meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Content
of notice</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
                                            of a general meeting shall specify each of the following:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            place, the date and the hour of the meeting;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            the meeting will be held virtually, at a physical place or both;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the meeting is to be held in two or more places, or in any part virtually, the Electronic
                                            Communication Facilities that will be used to facilitate the meeting including the procedures
                                            to be followed by any Member or other participant of the meeting who wishes to utilize such
                                            Electronic Communication Facilities for the purposes of attending and participating in such
                                            meeting;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                            to paragraph (e) and the requirements of the Designated Stock Exchange Rules (to the extent
                                            applicable), the general nature of the business to be transacted; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            a resolution is proposed as a Special Resolution, the text of that resolution.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            each notice there shall appear with reasonable prominence the following statements:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            a Member who is entitled to attend and vote is entitled to appoint one or more proxies to
                                            attend and vote instead of that Member; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 466 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            a proxyholder need not be a Member.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Period
of notice</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                            least five (5) Clear Days&#8217; notice of a general meeting must be given to Members, provided
                                            that a general meeting of the Company shall, whether or not the notice specified in this
                                            Article has been given and whether or not the provisions of these Articles regarding general
                                            meetings have been complied with, be deemed to have been duly convened if it is so agreed:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of an annual general meeting, by all of the Members entitled to attend and vote
                                            thereat; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of an extraordinary general meeting, by a majority in number of the Members having
                                            a right to attend at the meeting, together holding not less than 90% in par value of the
                                            Shares giving that right.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons
entitled to receive notice</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the provisions of these Articles and to any restrictions imposed on any Shares, the notice
                                            shall be given to the following people:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Members</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            entitled to a Share in consequence of the death or bankruptcy of a Member;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Directors; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Auditors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board may determine that the Members entitled to receive notice of, attend and vote at a
                                            meeting are those persons entered on the register of Members at the close of business on
                                            a day determined by the Board.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accidental
omission to give notice or non-receipt of notice</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceedings
                                            at a meeting shall not be invalidated by the following:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            accidental failure to give notice of the meeting to any person entitled to notice; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-receipt
                                            of notice of the meeting by any person entitled to notice.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition, where a notice of meeting is published on a website proceedings at the meeting
                                            shall not be invalidated merely because it is accidentally published:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            a different place on the website; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                            part only of the period from the date of the notification until the conclusion of the meeting
                                            to which the notice relates.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 467 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Publication
of notice on a website</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the Act or the Designated Stock Exchange Rules, the Commission and/or any other competent
                                            regulatory authority or otherwise under Applicable Law, a notice of a general meeting may
                                            be published on a website providing the recipient is given separate notice of:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            publication of the notice on the website;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            place on the website where the notice may be accessed;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">how
                                            it may be accessed; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            place, date and time of the general meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            a Member notifies the Company that he is unable for any reason to access the website, the
                                            Company must as soon as practicable give notice of the meeting to that Member by any other
                                            means permitted by these Articles. This will not affect when that Member is deemed to have
                                            received notice of the meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time
a website notice is deemed to be given</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            website notice is deemed to be given when the Member is given notice of its publication.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required
duration of publication on a website</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                            the notice of meeting is published on a website, it shall continue to be published in the
                                            same place on that website from the date of the notification until at least the conclusion
                                            of the meeting to which the notice relates.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Validity
despite accidental error in publication on website</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
                                            for the purpose of a meeting, documents are sent by being published on a website in accordance
                                            with the preceding Articles, the proceedings at that meeting are not invalidated merely because:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">those
                                            documents are, by accident, published in a different place on the website to the place notified;
                                            or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">they
                                            are published for part only of the period from the date of notification until the conclusion
                                            of that meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 468 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proceedings
                                            at meetings of Members</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quorum</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
                                            as provided in the following Article, no business shall be transacted at any meeting unless
                                            a quorum is present in person or by proxy at the meeting. A quorum is as follows:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the Company has only one Member: that Member;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the Company has more than one Member: one or more Members holding Shares that represent not
                                            less than one-third of the outstanding Shares carrying the right to vote at such general
                                            meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lack
of quorum</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            a quorum is not present at the meeting within fifteen minutes of the time appointed for the
                                            meeting, or if at any time during the meeting it becomes inquorate, then the following provisions
                                            apply:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the meeting was requisitioned by Members, it shall be cancelled.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            any other case, the meeting shall stand adjourned to the same time and place seven days hence,
                                            or to such other time or place as is determined by the Directors. If a quorum is not present
                                            at the meeting within fifteen minutes of the time appointed for the adjourned meeting, then
                                            the Members present in person or by proxy at the meeting shall constitute a quorum.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            chairman of a general meeting (including any Virtual Meeting) shall be the chairman of the
                                            Board or such other Director as the Directors may determine. Absent any such person being
                                            present at the meeting within fifteen minutes of the time appointed for the meeting, the
                                            Directors present shall elect one of their number to chair the meeting. The chairman of the
                                            meeting shall be entitled to attend and participate at any such general meeting by means
                                            of Electronic Communication Facilities, and to act as the chairman of such general meeting,
                                            in which event the chairman of the meeting shall be deemed to be present at the meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            no Director is present within fifteen minutes of the time appointed for the meeting, or if
                                            no Director is willing to act as chairman, the Members present in person or by proxy and
                                            entitled to vote shall choose one of their number to chair the meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
of a Director to attend and speak</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
                                            if a Director is not a Member, he shall be entitled to attend and speak at any general meeting
                                            and at any separate meeting of Members holding a particular class of Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 469 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
of technology</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            person may participate in a general meeting through the medium of conference telephone, video
                                            or any other form of communications equipment providing all persons participating in the
                                            meeting are able to hear and speak to each other throughout the meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Member entitled to receive notice and attend a meeting will be deemed to be in attendance
                                            at such meeting despite their attendance being virtual if adequate facilities are available
                                            to ensure that the Member is able to:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            participate in the business for which the meeting has been convened;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            hear all that happens at the meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
limiting the generality of the foregoing, the Directors may determine that any general meeting may be held as a Virtual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition to any measures which the Board may be required to take due to the location or venue
                                            of the meeting, the Board may make any arrangement and impose any restriction it considers
                                            appropriate and reasonable in the circumstances to ensure the security of a meeting including,
                                            without limitation, the searching of any person attending the meeting and the imposing of
                                            restrictions on the items of personal property that may be taken into the meeting place.
                                            The Board may refuse entry to, or eject from, a meeting a person who refuses to comply with
                                            any such arrangements or restrictions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjournment,
postponement and cancellation</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            meeting may be:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">postponed
                                            or cancelled prior to the meeting at the discretion of the Directors by written notice provided
                                            to all persons entitled to attend the meeting, unless the meeting was requisitioned by Members
                                            or otherwise called by Members pursuant to Article 10; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adjourned,
                                            with or without an appointed date for resumption, at any time during the meeting at the discretion
                                            of the chairman with the consent of the Members constituting a quorum.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
chairman must adjourn the meeting if so directed by the Members constituting a quorum at the meeting. No business, however, can be transacted
at an adjourned or postponed meeting other than business which might properly have been transacted at the original meeting</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
                                            a meeting be adjourned for more than twenty Clear Days, whether because of a lack of quorum
                                            or otherwise, Members shall be given at least five (5) Clear Days&#8217; notice of the date, time
                                            and place of the adjourned meeting and the general nature of the business to be transacted.
                                            Otherwise it shall not be necessary to give any notice of the adjournment. All proxy forms
                                            submitted for the original general meeting shall remain valid for the postponed meeting.
                                            The Directors may postpone a general meeting which has already been postponed.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 470 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method
of voting</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            resolution put to the vote of the meeting shall be decided on a poll.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taking
of a poll</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            poll shall be taken in such manner as the chairman directs. He may appoint scrutineers (who
                                            need not be Members) and fix a place and time for declaring the result of the poll. If, through
                                            the aid of technology, the meeting is held as a Virtual Meeting or in more than one place,
                                            the chairman may appoint scrutineers virtually and in more than one place; but if he considers
                                            that the poll cannot be effectively monitored at that meeting, the chairman shall adjourn
                                            the holding of the poll to a date, place and time when that can occur.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman&#8217;s
casting vote</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.13</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            the case of an equality of votes, the Chairman of the meeting shall be entitled to a second
                                            or casting vote.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amendments
to resolutions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            Ordinary Resolution to be proposed at a general meeting may be amended by Ordinary Resolution
                                            if:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                            less than 48 hours before the meeting is to take place (or such later time as the chairman
                                            of the meeting may determine), notice of the proposed amendment is given to the Company in
                                            writing by a Member entitled to vote at that meeting; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            proposed amendment does not, in the reasonable opinion of the chairman of the meeting, materially
                                            alter the scope of the resolution.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Special Resolution to be proposed at a general meeting may be amended by Ordinary Resolution,
                                            if:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            chairman of the meeting proposes the amendment at the general meeting at which the resolution
                                            is to be proposed, and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            amendment does not go beyond what the chairman considers is necessary to correct a grammatical
                                            or other non-substantive error in the resolution.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the chairman of the meeting, acting in good faith, wrongly decides that an amendment to a
                                            resolution is out of order, the chairman&#8217;s error does not invalidate the vote on that
                                            resolution.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 471 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
resolutions</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Members
                                            may pass a resolution in writing without holding a meeting if the following conditions are
                                            met:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            Members entitled to vote are given notice of the resolution as if the same were being proposed
                                            at a meeting of Members;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            Members entitled so to vote;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sign
                                            a document; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sign
                                            several documents in the like form each signed by one or more of those Members; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            signed document or documents is or are delivered to the Company, including, if the Company
                                            so nominates, by delivery of an Electronic Record by Electronic means to the address specified
                                            for that purpose.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
                                            written resolution shall be as effective as if it had been passed at a meeting of the Members
                                            entitled to vote duly convened and held.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            a written resolution is described as a Special Resolution or as an Ordinary Resolution, it
                                            has effect accordingly.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.19</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may determine the manner in which written resolutions shall be put to Members.
                                            In particular, they may provide, in the form of any written resolution, for each Member to
                                            indicate, out of the number of votes the Member would have been entitled to cast at a meeting
                                            to consider the resolution, how many votes he wishes to cast in favour of the resolution
                                            and how many against the resolution or to be treated as abstentions. The result of any such
                                            written resolution shall be determined on the same basis as on a poll.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sole-Member
Company</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Company has only one Member, and the Member records in writing his decision on a question,
                                            that record shall constitute both the passing of a resolution and the minute of it.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting
                                            rights of Members</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
to vote</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the following, unless their Shares carry no right to vote, or unless a call or other amount
                                            presently payable has not been paid, all Members are entitled to vote at a general meeting,
                                            and all Members holding Shares of a particular class of Shares are entitled to vote at a
                                            meeting of the holders of that class of Shares. Unless otherwise required by the Act, the
                                            Memorandum or these Articles, holders of Ordinary Shares and Preferred Shares shall, at all
                                            times, vote together as a single class on all matters submitted to a vote for Members&#8217;
                                            approval.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 472 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Members
                                            may vote in person or by proxy.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Every
                                            Member shall have one vote for each Share he holds, unless any Share carries special voting
                                            rights.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            fraction of a Share shall entitle its holder to an equivalent fraction of one vote.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            Member is bound to vote on his Shares or any of them; nor is he bound to vote each of his
                                            Shares in the same way.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
of joint holders</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            Shares are held jointly, only one of the joint holders may vote. If more than one of the
                                            joint holders tenders a vote, the vote of the holder whose name in respect of those Shares
                                            appears first in the register of Members shall be accepted to the exclusion of the votes
                                            of the other joint holder.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representation
of corporate Members</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
                                            where otherwise provided, a corporate Member must act by a duly authorised representative.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            corporate Member wishing to act by a duly authorised representative must identify that person
                                            to the Company by notice in writing.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            authorisation may be for any period of time, and must be delivered to the Company before
                                            the commencement of the meeting at which it is first used.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors of the Company may require the production of any evidence which they consider necessary
                                            to determine the validity of the notice.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                            a duly authorised representative is present at a meeting that Member is deemed to be present
                                            in person; and the acts of the duly authorised representative are personal acts of that Member.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            corporate Member may revoke the appointment of a duly authorised representative at any time
                                            by notice to the Company; but such revocation will not affect the validity of any acts carried
                                            out by the duly authorised representative before the Directors of the Company had actual
                                            notice of the revocation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.13</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            a Clearing House (or its nominee(s)), being a corporation, is a Member, it may authorise
                                            such persons as it sees fit to act as its representative at any meeting of the Company or
                                            at any meeting of any class of Members provided that the authorisation shall specify the
                                            number and class of Shares in respect of which each such representative is so authorised.
                                            Each person so authorised under the provisions of this Article shall be deemed to have been
                                            duly authorised without further evidence of the facts and be entitled to exercise the same
                                            rights and powers on behalf of the Clearing House (or its nominee(s)) as if such person was
                                            the registered holder of such Shares held by the Clearing House (or its nominee(s)).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 473 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
with mental disorder</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Member in respect of whom an order has been made by any court having jurisdiction (whether
                                            in the Cayman Islands or elsewhere) in matters concerning mental disorder may vote by that
                                            Member&#8217;s receiver, <i>curator bonis</i> or other person authorised in that behalf appointed
                                            by that court.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            the purpose of the preceding Article, evidence to the satisfaction of the Directors of the
                                            authority of the person claiming to exercise the right to vote must be received not less
                                            than 24 hours before holding the relevant meeting or the adjourned meeting in any manner
                                            specified for the delivery of forms of appointment of a proxy, whether in writing or by Electronic
                                            means. In default, the right to vote shall not be exercisable.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Objections
to admissibility of votes</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            objection to the validity of a person&#8217;s vote may only be raised at the meeting or at
                                            the adjourned meeting at which the vote is sought to be tendered. Any objection duly made
                                            shall be referred to the chairman whose decision shall be final and conclusive.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of proxy</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            instrument appointing a proxy shall be in any common form or in any other form approved by
                                            the Directors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            instrument must be in writing and signed in one of the following ways:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            the Member; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            the Member&#8217;s authorised attorney; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the Member is a corporation or other body corporate, under seal or signed by an authorised
                                            officer, secretary or attorney.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Directors so resolve, the Company may accept an Electronic Record of that instrument delivered in the manner specified below and
otherwise satisfying the Articles about authentication of Electronic Records.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.19</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may require the production of any evidence which they consider necessary to determine
                                            the validity of any appointment of a proxy.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Member may revoke the appointment of a proxy at any time by notice to the Company duly signed
                                            in accordance with Article 12.18.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 474 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            revocation by a Member of the appointment of a proxy made in accordance with Article 12.20
                                            will affect the validity of any acts carried out by the relevant proxy before the Directors
                                            of the Company had actual notice of the revocation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">How
and when proxy is to be delivered</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.22</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the following Articles, the Directors may, in the notice convening any meeting or adjourned
                                            meeting, or in an instrument of proxy sent out by the Company, specify the manner by which
                                            the instrument appointing a proxy shall be deposited and the place and the time (being not
                                            later than the time appointed for the commencement of the meeting or adjourned meeting to
                                            which the proxy relates) at which the instrument appointing a proxy shall be deposited. In
                                            the absence of any such direction from the Directors in the notice convening any meeting
                                            or adjourned meeting or in an instrument of proxy sent out by the Company, the form of appointment
                                            of a proxy and any authority under which it is signed (or a copy of the authority certified
                                            notarially or in any other way approved by the Directors) must be delivered so that it is
                                            received by the Company before the time for holding the meeting or adjourned meeting at which
                                            the person named in the form of appointment of proxy proposes to vote. They must be delivered
                                            in either of the following ways:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            the case of an instrument in writing, it must be left at or sent by post:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            the registered office of the Company; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            such other place specified in the notice convening the meeting or in any form of appointment
                                            of proxy sent out by the Company in relation to the meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
                                            pursuant to the notice provisions, a notice may be given to the Company in an Electronic
                                            Record, an Electronic Record of an appointment of a proxy must be sent to the address specified
                                            pursuant to those provisions unless another address for that purpose is specified:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the notice convening the meeting; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            any form of appointment of a proxy sent out by the Company in relation to the meeting; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            any invitation to appoint a proxy issued by the Company in relation to the meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                            Article 12.22(a) and Article 12.22(b), the chairman of the Company may, in any event at his
                                            discretion, direct that an instrument of proxy shall be deemed to have been duly deposited.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                            a poll is taken:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            it is taken more than seven (7) Clear Days after it is demanded, the form of appointment
                                            of a proxy and any accompanying authority (or an Electronic Record of the same) must be delivered
                                            in accordance with Article 12.22 before the time appointed for the taking of the poll;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 475 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            it to be taken within seven (7) Clear Days after it was demanded, the form of appointment
                                            of a proxy and any accompanying authority (or an Electronic Record of the same) must be delivered
                                            in accordance with Article 12.22 before the time appointed for the taking of the poll.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.24</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the form of appointment of proxy is not delivered on time, it is invalid.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.25</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
                                            two or more valid but differing appointments of proxy are delivered or received in respect
                                            of the same Share for use at the same meeting and in respect of the same matter, the one
                                            which is last validly delivered or received (regardless of its date or of the date of its
                                            execution) shall be treated as replacing and revoking the other or others as regards that
                                            Share. lf the Company is unable to determine which appointment was last validly delivered
                                            or received, none of them shall be treated as valid in respect of that Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.26</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board may at the expense of the Company send forms of appointment of proxy to the Members
                                            by post (that is to say, pre-paying and posting a letter), or by Electronic Communication
                                            or otherwise (with or without provision for their return by pre-paid post) for use at any
                                            general meeting or at any separate meeting of the holders of any class of Shares, either
                                            blank or nominating as proxy in the alternative any one or more of the Directors or any other
                                            person. lf for the purpose of any meeting invitations to appoint as proxy a person or one
                                            of a number of persons specified in the invitations are issued at the Company&#8217;s expense,
                                            they shall be issued to all (and not to some only) of the Members entitled to be sent notice
                                            of the meeting and to vote at it. The accidental omission to send such a form of appointment
                                            or to give such an invitation to, or the non-receipt of such form of appointment by, any
                                            Member entitled to attend and vote at a meeting shall not invalidate the proceedings at that
                                            meeting</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
by proxy</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.27</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            proxy shall have the same voting rights at a meeting or adjourned meeting as the Member would
                                            have had except to the extent that the instrument appointing him limits those rights. Notwithstanding
                                            the appointment of a proxy, a Member may attend and vote at a meeting or adjourned
meeting. If a Member votes on any resolution a vote by his proxy on the same resolution, unless in respect of different Shares, shall
be invalid.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of Directors</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
                                            shall be a Board consisting of not less than one person and a maximum of ten (10), however
                                            that the Company may by Ordinary Resolution increase or reduce the foregoing limits in the
                                            number of Directors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 476 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appointment,
                                            disqualification and removal of Directors</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
age limit</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
                                            is no age limit for Directors save that they must be at least eighteen years of age.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
Directors</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            prohibited by law, a body corporate may be a Director. If a body corporate is a Director,
                                            the Articles about representation of corporate Members at general meetings apply, mutatis
                                            mutandis, to the Articles about Directors&#8217; meetings.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
shareholding qualification</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            a shareholding qualification for Directors is fixed by Ordinary Resolution, no Director shall
                                            be required to own Shares as a condition of his appointment.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment
of Directors</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Director may be appointed by Ordinary Resolution or by the Directors. Any appointment may
                                            be to fill a vacancy or as an additional Director. A Director so appointed is not subject
                                            to a term of office and shall hold office until such time as he or she is removed or resigned
                                            in accordance with these Articles, unless such Director is appointed on such express terms
                                            that he or she shall automatically retire from office (unless he/she has sooner vacated office)
                                            at the next or a subsequent annual general meeting or upon any specified event or after any
                                            specified period.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            remaining Director(s) may appoint a Director even though there is not a quorum of Directors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            appointment can cause the number of Directors to exceed the maximum; and any such appointment
                                            shall be invalid.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            so long as Shares are listed on a Designated Stock Exchange, the Directors shall include
                                            at least such number of Independent Directors as applicable law, rules or regulations or
                                            the Designated Stock Exchange Rules require as determined by the Board.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board&#8217;s
power to appoint Directors</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                            prejudice to the Company&#8217;s power to appoint a person to be a Director pursuant to these
                                            Articles, the Board shall have power at any time to appoint any person who is willing to
                                            act as a Director, either to fill a vacancy or as an addition to the existing Board, subject
                                            to the total number of Directors not exceeding any maximum number fixed by or in accordance
                                            with these Articles.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Removal
of Directors</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Director may be removed by Ordinary Resolution.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 477 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resignation
of Directors</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Director may at any time resign office by giving to the Company notice in writing or, if
                                            permitted pursuant to the notice provisions, in an Electronic Record delivered in either
                                            case in accordance with those provisions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            the notice specifies a different date, the Director shall be deemed to have resigned on the
                                            date that the notice is delivered to the Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination
of the office of Director</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Director may retire from office as a Director by giving notice in writing to that effect
                                            to the Company at the registered office, which notice shall be effective upon such date as
                                            may be specified in the notice, failing which upon delivery to the registered office.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.13</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                            prejudice to the provisions in these Articles for retirement (by rotation or otherwise),
                                            a Director&#8217;s office shall be terminated forthwith if:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">he
                                            resigns his office by notice in writing to the Company; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">he
                                            is prohibited by the law of the Cayman Islands from acting as a Director; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">he
                                            is made bankrupt or makes an arrangement or composition with his creditors generally; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the opinion of a registered medical practitioner by whom he is being treated he becomes physically
                                            or mentally incapable of acting as a director; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">he
                                            is made subject to any law relating to mental health or incompetence, whether by court order
                                            or otherwise;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">without
                                            special leave of absence from the Board, he is absent from meetings of Directors for a continuous
                                            period of six months; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dies
                                            or is found by the Company to be or becomes of unsound mind; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">he
                                            is given notice by the majority of the other Directors (not being less than two in number)
                                            to vacate office (without prejudice to any claim for damages for breach of any agreement
                                            relating to the provision of the services of such Director).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Alternate
                                            Directors</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment
and removal</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            Director may appoint any other person, including another Director, to act in his place as
                                            an alternate Director. No appointment shall take effect until the Director has given notice
                                            of the appointment to the Board.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 478 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Director may revoke his appointment of an alternate at any time. No revocation shall take
                                            effect until the Director has given notice of the revocation to the Board.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            notice of appointment or removal of an alternate Director shall be effective only if given
                                            to the Company by one or more of the following methods:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            notice in writing in accordance with the notice provisions contained in these Articles;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the Company has a facsimile address for the time being, by sending by facsimile transmission
                                            to that facsimile address a facsimile copy or, otherwise, by sending by facsimile transmission
                                            to the facsimile address of the Company&#8217;s registered office a facsimile copy (in either case,
                                            the facsimile copy being deemed to be the notice unless Article 29.7 applies), in which event
                                            notice shall be taken to be given on the date of an error-free transmission report from the
                                            sender&#8217;s fax machine;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the Company has an email address for the time being, by emailing to that email address a
                                            scanned copy of the notice as a PDF attachment or, otherwise, by emailing to the email address
                                            provided by the Company&#8217;s registered office a scanned copy of the notice as a PDF attachment
                                            (in either case, the PDF version being deemed to be the notice unless Article 29.7 applies),
                                            in which event notice shall be taken to be given on the date of receipt by the Company or
                                            the Company&#8217;s registered office (as appropriate) in readable form; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            permitted pursuant to the notice provisions, in some other form of approved Electronic Record
                                            delivered in accordance with those provisions in writing.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            notices of meetings of Directors shall continue to be given to the appointing Director and
                                            not to the alternate.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
of alternate Director</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">An
                                            alternate Director shall be entitled to attend and vote at any Board meeting or meeting of
                                            a committee of the Directors at which the appointing Director is not personally present,
                                            and <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">generally
to perform all the functions of the appointing Director in his absence. For the avoidance of doubt:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            another director has been appointed an alternate director for one or more directors, he shall
                                            be entitled to a separate vote in his own right as a director and in right of each other
                                            director for whom he has been appointed an alternate; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            a person other than a director has been appointed an alternate director for more than one
                                            director, he shall be entitled to a separate vote in right of each director for whom he has
                                            been appointed an alternate.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 479 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            alternate Director, however, is not entitled to receive any remuneration from the Company
                                            for services rendered as an alternate Director.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment
ceases when the appointor ceases to be a Director</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            alternate Director shall cease to be an alternate Director if:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Director who appointed him ceases to be a Director; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Director who appointed him revokes his appointment by notice delivered to the Board or to
                                            the registered office of the Company or in any other manner approved by the Board; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            any event happens in relation to him which, if he were a Director of the Company, would cause
                                            his office as Director to be vacated.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Status
of alternate Director</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            alternate Director shall carry out all functions of the Director who made the appointment.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
                                            where otherwise expressed, an alternate Director shall be treated as a Director under these
                                            Articles.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            alternate Director is not the agent of the Director appointing him.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            alternate Director is not entitled to any remuneration for acting as alternate Director.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Status
of the Director making the appointment</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Director who has appointed an alternate is not thereby relieved from the duties which he
                                            owes the Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Powers
                                            of Directors</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Powers
of Directors</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the provisions of the Act, the Memorandum and these Articles the business of the Company
                                            shall be managed by the Directors who may for that purpose exercise all the powers of the
                                            Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            prior act of the Directors shall be invalidated by any subsequent alteration of the Memorandum
                                            or these Articles. However, to the extent allowed by the Act, Members may, by Special Resolution,
                                            validate any prior or future act of the Directors which would otherwise be in breach of their
                                            duties.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 480 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
below the minimum number</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lf
                                            the number of Directors is less than the minimum prescribed in accordance with these Articles,
                                            the remaining Director or Directors shall act only for the purposes of appointing an additional
                                            Director or Directors to make up such minimum or of convening a general meeting of the Company
                                            for the purpose of making such appointment. lf there are no Director or Directors able or
                                            willing to act, any two Members may summon a general meeting for the purpose of appointing
                                            Directors. Any additional Director so appointed shall hold office (subject to these Articles)
                                            only until the dissolution of the annual general meeting next following such appointment
                                            unless he is re-elected during such meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointments
to office</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may appoint a Director:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            chairman of the Board;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            vice-chairman of the Board;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            managing Director;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            any other executive office,</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
such period, and on such terms, including as to remuneration as they think fit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            appointee must consent in writing to holding that office.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                            a chairman is appointed he shall, unless unable to do so, preside at every meeting of Directors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            there is no chairman, or if the chairman is unable to preside at a meeting, that meeting
                                            may select its own chairman; or the Directors may nominate one of their number to act in
                                            place of the chairman should he ever not be available.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the provisions of the Act, the Directors may also appoint and remove any person, who need
                                            not be a Director:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            Secretary; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            any office that may be required</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
such period and on such terms, including as to remuneration, as they think fit. In the case of an Officer, that Officer may be given
any title the Directors decide.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Secretary or Officer must consent in writing to holding that office.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 481 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Director, Secretary or other Officer of the Company may not the hold the office, or perform
                                            the services, of auditor.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions
for employees</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board may make provision for the benefit of any persons employed or formerly employed by
                                            the Company or any of its subsidiary undertakings (or any member of his family or any person
                                            who is dependent on him) in connection with the cessation or the transfer to any person of
                                            the whole or part of the undertaking of the Company or any of its subsidiary undertakings.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
of voting rights</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board may exercise the voting power conferred by the Shares in any body corporate held or
                                            owned by the Company in such manner in all respects as it thinks fit (including, without
                                            limitation, the exercise of that power in favour of any resolution appointing any Director
                                            as a Director of such body corporate, or voting or providing for the payment of remuneration
                                            to the Directors of such body corporate).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remuneration</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.13</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Every
                                            Director may be remunerated by the Company for the services he provides for the benefit of
                                            the Company, whether as Director, employee or otherwise, and shall be entitled to be paid
                                            for the expenses incurred in the Company&#8217;s business including attendance at Directors&#8217;
                                            meetings.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
                                            otherwise determined by the Company by Ordinary Resolution, the Directors (other than alternate
                                            Directors) shall be entitled to such remuneration by way of fees for their services in the
                                            office of Director as the Directors may determine.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remuneration
                                            may take any form and may include arrangements to pay pensions, health insurance, death or
                                            sickness benefits, whether to the Director or to any other person connected to or related
                                            to him.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            his fellow Directors determine otherwise, a Director is not accountable to the Company for
                                            remuneration or other benefits received from any other company which is in the same group
                                            as the Company or which has common shareholdings.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 482 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
of information</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to compliance with Applicable Laws, including the appliable federal securities laws of the
                                            United States, the Directors may release or disclose to a third party any information regarding
                                            the affairs of the Company, including any information contained in the register of Members
                                            relating to a Member, (and they may authorise any Director, Officer or other authorised agent
                                            of the Company to release or disclose to a third party any such information in his possession)
                                            if:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Company or that person, as the case may be, is lawfully required to do so under the laws
                                            of any jurisdiction to which the Company is subject; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                            disclosure is in compliance with the Designated Stock Exchange Rules; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                            disclosure is in accordance with any contract entered into by the Company; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Directors are of the opinion such disclosure would assist or facilitate the Company&#8217;s
                                            operations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delegation
                                            of powers</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to delegate any of the Directors&#8217; powers to a committee</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may delegate any of their powers to any committee consisting of one or more persons
                                            who need not be Members. Persons on the committee may include non-Directors so long as the
                                            majority of those persons are Directors. Any such committee shall be made up of such number
                                            of Independent Directors as required from time to time by the Designated Stock Exchange Rules
                                            or otherwise required by applicable law.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="text-align: justify; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
delegation may be collateral with, or to the exclusion of, the Directors&#8217; own powers.</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            delegation may be on such terms as the Directors think fit, including provision for the committee
                                            itself to delegate to a sub-committee; save that any delegation must be capable of being
                                            revoked or altered by the Directors at will.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            otherwise permitted by the Directors, a committee must follow the procedures prescribed for
                                            the taking of decisions by Directors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The
                                            Board may establish an audit committee, a compensation committee and a nominating and corporate
                                            governance committee. Each of these committees shall be empowered to do all things necessary
                                            to exercise the rights of such committee set forth in these Articles and shall have such
                                            powers as the directors may delegate pursuant to the Articles and as required by the Designated
                                            Stock Exchange Rules, the Commission and/or any other competent regulatory <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">authority
or otherwise under applicable law. Each of the audit committee, compensation committee and nominating and corporate governance committee,
if established, shall consist of such number of directors as the directors shall from time to time determine (or such minimum number
as may be required from time to time by the Designated Stock Exchange Rules, the Commission and/or any other competent regulatory authority
or otherwise under applicable law). For so long as any class of Shares is listed on any Designated Stock Exchange, the audit committee,
a compensation committee and a nominating and corporate governance committee, if established, shall be made up of such number of Independent
Directors as required from time to time by the Designated Stock Exchange Rules or otherwise required by applicable law, subject to any
exemptions permitted under the Designated Stock Exchange Rules or other Applicable Laws.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 483 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Local
boards</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board may establish any local or divisional board or agency for managing any of the affairs
                                            of the Company whether in the Cayman Islands or elsewhere and may appoint any persons to
                                            be members of a local or divisional Board, or to be managers or agents, and may fix their
                                            remuneration.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board may delegate to any local or divisional board, manager or agent any of its powers and
                                            authorities (with power to sub-delegate) and may authorise the members of any local or divisional
                                            board or any of them to fill any vacancies and to act notwithstanding vacancies.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            appointment or delegation under this Article 17.8 may be made on such terms and subject to
                                            such conditions as the Board thinks fit and the Board may remove any person so appointed,
                                            and may revoke or vary any delegation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to appoint an agent of the Company</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may appoint any person, either generally or in respect of any specific matter,
                                            to be the agent of the Company with or without authority for that person to delegate all
                                            or any of that person&#8217;s powers. The Directors may make that appointment:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            causing the Company to enter into a power of attorney or agreement; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            any other manner they determine.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to appoint an attorney or authorised signatory of the Company</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may appoint any person, whether nominated directly or indirectly by the Directors,
                                            to be the attorney or the authorised signatory of the Company. The appointment may be:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                            any purpose;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                            the powers, authorities and discretions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                            the period; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                            to such conditions</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
they think fit. The powers, authorities and discretions, however, must not exceed those vested in, or exercisable, by the Directors under
these Articles. The Directors may do so by power of attorney or any other manner they think fit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            power of attorney or other appointment may contain such provision for the protection and
                                            convenience for persons dealing with the attorney or authorised signatory as the Directors
                                            think fit. Any power of attorney or other appointment may also authorise the attorney or
                                            authorised signatory to delegate all or any of the powers, authorities and discretions vested
                                            in that person.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 484 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board may remove any person appointed under Article 17.10 and may revoke or vary the delegation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
Powers</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.13</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may exercise all the powers of the Company to borrow money and to mortgage or charge
                                            its undertaking, property and uncalled capital, or any part thereof, and to issue debentures,
                                            debenture share and other securities, whether outright or as collateral security for any
                                            debt, liability or obligation of the Company or its parent undertaking (if any) or any subsidiary
                                            undertaking of the Company or of any third party.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
Governance</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board may, from time to time, and except as required by applicable law or the Designated
                                            Stock Exchange Rules, adopt, institute, amend, modify or revoke the corporate governance
                                            policies or initiatives of the Company, which shall be intended to set forth the guiding
                                            principles and policies of the Company and the Board on various corporate governance related
                                            matters as the Board shall determine by resolution from time to time.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Meetings
                                            of Directors</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulation
of Directors&#8217; meetings</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the provisions of these Articles, the Directors may regulate their proceedings as they
                                            think fit.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calling
meetings</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            Director may call a meeting of Directors at any time. The Secretary must call a meeting of
                                            the Directors if requested to do so by a Director.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
of meetings</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
                                            of a Board meeting may be given to a Director personally or by word of mouth or given in
                                            writing or by Electronic communications at such address as he may from time to time specify
                                            for this purpose (or, if he does not specify an address, at his last known address). A Director
                                            may waive his right to receive notice of any meeting either prospectively or retrospectively.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Period
of notice</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                            least five (5) Clear Days&#8217; notice of a meeting of directors must be given to directors.
                                            A meeting may be convened on shorter notice with the consent of all directors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 485 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
of technology</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Director may participate in a meeting of Directors through the medium of conference telephone,
                                            video or any other form of communications equipment providing all persons participating in
                                            the meeting are able to hear and speak to each other throughout the meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Director participating in this way is deemed to be present in person at the meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quorum</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            quorum for the transaction of business at a meeting of Directors shall be two unless the
                                            Directors fix some other number or unless the Company has only one director.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
or deputy to preside</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board may appoint a chairman and one or more deputy chairman or chairmen and may at any time
                                            revoke any such appointment.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            chairman, or failing him any deputy chairman (the longest in office taking precedence if
                                            more than one is present), shall preside at all Board meetings. If no chairman or deputy
                                            chairman has been appointed, or if he is not present within five minutes after the time fixed
                                            for holding the meeting, or is unwilling to act as chairman of the meeting, the Directors
                                            present shall choose one of their number to act as chairman of the meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            question which arises at a Board meeting shall be decided by a majority of votes. If votes
                                            are equal the chairman may, if he wishes, exercise a casting vote.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recording
of dissent</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Director present at a meeting of Directors shall be presumed to have assented to any action
                                            taken at that meeting unless:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">his
                                            dissent is entered in the minutes of the meeting; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">he
                                            has filed with the meeting before it is concluded signed dissent from that action; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">he
                                            has forwarded to the Company as soon as practical following the conclusion of that meeting
                                            signed dissent.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Director who votes in favour of an action is not entitled to record his dissent to it.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 486 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
resolutions</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may pass a resolution in writing without holding a meeting if all Directors sign
                                            a document or sign several documents in the like form each signed by one or more of those
                                            Directors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.13</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            written resolution signed by a validly appointed alternate Director need not also be signed
                                            by the appointing Director.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            written resolution signed personally by the appointing Director need not also be signed by
                                            his alternate.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            resolution in writing passed pursuant to Article 18.12, Article 18.13 and/or Article 18.14
                                            shall be as effective as if it had been passed at a meeting of the Directors duly convened
                                            and held; and it shall be treated as having been passed on the day and at the time that the
                                            last Director signs (and for the avoidance of doubt, such day may or may not be a Business
                                            Day).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Validity
of acts of Directors in spite of formal defect</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            acts done by a meeting of the Board, or of a committee of the Board, or by any person acting
                                            as a Director or an alternate Director, shall, notwithstanding that it is afterwards discovered
                                            that there was some defect in the appointment of any Director or alternate Director or member
                                            of the committee, or that any of them were disqualified or had vacated office or were not
                                            entitled to vote, be as valid as if every such person had been duly appointed and qualified
                                            and had continued to be a Director or alternate Director and had been entitled to vote.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Permissible
                                            Directors&#8217; interests and disclosure</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Director who is in any way, whether directly or indirectly, interested in a contract or transaction
                                            or proposed contract or transaction with the Company shall declare the nature of his interest
                                            at a meeting of the Directors. A general notice given to the Directors by any Director to
                                            the effect that he is a member of any specified company or firm and is to be regarded as
                                            interested in any contract or transaction which may thereafter be made with that company
                                            or firm shall be deemed a sufficient declaration of interest in regard to any contract so
                                            made or transaction so consummated. Subject to the Designated Stock Exchange Rules, the Applicable
                                            Laws and disqualification by the chairman of the relevant Board meeting, a Director may vote
                                            in respect of any contract or transaction or proposed contract or transaction notwithstanding
                                            that he may be interested therein provided the Director discloses to his fellow directors
                                            the nature and extent of any material interests in respect of any contract or transaction
                                            or proposed contract or
transaction and if he does so his vote shall be counted and he may be counted in the quorum at any meeting of the Directors at which
any such contract or transaction or proposed contract or transaction shall come before the meeting for consideration.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 487 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Minutes</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company shall cause minutes to be made in books of:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            appointments of Officers and committees made by the Board and of any such Officer&#8217;s
                                            remuneration; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            names of Directors present at every meeting of the Directors, a committee of the Board, the
                                            Company or the holders of any class of shares or debentures, and all orders, resolutions
                                            and proceedings of such meetings.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            such minutes, if purporting to be signed by the chairman of the meeting at which the proceedings
                                            were held or by the chairman of the next succeeding meeting or the Secretary, shall be prima
                                            facie evidence of the matters stated in them.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>21</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounts
                                            and audit</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors must ensure that proper accounting and other records are kept, and that accounts
                                            and associated reports are distributed in accordance with the requirements of the Act.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            books of account shall be kept at the registered office of the Company and shall always be
                                            open to inspection by the Directors. No Member (other than a Director) shall have any right
                                            of inspecting any account or book or document of the Company except as conferred by the Act
                                            or as authorised by the Directors or by Ordinary Resolution.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sending
of accounts and reports</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company&#8217;s accounts and associated directors&#8217; report or auditor&#8217;s report
                                            that are required or permitted to be sent to any person pursuant to any law shall be treated
                                            as properly sent to that person if:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">they
                                            are sent to that person in accordance with the notice provisions: or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">they
                                            are published on a website providing that person is given separate notice of:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            fact that publication of the documents has been published on the website;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            address of the website; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            place on the website where the documents may be accessed; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">how
                                            they may be accessed.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
                                            for any reason, a person notifies the Company that he is unable to access the website, the
                                            Company must, as soon as practicable, send the documents to that person by any other means
                                            permitted by these Articles. This, however, will not affect when that person is taken to
                                            have received the documents under Article 10.21.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 488 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
Year</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            the Directors otherwise prescribe, the financial year of the Company shall end on the 31<sup>st
                                            </sup>day of the month of March in each year and begin on 1 April in each year.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditors</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may appoint an Auditor of the Company who shall hold office on such terms as the
                                            Directors determine.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                            prejudice to the freedom of the Directors to establish any other committee, if the Shares
                                            (or depositary receipts therefor) are listed or quoted on the Designated Stock Exchange,
                                            and if required by the Designated Stock Exchange, the Directors shall establish and maintain
                                            an Audit Committee as a committee of the directors and shall adopt a formal written Audit
                                            Committee charter and review and assess the adequacy of the formal written charter on an
                                            annual basis. The composition and responsibilities of the Audit Committee shall comply with
                                            the rules and regulations of the Commission and the Designated Stock Exchange. The Audit
                                            Committee shall meet at least once every financial quarter, or more frequently as circumstances
                                            dictate.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Shares are listed or quoted on the Designated Stock Exchange, the Company shall conduct
                                            an appropriate review of all related party transactions on an ongoing basis and shall utilise
                                            the Audit Committee for the review and approval of potential conflicts of interest.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            remuneration of the Auditor shall be fixed by the Audit Committee (if one exists).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the office of Auditor becomes vacant by resignation or death of the Auditor, or by his becoming
                                            incapable of acting by reason of illness or other disability at a time when his services
                                            are required, the Directors shall fill the vacancy and determine the remuneration of such
                                            Auditor.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Every
                                            Auditor of the Company shall have a right of access at all times to the books and accounts
                                            and vouchers of the Company and shall be entitled to require from the Directors and officers
                                            of the Company such information and explanation as may be necessary for the performance of
                                            the duties of the Auditor.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                            any general meeting convened and held at any time in accordance with these Articles, the
                                            Members may, by Ordinary Resolution, remove the Auditor before the expiration of his term
                                            of office. If they do so, the Members shall, by Ordinary Resolution, at that meeting appoint
                                            another Auditor in his stead for the remainder of his term.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.13</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Auditors shall, if so requested by the Directors, make a report on the accounts of the Company
                                            during their tenure of office at the next annual general meeting following their appointment,
                                            and at any time during their term of office, upon request of the Directors or any general
                                            meeting of the Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 489 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>22</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Record
                                            dates</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                            to the extent of any conflicting rights attached to Shares, the resolution declaring a dividend
                                            on Shares of any class, whether it be an Ordinary Resolution of the Members or a Director&#8217;s
                                            resolution, may specify that the dividend is payable or distributable to the persons registered
                                            as the holders of those Shares at the close of business on a particular date, notwithstanding
                                            that the date may be a date prior to that on which the resolution is passed.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the resolution does so specify, the dividend shall be payable or distributable to the persons
                                            registered as the holders of those Shares at the close of business on the specified date
                                            in accordance with their respective holdings so registered, but without prejudice to the
                                            rights <i>inter se</i> in respect of the dividend of transferors and transferees of any of
                                            those Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            provisions of this Article apply, <i>mutatis mutandis</i>, to bonuses, capitalisation issues,
                                            distributions of realised capital profits or offers or grants made by the Company to the
                                            Members.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may also fix any time and date as the record date for (a) calling a general meeting;
                                            (b) making or issuing an allotment of Shares; or (c) conducting any other business required
                                            pursuant to these Articles.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>23</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source
of dividends</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
                                            may be declared and paid out of any funds of the Company lawfully available for distribution.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the requirements of the Act regarding the application of a company&#8217;s Share premium
                                            account and with the sanction of an Ordinary Resolution, dividends may also be declared and
                                            paid out of any share premium account.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declaration
of dividends by Members</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the provisions of the Act, the Company may by Ordinary Resolution declare dividends in
                                            accordance with the respective rights of the Members but no dividend shall exceed the amount
                                            recommended by the Directors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of interim dividends and declaration of final dividends by Directors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may declare and pay interim dividends or recommend final dividends in accordance
                                            with the respective rights of the Members if it appears to them that they are justified by
                                            the financial position of the Company and that such dividends may lawfully be paid.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 490 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the provisions of the Act, in relation to the distinction between interim dividends and
                                            final dividends, the following applies:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            determination to pay a dividend or dividends described as interim by the Directors in the
                                            dividend resolution, no debt shall be created by the declaration until such time as payment
                                            is made.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            declaration of a dividend or dividends described as final by the Directors in the dividend
                                            resolution, a debt shall be created immediately following the declaration, the due date to
                                            be the date the dividend is stated to be payable in the resolution.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the resolution fails to specify whether a dividend is final or interim, it shall be assumed to be interim.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            relation to Shares carrying differing rights to dividends or rights to dividends at a fixed
                                            rate, the following applies:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the share capital is divided into different classes, the Directors may pay dividends on Shares
                                            which confer deferred or non-preferred rights with regard to dividends as well as on Shares
                                            which confer preferential rights with regard to dividends but no dividend shall be paid on
                                            Shares carrying deferred or non-preferred rights if, at the time of payment, any preferential
                                            dividend is in arrears.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may also pay, at intervals settled by them, any dividend payable at a fixed rate
                                            if it appears to them that there are sufficient funds of the Company lawfully available for
                                            distribution to justify the payment.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Directors act in good faith, they shall not incur any liability to the Members holding
                                            Shares conferring preferred rights for any loss those Members may suffer by the lawful payment
                                            of the dividend on any Shares having deferred or non-preferred rights.</span></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apportionment
of dividends</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as otherwise provided by the rights attached to Shares all dividends shall be declared and paid</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">according to the amounts Paid Up on the Shares on which the dividend is paid. All dividends shall be apportioned and paid proportionately to the amount Paid Up on the Shares during the time or part of the time in respect of which the dividend is paid. But if a Share is issued on terms providing that it shall rank for dividend as from a particular date, that Share shall rank for dividend accordingly.</span></p></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
of set off</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may deduct from a dividend or any other amount payable to a person in respect of
                                            a Share any amount due by that person to the Company on a call or otherwise in relation to
                                            a Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 491 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to pay other than in cash</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Directors so determine, any resolution declaring a dividend may direct that it shall
                                            be satisfied wholly or partly by the distribution of assets. If a difficulty arises in relation
                                            to the distribution, the Directors may settle that difficulty in any way they consider appropriate.
                                            For example, they may do any one or more of the following:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issue
                                            fractional Shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fix
                                            the value of assets for distribution and make cash payments to some Members on the footing
                                            of the value so fixed in order to adjust the rights of Members; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vest
                                            some assets in trustees.</span></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">How
payments may be made</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            dividend or other monies payable on or in respect of a Share may be paid in any of the following
                                            ways:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the Member holding that Share or other person entitled to that Share nominates a bank account
                                            for that purpose - by wire transfer to that bank account; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            cheque or warrant sent by post to the registered address of the Member holding that Share
                                            or other person entitled to that Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            the purposes of Article 23.10(a), the nomination may be in writing or in an Electronic Record
                                            and the bank account nominated may be the bank account of another person. For the purposes
                                            of Article 23.10(b), subject to any applicable law or regulation, the cheque or warrant shall
                                            be made to the order of the Member holding that Share or other person entitled to the Share
                                            or to his nominee, whether nominated in writing or in an Electronic Record, and payment of
                                            the cheque or warrant shall be a good discharge to the Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            two or more persons are registered as the holders of the Share or are jointly entitled to
                                            it by reason of the death or bankruptcy of the registered holder (<b>Joint Holders</b>),
                                            a dividend (or other amount) payable on or in respect of that Share may be paid as follows:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            the registered address of the Joint Holder of the Share who is named first on the register
                                            of Members or to the registered address of the deceased or bankrupt holder, as the case may
                                            be; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            the address or bank account of another person nominated by the Joint Holders, whether that
                                            nomination is in writing or in an Electronic Record.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.13</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            Joint Holder of a Share may give a valid receipt for a dividend (or other amount) payable
                                            in respect of that Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 492 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
or other monies not to bear interest in absence of special rights</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            provided for by the rights attached to a Share, no dividend or other monies payable by the
                                            Company in respect of a Share shall bear interest.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
unable to be paid or unclaimed</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            a dividend cannot be paid to a Member or remains unclaimed within six weeks after it was
                                            declared or both, the Directors may pay it into a separate account in the Company&#8217;s
                                            name. If a dividend is paid into a separate account, the Company shall not be constituted
                                            trustee in respect of that account and the dividend shall remain a debt due to the Member.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            dividend that remains unclaimed for a period of six years after it became due for payment
                                            shall be forfeited to, and shall cease to remain owing by, the Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>24</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Capitalisation
                                            of profits</b></span></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalisation
of profits or of any share premium account or capital redemption reserve;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may resolve to capitalise:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any part of the Company&#8217;s profits not required for paying any preferential dividend (whether or not those</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">profits are available for distribution); or</span></p></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            sum standing to the credit of the Company&#8217;s share premium account or capital redemption reserve,
                                            if any.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount resolved to be capitalised must be appropriated to the Members who would have been entitled</span></p>
                                                                                <p style="text-align: justify; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to it had it been distributed by way of dividend and in the same proportions. The benefit to each Member so entitled must be given in either or both of the following ways::</span></p></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            paying up the amounts unpaid on that Member&#8217;s Shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            issuing Fully Paid Up Shares, debentures or other securities of the Company to that Member
                                            or as that Member directs. The Directors may resolve that any Shares issued to the Member
                                            in respect of Partly Paid Up Shares (<b>Original Shares</b>) rank for dividend only to the
                                            extent that the Original Shares rank for dividend while those Original Shares remain Partly
                                            Paid Up.</span></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying
an amount for the benefit of Members</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            amount capitalised must be applied to the benefit of Members in the proportions to which
                                            the Members would have been entitled to dividends if the amount capitalised had been distributed
                                            as a dividend.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 493 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the Act, if a fraction of a Share, a debenture or other security is allocated to a Member,
                                            the Directors may issue a fractional certificate to that Member or pay him the cash equivalent
                                            of the fraction.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>25</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share
                                            Premium Account</b></span></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
to maintain share premium account</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors shall establish a share premium account in accordance with the Act. They shall
                                            carry to the credit of that account from time to time an amount equal to the amount or value
                                            of the premium paid on the issue of any Share or capital contributed or such other amounts
                                            required by the Act.</span></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debits
to share premium account</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            following amounts shall be debited to any share premium account:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
                                            the redemption or purchase of a Share, the difference between the nominal value of that Share
                                            and the redemption or purchase price; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            other amount paid out of a share premium account as permitted by the Act.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                            the preceding Article, on the redemption or purchase of a Share, the Directors may pay the
                                            difference between the nominal value of that Share and the redemption purchase price out
                                            of the profits of the Company or, as permitted by the Act, out of capital.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>26</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Seal</b></span></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
seal</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company may have a seal if the Directors so determine.</span></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duplicate
seal</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the provisions of the Act, the Company may also have a duplicate seal or seals for use
                                            in any place or places outside the Cayman Islands. Each duplicate seal shall be a facsimile
                                            of the original seal of the Company. However, if the Directors so determine, a duplicate
                                            seal shall have added on its face the name of the place where it is to be used.</span></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
and how seal is to be used</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            seal may only be used by the authority of the Directors. Unless the Directors otherwise determine,
                                            a document to which a seal is affixed must be signed in one of the following ways:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            a Director (or his alternate) and the Secretary; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            a single Director (or his alternate).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 494 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
no seal is adopted or used</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Directors do not adopt a seal, or a seal is not used, a document may be executed in the
                                            following manner:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            a Director (or his alternate) and the Secretary; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            a single Director (or his alternate); or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            any other manner permitted by the Act.</span></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to allow non-manual signatures and facsimile printing of seal</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors may determine that either or both of the following applies:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            the seal or a duplicate seal need not be affixed manually but may be affixed by some other
                                            method or system of reproduction;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            a signature required by these Articles need not be manual but may be a mechanical or Electronic
                                            Signature.</span></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Validity
of execution</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            a document is duly executed and delivered by or on behalf of the Company, it shall not be
                                            regarded as invalid merely because, at the date of the delivery, the Secretary, or the Director,
                                            or other Officer or person who signed the document or affixed the seal for and on behalf
                                            of the Company ceased to be the Secretary or hold that office and authority on behalf of
                                            the Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>27</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnity</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.1</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            the extent permitted by law, the Company shall indemnify each existing or former Director
                                            (including alternate Director), Secretary and other Officer of the Company (including an
                                            investment adviser or an administrator or liquidator) and their personal representatives
                                            against:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or
                                            sustained by the existing or former Director (including alternate Director), Secretary or
                                            Officer in or about the conduct of the Company&#8217;s business or affairs or in the execution
                                            or discharge of the existing or former Director&#8217;s (including alternate Director&#8217;s), Secretary&#8217;s
                                            or Officer&#8217;s duties, powers, authorities or discretions; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">without
                                            limitation to paragraph (a), all costs, expenses, losses or liabilities incurred by the existing
                                            or former Director (including alternate Director), Secretary or Officer in defending (whether
                                            successfully or otherwise) any civil, criminal, administrative or investigative proceedings
                                            (whether threatened, pending or completed) concerning the Company or its affairs in any court
                                            or tribunal, whether in the Cayman Islands or elsewhere.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 495 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
such existing or former Director (including alternate Director), Secretary or Officer, however, shall be indemnified in respect of any
matter arising out of his own fraud or dishonesty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            the extent permitted by Act, the Company may make a payment, or agree to make a payment,
                                            whether by way of advance, loan or otherwise, for any legal costs incurred by an existing
                                            or former Director (including alternate Director), Secretary or Officer of the Company in
                                            respect of any matter identified in Article 27.1 on condition that the Director (including
                                            alternate Director), Secretary or Officer must repay the amount paid by the Company to the
                                            extent that it is ultimately found not liable to indemnify the Director (including alternate
                                            Director), Secretary or that Officer for those legal costs.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Release</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            the extent permitted by Act, the Company may by Special Resolution release any existing or
                                            former Director (including alternate Director), Secretary or other Officer of the Company
                                            from liability for any loss or damage or right to compensation which may arise out of or
                                            in connection with the execution or discharge of the duties, powers, authorities or discretions
                                            of his office; but there may be no release from liability arising out of or in connection
                                            with that person&#8217;s own fraud or dishonesty.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            the extent permitted by Act, the Company may pay, or agree to pay, a premium in respect of
                                            a contract insuring each of the following persons against risks determined by the Directors,
                                            other than liability arising out of that person&#8217;s own dishonesty:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            existing or former Director (including alternate Director), Secretary or Officer or auditor
                                            of:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Company;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            company which is or was a subsidiary of the Company;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            company in which the Company has or had an interest (whether direct or indirect); and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            trustee of an employee or retirement benefits scheme or other trust in which any of the persons
                                            referred to in paragraph (a) is or was interested.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 496 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>28</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notices</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of notices</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
                                            where these Articles provide otherwise, and subject to the Designated Stock Exchange Rules,
                                            any notice to be given to or by any person pursuant to these Articles shall be:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            writing signed by or on behalf of the giver in the manner set out below for written notices;
                                            or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                            to the next Article, in an Electronic Record signed by or on behalf of the giver by Electronic
                                            Signature and authenticated in accordance with Articles about authentication of Electronic
                                            Records; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                            these Articles expressly permit, by the Company by means of a website.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Electronic
communications</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            notice may only be given to the Company in an Electronic Record if:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Directors so resolve or otherwise accept the notice; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            Director or Officer provides the giver of the notice an electronic address to which the notice
                                            may be sent and a notice is sent to that address within a reasonable period of time.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the resolution is revoked or varied, the revocation or variation shall only become effective when its terms have been similarly notified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            notice may not be given by Electronic Record to a person other than the Company unless the
                                            recipient has notified the giver of an Electronic address to which notice may be sent.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the Act, the Designated Stock Exchange Rules and to any other rules which the Company
                                            is bound to follow, the Company may also send any notice or other document pursuant to these
                                            Articles to a Member by publishing that notice or other document on a website where:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Company and the Member have agreed to his having access to the notice or document on a website
                                            (instead of it being sent to him);</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            notice or document is one to which that agreement applies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Member is notified (in accordance with any requirements laid down by the Act and, in a manner
                                            for the time being agreed between him and the Company for the purpose) of:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            publication of the notice or document on a website;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            address of that website; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            place on that website where the notice or document may be accessed, and how it may be accessed;
                                            and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 497 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            notice or document is published on that website throughout the publication period, provided
                                            that, if the notice or document is published on that website for a part, but not all of,
                                            the publication period, the notice or document shall be treated as being published throughout
                                            that period if the failure to publish that notice of document throughout that period is wholly
                                            attributable to circumstances which it would not be reasonable to have expected the Company
                                            to prevent or avoid. </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of this Article 28.4 &#8220;publication period&#8221; means a period of not less than twenty-one days (or, in the case of
a notice of general meeting, until at least the conclusion of the meeting to which the notice relates), beginning on the day on which
the notification referred to in Article 28.4(c) is deemed sent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons
entitled to notices</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to Article 22.4, any notice or other document to be given to a Member may be given by reference
                                            to the register of Members as it stands at any time within the period of twenty-one days
                                            before the day that the notice is given or (where and as applicable) within any other period
                                            permitted by, or in accordance with the requirements of, (to the extent applicable) the Designated
                                            Stock Exchange Rules and/or the Designated Stock Exchanges. No change in the register of
                                            Members after that time shall invalidate the giving of such notice or document or require
                                            the Company to give such item to any other person.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons
authorised to give notices</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            notice by either the Company or a Member pursuant to these Articles may be given on behalf
                                            of the Company or a Member by a Director or company secretary of the Company or a Member.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delivery
of written notices</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
                                            where these Articles provide otherwise, a notice in writing may be given personally to the
                                            recipient, or left at (as appropriate) the Member&#8217;s or Director&#8217;s registered
                                            address or the Company&#8217;s registered office, or posted to that registered address or
                                            registered office.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint
holders</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                            Members are joint holders of a Share, all notices shall be given to the Member whose name
                                            first appears in the register of Members.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signatures</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            written notice shall be signed when it is autographed by or on behalf of the giver, or is
                                            marked in such a way as to indicate its execution or adoption by the giver.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            Electronic Record may be signed by an Electronic Signature.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 498 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Evidence
of transmission</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            notice given by Electronic Record shall be deemed sent if an Electronic Record is kept demonstrating
                                            the time, date and content of the transmission, and if no notification of failure to transmit
                                            is received by the giver.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            notice given in writing shall be deemed sent if the giver can provide proof that the envelope
                                            containing the notice was properly addressed, pre-paid and posted, or that the written notice
                                            was otherwise properly transmitted to the recipient.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.13</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Member present, either in person or by proxy, at any meeting of the Company or of the holders
                                            of any class of Shares shall be deemed to have received due notice of the meeting and, where
                                            requisite, of the purposes for which it was called.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Giving
notice to a deceased or bankrupt Member</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            notice may be given by the Company to the persons entitled to a Share in consequence of the
                                            death or bankruptcy of a Member by sending or delivering it, in any manner authorised by
                                            these Articles for the giving of notice to a Member, addressed to them by name, or by the
                                            title of representatives of the deceased, or trustee of the bankrupt or by any like description,
                                            at the address, if any, supplied for that purpose by the persons claiming to be so entitled.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
                                            such an address has been supplied, a notice may be given in any manner in which it might
                                            have been given if the death or bankruptcy had not occurred.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of giving notices</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            notice is given on the date identified in the following table</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Method
    for giving notices</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>When
    taken to be given</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    Personally</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    the time and date of delivery</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    By leaving it at the Member&#8217;s registered address</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    the time and date it was left</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)
    By posting it by prepaid post to the street or postal address of that recipient</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48
    hours after the date it was posted</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D)
    By Electronic Record (other than publication on a website), to recipient&#8217;s Electronic address</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24
    hours after the date it was sent</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(E)
    By publication on a website</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    Article 10.21</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Saving
provision</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
                                            of the preceding notice provisions shall derogate from the Articles about the delivery of
                                            written resolutions of Directors and written resolutions of Members.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 499 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>29</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authentication
                                            of Electronic Records</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application
of Articles</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                            limitation to any other provision of these Articles, any notice, written resolution or other
                                            document under these Articles that is sent by Electronic means by a Member, or by the Secretary,
                                            or by a Director or other Officer of the Company, shall be deemed to be authentic if either
                                            Article 29.2 or Article 29.4 applies.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authentication
of documents sent by Members by Electronic means</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            Electronic Record of a notice, written resolution or other document sent by Electronic means
                                            by or on behalf of one or more Members shall be deemed to be authentic if the following conditions
                                            are satisfied:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Member or each Member, as the case may be, signed the original document, and for this purpose
                                            <b>Original Document</b> includes several documents in like form signed by one or more of
                                            those Members; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Electronic Record of the Original Document was sent by Electronic means by, or at the direction
                                            of, that Member to an address specified in accordance with these Articles for the purpose
                                            for which it was sent; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
                                            29.7 does not apply.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            example, where a sole Member signs a resolution and sends the Electronic Record of the original
                                            resolution, or causes it to be sent, by facsimile transmission to the address in these Articles
                                            specified for that purpose, the facsimile copy shall be deemed to be the written resolution
                                            of that Member unless Article 29.7 applies.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authentication
of document sent by the Secretary or Officers of the Company by Electronic means</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            Electronic Record of a notice, written resolution or other document sent by or on behalf
                                            of the Secretary or an Officer or Officers of the Company shall be deemed to be authentic
                                            if the following conditions are satisfied:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Secretary or the Officer or each Officer, as the case may be, signed the original document,
                                            and for this purpose <b>Original Document</b> includes several documents in like form signed
                                            by the Secretary or one or more of those Officers; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Electronic Record of the Original Document was sent by Electronic means by, or at the direction
                                            of, the Secretary or that Officer to an address specified in accordance with these Articles
                                            for the purpose for which it was sent; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
                                            29.7 does not apply.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 500 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Article 29.4 applies whether the document is sent by or on behalf of the Secretary or Officer in his own right or as a representative
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            example, where a sole Director signs a resolution and scans the resolution, or causes it
                                            to be scanned, as a PDF version which is attached to an email sent to the address in these
                                            Articles specified for that purpose, the PDF version shall be deemed to be the written resolution
                                            of that Director unless Article 29.7 applies.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manner
of signing</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            the purposes of these Articles about the authentication of Electronic Records, a document
                                            will be taken to be signed if it is signed manually or in any other manner permitted by these
                                            Articles.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Saving
provision</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            notice, written resolution or other document under these Articles will not be deemed to be
                                            authentic if the recipient, acting reasonably:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">believes
                                            that the signature of the signatory has been altered after the signatory had signed the original
                                            document; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">believes
                                            that the original document, or the Electronic Record of it, was altered, without the approval
                                            of the signatory, after the signatory signed the original document; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">otherwise
                                            doubts the authenticity of the Electronic Record of the document</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
the recipient promptly gives notice to the sender setting the grounds of its objection. If the recipient invokes this Article, the sender
may seek to establish the authenticity of the Electronic Record in any way the sender thinks fit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
                                            by way of continuation</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company may, by Special Resolution, resolve to be registered by way of continuation in a
                                            jurisdiction outside:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Cayman Islands; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                            other jurisdiction in which it is, for the time being, incorporated, registered or existing.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            give effect to any resolution made pursuant to the preceding Article, the Directors may cause
                                            the following:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            application be made to the Registrar of Companies of the Cayman Islands to deregister the
                                            Company in the Cayman Islands or in the other jurisdiction in which it is for the time being
                                            incorporated, registered or existing; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 501 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            such further steps as they consider appropriate to be taken to effect the transfer by way
                                            of continuation of the Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>31</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Winding
                                            up</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distribution
of assets in specie</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Company is wound up the Members may, subject to these Articles and any other sanction
                                            required by the Act, pass a Special Resolution allowing the liquidator to do either or both
                                            of the following:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            divide in specie among the Members the whole or any part of the assets of the Company and,
                                            for that purpose, to value any assets and to determine how the division shall be carried
                                            out as between the Members or different classes of Members; and/or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            vest the whole or any part of the assets in trustees for the benefit of Members and those
                                            liable to contribute to the winding up.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
obligation to accept liability</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            Member shall be compelled to accept any assets if an obligation attaches to them.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors are authorised to present a winding up petition</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Directors have the authority to present a petition for the winding up of the Company to the
                                            Grand Court of the Cayman Islands on behalf of the Company without the sanction of a resolution
                                            passed at a general meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>32</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amendment
                                            of Memorandum and Articles</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to change name or amend Memorandum</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the Act, the Company may, by Special Resolution:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">change
                                            its name; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">change
                                            the provisions of its Memorandum with respect to its objects, powers or any other matter
                                            specified in the Memorandum.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
to amend these Articles</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the Act and as provided in these Articles, the Company may, by Special Resolution, amend
                                            these Articles in whole or in part.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>33</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mergers
                                            and Consolidations</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall have the power to merge or consolidate with one or more constituent companies (as defined in the Act) upon such terms as
the directors may determine and (to the extent required by the Act) with the approval of a Special Resolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>34</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
                                            Tax Filings</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Tax Filing Authorised Person and any such other person, acting alone, as any director shall designate from time to time, are authorised
to file tax forms SS-4, W-8 BEN, W-8 IMY, W-9, 8832 and 2553 and such other similar tax forms as are customary to file with any US state
or federal governmental authorities or foreign governmental authorities in connection with the formation, activities and/or elections
of the Company and such other tax forms as may be approved from time to time by any director of the Company or an Officer. The Company
further ratifies and approves any such filing made by any Tax Filing Authorised Person or such other person prior to the date of these
Articles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 502 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>




<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0pt 0pt 0"><b><span id="bm_001"></span>Annex E </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRELIMINARY
PROXY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>420
Lexington Avenue, Suite 2446</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
York, NY 10170</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXTRAORDINARY
GENERAL MEETING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>YOUR
VOTE IS IMPORTANT</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THIS
PROXY IS SOLICITED BY THE BOARD OF DIRECTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[&#9679;],
2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, revoking any previous proxies relating to these shares with respect to the proposals set forth herein, hereby
acknowledges receipt of the proxy statement/prospectus dated [&#9679;], 2024, in connection with the Extraordinary General Meeting
of Bowen Acquisition Corp (&#8220;BAC&#8221;) to be held at [&#9679;] a.m. ET on [&#9679;], 2024, which will be a virtual meeting
held online at <span style="text-decoration: underline">https://www.cstproxy.com/bowenacquisition/[&#9679;]</span> for the sole purpose of considering and voting upon the
following proposals, and hereby appoints Jiangang Luo and Jing Lu, his or her true and lawful attorney and proxy of the undersigned,
with power of substitution, to vote all ordinary shares of BAC registered in the name provided, which the undersigned is entitled to
vote at the Extraordinary General Meeting, and at any adjournments thereof, with all the powers the undersigned would have if
personally present. Without limiting the general authorization hereby given, said proxies are, and each of them is, instructed to
vote or act as follows on the proposals set forth in this Proxy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SHARES REPRESENTED BY THIS PROXY WILL BE VOTED AS DIRECTED HEREIN. IF A SIGNED AND DATED PROXY IS RETURNED BUT NO DIRECTIONS ARE GIVEN,
THE SHARES REPRESENTED BY THIS PROXY WILL BE VOTED &#8220;FOR&#8221; ALL PROPOSALS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BAC BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;FOR&#8221; THE BUSINESS COMBINATION PROPOSAL (PROPOSAL 1), &#8220;FOR&#8221; THE NAME
CHANGE PROPOSAL (PROPOSAL 2), &#8220;FOR&#8221; THE CAPITALIZATION AMENDMENT PROPOSAL (PROPOSAL 3), &#8220;FOR&#8221; THE BOARD UNIFICATION
PROPOSAL (PROPOSAL 4), &#8220;FOR&#8221; THE PROPOSED CHARTER ADOPTION PROPOSAL (PROPOSAL 5), &#8220;FOR&#8221; THE NASDAQ PROPOSAL (PROPOSAL
6), &#8220;FOR&#8221; THE EQUITY INCENTIVE PLAN PROPOSAL (PROPOSAL 7), &#8220;FOR&#8221; THE DIRECTOR ELECTION PROPOSAL (PROPOSAL 8)
AND &#8220;FOR&#8221; THE ADJOURNMENT PROPOSAL (PROPOSAL 9).</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PLEASE
MARK, SIGN, DATE AND RETURN THIS PROXY AS SOON AS POSSIBLE.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Important
Notice Regarding the Availability of Proxy Materials for the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Extraordinary
General Meeting to be held on [&#9679;], 2024.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
notice of Extraordinary General Meeting and the accompanying proxy statement/prospectus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">are
available at: <span style="text-decoration: underline">https://www.cstproxy.com/bowenacquisition/[&#9679;]</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 503; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROXY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    Business Combination Proposal</b> &#8212; to consider and vote upon a proposal, as an ordinary resolution, to approve the Business
    Combination Agreement and the transactions contemplated thereby.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGAINST</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABSTAIN</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    Name Change Proposal</b> &#8211; to consider and vote upon a proposal, as a special resolution, to change the name of the company
    from Bowen Acquisition Corp to Emerald, Inc.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGAINST</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABSTAIN</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    Capitalization Amendment Proposal</b> &#8211; to consider and vote upon a proposal, as a special resolution, to approve the increase
    of the authorized share capital of Bowen to US$25,200, divided into 2,000,000 Preferred Shares of par value US$0.0001 each and 250,000,000
    Ordinary Shares of par value US$0.0001 each, by the creation of 50,000,000 additional Ordinary Shares of par value US$0.0001 each.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGAINST</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABSTAIN</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
                                            Board Unification Proposal</b> &#8211; to consider and vote upon a proposal, as a special
                                            resolution, to remove the provision in Bowen&#8217;s Amended and Restated Memorandum and
                                            Articles of Association dividing the Bowen board into classes.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGAINST</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABSTAIN</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
                                            Proposed Charter Adoption Proposal</b> &#8211; to consider and vote upon a proposal, as a
                                            special resolution, to approve the amendment and restatement of Bowen&#8217;s existing Amended
                                            and Restated Memorandum and Articles of Association.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGAINST</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABSTAIN</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    Nasdaq Proposal</b> &#8211; to consider and vote upon a proposal, as an ordinary resolution, to approve, for purposes of complying
    with Nasdaq Listing Rules, the issuance of Bowen&#8217;s ordinary shares in connection with the Merger.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGAINST</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABSTAIN</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    Equity Incentive Plan Proposal</b> &#8211; to consider and vote upon a proposal, as an ordinary resolution, to approve and adopt
    the 2024 Long-Term Incentive Equity Plan.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGAINST</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABSTAIN</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    Director Election Proposal &#8211; </b>to consider and vote upon a proposal, as an ordinary resolution, to elect the following five
    members to serve on the Bowen Board following the Business Combination.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dajun
    Wang</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGAINST</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABSTAIN</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wei
    Liang</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGAINST</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABSTAIN</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wen
    He</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGAINST</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABSTAIN</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhenning
    He</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGAINST</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABSTAIN</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jun
    Zhang</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGAINST</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABSTAIN</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    Adjournment Proposal </b>- to consider and vote upon a proposal, as an ordinary resolution, to adjourn the extraordinary general
    meeting to a later date or dates if it is determined that additional time is necessary to complete the Business Combination for any
    reason.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGAINST</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABSTAIN</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 96%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MARK
    HERE FOR ADDRESS CHANGE AND NOTE AT RIGHT</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PLEASE
    MARK, SIGN, DATE AND RETURN THIS PROXY PROMPTLY. ANY VOTES RECEIVED AFTER A MATTER HAS BEEN VOTED UPON WILL NOT BE COUNTED. THE SHARES
    REPRESENTED BY THIS PROXY WILL BE VOTED AS DIRECTED HEREIN. IF A SIGNED AND DATED PROXY IS RETURNED BUT NO DIRECTIONS ARE GIVEN,
    THE SHARES REPRESENTED BY THIS PROXY WILL BE VOTED &#8220;FOR&#8221; ALL PROPOSALS.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _________________________ 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"/></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder&#8217;s
    Signature</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"/></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder&#8217;s
    Signature</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
    should agree with name printed hereon. If stock is held in the name of more than one person, EACH joint owner should sign. Executors,
    administrators, trustees, guardians, and attorneys should indicate the capacity in which they sign. Attorneys should submit powers
    of attorney.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 504; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
II</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION
NOT REQUIRED IN PROSPECTUS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                                            20.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification
                                            of Directors and Officers.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
Islands law does not limit the extent to which a company&#8217;s memorandum and articles of association may provide for indemnification
of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public
policy, such as to provide indemnification against willful default, willful neglect, civil fraud or the consequences of committing a
crime. Our Proposed Charter will provide for indemnification of our officers and directors to the maximum extent permitted by law, including
for any liability incurred in their capacities as such, except through their own actual fraud, willful default or willful neglect. We
expect to purchase a policy of directors&#8217; and officers&#8217; liability insurance that insures our officers and directors against
the cost of defense, settlement or payment of a judgment in some circumstances and insures us against our obligations to indemnify our
officers and directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
officers and directors have agreed to waive any right, title, interest or claim of any kind in or to any monies in the trust account,
and have agreed to waive any right, title, interest or claim of any kind they may have in the future as a result of, or arising out of,
any services provided to us and will not seek recourse against the trust account for any reason whatsoever (except to the extent they
are entitled to funds from the trust account due to their ownership of public shares). Accordingly, any indemnification provided will
only be able to be satisfied by us if (i) we have sufficient funds outside of the trust account or (ii) we consummate an initial business
combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that these provisions, the insurance and the indemnity agreements are necessary to attract and retain talented and experienced
officers and directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us
pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy
as expressed in the Securities Act and is therefore unenforceable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will enter into indemnity agreements with each of our officers and directors to provide contractual indemnification in addition to the
indemnification provided for in our amended and restated memorandum and articles of association, a form of which is to be filed as an
exhibit to this Registration Statement. These agreements will require us to indemnify these individuals to the fullest extent permitted
under Cayman Islands law and to advance expenses incurred as a result of any proceeding against them as to which they could be indemnified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 49.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                                            21.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibits
                                            and Financial Statement Schedules.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -49.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The following exhibits are filed as part of this Registration Statement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.75in"><b>Exhibit No.</b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Description</b></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">2.1</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="#bs_041">Agreement and Plan
    of Merger, dated as of January 18, 2024, by and among Bowen Acquisition Corp, Bowen Merger Sub, Shenzhen Qianzhi BioTech Company
    Limited and Qianzhi Group Holding (Cayman) Limited (included as Annex A to the proxy statement/prospectus).*****+</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">3.1</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1973056/000149315223024600/ex3-1.htm" style="-sec-extract: exhibit">Amended and Restated Memorandum and Articles of Association.*</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">3.2</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amended
                                            and Restated Memorandum and Articles of Association of New Bowen (included as Annex D to
                                            the proxy statement/prospectus). ******+</p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">4.4</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1973056/000149315223024600/ex4-1.htm" style="-sec-extract: exhibit">Rights Agreement between Continental Stock Transfer &amp; Trust Company and the Registrant.*</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">5.1</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Opinion of Ogier******</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">8.1</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex8-1.htm">Form of Tax opinion of Graubad Miller*****</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.1</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1973056/000149315223018281/ex10-2.htm" style="-sec-extract: exhibit">Letter Agreement from each of the Registrant&#8217;s initial shareholders, officers and directors.***</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.2</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1973056/000149315223024600/ex10-1.htm" style="-sec-extract: exhibit">Investment Management Trust Agreement between Continental Stock Transfer &amp; Trust Company and the Registrant.*</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.3</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1973056/000149315223024600/ex10-2.htm" style="-sec-extract: exhibit">Registration Rights Agreement.*</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.4</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1973056/000149315223018281/ex10-5.htm" style="-sec-extract: exhibit">Private Placement Units Purchase Agreement between the Registrant and the Sponsors.***</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.5</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1973056/000149315223018281/ex10-6.htm" style="-sec-extract: exhibit">Private Placement Units Purchase Agreement between the Registrant and EarlyBirdCapital, Inc..***</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.6</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1973056/000149315223024600/ex10-4.htm" style="-sec-extract: exhibit">Form of Indemnification Agreement.*</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.7</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1973056/000149315223024600/ex10-3.htm" style="-sec-extract: exhibit">Administrative Services Agreement.*</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.8</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1973056/000149315223018281/ex10-11.htm" style="-sec-extract: exhibit">Form of Share Escrow Agreement among the Registrant, Continental Stock Transfer &amp; Trust Company and the Initial Shareholders.***</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.9</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1973056/000149315223021101/ex10-12.htm" style="-sec-extract: exhibit">Form of Business Combination Marketing Agreement between the Registrant and EarlyBirdCapital, Inc.***</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.10</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1973056/000149315224003599/ex10-1.htm" style="-sec-extract: exhibit">Form of Voting Agreement.**</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.11</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex10-11.htm">Property Lease Agreement dated July 19, 2023 between Shenzhen Jingji Baina Business Management Co., Ltd. and Shenzhen Qianzhi Biotechnology Co., Ltd. *****</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.12</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex10-12.htm">Property Lease Agreement dated July 19, 2023 between Shenzhen Jingji Baina Business Management Co., Ltd. and Shenzhen Qianzhi Biotech Co., Ltd. *****</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.13</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex10-13.htm">Property Lease Agreement dated July 19, 2023 between Shenzhen Jingji Baina Business Management Co., Ltd. and Shenzhen Qianzhi Health Management Co., Ltd. *****</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><p style="margin: 0">10.14</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex10-14.htm">Property Lease Agreement dated May 19, 2019 between Zhijun Hu and Hubei Qianzhi Biotechnology Co., Ltd. *****</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">14</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1973056/000149315223018281/ex14-1.htm" style="-sec-extract: exhibit">Code of Ethics.***</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">23.1</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Consent of Ogier (included in Exhibit 5.1)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">23.2</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex23-2.htm">Consent of UHY LLP*****</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">23.3</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex23-3.htm">Consent of Simon &amp; Edward, LLP*****</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">97</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Clawback Policy******</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">99.1</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="#bm_001">Form of Proxy Card (included as Annex E to the proxy statement/prospectus)*****</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">99.2</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex99-2.htm">Consent of Newbridge Securities*****</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">99.3</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex99-3.htm">Consent of Dajun Wang*****</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">99.4</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex99-4.htm">Consent of Wei Liang*****</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">99.5</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex99-5.htm">Consent of Wen He*****</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">99.6</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex99-6.htm">Consent of Zhenning He*****</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">99.7</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex99-7.htm">Consent of Frost &amp; Sullivan*****</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">107</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><a href="ex107.htm">Filing Fee Table*****</a></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Rule-Page --><div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 25%; margin-bottom: 0pt"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">*</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Incorporated by reference to Bowen&#8217;s Current Report on Form 8-K filed on July 11, 2023.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">**</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Incorporated by reference to Bowen&#8217;s Current Report on Form 8-K filed on January 24, 2024.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">***</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Incorporated by reference to Bowen&#8217;s Registration Statement on Form S-1 (SEC File Nos. 333-272076).</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">****</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Incorporated by reference to Bowen&#8217;s Annual Report on Form 10-K filed on March 29, 2024.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">*****</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Filed Herewith</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">******</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">To be filed by amendment</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    exhibits and schedules to this Exhibit have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant hereby agrees
    to furnish a copy of any omitted schedules to the Commission upon request.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates
    management contract or compensatory plan or arrangement.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 505; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 49.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                                            22.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Undertakings.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -49.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The undersigned registrants each hereby undertakes as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration
Fee&#8221; table in the effective registration statement;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or
any material change to such information in the registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule
424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other
than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the
date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is
part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement
or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first
use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such date of first use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution
of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant
to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to
the purchaser and will be considered to offer or sell such securities to such purchaser:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
424;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 506; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
the undersigned registrant;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
That prior to any public reoffering of the securities registered hereunder through use of a prospectus which is a part of this registration
statement, by any person or party who is deemed to be an underwriter within the meaning of Rule 145(c), the issuer undertakes that such
reoffering prospectus will contain the information called for by the applicable registration form with respect to reofferings by persons
who may be deemed underwriters, in addition to the information called for by the other items of the applicable form.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
That every prospectus: (i) that is filed pursuant to the immediately preceding paragraph, or (ii) that purports to meet the requirements
of Section 10(a)(3) of the Act and is used in connection with an offering of securities subject to Rule 415, will be filed as a part
of an amendment to the registration statement and will not be used until such amendment is effective, and that, for purposes of determining
any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide
offering thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling
persons of each registrant pursuant to the foregoing provisions, or otherwise, each registrant has been advised that in
the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities (other than the payment by each registrant of expenses
incurred or paid by a director, officer or controlling person of each registrant in the successful defense of any action, suit
or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, each
registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of
appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be
governed by the final adjudication of such issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The undersigned registrant hereby undertakes to respond to requests for information that is incorporated by reference into the prospectus
pursuant to Items 4, 10(b), 11, or 13 of this Form S-4, within one business day of receipt of such request, and to send the incorporated
documents by first class mail or other equally prompt means. This includes information contained in documents filed subsequent to the
effective date of the registration statement through the date of responding to the request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The undersigned registrant hereby undertakes to supply by means of a post-effective amendment all information concerning a transaction,
and the company being acquired involved therein, that was not the subject of and included in the registration statement when it became
effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 507; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereunto duly authorized, in the City of New York, on the 10<sup>th</sup> day of September, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOWEN
    ACQUISITION CORP</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 45%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jiangang Luo</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiangang
    Luo</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">POWER
OF ATTORNEY</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL MEN BY THESE PRESENTS, that each of the undersigned constitutes and appoints Jiangang Luo or Jing Lu his or her true and lawful attorney-in-fact,
with full power of substitution and resubstitution for him or her and in his or her name, place and stead, their true and lawful attorney-in-fact
and agent, with full power of substitution and resubstitution, for such person and in his or her name, place and stead, in any and all
capacities, to sign this Registration Statement on Form S-4 (including all pre-effective and post-effective amendments and registration
statements filed pursuant to Rule 462 under the Securities Act of 1933), and to file the same, with all exhibits thereto, and other documents
in connection therewith, with the U.S. Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and
authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all
intents and purposes as he or she might or could do in person, hereby ratifying and confirming that any such attorney-in-fact and agent,
or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons on behalf of
the registrant and in the capacities and on the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Na Gai</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairwoman</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    10,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Na
    Gai</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jiangang Luo</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer (Principal Executive Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    10,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiangang
    Luo</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jing Lu</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer (Principal Finance and Accounting Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    10,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jing
    Lu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Lawrence Leighton</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    10,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrence
    Leighton</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Wei Li</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    10,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wei
    Li</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jun Zhang</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    10,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jun
    Zhang</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 508; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the co-registrant has duly caused this registration statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the City of Shenzhen, in the People&#8217;s Republic of China, on the 10<sup>th
</sup>day of September, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QIANZHI
    GROUP HOLDING (CAYMAN) LIMITED</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Xiaoqin Lin</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xiaoqin
    Lin</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>POWER
OF ATTORNEY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL MEN BY THESE PRESENTS, that each of the undersigned constitutes and appoints Xiaoqin Lin his or her true and lawful attorney-in-fact,
with full power of substitution and resubstitution for him or her and in his or her name, place and stead, their true and lawful attorney-in-fact
and agent, with full power of substitution and resubstitution, for such person and in his or her name, place and stead, in any and all
capacities, to sign this Registration Statement on Form S-4 (including all pre-effective and post-effective amendments and registration
statements filed pursuant to Rule 462 under the Securities Act of 1933), and to file the same, with all exhibits thereto, and other documents
in connection therewith, with the U.S. Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and
authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all
intents and purposes as he or she might or could do in person, hereby ratifying and confirming that any such attorney-in-fact and agent,
or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons on behalf of
the co-registrant and in the capacities and on the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Xiaoqin Lin</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sole
    Director,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Principal Executive Officer, and
    Principal Financial Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    10,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xiaoqin
    Lin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 509; Options: NewSection; Value: 5 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>SIGNATURE OF AUTHORIZED
U.S. REPRESENTATIVE OF THE CO-REGISTRANT</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">Pursuant to the Securities
Act, the undersigned, the duly authorized representative in the United States of the co-registrant has signed this registration statement
on the 10<sup>th</sup> day of September, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COGENCY
    GLOBAL INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
    U.S. Representative</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><i>/s/ <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colleen
    A. De Vries</span></i></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colleen
    A. De Vries</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sr.
    Vice President on behalf of Cogency Global Inc.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 510; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>2
<FILENAME>ex8-1.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
8.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GRAUBARD
MILLER</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chrysler Building</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">405
Lexington Avenue, 44th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10174</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;],
2024</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Acquisition Corp.</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">420
Lexington Avenue, Suite 2446</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10170</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel to Bowen Acquisition Corp., a Cayman Islands exempted company (&#8220;<U>Bowen</U>&#8221;), in connection with
an Agreement and Plan of Reorganization, dated as of January 18, 2024 (as amended from time to time, the &#8220;<U>Business Combination
Agreement</U>&#8221;), entered into by and among (i) Bowen, (ii) Bowen Merger Sub, a Cayman Islands exempted company and wholly owned
subsidiary of Bowen (&#8220;Merger Sub&#8221;), (iii) Shenzhen Qianzhi BioTechnology Co. Ltd., a company incorporated in the People&#8217;s
Republic of China and a wholly owned subsidiary of NewCo (as defined below)(the &#8220;<U>Company</U>&#8221;) and (iv) Qianzhi
Group Holding (Cayman) Limited, a newly formed Cayman Islands company (&#8220;<U>NewCo</U>&#8221;). We are furnishing this letter at
the request of Bowen in connection with the filing of a Registration Statement on Form S-4 (File No. 333-[____]) (as amended, the &#8220;<U>Registration
Statement</U>&#8221;), relating to the registration by Bowen of its common stock to be issued in connection with the Merger (defined
below), with the U.S. Securities and Exchange Commission (the &#8220;<U>Commission</U>&#8221;) under the U.S. Securities
Act of 1933, as amended (the &#8220;<U>Securities Act</U>&#8221;) The Business Combination Agreement provides for, among other things,
the merger of Merger Sub with and into NewCo (the &#8220;<U>Merger</U>&#8221;), with NewCo being the surviving corporation of the Merger
(&#8220;Surviving Corporation&#8221;) and becoming a wholly-owned subsidiary of Bowen. The Transactions are described in the Registration
Statement. Capitalized terms not otherwise defined herein have the respective meanings assigned to such terms in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the opinions expressed herein, we have examined the Registration Statement (including the proxy statement/prospectus
included therein) and such agreements, other documents, records, and certificates of representatives of Bowen and the Company,
and such other documents as we have deemed relevant or necessary in connection with our opinion set forth herein. In such examination,
we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted
to us as originals, the conformity to original documents of all documents submitted to us as duplicates or certified or conformed copies,
and the authenticity of the originals of such latter documents. We have relied, without independent verification, on certificates of
representatives of Bowen, NewCo, Merger Sub and the Company and, as to questions of fact material to such opinions,
upon representations of Bowen, NewCo, Merger Sub and the Company, certificates of  representatives of Bowen, NewCo,
Merger Sub, and the Company and factual information we have obtained from such other sources as we have deemed reasonable. We have assumed
without investigation that there has been no relevant change or development between the dates as of which the information cited in the
preceding sentence was given and the date of this opinion. We have not, however, undertaken any independent investigation of any factual
matter set forth in any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have assumed that (i) the Merger will be effected in accordance with the Business Combination Agreement and none of the material terms
and conditions of the Business Combination Agreement have been or will be waived or modified, (ii) the representations set forth
in the Business Combination Agreement are true, correct and complete and will remain accurate and complete at all times up to and including
the effective time of the Registration Statement, (iii) any representations made in the Business Combination Agreement &#8220;to the
knowledge of,&#8221; or based on the belief or that are similarly qualified, are accurate and complete and will remain accurate and complete
at all times up to and including the effective time, in each case without such qualification, (iv) as to factual matters, the accuracy
of each of the representations, warranties and agreements contained in any document, and (v) there are no understandings between any
of the parties that would alter, or are inconsistent with, the terms or representations set forth in the Business Combination Agreement.
We also have assumed that the parties have complied with and, if applicable, will continue to comply with, the covenants contained in
the Business Combination Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the foregoing and subject to the further assumptions, qualifications and limitations set forth herein (including the last sentence
of this paragraph) and in the Registration Statement, the statements in the Registration Statement under the caption <FONT STYLE="background-color: white">titled
&#8220;<I>Certain Material United States Federal Income Tax Considerations &#8211; Material U.S. Federal Income Tax Effects of the Business
Combination</I>&#8221; </FONT>insofar as such statements summarize U.S. federal income tax law or legal conclusions with respect thereto,
constitute our opinion regarding such material U.S. federal income tax consequences of the Business Combination. <FONT STYLE="background-color: white">We
note that the discussion contained in the Registration Statement under the caption &#8220;<I>Certain Material United States Federal Income
Tax Considerations &#8211; Material U.S. Federal Income Tax Effects of the Business Combination</I>&#8221; does not address all of the
U.S. federal income tax consequences of the Transactions that may be applicable to the Bowen or the holders of the Bowen Ordinary Shares.
Our opinion represents our legal judgment as to the described U.S. federal income tax consequences of the Transactions solely with respect
to the holders of Bowen Ordinary Shares.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
opinion is based on the Internal Revenue Code of 1986, as amended, Treasury Regulations issued thereunder, Internal Revenue Service (&#8220;IRS&#8221;)
pronouncements, and judicial decisions, all as in effect on the date hereof, and all of which are subject to change or differing interpretation,
possibly with retroactive effect. We express no opinion other than as to the federal income tax laws of the United States of America
and do not express any opinion, either implicitly or otherwise, on any issue not expressly addressed above. Our opinion relates solely
to the material United States federal income tax consequences of the Transactions with respect to holders of Bowen Ordinary Shares, and
no opinion is implied or should be inferred beyond those matters. Our opinion is not binding upon the IRS or the courts, and there is
no assurance that the IRS or a court will not take, and possibly sustain, a contrary position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are furnishing this opinion in connection with the filing of the Registration Statement, and this opinion is not to be relied upon for
any other purpose without our prior written consent. The opinion set forth in this letter is: (i) limited to those matters expressly
covered and no opinion is expressed in respect of any other matter; (ii) as of the date hereof; and (iii) rendered by us at the request
of Bowen. We hereby consent to the filing of this opinion as Exhibit 8.1 to the Registration Statement and to the reference to our firm
name whenever appearing therein with respect to the discussion of the material U.S. federal income tax consequences of the Transactions.
In giving such consent, we do not thereby admit that we are included in the category of persons whose consent is required under Section
7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder, nor do we thereby admit that we are experts
with respect to any part of such Registration Statement within the meaning of the term &#8220;experts&#8221; as used in the Securities
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
truly yours,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Graubard Miller</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>3
<FILENAME>ex10-11.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.11</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Property
Lease Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lessor
(Party A): Shenzhen Jingji Baina Business Management Co., Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact
Address: Unit 1101, 11/F, Block B, Jingji 100 Tower, 5016 East Shennan Road,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luohu District, Shenzhen</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative: Hua CHEN</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Ms. Luo</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
0755-82388888</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lessee
(Party B): Shenzhen Qianzhi Biotechnology Co., Ltd</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact
Address: Unit 1705, 17/F, Block B, Jingji 100 Tower, 5016 East Shennan Road,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luohu District, Shenzhen</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative: Juxiang HU</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Ms. Huang</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
+86 15658166126</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the Civil Code of the People&rsquo;s Republic of China and relevant laws and regulations, Party A and Party B, on the basis of voluntary,
equal, and mutually beneficial consultation, have entered into this Property Lease Contract (hereinafter referred to as &ldquo;This Agreement&rdquo;)
regarding Party B&rsquo;s lease of the property (including supporting facilities) of Party A&rsquo;s Jingji 100 Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
1 Leasing Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
Party A will lease the leased property located at Unit 1705, 17/F, Block B, Jingji 100 Tower, 5016 East Shennan Road, Luohu District,
Shenzhen (hereinafter referred to as the &ldquo;leased property&rdquo;) to Party B for office use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
The specific location of the leased property is indicated in red in Annex 2 of this agreement, which is only used for location determination
and convenient identification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
The construction area of the leased property is 177.75 m<SUP>2</SUP>. If Party B believes that there is an error in the construction
area of the leased property, Party B shall apply to Party A and jointly designate a surveying and mapping agency with surveying and mapping
qualifications to re measure the construction area of the leased property (the surveying and mapping cost shall be borne by Party B).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4
Rental property use: office use. Party B shall not engage in any other use of the leased property such as illegal direct sales, pyramid
schemes for sales, illegal training, etc. Party B shall not use the leased property for or engage in industrial or manufacturing workshops,
warehouses, guesthouses, hotels, bed rentals, catering, gambling, fraud, illegal fundraising, commercial training, entertainment venues,
medical beauty, etc. Party B shall not engage in illegal P2P financial business or other business activities prohibited by Chinese laws
and regulations within the leased property. Party B shall comply with relevant national and local regulations on housing use and property
management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5
Party B shall apply for relevant certificates, approval certificates, or licenses from relevant government departments before operating.
Within seven days after obtaining the relevant certificates, Party B shall provide Party A with a copy of the relevant certificates (Attachment
1) for record keeping. If Party B uses the leased property address provided by Party A as the registered address for business registration,
Party B shall complete the business registration procedures within fifteen working days after the termination of this contract (i.e.
Party B shall move the registered address out of the leased property). Otherwise, Party A has the right to refuse to refund the lease
deposit and demand compensation from Party B for any losses caused to Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6
During the lease term, Party B shall not occupy the shared part of the leased area without authorization. Otherwise, Party A has the
right to demand that Party B stop the infringement, eliminate the impact, and compensate Party A for the losses. The Party A and Shenzhen
Jingji Property Management Co., Ltd. have the right to impose reasonable temporary restrictions on the use of public areas based on actual
circumstances, and this should be a short-term event that should not affect the normal work of Party B for more than 24 hours.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
2 Lease Term, Rent Renovation Period and Commencement Date</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
Lease term: 3 years, starting from 1<SUP>st</SUP> Sep 2023 to 31<SUP>st</SUP> Aug 2026.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
Rent free period: 2 months, from 1<SUP>st</SUP> Aug 2024 to 31<SUP>st</SUP> Aug 2024, and 1<SUP>st</SUP> Aug 2026 to 31<SUP>st</SUP>
Aug 2026. Both parties agree that Party B is not required to pay rent during the rent free period, but shall pay management fees (including
air conditioning fees during normal office hours), water and electricity fees, and fees charged by relevant government departments for
the use of the leased property by Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
Commencement Date: 1<SUP>st</SUP> Sep 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
3 Rent and Payment Methods</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
Rent (calculated based on the building area):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
1<SUP>st</SUP> Sep 2023 to 31<SUP>st</SUP> Aug 2026, the rent is &yen; 180.00 yuan/m<SUP>2</SUP>/month, the total monthly rent is &#65509;31995.00
yuan; includes the VAT@5%, the amount excludes tax is &yen; 30471.43 yuan, and the amount of VAT is &yen; 1523.57 yuan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
Party B should pay the first instalment of &yen; 31995.00 yuan (Rent Period: 1<SUP>st</SUP> Sep 2023 to 30<SUP>th</SUP> Sep 2023) within
seven days from the date of signing of this agreement. Starting from October 2023 (including that month), Party B shall pay the rent
for the current month before the 5<SUP>th</SUP> day of each month (if there is any delay during the statutory holidays, it shall be subject
to Party A&rsquo;s notice). Rent for less than a full calendar month shall be calculated based on the actual number of rental days in
that calendar month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
Party B may pay the rent by bank transfer, cheque, bank remittance, or other methods designated by Party A. If payment is made by transfer
and remittance, the date of actual receipt of payment in the bank account designated by Party A shall be the payment date. Within seven
days after receiving the payment, Party A shall issue a qualified invoice to Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Party
A&rsquo;s designated Bank Account Information:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
Name: Bank of China Shennan Branch</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payee:
Shenzhen Jingji Baina Business Management Co., Ltd</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
Account: 7562 5794 7187</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
A has the right to change the receiving account according to the actual situation, but each change must be notified to Party B in writing
15 working days in advance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
Invoice issuance instructions: In order to avoid refunds due to incorrect selection of invoice types or incorrect information, Party
B shall determine the required invoice types based on their own company situation, and fill in the required information for invoicing
in detail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Invoice
Type: 1. General VAT Invoice 2. Special VAT Invoice</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
Shenzhen Qianzhi Biotechnology Co., Ltd</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
Number: 91440300799211588R</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 204pt; text-align: justify; text-indent: -192pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2in">Bank
Name and Account Number:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">Ping An Bank Shenzhen Nanshan District Branch 0072100506375</TD></TR>
                                                                                                                                      </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 204pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address and Tel:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Unit 1705, 17/F, Block B, Jingji 100 Tower, 5016 East
Shennan Road, Luohu District, Shenzhen 0755-22936176</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 96pt; text-align: justify; text-indent: -84pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
client of Party B who cooperates for the first time needs to provide a tax registration certificate. If they are a general taxpayer of
value-added tax, they also need to provide a general taxpayer qualification certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
4 Property Management Services and Other Expenses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
Party A entrusts Shenzhen Jingji Property Management Co., Ltd. Jingji 100 Property Service Center (hereinafter referred to as &ldquo;Property
Management Company&rdquo;) to provide property management services for Jingji 100 Tower. Party B shall sign a &ldquo;Property Management
Service Agreement&rdquo; with the property management company at the time of signing this agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
During the lease term, Party B shall bear management fees (including air conditioning fees during normal office hours), overtime adjustment
fees, water and electricity fees, and other expenses in accordance with the relevant provisions of the Property Management Service Agreement,
which shall be directly paid by Party B to the property management company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
Party B shall bear the telephone, internet, and other expenses related to the use of the leased property on their own.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
5 Lease Deposit</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
In order to ensure that Party B fulfills its obligations under this agreement, Party B shall pay Party A a rental deposit of &yen; 63990
yuan within seven days from the date of signing this agreement, which is the standard rent for the last two months of the lease term;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
When the lease term of this agreement expires and Party B no longer renews the lease, Party B shall return the leased property to Party
A in accordance with the provisions of this agreement, and both parties shall fulfill all rights and obligations arising from the leased
property and settle all expenses. Within 30 working days after completing the industrial and commercial cancellation or change procedures
with the registered address or business address of the leased unit, Party A shall return the lease deposit to Party B in full in one
lump sum (without interest).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above security deposit cannot be used as an exemption clause for Party B&rsquo;s breach of contract, nor can it be used to offset Party
B&rsquo;s rent or other expenses. If Party B fails to fulfill its obligations under this contract on time and fails to do so within the
period specified in writing by Party A, Party B agrees to pay all the deposit as liquidated damages to Party A in addition to continuing
to fulfill the unfulfilled obligations, and make up for the total amount of the deposit to Party A. If Party B fails to make up for it,
Party B shall pay Party A a penalty of 0.05% of the total deposit for each day of delay.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
Party A shall issue a receipt to Party B when collecting the lease deposit. Party B shall properly keep the deposit receipt and use it
as a valid proof when returning the lease deposit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
6 Delivery and Acceptance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
Delivery Date: Before 1<SUP>st</SUP> Sep 2023, if Party B fails to pay the rental deposit and the first installment to Party A before
this date, Party A has the right to postpone the delivery to the day after Party B pays the above fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
Delivery Standards: Party A shall deliver the leased property according to its current condition, and the delivery standards are detailed
in Annex 4 of the agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
Delivery Acceptance Procedure</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3.1
Party A, Party B, and the property management company shall jointly inspect and confirm the leased property on the agreed delivery date,
and sign the acceptance certificate, which is the &ldquo;Lease Property Acceptance Confirmation Letter&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3.2
Unless there are significant quality defects in the main structure of the leased property that seriously affect the renovation and use
of Party B, Party B shall immediately accept the leased property. If there are general defects in the leased property, but it does not
affect the normal entry, renovation, and use of Party B, Party B shall sign the &ldquo;Delivery Standards and Acceptance Confirmation
of the Leased Property&rdquo; and attach an explanation of the general defects. The defects shall be repaired by Party A, and the cost
shall be borne by Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4
Responsibilities Assumptions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4.1
If the delivery of the leased property is delayed due to the reasons of Party A, Party B&rsquo;s renovation period, lease start date,
lease term, etc. shall be correspondingly extended based on the actual number of overdue days. If the delivery is delayed for more than
sixty days, Party B has the right to terminate the lease agreement, and Party A shall refund the rental deposit fee paid by Party B without
interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4.2
If Party B delays receiving the leased property beyond the delivery date due to reasons attributable to Party B, and fails to complete
the acceptance and handover procedures, it shall be deemed that Party B has received the leased property on the delivery date of the
leased property, and Party B&rsquo;s renovation period, starting date, and lease term shall not be extended accordingly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4.3
If Party B delays or refuses to inspect the leased property, Party B shall compensate Party A for any losses incurred as a result. If
Party B fails to inspect and accept the property for more than seven days, Party A has the right to terminate this contract and rent
the property separately. The rental deposit paid by Party B shall not be refunded, and Party B shall compensate Party A for any related
losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
7 Renovation of Leased Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
Party B confirms that Party B is aware of the current status of the leased property when renting it, and acknowledges that the leased
property meets the requirements for Party B&rsquo;s use. If Party B needs to renovate the leased property, it shall report and complete
the corresponding acceptance procedures in accordance with the requirements of the fire management department, and bear the corresponding
costs on its own.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
Party B shall submit the relevant engineering drawings, mechanical and electrical engineering, mechanical and electrical requirements,
as well as the selection of various renovation materials, contractors, and other information to the property management company for review
no later than fifteen days before the renovation. The renovation can only be carried out with the written consent of the property management
company. The renovation plan provided by Party B shall comply with relevant laws and regulations, and ensure its safety, scientificity,
and rationality.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3
Party A and the property management company have the right to regulate and manage the renovation, separation, construction, installation
of equipment or renovation of the leased property by Party B, including reasonable management of the entry and exit of Party B&rsquo;s
construction personnel, material transportation, construction time, construction safety, etc., to ensure the overall safety and smoothness
of Jingji 100 Tower, and to avoid causing disturbance to other tenants or users of Jingji 100 Tower due to the actions of Party B. Party
B shall comply with the regulations and management of Party A or the property management company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4
The Party B shall ensure that the renovation construction unit has the national renovation qualifications and obtains all relevant government
approvals and permits before the renovation. Party B shall ensure that the construction personnel abide by laws and regulations, carry
out civilized and safe construction during the renovation construction process, comply with the &ldquo;Renovation Manual&rdquo; formulated
by the property management company, and accept the supervision and management of Party A and the property management company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5
The renovation of Party B shall not damage the normal use of the leased property, damage the main structure of the leased property, endanger
the safety of public facilities, etc., and shall not affect the normal office activities of other tenants of Jingji 100 Tower. During
the renovation process, if the renovation work of Party B must be assisted by Party A in accordance with relevant laws and regulations,
Party A may assist Party B in handling the relevant work, but the necessary expenses shall be borne by Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6
If Party B carries out any fire protection system, air conditioning system, water supply and drainage system or other works that may
affect or may affect the overall waterproof performance or mechanical and electrical system of Jingji 100 Tower on the leased property,
Party B must hire the construction unit designated by Party A to carry out the work and bear all expenses incurred as a result. In addition
to the aforementioned projects, Party B has the right to hire qualified construction units to renovate the leased property in accordance
with the relevant provisions of this contract, and shall bear all expenses incurred as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7
Without obtaining written approval or consent from Party A, Party B shall not:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.1
Build, install, dismantle, or modify any firmware, partitions, buildings, and facilities on the leased property or any part of Jingji
100 Tower;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.2
Modification, addition or permission for others to modify, add electrical facilities, air conditioning equipment, drainage pipes, fire/fire
monitoring or security systems;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.3
Install or allow others to install any equipment or machinery that requires additional electrical, mains wiring/pipelines, or electricity
not measured through meters, or whose weight exceeds the design load capacity of the ground;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.4
Install nails, insert or allow others to install nails, insert any nails, screws, metal hooks, brackets or similar objects on the doors,
windows, ceilings, walls, beams, floors, structural components, sanitary facilities, air conditioning equipment, fire/fire monitoring
equipment of the leased property; It is also prohibited to damage, damage, drill in, scratch, or allow others to damage, damage, drill
in, scratch, or damage the surface of the above-mentioned items;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.5
Lay or use any coverings that may damage or penetrate floors, walls, doors and windows, and do not place any dense racks that exceed
the maximum floor load of the leased property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.8
Unless Party A agrees in writing in advance and the Shenzhen Fire Department designates the installation of fire iron doors, Party B
shall not use sealed iron doors, nor modify the existing door locks, latches, and assemblies of fire exits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.9
Party A must bear the cost and, in accordance with the requirements of relevant government departments, remove any substandard structures,
buildings, partitions, and other renovations constructed by Party A within the leased property at any time during the lease term. Regardless
of whether such structures, buildings, partitions, and other renovations were constructed with or without the consent of Party A, Party
A shall not be responsible for any losses suffered by Party A as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.10
If Party B makes any construction or installs any attachments, devices, or additions to the leased property, even if such decoration,
renovation, or installation has been approved by Party A, Party A may still require Party B to restore, remove, or dismantle such renovation,
attachments, devices, and additions or any part thereof when the contract terminates and returns the leased property, and Party B shall
bear all expenses incurred as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the term of the contract, if Party A needs to renovate, expand or renovate the leased property for reasonable reasons, Party A shall
obtain written consent from Party B 30 days in advance and obtain approval from relevant government departments before proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.12
If the decoration construction unit of Party B causes personal injury or property damage during the decoration process, Party B shall
bear all compensation responsibilities on its own; If Party A causes damage to the leased property, Party B shall bear full compensation
liability, including but not limited to damage to the leased property and related losses of Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
completing the decoration, Party B shall obtain the acceptance and consent of relevant government departments and Party A before use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
8 Maintenance and Repair</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1
After the acceptance and delivery of the leased property, Party B shall use and take good care of all internal facilities of the leased
property, including but not limited to floors, walls, doors and windows, electrical facilities, water supply and drainage facilities,
fire protection facilities, air conditioning facilities, cables and pipelines, and ensure that they are in normal use. If there is any
damage or malfunction of the leased property (except for quality problems of the main structure of the building), Party B shall be responsible
for proper repair and bear the repair costs; If any personal injury or property damage is caused as a result, Party B shall bear full
responsibility.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2
During the lease term, Party B shall use the leased property reasonably within its business scope. Party B shall be responsible for the
daily cleaning and maintenance of the facilities and equipment provided by Party A to Party B within the leased property (including but
not limited to overhead platforms, ground wire boxes, suspended ceilings, lighting panels, doors and windows, air conditioning temperature
controllers, etc.), and bear relevant expenses. If Party B applies for maintenance by the property management company, Party B shall
pay the relevant maintenance fees in accordance with the facility and equipment maintenance cost standards provided by the property management
company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3
During the use of the leased property, Party A shall ensure that the main structure of the leased property is in a safe and reliable
condition. If Party B discovers any construction quality issues with the leased property other than due to Party B&rsquo;s reasons, Party
B shall promptly send a written notice to Party A and take possible effective measures to prevent further expansion of the defects; Party
A shall carry out maintenance within 7 days after receiving notification from Party B. If Party B fails to notify or take possible effective
measures in a timely manner, resulting in further expansion of losses, the (expanded) part of the maintenance costs shall be borne by
Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4
During the lease term, Party A has the right to enter the leased property to inspect its maintenance status, inspect the operation of
electrical, plumbing, and other equipment within the property. However, Party A shall notify Party B in writing in advance to choose
an appropriate time and avoid affecting Party B&rsquo;s normal use of the leased property as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5
During the lease term, in case of emergency situations such as fire, Party A or its authorized representative may forcibly enter the
leased property without notice, and Party A is not required to compensate Party B for any damage caused by forcibly entering the leased
property, except for those where Party A is at fault.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6
Party B shall compensate for the losses and damages caused by the following actions and events. Such compensation includes but is not
limited to any repair, repair costs, and any expenses incurred by Party A due to any other person claiming compensation or claiming their
rights from Party A in the following circumstances, as well as all expenses and expenses incurred by Party A and/or the property management
company in claiming compensation from Party B:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6.1
Damage to Party A, the property management company, any other person or any item caused by the malfunction, disrepair, or danger of any
electrical equipment, appliances, wires, etc. in the leased property;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6.2
The blockage, damage, or cessation of operation of the water pipes, toilets, and appliances of the leased property due to the fault of
Party B, resulting in losses to Party A, the property management company, any other person or any item;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6.3
Due to the fault of Party B, fire, smoke may spread within the leased property, or any source of water (including storms or rainwater)
may leak or overflow in the leased property or any part thereof, causing damage to Party A, the property management company, any other
person or any item.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
9 Insurance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1
During the renovation period, Party B shall purchase insurance for the leased property (including but not limited to the renovation during
entry, exit, and use) that may encounter risks. The types of insurance shall at least include all risks of construction engineering,
all risks of installation engineering (including third-party liability insurance), and group accident insurance for construction personnel.
The compensation limit for each accident of third-party liability insurance included in all risks of construction and installation engineering
shall not be less than RMB 5 million, and the compensation limit for each accident of group accident of construction personnel shall
not be less than RMB 500000. The insurance liability period shall be from the start of renovation to one month or more after the start
or resumption of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2
During the lease term, Party B shall at its own expense purchase insurance for the potential risks that the leased property may encounter,
and at least purchase property all risk insurance and public liability insurance for the leased property. The compensation limit for
each accident of the public liability insurance purchased by Party B shall not be less than RMB 5 million, and Party A shall be listed
as a joint beneficiary. Party B guarantees that the above insurance will remain valid throughout the entire lease period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3
If Party A requests Party B to provide proof of insurance purchase, Party B shall provide and present to Party A the aforementioned insurance
policy and the receipt for the last payment of insurance benefits, as well as proof issued by the insurance company that such policy
has been fully paid and is valid and existing in all aspects. Party B shall provide a copy of the aforementioned insurance policy for
Party A&rsquo;s review and retention.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4
Party B shall not engage in any behavior or event that renders the insurance of any part other than the Beijing Capital One Hundred Building
or the leased property invalid; Party B shall not engage in or allow the relevant personnel and contractors employed by Party B to engage
in any behavior or event that increases the insurance risk of any part other than the Beijing Capital One Hundred Building or the leased
property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5
If an insurance accident involving losses to Party A occurs due to the fault of Party B, the compensation received by Party B from the
insurance company shall first be used to compensate for Party A&rsquo;s losses; If the compensation received by Party B from the insurance
company is insufficient to compensate for Party A&rsquo;s losses, Party B shall compensate Party A for the difference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
10 Subleasing and Renewal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1
Without the written consent of Party A, Party B shall not sublet or sublet the leased property in any form. When the following behaviors
and events occur, Party B shall promptly notify Party A in writing. Otherwise, it shall be deemed that Party B has violated the provisions
of this contract regarding sublease:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.1
If Party B is a company and the company undergoes acquisition, restructuring, merger, or liquidation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.2
The name of Party B has changed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.3
The occurrence of statutory inheritance facts results in a change in the user of the leased property;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.4
Other situations where the actual user of the leased property has changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2
During the lease term, any change in the name, legal representative, nature of the enterprise, investor, merger, division, or liquidation
of Party B shall not affect the validity of this contract. However, Party B shall report to Party A for filing and change within 5 days
after the change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3
If Party B is willing to continue renting the leased property after the expiration of the lease term, and on the premise of timely payment
of rent and other fees, compliance and performance of all terms and conditions of this lease agreement, Party B shall submit a written
renewal application to Party A at least 180 days before the expiration of the lease term. Under the same conditions, Party B has the
priority right to lease. If both parties agree to renew the contract, a separate housing lease agreement shall be signed. If Party B
fails to submit the application on time, it shall be deemed that Party B has waived the right of first refusal to lease. Party A has
the right to rent out the leased property to others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4
Within 180 days before the expiration of the lease term of this contract, if Party B fails to make a written request for renewal of the
leased property within the time limit specified in this contract, or if Party A and Party B fail to reach an agreement on renewal, Party
A has the right to, together with any future tenants or relevant persons of the leased property, notify Party B in advance and inspect
the leased property at all reasonable times within 180 days before the end or early end of the lease term. Party B shall cooperate and
not obstruct, but such actions of Party A shall not interfere with Party B&rsquo;s normal use of the leased property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
11 Termination</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1
During the lease term, if Party B encounters any of the following situations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.1
Serious deterioration of business conditions, transfer of property, withdrawal of funds, loss of commercial reputation, which affects
the performance of this contract;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.2
If Party B is liquidated, goes bankrupt, has its property sealed and executed, or has a sharp decline in its ability to repay debts,
which may affect the performance of its obligations under this contract;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
A may request Party B to provide a performance guarantee. If Party B refuses to provide a performance guarantee, Party A may terminate
this contract, confiscate the lease deposit, and hold Party B responsible for breach of contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2
During the lease term, if any property of Party B in the leased property is subject to any form of compulsory measures and/or seizure
by the people&rsquo;s court or other administrative law enforcement departments, resulting in the inability to continue the performance
of this contract, Party A may terminate this contract, confiscate the lease deposit, and hold Party B responsible for breach of contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
12 Return of Leased Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1
If the lease term expires or this contract is terminated prematurely (whether unilaterally or through mutual consultation), Party B shall
withdraw from the leased property on the day of termination or termination of the contract. Party A, Party B, and the property management
company shall jointly inspect and hand over the leased property in accordance with Annex 3 and Annex 4 of this contract. Party B shall
restore the leased property to its original condition or return it to the good, clean, and suitable condition agreed upon by Party A,
including but not limited to restoring the ceiling open fire sprinkler system, smoke detectors, dismantling and returning fan coil units,
thermostats, light panels, air supply outlets, return outlets, ceilings, and auxiliary materials (the quantity shall be counted on site
according to the standard mechanical and electrical facilities list in the leased area, and all missing quantities shall be supplemented
or compensated by Party B for material damage or loss).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2
If the leased property returned by Party B contains fixed attachments, devices, and additional equipment added by Party B, and Party
A does not agree to accept it, Party B shall bear the cost of dismantling and removing it, and ensure that the leased property is in
good, clean, and suitable condition (except for normal wear and tear) at the time of return. If Party A agrees to accept it, it shall
be deemed that Party B agrees to waive the property ownership of such fixed attachments, devices, and additional equipment, and Party
B shall not demand any compensation from Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3
If the condition of the leased property at the time of return does not comply with the provisions of Article 12.1 and 12.2 of this contract,
Party A has the right to require Party B to take all measures or take measures on its own to ensure that the condition of the leased
property complies with the provisions of the preceding paragraph, and all costs and expenses arising therefrom shall be borne by Party
B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.4
After the expiration of the lease term or the early termination of this contract (whether unilaterally or through mutual negotiation),
if Party B refuses to conduct acceptance and handover with Party A in accordance with the provisions of this contract, Party A has the
right to unilaterally reclaim the leased property (including but not limited to: lock replacement, etc.) without notifying Party B, and
Party B agrees to authorize Party A to dispose of any items belonging to Party B in the leased property. The decoration and all ancillary
facilities/equipment of the leased property belong to Party A, and Party A does not need to compensate Party B. Any losses caused thereby
shall be borne by Party B, and Party B shall not claim any compensation or breach of contract from Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.5
If Party B fails to return the leased property on time, in addition to paying rent, management fees, and other expenses during the overdue
period according to the rent standard of the last month of the contract; Every day, Party B shall pay Party A a penalty equal to twice
the daily rent of the last month of the contract, until Party B returns the leased property as agreed in this contract or Party A reclaims
the leased property in accordance with Article 12.4 of this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
13 Breach of Contract</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1
Party B shall strictly pay the lease deposit in accordance with the provisions of Article 5.1 of this contract. If Party B delays or
fails to pay the lease deposit in full, for each day of delay, Party B shall pay a late fee of 0.05% of the total lease deposit to Party
A. If the delay exceeds ten days, it shall be deemed as a serious breach of contract by Party B, and Party A may choose to unilaterally
terminate this contract. If Party A chooses to unilaterally terminate this contract, Party A may reclaim the leased property and lease
it separately without notifying Party B. Any deposit already paid will not be refunded, and Party B shall still pay the full amount of
the lease deposit as liquidated damages as stipulated in this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2
Party B shall not refuse to pay or delay the rent for any reason. If Party B fails to pay the rent, Party B shall pay a penalty of 0.05%
of the total rent payable per day; If Party B fails to pay the rent for more than ten days (including ten days), in addition to paying
a penalty of 0.05% of the total rent payable per day, Party A has the right to entrust the property management company to take temporary
suspension measures for water, electricity, air conditioning supply services and other collection measures (any losses caused by the
collection measures shall be borne by Party B); If Party B fails to pay the rent for more than fifteen days (including fifteen days),
Party A has the right to terminate this contract and confiscate the lease deposit. Party B shall make up for the rent during the decoration
period, and Party B shall pay Party A the overdue rent and the late fee during the overdue rent period (calculated at 0.05% of the total
overdue rent per day until full payment of the rent) at the time of termination of this contract. Party A shall also be paid a penalty
equivalent to six months of rent at the end of the lease term based on the monthly rent standard. If the penalty is not enough to compensate
for Party A&rsquo;s losses (including but not limited to intermediary service fees (if any) paid by Party B to third parties due to the
introduction of Party B and losses during the vacancy period), Party B shall also compensate Party A for its losses, and Party A may
unilaterally pay Party A a penalty. To reclaim the leased property and lease the leased property separately. If Party B refuses to pay
or delays payment of rent or other fees, without the written consent of Party A, Party B shall not dispose of or remove Party B&rsquo;s
belongings from the leased property without authorization. Otherwise, Party A or the property management company have the right to prevent
or stop it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3
During the lease term, if Party B engages in any of the following behaviors, Party A has the right to terminate this contract, unilaterally
reclaim the leased property, and rent out the leased property separately. The lease deposit paid by Party B shall not be refunded, and
Party B shall make up for the rent for the decoration period. At the same time, Party B shall also bear the remaining rent for the lease
term (calculated as six months rent if the lease term exceeds six months) as compensation for Party A:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Party B engages in illegal activities using the leased property, causing harm to the public interest or the interests of others;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Without the written consent of Party A, Party B changes the lease purpose stipulated in this contract without authorization;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
If Party B violates the provisions of this contract, fails to bear maintenance responsibilities or pay maintenance fees, resulting in
serious damage to the leased property or facilities and equipment;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
Without the written consent of Party A and the approval of relevant departments, the leased property is renovated, the structure of the
leased property is changed without authorization, or there is other destructive behavior;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
Party B has not obtained a legitimate business license or other business license;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
Party B has not obtained the approval documents for safety or fire safety acceptance after decoration;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
Party B sublets the leased property to a third party or sublets it without authorization;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)
Engaging in commercial bribery of Party A&rsquo;s staff;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)
Serious deterioration of business conditions, transfer of property, withdrawal of funds, and loss of commercial reputation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)
Party B&rsquo;s liquidation, bankruptcy, property seizure and execution, and other sharp decline in debt repayment ability may affect
the performance of obligations under this contract;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)
Other violations of laws, regulations, policies, and the provisions of this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4
Without the prior written consent of Party A, Party B shall not erect, hang, post or allow others to erect, hang, post any advertisements,
announcements, notices, signs, or other objects on the exterior walls, surroundings, and public areas of the leased property. If Party
B violates, Party A has the right to dismantle or entrust a third party to dismantle the above-mentioned objects, and the dismantling
cost shall be borne by Party B. At the same time, Party A has the right to demand that Party B pay rent equivalent to one month as a
penalty for breach of contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.5
If Party B unilaterally terminates this contract in advance, the rental deposit already paid by Party B shall not be refunded. Party
B shall also pay the rent for the decoration period before the termination of this contract, and pay Party A a penalty equivalent to
six months of rent at the end of the lease term based on the monthly rent standard. If the penalty is not sufficient to compensate for
Party A&rsquo;s losses (including but not limited to intermediary service fees (if any) paid by Party B to third parties due to the introduction,
and vacancy period losses), Party B shall also compensate Party A for its losses. Party B shall withdraw the leased property and handle
the handover procedures according to the provisions of this contract. Otherwise, Party A has the right to unilaterally reclaim the leased
property and lease it separately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.6
All costs and expenses incurred by Party A in urging Party B to pay rent or exercising any other rights under this contract (including
lawyer fees, litigation fees, preservation fees, etc.) shall be borne by Party B, and Party A has the right to recover from Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.7
Party B acknowledges and confirms that if this contract is terminated or terminated prematurely due to the breach of contract by Party
B, the losses caused by the labor, material resources, and vacant time of the leased property, such as Party A&rsquo;s re recruitment,
will exceed the breach liability agreed upon by Party B in this contract. Party B has no objection to the breach liability agreed upon
in this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.8
For the purposes of the lease agreement and these lease terms, any act, negligence, negligence, or omission of Party B&rsquo;s contractors,
employees, agents, franchisees, or invited visitors shall be deemed as an act, negligence, negligence, or omission of Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
14 Force Majeure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1
&ldquo;Force Majeure&rdquo; refers to an event that is beyond the reasonable control, unforeseeable, and unavoidable of both parties
to this contract, which hinders, affects, or delays either party from fulfilling all or part of its obligations under this contract.
This event includes but is not limited to earthquakes, typhoons, floods, fires or other natural disasters, wars or any other similar
events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2
Any delay in the execution of this contract caused by force majeure shall be deemed as an understandable delay, and neither party shall
hold each other liable for breach of contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.3
The party encountering force majeure shall notify the other party within 3 days after the occurrence of force majeure and make every
effort to avoid, eliminate or mitigate the impact of such force majeure on the performance of this contract. At the same time, within
10 days after the occurrence of a force majeure event, the other party shall be provided with a legal certificate issued by a notary
public (or other appropriate government agency) in the area where the event occurred to prove the force majeure event. The parties to
the contract shall negotiate and decide whether to terminate the contract, partially exempt the performance of the contract, or postpone
the performance of the contract based on the degree of impact of force majeure events on the performance of the contract. If they cannot
provide such proof, the other party may demand that they bear the liability for breach of contract in accordance with the provisions
of this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
15 Notification and Delivery</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1
All notices required to be issued under this contract shall be in writing, and both parties shall send written notices or other documents
to the addresses specified in this contract. The addresses of both Party A and Party B listed in this contract are the communication
addresses of both parties, and Party B&rsquo;s lease of Party A&rsquo;s leased real estate is also the communication address of Party
B. If either party changes, they shall notify the other party in writing in a timely manner. Otherwise, any notice sent by the other
party to their original address shall still be deemed delivered in accordance with the provisions of this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.2
Any document, notice or other communication shall be deemed to have been delivered on the third working day after mailing, and rejection,
inability to deliver, inaccurate address, etc. by the other party shall not affect the delivery effect, and shall be deemed to have been
successfully delivered in accordance with the agreed delivery method.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
16 Applicable Law and Dispute Resolution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1
The signing, performance, interpretation, and dispute resolution of this contract shall be governed by the laws of the People&rsquo;s
Republic of China (this contract does not apply to the provisions of Hong Kong, Macao, and Taiwan).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.2
Any disputes arising from the performance of this contract between Party A and Party B shall be first resolved through consultation.
If consultation fails, either party may file a lawsuit with the people&rsquo;s court in the location where the leased property is located.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
17 Miscellaneous</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1
The terms of this contract have been reached through consultation and negotiation between both parties and do not constitute any standard
terms of either party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2
The title of this contract is for convenience of retrieval only and does not have any explanatory or restrictive effect on the terms
of the contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.3
Any matters not covered in this contract shall be supplemented by a separate agreement signed by both parties. The supplementary agreement
is an effective part of this contract. In case of any inconsistency between the expression of the supplementary agreement and this contract,
the expression of the supplementary agreement shall prevail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.4
During the lease term, Party A has the right to temporarily close the public areas (including squares) and public facilities or parts
thereof (including but not limited to corridors, portals, windows, electric assemblies, cables and wires, water pipes, elevators, escalators,
fire prevention, security equipment, and air conditioning equipment) of the building where Jingji 100 Tower is located due to reasonable
changes and repairs, after notifying Party B in advance. Such changes and repairs shall not affect Party B&rsquo;s normal office operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.5
Party A has the right to set up advertisements and obtain benefits in the interior, exterior, and outdoor spaces of the building of Jingji
100 Tower, but such installations shall not affect the normal use of the leased property by Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.6
Party A has the right to use and obtain profits from the atrium, roof, garage, square, and communication network of Jingji 100 Tower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.7
Party A shall provide Party B with tenant water sign signs installed in the lobby of the office building. Party B is not required to
pay the first production and installation fee of such signs to Party A, but Party B shall pay the installation and production fee for
subsequent changes to such signs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.8
After the signing of this contract, if Party B needs to handle the contract filing and registration procedures with the local housing
rental authority where the leased property is located, Party A shall provide assistance, and any expenses incurred shall be borne by
Party B. Both Party A and Party B hereby confirm that in case of any conflict between this contract and the content of the demonstration
text of the real estate lease contract made by the Shenzhen Housing Lease Management Office, this contract shall prevail and both parties
shall abide by and execute it jointly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.9
Except for those that are required by law or agreed upon by both parties to be withheld and paid by Party A, Party A and Party B shall
each bear all taxes and fees that must be paid by the government department in accordance with regulations regarding the leasing or use
rights of the leased premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.10
This contract constitutes the entire agreement between Party A and Party B regarding the matters related to this contract, and supersedes
all previous oral and written agreements regarding the matters contained in this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.11
This contract is made in six original copies, with Party A holding four copies, Party B holding one copy, and the contract registration
authority holding one copy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.12
The attachments are an integral part of this contract and have the same legal effect as this contract; If both Party A and Party B need
to add other attachments to this contract, they must be confirmed and agreed upon in writing by both parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table of contents for the annexes to this contract is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attachment
1: Qualification information materials such as business license and identity certificate of Party B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attachment
2: Schematic diagram of the location of the leased property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.14
This agreement shall come into effect from the date of signature and seal by the legal representatives or authorized representatives
of both parties, and shall terminate upon the expiration of the lease term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(NO
TEXT BELOW)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
A: Shenzhen Jingji Baina Business Management Co., Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative: Jiajun CHEN</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised
Proxy:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19<SUP>th
</SUP>Jul 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
B: Shenzhen Qianzhi Biotechnology Co., Ltd</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative: Juxiang HU</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised
Proxy:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered/Filed
with:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.12
<SEQUENCE>4
<FILENAME>ex10-12.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.12</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Property
Lease Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lessor
(Party A): Shenzhen Jingji Baina Business Management Co., Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact
Address: Unit 1101, 11/F, Block B, Jingji 100 Tower, 5016 East Shennan Road,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luohu District, Shenzhen</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative: Hua CHEN</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Ms. Luo</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
0755-82388888</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lessee
(Party B): Shenzhen Qianzhi Biotech Co., Ltd</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact
Address: Unit 1701, 17/F, Block B, Jingji 100 Tower, 5016 East Shennan Road,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luohu District, Shenzhen</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative: Juxiang HU</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Ms. Huang</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
+86 15658166126</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the Civil Code of the People&rsquo;s Republic of China and relevant laws and regulations, Party A and Party B, on the basis of voluntary,
equal, and mutually beneficial consultation, have entered into this Property Lease Contract (hereinafter referred to as &ldquo;This Agreement&rdquo;)
regarding Party B&rsquo;s lease of the property (including supporting facilities) of Party A&rsquo;s Jingji 100 Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
1 Leasing Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
Party A will lease the leased property located at Unit 1701, 17/F, Block B, Jingji 100 Tower, 5016 East Shennan Road, Luohu District,
Shenzhen (hereinafter referred to as the &ldquo;leased property&rdquo;) to Party B for office use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
The specific location of the leased property is indicated in red in Annex 2 of this agreement, which is only used for location determination
and convenient identification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
The construction area of the leased property is 309.79 m<SUP>2</SUP>. If Party B believes that there is an error in the construction
area of the leased property, Party B shall apply to Party A and jointly designate a surveying and mapping agency with surveying and mapping
qualifications to re measure the construction area of the leased property (the surveying and mapping cost shall be borne by Party B).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4
Rental property use: office use. Party B shall not engage in any other use of the leased property such as illegal direct sales, pyramid
schemes for sales, illegal training, etc. Party B shall not use the leased property for or engage in industrial or manufacturing workshops,
warehouses, guesthouses, hotels, bed rentals, catering, gambling, fraud, illegal fundraising, commercial training, entertainment venues,
medical beauty, etc. Party B shall not engage in illegal P2P financial business or other business activities prohibited by Chinese laws
and regulations within the leased property. Party B shall comply with relevant national and local regulations on housing use and property
management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5
Party B shall apply for relevant certificates, approval certificates, or licenses from relevant government departments before operating.
Within seven days after obtaining the relevant certificates, Party B shall provide Party A with a copy of the relevant certificates (Attachment
1) for record keeping. If Party B uses the leased property address provided by Party A as the registered address for business registration,
Party B shall complete the business registration procedures within fifteen working days after the termination of this contract (i.e.
Party B shall move the registered address out of the leased property). Otherwise, Party A has the right to refuse to refund the lease
deposit and demand compensation from Party B for any losses caused to Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6
During the lease term, Party B shall not occupy the shared part of the leased area without authorization. Otherwise, Party A has the
right to demand that Party B stop the infringement, eliminate the impact, and compensate Party A for the losses. The Party A and Shenzhen
Jingji Property Management Co., Ltd. have the right to impose reasonable temporary restrictions on the use of public areas based on actual
circumstances, and this should be a short-term event that should not affect the normal work of Party B for more than 24 hours.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
2 Lease Term, Rent Renovation Period and Commencement Date</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
Lease term: 3 years, starting from 1<SUP>st</SUP> Aug 2023 to 31<SUP>st</SUP> Jul 2026.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
Rent free period: 2 months, from 1<SUP>st</SUP> Jul 2024 to 31<SUP>st</SUP> Jul 2024, and 1<SUP>st</SUP> Jul 2026 to 31<SUP>st</SUP>
Jul 2026. Both parties agree that Party B is not required to pay rent during the rent free period, but shall pay management fees (including
air conditioning fees during normal office hours), water and electricity fees, and fees charged by relevant government departments for
the use of the leased property by Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
Commencement Date: 1<SUP>st</SUP> Aug 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
3 Rent and Payment Methods</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
Rent (calculated based on the building area):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
1<SUP>st</SUP> Aug 2023 to 31<SUP>st</SUP> Jul 2026, the rent is &yen; 180.00 yuan/m<SUP>2</SUP>/month, the total monthly rent is &yen;55762.00
yuan; includes the VAT@5%, the amount excludes tax is &yen; 53106.86 yuan, and the amount of VAT is &yen; 2655.34 yuan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
Party B should pay the first instalment of &yen; 55762.00 yuan (Rent Period: 1<SUP>st</SUP> Aug 2023 to 31<SUP>st</SUP> Aug 2023) within
seven days from the date of signing of this agreement. Starting from September 2023 (including that month), Party B shall pay the rent
for the current month before the 5<SUP>th</SUP> day of each month (if there is any delay during the statutory holidays, it shall be subject
to Party A&rsquo;s notice). Rent for less than a full calendar month shall be calculated based on the actual number of rental days in
that calendar month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
Party B may pay the rent by bank transfer, cheque, bank remittance, or other methods designated by Party A. If payment is made by transfer
and remittance, the date of actual receipt of payment in the bank account designated by Party A shall be the payment date. Within seven
days after receiving the payment, Party A shall issue a qualified invoice to Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Party
A&rsquo;s designated Bank Account Information:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
Name: Bank of China Shennan Branch</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payee:
Shenzhen Jingji Baina Business Management Co., Ltd</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
Account: -</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
A has the right to change the receiving account according to the actual situation, but each change must be notified to Party B in writing
15 working days in advance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
Invoice issuance instructions: In order to avoid refunds due to incorrect selection of invoice types or incorrect information, Party
B shall determine the required invoice types based on their own company situation, and fill in the required information for invoicing
in detail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Invoice
Type: 1. General VAT Invoice 2. Special VAT Invoice</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
Shenzhen Qianzhi Biotech Co., Ltd</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
Number: 91440300MA5FP11T27</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 204pt; text-align: justify; text-indent: -192pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif">Bank
Name and Account Number:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">Agricultural Bank of China Baishizhou Brancht</TD></TR>
                                                                                                                                      <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41003000040032119</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 204pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address and Tel:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> B-1701, 17/F, Block B, Jingji 100 Tower, 5016 East
Shennan Road, Laowei Community, Guiyuan Street, Luohu District, Shenzhen 0755-22936176</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 96pt; text-align: justify; text-indent: -84pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
client of Party B who cooperates for the first time needs to provide a tax registration certificate. If they are a general taxpayer of
value-added tax, they also need to provide a general taxpayer qualification certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
4 Property Management Services and Other Expenses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
Party A entrusts Shenzhen Jingji Property Management Co., Ltd. Jingji 100 Property Service Center (hereinafter referred to as &ldquo;Property
Management Company&rdquo;) to provide property management services for Jingji 100 Tower. Party B shall sign a &ldquo;Property Management
Service Agreement&rdquo; with the property management company at the time of signing this agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
During the lease term, Party B shall bear management fees (including air conditioning fees during normal office hours), overtime adjustment
fees, water and electricity fees, and other expenses in accordance with the relevant provisions of the Property Management Service Agreement,
which shall be directly paid by Party B to the property management company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
Party B shall bear the telephone, internet, and other expenses related to the use of the leased property on their own.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
5 Lease Deposit</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
In order to ensure that Party B fulfills its obligations under this agreement, Party B shall pay Party A a rental deposit of &yen; 111524.40
yuan within seven days from the date of signing this agreement, which is the standard rent for the last two months of the lease term;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
When the lease term of this agreement expires and Party B no longer renews the lease, Party B shall return the leased property to Party
A in accordance with the provisions of this agreement, and both parties shall fulfill all rights and obligations arising from the leased
property and settle all expenses. Within 30 working days after completing the industrial and commercial cancellation or change procedures
with the registered address or business address of the leased unit, Party A shall return the lease deposit to Party B in full in one
lump sum (without interest).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above security deposit cannot be used as an exemption clause for Party B&rsquo;s breach of contract, nor can it be used to offset Party
B&rsquo;s rent or other expenses. If Party B fails to fulfill its obligations under this contract on time and fails to do so within the
period specified in writing by Party A, Party B agrees to pay all the deposit as liquidated damages to Party A in addition to continuing
to fulfill the unfulfilled obligations, and make up for the total amount of the deposit to Party A. If Party B fails to make up for it,
Party B shall pay Party A a penalty of 0.05% of the total deposit for each day of delay.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
Party A shall issue a receipt to Party B when collecting the lease deposit. Party B shall properly keep the deposit receipt and use it
as a valid proof when returning the lease deposit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
6 Delivery and Acceptance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
Delivery Date: Before 1<SUP>st</SUP> Aug 2023, if Party B fails to pay the rental deposit and the first installment to Party A before
this date, Party A has the right to postpone the delivery to the day after Party B pays the above fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
Delivery Standards: Party A shall deliver the leased property according to its current condition, and the delivery standards are detailed
in Annex 4 of the agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
Delivery Acceptance Procedure</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3.1
Party A, Party B, and the property management company shall jointly inspect and confirm the leased property on the agreed delivery date,
and sign the acceptance certificate, which is the &ldquo;Lease Property Acceptance Confirmation Letter&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3.2
Unless there are significant quality defects in the main structure of the leased property that seriously affect the renovation and use
of Party B, Party B shall immediately accept the leased property. If there are general defects in the leased property, but it does not
affect the normal entry, renovation, and use of Party B, Party B shall sign the &ldquo;Delivery Standards and Acceptance Confirmation
of the Leased Property&rdquo; and attach an explanation of the general defects. The defects shall be repaired by Party A, and the cost
shall be borne by Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4
Responsibilities Assumptions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4.1
If the delivery of the leased property is delayed due to the reasons of Party A, Party B&rsquo;s renovation period, lease start date,
lease term, etc. shall be correspondingly extended based on the actual number of overdue days. If the delivery is delayed for more than
sixty days, Party B has the right to terminate the lease agreement, and Party A shall refund the rental deposit fee paid by Party B without
interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4.2
If Party B delays receiving the leased property beyond the delivery date due to reasons attributable to Party B, and fails to complete
the acceptance and handover procedures, it shall be deemed that Party B has received the leased property on the delivery date of the
leased property, and Party B&rsquo;s renovation period, starting date, and lease term shall not be extended accordingly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4.3
If Party B delays or refuses to inspect the leased property, Party B shall compensate Party A for any losses incurred as a result. If
Party B fails to inspect and accept the property for more than seven days, Party A has the right to terminate this contract and rent
the property separately. The rental deposit paid by Party B shall not be refunded, and Party B shall compensate Party A for any related
losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
7 Renovation of Leased Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
Party B confirms that Party B is aware of the current status of the leased property when renting it, and acknowledges that the leased
property meets the requirements for Party B&rsquo;s use. If Party B needs to renovate the leased property, it shall report and complete
the corresponding acceptance procedures in accordance with the requirements of the fire management department, and bear the corresponding
costs on its own.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
Party B shall submit the relevant engineering drawings, mechanical and electrical engineering, mechanical and electrical requirements,
as well as the selection of various renovation materials, contractors, and other information to the property management company for review
no later than fifteen days before the renovation. The renovation can only be carried out with the written consent of the property management
company. The renovation plan provided by Party B shall comply with relevant laws and regulations, and ensure its safety, scientificity,
and rationality.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3
Party A and the property management company have the right to regulate and manage the renovation, separation, construction, installation
of equipment or renovation of the leased property by Party B, including reasonable management of the entry and exit of Party B&rsquo;s
construction personnel, material transportation, construction time, construction safety, etc., to ensure the overall safety and smoothness
of Jingji 100 Tower, and to avoid causing disturbance to other tenants or users of Jingji 100 Tower due to the actions of Party B. Party
B shall comply with the regulations and management of Party A or the property management company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4
The Party B shall ensure that the renovation construction unit has the national renovation qualifications and obtains all relevant government
approvals and permits before the renovation. Party B shall ensure that the construction personnel abide by laws and regulations, carry
out civilized and safe construction during the renovation construction process, comply with the &ldquo;Renovation Manual&rdquo; formulated
by the property management company, and accept the supervision and management of Party A and the property management company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5
The renovation of Party B shall not damage the normal use of the leased property, damage the main structure of the leased property, endanger
the safety of public facilities, etc., and shall not affect the normal office activities of other tenants of Jingji 100 Tower. During
the renovation process, if the renovation work of Party B must be assisted by Party A in accordance with relevant laws and regulations,
Party A may assist Party B in handling the relevant work, but the necessary expenses shall be borne by Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6
If Party B carries out any fire protection system, air conditioning system, water supply and drainage system or other works that may
affect or may affect the overall waterproof performance or mechanical and electrical system of Jingji 100 Tower on the leased property,
Party B must hire the construction unit designated by Party A to carry out the work and bear all expenses incurred as a result. In addition
to the aforementioned projects, Party B has the right to hire qualified construction units to renovate the leased property in accordance
with the relevant provisions of this contract, and shall bear all expenses incurred as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7
Without obtaining written approval or consent from Party A, Party B shall not:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.1
Build, install, dismantle, or modify any firmware, partitions, buildings, and facilities on the leased property or any part of Jingji
100 Tower;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.2
Modification, addition or permission for others to modify, add electrical facilities, air conditioning equipment, drainage pipes, fire/fire
monitoring or security systems;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.3
Install or allow others to install any equipment or machinery that requires additional electrical, mains wiring/pipelines, or electricity
not measured through meters, or whose weight exceeds the design load capacity of the ground;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.4
Install nails, insert or allow others to install nails, insert any nails, screws, metal hooks, brackets or similar objects on the doors,
windows, ceilings, walls, beams, floors, structural components, sanitary facilities, air conditioning equipment, fire/fire monitoring
equipment of the leased property; It is also prohibited to damage, damage, drill in, scratch, or allow others to damage, damage, drill
in, scratch, or damage the surface of the above-mentioned items;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.5
Lay or use any coverings that may damage or penetrate floors, walls, doors and windows, and do not place any dense racks that exceed
the maximum floor load of the leased property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.8
Unless Party A agrees in writing in advance and the Shenzhen Fire Department designates the installation of fire iron doors, Party B
shall not use sealed iron doors, nor modify the existing door locks, latches, and assemblies of fire exits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.9
Party A must bear the cost and, in accordance with the requirements of relevant government departments, remove any substandard structures,
buildings, partitions, and other renovations constructed by Party A within the leased property at any time during the lease term. Regardless
of whether such structures, buildings, partitions, and other renovations were constructed with or without the consent of Party A, Party
A shall not be responsible for any losses suffered by Party A as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.10
If Party B makes any construction or installs any attachments, devices, or additions to the leased property, even if such decoration,
renovation, or installation has been approved by Party A, Party A may still require Party B to restore, remove, or dismantle such renovation,
attachments, devices, and additions or any part thereof when the contract terminates and returns the leased property, and Party B shall
bear all expenses incurred as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the term of the contract, if Party A needs to renovate, expand or renovate the leased property for reasonable reasons, Party A shall
obtain written consent from Party B 30 days in advance and obtain approval from relevant government departments before proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.12
If the decoration construction unit of Party B causes personal injury or property damage during the decoration process, Party B shall
bear all compensation responsibilities on its own; If Party A causes damage to the leased property, Party B shall bear full compensation
liability, including but not limited to damage to the leased property and related losses of Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
completing the decoration, Party B shall obtain the acceptance and consent of relevant government departments and Party A before use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
8 Maintenance and Repair</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1
After the acceptance and delivery of the leased property, Party B shall use and take good care of all internal facilities of the leased
property, including but not limited to floors, walls, doors and windows, electrical facilities, water supply and drainage facilities,
fire protection facilities, air conditioning facilities, cables and pipelines, and ensure that they are in normal use. If there is any
damage or malfunction of the leased property (except for quality problems of the main structure of the building), Party B shall be responsible
for proper repair and bear the repair costs; If any personal injury or property damage is caused as a result, Party B shall bear full
responsibility.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2
During the lease term, Party B shall use the leased property reasonably within its business scope. Party B shall be responsible for the
daily cleaning and maintenance of the facilities and equipment provided by Party A to Party B within the leased property (including but
not limited to overhead platforms, ground wire boxes, suspended ceilings, lighting panels, doors and windows, air conditioning temperature
controllers, etc.), and bear relevant expenses. If Party B applies for maintenance by the property management company, Party B shall
pay the relevant maintenance fees in accordance with the facility and equipment maintenance cost standards provided by the property management
company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3
During the use of the leased property, Party A shall ensure that the main structure of the leased property is in a safe and reliable
condition. If Party B discovers any construction quality issues with the leased property other than due to Party B&rsquo;s reasons, Party
B shall promptly send a written notice to Party A and take possible effective measures to prevent further expansion of the defects; Party
A shall carry out maintenance within 7 days after receiving notification from Party B. If Party B fails to notify or take possible effective
measures in a timely manner, resulting in further expansion of losses, the (expanded) part of the maintenance costs shall be borne by
Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4
During the lease term, Party A has the right to enter the leased property to inspect its maintenance status, inspect the operation of
electrical, plumbing, and other equipment within the property. However, Party A shall notify Party B in writing in advance to choose
an appropriate time and avoid affecting Party B&rsquo;s normal use of the leased property as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5
During the lease term, in case of emergency situations such as fire, Party A or its authorized representative may forcibly enter the
leased property without notice, and Party A is not required to compensate Party B for any damage caused by forcibly entering the leased
property, except for those where Party A is at fault.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6
Party B shall compensate for the losses and damages caused by the following actions and events. Such compensation includes but is not
limited to any repair, repair costs, and any expenses incurred by Party A due to any other person claiming compensation or claiming their
rights from Party A in the following circumstances, as well as all expenses and expenses incurred by Party A and/or the property management
company in claiming compensation from Party B:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6.1
Damage to Party A, the property management company, any other person or any item caused by the malfunction, disrepair, or danger of any
electrical equipment, appliances, wires, etc. in the leased property;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6.2
The blockage, damage, or cessation of operation of the water pipes, toilets, and appliances of the leased property due to the fault of
Party B, resulting in losses to Party A, the property management company, any other person or any item;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6.3
Due to the fault of Party B, fire, smoke may spread within the leased property, or any source of water (including storms or rainwater)
may leak or overflow in the leased property or any part thereof, causing damage to Party A, the property management company, any other
person or any item.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
9 Insurance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1
During the renovation period, Party B shall purchase insurance for the leased property (including but not limited to the renovation during
entry, exit, and use) that may encounter risks. The types of insurance shall at least include all risks of construction engineering,
all risks of installation engineering (including third-party liability insurance), and group accident insurance for construction personnel.
The compensation limit for each accident of third-party liability insurance included in all risks of construction and installation engineering
shall not be less than RMB 5 million, and the compensation limit for each accident of group accident of construction personnel shall
not be less than RMB 500000. The insurance liability period shall be from the start of renovation to one month or more after the start
or resumption of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2
During the lease term, Party B shall at its own expense purchase insurance for the potential risks that the leased property may encounter,
and at least purchase property all risk insurance and public liability insurance for the leased property. The compensation limit for
each accident of the public liability insurance purchased by Party B shall not be less than RMB 5 million, and Party A shall be listed
as a joint beneficiary. Party B guarantees that the above insurance will remain valid throughout the entire lease period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3
If Party A requests Party B to provide proof of insurance purchase, Party B shall provide and present to Party A the aforementioned insurance
policy and the receipt for the last payment of insurance benefits, as well as proof issued by the insurance company that such policy
has been fully paid and is valid and existing in all aspects. Party B shall provide a copy of the aforementioned insurance policy for
Party A&rsquo;s review and retention.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4
Party B shall not engage in any behavior or event that renders the insurance of any part other than the Beijing Capital One Hundred Building
or the leased property invalid; Party B shall not engage in or allow the relevant personnel and contractors employed by Party B to engage
in any behavior or event that increases the insurance risk of any part other than the Beijing Capital One Hundred Building or the leased
property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5
If an insurance accident involving losses to Party A occurs due to the fault of Party B, the compensation received by Party B from the
insurance company shall first be used to compensate for Party A&rsquo;s losses; If the compensation received by Party B from the insurance
company is insufficient to compensate for Party A&rsquo;s losses, Party B shall compensate Party A for the difference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
10 Subleasing and Renewal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1
Without the written consent of Party A, Party B shall not sublet or sublet the leased property in any form. When the following behaviors
and events occur, Party B shall promptly notify Party A in writing. Otherwise, it shall be deemed that Party B has violated the provisions
of this contract regarding sublease:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.1
If Party B is a company and the company undergoes acquisition, restructuring, merger, or liquidation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.2
The name of Party B has changed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.3
The occurrence of statutory inheritance facts results in a change in the user of the leased property;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.4
Other situations where the actual user of the leased property has changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2
During the lease term, any change in the name, legal representative, nature of the enterprise, investor, merger, division, or liquidation
of Party B shall not affect the validity of this contract. However, Party B shall report to Party A for filing and change within 5 days
after the change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3
If Party B is willing to continue renting the leased property after the expiration of the lease term, and on the premise of timely payment
of rent and other fees, compliance and performance of all terms and conditions of this lease agreement, Party B shall submit a written
renewal application to Party A at least 180 days before the expiration of the lease term. Under the same conditions, Party B has the
priority right to lease. If both parties agree to renew the contract, a separate housing lease agreement shall be signed. If Party B
fails to submit the application on time, it shall be deemed that Party B has waived the right of first refusal to lease. Party A has
the right to rent out the leased property to others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4
Within 180 days before the expiration of the lease term of this contract, if Party B fails to make a written request for renewal of the
leased property within the time limit specified in this contract, or if Party A and Party B fail to reach an agreement on renewal, Party
A has the right to, together with any future tenants or relevant persons of the leased property, notify Party B in advance and inspect
the leased property at all reasonable times within 180 days before the end or early end of the lease term. Party B shall cooperate and
not obstruct, but such actions of Party A shall not interfere with Party B&rsquo;s normal use of the leased property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
11 Termination</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1
During the lease term, if Party B encounters any of the following situations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.1
Serious deterioration of business conditions, transfer of property, withdrawal of funds, loss of commercial reputation, which affects
the performance of this contract;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.2
If Party B is liquidated, goes bankrupt, has its property sealed and executed, or has a sharp decline in its ability to repay debts,
which may affect the performance of its obligations under this contract;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
A may request Party B to provide a performance guarantee. If Party B refuses to provide a performance guarantee, Party A may terminate
this contract, confiscate the lease deposit, and hold Party B responsible for breach of contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2
During the lease term, if any property of Party B in the leased property is subject to any form of compulsory measures and/or seizure
by the people&rsquo;s court or other administrative law enforcement departments, resulting in the inability to continue the performance
of this contract, Party A may terminate this contract, confiscate the lease deposit, and hold Party B responsible for breach of contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
12 Return of Leased Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1
If the lease term expires or this contract is terminated prematurely (whether unilaterally or through mutual consultation), Party B shall
withdraw from the leased property on the day of termination or termination of the contract. Party A, Party B, and the property management
company shall jointly inspect and hand over the leased property in accordance with Annex 3 and Annex 4 of this contract. Party B shall
restore the leased property to its original condition or return it to the good, clean, and suitable condition agreed upon by Party A,
including but not limited to restoring the ceiling open fire sprinkler system, smoke detectors, dismantling and returning fan coil units,
thermostats, light panels, air supply outlets, return outlets, ceilings, and auxiliary materials (the quantity shall be counted on site
according to the standard mechanical and electrical facilities list in the leased area, and all missing quantities shall be supplemented
or compensated by Party B for material damage or loss).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2
If the leased property returned by Party B contains fixed attachments, devices, and additional equipment added by Party B, and Party
A does not agree to accept it, Party B shall bear the cost of dismantling and removing it, and ensure that the leased property is in
good, clean, and suitable condition (except for normal wear and tear) at the time of return. If Party A agrees to accept it, it shall
be deemed that Party B agrees to waive the property ownership of such fixed attachments, devices, and additional equipment, and Party
B shall not demand any compensation from Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3
If the condition of the leased property at the time of return does not comply with the provisions of Article 12.1 and 12.2 of this contract,
Party A has the right to require Party B to take all measures or take measures on its own to ensure that the condition of the leased
property complies with the provisions of the preceding paragraph, and all costs and expenses arising therefrom shall be borne by Party
B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.4
After the expiration of the lease term or the early termination of this contract (whether unilaterally or through mutual negotiation),
if Party B refuses to conduct acceptance and handover with Party A in accordance with the provisions of this contract, Party A has the
right to unilaterally reclaim the leased property (including but not limited to: lock replacement, etc.) without notifying Party B, and
Party B agrees to authorize Party A to dispose of any items belonging to Party B in the leased property. The decoration and all ancillary
facilities/equipment of the leased property belong to Party A, and Party A does not need to compensate Party B. Any losses caused thereby
shall be borne by Party B, and Party B shall not claim any compensation or breach of contract from Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.5
If Party B fails to return the leased property on time, in addition to paying rent, management fees, and other expenses during the overdue
period according to the rent standard of the last month of the contract; Every day, Party B shall pay Party A a penalty equal to twice
the daily rent of the last month of the contract, until Party B returns the leased property as agreed in this contract or Party A reclaims
the leased property in accordance with Article 12.4 of this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
13 Breach of Contract</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1
Party B shall strictly pay the lease deposit in accordance with the provisions of Article 5.1 of this contract. If Party B delays or
fails to pay the lease deposit in full, for each day of delay, Party B shall pay a late fee of 0.05% of the total lease deposit to Party
A. If the delay exceeds ten days, it shall be deemed as a serious breach of contract by Party B, and Party A may choose to unilaterally
terminate this contract. If Party A chooses to unilaterally terminate this contract, Party A may reclaim the leased property and lease
it separately without notifying Party B. Any deposit already paid will not be refunded, and Party B shall still pay the full amount of
the lease deposit as liquidated damages as stipulated in this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2
Party B shall not refuse to pay or delay the rent for any reason. If Party B fails to pay the rent, Party B shall pay a penalty of 0.05%
of the total rent payable per day; If Party B fails to pay the rent for more than ten days (including ten days), in addition to paying
a penalty of 0.05% of the total rent payable per day, Party A has the right to entrust the property management company to take temporary
suspension measures for water, electricity, air conditioning supply services and other collection measures (any losses caused by the
collection measures shall be borne by Party B); If Party B fails to pay the rent for more than fifteen days (including fifteen days),
Party A has the right to terminate this contract and confiscate the lease deposit. Party B shall make up for the rent during the decoration
period, and Party B shall pay Party A the overdue rent and the late fee during the overdue rent period (calculated at 0.05% of the total
overdue rent per day until full payment of the rent) at the time of termination of this contract. Party A shall also be paid a penalty
equivalent to six months of rent at the end of the lease term based on the monthly rent standard. If the penalty is not enough to compensate
for Party A&rsquo;s losses (including but not limited to intermediary service fees (if any) paid by Party B to third parties due to the
introduction of Party B and losses during the vacancy period), Party B shall also compensate Party A for its losses, and Party A may
unilaterally pay Party A a penalty. To reclaim the leased property and lease the leased property separately. If Party B refuses to pay
or delays payment of rent or other fees, without the written consent of Party A, Party B shall not dispose of or remove Party B&rsquo;s
belongings from the leased property without authorization. Otherwise, Party A or the property management company have the right to prevent
or stop it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3
During the lease term, if Party B engages in any of the following behaviors, Party A has the right to terminate this contract, unilaterally
reclaim the leased property, and rent out the leased property separately. The lease deposit paid by Party B shall not be refunded, and
Party B shall make up for the rent for the decoration period. At the same time, Party B shall also bear the remaining rent for the lease
term (calculated as six months rent if the lease term exceeds six months) as compensation for Party A:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Party B engages in illegal activities using the leased property, causing harm to the public interest or the interests of others;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Without the written consent of Party A, Party B changes the lease purpose stipulated in this contract without authorization;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
If Party B violates the provisions of this contract, fails to bear maintenance responsibilities or pay maintenance fees, resulting in
serious damage to the leased property or facilities and equipment;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
Without the written consent of Party A and the approval of relevant departments, the leased property is renovated, the structure of the
leased property is changed without authorization, or there is other destructive behavior;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
Party B has not obtained a legitimate business license or other business license;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
Party B has not obtained the approval documents for safety or fire safety acceptance after decoration;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
Party B sublets the leased property to a third party or sublets it without authorization;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)
Engaging in commercial bribery of Party A&rsquo;s staff;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)
Serious deterioration of business conditions, transfer of property, withdrawal of funds, and loss of commercial reputation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)
Party B&rsquo;s liquidation, bankruptcy, property seizure and execution, and other sharp decline in debt repayment ability may affect
the performance of obligations under this contract;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)
Other violations of laws, regulations, policies, and the provisions of this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4
Without the prior written consent of Party A, Party B shall not erect, hang, post or allow others to erect, hang, post any advertisements,
announcements, notices, signs, or other objects on the exterior walls, surroundings, and public areas of the leased property. If Party
B violates, Party A has the right to dismantle or entrust a third party to dismantle the above-mentioned objects, and the dismantling
cost shall be borne by Party B. At the same time, Party A has the right to demand that Party B pay rent equivalent to one month as a
penalty for breach of contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.5
If Party B unilaterally terminates this contract in advance, the rental deposit already paid by Party B shall not be refunded. Party
B shall also pay the rent for the decoration period before the termination of this contract, and pay Party A a penalty equivalent to
six months of rent at the end of the lease term based on the monthly rent standard. If the penalty is not sufficient to compensate for
Party A&rsquo;s losses (including but not limited to intermediary service fees (if any) paid by Party B to third parties due to the introduction,
and vacancy period losses), Party B shall also compensate Party A for its losses. Party B shall withdraw the leased property and handle
the handover procedures according to the provisions of this contract. Otherwise, Party A has the right to unilaterally reclaim the leased
property and lease it separately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.6
All costs and expenses incurred by Party A in urging Party B to pay rent or exercising any other rights under this contract (including
lawyer fees, litigation fees, preservation fees, etc.) shall be borne by Party B, and Party A has the right to recover from Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.7
Party B acknowledges and confirms that if this contract is terminated or terminated prematurely due to the breach of contract by Party
B, the losses caused by the labor, material resources, and vacant time of the leased property, such as Party A&rsquo;s re recruitment,
will exceed the breach liability agreed upon by Party B in this contract. Party B has no objection to the breach liability agreed upon
in this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.8
For the purposes of the lease agreement and these lease terms, any act, negligence, negligence, or omission of Party B&rsquo;s contractors,
employees, agents, franchisees, or invited visitors shall be deemed as an act, negligence, negligence, or omission of Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
14 Force Majeure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1
&ldquo;Force Majeure&rdquo; refers to an event that is beyond the reasonable control, unforeseeable, and unavoidable of both parties
to this contract, which hinders, affects, or delays either party from fulfilling all or part of its obligations under this contract.
This event includes but is not limited to earthquakes, typhoons, floods, fires or other natural disasters, wars or any other similar
events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2
Any delay in the execution of this contract caused by force majeure shall be deemed as an understandable delay, and neither party shall
hold each other liable for breach of contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.3
The party encountering force majeure shall notify the other party within 3 days after the occurrence of force majeure and make every
effort to avoid, eliminate or mitigate the impact of such force majeure on the performance of this contract. At the same time, within
10 days after the occurrence of a force majeure event, the other party shall be provided with a legal certificate issued by a notary
public (or other appropriate government agency) in the area where the event occurred to prove the force majeure event. The parties to
the contract shall negotiate and decide whether to terminate the contract, partially exempt the performance of the contract, or postpone
the performance of the contract based on the degree of impact of force majeure events on the performance of the contract. If they cannot
provide such proof, the other party may demand that they bear the liability for breach of contract in accordance with the provisions
of this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
15 Notification and Delivery</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1
All notices required to be issued under this contract shall be in writing, and both parties shall send written notices or other documents
to the addresses specified in this contract. The addresses of both Party A and Party B listed in this contract are the communication
addresses of both parties, and Party B&rsquo;s lease of Party A&rsquo;s leased real estate is also the communication address of Party
B. If either party changes, they shall notify the other party in writing in a timely manner. Otherwise, any notice sent by the other
party to their original address shall still be deemed delivered in accordance with the provisions of this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.2
Any document, notice or other communication shall be deemed to have been delivered on the third working day after mailing, and rejection,
inability to deliver, inaccurate address, etc. by the other party shall not affect the delivery effect, and shall be deemed to have been
successfully delivered in accordance with the agreed delivery method.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
16 Applicable Law and Dispute Resolution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1
The signing, performance, interpretation, and dispute resolution of this contract shall be governed by the laws of the People&rsquo;s
Republic of China (this contract does not apply to the provisions of Hong Kong, Macao, and Taiwan).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.2
Any disputes arising from the performance of this contract between Party A and Party B shall be first resolved through consultation.
If consultation fails, either party may file a lawsuit with the people&rsquo;s court in the location where the leased property is located.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
17 Miscellaneous</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1
The terms of this contract have been reached through consultation and negotiation between both parties and do not constitute any standard
terms of either party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2
The title of this contract is for convenience of retrieval only and does not have any explanatory or restrictive effect on the terms
of the contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.3
Any matters not covered in this contract shall be supplemented by a separate agreement signed by both parties. The supplementary agreement
is an effective part of this contract. In case of any inconsistency between the expression of the supplementary agreement and this contract,
the expression of the supplementary agreement shall prevail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.4
During the lease term, Party A has the right to temporarily close the public areas (including squares) and public facilities or parts
thereof (including but not limited to corridors, portals, windows, electric assemblies, cables and wires, water pipes, elevators, escalators,
fire prevention, security equipment, and air conditioning equipment) of the building where Jingji 100 Tower is located due to reasonable
changes and repairs, after notifying Party B in advance. Such changes and repairs shall not affect Party B&rsquo;s normal office operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.5
Party A has the right to set up advertisements and obtain benefits in the interior, exterior, and outdoor spaces of the building of Jingji
100 Tower, but such installations shall not affect the normal use of the leased property by Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.6
Party A has the right to use and obtain profits from the atrium, roof, garage, square, and communication network of Jingji 100 Tower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.7
Party A shall provide Party B with tenant water sign signs installed in the lobby of the office building. Party B is not required to
pay the first production and installation fee of such signs to Party A, but Party B shall pay the installation and production fee for
subsequent changes to such signs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.8
After the signing of this contract, if Party B needs to handle the contract filing and registration procedures with the local housing
rental authority where the leased property is located, Party A shall provide assistance, and any expenses incurred shall be borne by
Party B. Both Party A and Party B hereby confirm that in case of any conflict between this contract and the content of the demonstration
text of the real estate lease contract made by the Shenzhen Housing Lease Management Office, this contract shall prevail and both parties
shall abide by and execute it jointly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.9
Except for those that are required by law or agreed upon by both parties to be withheld and paid by Party A, Party A and Party B shall
each bear all taxes and fees that must be paid by the government department in accordance with regulations regarding the leasing or use
rights of the leased premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.10
This contract constitutes the entire agreement between Party A and Party B regarding the matters related to this contract, and supersedes
all previous oral and written agreements regarding the matters contained in this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.11
This contract is made in six original copies, with Party A holding four copies, Party B holding one copy, and the contract registration
authority holding one copy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.12
The attachments are an integral part of this contract and have the same legal effect as this contract; If both Party A and Party B need
to add other attachments to this contract, they must be confirmed and agreed upon in writing by both parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table of contents for the annexes to this contract is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attachment
1: Qualification information materials such as business license and identity certificate of Party B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attachment
2: Schematic diagram of the location of the leased property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.14
This agreement shall come into effect from the date of signature and seal by the legal representatives or authorized representatives
of both parties, and shall terminate upon the expiration of the lease term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(NO
TEXT BELOW)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
A: Shenzhen Jingji Baina Business Management Co., Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative: Jiajun CHEN</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised
Proxy:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19<SUP>th
</SUP>Jul 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
B: Shenzhen Qianzhi Biotech Co., Ltd</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative: Juxiang HU</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised
Proxy:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered/Filed
with:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>5
<FILENAME>ex10-13.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.13</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Property
Lease Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lessor
(Party A): Shenzhen Jingji Baina Business Management Co., Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact
Address: Unit 1101, 11/F, Block B, Jingji 100 Tower, 5016 East Shennan Road,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luohu District, Shenzhen</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative: Hua CHEN</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Ms. Luo</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
0755-82388888</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lessee
(Party B): Shenzhen Qianzhi Health Management Co., Ltd</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact
Address: Unit 1703, 17/F, Block B, Jingji 100 Tower, 5016 East Shennan Road,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luohu District, Shenzhen</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative: Liangwen Wang</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Ms. Huang</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
+86 15658166126</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the Civil Code of the People&rsquo;s Republic of China and relevant laws and regulations, Party A and Party B, on the basis of voluntary,
equal, and mutually beneficial consultation, have entered into this Property Lease Contract (hereinafter referred to as &ldquo;This Agreement&rdquo;)
regarding Party B&rsquo;s lease of the property (including supporting facilities) of Party A&rsquo;s Jingji 100 Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
1 Leasing Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
Party A will lease the leased property located at Unit 1703, 17/F, Block B, Jingji 100 Tower, 5016 East Shennan Road, Luohu District,
Shenzhen (hereinafter referred to as the &ldquo;leased property&rdquo;) to Party B for office use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
The specific location of the leased property is indicated in red in Annex 2 of this agreement, which is only used for location determination
and convenient identification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
The construction area of the leased property is 171.06 m<SUP>2</SUP>. If Party B believes that there is an error in the construction
area of the leased property, Party B shall apply to Party A and jointly designate a surveying and mapping agency with surveying and mapping
qualifications to re measure the construction area of the leased property (the surveying and mapping cost shall be borne by Party B).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4
Rental property use: office use. Party B shall not engage in any other use of the leased property such as illegal direct sales, pyramid
schemes for sales, illegal training, etc. Party B shall not use the leased property for or engage in industrial or manufacturing workshops,
warehouses, guesthouses, hotels, bed rentals, catering, gambling, fraud, illegal fundraising, commercial training, entertainment venues,
medical beauty, etc. Party B shall not engage in illegal P2P financial business or other business activities prohibited by Chinese laws
and regulations within the leased property. Party B shall comply with relevant national and local regulations on housing use and property
management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5
Party B shall apply for relevant certificates, approval certificates, or licenses from relevant government departments before operating.
Within seven days after obtaining the relevant certificates, Party B shall provide Party A with a copy of the relevant certificates (Attachment
1) for record keeping. If Party B uses the leased property address provided by Party A as the registered address for business registration,
Party B shall complete the business registration procedures within fifteen working days after the termination of this contract (i.e.
Party B shall move the registered address out of the leased property). Otherwise, Party A has the right to refuse to refund the lease
deposit and demand compensation from Party B for any losses caused to Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6
During the lease term, Party B shall not occupy the shared part of the leased area without authorization. Otherwise, Party A has the
right to demand that Party B stop the infringement, eliminate the impact, and compensate Party A for the losses. The Party A and Shenzhen
Jingji Property Management Co., Ltd. have the right to impose reasonable temporary restrictions on the use of public areas based on actual
circumstances, and this should be a short-term event that should not affect the normal work of Party B for more than 24 hours.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
2 Lease Term, Rent Renovation Period and Commencement Date</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
Lease term: 3 years, starting from 1<SUP>st</SUP> Sep 2023 to 31<SUP>st</SUP> Aug 2026.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
Rent free period: 2 months, from 1<SUP>st</SUP> Aug 2024 to 31<SUP>st</SUP> Aug 2024, and 1<SUP>st</SUP> Aug 2026 to 31<SUP>st</SUP>
Aug 2026. Both parties agree that Party B is not required to pay rent during the rent free period, but shall pay management fees (including
air conditioning fees during normal office hours), water and electricity fees, and fees charged by relevant government departments for
the use of the leased property by Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
Commencement Date: 1<SUP>st</SUP> Sep 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
3 Rent and Payment Methods</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
Rent (calculated based on the building area):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
1<SUP>st</SUP> Sep 2023 to 31<SUP>st</SUP> Aug 2026, the rent is &yen; 180.00 yuan/m<SUP>2</SUP>/month, the total monthly rent is &yen;30790.80
yuan; includes the VAT@5%, the amount excludes tax is &yen; 29324.57 yuan, and the amount of VAT is &yen; 1466.23 yuan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
Party B should pay the first instalment of &yen; 30790.80 yuan (Rent Period: 1<SUP>st</SUP> Sep 2023 to 30<SUP>th</SUP> Sep 2023) within
seven days from the date of signing of this agreement. Starting from October 2023 (including that month), Party B shall pay the rent
for the current month before the 5<SUP>th</SUP> day of each month (if there is any delay during the statutory holidays, it shall be subject
to Party A&rsquo;s notice). Rent for less than a full calendar month shall be calculated based on the actual number of rental days in
that calendar month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
Party B may pay the rent by bank transfer, cheque, bank remittance, or other methods designated by Party A. If payment is made by transfer
and remittance, the date of actual receipt of payment in the bank account designated by Party A shall be the payment date. Within seven
days after receiving the payment, Party A shall issue a qualified invoice to Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Party
A&rsquo;s designated Bank Account Information:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
Name: Bank of China Shennan Branch</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payee:
Shenzhen Jingji Baina Business Management Co., Ltd</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
Account: -</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
A has the right to change the receiving account according to the actual situation, but each change must be notified to Party B in writing
15 working days in advance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
Invoice issuance instructions: In order to avoid refunds due to incorrect selection of invoice types or incorrect information, Party
B shall determine the required invoice types based on their own company situation, and fill in the required information for invoicing
in detail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Invoice
Type: 1. General VAT Invoice 2. Special VAT Invoice</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
Shenzhen Qianzhi Health Management Co., Ltd</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
Number: 91440300799211588R</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 204pt; text-align: justify; text-indent: -192pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif">Bank
Name and Account Number:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">Bank of China Shennan Branch</TD></TR>
                                                                                                                                      <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">745872163341</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 204pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address and Tel:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Unit 1701, 17/F, Block B, Jingji 100 Tower, 5016 East
Shennan Road, Luohu District, Shenzhen 0755-22936176</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 96pt; text-align: justify; text-indent: -84pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
client of Party B who cooperates for the first time needs to provide a tax registration certificate. If they are a general taxpayer of
value-added tax, they also need to provide a general taxpayer qualification certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
4 Property Management Services and Other Expenses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
Party A entrusts Shenzhen Jingji Property Management Co., Ltd. Jingji 100 Property Service Center (hereinafter referred to as &ldquo;Property
Management Company&rdquo;) to provide property management services for Jingji 100 Tower. Party B shall sign a &ldquo;Property Management
Service Agreement&rdquo; with the property management company at the time of signing this agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
During the lease term, Party B shall bear management fees (including air conditioning fees during normal office hours), overtime adjustment
fees, water and electricity fees, and other expenses in accordance with the relevant provisions of the Property Management Service Agreement,
which shall be directly paid by Party B to the property management company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
Party B shall bear the telephone, internet, and other expenses related to the use of the leased property on their own.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
5 Lease Deposit</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
In order to ensure that Party B fulfills its obligations under this agreement, Party B shall pay Party A a rental deposit of &yen; 61581.60
yuan within seven days from the date of signing this agreement, which is the standard rent for the last two months of the lease term;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
When the lease term of this agreement expires and Party B no longer renews the lease, Party B shall return the leased property to Party
A in accordance with the provisions of this agreement, and both parties shall fulfill all rights and obligations arising from the leased
property and settle all expenses. Within 30 working days after completing the industrial and commercial cancellation or change procedures
with the registered address or business address of the leased unit, Party A shall return the lease deposit to Party B in full in one
lump sum (without interest).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above security deposit cannot be used as an exemption clause for Party B&rsquo;s breach of contract, nor can it be used to offset Party
B&rsquo;s rent or other expenses. If Party B fails to fulfill its obligations under this contract on time and fails to do so within the
period specified in writing by Party A, Party B agrees to pay all the deposit as liquidated damages to Party A in addition to continuing
to fulfill the unfulfilled obligations, and make up for the total amount of the deposit to Party A. If Party B fails to make up for it,
Party B shall pay Party A a penalty of 0.05% of the total deposit for each day of delay.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
Party A shall issue a receipt to Party B when collecting the lease deposit. Party B shall properly keep the deposit receipt and use it
as a valid proof when returning the lease deposit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
6 Delivery and Acceptance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
Delivery Date: Before 1<SUP>st</SUP> Sep 2023, if Party B fails to pay the rental deposit and the first installment to Party A before
this date, Party A has the right to postpone the delivery to the day after Party B pays the above fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
Delivery Standards: Party A shall deliver the leased property according to its current condition, and the delivery standards are detailed
in Annex 4 of the agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
Delivery Acceptance Procedure</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3.1
Party A, Party B, and the property management company shall jointly inspect and confirm the leased property on the agreed delivery date,
and sign the acceptance certificate, which is the &ldquo;Lease Property Acceptance Confirmation Letter&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3.2
Unless there are significant quality defects in the main structure of the leased property that seriously affect the renovation and use
of Party B, Party B shall immediately accept the leased property. If there are general defects in the leased property, but it does not
affect the normal entry, renovation, and use of Party B, Party B shall sign the &ldquo;Delivery Standards and Acceptance Confirmation
of the Leased Property&rdquo; and attach an explanation of the general defects. The defects shall be repaired by Party A, and the cost
shall be borne by Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4
Responsibilities Assumptions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4.1
If the delivery of the leased property is delayed due to the reasons of Party A, Party B&rsquo;s renovation period, lease start date,
lease term, etc. shall be correspondingly extended based on the actual number of overdue days. If the delivery is delayed for more than
sixty days, Party B has the right to terminate the lease agreement, and Party A shall refund the rental deposit fee paid by Party B without
interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4.2
If Party B delays receiving the leased property beyond the delivery date due to reasons attributable to Party B, and fails to complete
the acceptance and handover procedures, it shall be deemed that Party B has received the leased property on the delivery date of the
leased property, and Party B&rsquo;s renovation period, starting date, and lease term shall not be extended accordingly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4.3
If Party B delays or refuses to inspect the leased property, Party B shall compensate Party A for any losses incurred as a result. If
Party B fails to inspect and accept the property for more than seven days, Party A has the right to terminate this contract and rent
the property separately. The rental deposit paid by Party B shall not be refunded, and Party B shall compensate Party A for any related
losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
7 Renovation of Leased Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
Party B confirms that Party B is aware of the current status of the leased property when renting it, and acknowledges that the leased
property meets the requirements for Party B&rsquo;s use. If Party B needs to renovate the leased property, it shall report and complete
the corresponding acceptance procedures in accordance with the requirements of the fire management department, and bear the corresponding
costs on its own.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
Party B shall submit the relevant engineering drawings, mechanical and electrical engineering, mechanical and electrical requirements,
as well as the selection of various renovation materials, contractors, and other information to the property management company for review
no later than fifteen days before the renovation. The renovation can only be carried out with the written consent of the property management
company. The renovation plan provided by Party B shall comply with relevant laws and regulations, and ensure its safety, scientificity,
and rationality.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3
Party A and the property management company have the right to regulate and manage the renovation, separation, construction, installation
of equipment or renovation of the leased property by Party B, including reasonable management of the entry and exit of Party B&rsquo;s
construction personnel, material transportation, construction time, construction safety, etc., to ensure the overall safety and smoothness
of Jingji 100 Tower, and to avoid causing disturbance to other tenants or users of Jingji 100 Tower due to the actions of Party B. Party
B shall comply with the regulations and management of Party A or the property management company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4
The Party B shall ensure that the renovation construction unit has the national renovation qualifications and obtains all relevant government
approvals and permits before the renovation. Party B shall ensure that the construction personnel abide by laws and regulations, carry
out civilized and safe construction during the renovation construction process, comply with the &ldquo;Renovation Manual&rdquo; formulated
by the property management company, and accept the supervision and management of Party A and the property management company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5
The renovation of Party B shall not damage the normal use of the leased property, damage the main structure of the leased property, endanger
the safety of public facilities, etc., and shall not affect the normal office activities of other tenants of Jingji 100 Tower. During
the renovation process, if the renovation work of Party B must be assisted by Party A in accordance with relevant laws and regulations,
Party A may assist Party B in handling the relevant work, but the necessary expenses shall be borne by Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6
If Party B carries out any fire protection system, air conditioning system, water supply and drainage system or other works that may
affect or may affect the overall waterproof performance or mechanical and electrical system of Jingji 100 Tower on the leased property,
Party B must hire the construction unit designated by Party A to carry out the work and bear all expenses incurred as a result. In addition
to the aforementioned projects, Party B has the right to hire qualified construction units to renovate the leased property in accordance
with the relevant provisions of this contract, and shall bear all expenses incurred as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7
Without obtaining written approval or consent from Party A, Party B shall not:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.1
Build, install, dismantle, or modify any firmware, partitions, buildings, and facilities on the leased property or any part of Jingji
100 Tower;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.2
Modification, addition or permission for others to modify, add electrical facilities, air conditioning equipment, drainage pipes, fire/fire
monitoring or security systems;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.3
Install or allow others to install any equipment or machinery that requires additional electrical, mains wiring/pipelines, or electricity
not measured through meters, or whose weight exceeds the design load capacity of the ground;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.4
Install nails, insert or allow others to install nails, insert any nails, screws, metal hooks, brackets or similar objects on the doors,
windows, ceilings, walls, beams, floors, structural components, sanitary facilities, air conditioning equipment, fire/fire monitoring
equipment of the leased property; It is also prohibited to damage, damage, drill in, scratch, or allow others to damage, damage, drill
in, scratch, or damage the surface of the above-mentioned items;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.5
Lay or use any coverings that may damage or penetrate floors, walls, doors and windows, and do not place any dense racks that exceed
the maximum floor load of the leased property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.8
Unless Party A agrees in writing in advance and the Shenzhen Fire Department designates the installation of fire iron doors, Party B
shall not use sealed iron doors, nor modify the existing door locks, latches, and assemblies of fire exits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.9
Party A must bear the cost and, in accordance with the requirements of relevant government departments, remove any substandard structures,
buildings, partitions, and other renovations constructed by Party A within the leased property at any time during the lease term. Regardless
of whether such structures, buildings, partitions, and other renovations were constructed with or without the consent of Party A, Party
A shall not be responsible for any losses suffered by Party A as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.10
If Party B makes any construction or installs any attachments, devices, or additions to the leased property, even if such decoration,
renovation, or installation has been approved by Party A, Party A may still require Party B to restore, remove, or dismantle such renovation,
attachments, devices, and additions or any part thereof when the contract terminates and returns the leased property, and Party B shall
bear all expenses incurred as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the term of the contract, if Party A needs to renovate, expand or renovate the leased property for reasonable reasons, Party A shall
obtain written consent from Party B 30 days in advance and obtain approval from relevant government departments before proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.12
If the decoration construction unit of Party B causes personal injury or property damage during the decoration process, Party B shall
bear all compensation responsibilities on its own; If Party A causes damage to the leased property, Party B shall bear full compensation
liability, including but not limited to damage to the leased property and related losses of Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
completing the decoration, Party B shall obtain the acceptance and consent of relevant government departments and Party A before use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
8 Maintenance and Repair</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1
After the acceptance and delivery of the leased property, Party B shall use and take good care of all internal facilities of the leased
property, including but not limited to floors, walls, doors and windows, electrical facilities, water supply and drainage facilities,
fire protection facilities, air conditioning facilities, cables and pipelines, and ensure that they are in normal use. If there is any
damage or malfunction of the leased property (except for quality problems of the main structure of the building), Party B shall be responsible
for proper repair and bear the repair costs; If any personal injury or property damage is caused as a result, Party B shall bear full
responsibility.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2
During the lease term, Party B shall use the leased property reasonably within its business scope. Party B shall be responsible for the
daily cleaning and maintenance of the facilities and equipment provided by Party A to Party B within the leased property (including but
not limited to overhead platforms, ground wire boxes, suspended ceilings, lighting panels, doors and windows, air conditioning temperature
controllers, etc.), and bear relevant expenses. If Party B applies for maintenance by the property management company, Party B shall
pay the relevant maintenance fees in accordance with the facility and equipment maintenance cost standards provided by the property management
company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3
During the use of the leased property, Party A shall ensure that the main structure of the leased property is in a safe and reliable
condition. If Party B discovers any construction quality issues with the leased property other than due to Party B&rsquo;s reasons, Party
B shall promptly send a written notice to Party A and take possible effective measures to prevent further expansion of the defects; Party
A shall carry out maintenance within 7 days after receiving notification from Party B. If Party B fails to notify or take possible effective
measures in a timely manner, resulting in further expansion of losses, the (expanded) part of the maintenance costs shall be borne by
Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4
During the lease term, Party A has the right to enter the leased property to inspect its maintenance status, inspect the operation of
electrical, plumbing, and other equipment within the property. However, Party A shall notify Party B in writing in advance to choose
an appropriate time and avoid affecting Party B&rsquo;s normal use of the leased property as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5
During the lease term, in case of emergency situations such as fire, Party A or its authorized representative may forcibly enter the
leased property without notice, and Party A is not required to compensate Party B for any damage caused by forcibly entering the leased
property, except for those where Party A is at fault.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6
Party B shall compensate for the losses and damages caused by the following actions and events. Such compensation includes but is not
limited to any repair, repair costs, and any expenses incurred by Party A due to any other person claiming compensation or claiming their
rights from Party A in the following circumstances, as well as all expenses and expenses incurred by Party A and/or the property management
company in claiming compensation from Party B:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6.1
Damage to Party A, the property management company, any other person or any item caused by the malfunction, disrepair, or danger of any
electrical equipment, appliances, wires, etc. in the leased property;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6.2
The blockage, damage, or cessation of operation of the water pipes, toilets, and appliances of the leased property due to the fault of
Party B, resulting in losses to Party A, the property management company, any other person or any item;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6.3
Due to the fault of Party B, fire, smoke may spread within the leased property, or any source of water (including storms or rainwater)
may leak or overflow in the leased property or any part thereof, causing damage to Party A, the property management company, any other
person or any item.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
9 Insurance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1
During the renovation period, Party B shall purchase insurance for the leased property (including but not limited to the renovation during
entry, exit, and use) that may encounter risks. The types of insurance shall at least include all risks of construction engineering,
all risks of installation engineering (including third-party liability insurance), and group accident insurance for construction personnel.
The compensation limit for each accident of third-party liability insurance included in all risks of construction and installation engineering
shall not be less than RMB 5 million, and the compensation limit for each accident of group accident of construction personnel shall
not be less than RMB 500000. The insurance liability period shall be from the start of renovation to one month or more after the start
or resumption of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2
During the lease term, Party B shall at its own expense purchase insurance for the potential risks that the leased property may encounter,
and at least purchase property all risk insurance and public liability insurance for the leased property. The compensation limit for
each accident of the public liability insurance purchased by Party B shall not be less than RMB 5 million, and Party A shall be listed
as a joint beneficiary. Party B guarantees that the above insurance will remain valid throughout the entire lease period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3
If Party A requests Party B to provide proof of insurance purchase, Party B shall provide and present to Party A the aforementioned insurance
policy and the receipt for the last payment of insurance benefits, as well as proof issued by the insurance company that such policy
has been fully paid and is valid and existing in all aspects. Party B shall provide a copy of the aforementioned insurance policy for
Party A&rsquo;s review and retention.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4
Party B shall not engage in any behavior or event that renders the insurance of any part other than the Beijing Capital One Hundred Building
or the leased property invalid; Party B shall not engage in or allow the relevant personnel and contractors employed by Party B to engage
in any behavior or event that increases the insurance risk of any part other than the Beijing Capital One Hundred Building or the leased
property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5
If an insurance accident involving losses to Party A occurs due to the fault of Party B, the compensation received by Party B from the
insurance company shall first be used to compensate for Party A&rsquo;s losses; If the compensation received by Party B from the insurance
company is insufficient to compensate for Party A&rsquo;s losses, Party B shall compensate Party A for the difference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
10 Subleasing and Renewal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1
Without the written consent of Party A, Party B shall not sublet or sublet the leased property in any form. When the following behaviors
and events occur, Party B shall promptly notify Party A in writing. Otherwise, it shall be deemed that Party B has violated the provisions
of this contract regarding sublease:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.1
If Party B is a company and the company undergoes acquisition, restructuring, merger, or liquidation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.2
The name of Party B has changed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.3
The occurrence of statutory inheritance facts results in a change in the user of the leased property;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.4
Other situations where the actual user of the leased property has changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2
During the lease term, any change in the name, legal representative, nature of the enterprise, investor, merger, division, or liquidation
of Party B shall not affect the validity of this contract. However, Party B shall report to Party A for filing and change within 5 days
after the change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3
If Party B is willing to continue renting the leased property after the expiration of the lease term, and on the premise of timely payment
of rent and other fees, compliance and performance of all terms and conditions of this lease agreement, Party B shall submit a written
renewal application to Party A at least 180 days before the expiration of the lease term. Under the same conditions, Party B has the
priority right to lease. If both parties agree to renew the contract, a separate housing lease agreement shall be signed. If Party B
fails to submit the application on time, it shall be deemed that Party B has waived the right of first refusal to lease. Party A has
the right to rent out the leased property to others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4
Within 180 days before the expiration of the lease term of this contract, if Party B fails to make a written request for renewal of the
leased property within the time limit specified in this contract, or if Party A and Party B fail to reach an agreement on renewal, Party
A has the right to, together with any future tenants or relevant persons of the leased property, notify Party B in advance and inspect
the leased property at all reasonable times within 180 days before the end or early end of the lease term. Party B shall cooperate and
not obstruct, but such actions of Party A shall not interfere with Party B&rsquo;s normal use of the leased property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
11 Termination</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1
During the lease term, if Party B encounters any of the following situations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.1
Serious deterioration of business conditions, transfer of property, withdrawal of funds, loss of commercial reputation, which affects
the performance of this contract;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.2
If Party B is liquidated, goes bankrupt, has its property sealed and executed, or has a sharp decline in its ability to repay debts,
which may affect the performance of its obligations under this contract;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
A may request Party B to provide a performance guarantee. If Party B refuses to provide a performance guarantee, Party A may terminate
this contract, confiscate the lease deposit, and hold Party B responsible for breach of contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2
During the lease term, if any property of Party B in the leased property is subject to any form of compulsory measures and/or seizure
by the people&rsquo;s court or other administrative law enforcement departments, resulting in the inability to continue the performance
of this contract, Party A may terminate this contract, confiscate the lease deposit, and hold Party B responsible for breach of contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
12 Return of Leased Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1
If the lease term expires or this contract is terminated prematurely (whether unilaterally or through mutual consultation), Party B shall
withdraw from the leased property on the day of termination or termination of the contract. Party A, Party B, and the property management
company shall jointly inspect and hand over the leased property in accordance with Annex 3 and Annex 4 of this contract. Party B shall
restore the leased property to its original condition or return it to the good, clean, and suitable condition agreed upon by Party A,
including but not limited to restoring the ceiling open fire sprinkler system, smoke detectors, dismantling and returning fan coil units,
thermostats, light panels, air supply outlets, return outlets, ceilings, and auxiliary materials (the quantity shall be counted on site
according to the standard mechanical and electrical facilities list in the leased area, and all missing quantities shall be supplemented
or compensated by Party B for material damage or loss).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2
If the leased property returned by Party B contains fixed attachments, devices, and additional equipment added by Party B, and Party
A does not agree to accept it, Party B shall bear the cost of dismantling and removing it, and ensure that the leased property is in
good, clean, and suitable condition (except for normal wear and tear) at the time of return. If Party A agrees to accept it, it shall
be deemed that Party B agrees to waive the property ownership of such fixed attachments, devices, and additional equipment, and Party
B shall not demand any compensation from Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3
If the condition of the leased property at the time of return does not comply with the provisions of Article 12.1 and 12.2 of this contract,
Party A has the right to require Party B to take all measures or take measures on its own to ensure that the condition of the leased
property complies with the provisions of the preceding paragraph, and all costs and expenses arising therefrom shall be borne by Party
B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.4
After the expiration of the lease term or the early termination of this contract (whether unilaterally or through mutual negotiation),
if Party B refuses to conduct acceptance and handover with Party A in accordance with the provisions of this contract, Party A has the
right to unilaterally reclaim the leased property (including but not limited to: lock replacement, etc.) without notifying Party B, and
Party B agrees to authorize Party A to dispose of any items belonging to Party B in the leased property. The decoration and all ancillary
facilities/equipment of the leased property belong to Party A, and Party A does not need to compensate Party B. Any losses caused thereby
shall be borne by Party B, and Party B shall not claim any compensation or breach of contract from Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.5
If Party B fails to return the leased property on time, in addition to paying rent, management fees, and other expenses during the overdue
period according to the rent standard of the last month of the contract; Every day, Party B shall pay Party A a penalty equal to twice
the daily rent of the last month of the contract, until Party B returns the leased property as agreed in this contract or Party A reclaims
the leased property in accordance with Article 12.4 of this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
13 Breach of Contract</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1
Party B shall strictly pay the lease deposit in accordance with the provisions of Article 5.1 of this contract. If Party B delays or
fails to pay the lease deposit in full, for each day of delay, Party B shall pay a late fee of 0.05% of the total lease deposit to Party
A. If the delay exceeds ten days, it shall be deemed as a serious breach of contract by Party B, and Party A may choose to unilaterally
terminate this contract. If Party A chooses to unilaterally terminate this contract, Party A may reclaim the leased property and lease
it separately without notifying Party B. Any deposit already paid will not be refunded, and Party B shall still pay the full amount of
the lease deposit as liquidated damages as stipulated in this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2
Party B shall not refuse to pay or delay the rent for any reason. If Party B fails to pay the rent, Party B shall pay a penalty of 0.05%
of the total rent payable per day; If Party B fails to pay the rent for more than ten days (including ten days), in addition to paying
a penalty of 0.05% of the total rent payable per day, Party A has the right to entrust the property management company to take temporary
suspension measures for water, electricity, air conditioning supply services and other collection measures (any losses caused by the
collection measures shall be borne by Party B); If Party B fails to pay the rent for more than fifteen days (including fifteen days),
Party A has the right to terminate this contract and confiscate the lease deposit. Party B shall make up for the rent during the decoration
period, and Party B shall pay Party A the overdue rent and the late fee during the overdue rent period (calculated at 0.05% of the total
overdue rent per day until full payment of the rent) at the time of termination of this contract. Party A shall also be paid a penalty
equivalent to six months of rent at the end of the lease term based on the monthly rent standard. If the penalty is not enough to compensate
for Party A&rsquo;s losses (including but not limited to intermediary service fees (if any) paid by Party B to third parties due to the
introduction of Party B and losses during the vacancy period), Party B shall also compensate Party A for its losses, and Party A may
unilaterally pay Party A a penalty. To reclaim the leased property and lease the leased property separately. If Party B refuses to pay
or delays payment of rent or other fees, without the written consent of Party A, Party B shall not dispose of or remove Party B&rsquo;s
belongings from the leased property without authorization. Otherwise, Party A or the property management company have the right to prevent
or stop it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3
During the lease term, if Party B engages in any of the following behaviors, Party A has the right to terminate this contract, unilaterally
reclaim the leased property, and rent out the leased property separately. The lease deposit paid by Party B shall not be refunded, and
Party B shall make up for the rent for the decoration period. At the same time, Party B shall also bear the remaining rent for the lease
term (calculated as six months rent if the lease term exceeds six months) as compensation for Party A:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Party B engages in illegal activities using the leased property, causing harm to the public interest or the interests of others;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Without the written consent of Party A, Party B changes the lease purpose stipulated in this contract without authorization;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
If Party B violates the provisions of this contract, fails to bear maintenance responsibilities or pay maintenance fees, resulting in
serious damage to the leased property or facilities and equipment;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
Without the written consent of Party A and the approval of relevant departments, the leased property is renovated, the structure of the
leased property is changed without authorization, or there is other destructive behavior;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
Party B has not obtained a legitimate business license or other business license;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
Party B has not obtained the approval documents for safety or fire safety acceptance after decoration;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
Party B sublets the leased property to a third party or sublets it without authorization;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)
Engaging in commercial bribery of Party A&rsquo;s staff;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)
Serious deterioration of business conditions, transfer of property, withdrawal of funds, and loss of commercial reputation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)
Party B&rsquo;s liquidation, bankruptcy, property seizure and execution, and other sharp decline in debt repayment ability may affect
the performance of obligations under this contract;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)
Other violations of laws, regulations, policies, and the provisions of this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4
Without the prior written consent of Party A, Party B shall not erect, hang, post or allow others to erect, hang, post any advertisements,
announcements, notices, signs, or other objects on the exterior walls, surroundings, and public areas of the leased property. If Party
B violates, Party A has the right to dismantle or entrust a third party to dismantle the above-mentioned objects, and the dismantling
cost shall be borne by Party B. At the same time, Party A has the right to demand that Party B pay rent equivalent to one month as a
penalty for breach of contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.5
If Party B unilaterally terminates this contract in advance, the rental deposit already paid by Party B shall not be refunded. Party
B shall also pay the rent for the decoration period before the termination of this contract, and pay Party A a penalty equivalent to
six months of rent at the end of the lease term based on the monthly rent standard. If the penalty is not sufficient to compensate for
Party A&rsquo;s losses (including but not limited to intermediary service fees (if any) paid by Party B to third parties due to the introduction,
and vacancy period losses), Party B shall also compensate Party A for its losses. Party B shall withdraw the leased property and handle
the handover procedures according to the provisions of this contract. Otherwise, Party A has the right to unilaterally reclaim the leased
property and lease it separately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.6
All costs and expenses incurred by Party A in urging Party B to pay rent or exercising any other rights under this contract (including
lawyer fees, litigation fees, preservation fees, etc.) shall be borne by Party B, and Party A has the right to recover from Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.7
Party B acknowledges and confirms that if this contract is terminated or terminated prematurely due to the breach of contract by Party
B, the losses caused by the labor, material resources, and vacant time of the leased property, such as Party A&rsquo;s re recruitment,
will exceed the breach liability agreed upon by Party B in this contract. Party B has no objection to the breach liability agreed upon
in this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.8
For the purposes of the lease agreement and these lease terms, any act, negligence, negligence, or omission of Party B&rsquo;s contractors,
employees, agents, franchisees, or invited visitors shall be deemed as an act, negligence, negligence, or omission of Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
14 Force Majeure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1
&ldquo;Force Majeure&rdquo; refers to an event that is beyond the reasonable control, unforeseeable, and unavoidable of both parties
to this contract, which hinders, affects, or delays either party from fulfilling all or part of its obligations under this contract.
This event includes but is not limited to earthquakes, typhoons, floods, fires or other natural disasters, wars or any other similar
events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2
Any delay in the execution of this contract caused by force majeure shall be deemed as an understandable delay, and neither party shall
hold each other liable for breach of contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.3
The party encountering force majeure shall notify the other party within 3 days after the occurrence of force majeure and make every
effort to avoid, eliminate or mitigate the impact of such force majeure on the performance of this contract. At the same time, within
10 days after the occurrence of a force majeure event, the other party shall be provided with a legal certificate issued by a notary
public (or other appropriate government agency) in the area where the event occurred to prove the force majeure event. The parties to
the contract shall negotiate and decide whether to terminate the contract, partially exempt the performance of the contract, or postpone
the performance of the contract based on the degree of impact of force majeure events on the performance of the contract. If they cannot
provide such proof, the other party may demand that they bear the liability for breach of contract in accordance with the provisions
of this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
15 Notification and Delivery</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1
All notices required to be issued under this contract shall be in writing, and both parties shall send written notices or other documents
to the addresses specified in this contract. The addresses of both Party A and Party B listed in this contract are the communication
addresses of both parties, and Party B&rsquo;s lease of Party A&rsquo;s leased real estate is also the communication address of Party
B. If either party changes, they shall notify the other party in writing in a timely manner. Otherwise, any notice sent by the other
party to their original address shall still be deemed delivered in accordance with the provisions of this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.2
Any document, notice or other communication shall be deemed to have been delivered on the third working day after mailing, and rejection,
inability to deliver, inaccurate address, etc. by the other party shall not affect the delivery effect, and shall be deemed to have been
successfully delivered in accordance with the agreed delivery method.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
16 Applicable Law and Dispute Resolution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1
The signing, performance, interpretation, and dispute resolution of this contract shall be governed by the laws of the People&rsquo;s
Republic of China (this contract does not apply to the provisions of Hong Kong, Macao, and Taiwan).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.2
Any disputes arising from the performance of this contract between Party A and Party B shall be first resolved through consultation.
If consultation fails, either party may file a lawsuit with the people&rsquo;s court in the location where the leased property is located.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
17 Miscellaneous</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1
The terms of this contract have been reached through consultation and negotiation between both parties and do not constitute any standard
terms of either party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2
The title of this contract is for convenience of retrieval only and does not have any explanatory or restrictive effect on the terms
of the contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.3
Any matters not covered in this contract shall be supplemented by a separate agreement signed by both parties. The supplementary agreement
is an effective part of this contract. In case of any inconsistency between the expression of the supplementary agreement and this contract,
the expression of the supplementary agreement shall prevail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.4
During the lease term, Party A has the right to temporarily close the public areas (including squares) and public facilities or parts
thereof (including but not limited to corridors, portals, windows, electric assemblies, cables and wires, water pipes, elevators, escalators,
fire prevention, security equipment, and air conditioning equipment) of the building where Jingji 100 Tower is located due to reasonable
changes and repairs, after notifying Party B in advance. Such changes and repairs shall not affect Party B&rsquo;s normal office operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.5
Party A has the right to set up advertisements and obtain benefits in the interior, exterior, and outdoor spaces of the building of Jingji
100 Tower, but such installations shall not affect the normal use of the leased property by Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.6
Party A has the right to use and obtain profits from the atrium, roof, garage, square, and communication network of Jingji 100 Tower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.7
Party A shall provide Party B with tenant water sign signs installed in the lobby of the office building. Party B is not required to
pay the first production and installation fee of such signs to Party A, but Party B shall pay the installation and production fee for
subsequent changes to such signs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.8
After the signing of this contract, if Party B needs to handle the contract filing and registration procedures with the local housing
rental authority where the leased property is located, Party A shall provide assistance, and any expenses incurred shall be borne by
Party B. Both Party A and Party B hereby confirm that in case of any conflict between this contract and the content of the demonstration
text of the real estate lease contract made by the Shenzhen Housing Lease Management Office, this contract shall prevail and both parties
shall abide by and execute it jointly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.9
Except for those that are required by law or agreed upon by both parties to be withheld and paid by Party A, Party A and Party B shall
each bear all taxes and fees that must be paid by the government department in accordance with regulations regarding the leasing or use
rights of the leased premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.10
This contract constitutes the entire agreement between Party A and Party B regarding the matters related to this contract, and supersedes
all previous oral and written agreements regarding the matters contained in this contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.11
This contract is made in six original copies, with Party A holding four copies, Party B holding one copy, and the contract registration
authority holding one copy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.12
The attachments are an integral part of this contract and have the same legal effect as this contract; If both Party A and Party B need
to add other attachments to this contract, they must be confirmed and agreed upon in writing by both parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table of contents for the annexes to this contract is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attachment
1: Qualification information materials such as business license and identity certificate of Party B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attachment
2: Schematic diagram of the location of the leased property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.14
This agreement shall come into effect from the date of signature and seal by the legal representatives or authorized representatives
of both parties, and shall terminate upon the expiration of the lease term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(NO
TEXT BELOW)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
A: Shenzhen Jingji Baina Business Management Co., Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative: Jiajun CHEN</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised
Proxy:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19<SUP>th
</SUP>Jul 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
B: Shenzhen Qianzhi Health Management Co., Ltd</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative: Liangwen WANG</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised
Proxy:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered/Filed
with:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14
<SEQUENCE>6
<FILENAME>ex10-14.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.14</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Property
Lease Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lessor
(Party A): Zhijun HU.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
Number: 420700196804270975</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
13986426569</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lessee
(Party B): Hubei Qianzhi Biotechnology Co., Ltd</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the Contract Law of the People&rsquo;s Republic of China, the Urban Real Estate Management Law of the People&rsquo;s Republic of China,
and other relevant laws and regulations, on the basis of equality, voluntariness, and mutual consultation, Party A and Party B have reached
the following agreement on the lease of the following property:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
1 Leasing Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Party A&rsquo;s property (hereinafter referred to as the &ldquo;office building&rdquo;) is located at No. 71 Fanchuan Avenue,
Ezhou Economic Development Zone, with an area of 879 m<SUP>2</SUP> (2 floors, 4-5 floors), each floor of 439.5 m2, with the frame structure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
2 Use of Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
B shall not change the purpose of the property, and shall not sublet or jointly rent for additional fees without authorization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
3 Lease Term</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
lease term starts from 1<SUP>st</SUP> May 2019 and ends on 31<SUP>st</SUP> Dec, 2025. From 1<SUP>st</SUP> May 2019 to 31<SUP>st</SUP>
Dec 2019 is the rent free period, which is the decoration and renovation period for Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
4 Rent</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rent of the office building is &yen; 21.50 yuan/m<SUP>2</SUP>, with a total amount of &yen; 226776.00 yuan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
5 Payment Methods</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
B shall pay the first year&rsquo;s rent (&yen; 226776.00) to Party A on the effective date of this contract. Starting from the second
year, Party B shall pay the rent on a monthly basis. Party B shall pay the rent for the following month (&yen; 18898.00) on the 25<SUP>th
</SUP>of each month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
6 Delivery Date</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
10 days from the effective date of this contract, Party A shall deliver the property to Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
7 Maintenance Responsibility</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the lease period, Party A shall inspect the house and its attached facilities every two months, and Party B shall actively cooperate
and not obstruct them. The daily maintenance of the house shall be borne by Party B. Party B shall be responsible for and compensate
for the losses and maintenance costs of the house and its connected equipment caused by the poor management and use of Party B. During
the lease period, Party B shall comply with the regulations of relevant local departments and assume all responsibilities and comply
with Party A&rsquo;s supervision and inspection for fire safety, three guarantees in front of the door, comprehensive management, safety,
and security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
8: Agreement on Decoration and Change of House Structure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
B shall not damage the facilities of the house at will. Unless otherwise agreed upon upon upon upon termination of the lease, Party A
has the right to request Party B to restore the house to its original condition or pay the necessary fees for the restoration project
to Party A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
9: Relevant Expenses During The Lease Period of The property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the lease period, the following fees shall be paid by Party B, and Party B shall bear the liability for breach of contract for delayed
payment:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Water and electricity bills;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Internet fees;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Gas expenses;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
Property management fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
10 Lease Term Expiration</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the lease term expires, this contract shall terminate. At that time, Party B shall return the house to Party A. If Party B requests to
continue the lease, Party B shall submit a written request to Party A one month in advance. Party A shall provide a formal written response
to the other party one month before the expiration of the contract. If Party B agrees to continue the lease, the lease contract shall
be renewed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
11 Termination of Contract Due to Party B&rsquo;s Responsibility</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Party B falls under any of the following circumstances, Party A may terminate the contract and reclaim the property, causing losses to
Party A, and Party B shall be responsible for compensation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Unauthorized subletting of leased property;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Unauthorized transfer, lending or exchange of leased property to others;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Unauthorized demolition or alteration of the structure or purpose of the leased property;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
Engaging in illegal activities using leased properties;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
Intentionally damaging the leased property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
12 Early Termination of Contract</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the lease term, if either party proposes to terminate the contract, they shall give written notice to the other party one month in advance.
After consultation between both parties, a termination contract shall be signed. This contract shall remain valid until the termination
contract is signed. If Party A is required to terminate the contract due to national construction, force majeure factors, or circumstances
specified in Article 11 of this contract, Party A shall generally notify Party B in writing one month in advance, and Party A shall not
compensate Party B for any economic losses incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
13 Breach of Contract</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the lease term, both parties must abide by the contract. If either party violates the provisions of this contract, they must pay 50%
of the monthly rent to the other party as a penalty for breach of contract. If Party B fails to pay the rent on time, Party A has the
right to pay 0.3% of the monthly rent for each day of delay. Add a late fee to Party B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
14 Force Majeure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
parties shall not be liable for any damage or loss caused to the property due to force majeure reasons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
15 Miscellaneous</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
matters not covered in this contract shall be separately agreed upon by both Party A and Party B, and a supplementary agreement shall
be signed. If there is any inconsistency between the supplementary agreement and this contract, the supplementary agreement shall prevail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
16 Contract Validity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
attachments to this contract are an integral part of this contract that cannot be separated. The text filled in the blank spaces in this
contract and its attachments shall have the same legal effect as the printed text. The matters specified in this contract, its attachments,
and supplementary agreements shall be governed by relevant laws and regulations of the People&rsquo;s Republic of China</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
17 Dispute Resolution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
disputes arising from the performance of this contract shall be resolved through consultation between Party A and Party B. When negotiation
fails, both Party A and Party B agree to submit to the Shenzhen Branch of the China International Economic and Trade Arbitration Commission
for arbitration. The arbitration award is final and binding on both parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Article
18 Number of Contracts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
contract, together with its attachments, consists of two copies, with each party holding one copy, both of which have equal legal effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(NO
TEXT BELOW)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
A (Stamped):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative or Authorised Proxy (Signed): Zhijun HU</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Signing: 19<SUP>th</SUP> May 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
B (Stamped): Hubei Qianzhi Biotechnology Co., Ltd (Contract Seal)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative or Authorised Proxy (Signed):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Signing: 19th May 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
A: Shenzhen Jingji Baina Business Management Co., Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative: Jiajun CHEN</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised
Proxy:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19<SUP>th
</SUP>Jul 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
B: Shenzhen Qianzhi Health Management Co., Ltd</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Representative: Liangwen WANG</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised
Proxy:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered/Filed
with:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>7
<FILENAME>ex23-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consent
of Independent Registered Public Accounting Firm</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the inclusion in this Registration Statement of Bowen Acquisition Corp and its wholly owned subsidiary (the &ldquo;Company&rdquo;)
on Form S-4 of our report dated March 29, 2024, with respect to our audit of the Company&rsquo;s consolidated financial statements as
of December 31, 2023 and related consolidated statements of operations, stockholders&rsquo; equity, and cash flows for the period from
February 17, 2023 (inception) to December 31, 2023, which appears in this Registration Statement on Form S-4. Our report contained an
explanatory paragraph regarding substantial doubt about the Company&rsquo;s ability to continue as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also consent to the reference to our Firm under the caption &ldquo;Experts&rdquo; in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
UHY LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
10, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>8
<FILENAME>ex23-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; width: 50%"><IMG SRC="ex23-3_001.jpg" ALT=""></TD>
  <TD STYLE="text-align: center; width: 50%"><IMG SRC="ex23-3_002.jpg" ALT=""></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianzhi
Group Holding (Cayman) Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the incorporation by reference of our report dated July 19, 2024, in the Registration Statement on Form S-4, relating
to the consolidated financial statements of Qianzhi Group Holding (Cayman) Limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also consent to the reference to our firm under the caption &ldquo;Experts&rdquo; in such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex23-3_003.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rowland
Heights, California</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
10, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>9
<FILENAME>ex99-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-2_001.jpg" ALT="" STYLE="width: 180px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
10<SUP>th</SUP>, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
of Directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Acquisition Corp (NASDAQ:BOWN)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">420
Lexington Avenue, Suite 2446</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY | 10170 | United States</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Newbridge Securities Corporation</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
is made to our opinion letter, dated January 18<SUP>th</SUP>, 2024 (the &ldquo;Newbridge Opinion&rdquo;), with respect to the fairness
from a financial point of view to the shareholders of Bowen Acquisition Corp (NASDAQ:BOWN), (&ldquo;BOWN&rdquo;) of the Merger Consideration
(as defined in the Newbridge Opinion) pursuant to the Agreement and Plan of Reorganization, dated as of January 18<SUP>th</SUP>, 2024,
by and among BOWN, Bowen Merger Sub, Shenzhen Qianzhi Biotechnology Co., Ltd (&ldquo;SQBCL&rdquo;) and Qianzhi Group Holding (Cayman)
Limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Newbridge
Securities Corporation (&ldquo;Newbridge&rdquo;) hereby consents to (i) the inclusion of the Newbridge Opinion as an annex to the proxy
statement/prospectus that is being filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) in connection with the proposed
business combination transaction involving BOWN and SQBCL, which proxy statement/prospectus forms a part of BOWN&rsquo;s and SQBCL&rsquo;s
Registration Statement on Form S-4 that is being filed with the SEC (the &ldquo;Registration Statement&rdquo;), (ii) the references to
Newbridge in the Registration Statement and (iii) the inclusion therein of related information such as (a) the summaries of and excerpts
from the Newbridge Opinion, (b) the description of certain financial analyses underlying the Newbridge Opinion and (c) certain terms
of our engagement by BOWN.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
giving such consent, Newbridge does not thereby admit that we are experts with respect to any part of such proxy statement/prospectus
within the meaning of the term &ldquo;expert&rdquo; as used in, or that we come within the category of persons whose consent is required
under, the Securities Act of 1933 or the Securities Exchange Act of 1934, each as amended, or the rules and regulations of the SEC promulgated
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Newbridge
Securities Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
  Chad D. Champion</I></FONT></TD>
  <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chad
  D. Champion</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
  Managing Director</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Head
  of Equity Capital Markets &amp; Investment Banking</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>10
<FILENAME>ex99-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Acquisition Corp has filed a Registration Statement on Form S-4 (together with any amendments or supplements thereto, the &ldquo;Registration
Statement&rdquo;). As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named
in the Registration Statement as a Director Nominee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
10, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dajun Wang</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dajun
    Wang</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>11
<FILENAME>ex99-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Acquisition Corp has filed a Registration Statement on Form S-4 (together with any amendments or supplements thereto, the &ldquo;Registration
Statement&rdquo;). As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named
in the Registration Statement as a Director Nominee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
10, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/w/
    Wei Liang</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wei
    Liang</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>12
<FILENAME>ex99-5.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.5</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Acquisition Corp has filed a Registration Statement on Form S-4 (together with any amendments or supplements thereto, the &ldquo;Registration
Statement&rdquo;). As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named
in the Registration Statement as a Director Nominee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
10, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Wen He</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wen
    He</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.6
<SEQUENCE>13
<FILENAME>ex99-6.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.6</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Acquisition Corp has filed a Registration Statement on Form S-4 (together with any amendments or supplements thereto, the &ldquo;Registration
Statement&rdquo;). As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named
in the Registration Statement as a Director Nominee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
10, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Zhenning He</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhenning
    He</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.7
<SEQUENCE>14
<FILENAME>ex99-7.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right"><B>Exhibit 99.7</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-7_001.jpg" STYLE="width: 800px" ALT=""></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-7_002.jpg" STYLE="width: 800px" ALT=""></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>15
<FILENAME>ex107.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
107</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation
of Filing Fee Tables</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
S-4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Form
Type)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bowen
Acquisition Corp</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Table
1: Newly Registered and Carry Forward Securities</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security<BR>
    Type</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security<BR>
    Class Title</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee<BR>
    Calculation<BR>
    or Carry<BR>
    Forward<BR>
    Rule</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount<BR>
    Registered<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed<BR>
    Maximum<BR>
    Offering<BR>
    Price Per<BR>
    Unit</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed<BR>
    Maximum<BR>
    Aggregate<BR>
    Offering<BR>
    Price</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee<BR>
    Rate</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount
    of<BR>
    Registration<BR>
    Fee</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Carry<BR>
    Forward<BR>
    Form<BR>
    Type</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Carry<BR>
    Forward<BR>
    File<BR>
    Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Carry<BR>
    Forward<BR>
    Initial<BR>
    Effective<BR>
    date</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing<BR>
    Fee<BR>
    Previously<BR>
    Paid in<BR>
    Connection<BR>
    with<BR>
    Unsold<BR>
    Securities<BR>
    to be<BR>
    Carried<BR>
    Forward</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees
    to Be Paid</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
    457(f) and (c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,646,377</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.68</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(3)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92,343,306.36</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0001476</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,629.87</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(4)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees
    Previously Paid</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD COLSPAN="34" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carry
    Forward Securities</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carry
    Forward Securities</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="8" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Offering Amounts</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92,343,306.36</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,629.87</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="8" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Fees Previously Paid</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="8" STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Fee Offsets</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="8" STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Fee Due</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 2.25pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,629.87</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Rule 416(a) under the Securities Act of 1933, as amended (the &ldquo;<I>Securities Act</I>&rdquo;), there are also being registered
    an indeterminable number of additional securities as may be issued resulting from stock splits, stock dividends or similar transactions.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the number of ordinary shares of Bowen Acquisition Corp, par value $0.00001 per share, issuable upon completion of the Business Combination,
    as described in the proxy statement/prospectus, in exchange for the securities of Qianzhi Group Holding (Cayman) Limited.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of Bowen
    Acquisition Corp Ordinary Shares on the Nasdaq Stock Market (&ldquo;<I>Nasdaq</I>&rdquo;) on September 4, 2024 ($10.68 per share).
    This calculation is in accordance with Rule 457(f)(1) of the Securities Act.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated
    by multiplying the proposed maximum aggregate offering price of securities to be registered by 0.0001476.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>picture1.jpg
<TEXT>
begin 644 picture1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +0!.H# 2(  A$! Q$!_\0
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M_P"&?;3_ *'OQ_\ ^%-<?XT?\,^VG_0]^/\ _P *:X_QH ]4W>QHW>QKRO\
MX9]M/^A[\?\ _A37'^-'_#/MI_T/?C__ ,*:X_QH ]4W>QHW>QKRO_AGVT_Z
M'OQ__P"%-<?XT?\ #/MI_P!#WX__ /"FN/\ &@#U3=[&C=[&O*_^&?;3_H>_
M'_\ X4UQ_C1_PS[:?]#WX_\ _"FN/\: /5-WL:-WL:\K_P"&?;3_ *'OQ_\
M^%-<?XT?\,^VG_0]^/\ _P *:X_QH ]4W>QHW>QKRO\ X9]M/^A[\?\ _A37
M'^-'_#/MI_T/?C__ ,*:X_QH ]4W>QHW>QKRO_AGVT_Z'OQ__P"%-<?XT?\
M#/MI_P!#WX__ /"FN/\ &@#U3=[&C=[&O*_^&?;3_H>_'_\ X4UQ_C1_PS[:
M?]#WX_\ _"FN/\: /5-WL:-WL:\K_P"&?;3_ *'OQ_\ ^%-<?XT?\,^VG_0]
M^/\ _P *:X_QH ]4W>QHW>QKRO\ X9]M/^A[\?\ _A37'^-'_#/MI_T/?C__
M ,*:X_QH ]4W>QHW>QKRO_AGVT_Z'OQ__P"%-<?XT?\ #/MI_P!#WX__ /"F
MN/\ &@#U3=[&C=[&O*_^&?;3_H>_'_\ X4UQ_C1_PS[:?]#WX_\ _"FN/\:
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M_P"%-<?XT?\ #/MI_P!#WX__ /"FN/\ &@#U3=[&C=[&O*_^&?;3_H>_'_\
MX4UQ_C1_PS[:?]#WX_\ _"FN/\: /5-WL:-WL:\K_P"&?;3_ *'OQ_\ ^%-<
M?XT?\,^VG_0]^/\ _P *:X_QH ]4W>QHW>QKRO\ X9]M/^A[\?\ _A37'^-'
M_#/MI_T/?C__ ,*:X_QH ]4W>QHW>QKRO_AGVT_Z'OQ__P"%-<?XT?\ #/MI
M_P!#WX__ /"FN/\ &@#U3=[&C=[&O*_^&?;3_H>_'_\ X4UQ_C1_PS[:?]#W
MX_\ _"FN/\: /5-WL:-WL:\K_P"&?;3_ *'OQ_\ ^%-<?XT?\,^VG_0]^/\
M_P *:X_QH ]4W>QHW>QKRO\ X9]M/^A[\?\ _A37'^-'_#/MI_T/?C__ ,*:
MX_QH ]4W>QHW>QKRO_AGVT_Z'OQ__P"%-<?XT?\ #/MI_P!#WX__ /"FN/\
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MWX__ /"FN/\ &@#U3=[&C=[&O*_^&?;3_H>_'_\ X4UQ_C1_PS[:?]#WX_\
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MQ_\ ^%-<?XT?\,^VG_0]^/\ _P *:X_QH ]4W>QHW>QKRO\ X9]M/^A[\?\
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M_P"&?;3_ *'OQ_\ ^%-<?XT?\,^VG_0]^/\ _P *:X_QH ]4W>QHW>QKRO\
MX9]M/^A[\?\ _A37'^-'_#/MI_T/?C__ ,*:X_QH ]4W>QHW>QKRO_AGVT_Z
M'OQ__P"%-<?XT?\ #/MI_P!#WX__ /"FN/\ &@#U3=[&C=[&O*_^&?;3_H>_
M'_\ X4UQ_C1_PS[:?]#WX_\ _"FN/\: /5-WL:-WL:\K_P"&?;3_ *'OQ_\
M^%-<?XT?\,^VG_0]^/\ _P *:X_QH ]4W>QHW>QKRO\ X9]M/^A[\?\ _A37
M'^-'_#/MI_T/?C__ ,*:X_QH ]4W>QHW>QKRO_AGVT_Z'OQ__P"%-<?XT?\
M#/MI_P!#WX__ /"FN/\ &@#U3=[&C=[&O*_^&?;3_H>_'_\ X4UQ_C1_PS[:
M?]#WX_\ _"FN/\: /5-WL:-WL:\K_P"&?;3_ *'OQ_\ ^%-<?XT?\,^VG_0]
M^/\ _P *:X_QH ]4W>QHW>QKRO\ X9]M/^A[\?\ _A37'^-'_#/MI_T/?C__
M ,*:X_QH ]4W>QI"P'7->6?\,^VG_0]^/_\ PIKC_&M?PK\(+;PGK<6I)XI\
M6ZJT:LOV75M;FNK=MPQDQL<$CL>U '>JVX CI2TG2EH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7\4-4U:3XE7UE!KFI:?:6^FV<D<%C<&)=[R7(=C@<DB-/RKG/M&M'_F:=?\
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MGBO/G%TY.+W1Z$)*<5)=0I:^8K75-9U#[7<3>)-;$C7UXFV&_=$ 6YE10%'
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M.[:% SM<;FPO4G8O7TKGHTG6GR+<WJU51CS,]XI:^:/M&J_]#+K_ /X,I/\
M&C[1JO\ T,FO^G_(2D_QKO\ [.J?S(XOK\.S/I>BOFCS]5_Z&37_ /P92?XT
M?:-5_P"ADU_/_82D_P :7]GU/YD/Z]#LSZ6W8ZT!LU\T/<:J%;_BI=?'&?\
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MUI\D6=E2JJ4.=GO-%?-'VC5/^AEU_P#\&4G^-'VC5>?^*EU__P &4G^-=_\
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ME<)Y<9"[F))&2?SKTNO,E'DDXOH>C&7-%274****DH**** ,3QO_ ,B7K_\
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M0E9GQP_Y)KJ'_7S9_P#I5%6G\*?^27^#O^P-9_\ HA*S/CA_R374/^OFS_\
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M+,%7 R>I/O0J;33N$JBDK6+&@?\ (^>$?^PD?_2>:OHOM7SIX?\ ^1[\(?\
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M-5L<@_\ 7S%1)<M*2\A)\U2+\SZ<:O,OCQ_R!?#G_88C_P#1$U>FUYE\>/\
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MJBXB(T V+VD>LD,^J_9'2.^#$@!$+>5MSEF(E*@H,_67_"G/%O/_ !-M"_\
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MJ2^LX]!^SZI,AT^R_M68R)@-^]#6QCW<L550'*A%+?9?_"F_%O\ T%M"_P#
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MI5>(_,V5C0(4SDL=VT 9]@_X4WXM_P"@MH7_ (!S_P#QVC_A3?BW_H+:$/\
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MS%!E9G894A1A3]:_\*;\6_\ 06T+_P !)_\ X[2-\&_%V/\ D+Z%_P" D_\
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MFGG5M%O[%7\LW5O)"'QG;N4C./QKQK3_ ()>+;&QMK8:QH3^3$D0;['.,A5
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MLT<E?#U9U7)+0^9?^%7^)=8UZTO-0M/LNDW5Z]Y>Z:;\91'U1K@QOL;#GR2
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M7D@VL?EE\LF;9)O,WJ=S-Z,.*Y.\\._'"31I[[3K_5[?4H)70Z=>W,#K=2O
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M (D_%*]T?4M/T;2+Z7Q''#%8122Z2(HXKS[3<F67,ICB=%MHHV!#["SH V7
MKZ2I.G- '@WP_P#B/\0O$?Q&MK?5_#MQIWA:_EFDB>6P=&M EG;L8)G8=?/D
M?9(.'PZ_P#//6OQ,^*=S#HZZ_97'A;39[*SDO-8TW2GU&XB9UNBQ\CR?W;,\
M<"LFV01@]?G##Z7,R@=\=.E*KJV,?RH ^7)_BI\;+9IB_A=VCF&(3#I<C^04
MTY97+IG)#2.'50V=\<D).<9]A^#'B;4_$6CZG_:/]J7*6NH26UKJ&J::+"2\
MA"JRR"(*O&6*YV)]W&"06/HE% 'F7CJ5(M1^(+6TB1:DOA6W;?>!/LR@-?\
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MH,RBZMI#RL"HOS#YDW;SAQL(/OOF+QS["CS%&!S^5 '@^G?$7Q[=^+-,T_\
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MZ#DX!H ]4HKRBT_:<\!7.G17\E]=V=I/+-!;RW5E(@G:*!YW"\?\\XW(SC)
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MR8#%49P _P I4Y&>&'K7.ZXT:7WQ'-J^R_&F6I=KH1FW'[N;8?F&,=<[N.E
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MLFB^8\9D49R<4 >?>+OV9+O6]+U:SL-3CA2ZO;I;837$W^B:?)9S1):QE1E
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M[62QFO+6*X>UE^_"70,4/N"<?A5'X@)))X-U58K1;Z0PD+;OG$G(XX(/Y$4
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M".*XB']G7P?; 00)?V^F,RR3Z5%=LMI<R(Q:)Y(QP2A(VXP/D3(.Q<==X_\
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M4-%GT>PT?R[R[AAU>]:1K..!+]K2*XD(Q@$QR(RY&)"F6"OFO9OA7XT;XA>
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MU66,6]V&N#G,1/E8 YQ\W/4'[HZ5#\,_L_\ P@^C?95D6W\CY!*06QN/7'%
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M%\1G.&^4\<>O2KM4-;V_V3?;\[/L\F[;UQM.<4 <9X=$2>*_"*2(]G>+X8F
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M.M3?"OXT7?C#QA<Z3J,VC2*RW;I'ILC>;9&&[,"0W 9B-\@!=<;3^[?@@9H
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M.,D9)./<TS^R+$6_D"TA$&,>4(P$(ZXQC&,G.*N44 ,CB2&-8T1411A548
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M,ZG5]!U[Q)<6$&HMI\6FP7-K>.UKYGG>;"ZR@ ,-NTN@![[3ZTNFZ7XMT?\
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M,Y=-O&6$P'/]P=>TN[QE]EDPFA?:?,'E_//L\O!SGC.[.WVZUTR-O4,.].H
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ML*!FV*QP",\;L'W5AVH KK_PF:VT ":&9@Q$F6GV[>,;>,Y^]G/M4LC>+O\
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MH_X1'0O^@+I__@+'_A2T#4U?,3^\OYU!>RI]EF^=?N-W]JH_\(CH7_0%T_\
M\!8_\*0^$=#[:-I__@*G^%&@M3DM<^'>E_$CP+HMCJ4]W:B*!62:QF$4H5X#
M%*FX@_*\<CJ>,X;(((!&+XL_9M\'^,M8.K:G]KFOELQ91-F$^4@/!7=&<X7Y
M,-E=N<KDDGT=?".A#C^Q=/ _Z](_\*7_ (1'0O\ H"Z?_P" L?\ A3NF[@DT
MK'G6E_LZ^$=)MY;:'[=):?V;_94%O-<*Z6L)6-6\K*Y#-Y,9R2=I!*[<G/7_
M  V^'>A_"WP^^C:"LL-@T[W CFEW["P VKZ* H'KQDDDDG6_X1'0O^@+I_\
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MT_\ \!8_\*-!ZGEMU^S!X.OET0R/>Q7&DR^=%=6[Q0R22&9IG=MD8&2S-C:
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MPEQ)=L)VFE?=)*[C&7.6&>@#N !FO4;=8K>WCB0JJ(H55ST Z"L__A$="_Z
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M?Y/V@H"A/[T6\0;).WDIL+$GK?\ A$=#R"-%T\'_ *](_P#"G?\ "(Z%_P!
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MS-T)D;?E\K\GS$_* .PQV0\(:%G_ ) NGC_MTC_PIW_"(Z%_T!=/_P# 6/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4GYLL"<E<U[0;:!I&<P0L[ !F,:DMCIDXY_&JNI:'9ZM+9/<Q[_L=PEU&H)
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!Q/Q!^'#^.;K3+F+5I=*GL?-56C@24.L@3((;IC8,8]:Y?_ (45?_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC(JDJ J3Q-][!W#&3Q73:CV7W&'[[S^\[[R9_P#H+:S_ .#6Y_\ CE'DS_\
M06UG_P &MS_\<KSWQ3\<-)T/1I[JRL]0O9Y=*N-5TZ1[&5+6[CBMO/W>;CY4
MVE06(&"P'4@5=T?XM:;KFIZ7IR0WFF:A=3QQM9ZK8RP3.DEM--&Z C 5A!)@
MMC[C @-@$M2O:R^X5ZMKW?WG:^3/_P!!;6?_  :W/_QRCR9_^@MK/_@UN?\
MXY7$:C\5K?1?&&L:)>6%W</;R6<%C%IL#W$]W-/!-,4V 87"P-\Q('J15G2_
MBYX9U:Q%W%=S1HQME$=Q;/'(6GG>W1=I&<B6.1&_NE&SP,T^6CV7W!>KW?WG
M7>3/_P!!;6?_  :W/_QRHOL+^>9AJ6KB8J$,G]J7.2H)(&=_3)/YUPG_  OW
MPE]BN[MI+Z.WAA2Z@DDM&47T+2I"LEN2<.IDEC7+;?OACA3FFW?QQTG3[T"\
MTS6+2Q_LV&^:XDT^7S \EY]D6'RPI)8R8P1D$$$9'-+]SV7W#_?^?WGH7DS_
M /06UG_P:W/_ ,<I/)G_ .@MK'_@UN?_ (Y7$V/QJ\.W7VMKJ+5-%BM(KJ2>
M;5;!X(XVMB!<1Y.<O'D94<'/RD\X@7XY:!+-%9I8:Z^LRRF&/18]-=KQCY32
MAM@. I168,6 ^1@<,,4/V/9"_?>?WG?>3/\ ]!;6?_!K<_\ QRD\F?\ Z"VL
M?^#6Y_\ CE<KX%^)FG_$#7-2L]-MKK[%:VEE>17TT+(DZW"R-C# ;2NS!!YS
MGTKC-'_:.T;5K+PW"MSIXU[4M;_LJZTT2OFU02S(TN2,' C5CGCYJ+4=[+[A
M_OKVN_O/7O)G_P"@MK/_ (-;G_XY1Y,__06UG_P:W/\ \<KSVX^-VF7%G!+I
M]G>K)<36#6XU.U>V2ZM+F[BM_M,+$?,B^;GG!^[D ,#5=?CG87WB*QL;*RN[
M?3[JU2ZBU'4K.6*.Y22\M[>)H>,NK^><-Q@A20%.:7[GLON'^^[O[STKR9_^
M@MK/_@UN?_CE(;><C']K:S_X-;G_ ..5PMK\<O#%Y 9@FK0PR6PN[-Y]-E3^
MT$,T<&+<8S(WFRQH%P"2X(R.:Z3PAXRL/&EI?36,5Y;26-VUA=VVH6S6\T$Z
MHCM&RGK@2)RI*GG!-6H4GLE]Q/-5CJVSTGX+S7*>--:M7O[Z[M_[.@E$=Y=R
M3A6,LH)7>QQP!T]!7M KQ7X-_P#(_:S_ -@JW_\ 1\U>U5\[C$HUI)'O85N5
M%-BT445QG6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!X=\6O\ DIB?]@>+_P!'RUYCXT\"'Q3<V5_8ZS>>'M:LX9[:
M'4+)4<^3,%$D;HX(8$HC \,K*"".0?3OBU_R4Q?^P/%_Z/EKFJ^HPJ4J$4SY
MK$MQKR:/)_\ AGG3KC08].O]?U*^GC-X6U QPK/=&YN8+AWN!M*2MNMU4C:$
M925*5I>"_@?I/@G5+N_MK^[N);E+M&C,5O#$@N$ME<(D4:*H46D>T <9;.:]
M&HKI]G&][&/M9[7/++/X"PV=AJ-@OBK5I;"_TI-$ECF@M7=;-+<0K%'(8MR+
MUDPI +LQ.<UTMQ\,].N/&UCXH:YNA>V8MQ'""OEGR8;J%<_+GD7<A//55]ZZ
MZBCV<5T$ZDGU.7_X5[8_\)P?%/VBY^VF:&8PY7RLQVT]NHZ9P5N')YZ@=L@Y
M=C\&=%L=4\.7WGWDKZ))>21QLZB.X-Q+++^]4*-WEM,Y3&,9[UWE>-M<1:CJ
M/C+7]=\7:EX<N= \0)96Z6]W)]GM;<"'R4>V7Y)OM D))968^8 I&T8F247L
M7%RDMS2T/]GG0_#>GW=GI^H75K%):BR@\NULU,,(D5]CXA'VC.Q4/G;\J"#R
M23-8_ 31M-L+*SM]1OH;:W1%>&)(8XY-E^M\I"K&!&!*I 5 JA6QC(!H\/?$
MK5]0\56$=V=(.E:IJ&H:=!I]OO&H6)M/-S).2Y5@WE?,-J[#)'RV>?1+Z7;I
M]VT;\K$Y# ]"%)I*--JZ0Y2J)V;.3UCX2Z+K]O?6VH/<7-K>/J;SP[E /VX@
MRC..-I'R^G?-4_"'P9TOP?KNG:Q#>3W%]9RO*NVUMK:)]T)BP8X(D7H6;(&2
MQY. !6%H_BC6[GX0_"^\L]9@&IW\^C1W]S= S-,DNP2!L,#EB<$YYS47@7Q]
MKGB[XA>&9KN_TM-*U70]1U"+1[)G%S:E+BU15N,N0[J&8%@J;6+K@]:F\+K0
MKEG9ZG;>!/AS9_#ZZ>33[Z[FBDL[>U>"XV%286D*29"A@V)6!&<=#C/-0Q_"
MO2U\)Z'X>DN+J?3])U(:G&LA7]ZWF2N8W&,;3YS#C!P!7945OR1[&'/*][GG
M=K\%;&.WLH+S7-6U2+3X[6WL%NFA_P!%@@N(IUC&V-=VXP1*SMEBJ 9!R3';
M_ ^QAN=/:77]8O+73((+73[.X:(QVT,5U!<H@(C#-\UO&I9R6*@<YYKTBBI]
MG'L5[2?<\T\4?"&.X\,Z5!I<\SZEH>GK9::TTZQ8*W%M,LN_RV"R*;9=I*E<
ML=RD&M;X4^%=8\,:7K,NOWAO-5U?5IM4DWRK*8@\<,2H62.-3@0C[J*!N &<
M9KM:*/9Q4N9"]I+EY6=7\&_^1^UG_L%6_P#Z/FKVJO%?@W_R/VL_]@JW_P#1
M\U>U5\WC/X\OZZ'T&$_@Q%HHHKB.P**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@?\ 00US_P &<G^-'_"B= _Z"&N?^#.3_&C^T:79A]0J=SS*EKTS_A1.@_\
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M^8X_\B5!_97Q3_Z&/PU_X+)?_CE>D[:-M'MW_+'[A?5U_,_O9YK_ &7\4_\
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M+2/_  2'_P"/5Z#12]O/LON7^0?5U_,_O?\ F>??\(]\1?\ H<M(_P#!(?\
MX]1_PCWQ%_Z'+2/_  2'_P"/5Z#11[>?9?<O\@^KK^9_>_\ ,\^_X1[XB_\
M0Y:1_P""0_\ QZD_X1[XB_\ 0Y:1_P""0_\ QZO0J*/;S[+[E_D'U>/\S^]_
MYGFK>$_B0W_,_6 _[@:?_%TG_"(_$C_H?K'_ ,$:?_%UZ72T_K$^R_\  5_D
M+ZM%[M_>_P#,\YA\)_$  ^=X[MF;/'EZ+&!C\7J3_A%?'?\ T/47_@GB_P#B
MJ]!HI>WGV7_@,?\ (?U:'=_>_P#,\^_X17QW_P!#U'_X)XO_ (JC_A%?'?\
MT/4?_@GB_P#BJ]!HH]O/LO\ P&/^0?5H]W][_P SS[_A%?'?_0]1_P#@GB_^
M*H_X17QW_P!#U'_X)XO_ (JO0:*/;S[+_P !C_D'U:/=_>_\SS[_ (17QW_T
M/4?_ ()XO_BJCF\'^/)L8^(/DX_YYZ-#S^9->BT4_;S[+_P&/^0OJT.[_P#
MG_F>:_\ "$^/?^BD2?\ @FM_\*5?!/CS<,_$B3'?&C6V?Y5Z315?69]E_P"
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MD*LH R/F IVF_M4>&M85S:6&J'_1(Y88Y!&LLURS0J;39OW+('N8DW'Y"WF
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MSZA<$_\ H=>BT4OK%;^=_>'U:C_(ON/-O^&?? O_ $"I_P#P.G_^+IR?L_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E%9'BS4I]&\,:OJ%
ML%,]I9S7$8D&5W*A89 [9%&^B%MJ:]%> VOQ,\<36L,AU;1P7C5B!I#XY /_
M #\5)_PLCQO_ -!?2/\ P4/_ /)%>A]1K=CB^NT>Y[U17@O_  LCQO\ ]!?2
M/_!0_P#\D4?\+(\;_P#07TC_ ,%#_P#R11]1K]@^NT>_X'O5%>"_\+(\;_\
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M "11]1K=OQ%]=H]_P/5_A]X53P-X/TK08[EKM+& 1><R!-QR2<*.%4$D!1P
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-%>.:9\7-1TG2;DZNR:G>Z6^KVCS++%:07S6MY;P1R.6!",1.-P0XR' 1CM
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7\R#V-3^5DOF-W8FL'Q!X&T#Q5?6EYJ^DV^H75JNV*2;.0NX,%8 @.NX!MK
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME'V6;_H+:Q_X-KG_ ..5-11[.'\J#VD_YF0K:3%U!U76#S_T%KG_ ..5[/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY(DMS:QJ=LK)M\L-DY*J$4!>@ P!CBN9_P"%[77_ $*5W_X&P?XT?\+VNO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?]"M)_X,+?\ ^*KZ#_STH_STH^OUO(/J5+S/GY/!WC)'4GPM)C.?^0A;^O\
MO5ZQ\*]#O?#/P[T#2]1B6&^M;54FC5PX5N21N'!Z]:ZG;ZTM<];$3KI*?0WI
M8>%%MQ%HHHKF.D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH ***K7]]#IMK)<W,GE0Q@%FP3U..WN:>X%FBL/_ (2[
M3?\ GI<?^ DW_P 31_PEVG?\]+C_ ,!)?_B:+/L3S+N;E%8?_"7:=_STN/\
MP$E_^)H_X2[3O^>EQ_X"2_\ Q-%GV#F1N45A_P#"7:=_STN/_ 27_P")H_X2
M[3O^>EQ_X"2__$T6?8.9&Y16'_PEVG?\]+C_ ,!)?_B:/^$NT[_GI<?^ DO_
M ,319]@YD;E%8?\ PE^F_P#/2X_\!)O_ (BC_A++)N(DO9SW$=E*<?7Y:+/L
M',C<HK%_X2F#_GSU+_P F_\ B:/^$I@_Y\]2_P# ";_XFBS'S(VJ*Q?^$I@_
MY\]2_P# ";_XFC_A*8/^?/4O_ ";_P")HLPYD;5%8O\ PE,'_/GJ7_@!-_\
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M  E,'_/GJ7_@!-_\32_\)3!_SYZE_P" $W_Q-*S+NC:HK%_X2F#_ )\]2_\
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M+IO_ (FBS#F1OT5E:/K\&LS7$445U#)!MWK=6[Q'# X(# 9'!K5I#3N%%%%
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MLCU-?CIX248\S6/_  0W_P#\8I?^%[>$_P#GIK'_ ((;_P#^,5Y711_9M/\
MF8?7ZG9'JG_"]O"?_/36/_!#?_\ QBF3?'OPA!&TDD^J11J,M))H=\JJ/4DP
MX ]S7EU9/BS_ )%?5?\ KV?^5)Y=32OS,:Q]1NUD?5*L2I-/IHIU>">X%4=<
MUBU\/Z3>:G?2>396<+W$\@5FV1HI9CA02< '@ DU>KDOBY_R2OQA_P!@BZ_]
M%-3BKM(F3LFS*_X7KX3'!?6 1P0=!O\ _P",T?\ "]O"?_/36/\ P0W_ /\
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MIV1ZDOQR\)*?];K'_@AO_P#XQ3O^%[>$_P#GIK'_ ((;_P#^,5Y711_9M/\
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M$,J;M10-X>*[M(&;P VN"8!G_6@<K_M 5[.7;S/)Q_V#K%974LK*R@[2RD$
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEJ:Q3/"[M9;9895.61T=0Z."<D, >0>];;6<#*J-;Q%5&U08UX&0< =N0#^
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M>M&??]:Z[_A2_B?_ *#ND?\ @#+_ /':/^%,>*/^@[I'_@#+_P#':/KU#O\
M@'U.MV_$XIK*V>>29K>%II(_*>4QKO=/[A;&2OMTJ6-5B54151%&%50  !T
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M#+_\=H_X4OXG_P"@[I'_ ( R_P#QVO4^O4._X'F_4ZW;\3D:,UUW_"E_$_\
MT'=(_P# &7_X[1_PI?Q/_P!!W2/_  !E_P#CM/Z]0_F_ 7U*MV_$Y'BEW5UO
M_"E_$_\ T'=(_P# &7_X[1_PI?Q/_P!!W2/_  !E_P#CM'UZAW_ /J5;M^)R
M/XT XQSTZ>U==_PI?Q/_ -!W2/\ P!E_^.T?\*7\3_\ 0=TC_P  9?\ X[2^
MO4-K_@'U.MV_$X]41555555?NJ  %^E.SUKKO^%+^)_^@[I'_@#+_P#':/\
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MO4^O4.[^X\WZC6_IG$4E=Q_PHK4?^AO?_P %L?\ \51_PHK4?^AO?_P6Q_\
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MMC_^*H_X45J/_0WR?^"V/_XJCZ_0[O[A?4:W],X>E5BN<''T.*[?_A16H_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
IHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>forms-4_014.jpg
<TEXT>
begin 644 forms-4_014.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '" R # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^#^BBBOV@
M\\**** %1]HPV1GGCD G[P]@#SGW]JF/5?K_ $-04!P@Y!/)V\]!CIC\ZRFF
MFWT;5M?+M\AQ5Y+[_NM<G[CZ'^:T$@ D] ,T@96/!!(!_+C/]*K2L?F.1PVT
M#!^;&<#KUR3@XQD9/M!T).6BZ+]?^".,F]R,YVGYL]=^"/0=@P '&!ZGA::%
M )(SDG)Y/)YY/OR>F!S]*:C%ESD>AX_^O[_UK9>[%7_#7NS>S>BWL_(>O0?0
M?RI:!P /2D/3ZD#\"0#6/]?G_F=  %C@#IR >,X_E@D'D<\5+&<KD=S_ (4X
M( <\YQCK[@_T%(@ 7 Z;F_1B/Z5QSJ<_S2_SZ^NKW;,*CYXV5]&GKHMF/HHH
MK,YVFG9A1117))N,5:VMEKZ?+L=$5S.UVM&]+>7=/N%%%%9MMN[W_P C:,>5
M6NWJWK;KZ6"BBBD,*#P"?2D) ZFGJBNNXD\Y[D#&2!Q]*F4DFTT_EY_,!45@
MV2 !@CKGJ1[>U2T45B Y#@D=^3]1A1P>><C&/>I3D@C YXZG_"H,X9><$L!]
M02,CZ5.>AQUP<4$N$6[M.^G5K;;K86D+ 9SGCD\'L,_RIA)&,L<9Q]TCU[XR
M.G4 XJ,G=USU..HST&<<>@(J7)+S]+-_F;*#O[VWD^OGIMO^ YG#8QGC/4$>
ME-I,#W_$D_S-+63=VWKTW]/F6DHZ*]M]>X4444AA1110 4444 %'=?\ >7_T
M(4A('4TJD,ZJ.23TY&2 2.WJ!0!8I,CU'YT[:_\ ='_?7_UJ>B\$$ $'T!Z@
M-^.<_ETQ4N276_I9_J!%D>H_,4H#$94 @]\XZ''I[5-M_P!W_OG_ .O1D#@G
MD] !_(<X_P <U#F[Z6MYK_@@1;7_ +H_[Z_^M1M?^Z/^^O\ ZU2EE7&2!GIF
MD\Q/[PHYY>7W?\$"/:_H/^^O_K4]%8%B0!D #!STS_C09$[$GZ G'UI#(.P;
M\B/PSVSTSVZUE*:YG=.^EVEILK=0):8WW9/HW_H./YU&6)& "H/7)R3[#DX]
MSU]/4, &3P.",<=.!5%PW?I^J'4444&H444@^9@,GG.0%]#_ 'OIU/8YIJ3C
ML H ).6V@8Z#.2<Y_+';UYIXV@<,225Y(/8\<?CVZU-&53(R%&%P/Q;/\ZE&
M" 021ZY)S@_EU'I3D^9);/5.WGI=$RDE=:W_ ,T5L@]&)_#_ .QIP_\ U9X/
MX].^>PJ<JK8R <=,TGEI_=%81I6WG)^J2M]R_0RO_7](BHJ1D4*Q P0">/8<
M9J,9/16P>AQQCUZYI^S[2:U[-]NTHK\/^"@J-HQR03DY(YXR>>G3&:DY[@CT
MSWQU_F**T5"7_/Q_)/\ 63 KD,OWAC/IEOSP./;\:3(]_P C_A4Y95QD@9Z9
MI/,3^\*I4TE9SU7>WZZ@0Y'O^1_PI-RY'/1ESP>S#/:K 96S@@XZXIK.N&&0
M3AACGKR,?TH<4MI)]UIM\@$PLA;[K#"CG)(Y;.,8P"#S^''%'DQCHH!['G(/
MKUQ^'2H=N#CCH>HSTQZGW]:7&,'Y>HZ+CJ<>OXT*35EI;T\]>I2BVKJUO7M_
MPPK!E.& P<_-GDXQSC'')Z9R">.].\S:/GX!(VG'49SVSV&<]R::  5P!]X=
MAW./Y$U(QC;*DC.<8)/7D?ID\=*UC42>FFG71;^NY+3::2O=-=?/_,?N& 1R
M#WY^GIU^N/YX4$'H:8NU2@W\;@,#T)YQUP>X/7J!U-.89.[)(&=I[E><9.>N
M,'L <\57ME>W+K=+F3?6VROTO^&S,7"23;MHK[]OD.HIN]?7]#_A1O7U_0_X
M5MS1[K^OD2.HI 0>AS2T[WLUKJOP:_R ****VC)2=DFNNOW=V 5 \6[.1OR>
M ?E"@= ,<GJ1V]3FIZ*H"CY0."AV9'/5LYQCJ>,?UIG0D<\,PZ''4XYZ<_6K
M3H%QAF&<]M_3'Y?U_"F;01R,@D\9.#SZ9X]<=C51:BVW?56T];]T!#13S'R
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MXL3_ $%,9G;OCL0O.X<Y!)Q@'.,]OQ-+2'@'Z&IYY=U]W_!!:M+NTOOT_4,
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MX/O@^N/4=CR/8]J0@$8/2FI.*M=67ETO=ZW\V C(K8W#.,XY(Z_0CTJ+8XR
M!C)Q\W;/'8]!4W0X]<X]>,<>_K[?R6NNE*,E>/7?Y/\ SW KD%?O#&>F.>GT
M''6BK%,,:G)Q@GG(X/YU5_>DGLDF!$1G@T@Z?GCZ9X_3\?6I!&O'WN<G[Q[$
M8_/.::8W'0Y'8#&<?4\<#UZUT8>HI1;N][>6C:^_2U_EKHP$I,#K@9]<4$..
MV<YZE1TQW!QWHRPY*@ =2&4X[=!SU-=*::NM@ \%3@D C..?XE/\@:L Y (Z
M$ _G5;>OK^A_PH5@I4\Y &1DX/R_D.N?PYQUIF<TM'U?Z(M44@((!'0C-!./
M7\.M3)1LVTMG=V5UYWMT,Q:*3)]#^G^-&3Z']/\ &LHSA%NT]]-6O^ .W]77
M^8M(>J_7^AHR?0_I_C0,D@ >O7'H?0GZ=*?-3D[7C=Z77+>[[/>Y+6C]'U7;
MU,BBBBNXX HHHH *:S!<9SR<<>O/^%*<\ '&3UZ]B?Z5#)D[0&SU.<#M@?\
MLQH&HRDM+6U6KM^C[C1G R2>AQVSCK^7K2=\=L@G';.02/<@ ?J>,T8Z#G&#
MWQTP.WUI<8Z?J2?YFLZC5G&SOIKI;O\ UH=#ZOO_ )DQ<  G/S#(P,GMU].H
MJ *<84#)7GMTP,Y]<FGDYQD ;01G.>./8>@Y_3FB,C+D_P (&/QY/IUP.M3.
M::6Z2=W>W3MKOV1JI*3LKD@55;(&,;3QZ!LG^7Z5:!##(Z'/7CH<57 ]>I S
M_G_"E&<@;B 2<@'&."3[CGGK7G2=Y-]WIZ%,L444UR0I(ZY ]>I _K4RDHJ[
MOJ[:?UY .JOG.,9X+]?]I\C^7/I1O?\ O#\$)_E33D D$8Y/(]>>N?7I6<I*
M22MUZ^A,DVE8>" 03T'MGGH,?G4V1D\=>_8GIC],?_K&8XP#DG.0=HZC PIX
M_'OW'M3\<GT!]\]CUSZ_CUP1FLI)M67=/>W0FG)Q>GG?_#V\]MAU%%-)X.,]
M#V/7ZXQ6)V?U_7X$D8.=V.,, <\YR.WX&IJ0 *,#H,]>>IS2U@VI-M+=+??8
M HHHI %1.V RC(;C;@<>IR>Q/3\R<Y #F;;C&"<XQG&."?0^E1DDDD\9[=?U
MX_D*RE)26SWOK_3-(QDG=VM9];]O(:-Q&6^]C!YSTZ= /KT[]32K\K9'\1 /
MOG"_I@$?CZT4@/*_[R_C\V/T(_3TJ#0LT44G.3TX..F>P/J/6@4I**N[[VT_
MI 3C_.?Y49'O^1_PHP>,D<>@Q[>I]:#T_$?J1F@R<Y.]M%T36NWJ(%&!D#.!
MG@4J@GA1D_,>N!@-C^HIR(&!)+<' Y([ ]_K4BH%.1GH1R<]3D_J*CVD?[S^
M7_!*A!Q=VDM+:6\O)=AJQ@CYQD\\=AZ?4^_N:D "C X _J?\3T_*ER!U.*B=
MP-P!R0/7L5],8[YW?AC'-9M\S;MO:R=NUO,TL/+ #)X^N0/Y?Y_+,;.ISA23
MC&X-QD@8.",G&?QQQ3/F[L#W^Z!SR.V.Q- '7W__ %?TI&L8M/6VP8]22/0X
MQG\ /4T  $8 ^\OM_$*6@<LH'=A]..>O3J!W_K4RE%73OL^G2S+)LM_=_P#'
MA2#G)*YY]CTX_I3Q$Q/)('KNS_05((U&.22#GKU.<\BN5U.R^]6_)D*4(W:3
MO\_7N0@;NBXQZKD\^PZ?U_"E$;9&0H&1D@88 'G ]>./458 Q_\ K)_G2U+G
M)WVLU:UO*WKU$ZDM;:+SU>WJ1",'J6/_ ([_ (9_I^-."*,>QSG)]<^O_P"N
MGT5-EV7W+_(AMO=_E_D%%%%%EV7W+_(0C< GTP3] <G]*@4LH !  [$9Z\GG
M/K4S_=;_ '3_ "J =_8_T!_K19=E]R-(-:KOKY:)(=N?^\/^^?\ Z]2H25!/
M7)'IT)']*@SD[5^\<X_#&>OIG/X$5.H &!T!/?/<YR?KGZ=.<9)9=E]R_P C
M2R[+[E_D.HHHH 3H<XSP.F.V?4CUHR?0_I_C2T4679?<O\B7!-W=]?-B9/H?
MT_QI >O!Y/MV ![^HIU)@]B._4>O/J*.;DU26NFWSZ6[$N%E[NKZWD]ON[B'
MDCC'!Z@'T]#V_K1M_P!WJ#PN#P?K2X.<D_D,=<>Y]*6DZS?S[)>G5W+C=12>
MEK^?5B8'H/R%& ,$ 9!!''H<_K2T4E)2VN,>)%'7CIQT&>^,]>W2I P..1SC
M'([]*@I,8((P"#G./Y]/YU1$H7;=W=^G8LU&T8.XC.3GOQDY[?6FB0C.[VQA
M2?7.>?I4JG<H/3(SZ4K>2^Y&;BUO]Z9 .0#ZT$9!!Z'@U)Y2^K?]]&F%  QR
M_ )&<XXZ=SD?@/?T.W.NS^Y?YL1"R'(VCUSDX],>OO48X)!X()X^I/-6:C9
MV>2#SCGH3_3/)'M6L6DW?M^I<6DW?K_F1T4W!5L$GOUYZ$8(X[@Y_P#U4ZM4
M[JZ-$[JZ"FXQR.H)(^I_R/KC'0FG44P:NGYK7S_KIV+$<H8X.=W3IZXP.<=\
M@$]<C)JP*S2O(()!_G[=>GMZ59B<LH[X!!.XYR,]NAZ<CH/4XYTC))):WVV[
MO3\SEG2<;M)<O377:[TMWOUU+-%%%:&0UE#8SGC/0XZX_P *KM$ 22@QN/.>
M>3P<?CS^GI5JD8!A@]#CIQT.::T:?F@*OEI_=%/ P,#H.!2LH4C!/(.<G/3&
M/YFDK=2:U75=5?S[@,=-Y'S$8ST]\?X5"1P1GH2,^NTX_7%6:A=0N&&>6.>I
M'()Z?6JYY=U]RZ?,"/;CH3^ 7_"D#9XP2<9Z8X.,=<#.",CUS3L9P?Z<\>GI
MZ,._3M2KC<HRI&6.,#(X8\GN ?Z5K2K5+N[3T[+OY )D=^/KC_&C(]1^8J<
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MQTRS@NW?35A2/Q+JFDZ9?BW:^LHDMKSSY+J-Y6^1M>^*?C+Q)X#MO 'B._\
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M_04N1ZC\Q2<'OCDCJ1G'''(_2IG6A32<KI-VVMK:_EV'%<SM=;7UO^FH;O\
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MG**?X/TY8I'CDE1&,<.SS64<)YCM'&#Z;W!52.IXSFOV:/\ P0!_X*@ @_\
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MGO4Q7D8)&3T!X'!/'Y4%>W?/.,^L]+;7??5=.WIT*)7:2O'.0,=@"0<\#/7
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M,RZ9X;TT2Q2ZWJZ1X:2"&2"STY'BN-7OM-@EAED^?/%OQ TWP:CC65&L>)@
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M;Q;\=?&7@CQY\;9(/BQ\>M?\-Z9XT\1:'\,-2TW4O@!JWA.V@\*^*_AMX/\
M'UEJ>ES^"Y?$$$^@^._&Y\/^';V^M8=._P"$>2*QN?[;UFUGO5] _8>\?_$/
M7?&.O^ /B5\3_%^I'P1X USQYJ<GB.Z\*ZCX9_LW7O&EQ9V5[+XF?P]H_C.V
MOO#MO*]S<QWU]-H\-M'Y%A!;V-G8PKT/Q'_9#^(=WX<^,OB'X<_LXV?AS6_B
M+XQ\(?#WP#X(\+ZOX.TB]\'_  O^%OQ!LO&VM_%/QMJDOB/2!XA\6?&7Q#I'
MVJR&D>*8=5LO#EAX4M=4O[.;[3-9='^R[^SY^T1X-^./C;7?%OPSUWP;X?\
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MJWA7P#XXT/Q-^T+\'/!GB3PC\3OA]X)^)_@G7_#7B[XB>&_#WB'2]9\(>/\
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MMG>6HN[E(*AMMWO=Z=NEK??^-B_:58P@T[N7)?1=:4IV26BNU?T7J>+>+O\
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MTUU=WU\V1D@=2!]:159B,!@2!\Q''3KG!ZCZ9X'TE1.I;:W0=.F,YZC/.?\
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MP<J&.R-9EBL?@LRQ\:..AEN+Q^88_&8_,'#+)9CC9T\NGB)4*TZD)NAA'1A
M,5Q]F69</8S(<QP&55Y8W$JKA\XA@J&7XC X>,\!_:6$R_ 8#!9?E])9HLNP
M,:N.H895:<:$H_6,5[1RC2<@YQD8.,DY.<[,Y.#@9)7.>F0>*<#D#)W84*">
MNU0  ?3 XQSCUYIDHC"HB[GV;A)(S 1.H8O%L&Q''!979RTF649Q@B:6/9),
M)HIK5MJ206[PS!BLCLK%S<,CJJ*"P<J0Q!4'Y0*_1I.+DTG%MJ<U%N$)249.
M4Y4Z3ES2LG[2<:4:G)SROTO\+5IJ:E/G:BKN3BG*%)2G+V5.=2R;DTU3A-J\
M^572L+;PO+-'#$T"M)O :XEBAB&$9OGEE*HOS!2A)!+[47E@#]S?\$S?B9X$
M^#O_  4$_9"^)7Q+U^T\+?#_ ,)_&[PO-XJ\3ZG)';Z9X=TO4H[W0WUO6;B2
M1(;#1M+N-5@O=8U*5Q!I^F0WFH2DQ6DH'PO##<3M(L-O<7)CC>XE$-O-<"&W
MB1I99IA!')Y4,2*TCS2!8TC5G=@JDJHPRI@ DA5P!G(.T*HQC<IP  <D[@#G
M=7G9E@Z>8X''X*M54,/C<'B<#7DY4U[.&*H5*%3EA5E3=2I!3M*"6EVKNYI@
M,;5P>*PF)A%NMA<5A<91A*+<9SPF)HXFDU5CS4W&4J2O.G*?)HJOLY2BG_KO
MVEMI.I6=KJ&F:MI&JZ??01WEAJ6FZIINH:=?V5RBS6UY8WMG=36MU:743K-:
MW$$SPW$#)-"\D3H[61H\)&?.M>?^FUMV./\ GM[5_D96^L^(8K,BV\0ZU96M
MFL:+;0Z]?VD<$;;PD-M8+J,2A%( 6*&- JL2,*@ E7Q%XE 7=XE\2#J"/^$A
MUM2".Q_T]<'/&TC(;C)YK^>9> -%WE'B6A)/5>TRQJ48I*-.'-'%4HR3A"'L
M[1<I)2N[I-_MZ\9ZZBF\BYUS23J1S&I**?,YS<O9QDH)5*D^9:\G,D^Z_P!<
M@Z-$!GS;;Z>=;#/L,S ?F11_8T7_ #VM?IYUN3].)CD_2O\ (V/B7Q",$^)_
M$B@G:I;Q'K(^8CI\U_C(Y[$?SJ!_%/B!7*-XL\0ID84-XEUA3)(S >6!]OQS
MNY(SUQWP<WX!)*_^L5'3?FRC$0@E;_G[4QD:3;=DH1FYN]TFE)H7C/5DM,DO
MYT\QJR3V^UR<KWOHV[*]FD?ZZ']CPXSYUKCCI/;'DYR,K,1E>-P_A) /.0$&
MD0Y \VV/(_Y:V^/UE_I^=?Y'5QX@\7?:3%)XH\2W$Y:*/(\0:M(YX18D58[X
M[]JNJ@*-YW#'7#0W'B7Q'&\<)\0^)8)8$$5T6\1ZXQ:X61M\C!KF,0$92)HF
M3AE) ).3G_Q >G9_\9'1TOS+^R*Z:=](OEQL_?EO%+?1WO8;\9:BU>3))MJ/
M-FSBY)=5&5.+MVUUUL?ZYW]CP9P+BT)'4>?9_P!6 I/[(@!P;BTS[SV>/QP_
M\L5_D9GQ-K_E*/\ A(_$WFB1F9_^$EUDJ\17=&H3[8N, ,2P)X5AG@D,_P"$
ME\1XS_PDWB0*3@$^(=:YZY&?MX!/4D ],Y![1_Q :FM?[=2CUD\KQ44DKN4G
MS8R,E&,5*<GRW44W9O1G_$9IM763IKI;-D[O39*+>B=WI:R>M[(_UT3H\6.;
MFSQVQ/:=_P#>D(Y_.D_L:+&?.MB/436>/SWX^O.!WK_(RB\3^(G9HQXF\2D+
M@G_BHM;#*3NX8?;QPP!()&3CCH:E/B'Q+N4+XE\2?>(.[Q'K><  DC_3\=\#
M..?4=)7@10DKQX@I.+5TXY?6E%KHTXY@U9[KJKZI.Z6C\8:Z;3R22DG:2EF-
M5.,M+Q:E13NKKRU5FUJ?ZXW]D0_\][7_ ,"+#_XY7YJ_\%>_B1\-?A%_P3G_
M &KI?'?C#0-"O_'?PC\0_#KP)HUQJ>G?V[XQ\:>,9;/0]'T7PYHZ7+:AJ\\4
MM^=0U5["VDATG1;2_P!7U"2WL[*>5?\ -E'B/Q&?^9F\2Y]/^$AUK.?I]NS^
M54;R^O\ 4FB;4=2U'4FA#K VHW][?F 2;?,6$W<\WD^9M4/MQNV@'(X/;EO@
MCA\%F&!QM3/%5A@\9A<6Z,,OE'VOU:O"LJ<I5<75BDW!.ZCS<R6J5SEQOBWB
M<3@\5AJ>4.G/$8>K052685)**K0E3DW'V:YK1D]'HW:Y1.43! .Q$##((R<9
M(QR< $D\XZXQFK0.5[DD $XXR%"^O;&#VSG'%5^5(9.'#+M;&%5D(9?QRH]?
MFZ]P;]S,LTJSB66>2XVS74CP+;@W,Q+2K&B8#1C():,+L?((V9K]U<K+WKW=
M^M^LK6;V27*DNFJ6B/R*G!<D;WT5K+1*S;ML[I<UKZ76MEL1$>P/X _S(_G^
M'HF2.FT=>.A(! )P#T!.,_7T-*6 ]3V__6> /?\ PJ2.4I'-#LC=+F6W:1C#
M&\\8B,@"PS,-\4; [I51U$A*[NBFN><I1Y5&UY24;-]'>^E_+M8V_K7_ (<$
MMY9HIY5$6RT6.2=Y)8HPJ331P+L21A),QDF7,<*2.$#N5VJ34:.@,2O"JE4)
M^0AP_FE2TDR'<KJL7RHT.%#*'^;)=K=LUY:F'4X(PGV:XMBLSI#,C3K_ *3"
M3!.I+K((098VMS;L!L:1@=IG>6\U"]U#5);>*[E\^74]1"VT26$<MU<KYC3V
MT,444</G73*L-LBQIO0+&B!MN,G*\D_@2;:3L^:S<K=M;\NNBM:U@;N-@DME
MANH9+5I[F=+9+*X69XEM?+G65R\&PQW*3P(4C60>6GWT.0<50HVIG:)"/G4!
M0RE<JI8Y9L<+G.,EOE4+MJ[*WV^XB&GZ;;VI%I$@M;.26=FF@A#7-X[.Y:2>
M9G:6Y",L496- N%%16L<]P8X8K=;AF98D2&!II5:Z9D0;$!EGN&=!Y$8\TC:
MX R%KFA54+S47>UHJ=1RLW;IWM=75]+KJ"3>R;MJ[=%U>Y69-P92.P'.1GD<
M9&#C (R.>1D<9I[NA9MJA%SG8"S[>A W,2V3RV23@G ( !J*1]DCHC,P1BH+
M(REBO!)5@KJ202R.NY&! XP @PQ.X9)QR$.>/O<'J2!\OOP??6<O9VKOE]]?
M!TBTK-Z]WJ^E^]ANZ>NG];_K^ C,^?E.!V')/X\'TX_&DQR&;&2&.X ;LKT#
M%MH"GA3DC@^F*D5&7.S8!QG>QR>H  X!P=W ^;IGOA"N\[NGRMD?=))7:<A@
M2!T'S#& 200U<=;&RDN11BFG?FBEKI:U]'U["?\ 7?YNY9O+5K9H8)[._L[M
M4+W,=Y"T#^7,L4UDT4+Q)*BO;,D@9_E:.10H(R:;!%%/<V\,UQ;V0N)X8I+V
MX6;[-:)*P!N[@01S3B"!,O+Y4$LQ"MY<<C8!)GEGD\VZDN;B95B7?<S2R3-!
M%&(XE4S/)+L6-52/YO+"JJH%P!2 P@Q&-IE=HR9XY$C01RF281")PS-+$T2*
M[F0*RRLJH57).,<5.,.7EB])*[6OO7_*Y:FE&VO7OUOYB%0#B,H54LN<N=V&
M)210QW*KC#+\JDH0& .0$ Z*<D[AR22<9S][';)'M5@E5!(YP ,#VP .._UR
M0.>E/D>V6VMMC7'VUGG-UO$/V,1%HQ;1VY#"8W)S(9UD!5!Y6S@D5SJ4N:-Y
M-W?6R2=F[O\ *Y!%Y:GINZ \L1UZ>M-*J#@L ?=R<?48R?7 !)[ FK\=O;&P
MN[M]0B@N8+BTBMM-:WNI)[Z"?SS=W4=VD7V&%-/,<6^"61))UN1Y3%HW*TBA
MDQM4[V.P!59G9RP1 J[0V2>%7;NR0.3\QV>)DV[+;1)Q6K6FO6S?5=&VET':
MUGI:_P ]_P#@$)!.]5+8 ==X4L%()7<W!7"R@\L 6:)TPN6-37$D4TH>WMOL
MD9AMXWB\Z>X#S1(!/<^9,2R&[F G=%^6#'E1%H^:V=7UC5M6.FV^JR1;M!T:
MT\,VL<6GV>G,FGZ1+<"UBNTM((#>7,+W$PDO+P2WTAPD\[B-57&W$,@'.3C&
M#\P4J, #+$9SD@$X/ .0*Z(XJI)1E-1C.*Y4H[<M[Z:+6]M-+?(J4E):7NG?
M^M2A<KB+H1P3SUZX'8=<G\/KS]!:7]P_]='_ /1AKP^73+B?2-2U9;G3EM]-
MN;.TD@GU""+5)WU%;DQ2V6F.RW>H6=JUG,;R[@C6&U$T G:(21E_;M(.ZWB8
MD%F&YR!@%V;)*CL#U&,@@@CCD\^-Q"KQH)*3G2Q'OII+1T]+6>ME9MZ:79\#
MQW_N6$_Z_P!3_P!(E^ATT!Y0]@\JGUR7;GZ<<]_:OL[_ ()\,R?MS?LD,"/^
M2]>!T /?S;Z6(CZ'S.?;)P3P?C&WZ#_KM)_Z&]?8/[ \QA_;;_9,D_N_M!?#
MP)P,@OJ\29/J"'<#.<$Y[5\%QHF^%>+(JUWPOQ#:_=9'F\_RIOYV^7Y]P[IQ
M/PSY\19#_P"K?+D?Z&FBP2W<JQ1&.,(MQ,[R%A'%#!$UQ<2OL!D8)&H.V)6<
M_, A568=U;Z<)+::Z34K-[2VMK.X<[;XN%NIWMHD"^3(PF$L15U8L%#HZ,ZD
MLO$^'&NH[R*73YHX+VW-S-;M,4"2E(71K5Q)^[<7$1>,QR828;H#EIE*^I)'
M!)IVJ-:6D5M>W5GI$EWI]L\'EQ7::A<^:MO ;IBA>T>">2!7/V4NRL3DBO\
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M_M0CGGX ?%GIW_XHK6./J3C'\J_S@;7_ (]K?'(\F+DDD_<7J3S7]K_0F?\
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M_P"*W@/3#]IOK:*%=!BDN95.D>4/YJX1XEAFG"N2X.4U*OGO&F6U,WQ=//\
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MY,TQN8PRO!XJG2QV(:6%E7ITZ3KX*KAW;!4<1.OG<ZJP,%1J13>Q^S=\"_\
M@F)_P2!^)W[1OP@^*G[?%AX@U;XP_"RT^'?Q-^$?Q>\#V.FW&EZ+KMK-=Z7K
MECJ/A[1]9^S7>I>%M<U:SFMH7$=Y8:Q;RW+%K"VC/XX?M8?\$K_V+/AI^P=\
M0OVUOV3?VS/%_P"T?H?@7XA^#OAQ';'PAX>TKPO+K.N>(O#^E:SIUS?QK:ZX
MFHZ1I/B33-2C:.T\J],MN)7DA"@?HW_P4_\ ^"6O@?\ :O\ VS?B5\;-7_;W
M_9E^!.I>(=)\$Z3/\-OB'?Z9#XJT5?#WA2QTF&[U!)_'.BNL6L+;_P!IZ?FP
MBS930'YOO/X7^TC\(/A=^QW_ ,$3?CA^S!I?[5OP&_:"\8:[^T7X%^)U@_PS
M\8^&Y+^?3M8\6_#RTN+"'PO!XJU[6KB32T\,R:A?W<$;6T=M=122<PLP^0X=
MXGC.KPIFN7<:\0X_B+B;,^%Z'$F75<GE1P%?#UYJEB*?UG_5RCAH?4XU/8QE
MAL=.$U5=6K4KRI1G'WLZX<JTX\1Y?C>$,GP&0\/83B*KD.91S)U<9&O3E"=.
M4<-//*M6U24'.:G@$G*"BE3YG"7\L@ ;@$#(89*\*"C(6'!);Y^!CY_ND!6.
M/Z+/V#?%G_!*7XQ^'?@M\!;'_@E9^T1^TU^UJW@W2=.^(VI^%O%]O;>"]>\3
MV$:V^M>-KZ_N?BWI]EX-\(2-Y-YJ6LZ_I.@Z3IAF(F6-'A67^==" 8SR-JEV
M+'(+;B^=JX88"CE3DD?,RC##^J;_ ()._M!_\%*_"GP+^&WP=_9E_P""?OPG
MD\&21:G>7O[4_P 6-.\1_#+0?&^CZOX@U'5]-U+Q%XPTR+1;OQQ#X?CO?[-L
M!H+>+-1>TL(;BULXWC/E?K'B=B*N&X?6(IUG2JX?$>U52IQ93X4P-"3512KX
M[$2A5JXVG222^H8*D\37?[R"Y4VOS[@6A3Q><QHU*;JT:U&5*4:7#5+B;%XF
M$:GNT,-A%["&#G-6E+,,;4CAJ$4XMN3C?VC]MOXG_P#!%O\ 8!^(G@OX/>%?
M^"<7P._:3^-^I:<6\>?#WP;XXOM=D^%WB&<Z;'HWA#Q#JNMV_CG3M=\3ZU<W
MMY';:%IM@VLVD-M9SZCID7]J:5'+G_MC?M'>%_V'O@;\(_'GBC_@B3^PI\'1
M^TWX;\<Z-HGA[4=4\ ZK\9OAO)!IWV6$>-K#3?@UX>\0Z;J]WHVJP:YIUWI.
MI7J>'-1@&B:[=:+XGMCIA_1#X]_&;QG^R_X,TVT^$'_!/30_VHOVR)H/[=N/
M$_[._P"R+J_AWX%>"_%FH,UXFNZI\2]0TG5O%VL7UI+,9Y+70O$G_"2ZS=&X
MN=:O_!4UV-_XK?MF_P#!-?\ :J_:P_9HT3]NWQ%K/[0GB_\ ;!T_3==G_:'_
M &?OCAX,A\%ZII^@:7>->0:=^S9X'TZ.2UTCPEX*TQC<Z9X<M[RYE\=:-_:&
MLPQ6/C>/5/#=]^(<-9SDN*J</5<^Q5;!8*IF/U*MFF;\68K&XG.\=5<HX.KA
M<#EF<X;^P\GH8E04\US/ .CC*TL+@W1INOB)K]3SW)\UPT<[HY-@Z.-Q='!R
MQ<,!E7#.!PV&RK!4W'ZS&>+Q>68J&>9M5H2DWEV6XFG5P-..(J^UJU,/&F_Y
MF4@-NBLLZB="LF 9$F57)\MA*0 THRK[E+RMSYC;T22OV<_X),?M!?LX>'?$
MGA[]F'XJ_P#!.KX8?MF?%/\ : ^.WA;2O!7Q"\?:KX?M[_P/I'B&#3- NM)%
MAK'PZ\9W]YHNDR0ZKXPU66#5]/MA$MSYL,,H-]<?C(TI=Q(@*X4C,8=0NPL"
MY#*VUD0QF162)D=9$*L0&']17_!O'^QE=V_B36/V\?B/I6GZ;IVB0ZK\,/V8
M[;Q1=MH]AXO^)'B.WNM!\3^+K6XG@EF2WL[2<^!-"N-*AN=0N]5USQ%-I5K-
M?:$D$G[9XC9OEF3<)9EB\RG-T:;IQR^G1QU? XG'9C.G*A@J%/$997P]3V:E
M">*DZ<Z\9X6EB*U5*G0O+\IX&R_,<SXFRW"8"-+VD:CJX]U</'%T:& H/ZQC
MJOU?,*5>E&:H5(X2$)4J4UBZV%C!RG5M'Z3_ &Y/VB_^">'['O[2?C+]GGPG
M_P $3?A%^T%#X)T[PK-J7Q&\-^"]#\-Z'<:_XCT+3?$5YX?L+*'X->,UOFT&
MUU2PL=1O8=9E6;5H]1L(K.SDMB6_++]K+]EW]F/XM?\ !.GXE_\ !4SX9?#K
MQ;^SKXT\>?M4W7PS\/\ [-_A[7O"UQ\&?AQX'L;R+PI_95II-C\.?#&MOX@,
MNBW&KWUXE_I^G_VMJ%WC1(R-Q_=7]@K]M?\ X*5W/[2/[6&B_M_77@CX=_"'
M]COX:7/COQWIOA[X=^']"LI]3UHOXE\!7'ASQGI,OVGQ!X7G\$:#XA\0:?>V
M\T\^I6ZZ;#J"QWMR8S^3/Q:\<S_$'_@W=\2^-+FV33YO''[?'C#QE/IZ.)([
M*?Q+\3?$.N26L;A45EMVO9(0ZJN\)N"@9Q^1Y+F6-RO&Y/@++ZUA\YX,R_,\
M[P7%.8\087-J/$F#QN.EAW'$-8+"O$X*A1QOL\)]8Y*=2,(XA14H2_1<ZR_#
M8[!9OC)*3P]3)>,,9@<KQW#&7Y!C<MQ&18G!8.%>,L-?&8A4:F*KX.4\5'#.
M=2$JCP[=JD,G_@X?LM&LOB!^P.VCZ/I&D"X_8G\)S7:Z1I&F:0+VY;4X2UW>
M1Z9:6RW-VZD"2ZN/-F=0(]RK$"_\[?SX=@N0J[P=I(7'&UR%/5L\8+,"0H;(
M _H<_P""_P#?6#_$S]@.75K2ZU#38/V,/"@OK.SO$L+NXA&H1AXK:[>"X2WD
M#!&W&"4,JLFQ=^]?P!L=(N;^#4;*R.E7LIM;&1IWOVLYHD99;J?["MU):).T
M/E/;7Y>*0P2[&B*%G:OU'P]QOM^"LCQ%24YSJ4L=*524G4=1PS?.J45=N6JA
M0I4T[O2,;:*R_/N-<+&AQ9G&&I15.%*K@XQ5N51C+*LHGM:.\JLG>VM[Z[NG
M<I"D$,L%S/<0&..W<W%HT$D$\,6XP1RK)/'+&GGD))'*'EY:6&,QK5%$:1L+
MN&\+$J(N2TCOB/?SDEL@?*&;)X!/ ]'\<S^'=3NO[8LFMEU+4+31I;JS\.:=
M'I_ANUO(-/LH;NZC@-G;PPIJZK$EG:6J!UNX+R>6:1I7SR%O%HRBRN;VZE82
MK<2W%C C&4F-[DQQBZ#$6]S,@B>,I!<1H&4L1RM?6X?$QE05=TZKDY5%.#2B
MJ;BURPO%R<G;[5M4CYF5&4*CA*5/E2OSQE)M^5I)6TN[Z[=F55TG5'TZ]U46
MDO\ 9^F7MMI^I2%H@;+4+U)6MH+BW:47,7GF&6$3&'[.LRK')(CRQJ]>%&;;
M$%_>2N$7<4"(K/AV<,K-'G(WG/F%%*X("@;&I:TES:W&GVFG6EO8+J\U];SR
MP12ZW':I$]O9:7=ZQ (EN;:)&ED,0MHXI)REQ'AHW+9KFT2#3YX9Y;F[D:::
M]LY+54@M9%NO]$ACFDFS?+=0*K2MY:>4Q>'!VLS4JM6;@I4N7G<N57O:*ZM^
MFNK7^:O!:1=UZ/=[].Y'O+(L4;.3YF7 5?+>0;@$C+!25?:0"2,DA<$D@R3&
M-4QY5JKEHI7GBE:41(\*YM'9695\J0,\B-'O2YRID91MJ$A-J%  9/,+Q)'M
MB@16)C\MM[JRNQD4C&%$08<,26L <94 D J1\HV@C 7L"3\V&!VDX VCARIJ
M3YDVI+57=TVNEMOF479["^TZX07MC-$(V<O#>0,GS6[02W$,D99950;XXI =
MI97;:2I!,43 722-$DL;@R/:H3L)3S%$,APK+&2>@>1@BQX+GJMR]NTD;6J7
M4)^S1)<F><2O-<F(+<,KQJKBUD(3R[>=GDA 82NS,I#(URV6D2)"5#2.&.Q2
MX0G"AG=0N6( ;." #\HK*7-R7DK2?/=;^2^^X$[Q);I&T^T">S,L MI%8^8Z
MR)#YCEVVN-SB5 T5PA"E2K &MB^US3[JUD%OHD&F7PUD:E#J%E?7QDM;-K81
MMIC17D\PN?L\JBZM+F27S8I&9-XC 1>?38LI!9&&)028_-5BP&9%B9$<E^&+
M80[CG.X<36LDEM,+F&<P2K;31%@AD&V1?*6%T$9*F=6?:'+;6&."<'@FH)IS
MOS1?-:+LKZ[JVMNW<:;5[:75GZ$ $:GK@@CAF#%1R5^ZJ9+YWMN!;=SN-2!L
M@\''J/XB>NW&20.1CKD!?:KSJ99+6>[O!=17"O&TRL99U-LK*ZM&TGG)&C!1
M TA'GH6D#!5*B@L@"[NA"G(( R2,LHZ892"./F4CUYKDK5G4T3:@M$M4[K?7
MUUV$KI=7J]7=O7S?X+H*Z2A4D!0K,\@15EC=RT 0N'1&+1[]WR&0()3]TX#&
MG,JJRA9DGW)&S/$L@2,R NT3F1(VWQJ"),*R CY)&7YBTJ2P3:SDLB'8#EMR
M )DJ/F"A%V@D[=K=,D&1H)\VB/$\;W_E/;O.WDK)&TQ@\\2R800"8.DKO)$D
M<8<L0BEJQ*C%R?;2^W_##0KDHQE2:9EE7R$:62:&.)QL# Q[!'AB(5B=R%BD
MWJFT;A/WJR;&B&V-G&Y\;R&"[$! WNVX,H'#+T.2!5JY6>QN?[-FFM_-TVZN
MX/M-E+!+&TK2E9Q%J-L!]LC!C(BE$SQHDK+& KDMG(,$HQPWRG:"<A0Q7<@S
MP -J[AQT7/2@OD26J>B;OJNC?GV+GF( ,?W,@<[GP"68C'7(P3VXX --,4C!
M)FC802DE)& (8QF,LJD$@LH92R<,%.XC: :MZ?\ 9V;[/->)8^6&O8+B1;B1
M+>>TCEGC$:012RR2WCHEC:AWAMX[NZA:618RY,%T6W@2RQS2*$+W5L"$8.&F
MG1_DC+L)F=9696?>I42.JHQ"XQ7(IQ^TTM[Z6O\ U]P[; R2,TA=G@1K86PB
ME5))EC9ENF<AHV6!W3]UN/F':<K\PC61E90 Z.&#!U)!20D-O4Y# J_S*0P(
MP"-I'#RK*2KXW(50C_6 $(H4*0<$>6%SCCU/(S&TBC*Y(;(&-O<]/E/...?7
M)/N-*<8-^]*UGJM?ZZ;6!I/?;YDC/(S,\CR2N[/))+*[22222,TDDLTK99I&
M=G9I'.9"S,Q!R U6C(DYW.73 3(5$&W:\I.1*S-Q&$*B-@&?>.*'/EJ2Y*LK
M.CHR%E0(I)<."058J&7<,,05&!4@CMWN88VN6BB:X\J2Y-L6%O$9 KS_ &5'
M,KF!=S-$N9)A'M'+A:<G:7-'6"TNGWV5M;::ZZ^I/)'L_O?_  Q4NL"-\X),
M4OI_= .">G!''? R>N?=]'.;:/((*K$O(&<A #_];OBO"IY((VE\R,7D2172
MA"S1;\[XX9]J?OH\#R[@(^TC)C8$!E'NVD*4@"MG*^4"2<DGRURV2!PWW@,#
M ..U856I2A)*UI*2LK7:2AKW5KZ'P''JM@\(EM[:?W^SE_5CI;?H/^NTG_H;
MU]<?L)N$_;3_ &3G.<)^T'\,F.,?Q>(;= .2!D&52>> #SG /R-;D8'(_P!=
M)_Z&U=_\.?'7B3X7^//!OQ*\&7%K9>+_ (?^*=(\7^&+J^LH=1LK?7=!O(K[
M39[S3YCY5_;)/$IFM9?DGCRA*L0P^8XCP=7,<GSO+L.X+$9ADV:8"@ZC<:2K
M8[*\RP5)U)QC.48*IC*;;C";M?W3\PR[&TLMSC)\PKJ;H8#-<LQU94TI572P
M>88+%553A*4(SFZ.'KI1E4IJ[3YKI(_TL+#:2,KDF67(.#U)8<9Z<=0<<'J*
MZZ *J!E!!('.!\P(7(+# !Y/09/7H./XA-,_X+I_\% ['!?7O@UJ)!9B+[X/
MZ8A;)8!2UEK-DS';U( Y((]*[VQ_X. ?V[[4J+C0OV=]3VA,^=\-_$5J>,9R
M++QS;J2P' RH!X!  K_-3%?1'\6X\WL?]5JUG.,)1SMTYK[.GUC)Z=2$N9.[
MG:"E[RFZ:YS^]H?2F\++<M6/%%+FU<I9#"JE=WC:=#,JT7%1</@DYM)WC&H^
M1?VLV,.GR31)J$DUK9*Y,YM(1-<.B%#(D8:6)09!@$L=PSP"=U;/B.XTN]U.
M2_T@SK;7"P+]EN;<VYMC#;PP8A82O$T.R//"AMN.F#C^+VR_X.(/VRX!B\^%
M7[.-]@_-CPY\0=/#<?-GR?B#*O. 3C=MQWSST]I_P<8_M.1\WW[/_P  ;L]&
M-K=_$2S!!^]@OXANNH[N7//S&N.7T7/&FEE]?+Z>0<-8F-2O1Q,JL>(\L]M[
M3#PE"E%57'F5"*G-JE9Q<YRFY-M6ZZ?TF?!^IB:>+GG7$-"=*FZ7)+AS,8T7
M"22:]G[3E<]GS*2=KH_LD\)W>GZ9K5IJFHWK00V32D)#!--+.SQM'CY $6,A
MCG>X9\' ^5LZ'C2]T#6;\:KI%Z4N'A2.\M+BUNH3,8%\N*6)]C1&0PYB(=D7
M:0X^<8/\>=I_P<??&E-HU']EWX3W(S\WV3QUXQM,XR"(UEL[S9G@;6+X&>.3
MGJ+3_@Y$\:#!U#]DKPK)R,_8/BOK$.<<DD7'A*;;QW920<D[A4Q^CMXXX7):
MF0K@O)L7A*N(>,4H\19'*O'%*E3HJK1KU<?AZD)J%*%-)X6*:C;WXR<GJ_I!
M>"U;'QS#_6G-,-7C1]BHRR/'4J7L7[S56C*G6=V[MS=24DO>BE91/Z'OVQ@)
M?V2?VG5'?X!_%D8)&6)\$:S@  YX;:3T.T,<$#G_ #>K3_CUMO\ KWA_]%K7
M])'Q7_X."A\5?A+\3OAC=?LI2Z))\1/ 7BWP0NMVGQ:@O8])E\3Z)>:,NI-9
M7/@J WD=D;W[4;87%M)<&(0I)F3Y?YNH5*11H3DHB*6P%W%44$[02%Z?=!.W
MH22#7]2_1<\/>+_#S(^+<#Q?D_\ 9%;,LXR[&9;!XK#XQXG"4,MQ&$JU75PM
M>K27LZL(TW%1BY/W]G8_E[Z2O'W"?'^=<*X[A3-/[3HX'*<RPV.?U;%8;ZMB
M*N8X?$QI/ZQ0HJI[2,Y54XN3C'W?A5R6FO\ =;KT[=:=36S@XK^I3^;(?'#_
M !P_]+@4]/\ ^/"P[_Z-#U'K$#QR>#U'3MUSQ=/5?K_0U3L/^/&R_P"N$0_*
M/ JX>J_7^AH!_P 1_P",BD_U8_W6_P#13UGG[D/^]'_*M"3_ %8_W6_]%/6>
M?N0_[T?\J3V?H_R9Z5/?[OS10O3AP/4@#_R&?Z5AZ@V$88Y E7/;_42C_P!F
M_0UMWW^L7V89]N%ZUCW48FE6,G DE*DCT,3 X^O('OTYKU:=N;#_ .*C_P"G
M3W\I_P!]P'_833_.)X/#PO Z.#CZ!21^AQ^&:N9RH8 \@$#OS^=4HA^[4C)Z
MY/ODCLR]@/;&".Y-J%9[ATMK6"XN;DDA(+:&2XFEQ_!'%"KR.0"/N!C@9.1F
MOLKJSNUUOJ?O$[*,7LDEOVLG^B',KN-JKEOO8RHSMY(!) SCL<9YQFH0<C(Y
M![^OOSSSUP:;*;J%YHKFPOX)(&*S)<6=U T)/3?YT<31G@C)!(/!VY&8XYHG
M *$!<<$'*G_=[#Z <DGT K2C.+O&,D[6=EOV[MN]ATYQE>,;.VNE^K\_/8E.
M0<@9R .N.F?\:,M_=_\ 'A03GH<XZX__ &E_K^'=1T_0_7T_SGZGK6Q;BGJU
M=^K_ $$RW]W_ ,>%*.GXD_F2:6B@$DME:_FW^8Z(A7+'C##GC(^0C(S[FO?/
MV??V9OV@?VK?&<GP[_9T^$?C+XM^++2SCU'5K+PM8PG3_#VDO.MLNL^*?$.I
M7%CX=\+:0URRP1W^OZI813R;DM_.9'"_/C$#S&89"*3@],;2?YXX'7D$8)K_
M $JO^"/O[-_@7]F[_@G1^S/:^$M*L(=>^-_PL\!_M$_$SQ"MM#_:?BKQA\7O
M!VB^+[0:G>&(3W-KX6\.:KIGA71=/=GM=,M-)DGM8UFU*]DN?C..^,)<'9-3
MQM'"QQF-QE>6%P5*LW#"QJ4H.M6J5JD&JDY>S?N44XQD^5<\7*Z^FX2X67%&
M;5,-5KSPV%H4H5\36@HNHXSDJ<:5)23BJDVN6+DFN:2;32:/X\&_X(&?\%21
M'NE^!/A"/(&Z.7XW?"KS(FQEX9#'XCEB$J$@.$E=,%6RR.IJJW_!!K_@IY ,
M/\$?!ZMU)7XU?"T@\<[2/$ )'T]<],FO]!?Q-J]EH&EZEK.ISK;:=IEK<WM]
M<R$B."TL[>6>>61@"52"*+>>&PJMA<8KX.N?^"@W[*$SMY7QA\'R;7P&_M(@
M-UR &@5E7.<$JN.<[2,#\/AXR>(>+53^SLCRK&J@^2M*AEV85W"I*\HQE&AB
M:K24+)2DDI23LVTTOU'$^'GAUE4J2SCB*KE3Q"O0AF&>99@)SA"RJ2B\7AJ4
M*CY]7"DYRA%IR48M-_QES?\ !"K_ (*9*,-\%_"&02,?\+F^&7&,'G_BH/3L
M,^N.AJFW_!#G_@I1'][X,>%!U&T?&7X9[CQ@@#_A(>>N>/0\@"O[%KO_ (*!
M_LI%RH^+WA OG[IU+;N;';]V,CUSD$=.>*YR[_;X_9:!,9^+7A4ODY OF? R
M"&4I;D'(P>N,=ZXZ_C)XOTH_N^$L"TKV;X<X@J7W^U3J*#WW7SU3-Z/!/@G-
MWJ<?81;-VXOX=5NO\O8_D"?_ ((C_P#!1Z,Y;X,^%AM^]GXP_#1L9XQQXA."
M?J#Q]15"3_@BM_P460G=\'?"Q7<>%^+OPT/\7;_B?'."1Z^_-?UT3_MW_LQR
M%_+^*/AN3=Z74C9'0$[;<^G0G![$<8['X=_'WX6_%^ZU&Q\ >*-.U^XTR.WF
MO4LGWFVCN"_DM*6CCSYK1N%"@X51NY#$^%F'CUXQ9=AZN+Q7">68;"4%>KBJ
M_#^=TZ5-/W8N3KXJBK.6GNN35]4E:_TF4^&'@KG.+H9?E_'4<?F&*;CA\#@^
M*\@KXFM**YI1I4:5*K5J244WRTZ<Y:-VM=G\2'Q:_P""87[='P3\+7_C;QE\
M!=7O_"VDVTE[K6J^!-=\,_$%]$L84>2?4-6TKPGJ>HZW::=;HK-<:@=-DLX.
M!+,A90WP0KJX5XW5TD4.K*=RE2%((((# JR,-N1LD1\X-?Z4MR[1.'0E60,%
M8  XW@E22.8W*@.ARCKE'#+D'^(3_@K+\$/"/P+_ &V_'6B^!=.M=%\+>/O#
MGA3XMVFA:?%';:=HFJ^,X]6A\2V&G6L*0Q6=E/XATC4=6MK6%/L]NFIO;P+'
M!%#''^A>"/CSF/B'G6,X9XBRS+\'FL,!B<SR[&95*O1PV)PV#JT8XO#8K!XZ
M56I#%PIXFA5H/#8J-.K1C7E*E*I!0E\WXN^#.!X$RC"<19%F&88C+98VAEN8
MX3-J5.>)P^(Q5*O5PF(PV(PM+#Q>$J?5YTJRQE"G6IUY4524J593?YKE&<=/
M=2 >""1[^G(]#2HK852& QM+8] <X],D8!(_6K"@ 8'09[YYSDY_.@=/Q;^9
MK^GXS<M':T5=:6U;U^\_GKO\AH&,+C@D8.>F /QSQS_/-,="XP",C.2>_P P
MQT'HO/X5*>J_7^AI >3_ )_B:MZ#?MFKZ>S>G2[;7WCY59^;4OFFE?[DM"-_
MO_\  5_FU-I\@&-W.?E'7@C=Z=^":C)XXZXXP,_2NP09&1[,I/L PS^0Y/H*
MLH<A8SG&"<@]>2>"#TY'85$R *<9R,L#G)SC'Y<=*GA4;4;G.SUZ'Y1C'TZ_
MG0142<97Z1DUZV/,)TD@80RQO$Z,%>.161U.0!D,%/!()P._.!UC/0_0_P">
MU2R3SO#Y#A&C>X-UDI&9O,0-&N;@J9B@5VS'YFPMABK,JE81ECM &YN%&>#P
M.K<  _7H#@YZ?0'D132L^[>GF/<!<1CS <H9%D*LWFJFUR,1J40\E%!R?XA@
M"DPFTY8B0N% *J5\O@E@2<[D;#<C:.::268LS,S/EF9F8L2<<DYYZ_A^-(?P
MQN'S,&.PCH000"#U*GN,'CI+FD[:[?G\RB>/HW^]_P"RK7ZN_L:_MS?"O]C3
M]C[]JJW\ >&M:L_VY/C!>:;\.O!GQ*F2.ZTKPQ\'-:TF?^V]6\/7@BB;PYK'
MAJ_AOYIK-I+F?Q%XGU?P)J^38^$IK6/\GU.W&'#[ADJ-P*/P A)0$YQ][.!W
M-#_O$:++ N&0\C";U*L.>I;)4GJW)'85\CQ%D&6\28+^S,W6)GEZQ^ QU>AA
M\5/"T\7_ &;BHXVE@L=*$9>WR[%5J-*GC,).+IXF$:5*?NMM>MDN=8W(,9/,
M,OE0IXIX/&X*G7K48UIX19AAYX.>,PEVG1QV&A6G/"XF#53#SG.I!\R5_P"M
M']K^X_:%\3?MP_\ !.SX0_L\>/O$O@74?CE^P-X$^%GQ1U/1-8MK"\O?@S>:
MQXLU/XGW-U<7\BM/J.C>$K37M;TG4+!CXFLM4B%SH,\.I.)&D_X*Q_\ !/#]
MN7]M3]J;PYJ_P,^&^@Z9\$?@W\+O!WP\^%>IZU\1/"GA>W22U>?Q%K>J:;I,
MMW_;-NMEJU_;:#&\MA]HF@\-VMY$ LD03\ _C=^W[^T%\;OB)\%?BM/JFC_#
M7X@_ +X8Z/\ "OX=>)_A?!J_AK4].T/26U0P:G)>W.K:I.NN7-MK&H65Y>VT
MEO;3V-SY:V<)=Q7B'B3]I/\ :,\6F8^+/V@/C7XE61F=XM9^*WCO4H&=VRS"
MWN-=>U3<=S;8X509)50!BOPK)?"SCS*ZG"698',>#<GS').'LXRS$TLQR+,<
MTE+&YOF^;3EC[X''9?1Q<Z.15\OP.7PQZMEU-XW#T(\E=SJ?KN;<?\&X^GQ1
MEV-R_BC,\%G.=Y9F&&E@<XP>70H8?+LMRZDL+4CC<-CY+FS*..Q>)^K1I+&U
M7A,35JN=+EC^_/\ P7S^!7Q N?AM^QM^TY\2-'LK/XLIX#TOX#?M"-H=Y)J^
MEGQU9:2WBC0M2MM3CBC^WV%_JY^(,,%Y+ DCP'3XW>21L+_/=\#?C5\0OV<O
MBSX!^-_PGU>#0_B!\.-<B\1^&[^XM(M1L1=Q6T]K-;:IILS"'4-+O=/N[K3K
MW3Y3%%=65[=1R.$F)?N;W]JKXZ>(/V?+?]EC6OB/>R_ _3O%NJ_$>'PM=:1I
MVH7VI>-+IQ-;27OB:\MI_$9L[:Z6[N;*VCU&VLK:[U+4)IK:::Z\VOG$R.@=
MXVPS*T9.T9,;-@@<$;2IX"@ #"J % K]$X"X4S+A_A"?"G$M;+<UHTL9GV#P
MTL%2K1PE3AO,L?B\3A<)4P6-=7V#H4,SQ^'A@J59T,)AH87"TL1.FI-?!\9\
M1X'.N*(\39!3S#+:M3#917JQQ=:E4QE+/,!AZ6'KXRGC,(J7MIU/JN%Q<L94
MHPJXG&JMB*M"$ZG,OZ2_VGO'?_!11_@-^PQ^W#\-OVH_VKOB?\5OC)I_B'Q3
MK7@'P-X;BE^''PP>WT^W%LNF> ? &@-X=O--U2WN[O37_P"$UT'4S>VUN5::
M[DBD+?4GQ'_:Z_X*<^'O^"97P ^//A?QG\=KC]J3QM\9_$G@SXD>'U^$'AG4
MIK+P'I\GQ)BTK4!\,8OA</\ A'7CBT'PV/[<:T6&Y%WM0*MPK#\(?A3_ ,%7
M/V_O@Q\/_!WPH^&?Q_;PMX"\!Z):^&_"FACX;?"34O[*T:QEFN+:U.IZOX&O
M]5OFCEGD<SZC?W5PXD96F;I7=+_P6I_X*:*=Y_:9D,C*!O'PG^"&7V!0/-<_
M#G< "JA1WRV0=[;ORK&^&?'&(64X>7#'A/CL/DG$6*S"A7QE7%X?$9AP_/%Y
MJ\'PYC</A>#EA:>"PN$QF DN6KB:DJ^74HU)U[1K1_2,'X@<(45CZ_\ K#XE
MX+$YKD6$P6)H86CA<7A\'GE/"Y93Q&?X3$8SBY5ZF+EB,'BY45[+"PC3QDU"
M&'NZ;]9_: _9\^)?QN_8/^(/_!1[]K+Q[\=]3_:HT[XZ:!\'4\+_ !)T72O#
MGAR7X=H/#4>BW%EX9N_"VAZOHEG:R:]K"Z?:Z#+8^'#<V]PT5FMQ+J#-^,;A
M0 PE0LRLP&#A-K%2'!5!N(4,VU0IW$  #)_1KXY?\%5/VM_VFOV>M;_9V^.V
MO^$?'^BZYXNT3Q;/XXN_"FE^'_'$(\/W$-YI&B6S^%DT'PPNCVUVMQ,_F^'&
MU.4:A.)+]B;9(_SCP-VX 9!8YX&-YR >!DA2 V00'+!00,G]:X#P/$^79=CZ
M/%5#+<)4>?9B\GP&2UHU<FRW(:=+"T<OP.7N>5Y57CA,)&.(C2CC<&\1%5:;
MJ5,3*_L_S#C7&<.8W,,%5X;KYIB*3R3+HYIF.9P6&S7'9LZN+K8[&8NFL=FV
M'57$RJ8655PQ/M7*C92BN9S_ 'N_9D_:X_X)W_LE_"WX,ZU^SQ^REXQ_:1_X
M*%>*_#V@6%Y<_$V.77/#_@#XQ7\@TB2U\&B6S83O<^($MM1\+6'@/PS_ ,)$
M^FZK%9W/Q"T_4%O%;H_^"_\ ]A/C;]D&Y\;)#-^TQKWP#@\1_'U[/7O$E]HE
MA=W+:+8Z?I'A[PKJ/B'6O#OA#08_&&G_ !%GM-.\.VE@FHRVTNI:FVJ7%]%=
MC\X?V&_VYM6_8:UGXB>*_"WP:^%OQ,\9>*O"R:=X-\6^/-(!UWX7^(X)0!JV
MAZM:V[:M-HU[8S7$.N>'K34- &L7<>FW<FLVT%M=VM_\P?&;XS?$[]H7XD>*
MOC!\7?%%YXQ\=>+;X7FLZS=1QV\,$447V>QTC2-/MUBM-(T#2K/98:1HVG00
M65G:(J1QF5I)Y?C,MX#S&EXF4.(N3'0RK*J.83EG.=<13S?.>(\=GM.5*EE6
M%R]+#X/*.&^'J'-.EAGAZ57'XRG@Y3Q=3#TI0A]AC>,<#6X K9$JN#GF&/EE
MRAEF7Y/A<KRCA_!Y-55>KFN)Q4V\3F^?9_6M"M4C5FL/AJF*4849.-&K_4;?
M_M6_"_\ 9)_X)5?\$Y='^+WP$T3]I3X(_''P[J6C?%#P+XUU:ZUO5M,-MH\F
MIV_B/P!=>+;C5=/T74-*,ET-,T>T_L:TT^&06?A;4?"+O->3?@I^WCJ'_!/O
M6/$OPYUW]@;0_BKX9T+Q%X>U;6/BEX:^(MY>2VW@_P 376K!-%\)^'K35UU*
M^"Z?IEI<7=[<1^*_%.AO!-I5I87:RVMU+)P_Q7_;1^*?QF_9\_9V_9M\6:1X
M"MO 7[-#W/\ PA%SIFDZE:^(M62?3VL)8_$E]=:E>V6H(85=?]#TVQ1I'AD"
MA6$=?+EI:W>OZO=1Z/I0,US#?7-OI5JL<DD-HBSW4\%N\Q#R36RR#9*"UTR!
MLQR\O73P+X?5^':^*SC,L1F&#SBOG_%>-QF$P&;8UY#F&%S+,,54R:OC\IG4
M>&EBZ6!JT7'%87ZGB'7A4=2>(48U7S\7\9PS>AALLP.'R_&9;1R;A?"X7%XW
M+*/]L9=4P.68*GF5/"9CS?6OJF+QM#$Q>%KRQ%*%"5&IAW@[SH/N_AQ\;OC/
M\);+Q;X=^$OQ4^(7P[T_XE1Z-HWC&T\!^)M8\,7'C&QTJYGET?3-7;1+J"]N
MX+66_N3%9I.8W>>>(H8Y<)_5Y^U#\'=?^.W_  6-_P""9=A9:?<7FF_#3]FG
MX3?%_P <S2QSR+I_AWX7_$/Q?K[_ -I3,2ZRZIXF.B^&(WE"ROJ>OVJ',T@>
MOY@OV4/VHO'W[(/QJTGXW?#6P\/:CX@TO2?$?AV70O%MA=:KH-]I/B.P;3[Z
M._@M+O3+V=M.NDM=7L6BN[=_M^GVI>1K<2P/]G7/_!9[]LN_\?\ Q<^)-S-\
M,(_$OQ7^#L7P42ZTOP-%I5S\./#5C<^)=5T/4/A_JUO>S:WIVKZ1K?BK7-;:
M+5;_ %BSU/5;BVOI[5KC2=&FL?-X^X9XNS?/XXOA3*\DP]+#\+<3826:XK,J
M-#&8K'\2Y?E^2U?;TUE=7%U%P_EBS#&X.M4Q]6>*_P!FPLH4H<\X>EP=G_#.
M6Y)/"\18_.JTL1Q)P]BU@,-@,5C*&$P.0XK'9CR4<1+'T\*GFV*JX=8NG'"1
M]BO;.56K+D9X?_P5!^*^C_'/_@H#^U+\0='N+;4]"?XG7GA#1-07;-!J.F?#
MC3=.^'EOJ-K(V1);WS>&Y;N*52$FBECE3Y' 'P]I&DV]]<R1/=Z;I(2WOIH;
MR_CFB@EGL[9YQ8PR6]O,QN[P[;>U! B::15EEB4,RTU&0&=W9G<L[.S.\CYP
M7E=LL\CE=SR,278L6)+$F0Y9,-P,LVT8(4GJRD $/CD,.5.".0*_5,JRVGD^
M2Y9D^%J2='*\KR_+*4I:.5/+L'1P<:CL_BKJE+$U?^GU6>_Q'Y;F68U,TS7,
M,VQ$(^VS',,=F-6"MRQJ8_%U<3*E&UOW=!57"E+=K>UD7Q8RF^2QLB-6N)9K
M:&S73([NY-[=72PK!:6, @2ZN9I+B>.S%O%"97NB5C1X_F/]7'[#Q_;<_9P_
M9B\,>/?VV_VL]9_8M_8V^&?A&]TGX9_#6#P3\-YOCOXP74DU35M$M+:V\5>"
M?$FOZ<?[3U*2_P!)\-RVU[XTUEHHM-?2?#N@B76(_P"473KV_P!(OK#5-*NK
MC2M4TR\LK[3-4L9WLK_3;_3YXKFPO["[A(FL[VTNX8;BWND=7CFC67<",U[G
M\>OVH?C]^TYXUL_B'\<_BEXD\>>*-*6V309[^6"RTKPTMJT,L7_".^'M.2TT
M/199)X(KF^N+*SAN]2ND%SJ5S<3?O!\-QUPQFG%M/+<KHU<EH95"=6MF>-QV
M6TLUSBC*DTZ%+(,/CL/6RG"8G&0G7PN(S?&0Q>)P>'J>SPN%G&<DOL."^(LO
MX:EC\SJT\VKYG)1HY=A,+CZF791.-37$5LXK8*O1S+%4*,Z>'J1RFBZ>$QLX
M>TQ&(IRIQC+^C?\ 9Y_;I_:^\>_\$R?^"CGQQ\4_'#XA^(/''PN\2:!8_ OX
MGZOX8T#P7KNEZ!)>:(L]YIEAH6CV^C6U[>V5]&^JVBR:L-/N[MH(M0D22%V[
MWX9^-OVJ/C;X(\ ?M&_\$WO^"C7CG]HWXH_#3PEHUS\;/V2/VE]3T^!?$/BN
M31(K+7YK7PMOT>VTG2[W69;V\\.:?J>H3Z";F*U;P]\2(+JT-DOXE_M)?\%>
MOVP_VH/A#K7P.\<7?PV\.?#[Q/!H]OXKM? W@EM*UKQ/;Z+=6&I16VJ:W>ZI
MJ]Q!;7NJ:78ZCJL&C6]C+?7$3Q&1+&5XF_/OX;?%+XC?"#QMX:^(GPT\7:QX
M*\;>$W#Z#XB\.WCZ9J%J6=I6@N)( J:II]S)-.NH:=JJWNGZE;.UI?07%L?*
MK\XP/A?FM7!Y[C*N!X;X=SC%9W/'Y=E2R[+<]R&OE7]CY7EO]D9NY9-EN*IT
MZ]7+JN)E5RIX2>%Q&,GB**J2@HO[S$^(^5TL5DN%ABN)L]RG"Y/3P&89J\RQ
MN1YYA\S6<YKF?]KY,Z6:8ZA4JT*>8T<+&CFRQ-+&8;!1PU=0C452.C\5]'^)
MUI\0/B3+\7_#^O:#\4HO&>IW_P 2M,\0Z%%X9U'2/$^OW\FLW@O]!M[33;72
MI=3U"[:YL[6TM%TU[*16L(/L:QSS?6'P1\0_MV?MG>%/@I^PM\)=?\4^*_!7
MPG\::AX\\":1:W#Z-IGPTN]1N8Y_^$J\9>-[(Q7VB^$_ ]U)J6J>%A>71'A[
M4]=UBR\+6]UJ6K6UBGQM\0?B-XS^+?COQG\3_B-KUYXH\=?$#7=1\3>)_$=_
MY7VK4=8U>8W-S<^7&(K:UC :.WMK"SM[>SLK:"&UL[>&VMH8D^O?V9?^"BO[
M0G[(_P $_BU\%_@M/X7\.#XJZMI^K#XAG0+-_B!X*N8+2;3M6E\,:L$19Y=0
ML/LD=E-K2:JGA*>"YU+PS#8ZQJ4D\/Z7GF'SJKD.'CEF4</YAQ'AYX)8*&9*
MJ\FRW'?584*N+H4ZE&M7^JX2G7S"-*G2E2QF*P\:&$K8J$*U10_-\GQ63T\[
MQ,<RS//<!P]B(8R>+JX#V:SC,\(L5.M1P6+G3JTZ+K8J5# 3Q%6'+1I5IU9T
MJ4HX>'M/UL_X*H_M56?[-_P%U'_@G_X+^+6I_&S]HOXMW>A>*?V[/C]>S1G7
M?$E_IVE:!:Z7X+NKBT$0L[O4-/\ #V@Z-'X>+>=X7^'FCVVFZS'/K'C36]GY
MA+^V>?$G_!,JV_X)XZ%\'?&6L^*(?C3/\5(_B-I&IC5-,F@GUN]UA/#\?@^P
M\/RZN+M_.CMS=2ZL8<PFXBM\*T3?G1=7U[>ZA/JNIW<^L:C?:A/J6I7FK3S7
MUWJ]]>7+7=]<ZK>SRM>7]QJ%P\DE]<S3O=7+22,\I=MP^VOV-_\ @H-\</V&
M]7^)^K?!;2OA[<K\5[70H-;TOQAH6I:KH^ES>&;_ %*ZT:^T2"SUC3);2XMA
MK-[8R?:;FXC:TFA21'DMHFC^=P_!%/(>&L+AL!@*'$F?X+.,/Q,ZF-S!Y!A\
MUXCC*I2EB*U>A2JT\!EF"PDZ5++,M4'A,+A<+0P45"4JM:K]%6XPGGV?XK$8
M[&5\@R/&91B>'7'#8&&=XG+>'ZE.'+A*<<15I3Q6-JUJ5.>/S:4UB\;B<1B<
M357*Z5&G^CG_  7X-U;?$G]B2SOK:6"]TK]D30;"[L+E'AN+>]M-92&XM+F'
M!DAGMI$DBFC=5>.XCDBE57C<#\$EN+9;4X4B]66W:%6M(F2&.&4SS2B8R9(,
MBVRO%<6TRW,3/"9+=(D\SZ!_:=_:R^-G[8/Q/B^+'QM\06&J^)K'1K;PWX?L
MM!T>T\.^&_#'AVQN+J\M]'T/1[0R&VMI;Z]O=0NI[VXN]0O;NXEGOKF=FBV?
M.SG>S.0B[@F1& L9VJ">  .6RSGC<^2>0,>YP3D..R'A#),ES>6&J9EA,)66
M8?4ZTJV$6(Q6-S'&5J6&K.G3]I1I_7G3IU(TXQ:3<4TW?R.,LWP>>\4YSG&6
MPQ$,!C,52G@EBJ,<-B'AL/@LNPE&=2A"I5C2E46!Y^15))*2UZ+TOQM\3]2\
M7:E>ZI9Z98>&)=<\.P:)XLM=+:273_$-Q_:_]LW6H1V-P#;Z&LVH&)UL-$%E
M9VB6\45G';HTZR^<,/*,\%PNXQ^9&L890J7&Y 2&C<*2(R"JJNUF!! &3415
M@2K#!'#*R8(R,X*MR,\,,CT-*[O(JH[?)$%50%5?NC(9BH!9N26=LLQY8DFO
MIJ5&CA:4:.'ING"*6DINK/\ \&-*37E;MV/G)3JUISE4GS2;YM=K;??JDE^1
M=4V*V#B2*_CU<W<,MM-&]J=/^PO'*MU%)$\?VR.Y4E3;-#<>409%E2+()JQK
MD!9"H261'=% W.(V8,$8C"X&]5R,<@N,$YA^4$98L1\H&<G:.2 !TP 0.@&>
MHS4BA68D9V84;2PW_-D/M8D@#(R21E>>!SD225EHM?Q+BN5)>;_,MW'V3[3<
M_8EN%LC(_P!D%W)#)>)"-QC-S);QQQ23A%02;$$3; H(P2\.",9!;[N"1@<@
M'(4948))XP%Z @#%! ;C&,C:< CCN#G)9LA<R A6'&.F7HOFL [.$B4NQ0IN
M"("JD*SQ[@KF,D+O8AI."1BDDUO)O3KZ^HPCX<@ ?=]0,#)[=_\ /K3)'5P
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M7VF27*+?W0CGC>3C#B5OL\,#R/+.1'P[7%PDC$6\8A \O+#+DQ1KO+E%#+M
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M8ZXR.,\CD<=^:"H_'#_'#_TN!4L!BSL^2?W$0Y]D;W/J/RJX>J_7^AJI8_\
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MIUXK&C*4*L)1=K/7[M/Q.2DVJD-6E?6V[5COH4D*DHC2%4:279EA'''R\CD
MA$0-EV; SGOP6;&^8Y'5C@AL_0^F.G&0,=34T?F0IE3)$+B JX1F7S878;X9
M I^:,E$+H^0W&003ESF'RXP@E,@4^>SE!$S,Y(,2XW_+&=KLS;206 R<CUU.
M;L^7F;>METTUW70]5*$&U*5KVLY:7;U6U^Z]65O7/8D?D2/Z44Q=Q)/?@G+8
MZY/ Z<]>GN.HIX_Q'Y'%:Z]4UY.U_)Z-[BTZ-/S6WR()?NR=^!U_W2:_U-?V
M$/\ DP7]A'M_QA7^RKP.W_%A/ ? ]A7^6:R[ED/8+GZ_*1Q7^IG^PA_R8)^P
MD?\ JRS]E3_U0?@2OQ#QP7_"-D7GFF._'+J5OR/U;PH:>8YPENL!A;]O]^E_
MFCLOCT-WPE^(BY(W>$O$@X.,YT/4, D<X)].<XK^$BXU(QOA6*@Y  8@ 8X#
M$XSC(!R>HR,U_=_\;X_-^%_CN/&[S/#6NIM)(!+:-?@'(Z$'_P#77\$U^7#.
M\BX0.X*_W@&PH/&<#KU[ \Y)KXSPFUIYY_V%X+_U'QMC\P^EEIB>!6_M8?B%
M+KK];R_>^P]]18[<ON<!@S%F Z_+CC!P 03@8]Z1-4" 9=F(R"223D YXSC&
M1@<=QW(K[(_X)_?LN>"?VM?CQ<?#'X@>(/%7A[P];_#GQ9XN%]X0;34U@ZIH
M5_X=MK&V?^U-.U.#^SYX]4N?M)CMC,&2/8^XBOOG]K3_ ():? K]G_X ?$_X
ML>%O'/Q:UK6_ OAQM8TVQUV;PS_95Y=MJ.EVT=MJ,=KX;LKL0_9+UY6^SW$$
MD<@C$C;E\MO?SOQ.X2X>XBP?"F9XC'0S?'U,KIT:='+L17PR>=8FIA, ZN)A
M/V<(SQ,8T:K49>P=6G*I%4^:<?P#)/"_B[B'AC'<799A,#/),OIYI/$UZV8X
M>A72RBA#$XR-/"SHNK5FJ$W4I*$FJBIS7/!J*?XF6VHL4W 'YB%#;CP-S9.,
MXQ[D9ST]:_7/_@EU,9?%_P 25Y(32/#OS$\D^;J(Y RI!*$\'C(QU./QRLY<
M!,?=RR]",,I=23GDGA7/0#<,C((K]@O^"5Y)\7_$T;@<:-X:)Q@_\O&K CCO
M@+G\#WK+Q8@GX<\32C&,5/!X9IK2]LQP3L[+M=]?U/L?HQR4?'7@&-_>689C
M%I=/^$3-?P\_P/VGO.O_  $#\,CCZ5_'A_P7/4G]N332,?\ ) ?AG[=-8\:9
M['KD#\/85_8A>]1_NC_T*OX]/^"YH'_#<6E$]_@'\,P<GC']L>-/R]S[5_._
MT8?^3L4?^R8XC_\ 3F5'^F7TAU;PP:[9WD'_ *=Q1^..W!8$ G(_]!7UI:1E
MERTA23RO-V"8 ^7O4+F')&TN%Y(!W <X]$SVX[<%N>?48S[#/)^M?Z2QG%Q3
MNE;3WG:[6]MS^#!U(>GXK_,4 9*Y.T9.XCG:,<':0,Y.<^@'N<IVP0?J/8\>
MI_0GU/>KC*-XNZ=I)Z-/9IZ>?W#6^_\ 7WB2*6  P.<\_0CM]?\ /2E50N<=
M6))/U_H.U&?E/MN_0G% #L<@@*-P(..2,XYZXY7)]N3USZ';S2?R86_.PZI(
MESG/3<3@9S]UE&/?*D_B.:K@G)!.<D%>@P"1P2.AYQGKCFK<7RD#L$!//\6>
M3D_[S8'?\J-.NW7TZDR7N3?1)I_-6_4\G<?O4<G "#@_=<,20>O?KUR"!UYI
M!@YX')[<CUP/89XZ?0=Y/,53(#$LC/&J(SLX: [A(SHJD+)MCRF'!4?,V 5S
M4:DL"6P#DC   P"2O3@G:1DC\><U] >0*>#D] #D^G3GZ<<TU]ZJ&Y"[U8+E
M?F )#':3G).!C'7'.2<O0%]_)#J<JORX**02Q+#'0$8R.N1R!2Q-(T5P$+JO
MEKY^%,B^2'#*69581H&9 &RH!P,_/\TN,6[OTWL!*;>=$<-&#MCCE<JZ.(HY
M_FC.8W8 L$)6-B&_O!33[2<6US;W?V>VO$AG24VM]&9+6Z1/^65S&LD9DA;@
ME!(C,0#O %*-Z60S<!5GN/,:WC5'D(53&TER596C"MM6W4HRS"5BHBV8-9N8
MT8^7DNZM%N+-'L4E69"  IZKANV" N!7E2;YZB:5KZIKW6M6U);-7L[.VJ78
M++2Z3L[JZOKT?XZ#E!\PMT#;BR!#$(G+;FB"$$XB)"+S@**)"5!;@K@AE)P#
MN&T," 3N4GZ >I)%2DS3+]I_U@=F$TNX$)*24WOA0J!WY&2JML( ."M0ON*X
MZC=AR/X=N<GCL2C,#G'! &. M.B6^MMV[7;;;=VTM?))VLKCU=KMR:5KMW=D
M[;V3=KI:]TKWM>/"C;M.25PX('#C[VW!.5?*E<<84]*=0#B.2(I&K&6(+*69
MF14W<#YO+Q("3@J2&5<$"F@Y&3QR>O'\149!Y!)&,'^+CKQ7/_7ST_SV\UW5
MT+@8Q@8].U+1WQW]._Y4?09)R .Y(SQCKG@\8SP:-UI_GOMM<!8PP(!&"4##
MU*L00<C^\ ?3)!R/27;VP",Y"DDKT Y  /OG.<].^6(A4Y+!N"HZYXQ@=3T
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MLO%L.M^'_P"V]-CU'4+:#PYJ7B@^(?"UU?VVH75CKFDZ/JIB9X\2^S_M'_\
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M0L](\&^!=*\:>#/"]QIFHVSZMXDT=QX7T#1'C\0ZYXI@_F:)VQ6Y;'RFWSR
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M\(R/KLQ_(G@_4=*_';0R?[5N2>ODL23P!^^;)/L.I'M@5E3^./J<=/XX^IZ
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M"6=V6-]1U*PTJRPJ@_OK[49[>SA)7/EFXGA#MA%<OA3GZIX5OK*QGOY9-+,
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M8-M[MO)<U6[2[JR].KU_=^^X('^S_P"S5_'K_P %SAG]N#2QTS\ ?AL..O\
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M;&XWIF.-RKJI&U@,L!D=2@1@V2L8/W?E1N -IY+9 /S$D#KGD$HD\R1S0QR
M1W*Q>>NU3Y@CF$JKN96="K*S-Y;+N0X;,>0<YR35EWO^ XNS3%C5=MT&5I,A
M8U&9-J+YJXF?&X,BD,AC<J6+*2V%HPCQ>6D9+AI)/-42D^6 5(=8RP2/.=S
MY3\:DCV1"XC$<-P)8A;)/.C*82LR2^?:J6"B0@D*K@KY1'RA\UHZ2;*&>\EO
MXY9XCI]]##"MW/8SRW<R-!:L)[6"Y:4V,\B7S63)'#?K$UL]Q "2?-JR_C:-
MVOM;7KIJ."O**VNTKO8J7-T\\]S+!#':I<PQ?:(8?,:$^7$BE_+RP5FEC#D!
M?DDF8 @/S]>_L<_L[_#_ /:&U?X^V'CWQ-XR\.K\(?V5/V@/VBM*C\&V.B7$
M^K:E\$?!\7BZU\.ZQ-KZM!;:5XI82:;-?Z>D]]I9C2Z^QWD9,#?'V&*DRR!
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MGWQ9I7@J34=%\4K>+9V>@> =#^(LNL:/X.\(PZ9XEH_[?O[7'AS4]+U<>+?
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MWO&C4FU_(DVEW=VM.GK]YRH^0C.<G:G)SZ@$\DX '0DGD@$XS3MQ[@CC&2I
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M^+_%NK7EW'ID?@?3?#LWPWF\-?$)7T[P-X$UJS\4>"'/B2SOM.D]-A_X*"_
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M'1K"ZDOO$XGOVEVQVXD+1"%03D#+=3U&3@$DX)Y\19]GF,IPC2]I*2E.+5'
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M8EE^=^1N. "OWL]?(M:^"OP[\.:Z8]5U"VBT2PE8RR>8'/EARY@.URPD**0
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M+'5-6T.]AFL=?M]+^TO>1:/?XL;J^ALVO4FMHY8S]7^$_C[^S3>:!X-7XM?
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MGS2C3]VW(U*[:4G:^GK^J:_J=O'<7-QK6I111!Y)I&O+PE0,,Q+)* 2>69V
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M96O&\UJK7UMJ9OAJPBN-2:_N]9%C=:;>VML&GN4M;A"S2QSL)+D!;:.VCB*
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MA+ %0"6/&2NW?T  8#L2,70M&19X[N]AEU)66U_LC3+>"Z*:_<W$S6[6\%S
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M3/DSN(7J#D'J<@_WL\GID#WJ+ Y^4<@8)&,8/)&1@YR.>1W/8%1L&"1D=>,
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M'XHB^"G[./BRZ\/_ !.^%]K\.3J3>*KO4?BG\(=0^+W[20U9]'GBNO"_P.\
M76DNND:[+J=QHWGPU^"GQ%_X)_>(/$?[/^E_"-/BY\%OV9_A_JO[4_P)^*7@
M!?#_ .T=X)OI/C7X,\0R_MP?LY_&:XTZYC^-GPU^*'A'Q-X=\%^/OAI/K>@Z
MI\+O!WB2P:S\,:YH-II.MM\%:+^TU^T+X>^+?AKXV>#OBCXA\._&'P=X3L_
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M$9U(N\:LX/O&R;]7=6UZI?H=L/'/B*STV32[#Q-XBM=.U 6D>L6$&JWT=EJ
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M9;74T&D2W<%Z]J@0*MU#O!D5L"X1I&=F;][DR8;(."N7HUZ=/F,RA&5U",Q
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M:^CCAE8Q.KC><J &)&<G.,YP2<!NG08Q4\TEDVGPP1AUE\S,@((+!223G(/
M.0 ?ND#TQJX04YRC3BN90OWO&-GT>_36]NVI+J2MK*=EWFY6Z72=DGKOVT]-
M6"WT_5"%ALX+%4$4K7$\INYWGM8#',2;G=B.X.9'&PE&"^7MY8_3W[/7CGX7
M:'X \>>$M:^&&H^,?B)KNJ:7;>"==L(G:"PDFNX(76YN\JEE%%A9&9Y%0$J
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M[72Y;-^N?',X^&GC/_L ZQGV L+LY]^G;Z]!7\WZ7 "[/,_@4C"Y'S $+GU
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MJKO*K&ORJ%PN ,#Y#/B^_N?%]AX@&EP6LMI<M(T$:D1R-N4-E&!PC'.#MW$
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MTXK[B22D[;:6Z]#YJGL_7]"X(U#!<*-PY(Y&WG^9 XY(SQSTH7*".1=I! Y
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M*235]^[ZI_A_P"BC>6\%E (77$X124YP07X)/ //7D<9Y(-16\B1&*XC@8[
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M;$!I #M5$0$\]N2.GIZ5Z'XJ^%VM>#]<DN=0A:6)7Y?YB0JN3R&&6W D!LL
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MS-9WELTL#Q2^1=VKQ30^;%))%*8I%\V)WCDW(2#6$CEAN(Y<L6.%^\6.X$
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M[Q.VH,EI?"$2.3A;EXT8JQPC%'<+C.0#D],\<8QFTFU*AH9XHSM!98YX0-Y
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M^^/VH-/_ &?=>?X2^/\ 0?B)KNC^!M<L6\-V'A7PEI'P_P#&>M>%?!EEI/\
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M]<UE.A!_95N[U?W[Z?YKJ;TZ[A&SLV][INZOILGW9] P^(U="BRYRN"=V.H
M/&>3@\#MU&>:S[>6*[N<RL'PQ."?ER&R".3V."2#WSP#7AC:Q<VK*X;> %W!
M21U!).TMZ+DY.#S6IIOBB5;A':0;2PW Y!4?)D$YQUR>G<<$US+"<O,Z<N>3
MU:VMY^7IIOMHBY5W)6T5O*WYI7W]3WB2VC;!0XC)"X0#[V#PO&,D9&?4'J,"
MH;O0K80"?R]TK+E1M!!4,Q!;'&<8Y) SG'7)Y>+Q; (8@KQN<@MEAD<=#AB1
M]?R/:KJ^*4N3$K,"BG;A7SD9ZD Y RQSV]L5RNG5LU/F5F]$I;+;5*VJWU_
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M5VXV@!B>O0-UP>OYG6G.4K)OI?9+7;\CFG%)Z+37\S%ELT:V*[8U/EG(V#.
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M+BPLKJY@N+VWL+N>U66.WD9?Z([;]@;]FOXD^+;OX7_#S]GS3])\5>"?%_\
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M]FW4P"=%U5)MNDI0BE>]2,[.%N;FM[-.JG9+1QO(_EI9C(<[1D'^$' QG)(
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MP<XK6$9  7J2O0;>O1L@?>!'./;BLR,!7 QB/8&/LV?X23][' &>G..*UXI
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M).?N@CCID9QP!0,QFM"5)8!5XY<D@D'IT'ID\G@=/2%+>-"3D$^F01G'&WG
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MY<[N"&'0@C!!(&0<# )]0*2YM&CG6./(SD9'1B><<8QUQG'R]<8 )Z.RNXE
MR4  .5++SG/JQ/N.O3H0<U7B>.6Y)&QN>.02"0> ,GY<]3C/)(QC-8RC9+FC
M#?I?_@&EH/=2?W,GT^UFA7<V1M!&6;<.?J.!C'<<G)XJO>QM/*LCE2%(.%/
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MI"9(Y S'=P#P1ALD,"5&1T R.XQG'Z-:=^SZ)XO.EM_F9-Q#1EN !D#=$3[
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M(5VG 0_+D<')/3)!ZG('3(/$M)[E<\N_X(VX]>&TI)*<=#\_!&>,#/!Z^O\
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MHSR1D\]\]<8GMH=PWDC)R/F_AYQC'3MR,$GC. :VH(]S.6&/E#*I ! &[)4
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MQ".L:WX#^$_P[_9X\$_!O6YM#A\)Z+JWAV*Z^(WQ,UGXNRWU]K^LZC>-X?\
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M\]-?3H7)+IBIPYQW+DX'![\>PQ@GOTR##]H<J<2!@%)*AC@X'3'!(S@]N.V
M:IM-DG(##IC(V]P>"><Y(SW'M31+&3@8#=#P,@?Q#(]LUJEJM'NNC[@Y)JW+
MNK7;[^;29>620X?H.FU3C&#@G)/M_CD9%2K-@\@[6())(Z\$<]LD <C&20,
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M(]NM0JG*,5QM#G:03@AB0!R#SGMR0H /-3[@ =PR.>F<X)R1UX&"1UZ8&>]
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MUHC(VCZM^9)8?F.1[4\G@XY(SQ[XR ?KD?G]:RG!\SVT2[]K]C5.ZN/0XPO
MZ 'UZ*,^XSG Z]1CFMBUC.X X "E<XY*@XY.>IQ\O;DCJ#61"I=D8Y'SKQT&
M1M.,]00QQ[8)/0UN(<LBJ3AF0[AW'&Y2W(R6W97U)QP:R_K\W^@S9M6PN_&0
M5SCO]]CWZXZ'_P#56Y"I52>#L"$@'!P%=3@^O.1QT_.L1 !$ , *K XSQ@Y)
M_'''7()[BM>&1#O/RMO5!QW(R/4Y'!)YZC'J:PD^9W]/P149*-[IZVVMTO\
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M'OG/:HY4]XV]'_D<UV_L3_\ )?R4F6BSN26'3'1L9+''KZ  <X[G YJ-]V"
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MG:?F(P5]"".2>?3C&.]027TKAE"@ \;]S$E5X'!)R2 .N>^,9JBN #QR68G
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MEXP3T.>@48QZYYP,@DC Y!Q$QXW.?7@\J,]L#&>W?J ?:M(4WO=6=N_1_P#
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MCV QUKG:NK-/OU6R9TKWDY-7:M:W6R\M_-ZN^Y;=L ;2,DX['C!/]!4?F-R
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MA %'.U,Y'/!8D <X (ZGOZYS87=@,,!B,CC &>2#[\G/KU/>JL*9(89 1B
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M>GI[5=N6+2Z)VZN__#F>[3>MVK_>E^0I.23C&2./H /Z4A) ) )]AUICRJA
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M/S.>4!FP>FTGJ1W7N,'O4P4+P,]<\DG^>:A4@,,\9! ^I*X'XU/5S^)_+\C
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MD"*,C._.<]#]T9P,X'/)/H";,9= &8@D'<1@#(#$XZ''L1SZ] :P1=/D;U!
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MK\_-]0=N,'(SUXYXSGKC!SQ4V]AC!!&01@ >_'.0>>, ]1Q3LUNFEYJP&CM
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M.0#ZC-6:K#@8(P1@$'Z"H,1::!N)3IR>?7@/TX]2.#VS3J=&OS$X/7@]<G#
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M,_7/7VQ59SDGGA<MZ[@ O3Z9..>O;T8S@G#R;L<X8C R.OITJ%W*?,K@@@X
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M1&!E>!T]!Z444 1-T;Z-_*2F445T8?:?^+]$-]/0*@G[?1OYK1170(B0 CD
M\]_H*MP@#;@#OV^M%%;0^%?/\R9_!/\ PR_])98P/0?D*J8'F,,<;FX_.BBL
MI?%+U?Z'"6$ P>!U]!Z"GX'H/R%%%(""4 '@ ?(3^(/!^H[5,H&!P.@[#THH
9H 7 ]!^0JL_&_'&&XQVZ=/3J?S-%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>forms-4_004.jpg
<TEXT>
begin 644 forms-4_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (6 [ # 2(  A$! Q$!_\0
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M "4G_P#B*/\ A;_@3_H._P#DI/\ _$5\L44>R07/J?\ X6_X$_Z#O_DI/_\
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M@/J;_A;W@7_H.?\ DI/_ /$4?\+>\"_]!S_R4G_^(KY9HHY4!]3?\+?\"_\
M0<_\E)__ (BC_A;_ ($_Z#O_ )*3_P#Q%?+-%'*AGU-_PM_P)_T'?_)2?_XB
MC_A;_@3_ *#O_DI/_P#$5\L44<J ^I_^%O\ @3_H._\ DI/_ /$4?\+?\"?]
M!W_R4G_^(KY8HHY$!]3_ /"W_ G_ $'?_)2?_P"(H_X6_P"!/^@[_P"2D_\
M\17RQ11RH1]3_P#"W_ G_0=_\E)__B*/^%O^!/\ H._^2D__ ,17RQ11RH#Z
MG_X6_P"!/^@[_P"2D_\ \11_PM_P)_T'?_)2?_XBOEBBCE0'U/\ \+?\"?\
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M_P!!W_R4G_\ B*^6,T4<B$?4_P#PM_P)_P!!W_R4G_\ B*3_ (6_X$_Z#O\
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M_0=_\E)__B*/^%P>!/\ H._^2D__ ,17RO11[)!<^J/^%P>!/^@[_P"2D_\
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M&KV_]GC[WB+_ +=O_:M3*FDK@F+^T+]_P[_V\_\ M*O$J]M_:%^_X=_[>?\
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M% !1110 4444AA1110 4444 %%%%,04444 %%%% !1112&)12TE.X!1111<
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MHHH ****3$%%%%( HHHH ***6@84444@"BBB@ HHHI""BBB@ I:*2@84444
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M:2GLK(Q5U96'4,,&FTP$HI:2D,**6B@ R<8QWS24M)0 4444P%HHHH$%%%%
M!1112 *2EHI7&-I11WHI@%%%% @HHHI@%%%% !1110 E)3J2@ HHHH ****
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M4 %%%% @I*6BF 4444 %)2T4P$HI:2F 444Y$>1@J*S,>@49- #:*L?8;O\
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M79^71Y=>7[>M_,STO8TOY4<9_P *ZT/_ *>O^_O_ -:C_A76A_\ 3U_W]_\
MK5:NM>N;6ZDF+VK1J-AMQ+DYSUZ5;T6_N;FY>*::VFW$O^[DR4'8 8Z5N_K"
MCS<Q@GAW+EY3*_X5UH?_ $]?]_?_ *U'_"NM#_Z>O^_O_P!:M*XUMTU9(?*E
M"Q/(DL48W%P%!4BF6'B'$&ZZ@NY#-*WDE8N"O8#UI?[3:_,POA[VY44/^%=:
M'_T]?]_?_K4?\*ZT/_IZ_P"_O_UJV=7U"ZM+NRC@MIF220;BH'S\'Y1GO4 O
M]5NIFN;6T3[-;M(DB-*!OQ^'&*2>(:OS_B4_8)VY?P,W_A7.A_\ 3U_W]_\
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M,5Z[I_BFVF\$7VIC1K9(H)0C6P V2'Y>3Q[_ *5Y19VKWM[!:QLBO,X12YP
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M)]?:@<X&.:*,<9[4 (W0CC(KZD^'?_(DZ1_U[+7RVY!R<5]2?#O_ )$C1_\
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M^AK5T746C2VM9V+"0,$<G)!!X%5]/L)+IHY"RI$$VY)K171HQ)"RRK^[<D8
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MZ"DIQ4*2#@GC&#Q1_#DC(Z4A#*7\:,9(!(&>] P!R,F@8$$ 9'6DHR10.M(
MI2Q;&<=,=*#U]*2@044XC9E>0>A%)QGC.*!@3G' '&*3ZTIQCC.:<BLYVJI;
MO@4@&@D CL:#T!P?RHR1G'TQ4F5$('S&3/0],4F,8[,[;G)9CU).2:0,0I /
M!ZT'&3@8%)GO0(*7/&,]>HI/Y44 .7 *EERN>GK2R-YC96,*O8#TI@YI<%B%
M4$Y].M #@0B!E;Y\\C'041,5<,K$,&& *1E;J5([=,4N/FX&T$=^>*D8GWB<
M=2>E*ZN$'F!N/E )Z>U"MY988#9& ?3W%)C*,Y)SZXS0 T D@#.>@I6.23M
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MK7A]>X?L\?>\1?\ ;M_[5J*GPC1+^T#][P]_V\_^TJ\5KVK]H'[WA[_MY_\
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M6 F2!I<)&F6VEB<]<=:@ZU(FY,."5!XR*C(Y/.?>DAL/2@44M A*,''4444
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M@'FHFAC*]!5>U%[,P]O..?PI#&V2%4XK>2Q7AN/PI6M IR!S[4>V0>S9@[&
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MD,<UQ>VZ*J[=GG*#_.M-;73I'0I=Q$HQ/$XKRRY\':B;GS8HK0@G+!WZ_I4
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MQ'&:G6P&"/#M])/>Q0@2&T0.Q4<-G' ]^?TIEYX?O;& 32&%@,"4)*K&)B2
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MGEC@^U(+G'V^AW$U]/:-+!&\'#,T@QG' _I2:CH-UIRPB9X3([;&C6124;.
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MF]Y&L,P<5901YHJ^([JUGW6DH=G5BNT@'@YX/X5!_P (QKT\YD^SK$K#GS'
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MZ4G>@04>M':CO0,/6BCUH_PH /2BCTHH .U'K1ZT>M !12]Z3O0 >E% [44
M'K11ZT4 -D^XWTK-T'_5W7_78_RK2D^XWTK-T'[MW_UV_I0!KT444 %%%%(
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MYI 0*FU\FKJ2A5ZU6E.*@:;'>@+EJ6Z(/6JSW);C-1;MU-(P:.4=QDSD]:2
M@]:D,6\4PQE.E A92H%4VP31<.PXJ)&YYJD@N6(@N>E2.@;I5</@U/'(.](0
MPP 57:&K;R9Z4T$$4QE,H11N*U+)C=4;8H$,>9NF:2-<G-,>G(^*+"+ULVUQ
M716L@VCFN9B89!K1AN2N!FHDBD=+*ZM:-TZ5Z[X-_P"1:T__ *XK7A9NS]F8
M9[5[CX(.[PMIQ]8%ITU9DU&=/ZTF?Y4OK2?X5L9!Z4=Z/2CO0 =J.]':CO0
M>M'^%'K1_A0 >E%'I10 =C1ZT=C1ZT +WI.]+WI.]  .U% [44 'K11ZTE
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M1:5:>%-,@FU"VCD2!0RM* 0:^? <M5V&/=VH"R>Y]-_\)9HO_04L_P#O\O\
MC1_PE>B_]!2S_P"_R_XU\V"W_P!FAK<8^[4W8^6)])_\)9HO_05L_P#O\O\
MC1_PE>B_]!2S_P"_R_XU\SF#':@1^U.[#E@?3'_"5Z+C_D*6?_?Y?\:/^$KT
M7_H*6?\ W^7_ !KYK2(=Q4HA!_A%*[#E@?1__"5Z+_T%+/\ [_+_ (T?\)7H
MO_05L_\ O\O^-?.'D#/W12FV4C[OZ4<S#EB?1W_"6:+Q_P 36S_[_+_C1_PE
MFB?]!6S_ ._R_P"-?-;VWH*KO;GTIW8<L3Z<_P"$LT3_ *"UG_W^7_&C_A+-
M$_Z"ME_W_7_&OETP-[TGD/[T]0Y8GU'_ ,);HG_06L_^_P O^-)_PENB9_Y"
MMG_W^7_&OEW[.^>](;=_>C4.6)]1CQ;HG'_$ULO^_P"O^-'_  ENB?\ 05L_
M^_Z_XU\M?9Y/>CR']Z-1<L3ZE_X2W1/^@K9_]_E_QH_X2W1/^@K9?]_E_P :
M^6O(?WI# _O1J/EB?4I\6Z)@_P#$UL^G_/=?\:A\-ZO9W5S?_9[F*8!P3Y;A
ML?E7S!Y#Y[U9LY[^P<O9W4UN[#!,3E<C\*>I+4>A]:F\0#)( IG]HP?\]4_.
MOEB;5-;GC,<VIWCHW!5IFP:HD76>)Y?^^S3L*R/K0ZC#_P ]%_.D_M&+_GHO
MYU\E_P"E_P#/>;_OLT W?_/>?_OX:+!8^M1J$1Q\X_.G"_C_ +PKY*W7HZ7,
MX_[:'_&G+/J"]+RY'_;5O\:?**Q]9_;4_O"E^VI_>KY2%YJ@'%]=#_MLW^-/
M&H:N.FHW@_[;-_C1RA8^H;N[4H>:^5?$$OF>(]2;/6YD_F:MC6=<B!VZK>_]
M_B:Q90QD9W)+,<DGN::0S7\.:DNGWI$AQ')CGT->B0SQ2@2=^U>1*":U[#4[
MVS4+%(2G]QN17)7P_.^9;GKX+'.E'V<EH>R:[M"VF"6(3H#UXK'BVLGS#=S_
M !-V_.N03Q3=NH$J.>,<-Q^M*?$#$Y\E\_45QU*4Y2O8]*EBJ*@DW^!W@\N/
M1SG:%W' STK OM3M-.MGF9@7QA0.I/MZ5SD^OW+1[(X]H]SFL"ZEFGE+RN7/
MOVK6&&<FN8PK8^,(M4]6R"\G:ZNI)W^\[$\57)J5AZU'LYKTUHK'SK;;NSV;
MX'_9WTS5D< S)<(X'< K@'\P:[[Q.(AIX8*OF[P%/?WKYS\-^([[POJGVVR;
M(9=DL1)"R+Z''\Z]!'Q1T>= ]S:WD<AZA55OUW9KDKTY-OE5[FU.2TNS;:-I
M/E(QZDU,L:CKS7-_\+&\/?\ /O??]^E_^*J6W^)GAR,XEL;MQZ^4,_\ H5<:
MH5+['0ZL;;GJ]NQ-J"N,^]/0MGYL?A7F4?Q=T*$MY<.HA3_"8U(_]"I7^,6A
M,"&BU)0?[L2 _P#H5>@D[;,XVCT#)SP0>:^8O$,B3^)=5FC8,DEY*RD=P7-=
M[XB^*\5SILEEH5G-"TBE6NKAAO4'KM [^]>8UI2@U=L)23#%(11WI#709C32
M4II,4 +112XI@&:4&FT4P)*#30:7-  >*]L_9Y/S>(O^W;_VK7B)->V_L\_>
M\1?]NW_M6HG\(+<D_:"^]X>_[>?_ &E7BE>U_M!?>\/?]O/_ +2KQ.IA\("T
MAHI*L I:2C- Q:2C-;NE6-A'H5UK6I02W4<4Z6T5M'+Y89V!8EFP2  .@ZDT
M 85%=9IOAZP\2W5TFB*\2[8 HNI3^XD=PI&0/G7W..*C_P"$*D:)+J/5K*33
M]DKS785PL7ED!@5(W$Y9<8'.:EZ;@<MFES7=7/P\>>[4:?=+]D2UMW>X$<DH
MDDD7/RA5) XSR.*IQ?#S46D2WEN[:*\DGEA2W*NS'ROOMD#& "#ZGM2N@.1H
MKM?^$%:PBO)+]GDC^RI-;2*CQ9/G)&P96 (P&/7V-%WX DFOM573;R+;:RS^
M7 RNS!(V(^9P-JG X!.30!Q5%>D2^"]!MM(1I6N2YD\AKK?C]YYAC^5>A&X$
MXQR ><UR^G:/:V\&L7NJ))/%IDBP>1%)L\V1F*C+8.%&TGCGI2N@.?I:W4T[
M2]<U.*/2I7L4,!DFCN=TNQP?NIM&Y\\$#&>OI5^3X?WL-Q<PRW]LCQRPPQ H
M^9GE7<@ QE<CKG&*8')TE=#XA\'WWAZSCNYI%F@:4P,PB>/:X&<?.!D>A''%
M3_8M!T>TTM=6M+JZEOX!<2RPS[/(1B0NU<?,<#)R<=J5P.6I>:Z-?"$LUD)X
M+^W,TL#W=O:.&$LD"D_/G&T' )QG/%6YO %Y#J5G8-J-IY]R&)R'41XCWYR1
M\RX_B7(S0!R-!%=9_P (+--"C66K65W)-;&ZMXHU=6FC#;6(R, @YX/7%:5I
M\-+B/5K.+4;L+:23F"=TBD0HX4L "R_,#M/S#(XHT X"BNL_X1!9=+M-0:]M
MK.R:,E[N5G8.QE9%PH7(SM/X#)J"]\&W%AH;:I+J%FR9;8L99ED"OM.UP-N>
M^W.<4.PSFA3@*V]%\-'5M.>^DU.ULH5N4M09PQ+2,"5 V@\<=>U:">!+P+"M
MQ?VEO<2&;,+AB42)B)') Q@;?J>U)Z!<Y:BNF/@UUC-V^JV::68DD2^*OL?<
MQ4*%QN!R#GCC&:LZUX,-MKXM+&9!;S:A]@AWL6(;8C;B?3YZ N<B*>M='#X0
MV_9Q>ZM96LLV'6!]V]HM^S<#C&>I"]33SX4^T^,=3T73[M3#9M(WFLK,=J'D
M;0,LWT%(9SH%/ KJ=/\  5_?O/Y5U"8TG^SQRI'(ZRO@'^%?E'(R6Q@TMIX0
M=+FPCNYX&N+L2E;/<RN F\$E@"!@IT[TA'+ 4X"NKE^'VK111,9(_,,D4<J,
MCH(C(0 =Y&UN2,X)Q65J^AOHVI16CW$<Y?KM5D*G=@AE8 C_  HMK8=S-[4
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M-9DC98U8DDXJF[?-3 N6[XJ\DOO65$^*LK)Q3$7_ #N.M(9O>J1EXZTGF^]
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M:%^]X=_[>?\ VE7B->W?M"_>\._]O/\ [2KQ&B'PC844458@HHHH *3%+10
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M4@/-)29I<TACA3LTP&C- #B:C<TI:HG:@"-VYIN::QYI :8B=3FG5$IIVZD
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M &RC_AGW_J9__)#_ .V444<S /\ AGW_ *F?_P D/_ME+_PS[_U,_P#Y(?\
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M_P#DA_\ ;*0_L^Y_YF?_ ,D/_ME%%',Q7$_X9]_ZF?\ \D/_ +91_P ,^_\
M4S_^2'_VRBBCF87#_AGS_J9__)#_ .V4?\,^?]3/_P"2'_VRBBCF8!_PSY_U
M-'_DA_\ ;*/^&?/^IG_\D/\ [9113YF ?\,^_P#4S_\ DA_]LH_X9]_ZF?\
M\D/_ +9111S,!?\ AG[_ *F?_P D/_ME+_PS_P#]3/\ ^2'_ -LHHHYF ?\
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M *F;_P D/_ME%%',P$_X9_\ ^IF_\D/_ +92_P#"@/\ J9O_ "0_^V444<[
M3_AG_P#ZF;_R0_\ ME'_  S_ /\ 4S_^2'_VRBBGSR 3_AGW_J9__)#_ .V4
MG_#/O_4S_P#DA_\ ;***.>0"_P##/W_4S_\ DA_]LH_X9^_ZF?\ \D/_ +91
M11SR 3_AGW_J9_\ R0_^V4?\,^?]3/\ ^2'_ -LHHHYY )_PSY_U-'_DA_\
M;*/^&?/^IH_\D/\ [9111SR /^&?/^IH_P#)#_[91_PSY_U,_P#Y(?\ VRBB
MCGD ?\,^?]3/_P"2'_VRNX^'?P]_X01M1_XFGV[[;Y?_ "[^5LV;_P#:;.=_
*MTHHI.3:!'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>forms-4_005.jpg
<TEXT>
begin 644 forms-4_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '" R # 2(  A$! Q$!_\0
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M&YZ  =CSU-*R*V21R>I[_P"?\]:SE)IV5NG0TC%25VWN]O*WD09V@9_'_/\
MGOWP"[DCA6(/H,>WJ#4NQ1T 'X?R]#Z']*4KD]6'T-9FHU%*@ _7 & .O4CK
M^0[8X!IY./T_7B@D#K2CYAD\#DCU8CI]!D=^N/K3L^S D12,YP.3WSU"C^AJ
M2BBN:[EJ]VELK=/GW **** "BHE*,<!V.!GJ1Q^(%2 '' 8CU_'WQTZ5G*I!
M)\LU)]E&2MIOJ]?1:MM>8"T4Y4)/S<#GHW.<X]![T[RE]6_$DC\1WKD==7;=
MO/?IIT35^^H$6Y1W'\_Y4H#-@@?*3US@X!P>,?7%3# /5?PP/S.?\*7(]1^?
M^?0_E6<JTI)+EY=;W=WTVLTOS C$8SWZ'^(GT]13]H"E1[]?4Y/\Z=163NW=
MO739);&D(QDN;7=[/31KR?YA1112:O\ Y]?QN:!1110E8 HHHI@%%%%)V[?D
M 4PCD_+GWSCL*?14^TMK%6>VJ6PUZ)^I& <@A<8SWSG^=.;)!X'YGMSZ4ZD;
MH?H?Y4U6FVEIJTMN[7GYDN*<KZK5:)Z:->0M%(&!Z'^=+74/;<**** "BF[U
M]?T/^%&]?7]#_A0.S[/[AQ&00>AX-5R-I(YQU4GG(P,\^Q]?:I=P[$8XY()Y
M.?IZ4UPS 8 .<X;E<$$#OG.<D8J7**;3>OS_ /D6OQ$,HHVOW _ $_UHVO\
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M$].]0_SYY^IR?S-/E8 !2>6X7TR#U_[ZV\>Q&.33*N$FVT[;7VMU]0"BBBM
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M'&"./\\U5.M9\JO:U]4MU;I?L]Q_C\O\G?\ 08-S9PO3'4D=<^H'I3MCG&0
M,C)SGH0>F*FR#T(-+6_/*2W5G=;+S7<.O;^O,C$8&<DMTQGC'7T]?Z4[8OIT
M(/4]0<CO3J*5EV7W+_(04444 5W ,C9&?K_NI28'H/R%2.@PS<YP3P<<@?\
MUA48/4?EG/3 ]?K^'Y4&L&K)=5>_WA@#H *!T_%OYFEI!T_%OYFBP3V7K^C%
MHHHH,@HHHH **** "BBB@3BF[M7>FMWTM;K;HNA7[M_O-_Z$:*.[?[S?^A&B
M@J[[O[W_ )A2-T/OQ^? _6EH//Z?H<T?U]W_  Q$H)MN[N_/2Z5ET?97U$Y]
M!^9_PH!S^OZ<4M)@>I_,C^6/K5J;3][732R7^?8R<7&U[:NVCOTOV701^$;W
M!'XG@?J:AIT@/ !(!!SU/W2I&,GBH2"!G<3C_'ZUHG=77X^0^5M<RM:S>^NE
M^EO)]22BBBF2%%%% %?NW^\W_H1HI P8L1G&XCGU[_J<^V<=J6@ HHHJXR22
M5GOTM;5Z=?/L 4445J 4444:73MLT^G1H3U37DPHI.I[]!W(ZY]/I0> >>@/
M)K924G97VOJO^"8VL[==/QMU^8A(7)/0!>GN2/ZU#UR?4L?P))%.?J #P<YY
MS]T@@9/3D\TVMXR5DM;[;'/)IMM;/NK/9(**C,B@GK@<9 R"?;\>/KGTH$@+
M 8.#T8].F?Y59<(M:M635EWWOMTT)****TC))):W_P V:",0HR>@QTYZG%5S
MT8^NX_@22*<Y))&1M!';V#=?K2=:T_K\4"W"DYYQV&23VZGIWX!]*4*Q^[^.
M>?YGV_6D(9<AOXMH!X[Y!'4\@,?R[YS6Z::NNO?UL2YP5US1YET>][::?=U$
M&>0#WY/7GN .<<8'/3I@]:=TIN#C ('IQS_/'Z4HY ^@IG)/F;O+JW;7_@=K
M?DDDM5HHHH("BBB@ HHHH WSD=58?4=_PS1G/^<?SJ<8SPQ/MG-(R@G)3=QU
MR!Z\<_YYKSST"*BI?+3L,>XX/Y^E)Y2^K?\ ?1H^2_KY@1TW/)' ZXR>N.IP
M,G [''+80?.RJ7$8(&X-QR!C(ZG/&>.@Q[BO3OAEXSN/#%[=:78_"?X<_%C5
M/%-[HNF:1I7CKPIK/BR_@U+[3-;6MAX6L]%U[0[E;_7;F_AMYXO]*:\EM-/B
MA1).3SXJM4H8>I6I4(XB=-*?LYXK#8*FX1:E4E4Q6+O0HPC2C4DY2C*3Y7&F
ME.490ZL'1I8C$4Z-:O+#PJ-Q]I#"8K'5.=Q:IQIX7!?[16G*HX)1@XQBFYS;
MA&49^5$%G!VD8VYW C&'QW ZDX!. 0"V=NUFFR>  ,G/&1V.">><#N2 ." 2
M>*_1_P 4>#_AM\2_BQ\$_P!EJU\$_"7P+XV@\1ZE??M!_$[X1:%=VR:==V&D
M7^NZW\+_  2]WXDUS2]</@7PYI6IZ?JNM%6B\1_$6XDL;5Y?#^A6D^J_/UQ^
MT)\-K>]EM- _9,^ O_"N XBLM"\36_CO6/'UYHH*[6U3XKV_C;3M>'B>XMP9
M;O5M#M-)T^TOWE.GZ!#8Q16L?S>"XHKYC3I?4^'\=5Q4\.LPJ86>99+AU1RR
MMC\;E^78I8C$5(1Q$L[>7XS&Y5AJ6%HXFI@J%*OB/J2QN'I'T^-X6PV75:JQ
MN?8*CAH8AY?3Q-/+LZQ,JV94<!A,PS'#O#X>G.6&CDJQV$P6:UZV+JX>ECJ]
M2AA_KKP5>HOF'KT!(SC*C<N<@ ;AD9.?NYW9RN-RLH3>,$C!  8Y." 3P3D
M*IR/G8K& <LZA6*_I1X9^''[/GPM\3_M%:AXV\!ZA\2_A'<? CX)?$?P$FKW
M0;XE?#KPM\?]:^'/EZMI-_:R6.E7OQ&^'>A^.[V&S_M*U?0/$E_I%K+>6ENM
M]&\7D-C\#=.\!-^T)9^(H]!^(GAJ/]G*X^(_P5^)EK9R-H_B32=0^*7PUT/2
M?'_A8-*K:9K$&E:GKVAZ[H>H&YO?"NO-JFAZO9K>V4CGFAQIEN+E5A##8R%-
M+)ZF$J5%3IQQ\LQJ99AL5AL-*K94\3E57-:-7'87$I8F.'IXO$X9XS!X6I5I
M[5.!LTPT*,JF)R^=6=7-Z.,HT:\ISRO^SJ>9XG"U\7I:MA,UI997I8+%X24J
M+Q$\'A\1'!XO%TZ53XVR2< 9YP3R ,#)SQD <\D<E6 Y !0G'4#TZYP1ZX&!
MZ]<@=0#D#].?$?@V+0O"'P/E\#?!;]C2^M=>_9X^&OC/Q%J7Q4\3>%=*\<ZO
MXIU/1M1O/$6I7.AZO\6_#>M2?;_L DTZ.S\/A-5G;RM,BN)YECKX2TNTF^-_
MQ>\+:)IFB^$?A_<?$SQEX-\(VFE^%=,GTGP?X=G\0WVE>'(;BQTR[OKZXMK:
M*2X:]O8IM0N6$RS S_O#LK*.(*.<T<1BU@X83!X:EB:E6O4S'"8FM36&QF88
M3][@J.$HUZ<Y1RG'UU#VLXNG&BHR;J:X9UPQ5R:MAL&\7/%X_&5<-3P]&&68
M["X>L\1A<OQ/[K&8K%5J-2$'FN HNHJ<+U)U;12IZ>:9. <<,,@] 1R,J2 &
M&1U4GJ/[P%)NY(QDC&1SE0S,H+\?(,JW+X7Y3AL[=WU[XU^+OPO^'GC#Q-X"
M^'O[-GP:USP/X/U[6/"\>L_%G2/%?BOXE>.(=!U"[TB\\3^)O$MGXNT4^&M7
MUU[&345TGP=8Z+IGAA)XK"W^VM9/?7.7X;M/ASXP\!?MB^+-%^'&E^&+/0?"
MWPUUOX=:-=:OJGBJ[^'LNK_&'PKX=U>#2?$>K3_VA?\ VK2KJ^L'N-26>0V<
MZ1A?,A$[Z4\[KJC1Q>)R3&X7!XF>4K#5ZV,RVI4G'-LRRO!4(U\+A*DZ^"K2
MI9Q@L1[/$.LHTYRI2K?6J-6$\:G#])UZN"PN=8+%X_#QS;ZQ0H8/,J=*,LIR
MS-L=7J8?$XVG"CC:$:N2X[#.=!492J052-)X6K1G'Y7SGIC^'J<8W$ 9P#U8
MJH_O,P4<D F&;<,8PN22&P!\_P Q.W  $;DY(*@#>%W+GZ$_9)\->'?&/[3_
M , O"7B_0].\3^$_$GQ7\&:'XE\/ZNKMINL:+JFLVUG?V%\8[FRD2WG@F*R3
MQ7=M) @:=;B$1;U]7^(>K:UX)\+:C?ZM\#/V($L=4O)?"-M>_#[5O#?C/Q?I
MEYK>D:XUKJ]IIWA7XO>(K_3)M-BTF>XM=:U#2QIMGKO]G077G7$ILP8S/?JN
M9X;*:6"^L8FO@J.,E*IF67X**57$8C"\M&EB*52M7FJN%J\Z=2A%)Q]G*96#
MX=EB\HQ&=2QOL,'1Q^,P/N99F.-=.>&P-#&*IB*N&J0I4J4UBJ/(XTL1-J,O
M:0@FF_BS)YXZ#+8W$J 2I+;5(PK*RY!(9D98_,88*9;(&PDYQ@')!W!<>F=Y
M"XSUZX&37WA^S5\+_AE=> H+;XI^&H]1\0_M.Z]K?P?^"GB>_L]2E@^$\NBZ
M5+:V_P :GGLF2$6%]\6]5\'>!I)=3WV \-Z5\1+U+=]0L+6YM,#]G'P_\+O#
M&G?M20?M%?#,^([;P-X9\,^#-3B2*XA\;_"W7-=^)]A\._$7C#P5#]JM;.X\
M;^$+:[NKS3='UQ+K1=1OM.>RNH8T=;VSX*W$^'@\WIT,!CL76RFM@Z,*&']@
MZ^:QQ&,PV65ZV61J5(PJ4\!FE:IEM;ZQ*E[7&8>OAZ4E5GA'/HH<(XJJLDE5
MQ^ P=+.</C*TZV)=54<HGA\%B<TP]'-I0IRJ4_[0RJA#,\'4P\:S>"Q%#$U8
M>RABXT_BW<><*3CEL9.U>#O) ("@$9)(P< @%D#+N/H/S[\#&,9!!."",CN,
M\5]@1?!*V^'MI^TIIWB.WT#QSI]K^SUHOQ'^"_Q'M())=%\1Z+KGQL^%WA_1
M?B+X1=Y5-I=W>A:SKVAZIIM^C7_AS5#J?A[5;.'5=(G(^/!D@<GHH![GY5(R
M>#DD'GDY)R><5ZF S7"YH\4\%*-2EAI82$,3"4I4L5/&X*./@J2G&%2DZ-.4
ML/7IU8PK4L3AL31K0I5J5:E2\;,<HQF4K"K'1E3K8F&,J3PTXQA5PL,%C7@9
MNI*$ITZJKS4,30J4I2I5<-B</6HSJT:M*K4DY]!^9_PH' _$G\R31D>_Y'_"
MC(]_R/\ A76Y.5KM6WVMT]?,\P6BF$GGY6QR0W(R1T&#P!U&3P=IS2J6(!*G
M/.0,<<D>OM2-(QBU=WW>SMV\F.HIWEMC.0#GIU '/IR3T.?KZT>6_JOY'_&@
MT&T4[RW]5_(_XTUED4#: Q)'MCKGWQP/S/M1==T 4F>2/3'ZT@WC[ZX'J,GG
M\OK0/O-^'\J3>C:Z*_XK_,:Z^GZH&+=% )XZ\#'/?UXH!./F&#W !(_/'I2]
M_J!^F:6M%&+BKMW:N[/NO1A_D)D>_P"1_P *,CW_ "/^%+29'3_/Y]*7L:?=
M_?\ \ /E^/\ P R/?\C_ (49'O\ D?\ "@G'^<_RHR/?\C_A1[&GW?\ X$O\
M@^3^\,CW_(_X4 Y_7].*,CW_ "/^% Z?B?YFIE2@DK-ZONGT8=-K?,#] >O!
MSCZ\=Q_4TZ,?,PP!G:0!G VGD#OW!^II*55888$?='!'/."1^)''IG%9N"LU
MJW9JU^K3MT\T"W1/12<^@_,_X49/H#[9//MT[UR^SJ_RK_P+_@%>SEY?>@[C
MZ'^:TM-!);E0N >C9SD^_P!#3JZJ2<8)25G=MJ]]W=:^A+36_1?UJ%%%%:""
MBBB@ J%_O#_@7\DJ:HW7.>H89VGG&2 !GL1D#O07#=^GZHCIH..#GJ>Q[GCG
MIW]?UI1G)![<=1@\ CI^.?J!VH/3\5_F*#2236OK^#%HHHH, HHHH **** "
MBBB@"OW;_>;_ -"-%'=O]YO_ $(T4 %%%% !1110)I2T=]'?1VZ6[,BDZK]&
M_FM1,,@C_/6G,V6[@ ,.3DY!&3GN.PZ=,X&<4A('^?\ /'OTK6'PKU?YL+)*
MW2SZZV=[ZV\WT$W'T_\ 0O\ XFE!R/\ /H#_ %I:8& ZGT]?[HJS.<5%)J^]
MG=WZ7[+J/IK_ '&_W6_D:4,#T-12N1A>S8!P,GYLC\!P<GZ4$#:*** "BBBC
MMZK\T 4445T %%%% "=#WZ#L3TSZ?6D))!PO!'!R._?%.J-FP@P0#\H'XD9X
M^AJZ>[]/U,*K<6I+>3UNKK1)JVWYLC[M_O-_Z$:0_P!1^A%+_4DGZDY-%;+=
M>J_,YMM>VOXHK,"K$D9^\R\]B>>W!Y_+CZJ7!0+@Y 4'@D?*1GZ]#3W4-N//
MW6Q@\' ! ]\\_7'M48Z?BW\S70]ON_'_ ()W<J:BO)/YZI_+K;O]Q-&P*@<Y
M4 '(QSBB3[A^J_\ H0J)692VT!LD9'/H>./IGFI25?Y2>3U /((YQD>F*%NO
M5&<E9M+9$5%)T)'/!(Y] 2!]>,<_G2UN2*&"MR#R#T&3U'Z?_6H=@Y7&>,YR
M,=U(QZ]*;W'T/\UI:I2DE96^XYY).;=M;[W?1*W6P4T'H.<@>GI@?C^%.I.X
M^A_FM:1=U=VOK^?8B:O&_;7[[+46BBBJ,@HHHH **** .G2/ RB]\<D<@9!)
M/)SD?3'/4\!RO!4YQGCG]>.>*L !1@=!GKSU.:6O//6Y(]OQ*P.>Q'U&*6IG
M&1C=MYZ\>_'-1[!_ST_]!H)<-=-O,@\I1]TD?K^A_G7M7P,^+&F?!CQ+K/BN
M?P4/%VO7/AW4=#\,ZM'XGN_"^J>!;O6(FLM3\3^&[NSTS4O)\3G2I9]/TG5I
M8FGT)[F;4M-$>IPZ?=67C&)5Y<+CH-N2<^XSTP#^.*]>^$/PVTKXD'XJC4]5
MU;3)/ /P9\:?$[24TNQM[UM7U;PK-I$=MHEXEQ)&T%A?C59#<WEOYMS;F*)8
MH7\Q]OF9U'+Y97C89JY_V;.%*GC/95,72J.E5QF H0A&6"K4,1*,\3BL'"K3
M4W3G1=:->G4HJI3GZ>20S/\ M7!/*(T7F<)UJF$]NL-*FIT<'C\15;^MPG0C
M)87"8SV<Y)5(5O8NA*.(]BU8;XD^#_#MUH/B+X2_#W6?ACX_\,>)]&\2:%XQ
M/Q,U'Q@UB^F/>RR6HT;4O#FF64YO)Y;%YKBX:XB:"TFL;JTN[749D7>N/BM\
M&M1U67Q-JG[-6@OXEN9GU&^TS2/B/XOT/X77>J3R/-//_P (-;P7&M:?IDMR
M_GOX=TKQS8Z6$,]E;K:V$X@@YWX4_"^S\?6?Q<N=:O\ 6M$'PY^#/BSXHZ6+
M'3K:8:QJOAS4O#]C;:'?MJ#0M;V%['K4DLMY9":]MS$J);RLZ Z,G[._C^'Q
M?H/A,WGA*2U\2?#[_A:FF>/H=<GD^&G_  KV#1KK5=1\2W?BS^S0EI;:+/97
MGAS7X'LGNM,\:6S>%'M$UEHK*X\*NN&:>)Q&"KYAC*6.P$%"O6J9UG-/$2PM
M7!_VC' U,P>->)Q^"4*-#,_J%'&5_J$<9B,-1PJ]NZ</=I/BF6%PV,I8#"5\
M#CYIX:C')LLJX=8JGC_[)ECO[-K83V669A.>(KX&IB\1@Z#QJPM'&5<5)4E5
MJUM4^.GBCQ$?C;=^*+:UUC6/C=H_A30]1O[=O['L?"VG^#_%'AOQ#HUCX>T6
MRB:RBTC3;/POIWAO2='!MK72M&ACCM7\R%&%SP3\??$7@_X1?$KX,W6EV/B3
MPOX\TIK30Y]3F=+_ .'.HWFN:'K7B#4/"LL<#NMEXK?PUH,'B+0)9XM*U$Z=
M;7TD?]HP179O0?LYZS_9_@*\U/XH_ [PU>_$KPWI'BSPGH?BCQKK>D:O=:-X
M@U*_TO2)-0(\(7&BZ,UU?:;=V[_VGKEM%:I&+J]N+.V?S!3L_P!GKQC;Z?J6
MJ^/M<\#_  ?TK3O%'B#P1#=?$_7+_2[G6_%7A*[33/%.F^'=!\.:/XK\2:_:
M>'=2ECL]8URPT5O#FGW\D.E2ZW)J?F6QYZE3A"M0>&E/!K#_ %[+L1AZ,(9A
M[7ZUD^,A@<#7P$:&6?7*M3"8W*(TYO+(8R'+A<31Q7-"ICZF(JG3XVH8EXN$
M,;]:>$S##UJ]6> A2^K9Q@ZV/Q^'Q\L3F7U*A2Q>$SESI_VK4P3<\5AZN&Y:
MD,NHT=+7/C-\-/&.G>!;;QS\$9=?U;P+\._"'PX@UBQ^+.N>'X]4TKP=;3VU
MA?7&EP^%]1@M[R<7$TDZQ3/ "RHB#:"?%]9U?27\3'7?!.CWW@>SM+G3;[1+
M!?$-YKNHZ+?Z=' Z7<?B">VL+NYN!JD3ZG:S&V@^S2.L2(5C%>H3?LZ_$Q/&
M7A_P586?AS7W\6>'[[QEX:\8Z!XFTN]^&^K>"-)6^?7O&H\<3SVFCZ3X:\-#
M3-1B\5WOB"32[SPM<6%U;:YI]K>B&TEHZ]\&GTO1[O6=%^*WP6\=0:9=Z=9Z
MO9^$?&FH'6K :KJ=OI-I>0Z)XJ\.>$]1\3:6M]<PQ7.H^#X-<MK19ENKP06I
M 7;!SX>P?LX83'2]GBJ4W2PM3,<[S/"T/KF*QM7E>&JQQF RVG4Q+S"4:6+_
M ++C3DZU&-.G*FZ%/GQU/B/&QKO&8*G[;"5:<:V*CEV197BZLL!AL%3DGB:3
MP>/S*M1PZR^$JF$>;NK'V-=U:T:OMJO6Z[\:_AUX[UJY\;?$?X"Z1XC^(.IS
M'4/%.J^'/B#XD\!^%?'>NRD37VO^*_"&FV%_+%JFM7#/=Z^?"'B#PK;:M>RW
M5X(+&XNY&2IH/QVTJWO/C'_PD_PK\,ZGH?QDT?PYHNJ>%O!&HW7PTT/PY9^%
M_$&D^(=)C\/Q:?8ZZT8271;&VN9;L7-S>Q+<75[<7.I7MQ>MSD'P,\977QNU
M']GZ&]\+?\)]I?BGQ!X/N;A]9E'A<ZSX9M[ZYU98M;:T+M:1C2[V*WN6T^/S
MIT2,A#(K+R'B#P%K7AOPM\.?&%_/I,^D?%'1]?USPNMA>R7%\ECX<\4ZIX0U
M#^VK62W@_L^Y;7-'U!;:W22<RV<4=Z6$4H Y88+AMQP^%HU6_KF#P4\MP\<Y
MS>M&&"L\TR[^RXU<RJ4L+3KT\MK8BE2IN%54,.J%Z>&PU'#FM3,N*X2KYA4H
MJ#P&+Q\<?BJF3931Y\<[97F?]I2I993J8FI0EF<*%2J_;4'B<2L1>>(Q=6N>
MK>#_ (R?#?X>>-OA[\0_ OP6NM&\2?#[QYX=\:VQU7XK:OXAL-6MM DN+@^'
MY[>3PSI;:?#?WALIYM2LV>XBBLY;182M[))'S%UXN^!\]M>BV^ VL6-_/:7<
M=K?CXTZW=BROIX)(K:\-E)X1MUO(K6>1+K["US!'=^1Y$[LL\DJGA3X)ZWXB
M\)6WCW6_%7P_^&O@G4]5OM"\/^(/B+KVHZ8?%>K:7';2:K%X3T+0-!\2^)M<
ML]$^VVL.MZS;:))H.F75Q#IMUJJZJTEC%T-M^S/\0KCQAI_A5M5\ 066K_#[
MQ7\6-$^(2^*C>_#/7?AYX*TW4=4\3Z]I7B?2M-U2>ZET:+1]7AU#1)=-L_$5
MAJ&ESZ/?Z1:ZL\%O=JI_JY1Q%:<LSQU/$X>C5HU:CSK.G.4,)BYXW$82K7C4
ME0QJP>(Q=1+!87%8ZOA88FK3GA:=1^PCK'_6BOAJ%*EE6!JX*O.E6H4Y9)DG
M)&6/HQRW"XNE1G&%; ?VA'"04<;BL+@<-BJF&HU(8N=.U<B\2?M*?%.^.AZ?
MX&\9>._A7X/\,^$/#7@O0/!/@OQ_XGT_1M/T_P .Z9':W-\\=A=:7;WVJ>)-
M7?5/$NO7D]IYT^JZS>A9&ABMECM>-/V@I?&I^*][=^#K.TUWXT>$_AOH_CS6
M8]9NI#J?BWP)J^AZYK'Q!:Q-C';_ -L^/]2T&'4O$EGE;*'5=2U*_LF5Y5CJ
M@/V>?$][;:7J/A;QM\*/'>E:AXY\'_#O4-2\&>+=0NXO"_B'QY>7&G^%;GQ/
M8ZQX=T35[#P[JEY97L']OVFGZA8V4T7V*ZF_M 1VMQMZ'^S)XCUR;Q=86OQ.
M^!MKJ_@/3O&NK^+]'U3QKKUEJGA[2_ .OW'A[Q!J&H6\?@Z[A>VAN;9;RUBL
M[R6]OM-U"RGA@$IDCCY9_P"I6#5.O'^SL-5PGLINIA\)C\'B(I8S XARS&I2
MRA8S&SIYU_9M:$\XAB,35S/%4,1.NZ&*E.INI<=XOVE*2Q^*IXIU(_5\1B\O
MQ6%J3E@\QPL5@(U<W6$P,*F23S&$XY/*CAJ>7X*KAXT%B<-#V6+X1^/'B#PO
M\&/B-\$+O2K'Q#X:\;6,5MH%[J$[0ZE\/+F?Q'X=\2:_)X9N([:0C2O%MQX7
MT5=?\/RNFF7%UI=IJT4<>J(]S)X.T:DKG/!51T[  87D( !P!P!C@5]!6O[/
MNH7/A_6O%K?%GX%VWA#1/%>D>"I?%=QXQ\3'0]0\3:UX:NO%EO8:3):^!;R^
MN4M=(M+M+VXNK"TB@O[6>V\UW:$2>4^+O#5OX3U2#3X/%_@WQM!-86M^^L>!
M=1U75-#@-S+=+)837>JZ'H5XNH6D=J&NXA8A(_M%KLDF$GFGTLOK9-]8S"&5
M.B\9C,74Q>9+#X;'TWBL7'"8*G7EB:E7*\/A(8AX>&#J58_6HU)<\95H3KRJ
MU*OBYG1SZ6$RV>;JM+"8+!4\'EU3$8G U'2PSQ>+JX?V%.EFV*Q<Z3Q%;$T8
M<N&J17L7&E.-#V5.CS5%?2^I_LK>--/\67_PYMOB%\%==^)EA<KIW_"N]'\=
MZA'XLU+6C:PW2>'=#CUOPMH>@ZKXBNA/%!INCVNO/=:K?2IIFGK/J#Q0OP>A
M_ _Q_P")++X;7VC1Z#-%\4;GXA0Z+'>:Y#I;Z%:?"J.*X\?:UXUGU."TL_"F
MA>']-F.KW>KWEQ<VPL+*_N-D9MVM*<,ZRB=.-6&8X5TY).G.<J]!5(O#UL7[
M2"Q>#P4W2^JX;$XA5E2=&=+#U72JU9J%&M$N'<\A5E1EEF*]K"7LYPIJCB'"
MK]9I8)T7]3Q>-C[>.-Q&%PDZ/M56A7Q>'C.C&$YUJ/C[N""H!R& Z<?*W//X
M'_\ 71&/O-V. /\ @)8'/^>GY5[/??!26---?0/BQ\$O&YU#Q+X=\+26OA/Q
MGJW]K6&I^*-0&FZ;<3Z-XE\,>'-3U#1DNGS>Z[H%GJVG6D(BFN&CCN(//V+[
M]FKXFZ=X&^*OC]!X9U31/@S\0]6^&?CBRT?76O?$%MK&B7%M9ZMXBTW1&L8K
MK4?!.FWU_I]MJ'B9)%L].FU'3DU!(%NE=R6=Y13=*-3,<+2G7K4<-0A7=?#3
MJXC$XJ."PU",<7@<'*-7$8N=.A2C5C24IU:=ZJC+VD=*?#V=R57V>5XNLJ%*
MOB:\L.L/BHT</AL%+,,37D\'C\:I4L-@J=7$5I4IU7"E2J2=*Z4)^"T5[3X3
M^ _B_P 8_P#"(/9:UX(TFV\:>"/B/\0[#4/$&OW>GZ?I?AGX57FMVGC&XU]K
M?1]0N;&XM6\.ZO/IUI;0WDNH6L$;JT<L@4Z&B_ *\\4^(?"OA3PC\7/@=XK\
M1>,/$UIX9TS3=#\7>)L6LMW8:GJ!U75+C5? VFI:Z):II4EM=W</VNYAO+W3
M(UM)(KKS5JKG&54IUX3QU'FPR;Q'+3QTEAW!XN-2->4,LJ1HRIRP&,A-5)Q]
M[#S4/:WIJJJ>1YO5C0G3P%:2Q4Z<,*E4P/-BG6^I>P^JP>;1J8GVRS' NG&A
M2G*V)ASJGR5G1\&HKU?5_A2FGV!N=)^*7PC\<ZK)=:78Z9X.\!:YXMUOQCKU
MYJVHVFFVMKHVDWO@C2(+^=);I9[B*"_6<VJRFUAFG5(SU=_^SGK^F7E]X?O?
MB?\  >V\>Z4EV-3^'5Q\38X/$5C>V,3R7NA76O3:+%\-E\36/E2Q7>@0>.)+
MZ&]BGTZ0'4H7L4SEFV6/DE]=IKGORQ=#,8SY825.4Y49Y13Q%.DJDZ=)UZV%
MH8:-2I"G+%JHY4X']B9K>:^I3_=\JD_;Y:X<\E4E[*-6.=2H3K*-&O)T*6*J
MXEQH3G'"RINE5K?/M1E02<KG/\6<'TR!VP,#WQGO7T-H?[.^H^(_"FJ>-=,^
M+_P$_L'0--\+:CXD>\\<>(K>^\-MXQ98M&TS6K2+P5<!=5%]OT>^M]-EU"&S
MU2WNTDN%@5)QAV_P'\::CX&^*WQ*T34_".N^#/@_K-AHNN:KI6MRS-XF%[J-
MAIDVL^ [&XL+6]\3Z#HSZQH=YX@U".*Q?0;#7-&O=4M[>WU" 29K.<I;J_\
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M <9!R:.:/=??_P  GFCM<_%/NW^\W_H1HK]M$_X-^_\ @H2Y;]U\"E&<C?\
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M'0M7MFVEOWVG:I;6EV@8@@%K<*W&QE!%:JI"5[26GG_7Z=RD^S_1_F9.,/@
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MMAAZ5?&\TL14E6AA<-7<'4JXJIA\+SJGA9X[&*,JRJT5@LZ'%6-PM=8S#87
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M5T3Q-;6=[HOB7PAJBO)/IUPT%[ MO<&1?D8KD=NAW9&.QQVR&4$X888 _*0
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M>Z-8R;=G;;L1T4AP&*@YQC'.>, ]>_.:7.>E%UW18UAD#DC# \>H.1^&0#^
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M]2__ ()>_#;PG\*?^";G[#_AOP9IEOIFG:_^S)\'OB?K"P010/J7C+XO^ ]
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M;YLLC,>,;3^#$XQCZ'OBHV5AN&">.W([\\X_EV/I5@\#\0/S.*[_ .$7@/\
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M1Z\0:E*E5E+(*+JTH5'1K9I6A6I<Z;]G6A'+9QA4BDN>*E-+F5I.Y_%\@95
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M/_X)7?LDZ;^U6O[%WQ6\0?M#7OB&Q_X)U67[=&H?M,?#GQ[\/M.^&FLZM!\
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M/?CTY-6!;  Y.6P"#M!;.['&5')_A!XR,<#%5R2\OO\ ^ 9RDFM+[G&II Z
M/GCH#M.>Q&.2  .GMZU.-(B4'*G=S_"1SCK]S Y'KC\N=O5;R#1=*NM4G1WB
MM5WLH!>1@2%550$%W<G;&B$,TA"YQO#-M'UNZM8KF33;.R-Q&)8[>ZNF-RD;
MKOB\^..-E25U(\Q Q$;?*2"#F4K_ '-_<08ZZ4N. 1Z[<'Z>G^?I3QI2]D/'
M?T]R,?UQ[UN+'J^W/V?2MW8--/M(/(_Y9<?7C(.>0!1Y>ME@3;Z* ".EQ<X4
M#G_GGV&30--K8QUTJ,YWI& 3GY<C)'0G.<GN3Q]":3^RCV0$=@&[=@,IZ>I'
MX5NF+6FQBWT< =6$]T>N.H$8QCD=\Y!QZ*8=;& (=';*]0]T,>I!(Y(]=N">
M<<&@?/+O^",!M+"D *"#C&#C!;U^0CG'XX_ (=*7#';R!TVCD^Q[_7 ^E;PM
M=:.,1:3P0>9+@\\X^["/?K^'>J[P:SYFUHM*"#C>DER#D'.T!HP"1[G'7/8T
M!SR\ON,!M*W'E2HSP3W)R3T7L%R?KWYPAT>, YC)X(/7).,'^'')]^G;M7>S
MZ4UM;:?=LT4D5ZK./+_@:-A&\9X_@)SDY)R02, FDUL 20&"Y)P'[9Z 8].
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MW%QHMQH<LN7>0M%YSEOE+?Z!/Q!TI;_PK!<F,,S6<<F["Y^4)DL2.?G0D=,
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MOC.$W+E? 7AG RNX)YNJD@J#D$,5R " 01QQG] ;G4=<M?!^@P^+3X(TU?\
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MUD27+:U:7/B%(]!TW59+@KJ5KX>.JV[SQZBSK^03E-K%R @^;>2 , 9)+,0
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M"\TO]GWP=/H5[X+UCQ ]_;7KZ_=> +?X4GPC:BPO[6UU;4_%&J:?!8Z0+?\
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M#\7>*EUOXP7'_"Q?BM:^'-;N=07Q9XSA\)Z_J6H:9I/\NWPN^(V@?LP?M;^
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M/40E^MK=6UGJ4"R7<44UNEU!$]N)E!E.VEN0*'9E4$KAF( (8_*<G&&;@8
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M9(<C#[@1QDQ1&_:]N9)Y+<6K16T<-K;R22-%*OFBX>1GBC.Z19 T8"E>&(Y
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MYBIUL9BJ-;VM:&(AEZC0]E@\=6]C&"KSHRY)_69.FL.?DQXOL8M*\5>+-'@
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M\G9K9I#7BW7:O_8R22>DL;5<E;=7<+^C3<>J;6I_K;>5HW_06T?_ ,'&F_\
MR57FWQ>^+?P?^ 7PW\8?%WXM?$#PGX.\">"- U'6]9U?5/$&E0M(D%I<K:Z9
MI-L]VL^KZ[JUX8-+T71[!9[[5-4N[6RLX99FD6'_ "D_[5U8<_VUK0[<ZSJ?
M<CUN_7%-ENKZ\B47EY>WL,<A:-;V]N[R-+A?F61([F>5$<1XQ*%5P3@-C%71
M\(\/"M1G4SB4J=.M1JSA#+Z,)35*K"JHQDZC46Y0C9VTWUM9X5O%K$3I584\
MH]G.=*K3A-YA5DHNK3G2;<>1)I1J/32YF6RE88]R;&V+N0G+QL,AU;!P,$!>
M@#.DFUFV$U,=O/ [\D  'U+'  '<D@#N13G.&( 4#( PH!)8 (!C&1N(4#H
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M2L_[.O[-7PW^,/[-G_!2'X;? [P!XI^$_P &O#7A>77/@]X__9X\<_$N_P#
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M[5N1JZE&R6UU))O5*VK?7K9:LGZM5]W]Y;EDFWK[R<HMJ]KJRC;]4DDOK?\
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M,@;*MA6:-064,P!!"G.1<MXII;6W\\K:W 5$E43<ATB6)BC*=Q23G+%@V2>
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MD76L>#M4@U?3[;58K6WO)=-GN8&>)+N.VN;6XDAWLRI<H_".L:>2?$ $00Y
M+BYP>@.?,8'./;G'Y5\_F%&M0>(H5Z-;#UZ4N2K1Q%*K0K4YJ,;QG2K4Z56#
M5UI.G%M6DKQ:D_J\MQN#S+"X?,,OQ>%QV!QE*%;"XS!8G#XO#8BE*3Y:E'$8
M6MB,/5@W&4>:G6J)2C*,N64917AMJG_%/ZCM XOKY4SU#>6H8G'8DKCN1DGG
MK^/_ .WU!&_[.7[2<+%41_@K\6D9FY0%O!>J?,P"L=G3.%8XYVXX'["V'_(
MO]Z]=1N\8SU:&(G..V3GT!_(?D5^WJN?V=OVE0W 7X+?%GH .?\ A!];R>.G
M,2G([<Y&2:\ZJTX4-_CIR^4;-^=^WGN>W1^*3[1_5?Y'^;?;_P"KBY#?NU (
MS@@!0.& (]>G.<_2QM0J[&159=NR,YW2[B1\N 00I#;]S+@8QDG%00',$!(/
M^IC *]2Q1< ]!SC&/89ZFIG$86(+%-'.JO\ :VEEC=9)&DD:$P1)'&\$:P;$
M;<\AEG#88!LGV_\ A_O!+W;=T_\ R:[7YHD2$LBD20C;%/*2TF681;6*G8K
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MXE_X)A>+O#7AS]BO]@"S_9[O_''[ ?PS\4V?Q?\ VQ?C';?$KP+\,O'GQO\
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M1I)65HY2SAH0C%B5"L S-G:5?;@9(/!%/4_P\ CL.P]1_L@_+SSTSS2;@(V
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MGDB>,F;)NUW;365E=:7V;Z7M_P $R4Y1=)IKF4;2?2^O];*Y2G8O=2/)-]L
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MHX*VD:=.%E96A0C9.VB]U;ZW>O5GS^66YJ;5])XAV;O9.O6?*GV5VH]E8\>
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M!GIV/\Q2Y_S_ )_7TI".X]_?KCZ>E;BDFXM+=_YK_(1LY&,$@J2&) *@DX!
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MZ?,ULY2MKTN<S5VFV_=V2;2MYK9_,F\R1$D42,BNJQRQ!59I%4AT3<5<JBN
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M'MD,2/$TG&?E9EXQG@$_2>K1L)K+(STQQR,RJ<#OT!)XY R?6J/P8Y^&W@W
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M1S'+\&\PP6)P=/"X?V537 U++VLTJE2'LE*=ZCJ48\[EI+35_<__  2$\?\
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M\G YQCR)?%A5T2DUZ\^Y[&&2<ZV^D7Y:N;_3<_SB8/\ 4P_]<H__ $!?\_\
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M45N/[4NM0U;8FL-J(U :<-3O+Q-(,K:UJ<T']EBS^R7FHWMS:"&6X9VP]8\
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MF^T+5=.UFP=WB%]HU]8ZC:--&!NB6ZL9Y[<21[P=N28F="X7()^/OVM_V:-
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M=&PWIAU42H"WE.3@'ZFO].7_ (([?M(>!?VE/^";O[,&I>#-3M+C5_@M\*?
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MJ;7Y'YL7]K<1W)5+>4,X#21R^6SM(06ES\B$;I#\BH"HX"@#H1&!+V$M9I/
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M88/7^=?CE_P45M+&Y_9=_:,M=3TI=<T^[^'NMVU[I+M.%U""X2RA>R8VS)<
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M)9=+UNY-YI"R:8]E-KT=QJ*.;:WB,6^23(N"&+0[Q(7,7Q L?"D^G> %\/\
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M\(ZK=:+XBT>ZA1-MWINJV%S;:E8R20H5FDM9T:4IY<PD!DK]B?A)_P %Y/\
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MBOQ,H&N^./'6KW_B#5[FV$9>&-M6U>YN;R7R)WN4&GPF*SMHFS:*B.X?+"\
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M',?[$.2#X6^(&3C/_%R_%'/H/]>1STK59/X;-?\ )1\97U3MPKDU2S6C]_\
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M (C?!_4_%GBVW\8>'A8^,],TNYTOQ?+8_/.HZ/\  7]H'P[\0?B/X-L?A/\
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M9E)@Y1HY8G50=H+!B<(2H8$*&+9Z Y&?ZR/^#9#4X/[)_:ST9"!M\5_"K4T
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MO6-'M[EXU:/*E2<8R<] V2,8Z 8(Y)SGIJIX@L3 IAD6.7D'"AL!, $$9P0
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M:=.46Y)I-1O;3W/@5GVC'S?1?P]/-\6J+7-JURII0YTI;VDES*ZLK]4?N/\
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M^(RLZV?VN*&*6YN%>9H'CNBL3<&"%B/-VNP7(+MD^;_969Y:I1Q"QKH?P/\
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MSPW9S&&\6\L-6M06C1+F73+A939R/*/+0W,321P22,D:71MWEDCC5G'YS_\
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M)/B'X<UB]@\.W^LQ>+=4U>UUHZ+;S2:E-K,:00O>M-<06,5HH\F2XG,ON8/
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M?O$D*DG<.@'.U@K8.X]0#R20!M+(-7F6)O,+!E5",$GA@.G' P0#]>F.:O\
MC^+3M.\<^,-,TEA)I6E>+?$VDZ:P8DOING:U?6NGR;?F(7['' %+.WRHHVH
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M.^B5M/G?9:Z=^IQ/D.%#RJ%V'<!UP0!A<].<'/;U. 356?4$1-I  0-R<#(
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M2VEKI?B![_P]I&J76K>&8I7;5O"#ZO=6QUS2?"GC&TDDTGQUI7A[5=&D\7:
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MXQ\">%]4T_X9_%'QE#XHD^+^L^,?@A=0?V=X\^%FC:)X/O-#O_'-YH_C72-
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M/E2L\1.<_P!U:3;?P1<7S;NSOI;5GN.C^%O#Z>)#HVE&^?3;;3='E9M2\<^
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M:.(7U_I^F27%T=/M+J6:"U::9843>V?HIXT!7@@!/[[KGEAAL,,IR2"?XFW
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MV'L>:<Y7F_Y]XXJ\(<$<9RR;!>&O'V(P^6XJAB\!5R+$U<KX>=?/<KE4QU?
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M:7M8N2LFW1C_ !%:U[S;33T:L^6ZO;Y<_:4^"J?L]_%G5?A3_P ))J7B74-
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MVLFIRJS2:3M:,K+IL^6;7=26KT/4IJNN5\W,E"GSK:\I1O)I]+/HMGV)KO\
M8[\'Z5J</AWQ%\6--\)^*],U+0]!\7Z/J,6LWJ6FO:E\"?$GQCN8--NO#_A#
M6M/:&P:ST.TDDGU$O+I^G^*6DB75ETJTF^ H-7FD'E1W,%Q&C&-+NU%RMO=(
MOW;FW%S'!=+!.-LENMU!;W7ENGVFW@G#PI]KS_MA^+=/N_"<'AF3QSINDZ9)
MX8_X2K2Q\2O$^F6NJVV@_#C2_AQ<6'A2'PY-I-MX0^W1Q:SXL;6G&NZU+XCN
MM*>[F_LFPGTC4?E2[T][N\U'6)9;Z\DO]1O+^2ZU25;G5+F2\N9+AKC4;J..
M*.YU"=G\R\N(X8HY[AI98X8T81KR8M867LG15N6$?:+5\TN77=::]O0Z*"KQ
MC-59:N3=/EMHFUHVGKI?XM;>9R<GV]I-PEF*C!4EV[\@X R/<9[]>@$%U=WL
M*,'DDD^7./WG.0PQU/; [#DCL16C)*Z3L&39A\Y;.,9P!VP .,X'3&"#6U%9
MI=PEVP1MP %"X&!GD@]3DGG@D*.!SPNST:COV2.OYOYMLR_ T[7.H+)-'M02
MDLQ!^\H;(.3C &3P.>>@KZJM_$=AIMFF5C3Y<>Z@ D,V#CDYPOH#DX-?)\-Y
M'HUV^T$'?G:.-V?7!'8Y  SD^YJKKGC:>XC\F-QNR%(,FPCLJY5A@XY_O<?4
MUR5L+[>>B>R[I:+IM_6IM"NJ46GU3NK7>M[;:^>W0^A=>\>:=)!,))P1DX ;
M  RPVC&..I&1CCH.H^.OB-=Z5J'G2+MD+@K@$%B2>"#R21COR3SG%96J:KJ&
M]M\SB$M\I!89R6!)R<>PQUZX]>9UBVEO(!]G4N_!8$G[V"W!!.,YW'.221D8
MP#IA<O="JI/5->[[S]W:WS];&=7$2J);W5OLVTU\O^"8VA:%:W?G>4A!0%CD
M#^)@P ZX 'X$ $53\0Z*;8,&8)&"P()&2 64!1QM)QSG()YS6EH,UQHP<W"X
M)&6#%B".<YR5Q[].PP,FN/\ &/C*)I6B.TDY(QMY."20-WN> #ST'.*]"$*T
MJR2;<$[_ !=%][TMI]W4Q2CRZV3UW=N_1M?\$\PU/2;B>5DBW;2[8;N068!<
M_0?4'G/:NBTSP%_H7G3IS][+$'J $ZKQP0<8QP1QR:BANFF59N0)"&"^FXY)
M&2./4G.,\8#5Z)H^K1S1);,PY(4@@9 PHZ@GD=?7MCKGKJ\ZC>"3=U>ZU2ZM
M=;[;*YC:+=]&_6_ZGA.I>$Y&GFA@B9E<C<2J@<CG:0H'08R?8\CISO\ 8DNF
M/N,)781@YW$,0-P(V]PV,YP/3C%?6EW:Z;;PERL)?"^C,.0,$$#&!GGT'(]>
M#N=*M+WS94C5B2.0"1R H^4,1Q@\X/3C/%:K$5'&*]Z44E=M.+V7-?;;5>GW
MD>QBDVHI+66J3UW>K=]]NW0\=T^X>WN$E*G: RL3G"@@@'GG'4XR2,$<'%?T
M+?\ ! S58[S]I#XKQQL7\GX-P.Z@\X'C30H\CTY&1GD\#.:_ _5M-AMY3&5!
M#A2NS\.&V\X[\9QDG!Z#]PO^#?U'MOVIOC"/^6+?!&,X!YR/&_A\J%&,9RQ(
M [MWQQT8/EGC*%1+53NM7IHT^G9OO]YS8G_=ZVEWR?JO)G]I6C!I#9!3M)FA
M3&1GF:(9[$>X]\9K^7OXFY'Q;^+*XS_Q='XA+C/5AXNUG!X!/(7'&2,\9K^G
MW09=WV# ',D+ KV;S4/S8/4@ C/ VG P"*_E^^)>&^+?Q7.0#_PM+XB<Y'('
MB_60,<C.<YX(R#P>:_K+Z/G-#->)>2+<O[+PCC&WQ-8ZORI-JUG*T;O1<VNB
M/\P/VC46^#_"ZR;MQ)Q,WHVE;AW*=9.,7RQVNW9*]^U_0? OPF\3>+-)CUJQ
MTOQ)?::]W;:7 ?#GA;4/$5T]]?-(+..X:W7['8B]-K>II<=U<K=:K+87XL;:
M2*U$LL?CCX?>(/ ITJXUFPU2RL-=TZTU;2'U?2+O0KV[L+Y&FL+H6%TF9;*_
M@62;3-3LY;K3=1BMKU[:ZW6DT:^[_L__ !1T[P[8"WN_$'B[3X[9/#TJZ%X5
M\13>'I6U[P_X@M[U?$+6\7B'PXE_'_PC<^I:7ITJ->W&CZCJE]>06<=V+:]/
M$_&GQS_PD$O]F3>)]7\7I9RV%AX?EUFY2\N?#W@G0(]4MO#WAH^5?:G;V<FF
MG7KU;33H-1OXK.ULS-)<)=W<D:/AOQ(\7\3X\8CA3&Y5C7PI3SW-\%/ RR>&
M%P679!AJ>+^H9_3XE>#ITZE2M2I8/%>TABZU'$3QT\KIX.E6I.HO6\2OHR?0
MIR;Z F7>+/#G&.2S\69<&<)9_EO$,?$*.-XGXI\0\SJ93'/_  ^J>'\,[JX3
M+:66XG'<0X'$TO\ 5?+<7E>#X:PF=_VWB)8JM];\!;.3G&W<00K-\IQ\R JR
MN#C:"0W 7 W G'L_P8_:(^-G[/6MQZ[\'?B-XA\%NTXEU#1[*Y6Y\,:Y\ZLT
M>O\ A>]2ZT/5XY0@25[FQ^W"+<MM>VY(D7Q@A5X+!VR#E0-@C(&WD8_><'<.
M@[G)P'C P4(##E3D<-_">>X)[_CT&/ZUQ."P6882MAL;A<%B\/75ZM"M3A7P
M]:7LX^_4A5@_?YI24W93BXMJ?,HS7^.64Y]G7#F9X7-<@S?,,HS+!585L)F6
M5XW%9=BJ-2\).I2Q6&K4L134W>-1\THSCS\]&HG)3_HM^ 7_  7$T.;3ETC]
MI3X:ZAINKVMFSQ^,_A3:C4](U::.&,B/4_">JZA'J&B75ZXD!ET_5-2L(9VB
M,L5G;;G3YP_:/_X+.?&[XCKJOA[X!Z#'\%_"TBRQ+XEO%M/$'Q-NK9_,22XB
MN ;GPWX99H7BEQ96^L:C;L&ECU.';&1^+VP\D#+$DM\Q0$GJV<@[O0\X/3H#
M7UQ\"_B;\&?!W@7Q1HWQ!\,WVL:M>Z@FHP6PL(-2L=:BLXK6/2[99W:!])OK
M6.?Q3IMY<7,OV6>V\06FMQ&;5M TZUF_!N->#.'.",-_K1PYX=8WC+&5<VR[
M#0R'#8BO5R[ 4\55E'%YC/"N&.JRI1J^SHTX+"UZ5.K7H5*OU?#0K5Z7^@?@
M1XV>)/CWFZ\*/$7Z2N1>"/#^'X7S[-*OB/FF699A<\SFOE>&I2PW#]7.YX_)
MZ<:^*IUJ]>5>%?*\=B<#E^->%J8O-ZN'P]?P2ZM?B5\4M7O?%FJ?\)I\1=>U
M.\FCU/Q-J<^H^(M6OK](TNI$O-4U&YNIS.L=TC(DTR1HLD:0O@B-<N?P/XTL
M8K:ZN_"VO06=_?G2["XFT^8)<Z@%N/\ 0;=T)#WH-E>DPC)!M)N?EP.S\%QV
MEQILD$]YX/LK:^U/7XKE-;F\(6NL1V=WHMC;V[6-YKKBY4VKL%M7NW-C'=1"
MZLE^T074*=WXDE\'^&4CO;>?1=5LDTB+PA/;:7)\'M=U95-Q/<#68M/T.-C+
M?H+(I)XL4)J,KWY$\B0W\C/^P4\?5IPPU"C@886,Z-&?U.-)P6#FL-0_V67U
M>"H*>%E*>&FJ%2E3J3H3:YE)2?\ &6(X>R_$SQV.QG$%3,IQQ.(]MG57$O$4
MLT<,9C:,,QP[Q4Z^8U*>84L-3Q<9XOFQ,:6+4<5%3C*)XY)\./B"B23OX+\2
MB*"$7,TLFFS)'%;"58FN)'<X$2RL(BX)C#C;OY &=J?A+Q5HVGC5-7\.:UIM
M@9X;4:A=V,D%H+J=)7A@$\F!YTBQ2/&"%#B*782P19/0T\9?#D_9))=-\3B;
M3=,_LRQ6/PO\.5LITB2U$%UKEJUNKZMJ&;2*6?4[AFNY&DN#$L4CD#"\8>)_
M"NMV;MHNG:K:ZG,NDPW#7>B>#M+TUK:P%_+,\,&@P+>17\]W>1F2Z:0G4+*"
M(7_[ZUA [*&+QTJU.-2A&-.4FIR<)T[*U_BG6J+?HDN[;V/"Q>5<.TL)B:E#
M-J=>O"DY4*,<50IJ<U+2-G@[R5KM4X2@VTO>MH?IO_P1N8_\+A^,W)^7X5:7
MSC .?&FD\=>G'.>N.N>G[M:QN2^<D9^51GCLQR3SD]\ "OPD_P""-Y)^,OQI
M);&[X4Z60,X!/_"::7D#U..3CU&>O/[H:],%OY3C "DDL1MZ,3W4]?X0<YXX
MR:_BWQUY7XB9HT[WR_)'OVR^HNG12]V^S>E[Z'^W/T#W%?1PX536KSGC/ONL
MX@VDO*]W;1)IM(]U^! V>')WR&$NJ:U*NTY)0:S,G"@$MRIZ9P/UZ6'XQ_"R
M]^(5W\)[7Q]X6N?B386;WEUX+AU>V;7XX;=5N+A!:$C?<VMLZ7%[9HSWME \
M<]S;)$RN>7^!,H/A&W*D$M-JSX7[ASK=^2C '/S;2!G(#''';S?1/V1/ &@_
M'FY^.EKJOB#[9)XAUKQI:^&'6QATJW\8^(K&\TW5]9GU"&S75[^&2WO;J:WL
M+N8I"\D,9N)['3[&QM/S_+*> J4:WUVO7HSCA'/!1HTXSC7Q2FK4JTI->SI^
MRYI<R:;>G9/^E.(J_$U'$9/#AW+<MQ]&OG.'I9Y+,,75PTL)DTZ=15L7@_9?
MQ<53K*G:E/W735K?O74H>=6W[2'Q2\1ZW8^'O"TW[*6N:GK$FJSZ#:6GQ@\6
MSWFLZ9X82*^\2W%M91>%_M*W&E64=Q).K1R>7-:E9<V\<TJ96F?M.WTXO/%G
MBKQ'^S59_!^WU&W\-OX\\-?%C7M1OHO%>M>'-#U+PEHM_IVK^'+6QLUUW5KC
M5H"\M^7BT)=)U:!?M,\D<<&NZC\7(/#6C2V7PI_:(T_7='@UR9_$7@WP7\ I
MO&6J1ZAXAL[>R7=?ZREKI=S80-JA%M96WG7_ (<N-0N;B&.XN+,W?'^ ?#OQ
M2U/4],\)^+G_ &J-/L=:MTU'4?%GCWP+\![?0+*]T'1]#2RTO4IO#-O=7UC<
M:G]DU"U%W_9\UFMW-KEM]JMK#4M'>RX)-Z>[%6E&H[1;3FH<MYWNIV722E%-
M:)VU^@IVB[I=I)MR7/RI*$G:<%ROE52"Y8S@W;FT:J5M:^.GQ,N_$_ACPK9C
M]FJ;7/%VC:7X@T#0C\7?%,VOZKHVO6AN](OM,@A\+"RO8]8>QU]M,N%E2":.
MR@<QI++<11^/ZU^TMXD\-Z1<7'BCQ!^RQI6KZ7Y9\0V+_%OQ =,TC=)I<&9+
MYM(=VGENO^$@BLD>U9/*TS2X7E:XG.?I;6/@GXMBA@C_ .&@?B+]HM;&RL_[
M2M?"7PSM[YTL!8&.99)_"UW);F>ZMI[^:WMI?(BGU*_DMH;>1EV^42_ ?Q7_
M &;_ &=-^T-\2;EUF$JWUQX3^$\MR%*/]H29&\$26,YN;E_M-S<O9B2XN8(Y
MFW.VYO&Q:@OB3;3ERMRDY*[NXKWE%1OKRJ$4NG8]?!Z**NY.W+S3E.<N6Z:@
MI3G-Q@G%-0@J<.;FDX2FW-]3X7\2^)M6_P"$QTKQC!X'LO$7A;4HM-U+3? _
MB:]\2Q:>M_HD.JV46O'4+#3[S3-4N(KD7L-N1<6USI]Q;7<$YDDN8T^@?C1X
M4^(WC#X'ZKH?PFN]9M/&<FI^&;NUCT3Q(_A.74+.T2*74='U#7XM<\.WFFZ1
MK%L9+'4+K3=274K>)Q>VEK=SVZ(?!/#WAN_\*:5K=GJ7C#Q#XWGO]0O=535?
M$\>B)J=K;SVR16^D(^A:9I,-Q9Z:L7V:R>ZMI+P6_EH\\BA<??W@5Q_8\GWN
M([+!W[=J_P!GIN(V]-P;$A&-X(W>_9P[B987%K$PIPJRP]:G5C"I%3AS)PLY
M4Y:5(.R4H/W97:^)GE\69;2S?**^58BKB\-A\QPV*P=3%9?-4<90CB(P==TZ
MLFI4I2A1I^SJQO[.2NM93B_SLE_9^_:%TWP=\-_'^I_&;XJV_C#X?S6+>+_A
MEK/Q433O#7BSPZGQ*&KZY;7WCJ#Q1=V5K9V7A._NK2TOO$+ZA=ZC8Z/I^G:M
M)IQNYH(OE_7_  5^T/8^%/B$+G]HSP#J&M:O8^%Y/!@M_P!I>\2YTZ?2?'.N
M:]J'_$WUKQ!JNBQW&K>'%TNPUBUMO#VB,98]-L]$UU+*V\3._P"LG[2GP?TW
MX^?"7Q-\*=6UW5?#-IXA?P]>C6M(@M;V:UN_#'B/2/%%C%?Z7>E--UO1;R[T
M2&RU[1-1>.UU72I[NTF<"0R+^1NO_P#!+:UTZ:_U"+XP>$_M>J06,%YN_9@^
M';0/_9=AJUC;O9VDWB%H+.:.+6KM[@VP07EU:V!O%D73X1<?J&79SE^*PM:K
MG6;X#+<33KSE0PCX:6-2H>T=:,DZ"I2_B.UI\Z</<^&Q_,W%/ ?$&49K@,+P
M?PCQ!Q/EDLKI4L;G$/$O%Y/-9A3PV(R>IB*^$KUG45:E@Z.$J1J4FLOJUX3Q
M%# TL2ZM2I\YP?"O]KG4?#GP\T_0/B;#JMYX'U:5?%VK:9\=X_%C^(TB\>ZA
M-I5G-J-G>WCSV4/A"Z>XN4URX74-46$Z=LABM;:"O4OA;\./VB_!?Q8^+FO_
M !2\3Q:Y\/?$J7UYX4CA^(.L^)+#1[J;Q58R:38:=X<UFS@GT46>A17$-[)'
M%;0(DEC!;/>3RR"/T7X#?LFZ7^S_ .-O&GC9?&*^)M=\8^'M-\,7-OH'@70/
MAIX:ATS3=:OM<M+J[\->'+N[LM5UJ*348],L=7NC;RVFAV\5B$FF>6<^[>*Y
M@ND7S@ $)#(CL@W F;*@#*L!R5 !4A28^$RI_.^(>)(RK8_ 99'*,?E^)HQI
M?7_["JX+$>U=18JHZ<74]I12JSG!6O&T4_A]T_5/#[PXE1PN1\0<0_ZVY#Q!
ME>.IXN.35./:G$.!G#*\%B<IPE3%2C1I4L12Q^#Q4,=B,)4;=*O0CB:DIU*2
MIGT_;_'O]F7_ (5CIG@OXG>./#,1\-Z5I.F>(=-U:#5U_LW5W=;(PI<PV)47
M-G/=QVU]<64[_P!G27$271B2XC>2IJGQR_9K^&^C>)]-C^)6F:)H_AK4+2VO
M+"]M=>-IX8GO_P"T8;31K%%T=IXC?2Z-KDXB$DT\T]C>R22DVTBUVWP^^"O@
M2'X9WOC#1/!&BZUX[\?_  Y>#5U\2:AJ<^B>)]2-C/\ V59ZM'=2ZA::?:&^
M6V@EO]/LTN;"UEED@>-D0U^7OB#X.?M<ZII6NZ=K?[&_P0N+76H-$N-3_P!#
M\+SW^K:WI4>H[7U;69OV@H=2OX[.2_N/[/U*XF.HWD5P\M^L5VBI%]MDV2<,
MYI)8E8F>!JT*>"A*KC<SRO!8B=65.G*7U2-:G&4L-3JPYFZE2HK6A-+F=_EN
M-./?%?A.<<OCEN#SW!X['YQBL)@\BX9XSX@PV6O X_$T\NJYGBL#CZ-&CCI8
M>MA98BO'!47=8KZHJT53D_1OCU^T%\!+.'59;WXH^'8;G1-0T?P]JBSMJ;26
M.K>((KY]'M)H8]+G97OH[2Z\AX\Q^7!-->.@0N/TD2Q!TZPFV$G[%:%E SN5
M;*W5",\_=0,#R2IR3D9/Y6W_ .S?X0U_X3V4_P =O@?\-]&^(VO7+WGC72/#
MEWJ6H6)N=,U?61X<U2.ZG\0:Y]B\0-HES#+JBV&MZK!:W5]?64>IW>GQP1I]
MJ:U:_MO"2X/AJY_8_3PR',?AM=>T_P".']OQZ'@)I2ZT=*NQIIU1;$VZZB=.
M3[&+GSC:H(@BUX^*R[*I8K$X?+,=[!X.<XUJF:XO _5L3"/-!1P-7+\&U4K>
MUO.3:5%4I+E;:9]GEO$/%V'R;+<?Q)D$\71S&GA:V7X+@[(,]Q&:8"$J.,G7
MCG>$SK-<#'"R4)99!)5JL_K53,G*'LJ5%%_Q[IB+ S(&7?!EQLY)!+%L\@_0
M\G^+M7YC_''3DDBU(JC$,DI9B,Y 1\L <?7IW['K[=\3OB#^V7HVL77AV\L_
MV7M7F@T>UU0W_A_P[\<-0T8BY>\B?34OQK\4@U:P>U2/4=/DMXFMY-1TM#<2
M7%_#!7PK\2[[]K35M,DU"YD_98MA<6WVA]/^S?%B2_L1*)?(BU"WBU2ZAM[@
M["TMM<2%XF22!P7B<UYN8<.XFA2=6KC,K=.47RVQE1RO)*ZE; .4-&K.2CJT
MEK:_H9-X@9=F&-EA,-DG&#Q-"<E6I5.&Z=.=)QDU*,I/B2491BU).5.%9QY6
MY144VOY#/^"Z?A=1\9_@IXE5$#7WP\\2^'99%&3+)HOB<:C"DI W91=;>:,G
MH)&P,G-?A>;8H"5&&7HH #C! QG&0<'J3WY/-?O5_P %BKWQSK/B/X6:=\0)
MO <VKZ ?%<-O%X%L?$UG:00:E;:)=A;IO$D[SSEXH[=DN+-?(!6:(RR.F$_#
M62!8KCYQD%B">Y*[@>"2<DL,@$L!D=1D^)1A.C2ITYSHU'!7C*C4]I2E&3<H
M.%1PI.:<7%<W(DVG9R7O/[NGBX8Z"Q5.E7HPJMVI8BG&G6@Z;=*2J0A.M&,N
M:G)\JJ2:32=I7BN5>VFG^;8X/.,\]4*<YQWY]/;(!K,FMYHV;>O"L ,^A(S@
M <D@C//)YP0<'U""SA8':,Y/RA5#'J0.BG@DX![_ %SG/U/3XA&7( X+ $ <
MG:<'C P,C&<Y'0\&NB%6HGK!:]G\^C9I9]G]S_R..M)Q';L%R#M8#)Y!4[QV
M[XQ[@Y.*_P!4C]@L*G_!/_\ 802-%13^Q3^RFP" (!YGP%\"/(<*!G<R[B"!
MO<R2N3)(S'_*IN"\"2X"A51\#!R?E!R1QSC\#GC.<G_55_8*._\ X)_?L&$=
M6_8D_9/88YPS? #P*P'<]3]:_*_&"TLIR=M<J>88J4N5M7?]GQ5IO[7NI64E
MIT/U/PG=LSSEZZY?A4[-IV6-::36NJT:6^SOU^C+PG)XYWMG _V6/7OP>!U_
M.ON?]D:*./X0ZY=>6!)/XT\9/+*HQ)(MK;^';=-^2!OCAC$,0) 523N0,S#Y
M.T#P%<^,?#7BO7+26_:[T77])T+3+2S^S^1>2W=C<7FIR3&6%VE-I#]A81P2
MJRB[MY)49)HV?Z>_9YC\8^%/AQ<Z!9Z!;:T&UC7+[6;Y=8TVW6PU74H].DOM
M(AC-T&NFTF&"T2>=8T2:\FDBA5S PKYGPMR#-,'G>#S_ !&&E#+<9D^-E3Q-
M)QG.#KXC"8>'[N2E9N/M'&R3<>:2O&+:]GQ1X@RG&9)C.'Z.)53-,OSO+X8F
MA.$N2JJ=+%XJHX<KY)<B=.$E)N$:G*GRU'RO'O\ ]JK]FY9A&_QK\!12VT\J
MRK+K$&^.18I[=E567)EAF=DD#8 >-U&>"6)^UC^S2K(?^%W?#]G5HCQK%H,E
M6)YQ@@,3RV1M +$$"O5/B)\1M#^!/@;QE\6_'OA80:=H/AG4=>&G6.IVFJ-J
M5W:PV-KINBVUE+&UCIS:O=O96EI-;F-;>>1Y+E'4R,_EUI^UU"G@[X#^/M6^
M&.C-X5^)VN^$_#'C_5M)NM*NK+P%J/CO0M#U+P_>:4\G[WQ%IFEZKXDTK0/%
MBSQ:=?Z9=S7'E6<GV&X:OZ8IT,)7IT:D,+F56&(KU,+&I&MAZ5.IBJ5'VU>G
MRSI6I*5/WZ:J3IJI.7LZ;J-JF_Q>&"HUJ*Q&'PF8SH1FZ'M/K.$IVK4Z2K2I
MTXUZ<I2:A[D%)S;ERI)MI$MC\=O@_P#$L:MX<\#?$?PKXKUIM(U34UTK2=22
MYO%LK&!7O+D1A0!':K(CSL"S#("+(V5K\U/VI(4@^-6K,@(>\\*>%+R;&%W2
MFTEA9GQ@E]EO'R<\KSD\U^Y'Q*\+:3::1K_B2WA,&H3Z+%HS+&P2PCLH)KN_
M$L5A&1;Q7<EQ*PN+N-!/-:)#;\A&(_#W]JS_ )+9J:KDF/PAX349 #!6@NCM
M(!89!;YL%B"?O$ &OYV^D7'"_P"HW^SQJJFLXRB$EB*M.<E.57&4YQ480C%+
MV3E[T;IV>SBVOV/Z/DZ,O$6G["%:FO[#S3GC5J4*E3W)Y<U*3H4:22C)W<G*
M45>WNMW?RU>8);WSUY]B??UZ=><C%?Q>?\%\B!^W7I.!M#?L_?#)I,8!D:/4
MO&(1W(Y<HFU06Y"C;PJK7]H=WU/X_P#H5?Q<_P#!?4X_;LT@D97_ (9\^&8(
M[<ZGXO'7H,C/Y>U?S_\ 1KE+_B*<%S2?_&-\263;?*W4RI3Y$_@Y[)32^+EC
M=)Q1^_\ TC6EX8*-DU+/^'I.ZO=P>8JFW??D4YNG:W*Y-IN]C\>_#]RJ31!B
M",  'C &T^W<8X')'8YKVJQO;8PQAB/FC7!P,+\H7."<]LXZ')SZU\[V3_O4
MP63 &"!C.",=SGV(^4\XQBNVM=0D5$_>$8[$D'!P,\'')XX';/; _P! JM!3
M:>SOJW?72RTV_P S^$(2=E9ZV5]NE[>GX'K%RMI.C<*QQP2%&< Y)'(QG(S^
M'N<"6SA^=E!7*,1P. 0P&<=QC] <YZ9%MJNU "X(P.OH!TY;OGH2>.?:K3:G
M$W)<'(P1D8'?& 0V.3],Y/I4QIN,ENW=7?O-;KR\_O-;WCJ];/MYF!K5H$1F
MR#M3C@#!(?:<^Q'8#CH*XHRK&^>"P9LGCD\@CN><G&>G&>U=9K-]YJE5;).0
M.,= V.C9P">HQCKG'%<25)8$XP3D$]3_ !*3ZY/;C.,XX->A25UK?3Y=3GJ2
M<8-K>ZM]^O\ 5F=1ISQ)L+$XR2<E>,XR!G'3OS@X(XR:T;AT<ED8\[AD%>X8
M GL1\V,\$# !Y!K$M[=W50,\@'(#'L #D#D''IR03GH*T5MY%C*X<X.,=<X(
MZC;GD#/Y?054C'W4^GGYIKJ$I-*-FKO?9]$_S?Z&K&V$ 0\==QPQZ 8Z]..>
M<<#&>"'$L2-V#C//3KCM[8/YBHHB%B0D@9 Y)QDXQW]A^E([<@AR!CJ"-O&<
M\X(SCKSTKR5!WULUKW_X'YG2I)NUF0R2-N&W:1S@<X !(!X..><8'KV J/<_
M^R/HO^)I&90Q^88X"Y(Z #ISS@D_CFF-( /E*L3[Y ]SCM_4U:26B5OZ^90N
M!QM(&,9.><#J<@CGZ\>U3*3T;/0D=02/<<?-U/OGD>D$"J6;@$9?'T!3'X<U
M:(R>V0?QQC]1DG([],BLYTTTEJ]5U?Z)?/R)C*,G9W5]GI9/HWY7T?JF?0?P
MI_95^.?QJT=/$O@7PK8'PO-!XUDMO%GB7Q3X<\*:!?W?@#14UKQ#I-A>:YJE
MG/<ZC&ESIFE0A;5;%-;UK1=-O;VT.HQS+S%S\!/C/8?$3PY\)[WX?:U%\0?%
MNFZ;KN@:!#-IFHQWWAK54NIH?%?]M:3J.HZ#;^$K6TL=1O=8\47.J0Z)HEEI
M>J7NJ7MK9Z9?W5O]W_L>_'GX1?#3X,>*/#WQW\7?##2O"OB":WT;2;?P1\%?
MA9\9?VE(O"L7BA]>\=>!+WP7\1OA'<^$=;\&?%2]A\.MJ&O>.OCAX3O?#5CX
M4T>70]'U^*.?1+N70_VAH--_:)^)FK:%\</V>_A]\%_$WA#[#IGAOX4:5J/P
M$\!Z[\/]8UW5=;\+?"_7M#MOV2_BUJ.IWW@&VU6^L?%GA3QQX*N;"[U"6TO;
M+QKK26-G=B)PCS6MI9:ZVZ_EULK:F'M*J]JD]$^5;ZV[>6M_1'P/XR^"?COP
M+\0M.^'>O3>#'N-?BBO?!_CFU^('A&'X/^.M$GC9[;Q1X,^+NO:OH?@'6/#$
M\L<^G'5I-9LUL]<AFT#4XK+7(I=/3T'QM^R#\;OA]X53Q=XHM?AK8:,-)O-1
MU+=\;_@XM[H<UK>ZA;)HFH65QXW@FN_$NI1:<-1T70- _MO4M7L]1TR*P@GU
M6:ZTVS^X_P!I3XX_!?XG?'CX3Z9:?&7X?ZO^R1;_ +1UYXHU/X5^'/$/B:Q\
M-^%?"MWKDE]:^*;3P?X?_9D_9_C^&5K'HR#2=8B\,^+_ !KXEO%NM/TV35IK
M'2;.^M][XO\ [8GP&^//[/WQ=T'6/'NH3>+O$GP\7Q)XET'Q;X<UOP?<^+_B
M_;6.EZUX:E\*WN@^)=2G\57V@?%B?6KV2R\9WWB'1+CP83XCU#4[3Q*QTVH4
M(^S36G[QPMVY=&^UE?Y>>K5\TURWUM%J3:T<]+-=;6OJ]7T1\)V/[!?[7.J6
MFBW]E\%/&5W'XA^&NJ?$W2;2VT;5KS5)=,TW7/[ B\,2Z59Z?<ZC'X_UJ\FT
MFZ\/>$Q;27NMZ-XA\/:M8236^JVX/$^"OV6_C+XZO/[*TK2/#FFZY!XQU'P)
MJGA3Q3XQ\/\ AKQUH?B;2M1TRPU2PU?P'J5['XOC^Q#4+[49&LM&OVGTKPGX
MVEL4O+_POJ&FC]8/!7[87[.'A'3?"FE>)OB1X*.@>';/PY8_&WPEX'^''BSQ
M!HWBWXRZ%8^!F^ WC#]F[[;J.E76D?L[? ;4OA]X+U[XK^%GO?!@\0^*? ^M
M2^#M \;6_C?P)+X5^</V:_VBO O[-_A3QU_PFOQKU+XE>.-)L?VA=+\(Q> ]
M:UR70K.WUCQ_^SVVG:E\.-:O++P/XJTG4/BWJ.C_ !%^(<T:>)="TQ-#T%+O
M4M L_%6N3V]S,814O[G5=>;6[6WNMV:V]%L2YU7S249-I+5=NB75M:W[>?7X
MLTK]E;XQZW\1[OX2:?8>#3X_L/"D7C2\T._^)'@?0VM=!GNX[>W^V7.MZUIT
M%IK4MM<Z=K#>&+EHO$=IHNJZ;J.HZ79QW++%T'Q;_8P_:#^"GCO1OAKXS\->
M&;OQGXE\4:YX.\.:'X0^(7@GQ9>ZSJ_AYV74FAM=+UEKS3=.4 &&]UVWTI)7
M/V<(+E7A7]$A^VA^S]HG[4.H?$CQ;XI\8>*-'O\ ]DOX5>#%U[P9=GQMH2_%
MW1;V.\U:W\6:/XQ\/>([SQQJ&C:%JVLV^F^(Y]3N=.T7Q) ;$1:S;75KJVC5
M_P#@H-\8?V5OVGA\%/#'PX^.,.B+XP\?^*?&'CS5M:A>'PE\-OAQK=E:7.E7
M'Q&T3PSX#-QKGQ7T&.PUJ/3O#]CK_B;78KO7$T+4-4U26XTM] F46E3VLFE4
M\^MU\^]M/D4IR=2:2M%KGA=;1<)3BG;K*RBK7O*25S\\_'/[%?[3OPV\-6?B
MSQ?\*]3T[2F\*ZEXSUR$:IH;ZSX+TC2KS48Y%\;:+)J4.I:'=WNE6%MXKT>(
M07:ZSX1UO0-;TR2YCU..%=ZP_81_:AU'PW8>)U\"^'=/M]8U;P?H^@Z-KGQ3
M^%6A^)]>O/'/A^+Q1HD>FZ)J_C*TE2Z&AWWA^[U'2-3FT[7]//B[PF)=)-OK
M"W,'J/QH^-GPW^+GPI^/OB&Y'P-M/^$E\1_#?P#^S5X"3X2>"[']H_P3X+^&
MNO:'IMCXS^(/C_0_AW;W<=C/\)_"MAX?U'[9\3?$<FJZQK-SIMKH_P#9\$-W
MI_Z:^"_V]?V7_!/P)M?AEK'QU^+E[XG\-R>$O T%WX?^)?CGQMH1T+QSX6\7
M)\0;:S^+OBKP7H?QQT3PW+J/A_18_%OB7X1>!]_PYOM?\+6?@2?Q5IM[XE2"
M)0@O;;74Z4:>VOM5*5[7V@HVGUNURW6I#JU%*"CJKU.>*W<8<EWVM>=DWUC*
M]M+_ ,XFLZ9J>@:SJV@ZW8S:=K6@ZMJ>A:SIEQM%QIVL:->S:;JFGW!4LAGT
M^^M)[:<HSQ%T5XI9%<%<OYR<L01P0.>#@>^,=>WOUSGLOB5);3_$GX@SV.NR
M^)K"Y\:^)[FP\1S^)-4\976N65SK-[/::G<>+M;T3PYK'BB6ZMY(WD\1:OX?
MT/5-;?.H7^D:=-*MLO&#G^(_I]?3TK)1<DFK*ZNE+>WG9/\ ,Z1U(> 3Z9/]
M:8WU'?EL 9]CP-V>V<@9[C!"RG # D\@,5&X\   ,<CKG ZCC)XH::=G:_EY
M^H$P&Q@6*X96'IT8#')YZ<4ID&2 N[&.01CH#Q^E1_>QDEL#C..,\GL.OO2U
M+294$F[-75F^W5+MYL;*2Z8"D8.< ]>",?+SU.3].AJ%&*'<N>1V//0]R>00
M>?HN.E6.,KNQC)SDX'0XS[9QQT-5MN">&^\V,!L8R<=..E0X.^EK%.%W[MDM
M-[OUZ&O#.VTLI8YQD'YMI&>G/?)/_P!;%6H9G:50 ,$9;*MZXY //"@X]/Q-
M8UNQ7A2,D,2&SV<8)'4<$_7/-:ED6,QST('3. V5& >I.,';GDD8'-9VCT6O
MHE^1:BEM?YOI?M;]3USPH[QF,X'S&,=#QD)V)X]#W)Y]*]CL[[8(P&VE% /H
M?E&>,CU!(P2<DD9KQ?P](8S"F<[2I) !'&T?,>F0< #KMXY)&/3[*9 HW!?X
ML],E21D8+<9QMQC(QMP37%B(ISDW>_+'KV3.RDUR*[2U?YGNG@_66CN+>,RY
M1F!)'L%!^8'&23G'IVSQ7U)INK0R6L*+*,E%+#IGYNV6^7'T//(&,5\'Z;JR
MVTT>US'M ].HP,=>,XQ^F,DFO6]&\:/Y:QB0K@*OWN#P.A)]>2,\'G@CCP,5
MA932E%65^CUV?;H=E*I;27;NOU_IGU/#>6B2DR<Y..B\9((YYZ#CTQ@8'?N=
M/O;*ZC6(; 2%4X R. H &<8P><Y(/0XKY-C\2SR)GS3CC/))P<9/WLXY_*NM
MT/Q4]N?,$C-C!R6S\W/7).,],=P,5YSPKN_CO^'_  U_U-XSB[--;_DSVS4-
M'M?/>;< .YR"HY.#CN?EZ @\G/6J,NK66GQM$LH.%"X4[025SGAL<'(. 3U[
M8-<'=>,&N(VW,N2,'#8&<$X^]_7H._?R[5-:O3,-KG:Q.!\P'H,@]CG(.<8.
M1UK&-)N34OL^NK-G473?SL_R9W7B*]\^2:6.0YRFP@G@\ M\IYP 3V^IQ7E;
MZE<1WVUY"RF0#'S'(8$Y!W#IM/<\G&>,'=^U-<6N'<[V7DALC(7)R">IXSQP
M1P.]>7ZE<36U\A=SE67@M@KD-R <=B.3Z]QS7;1I*4FEO;KZ.WI>WY+8QG52
M=Y)O;:WZ_B>UQ6GVVW0["Q(4$D=?DSP,$]3TYYSTYST^@>'!*0LL3,,D\KC@
M': "%Z8&,GJ#G KBO">I"Z-HK.,'&<D%21@98@D# &<XZ] :^E?#EM NR1B&
MQR5*_P *@'D=\X)R3@YY)%<V(J.DFGI*]K?+R^1T1DIQYEL>3>(_ T8MR\,
MY7YMNW))R<9P,#\^1DXR*^4?&'@:2&X>X:-QM;<$] !T&0.&P"?KD8R*_2G5
MWM)+<YA (4*-H .WD@GG'0<L>V#[U\W>.]-M[@2A(B6*DX. <;>" %)/ SG
M'<5CA,1-RO>ZN_PDDQ3@IKS[OI_7_ V/B$W"69\EOD*L4YRN!D@<$C."!TP/
M3D\30:X+20$2;2'X(/'. #G=QSSCGCJ3R:T/%.AR+=OM1U&7)."!D%L8)7MZ
MYSSZ5P$MC+'-MD=L#&>20. >3TWX)(7CH,CN?=M!QC*S;DKZ]M>SW_J_0X/?
M4FKQO%V=KZ^AZ8WB"34$7]]N'0E2P/!P!@L<] /0]L5,-;^R(W[Q8B2 0IW
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M!)Z#;N /B-U8@9'*D@%@&R!6JG_!.K]M/M\"-;3( "IKG@<1KP%"@-XG!4
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MY_V$?S0'_@G;^VBI 'P)UE_4_P#"0>"7/KV\2,!U]!^-!_X)V?MI-S_PH?7
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M]Y:MJS[]_O'2YX/XO=2>C5NJ[GUQ<Z['/&'WJ4*#.&QG@G!.<#&<YYZ\#O7
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MK3]0TV[C3>8;FRN8I-LL%Q'#_E_W>GI<,'0CD $< D=/X0>2?<DX/T']!_\
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M;D_7C-=CC;W7O9+\$C#E<KR6S;WWT]%;HS3"11KQ@D=PR^F..."#@Y/&!TX
M&%<N$F&X[0')+'G 9"<'..<-UX&3US3)-19AC+>HSP.G3(.#D'^77G/,:QJ,
M@C;9DMA3Q@DY)4YP> 5 4G' SD YRHT6G=M-?/\ 4@]%@U+RHT!<<] &! P>
M"#D'!_/C/&1GI8=;B$#[F0Y SENF"2"/FQ_@<9[U\XGQ%<* K G .<GG Y&0
M#\O4<':#[#-4U\3WKH45W4-GH., ],D\9 P .<'CWY9823FWT<KZ=F[OIVO_
M $S2,TDEKI?MWN>I>)-3BG?]VRX)&=IYQN4D<$YY[^I-<!JLD;(.01G>/7A
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M*24;:]?QN>/'2=<FC'EM-%S@!)94(R0."K#@>OJ>.#BN<NO#GB?<5^VZF 6
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M%?M$:M:>"K=?B;^SSI%I^T7K%I#X;D@\.1Z7I>@ZVEUJJ0_$WQ.FG^4_'/\
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MOLVEO;;Y$CW<S* SY*YRQQ_%PI!Y&,9ZX'/<\UESW-P"2'("J.!GJ<# XSU
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M3[KK[C;@U>>)OGD)_N]"&P#P./\ :''7)(YYSNKX@E>([7'W2%^8<9R,$8
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M>MKZ"G'FC;UO]S/)-<L927"@'8V=Q!4G.200<\ !@#G@9..37(M8993G'()
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M0:>ZULNO<SDU3M%WEYZ=7UOZV^1M%U'4CZ=2?I[U6:<(WW\9)P,$X Z G..
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M@_*, G;G(ZD'J>.0-H/:O3PDO?E=]/)=/EVW/%S*C*LZ:3T6_EUWZ=?P?2Y
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M+WV] I(;:0#@8/!'3G;CMUSCOFLSK4Y7Z/[E^J^[4]G@UU BEY"&(' /.U0
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M/9/2RTV6AX7KEB86;)(8R ##=#A,X!'TZDC(!R._GUX0&.YL[=W'+9RP&=W
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M].P&<<CDY]:OVDX2?*[:6^37]?\ #$RA&=KKJK^:[:>7_!T+'DQQ*< ;L'G
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MF>9RV9RVU1R1QP>F>O.?<8ZGU&2:HLR6SUY)QZ^W7MVY.>Y(KKYX>J\C.,<
M#A<X)YSG.<$8XXXQ54P,!USC:3@9(/ '<9R0>Y-=D9J-KIV3NWIM>]_D85-7
MIT<?PW_,Y@P8.-F?I],\ALX]."<\^@%1>2Y)'\/('RH3CH.0 W3G)8'(YSWZ
M"2)DD& <'J!P3A1Q@GC'!.#T.,\ U"T&\A@I &3C (.?^!#/8_@/QZHSC-7C
M)/O;H(PVMF.-H'?A\Y/3& 6/OG!'TZ5 T)*G.T#C)&,CYASU)Q^'-=$(XPI
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MY8XQC@G.<]Q[#'7UH* L6XSP02#D$#C&&'IVQ5<$+T9EXQTQQQ_L\]J<'/\
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M..G/3^>.W7C&REV7^ZV!P,>7G!., _S)/3OUKSY4VFTK6]7^=O\ ,V-6-CN
MSR"I!'7E@.1PI/N?QQP:UHK@(S(6^8'IP.,*<]&SQR2<MQVYKF!,VY2[< Y'
MRE<$<]?0XQCWSCBK:7>"IQD# 8\9*C&X<]<\DCOG@XQ42@[:J^O2_P#D--K8
MWY+D]V!R<@#V'4\#^7OE<9',:M<D \G)"]!NQC8<]!NSDYP!TQDX.'7&I* 0
M" > 1@#G@\?+U[GWQQQ7&ZMJ61G.[C^Z<GA<'@?AGJ ._-5"#O;EE:W:6CNO
M+NQ\TNK_  1A:G>YF8,2 "N3@<DA21CDD\#KG'IV%&&X ?*E@"5W-@'(8X)Z
MG'?C///3@5AW=X3(S;CN8H>06(4<$@8SC'&.G&<D&G6TX>3)8*%(YP!P#D$D
MCL  ,@#L.X/6J5E=J]W;K^5MO/KZ&,I--V>GHF>BVL_RJX)P00 O7&2,XQGJ
M>^3D=>2*+JYX&#D\X!X/4$ DCKD#&1T R3T.!#>!$"G .<?>Y)8D@<8&3R1C
M/?M45Q?YP1R,;@,C!(!P<XZG:1UZ9-92I7EHGK;KZ+KJ4I>[JU>S[+O;]"Q+
M/N(&XC;T^4GKSN'&!GUY/<$=!$C9;/.%9"<[AD$\]3Q@ CH>F<^F2URKNS!\
M$D$J-I(XXR6R>G3L!Q@5)%<!=V)#E@>-H)S@@'@XZXP0!V'.2:M4&GHFOE_]
ML9\\N_X(TI+@*,[MH&>,;L9.<;B/< 'H?6LRXN Y8G)!"GT&%P,GIUYP,#')
MYZU!+<J!)\X[#!4 9. ![<<=<_Q#@&L*XO/O.3QWY !R ,D=L9/I@^H-4J=K
M73;NNC[KMI_6H<[ZM?@OZ_R)IT,C, ><]V W$A<\D?*,*2 1P>.HK/EC"HQ/
M0K@,3T^7D[1W _/!R03RXW88[1@J1DC. <D8/ '8?3/3/?'NK\ 29R<*2>1@
MX49SP00 <\<<X]JZ5%+5*WS?ZD-JSU6SZKMZLG:93(.0/O+G/3 ;!QW^]V..
M.O) S9(PY8X)).5/8YQQC<,Y/'8' )K-:]W$D9P>< J!V[D>O8=@*?'=AFPV
M0PP0Q;T(YP, X)4$C YZ]2&*,KI7:OKU2>_:_P"@^11OR!MVJV5Y/)&#D_J,
MYSSS5I#M=6P,!L8''7*=?QST]O>J,TRC>23P@QTZG'/X #(_'@'%3"7*#:"<
MCALC[Q[_ %#?K0*4M%RM;VTL^C]?\Q]RIPH&,L<$G/\ #MQW.>F.WZUDS;@.
M /G)'MT)+<YZ_ATSU-;!<'EFRHR26Z#) '4?6LBY)#CJ?OD#U.3C'N1FE97O
MU'%)I.2N^[NMGIHK+HNA2D55^; Y8 CU+'&?PR3CH<GIS4+DA.1QG9G.>2IQ
MQCISG^=2LX? Q@=<9!R05P>/[OOZ]*K%P^XY^4$@XZ''<G&>GITY[DUO1C>3
M;6RNMUK>PJFR]=/N*\F2Q '3OGU"].F",=:IW#XQ\V#C! /)(#9'3@]N^<Y&
M0I%7"03D]&?WY&?Y;!^59]P/F![?+^9#Y/KU//X]JZ'&+W5]_P =S-2DE:^F
MNEEUWUM?KW,UW9&XR?F;'S 8"G'<'U[^_K4RWDB@')YP"-PXSP> N>.0<_@3
MFJK_ .M<9X&"!Z;BV<?7 )II56Z@'O4JG!;1=_)R?^8)M;.QLQ:DRE<L<=20
M<=,?[/H?; SC.<G0COMQSD'(XSGH<=L8R2>>/7GJ*Y-F,;1E=HPRYS@?*,@X
M[_7VP,C-3)=%6R1T)QGC/(QSCIGD#J,9'6K5)-;;]VT_NW0G-)ZKWN^N_1]%
MII]VIUAN"W0 ]?NY&/KD+^'XU 9RK;FQC!!&<G ZYQGG'!./?/>L-=07G(ST
M PS>_';\*9-=&08 ;IZG X8\DCI\W7GKGI5>Q7:WS?Z"]NEO)KY(WQ>\X4C:
M0<C.W&.AZ-DC/''UR.FA;7A&-SY(QD=/NX)&0I[@],Y&!SSCAQ.Z_P "GIGY
M\D=>1D?GCG@5H07FW!(&,C.2#GZC&>.<X]2!5?5ERMVOH]+V3W[N_3_(GVJD
M[IWNU9W2?3HK;?I<]7LM49$0 XR05.>%X48^Z0<GD\#Z<"NZTGQ&\?\ &P)P
M<@\]5Z9')!/X_G7A,6H%44@\C& ><<#VX&1COD9YQ6E::NZL&W -G.<XY&,G
MD$@ _CZ>HYY4)227+%).^]^ENMS5590UO>^FS?GT3/I$>(S)%\S=0 #C!Z#.
M3@Y[=0,'<.2>,^763R6;OZ>O?..GI]:\BMO$3(JAGW#"KP<<GZ] ,'G(YSZF
MK;:V&)W$%@< @ANO3(QWQ\I/U'2L)8>TFFGNM;.VR[:6_KN5[5/5[OS2_!V?
MX'KT&L)M)8\G'W3]>ORCITZ>M9NH:NH(PY(R3],[?]D\]NW SS7FT.LM(=JM
MG!P?1>#CG&><$8QZ8Y-:0O-ZY)!XX/W@,GJ,#&#@8[_D:N&'C%MR2>FEG+?_
M (83F^FGW,Z*2[,@# YQSR>1VQT'IC&,#JW3-8\CXY)&[^$X/(R1D  X!!/J
M3U(/6JZW((;D<[<X4\_>[8SGU(Z9[]*KR7$;$%\XYSGG)XQQ@9&<#OT'ISMR
M1[?B_0ER;T;_ "_0N&? ;.#Q[@]\]5 /;T^O(K'N&3^+'!8GVRPQSC/ )..O
M.."14#W<2L0&)!QT7CIS_"2.<\@Y'0'BLR>Z9MP4Y R,CC&#D<8R.!] >1G'
M.D(1N]'MW?<6BW?WE>Y3+#!QDEN1G!"*".H_O>V,8^E1#PS=L*#WQUSQU/W@
M!W/) (%3SRJ(PV/FQP?=N"01D9)QD] .,?+SGQ$[@P/?<V&Y)((Z$<$GCCU(
MK<PE\3]?\B22/:"<],#C^+"9YSG'W<>A!Z=<TSPS#.<,V3C&#N/'?/J?3I]+
M<C?>!XSC([!0.I./3*YZG)_"GG/S=2Q+#!S][)Z\9X)KJI:1>R]U/MKKW$0R
M)G@#&[<O&.X&...@#?D?4"J;(&QG((R#@_F,^Q'4?R-:)SE3@@!B23C^ZP]?
M<?G5+:Q+8'\38S_%RQ.#V  SDCGI[UK3;D]==4OP\@(O*4\<\@CDD@?*3TR,
MYQC^594L1(&"0'^;VYP<?@<@ =N2.<C8/!YXQSP<XX[\=P?Q&:K.=@(&.P7N
M "<8Q_L],>P]:Z4K;=!-)[]#(.<D8''J?Q[ ]L'\?K0V0%/'S -W.,%2!C'.
M20*DE \S&X+G)).!D$D@<GC!)'')Z]N&#+L 0 %W8!QRO !"Y]@<=CGC JHQ
M;L]+7\^C]/(SYZ<'R\TE;I9O[GRN^]]W^@G.TMD<'&-I]O?W':FXR-I'&!@@
M]<8P?4=C_C4_E\%<C!Y(VC_/85&P"L,<#;@X]<XZ=L@#Z=*V,ZLX3C[LFVKO
M5-;V75*_XF;/'M)P,D8RW3KEF&.<\<X'KD= !" &*@\@DY'_  %C[="/TK1E
M"YYQ@C+?FH7/Y''XUFD\GG!#-C!YZG^AH,"P%"C &!UI:9&<KR<D$@YZ]3C]
M,4^@ HHH_ DGH!U/?^0H JV_8]]IY_[XJU110 5&?OD=MJ\?\#(_EQ1101/X
M?FAXZ#Z"EHHH,@HHHH-8?#\V%%%%!8Y "W(S\K?S6I<#T'Y"BB@ P/0?D*0
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MI_Z+DHHK&?Q/Y?H!SFHLWG2?,W7U/J/>KNGDY!R<X'.>>CT45L!5DYN+C/\
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C=57 VG@?D/4444 $8 !P,<_T%/HHH *:WW3_ )[T44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>forms-4_006.jpg
<TEXT>
begin 644 forms-4_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" (2 >L# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ?V2/"'Q2N/A%XL^+/\ PC'B2TN?%.FR>)?$/@3XDZ+\&Y?$?@C0]1\3>,?
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M>>*CRZJ-*%:A13E*]N:K]9HUJ:@YIT*D*CE'GA"?PU_P\L_9U_Z)S^W_ /\
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M/V=?^B<_M_\ _BIW_@J;_P#0;U]_T4 ? '_#RS]G7_HG/[?_ /XJ=_X*F_\
MT&]?('_!0G]MKX8?'']@7]N'X*?"WX.?M_\ BCXF_&#]D#]I;X6_#KPS_P .
ML/\ @IKHG_"1>._B!\%_&OA/PCH7]L^(OV1](\/Z1_:_B#5]/T_^T]=U73-'
ML/M'VK4]0LK**>YB_;ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **\?_ &A?C7X5_9K^ 7QP_:,\=:?X@U;P3\ ?@_\
M$OXU^,=+\)VNG7WBK4O"OPK\%ZUXZ\0Z?X9L=8U70M(O/$%YI&A7EOHUKJFN
M:-IUQJ,EM#?:KIUJ\MY#\P?\-D?M%?\ 2)W]O_\ \.-_P2R_^F64 ??]%? '
M_#9'[17_ $B=_;__ /#C?\$LO_IEE'_#9'[17_2)W]O_ /\ #C?\$LO_ *99
M0!]_T5^+_P"U9\5/VI/VA/"'@;P/8_\ !*[]O&V\-V/Q.TCQ/\0M)U'XR_\
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ML\<D<BLDB,RNI4D&OIG[/OB/1--T[1M&_P""+?[8VDZ/I%C9Z9I.DZ9\;?\
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M\1/B/X5L=9NO"O@7Q1J.EZ==7.J'2I[:RN"H!^C]%%% !1110 4444 %%%%
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M _"_@3P=\/M0TWQCXA^-'Q9T3QW?>%=.^%/PVUR.YN/ GA&WO_&>E^(=6N+
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M51RYYPEFM?B2C324J:PV#P+33FJF(],HHHKG.P*^ /\ @I9_R;K\.?\ L_\
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M]/T_^T]=U73-'L/M'VK4]0LK**>YB\__ .&R/VBO^D3O[?\ _P"'&_X)9?\
MTRR@#[_HKX _X;(_:*_Z1._M_P#_ (<;_@EE_P#3+*/^&R/VBO\ I$[^W_\
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M^F64 ??]%? '_#9'[17_ $B=_;__ /#C?\$LO_IEE'_#9'[17_2)W]O_ /\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /Q@_8-_8^^!GQ'@'[47BFR^)TOQE^$G[<W_  5M
M\/> M6T/]H/]H+PCX,T;1-4_X*J?MA7&N:;=_"'PC\4-"^#WB*W\3R6FF+XL
M'B;P%K3^+(-"\-VGB-]3M?#6@0Z;^@/BK]CWX#>-/VD_A]^USX@T;QY-\>/A
M9X2UKP)X&\2:=\;OCCX?\)Z1X2\23+<^)-$NOA'H'Q&TSX/^(+7Q%=P:;>:_
M)XC\!ZO<:U=^'O"5WJ<]U<^#O"TNC^/?\$T_^3=?B-_V?_\ \%8O_7IO[9%?
M?]*'[MTG3;@Z#Q$Z+@^7V4L7&K'%.FU\/UF%>O"O:ZJQK58S352?-,O?=3GO
M+VM*E0J<VO/1H.,J-&5W9TJ3A"5.%DHRA&2]Z,6OC7P#^P'^RA\,/BS>_&CP
M-\,+K1?&%WXM\3_$&RT=OB+\4=5^%'A;XA^-K.ZL?&?Q'^'WP&UKQMJ7P.^&
MOQ&\76NI:O#XI^('P]^'?AGQCXB37O$8UC6[W_A(];-_8^&W[!_[,'PBUKQ;
MJO@'P/XGTG3?&C>*GU+X=ZA\8OC5XG^"6B3^.GU.3QC>?#WX >+/B'KGP/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?^"IO_1Y'[ '_BM/]HK_ .FQ4?\ "N?^"IO_ $>1^P!_XK3_ &BO_IL5??\
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M%;_''Q;^+5AJ5]X1_9B^'/\ P5<_;MUSXZW$OAGPD_C;Q_IKMJO_  4E\/\
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MFJ5#VTE+G4.9X:$7/$WA7QN&Q,845=U'A*V Q$,1*GS4Z<HJ,JD:EZ2_H?\
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M^&QS['ITSUZ'^9+P!^UU\5_CQ\#?V//!?B+_ (*A6'PE^"/BS6/V]_"_B_\
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M_#;_ .:6C_AM+]CS_HZS]G'_ ,/;\-O_ )I:^3/^':OQ$_Z2@?M__P#A'_\
M!,__ .ES4?\ #M7XB?\ 24#]O_\ \(__ ()G_P#TN:@#ZS_X;2_8\_Z.L_9Q
M_P##V_#;_P":6C_AM+]CS_HZS]G'_P /;\-O_FEKY,_X=J_$3_I*!^W_ /\
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M]\8>'_&>F:-XDATG2->E\/ZK?>'=0U&VT_6H]#\0:%K,FEW<L-\FE:UI.H-
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M]>F_L;U]_P! !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P -3?\ !HQ_T+'_  2._P#$._A'_P#.0H _J+HK^73_ (:F_P"#1C_H6/\
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M?\$LO^DEG[ '_B9'[.O_ ,\:@#[_ **^ /\ A[%_P2R_Z26?L ?^)D?LZ_\
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M?L3>-OBWX(E_:.^+&N_%KX8>"(/$\GQK\;:5X4^ WQ6TWQ39Z)\6=0\$V?Q
M^($?Q!\ Z(O_  @FA^'=*T/XE7?7BZM"A3S7V6']K7PV&HXB%*E-SA5BLPQ-
M987!8FK-TZ^+67TZU#$8A4X_6;Y9"&74<1"?UYNC0Q&8QHX?%/#Y=/.,5A8X
MNLE-K"0CF.&I8VM3J4Z-:."O+*L3&C=5'.CC:_UOV.,A1P']*WQ+_:/_ &>O
M@Q=^"+'XQ?'CX-?">]^)NKVN@?#>S^)7Q-\$^!KKX@:]>R0QV>A^"(/%&M:7
M+XKUB[DGACMM,T%;^]N&FB\F!BZ9KI\6O".@^)OBB_C#XY?!./PYX/N?!%C+
MX>2\TWPWXE^&%WXELYX;:T^)_B+4OB'J]C>W?CG5(C/X(@/A#X?R16D$VFQQ
M^*[EO[1B_'7X8?L__M'?#/QOI^L?&C]AF?\ :A^'O[0'[%7[+'[//CSP58>-
M/V:O%M[\#M?^!DGC:P\3>$?B]I?QP^)O@CPEXM^%/C@>-M+\<ZR_P@N?BQ>:
M=XP\/:]8CPSXUME\-:_??)/[1G[%'[07B[5/^"G.C>'_ /@EQKOC/PY^T1^U
M'^Q+\8_A!'IOB3]@Z#P=XLU+X&WG@V/XY_$];+QC^T3X9U70]=\;Q:%XYFT_
M5O%?A3P_XS\7V7C=6\4V.CW6N>)K'2RI3IT\Q>$5:-2BL9CL/]?IIO"JA0SO
M+,MA-KWN>J\!7Q6:*O&3P=6DJ3P5:I1IYC4I^=A:E?%8'#XF>'>$KU<%E>)E
MAJ]6G*<:^,R?'8ZK2;I2C4IPPV84Z&6UJ%>G#$TI1K/%4Z52KEOM?Z.M)_:=
M_9MU_P !^/\ XIZ'^T%\$]:^&7PIU77M"^*7Q&TGXJ>!]2\"_#;6_"21R>+-
M&\?>+K/7)] \'ZKX726-_$6G>(K_ $V\T-9(SJD-KN4F#X'?M7_LM_M-KXD?
M]FS]I+X!_M"1^#VTU?%LGP/^,/P\^+">%WUH7QT=/$;^ _$.O)H;ZL-+U,Z8
MNIFV-]_9U_\ 9?-%G/Y?\^O[1OPP_:!CUS_@H7K6K?LN>//ARG[0/[4?_!.S
MQ5^Q?9^(/B/^R1<Q_$'XH_ 9OAIHY?1?ASIW[4.GZ%XEU30KKX>7?CUOA9\2
M?%_P?T7XD^"O#4>BWOQ*\!ZB\FH^'?TH_P""9>CZQX9?]J'1?BE\-/BE\.?V
MAOB)\8;?]H/XYZ%X[\.?!/PGX(N];^)_A#2?"&EW_P */!GP'_:F_;'\*>!?
M#%]I?PH$VK>$?%GQQ\1_$>?Q')JOC+Q$LFD^,/#][=K#*.(P]6LG*%6.7T*\
M:$^1-8N4,+]8HSG&<DZ>&=2K5KPC%8K"T:F6QJQJSQDZM+IQ#E1=)02JJ>-K
M4YU%*/)3P</9^QK*":J.I6GB(8:C5:>%Q.*P^80IJA]3G!_<^G?M2_LRZQ\0
MM*^$>D_M%? G4_BMKLGB"'1?ACIWQ;\ WWQ#UB;PC(L'BN+2O!5MK\WB2_D\
M+SD0^(DM=,F;192(]2%JYQ4&E?M7?LNZYKOC+POHG[2'P&UCQ-\/?#^K^+_'
M_AW2OB_\/]0UWP/X4T+5Y_#^M^)_%^D6GB";4/#7A[1]>M;G1-4UK6K>RTVP
MUBWGTVZN8KR*2%/YJ?V//V<_%7QH\ >)?V>/A5^R]#X!^&?P5_X+0?'O]H"+
M]HO0+SX!Z5\._#'ACX&_M1:[JNI_"WPAX$MO&NF?%O3_ (E>-O"VAO\ !BUL
M%^&5E\+[;X9>*;N>_P#B.MK!+X+E]S^#G[$?[5EG_P $V/'/P-\*?LLG]G;Q
MSX)_X*#:S^U#X)_9P\7>+O@%IO@SXO\ P.T_]K^3]H_P]\&K'5?@-\2_B=X
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M,TCX+_MC?LB^']&\9ZWY5UJ=MXJU74[CPGX:O]'\8>)[CP'#;C5K'T[XA?\
M!/?]G;X/?M[?L#_":3X&_M$_M'?"[Q1I7[7OBO\ :A\:?%GX7_';]I#X'_$+
MXJ?&BTT:;PO\1?VA;JQ\#ZS^RIHGQ$\7^,#XV^UZQ>>&O!J>&]!M?#UC>6OA
MCP18^ ;*#*E)R="G54HO%XW%X.A4C&=Z;PLW7=248R5"5"6#H8C#7K2H5IX^
MK@:E&I4PCQ49<U><X2Q$H7BL)A,%C:E-PGR5,/5P\85ESSES/%/&8C#5J"PR
MJT(8>CCL/B:-.N\-4A^GVA?\$K/^"<\^L>*XO$G_  2V_P"";.D>'[/5;.'P
M+JFC?LR_ O7]6\1Z%)H>F7&H:EXMT2_^ GAFR\&:M;>)IM9TFRT71_$/CVSO
M]$L-,\03Z]IE_JUUX8T7J_\ AU!_P2Q[?\$U/^"?YZ@X_8W_ &=3R,\'_BW/
M/0>G/UK\,V\">-H/BW^VCITG[/?[7_CW]DNW_P""H_@+XH_'KX6>,?@)^U;X
MJC^._P"RS?\ [*\'PU\3+\.-'^)?@V]O/VCO@SX0_:ILD\3:U\"OA9=>--'U
MCX8^&8;3P?\ #_5_A?J?A'1M:[S]L+]F+P!XP\*_L:^#/AO\'?VQ/AQ_P2W@
MO/VC;?XA_"_X3?L@/\9O&O@WXD>/[_P-XG^%7BS6OV'_ -K#]F/]ICXEZ!\&
M?#VKI\5_#GA31M$_9MT76O@KK5YX=U7P#X<\$_#U-%UFXTY7*C@ITZE.<L91
MRR:CS\OU=XO!1Q=2&,JU&HTZU63>'R]TZ<J>,Q:]GBEE#FJ5/LG&$*]:E.HE
M[&&-JR]G"4_:+"5*%%4L/!3DYU[S^L8BC*K)T<.YU*-3&2C.G']D#_P2@_X)
M9;<_\.U/V =O7_DS?]G4 ?C_ ,*W([GJ<9Q@\XH_X=1?\$L"<#_@FM^P!P5
MQ^QQ^SH<DC(&/^%<$@X_''3%<WJO@*W^!/\ P3+\3_#K3_ W[5O[56C?#W]G
MCQ;X5TKP!XM\8WFC?M8_&CPWIVB7VFZ5H%]XQ^%T/A#Q+HOC;Q+H0BMK"^\*
MZ7HGQ$TFRFLXU\.Q>.K:?1#_ #,_%;X3:A\+/AQ\>/MO[-_Q-^#'[/\ J_\
MP40_X)+_ !K^!GP^^"/P0^//[+'P@NO#_BOQ;\&_AW\3_!V@_!/7;_P)X@\8
M_$/7IWUFP\5>$]>\ V&L2^.-)@\9ZUX%\">*-0\"7NJ:X>G#$9D\#3JU%2EB
M,-AZ>+JT94H7Q6,P&'INK1E5<X59TL<Z].A2E7<I83%4*E>G)4XRY74E# QQ
MLX/G?UMRPU.4:DY+"Y=FF-O2FFKQE/+Z-&=2M"E3A#'T*D/;.G6Y?ZBQ_P $
MG_\ @EB<X_X)J?\ !/X],?\ &''[.IZ^N/ASWYQ@\TT_\$H/^"6?S ?\$UOV
M 2>?^;-_V=B>@QP/AN3P<X '7H#7\]WQY^"O@;P-8Z9\5O"'P2^.7PI_8H\5
M_P#!6#]B#6?@=^S58?#SX\_!/4M41] 32_VEO$.E_L<WEMX$\467A'XB^,K&
MPN=#^&7B?X5V6I^(/$GAOQ-XS\(>"6G\;6.H^);?C_\ 9LTW1-5^$=WX7_9A
M_:<L/V./&/\ P5B\&_$[X(_LV>&?V:/VLV\ _#[]EQ/@3X:T/X^Z[\6/V6?#
MW@*;0_A3\,/&W[05M#XG\&?#OXU_#?P_>Z/:WOBGQ+X7\*:!HFO^.!64$YT8
MR]Z-66(P^&G0E&,JF'KUUDC5*NZ=::56I'.)5*$*4Y15'"5)XRK@I2G3H*5>
M*>-LURX7!8C'4I.7*\;2H0SB4XX91Y[2H?V3&.)E64(<^)4,'''3A&G6_H&/
M_!*'_@E@<@_\$U?^"?\ SC&/V./V<\_-TY/PZY)]OYGAP_X)0_\ !+#J/^":
MO_!/_ /4?L<?LYXSSCD?#KCH>N*_%C]H']E;Q,?%W[7?P?L/V6?'^C_M2I\0
MOADW_!(G]H_X,_ CQ/\ \*K_ &<OA#H'PS^%V@^%/"?@;XY_#SPM'\-OV2/!
M?PQ\:^&?B%?_ !>^&/C/Q3\-+/XL>&=7FTO2M%^(D'B/2M#'U;J?["'P^\*?
MMJ?&?X*M^Q7\//&_[.?_  4+M_@_^T'\=?B,/@?X7UGX=Z3\5/V>M?O-6^*'
MAOXG7M]I5WH41^+FICX9^)/AYX8OH'N+CQQXG^.WQ TTMJ_]M7S:4(4JT<-)
M8E1CBN=TKPM+W<'0S*4*O-.,*-;"X2.:X+'0JNG"GQ!EM++<'/&X7,<+CY7.
M?L_;J<:G-AX*K4A&*E)TEBZ.#E.ERSG&JJT\9@L5@X4Y2JU<!+'8G$4\+/ 5
M:3^Y=4_X)8?\$MK#3+^^M?\ @F+^P5J]U9V-S<P:59?L=_LT0WVI3V\!FCL;
M274O 5AIT=U>,$AADO[VSLXY) ]U=6T"R3)\K?L-?LE_\$N/VSOV=/#7Q^N/
M^"0_["_P>N?$/B_XM>$KKX<Z]^RY^RUXMUOP[>?"SXM>./A7=PZMKGAOX:CP
M_<:E>W'@J;4+RWT.[UC2+"XO)-/TWQ!XAL[6+6[_ .,O^$5\1Z-_P4X^ _[1
MOPT_80^+'P>T?PA^T_\ M<_#7]H_QEHW[.GQS\7?&3XH^!M9^"GC'_A7_COQ
M7\?M1@3P;XJ_9L\1^(_#_AW6/A5\+? =_P#$/P/\/+J+P=X5TS6/A[XQL[#X
M8:M^@G_!'O2M7U?]@J?P5XY^''QN^%>ICXS_ +64&N>&/BU\+OC+^SMX\CT7
MXD?M#?%GXB^'-6T:Q\?>'/A_XSBLM7\#>/O#>J:;XL\+L$T_4KJ\TN#5['Q3
MX?U>RTO"#DLLQ&82:JU:N6X?%T<+*?L986I#-\7AY)RNVZ>88"I@*R=:DZF%
MA&<Y8:A*-5*<3.5'%4<.[JG''QH5:\(>UE5I3RO$U:L8QC.4%+!YAA*T+PJN
M.(Y\/%8AQK0E+Z&/_!*#_@ECD8_X)J?L C.<?\8;_LZ_W<YP/AQDXSU['-<K
MXM_X)5?\$Z+.RTZ3P-_P2U_X)M>(M1D\0^'[;5K7Q5^S+\"_!UG8^$[G5K2#
MQ5K>FW^D? /QQ-JOB'1-">^U+P[X8N=.T;3/$^L6]IHFI>,/"%G>S>(+#\ /
MV$/@YX*\;_"_]B3Q1\*_@U^T/X>^)_P<^('[9K?M??M':=\-OVF++Q+\0?V-
M[Z]_:AT*^^%VC?M)>';.?Q/^T9XE\5^.]4\#7WPU^'OPR\>>//BMX'\;Z1=>
M+M.TCP;XJM?M>IO\!? C1O 7_!-__@G'XZMOV2OVLO#O[2_AO]MS]FW7/CY=
M>'?V2_VPX?CSKOA?X2_M":MX[\6^(?VCM!\/?#-_B%\5_"'@_P ":YJ&K>"=
M=^+>F>-/#T>M:C>-\,[R;Q6UR8[CR3JX=1G4G3K2RI1<*5Y3AF>/PN$HU53E
M7@OJRABZ<ZBJ5:-=NEC5_L^'HTL;BE7E*EAZM3256$,^A*C3J7J4<1DV SW$
MRPTI\DX?6,34R5QPLJ4:]%+,LJE)U\56KY;1_HG_ .'4'_!+#./^':G_  3_
M ,YVX/[&_P"SH#D].OPYY]L=?3T:G_!*#_@EB>!_P34_X)_G.3_R9Q^SJ3C/
M?'PY/?Z#(QG-?G7\&_A'H[_'#XPWGQF_9Q^,M[_P4DT'X]?M(^)_@#^UH_P9
M^-\W@K5O@_X\OO&D'P&T]/VL-!\/V_P7T_X-> _A)XKT#0]5_9G^(OQ @ATS
MQSX-U?Q%I7P=U[X@7GAW6-:YG_@C)^R=:?#;Q;I7QE\:7?\ P4"\,?M6+\'9
M/AC^UEX%^._P+^#?P?\ @IK_ ,2X+[0[K6_'=_\ %'X?_LO_  9_X;%\33^(
M] U,?#3XY1_&7]H[Q78>#-8U"V\6^+K-?$$WVHPR591<ZBIKZA3QCDDYJ=6M
M3C4I4*$)3I5JD*%5RP.:5JD*,\OQJBEAL3AI>V6F*DJ,ZL:35=T\P>"C*-XT
MIPIN\\1[6\N6&*H\N*RI.DX8[#JI&I5PF)A&C+]/O^'3O_!++_I&G^P!_P"(
M;_LZ_P#SN:/^'3O_  2R_P"D:?[ '_B&_P"SK_\ .YK[_HIFA^,'Q>_8B_8O
M_9K_ &M/^"5OCK]G3]D/]F#X ^-M6_;?^*/A/5/&/P4^ 7PI^%?BK4O"M_\
M\$P_^"B^L7WAG4/$/@7PGH.KWGA^\U;0M#U2ZT:XO)-.N-1T;2KZ:V>YTZSE
MA_9^O@#]LC_DXK_@D[_V?_\ $?\ ]=9?\%+*^_Z "BBB@ HHHH **** "BBB
M@ HHHH **** "O@#]LC_ ).*_P""3O\ V?\ _$?_ -=9?\%+*^_Z^ /VR/\
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MD]93J5).=2I.3;E.I4G*4ZE2<IU*DY2G4G.<I3D4444#"BBB@ HHHH ****
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M.$6H0C%.=2HU%))SK5*E:K-[WG4K5JU6I)MN=2K4G)N<YN11110:!1110!\
M?MD?\G%?\$G?^S__ (C_ /KK+_@I97W_ %\ ?MD?\G%?\$G?^S__ (C_ /KK
M+_@I97W_ $ %%%% !1110 4444 %%%% !1110 4444 %?F__ ,% =?G\!>/O
M^"<WQ=O/!'Q@\:>"?A!^V_XK\6?$F3X*? [XR_M"^*O"?A7Q'_P3T_;V^%&D
M^)M0^'?P'\"?$?XB2^'Y?B)\1_ OA6ZUJQ\*W6G:7J/BC2CJES9VLYN%_2"B
M@#X _P"'EG[.O_1.?V__ /Q4[_P5-_\ H-Z/^'EG[.O_ $3G]O\ _P#%3O\
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M7_HG/[?_ /XJ=_X*F_\ T&]'_#RS]G7_ *)S^W__ .*G?^"IO_T&]'_#M/\
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M<_M__P#BIW_@J;_]!O1_P[3_ &=?^BC?M_\ _BV+_@J;_P#1D4?\.T_V=?\
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MO_1.?V__ /Q4[_P5-_\ H-Z^_P"B@#X _P"'EG[.O_1.?V__ /Q4[_P5-_\
MH-Z/^'EG[.O_ $3G]O\ _P#%3O\ P5-_^@WK[_HH ^ /^'EG[.O_ $3G]O\
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M_P"TAKGP]_X+5_"KX>?LP']G"']JCXY^'_BC\!+_ ,0^(?V?-,^'7QUT'1_
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M$OA*PU30O .JV>@>(]"\*KI'BR[TP^.?%'X9?#/X&?MY^$]'_8QBU'_@G?\
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MOX17GC[]F>Q\"?M5>"_AGX"\ ^&?BGX/T"]\!?$[6X?#GQ \4_$OP9K7QO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&T4T$J++%+%(NR2.2-P4='3*LC JZY# @D5POPR^$OPK^"OA#3_A]\'/AIX
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M (=._P#!++_I&G^P!_XAO^SK_P#.YH_X=._\$LO^D:?[ '_B&_[.O_SN:/\
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M_L ?^(;_ +.O_P [FC_AT[_P2R_Z1I_L ?\ B&_[.O\ \[FC_AT[_P $LO\
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M0 4444 %%%% !1110 4444 %%%% !1110 5\ ?\ !2S_ )-U^'/_ &?_ /\
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M*_Z1._M__P#AQO\ @EE_],LH_P"&R/VBO^D3O[?_ /X<;_@EE_\ 3+* /O\
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MZW#I5]\8H;"XN]9MO6Q\;?\ @H?\(\2_ K_@GU^WS\3O"<#?N?@Y^U'\7_\
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M<H0DM]%J[-V2;=HJ4I.R3=HQA.4G:T8PG.3C&$Y1_2JBO@#_ (5S_P %3?\
MH\C]@#_Q6G^T5_\ 38J/^%<_\%3?^CR/V /_ !6G^T5_]-BIC/O^C_/_ .O\
M^GX_3\_O^%=?\%3,9_X;(_8 [=?^":?[10QG&#S_ ,%8NV1T_3K7,>+;#_@H
MUX#TZWUCQQ^WK_P3:\':1=:II>AVVJ>*O^">/QV\/:=<:WKMY!IFB:/!?:M_
MP5JM+6;5=9U*ZMM.TK3XY#=ZC?W,%G9PSW$T<3IM:+K*48Q764IRC"$8K5RE
M.<X0A%)RG.<81C*<HQDFU9ZZ)2;\HQC*<I/M&,83E*3M&,83G)QA"4H_I/C_
M /7W^GM^'UZT=^W'Y_\ UOUS[5^:ME9_\%&-4U[Q3X6TS]OC_@FQJ/B?P,FD
MOXV\.V'_  3Q^.UYKO@]=?L7U/0F\4Z1;_\ !6J74/#ZZUIL<FHZ.=5M[0:G
M8QO>6?G6RM(/+?AA\9_VK/C;X@NO"?P8_P""K'_!(;XN>*;%/$4M]X;^&/[&
M?Q)\?:]9Q>$-3TG1?%DMUH_A3_@L%JVH6T?A?6-?T+2/$;SP(NB:IK6DZ?J9
MM;O4;.*91DIMJF_:25/VSC3O4E&BI2@ZSC!3:HJ491=9I4DXRBZJE&48S*<8
MKFE*,8^T5'FE*,8^V:C)4>:32]JXSA)4K^UY91E[/EG&4OU]HK\_A\._^"IG
M_1Y7_!/_ *X_Y1J?M%=<@?\ 26'KE@/Q%<OH]C_P49\0Z_XD\+:#^WM_P39U
MOQ/X-.F+XP\.Z1_P3R^.NHZ[X4?6H;BXT9?$ND6G_!6N;4-"?5[:UN;C3%U2
MWM&O[>WGEM1+'$[J[INR:;LY66KY8\G-*RN^6//#FE;ECSPYG'GCS-RBK-M)
M.48IMI)RES<L4VTG*7)/EBFY2Y)\L9<DN7]*:*^ /^%<_P#!4W_H\C]@#_Q6
MG^T5_P#38J/^%<_\%3?^CR/V /\ Q6G^T5_]-BIE'W_17P!_PKG_ (*F_P#1
MY'[ '_BM/]HK_P"FQ4?\*Y_X*F_]'D?L ?\ BM/]HK_Z;%0!]_T5\ ?\*Y_X
M*F_]'D?L ?\ BM/]HK_Z;%1_PKG_ (*F_P#1Y'[ '_BM/]HK_P"FQ4 ??]%?
M '_"N?\ @J;_ -'D?L ?^*T_VBO_ *;%1_PKG_@J;_T>1^P!_P"*T_VBO_IL
M5 'W_17R!^PO\8OBG\<OV?Y_%WQKNOA_J/Q-\+_M ?MB? OQ-K'PM\'^(OA_
MX$\1?\,R?M?_ !T_9OT;Q1H7@CQ9\0OBMX@\+?\ "4^'_A3I7B+4]$U#XB^+
MOL&L:GJ$%KJ\MDMM'%]?T %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 -R !WZ <=^F1_C7YKV7C/P_P##O_@HU^WGX]\67\.E>%_!G_!-
M[_@G;XI\1:G.VV&PT70/CS_P5HU74[R0XSLM[*WFE(&2VW !)P?TIX.#Z?SR
M#S^7(K\0/VB/V>?B7^TW_P %!?VJOA7X+^)OPQ\!^";_ /8V_P""6&J_&OPW
M\4_@7J7QT\/_ !C^&>A_M0_\%4-8U3X0WNCV?Q@^$UKHWA[QL^G#1O&<^I_\
M)?8ZYX7O-1\.W7A^73]1OTN,:L:DZ;ITYJE.K*-)5FN:.'56<:4L5./)-RCA
MH5)XB4(PJ2FJ48*G5YI0;A*G"2G7A4J4J:E5J4J,H1K5XTHNJ\-0E4M3C7Q/
ML_J]&=5PI0JUHU*E2%.G*1Z+^P1^UA^T+KOQ(_:_^!'[9<L,GQ:^$MYX%_:)
M\ :9X;\)6\%_:?LR_M#>$;_Q9X'\!6VB^%M.:\\8^(O@KXM\,_$+X-:MKUK9
MW>O>--2\)Z?K,]J+[78;04--_P""SOP7U?X:?#3XPV/[,G[:C?##XU?&?3?V
M>_A!XOG^%7P]LH/&OQ9U+XP>(?@I)X7U71+OXOP>*_A"^F>*O#\MQ>:C\?O#
M_P )M,NK;4-/T?1+K5_&Z:KX1TRK=_\ !*;_ (5)^UW\._VF_P#@G]KG[('[
M#GA[PW\*_$OPO^)GP=\&?L+0W?A_XZ:=XO\ $.B:]>:C\0+_ .$O[1'[/6DW
M-[X3/AO2F^&=VW@^[UKPEJ-]XLFU'6_$^A^(_P#A&M-\_P!-_P""4/[2.E?L
ME?!C]F>W_;*^#$FM?!O]LV/]KZV^(MQ^QMXT.F^(KBP^->I_M%:9X!OO T7[
M9T=QI\*?%+7M:74?$]GXU9K[P.='\.6V@:;K>G7WB_6>BG]7G]7E.,J%)T\G
MPM3"SO3G06'SS&Y?F>)>(I_6WB?:<-QRC,:>(FGB)8VAF-?$8;$8W'U,)'DK
M_6*:Q,J3H5JE:6/QE)P=:%*%2OP_5QE#!*C-0C0I0XIIRP2HTJE6EALLQ^%P
M^&Q;H99+%UO9?B#_ ,%(_A;\-?'?Q@O=:_9H_;FOOCG\"/V3=%^/GQ0^!6CV
MOAB>32/A'JGBV-+_ /X171[_ /:#T_\ 9>^*GQ%\+LNJZCXC\3?"#QAX[U6#
M2?#FN^ ]/\<ZIXBL[?P%=?0$_P"W#*FF6NL6/[)O[5?B*PN_V?/A_P#'F%_!
M6E_ ?X@7K7GQ0UX^&_"/P871? OQ\\1Z]/\ $VXNXK_4-1\0V>EW/P#T;P[I
M&M>)M4^-MIH6E7M]#B1_L=_$V7]OSQ1^V%JGQH^'^I?#;Q/^S9IG[-5U\"S\
M#=<B\2IX?TS7M5\;/KTWQ>E^.%UHUW>W_C#7M6DN]/E^#B6;>&&T_08Y(]3L
M[OQ-J7EG@O\ X)R?$CX8?L:>.?V6?AG^UUXL\,>*]6\1:1!\.OC*_@$2WGP_
M^"_@7Q!HS?#+X 7GAW0O'_AC7M?\"Z!\--$3X7>)=7T'XC> O&'BBSUSQ7XG
MTG7/!6NZTC6'+2DWAOWM-4J[A":4'.I&G.IG&9X*M24;M15++JN6Y^JCG7=6
M%'&8**EB<1#!QWCRJJURJ<'7IIN4ITU*C/)<MQ?M'.,>=RHYGALRR6K%4J;_
M .%#"8J#EALO>*K_ #/^V'^VMXE^-W[)^G_$SX*:]^T5^RE\0/@A_P %&_V5
M/V??C9\,-9N_AAHGCHW^N?M"_!7PAXT^&7CW7?AUXC^,/A;5/!7BGP#\5M,\
M56]_\)OBDC:M!<Z)::CXB;3&\3^$[[])_P!M#]H;X._L]?#?X?ZO\;;3XUW/
MAWX@_''X*_"[0;GX(P_$JPU>Q\>^,_B)X?T[P)+XP\9?#?7/"A\%_#^\\6'2
M-*\577C#Q7I'@WQ7I]^?A]K%GXH7Q;%X0U[\WM7_ .",WQ+TWX-?&GX0_"+]
MJSX6_#+2_C-^VW\*/VV+JR;]D.ZUSP=X4\3_  TN_A1XPO/"F@^&-(_:3\&:
MW<1>+OB?\(= \0ZIXDUGQMJ%^?"^I:]H.H6.M>-M3G^*3?>O[>O[)7Q6_;!^
M!O@SX2^!?C;X"^#FN:!\8?@I\7M=\7>+/@=K_P 7])UV[^!WQ \/?%?0]"TW
MPEI7QT^#U[H-IK/CKP?X;.K7MSXPUZX3PLFL:':10ZKJ5GXHTGT(O!PA@Z=Y
M\DL\RG$YA&GSU*T,%6RKA"GG;PU:LG)T<-C\-Q']0@W*<'#"U*>&J/$RJ5(7
MMF[2E%RI9;GM'#5&HTH.M+'YUB,D^LTX1ES594:^5T\4[33I_6:,\33ITXV\
MZTS_ (*M_ S6/&<?AVT^$_[2]IX7M?VM8OV)_%'Q7\4?"W3O '@+P=\=-5M=
M"/@VQUBQ^('B_P +?$S6/"OQ UCQ#IGAOPMXK\#_  Z\6Z=%JES8W_B<>&O"
M^M>'O$6KW=8_X*E?!;P_\-_CY\:]2^$O[1]Q\$_@ ?C%_;?Q8\+_  ZT'XA>
M&O%K? GQCIG@'XD1>'=(^'/C?Q=X\\,76C^*[S5+6.Q^,?@[X67MSH/A+Q?X
M_2W'PXT.7Q?+\LZA_P $KOVM=?\ #.OZ1XB_;:_9]N-5\2?M^?"[]OS4]2T?
M]AKX@Z3ID?BOX9R^#;VV^&^GZ1=?MVZS=VOA;5-3^'OA2=]4N=>U#6[2T77+
M/S;R35+*\T;S#]N[_@GGJGP^^'/_  4"_:C\/W@\8?$+XP_L<?M#_!:S^&G[
M*_[)_C32?BM\?O'OQITI]'\'7O[0%A\'/$WQ!C_:$U?P'J4VF:!\,O$T'P4\
M%:U\./#^J>*?$/Q"\<>(=)GU/5]+\[$35' SJ>UMB88"HI2C3G53QT<KX>K1
MG"@J:4XU\WJ9_EV'I1FHTX2P6)KJK0H\U3LRBE]>S? 83%QCAL)B<SP="M-5
MHQA2P5;B#%8*K/ZU6G#DG#(JV"S6I6KTX4:<\#BJ$O9RQ#=/[C/_  5G_9Q\
M-0>/[_XU^$OC+^S;I/@O]GW3/VI=#UGXY:!X'T;2OBG\#]1N]!TB7Q;\/+KP
M=\1/&X34-%\3>*O"WA3Q)X(\?#P)X^\/ZUXF\/R:GX6@T;5[#5YN#^#'_!;'
M]D+X_>%/%%]\++3QGXT^*6@?$?P?\)-*_9^\#>*_V<OBS\1?'GC[XA^&O%/C
M'P/HW@?QQ\&?C]\1OV;-2MM=\*>!_&7B#4=>U7X]Z+X<\!:9X6UZ7XGZOX'D
MTN\BB\4^'W_!-35_VP?V>_#_ (P_:F^,?B>X\=Z_^R5X3^!?P1O_  S^SOXP
M_98^(G[.?AZ'Q+\-?BF^L^-/ /Q0\9^-]<\3?&ZV^)_PC^&NH^(]4UOPY\-_
M!U]9>![?2=+^$OA_3M?UN35/K#QU^Q/^TC\6/AY\([SXH?M<>"[_ /:=_9[^
M)7AKXJ?!?XR^"OV:)O"'PPTSQ5H7AOQQX(UJ;Q[\#M2^.OBSQ!XTM?B5X#^(
MOBGPE\1M/TCXY^"=-EM9M/U'X?6?PYU6TFN[OT\53PN'Q^,H2E6EA:.*J8:$
ML/*E.K&A'-<VITL52E+FHXK$QR^EE$<=AN>GADJV+Q>6XG$U(4*-7R\%5K5\
M!@:U11^LUL'#$5U*G.G26,>28"J\&Z<HTZU+!5,WJXZ%/%S2QM#ZM'#8O"^S
ME[=<5\2?^"F/Q \,^._V'?"/AS]A[]II'_:L^+'Q?^''C/PW\0=,^$?@7XD?
M"YO@]X(\>Z[X@M8_#FO?&S2M'\6W3W/A:'QAIOBWP)XC\;_#SQ=\+M,UO4OA
MKX@\>>)]=\%:#K.S\*/^"BO[/FI_!OPIXX^"7P[_ &J/BGKGQE^/OQ^^'?PW
M^!?B"*]@_:!\8_$'X8^+O&MQ\9H['2OVHOBOX/T[X4>!O EQX>U^YAT#XE^.
M_A9X9^'>BIH?@32/#?A:^N?#/@J;N/B?^QG\=?B_XA_9$^*GBK]ISP=IGQP_
M9A^*_C;XBW_B?PA^SQ+IWPW\5Z1\0/A#XK^#FN^%O"'PV\0?&CQ5K_@.:#2/
M$_\ PD6C^(/%OQ1^+\EGXDAU WVF:MH%[INA:!\J_#/_ ()/_'3X:>%_AWK^
MG_MA?#P_M)?!G]IS]I7]H?X6?%73?V5_$6F_#%](_:]US7/$GQX^$7Q4^"E[
M^U+K>N^//"6L:MK]Q/X4U;PM\9OAAXA\,'0_!TLEYJ]YHVKW?B;F7LW0E&3=
M.NJU52G13K7I2S#"SI0H^TA&->%/".37MHX>K2?]H-3Q,Z. CB>WFNE)12O3
MH<E&K*=.FZL<-GCJ2Q<Z4)U*=3ZR\M@JF']K2J4I86,J5&%;,:F$]_T;_@K3
M^S[XKF^"_AWP1\,/VFO&WQ,^-OBWXX?#+1OA5H?P=GMO$G@KXP_L\:1J^J?$
M[X/_ !4\5^(]=T#X0_#_ ,=Z;/HLVG::-:^):>%M5ANK+Q;:^)C\.99?&D'V
M-^S'^TEX#_:K^"G@[XY_#VQ\2Z)X>\7C7;.;PYXTLM*T_P 8>$_$OA+Q+KO@
MSQEX/\56>@ZUXBT*+Q#X3\7^&M>\.ZN="\0Z]HDM]I<T^CZUJVF36FH7'P'I
M7_!-/XM>#?B5^SE\4OA[^TM\-M-\2?"[XR?M ?M%?&:?QC^S/K7BE_C?\8_V
MC?"VH^"?%VH:-)X=_:*^'\?PN\%>&/"NHQ:!X#\*SVWQ%UO3=/T/PXGB#QGX
MFGLM2GUGZ8_8!_9,\>?L;_L\VGP-^('Q>\*_&K5-/^(GQ7\=6WC;PG\)]5^#
MED\/Q9^(OBKXIZKI5WX3U7XL?&*22XTOQ1XU\0V]EJD'BBUAET+^QK&;25O]
M/O=6U<_=NA.345B5&+483JRHNHL93IU88>52G&I4PKPTZU7#5L3[+$U*5&A.
MM3HXFK5P\N*4\4JD(QAS4?;Q49R4?:RPT\#C*BGBESQA1Q-+&4L'1JTL-"K1
M<L365.4Z,(U*7W11112.X**** "BBB@#X ^'/_*4W]LC_LP#_@FG_P"M%?\
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ME7V57"XJI]5PU2G[3!5WB%]:JT<6XT?K&BBBI.L**** "BBB@ HHHH ^ /\
M@FG_ ,FZ_$;_ +/_ /\ @K%_Z]-_;(K[_KX _P"":?\ R;K\1O\ L_\ _P""
ML7_KTW]LBOO^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KX ^'/_*4W]LC_ +, _P"":?\ ZT5_P5BK[_K\P/'^I_M ? []OKXW?&OP
MC^QC^T!^TQ\,OC!^R!^QS\+='\3? OQM^R!HO_".^._@5\:/V\O%GC;0O%.C
M?M(?M3?L^>((_,\/_M!_#K4-$U/P[I7B/1[_ .T:O:SZA97NER6TH!^G]%?
M'_#9'[17_2)W]O\ _P##C?\ !++_ .F64?\ #9'[17_2)W]O_P#\.-_P2R_^
MF64 ??\ 17P!_P -D?M%?](G?V__ /PXW_!++_Z991_PV1^T5_TB=_;_ /\
MPXW_  2R_P#IEE 'W_17P!_PV1^T5_TB=_;_ /\ PXW_  2R_P#IEE'_  V1
M^T5_TB=_;_\ _#C?\$LO_IEE 'W_ $5\ ?\ #9'[17_2)W]O_P#\.-_P2R_^
MF65YSXY_X*1_$GX;:KX)T3QK_P $O?V_]%U3XBZMJVA>#;7_ (3'_@F;J/\
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MS_P2R_\ I:='_#&_[17_ $EB_;__ /#<_P#!++_Z6G0!]_T5\ ?\,;_M%?\
M26+]O_\ \-S_ ,$LO_I:='_#&_[17_26+]O_ /\ #<_\$LO_ *6G0!]_T5\
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MG0!]_P!%? '_  QO^T5_TEB_;_\ _#<_\$LO_I:='_#&_P"T5_TEB_;_ /\
MPW/_  2R_P#I:= 'W_17P!_PQO\ M%?])8OV_P#_ ,-S_P $LO\ Z6G1_P ,
M;_M%?])8OV__ /PW/_!++_Z6G0 ?\$T_^3=?B-_V?_\ \%8O_7IO[9%??]?/
M_P"S%^SWHW[+_P (;3X2:-X\^('Q0_XN!\:_BEX@^(7Q2;P)_P )WXP\=_M
M?&SXA?'[XCZ[KL/PQ\"?#+X?V7VWX@?$WQ+)IFF>$_ 7AG1])T?^S]-MM/\
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M>&X3Q;X?\>$6KZ9^T6F?L._L5Z+X<U#P?HW[(/[+VD^$M6\+^)/!.K>%M,^
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MOCSX@6?AWPCXDU/Q'\1/%\=E?7NE_P!&ZDXX&>!C/&.I!Y[]?RKQ#X:?LO\
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M_P#9(_\ 4B_:CH ^MJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
MC_\ :&_:WNO@;\4_A+\%/"/[-?Q__:8^)OQ@^'_QF^*6C^&?@7J/[..B?\([
MX$^!7B+X'^$_&VN^*=9_:0_:%_9\\/Q^9XA_:#^'6GZ)IGAW5?$FL:A]HU>Z
MGT^SLM+DN)/KW<V>@_,>J@]_0D_D.O7\'?\ @J[\3?V@OA!^T]^S7X^_9O\
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MZ]=:FT\,ERMSHVD"TEBB>\6;];J "BBB@ HHHH **** "BBB@ HHHH ****
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M$?$4?BKPQX<\2QVTEI%X@T+2M;CMI&61[:/5+"*^2!Y% 1WB241LRX5F4D
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M  ZO_!+7_P"F35]]?\,F_LL?]&T?L_\ _AFOAU_\SE'_  R;^RQ_T;1^S_\
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M?_0%_;9_\5=_\%.?_H0:/^'L/[(?_0%_;9_\5=_\%.?_ *$&N\_X=R_LR?\
M/S^T[_XGC^W5_P#1'T?\.Y?V9/\ GY_:=_\ $\?VZO\ Z(^@#@_^'L/[(?\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>forms-4_007.jpg
<TEXT>
begin 644 forms-4_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $/ CH# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]B?BO\>/C
M#H_[07QGTZQ^-OQAMM,TOXR_%C2K'0;/XG?$*VTG3=,L?'OB*SL=/TW3K;7(
M]/L;+3[6**TL+6UACM;*W@@@MHD@C1%5?C'\=GC6<_&KXPFVE#&VDB^*GQ!W
M;0=VRY!UY0DX#[=I;Y@$*9!X^<?CS>R+^TA^T'):RR;K;X\_&9)HI(_)D0_\
M+,\5*LBI+L>2W<J5BN4S#)M<1,2K8Z_PEJ<US8*\C!DD"[T+;F=D0%&4;B$=
M64%&Z@# 8!F!^5JU*OM*J56K95*B7[R?2=316J:))+3\ /7)?C/\<8U8?\+K
M^,FX!?\ FJGC[."S'(_XJ#[VT#/!P,@]L9MQ\;/CJK#R_C=\9CG<<?\ "UO'
MV>,'@?\ "1CCL._K7%37+JI\QMWF [7(#$,&/W\9*LG0\?*#T;)QEW$S-YBL
M,$!BO0CC.[)['YEX (RI!.<DQ[6K_P _:O\ X-J?_)@=Y_PO+X\;2S?&KXU#
M&<[?BK\0&P #GA/$1YSVZ\#CJ#5D^/'QU5^/C=\:0 !\C?%7XA@\YZD^(1GU
M! QC'?-><RD@E02!LS@$C//S#@'D_+@G/.,@\*T#9V,QWJ5[DAF &.1P@QCI
MZ'/)Z ]K5U_>U=?^GM3_ .3 ](/QY^.I))^.'QJ'(X'Q8^(( X'3_BH^^,_4
MFHU^/OQQ8X7XY_&HG&?^2L?$+IZ\^(_<5YD\KJA"O(Q;C+LVU<X!PJNRY]BH
M&<DG<<FBYFV@%HV[<PPD$\D'!BRAP,;@[$<C!SN4]K5_Y^U?_!M3_P"3 ]=/
MQZ^.6<?\+S^-.20H'_"V?B#D,>Q_XJ/W'3/>I5^/'QU:1 ?CC\9\9(('Q7^(
M*CIGD?\ "1\]!@]OQKQDD9W-'$0@W8"R(3@\@/%*A!Y&"$ '7  P)DFRK/L8
MA03\DLJ$X.UN)#*#D\@*4('!!.VCVE7_ )^U?_!M3_Y,#W:W^.OQO(C4_&[X
MRL7SN)^*OC\D C!Q_P 5$<$=0<=2#6DGQL^-@&/^%W?&0L&SAOBIX])(!#;?
M^1AQ@KP,COS7@]O+&54DR(R %>5;"DE.#M4L=W.<J74GY@2#5^.Z4$'SF<;C
MD-$V2"!P"EP,8&#EM^,=.A![6K_S]J_^#:G_ ,F!V_B#XX?'VQU2"\C^.OQJ
M2SN(2R6Z_%KXB+ )(6*R+L7Q(L>-KQY^4$MEN0IQ];?#KXQ_$[Q?X#UBV?XJ
M?$Q-5>P>>QOO^%@^+VOTG121&MV^M/<I^_A*.$D5C'(0,9Q7P?J$27UA*(U+
M31_OHMRD*"G!C);>R^8OF*<$DY094$E?0?@OXN.DZI)8RNZHSBZ3+*1';'9#
M>,$0Y/DD07!!Y$:2CDDECVE7;VM6_3][4^?_ "\[?TBHM)ZJ^GE^ISGB;X\?
MM 6E]JEHOQX^.-N[+'<1+%\7?B-$83%^[GA0)XE7RP%Q(P3 +$9!(KYX\7_M
M(?M*6@S;?M(_M"PAKF-<P_'#XIPX"!BP_=^+%PK!UR. Q'.<<>Q_&[3H=&\5
MW-_%E;2]F%[;,02OV34%$<RDA>"D^U7XVELMP#D?'GCI2LD*$8W3R28YP5$0
M.><$G(^7IDCMQ7JT9NK%2C4D[637-*]U9._O/=KOK\V93>JMWO\ CU/<OAO^
MT;^TC?ZC<B]_:._:"NXX996\NZ^-WQ1N5PEM#A<3^*Y$V;I-VW !89ZUZWIG
M[07[0+7DDX^/GQPE2)R5BN/C#\1Y(&^8[0T3>)BI4@C(QCCIZ_(7PG5WNM<9
M=Q(#X8#+IN@M@I&3@'<.Q(R.HR#7M^E6,BP2R>:"SL2#MY;G )/4#KD@''/M
M73S26O-+O\3Z?]O%Z'N;_M"?M"2[YA\;?C"@<N"J?%;XA)&I?Y&*!?$QV>7M
M!0 ?*7R!P2?6?"?[6OQ3BMX=.\4?$/XH31(/*&HZ?\1/&37['H/.:XUR<R.5
M _>&3)8DD*<*?DIE<*%4890=SC.TL6W'''89&<9R<'U-N(-T4%05.2<* 00<
MD_GTR>0!SG&7M7+2\DWI\36OFD[_ '@?4]_^TW\7DUK4[G2_B=\5)-'NC#]D
MM;[XF^-Q/;>7!%'*T;QZR846682R+&D"$!TW,71BV=)^TI\;&1=OQ0^*<<K\
M,3\4O'/EHQ.Y0JKK.[N5/."H' !%>"(PD"A=N&50"S(.2 01\QRI!&"!R3@5
M<5K<;C<.B#&^/+(=Q3.[.-V!\R[O7C!..*2T]Z51O^[.5O+[2U[[>8'TYHW[
M1GQ,F*W-]\4_C$MTK>;);0?$WQC-9-Y(X"B;6AB*8YWQ$$C'\1S7=-\4]=\5
M0P&;]I+XW^&+V[;RY[:+QWX]L;>U"0QI'+%?6>N2Q!9'+&0A049&D<#>*^-[
M20#]XCF+)"E 4$;9SECG+8'< 8Z8))R.ULKAHY2H2-HY(\*JG<<E%SR0 !G/
M W,,YQR<;4Y62BG+16NY-_?=M]=]?4J%FUUT9])V/PY^+7BCS8O"'[:?[06I
M:W;VZ7MQI]G\7?B9J,$-O*QQ,8QXELEDM8/+"W,B2$1"9'("ER,#4?@I^VU"
M@.E_M.?&G44(!MA/\6_BO8RW:LJE71E\57,;QN&1T)D"[6)#L#BLWPCY0GC)
MB$#"!XVDMUEMY5CD1XFC66*<YC<28D1EV'<692!M;ZX\#:5'J0LPFK:Q;"*(
M6T CU&>1((5ZQ)'YR%8P%& J@895. ,UG.IR7<IN*NTKR?\ GY7L7*$9*SNE
M>^CL_P +'Q#J?PR_X*,Z>LDEO\2OCWK<:!-PTGX[?$1YE61%E0?9Y_%44@FQ
M(H<= S)$"=C$^<^(Y?V_O"WE'7?$O[7NGQR!1'./B!\6[ZWD:3&P"73?$=X-
MQ'S -@D,,'T_HP^%.E2V&C65O/>+=01!A#'=6\=Q< AMPS=-MG50S2M!&SOL
M5F& 6%>UKP ,9QCN020IP=IX]1C)(/ SW5*4JBDX1DN63@VJDY<S24D[3F^5
M-.^EGTM:ULJU!0<%&3O*"GI*5K2;TWWT>US^0S5/CS^TUH4ZV^N_'+]HW0YS
M@B#6_BO\6-(G8;BO$6I:_;.P.,@JI[$]0"EO^T3^T+(X*_M"?':11GE?C1\2
MI%;((!!'B<HPY&W&<D'@D8K^MG5O#'AW7H_)UKP_H6KPL,.FJ:587ROTX(N;
M>49Y/0\$D8&,UX-XD_8Y_9>\72O<ZY\#/AV]W)OW7^F:%!HE^6D;+RB^T<V%
MSYV<E9/,#("P1B)#LUM/FE%N2:M:[?O;[6EY6\KF7LFK/FEIWE)K\]3^:L_M
M#?M! X/[0'QX'O\ \+E^)7?_ +FC/MTZTH_:&_:#()'[0'QXP.__  N7XE<^
MN/\ BJ.V,&OW1\3?\$MOV6===IM'L_'_ ('F8DG_ (1OQQ>ZC!DXZ6WC:T\5
MP1C(SLMUMU )08&"/GWQ)_P2"TPR22^!_CUJ]A!C='8>,_ NG^(9 V[A%U7P
M[KO@X1JJ$_O'T:ZD=E5LHY9ZM.II>$EUOS;+YO\ I#Y)?S?B_P#,_+$_M _M
M#XX_: ^.W\)X^,WQ*_O<\_\ "3\@K^ _E=7]H/\ :"QS\?OCIT7_ )K'\2/3
MG)_X2<\^OX'O7U;XW_X)A?M'>$-/U35]&U3X:^/-,TNVO;L0:1KVKZ/X@N;>
MTB-PY71_$&@6^F"801N([>/Q3,9&)VN'1!-^><4BNBNN=I'<8QTQQEL  G&2
M3CKTX7/:2C=W?5/U\_O,ZMX1W=Y.UTVK6U;O?LK=-SUJ;]H']H4D%?C]\=0
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M .Q[ZW5MW4J&/4?-3/["^.8X_P"$AU0XXR=6UD$X[D?VR<'U&3@]S7V,% &
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M<9R ?ZCOTJ[!IX\K<Y)P"1D^A8'N>@'3T ]L:9(B*G=G(*CC/H?X?IWIIN5
MYR#M//0$X)R 1WP<<8]:VA\*^?Y@9[PHA"@*=PW#!)/!Y +$]>W.."#Q566/
M9EP0%) VGJ.V<YQ[_0>N:N23 X#&1N,@D9QR#Z9_A]>G:JAN5*'C[V0,9.>=
MIP/S-4! 2,\GJ..2!W.>HZ\8//2FLI88!/49SGMGZ$$YY]J<&!#'ODDYXY/.
M.?KBHC.H)&"3P..1WZ$#!Z]:#2$EM9:==/\ +]1CJP9&WE1L V],E=O7)(SG
M/3\32EMV,'E1USR3@8SCT/7MGIFE-PO(*M^7_P!;!'Y@]^*)MSH%4#GDG/3&
MTC' '?&.,= ,5:GT<5V>NZ^[\/Q+T6NB^X0O(3G>X(QQA3U)P>F/J/0<]14?
MF77;##(YV-@^N?FSQC! [C XS2@D EE4;5XP1T]/8' ]N*A\^(GD$9ZD#/UR
M.ASW]>_>CVG_ $[INVSDG)K_  ZI+OL]>_5EHS3D<X3;C"J"O !SGL<\<<<=
M:B:]=@"C.I+!BH=@>#D]" ,^N.0<=ZHROO8OM7D@ ;CT'0XZY/<<X Y.:9YC
M^B_F?\*EN[O:VB\_G>RW VDU.< ?OG(P/E[@_4@Y(YST)/Z6(M<NX6#+<RKC
MH%8J 3TZ<8(!R".HXZ5S)4,Q<]2-I Z<$=^O84H 4A@!D9QGWP.3UX Z=.:J
M,K65EJ]^JWW\O^ !V]OXPU>!@8]1NE^8$8G=0&R #DM@<9&.AXXXKK++XE^*
M+<_)K-Z J@'?<M(F!@<@L47L>![8]/'B[8Y5<#GJ?\*0,P((RI!!QO;&X<'C
M&.W/4^_>J4(*7/\ :UOJFM4EHK^NZWV\@^A;;XS^+("L9U1)B <"1(WSW^9B
MJCIR!G/N>@Z"T^/&N(SI/%97.W:6W1A2<C@ QL2 1UP#Z9%?+AEE[L>H/WB>
MA!Z8'3K_ (U86\=0!Y,9QU)5"<?4QDD]>_;W%5IY?@-.SVNK?UT9]<V7Q\9B
M1<Z1;G'!V3LG"X^[N;AN1DGVR.:Z:S^.OAZ;'GZ?=0DE00DJ.W)P"%*X;<!T
M$F2/05\317R!3OC5<LW  X.Y?0+D9'7')[G%2C45&0&<@C&../8>B]L=^/2E
M*-[6LM>PY2OTM;^NR/ONU^+W@NY"YO+JW). )[5ES@#!!!._/^P&Y[YX/3VO
MC7PO=[!#K5CN?D+)(\9'<@EXP PSD@D8]:_.#^TY!D1NP ^9@<'/49.0>,<<
MYZMP<FG)KMRIP-VP9.-VW ('&3D@<==ISWSBLY1Y=+W)/TWBU/3YV58+ZQF+
M=/*O+=R<]-J)*S,?8<YXX/%7QDC.#CU*L/\ T)5./0XP>V1S7YB0>)KN$ADN
M9X V>$E8CKT.W9@DG(R,YP6)P"-B'XCZU8LHM=:N[<8.=EW<1MP.#E&VD@\X
M96/RX!Y),@?I'2X/H?R-?G'<?'?QO:HT4?B.[(==I=Y!*\8[RB61]R[%&2QX
M.<MSR?%)_P!J;P^DTR7'Q:L1<)+(LX&OW! F5R)0"DNP@.&&4^4_P\8H _%G
M]H[P]X=N_P!I7]HN>]TV*YEE^/GQM28SRW6+E9/BIXIE:&0+. R)(/.MP3BT
MD/FVJQ2'-/T*#2O#CW-WI6BZE:'4XK4ZC''KFI75M>3P(J1ZA<V5XK6[:ND0
M6&?4E*7MTBJEW-< %A]3?'+P_HC_ !S^-UQ-IMA-++\9_BM-(3;0F1Y9/B!X
MBD9W;869R[%F8G<6)).2:\XFAL2 HACB"M]U-RC/8$<@C Y(X!S@<UX>)KTY
M1JQ52[3FG%N*LU*46EK>]UZI+U,XI\SO?K;[SS/6+33/$%LK2F1"I#P3QJR3
M03C)#&:(X617'S%2,@[0=I-0Z/XIO]+<:/J^6=O^/34I$PDT8) 6Z*C F&3L
MDCW)+W$<A,2=[<)I^[:P1,D\="W( ^[GZG(!Y';ISMU8:=)-!("H\IG*+N&R
M7=C:)%*Y;83F/!&TX/S9X\M)O1)M[Z:_EY:_?V-#>@U% F&43Q2J[AU7#)*%
M)2:,$(0[DD$,Q2;HQ.U=J_:R1^\4?, P(=6.-WRY("CD]<JK G!7O66AB1=J
ML,9.!UQS]T #H,8QU[>N())8XV*Y=@XY)!*YS@G/&-IY[<^N:5U]^U] -:26
M,EG;<N5,?)7 /(/')X((/!Y!QD8JD\Z;2K*R[U]5SCG!YQR?4\8QD@YQF2WT
M$*N\A,4<0QNP2'8 88#G 9N3@$Y.3@X%<E-XDBEF*08DPQ49+8(/3;[XY'..
M!@\X)=+=I =K),B^C E@IW+D<#&<[?<D@8&.3WHENH\KQD<]Q_LD9Z].X&<$
M$<]^..M,H!Q&H.<?.22.2&( Z8(XX//.,4[^UI)L_/'&4'W1@GYACDGC@J0-
MN<'.>*>^VOH!Z!;RJJQE71V"[>3ZG&<CZ=\$YR<=*NQSL[ $*/E+>YQR ,G'
M(^A')(P.>%MM9M8X0K@E@!N93N"\<D$$X]?;&>16A'KEHN$9RG))#(Q;ZY&#
M@C'OC@GT/ZZ?Y@=8TP5V4JQ Q\R[>Z@CKN)Y// _3)CG2*XB:*0AXY04<!<Y
M1PT;D*>25WY3&XA@H((%<^-:M#TECY[G?GIUVX)(R O&<<GIFK,6K6;, +F#
M@'&7"<EE/(;&"2.AZ=* '>"+IM)UZXTJ]G$,=R9+.27.V,.IS;3 ';A9"L3Q
MY.X(VQBY)8];\.]-AMOBIK;'=_HWAS4I0V0(O*N]1TI+AY?F4>4BR8YW*-^'
M!W 'S^]@6]O$OH;N%7#KYB$HT9,1(C)4,&<XX.X  ;<%L&NX^$NAWTWC+Q-J
M&H:@+V35_#5Y;2'(V1;M5TFY 15^6.,B!D"#Y2JX;+*IK;#_ ,6/S ]H\1:-
M'/#:I!JSQQ-<&*2VM[F:-&8JIVCRFC5V=<HH53M!P01NSZ3I]O93QI!)%97F
M$!)FLH9V*@D(LGVF-T<Y5MLB(&VA0&*KA?-&\(WJZB483,4E81%FE52_ 78/
MN#)'; ]< 5Z[INAW5K';IE,IN$K;) <@ >['#9'(\O@X(&2?:&MUZK^OS+4O
M@OP5J]O+9ZOX3T"^B4<1W&EVB@,9!('411QE7+8+;!EF8MMSS7,R?!SX;E7%
MKH][HA)"*N@ZYK&B( 5R&^S6-]% Q!Z&2-SR0V>_=Q&6"9]PRSYVKR <+QU
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M\8XH2:TB;R\J*5'!#@# (!ZYR221U QCC(*GY^U;XFV5@9!)>1M+G:(XB99
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MH.XLC#!7:K;><G W+@#H=XZ@BOF02I:A0OC?P=*B2^;%!=?\++TY/G 5H_\
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MT/Q%'*EQ<Q6#I,MNDC3I-;7<FT-N290K1;20-DJ*V, D\U\>W.J6.CF&[O\
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MG=ZX'4X/8 5$8$M[4 (%"KS@#YLY8'\T(P>Y.#U%>@:I8I;PSR?:!$-Z)Y9
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M0O& >I)(]^N,&M2VA$RF-PRE%#="I;9G((.>"21G&20W.#6.MRB#".Q )+9
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MU2C'5QM",++2*=V]+*R35FNMTEULCU.>TM;J!D>2,#&9 [@@D Y50\B!6)/
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MP,#KCH.<;LG/!%:VGZ,@0$B0A@G5CC@[>5 YZ$@9&#T  Q79VNEQ[0K A=R
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MG'!(^]C N]65">06QM8C..>.!G 8J2">N,DGI7/7FJ@GB0!MHRJ$@KP1].V
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M&XP." /3OR>@&3T.",'TK2]/C7'R* V>"1\H&,G&2>!R5 X'&3T&1862Y7
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M_DSZ)@L46.,XVO\ . "&!!+OMR2.,;E;GISDG/'0VMG'Y9:9E14C#/(Y6.-
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M-DSJUI;AV &<FY:9L$G$9"X( K&\5?$+XC^-+J/_ (2G7M9UJQBO2EM'<?\
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MU9VU5I)-6=U9I.RVZO\ JC;K?S[]4[:;II[=2&QL-Y4[0<GC(VK@'C&, X'
M[\DD]J[&PLT^0/&HPPQAB02#@YP> ">>_/!'-5K&SXX.W:5.<;<!N<#/<J3Q
MUX.""!GJ[.T!V&+O(,X7:=I./?!.> <CG(..0@-.RM5)5D7:%!W*?4?>QDYR
M>!N'3:.#FNKM850.N6P O/R\+GGA0 3@'DY/O63;Q/&\:E0N,,^W)&UL$@Y
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M(ENA$:KM.2,D!N<MAN&&".,=*;':VIC96B#EMV,G)RI*G!/7=M#$;1@'C=G
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M$KP\1<O#%XHTA(4UVVC5(S,DFX0:M @4$6]X5(E1 !#<AE&(WB%>\)I[G86
M Q]X,JYZGD @\[03GC!STK\>OAYXA\2?#GXE17>DR>=J&F)/+);/-)]G\0Z:
MK>=-:%XLQO'?VCF6W9O,6&X:.555TD5OV-\*ZWIGC'0-)\2:-<I-IFKV<5W
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MO'%QJNH>&/"+>"(;?2BL%W#J-Q;:78Q^)KA[6TM7A$&FV=[<7,4D4;01"26
M/'^=83QDX*S'%YAA,+C*U>%'!UL9A*E++\WQ#Q6'PN'EB,95Q-+#Y?*>$P]"
M$;U:KE/V=-.<HM2@GO/"5X0A*4'%SFXI23CLERVNE=R=TDKWMI=WMZ=X=_:"
M\/P^'?$7QPU#PIKLNGZ+XD_X2W5/!1N[:'Q)9Z'JMIXQ\%7MG-/=V,-N=0T'
M5;_0%U$M9QK+]JB 2-S)Y:V?_!3CX$;2MS\,_B=9D8!>&X\-7H/' _UEB/FR
M.A(( ()SFLW6/@K<_"R74K;Q%XC/BSPO\6-1\4V>ISII)TN/0K[7K>*].GQ6
M\%S(C0R7<<WB'2I-RO\ VEHYAF#^:"WG?@S_ ()W75[I&D76G_$?PMJ,0UZV
MU9X-6\+WLDLPL&MQ_8>IRQ&:8Z6\UH9;A=/GM&NXI[HM(ZS0/#Z&&\1N",/E
M4<YQ.=8;#Y5C*\8X3$U*6.C1J5(TTJE"">$E6C5HU%.DH5Z%"=;EYZ<'\(XX
M2O)N,:;O'=72:N[+23CUT/=;/_@I?^S0S#[;X4^,,"[V8F'P[X8O"C-G/)\8
MV08 L!C<F,@;5KU'PA^UM\*/CQJ5K!\*=.\>1W/@Q_MOB%?&?A_1-#1K;Q#L
MTS2HM*.E^*M?-\XN;*YEOUE2U%G:JMQYDQW(OPCK/[(_PZTO6[K3KWXW? JS
MOH=2NVO;*2V\536MEY^HW-[]AGGTRQO+>S2S^UFP3SKQ9(K:"".5$:%7;Z>^
M#WP$/P&L[[5?^$E^''B+3?B1/;WVD:YX'^WS&\@\+Z9!I\]M/<7:I8/IZ7>J
MRZE8P:9#'<)JFH:S]K4116447JT...$\RJ4<OP68QGB\QDJ>"I5,/F&%6*J*
M'M>2C5Q>5T*,I^S?M%!55*4$W&$DG)=5;*<TP48XC$Y?BJ-!<KE5JTI0IQ4^
M54[N48M^T<ER\M]UKK&_W7I?B9H8EFD=4(4.[1NI*%%P5*JWR@9)*D G\14F
MJ>*;,VKE;DN2N6[_ #$N2"W8@=?7'7%?/MQKZ6L0 \N3>IV-A#C/W1P,[LGC
MKC@=!QREYXQF;=$HC",P0$*-P W'!QU(&=QXSQ@<9/6X*.B;U75?+N[]7T_$
MQ4^:[=E;S_&[>I]&6_B:/=%+YN$/0LZ[3R68YRQ)SZ<YQGUKKQXLBN(XE@F!
M4;1M$@&XACGJ#N&.NU<8SR2.?DJP\5,L<HEGVJK97&< $'&T$Y^\<8)SELGB
MNCBUWY%9)BS.0?F8$X( Z8P.XZ>_ .3C*-N[7>Q5U9M6?:S>^G;U/J4^+(S%
M"\;(QC^^?-!&[KDN-J\M@X)SR,@ 5>@\7(X+L4D7< 1'+EER&/()'!P3QP,$
M] :^8K?6&@9))YB5_=D'<BLC$!MI &&"J"N>WU JY/XL9D(MYY V[D* J@\%
M1GN"0W0 8 XP1AQU7+;1N[?]:&?.T]8KT=SZ)NO$GG;F@8#:0P*ON7!/4G(&
M0O7!)/'0&JEEXDN( SO+@G<6R<  $?+\VW!(.2#AAD #@Y^>U\07J=+G*@@M
MO(^Z.N 0>HY/O71VGBG>P6Z*KN4?,""<'^%AGYB3T'H1STH4/>:ULNMO3Y$2
M]YW:6NOI_7<]ULO$ERSI)%+O"D<%B=W\!Y4DDY&1C_:S7H=EXQ$0):4ARJ!P
MSA2<#D<G([C;CCO@]?F>'6+7AXKH(4.=N" 64$X."<D\A<'I@8K0/B.*56FW
MJ$&,DD@LP!7()).&().<]B#Z*3TY?Y7O\K;?,A-MM-:*^NI],_\ "9>:H"S!
M@=I93*K  GYMVTM@YZ^Q.#TSLCQ;&BQLX15*KAED!5B1TR=O/ (&3GG@X)KY
M2LO$OF.50@'D#.X'&X8&=PR><'Z?W<&M*\\3J$0&X&4 !#@8&!P03T P>A[+
MDXXJXQMK?>W1%;=CZ,F\50 $L?O!@ 2.#S@#+=<>G) 'I4,?BZVCWDNJ# ()
M< $GY2!EAGC'"\CC.!BOFD>+@A),P8J <,Q8#/.< ]1P>_KU%4;WQW$1L,S;
M@F2N?<@D' .".O.0 <5>^PKKNM/-=CZ,U/Q-;R(S><F=O!#@,<_[).,8)[\^
MAKA)O$:AY8PVXX+1@DEMV23@#MG/;'?/%>/W?BQ9(HA')D''#.",<D_*<#D
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MW9..NCT47KYIM_<NI_<?.I1O>.L7+MK**DU;I?FV_(\MU&Q4Y4YR>!M&X$,
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M^=&WFMIK>I6>B:UXJ9I!KWC^ZETS2( QR+%/^/J?YRSAMJBW%P"K%04+/%(
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MM7VHH;:@4)YZG<7;S"I?()>U^RIHB&PU?5M,CB9=+NK262)G1HFADUQO,$@
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M.*2L[1NU*,5=OJGNM^C Y9C:S:CAI1FJD9<]:E)V:OK=N[?O*TME9=D?I?\
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M\/=(U#Q#IFH6FL7SRZ-J%AK?B75=*O=0WR7NHZM?ZI;W,#W6D7[::$MAUX'
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MXV_$@6UW8>%K[1M*N0ADUW5HUM8D0@,TD;W"KGY2'$C.H&2QW=_O?P)^S?\
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M6?[9\>]3LK*XEN'VQHZ/X[C822'=Y<<<BN[KDD#*GU'X)>%_"J_"_P #R?\
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M?1J[:E:^^UVO9P6 H8G+,5CJE>-*M0J.,*?N?O8N[7(IM7G%:SZ.SY7>R?\
M2EH7[1G[/6OD6^B_'GX.:I<@1F.#3OB;X)OI6#JLD68;/7;J1"\;*P5PC,K
M[1QGV[0]=\.:Y")-'\0:)K*D*J'2]7L+Z,L^\JNZUN'1BQ4Q@*['.!@'&?S
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M-6EI:VEY%XQN[RUMX;>ZNE\?>)85N;F"-8I[A8H[M8XEFE5Y!&BJB!@JJ%
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M%+ZG[2M)*2<5&"7.H2M=<U[M7<>:*M%.1[K^SG=P0?$W0-.N=)TK48M<O8;
M6NJ6D=U:-)+*/LS/#)B.0>:-K(X*,CE7##<*_4ZW_9C_ &D_BO=+9>1IOA;P
MG:W)%O9:7:6UAHMN P"NMI8K!!+^[D #3N(U96*JS%37Y,:'J7AOP-?6^JZ9
MJ-SJ6N1/YMO=1PM&+.1&/EO:0!G%M(I&?M=S=2RN,,MK:[P9/J33?VD_VD?%
M=I;Z;IOBKQ0+%EA@BBM[IK:"0$-&@,Z+"&:4%R<>8<Q$9.X$?7Y/56#PU3#R
M=/ZU5DITZ:H5,9R03]YN%*=%MQE9).I&#6DERGYMQ9AL3C\5'%82,J.%]C"+
MK8N2HQG42N^2%25WRZ13E%W>R1^F/A_]A_X>^ XOM/Q3^(=A=W2PL+FWEN;2
M&!'9-K[(6O(XS+$06:3<P9@,IN4&O4]!G_9O\$*\6C&T\37=I''Y<=C-;M%"
M2Q=G+Q)%;JK2I<;E9[ULM&,LQ*K^5^A_"WXL>*[E=3\;:UJ&GZ;-A[B]U&]N
M[NYDB=PSM#'<98@1-N=UQ&%R 78!6]QM?#'@SX73Z?XD\-:I?>)-*NM.NM.O
M-.N"7OQXCAFM+RPD:!(E417=LUXK(24@>!E+NQR/ML%AL1BH)8C$XE0FHN<:
M$:6#@XI)R2A352M#FTNG6<DK13L[GYWB8O#QE^\A6G%--I0:B[;-J,5)IZZ1
M;LV^:Q],_$[]I*WL+1K7P[X4TRP6>*?[-)I]KLD<W$=P9$5R5VW,IG#22010
M_NXG5L[^?EH:/XD\9ZA=^*?$<DUS<1AI)'N?^/2WWL6@L[>-B8HEAAWM&L:E
M]TF<@(F.KT3PSJ>O7$_B;Q&L$%P+>6YT_2]^RVTX%3.9_* 2-KEHA=*F0_EX
MW#=PH[OR;&&$;9!<6MLH;[""?WMPI5(W"='4I"JQECE=YW9QA_I,/AL/0C&G
M2AR4E;W>:I*3EUE*I4G4DVV[ZMI;121X,W)J3]WF;DU)16C?EI?3T1Y&? >O
M:]?0VEO#<:9"I9;B_DW1PQ+"(!Y-M$0'E)9UN,QO'&QF#,[R[E'K'AWP5X8\
M*QF"/Q-I]Q=*4DO!<Z?IM_<VWF(T37$*W)\J*>U,XE+NLBF,/%(6C<J>MT3P
MYKNN1K-=ZC)963ES#802D;+=5D5,NL3%3)/%$TBAV(R!SMR4U?1=+T*"\BCT
M>UU>-EN[N]L$F@FOEM&86\MVT5U \,MK%+#%/<;+M)&">7;PO*^%];"THQJ0
MJ0NFE-N/-9QBE--IOW4]+INUFTE9V3X:\Y5J/L]8S<HWFG9)J3Z12=G:UD]W
MOH[X7B+5=&N+.UL]"B$6G1P0F$Q'$4;12RC:2@6(E@-[[0<G)8E@2?:?!G[5
M7P[_ &-/@CX^^+WQ C.I^)_&OB+2O#/PT\#:7+&FO^-K_P +:)/)+Y9:.8Z=
MX?M)O%%L-5UJ2&2*WD3[);0W-WL@;Y5OM7%_%?7=JHA@^V11&TB'E1P2LY5[
M=62%,I&%8>8(@C8STSGJ/V*_V8T_:(_:/\:?M&?%^TDU/X8_!'Q;'\.?@QX.
MU<K<Z1XB\8>&#%_PD&OW%C+(T3^'O".HW$-X+81-:Z[XOU><7,IC\.7MG=_B
M'C'F-./#SPZF_P#A1Q=&@OB;Y:%7V\U?3XHTFW?2T6G&5T?L7A!ETL1Q)+%R
M2=++L#B*DVU\-3%PCAZ2M_-=MII77=-7?AO[,/[/?QW_ ."@'CGXP>)?'GQ9
MU_\ 9R^'>K^)6\4^+/ /@2'5EUGQ#=:O?W-Q;V4EC=ZCIUJ+>QBDD2&^\32W
MLEM(WGV^CS$LM?JU\+O^"4WP-^$$M_=?"_XL_M">&_%.LV$&EW?BN^\7^$=9
ME^SVUW'?*\4,7@72KZQ5YXHQ*FD:MI<OE80W4FW<<W]D>XMK;XZ?M4?9&(%Q
MXXNYYP6;*W$OB'5(P!RVU'5,@!CA2 J@"OT)74Y+9)9@9!M1W&P\C]PSD$X/
M'8' XQQDFOYA<_>:M&4>9\CMRNS>E]-;W5K:7/Z?VBY-_"M5O?Y^5M7;KJ?S
M;?$?XU?M#^,_A/XO^%B_&WQ7J&F>+]6U3X=7<_B+Q#K>NZA=:5-XCT[3+RZ\
MS6[C7;FU+:9>21W::+-HQ&E17-I%=22W4MO?? _PS\?^._@[<R:EJ&N7NEZ%
MI>C7&F6OB7POKU]H@LX+CR[H:/\ V>)(;OS-1EMX$0:.@\OYI)]/O(6DV_2O
MC;Q)H7@/P1K?BG5!$@TGXJZO=1!'C@OKCSY[9Q8:?&^6N)YYK%1]FC=<1&2[
MFDM;>VN)X_D#X8^'H_BOXDM?&/Q(\-^+]:^&^BRS)IW@3P7%=MJNL*B-L>"Z
M^QRQ?V5;7/V=-?OXS_:-P9!;V211;GC)J4*R]HH1I+25TG*4G91::7NI1;5K
MO1LNG*E/#2;=>-5SBZ<*;]SE^WSIM:MI*Z2O&Z9^A'[/WPT_:M_X*BI8>#;;
MQ_J7PV_97^%.K7FDZCJ^I7]OJ.LR7WB'5=0\4ZBEMI5FFES>)_%>K'5KB274
M]1CM[&VLY([2ZU":!#8']$_V@OV/_P!GG]D_X;^#? OPB\ R2ZS<6&H:@+RY
MN=/N/&OQ:\8LG]D6UEXM\3ZJ$!L;;0KWQ9XAT_2[6)= T*ZL&?2/#T$,^I)=
M_G+^RQ\2-<_8+^/W[/OQ+MY-;L/V7_VO-.UG39M&UAY9IO#8TGXAZQX$U;2;
MYW"I<:EX'\06>C^*=#U"2*WEN/"WBMM/FEDFCUAV_H)_;0^%7[.?Q<\'>'=1
M_:"\>>(?A_X9\+:YIEYIFO\ A[6Y=(FEU*66[ATMXY+72-6O)+<R3W:&ZBAB
MM&27RIYFCDPV].I3I.-G=7NHM[NUK*]UK9+JDNG?*:;C)*]VG;U/YJ]+LHT\
M?^*K-!;6,%KXCURTBV(&M+<VVB0D11>4KAH0+4Q(RJ%9G)4#?7IOB&:V.OZX
M?+G&=8U,X\L#'^FS]B 1]" 1W K _:'^(?P(^"GQPU'2/!/A2_\ BA\/;C2]
M/\0:-XKT'XDWFBZIXIMM?L)-/?49[^[\+>*-%@>S2QE@@LK/PWICBZ$[70)R
M3@7/[6_[+>HW-QJ%]\#?CFM[?SRWMXL'Q8\#-"MU=2-/<+"9/A[$YB$TCB,O
M%&Y3!:-#E1[,,5",5;W6[NUDU9N_IOVT\D[H\VI1J.3M&SLKVDHZ6ZVWVW/%
MOVV='MKO]H7]I2XANX6GB_:-^.&Z*-T,BN_Q6\7&1)%)$BA2<,=I4D$ \<^%
M^$=(N'\/Z\T:K)Y-BI("D%2+V"4, !M"JB/O.2 ,'(R ?H_]KNTAN?VA_P!I
MUV0'R_VC_CB/-&6*M_PM;Q>1&6Y*@D#*C'7!X.*\J\'Z'/<^$/&$UIJ+Z==V
M'A_4;QD%M:W$4MM!#(TT4L=S%+*$EB41AXKF%H3()E;<BU\71J2O5C4EHJU7
ME3:C]N:5KVNWLEO9:;GT5;#P;A*+M>E3<FDK7<8.SUTW=WOW.-M+CSKG0IW7
MS5TVVOKWAAMB>"*$VQ#9P#+(BB(=6<8 )QG]<KO4W-G=!L>5!IUYN=RNXM''
M,Q8, ,X49!/7+'D\G\K/A^FB7?@+XB7-[:QW5WIGA_2I=)N9)IB;*_N-2MXD
M>+RY$5]]NTZRK<K<1 !G1 R@C]'-8OPFFZX,@&+2M2,)8[?WC6C-ACT/+ '!
M'RG!Y(-;3^"?^"?_ *1+^NADEJEYI7^:5_U/RF\8SI<_'6S*DNG]OP,K$$,Q
M5"C%EXY#!#QP"%SBO7OBX!#X2U+!#;H[<9(P<-YF1QD=47.3GH/[M>&:E=R7
MWQML)I1$K_VU>/MCR%41R7#HBY+8#"#(W,Q(/# '(]C^,-SN\*7^5R&\A1A@
M.46XD#;<G/"X!!'S8QWP89)8;!J[_AQ_&6Z[WOH^O39FF+GSXG%2VO4<K*]D
M^2$=+J[_ (=[ON]-$W\- \8P3P!@#G..  /FR<'MZ>O/]#7_  2K\"^#/@IH
MNL_&_P"(]GI<US;:!#JVE-J%K;W^HP^(M1O;*+PQI>B6$L<TD^K1Z19^)M9G
ME@@EFTNW2RN(HX+M'FB_!+P'H@\2^,O#FBL\,:7VJ6R2O/.+>!88CYLIEN""
M(8S' PWM@;F49Y!/[6?LT?&'0-'\.?%SQ=:VD-_XU^&WPZ\3K\(K+6H]6.@R
M^//B%J>G?"?R+S3])U+2WU35-3TWQ980->_:=VDR6$;6\MHUS)<+VU=;132:
MU=[=4ULVNE]^OW/DBE*33V46_FMO76VB\^Q^T'P2^.OA#XR_&'2=>U?7M)M%
MTGPMKGB(:=J[6L&K'3;&57TW[!<3722KIQ:.YU"^L5A+O?0*UU<,;(1)\&_M
M$_#GQ1\6?&'B_5]"\;Z-##XBUJYU34B-12-M:N&=7LM->ZA_?FQT\.);&!F%
MM \BA5+10D?&/C?Q;XI\$>,7T;P-)I7]K:1#'!XWU>#3-,N]/U+77)DOM.T2
MQOA=-8>'=,NVFTRUM[>1# EHD9=]ADFLW'QVMO$B:</%.A6N@>(M#O[6X;7]
M"DN--FETN% UQ:BR5TAE:5&:1)4+^0RA8Q&8E)[<%1P%>/)*$Y0M3A*FK0<I
M4]')-R5E=<^W*UL]V>?B<1BX/V3<54DU%5/?<80<DX\W*GJXZ6MN^VW&^,/V
M'_VC;70=;\8/\/M?U+P[I1,MWK-O&=0MO+"[S/&\$DUR;2!,27%P\*1VJ?ZZ
M1"&5?AS4?#>IPV6N22Q+%+I_V>!XW0HZO/(RLNT9;[HP6( ))'KG^NC2OVU?
MV<_!?[+FE:WIGQ)T2?4SX7MM-@\/7=])>>)GUG4XYHKK[1IS&:]G" SRM=,L
M]F@2-YY#'P/P7\0>&_AY\:KO4!X'U*R75-368ZCX1AFBTG67N&8.LNEB_6"'
M6HX77S+>.S_TL F.:('$K\TL'3E4JQPU/ZNE4:5.I-:Q5ES.4K7EU5DTU+?1
M7RJ3J4*2G.JZCFTY2C%M)ZZ+[35E]JVJ=E8_*Z:&Z4S-RI4_*, ED'!V<@D%
M/N]=PQCL:R6U*:T+6KLZH4+>1*I:)\GEI$D' *Y*E2 &(VG.#7U9\1?V=_$W
M@V66TNX]6T>Y4LZ#Q#87.GOY4C!E$0GMHXYV!W E;AE<#"[5RE?/>H^ M=>8
M?;+F.[D7;&9(5+%$16566%&??G*KA6#;LX('!Y*E*5*3C-PYN9Q45*\FUU2W
M:[6\B:5=RU4XM-6Y6U>_;1O7>Z>JMLM3A(]0L)-2C=T2UMTVEQ+$US#*,@F*
M15<2"-Q\K@'<@(QA@<2M#!;SLEK<0W4$I,HE@CDCC7>[%E43*LA$0*H2Z\*J
MY)SFFWGA+6[>6;_B77$\4;&19!&XB='+!2% W*1G(&\@]?4#,AL-121 D,B%
M&QLD#['P<%3\H.!D;@H/WA]T!0'R)VL];=T]>NF_X:'3&<9W3:]%+1V>V^Z:
MU[=^AM1<J> ,N!CTSM&?Q&",<\]<U92W+RQJA;S6*QHRDI@E@0/E#9SG !!
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MX_\ V$?V:/A!X;M_$7Q._:#O-#DNH6DTG3;:#3;B\U>[6WEG2'2M*&FW5W)
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M2KO!W-A#E2X/C>H>-+_7;NWT#2+S[%;SM#;3WGFLBA)7(,\CH0Z+R0J@!F;
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0^[OV,)QFY-\LODM_/<__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>forms-4_008.jpg
<TEXT>
begin 644 forms-4_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '# B4# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***_(']D[Q;_ ,%3?VH/V6/V:?VE
M_P#AJ#]@#P/_ ,-$?L__  ;^.G_"%?\ #N[]HKQ-_P (?_PMOX=>'/'_ /PB
MW_"1_P##TOP__P )!_PC_P#PD']D_P!M_P!@Z)_:OV3[?_9&F_:/L<(!^ON>
M0/7./PI>O^>?P_QK\_\ _A77_!4WD_\ #9'[ &.,?\:U/VB>1]3_ ,%8@/\
M/2N5%E_P47?Q>_P^7]O?_@FRWCR+0SXGD\$I_P $\?CNWBZ'PTMY#IW_  D4
MGAM?^"M9UA-"&H3P6']KO9+IWVV:*U%R9Y%C9-JZ5]7=I;MJ,7.32W:C!.<F
ME:,$YR<8IR4RDHKFDU&*<4Y-I13G)0@FVTDYS<813=Y3:C%2DU%_I517P!_P
MKG_@J;_T>1^P!_XK3_:*_P#IL5'_  KG_@J;_P!'D?L ?^*T_P!HK_Z;%3*/
MO^BO@ _#G_@J;_T>3^P /^\:?[17_P!-BJCJ?@S_ (*=Z-IU_JVK_ML?\$]-
M*TK3+2>_U'4]1_X)N_M!V5AI]C;1//<WE[>7/_!62.WMK6WA1YI[B>2.*&)&
MDD944D3*481E*4HQC&+E*4I*,8Q2;<I2DU&,4DVY2DDDFVTDVA)R:C%.4I-)
M1BG)MMI)))-MMM)))MMI)-M)_H:/\_\ U^F**_.'PQH/_!2CQKX=T+Q=X._;
MI_X)R>*_"?BC2-.U_P ->)_#7_!.CX]Z[X>\0Z%J]G#J&E:WHFM:7_P5INM-
MU;2=3L9H;S3]1L+F>SO;2:*YMII(9$<[W_"NO^"IN?\ D\G]@#_Q6G^T5ZX_
MZ2Q>O'Y>M6XR@W"<90G%N,XSC*$H2BW&49QG&$X2C).,HSA"49*491C*,HI)
MIJZ::Z---/?9IM/5-:-[/MI^@%%? '_"N?\ @J;_ -'D?L ?^*T_VBO_ *;%
M1_PKG_@J;_T>1^P!_P"*T_VBO_IL5(9]_P!%? '_  KG_@J;_P!'D?L ?^*T
M_P!HK_Z;%1_PKG_@J;_T>1^P!_XK3_:*_P#IL5 'W_17YK6EA_P4:OO%>J^!
M++]O7_@FU>>-]"TK3=>UOP9:_P#!/'X[7'BK1M#UB:[M](UG5/#T/_!6M]7T
M_2=4N;"_M]-U&\M(;.]GLKN*TFEDMYD3J?\ A7/_  5-_P"CR?V /3_E&G^T
M5U]/^4L77VI)IJZ::=VFM4TG*+::NFE*,HMIM*4)1;4HRC%7LVGHU:Z>C7-&
M,HW3LUS1E&4;I<T)1DKQE&4OT HK\_\ _A77_!4S_H\G_@G^!D#G_@FG^T4.
M>,?\Y8NV1]*Y7P[9_P#!1CQ?>^*M-\*?M[_\$V/%&H^!?$#>$?&UAX?_ .">
M7QUUF\\'^*TTC2?$$GACQ5;:=_P5KN)O#WB%="U_0=;?1-72SU(:1K6D:D;4
M6>I6<TPW_P"2KFEO[L>:,.:5D^6/-.$>:7+'FG"/-S3A&2<HJS<DKM15VE>3
M4FHJ[5Y-0FU%-R<83:BU&3C^E5%? '_"N?\ @J;_ -'D?L ?^*T_VBO_ *;%
M1_PKG_@J;_T>1^P!_P"*T_VBO_IL5,H^_P"BO@#_ (5S_P %3?\ H\C]@#_Q
M6G^T5_\ 38J/^%<_\%3?^CR/V /_ !6G^T5_]-BH ^_Z*^ /V:/BA^U/_P -
M3_M&_LT?M+^//V?_ (H?\*O^ '[)WQT\%>-?@7\!/B+^S_\ \G ?$7]LCP!X
MD\+>*?#GC_\ ::_::_MK^Q/^&9=!U;1-;TG7O#'_ ",VKV%_I%W]DL[ROO\
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M4<OAOQWIL.C?\%<;R2^\&^(8Y8Y-#\3VJOHNJI(C6%[<!EK<^Q?\%%V\7O\
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MJ7AW]H[XOV(ADUS6%\&6]GXS\%:3\+KN8ZMX247=U+#!]O:E_P $]OV2M?\
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MQ+IS^ DUOQ/XR%WXPA\5:%X?FTOX=:%^6G[5_P"QWX6^(_[6W_!2KP/\!_\
M@F5X2^*GQV^(OPU^ &L?"O\ :S\&S_LP?""[_9O^/?CWPU\0/MGQ;\0?%'Q'
MX]\$?M'^#M7LM8@TCXDZWXM^ G@[XE>*/%MUI-U9:M8-JDD/V[^BWX=?LJ?
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M'VLNN<ZJJ8FM3C2YJF:X#,*>&KPC6P2IT)4YSHU<'.,\OK4:+]K36!Q6$Q>
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MWRW'I?BS]@O]F7QKX)TOP#XI\,?$'6-!T_2KC0M2NIOC_P#M"P^+O'F@WO\
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MH'0)$ET3XF0PVO[0$$.GZOI$MO8/IUCI\=MH=D=&\/?9M)B'AS05T[U+6?\
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M(['Q9^P3\?/C7^S+K_[.'[1_[7>C>,7TF/X;:A\$_BO\)/V?1\(?'_@KQO\
M![QMX1^(?PT^)OQ+C\2?&+XR>&_BGXWT+Q=X&\/:CJ4'A?1_@_X"U^"Z\36E
M[X#0ZGHL_AKI?C)^Q7\9_P!I+]G5_@Y^TG\7?V8/CCXANY5?5H/'_P"Q##K_
M .SOJ\UA9ZK::'K$_P $M9_:(U3XEZ3XJL)M1M]=E\2>&/VEM!NH?$>B:1>^
M%XO">E-K&B:N5)4(3Q<H1G7IQJ8>.$IJ<J,ZF&4ZLY5ZE:I2E%8NLE3HXW!S
MHT\/@E[.O@\3B'6Q,,'-+VE3#X.-:V&Q4XU_KTH_OZ.'KJGAH0A0@G"5;"1J
M3Q&(P]>555ZSI+#XBC!*E4K^BP?MV>#M1^+7AGX,Z#\%?VA-?\7ZA\-?A)\4
M/'5M9>$O!ECJ'P6\/_'#Q1/X1^'\'Q1\#^(/B#HOQ2BO)=0TSQ%>>+;KP+X!
M\=>'_AQI7A?6KWXB:YX6/]F0ZG]R!L@=OJ/K],=#STP,]Z_&[Q5_P28C\5V/
M[(.FW_QRT_6=1_9.M/A!8Z%\<?&/PCD\0?M@VUG\+]0M]6UBT^&'[46E_%#P
MSXK\ 6'Q8FM8_#?Q.T3QOH?QH\-Z[\/I+OPU;:)9:K>W7BF3]D$&% R3@*.0
M,D 8SQV/7TZ^I-:58T(Q:I3<YQQ>.I\SC4BJN%A7D\%B8PG_  HU:$X4_8S<
MJ\94)U:LW&O3C2:<W43Y4H2H4IN*;DZ59R<*M)RE:55+E]M"HHP2IU84:E..
M(HU95'T445D;!1110 4444 %%%% !1110 4444 %%%% 'P!\.?\ E*;^V1_V
M8!_P33_]:*_X*Q5]_P!? 'PY_P"4IO[9'_9@'_!-/_UHK_@K%7W_ $ %%%%
M!7P!_P $T_\ DW7XC?\ 9_\ _P %8O\ UZ;^V17W_7P!_P $T_\ DW7XC?\
M9_\ _P %8O\ UZ;^V10!]_T444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!\ ?\$T_P#DW7XC?]G_ /\ P5B_]>F_MD5]
M_P!? '_!-/\ Y-U^(W_9_P#_ ,%8O_7IO[9%??\ 0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7P!_P $G?\ E%E_P33_ .S /V-__6=?AS7W
M_7P!_P $G?\ E%E_P33_ .S /V-__6=?AS0!]_T444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ? 'PY_P"4IO[9'_9@'_!-/_UHK_@K
M%7W_ %\ ?#G_ )2F_MD?]F ?\$T__6BO^"L5??\ 0 4444 %? '_  33_P"3
M=?B-_P!G_P#_  5B_P#7IO[9%??]? '_  33_P"3=?B-_P!G_P#_  5B_P#7
MIO[9% 'W_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'P!_P33_ .3=?B-_V?\ _P#!6+_UZ;^V17W_ %\ ?\$T_P#D
MW7XC?]G_ /\ P5B_]>F_MD5]_P! !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %? '_  2=_P"467_!-/\ [, _8W_]9U^'-??]?G!X3_X)3_LE
M^ O"OAKP+X%\0_MO^"_!/@OP_HWA/P=X.\)_\%2?^"GGASPKX3\*^'-.MM'\
M/>&O#7A[1_VO[/2=!\/Z#I-G9Z7HVC:79VNG:7IUK;6-C;06T$42@'Z/T5\
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MW[?_ /XMB_X*F_\ T9% !\.?^4IO[9'_ &8!_P $T_\ UHK_ (*Q5]_U\O\
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MP!_PZ=_X)9?](T_V /\ Q#?]G7_YW-'_  Z=_P""67_2-/\ 8 _\0W_9U_\
MG<U]_P!% 'P!_P .G?\ @EE_TC3_ & /_$-_V=?_ )W-'_#IW_@EE_TC3_8
M_P#$-_V=?_G<U]_T4 ? '_#IW_@EE_TC3_8 _P#$-_V=?_G<T?\ #IW_ ()9
M?](T_P!@#_Q#?]G7_P"=S7W_ $4 ? '_  Z=_P""67_2-/\ 8 _\0W_9U_\
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M\46'B[6O$]GX2U#P=J%AXQL=<G\+WMMK$WOW_!)/XR:WXOE^//PA\6:]KOQ
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MY_XVP_\ !4WKU_Z/'';').,>N,U_-!X?L?VD/@;\"?V>_ 7CSXQ3_P#!,_\
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M?LI2!5'15'T 'IZ?0?D/2@#\:?\ A\KX8_Z,G_:?_P#$@?\ @DG_ /3.*/\
MA\KX8_Z,G_:?_P#$@?\ @DG_ /3.*_9>B@#\:/\ A\KX8_Z,G_:?_P#$@?\
M@DG_ /3.*/\ A\KX8_Z,G_:?_P#$@?\ @DG_ /3.*_9>B@#\:/\ A\KX8_Z,
MG_:?_P#$@?\ @DG_ /3.*/\ A\KX8_Z,G_:?_P#$@?\ @DG_ /3.*_9>B@#\
M7V_X+1>#$O(-.?\ 8Q_:874+FUN;VVL6_:&_X)(+>7%E9R6L-Y>06Q_X*=":
M6UM)KVRANKB-&AMI;RUCF='N(5>P/^"RWA<@$?L4?M/X(R/^,@?^"28_'!_X
M*<9&?>OM'Q<J-^WG\"OD7;_PR5^U8,%1C_DKW['3=,8ZG/UR>M?8] 'XT?\
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M\+&_X*F_]&;_ + '_BRS]HK_ .E.T?\ "QO^"IO_ $9O^P!_XLL_:*_^E.T
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M/V=?^B<_M_\ _BIW_@J;_P#0;T ??]%? '_#RS]G7_HG/[?_ /XJ=_X*F_\
MT&]'_#RS]G7_ *)S^W__ .*G?^"IO_T&] 'W_17P!_P\L_9U_P"B<_M__P#B
MIW_@J;_]!O7T_P# CX[_  S_ &E/AGI?Q=^$6J>(-6\$:MX@\?\ A..3Q9X
M^(7PK\5:9XJ^%?Q"\4_"CXB>&?$WP[^*_A;P3\1/"'B#PA\1/!/BKPKK.C>*
MO"NC:C;ZCHUR1;/;/;W$X![!7G_Q9^*7@3X'?"OXE_&OXHZ[_P (O\,O@_\
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M6KI2E-P]Y:J=2.UE*,*M6$)I-)J-2$(58\T83Y*L.>G3GS0BZBBBI-0HHHH
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M"EL^F^&/B%H.B^3IL?A7PM;?&319+BX\,6WB3XHZ3X"_J[XQ@<>_ Z8'8@C
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M[*?@;PSIOQ9U.W\%:E#X635_AI\>?%_BJPL]=N_ GB*WT3X@Z#X+UZ+3M?\
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M ()I_P#)NOQ&_P"S_P#_ (*Q?^O3?VR*^_Z^ /\ @FG_ ,FZ_$;_ +/_ /\
M@K%_Z]-_;(K[_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!I(
MQUX!'<8/./?/4?ICFOR#^$GQT@^$G[1?_!23PSH?AJY\?_%?XM_\%(O ?A;X
M7_#RTU%=%&MW^G?\$H/^"<.N^(?$'B7Q"]CJJ>$O /@[0=/NM8\6^+9=*U5[
M-/[.T71='\0^+?$'AKPWK/ZZ[3Z8P5]#_$G! ]/I_#7\Z?PGTK6=$_X+C?'C
MXC:QJ"VOPXU/XV?'KX*:2+HHEDOQH\4?\$V/^"+7Q,\/Z7#+(RJ^N^(/AO\
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M_BI\(-=E?Q]\7)8-1T:3P;^S?\:KB?2O#OANWU*+6-;M[[P/H.9XE^(_A/\
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MO"NO^-]7L-)M8XY)9/[,\*^&-<UF_N91%9VMO8^7-<)<7-E#<]XK*1@%>.<
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M_OJO@#_@FG_R;K\1O^S_ /\ X*Q?^O3?VR*^_P"O@#_@FG_R;K\1O^S_ /\
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M;_Q[!XMU.#P1J-YJNF>'=+^)?Q)\*^"-=N+Z"*WEMOB/\/O"7BW0_ WQ<T>
M0Q7.FZ!\5/#WC+0=(U)$U;2M-L]45;L>A77AW0+_ %/1]9OM#TB]UCP\UXV@
M:K>:99W6I:&^H6K6.HMI%_/ ]UIIO[)C9WC64L!NK;,$[21MLK:[CIW^OX?U
MH_S_ )[5"5K):)3E423:Y:DURSG'6ZG*/NRDFGRW@K0E*$H:3ES2UER*E=VN
MJ:DYJG>WP*4I2Y=4Y/F?,TG HHHJRQ, GG_/(/Z'_/->?_$SX:^'?BOX0O\
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P!_P $T_\ DW7XC?\
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M .B@H_X0W]KS_HO?P'_\1G\<?_105].44 ?,?_"&_M>?]%[^ _\ XC/XX_\
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M+Z%XW\6?#WX4^(/%/_"+>'_BMI7AW4];U#X=>$?M^L:9J$]KI$5DUM)+]?T
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M'[17_2)W]O\ _P##C?\ !++_ .F64?\ #9'[17_2)W]O_P#\.-_P2R_^F64
M??NQ/[J_]\C_  HV)_=7_OD?X5\!?\-D?M%?](G?V_\ _P .-_P2R_\ IEE'
M_#9'[17_ $B=_;__ /#C?\$LO_IEE 'W[L3^ZO\ WR/\*-B?W5_[Y'^%? 7_
M  V1^T5_TB=_;_\ _#C?\$LO_IEE'_#9'[17_2)W]O\ _P##C?\ !++_ .F6
M4 ??NQ/[J_\ ?(_PHV)_=7_OD?X5\!?\-D?M%?\ 2)W]O_\ \.-_P2R_^F64
M?\-D?M%?](G?V_\ _P .-_P2R_\ IEE 'WX8T/5$."",J#@CH>G4#H>HIP
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M*U\:>#_"^C^(--URVUSX?ZWXRT2*ZU"W\>^&?_!.;XU^$M+^'D7CO]JSP?\
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M:?KWPEL?BH;OX6Z%XE\:^*M,UOX07S>./ ]M\./BY9:CX_U^*'Q;XYTCXT^
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MZ+XI\4Z'H_AW4M$U34_F?QI_P2I^)VJZ&GASP9^V/<:/IWB;_@GY=_\ !/\
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MQ4W_  2D^)<GC?XJ_'"/]LK4D^/GB[]J'X;?M>?##59/@5X7'P9^$?Q8\'?
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MX _X)._\HLO^":?_ &8!^QO_ .LZ_#FOO^O@#_@D[_RBR_X)I_\ 9@'[&_\
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MC/QM^VUK_P"T3\#/@[/XQ_9ATC3?'/PUO/V@?AW\6-%\/>%+SX9_&/Q/\/\
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M "O@#]C?_DXK_@K%_P!G_P#PX_\ 767_  33K[_KX _8W_Y.*_X*Q?\ 9_\
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M2IRPASU)M<]2?)3IPYZDYSY*=.'/R0A&!1115%A1110 4444 %%%% !1110
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MJ5K87MQI^D1W<=@VJWL%M)+;:<+V8^19&]E1;9;VX!@M&D$TH*K0!^17@?\
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M11_P[3_9U_Z*-^W_ /\ BV+_ (*F_P#T9%??]% 'P!_P[3_9U_Z*-^W_ /\
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MC_AY9^SK_P!$Y_;_ /\ Q4[_ ,%3?_H-Z^_Z* /@#_AY9^SK_P!$Y_;_ /\
MQ4[_ ,%3?_H-Z/\ AY9^SK_T3G]O_P#\5._\%3?_ *#>OO\ HH ^ /\ AY9^
MSK_T3G]O_P#\5._\%3?_ *#>C_AY9^SK_P!$Y_;_ /\ Q4[_ ,%3?_H-Z^_Z
M* /@#_AY9^SK_P!$Y_;_ /\ Q4[_ ,%3?_H-Z/\ AY9^SK_T3G]O_P#\5._\
M%3?_ *#>OO\ HH ^ /\ AY9^SK_T3G]O_P#\5._\%3?_ *#>C_AY9^SK_P!$
MY_;_ /\ Q4[_ ,%3?_H-Z^_Z* /@#_AY9^SK_P!$Y_;_ /\ Q4[_ ,%3?_H-
MZ/\ AY9^SK_T3G]O_P#\5._\%3?_ *#>OO\ HH ^ /\ AY9^SK_T3G]O_P#\
M5._\%3?_ *#>C_AY9^SK_P!$Y_;_ /\ Q4[_ ,%3?_H-Z^_Z* /@#_AY9^SK
M_P!$Y_;_ /\ Q4[_ ,%3?_H-Z/\ AY9^SK_T3G]O_P#\5._\%3?_ *#>OO\
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MHU7K9SQ*RZK/#<LZE*KAE[9U*<Y*DOJ$_L;_ +1 P?\ A['^W^,G '_"O/\
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MZ)]=_P##&G[1/_26+_@H#_X;O_@EI_\ 2U:/^&-/VB?^DL7_  4!_P##=_\
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M^%C?\%3?^C-_V /_ !99^T5_]*=KZ _9.^.G_#4'[+'[-/[2_P#PBW_"#_\
M#1'[/_P;^.G_  A7]M_\)-_PA_\ PMOX=>'/'_\ PBW_  D?]D>'_P#A(/\
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M]^)-1^&W[4WAKQA^S7X1^*FE>&=,\9Z1XB3XW3_"W0_B3XK\+:YX>U&Z#?\
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M?&5P;GQ%XLUOQ'?ZE>^(]0UJ\<10VUY<:JTFE6-K8Z?I!L-/L+.VM_@O0O\
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M_A#XD_"GQ1-HOQK\17VL>(O&=MX/^)_A*=]5OVM;JYU?PM-K'AG6?S@\#?\
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M3I1A2A3BI5<17:7M<35=>O-)+VE5PITW-Q7NIN-*"DTFYN/-.=2?OI:^ /\
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M %? '_!)W_E%E_P33_[, _8W_P#6=?AS7W_7P!_P2=_Y19?\$T_^S /V-_\
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M$G?^S_\ XC_^NLO^"EE 'W_1110 4444 %%%% !1110 4444 %%%% !1110
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M]G7_ *)S^W__ .*G?^"IO_T&]'_#RS]G7_HG/[?_ /XJ=_X*F_\ T&]??]%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
-HHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>forms-4_009.jpg
<TEXT>
begin 644 forms-4_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %6 CH# 2(  A$! Q$!_\0
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MC./P[X.GEO/!FLP>#;#1YGO=-\8^,?".OZ;'HFH_BAX"_P"";'Q&\4?L>?\
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M7.M>$=#;88_$NL_$.X\4^$?!OA7Q*_A/5+F'U/2_^"/6G:C\4/#_ ,??BO\
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M$;=6^(VA6.B']OK]J*RG^(_[*OAO]C/]LOQ;KFB?!KQUX[_:U^"'ASQ3X_\
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MTCX3>,]<^,7BNQ%KX.\'VEKI^G_\)!?^(M7T[0[CZ$^.?[?/P\\)_L6_#O\
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M567L(YECX8E<T/9R=:KE5+ 5<-*48>SQ6*KTI-.E"I#RCQC_ ,%J_ GP5_:
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M>4N67L5"A[5MU'AI4Z4X8AR<L35E7515H+"X>G4_$Z3Q-\4_&O\ P50D\'?
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MI%M).-YA)RY[KX:DHI])12IM2^?/).VBE!K5J5BBBBI+"BBB@ HHHH ****
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M:VGAC2Y-(U+2+%/&;7/B"W /Z1Z*** "BBB@ HHHH *,#THHH ,#THHHH 3
M]!^5+110 4444 %%%% !1110 4444 %%%% !1110 45\'?MF_P#!3G]@[_@G
MYH[ZE^UI^TM\.OA9JKV5O?Z;X :^N_%?Q8UVTO)FM;*ZT+X4>#+3Q!\0M3TZ
MYND:W.M0^'/["LRLL^I:I96EO<W$/Y<M_P %+_\ @JS^W8([/_@EY_P3DN/@
MI\)]6$L%K^V3_P %-[N]^$_A.:TF=XX->\!_LZ^#M2O/BMXNTN_LHY=1\*^+
MK6;7M">X>R3Q/X:LX_,L+L _HDUK6]&\-Z/JOB+Q%JVF:!X?T'3KW6-<UW6[
M^UTK1]'TG3;:2\U'5-5U.^E@LM/TZPM(9KJ]OKN>&VM;>*6>>6.*-F'X9_&G
M_@X0_8NT3Q_?? C]C7PS\9?^"F/[24'GP)\+?V)O!%Y\1_"^CW'V<R6FI^-/
MC3*+7X:Z3X-^U;+'6?%'A+5/'S^')F=M6T>)+>X\K@=&_P"""\W[2.N:1\1/
M^"O/[;'Q_P#^"BGBBPOH]8L_@C;ZG+^SS^QOX8OD:*YM$TCX&?"Z\TZXU;4=
M(N$-L/$EYXETE?$NGQPQ>)?#5WAD/[C_  :^!/P5_9V\#V'PS^ GPF^'7P8^
M'VF.TUGX,^&'@[0/!'AN*ZDBBAGOGTGP[8:=:7&HW4<$(O-2N8I;^]:-9+NX
MFD&^@#\)(_A%_P %_/V_G$WQO^-OP?\ ^"/W[/>L$_:/A/\ LR_8OV@/VSM5
MT.Y5/M>A^*_CKJ^WX=_#K5MA$VB>-O@_=66MZ9.TEMJWAB46O^G_ %Q^R7_P
M0T_X)S?LB^+6^*^C_![4/C[^T-=WMOJVL_M+_M8^)KW]H+XVZQK]H0UOXG&M
M^,H7\,>&/$R;41]=\!^$?">I3QI$EQ/*D,2I^O-% !1110 44?Y%?./@S]KK
M]F_XA?%K6O@=X-^*_A_7?B;H5]XWTF?0;>VUF"QU36_AAJMKH7Q1\/>%/%5Y
MI=MX0\;>)?A;KE[;:+\3O#?@[7M=UWX=:O+_ &9XST_0[Y)($ /HZBOG'6OV
MN?V</#WQGM?V?-9^+'A^P^+5UJWA_P -MX<DM]8>PTWQ=XOT.?Q/X.\":]XO
MATR3P3X<^(?C'PW;MX@\'_#WQ!XBTSQMXKT26TU7P_H.I6-]97%Q+\%_VM/V
M<?VA]:U[P]\%OBUX9\?ZMX>LY=6N(-(_M*&'6/#L/B#5/"<GC+P7?ZE86.G_
M !!\!#Q1HFK>'5\?^!+KQ'X+DUNPN-+CUU[U!"0#Z)HHHH **** "BBB@ HP
M/3_/^2:** # ]*3 ]!^7X?RXI:* $P/0?D*,#T'Y?A_+BEHH ,#T]/TY'Y'D
M4444 &!Z"BBB@ P!T %%%% !1110 45A>)_%'AGP3X?U?Q;XS\1:%X1\*^'[
M&?5-?\3>)]7T_0/#^AZ9;+ON=1U?6=5N+33=-L;=/FGN[VY@MXE^:211S7YK
MS_\ !97_ ()[:GJFJZ%\)_B]XS_:@UG1SY5[;?L=_L_?M#?M<Z3!>EXE73+O
MQO\ L[_"WXC?#S2=2=9HYDL]<\7:7*UNPG \IE=@#]1:*_*>3_@JWHI9S9_\
M$_/^"K&H6D9!>^C_ &%OB!IZ*A)VNFG:[JFD:Y/D=8[;2IIDS^\B0Y GF_X+
M"_LH>%[&74/C7X'_ &T/V:;*!HC=:K\??V"_VO\ P=X4TZVE8J=1UKXAZ7\'
M?$GPW\/:7 =INM3\0^+]+L;5&$EQ.D89E /U1HKPOX"_M._LZ?M3>%;CQO\
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MD1KS5-9U:XM-.T^U5Y$1KB[N88@[JI<%@#^+WQT_X.'?^"7OPA\5S?#+X?\
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MM3Q-I"ZC<165REY9V]S+,K_\$7?VO/VHDN+G_@IM_P %<_VI_C/H6I"--0^
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MV7AWPQX>T#1--TKPYX0T'P_H-M'<'3GO;GWJF!\D?M^_\F)?MJ_]FD?M(?\
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MK3+2XO\ 4M3U*Z@L=/T^QM(GGNKV^O;J2*VM+2VA1YKBXGDCAAB1I)'5%9@
M7:*S8M9TB?3K'5X=4TZ72=373'TW5(KZUDT[4$UJ6W@T=[&^25K:[75IKRSB
MTUH)9!?27=M':F5YXE:/7->T/PSI=WK?B/6=*\/Z+8+"U[J^MZC9Z3I=F+B>
M.U@-UJ%_-;VEN)KJ:&VB,TJ"2>:*%-TDB*0#6HJM+>6D!M%FNK:%K^86UDLL
M\49O+@P370M[4,X-Q.;:WN+@10[W,$$TP7RXG9;- $4_^ID_W&_E7\2?[5Q8
M?M1_M)?,0/\ A?WQD_B<#GXE>*1V.!]!W)Q@EC7]MD_^IE_W&_E7\27[6/\
MR=)^TA_V7SXR?^K)\55_:?T)FUQEQW9M7X2RE.S:O_QE$NS6A_F+^U M_P 0
MX\*M$_\ C/\ /=TGOP2O)]CP'GU;_OIO\:DC)WIRW^M@'+/VD<\?S!'0YV\[
MJA &!P.@["I8?OQ_]=X__1E?Z/Q;YJ?O2^.'5_S0_O?F?XNIWY^MH3W2[2_N
MG]NO[+@_XQL_9]_[(;\(?_5>^'NW7\_Z5[K)]QOI7A/[+?\ R;9^SY_V0SX0
M_P#JO?#U>[2?<;Z5_A#GW_(]S[_L>Y[_ .KS.C_J[X2_Y)+A3_LE>%O_ %F>
M&#^=C_@MO_R/O[/G_8G^/?\ T]^%J_#A>@^@_E7[C_\ !;?_ )'W]GS_ +$_
MQ[_Z>_"U?APO0?0?RK_6?Z,__)CN _\ L%SC_P!:3/#_ )[?IN_\I/\ BK_V
M,\D_]9'AD6OZA?\ @C)_R:AXF_[+?XQ_]13P#7\O5?U"_P#!&3_DU#Q-_P!E
MO\8_^HIX!KY7Z7O_ "9K$_\ 95\*_P#J3FQ]_P#LY_\ E)7!?]D!Q]_Z@Y"?
MK71117^5Q_OH%%%% !1110 445^/O[6'_!=7_@G-^R?XQ3X1W'Q8UC]I#]HF
M[U"]T;2?V9OV0/#%S^T/\;-3U[3H7GO?#DNC^$;I?"GAKQ) B$_\(_XV\8>&
M-6E3S)X;22VM+Z:U /V"KR'XV?M _ O]FSP3<_$G]H3XQ?#/X)> ;69;67Q?
M\5/&WAWP+X?>^DC>2#3;;4O$FH:=;7NJW2QN++2K-Y]1O77RK2UFD(0_A4?B
MK_P< _M_2)'\'/@Y\'/^".W[/VKI$\7Q0_:(73OVC?VSM1TT[VBU/PU\%[-8
MOAGX"GO4D^R:KX0^*VF6'B32)(6O=,\2L5ACNO7O@A_P;Z_L3>&?'NG_ !V_
M:[U?XN?\%*/VE[<6\\WQ>_;=\;W_ ,4M%TRX56ENM-\(?!QWM_A=I'A!=0DD
MO]#\.>)M"\;W'AIRD>E:W&J%W /*]4_X+V:I^TWK&I> ?^"0'[#/[0W_  4(
MU^*[FT=_C]K6BW/[.O[&'AC5%:Y@N&UKXT?$VTT[4M4O]#%NVIW/A1?#GAJ?
MQ)8^3:^&?$5S?7$@M*B?\$Q_^"HW[=B37G_!5#_@HK>?"SX3:TL\EY^Q3_P3
M2M;WX0^ I+*[,1;0/'_[0WBK3KCXL>/M&O+.*&S\3>#M3M=7T9+PWC>&?%4$
M$AO;O^B/2-'TGP_I.FZ#H&EZ=H>AZ-8VNEZ/HVCV5MIFE:5IEC EM9:?ING6
M44-G8V-G;1QV]K:6L,5O;PQI%#&D:*HT: /AG]CO_@FC^PE^P)I)TW]DO]F;
MX:_"34)K2:QU'QM::==^)_BCK=G<3M=3V>O_ !7\:7OB/XCZW8/<,TL>F:CX
MHN-,M?DALK.VMXH88_N; _7/XT44 %%%?/MM^U3^S]??M-W'[&^F_$_PYJO[
M2VG?"/5OCIKOPHTJ6?4]?\+_  PTGQ'X)\*MXB\6R6,$^G>%I-3UCXA>%U\/
M:-KU[I^N>(M/N[K6=%TZ^TC3;^^MP#Z"HKY.^)O[;?[.?P@^+NG_  2\>>+=
M?TWQG<'X3)K>H6'PZ^(FO> / -Q\?/'>I_##X&V7Q/\ B?H7A?4?AY\-]0^+
MGQ#T?4/!_@6P\8^)='N]6UE+*-X;:WUC1;C4;7PH_;"^$_QK^)WC'X7?#W0O
MC9J=UX'\1_$WP?K7Q"U+]GWXT>'?@C<^*_@[XXO?AK\1?#GA_P".'B#P1IOP
ML\3ZQX=\=Z5KOA>6R\/^*M1EO-5\.^(H+ 77]B:BUN ?4]%%% 'Y;?\ !1Y_
MVG_$9\ _"?X%_L\_&KQW\,/B9X;\=Z%^TI\;/V<=>_9HT?\ : \*?#2>7PY;
M/\$?@_>?M"?'WX"6_@C6?C7%/JO_  DWQKTC6/$.K_"K0/"B#P)X6'Q,\6>%
M/B=\'U^+O@;XGEOV+_%_P?\ V4_B#I/@W]A7XP^%/&NE? G3_&7P-TCQ-XR^
M%GC+]B'X[_L\W7A7X7V-U\5%^','C/X"Z_\ &WP_I6K:9XV^)7@_P]JF@^#O
M'J_#_P 5>,#>^$SXA_G^_P""JO\ P6W_ &^OV3O^"@_[2/[.WP9\5?"[3?AC
M\,K_ .%%MX5LO$7PNT[Q%K,$?B[X!?"?XA:U]MUF?4[:6],GB7Q?K4UN7A4V
M]I);VBEDMU8_GW_Q$??\%2/^AW^"G_AE-)_^7=?H>"\,.)L?@\)CJ$\J]AC,
M-0Q=%5,=.%14L32A6I\\%A)*,^2<>:/-+E=TI/<^"QGB-P_@<7BL%6IYDZV$
MQ%;#573PL)4W4H5)4Y\DGBHN4>:+Y6XQNM;+8_>Z;]@;]L+PY\)/VI/AI!\'
M[#Q/J_\ P4?_ &3?%?P-\0:CH?Q#\ GPQ^R#X]^*7[7'_!0+]H'Q!-\6CXA\
M0^']4\7^!? W@G]O2TT^RU/X&Z7\2=5\2>./A!XPL;?P[I>E^+O"6N7G]+R@
M!5 )(  !)9C@# RS$L3ZEB6)Y))S7^=D?^#C_P#X*D#/_%;_  4Z$_\ )%-)
M[?\ <;]_TK^U/_@EW^T'\2OVJ?V#/V=?C_\ &"\T?4/B1\2?#?B;4_%-YH&C
MQ:!H\UWI?Q \6^'K1K+2()KB*R1=,TBQ22-)G$DR23$@RE1Y7$/!6=<,X6AC
M<RE@71KXE86'U7%2KS]JZ-2NG*+P]&T>2G)<W,_>LN76YZ60\8Y3Q%BJV$P$
M<9&K1P_UB?UG#QI0]G[6%&T91KU;RYIK1Q6EW?2S^^Z_E1_X.LY9H?V;_P!D
MXP3SP%OV@_$88P32PEA_PJWQ&<,8G0L,\@$D \CFOZKJ_E-_X.N/^3;OV3?^
MSA/$?_JK/$=/@!)\99 FDT\94NFDT_\ 8L=NFFG\TQ<<MKA3.FFT_JU/5-I_
M[W@NJ:?XG\1_VN]/_+_J'4C_ (_KKL<#_EKZ4UKN] .+_4.0?^7Z[]0.TP]:
MB'3\6_F::_3\#_-:_JYPA9^Y3Z_\NZ?][_IT?S,ISNO?GT^W/^[_ 'S^M3_@
MU!GN)OBY^V\)KBYG"_#GX!E1/<33A"WB?XNABHE=PI8*NXK@MM&<X%?VKU_%
M'_P:>_\ )7/VX/\ LG/P"_\ 4H^+U?VN5_+OB6DN,\V222]GEVB22_Y%]'HE
M%?@?T?X>-OA/+FVV_:X_5MM_[[4ZMM_BSY(_;]_Y,2_;5_[-(_:0_P#5.^,:
M_P HF#_4Q?[B_P J_P!7;]OW_DQ+]M7_ +-(_:0_]4[XQK_*)@_U,7^XO\J^
M_P#!K_D7\0?]C+ _^J^N?#>+'^_Y+_V XW_U-H$M?8?_  3N_P"4@W["?_9X
MO[-/_JY?!E?'E?8?_!.[_E(-^PG_ -GB_LT_^KE\&5^KYM_R*<U_[%6:?^JW
M'GYIE?\ R,\L_P"QEEW_ *L,"?ZL"?<3Z#_T):EJ)/N)]!_Z$M2U_%<.OJ?U
MPNOK_F%%%%64%%%% !1110 5^7'[=7_!1+XL_LL?$?P;\#/@)_P3M_:__;;^
M,'Q#\&Q^,_#>H_"70/#OAG]G?0K8:YJ^AW>B_%+]H'Q%JEUIOPU\06QTI-1C
MM=7\(W.FW=CJNC!-8BNKX01_J/10!_.W_P (G_P<A?M@""ZU_P"*'[%__!)7
MX::M<SW$>A_#SPO)^V9^U1HNF2S1!=%\3ZEXQB3X 7DSV$LR+K_@W4M"U.&]
MB\R.QTYC%)'M^%_^#<O]D'QKKVE>/OV^?C1^UO\ \%,OB5I9L;ZQU+]J_P"/
MGC>?X?>&M9@ELKF^E\"_"[X?:IX1TC1/#NI75F!<>#?$>J>-- EL9#87L%^@
M,C_T$T4 >+_!#]G']G[]FGPM_P (1^SQ\$?A3\#O"+/'+-X>^%'@#POX!TN\
MN8HD@6]U&U\,Z9IJ:E?F*-%DU"_^TWLP4&6=VR:]HHKX*UG_ (*6_L@Z)XT_
M:T\%W'Q&NKZ;]B#X56OQ;_:.\0Z'X<UG7O#/@_2I]1\=:5>>%-)O]'MKV[\:
M_$+1-1^'GB#2]=\'^#=/US4-,\0BW\'SM_PF:W_AVP /O6BOGCX%?M':!\<-
M1\>^%9O ?Q)^$'Q-^%\OA1_'GPF^+FF^%;#QOH.C^/=&FUSP-XH2Y\">,/'_
M ((UWPQXKM;'6[+3=9\,^,M:@MO$/A?Q;X5U@:7XG\+Z[I%C\A:9_P %:OV<
M=4\ :S\1(?!/QQATNZ^%7@#XY?!?3+KPGX/@US]IOX1_%CXHZ'\&?A?XW^"E
MN?B"UA;V_CSXC^+/!6@:+X>^,>I?"/QE:Q>-_"FMZ]X;T;0-575(@#]1**\F
M^"OQ.U?XO>!;3QMK'PD^(GP8EOKVZALO"7Q-U7X0ZWK]WID2P26'B2SU3X'_
M !5^,G@*]T#7(9O/TBXL_&L][-!&TMW86:O 9O6&Z'Z'^5 /9^C_ "9^:'[5
M7[(_[3/QR_:4^$/Q@\(_&WX"I\)/@G8:)K_@3]G_ ..7P(^)7Q,\)Z;\=].\
M0W^HM\?KR7P#^T1\'M/\3^._#>B_V-I?PFC\;Z%XIT?X3:W9ZEX[\)6%MXVU
M&UUW2_H36OV>]7N_VL1^U-H_C2PL-2M/V5_$W[.VE^%K_P ,W.HVD&LZW\2=
M#^(MCXUO;Z'7+"2[TZPGT2/3KGPW%#:W%[',\T>NVC*%/P5_P62\8>+_  A\
M-?@I<>$?%GB?PI<7OCKQ)!>7'AKQ!K&@3W4*>'!)'%<RZ3>V<EQ'%)\\23,Z
MQL2R!22:_G^_X7;\:<G'QA^*@ + #_A8WC0\ D?]!ROZ?\+_ *,>;^)_!V!X
MPP?%^4Y/0QN+S3"1P&+RC-<77IO+,:L'.<J^$QE&A)5I/VD(QIJ4(^[)MZG\
M(>.GTZ.'_ WQ'S7PZS'P[SWB'$Y7@,DQTLUP/$&2X##5H9UEKS&G3CA<9E^(
MQ$)T(ITIRE5E&I+WX<L=#^G?XA_L:_'OXM^(K&P^(7[2_A+4O@[XH^(W[)GQ
MQ^+G@'3/@1_8_BQ_BS^RKXD^%_CZ"P^#/Q(L/B3!<>!_A3\3OB)\'O OB37_
M  [\1/#OQ@\<>%+%?&VA^$OB':Q^,=$OOA]SO[)'_!-^Y_9B\?? Z_'Q-\)Z
MW\+OV3/@O\:/V?\ ]FSPEX1^%-U\/?&H^''QI\=?#;QC>+\>_',?Q!\0:7\6
MO$/A"R^%GAO1M*U32?!7@.#Q+XAO?%'Q.\966K^,-:L3H/\ -6GQN^-!8 _&
M#XJ_>3)_X6/XT[R 'C^W".1P>N5^4\<5^^/_  1C\8^,/&'A/X[S^+O%OBCQ
M7-9Z[X"2SE\3>(=8\026:3V'BHSK:OJ][>-;B<Q1&80E!+Y4/F!O*CVUXF_1
MASCPSX.S'C#%\891F]#+\3EF&G@<)D^:X2O5>98Z.!A.-?%8RM1BJ4Y>TFI4
MW*<5RQ:D[AX&?3HR#QP\2,G\.LO\.\]X>Q.;X+.L;#-<=Q!DN/PU".397/,Y
MTYX7!9?0Q$Y5XP]E!QJQC3D^>:E%<K_;"OSQ_P""G/Q/_9W^#_[-5CXY_:1^
M&]]\8_#NE_&'X3-\.OA0FJZAH_AKQO\ &Q/%$5U\+H?B-?F[MO!MC\,_">O6
MH^(?C?6_B?;:WX#\(Z+X.G\:S>&_$?B?PWX8T:]_0T\#M^/2O(OCQ\6(/@=\
M(?'_ ,6;G0YO$<'@70I-;DT2"_33)=25+JVM?LZ7\EM>):_-<!S*;6X(5& B
M9B!7\T8'!XK,L;@\NP-&6(QN88O"X'!X>,H1E7Q>-Q%#"86C&52=.G&5;$8F
MA2C*I4A3BZBE.<(*4X_V_FN:8#),KS+.<TQ$<)EF49?CLUS'%2A4J1PN7Y;A
M,3CL;B94Z,*M:<:&$PF(K2A2I5*LU2<:=.<Y1A+\"-3_ &<_ 6L_L%?L4^/_
M  M\5(OBSJ/@/_@J+^RK\8;;1?V:O%GCWP[^RMX:\>?'?_@K=\ /&/Q2\+>#
M_AOITNBVWC3X7_L\:;K_ (Y^'_PKG^(^AR6.B:+)XB^)=QX3\,^,-0LI/"GV
MA_P4U_:7_93\%>'/ 0^(/@7PC\;OBWX(_: O_AK\(/!?Q=OO%'AG]G;P%\>=
M?^ ]UKES\1OVB-1O;"\\&O\ "SX?_!_XHQZQJ7B=?"/Q.\2V=YXMMO#'PA\,
MZO\ %K4K72;?RK_A^!X8Z_\ #/&O=!_S473_ /YD/>@?\%P/# X_X9XU[_PX
MVG__ #(5^R_\2W>-_P#T;_,O_#CP[_\ /\_FG_B=?Z+W_1VLI_\ #+Q=_P#0
MP<+HO[,7P^\"WW_!!KQS\-OB]X\_:!TSX<?':;X2Z)XUT?Q'XML/@@W@J3]@
MW_@HEKGB+QIX5^#-AJ]WX&\(VNL>+Y_"O@SPSJFM1>(-;\"_#[PEX ^%_ACQ
M1:Z8-</BO^A2OR(_9^_X*PZ#\>_C+X"^#]I\%-8\-7'CK4M1TV/7;CQO9:G#
MIK6'AW6_$!EDL(_#5D]RLJ:,UL56[@*&X64,_EM&?US63<VW&,#)_3_&OSKB
M_@CBK@+,</E/%^3U\DS'%8*&8X?"UZ^"KSJX*=>MAH5U/ XS&THQE7P]:FHS
MJQJ7IMNFHN,I?LOASXJ< >+648O/O#SB/#\391@,RGE&+QN&PF982%',:>%P
M^-GA73S/ 9?6E*.%Q5"JYPHSI6J**J.:E&*3_P"IE_W&_E7\27[6/_)TG[2'
M_9?/C)_ZLGQ57]ML_P#J9?\ <;^5?Q)?M8_\G2?M(?\ 9?/C)_ZLGQ57]4_0
MF_Y++CK_ +)/*?\ UJ&?P-^U _Y-QX5_]E_GO_K$H\ 7H/H/Y5)#]^/_ *[Q
M_P#HRHUZ#Z#^520_?C_Z[Q_^C*_T>7QT_P#KY#_TJ)_BY'_EY_@G^4C^W3]E
MO_DVS]GS_LAGPA_]5[X>KW:3[C?2O"?V6_\ DVS]GS_LAGPA_P#5>^'J]VD^
MXWTK_"+/O^1[GW_8^SW_ -7F='_5YPE_R27"G_9*\+?^LSPR?SL?\%M_^1]_
M9\_[$_Q[_P"GOPM7X<+T'T'\J_<?_@MO_P C[^SY_P!B?X]_]/?A:OPX7H/H
M/Y5_K/\ 1G_Y,=P'_P!@N<?^M)GA_P ]OTW?^4G_ !5_[&>2?^LCPR+7]0O_
M  1D_P"34/$W_9;_ !C_ .HIX!K^7JOZA?\ @C)_R:AXF_[+?XQ_]13P#7RO
MTO?^3-8G_LJ^%?\ U)S8^_\ V<__ "DK@O\ L@./O_4'(3]:Z***_P KC_?0
M**** "O"_P!IC5_VAM!^ _Q-U?\ 9/\ "/PY\=_M%6/AUY?A/X2^+>M:IX>^
M'.L^)FO+2)8?%>K:+)!J<&G6]A)>WJP6EWIS:A=6UOIKZKI$5V^J6GNE'^?R
MH _G,E_X)!_MQ?MTQ/JG_!7S_@HGXW\1>!M6;[5=_L1_L"B]_9[_ &9K6&XF
M47WA#QSX_P!1LKKXM_&[P=>:<9[22S\4IH>OZ?<3O+IWBZ6.)3/^P7[*G["G
M['O[#_A3_A#?V3OV=?A=\#M)FM4L]3OO!WAR!?%WB2&*1)8SXQ\?ZJVI>._&
ML\;1Q>7=^+?$FM7<:PP1I.J00JGUC10 4444 %%%&1_GW./YT %%%% !7PAJ
MW[/GB:+_ (*2_"G]I/P[X2T#3?AKIW['?[4_PV^(_B>PET+3=7U?XO?$[XO?
ML0ZOX'DU?3(&AUOQ%=W?P]^ /B'3W\2SP7D.EZ;X4T+0;F]MXWT:T/TK\>?%
M>M^!?@=\9O&WANXBM/$7@[X4_$;Q5H-W/;0WD-KK7A[P?K&KZ5<36ERKV]U%
M#?6EO+);3HT,Z*8I59&8'_/=M?\ @XE_X*N26UM(WQO\!;I8(I&/_"COA>N6
M9 6.!H0')ST  Z #%?4\.<'YMQ33QE7+)X&$,#4HTJWUNO4HMRKTZE2#IJ&&
MQ',E&E)2;<;.RL[Z?,<0<5Y;PW4PM/'PQDY8N%:I2^JT(5HJ-"I"G/GYJ]%Q
M?-4CRV4DU=MIZ/\ IZ_:%_9!_:A_:!^/O_"\KSX':]H/Q)^(6G_\$^O%'PA\
M7GXV> K;X??L<W/[/WQ,7XL_%WX;_M&_#;0_%\>A_M)ZSX7\3ZSX]\0?##Q7
MI7@GX[:1KOB;Q-I>A>'M1^!,'A73_BM-[!^S7^R-\5_ /[6G@;Q_I/[/7A?]
MF30_ 7B+]LO4/C[\2/!/Q/;Q9X;_ &S+'X[_ !.U+QM\*/L?A^^\;>+/B/=W
M6FZYK-_\7_%EU\;+/P_<?!7QO)K/PS^!_P#PE'P^\<>(-9L_Y+/^(B+_ (*M
M_P#1;_ 7_AD/A?\ _*.O=OV6/^"]/_!3;XH?M3?LO_"_QI\8_!.H>#?B;^TG
M\ OAQXPT^V^#?PXT^YU#PGX\^+?@_P )^);&WU"ST5+S3[B[T35[^WAOK22.
MZM)9$N+:6.>.-U^AK^%7$]"C6KSJY.X4*-:O-1QM=R<*%&K6GRIY>DY<E&?*
MFTF^5-J]UX5+Q-X?K5:5&-'-5*K5I4HN6"IJ*E5J4Z47)_7':/-4C=V;2N[.
MUG_?_14>XX/;C(/_  +&/P_J*DK\T33_ #^^S_5'Z&G?\/Q/\TK_ (+S_P#*
M7G]M'_L+_ +_ -9*_9_K\C*_7/\ X+S_ /*7G]M'_L+_  "_]9*_9_K\C*_L
M?AK_ ))S(/\ L295_P"H&'/Y1XC_ .2@SS_L;YC_ .I=4:W?_=;^E?Z8?_!"
M_P#Y11?L<_\ 8F>-_P#U;?C^O\SQN_\ NM_2O],/_@A?_P HHOV.?^Q,\;_^
MK;\?U^?^,/\ R(,L_P"QS'_U78L^U\*_^1YF'_8J7_J=AS]9Z_E-_P"#KC_D
MV[]DW_LX3Q'_ .JL\1U_5E7\IO\ P=<?\FW?LF_]G">(_P#U5GB.ORG@#_DL
M^'_^PRI_ZA8X_3N.?^23SK_L&I_^I>"/XB!T_%OYFFOT_ _S6G#I^+?S--?I
M^!_FM?U>]G\__;C^9%NOE_[:?UG_ /!I[_R5S]N#_LG/P"_]2CXO5_:Y7\4?
M_!I[_P E<_;@_P"R<_ +_P!2CXO5_:Y7\N>)?_):9M_U[R[_ -5]$_I'P[_Y
M)++O^ON/_P#4VH?)'[?O_)B7[:O_ &:1^TA_ZIWQC7^43!_J8O\ <7^5?ZNW
M[?O_ "8E^VK_ -FD?M(?^J=\8U_E$P?ZF+_<7^5??>#7_(OX@_[&6!_]5]<^
M&\6/]_R7_L!QO_J;0):^P_\ @G=_RD&_83_[/%_9I_\ 5R^#*^/*^P_^"=W_
M "D&_83_ .SQ?V:?_5R^#*_5\V_Y%.:_]BK-/_5;CS\TRO\ Y&>6?]C++O\
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M>'JXC+,=BL!7J4'5A3JNC4JX2I.DZD(5'3E!SA&7-%?Z \+\087BSACAWBG
MT<1A\%Q+D.3\08/#XM4EBJ&%SK*\%FF'HXE49U**Q%*CCJ=.LJ52I356,U3G
M."C)_A[_ ,%L_P#DE_P+_P"Q_P#$W_J,BOYTN[?[S?\ H1K^BW_@MG_R2_X%
M_P#8_P#B;_U&17\Z7=O]YO\ T(U_J9]$W_DR60?]CGBO_P!7D#_!']H#_P I
M-<6?]D]P+_ZS,@C^]_P)/_1U?T._\$0?^1._: _[#_P]_P#3?XNK^>*/[W_
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MX:IX9N/B3=ZE-=/?_%W5?B!>:2VF^%I/#WA_1?T0K\\OV+_^"F'[$7[;>O\
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MXW_]6WX_K\_\8?\ D099_P!CF/\ ZKL6?:^%?_(\S#_L5+_U.PY^L]?RF_\
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MW2S_  <U&YTGPI\<_'VH:EXV^)WA2/PK=#X5Q?NQI7]IG3--.M+8+K)L+/\
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M=.WF5<ZR>A5G1KYKEM&M2DX5*57'X2G4IR5FXSISQ$9PDDTVI13U6FJ+VO\
M[4/[5]I^S#\$O$'PU^+6I:9KWPO_ ."CGP?_ &4_VT=:^/6C?#+XE?&G6;S6
M?V[_ ()? SQ-\,OA5KWPF^&7P;^!LO@;Q7X2^(^KS:=\7KCX5Z-XUL/A:?#5
MD? GASXRZUKWB'X>?O97X!6/_!3#_@@SIWPD\-_ RT^//A"/X8>%?B-X4^+V
ME>'Y/"7[3,]Y-\4_!GQ@TSX_Z+\0]?\ %%SX-E\6^+/&$_QHTBS^)'B7Q!XJ
MU[6=2\:^*&O[_P 9W&O?VMJJ7O[-_ /X_P#PA_:@^$_A;XX_ CQG;?$#X5^-
M'\0Q^&/%MGIFNZ/;:J_A3Q3K?@KQ (].\2Z7HNM6_P#9WB?PYK6E.;S3;832
M6+W%J9[*6WN9L\7E.:X"G&MCLLS'!4I35.-7%X'%8:G*HXRDJ<:E>A2@YN,9
M24%)R<8R:5DVM,-FF6XVI*E@\PP.+JQ@ZDJ>&Q>&KSC34E%SE"C6J24%*48N
M3BHJ4DKW:3]BK^8;_@ZI_P"3(_V=!Z_MC^'/_5!?M ?XU_3S7\PW_!U3_P F
M2?LZ?]GC^'/_ %07Q_KV^!=>+^'O^QC'_P!1L>>-QK_R2V=_]@;_ /3^$/X3
M=I!R&_0'_/OZGFEVD]6S_P !%.HK^M)6][1=?LQ\_P"Z?S!=G]2G_!JB,?M1
M?M6<Y_XL%X2]NOQ"4]/\]Z_N4K^&S_@U2_Y.C_:L_P"R!>$?_5A+7]R=?R_X
MGJW&F96T_P!ERK;3_F 78_HWPX_Y)/!?]A.8_P#J:SP/]JC_ )-C_:._[(/\
M8/\ U7?B"O\ )(L/^/*S_P"O2#_T$U_K;_M4?\FQ_M'?]D'^,'_JN_$%?Y)%
MA_QY6?\ UZ0?^@FON/!G_=.(_P#L+R[_ -1L6?&^+'^]9)_V"YA_ZE80MU]1
M_L,?\GR_L0_]GF_LH_\ J_\ X>5\N5]1_L,?\GR_L0_]GF_LH_\ J_\ X>5^
MN9E_R+<R_P"Q=F'_ *@8X_+,%_ON"_[#,'_ZEX4_U@/X!]#_ .A+4M1?P#Z'
M_P!"6I:_BB'Z+_TF!_7D>OHOU/\ -*_X+S_\I>?VT?\ L+_ +_UDK]G^OR,K
M]<_^"\__ "EY_;1_["_P"_\ 62OV?Z_(RO[*X:_Y)S(/^Q)E7_J!AS^4^(_^
M2@SS_L;YC_ZEU1K=_P#=;^E?Z8?_  0O_P"447['/_8F>-__ %;?C^O\SQN_
M^ZW]*_TP_P#@A?\ \HHOV.?^Q,\;_P#JV_']?G_C#_R(,L_[',?_ %78L^U\
M*_\ D>9A_P!BI?\ J=AS]9Z_E-_X.N/^3;OV3?\ LX3Q'_ZJSQ'7]65?RF_\
M'7'_ ";=^R;_ -G">(__ %5GB.ORG@#_ )+/A_\ [#*G_J%CC].XY_Y)/.O^
MP:G_ .I>"/XB!T_%OYFFOT_ _P UIPZ?BW\S37Z?@?YK7]7O9_/_ -N/YD6Z
M^7_MI_6?_P &GO\ R5S]N#_LG/P"_P#4H^+U?VN5_%'_ ,&GO_)7/VX/^R<_
M +_U*/B]7]KE?RYXE_\ ):9M_P!>\N_]5]$_I'P[_P"22R[_ *^X_P#]3:A\
MD?M^_P#)B7[:O_9I'[2'_JG?&-?Y1,'^IB_W%_E7^KM^W[_R8E^VK_V:1^TA
M_P"J=\8U_E$P?ZF+_<7^5??>#7_(OX@_[&6!_P#5?7/AO%C_ '_)?^P'&_\
MJ;0):^P_^"=W_*0;]A/_ +/%_9I_]7+X,KX\K[#_ ."=W_*0;]A/_L\7]FG_
M -7+X,K]7S;_ )%.:_\ 8JS3_P!5N//S3*_^1GEG_8RR[_U88$_U8$^XGT'_
M *$M2U$GW$^@_P#0EJ6OXKAU]3^N%U]?\PHHHJR@HHHH 1NA^A_E7CGQVY^!
M_P 9L_\ 1)_B/_ZAVM?XFO8VZ'Z'^5>.?'7_ )(A\9O^R3_$;_U#M9KNRO\
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MRK_6?Z,__)CN _\ L%SC_P!:3/#_ )[?IN_\I/\ BK_V,\D_]9'AD6OZA?\
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MM4?\FQ_M'?\ 9!_C!_ZKOQ!7^218?\>5G_UZ0?\ H)K_ %M_VJ/^38_VCO\
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M\V?:O_!.K_D];]G_ /[&?Q)_ZK?QQ7]B<?\ K6_W?_B:_CL_X)U?\GK?L_\
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M=I/N-]*\)_9;_P"3;/V?/^R&?"'_ -5[X>KW:3[C?2O\(L^_Y'N??]C[/?\
MU>9T?]7G"7_))<*?]DKPM_ZS/#)_.Q_P6W_Y'W]GS_L3_'O_ *>_"U?APO0?
M0?RK]Q_^"V__ "/O[/G_ &)_CW_T]^%J_#A>@^@_E7^L_P!&?_DQW ?_ &"Y
MQ_ZTF>'_ #V_3=_Y2?\ %7_L9Y)_ZR/#(M?U"_\ !&3_ )-0\3?]EO\ &/\
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M8_WK)/\ L%S#_P!2L(6Z^H_V&/\ D^7]B'_L\W]E'_U?_P /*^7*^H_V&/\
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M_P"F_P 75_/%'][_ ($G_HZOZ'?^"(/_ ")W[0'_ &'_ (>_^F_Q=6OTJO\
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M_;;/_J9?]QOY5_$E^UC_ ,G2?M(?]E\^,G_JR?%5>O\ 0F_Y++CK_LD\I_\
M6H9X?[4#_DW'A7_V7^>_^L2CP!>@^@_E4D/WX_\ KO'_ .C*C7H/H/Y5)#]^
M/_KO'_Z,K_1Y?'3_ .OD/_2HG^+D?^7G^"?Y2/[=/V6_^3;/V?/^R&?"'_U7
MOAZO=I/N-]*\)_9;_P"3;/V?/^R&?"'_ -5[X>KW:3[C?2O\(L^_Y'N??]C[
M/?\ U>9T?]7G"7_))<*?]DKPM_ZS/#)_.Q_P6W_Y'W]GS_L3_'O_ *>_"U?A
MPO0?0?RK]Q_^"V__ "/O[/G_ &)_CW_T]^%J_#A>@^@_E7^L_P!&?_DQW ?_
M &"YQ_ZTF>'_ #V_3=_Y2?\ %7_L9Y)_ZR/#(M?U"_\ !&3_ )-0\3?]EO\
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M&/\ D^7]B'_L\W]E'_U?_P /*_7,R_Y%N9?]B[,/_4#''Y9@O]]P7_89@_\
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M?_!T#_RDB\ _]F9?"/\ ]7-^TE7\ZE?UUP/_ ,DAP[_V+*7_ *>QI_+7%O\
MR4V>?]C&M_Z1AA&Z'Z'^5?Z1'_!OC_RB*_93_P"OW]H[_P!:O^.E?YN[=#]#
M_*O](C_@WQ_Y1%?LI_\ 7[^T=_ZU?\=*^1\8?^2:P/\ V.J/_J#C#ZKPL_Y'
MN._[%%7_ -3<&?M#7\PW_!U3_P F2?LZ?]GC^'/_ %07Q_K^GFOYAO\ @ZI_
MY,D_9T_[/'\.?^J"^/\ 7Y#P+_R5_#W_ &,(?^HV./U3C7_DEL[_ .P-_P#I
M_"'\*%%%%?UK+:7S_4_F _J5_P"#5+_DZ/\ :L_[(%X1_P#5A+7]R=?PV?\
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M_7W'_P#J;4/DC]OW_DQ+]M7_ +-(_:0_]4[XQK_*)@_U,7^XO\J_U=OV_?\
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MRKX5_P#4G-C[_P#9S_\ *2N"_P"R X^_]0<A/UKHHHK_ "N/]] IG\9^H_\
M06I],_C/U'_H+5$]OFOS1+Z>I_ +_P '0/\ RDB\ _\ 9F7PC_\ 5S?M)5_.
MI7]%?_!T#_RDB\ _]F9?"/\ ]7-^TE7\ZE?UUP/_ ,DAP[_V+*7_ *>QI_+7
M%O\ R4V>?]C&M_Z1AA&Z'Z'^5?Z1'_!OC_RB*_93_P"OW]H[_P!:O^.E?YN[
M=#]#_*O](C_@WQ_Y1%?LI_\ 7[^T=_ZU?\=*^1\8?^2:P/\ V.J/_J#C#ZKP
ML_Y'N._[%%7_ -3<&?M#7\PW_!U3_P F2?LZ?]GC^'/_ %07Q_K^GFOYAO\
M@ZI_Y,D_9T_[/'\.?^J"^/\ 7Y#P+_R5_#W_ &,(?^HV./U3C7_DEL[_ .P-
M_P#I_"'\*%%%%?UK+:7S_4_F _J5_P"#5+_DZ/\ :L_[(%X1_P#5A+7]R=?P
MV?\ !JE_R='^U9_V0+PC_P"K"6O[DZ_E_P 4/^2TS+_L%RK_ -0$?T;X;_\
M))X+_L)S'_U-D>!_M4?\FQ_M'?\ 9!_C!_ZKOQ!7^218?\>5G_UZ0?\ H)K_
M %M_VJ/^38_VCO\ L@_Q@_\ 5=^(*_R2+#_CRL_^O2#_ -!-?;^#/^Z<1_\
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M $&.OX@_V9?^3E?V<_\ LOWP2_\ 5I^$*_M\BZ?G_P"@QU_G)]-S_DJ^ /\
MLE\Z_P#6FPQ_LY^R\_Y(+Q9_[+;AK_UD,435_']_P4Q_Y/G_ &@/^PC\.O\
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M;_\ ))X+_L)S'_U-D>!_M4?\FQ_M'?\ 9!_C!_ZKOQ!7^218?\>5G_UZ0?\
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M2'_9?/C)_P"K)\55_;;/_J9?]QOY5_$E^UC_ ,G2?M(?]E\^,G_JR?%5>O\
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ME7^L_P!&?_DQW ?_ &"YQ_ZTF>'_ #V_3=_Y2?\ %7_L9Y)_ZR/#(M?U"_\
M!&3_ )-0\3?]EO\ &/\ ZBG@&OY>J_J%_P"",G_)J'B;_LM_C'_U%/ -?*_2
M]_Y,UB?^RKX5_P#4G-C[_P#9S_\ *2N"_P"R X^_]0<A/UKHHHK_ "N/]] I
MG\9^H_\ 06I],_C/U'_H+5$]OFOS1+Z>I_ +_P '0/\ RDB\ _\ 9F7PC_\
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M"9K_ .KG(3[7]I9_R8OA;_LZ>2?^LWQ4?"+?>?\ WW_]#--[CZ'^:TYOO/\
M[[_^AFF]Q]#_ #6O].G]OTG_ .WG^%\?B7]=(']A_P#P3D_Y,Q^ O_8O^(O_
M %.?%E?<+=#]#_*OA[_@G)_R9C\!?^Q?\1?^ISXLK[A;H?H?Y5_B!XB_\G#X
M^_[+?B[_ -:3.C_J3\&?^3/>%/\ V;3@+_UCN'3\/?\ @MG_ ,DO^!?_ &/_
M (F_]1D5_.EW;_>;_P!"-?T6_P#!;/\ Y)?\"_\ L?\ Q-_ZC(K^=+NW^\W_
M *$:_P!+?HF_\F2R#_L<\5_^KR!_A]^T!_Y2:XL_[)[@7_UF9!'][_@2?^CJ
M_H=_X(@_\B=^T!_V'_A[_P"F_P 75_/%'][_ ($G_HZOZ'?^"(/_ ")W[0'_
M &'_ (>_^F_Q=6OTJO\ DR7$O_8TX7_]:&F/Z 7_ "D[P7_V(N./_64JG[HO
M]T_A_,5\=_M^?\F;?M _]B'+_P"G?3:^Q'^Z?P_F*^._V_/^3-OV@?\ L0Y?
M_3OIM?YC\!_\ESP1_P!EGPI_ZTF0G^Y/BW_R:GQ._P"S<\>_^L=Q,?QJ+T'T
M'\J6D7H/H/Y4M?[B'_+"]WZO\V?:O_!.K_D];]G_ /[&?Q)_ZK?QQ7]B<?\
MK6_W?_B:_CL_X)U?\GK?L_\ _8S^)/\ U6_CBO[$X_\ 6M_N_P#Q-?YE_30_
MY.9P]_V1&#_]:#/#_<+]F9_R9?C'_LYF-_\ 65X>'S_ZF7_<;^5?Q)?M8_\
M)TG[2'_9?/C)_P"K)\55_;;/_J9?]QOY5_$E^UC_ ,G2?M(?]E\^,G_JR?%5
M>O\ 0F_Y++CK_LD\I_\ 6H9X?[4#_DW'A7_V7^>_^L2CP!>@^@_E4D/WX_\
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M_P!:O^.E?YN[=#]#_*O](C_@WQ_Y1%?LI_\ 7[^T=_ZU?\=*^1\8?^2:P/\
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MG[HO]T_A_,5\=_M^?\F;?M _]B'+_P"G?3:^Q'^Z?P_F*^._V_/^3-OV@?\
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M "N/]] IG\9^H_\ 06I],_C/U'_H+5$]OFOS1+Z>I_ +_P '0/\ RDB\ _\
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M?@?YK3AT_%OYFFOT_ _S6OZO>S^?_MQ_,BW7R_\ ;3^L_P#X-/?^2N?MP?\
M9.?@%_ZE'Q>K^UROXH_^#3W_ )*Y^W!_V3GX!?\ J4?%ZO[7*_ESQ+_Y+3-O
M^O>7?^J^B?TCX=_\DEEW_7W'_P#J;4/DC]OW_DQ+]M7_ +-(_:0_]4[XQK_*
M)@_U,7^XO\J_U=OV_?\ DQ+]M7_LTC]I#_U3OC&O\HF#_4Q?[B_RK[[P:_Y%
M_$'_ &,L#_ZKZY\-XL?[_DO_ & XW_U-H$M?8?\ P3N_Y2#?L)_]GB_LT_\
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M:TYOO/\ [[_^AFF]Q]#_ #6O].G]OTG_ .WG^%\?B7]=(']A_P#P3D_Y,Q^
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ME%;\,;@S]GZ_F&_X.J?^3(_V=/\ L\?PY_ZH/X_U_3S7\Q7_  =3P3R?L/\
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M_P#!>6*5O^"N_P"VBR12NIU?X!X9(W8<?LE_  'E5(R/3K7Y&^1/_P \)_\
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M^!_&<#@#KT'8_P"%+D>_Y'_"M$:5J>!_Q+K[_P !7'Z=J/[*U/\ Z!U]_P"
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M\(L^_P"1[GOGGN>?CGF=?Y_UN?\ 5WPE_P DEPI_V2O"W_K,\,G\['_!;?\
MY'W]GS_L3_'O_I[\+5^&X. .O0=C_A7[I?\ !;*QO9_'/[/DD%G=2I_PB7Q
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M'V 9[_D:\$\._P#!/G_@WP\7Z?\ %C5O"G[.?_!,WQ-I/P&DOH?CAJF@:?\
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MV9\3+_X!?$"__P"$S_;YM?VH?V2?AWXR\%^./"'C73+:V\-?LU_"W5_BC>_
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MR7_P2,_Z1S?LC?\ AE_"/OC/_$O]/7O^%+_PY+_X)&?](YOV1O\ PS'A#_Y
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M#?#77/!W@:^^-'QE^(?C+3#X5T2WN_AEX+TC2]1UGQM\4/AI\8^&/!FL>$/
M_P %=+^*O[%OQ\^*=G^Q=^RC^W-X(_:P^'=M^SUXK\16O[17C?XL_&CX(ZUX
M1^'?PFO=3T!/#7[0Q_:(\?\ @:[^/]QKWP[U+QCX7\-6.CQZI\8M4\&>*-0.
MA2XQFW3525HQ?UE\RC5DN2BZJ]HHQIRJ.,94E3E3M&K5=>A4I>SI3BYVU)59
M4E&I)J6%22="+OB(TY)-SJJ-I*I=3BW"DZ=2-:4I1G&E],I^P[_P;GR?!U_V
MAT^!_P#P2W;X PZVOAJ7XW*?@,?A+%XC:[CL%\/R_$3^U/\ A$H];-[-#:#2
M7U9;\W$L<7V?>Z _16G_ /!%W_@CYJ]C8ZKI?_!/3]CK4M,U.SMM0T[4M/\
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ML1AXES0A.;=U"@JBDN5J<YXBM1H)14G)1Q$:3K73D\)0_?8J?[S#8:O[X?\
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M'QY^S7\;_A!H7[3OA[XNZG^T3\;=&_8W^/WQJ\5^&OV,?B5^V%^TC\6?@/\
ML3^#4^!/PL^)6B^!/B[I'PX^+VH:;XAU#QUJ>BZ+^RYI&OW-_HNC^)_B!>:=
M;^#J4$ZB@X3C+VV%I<LG2NW5LZT8RA4G"4J-%RQ+J1]I1E&E5H4I8BLZ%2MC
M[:K[)5$V_P!W6G*T9Z>SB^63C*$9J#JI4&I^SJMUJ%5PH0=:%#[JTK_@F%_P
M0AU_XL^*?@)H?[(W_!/36/CEX)T"R\5>,_@UI7A3X2ZA\5O"7AC44T>6Q\1>
M)?A]9S2^+=#T.[B\0^'Y;?5-2TJULI8M?T.19C'J^G-<^J?\.3/^"1F?^4<W
M[(V,<?\ %E_"'/3_ *<.G(_7\?F+X4_#CXD/\>_V<OA0WP:^*'ASXA_ +_@I
M/^W_ /M7_&7XM:I\,O$6E_"?7OV?/CSI7[9K?#2[\+_'C4=.B\#_ !&UCQ]:
M?M(_LZZ#+\,_"OBC7_'7A2;X:>(+'QIX;\/Z?\*[:Z'[NQJ58Y&/EZYSD_+G
MCW]>^*5-MTZ,^6475@Y2B]''2DTW&[:7[R5-QD^95,/73O'D93G)UJL&FXTY
M*,9MIJ2?M-4XKE::A":<6TX5Z=[2NG^8!_X(E_\ !(S!S_P3G_9&_P##,>$?
M_D"O(+#_ ()G_P#!!?4_B[K/[/VF?LG_ /!.S4?COX=T./Q-K_P6LO#/PAN_
MBQHGAV:&RN8M=U?X>0SR>+=/TA[;4],N?[0N])BM5M]3TZ=I1#?V;S?M#("4
M8#.2,<$ \^[9'YU_.S\:?"U_^T[\6/CO\$_AE\&_BW^S=_PJF_\ VV-1_9P2
M3]E#]H/PQIO[0_[:GQF_9K^/'P>\:_M+^-?VF)?A*/V?_ 'P=GTOXM^/]/\
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MC __ %D]SZG&?3'\BBDDDK!83:1Z=/?C'( YZ9Z_I3Z**$K; (1P0.#S^O\
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M)[GW[?D.OZ=J**$DA6%QZ=NW0?RI:**=AA3-I]>.<CGH<Y_'D<_4XHHI-)@
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'6BBBF!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>forms-4_010.jpg
<TEXT>
begin 644 forms-4_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %9 CH# 2(  A$! Q$!_\0
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M !'LM%U/Q1:ZC=> H? _A[7?&,WC"WMI/#T7AG2=0UR34%TVVDN%_%7XS_\
M!&']JWXU^,O&_P"TYKO[1_PE\)_M3W_Q^^#7Q&\-^'?@A'^TC^S=\$]2^'WP
M3_9X^*G[,^DZ=?>-/A)\8M/_ &@?AW\2O%_A'XMZMXEUCQ=X2\7^(8-#TGP_
MHWP.DA\6^"+N^\2I[3X"_P""-5[X#^$'[4WP6;6?V??&_@SXV?L,?L2_LE>#
M?#?Q"\!?&;Q'\.]/U3]E4_'"]\07WB3PU%\<M-^+6G^"/$6K_%#1;GX?Q>'_
M -HF[\>?#R30K#4X?%E_?^&=)74.FJW%R]G%NSF[7C-VC0DX14HNG&4ZE5P:
M<8^SI1Y\/4YJT57ES4FI.'/+EA)0YI*$X.,I5J*J?NY.7N4J=2IRRE.+K>R]
MNHTJ=2-&/Z>7W[>7[$&E_!K1_P!HS4OVP_V7[#X >(?$4_@_0/C9>?'CX86W
MPIUSQ;;27\5SX5T?Q]+XG3PQJ?B2W?2]4^TZ'9:G/J<*Z=J#RVJI9W)CU/%O
M[;7[&W@'QUX/^%_CG]K#]F_P=\2OB#'X(G\!_#_Q1\;OAOH7C/QO!\2[B[L_
MAU<>$O#6I>)+76/$5MXZN["[M?"-QI%E>0>(;F!X=*DNI2JM^/G@7_@E?^W)
M\-=/^"GQJT;]HC]GOQ]^U3\"OB_^U3XR\#>%?C9X8^,'Q/\ @S:_#C]J?X7_
M  N^%NN>#_%GQIUWQ9/^TQ\5_B+X,_X5>/%^A_''XFZAKWCC4?#OC;Q-\"=2
M=? MAX>\06&5!_P0U\8>%_V>?BC^SYX9^-7@SQ19^(/V2?\ @EW^S7X.\<^.
M/#.LVFKOJ'["7[0OQ'^-OQ&\0ZYHEC-KB^'O#_Q#C\7Z19> _#FB^(=>E\*M
MI%EIVHZA=0Z#8:K>.G;ZQ2A44E0EBJ%&I.'+[2EAZOU2-:M[TI4ZD:"K5ZSG
M%\LUAY82-!UD\3,JN4::=*U2K[*3:;<8JKSXE1CRVC4:4:=!./NN3K.I&I&F
ME3/U(^-/_!2C]C7X*^#OVH=?;XX_#KXJ^,_V/?AEXW^+/QT^!'P9^(GPT\;_
M !]\*^&/A[# WB:*]^&DGC72+_1]2LKRZL-(E3Q3=^'=/L]9U&PT_5-2T^:Y
MC#='^U!^WO\ LV_L<>+?V?/#?[1OC6P^%NA_M&>(_'_ACPW\4?&FN^"_!GPH
M\%7_ ,/?AOJ_Q+U&7XE^-?&OBSPW:>&[77--TD^'_"QL+?7;K5_%VHZ5HQM+
M5+L7B?B-\2?^"'7[5WQ)\:_M7^)O$O[2OPM\6CXV? ?_ (*4? GX>:GXCG^/
M4FN:#HW[;?Q"\)_$[X?W&N>'-6\:>+?A#X$T/X9ZAI>K>$-3\'_ 7X9_#BRU
M>(W'Q(\0ZGX]\5^*;C2/"_[0_M!_LH^(_C-^T]^P'\==/\2>'-.T+]C_ .('
MQS\:>*-!U:QOKK5?%*?%/]G7QI\&-%B\,S0J]G8WNC:SXIM]:O9]1>,-IMO<
MPVK-<N@/)">*7+.=*+BZ&%J.BK)JK]6S6IBJ/M.?G4O;TLLI0<HOV=2I4CSU
MJ-1U*>M10C.I&#E*,(8]0G=)U9TY9>L$].:,8U.?'RLE>=.--U8T:T'&?K]E
M^UK^RQJ>@:QXHTW]I'X%:CX:\/W7PFL=<\06'Q7\#7NBZ3>?'JQ\-:E\#K;4
M-3MM<ELK:?XQZ=XR\(WOPMCEF5_'UKXGT"?PJ-3BU:Q,WD7CW_@H]^Q7X-TK
MXZ+HW[1_P-^)_P 0?V>/!?Q=\:_$GX*?#?XY_ Z]^+NE6OP+TQM5^)VD7GAW
MQ3\2O"6E>&-6\) P6/B&?Q]X@\'^'_#.H7,<7BK7=!@2YN;?\,OV?/\ @F5\
M5OAQ^V1_P3?^ %^OC36_A9^R-^RK\&/$_P"VUX_M?A7XE\-?L[?&3XQ_L>ZK
M\0KG]@?3_AK\2O%&FV">-?&7@SQI^T'\3?'GBWP[HAOXO#6G_"WX;R^*TL]8
ML/!T6D_(WP-_8%_:I^-TMQ^Q9IO@#XA_#CX:_ 7]A_\ X+!?LA^%?BE^T!^R
M7\1/V?[O2KO]K_QYX"B^%6M^/OBI_P )K\1/A/\ M(:KXKU^U\:>(A?_ +,=
M[XG\,Z+X+\.'XD>)?$+>+OBY%X"\)=-;F;DL,_:QG/'*AS+DE['"5,10C6J.
MI&$(^UK4(.E"48*M1G.=-Q<:/MLX22A>M&<9P>#A65X\D)XE4ZDHQ<74J5%&
ME42E*GI2JN$9RG'VRH_UO2?M<_LM6OQ!\6_"'4/VCO@9IGQ>^'W@"?XI_$/X
M37_Q:^'T/Q)\ ?#FUT+3O$M[XW\:>"U\12:[X<\*:?X?U?2M<O\ Q#J5G#HM
MOH^J:=JSWYTZ_L[N?BO#7_!0;]@OQGX!^)'Q5\'_ +:_[)OBSX7_  <'AIOB
MU\1O#?[1'PDUWP-\,QXPO)-.\(_\)]XKTSQ==:%X3_X2K4H9],\-_P!NWUA_
M;NJ07&FZ6+N^@F@C_'6Z_P""&GQ%C_:D_:)^,-E\;O"VK> /BQXA_;$^-'@;
M3_%OB7]IZ_\ $?@?XW_M=_LWZ]^SYJ^FV7PVTOXW:7^S3IWA[PE;>*-=O3\6
M)_A%XI^)WBKP!<:5\+;[2-,;PYI7CE(OC)_P0V^)_P 2?!OPITS1?C;X2\)>
M)/@1^S1_P2R^'_@)_#6I_%GX>V.O_%K_ ()W>(/VD=0UI=7\6?"O6_!GQ)^'
M_@7Q]I'QUL[;P5XT^'/B>U^(WPZ\2>'=.\46>GW+Z%::9JM3T47!7YJCBTKO
MV$/:5VZDD_>K1ITZ<::A"4:E:56E7C*-.<J$+BHV@I2FW:/.^6$.:V&P\VHW
MDU3=3$U*D4YMQH0ISA44Y4_:U/WEU;]I#]GK0/@WI_[1>N_';X/:-^S_ *KI
MOAG6=-^.6J_$KP;I_P (+_1O&FJ:;HOA#5K/XD7>LQ>#I]+\4:OK&DZ7H6H1
MZRUIJE_J5A:64TT]S C^-WG_  4:_P""?NG^!_!WQ/OOVX?V1[/X;_$/7=?\
M+^ ?'MU^T7\)(/!WC;Q/X4;3D\3^&_"7B23Q8ND>(?$'A]M9TE=9T72KN[U/
M3_[4TW[5:Q?;;;S?RI_:E_8#^*'P>_X(B/\ L8^ -(MOBS\5F^,'P*\3ZU#\
M/_ WQA^+V@W?B/QU^W]\//C;\3O$1\&?%/XJ?$[XK_$'PAX7&O\ B7Q-X^E\
M7_$V.X\8Z3I'BCQ)J=SX#T[69M,\.^H?!3_@E[\?]%_;'^%'[:OQO^*7P/U?
MQ[8?M0?M/_M'_%+P)\*O!OCC0/ 6D3?&#]COX4_L?_#_ $3X6MXMUO7M2N_$
M%EH7PGMO&OQ+\;^(!H=WXAU/Q5?Z+IVEBTT:TO=14&YXB<&E&A#$T:4Z[G;W
M'@:.,FJ4'"4JLIU7B,)"LHPP]&4:%:LJKJ5,+3RDVJ4&G^]G3Q%2-*SN^7%5
M<-0<I+W*=X*CB*M-U)5)*5:C1Y72AB*OZE:3^US^RGXA\5?%[P)H/[3'P!UC
MQM^S[I6L:Y\=O"6F?&'X?WOB/X,:)H E_P"$@U?XJ:-;^()+_P  Z7X>-M<+
MKVH>*K?3+31G@ECU.6V='4>#? K_ (*??L4_M'_%/XB?"WX0_'+X?^+CX&\5
M?"CP'H'Q#T;XA?#/7?A9\9?'GQ=\"^-_B+HG@7X(^+O#/CC7!X_\9^'_  Y\
M./&DGC+PS#8:?K&BS^'M7\NSO[;3-1N[7\EIO^"#'Q<\6_#+4/V;O'W[3?P_
MTSX%?!O]GS]NKX'?LJ>)_ ?PP\21_&77KK]O+Q7I7C?Q9XL_:D?6O&K^%?%-
MO\,]5T+3[&X\.^!SIW_"\[Z^O/'GB?6O .N6%CI+]O<?\$K_ -O36_C-XG_;
M"UWXR?L;67[4%_\ M4?LE?M,:1X6\._#;XPVWP'N_P#AG_\ 9G^-G[*7BOPA
MXBN)_%G_  L)[[6O WQ<M?%_AOQE%<7DD>L^&+3P;J/AZWT#[+K%FL,YSG3]
MNHT:;I4G.S;DJE65.,FDXR_A*53FHMN4>1U:E:I1E2C&JUXTJWL4IUE*M[#F
M;5-QI/FIQFU9MXBG&3=5)0ISG2H0INM[6I']C]2_;A_8OT?3OA9J^K_M:_LV
M:5I?QQ\4Z_X'^"^H:C\;OAM86GQ:\9>$_%<?@3Q3X6^&]Q=>)(XO&NO>&?&\
ML/A#Q!I/ALZC>Z+XGF@T+48;;4YH[9_GOP)_P5\_X)O^.-"^+/BB?]L'X!?#
MWPO\'?C[XD_9O\3>(OBO\7_AC\/-)U/XC>&[6YNY#X9N?$/C"V;5?#FO)I7B
M0^#]<DCLHO&%IX3\2ZUX?@O_  _81ZO<_E]\.?\ @BE^U?\ !KP=\)[?P-\<
M?V0/&7CRX^"WQ?\ V9OC_)\=_P!G'Q!\5?A'/\-?B5^WEX]_;1TSXD?"[X5Z
MKXMC@U+QIHD_CNZT#4OAE\1-=N?"6M:CIOAC41XXLKGPG:ZGJ>W\:_\ @CK^
MU3XNC^,R> /B9^S$NK:Q^V;^UI^TY\"OB/XB7]J7P#\9/AOH'[8WAV"W\=>&
M8/'_ ,%_BSX5T^PA\,ZW9VVE>)O /B/PC\6?A/\ M$>!A!H_CKPSX,ETXC4E
M2=3V:=;EE5=*%X4=(+$7RYU5"=:2<J,?:XQ4:TW2C7C!-TZ%2A-UNB<*/-45
M*L_9JM:E*JK5947]=Y)SI13496IX5U81E4E3<FZ?M85X1I?NK\7/VA? WP>N
M?@7:Z^DVJK^T!\9?#'P2\$7FE>(_AQI=FOB3Q;X4\7^,=*U25O''COP=-XCT
MIM(\%ZF1I'PY@\<^/KWSH+_2/!6IZ+9Z[JFCXWP2_;*_9%_:7UC6_#O[.?[4
M?[/7Q[\0>&-&TWQ!XDT+X-_&;X=_$S5] T+6&1-+U;6M,\&^(M8O-+TZ_D=(
M;>\O8((&EECBW"25$;YO^+?[$_Q(^)'@;_@F[X6NOBIX4UKQ%^Q1^T)\"?C-
M\2?&=QX!M/ 5E\6(?A1\#?B9\*?$4OA/X?\ @MY_#/P[O_%FN>.K;Q'I?A?3
MY9/"_A;38+G0K"9H+>R+?-G[ G_!*[QU^QYXM_8B\1:WX]^&VN6W[+W_  3X
M^*/['WB^W\(Z#J^FW'B_QO\ $/XZ?#KXPGQOHTUU;6T<>@AO".NC58M45=7O
M->UV34_++7-[(_5&%)1J<U5N4<=BZ-/EB[3PL*<GA,2W)*T:DZ7+*/+"H_K,
M&X4U1<7PJ59TY3]GRU(X6A55)M6EB)5J5.MAE*,I)2C2K3JQE=T^7"S3E*=6
M-O1]<_X+.?LM:-^UA9_LMV_P[_:I\2Z0_P <]#_9:U[]K3PE^S]XD\0_L9^#
M?VH_$.LP>&=,_9V\6?&RQO6FM/B6/%6J>'/"VJIIWA35/"7AW6_$NF6OB'Q5
MI45CXCN-"[_X=?\ !6O]BWXJ_"?XZ?$7P=\3?#]UXR_9X\(_M,^._B5^SEJ?
MQ$^"&@_M&:/X/_96\=>-_A]X^\4:CX#UGXLV.C^$_"VNZUX(DO/"'BWXA>*_
M!GA1M!\3^$-9\8:YX/M-7E-EX-X#_8._X* ? CXZZYX8_9X_;.^$/@/]A+QW
M^U]XB_;&\9^%=:^ 4_BC]J33)/B5\0;KXG?&K]F#PKXYU#Q7+\,9_@S\2O%]
MQK6I6WQ$U7P5#\7?!=GXXU/1-*O;^R\*:3+KGR_XV_X(C_&#Q'\%_#'PWTOX
MO_"JQUK1OA'_ ,%R/A_J.HOI'BF&PU;5_P#@JKKVKZM\,-3DE@L9;TVOPPM;
MO3++QY)<Q7%U?)I\2^'XKY+>VV\]'FE"BJW[N4L!SU)QM-QS'V=&I*FZ;?(J
M$,1'%86BXRE/$8=8;%R5&I.I$VKOEC)T(.I)8QQC%S]QX)1J*G)2<(356K%T
M:E6\;8>NJM"*JT8J;_:;2?VV/V1-4^*.@_ 9?VF?@%9?'[Q&]G:Z=\!+SXR_
M#)OC*^IW?@W2?B FB#X>6/BJ]\076JQ^#-:TOQ*]OIUK>Q3:'>0:M97%UIDT
M5X_4_!3]J?\ 9E_:0N_&FG_L\_M#_!#XZWWPUU"RTKXAV7P?^*O@?XD7?@;4
MM3FU6#3+/Q=;^#]<UB7P]/J4NAZY%IJ:JEK_ &A+HVJI:&9M.NQ#^4GBC_@D
MY\2]=\8W_BVS^)GPWTG4+K_@IY^R+^W5!JR^'M5OM8@\"_LV?LC_  O_ &>K
MSP:'NK!H7\77'BGP;XB\4>%Q=M>>&[72M:\F_>.YU#4[5?)?V+_^";O[=W[!
MGB37OBO;?%+X._M!?%'QU\/_ -AG]F;6K[5;S]H'Q#*_PP^$'[3'B(_&7XCZ
MK-\6_BQXC30=3O\ ]G?XE^*/$WA/P=\,[WP-\)_A7XE\+:%X!\$?"#Q%I=N^
ML>*.AQHNJX0G)1?UA1G)+D<U5A#")--R4)QFU6G42E"$'B$FH5*3YX3Q/L(R
MG17MDZ"=/GA?E49?69O5+F:@ZF'A3;3E)8>JTY4ZI^D'[9'_  4E^#W[$OB?
M2=$^)?PQ_:(\9:%:^"(?BK\6?B3\*?AE:>(_AG^SS\'YO'VA?#@?$[XN^*]?
M\3^%%ETJ/Q!JUU<OX.^%=G\3_BR/#OASQ+XE3X=2:+I\5Y><SX=_X*P_LH:W
M\</BE\'-7G\?> -"^&%I^T7+_P -!_$/0-$\._L\^.[S]C^/PZ_[5VF>"/&_
M_"4WFO>=^SZWB2U3QSJOC'P=X.\-:D-,\2W/@/7O&5CX9URYL?*_^"D?[&7[
M9G[7OQ<_9\C^'/C3]G+4?V2O@]J6D_$[QY^S;\;KOXNZ9H7QY^.7AOQ,^L^
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M_AX/A3\;_"/]@>*-;\+A?&_@(:SKXT%M:&B?\)%H &K7?]I>%]6T75OW!O\
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M^TRPNM>U.STB6PT6TO=1L+6ZU.YM;>>]M8I&G3\;OC5\)?AMHWP"UO\ ;O\
M^"Z_Q1?Q!X"T2#P5XCO/V18KWQC?_L,?LW2>*]>T/0_ O@+7/A#X T[4;G]K
M+XD6WBCQ+IGAWQ?\6OCUI/Q!\+W?B"]N]0^'GP_^%7@N 6==7^V-_P %J?\
M@DY::%\0?V5=8^(=]^W/XP^+/@GQG\-/$G[+'[%OA+Q#^TSX_P#B/X<\5Z1J
M_A#QGX!BO/AA<Q^"]+U;4=-NM2T/4=*U?XC^%]:L#=JS-9,T=PG@_P"P7^VA
M_P %'?A;\#[C0?VNO^":G[;7C;]FSP?+_P (O\%_CS)-\(?$W[;FH?!3[#I=
MIX.3]I_]DOPE\0U^)?B'X@^$=$:ZTCQC\1OA/9:GX]\>W5C8ZG/\!M,\13:[
MK%_CB%6E1J1P\HPK.G-4Y3^&,W"7(W>,TK3Y7S.$XQTE*G5C&5*K4'!3@ZD7
M*FI+GC%V;A?WDGO>W9IM7BI0E*,X?/OQ#_X+[_ ?X7_L1?LZ_''_ ()L_!CX
M'6OPG\5Z?\>9/B5X0U7PA\1_!_ASX*_$G]G_ /9[\!?'K7OV9K'X<_!+X8K?
M7/COQ5HOCK2=$N?CQ:VD7[.'PH&B76I>-_%M]#J>BVC?LW^W'^U?^TK\#/V/
M=*_:+^ WP9^'FL:W!X4A^(_Q5E^+'BWQ#K?@WX+> -,^&NL?$'6Y[G1_@?I/
MB_Q[\7_$.L>(-.T;X2>&;'X6V%]80:UXOM_B-JM^W@CPSJ4&H?F[\8?$7_!$
M;]JKP=\#O@RO[=L_[#^M_LY?"OQW^S?X$\%W/Q=7]C7XWV'[/7Q9\$:#\/OB
M-\ O$GP[_;(\&VWC+5/ /B_PQX(\)V2ZLW@^/QIH6J>$=)UKP!X]\/:S;2ZA
M/]#>-?A)_P $Y_%/@:72O!O_  4^\0?!?P]X>\4> ]<^"VM?!_\ ;I^$.EV'
M[-F@>!OV>] _9I?X7_!"T\5Q^,O!FC?#'QE\.=#OM1\7^&/&FA>.9;KXA^*_
M$OQ+T/4O#_C-]&U?1*JJ4L+B847['%/$5:N%JS<JL%#DA"A"I:-O8JHXU9TE
M3E-*E5I2E5]K3J8K.BW"OA95H>WH1HQIXN$9^SG*;J<TY0:A%N?LU.$)P<4E
M4IR4%.G*-'B/'_\ P4)^-OQ)\)6LOCS]@[P9XW^!WQJ_9=^$'B_X2^%?&S?\
M+*^'/Q$_:+_:'\/_ +/%C\"OAK>?&]='U7X$>-?#7C?XX?'?Q5\%==T#PSI=
M_P",? 7A3X$^*?VD]8FO_ACX]\-Z5I'/?MJ?\$%OA#\8/@=>>'?V8]9\5?LY
M:W9[?&?BK]DKX3?%[XW_  ?_ .">O[2_B>TL8KS7?AS\1/V>_AW\0] T/X5>
M'?B+<VMSX=A^(WPECT+Q)X)&LIXMUW0OB=+I#^&]5H?''Q__ ,$6W^#GP4_9
M/T+]NWP'!\-_@+\#OBS\ OA)\!OV4/B;#^T3\8=(U3XH_ S4_P!G72OB=I7A
M'X,67QA^+^N_$WX9_";QA\3M+\):O<>&]5M4UOXEZ[XL\20ZEK5GHUW8]9^S
M3X4_:W\3_L^:+^R=^QO\+/B=^Q[^SW=ZW\7M1\9?MI?M0^ = ^"7Q<T?3/BY
MX]^('Q#\1:/^Q)^PCX;<:W\-QINM>-/[#^%>L?M#)\&?#WP4\.6VG:GI_P *
MOC;=:,-,U/HJRIRG4]C#V5-5Z[HIJ3G.@\3B9454<YR4:BHXB-/W;VI8+"*I
M)XB>(;RIQJQA0]I/FJ>QI1Q"33IJHJ%/GG!M*I)2J4E%IV7M*]>I%*G&*E]<
M_P#!*CX$?L Z!^RM\$?C[^Q1^R+\,?V;=*^+?PXTK7+B&P\&Z*_Q<TFZNGN(
M?$O@?Q_\4;J/4O&_C35/"/B6'6?#-Y?:SXHUBVFETQVT^7^SC;(/U(KRSX'_
M  8^'?[.GP=^&7P'^$F@KX9^&?PA\$>'/A]X'T/[5<W\UCX<\+Z9;Z5IRWNI
M7LDU_JVJ3PVXNM6UC49[C4M8U.>[U/4;BXO;N>9_4ZS-RIJ&H6.DV%[JFJ7M
MIINF:;:7%_J.HZA<PV=AI]A9PO<7E[>WER\=O:VEI;QR3W-S/)'#!#&\LKHB
MLP\"D_:\_9.A^%MK\<9?VGOV>8_@K?:]_P (K9?%]_C1\-U^%UYXGW3J?#MK
MX_/B0>%+C7 ;6YSI46K/? 6\[& +#(5Y?]O#P#XZ^*W[%'[67PM^&GA+1_'W
MCGXE_L[_ !?^'WA_P1KMR+33O%UQXT\"ZWX;N?#9GDUOPS;)?:U8:G=Z?I*W
M_B?PQI<NK7%E%JWB7P]IKW6L67X9S?LW?M 7/BS4OB/>:1^VV?A)J?[6'B[X
MM_\ #1MK\.?A1)_P47NO$&M?\$Y/!O[)D6J7GPJN? X^&5K\-;AM'U'X11^)
MF^ (\8)JFA^%_%%QX8M/!4FI_M!:J ?TMS^+O"EKJ_ASP_<^)_#UOKWC"TU3
M4/"6B3ZUIL6K^*+#0X+*ZUJ^\.Z:]RMYK=GH]MJ6G7&J76FPW,&GP:A92W;P
MI=V[2<?XG^.'P6\$^/\ P;\*/&?Q>^%_A+XH_$57?X??#?Q-X^\*:#X]\=+$
MUPDC>#_!^J:M:^(/$P1[2[1CHNGWH#VMRIY@E"?D7^SQ^QQXX^''QJ_X))_%
M3Q'\!='\%?$KX5_L&^._V??VAM7\':E?>(?#'PKB\+_"[X&Z1\-_A'I^IZMX
MF\2C3/#MEKUEXW33]/\ #VIZQINI:[:ZMJ5[K_B29;77[P^/^M7WQZ_:4^&/
M@6Y_9'_:%^%_P;\>W_[&_P ;?CM\;K/]GSQ#XE^)/Q7\8_!7XOO\5?V?/V=M
M4UGP_#K&A_!WPA\#?B/I>A?$;XV_$CQ)K&IWVE:%J^M_#OX;Z+INK^*O%7Q8
M^'P!^XM%%% "-T/T/\J_C_\ ^#LZQLKWPA^PL+VSM;L1^+?C_L%U;PW 3=HW
MPIW;!*CA=VU=V,9VKG.!C^P!NA^A_E7\A/\ P=B_\BC^PS_V-OQ^_P#3-\*Z
M^R\/?^2SR/\ Z^XO_P!5V//C^//^24S?_KSA_P#U.P1_%NN@:%@?\272>@_Y
MAUGZ?]<:7^P-"_Z ND_^"ZS_ /C-:J]!]!_*EK^L'*5W[TMW]J7=_P!X_F=[
MOU?YLT? FA:(OC_P&RZ-I2L/'/A$AAIUH"#_ ,)#I?((AR#]*_V%AU;Z_P!!
M7^/]X%_Y'WP)_P!CQX1_]2'2Z_V 1U;Z_P!!7X3XSMO$<-W;?^SYINV_^7V"
M[MG[1X3?PL\_Z_9=_P"F<8+1117XF?L 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 445ROC;QUX(^&GA?5_&_Q&\8^%? '@OP]:O?
M:_XO\;>(=(\*^%]#L4X>\UC7]=O+#2=-M4) :XO;N")21EQ0!U5%?A1\2O\
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M*UZ,G)Q='PB9^H!_UG49K\1?^">?Q$_:C^*.A^-?!L_[5'B71_$WQZ_X)\_
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MQ_K=_LO_ !(\1?&/]FK]GGXN>+H=)M_%7Q4^!GPD^)'B:#0;6ZL=#@\0^./
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M?M'A-_"SS_K]EW_IG&"T445^*'[ %%%% !1110 4444 %%%% !1110 4444
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MXC6?ABT^(-SXHM_$6A2^&I/ 5WXDMM=;5K.#39KBYD:%/OJOQ>_9!_X(#_\
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MMK_LBVJ?^GG2:_3NOS$_X+-_\HMOVVO^R+:I_P"GG2:SR+_D>Y'_ -CC*_\
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M?&#]H/Q_HUA<265SX@TSP!X8BD'A;P-;7\,VGZC\5/B9JW@3X2Z'?126NO\
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M_$K]HO\ :A_;4^!OQ;\8Z=H6N^#OB#H/Q:^!O[<VM_LX0P>&_A]IGP=?X\?
M_P %:]XJ_9U_9Y\(^/V\;/XXN_COJ/AOX<?$GQY^T'??'&#P9\#I;'3K_0OA
MEXET?5_ VNZ;JWIOPM_:N^)/PA_9\_;PU7XW:W\5?B=\?/V)_A]KOQ=\8>#?
MBMH/P'\(2:GX:3X$W?Q4\"?\(;KO[.]D_@V\\'^.9O#/B;2YI]<CE\;>%?&.
ME>+]%O+;4_"VF^#_ !/XI /UHHK\S/V _CS\;_B+XO\ BS\-?C[XQOM?\8>&
M_A;^SC\:M+TCQ;\']$^#OC6UT'XZ1?%G2;CQ-H.B^#O%WC?PXWP%\3>)?A%K
MMM\']#\;ZW!^TKX(U'0?B%X;^/>D*(?A_P"(?$WZ9T %%%(>GXK_ #%)NWWI
M?>[ S\<_BC\7_P#@C]JGQYUKQU\0OVU/@#X?\<:+\2/ ?B7XE_"Q_P!KGP_X
M6^'_ (F^-O[.>N62?#/QM\5_A)#XVL_#^M_%+X0^(/"7AJ+3M7UC3(]3^W_#
M?X9P>*8]:?X1_#5/"/S/KFB?\$(=?^'NJ?#2\_;W^$Q\/W\GP4TZQN9OV]M-
MU;6?#OP\_9Q\7:GX^^!OP8T'4/$/CS6?(^#OPZ\:ZM<^)M/\#7\.HV>NZK;Z
M/)XQG\20^'M ATS^'[]KO_D[O]K3KS^U-^T9GD_]%F\<?X#\J^?,#W_,_P"-
M?O>&\(<JKX;#5WG6:1E7P^'KRC'#9=RQE6P^'K2C&^K495G%-ZM13>K9^(XC
MQ3S2E7KTHY5ESC2KUZ46ZV.NXTJU:DF[65Y*DFTM$VTM$C_2 U/]H/\ X))>
M)OA_!\-O'G_!33X=?$;08/#.I^'TN_&7[>FC7FOKJLOQ(\-?%CPK\2(-;TSQ
MQI-[8?%WX5^-_!_AS5O@_P#%+36LO&GPS.EP+X5U?3VWR-]E?L3>/OV*]<\.
M^._"'[(?[0'PY^/M[I_B=_B+\9?$WAGXR:+\:/'NK^-/B1+>Q0^,OBAXEL-9
MU;49-2U^W\*3:%X<%Z++2],\,^#].\(>$]/TOPQX4TO1]-_RM"!@]>A[G_&O
MZ[O^#37_ )&_]OX]_P#A&_V5/TU;]I.O%XI\-,NX?R''YO0S7,,35P:P[C0K
MT,%"E/V^*H8=\TJ/[Q<L:KDN7>45?2YZO#GB'C\ZSG!997R[!4:>*=92JT:N
M+E4@Z6'K5URQJWA*[I<KO;1W6J1_9Y1117X^?K)YA\:O^2/?%G_LFGCW_P!1
M35*_R%-(_P"07IG_ &#[7_T1%7^O7\:O^2/?%G_LFGCW_P!135*_R%-(_P"0
M7IG_ &#[7_T1%7[IX,_P.(O^O^6_^FL<?B?BQ_O.1?\ 7G,O_3N$-*D/5?K_
M $-+2'JOU_H:_;5N?D3V?^&7_I,C^\#_ (-6/^3"OC__ -GN^.?_ %G/]F"O
MZ::_F6_X-6/^3"OC_P#]GN^.?_6<_P!F"OZ::_D?C?\ Y+#B3_L:5?\ TQ@3
M^I.#O^27R/\ [%]/_P!/8T*_,3_@LW_RBV_;:_[(MJG_ *>=)K].Z_,3_@LW
M_P HMOVVO^R+:I_Z>=)KRLB_Y'N1_P#8XRO_ -6&!/0SW_D2YO\ ]BK,_P#U
M Q9_F(+T_+_T%:=35Z?E_P"@K3J_LS^OS/Y->[&MT;_=_P#9TK_26_X-^_\
ME$=^R9_UT_: _P#6H/C17^;2W1O]W_V=*_TEO^#?O_E$=^R9_P!=/V@/_6H/
MC17Y3XP?\DYEW_8[H_\ J#CC]+\+/^1_C/\ L45?_4W"'[*4445_.I^^'\\O
M_!S7_P HTX/^SC/A!_Z1^+Z_S\!T_%OYFO\ 0/\ ^#FO_E&G!_V<9\(/_2/Q
M?7^?@.GXM_,U_2?A+_R2;_[&^9?^Z)_//B;_ ,E*O^Q7E_YXP6H)_P#5R?[A
M_P#07J>H)_\ 5R?[A_\ 07K]/C\4?5?FC\\E\,O1_DS_ %?OV"O^3&OV,?\
MLT[]G/\ ]5!X0KZQKY._8*_Y,:_8Q_[-._9S_P#50>$*^L:_B7&?[[C?^P[&
M_P#J9BS^O\#_ +E@O^P/"?\ J)A!&Z'Z'^5?R$_\'8O_ "*/[#/_ &-OQ^_]
M,WPKK^O9NA^A_E7\A/\ P=B_\BC^PS_V-OQ^_P#3-\*Z^J\/?^2SR/\ Z^XO
M_P!5V//F>//^24S?_KSA_P#U/P1_&:O0?0?RI:1>@^@_E2U_5[W?J_S9_,[W
M?J_S9TW@7_D?? G_ &/'A'_U(=+K_8!'5OK_ $%?X_W@7_D?? G_ &/'A'_U
M(=+K_8!'5OK_ $%?A/C/_O'#?_8/FG_I[!'[1X3?PL\_Z_9=_P"F<8+1117X
MH?L 4444 %%%% !1110 4444 %%%% !1110 45!=75M8VUQ>WMQ!9V5G!-=7
M=W=31V]M:VUO&TL]Q<3RLD4$$$2/+--*ZQQQJSNRJI(_)S]H?_@NE_P2C_9H
MOXO#_C?]LWX6>,O'%W>KI.G_  Y^!%QJG[0_CR]UV22&*VT"30/@KIWCA]$U
M>\FN(8;2V\33Z&L\LBQK+NXH _6JC/Z\5_/Y;_\ !7;]N[]HA2G[!W_!%;]K
M7Q3HUQ)<6<?Q2_;C\7> /V'_  79AHKU;'Q/I'ACQ1=>-?&/Q"\./<6T,GV;
M0QHNI3VLZK*^FW;+#4TW[+W_  7Y_::D<_'S_@H?^R[^PAX,NE$5U\/_ -@O
MX":K\7O&FJ:3=%6EL;_XR_M&W.F:IX*\3VT,CPG7_ ^CWUE#<0*]E;3)(+D
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M/+*SLFTE)6::6J?PO\!M#_9ZL_@W\"_"/A']H?X5_';XO?L/_"W_ (+I?\%
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MW"E&I"E2<YNI[*C#VDJE2=24O/\ _@DEI_A]_#W[77C/X#^'=1\%_L(?$O\
M:FU/QS^PUX5NM+O?#OAJ3X<ZK\*OABOQ>^('P7\(W;HO@K]GGXL?M'P_%KX@
M_"?0[#3M!T76X];\0_$KPMH=IX.^(/AR>[_72B@_Y_K^5!9^>O[<O[77BO\
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MG_AE_P"DR/[P/^#5C_DPKX__ /9[OCG_ -9S_9@K^FFOYEO^#5C_ ),*^/\
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M_4ATNO\ 8!'5OK_05_C_ '@7_D?? G_8\>$?_4ATNO\ 8!'5OK_05^$^,_\
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M:<\,VBR+MMM2?7H_"_[.6M*\+'%SICVMS-*K9CTP!&< _?FOS-_:<_X+)_\
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M_L0_"/:7C1B ?CO^U,2 65B![#C-?SB?8;3_ )];?_OU'_\ &Z_I _X.CO\
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M:_OG_P"#HG_E'?\ #K_L[7X:?^JP^--?P,CI^+?S-?TKX3?\DC'_ +&N9?\
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MZM]?Z"O\BGX$?\EY^!7_ &6WX2?^K"\-5_KK#JWU_H*_!O&7_>^'?^P3,O\
MU+PQ^T^$W^[YY_V$X#_U'Q0M%%%?BSV?H_R/U\_@+_X.CO\ E(_\,/\ LR'X
M1_\ J]?VIJ_G+K^C3_@Z._Y2/_##_LR'X1_^KU_:FK^<NOZWX&_Y(_AW_L6T
M_P#U(QY_+?&/_)4Y[_V,)?\ J-@0K]+_ /@C-_RE/_8E_P"RKZO_ .JV\?5^
M:%?I?_P1F_Y2G_L2_P#95]7_ /5;>/J]3B#_ )$&>?\ 8FS3_P!0,4>=DG_(
MZR?_ +&V6_\ J;AC_3X'3\6_F:6D'3\6_F:6OXT6R/ZT6R$;H?H?Y5_F<?\
M!=/_ )2V_MI?]C1\'O\ UFKX(5_ICMT/T/\ *O\ ,X_X+I_\I;?VTO\ L:/@
M]_ZS5\$*_5?"'_DI,=_V)JW_ *FX$_,?%7_D28#_ +&U+_U$QA^3]%%%?T8?
M@Q_0=_P;(_\ *3'5/^S5?C#_ .IQ\%J_T&5Z#Z#^5?Y\W_!LC_RDQU3_ +-5
M^,/_ *G'P6K_ $&5Z#Z#^5?S1XL?\E?+_L4Y;_Z1BC^A?#+_ ))E?]C+,/\
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M1_R"],_[!]K_ .B(J_UZ_C5_R1[XL_\ 9-/'O_J*:I7^0II'_(+TS_L'VO\
MZ(BK]T\&?X'$7_7_ "W_ --8X_$_%C_><B_Z\YE_Z=PAI4AZK]?Z&EI#U7Z_
MT-?MJW/R)[/_  R_])D?W@?\&K'_ "85\?\ _L]WQS_ZSG^S!7]--?S+?\&K
M'_)A7Q__ .SW?'/_ *SG^S!7]--?R/QO_P EAQ)_V-*O_IC G]2<'?\ )+Y'
M_P!B^G_Z>QH5^8G_  6;_P"46W[;7_9%M4_]/.DU^G=?F)_P6;_Y1;?MM?\
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MG\WG_!T3_P H[_AU_P!G:_#3_P!5A\::_@9'3\6_F:_OF_X.B?\ E'?\.O\
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M *EXH1NA^A_E7]=O_!IK_P C=^W]_P!BW^RK_P"G;]I.OY$FZ'Z'^5?UV_\
M!IK_ ,C=^W]_V+?[*O\ Z=OVDZ^3\1_^2*SO_#@/_5EA#Z7@/_DJ\H_QXO\
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M!T_%OYFO] __ (.:_P#E&G!_V<9\(/\ TC\7U_GX#I^+?S-?TGX2_P#))O\
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M>[&/T_ _S6O],'_@A9_RBA_8[_[%'Q[_ .KA^(=?YGS]/P/\UK_3!_X(6?\
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M)^+'^\Y%_P!><R_].X0TJ0]5^O\ 0TM(>J_7^AK]M6Y^1/9_X9?^DR/[P/\
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M[_@V1_Y28ZI_V:K\8?\ U./@M7^@RO0?0?RK_/F_X-D?^4F.J?\ 9JOQA_\
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MC_D%Z9_V#[7_ -$15_KU_&K_ )(]\6?^R:>/?_44U2O\A32/^07IG_8/M?\
MT1%7[IX,_P #B+_K_EO_ *:QQ^)^+'^\Y%_UYS+_ -.X0TJ0]5^O]#2TAZK]
M?Z&OVU;GY$]G_AE_Z3(_O _X-6/^3"OC_P#]GN^.?_6<_P!F"OZ::_F6_P"#
M5C_DPKX__P#9[OCG_P!9S_9@K^FFOY'XW_Y+#B3_ +&E7_TQ@3^I.#O^27R/
M_L7T_P#T]C0K\Q/^"S?_ "BV_;:_[(MJG_IYTFOT[K\Q/^"S?_*+;]MK_LBV
MJ?\ IYTFO*R+_D>Y'_V.,K_]6&!/0SW_ )$N;_\ 8JS/_P!0,6?YB"]/R_\
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M_P#E%'^V/_V)7@[_ -6SX#K]9:_)K_@N7_RBC_;'_P"Q*\'?^K9\!UZ_#_\
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M /5Z_M35_.77]&G_  ='?\I'_AA_V9#\(_\ U>O[4U?SEU_6_ W_ "1_#O\
MV+:?_J1CS^6^,?\ DJ<]_P"QA+_U&P(5^E__  1F_P"4I_[$O_95]7_]5MX^
MK\T*_2__ ((S?\I3_P!B7_LJ^K_^JV\?5ZG$'_(@SS_L39I_Z@8H\[)/^1UD
M_P#V-LM_]3<,?Z? Z?BW\S2T@Z?BW\S2U_&BV1_6BV0C=#]#_*O\SC_@NG_R
MEM_;2_[&CX/?^LU?!"O],=NA^A_E7^9Q_P %T_\ E+;^VE_V-'P>_P#6:O@A
M7ZKX0_\ )28[_L35O_4W GYCXJ_\B3 ?]C:E_P"HF,/R?HHHK^C#\&/Z#O\
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M]G_AE_Z3(_O _P"#5C_DPKX__P#9[OCG_P!9S_9@K^FFOYEO^#5C_DPKX_\
M_9[OCG_UG/\ 9@K^FFOY'XW_ .2PXD_[&E7_ -,8$_J3@[_DE\C_ .Q?3_\
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M44?[8_\ V)7@[_U;/@.OUEK\FO\ @N7_ ,HH_P!L?_L2O!W_ *MGP'7K\/\
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M2,?^QKF7YX,_G;Q+_P"2GE_V+,N_+&"U3OO^/2Z_Z]Y?_1<E7*IWW_'I=?\
M7O+_ .BY*_3(_'#_ !1_]*B?G\OAEZ/\I'^ME^R9_P FL?LT?]F^_!C_ -5U
MX=KZ"KY]_9,_Y-8_9H_[-]^#'_JNO#M?05?Q%B/]XQ/_ &%8G_U)Q!_86%_W
M;#?]@]#_ -,4 K^-[_@[._X_/^"?7_7+]K/_ -&_LSU_9#7\;W_!V=_Q^?\
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M;\#?\D?P[_V+:?\ ZD8\_EOC'_DJ<]_[&$O_ %&P(5^E_P#P1F_Y2G_L2_\
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M_P#[ ,#_ .H6!/Y!QO\ OF,_[#,9_P"I>*$;H?H?Y5_7;_P::_\ (W?M_?\
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M/F>//^24S?\ Z\X?_P!3\$?QFKT'T'\J6D7H/H/Y4M?U>]WZO\V?S.]WZO\
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M_8!'5OK_ $%?A/C/_O'#?_8/FG_I[!'[1X3?PL\_Z_9=_P"F<8+1117XH?L
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M,/\ LR'X1_\ J]?VIJ_G+K^C3_@Z._Y2/_##_LR'X1_^KU_:FK^<K(]_R/\
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MZ'L?\*_KN_X--?\ D;OV_O\ L6_V5?\ T[?M)U\GXC_\D5G?^' ?^K+"'TW
MG_)5Y1_CQ?\ Z@8L_L\HHHK^5C^F3S#XU?\ )'OBS_V33Q[_ .HIJE?Y"FD?
M\@O3/^P?:_\ HB*O]>OXU?\ )'OBS_V33Q[_ .HIJE?Y"FD\:7IG7_D'VO8G
M_EA%Z5^Z>#/\#B+_ *_Y;_Z9QQ^*>+'^\Y%_UYS+_P!.X0TJ0]5^O]#1D>_Y
M'_"DSDCKU]".Q]17[:MS\B:T?^&7_I,C^\'_ (-6/^3"OC__ -GN^.?_ %G/
M]F"OZ::_F6_X-6/^3"OC_P#]GN^.?_6<_P!F"OZ::_D?C?\ Y+#B3_L:5/\
MU'P)_4?!W_)+9%_V+Z?_ *>QH5^8G_!9O_E%M^VU_P!D6U3_ -/.DU^G=?F)
M_P %F_\ E%M^VU_V1;5/_3SI->5D7_(]R/\ ['&5_P#JPP)Z&>_\B7-_^Q5F
M?_J!BS_,07I^7_H*TZF*<#OV[$_PCT%.R/?\C_A7]F?U^9_)KW8C=&_W?_9T
MK_26_P"#?O\ Y1'?LF?]=/V@/_6H/C17^;0Q&#U^[W!'\2>HK_27_P"#?O\
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M^$-&_P"":_CO1_"OB+4]'6SO=;\.:5XW\8Z;H>I3W.F6/BKQ#:VL6KWGQ?\
MMQ?"+_@JM^V?^RE\9?V8I?V=?^"?'PY7XMZ'H^C#QM'^W]^T?XL;P^VD^+=
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M4I/1):Z)+1?84U&,(1@K1C&,(J][1A&,(J]W>T8Q5VVW:[;;N_SU_P"%A_\
M!5S_ *,__P"">O\ XL?_ &D/_I5M?CI_P5C_ .";7_!5/_@J')^S_++\.?\
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M[='_  0;_P""J/[:7[6OQH_:E>/_ ()]_#9_B_JG@_4F\#)^U+^T?XO7P_\
M\(I\,_!/P[$(\2G]A+PP=5-^/!BZPTO]@Z:+8ZBVGB*86HO+C^V5AD8SCU/'
M]>/\^M?G7_P4A\>_"7P!\*_ -[\7/BK\9_"=CJ_Q+CT3P9\(O@'\:K_]GCXC
M_M-_$*]\&>+?^$5^$=K\8O#_ (W^%7B?P'X>TZ[#_$GQ-XFM?B[\+O!^AZ;X
M&;5?BOXO@^&-EXITW4O1RS/LSX?Q%3%Y3B7AL35I?59SC3P]64Z52I"HZ<88
MBE6C*4JE*')&$/:3DHQ4HQ]I.GYV9Y-EN>4:>%S/#QQ-"G5^L0C*I4I1A4A3
ME!5)3I5L.XQ4:DE*4ZGLX1<IR3Y8J?\ ']_Q"]_\%4/^AS_X)_?^) _M(?\
MT&-'_$+W_P %3_\ H<_^"?W_ (D#^TA_]!A7[:V?Q%^*_@[Q'\/[3XG_ +7W
MBKQ;^T_\(_$/_!)3X>_!_P ,?#W]H7Q?)\*_VA/A[\>?B_X8\)?M!^/(_A_9
MZSHOA#]IVQ\>VNI_'_X<ZK\8/B#\,M8U_P +^'O@5:_%;1;;X9^)M'UW5HM;
MPC\7?@E>6'[2GQ4M?^"A/Q]7]COPKX T?PQ\6?C->_M8^(/&OQ8_:<^+R_M%
M^$9=?\1_LQ?#G0?$6JZI^S/\-]<;_A*/V2O"6N?LS^'O@EK'Q?\ $GQ@\SX
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MS/IK_A8?_!5S_HS_ /X)Z_\ BQ_]I#_Z591_PL/_ (*N?]&?_P#!/7_Q8_\
MM(?_ $JROT*'0=^**^9/IS\T/&7B'_@JSXO\(>+/";_LD_\ !/6P'BCPSK_A
MW[>/^"C'[2%R;$ZWI-WI@O/LW_#K*W^TBU-T)S;"XMC.(S"+B OYR?R'VO\
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MV9OB-XH^,/QH\>? ;X:Z7<^"'\7>._A?X@U'PM\1M0TV?X@>%K9?AAX'\0Z
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M?/\ @GQ\3U^%W_"?L?'4G[?'[1_@UM=;QS\4/&WQ()'AI?\ @F9XI&EC3/\
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M\:OC+^V)XNUF^^)/B+X@_MG?#_P9\:/VH/AWH7AKQE+K7[(G[/?A71-<\3_
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M49;FXCM8H[=)%BC1!OT4467W:+R2Z+LO)67D/]=7YOOZ^>_F%!Y_S_G\:**
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2[NWE>VBTT5BBBBF 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>forms-4_011.jpg
<TEXT>
begin 644 forms-4_011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %@ CH# 2(  A$! Q$!_\0
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MSXLM]#\"Z;J?B6S]]_9A_P""K?[/?[1W[(/[1?[8C0S^#_ _[)5_\6M-^/\
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M$OACX>:AHOCGQ7XIU3PY;V6@>"O"VF:WH,0UG5)M8UO4X])T*]MKGX]^(/\
MP4M_X* ?LR:S^R_X+^/O[+OPB^-/Q#\:?"G_ (*,>./C/X;_ &2/&^G2Z7JU
MA^Q;XJ^"=AX9^)?@GQ7\9_B-X/T?X8>%]<\,^./&MYXR^&OB:;XH_$/3_$L'
M@WPO%/H^M7/B+2]'MOEG5A47L71JXNC4]LU349X"GB:F.NVI66#6$Q$<0Y6]
MFZ=25I4Z5:K2SC4C4A0G1?MXXF.%G0=']Y[2.-G2A@W'X$WBG6I>P2;E/VE.
M'+&I6HTZG]!5%?@>?^"U6G6_CW77\*_";XA_'3P?\2?&G_!.CP)^S=\.? _@
MGP;\._B,=5_;Y_9T^(?QT\)WOC3Q[X__ &@+OP?XET](O!EI#KSR^$_A'#\,
MK>ZNTEN_B7:P3:Y:87Q(_P"#@_X)_"[X7_ 7XH^*?V=_BQ8V?Q/UOQIX>^)_
M@V;XD_L\)\2O@IJ/PV_:8N_V4_'[1?#V#XKW7C'XPZ5X=^)FC^(;B;Q=\,=$
MU/P'!X=LM)N-:\6:+K7B"ST.&W"HJD*,H.%:=:.'C2DXQG*O/$U<&J45S-2D
ML51E0FXRE"G4E252I!58R-)*4(*I*+Y)4Y5E.UTZ4,/3Q4I_S)>PJ>TC&4(3
MG&%5PA+V<D?T&T5YE\8+WXLV?PK^(-Q\!])\!ZY\:(_"&NM\+-,^*>L:[H/P
MVNO'3:?,OAD^.]7\,:7K/B.U\)1:H;>YUP:'ITNK7.G0W%G82V=S/%>6_P#.
MWH__  5F_;/\<#1_A5\)O$'[)?Q(\4>/?VDOVL/AK\%_VT+7X$?&'2_V9/C+
M\-/V0?V/=-^/'Q*UKP+\%D_:7U7Q3XD4?'Z77?V:[?XL>%OVB/$'PYNQX2\5
M>,]!TOQ!J.AR^$KGEJ8FG3=524W['#SQ4^6$G^XI*O.O-65G["EAL15G"\9R
MC0J0HQQ%>/L"H0E4=)0Y7[6K&C%N2C%5)NG&DIR:Y8*M4JTJ=*3YDY5(RG[*
MB_;'].-%?A+\+/\ @J/^T=\7OVC_ /@ESX=M?@!\/OAI^S+^WC^RSXN^.NM>
M/O%/C6[\4>.]7\<Z3^S3X1^.MYX*^'.FZ9)X?L_!?@;X9:EXLT_PWXC^(/Q"
MTO6=4^(]_/J-KX=\%>#=,\,IXI\4^7?\$Z/^"S7B7XOCXG^(_P!O;QS^S+^S
MK\-]"^!G[._QHT/QOXJT?Q#^RQX;T+6?CG\0_CMX+?P+X7\7?''XQ^./"W[5
M?PGBM/A7X=OOA]^U_P#"+4/"'PE^)^I>(-1T/POH5Y>V%VNE]<J<H3K4YNG"
M6'6*E5YJL+1^J8YY?47-\+E/$)>QC=2JTITJD;>WHTY<OUB%J4DIM5I8:--1
M@YN7UK"?7:<K1E+W84;JO)<WL:D:D)K]S5G'^BNBOYP_VG?^"K7[7_[)_P 5
MOVG=-\2:-^RK\;/"GPF_9-_:<_:=?X>_!;2_BC=:_P#LVZ'X6U#P;I/[$UQ^
MT1\=-6\;CPAXSU+]K276/$>H:E\,O#/PH^&7BKP9IGA_4=9\*:W\0O#&FIXB
MU;?^+G_!0G]N?X6_"/\ :OOO$/Q(_8.\":M^P?\ 'GQ'\/\ ]H+]H?Q_\*/C
MM%X/^(/ACQ!^RE\(/V@/V>O"OP)_97T?XY3^)-3^+WQ6^(GQP\/_  6U/2K_
M /:FU632)/#2>(_!_A;X@ZS\0-*\%>&.26)IQ2NIM^QG7E",*DIP5.LZ%:E.
M$:;FL32J6A+#QA4K3JRAA</'%8UO"QWI_O)12<(JI4]G3G4JTZ=*H_9PJQG"
MK.7(J,XS4HUJDJ5.-+_:JLJ."<<7+^AVBOPZTS]KC_@H7K_[4O[!OPB1OV>/
M!EU^TK\$=)_:D_:6_9J\5?L[?$:Y^*G[)GP3\%^ _ -I\7=-UOX_0?M:Z9HW
MB3X@^*?V@?&=E\*OA+8-^S)I%CIUI=>)]6\6/?2_"^[MO'/S#_P1=_X*K_MI
M?\%"?'/@B3XX>(/V:+;P;XF^"&N_$_6/ _PL_8P_;N^%OB/0]5@U30=*TRTL
M/V@OC!XA\1_LW^,;"TN=6S>0^#M?UNZUV%O/\.W$]OI^IW%MV*FW.K2YJ?/1
M>(52*FI*/U:OB,+4DIQ4X5*<J^&KTZ52E.I"HZ<G&7(G-8+$0<(SM-1G##3B
MY0<7;%4Z=:E&496E"HJ=6G.I3G&,H*<&T^>'-_3'1358,<<YV@G@@?3GO^OK
MVIU9)W-]PHHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X!\=?V8?@S^TE/\
M+Y?C%X8E\5P_"#QWJOQ%\&V#ZKJ=CIB>(]<^%_Q$^#FKC6]/L;F"V\0:3J'P
M_P#BGXTT6ZT;5H[G3ICJ:73P&XM;=T^+[;_@C1^P=IG@#P9\.O#?@3X@^"M+
M^&_@[]GWP=\.-?\  /QI^*?@3Q[\/U_9E\1?'+Q/\+?%/@SQ]X2\4Z/XL\.^
M.+?4OVDOC8GB/Q9INJP:IXHL/'VKV.KR7%N8%B_4^BIA"%.3E3BH2E4C6E*-
MXMU83C4C5;35ZD9PC)2^*ZM=Q<HR'[WQ:VBX:Z^Y*,HRA_AE&<HN.SC)IIK;
M\U/ O_!)']AWX;?#_P =_"[P;\._%>E^!_B)^R]\0/V-_$.CW'Q4^)&LRG]G
M[XE_$KXL_%CQ/X1LM6UWQ+J6LP:B_C'XU^/[FP\72ZA<>+;.PU"RTU=:>UTN
MQ2*QXK_X)1?L=^)SK=W9:+\6?A[X@U7QIX ^)6E>,O@_\>_C%\(?''@3XD?#
M_P""H_9SC\=_#CQ?\._&7AW7? _B/QQ\#(K+X9_%:?0;VUL_BAX>TG1F\:66
MKZII&GZC;_I'15S;J<O.^?DC3C#FM+DC2YU2C&Z]U4U4FH*-N53FE92DF/WJ
MDJLO>J3E.4YRO*4Y56G4E)R<N:51I<[DFY?:;6C^5?A_^QI\$/A;\:=)^/'@
M*#XA:#XVTO\ 9Y\!?LOW%FWQ;^)FM>$?$WPI^%>JZYK'PU3QSX3\0^*=7TCQ
MWXY\#7/BGQ7#X>^)OBZ#6/B#;6?BOQ/;3>([A->U/[3\\>)_^"2/[&WC;5/C
M1JGC/3?C=XRC^-GPR^,/P?U'0O&O[3'Q]\;^$_AO\/?V@=7T#Q!\:O#WP+\(
M^,?B%KOAOX+VOQ'USPKX;U#75^'^F:*(4T33])TA=,T&'^RC^F-%0X0D[RC%
MNU:-W&+TQ%6=>NOAWJUJE2I-Z2<JE2TXQJ5(3%[J45HE*C-):+FP\8PH2]:4
M(0C!WT4()\W)#E_+6Z_X([?L6ZEXN_:2\3ZS:_'K7-)_:XUWXA^*?V@?AAJO
M[3OQZG^#?Q \4_$BUAL]0\577PMC\>P^$--\5>$H;'13\+/%&CZ=8>(/A//X
M9\)W/P\U+PY<>%]"EL/J_P"&O[(WP=^&_P $?&?[/UP/B'\6OA[\2[;Q=9?$
MT_M$?%KXE_M"^+/B-8>.M!A\)^)],\9^-?C!XI\7^)M7T?4/"EM:^&4T-M2B
MT:RT2W2SL;"W$D[S?3=%$HQE3=*48RI.FJ+IRC%P=*+FU3<7%IP7/-*.RC)P
M^"T(N[YE.[YXU/:QG=\\:MJ:]I&5^93_ '5)\R:?-3A/XXJ9^;7@'_@D]^QQ
M\._"UYX5T_0_BUXICN_B+^SC\1E\1_%#X_\ QH^+/CBQ?]D;QS!\1OV<? >E
M^-OB1XV\3^)M-^%'PG\6)?:CX8^&MIJ47A6%M=\0"XL+AM8O'D],_:T_X)\?
MLT?MK7_A/5_CAH_Q$CUSPCX4^(GPZMM?^%?QH^+7P1UW7_A7\7(="@^*/PD\
M::M\)/&7@Z]\:?#'QX/#'AZ3Q!X-\2RZEI4TVE126D=HUUJ/VW[9HHE"$OBA
M"7[SVKO&.M7V52BZC]U<U25*M7ISG+FG4C7Q"JRK/$8B5<C)PDIQ?+*,%",H
MV3C!5:=>,(V6D85J-"K3BDE2J4,/.BJ+P^']A^8_A/\ X)#?L3^!_B-\-/B=
MX7\-?%C2M:^$GB?X0^._!7AV']H+XUO\,K/XA_!/X)V/[.?@[XD:C\)9?'$G
MPTUOXAW7P2TG1OAUXG\:ZKX6N_$7B+0-)M$O]0:ZDO;B[\+_ &G/^"0G@;Q#
M^QU\2/V6OV2=/\ ?#^\^,'[-_P  ?V(_$/BOXZ:A\2OB3I'@?]F;X$ZW\2M:
M\%:_X.\.Z7KUA<:U\9_AKJGQ3\2>*O 6HZUK.EZ=JOB>'1I/%.J&PTBVB/[6
M4A&?\/S_ ,?T%%2*J1E":YHRG*I.+VJ2J5UB*RFURRDL14YE7]].I"I4@YPC
M)>SF*C"<:D(PC."@H24(WA[*')1E#1)2H>[4HRY9<E6G3J-5)1?/\K^.?V,O
MV>OB/^RM8?L7>,/!+WW[/VD^ ? /PZT/PK8:UK/A[5/#^C?"U?#[_#G4O#GB
MGPY>:5XB\.^*/!.I^%?#NO>'/$FC:C8ZII>NZ/9:C;3K+&<_/'@?_@DA^Q;X
M$:PN+3P[\6O$NJVOQ*^,?Q?O_$_C_P#:$^-WCOQMXD^(OQ__ &<M._96^+?B
MCQ/X\\3^.M1\::UJ?BOX/Z;#IBW%SKWF^'];D?Q'X7?1-4BM)K7],**<OWDZ
MM2:4IUJDZM632O4J5%4C4J2LHKFG&M5C)I1;A+V;]R-.%)TOW-.G2I-TZ=*,
M(4X1;M"--1Y(QO=VARIQ3E*T^:HOWDZE2I^;?PY_X)1?L@?#;7-'\86VG?&+
MQU\0M(^/?P\_:1D^*'Q@_:#^,WQ@^)VN_$OX3?#'QQ\'OAF?$_COXC>,_$7B
M/Q!X4\$> /B/XST7P]X,U*_G\.V1UN>[%@]U'!+'EZM_P2"_89UOX:>&?A'J
M/P]\73>"/"/[*>E_L6Z)81_%'Q_;75O\ -'^)7@OXM6/AN34+;7H;J?6(_&W
M@#PS?MXJDD/B![.TGTDW_P#9MY<VTGZ<45I[6I[OOS]UPE'WG[KIM2IN.ON\
MDDI1M9*5Y6YI2E.8QC"4IPC&$IPE3E**2<J<VG*F[*W(W&-X644HP2C&,(1C
M\(P_\$W/V3XOBW\7?BX?"OCR=OCNGCRY^+/PCN/C1\7YOV;/&WB3XJ>"1\-_
MB;X[UG]FMO&W_"DKGQY\0/ F_P -^+?%+>"#J.L07%YJ5P_]O7]]JUQX_P"%
M/^".'[$W@WP=;>$-&T[X\23:7\7?@[\:_#?CK6_VH?V@O$OQ1\'^+OV?_"^L
M>!?@WI_A'XC^(?B'J?BO0/!O@'P-XD\2^"]$\&V6I)X?7PSXAU/2KFRN(#:?
M9?U.HJ8-T^54VX<D81CRMKEC3JQKTTK2TY*L(RB[W2BJ:E[!?5RY-S;<WSN4
MI2DY6;<IT)8:<G=/6="4J4G]J,FY7G^]7Y(:-_P1!_X)\:#8>,=(T_P)\5I-
M%\9?#O3_ (/R:'K'[17QU\1Z'X2^$.@_&OP?^T)X4^%GPUT?Q'X^U73OAIX"
M\'?%+P5I^N>&/#O@BVT.ST^VU/Q#I,@N=.UFZMZ]^\8?\$W?V6/&WCX?%#4]
M \=Z;X\'[4MM^V$/$GA7XK?$/PAJ)^,8^"WA?]GC7%DF\-^(=,:?P!XU^#7A
M'2_ 7CSX<7!E\'^+] GU>QUO2KJ#6-0CG^\:*F:514U4_>*DG&DJG[SD3A"G
M)1]HYOWJ<(0FVY.<8VFYWDYOFEK[TO>U=FU?6I);.*23JU&DE%1<Y.,8WT^,
MOV9/V"_@!^R;XM\=^/?AE)\8?$?C?X@>&?!O@'4O%WQP_:!^-O[0OB71/AC\
M.M3\6:UX"^%G@[7/C9X[\=:GX2^'GA/5O'7BW4M,\.:)=6L,]]K=Q=:I+J,\
M-G);>4Z;_P $G/V*=(\+>-/!NG^ O%4.A>/OV<?VBOV4_$EN_P 2O'-Q+=?!
MC]JCXO>+?CG\9=#AFN=:F:VU77?B-XW\0ZKIOB2+&MZ!97,.C:1>6NE6L%HG
MZ1T422G\24OW/U?77]Q>HW2_P.5:M*2^U.M5G)RJ5:E2:BW%5%'W55JJO4C%
M*,9UE[.U244DG.*I4E%V7+&G3BDHPA&/R'^T[^PO^S;^U_\ "KP=\(/CAX/U
MC6/#OPWU_P .>+?AIK_A?QOXR^'_ ,1OAOXM\*:=-H^C>*/ OQ)\$:YH/C3P
MWK<>D75YI5[=Z?K,:ZKI][=6FIQ7<,I4>1_#C_@E+^Q!\)/#7P]\*?#SX5ZE
MX<TOX;_#O]I;X;:5/%X\\;W^N:_IO[7W_"#M^T'XD\=^)=5UZ^\0^.O'GCV7
MX=^%99?&GB?4]2UW15TV&ST"ZTS3X+2SMOT8HJI-S^L.;YGBG6EB>;7ZQ+$P
MKT\0ZW_/QUX8G$1K<VE55I\ZE+EE3B$(TUAU",8+">Q^JJ*26'^KRHSP_L5K
M[/V$L/0E1Y?X3I0Y.5<T9_G)X5_X)3?L7>"]9\!:]H'@3Q7;:E\-/$O[)?BW
MPE+/\3/'EW'9:W^Q)\(_$WP/_9ZN+F&YUV2+4(?#/P[\7Z[IFMVEZLUOXPOK
MB+6/$T>I:G:V]S'YGX[_ .")O[ 7Q#TQM&UOP3\6-/TN\L_'UAXBT[PC^T3\
M<?!&G>.+#Q[\??&O[41T[XAZ9X3\=Z1IGC_3/!?Q\^(GC#XF?#K2O%UGK&E^
M#]?UF86%F;%(;2/]9Z0C(Q^=-SFZL*SG+VT)SG"KS2YXSG6^L3DI)IWG7M6D
MGS*551G*+E&/+;E*4>1R;ARJ'*W>/(J;I*-G=65*3IQM9QBVHN-VW\56W[$G
M@?5_@I^U1\!/B/XT^(OC?P%^UM\1OCCXR^(-M'XW\;:+J.B>%_CE<1PZ]\-?
M!>O3^+-<\3>%_"L7A^-M)GL-$UW3M%$VJ^(QX7\/^#?#.HZ=X2T7P%/^"-W[
M&C? [PA^SYJ%[^TSK/@7X::W#JGPCU+5_P!KK]HZ[^(/P9TD_#*[^"^J?#[X
M0?$8?$>+QE\./A/XD^$NI:M\/?$_PK\+:OIW@/7?#.K7MG?:#)+]EGMOU3 Q
MSU__ % =OIG_ .M2UG*$9QG&<8RC4C1C4C**E&<</#DH*<6G&7LX.4$W%MQJ
M5HS=2%?$0KTJE1.,E.<90J5*L90DX2A4K*U6<7!P<935N9IKX8-*+ITY4OE^
MZ_8V_9WN/&'[+_C.#P##I5[^QQX-\=?#W]GS1=&U/5-,\(>"?!/Q$\ :'\+_
M !'X8D\)VMVFA:[I \#^'-'T/2K37+._31X;7SM/\FXEEE?P?X#?\$HOV%OV
M>(_&5KX3^#UQXYTGQCX4\$?#E?#_ ,?O'7CO]H[PWX*^$WPSUWQ)XG^'/P=^
M&/A_XY>(O'ND_#GX5^"/$7B[Q%K?A_P7X2M-+TNWU/4%O+A+F:PTQK+]&**T
MYY\]2ISRYZJJJK.[<ZGMZRQ-;GD[RFZN(BJ\W)RDZMZG-&4I.>*ITU&$5""C
M3]FZ:48VI^QINE2Y-+P]G3;IQ47%*%HM248<GYB>&?\ @D5^Q]X9\1_M%ZQG
MX_>(/#W[6D_Q@O?VB?A1XI_:<^.VM?!7XI:E\<M#7PQX^UKQ!\)Y?'4?@L>(
M'\-0V6@^%_$5CI5IKO@C2])T6V\(ZCHPT;3&M>7\6?\ !%W]BWQIX0^'GA76
MK[]IUK[X:_&KQ!^T?I'Q'M?VO?VC8/C)K7Q[U[PKX7\!0?%[QC\73\19/B!X
MK\?>$O '@SP[X$\ >(=7UZ>^\"^$+%]#\,2:;:7EZMQ^L=%9*E3BZ<E3@I48
M4:=*:C'GIPP\I3H1A4M[2*HRE)T[54X<S2ERMP>KE)\]VVJDJDZB=G&<JL(P
MJRE!IP;J0A",_P!W[RC%M<T8S7S?\/?V4_A'\-OB>WQHTF#Q?KWQ5F_9Y^%_
M[+][X]\=^._%?COQ5JWPG^$GB+QSXL\,6FMZ[XIU34]3UOQ-?>(_B)XDUCQ7
MXRU:ZO/$OBN_ELKG6]1NY;&%Q\I?LD_\$BOV1/V)/&OA/QK\ [W]HW2F\#>'
MM7\+>%/!?B_]JCX^_$'X6Z)H>LV,NG7%E9?"[QCX\U?P+$EK;S2'2MNAXTJY
M9;RQ$%W'%,GZ>T5HFU+G6DG"5.ZLO<E4Q-:4+))<KJXS%5+<ME/$5I1Y7-VR
M5."CR**Y>92M:_O15**E=MNZC1HJ[DVU2@GS**0@ '^/?U_G2T44BPHHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#Q/XW?M#_"G]G?2_!^J_%/5O$EBOQ \
M9)\/O!&D^#OAQ\2OBOXK\5^,6\+>*?&[:'H7@KX3^$?&_C#4)[?PCX*\5^(K
MV>WT-[*QTK0K^ZO+F".-2_'^'_VR/V;O%/ACP7XRT3XDQ7?AGX@:O:^&_#>K
M2>%?'%C"/%MU\:/"'[.W_"#^(XM0\,VESX)\?V7QM\=^&_AMK'@'QI!X?\9:
M%XDGU6WUK0["#PWXDN-)^<_^"D?P@^*/Q1T[]D_7OAG\)OBA\9X_@Y^U!<?$
MKQUX+^"WQ^M_V:/B?+X.O_V:/VCOA7'J/A;XIO\ $[X07=@]EXP^)?A,:SI.
MF^.]*NM9\/S:I:2PWU@;VTD^!/ 7[ O[5VG7'P%U#4? L&DZ#X5^)FO^.4\+
M^)/BYHOQ$\??#KP9XH_X*Q_L)?MA1>&_B;\3KV=-0^,?Q3@^&GP=^,WCCQMX
M]FU'QGJNL>*#;>%=1^(_Q1\37%OX[\6Y1E4?/>#LL2Z2>B7LE&$E-\SO+F3G
MRRA&45*#4Y05HS:2<TF[1<(2;ZN4I2C))_"E3M'F4K2:FG%3^*G^YWPL^-OP
MR^->DVFO_##Q(WBK0M1\*^"O&VFZU!H?B/3=*U3PM\1-#3Q'X0U?2M0UO2-,
MM-4AU31I$NYH=/FN;O26>.UUFWT^]D2V/J>[ R01T_ 'J3Z <Y],9. :_FR\
M%_\ !.W]H'POI'P<OOBY^S!X&_:6^'OPZ^&O[)?AWXA_LP>(_&?PQU'2/B-X
ME^&W[(7B;X,ZIK]KIOCK4#\*_%6J?!WXC:JKZ3HOQ$O]*\/:IH_B36O'?A35
MYO%_@_PMIVK;_P .O^"7OQK\+)X3\9^,?AS\.O%'QZ^&_C+_ ()0_P#" _%F
M+Q1IGB3Q+X&\"_L_?%+PW>?M.>%_AY\0O%MOIWCBTT#0?@_>>*_AI<ZG=67A
MGQ'\<_"-A#;:[H]Y<:E#H]FE4FH*;IS=I14XP2YUS2I0]R$[*32J>W?O<BHT
MZD74CB8JC)N'O-*4?X/M(N3TE-4JE25-N',X^_35!<UINM5IN-.5'FJK]EOB
MO^U[\#O@QXSF^'OC*^^)>I>,[/P18_$C5M ^%_P _: ^.5WX>\":IJWB'0]*
M\4>*I/@G\,/B#:^$]*U75?"?B>STR;Q)<:4VHR>']9:R2>/3KIXM7X:?M7_L
MY?&3QW>?#3X6?%[P?X\\9VGP=^&'[02Z9X;O9M1M-3^"OQF;7$^&7Q)\/:_'
M;?\ "/>)_"WBK_A'=2>VU#P[JNJ"QA;2[C5DL(->T*34OC+]HO\ 8V^/GQK_
M &BOCKX\^&GQV^)7[,J>*OV+OA5\(_AM\5?AKK?AB=3\6O#'Q0_:)\4WEMX\
M\&ZCI]UXBU?PGHFG^./!SW$WAK7/ /B.ZTGQ'XHL_!OCSPQXNAT[Q/X;^'K?
M]@7]J%M4\->*_AW\"O"W[/J>(OV=?V8/V)_%7P]T?XP:1KL'P?\ V9?%OPS\
M:_"O]JK3/AYXOM[R\U3Q;JGP/UC1O@C\3?A#K&MR:;K7Q"M?!BV=]!I7B'7=
M:M]+="4ZM.DY)4:M6-5.-6%14Z52I];HX.564+S5*&)A@YXR,$ZZPD\15IJ/
M^S2>=W>6DN6$HMN*3E*G!86MB%!5)04JTL/+%PPMW&A/%4Z%&<TY5N7]*H_^
M"J/["5WX0T#XA:/\:M0\4> /$/PR'QHB\=^"_@]\=?&_@OP_\(SXK\<>"?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9[^ GQ@\;_%+XI6^A>,?A;KGQ8T[4/C*_P 3?V</V>M)^#W@*/PUHMWJ%O\
M&+39/B=\*O%NE:/XMG^&_BKQOK>C:/X<\3_LEX:UC_A(?#F@:_\ 9Q:?VYHF
ME:Q]E$QN!;?VG8P7OV<7!AMS.(?/\L3&W@,NW>88BVQ0#:HHHH *_&#]J/\
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M%% !1110 444UW$:.[9VHK.VU6=L*"3M1 SN<#A45F8\*"2!0 ZBOC_]F_\
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MW,MS_2KHHHK\?/U<*_RW/^"L/_*2_P#;A_[.%\9?^@:?7^I'7^6Y_P %8?\
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M/'_]?\N_]38'\GM%%%?U$?S>?5_[ _\ R?M^PC_V>W^R-_ZT/\-Z_P!7FO\
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M ^&/VZOA[^US\6/!G@KX=_LR7WP\TSP?XE\1:E;_ +2$OB'XS^._@'\2=?\
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M97WV:>/[1;)=7"Q2959G #'_ ",,'U/Z?X5_J/\ _!)G_E&7^PA_V:W\'?\
MU#=,KX'Q X+R;AG+\OQ>6/&NKB<=4PU7ZUBUB(^SCA)5UR16'H\LN=*\KRO'
M2W4^WX%XMS;B+'X[#9A]4]GA\%3Q%/ZMAG0E[26*5%\S=>KS1Y'HK*SUN]C]
M"J***_*3]./Y>/\ @ZM_Y,X_9H_[.SL/;_FB'QF]*_A=P/?\S_C7]T7_  =6
M_P#)G'[-'_9V=A_ZH_XS5_"]7]/>%W_)'8/_ +#LU_\ 4ND?SEXD?\E7B_\
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M_P C4?\ #UC_ (*6?]'R?M%_^%U/_P#(U? 5%?K']B9+_P!";)__  U9;_\
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MZ(4445^<GWP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7^9O\
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M_80_[-;^#O\ ZANF5_EPU_J/?\$F?^497["'_9K?P=_]0W3*_(O&'_D2Y/\
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M45_81_*(5_J/?\$F?^497["'_9K?P=_]0W3*_P N&O\ 4>_X),_\HROV$/\
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MMRK_ -1\0?T5X:_\DK0_[#\R_P#3]$****_.3[X**** "BBB@ HHHH ****
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M.P_]4?\ &:OX7J_NA_X.K?\ DSC]FC_L[.P_]4?\9J_A>K^GO"[_ )([!_\
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M _BG4?!FI6LUIINC:YJWA]];T[6;#3M1L]0^6/AK_P $^OC/\+KZP3PM\9?
M&FZ;^SW\"?VP_@[^Q=J$/@36;CQ#X:U#]JKQQX,\=Z!XQ^,TE]X@N+#6;_X'
M1_#OPSX&TN#P?%IT/Q'TV_\ $WBS74\.W][IOAW3 #[,_9)_:BL/VM_ASXD^
M)6E?!_XN?!K3?#GQ3^(?PGCTCXOR?"&[U'Q+JOPOUG_A%?%OB;PCJ_P2^+?Q
MG\$:]X*MO&MGXD\%V6MV_B]9M0U[P?XBDMM/?1!H^LZQ]15Y)\ ?@YX7_9W^
M!GP<^ G@F,1^$/@M\+_ ?PK\-CR_+>71? 7AC3/#&GW,ZEY7:ZN[?3$NKR66
M:::>ZFFFGFFFD>5_6Z "BBB@!,CU'YU\<?LY_L__ !)_9X\.ZSX6TKQEX%U_
M3O''[8G[5W[0/CF?4/#FOQ7J?#C]H?XL_&;XQ:%X/\*/;>((8+'QOX7\1^./
M ^FZMXBUB'5="U71-&\5I9Z#97^K:1>:3_&G_P %Z/VL?VLOA5_P4S^+_@GX
M4_M6?M/_  L\$Z=X'^#=UIW@OX9?M#_&+X>^#]/NM2^'NDWFI75CX7\(>-=%
MT&SN=1O))+N_GMM/BEO;N22YNGEGD9S^.G_#>O[?'_1]W[;O_B7G[1'_ ,\F
MOU3+/"K,<SR[ YC3SG+:,,=A*&+A2J87'RJ4XUX<\83E"2A*45HW#W6]5H?F
MF8^)N79=C\;E]3*L?5G@L36PLZD,3@8PJ2HSY'.$9ISC&3U2E[R6^I_H1?$7
M_@GEXK\52?&W5X/%OPM\9-\0?^"@>@_MN:9\*_BQX)U3Q'\&?&^B:+^RA\-O
MV;(O@[\:-!BU27^W[;3-<\&2_&CP7XFATW5+'P?\4?#/PI\4CPCK5[X,,5Y]
ME?LB_ B]_9F_9\\!?!34?$UAXJNO"4WC*]^U:'HMQX9\'Z!;>,_'OBGQU8_#
MSX;>%+O5]?G\'_"3X5V/B6V^&?PA\&MK&H)X1^&/A+PEX;BN&ATN,+_F)_\
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M?#]U/Y>/^#JW_DSC]FC_ +.SL/\ U1_QFK^%ZO[H?^#JW_DSC]FC_L[.P_\
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M?L(_]GM_LC?^M#_#>O\ 5YK\#\9/^1ED/_8MQW_JQI'[AX3?\B[.O^QAA/\
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M_JQ/RGQ8_P"19D__ &,L1_Z@'Q+1117[^?AI_4%_P:L?\G?_ +2W_9MNG?\
MJS_#=?W35_"S_P &K'_)W_[2W_9MNG?^K/\ #=?W35_,7BC_ ,EAB_\ L!RO
M_P!19G]&^&__ "2F$_[#,Q_]2HA1117YX?=G^.E#_JU^K_\ H;5+44/^K7ZO
M_P"AM4M?W"]WZO\ ,_C<*_M@_P"#43_DB7[8W_99/AW_ .H!-7\3]?VP?\&H
MG_)$OVQO^RR?#O\ ]0":O@?$S_DC<R_Z_P"6_P#J? ^V\._^2MR__KQF'_J%
M,_K(HHHK^7#^DCXC_P""F/\ RC?_ ."@?_9D?[5O_JB/'M?Y6=?ZIG_!3'_E
M&_\ \% _^S(_VK?_ %1'CVO\K.OZ \'/^13GG_8TPG_JMD?AWBS_ ,C')O\
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M %1_QFK^%ZOZ>\+O^2.P?_8=FO\ ZETC^<O$C_DJ\7_V!9;_ .HM0*R]<_Y
MNL?]@O4/_22:M2LO7/\ D"ZQ_P!@O4/_ $DFK]$C\4?\4?\ TJ)\&]GZ/\F?
M[$OA_P#Y .B?]@C3?_2*&M>LCP__ ,@'1/\ L$:;_P"D4-:]?P_/XY_XY_\
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M+,7#7_)19'_V-L!_ZDP/](2BBBOX\/ZM"O\ *Q_X*6?\I$_VZ?\ L[#XZ?\
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MY!7XL?\ !PQ_RB,_:A_[#O[-W_K5'P3K]IZ_%C_@X8_Y1&?M0_\ 8=_9N_\
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MF(5_$S_P=>?\EK_8K_[);\;?_4L^&U?VS5_$S_P=>?\ ):_V*_\ LEOQM_\
M4L^&U?>>&7_)99;_ ->,R_\ 4"J?$^(O_))X_P#Z_P"7?^IL#^3VBBBOZB/Y
MO/J_]@?_ )/V_81_[/;_ &1O_6A_AO7^KS7^4-^P/_R?M^PC_P!GM_LC?^M#
M_#>O]7FOP/QD_P"1ED/_ &+<=_ZL:1^X>$W_ "+LZ_[&&$_]0)A1117XV?K!
M_G=?\'(W_*4?Q=_V0KX*?^DWBBOP<K]X_P#@Y&_Y2C^+O^R%?!3_ -)O%%?@
MY7]?<(?\DKP]_P!BC!?^D5#^5N*O^2ES[_L:XO\ ]*IA7Z\_\$$_^4NW[&__
M %__ !\_]94^.U?D-7Z\_P#!!/\ Y2[?L;_]?_Q\_P#65/CM71Q+_P DYG__
M &),U_\ 4#$&'#W_ "/\C_['&6_^IM _TKZ***_CD_K *_RW/^"L/_*2_P#;
MA_[.%\9?^@:?7^I'7^6Y_P %8?\ E)?^W#_V<+XR_P#0-/K]>\'?^1SG'_8I
MI?\ JPIGY9XK_P#(HRK_ +&=3_U!J'Y]4445_01^%']+'_!K-_R?M\;?^S0_
M%G_JYO@G7]Z%?P7_ /!K-_R?M\;?^S0_%G_JYO@G7]Z%?S+XJ?\ )7U_^Q;E
M7_J/B#^BO#7_ ))6A_V'YE_Z?HA1117YR??!1110 5_#?_P=7?\ )T7[*G_9
M _&'_JPQ7]R%?PW_ /!U=_R=%^RI_P!D#\8?^K#%?H/A?_R6.!_[ \T_]0SX
M7Q'_ .23QO\ V%9=_P"I9_+/1117]/G\XGV+_P $[/\ E(+^PI_V>+^S3_ZN
M/P=7^K'7^4Y_P3L_Y2"_L*?]GB_LT_\ JX_!U?ZL=?@/C'_R,\C_ .Q;C/\
MU8P/W'PG_P"1;G/_ &,<+_Z@2"BBBOQT_5S_ #D/^#B+_E*S\:_^Q ^!W_JM
M-&K\1J_;G_@XB_Y2L_&O_L0/@=_ZK31J_$:O[!X4_P"28X>_[$V7_P#J.?RG
MQ/\ \E'GO_8VQW_IX*_:3_@WN_Y2Q_LZ_P#8L_'7_P!4KXWK\6Z_:3_@WN_Y
M2Q_LZ_\ 8L_'7_U2OC>JXI_Y)KB#_L2YE_ZBS%PU_P E%D?_ &-L!_ZDP/\
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M_P"QM6_]5TS]3\*/^1MFW_8LH_\ J?$_0JBBBOY\/W4_EX_X.K?^3./V:/\
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M/QA_ZL,5_<A7\-__  =7?\G1?LJ?]D#\8?\ JPQ7Z#X7_P#)8X'_ + \T_\
M4,^%\1_^23QO_85EW_J6?RST445_3Y_.)]B_\$[/^4@O["G_ &>+^S3_ .KC
M\'5_JQU_E.?\$[/^4@O["G_9XO[-/_JX_!U?ZL=?@/C'_P C/(_^Q;C/_5C
M_<?"?_D6YS_V,<+_ .H$@HHHK\=/U<_SD/\ @XB_Y2L_&O\ [$#X'?\ JM-&
MK\1J_;G_ (.(O^4K/QK_ .Q ^!W_ *K31J_$:O[!X4_Y)CA[_L39?_ZCG\I\
M3_\ )1Y[_P!C;'?^G@K]I/\ @WN_Y2Q_LZ_]BS\=?_5*^-Z_%NOVD_X-[O\
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M_E;BK_DI<^_[&N+_ /2J85^O/_!!/_E+M^QO_P!?_P ?/_65/CM7Y#5^O/\
MP03_ .4NW[&__7_\?/\ UE3X[5T<2_\ ).9__P!B3-?_ % Q!AP]_P C_(_^
MQQEO_J;0/]*^BBBOXY/ZP"O\MS_@K#_RDO\ VX?^SA?&7_H&GU_J1U_EN?\
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MG%[)N+?^X[*2<6]E).+:DG%?S(?\$[/^4@O["G_9XO[-/_JX_!U?ZL=?R0?
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M^@W)OL_\Q&+WDVHK_<=Y--17VFFH\S32_COK^V#_ (-1/^2)?MC?]ED^'?\
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M$H8:O7G6;K4)4(\L9X6G!J,[\]YIJS5N9.)_0'17Y:_\,8?\% ?^DQGQ\_\
M$1_V#O\ YP='_#&'_!0'_I,9\?/_ !$?]@[_ .<'7XR?KA[=_P %,?\ E&__
M ,% _P#LR/\ :M_]41X]K_*SK_2E^)__  3I_;/^,?PT^(GPA^(W_!7;X_Z]
M\/?BKX%\7?#;QWH<7[*_[#VDRZQX.\<^']1\+^)M+BU72?@99:KILE_HNJ7M
MK'?Z;>6M_9O*+BTN(9XXY%_&FX_X-<?V7+7QW8?"ZZ_X*:?&>V^)NJ^'9_%^
ME_#FX\._LN0^/-1\)VM[)IUUXHL/!\O@I/$%YX=M[^*:QGUNVTZ338KR*2VD
MN1,C1C]0X!XVRKA;!9CA<QH8^K4QF-HXFD\'0HU8J%+!RH24W4Q%%J?->248
MR7(G)M6=OSGC?A#,N)<7E^(P-? T883"UJ%18NK6IR<ZN*C5BX*EAZR<>6T6
MY2B^=J*3NK_QX45_7L/^#93]CL^&O'/C0?\ !5'XGGP;\,=7UOP_\2?%PLOV
M3CX8^'FO>&5MY/$FB>.M?_X1(Z5X2UCP_'>6CZYINOW6G7NE+=6[W\$"SQ;I
M[W_@V*_9%TV3X>1:A_P5(^*VGS?%YXHOA/%?:9^RE:R?%"6>QM]5@C^'4<_A
M"-O&TDVEW=KJ42^&AJ;2V%U;7B!K>:*1_O%XO<,NS6$SMIVM;"85WYES1M;'
MN_/'WHVOS)7CS+5?$/PLX@6CQN3)KFO?$8M6Y;*>^!7P-I3O;E;2ERMI/]0O
M^#;7_E%MX!_[*_\ '7_U86I5^]-?AO\ LS_\$D_VD_V0?A1IGP2_9[_X*O?M
M!^"/AII&L>(-=L-!N?V9_P!BWQ1/%JOB?4YM7UNYDUCQ-\%-4U>?[7J%Q-.D
M5Q>2);(XM[=8K:.*&/W[_AC#_@H#_P!)C/CY_P"(C_L'?_.#K\)SW'T<TSK-
M<RP\:D:&.Q^(Q5&-:,858TZTU**J1C*<8S27O)3DD]I,_:LEP57+<HRS 5Y4
MYUL'@J&&JRI.4J4ITHRC)TY2C"3@V]'*$7WBC]2J_%C_ (.&/^41G[4/_8=_
M9N_]:H^"=>N_\,8?\% ?^DQGQ\_\1'_8._\ G!U\Y?M:_P#!-/X\_'3]GKXB
M_#7]K#_@L1\8S^S]JEMH&O?$6X\1?L^_L,_#G0]/L? OBO0O'FCZMJWC>R^#
M?A^?P]8:3XC\-:/J5U=MK%C:RPVKV=_))87-S;S9Y-CJ.6YOE>8XA3E0P.8X
M/%UHTU%U)4L/B(59JG&<X1<W%-14IPBY63E&]R\VP=7,,KS+ 4'!5L;@<7A:
M3J.2@JE>A.G!S<(SFH*3O)QA.22;46U8_P ZZBO[ Y_^#8+]DRV;X?I<_P#!
M4+XN6S_%ED3X5)<:/^RM$_Q-:32EUZ)?AZ'\'*?&C/H;+K*CPW_:32:4RZBH
M-H1*;-C_ ,&NW[+&J>*?%W@;3/\ @IO\9-1\:_#^STK4O'O@^PT#]EJ[\4^!
M].UVR?4=#O\ QAX?M_!<FK^&;+6;".2_TJZUJSLH-1LD>XM))H5,E?O3\7N&
M4KO!YVE[V^#PJ^!)SWQZ_AIQ=3;D4DY\B:;_ !)>%G$#M;&Y,[\MK8G%N_.V
MH6M@7?G::A:_.TU#G::7\>=?ZCW_  29_P"497["'_9K?P=_]0W3*_FRUG_@
MW)_8)\.^!?#/Q1\0_P#!7_Q/H7PS\:W=Q8^#?B)K.H_L<Z7X%\6WMHUXEU9^
M&?%U]X<@\/Z_=6SZ=J"7%OI6H74L+6-XLB*;6?R_V@_9P_86_:0\+? GX5>$
MOV:O^"T7Q5USX#^#O!VE^#?A;J7@W]G?]@?X@>&Y/"GA%6\-V-KIWC2W^"^M
M+XB_LY],ETR[U&75K^\EO[.Z74+F2^2Y-?"\>\;Y3Q3EV!PN7T,PI5,'CYXB
MM+&4*5*GRSPDJ$8*5/$5G[3G:?+)0O'5-O0^TX)X/S+AK'8W$X[$8"K#%X*%
M"E'"U:TY\T,4JTI-5</13@HIQYH2G:6C26I^V]%?EK_PQC_P4!/(_P""QGQ\
MP>G_ !B/^P=_\X.@_L8_\% 1U_X+&?'W_P 1'_8._P#G!_YZ=2*_+3])/S"_
MX.K?^3./V:/^SL[#_P!4?\9J_A>K_0&_;J_X)2>+_P!I+X8^$/#/[<?_  6(
M^*@^&GASXDZ+KOA*Y\6?!G]ASX1Z?'\2=3TC7?!^@6=MXDL?A/X7DO\ 4]7T
M_P 2ZQIFF^')-0G75+NZCDAL+F]L[-[?X.D_X-:OV9(?&UK\-)?^"EOQMB^(
M][X<F\8VGP^D\,?LOQ^-[OPC;Z@=)G\56WA-_!(UZ?PW#JH.F2Z[%8/I<>H
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MK+ 7NHM2:M=1:DTHM2?\[/[ _P#R?M^PC_V>W^R-_P"M#_#>O]7FOXR/"O\
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M^*OQ/\&_$W]M+4-;^'/AO3OBSXCM?!?C:RT3PG+\.=#O_P!G?_A)O"O@;4O
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M_P"(5UHU@GPX^"/A2'POXR^(/C/X<^#I?$GL]OH_PN^+7QI_:%O-1_82^/\
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M&?C[X^_$?X?Z#\(_$W_#55C\/?%>C? CX!6'Q#\2V_CKPUXO?XB_$/7?[?\
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)12U"BBBI+/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>forms-4_012.jpg
<TEXT>
begin 644 forms-4_012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %I CH# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MK\S/^"PO[1GQ<_91_P"":W[7?[0GP&\10>#_ (O_  M^'-EK?@3Q/=:'H'B6
MWT?6;KQIX6T0WDF@^*=/U;P_J(%CJETBQ:KIUW:*TBRM"6C5E_%KX0?\%>/V
MQ/'W[9__  3J^$.I^*]$;P'X7^&/Q?\ A7_P46\+Z;X4^&6D:E\0OVS/A3\'
M?VS-<\9>%M(\1^,(O#VF?#)?"^J?LDZ'\2K-++Q9X"\&R>%?CMX(U#Q+JMEX
M2NX9[2*<X5'42DHJC.$:LI\R4%/"X_%^T=H2;IPA@)4YRBFXUL3@X6:KWB.Z
MBI*,I*2KN*C&3;E0JX*BZ=[<JJ5)8V#HJ4HQJ1H8E\T72Y9_UL45_.SX&_X+
M_>&_'O@[XAS>&OV7KSQ?\4_!7[0W[&/P!TOP+\+_ -IKX$_%CP#XSU#]NF#6
M8?A!=>'OV@/!.H:A\+;W6O#OB+PUKWAGXG:;IFH:OX,\/:A;VD^@?$KQ=9SW
MTNEX_P"S_P#\%G]=T_\ :J_;:_9C_:'TD:KX[_9Z\??&OX]?$K1-*U7PY8Z)
M^R+^Q3\&OV4/V:_'&N1V&MZ9X*T?6?VEO%-[\=_''Q#\+^%]+\+Z1J?BR]MH
M=9\4>,M6\#^#;?P'INLS*M&$^2:</]FKXISDK4XT</A:6.JSE)7<8QP=7V\I
MN#C&-.<)N-65"G7OV<[)V5W5H48QYH\TI8FO/"TFKM1Y9XF,:,&YIU*E6FJ:
M<?:3I?T?45_,/KG_  7O^(?QH_9HUGXA_LI?LT"V^*FB?M&?L"^!)]#\=?$[
MPEJGA'5/@_\ MI_$W2_"_A^]TGQWINGOX?T[XO1WEOJ7PI\>>#=0L-6TWX->
M+M?TGQ]_:'Q0\#Z=&VL_HS_P49_X*C:-_P $\+SX Z7XH^#E[XMG^.4WC-6\
M6^*?BIX$^!/P5\$3>!].T"ZN/!_B#X\?%#['\,](^)GC6[\0P6/PQ\/>.-:\
M!^#O$<>C>*-3\2?$7P9I^CI/?4YV;4HRA)8BEAN6HG!^UK89XJ"]Y*T?91FI
M2ERJ-6G4I-.:BJV*FG/DC[S^KU,3>#4H^RIXA8:3T]Z[J.$H6C)3I3C5C+D]
MHZ/ZOT5^"'QI_P""M6N?L_-_P46^*EEX U_XQ^ /V1_&/[+D6N^$?&'Q;^"G
MPVT+PMX4^.G[+?A;XK:';_!77_!OP^\4ZM\4/%7CKQ]XH\)>!M+\':YXL\>7
M?BCXA>-K=O /BW3? \5IIZ7H?^"YG@?2_P!JCX/?LG>/?V;_ (C>"?B/XI?]
MEGPC\<](G\8>&M7\4_L_?&/]K/P=9^+/!/@&?P9:64&H_$?PY\/GU_P;H_QJ
M^(^@W>E:9X'O/&FF3Z;H_BFUT+QL_A6TI.48)?O)2IP5-OW^>I1J5XQY=6[T
MJ;ES1O!*5*\H>UINHE5@X2J)KDC&I4<KZ>SI2I0G.VDDE*K%6<>9\M2RDZ=2
M,/WAHK\O?VTO^"E%O^RE\0M7^&/@O]G_ ,>?M$>+?AE^S=XG_;._:!T_PEXM
M\&>!3\*?V5?!OB2\\-:SXTT>X\>75A8?$?XD:Q>Z+XNE\$_"K2;W23KEOX)\
M0'7/%_A)Y_#2>(?"/V$?VR?VB/VO_P#@HI^V[&_B!+7]B7X*?"W]F>/]GWPY
MH*_#V32/&I_:&^%/@[X[^&_C!XMN=3\!V_QJB\4^*?!'B%;C2-!3QAH7@CPE
MH=W)X?U[P9K?C&&/Q- 4E*M%SA%NE&GB:KK-2C24,,KS?,TKJ<E4I4I*\)U*
M.(BII8>LXZ3O"+E);.BDDTY-UYPA%)7W@JE.K43:E"E5HS<?WU+F_;FBOQ0T
M;_@L[X7G^"GQN_; \1?LK_&[1_V&/ ?A?X@Z[\'_ -I72==^&WB"Y^.VL_#K
MXT/^SS+X%A^$$OB71?'GPW\7_$[XL^58?!6#Q2EUI/B/PJ[>*/B1J_PD:WN-
M(BX3XO?\%OX?V?OA[\28_C7^R;XQ^'/[1/P7^-/P8^$WQB^%FL?%;PMJ'P=^
M%VA_'_X?>(_B?\+_ (T>-_VGO#OA[6O"VB?"+6O#WA+7O!]WKD_@K^T]'^+]
MG'X)U/1[?P]J.E^/K[/VBM=IQ7N7YE*#4JD*52,&IQ@XU/8UZ%>5.7+.%&O1
MJRBH58.3<91DX.+YE*<6E[UO9SJ4YN\>?W55HUJ//K%UZ52BG[2$HK]ZJ*_
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M./#$GC/]H*V^)T7Q(\5^%_#OPW1/ 6B?#[7];U'P!IFA;KBT\,1>()9=;?\
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MY_L5C:7EO ]C::?;K!'#86J1?/I_X(V_L07UI\2[?Q5HGQM^)5]\4/"_PT\
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M26R6^B"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJGX@Z[J6F/\ $WP]/XGZGX-^ O&-K^U%\!OAM+\'_B?IWQ>^$G_!6;_@HO\
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M:]6E0I1^IXR/-4K5(4J<;RH**YIU(*[:BKMMI(_JMHHHKXL^Q"BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;?V+/^R6?&S_ -2WX<5_)]7]6^'G_)&Y'_UYQ7_JQQQ_,G'?_)6YU_U_H?\
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M = .H[>XK]IYYZ^_/9_:GV?_ $\/R+DI_P J_P# 8?I"_0_T2?\ @V\1(_\
M@E;\+4C1$7_A:?QZX0*J_P#)4_$715 'IT'2OWAK\(/^#;W_ )17?"W_ +*C
M\>__ %:GB&OW?K^/N+=>*N(V_P#H<X__ -/R[MO\3^JN%?\ DFLB_P"Q5@O_
M $R_)!7XB_\ !Q+_ ,HE/VC?^QL_9S_]:4^%-?MU7XB_\'$O_*)3]HW_ +&S
M]G/_ -:4^%-1PM_R4_#O_8[RW_U*IE<3_P#).YY_V*,P_P#469_G(T445_8:
MV7HOR1_*A!=?\>UQ_P!<)O\ T6U?ZR?[$_\ R9K^R5_V;+\!?_55>$Z_R;+K
M_CVN/^N$W_HMJ_UD_P!B?_DS7]DK_LV7X"_^JJ\)U^->,G^XY!_V&YA_ZAX<
M_6O";_?LZ_[ L'_ZEUCZ<HHHK\$/VX_B8_X.O/\ DMO[%G_9+/C9_P"I;\.*
M_D^K^L'_ (.O/^2V_L6?]DL^-G_J6_#BOY/J_JWP\_Y(W(_^O.*_]6../YDX
M[_Y*W.O^O]#_ -0<&%?H?_P22_Y2;_L/?]E[\/\ _IIUNOSPK]#_ /@DE_RD
MW_8>_P"R]^'_ /TTZW7T&=_\B7./^Q3F?_JOQIX>3?\ (XRG_L:9;_ZG80_U
M&:***_C(_K<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OSU_P""
ME'[:'B7]B[]G#QUXZ^%/@33?BQ\=X/A[\4_B#X!^'>KW&HVWAVV\'?!3P7>?
M$7XP?%7XAW>C_P#$RTGX:_#/P=8HMY>++ID7BKXE^*OA3\&['7]#\5_%GPM>
MC]"J^!OVW_V*OV/_ -L/PEXO\)?M"Z;X6TSQGXN^"GQ'^"^@_$L:Y8Z%\1O!
M7@KXF6IMM9F\*W-[>Q6MQ#!K=GIGB&WL-8T_5M N=?T#2YM2TV]2R$%-)R:4
M4Y-]$FWZV2;M\B92C!<TI**[R:2^]M*[Z:ZGG_QV_:Q^/_P3_;"_9_\ A)K.
MG?!JV^$7[2/QC3X,?#/3)?#?Q4O?'U_8V_P+\5?$?7_BYXD^,\VH>'_@1X'U
M72/B+H/_  @GA3]F76;:Y^(/QA\*:?K?C;X??$.?Q'!)\-;';_9'^,7[7OQ&
M_:)_:7^'?Q?\4_LX?$#X/_L]P^"OAO=?$+X-_!WXD_";5-4_:4U[1=/^(GC/
MP#8VGC;]H7XUVNL^%?AA\+?%/PTNO$'B*WM],CU#QU\0[SP;8W$6J_#+QE9R
M5-?_ &5O@WXD^(?A/5M4_:O\?77P+\&?$OX0_&?0/V5KWXB?#35OA+I/Q+^
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M ,&IT$,/[4'[5_E1)'GX!^#,[%"YQ\0Y2,X^E?RV5_4Q_P &J7_)T'[5W_9
M_!G_ *L*6OG/$!O_ %-S[5_[K1ZO_H.P)[W!"7^M>2Z+_>:O1?\ 0'C3^XY>
MI_S_ !-3J:O4_P"?XFIU?R;'X5\_S9_3JV^_\SP[]IW_ )-K_:%_[(=\6?\
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M;/\ U+?AQ7\GU?U@_P#!UY_R6W]BS_LEGQL_]2WX<5_)]7]6^'G_ "1N1_\
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M[>7^QX5Z=M==+!1117Y2?II_E+?\%"_^4@7[=O\ V>7^T]_ZNOQK7R!7U_\
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MDL^-G_J6_#BOY/J_K!_X.O/^2V_L6?\ 9+/C9_ZEOPXK^3ZOZM\//^2-R/\
MZ\XK_P!6../YDX[_ .2MSK_K_0_]0<&%?H?_ ,$DO^4F_P"P]_V7OP__ .FG
M6Z_/"OT/_P""27_*3?\ 8>_[+WX?_P#33K=?09W_ ,B7./\ L4YG_P"J_&GA
MY-_R.,I_[&F6_P#J=A#_ %&:***_C(_K<**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *HZG(\&G7\\=[9Z;)!97<R:
MCJ$7G6%@\=O*RWM]#]KL/-L[5@)[F/[=9>9#&Z?:[;/G)>KC/B-XM\$^ ?A[
MX[\=?$K4M,T;X=>"_!OBCQ9X^U?6X&NM&TKP5X<T.^UGQ5J6K6RP73W.F6.A
M65_=7\"6URTMI%+&()BWELXQE*48Q3E*4HQC&*<I2E*2C&,8I-RE*4HQC%)M
MRE%)-M)J4HQC*4FHQC%RE*32C&,4Y2E)MI*,8QE*3;248R;:2;7X2VOQ ^*/
MPL\4?MM?!_\ :F_:^_:]L/AU\&/V1OA3^V!X4^,FGS_L]V/Q1^+ND_#>^^+\
MG[3?QC^"5]\'_ >I>%O OPN\87-E\+?#=A^SWXRT]_$FE:@T%YX%TWP[H'B"
MXN-7\*_:@_;,^.?[#'[&WP?^!/Q._;&TOP#^V5XU\(Z7^UC\;/B%\>O&?PVF
M\3_#+X4ZI\:/"D,?[,_PLN=9T_P[I/Q"\;:E+J]Y\%[#Q<GAK4'@^&/PO^/'
MQCU1_"/C.;X9:-J'M7A3]JC_ (-Y_!G@7XC_  T\/_%_X$Q>!?BSX3\._#[Q
MOX>U+5/C%X@M[SX7^#I]2N/!/P@T&X\0Q:K?>"_@KX'EUK7#X&^#?@FZ\/?"
M[P6FO:]#X7\):5%KFJI>?2OQ&_X*T_\ !'OXM^#-;^'GQ%_:T^$7B?P;XC2R
M36M"NO\ A/[6"^33M2LM7LEDN--T&SO8Q!J6GV=VOD7,19X CEHF=&]7^P,^
M_P"A'G/_ (:LQ_\ F(\O^W<C_P"ASE/_ (<\!_\ -AH_\%8?V]M%_9B_9H;2
MOAC\=/A1\)_C3^T1\+OC/K7P-^+7CKQ'X9A\(^$_"OPU^%\OC3Q9\7/#4NO7
MMOX8^('BG3QK7@/PG\(O!-O>ZB_C'XI?$WX>W5YH^J?#W3?'-]I?Z"_LU?$7
M3/B[^SS\#_B=H_B[1_'MCXZ^%'@+Q,/&6@ZKINN:5XCN]4\,Z;<:EJ=IJNCO
M)IEX)]1:Z\Y[)A"ERLT02,QF-?S1O?\ @J9_P1JU+2OC-H6J?M:?#+5-%_:!
MNK^Z^+6E:GK7Q8U&P\2MJGPS\*?![4;6QM;VPGA\):7>_#[P5X>T>XT;P8GA
M[29=0AU/Q0UD?%GB'Q#KFJ_I?^SK\6/@E\:_@OX#^(G[.?BO1O&_P6U'3K[0
M/ ?B/P^=2;2+O3O >LZGX!OK*S;6(;?4W71-;\,:GH,LEY&9)+C397$LZ,LT
MG/B<LS/!4U5QN6YA@Z4IJG&KB\%BL-3E4:<E",Z^'I0<W&,I*"DY.,9-1LFU
MT8;,LNQDW2P>88'%U(Q<Y4\+C,-B)Q@FHN<H4:]648*4HQYG%1YI15[M)^V4
M445PG:?S*_\ !U-Q^P9\ 1_U>SX)/_FO'[3/^)K^#_!.>>Y_O>I]&'\J_O _
MX.I_^3#?@#_V>QX)_P#6=_VF*_A '3\6_F:_IKPJ_P"2.H?]C3-N_P#S_P +
MYG\Z>)/_ "56(T7^X9;NK_\ +FN)M/K_ .A?_%5G:OD:3JG/33KQAUZB!ASD
MGCGI6G6;K'_()U3_ +!M[_Z)-?I$6^:.OVH]7_,O,^"TL]%\,NB_E?D?Z_/P
ME_Y)9\-?^Q \&?\ J-Z97H->??"7_DEGPU_[$#P9_P"HWIE>@U_$%3^)5_Z^
MU/\ TY,_L.C_  :/_7JE_P"FZ85_"-_P=0_\GK_L]?\ 9KEI_P"K8^(U?W<U
M_"-_P=0_\GK_ +/7_9KEI_ZMCXC5]]X7?\EE@_\ L S3_P!18'Q'B1_R2F*_
M[#<M_P#4J9_,A1117]/G\YGZP?\ !##_ )2U_L6?]C5\7O\ UFOXUU_ID5_F
M;_\ !##_ )2U_L6?]C5\7O\ UFOXUU_ID5_.OB]_R46 _P"Q+1_]3L:?O7A7
M_P B+'_]C:?_ *A84****_*3]./\I;_@H7_RD"_;M_[/+_:>_P#5U^-:^0*^
MO_\ @H7_ ,I OV[?^SR_VGO_ %=?C6OD"O[3RS_D699_V+,M_P#5=EY_(>9?
M\C',?^QAF'_J?C@K^IC_ (-4O^3H/VKO^R!^#/\ U84M?RSU_4Q_P:I?\G0?
MM7?]D#\&?^K"EKYSQ _Y(W/O^P6C_P"IV!/>X(_Y*O)?^PFK_P"H>-/[CEZG
M_/\ $U.IJ]3_ )_B:G5_)L?A7S_-G].K;[_S/#OVG?\ DVO]H7_LAWQ9_P#4
M"U^O\CK3O^/*S_Z]8?\ T3%7^N+^T[_R;7^T+_V0[XL_^H%K]?Y'6G?\>5G_
M ->L/_HF*OWGP:_W7B/_ +"LK_\ 4;%GXKXL_P"]9'_V"X__ -2<,7J0]/Q7
M^8I:0]/Q7^8K]I>S]'^3/R);H_T2O^#;W_E%=\+?^RH_'O\ ]6IXAK]WZ_"#
M_@V]_P"45WPM_P"RH_'O_P!6IXAK]WZ_C_BW_DJN(_\ L<X__P!/R/ZIX5_Y
M)K(O^Q5@_P#TTPK\1?\ @XE_Y1*?M&_]C9^SG_ZTI\*:_;JOQ%_X.)?^42G[
M1O\ V-G[.?\ ZTI\*:CA;_DI^'?^QWEO_J53*XG_ .2=SS_L49A_ZBS/\Y&B
MBBO[#6R]%^2/Y4(+K_CVN/\ KA-_Z+:O]9/]B?\ Y,U_9*_[-E^ O_JJO"=?
MY-EU_P >UQ_UPF_]%M7^LG^Q/_R9K^R5_P!FR_ 7_P!55X3K\:\9/]QR#_L-
MS#_U#PY^M>$W^_9U_P!@6#_]2ZQ].4445^"'[<?Q,?\ !UY_R6W]BS_LEGQL
M_P#4M^'%?R?5_6#_ ,'7G_);?V+/^R6?&S_U+?AQ7\GU?U;X>?\ )&Y'_P!>
M<5_ZL<<?S)QW_P E;G7_ %_H?^H.#"OT/_X))?\ *3?]A[_LO?A__P!-.MU^
M>%?H?_P22_Y2;_L/?]E[\/\ _IIUNOH,[_Y$N<?]BG,__5?C3P\F_P"1QE/_
M &-,M_\ 4["'^HS1117\9'];A1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !12$9Q[$'_/^>#@]J_G:_:-\5?LS^#_^"B_P8\;^ OBSX+MO
M&=[^T5\7OAO^V/#9?$[QSX1_:]\%Z9??L._$\^=J.H^+-9MK3PO^P9\'?!,/
M@?X]ZYX7L-+\*_#/1_B7;>!_VC?!?CAO&6D:AX>^*8!_1-17\K/PRUK]@/Q5
M^S-^W?\ M,?#CX1_L[?%O]D3PQ\"/@9J?P%_9"\;>+?!7Q9\1_&_XH?#%?C"
MOPW_ &M_C[\-=2O/%6I_"SXI?M;^*_B7X*^&OA6_^(4"_M">+O"'@;2/&?Q_
MFMOB!K%E\*OA'^J7A/X$?LD?L+?\$][3]D3XS_$W1_ W@+1?@]XM\8_'76O
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M^3#?@#_V>QX)_P#6=_VF*_A '3\6_F:_IKPJ_P"2.H?]C3-O_3^%/YT\2?\
MDJL1_P!@&6_^F<0+6;K'_()U3_L&WO\ Z)-:59NL?\@G5/\ L&WO_HDU^CQ^
M*'^./YH^"Z/_  R_])9_K\_"7_DEGPU_[$#P9_ZC>F5Z#7GWPE_Y)9\-?^Q
M\&?^HWIE>@U_$-3^)4_Z^U/_ $Y,_L.C_!H_]>J7_INF%?PC?\'4/_)Z_P"S
MU_V:Y:?^K8^(U?W<U_"-_P '4/\ R>O^SU_V:Y:?^K8^(U??>%W_ "66#_[
M,T_]18'Q'B1_R2F*_P"PW+?_ %*F?S(4445_3Y_.9^L'_!##_E+7^Q9_V-7Q
M>_\ 6:_C77^F17^9O_P0P_Y2U_L6?]C5\7O_ %FOXUU_ID5_.OB]_P E%@/^
MQ+1_]3L:?O7A7_R(L?\ ]C:?_J%A0HHHK\I/TX_REO\ @H7_ ,I OV[?^SR_
MVGO_ %=?C6OD"OK_ /X*%_\ *0+]NW_L\O\ :>_]77XUKY K^T\L_P"19EG_
M &+,M_\ 5=EY_(>9?\C',?\ L89A_P"I^."OZF/^#5+_ ).@_:N_[('X,_\
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M"FOVZK\1?^#B7_E$I^T;_P!C9^SG_P"M*?"FHX6_Y*?AW_L=Y;_ZE4RN)_\
MDG<\_P"Q1F'_ *BS/\Y&BBBO[#6R]%^2/Y4(+K_CVN/^N$W_ *+:O]9/]B?_
M ),U_9*_[-E^ O\ ZJKPG7^39=?\>UQ_UPF_]%M7^LG^Q/\ \F:_LE?]FR_
M7_U57A.OQKQD_P!QR#_L-S#_ -0\.?K7A-_OV=?]@6#_ /4NL?3E%%%?@A^W
M'\3'_!UY_P EM_8L_P"R6?&S_P!2WX<5_)]7]8/_  =>?\EM_8L_[)9\;/\
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M9M=6O? ,OB#P79:/XQ\3?/G[%/[,O[7/[-W@[QK8_$?Q3^SC\0/BG\1?B/\
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MT_\ U"PH4445^4GZ<?Y2W_!0O_E(%^W;_P!GE_M/?^KK\:U\@5]?_P#!0O\
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MA7XB_P#!Q+_RB4_:-_[&S]G/_P!:4^%-?MU7XB_\'$O_ "B4_:-_[&S]G/\
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M/_R8;\ ?^SV/!/\ ZSO^TQ7\( Z?BW\S7]->%7_)'4/^QIFW_I_"G\Z>)/\
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MR+,L_P"Q9EO_ *KLO/Y#S+_D8YC_ -C#,/\ U/QP5_4Q_P &J7_)T'[5W_9
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MW_U*IE<3_P#).YY_V*,P_P#469_G(T445_8:V7HOR1_*A!=?\>UQ_P!<)O\
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M(>GXK_,5^;O9^C_)GZ"]F?P%?\'1/_*2#X:_]F4_"/\ ]7=^T[7\YM?T9?\
M!T3_ ,I(/AK_ -F4_"/_ -7=^T[7\YM?UOP/_P D?PY_V+*?_I_''\N<8?\
M)49[_P!C&K_Z:P@5^S7_  ;[_P#*6;]FK_L _'C_ -43\0:_&6OV:_X-]_\
ME+-^S5_V ?CQ_P"J)^(-=G%7_),<1?\ 8ES+_P!1I'-PU_R4.1_]C; ?^I"/
M](ZBBBOX]/ZM$/3\5_F*_P EO]KK_D[G]K3_ +.G_:._]71XWK_6D/3\5_F*
M_P EO]KK_D[G]K3_ +.G_:._]71XWK]F\&_]_P __P"P# ?^I]<_(_%G_<\D
M_P"PS&_^H=$^?****_>C\3/ZZO\ @TX_Y'#]O[_L5_V5O_3K^T?7]GB]O]U?
MZU_&'_P:<?\ (X?M_?\ 8K_LK?\ IU_:/K^SQ>W^ZO\ 6OY6\2?^2US;TP'_
M *K,*?TCX>_\DIEO_7S'?^IM<=7QG_P4;_Y1Z?MX?]F9_M0?^J0\<5]F5\9_
M\%&_^4>G[>'_ &9G^U!_ZI#QQ7R>7_\ (PR__L89?_ZL, ?68_\ W#'?]@.-
M_P#4/&'^4_']S_@*?^C*DJ./[G_ 4_\ 1E25_:\MW_BE^9_(*V7]?9@(W0_0
M_P J_P!(7_@WM_Y1%?LJ?]A3]I/_ -:W^.U?YO3=#]#_ "K_ $A?^#>W_E$5
M^RI_V%/VD_\ UK?X[5^4>+__ "36"_['=#_U!QQ^E^%O_(_QG_8GK?\ J=@3
M]I****_G0_?C^97_ (.I_P#DPWX _P#9['@G_P!9W_:8K^$ =/Q;^9K^[_\
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M;/\ U+?AQ7\GU?U;X>?\D;D?_7G%?^K'''\R<=_\E;G7_7^A_P"H.#"OT/\
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M^)J=7\FQ^%?/\V?TZMOO_,\._:=_Y-K_ &A?^R'?%G_U M?K_(ZT[_CRL_\
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M]GL>"?\ UG?]IBOX0!T_%OYFOZ:\*O\ DCJ'_8TS;_T_A3^=/$G_ )*K$?\
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M$7_@XE_Y1*?M&_\ 8V?LY_\ K2GPIJ.%O^2GX=_['>6_^I5,KB?_ ))W//\
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M(/AK_P!F4_"/_P!7=^T[7\YM?T9?\'1/_*2#X:_]F4_"/_U=W[3M?SFU_6_
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M_9F?[4'_ *I#QQ7V97QG_P %&_\ E'I^WA_V9G^U!_ZI#QQ7R>7_ /(PR_\
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M^BVK_63_ &)_^3-?V2O^S9?@+_ZJKPG7^39=?\>UQ_UPF_\ 1;5_K)_L3_\
M)FO[)7_9LOP%_P#55>$Z_&O&3_<<@_[#<P_]0\.?K7A-_OV=?]@6#_\ 4NL?
M3E%%%?@A^W'\3'_!UY_R6W]BS_LEGQL_]2WX<5_)]7]8/_!UY_R6W]BS_LEG
MQL_]2WX<5_)]7]6^'G_)&Y'_ -><5_ZL<<?S)QW_ ,E;G7_7^A_Z@X,*_0__
M ())?\I-_P!A[_LO?A__ --.MU^>%?H?_P $DO\ E)O^P]_V7OP__P"FG6Z^
M@SO_ )$N<?\ 8IS/_P!5^-/#R;_D<93_ -C3+?\ U.PA_J,T445_&1_6X444
M4 %%%% !7\H?_!UW_P F^_LB?]ET\9?^JWU"OZO*_E#_ .#KO_DWW]D3_LNG
MC+_U6^H5]CX?_P#)9\/_ /894_\ 4+'GR?'/_)*9S_UXH_\ J;@C^)(=/Q;^
M9I:0=/Q;^9I:_J__ (/YL_F/_@?DCU_]G;_DXO\ 9X_[+[\$_P#U9WABO]<@
M=/Q;^9K_ "-_V=O^3B_V>/\ LOOP3_\ 5G>&*_UR!T_%OYFOP;QE_P!\X>_[
M!<Q_]2L,?M7A-_N^=_\ 81@/_4;$BTAZ?BO\Q2TAZ?BO\Q7XN]GZ/\F?KKV9
M_ 5_P=$_\I(/AK_V93\(_P#U=W[3M?SFU_1E_P '1/\ RD@^&O\ V93\(_\
MU=W[3M?SFU_6_ __ "1_#G_8LI_^G\<?RYQA_P E1GO_ &,:O_IK"!7[-?\
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M_P#V-I_^H6%"BBBORD_3C_*6_P""A?\ RD"_;M_[/+_:>_\ 5U^-:^0*^O\
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M]0L>?)\<_P#)*9S_ ->*/_J;@C^)(=/Q;^9I:0=/Q;^9I:_J_P#X/YL_F/\
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MEK]FO^#??_E+-^S5_P!@'X\?^J)^(-=G%7_),<1?]B7,O_4:1S<-?\E#D?\
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M0\<5]F5\9_\ !1O_ )1Z?MX?]F9_M0?^J0\<5\GE_P#R,,O_ .QAE_\ ZL,
M?68__<,=_P!@.-_]0\8?Y3\?W/\ @*?^C*DJ./[G_ 4_]&5)7]KRW?\ BE^9
M_(*V7]?9@(W0_0_RK_2%_P"#>W_E$5^RI_V%/VD__6M_CM7^;TW0_0_RK_2%
M_P"#>W_E$5^RI_V%/VD__6M_CM7Y1XO_ /)-8+_L=T/_ %!QQ^E^%O\ R/\
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M7?"W_LJ/Q[_]6IXAK]WZ_"#_ (-O?^45WPM_[*C\>_\ U:GB&OW?K^/^+?\
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M?5_5OAY_R1N1_P#7G%?^K'''\R<=_P#)6YU_U_H?^H.#"OT/_P""27_*3?\
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MK_L _'C_ -43\0:_&6OV:_X-]_\ E+-^S5_V ?CQ_P"J)^(-=G%7_),<1?\
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M;_Y1Z?MX?]F9_M0?^J0\<5]F5\9_\%&_^4>G[>'_ &9G^U!_ZI#QQ7R>7_\
M(PR__L89?_ZL, ?68_\ W#'?]@.-_P#4/&'^4_']S_@*?^C*DJ./[G_ 4_\
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M_L.C_!H_]>J7_INF%?PC?\'4/_)Z_P"SU_V:Y:?^K8^(U?W<U_"-_P '4/\
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MO*_E$_X.NE8_L^_LBD*2!\=/&() ) )^&^H8!QTS@X]<'TK['P__ .2SX?\
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MN?VM/^SI_P!H[_U='C>O]:0_U'\Q7^2[^UVK#]KK]K4%6!'[5'[1P((((/\
MPNCQOP01D&OV;P;_ -_S_P#[ ,!_ZGUS\C\6?]SR3_L,QO\ ZAT3YZHI<'T/
MY&C!]#^1K][L^S^Y_P"1^)77=?>O\S^NG_@TX_Y'#]O[_L5_V5O_ $Z_M'U_
M9XO;_=7^M?QB_P#!IPK?\)?^W\=K8_X1C]E49P<9.J_M($#..I"L0.I ..AK
M^SI?_95_K7\J^)*?^NN;:/; ?^JS"G])>'G_ "2F6_\ 7S'?^IM<=7QG_P %
M&_\ E'I^WA_V9G^U!_ZI#QQ7V97QG_P4;Y_X)Z_MX8_Z,S_:@_\ 5(^.*^3R
M_P#Y&&7_ /8PR_\ ]6& /K,?_N&._P"P'&_^H>,/\I^/[G_ 4_\ 1E24V-6V
M?=;[J=C_ '\^GIS3\'T/Y&O[7DG=Z/XI='W]#^04U9:K[U_+'S&MT/T/\J_T
MA?\ @WM_Y1%?LJ?]A3]I/_UK?X[5_F]E6P>#T/8U_I"_\&]H(_X)%?LJ9!'_
M !-/VD^Q_P"CMOCL?Y<_3FORCQ@3_P!6L%H_^1W0Z/\ Z <<?I?A;_R/\9_V
M)ZW_ *G8$_:.BBBOYT/WX_F5_P"#J?\ Y,-^ /\ V>QX)_\ 6=_VF*_A '3\
M6_F:_O _X.IE8_L&? ' )_XS8\$= 3U_9X_:8Q^>#CZ5_" %;T/4]CZFOZ:\
M*D_]3J&C_P"1IFW1_P#/_"^1_.GB5_R56(_[ ,M_],X@*S=8_P"03JG_ &#;
MW_T2:T\'T/Y&LW6%8Z3JF%/_ "#;WL?^>+5^D13YH:/XX]'W7D? W5GJOAEU
M7\K\S_7X^$O_ "2SX:_]B!X,_P#4;TRO0:\_^$P(^%OPV!!!'@#P:"",$$>&
M]-!!![@\'WKT"OX@J?Q*G_7VI_Z<F?V)1_@T?^O5+_TW3"OX1O\ @ZA_Y/7_
M &>O^S7+3_U;'Q&K^[FOX1_^#J%6/[:W[/1 )'_#+EJ,X.,CXK_$7(S[9&?J
M/6OOO"[_ )++!_\ 8!FG_J+ ^(\2?^24Q7_8;EO_ *E3/YCZ*7!]#^1HP?0_
MD:_J"S[/[G_D?SE==U]Z_P S]7_^"&'_ "EK_8L_[&KXO?\ K-?QKK_3(K_,
MY_X(7JQ_X*U_L685CCQ3\7B< G '[-7QL))XZ  DGL 2>!7^F-7\Z>+W_)1X
M#_L2T?\ U.QI^]^%7_(BQ_\ V-I_^H6%"BBBORD_3C_*6_X*%_\ *0+]NW_L
M\O\ :>_]77XUKY K[ _X*%JW_#P']NS@\_ME_M/$<'D?\+K\:\U\@8/H?R-?
MVGEB?]F99H_^19EO1_\ 0NR_R/Y#S)K^T<QU7_(PS#JO^@_'>8E?U,?\&J7_
M "=!^U=_V0/P9_ZL*6OY:,'T/Y&OZF/^#5)6_P"&G_VKCM./^%">#!G!QD_$
M*8@9Z9(!P.IP?2OG/$!/_4W/M'_NM'H_^@[ ^1[W!#7^M>2:K_>:O_J'C3^X
MU>I_S_$U.IHZG_/\34ZOY.CLOG^;/Z=6WW_F>'?M._\ )M?[0O\ V0[XL_\
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MPV&53FE3PTVKTL/'V;I^TKMUHR:=2G&C!)J=5W?^'17[&'_/Q^V5_P"+./\
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MX*2R^*? ^F?!36=(\/?&CQ%\8_ \'Q!E\;? ?PC\'-;\0^'=+^+/C+XU>'_
M'A3X;7WB/P];^--9T1]=TK[9]!^"_"?[<?P8\"?"'Q_X'_8K\3ZO\6/V4?V#
M/AQ^P]H7@CQ#XJ^$.I^&OB5\7M>^(_P7C\6?&KPW:Z+\5-,N?$WP0_9_\/\
MP4D^)>A0:[KOPK\??%*/QO9>!?#EE\/?$DOB36_">WX\^"WQ8UG]B3QE\ ++
M]D_]LOX@>(OVC]$_:&UWXI?%J[^*7[/?PC^.FK?M1>-]0TJ>TU#XK> M'^*-
MU\*K7]FCXI2ZG/;+X6L?%?Q)^'&@?#7X;Z-\(?B?\%?%/A6[M%USH^OYC9R^
MOXV2C4I0Y8X[&J=1.O-*<.?%Q457PD'B5S27U>K5P^"J7JSK3P_.L%A7)*6%
MP=.,IU>63PN&DHPBK<TN7"RLZ=5QIN.CJQC6Q$/W%."Q'A^F?\$ZO^" OPM^
M.7B#P9\//V?/VL++XR_![QOH?@37?&'[/UY_P64\5V/P\\<^./AYX/\ &FG:
M/_PO?X'ZYKO@?0;Z_P#AG\6?".LZY<V?C^"WTKPKXQC7Q)<V-E<W\2?IY_PZ
M,_8OZ&?]LL'C_G)Q_P %,<=3GG_AKG' !-?&/PX^#/QJ^$_[3?[2WC3XM? G
M]O/Q?K?CS]H7X#?$_P />*OV/_C7X=\!?LR>,;?PM^Q/^QC\*O%NIZO\++_]
MISX:M=Z:/B]\)?B3H^H:-XH^'UY?7_@+3=#TNZEU?2AI]I%_0%W[]O3'4CI^
M.?P]L5$ZU:M&G4Q%>K7J>]!SJ5:M:T8NI90E5J5*B@[*:NH1]_X5*5DZ,8P]
MVG1IT(RA3J.G"E"E[\X4G/FC"$%S1<ITVGS27)9R?(W+\S?^'17[&'_/Q^V5
M_P"+./\ @IC_ /1=4T_\$C?V+P#_ *5^V2/K_P %.?\ @IB!T.>O[76!P#WZ
M=\5^FU0S.(XY&\II=D;-Y:*C/(%!.Q%9E5G?!"*S*"Q ) R1A4DXQ<DTN6,I
M:QG)>[&4KM0C*32M=J,93:NH1E)Q3Z.R6[=NV[2W;26^[:75M)-K^7JW_P""
M>?\ P;>?%&+XB?$^]\">+/$[VFC+\6]=\=>-OCS_ ,%(TU3XQ:!XS\9+X7T_
MXH?"37O&OQ2M]4_:HTOXB_$35]*\.^&O&_P0N?BI;?$?QOXS\'Z1X>U37]?\
M?>$[?7:.O?\ !,W_ (-M?#?@WPMXWU3X&^.'T[Q:?B7]B\/Z1X__ ."FGB+X
ME:);_!2]M-,^,NI>/_A!X>\<:I\6/A=HWP@U/4]%TKXJ:[\2O!?A/1_AWJGB
M'PUIOC"^T:]\2Z#;ZC[3<?#3]JO]I6'Q#\=OBY^R+\</ /QY\ >./V5O&7PE
M^">I2? '2OA-\._V9_V=OVW/V?OVD/&?[.OPF\2Z'\;O$(\>_M)?%G1/@_H_
MBOQ#XZ\<6?PR^%^L>-?A]\,/ 'AR]^&_A'PC>>+_ !=TWQ!\._MIZ/H/Q9L/
M _[-/QW\+^'_ -NW]H[XP?$WXK^,/AC/\!/$G[0?[-/[/</PH^!'P5M? 7@[
M2?$_QC\->!]%^.G[1EM\,+CQEI?BVV\3>./"_P #["\N=;\1Z!XL^(NDZ-X9
MCZ/[0S*/+"&*QT7[.FJ<9X_$P@I2;5*,G3Q4XTZ<Z*7MHP4I8*>%KTE&OSX1
M5L%A,$W.4\/A6E4=^3"8><ZBYU&JZ?/A8N3IW=2E*LZ?UM8BC*]",<5*ES.L
M?\$3O^#?G0_%OP3\"W_P3TU_%7[1VF>+=>^!ND:9^U=^V/KDGQ,\.^!?!]OX
M]\7>)_#-SHGQ[U"RN/"VA^%+S3-4N_$\]S;Z"[:WX=T^WU"?5/$>AV6H8/[(
M?[!?_!#7XB:YHMU^R#\'OVVO!1^*7A&/6]'^(WA+Q1_P6L_9S\ >.?!4%LGB
M#3KAOC1K_BCX9_#G6M$OH6AU3PW;7?C2:#799(9O#T%_<RQ;OH'3?V)OVB_"
MW[4'[*GQA\'Z5\-9/A%X?\>6>D:7X0O/ ^M:%\1/V6/V4_!/[%GQE^%?PL^
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M/PU^ GQ#\<?!+X%7O[2OQ<\/Z=I]S\.O@O9:[X:\+_\ "7>+9]<TNST:>_\
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M_P#HNJ^6/VI/^">/_!)+X<^'=!\%?M+VW[6OC?2?B5+JUQH?PEF_;*_X*O\
M[26K>,H/AW!9^*_$'B)/@SX%^/?Q/\0ZKX<^'N-%UG7_ !A<>$)?#G@K4;WP
MU-J>L:7J6JZ%]J_=NOSK_;\\;?M/Z)I'PW\ _LV?!SXL>)!\4+OQ?H/Q9_:
M^#5A\'/$'Q'_ &=_AM::=I4VHM\,O"OQ?^)'P\T?4OBY\3;N>WT/X=^(M5;Q
M/X"^&M]HM]\2/'?@[Q\/#'A_X:^.N>K4K4HJ>'_CI_N;2G3_ 'JC-TVZT+2H
M04XQ=2LKRI4XU)4XU*SH4JM\L)WC57-2<9>T7+&;<+1YDJ<E)59.+E&%)I*K
M4E3C*5.'M:M+\I+3_@D]_P &XNI>/_ GPWT7X2)XAUSXDZ9X'U7P=K?AG]HO
M]NWQ/\--1C^*'AR[\7?"W3+WXS:!\8M2^$'A[Q/\4/"]F_B+X9^#_$GCG2/%
M7Q!T2XTW5/!^C:S::OI4MYR?AS_@FI_P;1>*=)\9>(-*^%UW'H'@OP7<?$B3
MQ!K7QO\ ^"AGAG0?'7PZM_$EOX-_X3WX(ZUXF^)^D:7^T/X+O/%VH:%X5TGQ
M3\!KKXD:'KOB/Q9X)T31[Z^U/QSX0M=<^I=$_9-^)OA>WN/V=/A+^S/XX^'_
M ,$OB/\ M9?\$O\ ]J7X:^+=8\3?#Z3PY^S]\#_V*_!?["\'B#X&_%6.;XD:
M_P#$.Y^+GAZU_8IG^'VA6GA;3_B/X>UZ[^)?A#5)/B'=:;I?Q U?P[Y;XU^#
MG[5'[8_A_P"(/Q'^+G[*'[1GPE^,WAC4OV?]1^"GPEL_$_P7^'?@?X9?LQ_
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MT_8\^'GC[X"?%?5/B1\+[?X)7MC^T3\:?#7B71O&_@T^/]6USXT>%_'/@/X
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/N /\_G1113 **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>forms-4_013.jpg
<TEXT>
begin 644 forms-4_013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !< <(# 2(  A$! Q$!_\0
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MN7*E1KO&TY4OT&4YB?(CR"K+OQ@YXRY."3][!.#SQD<EL)8(V!!NW9*QL<$
MD'/)]>1GH<$9S7RCXQ_:Q^%G@O\ 9DG_ &K+1M4\7?"L^#=!\=:;)H&F&/6=
M:T?Q3/80:*+:SUB\T^*UO9KK4[*TN+*\FM6M+F1A.R)&X7-^#?[66C_$#XB-
M\&/&OPG^)_P.^*M_X$N?BEX7\)?$2'P;>VWC#P%9ZCI6E:MK7AKQ5\._&'CG
MPS<WFBZAK>E)KGAV]U:Q\1:9'J-E>7&D1VES'+6<\5AXUX8>48VKQA6BVM)*
MI%2ISNFX\LT]).2N[6['CQX7SZ> QN9PRRJL#EF)S;!9C6JTZ5+.,!BLBC1G
MGF%EE_MGB8K)H8C#O,72HUZ6"HXBC4K5G2JQJK[6YR.1TYY_4#Z]_2F2E0GS
M8P6 '&?F+?+V//X<D^E<[8^+_#>I3W=MIVLZ=?3Z=*;?4(K.YBNI;&>,;I+>
M]2!W:UG4<F"<1R\CY,D"J=UXOT*ZT_5Y='O[3Q#<:1-<VU[IVA7UC?7Z:C8V
M\MY-I#PQW2^3JOD0EQ83217&UD<H$8-3A4I-1DJD'&3LI\ZY7>]K25U]EVMK
MIWW\]8;$.=2G[&O2J4G057VF'Q%)X?ZS.$,/.NJV'H.A#$3J0A0J5O8TZ\I1
M5"K6UMU411B,<D $'/3MSQ] /Z8%2@Y=N"0,8/8^A&>/H<^OK7D7@;XHZ7XC
M\)^'O%_B#2M9^&O_  DP*6WA_P"(RZ5HNOV5S'=26HT^[:RU;4=)DN96C%Q:
MV]K?S3FUD221 VY5N>'OC/\ "_Q1X[\;?#/P_P".- U;QW\.9-#B\:^%[.]2
M35O#TGB&SN+_ $B&^AX4S7-E:SS210-*]H(F2[6"0A"/$4.9Q5:ES-0M#VL.
M:U2G*M#2_,O:4H3JP3LY0BY)63-WE>:16,E]0QU6GEJKO'XBG@L74P^!CA\1
M1PF(J8G$4\-4PU&E0Q6(H86K6EB)4:>(K4Z,JRJ5%$]3!ZYQ@,?3_/6@8QC@
MGC.WW/'3'X^U<AIGCOPAK,FNQ:3XATG4Y?#EV;+7X["]M[R31[I4DE,&HQV\
MLALY5C1WV7 C;"DD8 J>X\:>$[#3[W5M1\1:-INF:<XAU'4-0U&TT^RL9\(1
M!>W%W+#%:W!\V/$$[I*?,0!.1G27N/EE[KO#W79-^T2<++=\_-%Q<4T[I\RU
MMSQHXF=:.'CA<8\1-TXQP_U',(UY2K-*A'V$LNA7YZZE%X>FZ*J8F,Z<\+3Q
M4*M*I6Z1P/+;)7E6!(QP,'.,8.<&L]A%\K1$/(T8\L#/W% 7=TR,@@#OGC&#
M6/<^,O#-MI(U>YUG3K;2IX8Y+?4KR=+;3YUNR([-X[V=H[:1+R5TBM&24BZ=
ME2 R,:^?_@#^T9I'Q\G^/%II6A7WA^/X'?'OQ%\![Z_O9K2ZMO%.H^'/ _P\
M\9S>*]'%FS"RT34[?X@VVG6<%V_VAWTN>Z4M;S02&9UHTI4X2UG5J3IPA=.<
MYPBI5*48)\\IQA[TH*SY5+>S3(8+%8C 8O-8X:57+<IKT(8NO4I5Z=&CC:U6
MK0PU"=:K0I4HUG6I5*,\/SRQ%&JE&MAZ#E357Z3;Y1$6#%E5@2,$*2X('1P"
M.H(Y&1@\8+RPS\IC.T;6#2+][('*F,@YSW_"OANT_:^U3QWKFKP_ O\ 9^^+
M/QR\!^&/$]QX.UKXG^']2^%_@7P?/KVFZM'HWB6+P=)\3O'7A+6O&^G>$7DN
M9->UO1-(N=%8VEU;:7J>H7<?D+QOB[]O[POX+\1?%]+_ .!/QTN_A_\ L_\
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M9?&WA)K,Z@/$N@_8?MS:8;[^UK 60U)'CC.G-=&X\A;\NZ1BT,@N"[HHC+,
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M,KI95A<%0R*N\+%JK5AC<GRS-5F%>A2]OC,?G6)KX95LWQJG^27[4'P?\7>
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M'^*_#'BA-.>2&]?0=<T[65MY%"D)<#3KJX:!LDJ5D&&QN!&179K(P WA=Q3
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M^-O$_C+25@D>P\0>(]47Q5HT?@RV\1:L(T5H-%UZYM?#\K3G2)6EMX;CD?\
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M3G&C1KTIQ49\M?V*<X35X2BJ52HDIJS2GRM1DG)+9_@K_P '!'Q0OO#WPG^
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M&A^%;RX9>$TSXA+=>!;^/;E,">W\0RJ!G9YI5V!89/\ ;)^VEX 3XE?LH_M
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M+]KO1KG4[;Q#:QZG^SG^S1=3?8_$WQAN(D2[M/&'CN'FZ\._".POX[:>X:\
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MSXLG@<L6(7#\)I.,G5<*=-58T7BOA2J573E*$,(K0L^;F4E4FO\ 9;PX\,/
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MN?V</%7P'\&>-=)^'M_XLUGP]<ZCK^LZ/?ZY8'1-$U2+4[_2)K'3IK>2XDU
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M!%<:U90ZEIFF)>RWD(DU2]BN((?LD1W13N(I IW"OD?]CG_@F_J'_!-/Q_\
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MJ4$J-J.^-DO[BXS& &!C"L-B&O2_C]^T/\/[3]E/]H'XL?#[QQX6\9Z;X/\
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M'9GETW4[599+><,L\<%U97=G<1/:W]AJ-O:7EC<Q/;75O%,I0?S\_L\_%O\
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M$"[AE  8E@$SEB @R5PV0"%("X9!G)VU\C_M=?MT_LT?L,Z)\-?$'[2OCU/
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M;:[O)K:SMX+.."%/NX01C/!P0 X))WD8^9R>6;@?,3G\SF4   #L /R&/Y4
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MM>'-3_:7DN)/$&FZ/!$[VD]CX9%UY6AF[(>2&&*.Y&%)/Z&>6.Q(]@>!R3@
M@@<GL,\#G I54+D9)!.<-@_EP/0?CSU)R ?DIXN_X)5>';_X*_L)?#CX<?'W
MXB_"KXF_\$^+73K'X(_'/2] \,:_KMY:1^!W^'WB2P\6>$-64>&]5M/$WAYP
MEW;-M2UGVS6IW @[O[3O_!._X@?M;6/C'X:_%7]M'XNW'[-7Q.TCP9H_Q1^
M.D?#[X9:=9>)](\.Z?:+X@TO2?'<>E#Q-X:LO'6MV:ZYKT-O_:%Q:R,VGZ?<
M6UJJX_4PQ(Q)8;@V"5))7(Z,%S@-_M#!/<TWR(^<;@IQE QV9!SD+G )/)*X
M)[F@#YE_:,_9'^#7[37[.NN?LQ?$/2+ZU^&>I:-X>TO1$\-:A/I/B#P1>^#+
MC3[OP/XA\&ZV&EN](U_PC?Z7IMYI%^&ED62V"3^=%+,DGYO_ !C_ ."-E]^U
M/X;\)^'OVM?VW_C]\=)O@_/9:_\ L_ZL?"/PK\!W7PP^*VE?V@NG?%W5AX?\
M.R-\0?%EIIUU9:3%9ZM-IWAJ>PMKTWNBW5[JDEY!^W[*&!!Z'^AS3!&H(;DD
M9(R2>HQW]N* /+)_A9I_BOX37'PC^+\^G?%W1_$7@2?X?_$9O%/AS2H]/^).
MAZKI+:)XJM_$7AVVW:4MEXGTVXO+;4-+MP+)$NY1$FT*H_+KP-_P2N^-'P&T
M6T^%O[,O_!2_]J?X/_LY:!';:?X!^"VM>'/AM\8)OAEX8M'B6R\$>!/B7\0=
M(O\ QMIW@K1=.@AT/POH>IWFK+X9T2VM-.TN9(;<9_9ED#,K$GY3D 'C/Y9P
M1P0#@^F232/$K]2W/<,0<9+8SZ9_08Z9! /S'^)O_!.V]U#X[ZQ^TW^SK^TQ
M\4/V6_CA\0?A_P"%?AU\<]?\*>&/ OCKPI\<K/P':WUMX*\6^-_ WB[39-$M
M?B/X=35+^"V\7Z/)87-WIKVNE:E;WMC8VT:\-K7_  1[^ VH_LS>#?V<--\=
M?$JU33/VJO!'[9/Q'^*NM7EAXH^)?QK^-_A;QC8^,]<\1_$'5M1BBAGD\7ZC
M86]I=BQBA32-(AMK#2HXH[92WZW^0GS<M\YR_P!W#'D?,-N".3P00.PX%/1%
MC&U1A>PSP/8#L/8<4 ?(/Q1_9#\,?%/]K7]EW]K?4_%7B#2_%'[+?A_XV>'_
M  YX2LK;3Y= \4P?&OP]IGA_5IM;NIU^WV\NBP:8D^G+9D1S22N+D% !7SIX
M6_X)T>*-3^-?P6^,7[2'[6OQ3_:?3]FOQ'XH\;? GP=XO\#_  \\&:;X5\;^
M(=,U+P\OBOQ)J7@S3;*Z\7:KH'A[5M3T+1,Q:+;QV=R)+Z"_N$\\_J6RAU93
MG#*5."0<$8.".0>>".1U%1^2N02SG!# %CMR!@8'0#U P&/)!))H _%77?\
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' 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>annexc_001.jpg
<TEXT>
begin 644 annexc_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  X 'X# 2(  A$! Q$!_\0
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MO"ND:Q8QVZ-Q)J>FQ:=9ZUI(;!!=Q-8Q$DO>Q%@:_6@DGKS]>?TINU3C*J<
MJ,J#A3]Y0#_"V?F7[K=P:[,IXCEE]=2QF49+G.%;_>4,PP:=:HGHW]=IM8B+
MM>T8MTXRO)*\I'/C\AIXM7PV-Q^634;+^S\3.A3;5VI2IJZE-MI.6[22\C\E
MO!O[?OQ;M7@3QW\,-!\06C2$&]\*W]UH5Y)$K!998K2]75=,>2(G!\R]@5B2
MHD!-?9O@7]JOX;^/88X].U.\\-Z[)L5_#7C.S_LB[+LQ79877FS:9J/0,GV2
M\D:3<,1JV8T[SQ+\%_A[J,UUJ\?A6T>_<R326UBJ6,=Y,_SNPB15A%S*1P=N
M)'&/O$"OF*XUC]GJVFN-/O=(N8KNTN);6ZM;EDBG@N87;S89$>(-&T.TGYBI
MV+O3*X)^DQ4>$>(TWE?#N/R[%VYXPP&,J8NG'2UW1KZJ',U^\BU*^G5H\K"1
MSO**BIXS,J&,IOW95L>IQG)73Y5-N,>9I?GH?7*_$2!"1(;>4$*4DCV"-@02
M=K9(<=.0<5KV?C;1+V9(+B?[-=OL6'SL+ Y<9"";E5+Y*Q*<!F*C(SFOC\>/
M/@W;6<EMI6HZIILFS-N_VZ*Y@1T!V(]M*"ODG/SB)XVQ@ ]QQT?CVUDE;[)J
M<-UM8G=:2ABX4Y"F-F9D5AUX<1C/S<!J^/QW#^<Y='FJ9;F$Z+<G"K/#U.9Q
MN]:B47R*.S<G:ROM8^DIYG@JLH16(PD9S:BJ5.O3?O/2T8\W,VWJENVS](64
MKC/!*@X.,C/8X)'OP>AIM?-_P3^)[ZTTWA+6+EY+NVCEN=%NY"C2W5I;H9KG
M3F+ M)+%$6FBE)W&!7P!MKZ0KQ8R;E*$HN$X-*49;IN^C6EGH=_IJN_</\_0
M>I] .I)X R3@ FO@_P".7[8'A[PYJ.H^"_ 6LV-YJ=JSVFL^(X;FTEL].N$;
M;/8:62Q2XO8FW0W-VN^*W?<L8:2/</L;QSXJT?P/X-\5>,_$-Q-:^'_"7AS7
M?%&O7$%M+>SP:)X>TJ\UG5YXK*V5[J\D@T^QN)5M+6.6>X*B*.*1F"GPSX2>
M-/V7?CU\%_#OQ^^"-G\-/B_\+_&>A'Q+X7\3^ O"^@:^-<LY8VNI;>.RBM([
MV'6[9BUKJFB:BEKK>G:HD^GZC96U_')"/9R?%97@\92Q.:Y=4S.C1;G##4ZT
M,/>KIRSJ3J0FIPC'F7L^75M2;=K'!F5#&XG#.C@<5'"5)RM.K*G[2])QDG%1
MZ-R<7?LFNI^<#_&^&21Y9=7@EED8M)++>Q/+(S$L3)(TA9SDD@L3@' P*:OQ
MK@+ 1ZA;2NQ"A#>QX.X@<E7) &<D\ 8Y(&:^[?!7QB_9C^(W[/,/[5'@_P "
MZ9J/P1N?!VK>/['7S\'&@U[4O"&BPWESJ.NV?@^YTJ/Q$]G;VVF:E.L#V$6J
M7"6S/!9&-HGGYC]GS]I#]D_]IZQ\!^(?A!\,/$>K>!?BAX)O/B'\/OB5K/[-
M?B3PI\.?%?A.S73P;[2O&&O^%K'31=7S:C&^EZ1J#6.JZK#%>2V%G/#87,@_
M0J/B)D=""A3X3KVBY.-\RPZ@KMM)QCAT^6-[633:6CUN?$_ZFYJTU+.J,E)R
M<I/#UN=\S;=K5%3NKZ>[;:]]3RCX9>$/'WQICCN=.CCM/#4<ZO-KE\LW]FA5
M;:QM%1?-U6Z0\16J*;<'+2N01C] O 'PI\*> (O.T^T.H:U(D8N_$.IJDNIS
M.BXQ;( ;?3+5?^6%O8A&1!MN)9F(:O'/V??VMOV??CQ'\;-'^%.LSZ<?V8O'
MNL_"GXSZ%XB\&:W\.)OAGXQT+28]?U/2+[3]?L].(LH=&E76DUFP2?1;W3[B
M.:ROYE$I1U[^VK^SO!^S-HW[8.E>-W\8?L]>)K'PIJ7A?QWX%T35?%I\26WC
M?Q58>!_"L6BZ#I5O+KM_J&L>+M3LO#T.F6]A)?1:G,MO/;H1+Y?YMFN/_M+,
M,1BXT%AJ-65Z5!3Y_9IMMKFLK]%LMC[K 8>>$P=#"U*BJRHQ:=10Y'.]M6OE
MU9]8;CUXZ$<*H^]DMT'5B22>I)))R33:^2/C'^V9\)?@5XT^#?PY^(47CRS\
M=?M!W^N:+\&_"^@?#CQ5XMU?QOXA\+^&KSQCXE\-6L.AVLT>G>(=%\+Z??:W
M?Z;J<MMLLK63R9Y9V2)NX^"O[2_PE_:)^%-C\9_@KXDD^(G@2]F\2Z>+K0]"
MU^TUJV\1^#=:O_#OBOP=JOA;7=/TOQ!H'C#P[KFFWFCZOX8UBRM=9L-4M9K6
M>W($<LO =9[_ $5^</P[_P""J?['/Q+B^#NJ:+X\\5:+X2_: \=:E\+?@WX\
M\<_"?XD^"? /Q!^)^DZOK?AZ^^'>B^-]<\.P>';+QDFO^']7TBVT3Q!=:1-J
M=UI\XTJ6_#Q!_H?]H;]JWX2?LN+\+YOC'JVN:+;?&+XH>%_@I\/9=#\&^(/%
MJZ]\5?&LLT'A/P;(= BNWTK4]=DM[A;&74([?3%,%Q]KOX1&I(!]+%0<9YP0
MPSV(.0?J",CT/3&!7X@_\%>_"OB#X4>"$_:K\":;>7-AH%[I.C?%W3=/:1O^
M)5=O)8Z+XV6&/;METF^N[;3M;F<A18W%E=/^[LKAF_2C]I?]K/X._LB^#?#'
MCWXYW_B?P]X8\8^.?!_PRT#4-$\&>(?&$L_Q \?ZBFD>#/"USI_AJSU"]MM1
M\1:M+#I6GL\0LFOYHH);R$RQD^7>(?VY/V7+7QKX0^#?QKN_%/P?\0_%O4X?
M"O@31/VC?A#XV^&?@[XH:Y>I%Y7A3PUXL\:^'D^'.O>(YMJ);^$I_$8UZ]=B
MMEIMXZLB_0<+\05^&,\R[.*5&.*I82O&>*P%27+2QN&NG4PT[WBE-I-.49*,
ME&5KH^>XJR.7$62XW+*>)>#Q6(IM87'I<U3!U[-1KP2:DW%-IJ,DW%M75S^/
ML_\ !1IQUEO^>G[U?_CU36O_  4AN;>[@NK:[U:WN875HIH+A4EC*\_)NE:(
MCC#1RJ8)%RDHV$U_9)\<-<_8_P#V>+#PG>_%#PK\+M#O/'WB>/P5X \*Z9\+
MM.\5>/OB+XQFMY;N/PK\/O ?A3POK/BGQ9KBVD%Q?7D.E:3<6VC:?!-JFMW&
MG:7%->1^>V'Q1_9>;QQ\/?AUXF_9M\:?#WQ'\5-2&A^!+CXA?LG7^A>%M;UX
M:5J^OMH-UXSM?#6H>%/#NM2:1HFHW$&G>)=7TBYE:V\F&*>ZFA@;^EJOTC^#
M*T)TZOA*Y0J0<*M-9_AW2FI14:D5&I@Y-0G[WNNZBG9:)'\[0\#_ !/HUH5J
M/BMA8RI3C.C-Y'B(U(\C_=R;IXI+GBE&\E9R:<F^9MO\7?V(/^"H?@?XF_$7
MP;X.\;ZG:>$/B1'KFF_V!=W=S:V'A[QRD\\%O>:;;SR3_9]+\236?FI;Z5)+
M+#K3;XM/E\\^0?ZK9E08*#&2WKT!QWZ8-?G=\7_C1^QK\"/C'\*?@=XO^%<5
MY\7?C#I7B[Q+\)O"7@3]G&Z\;ZGXT@^&EI!K/BZZT"]\,^&;JWAO?!=K-;ZO
M>1R7%K=VZR0SV;2SE%K[1^&_Q TKXG^#M$\9Z'8^)],TS6(K\V^F^-/"^M>"
M_%EE)INK7NC7L6M^%_$%M9ZSH]P+[3[CR[?4+2":6W\JZ0-!/&Y_G/C'-N&\
M]SJOFO#?#N(X9P^*2=?+ZV80S&"J+:5&I"E25..L[PY;:QML?O\ P=E?$V3Y
M13P/%.>X;B+'TI/ES'#X2I@W4@[^[4I5)U&W&T;2YK[WN>6_M@6VOWW[*?[2
M.C^$]#UWQ/XM\1? GXN>&O"?A[POIUUK&OZYXG\0?#[Q%I.@:7I>GV :XN+F
M]U2[M88V1X(H'*W%U<VMK%-.GX[^#?V"_C[^S=X$^%'[6_\ P3FL(_AA\:-8
M^%'PPOOVJ?V#/BJMSX3^ '[2_BO2O VAV7B_4(-*>U6#]G_]I2&[MK^SL?BE
MX4@;PQXMU"WM[?QG8:C9R3:C=_I7\=?V$?"OQM\2Q>++/XX_M+?!O5I)9)]6
M@^#WQF\4^'?#^L2OG;+<>%=1GUCP[93C.9+K1M/TN><JHG,N6-?&GB/]F;X4
M?#'XD:K\+/$'[8G[?4GBC2?A'XC^-:I=?%:%-)UOP?X2^V-X@M?"]WJ%I8Q>
M*_$>DI9QSZWH.BB\N=!M=5\/W?B$Z59Z_I-S<^?AL%DU2G&IB<]>&FXVEAWD
M^-Q+C*ZM+ZQA\1%/31Q]FEK?F35G=;,>)HXFI2I<,TZU&#M#%QX@PM*G56BM
M'#3P4JL7K?GE4LDK.+W/8?V<_ /Q#\!_\$CO!OPO\0_#/QUHOQ*MOV/O&7AK
M5OA7+I4^I^-]$\:>(O"GB6.#P*=.TX7(U'6[75-3CT?SK:1[*Y:*&Z29+>XB
M9OG3_@C=X!\=?!C]G+]BWX0_%#PS^W'X.^)_A+]G%O 7Q*^&_P 3/#/B33?V
M?_A]KFA6UM=2W@U/4]*M_#8U,26BZ1X+A\->(M;N;BWU.]6ZL8(K6XFMNE^'
M_A'X2>.D^%D?@7]H;]O7Q9KOQ:^$%U\>O"OAI?B/H5GK5M\)[+5_#NA/XHU9
M]8O]/TBTDGU7Q/I5I;:):ZI>ZN\HN'>V@M;<W1[&WTOX,P77C.R/[0_[:,TW
M@#6/C[H.MM)XQL)0;O\ 9LTG0-9^(C6,44GG7=O-:>)-*7PT3#'-JUQ,PEAL
M5 D:*V"RE3E['/93@OA?]CXN%]-DJN(YUKI>2Z7CH=<,?G<DE/((4VW9O^V,
M/545=^]IAHN6EGHEV/*_VA_V(/CK)_P46\6ZM\$[&73_ -D[_@HO\'/"GAC]
MO+6;/46TJ7P5X@_9UUW3WMM7T>WM41Y_$?[27PCUJ\^!&I7$0WII=MJNMW5P
MMUI^G@X?[/\ ^P7\9?@W^V7XK_9STKPU!:_\$Q?!GQAM?^"AWP'BMY56W\&?
M&_Q.FLZ-<?LNZ9H<!$5G\// 7Q>NM2_:/\.V,*1V.DWG]A6-KF-2D/OOPK\5
M? SXDZ)\#==\)_'#]K^_M?VA/%?C_P &?#JWUCQ#:PW4^O?#3P;XA\=>(8-6
M>*YDM+2WDT3PMJBZ5=6MU>P76HI':R/;9FDB[7PSX\^$U[H^A:S/XY_:QTBQ
MU[]I"3]E737\0Z[H,\D_Q9M/%'BCP9JEG)%H^M:JL.@:3XB\):GI]]K3,-P>
MTN;*UN[.=IX^:6'P,;<N9.I?>^ JT[??6=[_ "_$ZH8K,]>?+*72W^W0_2GY
M?CZ'AW_!3GX8?$7Q]^UU_P $J?%WA?X>?';Q%X!^"7QW^.'BWXS^//@EX=\3
MZAKGP[\*>-/@=J_@/1=7;5/"\,FN0RZAXGU.WT^Z@T"VU/5ET=+^XN+.* ?:
M!ZK_ ,$MO WQ_P#@1\,/C_X"^*7A;6]*^!?@[X_^.;[]D*?QAX8TS1_CUXM^
M"&M ^*-;\2?&/0/"D!OM8\=ZO\1-8\3W-KKWB72['XC^-[">+Q'XQLFU74#<
M3=1)^T!\"M$\!>-/B9J'CO\ :&M?"'@3XW:G\ =?U+5-0TZ*SM/&^B^,-1\"
MZMJ>I:C-J TC0/ MEXBTV>VN_&_BO4="\.P07.GS75[;)?Q ?0WC;QAX/^%_
MBKP#X N=8^*_BCX@_$NS\<ZKX)\'Z)J6D3ZCJND?#/3=-U7QGJAOM9OM$T*S
MCT>VUS1$%K<ZI'?7E]JUK;6=O-'%>W=IA*E02?+BY2=]$L-*%U_B=225O1W.
MV-:I)1YL-*$G%<R4U*,9=4I7][JE*RNDG;6Q_.G^RY^R;^VM\-_V*?V.?&'B
M7X+>-OB_:?LH_M6_&CXW?$G_ ()V_$?PKX=^'OCZ]EU?XP?$K7_A=\:O@=XS
MN%TJW\;_ !-^&NF>)3\2?"7@+XAZ]J/@[Q1J6L:CIR76B^)/#OA\1?HS_P %
M0=-^)O[1GPU_X)\Z[\)/@A\;_%-QX+_X**?LO?'KQGX6G^&^O:/XR\$?#+P%
M=:W=>-?$'C+P_J<4-SHR>&SJUM#=VJM?7]].SC2H=6VR3G[\B_:H^$.F^.;#
MP)<7WQ*N+NX^-^G?LWW/B1[&RDT#1OCEJOP\M/B7IGP_UF2+47UN"[OO"]_9
M;?$$.B7?A;^T+@6$FNJRO(G!Z'_P45_9[\=_![7OC%X;L/BW>>$_#7Q%\,?"
MF6TTCPUI \6:AXL\7S6EMH=OHNG1>(Y(;^&ZDO;:-XXKV/4HY9$MWTS[1B,X
MM15E&3DM+MJUGUTZI;_@:1;:NXN+[-K]#YR_X+=^ ?BA\8OV6O@IH'P=^%7Q
M&^+'B/0/VU?V3OB]J7AOX>^%-0\0Z[:^ /A9\3=.\:>,M=N+!1:BW73M'LL+
M87$\&I75W-%:V=I<7#I"V7_P5 \%>,_^"B_[*/C#]C7X*_!7XFW/B/XU^*/A
ML9/BU\5?AWXB^%7P]_9YTOPI\1_"OB_6OBG>ZK\0+;P_XBUGQOH.CZ-=6_A#
MPQ\/=*U;7;K6[F*.XNM(TW[==Q_4^I_M)?!NY\6VGA:?Q!\;=,%W\6/AO\"-
M2UR&U^RV'A?XQ?%CP9I/CKP5X#\2:?<7*>*M(U6\T+Q!X>BU'4CX>GT31=9U
MFWTC4M3@GM-2>R\)M/VJ_P!E[Q5\)OB[\:O^%O?M+:)X%^"OB@^#O'%Y*&_M
M=]:34;O3GAT>QTF;5+G6#;R6EU=7-O&(KZPTV":^O;2W@BD8=$:&&;]['.*M
M>_U.H[^6E3\3"I6Q$8KV6#565]5.O&DDK;\UI7=[>[;JW?0X']M#]G;]H[P'
M^V]^P5^WS\'_  -XJ_:?\"_LL_"GXM? ?XR_!72-5T"V^+Q\+_%?1=*L)OCA
M\*].\3:EH7A[Q9XZL[G28+?Q=X5FUG3-8UO2(OL^B-+,9XAW?Q9^.?[5WQ-_
M:D_88T#]FOP1\??#GP(\4^.O'=U^VA<_$/\ 9YE\#1>!/ &D^ KS5_ ,D'B3
MXI>$[2ZTGQ3J'CTVVBW5OX)O==NKC2II)(C DC7IZ?6Y_A?)X^\5> /^%K_M
M9W$_A3X(_P##1%UXH\->-/#E_P"$]2^$TW]M_P!G>)/#VKVNJRWNHC6+OP]J
M=II%H=-AENI5MKC,=C>0W3>*ZKKO[/\ >:=:Z[%^T5^W+-H8\(_LX>-?$FI:
M=XRM7C\"Z'^UAJ8TCX+3^*;#>-7+:SJ#I!J[^';'7[;PT)(IM5GCB,AAZ*6$
MRZ4X>USB5.#DN>V5XBHHQO9N].NI2LM;0CS=%>VO)4Q>:1A-PR>G5FDW"/\
M:M*DINVD?>PT^6[W;;^YZ<Y_P4(^&/Q0\2_\%)O^":WQ8T7X<_M+ZK\*_@QX
M"_:VL/BQ\4/V??#>M:GK?@*]^)O@WPWHW@2Q2\TFSO;Z<>(M5TJ:'6;?2M(U
MB2'36=[N.S4KYGZP_LWZA-?_  K\-M-!\:&_L\:OHEOJ7Q_TRYTKXO\ B"UT
M?5[FS@\1>,M-O+'3;ZUN-71%GTPZC9Z??W6B+IE[/IMJ;G8OY<:+\)O@5\4/
MBKK7P1\.?MF?MVVGQ+\/Z_X^T+6?#+_$H:!J-A#\/;ZTT_5/%-F-6M;>36_
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M]0^(6F3Q2VWF0W-X44 >LZ3XT\+ZGX37]HR']ES7/^%E+X'\0ZOJ^G:GX?\
M">F_$CP[XI\"W+^&A\/]4UF]ECO+SQ--->ZWI?@GQ)ID6I:)J6BVVH-9:QIV
MEZA96MYYSIGB;P6?$F@P>!OV)GCOM0\8:5H$-T/"N@^#?LUE>_"4?%_4?%&K
M+JWAVTCBM]&3XF^-_!ATS79[6>X\<R^*]%M+F'5-;N[8E% 'NWP$T_X;^/\
MPR/$5K\#O"OP\MY?AYH'PYMO"]_X=BL_$V@_#IX[Z\?X3>*=*N?#VE6^C:+H
MMY/<QOX+TZYU;PY;7%Q?"VD>-Q+<^P+\&OA$M_X<U1?AAX"74O"&CZ-X?\+W
MR>%='2YT#0?#D@E\-Z-IDJV@:VTOPW,/M'ARR4FWT&Y+76D)9W#O*Q10!L6'
MP[^'^E:G::WIG@?PG8:WI[>)VL-:M- TR#5[(^-M2AUGQF+34TMQ>V\?BW6+
;>WU?Q+%%.D6N:I;P:CJ27-Y%',O8T44 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>annexd_001.jpg
<TEXT>
begin 644 annexd_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  O '8# 2(  A$! Q$!_\0
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M[D"HM7MM*CVR:9=^8"<-$<Y'N"14NDP:)<P[;^:6"<'KOPK#VXJTUMX8%VL
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MK!()+F5K@CD)C:OX^M='13N!6OK,7NGRV@;RQ(NW('3\*HZ+H0T=YF%P9?,
1'*XQC/\ C6O12 **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>ex23-3_001.jpg
<TEXT>
begin 644 ex23-3_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !< ;D# 2(  A$! Q$!_\0
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MZ4ZT*:J11O4445L>8%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ*C)4J,OW^B::BW*'-4G"<E[Q_P1-\0_#K]FW]F']J']K+XPZH_A?P++X_\
M!_@BZ\3KH^K:V;73O#=I!$0MEH.GZEJTJS>(_'<%M.+:SD1"L$TP5$9X_P!Y
M_P!G#]KK]G_]K33/%6L? /QR_C?3O!6IZ?H_B6X?PWXI\.?V=J.J64FH6, B
M\4:-HTMUYUI&\OFV:7$4>-DKHY"G\<_A]\%DT'_@@+XUTE[3R]0\9_"+Q=\:
M]378(WEEF\71^.--GD#+DR1>'=!T56+_ #,(!DIP$^&_^"87[3-M^R9^Q/\
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M8:9H8FUN.!F2^T?PE<SV_A[0[*87%K8KINI:JD37MV?*^K_VPO\ @FS^R?\
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MJ.M^$/AMI-ZPV@VNAZ;=^*/$$>2!E#<:YH3;@=JM%(IRP(7\:++0/B5^U_\
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M&/M'[9?Q*3X0?LI?M"_$8S""X\,_";QG-ITI8H%UK4-'N=(T$;P05+ZS?V*
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M:QM7$5J%->SK_O4O95DW5C^\]Z,>6[48N:O[OR%?$Y1B^(N)L1FF78O-??\
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M?X6T[4XY]3N->M[5[>&?7;^STQI( ;<6_P!H9Y Z,%_7W_A%?#'_ $+F@_\
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M;^T08=7LI+^)_P"TM&^&5O<2W/AZVD:8>?%<^*[Z6X\6ZD&^:>"?0_./G6I
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M'G_!(S]H?XG?#O\ X*AZ1XE^+'[/7AWQ=_P4)^$W[-7@?PQIGPZ^''B?PO\
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MK6@6&I:1XFT.^\.ZNT91KY<.[_X)G?M@Z[^RY^PQ\'/&7Q"_96\8>)_^"?\
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, !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>ex23-3_002.jpg
<TEXT>
begin 644 ex23-3_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !> (H# 2(  A$! Q$!_\0
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M*FT+_GYOO^_B_P"%'_"IM"_Y^;[_ +^+_A5OQ5K+W'@*'5-/G>(SM"RM&V"
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I1I_:N(YN966MWYZ)6>]U96^;U&0L[01M*FR0J"RYS@]Q3Z**T/+9_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>ex23-3_003.jpg
<TEXT>
begin 644 ex23-3_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  B +X# 2(  A$! Q$!_\0
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M>YN+[5M WKINE0PDPHZKAKA^VT<GU)Q7"SW?CN^2);B\O[E&0ZP8WD)"J/\
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M[1H7C*PU[0;S6X(;F'3[9Y%$DL>#*J#EU Y(Z_E70&-6SE0<C!XZBFP6\-M
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MAA.,95/[W/6N^HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
2HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>ex99-2_001.jpg
<TEXT>
begin 644 ex99-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #& 6(# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBC(]:
M"BC(]:,CUH **,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6@ HHR**
M"BBDR/6@!:**,CUH **3</44%U'5@/QH"XM%1F>(=94'U84GVF#_ )[1_P#?
M8IV8KHEHJ'[5;_\ />+_ +[%*;JW'6>+_OL46871+14:SQ-]V5#]&%/!!Z$&
MD,6BD) ZD"C</44 +129'J*7(]: "BBB@ HHHH **** "BBC(H **3(]:7(]
M: "BC(]:,CUH **,CUHR/6@ HHHH #TIE//2F4 %%%% !1110 4444 %%%%
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M-6<;C\W6N4W8*H10H4 #L*<#BDY[T4"%S29HHH **** "BBB@ HHHH ****
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M@>E&!110 C*K## $>A%&T9!P,CI2T4 (54@@J"#U&*-B@8"C'TI:* $V@D'
MR.] 5020H!/7BEHH 0@$8(!%((T  "* .@QTIU% "!0.@% 4#. .>M+10 F!
MSP.:-JYSM&?I2T4 -V+C&T8],4N!G.!FEHH 38N"-HP>HQUIOE1_+\B_)]WC
MI]*?10 SRH_^>:]<]._K3MJ[MVT;O7'-+10 A5202 2.AQTH*J>JCICI2T4
M(%4# 4 >F*-H]!2T4 -\M,*-BX7IQTIV!110 8'I1@>E%% !@>E&!Z444 &!
MZ48'I110 8'I1@>E%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
7 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>ex99-7_001.jpg
<TEXT>
begin 644 ex99-7_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" \2"JH# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+@X^\:Z"@ HHK'U76-)T&S-_K&IZ?I%DF%-UJ5Y#IUFI/(&^=U0'U#'W'!H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-=6FKZV=,U#Q!I9^)GC_ /MS1-$T1=WB?Q!X@.>OA)7QPVTD CDQ+C+'<7/
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MBQK;Z[K>C9 \.^&O%7_"=J/!D8!+?V#XD?CRJ_/[]@KX[?M?^&_#GQ)_9_\
MV+/!-WJ?Q6^*?B;PQXVN?&6E-HFH7OA7P[X'T?6UUAY5\0 >&=$;Q.PS!XD\
M7.81.R>#3"]SXGLY;?[5_P"",G/[.'_!4;_LB/A?]/!W[3!KZ0_X-V[.R_X0
MW]I^_%O;_P!HKXD^&-H+K[+LU!M.&AZ^%60XSLSSP#R 2#C%>OF>*6'?&6+E
M%24:E-)6NKNTHR:=U[KL_DM#SL-AOK2R9WM[KO\ C='W1_P3._8)^(O[)>E?
M$KQC\;/BG=_$#XF?&"^BOO$NA:/K>KZCX%L7#MYFK!==F6?7?$OB)D5[GQ)-
M$@=3Y&'W2JGY\_\ !5+X+_L_?LH>(O@7XD^"7[)?P4\2^-_C=\2?&XU6T\<)
M\2K[3!XG.I>&GT,Z'H'A_P")/A'PYX>+>)?$!)6=(?!ZC"^4J!9)/W4\%_M8
M?L_^-_C3XK_9R\,?$W0-8^,/@ZT2\U[P;%?.URK1^:NMZ5I>K29\/:YKOA9(
M87\9^&O#=W/?>#_M&R_@MY4E1?SM_P""O/P!M_CC;_LXW8_:0^ G[.6H_#GQ
M+XYUK2-5^.GQ#_X0A=<U64>!IP_@W<L?]N7/A@Z)YEQ&P!C,]N9% D,A^=R_
M%XG^V(5,:Y)-IR^)7BXM1O&*<FM5:T97;OTNO8Q.%PG]D-8*UNFV]]==/Z^X
M^+OLW_!4?_I%A^Q-_P"&M^&?_P ^ZN"_:/\ B5^VY^RO\/?"/Q,^+/[#?_!/
MNW\+>*44WA\-_ K6O$?_  @NH2H2ND>-73Q*&\/^(&!;9+&?&'@LLC;7RF!P
M?[8#?\%4/V./A_X(^*WBG]L4?$/P+X]U=?"EKXJ^&WBV/4+.QU#5-(/B#PZ&
M&O\ ASPFWB!?%'AW2=<EB\3>%2&C&CAMD;2_-W'QW_98_;4\0?#_ $KP)^T]
M_P %-/V;?#7@[XAZ7IOB>W\$_&#XK3>!TUW3M'DT+7V91XA\+@S_ /"+RG1F
M>2 2J"QEF9$?>?IZ'U*^_!RLW=?\9B[Z6MI=IIM/2[Z.R9Y%MTD[^=OTW\C]
MUOV"?AI\)O#O[+/P.\5> /A)\/\ X=3?$WX0^!_&'C*R\(:4[K>:GXXT*W\4
MZ[H\NL>(+GQ-XHU_1/\ A(]<UD0?\)-XGO)HE(;>J2NE?EQ^VCI7_!'O]DSX
MSV_@?XS_ +)OBS6?&?CCPV/BP]YX!&KCP[_9VO>,-;T8!HA\8_"46C$^(=(U
MG=X=M?#@MF8?ND(#H/WQ^&7@'P]\)OAUX&^&'A<WJ^'/AWX3\->"_#QU&Z:_
MOAHV@:7;Z%HXFE8DO(+>V2+>50-M*A50#;_/#^VYX2\-?&/_ (+2_LK_  ]^
M*?@'^TO .I?"/0-(O=&UVXT[4=.\<:4I^/NOQ:Q]FT+Q"9DT)M=$7AR2+Q/
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MT7@7Q%I6GZ&WB3]M?6O$^A6FI^)O$GP]^ _@31?$?AFP\,:)K876]9Y^)/\
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ME?\ I^-?*YE_R)\Z_P"RPE_Z3(]O".V;Y3_V27_MU,_7KLOT?^1K\,_^"_\
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M0/#4B@F(E;O_  2V_P""@'B[]D ?\(U\5_"NM:E^R+X^\7FPU#QM:^&M;/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>=R<%AGEE!P34W/DJ*-T]+-5;_)JW>+V,/[/EO\ VI/T]VZ^]?E^!^9_P_\
M#W[9GB+]A_\ :%\+_M30Z%K?QU\0^#/C)HG@_2?A[;:1NO?#.M?#5M'\%:1Y
M6@$Q_P#"02>(Y-8621!YA=D#$J%*_EC^QK^P?_P4P\/_  5LO#L'Q ^''P$\
M+QWC:WX>\)>/O &D>*?%(.MC.O)K:1AFT&3&,1JID/ "\BOZ>IHI,?N=H/N
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M^)!I.K^2Q;2-9/A[7M$U_P F6.VD$&L:),7FCDB,G6T %%%% !1110 4444
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MOF_]JO\ :%\/?LL? CQM\>O%6B:UXB\.> 7\-'4]*T$Z:NIW@\0^,-!\%Q"
MZO+#$76YU^!G._<T*R*'Y5ZB@_K"5DM79>O3=H&K:,^DZ*\ _9W^.W@G]I3X
M.>"?C1X"N,Z%XST>.^?3#?Z5?:AH>K,RC6- U<:,T\2:]X;>/[/-%&XD^9&*
M$RH]>_U8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKY*K8A\-^(YO#EQXJ@\.:Y=>%[6\_L6\\0_V/K/_  C-AJG'_$E_MS_H8O\
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MC\<_]$Y\;_\ A':S_P#%56O+/Q5]EN/[5\#^-M-T_P#Y?+O_ (1O6=-_L_\
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MQ_\ K_R>E?08C!X#_5W*,PP48\\K.4E%<TG%<J;>[LFTKZI.USQLM;_UDSC
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;)E=]&]'Z-=?._\ 5S\8?V,_B;KWQFT+5_&7[2O_  5H^-'P0CM-6U;0]/\
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MK$U5]=:P<*^DG'^#P@T[:7BU*SB^DE9/LM4<&&2^IKZZX[=92_'S]/F>O?\
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M.Z7X>^)&M_#G2V,G@_0_$6OG66T-G?Q!K;.[F!"V$B9$5550HRO@KX.\4?\
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MW4OZL?O3_P $L_A+^U+XXF^$_P"U=XO_ &Y/&WQB^&&I:-XFC\0?![Q!XO\
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M+/#G]A^%^X(T#_B@O4?5$/B3_@@?>2V\$'PL^-=S<W1^Q6=I:77QE/V_\/\
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MT2'Q6V3AF 3(5?W4_P""GW_!1J]_8MTSP/X/^&NB:!XK^+OQ$L]2OK6PU34
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M\,6V5UI$$_PD_:T\$_\ $GTNR^R7?C#P;_Q/M4_YCFM?\5!\./S]3UK]4O\
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M=M..LE%*^S.C+<L2QE]>Z=K7MU^1]UT445\*?7A1110 4444 %%%% !1110
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M $*OBSX+TSQU\-O%/A71I=.6^_X1[5%0\'._1-;T)<[<D?,TB$G@;.3RI/\
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MT/UF_6_7^M2>BBBF= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!!(.5'I@?B 37\:?AG5
M_P!J/P__ ,%/OVP]8_9 \ _#OQ_\6X/B=\7UM;;XC:EX1TC5[#29?&6N+KK>
M#8M>^(7@MM9(W9F#0>*5@&\RI B.$_LJ<Y"'UQS['<,_7'ZU_/[\5?\ @B+8
M_%[]IGXS?&C6OCQK_A7PQ\1?$FH^--(LO"&D*/$=AXEU_6SK>M:/K$TC)%+X
M<8@!$#^:=R[T0L0/;X>Q6#PKS;ZXXI3HN$.:+FG-S3LXIJZ<6[KFB[7ML>)G
M&&Q>*>6?4_LU&Y:I67*NI\P?M1_#'_@MA^US\,/^%3?%?]F[X;V_AB+Q'I'B
MH/X4\9?![3]3;4]%CUQ(RK/\;6 #)JZ?*IPQ7<PWDD\5X1_9Y_X*]^%_VD/A
M7^TJ_P"S)X3?Q-\,/!OACX>/H_A_XA_![P]I/B_P#HFBR^'FT/7/^+TLC^(C
MX=U=P?$PW9_L#PJI7'A:/?\ 97_#@SX?]OVKOC>1Z_9-"_K)6GIW_!!WX96=
MOKMO>_M)?&G49]4TO[#I5V[:-ISZ!J/]J:*XUI57=_;TG_"/)K7AC;,8U\KQ
M!(V[>NVO>_MW)U'ZI[7#\NOO+@_2SWL_K#=^MTU9*^EKGF_V9C=[/YR5[W]+
M_@?&_P#P0AU;6KC]JK]I:QU":XTXW/@35=;U;P^;O^TM-T[5F^)FA(2IZAMC
M,N5(.&89P37J'_!93X._%3XH_ME?LIS^ / 'B?Q'IMWX?\,>&$UZVTF&P\+1
M>)$^)>N:W'H6J>.-94>&/#^M,D8EC$G[[]X=VT;47[>_X)M?\$Q-?_8=\>?$
MWQ_XQ^)VC>,]0\9>'5\,:19>'K'6;#3[+23K4.N_VSK*ZV7,GB#?I<*/)&'B
M0%]SK\K-Y=\??^"9?[7_ .T3\5_'/_">?MG7D/[./BGXJ:IXTTCX;6=SXPOM
M1\+>&O[:U?6O#^C:%HTC)X9?Q!X9,D:12#?&XC8!SL4-B\SPG^LLL>LU245S
M*HU)MWBT[0BN=RC[JM)+F6B:T9M]5QG]C?4K.^WIK??;5_UT/SG_ ."ZG[3'
MPF^+OQ$^%/P<^'>OOXG\1_ G_A/1X_U;2III?"UCJOCF;P1)_P (<FM2L1K7
MB'PO_P (9GQM;QKLM8]>CLHI'\8VOBE/!/K'_!0']O\ _9"^-?[ /A[X(_#S
MXE>)?%?Q5M[;X.V']@Z;X'\7^'+#1M2T&31CK9\<:MXZ\->$8H_#42:)JT4,
MOA1_M,WB]?# ND'@:+Q>3^SG[+?_  3>_9E_93O=0\1^ ?#MSKWCG7] TW1?
M$7C;QG>+XCU6\B$?_$[DTKSBBZ(GB5SYEQ';,>%CC#R1B03>7?M)?\$DOV._
MVB-,O/[)\#6GP=\91WLM]:^,_AK;)I<AO]:US2-<U>36O#^1X=UXW#P2*!+$
MH!U:YP?W8W\^&S/*$LFP2A4Y,AE?FC9ZSES>]%OFBG))65[Q;TBM$8C+LW_X
M5L6G&\E[JN]HV6G3JEK;7NUI]+?L&:%JWA_]C+]F+P[XATC4M&UO2O@YX%M=
M7TG6+$Z;J=C?KHD:NFL:2"HB;(#%6)#':WRJ"R_G)\4?B3_P6[L_B9\2;'X1
M_L^?![7/A5;>.?&]I\.M7U36_AS'K.N^"/[:UT^"-9UUM=^,]G*DAT :()4\
MBW<ME);>/YH5^V?V'?V#/#O[%-IXUMM#^+'Q'^(J^,KG39&@\77P.GZ:ND12
M1Q-;:5$6C65B^/,$F50D+N$@9?T!0 AE& ?4]^G&??W]:\:>+PV$QF9NG*EG
M:D[N56$T_>O)M0YH-3E?53DK.]TSV5A_K>$UO&UK-/;I?2^GZ>1_/I)\6/\
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M\,?\$*OV(M7\,>&]3O)OC3]IU+P]HUU=FW\>Z4JEI-'C&"1X8(Z.0""1NP"
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MBW4]+T\:W_PCNE%L:1N-OX?\-:#+K;:Q+#X9C0);W&N'-Q*# L_\U%]^UEX
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M"RO?$5X-6L=4NXU7(\Q]&N;=G) R9&);J6W'YCX3^T#_ ,$Y/@IKW[)/QB^
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MI-).]UJ9=EV*PG2*?>[7X.^^_P#P#ZTHHHKY\]\**** "BBB@ HHHH ****
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M8O\ HF1^OOP.F/3W]0^!OP]\?_%3XO\ @_X9>#M"TW6]/U[1_%%[>7=Y9_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !3-@]3^G^%/HH **** "LZ6S,O6>Y'X\'_ #Q6C10!G0Z>(NES
M.?\ @0'^/^35[8/4_I_A3Z* &;!ZG]/\*?110 4444 %%%% !1110 4444 %
M%%% !3-@]3^G^%/HH 9L'J?T_P *-@]3^G^%/HH **** "J\T/F_Y_G[=.]6
M** *L-JL/?/X?X_YZU:HHH **** &;!ZG]/\*-@]3^G^%/HH 9L'J?T_PI]%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,V#U/Z?X4^BB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH KOPF?7/ZX%?Y@_QX_P"2W?&C_LJGCS_U-/$-?Z?)PV!T
M'3GW/)_SC\*_(CQ%_P $1?\ @GEXJ\0^(/%&O?#'Q5=:SXGUC5M;U:['Q1\=
M(TFHZQK UN5@O_"0-LVSD;1EQY>#DD[J^EX:SO!90\TEC(R:J0BDHQORV<I7
MD[I)6:UUUTL?/YYEN+S2$%A&E9-MMVW9_!+17]Y7_#B7_@G!_P!$M\8?^'6^
M)G_S2UZ#X?\ ^"/7_!/GPYX#\3^ 8/V?=%U/3_$]X]W>>(M?O=4\2>.-(=4#
M!O#OC?79IO$WAQ6(*JOAJ> KG#;S\P^P_P!>LG_DF]5]A+=VOK/IN_+S/G_]
M4L3_ #P^\_F>_P""!OA*]\3_ +>UC?V7B27PU;^!/A!X[\8:M:PVHOX_%^GR
MZYX?\.Q:$Q/_ "+_ )LNOIXD"@%F;0@JJ6-?U"_\%4/CAX+^"/["/[1]WXNU
M&S6\^(7PR\:_!OPEI;WFE6FHZ]XF^*>B:QX$TE='M]<GACUAO#,.NOXG\61B
M69(?"6A^(;\P2^2\+=9^R]_P3M_94_8XU_Q1XL^!OP[N-#\4>*=)T_1;W7M=
M\1:UXFU.ST>*4R+I.BZGKIFETB%]D$$T$4R^;'I.@1RA=JA?XJ_^"IU[-/\
M\%!_VKX)Y[@V]K\4]3Q:#IC^Q- Q@\?_ *NG.17BT%A>+^)?K=W&+Y9;*[46
MKQ5GIS.UVVVDG;='H_[7P]D_1M/[G;^OFS\^*_77_@B%X*U3QK_P4%^'=QI<
M7A.8>#?#'BKQKK+^*[35]0*Z5H0_L'=X&9B%7Q&/[<!#,=HQXG+<"OR*K^FW
M_@W7_9JUR[\;_$_]KC59[JW\/Z%;:G\%_!]MM5EUO5-;70O$7CCS-[IM'AAH
M]"MXF7<WVB;Q" C9)'VG$N)6$R?.%=*[45?N]$O-O6R5WH]-';Y7)</]:S?*
M)=DW\DF_R1_74>GXK_,5_"5_P7T_Y2%>)_\ LEOPS_\ 32U?W:GI^*_S%?PE
M?\%]/^4A7B?_ +);\,__ $TM7YYP3_R/*?\ AG^<#[#BS_D43]5^1^+M?Z!_
M_!&VZNK[_@FM^S+=7MW<7-R^C^/()+JYN-TDI3XQ>/8P21C=)L1$!/)"K&..
M*_S\*_T"O^",/_*-']F3_L'_ !+_ /5S_$*O?X[_ .131_Z^/_TU4/)X1_WJ
M?^']3[!_:;\(Z_\ $7]FC]H+P%X/LQJ7B_QM\%_BAX-\,:<UVE@M_P")M?\
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MWNO'7@#_ -4OXBZ?EV]<5_'S9V<__"9:S/\ ]/FJ=^?0?Y_#CI7]?G_!;O\
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M_P"#OJ>RT4Q.A^O]!3Z\0]@**** "BBB@ HHHH **** "BBB@ HHHH ****
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M?[>Y_P"$?\2?S_"OB?\ X)X_L0_\-=?'.WT.#^S / 5GI?Q!O#>=/^)%XTT
M?]"WXN_Z#O&?TYK^\O\ 9R^#ND_!#X:>'_!T-OIXN-+TC1]/O#9@8+:-I(C7
M!/.5)!/&,')!SS\?Q)G?^Q_4EKY?U_3/1X;RW!_7/KI[7<Z78WUYI-X?^8;=
M&[M"/<%3[^G%;7]HV7_/;]3_ (UC3164)_M3%SBU'_'L.N>,C;_+L*LVEY;W
MF?\ 0;D#N;RS'USD^OY_T_)OK6$\_P"OF?I!K"6"08&2#_GN<?Y]Z=YL/K^I
M_P :;P@]1G\S^./Z5#Y4/I^A_P *[TE;1RMY-_Y'.OK=E;];?(E$T9/3^8_F
M34V%/0X]C_G^IJF(H1UY_#']*M(5"K\N3CG/3^M973W5NW+_ ,$FC]9M[Z5O
M.^_EU^XGHHHI'4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 0/ST[K^O(]3C\Z_BP_X(EV
MFBR_M]0W%WJMQ;:U;>$?B8NC:7;:2-1TS7-^DHFNR?VV?^0$4#;UBX\XH(@<
MN#7]IJG(7VX_ 9]_\\U_)[^U/^Q]^V9^Q-^V+XH_;%_90\'#X@>$=;\7:GXE
MTG3_  7X2_M=]!7QSK077/AEKWPNT$MXGF\/9^67Q9X0:55\(K)&9?![HQKZ
M'A_$1C0SG!<RC+$45"GS/1RIRG)17=\L^:RULG971\]G/Q97B_Y)^];M))M_
MI_2/Z8/CU>66F?!#XO7NJ7EOIUE;_#+QRTMU>78L;&,#PWK.3))N 0C"[C\S
M-E=H)K^7W_@CVV/V2?\ @J8/7X)Z:/\ S&/QZKJ?CG^V1_P4Q_;+\%_\,X:+
M^Q+XE\%:3\3_  AI/@SQU>:SX%\:Z>NM^*=K:WKNMZ!XV\1MX2\+?#OP^1HS
M(?#'BH>+RRL4;QR0>?T,_9:_8.UO]D'_ ()_?M(>$]?M+3Q)\;/BQ\(OB3JW
MBRV\*6>J:DRN_P -/$&C>!OAMHV]F?7H/"\FKZO;VY"*\EUKCX7RS!,=I81Y
M3E-3!XR252K4HS4;IVC2LFVE9J\5*[LUK&SU:6,<2LUQ<<9@KM1BU?S?S\EU
M/S>_X(7_ +)?P,^-K?%_XO\ Q8\&Z9\0M:^'FLZ3X8\,Z#XKMM#\1>";-];T
MC7&US5-:T.2&==?\03@-%+)XK1Y(D8M$HD*R1\9\*]&\"?L=_P#!:&Q^&7[/
M-L9O FI>*U^&O]F^+!JFJCPIIOC71%DU[1-&UQOL_B-D\,>)%_X13P;_ ,)6
MWB?,;L8Y?%+;98_T0_X(0?!GXL?"+X3_ !JNOB=X#\6_#Z'QGXY\-R>&['Q9
MHDWAW4M0&A:1K,6M,VC:X?\ A(8\32H!YZL7&]H\"&5AXA\8/@+\9/%W_!<+
MPC\1_#GPP\:ZC\//#WB3X0>(=7\=KX?URV\#Z?IV@?#70H-<3^WL_P#".RW'
MF 1&$$RF<&$;I,$^EC,1?.<\3]Z$J<X\K:Y=$G9KI=NW2U_>Z(YUA_\ A(R?
MRY7MT?Z::'C_ /P3+LK'4_\ @KA^V!I.J6=OJ&GZI:?M/65Y:W5HNHZ;?Z6/
MC7X>.W+ KAL!6&#N!(')KS#PY\$?A!XQ_P""YES\&M6^''A>Y^%4/Q%\2WJ?
M#ZRT1=)\%I_PA7P8USQUH;G0-)$:Q^'X_$6C:([>%9XSX,\7["7MY2I@?['_
M .">O[-/QZ^&O_!4K]K?XC>.?A;XG\.>!I)/C%'9>+-2L$D\-ZC_ ,+6^)^@
M>/O!*Z)K;AD\0(?#*.DB^%,2>#0#%XV)N7A4^,_M+_!/]LG]F[_@JOHO[4GP
MH^"&I?&:R\=>.EUCP/\ \(]::OJ7AR_T[6O!8^$NN^#_ !QKL6P?#WQ(?#VM
M"1?%7BE8_!J$KXY">+7\(>,T7LEC(O-LW2J03GP<XP?/'WI<O-:+YO>?*G))
M-NWO6LFU/U9_5;:_\EAS6\N;EO\ ?I^'D?U'Z%X>T/PAH>G>'_"^BZ1X>\.Z
M':+9Z7H>@:3#INFZ+IB*@33M*T;1HXXH$4H&$=M&B*[%HD8':. ^*TWP<\+:
M);?%CXNV'@JVT;X41?\ "36OCCQCX?TK49O >Q(XVUO1M8N(I)=%D"K&DDN@
M8F/&>&Q6_P#"_7O%_B;P!X4\1>/_  1)\-_&FJ:%IU]XE\ MXATSQ,?".JM&
M3+H_]O:(JVVLJC$L)8\PO@H ) P;\3?^"VOA_P#;!^)7A;X>?#CX#_#+QYXC
M^$.IW23?$?Q!X-UG2-1&O>)M;UG^Q]!\'ZSX#?'BA= \,+I*>)Y_%A \(/\
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M*/&_C70$\#RZ'K)XBU]V5G10Q7RRL@.7*C.^)O[//[;G_!+[]HGQS\:_V4?
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M_H\/]IC_ ,/5\3/_ )HZ^C_U!S#_ *&M'[Y_Y'A_ZV87_H6U/_)?\C_2@4C
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M/\&.I:E?:QJFHZWJM]<ZEK&JWFJ7NL:M>7G]I:G?ZIKO']M<?Y&/>L^O?PG
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M/ZQOVZ;<:M^R3^TJH'%Q\*]44>G"G!(]\>OU/K_G=?$[3?L?BW6((..-4_\
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ML@)_]&-MX@51GG"QD[>>YS)Z\_6N^'W3GH"2??I@?C_DBOBOJRPJ:^3]=/\
M-'KX?%?6DWO^MR6BBBF=(4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5ZL44 5Z*
ML44 5ZL444 %5Y^WX?UJQ10!7HJQ10!7HJQ10!7HJQ10!7HJQ10 4444 %%%
M% #'Z#Z_T-158HH ^,?C+^Q%\ _C]\:?AW\;_B=HFJ^(O%_PRL]+M/#>FC7I
M$\,M_8FL:UKT+:QHA5H[IDUK67)96('EPQ,JIN*_9FQ?3]3_ (U'O;U_0?X4
M;V]?T'^%5*JY6O+;;WB/8K^5_<O\B:J]6**DLKT58HH KT58HH KT58HH KT
M58HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M .O\C_-X\.?LQ_M&>,+_ ,/V/ASX$?%K4KCQ1>:79>&[O_A _&7]F7_]N_\
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M@'  ] *@\J'T_0_X58KX[$5_K4G-N[>^BT[==M.OF?9!11160!1110 4444
M%5KJ;R8R>Y_E_G_/6K-,9 _6@#(C@@Q<&$@3W/// XX!/8 <GG@\<C-?R#_\
M%Q?@G\;?B'\;-&\1>&?"NH:WHMG>LHL]&T?QCJ6HWQ3P;X"1EP/#> 592I Q
MM(*D#&*_L($$*Y]_;_/\ZYK6?!OA/Q#?6FJ:WHFG:E?Z9G[%=7:,SVG<E2I
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MK_H@/Q(^G_"J_&?X?\RW^??\*_TI/*CE!)Z8_P ]/\>_'6F_9+<]4!/N /\
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2V/@?5=+7_A.#IFGIB#67DCTK0YDM9D6:1M%E:,XAE#>._\ !(7]O/X ZO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX\''Q!X6<:\FAQZ5";_P_P")[ K%H-M&\%S=;IKG]?Q$#T;]?_L:7R/?]?\
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M_B[HDVI:/<$7>D:KIDAT[Q'X6U/!(UC0M;&3#,IP=P1T="P96;RVB_);2?\
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M=QXSN])U'Q =1UW5'UBX6X?0O#_A>"9?-?<@-NC($V/O <U],>4,;LG'U_\
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M;;7_ (!\%?#G_@GM\"/AG^TK\0?VM-&/C34_BWX_O/%&JW!US6]*/AOP_?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4T[1/#GQ[^#.NZ[J=S]ATS1M(^*7@O4]5U+4D!!TW2=(@U]YYYV5<+% "2[
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M_P $[?BUX]\-?"'_ (*1_LB^)+U]<\,>#/V7/VB/&.CW:7(;3="U+P5I&N^
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M$_AW7='\0>&U73'9=6V:]HA^SNR%&$K)(PC:-BXC "G^5W_@GYX2\1_M&_\
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M\56=^?\ @GCXEL_*N3?C]B_5[(VPA/V\ZB?@I+$$VYP9!-A60 X?N2,#[08
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@"M\I7 Z<]_I[9'KSGK7@7QH_:4^!7[.-AI-[\9OB5X;\ 6^MF[32?^
M$@O?+N;]HB&<6Z@,Q5<D'<H4D*@;<KX]-\8^,O#?@'P;XI\>^*=3@TCPIX,\
M-ZOXP\1:O=0'R=.\/>'-+FUG6]4; #M';Z3#*7VKO01,JJQ!2OY#?V;_ (>7
MO_!8;]MOXJ>-/C9KWB/3OAAX3L+W7X_"MCXWF?Q/X5\--K:1> O!G@N>X\/S
M>'Y]!=B#XX>3PIX4N9Y&R7EF?+>GEN AC'5Q6,E)Y/34/:N$5S-RCS12;6LI
M)722T5M4SS<?F#PML+A=9R>B;T5OQZM-W^1^ZOPR_P""Q7["'Q'EU>&?XJR?
M#LZ3]BP/B9I$WA9-068<#2 SW/GD$?,3M ZHHQBOT3'Q#\$R^ YOB?'XDT>?
MP!#X<;QE_P )1!>+)I9\+KI/]M'6?-7Y3$;96F52!(4P,>;NCK\J_CW_ ,$6
MOV0OB#\,]=\/?![P'9_!?X@E?MOA7QOI>K^,O$'DZBJS%=+UG2-<\1RPW&@R
MN(TDA$L81")5*E#'+YM^S3^R7^TY^R#^Q#^VG\._CYX]\$^+O"=U\%/'%Y\,
M=)\(Z_K'B33O"\<7PV\?+XU21_$'AKPC)L\233Z-<(,%%9)2QC!<MKB:&48B
M*E@G4BW*,?9U7%NSE&-TU=MZWT;ZJR9AAZ^:X?\ WU1:LW=?/_AOUW/T[_9@
M_:X^"'[7GA;7/%OP6\0W.MZ;X:U@Z'K-OJ5B=.U#3]3568(\#,YVNH8!E)PR
M@';D9^F_,&,8/KTY[^_O_GG/\47_  3'_P""@5Q^Q]X.^(G@#P;\!/&O[0OQ
M'^)GC+2M=L_"7A/4X_#YLO#6@Z+KQUG6\Z'X9\8>)]>V')RG@X.205=,$-^_
MO["W_!5OX/\ [:FL_P#"O5\&>)/AE\74TG5]>D\(7%P?$OAK4-.T=B[2>'_&
M<=MX;GD9M&99BGBCPAX/?))1961(GO.^&L7A)RG@Z<O[%C:,:CY9<T6D]&I7
M23;3YHQVOJK,K+L[P>,6CUO>UWO_ )_,_5[S,+M Z]?3CMU^OOZFI@"PVD<#
M/..,\<?YR17X5?M#?\%J?A_\-?C%?_!;X'? ?QU^T7X[T+Q#XF\,^)$LM>_X
M0G3/[8T7RI7TCP? GASQEXA\1RVTL>MCQ:6\*^&UM!X?86<OBU6J]^SG_P %
MI? 'Q8^,.G_ WXT_!'QU^SO\1?$GB;1_!WARPOM<3QQILGB;6<J^A>,$F\.>
M$/$'ABX.NOH_A:VDC\)^)5-SKL#7LWA*'S,X/(\Y^J?7?[*J);WLK_ES6_[=
MV-_[0P7.L)S:VM?\?3_@_>?N6-J],<\>OZ\XIKA<]\G\1^O]#7YE?M\_\%+O
MA?\ L.:=I6ESZ"/B=\5M>1+K3OAOIWB4^'WL]*7<'UC7]9C\.^*WT&W)VM'O
M\-3&?>SG:JHTOY^VG_!>C5=(N_ FK_%S]B7XE_#;X<^+T:YM/'*^.M3OWU+2
M",?VMX)T?7OAEX1\.>/$!PRBW\90$,,@\9,T,CS?&X7ZUA:+E#^;W&KI-Z1<
MN9VM;1=M+:HQ&8X/"?%+Y)6_'7\#^C+SC[_D*/./O^0K\D?VR?\ @J+IG[+_
M ,,OV=_B_P""/@U?_&SX?_'O2/$^H6_B.V\=1>#=%\,3Z1I?AVZT30]:UO1O
M#GC;0D\0^)3K6M^2BR1P01^"?$<<3RO HMOO34_CCX2T7X!:S^T1?-_:O@S1
M/A7JGQ8UEO"MQIWB,'1="\('Q%KNDZ'+"3'K$B0:3<1(1Y?VB=0!)&!Y<?"\
M#BE9O:4G%;:R3::WWNFM=^ESH^M87^K;'O&\>A_3_&C>/0_I_C7X\_LD_P#!
M5S2/VAO!/QA^+7Q'^$=K\ O@S\'K73X]1^(>H_%!/&W]L^)YU,C^%(] E\ ^
M$/$<6OKHRI*_[N\D;<L0C.3(OR]8_P#!=?QSXI'B;7/A;^P1\2OB!X T'5]6
MLH/&]EX\UI$?3-%D\Q_[;3P]\%O&'A;P]XA/AX?\)*/"S^,)95A/EB7<7=NY
M9'FK<HJG=Q<5+W8V3DKI7YK-I6<DFW%-7LVD^;^V,%_31_15YWMC\!_4FCSO
M;/X#^A%?E)_P3_\ ^"G7P]_;EO\ Q7X2_P"$)U#X5?$WP=:-XC;P7>^)7\8Z
M;JW@'?HVCGQ#HFOKX=\($E-:U[1TN-"N_#:-''K?AJ6'S9[B:V\,_$6E?\%Y
M[_6/$WC'P1X=_8U\8^*_&>F7>J6'A#PWX,^)DOB=_%HT#53'K7]LB+X/0:[X
M;">'EU7Q0!%9^+B8HGCR))?/C2R3-7C)814G[2-KP:BI*ZNM>;EL^CO\K%?V
MC@]'T>VCZ?(_HW,P/!'Z?_7H$P' 'Z?_ %Z_#G]F3_@L6WQF_:+\.?LZ?%C]
MFO6_V>=>\3I-9:7>>*/'FMZ]JS^(2&;0=$;PC-\'?"4Z2^)QO$4_VN)(@Y8A
M=J%/;?V[O^"HGPZ_8RUOPY\-]#\'S_&[XT:[J&G;OAKH'B:3P^= TK7%8>'W
M\0:U'X?\52)XD\6R$?\ "'^%8_#CM=Q@EI;9KCPA#XLR>39LL8L%R/G:NHV7
M-V;=FXI+JW*VJZM(7]HX/ZI]=NK=_P"E<_5S@XV@@_7C'U/_ -:GA?E(/?KC
M^5?S8^-/^"]OQ+^'4EA!X]_X)\^,O!%QJF/[&_X2WXMZ[X;.H' 4G2!KG[/$
M*R@@8VX5<<#'%?M=^R?\?I_VF/@3X'^-EWH&@>$QXZT[^UHO#WAOQW+\0AH1
M(C_XE6K:ZWACPDW]N(LC-/H"^'%%JRQJ[/(Y"+$Y-C<&EBL9"4(_#!R<;;7L
MDI2>UVKVV^3,+F6$Q:MA)*2O>UOQZ'I'QG^+7A+X%?"_QI\6/&[7_P#PB?@/
M1I=<\0?V59-J.HKIT)",RP!@7PS\Y?.T_>&X9_+NW_X+H?L0W,,\UO\ \+AN
MA:61O[S[-\..;.P(Y=\>(<YX'(/<X PM?4W_  4X/_&!_P"TV.P^%NJ?G_:N
MC?T_E7Y??\$-/@)\)/'7[)?QHUSQA\.?#7B75/B%\3O$GPV\5ZEJL"7DFJ>!
M]"\(^ ]9TG00'EVZ,K:_X@U?Q,H\,QV\<%RUL!<R#PWX0-GW8##X-Y0\=C%-
MR52$$H34;\T5)MW334=6^KT6VW/B<3B_K:P>$LKIR;?2WSVVW/TC_9T_X*=_
MLD_M/^)U\#_#[QQ<Z/XNN;Q[+1_"_C72I?#FK>)AM;Y]$AEDD%R >H#+)R-D
M;YPOI_[67[9GP7_8P\-^$_$WQIG\26^F>--6U+1M'/A?P_+XAD.HZ/I,FMS*
M\49B9!Y2 0.>LF25&PEOY[/^"M__  3X^'/[*_AWX=?M)_LU:=K_ ,/K2T\7
M:1X;\0:!X<;7K^R\):I))+X@T'XE:3XP?Q!_PDOAMHM;T.V\*O+'<2K+<>(=
M 41P+"HD]^^.G_!0[P!\0_V OV<?C%^T=^RAX2^.(^(OCKQ/X;O/"K_$;6?!
MVF:)XI^%GV@#Q=HNL_\ ",^*?$JQ>)GT2.5?#"R&=\M&S^+4 ,OH2R7!UXY7
MC\!&K/):LE&4$X*?-%-*,7-QBFN633<K:.TK.*?-_:.*P[S3"XVUX7E"2O:T
MDE=[[Z:[^CN?T/\ @'QKH7Q)\"^"OB1X=$QT+Q[X1\->,= %Y;M9WSZ/XBT>
M#7-&$B-PLAMM4B^0@HC.P&\$LW;>?[?I_P#7K\:OVH/^"H/A/]EC]FS]G3QO
MHOPKT_4/'/QT^%GA?QCX/^%6G^,-*TCPO\-_"^M>#="UP2:M<KX<AN#X?\,K
MJL/ASPG$WA#PK#XP.A>(K9)_";02NWY\W_\ P5U_X*%?!S1/AI\6/VA/V8/A
MTOP1^)3:A)X>?2-*\9^#=8\5[-*$L037)O$GC,>&E1T?Q3"/%/@U1XM\&%GM
MS%)\X\O"Y-B\9&\4FFVE=J-VKZ*][ZQ?W-[)LZ<3G6#PFC]>ZUMJ]NC77J?T
MG?$[XM_#_P"#'@[4OB!\4?%.C>"O!>DMIUMJOB#5I#'IEG_;>L1Z/HID<*Q"
M233*LBA3]_(0A2 ?#'XM_#_XS^#M-^('PN\4Z-XU\%ZLVHVVE>(-)D,FF7G]
MB:Q)H^M&-RJDI'-"RQJ5'W,E & /X!?\%<_VH_&_Q6_86^$>N_#CX7ZHWP0_
M:+L_"_C'QE\0/$08ZGX%_L+7-!\1>'O!KZ1HGF7&B2>*M>T98_\ A*C.T2X8
M(D>=J0_\$5_VE?C3_P *=NO@?>_ .^U#X1?#G1/'WC'1/CA+=:YX>TC<^MZ]
MKR^"I(]=T"$^)=;;Q*-:\[Q#X2D1?"BA8V\%*%4C?^Q9/)_KZ6G,XVO&W*G9
MR[W6NE[Z;;!_:2_M?ZE;IY_=_7Y'])XE P0N/J.?YYK\Y_C+_P %#OAW\&_V
MN/@I^R=J7@[Q=K/B;XLM8"Z\0Z9"IT[PHOB&Y.A^#2NDXBE\012:\GE^*Y86
MC7P7$ZW,INPT2I^,GA?_ (+N?M.>/K'QOX;\#_LJZ)XW^)-WJ>J:SX(?PO=>
M-O%&F>$_!43^'S:Z7XP\$Z#H7_"0^-A&LEP+CQ1%XG\'S7+Z_9M_PA\*6C17
M/LWA3]NWXD^$?V[_ -F?0_VOOV7OA1X9^)WQ1^%WA+P=I/C'P"VMM\2/ VJ?
M&[QJ^A:+K&N2:^5T"/P[.VA^'_#$WA?S)?&'@W^V?$Q;QA();KP3<;4^'<=@
MXR>,@YM1DU'GBI2LD]$[MI7UUNNB=U?!9W@\9_N;[7=O\OZ[L_I-,P(P1^G_
M ->F;^>G'?U_G7XZ?\%"?^"DWB7]G7Q;I?P"_9Q^'-U\6?VDM7M=,UJZT>Z\
M/ZYXD\/>%_"ZH^JM<-H_AJ4>(M>UVYA"/#!"B"+B9G\V0QP_%GB#_@JW^W[^
MS%\2O".D?MJ_LP?#CPSX0\86FVS/AJ36O#A1FUD%]9;QN/$WQ<\,"3PPC_O/
M#.5G*R[TD5]DJ\&'R7&8K#)J,;R3M>:C.:5FW&+>J2MK;M>R:;[L5G."POQ?
MJUKI_7ZG] /QA^-_PD^ OAJW\;_%[QOHGP_\,7VM6/AN'Q)KLC)IK:MY&M:O
M%I)D52PE-MHVKNF%^7RP<[D%>H:;J>GZS86FIZ=<6]U8ZC;+=V=U!\RW=BZJ
MZN"PR1^\4D G'( !)%?R3_\ !:?]HS]HKQ8WA[X8^(_"/@:+]E7QWXC\+_%G
M]G7XC6=F_P#PD_C_ $[0?AEH7]O_ .L\43RA0_Q4<1I)X5\)M&G[OS&QD_LM
M_P $G=4_:CU']EWPQ_PT;H>DZ)I.DZ/HND_",W@\0?\ "Q==\*H9V&K^.#X@
MUNYA5I@-(B\*>4JS"S<M,X00*W1B,F>%RB./YHI2FXI*2::L]%;5S4DU-*]D
MGM9F&'S)8K&/!VV5W=6^_P C]6ZYGQ)K]CX7\/>(_%&I+)_9OAC2-2UN^,&2
MQT_1-+DUB<CMN$44@0?Q,0#E2:Z:O*?CG_R1?XO_ /9+?'__ *B.N5XA[!^!
MNH_\'$/PT@U&_ATO]F[QIJ>G6ES?K9ZJ/B'HNFM?Z7&23K0T=O#C.4;KAR[*
MW*R98UW?P]_X."/V??$E_J5O\2/A%X]^'6EVVG"XL=5TS4M)\?\ ]H:GN ;2
M/[,BB\,7*2JF2& 8,Z@87<9!^+W_  2>^)?[-/PH_:*\;>(?VK+GP3:?#^Z^
M"WB71M+'C;P@_C73F\<CQKX!_L14T9/#_BID\1?\(YH>MDMEOD#*%)(Q][?\
M%/OVCO\ @FA\3/V:KOPK^S[9_#G7?B_=^,/"]YX.U?X?_"S6/!#Z"%UA$UW6
M]>UM/#GA.-O#TGAV/7_#A:-?%" 2*IM]^]J_0,5DN41S%9>LEKOFM^]4Y.*<
MDVWJFK1Y4G?9RTB];_'X?,,4\%]>>;P[VY8_Y?U;H?T^^"/'GA+XC^$]!\;^
M!M?TSQ3X/\3Z6NL>'O$.DW(O=-U/39-NV6.13A\[L'!W;@ZMAE*GL#,%!(')
MXZ?IUK\7_P!C?XC>'?V"?^"4WPH^)GQNO[:?2(_#FH^/M)MO"\3:EJ6NK\5]
M<UKXA>#-!C+*HFU^XBUU(69&:.)U/WI8WCKXZ\ _\%&_^"MWQ\\(^(?B[\$O
MV3/A3K7P?M]9\3/H]U<:?K][JXTS0CQHJ/K?Q,\'2^/58J1_PDWA'PBL;8(V
MX+9^1>28C$K,GA''EA)P4ZDHP]Y^Y%)R<%*4FN6RLV_A3>B]O^T5=:>;23>E
M[^>A_0M\6_B#!\+_ (3_ !.^*<^G-K-O\-O ?C?Q[-I\%PEG)J2>!]"UC7GT
MN-R"%DE726M_,.5#$NR,,H?SX_9R_P""F^E_M&_LZ_M!_'_0_@OXET9?@)::
MG=R>#5U]/$&K^+O(T%O$"G1Y+?0+8J&C4QJ%AD"DXVJG \[^ /\ P4TM/VJO
MV8_VJO$EY\--$\&_%CX%_"7Q_K7B+X8>*KZ3QGX=\3OH_@O7BV_03_PBOB"?
MPVOB+19_#WC3PW+Y:VXU6WLX?&,TET9X_!OV'/VX_'_CC]B?]M#X[6WPF_9\
M\ >)O@II6M:QH&C_  R^'<W@CPWKNI:+X$FUXOXSTA?$32ZS*CD(CQ3VRK'(
MZ!F;RHZWI9:U@\S^MY7[U.=*,I.7+RJ<DFI0T4W4C[L;VY6^:+;3)_M!/%6P
MEI)Q>EM.NG=?KMHCZV^#7_!4+PW\9?V2OCK^UM9?"+7-#TGX%:MJ6DWG@B?Q
MCI5]J7B!X-%\/:T[OK,>AK%H89-?@5%>"0)Y>79@8T3Z%_8@_:^M_P!M/X/:
MA\7;#X?:K\.;*U\<ZKX.L]#US5DU4WR:+HOA_63K:ZJNAVR&-SKAA0;'Q/HY
M^;#NK?EG^S#^VKXI\?\ _!-S]KKX[WWP7_9T\.ZM\-O$.JZ59^!_"OPPDTWX
M9>*/+T/P1.9/&?@E=?=]>DE_MT)*6N859(X@H8QA&ZKX"?\ !0GXMZE_P2[^
M.O[4=AX!^#7A+QO\'OB-_P (?X2\)^$?">J>&_A=_90U?X3QA6T!_%!G12?'
M6MD^3XM4>:D+>8!YH?;&9?&"S-X;+'"U:E2C[[DU*HN6-%MI<\JC5E)KF:?3
M5F.&S&_FN5O;HG:ZUTM_3/Z OX<#G@C@'.3_ "_'^M PRXYX^G/L/8?IQ7\G
M7PY_X*(_\%<?VSO!WC2S_9V^%?PK5_#]_I5EJGCCX?Z5H^F>*/"C!'UH GXP
M_$D>&9/^$K32)%57\'L!NR , C[A_P""6_\ P4D^*G[07CWQ1^S3^T[I>AZ5
M\7?!NCD^'-370M8\.^)_%DVA(D/C72_&FBJC>&XO$HB#>(',8\&'R)&_XHF(
MQJXQQ/#N,P>&G)R@_9I*<8R4IP4E=2FD[QOJ[2C%N*YE>*9KA<ZPF*MRMKM=
M?E_P&_,_>>D+ =3_ %_E7\T/[17_  5 _:R^+?[4GCC]C[]BGP!H]C=Z3XEU
M7X</XZ\2:,FI^-(/%/@;7DTGQYXQA+>(D\+>&_"T$L2>&H6\5>#/%K8ACFF+
MW7BU_"7A#R+XZ?\ !3#_ (*>_L,^(M&^#?QR\-_ ?Q?K%II/VW2/B=J?@[QG
M?6'Q)TY6,IU72M:\/>)/!WAQ721SX;>";P=X-9)CO=!)S3H</8R2C&+@ISBY
MQISE:3BK7:2;>G,KV32NKM#_ +:PFNLK+1M6M<_JV VKCID],'I]3[\\?_JR
M;W4+#2;2>^U2[M[&RM$^T7=W=W2V-G:H!G+RNR(%.<MYC!2<9)9@M>>?!;XC
MQ?%GX5> /B0NAZYX<_X3CPII'B?_ (1_Q-I3:)XDT[^VH%DV:UHK,3;S ,'V
MN3NC_>*#O 3Y*_;Z_8J\5_MK>"?"?@O0OC]KWP/T[1-1U6[\1#2O#>J^)-.\
M<Z5K.EFW;0=:T2+XB>#_ -S&P:4&6667,DHX"A1Y5&C;$O"XV7*DWS2Y6_A;
MB]%N[JRW5[/6QW>W;PSEA$FW:RV7E_77T/,K'_@JE\(/$O[:'A']D'X<^'=3
M\<R:SJVK^&M9^*&F:Q;6/AC1O%.@Z'X@US5-%T_2W@N)_$$T,>A[6DMKC:K2
M2@/.FPG],/$GB;1/!GASQ#XL\3W]II'ASPQH^I>(O$6K76$L=/T?1M.?6=7U
M=B 3Y-M$'EE/S, C,JLW!_C9_9B_9V?]E;_@L9\+_@'_ ,)A_P )W)\/?&HM
M/^$K'AUO#)UMM?\ @G_PGN!HLFO^+G&TZ[@,_BG(QEH@<H/W9_X+6_%M/AM^
MPIXVT.'4->TO6/C!XJ\$_#'0+SPZHE-L?[9?QQXAAUJ1) L6A>)_ W@?Q!X7
MN&*N0=;$84&1WC][,<FP?UW)\'@.:2J0A+FN[OF:L[.W+[CYFM$K-6NK'CX;
M,,6L'FN,QJ24&^5+9)+;^OOUN?-WC;_@OC\)+3Q)K-C\+O@+\1_BGX6T*S6\
MO?%7]J?\(UD1$_VK)_8P\.^+)_['A 11<"8;MI811L5*?J1^R/\ MB_"7]L3
MX5:9\1OAQ=BWO@@L/%_@F^O3)XE\"^(]@$FBZ[''&&^4[@-<C MY 0RD.[K'
M\)_\$=/V</"OA+]B?3-?\7_#30[;Q5\>/^$FO_$VJ:K9Z1JC>+O >OLR>'48
M*/W7AN70-H'AM]R*%?<H&&'Y/_\ !/\ N-0^ ?[;O[;G[.O@*6X'@K3=$_:*
M\-6NJ:F2_B1=-^!NLZ[H/@<+K^A)$S>(%)X+1HY R8U8[!U8C*\GQ4LYPF"4
MD\@L[N7-SQB^5NVJC9Z*VO6R5T+"XO%8=Y0L99O/9).UO=DX\R3VZ-;]-#]6
M_P!H7_@M1\%OA!\2[CX2_#/X=^,OCSXQT/6?$7AOQ:GA:ZDT'3]*U7P_L\Q=
M%E&@^*1XC,BIK?$*Q+&^@R\S!P:^B?V&/^"DOPD_;6CU[P_I6F7OP\^)OA@"
MXOOAMXBU6#4=4N](.0NLZ)J\44,6O6X'RR&&-2ORLP"!Y$_+?_@@A\!+77;#
MXT_M6>,M*T7Q+XCO/%VF_#_P)X@U*_U2^\6:#JBZ&WB'XK:S'Y_[@OXM7QIX
M+*>)YS_PELK1^)H+@I#))/XL\;^.>G:=^RC_ ,%NOA%??"JSTRT3XG>-?ADN
MKZ9K%NJ:5I\OQQUAO /CEM&T?0O^$>$:CP_K6?!1D%UL\9D^:)B&5IQ65Y.L
M9FV3X3FG*E%N-232<I**YVXQM%<UG?2R^&-E%-YK,<9&,<9BTDF](I:)75OQ
M]7U>Y^N?[:W_  5,^&O[(/C_ ,/_  EL/ >K?&'XGZI$EYJWA/PIJ<FF2:!8
MZQ)*_AWS)(_#_B03:OXF+[8K4P1=&D,I,F!A?L=?\%7O!_[5WQ:\0_!;5OA/
MXC^#OC72O#?]MZ/9^*M6.I/KS(;?^U]*9Y/#GAAM%FM_[6T0JTBN)&<!A\H)
M_.3]B'P;<_'#_@L1^TI\5VUGP[XW\)_"[Q;\3-8M+[5-67Q%OTW6]9U[0? X
M\$X218E\,8*.P7Y%9@CJX5AU/_!9+X8'P+^U_P#L:_M >%-8DT/7?''B71_
M.J0>']+BL+]M3\%^,M!<>,-9UE6,VM%?#?C=?#OV>=?W<.DVXCD*YAMXCEN4
MN5/)Y0:E.BN:=](U'&,G!T]M+RUNK-6N[W2_M'&<KQBV3VMHU>V_W?UH?K/^
MVO\ M^_";]B+P/I>K^-HG\5>-O$EREEX0^'6@WD=EK>OE,_VKK!:?[0-$T.#
MEVN)Q(2P7;YCR2/'\7?"_P#X+E?!SQ!XPT_PM\;_ (-_$7]GJSUY=._L?Q5X
MAN3X@T?S9-4$)EUP-X<\,_\ "/\ AU59B/$DJSPM\JM&& E7\Y/C4D'[9/\
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MBY<BTT[XM_%7X%^ S\+?#9L=;\2Z4_CK7? 7AK665QXC\3CQ*?#_ (7_ +;
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMK*PT'6ELOB%X2TU_$&EJ=!,S^-(_#Z%_B"2^CLS)XG3,DLTD@5I9G=_V/\
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M\N_$%[H^F:>-3'[/>@?V%@ZV0=W_  D?]A\QMG."C< U^H?Q)_X)L^,_'?\
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M0:/HRL, H^0A4E=K'@,37T)_P27./^"6OA8>MC\>?S_X37QYBOJOQ/\ L%_
M+6/V1K_]CK3M*N?"?PQO=+CMXKK09Y(?$?\ PD^EW$6N0>,MP$QUOQ*?$FE1
M>(Y3)@SSQG9'&JJH^0?V)_\ @F+\2OV2/%_Q2\K]I#6/$GP@\2:5XDL?"?PS
MM9-5T_1[W4]9TC^P-*U_QOHN?^$;77;;0(])0R>&HH-TL) 4*0U</UC+'D\L
M"I<LE7YXW5TZ2Y?<NG:[7-Z.U[F_U;%_7?KOE;Y_<?GQ_P &[OA?P[J'C7]I
M[QC>Z3;7/B?PQX=^&&B>'M:.W^T=+TG7-7^(+Z[I3;B !XI;0=!SGOH-1?\
M!2 Y_P""SW[*)_ZF3]DW]/C4P_I7["?\$Y/^"?NB?L(^!?%EC<>)V\;?$GXC
MW^DWGCSQ#:0MI_AQK#07ULZ!I.AZ&?D@BMFUW7)6>4;V;6F*JJQ@S87Q<_X)
MUZ!\9_V]/ /[7/C[Q>3X4^'/ASP4OACX?Z7]OT_5;WQ]X#US7-<T+5];UB*9
M$D\/07$\&M"%#YLESH<49!5S-79+.\'+B/-\=%MQE"I%6^USQ2C:]M];7LN[
M1RK+L7_9&4X+2\7'F\NO2_ZOMY_C[^SMXILM._X+N_$VY\5^(=.TRWN/B)\<
M?#ND7'B+5OLCW^IZQHVMZ-HF@Z#_ &PV'FPA2/PS!NQ)MDB5\*C?NC^W-\3?
MV)_ ?@[PCH7[;MOHEUX.\3ZS>_\ ")0ZQX-\9^+XIM4T2*)7D4^!?#][<Z--
M#'J\:!G,$4@DQYLKH6C\I_;P_P""8/PM_;,NH?'FF:O<_#/XV:9I,MKIWC72
M;539ZWY6!I$'C"&.)7N8;=@P5ES*%/EA&"H#\E_#7_@D'\9/$?Q[\ ?%?]LC
M]IB#]I3PSX#LF">$/%5AJ_B@:\V;C.BZR?''G1OH&=4F8QKND!4*\8=@M95\
M3E&,CE6.>:3@XT53J4XIJHG3B^3V-1-0E%J\824D[N%^1J:CU+#XO#+ZFK-2
M=U+1JS;;OU]?1]+7\!_X+O:E\'[WX$?L5CPII>O+/J%EXJN_A'<:;$-,\-V7
MP>/A#P(VL:7K.CZTW]NCQ%(/^%7R^#8U0W!71O$#7!@*B)OV!_8P\6>'_A'^
MP5\ O$OQ@^(W@OPYI.A?#?PT?$/C?7?B!X27P18)J^I8T-)/'8\077AN95,^
MD^'H"GB9X6G\NW),SHDG/?M^?L">&/VS/@=X9^&7ARX\-_#KQ+\,-8TZ^^%^
MO'P_ ^G>&](71O\ A'=7\(0QVUN)="\.76A+I1=/#AC=)_#N@! $B"#YC^)?
M[&/A7X _\$N/BY\#OCE^T?XH?2+3PYHVK7WQ!U2YU75/"WA34O!NNZ-KO@GP
M9X*\$JQEMO#WB'Q'::1X:?PSX;$7BWQPVOFTA\^\D1(<5BL)B\GRG )M2A5D
MY*S>DVFFMU:TD[=XRT5B5A\7A<9FV-T:E%<O39?GY^FKN?L/X)^('@?XG^&[
M;Q?\._&GA3Q]X9NQ>06?B;P9XET?Q/X=NVC(WA-;T*6>V9HR!O$$A$>0Q+%H
MW;&^. _XLK\7P.WPO\??IX1UJOR+_P""%WP=^)?PL_9I\:ZSX]T&[T"S^)WC
MBS\8^!%U+Y=1O?#:Z'!I":K/I:G-KYBA"JMQ*I#$%57/[0>,/#EOXK\(^*/"
MEY/+:V_BKP_J_AVZN+<C?:QZYI<FD2M$,Y+*)=Z<?>ZD Y'E8J@L)BY82Z?)
M*UU9VM;FV;VNTUNFFK731Z^'K_6\*I=UV^[^NI_%I_P1>^!GPF^/_P"U+X[\
M'?&?P%H7Q&\+Z;\ /%/B:UTCQ%&\NGVGB5/B1\)]';5HE1T/FLNKZYM+;@!N
M&QB1C]9O^"GW["O[ _PI_9:\9^-K'PYX/^ OC323]K^&]_X:0IJ7COQ^!_Q)
M?!)T1I6'B+_A)W7:SIN_X0V23_A,RJ-:S,_.:?\ \&^'PJL]>U69/VA/B;#H
M!LM&.D-::;HRZ^=3EEUM-;35YS&4ET.17T1X(1@N3X@65H$N$DK=N/\ @WO^
M"=R?]+_:'^-5QG/_ !\6WA*3^5N/6OK<7F>4XK.OKZSF:@W%N*HSE*R6JWTN
M]_=;6JW6GS&&R_%83!?4O[)CIUYHV_/6Q^17CO4/C]\8_P#@E1X \9^/=3D7
MP/\  3XT#X?>!GU6QU;2YO&7P^U71] T#P^-&;_D7/$:>#?$NEZ[X74'*QG1
M3C;O(/V)^QE^S+_P4*^(/[/'@C7?V6_V]OAWI7PHM1?Z?:>#M&U/Q4=1\!>)
M)Y%USQ)X,U_1I?AZC>'-=MM=U;[3<%PHECUE/&=H+KPAXNBM#_0]'^R?\$K/
M]FN^_96T7PR-!^#E[X0U+P0VDZ-=&+48M-U>.1)M<36-[3MXA:Y<:\==E\R>
M*YRV"5VK^(_C/_@WTTI+WPLGPL_:(\26VD/?,/'!\:Z4IU%]'!T0B70#H8B$
MFOE%U8EO$_FJKW")DJK.,*.<X+'1^IOV611Y^:/-15:*ARVLTU)J5^;WTKZ\
MMN6][66XS!NZO+2VDFM?7>R^[K9:'@'['/PL^#_@;P[_ ,%![VR_:9LOB]^T
M._[(W[5^C>/O"?ASP/\ $;2_#EAIBIHDNN^,&\;>/_#?A7_A)/$'_"31HDJQ
M,3M\0LX<1(["M_P3;_Y1@?\ !33_ +$_Q9_ZJ_7O\:_=OX*_\$^O@Q\!OV=/
MB9^SOX$GU$/\7_!_BCPKX\^)5W:Z:_C/7&\2:/K&AC6'1-D4G_"-Q:S*MGHS
M@00L2HR9723X>^(7[,GP)_X)L_L$?M<^ %^-$^I3?'[P+X^L/"8^(+:/IVK:
MUXJ;P-K.C0Z'I$>AI%)K4LD4ZRLC(2BA0S#?BE2S? XQO!7G>=3A6,>=)75&
MT)6<5RQBM?9\SYII-MN3LNA9;C,(DU:W*]G_ #>NM]OGIIU^!OV)1G_@C1_P
M4$/IXPU?]?!/PCJ/]FS_ )0,_MA?]EO_ /<K^S;_ )_"OHS_ ((Z_!:Q_: _
MX)X?M1?!KQ%JFK>']!^*'Q2UK0;G7-'MUCO[/36\$_#Z0/HV]E7<HA*HS$A1
M(W!)!K]%_ /_  3(^'/@#]C3XJ_L9Z?\1/&VH^$OBUXI;QGJ_B^[M='7Q1I^
MHL_@-]FDQ&$:&FS_ (02W8;H<)]J?*DIN;KS7,L%A,;G&!;::XQ5;9VY*;M+
M6UKWOI>]F<6$PV+Q6#REZ:\(J+U7Q2BN73?5+M8\=_X(1V=E%^PVMY;VT$%S
M=?%_QZ;R[6VV&](70@&/()#9VYY /)7(K\U_V5XIKO\ X+>_M*0VV/M%UXD_
M:NL;3G'SEM<5<#@#]X1C\*_HL_91_9C\ _L@_!C0O@MX N]:U+1M.O\ 5-8O
M-7U^[\W5-9UG6GCDUC5I60X1I6V949VL/OG*M7@7P;_X)U_"SX3_ +6/Q/\
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MP_XM\0>$/!>H^%O'WAZ%))=)UCP1X]\1^$\ZY%N\F64[8X[A)(G(=0#\:_\
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M+^$=6GUOPUXGMM9\,23S74^VZB:X\/W$\SV;PVWB+Q7!=_H46^7('7CG\?\
M"F94]MON,D?EZ?2M,/B\1A9K$X23C->\G%VDM&M.FNS333[=5AB</'$_%HEY
M7/QQ^ __  1:_9 ^!?C^+XAM!XY^,MY9Z;J6GZ1X7^-MSX.\3^"-.U+69HC-
MK(T+0_"GA6#7W>%BJGQE_P )>-K&[7/B]!=G]AX8%BBAMX8A#!"  #C  S@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!9MZ)>TA"3=F[+F:OHF[)-V3=K)M>?BLQPF#TQ<N5+KRW7379]_(_I\4C/0
MCODX_K^M2'ITS^7]2*_E4\/_ /!<G]LGQ3I?]JZ)^S-\'KO3[I_LME=O>^,K
M 7K 8^3=XD)7')&.G.W -?T3_LU>//'OQ-^"'P^\??%7PKI_@GQ_XMT@ZWK_
M (5TI-333-+\W5)#HRP'652X);0%T>>1IBSM+,_E/M "+'Y7B\$K8V/(NR:E
M^*%A<QP>+_W-\WRL?0>U>O7ODG_#C%1D+V/X8_J2*89@ 1MXZGC\?[U?BU^S
MY_P4B^)?Q>_X*#_%;]D#5O /@33O!'@'Q#\8](L?%>FKK*^*=27X6Z\-'T@2
M>9K<WA]#<MAIT$0<%0$6)@37-AL-B,0I.R7)'FE:UU%)MO7T^9TXG$+#)<RN
MWYZ+M_70_:ZBJ]6*S.@***YW7-;L/#^C:KK5_P#+8Z+I.IZQ=>1@D6&B1O/(
M /41AB ,+D$= : -Y?F&#]/<CM[\'\/K2L=H &>_/^1[]L?6OYEM+_X+-_M5
M_&[XH^-O!W[)'[*^B_%3PUX?*WNDI?V?BW4/$[>&3<#2!K6N+X?\0K#'NEP
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ML)=^])ZVOI]S>W_#'])%%8VF:C9:SI]AJFDW"7%CJ-I8WEI=KR+NPD D4@D
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@"NW\'X_^S5^0_\ P7$_Y1^^-_\
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M-4U7XH:OJEO>7&M7MBWBCXW>,?\ A(3X.T;Q$-"M_#OB$>$EB+7!CE61HO\
MA'"&&2P/#(/CG_@X*UO6O!++XKTG1/%6K7>LZUX4C'B/2= TW1/V>CX?UUM=
MU?1&?_A'D_X20_\ "+^5(S#_ (3/Y'+<FOI:R2Q.;Q;3<.#*<)I-.THP@[/[
MDUL[<KTNCQ,/_NN4>?%S:[-7:ZZ>6OSTN?U:,IVK]>WL,<9]S^E?R)?M??#G
M]ICX]_\ !5S5_$O[,7@GQKX<\3^&/$GAC1_#?Q#\;>#O[/\  N@^*/A;H_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\6^-WP*
M^&O[1/PW\1?"CXL>&K3Q%X,\3Q".]LI 5EM6C#LFJ:3<-"S:/K,+RLT5Q&"R
M$N<REY0?::* /#?@1\#? /[.OPG\+_!GX6V-_I_@CP8-971;34]5?5=03^W]
M>UCQ)JQFU1L.\IUW6M5<D8\IB4& 0Y^1/CM_P2S_ &.?VB/B%J/Q4^(?P^U2
M+Q?K-G8IK5SX7\2:UX:L-?E1@4UC6-'T00)+KB_-&)V)9@J,[/)YK#]+< ]1
MFHRB@9Y_3_"M*&*Q6'Q3Q,:CC+^:#7.NK=VFFWUT=]SF6&PST:]%O?\ !6/F
M[]G[]ESX(?LQ>&3X6^#'@31?"%A-9Z<FJZE9VBGQ'KS:2NV*77M<\LSZU*H8
MH"2JC<X"G<".'^&G[$'[.OPC^-WQ&_:'\(>%9S\5_BCK'B/6?$_B/5=6U+5!
M;:AXBU8ZUK@TA)%>+0$FFS\D00L-J(1E@WV5L'J?T_PHV#U/Z?X4_K.(NW=7
MDK2=WJO/^EZ;W/JV%^[R_P" ?#WP@_8+_9V^!7QR\;_M%?#S0_$6G?%#QZ?%
M'_"1ZKJ/BW5]4TW4&\:Z\/$6MG^QI',2F77PDJJPW1Y)#LP!K[>;@X[#I_/^
MM-!4\C/Y_P#V-*<L?<TJ]?$XI\V+;E*W+S.7,VD[VO9:)W?JS2C06'5H]?*R
M)Z***S-3\P?BO_P27_8>^,WC*\\<^(_A;/H.LZF ^K1?#SQ#K'@?3=0U+^U-
M8UT:SJVDZ$T,<NO>=KDSF=E7(=5V!0"WU/\ L_?LJ_ O]EWPROA?X+^ M$\(
M6T]GIEGJNIVT2MXDU\Z.I$,NNZTZBYUB6-6*L6*H,R!E.1L^DS\HP._?_/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#^,.J_LO>$-6UC5;V[_X5UJGC7P;X9\6>/ K:_H?PR.A^'/$7A,)X=\)KK3
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MAXF3[1)X&W^"U^W_ -N[]DCXA_M!7G[,/[5_PH^+W@ZU_:AT#X7_  AURZ\
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MOV8?A+JVE?#[6O$.E^)G;PW8ZL=$_M_QUK6NO+GPYH/B+_A(_P#BUX,A+?\
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M/'P9^+/P)76_%7Q^^$UUHS?%&T^'^C-J.F^(-5?5]=\1Z+XST#1BH\0W.O\
MA'7Y?#WA@RV?A2YB\92_\(]XS?P7X,,?C$-]2>/?VMO^"AOC;_@GVGB3X?\
MPB^(7@K]IWPG\1?#/@_XHBU^'&NOXB'@,MKXTGXD>"- U_PLL6NQ^*_$NCZ%
MX>\8KX7E\:R^#_!]U?>.8T2&/ _H91QSCG_/IW_/\JD94/)[_K^'-<,\WQF*
M47CH^TE&4I1<VFUS-MI-+1:V2V5H[V1JLNPL?]TM&ZUL[JRZO97_ !/ST_X)
MG^+_ -H7QU^REX7\1_M,KXL_X6O=^(/% U7_ (3CPX?"_B ::FKR_P!BB71A
MX;\+*B^5P";;("D>8V55/H']J3X-S_M#_L^?%7X)V6MP^'KGXB^#]4\+VNO7
M%K]O&EWLQR)Y(2WS[&BP2!O53(P!QMKZ,  ''2@@$<]*X7B/]J^N*R=[I+9-
M--:*RM=;:?J=WU=?5/JG2UOZ_P ^Y_*#^RO\1_V\/^"75AXV_9Y\2?L3^-/C
M7H^M^+6\?>&M=\!ZAJS:-YNNAM"U?Q$?&FA^%_&?A9=$\2?\(9I#1>%_%?\
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M3PJC2Y.9<L7[L5*UUMJW97>CZ(X/[&PCPKBTWHG=O7R_X"V\C^8[XA?LN?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 1'!"$_0_0&FC!W8(/''YC^G\_3-?,7[67@OXE
M^/\ ]GCXF>%?@QXT\1> _BK>^'GO/ >O^$M8_P"$=U1/%&A,FMZ-HSZR&D&B
M:+XJFT<^&+JX^Y'%K<KD@A@_\VG_  2A_;P_:(\2?M=^'OAG\=OCUXB\5^$/
M'&D>)])CTKX@>(VU$KXKC7&@:-H/]M@2?\)$?$ ,3(G,D3-"04=E/H87(YXO
M"9GBX3BHTDO:P:;E)<MHI6T6S=WNTUV//Q&8QPV+CA''5JZ?SO\ U]_D?UUJ
M-IR2.GK]/6FMG.?7T.0>E?QZ_P#!4G_@HM\?-,_; \;> ?@7\;/$G@CP%\+K
M/PY\/1_PK7Q;J8T_7?$AT@:[XXUC7/)R@U_PGX@UC5O"P48.SP['YG[Q37Z2
M_L.?M[Z[XQ_X)O\ QA^)GQ ^(VD#XN?L^^'/&^E7GB'Q;XE&HZA?ZQK6BG7?
MA1K'C)M;D26/_A*O$>L+X7\(K*IAFCT81JS!IXZZ\1P]CL-@H8^23A4Y=&I*
M2Y]8\R=M]$U9-7^1S4<YPD\9]2O:2ZJUM#]Y2N4Y]?\ #I^(SZ=:8, >P]:_
MDQ_X)(_M(?MF_M$?M@V#>.OC1\1?&OPP\,>&O$_B;QWX?\0^+E;PXW]KZ*VC
M>'PF@D$NT7B36M&E1 &*E68#K7@/PP_;._:K^!'[=WA_X6?'O]J7XK^*_ _P
MQ^/#^ ?B.?\ A(-7U#PUKNFZ/K7]ANQT(J"/#[L2SD@DMDL"<UT/AW'+%SP*
MY9U8P<[*]VM6DE>]Y./*KM7<H]'<P6=8-)8S7E6B_77T/[3:*_E\_P""U'[>
MOQ@^&OQW\!?!'X!_%37/AX?!G@?_ (23QUJ_P_\ %Z:9J$OBCQKK'ECPGXRA
M62411^%O#>AZ)XFB)VRM%X\3>"NPU]#?\$:/VXM?^*GPP^-_AC]H3XH0ZWK_
M ,*UC^(C^+?'?BR;4_%)\ _V.R^,M6UM]8^>V\->#WTK1W:Y($<*>(':1T W
M#!\.XY90L[]WV;:CHI<UV^7F?V>7:^ETG?8Z?[:P?USZCUWZ6V[]S]^N6ZK^
M9Q^7&:.5Z+^1S^?&:_C;_8V_;"_;;_:4_;[^'7AL?'7QKK'A;4_BF_BGQ?X*
ML?%PTSP2O@;0]7;6M=TA-$ )&@_\(R2J^&!\Q!(Y&0;'[>G[17[<7[*?[;'C
M_P -Z]\>OB_#\-M7^(K?$SP/I.E^(=5T[PSJ7PN\1:T?$&D:'HP4!#_PC#LW
MPQD &QVT(G&#SM_JGC/KZR]YK351T_:7O=:2Y6D^52=F[WT36MD<_P#;>#^I
M_7K:7[/??N?V/T<'T/ZU_/[_ ,%@OVVO&_PX_9P_9AO/@UXB\>_##Q=\?[Q?
MB=9:]X6U./3-3L/ ^@^$-"EU[PGK;JB@M,WQ2\/3$*JA)O#Q;&[&SXY_X(]?
MMV?'?QY^UK;_  K^-_Q;^*'Q/TWXA^ _%.D>';+Q5X@.JZ9H?B?0$/CP:R$U
MP>9E?#VA:SX;3RL2;];C"FL,/PYC99.\[7*Z:<HR6O,W%I.S7NV3O=/71Z:J
M_1_;6#^N?4>NC^_S_$_K%8J" 3@GC\.1_7T)_.E(!!'U_/.?Y_\ UJ_C2_X*
M'_M\?M+O^VO\7/ WP.^,'Q8^&_A;PKXLC^%]EX4TGQ8NE:9_PDN@#^P=:UC0
MUP"J^*?$9.U2/DST!Z_UH_!+3O&ND?!WX6:3\3+J6_\ B/I?PX\"V'CR]FO&
MU"6^\<Z9X5T=?$DAU<$'6 _B"/5[@W>2+AW>7: ,GES#(Y99@\JQE2<7&K'F
MIP2:E&'*E+FU:?QQ=UI=V[&^'S)8G%O")6<5=OY_@O7M=GL.$Y.2/;O_ )],
M]^N:_FA_X*Y_\%*_VB/@1\9+K]G+X+W^F>!-,MO!_AOQ#K'CZULSJ?C*]O\
M7"-8,.B1$[-#"+&(VDD#,X+D%8W\M?Z"/C!8^*=7^%'Q0TKX<S36WQ U3X>^
M-K#P->6M])IC6OBY]!U5?#KG6%0KI6S7WME-R[$0[0PQY9"_YZ/[1&C?%GPW
M\;/B/X<^.NJZEK?Q>T#Q'J=CXZU75-8'B/4;[Q-CC&N#(\0+C&,< 5[G"66X
M/&YA;&M<D8_ U=MNUI)WMRJS5K;L\[B/$XK"8-N*M=[KR_JY_4%_P26\2?\
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M _5_CC\:/V[?V@-.M_C;^T5H?PMT[4[SQ/>Z-K_Q \1ZQX:^&?PS!T8:^=%
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M5KXN:W\!_P#"RK>5?&[>%=@_M<Z__;A_M]R\H00FY.W D,63N6OQ'_X*Q_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!5?R/?\ 7_ZU6** *_D>_P"O_P!:K%%% !1110!7\CW_ %_^M5BBB@ HHHH
MK^1[_K_]:CR/?]?_ *U6** *_D>_Z_\ UJ/(]_U_^M5BB@ HHHH *K^1[_K_
M /6JQ10 4444 %%%% !5?R/?]?\ ZU6** *_D>_Z_P#UJ/(]_P!?_K58HH K
M^1[_ *__ %JL444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME7&K65_I%U>:I86":CH63K,<>OZO;0>%R( >$3Q+(26VH9&R6^X*_A(\#_\
M!!3_ (* 7/QL_P"$>U/PKX$\-^!]!\1ZC?67QAUGXB>$;[P5KVF:+K =5T7P
M_HB^*OB@DGBM2&=/&'@Y3$/]:$VG']U] %BBBB@ HJO10!8HJO10!8HJO10!
M8HJOY_M^G_UZKS>?-S"0!^?X?_J_K0!H5Y%\1_C+\*O@[HTFN?$[XB>%/ .G
M0:3J.KN?%7B#2],NK[3M"@$VJ/I>D2RB;5V@A96FCT*"60NZ*$+,B/\ %_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5IJEUC_A%-/UGQSXZ\=,VLM\JZ-]DT#64\[8Y,!CD1F#H8J_B0^)_AG]H/\
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M@3PIX6\!Z7JNM75OXV7P@=3UKPM)KG]AZ'K.NOXY0>7K@('F>&_#&%"C,\N
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MQ3@C7]8\>Z&25F\.>%_#G]N>*)/-#EG\/1SJ5\%P^+)HOTU_X.-/^3"?#?\
MV<9\/O\ U#?B+7Y)?\&UW_)Y?QA_[-D\3_\ JT/A#0!@^,/^"U__  4O_9]^
M-FM?#GXTWWPPU/5_AGX\;1OB/X*L_!'A'^SKP:-JX37]%@\0>'GWP K]WQ1"
MT:JWSIM;FO['_@K\3M,^-?P>^%'QAT:RNM+T?XM_#KP+\3-(TR]0#4-/TOQS
MX?T;Q'#IFIYW9FC36E27 "DAFV@* ?XB/^"_/_*1WX@_]DV^%O\ ZA=?TP_\
M$+/^48O[/?\ V%/C%_ZNCX@T ?KM3'Z#Z_T-/IC]!]?Z&@#\F/\ @KS^U???
MLQ_LL7NB>$=5N=.^+/QWUA/A-\.KNTBUF*^T6;6RS>(/$"ZIH>]H6\+:$S2\
M-O+!6:1SDM_#]^UC^RI\6?V-_C/K_P &?B_I?V?5M,S>^&O$-H"/#7COPP"5
MT3QEHBD IX?5P5=6561U\4^ W56# ?T%?M'?MU?LP>*/^"NN@^._B^_B;5O
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M[8U73-.-\Y' C:=EW$C( 4Y7@,RDBNJH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+1-$X)Q_PA>#P0"/ZH?$O_!7SX,?$_X@^!?@%^Q&TGQ\^-OQ-U#3;/1M;O\
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MM6UO?F^OM(U2?XT?$77([?6% (TFX'A[5]#)MSC:DBD$L^T\AK/_  ;_ '[
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M^$??^V5V^)D=1YOA_P 0R-@HA'Z,R_\ !'/_ ()Y3?$"#Q\?V>?#6ZU\)_\
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M-_VC/@_KGCC[3X;T_P !_&WP'K7C#^U[/6?[4T#2]"\::!_;O]N:%_W ^/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,B-*A\26T1AGN8TAUY2W._\ !0O_ (*Y?!_]@?QCI_POU7P3XN^(_P 5-?\
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MXI^)OA"3X8^%_$^F:]JVDZCI?AWQ/X%U;XA^"->TG1-'\-@^%X )- #/+X9
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M^"C?B'4OVD?C]KE[_P )1X>\.>(?%NNZK\.O NDZWH_@36=$*> ]>\->$/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJZPZ*PUK6KB2)OM+2J6?;M+!$B\O^</_ (.>O^0G^QA_UZ?'O_T+X25_4O\
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M/I<SZ'))%)(ZK(LBR-(%8M0!_7%5BJ]6* /*_B_\3_#GP5^%OQ ^+?BTW/\
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M!]"_8;^)_C[X+_M"'6O!_P +/B)K*C5K^[T8;OAG\3=#EBT635M>T3_A&?\
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M%'A[Q3I>LKINLW6BZ5XPUJ99O#OA_P /SSQKX<;Q5X:NO&JPS:K:2>5<D29
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<UG2_%?A/PK_ &K&Y?P5'HH\4>&?'WB+^P9-:A \4'PHO[R%V=5=_)_KJHH
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MX4>/?A!XYLH=0\+?$'PWJ?AK6+2Z1"&CG1T6^ &3E)!%*"!GY8QG:Q!]>HH
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MNF_VM#::E?36^G-JFC:]MA;79KAD9=>T'1;E/*,<JO"K!RADB;[;HH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI?1-<\4_\))X4\GP8)6\2^#AX.\$MX,=+C]VJ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>..*,,Q*A#DMNW'L* "J]6** /S+_P""P7_*-K]JK_L4_"__ *LCP)7Y&_\
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MS\>5\:/X&_X1W<_]OY'@$'Q,-:VB(6I0"-?WIE(<QY_FP\'?\$@?^"H?@O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *\_;\/ZT58H
MH KP=_Q_I5BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH KT58HH _
M(CXR?LO?'C]M#]HO4?#G[4&D>$O#?[#7PB\8>%/&OPZ\ :5>:7JOB7X[^)=
MTC78AJ_C5E24Z%\/BWB!AXJ\%>)1NO+C1/#0MTS)/,OZSV]O!96T-I;Q""W@
MMQ;6UOQ@*J@!1UX "C)SU)/.0="B@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M? 'B+QIXHNC8>'_#]N-8TV?4M07+>5&^M:% B.S<*QDV@\L/XJ^]* "BBB@
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MBSZS'N^4[6^/_P#@F]_P47L/^"B?A+XH>*M)^$^H?"=?ACXB\.:&]G>>+_\
MA,3K3:_HG]O)(DH\-^%/+6*,-'M:.0NSHV] CJX!^G5%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_$W_P7
M(_;>U37OVT_AWX6^#GB._P!$UC]D.Z2_L_$5A>ZNR6/QD.L+KP*Z+KWAE?"[
M^(/"8T)0K!/%P90"%0?*/ZT/VJ_C]X:_9=_9Y^*WQ\\3-Y^G_#GPG)K6GV/V
M74)!JGB?4YAX?\$:&RZ/&UPP\2^*M7T'PVKQ@;#=*P;=AD_G;^"O_!(6;XW_
M /!.CXN>+?B!\)KCPW^VA\9[WQ5\2_ >J^++Z-/$VG,-6D\2>!O!C'Q&X;P&
M?%B1CPMXWC\3*SH&\R4>40R '[D?L!?M9Z-^VC^RQ\./C+;3V-EXON=*32?B
MEH5DFEVDF@?$S0@VC>)TAT-?$?BNXT+0[G7K2;Q'X+3Q!--=MX.N_#=S-$P;
M)^\*_BJ_X-X_VI-+^%_QX\=_L[>,/$=UIOA_XUV.FW_@*SN=5TBS\-?\)YH*
MMDB&,%Y?$?BKPX="\-+$F7D/AX(F685_9OJW]K?V7J7]C_8/[9^PZA_9?]H;
M_L']I;1_8_\ :7E?OO+W^5YFWY]N[;\^V@#X2_;#_;DT#]DOX@?LN_#)_#L7
MCCQG^U!\<_"7PNTG09=9U;PVWAWPOKVMZ/X>\1?$I=8'A3Q3H.MGPCX@UOPZ
MK^&Y+GPL\Z:_&5D5D9G_ $#K^!K_ (*/^"/VS=,_X*.^!/#GC_XIZ%XV_:#\
M5:Q\,-=^#E[\.[W6-/\ "_@?5/$/C9M%\#:5H;Z\WA+^PCX8\2:*9&D9BSER
M[EBQ-?U-_#OP%_P5?TWP7\1K#XC_ !N_94\2>,=4\):1H_PNO;'PCXOTS3/"
M/BE9'.L:SXA_XIT2>(E;1"VQ5# S Y&"^0#U+Q9^V3X2\/?MR_"3]C*SU[P[
M#K'B;X;^/?'WC==3OM'$EA?Q/HH\!>"]"N)?$@N_^$KGB?7?$L_A^7PQ(Q\(
MMX;N87C\PD_H!7\"?[&7A3]M6S_X*E?%#P-\(_'OP^\7?M->%_%OQW\+^._B
MM\2K'_A)O"[)H7C/^P?'/C-4UW/B9D/B'0P B@^,V4X .<'^RWX+7O[07PH^
M"?C?Q5^VI\0OAWXU\5^#;SQ5XSN_%GPI\,:MH_AJW^&&@:)H^L%7T*XVSOK<
M!TG79G9(SD21M TH,D; 'U_17\WN@_'7_@IA_P %/8/B'XK_ &0/&'@']F+]
ME,ZZWAGP%\1_$5P[_$W7=8\#ZSH[Z^=V@^9XH\,0^*4DG6/?X3"Q1,(-[%@'
M\-\8?MH?\%(/^"5OQ2^&W@C]L?7;']H[]GGQ#?&%_B?I6CW-WJVN2:I(ZZUI
M&B>-=>>WF'B#PFWSIX:\4M&+F QO',]N\+D _JTHK\1?^"AW[>_[57P0^!NA
M?'G]E/X+:+\0/@-XO^%O@KQX?CQK.H/+J/@B]\:R'5]#DUCX6&./7_\ A')/
M#0\./>>(_$$:PVMSXB%M(-\8W?%?[&G_  5$_P""@?[:?PD\3_##X.?"_0O$
M7[2&D^/]&O\ Q+\==9T31/#_ ,#?A1\(==D\/BW&LZ*_B.27Q!\2&N6U>2'P
ME !._AE/$#PMYGA299@#^HZN3\6^+?#O@/P]JWBWQAKFG>'?"_ANR?5M?U_5
MKC[#IFFZ='N#S32$LH12%!#$Y8JHWNX6OY*[+_@HM_P4A_8)_:Z\.>%_^"@,
MT,WPE^*7C+2O$'B+[3HTNN>&]"\#$C1-=UKX8ZQX>/BAS_PBC >*)_!_AE1N
M(:.=#\PK]0/^"TW@7]K#Q7^S5\3M3^%7Q5\!>!?V>_"OPLU37?B]X2O=$U1O
M'GCLZ1K#2SZ5I&MVP,-OH4FBG3(YLE/-GCDP6#1B@#ZC_P""?7[94W[;_@WX
MZ_%/3].T>P\%>$/VFO'_ ,)?A8^EQZTK:O\ #O0?"/@'6]#\8ZJ=4MH&_M[Q
M7_PDNI^(L2>';=;1-5MO"[.TUO=3S>Y_M@?LV>'OVO/V=/BA^SMXJUK4O#VB
M?$/2M+LF\1:1&;_4] U+0->TKQMH6L)!(Z)JZP^(="T-GT-SLN8D95+(T9C_
M )L/^"(7@S]O?Q%^S;XOO?V9OC+\#OAU\)&_:,\56?B_1_'_ ,/]<\2>.'\3
MIX*^$PUS5M(E.V !O#KZ.(DN)40NV5^8;A^O'_!2?]HS]O#]G/X2:KXD_9F^
M!MEX\T?P9X+TKQ)\1/CMJ<^E7C>'%M=;T-M:U/1O@E#XB3Q1X@M!X?3Q"WC%
MW\N'PE;3+XSS+#X:9+@ ]V_X)[?L*>$?^"?GP5U/X6:)XI3Q[KVO>)=2\2^*
MOB$?#Q\-:EXC<NL>@Q2:&_B'Q2D;>%]"*P1!991,7#!<':?T(3H?K_05^-/_
M  1A_:N^/O[7?[/?C_QQ\>],N9;^T^*6IIX:\;?818:1XJTS6\Z]JVC^'X&S
M&-"\'3&/PRA5?F"[&) CV\=^W/\ \%.?'WP^_:9\,?L'_LE>#]%\6_M+>,?[
M(T+4_%'C61M/\*?#_5/&FCZ/KV@R*FR,ZY,_AN=O$<R NFR../[J8H _<JBO
MP,\6_L+_ /!4JR\#VOQ!\'_\%&?%/B'X\6GB+5?%.J_#'4+=M+^"%_&)M?UN
M/P;H"[68[WAT#PX(_%6?"$:-X@>>.%G13B?\$G_^"K'Q _:B^)7C+]FC]IR'
MPEI?QP\/OXCU?PCK.EC2M!T_Q<-#:./7O!>C:*]S$?$?B/PQ$NN^(2_ACS]O
MA+0M=NY@8[5C0!_0=17\JW_!8[]M'_@I=\ +S^S])T/1/V??@=K_ (YU;PK\
M._B)X*\8:)XE\<?$(Z)K*Z[H^NRJ@7Q%X#DD\.KF3PR$^9LJ>,J/3O@K\5?^
M"F7_  4M_90^$-S\"?%-O^RM9^#M(TOPUXR^/7CC6-=F\3_M!>//!+:MX>UW
M5_ K:!X;=;?PW(VA0/XU\0QF,2^-M=\4^#(XI'\'2, #^ENBOY?/^"<'[=G[
M5OPS_;@\2_\ !.C]LK7-4^+?B_4?$?B:T\/?$"]U73=4U7PIXBT#P3+X]VIJ
MJ_-KW@'Q7X<T<D@0M+X1\9!K1@%E)3]G?^"@]_\ M':9^R)\:[_]DBQU#4/C
MA#HT/_"-VN@6@O\ Q2VFG5(AXW7P:A SXM_X1D:U_P (8" P\7?9EP1@* ?<
MU%?S_?\ !"#P/^VKX'^%7Q4\/?M,Z5X^\)^ =+\2C3_AMX+^*_AGQ9X>\<V-
M_.1KVO:MHW_"2!B?"UPVLH'6/#/XU7Q(V1L++_0#0!^8O_!7CX;^./B]_P $
M]_CK\,OAOX:OO%WCSQEK7P.T;PQX?TZ*07^H:F/V@/A/*522;:B>5!;RRR:V
MORVT2F0A5@W'H?V<O^"9O[&/[.N@:1;^%?@#X6U'Q&WA/2]$\0^(OB%:KXVU
M37?)175]836(Y/#/]L/(&2>3P_X8M0K+Y9 CD0R?HS10!_G]_P#!3/X8^ OA
MC_P5J\;^!O ?A#0_#WA&Y^)/P)UC_A%M(LQ_9K:GXX\&^ M<ULMH:@+O\6^(
M=;ULR! %$F[:JC@?V8?&7]@C]DGX\>"I_ 7C?X#_  XM='N'>\L[CPKX9T/P
M;XCT34'TG6-'&M:1K7AV*">*X2#698H%63RD,Q>X6Y81(O\ (1_P5L_Y3)>,
M/^QS_9B_]5E\)*_O#H _GS_8G_X)QZ79_#K]J3]E+X__  ]CU_X0_#_XJ?$?
MPU^SA\9-7\-Z5X9^)M_I7Q4^'>L^ OBAXOT.*Y?Q/:P-X:T'Q+H:^$?$S>$X
M?#-WXKCE\7VT<LR)):? ?_!M; +3]H+]J>" 9M[7X;^%[,9[$>,R#TZ$#CFO
M["*_A,_X(U>,OV@]+^,7[1/@+]F?P/;ZW\3OB;X.TSPW:?$'Q N_X:?!C2D\
M9DZ[XT\<*JL[8X;P-X54;_&K*H&<E6 /[LZL5_&?^U1XG_X+ ?\ !,KQ3\,?
MBG\2/VDO$/QT^&-UK!-_J=IJFLWWPW_M,SSA?"'CI/$7AE7\/QRZ&EP\,V-D
M_P \T3R+X3+G^H?X2_M/_#[XH?LK^&/VK)M0.F?#V[^%E_\ $[Q!?PV.K*-#
ML/#^FZL_C9?[(,3>(%'AJ;1M7MQ'Y8G<Q;HPSJI4 ^J:*_ ?X->.OVO_ /@J
MO#XW^+?PY^/7B3]CS]E#1/%^I:'\';GX?6NBZI\8?'^K>'"^C:SK7CAIG"Z!
MH1D)9?##-O,C!V;"LZ_ _P"W!\2/^"D7_!*WXO?#KQM-^UGXX_:#^"'C=TT'
M2+OXEC2+[&IQ;)O&NB:UX*3"R:Z4=&\$>)T9XL.\$@R)8P ?UX45X?\  CXO
M^$/C[\(_AU\9? 5]#?\ A;XB>'M/\2:4(+W3-1-E-*'/B#1]3;1I;BW&O^&/
M$/\ :?AGQ5#'.PMO%FBSV[K%(CQI[A0!_*O_ ,'(OP@^&.A?#;X%_%30O!?A
MW2/'VN_%;Q+HOB/Q9I>DQ:?J>LZ6?#VMZ_Y6M^6H?Q!CQ#MG)G9Y&:=BK>5Y
M2K]M_P#!%GX)?!OQC_P3=^ WB+Q9\)?AAXL\0W%[\8VN_$&O>!O"7B/5;_\
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MI\9O#7BOP]X[UK3-+T#4O'FA-K^@?VWH0&S7->SK8C\9NS!7D22)1N0;J_\
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M:C_:0U6/^R/%/@[X6Z_XRBT";5](UKQ&J^&UT,Z)'KYG#JD@\'>'EBE ?Q0
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M[4]>U^_BTS3M$TR-7W:EJNM:W)'%$J;-A>9T4.P21FSN'X)?MN?\$7/@5/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-I_Q/TGQ#\"==OM)/@B['B#5?^)SH\.LP!M#M]VOZ3KS1;FA\.7!BN5C$:-
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M6C_#KP'^T9\/-&U?5,?VK?Z7X'^-'@#0!_;9Z YT,8)Z<'FOOW]GC_@M5?\
MQ+^!/P_\+_!;]BSXD>-?V@;9M(\ -\/_ (::&OA_]GO0]5C1$5M#\<R$KX;\
M/I_Q)Y(?"WB588HYY/\ A"V\:2?O?&,WY(?\$W?CKXX^ O\ P4X^-'B_XT_!
M[Q_<?&#QY:_$OPUK/PS\$>&M8;^P?BA\5/BEX>\0XUOOX=^'I\1*0OBQ3XP:
M/P80Z'QBZK0!]E?\'-__ "-W[''_ &+?QE_]/?PBK^L3PC_R*7A;_L7]'_\
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M=/#'C#PWKDENP\.+XN\;FXU;QAXW_P"$V\'(@9@#^NROXN?BS\/_  S\.?\
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M?7->OA+H</B2UUZ0>($C\+2>+5GCEO;)&11& ?9_[3/AG2O!_P"Q-^T!X/\
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M7&T+QCH.M^&9?&/B9$\5Z!'H2M#XK\*21E1Y3MX1CR& /A#P=^V!_P %&?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIC]!]?Z&@!]%5Z* +%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M3'Z#Z_T-/HH KT58HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***9O
M'H?T_P : 'T4S>/0_I_C1O'H?T_QH ?13-X]#^G^-&\>A_3_ !H ?13-X]#^
MG^-&\>A_3_&@!]%,WCT/Z?XT^@ HHHH **9O'H?T_P :?0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %86IZK8Z+IM]JVIW5OI^D:9::A>ZG>7)V1VFG:4'
M:63/3;&B,[$@G!(4%RH.[10!^5E]_P %C/\ @GSIOC/Q_P""-4^.=KI>H^ ?
M#FI^)[K6;S1]8L?#GBI=%^670_ >ME8X_'WB1<*5\.>&!<2,#*K+AAGCK_\
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M[VY%K:7GB+5M+\/17U^1CRXVUEXD+G'&&=PIS@J4SVE !1110 4444 %%%%
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M7-!\0R^%[7PC/&TL/AGQBWCJ5HC&O]+W!."<8\W]!G^HKP?XE?!?0?B3X_\
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MSIK/A6>PA\12^*X8DZ#]F?\ X+::A^T+^WD/V,/$'["'[2WP%?Q!X<\3>)O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _
MG1_X.6O^3)OA%_V=1X6_]4U\9*]S_P"#??\ Y1O>!O\ LJ/Q2_\ 3XM>&?\
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MT33?$+>&[3QA_8<WB/6=5:'QAXIC\-'P=X0BN9O%=U MCX<>8?)W_!/GP?\
M%O\ X+!Q_''X\?M/?M.?'7PK#X$\72>#? /PZ^ OB-_AMX7\*'6(F\0[3Y,<
MTOB+P\P0(L?B6">X?_EGXQ=4?;^B_P#P3<T#P/\ L(_\$K_"WC/]H/5[SP;X
M1O='\3_&7XC6?Q!TL:8-#?QL\6C#PBNAX>/7(?$K#1E\(>'V"7'BR;784MXI
M9IH%?Y'^'W[<G[7'_!277_&OPR_X)U_#[2/V5O@QIMFD7C?]H#QSI4DFJ6.I
M:[HJQ_V+HB>'RSZ)XB 8/X.F\,^84&^:1TB4LH!\4>&/B/\ M-?\$@O^"DG@
M_P"#/Q2^-/Q%^.GP*^*5C\/(;S6/$=P^K7_CKPWK@71?[;\.>$->^(WB=_ N
MM^%/B/\ V[X5#MXKC2Z@T)DFA,4G@^(_?7_!?']BJ7XD? [Q1^V"OQ@\;:)_
MPI+PCX=MM6^#UUYFI^!_%T<GCK1-#\-ZWI);6[;_ (1OQ7X7A\;ZW<77B(P>
M*U\422I:1_\ "*B,7,GX\?\ !2S]FSQ7^S9_P4+_ &=]*\<_'CX@_M%>*/B+
M:?!OQGK'Q ^(EI#I_B;)^)NO>!=$T5?)DD4 >'O!#(<E&W*WR[2K-_3[_P %
ML/\ E&)^U/\ ]@;X8_\ JZO % 'XK_\ !&+_ ()YS_&[X">!?VB)OVI?V@OA
MS#H?QM\2BR^'WPOU]]!TI/\ A"'\L&1=</BWPTJGQ,=!\3%F\'A570G\&DFW
M\373P_I[_P %</V]?B#^S9HWPN^ 7[/NN^%="_:+_:#O9=/TGQ1XMU72O#&C
M_#3PQYO]@CQHFL^*(T^&RB+Q&IB$WBKQ= OA<?Z2T3JUN8Z7_!O1_P HZ=!_
M[*_\3?YZ#7X=?\%3?$?@?0O^"V5KJOQ?\+S?$?X8:'JGP';Q%X!N$&HQZ_X:
M?P5H+:[I(C)X#,2Y4L2<D%B26H _0:__ &)?@!XC^#-_>^)_^"PD]U^UKKNC
MZGK.L^-]*_;!\(:;\$7^*6NZP?$#*O@8^(!XB3PX%*>&$E:9D>0-XQ;P-&Q'
MA!?"?^"*7_!1#X]I^U$W[$'QJ^)>I?&;PEKFB^/_  K\+=>M&A\1?V)XU^%P
MU_QQ/K*>.+F'PQK_ (A\ ^*?"^B>.9H$GC\7^+I9HO"MO/-#:S3R+^[>C?\
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MC/\ 8Z^,7P7TNV\+:1^TGXT^$&O^*M)TM5T[2[_6?BGXV\0?"/XN1L% 5O\
MA*/#I_X21FVJK^--<+ ;6!K] _\ @[&N$?\ X)]?!Z)1PW[57@^<'V/PR^+T
M>/\ QT8KR3]H[PG;?\%$O^#B7X ^$?ART/BGX8?\$^?"/A3Q5\=O%<$27_AK
MP]\0/!/C#6_&L?@L:K&$(\22^)-9\"^'6@!\PS:+XJB0*?"/C&-?7O\ @["M
ME/\ P3[^#TB'Y5_:M\!PCU*GX:_%Z4'OV8<>A]:X,1._"_",-'&'%+=2S3Y>
M%I\94G3C9:J\(XB5VDG#EL>WAO;/BO,91Y>=\+0]IO=\3?ZH8KF:<O>OR_5&
MTVWS.5]3]T/V*;R+3_V&?V5[^Y8+#9?LN?!FZGS_ '8_A?HLC>O]UA^/:OY3
M?^".W[87[=WB'4OVX?VGO@%_P3DC_;/UK]HG]IK5]4\<_%2[_;&^"WP#OO".
MF:/H2ZI\/_A?#H7Q#\+MXDUS0O"/A[Q"D%OXF *R^:UMY,A\+*%_I;_8S^,'
MPF?]BS]@_P ,77C'2-0U'XP?LX?#+PAX%TJU=;K4?%VI^'?@[#-XW@AT;12Y
MW>%K?1=8;QEY*"R\*3V\\-]<6C8-?R5?\$S?VUK7_@B1^W/^U+^P]^UY:Z[X
M1^ _C3XB37VA>.#I$E]_PB6K:-$Z> _B7+#HL<GB+7O 'Q3^'_\ 8!9= L;K
M[-)'X;5K03+XSV_38Z,WQIQ7HTE_K8VI75G'C*=[V:][EM9/3HTUH?-93[-<
M#90KKVK_ -4WTNZ;X4DTU=7Y>=ZV\F^C/NS_ (*Q?"S_ (*Y?\%1/@3X)^#U
MY_P2"MO@EK/@?XHZ5\1-%\?-^WE^RG\1M0CMX="UW0=<T2/PZQ\(1Q1^)UU]
M/,9/%J'.B1F7EDS^G#>#OCQ\.?\ @@7\1/AQ^TWX9/A/XV?#S]@/XT>!?'>@
MW>O:%XR&G2>"OA;XXT/0L:UH7B;Q3H&OM+X<TO19'=/%,J,[.DT\4J^57T]X
M[_X*X?\ !-GP-X&N_B!/^VK^SKXKL[+3/M<7A/P!\5O!?Q!^).OJ%<KIF@?"
M_P .>([CQ9<:X[*,6Q\.!U#HLZHN0.-_:N\3^//$7_!(_P#:A\<_&336\(>,
M_&7[(WQ_\9:YX1U@6&G:IX&T_P <>!_'.M:!\.]8+ 1KXE\(>'M7TCPC,YSY
M_BW1))/,?>0WS&9KV'#_ !/A-$DJD[23]HI.C)66UERMJ:=G=+70^ARB7UGB
M#A3RJ4TNS4JM+5]6W)Z-7UZ631^4_P#P:=^#_"\7[$?QB\?0Z3IT?BO5/VCO
M%7A:^UW['&FHR>'M(^&?P@UNVT=)64L-$B?6F:! 0K.=S*7CC*_-W_!VQHFE
MQ:I^P)XPMX3;^)AK?QET5=5M)#9:BNF(?A+K#HK]2$>-CAOF4NR]"%'UG_P:
M<3V\O_!/WXLPPR0F>W_:Q^(*7<*#_5N?AA\(=N?3(SV(XSWQ7RU_P=R7=E#;
M_L!Q7$UO]HM_%OQPO&MB,%M/2/X0JYQVQ\JGMG..O/U>;N7^N/"/,W?_ %Q\
M(DM.7W/;\'1BM'=^[I=Z2CNK)'GY"VL-Q2E?5<9<UK;-5VW*U^L8ZNUGRI>?
M]?/PR\$^$/AOX!\+^"O 'AS1_"OA'0=$LK'1/#^A6B6&FZ;8*<)'!"H'RA<G
M)'F,?O,<YK^-[_@ARL'A'_@NM_P5&\ >'+<:=X65_P!HIK72+0 Z;I\6A?M-
MZ$ND[1V8P:[*H( /..A-?V@^'+F&\\/:%>PR;H+K1[&ZM3ZQS68=!]#&Q?OW
MK^+C_@BU-!-_P<#_ /!4">*:!EN9/VL#:A/O;1^T]X )]L #)_QKDP2OQ1F]
M[R_XP[BSO=N.(H-/U32=^ZOL94M.!ZEO^?G!R_\ )EMLNI],_P#!W#_R:)^S
M'_V<??\ _JJ_']?TC_LH^$/"W@/]FOX"^%O!'AW1_"?AC3/A%\/8])\/Z#IJ
M:;IEA%_PB&D[4CBC 5< E077S'4@.SF,D_S<?\'</_)HG[,?_9Q]_P#^JK\?
MU_23^ROXH\/>,/V:O@)XC\+:YH_B3P_JOP@^&EWI6NZ%JR:KI>H0GP;I!5X]
M5A+"02;@ 6_>,N1(H<L@X,JO_8^;[V_UPUMM?_5'"V;]-;==[=2<Q_Y&^4;?
M\DC/?_LKJO\ P#^.C_@HY\/-*_84_P"#@W]B;XW?!"UM_"T7[0WB_P"%OB'Q
MIH.E0K9Z;J&K^._B/K7PI^+&=(14$G_"5^&_$*^)Q(5#2^,M>\32L,L<_7?_
M  6.^/\ \4=7_P""NO\ P3;_ &>OAI\$)OVE;CX4:%K/[2/AWX )\3M"^$EI
M\2OB7K'_  L)?#QUCQKXUC?PIHW_  AT7PI'B:U?Q)$ZW$:^(O!,:/\ \)BN
M3XT>!X?^"GG_  7X^#EU\++9O$_[/O\ P3F\,>%[_P"-/Q)L2Q\+1?%G1O%N
MN>-T\%:5KL D_MS7D\2)X%\-77AI,HAT#Q=<$_\ %),:\U_X.+/#_P 7_P!D
M_P#;0_8B_P""HWPGT:ZU2P^'":5\.?%5P+=OL&EZIX*\7:[K^B:#X@D1@ZZ'
M\5_#7COQQX99D=7']AK(K+N4URY=BYX?+/#RGC%'FCQ1Q<ZDN9\BX5J.:X/I
MVC9J*M*HI1:E[*4;*/N,[L6OK%?BE81W2X0<5;XEQ;%S?%;?/>7,Z*IQM)N7
MM%+GYI<U_P!7]?\ VR?^"O?B71]4T#5O^"$$>I:/K>FZGI6IVES_ ,%-/V5&
ML;[3M6B>"57'_",N[!XV=2"BL-[,AW%6'P/_ ,&\'[!'_!03]A+XN?M*V'[3
M7P)'PG^#/Q9\)^&=;\-$?%7X0^-&3QWX<UDC2=';0OAU\1/&3_)X9UW74/B6
M0)'*VAI [*9T#?JW^S;_ ,%K/^"<?[1OPQ\.^/X_VJO@K\$M8NK;3SXE^&OQ
M[^)/@[X3^-?"FH,C2-HK6WCS7/"J>(PLC!5\2^$I/$_A.0(0+PM(RGV3]G7]
MM'P;^U_\8_B->?L[^(;7Q[^S1\&-#_X0OQ%\6M)M7D\+_$;XZ>(-8T35!HW@
M/6TA-QKFB_"KPOI1B\7>(-/7_A%;J\^(45J)W3PM/*?2PV'GAL5FEXV<K<Z?
MV+=%:ZO=66K75.VKY*]=8G">[9+?3OKW?;R/YHF\$^&O%_\ P=H^([#Q1H%C
MXBL=+L=(\8:1;ZG9C4+*T\2:%^R;X>UO1-<C(*JD_AG7P3"QP$E=&Q\H%?VR
M1?<_ _\ H4U?Q7Z#K>BVW_!W!XG6;5+8M=:1?:-:$W0S_:B_L:>'6?2"O9@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAYX%\!#Q#>G4M='@KP=HGAEM;U(J1_:>L#08+5M7E(;:K7'F2A692XYV^DT
M?Q0_L4?\%V?BA^S)\&-&_9N^*?P'\2?%CQ#\.?#I\-?"O5EUC6%\<'>==U_1
M=$\=KKXVOX<\+^'=9T'POX+/A4%CX,\/@@A@I'Z8_P#!-_P'^U/^VM^TMI?_
M  4C_;!TEO"7A?P-X-\4^%_V5_A5;R:UIFF^%-4\;K_8/CCQGHFE-*MR=$;P
MXNM^&!-XG6XE\7?VYYLFT^$HF;]S)O@A\&Y?'O\ PM>;X1_#.X^*HN_M(^)E
MUX&\)_\ "<B3^R?["S_PF!T@^(M@T$CP\,W!86?^BD>6*]AH _G4_P""WO\
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MV=<U?6-"3Q)H,YT7Q#+<$ >(8)XIC'HD,43Q,4,GPKK/_!$WX(:;!#H_[/\
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MYX%&A>*_"Z-XA4".67PH/"1F35)SL25]J?(7_!33]EGP)_P4]N_#/A3XA_\
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M%?B?X2614.S2]=0HNNZ/+(P<^&/%<'BSP6H?FT8C<?<_^&W?V)/^CP/V8O\
MQ('X.?\ S55D7'_!0#]BRUD:WB_:@_9_NUMAAKFV^-7PS8'U!!\2<YST([48
MG_:M<8KW[N_Y]/3\.IAO]E_W*_RT_P _QO\ /I^<W[(/_!OI_P $^?V-_B#I
M/Q7\->"/BC\9/B'X9UD:SX,\2?'GQSI'B1/"6J,#C5=%T3X?^'O!OAIRV#D^
M)?"OBF=1C9)&PW5^BO[37['WP/\ VOO#MOX.^/\ X*^(WBSP0MK?Z?J/@?P]
M^T)\>OA3X,U^Q9]YA\>^#/A'\2/"'ACX@([:;%Y47BJ#Q6T2NGEA$E5%</\
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M@K>2_9H/"WQ MI[H?\?=W:^$/[.^I;_A)MS#IUY/))- 'Z93308\CC_/&?\
M'\^U?PN_MQ? G_@IE^R_^U?\6?VX?$'C/6;J?X2:SX6\3^&_VA+*]&G>&;_P
MOKWC+P]X%T#P7HFA@D E=?7PSXW^%I_XHL^"6\3-T89_J0\!_M\^$_&_B:VT
M&QL;O%S=X&+72. =8*<-_P )+G(5CSD\\CYNGDGQ*_90_:8_:\^-^B:U^T5\
M4/ N@_L@?"OXMZ1\0_AI\ OAMX0U75-3^-^F:*EMK&AP_M#:YX^0: T'A7Q7
MHJS_ /"+>'/"=UX/\7^$+PQK,GC!;;Q;  ?KC:2^;:V\_P#>MU/X@#/XY'KZ
MU<HHH _D4_;B_P"">7_!77]KG]I!_C1J>H?#[0--^''B/S?@1I/ASXNOX;_X
M5QIVBZ^=8T/6M!8*3H_BMI]!T+Q)+XE0R7'FR1+(N_PQ$).1_P"'?_\ P<%_
M]'3_ !)_\3(\:_\ S1U_8C10!_)/^SC_ ,$CO^"A?C3]KSX(?&/]NSQUHGQ;
M\#?"_5HK^[;XE?%)_C?J%_I.DDZW#X.&C:['(GEGQ*,O* T<2 O)M0$U_17^
MUU^RO\-OVT_@3XI^!GQ&\VWT;7[O2M0TWQ'I]GI&H^(?"VLZ)J<3PZUH+ZU;
MR1Z1K[6PUKPTMP&66*#6M<B*D2R ?62=#]?Z"GT ?SY?#;]G_P#X*U?L1_"&
M^_9G_9N;X!_'7X>Z;8^*;OX=?&+XE^+-=T_QMX(76W*:#X>TGP3KWB!O#&_P
MG*Q\2);$KX/DD,D C</+$WN7_!/;_@EG!^R3\1?&?[1'Q<^*MS\>?VD?B';:
MI'XC\<:MI$4NGZ)JFN:K-)KNM^'=8UU+OQ0GB7Q5$B:'XNW^*)//5%0Q!9-U
M?LW10!^+/_!7K]FS]N_]J7P%X8^%?[+'B'P;IWPN\1+J,7QAT#5?$TW@SQ!X
MA 59=&TK4]6WR1:QX8DDD_TCPW''#Y\B1F=I/+@8?B!\,_\ @DW_ ,%LO@SX
M:N?!WPA^,%_\,O"=UJS:U>^'_ '[3.L>#-(.HO'A]:&BZ""K:^\>BZ&&()#J
M77LP']LM5Z /XG/BG_P2._X+3_''1].\-?&CXJ7/Q9\/Z5K']LZ/I7Q"_:;U
MGQMI-AJ@.T:N-%\0 (6' V9R,],&OZS_ -D?X!:5^S%^SA\&_@5I8\,M/\./
M _AK1?$>J>$]$CT#2O%7BN'28X?$OC%=)3<(9/%/B%;KQ X9BXEG==W[L1CZ
M4JQ0 5^$G_!7G_@FQ\8?^"AOQ#_97M?AUXA\*>$?"/PZL?B_;^//%7B&9[^3
M0QXF'@$Z%)I/A\(!K<CSZ#,9%) CV[I"H-?NW10!SGAS3E\/Z!X?T1Y?/;2M
M(TO17N.@;^RM,6/S&/0Y$+-^//.:Z.BB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN/\ BC]&SUZ=,?3C@>M-F_X)/?L9S8^T?![X?W';GP)HW'^';WK](/\ 0/\
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M0_LO?!,#V\":.<^W,>,_\"_^O-_PP-^Q;_T:]\&?_"'T7_XBOKM.A^O]!3Z
M/D.']@O]BZ'_ %/[,OP=!_V?!ND$^O=,4?\ #!?[%TG7]F3X.M_W)ND'_P!!
M0^E?7E% 'R%%^P-^Q=!+]HA_9?\ @RDW]\>!M%)'X&/'Z]^W-:7_  Q%^R'_
M -&X_"3_ ,([2/\ XFOJNB@#Y4_X8B_9#_Z-Q^$G_A':1_\ $T?\,1?LA_\
M1N/PD_\ ".TC_P")KZKHH ^5/^&(OV0_^C<?A)_X1VD?_$U?A_8T_93AA\B'
M]G_X6"#T'A+22/S\O^G?GBOIRB@#YE_X8Y_97_Z(!\+?_"1T?_XBIH?V0_V7
M8!^X^ _PQ!]1X7TH_P D'\O2OI2B@#YR_P"&2?V9O^B$?#C_ ,)?2?\ XBE_
MX9._9E_Z(=\-_P#PFM*_^(KZ,HH ^<_^&3OV9?\ HAWPW_\ ":TK_P"(H_X9
M._9E_P"B'?#?_P )K2O_ (BOHRB@#PK0_P!FWX!^&[K[?H/PA^'^C7^/^/JU
M\-:4K9^GEMG]/K7M,$$-I#%!!$(+>W&%'0  $8'))SGD_P!,"KE% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'7O5BB@ HHHH **** &;!ZG]/\*-@]3^G^%/HH 9L'J?T_PHV#U/Z?X4^B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@"";_4GZ#^553>0P_Z[@_@>Y[=
M.O%:-<GXBT*]U@!8+V*UP /F5B?KT/\ ]>@#:DE^U#$&>.IZ?IFM*L71-.GT
MVU\B>X^T'L>W_P!?O6U0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !115'[991S>1]
MKMQ<$<6[7*Y&/]DDL/Q7\* +U%%% !1110 4444 %%%% !1110 4444 %%%>
M7?$CXI?#?X->$M0\>?%?QUX4^''@K2;K3;>[\5^,]<TGPWX:LI-9GCTC2TDU
MK6Y(K5)I'D48:52Q>3(:!7% 'J-%<=X6\6^%O'_A?P_XQ\(:]I/B?PAXFTG3
MM<\.^(="O(]4TO6M)UE$?1]5TK5HG\J5)8FWK)&SLOF#)1U /8T %%%% !11
M10 4444 %%%-X0=^OXDT .HKX[\7_MY_L6^!?$FM>#?''[5'P#\(>+_#-V=.
M\1>'/$'Q/\(:=JV@:BRC_B6:WI$FNK,EP QS&Q(5A]X$$GZW^VV7E>=]KM_L
M^,^?]J7;_P!];MO_ (]^&* +M%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45^='
M[3O_  5"_9%_8^^(?_"K?CMXS\4^'/&!\/:7XF-KI'P[\:>)]+&EZVVN)I0_
MMCP_X?N(0[-H=RI 8F/Y4<E_,*?._P#P_P"/^":7_15?&_\ X9[XF?\ S-T
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MQ?<_!G2O"OQX\,^)?$_QV\8^$OA_X,\"Z,3?>.['Q/XVU8:%H:>.O!9W^)/
M8EG&UF\56]IB(D%6V@L ?I)1110 4444 %%?C3^UC_P65^ G[*7[2D'[+NL>
M /'OCSQN9?"]GXEU3PZ-'TW3=#U/QP=#DT+2C_;CQKK=Q)HNO:-<.\1 92(F
M!8;Q^RU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@#Q%X.\+Z=X>UCXG_"S_ (33Q[>Z3_Q+5\7>)V\9Z]HRZQK+ *)-?5-&55<
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M/AS7/V-_B#INMZ%JVJZ'K.FW?Q1T#?9:MH0 UK2F_P"*6VF2/!V?+LZ[HVP
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M\=>.=5'A\ZO%I$'QI\4>'?#N]];,C3>%?")="28PHV*@!_4SY_M^G_UZ//\
M;]/_ *]>0?&/XU?#?]GSX=>*/BQ\6?%&G>$O!/A:S-]J^JWK*. C^7INE1EP
M^LZS)+&4CBCW2N3DQJB3;/Q>MO\ @O\ ?L\:MIZ^-_#G[.G[7VN?!;28M5MO
M'?Q,LOAIHR:9X2\0AM _L#P]O;Q-)X;D,J:VGVV:Y\8^%F\*2GP[+&OBAO&$
M'V8 _H \_P!OT_\ KU_'S_P5/_X*^_MT? K]K+QI\%O@_<1_ 7PC\.=]I9RZ
MSX0\%>,=<^(^GN['1_&>?&OAGQ0D&A>+'W1^#Q (RS*PD+N79OZ&?V=?V[OA
M)^T_^S-XS_:F^%_A;XL7'@?P0/'T-_X2U3P[I$OQ)US4? &D+KVK:1H.@Z%X
MG\40:SKDR(L'A:"U\2*+F:YB3>JQAV_##]IG_@I3_P $9?CW\1&UO]IO]C;]
MH_7?BCX-+>&;P^(? 6D^"?$VGEF+'1==_L+XX^%6*Y/">*W"HN$3"A0 #]U/
M^"=O[0WBS]J#]B[X#_&CQ]I^HZ9XT\7^$&M/$MQJMD=-N=;\5^"M8N/!/B7Q
M?%I&FZ'X=BTK0_%OB+0;CQ7:6L=M!;VEEK2VNU;6)-O:_M'_ +87P._92UCX
M/Z/\4];OK+7OCSX\L/AY\.O#^CZ4=3U/6]5DO- TJYU6-$P(]"\/2:]HWVR?
MS2R/K4.R*3<3'\E?$/\ X*Q_L;_!#]D;X+_M(Z5;^)K[X<?%C1Y-(^$'@'PE
MX5TRQ\2G4?!5P-!\1>"#HGFQ>'O#;?"W7HSX8\7+%-)#;$?\4-'XR$$"2_QO
M?&K_ (*&?$S]J#]LOX7?M,_'"?4O^$.^''Q4\!^)_#?PR\/?\3+3/ ?@/0O&
MF@Z]_8NAXP-?\1?\23/_  E  7QGT  P  ?Z1/G^WZ?_ %Z_A-_:F_X+3_\
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M&.NZS'K6C> _AE\7?#>B"V3"+))XO4S-ND>)5<0I]J_\$_/^"PWP"_;LUI/
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MW\4?VA/A_P",+S2O#/BWP3\5?B1XR\:;-,UO6@%UOP-K>O>)?%O_  C_ (A
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MT8^+?B#49$T#Q!]H?XH^'+K_ (2?08VFC5%\->%_%8\)H(Y4AC5997?\%/\
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M'GBVTO!J>EW_ (HT+6O[!_XD?_%.>$?^*=/?_BC_  </RS7]8_\ P3A^"/\
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M!_?UY_M^G_UZ//\ ;]/_ *]?Q*ZCI_\ P6&_;$_8E'[5FJ?M%Z+X)^"'P=\
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M^(/B*#18);32[35O&W@[1-?U:+2S(7D:))KR1T <E?E52H"J/I"@#XP_;_\
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M\+7]G^T=I'Q*UCQ)X9L%T0Z#KNMMKGC?Q!_Q<_P\OA7PXK>%P?\ A#\-@_\
M" GY3@ _N/U;XG_#S1+V?2=;\>>"]&U:W4-=Z9K'BS1=,O[(,,X:&6=90?\
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MFA:^ H/BYM%U[Q3XW\*J% \:>(/$X  P!_HQU_$5_P %J?\ @EK\3_ 7QO\
M'?[5GP4\)7/CKX3?%W7I?$/C70/!.@ZW=^)OAGX]UK26_P"$WUG7D;_A+?\
MA(O#_BS7CK'BEO%X2%/"J^(?$GA.WMX+7PW;IXQ /ZVOV;/V@O@#^T3\--/\
M3_L[>+_"OB?P3HEMI>C#3O#X2R'A-H])AFM_"L^A^7%_8$L&BA!# K*B(&\L
M>5&=OX(?M]?L!Z-\)_\ @HW_ ,$^_P!I?X(?#O2/#7@/QG^TS\"O#'COPMX
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?YR'_!8S_E)9^UC_P!C[X5_
M]5CX K]P_P!E_P#X+6_"7]D']D;]F'X5?%S]F?\ :JTRXTOX5:79>%O%R^#-
M%TWP3\1M-T-"AU[P+KOB/Q+X43Q#X?PS;3Y8&TE6#C-?AY_P6,_Y26?M8_\
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M&&F?"+X5^(_@Z=6\,^.=>\+Z!H3:$=>?_A(-O_"/KXM\.@*WE(Q#.#Y80,5
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M;:TUC3/L=I:]/^1+^+N2<D#C^7/6OI[_ (.=&,7Q*_9'@/\ Q[_\()\4@/\
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M"QZ;X?\ $W@@ETT+6]9&,+XG5AXC7(W )ABSAF(!^N__  ;P_">Q\$?L%?\
M"??VK<:D?C;\2/'OBB[TJ]LR%T'^PM6D\!_V(TBY.M ?V#@RLA4@[%+,V!_*
MW^W%%I7[-?\ P4<^.^H?!;QOHWB(>!/CQ_PL'PUX@T :,--L/$^N_P!@^/-<
M\&%?#YR!X4\1:YKGPP"G##^P?F56!5?ZX?\ @@=XH\/:S_P3?^&NAZ1KNGZA
MK7@SQE\2[/Q?IEI<I)J&A:CK?CG7O$&CQZVK$!)+CPOK>B^(2YP0)5*%F0JO
M\<'[5WA6Q^)'[>O[0'@[X20:WJ7_  F7[3GCS1?#=IX@O-&_M._\4:YXTU_^
MW0?^$>_YEW_A(_[<]/\ BB_I0!_8[_P4K\<Z)\5O^"-'Q2^(WC1O&.D6GC;X
M:?!#Q/*+/P9K.@Z_#XM;XH?"B7167P5X_/A27PUX?;XAG28Y'NG\J/P@I\76
MH\41R10W/\2/[+_PFL?CY^T5\$/@OJNJ76BZ?\3_ (I^!/A_>:K9V8U$V/\
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MZ?PMM/X#(_\ K5_.C_P<=:Q8Z;\#/ _G_P#/GX\./IK7PBR>_<?SXH ^#_\
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MI\=ZWX^UT'1 ,?*N=S'. H)K^CJOYW/^"/O@/PI\'O#_ ,;_ (Q:)I&I^'O
M^J>$M'UGQ&-6T=--U,:9X&?QX _]AZ%X=0$1DZXY .XA2L:O)M1OERS_ .#E
M>UF^/L.BWOP/T^T_9E;Q;_9__"7?VAKO_"T#X8VE/[>.D[QX>,O_ #-!\.>9
MYY\&8<R!P&H _J?\3>%]#\7>'==\*^(+"/4=!\2:1JNBZMIK-A;W3=:C:'58
MV (/[Q)F&1R&)P,LHKA?A%\#OA+\ /!MOX!^"_@/PW\-_!UK>:AJ%IX<\.V0
MT[2UU+5GWR.%&YR7)"$ LP&S W!MWHND:K9:WI>FZO8-YEIJMAIVK6C'JUEK
M,:31$^[*S.>O. *W* /Q"_X+U?![XE_&3]A&[L/AIX2O_&6I>"/BIX8^(_B'
M1M"07^JP^"=!\/\ CS2M;UF+16;.O-##K.FN;8!WV&6486%R?Y,/^"?G_!2'
MXS_\$_?&FL:EX0@M_'WPV\3VJGQA\*/$&L+IOAK7M4!_XD>LZ'KC!AH'B#PL
M,HZX(>-G1OE8@_VV_P#!37]M/7/V#?@%X8^-FA>"M'\=KJ7QB\$^ -8\.:K?
MMIDC^&]=TKQ'K.M2Z.RG#ZVD>@D6T,F^)@Q9T9HE*_B%^VY_P2)^%?[5WPMU
M3]N#]@:\MY_$'CG2='\?77P5\/7&FZCX8\02R"23QRO@C^P8O*'C\1>0D>@"
M9H9[K0IK5=D_B=HB ?JC_P $U](_8Y^-?C?XP?MY?LRWAL/$'QVT;POX:^)'
MPKMAI.FK\)_$^A$:YKVC:[H4!^?Q+XI\0G_A*7\0E8UN=W[IE4.J?L77\.'_
M  ;IP?%BS_;1\;6/A<6%OX"M/AUJ@^,UIJ']C?VD-.\MQX'.@_Q CQ^=(W;#
MGRC)O/E[Z_N,3H?K_04 /IC]!]?Z&GTQ^@^O]#0!^"?_  <+?$'PIX;_ &"[
MGP1K6IFU\3?$;XD^!;7P;I9L]39=1/@K7!XA\0[3&=P*^'PV[/#%LAG&"O\
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M4CZ ^U0?\\F_\!'_ ,: /\O#]K7_ ).J_:8_[.%^,G_JSO$%?Z#_ .T48O\
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M?":\\<>)OB)H-GAV\+:7X[T3P'/HCZS(&+'6U\/Z4?$,$+HKQC6?#3[G692
M#P'_ (-LY?)_;J^*(\C[1_QBOX\Z8S_R4_X!] <C]#Z?3X^_X+-^(_ 7B/\
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M_P#'&S\*WND:1HM@VH/X4\.:#XWT77YO&NO;@!Y32Z,WAN( <LTLY=CX88
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MQ TOXJ:7X8O/"0\-:S_:=AJFA>-#_;NB_P#E"[5_IX00P:;%U'TYZ_S[?TH
MV**S([4BZ%[Y]QS:A?LI/ Z'ZYSP!QSCGBM.@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *JS30PQ>?-@#U[^@[\=JM5E:CJ=OISV23 ?\
M$PNULUSZL&Z_YQR?6@"W#-#-%Y\."/7OZ'OSWKPCX[_&JW^"?@ZU\00>!/'/
MQ2UK7?$FG^%/#7@SX>Z4=8U?4_$>K:3KFKZ2DP'E1Z)H!_L65)O$S"2.VN&C
M9TD< 'U"\L[XZS;_ &&?[/;D9O._4<?F *_+G_@I3^WQXM_9"T-8?!^A7MUK
M%W_:)L]4DTG3-2TT&/2= D7*R$,&5];!Y568 *<H%  /Y<_VIOV$?^"G'[5O
M[0WQ7_:#UO\ 8P\:^'+_ .)_B0ZNOA_2K_1GTZQTN/1_#_AW1 6/B5F9E\/Z
M'L<L2V\X8ACBOZ-O^"8OQ3_;#^%GPB^$W[,/[1_[#?Q/\$6/@71],\&>&_BO
MX<O_  AJ/AN;2#JS+HK>-=#@\1/<Z(T4#2S>,?$EOLDEE5%'@R'<9!^0,W_!
M?7]J[_EQ.C@=_P#BA_"&,<>C?_6Z=>^#/_P7W_;2./(M],Y_ZIMHQ_3]<_\
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M/_A[U_P4M]-#_P##0:-_C7J'@G_@JY_P5)UC2[BXTKP/<^)+?[9@7>D_!/\
MM+ /L/I_+WH _KA\4^$M$\<>$_$O@WQ18_VEX:\7Z#JGAKQ!IK7<EI]LTC7=
M)DT/6M)+Z2RR?O+5G@D:-B5,KQPMM1<?S/\ _!)O_@E3\5OV:?VWOB_\8/CA
M\,])TCP9\,;?Q1H?P&U^T\2ZQJ?]H:QXT9M#_MG03N!UW0H?A[J^N^&<^*@9
M87UHLJJZ;D^?M9_X*B_\%<_^7'X2>)/_ !'OM_,>W\S7+V?_  4X_P""Q'F_
MO_A)XM^S],_\,]]O7_/XF@#]UO\ @KW^QD_[:'[)^O:'X7TNZUSXO_#*X/Q
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M--^-_BI](G_MZ?P;X"T?04;PTH\5Z!HP\*2Q^*+F9/%C>(3 \WA(1QR'CO\
M@EY^S_\ \% _V-OAYX5_9\^*7PV_9Y\1?!G1]>U.^M/%OA/XH>+]-^)FC?\
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MX?\ A_\ &?0?"CZ-J>F:UHFGKX;^)XT8"XT'^W=<T9!XH\/>(E25?"I\3_\
M%6K'X170;2*&-+,Y_%[_ (;&_P""X'_1,O%G_B-VM_\ S-58_P"&QO\ @N!_
MT3+Q9_XC=K?_ ,S5 '1_L8_\$X?^"TWP=\3>/O!7PH\<:A^S/X-%]J/AGQ#>
M>(O%W]J^!O%NG:^1X?UKQIX$\#!?%_AD^)3X<\$Z&%\4J/!_C4_\4QCQQBOZ
M</V5?V)_A)^R9\*6^$/@K3+O7=1\479U?XL?$[7[E[[QQ\2/&Y>+6I-?\0:N
M69YY#.CE-!VQPQV[HD2!6GGN?Y;/^&QO^"X'_1,O%G_B-VM__,U6C#^UI_P6
MYGB\_P#X5EXM]/\ DWO6?Z^&_P#Z] 'W;^V5_P $7O&5[\2M&^*G[+ 5?$-M
MK.EWMY::/:>#M/4C0CE2&^(/Q&7=GQ" 6 !VG*Y;&X\#^V]^RO\ M-:/^P5;
MZ'\39]2U/5]!UCP&+PW=YX-_XE^EZ#HQ!_Y%_P 2<8/;MC%?+'_#6G_!;K_H
MF'BW_P 1\UC_ .9NO)OBU\3O^"O7QGT&X\.^./@[X_N=/NAUL_@/K.F_^ZWU
MZ]ORH X__@A[X;\*_P##7.D:K8ZY_:5OIFL:6+S_ (D__4E^/C]/UK^L[_@I
M?^Q3%^W7^RKXF^$NERZ?IOQ,T+4-!\>?!WQ!JE[K:Z+IWCG1L8.M'1K@1N/%
M&@S>(?"TEWY'B5O"HUZ+QA'#//!%&W\7/P?_ &=?^"DWP3U__A*O _P6^)']
MH9S_ ,D?\9:E_P!!_P#ZEO\ ZC@/'MUK[@O/VBO^"SOV6V@\.?"3Q_;:A:_\
M?GVO]GO6=2_XE?K_ ,BWC_ZW3F@#V_\ 95_X(@_\%)_@M\0=8FTO]I3PG^SG
MX?\ &7AC4O#GB_QM\)/%VM>)_$NH:471(]$&C?\ "-^$8_,D>1?(\2E_-\)$
M-Y"R;6QYO\<_^#>+]L34_C%\2-1^%WQ)\ _$KP3J?B35M:T?QM\6?'.NZ7\3
M-?\ [:(UR4>-B_ACQ8'\1P>)L17'BA2Q\63$>,YQ'*P0\5_PT5_P75_Z)AXD
M_P#$;]8_^9NJLWQ^_P""X]Y%Y&J_#+Q;<Z?_ ,OOV3]GO6<>G_0MC_/KV /V
M\_9\_9W_ ."HWP;_ &#/%_[+VDS_ ++/ACQQX,\.Z?X)^">O:3J_Q(OM2U'P
MSXU;QNGCK6-;\;Z%KWA"3P+X_P#")U[1?$O@?Q9X2\)-"LFD,O\ PA!E-N8?
MPRF_X-WO^"A5[=W%]?:K\"KJYNKP7M[=7?Q(UG_3SZ?\DWXZYZ_A3O\ A;__
M  66_P"B.?$?_P ,3K7_ ,S5'_"W_P#@LM_T1SXC_P#AB=:_^9J@#^A;]O7]
MC3]IK]N/]ASP9\,_&&I_"W2OVE+?QCX4\3^(5\%>(?B7X%^#^AR-.\.NZ;_8
MA\1>*_\ A/QH.BR>7;CQ8 EX\3W%I_PB:S.Y^&=4_8D_X+&6O[)'Q _8+O\
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M></AO_@L#YO'@?QMQ_U1/QEWYS_R+>/Z#WJQ_P ([_P6!_Z$?QM_X9/QG_\
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M:5'\2D>/08V59(IH)4E@D1)(W2148?TO1W4##_7 GW^G/^?R'6OX.;SX#_\
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M\;Q JT)">*EEBD>&3^//3?V"/^"KWE?\?VM^_P#Q;?XEGT]?#?TJMJ7[!/\
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MW^+/"G@P>+(6CFBFE\6^"/%,O@A?Q[_X<>_\% ?^BN?^4;XF?X57_P"''O\
MP4!_Z*Y_Y1OB9_A0!_5C^Q/_ ,$]_P!G7]A'P[X@T?X26WB+Q!XG\979OO%?
MQ/\ B#=:'J7Q+U]BN5TS^W-!\,^%T&@VX(:*WT&!(OM&&,;M&C)]_12PG@$
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MP+IA9QKL7@I?#7P8\(>'-$\0^*E53<>(I(AXMECD"I/O\6>-&\8;7C#X/_\
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M_P"(=C]FW_G^U'_PO?&%+#_P;N?LV0RX_M74O_"\\9 9_P GW[9H ^D?'_\
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M D)<_2G_  X"_8\]-<_\+S6_\*OP?\$&?V)H8O(G@UP7'J?B/K(/UY'^1VH
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MOQ&\8ZG]A&K^(?''P9E\3^)=<_LG2!HNB?VWK7B7X+2>)#Y?AX8@5D9;>/\
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MV9(O]?X;NO\ P;D?AR!_A[YYH _#3_B)ZO?^C4=$_P##O:Q_\[:J^H_\'/\
M>V]A/<#]E#1/E& /^%OZN/;G'PU!';@'IGUK]VO^';_[,'_0MW/_ (-__K4[
M_AV]^R]_T*ES_P"#<_XT ?S[0_\ !TU?DD3_ +*&B9_[+!K/_P Y/\*W8?\
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M&?Q(QQU]_P#)]ZLT4 5_-A]?U/\ C5>:&"\[]1[=?\<X_'\*T** ,W^SXO\
MGM<?G_\ 84"T@A)F'VC/<;AD>Y&!Z^O7-:5% %7]U_SQ_2C]U_SQ_2K5% &;
M_9\7_/:X_/\ ^PH_L^+_ )[7'Y__ &%:5% %:&$11>3GIG'N#_\ J_"K-%%
M%:;R(<S2\=L]?4^W\Z2*Y6<9BP?J<?Y_&K5% &;#/-]H,,T74<-U'USTQ@?E
M6E110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_1;17\=/[6?PR_X*[_\ !+#PT?BU\.OVW?BK\??AKKUJ-&\>>+/$6CGXC?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHBRU?2-3.K)X1TM-7E?2/AE.YB?R-:^%D(_X0Z300,1'0U&X-\I /Q?\#_\
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MWWP)_9-^/_Q;TK2;;7-1\!_"OQ7K=GI5U>?V>E\8](9"I8C(.6R%&""C#/#
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M%(D;-%'&D7A#QEXP&)_P< 0PS_\ !1;]C>&=!- ?AS\,LCKG_B]?Q &<]#D
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M/A/_ (-J/^3B_P!K#_LFWA?_ -31:_7'_@JQ^T]^PM^S;9_#'5OVD?A3X?\
MCI\:=+?4/$OP?\$7%AIFJ>*-!C1B_P#PF+&1D_L7P^-=T@1)>%1<'9XB7PB)
MI[::-@#X=_:Y_9]_X*P?L[?L^#]K;0O^"@WQ'^(_Q%^'/@O3V\>?"QOA%X.T
MS5=$\->-SX9_X3H>'4\.Q^+_  MXBUWPEXATG1!+(_A2,IX/\/\ B3QK'XTF
MS)X-\6?HW_P3_P#VS?BW^W+^PGJWQ'\++\+M$_:=T/3?$7@NQM-4UK4=0\$'
MQ]HVBF/P9XS\;:'HCQ^)O#_AOQ/KB-=7'AK+7"VZ7"V_FEA&GYR_&5_^"NO[
M9W['WQ)^.VM^.OAU^R=\$;KP)XX^)%K\'+.WURS^)NM_#+0?AAKG]LZ%KVL_
M\(Z[IH'BY)=<E?PSXKC_ -4OAJ:X<(JO3/\ @V._Y(_^U/\ ]E,\ ?\ J':Y
M0!\*?&S_ (*A_P#!4']F;]NP>!?CWXA\,ZE+X&\7^&;7Q%\"?A=?Z1X9^&WC
MS3)=!,>AS:!XCUWP[XL\6>'M"\7QOHOBCS_%3B7_ (J$D>"O!I.:^T/VS?V<
MO^"X_C_PKXX^/NI?&[X7^"O!?AA-,^,^D_LZ?"GXCZY8^*_ D?AW29-NA/XC
M?X<>%/#7B'Q!X1T"65O&*2>-/^$+\:;O%AB7:O@_'@G[45G;7O\ P<>_#>RO
M(+:ZMKOXC?LYFZM;K!R/^%8:!@J.A&,8ZYZ"OZL?VE_^3<_V@/\ LBGQ1_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH ***^9OVFOV=+']IGX<)\-=4^*7QG^#\
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MB\3>"O%VDR:+XCT"ZO-3L;#4=*D.^2%WTEUE"NRHY"RQL?+CRVU0M 'XC?\
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M!_V7/ 37^H:/_8U^?&][XR^*EA)IH\IRC:)\6?$7C#P_$Y72X_+UU;:.XD=
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M^7$BYP0,;OF+AN=P\+_X8X_9"_Z-9_9Q_P##)?#3_P"9F@#\AO\ @WZ_:?\
M"_C7]B>+X->(_$?@[1?%WP)^(?B;PSI/AXZL;/Q!=>!?&3GQ_H&M:Q!KLBSF
MXF\2>(/''AC=$'4CPNH(1ROG?B]_P5J\;?%'X)_\%?/!?QI^+^E?\))X3^'/
MBWX,_$[X::1I0TC2S??"SP+XR&O+HG]MO\X\1_\ "0Z'K?#88'7\$$@BO[&;
M/]D7]E&POK+5--_9F_9[TR_T^X-W9:II_P &/AQI^HV-_P!/-BFB\-))'(RM
MPRL'!"E3G:X/CS^RS^S[^U5X8_X1+X]_"7PK\1=+$47V:?5[1K#Q'HV-6TC7
M@N@>,M$EM_%'AI_M6C:0TMSX5\36,MR($CE/EQ(8P#\8OVX/^"L7P"^-_P"R
MGXY^$W[,OA[Q=\?O''QW_9\^*/\ PD6D>!K0_P!H_!?PK_PA/B Z]KGCM&&T
M3>%'=S)X;4[WP,L%8QCY!_X-Z?VP_@[\-/!?B']E[Q$OC:\^*/Q8^/']N^&E
MTGPAK.H^&;'3M9\&>']&B.MZX2$T!EFT#62"_ YR<;L_TR?!W]F;]GO]G?1H
M-&^"OP;\!_#J&VT2R\,"[\/>'-+7Q'?:7;L'BTK6_&,H;Q1X@.]E D\2^([M
MRYB(9E5 U'X&?LN?L\_LTZA\0M5^"7PB\'_#/4OBAXGU'QAXWO/#=J\::EJD
M\L*M&@E9UT+0X-RBV\,^&H;?PGX:=91:V4$>6D /XT?^"BGPR^+W_!,C_@ID
MW[4OPK\(_P#".>!O%GCC5/B;\(O$6H3-XA\-Z[J?B+0S_P +7T?69=;=9(_$
M9\1:[KIC\-QNK#^W_"\D;YVM7[K?#+_@OI^RU\2_#'AG2=!\%?%[6_V@?%6D
M_9=)^"/A?P=)J3ZY\3F$JZ-X)T/7 _D20^*==<0V_B%XA%$ )7,C1['_ &I\
M??#3X<_%+1HO#OQ)\ ^"OB+HD%W'JUIH/C?PUHOC#2DOD+&/5/['\003VY:)
MI6484MERH(P*\2^$W[%'[*WP'\0_\)=\)?@+\.?!'B@6QM+77M(T9+_Q'9(I
MUJ54TC6=<:>?1QG6]961()(HIX[AXI<J0E '\=W_  0K_:D\/?L\_M3?$+1O
M$7@+Q]XJ_P"%Y:1I/@K23\/O#;^)-4T+Q(==77M'36]$1XW1GCWHDJMF)F$@
M5]NQK/\ P5IAG^#/_!9'7OC#\3? .HZG\+]3\1_ CQ_H[:J=;T[3/%WA?P_\
M,_ /A[7=:T37- ^8-X3\1Z%KF]6+%'T!E);;D_VN^!?@C\&OA;=W^J?#'X2?
M#'X<:EK%O'#K&I^!_ GA'P=J.I;1N5-7E\/Z#:>>H(#'SV= ^%*8" 1?%#X)
M?![XS:9#HWQ=^%W@7XD:?'!J5K9CQOX;T7Q*^C#6+>.'6)-'EUZ*>71&GBBC
MC>;0YEE B4!E$8! /P7_ &E_^"Q_@_\ :8^"'QE^%'[#?P5^+?Q^\3Z[\$_B
M2_Q U*Z\%ZIX=TGX5^!]771?#^N:WX@T299I->0:#X@U>>)8'B>.XMHV\YUE
MGCD^%/\ @AE^V;\%_P!FCX??$OP!K?A?XHW_ (Y\<?$OPOKWB_5_L"'X:^!/
MAAH2/'X[^)FM:^ZLWAKPY\*O#3Z[XE\=2>)PLWEZ$ZHZ%B:_K,^&/P)^#?P0
MTJXT?X0?"WP+\.-/FM-.M;I?!7AC1?#^JZT-'CV:1_;6KVJ1W&O2Q(SPV\GB
M&>:7,C!I65FSF^"?V;_@/\.M%\=>&/!?PB\ ^'-#^*.JZQK_ ,0- L_#6GG1
MO%FH^(=D6M)K>D.L]O/HLP#P_P#"/!1X:CAFECA@C6ZF+ '\77[07[9?P#U[
M_@MWX?\ VKM%\5W&M_!'P;\5/AC]M\6:/:'%]I?@;P9H/@37=:T(\'Q#X=7Q
M'HF,_+G!("DX']1?[8'[>'[)WA']CGQ9\1KSXV>%-0\+_&[X8?%WPU\);SP]
MJ":G)\2=3@5O NNGP. HCUY_#?B#6X(9UCVKL=MA8?,?J7_ACC]D+_HUG]G'
M_P ,E\-/_F9K6U+]F_\ 9ZUWP_X<\'ZY\"?@WK/A/PC_ &E_PB'A+5OA=X,U
M'PSX1&M$C7#X=T"?07M/#I\0J6:\-M&HF*KYHD*^4X!_*)_P;H_M0_ SX/\
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M?T)$/B ^$?#>AZ]XI8NTC8&YY6)./Z*O^"E_[7OCW]AG]EV?XL_#CP+_ ,+
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MHK2T235YVD:.&&WC,LLSJ&9\MW5 !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUMFT198D\ >'?"?B-1X59SXG<KXMVS*1',)(\)7T;_P2>_X*C?&3_@H!X_\
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MHHHH **** "BBB@ HHHH **** "BF/T'U_H:BH L457HH L457JQ0 4457H
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MS]C#P9\:/C#KEKXA\<^(/&'Q.L;K5;31-(\.*=+T#QKKFAZ*HT30!Y2 0PD
M##?Q## 9 .7_ &I?^"PW[#G[+^I>)_"?B#XG6_Q$^)_ARSU![WX=?#*QD\::
MFFIZ'JTVC:WX-UC6=')\,>&_%$4VEZQ_Q3?B[Q+9W1DMR9D*".(?:/[*_P"T
M'X?_ &JO@%\.?V@_!^B:WX<T#XG:5J.K:1H7B+^SAJM@-*UK6O#Y&K-I+R1;
MGGT5OE21U1/*B.7&*_FF_P"#C'X+_L^?#3PG\"_&'@?X3>&O!7Q-^)OQ'^)N
ML>(?%/@GPYX,\.R>*B!H6O:]K7CN1/#\OB7Q'X@EU_7(KB)6<SK'-XF:;&]
M/VP_X(V?\HT?V4?^Q/\ %'_JS/'5 'Z=457HH L457JQ0 4444 ><?$[XH>
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M==N->T6#10O_ "%[C5]-32">W_$U>8Q=,G)D!R.O%8O_  LGX=R?\SYX,/\
MW,VB'T_O3<CI0!WM%<YJOB7P]X>$(U[7=&T0W)VVW]LZIINFB\;!!*&>2,,
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MA\'OV@/AC\0_%5M:F]?0?#GB2.348],358]'6?RCMDD FU*&*-(@9#(ZN%5
M7C^M: "OR]_;*_X*%:U^Q5-J7B'Q_P#LD?M">+OA5;>3(?C#\.O^$0\1^![)
M!_8L8D\0&/Q1&W@17\0ZU_PC5K_PF:^$QXIG1W@D=0JK^H5?E7_P6P_Y1A?M
M3_\ 8%^&?_JY_AY0!\^?LW_\%O/!?[7GC]_A=\!?V2_VAO&7BZ'3=0UB[,E[
M\,](TC0=-TF18$U37-?USQ/;^'-#:>:18XDDFD+RR1HH=MJ']HO"M]K&K>'-
M!U+Q!X?O?".L7^DZ?=:GX8U2^TK4K_1=2=-K:5+J^A3W/AV>2$CRWDT)C&S
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M.ZV@!4Q2PR;F^?@*I?T'P;_P6C_8/UWX#Z!\:/%GQ8TSP5K&J^'3K-Y\)]2
MO?B79:@)UT36-$T70EP^NR0:[F!3&^R;!>15RD<8!QO_  1M/_!1*+X<?$V]
M_;P'C-=+\0ZKX6UCX.K\4_LZ?$VTD=_$FC?$#1M<T279XET/P]$-%\'WOA"/
MQ0XG>/7)V42,S))^FO[0?Q\^&?[,WPD\5?&WXRZ]=>&OAUX)&C-XBUFUT/5_
M$;:>=>UW1?#FCL-)T."XUUS)KVN:1&RI"S*LC F/S(F'Q;^Q3_P5%^"_[:WA
M+]H;QAX.\+^-_#=I^SG?27OB6WU>V^VZKKW@2;2->UKP_P"+]"2%(U8>*H_!
M6N)%X9#).GDQ R2-))(/Y3O^"Q__  4=N_VVOB7X8\#>"]"\:^"/@?\ # ZG
M?>'=*\6?VSX<U3Q]XIUM5C7QKKW@DY+,(TUKPKX(9B21KOB8$G% ']]MI>P7
MMI;7EOAH+FV6Z@X )5E#=/7#K^M?S[?\%'?A7_P4Z^)O[:7P /[-UQXBLOV>
MO#TGA;Q%*WACQZGAK3;'6_!GB#;XYU;QU+KP6WT/Q0^AZ_Y7@U+5GA\9>%_,
MMHR63QFH_2?]D+]MWX2_M6Z'K!^&>A_$_3+#X>Z7I<?B#Q!\0/ASK?@?PTVI
MO$JMH^C:QX@*I-)&49L'[MNA96!4@_"GQF_X+R_LC>!_BGX/^%7PGM==^/=[
MX@\3:1X:UKQ1X(N8;#P3HBZX/#XT;5=*UZ1)H_$4<PUPK(L"1;!HDBQR$E9
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MWX3_ !9^.OPY^!_B_P#9]^)/P>G^(WB32?!UEKWBGQ'I%_9:'J^MS?V-H_\
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M'U^!G@4_]\VQ/]/_ *W:OOBO@O\ X)>_\H\OV/\ _L@_@3_TT15]Z4 %%%%
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MWA?1K'1]'762FN:[H'BCQ-'H\LZE(8$F1<SM& W(Q^CWQ5^'/A7XP_#OQO\
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M=QZKXX^"I&MC1/&TF@?\("OC%/$/AU6"21^&/"88!E5@#C!_HZ_X+P_M.3?
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M'A?P/\2]7\(748U0:=X1U!O&_A[P [:#YI$:K%X9UW7?#DN5=A!K<@C0R%"
M#Z6^-_\ P46_X+"_L@>%_ WQH_:4_95_9@O?@?JC>&=0\=6OP^N_B-I7B?PF
MFOZML_X0K6->UOXB>*O^$?\ B"B2*%FC\'^,?" )"&;!*']IOV-OVH_ _P"V
M=\ ? '[0_@.TN='T[QK:ZE8:OX6U"YTO4]<\*>(]$U>31/$&A:Q<0-A1'<Z1
M)-93,BMXF\(3^'?%=FD,-]#MV/VMOV7/AG^V7\%M8^!?Q7F\01>$==UC2=7:
MX\+:@=*U./4M!F&L:4ZS;'W!"F60J-[(I+H2*\B_X)Y_L*>$O^"?WP)U#X/^
M%/%^M>.KCQ%X\U;Q]XH\4:Q9IH0O];URWT70W.G:#;SNFA1Q:!H.C0-!%(Y,
MT.Y9FW*4 /T!HHHH **** "BBB@#^67_ (.>_P#DG'[(_P#V/GQ2_P#3-X"K
M-_87_;:_:)\/?\$\O@K\(?V%/V7-0_:6^+/P]\'^)M/^(WB[7;U?#GPV^%'B
M77/B;XW\0:+X-U[.O^#_ /A/?$<WAZ+6O$-Q'X5\8^%4\(P:OX/WL/\ A+!&
MFE_P<]_\DX_9'_['SXI?^F;P%7ZD?\$??#7A[PS_ ,$XOV8[7PWK.@^(H=4T
M#Q!KT_B#PMI&LZ9INHZEK7C3Q*T\=P/$7ASPQXA;5_#,8;PC<-/;1!5T1#:2
MGPHMB\(!\,?\$W?^"Q/QG_:0_:DO?V2/VK?@YX3^'GQ0OCXML_"%S\/]$\9Z
M%_8VJ>"](USQ!KVA>-]%\?\ B7Q9=[QH&@:Q]F\1P7$<>]84$+?\)5;B+]J?
MVGOVE/A?^R5\%?%WQV^+-]-:^$/"EJ0MII-J;[5=>U?4I)4T70=#BC$9EUKQ
M#.R1QH6V%B6+9"O+_(%^U'X<\1_#?_@O[\([[_A'M=\ 7'C+]J_]G#Q/9WS>
M+M*\1/XM\+>.OB7X?T'^W&31RTOAWP_XL_XGGAAO"DQ:13Q(2P8GZV_X.5_C
M'JBW7[.?[/5M VFZ-JUOJOQ/UCQ"VK:FNEWP&KKX?&A:UH<*J&6( >(P7+2#
MRRI9@JL0#[7^%/[8'_!8+]J[P3JG[0?[.G[-?[)OPO\ @OK[_:/AWX.^/^J?
M&'4_BUXKTS1-%M%U;6](UOPUK_A3P[KN@>)]>CU=?!,DGA7P8LD,C-<!K>*T
M\9>)\#]C+_@L-\4/&G[43_L3_MQ_ [PC\$_CCJFM:II5KKW@O5WL_"]EK":+
MX?\ $/A[P?K>@>(/$WBZ3?XFT(:Y<Q^)XO&:;[H^&_!I\$+=2FY7H?V>/V"/
MVSM8^!'P5U/P7_P5H^*&E>!K[X2_"ZZ\%Z9X8^"FC_\ "-V?A4>"O#SZ!I>A
M?\)#KWA'Q$?#3:"(VC_X2/PMX6\:HC(US]FN4>VC\MNO^" NK^*OC]HW[1?Q
M _;G^(GC7Q_:>./"?Q U?Q(WPDTC2O%&NZOX*.@"V$>LQ_$"6#0]9<:(G[^'
MPPXCRRF+<C  $7_!1W_@M+^T-^RGXQ@\!_#3]D75?!OD7=B;KXA_M&Z9K%_X
M8UQ+G1]9E;1= T7X;^(H?##E6AB:*YD^,#W2G<P\'9=B?(/''_!<+]MGQ!^S
M7H?Q[^ G[(>@WG@?P?8^&]#^-7QP\<Z+XJU+X;W?CR31]$/CG1O O@CP_P#$
M'PCXET/PYX.U]]9@3Q/<>+?&RRPPI]J'A9VD>3U7_@Y9A-I^RC^SS 9Y[AK7
MX[_8S<3G-_>D_#;Q+\P.U27<_P"M)4?,O.3DG]:_^"?GASP[=_\ !/O]D?0I
M?#^C7&CZO^S)\&[K6-)O-'TM=-OWUKP-H,NL?VKHA'DL<EC)O#*_W&W>7Y=
M'S8/^"H-GX)_X)U_"C]M#XK_  \LM(^*'Q-TB2T\(? .#4]6\.ZO\1/'I\73
M^'X;;P5)'X>\4^*UT'Q,M@OBBU:+P?XMF^Q:_P"'4N)#+,L\_P O>(M?_P""
M_/Q5\.^"OCCX'LOV7/@CX?TZUU;X@V?P'M;36+_QSX[TN9QK^B>"?BA_PGWA
MOQ6!XB?0=''AAF\)>,/@[))-XB!=_!\F#X-^!?\ @O%J?C+6/^"AG[%?P/\
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M=8M?%OPO_:9\.Z5>^'DTSP]H/B@:R=;T/1SHT#!->T%O$?@8MNB9=I.5V$8
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M0]!.L22 -+)]FT>*.610J$AB%3<\2 'XM?\ !.[]LO\ X*N?M;_LW?%#X._
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M^/OQ8^#_ ,&/VC_"W[>?QF^#?PWTKXC>([Z[^"?@BRU@Z4Y\%^-Y5UQ4&O\
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MIGP)X<\"_%>>Q;QYXH\":H/&6@-H>L^--!USPSX3\.>)?$?A/_F=5C0^#G.
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M6=/T[\4>$_#GC+1[CP[XNT#1_$6A72XN])UW28]3T]U'.-DRM%D==V-P!(W
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M3X6^"]3\>:%\*/A=HMQ\2=5^&7@237$T#P_X#\<Z3X=UKPW\4_"VA#Q;\._
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MMWP>\(:KXVM_AEI/BCPS^SMX<UCXEW-ZNFGX<:;X@\;>(=$_X3-"]SX80?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2? 7BGP+\3?$&@9T+_A'_P#D/D>(M=(STP2.!7^DCY'O^O\ ]:OYS#_P3/\
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M6-8\5KJJ_P#"1:?XY3P?XE7P_HPT=8T#:#+X=&OS2^)-[&!M$"$ $-+]Q?\
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M+9O"/CGX+:;X6\/7/V_>UYJ_@;6]?DUZ-M%R3E1X[T$+GDIM/<9_MVK\/_\
M@N]^R5KG[2_[&LWB?P#H$.K_ !-^!/B[3OB5ID5GX<M;_P 8:_X*DTK6/#GC
M/P?I&NR11W>@:)G6=$^(OBKRG\F6'P$1-&\@MFC /TO_ &2/BMI7QR_9G^!7
MQ:T32M1T32/'?PU\*:U9:3JX/]H6"2Z.B%9#R"Y:-L' ^3'&<Y\C_P""E7B+
M7O"'[!?[5WB7PQJMSHGB+2/@[XHO=)U6S7_B8V$A1<NA;Y@-I=1ST)!Z5\M?
M\$4/VD/!/QH_8?\ AAX%TB>UTWQO\!]'3X8>,_"5UK*WGB2P30=RZ-KT^E%2
M5C\31$RIC9\R,H9BZ*)?V\OV%_VU_P!KZ[\;>!_"7[;EE\)_V</%]GX7LS\(
MK7X5:1+JBG2M)=M?37O'FA7'AKQ7KOASQ-XA"&;PS)+Y")Y>Q@BB., _*+_@
MU^F']L?MH0?]0GX"<_\  OBX>>W:OZX<B*,S3<$=?;G@=>O?Z^IK^3OX<?\
M!NY^TS\'M?N/%?PD_P""@%Y\+_$US8'1SXD^'GAKXD^"/$HTSJ-!_MK0/B6)
M!H..B[._)W<5]?:U_P $K?VY_C#XGL!^TI_P5*^,OB3X33>#]2^'WB_P7\((
MM;^$C^+O"DNCZYH>-9T%?$,GPYUZ6236"GC7Q!XO\%>+;CQOX6@2%XXW>W9P
M#^</_@J9K7PT_:1_X*/^/8?V2]/@\>P^/=6\+>&;1/ &CIJ3^.?BB0-"UY=&
M,;/'XA?Q5XD.UO%,;,F0=C%<$_M[_P %=OV2/'<__!*C]D.\UBS\0W?Q(_8^
M^'/PP\,?$#P]X:9?$NF1R-\+_#G@GQWK'B#6PQ*Z!X7\0>#DE_X2C;\RN)3Q
M*N?T@_8O_P"".?[(O[&/B+4/'&@Z)J/Q>^('VW3+SPSXU^,>G^%?%.J^ Y-$
M*&VE\$&+P["-!UH$,)_%"%_%DHRGVQ41P_ZF:UH&E>(M(U71-6@6[TG6]+U3
M2-3M<9%WI^M*T4REN2-T3R(I()&]CC@9 /Y@_P#@BW_P58_9\T+X :-^R[^T
M!XS\.?!+Q)\&X-0E\(>./&WB4Z;X9\?>%=:UO6M;EA&L:^\$>A>(O#6MZW+'
M_P (S.[B+PC]GF*O]E\5+!^IO_!1S_@H?\-/V,_V?-:\3:)XMTS6/C-\2?"=
M_9_L^^'=&_LOQ'-J/B;5M"A'A[QG-I'GO'-X!\*MJ^B^);N01+YUNT%L[-_P
MD222_F?^TE_P;:_"7QSXIM-?_9G^+VI_!/0+P:D=:\$>-;36?B1I6FY.AC1#
MX)UR;Q%;^+5$6S7B_P#PE_BKQ<?^)^%56<.J_0G[ /\ P0R^#?[(_P 0?"OQ
ME^*'B/\ X7Y\4O"ES)J'A.2^T--'^'O@S5X)H5T3QEH?AEHI#+XZ\,AI(/M7
MB.60F=[7QO;JWC?PXE]" ?8G[;5MX\L?^"6'[1,/Q3UK0_$GQ)MOV5?%2^._
M$7A_3SIWAW7/$H\',VN:QHND$L1"S[WAC.%4?*@ 78/@;_@VCFS^QE\9X3CS
MU_:=\4,<^G_"K_A(#_,&ON'_ (*!_L(_&7]LWP7J_A/PC^U_\6/@UHFJMI]J
M?A_H]OH$/PTU#27TMM%\1:;XWCT'0_"WQ+^(%OXH1P\WAKQ5XZ?PCN+8M(P4
M0_-__!-__@CMK'[!WC34/B;)^U+X^U_Q#JMW-9>)?"?@K1M'\._#;QOX56#=
MHFD^-?#FN'QA=R^)?"VN2ZVT7B6V\6F9DE",T)>@#AO^#EC_ ),7^$O_ &=I
MX'_]4U\>Z_1W_@EC_P H[OV/O^R)>%O_ $":OSB_X.6/^3%_A+_V=IX'_P#5
M-?'NOT5_83^'WCGPY_P3Y_9U^&NM7&O?"WXA:?\  K1-"O=4M;+2;GQ+X-UA
MM&+1ZJ=,\0)XM\.2ZU"SI*R>(_/1G:6*9&.^.@#^3;_@M3H,NF_\%9=0U26]
MT>>V\3R? V[M+/3=8TK4=5L'T#PAX%T"0ZWH<H5M!C:0,T4GW98RCH2C*3_:
M[^TO_P FY_M ?]D4^*/_ *A/B"OQ>\8_\&^/P,^)7BZ7X@?$/]K+]L?Q[X]N
MTTHW7C?QMX\\$^)O&JIH'&B#_A(=;^',GB!?+QC E&2I"YX)^MO&O_!-KQ+X
MX^#W@_X+:]^WQ^W.-/\ !5[X\:Y\5V/QBTC2_'7Q \*_$ Z$[^$?BKK<7A:0
M?$#0?"]SHVLR^$8_$Z2R+;>(O$7A"623P5(ED@!^57_!L)-GPE^V/!_R\?\
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M+X[^-OV4_CE;?LC>.?AA>&Q\(6UW=C3-4^-7[1?]M>/_ /A.=;\$Z#KY"_\
M"O-NAA?'/A=0JLV65$3Q?L7]Y?V9_P!D;X4_\$KOA7\4/%ES^T;\<O%GP6\-
M^&#J]WX>^+WB_1=2\!?#?3](U;7/$6OZMX&\'^'?#/A7PWX>UOQ3XBUK]\4A
M FD6)%D 1T/\[7PA_P""1&L_\%.[OXO_ +8G@+XD>&OV?_A_\1_CQ\4&\!^"
M+WP?K/C4:AX7^8GQH"?B1C0/^$J\1:UKS/X6!.Q1N;"G- 'WCX0_8KL?V_OC
MQ:W?[>G[:O@#X_ZAX$\#G6O!_P &_@EK&E^"_# \+R.VC7'B!]%1)I-"D/B/
M^R)!XI\*X-Q<:$L32QM-YB_TD^!O"7@[P%X.\-^"? .CZ5H/@GPAH^F^'?#?
MA_0F4:3HVE:)%'%I.E:7&#M$<,(CC4%R2J*K,2<U_)=_Q##?$7_H[OP7_P"&
MGU[_ .>+7V]_P2%^%'QB_9)_:4_:I_8@UKXT7/QA^%7PD\)^ /&>BWEMHSZ7
MX:T/QYXYE&M:]H6@XNO$)\/R.K2+XM\-&=1%<217*J[1JK '[3_M2>)_#?@O
M]G7XY>)/%.M:?X>T"Q^%GC>'4-9U:Z^PZ;I\>J:#=:0CS2'[@\YU"$CB1E"\
M.2O\?/\ P;>_#.7Q%^VE\1OB+?\ A"XUK0?A[\"?%*:?XKN[/_B7>%?'VN>,
MO >C:(J:V<;O$GBOPQ'X\<J 253Q2<'%?N/_ ,%V_C[:_#S]C/6?@WX;ET;6
M_B1\?M6TSP19>"MNJ:IXDU#P0CRZUXAUC0M(T)3=-);-H>EQAOW4)6Y=561R
MY3T'_@C1^QSK'['_ .R190>-K3PP?B+\8-7A^)OB34=%T<:=J5AX<UO1=*;P
M9X)U[68[>2XUQ_"<+:K)&LS^3X7DU_7(8/*$D[S@'Z]T5+L'J?T_PKYU_:0^
M!=]^T#\,KKX>V'QE^,/P)N;K5]*U@?$#X$^,#X'\<6"Z,\DCZ5%K:0%AHD[L
M3/#M!<I$Q(V@N ?Q-?\ !376=*TC_@MKXVUW5-3M]*T;0OC5^R[K>L:I>W87
M3M-TK0_!7PA_MW6"H!P5Z$#H1CM7]ZVC:QI6OZ98ZSHE_:ZGH^I6:WFF:I97
M1O;&]L7P1*CA@K!@>H+$$%2Y*N@_GCUG_@V[_98\2ZUK'B/Q!^T3^U)KOB#7
M]5U76]8U_6/$GPWOM8UW5]>)&LZSK^KM\,RVN:]+MD_>R;0A4?*025^Y_A%_
MP3,L/@E^SE\2/V;O!?[7W[8ECX9\?GP-%X?\56GQ3CT_QG\$].\$ZRFL_P!E
M? ^72?#EO_P@4/BT/+!XR,,4C74<X*J%+K0!^"/[,WC'PQX4_P"#B3XKZKXA
M\0:+H=AJGQ@_:(\+Z1<ZE>IIVFW?B;7]&UWP_HVC("NUO$7B?Q 6<*$+.%VH
MNX@'^BO_ (*RRB'_ ()T?M;D_P#1*-0(_P#!SH?_ ,5V^O%?FQ-_P;2?LDSW
M'VZ;X^_M,FZ%Y]M^T_VS\,PV<9P2?AO@#WSTY^GVM^U+_P $K_"O[6W@OX5>
M /B?^U+^UF/#'PM^''@/P%J/A^Q^).AZAH_Q*U/P5)O?XI?%#2/$GAKQ0GB;
MXP>)?,=Y_%Q*RY1F,1DE"$ ^*?\ @VR\2^&KW]C?XK>$;'6=+N_%&B_M">)?
M$FN>'[6?=JNBZ5XT\&^!=&\-:SKFC[P(QXF?P3XA>-BG$^B^(MDB?,&_"[1_
MB=\6?^"0G_!3[Q?XC\5Z5KFM:-:^,?$[>,?#MF^L^&M.^+/PQ\;N&_MC1&UQ
MR/$&'7_A)O!B;BC>,] 9'#(6!_I6_9<_X(P^ _V0/B#IOCWX'_M7?M9^$775
MM)U'Q5X4MO%O@;_A ?B+%HCZX/[)\<>"%^'+:!XA29-<\2/:L]K&/!YU9U\%
MFS!#C[3_ &O/V#/V<OVW_",7A;XZ^#7U?5-"M=:'@CQ]I=S_ &5X\^'FL:[I
M$^F2:UH.LQ+Y5RL;3PZ])X<\0)=^$9;K1/#QNO"-P]L!0!YO-_P5B_X)\Q?#
M$_%7_AISX7SP?\(H/$__  A0\2:-_P +(:/^R_M)T4> ?-_X2,>)3GR3X=,8
MGWEG'R$$\+_P3&^*WQ>_:CT?XV?MM>/-6\6^'?AA\>_'9T?X ?!+4O$0U7P]
MX&^&7PI4^!CXP\F,(NB>*O&7B/2=>?QI$1CS=%23RSO56^7_ (9_\&YW[#_@
M7Q98>(O%OB/XQ_%K2;0,I\%>-?$VAZ;X9NC@XW?\(%X:\)^* >XSXK<<9*G)
M%?NMX<T#0O".C:1X;\-:9I^@:#H6EZ7HNB:!I%HNEZ9HVE:1%'I&CZ5I&B01
M&'2-&A@B6*!( J10@1Y$2C: ? %G_P %8?V%+_\ :)@_9?MOC3;-\3[KQH?
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MD' )#,"-P88'W30!_*[_ ,'/4W_%O?V1X1GS_P#A,_BF?;)T?P&3W]:_6/\
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MM7P_HT4>J^(+C2(A FK>,O$!)\2^-]?&93_PDGB>:ZNR)4S/EBDNI\6_V?\
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M'ASX(W/B/Q)?^$O#GP]CU@^.8_"LFLM_87@S7=?\0-Y<K1^'U9)/$EN\TX;
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MAK7/#&KZ8V@+H4\+ W?B$3Z%\_BGQ'XAB\R]GUB=6(C^:3\1/VRO^#>#X?\
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M/PEX=T8?V;J'AI"X.K>!\MM\/>) 4*[BPC+ D. RY_HBV#U/Z?X4;!ZG]/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5\V?M-_M,_"O]DSX;GXM?%Z7
MQ)!X3/B#2_# ?PMX:UCQCJ;:IK/F-!&VBZ%%)-MQIDA:1=VPA@%R\B-])T4
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M&J(M?H_7\X7_  ;67L%E^Q+\;+B^GAM[>U_:=\57=W<7) 6S+?"[X1G#Y.
M%)!R,-TR3BOZ _"?Q!\"^-4OAX,\;^$O%XT\ 7H\*^(M(\1K8D@;5D&B22%<
MD@ ,=VXA1\QVT =U117E^O?%WX5^&]3N=$\2_$OP!X;U2! UWI^O>,M#TG5+
M?(W*RZ7J]Q&^T@@[MF"IW8/% 'J%%<YH'B#1?$VE6NM^'-8TS7M(O(V-GJ.B
M7\>J6%V%Z%-5A:6.0 \$B0$9ZM]T]'0 45Q%KXY\'ZAH-QXKLO%/AVZ\-6 O
M_MWB"TUS2I?#NGG27*:IYFLQMY2K 0_GON"JJ%F,0()C\*?$+P#XU-U%X/\
M''A'Q?+IP!O%\+^(M(\0_8MPP%?^QI9-H.=I5E4YPI&>* .[HHKB_$WC3P?X
M+L[>^\8>*_#OA"QNKG[);7?B/5M*\.V%[?D9,22ZQ)&/,W+_  R.W(/S94D
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MO@M9?M"?"^X^).@6/]KZQX?/B: BQTW^R=%UH3'7]P\, >3KNBRM'_PDN?\
M2%7EEDC3Z=T37]#\1Z5::UX>U33=;TG4HRUIJ>E7RZC87J\JI35(/,1E!RJD
M,3GY5SD"@#HJ*\J^)GQ:^&OP8\*ZOXU^*7C/P]X#\,:1::EJ-YJ>OWJ:9$L.
MD:7)JVJ/&99$;6&AMD>61((\L-R#?*5#<3KO[3/P%\,?"?1_CKXB^*?A/0OA
M/XE\)Z9XS\.^-=7OUL]+U_PMJFBKK]OK>BKAM>U1I/#S1W(6*$RE C!%<,$
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MB^KRZ%H^[PG+HV@R :#KOA4R2^+9+NT\0 &=)(6^T@']"=?SJ?LX_P#!*O\
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M/&E]I?BO2_\ A-M<T/P]XST6?0&\(S:'H7BG1-$:2/PXGA'Q4QDD!'C4. 2
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M6N^'HX_&'B&"3S+6'6H \B>>GE@'Z#45_,_^S]^PW_P4 _;2^%2_M+?M%?\
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M72W^&/B+XT^)OVAO$_@_Q>WPR\-_#/P^=8^$_P #]<U7Q[X+\0-X&_MSX6>
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M15$44:H J*J* ?TW?L[_ /)O_P #?^R/_##_ -0K0J]DKQO]G?\ Y-_^!O\
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M&":V-$7XEJ=!\.^#D/B+PMX= \3-XE\,^$?(E1FBN T,DBG_ $!J "OYU/\
M@OU\;/%7P:\,?L:>)-$^'>H^)+'X<_M4^%/CH_BFY(_X09=6^$X)T/X;:^O)
M#^,VU\NI)P;?P_X@PJ;6W?T5UX_\7?A/\.OCMX \2_"WXI^#=-\<>!_&VCSZ
M)X@\+ZY]I&EWVFSB>, &-XIM)U1-LC1:[H)A\2^&Y_LEW9W%O+!!,H!^4_\
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M3^%KOXR:'XC\/:O:?8=4T+6-(_:!^+$>K:7J\9)5&CDW)M( ))<_?)K\&/\
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M%\1?%SOKWA<MX3C#/X/T'X9;AYFX#N_^"U7P1_X)Y_"K]AWQGIW@GX>?L^^
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M>#BGB+Q/%XZ\%^*Y)$N(@#^B[X2_\%G?V /C'\6?"OP<\&?%;48?%WC+6?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLM]-O([^_P!#\2#0M"\3+HNKB!S_ &1K7_".:]H.O-;S+;2B+6=#FW&.2(S
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M_9:_:8\;>#]2ET3QAX.^ 'QC\3^&-7MBH_L3Q/H'PV\1Z[H>L*I&=\&MP12
M\ERH^[M9J_A__P""%-G8>)?^"F7PJFUVR@UBX;PS\4=8#:I:"_8:L_@O7];7
M6D8\!R2 A/\ 'C%?WR>*?"VB>-_#NO>$O%.F6>N>%?$^CZMX=\1:!J:[].US
MPYKFE/HVM:1JHPVY+B&::.;8P<QDQHXW.R_Y^G["WB^]_83_ ."J/@_2OB99
M^'/#0\'?&#Q-\&?'3>(/$VD:9X9\!Z9XY(\#:WK?]NQLOAED\)G7!N4,%=24
M?*LP(!_H<)T/U_H*?3$Z'Z_T%/H 8_0?7^AK^03_ (*H?ME_$S]L3]L7P_\
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M%^//#FD^+O"6NBVU2QCU/PUK^D1ZWHNK)I>M1PSJT\4\4T0EC1]A1R$!*K_
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MXZL@]C\1/'OCSQGX4LKR^.IB\\":Y'H>C0+( '%NKR:'K3-X>:-BBJ 00P9
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M[Q-XU:X77$MV\/PL=&URU\!KXU\31:ZSPQVPT0W!E9XX8Y/TVK\J_P#@L?\
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MN/\ L1OA7_ZD'CROZ&OV;_AO^RG^SA^R?X0UOX2_\*Z\._!_0/A>OC8_$O\
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M>/HUT/P-K&DZY'X!T%/"^@'^PO!&@^)8O"RJT@\*>(+>3:!XI26+]H?^"O\
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M4_[*T%-9^*^BC1QD(95\4> M%'(+(,@$%G4_DS_P3[^+/@+]DW_@LM^UA/\
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M95_8.7XD>/\ XL_'8Z7X/TKXFZ5X9\8>&H?""ZWJL::]''H,OAJ7Q3K&M_\
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M)/V(-6\ :5>SW7B?X=?%7Q1>^+[1[8J-/;QTPUO0P!R69H]'D(''S*!@[@0
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M\+1_$'PEXDUW_A)%\,+XK:1O!.N>)MYFD7) /G[_ (.?/^2@_L??]B?\9/\
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M(,+$KJH_K"_9N^!'A+]FCX$?"WX$^!;>"+P_\,?".E^&A=+9KISZ]J@!.O\
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MTR-)T%_ ZR,P= #]N?\ @E9_RCL_9"_[([X6_D]?R\^-Y_'#_P#!PQH3^/\
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MM1^#_C!\??VE_!OQ,^&^A:3XWL=7\):-\:_C%XXU/4-2U_P=K&@Z'*NB^/\
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M/[/7C>V_:Y^+WACX7V+_  Y\3W_A#]G'X>6FB:8?B7X\T>3PYXX^%FC_ !4
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M4)(85D,;A?Z\-,M)K'3[*RGNYK^XM+6QM;J]N5!-Z5&UI&XP6<LQ)]" <G-
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MO^"U'@_PMX#_ ."E^O>'?!/AO0_".@VWAKX-?9-(\.:1H^G:7IY.B:!D#1-
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MUPOQ$T[6[$>!M9UEM$UOPUKDGAQHR%T#7_&2MX8D_P!'6774,IV*&(!\)?\
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M-OA_HTND^"_A++X[TO08A\+]!$FMR*5\*'0E$0 (\+)<1^"EG\60^$8?&MZ
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M-O\ A&],\,ZM=^";SP_=V.NZ3HC,^B^=%XC\->)8T\K=DE>70AB"V6?]C**
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M3X7_  UT(^$_ 7@;1?[%\.>'EOM7U#^SM-3)1%U77Y)]>8@[F+O<,0QR&(5
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M>)CH$^MZT]N?%5S=3Q"7RXV\S,9^L** /ECQC^Q=^R+\2O%.J^-_B)^R_P#
M/QOXSUVX6YUCQ7XM^$/@CQ+XBUORUP#JVL:YX;FNI7;&&229N ,,223-X!_8
MZ_93^%/BO3O''PN_9K^!GPW\;:8VHOI'BOP)\*_!?A7Q'I_]L::NDZPG]MZ#
MX>BFS<0#R98VE:%T#*R[#('^H:* /C;_ (=Y_L%_]&9_LN?^&'^&G_S-5U$/
M['W[*,/@"?X4P?LV_ R'X77/BYOB!=^ 1\*O!O\ P@]UXZ.BC1#XS?PS_P (
M^OAQO$AT)5M5\1K;_:@P\LR>9FOJ&B@#XW_X=Y?L$_\ 1EO[+O\ X8?X9_\
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MDD9I#]]WU21G*X$:ME5+$[S[?10 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\8Z(H$^@>(5CDQ/X>N&\^-M[#,94K](4 %%%% !1110 4444 %%%% !1110
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M_';PM=ZQX9^$7BWP.$\/W":)H>L2;?#2Z$GAI=#\.#PFRB10O_"$D#_A#\T
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MG4;FR\+>&=*CTS2K";6)CK&K,(8P%5[B9V=G55Y$<9X14C /5J*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBN;U[7M)\.Z-J_B'6;];#2=$TG4]9U.[(&RR
MTW1(S/J\A(P=J)&2V!N)7*\@4 =)17\L.A_MZ?\ !2'_ (*A_$/XF^ ?^">@
M^$W[.OPS^"-_INHZU\6_%6OR^)M0\63?VUXDT?0])CU77_AO,(?#WQ8\.%_%
M"^&3\'VE\'/X#_>>/IKB4^#9-?\ 9F_X*R_M=_"']M?PM^P1^W7X5\(>-]8N
M?%_AGX-6?Q9^'FBZUX>\3:GX]UW5QH.@>-]:&O?\(EX6\0^ /%92+9)X4\%>
M%6$:MXU1?WG_  A8 /Z?_/\ ;]/_ *]'G^WZ?_7K\O\ ]O3]KK]JO]GGP=XN
MNOV;_P!C;QI\8)O#&AZIK&K_ !.UCQ+X/LOAUX>$&D/K1UC2O!>A>*YOB3\1
M)$+&.?PS$GA F7A;J9%5G_$W]FG_ (+J_MR?'\>-?A=X._9W^'_Q1_:/UO\
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M1:$Z9?\ _"#?$_02=9&?$OB_"^+#KI\3JHPJ* J@*J@ '^@3Y_M^G_UZ//\
M;]/_ *]?B]_P4P_;J_;<_9,T3X@ZQ\#_ -C6T\7_  V\+:'X7U0?M+>(/':^
M)/#&FC6WW>(5UKX(:!_PB7BM4\*[8E?Q&/&8AP@/E_.<_G)_P3@_;M_X*9?M
M:_!CXD>!?ALOASXH?&^U\>ZG>7_[07QVLV\,_![X=>!I/!GAR+0?!>DK\.O#
M0?Q-\0F\1)K/B-XW)@\(($%Q'(/%,)B /ZO//]OT_P#KT>?[?I_]>OXV=?\
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M=='8>(=:V; ?^$A\5G0M:\4#_A+/"7A%6\&:]X8941O%8;P@ ?T+>?[?I_\
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MU?JNK75Q8:IX0\3M=6WBWQE)X@\;:=IOQ3\:Z!+X$T;1WCYU[PQX2\.>!/\
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MX,C4/&&E_#;^T?&L3MKB>']=F\2CQ$V@>%61$;PMX;GMHH_%[23R7"+$?!9
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M^TA\-_!_C?PS.MMX@\-:UK+1:KITCKG9<1!&*%<X;#,5(8;<\U\%_P#!9_\
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MIL/#_P 1]0\,^.[[3/%GC6_\3ZCJ6OPQGP*=';Q!KWBB(R>%7T/7V=(T79D
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MW'B+Y(_"4_[S$2[B" #][OBI_P %@?V#OA1XS\/_  ^U#XQ6OC/Q3J_C+4_
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MSXO\0:3X-\>?$^SU35M9UC4=3;QX.?\ A,];UUB%U_Q&W]MZX,L=H)RQP,4
M?WFZ/H>D>&])TW1-%TRPT?1='LM/TG2]+TRU73M/L--T88TG3-+TU,11100@
M11I$$4*@6,%514Z6BB@#P[X[_&OP=^SS\+?$_P 7/'L6M7?A[PS:?:FTKP]H
M^I>(?$NM7K%CI&D:#HJ;I)=;N750L;*"TBEW*8&W^.?X/?\ !7W6O%7_  5)
M/[47QY^'GBBV\+-X%\1_L_\ A+X;>!M(34/%?PV\"Q:['XAT,C10G_"3>._$
MK^(X];_X3B6!8I8CX@\VV>#P4(_""_W$U_&7_P $S-(TO5O^"[G[73:II>FZ
M@=)\>?MCZYHYO+5=073]37XT@G6=&9E<)KQ Q(P4LL98IAPIH _J4_9C_:?\
M!?M8?#RZ^)GPWT3QYH6@6GB74O!YL_B5X.U/P1XF;5=(TK1-8$C:%+NF_L8P
MZVJ"9W*2NKH%QE:_DL_X(F?''X2?L_?MA?MH?$7XT^/_  U\-_ ]IX%\2VEY
MXA\17HTW3#JNM?&KP^X'0CD@#..!R.<8_MKK^%[_ ((U_LO?"/\ :6_;^^-4
MWQ;\/_\ "4VGP=M/$WQ.\-^%KM%D\-7OB4?$_P#L/1SXUT)R(=>T(P:W)XGM
M_#5P?LR3F-IDE3,+@'[#Q_\ !Q;^RA'\7/\ A#-5^&GQ:T3X77&CZ3?V'Q4U
M2R2/4+Y]8TL30O\ \(0(W8>'PRJ&\4_\)@\;8+>3R5K]]?#?BK0_&OAOP_XO
M\+ZC::QX:\5:-IOB/P[JML1)I]_HVM:9'K6CZP#C=Y4\11TY5AO#,JOC'\\7
M_!P3^S5\&+?]C;0?C!HG@K1/"OB[X8^//!'AK1;GPGX>\'>'C>^&-;F?07T?
M7'/ADE_#_A7P]H^WP9&K+%:>7'!%&$(9O5_V)/V@[_X'_P#!"GP?\=O$.J>+
M=2U/P+\,/C"ND:O O_"1^);&]C^,?C_P+X) 776C:>'PGYVBQ+YI98?"FCM+
MM<(L9 /K_P#:Y_X*6_"O]FKQ;IWP7\+^$?&'Q\_:/\06FE-X:^#?PSM4FU%1
MK6M:#H,;^,M=P8_ 0+ZVD\,EQ',Q4 LB,<1_*O@K_@N=\%]+^(,GPI_:F^#'
MQ6_90\<#QEIOA>UB\<6@USP^J>6QUW6]<UM;?PQ%H>A>&Y^+AXE\2D1N7C4M
M&D;_ )G?\$DOCW^UQX9^&GQ,^-WPP_X)Z:G^UQ\0?B?\2O%-OX\_:7N?VD/!
MOPW\3>(_+_X1\KX*?0]>\.^*Y/+\(3&)G5'59%W0REH_"Q%;/_!37X._\%"/
M^"BUC\.;@_\ !+K6O@[XY^'=WJMJWCEOVFOAA\1CJ'A?6QM/@YM$1?!P;;KY
MB\2%B,!(T!.3D@']<-E?6&J6,%_8W=M?:=>6WVFUNK6X%]97EDP&)$<$I('5
MNJEAGC>V&0:M?FM_P2D^%?QH^!_["OP6^%GQ]T37?#?Q1\&+XZT[5?#OB+7-
M(\0ZAH>F/\2_$K>"M'@UO0?$/BN&715\*#1 C"=BJ&0R(BQ'S/TIH _FU_X+
MR? C]KSQ%K/[/7[27[+$'C^UN_@1X<^,%KXH\6?"CQ'K/AOXF>$M,\0Z&-:U
MK6M'E\.@>()-%/AOP]K?AB9(3A#XA0;2KQRRP?\ !*R7]O?]I7]A7]I/X:?&
M+QS\6_#.H^+['Q1X7^ _[0?Q+\2ZZGQ+T+5/$&C+#K(?#I\2&'A+Q)(WE>)9
MO%SDL6,"AT;/]*-% '\(/[+7P/\ ^"O/[//[6?P>_9G\,Z_\>/ FB^#O$M[X
MILO"K^.?%[_L]'P+#XYUZ?QCK@T1@?AB?#WB>?\ MJ: _P#"'YCEUX21D/@U
M^F?_  <C?M3Z?X>^%OPP_9-\,Z_JEMXM\>>(5^)7Q#L-)\1:CID0^'VA1:MH
M'A_0O&>B1Q^9KWACQ1XEUB3Q4D?F! _PIF)5E\CROZBZ_A7_ .#D#_D_CPK_
M -FW^ O_ %,_B[0!F?\ !OM^SYX4^,/[8VH_$+QGHUUJ]I\#? 9\=^$8+G3-
M+O/#J>.GU?0M"T,ZP^M>&_.3Q)X3_MO_ (2CP7+%)#);>+M ENEGA,&X?W=U
M_('_ ,&SGCS1(?$_[27PTEU7Q>NO76@^%?&-GH"VNBQ^!5TO1]9;P^NLLV5\
M6?\ "1R3:Y$ML+<GPB?#)ULH,KD?U^4 <5XY\)V?CKP9XR\$ZG//;:?XS\->
M(/"]Y=6AQ>6>GZ_I,NCW$D/4EMDKN.0"0H;@$CX1_P""9_['?B+]A+X%>,_@
M9K>N6WBW31\;?'_C/P?K]H#Y][X(US2_#<6A'65S@:ZG]BR)<'D8,95@.3^D
M=?'7[<O[1=K^R9^RC\:?VA#976J7OP[\)"7P_:1V)U**7QSXAU;1_!?@)M:T
MS^WO##?\(ZGB[7M!N/&+0W5J\/A"/7Y(Y%&(;D _-G]O7_@N%\%OV4_$OC'X
M*_#'PK<_&3X[>&;G5/#.K6T[C2/!'A+Q,^D^8B:YJ\*K'K9L_$"10^+/#T<_
MA2=$W%9@X\R3X_U__@N+^V_^S)\1?"^B?MQ_L6>'_A]X8\3:4;^RM/#W_"7^
M'?$>H8U46_\ :ND:WX@\1>+?#4B *"WADR+<Y78MRJ96OYZ?V(]2N?BU_P %
M#/V:-5^(8M?&]UX[_:;^&%[XN'BT_P#"1#7VUWQGH/\ ;G]NMX@5CKX)QD[6
MP"3AN0?ZTO\ @X=T72+K_@G\VJ7FEZ;<:QI7Q?\  2Z3J=S;*^HZ>=:_MU=9
M;120'$K1;2<D@JO.6"L0#]:?V;OVC/AC^U1\'_"WQL^$M[J.H^"/&*ZG_9S:
MQ9/IFJVG]C:O<:-+#JNCR.YTB?=;--)%\I2$K(VX\U^-?[4__!=F[_9!^-/B
M?X(_%K]C?Q;:^)=" O[.[LOBYH(TSQ!X7D+-I&MZ,6\+L"L^5WJ IR#@] OY
MD_\ !MA\9_&^E_M!_&GX"Q7UM<_#?Q=\+!\4+RTNAK;G0?%'@76_#^@ Z!&O
MB";PUH<WBKPYXYW>,8XXS)++X?\ "T2D#PJV?!?^#B#_ )2(7'_9%?AC_P"A
M>(* /U8\5?\ !QCX5U/X&W_C+X2_LU?$34?BA:KXBL-9TG7Y)M1^&?@/RB3H
M>M:UXVT'0'77C(0 WAP_\(C<%&=3.3Y;1I^P/_P<"V/QU^)FD?"?]ICX?^%_
MASKGBF?5ET?XB>"[O4].\$65AH>AIKC:9KFBZ_KOB\H[B/6 _B5/%XM<(,6N
M!@^R?\$-?A5\/C_P3$U75KCPGIEU=?%C6/C$/B,=5SJ6G^+5T37M=T+1O[:T
M77<^'-G_  CZ0^:I"1%?]:S+]S^*[X2Z/I7B3XJ_"_PYKD U+1]>\>> ]%UB
MT_Y_]+UW6M _MW/;N/KT^@!_5=^U9_P<0>.?"'B,?\,R? 33-=^%]GK6K:*O
MQ6^*UCXS_P"$9\>PLK+H>J>#6T1O"SZ,K'1M=+DGQ<KE(V6*,J<_J-_P2^_X
M*@>"_P#@H#X%U"PU;3M/\$_'/P-:0S^// ^GOJCZ7J&F-B*/Q?X+FN-TLWAV
MXE9(AO>29Y9%520P"_#O_!PSX'\(?#7_ ()R_!'P#X \.Z=X5\'>&OVF_ FC
M>'O#VE6W]GZ9INFI\%_CRJQQH  L?+L3]XMRQ))K\\_^#9S_ ).L^/O_ &;Z
MW_JRO 5 '[F_\%"O^"I.L_\ !/3Q9X<L_&7[,'B;Q]X"\7VH'A3XFZ-\1](T
MK3M4U6$DZQH,^C2^'))M$\01JQ92TA67=YJYCD /Q3X(_P"#C/X??$?2O%>@
M^&_V:OB+:_%^XLM,LO@SX*M-3;QU8_$'Q1K7^IT;69=%T+PL?#FPY+M*MPS]
M5:,\CF/^#G/_ )(W^RQ_V4KX@_\ J'Z%7YB_\&[FCZ5K'_!0#4KC5-,T[4+C
MP_\  ;QWKFD&[M5U 6&IKK?@!FUC1G=7"Z\RZT5D8+O5&9HRKA6 !]Q0?\'
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MK1_$53_8/B=$"PN"&12>K<C]'O\ @W>_Y1W6O_9=?BC_ .A>':_G8_X+[_\
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MZWH6OKH7BGPS%HAE3">$)27^T,"6;*H(_E;_ ()__P#!:O\ ;#_;:_:B\ ?
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M&CX1)?P=X^8.?-$C>#_WKT^RL=,L;>QLK>VL=-L[86]I:6EM]ALK2R4 *B(
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MU RX&2&4D]%7PU_P36_Y1_\ [''_ &;=\*O_ %#-$K[EH **** /Y^?VMO\
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MSTO3=-LXK#3K'3XT5$T[2UC$:!=D2#:NP!?+7"?P 'Y4_M3?\%!_'_PIUCX
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M=XST[X(>'=435T?7M9UM(GF\4^)-"705+Q_\)/XR\(^-@VQ(O [,@=P#RWX
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M[2&FZO?_ +1/Q._:1_9P^(FK-<^#[KXW^+]6^)3>*O"VALID\#:X=>+#X?\
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M#?MR^.9?AI\2_AGHOPS_ &DXO"J/8:EX;,NI>'/B)I.BQKK/B-M%,^BR>(O
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M^(_!_P#P2A^'G[3'Q&U'Q-\4M>\!?LM^)?BOXEN?$7B74M3\2^-E\#>']?\
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MX<U[P_;_  E^&=E<ZOI>JZ4^EV6HZ-H6B:'("T;$1 :]I,MO&)F4;D 089
M#^-3XA_\K!&G?]I!OA=_ZL_P_7KO_!=SXOZI\0O^"DGP^^%5[I+6OA_X(V?P
MPT6T+:M]OT[7V\=-H/CQ]<.@[0,L^N'PR2!ACH.X9!!/S!\0?BU\,_\ A]J/
MC&?&_AW_ (53:_MQ> O&E[\0CK"?\(W8>&-"^)N@?V]K1UQ<Q_\ "/\ KM.S
M/3Y<&OU%_P"#D'X%>.+[6?@3^U=X/%UJ'A+P_P"'6^'VM7.@6B[M"U,:Z^MZ
M#KVMZT'<K%*=99HLG)7P_P! 1P ?UF65I!96\-E8Q06ME;6Z6UO;6P %H%&
M@ . JC&.,Y&3DDD_QV_\%0+.SLO^"[/['PL[&WMC<^,?V.;V\-K9@MJ&I?\
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M->$FNZQ"P5<!<D84Y) /T(_X)*>/M9\<_P#!/?\ 94U75/$/A[Q;)I_PUMO
M]K>^&-#UW2-/L-,\"ZS?>"- T.2;7U+7FO>$M \/1>%_&FOV@7PEXG\8Z'=W
M/@YQ97 1_P B_P#@L3_P3+^-UW\8Y?\ @H%^QI#XY\2_$-]8\*7OQ$\%^"['
M6-0^(NB^(-$30-"T#QS\)M'\._\ %1>(%4Z!H\?CGPEN#*(Q.H:TG\4W'A3U
M[_@E!_P5&_9RG^!'[(_[(VA^"=4TOXU+=:;\,-8\)^!O!FL:?X(L5_MCQ$#\
M3-<UU4/AX^(?%K:*OBOQN(G5SXWUOQ)M(!=6K6O_  5-L?V6?^"L'[9_P8_:
M8^(GB,_ /7Q\*;/X<7NK7NNZ[IGPG\3Q^#O +C1-$T1?^*=\.^&_%1\<^(/%
M/C;Q(Q8#^PO#2.&5GR ?(O[//_!>O3/&.A:O^S]_P4A^#]OXK\%^)F/@'QAX
MW\/^'&VVFFZ[J^C>']<3Q[X(7+-%X4\.R:WXI\;CPJ)/&4:HOD^!8W57'];O
MA'Q1X7\9>%_#WBKP7KFD>(O">OZ3I>L>'O$.A:K'J_A[6M*UA5?2M3TG6H3)
M;ZO'+&L;QLLK!Q*A)WM&&_DF_P""WOQ1_8]_:FT_X#^$_P!DJY^''QM_:>\>
M?%+2-$NM5^#VE:/XI\3ZYX8&B:_H&B>"=<U_0E\V3_BI-<T(_P#"-2.S.205
M7 W?TS?L9?#;Q/\ !O\ 9-_9M^$GC:PM;'QC\._@M\/O!GB*SM;S[?';:IH'
MA[1M)U9$FQM<"6/>6!94/!X)! /J>OYW_P#@Y9_Y,6^$W_9VG@3_ -4Q\>Z_
MH@K\'O\ @X?^&OBWX@?\$_[76/"]G;ZA9_"CX[^ _B9XN62Z$9@\,QZ#X[\"
MLZ KERGB'QSH0*@@H%?Y<(2H!K_\&]W_ "CF\+_]E>^*G_I\2OCW_@YQ_P"2
M/_LL?]E,\?\ _J':'7,_\$-_V]?A%X%^ GPO_9!TS0_B!XW^._B;XT:H'\->
M'?!>K-IVB>%_&^MZ"^L^-]9\0(G]@+H?@WPZ=?\ %'C QR87^Q9=L9D:.1/)
M?^#C?]IKX(?$V+X,_ _P#X_T;Q;\0/A-X^\>7OQ'TGP_=IJ(\):F5&A+HFMA
M#C_A(5\1Z)L_X1AP'8KSE M ']._[',F/V1?V5CUS^S=\"_S;X9>&_3IT^E?
MRL_\$/?$WA[1/^"J_P"U7I6J:QH]A?\ C+PM\=-&\):9JNJ:)9ZAXFU&/XSZ
M#XD.E:1#YT4OB/Q ?#OA_6_$,;0+/)#X4T7Q!<M 889I(_W8_9D_;X_8U\'?
ML6?![7-;_:'^%XM?A+\!O@;X8\=6UEXHT:^O_#_BI_AEYA\&M$LN?^$FD/@G
M7P/#R#S=VA/N55.X_P PW_!*/]IG]F?X1?\ !1OXC_&'XS7)M= \8M\3K/X0
M>*[OPVNHCPGXG\=_$[00VM,3'(WATI\.==\<2^,_%2;3_P (AK?B,,_EEU(!
M[5_P5BT'P1\1O^"T_P /_AQ\9_%/_".?"#7+O]G31?%VJWGB;_A&],\)^%]=
M_L#^W-9.O>(=WAGP^3_>;)[G<<U^X5Q_P0D_8ON]2_MF\\5_M,76O?V>-&_M
M>Z^.NL-J0TLC TL:J-!\TP[OX%<OSM#9^8_FU_P70_8:UKXWVGA[_@H-^S7;
MVOC[0!X#TMOB3=^'KK5M0U74_#.C%GT7QQHHC58SH/A?P^)'DV#EBSE1N%>1
M?LB_\'$7CCX5>!+#X=?M/?"K7/C!K'@_3--\/:1XU\.ZS_9WC?79=&5UD?QH
MGB,,-8\2RB32&E>V$3222R2N7>21F /V9^"G_!(+]@[]D7XW?"CXS^#-4\;:
M'\1M,\2ZCH?PZM_&WQ0TO^S=7\3:YX0\1I<Z1I&AOX>M&UW7&\-)K?B.VT")
MW(?1#=^0UI;3.?R-_P"#GS_DHO[(W_8H?%+_ -/O@.OJ_P#8P^*OQA_X*7_M
M3:-^W+\:-"'P"_9^_84@\<1?"S1&T;5HW\8^(_B=HFO1^-=8U[7]<1$C3PA\
M/-*T3_A,X88T1)KCPX\,"EY37Y;_ /!P-^U9\+/VB/CM\&/"GPEUS3O%FC?#
M#P-JQO/&WA[6$U+PQKVJ>.];T'.C?(B\^&#H1F8D$[Y&&<   ']QVB_\@C2O
M^P7IG_I.E?P0Z-K?PS^+G_!;GXF6O[75GH_Q&\$^)?VI?BG\-+J;Q]XEB\,^
M';;3- UCQ!X$\"1:P9I(8=?T'POX=T+0_"J>&)98H@S>%S)(BY8?VP_LV?M'
M?!O]IOX;Z/\ $#X+^,--\6Z%)I6D/>I8MLU70M0UC24UDZ1K^C@)_8>NQQR!
MY(9 XRS(K$;:_EH_X+:?\$R/'_P[^*WBO]NK]G6PNIO"/B76M*\2_$?P]X4T
M:33-3^&WCHC0@/&FB'0XHT&@^+/$D<GBKQMXC#RR#Q9X@\07$I7[0JT ?L1K
MO_!!_P#X)XZQ\0C\0#\//%>B*NLZ7K;>"='\93:?\-Q%H@S'HQ\.BW)_L(GA
MH=X*#YM_(%>P_ 3_ ()K?L+_ +,7[2VH?%GX1^&XM"^,NI>'?$^N:!X-O/%@
MU%/!WAC6=NB:YK'@;P<__$]T'P\K:VWAF66,S01MK#VS$7#Q&OPA_9P_X.,_
MB3X/^&5QX$^-OP5N?BO\4]"\.G1O WBWP[>?V;JOB'4]#775?6/BGHASM#A?
M#_F?\(BH+%/$K'#JK#]0/^";GP<_:!^-O[0GQ8_X*)_MD?#1?AO\3_%&C:?\
M/?@MX(NM&AL$\)^!(@K3:KHWG ^(EG,;/X=C\42E5\9^#]:WRYB61& /R'^+
M7Q!\,?$7_@XR\#:MX/U=M4L=!^._PR\ ZO>/8ZKIS:;XF\#^#-"\"^-M!*ZN
M/+?RO$.B:U%^Z+!PF0TC'>W]#/\ P6._Y1J?M6?]B/X8_P#5E>!J_F^_X*&7
MUG^QC_P6R\/?M':Q\*]4T[X8-XQ^&?Q:M/[ T9-,'CW4_P"R="'CK6_#^P >
M(=;;Q$-;/B]C^\?Q:8WD/F%B?Z5_AE\4M)_X*0?#'X]:+J'PJU;3?V3O&WA3
M2O ?PX\<?$#1&TWQ#\2/$RGQ#_PF_C+2/ VN1ND?AKPIKJ^";?P5=SJ'?QGX
M?\3MNW00)" ?G[_P;@>/?"^N_L;>/OASI6J-<^+_  -\:-8UKQ=IGV;5-NF6
M'CC1- 3P\JZQ)M,CS?\ "&Z\."5S$BL '&[]R/C=\,O#?QG^#OQ/^%?C%K\^
M&/B/X%\4^#/$1TJZ-AJ+:1K^BS:+K'E2955(A<@D9&WY1P1N_CC_ &-O%WQ@
M_P""*O[:GB[P]^TSX5^('AK]F#XBV?COPWJGBTZ/K>O^&]=TW0U;7? OQ-T0
MZ A\-ZWXC?Q ^B^$W.SS4'Q!\5;=D@!'[,?M[_\ !2O]FSXH_L[_ !$_9V_9
MV\2:A^T;\7OVBOA_JGPR\$>'O@U#-XH%EJ_CJ-/#HBU[6M#7&A^($&LJ_P#8
M,C"X9E"[$C=PP!^;?_!L-_R47]K?_L1_A5_Z?O'E?V#[QZ']/\:_'[_@E=^P
M"W_!//\ 9M\03>)K/3O%_P =?'EO_P )?X_'A_3M,.JV!T+2&70/ACHFL>6#
MK\'AD)(8[A\02^+]?\1S1F6":.1ORU_9U_X+M?'S6/VXIOA9\?/ASIO@_P"#
M_P 1/B]I/POT?PW<^&M6'C?X,:G&^O:)%HC'P^ADU_Q#XG\2:YX)/C-?%3*G
M@D._RGC: ?UG457@[_C_ $JQ0!_#I_P6]^*>JG_@JU\.;GQSX3U/P=X1^">E
M_ JQ\/\ BZ[M-9*>._ \&M#XH^(/&?AY3H%PVMIX4\2^,?'/AIHO"TSR)+X#
MD\XK*71?[7?"_B72_&'AOP_XN\.S#4-#\5:/I7B71;DVYM&O='UK3$UG1I 7
M&07@EB;)Y7S,..&+_@Q_P70_X)S>(OVJ_!GA[X_?!GPQXD\7?'GX:V6F^#)_
M"GA^Y%\WBSX8Q:QKNME-'T1I TOB7PUXAUF6>W*1_-#J]R<@09/SW_P3O_X+
M,>"O@I\"])^ G[:NB_%GPU\1_@_=_P#"O?#VOMX.\8>--2\6:=H0U]/[*US;
M$7T3Q'X4CT0>%G29C&WD6ZIY6)&8 ^?O^#G/_DL'[*/_ &3GQY_ZF/A^OZ&?
MV.?^48G[-O\ V91\+_\ U2VAU^''Q7^'GC;_ (+>_MH?!CQ=HGPA\6^$OV(_
M@E>:IHVL?$SQS::UX>'Q*\,MK&A:[XWT/P_&"K?V]XJ6,^%U50K>#5C9V8RF
M61OWD_;;_:X^"W[)/PR@/Q;G\66<'Q-TOQ-X.\)+X0\(:UXC+ZL-$,6)%T.,
M_P!BC_B;1A)B58A28ROE#(!_/?\ \&P.FV4WB']L^^EL[5=0M-)^ EE:7;68
M&HV2Y^+H*DD' .>PR2 ">6K^O2OX,_\ @BI^VKX=_82^)WQHM_C=X6\7:9\.
M?BSX0\+-=^(M)\!>+_$GB;3_ !3X$UKQ -!T;^Q-"CE /BK_ (3G7""$//A\
M#H2#_;A\&/B]X-^.WPR\(?%[P#/JMQX/\>Z.NM^'GU[1]5\-:I+ILA8*\FB:
MTJ31OE#N8*D6. Y^8  ]<KR_XT_\D@^*W_9-_'7_ *B6LUZA7X__ /!1[_@I
M)\,OV7O!_P 5/A!)H'Q!U3XV:I\.-4E\ :;=^ /&<G@;Q8/$&ER:25B\::#"
M\>P(VM6T;HR,?%&C21!E$,1< _GG_P"#;+_D_7X@?]FJ^//_ %9WPAK^WG7M
M$T;Q+IMQI&N:9I^M:1=KB[T[4[%-0L+P=MR2*Z97!&2K8Y^7G)_SQ?\ @EO^
MUG/_ ,$_OVB_$'QH\9?!WXD>/]&U_P"#_BCX>G2?#]G_ &=J7]IZ]XT\ Z\=
M9/\ PD/8CP/CZ"OZ3OBA_P %Z/A3/'X7\,?LV? ;XW_&KXH^.K./0_#&E7/@
MW4O#FF:7\2M;DAT3P7X>UII('?Q#%=^(M5C2Y'A=G<H,PO"X1U /YK_^"LOP
M:\$?LF?\% ?B-X/^!5EJ/@+0-,7P#XT\.VVC710>%-6UW1/#^O,=!5F=E!\2
M<A69B!P6)!)_;[_@J5\0]:^*?_!$?]F+XA:]J7B75-<\67O[/^J>(-6\5>&K
M_P ->)/$'B@_#G6TUO5IM%U_PVEU+)X@UX:OX@M_%,4$4'BRT*>+_!<MYX)\
M403M\8>!?^"8G[=?_!17]K?Q/\?OVK_ _B3X$^!O$_CS^V/%P\:AO^$DT_PN
MO&@^"_!.B:ZI_MWPROAP?\(J[E=D8^]BOZWOBQ^SA\+?C!\ /$'[,>O:%#HW
MPCU[P/8> ;71?###2O[ \.:'Y">'X=#  .D'PR-)T@P;5V(84@P&5  #\;_^
M#<'Q+X=O/V(_'/A2SUG1Y_$GA_X_^)M;UC0K75-'?Q#I&F^(/!O@1-!U77-#
MAE,V@-XE71->;R980DTVDZ]]GE>6.58_TI_X*9^$?#/C?]@3]L#3O%>B6^NZ
M=I/P"^*7C32K:\9=ECXH\#>#M;\0^'-=2,'<!X7\1:-I7B-9,D%K4^F#_,M^
MS3XF_:._X(6_M6:UX%^,'PUU#Q-^S?\ M WJB_\ $'AVS3Q-JMWX9\#:OKFC
M:!XRT;6="5MOB7PI'X@1_&_A210VSQ&K8PW@LU^D?[7O[7GQ2_X*7_!KQ#^S
M3_P3E^&GQ+\10^/ VD?%WXQ>*M'U;X2^&O"/A1437G\'/KWB)%8M\5="TBX\
M,>8H10ER0XS(  #PG_@V=TWQJW@;]H_69+[Q(OP_/B_PQI%II@.C?\(0/%,6
MC*VMZP%/B!O$C^(IO#QT*-Q_PBD'A 1L[V\JR*'3QO\ X+P?#BS_ &=OV[OV
M6/VR]-@ATW2?'9\,-XQM/"MYJVG>.M<\4? [QKH#Z[JP:+",/$WPZUWP/X2'
M\>/#H9V<GS)/Z./V"OV5+?\ 8I_9?^&W[/G_  DI\9:EX375+[Q!X@:T.G#4
M?$WB/6CX@UY]'APK)H:^(-5E$0;.U'.\;F:-/F?_ (+3?L[:E^T1^P5\2+'P
M]I_B75?%7PTUC2?BSX<T'P[:_;M0UN\\/_:=%UG23'(0QT,>'M>UCQ'<",<M
MHL3X1 40 ^*_^"@\^I?\%4_'O[-?[&_[.WQ)T>V\!ZY\'_$_[6OQ2\06HDU;
M3_#ZKH@\/? E-:UKP]XE?P[XGT*;XE:X?#/C7POX3_X32X\)/*OC8;V\(HM?
ME5_P1@_;R\#_ +%@_:M\#?&+Q5INF>%?^$%U;X@^$M*L[5D\4^._B=X&AD3^
MQO#VOZ\I\-Q^)?%GAU@/!'AGQ2\3^,O&18I("-K?ME_P0L_8CE_9R_9VG^+G
MQ.^&:>$_CU\6+K4'_M/5BLGBFP^#<KZ%K>@Z$\)CD;P[#<:^EQXD_P"$; *B
M)=!8X\K>OYJ_\%'_ /@EEKOBS_@I]\([[P)X;\6-\*_VL/'FF:OX]U_PMI6K
MZC_P@>L#5P_Q5UF5M;\SPQ'N\-MK/BH_(6",&$9!4$ _7W_@B?\  SQE\//V
M3)_C7\6M8N-?^*7[7?C/6?VD_%.JZK)HFHW\EGX]D35] U,ZUH0\B?\ X2[0
MAH_Q#="Y\JX\1&,A9HW,/X4_\%R]7TOX8?\ !5/X&_$GQ++XD\5^']+\"? G
MQ_JWAZ\N-)O?L6E>'_BA\0(]<\'Z#&X+1^&9?[ ,D2[G_P"*P\0^)#O;.:_M
MFBB$$7DPG[O3/;@ _P"17X<_\%D_^"7FM?MW^&O _P 1O@PV@:;\??AG::CH
M,=IJL6EZ?!\2? VNZQI#-HNO>(#&S0OX1,6N^(?!RSR+$DVN>((U$=Q<B)P#
M]6_#7P\^#7BCPUX>\3V?PB^']O9>*='T_7+*VN? GA+[=Y>MZ:NLH&?R&02[
M) 9$ZAT/_+,>8G(^-+[]FCX(ZU\/+CQ5I?PQ\%^)OB-XXTGX?_"VW/A72H?$
M6N^.-6ED.A:+H*:-H#^($D6,LS7"HL'AH!&ED2W\IE_C3^#?_!0O_@IW_P $
MV[_P]^SYX_\  ^L>(/!W@"35ELOA5\2_"&L$KIVL.8]&30_':'_A*!X=5Q)X
MC\'1DX/[R&52I=#^QG_!/G]E+]L']H;X_P"D?M^_\%&3J=OXH^'-CJVA?!3X
M/>(/"FE:2N@\O&WC(^$ KMX?E\Y#XC\'-&S7,3/YA"R%&(!X9_P<_?\ (F?L
M<_\ 8S_&?_TU?":OZ1/V:/\ DW/]G_\ [(I\+O\ U"?#]?S'_P#!:.Q_:A_;
MQU+X5^$?@G^Q)^U.?"_P=UGQ3?OXYU[X:ZOI2>+?^$YT?P&4?1]%S_PE.A2^
M$];T/58I)&;#^4KHD:OL'[&?L^_M0_%?1_V-;C7-8_8L_:+T/XD? #PI\,_"
M,'P2U;P['I_BKXE"V3P]X:FUOP'OWIKJQXUC7IP(\QKHCY9)I!(0#\._V9?^
M5DCXH?\ 92?VC?\ U6/B"O[&:_BN^%F@?MH_#[_@J5XP_;[OO^">O[4>I^#M
M=\2_$[6K/X?6GA _\)-8'QQX,U[0@3KN?^$9.#K>>2<]SUS_ &$?#7Q;J'CS
MX>^!O&NM^#M;\ :SXM\(^&?$NJ^ O%?D'Q/X3U76M'BURY\'ZXL8P/$'AB:5
MK:Z5539-#(0B8WH >DUYWX_\8>&_AKX(\7_$GQ?J']F^$_ WA/Q'XO\ %VKK
M:ZCJ/V+PSX>TB36M<U)]+TI6DF$&B:/-,OEIYB;"(HV9FBF]$K^8/_@K;\:O
MVYOVG_ OC#]E;]GC]B3]H2#X4W_B7[!X]^)6J_#S6&'C?3_!6L^'/$6B-X*
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MS?\ \% +C]J#]BKX:>(]4T77_%FJ_$[P-J_P5\-#4?\ A!-2&B#0?$'@W7]
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MF^/4/#.N:/\ "F\\'ZLNK-XHT;2?^)IJNO:]HGDG7F;Q%+J_B&U@?#1J8H.
MFZNV_P"":/[#W[7G[#ED?AO\1/VFO WQ._9UL+'Q+<^%_AKI?A+5X]4T3Q5K
M>M:)-&FBZ_KLBR:'X715\0W+>%8F9&\5:]-*K-&7) /PD_X-Z?VQ_!OP7^,?
MCO\ 9P^)'B#3?#VB?':3PS>> /$.OZV^F6*?$C0XW;0_!\$4<3>&](F\5Z!K
M6KIY E@/_"7:)X>\&1M+<^)[>WE_K^^,_P ;OAA^SU\-O%GQ<^+?B[2_!/@;
MP=9&\U?7=7,FU5\J4C3=,1 [:WK,[VLD=OX?T+-Q),'CC0G)/X4?MQ_\&_WP
MX^/GQ!U?XL?LX_$"Q^"/BKQ+K*ZKXF\*ZOH\=_\ #>64QZS+K>M:"-!$'B'0
M_$;Z[)HLSO ?) BD4893&OB/P!_X-OGT;QK8:O\ M)_M!R>/?!&E7FFWJ^$?
MA_8ZSIC^(=NIK<_V)KVL^(#NA\/^6P^3PZ(9 P(9 "I8 _=#_@GS\<_B9^TQ
M^RG\,_CK\6O"#^ O%'Q-O?'7B6P\*RZ9K>FG3_ LWCGQ$_PO DUQ@^MM_P *
MZ/APIXF,:P>,T\OQ;;+''/Y:?<511Q+#&(X^ HP,\_Y^E2T %%%% !7\[O\
MP<"?L1>(_CW\!?#_ .T/X $]YXG_ &:K'Q5?^(_"^G>']7U74O%?@+QMJWA=
M-;U@?V&RW!/PL71O^$L8F-POA!?%_FRJ6B\S^B*F\.._7\0: /\ .\_X(V_M
M@Z7^R+^V9X4U?QA?:=HGPP^+$;_"7XC^(=4&DZ;IV@Z9K>L$Z%XTUK6]=\0>
M%?#?A_P_X4\2?V%XH\:^*4CD<>#?^$F(C<X4_P"B+7XE?M3?\$+OV+_VD=:A
M\4^%M(U#]GOQ1<WGV[5[SX2V6EZ=I6MJ"!B?P685\+K<N&7&O)$958@$$,&7
MXC^'G_!&W_@I;\)O#.G^"?AE_P %,M1^'_A#3;W4KK2/#'A35OC'INE61UNX
M;6-83^R!XD96)F<F*/<74ON*H7P0#^A+]H#]H3X0?LP_#?6/BM\</'6G_#OP
M/I3V5D^K:QY^HR7^JZM+Y-MI&BZ+HT=SXAUW7Y9(W\K0/#D,\]Q$KRVT3HDQ
MA^-M8\=^%/\ @J!_P3Y_: N/!/PF\:/X>^(_@WXH>&OA9H?Q?TA?"Y\<^)]#
MT1-=^&/C;0/+UH(/#DGQ'CT*Y\'^)_,1&DT!Y66.-2U>#?#O_@C-X!N/B;X&
M^,_[87QZ^*W[97B_PSX+T[PU-X;^-U_'XB\"OK09GGB$>M"5_$'AV'Q'K>O2
M^$O#?B>.58AK[OB1E9:_:71M)TS0-,L=%T&QM=.T;3+.RL]+TJSMA9V-A81@
M(D<2 !?EC!.W ;*@.N]I'8 _S6?V-K*Y^"?_  4&_9RL?C!;CX7W7PY_::^&
M/_"=CXAC_A"QX$.A>,]!.N?VXOB%T70 3CY2Z YP77[P_J<_X.._BOH/AC]C
MWP%\*[ZPU*XUCXK_ !6TR[T:\M /[+LE\#JLFN'66!P8RFO(. /F5@<D5]$?
M\%#?^"._P6_;?UO5_BUIWB/7OAA\?[C24L;7QA:7#ZCX:UM=$T&71- T3Q%H
M2^88] C6-#//X:%MXI_>!EE!!B'Q)!_P05^,'QR\6P>*OVY?VW/B!\:[CP]9
MZ9H_A*XTF\UC4M7&D'66U_6M'UO6/'V]AH$KE0D7AGR7(\QB T90@'Q__P &
MV'P(\:ZE\=OC/^T<^GSV'PZ\-?#?_A4T.IWUCK>SQ#XM\9ZYX=\2*N@Z^%/A
MC7)O"7AWP*)?&3#,D9\=>&;B-6'B=]OS=_P<0?\ *1"X_P"R*_#'_P!"\05_
M:M\#?V?O@]^SCX)M?AO\%/ 7A[X=>#[>Z6ZGT;P_IPTT:AJB:/H>C2:[JS*#
M_;?B&:#1='BG\02@RRQV\:[@R%Y/Q?\ CK_P0*\ ?M#_ !&UCXE_%?\ :X_:
M.\;^*M4>46EWXC?PAXAO=-TM77^Q-$TB37(91'H?A@RB2*)AF8DC<'." >F?
M\$,?^45?A#_L,?'G_P!33Q!7\/\ \!_^2W?!?_LJG@/_ -33P]7]MWP;_P""
M*4_[/O@[QQX"^"W[>'[3_P .O#7Q!O=*O_$5IX4_X1'3RNHZ,KJK^'W%NYT!
MF7<CK%N"Y8%R.OSG_P 0RO[.?_1QWQP_\%7@;_Y04 >D?\'*G_)BGPP_[.R\
M ?\ JK?CO7YA_P#!LY_R=9\??^S?6_\ 5E> J_7SXL_\$69/COX!\ ?"SXJ?
MMV?M.^-/A]\/K72K'P;X7U4^$O\ A&;)O#\FO0Z-K$^BBVQK7BA/#6O:OX4C
M\22OYLGA)FML*8Q(W _!'_@@3\/?V=/BAX;^+_PB_:V_: \)^//!UPM]H^K6
MVD^!665&8I=:+KR_V ?[?\,^(<K]J\,2[4P^U#(< @'B/_!SG_R1O]EC_LI7
MQ!_]0_0J_+[_ (-X?$OAS0/^"@-S!KFMZ-HUQXI^"?COPMX<L]4U?1M..O>)
MVUOP!KAT;0URI\0^(5&B:ZS!?FV^'SM!8 ']0?\ @YM_Y(U^RO\ ]E*\??\
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M\-_^"&R_!SPCKW@'X6?M\?M<?#OP3XGN]4O_ !)X2\(:YHOASPSKVH:_HO\
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M>,+:RU+2I[P?%#QIJ>F:UI>K,DBZ7KNC7&MO:ZWI,$P26""=04EB5F8A6:,
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MQ\6KWX[>&-'^"7P_\'-JGQ?T_P 4>./BAX>\>_V+K?@=7C9?$OA+PWH6N?\
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M_P .OAOX&&J^(/#NHSG4;WQUKGQ0\#ZYXTUU]85%U\Q3Z[K.N2AW9IHO"+K
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&>_D\*G0L:V6\0:GM"0!H]6@>-<^8NYDEB@D$@?ZI_X(5?'GX0^+OV$O@O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!\\T8V'Q>A>>W F39+^V% %BBF)T/U_H*?0 4444 %%%% !115>@"Q15>K%
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M3)&)<@ ^YJ*KU*G0_7^@H ?113'Z#Z_T- #Z*KT4 6**** "BJ]% %BBBB@
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MXIMM,OO#-[H\B.-737(-=)MI=%4$%PZA(UV2ML1490#\P/\ @E=_P4>\8?\
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MA(!]"45G7-U!9VTU[?2PVUO;6[75S<7!4+: +EF). $4*W?.1@9R!7Y[3_\
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M;;@LA8/)\%?VQ_V6_P!HC7=1\._ [X[?#GXH>(=*LQJNJ:3X4UE-3U"QTUP
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M3]*OV\%:\^C>(O!_@;^WQ_Q/VE?1V)\4@[0H4($&00#^HWX6?%;X??&SX?\
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MO\']2T/X0_$'X(:[K?CCPJOCT:M$5\%^-]6U]C%$QC\MAY:)E7W<B0D^[_\
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M3QPVCL)?#^LQ&5"R1/X:$.U!#^\&Y7 /WVHK^8?]E+_@N=XL\/?$[3_V9_\
M@H+\/#\*_B=I.M0^#-7^)MK9_P#".Z38ZE%,NC/JWCCP^^^-#/X@#P-/X10^
M$(UDWJ<HH'T=_P %,O\ @K)\7_V$_$>I>#/"G[*6M:E8_P!M:5;^$/C9X_O
MGPA\=E_!VA>(-?TC1!X;\OQ.?$'AJ767\.,'5@TNAS?.ZDX /WJHK^<K0?\
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MOO\ ]I+Q?\)-5_94/P:T5?!VD6%EX4'B4Z<='\._\(&FCR>'?#'A3Q*NK?\
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M&=3\?W>J>+?%NK::M_X:31Q/H&E^"M$T!/\ A)=>\1>)64>01M2-LY9Y)$"
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M\(ZE-JVL:,^A/HDWAKQ?XBNY \6AS">&..(#7S"49HII).\_X)T?MQ1?M_?
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MXH,?G2[;>1Q]HS_/-_P<Z?\ )7_V6/\ LF_CK_U-- K^A?\ 8Y_Y1B?LV_\
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M*8E_=C^6O_@HCXJU7P7_ ,%YM.\4Z'\.;OXM:QH/C#]G2]L_A]:V1OG\7?\
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M^//^$OM=)NM*?7[!#-#_ &.-?6(G$PC!\AG "LS$;E\P  _'&[_:Q_X*1_\
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M/X8?\)C^[?Q ' .,'^BO_@F/_P H]_V/_P#L@_@3_P!,PK^=GX\?\K*_@_\
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MP4JMX9\2>(/"^O127/A">Y\,R3PS2_O0P>.%/PM_X-?_ /D/?MH_]@GX"_\
MH?Q:K^FJ+XB>%_BS^S[+\2O FL'7/!?Q!^$>I>,_!^L/9:KISZAX:U_P@VM:
M%K4FCZS'%KRF:*6)XHBD<NR4$Q[R"O\ ,K_P:_\ _(>_;1_[!/P%_P#0_BU0
M!ZE_P6Z_;$_: U[XV?#G_@FA\$I].\ 1?'VT\!V?C'QN=8?2]3\6I\5O&S^
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M3_$KP[H>D7(\;^+[_P "ZQX#^*GPV;7H]7TGP3KT\X\ RR6_PO\ #C!O"/\
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M7H/_  <4?%;2M#TW3M&T?2O'?[3UG9Z9I-BNG:;9X\%Z\2Q" +EP.JJ%!.5
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M.N;6#Q04 /E#]G.^_9._X(.>"/B[X6^+G[4VF_'7Q?\ $_Q'X9U^T^'OPW\
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MW]@*)]&T35-9BT#XZ^ M<\03:59MJ*Z#H[Z'XXT&76=<<L5TC08I]<T0R3@
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M .F> -03X5^*_B%X0;PU\6OBQI.LZR1K8\:1%G">'O"?B312?!?ADL\O@_\
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ME8>/@/!E 'UW_P '._\ R53]D[_L0_B?_P"GK0:_L%M/^/6#_K@/Y+7\?/\
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M:YKR3>)QX4F\'P3^'?#MM<RM=^*/">/IS]@3_@O?^S2/@MX%^'?[7'B#Q?\
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M588!# Y8-D'&<\C*L 15^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGB 7H.HV&H^ ]&_X02'1T*_*5G@^*NL7&06P=%*[LJ57]2/^"+'PEU3X1_\
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M0M=\/>)/"?Q,$7]OPZ-,K^+O&/B\XC/RB0*#]F?L[_\ !*/]G[X+?%F#X_\
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M%9_LP>9;7PQ<P 'Z*?LP>,O"_C#]G/X(:_X2\0Z/XDT&Z^%G@5+75]*NEO\
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MQ/!:M;1I9VBPLQ(!XM^U?_P4=_85D_9H^/EGHW[3_P '?%^KZ]\'?'OAC1M
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M+7_"^CMXUT+3=<&ZXC\'>.UC_P"$J\-%MQ=G\+^)[0[RO+9VFY\#OV7OV?\
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M(901G(4 JN W/Z[TS8/4_I_A0!_&Q_P26_X*)>%O@-^RKI?[,'PL^&NN>/\
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MO&_AWQ9X)\(:9I'A#5?$GAN_\3ZOH\J6^C>,]:\JX\,:!;W,4\TX3Q5<0_\
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ML= \-^ /'"^.=(O/"XT706.KMK**C;WUZ;6EV.6)ACBRH)+2?5=%% 'YG_\
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M$T[0?#&B:79:/H^@Z;:K8Z=IVEHHB32X8U)41A% **%8E@7W.[L_XH?M+?\
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M4?"+Q):7'Q'\6:IIX\+>./[#.O/HRM*S:%KLHT#1<>)81]H548C!)\OPB?\
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MN",O@\'_  0#_P""<=I+;W%OX(^)]I<6PRD]M\7?&0?CU/FD$>V 1[U^UU%
M'R-\2_V./@#\8/V>?#_[+'Q&\(W'BGX3^$?"_ACPOX:M-7U6:3Q#H-EX'TB/
MPWH6L:/XB!&NQ>)8M#1X1KJ2F5G:1PRO(X/%?LL?\$[_ -DK]C5[_4O@5\+;
M#2?$^H?VII][XVU^[D\2^.!I6NKH?FZ"/$.LLMS%H!70=&9-!7:D92-D.[B3
M[NHH _/_ .//_!,K]B']HS_A,K_XD? 'P7)XO\=:HNM>)?B%X=LT\,_$K4-4
M &Z4^.M"$?B-20,D"9E"C.P<D</\#?\ @DW^Q'\ /&]K\1O#'PTO_%GB_3&T
MMO#FK_$[Q'K/Q%/A+4=%#>7JF@CQ"\JZ',,*)&1MK8)1 6&/TXIFP>I_3_"@
M"M;V\,,,$$$0MX;<?+;@<*.2H')X!)/4Y/>KE,V#U/Z?X4^@#Y<^*O[&G[*_
MQU\1CQ=\8_@-\,OB3XG^S:=:C6/%WAC2]5U)DTF1VA7SI%(_=APH&[";54@*
M *\^L_\ @FW^P7I<_P!HTW]DGX%Z;<][JR\!:/8GOTV("<=\*?KBON2B@#Y-
M^(O[%/[)?QCNO#%]\4?V>_A=X^G\&>'=,\%^#[KQ9X2TC56T#POHK*^C:)HY
M>)O+T.(NWEP;B,80A4P$K?##]AW]D;X+^,+'Q]\)?V=OA/\ #?QMI?\ :9TC
MQ5X/\):1I.JV)UG2QHVL!98E5]LL0\N9?F#*0@ZR%_KC8/4_I_A3Z "OS\_:
M%_X)D_L4?M0S:QJOQ3^"'AL^*O$%]IU[J_CCPFY\(>-[R30](?0='!UW0?)E
M:./0CY(7Y2$5  @W!/T#HH ^1OV:OV+/V:OV/_#[>'_@3\--'\)>?;V"ZOX@
M2W&H^,M?&BG63H[^(M==#KFNRP#6M9\DRR,2LDRA<,V>S^-'[+W[.W[1$FBS
M_';X/^ _BM/X7&H0^'9?&_ANW\0'11K 7SQI@G0^6LB;59HQO4 E9(L9KZ&H
MH ^$[3_@FI^P)97-O?6/[(GP#MKFUNOM=G=KX"T5L,>2X^0Y/3J"G3Y>N>F^
M(7["_P"Q]\7_ !IKGQ%^*W[-OP>\?>.O$CZ</$GBWQ7X0T?5_$VI_P!B:+%H
MFD2:MK+(TOE0:%H^CV\28*HL:KC;M"_8>P>I_3_"C8/4_I_A0!\D^ _V(?V1
M?A9-XJD^&W[.OPH\$W?CGPCJWP]\7GPYX-T?36U_P%KIA&O>$M82-29O#GB+
M^RE66!P4D(!)#*0>+_X=C?\ !/G_ *,[^ '_ (;G1O\ XU7W;10!Y=\,/A3\
M-O@OX.T?X?\ PH\%>'/ 7@?0#JQT+PKX6TQ-,TG31K>JR:SK$L.DPH@7S]:F
MEG8KN=/-QE54"O4:** &/T'U_H:^*/%7_!/']A[QKXB\0>,/%W[+/P4\2^*/
M%&K:CK?B#7]7\!Z-J6IZCJNL'$NJR2.CG<_0MM#85BNTJS'[:IFP>I_3_"@#
MR;X8?!KX5_!GP[I7@_X4_#OPMX \+:&=732-&\)Z3I6FZ?I_]N:P==UH1QQ*
MC9EUPO-(,%UE(V\HOE^N444 ?%WC#_@GQ^Q'X_\ %&M>./&_[+'P3\3>+O$U
MX-7\1>(-8\":-J&IZWJ*KDS2RR*S._&>X(QD$EF/K'Q1_9T^ _QPTSPWI?Q;
M^$O@#XC:1X1O%U'PAI?BSP[I&JZ?H6IB-4631HWC"0L50+@*5.T]P0/>:9L'
MJ?T_PH \5^)WP(^#7QI\(1?#GXK?"_P3\0/ UIJJ:Y:>%/$FBZ9J7AVVU14N
M%&K+H[XC5]VL:J3G*X>5BNZ57/DWP_\ V#/V+OAAXLT?Q[\-_P!F/X+>$?&/
MA^6_.E>(O#7@31=-U+3_ .U=)DT26,.(0Q$N@:G);SJW6(DH(V8*?L/8/4_I
M_A3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /D3]L?]E?P1
M^V=^S_X]_9_\=WDND:?XIAL+C3/%MCHNF:IJW@7Q/HD\6L:)KVBG6!<01213
M&2"]C:-1>^$=6\2^$I+BV@\0NJ^:?L$? []JO]G'X<^)?A!^T/\ %SPA\;/#
M?@S5;*P^!?C_ $FSUO3_ !MJ/@-(V'E_%'2]=C=X_$RW CY'BSQJS1>;N\7.
MX7ROT&HH *^8/VF=(_:8U?P!#IG[*>L?"CPC\2=6\2Z99ZQXM^+&GZ]J.D>'
M? TVG:W'KNL^'-%\..4UOXA:!.FB3>$[?Q4#X/E<LVH':%4_3]% 'PE^R+^P
M_P#"K]DB3QOXB\-ZKXI^)7Q<^*MXNL?%#XU_$B[L=4\<^+M0+EY=-%TENHT#
MPZ=95FA\*Q[(XYO)C,]P=!M6A^[:** "BBB@ HHHH **** "BBB@ HHHH **
M** "BF;QZ']/\:?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%,WCT/Z?XT^@ HHHH **9O'H?T_QKBX_$V@77B+4?!ZZQ
MI$WB32](T?Q'K7A^UU+3)=?L_#FO:QKFDZ%K>JZ67\R/0?$3^']?$-TT$,+R
MZ-KD,+O<P-'& =O1110 444S>/0_I_C0 ^BBB@ HHIF\>A_3_&@!]%,WCT/Z
M?XT;QZ']/\: 'T4S>/0_I_C3Z "BBB@ HHHH **** "BBO./'_Q$^'WPL\+:
MCXT^)?C?PG\.?">F?8#K'BOQYXCT?P;X9L&U=UTG3QJVOZY-!H$+37#+$/-G
M6,2K""FQE$@!Z/17'>&?$_A[QCH6E>*_"6O:1XE\-^(M+TS6O#WB'P]JFG:Q
MX=US2]5C232-2T76-&D,&K:-,L@\BX61HKB%Q+&71D9NAFO/*_Y8]N^/_K4
M:%%5H9A+%YV.N<>P'_Z_QJS0 4444 %%%% !1110 5ROBGPGX<\;>'M4\*^*
M]$T[Q#X7URS.EZQH.JVJWVFZCISYW12PX(92ISDY*E5(*LJM7544 >._!/X/
M?#/X"_#/PQ\)OA#X8@\$_#KP<-8;PWX5L[K5M0CTM-=UK6?$&L!)-<>?7<3>
M(-:UB=3/<22DS?*4C)AC]BHHH *P]6TFQUW3=1T?5H1<Z=JEEJ&DWMJ2"EU8
M:NGDRKGMNB+(#SC#MZ5N44 >'?!'X#?"3]G7X?Z=\-/@GX(T?X:>!=,>]O+?
MP_HYNIE.H:M))+/JNJ:EK,\^MZS=LSM&\^OS7-U)LC1WD%K;A/<:** "BOF[
M]HK]J/X%?LJ^$M+\8?'KXC:;X TG7O$.F^&/#;7MMJNJZEKFNZJ52WTC1-#T
M&*?7]9E;#-((;2380K2 L(D/TC0 4444 %%%% !117PM^TA_P4/_ &/_ -D:
M]M-"^._QM\->&O%,Y\O_ (0K2?[6\;>-[*)-*;5SK6N>"/ 5MXK\4>'/#KV\
M:S?\)'XEM(;8R,1'-)&_GD ^Z:*^7OV:?VD_AI^U#\ / _[1_P .[J[M/ 'C
M/2-2UI/^$G@ET&^T!= NKC1/&FE:Z+A8H1/X4\0Z+KF@7T\+MX=:;1'"7#I#
M#,?ECQU_P5G_ &#_  5\6_AA\(M#^/'A;XE>*/BIXG\,>'[:Y^#MT_Q*\,Z,
M?$;Z[HNCZOKOB[P#'XF\,V\LGB31=(\,-X8^T'Q?Y_B+PY=2V+^$)FN(P#]2
M**** "BBB@ HHIF\>A_3_&@!]%,WCT/Z?XT;QZ']/\: 'T5^?_[<?_!0_P"
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M$V^J^*;<:AIWAW3Y=!USQ#)K(T.)@^M&5=%300F\,K3B7@^6X /U[HK\ _\
M@DA_P5MU[]M.R\=?#3XVZ=X?L_CKX'TC4/&6ECPB^B:</B/X61V=M(\/>!7\
M02^)!XB\-$B.X1E"2(1(#'(KM)^;8_X.)/CQX?\ VJ/%&G>+?@WX=\+? 6T\
M9R^$#\//$VEZ[X6^)GPUT_2=:T/0O$FN>.M=1@6\2>&7T?Q!-)X7;P>6:=_^
M$/)^T!90 ?V045^-7[0OQ;_:L_98?Q3^V;\.=0UW]KK]E+XB0>%?&'C+X)FP
M'AKQM^S[\-8X_#\Y^)OPG=HT_P"$E\.+X?.O-XY\-^(_+>.;6?#OC=9(?!'@
MWQLJ_I+\"/CU\*OVCOAIX7^+OP>\4:?XQ\$^*K$7NGZO93*\EKS;+)I6KP L
M^B:["TJ+<:!.(Y8VR2HC=)& /<**** "BBB@ HHHH ***9O'H?T_QH ?13-X
M]#^G^-/H ***^:/VG[;]I?4OA7?6_P"R9K?PV\._%V'5=*N[2Z^*VG:MJ/A:
M[TB-Y?[;TIET!FD76Y0@\D_-$FTG<-P- 'TO17\GG_!';]LK]M+XV_\ !0SX
MT?!S]IGXM>)/$EOX6^&_QCO=7^'EU=:&?#7A/QWH/Q/\ :$4T+^P1M'_  BP
MUK7/"O) '4$$ C^L.@ HHHH **** "BBB@ HHHH ***9O'H?T_QH ?1110 4
M444 %%%,WCT/Z?XT /HIF\>A_3_&HO/]OT_^O0!8HK^$/_@L1>?\%#_@G\2O
M"_AS]HO]I^V\:Z3\1+OQ-\2_ OA+X4:SXQ\.>'/"&EC6!H8T)V'AWPGN*A@?
MO,,$MD[LG^OK]@6_N]0_8;_8ZO\ 4+VXU&^NOV8?@7>7MY=W7VZ_O+^7X8^'
M'G+OT9F8,Y8$9Z8!#R$ ^PJ*** "BF;QZ']/\:-X]#^G^- #Z*9O'H?T_P :
M-X]#^G^- #Z*** "BBB@ HHHH ***9O'H?T_QH ?13-X]#^G^-&\>A_3_&@!
M]%,WCT/Z?XT;QZ']/\: 'T4S>/0_I_C7QG^TU^V-\+?V5]9^ VB^-UU36_%/
M[1OQJ\+_  7\!>$O#=UHH\0A]<:1)_&CZ)KWB"U:7P#X1D.DIXU\1^'8Y39S
M:]X>:2(/*BJ ?9]%,WCT/Z?XT^@ HHHH **** "BBB@ HHHH **** "BBB@
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MA]\=M#AMM.NO$UE]C\6^'K6[%^/"GC?12%U[0F<9):%\-D $(T:G>[,QX/\
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M1@-5<:'H.A:1KVN:WXA%MX8\/QGQ=KL,VN'PY#X5MV@\37=X;:>'P<EGX0@
M/T0HK\%/VP/^"@G[0OQ%_:+E_8*_X)RV_AFZ^/\ H5EK\WQ=^)?CC1=*U/P[
M\--.CT7P%X@\.:WX-UJ37/$OAR2?S-?UGP[XSA\6^!/%7D7!2.&V2:%9)/ _
MVH?&/_!:;]@;P;X0_:-U']HGP5^UW\.?#SR#XP_#Z^_9_P#AMX,L/"0US2!X
M>T?6-=;X?^'_  KXH\0>&O#7B75XY[CQ%X6\9>#6>70_"\UY"O@R3QMD _IG
MHK\LO^"7_P#P46T7_@H+\&[[Q#JFAV/@OXK>!+BPT#XB^%-'OFD\/WFJLC2'
M6_!9G9_$,WAUO+"H]R (WVH2XE;'ZFT %?"'_!07]LOP[^P[^S/XM^..IVEA
MJ_BA'T[PQ\./!-YJQTN3QAX\UR5XM&TA2LN1!X=02>*_%[ DIX+T'Q%,AS&J
M+]WU_$)_P<6_M!>*?%_[3W@[X"0:S:)X ^%/A+3_ !2=*TC6=4;^T?'/CIV7
M5O[:T:'Q#%X6?7/"5OH,26Y=!*+;7?$2S9E5R0#];O\ @DS^S/JGQVT*]_X*
M%?ME>'+#XG?'GXS^+],\;?"K5O&FCNS?#KPKH6X>"]8\#Z'K*2:!X:5 WF>"
M[KPEY(C\)O:JLLCR-%7]!M>3?"+P!X.^%?PL^'_PT\ :2^A^#/ OA'P[X6\,
MZ2=1U:_^PZ+HFE10Z-I9U776;7IQ##Y31R70>95&PHA=HS^;_P#P4S_X*;:1
M^Q#I/A+X<_#_ ,.6'Q%_:9^*O]F?\*Y\ :JVJQZ#%I>M:S+X977=>F@C618V
M\1A-$MO#\5PMT\DBL&@1#%( ?KS17\[?Q'\ _P#!:_PE^S9XW_:%U7]O?P%X
M0\9^'_ OB/XLZQ^SW:_LX?!_^S?"6FZ*A\0:OX.D^*_B'PYXN9AX:\-QM$+E
M_"!2>1'MC*TQ;Q>W-_\ !'G_ (+ _$C]K[QW-^SE^T:O@YOB59>#VUCP+\0=
M%M$\/:E\2]0T7<^OZ1KV@:*7\*_\)$OA[/B9Y?!]OX8\*"#19X[>!GE!0 _I
M(HK\*?\ @H5_P4=^(/A;X\_"S]AK]BWQI\./^&E?BGXG/@[Q9XF\5Z.WB+2_
MA -<55T"3S?.F\-GQ1D2,/#GB;PGXH1HY0KVXE5I&^4_C)^Q!_P5]_9=\-^/
M/VD/@G_P45^(?Q]\>VXUC4/$7PTU3PBM[I=YX8U&XBUO7-6\%>!/'_BGXL_#
M@>(G?)_X1/PGX*\'QA(Y(?!GE,Z12 ']/5?RO_\ !?K]CSX%>!?V?H?COX/T
MWP7X,^)_B#XZ:EXH\8:E>6,=_P"./BF/'#,-<T;1M:)^T'0?#3,_B@>&<&W*
M6^$6)@S7'U;_ ,$F?^"L^N_MPZ]XK^!/QV\*Z-X6^._A+1?^$FTO5] B.C^'
M?'6D^'7TG2=81=$UK6I)-)\?F:=?$3VGAQY+7[./$X-OX2/A.>*XU_\ @X/T
MJ\OOV -;O+;3[RZM] ^(O@26]U"V\?:WX>_L!9O$&AM%*?!.B(/#_C[?M94C
M\6D0>"0K>,[<,+5R #T[_@AK966J?\$L_@-I>H0V^H:=J-[\<[2XM;H9%_IS
M?&GXA1L,8Y4JP5L] V05(##\"O\ @I=^SW\'?V;_ /@KG^RGX4^!_@K1?AYX
M7\8W'[./Q UGPQH%G'IOANT\4#XS:]H!?1=#B58O#[-X<\#:&3Y:*F3A55<"
MOZ"O^"$O_*,+]GC_ +"_QD_]71X_K\9O^"T'_*93]B[_ +%G]EW_ -:;\>T
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M:<+DXM!>7BZ?N..5!9AW/? !SWX'\&G_  ;X?\I'O"W_ &2OXH?^F6OZ7/\
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MHA+")<GPKX$C\5#Q=&B:!XF5(O!*^+O&:@ _M"^%_P"V%^R?\?M>O/"/P?\
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MXH^%/AK_ (3/X<ZY<*ZZAX2\4?VYI&D>?H6JD$(TGF;9=#W;;EU$90,(MO\
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MI_P<*?#WP?X)_P""@5QJOA:$6^H?%#X)^!/B#X\87G]H@^)_[;\?^ P<9/\
MPC__ !3?@?0@2.#R0%! 'V#\.O\ @M3XR_8\_8Q_9V^'?A?]A:Z\$H/@IX8L
MOAM\2_$/B"/3OAM\3=3T4/H'B+XDOX+T+PSX3Q;^+_$6AZMXIV1>+8I0^LAF
MGD#LM?CIX&^'?[17_!6K]KOQ]>6_B3X='XW?$*PU/Q_=GQ=?2>#_  [J&DZ
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MK:+J:$^'O&N@^!-9T0#P^Q:/7HYM=6;"L=H0A>N1^P-?QS?\$,O^4K_[9O\
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M R"2)XY@RL)$*RP"-B_Z%?LF_LO_  Z_8:_9C_:'@^ /C*/Q!X?\;>*?C?\
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MQ3XTTGQCH^F:?X236-?=-:76=#60^)X[=- C(A\2 -;GQ9K_ (<A>!Q([5^
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M3:T:*9 8S]PIT/U_H*BJQ0 4444 %%%% !1110 4444 %%%% !1110 4444
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M^#?BEK.JAO$>FZ=X$^*^M#Q_X"+:SH&W^PD_X20>!O,\1R Q^$$+0S(\;NA
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M!_9=\/:/\4O%>E3!M-\7^/-%TG1$\<:YHRIX?\+*T/BS78M5EML^&/"<@6[
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M:HH\1^.-9;1'+Y\/(%3PFJD>"CX5_P"$17P:#Y9CDW[:]7_X(K? #XI>,_\
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M:YX:-]\& GAW42NH^'E7Q!I?Q8BU^9=$8[?+\2_V.))D9'5U4(58?NW^0/\
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MOVY="T2[_8:_:MT*_P!&T^?1K+]F7XRWEMIEY:HFEVDF@_#7Q%K&@L\"]/\
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M_)"OC/\ ]DK^)W_J&:]0!_-!_P &P/\ R!OVUO\ L,_LZ?\ HOXP5\2?L/\
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MSPDB?\(]J'B7^QH_[<UI2NA>& 5EE+@DV\;L B,NZ-)&_F\_X.:-2L-8UO\
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M&F^'='U?X2ZN!_Q(=;;X<^+0?$OB[Q$J^)D\*MX1\8@85 P11C[F_P"#8/\
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M\/F&X+LV>3*=S<$4 =]7YM?\%=_^4;'[6_\ V3A?_4P\.U^DM?FU_P %=_\
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MC-X<T">#_@KO\2=/M[G1M+^QVG_#,?PR_P!!_P")-T^;Q,#VW<\>G/%? ?\
MP<C?LM:IK?A3X3_M;>$_#MM=6_@R];X9_%_5=*TC5-3U7^R->=AX!UW6]<A)
M7P_X8\+^(5USPS"Q^9O&'C[PL7PX<#,_X)C?\%PO@%\,OV>/!/P*_:KU_P 6
M>$/$GPQ\-/HNB^.8/!^O>*=*USPWH8C7P_HNSP[-XJ\3_P!MCP[&KR^(/%#1
M+.R@LZ,6=@#U^7_@WZ\9ZE\;[3]H/Q?_ ,% ?&?BKXFQ^.;#Q_JWB:X^"1TW
M5;W4K;6AK1C@U2+XT.^AJN-H6- 53:%0E@M>(?\ !T-T_8>^G[4'\O@+7U[;
M?\%%M:_X*$?M2_!_X&?L/M\5Q\&/ 7C'3_&7[3/QDTBT_P"$'TO4? 4FCQMH
MFE:3K6N+'XBT*:3Q)#K7AZ3PUY"_\)6#*J,(E>1_D+_@Z&Z?L/?3]J#^7P%H
M _<[_@F#=Z%>_L"_LNW'AC2M2T;P[<?"W3&TG2=3UAM?U"QB.J:PKQSZV-"\
M,_:9#.)F27[+!Y<;)"L19#<7/\S/_!:OQ_??%S_@II\-/V=_B;\3C\+_ (/^
M K;X:6-IXUM/#NK^)E\&GQUI>AZ_KWBW6/!*>((5\0ZW;_VX8+?,2,((XPXW
MAB?Z+_\ @D%XF\.^)?\ @G9^S OAK6M.UAO#O@,>&O$;:9>+J(TCQ/H>KNNN
M:+K+H[/_ &_"\G[T,@9<AU!#H7_GU_X.'_V2/B+X5^/NC_MD>'+'6]9\ ^,-
M&\+>&/%^O6UJ&T_P)XET(#0-!TCEBQ'BT_*6.<.&&3P2 ?L9#_P3G_X* 0>)
M-0\51?\ !7WXG+XDU71-*\/W5V/V;O!C:<VG:%K&OZQHI70?^%C#P^6C37M8
MB9S"I"2HF,DHOA/[./\ P0EO/@'^U/X&_:HO?VQO%WB_Q/X:\7^)?&6LV.F_
M!_1O!&J^*]4\1:;KEMKQ?6W^(_BN'0H_%C:^[>,]GA9C>I&PLAX5# UPW[%G
M_!?[]FR]^#OA'PG^U9>^-/ OQ0\!>$?#&D^(/&L^@:YXXTWXCZOHS7.A3:TD
MNBI=^)H]>DCTO1=>\:KXG@C:'Q3XB>&)_+$,<79?L^_MR>*_^"GG_!0CX0ZE
M\"]$\9>"/V7?V0M$^*?C[XBZWXB76WL/B5XW\<Z/KOPC\ ($T&5O#^B^(1X?
MU[5O$G@J+Q.^9_"<GQ-*(LGA<  'Y8_\''NM6]]^UY\/M$7XGW'B:;0OA4#=
M?#1?#G]G#X;+KV<,->.?^$B'BT?\53NR1X,_L ,#@@5_8;^T-XKUCP3\"_BQ
MXOT:PBOM7\/_  Z\4:A8VMVGBW;-?QZ.#&KGP#X;\;^*E^9R?^*7\(^)KCS(
MB4B4+*:_D!_X.1H?B,/VK?AA-XCTO1K?X<?\*NE/PWU>V_LG^U+YFD=O':ZW
MO ;8OB0Z&L9Q@Q!2AV%:_IU^%_[<W[./[5_BMO@Y\#?%MU\1HO&'P3;XA7OC
M'PE9_P!O^&O"FG:])J_A\>#_ !NT3,? 'C]%A:=O"GB^/PS=NI"1[I%^SR '
M\\?_  ;36G@G7?C7^U3XR\4WNF:G\8;3P?X"_P"$0U;5M7)\37VDZ[KGCW_A
M;14!6/B)QX@T/P0?&GB;:VY_^$67!!K^OW5=+T[7-/N](U6PM-1TS4K22SU/
M3M3LHK^PO=/>)EDT[4HY?-C8$3.3OWK@DLLI/S?PP_L^Z-KG_!''_@K=I/@7
MXJ^*K?2OA?>V#>%M9^)OB'PWJQT[Q5\'/'BG7=#\9Z&?G0NOB30]$\+>./%7
MSI_PFWA_Q/\ >%?V!_%[]L/]G_X0? ;4/VD]<^*7P^U+X<S>'M;U7P'K.E^.
M?"1TKXJ:EHFAZ]XAMO"'@/7Y?$:>&_$WB'Q;%X?U6+PFD%QY;S%@=I63 !_(
ME_P11U+QU\*O^"J>M?"RVU6WTVPURT^,7AKQYI/AW6-&\2>&=>_L#2-=\0:&
M?[<T";Q-X7 'B+0B?^*4F48&2&'R-_=&G0_7^@K^8+_@A3^R3XMUGQ=\4?\
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M ,((/V*M#'B3Q9XCT3Q8?BCX5_X5QX:TN[U06'CO6 [C7-,UL1Y+1^&O#/\
M;?B53(4:/[, %<R.4^=/^";7[,GQ+_:J_;^\<?\ !5[Q+I0^&_PJN/%WCF[^
M#NCK8:N=0^*BZWX)\0_":/7=)BUUH]OA0^'-7;Q,WB9-OF>,@T,0R?&8%'_@
MXF^,W[//CCX)^ OAOH?Q;\.>)OC'\/OC7J(O? /@KQ)X,\1ZOX3U$:/+HFLQ
M^.M 7Q!%XE\.K!YK1QG8)#XO"+*6="2 ?I3_ ,$)?^487[/'_87^,G_JZ/']
M?C-_P6@_Y3*?L7?]BS^R[_ZTWX]K]3O^"*'[4/PM\1?L)? ?X;^(OCCX%U'X
MO^#?#/Q-BUCX?7/C/1_^$XT#P)X(\;>(ET#^V/#Q9O$6@Z)X3^'Q\.J'FA6.
M-"S-*5#(/PH_X*R_M4? +XG?\%3/V?/BW\.OB+HOC[X<_!O1?@-9>,?&WA3_
M (J7PT-5\"_&?7_'NNC1-<\/N_\ PD!_X1W7=$&?";OD_P 3=2 ?L[_P<4_$
MSQ'X(_85TKP1I,6FMHWQD^,?ACP3XN-U;%M4_LO0$UOXK:)_8PSM,@\3>!-$
M!/)7ID$N#\7?\$B?^">OP:_:@_8[\*^/=:_:(_:@\)^+K;Q?XZT;Q+X+^#_Q
M\_X1CPOX?']LR?V)CP2OAF0Z"_BOP\(?$^QD0$2ET=S&Z+^UO[3WPV^&'_!4
M#]B/XD?#WX+_ !9\&>(=&^(5MIC>$?B)X<O]*\3Z7X=\>>"]>\/>/=$T377T
MF>6;0A]HT?2_#?C&"$IXKM+'6W0)&8X(Y_Y!/V'/VV_V@O\ @DK\=]?\!_%3
MX<^-=.^'^NW6EWGQ1^$'BO2-9\-^* K%'T/QGH.C:]R-??PZB%E!VN%7<& Q
M0!_2#XO_ ."!_P"QAXEAO]5\??%_]K+78K:Y;6]7U+Q7\;M#U+?(FAZ'H+ZK
MK,FO?#QTW1Z!X>T1)&8*BC18QN+JRM^3W_!>[PW\+_AA\"_^"=/PK_9^\1VF
MI_ G0?#OQX_X0\^&_%K>(?#&OC0M9^$ _MK^VM"9_#/B'Q$#KFNJ"2-PUWQ,
M0 *^HO'_ /P6,\>?\%"+%/V1/V%O@-\1]'^(WQ@TG5M$U_QQXRU?0],;X9>'
M+B30E'C0'P]_PED?_"/8DUJV\7)XICC>-&:(-)YN*]W_ ."B7_!*K5_$_P#P
M3<^!/P7^ 7A;3?%?Q9_92N!JVBC=->^)_%?AG7/#_B!?BMX-\'NR$D>,/$FJ
MZ-XDBT"7RH)/^$?MK6$O,4,P!^Q/[(7CKP?\3OV7?@3X^^'6A7OAOP-XI^%?
MA?4/#>@7FFZ/I5]8Z:^CQJD?]C:"[^'XF+*-J0*(CU9=T@2IO%GP*_9N3XI:
M=^U-X[\ ^ K3XH^"-$.EV'Q9\2AM-D\/:9*5D#2:K<R)H,2*TFT^('0/ &6%
M7CVJJ_QZ_P#!,?\ X+)W/["?P^U_X!?&WX>>+/&?@+2M7U;5O"'_  BPTNP\
M:^$_$DFMJ?$.B:[#KEQ IT$[%"2L6>(%Q'@2N&^YOA_\?OVD?^"W/QWT/PYH
M_@C5?A3^PA\'_'\&K_$GR]1UG3]4\=?V)K:ZSH&A:UK4,9D'CT:%)HT[^&O#
M;R);":XFEGBMD)B #_@Z!_Y /[%__89^.W_H/PBK^E_]GK_D@/P/_P"R0_#+
M_P!0O0J_G1_X.:OA_P"*=8^%/[,7Q,L+'[1X0\!>+?B;X9\2ZI]J8C3]4\>Z
M1X'?06&DD!90_P#PA&N9521&5)/+X/U1_P $_?\ @JSX._:1N/V0?V<_AUX&
MU_7_ (DW/@368_VB[G1[#7T\)_ OPK\,_ VL0Z%JTVKG0DB\03>+?%D?@3PS
M;S0>1X3B?Q 5AFC^U^&5N@#P+_@YM_Y-O_9S_P"RWZI_Z@^MU^S_ .P-_P F
M+_L6_P#9I?[.7_JFO#E?S/?\'!?[</[/OQVT?X4_ /X,>.=+^).L^!O%^I?$
M#QAXL\#ZKI/B+P3I^-&?0SHC:]H,TP;Q"&D8HHP$!*Y(V[?WL_X);?M#?!'X
MT?L;?LW^$?AE\2?#OBSQ=\*/V>O@YX*^(W@NRUACXL\(ZWX(\(:#X'UX:_H#
M,VNZ,/[?T#6([5[F%5\2K&S>;*DKB( _#G_@X?\ V=_%WPW^,/P&_;I^&TT6
MF6TJZ3\._$FK:=IFCV<GA/XG^!=7UWQ_X$\9O*\LS^)?$OBM)-89Y&\)R?\
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MQ.PEE8-EM[_?4 1/_()_P0S^"W[+7[5?QI^/7@?]JKP9IOQ;\=ZKX:\,^,_
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MB$?R9? 7]B#_ (+.?L__ !-\<?"?]GWP;\:OA3J^J65CK?B3Q!X:\2:-X?\
MA)KYM](;6M)0?$] ?AKXA\30S:R\4L0\6F6.96B=!("M?TZ?\$WOV"/&_P"S
MU<^+OC[^U/XBT_XQ_M?_ !/BTVTU7XG3ZGKWB/4O#'@6/1M#9?!D<OB!4B@U
MP>(H=9/C"?PP_P!EOX]'\,B$LD9+ '\;7_!5;_E(E^V#_P!E?\4_TK^T'_@C
M-H>L>&?^"=/[/-CKOC31/&-UJ.D:EX@L[W0_$,FO)HVF>(M>U77M"\%:Q));
ME-%\2^$/#MU;^%/%GA:&25?"5WHDUF LT<IC_B^_X*K?\I$OVP?^RO\ BG^E
M?K3^RCX*_P""V7[-'[&7@GQ#^S+H7ASQK\$_&_A+4?BUI'A*W3PCXQ\<^%M+
M\;1KXC0Z#HC^(T\376N>*/M(\4CPSX0\Z&.Y\0,NY+F%A& ?A?\ MJ?\GA_M
M8?\ 9SGQY_\ 5G:_7[P_\%[/ OBJ]_9K_P""<OQ,AT=IO!'A_P"&)^'VL>(#
M<Z4HT_Q/X[\%> ->T'1UT9L^(Y1)X<\#>.)28<*AT,I(HF61FT/^"=/_  1E
M_:4\0?M):1^TS^W%X=M]&\,6=V_Q<;PYXSNM(\4^*/B3X]\<1CQ#L\<Z#&&;
M09?"WB$KXI\90>*0UQ-XT),4;A'*_P!.7[5_[,G@3]K+X ^/OV?/'GVG3O#'
MC32M*L+?4M)$<>J>%M3T76H->T+6](<H6$MOKFB:/(D:X,J1[20,$ 'X2?\
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M]QJ^M0B/Q/XND8R"(.@W1D@'D/\ P1V_Y34?MG_]@K]K'_UH7P#7]C-?RR?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPUXFOM+BU)A\3M9TD1K\2?&2+L_X2'7'UU=)N[L3+)--%I1MQ))"BQ1?7E%
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M#E\M] \.:'XB(6/QI#X:M[4^*6:Y-RVZ55M_U3HH _G%U;_@W.^!'B#Q??\
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MJ8KPZ1X4T?2]*%_?II5II+:UK(B0?VSX@:/2-(CFUZY#SW8B@21WBC)/MU%
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M[HWU]I7@#PEHG@O3M0U)RA.IRP^'(+>)BR_*&:-I%&?FY.X ]-HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 45PWC;Q;;^!?"FL>*+W2/%FO0:)8I>
M3:/X)\.ZSXU\2WVT+F/1O#^@PS:[K,N2V8XHV9P"<?*P7^>#5?\ @N]X^F_;
M4^&W[+FC_LLZEX,TKQ1\8/AE\)?$C?&*ZU?PQ\2M /C[QIH>@G64\/@,NQ?#
MGB#1O$T:2>:0IQ(\C99@#^EBBBB@ HHHH **** "BBB@ HHHH **** "BHHY
M5FC$D?(89&>/\_6I: "BBB@ HHHH **J>?#YOV?SK?SL9^SY7.<=?[WX[?PJ
MW0 4444 %%%% !117&-XH\.Q^)[3P1=:W8)XOU'1=4\367APW*KK%WX=T35=
M$T/6];72%WM_8L6L:YH=O)/(Y5SK**CJQ<4 =G17PQ^VC\;?VH?@Q\.]>\2_
MLV_LX#X[:OI/AV77KNXN_&>CV%E8IHTTAU/2O^$-BE'B7Q#J\L*.R1>&8I Q
M**762 H?S-_X(@_\%"OVEOVZ/$/[1UC^T+XC\.:Y#\.-'^&%WX770/"FC^&_
MLTFOZMX_BUQ9#H;XG8IH>A@>:7; XZ<@']#-%%% !1110 4444 %%>3_ !7D
M^+=CX/OKGX*:?X#U/QS;LHL],^(%WK]CX:N[$L[2Q[] 7S$U4D+Y3$+%C<'9
M5=%K^9?XP_\ !=W]L[X'?''5_P!G'QQ^QY\)E^,/A_6O#?ARZ\+>'?'?B[Q,
MUYK/B+1-#UW1M+T Z$CC79"OB#2%)0*-LTBX ;% ']8%%?,G[-GB7]I+Q?X!
MM?$7[2G@SX=?#KQ/KMOIE_9>#?A_JFO:IJ/AZ.2WDDU;1?&,VN1K;R:Y'(R%
M6\.&2%5WJ\HD5:^FZ "BBB@ HHK\@_\ @JA\>_V]OV?/AOK7CW]E#P)\-W^'
M?@SP8GC;XE?%?Q5K6CWWB;PE'I&M/_;FE:+X#UIE3Q")]!72Y5E*D[S(%8-&
M0H!^OE%?A)_P0D_:<^//[3_[/GQR\;?'?6_$_CG48OVB?%)TGQGJ.L:;?Z9
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M#6OR:+<-&8M5T=/$&DW,<&N0F2*Y )20#>$]LH **** "BBB@ HHHH ****
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M -I#Q3J]E;ZCXFT+X<^%!H_B"ZQ_:=E_;VO:Z-<C.<@B0XC;/!5CGJ37]FE
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M]=T+6-.\9CX9^%=.TGP_X7U/QQH8++XQUO5MSW,TO]O;?$LD913))O"C&$H
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MN:)-;/X?FVREHE\M"DHDC /YVO\ @H-_P5'_ ."J_P %OC]X7\+>/?#OA_\
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MP=X0^^OA_P#\$D]=_;+^%'PV\=_MT?M/_$[Q+;ZK\+O@U>?#GX.? >^;P/\
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ML]<U+6_ -K^T'^R_XF^$-IJWB+6?$6I>$OACKGQHT#^P_!:J?#KX'_"2C7<
M.PZ89A\Q /[R;W4;+2[";5-5N[?3K"UM!=7EY=W2V-A:(JY)>1V4*,YR7//
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MLZO%'IU[I^U0DVD,-QUH.^K:5&!:QRJXF\P?*-U?QT_\%YOV'K+]G;6/A/\
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M2+]I;]IWXZ^)O"GP"\$>,/@3I'@'P&_B*]U9&U/3O#WC;0)-";7\1,@\12:
M-TGEQKP24 X4_P!6'@WQEX9^(7A3PO\ $'P7K-GXA\(>,O#VD^)_#7B#3)!+
MIVL^&M=TN/6-%UF-MO\ JYX9$>(X21?,(D1"WEK_ !<_\$'_ (#?"#XE_MO?
MM$Z?\0OAUX4\:V'PZ\!^*+WP?I/BJU_X2#3-!U,>,]!T/:VC^( [ZXK^'=;\
MMI/%$;RH&)C"L!(G[R_\%>/VT8_V$/V4-+T7X<>'-0T#Q[\5M.U7X6?"&\\*
MG1_#7AWX9?V+HB2-JJ1M%)$J>%_#I#^#_#5IX:D1I;>&%IO"ZP*Z 'V5\6_V
M]_V-O@3XG;P3\7/VC/AQX%\4O8KK7]@ZKJY&K-IC:OK>@>8(]&69U/\ ;N@Z
MS%(LX23?&^Z/#*YZOX'?MB_LP?M'7=[9?!'XV> ?B5J.F!5OK+PUK*2:BC;]
M<3G27V3L&.B:Q(7$9"K S/@A,_E__P $BO\ @G[\(O!O[(O@WXM_&WX1Z)XZ
M^.G[0[?\+.\?^(?C#9Z%\2=5.FZWK>KR^!VT<^(EE7P[#XH\+'1O$T\3+'XY
MD\6>)9I_&[0S6MOX0\)?D'_P67_8XG_X)^_&[X-?MB?L@V]Y\'/"^MZX;#/A
M5"H\"_&/1$UWQ#E/^$A\1>*SXA7XJ^''UR)_"Q\&_P#"&)+X<DB<F3Q6Q(!_
M:_17R[^R-\>[#]IK]FOX1?'&R@L-/F^(O@C2M9U31M*\00>)$T#Q T.W6=#;
M6(BAEU6WE=T*N$E5E!?**LLOU%0!Y=\3?B?X ^#/@;Q!\4/B?XHTOP;X%\+6
MUC/XG\5ZHVS2=-$NKIH\+W#!6>/.MZI;H&$;'?(JXY)'\PW[(O\ P5D^%_Q9
M_P""E/QT^-_Q_P#B-HOP=^$-C\"=3^%'P>TWQ#XEU;4O#A?_ (6/X$U=GT8-
M&\4OB3QA#HS>(G7PO&5V:&Q4!UCQ_4YXE\+^&_&6CWOAOQ7X;T/Q;H&I*!J?
MA_Q#I.E:_H]\CHNW^UM'UR*2"8  %8V5^1D@8P?XV/\ @AE\,OAIXZ_;Z_:[
M\.^-? '@?QKH.E^ O'E[HOA_Q=X2T?Q!I6G_ /%Z?#_.BZ/X@BF$:X!RQB8#
M/0<$ ']>ND_$CP/\5/A)=?$#X<^*-%\9^!_$_@_5-8\.>(=!NDU+3-2TPZ0Q
M5T=2<AB3E#AAN&]58_-_*7_P;2^)M$\'7W[;WBCQ3JEAHF@:)X1^#6L:OJ^I
MW0T_3=-TO^V?B\V]]PVJH"\LW\155R[*#_4WXG\!0>#_ (.>-_!_P:TSP+\+
M@GA+Q4OAN&S\"0R^#=$OY-(!359/!/AW7O!(UA0P*O%%XL\*M(1&6N5V,[?Q
MG_\ !"/]EC1?VI?%G[1/AKXE^+O$T7P1\/Z3\+=;^)'P8\. :;IGQKU)3X^;
MP2/'&OZ')#XBB\/>%(UU_9X:\-S10>,I/$">8X'A( @']8_P[_X*/_L-_%GQ
MGH'P[^'/[2_PN\6>-_$]TUEX>\-:?K)DU74=056(BB1HU#,WW0/EZX!P0*^X
MJ_CX_P""\?["OP-_9O\ AK\$?VH_V>/#^F?"#Q!:_&'2OAEXCTOPG#KNBG7=
M5/@K7]>\$>,/[7D\0AO#G_"'-\*L,GA7PG+-XLD\0OXNG=Y;=II_V<\<?M]R
M?#S_ ()6:9^W"?"EU:^)M7^"GAF_\(^%I;C_ (333]-\=^-C%X(\#1^(KH/X
M4DUO1#XIN]'F\6F,V\D<<DS0*K1K<4 ?1G[0/[?O[*/[,L]_I'Q,^+&B+XVM
M](U37+/X?:!N\1^.M>.CM_9<VD:)H6B%Y3KSS%8C;R"%UQ("!&(]OG_[+'_!
M47]CG]KRZN])^%OQ*M]+\56<^H+'X)^(%JW@WQ5?:;#_ &+)_;FD13NR2Z"?
M[9MT2=7>:65QN2)(_,;^>#_@E3^T%^S%\"OA1/\ %KXD_L>?MF_M'_M$_$7Q
M1XBUSQA\</#_ ,"=*^-?A@JGB#7&T8>"/'&N>)HV/B(Q*P\:*6/C!_&Q\3+*
MC1!T?Q?_ (*F:CX5_:A\2_!'QQ^QS^P=^T_\%?%O@.R\2V/CG4[O]F'6?AQ)
M?:<FN:+KO@B31M)^'W_"51OX@\,:_P#\)BP\2+;H8)->F_?3I)&(0#^Z:BOC
MG]A#QM\2_B-^R%\ _%_Q?T.Z\-_$_5? &E_\)EHMUH>L>'=0L-8T7S=$(UC1
MO$++K\5Q*VE!W$X+S!U)&P[A]C4 %?P/?MZ_\IW]7_[.G_9?_P#3'\(Z_OAK
M^![]O7_E._J__9T_[+__ *8_A'0!_>%K>NZ3X:T^XU;6]2T_1])LUS>:GJEY
M'I^GV@S@ O*RIS[NH.#\W:OBGX:_\%'_ -C+XN_$FY^%?PY^.O@_Q;XAL_"F
MK^-KF\TZ[B7P[_8^AX&L%=99%A62*+_B>'DEH%W^<&Q%7N7Q]_9N^#G[4/@F
M/X<?'3PE+X\\$_VOIVKOX;;Q'XM\/:?>:KH^3!-JO_"-^(O#CZVD3;Q$EP'B
M"[LQ%0:_BL_8^_8R^#WB#_@L!\4?V3M;F\:ZG\&/ 7B_X[>&?[('B1[#4O%G
MA;P.=>SX,\:ZUX;4R3>'_%:MGQG%&O@YYVVQKM9P0 ?TD77_  7$_P"">-G\
M4?\ A57_  MW4Y8?M=E9?\+-M/#S/\,AYNB?VZN=>^6<J3CP_($\,*ZW *K,
MX"R+^L?A7Q;X<\;^'=*\7>$-<T_Q#X7URS75-'U_2KH7VFZCIS\K+#*&PRL"
M0-O*E&!"LI6OY<_^"]/[#/[,WPE_95^'/QE^%?PWLOA]XQ^'GB3P1\'-(_X1
M1/[(TC5O 6MZ9X@2-?&RS%KGQ#K_ (;.B2F'Q:SR^+)!J\K>-#XM@\J*OO[_
M ((N_&V/_AV!X0\0^/?#VJ_#+P=\"$^)>BW/B35QJ.J0^(?!7@IIO&^M?$K1
MQ)HB73^'(6US6=!2.V7Q,Q/AQ_*N9I)'A0 _17]IK]KGX _LB^"O^$X^.WCO
M3?"5C<V^JC1=)=C?>)O%.HZ'I UF71/#>BH7?6M>,*!X(DV@DHID )=?QF_:
MQ_X*X?L:_M/_ +,7QS^ ?AWQ+XS^&_B_XM_!/Q2? 'B#XQ> -;\$^"-;+X.C
M_P#$^9V!5W 8(JJ%.<ER<U\&?L)ZE:_\%9O^"JGCWXW?'2X_X2/X9_!'2-1\
M?_#;X.^*4'C3PL-*76AH?@C1#D>%4@B\*^(-9T;Q,7;P>Q\8C0<>.M\IC1OW
M#_X*Q_ /X(^)?V!?CMJVK_"KP5+K'PH^#.HW?PVU2UT#2M-U/P*V@1B31-&T
M+5]&CC?0?#L>60^'%V>$) 0MQ"1%&R@'P9_P;Y_$;PW\)O\ @F[\?OB+XPDO
M+?PSX0_::\>:UK+V5F]]J02/X,? ,8T?2%P3_K"8HLDL=YP$WLOVM\-/^"U?
M[$?Q>^,'@SX#:9J?Q,\(^.O'7B:V\*Z2GQ$^'0\-Z4GB+6F']B:1JTLFM7!C
MG\0N5T2T_<XFN=4MDD>W6226+XV_X-JT\1K^Q_\ &B^GU33I_"U[^TQXAL=(
MT%])N/\ A(K+Q+_PK;X3IKNIZQKC>(4M-:T>70I/#:6_A=/#<%SX1ET/Q)(_
MC?QK'XABA\*?#W_!3G2-+TC_ (+L?LC7.EZ9IVGG5?&/['.MZP;6T33A?ZH?
MC6Q&LZR45 VOJ/EC8J':,*TF9-Q(!_3;^US^V5\*/V,/!^@^/?C#I/Q O_#^
MNZOJ&DB]^'_A"3QE_9Z:3I#:W-JNOK#,/[#T1(HSMG=VVRNCKG!W>=?L;_\
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M#PAXH\<_!*+QS_PCWAG6SX;U"]\;>$9/#,=[J:QR.?[%+R2?VQ%A<,R,@R0
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M^M!/$EO%H;>$_#<GQ7\,(8O#'BGPGXS7Q_XF,'BR9O!@60 _6*BBB@#\EO\
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M9W_P2U/QWIIO=.FMXSJ__"/ZMXR3PZ8X-:30HO,DSX7<),&MY 9)%=?X[/\
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MB'3_  -XZ\<_9?#>AV._5-=\3:_^S'KW@3P3H.B@-C?XM\0:[HJ9W,%8Y(<
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M9C_@VSUCX9:]XU_:OUS5?[//Q_UU])URU^PG6E8?"_6M;+ZT005\,8_X2==
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MG76UIE\M==\0[3IBR^)&$WGQD$RJBM&MO_@LA\)O^%O?\$Z_VAK!?$4OAM/
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M^+_$,3Z\ND>+XM)<&/PWXB\7Z#Y,5UX6 E?R/ ;1_P#":QO+%<1=S_P;?_\
M"N_^&3OBQ_PB_P#PE_\ PF?_  M9/^%E_P!J?V-_PC/]J_V*_P#87_"$8_TC
M?_PCWE_\)9_PD'^D?:_*Q\N:];_X.*O^4?-M_P!EU^&'_IF\>4 ?EQ^S#I__
M  3$_:3\(:A^T%_P4U_:CM?BY\>_BAK6J7L/P_\ &WQ@^,.F#X">$EUG7H]!
M^%V@#0/%47BA=!#Z^DP(\6RQFWM] CPLS^*P_P "?M9^(_@[^P]^TSX>^*G_
M  2R_:MU$>$/%%D-;O?#G@CQ+K.J#PA_8.MZ!X@'@OQNWB #_A8'P\\5$<>&
M/%?_  F)#<^/#D U_1%_P13T?]DKX[?L(_#^TN_@U\(_%7Q$^$^H^(/ WQ%O
MO%_PY^'%_P"(KS5YM?UW6?#^LR,9?%?B270;C0]<AM;77O$H,TEQHGB*/YE\
M.RF/]2O'OP/_ &-?AIX&\7?$;QG\!O@#HW@OP'X>UGQAXNUVX^"G@B\31_#G
MA_1I=8\0ZN_]C>&9)@L.@0RR,\*%MD995G ,;@'\^W_!9_0_&O[1'["_P@_;
MGTCXW?%SPY\./''AKX.:W>_LO7FL*WPQL&\=Z*GB+1=89O#A\)#6_$OA+Q%)
M&X\1^,!XLS&P^SIX/BC;R_FC_@F!^QA\9_\ @IE^S+I_P[^-_P"T)XO\)_L9
M?L[^,/$WA;X;_##X>GP?I?B/4OBCKA'CO7-9UQSX:,&N:%X6_P"$["1GQ@?%
MIF?7_$<7@)_!H1=GZL?\%K?$/P]\6_\ !)33/%/PI.CW7PUU_7O@3K7P\_X1
MW2_["T;_ (0?7)$;0VT?2O)@.@Z"_AR3,*"&&..%76.*.,*M>I?\$$?$7AO5
M?^";WPUL="\&ZMX:U+PMX[^*.D>,=9U+PW_PC>G^//$@\83:X?&F@ZQN4^*?
M#X\/:]H/A-/$NV4)/X(U_P %&-O^$1 H _FF_;Y_8J^+'_!(?]HWX4?$WX$_
M$OQ(WAW5KS5O$?PC^)3*VG>-=$U30AC7_!7C;^PT3PQ-"W]O860*8_'/@@^)
M_ X\#E37]4/AW_@IYX.T7_@FCX;_ &[_ !U;V?BG5(/"&C6WC'PEX"/V"R?X
MN:E+#H4W@Q3X@<3:*&\1RQP/)+(PA,RLP?>(Y/C[_@Y:_P"3)OA%_P!G4>%O
M_5-?&2ORQ^)'PS^.OA3_ (-]OA==P7$'A+P3>?&D_$/QWX=N[G1_[0\=^ ?&
M_C95^%1T20+M#'Q')H'BC8S^#BP4LBD+(0 ???\ P3#_ &8/!7_!23Q%\5O^
M"C/[<GPHTGQYXU\>?%'[#\*/#FJ6BQ?!]/#/@C28_#D,:^!E&WQZ/#$FCGPJ
MK?%<^,,-X>PBL2=O@_\ P5G_ ."="_L3:E\/?V[_ -@70]<^$,7@7Q/JVK_%
M-/"_B/68].\"ZOK6LEM%\9:!H)=O["\.^*1K>O>&/&WAA2W@B2-?#'@Z+P0]
MMXR\72O^GW_! GQUX5\2_P#!.3X:>%M$UF#4-?\ AUXQ^)NB>+M*%GJ!'A[5
M==\;Z_X[T32,SINS-X;U_0M=RC,V+G"HK'>OO_\ P69_Y1E_M7_]B?X4_P#5
MG>!J /GK]F;X@^*/^"O?[#W@;Q5J7QG^-G[*OQ%\&?$?4[#QOK_[,'Q,/@?7
MO$VJ:#H=UH0&K>5!,\/AOQ2=>3Q'+X9=$B@\4Z"I1V6 PM_*)_P3<^!'C#]I
MO]K*X_9ATOXS_$CX3^!_B;H_CVT^+]WX'\1:S8:KXZ\!Z$IUS7O!FM* ?#7B
M%O%B,W'BD>,O!Q4E55VPI_?S_@V;\"^*]&^"?[2GC_4]+FMO"'COQ]X#TCPA
MJK7.ER'7-1\"Z)X@37V7R_NG&OZ(!O&ULGD8-?EM_P $'M(BNO\ @I39:O+K
MVDV=SH/A'XP?9/#<K:TNKZZ->TK7<R:$5T"/PYMB7,L@\3MX1G:-&6"&XF,<
M$@!^IO@3_@VW^#'AOX\KXG\9_%KQ/\1_V>]-LY/LOPPU:T_X1[QMK6IQZ7"H
M3Q#X\\,CPKMT1]<GUJX2'PDOA %$\.CS-D9DK\<?A!^R/^RMXO\ ^"S$'[)>
MF?:?B=^S,/B-X\\-/:7WB76-,U2]&@_##7]?.BMKOAX^$O$H'A'XBZ'_ ,(N
MQ#%1_P (^2"1R?\ 0*K^"#_@GC_RG7\/_P#9R/[4'_J%?%^@#^JSXK>#/A9_
MP36_X)__ +0B?LV:;-\)M.\!_#OXG>-/ K7%YJ_Q%&F?$[6]$N3H$SR_$";Q
M:'BD\30Z GD^(R_A13-$+F);:68I^+/_  1;^#__  3:_:3_ &4O$_PD^+GP
MS^$_B[]H;4/$GB?_ (63<^-]+T9/B1>Z3X@UIE\$R_"[QL7B\2:"L?ALZ!([
M?"QO">SQA')Y,:R$F3^H;XK:]X \*?#+X@^)OB=_9=M\-/#/@_Q/K?Q";Q!I
M;:WH[^#-#T>XF\1MK.B^3.=;T;^P4N'N86CG!C"K-'(#)&/Y-/VVO^"&OC+P
M=>_\-,?\$W_&-WXS\-:YK6E^,?#7PT\,:U#IOB?P3I>MLNM+X@^%7Q4B\2A/
M$'AR5F4!=D7C;_A#G"GQGXO)4$ _2#]@3_@E?:_L9_\ !0#]IWXG:!'XFM/@
MNG@?PS9?L_7-QK-KJVG:GI'Q.N?[:^(/@;7?,$_B :Y\+?$?@/1H/!WF&)XO
M _B+PXKS>)+A#+;_ +_5_(Q_P1S_ ."M?QTUKXS:#^Q/^U4OB+X@W_B>Z?PS
M\.?&NLV*:=XW\"^)O VA[)/!7CH.RIXA\/-%H;1_\)7(W_"8KXS/S#QFOBPC
MP=_7/0 5_-[_ ,%]_!7[9WQ<\*_!_P"$/P0^'3>-O@KXU\0:6GB.R\*Z4^J>
M-[_XF1-KW]B:/JH<JNA>&6\/RJSW*(&F5_$"RL1%"D?](5?S[?\ !8G_ (*@
M>+_V4[CP]^S/^SE;V=[^T/\ $>VT?4KOQJ;[2=63X:V&L:Z=$\.:0NBO(R-X
M^\38C>UC\3Q6T,?A)7NX[?Q;))&D !U7BO\ X)_?L._#;_@G(WA7XB?LW_ [
MP;\3K+]E[4-;OM?\0:3X5TGXO_\ "T-(\#)XVUR5/BM/)'\17UR#XADM/:1>
M,'0E6\(H3X0*V[?)?_!LQXC\1WOPM_:F\-ZAK^L77AO0O&_PTN_#WAB]U;4V
MTS0M3U_1_&_]NW6B:+,Z_P#"/Q>(ET/11(BA@XT9=PRJAO2H?^"0^B']G;XH
M?'7]N#XK_%G]J+X[6GP8^)_C_2O"OC;Q/K/AWP)\)/$NO^#-#\<ZUI&@:'X=
M\1>,"WB3PGXIT 12^)?"OB^/P9XO;>[>"#&BM+Y!_P &P?\ R(?[8/\ V.'P
M;_\ 3-X_H _,O_@NK^R_H?[.'[0'PGGTKXA?%SXF:O\ $3X6OJWB_P 4_&7Q
MWJWQ&\37^I>']<_X1]'37-<9D\N1 KQ^%0P958)X&2.59(T_9']C?_@C+\"?
MC3^S)\%/BG^UEXZ^+W[1WBSQY\ OAG=_#ZTUWXD^---\,? OP+K^A_\ "1^"
M_!_PQT+^WX_+\/>%M&U[283X7\3"Z\&/)H22GP29'DB7X3_X.<?^3@?V9_\
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M?Q6NA:$LDBG;(X+A5#;!_29_P4-_8_\ V??CY^PSKWQE^*O@2X\1_$?]G_\
M8W^(/B3X5^(5\9>,-.&@ZKH7PN_X22-CH>A^)H/#7B R>(-"T<E?$L5S\P;=
M*%CD-?A)_P '!GAB?QG_ ,%)?@_X,M]6T/19_&7P)^$'AJSU;Q!=?V7X9T'_
M (2#XI?$'1/[9UW7 6&@>'QNP[9RS L<$D#^HS]KS3YM'_X)K_M.:9--;7%Q
MIO[%?QEL/M6DS&]L;TQ?!?Q%$7TAF?,D<GEY@?8 R,A4NA#* ?S0?\$(/V"?
MAW^U'8^,OBO\;=2O/'/PP^#_ ,1GT[PU\ ==\O4_AQK/CTZ%H>/''C'P_)#<
M>%/$LT?AP'PTB20R1G83(C*#&][_ (.#/V7/@_\ LV^,_P!ECXL? 7P?X<^"
MNJ>)M)\4^&K_ $'X4>&O"/PU\+VFK?"[6O#_ (DT7QO%'X&T/PU-%X^\SQY(
MD?B.20"W'AWPS!&HBB3/W/\ \&R__)L_[1/_ &7C3/\ U"] KRC_ (.@?^1:
M_8P_[#/Q[_\ 31\(Z /U1_98_P""</[)-E\+/"_Q(^)?PG\._M'_ !7^,/@7
MP)XP^)/Q4_:5MH/CYXY\4>))]&&M)>2:W\1!XP.B/;'67\/!/"CP0?9]&\.Y
MBN)[>'/\^/[%?ACX9_L\?\%]-?\ AQX6L+;PKX!\*_$CXZ> O!VDQ_VO?_8W
MUCP;KNC:!HBARX4-)K( #,< _>!^8?V&?L[?\F^_ C_LC_PP_P#4+T&OY$O@
MA_;'_$13\0/[%_X3;[5_PT%\8OMG_"$?\(3_ &K_ &3_ &+KW]O_ -M_\+ _
M<?\ " ;-W_"9_P#"*_\ %7?\(AM_X03_ (KG=0!^T/\ P6__ &P=3_9<_9%N
M_#'@R^U/0_B+^T#=ZI\//#NJ:1=:MIFHZ)IV(SXVUK1->T#689-#U^UAUF-;
M:832;A-/'*&:&)E^&_\ @F[\7OVBOV4OV8/ASX7\#_\ !)+XF>+?$&O>'$UG
MQ'\;/ ][\,/!E]\9M,UG7=?\=^"M8US6&\,-XF\0CPUX:\;-;^$/^$N)<1-*
MD+0/)*[>B?\ !R=\+O$'B?\ 9E^#7Q,TZ;3%\/?##XDZK:^);6ZNL:CJ!\>Z
M3HNB:+_89'WG,NBR-)WRX)&3D^G?\$(_VTO ?Q5_9-\)? CQ+XXT[3/C-\(-
M:U'P9!X<\5>,)=2\3^/O#NO+KOC7P[K^B0ZRJ+(L6W6?"DOA?PQ)XP_X0^'P
M+NGGCAU^V0 'XU_MY?LT?\% OVJ_VK%_:=^#W[ WQB_9YUH6?A:[)\.WNBCQ
M,?B!H6L;S\35UKP^WA+9XBVG1&7Q,#_PF:1Z  H"**_3[_@KC\/=*\7_ /!*
M^R_:*^+_ ,!/A?X)_:VUNS^!'_"?>*F\":*_Q,T#6)=<T#1-=\%#QT6;Q8H5
M2/"X0^+P@211&0JA4_6S]O;]L'PC^QG^SE\3/BIK&L^'E\?:/X2U(_"_P-J&
MH:0=1\6^/-2GT70/#3Q^'?\ A(O"_B+Q+X<\-^)-<T6X\<'PO<+<6W@Q=;E=
M3,B!/SZ_X+)>)O&/CG_@D'=>,?'W@EOAUXY\3W?P&U;Q-X!;6$\1MX4U/6_&
MN@OK.B?VU$L46O"/S&0;8PS +O+$;B ?(/\ P0W_ .":G[,OCC]GVS_:U^-'
MAGP7\=_%7Q&N/%?AS1_AUXU\/:1XT\%?#?1?#WC+7="F?5M!UA)]$\1^(_%9
MT9/$8\4>)+=ISX/E\*+"%9DDKY,_X+Q_L]^%OV/_ -I?]E?XZ_L^>'?AU\'K
M#7?#FJ-X;\%?#7X;^$/!6FZ'X\^!_C30/$1\9ZWHFAHOAKQ /%#>.M$B56\(
M-(J^'5$C;\U^RO\ P0#\*P>'?^"=G@O6;/PAI'AN^\:^.OBAXDN=;TK7?$.I
MW_CR;1?%_B#P=%XB\0Z'X@\/P1^ ]:5?#;>%(_#?A6;Q5:/X3\/^'O%OVU;K
MQ<\4?Y[_ /!T-_Q\_L0?]>G[1_\ Z,^ E '[R?M>ZM>:Y_P36_:;US4Y%FO]
M<_8G^,6K7ET, '4-;^"FON"JC&,/.0<<<#IFOR4_X-E_^39_VB?^R\:9_P"H
M7H%?K#^U1_RB^_:'_P"S$/BC_P"L_P"OU^3W_!LO_P FS_M$_P#9>-,_]0O0
M* ,S_@Y!\-^,/^$3_9#^+FD_#\>-O!_PE^('CZ]\8MJNCC4O#%F=;7X?KH6C
M>. "<>'O%/\ 86MPMG#;HN5X KZ@_9L_X*2_L#?\%$_@O;?LV_%*S\'^"M8\
M8>$]%\(^+?@5XSACTOP7J$BZ9K>M^1\,=9FC,+V/A2V\$2>)_"DC_P#"+7O@
M^(^&Y+7R[ZVL9!]L?M9?M#_!SX=_$KX _LU?'7PE8Z]X%_;#7XG_  [EU;5;
MK0V\-Z1J>A:7H%Q!HWB72=>C!.@>)QK4J1:_%,!;^*-.T!9$'VN!H?PH_P""
MDW_!!?P#X;\">+OCU^R#K,?@"R\":3XX\??$?X5_$#4=9U7PK:^!/!'@AO$.
M[X5Z[;>'[GQ)#X@1O#\D,WAGQD_BQ/&4^N;1XY\&IX6MS* ?O'_P3X_9)NOV
M)/V==/\ @5)XQTOQK:V7CKQ]XJL-8TW2FTJSCTWQIKKZSIFEQ02:M,28DD15
MD!=9O,V!40B23[QK^=K_ (-_?VPOBE^T'\$/'GPH^*_BV\\6:K\$KWPYIW@O
M7+C0]3;4W\"S1HD.G:WXX:WD\.>(;BW>*.&,M+'XJ%O<7#74<OE0/!_1+0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW6?%O@K1_!^JEM.TWXK#.MR>'];D62,O&<.F^-UW*"5(!!_H,_X*#?L(V?\
MP4P_9B^&]]J%IKOPJ^.'AGPTOQ#\ Z9XDDC>3PGXG\;:+X?U7Q#\-/&Z1QQ9
M =(?#=R8T5(9],8DA,F@#Z[_ &>]'^#'QD^!OPL^*.G^"_@QXB3QQX$\+ZW>
MZUX6\(>#]2\-W^KR:3YFOC0Y-(A>*2*/Q!)K*H8W<KB2(@NF OQ/\6_LO_L^
M>(/@_%XW\,>"?"GB/XP_%/PQ\+_A=<Z7\.EO=1U+XFZ\KG0M+AUCP_X=E;06
M9@JIXBN9H%56;?*I3<?Y'O@3X+_X+D?\$^%\<?!_X)_"7XG7/A:ZUC2=6O;3
M3/AOHOQ8\#?VM/HJ*NJ^"=;;'AD-*SQCQO%X6 +MH48*EL5^L7_!/G]B']KO
MXL_'6Q_;1_X*87$_B+Q%X<M5UKX%?#[Q3>N)/AQXHUW5UUTZRO@B!6\/> )/
M"T2+'_PC<8\R'Q?^_4XA52 >7?\ !SC_ ,D?_98_[*9X_P#_ %#M#K]]_P!C
MF//[(O[*PZ8_9N^!?YK\,O#?IUZ_2OYDO^"P%[^V;^WWJ'@'P3\*_P!@;]HS
M1/AU\*O$_B:ZTCQ;XA\ ZI'J?BU]>SHAU5=$55DT'PZ^AZ/I5QME:67S;F9M
MY5@J_JA^P?\ M(?M6>"_V([[PW\<?V+_ (^)\3OV8/AUX$\,:1I+>'-%\-ZG
M\=]-;6M=T#P]I7@'06!03^$/ .A>'6\9LRL%=G(4R2<@'Y-?"W_E9QO_ /LI
M/QD_]9)\?U]6_P#!S?\ \FY_LY?]ENU+_P!0C7:_.+PAH7_!1/P]_P %-/\
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M)WB32/"ND>$/%'C)YB=%\"^" L;OX=\*27?D>$(I7>)?",,41BCG1M_Y;_\
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M1?V!I1\:^/AHNCC6\-_PD9C3=)_PDH4A]NWOD?0G[/G_  1__:B^-.FZ;/\
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M/$_AOP]>IJ^C2ZK/K.@NZKK@ET&/5X4CR@$DL99@8R: /XG?^#B#_E(C<_\
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M:E\+?\(,;L'Q';^$_#.L'Q)_9C9.S1%U\GPZC ?>WQJJY )W9% '[-?LP?\
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MQ-K7AJ30795\-7$KP! S1 2/)D _E._X-[?BEJ=Q^W+\6M+L[SP'X+T_XK^
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MKNC>'8=6^&3:S):^![_Q=X:?0HM%\9\,LD^WPYX?T?PT?"OF#PG(B,?+$@8
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M4?\ @H1K[>+_  #J.J:;IUCJG@S5[;7[3^S=1^)GP&U[6O\ B0^-O NO _\
M",$$>!]#((//C30/$_@<=J_ID\7_ /!?K_@G7X<\#3>*O#_CWQO\0/$P@TJ5
M?AGX;^'/C32O%-X=7:(:PBZUX_\ #7A#PGM\-1BX%V5\61EAH_E+\@5A^C/[
M2_['G[._[7WA>'PQ^T!\-M&\<1Z=8ZG8>&M?O(%L?%/A!==ET;^W$\&^+(B-
M<\.OX@;1])2ZDLYQ+.MJ@=Y-D4:?&OP]_P""(?\ P3@^''BK3O%]C\"E\27F
MEC4<Z;\0?%&N>-/#&I?VYHXT28:SX<\03SZ!K;^02$6:-@DI4L9 PC8 W?\
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M@+0_A!KMEJUCK/PVTKPUHUAX*OK'Q!O77$U30T1891XA#R))F*0X"F0ET8D
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M!X0\#Z3HGBC7<+HW@[6_$+ZZOA91X2BE'AFWECN$6<EUC+!'-?SR?L.?M%?
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M67Q/LVN/"UE'I^JWW@/XL>,]!^+.B>+_  7_ &\?"B>(=OB30SX5<1N1E?%
M5ROA')_NDKP[XC? ;X(?%[7?!GBKXI?"7P#X_P!=^'&I?VWX!U_Q=X8T;7=0
M\(ZH\FA:J^JZ%+K,<K:+,;OP_I$[,@63=H\6[ (W@'\MG_!0S_@H'\8/V_\
M]A7XW^+O@]\"]0^%_P"R%X0U;X8-XP^)?Q8)'CGQ]XGC^)WAU'\&^!/#^@L_
MAH+X2\2-X?\ $[>*!XQ95.AKD[F);ZW_ ."&O[5-CX3_ &*M!\ >,/A1\4_
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M1JWX%57' ZC\<5JT ?YWO@CXI_\ !0C_ ((O?%/Q]X0@\)W/@'_A/0-(NO\
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M#Y,?[Z44 ?R??\$POV=O^"MO_!/^X\6>$)OV2M)\>?##XD>)?"NN:KI6K_M
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MG'4_C+I?Q$/Q/?Q#JUS\2W37O$_]M_VX8=="_#=@^@D[E\I Y/0 Y /]<]%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** *]%6** *]%6** "BBB@ HHHH **** "BBB@ HHHH
M *KU8HH KU8HHH **** "BBB@"O15BB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** *]%6** "BBB@ HHHH **** "J]6**
M *]6*** "J]6** *]%6** *]6*** "BBB@"O15BB@#\$?^"VUW^WY<_"OP'I
MG['UI\1M-\)17NIZ]\4/%7P<\52:/X]$*PPQZ%HDAT2.'Q5HNA(Y+3'PGXJB
M/BMYA9R1JT6Y_G_]AC]B_P#;]_:+^)7PC^,7_!3GQ!J-[X9_91NM5LO@-\)O
M'/A'X<:GXEU_Q3K&A>'1KGC'QKKWA_PXL>OZ"J:-H<L.O>+9_$WC&;QMH,TO
MG0J;BY\7_P!-U% !1110 4444 %%%% !5>K%% %>K%%% 'COQK\9^-?AS\+O
M%OC;X=?"_6_C3XST&R:[T+X;>'M8TCP]J_BV?[>BKI,&LZ^6M;5@KNY9T<.%
M*+$RL67^0Z+X/_\ !2[1O^"E]Y_P4*\-_L"^/+)KSQWJGB%_AKKOB?P3?,OA
MW7/ O_"K=?T5=9T/Q+X63_A(U\+ZWKL_@GQ%.LT;^+01/'- SJ_]J=% 'E/P
MF\2^*?'7PT\#>+O&O@#4OA=XM\1^'=,U?Q%X!U;5H]4U3PGJK(P?0]7UF!8D
MU=HR=C,(P&&0P9CN'JU%% !1110 4444 %%%% !7YL_M'_\ !/KP+^UU^T%X
M-^*GQR\>?$S7O@_X T'P=8:;^S3;>);[2_@]XN\>^%]?\>:Q_P )SXWT&&XF
M?Q(+N#QKI.@V:Q?\(M(D'A:2VU!O$OA3Q3)9)^DU% &386.GZ196FF:796]A
MI^GVPMK2TMK?[%965D@4+''&%6-%14&%3!)RS!1N:M:BB@ HHHH *KU8HH K
MU8HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HKE?$.O:%X1T>_\0>*-<TGPYX>T.U-WJ^OZ
MYJVFZ;I6AZ;&"#JFKZQK;Q0VT8*[?.GE6(.<.[<O6%\/OBA\-?BII$^N_#?Q
M_P"!_B'I5K=MI%[J_@#Q9HWC#2K'45V%],.L>'YIXU=2P)$C(X.2RKC@ ]'H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBLZ\O;>RM9KV]F@M+
M:TMFN;FYN"-MFH7)9NF  &SSDE<<D@$ T:*^5/@K^V!^S-^TAJ6O:-\#_C1X
M)^(^M^%-7U;0]:T+2-5DL?$8DT./1?[<U/1])UN&WUW6_#"-X@T-+?Q=X>@N
M?!T\\RB+Q5)(&"_5= !1110 4444 %%%% !1110 57JQ10!7HJQ10!7JQ110
M 4444 %%%% !117GOQ"^)?@#X5>%[[QG\3?''ASX>^$M,3??>(?%>KZ5X=TI
M/]EI]:>.,/R $\P,P^8 J": /0J*_-W]G7_@J3^R9^U=\=KOX _L]:WXP^(^
MMV'POUOXH7GBZS\&ZGX;\#V>FZ)K^A>'Y/"Q;QTWA;Q5_P )%*=?TB[4P^#S
MX3^SSE#XJ:]S;U^D5 !1110 4444 ?#G[0__  3Q_8V_:NU*WUGX^? #PGXS
M\064XD7Q59WNO>#/%-\6T<Z.8-6\8?#_ %_PMXE\0Q1Q'RHE\17<\<2@10PJ
M%2M+X4?L.?L?_ G4[35_A3^S9\*/"/B.SU32;_3/%<?A'3K_ ,3:!?:%X-T;
MP+;R^'_$.M07'B/0_,T/P[;O/;^%[B"'Q3XHNO$GCO4/,\:^+_%_BJ^^T:*
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M>&9/!LFLIK6L?%F36_"7AF?PQX9\6LL</@ZZ6.00^*3X=\'3*TGBE+B$ _H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:OL7GV_V[[']J^Q[E^W[>F[;GIGY<XSGMM^:KE %BBJ;S0P1>=+((((."6.
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M]#^$.OZ]:Z(C#2=$DU[7/'G@_0]>+(?#O_"2J?!$X\+HXE\9GPV#%OD\(*C
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M9.6_/WPQ_P '&7PDO_'7A'P9X_\ V8?BY\+;#Q7JVEV-]XBU76]+OSH6FZV
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M?$[POXO\)_$HZSI>F:  1H6M_P!L_P#".X_X1[P]X1.A+X77PL!CP7C&,<4
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MPD^+7B/XL_$?XVZ/XILSX?\ '&L#4? O@/.=WC7P/H?_ "+'P_'A3G)\)_\
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M\^/Q#+O>;P=%X5VL(X97'H__  4:_9"\/?MV?LWZ-<^*?'OQ?^&'A[P%X/\
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M%+1];^(%U\1/%P^(\MC'\2-<T*";2O&HU_\ X2O1'MH[.,1,D\;QI&J#*A,
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M6\&+9#PUXVUC18M0\2:"%QL\F0C"",9*;T=2H.1M3!^A*_AQ\>S_ !)^#O\
MP7=^&'A[]HKX^>(OC&G@;XS^&-:T;QGXXU&6)-!\#^.]"/CO0M"T32?)7P_X
M;7PG)XYVGPWX2@'@]!\XB#?+7].'_!1'P#^T;XW^!'CO4O@5^T5KWP!@\&?"
MSXG^*/$MWX6TJ-O%'BK4]$3P_KVAIH7CB+?XF\!+'X?T+QQ"9/#$C2RSZ[H1
MSY<0R ?H]7'_ /"3^'O^$G_X0W^UM*_X2K^Q_P#A)/\ A'?M2?V__P (Y_:O
M]B_VY_96?M']A_VW^X^U;_L_F?N\^9\E?Y_?_!(_X7?M,?M$?M/^+O!'P8^-
M_B3X)GQEX$;6OCM\6/#VK-IWQ*7X8CXE>!/$&O'P3KX!\2Q>(/%GB%=&7>Y5
M,^( FX^!74-[U_P5#_X)J6/_  2]E^!_QX^!'QP^)&I:QKWCS4[.RU?Q#_8N
MG>.=#\=Z&!K^A:YH6N^'3X2&,DKR>HR."#0!_=U17R3^S=\7KOQG^QW\%/CI
M\0M4AUO6-<_9S\!_$OQYK&EV-CMOM6?X8Z+XC\<-!HVAA8@5U^760/#L#,L<
MNZU!#1QQK_+M^S9\6_&?_!9;_@I;=Z!\</&$^L_LG_":T\2_&CP[^S[=C6=.
M^&OB+PWX'UJ/X>> =W@@9DE\3M_PM*+Q'XU\4>*R\LN/$?@)-W@8HM ']>W@
M3XF?#SXHZ)<>(/AGXW\)?$#0+?5=3T.\U_P1X@TKQ-I*ZSHSK%K.E+JN@W#Q
M#68-V98D<LF%<;05)])K^/S_ (+?_LK^%/V+=5^!7[7?[(!MOV;?$&H:_J?P
MDU:V^"RZG\.=4;4];T76IX->T,^&56#0-OAW1-9\-^,71$;QDNO1;_WZ.Y^P
M/^"(GPZ_:L^*'A'0/VQ?C;^V?\;?BEX)\0VGCGPSX<^!WBGQSXR\1Z8=1TKQ
M%KOAZ;7M<_X2#7Y$<(VCF7PCE245C)*4$BLP!_07XX\<^#_AOX9U;QM\0/%/
MAWP3X/T"S>^\0>*_%FLZ5X<\.:+IT:Y,FLZSK<L4-NA!VAG9 SLJML9E+'@?
MQMX/^)'AG2?&W@#Q3X=\;>$->LTO?#_BSPIK.D^(_#FLZ=*I(?1M:T262"XC
MXVEHW<*Z,HWLC;?Y.O#_ ,1/@-_P4A_X*:_M"?![_@H+XOU&V\(_![Q/X^^%
M'[+7P=TKQ)K7@SX:R-X&\::_H7CO6M>U[0?$ZL?B)XL70M"\21[GV>+T$<:!
M8O!W@I!Z)^UE_P $@/AG^S=\=?V)?VD_V3-"\26W@+3/VJ/V=?"_Q4\$"\U?
MQNN@Z;K?Q0T!=&^)!UW7);CQ&NAP2#1O",L8G<^9K7AQD+(IV@']7-%%9&H6
M-CJ5K/8WL%M<V-W;-:WMK=?,EW8,I# @$$C+-UX.3RI(H UZ*_@)_P""WO[!
M'@[]C+]H+PEXI^$FD0>&?@S\?](\3ZSX>\._:P4\)>/M#UG/CO0]!T=<IH7A
MY&UOP3XD\& '<CZ[XHRH7PDA?^C?XW_L*? ']OC_ ()P?"?0OAEX=\'GQ/X.
M^#>EZY^SEXJ\%KI?A_3=!\:CP^W_ !(+;7H( W_" >+?$,3Z%XY659W\P-XN
M7'CCPU;W$(!^W]%?P1_\$*OAC^SI\2/VQ/$/PZ_:$^'FB_$3Q / >J'X6Z#X
MKT8>)?#8\2Z"<^(-:UK0BC^%RW_"-9(!1@3@8R=U?L)_P7V^']A\4;C]DGX+
M>!?A9X+\2_&[X]?$?4/"]E\0&\.IJGQ=\/>%_ ,::R=#T'6D \20^'?^*UUS
MQ.\41\G?X?+J%9Y,@']+%?)/PBC_ &/M!^,?QF\-?!6_^"-O\==2OH]:^.GA
MWX>:SX0/Q*_M/  U7QWHFASMXETB;S-954EN(XEW2(R#S@<_,T__  32\!0_
ML7^"OV/?AO\ $GXD?L^Z'I-Q8>(/B+XK^!6L#PUXD^*FJZWX,UWPWX\M_&DN
MLPRR>(_#WC ZP[R)XG6XEB?P_P"&(Y"%\+6R'\$_^#=/P_#X<_;B_:E\.6]Q
M<7-KH'PA\4Z-;75W_$NA_&7P(N,?[S*?PH _=?\ X*J_\%"?!/[$OP$\1:59
MZ] /C_\ $/PWJEE\+?"MO9QZKJ)E=CHS^,-7T96R?#MJ^$=B@4O@(VZ)@O$_
M\$5_BSX/U?\ 8(_9;^&>O?$7PYJGQ>U'PA\8/&\?@G4_%VD7WCV\\$1_M!_%
M?1(_&:Z,]P?$EQX=215\.)XD^S_9VE78Y+A]WPI_P7>_80_9A\'_   ^*'[7
M7A+X;VOA_P".'B+XB> X]:\1:7K&LVECJ,^N:\5U[5_^$2$__",GQ'XD$;Q3
M>)IK83N[)(\Y82!_5_\ @AY^PO\ LPP?LR_L]_MD2_#2RU#]H76K+XFQ7GC3
M5M6UG5[*RN=%^)WCOP0FN:#H&M7)\.Z#KT?A;0M'\-2^(?"MO')(J[TE$.XT
M ?(7_!T#_P C'^Q?_P!@CX[_ /IX^$%?TO:W\<O@W\#?AI\.==^,OQ2^&_PF
MTC7-'\,:)H^I^/O%VB>"M+O]7?18MFDZ2WB*>!78+&Q$:G>J,NX\JK?S-_\
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MNM-^'>@_#EOB5<F_32['51I@T8ZZ=*-O)<PQ_P#"1>()7MM 70BQ=_%+)9P
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M-@_@;PNOC(^#?+?:X1]Z+^DO_!3+]LK]NGP'^SIIW[3/[&#?!F3]EWQ/\,O
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M$G[!_P"W88Y_CAX?\1^)])\.^/YCX4T[4WU;PYOEUKP9XWA\,21^&979B/\
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MXZC03XDT7XI:G'\;QXC\2+H%K:^))/L]LF/^$0\:>"#X6>?P4\TEQ<O\J?\
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M>#?%.L:/)Y>@J,IHVEKI2B<>.M=(C*P"6W\4>+[F16:%I#)))7P7_P %R_\
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M?P5X5UGX6^/M&\/K;Z4JV'B;QYI/CO0M=UM]74GQ#*WBKP[X$\#>6TZ-Y/\
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MS\::/\0/"^B0J=?T:,>(O$/BW^VW_L&*X/@NU\*3^&W3Q?Y$IN%\PQK]A_\
M!2O_ ()7?";_ (*&ZTOB'PS\0=(^&_[2OP[\,M8W%W*UOXBL=>\-:QH^O?\
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MO^#EW_DROX._]G3>%?\ U6'Q<H _43_@F+_RCW_8Y_[(/X"_],RU]W5\&_\
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MM(U+]@2UTC3=*ALM;\(_$KQO;Z[J-E?>#;[4M;?6M;EUG1Y-=T?P[KT_B?1
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M$/\ +G^U]KGASPM_P<3?#;6_%.K:)X;\/:9XZ_9SO-7UC7[S1M+TNQS\,-
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MGPIH_@;]H7]HS]GGXC^&="\1?\)1H^E7FJ:3X;^P^)_['UWP^-9W?#_X(>$
M6_X1[Q!K86/._+' ZU^GW_!*;]BK]H7]A7]G/XV_#'X^>*?".N'7?$>J>)_
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M'-+:=+'^T=7UWP;KFCZ-IS-J>(XO.FN$,CR;(D*/.RF,L3_&G_P0%^(7P[^
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MTA&/BGPQK>L>&=T@9_WA;Y2QW?E[_P '0W_'_P#L3_\ 7I^T=_Z%\ J_5O\
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MZ/8WVF7FJ:&=7UYI=*36](MVWZ)(\&&CMF7#>6Y7>IF,8!X1_P ''7QM\<>
M?V;?A7\+/"]_#IVA_&GQCXHLO&-Y!=Z[INJR:/X'TG1=;72]VA:W;1GPY-+J
M\Q\:#Q*&A\I8Y(]J2*H\^_X)G_LK_P#!0#Q_^P_\"_&'P<_X*-R?!3X=:[I'
MBH^&_A@G[+_PU\;GPLR_$?Q[HNND^.]?\2?\))KN[Q"-;\21M/)$&?7?+#8
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MB1HV\)R+7$?\'$WP\\3:%^R'^R]:1?\ "7^.+'X>?$#['XP\=:K:2ZC>F/\
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MTG_"71>#/$OC12J>,F@94=Y?RU_X+ ^)_P#@II\3OV4_#/Q"_:C\ _ CX%_
M!OC7OT;X.>$+[6-3^+HU*1O$$G@5OBCK6O?\)=X6U_\ X1GP_H>O222>$1X.
M:9]?R_@E]B#P7\<?LJ?M71_L^?\ !6GQQ\</V][*?0O%=KX\^)WAGXI'3=$?
MQUIGPT\=ZYKBZ$1HB>'Y?$[?\(_X5\0 J#X6D\8%6(;P*&4,C?I!_P %JOV[
MO@I^UC^SS>?!;]FFV^('QNMO ?B3X._''XA_%_P1X.U75?A!X T;7M#\;C0=
M%\<>(F@2YT#Q$3JVAR^6_A67$UQ<>"))9_'/A'Q3X(M0#[M_X-S/^4?NK_\
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M\(>)8W\)>(H=8\,B1$G_ .$G?1)8[7SE(+@'X/?\$<_^4TO[9_\ V"/VH?\
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MHHT-O#(U%-!=SK1#>'#XI&ON5$;^3XKG\([781Q9S+'^A/\ P76\6_$#PO\
M\$\?B:/ %QJEN-<\1>%?#'B_^Q]&_M2(>!-=EN$U_P#MJ;:O]@Z$?+ G\1C_
M %!"#G?N/\[_ /P0A_;<^&_[+'QO\8^ ?BM!K<&E?&O2-+T?PUKOA3P=XO\
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M4Z_:G^+7B3P[\.=2^+]U?>)?AG_PCWQ TI_&GAK0?AAK3>'GT#^Q-%7Q*K:
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MGH/C=1H]Q%&+?P_\16\/>(?#L7C2!5_X0[Q>NN---/X4\=2>-'\7?GK^R_\
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MFZ;KWBD%E^+'@OQQHGAUO"6/#WBPC7?^*6_X3+QBP\&<$*1@?NO\ ;WX??\
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MT@_QE_\ 5G>/J_OAK^)KPK^P%_P59\.?M[W/[<O_  Q#;W.H77[0GBCXZ_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0YKV-<),-!\/@+YD$##VO8/4_I_A0!_!_P#\$Z/^"M7Q,_X)T6WB;]G3X_>
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M^UA^S-\(?VA;?P]/X5'Q'T#4+Z[\/7=TE\^F:CHFN:UX=UN,,F X37]%G*'
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M^"_'6@Z%X.UXN6D'B+Q./&C>(X%#J$@T)8763_A*(2GWY_P33_;B_9U\.?\
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M_"O./%'PZ^'_ (XU+PMJGC+P+X.\6ZIX&\1)XF\#ZMXM\+:1K^H^$/$L4?\
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M/[)_[/'@;7?$W@NW\3+=WG[:6K>$HM0^&WPI\4>#)4UY4\% E/$6O_\ "T=
MTC7O"$'B7PE/X5*PZ\ LTLLI! /J#_@K/\0?B'_PS7\2/V??A9^S;\??CIXH
M^.WPX\4>&DUCX3^!=5\2>&O! F'EK/XAUB,"+S)65A%X;0!I$^4%59D/Y._\
M$,++]J']CCQ%\7OA?^T%^S#^U1X:\ ?%N]\"Z[X/U9OA#XUU+PQX3\=^'U;P
M_KW]NI'X>0Z(GBK0=>\/B7Q(S"-T\!%6()6OZSZ* /YG/VW;S]L_X&?\%</
MG[3/P!_9V^.OQG^%-K\$?#'@;XEZ/\/?#/BO4O#GCK27D^(,6M:.NK:&)XAK
MGAC^V=$\40)*CAO&&@>%E8%MP'!?MS?M>>,O^"J?[.WA_P#9T_8W_9F^+/C3
M4?&?C'P(GQ=\5Z_X2UG3/#'P.\4Z'JL.OMX.U_QJRCPUYJF&0)XH,L_@T1 L
M9#NV1?U04S8/4_I_A0!^2'PA_8"U3PU_P2GM/V$_$NN:E9^,-?\ A!K&F^(;
MNU.C7[:%X\\:ZO+X]U[0]"7RAX>GT/PSXEUR3PU!KZ[X6MK=KT.)/+C;\(_^
M"7/Q)_X*8_LR^)_C+^P;\)OV;;?6M1M?B1]K\7^*?'&DZQIOA?\ 9[\4ZYHC
MZ&/&FN:T03K_ (?\6>&O ^C>*?!7_"4%#XY30"G@C>GBM57^TZB@#^:W_@N%
M>?M;_&/X6^$?V3?@Y^SM^T)X]5KSP-XU^*GQ-^&?@_5[_P"&7CI8]'\0!O!C
M?V$JRJR?$)/#OB.9'.(A B[4*$GW;_@AW<?&;X;?LX6O[,OQC_9H^-WP;UGX
M<W?BCQ4GC7XD^$9_#7ASQ<?'7C;6]:&DZ(NL2I+)K41E!N%PR!65W*X!/[N4
MS8/4_I_A0!_+?_P7]_8(^-/Q\\7_  <_: ^ O@;QM\5M8\/^%&^%'C'P1X)T
M23Q!?:-IFE:YKWB30]>M]'T(+XCG#R>(];\UX&=5N-#\-(Q#M@]=^R9^T9_P
M6)^)G@SPE^RW!^RWI7[/>H^#O >FV)_:C^-/@?QIX<\/^'M+\&MH\6B-'X&U
MKP[_ ,([KGB5] 33/"W_  C<>UU,<WCD.@A;9_3%L'J?T_PHV#U/Z?X4 ?Q3
M?\$__P!G#_@J-^R;^US\7O#?A#]G6?3O%'Q;T?Q1\-;KX[^./#FKM\(/ P37
M%U\?%#0=;Y\,^(=CZ+&Z^&$ /C)_+P>0#^E7_!?W]D?X[?M$?#OX)^+O@7X)
M\=_%+4_ GB;5+3Q'X+\)7>K>(6M]+UF..+2-?T7P.C%6\2QR(T3^)QAH42)&
M &QG_HOV#U/Z?X4;!ZG]/\* /Y_?V)]7_P""A?Q2\.?"#Q9\:?AAX^_9J^&G
M[&'PZU/P_:_"C2_^$PTWQW^U]J>A?#;P]H.@Z9KO@OQ(AC3P_;KH9DME?]X_
MC+5RL080N4_%+_@I]\+?VROV[_VE+?XY>"/V!?VLO!&C6OPU\+^#/[,\6?"S
M6-1U ZIH.LZ^Q;.@-@#&MENIX&2<5_=?L'J?T_PHV#U/Z?X4 ?GA^R=\3O&'
M[8'[/OB7P5^TM^REX\^!LT'A_3_A]XQ\#?%CPLUCX:\=V.M:"8=<.@Z3K88:
MQX<54DBF:5).6$8:-OW<G\^/PJ_9$_X*#_\ !'_]J+Q7XY^ OPB\8?M7_!#Q
M=/J?A.VM/! UF_?7?#<<RZYHFJ^.=!T:,-X>\0>&AKFM*CA%\&3>+9O$DUJX
M$L,U?V.[!ZG]/\*?0!_.M^U-\9/VT_\ @HM\+_$/[)/PK_8 ^,7P+\/?$_0@
M?B5\4?VFK8>"-*\)Z3H?C/X?Z[HDW@QE.SQ%XC98M:W>&VX58\*54/G]*?@]
M\'K?_@GO^Q5I?@/X2_#G7OC+K/PG\.?VMJGA/P39:;IGCGXE^(WDCDUS6-+@
M9%BUSQ/<11;09U6X\4_V,D2[)KDH_P"@%% '\-6G?!#_ (*0? 7_ (*9S_M=
MZ_\ LB?'*YFU7XOZK\3/'GAWX%Z3K'C;PSJ'A;QSJ[>(-?\ !6B^.-#)\->(
M2$UF3PR^_+;4<MG:Q'],7[:7Q5_:1U3]BK6?$?[/OP!\>:]\3OB=\(C=W'A'
M=H@\=_"BX\::+HL<FAZYX*UIHO$/B7Q"G]L>(/#TMKX7ADEMKK0II<QJD&/T
MPV#U/Z?X4^@#^8C_ ((@^ O^"A'[,_@WQ1X ^(O[*NN6?P2\3>/5O;*\\5:A
MI/PV^)?A'Q1YOAO1->UEM \>2)XE\1_#P^'$55\P-@:"R> UDBDEBD_IWHHH
M ^5OVT?A%KGQ_P#V4?CW\%_"M_;Z=X@^(_PW\3>&='N[NU-\J:A*C!"T>[]Y
MND01HIW,&?('RG'\VO[&G['/_!8+]@SP5\/?BC\(8]&\>>%/$^B>*/&/Q)_9
M*U_Q7_9K: %TG0X]";6-&DB>*7XB>(M!T71/,'A,2^,+=]"_X0:=5#D'^O.B
M@#^5KXG?M;_\%HOVM?"^K?L^^"OV#]9^ H^)VE>)O"_B?QMXL\-^++#38O#>
MO^"O$&C:UH?]O>/$_P"$=\/.;>YBCA\2,S;?%8MQ"@#LTOZ@?\$MO^":VA_L
M ?##65\1?\(UXM^.OC"^U ^.OB)X>.LLFH>'HW+Z#HFD#7#YD:6YB1Y-Q16+
MJK,,%3^LM% '\V?_  7%_8'^/7Q_\9?!S]I_]FKPYJOC_P 8_"3P\=%\2>"M
M,BTF]U*TTK0?&:^-_#^N^']$8#Q%XE\0'Q!K.L8\-6Q\H_V$I*(S[3]3_L&^
M%?V_/VA/ ?C#Q[_P47\2R>$O#'C#P1XY^$.@?L]Z9X27X=ZG=:9XY/A_2]=\
M8>.5:0,OB1(M%/A[P(IVK;P:]XIG $7BE8W_ &EIFP>I_3_"@#^''PO^P5_P
M5/\ ^">?[6=IKW[)_@G6?$UOXSUG6/!?AGQMX6M!XU^&UYX&UG6Q#I*_%,=?
M#V@PO)HGB"<>*SF*;06\9.5<,M?</[>'_!/#_@H]^T_^RI#\3?V@?B5;_%?X
MX_#M],UGPG^SG\(/#&EZ9X<M--UG$7CEI)=$7S/$OQ#P@2*7PLQ$D:*(G9 M
M?U6[!ZG]/\*-@]3^G^% 'Y%?\$J?!7[<?AOX(>"K/]KC7[;PGIOA/PGX8\#?
M#3X-V?A'P>NHV?PUT'P9X%'@O6?%VOZ&R^(="\36Y@\1>'+SPEXA9YHS"[S1
M^=M#?CS;?L3_ /!2#]A?_@HK\4/B=^R-\*[7XH^'?V@;3XS:-X;\;>(3HQ\-
M6&F^-AH7CUU\<:XA)\ 'PE\15T=?!D?BHM_PFR^'Y(W#(74_U][!ZG]/\*-@
M]3^G^% 'Y?I^P9XB^,7[">H_LL_M@?&+Q7\6_'?C-CXF\3?$@7JIJGAKQ8-7
MC\0:&-"; WZ-X1UQ%,*L1OC1E8K'B6+^87QK_P $G/\ @J9^POXJU#QY^SGJ
M'BOQ9%IJZ;H]EXR_9R\2ZPOBK4$UK1]GB!O^$$)/B@HK$*6 *$LI#$,I/]W6
MP>I_3_"C8/4_I_A0!_,M^P#_ ,$POVD?B;\2M _:J_X*>>,?%?Q \6>"[/PM
M)\)?AE\0?%W_  DVIV "#Q#H6K>-MK)_8ESX7U[6]:"^$@Y,/C!_$4TJ[&@C
MGZW_ (*U_LY?\%'OVX;.Y^ _@/\ 9]^&!^#/@+XOZ5\1/ ?Q,/Q?T73?$OBL
M:'X*U[P]LUC1-=U^/^PP&\<:Y\H0R9T-<@!XU/\ 1YL'J?T_PHV#U/Z?X4 ?
MS\_\$V?AC_P4A_8N_9W\4_L_>+?V7_AYJEMX4\-?$SQM\*_%47QE\)3_ /"0
M_%#7V?7?#_@OQJD.O2/HGAX,/^$:?Q1#N>-421PL9W'\^_VR/V%_^"NO[:?[
M1?@C]H?QM\ OA-X:G^'-GX8TCPEX(T#XP>#UT_3=,T365\18EUJ3Q&'UMAX@
M?6OW<@5D37U7:H4*/["M@]3^G^%&P>I_3_"@#\KOCC\0/^"F6H? #X=6GPM_
M9N^$L?QQ^(GA/XG:+\7[*7XTZ5H\7P8UBYEBT3P'K?@/7I0L7BB1M$EUCQ,&
MB+M%-HB0$)(^UOPT_89_8#_X*]_L,?'+7_CEX0^!_P +?B#J7BOP[J_AOQQX
M?\5_%[P<TGBK3]:UAM<=H-;7Q$S:"X\0:/HOB-O+#%M[P-G<Z5_8YL'J?T_P
MHV#U/Z?X4 ?EK_P4>_X)G_#?_@H#\-(OMO\ 9O@GX[>%K5O^$#^)BV1<Z>QP
M[:+KRJA;7O#Y9CE#V (QDJ/YW_A;_P $FO\ @LQ^SKXMU[0_@'XXN/ 'A?4]
M:_L6\\6>"?C5H_AO2];\,:'J_B+^PM<;1#XB_P"$GC!76W\2?\(R^Q2Y:'.\
M[#_;5L'J?T_PI] 'XY?\$Q?^"8^J_L5:S\6/BA\9O'VB_&O]H+XH7BV9^(-I
M9ZJ6\/>%FF&LZUI.B:YXA$GB)6\6>)"D_BX.V9O^$=\-?+^[<#\D_P#@HU^P
MK_P5D_X*"?%7P_XO\4_ OX1^$_#/P\TK6?#'@/2/#?Q?\&N\FGZOJY,NL:TN
MN>(F>23Q.B%2B!G4((]N0JU_7S10!^2$/Q%_X*SZ!^SW\/YY_P!G+X">./V@
M;O4=6T;Q[I*_%33- TO1]/T;11#HWC:4J7\,S:]XG\0,GB)_#/A@M;VL16',
M:)L3\3_V6OV#O^"Q/[+_ .U7XJ_:WT7X+?"CQ?XU\=W?CM_'>E:G\4OASI^F
M^(1XZU@^(];,)A\1E]$8>(EW 0;VXXK^Q^B@#\8?^"K?[ 'CG_@H!^SC\,8/
M#%KX"\*_'SX<Z@GC+S==5YUNS)X*U]M;^%^CZW DGV>W\2^/SX<:2YF*0!-$
M$LLB;B[>1_\ !/\ _8+_ &S=%O/V<=:_;7\?^%_^$'_96\.:AH/P4_9Z\)QZ
M;>:=I^K:1&NBZ!XS\;:]H")X<U[Q%X3C96\&-$"]N-S2",QL5_?JB@ KX6_;
M\_8N\,?MW?L\ZU\$?$FN77AO4+;5]/\ &O@;7K,L5T+QSH6C:]HN@S:Q"0TF
MM:)_Q4&L">W*Q;_,\Q3(T85ONFB@#^1[]C#_ ()P_P#!9SX"VOQ'^$GA#XX>
M#_@/\+];\.>*K31[G5/$G_"=>&4U37M6T>)M<\%Z%X=SXF^'OQ"91/XB_P"$
MJ<;6<-'RXQ70?M-?\$+?VD8?CW\*OC5^RS\>M>U?QOJ.M:5>?%'XK_$/Q'_9
MWCOPOXY:(2:U\:DUA?WVN%O$9;Q'_P (EX:BBE\^-XU1U,3R_P!8-% 'X_\
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MIOBSXB^.O'WQPL-,;3+W2O!/BNRT3P]X>&HZ+K6D:U"VLIH3!M=\/9A;0/\
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M&UV./ EAP_*D<, 02P5D\\_X=C_\$]_^C._@!_X;C1__ (BOO#8/4_I_A3Z
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MIJ2>./\ A'];?7]#_P"$C.[?KG_".ZY(DD22[5C,:EF+95\'_AV/_P $]_\
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MP8 D9Y ."%!R#]A10I"BQ1@", @#.3S[U-10!\V?&']DS]F;]H/4M(UOXX?
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M_0M$U.2WGU/2]/U":WS]EDN[1;\QCCY@)$;/XC /(/:MVB@ KE_^$4\,>?\
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M0 4444 %%%% !1110 4457\_V_3_ .O0!8HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIF\>A_3_
M !H ?1110 4444 %%%>:?$;XJ?#OX2^'+CQ?\4O'W@KX9>%K.YLK2X\5>/\
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M._V6?@3X.\;^((O%^M^-_M?Q-\0V*>'/#%YX9\#_  RU_P ;RZ]X?T65QXN
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MK?\ @GA_PT,G['?P//[5=QX@N?CY=:/XFU;QX?&,K2>)9&UCQWXIUOP?#KD
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MXT /HIF\>A_3_&C>/0_I_C0 ^BF;QZ']/\:-X]#^G^- #Z*9O'H?T_QKY?\
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M/]K#PQX:'B""6VUP:!H_]KV=Q>OJ;6FJ_P!F+_:BG5R,:R?/+(906\PIYWR
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M #Z*** "BBB@ HHIF\>A_3_&@!]%,WCT/Z?XT;QZ']/\: 'T4S>/0_I_C3Z
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFF^&/V@_@G:?$CQ@VEWRZ^\GA^/6@?OZYH,D&M0^'9(F4-&L\:DL02/Z._\
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M194T'X51Z_X;\8>%-9\NV&NPO+XH\'>*EN67=,/"$SQX /Z(**_EZ_X)>?\
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M >AZYXAT.5O';Z_YTWB'Q/XK\0*\I>90)YF2,S?\(1+X,\&># #^G&BOX?\
M]K'XY_M>?\$L_P!I/PGKWP6_;M\8_M-_"GX@6$.HZ5H'Q@^)$?Q^FF\.:'K'
MAV;7/ _CO1M8EG@T"?Q')M_XJ[P3<^%/%Z>$8_%#03^$-JR'^R3X*_%;P]\<
M/A'\-OC#X5^WKX8^)W@_PYXST3^T[1M/OUTS7](BUJW\V/ (8I* 0#@ ,0V"
M" #URBBOQ=_X*Z?LS?&[XB_![7/CW^SG^T?\9O@?\3O@MX7USQ#X@\.^$/C'
M\3O!/PX^)G@;0-+GU[5W/A[0]>M_#6B_$;PY##)=>$/%,4*IXK8MX'\</?6B
M^$+_ ,$@'[145_*I_P &\'QF\<_&#Q7^T!>_&+]IKXT?%'Q]H7A[PU8^&?AG
M\1/BKXQ\;>'M/\#G5777/&<&A^(@%3Q&NOMI/AV28/YB1ZRR)#+YQ,?P?_P5
M&\._M&_L#?M*?#?X:>%?^"@7[9_B/X<?$?P?IGC3[5XL^/'Q-_X2;PEI8ULZ
M!KO]N:YH/B)/#7B _P#$BUSQ00W@Q2&!'( 8@']S=%?"/P@^"?PD\!?LI+X<
ME^.?Q[^*GPC\2>&[CXF:]\:_B#\>?B?J/Q(\0^&M=T.#6X-=C^*/A_7O"?B;
MP/X>3PYI6D/'X:^%;>#;5%$CSV<T_B?Q;/XB_(G_ ((R?#7XP?&_QK\3/VKO
M&O[6'[1_CGX6^!/C3X[\&?!3X<ZI^T!XW\7?#CQ9I,NB^)- U;_A:?@OQQ_P
ME]QK?_",^'_&7@OQ-X'FC\7@1>,(YIBQ$)1@#^F2N8_X2/PY)>'3?[=T;^T2
M#;?91JNF'4CD9P(!(7R1SL X/\.ZOYQ?VY?V\?C;\;?VV+/_ ()V_LK?'CPG
M^SCX8A&J:/\ &WX\W-YHMAJECC2)9?'&BZ#K_B(-+H7B+PDLOEHGA67P?XN3
MQBB+;^,X%RK<M^U[_P $P/V0;/X7'XI?LB?M'Z?X!_:V^'3:GX_O/C)KW[3.
ML^(?&_QE\4#19SK^O>.]?E\3HVA_$+Q:T>M>(U\4>#X_"#'QIXA\13E1%,?(
M /Z@)H(9HO)FA$\)'0_-G'3@8.?<'\^<?QS_  !AA@_X.6_&$,$ @A'Q'^/&
M0. 2?V??'V<<\#J?T-?3/_! O_@H9\6/C^WQ'_95^.?C77/B%XF\(>&T^)?P
MQ\=Z[G4_%G_"*C7ET#QKHOC7QPNO2CQ#Y?B77_!4O@H7*S>*'37?%5O=>+I;
M7PUX3>/\X_%OB3X_>$_^"^7Q)U7]F'P?X4\<_&]OC3X[T;PEX>^(AU,^"$&O
M?# :%X@UC7O[ \1^%O$)\.^$O#6N:[XF<J73&@G8WW6H _N.EU33+*[MM/N-
M1L(+ZZ&+6UN+N,7MWM&?E5F$C<XQM60'H/[M:]?R0?MB?\$;OV^]377_ -J3
M_AM?Q/\ M"?'CP+=:GXU\,:!;:/J_P -M2T1O[9;7_$$?PJUH_$L^'?A^\*@
M'P9X8\*Q^#8@75%D:3>B>N_\$&O^"E'Q)^.-UJ/[(?QQU+4?%_B;P3X,U7QI
M\/\ XG:O<^,/%'CKQ=IA\:Z[K_C>/XH^-O$GB;Q6!_PB\WC3PYX:\$(DD)D\
M(10;I/W:;0#^G*[O;/3;>6\OKB"UMK=26N;F<*@'?<SGC/H"2?2J.FZ_H>K,
M8=*UC3K^903BTO4O]H R3E'(X ZY%?RY?MC_ !Y\+?MH?\%3O#W_  3]^.?C
MSQ7\%/V8_A.=8M_%NB>'_%^M>%M*_:&\5?V#X>^+$7A_XK:]%XB\,>&_#WAQ
M$\/QQ>"G F\:@+XH$$:P^+8?%O@JM_P45_X);^%OV/\ X,^,?VI?^"=7C?\
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M7AAUU[_A(M US7-'@B\-/\0?"3%O$O@GQ3X9MHG\&C7_ -Y#'X&_X33P1XP
M/[D-3UC2](B$VJ:E8:=!-]U[V[2PR3_=9V!)_O$%2#P3VK^.?]B'5]+^(?\
MP7U_:5\0_$_4M.\:'PK\1?VFX_!>O^*[E-2_X1X^!O&J>'? 0T;6=;"HL7A#
MPX1X7\&^3M5(@YC("BOZ4/BG\ OV2?\ @I!\&?A9X@^+7A&+XO?#&[LM+^)G
M@![#Q9\1/"I!US2!Y&K0/X&\0>$==>0I((U661LF/Y8U)<#^2']B?]C']G#X
MN_\ !7G]I#]F/XA_#9?$7P,\!>-_VG]'\)>!$\9^--/6PT_P+\3!H7@>./7]
M"\0Q>*6'A3P\-D;OXKC9_E+1*24 !_:3\1OA#\#?VA?"UMX;^*7@+P!\7O"&
MF:S'K-EI7BG1=&\9:/8>)K=6QJ:)(DJ0ZT4U=B?*.Y0Q="I96/K>FZ98:386
M6FZ5;6VGZ?IUH+2SM+3Y;&TL5P$1%PJX"H-O/8D\98^!?LV_LM? S]DGP)J'
MPT_9W\"_\(#X'U3Q'J'C.\T<^)?%WBAKWQ1JVD:'H,VL/KGCKQ#XJ\2+</H6
MA:/:S)]J>!?(4HJMYJ/]+T > _M#_M%?"O\ 9?\ A;XF^,7QA\1P^'/!_AJT
MD=W5EDU34;YLF+2-#T@R$ZUK<CC]U#$"2>0 B3-7\]7_  1F_;*T;]I7]MO_
M (*$_%CX@>)]+\+Z]\;9/AEXA\"^$==N=%TS4SX'\$/XCT?1M+1%&&N/"G@&
M3P3H'C5F!9[K$K'S#O'[G?M=?L@?L[?M;^ (-'_:'^'?_"P=-\!1^(?$W@^U
M;Q?XT\,I8:N=(E5M95_ ?B7PK-)(P"*PDF<C"8*ESG^2+_@A#^Q3^S)^V5XB
M_:8L?VD_AG_PL>#P)H_POO/!H'C'XD^"&T)M=UGQ\=<5?^$!\2^$ 6/]A:&0
M#QGJ,9P ?T@?\%KYX9O^"7?[4,T.+F Z1\,",'J!\9_A\"3CIZ?YS7YB?\&S
M-Y8Z=\&_VKKR_N[?3[9OB1\,\W-W<BP4_P#$B\0@ABQ 7=G !.'R5.%R1^CO
M_!8CPYHO@W_@D[^T-X-T"T73] \->$?@WX8T.V$YO39:9HOQH^$^C:%'AMQ_
M=PH@QPV8R7.[(7\-?^"(7[+NE_MF_"?XN?#[X[>+=1U?]F+X?^-M(N-7^ _A
M.R'PYD^)7CO7]&\0?V+KWQ.^)_@!?"?Q-\2:!X/4%_!?A=_&'EV_BY9+J4/'
M"T4@!_5Q\'?VL_V9OV@]2U;1?@A\</AO\4M;T&S%YJVE^!_$VE^(-0L;%B%4
MR)$Q.QG90<[L$X) ^:OI*OX=/^"BOP.\)_\ !+W]OW]F_P 0?L3:SXP^$$OB
M_P .>&/$C:=:^(M6U_3]$4^,E\#ZSHS_ /"<MXO\1>(=#\5PZ/&MQX:\2?\
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M>++J\U72-5UG3\ZAX(\*:OH>K:OH^K:/XV\91LGA[P[K,4VC7,4EI=2"0,I
M/E%"/Y,?@'^QC%/_ ,%>O&G[(WPG^,'Q0^#_ (:\!?$;XH:+8>/_  MXF?2O
MB2? _@?1M>&M:+I'B#PW%X8:'7/%?AYE\+S3B*00Q!Y2C!2#^Q/_  4U_P""
M.'[%?PF_8P^,'Q:_9]^&$'PG\>_##3]/\:CQ!)XY^,'C9]2\+Z%*&UOP;_8O
MCWXB^)O#43>*(W6&7Q%+:JZN%#.S*TDH!_0!\0OCY\(_A7\);_XZ>./'7AW1
M_AA;^%XO&<'BAM1A;3M2\+SK;2:)=Z0ZJQU?^WAK.E);1QG][)K$ 21=T;5\
M[?LZ?\%+?V+_ -JZ]TC0_A+\9?#MWXP\0WFH6&D_#OQ/(WACQY>'2-)36KAX
M_"&MF&XQ'"Q8, '81\$-A1^!7_!);]C3PQ_P4:^"%K\6OVX_&GQ!_:!\ ? J
M[U;]G#X#?!W5?&?C#PQX:\!Z?H3>'?'>M>,$UWP)X@\)^(=?\3R)KND>&(6G
M>*!O"GAVWMY9?%__  C?@EO!GR;_ ,%9OV7?AE_P3&_:_P#V6?C/^S!X<T;P
MWX=-YX9^)7AKX::IJ'C/Q#I]EXZ^!GC+P_KA;7->USQ)XI\5:UH7BLG1595"
M/%(IVD;0: /[:_'?Q \$_"_PUJ_C'XB^*M$\'^%=!L[W5=9U_P 0:K'INGZ=
MI\;$M-+)(Z[E52ORJ"RD$Q@N<5\]?!S]M+]ESX^R_%@?"/XT^!_&6F_!5]./
MCS5-*U=/[,TS3=:T3^WHM=_M@22*_AQE,EL?$:.H_P"$DT'Q%;-(OV8%_._V
MSOV%_P!GC]N'X;K+\==#\::AJVA>"M:NO!VJ^'?'7C+01X)U;7-%;=KFD>"A
MXAF^&FMZ[&1LC;Q?X3\5@,J1'*^4K?R;?\$./V/=$_:[^(WQRT;XB>/O'^G?
M!?P7X9\"GXD_!WPEXM\:^#M-^,XUS5_$)T'1_&VK>&_$GA&6?P_X3;0M;588
MOWLK,$0@D&@#^I3P5_P5M_8"^(/QGN_@CX=^/OAR3Q5;2:;I^D>([G98> ?%
M.I>(-3T;1M'TCP9XVN&_L#Q!KDMUKD:+!;S.T9BUG;M@BFV_IS7\D'_!8C_@
MD1^S-\!?V6;GX_?LI^!9/AIJGPL\1:<?B;ID_P 2/&GB'3-=\"^-V3PV=;$'
MQ \0^,E@U[POXKUGPDJ)X9N_"DJ>#-8\51"2:2/PHMK]W?\ !!7]K#XD_M+?
MLN>)/!GQ*UO7O%/BCX$>)=*\*6OC;Q%?C4K[7/#&N:'*?#^DA!&UQ)+X4?11
M#_PD?B&?Q1-<I*8S(0B%0#[W_:._X*1?L:?LI3ZMHGQ8^-/ANU\8:#<Z59ZO
M\/- =O$WCNT_MHYA\SP=H2O/R#DEE+KN8-N.0W'_ +/7_!5C]B?]I/QS=?#3
MP#\3YM"\>"ZTNQT;PG\2?#VN?#O5O%>HZQ_;@B7P]#K\2C7@5T2?<L;%U(39
MYK/MC_('_@EQ_P $M_''PN^-O[2'QU_X*)_#;P1XK;0KW4K#PEXW^,7B,^-[
M'6O$\FKD^.?B?CQ$&\,:WH/BL$2)XI\91-XR)78RC=O3Y+_X+Z?$C]F6;]H3
MX'?$S]G?Q-\/[[]I'PK?:B?BOX@\$,-4EV:(O@'7_@AK'B$!4\+:WXCBEUW7
MXH_$<8GA$"1>#/'5Y+_PC'@ZWM #^R?QAXT\+> ?#VL>*O&WB'1O"OAKP_9Z
MAK&MZWK=W'8:?8:/I6G?VMJUV\LKKE(8HY991EGV*^U9)%2-_C[P)_P4>_8U
M^)?B?XG^'? OQO\ "FO6'P<\!)\2_'WC:SO4_P"%9Z%X7)"^:WCEV7PVVP$L
MP\W<4#; \FU3F^./V4O@3^W=\&_@1>?M5>%=2^*0LO!7AGQC'I;?$+XE>"O#
MY\3^(?!^D'5_$#:+\/O$OA'P]JVM@1SQ6[31/'X9&KZXME)&LA$_\D/_  1U
M_8V^'?[67[5?QH^''Q2_M74/@AX/\'ZKK'C#X66/B3Q?X;TSXBK_ ,)B^B>!
M]*UW7? GB/PEXB4^$?$*:'XHC,BM&9M!C610C,0 ?TYZ%_P6Q_X)Y:W\4;?X
M36'QAU!]8N?%O_"#V?BBY\-:LG@6_P!175_[$&LQ^-RB^&V\.O.JJ/$;W*0^
M6Q+,-NUOT6^*_P :_A+\#_!\/CWXO?$7PK\.?!%S>:;HT'BCQ5JT>FZ3)J>M
M/MT>$:M,X13=?.(V9@O.]I@N"W\Q?_!=G_@GI^SM\&OV7OA-\:?@9\.?"GPF
MN/A/J_AGX2ZKI/A_1]775/'OA36?+30CX@UH^)$?7_$WA9M%UQG\4>*X/%GC
M+Q>=?,3>-$=5:7]=?^"<4=I^U#_P2P^ .B?'W3++XJ:7X[^&VL^"?$>B>(--
MT2QTZ_\ #7A#QOXB\$^'](<:3(J@>$]!\/Z-!9>)1*GB]YM$B\7[[?QF&,0!
M@_#_ /X+8_L$?%'XK>#O@YX(\<>-->\7^//'VE?#SPXUK\/=<&F:CXDU[5AH
M6C2C5_**+H+SY7_A(E)A\L*X=6S%7Z4?%3XD>&/@U\-_&OQ4\8G41X2\!^'-
M1\2^(ETG3)-3U1-+T- T@TC1E8&9U7<50?>PI+*&\Q/X>O#.B^#O^"4O_!9[
MPQ:^(M$UO2?@OX0\=ZG9>&]5\7:LKZEI_P ,/BKX,U[P(WQ*FUD>'"K^&?"O
M]M:[XCGC#C='H+HKHQ#C^S3]JGX\:;^S[^S;\7_C?>06^H6W@3X=>)/$UGI:
MZQ'X=EUS4DTB:31M&TG6Y0P76IS$L49B'F9?*>6%#1@'S!^SM_P5J_8N_:>^
M*6G_  =^%_C#Q:?&NH"_^Q6GBGP'KGAC3;W4H@<Z(NKZTH#Z^H *VZC#@LF?
MN*/U"K\-O^"('[*MM\)?V7K#]HKQC:^.)_VA/VL6U'X@_%'7O&7B6?7=;O\
MP\OC#Q#/X#F$JRB&X@\6>'-;'Q,_MZ>,>*I6\>2B>63_ % _<F@ KX/_ &K_
M /@H=^RU^QAJ_ACP_P#&WQMJ5KXK\7JUWHOA/PKX<UGQEXEETY"RG5FT70H9
M'6$N,>8$+D9=%9=I?[PK^9SPA_P2V^/4/_!4KQ?^W)^T'\0O#4?P2T'XO>._
MBQX2U27XC?VCXFL]*T36G3X4:5KJ>(O"\(T3PMX8\.1:3X:C\-Q^+%A\*(CM
M Q3& #[J\!_\%LOV!_'7Q"\+?#2U\?\ C3PUX@\97ZZ+I%QXY^'.M^#-)74$
M7;LU76?$#11Q-C #%2!\V[=G*_I]XI\;>%O WAO6/%_C'Q!I'ASPSX?TG4=:
MUK7M4NTT_3;#1M(TMM9UG6F9V ,<$8:2502X5<J7<E)/Y,/^"^'[27["'QS\
M!>!],^%WBCPI\3?VG?!/CG4_"]YXR\,6>JM/X:\"Z$-<.O\ A'7]<BB@BUMW
M\3_V2?!D4</C"$$^(S!Y4?BXP>+OUZ_8F^!GPK_;-_X)7?LP> _VH/"T_P :
MO#^L>#]+UF^E\6ZYK3^(%U30_&&O'1M8T/QGH'BE_$OALQQVJ^'$;PMXJCAC
M\'22^"4>7P1<SV\X!Z[\)/\ @JU^Q-\</CR?V>OAC\3KCQ#XX+>)1:ZO'H6J
MIX&U.'P]HS:[K.IZ1XX96\-/'&C8W!U+$M@(IV'YO\8?\%\O^"??A;QZ?"$'
MC3Q9XBL+76/$NBZOXV\->$=9U#PQ8R:&,:-<:,S1.?$>@>*%9A!XA\+^9!^[
M0R8+*8/YYO@G^PY^S[\3/^"S_P 0?V0]5\.:A8? /PK\4?B@;/P1IGB?6574
MO#7@30]?U[0?!;Z^D7_"3KX;8Z%EG7Q5_P )H!EAXT& I_>S_@I__P $_?V1
MO"O_  3P^*[_  \^"G@#X:ZM\%/!6D^)O!OBWP'X)\&Z7XWNIO @;1]&T?Q#
MXZU[1)?%&OPW$31CQ83XJ'C'Q;]GDCFO)9[J)& /VV\">-M ^(W@?P=X]\*7
MJ:EX:\>^'M&\4^'+S 'F:3KNDQZUI4I XX@<'G[K< D*#7BO[4W[6_P+_8[^
M'/\ PLWX\^,/^$;\/76K:?H>CV=E;+J?B+7M6U=PD6DZ%HBE9-9E<98B)750
MI5F$BH6_);_@W4\5ZQ>?\$_O%H\4>)=6NM'\&_M">.]&T2/7=6_XE7A'PR/
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MNA-H'F:-HVC^'5DF$P7703@J"Z#*H6R/SU_X+<>-_BE^S!_P4)_8Y_;1\.^
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MZU%I_C[23J[:WX&\8^"/$"X\.Q^(O"@?0_#(D\2^$_%5Q'X.7Q)X(AFB=0P
M/W7\(_\ !:C3]2_:?^%W[*/Q'_8^^.WP2^)'Q.\6^$_"UK!\0KO0]-DT6/QK
MDZ'J\VD,K.\;<%P"I)W?-ABM?6_[<_\ P4D^ G[!>CV1^)7]O>(_&?B+2Y-6
M\)_#_P ,VA.IZE$=2,)?4M797M]"B=X]4DCDF$RLFB77R(2 WS(WQ._81_X*
M9?$+]E?XJ?#+XW^$]&^-_P"SY\1_ WQ<TKP]J>CZ-I_CF]TK^V%_MKX7Z_\
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MB!X<'@?PM8ZK)X/^(&C>"-&T6()XM37I/%DA\=.TT)C/A3_A!BMS&Y\36[@
M_J(U?]J#X(Z5^SS<?M47'C.PN_@M'X23QG;^+-*9;]]1TYM\&CZ;HL<4DJ:O
MXBEUK'AV#PX7>Y;Q7*;5TBDP&_'CX<?\%]_@C\2?VL;#X2W.B:9\)O@);:/X
M\;5_C%\6M9/AO4-0U;0#GPZ-&T3&= _X2=@H'A[Q4J7&$1@P;K^A'_!)C_E'
M!^R-_P!DM7_T^:[7\N?@/X.>%OCE_P %]_B/X0\8:AX;@T#3/VL/B?XVN],\
M6:1H?B/3/%O_  @OC+7M?_X0XZ-KZM&1XK_Y%DLB,N,E$?A2 ?I-XD_X./O
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M#_$YTWQII?@9'T<KX#^''A3PRGAM9/!+(TY\'#QD4U[Q"AD,*6ZK]0_M;_\
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M$/V#H/$G[=__  6]^)/Q;^+&HZ-?GX"GXG>-K'PEJ6C:OXD\-MI?@'7!\*/
MV@:&OB'7IO\ A'U\+^(O&VB?$R39"TJ^,-"=HMLH5U_LLU3_ (\;[_KV/_L]
M '\@'_!L)_R4_P#:V_[$/X7_ /IX\05_8A7\=_\ P;"?\E/_ &MO^Q#^%_\
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MZ^"_#O\ 8.NKX?7Q#)_Q4": R$^&RCB-V + '8?%O^#F3_DU#X#_ /9P8_\
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M6/'.E_M ?"RW_9,^W?%!Q\$KCX9AO'QT]/B1\0]"UL#QR &\S_A8"R^)E+$
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M\IY=/_[.V_:@_P#>N4 ?VF?LV? _Q%\ _AL/ ?BKXW_%+]H36/[>U?6'\?\
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MV=,T/QQH>K.LL<L;!_[(UEO#\VA^)S"2HB_X2"/80$C5/A;_ (.)/^4>3_\
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M@)XY^*&A:(1_PC'AY_"HT3_A%? [<,1X_P!O@(\\_P!;/[+?[$_[(/[(%_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]'\4>#&T;QMX;7PUXFT7POX(\::_X;\!:*^B[2Z!?AYH>@;6!W':1M;:-O\
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M-H?Q T.[C\3_  U\6:O:I?KHGB7>P.EN)&BQHGBB(?\ "/W9"H1"%VK(T>
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M3XH\4:UX$T+0M%99'ULR1:%)XLCT0+*4E=(VC5%>0,IH Z;_ ((@Z9IND_\
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M!X(\,^']?T'6=($+OH$WW;NWMY5\R7PEK'AWQ:F+'Q+%<, ?H?1110!_'/\
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M'3%31AHFLI<7"ZUHHM0@MYUN)1*%20,$52O\O5Q_P42_:]_X*YWJ_LI?L^_
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M?"NF:R5ULI\+SK_B+_A&8O OA77]<UEUM)Q'<LJ^&U2)S:W(A /Z=/V>O^2
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MG9@P(4;,I%^J7_!(;_E&U^R;_P!DXU3_ -3'Q%7YB_ME?\$F/VMOVB/V5/\
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MAE9O*8D %"P!_351110!_,-_P<NZ1;7OP"_9WU.[\0Z3IL^D?%#Q(EGH5_\
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M3OC+)8^.;O2QH*?VEX3D\2>)!Y;*PD!\1Z!X>W-A[?PL^\QG(#EE5N%\,_\
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MU3=KS-KG@@:YK&%_MXGPTR>7-ND&2ZF-,9F^A/VJ_P#@E<W[1?ARW^%7@_\
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M[0_M4_&#7#J_]H]"W]K!/,8YR O'/4@_+0!]@?\ !4+_ )1Z?M@_]D,\=_\
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M=0AT Z#=>'] UO5M+\+ZEA-?']M:KHBA@_B-GUO(\222"7&@>'B"PAVM[?\
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M'_#K+_@G;_T:!\%/_"2B_P#CE 'C?_!43]I+X#^%OV"OCWIVJ_%[P$+SXQ_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH _%#4_\ @AK^Q)XH\/>-[/QWH/B'Q5XM\9^/_BGX
M]M/B4^M'PWXHT#4_BG)H9.DI)X:3PL/$6@^%=:T-9O!5MXN'BTHNO>*3YP7Q
M1.5\H^)__! WX?\ QLDT"X^,'[:_[7_Q2G\+69T;PZ?B'XN\(>-O[!TG!/\
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M^H_%#XU07%O8?V-H_BWQ*WAW3="OXA_K"OP^3P@^O[FP /$T=P/G09)8A/Z
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MN%M_&GBR>7]_J *UY907MO-97T4%W975NUK<VUR PNPP(VMS@A@3D8W9.1C
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M7QIIMI_Q3UW\8=8\&^)-/\+7^#_Q._#^E>&_A[X/%MX@8#FY.]T!/EK',$<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1M#T;2HY0TNJ:Y-.OEI N]VV-(%*[R@![31110 4444 %%%% !1110 4444
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M:1HO]B>'M7UM-?UP>(M;C^RVS6\;_:)C' Y,^_=[A7X5_M&?\$<= ^-G[?\
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MA8VC^7<7EM >.+BY5&Y_ZZ-_-A0!?HHHH **S/[9TK_H)6'_ (%P_P#Q5:=
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M_P"$-_X1?R?[7_MW_A(?-^S_ -B^7SYV_I\GE[JS/A)\?/@C\>=)U+6_@O\
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M3+^/WP>_9P_X))_LP?$/XU>/O#?PW\(6NE?$NVAU?7]873QJ.JK\3?BYK?\
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MX/\ "OCSP#H4%AJ=]XZ\0^%?'$<4F@ZS%X(2(^(S =WE.?*!5UE"J0J%0#]
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MX+3?\$]/B1XPL/!-K\:+GP?J6IVA-EJ7Q)\*ZU\/?#+@ XSXB\216WAT2$C
MS+M' +%/EKU7]O'_ (* _!']B?X6>(=<\6>+=/F^)>I>'#>_#CX>Z5=:;>^*
M?$.JZ[_;.D>&]9&BNT;_ /"+GQ!I#1R^(2CPB2.2$D!61@#[(T;XA^ _$6O>
M+/".A>-?"FN^)O L^F6GC?PQH_B71M5\2>$IM;B9]%@\6:';LUYH5QX@MX99
M;>+7T@>5$9H"=KO%PO[2'B_QUX#_ &?OC=XW^%VB3^(/BGX.^$OQ \3?#G0K
M32-6\0R:]X[T/P?KVI>&]'.BZ*YN/$#W'B".*V7P[$Q:<M\FTO$T?\E'_!(3
M_@I_\+/@UX[_ &R_BE^V/\0/%LWC[X_^)/@[K-EJFC>$/&'C);X:'#\0H]:
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M^&OAGPC^S'\,+*R^.WC?PQ%I_P ,O&'_  @_@WPYH&D/HNLL TB>+DV^)?"
M##,!8 HQ#4 ?@#^W1X%^/'P4_P""I'[&WPE^,?[4_C_]I?[9XP_9@\:V7B'Q
M9H[>"=,L%_X73X@T%=&/@;0?$2^&E)70];)\3E05;Q 5.<9K^Y*OXS/^"T.N
MZ3X9_P""QW[(OB'Q%JFEZ'X=\/\ AG]E[6=7U75+P:;I6G:3H7[07C[7M;UC
M6\!1A1A5X&5'/)K].?VE?^"SVO:)+\0!^Q%^S=XL_:L\)?!]EO/BG\<-*LM6
MU#X(Z%ID>A>(=?UN--?\/*LC;$T*0KXJ9W\(JI<^:W) !^_5%?DW_P $TO\
M@J-\/_\ @H7HGB;2;#P;K7@+XK_#C2/#5_X[\/W?_$R\/WS:[$5_MCPWK,:#
MSM"&MB2./<?,55&3(-Q'TK^V5^VK\*/V+/!&B>*/'UOKGB7QAXYUA?#7PL^%
MOA.+^T?&_P 3/%#E NA>'M*)/F2Q'44:5OF"AH5.< ( ?9]%?ST_%#_@H?\
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MT\2>%OAE=^*/"DCW\9\5:TLI36]<T1,[?#WB^2303X-?PM'.K)KB@Q,0A7Z
M_P""EG_!6?XA_L1ZG;Z5X)_97\?>)=)7Q+IVB?\ "VOB3I&M>%_A'KFI2Z#K
MVNOH/@C7T*MXA\0$:&I4 KA4\0-@O$LE '[H45_.99?\%Q?&'Q?^%?A>']D;
M]E7XC_M!_M!#P-I'B/XH>'O"OA+QAJ'@;X;ZM*T4>KZ&Q"Q^)==Q*_V>#Q!$
M-C[E)\R24(GA7[!G_!=+QO:_%+QO\$?^"CG]F^!O$.F:OJ>G6OCA?![>"/\
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MBU&PL-.?5]6A$NC:Y$D#^(@%B,DC0^%K<@*$1& A\G@H8?\ @O!9PPPPP?\
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M-)H6L:YHNNZV-=\0>)] TE/W<:W*GPRX(8PEXL1B/F/^"_W[(_QD_:"_9_\
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M?"G]GCQM=?$3X5>'[SQ5>>'?%%SXL\)^-?MU]XA\7:[XEUXC7_!%M;^'I_\
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MBOQIX6^''BSXP>)=#TYGT?X;>!P/^$D\4:D_G_V9I44LJ30:,KOY8?7IP8X
M@E=641*?Q%_94_X+,?$C]H#]OJ]_98^('P3\-_ OPK:Q>)?#<FE:_=ZQXB^+
M.B?%3PX%T1O!VLZOHMPOA6/S/$4>M)F3PO\ )&J@SKM:1OZ'J_C<_9V\9:X/
M^#A#XQ2>#M U/XHM=?$/XQ>#O%$\VF^$/A0O@/3HM:71M=U8:/H!\2MXHA\*
MR)L?Q-*8_&'C^(MXTN4\&Q2R1D _7O\ X*2?\%,/C=^Q5IWBF;P1^R1XU\:>
M&M,MO#]C:?'?Q7>S67PDL?'&OR;X]$_L70Y$\1Z[X?30 ^[Q(_B?PC$GBYOL
M04QQF23XT^$?_!:']J/XZ_!.6T^"/[.OA[XW_M9_:=-\27G@OX::3XQO_A%X
M'^&+ZLJOKOCC6-:\10^(%\3F.,X\,0^*D\L>(/#OEA!))N_37_@L=_RC4_:L
M_P"Q'\,?^K*\#5\9?\&Y_A[0[?\ 82U[6XM*TVTUC4_CEX]L=4U:UAQJ6JZ;
MHND: ='&MZFN6DDMQJ^K;'Q@+<NJ,"6# 'QA\&/^"TW[8_P;_:[L_@G_ ,%
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M3O'?@76KE&T#QCXZ^+0D'BCPUKLFA:V?$RV7A)DMYH_#N@0+ \'BR>,>H?\
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MX(W ;RK=/!?@KP9\.3_\%#_VN/\ @EU^UJOP%^*?[14'[77[/.H:SX9\2?\
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MMN_!CX6?M._M"ZA=>'_B<WP?\8VGPS^#?B36?!7P@'AG7OB@/-\%:UX)\/\
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M1?$?CKXBZMK/B;Q)XJTS0OA?X@_X077&UOQ#XF\6^)ROBOX=?V&W@D;E!\%
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M(9(QX@F\7_#9->\*V_AHN!#-\0(YBD@C,;_=_P#P<$?\$_? .E^"S^VY\--
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MX_\ !*;]FKPU^Q2M[^VG^SOX;\+?&OXB6GCOPUX]\0?%K41%X@T'2SXUUU/
MVK^##KOB"?P]\/\ Q&?##Z-+%XH\(P>$/&#-$%DECW*Q^^O^"H7_  4/T_\
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MB'X=^+- UCP9XD*^+?&'C(GQGKGB<NJ-X3\'1+_8U\&OB?X<^-?PC^&/Q?\
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MZGXJUOQ[XT\/^'=;U/1/+T/Q3+)'X1\,ZYKOBR2&6V,%P=!MO"D4\$_B6#>
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M/$'Q(UR_;2/[ U75M6UTD3%O$]OH*/>>%_#"^$O!37-P?)\%QHGV>, _2/\
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M^J:'X&UKQ)"6T+1/$=MX;UXOK^B:,3'XG@GPP8-+'Y;H?RB_X->/^/']M?\
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M\<>*]49_)T6'P_X+6:.[UN=]> ^>*-5CV'$HD"@@'X#_ /!99_VF? W[)?\
MP3/^(.JZ=X\UFY^$UIX4\2?M!6NOZQJFIZ8WQ>T'P9\)IO#W_"U6CUV)M?\
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M'QZ_]:6^$U ']C6P>I_3_"OX9?\ @X5^'UA\)OV^_"WQ5\-ZGJ2^)_BC\.?
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M.?/^1#_8^_['#XR?^F;P!7]%?[+[Y_9J_9WXZ_ GX.'\_ V@KT_S^-?SJ?\
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M_9HUGX??\%%/A_X#\ :K\!/@[<^!?!5[^RK\,?$VH>$?"DO@SPTNA>'WU]V
MU\^'?#YAC3Q"<-.X4^64&\?*O_!<CPKX'_;1_9M^$_[:_P"S/?Z_\8_#/PE\
M1^)_ 7C'Q#X8M-WAS0/ <I9M>U@Z-KWAL^(=R>)1HR_\)+"S)&@3@(R9T_\
M@E;_ ,%M?@'X"^ /P_\ V;?VKM=\2^"O$'PLT?4?#?AKXJW6D2>(?!&H^!?#
MK^;X#T36I/#6@P>*?#_B#PMH"1>%IHG\)^,+>Z@\/2>+[GQLT-P[( 2?&_\
MX-]?VC_VDOBIXP^-/Q?_ &V/!7B[XC>.KW3+OQ)XB3X)+X;%[_PC^CZ'X<T0
M?V!X>\2CPV-N@>']%CQL."I &%)'IG_!Q!X;'@G]@#]E_P '37O]H3^%_C9X
M$\,BZ(VF_.B?!KX@Z$S$#&-YRW.&R3NPV17<_M8_\%==,^.-]X)_95_X)?\
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M7Q-HZ6'C&U_:<MO"%Y'K&D?V?XO76?C;X=\1:+'H(0AO$'F^&4;Q&=I)VR'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF=0@ /0O^"!7PJ\47/[$O@?Q[XCO?"1T"Z^(_CJ]\"6ND6NJ#Q,FEZ+KFO\
MA[6!XZ#R(?\ A(YO$PUY(L*RMX.7PTI((&?S>^*FMZ'X6_X.3/[9\2^)='\,
M:18_$_X7VK:QKUQHVGV%L=:_9@T#0M#*:OK@RSR>)!_PC"HB\DA5'05_7K\+
M_AUX2^$7PZ\#?"SP':2:=X+^'7A#PYX+\(VD]T]\]IX:\.Z3'HNAQ'4I-SRR
M+;0QH92Q<KEDC2-PH_#7_@L+_P $D?B9^W)XX\,?M ?!+QGHME\1O!OPVTGX
M?W?P\\2JNDZ9XI70?%FM^(M$UG0]>$C0:)XBC'CC72\OB%C;!M \,JO,<C4
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M/XA> 7^#OQ$_X*$?#F?X<ZWH^G^#?&-WX4^%#Z7\2=0\,1OL\1LGCH@>(?\
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MIZWN-<MQ\0+NVTK63X6L_#FL)Y?A=M7=6UO_ (2 ,OAR+?XA+0_\(Y 3-$9
MX'EK(1YW_P ' UY8:;_P4-_9 O;V^M].T^S^%G@.[OKV\O1IVG6>F+\9O'H)
M8@#YNQR,X]!@#[ _86_X(L?M5_L0?M!^$OB]X6_:J\!R^&!?:59?%+PAH_AK
MQ67\=^"X]66[U;15\]A&DX(CD@:0A(Y51F9"H8?>?_!3G_@E[X,_X*%:/X8U
M*'Q1!\-?BK\/M(U:U\->+VT32]1AU_3];:*)-%\93,!K[>'?#R2:Q+%!;[?W
MNOW+?O)#+M /T1N/BO\ #&RU7X?:'/\ $SP+;:U\7K+4=0^$VCW?BO2?M_Q/
MT_2-*CUO5M4\"Z8FK*WCNWAT+5M+\0W#>%()S'97"7T\JQ.NW*^/GP/^'G[2
MWPF\;? _XI:)%K7@7X@::MAK=H97LKZR>*4:QI.KZ0\;AX/$'AO7[?2/$%I<
MN D=S%&\B7 4VTOP=^Q+_P $V;_]GO4O /C_ /:)^.?C;]J#XL_##PUJ'A7X
M53>.-:U34_ _P.TS7<Z+K<?PFT+7':705\3>&=$\%^')PZHRQZ ?LZN7,D?Z
MS4 ?YQOP9\0?M2_";Q-\>/\ @F?X5L]0MM<_:"^*6E_!KQ?X+M/&6B::FG^)
MM"\9_P!A:[I']OY_X1?;XL\-$^&-W_"8@8SVS7^A!\)_AEX5^$'PT\!_"SP3
M9/IW@_X=>%-$\(^'+7<7O1I>@Z):Z/ =1EPJOJSB(M,XY:4R'"DE%_%[]G+X
M7:!^T!_P6#_:N_;#\*:I//X+_9\L-)_9_L@L>EJFM_$U?!J:#X]"1Q+.SZ%%
M$28O$(/^DO'L78C.8_WSH ***\:^,G@3Q'\3_ASXG\"^#OB9XL^#NJ>)+*33
M?^%@^!K?37\4Z&C/<KJ3Z ^KAH=)UMT+F#7&B9K=RDT>^58]P!_*7_P3]B_X
MZ#/VJ#_U4C]L?Z\^-=? X[]<_K[5^[G_  6.C!_X)J?M5^_@?PRI_#XE>!OQ
M/W:^./@1_P $'/!?[-7Q4T'XS?!_]KOX^>$_B#H*EK35?['^&VIQZA%(S+J^
MB:]H\GA:.'7]#G&T&WD=2"YR64!F^S_VR/V#/$W[9GAGPU\/O%W[67QG^'_@
M73/!EIX?\:^%?AYI_A72/#WQ8UEKA&UGQ;X[MQ:DZ\]P^F:,8O"S$>$O"TFZ
M>WMIVFF:, ^2?^#=#_E'SJ?_ &<'\3O_ $S>!*_-'_@Y7_Y.+_9/_P"R;>*/
M_4T:OV6_82_X)2Z)^P%\0-2\4?"S]H[XQ>(O#/BC3W@\9_#/Q%9>%V\%^+&0
MRIH&N21PP+)#XC\+(8BOB(3"YGC:\A,0_P"$CG#?+_Q=_P"#?KX?_''QK?\
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M>,=/T[0-#U&YU3POX@TCQ!I]MI6M:4NN:'K#2:-M5(_$^@NOB"V)VI/;LDD
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M5T1_%C>'_(:W;7O["B^R_:3'YHAY\PR!ICQG_#MW]@/_ *,T_9N_\,_X*_\
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MV\/QQ^)/$7B&!]<V)X60;9(@KQLX#E>D_8[_ ."ZG[*>@_"CPW\+?VI7\>_
M#XL_"#PEX:\">)H/$G@WQGXT?7=9T!=9\/ZHLB^%O#GB7Q3I&NQ?\(_HG_"<
M'QGX5\'O_P )AKRP992&C_H_K+.CZ5(.=-L/QLXL8Y_V5H _EBU;]GC]H#_@
MKU^WUX4^-'Q;^#OQ&^"_[%OP'O/"=YX=\._&WP=K_AK4_BYX5_MZ/7+C2_#^
M@:ZGAV0GXJ)HVBR>-$8.O@WP?LBFGC\=NWA)?(/^#@K]E[]HNZ^-/@?]IGPA
MH7Q!^(WP9T'P)]BNAI?A>37O#7P*7P,@DULZRFB!7\/^'O%2$>)I?$_BT?\
M"&QRK)&P!4Y_L0J&6&&XB,4RB6,@9#<AL=#E<9/TH _G'_9Y_P""I7[1W[=G
M[//_  KKX._L7?$'X@?&C7](U?X??%+XF7VI:5X,_9FT$R:2='U[61\4I)'7
M_A(QX?UW1/%2?"T*/&<4>O+%&%BC4#\<_P#@D=;_ +1?[)G_  4T\5?!SPO\
M!]3^)/C\Z-XH^"_Q(TFZ.M^"#X#^%X^)W@'7]<^-.M'7O#@8>'O^$=T/0O\
MA!SXK/@YO&9U_P +D'/B[P77]WUM:06L7DP0P6P/:W4*/Y GIWS0+2".3[1Y
M$ GQ\UP5 ;_'VZCV- '\D7_!;[_@E)\4_%7Q-U']KC]FCX?ZO\1HO&-UIUO\
M4OAIX \+ZQXB\;6?B-2F[QOH.B^',^)-=7Q491'XUC\,F.YVH69&"M*VQ^Q1
M_P %W_C'XJ^$EM\%O$7[//Q>_:<_:QTK1GL_!M]\+M'&J:?XYT_1(_+C\0?%
M%=$$GB#0'ASO\9>)O#7@B> R8=HF8 U_6C69#IMC9N9H+*V@F((+6MJ%)]OD
M4?GQ0!_";X7TC]O[4_\ @L-XG^,,7[(W_"6?M"?#WXB:9XF\=_"GP/J.DK\-
M? J>._A:S>!='\:_%GPZX^&WA]QX8#/_ ,)9XI<2>,_&:EU;(W#^W_X:ZGX^
MU3P%X5O_ (FZ!H/A7Q]>:/'<^+/#_A;5)-?\/Z%JQ+!]+TC5VBB;6(DQ_K=B
M%FWA5QY1?N5MX(GEF$4(FGV_:FSRPQCG()/XX!QD].+M !7\MOQK^*/[5O[(
M_P#P6(_: _:+\*?LM_M,_&3]F_QGX.^&>A>/+WX7?"WQGX@\.ZYI.@?!OP+$
MFMZ+K0\,Q^&M:G\(^(X]<66,^+8S#.DL113&5']25% '\>O[:?[8O_#ZCX1^
M&/V=OV-OV5/C_KOQ!\&_%WPOXSUSQ9XA\->#[#P/X4TT>#/'S'1M;\=2>)IM
M!\ CQ8Y?R(?%LWA'_A+UT0Q+N C"_J/^T3H7C;]C[_@E7)^R/\//AC\7OVA?
MBYK_ .SIJ'P5T/1_AY\(/B;XTTWS/'I'ACQUK/B#7O ?A_Q?X6T!O"^A>-M:
M\20KXH\61-XR?P\R*TAF<']M8;*QLABTL[>V[?Z/:HO_ *+5?Y\U>H _DU_X
M(1ZS^T;^RKJ_CSX ?&W]C3]J/P9X9^,'BO3O%.B?%;4_@1\7-,\.:'XG&BKH
MK:+XS>Y\-B'P]H.V,F+Q5-)';^9M,[*B[X^>_P""[-[\;?VOO%_P[^%/P/\
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MQEOZW[:S@L[6*RL88;6VM;86MK!;J +0!=H5>0 J@+V!R,G.2:T:* /YRO\
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M*=)D6;:Z$)-_PC_B6+SO#7B^*$NSV>LRCRY9DB4_HA10!_*;^QQXN_X*/_\
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M!D6HVWAGP=I"Z+I?]JZF=2U5XHP@;4-7U=XC)<:PQ:0O.2=S2,%PF%B]3HH
M*_DU_P""S/PFU[]ES]MO]G'_ (*.>"/A=JGB+P3H?B/P-K/Q3UBTNBOAX>._
M ^M%=#TC7(=(A!\.+XIT#>D/B>1)D;Q>D<C/)O91_657%>-_!/A;XB^%/$'@
M?QSX?TSQ;X.\4:1J&C>)/#NNV:7VFZYI6KJR3:7,K-M,+C$9P'VKY90JX21
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MUS\-])_X2#_A)0<#61,/B&$4X&0@&X#! QDC^EZB@#\V-;_9"_:*\1_LO?\
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M$DU759=ZR:UKGB&2.:>YUZ<--)*7 ^3,+ 'ME%%% 'YO_P#!0[_@G?\ #?\
MX*%?#CPWX.\7^*=6\!>(/!WB/^W_  YXU\/:7I>K:A9AE1-6T?4]'GD$.M12
MI'Q )8T23. 6=Y7\(_8S_P""0G@+]D?4=0\7CXV?$_XI?$ZT\,>*/!_PX\5^
M()&TWPW\-](U_1]$\/VZ^'_!+>(?%=L/$OAS^PH6C\327*L1(Z.@"%S^R]%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)NK,ZG9_#IO%NACQQ=:<L(U)M67P6;A?$H@";I0_V8P&+=*)"2,^FT %%%%
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MQ(OO$/BSP_K;1W'PNUKPYH>@3/X8\.KH;:5XBF\13-]H\8-KAMO!&X>"_&-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH)\9O^"?W@SX0^)OA7\*=*\:Z5\1/$/B31/$OCGQ =4&@^ ]3\/R>#->\/\
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M3>HWMAI5C/?:G>VVGV%LF;JZNKL:?8VJJ!R9&954'(QN;#'H1P* -BBOQ_\
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M_"OQ)XWM_B!=Z5JE];:3XU\":QX::\_L1U&NZ4&FDV+KL"EI7BYR 2FYL1R
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MS.\.T1I S]GO_@N'X=UCXS>&/V9?VM_@5XV_9Y^-VJZQX4\&788'4_#:^/\
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MK+2=0UG6/$MZVF_#3P##JX$JGQ)/I!:4^5H :;<S1!,A74[69_S>^*W[7_\
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MS%YS&BE #^B^BOY'/%?_  5=_P""@7_!//\ :LOO@Q^W3%X1^,7@6[O]-O\
M1_$GACP?H/@S4=0^&0EUTS^-/!*Z"OA:W>1FC:&7PUXM1ID&A2B.6*1F:OZ0
M?BW^TW\-?A!^S3K'[4'B35;:U\"V_P /%^(FD-JUU'X;U#7O[;T6/7?!/A*$
M.)_+\0>*'DTCP];QR&1A</E\IN  /J*BOYR?@+\=_P#@JU_P42NM=^.O[/\
M\4?A[^R/^S)J4>IZ/\-],\4?#WPA\6?$FH:IHTD4$KZW)K_AI-?$K-+YO_"0
M)(?"LH#_ &:"9\*WSUKW_!2G_@H+^P!^USI?P<_;ZU3PI\1O@OXGU?2[2R^)
MVF?#C1- L#X#.KA&\8^"Y? @\,EO$,BC;-X9\5L[>$#ER[EBS ']7=%?'O[0
M'QG^(.F?LS:Q\;?V5= \$?&G5U\,0^,/"D6K^*6TWP9J7A;^RI=:U/7&ET,^
M?KNW0P\EKH$+QW$URJ,DBO$5?^:S]A?_ (+;_MV_%GXQ^*/@[XA^%>F_M">.
M?B/::I9_!_P]I.D:1X*'PT\3Y4N/&^M^'_#H"_#OPHH9?&S>*L>-(SH;LHY;
M< ?V*T5_&E^U!^V-_P %KOV!OB/\._BC^TEXI\)ZWX0\37ZZ+:^'?#^B^$-0
M^&>N:9_;"Z]K?@W6#H'AI?\ A'_$&  OBV'_ (K$>#E8*PD23']1W[/_ .TI
MX$^/_P"S7X(_:4\,S*?"'BCP#)XSO[.RN!JE]X6U'2-+E/C/PA,0(0?$GA/7
MX==\,W,2!4:;1W5?D9<@'T_17\U'P"_;3_;A_P""I'QE_:%O_P!C3XY>"/V7
M?@S\$#X"T/1-,\;_  <T7XD^*?'1\<_\+!5/&>MMKP,GAXA?!LP_X1@9"HWA
MXR, SEMWX,?'?_@I[\)/^"G7P2_9)_:R^*7ACX@_"#XG:1\4==T3Q!X<^%G@
MGPWIOCRR\$_#'7_$ .AC0= A\2Z _ACQ+I&AEPTJ><)&5F(E.X _HZHK\OO^
M"BW[>&J_LGZ'X ^'?P=T/1_B/^U1\:_$FE:)\(OA-JUEK.H'Q#IS:RND:WK+
M#04\W;$) $&]1N:19$&T5\$?$+]D/_@M9<:?H?Q]M_V\].U'XJ^!/!&EW%E\
M"/"OAL>&/ >L:LI.KZWHNN:'HC)\,?'_ (@>76]:MXO$_B;P<S2/HGA7RT,9
M:10#^CBBOYK?^"7G_!8#XP_M$?$WQ;^RU^TSX9\)Q_'CP[X.\5WW@35[2\3P
M1J7Q)\>^"-79->^&^N:$T;>&-!\31QM(D:^%F^SC_A!_%4LL4Q2)1\%_\%+_
M /@HK_P5M_9[^+^B^%_B')X/_9^T;6SX;\9^#-(^&MEHOB?PMKK>"-8;69/^
M*V\0C_A)/$#!#H\/CCPR1_PAP1Y8P=LDJN ?VC45_,=\8/%'_!93]O+X.ZE\
M5O@K_9G[(OPEN;-?$WP[\$Z/XL;P9\7?'/AE-9UV>/5_$/CT(?$7AV9/#3Z#
M/'%X7<>$/&:2+*BA) S=E_P0P_X*)_&7]J*Y^+'P(_:5\=:=K_Q"^&&D^%=:
M^'5UJUK)IWQ'\1>%AYNA>-X]<B#!=;3PK<Z1H%Q<>*?$PB\:W)\= 7#2+T /
MTV_X*1?MF>'?V'/V8O%OQ;O6F/B[6Y_^%>_">RLM+;41>?$W6]%\1S^'SK$?
ME[/[#\.KI&K>);LL0&MM$FC7A\M]5_!3XH>&_C9\(OAQ\6?"%]_:/ACXB^#M
M&\5:/JK6KV!OHM8TY91(VEN-P.=Q\HE@-N$)52:_BH_X+S_"7]I[X>?%WX4^
M*/VB?V@]-^-6F^.[7XH_\*J\/Z3X<3P5IGPX\,:)K/A]_P"RO[%5W\--XB<Z
M]H;'Q7)B1VT NP.X,W]1G[(GP@_;U\(ZQI7B']I']KOPG\6?AY_PB&DKHWP]
M\%_!3P?X'4:FVDHIDUG7E\/+XG*+\LC1QR(SD!&VNPH _2FN;UG7-(\.:5J&
MNZUJ=CH^D:+9ZCJ^K:KJ-RMAI]CIFD+OUC5-1ES'"L5NBO*[28C5<.S 9QN5
M^,__  6C_9T_:,_:'_98U33/@W\6-.\&>"O ^D>+/'WQ;^'=T'L6^+.E^&_[
M"U_0])FU_+-'X>\*0Z+XR\27'AAHXHO&-W_PC2;_ #/#D"2 '3?\$R/V\?%7
M[='CO]L[4;J331\,_A=\4O"VA_".VL[32OMQ\,:YH^ONS:QJVB320ZX[2Z("
MC.9'52$WLJC'Z]5_$[_P06^&_P"UIX\L?C3<?L^?M(:!\#/!&E?$'X8?\+>T
MFY^%_A#XB>(/%6FF'Q(5;PEK>O>'@-"UP^'AK48#QSA9I(G$6Y=Z?U$_MP?M
MK?"W]A+X)W'Q3^)=Q/J5[=,VB>!_"EJ2=6\<>*?*^31K?Y=JLV]7=B3C)4 [
MLJ ?;-%?S;_LZ_LL_MX?MS>!=5_:X^-/[='[2/[.5U\>-%'C3X8?!/X*>+]:
M\%>$_ >BAM;T/P9YVE*DT<'A_P 4>%],\$^+(H/#QM_&DXU]SXYQXU2:>+X]
MTO\ X*(?M^?\$MOVE/A_\!?V\?&1^.OP5OO#LEZVKC^QO$GCO_A%M?\ &FNQ
MZ3\1_P#A-Y%/BK6?$7A1_#P$_A'Q3XO\5NOA+7&:0+/_ ,(>: /["J*YOPYX
MATKQ7H>C>)]$G74-)UW2]-UC2;L #S-/UB-)HF'H/+VNP[8V9(7-;E 'Y<_\
M%6_VZ3^PS^S#=>+O"VK:./C)X[UK_A%OA5IFJ2:/J#/JJ8UWQ#KIT;6&B76]
M#\*Z$"L\21J$EUKP^&&)ES]P>#(;+XS? KPBWQ#T[2M>L?BC\)M&/CK2+FT4
MZ5X@TSQQX.B?Q#HSIA6_L2==:EA.P\PD#*L23_%K_P %YOV:/C?\+_CIX;^/
MGQG^-47Q57XYZUX[T+X:^'[?1M4TQ/A1X"\"ZSH!T#P9'Y<CDH8_',;C_A%5
M3'C)_$OC8XE\5RQQ?TT?L"?LC>*O@9H?@SXI:Y^UI^U%\:K'QA\$/#5A;?#3
MXO\ CW_A(_AWX5.N)X#\00:KX:T%TC.B2^&(]'F\-0O$7C3PEK4T&2PD8 '\
MD?\ P6:^#7PL^!/_  4 U[X=?![P1X;^'/@BV\'?"^^LO"GA.S&FZ:VIZ[HI
M&N-P=HWJ Q  QG&%/ _T+*_@R_X+J>*_$7@K_@J+JGC/P;K6J^&?&'AKP;\&
M]>\.:_H5U_96KZ!JNC:,9-$UG1]:Z*^XG>N.#D5^LWQ]_9J_X+"?M&_#0_M.
M7G[4,W[+?BBU^' UNU_94^%'B/XB^#--\/?V3!+K9T_Q'X@T3Q,KR^)+H(?$
M+R>*/-F\(O*/ SJ8O.DC /Z9Z*_ 3_@A5^W=\9?VR/A7\6_!7QTUW4_&OQ ^
M!6M> /L?CF[M-$T]M7\#>-M'U_0]$T;51H0)UGQ#H&M?"WQ-KEWXP\2!KGQB
MOB2"2, 1R2IS7_!07]N;XM^.?VI?AO\ \$[?V+?C3X4^&'Q%\9CQ1HOQY^*^
MKLU@/AIIG_"':[*='T;7=?.W1_$O]A+KOBJWD\)Q0^,[?Q;H/A:&V\7VBM-'
M( ?T045_,K^T/_P3_P#BE\)_A%\8OBU^SO\ \%0OVKO%?QO316\3W&AZI\>Y
M7?XEZAX)TCY=#)T+68O$FN^(Y/#</_"->#HTG<Q,L*L'#Q2'TK_@B)_P4T\4
M?M8^%]5_9\^.^L1ZS\:?A5H&DWWAOQS>7)G\1?%/P%*!!)-K<;$C6_$GA*$Z
M(GC7QBN(O%7_  D?AR>X \8M>[P#^B"BBO OVAOA%JWQS^%?B+X::+\6OBE\
M$;[7[K1+BU^)'P=\11^&?'6@_P!EZW;ZS*-&UHMF./Q!#&VASH5*^3.[ 'R_
MF /Y??VBOB;X=^*7_!P5\*O!OB3X@:IXQ\ ?#CQS\-/!G@[0/#=[H?B7P[X=
M\=G1=".M^#-:$@>+P^Z?$7^VSXV5E;Q<&&T)Y8"5_1)^US^PE^S?^VWH?AG1
MOC]X/GUJ;P=?&]\/:[X>OV\/>)M-4EAJ^E1ZT(A(=!GR@DM\A<C,9$@<S?Q
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M1=9&A-K.L:U''-X<UR#Q6P'_  A/A7Q1#+X/V!I62><N9 #^NRBOYI/VJO\
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M\9\@C(8']H/XM$@\C &!TYR>G)K\J_\ @O'_ ,$[O@%\/OA%XE_;#^'6G_\
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M@W1/$>L:-X)UOQ"GBB7PVQDUZ2"W\2[I/%B1PJP>-VD%?RI_L]_"OQS\&?\
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MC:5HRO-JVJZIK,\IM])TB"* 2O([ +&#+DX9!V=?S;_\%YOA5^VU\>9O@O\
M";]GCX?_ !+\?_!74K'4?$7Q6TKP+I0DT^\\3:'K D\/Q:[(0'"[2)50@*0=
MX!W;B ?L!_P\-_8)_P"CTOV7?_#\?#/_ .:2OJ+1-?TCQ3H^D>(-!U6PUCP]
MK6F6&K:3JFEW*:CINKZ;K*)+H^IZ7JL;!)8YX2LL<D>\,LR.I&8Y&_$#]O\
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M3XV\1><NA^#?#NK>)M7^RVC7^HC2=#TF36M9(09WL(HF?:" Q3J@(9/Y&/\
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M/OV/-=_;&_9YL?#G@32/#=_\4O GC_PK\0? 4^O7?V!\:'JL(U_1M(U]=_\
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MQ)HYVS:'KI4,9(F9B7+!6;[U?3U !1110 4444 %%%% !1110 4444 %%%%
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M^+9?"OB'6[**?PC-=,UG^3__  =#=/V'OI^U!_+X"U^W_P#P2=_Y1T?LE?\
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M\*>)]9T=-9UOP?/JZK%%K<WAB\DET-IX(ECF6"29 B81/1J** /R0_X*-?\
M!*CX1?\ !0;3-,U=M8_X5!\9_#\MI9Z-\6M-\,Q>(I-5\-MY4G]C^,M"%YX5
M?Q#' PN4\*-)XGB?PG/)'<P^=$TGA:X_DD\7?"[_ (*'?\$:_C'_ ,)+I&H:
MAX,OM4TG3EO?B'X&M!XW^#_BS3M9=D?0]=_X2#PW_P (P'C="CKXMQXU5U*^
M \,N!_5#\$/^"B;^/?\ @J]^T'^QYJWB6_T[P3H'A)-(^'/A?7O#:KJ>H?$_
MP(2WCE?#VMZ&DZMX?F\.C6O$+?\ "6&-O+T5WB=)!&I_5WXG?"SX?_&;P1K_
M ,.?BGX6T7QMX'\36@LM9\.:_:!M-U $8^8'YN>H(RP(&"5W*0#\H?\ @FA_
MP5]^&?[><UY\._&FA6'PC^/>G:?IEX_A(ZZ=0\._$C38M%C_ +6UWP(9'RI'
MB"/6V_X1F.?Q4(?"G_",W*^-?&!N))8/FO\ X+S_ +2'C_3= ^ _[$GPI\:V
M'@KQ-^U5XS;1O'7BZ_\ &6C>'=*L/ /]NZ/H<7@[QH@T2Z\1>&_A_P"*M>\2
MZ-XA\=^+XC$9?!/P^\3^!%B\6VOBSQ7!%^.7[0_[.,_[%/\ P62^%O@/]E'5
M1<6^J_$;X7>-O"'A3X>WO_";>-_AKI?CH?V#X[\&:WH?_".,- \0?\(X-=\4
MCPOD@_!;7_#!#$'=7K'_  <D?"W6O#O[67PI^+=Y?:=<^'OB?\(3X8T>UM03
MJ5EJGPJUK?KC:RW(>-AXZT)E96( )3Y64JH!_5!^S%^Q9^SY^S+^S[:_ #P-
MX'TJ]\):YH36_CJ[\16&E^([[XFZGK>G1QZQJWCB9K>:TUUKM-RR1<^'8XI"
M+=%8L5_GY_9)_P""8O[8/[+O_!6#5_&_PP\":?\ #W]EFP^(/CZ^L/%D7B+2
MM=T&_P#@/KNL#7-#^&FC1>(E\3^+HO$B^'I- \+N-D3H=#\3?\5NA*"OZ)?V
M.?VDOAQ^UA^SO\._C%\+)=6;PQJFDG1I[77=,72]4T/Q'X?A.C:SHVKQ';#]
MHAND3:="WVYW!A,HF:W3%^-O[4&F_"SXZ?LZ_ #1_"VK>/?'7QW\3:H+O1_#
M]["Q^&_PU\/YDUSXI>,-%1?^$B'AA)670(+EE'ADW:GSI8U@$3 '\_G_  =#
M=/V'OI^U!_+X"U^GO_!.C]@[X6^'OV6OACXR_:*^&4/QE^._Q#\'>&]:\?:]
M^T8FC_&KQ5H>V&1M"\%>'YO$K^*K;P[H/A;P\T:Q>&/#4B6^\2*[EP/*_,+_
M (.ANG[#WT_:@_E\!:_?+_@GIX[NOBG^Q3^S9X^U#^T3-XA^%NB2)_;FK#Q%
MJJ>4AT?$VM_V#X7:>1VMRH=;2%O*985:0H74 _F=_P""4FC7/[-W_!9WX\?L
MR?#;Q'KZ?#"VUKXX^ +NUU\:-J.KZWI7PFFUQO S:YK1\.*-Z*I;9X6'A%"5
MVO#.A:&3ZS_X.&?VLK[PWI?P?_8S\.6_B2;_ (68=,^*/Q23P\NK:5J>N> 3
MK.N^'O#O@K1-<AGN;9_^$JUOP]XQ3QKX9\2^$?&$;!?#+!5:1U'SG^P]_P K
M$O[0_P#V4C]K+_T+7JXK_@Y$@\8^&_VS/V>_B/I5CK.FV%M\#?#5EX=\7KI(
M;2Y/%7A[XG>/=9;2-$UL<)XD\)'6=#\2R(,;7UWPUP222 >R_";_ (*7VGP:
M^!FE?LY>#_\ @C%\5+GX1Z;9H+GPIXKU?6/$FE>*+]78G5_&J>(?V<&3Q#XB
ME\0:+MF=PY>18Y#@0011?/?[%'[#O_!17X)_MU_#'XS?#7]G?XK? [X'^*?C
M!X6;QS8ZUX]^&OB(6/P-UGQMX>E\::/XW?PZ/";ZZ\>@)K4D<L?@XR1.BR1X
M= :_JG_8Q_:8^%'[2WP*^&_BOP)\5/#?Q-\00>!/ O\ PL,Z1K!D\1:#XL71
M/)UA/&>A2,?$?AR:;Q!I6M!+?Q/'')-)', TB?>\V_:/_;PT#X)_M"?LW?LR
M>#/#EE\5?C!\=OB3X:T+Q5X*TC4-=;Q!\-?A7JQD77/BQKT6A^%O$JP>'_#1
M+-(GBB3PE$T(0QW3(V^@#^?7_@IU\?;[]O'_ (*0_"G_ ()]^$?'>J^&_@WX
M7^(GACX9^,ULQ_;.@:_\34UN23QQJVN:'&OA'Q.S^$][>&!!%XP:))-$?QI;
M[HPF?ZC-$_9A_9^\.?"'5O@)HGP@\#Z/\'-;TM-)U[P#I_AR&PT;Q"AT?1=$
M?4==\I8FU[Q"UKH>B#_A*+X-XI231K21+J2[C25/XGOC[>P?L5?\%O\ 7/B+
M\4I(-3T#3/VI!\<[R/PF(@\'AGXK:P?'.B1A=>;PO /$D/A[QN4\;['FARF$
M>6/#-_>-HVN:1XDTG3M;T34[#6-%UFRT_5]+U33;M=2T^_TW6A_Q*-4TK4US
M%+'-$1)&\>]2K!HR%9"X!_$7^PG\#K3]FK_@OKX6^"&C:H=<TGX=^/?CI8Z-
M=&Q;3"ND/^S-\6]<T71RI\3>*6 1->9CDHXV_=+ *?N[_@YE\-> I/ W[-7C
M$V^F_P#"S/\ A+/$GAE+O^U6_M/_ (08Z3/KCAM'+#.@CQ"D>_Q'Y,9@<$-)
M+O41^+_"W_E9QO\ _LI/QD_]9)\?UZ1_P<U:3>'3/V:O$"_#33_L"77B71O^
M%OGQ'LU)=2<,R_#1= 8"14?)\2CQ0Q*HT3Q+@QOD _H3_8#_ .3%OV+_ /LT
MO]G/_P!4QX&K^83]GWX@^.?"_P#P<1>,;#2/!5K\#X?B/XV\>?#[QUX!LSHV
MH#4_ G_"KO[?5]T7AV/;_P )=XE\#^!OBEE'3']O_*RC!K^GK]@?_DQ7]C'_
M +-,_9S_ /5->!J_ED^!WQDO_'7_  <0ZQXHT#5M)AL/&WQ-\>?#W6_["?6+
M^RN],\#_  3U_0&T623QKH'@[Q*DJ>)/!&B;GM/"J*K@M!+XP\!;7 !_5!^W
MY_R8O^VA_P!FF_M&_P#JFO&]?BG_ ,&R7_)N?[1O_9;M._\ 4&T2OVG_ &^?
M^3%OVU?^S2OVC/\ U3?CBOQ8_P"#9+_DW/\ :-_[+=IW_J#:)0!XA_P4'^,G
MQD^-_P#P5]^'GP2\&?L[+^TOX6_8P\/6'BF[^!%UJ?@Z#2_B/>^-_!>@>.O&
M?C,ZWXDT";_A'S'!XU\">&'\-,?%ZNW@%I/(@'C'R4^]?&O[4'[9_P 2/ASK
M/P@\:_\ !$[7O$GPV\1^&SX=U3P9>?M(_#4^%GTR17BMM'>*/X?(NBH(]BD*
M4_X1,Q1LK(T:;?P>_;)^)_Q$_8/_ ."V7C+X\>-9O''Q"M;#QYX<^(-A?7%I
M#X*;Q[\+O$'@[0@OA3P\T;2Q>(O#GPM!_P"%;Q%B6*>!%,L:2>9&O]IOP/\
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MC9?^)]2TOQSJFO>/ -8;P[XE'AIM=3Q!K_\ PC1^SD1I*KNQ619J^4_VR?\
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M6MWXPU0Z7ITFC^$AY>M:V)=;D9FTKP^HT:/Q!<-+,MO&=&,UPR-'&Z_Q/?\
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M4ZT?#">+!_PARNNO[OA_XY\'KXN\9^##^X?[$_\ P5<_9 _;X^+GP=LOB?\
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M!KP[X6_:N^'?Q0\9_%OPNZZ+>^-_AKI/A#4]*\=Z0<#1-<UH:]XF\)+H'B1
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MK)JWCCP3XH\'>*?!.I7_ (WUW0=;ATG1_$&@>(P7E\,QZ"LLH*_*[LF7V[W
M/[FXO]4G^Z*_CK_X))_\IPOVTO\ KZ_:U_\ 6@O#]?TS>$_VQ_V5O%OP=3XZ
MZ%^T-\*;WX4K;:,+SQOJ'C'1=-T[1+_5M&CU;1]'U^+6;B#7?#WB.XBS.GA/
MQ/##XM1GR]F)%\MOY(/^"6_[3?P"\%?\%=?V@OC%XO\ B;X<\)?#'XR7?[1U
MEX"\;^*_[7\-^&[\^.OB;H'CS0?[;USQ%E/#[?\ ".:'P?%P\'KG&X%>* /J
M'_@Z _Y&O]C;_L6?CO\ ^GKX0U_5[X(_Y%'P;_V+'AG_ -,R5_+W_P '+GP^
MOO$GPU_9/^/FE:UX<U'P-X>\3^*_AV#;79U+5-1U/XK:-H'CS0=:T0M))X;D
M\/KX<^%6N))+(V99=<\.2K^[="?T1_8O_P""K?PO_:U\2_L]?!CX8^#_ !-X
MA\;:_P#"Z_\ %7[0=QI>C^,1X&^ VJ>'_"(DBT/6=<U[PSX1_P"$@?Q+XG*>
M&[>2&-?"ZO%'Y<SRA<@'[/5X)^U5_P FP?M(_P#9!OC%_P"JUU^OH.O /VE=
M-OM2_9U^/FAZ-I]WJ.K:M\%OB?IFD:=IEL-0U34-3UCP9KT$.DZ7I1"F::XD
M:)(H<YD,F I*,0 ?SN_\&P?_ "3_ /; _P"QO^#G_ID\?5X1_P '*'B>_MOV
M@_V6-$OM4U&X\'VGP[UCQ+>>'1>$Z6-7C\;&*75QHK;6?7UT%71&*(2@4;0.
MOFO_  0Z_;>^ ?[&?A+]IOP?\9]5\6P?%#QUXG^'_P#PJWX1^%?AYXT\8>-_
MB;XFT+3?&VBMX0T*7PUX8?P\/$_B7Q%J^B^&X(_%?_"&PS^-=>:"8HLBS0_>
M_P#P6?\ V(_CM^UU^SM\%?VG_#GPKU;1OCO\+_ 1'Q/^"ND^)=.\6ZMH/A?6
MT'B#7M#\(S>'X2GCOQ)X0\0;%C?PW</-<##>!7:9B7 /Z#?@MXJ\$>/?A#\+
M/'/PXTAM!\ >+_AWX&\3> ] ;2;'P^_A[P3X@\*Z'KWAW18=!TD20Z$L.@3Z
M4K>'87V6BHMJB+!"JI_.K_P<U?"<:O\ !?\ 9H^-8UO[/!X"^*GBOX4-H TD
M'[</BWX-'B$:T^LD^9&?##?!*38I4C&MOEAA0W:_\$9/^"J7P0UG]F'P3^S]
M^TC\:/"7PX^+7PD75/#'AVZ^(FKR>'M*\7_"O0?[!'@K5_\ A-=;\->%/AIH
MC>%H]>;X71>$CXKF\8B7P &\IWP&XW_@HI/J?_!7G]H/X._L9?L@^-'\4_"/
MX+WFH_$S]J#XQ:1'I.J_ [P=J>O-HFB> DTGQO#)=1^/?B)%X;E\=CPAX=\)
MS- 9-?>5IBOA/QDW@T _8'_@E5_RCM_8^_[(GX8_] >OORO/OA-\,?"OP:^&
MO@GX6>"+*#3/"_@3PYI7AK1+2 8$>G:/&L2( .N27)ZX:1AGD8])H _D^_X.
M@?\ D _L7_\ 89^.W_H/PBK^EG]GK_D@/P0_[(_\,/\ U"] K^;W_@YU\/Z_
M=^#?V1?$=IH.IW/A_0_$?QCL]8\26VFL^FZ'JFO:9\+/[!T/6]5)*Q1^*4T3
M62C!LR#0F1@/(!;[4_8F_P""I?A?]H/4_@I\*/@U\)?$]]\)OA?\")-<_:T^
M._CBZTOX=>"_V>_^$&\$R1Z%H[/KL<GAWQ&_BWQ!H<+IY'BI)8/!NM_\)DDL
ML'A+QJOA  _"K_@M+#\.I_\ @K?:0?%V;Q7:_##^Q?@-_P )[=^!/['_ .$V
M_P"$7&B#^W?[ /B$#PP=?_NY'W<<5_:]\6?^23?%7_LGGCK_ -,6MU_ Q_P6
M?^,WPL^-G_!0GQIXX^$OC71/'?A#2O#'@'PQ>>*/#H74/#-YJFA:(/[=30];
MC9DU_:/E/BCP@\B+C"R.H#G^S/XP_MJ_LJV/[*6K_'6?X\> K;X7_$SX6^*=
M0^'6O7>JS/?>+@VCS2-HNA>#IX/^$IUWQ%;K>PIXN\+Q^&I/%GA'9=0>-+"T
M^SS"W /PN_X-=?O_ +<'^]^SA_/X]5^8O[,O@GP]^U;_ ,%B)_!W[9VEKXJT
MCXB?%7XPV7CW2?%MQK?P[&O:AH'@WQX?!&A+'X<;P:=S:_H7@E(R"1XQ=E<Q
MRA2C^Y?\&_7[9/PJ_9J^-WQB^&WQA\0^%/ /ASXZ>&/#-]HGQ$\4:O\ \(WX
M>TSQ/\*O[>&AZ/K*^5/X8T,^*?#GC?6IE\2>+?%7A4/+X;B*PR2>*XP/2_\
M@LO^P]\>/A-^T[9_M_\ [-^A^)_%O@7Q-J>C_%W4/B%X*CD\9ZE\-/'W@;/C
MEO&FM:+H7AV4:%\/!X?T ^*&\4">?P:BZ#&WQ D998Y) #]]/^')?_!+[_HU
M>P_\.I\>?_GE5W_[/_[!7[ ?[*GQE37_ (%_##PI\.?C3<^#]1L;&R_X6EXX
M\0:_?>!]8D4ZLT7@[Q)\0O$D;Z/+<:/ C^(/^$= 1HC&D@D2<M_/3\./^#ES
MX[Z1X2L-#\?_ +-O@'XC^.#_ &H#XL\.^,=9\$:9?#.=# \$?\(WXN(#C )7
MQB,\8PWS5^M7_!+7X&_'GXA>-_B#_P %%_VR=(C\/_M"?&G1](\"^%/AY?>$
M/%O@B_\ A-X!\"F3P.T<6A^)+A)] _X6FVA1>+)O#7D-:?9SX<\8Q2-/XLDC
M@ /W(HHKPOX[_'CX3_LR_#77?C)\;/%A\$_#?PQ=:/9Z_P")!HNN^)#9/KVL
M0:'HTCZ3X;T3Q)X@F677-5BMT\FUD$,OSL!&9(B ?Q)>"?\ E8!U#_M(3X\_
M]69K]?WLU_G9^%OVC_@SIO\ P6"N?VIKSQHEK\##^V3XI^+2^.CX8\:&,>!]
M=\9:_KHUT^'_ /A'QXJ*CP]\Q3_A%0Q'RB7.'K^SV#_@J7^PE=? 6_\ VFH/
MCR6^"FF_%3_A2MYX[/PK^,6Q/B<=!76_[&_X1[_A7(\5F,:&WVC_ (27_A&F
M\)%58B\+!86 /Y_OAO\ \K.6H?\ 92/BA_ZR3X^K^C__ (*.?\F"?MD_]FX?
M&3_U"M>K^.3P9^WI\"](_P""U+?MR:F_BVU^!=U\4O% 6^;1\>)K#PUKGP6U
M_P"$R^-GT)0 ?#F=;'BEE"_\)DW@K*E3X[/_  A1_I _X*2?\%!OV/8_V(/B
M%HEQ\6D;5OVL/V6OB;??L]6:^!/B4&\<V6NZ#<:#HTK+_P (PA\.[]=E@5?^
M$MD\*G:V"JD-*P!^4/\ P;%_\E*_:Y_[$7X6_P#I\\?5^A/_  <C?\F%>!_^
MSF_ ?_JLOB]7XR?\$$OVO_V=?V4OB;\>1\?/'P\ /\4-'^&'AGP"6\&^,O$R
MZWJW]LZ^1HY'P_\ #WBHZ!SKFA@#Q5(A^;[RC+#[?_X.'?VSO@3XH^&6B?L;
M>$_$.J^(?C7X$^-7ASQO\1=,M- U>STCP3I.E?#;7I?#VD:SKVNA%U_Q!XIC
M^*6@F-/"">,8HX]&\3Q>.'\'H@) /VK_ ."3'_*.#]D;_LEJ_P#I\UVOP"_;
M&_Y6,/@1_P!E)_9?_P#3-X?K]%O^"0?_  4$_9CUG]B;P]\*KCQ;J?AKQO\
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M?CF+Q3X,MP#\Q/\ @V9UKXC)\1OVG/#UAX;TVY^#^H^$/ VM>)_%N0NJZ?\
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M_$@>)O\ A%A\+_\ A4>?[:3PRL8\1_\ ".#_ (2C:L83L$"@>,P ?UT_M:_
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M>*/^RE?'/_UF?QY7Z@_\$[?B'_P4#_::\7>"?%WQQ^&/C3]E7X"_ +X2:?\
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MG?L\W.O_ +;>L>+OVM?VD-+\#>*-9U7XA^.?BK\8=4LO 6HG0I=;B\&^ _\
MBK4_XICPQ=%+?S?%:2R>,+B%O&/V7PDETWA:P^)O^#7G_CY_;?\ ^O3]G#_T
M9\>Z]Q^%FF?\%DO^"DGPN\8>"OV@'\,_L9?!OQ/X=U%+?Q%9?#?6/#/Q>\4Z
MF=7U[1#X+?P5X@^(Y\3Z#H(AC1O&OB+Q3X.\(3,# ? B>+H&\]/EW_@D?^Q;
M_P %*O@;\7?C#X/T?2;7X%_ [7/B1I?ASXO_ !A\6^&B?$WBT_ ?6@^@Z/\
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MZ6A=(KKQ7XEFUCQ-<>7)*%N-:G6$M%AS]%4 ?R=_\%,?^"GO[1GQ)_:LL/\
M@G7^R%K<?P?U35_B7IOP-\7_ !,U;R;+Q%XH\=>.IO\ A"8M"\/>(%M?$K>
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M:\[PI"T.T Q?^#<[_E'SK'_9PWQ+_P#40^']?FQ_P<T_\ES_ &4/^R;>._\
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M>&9A++K<6D^.- 'BSQ1J\T>M)%<>$DF\'K';>>BF>52LS@'[T?MB_MC?#/\
M8V^!/B_XX>,-0T[Q%=:9H*:GX2\ :7XATJQU_P").I:MK'A[PWHL6@K+*Q&@
M'7O$&A?\);XJCB\20>#/"8EU)H+A2;>;U#]F#XD^,_C)^SO\&_BG\1O#<'A+
MQO\ $7X;^&O&?BSPK9V&K:?9:%JFOZ1%/)I(TKQ"3X@BBBW[$BN8U>1HR0S
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MVP%RR+7K5% '\97_  3N_:F_;._X);_"+XB^'?VE?V)OVA-2_9RL[T^,]/\
M$3> M8\.:IX"\5Z[JVAZ!_Q.M<\0$>&3X?\ %:-H^"I5QXP,@#!'?=]0_ 7]
MF/XV?MX?\%.[']N_XV_L[^,?V<O@O\*#X%\2>#O#OQ M-6\+^+/%7B7P:\NO
M> =7C\A8?[<6'7QHOB3Q>RC_ (1)U@50\]T2TG]2.P>I_3_"C8/4_I_A0!_/
M-_P5S_X)"^)OVT?%5A\??@%JWA/0_BKI'A Z+XO\+:Q9K8#XFKH9+:$W]O(S
M :_L*>'0WBM8X8X=&A08VLJ_BY\$?V@O^"SO[&5V/V*OAO\ #CQWJ.L>&+7Q
M%XQ\-_#_ %GX0+\1]2LO P\0+H6JZSX(+<-\/E\5:+K?V?\ X13/@U9?$7[K
M#N<_W>;!ZG]/\*-@]3^G^% 'XH?\$U?V6/VI-(^*WQ1_;3_;SN[2Z_:.^*'A
MG2/ '@_2+:^WGP)\+MT>O:MHKZ-H#OX>T-I/$*:08((XWE\,2Q>*$$J)XKF9
MOS+_ ."NW[*O[9&C?\%%?AO^V%^S/\*_&OQ5N;'2? 7B+PW<^"O >J>---\(
M^*/A1(8XCXW5'956<A6A7.XJZ*55R4']<U% 'YR_L/:E^V5\0Y/&WQS_ &N?
M#R_!RY\>:;X(TKX7?L]:/<P:CI?@7PI'H:ZPWB_7W\H>)%^(GBC7_$.K6OC+
MPKXKVS^#$\.PPE]OF2#]&J** /SP_P""C?["GA/]OOX!S?"S6M;'A7Q?H%[-
MXR^&'BM3(]AH'C6/1+O1+>7588XW>ZT:6/5U$L$0\UB=Z ^6$?\ $7]@SQG_
M ,%)_P#@F8VO_L[?%/\ 8H^.'Q_^%-OK,?B32-6^%(U?QROA7^V](2X30_!&
MM!U\,G0H_$09_%[%LPM(TJJP)#?UDT4 ?SU:_P#L_?M)_P#!3O\ :B_9_P#B
MC^TA\ =?_9X_8]^"MGXD\9>!/!'BS6-(TGXXZ[\2HM9T!-6B\;:$2_B7PUX;
M\3ZYH;M'!&(HI/!_A_0)XXX_^$RG8?L?^TQ\%=%_:$_9Z^+WP/U*RT.X@^(O
M@+Q'X<TG_A(+'^TM T[Q&='=_!>MRV_!8>&O$D6A^(8C$C.)=%=D4A"U?0U%
M '\+_P"R!\(/^"PW[ WQB\?_  N^"W[//CW5=-\=WNH^ [RYU?PCK=_\#QXF
M4C0O WQ.;QPI3PWY7A;!\1S^)6_=30N]O.CPR21M] ?\%#O^":__  4,_:#T
M[]G'XE_$/6_$_P >_P!H[XA:C)X2\=>"/#&C:1I?PC^!6FIHQ.B%=<T0GP[H
M0)#MXT\5L!X+F\8KY\7F0/%*_P#9!3-@]3^G^% 'YA_LI_L]?M9>&_V1?$OP
M,_:6^*O@#Q)XBUCX*Z7\*?AUHGA#P@-'TWX:>&(_ALW@C^R=:UD!9/$VN";:
MT\W$1_LF-E,R2S&/^>S]A#X3?\%:OV!/BM\<_@7\%_V8+CQ>?B?8ZOH]C\0/
M%VDMI7PAL/$O@G1?$&L>"?B7I/Q.)7PRZEM<UM'\(3QD>,I]<4%%FB7;_:?L
M'J?T_P *?0!Y7\(/"GB/P%\,/ ?A#Q;XRUKXA>)]!\-:38^(/&OB,J/$'BC5
MT0#5]8U@'CS'D?)8'.T*IP0@/ID_;\/ZU8HH _F%_P""P?[&_P"WO_P4%\<?
M"NP^'/[.OA_PY\/O@DOQ.@T;Q%XC^+7PY_M/Q9J7CK6?#\0U<Z.?$&=#T3_A
M'? >AAHV9KH'Q!XE5EQL!^ZOV++3]N+]FW]C#3/@KXH_94T>[^)_P>^'NJZ!
M\,?L/QE^&_\ PC/Q#U;^UU_L#^WF'B GP\[+JVL^(?&-P<ATT4V]NQN)[9U_
M8W8/4_I_A1L'J?T_PH _D6^"?[$'_!5KX0?MX^-?V[K?]F/X3:UXE\=^(_B;
MKFK>!KKXT^#UTW3A\5"&UH:'K/\ PD8*[2H^4J,$ $#I7ZW?\%+_  S^VO\
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MWP/^T!^SU=_$_P"(WB/XFZ[XW\3WW@O6%\.Z+_PG)C?62GAZ3:T;>*9"H/\
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MZKHAE,6IZ#K48:XT.4PS:WH,FUE8PZQKJ*%,\LA^J=@]3^G^%/H _!7X6?\
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MOQ+HI1]'UO5]%,,<4VN1C9LF*DD#YS\W/#_\.Q_^">__ $9W\ /_  W&C_\
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M._\ @ETG_P",4^3PYX>EMH;*;0]&N=.M_P#CUM'TK3&L+':!S' \>U,]2(U
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MG^% $4'?\?Z58HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH KS]OP_K15BF;!ZG]/\ "@"*#O\ C_2K%%% !1110 57JQ3-@]3^G^%
M$56*9L'J?T_PI] !1110 4444 %%%% !1110!7HJ78/4_I_A1L'J?T_PH ?1
M110!7G[?A_6BK%,V#U/Z?X4 10=_Q_I5BBB@ HHHH *KU8IFP>I_3_"@"*K%
M,V#U/Z?X4^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMVGH"0>* /[*Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;6-*@3Q5XNUJ223<Y:'PE!X2CW1&;QI;7&^&, _3FBOR/_X(^_MJ_&+]N_\
M9K\<?%[XSZ?X'TWQ5X;^.WB?X<Z?;^"-"UK0-)C\/Z'X-^'WB"*6:/6O$7BF
M=M;W^,M56;%TB,L<:,$7=*OZX4 %%%% !1110 4444 %%%% !1110 457HH
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M^#O OP\\*(K:MXK\=^-M8'A_P3HY<;&ATF;7;J))9<LPC8B/:6WUD_L>Z/\
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M4_BEX9U'7M&^,^B?"OQOI.K^$_ Q\(:]XDUWQE'X??XD^)O*^(OAK0=%UO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZKXF7XB>*_#QUY5\3J7'E_#]&+98HG]1_P"R/\:M._:(_9I^#'QGL+>XM?\
MA/? /AK7;RRN]5_M/4;+4)=(1[E-9U:,@RRLZF21RA(:9<^9O*@ _C7^&O\
MP64_X*#_ +0_QW^!7@;4OV@_AQ\&].N_B/I5C=Z]<^'-'\-^!0-;0(L?Q/!8
M)KGAL*N%1=B*Q9^&9V/]L_PK\+_$3POH-[8_$KXG1?%;7I-86\M/$,?@C1_
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MEJ_A?4AX7UZ30G?7-#T.,*_A]_#&?&OG?\):WEL?#@9(XMSJWJW[6'_!8?\
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MQB\;7VMR2_$V\U7_ (34PIX,T+1&S%%H']N?\(+XDE\36A'BA)A<1VV8PYH
M_3K]B7]K;1_VT?A5XK^+_AG0Y-$\-Z7\7?'7P]\.2+=KJ#ZWHW@N31ECUM9
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ML'2?A<I^(?B +JGB4?\ ">:SX_USQP6UL\LOBM]$T L%*G_BG\D[ RM^O?\
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M13PWH>N>&!D<KKV5RIK[^_9E_P""5GQ+_;S_ &+OV:=<_:\_::\>Z9X)\,>
M_"__  SY\,OAE9^#=,\,>$_AF=&C3P]K&O$>&2/$'Q&;PXR*/%1)?!7 8<
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M]G[X'_%?]L;]I_P3\5/A/\/OB;X/\'_#OQ(GAK0/B)X1T7QGIFA/HOQ1\/\
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MQ@\8^'=*UZ*2!?$L;:SHQCUY%>3PA)X?@C\#-:PR>9)Q/_!<W_@F7\3?B?\
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MT_XCV]UK6J:GI/B'5=;T=]:DUA1KLKOX=,;H5=?"RQE6^4 LKA0#^@WXQ_\
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MW0M8_9I^*$/Q.UJX\)_VPVOV&EB,1-XRM_[!&\KX0*?\)+() ,-V!+5\Y?\
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MAL]2DUO7-;*IK.AJ+:2-HYQN>%F 8D,"R[3_ ""_\%]_^4F/B?\ [)O\&_\
MTR"O[1/V5?VGOA5^U[\&O"OQL^$>K)?^'M>4VEU8W6Q=5\+^(82HUG0=:4']
MWKEL90LBJI4[D.1YSH?XN_\ @OO_ ,I,?$__ &3?X-_^F04 ?WP44Q.A^O\
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M_%V-X?!,+H3)_3'X)^!W@/P3\"?#/[.UG8SZI\.?#/PXTOX4V=IKK'4[R_\
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M#'@]HV#X.W;N'Z&?M-?\%M?A!XS\/^%O@]_P3S\07GQT_:,^,7B$>"/#D_\
MPKCXG>'M-^&[:S@0^-M=T/Q!X>\'^(]>AC+7#+%X72=Y/[$\02LT$EOY9 /0
M?^"D/PO\8?!K_@BE\6_A;X^^([_%7Q/X#\#?![PU>^/3X<TOP.-?T[1OC]\/
M!H9.A: WDZ"5\.II'AID@+(3H@G;]Y(SO3_X-Z?#^AVO_!/C3-=LM*TRUUG6
M_BEX^.K:O:6N-3UP:+K8CT>36=<&&UV6*-B$F!PJRLG1SG6_X+.^-;;X;?\
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MUC1XHHO$L>N:(/"TVL^)(S%'*KVL4<BNR,78 ^/O^#=#_E'SJ?\ V<'\3O\
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M^,GPND_X*O?LR^/=-\?>$?$?A#X6>&_@0GCOQ%X2U@>-_P#A%-1\!?M"^/\
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M\58=-M_BM^U?^WY\3(="9KK2+7Q]\=O!?C0:6ZJ6VZ/_ &_\&9ROID%B"5!
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M?&'Q"\/^)F\3>&_$&IZ+([#1M%W^&(V1O"P.YO$GA+Q;XO3Q:WB$PQ#RXT-
M'[$?\')&N:YI?[,/[,FDV&J:E;:-K_Q+U5M9TJTOPVFZ\VB^"O,T1=<&/^)X
MH+[@I/.XL  03^M7_!+;QGX#\=?L _LK:[\.-#'AKPW:_"S0O#5SIK:)IOA\
MGQIX(FUOP)\0-7_LC1%CM$_X2KXA^'/$/B5=>@,DOBM=<^WRLTM\RU\??\%
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MX\M_#USH<C>%/"&[_A!HV\4CQMXS9_%_@F)P#^JNBBB@#\)O^#B'_E'C?_\
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MU'U_'M_P0^\;_M#?L=^+O$GP5^+7[$_[6MMH7QZ\>>!K33_B7:?!+QE8>%_
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M)LN?X5!4#/K@^E?;?[/GQ5_X*O?\% _A];?LT^/OA;?_ +(/@_2?AUJWAO\
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M5ZL5S^N:)I?B71M5\/ZM$+G2=;TO4=*U.U\U[<7&GZS&T$ZY3# R1O)$'RK
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M-^$!XP5CHD2D)+((Z]B_X+Y?#OQ?\+?V)OV5/!OCSXL>*_C3XOTKXVZB=?\
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M !UJUV=573K'3Y/&WCSP]'H2&4K'_P )/))KZQQ!B%:30O$JGK7TY_P=!_\
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M6DL?!FNV_C+0-<UW3$T<#6H_%WC70/#?BJ26-_$,C/#X?@LEBG@C#S2JZJA
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M#OC7XFUCQ)I*B,RV&E^.='T(:!*VX9,?B,^"]>( 9@O]CR,5& 7\#_X+N?\
M!-2Z\8:3??MJ_ K0?#>G:IX.\.ZMK'[0/A[3H(=/U;Q#IFB>=*GQ,BV[/#<F
MO>$88W/C"22,336T7GR-*WFRGZ#^ G_!$;XS_LK6WB>W_9Y_X*2?$GX80^,W
MTB[\3)X=^"/A*1M:?0?[<;10_P#;'Q"G1&C'B#5V!+!26Y=57<?WUDT2RU3P
MZ_AWQ%';>)-/O-(&DZJ-6LPZ:XCH8=5;4M)9%BQ,$#E#YA#3.,C(+@'X;?\
M!'__ (*G_#?]I'X7_"G]G'XH^*KK3OVG/!O@#2?#E[/KLCQZ?\3;3PXQT#0-
M:T36M?\ $_BKQ%XF^(,_A;1M%\1^/5GD51XTUG7R V T7[[5_+L?^#;?P;H7
MCNX\;?"_]L#Q_P" Y=*\2'6? MFOPXTS5O$/A&PCU;SM)A'B&#X@>%Y->GB
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M(K[1C ^/7[)'[-'[3-K90?'/X*^"_B.=)G%Y97>KZ?LU-9  @\O6=%:'Q!L
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M%W_@GA^QA\>O'%[\2_C%\!_"?Q \<:C9:;8W?B+Q%>>*SJ+:?HS?N8LQZ]$
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?QT\1_$'7M9_X276O%6J>'?!CZG>ZQP3JY88^8=!V![],_N;^SO\,O$_P?\
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MOY_M^G_UZ +%%5_/]OT_^O5B@ HHHH **** "BBB@ HHHH **** *]?QT_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUWP)X+\/:1JP;0?A?K0$>C2:UKK8CUR5M:,D9D4*VP@%@JJ% /VZHHK\>?\
M@I[_ ,%*/'O[!'B+]GCPMX"^ EM\<==^.]WXXL+'1QXCUO2]5_M3P_K7@'1M
M#T/0='T#PSXIFU[7/%$OCL1QQ^7"R& L1MD*  _8:BOY^/B?\>?^"^?C)]!U
M'X2?L2_"?X3Z<MIYFM:5KOQ<^#WCK5=29B0 %UKXB^$6T0KR-H#MPI?YN:_/
M;X5_\%KO^"D'[8GQ7\3?"O\ 91^!OPG/C'Q'I&FZYX(\+:IK.D^=X5TOP.Q/
MCC_BH/'?B7PAX=\0'Q-N"VY#;H%51$5"C !_8A17\HWQL_;/_P""]_[+'@P_
M&;X[? ;X1VWPK\.:SILOC&Y\.Z/X/\1K8:;(RR.VN+\/OB1XM\1:%X?W[/#C
M^*,,T;O%*X5IHV;]$O$'[37[>?QB_8X^#O[9G[)'PY^%^H-K?P?\?>+/'O[/
MNJOK6O\ C37-4F>?1O!2_"S64\/K%XAE\)O-KGBZX\-&)7\<C0K3P7X)DFF\
M40RJ ?M/17\7'P4_X+-?\%4/VGO''A'X%? GP'\&]=^,T]AXKO=9L]6T72=!
M?Q NB?\ $_D4)X@\1^%?#FAOX8\.@%U7Q>TD\AR1)(PS]X_\+)_X.4_^B ?
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M\/7+B4712, _H>HK^>W1OV O^"N%W\))]2U/_@I[XCTOXW7%QIPL/"@LA?\
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M_AJW]E?_ *.3^ '_ (>+X;__ #1T?\-6_LK_ /1R?P _\/%\-_\ YHZ_@O\
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M/P>']-N=/L;]_#WC31_&^H1RZNP$1_L'P&WB?Q+F3EE:.R*$KN=PGEN_A_\
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M=\'_ /YK:^IK*]MKZU@O+":&YL[BU%U;7=JRFRN4D!PRLI;"GAA\QR"23E2
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M+:OJ.G:#X;U[6_$>A/XWUW6W1_#MNL#^#?$]I9P075QXL7Q,_AEE\'W G5D
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MW_P7\>Z-\4OV:_'MIXB7P9:Z+\>?#0\-M+X\CU<Z%KG@G69/#TGBG_A M?\
M#4F#/'XVE\)QRAB"\>2Y /VOHKRGXE?&#X7?!O0HO%/Q8^)G@#X9^&)]6BT+
M3_$'Q'\8:%X+\.7.K.DKC2GUSQ%=6]N^KB/2=3DAA$I>5$D 5V7='\ _!_\
MX*Y?LB_';XY>,/@S\+=>\2Z]H_@'X=^)?B#XI^--WX5U33O@_H^E>")6'B:;
M7/&FLBT70-%\.&3SKCQ7XMC\,>#"59;;Q9-*ZQR@'ZJ45^!OB7_@X;_8,T?X
MFZ?X%L6^)_B7PA<7NGV=U\8])\'F/P-89(.MZP^B:UY?Q-*>%B \RGP65?.
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MA1X2\'ZWJ.K^(M&\0ZQ-H4,FE:[);6_P[AG5M(UV0P>)?&=F;>31[A Q"C<
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M#XSTG2?'7BOQ-H4>A1R^"?\ A"H89?#MSXB)D\272IX>\6WK/X8T4S'+"(Q
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"UMH$OAOX?>)- \)>4;;?>/H,?C21Y4\5HB_M10 5_ Y_P &]O\ RD<\+?\
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MG]DO]J7P/\,OCAXJT3QMH^J6?PO^(/CS5OL?C+^S#X7\=?\ $^UW^W/^$?\
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MH4.NZLEG%XDBG\,"5UEN+6>*,* #Y&_8-_X*W_LW?MLV4&B#5[#X3?%YKI;
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MQ+TW4/$/C;XC6GQDO?">KZ5=OX;T[0OB7KVA^(-=\0:QK.C++$=:T'_A'/\
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MN/$7B37OA7K<>D:3:_?OY(6CU<*N21C;!)G')"*>] '\CO\ P2HT77?V\O\
M@K WQE^+4VG>)KG0#XZ_:.\7Z1XL#>)!?'17\/>'O >CZ,=>5BL?A'Q)XY\#
MMX-DVD11^ 'D;Y5:O[U*_AF_X-M/^3\_B#_V;)X]_P#5G?"*O[F: "OSJ^%W
M[ O@+X2?M=?M0?M)Z#>,WAW]I[PEX8L?$WPFLXVL/#*^*%;73X]UO7- 5?\
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M$D?B9;_&K_@M-\4/C#8Z)J?ANV^)UU^T_P"/[+P_JN!JF@CQSK(UT:-K84
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M\2_#/2]"=-$_L;P.AS'H+KX>C0IX9*GP;&P.PKN;/]OGBCX]_#CPA\=/A?\
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M@?@CXD\4Z FMQZ-K^OZ&BYDGC363E<,SB-$##.U/YUO^" '[:GQ,\%?'&?\
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M$WD+KPFRP!K]U*_(+_@NM_RB\_:._P"PC\&?_5]?#N@#Y=_X-^?CU\;/C_\
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M+(\_B Z#XUD\.K,1&/*T> ;&<N]?OW7YF?\ !8K_ )1J_M8?]B)IG_J9^'*
M/PR_X(A_L'ZI\7_V?[SX\^'?VJ?VC/@Q;ZA\8G\-^+?A]\'O&2>"/#WCG3_
MR:%K*_VKK>A@>)/,E'B'7X,F6(@2E261WQ^G/_!?+PS!=_\ !-[QW?G4O$=H
M?#/C#X7FUM+3Q%K"Z=?,WC;0M&,>NA24\0@>:.?%#.K2&5V8NS9Y?_@W1_Y1
M^:C_ -G!_%#_ -,O@*O3O^"^/_*,[XM?]CC\'/\ U9WAZ@#\J_\ @GG^QO\
MM5_MJ_L"?";P-JO[0ES\ ?V4].L/C)HVC^%/AC=$>)OBWJ&M?%'7M=.M^.I#
MA?\ A&X_$DNN>&3X49\@:$Q4$G!\8_9"\=?';_@D=_P4ET#]D+XS?$#Q'XC^
M#/Q&N]-T-+<?\)BW@?6]5^+!\/\ ]A?$WP/X'Y!\0_\ "2Z OPO?Q.<JQ7Q.
M&5@,5^[G_!";_E&!^S]_V&/C'_ZNCQ_7X@?\%A=)O]._X++?LH3ZAXCU+7(M
M2M?V8=9TJTU:RT<#PCII_:#U_1#H>AOX>\-[)/#R#1M;\2R/XG_X3'Q@9===
M56/;X-C0 _HK_P""C/[<'AK]@/\ 9XN_B_J.B7/BKQ1X@UO_ (0KX=>'HU1-
M+UWQ]K.CZ]KFA)KVMCS$T/05BT#6==FEW,RB#9$T1R%_%_4_@?\  GXR?"70
M/&/_  4R_P""D#:[\0/C9X1U#XE_#;PG9?&R+3/AG\)]1U\JIUWX5:&TB^&-
M?2$.WAEP<>#BJ.(DD9D#><_\'.6O:W#XA_9+\+_VQJD?AR]TOXH:[J?AY[M?
M^$:U#6M&U7PYHNA:R-(55$WB"&/7M7MHY1G$>L+'D^77Z(?LM_\ !*3_ ()4
M?M'?L\_"/XW:;^RK9:=!\4/ GA_Q3/I-K\?_ (^>(SH6H:]HT;:QHO\ ;*_$
M]GD$ ?RI&_=&0X)6/<K. ?@]\)_VN/BI_P $ROVZO#/P-TK]IKQ;\8OV0/!^
MK>&$L]+M/$K:CX'UWX7_ !TT30?BSH6M:'HFO%/#?A_Q$/\ A.3XI\;>*E=3
MG_A)RK#(-?W5:/KND>)-'TOQ!H>HVVI:3KFE:;K&D:E:9DLK_3M:CCGT?4H]
MVW>DT)CD0\,$<%@ORA?QW\:_\$D?^"/OP2T9?B)\0?@5X:\%>']#U33C_;'B
MSXT_'MM+&JIJD8T,/I>M_$R:WUF43RH0ABN"ZI)LCEC5I(_V&T&VT6QT;2+;
MPY!IMOH-MI&EVNB6^EK'_9UOI0AMTT=--^S!$_LKR HA* *T:+L_=K@ '-?$
M[X?>$_BY\._''PM\;V<NI>#OB+X1\2>"_%MI;W3V,EUX:\1:5+HFN1+J*!6C
ME:VG>,2!@X!!>)XT*G^#G]L;_@F;^U=_P33^(D'QQ^&.JZ[K7PQ\*^/M,3X6
M_&+PI<RIXDT%EQ_8;>,]%T2.(Z+K9Y\+1SHIBF W(2,X_N>_:!^*<7P.^!WQ
MC^,LFC7'B*W^$?PO\>?$NYT*TO/[..N1>!O#NL>(9-(BUB17BT@N-(:/SF!2
M(R?<DPZOC?LX_%W0OVD/V?OA1\9M.TFVT_1OBU\-O#'BJ^\/OJ\'B,Z)/K^C
M>=KWA/5]7A6.+7)O#MS)-X?N9O)423QR.8]I1@ ?S@?L&?\ !PI:ZWJ,/@+]
MN:'3M*9[ II/QC\(Z.,:EJ@UO]W_ ,)WH?A\?\(UH*1>'-=T<KXC\*-]G8Z-
M*9(G+Y']/O@?3? ,.DW7B7X=V?AY-'^)-XGCR[U3PO;Z>NE^+=1UO1M$BA\9
M;HB%U2>?1-*T51=1^8\\,4(/FE%,?\\'_!1C_@@S\"_%'@OQU\9/V3-/N?A/
M\2=$T?6?$MY\-K*]US5?AIXN\L^(M=UM]%T-(/%?B7P[XA:/6"?"'ACPH(_
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M\++?X@VT?B'P5X6\!Z-K3Z'H7B'P3Y/Q'C\2^'O$<_AW0)9"\:HCMX\\5LH
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M']N) ;D:X)")6=9 Z29R_D@1U\=_\'%/B*P\9_\ !/O]GKQCI(F&D^*/VA?
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M_C5^R\NC^%_"NCQ^'/#FB_VYX+^$6NZY+HNAQ)'&&D\1:WKDC"-$12Y"J%
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M((+C5?#O[3NGZ/:7-XN;W4Y/VAOA_K3Z5HFXA=D2Z+KLKYR=B-P3@$ _:/\
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MB]?_ /!)_P#X**^(I?BIHNN:AX/\,:O\4?@OXOUFY\'ZOIVJZWX$_P"$S_L
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M4JOZM4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5Q8>(OB$\6MZ'KND:PS:%.JQQ_!C6_BQXE:(S>&0W]AKMO!]G*31?\&\FO\
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M>M:IH\4DJ6\FU%D\D-*/-)#0@-( #^+O_@BM\;O%W['_ /P4 ^)7[%7CN?\
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M?%NI>"?$>M>(?%^N3CQ=KBC0QXFUSQ+%X6_L+PPZ7,0#?V+$\<J(I,GYW_\
M#IW_ (*<?\->_P##</\ PU%^S/\ \+X^T[_M7_"-_$K_ (1G'_"&?\('_8G]
MB_\ ".;/^$?_ .$>_=XWYW?G0!_3T_0?7^AK^*W_ (+"_P#!+?XD?LX_$?7_
M -M_]FB?5+GX=:CXO'C_ ,9:7X6!TSQ1\"?%(U@:\VNZ&?#\4*GX=LV3N2-5
M\&#'RQDGQ@O]?GP=L/BMIOPQ\'VGQOUWPYXL^*=MH@'CC7O!FGR:5X;O]8!=
MG?1M'?)2,J45%=%^9&VY!4'NM7TFPU_2-1T36+-+O3]3M+^QO+.X.1>6+Y0@
M]P&#I@-R <D<@T ?RX_\&\/Q>^)?Q_\ CI^W3\6?C%XHU+QO\1O%'AG]G4>)
M/%6K6.B:=J-^-#3X@>']##+H.%*CPWHFB':Q"GC.<XK^JVOQU_X)Q_\ !,R/
M_@G]\9?VI/$GAOQCIWB#X2?&)_ C?#;2+X:L?&_A#3]";Q'J^L:7XKN9U2"X
M$TFO*EM(I61H]*@,\4!E:*OV*H _'#_@O+_RC'^.?_8R_!S_ -6KX*KX2_X-
MG[3Q+_PS]^T'>+K>G?\ "+GXP:?9V^@C2)%U-?$:^"?#YDUA=?7Q&L::%(N4
MB\-/X6MVB+,Z2-M>.3Z3_P""@G[!7_!2']M8>-_AG;_M(? +PS^SEJWB[^WO
M#7@AO#OC#3O%']E:2ROH^B^-==T'P^_]O(& >1$8H,#;O8#/RS^QO_P1]_X*
M-_L0^/[GQC\'OVI/@%8:?KA6T\8>&KRR^)&H^&M=TN-@ZR_V'+X=2,>(%9=X
ME+;0R@JV[ (!_4?7\]W[*WAMOVH/^"Q/[7/[2>N2_#KQEX1_9(\':/\  KX6
M:GX:U?6O[4L_%7C2,R?VTKZ-)-X9UAAX?3XI^&O&#R709)]=A3_A$XV83+^Z
M/Q TCQ'K?@7QIH?A#55\-^)]9\)>*-)\,Z^K*O\ 8GB/6M'FCT762IR6%IKD
ML<^T#>SH HR:^-/^"<?['NM?L6_L_3?#?QCXST_XB?$;Q1XZ\4?$GQWXPTZQ
M>VM=0\0>)@C3,H8QW&J(OEB5VE6*9I-3<"-56*9P#]"Z_P ^O_@M[Y'_  ];
M^-OVC^S/L^/@/]M_M;^U_P"S<?\ "F/ /_(>_P"$<_XJ/_A'_P"_Y?R;MVWY
M<5_=A\;='^+FO?#3Q/I/P+\:>'O /Q5>Q/\ PB'B+Q7X=/B7PU!JBJRH-;T0
M%I7T9\D,T3,ZL %/1G_ET^,W_! S]MS]HOXQ>)_C/\</VG?@MXB\7>.?$<>L
M>+]4LM-\:!5TAG,::-H6B+X:\M$\(>&Q_P (UX,&X-#" \J(.* /Z@OV?S:'
MX$_!K[#+H\VGCX3_  Z%DWAC^U#X:.GCP;X>$9\._P#"2$^)?^$>*!C8_P#"
M4Y\4_9RWVW%UN4>U/T'U_H:^+_V,/@;\8_V=_A-IGPL^+WQO/QHM_"UM;>&?
M ]Y-X3@TJ_T/PWI&MZY'H,4FMQ2R2^()#X:;0(3#/$B>%UT188FFMW=U^TZ
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M&\0%-9\/^9X6\4>'_A]X5.B?\(L/$WBR;PF6\;^/_P#D3)&\)^#9/&O[._\
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M:OX1TAGL-/8E@J?*!M'(R<$ ;0J@< '\K/\ P5'_ &F-'_X*U_M _ /]F/\
M8F\,:[\4G\#WGB:]'Q+>UUGPUX:UJ_\ &^BZ"=:$V@ZYX>&NZ!X"\)'1=&\S
MQ?XFBCSXP'B&%_!5S]F\$S^-?Z*KKX V7[+_ /P2\^(WP%TZYDU"V^&_[(WQ
MAT*XO)+R.^%]JK_#7QOK&O&21-$\,B;19?$.KZO-:%H8)!#);V[;)#(5^K_@
MW^S3\!?V>-.U/2/@A\(O!7PQTO5+S^U[VR\)Z2NF+?ZD?(#,V/G+$:/I.%R$
MQ$,("03[=-#!>PSP3P_:+>Y_T6ZM;GH1@Y!ZY!!!X/(P5.0, '\0/_!*'_@H
MI\5_V"-,\+^"?VCOASX^TO\ 8U^*_B3[=X9^)UWX UJPTWP+XDU\J+CQ=H6L
MG08(_B%X?FA#IXR\+^&V?Q9%<>1<^!X)Q / S?O'\5O^"]'_  3Q\">"-7US
MP5\7/$7Q9\2*?L6C^%?!'PR\9KJDEVR2!-29OB#I'PL\-OHL#B)Y[EO%D2RJ
MP6''[PC]9M&^&/PZT'PMH/@K2O!'ART\(>&$2T\->'AI.E-IFB(N\A='A>,K
M!RQ&4/F-@@G*E:\!@_8%_8NM/B&?BU;_ +-/PF@^)/\ PDG_  F0\7KX0B_M
M;_A*@,?VT?\ EGYH/.-@C'3:!0!^!'_!&#]@;XH^/?C;X@_X*7_M*>';#PTW
MQ!UOQQXO^$'@JYL=<TS4KWQ/\0-9DU_7OB@NCB2 Z!X?2/5_$'AOP;_PDLWC
M*?Q5#K_B:[E5(!X,\;^,_P"KZL^W@M[.*"W@@@@M[<+:VT%NJ[;4;<;0!@*,
M 9 48'7=DFM"@ HHHH *_ G_ (+X?M(_ [PW^QA\4OV<-:^(NDVOQP^(EM\,
MM8\(_#ZWL]<U/5-0TO0OC/X UW7M5UA](C;P_H-N/#^A:ZZ-XH>*%V57B5HW
M-?OM7'ZIX.\'Z[<K>:UX6\.ZQJ"+M^T:KHND:A?87H/,DC9L <##< 8P* /Y
M0/\ @W0_:8^!/PT\*_%;X(^/_B+HGA3XF_$7XB:?XD\#>$-7M-7 \0:9HO@Z
M'C1=;,9\--KX57W>%1*OC''#PSML,7R!_P %U?V[?V=/VQ/&/P'T7]G/5='\
M>:+X%\,>)-9\1?%*VT?QAX;U*YU36]9Q_P (2-$U[P[X5\3[_"@T1?$S[9&A
MSX[!C4%I&D_MRM?A[X'M+F&\LO!'A.WN+8$6MW:>'M'C95.<[&0*X/H000>0
M0>B?\*V^'_\ T(/@K_PD=$_^,4 ?E-^R;_P5+_8DUG]CCPY\0=4^+K>#=$^!
M?@#X.^ /BE8>-/#NMV.K>&/%&LZ'JV@Z%I TG1&\2KXON/$X\"^(_$-C'X+N
M_&*OX2TMKY]K1SO'_,#^RK^W%\%O W_!6Z3]L'QSH1^''P?\5_$;XI+=V?A*
MV?7],\):9XZT37_ >@ZT-(C_ .$1DB\/9UP>*/&TB>$/^$W0X9/!&Y17][?_
M  KWP$+2>P_X0GPI_9]U/]JN;<^'='^Q.V "S1&'9O\ E!W[2!SA0IQ4?_"M
MOA__ -"#X*_\)'1/_C% &EH/B+0O%FBZ1XC\.:IINN^'-<L=.UC1M;TN[34M
M-U?2]94-I&J:5JD<CQS))&RNKH6^60%" T;-\?\ _!1_X1>,_CW^Q+^T-\)?
M ,%@_BOQ=X$;^QX-3;45@EGT36-(\0#3)#HV@^);AFNSH_V=5MK29S+(FX+#
MOE7[:L[*"RMX;*QB@M+*UMUM;:VM@%%H%&-J\X 4 8&-V1DYR36C0!_$-_P2
M0_X*2>*?V;_A;\3_ -C73/@]\1_B!\=/&GBO5I_V:/#/@KP!HNJBU^,.OZ/K
MFAZZGQ5_X2/XD^$T\.^&/"OB'0O!23H(\^$_!.A>(Q(X6)0?IO\ X+M_\%!O
M@'\0/A-)^QUX=M]2\:_&W0O&FFM\1=7M9=<\/^&_A1XG\$8?7]%970#QUXA5
MRRQQH[^"1&%)\<*S,B?U76?@OP?INI#5K'PMX<T[6&7']JV.C:397_ID2I%Y
MA)[DD\^_2M?> / ^H7-SJ%_X*\*:A?W*_P"F75_X;T>_OKT 8RTKQ;L^[$Y]
M!B@#\#?^""7[77P-UK]C31?V>'\4)H?Q7^ Z?$OQ+XRT#5[.-/[3\,ZWXZ\0
M^/(_&/@MV!?Q%H47A[Q$'\3 B3Q8L[W#3QAF@<?A;_P4F_;M^$O[0'_!2OX9
M?M!> OM'B3X0? 1/@SH>D^(?#UKKLFI^//#'@3QG_P +:U[6]#T?Q+X<\)2Z
M'XCSKFN^&#X:D8O(= +N=S&O[S=-\%^#M(E\[3?!_AO3;C;]G^TZ?X?TC3R5
M[8\N-'923QC);I@C@4O^%;?#_P#Z$'P5_P"$CHG_ ,8H _&O]OKX,>"/^"NW
M[ ]MX[_9IBNO$_CCPWJ<?CWX+7_B70M9^'4FOZMI($?C+PC+%X\\.O*\7BCP
MSK&LVO@VZ*_\(:/&L7ANYE\96UA!+/%_.[^Q?_P53_:N_P""8EK-^SUX_P#@
M\?$7@#2;[4M<'PH^(%EK'PW\=Z#JFMLI*Z'KC>&B/^$<=5/B5C_PAV[RV8*R
MELC^^"RLK'2[6&QTVRMK"QM4(M;6UM%L;*U10>!&BHB [C]Q "<DJ"=U86H^
M"_"&LW(O]8\*^&M4U  YNM7\/:1J5^1Z^<T+L?;![<]* /Y8?AC\5OVR?^"W
MOQH^'%GXM^#=K\&_V O GB[2/BMXC;9JP_X2S4=!=]!BT+0_BGK_ (;C'Q!U
MV#Q'I&O!4\)^$/!K>"U/BGP)X\+2-EOZN;*RL=,M(+*RM[>QTZSMOL]K:6ML
M+&RLK- /D1% C3:J@ +L&!G8OS-3-+TS3-'LX+#2[.PTVPMA_HUIIMI'I]B@
MQ@ 1P@Q#ZJ/4D,>*V* /D#]NW1]8\2_L4_M:^&_#VD:CXEU_Q!^SA\:]#T#0
M=(T_^U-2UO5]7^&^OP:3H^CZ3L5-:EGEE6-(=V]R'V@GS%3^:;_@F_\ M(_M
M^?\ !/SX%_#FV^*7['WQ1^-7['7Q0C?Q]\-_$/PF.D^-O''@+PMXB_XKK7M=
MT/0_#4GBB9=!\5KK3^)HO#?Q4F\$NA9V3QUG(K^QBL>VL;"RM8;"WM((-/M[
M7[+:VMM;C[ EAA J!%7RPH51E<X(R0&#%B ?S6_$W_@XG^%?CWPW/X(_9,_9
MQ_:-\<?&[Q>FIZ'X8TOQ%I'@[PZUD7T;7FFUG18_ /B/XN^)==\0^%)(XIO^
M$87PDSO(,L5VXD]@_P""-'_!-;XC_LS2^,?VL?V@[_48?V@?CGX=O-*?P!'M
MC7P=X5\0Z]H7CC79/'#.4,WQ"\2^(="T6>XAC;_BDH(Y+8B<S?8_"G[I6/@7
MP3I]S;W^F^#_  IINH6R_P"AW5AX<T>QU"R!'59$B5P?]TK@\CGFNXH ****
M "ODW]MS2M5\1_L<_M9^'-!TS4];U_Q!^S/\=]"T/2=(L#J6IZUK6L_##Q-#
MH^DZ/HS,RZUK<[^5%;1*Q9I" N1(Z)]944 ?S6_\&ZOP4^+OPD^%/[0=_P#%
M/PI\6?AQ-J7Q TFVTOP/\0_!VK^"=,U)8]&W'QCH.B>(M$MO$J,#_P 4Z6<R
MQ^7#(&B9BA'KW_!>']K?]J#]E+X2_!74OV=M:U3P7:^,/%_B6V\=?$/3/#EO
MJ5]H*Z/I.B'0-$35];;_ (1S0#XI;5M;?S;E-Q;0287)\Y5_?2OBK]L7XC_$
M7P1\/;'0?@W^S_K7Q]^+/CN?5] \"Z%_PCYOOAYX?U==(S_PE/Q1\;:TG_"*
M^!?#-OYLBB7Q),@\42@6MN'9IS& ?#G_  1;_P""A'C_ /;M^$WQ-MOB];VJ
M_%GX*>(O"FFZUXAT70HM,\.:YX5\::#='06!_P"$G\5/)XD3Q)X,\;_\)FAC
M\,K$%\-^7;;I9''[<5^:'_!-/]B6]_8Z^$'BZX\>2>'-7^.OQT\;ZC\4/B_J
MWAW1/L&D66K:NTCZ/X+T9 23X=\'_P!L:TUNQ4'[7K^ONK&-MQ_2^@#^)/\
MX+O?LF_M&>%OVO-8_:\T3P->>+/A#XGTKP3?6OBGPM8:EX@;PCJ?PK\(Z)H>
MM/\ %**!B/#<,B:(KVWB>0_\(H(&07G^F"<5^C_PA_;._P""F7_!0CX2Z_\
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MZ1X&LK3X1>(_%GBN+Q#\1=,\/?#CP!X$U30-=\.R:'X3^'2D>(=#UCQ3;O\
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M%% 'R/\ $CX<_%;P1\ ]/\!_L.2?!CX:>+O!J:3IW@?P_P#$KPUXAU#X8?\
M"/6,LL,VBS-X9=-<T225IX_$!\0):>*YIIH)89H7/B4^*M/_ )K/A'_P1%_X
M*>_ _P#:#T;]J'X=?&?]CW1_BAHOC'4_&-J(_$WQBU#PW=?V])KD?B+17TC_
M (4Q&(]!\1^&M>U_P[*$E\Y$UB5XPTB*K?V%T4 ?C]_P4._9(_;D_:R^ ,'P
M(^'7QA^ N@Z9JOA+PM'\1-6UC2_B1X(U#QOXYTG6(FUUM(_X1^Y\8?\ "#>
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MW'\5T^.\/QE\9_"7XEZDGA>S\37 \.Z9XX\,WVE:!H::'HRZ!H0UOPA-X?\
M$B!R/^$E?Q)XG;<%BCMT3:1^X-% 'YR^#_\ @G)\&_AM^SCXI_9J^'OCSXZ^
M#?#WQ!\8:Q\0?B+\1_#_ ,18H_C'XY\5:U$_]LSZOXX/A^15^U_\2E0_A[PS
M:*D6A0PLL4AF,_QUIG_!OI^Q?HGB,^,-"^)O[66A^,OMFK7X\6Z3\8-$L?$O
M]H:Z6_MA_P"V5^'0=A*!Q@9+!@<8 K]WZ* /S0_:K_X)G?![]L1]!M_BS\6/
MVCH/"_AGPWIOAS3_  /X2^)6E>&_!&HOI#QR)K&NZ$GAFX7Q'KR_V9&LUSXD
MDGA5@Q154&./G_V0O^"3?[._[%7Q$7XA?!OQ]\>I[C[)J5G>^%O%GQ%TK4_!
M.H7&K:2FCMK.K>'-$\*^%$?7A&NZ.Y$C;90I"!L%?U/HH _.S]L;_@F=^RU^
MW1<:;KOQJ\/^(;?QQH5GIFC:1\0_!/B(Z)XGT_PUH6K:UK<'A!_[;A\3>')M
M DUS6]7N)XY/"CSL9-D<R11J3^<_P$_X-U?V7/A7XUUOQ7\7?&_B[X^:3_:;
M7_A'P5J.BCP9X?TW2U&OE]#\:?V5XB\2ZYX[<IK.E^5/H$W@N"*3P[ TD$ZR
MF&OZ*Z* .<\-^&]"\)Z'I7ASPSI5AHWA_1+-=+T?2-+MQ8Z?IVGH%VPP0KD!
M5V9RN-SEF)+EGKHZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH ***KSSQ00S33R""&$9>=B %'&XG@\ D Y!R?I0
M!8HKX;\:?\%#_P!B;P!X[\.?#7Q%^TG\/#XT\:KHY\,:+H5WJ?C)M1&NZRNA
M:*T6L>&X/$>@12R:ZQMU-Q<QM&X :%47<_W)0 4444 %%9=[?6&EVD]_?7=O
M8Z?9VWVBZN[JY%E965DH/[QW8K&@55/+E0,8WKE4/QIX>_X*&_L6>)OB['\
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M"&:T* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+-_X3;0_^$(_MC^V/[ _LG_A(?.^S>=_;_\ H^W.=_SX^S4 ?0U%?D7^UO\
M\%=?V3?@U\!?'_C3X/\ Q^^"OQ:^*ECI#V?@/P5X5\8Z/XIU+5/$S!UC76-'
MT*X>XCT2(;3)*R@,6(3).Y/AO_@AO^VU\'D^ /Q%TKX[_'_X=>'/C=\6OVOO
MB!XFM/"7BOQ?H/ASQ%KNK^.M'^'CQ2Z)H+'?_8?B?Q-'K;0.BLJYDW ,8V4
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M(7\F/: ?W%VE[!J%K!?6<JW%O=6XN;5@,!E(&#V[L%()X.>3UJ_7YY_L;?\
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MK7@GQ!KFAG1]#\0>"+=V\*F1=$+B<QR,?,WD.6RU?V[U_"5XQ_:A\#_M>_\
M!:_]E'XX> -+UW1-/UWXI_LQ:-J_A[Q18_V;JV@>)M"UK0M"UO1-84!PS("%
M0;6S@?*<X']-W[</_!1*[_8.MK;Q3X[_ &9/BIXS^$UWJ]AHNG?%;P/K_@?_
M (1V379-)65;'6]&DUQ/$>@$7 N- CE\26Z6L\^CM/$"JID _4>BOE7]F7]I
M;3OVI?V:/ _[27@3P9K.G:?X]\.>(-7\/>"-3O-'7Q$M_HNN:YX?.D'5DF_X
M1]))[C0Y8TD#O%$C!I6?RG#?D5\7O^#@'P5\ O&U[\._C'^QQ^T7\.O&-K:B
M_P#[ \5W'A'3=0;1_O#6E0SLHT+&/WY+$@\)@XH _H7HKR;XK?%_PA\&OA%X
MP^-/CN>YT_P5X!\(:AXU\275O;-?WRZ/HFDG6Y2JQ@YD6-9-H88,F,-&K,1^
M)WAK_@J'^W1\9?AOXG_:;^ /[!D&N_LL^'[HBQUCQ=XQ%C\8]<TC1%T5/&^L
MZ+X(T(,/$BIX@D\01QCPT'##P^Q?S'#L0#^@JODK]IK]JOX1_LL:)X!OOBS-
MXQGB^)_Q%\(_"SP5IO@GP1XJ\<>)M=\2^)=217":3X<$VMR2>%]!2?Q/<K"#
MXME@T::#P58^,O&=Q;>$[OY:_8M_X*C^#?VX_ _[0?BSX>?!'XGZ'J'[/N@:
M1K%[X+U<Z+?^(_'VI^(M&\>:SHN@>"_["9O,\03GP1Y<<>3F;Q#;@*60./Y+
M?^"EO[8?[17[0'[3'PUD_:>^ 6M_"6U^%@TJZT;X#:M_PF/@CQ+?>%]:UD:W
MC6]:0#Q(G_"5G0<'Q,BH@.55%&10!_H:45^9*_\ !0^'P'\"=<_:,_:/_9Q^
M-'[-7PWTZ^T?1]*MOB';:5J?CS6?$^MZL=#BT?\ X07P](_B305:4*?^$A\4
M+:0F-Y#SRLOY5_#+_@Y#^%_B7XQ^,-)^(WPEU/X;_ ^T\'ZC?>#M79=3\4?$
M[7O'L)T-K?P;KNC:'$_AK06\2,VM/"S,S!HD<L6,OF ']15%?RR?#_\ X.%O
M'7Q6^+WB;X8_#/\ 8U\7_$&ZUSP]XK;X)>%?"=ZVH_$W7?$^BZ,VOK_PF^@H
M4C_X1^W&B:VOBY_"RR- J*5._+E_[,W_  <+^/?BQ\9M ^#'Q _93M1XI\=>
M)-*\ ^!=/\!>,1IFH_\ ">:SK?\ 8@TCQ"OCQH5T%4()R2 .I)Y% ']3%%><
M6VM>*KOP';Z\?"_]E>.[SPM_:A\"ZIK.EW@LO%+Z7YQ\':GK^CO)X>;RM90>
M'V\0PNT$B(SP @XK\#?V//\ @KS^UW^U'^UGJ/[,UQ^RG\.[6X\!7/BP?&&[
M\.?$IO[5\)Z7X'U]?!&N:UH;Z[MT#Q"(_$FM:&J1QRJIC=HRK'9L /Z.:^(O
MVL_V*O"'[7MGX?MO&GQ.^.G@@>%;;4?[(TGX3?$4^"-,O=4F!V:IK<8T.=M:
M:-FC!W[8@IVQKCYA]NT4 ?YROP+^'_QX\<_M[Z'^Q3X]_:2^*.GW5G\=?%?P
M9\7>*O"GCSQKJ6EL? FL>(-"UQ=#_MWQ#X6D^8Z$!\D<C]=J.V%/]'G[2/\
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M3]39;2X*:EXA\ X70-6G$.J?\(@GB FTN)$ECFWS"=: /ZK:*_._]G?_ (*
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M/$VF:;X8UW20? G@[P7K:EO$A^(*,8V$K1K]F42RO*L9<H ?UKT5_%/\-?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!O%AE\3^._"K#7-!T?11X'0/+H'A[X4:XLRKXCCB<3/X_16*8&?Z3OB?X/\
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MK>(;27Q?XT\5"_U31X%T9)_,\>>(O%4\9$095$,B;C*!O+&)D_F;_P""#?\
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MGXI>!/!'Q"\-6FNV9T_4K32/'&A:'X@T6+689/,,.M"'5XBT4;%1(=@RV)'
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M_P $J/V>/&_BB]31O#'A'X6>/?%'B+59F 6Q\/Z%XQ\>:[K6L 8R56*.25U
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M/QMM?!_AJQ\.V@OM935!\,6UC;XW)T<$>&XT_P"$CT3X6@M"#,':/9\F_/\
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M_P!E+( XT5WT:4[2L;")E#IN5F?QC_@W&_Y,"\4?]G(^//\ U"?A)0!^-_\
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M^?\ )#_C-_V2CXA?^H?KM>NUY%\?/^2'_&;_ +)1\0O_ %#]=H _F8_X-?\
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M=GXG\>:7I7B'QOK>+8K#X=V_#K2/&CP^*O"I:;PAXLD\,'PA')="&6'\N/\
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MOA#P].GA=2C210G15MT,<:1P1_U!_LB>%?BKX)_9D^"_@?XVZ3X5T7XG>!_
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MCX;ZO^T_X.\(:3]IUK5!I_AC0-:&AZ%HPUG769FP1N"*Q). &).3_8A\,?\
MDG/@'_L1?"?_ *9$K^2K_@G]_P K"'[4_P#V4?\ ;(_]377: .E_X+\?%7Q#
M\2OVN/V4_P!B@>(+C3/AE?6W@'QKXUM_#NK:K_:FJ>+/BI\1]9^'A?7]'62;
MP]++X0\,^'8]?\&/<^%I92?&OB9 QB\5Q&OZI/A5\-_"WP>^'7@_X7>"=(T[
M1?"?@7P[I?AO1;/2=*TS3--CAT:)(4\C2-'6..W=O*,DD4051(7+!I"SO_%G
M_P %Z/ L_P"S[_P4B\$?'[P=I^NW$_Q#\)?##XRW=WXDLFU'P,?B?X#UK7_
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M)8ULWB6=YET/PC-!XW62$31 'CO_  ;.>!/"O_"O_P!I;XMG3PWCZX\=>&_
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M7]BE?Q#_ /!<OX^_!OXC_M^?L\:KX%^(_AOQOH_PP\"> ;+QSJOA.Z'B'2]
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MP)X@\67:^'=+U[4G^)F@^.=SZSXA9&T-(O#NBZW,\?BB6*9UC*1N6(CDP/\
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MA[5CHO!\$^-5?Q7X9T'PV<?\).P3PGXLE\:(76*:%V60?J-\:/\ @H]\:?\
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M0L$)\7>#?"8^9%8!24(!^3'_  3G_P"4_P#^U]_V4G]M?_U:6MU^]'_!2O\
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MXF>!(=>/]AZOI'@?7-%UVVEU_P //$R&9&\4IY'A+S;?=)Y?FOZS_P $[O\
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M!K:Z!K^E:-XV^$/Q*_L-0=<.@Z_KISX>/BU6#>-CX2/@WQH001QX2!/[L?\
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M4M)K8\.1^$8Y=&\4+)K/A:;Q(GA)Y/"$>M'QK:^";B>V^SL 97_! ^]L9?\
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ME<77P/\ %9/BR,:Z9/"0&L:#G14$/_%/%O%@Y4>)AYQ.@8B_>%<\Q^VMXO\
M"GPG_P""YGB[QM\4/!7P_P#%GPU/Q=\ CQ;H7Q>\-IXD^&5_X"U[X7:!X#UO
M7=9T+Q &C\0?\(F-=UOQ4@VLA\:: !@@8.3_ ,$F_%'QH_88_:3U+XI?%3]F
MO]L74_AQJOPV\3^&=7\/?#[X)>,]2U.^U8'P^V@-K>AZ^WA#PSN5EUME92&5
M@&5@R@U^PG_!83_@F?\ $#]NS2/AY^V#^SM::[?_ !5LOA]X<\)ZK\%/%PT_
MPUJ_B#P'K9DU_17TA)HE_P"$;\?>$V\:Z^/%_AWQ5++;3HJF-XV\*QV_C$ _
M8_3/V&?V"M9L;+4[#]C7]DFYLM2M%NK:Y'[./P<(O-/8*RC/_"*G(*NIW,,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.J^.]5O6^(%WXDTCPUIWA'POKFL@2:)\4O!.O?\ %3^(O#J>'6"GPSX/;QD
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M0/#?B>%-$.A)HD(CE"R+<"<%@N]S\D?\$O/^":W[</[ 7Q$OXM7^,GP$\1_
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M7Q+X;\4^*;I9H?#W^C!(F:OZMJ* /YV_B-_P;P?LW^//C!X<\?V?Q1\=>&_
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MU?:GR'\./^#>B_\ A!\0-/\ BI\,?V\_BQX+^(^F7>JWEIXLTSX<:2NI9U[
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MT\42ZA_8N@:"JG6I8HR-(31- T=(X#O,8+-E7F$8^@** /SL_;!_X)E?LO\
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M#F@Z]I#Z1K>BZ5J^DLJ[M,U/2(M1TUMN0H.E2*T;!03@%<KDXZ\]'10!Y?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&XDAY*O$95C9<J5P=U>^T4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-8T[3?"FDZ^VC#0]9\(:'#X9\4>(/$HE236VD@\6P_")(9M!F\N>;>DJX/\
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M-2?#0Z"ZZI%N\3W/B[_A%H\DFXCDBVG]!/AS\4OAM\8/#2>+?A5\0_!/Q/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU@UZ)=S'+5_3=_P33^T0_P#!/W]D?[=]HMKBV^ _@,W?VH<C&C '.>N#W'3
MZ]:_FH_X*D:IKO[?'_!6WX+?L9Z)/XPU'PCX%UGPQ\-=:T?2]*\'Z?J?AYM?
M'_">?'3QAX?UII)5UJ-/ASH>A>)EA\3NT48\/X7P2YW2-^S/_!5;_@H!#^Q=
M\!KGX<_!;Q/!<?M*^)O#YM/!.D#PNGC35/"?A+18@GB'XD:YH[1_\(UH<'A?
M05CNMWB<E9)50KX1F@_=* ?D!^S+XOT[]N;_ (+U?$'XIVFN"W\&_#SQAXH\
M2^!-5\'7W]I^%_&'AOX):1H'@'P'JSL=P_XK#0-''B4*JE<NJ(A7:M?5O_!P
M;X \9^ ?@R_QK\(_M(_''3?#WQ0\?^!?AAXE_9[3QUK*_"*_SHWB#Q$?&6DZ
M!C='.DG@O1Q+'(?^$/\ ,+2.(VD*BI_P;._!RRTOX1?'[X[3CQ);ZMXT\=Z9
M\,;2UNV_XIN^\,^!M)CUI=:T),?,G_"1^(->\,.V1L_X1Y1AM_R_'G_!P)\3
M[W]H;]M?]G_]D3P/?^%M1NOAYHNE:(;AWUK3M1TSXG?'37=$==!\:ZPI$*>'
M(O#>C_"SQ&K1H'>+7/$2R._EJ0 >X?L8:#X\_:'_ ."=^@?L(?LC>--1MM7^
M)^@ZIX__ &IOV@_$=UJW_"-?!)?'3 S?!K0G\/\ SZ_K_B[^PX?"\OA8MY:^
M"M:\2,^T L/I'_@B3^P1\>?V+-?_ &D/BO\ M$QZ;X3T_6--_P"$/LM+GO6U
M+4K^+P3K1US6_' F0;%\/.<F(APS;69,A&(_8S]B;]DWP/\ L6_L_>$/@AX#
MM]0:VTQ7UKQ1J&I:F^I:EK7C774@;Q#K$T[%DS+,K,H4*KQK'P64M7Y?_P#!
MPS\=-5^%G[%ND?#C0SKEK<?'7QRGA>]U_1_$?]E1Z?I6B*->UC1-=C=0^LZ%
MXKB5?#3P<;!,NX-E2 #Q/P#\;OCS_P %E_CKX[\)>#[?5O W_!,/P+XGE\->
M/'/]L^'?%'QHU+1 9#H0U_1''B*WC\5QZMH/BF3PP\D$/A'PD/#,TI:ZN&>3
MYX_X+?\ P:_8X^$_@#X$_LS_ ++'PD^'VB?M9^*OBGX5OM/T?X9>#M)'Q1OO
M ?\ PA7C_P "$Z_K>@JOB<?\)=XBUW0AY93=XP;P\27?_A%=D/TC_P $\/V(
MOVZ+;]C/X"'X0?ML?#/]G?X9^/?"NI>-O$7A/X7?L_\ PW\<>(_&$GCWQ5KN
MN'7?%GQ3\2R-XC3XA)X5U;1_"\L<"H?!)\.Z%X,,6[PQ+)-^CW[._P#P3G_9
M2_8_^(<OQRU;Q%XP^*'[07B/6-0T.T^/G[3/Q*A\<_$;45UW2M!T3^RM&N%B
M\+>&/^$AN(= 4CQ)%X1?Q[#87/B/P@_BUO!DL-M& ?7'[*EI\6]._9Q^#-E\
M>H;:V^,-I\//#5IX_M[3^R#IR>)D@5)!!_8P:$#=Y2L(R(P_F%E\X2FOH:K%
M5Z /X[?^#D[X:^%?"/Q!_9]^+&B:GXB7X@?$NW\>:%XD^T^,-9U'3+#PSX%'
M@!O!.B:-H!=G\.^'V?7?'-PI\*J!)XL\3>()06:23'TK_P $Y?V!_&_[8G[&
MWP@B_;D\9ZWXB_9[\)Z-J!_9S^ _@O4]:\$Q:>DNLRX^)WC;Q#H<MOXA\1^)
M8%CU[0?",/B>62>&UUSQ,SPH+JU>3X?_ &P;J#_@HA_P7$\#_!S1)_#FH^!O
MAAK?@?X4MX@TOPUJGB/3+WPQ\+9/$7Q!\>+XYT+6U5"%^(^O^.?A;N^;P:X'
MAAY)))&:1O[(/%7BKP!\'/ &L>+_ !=JNB^!OAUX$\/-?ZQJ]X5T_P />'O#
MFCJWSR'A8H8HB% 53D%556) D /XXM+\"WO_  3A_P""V?PP_9__ &;/&7BW
M1?A?\2/''P9\->)?"^J7!OM.O/ _Q4UKP])K7A+5X9A*VM2Q2*LT/BA]\D,B
MIG,B9K]_O^"GW_!2_P #_L#?#RVTK2X+;Q;\?/'6F22?#CP,&1A96)N#I#>,
MM>*YV^'K>?<A 8,TB,' 5=K_ (E_\$U?AUJ/_!1G_@IU\7/V[?&VFZS>_#+X
M2>/+_P 8^$+/7?$6MZ_'I_B< 'X5^#=!UI?$?AAT7PBJMXIBB'@^3P:SZ!'"
M"2^^N \0:/>_\%#?^"]'BGPCKNE7-S\./@C\4]8\-:KX*\2>.=8.FV/@C]G-
MF\$:\_@M/#AA_L-O%WB?1CXLE\+EHY)6\0.TDGF.\A /U9_8!_X)H^'/B!X'
MF_:L_;[\)^&/VA?VC/C]=ZG\0+U/'DMQXS\+Z'X!\;Z3X8_X0O1U\'ZZC^$T
M\01VVCN((C&3X3\)Z^/ JR1Q6]QG\.O%GP0F^)G_  6JTG]D;PAX=T&?X'>
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M\1>.=+^%.A:NZZ]XR;08HAXDU]%?7)BSY;S==DBCW#:%_FJ_8$\7V7_!0?\
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M.6ZZ%H:?\(U-(UO'+H@,L0DC3=_.O^R5X*U/]KS_ (+P?&/Q'\5M6T3Q'/\
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M5X$\76!BT[X0ZZ?&GPW\>>"/ NL:WX[9?"OA7PZ?"?AW6#&WAKQ.?!LWB\Z
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M?B'1_$?PWU+PUK_B70CX>\!?"LZWX)C\3>*_%,0_X5NW_"3"<NB0>-M"5V8
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OE;QO^QE^R'\2_%NK>
M-OB-^R_\ _'WC;7-LVL>*?%WPA\#^(_$>N;;?^R@VJZSK?AV::5C$54HTQ)"
MF100"S?5-% 'SU\,OV6_V;?@EJ]]X@^"OP ^#GPE\1ZGI<6E:EJ_P\^''A#P
M3J-[IJ$&/3)]5\/:%:R2P)( 6AWN"RJV#M!'T+110 4444 %%%% !7QWJ'[
MO[#NL7^HZKJO['W[,^H:MJM[>:AJ>J7_ ,#_ (:WVI7NHL0AU-Y'\-R/),Q&
M6.%=69 %&3N^Q** /G[X7?LQ_LZ?!#4;_6_@S\"/A%\)M9UNRATS5M3^'7PX
M\'^"K_4["-DEBTS5Y?#NA6PF@5]K,KC:71>0=N[Z!HHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***_*G]N'_@KY^Q)^P%;ZOH
MOQ=^)VG:Y\7]/AX^ WPSO]'\:?&&&^DT?0O$$5IKN@6UQ)'X!F\1>'->T?Q'
MX*E^*$_@Z#QBCHUE/(CML /U6HKSWX;>-;#XD> ? OQ'TNVN].TCQYX.\->-
M-(L]10IJ-IIWB+1(=:@CU3<Q'F1PZG&K!6 #X88R0OH5 !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
&%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>ex99-7_002.jpg
<TEXT>
begin 644 ex99-7_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" \2"JH# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJ]% %
MBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&YNKNZNELK*U1< L\C%44$\MOPA8\G<P4^8V?QR^$%[XYL/AA8?$/PK?>/\
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M!Y(^TZ_Y>(BR1X7<7(!] T57\_V_3_Z]6* "BBB@ HKPWXH_M#?!WX*-8?\
M"U/'VC>"#J=HUS:7FLC41I[JI*D_ND9<9!P/D;CYMIKT?PMXL\.>-O#ND^*?
M"NKZ?X@\,Z[9+J>C:QID^_3M0T^3&R6-QPZG)!R-N5(<(014^P2UY7;T7^0'
M5T5Y3\4_C#\//@OX<_X3#XF^*].\(^&OM*:2=5U4E+!=0D+% S @@$HZ]1]T
MCJ*Z+P5XT\-?$'PQHWC#P?JMIKGA?7;3[?HVKZ9\VGWVG-E592Q..C   <CY
M<<BJ [2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$K%858N*]UI[W_7H=F1GRL<X^GJ>O^>M*%VB8]<\$_EC'Y_U]J_GN_X)M?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7'>*M U#Q#X>U+1M.\8>)?!ESJ$*1P>)O"?\ 8#^(M.(4
M$S:4/$GA[Q7H&\J-H$OAN9=F6VEMSGL:* /YP/V-_BM^TW^V!\>_BM\'/'7[
M7GQQ\#^'?AWI'B?5=$U3X3V?P7\,^)=0_L/QEH.A!-;7Q%\%/%@(V:T3L!Y
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MWZO6_5Z[W/0P]OJL?JNUM/Z]!1M.0.IZ9^A]!CN?\XKX?_:6_9#T[]I'X@_
MOQSJGC_Q1X,M?@=K'CZ^NM'\'[].\0^,(_&HT"*/2$\7IKT,GAR*)="*[88+
MBYG@UD+;R>'I(DW?<2JHY'/O_G_]=,9E)Z'ZYQ_0_P"-+"UWA6I89V<?AY&K
MJZ:>_6S?>VC2T*Q&'6(24G^O_#G\SW_!71-0_9M\1?!F#X0>.?B?X"L/$_AW
MQW>^(_L7Q>^)6H?;AHFK>'9 "/$'BJ8%AOP6# $8VC;AW_4KXY?\$_\ P)\8
MOAG:>&?"'B[Q/X#UU]:\+>)8]=\2>,/B]\5M(A?0=8CUI$3P1X@^,T?AQ_/D
M+'<TDH5F 3"8"_F)_P %Y8+>[\6_L]P7L'VJTNO"/Q.LKFU'\2_VGX: ;^8_
M GBOZ0+' TZP;O\ 8;#](T']/US[5[>8XG%_V1DNK?QVUZ<SO?O9;=DOF>/A
M<-A/KF;W6]K^2LKFO1117@GT 4444 %%%% %0+GR_8YSZ9_SBOQ?_:%^,7@?
MX]_&'XA>"O%6O:E8?LI?L\VJ:1\;EMK;5] E^)GQC75-:AC^&6E^(4!_X231
M?"4<2)+X:,OA<_\ ":(J"YFB2/;^TI $98=0#C^7Z#I7\T7[-'@'P'J'_!4'
M]H+1?C-XFUOP9K6F?';XE^/?A;\+_$-HFFZ=\2-6U_QGKVM:%K;#6%>/$>@G
M0?%'@_RRJ>+X]>ED0GRU1_3R6A%2S7$N]Z=.4TEJ]U3;MUM?Y;O0\;,*UI99
MA>DYK_R6*:U_S]#[=_9C_8H\"ZE\4?\ AJ[QI\'-$^'+7%KHEE\%_@E;YOO^
M$4T71]*$>C_$_P")TBQ2@?$KQ+&3-_PBTD7V?P7M6.XG\4>-Y)+NV\FT%OA9
M_P %0?BQ\:_ _C_XO_&7P_IGPZU<V/A3X-^%VTKP-X;D\$Z)K2+%XTUN0_\
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MO4>3C&WCTZX_3I^E9YCF/UQR?*HIN[?65E9-VTVT[[:BR[+OJ?4M4445Y1[
M4444 <'XPU/7=%\(^)=8\,^'I?%?B+3/#^N:MX?\,)?QV \2ZOI>F32:1HL>
MK/%)#I#Z[<I;VJ3-%+'"9FDD!"3(_P"(O_!+3P+^S7\1?"GC3Q;\1#X5\??M
M$^+O%WBRV\:>'/B3<:1XFU6TTV/6-\:Z-H^O"237(3M;S/%$5O+)*2BAD562
M?]S=9UO1O#FE:GK.M:EI^DZ-I=E?ZKJFJ:C=+IVGZ=IVD -JNIZEJ3$0PQ00
MCS9)93&J(C,YVJ[)^5_[4'_!+_X>_%K6==^*_P %/$NJ_!_XLZJU_JZWGALA
M/#FN:F^EM$Y8:1(C:)'X@0PM<7,;R--YADC@7(2O2R^KA?JT\'BFX.:@U4C%
M2?-#FTE%NS@[WT2>ZOL>1F.'Q5UBX^]:ZMZ[V=MUK;[[=3[I_9[_ &</ 7[,
MWA[Q%X1^&M]XJ_X1/7O&&J>,+'P_K^MRZ]I7A1M:R9-'\%PL VA>'D8,8K5C
M*$RY,O.\?1:=?P_PK\D_^"8G[6WQ3^/FD_$WX6_'&RU8?$_X.WFEZ?=76HZ2
M?#NI1:4(QH,>E>,HY7;64^(D/B#P_KC>,O/A:'SBC8+,5E_6O)4\8/\ 4'FN
M?,</BL+BYPQ;3G:+;33OSQ4HRNM)*2LTUZZW3?9E^(PN*PL98/X5?IJFORL3
M5QGC73++6?!_B?2M4L;74]/NO#VK6EYIFIVBWUA>JVENQ22-A\R')5L\EMQ4
M+(JN.SK!U^*671-6@AB6:>?2]25!T#,T; +GWWY4=<J *Y3K/YS_ /@A9IMA
MJ.O_ +1'VZTMK\Z;:_"R[LOM5LM^;/52WCX'5E<XVM(,JNPJX8@JR'YA^CW_
M  56\-^';_\ 8I^,GB+4-!T;4]=\-V/AC^P=:O\ 2],OM6T#^U_B9X#353HN
MJW$9?19)$PLLP=';R59F=%45\ ?\$.=$U71/&O[4VA:YI6HZ%J^A6OPPT36-
M,U:T_LO5],U71M6^(,6MZ1JNC8/ER[Y%"O@_*6 &2*_2?_@J3_R8C\??^P?X
M$_\ 5G^!*^JS>5N+DT_^7E%:/I*I37W-/IH[GR^6_P#)/6\I/[CZ+_9W^&/A
M/X2?!/X=^ ?!UM)!I/A_PEI$7VJ\ATA-4O[_ /LF'S=6UG^QT6.;7)<9GDBR
M"GR!W:./;[N_WC^'\A7*^"/^1,\&?]BSX=_]-$5=4_WC^'\A7S%9W<O^W_S:
M_0^EH[1]5^2&M_!^/_LU?FO_ ,%9-.L;K]A'XQW5U96MU/I-]\-;S2Y[F(,V
MG:C-\3O FBO<Z5&<'S/[%U?6HD*E]IFF'0G;^E#?P?C_ .S5^>'_  5;_P"3
M!_CO]?AA_P"KD^'M;X!VS;*K77[Z*TT>M2"_)V?DVNIPYA_N.9?X)?A$\Y_X
M(]Z;86G[&/AZ]BL+6#4-2\=^.7U2ZAM434+Z4:W( ^KG:SF8 X;)VA=N,%F)
M_5D_>?\ W3_(5^6G_!'[_DR3PC_V//CW_P!/IK]*;C7-$LM6L=%N=4L(=8UI
M-1N=+TNXN5%_J(T=5.JOI>G.YEE2W1O,F: L4$Q=@PZZYW_R-LX_Z^5/PL3E
MO_(KRO\ Z]Q_4Z:BBBN ],P=7T;2_$&F7^DZSIMAJVCZE9M:7NFZA;Q7]A?6
M+ Y22&56C<.&W .K89591D*]?S2_L#>&]#B_X*K_ +0=A#H&C-IOAKQ)^T5'
MX?LTT?2?[/T!-&^**IHQT'R@TF@,B,Q 0;B1P5/(_IT?^+_KFW]:_FF_8)_Y
M2R_M*_\ 8=_:7_\ 5JQ5[>3-_4\Z=WI26GFW+7ULK>C/GLY?^V93_C?X)']+
MM%<?XM\6>%? FA:AXG\:>)/#GA'PSIL9?5M?\5:UI/AWP[91@84ZOK6MS100
MJWW4E>10Q.".<UT-O/!>Q07$$T-Q;W %S:7$&"K# (8'+!L@XSGD95@"*\0^
MA+]%%% '\U__  78TVS@\8?L\ZK%8VMMJ.J>'OBA:7NIBU#ZG='1=6^'TFB1
MA@!N'F.S*6_A=0 %  _HK\.?\B[H'_8(TS_TTK7\]_\ P7)UB^T'QW^RSKFD
MSBVU?0K;Q]KFC7@Y%EJ>BZSX <$'L,M@^XSTK^A+0)9IM"TB>; N+C2M,+>[
M%<D_DX)KW\Q_Y$V2_P#;WYOOVL?/9;_R.,X_[=_K]3H$Z'Z_T%/IB=#]?Z"G
MUX!]">,?&+X4>"?C+X$\0?#WQUHMGJ^CZ[HVK:()Y;+2]0U71?[<TJZT235_
M#\VL1W0T?Q%#%K$QMM9BA::(#+L#(N/QT_X)">.]=\!Z[\<?V2O&^EZ=H?B;
MP%XCU;6[=KBZT1M534AK#:'KFD*N@K(/$+1NJ.OBC_A*9RQ4)Y3!BR_O83PO
M3C/&..N/UQ7\]?\ P44CUS]DS]L/X)?M@^"-,NK?3_%&=$\=LNKZ-INFZYJ.
MC MK&BKHY#^(I)/$_AEE0R1O*AD0DG.5'M9)/Z[',\GMK5BI0ULG5A%U5&^C
M]Y76SV=U97/'S'EPG_"O?6"2DK;)MKY]^_WZ?9/[>&F6O[07CGX)_L8Z=%#?
M:IXO\2:?\9O'5Q([[O"'PT\"/-I(U>;2A+X;.MP^+]=FU'PLL2>)DD@"O*(Y
M4FABB_3#0M#TSP]HVEZ'I$26FE:/IFG:3IUJOW+73]'1+>! 3@GRX4CC)(!)
M12>^/R\_8:M=%^/OQG_:._;8NM-U7R?'GB]?AM\&;O5])U>/2Q\*O >G>&M$
M'B[P;_:Z+_R..OZ*X\86OD[?#?BWPQ/!*64S.WZQ!LDCM_\ 7K@Q]\-RX1Z.
M*]Y)W2G)+F3MUC\+UT::T=[;X"7UE?7/YMO3^G?S]-W4445R'H@<#D]J_ '_
M (*$_#*^_:V\8_M"3^']:\.1:7^Q?\%X];M%%SKFG:D?B%KVK0^-?'&A:V$\
M/31:YX>'PU\":NJQI(P'B_6_#DH+)%-*/VH^*WCW2_A=\.?&?C_6[W3+2Q\*
MZ!J&M>9KNH)8::=1AC+:5I4^KN (DN-96*R60[WB>YB4*!L%?E)\ OV2OVA_
MBI\./^%NW/[5?Q:^#FM?'*\O_B'XM^'W_"!:$_\ 9Q\1B6.+2-:776>36U/A
MQ-)B\R2.)20ZHS+OQZ>3R^J?[;S*+3BHN2;7,VFTDM=8*2TV<DK[GCYBEBKX
M.V^KU^[\7MUL?9?[!'QWM_V@OV9OASXHN];N-=\6Z/HNG>&O')O(M(L-0'B3
M04ACGU&72=#9X85G81NB+Y2R['_=LRN[?<*CY,=LXR>W QG\1C\:_ #]@ >)
M/V2?VR?B]^Q7XE^T:YI/C0ZEXQ\(Z_%;:2XO?[$TE=8TK6-;:#7YFT&3Q-X<
MWE?# BVB6(!VCC\QU_H$(SP:PS>A'#8M2BTX24:E.2U3C-*2?IJ[=4M'JM.C
M+L3]:PFN]W%^5KIA3'Z#Z_T-/HKC/0/RY_X*X6?]I_L::_9B<VOVSXC?#"T^
MT<<9\8P #T&,<>I:OB?P#KGQQ_X)+^.]'\"_$_4]3^+G['GCN_E31O&NCZ1)
MIQ\ >)5G8:PS:#<:[XG_ + ,L**Q\,+XK:/QEYDGCBTN9O&Y\8>%9?N7_@JV
MP/[(U^!Q_P 72^%A]N?%\)'XX/ITKZZ^/_P#\ ?M(?#+6OAA\0[);G1=55;F
MUO;5A_:>A:I$S#2=:TIPIV3P-O(R0C@LO&-Z>SA<6L+A(X+&Z9-*<N:%U=.*
MBI33:^*G>%M5=2>C>_@XG#/%8MXS!_$DK/[]_77[NUSC?V@M7\&_$S]E#XO^
M(=%GT3QIX2U_X(^/==T2["KJ6DWJ+X*UK6=&U53C)7<$E'"MEE!P 5-C]C4^
M#!^S%\$CX!_X27_A#_\ A7>C_P#"-?\ "7'2?^$E_LORSL_M;^Q/W/G>9G/E
M\8QO^?%?S_7^O?M)_P#!.33_ (S? +XGZ#XE\;?LX_$WP?XX\(>$/&EG9M%H
M&G>)O'7@_P 1KH&M:/J\BKX?B\0.\,R>./"KJA<QR^-2"!(I_?#]A[4_[6_9
M)^ 6JG3M.T5;WX<:1>?V5I5J;#3+,E6!6./D*% #'H"68D<$EX_ ?5L(FI1G
M"I->SG"2DI1<)-ZQ;5XN-M&D]&[--&V7XGZUBGH[I:K56:?ZW^1]=4445XI[
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% %=\?*">QS^(8_R(K^+WP[^S-\/_VM/^"NW[1_P9^)=_XGTKPMJ7Q/^.FL
M7%YX)OM$TS7QJNAZSKNMQC=KWAOQ6OEEBH&P(,8"*#A:_M"8YE4=NF/T_H*_
MDRU3]E#_ (*#C_@H_P#M&/\  N;QA\![7XG>-?'WCG2OC;?Z!K?_  K2[\*:
MIK2Z[I6D/XYT;PWXJ\/?\)#XB<A;CPS.D<D3X\]8Y,J/H.'<1R+-_P!Y&G*6
M&Y8S;2<9<UTU=W;6KLE)Z7L['SF?T>=Y7I?EJM-=]$WZ?UJ>6?\ !27_ ()I
M?!']E#6OV8M"^#WBGXBW4WQM\>>)O!>KWWQ UG1?$AL'W>!8]'U71D\/^'/"
MFUX9-896^=ERP4'*FOO#XL?\$.OV5OAI\"_B=X_@\;_&_6?%WPZ^$/Q \96L
MQ\3>#M.\.7OBC0?".MZ[$7TC_A72O%HDNL:3'<_96\2-M8^7)<("DC_FM_P4
M-^"__!0/X4^.OV?-+_:(^-UG\:;WQ!XDU)O@OX@TKQ)%]AT7QO\ VYHB:KIC
M'7/#WA,Z#KDRIX*:W=C_ ,(9C>C*DB2QI^BOB/\ 8;_X+(>)?AYKNG:U^V5X
M=UVTU[PCJUMK7PWNO$6IKJ.KOK^AE];\&RZP_P .UT%&E#MX81T\4MX,P7>1
MD0ES])B<5COJ637XQCO)[U-E/17Y+Z*ZDVDKV2]W4\3#8;!_7<X_X1NU[);M
M:];:[FC_ ,&\'_),/VF/^Q]\"?\ ID\0?XU\ _\ !(;P5H7Q3\.?M7^!_'_Q
M;^)'PF^'&F>'/ ?Q U?Q#\/?B.?AQJ>@_P!AZQX@8ZT== .Q2%ZM@9PO+%0?
MV*_X(Z?LF_'G]D[P%\;=#^/7@JW\%:CXT\8>&M6\,VMGXA\)^(UO=+T32=8@
M<._ASQ+XJ6*16G0K&\B3,-[1@F-ROX:_\$I?V@_V6/@G?_M'Z'^U;JMM;> /
MBSX$\+^&#I-YX/\ &7B33->']M>(/[=T7_BG_#9]OKUR#UA/ZY+C.I@/?C*%
M-PY;23CSO6.J3W;33T2=G?0V_P!T?""QNC3L_)\JMW_X.ATG[>.G_#WX3^,?
M@CH7[/W[?GQL^('@+XP^'M,N_'MKX@^)^N?$1? GA?7M9#KXTUH:$_A4./%7
MAK7]:1OAC'X2;QDTOAYU C/BQHU^_/V5/V?OV&+,?$'5OV'OV@OB1\</VG?A
MA^S]\8M8^%.@>))-4TS2_"GCS7_!1\"OXUT+0]?^'7A/PR?$/B;7]:T?P[,?
M%P\7;8];=E#(K,/S,_;S^('_  3R\=_$'X$:'^RGX1TWP]\/]+UC4KSXV>+/
M#W@[QCX:%_IFN:QX?W:.%\0+_P )2OB+PMX>T/725;PBX']O_*1TKJ/V)OVF
M/@[^RA^WGX^O/@O#J?BSX0?$3PGXD^$_PWU?5K'Q?JFI_P!JZT_A_P 0>!1_
M86A>&7^)FOCQ=\1M"T/PID>#@ZCQ 2C*X##HQ&$S#%Y+!J57FBI>[+V:Y[M)
M<[L]8K6-I*^[NVK<&&Q."PF<O1?CIIT_70_03_@B5X9\=^*_V;?VQ?#WAKQ=
M<_#OX@:]XS71-)\9C1]%\1MX4\3/X-$?]M)HSND>O,KR(^)&&\!@GS8-5O&O
M['/_  6AM/@]KW@;Q%^US\*M2^'.D>!WTG5M+L]?UC_A)KSP[HNB8D==>/P1
M'B9)9%TQ@Q'C$,XDD!+9<5VG_!"SQ-H_AKX,_M:>+_%FMZ)X5T'3OBKIVLZ[
MKGB"]?PYINCV2Z"SZUJVN:MK[Q1:*N$=V$\T44>Q79T'[R/V/]K;_@L[^RCX
M)\'>/?!7PLU>\^-7CG4;#QOX)'_"*66I:9X)M-21#H8UB;QSK<">&->\.AW;
M/B3P:_C"#*+M"J\B-Y6,6-?$N;_4,HBVIIM2@I\J5F[-OW';52WNU9=3U\*\
M'_8^4?7<W=K:.]K[[KR_S/SP_P""*]A?:M\!?^"F&DV1A_M#5?A+X"LK,7-Q
M-8YU/7O!7Q]C!;6M:!VH)'C+2RCRHL;Y"H (^6O^"==M^W%XRTOXZ_LQ_LG_
M /"(^$].^)-H9OBE\6/$3ZUI:> CH"^(="_L?1O&V@-XLCT'_A*?^1:7_A&/
M!_C+QDCJLH_X0MXT\;I]H_\ !&SPY<ZM^R3_ ,%"8=#T,ZEXE\4^!4T.U_L?
MQ-I/B#Q1KS'X>_%$>']$'PQT!T\0>'4']NM_PAOB.0M-X^37S%;*S>$I%;VO
M_@WJM9;'PC^U-97\%S:ZC9^-?AO:WMG>VP2]L=032/&WF>9P><8*L1\HW9(5
MJ[\TQ2PW^N.+E%2M4I6B]E>2<96=]8RCS1NK<R7;3APN&^M_V-K9<LM5\[KY
MK3T/T:_8%_X)U^!/V%_#WBGR_%,_Q+^(7COR[?Q5X[N]+D\-V.HZ5$<Z7HNG
M>'GU[Q/';0P$+AENI3,I(*I@1R?G]_P6!LO^%#W/[+FB_LY^"?@O\.=:^+?B
M_P <^&-:NS\%O@]JFDWS1_\ "!QZ(NLIXB^''BU5P^M.69(T\PD$[@%Q^HGA
M3]N'X3^*/VK?%W[(4.E>/-#^)OAG1X=;MKCQ'X,UG3/#OBM%TL:[K2Z)<_9T
ME6*VB=VC\3S6T7A+QA("?!%YXJ ED7XO_P""PW@7]F;QMH_P"/[1W[1>O_L]
MV^@ZQXZOO!UUH/PZUKXB2ZY?8\#+K)8^'XY7T0>&)4T:5)7VAUED*EFC._YW
M+L3BGG%.IC')W:D[)MSBX222C%^=TK:6WZOWLQPV$_LB2P=K6T?YWOV/DK3?
M^"='_!6+1[_3]5TGXJ?L8:=J&F79OK+5[/X;?#73=1L=4Y!UD,/V2R"QQ]U3
MNX)"FOGS]J#]FC_@HW^RU\)/%'QS^)?Q"_9+UWPSH-QI-OK'_"(_![X.ZGXD
MO]0\0:VWA]6\SQ!^S=X11BQUD@#<6P,@ 8->9_M[_L6^,OV1?@K\*/CS\/?V
MLOB-\4O!7Q$\367A8#5;_P 7>#=28>,/".O>-?!FMZ&T/B>54\O0]$UV%HY3
M',)%\.(T8*,%]G^+_P#P3@^&'P0^#OPZ\9_M<_M[_$7PEIWQ!.D64FEZ=X*\
M8_$7P[_PDS:.=<&D1Q)X@E+1D+(%:7PE"6DC9 H7+K])A\9&\<9_;<+RDXQ2
MX.NY.*YI15F_>BK-KHM6CP,3A7J[/:^O&+6CT3=UMY[/OL?T ?L1^%?!]U^R
M]\!/B!;^"_ .G^,/B;\#/A9X@\=ZYX<\$>$O#$GBS5?$/@K0M8U@:X/#^BP1
MRQO.Y!AEW0D[5V;TC*_FC_P4#_;+_9T_85^-?AOX2_\ #!/P5^)J:Y\,=*^(
M$>N^5X,\$I8PZ[XJ\>: -$_LA?@UXQ>8^?X,,C7"20[FUI8A$NQY9OV&_9T\
M,^&? GP'^"W@;PEXMLO&_A#PA\+?A_X5\->,M/N-'.G^+-"T+PWI6CZ1XKTS
M^P&DM&C\1Q1)<"2VG>"1SNBD<,'F_&3]L/3]-UC_ (+@_L4:7JME:ZA87/P3
MTW[19ZE8)?V%T/[2_:7*H5DW(LJL2PW@IAEW*5S7R. Y<3F^9_7%)PM7F[2D
MI/EA*HNJ>LN:*3T6S2MI[^/;PN597;=.$5=)[I+M;_@:W=['X4_MP_MB?#O]
MKC4_AO?> OV:/!7[.5OX$M/%-IK%KX3U?1=1'BS^WO[ XUL>'_AQX2(7PD=#
MZ$L0-?QDBON#PE_P5L_9C\&>&M \,Z7_ ,$Q?@]<6>@:1INBZ==ZGX]\)7]]
M=JRX ?5=?_9V_P"$BG8'+;Y$."<*J@*!ZW_P<'>&/"WACQ/^RRWAWP_HOA[[
M5I/QA^UC0-'T73&O<ZG\/&*G$:<[F+'@Y+=1PB_L#^VUX<^$'A3]@?X\:UJ'
MAGX<^&)Y_P!G[Q99:+J=UI/A'2Y/^$HUGP;=0Z)I6DZRZ1J=9E\0"%K=D\P/
M(Q9=RQ^8OU6*QV7SR_)8/*)\FJ5JU2+>K3O.,N:3W:;E=:VM9V\##8;&K&YS
M_P +"OI?W5II?9Z?A:VGK<_8HUOX0_M(? KX??M%^$_V6?AQ\*KCQW9>.;)H
M/"L?@T:IH1T#QAX@\"2Z1)KOA_P[X337!*V@.P*B**,$1(N[#'^7KXR^-I_V
MA/BK\<? '[0O[4-S\+O!WPE^,'BBR^&_A.[\!_\ "2:9?G_A--?T'_F7_P#A
M$?\ D4_#FAZ'C_A+#_S'\^P_H!_X(VZWHT7_  3Z\):UJWBZU\06O@W6?B<N
MJ:9H+(=2^'>F?\)EKWB!]$UI/#K;AK_S_P#"3*6*R'P?KGATF/RA')-_/=XP
M^,&E?!+Q'\6/C%\%OBW\"OBUI_QX^,'BB]_X1/5O!WC+4O'.@Z7H6M>(->_M
MK7-#\0>&_"/_  C_ /R._;'_  FO7P$/^*1\9UGE6%C'-LWA%-1A[JNY-Z.U
MKS<I/1+5MWWO9J^^9XG_ &/)V^N_W?<D?;W_  3;^*WQ9N_%'[3_ ,#O /Q_
MT/6O!_PQ_98\>+\$OB#XAT?1O!/AKPGXIQH+:'XSUL?\(W_Q(/#OA/Q#K9./
M%?\ PF1"@GD"O#/^"='PT_X*&>.OA=\9-3_9%^-_@#X;>"M.\8-8_$32_%J$
MZEKNJ#15W:SHDG_"M?%ZH6\.[,!F7>X4+N8 #*^#?B+P#X>'[7'Q:\<?'_X6
M7/BCX[_L@_'71M'\#_#_ %;_ (1[2[_Q1K7@Y=#_ +%UO0O$!7#87Y/#&3XT
M1]K[6VE3ZI^P-^R+^WAXO_9OU+XG?LS_ +3'A7X._#SQMK'BO4-5\)W4VNV&
MHWNI^'P- =FD7PSXO2(?\24*"[*6)(7(W5W8UX1?VR^:G&\J48\\7)-N7O1L
MG=RDKJ%M(RM)WM(X%_S)]&]+NSMT>OIW\M#WG_@W4_Y&K]JS_L7O@Y_Z=/B'
M7P-I/P]_:6^(_@[_ (*::7\$)_"H^&>@_%RP\9_'72KN[F_X3/7M(\#>-_BM
MKNBZ'X*8?\4A_87A1O[8\3^,1(?/9= \/" %!<>"Z^]/^#=G_D:OVJOWV?\
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M5<]O+?\ >\G_ .R4E^=,_7H=$_#_ -!-?G/_ ,%;O^4=W[2?_8#\&?\ JSO
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MC^XOTI]?!GVX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[M>UKV[VT_0W]DOY?P5_R):***DL**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH _!+_ (+3_#3XN>/M;_8DOOA+
MX!U?Q]J^A?%[Q+(+*Q@$FG?VHS^!];T'2];"_*D-PGA_69X^=Q;0YMQR":_;
MSP[)K5]X9T*?Q-96^F>(KG2=,N/$6EVD_P!OLK+6)=-A?5-,AE. \,$SR+&<
M%9  X:4'=)U;$?+[ ?X]J7LV.@((_4<?I^%=%?&_6,)EV$G!*-%SE&5VW)2?
MM)*UM$M%;6[UT6BYJ&&5#%2Q2>LE:VUK.WWKI^&R:B89B'^>RY_2OXM/^"??
MP\_X*>^#+GXO>%?V8/#O_")P:%XB.C_$71_BKHVD6/AVR\=:"R(VD)'X[#2-
MX@4R('9 0@92Q53D?VFKDA1]/Y#^7^- 4*6XY_D?;K^7_P!:M\%FKP-#,8*$
M9JJN23;^!4_WBDHV:D]7;6-G9WT.?'9>L96@V[<J=_F[>O\ PQ_.K-X0_P""
M[<PS-_PH(\][+X.G/7_J6S_G]?3O&WP=_P""PVC^&='U/P?\8_@#X^\0W5YI
MIU?PG:_#?P;X:_L,+HP#%=<\0>&_FVEE!XR"1T!S7[N^8?[P_2J\2B)Y"&'S
M8]/ZY_3]*U_MNII_PF4M'TINST=D[SNK/6ZUNK/1LY_[/EK?-)KM\.O>WR[]
M/,_"'_@CM^S1\2/!7P:_::\"_M*_"'6- LOB7X[LOMGASXA>%TT^P\6Z8WAY
MM#UP1:2Y"ZQX?D9$0NYV.KE6 W*P^K[#_@EQ^Q;\-/AAX[T7PA^S]X2\5:KJ
M.B>(KW2KWQM8I\0_$<&LOHTL.D1Z-J_B99IX5B<(84656,C"-II5#9_26\AF
M%S 8, <DYQC'?/'U.3_^O0  Z"EB,VQ>+QD\==QE4E&<N632;C&$=-;VM"*=
MK76^FATX;+L)A<''!*UK/\=?U^7R/YW_ /@C#^Q[\7OAC\/?VM;+]H3X<^(?
MA[HOQFL/ OA&QT7Q"7\/>)[W3M(T+XB0^,I'MH76;2 __":Z7'#K^1]ID5S%
M^^MP\?S9>?LH_P#!3;_@G)?>-H?V2+32/B=\/?B9XETRZNG\+>#M%\;>)+%=
M,CUY-#CUK1O$./$LD?AN.14?Q*"R2;E5E8@ ?U:45N\^Q,L74QDX0J*LXNI"
M<>:$G&*BKQDGMRIK3I\WA_8V$6#6"3:MHFM&KO75>I_.[_P34_85_:BT#]J3
MQ-^V;^U#80^'/$GBWP]XD\16.BV5[H_]H7GB;XGNO_"01ZSH,0;_ (1YX4C8
MI$ /G01L%&XCUSQ1_P $SOB?\8_VV?&OQ[_:6^(&B?$[X;Z5I?VSX)Z!!<ZY
MX;3PGJ2>,/M?@WP:=(T1XE?P_P"%X-"T@^-YWF8>,YO$#O+YABG4?N-16-?.
M<9];>-5HR24%R)+EC&RBE?HDDK+2RLDM$C^Q<']4^I.[]>K\W^/]7/Y5/VY]
M5_X*._MLZ+I'[/'B']BO4/#6@^&OC;8:UI'Q!\/:7XO32-2?1=(\0^!]%UPZ
MQKNR/0]" \9'Q*)71I5BA9=^?-+?O-^T'^R/\-OVI/@#IWP9^+^EKLM/#^DC
M2]=TM5&I^"?%&E:1%"FN:%*<%)(75E52&62,A&PY1T^OMJ[EQS]!CK^0Y_,?
MA4KC(^G-95<TG_PG+#0C24)MQE!MN2<5)S?,FDW975FFM+;WWP^7:7Q7OWLK
M77?;1_E_PWY3_P#!,W]D7]HO]D'PAXQ\!?%GXKZ#XW^'!US43\-?".G1/YF@
MA/$&L!]:CU60QD:+XGT1X/$)\-LI-C<.RN$D#H?HOXG?L8?#GXG?M4? []K"
M]U?7=&^)?P5T/5/#EM;::R+I7BOPU,?$9T72M;BSO*>&Y?&GB.6%P'\PZ[+N
M(*EF^U2H..V/:HB"#@UEB,QQ4\5+&-I2DFIN-D_>CR2=K6;:;N]7MKHC6CE^
M%CA%@TKQ7GUW^Y?UU/YZ/^"Y7[+/QX^/,G[.WB3X+_#77_B-;>$/^$]T?Q-9
M^%+9-3UFU.L'PWJNAR2Z/P9]%7^P]5CG<9*R/%&V T9?Z$_:/_X(]_ C]J'Q
M98_$^^\5>-?A/XEU31].;Q9IOA*UT<Z3XB\2!%D&NZWHNMQR+_;RE_++$_P_
MQ,>?V..-R_@/R)'IV-*VT\'/ _GC^GZ9[UT+/<=AL+EF"PKY(TY/EE&3NXN*
MDY2337N]-'K=Z7L<4LEPGUMX[%I-M7U>BU[[_P!6]/F[]GG]G+P5^S=\#_"?
M[/W@R/4-1\'>%-%U+2;F;7[\:E?>(=0U^>YUO7M9UMGPQE\1ZYJ^LRW*@80R
MA4+ AC^4W_!43_@G/X0UW]FFSD_9-_9G\ :/\1M%^(GAK6-6@^&W@[1-(\;Z
MAX%71/$.D:YI&BG18HI]=N!K6LZ-(UN[#;%'+)Y9$3RU^\-Q#>2O^ZO1 !CK
M:9)]>7//3UI1'=Q#_CX$X[#[( >W=3]>_P"IK+#9CB\)BUC$]4U+=J[U?O-6
MNG?5:Z))IV5NC$Y;A,7@W@G:UOZWT7]:G\Z?[;O_  2[M]7_ &4O@/X5_9;_
M &>_"&D_$O1?%O@*V\>:S;V6E:5XWOM&UW19- \02>(/$$D<?B+7MOB;5]'\
M3^.$1G\N+P\D\CA/#,:C[EU;X.?M/_LR_LG_  (^"/[(O@GX4>+?$_ABQTK1
M?BU<ZU>'POI.LK_87_$_UO0XF*XE\6^(]Y9I%\Q$)0;5W"OU(A::89FX SQ[
M_D?;_&K)BB(Z8/X_T%:RSG%SC'"8MJ:C)U(J[DI/WDM4]5'F;BG=)I.VB'_9
MN#5]U?3\K_\ !/Q+_P""1G[ ?Q0_8\T+XM>(/C3);Z7XX\=ZQX8TBV\/Z5K&
MB^(-*'A/PUHPDT;6)6T5-JZW+XAUK6XI7P3Y>CHZE5=)!TW_  3/_9C^,G[-
MWQE_;CN_BKX<BT?2_BEX[\%>+_ FKVM\-3T_7=-.M_%KS5.L-@-KD<>L:3+=
M(65U.KJ-C/PG[#2'(A_=DY],?4<XP2>1R..?6E+;Q(,=.G0'KC'ZGKGKFJQ6
M<8S%K-_:.#>>\LJKBG%)PES)J[;24KNTGMUO>\X?+L+A%EBBK.%TK];I?/?3
M6S_ _*O_ (*R?L=?%+]L;X&^#_"?P?FT.7Q=X(\=IXI&D^(;T:7'KEA_8&OZ
M"\*ZP3^Y 76/,PW#%V).X8/PU)_P;^>'SX#9(?VCO&X^)H\-DAKNSTMO Y\2
MA 26Q;_\)&N@"0E/)$S.4 ? )\H?T@U(=I )R/0#OZ]1U'<_J<44,\S;!8-8
M/"3Y(W;M[JYK]&VF[;NRMOJU8PQ628/%8OZYC(\TK62OHK=>GW6^1^1'_!*3
M]D'X_?L;^"/C+\.OC!KWA*X\*Z]\43K7PWTGP^S7U^WEZ5%H6K^+[C6]R,/^
M$NT71?#Q@\*E2W@]-!ECCS%/+YGYZ:#^PK_P5*_9O^*/QWG_ &;+KX6W/@CX
MH>.Y?%%WJNJWG@TMKYAUOQ!K>D :%KV3H!C?6]CA<X;Y>N*_J [)QW/XC/\
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M;XO!J?)RKG:YDXQ:T22TY;6LNJ:OKOJ;8G+L)B_B6W9_T_N/YM/^'6_[?O\
MTD'N?_,E?_%5V?QB_P""2_QO\5_!^Y\-:-^VC\6_&?BVZTFP_P"$C\+?$+48
MW^&FNJFD!-9TC2(\AE^T>(_[%>(>*#, B9F,4AV+^^_V'6_^@P/_  $%'V'6
M_P#H,#_P$%7_ &SC=/?V?E9^3TU7S7J8_P!BX/\ E?W(_'_]C;]C?XW?!O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M10 4444 %%%% !1110 45'YL7]]?SH\V+^^OYT 245'YL7]]?SH\V+^^OYT
M245'YL7]]?SH\V+^^OYT <UH_GZ;:^1JLXSCC/;MVSZ?H,\5?6ZLE<2P6;L<
M8W6]IEOQ*A?Y<=SBG7=G!>C_ %_//?\ EQS^GO7F/Q-^*_@[X1:1_:.OWOV7
M[@3%L2"!'(-W  Y&DNI'.< YX! !Z)G3+JY&;TPW&.;478'/'\.>_!P._0=*
MV(H3".IF[9.,C^?Z<\\U^9^H?\%-_P!D/39C/?:]<V^OX'VL?\(=XRR"!S\W
M_".9;/')&<CJ<U[-\)OVU/AA\9[ZVL/!%^VI?:7^S MH^L6!#<]/,#X ' QR
M#]TCG(!]E000P@^5"(/PP.P]2,U:K/LS-+&)I^IR0![#_/U_6M"@"I=^=Y7^
MC_9_._A^T_=_#'?K[>E<[%;^)XKGD:!]F/I'.K?HH;Z_4<UXG^TU^U%\'_V5
M?"7A_P <?&'7KG0_#^O^(_\ A&=,O;30]9U]SJW]BZYKR*8-%21PICT-@2S*
M00% ;),?PMJ?_!<#]@'3I/LY^)?B,S^A^&WQ*(]\9\-<8_']* /UO_T+S(?/
M^P?:,<8V;L_[&?TW?A6G7PO\$?V\_P!F']H/5M(TKX<>+=1UK7M<NGM+2SO/
M!WC+2R25<L=VNZ!"H_Y H/S%0&&_<&^8?=% !1110 4444 %%%% !1110 44
M44 %%%% !1110!F0FYBN+TS$"WR/LH]L<@?5O7^0I\,%O:<00''MU_E_GC\,
M[6(9YY+>&#C\/\@_Y_'Y+_:P_:T\*?LP^%6US71D6SRH5-IK3J=FD-K)_P"0
M"!]Y5&Y<;>HYR20#ZTAU&<W-Q#/8W7V<#@_9"/IG!P1QW^H]K]Y/-:K^XA#
M^G?\,_7WZ9ZBOY\?^'^7P6FL+B>WL;;[1:WGV+_D$>,C[9_Y%OZ9_'%?H;^Q
MI^W/X3_:OM+B;0K<KQIW"VFM1C+_ /"0$G=KI!SG1"<@YR2WWL$ 'Z!VD)_U
MT_\ Q\$\]1C_ !_#]<UH57_Y:_Y_O58H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM?"?X0_##P=\,/V.?C)?O9^"?"6M>"O$MAXG_L%M!T'1/[#\0_$7QB1X:_L
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M"1HNN^)&7Q"6\/:]H/B;<&V#.2P0$CXE^"G[ NN_&;0_VQO$4'Q+\.>'+?\
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M.M5@L38IKCB(OHFKL&W :S/%"%E0;5WH&"M)*S#XC_;#_;NN?BAX=M_V#?\
M@G%H,OQ;\8^)O"6L>$?&/B'183J^G>#OA=HFCMHNO^#-%D\0X5/$+^'L^'7\
M2>*,P6V5L[9CXO\ $L/C+P;T/AK3T_X(O_\ !/\ U;Q1K*^$_%/[17Q-US3-
MVG37>K-X;O\ QWK!9-)\/Q3&0-K&A?"[P^VN>(9)8X_"4OBV""[2*2TN9X)X
MKK)XG!RCC:<(YQ*K!4(TX1I-0Y+S<X0A&,4FGRW2=FE)1:2,</\ [+C%]2;_
M +$46Y-OFUOI9MW[7U>S:;/(?^"RO_!1'QCX!\5Z=^S/\ ?'OC/P'XL\+7NE
MZQ\4O%OA36G\/ZB(]:T236_#WA#0M9T(CQ'%--&Q><P11 E_*8R+$CG]+?\
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MX)_Y'D/2?YQ/T'BW_D3O^NI^+E?W\_\ !&;_ )1L_LR?]@[XF_\ JY_B%7\
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M5_<H.GXM_,U\MQM_R/*FGV87??XUKZ6T/H.$_P#D40]7^0M%%%?)GU(4444
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MD/\ X%__ %J_.ZW"RQ'^Y5*LWWG4D_RLC['#YY?HO1(_T7O"_P"V)^QI\/\
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M6NI8P>Q();&/7#'D]^:?]LN/^@KIOZ?X5AB>+<X[G/AN&\'A-C_/WF_X(_\
M[8AN_&&E>'/A)XCU+4/!NL?V+XD_X2+^Q?!.F?VIVUG0]<\0>)/^$8^(';/_
M  B?_"8UPVI_\$B_VY_#=A<>*_$?PS_LW1[;C_D?/@WJ7\_B1^O\J_T.+L:K
M=BW%AJFG #_C[S:9SQU&23CZX^@!K\Y/^"E'QQ\)_![X!:U9>(O$?A[1=8U4
MZ6;/[?>Z5IIOO^)PH^59.5Z9P !G)ZDUZV2YYC?KL5:]WKK:R2U>JN^UM-^Q
MY&=Y9@\)@_3Y[G^>WXV\*^,=-UFX@GTK^Q-/TO\ Y#/V2\T;4NWMGI[],=:L
M:;9P316^E0?\3+4-4)LK3IIF/Y?RZ_KY^!H>I>+O$$]]XJTW4KC7O[+^QVEI
M>?\ '_\ \27%?0'['/PK\1_&S]H;P?X;\'6-SJ1TOQ)X7O;S[+9_VE_R O&F
M@:#_ .YO'MZU^I?VWC,)@_Z_K^NI\/EN&^MXS_8CZ(^&/_!,?]KWXA:7;^.-
M#\*W6I>'[K_3;/\ XK#X9\_^7+C_ #Z\U^O'_!-3_@EK^T+^SU^TAI'CCQ7;
MW)GM-8\+WM[=C5_!Q)&A=L>'O$9)_F?0U_5)\ O VI^"?@E\/O!NJ0VT&LZ%
MX<TVQO!=6@.&0'*GG(.!C'.#UQ7K=[/+",6-B...;3!]QQZ9[=/RK\7SOB7&
M8S[[;WO_ %MU/T_#<.+JUZ7MV]/P\_(Q+FYOM,&E#["+J=K;3K2[NOM07&2=
MW7KE@S;B.=WIR>YB'[G'3+']1UKFH?[6O+G,W^CV_;_1/;U([\8)/3J:ZF,?
MNR/3D?K_ (?K7@:N[[?\!?Y'H4,-]6Q4M=U]^W_R)/1112/1"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2?%#PW\4O&/Q,^(_Q@U#P%J>E^*O!NE>(W32]/T7Q3H.M:+K>D:R!H)']LI
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MY4TXU&I2DFY6DU%\J2Y8NZ>KLF[#Q& S5VM*+UOVNEI;3OK?\6?BS<?\$_\
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M3]5FT#5=#76X0NK:/#J^C"-H]#ECMM%>6V18U,NA:#,\DDD;&7A/"G_!-/\
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M@=>:MJ?P>^#_ ,/_ (<:EK5LMOJMWX2\/Z9I5[J%E&=R),\(7?"' )1AM8J
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MQF68O*,U>"QB2<>5V72\H_/77?\ X)W87,HYKE/UW!_:7XJ_]?H?YN5?7W[
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MMU:-IFO?L:?M46.LZ=I^HZ?'^S_\6]5%OK%K'J.FKJ>A^#M<UK0]3E@8@_\
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MTM;>?W>:*9D^()7LHK>\M'MH+:UN4N]7;Y0QTX!]YX[G /M@D=S7\;?_  <
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MY;K[W_FOZ>I\A?LU_%_5/@1\>_A1\8-$GMK:_P# OCO3-9^UZK:'4-.L-*(
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M7])GQITV6/X'_%2QGG!-QX&\4\@=,Z%*IY'N,'C].3_+)_P;QZE_Q<'7X/\
MI]TO_P!0OXNX]?U..XXS7]6GQLDS\)/B2WIX-\2X[?\ ,&E_+EO?ZU^3XO\
MY*/_ +>C_P"EQ/U!77#K?3E?WW:^[4_S4_VHM(^Q?'CXP00=/^%P>/.?^YT\
M0=?Y_P"->3Z/#Y-_XXQ_U"_IQC_#Z_I7O/[5W_)>?C3_ -EA\>?^IKK]>"Z9
M_P A/QS]=*_I7[3G?_(GR?\ KJS\WX;_ .1Q\F?UP?\ !:^;_C S]E#_ +*/
MX"Y_[HQX@Z?X$>U?R,6<'G>+=0]KS5/7T!'M^?O7]</_  6Q_P"3"OV4/^Q[
M\!?^J8\0U_)-IO\ R-VI?]Q7^9KDX9_W*?\ CF_OD=/$G^^+T_R/W^_X-_\
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M5>&/C)X"\4> =8L;6ZGU31=2L;4W5OID@L&UI=I($F2!D<XRS?>9G8@G_/\
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M_7_&O4/BU\6O&/QF^+__  L[7-5U*YT_7M8TO1;S[7>:S_R"CK7Y^V/:N?\
M&'AN?QMXC\/^#O ]CBXNN+S[)G3>N,Y_3_'H:_><-_PDX,_-L-B?K>,/U?\
M^"*_[/>N_&7]HOX4_$$:3<GP?X6\1F^\2"[M-8']H:6!X^T+&3@<_P!A<'('
M?IS7]ZF@:"OA^U&F62PKI5NNVTMMN&0'#%2V,=1[C/([U^5__!*']CW2/V;O
M@-H4U_HFFCQ#J?\ :2F\^QZ2-2!T;QIX^P2Z#*G&N9R""I*\@D&OUR#?*3@<
M<>W;_&ORWB[._P"U\X<D[I)JRVNG]Z:^%Z].Z/T_+</]4PB5N[(JL445\R>B
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'5T#2-7\42MX7>,+XQT-YWDQXJ>M74OA/XC_ ."=/_!57X*> _@7J7BKP_\
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MVP4)2>C;377NVU:W6U]]NAVXK'X3"?[U+E]=?P/W_P!X]#^G^-/K\JOV+?\
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M#L]%?U7?YV/M:BF)T/U_H*?7AGT 4444 %%%% !1110 4444 %%%% !1110
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MGC^IY]\U_$U_P0)\:Z5I'[87PWT*: BYNF\3'(QG ^#/Q<8C'^T.#W [>O\
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MM'?I?HWV\K%VBBB@R"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&X&>5+$#*Y_"/X('_C0K^U8,''_"Y=/.>V?^$W_9_P#UQ6S\1?AQ_P %<O\
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MC+Q;\0_%OB7PWJ$WC3PYX1\0&R\-:)IL.@ZGI&B3:SX<29?#_BW0=6>+QG;
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M\2^/]+CW+K^K:#H4/B/Q5XB\1-XK\/9B\:P^*F3_ (38J47&UB,/]I"ZM?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5F?0MHK<^W)X^M?YD-Y9^*IO&7@_7/#GC_3=-M[K^U/L=H-'_M+[!_Q)<_\
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M,_G_ )SD?GS99B/J>3?4O6]M+MMMNWF]_,ZL5_O?R/Z=O^#=K3/ML_B+5/\
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M3:^25HI*]DDNVK9]/A<-A<*O]DBHV71_UO\ ,****Q.D**** "BBB@ HHHH
M**** "J]6** &_P?\!_I7#^.YA%X2\4F;_4'1]5R>_&CMC\-V>GO^'=5E7UA
M9:E:7-E>0K<6UTGV:YMVY0COG&".,'([8],4L.TE%OI;] /\ZS]J+P?XQ\8?
MM&?$"P^'.D_:;BZO-+_Y<]9_Z$O0/^A?]O\ ZXQT^O\ ]@K_ (),?%3XL_$#
MPAJWQBTHZ=X7\+>,-+\3W@']L::=0.@^-- QM/B+X< 9/AP8&2!ZD=:_KWT[
M]B?]E'1O$5QXRTOX&^"[+Q/=_P#'UK5O:Z@-0?@XY%PQZ>BK_A]):/H.B:#8
M#3-%L+;3K)>1;6JE$'O@$G/U)/I@]?KI<78?ZB\%"'O7LG*44E?K97;MNE;5
MJS:3N?/_ -B)8OF?P];;_+_,\H^&GPRT'X/^!-&\%> -)L;/3])L],L5!LM-
MA!71P,%X]#2)6<;> RL8LD AF-?&?_!32W\6:C^SW\2-"\+Z7]JM]4\.O9ZO
M_HNM-\K/H13G03GA" 1T!&%RN*_3B"&"(9@AQDG/3K^)(SWZ@_G6+KOAO0O$
MEA?Z1K6EVNI:?J0VW=G<@&.[V@8##<#P.V1CK@=:\##8KEQBQCO)[].K_P"#
MZ:>1Z&)PR>#^IKK_ ,.?Y>FL>&_B;INM:Q!_PAO_ #.&J<'PWK/M_GT_.OUO
M_P""+@\?:/\ M\_#>>X\*_9K8Z/\3_\ 2_['UG_HF.OX'X^WI7]@UY^PS^R/
M>2S3WWP)\%7$US>?;W9[+4CF_P <R I. HX^]MQC)"#%=3X"_93_ &=OACXG
MM_&/@+X4>$?"?B>S_M(6NL:3 R:@!K##[0279AB3YE7G" '!8@M7T&8\383&
M8/ZER2CYOE_239SY)EO]E7V9[A(9XKFWB_T?[.?7CICJ, ?T]<FOS<_X*!_L
M4^%OVDOAOJ']EZ3I]MXI&1]LMK+202%T;Q N6W^%_%+;C_;9)^3!!#*65E8_
MIZ N1E1COQ34@AB&%P??V[=B.WM7S&&Q/U5IIVM]S7Z6W3Z'=C\.L8O/2]]-
M>Y_G _'C_@G7\:?@;XRT?[=X5\;:EI^E_P!J_P"EZ3H_C+4M,]L?\4W_ -1S
M_/;]K_\ @C=KM]<?LR_';1+CPKXVMKBX^''CVS'VOPX>O]L,IZ'G@G@Y'.<9
MP:_J@\7_  _\'>.K/[#XO\/Z?KEMU^SWJ%U_-2.W'?J.V*Y'X>? 3X0?"6PU
M#3_AWX#T/PG8ZH,WEKI,+1K>8&1O#NW)SV89->]B,]PN+P7U.4&GLTG&2[:.
MZ;WZI,X<3EML']3P;MYO3_,_SQ?VD/A+XJF^,GQ0OH/ _C^Y^U>//'E[_P B
MWK/_ $.FO_\ UOUSVKY@F^'OQ&$I\CP!X_/_ '+>L_3'_P!;VS[5_I<:Q^S'
M\!M>O[K5-7^&?A?4M0U*Y%W>W5S;NSW<O]Z0B0AE(Y*JJCK@]ZS/^&1?V:-V
M?^%.>$R>>3::A_2XQU]^^37O_P"O.%_LG*\![*HU3VE[BC4NK_N[RNW;^91Z
MH^7RSA+%X7&/&XR<9>CO:VC;TV_'\4?YO6F_!/\ :,UZZT__ (0?X<:W<W']
MLZ7]L_X2SP?XQ_LS_B>ZU_8/_,O^&_\ D8CXCUS0Z_6#]DO_ ()4_&_X\:QI
M%_KO@>UTR_']J66L^+?%O]L^&O#'A+4QSKO_ !)/$'PW_P"$G^('B'PGXC_Y
ME;_BCO\ L>*_M-\-_ 'X/^%9+F;P[\//#FE3SOIJNXLS=;UT76H/$&BNNV1F
M40Z]I.E^(0&)Q=1H[$,H*^S?980.(UP/?/YX)ZUX6(XE;PGU*UE;=O7[DG^9
MZ*X;3QOURZOV/F?]G/X'^#/@!X$T7X;^!-6\1ZSIN@_VH\VH^+K_ $:]\4:A
MJ&M:]XEUS6=9U^70-"\-13/=>(]7UV=(8XX?"MM"8QX3MX#(J'ZA<'"^W!_3
M_"L>ST32M.E\VQL8+8XP2H/'N,DX]_I6Y7S+>ECZ;#X=8>+2:M;^OP"BBBD=
M(4444 %%%% # 57@<^IZ_P"?PJO=R^3 QZ\ 9Z?YZ58 5N1QZCI_G\*'7/(^
MF/45QU^;ZJ_JMMERV[=;>>P^NKMW?^9R'VN"6YM[?[$?M%U9?;,_9.<=.2>A
M!XS]>:_BX_X*V? CX[>,?VTOC!XD\#> 1XEML^!%L[:S\.>,M3^W%?AEX"5A
MGP_X;SE6!4@\@@@U_;8L47F>88ANQ@,-N>G7_/UKE9? 7A"[UF7Q'-X?TVXU
MR=0&U0H3*VT8&6W<=<\(2<=:]3),RQ>4Z]=OUL_F>+F.31QE]5\_ZW\C_.^\
M-_LH_M&:]K.G>#K[X97.B>*-4L_MMGI/_"M_B7IO/U_X1OKST_+!KJ/#?_!.
M7XT^//'EQX @OM2MO&'VS5/^)3_8_P 9--_Y 7!_XGG_  K?_A&#^@S]<5_H
MB?9( F#&N/[N.<]N?UZ?K216]O!D11!<]_\ ]7^-?4/B[&=(IOHKO^OP//H<
M.QC:[2\OT_K_ "/X1/!/_!#'X_:]XB\/Z5XJ_MO^S]4_M3[9JUIK&L_V9H/O
MKG_"0?#?..?\,5^DWPX_X-YO#5EHNI_\)5XCM]%UA=8TPZ3JH\1:/XXTV_TO
M;H#:[_;>@K\-?"98D?VYX8"KXO+$_P#%< 9QX*K^I_RU'3(_+_"J\L$,L9\Z
M,L.X."1^(Q^O\J\S%9[C,5NTOQ^Z]OU^6A]!]5PGG_7R/RA^"'_!)7]E7X/^
M(=$\1I'XF\;ZKX864^'M*\17'@S_ (1G0#K&DZWH&N#^Q/ 7P^\&'Q_YR:W*
ML3?%A?&B^#&9)? A\%QHRR?HMI?@7P[X<>WB\+>%/#>A8SQ::/I&F8')S_Q(
MDC/3OM4>]=_::1IEG()[>QM[><C[R ;AU'!Z?0@#'UJ^P&>XSSV/]:\'$8K%
MM:._G_E_3!87"MV2;^:O^6IA0VGERB>\N TS#BW!!'X8//7Z9]3Q7/>)=!\.
M>+K2XT37=$M=2MKD<_;-'&H+@=R<$C\\8/MQV\EE;ROYDL>XJ!@GGI]/;Z_7
M%6=@]3^G^%<_-B^Z^\V>'PR2M"[MKVO]S;_#[S\I_CA_P2?_ &9_C#8G^T-.
MN]"U#[9]M%WI?_"%:;D]_N_#I_P!Y]SFOQ@_:(_X-_=42YN+_P"&'B.Z^S7.
M!:!O%Y4C.LAAE=!^&P(.UAD$<$D$9R!_7?/9VURH$\2S#!'.,8_,?S-6-@]S
M^7]<5Z^%SS-\+M)/YW_K[C'ZKA//^OZZG^?EK_\ P21_:A^&]KJ%]/I6H^)-
M/TO_ )A-I_PF7B34[_\ \QOG\QQGC(Z>+ZE^Q#\?O*(@^!_Q(/'_ $3?QE_\
MS?'^<5_HV^5"X.Z($].0!Q_]?//!_P %,4/]P'/L/U./Y9^M>_A>.<WPN$Y<
M7RR:^*SV[;)ZG!B<DP>+Z/RT/\UF\_8G_:,$O_)"?BC[_P#%M_&7_P S?T_F
M>M?I_P#\$I/V>OVA?A7^U=!?>./A)<Z'IUM=^!/MMW_P@GC+3. ".NO^&P1^
M!!'8C%?VR?9;=OOH#CU'/X$'],?XU4ATZPAO);Y;.%;VX4"YN5&&<* %&2"<
M<#ICU)XQ7!F&>XO&Z=>JW_$\[#\.*.[M;7^O^&_0S=-U:6?[/"8&MO\ 1 V/
MLS=1C& #P.IP."<Y%;]HP%M ,]%&>OHW^-!M+=Y!<-"!,!C)Z\=/8^F?SZ58
M*JHY!/\ /^@KY?\ VK^Z?4CZ***Z@"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_!1[XP?L^^.?A#^ROXZT+P-\+O!NK:IK5]XCMKO1_#GC=?$FLM_;^AZ1HVN
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M.2RH<Y\6J:Y/XTD-_P '!7A8]F\=?!P_G^SYH&?3O7+?LL^._"G[#7_!6/\
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MX@U[P_K&OV7">7;3HI,Q+;OY\/B_??\ !#;P)\,O#/C?P!\(]:^,/B7Q,=,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8=^IIH/@\>1'(GA];B9)POB";Q+.L]LH2Z5%>*3[@\M?[W\__B:/+7^]_/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVCI5[J&DW\MKX'^)FJZ>=3TH%;J*/6]$\!3>'=4,("D"WNYH^ (F;D#\?/\
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M%?[*$_\ P3%/QS\;_!'POX_\=:G\'?B_\3=9UW7\?VRNJ:(/$S2:5I&N,?\
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MTH\*1Z$&UW63HFA^(3#_ &\Q^5W\3_.!@H&.?,KSSX4^*K_Q#_P65\%^*O\
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MBL3+%.UYRG)I;7E)M]%W>N[W>MRL-AEAL+'"JUHJR?HE_7X;'\='A&'X]_\
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MQ)X>T'QU?CX4#5;RS_LW43X7USP9X\\!OK.B<@%A&SO"&(7S(TR1Q7])JL"
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M[6LEIU?V?A?K;QJUDU;LK:=;^1_,]_P13_9-_:(_9^^/7QEUGXT_"GQ9\/\
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M2]OT4MIGA(:Q''%<:SHWA-)=:%L9MZQRZSKTT.QKG+?HHQVXP ,]?PQZ8/\
MDY%(']?T'^)K"OF^)Q,)890A",I*I/DA&//*VDIV2<G=WN];^A>&RW"X5*6K
MZ*[OIMH24445YQZP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 57JQ5>@ JQ5>I4Z'Z_T%
M #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@!FP>I_3_  I]%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %9MNP$\ Y!/TP
M1CTQ_P#KKXP_:>_;M_9M_9&LQ#\6?&BKXFN;,:AIW@/P_;+J_C74M/(&)8-"
MCD61H^H!=HMPP57!W5]#?%+X@:)\*/AG\0?BAK\5_>>&_AEX'\5?$#Q%!IMI
M]OO[G2O!>A:SK^K0:3 K1_:=9\K29%2%FQ)*(HSL9_,3^4?_ ()S_!:R_P""
MCW[7?QO^/G[2>@IXK\,Z7_:?B+4?#EW8>,CX6O?%&N:SG0=%T/65\31KX?3P
M=&K,?"C2^*X]J;3-$"''IY5EF&Q=/,\9F$Y2RFG&+J*%O?DXV4=>DK7W5TE=
MK4\C,L?B<,XX7!17/+9OHD[IZ]?TW6Q^B_PH_P""^W[-_C#4+JP^)/P[\;_"
M>$W=A9:-JYU#2/&.FWK3').LNJ^%O^$?*Y) DCE^;!!"J%/ZR?%G]I+X5?![
MX%:K^TCKVL3ZQ\*M+TGP[K;:QX4MCX@:]TSQ%K>B:'H]SHT,+*MPLT^LVYVE
MHR?,9BT;Q[*^9_VKO^"<'[//[1OPFU[PSX<^&WP^^'OQ"31]0/P[\:Z'X07P
M^WAS6)CHTIN-6TGP]/X7B\112?V+;Q+;>(Y)88%"-&(QY@;\WOB=^S+\6?V2
M?^",G[2OP?\ C/XB\*^)M=M/%/A?7-(;PIK^K>)- L/#>M_$[X1E-$$OB#0?
M",J"+7=-UXM&UJ% N@5FR[1GKE1RK$^SE@U.G)U80E2G)3;C-\MXRCVNFWJD
MTTULWSK$9MA;_7+-6;32LM.Z_P G\S]NOV:?VDOAS^U9\+[/XM?"EM9E\)W>
MKZMHML?$&D/I-^^HZ-(JSGR'ED 0;E.=S8Z$K_%]"#@2'J<@#V)YS^'-?R!?
M\$^_VY/VK/AU^RGXM^#7[+/[*1^+'B#X6WOB;X@^)?B9JGB8W_AK1=.UO7/[
M?U?19/!2'P>WB/7T\//(1!X5\8MXO9WR? I.,_K-_P $S/\ @IY>_ME:?XL\
M'?%;1/#'@KXL^#K4:S>RZ!>/IOAGQ5X9;SWD?1=%\0^(;CQ-HNO>$R8$\86F
M/$D<&V1A<G,,449GPYC<'+-?=]VG.S5TY*+C:,K)MV?]ZSLKV:O:<NSK"8R.
M5I/6I'3LG:WW_P!7V/V=7;VSGWY/X8__ %_A0VWOG/MP?QS_ /K_  K^;#X]
M_P#!9K]H;5_BEXT\!?L5_L[P?$/P_P##'Q-JWAGQ#XVU;PYXW^*Y\5!V;0]#
MUK1-"^'LOA&+0O#Z>)=%UU891XL\6R>,(E2,MX/*%VU_V1_^"P?QQ\3?M"^
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M6BNB<[SK&)?[#;2U[;*^B7F_ZZ']V]%,C^XOTI]?)GV 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M26JDO0Q&&QEU@L&K9);9.SOKOUZK;77Y/Y"_X(>M?K^W]^T VJ>(M.\77_\
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M1\-M_P 23Q!I6L:MX;\1V2%W=]*&L:&\$_\ 8TI?,L3,X#KD$,SEOS8\&_\
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M,4OBJUE2X\-Z$[Q.DL+KUW[='C_P=JW[4,.D_P#!1']C>YTSX,:%JOBCPO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,^5,>IXS_G_
M /749EP3SCVQG^AYKY1_;+U+]H'2?V=_B)J/[+AM9/CAI]GIFJ^"[:YT[2M7
MDOCI.MZ1-X@TG3M)UK=;ZOJ]SX:AUI+5)]BR3!(E8S&*.OYNOB;^VY_P6M^#
M7A*X\>_%/2]?\#>#[.ZL--O/$'B'X+?#.QTX:CK;B/24S_PCK/A7&R4$\. K
MX(Q7IY=D^)S.T8.ESR=E&=10<G:]HQOS3=DW:*EL^SMY.89DL'JXMJVKM?\
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MQ1HND>)-):X7:S:;K>EQZQICE02$S%)$2@9BC*5SC!/@7[9'[0=A^RQ^S?\
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M+)ZT>',;/%RAADJEG9R2Y83?5)MMWC+1Z:-6T=T>/_K%@OJO.V[M;=;;*_\
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M*_LWE;_>WM>R::5FGY^7?3H?ONIVGGZ?2G.5&-QX[8Z\^^><^P_^O7?M^/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN>-QY'*EAI234>;F=65^91;BF]+I2=GNW:\C#?[WDW6SG;TM'K_P/^!]^_\
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M1_6CX$UO0_$/@CP?KWAFT_LWPUKGA3PYK?A[3'M!IQL-&UG2H)](T]]-"HL
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/Z?_ !-&P?W#^G_Q-?EQI/\ P6$_X)[Z]K.E:18?'M;>[U;4-,TBTEU3X?\
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M*5GV*PV/PF+_ -UGS6[:=/R\SW:BBBN4ZPHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *\O\7X?TK^&O
M_@FO^QM\)?VR?B=\<?#WQ9\3:IX6L/"O@YK[PY<:+=Z)ISMJFMZP=#_ME0Q
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MC_\ !8SX^3?!3]BSQOI6F:H=+\5?&&>/X3Z,BZ9)J2WFD^(TQXY1F!V:6?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** *83]T0.A)X].G?GD@FOY
M\?\ @CI^Q=^TS^S!\6_COXC^.?PTN? >C^,?">E6'AZZN/%'@[Q$;_4AKO\
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M>([3XGV7BKQK?7L/BWQ;I'C;5/[-UG799-%C.OZ%XA\4PNOE.",71:,LY,:
M[F^G/V@_@3X3_:/^$'C3X.>.#<KH7C'2'T[^TK2WL&U#1;IOFCUG23*K!+J-
MR&4L,X,D:L%E.WW*GAMHZ=2?Y"N3$5Y/%?7'I*3;]W5)M]+[[+?YJS9V8?#J
M.#^J/9*S^?\ 7]6/Y;?@?\!O^"OG[!4OQ+^%'[/7PJ^'_P 8OA-J?C-=9T?7
MO$>O>#4TVZG72O)&K:/HFL_$[PEXBT&?Q+HPT./QD?%<DGE7?AQ7MW,JH_C'
MUW]E+_@F#^U+K_[4OA3]L3]M_P 3^"]:UK3+V#QW:>!+76=3\0>--,\<Z23_
M ,(5H^KOHR2^$]"T7P=KO_%46T?ACQ5XTMI;S1K6WF81-</#_1R% Z#^O\Z:
M_0?7^AKTJV?XIJ<N2E&556JSA!*=1<O+[\K)MV;5VWH[>9Q?V-A-/BLMD[63
M/YNOVX/^":?[4>E_M-7W[9/[$-WH=OXGU36=+\2:OX(T[6HO#7C=/';RK%J^
MHZ/_ &\$\*:]H7BQG7Q#XTC\3>,O"\+,OEQ^$[ILR-D:+_P3V_;=_;J^.>C?
M&#_@H=<^&?AYX!\(7XTFR^#/A+76U#4-1TK2M.\."4Z%I6@^(_&/A3P]H7C!
MI]?_ .$K\1R^,X_&-Q,!#_PAEO;KX1N+;^E>BFN(,6L+%6AS0@X0J<B]K"#Y
M;PC)IM1:C&^NKBFTVD']C83726KNUI9OT^9B:)H.D^'='TCP]HUBECI.AZ5I
MFBZ99H1LL]-T:,6VEQ*N<XCBC3;N^8E?FR0:_%#_ (+J_!+Q/\2?V6]$\?\
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M#YY4CCU_Q!H/A/0]2\0^)=6TS0- T.P;5-8UK7+^+3=,TK3XE<2ZEJFJW#K
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M-ZR[._*M-?>#_6O&?4UC?['E;U_K_(_T::*\(_9Q^*-[\;O@#\%/C/JVB?\
M"-ZM\4/A9X$^(%_X>CDWMH=WXU\/Z-K[:0&8LQ"27*QL7.XJ,LWS!J]WKXH^
MQ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-;TWQ/\ #+Q>=$\>>%;JTT;3-5UWPQ_R =<TA3K_ "K>*O#N&7Q4,%6 8$$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 45G3:A;P?ZZ8#/'&!_0__ *ZL12B>+SH1][IGOP"?\B@"S111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4457H L457
MJQ0 4444 %%%% !1110 4444 %%%% !1110 445G2RS"7 Z#H!QU_7CZ9H T
M:*9']Q?I3Z "BBJ] %BBJ]6* "BBB@ HHHH **** "BBB@ HHKD=7\3^'_#U
MQHD.N:UI6CW7B[6U\->'+;4]1T^P?7?$XTG5]:.BZ-YI U/6O[!T769_LID=
MWM]"F=(@D-Q(H!UU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3)/N-]*
M?10!P^I:/?32_N/\_KCI71Z1 ;33K>&4C*KW]SD#\AQ[5JT4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>K%% %>I4Z'Z_P!!
M1L'J?T_PI] !1110 4444 %%%% !1110 4444 %%%% !61>?ZT?4_P C6O56
M:SAF^\,=>GTQ0!/']Q?I3Z** "J]6*9L'J?T_P * (JL4S8/4_I_A3Z "BBB
M@ HHHH **** "BBB@ K\XKS]@;P+JG_!1@_MUZK+H[G2_@KX6\%:'X'%CM'_
M  N!O$'B&'7/C3KDKE8Y?$,7PXC\%_#;P=Y3-+!;+XF>6/+Q-/\ H[10 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5_
M/]OT_P#KT>?[?I_]>BB@"Q1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 5_(]_P!?_K4>1[_K_P#6JQ10 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!1N)[>QMYKN>:&VMH0US=7%QPJ*!DLQRH7 P!UP,
M*H)Z_#/_  ]"_P"";G_1_'['_P#XD;\'_P#YJ*^]*_AF_P"#K#]G[X$_"*R_
M95\<_"KX,_##X=>,_BSX^_:)UGXH^+?!7@/1_#7B3QWJIC^'_B!M8\9:]H%O
M"/$NMGQ#KNL,L_BN6Y#R^(I4#IY.T ']4O\ P]"_X)N?]'\?L?\ _B1OP?\
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M2W).NAH9"N_'[,T %%%% !15>?M^']:* +%%5X._X_TJQ0 4457H L457HH
ML457JQ0!#-)#!$TTI"QPC<6P3MZ#IZ\@>QK^?+]J#_@XT_8&_9\\<Z7\//A[
MJ/B?]K#Q?=ZCI^G7D7[/ T;Q7X>LX]7T?2-9T&;1?',=X_@WQ\MZVMQ:'&O@
MWQ1XH:+Q6_V26&.4D6_]"=?P:_\ !V_X0T&+]HK]E_X@6WC[0KCQ/JGP5U?P
M9>?#%=O_  DVGZ=H?C;Q!KVB^-&"Y'_"/^+'UW7O"TASGS- ;.2<T ?W&>!O
M$\WC3P5X1\8WOAS6?"DWBCPWX?\ $=SX4\56JZ?XD\+2ZQIL.LOX?US3-L@A
M\0>')&6VNH3&KQS0R!26C+MWU?+W[%7_ "9[^RA_V;)\!?\ U6'A^OIF#O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>(O@SX?^"O['>O>-? _Q*\>7TFEZ-XZUC5?&WQ UW7E@?Q!;>'/''PO\,?\
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MF.^G@NKJVM/V9O"UY=6MI<G2]1*_\+D^+3#;KI).AKEC^\'!;*8PO(!_;?\
MLNZ3!H/[-'[/6@VL^LW%EH7P+^#^C6LWB#1V\.^)'CT3P1X=CB;7M!\@'0==
M9/+,WATJZV\H>W$CHK$?0T'?\?Z5\\?LKZG!XA_9G_9RUZQAU&ULM>^!7P?U
MJSM]6U9_$&KV>FZS\-O#D\$>LZ^DQ.O:VBJ8Y_$6T"Z8O* J22>9]#P=_P ?
MZ4 ?RM_\%T/^"D'[0&A_%_X=?\$P?V(]3>P^/'QY;PWHOQ#\;>%-1DT_XE^#
MH?'K[]!\#^"LR>$H-"\2^*?#N[Q,GBU?%BM%$%@,GA,QM//<\<?\&SG@&XTO
M4/BUX9_;B_;/U']N*V\(:5=Z'\?/%7Q)T;5;&^^*6@Z)I&A_VV\*^&S\4-!\
M,3) GABT>V^,,_CCPEX0F:W?QEXKDMRTGX/W^G^.-/\ ^#FS34\<V'BO3=1O
M/^"ABW_AP>+[75M/U"_\!Z]\2L^!M:T=M:S&_AO_ (1P_P#%%-$"C $IP0*_
MT@* /XCO^"2W_!4O]K']E3]N76O^":W_  4P^*VL^(M'%]_PJ/X>ZOXLM)/&
MOB;PK\<?[6T)O >B+\4E8>(_$?P^^*^A:WJ^U_&*^,_&L?BX_#?R#X)\$2>,
M9!]+?\'$'P]_X*0> /A%XK_:L\!?MXZAX4_9\\!>//"]M#\!OA)X9UGX)>)O
M"6FZ^?\ A M!UQ_BIX?\2>+_ !1\7O$+^(-;4^,/"\G_  AW@N6 *T7@F1$9
ME_,__@KM\*/"GPM_X.'OV7=7\-MJ3W'QD^*?[&_Q9\9-JUU_:!/BK6_C1_P@
M+C1%_@\/KX?\#:*KH>48%" 5./WV_P"#DWQ3IVC_ /!)_P"+^B7\.N-?>,/'
M?P?T_26TKPUX@U/3M^@?$WPQKBG7M<TG0[CP[X;9ET%BS>*)O#-O?$?\(M]H
M#3_O0#\B_P#@EU^R[^WI_P %.O\ @G/\/O@#\5_CX?@'^P=X-\1^)/#FB:OX
M1T37O%?QV_:$TC2O$.NKKG@G6?&FN?$9_#7AKX;_  J\3A/#7A&4>#%C$?AA
M?!EWX*$%H'B^<_\ @EUXQ_:1_P""3W_!8?5_^":_B3XN>%=:^#_C'XEIX<^(
MUIJDDT7@:_;6?AF/B!X"^)O@L:WXGB?P'\0/%OAX>!O"TL#MY<T9;P#*OC1/
M"?@[QD?Z-O\ @VY_Y1'?LZ_]CC\>O_5T>/J_GW_:E\ > &_X.EO#[?'>?P&O
MPQ\=?$3X.>)F.I^._"4NFA] _9[T#0/ Q\9MH>O[_ WB$?$?P-F/PUXLA\(>
M-)P/"[!7\">,/!@\9@']\]%%% '^>C_P4L\2_'GPC_P<IWWB7]FGP;X8\??'
MK3?&/[.Q^%?A'QH-<_X1C7?$Y_9E\!E1KPT+Q%X.?^P A42A_%J$2!P5'0?H
M+^VW_P &]O[>_P"V$=?^-_Q>_P""A/A[XL?&Z[8^)?#?P4\1> /&?AOX$> ]
M5UYO#J:UX+\#^(/^%D^+D\ ^'_#.A:1'%#XD7X0M/XZET3PNOCF)MLA3Y3_:
MWUC6-#_X.K/"NJZ)X6USQEJ=O\4/V<OLGA3PY?:/8:I>.W[,/@$DAO$WB#P?
MX98J3\IE\5 $CYXARE?WFT ?PN_\$&?^"E_[47PL_;$MO^":O[4WB/4_&WAG
MQ+XF\=^%_#?B#XK>(=5?QU\*O''@C1]=UW1O#VBZWXEBD\3>(/#'B_\ L-?#
M'@SPKXK: '^W/"Q\"W$$8?PAXP_07_@MY_P5,U#X8?&3X6?\$ZOA_P#'.T_9
MSB^*1\-/^TU^TYH]GK.J>-O@/X#\022L-*\/Z)H<:SQ^(YO"[IXG;Q'X7DG\
MA42 3>$RCW$WXJ_%KX.^(_'?_!SSX?\ #WPLO-(^(FL6O[<OP;^,GB*STJYU
M?PZ_A+PQ\*==\/\ Q5^*6D:XGCT^$EU[Q#X7^'7@C6?%8'A8^+O^$P1P?!*^
M+"KJGH_[?FI65I_P<R?#*]^.]K\.-%\$V?Q<_9X36+G5O%+ZEX(;X8IHFA)H
M6M>-YO'7AOPOX>\/;_#BY\:^&5#>$E!!/C3QC*"E 'T!\=_@I_P;%?$_X4:S
MHGA7]JC4O#/QM>T361\=V\<?'K4_B=\1O'BZ,YEUOXJR>/?A[XM\+NGC'Q $
M\3>,1X1\%^#I(I-TG@8^$498XO!_^#>W_@I1^U+HO[<7@C]A_P"(/Q;\1?'3
MX&_$31_BEX.\$VNL>)$U#3/ ?BKP)X)/CS0?&.A^(/$GA2Y^)NM>&Y?#?PLU
MWPEX,^&(\4>%/!JP_$&3QRD9<J1_:_#^Q]^RW!XKO_&47[._P87Q'JGAS2O#
M-Y>#X<^"COT?0]3U[5M$MUTH:%_8Q=+K7M:G:Z,:R[G1 Y&2OCL4?["G[*?Q
M?_9Y_9\T3P-\-/A7\:?CO>_%"Y_9_P##WASX3ZIJ.L:]J?@G16\;?%>2+QOH
M_AUX/#;67A_Q!]KF?Q5XI\-+<1ZR([>.Z9U@ !_')_P6X\0_%GPC_P %]_@M
MXH^!7A73/B%\;O#5U^R9K/PA\"^(@C:3XL^)VBZT3X&T#6PGB/PBAC\5>(6T
M., >,/" ** Q8Y8_J'^UA_P;IWGQC^#'Q8^,WQR_;3_:(_:5_;2TSPOX]\4>
M&?%_B_6/!?@KX'OJXU?6/$6A:/'\+8OAUXT\1> O##"=HCX5\,>,[?PBDUK*
M88O"UO)YT/Q#_P %-O\ E9T_8W_[*O\ L(_^IOH-?VW?%7_DE7Q+_P"Q&\=_
M^F#7* /YC?\ @UR_;.^)WQZ_9O\ C1^S=\2]8U_Q7_PR]K/@*_\  ?C76]6&
MJ:K9?#/XKZ/K8T+X:L@\/(\R^#M>\"Z_XI?Q)XH\9>,;AD\?'P3:%?!_@RV=
M?DW]M7P#^UA_P4S_ ."WGPY_8V^.VB>/M'_8<^$OQ>WZ5;VWPW^).F?"'Q)X
M;\!_"U?BSKK>(->AU[PA_P )#XC^+ T#6OA;_P )6GBG/@I-=7_A7\>!XQ3Q
ME6_X,_\ _D/_ /!0#_L#_LO?^]]KZD_:!_X+2_M3_MB?M5ZY_P $^O\ @DO\
M,[74_%::OJOASQI^TSXYM=6LM(\':=HFD:]HWCCQHND?9X&\!>&O _B0Z+';
M^,/%\<;^,_%V@-X*\$>!O&4GB_P<_C$ ^7?^"Y'_  22_9'_ &(/V??"/[9'
M['5YK?[+WQ3^%WCWPQ:V?A;PYX\\6ZBOCV_U_65\G7-#UCQ[XID\4>'?B%X8
M)D\4PGP?-=1LD3-)X/CG+^*XOZ'?^".W[3_Q4_;!_P""=W[/7[0_QOO]"UCX
MH>++/QSX<\47_AWP^/#%KXAG\ _$[Q9X"/B_5=)$D%A_PDOBRVT6WU_Q@/"L
M4/A(>)]3G/A'PGX4@SX1L_YW?^"R'_!)71_V=_\ @G]\2OVG_C!^U%\?OVF/
MVF=(^)'@.^OO%7BWQ&VF?#0:GX[\;:'X=UPZ'\*V7Q:/#X/A_5Y0,>+R&"A@
M=K*3^V'_  ;F?\H@?V7O^PO\?/\ UH/XM4 ?@E_P7M_Y3S?L#_\ 8G_L<?\
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M7?B_X<:%HGB4^+0@\)*FA-XWBEC_ .$P)/\ ?M7@'QA_9L_9V_:$/AV#X^_
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MK7=%\01)XH\/:]/X9F/B<>%0D'BGQ/XU\,^$;2! LT"'^FJB@#_/,_X(R?\
M!<E/V!?"5O\ LE_M0> O&%Y\&SXN-UX/\9>&M''_  E/PS&N:Q+_ ,)JVN:
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MP.0_@SQMH6A1LQ708-&T;2;2Y3PR$NEN8)'G0>;'))]M?LS_ /!QY^QSXE^
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M>'/VM?\ @GK\6OB]X1^/?[!/[8-GX:_:7U#X,^%K3XA6OP3\9-X;^&J^!/\
MA8/FZMXUVZ!&R:$T7C3246526C*.^UO+8#X7^(_@S]N__@A/_P %'/&?[5MI
M\,-8\<?#'Q9XU^)NGP>(+%O%UC\#_C)IWQ8C\=>)="\#>(=:T%7,?B3POK6D
MQ>*F\*,JR'Q9X)\*NFT21N?]'W8/4_I_A1L'J?T_PH _C2_;;TG_ (+3_P#!
M4;_@G]X^\0^(OV<_!G[/_P .-)N=.UBY_9E_L?7-0^-OQ:3P3KJZ^/&&AKKH
M37]!:/RUCA\*L&F\81 JI59)3)[)_P &YWQ(_;3O?V0O!6@ZQ\(M%\*?LA?
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44S>/0_I_
MC1O'H?T_QH ?1110 4444 %%%% !1110 444S>/0_I_C0 ^BF;QZ']/\:?0
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MB6\1VJ"XR<?K/0 444S>/0_I_C0 ^BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGA<:SX$T#X=Z]$+?PWX7\1QZU<GQ+XE_X2\^+O";^'?&D/@TVSR1R^>?'?\
MX*+_ /!=7_@D1<?#O7?V[+[]G[]J?P/\:_%/D:+>6GA[3-+?P)IO@270I/'N
MAZ1K?PC^&_PD\-:%KWC#P_XZ?_A"D\8KXS4_\("KJ T?BY_%X!_:W17YX_\
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M\+>)Y(_&WF(@;QRT9DC< ]>O?V=?VN/V)_\ @LI_P3G_ &6/C!^T;\4?CO\
ML[>'?C#X*U3]EQ?&'BO7=3TSP_\ #&,'0-$T.3PZRKX<T+7_  JNAKX:3"[;
MB#0XYH"\,T<C_P!\%?EK\&/BA_P3V_X*KV_P1_:!\ :KIWQ;\2?LU>,--^)?
M@"PG\3>+_#7COX*>.M<TC0@C>./!OA_Q+:Q:UK*6PA0P^)8/%WA*-D=DFG8&
M>3X-_P"#@G]HK]M/]B[X)?#7]IS]E+]JG4_A1H!\:Z1\'O%_PJN/A/\  WQQ
MINOZKKFE>*-:T/QKHFN_$#X9^*?$OA_6@VCGPSXF\/22'P?>!/#-S"O@TV7C
M"X\8@']'E%?Q-_\ !!?_ (*]_P#!1?\ ;&_;BE^#'[17CB_^/OPPU#X1>.=9
MU:YM? 7P7^&^F?"C4=%/A_6=$^(^LMX$^&_A#Q-KS2^(2/A;'X4WHDDOCV/Q
MM*6A\)R(WRK_ ,%-/^"H/_!8K_@GE^UCXN_9K?\ ;[MOB2F@Z-X6\467B2U_
M98_9L\..^E^.-#&N#23I!^'/BZ21O"JJ 969C*O)=PV2 ?WB_$_X:^"/C!X"
M\6_"SXE^']/\5^!_'&CZCX:\3>'M4M1)I^IZ7K*E)(I 0=W!P"K;O- 8\KAO
M\@#]I#PAH?PJ_:1^/'@#P=!<Z;X>^'/QK^*'@OPW:?;?^)G8>%]"\::_H.A?
M\3SM_P 4Y7^G)_P17_:*^,W[67_!.'X#_'S]H+QI-X_^+7C.\^,=MXG\4G0?
M"/A[^T%T'XR>//#.@E-%\">'/"GAF';X9T+0VQ;>%(&>0R2.)'EE+_YH?[:G
M_)X?[6'_ &<Y\>?_ %9VOT ?W[^!OV<O 'CC_@WO\*>#?VG_  9HVG:C\/OV
M'?B=XQL]?^('@V3QOJ'P6\4Z)\+_ (A/HOQ3TG18HI?$\?B+PC!J9\30R^&O
M*\6O+LMA+YLL8K_._P#@SINAZE\9/AO8ZYXK_P"$2\/W7CSPO97GBLZ/K6I?
MV#I?]M<:U_8?A_\ XJ?K_P#K%?ZE_P"QS\"OAA:?\$O?@_\  /XB_8+[X+:]
M^RQ?>#/B+;7GQ#35=-O? 7CKP?K*>.X=8^*WAV/PAY<$_A_6M;$WB;PU_P (
ME-X5WO\ 9I;;[-%*G^7S\ ;/X5S?M(_"^Q^+=_XMTWX/_P#"U/"]EXQN_A[_
M &-J7CFP\+_VUP=#_P"$@_YF+Z__ %Z /]*S_@N-^QG\5_VY_P!@[Q1\(_@C
M/ID_Q!\+^._#'Q/T?P_>*-_BL^"-*\2@^$-(96<1:W=?VL&MF<(KE&3=OV1C
M^>'_ (( ?\$I_P#@H)\#/VQ?!_[5/Q2\+^(OV=/A/X7TKXI>"/'OA3QG=ZQH
M7CCXJ:=K6C:,N@^#)/ B,'/AX>*M5T;XD#Q,F?![W/@ 0*/,SM_6O_@O;\:/
MVZ/V(_@U8_M;?LO?MH^,O ?A_6?B+X9^'NM_!+5_@W^SAX[\)Z>VK>%)'T?5
MO!&M>(/@Q)\1X&^T>#]?\2>.D\5^,O&#SQZT;;P,O@^VLHD3X3_X-Z_^"JG[
M>/[<_P"VE\3OA1^U-\=6^*/@3P[^S/X\^(>B: GPN^#O@8V'BC1OB=\(/#FB
MZPVM_#_X>>#?$DT;>&?'&M'R)R\!DUJ&5HGD@B( /[,Z*_AM_P""RG[<G_!8
MK_@F5^T5I'A/P[^W0OBSX1?%ZRU;QE\(;K5_@1^R@_B30=)T/6(H_$&A^-&/
MP3 %OX875(F_X2=%C2551Y(@Y85^G?\ P;M_MQ?M._MT?"?X]_$+]J?]HRY^
M*_B[PA\0=-\%^&O!4?A'X->"+70O#/\ 8.B>(9?&<&B> /AQX/\ %IEEUS6[
MCPM)-XC9O#"IH,CPJ7)DB /Z5ZKU_(M^T-I_[>7A;_@MY\)/V5/V0OV^/VB)
M_!WC3X#ZO\4?B_-XMOOAE\7-,^!O@3QQ^T%\7?'/C;0H? WBGP]'X17_ (1G
M9X$\+^!/%/BWPEXM^,/@WP=XB\,>"CX[_P"$"?P=X0/O_P#P7,_X+,_$/_@G
M):?#O]G/]GRX\(^+_P!H7Q]X&U76/&7Q!^(-L=5U'X:^%X]';P_HOC(^"?#S
M>$?#+?$/Q9XD'_"2^#4<#P:W_".^*H9/!$D 2-0#^FJI4Z'Z_P!!7^?]\:O!
M_P#P4T^-?_!/)O\ @K'I/_!6CXR>.YU\.^%SXO\ @]\)[O5O@#I7A8Z)K7]B
M>/-(4?#WXE^$OAG_ ,)%X4=CN/A;P:K>-7!8!E(=OM/_ (-V?^"P?[57[2OQ
M<N/V+_VEO$;?&.WTKX<_\)/\._BQJJ:/9>._"FC^!]&T#0G\%>-=9T#P^G_"
MP-K%7?Q3XK$GCEO%J>*X?&OC7QE,\3( ?V8T5_.C_P ''/@W]H.R_8XT?]I?
M]G#]HCXO_!37?V;O$4]YX[T?X8?&/Q7\)=,\>?#7XGSZ#H%R^L1^&8]_B+Q'
MX5\4Z3X+7PJ\LBB#PIKOQ*B"%[AFK^2C_@G!_P % ?\ @KQXE_:<T#X2_LW?
MM'_%/XP?$[XV>'O$GPTTCP_\=_'6K_%SP/H7]LZ3KDG_  LL:#\0T\9?V!_P
MJLI_PLO_ (2E%\W&A'_A-_!/B_P3_P )?X/\8 '^H+17^9-_P4V\8_\ !7G]
MA']JG7_!_P ;OVX/VC];OO&5WJGQ!\'>-_ _QA\8^"O OCS2AK6!K6A?"SP[
MXE/A?X?E>1_PBH\(?\(5X+P>:_LP_P""'/\ P4#^)'_!1/\ 8L'Q*^,NBV:_
M%7X9?$36?@WXYU[3DM=-TKXB:IH?AGPSXHM?&*^'HX8(_#6O:SX9\;Z(GBSP
M] L?A%?&%MX@D\%C0?#)3PEX3 /VIKAO&_C?PI\.O!_B?Q[X\U_2O"W@KP5H
M&J^*/%OBS7;N+3])T+PUH6ESZQK.N:K-,RA=)M+>%VN57YE&Y44_*!W-?SP?
M\')'[6/C']FO_@GIK?@OP1;26VM_M5>)A^S_ *EXB5=))T+P7KOA_7-<\=,N
MD>(?#'BB&?\ X2CPMHNN>$#<QP[_  >NO)XP=D:S*L ?DOXW_:+^)G_!Q=^V
MS;_LE?"W6_&WPO\ ^">7PGOW\;^/M6TK2=7.I>.M.TF0-HFK^-&"1#P]KWBM
MBH\$>%O%<:MX0*^;(LEP[O)_6YX9_9"_9K\)_LYZ-^RGI_P:\!W7[/FB>'E\
M,VWPQ\0^&])\2^$[[34UH:^J:WH^O6URFL:O-XEV^)99I("Z^*9#<HRSH&K^
M3W_@T<^#_BB*[_:]^.W_ !+/^$(U6T\!_"6S)NW&I?\ "3Z&/^$X(72%P(M"
M/ASQ#H8C^96<DJO\97^V6@#_ !I_C]H^DZ#\>/C1H>AV-MINCZ#\8/BAHNCZ
M3:6?]FZ98:7H7C37_P"PM$!_3!'/I7^AS_P3W_X);?\ !/[]H/\ X)D_LP7O
MQ._92^"NI^+_ (H?LS^%6\8?$RU\!Z+IGQ*O=1U[0UCUW6!XZ$(\3?\ "1M(
M=_\ PDIE,N0&5MC"*O\ /6_:6_Y.-_:"_P"RV?%'_P!337Z_N#_9P_X+N_L)
M_L7?\$P/V4/"LWC.Y^,7QV\'_L^>%?!U]\'/!%K(=4T#Q[H'@M =#\:ZWK[@
M>'?#C^( ?"W_  E*-XM59!O:.7S'H _C"^,NF^)_V)?VT/CQX(^!_P 3/&WA
MW7OV;/V@OC)\,? GQ,TO5O\ A&_')7X5>,]?\!Z%K1UK01G_ (2(C1""I&1G
M! [_ .D3_P $1/VP=7_;0_X)Z?"KXB^-/%=[XU^+'@G6_%/PF^,'B'5-);2V
MOO'GA">WUO3'5F41:P)/AYKW@>Y?Q&AS>W!EF(\YI7;_ #Q?A'\)/BE_P5+_
M &V/B.MAXD^#_P +_'WQ]\<_$_XY^+[SQSXFD\'_  WT/4_&_C,:[KFC:*_B
M,^,997(US_BB?##,TDC9+,S$D_Z:?["W[(OPY_X)^_LM_#[]GOPCJ5K=:+\/
M-+U76_''CW4=*T;PYJ'B_P 2ZY--J_B#QOXA?2(849DB-KH,8\1(TUKX4\.^
M'[8WIM_#*^< ?=%48;J"5289()@+@VQ-N00I'+*Q!.&4<D D <@FOX,/CS_P
M4A_;?_X*\_\ !1#P?^P?^R#\>;O]E_X/VOQA\>6?A#QSX UCQC\./'6O^&?
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MO>"O^"K_ /P39\#_ +6_PS^*O[57[+TL'P^^)?Q-\,WGP2^-FO?"'Q'8^*O
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M=Y6/PW^*7]FB?Q-X11=9_P!(.C>=)-/X2GD5VN/"DUK(]RTLDBI^AE?P7_\
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MO%W_  F/@KQJ2D2>!WGDB\8>$?R%^+6@_%3_ ()^_MA_&CX<?"3XQ>+?#?Q
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH_: T[0O'9\;WVE:5IF@%M"*Z#K?]OQ,GAQ?#OBS^W="/@CQ7&Z>#O&?]O\
MA@JRL-U?T]?\'9'Q.\&Z+^Q=\ _@S>ZG<6OC_P"(7[1R?$#P?I(M-34WGA;X
M5>#/$>A^.-2.K0DK&+;7OBKX"C5L9D77\Y;:&(!\"?\ !I#\7?$]I\=?VIO@
M+%;Z*? ^M_"O3?BU=W?V1O\ A)?^$F\#^-/#W@/0@=9'$GA[_A'_ !MK.P$%
ME8#81DJW\_'[<'[*OQN_X)R?M@>+OA[K%QXO\.:MX0\7ZIXH^#WQ8:P?PP_C
MOPO_ &U_Q0WQ,\%1Z%XB\621.ARLD4GBY)/ [AE=5=2H_IN_X-/OV3/$.C6O
MQS_;2UJYN[70O$^BGX">!M*632$TW6HQK6@>-O&FLG"MXBT*7PY<:/H,5O;W
M#1K.NNW,D19[7;7V_P#"?X^?LB?\%C?B5^V%^P]^V1\/?"8^*?P=^,7Q?TGX
M!Z?XH\'ZWX ^+K_!U=6UB$ZQX?T3Q)X?MO$OAOXA^$XX$A\9^&_W'BN(LUU<
MQ*@F= #\E_V"/^"Z'A']IY?A!^QK_P %7OAX?C?H7_"X--\4^ _VCUN=4T[4
MM%\?'5]OPG_X3OP1X"B\*G7F\)>(M<UOPRGBSPD/E=/"QD\"31AO%S_T;_\
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M_P )OC9X7\::QI.D_P#(3_LO0M:_Y@?_  D'N?<C]2 ?W;_\'3/_ "C$L?\
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M #^PNOX<?^#NB#QNOCO]CN]MXO%I^'!\*>/[.^NC_;/_  A"^/GUKP^^AJQ
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M;\6?^"OG_!0SXK?%']GKX$^-];U[XL7>D1^&?AIX6TK6_''BBP\!^!=%\/\
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M(&O^!]'TK2=5&F_#[29E\1Z+K7CC76"?\("TK1)-X*!4_P#"7N6AC=HU#/\
MS?\ _!"W]K_X$?L1_MU0?&_]HWQ5J7@GX;6WP>\>^%_[6M/#6L>)3_:>O?V
M-"_XD6@^&CXF.?[#Z$8YZ<< 'V__ ,'7G_*2+X;_ /9G_P ,?_5G_'ZOW@_X
M-N_ WA;XJ?\ !'WQ1\,/'FC6WB+P3\1/BG\=_ 7C+P_<D?V?K7A7QOHN@Z-K
MFCR+@DPS>'=7:"3 #,&8*P8%E_E-_P""[7[<_P $?V_OVU],^*_[/MWKFK_#
MGP5\$O ?PCM?$WB/1=5\,/XQU70=<^('CS7=?T?0=;2+Q$-!<>.3X:E'BB)(
MR^@ML15( _H]_P"#5?\ :P^&?B;]G?QM^QA$-9@^+OPV\0^+/C3>?;+(MX<U
MSP-KVM>'_#X_L#6E4[U\+:\^D+*&)YUV+RTR2U 'X"?&3]AW]HO_ ((F?M^_
M"?XX^-O .H_&3X#?"7XP^&?B;X/^+'AVTU?3O WBOPRNN,NBZ'XYUU?#GC ?
M#[Q(CJR-X4R2KJR^ SXR(K]!/^#@K_@KM^SW^VS\,O@S^R?^QMXKNOC)X?U3
MQI)\0_B/XDM_AWXVT!V\3Z.QT7P1X+\$MXD/A/Q0OB$2:_KZ^,XD\(>3%%KO
MA1(O&L,:^,88_C#]HG_@K=XQ^)/_  4>\8:[^W#\'_&GQ:_90^'?Q1\=Z-I_
M[$_Q/LCH"?#72RO]@H^O>!PZ^&I?C+X3X)_X2N0%_&? D!(:OT?^!W_!>G_@
MCI^SC?ZUJOP1_P"":'C;X;7WBE=,76+KPUX8^#<;7_\ 884:&Q?_ (2=V# Z
MX=A0IMW9(8@$ 'ZA_P#!NI_P3=^-/["'P'^)GCOX_30Z'X__ &G;GX:>*!\*
M%T_=J_PV\.>!E\=G0I/&.MF0EO$'B&+QR3<>%C:LG@\:3'!%<&0S67A;]&?^
M"KWB_1_"_P#P3:_;EN]<&IF+4/V8/C3X7@?2_#&N>(S_ &OXB\#ZMHOAU)3H
M&D7#1Z3!K&LV\<WB>^A3PGX660W7C%UMX[N-N;_X)]?\%8/V4?\ @I+::I:?
M OQ'?:/\5O"_AZ3Q)XR^#?C>VET;QMX<T5M<&CQZX53S?#GBK1/M$>@I-XB\
M)S^)+?PW'XE\-K=R[O%%O')\[?\ !QW>W]G_ ,$D/VBY+&:XMI[CQ#\%[1FM
M+DH7L'^-/@0R$YXY 0D $@GEL= #^3?_ (-A/^4J?A'_ +(E\9?_ $R>'Z_T
MGZ_A!_X-._V69O$GQA^.7[7.NZ+<)I/PST;_ (5#X"\16FM[''BC7V36O'6D
M:SH?)#+X?ET#! &&9.02*_N^H KU_DT?\%=?^4G?[='_ &<C\4/_ $]BO]-#
M]LW]M_\ 9O\ V#_ASH'Q0_:>\9:GX)\#>*/&6E_#_2=5TOP=XQ\:O?>*-8T?
M7]=BTA='\,>'_$LR>;H7A[69P2A5DB>/" HU?Y7G[</QP\.?M-?M@_M'?M!^
M#M+U'1/"_P 8_B]XZ\?^&]*\0J%U*QTO7-9 SKBC 7I]U0 .W% '^@Q_P;@V
M_BF#_@DM\"Y=4UJPU'2]2\3_ !IO_".GVOAV72K_ ,.:4_QF^((U?1-6UD:U
M=Q^*KN7Q3'K7B6/Q+]F\+M;1^(#X+>&0^%H?%-]^3/\ P>$?\X[_ /N[;_WV
M6K/_  ;7?\%0/V;O WPS\*_\$_?&WAZZ^'_QI\3?$?5O^$#\5Z1I>M^(-,^-
M>J>.]:U[7C_;L@5SX=\1>$U!\+!T1?""^"]"\,&*6/YBWR?_ ,'5W[6'PS^,
MO[1_P3_9J\(-KT_C#]D^Q^)J_%34+NU&G:0FJ?'#1_A/X@T'2="&U6U^;PQX
M:\%KXGFY<8UJ)$)$9>0 ^Y_^#0O_ ))5^V[_ -C]\'/_ $Q_$&OY9_\ @JY_
MRDS_ &\?^SJ/C'_ZF?B"OVO_ .#9C]O?X0?LT^(?C]^S]X]\.?%?6O%_QOOO
M"_C3X=V_PI^%GC;XL:KK<?@/1/$#Z[HT7@GX<^'O%7BL/_8.M:OXIR/"D>%T
M#Q2V2RJI_ _]NCQW??'#]I_XW_M06/@CQOX*^'_[2GQ?^)_Q-^&__"6Z1_9Q
MU#2U\::^,EB3X:\0GPGXC'_"+Y))[G/- ']M'_!0FU^(=Y_P;@?!P>#=1\4:
M3;6W[)W['-[XW/A72_".K-J/@=?ACX&_MG1_&#^)?$?A#^P/#<NJG0GE\1^#
MXO%?C&UG31$B\%WRO--#_.#_ ,&W7[0NA_ ;_@IUX$TKQ)%I%KHO[1'PZ\>?
M (Z[KWB*#PYI?A?5M:CT/XM>'M78S1M_;WB+Q1XH^%GA_P"'$7AF)X)%N/&T
M)\T1"2.3^MO_ ()0^.M,_P""DW_!'[P=\+_B]\&=;\$>"[;X6/\ LMS3>(])
M&H>&/B5I'PET#1? >C_%+P('95\0>'7DT2WW E(T\;Z!XJ\%D[O"TI?^'_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %?SP?M:_\&__ ('_ &T/'VN^+_CI^W1^VMXLT>^\
M>>.?&/@OX>^(O&WA_P 1>!?A(WC?7FUR?P_\+=$UWPZZ>'M @@&C: B([M)'
MX<\/J%1HCG^A^B@#^3/_ (A'_P!CS_HY?]IK_OKX8?\ SNJ_?G]C7]E[Q1^R
M?\-KSX;^(?VE_CQ^TC:M?K>>']?^/>L:/XD\2^$]-EA"G0M*UR+0XM?N=$B,
M:H#XGFNG@,>(B%<U]IT4 %?S*?M"?\&SW[.G[47QO^*?[0/Q,_:L_:?U+QS\
M6/&FK^,-7%UJ7@O5TL&6:2#0M#T5];\,R,FA>#M 31/"7A%&3$'A/P]X>BWR
M+&9F_IKHH _+K]CG_@D[^R1^PEK,6O\ [.>E_%KPGK36E@WBVV'QZ^+E[X*^
M(NIQZ7KFAQ:WXX^%,WBF;X7:[<F#7M7N+,R>#MG@Z?8?!J:> 17ZBT44 ?F)
M_P % ?\ @E=^R?\ \%(M&TZ/X\>%+JP^(OA71=5T7P)\8?!UX=+\=>#K'7"G
MF0+,D2P>*?#^_P"U-_PB_BV/Q'X10:WXA1[9FE>9?SS_ &=?^#8W_@G;\&M8
MO=:^(D'Q&_:.O?[8\*:UH-M\3O$SZ=HOAZ30)M;6Y@31? *>#-!\1Z#XLB.C
MOXM\-^+[7Q9!<?V#;L&59@*_I'HH X#P%X#\$_#/PEH/@#X=>#_#G@'P3X6L
M8]&\-^%/"6B:5X;\-:!IRJ<:7H>D:$8(-'B7A]D42JKDL 688_%_]JG_ (-\
M/V /VG?%'Q&^*<NC_$GX9?'#XF^/-1^)7B+XM^!OB+K%WJS>)M;U@:WKLVD^
M'_$P\3^$X/,E5_+C7PE@!HPH/.S]WZ* /QR_9&_X(O?L7?L?_$?3?C]'I'CC
MXW?M.V-SX[\0:O\ M!_&KQ9K?CCQWKWB3QWKNO:YK?C>72/.7PC%X_\ ^)RW
MAW_A+O#7A.W\7/"[@NO_  D%UN_5_P 2:!H7B_0=:\+^*]'T[Q#X:\1Z3J>B
MZ]X?U2T75-,UK3-7AET?6=)U?1IHO)U71YK>X:*X69"LENQ0_NVRW744 ?SB
MZC_P;%?\$U-3^-0^)_\ 9'Q0TWX=FS_TSX#67CW6;#P%>ZH=+\H:R=?4CXFZ
M&Z<EXD\99+*4)1F0G^@+PEX3\+?#_P *Z!X(\$>']'\(>$_">DZ9X8\-^$O#
MVD0Z7H.A>']'@&E:+I.BZ+HZBWTC1((X0ELJ1"."WC*.ODH!%W%% !7QC^U3
M^PM^RM^V]X2M_!O[3GP=\*?$FUTY<>'=>NK$Z;X\\&?:=:T/Q!KL'@KQ]H_D
M^+/ B>*9-#T.'Q8/"OB2Q/BNUMDCN<;%W?9U% '\WGA#_@V _P"":>@_$'QW
MXI\0Z9\7?'WA#Q.VWPO\,M:^).LZ9X8^'6=3,_\ Q(=9\,CPQXNUS& C+XS\
M5>*Y,Y*(_P @?];?V5OV$OV3_P!AWPG<^&?V8_@WX3^&L6HVBP^(_$5G8O>>
M.O&%A%K^L^(K2V\;>/\ 69)/%OB*/PU+K&N0^$5\3^);S_A&(KEH(  =C_:U
M% 'Y-_M2_P#!&/\ X)V_ME?%W4_C?\=O@4/$'Q,US2-#T7Q/KOA7QOXV^&TN
MM'0UD&E:QKA^'_B;PD=;\1"(6^BQ^(YS/=E=$\.0MC_A&+80_3?['O["?[,/
M["G@;6? /[-'PRM?A_H_B/5GUSQ+>#5=9\0^(]?U;;@SZUXPU^XNO$>MD<B%
MYYY"A+CDL:^R:* "BBB@#X0^&?\ P3J_8R^$_@_XU_#[P]\ _ VL^$?VC/'@
M^(/QKTCQYHO_  LFW^(WB9==3Q+H_P#PD0^(9\7C7?#_ (6\0;-9\%>&)E;P
MOX-<2R65K:_OR_PO>_\ !N)_P2.N[VYOYOV<?$-NUQ=F]:VL?C=\:+"R#_W?
M)3XAMD =27SC!QQS^Z]% 'R7^S5^Q5^RO^Q[HZ:/^SG\"OAK\*)QX7\-^#]7
M\1^$?"VD6/C3Q?I/A^$0:0/'?C,1KXE\>ZXDNZ0:_P"++N\NY#(/WJQQE!]:
M444 ?C=XN_X(4?\ !+KQQ\:;[X[>(?V9M)F\;ZEXST[X@ZUI%MXO\;6GPWU/
MQ);ZV=:N$U7X4Q>*3\,Y-"\5R1L/&_A=_"(\)>+B0L]GOQO^C/VH?^";?[&_
M[8OBCPYXS_:/^#MK\0]7\%?#KQ7\,?"9O-:\06&FZ)X6\<^2NNR:%H^@:]#;
MV_B*) Z^#_$Z1CQ5X)F^?P5<VDC2[OT%HH _,;]G[_@D1_P3G_9CT#Q;X8^&
M7[*GPZO[+QY::M8>+KWXFV(^+7B'4O#>OC0X]9\'-KOQ!;Q=XB;PJ1H6C2GP
MBERGA@&./$(#X'IG_#L#_@FY_P!&#?L<?^(W?"#_ .92ONVB@#XC@_X)V_L"
MQ>&KCP6O[&/[+4?@V_\ $&G>)KOPB/@;\,SX8O/$NDZ3K.C:5KCZ"OAM;*77
M;;P]K>L6T5S-:M<0PZQ=^7(QGN"_G7A3_@D]_P $U_"/A;PUX6LOV%_V8=0L
M=!TC3='M]4\5?!#P-XS\1Z@B91I-?\0^(?#\_B+7M;+ .WB3Q++/=+YD9+*!
M)&/TAHH ^(-7_P"">'[!&N6'A[0M>_8O_9;UG0_ ^E:CX8\&Z;K/P)^&FHZ;
MX0\,ZSKFM>,]:T3P]%-X5,>@:#=^*=9\0>)VC@=;<>+->U^Y18[B\:26IH7_
M  3B_P""?7A77M(\4^%OV)?V5/#GBCPQJ^FZWX:U_1?@+\,[#6- UC0W.JZ/
MJVB:LGA6*;0M8MI723SXY(I>/F<H<M]U44 %>%>*OV??@9X_^(O@/XO^-_@U
M\+_%?Q6^&V!X#^)?B;P+X?\ $?CWP0[.-4(\'^--8M6\0^'0)_WN;26 &0A6
M14+*?=:* "OC']JG]A;]E;]M[PE;^#?VG/@[X4^)-KIRX\.Z]=6)TWQYX,^T
MZUH?B#78/!7C[1_)\6>!$\4R:'H</BP>%?$EB?%=K;)'<XV+N^SJ* /GC]GW
M]G+X.?LK?"#PK\#O@3X)T[P%\,_!UBUCI'AW3X&D%\6&=9UO7]3>?S->\0>(
M]A>Z\0>()VNKB01DE441GYM^%?\ P2V_8,^"/QKUS]H/X6?LK_"#PK\4M4;P
MU>Z-J^F>#M&CTCP#J7AW2Y=%T?6_AAX-1SX;^'GB"YM-J^+/$/@RV\+W/B<Q
M[[R>Z9WV?HS10!\Z?&?]E[]G']HZX\,?\-#? 3X/?&YO!R:H/!Z_%CX;>$/B
M+%X3CUV31?[;&@CQ+HMS_8=QXA;1-&%W) J-/_8ULK,5@2-?'?\ AV!_P3<_
MZ,&_8X_\1N^$'_S*5]VT4 ?"7_#L#_@FY_T8-^QQ_P"(W?"#_P"92N\^%/[$
MW[('P%\5CQQ\$?V7O@#\'O&W]E:AHR^*_AG\(O!/@GQ&--U:43:II+ZUX>\-
MVD_]C3.(MT)8P#;M*@,XD^L:* "N(\6^%/"WQ!\*Z_X(\<^'M(\7^$_%NDZG
MX8\5>$O$&DP:IX?U_0-8@;2M:TG6M'UE#!JVB7$4SQW"M$T<]O)L53#(5E[>
MB@#^#7X2? ?XA_\ !O'_ ,%-/"GBSXC7GQ.\=?L/_'AM1\":'\0?"U[+;V5Z
MVL2"3PZWQ8T".2/P]KNO_"P*IDM9C&\D#OXP\'0KOG@K^S;XH?LZ?LQ_M4:?
MX8O?C7\&_@G^T)I/AE=5_P"$0NOB'X'\'?$O3-(.LRV_]MOH(\0P>)+2&6X;
M2-)2Y$48+3:1&0Y"1I%Z3\3?A9\,?C-X2O\ P)\5OA_X2^)?@W5T O/"OCCP
M[I/B/1I@. 9-)UR%XLC'RGRPZC*KA3@^7_LW?LN?!#]DCX<1_"#]G_P9J/@'
MX6VNMZCXET[P=?>-OB+XTL/#VI:P\4NN1Z#/X_\ %WBR;PWHL\H\^#PQX8DM
M?"$$QU>9+6.7Q%=O( >=:=_P3P_8(T#3]?T+0?V,/V7-&T;QSI>G^&?&.EZ/
M\!OAKIVF^*_#.EZQX?\ &L&A^(XK;PLL>OZ#!XH\)^'/%$4%T'A/BGP_X>O9
ME>YM(YHY]3_X)X?L#ZMH?ACPKJW[&/[+&H^'_!3:D?"?A^]^ GPRO=(\++XC
MUG^WM<;0=)G\./%H7_"0:TCW,XM=J/(F1M)EB/VS10!PWA3PEX;\!>&/#?@K
MPCH>D^%_"'@W1=(\->$_#.A64.EZ!H'AK0M)30]%T/1](B(AT;1M T2*UMX[
M:!(HHTC6*%8XQ'$W<T44 >5_%/X6?#?XU^"=6^'7Q@^'_@[XH^ =<?2GUKP3
MX_\ #^C>,?"^N/HFK1:WI U?P]KL,WAZ[V:[I6F74<,\$D;7,$:/Y>V.2'G/
M@[^SG\!?V=M(U70?@!\&OA=\$M"US4'UG5]'^%7@/PEX'TK7M3=!G5-9A\.Z
M#;1RS$#$<TH<H"Y3[S"O=Z* //\ XA_#WP-\4O"&N?#[XD^#_#/Q!\$>)["3
M3?$7@SQEH6D^)_#.MZ>0FZ/6]%UR.6'58040LLH92RH=I=0QU]%T+1_#.CZ3
MX<T/3-/T;0M$LM-TG2-*TVW6PT^PTW2$5-&TK3(ODC"0I''&BJ=@160 $@UU
M-5Z /Y7_ -G'_@J-XU_X+$^)?^"D'["VK>%/AC\ _ %U^S+\=/#'PV\:ZK<Z
MSJWB?3Y->!^'O]N^-@/$)\,ZX?"P\0+XFE?PD4C5(P[E$$K-_-7_ ,&^G[,O
MCW]H/_@I'\&/&/AXW-IX7_9UUC2_C+XZ\0_V4+_3;+3=&.W0-#5R1_PCS^+F
M(1.<[B,#.*_L2_:/_P"#>S]@7]H#XEZS\7?#P^,_[-/BWQ19>+[;QS_PS5X]
MTGP5I?Q#'CB)M$UB/5])\;^&/&D7A^*3PZ^K^&XO#GA-/"7A,VVO.OV*28/(
MGZ*_LH_L#?LB_L/6'B6Q_9;^"7AWX4Q^,[E;WQ-<VVI^+O$WB/7)(F27$GB'
MQWXD\6^)$TA I*^'X[I+6.8!D@5U0D ^U:*** "BBB@ KR[XI^)]<\"_#+XC
M>.= \&Z[\2/$GA'P+XJ\4>&_AUX=V_\ "1^.=7\/:'K&LZ+X,\/I*K$:]XHG
MBC\.P%MS&:9&.0W/J-,?H/K_ $- '^:Y^SO\)OA9_P %M_\ @I%\;O$7[3_B
M+P'^Q'J&M^&#XFUCX??#2TT?P]JOCWQWX?C;0M<;1SX_#2MXC8JOB;QP?%$<
MLI=P1&1N(_8G4O\ @V3_ .";6D:;J.M:I^W7\4[;3]*L]0O;N\/B[X"*MCI>
MB[BP#'PR -BC)/=B$(5B,_M=^U'_ ,$5?^"<'[67BGXA?$?XJ? -;'XK_$2S
MD;6?B9\/_%_C'P;XH35 I;_A+%T.#Q _PWN?$Z!&5/$OB7P9=W#."LA=W1C\
M_:/_ ,&XG_!*'2/&_CSQ==?!#Q?X@TGQI:^&(M$^'&O?%WXCCP1\,SH>AMH>
MMOX .B>)O"WQ%:3Q>2GB#QD?&OC'QA&EUAO \7A%#]G(!_-E_P $6OV)=9\.
M_P#!8_\ X3_X!^,=.^-_[)_[(FL^/-7\0_M*V6-.\$ZIX9\=_!;Q_H/@6--:
M) \0^(\>-R6+%41/#_BF21TC1G'V?_P4T\>?$C_@NW^UG\+OV&?V*VN=3^ '
MP.\1ZIXF^*WQ[U71]_PVL_%"_P#%/ZWXVT36XHHAXCT+POX;UO6_#!\)0^*D
M'C-_$/EQ(0%S_6UX<_9G^ 7@GX)^(/V>?!'PE\%^"O@UXA\,ZWX1\2> /!^C
MKX7T_6]&\1: /!FN)K4OAKR-<GUOQ+X=:.V?Q.+@^*V5(I)[YKF%B_HGPQ^%
MGPQ^#/A*P\!_"GP!X1^&?A'24)M/"O@CPYH_AS1XP>I31]#C2/)!Y.W<1PV5
M   /._V5OV=?AS^R1\ OA-^SI\,=/MK'PG\+?!VG>%[.]73=)TV^\3ZK J?\
M)'XRUM-*C@C/B7QAXE:Z\3^,;E(!Y_B;6Y)5D52$KZ4HHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+D>#/^07^OXBOZS5T.XTZTM;'19[2TLK8'*75J'_ %PO;V R>M6;W2;.;/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'MT_P_\ 9J +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?[7$8++'XC &/Q[?KTSVJ[9QRPVL,4Q!F5<$CD#'_P!;^?UH N4444 %%%%
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M?YYZ=R<\5^_WP@_X)G_LS?!C67UW1?AQX3\2>)[C1_L5W>>(/ ?@YV;@$_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MID'_  /TK2H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME_XFWP__ &2[>W'3[+X#^/I/TY)^O'?\CKZQ\?/^"S<.H7,5CX&_9#_L\_\
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M?'CQE[?]2V<YXH _<?R=4_Y_Q_X!C_&CR=4_Y_Q_X!C_ !K\+_\ AUA\6_\
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M>?Z_]JG]O0_]W(?T_P"%<9_SUK0_X<Q_#?\ Z.G_ &ZO_$@Q_P#.WH _9?\
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M)[D5T%<YHWAVRT?2[?2H?/N;>V^[]J;)/X8'X=?K71T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK0!6\J7_ )]+;\Q1Y4O_ #Z6WYBOP(_X*D?\%)OVO?\ @FGX9T_XJZM^R?\
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MOZ]KBZS_ ,(_XD\7,7D?P1K:HJ\LY54&X@$ _N[_ +-O/^@K<_Y_X%33!+:
MSSZG<&WMQEL@?-CLW!SCWSV^M?S8_M%W/_!QI\!?@WXM^+>A^+?V)/CA<>$+
M)=9N_AY\(/A1\2]1^)>H:<8S)K^K:#HNO-X43Q'L0?-X;C9_%<F0(9I2KA?U
M$_X):?M3^*OVWOV"?V=_VI?'7A_1?#OCWXAZ7XJL_$MKH5PYTG^V? 7Q,\<?
M"S5];T0[),0^*V\$GQ5_8( AMY-9\H_O-HH _0K^W=,_YZG_ ,!Y?\*/[=TS
M_GJ?_ >7_"K.+S_GXM__  %D_P#BJ,7G_/Q;_P#@+)_\50!G_P!O:-%C]\H_
M[=F_7"CU_7W%-/BC1(NMX.X_U#CG_@*C_.:W*2?S_P#EEC\?P_SS[T 8W]I:
M9=@3B<$#@;K5L_J"3^?YTOVS3?\ GN/_  %;_"MCRIO^>Q_7_&CRIO\ GL?U
M_P : .>EO+,_ZG4Y[7Z6I/T_A'_UZ//A_P"@U<?^ K?_ !-=#'G!\[&<<^F>
M^<?YZ^U6: .5^V1?]!NX_P# 7_ZU']H0_P#0:F_\!#_A7544 <M%>0^9QJEP
M3Z&TQUZ\X))]>.O:M#[;%_S^3_\ @,?_ (BMFOY!?CA?_P#!9#]N?_@IY^VE
M\#OV-_VK]._9Q^#/[),'PPT"YO-1U:3PUX<&I>-=#37-%TEM%TGP[XO\5:WX
ME\5B;QNI\4S^$QX1 \",';"^$#XQ /ZX?ML7_/Y/_P" Q_\ B*K^1+_T&Y_^
M^1_A7\.?_!7*U_X+ ?\ !+_PEX!^)[?\%1/B3\5_AQ\1?$^E_#VRW^7X<\=6
M?CI/!OB#7]9D70X_#TGAC_A&G.AEX]_C%9%_B2-\@?7O_!/[P7_P5W_X*)_\
M$Y?!WQFL_P#@I1J/PL\977B#XH'X436O@Y#XG\8?V+XVU_P_)'\;?'"YD'AU
M/$?A[5CX.;PMX.\6Q?\ "%O;(KR.2L0!_61G_J-W'_@+_P#6JK%K%G9BXGO-
M4GN8+7UM" #T/(!)/Y9'<8K^37]C;Q;_ ,%5/V2/^"L_PP_99_X*&_M6^,?&
MWPU^,OPV\57_ ,)/$L7A?5O'/PG^._BO1K?P[K0\'^"=;'A;PNW@+Q/X5MX]
M77QI_P )='+_ ,(A%'$H5X_BWX*\9#^O"*.X$LYED!A)7[, 1E0>3GU(Z#/4
M=/< ^6OVFO ?A;XY? ?X@:&9Q]G_ .$.\3FSNQ:%AG^Q23R5'&"/3Z#O_*A_
MP3W\5#]C/]MSXD_!V?Q3J7_"/^//'GQ0\:?9/L?3_BM/[!X'A_KG^P__ *]?
MVG:?9FSM?L\T_P!H]2>F.X Z\]:_FO\ ^"I/[,GC[X<_'CP_^U]X;U:U_P"$
M/TK1QHNM6?\ 8_*ZKKWC/7O$&UM;P"K;64[2,_,.U ']&ZZC9ZC<Z1>V5Z/L
MY&I8(MB=QP W) *X([9W8SP2:TIKN""Y/G7V,\&TQR.GX^]?!?[!?[8?PQ_:
MI^#^C:AX.\7Z-<^*-,L@VM:7::CI.H:C8-K.MZ_Y:E%;:RL-'D+?+MRJ[PQ"
M$?<=GJ<TAGL)[VU&K6V;YK4=?[-)4+D <Y.03ZXSP20 7_[7M/\ G]/_ (#M
M_A1_:]I_S^G_ ,!V_P *?!-?2_\ +:V_+_#^7)_D$,NJ0R$>3]H4]P<#\,8_
M#CU]J *W]L6G_/[<?^ O_P!C1_;%I_S^W'_@+_\ 8U9EU*Q@_P!?<6UOZ>_]
M,^U3F]LINEY;GZ$?ERW^>?>@#&U+69="T_6-;U6(0:?IEFUX<$'H/FR1GD=#
MCD9 )&:_BR\>7GBG]MC_ (*NV]N+ZYN/"WPXN_L(L[N\QQX$_:"U_@?\)!TQ
M_;F /Y5_1+_P4\_:WT']FC]FGX@17L+>)?&/BCPQXFL-'\/Z7?Z3I^I_VDNB
MLPX9CD@N?F/S$$ L1@#\>?\ @WQ^ /BO5_$_QH_::\?6-SII\9^//B?>:-X>
MO+(Z;J0TO7C\(?'>A$@$9 )R1D< \CJ #^J[31HGANQM]%M_]'M],4* ;9@N
M.3N&T$9.?O '@#':K?\ ;&F?\]__ "4/_P 15^S,LUM;RDC.,X)ZCD#V_D:L
M;)?4?I_A0!C?;-,FZ3+^-J>W_ >?UZ>W#O-LO^?[]36OY4W_ #V/Z_XTWRKK
M_GN/^^1_A0!@RSV?>]N._P#RZD_3JH/ Z=SVJ#[99?\ 05N/_ 0_X5T_E3?\
M]C^O^-'E3?\ /8_K_C0!SUI/9374)AOI[B< D'[*<8Y.3E1MP">1GUKHOWO^
M=U-6.5L>:0?I_7U]/_UTOV2'T/YC_"@!?WO^=U)Y1_Y[']/\:/LD/H?S'^%4
M/[,_VO\ /YT 7_*/_/8_I_C4$T,__/?_ /5_^OISZ_2J_P#9G^U_G\ZO16D,
M*;0.,')Z?R_R>XH A\F]_P"?C]!1Y,W_ #W_ %'_ ,55CRH?3]#_ (4>5#Z?
MH?\ "@"OY,W_ #W_ %'_ ,51Y,W_ #W_ %'_ ,55CR/?]?\ ZU'D>_Z__6H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_$?]OZQK-W-XKN$E\:"6\:.&ZGC0+#^KO[%'_!$C_@F[XM_X)Z?LT^&/B/\
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M[2M2TWX3VNL>%_MFD_\ %9:;I?\ 98/]@Z]_Q(_$'_"7>&!_R _IT]J_M0^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5'B,V/Q6T31/ VNZ_KFJAG UX_\ "?Z'*SRQC,\<DCIE68, ?S_?\$M/AO\
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M^$_#GBBT#S7GBOP@A_4C]@KX/?\ !37]GS]B+X7_  4\?6/[*5U\1/AG\./
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M\4/_ %"_#]?TM?L%?\F0?L=?]FK_ +.G_JF_ U?S]_\ !4'_ ((U_P#!3/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %?E7^T)_P6<_X)L_LG_&'Q?^S_\ M!_M
M%-\/?B_X&.@-XO\ "8^$'QU\3KIG]O\ @_0?'.A2/KW@+X<>+/#+&[\,Z_HU
MSM_X2,E!*T4RJZ[&_52OP'_8Y_X)L_$J3]O_ /;S_;I_;>^''P?\5>*?B/\
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MZ'X<L]/T;PQH>DV%GH^F:=:K8:=INEZ.%")"B#:D:(%^4@'"[G+L\DC?S,>
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MN=R\^H.#0!KT52MYX+R+SX)X)X6!*W%LP/(')R"X_(GZ=*\Y^*WQ8^&'P/\
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M)6<1KA)?Z";.SMK&WBL[.""VMK9?]&MK<[550#P <<$L<]>N2:_GC_X."O\
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M&4FC)I?B#QQ+/%_PD)30Q&XD'@[PK+YA#&,Y>:/^FA^@^O\ 0U_"1_P:9?\
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M_7I(//\ ^6N/P_'_ #Q[4 6:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(BQ@K&SG 5J /RX_X+$?\$C]+_X)I>$K+]O'_@FMXM^-OP)N?"WB/3-$\?\
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MSPZ?^U+X-^)$GP+^*?\ ;\/C+3_@?K'Q.^%.BZ/I'C7P_P"-8M4\+OXF\/\
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M>&/%7C$>#?!1U\'QWX(!P:_I7_X.1-3MM8_X(_\ Q;U2 S>1J7C+X$7EJ+D
M$%OB=X><;AGAB""?[V0PZX !?_X(">!_!WQ(_P""*?[.W@7XB^#O"GC_ ,%^
M)I_CUIWB#P1XT\,Z-XE\-ZYIDO[0OQ9SHVMZ-KD,WAW7ES&A<-$]NQ6,R)\F
M:_G._P""NG[-_P "_P!F3_@N7^Q5X=^ OPQ\(_"/PWX]N?V2?B%K?A'X>:4_
MA_P*GBK_ (:!U[P&^KZ#X+T.*'PYH:IX=\#Z(J^&O"\4<DB@.T:LQ%?TQ_\
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M_!Q\:^(/% 94;Q?@?TV_\&R'_*)WX:?]E6^,O_J8RU^(?_!0;]@#XY?L3?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=9\;>%O FD?VPGCO7/!JZ]\(W\9^&]?\?@Z$?#'C/PH)BBKXB(.\X:OZLJ*
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M0#_A6OAW0/":>!M"?P3%XN\7>#)1_P )!X85T5O%Q4?Z(U% 'Y;_  Z\2_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH K^?[?I_]>CS_ &_3_P"O110!
M8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** &;!ZG]/\ "C8/4_I_A3Z* "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JOY_M^G_UZ**
M+%%,3H?K_04^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *9L'J?T_PI]% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %5Z)^WX?UHH L457@[_C_ $JQ
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %,V#U/Z?X4^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBJ\_;\/ZT 6**KT0=_Q_I0!8HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *KU8HH KT58HH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHK._M&#S,9]O\_C^G:@#1HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH ***KT 6**KU8H **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""
M;_4GZ#^5>;?\37[?_P >.I_9\?\ /GSZ?GV]/PXKU"B@""'_ %(^A_E4]%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !5>K%% %>K%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!_.1_P &GO[77B'4M5^/_P"POKMO=:CH5MX<U7]I?P#?QKI'V/PZ-'UOX?\
M@'QWH^J,/^*EUV7Q2_C;P%+')*##%-X;\17#C=XH0C^VZOY0?^#77]B?Q3\"
M_@+\6/VI?B=X7CT/Q-^T#/X9\-_#P:[X,CL?'&G_  M\%2:[J^LZ[I&MO!+X
MEC\,_%7Q+KVBR_\ ",R21+CX>>')&6XAA\+>1_5]0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXVO_ "N>(?AMXT_X.%/VJ-'^)K/\2OAU_P $DOV>+^;PQX-.JZ@?#U[^U_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7SG^TY^S9\'OVO?@GXQ_9[^.OARY\6_"[QQ<>&I_$OA^U\0ZUX;O+
MT^%_$.A>,]#*ZOH-Q;:["L?B30='>01RQRO''MQA$4_1E% 'X1?\0WO_  2.
M_P"C>/%__A^/C1_\\*C_ (AO?^"1W_1O'B__ ,/Q\:/_ )X5?N[10!^;O['?
M_!+K]BG]@;Q/XJ\9?LN_!N/P+XL\<Z):^%]?\4ZEXG\9>.?$2>'8M=BU\:#H
M^N^/O%'B2;P[X?NM5&FOXG\/^&9[6S\52Z#X4FNHIY_"MBD7Z1444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
/ 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>36
<FILENAME>bown-20240630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaaFCbP9z5Z8WekhvWB5bekKXyMupnpsNyZHLHJWobMD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:BOWN="http://bowenspac.com/20240630" elementFormDefault="qualified" targetNamespace="http://bowenspac.com/20240630">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://bowenspac.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/StatementsOfOperations" id="StatementsOfOperations">
          <link:definition>00000004 - Statement - Consolidated Statements of Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/StatementsOfOperationsParenthetical" id="StatementsOfOperationsParenthetical">
          <link:definition>00000005 - Statement - Consolidated Statements of Operations (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity" id="StatementsOfChangesInShareholdersEquity">
          <link:definition>00000006 - Statement - Consolidated Statements of Changes in Shareholders' Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000007 - Statement - Consolidated Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/OrganizationAndBusinessOperations" id="OrganizationAndBusinessOperations">
          <link:definition>00000008 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/InitialPublicOffering" id="InitialPublicOffering">
          <link:definition>00000010 - Disclosure - INITIAL PUBLIC OFFERING</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/PrivatePlacements" id="PrivatePlacements">
          <link:definition>00000011 - Disclosure - PRIVATE PLACEMENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/RelatedParties" id="RelatedParties">
          <link:definition>00000012 - Disclosure - RELATED PARTIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/ShareholdersEquity" id="ShareholdersEquity">
          <link:definition>00000014 - Disclosure - SHAREHOLDERS&#8217; EQUITY</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/FairValueMeasurements" id="FairValueMeasurements">
          <link:definition>00000015 - Disclosure - Fair Value Measurements</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>00000016 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/RelatedPartiesTables" id="RelatedPartiesTables">
          <link:definition>00000019 - Disclosure - RELATED PARTIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
          <link:definition>00000020 - Disclosure - Fair Value Measurements (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" id="OrganizationAndBusinessOperationsDetailsNarrative">
          <link:definition>00000021 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails" id="ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails">
          <link:definition>00000022 - Disclosure - SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" id="ScheduleOfEarningsPerShareBasicAndDilutedDetails">
          <link:definition>00000023 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" id="ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails">
          <link:definition>00000024 - Disclosure - SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails" id="SupplementalDisclosureOfNoncashFinancingActivitiesDetails">
          <link:definition>00000025 - Disclosure - SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative" id="InitialPublicOfferingDetailsNarrative">
          <link:definition>00000027 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/PrivatePlacementsDetailsNarrative" id="PrivatePlacementsDetailsNarrative">
          <link:definition>00000028 - Disclosure - PRIVATE PLACEMENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" id="ScheduleOfAssumptionsToEstimateFairValueDetails">
          <link:definition>00000029 - Disclosure - SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/RelatedPartiesDetailsNarrative" id="RelatedPartiesDetailsNarrative">
          <link:definition>00000030 - Disclosure - RELATED PARTIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>00000031 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" id="ShareholdersEquityDetailsNarrative">
          <link:definition>00000032 - Disclosure - SHAREHOLDERS&#8217; EQUITY (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails" id="ScheduleOfMeasuredFairValueOnRecurringBasisDetails">
          <link:definition>00000033 - Disclosure - SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails" id="ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails">
          <link:definition>00000034 - Disclosure - SCHEDULE FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://bowenspac.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="bown-20240630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="bown-20240630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="bown-20240630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="bown-20240630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="BOWN_RedeemableOrdinarySharesMember" name="RedeemableOrdinarySharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_NonRedeemableOrdinarySharesMember" name="NonRedeemableOrdinarySharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_MergerSharesMember" name="MergerSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AgreementMember" name="AgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_EarnoutSharesMember" name="EarnoutSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ShenzhenQianzhiMember" name="ShenzhenQianzhiMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_RedeemableSharesMember" name="RedeemableSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_NonRedeemableSharesMember" name="NonRedeemableSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_SponsorsMember" name="SponsorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_EBCMember" name="EBCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_UnderwritersMember" name="UnderwritersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_PromissoryNoteMember" name="PromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_TenXGlobalCapitalMember" name="TenXGlobalCapitalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AccountingServiceAgreementMember" name="AccountingServiceAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AccountingServicesExpenseMember" name="AccountingServicesExpenseMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember" name="MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_BusinessCombinationMarketingAgreementMember" name="BusinessCombinationMarketingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_QianzhiMember" name="QianzhiMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OrdinarySharesSubjectToRedemption" name="OrdinarySharesSubjectToRedemption" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" name="SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_StockIssuedDuringPeriodValueToUnderwriter" name="StockIssuedDuringPeriodValueToUnderwriter" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_StockIssuedDuringPeriodSharesToUnderwriter" name="StockIssuedDuringPeriodSharesToUnderwriter" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits" name="StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits" name="StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment" name="StockIssuedDuringPeriodValueProceedsFromOverallotment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment" name="StockIssuedDuringPeriodSharesProceedsFromOverallotment" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits" name="StockIssuedDuringPeriodValueSaleOfPrivateUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits" name="StockIssuedDuringPeriodSharesSaleOfPrivateUnits" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits" name="StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits" name="StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits" name="AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment" name="AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts" name="AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" name="AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses" name="IncreaseDecreaseInAccruedOfferingCostsAndExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ProceedsFromIssuanceOfFounderShares" name="ProceedsFromIssuanceOfFounderShares" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_PaymentsOfUnderwritersDiscount" name="PaymentsOfUnderwritersDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_PaymentOfOfferingCosts" name="PaymentOfOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" name="NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital" name="NonCashOfferingCostsChargedToAdditionalPaidinCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption" name="ReclassificationOfOrdinarySharesSubjectToRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" name="AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption" name="RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" name="SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_DeferredOfferingCostsPaidByRelatedParty" name="DeferredOfferingCostsPaidByRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_PrepaidExpensesPaidByRelatedParty" name="PrepaidExpensesPaidByRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses" name="NoncashOfferingCostsAdjustedFromPrepaidExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_DeferredOfferingCostsIncludedInAccruedExpenses" name="DeferredOfferingCostsIncludedInAccruedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" name="DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OfferingCostsChargedToAPICFounderShares" name="OfferingCostsChargedToAPICFounderShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_DisclosureInitialPublicOfferingAbstract" name="DisclosureInitialPublicOfferingAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_InitialPublicOfferingTextBlock" name="InitialPublicOfferingTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_DisclosurePrivatePlacementsAbstract" name="DisclosurePrivatePlacementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_PrivatePlacementsTextBlock" name="PrivatePlacementsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_EmergingGrowthCompanyPolicyTextBlock" name="EmergingGrowthCompanyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OfferingCostsPolicyTextBlock" name="OfferingCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock" name="ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock" name="ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OtherOfferingCosts" name="OtherOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_WorkingCapitalDeficit" name="WorkingCapitalDeficit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AccretionOfTemporaryEquityIntoRedemptionValue" name="AccretionOfTemporaryEquityIntoRedemptionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue" name="NetLossIncludingAccretionOfEquityIntoRedemptionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_InterestEarnedOnInvestmentHeldInTrustAccount" name="InterestEarnedOnInvestmentHeldInTrustAccount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue" name="NetLossIncludingAccretionOfCommonStockToRedemptionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OwnershipPercentage" name="OwnershipPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity" name="AllocationOfNetLossIncludingAccretionOfTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount" name="InterestEarnedOnInvestmentsHeldInTrustAccount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_IncomeEarnedOnTrustAccount" name="IncomeEarnedOnTrustAccount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AllocationOfNetIncomeloss" name="AllocationOfNetIncomeloss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AccretionOfCarryingValueToRedemptionValue" name="AccretionOfCarryingValueToRedemptionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_NoncashOfferingCostsPaidByRelatedParty" name="NoncashOfferingCostsPaidByRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_NoncashPrepaidExpensesPaidByRelatedParty" name="NoncashPrepaidExpensesPaidByRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_NoncashOfferingCostsIncludedInAccruedExpenses" name="NoncashOfferingCostsIncludedInAccruedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_InterestsEarnedFromTrustAccount" name="InterestsEarnedFromTrustAccount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_EquitySecuritiesFvNiTerm" name="EquitySecuritiesFvNiTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_CashUnderwritingDiscountPerUnit" name="CashUnderwritingDiscountPerUnit" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_CashUnderwritingDiscount" name="CashUnderwritingDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_PercentageOfGrossProceedsOfInitialPublicOffering" name="PercentageOfGrossProceedsOfInitialPublicOffering" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable" name="PercentageOfServiceFeeOfTotalConsiderationPayable" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed" name="BusinessCombinationAcquisitionRelatedCostsReimbursed" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ServiceFee" name="ServiceFee" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ExpectedLikelihoodSuccessfulBusinessCombination" name="ExpectedLikelihoodSuccessfulBusinessCombination" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_RightsEachEntitlingHolderToOnetenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember" name="RightsEachEntitlingHolderToOnetenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OrdinarySharesParValue0.0001PerShareMember" name="OrdinarySharesParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember" name="UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_InterestAndDividendEarnedOnMarketableSecuritiesHeldInTrustAccount" name="InterestAndDividendEarnedOnMarketableSecuritiesHeldInTrustAccount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_IncomeEarnedOnInvestmentHeldInTrustAccount" name="IncomeEarnedOnInvestmentHeldInTrustAccount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AccruedOfferingCostsAndExpenses" name="AccruedOfferingCostsAndExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_PercentageOfGrossProceedsOfIPO" name="PercentageOfGrossProceedsOfIPO" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_SuppliersMember" name="SuppliersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AdvanceToSuppliersTextBlock" name="AdvanceToSuppliersTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ScheduleOfAdvanceToSuppliersTableTextBlock" name="ScheduleOfAdvanceToSuppliersTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AdvancesToSuppliersToPurchaseThirdpartyProducts" name="AdvancesToSuppliersToPurchaseThirdpartyProducts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AdvancesToSuppliersForRawMaterials" name="AdvancesToSuppliersForRawMaterials" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OthersSupplies" name="OthersSupplies" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AdvancesToSupplersGross" name="AdvancesToSupplersGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AdvancesToSupplersNet" name="AdvancesToSupplersNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_StatutoryReserve" name="StatutoryReserve" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_PromotionCost" name="PromotionCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_GovernmentSubsidies" name="GovernmentSubsidies" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AdvancesToSuppliersNonCurrent" name="AdvancesToSuppliersNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" name="ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_StatutoryReserveMember" name="StatutoryReserveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_EffectiveIncomeTaxRateReconciliationPreferentialTaxRateAndTaxExemption" name="EffectiveIncomeTaxRateReconciliationPreferentialTaxRateAndTaxExemption" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ScheduleOfTaxesPayableTableTextBlock" name="ScheduleOfTaxesPayableTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AdvancesToSuppliersCurrent" name="AdvancesToSuppliersCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ScheduleOfNatureOfRelationshipsWithRelatedPartiesTableTextBlock" name="ScheduleOfNatureOfRelationshipsWithRelatedPartiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_XiaoqinLinMember" name="XiaoqinLinMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_LiangwenWangMember" name="LiangwenWangMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_YuetaoLinMember" name="YuetaoLinMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_XIaolingYuanMember" name="XIaolingYuanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_JuxiangHuMember" name="JuxiangHuMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_YanminLiuMember" name="YanminLiuMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_YajunSunMember" name="YajunSunMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_LiangmingHuMember" name="LiangmingHuMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ShenzhenYelinNetworkTechnologyCoLtdMember" name="ShenzhenYelinNetworkTechnologyCoLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_QianzhiGroupHoldingCaymanLimitedMember" name="QianzhiGroupHoldingCaymanLimitedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_IncreaseDecreaseInLoansToRelatedParties" name="IncreaseDecreaseInLoansToRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_IncreaseDecreaseInOtherPayables" name="IncreaseDecreaseInOtherPayables" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_IncreaseDecreaseInOtherPayablesRelatedParties" name="IncreaseDecreaseInOtherPayablesRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_StockIssuedDuringPeriodValueAppropriationToStatutoryReserve" name="StockIssuedDuringPeriodValueAppropriationToStatutoryReserve" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_StockIssuedDuringPeriodValueDisposalOfSubsidiary" name="StockIssuedDuringPeriodValueDisposalOfSubsidiary" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ReserveForSalesReturn" name="ReserveForSalesReturn" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_DisposalAndAcquiringOfNoncontrollingInterest" name="DisposalAndAcquiringOfNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_NewCoMember" name="NewCoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_QianzhiInvestmentHoldingCoLtdMember" name="QianzhiInvestmentHoldingCoLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_HongKongQianzhiInvestmentHoldingCoLtdMember" name="HongKongQianzhiInvestmentHoldingCoLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ShenzhenShianBiotechnologyCoLtdMember" name="ShenzhenShianBiotechnologyCoLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_IncomeTaxPayable" name="IncomeTaxPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ValueAddedTaxPayableNet" name="ValueAddedTaxPayableNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OtherTaxesPayable" name="OtherTaxesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OperatingLeaseAssets" name="OperatingLeaseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_LoansToRelatedParties" name="LoansToRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_HubeiQianzhiBiotechnologyCoLtdMember" name="HubeiQianzhiBiotechnologyCoLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ShenzhenQianzhiHealthManagementCoLtdMember" name="ShenzhenQianzhiHealthManagementCoLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_JiangxiQianzhiBiotechnologyCoLtdMember" name="JiangxiQianzhiBiotechnologyCoLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ShenzhenQianzhiBiotechCoLtdMember" name="ShenzhenQianzhiBiotechCoLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ZhishangZhimeiMember" name="ZhishangZhimeiMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_NameOfEntity" name="NameOfEntity" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_EntityPlaceOfIncorporation" name="EntityPlaceOfIncorporation" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_QianzhiBVIMember" name="QianzhiBVIMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_QianzhiHKMember" name="QianzhiHKMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ShenzhenShianMember" name="ShenzhenShianMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_QianzhiBiotechnologyMember" name="QianzhiBiotechnologyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_QianzhiHealthMember" name="QianzhiHealthMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_LiquidityTextBlock" name="LiquidityTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OneCustomerMember" name="OneCustomerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_TwoCustomersMember" name="TwoCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ThreeCustomersMember" name="ThreeCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_TenCustomersMember" name="TenCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OzoneSterilizationProductMember" name="OzoneSterilizationProductMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_CustomerOneMember" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OneSupplierMember" name="OneSupplierMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_RevenueRecognizedPercentage" name="RevenueRecognizedPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_CustomersTwoMember" name="CustomersTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_SupplierOneMember" name="SupplierOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_SuppliersTwoMember" name="SuppliersTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_SuppliersThreeMember" name="SuppliersThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_SuppliersFourMember" name="SuppliersFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_TenSuppliersMember" name="TenSuppliersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_IncreaseDecreaseInDueToSubsidiariesCurrent" name="IncreaseDecreaseInDueToSubsidiariesCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_HubeiQianzhiMember" name="HubeiQianzhiMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OtherMember" name="OtherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ConsolidatedNetAssetsPercentage" name="ConsolidatedNetAssetsPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_WorkingCapital" name="WorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_DueToSubsidiariesCurrent" name="DueToSubsidiariesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AdvancesToSuppliersPolicyTextBlock" name="AdvancesToSuppliersPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ScheduleOfOtherPayablesRelatedPartiesTableTextBlock" name="ScheduleOfOtherPayablesRelatedPartiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ScheduleOfOtherReceivablesTableTextBlock" name="ScheduleOfOtherReceivablesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ShenzhenYelinMember" name="ShenzhenYelinMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_DisaggregationOfRevenuePolicyTextBlock" name="DisaggregationOfRevenuePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_CostOfRevenuePolicyTextBlock" name="CostOfRevenuePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_EquityInEarningsOfSubsidiaries" name="EquityInEarningsOfSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ValueAddedTaxPolicyTextBlock" name="ValueAddedTaxPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_RelatedPartiesPolicyTextBlock" name="RelatedPartiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" name="RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ScheduleOfPropertyAndEquipmentExpectedUsefulLivesTableTextBlock" name="ScheduleOfPropertyAndEquipmentExpectedUsefulLivesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OzoneSterilizationProductsMember" name="OzoneSterilizationProductsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_HypochloriteDisinfectionProductsMember" name="HypochloriteDisinfectionProductsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_CosmeticProductsMember" name="CosmeticProductsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_PrepackagedFoodMember" name="PrepackagedFoodMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_OtherProductsMember" name="OtherProductsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_PeriodEndSpotRateMember" name="PeriodEndSpotRateMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_AverageRateMember" name="AverageRateMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_InventorySelfProducedFinishedGoods" name="InventorySelfProducedFinishedGoods" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_InventoryExternalPurchasedFinishedGoods" name="InventoryExternalPurchasedFinishedGoods" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_LizhongGeMember" name="LizhongGeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_InventoryLowValueConsumables" name="InventoryLowValueConsumables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_EffectiveIncomeTaxRateReconciliationTaxEffectOfNonprofitSubsidiaries" name="EffectiveIncomeTaxRateReconciliationTaxEffectOfNonprofitSubsidiaries" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_EffectiveIncomeTaxRateReconciliationOtherPreferentialTaxRateEffect" name="EffectiveIncomeTaxRateReconciliationOtherPreferentialTaxRateEffect" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ShortTermBankLoanOneMember" name="ShortTermBankLoanOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_ShortTermBankLoanTwoMember" name="ShortTermBankLoanTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_CustomersThreeMember" name="CustomersThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_CustomersFourMember" name="CustomersFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BOWN_LongTermBankLoanMember" name="LongTermBankLoanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>37
<FILENAME>bown-20240630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bowenspac.com/role/Cover" xlink:href="bown-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/BalanceSheets" xlink:href="bown-20240630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/BalanceSheetsParenthetical" xlink:href="bown-20240630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/StatementsOfOperations" xlink:href="bown-20240630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/StatementsOfOperationsParenthetical" xlink:href="bown-20240630.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="bown-20240630.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/StatementsOfCashFlows" xlink:href="bown-20240630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/OrganizationAndBusinessOperations" xlink:href="bown-20240630.xsd#OrganizationAndBusinessOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="bown-20240630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/InitialPublicOffering" xlink:href="bown-20240630.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/PrivatePlacements" xlink:href="bown-20240630.xsd#PrivatePlacements" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/RelatedParties" xlink:href="bown-20240630.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/CommitmentsAndContingencies" xlink:href="bown-20240630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ShareholdersEquity" xlink:href="bown-20240630.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/FairValueMeasurements" xlink:href="bown-20240630.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SubsequentEvents" xlink:href="bown-20240630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="bown-20240630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="bown-20240630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/RelatedPartiesTables" xlink:href="bown-20240630.xsd#RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/FairValueMeasurementsTables" xlink:href="bown-20240630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" xlink:href="bown-20240630.xsd#OrganizationAndBusinessOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails" xlink:href="bown-20240630.xsd#ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:href="bown-20240630.xsd#ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:href="bown-20240630.xsd#ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails" xlink:href="bown-20240630.xsd#SupplementalDisclosureOfNoncashFinancingActivitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="bown-20240630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="bown-20240630.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/PrivatePlacementsDetailsNarrative" xlink:href="bown-20240630.xsd#PrivatePlacementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" xlink:href="bown-20240630.xsd#ScheduleOfAssumptionsToEstimateFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/RelatedPartiesDetailsNarrative" xlink:href="bown-20240630.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="bown-20240630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" xlink:href="bown-20240630.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails" xlink:href="bown-20240630.xsd#ScheduleOfMeasuredFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails" xlink:href="bown-20240630.xsd#ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SubsequentEventsDetailsNarrative" xlink:href="bown-20240630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000006 - Statement - Consolidated Statements of Changes in Shareholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses" xlink:label="loc_BOWNIncreaseDecreaseInAccruedOfferingCostsAndExpenses" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_BOWNIncreaseDecreaseInAccruedOfferingCostsAndExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireOtherInvestments" xlink:label="loc_us-gaapPaymentsToAcquireOtherInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireOtherInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ProceedsFromIssuanceOfFounderShares" xlink:label="loc_BOWNProceedsFromIssuanceOfFounderShares" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_BOWNProceedsFromIssuanceOfFounderShares" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PaymentsOfUnderwritersDiscount" xlink:label="loc_BOWNPaymentsOfUnderwritersDiscount" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_BOWNPaymentsOfUnderwritersDiscount" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PaymentOfOfferingCosts" xlink:label="loc_BOWNPaymentOfOfferingCosts" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_BOWNPaymentOfOfferingCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/OrganizationAndBusinessOperations" xlink:title="00000008 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/InitialPublicOffering" xlink:title="00000010 - Disclosure - INITIAL PUBLIC OFFERING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/PrivatePlacements" xlink:title="00000011 - Disclosure - PRIVATE PLACEMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/RelatedParties" xlink:title="00000012 - Disclosure - RELATED PARTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ShareholdersEquity" xlink:title="00000014 - Disclosure - SHAREHOLDERS&#8217; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/FairValueMeasurements" xlink:title="00000015 - Disclosure - Fair Value Measurements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/RelatedPartiesTables" xlink:title="00000019 - Disclosure - RELATED PARTIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/FairValueMeasurementsTables" xlink:title="00000020 - Disclosure - Fair Value Measurements (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" xlink:title="00000021 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails" xlink:title="00000022 - Disclosure - SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue" xlink:label="loc_BOWNNetLossIncludingAccretionOfEquityIntoRedemptionValue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_BOWNNetLossIncludingAccretionOfEquityIntoRedemptionValue" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccretionOfTemporaryEquityIntoRedemptionValue" xlink:label="loc_BOWNAccretionOfTemporaryEquityIntoRedemptionValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_BOWNNetLossIncludingAccretionOfEquityIntoRedemptionValue" xlink:to="loc_BOWNAccretionOfTemporaryEquityIntoRedemptionValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InterestEarnedOnInvestmentHeldInTrustAccount" xlink:label="loc_BOWNInterestEarnedOnInvestmentHeldInTrustAccount" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_BOWNNetLossIncludingAccretionOfEquityIntoRedemptionValue" xlink:to="loc_BOWNInterestEarnedOnInvestmentHeldInTrustAccount" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue" xlink:label="loc_BOWNNetLossIncludingAccretionOfCommonStockToRedemptionValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_BOWNNetLossIncludingAccretionOfCommonStockToRedemptionValue" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_BOWNNetLossIncludingAccretionOfCommonStockToRedemptionValue" xlink:to="loc_BOWNAccretionOfTemporaryEquityIntoRedemptionValue" xlink:type="arc" weight="-1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_BOWNNetLossIncludingAccretionOfCommonStockToRedemptionValue" xlink:to="loc_BOWNInterestEarnedOnInvestmentHeldInTrustAccount" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:title="00000023 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:title="00000024 - Disclosure - SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails" xlink:title="00000025 - Disclosure - SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000027 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/PrivatePlacementsDetailsNarrative" xlink:title="00000028 - Disclosure - PRIVATE PLACEMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" xlink:title="00000029 - Disclosure - SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/RelatedPartiesDetailsNarrative" xlink:title="00000030 - Disclosure - RELATED PARTIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000031 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000032 - Disclosure - SHAREHOLDERS&#8217; EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails" xlink:title="00000033 - Disclosure - SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails" xlink:title="00000034 - Disclosure - SCHEDULE FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>38
<FILENAME>bown-20240630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bowenspac.com/role/Cover" xlink:href="bown-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/BalanceSheets" xlink:href="bown-20240630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/BalanceSheetsParenthetical" xlink:href="bown-20240630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/StatementsOfOperations" xlink:href="bown-20240630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/StatementsOfOperationsParenthetical" xlink:href="bown-20240630.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="bown-20240630.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/StatementsOfCashFlows" xlink:href="bown-20240630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/OrganizationAndBusinessOperations" xlink:href="bown-20240630.xsd#OrganizationAndBusinessOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="bown-20240630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/InitialPublicOffering" xlink:href="bown-20240630.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/PrivatePlacements" xlink:href="bown-20240630.xsd#PrivatePlacements" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/RelatedParties" xlink:href="bown-20240630.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/CommitmentsAndContingencies" xlink:href="bown-20240630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ShareholdersEquity" xlink:href="bown-20240630.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/FairValueMeasurements" xlink:href="bown-20240630.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SubsequentEvents" xlink:href="bown-20240630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="bown-20240630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="bown-20240630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/RelatedPartiesTables" xlink:href="bown-20240630.xsd#RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/FairValueMeasurementsTables" xlink:href="bown-20240630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" xlink:href="bown-20240630.xsd#OrganizationAndBusinessOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails" xlink:href="bown-20240630.xsd#ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:href="bown-20240630.xsd#ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:href="bown-20240630.xsd#ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails" xlink:href="bown-20240630.xsd#SupplementalDisclosureOfNoncashFinancingActivitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="bown-20240630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="bown-20240630.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/PrivatePlacementsDetailsNarrative" xlink:href="bown-20240630.xsd#PrivatePlacementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" xlink:href="bown-20240630.xsd#ScheduleOfAssumptionsToEstimateFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/RelatedPartiesDetailsNarrative" xlink:href="bown-20240630.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="bown-20240630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" xlink:href="bown-20240630.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails" xlink:href="bown-20240630.xsd#ScheduleOfMeasuredFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails" xlink:href="bown-20240630.xsd#ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SubsequentEventsDetailsNarrative" xlink:href="bown-20240630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_30" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_30" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_30" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_30" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_30" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_30" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_30" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_30" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_30" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_30" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_30" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_30" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_30" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_30" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_30" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_30" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_30" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_30" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_30" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_30" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_30" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_30" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_30" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_30" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_30" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_30" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_30" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_30" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_30" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_30" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_30" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_30" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_30" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName_30" xlink:type="arc" order="58" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaapNonrelatedPartyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapNonrelatedPartyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAssetsAbstract_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsCurrentAbstract_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapCash_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapPrepaidExpenseCurrent_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapOtherReceivablesNetCurrent_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsCurrent_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsNoncurrent_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssets_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrent_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilities_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommitmentsAndContingencies_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquityAbstract_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapPreferredStockValue_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommonStockValue_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapAdditionalPaidInCapital_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_70" xlink:type="arc" order="22" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_RedeemableOrdinarySharesMember" xlink:label="loc_BOWNRedeemableOrdinarySharesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BOWNRedeemableOrdinarySharesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NonRedeemableOrdinarySharesMember" xlink:label="loc_BOWNNonRedeemableOrdinarySharesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BOWNNonRedeemableOrdinarySharesMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_160" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_160" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_160" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000006 - Statement - Consolidated Statements of Changes in Shareholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" xlink:label="loc_BOWNSubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNSubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueToUnderwriter" xlink:label="loc_BOWNStockIssuedDuringPeriodValueToUnderwriter_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodValueToUnderwriter_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesToUnderwriter" xlink:label="loc_BOWNStockIssuedDuringPeriodSharesToUnderwriter_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodSharesToUnderwriter_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits" xlink:label="loc_BOWNStockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits" xlink:label="loc_BOWNStockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment" xlink:label="loc_BOWNStockIssuedDuringPeriodValueProceedsFromOverallotment_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodValueProceedsFromOverallotment_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment" xlink:label="loc_BOWNStockIssuedDuringPeriodSharesProceedsFromOverallotment_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodSharesProceedsFromOverallotment_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits" xlink:label="loc_BOWNStockIssuedDuringPeriodValueSaleOfPrivateUnits_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodValueSaleOfPrivateUnits_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits" xlink:label="loc_BOWNStockIssuedDuringPeriodSharesSaleOfPrivateUnits_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodSharesSaleOfPrivateUnits_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits" xlink:label="loc_BOWNStockIssuedDuringPeriodValueOverallotmentOfPrivateUnits_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodValueOverallotmentOfPrivateUnits_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits" xlink:label="loc_BOWNStockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits" xlink:label="loc_BOWNAdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNAdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment" xlink:label="loc_BOWNAdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNAdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts" xlink:label="loc_BOWNAdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNAdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" xlink:label="loc_BOWNAdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNAdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther_50" xlink:type="arc" order="26" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_50" xlink:to="loc_us-gaapNetIncomeLoss_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_50" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_50" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_50" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses" xlink:label="loc_BOWNIncreaseDecreaseInAccruedOfferingCostsAndExpenses_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_50" xlink:to="loc_BOWNIncreaseDecreaseInAccruedOfferingCostsAndExpenses_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_50" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_50" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_50" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireOtherInvestments" xlink:label="loc_us-gaapPaymentsToAcquireOtherInvestments_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_50" xlink:to="loc_us-gaapPaymentsToAcquireOtherInvestments_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_50" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ProceedsFromIssuanceOfFounderShares" xlink:label="loc_BOWNProceedsFromIssuanceOfFounderShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_50" xlink:to="loc_BOWNProceedsFromIssuanceOfFounderShares_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_50" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_50" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PaymentsOfUnderwritersDiscount" xlink:label="loc_BOWNPaymentsOfUnderwritersDiscount_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_50" xlink:to="loc_BOWNPaymentsOfUnderwritersDiscount_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_50" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PaymentOfOfferingCosts" xlink:label="loc_BOWNPaymentOfOfferingCosts_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_50" xlink:to="loc_BOWNPaymentOfOfferingCosts_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_50" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:label="loc_BOWNNoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_50" xlink:to="loc_BOWNNoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital" xlink:label="loc_BOWNNonCashOfferingCostsChargedToAdditionalPaidinCapital_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_50" xlink:to="loc_BOWNNonCashOfferingCostsChargedToAdditionalPaidinCapital_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption" xlink:label="loc_BOWNReclassificationOfOrdinarySharesSubjectToRedemption_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_50" xlink:to="loc_BOWNReclassificationOfOrdinarySharesSubjectToRedemption_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" xlink:label="loc_BOWNAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_50" xlink:to="loc_BOWNAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption" xlink:label="loc_BOWNRemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_50" xlink:to="loc_BOWNRemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption_50" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" xlink:label="loc_BOWNSubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_50" xlink:to="loc_BOWNSubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_50" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DeferredOfferingCostsPaidByRelatedParty" xlink:label="loc_BOWNDeferredOfferingCostsPaidByRelatedParty_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_50" xlink:to="loc_BOWNDeferredOfferingCostsPaidByRelatedParty_50" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PrepaidExpensesPaidByRelatedParty" xlink:label="loc_BOWNPrepaidExpensesPaidByRelatedParty_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_50" xlink:to="loc_BOWNPrepaidExpensesPaidByRelatedParty_50" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses" xlink:label="loc_BOWNNoncashOfferingCostsAdjustedFromPrepaidExpenses_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_50" xlink:to="loc_BOWNNoncashOfferingCostsAdjustedFromPrepaidExpenses_50" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DeferredOfferingCostsIncludedInAccruedExpenses" xlink:label="loc_BOWNDeferredOfferingCostsIncludedInAccruedExpenses_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_50" xlink:to="loc_BOWNDeferredOfferingCostsIncludedInAccruedExpenses_50" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:label="loc_BOWNDeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_50" xlink:to="loc_BOWNDeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_50" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OfferingCostsChargedToAPICFounderShares" xlink:label="loc_BOWNOfferingCostsChargedToAPICFounderShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_50" xlink:to="loc_BOWNOfferingCostsChargedToAPICFounderShares_50" xlink:type="arc" order="35" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/OrganizationAndBusinessOperations" xlink:title="00000008 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/InitialPublicOffering" xlink:title="00000010 - Disclosure - INITIAL PUBLIC OFFERING" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/PrivatePlacements" xlink:title="00000011 - Disclosure - PRIVATE PLACEMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/RelatedParties" xlink:title="00000012 - Disclosure - RELATED PARTIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ShareholdersEquity" xlink:title="00000014 - Disclosure - SHAREHOLDERS&#8217; EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/FairValueMeasurements" xlink:title="00000015 - Disclosure - Fair Value Measurements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/RelatedPartiesTables" xlink:title="00000019 - Disclosure - RELATED PARTIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/FairValueMeasurementsTables" xlink:title="00000020 - Disclosure - Fair Value Measurements (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" xlink:title="00000021 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_MergerSharesMember" xlink:label="loc_BOWNMergerSharesMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_BOWNMergerSharesMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EarnoutSharesMember" xlink:label="loc_BOWNEarnoutSharesMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_BOWNEarnoutSharesMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AgreementMember" xlink:label="loc_BOWNAgreementMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_BOWNAgreementMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ShenzhenQianzhiMember" xlink:label="loc_BOWNShenzhenQianzhiMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_BOWNShenzhenQianzhiMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaapPaymentsForUnderwritingExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsForUnderwritingExpense_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OtherOfferingCosts" xlink:label="loc_BOWNOtherOfferingCosts_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_BOWNOtherOfferingCosts_160" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCash_160" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_WorkingCapitalDeficit" xlink:label="loc_BOWNWorkingCapitalDeficit_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_BOWNWorkingCapitalDeficit_160" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOtherReceivablesNetCurrent_160" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Deposits" xlink:label="loc_us-gaapDeposits_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDeposits_160" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_160" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails" xlink:title="00000022 - Disclosure - SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:title="00000023 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_RedeemableSharesMember" xlink:label="loc_BOWNRedeemableSharesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BOWNRedeemableSharesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NonRedeemableSharesMember" xlink:label="loc_BOWNNonRedeemableSharesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BOWNNonRedeemableSharesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OwnershipPercentage" xlink:label="loc_BOWNOwnershipPercentage_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNOwnershipPercentage_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity" xlink:label="loc_BOWNAllocationOfNetLossIncludingAccretionOfTemporaryEquity_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNAllocationOfNetLossIncludingAccretionOfTemporaryEquity_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount" xlink:label="loc_BOWNInterestEarnedOnInvestmentsHeldInTrustAccount_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNInterestEarnedOnInvestmentsHeldInTrustAccount_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_IncomeEarnedOnTrustAccount" xlink:label="loc_BOWNIncomeEarnedOnTrustAccount_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNIncomeEarnedOnTrustAccount_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccretionOfTemporaryEquityIntoRedemptionValue" xlink:label="loc_BOWNAccretionOfTemporaryEquityIntoRedemptionValue_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNAccretionOfTemporaryEquityIntoRedemptionValue_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AllocationOfNetIncomeloss" xlink:label="loc_BOWNAllocationOfNetIncomeloss_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNAllocationOfNetIncomeloss_110" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:title="00000024 - Disclosure - SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfferingCostsPartnershipInterests" xlink:label="loc_us-gaapOfferingCostsPartnershipInterests_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOfferingCostsPartnershipInterests_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccretionOfCarryingValueToRedemptionValue" xlink:label="loc_BOWNAccretionOfCarryingValueToRedemptionValue_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_BOWNAccretionOfCarryingValueToRedemptionValue_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityCommonCarryingAmount_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityCommonCarryingAmount_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaapProceedsFromOtherEquity_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromOtherEquity_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" xlink:label="loc_BOWNSubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_BOWNSubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLegalSettlements" xlink:label="loc_us-gaapProceedsFromLegalSettlements_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromLegalSettlements_120" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails" xlink:title="00000025 - Disclosure - SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsLineItems" xlink:label="loc_us-gaapCashAndCashEquivalentsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:label="loc_us-gaapScheduleOfCashAndCashEquivalentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapScheduleOfCashAndCashEquivalentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaapCashAndCashEquivalentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCashAndCashEquivalentsTable" xlink:to="loc_us-gaapCashAndCashEquivalentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCashAndCashEquivalentsAxis" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCashAndCashEquivalentsAxis" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashMember" xlink:label="loc_us-gaapCashMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_us-gaapCashMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaapUSTreasurySecuritiesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_us-gaapUSTreasurySecuritiesMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapCash_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount" xlink:label="loc_BOWNInterestEarnedOnInvestmentsHeldInTrustAccount_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_BOWNInterestEarnedOnInvestmentsHeldInTrustAccount_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldInTrust" xlink:label="loc_us-gaapAssetsHeldInTrust_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapAssetsHeldInTrust_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InterestsEarnedFromTrustAccount" xlink:label="loc_BOWNInterestsEarnedFromTrustAccount_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_BOWNInterestsEarnedFromTrustAccount_80" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000027 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="loc_us-gaapSaleOfStockDescriptionOfTransaction_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockDescriptionOfTransaction_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/PrivatePlacementsDetailsNarrative" xlink:title="00000028 - Disclosure - PRIVATE PLACEMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SponsorsMember" xlink:label="loc_BOWNSponsorsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_BOWNSponsorsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EBCMember" xlink:label="loc_BOWNEBCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_BOWNEBCMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_UnderwritersMember" xlink:label="loc_BOWNUnderwritersMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_BOWNUnderwritersMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="loc_us-gaapSaleOfStockDescriptionOfTransaction_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockDescriptionOfTransaction_110" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" xlink:title="00000029 - Disclosure - SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="loc_srtPlatformOperatorCryptoAssetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember" xlink:label="loc_BOWNMeasurementInputProbabilityOfCompletionOfBusinessCombinationMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_BOWNMeasurementInputProbabilityOfCompletionOfBusinessCombinationMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EquitySecuritiesFvNiTerm" xlink:label="loc_BOWNEquitySecuritiesFvNiTerm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_BOWNEquitySecuritiesFvNiTerm_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiMeasurementInput" xlink:label="loc_us-gaapEquitySecuritiesFvNiMeasurementInput_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiMeasurementInput_60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/RelatedPartiesDetailsNarrative" xlink:title="00000030 - Disclosure - RELATED PARTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SponsorsMember" xlink:label="loc_BOWNSponsorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_BOWNSponsorsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EBCMember" xlink:label="loc_BOWNEBCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_BOWNEBCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PromissoryNoteMember" xlink:label="loc_BOWNPromissoryNoteMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_BOWNPromissoryNoteMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SponsorsMember" xlink:label="loc_BOWNSponsorsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_BOWNSponsorsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_TenXGlobalCapitalMember" xlink:label="loc_BOWNTenXGlobalCapitalMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_BOWNTenXGlobalCapitalMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccountingServiceAgreementMember" xlink:label="loc_BOWNAccountingServiceAgreementMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_BOWNAccountingServiceAgreementMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_300" xlink:type="arc" order="302" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccountingServicesExpenseMember" xlink:label="loc_BOWNAccountingServicesExpenseMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_BOWNAccountingServicesExpenseMember_310" xlink:type="arc" order="312" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_380" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_380" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_380" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_380" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_380" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice_380" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_380" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_380" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable_380" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_380" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_CashUnderwritingDiscountPerUnit" xlink:label="loc_BOWNCashUnderwritingDiscountPerUnit_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNCashUnderwritingDiscountPerUnit_380" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_CashUnderwritingDiscount" xlink:label="loc_BOWNCashUnderwritingDiscount_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNCashUnderwritingDiscount_380" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaapPaymentsForUnderwritingExpense_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForUnderwritingExpense_380" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_380" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_380" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_380" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_380" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees_380" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction_380" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AffiliateCosts" xlink:label="loc_us-gaapAffiliateCosts_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAffiliateCosts_380" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdministrativeFeesExpense" xlink:label="loc_us-gaapAdministrativeFeesExpense_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdministrativeFeesExpense_380" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt_380" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForAdministrativeFees" xlink:label="loc_us-gaapPaymentForAdministrativeFees_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentForAdministrativeFees_380" xlink:type="arc" order="22" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000031 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_BusinessCombinationMarketingAgreementMember" xlink:label="loc_BOWNBusinessCombinationMarketingAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_BOWNBusinessCombinationMarketingAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_QianzhiMember" xlink:label="loc_BOWNQianzhiMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_BOWNQianzhiMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaapBusinessCombinationAcquisitionRelatedCosts_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessCombinationAcquisitionRelatedCosts_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PercentageOfGrossProceedsOfInitialPublicOffering" xlink:label="loc_BOWNPercentageOfGrossProceedsOfInitialPublicOffering_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_BOWNPercentageOfGrossProceedsOfInitialPublicOffering_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable" xlink:label="loc_BOWNPercentageOfServiceFeeOfTotalConsiderationPayable_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_BOWNPercentageOfServiceFeeOfTotalConsiderationPayable_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed" xlink:label="loc_BOWNBusinessCombinationAcquisitionRelatedCostsReimbursed_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_BOWNBusinessCombinationAcquisitionRelatedCostsReimbursed_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOtherReceivablesNetCurrent_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ServiceFee" xlink:label="loc_BOWNServiceFee_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_BOWNServiceFee_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapAccountsPayableCurrent_100" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000032 - Disclosure - SHAREHOLDERS&#8217; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SponsorsMember" xlink:label="loc_BOWNSponsorsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_BOWNSponsorsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockVotingRights_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OrdinarySharesSubjectToRedemption" xlink:label="loc_BOWNOrdinarySharesSubjectToRedemption_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_BOWNOrdinarySharesSubjectToRedemption_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockVotingRights" xlink:label="loc_us-gaapPreferredStockVotingRights_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockVotingRights_90" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails" xlink:title="00000033 - Disclosure - SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent_60" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails" xlink:title="00000034 - Disclosure - SCHEDULE FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="loc_srtPlatformOperatorCryptoAssetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ExpectedLikelihoodSuccessfulBusinessCombination" xlink:label="loc_BOWNExpectedLikelihoodSuccessfulBusinessCombination_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_BOWNExpectedLikelihoodSuccessfulBusinessCombination_20" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_QianzhiMember" xlink:label="loc_BOWNQianzhiMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_BOWNQianzhiMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_MergerSharesMember" xlink:label="loc_BOWNMergerSharesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_BOWNMergerSharesMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EarnoutSharesMember" xlink:label="loc_BOWNEarnoutSharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_BOWNEarnoutSharesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AgreementMember" xlink:label="loc_BOWNAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_BOWNAgreementMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed" xlink:label="loc_BOWNBusinessCombinationAcquisitionRelatedCostsReimbursed_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_BOWNBusinessCombinationAcquisitionRelatedCostsReimbursed_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>39
<FILENAME>bown-20240630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="us-gaap_NonrelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonrelatedPartyMember" xlink:to="us-gaap_NonrelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonrelatedPartyMember_lbl" xml:lang="en-US">Nonrelated Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyMember_lbl" xml:lang="en-US">Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_RedeemableOrdinarySharesMember" xlink:label="BOWN_RedeemableOrdinarySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_RedeemableOrdinarySharesMember" xlink:to="BOWN_RedeemableOrdinarySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_RedeemableOrdinarySharesMember_lbl" xml:lang="en-US">Redeemable Ordinary Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NonRedeemableOrdinarySharesMember" xlink:label="BOWN_NonRedeemableOrdinarySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NonRedeemableOrdinarySharesMember" xlink:to="BOWN_NonRedeemableOrdinarySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_NonRedeemableOrdinarySharesMember_lbl" xml:lang="en-US">Non Redeemable Ordinary Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_MergerSharesMember" xlink:label="BOWN_MergerSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_MergerSharesMember" xlink:to="BOWN_MergerSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_MergerSharesMember_lbl" xml:lang="en-US">Merger Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AgreementMember" xlink:label="BOWN_AgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AgreementMember" xlink:to="BOWN_AgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_AgreementMember_lbl" xml:lang="en-US">Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EarnoutSharesMember" xlink:label="BOWN_EarnoutSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_EarnoutSharesMember" xlink:to="BOWN_EarnoutSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_EarnoutSharesMember_lbl" xml:lang="en-US">Earnout Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ShenzhenQianzhiMember" xlink:label="BOWN_ShenzhenQianzhiMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ShenzhenQianzhiMember" xlink:to="BOWN_ShenzhenQianzhiMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_ShenzhenQianzhiMember_lbl" xml:lang="en-US">Shenzhen Qianzhi [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashMember" xlink:label="us-gaap_CashMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashMember" xlink:to="us-gaap_CashMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashMember_lbl" xml:lang="en-US">Cash [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xml:lang="en-US">US Treasury Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_RedeemableSharesMember" xlink:label="BOWN_RedeemableSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_RedeemableSharesMember" xlink:to="BOWN_RedeemableSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_RedeemableSharesMember_lbl" xml:lang="en-US">Redeemable Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NonRedeemableSharesMember" xlink:label="BOWN_NonRedeemableSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NonRedeemableSharesMember" xlink:to="BOWN_NonRedeemableSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_NonRedeemableSharesMember_lbl" xml:lang="en-US">Non Redeemable Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SponsorsMember" xlink:label="BOWN_SponsorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_SponsorsMember" xlink:to="BOWN_SponsorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_SponsorsMember_lbl" xml:lang="en-US">Sponsors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EBCMember" xlink:label="BOWN_EBCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_EBCMember" xlink:to="BOWN_EBCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_EBCMember_lbl" xml:lang="en-US">EBC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_UnderwritersMember" xlink:label="BOWN_UnderwritersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_UnderwritersMember" xlink:to="BOWN_UnderwritersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_UnderwritersMember_lbl" xml:lang="en-US">Underwriters [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PromissoryNoteMember" xlink:label="BOWN_PromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PromissoryNoteMember" xlink:to="BOWN_PromissoryNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_PromissoryNoteMember_lbl" xml:lang="en-US">Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_TenXGlobalCapitalMember" xlink:label="BOWN_TenXGlobalCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_TenXGlobalCapitalMember" xlink:to="BOWN_TenXGlobalCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_TenXGlobalCapitalMember_lbl" xml:lang="en-US">Ten X Global Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccountingServiceAgreementMember" xlink:label="BOWN_AccountingServiceAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AccountingServiceAgreementMember" xlink:to="BOWN_AccountingServiceAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_AccountingServiceAgreementMember_lbl" xml:lang="en-US">Accounting Service Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccountingServicesExpenseMember" xlink:label="BOWN_AccountingServicesExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AccountingServicesExpenseMember" xlink:to="BOWN_AccountingServicesExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_AccountingServicesExpenseMember_lbl" xml:lang="en-US">Accounting Services Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember" xlink:label="BOWN_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember" xlink:to="BOWN_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember_lbl" xml:lang="en-US">Measurement Input Probability Of Completion Of Business Combination [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_BusinessCombinationMarketingAgreementMember" xlink:label="BOWN_BusinessCombinationMarketingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_BusinessCombinationMarketingAgreementMember" xlink:to="BOWN_BusinessCombinationMarketingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_BusinessCombinationMarketingAgreementMember_lbl" xml:lang="en-US">Business Combination Marketing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_QianzhiMember" xlink:label="BOWN_QianzhiMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_QianzhiMember" xlink:to="BOWN_QianzhiMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_QianzhiMember_lbl" xml:lang="en-US">Qianzhi [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Defined Benefit Plan [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US">Other receivable (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xml:lang="en-US">Investments held in trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US">Ordinary shares subject to possible redemption (6,900,000 shares at $10.35 per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders&#8217; Equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 2,266,500 shares issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained Earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Shareholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Shareholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OrdinarySharesSubjectToRedemption" xlink:label="BOWN_OrdinarySharesSubjectToRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OrdinarySharesSubjectToRedemption" xlink:to="BOWN_OrdinarySharesSubjectToRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_OrdinarySharesSubjectToRedemption_lbl" xml:lang="en-US">Ordinary shares subject to redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US">Ordinary shares subject to redemption par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Ordinary shares, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Ordinary stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Ordinary stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Ordinary stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Formation and operating costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Interest earned on investments held in trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic weighted average ordinary shares outstanding, non-redeemable ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted weighted average ordinary shares outstanding, non-redeemable ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic net loss per share, non-redeemable ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net loss per share, non-redeemable ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xml:lang="en-US">Ordinary shares subject to forfeiture</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" xlink:label="BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" xlink:to="BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount_lbl" xml:lang="en-US">Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Ordinary shares issued to underwriter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Ordinary shares issued to underwriter, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Issuance of ordinary shares to Sponsors</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Issuance of ordinary shares to Sponsor, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueToUnderwriter" xlink:label="BOWN_StockIssuedDuringPeriodValueToUnderwriter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodValueToUnderwriter" xlink:to="BOWN_StockIssuedDuringPeriodValueToUnderwriter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_StockIssuedDuringPeriodValueToUnderwriter_lbl" xml:lang="en-US">Issuance of ordinary shares to Underwriter</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesToUnderwriter" xlink:label="BOWN_StockIssuedDuringPeriodSharesToUnderwriter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodSharesToUnderwriter" xlink:to="BOWN_StockIssuedDuringPeriodSharesToUnderwriter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_StockIssuedDuringPeriodSharesToUnderwriter_lbl" xml:lang="en-US">Issuance of ordinary shares to Underwriter, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits" xlink:label="BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits" xlink:to="BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits_lbl" xml:lang="en-US">Proceeds from sale of public units</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits" xlink:label="BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits" xlink:to="BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits_lbl" xml:lang="en-US">Proceeds from sale of public units, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment" xlink:label="BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment" xlink:to="BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment_lbl" xml:lang="en-US">Proceeds from over-allotment</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment" xlink:label="BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment" xlink:to="BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment_lbl" xml:lang="en-US">Proceeds from over-allotment, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits" xlink:label="BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits" xlink:to="BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits_lbl" xml:lang="en-US">Sale of Private Units</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits" xlink:label="BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits" xlink:to="BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits_lbl" xml:lang="en-US">Sale of Private Units, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits" xlink:label="BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits" xlink:to="BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits_lbl" xml:lang="en-US">Over-allotment of Private Units</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits" xlink:label="BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits" xlink:to="BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits_lbl" xml:lang="en-US">Over-allotment of Private Units, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits" xlink:label="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits" xlink:to="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits_lbl" xml:lang="en-US">Underwriter&#8217;s commission on sale of Public Units</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment" xlink:label="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment" xlink:to="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment_lbl" xml:lang="en-US">Underwriter&#8217;s commission on Over-allotment</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts" xlink:label="BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts" xlink:to="BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts_lbl" xml:lang="en-US">Other offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" xlink:label="BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" xlink:to="BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_lbl" xml:lang="en-US">Allocation of offering costs to ordinary shares subject to redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock_lbl" xml:lang="en-US">Deduction for increase of carrying value of redeemable shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xml:lang="en-US">Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustment to reconcile net loss to net cash used in operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xml:lang="en-US">Interest reinvested held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in current assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses" xlink:label="BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses" xlink:to="BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses_lbl" xml:lang="en-US">Accrued offering costs and expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireOtherInvestments" xlink:label="us-gaap_PaymentsToAcquireOtherInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="us-gaap_PaymentsToAcquireOtherInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireOtherInvestments_lbl" xml:lang="en-US">Investments of cash into Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ProceedsFromIssuanceOfFounderShares" xlink:label="BOWN_ProceedsFromIssuanceOfFounderShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ProceedsFromIssuanceOfFounderShares" xlink:to="BOWN_ProceedsFromIssuanceOfFounderShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_ProceedsFromIssuanceOfFounderShares_lbl" xml:lang="en-US">Proceeds from issuance of founder shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from sale of ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Proceeds from Private Placement</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PaymentsOfUnderwritersDiscount" xlink:label="BOWN_PaymentsOfUnderwritersDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PaymentsOfUnderwritersDiscount" xlink:to="BOWN_PaymentsOfUnderwritersDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="BOWN_PaymentsOfUnderwritersDiscount_lbl" xml:lang="en-US">Payments of underwriter&#8217;s discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Payments to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PaymentOfOfferingCosts" xlink:label="BOWN_PaymentOfOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PaymentOfOfferingCosts" xlink:to="BOWN_PaymentOfOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="BOWN_PaymentOfOfferingCosts_lbl" xml:lang="en-US">Payment of offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net change in cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash at beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash at the end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental disclosure of noncash financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:label="BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:to="BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_lbl" xml:lang="en-US">Offering costs paid by Sponsor in exchange for issuance of ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital" xlink:label="BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital" xlink:to="BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital_lbl" xml:lang="en-US">Offering costs charged to Additional Paid-in Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption" xlink:label="BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption" xlink:to="BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption_lbl" xml:lang="en-US">Reclassification of ordinary shares subject to redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" xlink:label="BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" xlink:to="BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_lbl" xml:lang="en-US">Allocation of offering costs to ordinary shares subject to redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption" xlink:label="BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption" xlink:to="BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption_lbl" xml:lang="en-US">Remeasurement adjustment on ordinary shares subject to possible redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" xlink:label="BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" xlink:to="BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_lbl" xml:lang="en-US">Subsequent measurement of ordinary shares subject to possible redemption (income earned on Trust Account)</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DeferredOfferingCostsPaidByRelatedParty" xlink:label="BOWN_DeferredOfferingCostsPaidByRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_DeferredOfferingCostsPaidByRelatedParty" xlink:to="BOWN_DeferredOfferingCostsPaidByRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_DeferredOfferingCostsPaidByRelatedParty_lbl" xml:lang="en-US">Offering costs paid by related party</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PrepaidExpensesPaidByRelatedParty" xlink:label="BOWN_PrepaidExpensesPaidByRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PrepaidExpensesPaidByRelatedParty" xlink:to="BOWN_PrepaidExpensesPaidByRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_PrepaidExpensesPaidByRelatedParty_lbl" xml:lang="en-US">Prepaid expenses paid by related party</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses" xlink:label="BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses" xlink:to="BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses_lbl" xml:lang="en-US">Offering costs adjusted from prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DeferredOfferingCostsIncludedInAccruedExpenses" xlink:label="BOWN_DeferredOfferingCostsIncludedInAccruedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_DeferredOfferingCostsIncludedInAccruedExpenses" xlink:to="BOWN_DeferredOfferingCostsIncludedInAccruedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_DeferredOfferingCostsIncludedInAccruedExpenses_lbl" xml:lang="en-US">Offering costs included in accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:label="BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:to="BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_lbl" xml:lang="en-US">Offering costs paid by Sponsor in exchange for issuance of ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OfferingCostsChargedToAPICFounderShares" xlink:label="BOWN_OfferingCostsChargedToAPICFounderShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OfferingCostsChargedToAPICFounderShares" xlink:to="BOWN_OfferingCostsChargedToAPICFounderShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_OfferingCostsChargedToAPICFounderShares_lbl" xml:lang="en-US">Offering costs charged to APIC &#8211; EBC founder shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">ORGANIZATION AND BUSINESS OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DisclosureInitialPublicOfferingAbstract" xlink:label="BOWN_DisclosureInitialPublicOfferingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_DisclosureInitialPublicOfferingAbstract" xlink:to="BOWN_DisclosureInitialPublicOfferingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_DisclosureInitialPublicOfferingAbstract_lbl" xml:lang="en-US">Initial Public Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InitialPublicOfferingTextBlock" xlink:label="BOWN_InitialPublicOfferingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_InitialPublicOfferingTextBlock" xlink:to="BOWN_InitialPublicOfferingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_InitialPublicOfferingTextBlock_lbl" xml:lang="en-US">INITIAL PUBLIC OFFERING</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DisclosurePrivatePlacementsAbstract" xlink:label="BOWN_DisclosurePrivatePlacementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_DisclosurePrivatePlacementsAbstract" xlink:to="BOWN_DisclosurePrivatePlacementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_DisclosurePrivatePlacementsAbstract_lbl" xml:lang="en-US">Private Placements</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PrivatePlacementsTextBlock" xlink:label="BOWN_PrivatePlacementsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PrivatePlacementsTextBlock" xlink:to="BOWN_PrivatePlacementsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_PrivatePlacementsTextBlock_lbl" xml:lang="en-US">PRIVATE PLACEMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation and Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EmergingGrowthCompanyPolicyTextBlock" xlink:label="BOWN_EmergingGrowthCompanyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_EmergingGrowthCompanyPolicyTextBlock" xlink:to="BOWN_EmergingGrowthCompanyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_EmergingGrowthCompanyPolicyTextBlock_lbl" xml:lang="en-US">Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investments Held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OfferingCostsPolicyTextBlock" xlink:label="BOWN_OfferingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OfferingCostsPolicyTextBlock" xlink:to="BOWN_OfferingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_OfferingCostsPolicyTextBlock_lbl" xml:lang="en-US">Offering Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Income (Loss) per Ordinary Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl" xml:lang="en-US">Ordinary Shares Subject to Possible Redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock" xlink:label="BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock" xlink:to="BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock" xlink:label="BOWN_ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock" xlink:to="BOWN_ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock_lbl" xml:lang="en-US">SCHEDULE FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Number of stock issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Proceeds from issuance of IPO</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2_lbl" xml:lang="en-US">Proceeds from issuance of private placement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Number of units sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Proceeds from sale of units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Transaction cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="us-gaap_PaymentsForUnderwritingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForUnderwritingExpense" xlink:to="us-gaap_PaymentsForUnderwritingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForUnderwritingExpense_lbl" xml:lang="en-US">Payments for underwriting expense</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OtherOfferingCosts" xlink:label="BOWN_OtherOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OtherOfferingCosts" xlink:to="BOWN_OtherOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="BOWN_OtherOfferingCosts_lbl" xml:lang="en-US">Other offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_WorkingCapitalDeficit" xlink:label="BOWN_WorkingCapitalDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_WorkingCapitalDeficit" xlink:to="BOWN_WorkingCapitalDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_WorkingCapitalDeficit_lbl" xml:lang="en-US">Working capital deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherReceivablesNetCurrent_2_lbl" xml:lang="en-US">Due from related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Deposits" xlink:label="us-gaap_Deposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Deposits" xlink:to="us-gaap_Deposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Deposits_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Shares issued price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccretionOfTemporaryEquityIntoRedemptionValue" xlink:label="BOWN_AccretionOfTemporaryEquityIntoRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AccretionOfTemporaryEquityIntoRedemptionValue" xlink:to="BOWN_AccretionOfTemporaryEquityIntoRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="BOWN_AccretionOfTemporaryEquityIntoRedemptionValue_lbl" xml:lang="en-US">Accretion of temporary equity into redemption value</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue" xlink:label="BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue" xlink:to="BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue_lbl" xml:lang="en-US">Net loss including accretion of equity into redemption value</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InterestEarnedOnInvestmentHeldInTrustAccount" xlink:label="BOWN_InterestEarnedOnInvestmentHeldInTrustAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_InterestEarnedOnInvestmentHeldInTrustAccount" xlink:to="BOWN_InterestEarnedOnInvestmentHeldInTrustAccount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="BOWN_InterestEarnedOnInvestmentHeldInTrustAccount_lbl" xml:lang="en-US">Interest earned on investment held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue" xlink:label="BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue" xlink:to="BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue_lbl" xml:lang="en-US">Net loss including accretion of common stock to redemption value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted average shares outstanding - basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Weighted average shares outstanding - diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OwnershipPercentage" xlink:label="BOWN_OwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OwnershipPercentage" xlink:to="BOWN_OwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_OwnershipPercentage_lbl" xml:lang="en-US">Ownership percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity" xlink:label="BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity" xlink:to="BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity_lbl" xml:lang="en-US">Allocation of net loss including accretion of temporary equity</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount" xlink:label="BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount" xlink:to="BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount_lbl" xml:lang="en-US">Interest earned on investment held in trust account</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Allocation of net income/(loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Basic net income/(loss) per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted net income/(loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_IncomeEarnedOnTrustAccount" xlink:label="BOWN_IncomeEarnedOnTrustAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_IncomeEarnedOnTrustAccount" xlink:to="BOWN_IncomeEarnedOnTrustAccount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="BOWN_IncomeEarnedOnTrustAccount_lbl" xml:lang="en-US">Income earned on Trust Account</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AccretionOfTemporaryEquityIntoRedemptionValue" xlink:to="BOWN_AccretionOfTemporaryEquityIntoRedemptionValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_AccretionOfTemporaryEquityIntoRedemptionValue_2_lbl" xml:lang="en-US">Accretion of temporary equity to redemption value</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AllocationOfNetIncomeloss" xlink:label="BOWN_AllocationOfNetIncomeloss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AllocationOfNetIncomeloss" xlink:to="BOWN_AllocationOfNetIncomeloss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_AllocationOfNetIncomeloss_lbl" xml:lang="en-US">Allocation of net income/(loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_2_lbl" xml:lang="en-US">Proceeds allocated to public rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Proceeds allocated to Public Rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfferingCostsPartnershipInterests" xlink:label="us-gaap_OfferingCostsPartnershipInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfferingCostsPartnershipInterests" xlink:to="us-gaap_OfferingCostsPartnershipInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OfferingCostsPartnershipInterests_lbl" xml:lang="en-US">Allocation of offering costs related to redeemable shares</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccretionOfCarryingValueToRedemptionValue" xlink:label="BOWN_AccretionOfCarryingValueToRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AccretionOfCarryingValueToRedemptionValue" xlink:to="BOWN_AccretionOfCarryingValueToRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_AccretionOfCarryingValueToRedemptionValue_lbl" xml:lang="en-US">Accretion of carrying value to redemption value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl" xml:lang="en-US">Gross proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="us-gaap_ProceedsFromOtherEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromOtherEquity" xlink:to="us-gaap_ProceedsFromOtherEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl" xml:lang="en-US">Over-allotment proceeds</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" xlink:to="BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_2_lbl" xml:lang="en-US">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_2_lbl" xml:lang="en-US">Ordinary shares subject to possible redemption</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Proceeds allocated to Public Rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLegalSettlements" xlink:label="us-gaap_ProceedsFromLegalSettlements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLegalSettlements" xlink:to="us-gaap_ProceedsFromLegalSettlements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromLegalSettlements_lbl" xml:lang="en-US">Over-allotment proceeds</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_3_lbl" xml:lang="en-US">Ordinary shares subject to possible redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NoncashOfferingCostsPaidByRelatedParty" xlink:label="BOWN_NoncashOfferingCostsPaidByRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NoncashOfferingCostsPaidByRelatedParty" xlink:to="BOWN_NoncashOfferingCostsPaidByRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="BOWN_NoncashOfferingCostsPaidByRelatedParty_lbl" xml:lang="en-US">Offering costs paid by related party</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NoncashPrepaidExpensesPaidByRelatedParty" xlink:label="BOWN_NoncashPrepaidExpensesPaidByRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NoncashPrepaidExpensesPaidByRelatedParty" xlink:to="BOWN_NoncashPrepaidExpensesPaidByRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="BOWN_NoncashPrepaidExpensesPaidByRelatedParty_lbl" xml:lang="en-US">Prepaid expenses paid by related party</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NoncashOfferingCostsIncludedInAccruedExpenses" xlink:label="BOWN_NoncashOfferingCostsIncludedInAccruedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NoncashOfferingCostsIncludedInAccruedExpenses" xlink:to="BOWN_NoncashOfferingCostsIncludedInAccruedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="BOWN_NoncashOfferingCostsIncludedInAccruedExpenses_lbl" xml:lang="en-US">Offering costs included in accrued expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital" xlink:to="BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital_2_lbl" xml:lang="en-US">Offering costs charged to APIC &#8211; EBC founder shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:to="us-gaap_ScheduleOfCashAndCashEquivalentsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTable_lbl" xml:lang="en-US">Cash and Cash Equivalent [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsLineItems" xlink:label="us-gaap_CashAndCashEquivalentsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsLineItems_lbl" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_2_lbl" xml:lang="en-US">Trust account, cash balance, with U.S. treasury bills</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount" xlink:to="BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount_2_lbl" xml:lang="en-US">Interest and dividend income earned from trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Unrecognized tax benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xml:lang="en-US">Accrued for interest and penalties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">Cash, FDIC insured amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldInTrust" xlink:label="us-gaap_AssetsHeldInTrust" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrust" xlink:to="us-gaap_AssetsHeldInTrust_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrust_lbl" xml:lang="en-US">Trust account, cash balance</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InterestsEarnedFromTrustAccount" xlink:label="BOWN_InterestsEarnedFromTrustAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_InterestsEarnedFromTrustAccount" xlink:to="BOWN_InterestsEarnedFromTrustAccount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_InterestsEarnedFromTrustAccount_lbl" xml:lang="en-US">Interests earned from trust account</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Stock issued during period shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_2_lbl" xml:lang="en-US">Sale of stock, par share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockDescriptionOfTransaction" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xml:lang="en-US">Stock holders equity related to initial public offering description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xml:lang="en-US">Stock issued during the period, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Private placement units of underwriters over-allotment per share price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xml:lang="en-US">Value of stock issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockDescriptionOfTransaction" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction_2_lbl" xml:lang="en-US">Units related to private placement description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="srt_PlatformOperatorCryptoAssetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_PlatformOperatorCryptoAssetTable" xlink:to="srt_PlatformOperatorCryptoAssetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_PlatformOperatorCryptoAssetTable_lbl" xml:lang="en-US">Platform Operator, Crypto Asset [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="srt_PlatformOperatorCryptoAssetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_PlatformOperatorCryptoAssetLineItems" xlink:to="srt_PlatformOperatorCryptoAssetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_PlatformOperatorCryptoAssetLineItems_lbl" xml:lang="en-US">Platform Operator, Crypto Asset [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EquitySecuritiesFvNiTerm" xlink:label="BOWN_EquitySecuritiesFvNiTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_EquitySecuritiesFvNiTerm" xlink:to="BOWN_EquitySecuritiesFvNiTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_EquitySecuritiesFvNiTerm_lbl" xml:lang="en-US">Time to expiration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiMeasurementInput" xlink:label="us-gaap_EquitySecuritiesFvNiMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiMeasurementInput" xlink:to="us-gaap_EquitySecuritiesFvNiMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesFvNiMeasurementInput_lbl" xml:lang="en-US">Founder shares measurement input</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_2_lbl" xml:lang="en-US">Number of shares subject to forfeiture</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_3_lbl" xml:lang="en-US">Ordinary share price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_lbl" xml:lang="en-US">Fair value of shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Fair value of ordinary per share price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Promissory note aggregate principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Promissory note maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Notes outstanding amount</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_CashUnderwritingDiscountPerUnit" xlink:label="BOWN_CashUnderwritingDiscountPerUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_CashUnderwritingDiscountPerUnit" xlink:to="BOWN_CashUnderwritingDiscountPerUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_CashUnderwritingDiscountPerUnit_lbl" xml:lang="en-US">Cash underwriting discount per unit</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_CashUnderwritingDiscount" xlink:label="BOWN_CashUnderwritingDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_CashUnderwritingDiscount" xlink:to="BOWN_CashUnderwritingDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_CashUnderwritingDiscount_lbl" xml:lang="en-US">Aggregate cash underwriting discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2_lbl" xml:lang="en-US">Gross proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Due to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Service fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xml:lang="en-US">Payment for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AffiliateCosts" xlink:label="us-gaap_AffiliateCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AffiliateCosts" xlink:to="us-gaap_AffiliateCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AffiliateCosts_lbl" xml:lang="en-US">Affiliate costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdministrativeFeesExpense" xlink:label="us-gaap_AdministrativeFeesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdministrativeFeesExpense" xlink:to="us-gaap_AdministrativeFeesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdministrativeFeesExpense_lbl" xml:lang="en-US">Administrative fee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xml:lang="en-US">Related party debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForAdministrativeFees" xlink:label="us-gaap_PaymentForAdministrativeFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentForAdministrativeFees" xlink:to="us-gaap_PaymentForAdministrativeFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentForAdministrativeFees_lbl" xml:lang="en-US">Administrative fees paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xml:lang="en-US">Business combination related cost</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PercentageOfGrossProceedsOfInitialPublicOffering" xlink:label="BOWN_PercentageOfGrossProceedsOfInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PercentageOfGrossProceedsOfInitialPublicOffering" xlink:to="BOWN_PercentageOfGrossProceedsOfInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_PercentageOfGrossProceedsOfInitialPublicOffering_lbl" xml:lang="en-US">Percentage of gross proceeds of initial public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable" xlink:label="BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable" xlink:to="BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable_lbl" xml:lang="en-US">Percentage of service fee of total consideration payable</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed" xlink:label="BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed" xlink:to="BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed_lbl" xml:lang="en-US">Business combination related cost reimbursed</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherReceivablesNetCurrent_3_lbl" xml:lang="en-US">Other receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ServiceFee" xlink:label="BOWN_ServiceFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ServiceFee" xlink:to="BOWN_ServiceFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="BOWN_ServiceFee_lbl" xml:lang="en-US">Service fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Commited for future expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_2_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US">Common stock voting rights</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_2_lbl" xml:lang="en-US">Ordinary shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Ordinary shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockVotingRights" xlink:label="us-gaap_PreferredStockVotingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockVotingRights" xlink:to="us-gaap_PreferredStockVotingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockVotingRights_lbl" xml:lang="en-US">Preferred stock voting rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_3_lbl" xml:lang="en-US">Investment held in trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Time to expiration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Volatility rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ExpectedLikelihoodSuccessfulBusinessCombination" xlink:label="BOWN_ExpectedLikelihoodSuccessfulBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ExpectedLikelihoodSuccessfulBusinessCombination" xlink:to="BOWN_ExpectedLikelihoodSuccessfulBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_ExpectedLikelihoodSuccessfulBusinessCombination_lbl" xml:lang="en-US">Expected likelihood of a successful business combination, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_RightsEachEntitlingHolderToOnetenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember" xlink:label="BOWN_RightsEachEntitlingHolderToOnetenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_RightsEachEntitlingHolderToOnetenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember" xlink:to="BOWN_RightsEachEntitlingHolderToOnetenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_RightsEachEntitlingHolderToOnetenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember_doc" xml:lang="en-US">Rights each entitling the holder to one tenth of one ordinary share upon the completion of the Company&#8217;s initial business combination.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OrdinarySharesParValue0.0001PerShareMember" xlink:label="BOWN_OrdinarySharesParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OrdinarySharesParValue0.0001PerShareMember" xlink:to="BOWN_OrdinarySharesParValue0.0001PerShareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OrdinarySharesParValue0.0001PerShareMember_doc" xml:lang="en-US">Ordinary Shares par value $0.0001 per share.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember" xlink:label="BOWN_UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember" xlink:to="BOWN_UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember_doc" xml:lang="en-US">Units each consisting of one ordinary share and one right.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OrdinarySharesSubjectToRedemption" xlink:to="BOWN_OrdinarySharesSubjectToRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OrdinarySharesSubjectToRedemption_doc" xml:lang="en-US">Ordinary shares subject to redemption.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InterestAndDividendEarnedOnMarketableSecuritiesHeldInTrustAccount" xlink:label="BOWN_InterestAndDividendEarnedOnMarketableSecuritiesHeldInTrustAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_InterestAndDividendEarnedOnMarketableSecuritiesHeldInTrustAccount" xlink:to="BOWN_InterestAndDividendEarnedOnMarketableSecuritiesHeldInTrustAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_InterestAndDividendEarnedOnMarketableSecuritiesHeldInTrustAccount_doc" xml:lang="en-US">Interest and dividend earned on marketable securities held in trust account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_RedeemableOrdinarySharesMember" xlink:to="BOWN_RedeemableOrdinarySharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_RedeemableOrdinarySharesMember_doc" xml:lang="en-US">Redeemable Ordinary Shares [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NonRedeemableOrdinarySharesMember" xlink:to="BOWN_NonRedeemableOrdinarySharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_NonRedeemableOrdinarySharesMember_doc" xml:lang="en-US">Non Redeemable Ordinary Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_IncomeEarnedOnInvestmentHeldInTrustAccount" xlink:label="BOWN_IncomeEarnedOnInvestmentHeldInTrustAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_IncomeEarnedOnInvestmentHeldInTrustAccount" xlink:to="BOWN_IncomeEarnedOnInvestmentHeldInTrustAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_IncomeEarnedOnInvestmentHeldInTrustAccount_doc" xml:lang="en-US">Income earned on investment held in Trust Account.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccruedOfferingCostsAndExpenses" xlink:label="BOWN_AccruedOfferingCostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AccruedOfferingCostsAndExpenses" xlink:to="BOWN_AccruedOfferingCostsAndExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AccruedOfferingCostsAndExpenses_doc" xml:lang="en-US">Accrued offering costs and expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ProceedsFromIssuanceOfFounderShares" xlink:to="BOWN_ProceedsFromIssuanceOfFounderShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ProceedsFromIssuanceOfFounderShares_doc" xml:lang="en-US">Proceeds from issuance of founder shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PaymentOfOfferingCosts" xlink:to="BOWN_PaymentOfOfferingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_PaymentOfOfferingCosts_doc" xml:lang="en-US">Payment of offering costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:to="BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_doc" xml:lang="en-US">Offering costs paid by Sponsor in exchange for issuance of ordinary shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses" xlink:to="BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses_doc" xml:lang="en-US">Offering costs adjusted from prepaid expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital" xlink:to="BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital_doc" xml:lang="en-US">Offering costs charged to Additional Paid-in Capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption" xlink:to="BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption_doc" xml:lang="en-US">Reclassification of ordinary shares subject to redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" xlink:to="BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_doc" xml:lang="en-US">Allocation of offering costs to ordinary shares subject to redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption" xlink:to="BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption_doc" xml:lang="en-US">Remeasurement adjustment on ordinary shares subject to possible redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" xlink:to="BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_doc" xml:lang="en-US">Subsequent measurement of ordinary shares subject to possible redemption (income earned on Trust Account).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PaymentsOfUnderwritersDiscount" xlink:to="BOWN_PaymentsOfUnderwritersDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_PaymentsOfUnderwritersDiscount_doc" xml:lang="en-US">Payments of underwriter&#8217;s discount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodValueToUnderwriter" xlink:to="BOWN_StockIssuedDuringPeriodValueToUnderwriter_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_StockIssuedDuringPeriodValueToUnderwriter_doc" xml:lang="en-US">Stock issued during period value Issuance of ordinary shares to underwriter.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits" xlink:to="BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits_doc" xml:lang="en-US">Stock issued during period value proceeds from sale of public units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment" xlink:to="BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment_doc" xml:lang="en-US">Stock issued during period value proceeds from over-allotment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits" xlink:to="BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits_doc" xml:lang="en-US">Stock issued during period value sale of private units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits" xlink:to="BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits_doc" xml:lang="en-US">Stock issued during period value over-allotment of Private Units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts" xlink:to="BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts_doc" xml:lang="en-US">Adjustments to additional paid in capital underwriter&#8217;s commission on sale of Public Units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" xlink:to="BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_doc" xml:lang="en-US">Adjustments to additional paid in capital allocation of offering costs to ordinary shares subject to redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodSharesToUnderwriter" xlink:to="BOWN_StockIssuedDuringPeriodSharesToUnderwriter_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_StockIssuedDuringPeriodSharesToUnderwriter_doc" xml:lang="en-US">Number of stock issued during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits" xlink:to="BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits_doc" xml:lang="en-US">Stock issued during period shares proceeds from sale of public units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment" xlink:to="BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment_doc" xml:lang="en-US">Stock issued during period shares proceeds from overallotment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits" xlink:to="BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits_doc" xml:lang="en-US">Stock issued during period shares sale of private units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits" xlink:to="BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits_doc" xml:lang="en-US">Stock issued during period shares overallotment of private units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits" xlink:to="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits_doc" xml:lang="en-US">Adjustments to additional paid in capital underwriters commission on sale of public units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment" xlink:to="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment_doc" xml:lang="en-US">Adjustments to additional paid in capital underwriters commission on overallotment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OtherOfferingCosts" xlink:to="BOWN_OtherOfferingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OtherOfferingCosts_doc" xml:lang="en-US">Other offering costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_WorkingCapitalDeficit" xlink:to="BOWN_WorkingCapitalDeficit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_WorkingCapitalDeficit_doc" xml:lang="en-US">Working capital deficit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_EmergingGrowthCompanyPolicyTextBlock" xlink:to="BOWN_EmergingGrowthCompanyPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_EmergingGrowthCompanyPolicyTextBlock_doc" xml:lang="en-US">Emerging Growth Company [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_InterestsEarnedFromTrustAccount" xlink:to="BOWN_InterestsEarnedFromTrustAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_InterestsEarnedFromTrustAccount_doc" xml:lang="en-US">Interests earned from trust account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OfferingCostsPolicyTextBlock" xlink:to="BOWN_OfferingCostsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OfferingCostsPolicyTextBlock_doc" xml:lang="en-US">Offering Costs [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_InterestEarnedOnInvestmentHeldInTrustAccount" xlink:to="BOWN_InterestEarnedOnInvestmentHeldInTrustAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_InterestEarnedOnInvestmentHeldInTrustAccount_doc" xml:lang="en-US">Interest earned on investment held in trust account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AccretionOfTemporaryEquityIntoRedemptionValue" xlink:to="BOWN_AccretionOfTemporaryEquityIntoRedemptionValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AccretionOfTemporaryEquityIntoRedemptionValue_doc" xml:lang="en-US">Accretion of temporary equity into redemption value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue" xlink:to="BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue_doc" xml:lang="en-US">Net loss including accretion of common stock to redemption value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OwnershipPercentage" xlink:to="BOWN_OwnershipPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OwnershipPercentage_doc" xml:lang="en-US">Ownership percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity" xlink:to="BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity_doc" xml:lang="en-US">Allocation of net loss including accretion of temporary equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_IncomeEarnedOnTrustAccount" xlink:to="BOWN_IncomeEarnedOnTrustAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_IncomeEarnedOnTrustAccount_doc" xml:lang="en-US">Income earned on trust account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AllocationOfNetIncomeloss" xlink:to="BOWN_AllocationOfNetIncomeloss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AllocationOfNetIncomeloss_doc" xml:lang="en-US">Allocation of net income loss.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock" xlink:to="BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_doc" xml:lang="en-US">Schedule of ordinary shares subject to possible redemption reflected in the balance sheet [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AccretionOfCarryingValueToRedemptionValue" xlink:to="BOWN_AccretionOfCarryingValueToRedemptionValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AccretionOfCarryingValueToRedemptionValue_doc" xml:lang="en-US">Accretion of carrying value to redemption value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_InitialPublicOfferingTextBlock" xlink:to="BOWN_InitialPublicOfferingTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_InitialPublicOfferingTextBlock_doc" xml:lang="en-US">Initial Public Offering [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PrivatePlacementsTextBlock" xlink:to="BOWN_PrivatePlacementsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_PrivatePlacementsTextBlock_doc" xml:lang="en-US">Private Placements [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_SponsorsMember" xlink:to="BOWN_SponsorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_SponsorsMember_doc" xml:lang="en-US">Sponsors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_EBCMember" xlink:to="BOWN_EBCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_EBCMember_doc" xml:lang="en-US">EBC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_UnderwritersMember" xlink:to="BOWN_UnderwritersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_UnderwritersMember_doc" xml:lang="en-US">Underwriters [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock" xlink:to="BOWN_ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock_doc" xml:lang="en-US">Schedule of fair value of early bird capital assumption estimate [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PromissoryNoteMember" xlink:to="BOWN_PromissoryNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_PromissoryNoteMember_doc" xml:lang="en-US">Promissory Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_CashUnderwritingDiscountPerUnit" xlink:to="BOWN_CashUnderwritingDiscountPerUnit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_CashUnderwritingDiscountPerUnit_doc" xml:lang="en-US">Cash underwriting discount per unit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_CashUnderwritingDiscount" xlink:to="BOWN_CashUnderwritingDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_CashUnderwritingDiscount_doc" xml:lang="en-US">Cash underwriting discount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_TenXGlobalCapitalMember" xlink:to="BOWN_TenXGlobalCapitalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_TenXGlobalCapitalMember_doc" xml:lang="en-US">Ten X Global Capital [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AccountingServiceAgreementMember" xlink:to="BOWN_AccountingServiceAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AccountingServiceAgreementMember_doc" xml:lang="en-US">Accounting Service Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ServiceFee" xlink:to="BOWN_ServiceFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ServiceFee_doc" xml:lang="en-US">Service fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_BusinessCombinationMarketingAgreementMember" xlink:to="BOWN_BusinessCombinationMarketingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_BusinessCombinationMarketingAgreementMember_doc" xml:lang="en-US">Business Combination Marketing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PercentageOfGrossProceedsOfIPO" xlink:label="BOWN_PercentageOfGrossProceedsOfIPO" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PercentageOfGrossProceedsOfIPO" xlink:to="BOWN_PercentageOfGrossProceedsOfIPO_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_PercentageOfGrossProceedsOfIPO_doc" xml:lang="en-US">Percentage of gross proceeds of ipo.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable" xlink:to="BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable_doc" xml:lang="en-US">Percentage of service fee of total consideration payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_MergerSharesMember" xlink:to="BOWN_MergerSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_MergerSharesMember_doc" xml:lang="en-US">Merger Shares [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_EarnoutSharesMember" xlink:to="BOWN_EarnoutSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_EarnoutSharesMember_doc" xml:lang="en-US">Earnout Shares [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PercentageOfGrossProceedsOfInitialPublicOffering" xlink:to="BOWN_PercentageOfGrossProceedsOfInitialPublicOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_PercentageOfGrossProceedsOfInitialPublicOffering_doc" xml:lang="en-US">Percentage of gross proceeds of initial public offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AgreementMember" xlink:to="BOWN_AgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AgreementMember_doc" xml:lang="en-US">Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_RedeemableSharesMember" xlink:to="BOWN_RedeemableSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_RedeemableSharesMember_doc" xml:lang="en-US">Redeemable Shares [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NonRedeemableSharesMember" xlink:to="BOWN_NonRedeemableSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_NonRedeemableSharesMember_doc" xml:lang="en-US">Non Redeemable Shares [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_QianzhiMember" xlink:to="BOWN_QianzhiMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_QianzhiMember_doc" xml:lang="en-US">Qianzhi [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AccountingServicesExpenseMember" xlink:to="BOWN_AccountingServicesExpenseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AccountingServicesExpenseMember_doc" xml:lang="en-US">Accounting Services Expense [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ExpectedLikelihoodSuccessfulBusinessCombination" xlink:to="BOWN_ExpectedLikelihoodSuccessfulBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ExpectedLikelihoodSuccessfulBusinessCombination_doc" xml:lang="en-US">Expected likelihood successful business combination</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount" xlink:to="BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount_doc" xml:lang="en-US">Interest earned on investments held in trust account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" xlink:to="BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount_doc" xml:lang="en-US">Subsequent measurement of common stock subject to possible redemption interest earned on trust account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses" xlink:to="BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses_doc" xml:lang="en-US">Increase decrease in accrued offering costs and expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_DeferredOfferingCostsPaidByRelatedParty" xlink:to="BOWN_DeferredOfferingCostsPaidByRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_DeferredOfferingCostsPaidByRelatedParty_doc" xml:lang="en-US">Deferred offering costs paid by related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PrepaidExpensesPaidByRelatedParty" xlink:to="BOWN_PrepaidExpensesPaidByRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_PrepaidExpensesPaidByRelatedParty_doc" xml:lang="en-US">Prepaid expenses paid by related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_DeferredOfferingCostsIncludedInAccruedExpenses" xlink:to="BOWN_DeferredOfferingCostsIncludedInAccruedExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_DeferredOfferingCostsIncludedInAccruedExpenses_doc" xml:lang="en-US">Deferred offering costs included in accrued expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:to="BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_doc" xml:lang="en-US">Deferred offering costs paid by sponsor in exchange for issuance of ordinary shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OfferingCostsChargedToAPICFounderShares" xlink:to="BOWN_OfferingCostsChargedToAPICFounderShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OfferingCostsChargedToAPICFounderShares_doc" xml:lang="en-US">Offering costs charged to APIC founder shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue" xlink:to="BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue_doc" xml:lang="en-US">Net loss including accretion of equity into redemption value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NoncashOfferingCostsPaidByRelatedParty" xlink:to="BOWN_NoncashOfferingCostsPaidByRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_NoncashOfferingCostsPaidByRelatedParty_doc" xml:lang="en-US">Noncash offering costs paid by related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NoncashPrepaidExpensesPaidByRelatedParty" xlink:to="BOWN_NoncashPrepaidExpensesPaidByRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_NoncashPrepaidExpensesPaidByRelatedParty_doc" xml:lang="en-US">Noncash prepaid expenses paid by related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NoncashOfferingCostsIncludedInAccruedExpenses" xlink:to="BOWN_NoncashOfferingCostsIncludedInAccruedExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_NoncashOfferingCostsIncludedInAccruedExpenses_doc" xml:lang="en-US">Noncash offering costs included in accrued expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_EquitySecuritiesFvNiTerm" xlink:to="BOWN_EquitySecuritiesFvNiTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_EquitySecuritiesFvNiTerm_doc" xml:lang="en-US">Equity securities FvNi term.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SuppliersMember" xlink:label="BOWN_SuppliersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_SuppliersMember" xlink:to="BOWN_SuppliersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_SuppliersMember_doc" xml:lang="en-US">Suppliers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdvanceToSuppliersTextBlock" xlink:label="BOWN_AdvanceToSuppliersTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdvanceToSuppliersTextBlock" xlink:to="BOWN_AdvanceToSuppliersTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AdvanceToSuppliersTextBlock_doc" xml:lang="en-US">Advance To Suppliers [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ScheduleOfAdvanceToSuppliersTableTextBlock" xlink:label="BOWN_ScheduleOfAdvanceToSuppliersTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ScheduleOfAdvanceToSuppliersTableTextBlock" xlink:to="BOWN_ScheduleOfAdvanceToSuppliersTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ScheduleOfAdvanceToSuppliersTableTextBlock_doc" xml:lang="en-US">Schedule Of Advance To Suppliers [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdvancesToSuppliersToPurchaseThirdpartyProducts" xlink:label="BOWN_AdvancesToSuppliersToPurchaseThirdpartyProducts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdvancesToSuppliersToPurchaseThirdpartyProducts" xlink:to="BOWN_AdvancesToSuppliersToPurchaseThirdpartyProducts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AdvancesToSuppliersToPurchaseThirdpartyProducts_doc" xml:lang="en-US">Advances to suppliers to purchase thirdparty products.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdvancesToSuppliersForRawMaterials" xlink:label="BOWN_AdvancesToSuppliersForRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdvancesToSuppliersForRawMaterials" xlink:to="BOWN_AdvancesToSuppliersForRawMaterials_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AdvancesToSuppliersForRawMaterials_doc" xml:lang="en-US">Advances to suppliers for raw materials.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OthersSupplies" xlink:label="BOWN_OthersSupplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OthersSupplies" xlink:to="BOWN_OthersSupplies_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OthersSupplies_doc" xml:lang="en-US">Others supplies.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdvancesToSupplersGross" xlink:label="BOWN_AdvancesToSupplersGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdvancesToSupplersGross" xlink:to="BOWN_AdvancesToSupplersGross_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AdvancesToSupplersGross_doc" xml:lang="en-US">Advances to supplers gross.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdvancesToSupplersNet" xlink:label="BOWN_AdvancesToSupplersNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdvancesToSupplersNet" xlink:to="BOWN_AdvancesToSupplersNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AdvancesToSupplersNet_doc" xml:lang="en-US">Advances to supplers net.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StatutoryReserve" xlink:label="BOWN_StatutoryReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StatutoryReserve" xlink:to="BOWN_StatutoryReserve_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_StatutoryReserve_doc" xml:lang="en-US">Statutory reserve.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PromotionCost" xlink:label="BOWN_PromotionCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PromotionCost" xlink:to="BOWN_PromotionCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_PromotionCost_doc" xml:lang="en-US">Promotion cost.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_GovernmentSubsidies" xlink:label="BOWN_GovernmentSubsidies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_GovernmentSubsidies" xlink:to="BOWN_GovernmentSubsidies_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_GovernmentSubsidies_doc" xml:lang="en-US">Government subsidies.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdvancesToSuppliersNonCurrent" xlink:label="BOWN_AdvancesToSuppliersNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdvancesToSuppliersNonCurrent" xlink:to="BOWN_AdvancesToSuppliersNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AdvancesToSuppliersNonCurrent_doc" xml:lang="en-US">Advances to suppliers non current.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:label="BOWN_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:to="BOWN_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock_doc" xml:lang="en-US">Schedule Of Weighted Average Remaining Lease Term And Discount Rate [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StatutoryReserveMember" xlink:label="BOWN_StatutoryReserveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StatutoryReserveMember" xlink:to="BOWN_StatutoryReserveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_StatutoryReserveMember_doc" xml:lang="en-US">Statutory Reserve [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EffectiveIncomeTaxRateReconciliationPreferentialTaxRateAndTaxExemption" xlink:label="BOWN_EffectiveIncomeTaxRateReconciliationPreferentialTaxRateAndTaxExemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_EffectiveIncomeTaxRateReconciliationPreferentialTaxRateAndTaxExemption" xlink:to="BOWN_EffectiveIncomeTaxRateReconciliationPreferentialTaxRateAndTaxExemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_EffectiveIncomeTaxRateReconciliationPreferentialTaxRateAndTaxExemption_doc" xml:lang="en-US">Preferential tax rate and tax exemption.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ScheduleOfTaxesPayableTableTextBlock" xlink:label="BOWN_ScheduleOfTaxesPayableTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ScheduleOfTaxesPayableTableTextBlock" xlink:to="BOWN_ScheduleOfTaxesPayableTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ScheduleOfTaxesPayableTableTextBlock_doc" xml:lang="en-US">Schedule Of Taxes Payable [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdvancesToSuppliersCurrent" xlink:label="BOWN_AdvancesToSuppliersCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdvancesToSuppliersCurrent" xlink:to="BOWN_AdvancesToSuppliersCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AdvancesToSuppliersCurrent_doc" xml:lang="en-US">Advances to suppliers current.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ScheduleOfNatureOfRelationshipsWithRelatedPartiesTableTextBlock" xlink:label="BOWN_ScheduleOfNatureOfRelationshipsWithRelatedPartiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ScheduleOfNatureOfRelationshipsWithRelatedPartiesTableTextBlock" xlink:to="BOWN_ScheduleOfNatureOfRelationshipsWithRelatedPartiesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ScheduleOfNatureOfRelationshipsWithRelatedPartiesTableTextBlock_doc" xml:lang="en-US">Schedule Of Nature Of Relationships With Related Parties [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_XiaoqinLinMember" xlink:label="BOWN_XiaoqinLinMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_XiaoqinLinMember" xlink:to="BOWN_XiaoqinLinMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_XiaoqinLinMember_doc" xml:lang="en-US">Xiaoqin Lin [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_LiangwenWangMember" xlink:label="BOWN_LiangwenWangMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_LiangwenWangMember" xlink:to="BOWN_LiangwenWangMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_LiangwenWangMember_doc" xml:lang="en-US">Liangwen Wang [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_YuetaoLinMember" xlink:label="BOWN_YuetaoLinMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_YuetaoLinMember" xlink:to="BOWN_YuetaoLinMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_YuetaoLinMember_doc" xml:lang="en-US">Yuetao Lin [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_XIaolingYuanMember" xlink:label="BOWN_XIaolingYuanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_XIaolingYuanMember" xlink:to="BOWN_XIaolingYuanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_XIaolingYuanMember_doc" xml:lang="en-US">XIaoling Yuan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_JuxiangHuMember" xlink:label="BOWN_JuxiangHuMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_JuxiangHuMember" xlink:to="BOWN_JuxiangHuMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_JuxiangHuMember_doc" xml:lang="en-US">Juxiang Hu [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_YanminLiuMember" xlink:label="BOWN_YanminLiuMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_YanminLiuMember" xlink:to="BOWN_YanminLiuMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_YanminLiuMember_doc" xml:lang="en-US">Yanmin Liu [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_YajunSunMember" xlink:label="BOWN_YajunSunMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_YajunSunMember" xlink:to="BOWN_YajunSunMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_YajunSunMember_doc" xml:lang="en-US">Yajun Sun [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_LiangmingHuMember" xlink:label="BOWN_LiangmingHuMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_LiangmingHuMember" xlink:to="BOWN_LiangmingHuMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_LiangmingHuMember_doc" xml:lang="en-US">Liangming Hu [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ShenzhenYelinNetworkTechnologyCoLtdMember" xlink:label="BOWN_ShenzhenYelinNetworkTechnologyCoLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ShenzhenYelinNetworkTechnologyCoLtdMember" xlink:to="BOWN_ShenzhenYelinNetworkTechnologyCoLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ShenzhenYelinNetworkTechnologyCoLtdMember_doc" xml:lang="en-US">Shenzhen Yelin Network Technology Co Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_QianzhiGroupHoldingCaymanLimitedMember" xlink:label="BOWN_QianzhiGroupHoldingCaymanLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_QianzhiGroupHoldingCaymanLimitedMember" xlink:to="BOWN_QianzhiGroupHoldingCaymanLimitedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_QianzhiGroupHoldingCaymanLimitedMember_doc" xml:lang="en-US">Qianzhi Group Holding (Cayman) Limited [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_IncreaseDecreaseInLoansToRelatedParties" xlink:label="BOWN_IncreaseDecreaseInLoansToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_IncreaseDecreaseInLoansToRelatedParties" xlink:to="BOWN_IncreaseDecreaseInLoansToRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_IncreaseDecreaseInLoansToRelatedParties_doc" xml:lang="en-US">The increase (decrease) in loans to related parties.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_IncreaseDecreaseInOtherPayables" xlink:label="BOWN_IncreaseDecreaseInOtherPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_IncreaseDecreaseInOtherPayables" xlink:to="BOWN_IncreaseDecreaseInOtherPayables_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_IncreaseDecreaseInOtherPayables_doc" xml:lang="en-US">The increase (decrease) in other payables.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_IncreaseDecreaseInOtherPayablesRelatedParties" xlink:label="BOWN_IncreaseDecreaseInOtherPayablesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_IncreaseDecreaseInOtherPayablesRelatedParties" xlink:to="BOWN_IncreaseDecreaseInOtherPayablesRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_IncreaseDecreaseInOtherPayablesRelatedParties_doc" xml:lang="en-US">The increase (decrease) in other payables, related parties.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueAppropriationToStatutoryReserve" xlink:label="BOWN_StockIssuedDuringPeriodValueAppropriationToStatutoryReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodValueAppropriationToStatutoryReserve" xlink:to="BOWN_StockIssuedDuringPeriodValueAppropriationToStatutoryReserve_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_StockIssuedDuringPeriodValueAppropriationToStatutoryReserve_doc" xml:lang="en-US">Appropriation to statutory reserve.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueDisposalOfSubsidiary" xlink:label="BOWN_StockIssuedDuringPeriodValueDisposalOfSubsidiary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_StockIssuedDuringPeriodValueDisposalOfSubsidiary" xlink:to="BOWN_StockIssuedDuringPeriodValueDisposalOfSubsidiary_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_StockIssuedDuringPeriodValueDisposalOfSubsidiary_doc" xml:lang="en-US">Disposal of subsidiary.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ReserveForSalesReturn" xlink:label="BOWN_ReserveForSalesReturn" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ReserveForSalesReturn" xlink:to="BOWN_ReserveForSalesReturn_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ReserveForSalesReturn_doc" xml:lang="en-US">Reserve for sales return.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DisposalAndAcquiringOfNoncontrollingInterest" xlink:label="BOWN_DisposalAndAcquiringOfNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_DisposalAndAcquiringOfNoncontrollingInterest" xlink:to="BOWN_DisposalAndAcquiringOfNoncontrollingInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_DisposalAndAcquiringOfNoncontrollingInterest_doc" xml:lang="en-US">Disposal and acquiring of non controlling interest.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NewCoMember" xlink:label="BOWN_NewCoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NewCoMember" xlink:to="BOWN_NewCoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_NewCoMember_doc" xml:lang="en-US">NewCo [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_QianzhiInvestmentHoldingCoLtdMember" xlink:label="BOWN_QianzhiInvestmentHoldingCoLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_QianzhiInvestmentHoldingCoLtdMember" xlink:to="BOWN_QianzhiInvestmentHoldingCoLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_QianzhiInvestmentHoldingCoLtdMember_doc" xml:lang="en-US">Qianzhi Investment Holding Co., Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_HongKongQianzhiInvestmentHoldingCoLtdMember" xlink:label="BOWN_HongKongQianzhiInvestmentHoldingCoLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_HongKongQianzhiInvestmentHoldingCoLtdMember" xlink:to="BOWN_HongKongQianzhiInvestmentHoldingCoLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_HongKongQianzhiInvestmentHoldingCoLtdMember_doc" xml:lang="en-US">Hong Kong Qianzhi Investment Holding Co., Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ShenzhenShianBiotechnologyCoLtdMember" xlink:label="BOWN_ShenzhenShianBiotechnologyCoLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ShenzhenShianBiotechnologyCoLtdMember" xlink:to="BOWN_ShenzhenShianBiotechnologyCoLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ShenzhenShianBiotechnologyCoLtdMember_doc" xml:lang="en-US">Shenzhen Shian Biotechnology Co., Ltd. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_IncomeTaxPayable" xlink:label="BOWN_IncomeTaxPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_IncomeTaxPayable" xlink:to="BOWN_IncomeTaxPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_IncomeTaxPayable_doc" xml:lang="en-US">Income tax payable.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ValueAddedTaxPayableNet" xlink:label="BOWN_ValueAddedTaxPayableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ValueAddedTaxPayableNet" xlink:to="BOWN_ValueAddedTaxPayableNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ValueAddedTaxPayableNet_doc" xml:lang="en-US">Value added tax payable net.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OtherTaxesPayable" xlink:label="BOWN_OtherTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OtherTaxesPayable" xlink:to="BOWN_OtherTaxesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OtherTaxesPayable_doc" xml:lang="en-US">Other taxes payable.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OperatingLeaseAssets" xlink:label="BOWN_OperatingLeaseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OperatingLeaseAssets" xlink:to="BOWN_OperatingLeaseAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OperatingLeaseAssets_doc" xml:lang="en-US">Operating lease assets.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_LoansToRelatedParties" xlink:label="BOWN_LoansToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_LoansToRelatedParties" xlink:to="BOWN_LoansToRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_LoansToRelatedParties_doc" xml:lang="en-US">Loans to related parties.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_HubeiQianzhiBiotechnologyCoLtdMember" xlink:label="BOWN_HubeiQianzhiBiotechnologyCoLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_HubeiQianzhiBiotechnologyCoLtdMember" xlink:to="BOWN_HubeiQianzhiBiotechnologyCoLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_HubeiQianzhiBiotechnologyCoLtdMember_doc" xml:lang="en-US">Hubei Qianzhi Biotechnology Co., Ltd. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ShenzhenQianzhiHealthManagementCoLtdMember" xlink:label="BOWN_ShenzhenQianzhiHealthManagementCoLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ShenzhenQianzhiHealthManagementCoLtdMember" xlink:to="BOWN_ShenzhenQianzhiHealthManagementCoLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ShenzhenQianzhiHealthManagementCoLtdMember_doc" xml:lang="en-US">Shenzhen Qianzhi Health Management Co., Ltd. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_JiangxiQianzhiBiotechnologyCoLtdMember" xlink:label="BOWN_JiangxiQianzhiBiotechnologyCoLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_JiangxiQianzhiBiotechnologyCoLtdMember" xlink:to="BOWN_JiangxiQianzhiBiotechnologyCoLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_JiangxiQianzhiBiotechnologyCoLtdMember_doc" xml:lang="en-US">Jiangxi Qianzhi Biotechnology Co., Ltd. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ShenzhenQianzhiBiotechCoLtdMember" xlink:label="BOWN_ShenzhenQianzhiBiotechCoLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ShenzhenQianzhiBiotechCoLtdMember" xlink:to="BOWN_ShenzhenQianzhiBiotechCoLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ShenzhenQianzhiBiotechCoLtdMember_doc" xml:lang="en-US">Shenzhen Qianzhi Biotech Co., Ltd. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ZhishangZhimeiMember" xlink:label="BOWN_ZhishangZhimeiMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ZhishangZhimeiMember" xlink:to="BOWN_ZhishangZhimeiMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ZhishangZhimeiMember_doc" xml:lang="en-US">Zhishang Zhimei [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NameOfEntity" xlink:label="BOWN_NameOfEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NameOfEntity" xlink:to="BOWN_NameOfEntity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_NameOfEntity_doc" xml:lang="en-US">Name of entity.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EntityPlaceOfIncorporation" xlink:label="BOWN_EntityPlaceOfIncorporation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_EntityPlaceOfIncorporation" xlink:to="BOWN_EntityPlaceOfIncorporation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_EntityPlaceOfIncorporation_doc" xml:lang="en-US">Place of incorporation.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_QianzhiBVIMember" xlink:label="BOWN_QianzhiBVIMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_QianzhiBVIMember" xlink:to="BOWN_QianzhiBVIMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_QianzhiBVIMember_doc" xml:lang="en-US">Qianzhi BVI [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_QianzhiHKMember" xlink:label="BOWN_QianzhiHKMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_QianzhiHKMember" xlink:to="BOWN_QianzhiHKMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_QianzhiHKMember_doc" xml:lang="en-US">Qianzhi HK [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ShenzhenShianMember" xlink:label="BOWN_ShenzhenShianMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ShenzhenShianMember" xlink:to="BOWN_ShenzhenShianMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ShenzhenShianMember_doc" xml:lang="en-US">Shenzhen Shian [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_QianzhiBiotechnologyMember" xlink:label="BOWN_QianzhiBiotechnologyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_QianzhiBiotechnologyMember" xlink:to="BOWN_QianzhiBiotechnologyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_QianzhiBiotechnologyMember_doc" xml:lang="en-US">Qianzhi Biotechnology [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_QianzhiHealthMember" xlink:label="BOWN_QianzhiHealthMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_QianzhiHealthMember" xlink:to="BOWN_QianzhiHealthMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_QianzhiHealthMember_doc" xml:lang="en-US">Qianzhi Health [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_LiquidityTextBlock" xlink:label="BOWN_LiquidityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_LiquidityTextBlock" xlink:to="BOWN_LiquidityTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_LiquidityTextBlock_doc" xml:lang="en-US">Liquidity [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OneCustomerMember" xlink:label="BOWN_OneCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OneCustomerMember" xlink:to="BOWN_OneCustomerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OneCustomerMember_doc" xml:lang="en-US">One Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_TwoCustomersMember" xlink:label="BOWN_TwoCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_TwoCustomersMember" xlink:to="BOWN_TwoCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_TwoCustomersMember_doc" xml:lang="en-US">Two Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ThreeCustomersMember" xlink:label="BOWN_ThreeCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ThreeCustomersMember" xlink:to="BOWN_ThreeCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ThreeCustomersMember_doc" xml:lang="en-US">Three Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_TenCustomersMember" xlink:label="BOWN_TenCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_TenCustomersMember" xlink:to="BOWN_TenCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_TenCustomersMember_doc" xml:lang="en-US">Ten Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OzoneSterilizationProductMember" xlink:label="BOWN_OzoneSterilizationProductMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OzoneSterilizationProductMember" xlink:to="BOWN_OzoneSterilizationProductMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OzoneSterilizationProductMember_doc" xml:lang="en-US">Ozone Sterilization Product [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_CustomerOneMember" xlink:label="BOWN_CustomerOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_CustomerOneMember" xlink:to="BOWN_CustomerOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_CustomerOneMember_doc" xml:lang="en-US">Customer One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OneSupplierMember" xlink:label="BOWN_OneSupplierMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OneSupplierMember" xlink:to="BOWN_OneSupplierMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OneSupplierMember_doc" xml:lang="en-US">One Supplier [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_RevenueRecognizedPercentage" xlink:label="BOWN_RevenueRecognizedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_RevenueRecognizedPercentage" xlink:to="BOWN_RevenueRecognizedPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_RevenueRecognizedPercentage_doc" xml:lang="en-US">Revenue recognized percentage.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_CustomersTwoMember" xlink:label="BOWN_CustomersTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_CustomersTwoMember" xlink:to="BOWN_CustomersTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_CustomersTwoMember_doc" xml:lang="en-US">Customers Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SupplierOneMember" xlink:label="BOWN_SupplierOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_SupplierOneMember" xlink:to="BOWN_SupplierOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_SupplierOneMember_doc" xml:lang="en-US">Supplier One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SuppliersTwoMember" xlink:label="BOWN_SuppliersTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_SuppliersTwoMember" xlink:to="BOWN_SuppliersTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_SuppliersTwoMember_doc" xml:lang="en-US">Suppliers Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SuppliersThreeMember" xlink:label="BOWN_SuppliersThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_SuppliersThreeMember" xlink:to="BOWN_SuppliersThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_SuppliersThreeMember_doc" xml:lang="en-US">Suppliers Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SuppliersFourMember" xlink:label="BOWN_SuppliersFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_SuppliersFourMember" xlink:to="BOWN_SuppliersFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_SuppliersFourMember_doc" xml:lang="en-US">Suppliers Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_TenSuppliersMember" xlink:label="BOWN_TenSuppliersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_TenSuppliersMember" xlink:to="BOWN_TenSuppliersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_TenSuppliersMember_doc" xml:lang="en-US">Ten Suppliers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed" xlink:to="BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed_doc" xml:lang="en-US">Business combination acquisition related costs reimbursed.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_IncreaseDecreaseInDueToSubsidiariesCurrent" xlink:label="BOWN_IncreaseDecreaseInDueToSubsidiariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_IncreaseDecreaseInDueToSubsidiariesCurrent" xlink:to="BOWN_IncreaseDecreaseInDueToSubsidiariesCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_IncreaseDecreaseInDueToSubsidiariesCurrent_doc" xml:lang="en-US">Increase decrease in due to subsidiaries current.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_HubeiQianzhiMember" xlink:label="BOWN_HubeiQianzhiMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_HubeiQianzhiMember" xlink:to="BOWN_HubeiQianzhiMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_HubeiQianzhiMember_doc" xml:lang="en-US">Hubei Qianzhi [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OtherMember" xlink:label="BOWN_OtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OtherMember" xlink:to="BOWN_OtherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OtherMember_doc" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ConsolidatedNetAssetsPercentage" xlink:label="BOWN_ConsolidatedNetAssetsPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ConsolidatedNetAssetsPercentage" xlink:to="BOWN_ConsolidatedNetAssetsPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ConsolidatedNetAssetsPercentage_doc" xml:lang="en-US">Consolidated net assets percentage.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_WorkingCapital" xlink:label="BOWN_WorkingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_WorkingCapital" xlink:to="BOWN_WorkingCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_WorkingCapital_doc" xml:lang="en-US">Working capital.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DueToSubsidiariesCurrent" xlink:label="BOWN_DueToSubsidiariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_DueToSubsidiariesCurrent" xlink:to="BOWN_DueToSubsidiariesCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_DueToSubsidiariesCurrent_doc" xml:lang="en-US">Due to subsidiaries current.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdvancesToSuppliersPolicyTextBlock" xlink:label="BOWN_AdvancesToSuppliersPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AdvancesToSuppliersPolicyTextBlock" xlink:to="BOWN_AdvancesToSuppliersPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AdvancesToSuppliersPolicyTextBlock_doc" xml:lang="en-US">Advances to Suppliers [Policy Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ScheduleOfOtherPayablesRelatedPartiesTableTextBlock" xlink:label="BOWN_ScheduleOfOtherPayablesRelatedPartiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ScheduleOfOtherPayablesRelatedPartiesTableTextBlock" xlink:to="BOWN_ScheduleOfOtherPayablesRelatedPartiesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ScheduleOfOtherPayablesRelatedPartiesTableTextBlock_doc" xml:lang="en-US">Schedule of Other Payables Related Parties [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ScheduleOfOtherReceivablesTableTextBlock" xlink:label="BOWN_ScheduleOfOtherReceivablesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ScheduleOfOtherReceivablesTableTextBlock" xlink:to="BOWN_ScheduleOfOtherReceivablesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ScheduleOfOtherReceivablesTableTextBlock_doc" xml:lang="en-US">Schedule of Other Receivables [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ShenzhenYelinMember" xlink:label="BOWN_ShenzhenYelinMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ShenzhenYelinMember" xlink:to="BOWN_ShenzhenYelinMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ShenzhenYelinMember_doc" xml:lang="en-US">Shenzhen Yelin [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DisaggregationOfRevenuePolicyTextBlock" xlink:label="BOWN_DisaggregationOfRevenuePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_DisaggregationOfRevenuePolicyTextBlock" xlink:to="BOWN_DisaggregationOfRevenuePolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_DisaggregationOfRevenuePolicyTextBlock_doc" xml:lang="en-US">Disaggregation of Revenue [Policy Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_CostOfRevenuePolicyTextBlock" xlink:label="BOWN_CostOfRevenuePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_CostOfRevenuePolicyTextBlock" xlink:to="BOWN_CostOfRevenuePolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_CostOfRevenuePolicyTextBlock_doc" xml:lang="en-US">Cost of Revenue [Policy Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EquityInEarningsOfSubsidiaries" xlink:label="BOWN_EquityInEarningsOfSubsidiaries" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_EquityInEarningsOfSubsidiaries" xlink:to="BOWN_EquityInEarningsOfSubsidiaries_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_EquityInEarningsOfSubsidiaries_doc" xml:lang="en-US">Equity in earnings of subsidiaries.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ValueAddedTaxPolicyTextBlock" xlink:label="BOWN_ValueAddedTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ValueAddedTaxPolicyTextBlock" xlink:to="BOWN_ValueAddedTaxPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ValueAddedTaxPolicyTextBlock_doc" xml:lang="en-US">Value Added Tax [Policy Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_RelatedPartiesPolicyTextBlock" xlink:label="BOWN_RelatedPartiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_RelatedPartiesPolicyTextBlock" xlink:to="BOWN_RelatedPartiesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_RelatedPartiesPolicyTextBlock_doc" xml:lang="en-US">Related Parties [Policy Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:label="BOWN_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:to="BOWN_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_doc" xml:lang="en-US">Recently Issued Accounting Pronouncements Not Yet Adopted [Policy Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ScheduleOfPropertyAndEquipmentExpectedUsefulLivesTableTextBlock" xlink:label="BOWN_ScheduleOfPropertyAndEquipmentExpectedUsefulLivesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ScheduleOfPropertyAndEquipmentExpectedUsefulLivesTableTextBlock" xlink:to="BOWN_ScheduleOfPropertyAndEquipmentExpectedUsefulLivesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ScheduleOfPropertyAndEquipmentExpectedUsefulLivesTableTextBlock_doc" xml:lang="en-US">Schedule of Property and Equipment Useful Lives [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OzoneSterilizationProductsMember" xlink:label="BOWN_OzoneSterilizationProductsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OzoneSterilizationProductsMember" xlink:to="BOWN_OzoneSterilizationProductsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OzoneSterilizationProductsMember_doc" xml:lang="en-US">Ozone Sterilization Products [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_HypochloriteDisinfectionProductsMember" xlink:label="BOWN_HypochloriteDisinfectionProductsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_HypochloriteDisinfectionProductsMember" xlink:to="BOWN_HypochloriteDisinfectionProductsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_HypochloriteDisinfectionProductsMember_doc" xml:lang="en-US">Hypochlorite Disinfection Products [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_CosmeticProductsMember" xlink:label="BOWN_CosmeticProductsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_CosmeticProductsMember" xlink:to="BOWN_CosmeticProductsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_CosmeticProductsMember_doc" xml:lang="en-US">Cosmetic Products [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PrepackagedFoodMember" xlink:label="BOWN_PrepackagedFoodMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PrepackagedFoodMember" xlink:to="BOWN_PrepackagedFoodMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_PrepackagedFoodMember_doc" xml:lang="en-US">Prepackaged Food [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OtherProductsMember" xlink:label="BOWN_OtherProductsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OtherProductsMember" xlink:to="BOWN_OtherProductsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_OtherProductsMember_doc" xml:lang="en-US">Other Products.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PeriodEndSpotRateMember" xlink:label="BOWN_PeriodEndSpotRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PeriodEndSpotRateMember" xlink:to="BOWN_PeriodEndSpotRateMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_PeriodEndSpotRateMember_doc" xml:lang="en-US">Period-End Spot Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AverageRateMember" xlink:label="BOWN_AverageRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AverageRateMember" xlink:to="BOWN_AverageRateMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_AverageRateMember_doc" xml:lang="en-US">Average Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InventorySelfProducedFinishedGoods" xlink:label="BOWN_InventorySelfProducedFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_InventorySelfProducedFinishedGoods" xlink:to="BOWN_InventorySelfProducedFinishedGoods_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_InventorySelfProducedFinishedGoods_doc" xml:lang="en-US">Self-produced finished goods.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InventoryExternalPurchasedFinishedGoods" xlink:label="BOWN_InventoryExternalPurchasedFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_InventoryExternalPurchasedFinishedGoods" xlink:to="BOWN_InventoryExternalPurchasedFinishedGoods_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_InventoryExternalPurchasedFinishedGoods_doc" xml:lang="en-US">External purchased finished goods.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_LizhongGeMember" xlink:label="BOWN_LizhongGeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_LizhongGeMember" xlink:to="BOWN_LizhongGeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_LizhongGeMember_doc" xml:lang="en-US">Lizhong Ge [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InventoryLowValueConsumables" xlink:label="BOWN_InventoryLowValueConsumables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_InventoryLowValueConsumables" xlink:to="BOWN_InventoryLowValueConsumables_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_InventoryLowValueConsumables_doc" xml:lang="en-US">Inventory low value consumables.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EffectiveIncomeTaxRateReconciliationTaxEffectOfNonprofitSubsidiaries" xlink:label="BOWN_EffectiveIncomeTaxRateReconciliationTaxEffectOfNonprofitSubsidiaries" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_EffectiveIncomeTaxRateReconciliationTaxEffectOfNonprofitSubsidiaries" xlink:to="BOWN_EffectiveIncomeTaxRateReconciliationTaxEffectOfNonprofitSubsidiaries_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_EffectiveIncomeTaxRateReconciliationTaxEffectOfNonprofitSubsidiaries_doc" xml:lang="en-US">Effective income tax rate reconciliation tax effect of nonprofit subsidiaries.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EffectiveIncomeTaxRateReconciliationOtherPreferentialTaxRateEffect" xlink:label="BOWN_EffectiveIncomeTaxRateReconciliationOtherPreferentialTaxRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_EffectiveIncomeTaxRateReconciliationOtherPreferentialTaxRateEffect" xlink:to="BOWN_EffectiveIncomeTaxRateReconciliationOtherPreferentialTaxRateEffect_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_EffectiveIncomeTaxRateReconciliationOtherPreferentialTaxRateEffect_doc" xml:lang="en-US">Effective income tax rate reconciliation other preferential tax rate effect.</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ShortTermBankLoanOneMember" xlink:label="BOWN_ShortTermBankLoanOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ShortTermBankLoanOneMember" xlink:to="BOWN_ShortTermBankLoanOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ShortTermBankLoanOneMember_doc" xml:lang="en-US">Short Term Bank Loan One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ShortTermBankLoanTwoMember" xlink:label="BOWN_ShortTermBankLoanTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ShortTermBankLoanTwoMember" xlink:to="BOWN_ShortTermBankLoanTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_ShortTermBankLoanTwoMember_doc" xml:lang="en-US">Short Term Bank Loan Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_CustomersThreeMember" xlink:label="BOWN_CustomersThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_CustomersThreeMember" xlink:to="BOWN_CustomersThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_CustomersThreeMember_doc" xml:lang="en-US">Customers Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_CustomersFourMember" xlink:label="BOWN_CustomersFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_CustomersFourMember" xlink:to="BOWN_CustomersFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_CustomersFourMember_doc" xml:lang="en-US">Customers Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_LongTermBankLoanMember" xlink:label="BOWN_LongTermBankLoanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_LongTermBankLoanMember" xlink:to="BOWN_LongTermBankLoanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BOWN_LongTermBankLoanMember_doc" xml:lang="en-US">Long Term Bank Loan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_2_lbl" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="us-gaap_PaymentsToAcquireOtherInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireOtherInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PaymentsOfUnderwritersDiscount" xlink:to="BOWN_PaymentsOfUnderwritersDiscount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_PaymentsOfUnderwritersDiscount_3_lbl" xml:lang="en-US">PaymentsOfUnderwritersDiscount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_PaymentOfOfferingCosts" xlink:to="BOWN_PaymentOfOfferingCosts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_PaymentOfOfferingCosts_3_lbl" xml:lang="en-US">PaymentOfOfferingCosts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" xlink:to="BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption_3_lbl" xml:lang="en-US">AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:to="BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_3_lbl" xml:lang="en-US">DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_OtherOfferingCosts" xlink:to="BOWN_OtherOfferingCosts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_OtherOfferingCosts_3_lbl" xml:lang="en-US">OtherOfferingCosts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue" xlink:to="BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue_3_lbl" xml:lang="en-US">NetLossIncludingAccretionOfEquityIntoRedemptionValue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_InterestEarnedOnInvestmentHeldInTrustAccount" xlink:to="BOWN_InterestEarnedOnInvestmentHeldInTrustAccount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_InterestEarnedOnInvestmentHeldInTrustAccount_3_lbl" xml:lang="en-US">InterestEarnedOnInvestmentHeldInTrustAccount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue" xlink:to="BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue_3_lbl" xml:lang="en-US">NetLossIncludingAccretionOfCommonStockToRedemptionValue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_IncomeEarnedOnTrustAccount" xlink:to="BOWN_IncomeEarnedOnTrustAccount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_IncomeEarnedOnTrustAccount_3_lbl" xml:lang="en-US">IncomeEarnedOnTrustAccount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfferingCostsPartnershipInterests" xlink:to="us-gaap_OfferingCostsPartnershipInterests_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfferingCostsPartnershipInterests_2_lbl" xml:lang="en-US">Offering Costs, Partnership Interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLegalSettlements" xlink:to="us-gaap_ProceedsFromLegalSettlements_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLegalSettlements_2_lbl" xml:lang="en-US">Proceeds from Legal Settlements</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NoncashOfferingCostsPaidByRelatedParty" xlink:to="BOWN_NoncashOfferingCostsPaidByRelatedParty_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_NoncashOfferingCostsPaidByRelatedParty_3_lbl" xml:lang="en-US">NoncashOfferingCostsPaidByRelatedParty</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NoncashPrepaidExpensesPaidByRelatedParty" xlink:to="BOWN_NoncashPrepaidExpensesPaidByRelatedParty_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_NoncashPrepaidExpensesPaidByRelatedParty_3_lbl" xml:lang="en-US">NoncashPrepaidExpensesPaidByRelatedParty</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_NoncashOfferingCostsIncludedInAccruedExpenses" xlink:to="BOWN_NoncashOfferingCostsIncludedInAccruedExpenses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_NoncashOfferingCostsIncludedInAccruedExpenses_3_lbl" xml:lang="en-US">NoncashOfferingCostsIncludedInAccruedExpenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BOWN_ServiceFee" xlink:to="BOWN_ServiceFee_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BOWN_ServiceFee_3_lbl" xml:lang="en-US">ServiceFee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>40
<FILENAME>bown-20240630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bowenspac.com/role/Cover" xlink:href="bown-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/BalanceSheets" xlink:href="bown-20240630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/BalanceSheetsParenthetical" xlink:href="bown-20240630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/StatementsOfOperations" xlink:href="bown-20240630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/StatementsOfOperationsParenthetical" xlink:href="bown-20240630.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="bown-20240630.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/StatementsOfCashFlows" xlink:href="bown-20240630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/OrganizationAndBusinessOperations" xlink:href="bown-20240630.xsd#OrganizationAndBusinessOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="bown-20240630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/InitialPublicOffering" xlink:href="bown-20240630.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/PrivatePlacements" xlink:href="bown-20240630.xsd#PrivatePlacements" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/RelatedParties" xlink:href="bown-20240630.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/CommitmentsAndContingencies" xlink:href="bown-20240630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ShareholdersEquity" xlink:href="bown-20240630.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/FairValueMeasurements" xlink:href="bown-20240630.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SubsequentEvents" xlink:href="bown-20240630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="bown-20240630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="bown-20240630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/RelatedPartiesTables" xlink:href="bown-20240630.xsd#RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/FairValueMeasurementsTables" xlink:href="bown-20240630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" xlink:href="bown-20240630.xsd#OrganizationAndBusinessOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails" xlink:href="bown-20240630.xsd#ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:href="bown-20240630.xsd#ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:href="bown-20240630.xsd#ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails" xlink:href="bown-20240630.xsd#SupplementalDisclosureOfNoncashFinancingActivitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="bown-20240630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="bown-20240630.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/PrivatePlacementsDetailsNarrative" xlink:href="bown-20240630.xsd#PrivatePlacementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" xlink:href="bown-20240630.xsd#ScheduleOfAssumptionsToEstimateFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/RelatedPartiesDetailsNarrative" xlink:href="bown-20240630.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="bown-20240630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" xlink:href="bown-20240630.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails" xlink:href="bown-20240630.xsd#ScheduleOfMeasuredFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails" xlink:href="bown-20240630.xsd#ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bowenspac.com/role/SubsequentEventsDetailsNarrative" xlink:href="bown-20240630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaapNonrelatedPartyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapNonrelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OrdinarySharesSubjectToRedemption" xlink:label="loc_BOWNOrdinarySharesSubjectToRedemption" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_BOWNOrdinarySharesSubjectToRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_RedeemableOrdinarySharesMember" xlink:label="loc_BOWNRedeemableOrdinarySharesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BOWNRedeemableOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NonRedeemableOrdinarySharesMember" xlink:label="loc_BOWNNonRedeemableOrdinarySharesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BOWNNonRedeemableOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000006 - Statement - Consolidated Statements of Changes in Shareholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" xlink:label="loc_BOWNSubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNSubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueToUnderwriter" xlink:label="loc_BOWNStockIssuedDuringPeriodValueToUnderwriter" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodValueToUnderwriter" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesToUnderwriter" xlink:label="loc_BOWNStockIssuedDuringPeriodSharesToUnderwriter" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodSharesToUnderwriter" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits" xlink:label="loc_BOWNStockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits" xlink:label="loc_BOWNStockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment" xlink:label="loc_BOWNStockIssuedDuringPeriodValueProceedsFromOverallotment" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodValueProceedsFromOverallotment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment" xlink:label="loc_BOWNStockIssuedDuringPeriodSharesProceedsFromOverallotment" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodSharesProceedsFromOverallotment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits" xlink:label="loc_BOWNStockIssuedDuringPeriodValueSaleOfPrivateUnits" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodValueSaleOfPrivateUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits" xlink:label="loc_BOWNStockIssuedDuringPeriodSharesSaleOfPrivateUnits" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodSharesSaleOfPrivateUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits" xlink:label="loc_BOWNStockIssuedDuringPeriodValueOverallotmentOfPrivateUnits" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodValueOverallotmentOfPrivateUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits" xlink:label="loc_BOWNStockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNStockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits" xlink:label="loc_BOWNAdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNAdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment" xlink:label="loc_BOWNAdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNAdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts" xlink:label="loc_BOWNAdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNAdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" xlink:label="loc_BOWNAdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNAdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses" xlink:label="loc_BOWNIncreaseDecreaseInAccruedOfferingCostsAndExpenses" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_BOWNIncreaseDecreaseInAccruedOfferingCostsAndExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireOtherInvestments" xlink:label="loc_us-gaapPaymentsToAcquireOtherInvestments" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireOtherInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ProceedsFromIssuanceOfFounderShares" xlink:label="loc_BOWNProceedsFromIssuanceOfFounderShares" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_BOWNProceedsFromIssuanceOfFounderShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PaymentsOfUnderwritersDiscount" xlink:label="loc_BOWNPaymentsOfUnderwritersDiscount" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_BOWNPaymentsOfUnderwritersDiscount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PaymentOfOfferingCosts" xlink:label="loc_BOWNPaymentOfOfferingCosts" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_BOWNPaymentOfOfferingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:label="loc_BOWNNoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_BOWNNoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital" xlink:label="loc_BOWNNonCashOfferingCostsChargedToAdditionalPaidinCapital" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_BOWNNonCashOfferingCostsChargedToAdditionalPaidinCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption" xlink:label="loc_BOWNReclassificationOfOrdinarySharesSubjectToRedemption" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_BOWNReclassificationOfOrdinarySharesSubjectToRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" xlink:label="loc_BOWNAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_BOWNAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption" xlink:label="loc_BOWNRemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_BOWNRemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" xlink:label="loc_BOWNSubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_BOWNSubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DeferredOfferingCostsPaidByRelatedParty" xlink:label="loc_BOWNDeferredOfferingCostsPaidByRelatedParty" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_BOWNDeferredOfferingCostsPaidByRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PrepaidExpensesPaidByRelatedParty" xlink:label="loc_BOWNPrepaidExpensesPaidByRelatedParty" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_BOWNPrepaidExpensesPaidByRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses" xlink:label="loc_BOWNNoncashOfferingCostsAdjustedFromPrepaidExpenses" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_BOWNNoncashOfferingCostsAdjustedFromPrepaidExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DeferredOfferingCostsIncludedInAccruedExpenses" xlink:label="loc_BOWNDeferredOfferingCostsIncludedInAccruedExpenses" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_BOWNDeferredOfferingCostsIncludedInAccruedExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:label="loc_BOWNDeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_BOWNDeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OfferingCostsChargedToAPICFounderShares" xlink:label="loc_BOWNOfferingCostsChargedToAPICFounderShares" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_BOWNOfferingCostsChargedToAPICFounderShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/OrganizationAndBusinessOperations" xlink:title="00000008 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/InitialPublicOffering" xlink:title="00000010 - Disclosure - INITIAL PUBLIC OFFERING">
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DisclosureInitialPublicOfferingAbstract" xlink:label="loc_BOWNDisclosureInitialPublicOfferingAbstract" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InitialPublicOfferingTextBlock" xlink:label="loc_BOWNInitialPublicOfferingTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_BOWNDisclosureInitialPublicOfferingAbstract" xlink:to="loc_BOWNInitialPublicOfferingTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/PrivatePlacements" xlink:title="00000011 - Disclosure - PRIVATE PLACEMENTS">
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DisclosurePrivatePlacementsAbstract" xlink:label="loc_BOWNDisclosurePrivatePlacementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PrivatePlacementsTextBlock" xlink:label="loc_BOWNPrivatePlacementsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_BOWNDisclosurePrivatePlacementsAbstract" xlink:to="loc_BOWNPrivatePlacementsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/RelatedParties" xlink:title="00000012 - Disclosure - RELATED PARTIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ShareholdersEquity" xlink:title="00000014 - Disclosure - SHAREHOLDERS&#8217; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/FairValueMeasurements" xlink:title="00000015 - Disclosure - Fair Value Measurements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EmergingGrowthCompanyPolicyTextBlock" xlink:label="loc_BOWNEmergingGrowthCompanyPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_BOWNEmergingGrowthCompanyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaapInvestmentPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OfferingCostsPolicyTextBlock" xlink:label="loc_BOWNOfferingCostsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_BOWNOfferingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:label="loc_us-gaapSharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:label="loc_srtScheduleOfCondensedIncomeStatementTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_srtScheduleOfCondensedIncomeStatementTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock" xlink:label="loc_BOWNScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_BOWNScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:label="loc_us-gaapScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/RelatedPartiesTables" xlink:title="00000019 - Disclosure - RELATED PARTIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock" xlink:label="loc_BOWNScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_BOWNScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/FairValueMeasurementsTables" xlink:title="00000020 - Disclosure - Fair Value Measurements (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative" xlink:title="00000021 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_MergerSharesMember" xlink:label="loc_BOWNMergerSharesMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_BOWNMergerSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EarnoutSharesMember" xlink:label="loc_BOWNEarnoutSharesMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_BOWNEarnoutSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AgreementMember" xlink:label="loc_BOWNAgreementMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_BOWNAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ShenzhenQianzhiMember" xlink:label="loc_BOWNShenzhenQianzhiMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_BOWNShenzhenQianzhiMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaapPaymentsForUnderwritingExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsForUnderwritingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OtherOfferingCosts" xlink:label="loc_BOWNOtherOfferingCosts" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_BOWNOtherOfferingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_WorkingCapitalDeficit" xlink:label="loc_BOWNWorkingCapitalDeficit" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_BOWNWorkingCapitalDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Deposits" xlink:label="loc_us-gaapDeposits" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails" xlink:title="00000022 - Disclosure - SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccretionOfTemporaryEquityIntoRedemptionValue" xlink:label="loc_BOWNAccretionOfTemporaryEquityIntoRedemptionValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_BOWNAccretionOfTemporaryEquityIntoRedemptionValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue" xlink:label="loc_BOWNNetLossIncludingAccretionOfEquityIntoRedemptionValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_BOWNNetLossIncludingAccretionOfEquityIntoRedemptionValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InterestEarnedOnInvestmentHeldInTrustAccount" xlink:label="loc_BOWNInterestEarnedOnInvestmentHeldInTrustAccount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_BOWNInterestEarnedOnInvestmentHeldInTrustAccount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue" xlink:label="loc_BOWNNetLossIncludingAccretionOfCommonStockToRedemptionValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_BOWNNetLossIncludingAccretionOfCommonStockToRedemptionValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:title="00000023 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_RedeemableSharesMember" xlink:label="loc_BOWNRedeemableSharesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BOWNRedeemableSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NonRedeemableSharesMember" xlink:label="loc_BOWNNonRedeemableSharesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BOWNNonRedeemableSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OwnershipPercentage" xlink:label="loc_BOWNOwnershipPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity" xlink:label="loc_BOWNAllocationOfNetLossIncludingAccretionOfTemporaryEquity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNAllocationOfNetLossIncludingAccretionOfTemporaryEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount" xlink:label="loc_BOWNInterestEarnedOnInvestmentsHeldInTrustAccount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNInterestEarnedOnInvestmentsHeldInTrustAccount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_IncomeEarnedOnTrustAccount" xlink:label="loc_BOWNIncomeEarnedOnTrustAccount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNIncomeEarnedOnTrustAccount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccretionOfTemporaryEquityIntoRedemptionValue" xlink:label="loc_BOWNAccretionOfTemporaryEquityIntoRedemptionValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNAccretionOfTemporaryEquityIntoRedemptionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AllocationOfNetIncomeloss" xlink:label="loc_BOWNAllocationOfNetIncomeloss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNAllocationOfNetIncomeloss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" xlink:title="00000024 - Disclosure - SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfferingCostsPartnershipInterests" xlink:label="loc_us-gaapOfferingCostsPartnershipInterests" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOfferingCostsPartnershipInterests" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccretionOfCarryingValueToRedemptionValue" xlink:label="loc_BOWNAccretionOfCarryingValueToRedemptionValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_BOWNAccretionOfCarryingValueToRedemptionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityCommonCarryingAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaapProceedsFromOtherEquity" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromOtherEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" xlink:label="loc_BOWNSubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_BOWNSubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityCommonCarryingAmount_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityCommonCarryingAmount_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLegalSettlements" xlink:label="loc_us-gaapProceedsFromLegalSettlements" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromLegalSettlements" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityCommonCarryingAmount_3" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityCommonCarryingAmount_3" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails" xlink:title="00000025 - Disclosure - SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NoncashOfferingCostsPaidByRelatedParty" xlink:label="loc_BOWNNoncashOfferingCostsPaidByRelatedParty" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_BOWNNoncashOfferingCostsPaidByRelatedParty" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NoncashPrepaidExpensesPaidByRelatedParty" xlink:label="loc_BOWNNoncashPrepaidExpensesPaidByRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_BOWNNoncashPrepaidExpensesPaidByRelatedParty" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses" xlink:label="loc_BOWNNoncashOfferingCostsAdjustedFromPrepaidExpenses" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_BOWNNoncashOfferingCostsAdjustedFromPrepaidExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NoncashOfferingCostsIncludedInAccruedExpenses" xlink:label="loc_BOWNNoncashOfferingCostsIncludedInAccruedExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_BOWNNoncashOfferingCostsIncludedInAccruedExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:label="loc_BOWNNoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_BOWNNoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital" xlink:label="loc_BOWNNonCashOfferingCostsChargedToAdditionalPaidinCapital" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_BOWNNonCashOfferingCostsChargedToAdditionalPaidinCapital" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:label="loc_us-gaapScheduleOfCashAndCashEquivalentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfCashAndCashEquivalentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsLineItems" xlink:label="loc_us-gaapCashAndCashEquivalentsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCashAndCashEquivalentsTable" xlink:to="loc_us-gaapCashAndCashEquivalentsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaapCashAndCashEquivalentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCashAndCashEquivalentsTable" xlink:to="loc_us-gaapCashAndCashEquivalentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsAxis" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashMember" xlink:label="loc_us-gaapCashMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_us-gaapCashMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaapUSTreasurySecuritiesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_us-gaapUSTreasurySecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount" xlink:label="loc_BOWNInterestEarnedOnInvestmentsHeldInTrustAccount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_BOWNInterestEarnedOnInvestmentsHeldInTrustAccount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldInTrust" xlink:label="loc_us-gaapAssetsHeldInTrust" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_us-gaapAssetsHeldInTrust" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_InterestsEarnedFromTrustAccount" xlink:label="loc_BOWNInterestsEarnedFromTrustAccount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsLineItems" xlink:to="loc_BOWNInterestsEarnedFromTrustAccount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000027 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DisclosureInitialPublicOfferingAbstract" xlink:label="loc_BOWNDisclosureInitialPublicOfferingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_BOWNDisclosureInitialPublicOfferingAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="loc_us-gaapSaleOfStockDescriptionOfTransaction" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockDescriptionOfTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/PrivatePlacementsDetailsNarrative" xlink:title="00000028 - Disclosure - PRIVATE PLACEMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_DisclosurePrivatePlacementsAbstract" xlink:label="loc_BOWNDisclosurePrivatePlacementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_BOWNDisclosurePrivatePlacementsAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SponsorsMember" xlink:label="loc_BOWNSponsorsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_BOWNSponsorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EBCMember" xlink:label="loc_BOWNEBCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_BOWNEBCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_UnderwritersMember" xlink:label="loc_BOWNUnderwritersMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_BOWNUnderwritersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="loc_us-gaapSaleOfStockDescriptionOfTransaction" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockDescriptionOfTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails" xlink:title="00000029 - Disclosure - SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="loc_srtPlatformOperatorCryptoAssetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_srtPlatformOperatorCryptoAssetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember" xlink:label="loc_BOWNMeasurementInputProbabilityOfCompletionOfBusinessCombinationMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_BOWNMeasurementInputProbabilityOfCompletionOfBusinessCombinationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EquitySecuritiesFvNiTerm" xlink:label="loc_BOWNEquitySecuritiesFvNiTerm" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_BOWNEquitySecuritiesFvNiTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiMeasurementInput" xlink:label="loc_us-gaapEquitySecuritiesFvNiMeasurementInput" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiMeasurementInput" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/RelatedPartiesDetailsNarrative" xlink:title="00000030 - Disclosure - RELATED PARTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SponsorsMember" xlink:label="loc_BOWNSponsorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_BOWNSponsorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EBCMember" xlink:label="loc_BOWNEBCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_BOWNEBCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PromissoryNoteMember" xlink:label="loc_BOWNPromissoryNoteMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_BOWNPromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SponsorsMember" xlink:label="loc_BOWNSponsorsMember_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_BOWNSponsorsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_TenXGlobalCapitalMember" xlink:label="loc_BOWNTenXGlobalCapitalMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_BOWNTenXGlobalCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccountingServiceAgreementMember" xlink:label="loc_BOWNAccountingServiceAgreementMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_BOWNAccountingServiceAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AccountingServicesExpenseMember" xlink:label="loc_BOWNAccountingServicesExpenseMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_BOWNAccountingServicesExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_CashUnderwritingDiscountPerUnit" xlink:label="loc_BOWNCashUnderwritingDiscountPerUnit" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNCashUnderwritingDiscountPerUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_CashUnderwritingDiscount" xlink:label="loc_BOWNCashUnderwritingDiscount" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_BOWNCashUnderwritingDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaapPaymentsForUnderwritingExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForUnderwritingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AffiliateCosts" xlink:label="loc_us-gaapAffiliateCosts" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAffiliateCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdministrativeFeesExpense" xlink:label="loc_us-gaapAdministrativeFeesExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdministrativeFeesExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForAdministrativeFees" xlink:label="loc_us-gaapPaymentForAdministrativeFees" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentForAdministrativeFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000031 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_BusinessCombinationMarketingAgreementMember" xlink:label="loc_BOWNBusinessCombinationMarketingAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_BOWNBusinessCombinationMarketingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_QianzhiMember" xlink:label="loc_BOWNQianzhiMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_BOWNQianzhiMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaapBusinessCombinationAcquisitionRelatedCosts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PercentageOfGrossProceedsOfInitialPublicOffering" xlink:label="loc_BOWNPercentageOfGrossProceedsOfInitialPublicOffering" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_BOWNPercentageOfGrossProceedsOfInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable" xlink:label="loc_BOWNPercentageOfServiceFeeOfTotalConsiderationPayable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_BOWNPercentageOfServiceFeeOfTotalConsiderationPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed" xlink:label="loc_BOWNBusinessCombinationAcquisitionRelatedCostsReimbursed" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_BOWNBusinessCombinationAcquisitionRelatedCostsReimbursed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ServiceFee" xlink:label="loc_BOWNServiceFee" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_BOWNServiceFee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000032 - Disclosure - SHAREHOLDERS&#8217; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_SponsorsMember" xlink:label="loc_BOWNSponsorsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_BOWNSponsorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockVotingRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_OrdinarySharesSubjectToRedemption" xlink:label="loc_BOWNOrdinarySharesSubjectToRedemption" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_BOWNOrdinarySharesSubjectToRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockVotingRights" xlink:label="loc_us-gaapPreferredStockVotingRights" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockVotingRights" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails" xlink:title="00000033 - Disclosure - SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails" xlink:title="00000034 - Disclosure - SCHEDULE FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="loc_srtPlatformOperatorCryptoAssetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_srtPlatformOperatorCryptoAssetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_ExpectedLikelihoodSuccessfulBusinessCombination" xlink:label="loc_BOWNExpectedLikelihoodSuccessfulBusinessCombination" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_BOWNExpectedLikelihoodSuccessfulBusinessCombination" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bowenspac.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_QianzhiMember" xlink:label="loc_BOWNQianzhiMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_BOWNQianzhiMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_MergerSharesMember" xlink:label="loc_BOWNMergerSharesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_BOWNMergerSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_EarnoutSharesMember" xlink:label="loc_BOWNEarnoutSharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_BOWNEarnoutSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_AgreementMember" xlink:label="loc_BOWNAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_BOWNAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bown-20240630.xsd#BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed" xlink:label="loc_BOWNBusinessCombinationAcquisitionRelatedCostsReimbursed" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_BOWNBusinessCombinationAcquisitionRelatedCostsReimbursed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300826057120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Bowen
Acquisition Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001973056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">420
Lexington Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 2446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New
York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(203)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">998-5540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">420
Lexington Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 2446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New
York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(203)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">998-5540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Jiangang
Luo<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300824546800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 272,630<span></span>
</td>
<td class="nump">$ 426,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">42,209<span></span>
</td>
<td class="nump">79,481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivable (Note 6)</a></td>
<td class="nump">45,199<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">360,038<span></span>
</td>
<td class="nump">506,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in trust account</a></td>
<td class="nump">73,284,700<span></span>
</td>
<td class="nump">71,419,358<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,419,358<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">73,644,738<span></span>
</td>
<td class="nump">71,925,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">219,730<span></span>
</td>
<td class="nump">103,860<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">219,730<span></span>
</td>
<td class="nump">103,860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ordinary shares subject to possible redemption (6,900,000 shares at $10.35 per share)</a></td>
<td class="nump">73,284,700<span></span>
</td>
<td class="nump">71,419,358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 2,266,500 shares issued and outstanding</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings</a></td>
<td class="nump">140,081<span></span>
</td>
<td class="nump">402,307<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Equity</a></td>
<td class="nump">140,308<span></span>
</td>
<td class="nump">402,534<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders&#8217; Equity</a></td>
<td class="nump">73,644,738<span></span>
</td>
<td class="nump">71,925,752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">189,730<span></span>
</td>
<td class="nump">78,610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">$ 25,250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300819254560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_OrdinarySharesSubjectToRedemption', window );">Ordinary shares subject to redemption</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Ordinary shares subject to redemption par value</a></td>
<td class="nump">$ 10.62<span></span>
</td>
<td class="nump">$ 10.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary stock, shares issued</a></td>
<td class="nump">2,266,500<span></span>
</td>
<td class="nump">2,266,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary stock, shares outstanding</a></td>
<td class="nump">2,266,500<span></span>
</td>
<td class="nump">2,266,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_OrdinarySharesSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ordinary shares subject to redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_OrdinarySharesSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300826074880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2023</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Formation and operating costs</a></td>
<td class="nump">$ 125,096<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3,105<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 262,226<span></span>
</td>
<td class="nump">$ 244,568<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(125,096)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,105)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(262,226)<span></span>
</td>
<td class="num">(244,568)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Interest earned on investments held in trust account</a></td>
<td class="nump">941,850<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,865,342<span></span>
</td>
<td class="nump">1,729,358<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="nump">941,850<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,865,342<span></span>
</td>
<td class="nump">1,729,358<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 816,754<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (3,105)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,603,116<span></span>
</td>
<td class="nump">$ 1,484,790<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BOWN_RedeemableOrdinarySharesMember', window );">Redeemable Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average ordinary shares outstanding, non-redeemable ordinary shares</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">3,819,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average ordinary shares outstanding, non-redeemable ordinary shares</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">3,819,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per share, non-redeemable ordinary shares</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per share, non-redeemable ordinary shares</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BOWN_NonRedeemableOrdinarySharesMember', window );">Non Redeemable Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average ordinary shares outstanding, non-redeemable ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,095,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average ordinary shares outstanding, non-redeemable ordinary shares</a></td>
<td class="nump">2,266,500<span></span>
</td>
<td class="nump">1,680,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,656,774<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,266,500<span></span>
</td>
<td class="nump">2,095,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per share, non-redeemable ordinary shares</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (0.002)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per share, non-redeemable ordinary shares</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (0.002)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Excludes
    an aggregate of up to <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230401__20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zUCnGgKbTQq4" title="Ordinary shares subject to forfeiture"><span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230217__20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zGqdNySigYo3" title="Ordinary shares subject to forfeiture">225,000</span></span> ordinary shares subject to forfeiture depending on the extent to which the over-allotment option is
    exercised by the underwriters (see Notes 5 and 7). On July 17, 2023, the underwriters fully exercised the over-allotment option.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BOWN_RedeemableOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BOWN_RedeemableOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BOWN_NonRedeemableOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BOWN_NonRedeemableOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300827130832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations (Parenthetical) - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Ordinary shares subject to forfeiture</a></td>
<td class="nump">225,000<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300819673712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Feb. 16, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Feb. 16, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,105)<span></span>
</td>
<td class="num">(3,105)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital</a></td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">24,827<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital, shares</a></td>
<td class="nump">1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Ordinary shares issued to underwriter</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">1,015,982<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,016,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="nump">180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">$ 191<span></span>
</td>
<td class="nump">1,040,809<span></span>
</td>
<td class="num">(3,105)<span></span>
</td>
<td class="nump">1,037,895<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2023</a></td>
<td class="nump">1,905,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Feb. 16, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Feb. 16, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,105)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2023</a></td>
<td class="nump">$ 191<span></span>
</td>
<td class="nump">1,040,809<span></span>
</td>
<td class="num">(3,105)<span></span>
</td>
<td class="nump">1,037,895<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2023</a></td>
<td class="nump">1,905,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Feb. 16, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Feb. 16, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,484,790<span></span>
</td>
<td class="nump">1,484,790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital</a></td>
<td class="num">$ (690)<span></span>
</td>
<td class="num">(65,235,677)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(65,236,367)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital, shares</a></td>
<td class="num">(6,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Ordinary shares issued to underwriter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of ordinary shares to Sponsors</a></td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">24,827<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of ordinary shares to Sponsor, shares</a></td>
<td class="nump">1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_StockIssuedDuringPeriodValueToUnderwriter', window );">Issuance of ordinary shares to Underwriter</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">1,015,982<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,016,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_StockIssuedDuringPeriodSharesToUnderwriter', window );">Issuance of ordinary shares to Underwriter, shares</a></td>
<td class="nump">180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits', window );">Proceeds from sale of public units</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">59,999,400<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits', window );">Proceeds from sale of public units, shares</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment', window );">Proceeds from over-allotment</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">8,999,910<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment', window );">Proceeds from over-allotment, shares</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits', window );">Sale of Private Units</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">3,299,967<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits', window );">Sale of Private Units, shares</a></td>
<td class="nump">330,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits', window );">Over-allotment of Private Units</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">314,997<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">315,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits', window );">Over-allotment of Private Units, shares</a></td>
<td class="nump">31,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits', window );">Underwriter&#8217;s commission on sale of Public Units</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,500,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment', window );">Underwriter&#8217;s commission on Over-allotment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(225,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(225,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts', window );">Other offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,593,898)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,593,898)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption', window );">Allocation of offering costs to ordinary shares subject to redemption</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,137,867<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,137,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock', window );">Deduction for increase of carrying value of redeemable shares</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(7,591,500)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,591,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(646,875)<span></span>
</td>
<td class="num">(1,082,483)<span></span>
</td>
<td class="num">(1,729,358)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 227<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">402,307<span></span>
</td>
<td class="nump">402,534<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="nump">2,266,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">$ 191<span></span>
</td>
<td class="nump">1,040,809<span></span>
</td>
<td class="num">(3,105)<span></span>
</td>
<td class="nump">1,037,895<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2023</a></td>
<td class="nump">1,905,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2023</a></td>
<td class="nump">$ 191<span></span>
</td>
<td class="nump">1,040,809<span></span>
</td>
<td class="num">(3,105)<span></span>
</td>
<td class="nump">1,037,895<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2023</a></td>
<td class="nump">1,905,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 227<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">402,307<span></span>
</td>
<td class="nump">402,534<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="nump">2,266,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount', window );">Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(923,492)<span></span>
</td>
<td class="num">(923,492)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">786,362<span></span>
</td>
<td class="nump">786,362<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2024</a></td>
<td class="nump">$ 227<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">265,177<span></span>
</td>
<td class="nump">265,404<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2024</a></td>
<td class="nump">2,266,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 227<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">402,307<span></span>
</td>
<td class="nump">402,534<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="nump">2,266,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,603,116<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2024</a></td>
<td class="nump">$ 227<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">140,081<span></span>
</td>
<td class="nump">140,308<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2024</a></td>
<td class="nump">2,266,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2024</a></td>
<td class="nump">$ 227<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">265,177<span></span>
</td>
<td class="nump">265,404<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2024</a></td>
<td class="nump">2,266,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount', window );">Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(941,850)<span></span>
</td>
<td class="num">(941,850)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">816,754<span></span>
</td>
<td class="nump">816,754<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2024</a></td>
<td class="nump">$ 227<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 140,081<span></span>
</td>
<td class="nump">$ 140,308<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2024</a></td>
<td class="nump">2,266,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital allocation of offering costs to ordinary shares subject to redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital underwriter&#8217;s commission on sale of Public Units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital underwriters commission on overallotment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital underwriters commission on sale of public units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares overallotment of private units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares proceeds from overallotment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares proceeds from sale of public units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares sale of private units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_StockIssuedDuringPeriodSharesToUnderwriter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_StockIssuedDuringPeriodSharesToUnderwriter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value over-allotment of Private Units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value proceeds from over-allotment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value proceeds from sale of public units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value sale of private units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_StockIssuedDuringPeriodValueToUnderwriter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value Issuance of ordinary shares to underwriter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_StockIssuedDuringPeriodValueToUnderwriter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsequent measurement of common stock subject to possible redemption interest earned on trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease (increase) in additional paid in capital (APIC) for the increase in carrying amount of redeemable preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 3.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300826947104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 816,754<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (3,105)<span></span>
</td>
<td class="nump">$ 1,603,116<span></span>
</td>
<td class="nump">$ 1,484,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustment to reconcile net loss to net cash used in operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Interest reinvested held in Trust Account</a></td>
<td class="num">(941,850)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,865,342)<span></span>
</td>
<td class="num">(1,729,358)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in current assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses', window );">Accrued offering costs and expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,105<span></span>
</td>
<td class="nump">69,143<span></span>
</td>
<td class="nump">6,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses &#8211; related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">34,050<span></span>
</td>
<td class="num">(79,481)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(154,283)<span></span>
</td>
<td class="num">(292,085)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Investments of cash into Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69,690,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69,690,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_ProceedsFromIssuanceOfFounderShares', window );">Proceeds from issuance of founder shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,520<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,615,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_PaymentsOfUnderwritersDiscount', window );">Payments of underwriter&#8217;s discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,725,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151,318)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_PaymentOfOfferingCosts', window );">Payment of offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(332,204)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,520<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">70,408,998<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,520<span></span>
</td>
<td class="num">(154,283)<span></span>
</td>
<td class="nump">426,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">426,913<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at the end of period</a></td>
<td class="nump">272,630<span></span>
</td>
<td class="nump">2,520<span></span>
</td>
<td class="nump">2,520<span></span>
</td>
<td class="nump">272,630<span></span>
</td>
<td class="nump">426,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of noncash financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares', window );">Offering costs paid by Sponsor in exchange for issuance of ordinary shares</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital', window );">Offering costs charged to Additional Paid-in Capital</a></td>
<td class="nump">1,013,480<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,593,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption', window );">Reclassification of ordinary shares subject to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,236,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption', window );">Allocation of offering costs to ordinary shares subject to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,137,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption', window );">Remeasurement adjustment on ordinary shares subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,591,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption', window );">Subsequent measurement of ordinary shares subject to possible redemption (income earned on Trust Account)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,865,342<span></span>
</td>
<td class="nump">1,729,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_DeferredOfferingCostsPaidByRelatedParty', window );">Offering costs paid by related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,108<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_PrepaidExpensesPaidByRelatedParty', window );">Prepaid expenses paid by related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses', window );">Offering costs adjusted from prepaid expenses</a></td>
<td class="nump">$ 639<span></span>
</td>
<td class="nump">$ 639<span></span>
</td>
<td class="nump">639<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">894<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_DeferredOfferingCostsIncludedInAccruedExpenses', window );">Offering costs included in accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares', window );">Offering costs paid by Sponsor in exchange for issuance of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_OfferingCostsChargedToAPICFounderShares', window );">Offering costs charged to APIC &#8211; EBC founder shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,013,480<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in current assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses &#8211; related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allocation of offering costs to ordinary shares subject to redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_DeferredOfferingCostsIncludedInAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred offering costs included in accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_DeferredOfferingCostsIncludedInAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_DeferredOfferingCostsPaidByRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred offering costs paid by related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_DeferredOfferingCostsPaidByRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred offering costs paid by sponsor in exchange for issuance of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in accrued offering costs and expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Offering costs charged to Additional Paid-in Capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Offering costs adjusted from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Offering costs paid by Sponsor in exchange for issuance of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_OfferingCostsChargedToAPICFounderShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Offering costs charged to APIC founder shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_OfferingCostsChargedToAPICFounderShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_PaymentOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_PaymentOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_PaymentsOfUnderwritersDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments of underwriter&#8217;s discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_PaymentsOfUnderwritersDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_PrepaidExpensesPaidByRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses paid by related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_PrepaidExpensesPaidByRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_ProceedsFromIssuanceOfFounderShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of founder shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_ProceedsFromIssuanceOfFounderShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of ordinary shares subject to redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remeasurement adjustment on ordinary shares subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsequent measurement of ordinary shares subject to possible redemption (income earned on Trust Account).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300826768224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BUSINESS OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION AND BUSINESS OPERATIONS</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zB2oomZDbBha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8212; <span id="xdx_82B_zG09NjEIsedf">ORGANIZATION AND BUSINESS OPERATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organizational
and General</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Acquisition Corp (the &#8220;Company&#8221;) was incorporated in the Cayman Islands on February 17, 2023. The Company was formed for
the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination
with one or more businesses (the &#8220;Business Combination&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early
stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth
companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s sponsors are Createcharm Holdings Ltd., a British Virgin Islands company, and Bowen Holding LP, a Delaware limited partnership
(the &#8220;Sponsors&#8221;). As of June 30, 2024, the Company had not commenced any operations. All activities for the period from February
17, 2023 (inception) through June 30, 2024 relate to the Company&#8217;s formation, the initial public offering (&#8220;IPO&#8221;)
and initial business combination, which is described below. The Company will not generate any operating revenues until after the completion
of an initial Business Combination, at the earliest. The Company is generating non-operating income in the form of interest income from
the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s IPO (the &#8220;Registration Statement&#8221;) was declared effective on July 11, 2023.
On July 14, 2023, the Company consummated the IPO of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zXkIXqVCmuq9" title="Stock issued during period shares">6,000,000</span> of its units (&#8220;Public Units&#8221;). Each Public Unit consists of
one ordinary share, $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z6ca4ejeCCl5" title="Ordinary shares, par value">0.0001</span> par value (&#8220;Ordinary Shares&#8221;), of the Company and one right (&#8220;Rights&#8221;), each Right
entitling the holder thereof to receive one-tenth of one ordinary share upon the completion of the Company&#8217;s initial business combination.
The Public Units were sold at an offering price of $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zF5aCDIpxIue" title="Sale of stock, par share">10.00</span> per Unit, generating gross proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z72vmFIlHsx4" title="Proceeds from issuance of IPO">60,000,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the consummation of the IPO, the Company consummated the private placement (&#8220;Private Placement&#8221;) of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zhrlXbAF2FXb" title="Stock issued during period shares">330,000</span> units (&#8220;Private
Placement Units&#8221;) at a price of $<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zM0dBaFGobXf" title="Price per share">10.00</span> per Private Placement Unit, generating total proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zxVLExIfYjwe" title="Proceeds from issuance of private placement">3,300,000</span>. The Private Placement
Units were purchased by Createcharm Holdings Ltd, one of the Company&#8217;s sponsors, and EarlyBirdCapital, Inc. (&#8220;EBC&#8221;),
the representative of the underwriters in the IPO. The Private Placement Units are identical to the Units included in the Public Units
sold in the IPO. The purchasers of the Private Placement Units have agreed not to transfer, assign or sell any of the Private Placement
Units or Ordinary Shares or Rights underlying the Private Placement Units (except to certain transferees) until after the completion
of the Company&#8217;s initial Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2023, the underwriters exercised their over-allotment option in full to purchase an additional <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230717__20230717__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zyjl9lYzFfma" title="Stock issued during period shares">900,000</span> Units. As a result, on
July 18, 2023, the Company sold an additional <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zRUXFuEHgEWe" title="Number of units sold">900,000</span> Units at $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zR0RnGh00WH3" title="Sale of stock price per unit">10.00</span> per Unit, generating gross proceeds of $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zkKjR6O89hX4" title="Proceeds from sale of units">9,000,000</span>. In connection
with this sale, Createcharm Holdings Ltd. and EBC also purchased an additional <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zv3df78rOIn3" title="Number of stock issued">31,500</span> Private Placement Units from the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of July 18, 2023, transaction costs amounted to $<span id="xdx_90D_eus-gaap--PaymentsOfStockIssuanceCosts_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zVlleXFyNmz3" title="Transaction costs">3,318,898</span> consisting of $<span id="xdx_907_eus-gaap--PaymentsForUnderwritingExpense_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zL7glKeIRxJh" title="Cash underwriting fees">1,725,000</span> of cash underwriting fees and $<span id="xdx_90A_ecustom--OtherOfferingCosts_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5S3xmFQghrj" title="Other offering costs">1,593,898</span> of other
offering costs. These costs were charged to additional paid-in capital or accumulated deficit to the extent additional paid-in capital
is fully depleted upon completion of the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will have until 15 months from the closing of the IPO (or up to 18 months, if the Company extends the time to complete a Business
Combination as permitted in its Amended and Restated Memorandum and Articles of Association) to consummate a Business Combination (the
&#8220;Combination Period&#8221;). However, if the Company has not completed a Business Combination within the Combination Period and
shareholders have not otherwise amended the Amended and Restated Memorandum and Articles of Association to extend this period, the Company
will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business
days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit
in the Trust Account, including interest earned and not previously released to us to pay the Company&#8217;s taxes, if any (less certain
amount of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption
will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating
distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s
remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject to the Company&#8217;s obligations under Cayman
Islands law to provide for claims of creditors and the requirements of other applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 20, 2023, a wholly-owned subsidiary of the Company, Bowen Merger Sub (&#8220;Merger Sub&#8221;) was formed for the purpose of
entering into a business combination agreement. See &#8220;Proposed Business Combination&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposed
Business Combination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 18, 2024, the Company entered into an Agreement and Plan of Reorganization (the &#8220;Agreement&#8221;) with (i) Bowen Merger
Sub, a Cayman Islands exempted company and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), (ii) Shenzhen Qianzhi
BioTechnology Co. Ltd., a company incorporated in the People&#8217;s Republic of China and a wholly owned subsidiary of NewCo (as defined
below) (&#8220;Shenzhen Qianzhi&#8221;), and (iii) <span style="background-color: white">Qianzhi Group Holding (Cayman) Limited, a newly
formed Cayman Islands company (&#8220;<span style="text-decoration: underline">NewCo</span>,&#8221; and collectively with the Company, Merger Sub and Shenzhen Qianzhi, the &#8220;<span style="text-decoration: underline">Parties</span>&#8221;,
each a &#8220;<span style="text-decoration: underline">Party</span>&#8221;).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Agreement, at the closing of the business combination, Merger Sub will merge with and into NewCo (the &#8220;<span style="text-decoration: underline">Merger</span>&#8221;),
with NewCo being the surviving company of the Merger (&#8220;<span style="text-decoration: underline">Surviving Company</span>&#8221;) and becoming a wholly owned subsidiary
of the Company. In the Merger, the holders (the &#8220;NewCo Shareholders&#8221;) of the ordinary shares of NewCo (&#8220;NewCo Ordinary
Shares&#8221;) will receive ordinary shares of the Company (&#8220;Parent Ordinary Shares&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Agreement, at the effective time of the Merger (the &#8220;Effective Time&#8221;), all of NewCo Ordinary Shares issued and outstanding
immediately prior to the Effective Time will be automatically converted into the right to receive an aggregate of (a) <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240118__20240118__us-gaap--StatementEquityComponentsAxis__custom--MergerSharesMember__us-gaap--TypeOfArrangementAxis__custom--AgreementMember_zsC8X59Cpna1" title="Number of stock issued">7,246,377</span> Parent
Ordinary Shares (the &#8220;Merger Shares&#8221;), and (b) the right to receive earnout consideration of up to an aggregate of <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240118__20240118__us-gaap--StatementEquityComponentsAxis__custom--EarnoutSharesMember__us-gaap--TypeOfArrangementAxis__custom--AgreementMember__srt--RangeAxis__srt--MaximumMember_zRFpl16lJ2Sk" title="Number of stock issued">1,400,000</span>
Parent Ordinary Shares (the &#8220;Earnout Shares&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going
Concern Consideration</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, the Company had cash of $<span id="xdx_906_eus-gaap--Cash_iI_c20240630_z1nK0Gly7TI3" title="Cash">272,630</span> and a working capital of $<span id="xdx_908_ecustom--WorkingCapitalDeficit_iI_c20240630_zvWgVVhBHkVg" title="Working capital">95,109</span> (excluding $<span id="xdx_903_eus-gaap--OtherReceivablesNetCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShenzhenQianzhiMember_zvn2MGHDrVEf" title="Due from related parties">45,199</span> due from Shenzhen Qianzhi). The
Company has incurred and expects to continue to incur significant professional costs to remain as a public traded company and to incur
transaction costs in pursuit of a Business Combination. In connection with the Company&#8217;s assessment of going concern considerations
in accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s
Ability to Continue as a Going Concern,&#8221; management believes that these conditions raise substantial doubt about the Company&#8217;s
ability to continue as a going concern. In addition, if the Company is unable to complete a Business Combination within the Combination
Period and such period is not extended, there will be a liquidation and subsequent dissolution. As a result, management has determined
that such additional condition also raises substantial doubt about the Company&#8217;s ability to continue as a going concern. The consolidated
financial statement does not include any adjustments that might result from the outcome of the uncertainty.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80D_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z9rOULZoOjsf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8212;<span id="xdx_82B_zqUp5u4n4yzg">ORGANIZATION AND BUSINESS OPERATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organizational
and General</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowen
Acquisition Corp (the &#8220;Company&#8221;) was incorporated in the Cayman Islands on February 17, 2023. The Company was formed for
the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination
with one or more businesses (the &#8220;Business Combination&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early
stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth
companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s sponsors are Createcharm Holdings Ltd., a British Virgin Islands company, and Bowen Holding LP, a Delaware limited partnership
(the &#8220;Sponsors&#8221;). As of December 31, 2023, the Company had not commenced any operations. All activity for the period from
February 17, 2023 (inception) through December 31, 2023 relates to the Company&#8217;s formation and the initial public offering (&#8220;IPO&#8221;)
described below, and following the IPO, the search for a target to consummate a Business Combination<span style="background-color: white">.
</span>The Company will not generate any operating revenues until after the completion of an initial Business Combination, at the earliest.
The Company  generated non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has
selected December 31 as its fiscal year end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s IPO (the &#8220;Registration Statement&#8221;) was declared effective on July 11, 2023.
On July 14, 2023, the Company consummated the IPO of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5QAUuQbyZU1" title="Stock issued during period shares">6,000,000</span> of its units (&#8220;Public Units&#8221;). Each Public Unit consists of
one ordinary share, $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ztoRUlt3J7N4" title="Ordinary shares, par value">0.0001</span> par value (&#8220;Ordinary Shares&#8221;), of the Company and one right (&#8220;Rights&#8221;), each Right
entitling the holder thereof to receive one-tenth of one ordinary share upon the completion of the Company&#8217;s initial business combination.
The Public Units were sold at an offering price of $<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zeBeRm19B9rk" title="Sale of stock, par share">10.00</span> per Unit, generating gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zOlW8wvtVtCg" title="Proceeds from issuance of IPO">60,000,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the consummation of the IPO, the Company consummated the private placement (&#8220;Private Placement&#8221;) of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zGIgiOqmJhAa" title="Stock issued during period shares">330,000</span> units (&#8220;Private
Placement Units&#8221;) at a price of $<span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcaS3eP1Lyq7" title="Price per share">10.00</span> per Private Placement Unit, generating total proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zjlY2IK9ruif" title="Proceeds from issuance of private placement">3,300,000</span>. The Private Placement
Units were purchased by Createcharm Holdings Ltd, one of the Company&#8217;s sponsors, and EarlyBirdCapital, Inc. (&#8220;EBC&#8221;),
the representative of the underwriters in the IPO. The Private Placement Units are identical to the Units included in the Public Units
sold in the IPO. The purchasers of the Private Placement Units have agreed not to transfer, assign or sell any of the Private Placement
Units or Ordinary Shares or Rights underlying the Private Placement Units (except to certain transferees) until after the completion
of the Company&#8217;s initial Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2023, the underwriters exercised their over-allotment option in full to purchase an additional <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230717__20230717__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zwhRT3WDbwzf" title="Stock issued during period shares">900,000</span> Units. As a result, on
July 18, 2023, the Company sold an additional <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zi0tGcTmtfS9" title="Number of stock issued">900,000</span> Units at $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zFkSr01l5ss" title="Price per share">10.00</span> per Unit, generating gross proceeds of $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zfMFXSC7Ll66" title="Proceeds from sale of units">9,000,000</span>. In connection
with this sale, Createcharm Holdings Ltd and EBC also purchased an additional <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_znLDoLu55dm1" title="Number of stock issued">31,500</span> Private Placement Units from the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of July 18, 2023, transaction costs amounted to $<span id="xdx_909_eus-gaap--PaymentsOfStockIssuanceCosts_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zNXiZIVGlbv9" title="Transaction cost">3,318,898</span> consisting of $<span id="xdx_907_eus-gaap--PaymentsForUnderwritingExpense_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zKrDfouXZQWc" title="Payments for underwriting expense">1,725,000</span> of cash underwriting fees and $<span id="xdx_905_ecustom--OtherOfferingCosts_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zbK04C5WaBJb" title="Other offering costs">1,593,898</span> of other
offering costs. These costs were charged to additional paid-in capital or accumulated deficit to the extent additional paid-in capital
is fully depleted upon completion of the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will have until 15 months from the closing of the IPO (or up to 18 months, if the Company extends the time to complete a Business
Combination as permitted in its Amended and Restated Memorandum and Articles of Association) to consummate a Business Combination (the
&#8220;Combination Period&#8221;). Sponsors or their affiliated or designees, upon five days&#8217; advance
notice prior to the deadline, must deposit into the Trust Account $<span id="xdx_907_eus-gaap--Deposits_iI_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z8G19rfIEFUg" title="Deposits">690,000</span> (or $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z2E1789Uvww" title="Shares issued price per share">0.10</span> per share) for the extension, on or prior to the
date of the deadline. However, if the Company has not completed a Business Combination within the Combination Period and
shareholders have not otherwise amended the Amended and Restated Memorandum and Articles of Association to extend this period, the Company
will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business
days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit
in the Trust Account, including interest earned and not previously released to us to pay the Company&#8217;s taxes, if any (less certain
amount of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption
will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating
distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s
remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject to the Company&#8217;s obligations under Cayman
Islands law to provide for claims of creditors and the requirements of other applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On November 20, 2023, a wholly-owned
subsidiary of the Company, Bowen Merger Sub (&#8220;Merger Sub&#8221;) was formed for the purpose of entering into a business combination
agreement. See subsequent events disclosure below.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Going
Concern Consideration</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of December 31, 2023, the Company had cash of $<span id="xdx_90C_eus-gaap--Cash_iI_c20231231_zHxvsMCLVSn2" title="Cash">426,913</span>
and working capital of $<span id="xdx_900_ecustom--WorkingCapitalDeficit_iI_c20231231_zaEtvKWjiU4h" title="Working capital deficit">402,534</span>.
The Company has incurred and expects to continue to incur significant professional costs to remain as a public<span style="background-color: white">ly</span>
traded company and to incur transaction costs in pursuit of a Business Combination. In connection with the Company&#8217;s
assessment of going concern considerations in accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2014-15,
&#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; management believes that
these conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. In addition, if the
Company is unable to complete a Business Combination within the Combination Period and such period is not extended, there will be a
liquidation and subsequent dissolution. As a result, management has determined that such additional condition also raises
substantial doubt about the Company&#8217;s ability to continue as a going concern. The <span style="background-color: white">consolidated </span>
financial statements do not include any adjustments that might result from the outcome of the uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300828168592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zg1xV1GwNg0d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8212; <span id="xdx_82F_zA83al8Onr2a">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zDGTG5XmeChh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zUxqRnHjUOqj">Basis
of Presentation and Principles of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;US GAAP&#8221;) for interim financial information and in accordance with the instructions to
Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the unaudited financial statements reflect all adjustments, which
include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The
interim results for the period ended June 30, 2024 are not necessarily indicative of the results that may be expected through December
31, 2024. All intercompany accounts and transactions are eliminated upon consolidation. The information included in this Form 10-Q should
be read in conjunction with information included in the Company&#8217;s annual report on Form 10-K for the year ended December 31, 2023,
filed with the Securities and Exchange Commission on March 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_ecustom--EmergingGrowthCompanyPolicyTextBlock_zSmJyp9e1Gmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_ztfXEU3hhLC5">Emerging
Growth Company</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--UseOfEstimates_zd8txaf1Tr45" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_ziK8M0jpATv7">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the consolidated financial statement in conformity with US GAAP requires the Company&#8217;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zipcGUzRtCtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zNGkI8nRUxtd">Cash
and cash equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had a cash balance of $<span id="xdx_902_eus-gaap--Cash_iI_pp0p0_c20240630_zAlO8iPeSzX7" title="Cash">272,630</span> and $<span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20231231_zmztkBWTdqn5" title="Cash">426,913</span> as of June 30, 2024 and December 31, 2023, respectively. The Company had <span id="xdx_909_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240630_z2CKN0fZxdza" title="Cash equivalents"><span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zkEELsKcwKJ" title="Cash equivalents">no</span></span> cash
equivalents as of June 30, 2024 and December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--InvestmentPolicyTextBlock_zL5lotToLD14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zgn1LlvFy8Aj">Investments
Held in Trust Account</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s portfolio of investments held in the Trust Account is comprised of investments only in U.S. government securities with
a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which
invest only in direct U.S. government treasury obligations. The Company&#8217;s investments held in the Trust Account are classified
as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains
and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable
securities held in Trust Account in the accompanying statements of operations. The estimated fair value of investments held in the Trust
Account is determined using available market information. As of June 30, 2024 and December 31, 2023, the Trust Account had balance of
$<span id="xdx_907_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20240630_zTCSUZQOVlMi" title="Trust account balance">73,284,700</span> and $<span id="xdx_904_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231_zqPrkszMnHZc" title="Trust account balance">71,419,358</span>, respectively. The interest and dividend income earned from the Trust Account totaled $<span id="xdx_90B_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_pp0p0_c20240401__20240630_zsiiM69cBkFd" title="Interests earned from trust account">941,850</span> and $<span id="xdx_901_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_pp0p0_c20240101__20240630_zXYhRnbC0yXk" title="Interest and dividend income earned from trust account">1,865,342</span>
for three and six months ended June 30, 2024, respectively, which were fully reinvested into the Trust Account as earned and unrealized
gain on investments and therefore presented as an adjustment to the operating activities in the Consolidated Statements of Cash Flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_ecustom--OfferingCostsPolicyTextBlock_zJohv5TrH4Le" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zDoEB7BkwZVg">Offering
Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
costs consist of legal and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that
are directly related to the IPO and that were charged to shareholders&#8217; equity upon the completion of the IPO on July 14, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_z71YEBUcSXue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zhUqkdxrCMji">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;<i>Income Taxes</i>.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were <span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20240630_zbzapixzmQ0k" title="Unrecognized tax benefits"><span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zSaQfj8d9C6d" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits and <span id="xdx_901_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20240630_zcLDqJZK7E8c" title="Interest and penalties accrued"><span id="xdx_900_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20231231_z7FZkptnHQR8" title="Interest and penalties accrued">no</span></span> amounts accrued for interest and penalties as of June 30, 2024
and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals,
or material deviation from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax
regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#8217;s
consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zlFO4bhF6Kk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zHGM35ZCbFJk">Net
Income (Loss) per Ordinary Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include
a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income
per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company
first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed
income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss)
ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement
of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public
shareholders. As of June 30, 2024 and 2023, the Company did not have any dilutive securities and other contracts that could, potentially,
be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per
share is the same as basic income (loss) per share for the period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net income (loss) per share presented in the statements of operations is based on the following:</span></p>

<p id="xdx_89F_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zFiYCcWKe56f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zZaHA01dQnV4" style="display: none">SCHEDULE
OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_492_20240401__20240630_zEPV8mzuxNO8" style="font-weight: bold; text-align: center"><b>2024</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_491_20230401__20230630_zgwKQxKgn7vh" style="font-weight: bold; text-align: center"><b>2023</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_49B_20240101__20240630_zNbVNk9ZmBQe" style="text-align: center"><b>June 30,<br/>
    2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_494_20230217__20230630_zcd2NavKx0ld" style="text-align: center"><b>June 30, <br/>
    2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Three Months Ended June 30,</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>Six Months Ended</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>For the Period from February 17, 2023 through</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2024</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2023</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>June 30,<br/>
    2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>June 30, <br/>
    2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_maNLIAOz10T_zbrmeHprLolh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Net income (loss)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">816,754</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0535">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,603,116</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(3,105</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_401_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz10T_zAbKlpGMN215" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accretion of temporary equity into redemption value (interest earned)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(941,850</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0540">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,865,342</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0542">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--NetLossIncludingAccretionOfEquityIntoRedemptionValue_iT_mtNLIAOz10T_zuPmzF721cVd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss including accretion of equity into redemption value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(125,096</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(262,226</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,105</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8AF_zsq1envgUrs1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zNJHbGlybjOl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_z4YUe7BJfSVk" style="display: none">SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED</span></span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSBy0peTNeqd" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zHFJtctmQ7Af" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_493_20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zrGeGu54Bja" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrUDxN5tolnh" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_499_20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zoS3vQSHFBhl" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_499_20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCvvcjVvYjp1" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zN0D5o5bki2k" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zco4vS2BZfp7" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Three Months Ended<br/>
 June 30, 2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Six Months Ended &#160;<br/>
June 30, 2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Three Months Ended <br/>
June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the Period from <br/>
February 17, 2023 through <br/>
June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Particulars</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and
    diluted net income/(loss) per share:</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average shares outstanding</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRlmacH7Veaj" title="Weighted-average shares outstanding - basic"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z7aUZCzHX6wh" title="Weighted average shares outstanding - diluted">6,900,000</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zOQnfAKWBQC4" title="Weighted-average shares outstanding - basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zw7LQikX1Owc" title="Weighted average shares outstanding - diluted">2,266,500</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zlAbDpzpBcE5" title="Weighted-average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zwdZB8aavyb4" title="Weighted average shares outstanding - diluted">6,900,000</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z4xwsqmQRZs5" title="Weighted-average shares outstanding - basic"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqoTpOOCEHOh" title="Weighted average shares outstanding - diluted">2,266,500</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zvYEr2B32Nu2" title="Weighted-average shares outstanding - basic"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zADwgPj1Bpz9" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0567"><span style="-sec-ix-hidden: xdx2ixbrl0569">-</span></span></span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFN1VzmKwYAa" title="Weighted-average shares outstanding - basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFBwNIxZYrE8" title="Weighted average shares outstanding - diluted">1,680,000</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; font-size: 11pt; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zfVl1CLuVOr" title="Weighted-average shares outstanding - basic"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_znOvNmn9lYB4" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0575"><span style="-sec-ix-hidden: xdx2ixbrl0577">-</span></span></span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYEWjo6tCvF5" title="Weighted-average shares outstanding - basic"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zuALVTokWFIa" title="Weighted average shares outstanding - diluted">1,656,774</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership percentage</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--OwnershipPercentage_pid_dp_uPure_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRX0VSo5MI3e" title="Ownership percentage">75</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--OwnershipPercentage_pid_dp_uPure_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zI77K3HjvqZd" title="Ownership percentage">25</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zcTLuYDNbyS5" title="Ownership percentage">75</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zq3nXiuDFsM3" title="Ownership percentage">25</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zz6QDtUW3A9l" title="Ownership percentage"><span style="-sec-ix-hidden: xdx2ixbrl0591">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zd3pzYuFsn3k" title="Ownership percentage">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zzQDZ6b20zb" title="Ownership percentage"><span style="-sec-ix-hidden: xdx2ixbrl0595">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFLbzzGvCPba" title="Ownership percentage">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerators:</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zshkQfUYiUi6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of net loss including
    accretion of temporary equity</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(94,165</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30,931</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(197,388</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(64,838</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0603">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0604">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0605">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,105</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_402_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_z6JeXvyniSQ4" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    earned on investment held in trust account</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">941,850</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0609">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,865,342</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0611">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0612">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0613">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0614">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0615">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_znOk6211LrT4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of net income/(loss)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">847,685</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30,931</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,667,954</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(64,838</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0621">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0622">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0623">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,105</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominators:</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average shares
    outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQzV0IDvSyj2" title="Weighted average shares outstanding - basic"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zOT1zbMGB639" title="Weighted average shares outstanding - diluted">6,900,000</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_ze0K9wVa10dd" title="Weighted average shares outstanding - basic"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zcDkDRb7KoM2" title="Weighted average shares outstanding - diluted">2,266,500</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zYvu0Nr3kbJf" title="Weighted average shares outstanding - basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zGimqSbrnS3g" title="Weighted average shares outstanding - diluted">6,900,000</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMUgytbR5TI3" title="Weighted average shares outstanding - basic"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zC3p20bgWXld" title="Weighted average shares outstanding - diluted">2,266,500</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zyptN8z7J0zk" title="Weighted average shares outstanding - basic"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zC95eqOTAu9k" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0642"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></span></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zbyRYDgivH3e" title="Weighted average shares outstanding - basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zXbDy5TMdmMb" title="Weighted average shares outstanding - diluted">1,680,000</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTdaJvG0QYge" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z9t6Q9aH3u9i" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0650"><span style="-sec-ix-hidden: xdx2ixbrl0652">-</span></span></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z34tVg8XqKUi" title="Weighted-average shares outstanding - basic"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYR4raUHLa09" title="Weighted-average shares outstanding - diluted">1,656,774</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net income/(loss) per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z34oXUuyBQ39" title="Basic net income/(loss) per share"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zvLOYwYGlhe1" title="Diluted net income/(loss) per share">0.12</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zuL9mXv5DD1l" title="Basic net income/(loss) per share"><span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrvsnXUJxtbj" title="Diluted net income/(loss) per share">(0.01</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQpX6slT0dG2" title="Basic net income/(loss) per share"><span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zG7Oo29qJ0Wc" title="Diluted net income/(loss) per share">0.24</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zJDyTrubNsA" title="Basic net income/(loss) per share"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zzlN34jafbG5" title="Diluted net income/(loss) per share">(0.03</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zg0u4HGHo3va" title="Basic net income/(loss) per share"><span id="xdx_904_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zdFuSn87WLE2" title="Diluted net income/(loss) per share"><span style="-sec-ix-hidden: xdx2ixbrl0674"><span style="-sec-ix-hidden: xdx2ixbrl0676">-</span></span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zhEKTZF2Z2Pd" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zsHEHZzJIhbc" title="Diluted net income/(loss) per share"><span style="-sec-ix-hidden: xdx2ixbrl0678"><span style="-sec-ix-hidden: xdx2ixbrl0680">-</span></span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z6KC1AJBXhJc" title="Basic net income/(loss) per share"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zA2v4GYzuEPk" title="Diluted net income/(loss) per share"><span style="-sec-ix-hidden: xdx2ixbrl0682"><span style="-sec-ix-hidden: xdx2ixbrl0684">-</span></span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_za6AczHeao4j" title="Basic net income/(loss) per share"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zKdoRSOAcBi4" title="Diluted net income/(loss) per share">(0.002</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p id="xdx_8AE_z9AwGfR5raC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_z3lZhr9911K6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zPYpyu6KgvTj">Concentration
of Credit Risk</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_c20240630_z3L1nYZwLMTb" title="Cash FDIC insured amount">250,000</span>. The Company has not experienced losses on these accounts
and management believes the Company is not exposed to significant risks on such accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zcJebipTI21i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_z7zkLhnilQEl">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;<i>Fair Value
Measurement</i>,&#8221; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zVKEDCaCr3jb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zRwInfBS5jUe">Ordinary
Shares Subject to Possible Redemption</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Ordinary shares subject to mandatory redemption (if
any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary
shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, ordinary shares
are classified as shareholders&#8217; equity. The Company&#8217;s ordinary shares features certain redemption rights that are considered
to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject
to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#8217; equity section of the
Company&#8217;s balance sheet. <span style="background-color: white">The Company recognizes changes in redemption value immediately as
they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.
Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital
and accumulated deficit.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zGAuRR7PPSeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2023 and June 30, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are
reconciled in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zpc5XAu9ccQg" style="display: none">SCHEDULE
OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 84%; text-align: left">Public offering proceeds</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPTO3JbwgL46" style="width: 12%; text-align: right" title="Public offering proceeds">60,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zC2iWnioAnWf" style="text-align: right" title="Proceeds allocated to public rights">(3,272,724</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3GYLMyaZGMg" style="text-align: right" title="Allocation of offering costs related to redeemable shares">(2,925,140</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3ebkpA4pQAi" style="text-align: right" title="Accretion of carrying value to redemption value">6,797,864</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ordinary shares subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20230101__20231231_zMmdN8mzOY43" style="text-align: right" title="Ordinary shares subject to possible redemption">60,600,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic">Over-allotment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Over-allotment proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ProceedsFromOtherEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zhdg83vT3Rme" style="text-align: right" title="Over-allotment proceeds">9,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z6J18rD4Rk1b" style="text-align: right" title="Proceeds allocated to Public Rights">(490,909</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zojTNcHsWDO" style="text-align: right" title="Allocation of offering costs related to redeemable shares">(212,727</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zHWQ4CTJT1de" style="text-align: right" title="Accretion of carrying value to redemption value">793,636</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zim6byzjMXwh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)">1,729,358</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Ordinary shares subject to possible redemption, December 31, 2023</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20240101__20240630_z6P1opG3tZBi" style="font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemption">71,419,358</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">Plus:</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">Subsequent
    measurement of ordinary shares subject to possible redemption (income earned on trust account)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20240101__20240630_zGjItKI6Dbd7" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"><span style="font: normal 10pt Times New Roman, Times, Serif">1,865,342</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>Ordinary
    shares subject to possible redemption, June 30, 2024</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>$</b></span></td><td id="xdx_986_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iE_c20240101__20240630_zwYfAIm1ZNUh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>73,284,700</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  </table>

<p id="xdx_8A2_z6s9ZdWbnonf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zvlTHZ2lITda" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zCZJ7hRWs7j2">Recent
Accounting Standards</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#8217;s consolidated financial statements.</span></p>

<p id="xdx_854_zffhMR6q4hoi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Correction
of an Error</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
preparing the Company&#8217;s Form 10-Q for the quarterly period ended June 30, 2024, the Company identified an omission in the disclosure
of the non-cash item in the Cash Flow Statement related with the offering cost charged to APIC for the EBC founder shares in its historical
filing for the quarter ended June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with SEC Staff Accounting Bulletin No. 99, &#8220;Materiality,&#8221; and SEC Staff Accounting Bulletin No. 108, &#8220;Considering
the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements;&#8221; the Company evaluated
the error and has determined that the omission of non-cash item in the interim period of six months in 2023 does not have any impact
on the consolidated financial statements in the full year of 2023 and 2024. Accordingly, the Company has corrected such immaterial error
by adjusting its statement of cash flows for the period from February 17, 2023 (inception) through June 30, 2023 related to the supplemental
disclosure of noncash financing activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following analysis provides a comparison of the supplemental disclosure of noncash financing activities as reported on the Form 10-Q
for the quarter ended June 30, 2023, and the final revised disclosure to correct the error:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_898_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zrIeFQGHFK63" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B2_zalQH45DorYe" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SUPPLEMENTAL
DISCLOSURE OF NONCASH FINANCING ACTIVITIES</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20230401__20230630_zDUmkvO9Pav2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As reported on Form 10-Q for the quarter ended June 30, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20240401__20240630_zTiJTaglAq4j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As revised on<br/>
Form 10-Q</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental disclosure of noncash financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--NoncashOfferingCostsPaidByRelatedParty_zILkhYJtkzLb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Offering costs paid by related party</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">144,108</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">144,108</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--NoncashPrepaidExpensesPaidByRelatedParty_zpSTUAqjtyp1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid expenses paid by related party</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--NoncashOfferingCostsAdjustedFromPrepaidExpenses_zA7wCbaY8zRg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Offering costs adjusted from prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">639</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--NoncashOfferingCostsIncludedInAccruedExpenses_zzWV27yzB3p4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Offering costs included in accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,505</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,505</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_zyq3q4cuHGo6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Offering costs paid by Sponsor in exchange for issuance of ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--NonCashOfferingCostsChargedToAdditionalPaidinCapital_zEU2RD3p88W7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Offering costs charged to APIC &#8211; EBC founder shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0745">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,013,480</td><td style="text-align: left">&#160;</td></tr></table>


<p id="xdx_8A8_zGyc7i1BEQZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zF6w2MMGASE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE
2 &#8212; <span id="xdx_826_zPhBxTWT60bc">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zHmSXfLEBGWa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_866_zwgilH11G9z2">Basis
of Presentation and Principles of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary and are presented
in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;)
and pursuant to the rules and regulations of the SEC. All intercompany accounts and transactions are eliminated upon consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_ecustom--EmergingGrowthCompanyPolicyTextBlock_zWKlwfrQmYzd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_866_zfYOuyVDRYsl">Emerging
Growth Company</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_840_eus-gaap--UseOfEstimates_zCA91RayHq8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zHOe49ZxvDKe">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the financial statement in conformity with US GAAP requires the Company&#8217;s management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zmfCyCJVr811" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_86B_zAwsvaka99Lf">Cash
and cash equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash
equivalents. The Company had a cash balance of $<span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20231231_zFK1kspiUhB5" title="Cash">426,913</span>
as of December 31, 2023. The Company had <span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_znrFr9kvJLR2" title="Cash equivalents">no</span> cash equivalents as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--InvestmentPolicyTextBlock_zqRWTWIBXBQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_866_zJ3NmQZbipc9">Investments
Held in Trust Account</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company&#8217;s portfolio of investments held in the trust account is comprised of investments only in U.S. government securities
with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company
Act which invest only in direct U.S. government treasury obligations. The Company classified its investments in treasury securities
as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period.
Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on
marketable securities held in trust account in the accompanying statements of operations. The estimated fair value of investments
held in the trust account is determined using available market information. As of December 31, 2023, the trust account had cash
balance of $<span id="xdx_90E_eus-gaap--AssetsHeldInTrust_iI_c20231231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashMember_zOzfr1rK79ag" title="Trust account, cash balance">8,208</span> together with U.S. Treasury Bills of $<span id="xdx_905_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zZqLbbU6cr9a" title="Trust account, cash balance, with U.S. treasury bills">71,411,150</span> which subsequently matured on January 11, 2024. And the total balance was reinvested in the money market
fund thereafter.
The interests earned from the trust account totaled $<span id="xdx_906_ecustom--InterestsEarnedFromTrustAccount_pp0p0_c20230217__20231231_zWbX4N8uaJVj" title="Interests earned from trust account">1,729,358</span>
for the period from February 17, 2023 (inception) through December 31, 2023, which were fully reinvested into the trust account as
earned and unrealized gain on investments and therefore presented as an adjustment to the operating activities in the Statement of
Cash Flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_841_ecustom--OfferingCostsPolicyTextBlock_zTKkNdQFKHJk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zamlBjzlDZ2b">Offering
Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
costs consist of legal, accounting, and other costs (including underwriting discounts and commissions) incurred through the balance sheet
date that are directly related to the IPO and that were charged to shareholders&#8217; equity upon the completion of the IPO on July
14, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zGDLIhZAEBn4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_861_zjwJMGXFhF8i">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;<i>Income Taxes</i>.&#8221;
Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the <span style="background-color: white">consolidated </span>
financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and
liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is
recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce
deferred tax assets to the amount expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were <span id="xdx_90B_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zsYWbZ380F1h" title="Unrecognized tax benefits">no</span> unrecognized tax benefits and <span id="xdx_90F_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20231231_zSsfZpwbEj33" title="Accrued for interest and penalties">no</span> amounts accrued for interest and penalties as of December 31, 2023.
The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation
from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax
regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#8217;s
consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_eus-gaap--EarningsPerSharePolicyTextBlock_zHgK6ZKKHid" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_86A_z0ppd2hs22Oa">Net
Income (Loss) per Ordinary Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><br/>
The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include
a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income
per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company
first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed
income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss)
ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement
of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public
shareholders. As of December 31, 2023, the Company did not have any dilutive securities and other contracts that could, potentially,
be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per
share is the same as basic income (loss) per share for the period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
net income (loss) per share presented in the statements of operations is based on the following:</span></p>

<p id="xdx_89A_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_z5fqU2qlhri2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_zHiJwUlqeU1k" style="display: none">SCHEDULE
OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230217__20231231_zbKQnV15xwDe" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Period from February 17, 2023 (Inception) Through</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_maNLIAOz10T_zOJii0vLKohb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left">Net income</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">1,484,790</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--InterestEarnedOnInvestmentHeldInTrustAccount_iN_di_msNLIAOz10T_zo7AJGrk1xXi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest earned on investment held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,729,358</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz10T_zAg74kxuxLM" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of temporary equity into redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,591,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--NetLossIncludingAccretionOfCommonStockToRedemptionValue_iT_mtNLIAOz10T_zKdGwxjFuO41" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss including accretion of common stock to redemption value</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(7,836,068</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p id="xdx_8AC_zYKcI8lxkzp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zcpFV3BsqmD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BF_zMFGGaplzlue">SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSbd0Fp6rMFl" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zGAERQ6dGDUi" style="font-weight: bold; text-align: center">Non-Redeemable</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Period from February 17, 2023 (Inception) Through</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Non-Redeemable</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Particulars</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic and diluted net income/(loss) per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%">Weighted-average shares outstanding</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zU6CljOH48ac" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zFYq4I4GQtSh" title="Weighted average shares outstanding - diluted">3,819,156</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zNfgYAWx4Gr9" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCzo2RWqf9bk" title="Weighted average shares outstanding - diluted">2,095,943</span></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ownership percentage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zECPHfL2glR8" title="Ownership percentage">65</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zsjNSrA2WIZc" title="Ownership percentage">35</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Numerators:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zVCdrxP2wiac" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Allocation of net loss including accretion of temporary equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,059,453</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,776,615</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--IncomeEarnedOnTrustAccount_iN_di_zAHwZN6mpoR2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income earned on Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,729,358</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1294">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_zDB0ptiEw1dk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of temporary equity to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,591,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1297">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--AllocationOfNetIncomeloss_zq0KsXBOf1Ke" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Allocation of net income/(loss)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">4,261,405</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(2,776,615</td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Denominators:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted-average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRIL4Yi3jFe8" title="Weighted average shares outstanding - basic"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTMeIKfe5D67" title="Weighted average shares outstanding - diluted">3,819,156</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zZ4GwgKssWo7" title="Weighted average shares outstanding - basic"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqU9AdEZFfK1" title="Weighted average shares outstanding - diluted">2,095,943</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income/(loss) per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zftFIOmZjSkl" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zVuMWGvFHwTb" title="Diluted net income/(loss) per share">1.12</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zHHmNNLje0E9" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zg1zZTQ3WBvh" title="Diluted net income/(loss) per share">(1.32</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A7_zWjFEaPV48a9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z2d9dRUEHMr8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zOFadp8Mtut6">Concentration
of Credit Risk</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zMylsduoDCS4" title="Cash, FDIC insured amount">250,000</span>. The Company has not experienced losses on these accounts
and management believes the Company is not exposed to significant risks on such accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zeMFmxxmd9tb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zpDX0PpSV6R5">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;<i>Fair Value
Measurement</i>,&#8221; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_z1WqK5dF6HTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zyQLC8aa7lud">Ordinary
Shares Subject to Possible Redemption</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Ordinary shares subject to mandatory redemption (if
any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary
shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, ordinary shares
are classified as shareholders&#8217; equity. The Company&#8217;s ordinary shares features certain redemption rights that are considered
to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject
to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#8217; equity section of the
Company&#8217;s balance sheet. <span style="background-color: white">The Company recognizes changes in redemption value immediately as
they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.
Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital
and accumulated deficit.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zd2wBE9lAYs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">At
December 31, 2023, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BF_zpu6m2fUs7rj" style="display: none">SCHEDULE
OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left">Public offering proceeds</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231_za2ZKsoTet4c" style="width: 18%; text-align: right" title="Public offering proceeds">60,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230217__20231231_zYj5oSuFxqL7" style="text-align: right" title="Proceeds allocated to public rights">(3,272,724</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231_zFJ7buaNy8O7" style="text-align: right" title="Allocation of offering costs related to redeemable shares">(2,925,140</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230217__20231231_zW9JCGlmekni" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion of carrying value to redemption value">6,797,864</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ordinary shares subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20230217__20231231_zgqwa1e5dh05" style="text-align: right" title="Gross proceeds">60,600,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic">Over-allotment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Over-allotment proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ProceedsFromLegalSettlements_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zfFMrSFQSlFi" style="text-align: right" title="Over-allotment proceeds">9,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zYxgPuaVAyvk" style="text-align: right" title="Proceeds allocated to Public Rights">(490,909</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_znuXsHmUR8Gk" style="text-align: right" title="Allocation of offering costs related to redeemable shares">(212,727</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zcZb6OK0dWm9" style="text-align: right" title="Accretion of carrying value to redemption value">793,636</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zeDGC1VR9Hp5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)">1,729,358</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Ordinary shares subject to possible redemption</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zgIlv0x3m5Tl" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemption">71,419,358</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zxvw1Qtx8jLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z2k0Bblpjmqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zNLZGX6jgbxd">Recent
Accounting Standards</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#8217;s consolidated financial statements.</span></p>

<p id="xdx_856_z0JNTepPBrP2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300824723600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INITIAL PUBLIC OFFERING<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_DisclosureInitialPublicOfferingAbstract', window );"><strong>Initial Public Offering</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_InitialPublicOfferingTextBlock', window );">INITIAL PUBLIC OFFERING</a></td>
<td class="text"><p id="xdx_80C_ecustom--InitialPublicOfferingTextBlock_zQN4fgvRk3Fg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8212; <span id="xdx_82C_zvmZL6zwQNOj">INITIAL PUBLIC OFFERING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 14, 2023, the Company sold <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ziNBSwTUyVal" title="Stock issued during period shares">6,000,000</span> Units at a price of $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zAIhRA4mUEN7" title="Sale of stock, par share">10.00</span> per Unit. <span id="xdx_905_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zSh5Bk8iblQ4" title="Units related to initial public offering description">Each Unit consists of one ordinary share and one right
to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company&#8217;s initial Business Combination. Ten Public
Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares
will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional
shares underlying the rights</span>. The Company also granted the underwriters a 45-day option to purchase up to an additional <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_z9RlZCZnFcSc" title="Stock issued during the period, shares">900,000</span> units
to cover over-allotments. The over-allotment was subsequently fully exercised on July 17, 2023. See Note 1 for further details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_805_ecustom--InitialPublicOfferingTextBlock_zHDaCE2xECgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE
3 &#8212; <span id="xdx_822_z93dWclkbSi4">INITIAL PUBLIC OFFERING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
July 14, 2023, the Company sold <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z70KqMXJ81qd" title="Stock issued during period shares">6,000,000</span> Units at a price of $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zjzkwGZXp3Hh" title="Sale of stock, par share">10.00</span> per Unit. <span id="xdx_903_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zkBlcL0EsE5e" title="Stock holders equity related to initial public offering description">Each Unit consists of one ordinary share and one right
to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company&#8217;s initial Business Combination. Ten Public
Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares
will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional
shares underlying the rights</span>. The Company also granted the underwriters a 45-day option to purchase up to an additional <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z7DTOAlYEYM5" title="Stock issued during the period, shares">900,000</span> units
to cover over-allotments. The over-allotment was subsequently fully exercised on July 17, 2023. See Note 1 for further details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_DisclosureInitialPublicOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_DisclosureInitialPublicOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_InitialPublicOfferingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial Public Offering [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_InitialPublicOfferingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300833270192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRIVATE PLACEMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_DisclosurePrivatePlacementsAbstract', window );"><strong>Private Placements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_PrivatePlacementsTextBlock', window );">PRIVATE PLACEMENTS</a></td>
<td class="text"><p id="xdx_808_ecustom--PrivatePlacementsTextBlock_zSuAeT4mq32e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 &#8212; <span id="xdx_826_zkjgIAqZ1Sxf">PRIVATE PLACEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors and EBC had agreed to purchase an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zMXlx0qQXuGa" title="Number of shares issued">330,000</span> Private Placement Units (<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorsMember_z8uyaXrHNnPb" title="Number of shares issued">312,000</span> Private Placement Units to be purchased
by the Sponsors and <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--EBCMember_zy0I1mPXndQ1" title="Number of shares issued">18,000</span> Private Placement Units to be purchased by EBC or its designees), or <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_z75nPHOfjBYl" title="Number of shares issued">361,500</span> Private Placement Units if the
underwriters&#8217; over-allotment is exercised in full, at a price of $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zdJXxhSitFPf" title="Unit exercise price per share">10.00</span> per Private Placement Unit ($<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zoojZRuJhkyk" title="Value of stock issued">3,300,000</span>, or an aggregate
of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zHmhlGb5hN3f" title="Value of stock issued">3,615,000</span> if the underwriters&#8217; over-allotment is exercised in full) from the Company in a private placement that will occur
simultaneously with the closing of the Initial Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the IPO on July 14, 2023, the Company consummated the private sale of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zPvRTKkuTfjj" title="Number of shares issued">330,000</span> Private Placement Units. <span id="xdx_903_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z8nQtTj8eqre" title="Units related to private placement description">Each
Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the
consummation of the Company&#8217;s initial Business Combination.</span> The proceeds from the sale of the Private Placement Units were
added to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the
Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the
redemption of the Public Shares (subject to the requirements of applicable law). The Private Placement Units (including the
underlying securities) will not be transferable, assignable, or salable until the completion of a Business Combination, subject to
certain exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2023, the underwriters exercised the over-allotment option in full. See Note 1 for more details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_808_ecustom--PrivatePlacementsTextBlock_z6RicVGoIEY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE
4 &#8212; <span id="xdx_82A_z3OdyWOSDWga">PRIVATE PLACEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Sponsors and EBC have agreed to purchase an aggregate of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zGzG654MNrnb" title="Number of shares issued">330,000</span> Private Placement Units (<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorsMember_z41JzLzYhRC5" title="Number of shares issued">312,000</span> Private Placement Units to be purchased
by the Sponsors and <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--EBCMember_z9ap4lEPiFsj" title="Number of shares issued">18,000</span> Private Placement Units to be purchased by EBC or its designees), or <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zF3PYUh11omc" title="Number of shares issued">361,500</span> Private Placement Units if the
underwriters&#8217; over-allotment is exercised in full, at a price of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zDhaSGaytAxe" title="Private placement units of underwriters over-allotment per share price">10.00</span> per Private Placement Unit ($<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcVkGIuQPWNh" title="Value of stock issued">3,300,000</span>, or an aggregate
of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zAF9PtaDHstf" title="Value of stock issued">3,615,000</span> if the underwriters&#8217; over-allotment is exercised in full) from the Company in a private placement that will occur
simultaneously with the closing of the Initial Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Simultaneously with and soon after the closing of
the IPO, the Sponsors and EBC purchased an aggregate of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zn6CdMyaY08b" title="Number of shares issued">361,500</span> Private Placement Units ($<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zuiz5k7UbKcc" title="Value of stock issued">3,615,000</span>), including exercise of over-allotment
option. Each Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon
the consummation of the Company&#8217;s initial Business Combination. The proceeds from the sale of the Private Placement Units were added
to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination
Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the
Public Shares (subject to the requirements of applicable law). The Private Placement Units (including the underlying securities) will
not be transferable, assignable, or saleable until the completion of a Business Combination, subject to certain exceptions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
July 17, 2023, the underwriters exercised the over-allotment option in full. See Note 1 for more details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_DisclosurePrivatePlacementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_DisclosurePrivatePlacementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_PrivatePlacementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Private Placements [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_PrivatePlacementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300827094816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES</a></td>
<td class="text"><p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z3GywOdgSHI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 &#8212; <span id="xdx_82A_zaXgTC9OiXe4">RELATED PARTIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Founder
Shares and EBC Founder Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 27, 2023, the Sponsors received <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zglblFNDvW7d" title="Number of shares issued">1,725,000</span> of the Company&#8217;s ordinary shares (&#8220;Founder Shares&#8221;) in exchange
for $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zkZoz5c7plq9" title="Sponsors received ordinary shares, value">25,000</span> paid for offering costs borne by the Sponsors. Up to <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zVcODg9xyeBc" title="Number of shares subject to forfeiture">225,000</span> of such Founder Shares were subject to forfeiture to the extent
that the underwriters&#8217; over-allotment was not exercised in full. On July 17, 2023, the underwriters exercised their over-allotment option in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 15, 2023, the Company issued to EBC <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zVWcQHN6JEha" title="Number of shares issued">180,000</span> ordinary shares (&#8220;EBC founder shares&#8221;) for a purchase price of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zp3zDrlFqLY4" title="Ordinary share price">0.014</span> per
share and an aggregate purchase price of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zOcA9RsGMA3h" title="Value of stock issued">2,520</span>. The EBC founder shares are deemed to be underwriters&#8217; compensation by FINRA pursuant
to Rule 5110 of the FINRA Manual. The Company estimated the fair value of the EBC founder shares to be approximately $<span id="xdx_908_eus-gaap--DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zYPoSV8plTk1" title="Fair value of shares issued">1,016,000</span> or $<span id="xdx_90E_eus-gaap--SharePrice_iI_pid_c20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zaU5F0wQ6GYd" title="Fair value of ordinary per share price">5.65
</span>per share using the Black-Scholes option pricing model. The Company accounted for the difference between the par value and fair value
of the shares as offering cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zOCn0l1Ycqmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair
value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zJYUcGy76vr" style="display: none">SCHEDULE
OF ASSUMPTIONS TO ESTIMATE FAIR VALUE</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 84%; text-align: left">Time to expiration</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90F_ecustom--EquitySecuritiesFvNiTerm_dtY_c20230315__20230315_zLaPy9wr7i8a" title="Time to expiration">1.84</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_ziZuy1TovcP6" title="Risk-free rate">4.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zh5axFQLqyh7" title="Risk-free rate">5.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zgEwwIudNqN1" title="Risk-free rate">0.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Probability of completion of business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember_zRD7Tcv0CwE5" title="Founder shares measurement input">60.0</span></td><td style="text-align: left">%</td></tr>
  </table>

<p id="xdx_8A4_zjmPdDVpjt96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur
of: (A) six months after the completion of the initial Business Combination and (B) the date on which the Company completes a liquidation,
merger, share exchange, reorganization or other similar transaction after an initial Business Combination that results in all of the
Company&#8217;s public shareholders having the right to exchange their ordinary shares for cash, securities or other property. EBC has
also agreed, subject to exceptions, that the EBC founder shares cannot be sold, transferred or assigned, until the consummation of an
initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Promissory
Note&#8201;&#8212;&#8201;Related Party</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 27, 2023, the Sponsors issued an unsecured promissory note to the Company (the &#8220;Promissory Note&#8221;), pursuant to which
the Company may borrow up to an aggregate principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20230227__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorsMember_z6PXcjJFr5V7" title="Promissory note aggregate principal amount">300,000</span>. The Promissory Note was non-interest bearing and payable on the
earlier of (i) December 31, 2023, or (ii) the consummation of the IPO. The Promissory Note expired on <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20230227__20230227__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorsMember_zBMTlxby19xa" title="Promissory note maturity date">July 14, 2023</span>. As of June 30, 2024
and December 31, 2023, there were <span id="xdx_902_eus-gaap--NotesPayable_iI_do_c20240630__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember_zMGyFeQuVqGa" title="Notes outstanding amount"><span id="xdx_902_eus-gaap--NotesPayable_iI_do_c20231231__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember_zGFILMtmypLk" title="Notes outstanding amount">no</span></span> amounts outstanding under the Promissory Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriting
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company granted the underwriters a 45-day option from the date of IPO to purchase up to <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zvvNXvDisHv5" title="Stock issued during the period, shares">900,000</span> additional Units to cover over-allotments,
at the IPO price less the underwriting discounts and commissions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters were entitled to a cash underwriting discount of $<span id="xdx_90E_ecustom--CashUnderwritingDiscountPerUnit_pid_c20240101__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zFo1GPhiffRg" title="Cash underwriting discount per unit">0.25</span> per Unit, or $<span id="xdx_90C_ecustom--CashUnderwritingDiscount_pid_c20240101__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zGRUy9PNOYw7" title="Aggregate cash underwriting discount">1,500,000</span> in the aggregate (or $<span id="xdx_90C_eus-gaap--PaymentsForUnderwritingExpense_pid_c20240101__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zQtc3S5fKzq5" title="Payments for underwriting expense">1,725,000</span> in the aggregate
if the underwriters&#8217; over-allotment option is exercised in full), payable upon the closing of the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2023, the underwriters exercised the over-allotment option in full to purchase <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230717__20230717__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zXGXoLPdIJE" title="Number of stock issued">900,000</span> Units. As a result, on July 18, 2023,
the Company sold an additional <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zaMFNVboA7p6" title="Number of units sold">900,000</span> Units at $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zYUYa8VCiJ1l" title="Sale of stock price per unit">10.00</span> per Unit, generating gross proceeds to the Company of $<span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_ziu6bwz3pv3d" title="Proceeds from sale of units">9,000,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Due
to Related Party</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors paid certain formation, operating or offering costs on behalf of the Company. These amounts were due on demand and non-interest
bearing. As of June 30, 2024, the Sponsors had paid $<span id="xdx_901_eus-gaap--OtherLiabilitiesCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zh40yas4j7Jl" title="Due to related party">151,318</span> on behalf of the Company for expenses related to IPO, which was fully repaid
upon closing of the IPO on July 14, 2023 out of the offering proceeds held in trust account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024 and December 31, 2023, the total accrued expenses due to related parties was $<span id="xdx_902_eus-gaap--AccruedLiabilitiesCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHgUxc2wuXme" title="Accrued expenses">30,000</span> and $<span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z4AFaZSrMok2" title="Accrued expenses">25,250</span>, respectively. See
following paragraphs for details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Initial
Accounting Service Fee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has engaged TenX Global Capital, a related party of the Company, to assist in the preparation of financial statements and other
accounting consulting services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
initial accounting service fee was only related with the initial accounting preparation which was incurred in the period from February
17, 2023 (inception) to March 31, 2023 with total amount of $<span id="xdx_90B_eus-gaap--ProfessionalFees_c20230217__20230331__dei--LegalEntityAxis__custom--TenXGlobalCapitalMember_zRvuXhchtJ5l" title="Accounting service fee">10,000</span>. There was no such cost in the subsequent periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Accounting
Service Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has engaged TenX Global Capital, a related party of the Company, to assist in preparing quarterly and annual financial statements
commencing following the consummation of the IPO. The Company has agreed to pay for these services at a fixed quarterly rate of $<span id="xdx_908_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20230714__20230714__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zOX2X97FTQb3" title="Accounting service fee payable per quarter">5,250</span>
each quarter. For three months ended June 30, 2024 and 2023, a service fee of $<span id="xdx_905_eus-gaap--ProfessionalFees_c20240401__20240630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_z2a0wkbhHnch" title="Accrued liabilities">5,250</span> and $<span id="xdx_901_eus-gaap--ProfessionalFees_c20230401__20230630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_z4qlek3Fzw52" title="Accrued liabilities">0</span> has been accrued and paid for these services.
For six months ended June 30, 2024 and during the period from February 17, 2023 (inception) through June 30, 2023, service fee of $<span id="xdx_90E_eus-gaap--ProfessionalFees_c20240101__20240630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zByW5qAe5wb3" title="Service fee">10,500</span>
and $<span id="xdx_909_eus-gaap--ProfessionalFees_c20230217__20230630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_z1LzqKOYjc84" title="Accounting service fee">0</span> have been incurred for these services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administration
Fee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
on the effectiveness of the Registration Statement on July 11, 2023, an affiliate of the Sponsors will be allowed to charge the
Company an allocable share of its overhead, up to $<span id="xdx_90C_eus-gaap--AffiliateCosts_c20230711__20230711__srt--TitleOfIndividualAxis__custom--SponsorsMember__srt--RangeAxis__srt--MaximumMember_ztqYf0fhDEJa" title="Affiliate costs per month">10,000</span>
per month, until to the close of the Business Combination, to compensate it for the Company&#8217;s use of its office, utilities and
personnel. Administration fee of $<span id="xdx_90E_eus-gaap--AdministrativeFeesExpense_c20240401__20240630_zoRz0cYYRfOe" title="Administrative fee">30,000</span>
and $<span id="xdx_909_eus-gaap--AdministrativeFeesExpense_c20240101__20240630_ziyK2jc0nw98" title="Administrative fee">60,000</span>
were incurred as &#8220;accrued expenses &#8211; related parties&#8221; for the three and six months ended June 30, 2024,
respectively. For the period from February 17, 2023 (inception) through June 30, 2023, the Company did <span id="xdx_90F_eus-gaap--AdministrativeFeesExpense_do_c20230217__20230630_zRb1uQYvrZEk" title="Administration fee">no</span>t
incur any fees for these services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zQXb3zCQnIz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE
5 &#8212; <span id="xdx_821_zWvrpnCnpcQ9">RELATED PARTIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Founder
Shares and EBC Founder Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
February 27, 2023, the Sponsors received <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zCIr7Y2Pgur6" title="Number of shares issued">1,725,000</span> of the Company&#8217;s ordinary shares (&#8220;Founder Shares&#8221;) in exchange
for $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zAr2KHkDuVQ" title="Sponsors received ordinary shares, value">25,000</span> paid for offering costs borne by the Sponsors. Up to <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zr1jFfUVVRJf" title="Number of shares subject to forfeiture">225,000</span> of such Founder Shares were subject to forfeiture to the extent
that the underwriters&#8217; over-allotment was not exercised in full (See Note 7).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 15, 2023, the Company issued to EBC <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zMUErzboSoLf" title="Number of shares issued">180,000</span> ordinary shares (&#8220;EBC founder shares&#8221;) for a purchase price of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zjkuABniQ4Zh" title="Ordinary share price">0.014</span> per
share and an aggregate purchase price of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zwQh6yIRA2u7" title="Value of stock issued">2,520</span>. The EBC founder shares are deemed to be underwriters&#8217; compensation by FINRA pursuant
to Rule 5110 of the FINRA Manual. The Company estimated the fair value of the EBC founder shares to be approximately $<span id="xdx_900_eus-gaap--DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zCwAnFuddb2" title="Fair value of shares issued">1,016,000</span> or $<span id="xdx_90E_eus-gaap--SharePrice_iI_pid_c20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zQ7ZMcax1Dt7" title="Fair value of ordinary per share price">5.65</span>
per share using the Black-Scholes option pricing model. The Company accounted for the difference between the par value and fair value
of the shares as offering cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_898_ecustom--ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock_zmfEjAVBnFBg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair
value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zG9F7VFpDzH4" style="display: none">SCHEDULE
FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left">Time to expiration</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0VXkd1AhY94" title="Time to expiration">1.84</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAKlvigTYDI8" title="Risk-free rate">4.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_znAtmI8QBi6f" title="Volatility rate">5.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWmPu4yISRsa" title="Dividend yield">0.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected likelihood of a successful business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--ExpectedLikelihoodSuccessfulBusinessCombination_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zDmVhFcRiIid" title="Expected likelihood of a successful business combination, percentage">60</span></td><td style="text-align: left">%</td></tr>
  </table>

<p id="xdx_8AD_zfiEO9D8VNCc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur
of: (A) six months after the completion of the initial Business Combination and (B) the date on which the Company completes a liquidation,
merger, share exchange, reorganization or other similar transaction after an initial Business Combination that results in all of the
Company&#8217;s public shareholders having the right to exchange their ordinary shares for cash, securities or other property. EBC has
also agreed, subject to exceptions, that the EBC founder shares cannot be sold, transferred or assigned, until the consummation of an
initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Promissory
Note&#8201;&#8212;&#8201;Related Party</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 27, 2023, the Sponsors issued an unsecured promissory note to the Company (the &#8220;Promissory Note&#8221;), pursuant to which
the Company may borrow up to an aggregate principal amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230227__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zLzIAFDWTmPh" title="Promissory note aggregate principal amount">300,000</span>. The Promissory Note was non-interest bearing and payable on the
earlier of (i) December 31, 2023, or (ii) the consummation of the IPO. The Promissory Note expired on July 14, 2023. As of December 31,
2023, there were no amounts outstanding under the Promissory Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriting
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company granted the underwriters a 45-day option from the date of IPO to purchase up to <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zRyZzePx7WJ9" title="Stock issued during the period, shares">900,000</span> additional Units to cover over-allotments,
at the IPO price less the underwriting discounts and commissions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters were entitled to a cash underwriting discount of $<span id="xdx_907_ecustom--CashUnderwritingDiscountPerUnit_pid_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zMYmFuKKNyXd" title="Cash underwriting discount per unit">0.25</span> per Unit, or $<span id="xdx_90A_ecustom--CashUnderwritingDiscount_pid_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z8k88KDa3uE7" title="Aggregate cash underwriting discount">1,500,000</span> in the aggregate (or $<span id="xdx_90F_eus-gaap--PaymentsForUnderwritingExpense_pid_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z3tJwdw31Mhd" title="Payments for underwriting expense">1,725,000</span> in the aggregate
if the underwriters&#8217; over-allotment option is exercised in full), payable upon the closing of the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2023, the underwriters exercised the over-allotment option in full to purchase <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230717__20230717__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zpp2EAKNx8Ie" title="Stock issued during the period, shares">900,000</span> Units. As a result, on July 18, 2023,
the Company sold an additional <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zQhAMBESvvie" title="Stock issued during the period, shares">900,000</span> Units at $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zZkiQYbsTnza" title="Price per share">10.00</span> per Unit, generating gross proceeds to the Company of $<span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z0IlAoK699Cj" title="Gross proceeds">9,000,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i>Accrued Expenses <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to Related Party</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsors paid certain formation, operating or offering costs on behalf of the Company. These amounts were due on demand and non-interest
bearing. As of December 31, 2023, the Sponsors had paid $<span id="xdx_902_eus-gaap--RepaymentsOfRelatedPartyDebt_c20230217__20231231_z2pzuxMiLAL1" title="Related party debt">151,318</span> on behalf of the Company for expenses related to IPO, which was fully
repaid upon closing of the IPO on July 14, 2023 out of the offering proceeds held in trust account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the total accrued expenses due to related parties was $<span id="xdx_901_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zdH8fz41AjNb" title="Accrued expenses">25,250</span>, which include $<span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zlZpdlDUxZc8" title="Accrued expenses">20,000</span> payable for administration
fee and $<span id="xdx_905_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--IncomeStatementLocationAxis__custom--AccountingServicesExpenseMember_zB6Ukb3G5L25" title="Accrued expenses">5,250</span> payable for accounting service fee. See following paragraphs for details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Initial
Accounting Service Fee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has engaged TenX Global Capital, a related party of the Company, to assist in the preparation of consolidated financial
statements and other accounting consulting services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period from February 17, 2023 (inception) through December 31, 2023, a service fee of $<span id="xdx_901_eus-gaap--ProfessionalFees_c20230217__20231231__dei--LegalEntityAxis__custom--TenXGlobalCapitalMember_zZlGfEKPQcTk" title="Service fee">20,000</span> of offering costs have been incurred
for these services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Accounting
Service Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has engaged TenX Global Capital, a related party of the Company, to assist in preparing quarterly and annual financial statements
commencing following the consummation of the IPO. The Company has agreed to pay for these services at a fixed quarterly rate of $<span id="xdx_90C_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20230217__20231231__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zY2C0ZoW5wz5" title="Payment for services">5,250</span>
each quarter. As of December 31, 2023, a service fee of $<span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_z0a3avIHDclj" title="Accrued liabilities">10,500</span> has been accrued with $<span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrent_iI_c20230630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zkcPy0KNJbw" title="Accrued liabilities"><span id="xdx_908_eus-gaap--AccruedLiabilitiesCurrent_iI_c20230930__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zlbmcucShdHk" title="Accrued liabilities">5,250</span></span> paid for the second and third quarter accounting
service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administration
Fee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
on the effectiveness of the Registration Statement on July 11, 2023, an affiliate of the Sponsors will be allowed to charge the Company
an allocable share of its overhead, up to $<span id="xdx_90A_eus-gaap--AffiliateCosts_c20230711__20230711__srt--TitleOfIndividualAxis__custom--SponsorsMember__srt--RangeAxis__srt--MaximumMember_zmzVt8HJElkh" title="Affiliate costs">10,000</span> per month, until to the close of the Business Combination, to compensate it for the
Company&#8217;s use of its office, utilities and personnel. An administration fee of $<span id="xdx_90E_eus-gaap--AdministrativeFeesExpense_c20230217__20231231_zYQyOU6H0wik" title="Administrative fee">56,667</span> was recorded with $<span id="xdx_90C_eus-gaap--PaymentForAdministrativeFees_c20230217__20231231_zP0trXX3c145" title="Administrative fees paid">36,667</span> paid for the period
from February 17, 2023 (inception) through December 31, 2023. The unpaid amount as of December 31, 2023 was $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zVcmXvdbCOlb" title="Accrued expenses">20,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300827125936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zyLIYCmATNUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8212;<span id="xdx_823_zKJ1iHLnOPih"> COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares, EBC founder shares, Private Placement Units will be entitled to registration rights pursuant to a registration
rights agreement dated on the effectiveness of the Registration Statement on July 11, 2023 requiring the Company to register such securities
for resale. Subject to certain limitations set forth in such agreement, the holders of these securities will be entitled to make up to
three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain
&#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to completion of a Business Combination
and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the
registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration
statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear
the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination Marketing Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has engaged EBC as an advisor in connection with its Business Combination to assist in holding meetings with the Company stockholders
to discuss the potential Business Combination and the target business&#8217; attributes, introduce the Company to potential investors
that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and
public filings in connection with the Business Combination. The Company will pay EBC a service fee for such services upon the consummation
of its initial Business Combination in an amount of $<span id="xdx_90E_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20240101__20240630__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_z8kVxINh0KM2" title="Service fee">2,415,000</span>, equal to<span id="xdx_90C_ecustom--PercentageOfGrossProceedsOfInitialPublicOffering_iI_pid_dp_uPure_c20240630__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_zyk8isjetBP6" title="Percentage of gross proceeds of initial public offering"> 3.5</span>% of the gross proceeds of the IPO. In addition, the Company
will pay EBC a service fee in an amount equal to <span id="xdx_90A_ecustom--PercentageOfServiceFeeOfTotalConsiderationPayable_iI_pid_dp_uPure_c20240630__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_z2VYbFe6dlTh" title="Percentage of service fee of total consideration payable">1.0</span>% of the total consideration payable in the initial Business Combination if it introduces
the Company to the target business with whom it completes an initial Business Combination and the amount will be payable in cash and
is due at the closing date of the initial Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Business
Combination Transaction Cost</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company has engaged several service providers including legal and valuation services, specifically for business combination between
the Company and Shenzhen Qianzhi BioTechnology Co. Ltd. (&#8220;Qianzhi&#8221;). Per the agreed terms, Qianzhi agreed to be
responsible for all expenses incurred by the Company in connection with business combination. During the three months ended June 30,
2024, $<span id="xdx_903_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20240401__20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zNbVaVR6mQbd" title="Business combination related cost incurred">45,199</span>
of business combination related cost has been incurred which $<span id="xdx_909_ecustom--BusinessCombinationAcquisitionRelatedCostsReimbursed_c20240401__20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zn5QdfCt14gi" title="Business combination related cost reimbursed">0</span>
was reimbursed by Qianzhi. During the six months ended June 30, 2024, $<span id="xdx_90C_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20240101__20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zTnFCog0Y3k8" title="Business combination related cost">252,002</span>
of business combination related cost has been incurred which $<span id="xdx_904_ecustom--BusinessCombinationAcquisitionRelatedCostsReimbursed_c20240101__20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zF0rcg51FBh9" title="Business combination related cost reimbursed">206,803</span>
was reimbursed by Qianzhi. This activity has been recorded net in accompanying financial statements. As of June 30, 2024, the
receivable from Qianzhi and accrued to service providers was $<span id="xdx_906_eus-gaap--OtherReceivablesNetCurrent_iI_c20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zT1W5C1zhSL6" title="Other receivables"><span id="xdx_902_ecustom--BusinessCombinationAcquisitionRelatedCostsReimbursed_c20240731__20240731__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXqmxgAxwRZh" title="Business combination related cost reimbursed">45,199</span></span>. On July 31, 2024, the outstanding amount was paid off by Qianzhi.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zDW4iBFCPjua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8212; <span id="xdx_82F_zWCny5HvGM6g">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares, EBC founder shares, Private Placement Units will be entitled to registration rights pursuant to a registration
rights agreement dated on the effectiveness of the Registration Statement on July 11, 2023 requiring the Company to register such securities
for resale. Subject to certain limitations set forth in such agreement, the holders of these securities will be entitled to make up to
three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain
&#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to completion of a Business Combination
and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the
registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration
statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear
the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination Marketing Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has engaged EBC as an advisor in connection with its Business Combination to assist in holding meetings with the Company stockholders
to discuss the potential Business Combination and the target business&#8217; attributes, introduce the Company to potential investors
that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and
public filings in connection with the Business Combination. The Company will pay EBC a service fee for such services upon the consummation
of its initial Business Combination in an amount of $<span id="xdx_90D_ecustom--ServiceFee_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_zGCuHHR5bgnd" title="Service fee">2,415,000</span>, equal to <span id="xdx_903_ecustom--PercentageOfGrossProceedsOfInitialPublicOffering_iI_pid_dp_uPure_c20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_zwsYgwylXRvg" title="Percentage of gross proceeds of initial public offering">3.5</span>% of the gross proceeds of the IPO. In addition, the Company
will pay EBC a service fee in an amount equal to <span id="xdx_90C_ecustom--PercentageOfServiceFeeOfTotalConsiderationPayable_iI_pid_dp_uPure_c20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_z1MHaUYqhHte" title="Percentage of service fee of total consideration payable">1.0</span>% of the total consideration payable in the initial Business Combination if it introduces
the Company to the target business with whom it completes an initial Business Combination and the amount will be payable in cash and
is due at the closing date of the initial Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Business Combination Transaction Cost</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has engaged several service
providers including legal and valuation services, specifically for business combination between the Company and Shenzhen Qianzhi
BioTechnology Co. Ltd. (&#8220;Qianzhi&#8221;). Per the agreed terms, Qianzhi agreed to be responsible for all expenses incurred by
the Company in connection with business combination. During the year of 2023, $<span id="xdx_90A_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20230217__20231231_zhFSJN0oMyzj" title="Business combination related cost">181,022</span>
of business combination related cost has been incurred and reimbursed by Qianzhi and approximately <span id="xdx_909_eus-gaap--AccountsPayableCurrent_iI_c20231231_zzlObPMfAG48" title="Commited for future expenses">$200,000</span>
is committed for future services as of December 31, 2023. This activity has been recorded net in accompanying financial
statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300826309280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS&#8217; EQUITY<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS&#8217; EQUITY</a></td>
<td class="text"><p id="xdx_806_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zeIgVsuanBU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8212; <span id="xdx_828_zgUlCuCAyM4j">SHAREHOLDERS&#8217; EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Shares</i></b> &#8212; The Company is authorized to issue <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240630_zyR5QrsW2Eb5" title="Preferred stock, shares authorized">2,000,000</span> preferred shares with a par value of $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240630_zEBeCxRsxLN5" title="Preferred stock, par value">0.0001</span> per share with such
designations, voting and other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.
As of June 30, 2024 and December 31, 2023, there were <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_do_c20240630_zMfFFe5S887j" title="Preferred stock, shares issued"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240630_zYqfeMLFear6" title="Preferred stock, shares outstanding"><span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_z09AC5Dpm2L" title="Preferred stock, shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_zLXarCeMPJy7" title="Preferred stock, shares outstanding">no</span></span></span></span> preferred shares issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ordinary
Shares</i></b> &#8212; The Company is authorized to issue <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240630_zfUpVDR31W4a" title="Ordinary stock, shares authorized">200,000,000</span> ordinary shares with a par value of $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240630_zfJvfrxZNPde" title="Ordinary stock, par value">0.0001 </span>per share. <span id="xdx_909_eus-gaap--CommonStockVotingRights_c20240101__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4o5zkecJ5da" title="Ordinary stock, voting rights">Holders
of ordinary shares are entitled to one vote for each share</span>. On February 27, 2023, the Sponsors received <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zimQWWaQ0bua" title="Issuance of ordinary shares to Sponsor, shares">1,725,000</span> of the Founder Shares
in exchange for $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zJ60AhrGcQQd" title="Issuance of ordinary shares to Sponsor, value">25,000</span> paid for offering costs borne by the Sponsors, of which an aggregate of up to <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zv71jJBVmkbd" title="Number of shares subject to forfeiture">225,000</span> of such Founder Shares
were subject to forfeiture to the extent that the underwriters&#8217; over-allotment was not exercised in full or in part, so that the
number of Founder Shares will equal 20% of the Company&#8217;s issued and outstanding ordinary shares after the IPO (excluding shares
underlying the Private Placement Units). No ordinary shares are subject to forfeiture since the over-allotment was fully exercised on
July 17, 2023. As of June 30, 2024 and December 31, 2023, there were <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_pid_c20240630_zne4WSgLqDCf" title="Ordinary shares issued"><span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240630_zK99cXm3ZeR6" title="Ordinary shares outstanding"><span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_z41EvWA6EZCe" title="Ordinary stock, shares issued"><span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zYds4ElMB4K2" title="Ordinary stock, shares outstanding">2,266,500</span></span></span></span> ordinary shares issued and outstanding (excluding <span id="xdx_90D_ecustom--OrdinarySharesSubjectToRedemption_iI_c20240630_zTDTCDdxX3we" title="Ordinary shares subject to redemption">6,900,000</span>
shares subject to possible redemption).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rights
</i></b>&#8212; Except in cases where the Company is not the surviving company in a business combination, <span id="xdx_901_eus-gaap--CommonStockVotingRights_c20240101__20240630_zS2WDoWWNPpl" title="Ordinary stock, voting rights">each holder of a right will
automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination</span>. The Company will
not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole
share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company is not the surviving
company upon completion of the initial Business Combination, each holder of a right will be required to affirmatively convert his, her
or its rights in order to receive the one-tenth (1/10) of one ordinary share underlying each right upon consummation of the business
combination. If the Company is unable to complete the initial Business Combination within the required time period and the Company will
redeem the public shares for the funds held in the trust account, holders of rights will not receive any of such funds for their rights
and the rights will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_806_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zxzDqZ7DJ07a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8212; <span id="xdx_822_z0FvqJdQcbBj">SHAREHOLDERS&#8217; EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Shares</i></b> &#8212; The Company is authorized to issue <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zLLMAE4iHR01" title="Preferred stock, shares authorized">2,000,000</span> preferred shares with a par value of $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zQN4FecLJtH" title="Preferred stock, par value">0.0001</span> per share with such
designations, <span id="xdx_90C_eus-gaap--PreferredStockVotingRights_c20230217__20231231_zkZ7SrAVjtb3" title="Preferred stock voting rights">voting and other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.</span>
As of December 31, 2023, there were <span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_z8Ity03v6p7d" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_zOAsmf68SbH7" title="Preferred stock, shares outstanding">no</span></span> preferred shares issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ordinary
Shares</i></b> &#8212; The Company is authorized to issue <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zWizlRhR6Eue" title="Common stock, shares authorized">200,000,000</span> ordinary shares with a par value of $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zTVpTrwnUc3a" title="Common stock, par value">0.0001</span> per share. <span id="xdx_904_eus-gaap--CommonStockVotingRights_c20230217__20231231_z9JBDOFQkyL3" title="Common stock voting rights">Holders
of ordinary shares are entitled to one vote for each share.</span> On February 27, 2023, the Sponsors received <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zuujyD6O0fd9" title="Issuance of ordinary shares to Sponsor, shares">1,725,000</span> of the Founder Shares
in exchange for $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zKcPZ1vI09rd" title="Issuance of ordinary shares to Sponsor, value">25,000</span> paid for offering costs borne by the Sponsors, of which an aggregate of up to <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z4EUK7diXbe9" title="Number of shares subject to forfeiture">225,000</span> of such Founder Shares
were subject to forfeiture to the extent that the underwriters&#8217; over-allotment was not exercised in full or in part, so that the
number of Founder Shares will equal 20% of the Company&#8217;s issued and outstanding ordinary shares after the IPO (excluding shares
underlying the Private Placement Units). No ordinary shares are subject to forfeiture since the over-allotment was fully exercised on
July 17, 2023. As of December 31, 2023, there were <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zQC5NH2oeJ7j" title="Ordinary shares issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zvJxokkXZFGl" title="Ordinary shares outstanding">2,266,500</span></span> ordinary shares issued and outstanding (excluding <span id="xdx_90D_ecustom--OrdinarySharesSubjectToRedemption_iI_c20231231_zWpy2SOMaTy9" title="Ordinary shares subject to redemption">6,900,000</span> shares subject
to possible redemption).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rights
</i></b>&#8212; Except in cases where the Company is not the surviving company in a business combination, <span id="xdx_909_eus-gaap--CommonStockVotingRights_c20230217__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zh7bguN3OHx6" title="Common stock voting rights">each holder of a right will
automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination.</span> The Company will
not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole
share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company is not the surviving
company upon completion of the initial Business Combination, each holder of a right will be required to affirmatively convert his, her
or its rights in order to receive the one-tenth (1/10) of one ordinary share underlying each right upon consummation of the business
combination. If the Company is unable to complete the initial Business Combination within the required time period and the Company will
redeem the public shares for the funds held in the trust account, holders of rights will not receive any of such funds for their rights
and the rights will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300824717536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p id="xdx_807_eus-gaap--FairValueDisclosuresTextBlock_zglg1BNMSnDb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8212;<span id="xdx_82D_zBPu0g79U7mj"> Fair Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which
transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets
or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_892_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zHevNpAQnl41" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis at June 30,
2024 and December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair
value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zrl4VqYdy7I6" style="display: none">SCHEDULE
OF MEASURED FAIR VALUE ON RECURRING BASIS</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Date</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Trading Securities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2024</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 45%; text-align: left">Marketable securities held in the trust account</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zbjEgAq8OH5k" style="width: 12%; text-align: right" title="Marketable securities held in the trust account">73,284,700</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Marketable securities held in the trust account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zD90qliMI9ii" style="text-align: right" title="Marketable securities held in the trust account">71,419,358</td><td style="text-align: left">&#160;</td></tr>
  </table>




<p id="xdx_8AD_zH3p57bs5Deg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_807_eus-gaap--FairValueDisclosuresTextBlock_znVM2BK1Thll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8212; <span id="xdx_826_z0bbJURugr27">Fair Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which
transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets
or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
significant assumptions which the Company used to value the EBC Founder Shares are referred to Note 5. The following table presents
information about the Company&#8217;s assets that are measured at fair value on a recurring basis at December 31, 2023 and indicates
the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.</span></p>

<p id="xdx_894_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z6NnfmmBvQmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BF_zSlcIVF1yKE1" style="display: none">SCHEDULE
OF MEASURED FAIR VALUE ON RECURRING BASIS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_491_20231231_zoAXwkwUOHz2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49E_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zwEAR7ev2ltj" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49E_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_ziheDFnDL1pl" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_495_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zeYDvkFcb7vc" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prices in</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Active</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Markets</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level
    1)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level
    2)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level
    3)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsHeldInTrustNoncurrent_iI_zO45lkmG0Kef" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment held in trust account</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,419,358</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,419,358</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="-sec-ix-hidden: xdx2ixbrl1506">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1507">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A0_zbyOkNUMQ2mi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300827086864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zicSOEJTmSq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8212;<span id="xdx_829_zB00o4Dzkw19"> SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were available to be issued. Based upon this review, the Company identified the following subsequent event that would have required adjustment
or disclosure in the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On July 31, 2024, $<span id="xdx_909_ecustom--BusinessCombinationAcquisitionRelatedCostsReimbursed_c20240731__20240731__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zBdO0ERmmxf1" title="Business combination related cost reimbursed">45,199</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">of
business combination related cost was reimbursed by Qianzhi.</span></p>
<span></span>
</td>
<td class="text"><p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zEoeOS28HpNb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8212; <span id="xdx_824_zMsFDRBzlrP6">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated
financial statements were issued. Based on the review, management identified the following subsequent event that is required
disclosure in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 18, 2024, the Company entered into an Agreement and Plan of Reorganization (the &#8220;Agreement&#8221;) with (i) Bowen Merger
Sub, a Cayman Islands exempted company and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), (ii) Shenzhen Qianzhi
BioTechnology Co. Ltd., a company incorporated in the People&#8217;s Republic of China and a wholly owned subsidiary of NewCo (as defined
below) (&#8220;Shenzhen Qianzhi&#8221;), and (iii) <span style="background-color: white">Qianzhi Group Holding (Cayman) Limited, a newly
formed Cayman Islands company (&#8220;<span style="text-decoration: underline">NewCo</span>,&#8221; and collectively with the Company, Merger Sub and Shenzhen Qianzhi, the &#8220;<span style="text-decoration: underline">Parties</span>&#8221;,
each a &#8220;<span style="text-decoration: underline">Party</span>&#8221;).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Agreement, at the closing of the business combination, Merger Sub will merge with and into NewCo (the &#8220;<span style="text-decoration: underline">Merger</span>&#8221;),
with NewCo being the surviving company of the Merger (&#8220;<span style="text-decoration: underline">Surviving Company</span>&#8221;) and becoming a wholly owned subsidiary
of the Company. In the Merger, the holders (the &#8220;NewCo Shareholders&#8221;) of the ordinary shares of NewCo (&#8220;NewCo Ordinary
Shares&#8221;) will receive ordinary shares of the Company (&#8220;Parent Ordinary Shares&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Agreement, at the effective time of the Merger (the &#8220;Effective Time&#8221;), all of NewCo Ordinary Shares issued and outstanding
immediately prior to the Effective Time will be automatically converted into the right to receive an aggregate of (a) <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240118__20240118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--MergerSharesMember__us-gaap--TypeOfArrangementAxis__custom--AgreementMember_zdnqll8HqLSg" title="Number of parent ordinary shares">7,246,377</span> Parent
Ordinary Shares (the &#8220;Merger Shares&#8221;), and (b) the right to receive earnout consideration of up to an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240118__20240118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--EarnoutSharesMember__us-gaap--TypeOfArrangementAxis__custom--AgreementMember__srt--RangeAxis__srt--MaximumMember_zcVhP7HKEhTa" title="Number of parent ordinary shares">1,400,000</span>
Parent Ordinary Shares (the &#8220;Earnout Shares&#8221;).</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300824632976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zDGTG5XmeChh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zUxqRnHjUOqj">Basis
of Presentation and Principles of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;US GAAP&#8221;) for interim financial information and in accordance with the instructions to
Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the unaudited financial statements reflect all adjustments, which
include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The
interim results for the period ended June 30, 2024 are not necessarily indicative of the results that may be expected through December
31, 2024. All intercompany accounts and transactions are eliminated upon consolidation. The information included in this Form 10-Q should
be read in conjunction with information included in the Company&#8217;s annual report on Form 10-K for the year ended December 31, 2023,
filed with the Securities and Exchange Commission on March 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zHmSXfLEBGWa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_866_zwgilH11G9z2">Basis
of Presentation and Principles of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary and are presented
in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;)
and pursuant to the rules and regulations of the SEC. All intercompany accounts and transactions are eliminated upon consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_EmergingGrowthCompanyPolicyTextBlock', window );">Emerging Growth Company</a></td>
<td class="text"><p id="xdx_84D_ecustom--EmergingGrowthCompanyPolicyTextBlock_zSmJyp9e1Gmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_ztfXEU3hhLC5">Emerging
Growth Company</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84A_ecustom--EmergingGrowthCompanyPolicyTextBlock_zWKlwfrQmYzd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_866_zfYOuyVDRYsl">Emerging
Growth Company</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--UseOfEstimates_zd8txaf1Tr45" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_ziK8M0jpATv7">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the consolidated financial statement in conformity with US GAAP requires the Company&#8217;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_840_eus-gaap--UseOfEstimates_zCA91RayHq8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zHOe49ZxvDKe">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the financial statement in conformity with US GAAP requires the Company&#8217;s management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zipcGUzRtCtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zNGkI8nRUxtd">Cash
and cash equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had a cash balance of $<span id="xdx_902_eus-gaap--Cash_iI_pp0p0_c20240630_zAlO8iPeSzX7" title="Cash">272,630</span> and $<span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20231231_zmztkBWTdqn5" title="Cash">426,913</span> as of June 30, 2024 and December 31, 2023, respectively. The Company had <span id="xdx_909_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240630_z2CKN0fZxdza" title="Cash equivalents"><span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zkEELsKcwKJ" title="Cash equivalents">no</span></span> cash
equivalents as of June 30, 2024 and December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zmfCyCJVr811" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_86B_zAwsvaka99Lf">Cash
and cash equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash
equivalents. The Company had a cash balance of $<span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20231231_zFK1kspiUhB5" title="Cash">426,913</span>
as of December 31, 2023. The Company had <span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_znrFr9kvJLR2" title="Cash equivalents">no</span> cash equivalents as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments Held in Trust Account</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--InvestmentPolicyTextBlock_zL5lotToLD14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zgn1LlvFy8Aj">Investments
Held in Trust Account</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s portfolio of investments held in the Trust Account is comprised of investments only in U.S. government securities with
a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which
invest only in direct U.S. government treasury obligations. The Company&#8217;s investments held in the Trust Account are classified
as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains
and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable
securities held in Trust Account in the accompanying statements of operations. The estimated fair value of investments held in the Trust
Account is determined using available market information. As of June 30, 2024 and December 31, 2023, the Trust Account had balance of
$<span id="xdx_907_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20240630_zTCSUZQOVlMi" title="Trust account balance">73,284,700</span> and $<span id="xdx_904_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231_zqPrkszMnHZc" title="Trust account balance">71,419,358</span>, respectively. The interest and dividend income earned from the Trust Account totaled $<span id="xdx_90B_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_pp0p0_c20240401__20240630_zsiiM69cBkFd" title="Interests earned from trust account">941,850</span> and $<span id="xdx_901_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_pp0p0_c20240101__20240630_zXYhRnbC0yXk" title="Interest and dividend income earned from trust account">1,865,342</span>
for three and six months ended June 30, 2024, respectively, which were fully reinvested into the Trust Account as earned and unrealized
gain on investments and therefore presented as an adjustment to the operating activities in the Consolidated Statements of Cash Flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84F_eus-gaap--InvestmentPolicyTextBlock_zqRWTWIBXBQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_866_zJ3NmQZbipc9">Investments
Held in Trust Account</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company&#8217;s portfolio of investments held in the trust account is comprised of investments only in U.S. government securities
with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company
Act which invest only in direct U.S. government treasury obligations. The Company classified its investments in treasury securities
as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period.
Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on
marketable securities held in trust account in the accompanying statements of operations. The estimated fair value of investments
held in the trust account is determined using available market information. As of December 31, 2023, the trust account had cash
balance of $<span id="xdx_90E_eus-gaap--AssetsHeldInTrust_iI_c20231231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashMember_zOzfr1rK79ag" title="Trust account, cash balance">8,208</span> together with U.S. Treasury Bills of $<span id="xdx_905_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zZqLbbU6cr9a" title="Trust account, cash balance, with U.S. treasury bills">71,411,150</span> which subsequently matured on January 11, 2024. And the total balance was reinvested in the money market
fund thereafter.
The interests earned from the trust account totaled $<span id="xdx_906_ecustom--InterestsEarnedFromTrustAccount_pp0p0_c20230217__20231231_zWbX4N8uaJVj" title="Interests earned from trust account">1,729,358</span>
for the period from February 17, 2023 (inception) through December 31, 2023, which were fully reinvested into the trust account as
earned and unrealized gain on investments and therefore presented as an adjustment to the operating activities in the Statement of
Cash Flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_OfferingCostsPolicyTextBlock', window );">Offering Costs</a></td>
<td class="text"><p id="xdx_84F_ecustom--OfferingCostsPolicyTextBlock_zJohv5TrH4Le" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zDoEB7BkwZVg">Offering
Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
costs consist of legal and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that
are directly related to the IPO and that were charged to shareholders&#8217; equity upon the completion of the IPO on July 14, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_841_ecustom--OfferingCostsPolicyTextBlock_zTKkNdQFKHJk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zamlBjzlDZ2b">Offering
Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
costs consist of legal, accounting, and other costs (including underwriting discounts and commissions) incurred through the balance sheet
date that are directly related to the IPO and that were charged to shareholders&#8217; equity upon the completion of the IPO on July
14, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_z71YEBUcSXue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zhUqkdxrCMji">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;<i>Income Taxes</i>.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were <span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20240630_zbzapixzmQ0k" title="Unrecognized tax benefits"><span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zSaQfj8d9C6d" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits and <span id="xdx_901_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20240630_zcLDqJZK7E8c" title="Interest and penalties accrued"><span id="xdx_900_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20231231_z7FZkptnHQR8" title="Interest and penalties accrued">no</span></span> amounts accrued for interest and penalties as of June 30, 2024
and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals,
or material deviation from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax
regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#8217;s
consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zGDLIhZAEBn4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_861_zjwJMGXFhF8i">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;<i>Income Taxes</i>.&#8221;
Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the <span style="background-color: white">consolidated </span>
financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and
liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is
recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce
deferred tax assets to the amount expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were <span id="xdx_90B_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zsYWbZ380F1h" title="Unrecognized tax benefits">no</span> unrecognized tax benefits and <span id="xdx_90F_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20231231_zSsfZpwbEj33" title="Accrued for interest and penalties">no</span> amounts accrued for interest and penalties as of December 31, 2023.
The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation
from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax
regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#8217;s
consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) per Ordinary Share</a></td>
<td class="text"><p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zlFO4bhF6Kk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zHGM35ZCbFJk">Net
Income (Loss) per Ordinary Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include
a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income
per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company
first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed
income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss)
ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement
of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public
shareholders. As of June 30, 2024 and 2023, the Company did not have any dilutive securities and other contracts that could, potentially,
be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per
share is the same as basic income (loss) per share for the period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net income (loss) per share presented in the statements of operations is based on the following:</span></p>

<p id="xdx_89F_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zFiYCcWKe56f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zZaHA01dQnV4" style="display: none">SCHEDULE
OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_492_20240401__20240630_zEPV8mzuxNO8" style="font-weight: bold; text-align: center"><b>2024</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_491_20230401__20230630_zgwKQxKgn7vh" style="font-weight: bold; text-align: center"><b>2023</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_49B_20240101__20240630_zNbVNk9ZmBQe" style="text-align: center"><b>June 30,<br/>
    2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_494_20230217__20230630_zcd2NavKx0ld" style="text-align: center"><b>June 30, <br/>
    2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Three Months Ended June 30,</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>Six Months Ended</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>For the Period from February 17, 2023 through</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2024</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2023</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>June 30,<br/>
    2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>June 30, <br/>
    2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_maNLIAOz10T_zbrmeHprLolh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Net income (loss)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">816,754</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0535">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,603,116</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(3,105</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_401_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz10T_zAbKlpGMN215" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accretion of temporary equity into redemption value (interest earned)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(941,850</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0540">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,865,342</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0542">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--NetLossIncludingAccretionOfEquityIntoRedemptionValue_iT_mtNLIAOz10T_zuPmzF721cVd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss including accretion of equity into redemption value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(125,096</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(262,226</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,105</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8AF_zsq1envgUrs1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zNJHbGlybjOl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_z4YUe7BJfSVk" style="display: none">SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED</span></span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSBy0peTNeqd" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zHFJtctmQ7Af" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_493_20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zrGeGu54Bja" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrUDxN5tolnh" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_499_20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zoS3vQSHFBhl" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_499_20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCvvcjVvYjp1" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zN0D5o5bki2k" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zco4vS2BZfp7" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Three Months Ended<br/>
 June 30, 2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Six Months Ended &#160;<br/>
June 30, 2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Three Months Ended <br/>
June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the Period from <br/>
February 17, 2023 through <br/>
June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Particulars</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and
    diluted net income/(loss) per share:</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average shares outstanding</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRlmacH7Veaj" title="Weighted-average shares outstanding - basic"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z7aUZCzHX6wh" title="Weighted average shares outstanding - diluted">6,900,000</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zOQnfAKWBQC4" title="Weighted-average shares outstanding - basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zw7LQikX1Owc" title="Weighted average shares outstanding - diluted">2,266,500</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zlAbDpzpBcE5" title="Weighted-average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zwdZB8aavyb4" title="Weighted average shares outstanding - diluted">6,900,000</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z4xwsqmQRZs5" title="Weighted-average shares outstanding - basic"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqoTpOOCEHOh" title="Weighted average shares outstanding - diluted">2,266,500</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zvYEr2B32Nu2" title="Weighted-average shares outstanding - basic"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zADwgPj1Bpz9" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0567"><span style="-sec-ix-hidden: xdx2ixbrl0569">-</span></span></span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFN1VzmKwYAa" title="Weighted-average shares outstanding - basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFBwNIxZYrE8" title="Weighted average shares outstanding - diluted">1,680,000</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; font-size: 11pt; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zfVl1CLuVOr" title="Weighted-average shares outstanding - basic"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_znOvNmn9lYB4" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0575"><span style="-sec-ix-hidden: xdx2ixbrl0577">-</span></span></span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYEWjo6tCvF5" title="Weighted-average shares outstanding - basic"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zuALVTokWFIa" title="Weighted average shares outstanding - diluted">1,656,774</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership percentage</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--OwnershipPercentage_pid_dp_uPure_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRX0VSo5MI3e" title="Ownership percentage">75</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--OwnershipPercentage_pid_dp_uPure_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zI77K3HjvqZd" title="Ownership percentage">25</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zcTLuYDNbyS5" title="Ownership percentage">75</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zq3nXiuDFsM3" title="Ownership percentage">25</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zz6QDtUW3A9l" title="Ownership percentage"><span style="-sec-ix-hidden: xdx2ixbrl0591">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zd3pzYuFsn3k" title="Ownership percentage">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zzQDZ6b20zb" title="Ownership percentage"><span style="-sec-ix-hidden: xdx2ixbrl0595">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFLbzzGvCPba" title="Ownership percentage">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerators:</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zshkQfUYiUi6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of net loss including
    accretion of temporary equity</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(94,165</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30,931</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(197,388</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(64,838</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0603">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0604">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0605">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,105</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_402_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_z6JeXvyniSQ4" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    earned on investment held in trust account</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">941,850</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0609">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,865,342</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0611">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0612">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0613">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0614">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0615">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_znOk6211LrT4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of net income/(loss)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">847,685</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30,931</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,667,954</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(64,838</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0621">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0622">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0623">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,105</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominators:</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average shares
    outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQzV0IDvSyj2" title="Weighted average shares outstanding - basic"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zOT1zbMGB639" title="Weighted average shares outstanding - diluted">6,900,000</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_ze0K9wVa10dd" title="Weighted average shares outstanding - basic"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zcDkDRb7KoM2" title="Weighted average shares outstanding - diluted">2,266,500</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zYvu0Nr3kbJf" title="Weighted average shares outstanding - basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zGimqSbrnS3g" title="Weighted average shares outstanding - diluted">6,900,000</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMUgytbR5TI3" title="Weighted average shares outstanding - basic"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zC3p20bgWXld" title="Weighted average shares outstanding - diluted">2,266,500</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zyptN8z7J0zk" title="Weighted average shares outstanding - basic"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zC95eqOTAu9k" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0642"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></span></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zbyRYDgivH3e" title="Weighted average shares outstanding - basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zXbDy5TMdmMb" title="Weighted average shares outstanding - diluted">1,680,000</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTdaJvG0QYge" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z9t6Q9aH3u9i" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0650"><span style="-sec-ix-hidden: xdx2ixbrl0652">-</span></span></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z34tVg8XqKUi" title="Weighted-average shares outstanding - basic"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYR4raUHLa09" title="Weighted-average shares outstanding - diluted">1,656,774</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net income/(loss) per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z34oXUuyBQ39" title="Basic net income/(loss) per share"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zvLOYwYGlhe1" title="Diluted net income/(loss) per share">0.12</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zuL9mXv5DD1l" title="Basic net income/(loss) per share"><span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrvsnXUJxtbj" title="Diluted net income/(loss) per share">(0.01</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQpX6slT0dG2" title="Basic net income/(loss) per share"><span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zG7Oo29qJ0Wc" title="Diluted net income/(loss) per share">0.24</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zJDyTrubNsA" title="Basic net income/(loss) per share"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zzlN34jafbG5" title="Diluted net income/(loss) per share">(0.03</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zg0u4HGHo3va" title="Basic net income/(loss) per share"><span id="xdx_904_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zdFuSn87WLE2" title="Diluted net income/(loss) per share"><span style="-sec-ix-hidden: xdx2ixbrl0674"><span style="-sec-ix-hidden: xdx2ixbrl0676">-</span></span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zhEKTZF2Z2Pd" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zsHEHZzJIhbc" title="Diluted net income/(loss) per share"><span style="-sec-ix-hidden: xdx2ixbrl0678"><span style="-sec-ix-hidden: xdx2ixbrl0680">-</span></span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z6KC1AJBXhJc" title="Basic net income/(loss) per share"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zA2v4GYzuEPk" title="Diluted net income/(loss) per share"><span style="-sec-ix-hidden: xdx2ixbrl0682"><span style="-sec-ix-hidden: xdx2ixbrl0684">-</span></span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_za6AczHeao4j" title="Basic net income/(loss) per share"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zKdoRSOAcBi4" title="Diluted net income/(loss) per share">(0.002</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p id="xdx_8AE_z9AwGfR5raC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_841_eus-gaap--EarningsPerSharePolicyTextBlock_zHgK6ZKKHid" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_86A_z0ppd2hs22Oa">Net
Income (Loss) per Ordinary Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><br/>
The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include
a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income
per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company
first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed
income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss)
ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement
of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public
shareholders. As of December 31, 2023, the Company did not have any dilutive securities and other contracts that could, potentially,
be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per
share is the same as basic income (loss) per share for the period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
net income (loss) per share presented in the statements of operations is based on the following:</span></p>

<p id="xdx_89A_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_z5fqU2qlhri2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_zHiJwUlqeU1k" style="display: none">SCHEDULE
OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230217__20231231_zbKQnV15xwDe" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Period from February 17, 2023 (Inception) Through</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_maNLIAOz10T_zOJii0vLKohb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left">Net income</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">1,484,790</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--InterestEarnedOnInvestmentHeldInTrustAccount_iN_di_msNLIAOz10T_zo7AJGrk1xXi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest earned on investment held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,729,358</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz10T_zAg74kxuxLM" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of temporary equity into redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,591,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--NetLossIncludingAccretionOfCommonStockToRedemptionValue_iT_mtNLIAOz10T_zKdGwxjFuO41" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss including accretion of common stock to redemption value</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(7,836,068</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p id="xdx_8AC_zYKcI8lxkzp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zcpFV3BsqmD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BF_zMFGGaplzlue">SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSbd0Fp6rMFl" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zGAERQ6dGDUi" style="font-weight: bold; text-align: center">Non-Redeemable</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Period from February 17, 2023 (Inception) Through</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Non-Redeemable</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Particulars</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic and diluted net income/(loss) per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%">Weighted-average shares outstanding</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zU6CljOH48ac" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zFYq4I4GQtSh" title="Weighted average shares outstanding - diluted">3,819,156</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zNfgYAWx4Gr9" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCzo2RWqf9bk" title="Weighted average shares outstanding - diluted">2,095,943</span></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ownership percentage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zECPHfL2glR8" title="Ownership percentage">65</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zsjNSrA2WIZc" title="Ownership percentage">35</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Numerators:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zVCdrxP2wiac" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Allocation of net loss including accretion of temporary equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,059,453</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,776,615</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--IncomeEarnedOnTrustAccount_iN_di_zAHwZN6mpoR2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income earned on Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,729,358</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1294">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_zDB0ptiEw1dk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of temporary equity to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,591,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1297">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--AllocationOfNetIncomeloss_zq0KsXBOf1Ke" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Allocation of net income/(loss)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">4,261,405</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(2,776,615</td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Denominators:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted-average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRIL4Yi3jFe8" title="Weighted average shares outstanding - basic"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTMeIKfe5D67" title="Weighted average shares outstanding - diluted">3,819,156</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zZ4GwgKssWo7" title="Weighted average shares outstanding - basic"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqU9AdEZFfK1" title="Weighted average shares outstanding - diluted">2,095,943</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income/(loss) per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zftFIOmZjSkl" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zVuMWGvFHwTb" title="Diluted net income/(loss) per share">1.12</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zHHmNNLje0E9" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zg1zZTQ3WBvh" title="Diluted net income/(loss) per share">(1.32</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A7_zWjFEaPV48a9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_z3lZhr9911K6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zPYpyu6KgvTj">Concentration
of Credit Risk</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_c20240630_z3L1nYZwLMTb" title="Cash FDIC insured amount">250,000</span>. The Company has not experienced losses on these accounts
and management believes the Company is not exposed to significant risks on such accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z2d9dRUEHMr8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zOFadp8Mtut6">Concentration
of Credit Risk</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zMylsduoDCS4" title="Cash, FDIC insured amount">250,000</span>. The Company has not experienced losses on these accounts
and management believes the Company is not exposed to significant risks on such accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zcJebipTI21i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_z7zkLhnilQEl">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;<i>Fair Value
Measurement</i>,&#8221; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zeMFmxxmd9tb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zpDX0PpSV6R5">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;<i>Fair Value
Measurement</i>,&#8221; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock', window );">Ordinary Shares Subject to Possible Redemption</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zVKEDCaCr3jb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zRwInfBS5jUe">Ordinary
Shares Subject to Possible Redemption</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Ordinary shares subject to mandatory redemption (if
any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary
shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, ordinary shares
are classified as shareholders&#8217; equity. The Company&#8217;s ordinary shares features certain redemption rights that are considered
to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject
to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#8217; equity section of the
Company&#8217;s balance sheet. <span style="background-color: white">The Company recognizes changes in redemption value immediately as
they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.
Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital
and accumulated deficit.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zGAuRR7PPSeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2023 and June 30, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are
reconciled in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zpc5XAu9ccQg" style="display: none">SCHEDULE
OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 84%; text-align: left">Public offering proceeds</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPTO3JbwgL46" style="width: 12%; text-align: right" title="Public offering proceeds">60,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zC2iWnioAnWf" style="text-align: right" title="Proceeds allocated to public rights">(3,272,724</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3GYLMyaZGMg" style="text-align: right" title="Allocation of offering costs related to redeemable shares">(2,925,140</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3ebkpA4pQAi" style="text-align: right" title="Accretion of carrying value to redemption value">6,797,864</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ordinary shares subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20230101__20231231_zMmdN8mzOY43" style="text-align: right" title="Ordinary shares subject to possible redemption">60,600,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic">Over-allotment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Over-allotment proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ProceedsFromOtherEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zhdg83vT3Rme" style="text-align: right" title="Over-allotment proceeds">9,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z6J18rD4Rk1b" style="text-align: right" title="Proceeds allocated to Public Rights">(490,909</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zojTNcHsWDO" style="text-align: right" title="Allocation of offering costs related to redeemable shares">(212,727</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zHWQ4CTJT1de" style="text-align: right" title="Accretion of carrying value to redemption value">793,636</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zim6byzjMXwh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)">1,729,358</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Ordinary shares subject to possible redemption, December 31, 2023</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20240101__20240630_z6P1opG3tZBi" style="font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemption">71,419,358</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">Plus:</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">Subsequent
    measurement of ordinary shares subject to possible redemption (income earned on trust account)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20240101__20240630_zGjItKI6Dbd7" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"><span style="font: normal 10pt Times New Roman, Times, Serif">1,865,342</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>Ordinary
    shares subject to possible redemption, June 30, 2024</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>$</b></span></td><td id="xdx_986_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iE_c20240101__20240630_zwYfAIm1ZNUh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>73,284,700</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  </table>

<p id="xdx_8A2_z6s9ZdWbnonf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_847_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_z1WqK5dF6HTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zyQLC8aa7lud">Ordinary
Shares Subject to Possible Redemption</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Ordinary shares subject to mandatory redemption (if
any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary
shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, ordinary shares
are classified as shareholders&#8217; equity. The Company&#8217;s ordinary shares features certain redemption rights that are considered
to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject
to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#8217; equity section of the
Company&#8217;s balance sheet. <span style="background-color: white">The Company recognizes changes in redemption value immediately as
they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.
Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital
and accumulated deficit.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zd2wBE9lAYs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">At
December 31, 2023, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BF_zpu6m2fUs7rj" style="display: none">SCHEDULE
OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left">Public offering proceeds</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231_za2ZKsoTet4c" style="width: 18%; text-align: right" title="Public offering proceeds">60,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230217__20231231_zYj5oSuFxqL7" style="text-align: right" title="Proceeds allocated to public rights">(3,272,724</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231_zFJ7buaNy8O7" style="text-align: right" title="Allocation of offering costs related to redeemable shares">(2,925,140</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230217__20231231_zW9JCGlmekni" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion of carrying value to redemption value">6,797,864</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ordinary shares subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20230217__20231231_zgqwa1e5dh05" style="text-align: right" title="Gross proceeds">60,600,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic">Over-allotment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Over-allotment proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ProceedsFromLegalSettlements_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zfFMrSFQSlFi" style="text-align: right" title="Over-allotment proceeds">9,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zYxgPuaVAyvk" style="text-align: right" title="Proceeds allocated to Public Rights">(490,909</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_znuXsHmUR8Gk" style="text-align: right" title="Allocation of offering costs related to redeemable shares">(212,727</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zcZb6OK0dWm9" style="text-align: right" title="Accretion of carrying value to redemption value">793,636</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zeDGC1VR9Hp5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)">1,729,358</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Ordinary shares subject to possible redemption</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zgIlv0x3m5Tl" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemption">71,419,358</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zxvw1Qtx8jLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zvlTHZ2lITda" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zCZJ7hRWs7j2">Recent
Accounting Standards</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#8217;s consolidated financial statements.</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z2k0Bblpjmqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zNLZGX6jgbxd">Recent
Accounting Standards</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#8217;s consolidated financial statements.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_EmergingGrowthCompanyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Emerging Growth Company [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_EmergingGrowthCompanyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_OfferingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Offering Costs [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_OfferingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300897076448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock', window );">SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS</a></td>
<td class="text"><p id="xdx_89F_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zFiYCcWKe56f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zZaHA01dQnV4" style="display: none">SCHEDULE
OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_492_20240401__20240630_zEPV8mzuxNO8" style="font-weight: bold; text-align: center"><b>2024</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_491_20230401__20230630_zgwKQxKgn7vh" style="font-weight: bold; text-align: center"><b>2023</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_49B_20240101__20240630_zNbVNk9ZmBQe" style="text-align: center"><b>June 30,<br/>
    2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_494_20230217__20230630_zcd2NavKx0ld" style="text-align: center"><b>June 30, <br/>
    2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Three Months Ended June 30,</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>Six Months Ended</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>For the Period from February 17, 2023 through</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2024</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2023</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>June 30,<br/>
    2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>June 30, <br/>
    2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_maNLIAOz10T_zbrmeHprLolh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Net income (loss)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">816,754</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0535">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,603,116</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(3,105</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_401_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz10T_zAbKlpGMN215" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accretion of temporary equity into redemption value (interest earned)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(941,850</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0540">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,865,342</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0542">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--NetLossIncludingAccretionOfEquityIntoRedemptionValue_iT_mtNLIAOz10T_zuPmzF721cVd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss including accretion of equity into redemption value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(125,096</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(262,226</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,105</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89A_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_z5fqU2qlhri2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_zHiJwUlqeU1k" style="display: none">SCHEDULE
OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230217__20231231_zbKQnV15xwDe" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Period from February 17, 2023 (Inception) Through</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_maNLIAOz10T_zOJii0vLKohb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left">Net income</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">1,484,790</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--InterestEarnedOnInvestmentHeldInTrustAccount_iN_di_msNLIAOz10T_zo7AJGrk1xXi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest earned on investment held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,729,358</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz10T_zAg74kxuxLM" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of temporary equity into redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,591,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--NetLossIncludingAccretionOfCommonStockToRedemptionValue_iT_mtNLIAOz10T_zKdGwxjFuO41" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss including accretion of common stock to redemption value</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(7,836,068</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zNJHbGlybjOl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_z4YUe7BJfSVk" style="display: none">SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED</span></span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSBy0peTNeqd" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zHFJtctmQ7Af" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_493_20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zrGeGu54Bja" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrUDxN5tolnh" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_499_20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zoS3vQSHFBhl" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_499_20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCvvcjVvYjp1" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zN0D5o5bki2k" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zco4vS2BZfp7" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Three Months Ended<br/>
 June 30, 2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Six Months Ended &#160;<br/>
June 30, 2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Three Months Ended <br/>
June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the Period from <br/>
February 17, 2023 through <br/>
June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Redeemable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Particulars</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and
    diluted net income/(loss) per share:</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average shares outstanding</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRlmacH7Veaj" title="Weighted-average shares outstanding - basic"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z7aUZCzHX6wh" title="Weighted average shares outstanding - diluted">6,900,000</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zOQnfAKWBQC4" title="Weighted-average shares outstanding - basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zw7LQikX1Owc" title="Weighted average shares outstanding - diluted">2,266,500</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zlAbDpzpBcE5" title="Weighted-average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zwdZB8aavyb4" title="Weighted average shares outstanding - diluted">6,900,000</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z4xwsqmQRZs5" title="Weighted-average shares outstanding - basic"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqoTpOOCEHOh" title="Weighted average shares outstanding - diluted">2,266,500</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zvYEr2B32Nu2" title="Weighted-average shares outstanding - basic"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zADwgPj1Bpz9" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0567"><span style="-sec-ix-hidden: xdx2ixbrl0569">-</span></span></span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFN1VzmKwYAa" title="Weighted-average shares outstanding - basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFBwNIxZYrE8" title="Weighted average shares outstanding - diluted">1,680,000</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; font-size: 11pt; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zfVl1CLuVOr" title="Weighted-average shares outstanding - basic"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_znOvNmn9lYB4" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0575"><span style="-sec-ix-hidden: xdx2ixbrl0577">-</span></span></span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYEWjo6tCvF5" title="Weighted-average shares outstanding - basic"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zuALVTokWFIa" title="Weighted average shares outstanding - diluted">1,656,774</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership percentage</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--OwnershipPercentage_pid_dp_uPure_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRX0VSo5MI3e" title="Ownership percentage">75</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--OwnershipPercentage_pid_dp_uPure_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zI77K3HjvqZd" title="Ownership percentage">25</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zcTLuYDNbyS5" title="Ownership percentage">75</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zq3nXiuDFsM3" title="Ownership percentage">25</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zz6QDtUW3A9l" title="Ownership percentage"><span style="-sec-ix-hidden: xdx2ixbrl0591">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zd3pzYuFsn3k" title="Ownership percentage">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zzQDZ6b20zb" title="Ownership percentage"><span style="-sec-ix-hidden: xdx2ixbrl0595">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFLbzzGvCPba" title="Ownership percentage">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerators:</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zshkQfUYiUi6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of net loss including
    accretion of temporary equity</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(94,165</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30,931</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(197,388</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(64,838</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0603">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0604">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0605">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,105</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_402_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_z6JeXvyniSQ4" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    earned on investment held in trust account</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">941,850</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0609">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,865,342</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0611">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0612">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0613">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0614">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0615">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_znOk6211LrT4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of net income/(loss)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">847,685</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30,931</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,667,954</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(64,838</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0621">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0622">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0623">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,105</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominators:</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average shares
    outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQzV0IDvSyj2" title="Weighted average shares outstanding - basic"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zOT1zbMGB639" title="Weighted average shares outstanding - diluted">6,900,000</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_ze0K9wVa10dd" title="Weighted average shares outstanding - basic"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zcDkDRb7KoM2" title="Weighted average shares outstanding - diluted">2,266,500</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zYvu0Nr3kbJf" title="Weighted average shares outstanding - basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zGimqSbrnS3g" title="Weighted average shares outstanding - diluted">6,900,000</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMUgytbR5TI3" title="Weighted average shares outstanding - basic"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zC3p20bgWXld" title="Weighted average shares outstanding - diluted">2,266,500</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zyptN8z7J0zk" title="Weighted average shares outstanding - basic"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zC95eqOTAu9k" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0642"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></span></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zbyRYDgivH3e" title="Weighted average shares outstanding - basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zXbDy5TMdmMb" title="Weighted average shares outstanding - diluted">1,680,000</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTdaJvG0QYge" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z9t6Q9aH3u9i" title="Weighted average shares outstanding - diluted"><span style="-sec-ix-hidden: xdx2ixbrl0650"><span style="-sec-ix-hidden: xdx2ixbrl0652">-</span></span></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z34tVg8XqKUi" title="Weighted-average shares outstanding - basic"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYR4raUHLa09" title="Weighted-average shares outstanding - diluted">1,656,774</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net income/(loss) per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z34oXUuyBQ39" title="Basic net income/(loss) per share"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zvLOYwYGlhe1" title="Diluted net income/(loss) per share">0.12</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zuL9mXv5DD1l" title="Basic net income/(loss) per share"><span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrvsnXUJxtbj" title="Diluted net income/(loss) per share">(0.01</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQpX6slT0dG2" title="Basic net income/(loss) per share"><span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zG7Oo29qJ0Wc" title="Diluted net income/(loss) per share">0.24</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zJDyTrubNsA" title="Basic net income/(loss) per share"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zzlN34jafbG5" title="Diluted net income/(loss) per share">(0.03</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zg0u4HGHo3va" title="Basic net income/(loss) per share"><span id="xdx_904_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zdFuSn87WLE2" title="Diluted net income/(loss) per share"><span style="-sec-ix-hidden: xdx2ixbrl0674"><span style="-sec-ix-hidden: xdx2ixbrl0676">-</span></span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zhEKTZF2Z2Pd" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zsHEHZzJIhbc" title="Diluted net income/(loss) per share"><span style="-sec-ix-hidden: xdx2ixbrl0678"><span style="-sec-ix-hidden: xdx2ixbrl0680">-</span></span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z6KC1AJBXhJc" title="Basic net income/(loss) per share"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zA2v4GYzuEPk" title="Diluted net income/(loss) per share"><span style="-sec-ix-hidden: xdx2ixbrl0682"><span style="-sec-ix-hidden: xdx2ixbrl0684">-</span></span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_za6AczHeao4j" title="Basic net income/(loss) per share"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zKdoRSOAcBi4" title="Diluted net income/(loss) per share">(0.002</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><span></span>
</td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zcpFV3BsqmD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BF_zMFGGaplzlue">SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSbd0Fp6rMFl" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zGAERQ6dGDUi" style="font-weight: bold; text-align: center">Non-Redeemable</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Period from February 17, 2023 (Inception) Through</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Redeemable</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Non-Redeemable</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Particulars</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic and diluted net income/(loss) per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%">Weighted-average shares outstanding</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zU6CljOH48ac" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zFYq4I4GQtSh" title="Weighted average shares outstanding - diluted">3,819,156</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zNfgYAWx4Gr9" title="Weighted average shares outstanding - basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCzo2RWqf9bk" title="Weighted average shares outstanding - diluted">2,095,943</span></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ownership percentage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zECPHfL2glR8" title="Ownership percentage">65</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zsjNSrA2WIZc" title="Ownership percentage">35</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Numerators:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zVCdrxP2wiac" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Allocation of net loss including accretion of temporary equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,059,453</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,776,615</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--IncomeEarnedOnTrustAccount_iN_di_zAHwZN6mpoR2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income earned on Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,729,358</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1294">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_zDB0ptiEw1dk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of temporary equity to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,591,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1297">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--AllocationOfNetIncomeloss_zq0KsXBOf1Ke" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Allocation of net income/(loss)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">4,261,405</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(2,776,615</td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Denominators:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted-average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRIL4Yi3jFe8" title="Weighted average shares outstanding - basic"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTMeIKfe5D67" title="Weighted average shares outstanding - diluted">3,819,156</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zZ4GwgKssWo7" title="Weighted average shares outstanding - basic"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqU9AdEZFfK1" title="Weighted average shares outstanding - diluted">2,095,943</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income/(loss) per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zftFIOmZjSkl" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zVuMWGvFHwTb" title="Diluted net income/(loss) per share">1.12</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zHHmNNLje0E9" title="Basic net income/(loss) per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zg1zZTQ3WBvh" title="Diluted net income/(loss) per share">(1.32</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock', window );">SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET</a></td>
<td class="text"><p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zGAuRR7PPSeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2023 and June 30, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are
reconciled in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zpc5XAu9ccQg" style="display: none">SCHEDULE
OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 84%; text-align: left">Public offering proceeds</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPTO3JbwgL46" style="width: 12%; text-align: right" title="Public offering proceeds">60,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zC2iWnioAnWf" style="text-align: right" title="Proceeds allocated to public rights">(3,272,724</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3GYLMyaZGMg" style="text-align: right" title="Allocation of offering costs related to redeemable shares">(2,925,140</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3ebkpA4pQAi" style="text-align: right" title="Accretion of carrying value to redemption value">6,797,864</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ordinary shares subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20230101__20231231_zMmdN8mzOY43" style="text-align: right" title="Ordinary shares subject to possible redemption">60,600,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic">Over-allotment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Over-allotment proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ProceedsFromOtherEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zhdg83vT3Rme" style="text-align: right" title="Over-allotment proceeds">9,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z6J18rD4Rk1b" style="text-align: right" title="Proceeds allocated to Public Rights">(490,909</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zojTNcHsWDO" style="text-align: right" title="Allocation of offering costs related to redeemable shares">(212,727</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zHWQ4CTJT1de" style="text-align: right" title="Accretion of carrying value to redemption value">793,636</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zim6byzjMXwh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)">1,729,358</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Ordinary shares subject to possible redemption, December 31, 2023</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20240101__20240630_z6P1opG3tZBi" style="font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemption">71,419,358</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">Plus:</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">Subsequent
    measurement of ordinary shares subject to possible redemption (income earned on trust account)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20240101__20240630_zGjItKI6Dbd7" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"><span style="font: normal 10pt Times New Roman, Times, Serif">1,865,342</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>Ordinary
    shares subject to possible redemption, June 30, 2024</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>$</b></span></td><td id="xdx_986_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iE_c20240101__20240630_zwYfAIm1ZNUh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>73,284,700</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zd2wBE9lAYs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">At
December 31, 2023, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BF_zpu6m2fUs7rj" style="display: none">SCHEDULE
OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left">Public offering proceeds</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231_za2ZKsoTet4c" style="width: 18%; text-align: right" title="Public offering proceeds">60,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230217__20231231_zYj5oSuFxqL7" style="text-align: right" title="Proceeds allocated to public rights">(3,272,724</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231_zFJ7buaNy8O7" style="text-align: right" title="Allocation of offering costs related to redeemable shares">(2,925,140</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230217__20231231_zW9JCGlmekni" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion of carrying value to redemption value">6,797,864</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ordinary shares subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20230217__20231231_zgqwa1e5dh05" style="text-align: right" title="Gross proceeds">60,600,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic">Over-allotment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Over-allotment proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ProceedsFromLegalSettlements_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zfFMrSFQSlFi" style="text-align: right" title="Over-allotment proceeds">9,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds allocated to Public Rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zYxgPuaVAyvk" style="text-align: right" title="Proceeds allocated to Public Rights">(490,909</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Allocation of offering costs related to redeemable shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_znuXsHmUR8Gk" style="text-align: right" title="Allocation of offering costs related to redeemable shares">(212,727</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zcZb6OK0dWm9" style="text-align: right" title="Accretion of carrying value to redemption value">793,636</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zeDGC1VR9Hp5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)">1,729,358</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Ordinary shares subject to possible redemption</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zgIlv0x3m5Tl" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemption">71,419,358</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES</a></td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zrIeFQGHFK63" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B2_zalQH45DorYe" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SUPPLEMENTAL
DISCLOSURE OF NONCASH FINANCING ACTIVITIES</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20230401__20230630_zDUmkvO9Pav2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As reported on Form 10-Q for the quarter ended June 30, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20240401__20240630_zTiJTaglAq4j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As revised on<br/>
Form 10-Q</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental disclosure of noncash financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--NoncashOfferingCostsPaidByRelatedParty_zILkhYJtkzLb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Offering costs paid by related party</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">144,108</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">144,108</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--NoncashPrepaidExpensesPaidByRelatedParty_zpSTUAqjtyp1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid expenses paid by related party</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--NoncashOfferingCostsAdjustedFromPrepaidExpenses_zA7wCbaY8zRg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Offering costs adjusted from prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">639</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--NoncashOfferingCostsIncludedInAccruedExpenses_zzWV27yzB3p4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Offering costs included in accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,505</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,505</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_zyq3q4cuHGo6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Offering costs paid by Sponsor in exchange for issuance of ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--NonCashOfferingCostsChargedToAdditionalPaidinCapital_zEU2RD3p88W7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Offering costs charged to APIC &#8211; EBC founder shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0745">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,013,480</td><td style="text-align: left">&#160;</td></tr></table>


<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of ordinary shares subject to possible redemption reflected in the balance sheet [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedIncomeStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300833217888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zOCn0l1Ycqmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair
value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zJYUcGy76vr" style="display: none">SCHEDULE
OF ASSUMPTIONS TO ESTIMATE FAIR VALUE</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 84%; text-align: left">Time to expiration</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90F_ecustom--EquitySecuritiesFvNiTerm_dtY_c20230315__20230315_zLaPy9wr7i8a" title="Time to expiration">1.84</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_ziZuy1TovcP6" title="Risk-free rate">4.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zh5axFQLqyh7" title="Risk-free rate">5.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zgEwwIudNqN1" title="Risk-free rate">0.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Probability of completion of business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember_zRD7Tcv0CwE5" title="Founder shares measurement input">60.0</span></td><td style="text-align: left">%</td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock', window );">SCHEDULE FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_898_ecustom--ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock_zmfEjAVBnFBg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair
value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zG9F7VFpDzH4" style="display: none">SCHEDULE
FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left">Time to expiration</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0VXkd1AhY94" title="Time to expiration">1.84</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAKlvigTYDI8" title="Risk-free rate">4.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_znAtmI8QBi6f" title="Volatility rate">5.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWmPu4yISRsa" title="Dividend yield">0.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected likelihood of a successful business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--ExpectedLikelihoodSuccessfulBusinessCombination_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zDmVhFcRiIid" title="Expected likelihood of a successful business combination, percentage">60</span></td><td style="text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of fair value of early bird capital assumption estimate [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300828232992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS</a></td>
<td class="text"><p id="xdx_892_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zHevNpAQnl41" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis at June 30,
2024 and December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair
value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zrl4VqYdy7I6" style="display: none">SCHEDULE
OF MEASURED FAIR VALUE ON RECURRING BASIS</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Date</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Trading Securities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2024</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 45%; text-align: left">Marketable securities held in the trust account</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zbjEgAq8OH5k" style="width: 12%; text-align: right" title="Marketable securities held in the trust account">73,284,700</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Marketable securities held in the trust account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zD90qliMI9ii" style="text-align: right" title="Marketable securities held in the trust account">71,419,358</td><td style="text-align: left">&#160;</td></tr>
  </table>




<span></span>
</td>
<td class="text"><p id="xdx_894_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z6NnfmmBvQmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BF_zSlcIVF1yKE1" style="display: none">SCHEDULE
OF MEASURED FAIR VALUE ON RECURRING BASIS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_491_20231231_zoAXwkwUOHz2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49E_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zwEAR7ev2ltj" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49E_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_ziheDFnDL1pl" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_495_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zeYDvkFcb7vc" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prices in</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Active</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Markets</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level
    1)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level
    2)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level
    3)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsHeldInTrustNoncurrent_iI_zO45lkmG0Kef" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment held in trust account</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,419,358</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,419,358</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="-sec-ix-hidden: xdx2ixbrl1506">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1507">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300819782960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 18, 2024</div></th>
<th class="th"><div>Jul. 18, 2023</div></th>
<th class="th"><div>Jul. 17, 2023</div></th>
<th class="th"><div>Jul. 14, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,272,724)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,615,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 272,630<span></span>
</td>
<td class="nump">426,913<span></span>
</td>
<td class="nump">$ 426,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,109<span></span>
</td>
<td class="nump">402,534<span></span>
</td>
<td class="nump">402,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Due from related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,199<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=BOWN_ShenzhenQianzhiMember', window );">Shenzhen Qianzhi [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Due from related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=BOWN_MergerSharesMember', window );">Merger Shares [Member] | Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="nump">7,246,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=BOWN_EarnoutSharesMember', window );">Earnout Shares [Member] | Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Transaction cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,318,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Payments for underwriting expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_OtherOfferingCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,593,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Deposits', window );">Deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of units sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from sale of units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Payments for underwriting expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,725,000<span></span>
</td>
<td class="nump">$ 1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of units sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_OtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_OtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Deposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Deposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=BOWN_ShenzhenQianzhiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=BOWN_ShenzhenQianzhiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=BOWN_MergerSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=BOWN_MergerSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=BOWN_AgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=BOWN_AgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=BOWN_EarnoutSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=BOWN_EarnoutSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300827909600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="num">$ (3,105)<span></span>
</td>
<td class="nump">$ 816,754<span></span>
</td>
<td class="nump">$ 786,362<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (3,105)<span></span>
</td>
<td class="nump">$ 1,603,116<span></span>
</td>
<td class="nump">$ 1,484,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AccretionOfTemporaryEquityIntoRedemptionValue', window );">Accretion of temporary equity into redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(941,850)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,865,342)<span></span>
</td>
<td class="num">(7,591,500)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue', window );">Net loss including accretion of equity into redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (125,096)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (3,105)<span></span>
</td>
<td class="num">$ (262,226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_InterestEarnedOnInvestmentHeldInTrustAccount', window );">Interest earned on investment held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,729,358)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue', window );">Net loss including accretion of common stock to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,836,068)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_AccretionOfTemporaryEquityIntoRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion of temporary equity into redemption value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_AccretionOfTemporaryEquityIntoRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_InterestEarnedOnInvestmentHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest earned on investment held in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_InterestEarnedOnInvestmentHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net loss including accretion of common stock to redemption value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net loss including accretion of equity into redemption value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300828158128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount', window );">Interest earned on investment held in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 941,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,865,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Allocation of net income/(loss)</a></td>
<td class="num">$ (3,105)<span></span>
</td>
<td class="nump">816,754<span></span>
</td>
<td class="nump">$ 786,362<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (3,105)<span></span>
</td>
<td class="nump">1,603,116<span></span>
</td>
<td class="nump">$ 1,484,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AccretionOfTemporaryEquityIntoRedemptionValue', window );">Accretion of temporary equity to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 941,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,865,342<span></span>
</td>
<td class="nump">$ 7,591,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BOWN_RedeemableSharesMember', window );">Redeemable Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding - basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">3,819,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding - diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">3,819,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_OwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity', window );">Allocation of net loss including accretion of temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (94,165)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (197,388)<span></span>
</td>
<td class="num">$ (5,059,453)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount', window );">Interest earned on investment held in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">941,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,865,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Allocation of net income/(loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 847,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,667,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income/(loss) per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income/(loss) per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_IncomeEarnedOnTrustAccount', window );">Income earned on Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,729,358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AccretionOfTemporaryEquityIntoRedemptionValue', window );">Accretion of temporary equity to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,591,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AllocationOfNetIncomeloss', window );">Allocation of net income/(loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,261,405<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BOWN_NonRedeemableSharesMember', window );">Non Redeemable Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding - basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,266,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,680,000<span></span>
</td>
<td class="nump">1,656,774<span></span>
</td>
<td class="nump">2,266,500<span></span>
</td>
<td class="nump">2,095,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding - diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,266,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,680,000<span></span>
</td>
<td class="nump">1,656,774<span></span>
</td>
<td class="nump">2,266,500<span></span>
</td>
<td class="nump">2,095,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_OwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity', window );">Allocation of net loss including accretion of temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30,931)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (3,105)<span></span>
</td>
<td class="num">$ (64,838)<span></span>
</td>
<td class="num">$ (2,776,615)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount', window );">Interest earned on investment held in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Allocation of net income/(loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30,931)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (3,105)<span></span>
</td>
<td class="num">$ (64,838)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income/(loss) per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (0.002)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income/(loss) per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (0.002)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_IncomeEarnedOnTrustAccount', window );">Income earned on Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AccretionOfTemporaryEquityIntoRedemptionValue', window );">Accretion of temporary equity to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AllocationOfNetIncomeloss', window );">Allocation of net income/(loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,776,615)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_AccretionOfTemporaryEquityIntoRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion of temporary equity into redemption value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_AccretionOfTemporaryEquityIntoRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_AllocationOfNetIncomeloss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allocation of net income loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_AllocationOfNetIncomeloss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allocation of net loss including accretion of temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_IncomeEarnedOnTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income earned on trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_IncomeEarnedOnTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest earned on investments held in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_OwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ownership percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_OwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BOWN_RedeemableSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BOWN_RedeemableSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BOWN_NonRedeemableSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BOWN_NonRedeemableSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300830449824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 14, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds allocated to public rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,272,724)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OfferingCostsPartnershipInterests', window );">Allocation of offering costs related to redeemable shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,925,140)<span></span>
</td>
<td class="num">$ (2,925,140)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AccretionOfCarryingValueToRedemptionValue', window );">Accretion of carrying value to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,797,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,600,000<span></span>
</td>
<td class="nump">$ 60,600,000<span></span>
</td>
<td class="nump">$ 71,419,358<span></span>
</td>
<td class="nump">60,600,000<span></span>
</td>
<td class="nump">60,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption', window );">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,865,342<span></span>
</td>
<td class="nump">1,729,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Ordinary shares subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,284,700<span></span>
</td>
<td class="nump">71,419,358<span></span>
</td>
<td class="nump">71,419,358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds allocated to Public Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,016,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Ordinary shares subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,284,700<span></span>
</td>
<td class="nump">71,419,358<span></span>
</td>
<td class="nump">71,419,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds allocated to public rights</a></td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds allocated to Public Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,272,724)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OfferingCostsPartnershipInterests', window );">Allocation of offering costs related to redeemable shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,925,140)<span></span>
</td>
<td class="num">(2,925,140)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AccretionOfCarryingValueToRedemptionValue', window );">Accretion of carrying value to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,797,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds allocated to Public Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(490,909)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OfferingCostsPartnershipInterests', window );">Allocation of offering costs related to redeemable shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(212,727)<span></span>
</td>
<td class="num">(212,727)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_AccretionOfCarryingValueToRedemptionValue', window );">Accretion of carrying value to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">793,636<span></span>
</td>
<td class="nump">793,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,419,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Over-allotment proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption', window );">Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,729,358<span></span>
</td>
<td class="nump">1,729,358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Ordinary shares subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,419,358<span></span>
</td>
<td class="nump">71,419,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds allocated to Public Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(490,909)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Over-allotment proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Ordinary shares subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,419,358<span></span>
</td>
<td class="nump">$ 71,419,358<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_AccretionOfCarryingValueToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion of carrying value to redemption value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_AccretionOfCarryingValueToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsequent measurement of ordinary shares subject to possible redemption (income earned on Trust Account).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OfferingCostsPartnershipInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred in connection with the offering and selling of additional partner interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 5.D.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480341/340-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OfferingCostsPartnershipInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph (12)(c)<br> -Section S99<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph (16)(c)<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (15)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (14)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300830491760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_NoncashOfferingCostsPaidByRelatedParty', window );">Offering costs paid by related party</a></td>
<td class="nump">$ 144,108<span></span>
</td>
<td class="nump">$ 144,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_NoncashPrepaidExpensesPaidByRelatedParty', window );">Prepaid expenses paid by related party</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses', window );">Offering costs adjusted from prepaid expenses</a></td>
<td class="nump">639<span></span>
</td>
<td class="nump">639<span></span>
</td>
<td class="nump">$ 639<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_NoncashOfferingCostsIncludedInAccruedExpenses', window );">Offering costs included in accrued expenses</a></td>
<td class="nump">2,505<span></span>
</td>
<td class="nump">2,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares', window );">Offering costs paid by Sponsor in exchange for issuance of ordinary shares</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital', window );">Offering costs charged to APIC &#8211; EBC founder shares</a></td>
<td class="nump">$ 1,013,480<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,593,898<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Offering costs charged to Additional Paid-in Capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Offering costs adjusted from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_NoncashOfferingCostsIncludedInAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash offering costs included in accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_NoncashOfferingCostsIncludedInAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_NoncashOfferingCostsPaidByRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash offering costs paid by related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_NoncashOfferingCostsPaidByRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Offering costs paid by Sponsor in exchange for issuance of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_NoncashPrepaidExpensesPaidByRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash prepaid expenses paid by related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_NoncashPrepaidExpensesPaidByRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300819922272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 272,630<span></span>
</td>
<td class="nump">$ 272,630<span></span>
</td>
<td class="nump">$ 426,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Trust account, cash balance, with U.S. treasury bills</a></td>
<td class="nump">73,284,700<span></span>
</td>
<td class="nump">73,284,700<span></span>
</td>
<td class="nump">71,419,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount', window );">Interest and dividend income earned from trust account</a></td>
<td class="nump">941,850<span></span>
</td>
<td class="nump">1,865,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Accrued for interest and penalties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash, FDIC insured amount</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_InterestsEarnedFromTrustAccount', window );">Interests earned from trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,729,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember', window );">Cash [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrust', window );">Trust account, cash balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,208<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Trust account, cash balance, with U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,411,150<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest earned on investments held in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_InterestsEarnedFromTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interests earned from trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_InterestsEarnedFromTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300826964000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INITIAL PUBLIC OFFERING (Details Narrative) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 18, 2023</div></th>
<th class="th"><div>Jul. 17, 2023</div></th>
<th class="th"><div>Jul. 14, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, par share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockDescriptionOfTransaction', window );">Stock holders equity related to initial public offering description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each Unit consists of one ordinary share and one right
to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company&#8217;s initial Business Combination. Ten Public
Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares
will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional
shares underlying the rights<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period shares</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, par share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Stock issued during the period, shares</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Stock issued during the period, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300825121184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRIVATE PLACEMENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 18, 2023</div></th>
<th class="th"><div>Jul. 14, 2023</div></th>
<th class="th"><div>Mar. 15, 2023</div></th>
<th class="th"><div>Feb. 27, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,016,000<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=BOWN_SponsorsMember', window );">Sponsors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=BOWN_EBCMember', window );">EBC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Private placement units of underwriters over-allotment per share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="nump">31,500<span></span>
</td>
<td class="nump">330,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Private placement units of underwriters over-allotment per share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockDescriptionOfTransaction', window );">Units related to private placement description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each
Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the
consummation of the Company&#8217;s initial Business Combination.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Sponsors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | EBC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Underwriters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">361,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">361,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Private placement units of underwriters over-allotment per share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,615,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,615,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=BOWN_SponsorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=BOWN_SponsorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=BOWN_EBCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=BOWN_EBCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=BOWN_UnderwritersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=BOWN_UnderwritersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300830816560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details)<br></strong></div></th>
<th class="th"><div>Mar. 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_EquitySecuritiesFvNiTerm', window );">Time to expiration</a></td>
<td class="text">1 year 10 months 2 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiMeasurementInput', window );">Founder shares measurement input</a></td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiMeasurementInput', window );">Founder shares measurement input</a></td>
<td class="nump">5.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiMeasurementInput', window );">Founder shares measurement input</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Measurement Input Probability Of Completion Of Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiMeasurementInput', window );">Founder shares measurement input</a></td>
<td class="nump">60.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_EquitySecuritiesFvNiTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity securities FvNi term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_EquitySecuritiesFvNiTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_PlatformOperatorCryptoAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section FF<br> -Paragraph Question 2<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.FF.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476188/405-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_PlatformOperatorCryptoAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=BOWN_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=BOWN_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300823780096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 18, 2023</div></th>
<th class="th"><div>Jul. 17, 2023</div></th>
<th class="th"><div>Jul. 14, 2023</div></th>
<th class="th"><div>Jul. 11, 2023</div></th>
<th class="th"><div>Mar. 15, 2023</div></th>
<th class="th"><div>Feb. 27, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,016,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdministrativeFeesExpense', window );">Administrative fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="nump">56,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Related party debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForAdministrativeFees', window );">Administrative fees paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=BOWN_AccountingServiceAgreementMember', window );">Accounting Service Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,250<span></span>
</td>
<td class="nump">5,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,500<span></span>
</td>
<td class="nump">$ 5,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Service fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,250<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">10,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Payment for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=BOWN_TenXGlobalCapitalMember', window );">Ten X Global Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Service fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">25,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member] | General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member] | Accounting Services Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=BOWN_PromissoryNoteMember', window );">Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=BOWN_PromissoryNoteMember', window );">Promissory Note [Member] | Sponsors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Promissory note aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Promissory note maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 14,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=BOWN_PromissoryNoteMember', window );">Promissory Note [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Promissory note aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (490,909)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Stock issued during the period, shares</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_CashUnderwritingDiscountPerUnit', window );">Cash underwriting discount per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_CashUnderwritingDiscount', window );">Aggregate cash underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Payments for underwriting expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="nump">$ 1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Number of shares subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Stock issued during the period, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Ordinary share price</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Payments for underwriting expense</a></td>
<td class="nump">$ 1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Sponsors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=BOWN_SponsorsMember', window );">Sponsors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=BOWN_SponsorsMember', window );">Sponsors [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AffiliateCosts', window );">Affiliate costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=BOWN_SponsorsMember', window );">Sponsors [Member] | Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Number of shares subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=BOWN_EBCMember', window );">EBC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Ordinary share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued', window );">Fair value of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,016,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value of ordinary per share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_CashUnderwritingDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash underwriting discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_CashUnderwritingDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_CashUnderwritingDiscountPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash underwriting discount per unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_CashUnderwritingDiscountPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdministrativeFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdministrativeFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AffiliateCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs associated with revenues arising from an entity that is an affiliate of the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AffiliateCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total fair value of shares issued during the period under a deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForAdministrativeFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount paid to managing member or general partner, affiliate of managing member or general partner, or affiliate of limited liability company (LLC) or limited partnership (LP) for administrative services provided to the LLC or LP, for example, but not limited to, salaries, rent, or overhead costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForAdministrativeFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=BOWN_AccountingServiceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=BOWN_AccountingServiceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=BOWN_TenXGlobalCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=BOWN_TenXGlobalCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=BOWN_AccountingServicesExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=BOWN_AccountingServicesExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=BOWN_PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=BOWN_PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=BOWN_SponsorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=BOWN_SponsorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=BOWN_SponsorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=BOWN_SponsorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=BOWN_EBCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=BOWN_EBCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300824608656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business combination related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,199<span></span>
</td>
<td class="nump">$ 45,199<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Commited for future expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=BOWN_QianzhiMember', window );">Qianzhi [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business combination related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,199<span></span>
</td>
<td class="nump">252,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed', window );">Business combination related cost reimbursed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">206,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,199<span></span>
</td>
<td class="nump">45,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=BOWN_QianzhiMember', window );">Qianzhi [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed', window );">Business combination related cost reimbursed</a></td>
<td class="nump">$ 45,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=BOWN_BusinessCombinationMarketingAgreementMember', window );">Business Combination Marketing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business combination related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,415,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_PercentageOfGrossProceedsOfInitialPublicOffering', window );">Percentage of gross proceeds of initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable', window );">Percentage of service fee of total consideration payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_ServiceFee', window );">Service fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,415,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination acquisition related costs reimbursed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_PercentageOfGrossProceedsOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of gross proceeds of initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_PercentageOfGrossProceedsOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of service fee of total consideration payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_ServiceFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Service fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_ServiceFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479405/805-10-25-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=BOWN_QianzhiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=BOWN_QianzhiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=BOWN_BusinessCombinationMarketingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=BOWN_BusinessCombinationMarketingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300830698064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS&#8217; EQUITY (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 18, 2023</div></th>
<th class="th"><div>Jul. 17, 2023</div></th>
<th class="th"><div>Feb. 27, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">each holder of a right will
automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination<span></span>
</td>
<td class="text">Holders
of ordinary shares are entitled to one vote for each share.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Ordinary shares issued to underwriter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,016,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,266,500<span></span>
</td>
<td class="nump">2,266,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,266,500<span></span>
</td>
<td class="nump">2,266,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_OrdinarySharesSubjectToRedemption', window );">Ordinary shares subject to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockVotingRights', window );">Preferred stock voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">voting and other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Ordinary shares issued to underwriter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (490,909)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=BOWN_SponsorsMember', window );">Sponsors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Ordinary shares issued to underwriter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=BOWN_SponsorsMember', window );">Sponsors [Member] | Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Number of shares subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Holders
of ordinary shares are entitled to one vote for each share<span></span>
</td>
<td class="text">each holder of a right will
automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Ordinary shares issued to underwriter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_OrdinarySharesSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ordinary shares subject to redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_OrdinarySharesSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=BOWN_SponsorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=BOWN_SponsorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300819916928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investment held in trust account</a></td>
<td class="nump">$ 73,284,700<span></span>
</td>
<td class="nump">$ 71,419,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investment held in trust account</a></td>
<td class="nump">$ 73,284,700<span></span>
</td>
<td class="nump">71,419,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investment held in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investment held in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300826989936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION (Details) - Fair Value, Inputs, Level 3 [Member]<br></strong></div></th>
<th class="th"><div>Mar. 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Time to expiration</a></td>
<td class="text">1 year 10 months 2 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility rate</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_ExpectedLikelihoodSuccessfulBusinessCombination', window );">Expected likelihood of a successful business combination, percentage</a></td>
<td class="nump">60.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_ExpectedLikelihoodSuccessfulBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected likelihood successful business combination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_ExpectedLikelihoodSuccessfulBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_PlatformOperatorCryptoAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section FF<br> -Paragraph Question 2<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.FF.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476188/405-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_PlatformOperatorCryptoAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140300824610112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jan. 18, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=BOWN_MergerSharesMember', window );">Merger Shares [Member] | Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,246,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=BOWN_EarnoutSharesMember', window );">Earnout Shares [Member] | Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Merger Shares [Member] | Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,246,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Earnout Shares [Member] | Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary shares issued to underwriter, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=BOWN_QianzhiMember', window );">Qianzhi [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed', window );">Business combination related cost reimbursed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 206,803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=BOWN_QianzhiMember', window );">Qianzhi [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed', window );">Business combination related cost reimbursed</a></td>
<td class="nump">$ 45,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination acquisition related costs reimbursed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>BOWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=BOWN_MergerSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=BOWN_MergerSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=BOWN_AgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=BOWN_AgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=BOWN_EarnoutSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=BOWN_EarnoutSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=BOWN_QianzhiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=BOWN_QianzhiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>77
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( !2 *ED'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  4@"I9!7/QN^X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>R'%'82;UI6.G#08K;.QF9+4UBQ-C:R1]^R59FS*V!]C1TN]/
MGT U1HU=HN?414KL*=\,H6FSQK@11^:H 3(>*=A<CHEV;.Z[%"R/SW2 :/'#
M'@B4E&L(Q-99MC !B[@0A:D=:DQDN4MGO,,%'S]3,\,< C44J.4,55F!,-/$
M>!J:&JZ "<:40OXND%N(<_5/[-P!<4X.V2^ION_+?C7GQATJ>'MZ?)G7+7R;
MV;9(XZ_L-9\B;<1E\NMJ>[][$$9)=5O(NZ*2.R6UE%JMWR?7'WY7X= YO_?_
MV/@B:&KX=1?F"U!+ P04    "  4@"I9F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M !2 *EG38D4.@P0  ,T3   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MK9AK3^-&%(:_\RM&KE2U$F![<H'0)%*2A2U;2"/"MMJN^F&P3Q)K[1GOS)C
MO^\9.[&IZHP=5 D1W\[K9V[G/9[A5LAO:@.@R4L2<S5R-EJG5ZZK@@TD3)V+
M%#C>60F9,(VG<NVJ5 (+\Z D=JGG]=V$1=P9#_-K"SD>BDS'$8>%)"I+$B9?
MIQ"+[<CQG?V%AVB]T>:".QZF; U+T)_3A<0SMU0)HP2XB@0G$E8C9^)?3>G
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M?V]"%B_ KCB\$%MY^"2RVQ4&9#^763F7R98S+HH'435<@(QDE[29]RU9Z>"
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M%A_51C*,HVC/P7'OK./YZSZ7';V-Q#L?,= Y)FS!(QV0$!KJ0#ULK%/\YN
M!]SRPQ:8;-,SUET 4T@L4:K%5&JZ[PKD')SD)HUU%T *W,42"4540C&!D-X
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M [X7:]B#P=Q\*?CGA+:?X3X$\6@ELBCP^392I=-Z^WG&/XY&E_2M_7:'@Y.
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M/*%V!C2_5J2\[;@%NN?8]#]02P,$%     @ %( J62PI'7:0"   -!\  !D
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M!V#+3N.@=ES+:0]%#TMR)&Y-<IG=I63UUW=F25%20BDIVAP*^)"(W)WW?/,
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M8=#SV[%YKT5N1.762)GMP#3<4$C]TH.Z;VA7/W6[3W%*%!S=F4C+NCIJY[K
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M;J+9!>RM)HE="%<9HSNS.>:>.[7)=-"D"T' <]*94\90] O-J0XW_+[>I-:
MK@A64J]'$B7,Y0L=XRUJVQY"7SE<1^I -";HS"E^;$/.;EQQ(GHG[!3.^]'D
MK#\^/X=1?Q*&_3 ,#UWDP[V.T>OO&FD7IU+:NGGLOG:]^JUO48?WR^M&_S73
M&TYU5>":3,/!^9->3;4=6%7X_C-6ECSTKQG]WT#M%M#\6BG;#MP&W3^8Z3]0
M2P,$%     @ %( J6;-SW"2:%P  KVP  !D   !X;"]W;W)K<VAE971S+W-H
M965T,3<N>&UL[5WK<]M&DO^.OV)*F]NBJB")X)N.[2J*HAQFK<>)\NY=7=V'
M(3 4$8, @P$D\?[ZZ^Z9 0842,F.G61W58EM$L \^O7KGIX>\.U#DGZ62R$R
M]KB*8OGN8)EEZS<G)])?BA67Q\E:Q'!GD:0KGL'7].Y$KE/! VJTBDY:S6;O
M9,7#^.#]6[IVG;Y_F^19%,;B.F4R7ZUXNCD54?+P[L [,!=NPKMEAA=.WK]=
M\SLQ$]FG]74*WTZ*7H)P)6(9)C%+Q>+=P<A[,_:ZV(">^'LH'J3UF2$I\R3Y
MC%^FP;N#)LY(1,+/L L._]R+L8@B[ GF\:ON]* 8$QO:GTWOYT0\$#/G4HR3
MZ!]AD"W?'0P.6" 6/(^RF^3A)Z$)H@GZ223I;_:@GNUV#IB?RRQ9Z<8P@U48
MJW_YHV:$U6#0W-&@I1NT7MJ@K1NTB5 U,R+KC&?\_=LT>6 I/@V]X0?B#;4&
M:L(8Q3C+4K@;0KOL_>S3Q<7HYK_9U3F;33]<3L^GX]'E+1N-QU>?+F^GEQ_8
M]=7'Z7@ZF;'&=1*%?BCDX=N3#(;&#DY\/<RI&J:U8Y@>NTCB;"G9) Y$4--^
MO+^]U]S3P0G07!#>,H2?MO;V^',>'[-VTV6M9JM3-Z']S<^$#\T]:M[>,YUV
M(8<V]=?>T=_(]Y,\SL+XCADVL_\9S666@J+_;QW#57^=^O[0^M_(-??%NP,P
M;RG2>W'P_J]_\7K-'^N(_4:=54CO%*1W]O7^_I3+4+)DP:ZQ[SCCRK[C "Z$
ML1^N(T&WQTDL@34!W:_CR-YAZHF@L9TO')O=+H7#06"K-8\W*+(\YGD09B)@
M?O$@?%F$,8=.>,0D]"P _3+)EOQ>L+D0,8-IK'D*SX4(9WZ2!O"T  #(EO1=
MZ\.ZG,F=B$7*HVB#]\4:QG"@;;84[%-,P\]P')KQ:"72T.>L\=>_#%JMYH^?
M9NS#:'1-W[P?#QEX !@W@X=6UCS#6'D&PX6:F>%H80R*F1,02Y8E#B(J\YI'
M_TF-1FD6^I%@ YS'C;C+(]7A[.B_\ IV,)N,C]E8I!DXFLJ@,*M%DF1QD@D6
MA-*/$IF#:%B,3R#AP(LH#Q33ZOCK[.,J<L 2  @K (\$S\*PR2K,@(4N6^>I
MS'F< 6$TUS1'UB-A:4&+M BI9Z4#TTA2%. Q&]$TX&.T<;'5A@4)4)098AA0
MIOE:9;]A!= O?"$E.%H:C3-4OD@ D]:VXL*D2IZL$QGB51>F(L&KT9S!_Z>*
M A>)]KE<L@7X<GG,IDJ3DG48Z[Y6/ 97CFRE:5MJ7JO9X(#1.Q,U//@%G!==
M=]G#,O27CB$VB4&,2I[0Q,_3%+7<:K!%+(Z\X&%:#F68/^<1RM8(1Q%IF@"A
M81)(PR 1')/=&D'5/\X$NA<&SD$4SH&!-I&TS+1"4L, K M#$#,9TV&VY!EP
M;@,JQL3C&A@"'6;+-,GOE@S<AEC-1>IHU]$!Y8@BI3T:3XSI*ZH _V/)M:7A
M1$040AA \)*OD]@"''B$2*QHD6TNV1)PMC15N4SR*'#F.'5.#T!?O^2QBJ_(
M7G;W)  2:;H(*%[_1YQMG)-$4>U!R,5(?RMXO!$\U1PVC"A\J.LLP@AN%!@S
M0]4 !=;BG3SZ2Q[?T;BK4%(8"?]?\-1?LM;0<+/.N?UQ?N%Y;V", BDN!*\U
M:FP4 H$8+C\L$T# H^0AAMYD/I=A$**1X'U4C4+3T2E\.IX= \Q$$4^EEBW*
M,LPV7^9@V%<Z& =G]:50^JVM84]TTBVBD^[>Z&0"9-XAESY 0^";%DI=_+&W
MHWH],[T[U=Y)D\SG$&EGFLO"3.=.-=!L<C7;&9>XB EC);B97BRU&ORP8'-I
M5R.?H-0;MMLNMN0K99P-?$X/6#[NP.-&NO3X*@G"10C/SS?4\\_Y:@VJ#=9_
ME:?L-)<P#2E19=(L7Q?#M9I>:^=P/U^=SEAU(-)^0M2,?P8#"^Y!H\ O85^^
M#B'$HUBME5HLTF3%[@&EDURRP@G#IU_S,-561QB-^L/7:PBV^1RB%5#1!":2
M@M+.X9KF++*I>!J=@!& 4Q$ /J9,&6ZY;)YG]#!J)\%_XM+WN;"F@I>5']_8
MD54@UL@6,!JPD5""*8C S,DRVD4(Z,HA8I$*G)P*@< :(_M.LU.(GJ=S#C(Y
MNGJ,( @!-KLP2)#[,$(9;+$$QKK3M@ESX!2Z((O]G!P>SAG")N,6")N4^PQ]
M'?8H<UVGR>/&0CLES&U9*>=9G3P@'0W*@6WQ')TMA0CWH4P \.XQ.DSB75."
M01RY!(%A+R!0$'*:W /N0L=H4'=X&<)O#FNK98XQ%-_HP -D!,9YC[J#&$@-
M,7(XSU/4#=<Q7/6:K<;\L.$59F445Y,G6;VEHJ(0U?M5(18/&)[A5&3%=90:
MX !?XP"$(QE>B!#&[X'3UD -TMQ08O262*$4F<)?)'0)3I]OPX'2.14B6@%7
M(/R(@FJQ6 A?A3TIN!='=01?(22-N"3AR;)+2X7S&&6!K"I<.0QX2(:USR*^
MB!4J "ID@>(+@\*$#5I"V O*0[$J6OT:8"DO@DKQF"E8(F=#$;0)#E%[MZ=G
M:ZZCAEGC QE&^/'1;BU C,"YR!P"F"*M9<T'<#],@>R$\$E19GS"$N"3VL \
M4005,AS5Y6XZ*!YG*\%CS9F')=@#9X:--+24N5H8&<YK(,:A ?<7(-0X,P!*
MO0<4&F"PI^#*P4_;2NG:H8UR _$.6X';*"@>(&DUJE!,EZO;6;@23P=TGFV/
MK 6*T<.LP,.HIBE 3;P5B16Q;FTHI\*JN,:);,P*")<V(=W?330NC?;=5L)#
M*204GVG516][]YP"H]Q"'Y8I*)IP!2M$&:+OFPN?Y[)8RJP!7\&P@#PC:)_\
MF^U_+/21B)!U@?=K0/0:$+T&1*\!T6M ]!H0O09$KP'1OW% 5,D]]8K<4V]O
M[NF3FL%$@B!1E>J23GM[J(^QH%O'[I:"*[5M4FPC(-7/92_KTHHZ"VA00-9J
M2[FO@'9**B;,9"AO"+B9&Y>H((105N,+^E,TOU61+87GA7:Q4<CG853FC6TW
MOL#IHK#(4'>TH5$<)-KPH8;T8W;!/R/0%O,N*:Y2!]XO]<&ZF SO8H@.?4R'
M_I('=ZJ;*<$:#!H)+M';<+ R@+<-*W21&$!ZK,<J@%DQ!?"-TU:6VNV!@;*\
MV$P#&HGN,/7S%:JH;\!?/*(C*K#B&8)=@Y$E<:@>X$OT5AMJ 65T@2D8_YC)
M F3A-@/3'DYGDV/<"0 WN&)!KB+-F!SH*@$Y+?(,Q86J!3$=A5KW""A/-]*P
M"D1M.JB]%S64LE''8CBP4T=6Z/4+F=6O6KZC1?U>1D01WY_+B)[="GDUJ7]%
MDZKXO7[A]_I[_=X8=Z4IML0/J 2P6,'IUCG O5W5FROV[]3U7TDS&&%(VM"6
M2S"8(^)O&-\+LU6M8QQ@= BQ"? -N("Q_D8)/A4"!$"%2R"*"%?_%%JN\Q2D
M)U6 /Q=/)G+L5(-;7)C0,WK+&WO_@;7Z+;?7;K).J^<.O38$2K6 ]B_#(<?F
M$'L)AW9RIJ*7@T(O!WOU<FJ1]9.(R$AOTQQ 1I=OU>GGWB[KN6^-X]2.8TNA
M< B(Z N V 1)MR6PU%V@=5>["25%T2E%_UNMJ$S#;"3?P:H_C0FCK,4LBA:
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MD#'XG,J@H%X%(9;_8-IDS<.@BG49U;S0M+/G"71 9VA3;<YEB00/=&P>M\
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;.U96W/J-A!^]Z_0T,O
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MQQV[@6CQ8K2XX"23[Q9GA'.RDL,E#D%ZL0#N+PCAZPNQ0?5V^OQ/4$L#!!0
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M9O3T064WT/I"4EBV@CV@?DSU_@902P,$%     @ %( J69\B"V2/"0  =6T
M !D   !X;"]W;W)K<VAE971S+W-H965T,C$N>&ULQ9U[;]LX%L6_"N$=+&:
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MD;?[ OIHY:B6;1J'9NY',]NQ=$L[-/,:XQ5G XCJ?5'LHX]6++&ZJEJ'=K[
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MBS6K45<(:E:G#PW4"!;(A<:!VJ9J636=0 UU1;<U73V@E1WKD/X*IT*>I;-
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MG<UC0FBGL],/PKZ 9VV+E05D^^LK&<?8Q(C0>K\$V;[GZ)ZCUXUZ6\:_IDL
M@9[C*$G[QE*(U95IIOX28II>LA4D\LN<\9@*^<@79KKB0(,,%$>F;5F>&=,P
M,0:][-T#'_386D1A @\<I>LXIOS[-41LVS>P\?+B,5PLA7IA#GHKNH )B.GJ
M@<LGLV )PAB2-&0)XC#O&T-\17!; ;*(/T+8IJ4V4E)FC'U5#^.@;U@J(XC
M%XJ"RI\-C""*%)/,XUM.:A1]*F"Y_<)^DXF78F8TA1&+_@P#L>P;'0,%,*?K
M2#RR[2?(!;44G\^B-/N+MKO8MF,@?YT*%N=@F4$<)KM?^IP;40)(GGJ G0/L
MMP*<'. < KPC #<'N)DS.RF9#X0*.NAQMD5<14LVU<C,S-!2?IBH<9\(+K^&
M$B<&D^GM[?#Q+W1_@R;CCW?CF_%H>/>$AJ/1_?3N:7SW$3W<?QZ/QA\FZ!T!
M0<,H17>4<ZJ&ZSWZ%4TG!+W[^7W/%#(;Q6GZ><_7NY[M(ST[Z)8E8IFB#TD
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M +@*D-_GC(F7!]5!<;4Y^!=02P,$%     @ %( J6;EP88H(!0  &!H  !D
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MK)'-7%CU+1KU8JD9* ]:XE.&.#T<WXR_C<^OR-WCQ=5X1&XO+\/[\<VOY$L
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M3@=-)ZB;SJ*8A6(SL5!)U)!TT@+SXX=ZQ#+]8"ST>)-8,N]W1=UCDCZ2?/K
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M1E$T4S2-9^J"3%,[I[4&MLW)ZD.P)02H)0JEA5 :/>"4F#5NC%'7[HQ>E\.
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MT/+__,/M.%\JV)LE>[-*W5^2L8%(\2WAQ$[V/$=8K>'" 9D$UX%(Q'JKP(.
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M'F?5!N7O']*T>/FFZN!+FOVVW>V;_P-02P,$%     @ %( J6>'2'UP%!0
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MURP39B8/SWBIIVGY0BET_H3#)==S(,RTD?$%3 YBGIS?['C9ARN W[@!\"\
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M-JMSZSL'1J9YNUE)0\TK'V[I;X'*)M#Z6DKS$=@.5OQ_@K]02P,$%     @
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MW[ZF?YA^U.SIY$3L:%Q!U_2@M!B4AJ%HIE#MXM\? *<FT$4]*"T&I6$HFGE
MV*[K ^OJ](=34XT_?+:CCC\8F"G@VMZ+<Q4 I6$H6J6 >W! G>F-+?UF@ YO
MD<OJK+JI;=X^N"K/W-VV>?7JPI3P=9(+E-*5,O4N>BK*O'H;H"I(MBV/N^=,
M2I:5EQM*U.Q7-U#W5XS)^X)VT+R3,?X?4$L#!!0    ( !2 *EFZ^$+7-@,
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MJRHT;6D=-WQSWJT^[[1__@]02P,$%     @ %( J64N*H MS 0  <!4  !H
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M"O06U%O>J;</C]+YL>>YQOW?277HWW7C]L/R>7/R00TX6SA@W?\"4$L#!!0
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M@2I'H2I'P2I'X2I' 2M'(:M (:M (:M (:M (:M (:M (:M (:M (:M (:M
M(6N*0M84A:PI"EE3%+*F*&1-_Y.L'UHO__IG9+LFM53-P9]U?WQG7U!+ 0(4
M Q0    ( !2 *ED'04UB@0   +$    0              "  0    !D;V-0
M<F]P<R]A<' N>&UL4$L! A0#%     @ %( J605S\;ON    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ %( J
M69E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    "  4@"I9TV)%#H,$  #-$P  &
M@($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ %( J
M6?K^!85*!0  E1@  !@              ("!Q@P  'AL+W=O<FMS:&5E=',O
M<VAE970R+GAM;%!+ 0(4 Q0    ( !2 *EE#$=<9(@,  &8+   8
M      " @482  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M"  4@"I9Y"]0Q^4%   R)   &               @(&>%0  >&PO=V]R:W-H
M965T<R]S:&5E=#0N>&UL4$L! A0#%     @ %( J6<34">-G @  ^P4  !@
M             ("!N1L  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4
M Q0    ( !2 *EDE2$MKW0H  &E8   8              " @58>  !X;"]W
M;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  4@"I9P:KFS'\)  #&
M20  &               @(%I*0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL
M4$L! A0#%     @ %( J64958W0Q"P  EB0  !@              ("!'C,
M 'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( !2 *EG+ "?8
MTQ@  &YJ   8              " @84^  !X;"]W;W)K<VAE971S+W-H965T
M.2YX;6Q02P$"% ,4    "  4@"I9W"0HA%4#  !_"@  &0
M@(&.5P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( !2
M*EFL#\S;?P,  )H)   9              " @1I;  !X;"]W;W)K<VAE971S
M+W-H965T,3$N>&UL4$L! A0#%     @ %( J62PI'7:0"   -!\  !D
M         ("!T%X  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M    "  4@"I9+!KAYV &  "Z&   &0              @(&79P  >&PO=V]R
M:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( !2 *EDN"G+[/P,  %D)
M   9              " @2YN  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL
M4$L! A0#%     @ %( J6;[DJ&\&!@  IA8  !D              ("!I'$
M 'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    "  4@"I9P8Q-
M30\%  #-#   &0              @('A=P  >&PO=V]R:W-H965T<R]S:&5E
M=#$V+GAM;%!+ 0(4 Q0    ( !2 *EFS<]PDFA<  *]L   9
M  " @2=]  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @
M%( J69;;_EU+"   J1X  !D              ("!^)0  'AL+W=O<FMS:&5E
M=',O<VAE970Q."YX;6Q02P$"% ,4    "  4@"I9 [-D<80#  !1"@  &0
M            @(%ZG0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4
M Q0    ( !2 *EE:>5!1MP,  %@)   9              " @36A  !X;"]W
M;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ %( J69\B"V2/"0
M=6T  !D              ("!(Z4  'AL+W=O<FMS:&5E=',O<VAE970R,2YX
M;6Q02P$"% ,4    "  4@"I9"_1)@C<$  " %   &0              @('I
MK@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( !2 *EE'
M7>CWP0<  '9!   9              " @5>S  !X;"]W;W)K<VAE971S+W-H
M965T,C,N>&UL4$L! A0#%     @ %( J6;H(7J<G!P  &#X  !D
M     ("!3[L  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !2 *EGB=E*F5@,  " -   9              "
M@<C7  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ %( J
M6:;=\C=C#P  PNX  !D              ("!5=L  'AL+W=O<FMS:&5E=',O
M<VAE970S,"YX;6Q02P$"% ,4    "  4@"I9X=(?7 4%   O(   &0
M        @('OZ@  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0
M   ( !2 *EGZSLSZL <  &E$   9              " @2OP  !X;"]W;W)K
M<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ %( J686ZF)$R P  P0X
M !D              ("!$O@  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q0
M2P$"% ,4    "  4@"I9B>R]0<P"  "+!@  &0              @(%[^P
M>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( !2 *EET03?V
M?00  )\A   9              " @7[^  !X;"]W;W)K<VAE971S+W-H965T
M,S4N>&UL4$L! A0#%     @ %( J6;KX0M<V P  3A,   T
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;72YX;6Q02P4&     "L *P"D"P  W X!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>148</ContextCount>
  <ElementCount>197</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>39</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/StatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Operations (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/StatementsOfOperationsParenthetical</Role>
      <ShortName>Consolidated Statements of Operations (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Changes in Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/OrganizationAndBusinessOperations</Role>
      <ShortName>ORGANIZATION AND BUSINESS OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - INITIAL PUBLIC OFFERING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/InitialPublicOffering</Role>
      <ShortName>INITIAL PUBLIC OFFERING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - PRIVATE PLACEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/PrivatePlacements</Role>
      <ShortName>PRIVATE PLACEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - RELATED PARTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/RelatedParties</Role>
      <ShortName>RELATED PARTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - SHAREHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/ShareholdersEquity</Role>
      <ShortName>SHAREHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - RELATED PARTIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/RelatedPartiesTables</Role>
      <ShortName>RELATED PARTIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://bowenspac.com/role/RelatedParties</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://bowenspac.com/role/FairValueMeasurements</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative</Role>
      <ShortName>ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bowenspac.com/role/OrganizationAndBusinessOperations</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails</Role>
      <ShortName>SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails</Role>
      <ShortName>SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails</Role>
      <ShortName>SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails</Role>
      <ShortName>SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative</Role>
      <ShortName>INITIAL PUBLIC OFFERING (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bowenspac.com/role/InitialPublicOffering</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - PRIVATE PLACEMENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/PrivatePlacementsDetailsNarrative</Role>
      <ShortName>PRIVATE PLACEMENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bowenspac.com/role/PrivatePlacements</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails</Role>
      <ShortName>SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - RELATED PARTIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/RelatedPartiesDetailsNarrative</Role>
      <ShortName>RELATED PARTIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bowenspac.com/role/RelatedPartiesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bowenspac.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - SHAREHOLDERS??? EQUITY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/ShareholdersEquityDetailsNarrative</Role>
      <ShortName>SHAREHOLDERS??? EQUITY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bowenspac.com/role/ShareholdersEquity</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails</Role>
      <ShortName>SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - SCHEDULE FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails</Role>
      <ShortName>SCHEDULE FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bowenspac.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bowenspac.com/role/SubsequentEvents</ParentRole>
      <Position>35</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>bown-20240630.xsd</File>
    <File>bown-20240630_cal.xml</File>
    <File>bown-20240630_def.xml</File>
    <File>bown-20240630_lab.xml</File>
    <File>bown-20240630_pre.xml</File>
    <File doctype="S-4" isDefinitelyFs="true" isUsgaap="true" original="forms-4.htm">forms-4.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>annexc_001.jpg</File>
    <File>annexd_001.jpg</File>
    <File>forms-4_004.jpg</File>
    <File>forms-4_005.jpg</File>
    <File>forms-4_006.jpg</File>
    <File>forms-4_007.jpg</File>
    <File>forms-4_008.jpg</File>
    <File>forms-4_009.jpg</File>
    <File>forms-4_010.jpg</File>
    <File>forms-4_011.jpg</File>
    <File>forms-4_012.jpg</File>
    <File>forms-4_013.jpg</File>
    <File>forms-4_014.jpg</File>
    <File>picture1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="608">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>83
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "forms-4.htm": {
   "nsprefix": "BOWN",
   "nsuri": "http://bowenspac.com/20240630",
   "dts": {
    "schema": {
     "local": [
      "bown-20240630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "bown-20240630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bown-20240630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "bown-20240630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bown-20240630_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "forms-4.htm"
     ]
    }
   },
   "keyStandard": 135,
   "keyCustom": 62,
   "axisStandard": 16,
   "axisCustom": 0,
   "memberStandard": 20,
   "memberCustom": 18,
   "hidden": {
    "total": 135,
    "http://fasb.org/us-gaap/2024": 91,
    "http://bowenspac.com/20240630": 42,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 148,
   "entityCount": 1,
   "segmentCount": 39,
   "elementCount": 355,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 608,
    "http://xbrl.sec.gov/dei/2024": 24,
    "http://fasb.org/srt/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://bowenspac.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://bowenspac.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://bowenspac.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "BOWN:OrdinarySharesSubjectToRedemption",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://bowenspac.com/role/StatementsOfOperations",
     "longName": "00000004 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-04-012024-06-30",
      "name": "us-gaap:OperatingCostsAndExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-04-012024-06-30",
      "name": "us-gaap:OperatingCostsAndExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://bowenspac.com/role/StatementsOfOperationsParenthetical",
     "longName": "00000005 - Statement - Consolidated Statements of Operations (Parenthetical)",
     "shortName": "Consolidated Statements of Operations (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-06-30_srt_MaximumMember_us-gaap_OverAllotmentOptionMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R6": {
     "role": "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity",
     "longName": "00000006 - Statement - Consolidated Statements of Changes in Shareholders' Equity",
     "shortName": "Consolidated Statements of Changes in Shareholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2023-02-172023-03-31_us-gaap_RetainedEarningsMember",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-02-172023-03-31_us-gaap_RetainedEarningsMember",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://bowenspac.com/role/StatementsOfCashFlows",
     "longName": "00000007 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2024-04-012024-06-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-02-172023-06-30",
      "name": "BOWN:IncreaseDecreaseInAccruedOfferingCostsAndExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://bowenspac.com/role/OrganizationAndBusinessOperations",
     "longName": "00000008 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS",
     "shortName": "ORGANIZATION AND BUSINESS OPERATIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://bowenspac.com/role/InitialPublicOffering",
     "longName": "00000010 - Disclosure - INITIAL PUBLIC OFFERING",
     "shortName": "INITIAL PUBLIC OFFERING",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "BOWN:InitialPublicOfferingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "BOWN:InitialPublicOfferingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://bowenspac.com/role/PrivatePlacements",
     "longName": "00000011 - Disclosure - PRIVATE PLACEMENTS",
     "shortName": "PRIVATE PLACEMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "BOWN:PrivatePlacementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "BOWN:PrivatePlacementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://bowenspac.com/role/RelatedParties",
     "longName": "00000012 - Disclosure - RELATED PARTIES",
     "shortName": "RELATED PARTIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://bowenspac.com/role/CommitmentsAndContingencies",
     "longName": "00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://bowenspac.com/role/ShareholdersEquity",
     "longName": "00000014 - Disclosure - SHAREHOLDERS\u2019 EQUITY",
     "shortName": "SHAREHOLDERS\u2019 EQUITY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://bowenspac.com/role/FairValueMeasurements",
     "longName": "00000015 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://bowenspac.com/role/SubsequentEvents",
     "longName": "00000016 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://bowenspac.com/role/RelatedPartiesTables",
     "longName": "00000019 - Disclosure - RELATED PARTIES (Tables)",
     "shortName": "RELATED PARTIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://bowenspac.com/role/FairValueMeasurementsTables",
     "longName": "00000020 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
     "longName": "00000021 - Disclosure - ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)",
     "shortName": "ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "21",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "BOWN:WorkingCapitalDeficit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "unique": true
     }
    },
    "R22": {
     "role": "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails",
     "longName": "00000022 - Disclosure - SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details)",
     "shortName": "SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2023-02-172023-03-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-04-012024-06-30",
      "name": "BOWN:NetLossIncludingAccretionOfEquityIntoRedemptionValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "unique": true
     }
    },
    "R23": {
     "role": "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
     "longName": "00000023 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details)",
     "shortName": "SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2024-04-012024-06-30",
      "name": "BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:InvestmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-04-012024-06-30_custom_RedeemableSharesMember",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "unique": true
     }
    },
    "R24": {
     "role": "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
     "longName": "00000024 - Disclosure - SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details)",
     "shortName": "SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2023-02-172023-12-31",
      "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "BOWN:ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock",
       "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-02-172023-12-31",
      "name": "BOWN:AccretionOfCarryingValueToRedemptionValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "BOWN:ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock",
       "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "unique": true
     }
    },
    "R25": {
     "role": "http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails",
     "longName": "00000025 - Disclosure - SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES (Details)",
     "shortName": "SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2024-04-012024-06-30",
      "name": "BOWN:NoncashOfferingCostsPaidByRelatedParty",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-04-012024-06-30",
      "name": "BOWN:NoncashOfferingCostsPaidByRelatedParty",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "26",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "us-gaap:CashEquivalentsAtCarryingValue",
       "span",
       "span",
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "unique": true
     }
    },
    "R27": {
     "role": "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative",
     "longName": "00000027 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)",
     "shortName": "INITIAL PUBLIC OFFERING (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2023-07-142023-07-14_us-gaap_IPOMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-142023-07-14_us-gaap_IPOMember",
      "name": "us-gaap:SaleOfStockDescriptionOfTransaction",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "BOWN:InitialPublicOfferingTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "unique": true
     }
    },
    "R28": {
     "role": "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative",
     "longName": "00000028 - Disclosure - PRIVATE PLACEMENTS (Details Narrative)",
     "shortName": "PRIVATE PLACEMENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2023-02-172023-03-31",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-142023-07-14_us-gaap_PrivatePlacementMember",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "BOWN:PrivatePlacementsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "unique": true
     }
    },
    "R29": {
     "role": "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails",
     "longName": "00000029 - Disclosure - SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details)",
     "shortName": "SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2023-03-152023-03-15",
      "name": "BOWN:EquitySecuritiesFvNiTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-152023-03-15",
      "name": "BOWN:EquitySecuritiesFvNiTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
     "longName": "00000030 - Disclosure - RELATED PARTIES (Details Narrative)",
     "shortName": "RELATED PARTIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2023-02-172023-03-31",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-04-012024-06-30",
      "name": "us-gaap:AdministrativeFeesExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "unique": true
     }
    },
    "R31": {
     "role": "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "00000031 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2023-02-172023-12-31",
      "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-02-172023-12-31",
      "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative",
     "longName": "00000032 - Disclosure - SHAREHOLDERS\u2019 EQUITY (Details Narrative)",
     "shortName": "SHAREHOLDERS\u2019 EQUITY (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-06-30",
      "name": "us-gaap:CommonStockVotingRights",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "unique": true
     }
    },
    "R33": {
     "role": "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails",
     "longName": "00000033 - Disclosure - SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details)",
     "shortName": "SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member",
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "unique": true
     }
    },
    "R34": {
     "role": "http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails",
     "longName": "00000034 - Disclosure - SCHEDULE FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION (Details)",
     "shortName": "SCHEDULE FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2023-03-152023-03-15_us-gaap_FairValueInputsLevel3Member",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "BOWN:ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-152023-03-15_us-gaap_FairValueInputsLevel3Member",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "BOWN:ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://bowenspac.com/role/SubsequentEventsDetailsNarrative",
     "longName": "00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2024-01-182024-01-18_custom_MergerSharesMember_custom_AgreementMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-182024-01-18_us-gaap_SubsequentEventMember_custom_MergerSharesMember_custom_AgreementMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-4.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_AccountingServiceAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "AccountingServiceAgreementMember",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Service Agreement [Member]",
        "documentation": "Accounting Service Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_AccountingServicesExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "AccountingServicesExpenseMember",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Services Expense [Member]",
        "documentation": "Accounting Services Expense [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commited for future expenses",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r459"
     ]
    },
    "BOWN_AccretionOfCarryingValueToRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "AccretionOfCarryingValueToRedemptionValue",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion of carrying value to redemption value",
        "documentation": "Accretion of carrying value to redemption value."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_AccretionOfTemporaryEquityIntoRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "AccretionOfTemporaryEquityIntoRedemptionValue",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails": {
       "parentTag": "BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accretion of temporary equity into redemption value",
        "label": "Accretion of temporary equity to redemption value",
        "documentation": "Accretion of temporary equity into redemption value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r112",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r112",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r459",
      "r551"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r502",
      "r503",
      "r504",
      "r505",
      "r526",
      "r554"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allocation of offering costs to ordinary shares subject to redemption",
        "documentation": "Adjustments to additional paid in capital allocation of offering costs to ordinary shares subject to redemption."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deduction for increase of carrying value of redeemable shares",
        "documentation": "Amount of decrease (increase) in additional paid in capital (APIC) for the increase in carrying amount of redeemable preferred stock."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r64",
      "r68"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC)."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other offering costs",
        "documentation": "Adjustments to additional paid in capital underwriter\u2019s commission on sale of Public Units."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriter\u2019s commission on Over-allotment",
        "documentation": "Adjustments to additional paid in capital underwriters commission on overallotment."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriter\u2019s commission on sale of Public Units",
        "documentation": "Adjustments to additional paid in capital underwriters commission on sale of public units."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to reconcile net loss to net cash used in operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdministrativeFeesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdministrativeFeesExpense",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Administrative fee",
        "documentation": "Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r385",
      "r553"
     ]
    },
    "us-gaap_AffiliateCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AffiliateCosts",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliate costs",
        "documentation": "Costs associated with revenues arising from an entity that is an affiliate of the reporting entity by means of direct or indirect ownership."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "BOWN_AgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "AgreementMember",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreement [Member]",
        "documentation": "Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_AllocationOfNetIncomeloss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "AllocationOfNetIncomeloss",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allocation of net income/(loss)",
        "documentation": "Allocation of net income loss."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_AllocationOfNetLossIncludingAccretionOfTemporaryEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "AllocationOfNetLossIncludingAccretionOfTemporaryEquity",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allocation of net loss including accretion of temporary equity",
        "documentation": "Allocation of net loss including accretion of temporary equity."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Allocation of offering costs to ordinary shares subject to redemption",
        "documentation": "Allocation of offering costs to ordinary shares subject to redemption.",
        "label": "AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r235"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r80",
      "r101",
      "r119",
      "r146",
      "r150",
      "r152",
      "r153",
      "r156",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r236",
      "r238",
      "r269",
      "r302",
      "r378",
      "r437",
      "r438",
      "r459",
      "r471",
      "r522",
      "r523",
      "r536"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r107",
      "r119",
      "r156",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r236",
      "r238",
      "r269",
      "r459",
      "r522",
      "r523",
      "r536"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsHeldInTrust": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsHeldInTrust",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trust account, cash balance",
        "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "us-gaap_AssetsHeldInTrustNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsHeldInTrustNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets",
      "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails",
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments held in trust account",
        "verboseLabel": "Trust account, cash balance, with U.S. treasury bills",
        "terseLabel": "Investment held in trust account",
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current assets",
        "label": "Assets, Noncurrent",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r156",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r236",
      "r238",
      "r269",
      "r522",
      "r523",
      "r536"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation and Principles of Consolidation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r232",
      "r447",
      "r448"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r232",
      "r447",
      "r448"
     ]
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combination related cost",
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "BOWN_BusinessCombinationAcquisitionRelatedCostsReimbursed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "BusinessCombinationAcquisitionRelatedCostsReimbursed",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combination related cost reimbursed",
        "documentation": "Business combination acquisition related costs reimbursed."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_BusinessCombinationMarketingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "BusinessCombinationMarketingAgreementMember",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination Marketing Agreement [Member]",
        "documentation": "Business Combination Marketing Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r485",
      "r486"
     ]
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r305",
      "r353",
      "r373",
      "r459",
      "r471",
      "r494"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "us-gaap_CashAndCashEquivalentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsLineItems",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash at beginning of period",
        "periodEndLabel": "Cash at the end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r57",
      "r116"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r57"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash equivalents",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r547"
     ]
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, FDIC insured amount",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of noncash financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashMember",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash [Member]",
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "BOWN_CashUnderwritingDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "CashUnderwritingDiscount",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate cash underwriting discount",
        "documentation": "Cash underwriting discount."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_CashUnderwritingDiscountPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "CashUnderwritingDiscountPerUnit",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash underwriting discount per unit",
        "documentation": "Cash underwriting discount per unit."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://bowenspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r103",
      "r104",
      "r105",
      "r119",
      "r138",
      "r139",
      "r141",
      "r143",
      "r148",
      "r149",
      "r156",
      "r177",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r189",
      "r190",
      "r192",
      "r195",
      "r201",
      "r269",
      "r334",
      "r335",
      "r336",
      "r337",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r354",
      "r365",
      "r387",
      "r407",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r492",
      "r497",
      "r506"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r235"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r75",
      "r304",
      "r364"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r171",
      "r172",
      "r428",
      "r516",
      "r521"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r462",
      "r463",
      "r465",
      "r466",
      "r467",
      "r468",
      "r502",
      "r503",
      "r505",
      "r526",
      "r550",
      "r554"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheetsParenthetical",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, par value",
        "verboseLabel": "Common stock, par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheetsParenthetical",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary stock, shares authorized",
        "verboseLabel": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r365"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheetsParenthetical",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary stock, shares issued",
        "verboseLabel": "Ordinary shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheetsParenthetical",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary stock, shares outstanding",
        "verboseLabel": "Ordinary shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r44",
      "r365",
      "r384",
      "r554",
      "r555"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 2,266,500 shares issued and outstanding",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r307",
      "r459"
     ]
    },
    "us-gaap_CommonStockVotingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockVotingRights",
     "presentation": [
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock voting rights",
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r84"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory note aggregate principal amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r277",
      "r278",
      "r441",
      "r442",
      "r458"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory note maturity date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r440",
      "r530",
      "r531"
     ]
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of shares issued",
        "documentation": "The total fair value of shares issued during the period under a deferred compensation arrangement."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "BOWN_DeferredOfferingCostsIncludedInAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "DeferredOfferingCostsIncludedInAccruedExpenses",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering costs included in accrued expenses",
        "documentation": "Deferred offering costs included in accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_DeferredOfferingCostsPaidByRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "DeferredOfferingCostsPaidByRelatedParty",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering costs paid by related party",
        "documentation": "Deferred offering costs paid by related party."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Offering costs paid by Sponsor in exchange for issuance of ordinary shares",
        "documentation": "Deferred offering costs paid by sponsor in exchange for issuance of ordinary shares.",
        "label": "DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets",
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Deposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Deposits",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposits",
        "documentation": "The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "BOWN_DisclosureInitialPublicOfferingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "DisclosureInitialPublicOfferingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_DisclosurePrivatePlacementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "DisclosurePrivatePlacementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placements"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r485"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r485",
      "r486"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r472"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r485"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r485"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r487"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r475"
     ]
    },
    "BOWN_EBCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "EBCMember",
     "presentation": [
      "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EBC [Member]",
        "documentation": "EBC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://bowenspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic net loss per share, non-redeemable ordinary shares",
        "verboseLabel": "Basic net income/(loss) per share",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r136",
      "r138",
      "r141",
      "r142",
      "r143",
      "r145",
      "r230",
      "r234",
      "r248",
      "r249",
      "r301",
      "r315",
      "r434"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://bowenspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted net loss per share, non-redeemable ordinary shares",
        "verboseLabel": "Diluted net income/(loss) per share",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r138",
      "r141",
      "r142",
      "r143",
      "r145",
      "r230",
      "r234",
      "r248",
      "r249",
      "r301",
      "r315",
      "r434"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) per Ordinary Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r15",
      "r144"
     ]
    },
    "BOWN_EarnoutSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "EarnoutSharesMember",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout Shares [Member]",
        "documentation": "Earnout Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_EmergingGrowthCompanyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "EmergingGrowthCompanyPolicyTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Emerging Growth Company",
        "documentation": "Emerging Growth Company [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r478"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r96",
      "r111",
      "r112",
      "r113",
      "r122",
      "r123",
      "r124",
      "r126",
      "r131",
      "r133",
      "r135",
      "r147",
      "r157",
      "r158",
      "r166",
      "r202",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r231",
      "r233",
      "r234",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r247",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r279",
      "r280",
      "r281",
      "r314",
      "r321",
      "r322",
      "r323",
      "r342",
      "r407"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNiMeasurementInput",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Founder shares measurement input",
        "documentation": "Value of input used to measure investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r254",
      "r255"
     ]
    },
    "BOWN_EquitySecuritiesFvNiTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "EquitySecuritiesFvNiTerm",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Time to expiration",
        "documentation": "Equity securities FvNi term."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_ExpectedLikelihoodSuccessfulBusinessCombination": {
     "xbrltype": "percentItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "ExpectedLikelihoodSuccessfulBusinessCombination",
     "presentation": [
      "http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected likelihood of a successful business combination, percentage",
        "documentation": "Expected likelihood successful business combination"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r262",
      "r452"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r262",
      "r452"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF ASSUMPTIONS TO ESTIMATE FAIR VALUE",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r254",
      "r454"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://bowenspac.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r528"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails",
      "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails",
      "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r261",
      "r262",
      "r264",
      "r293",
      "r294",
      "r295",
      "r441",
      "r442",
      "r444",
      "r445",
      "r446",
      "r452",
      "r454"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://bowenspac.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r257",
      "r259",
      "r260",
      "r261",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r300",
      "r452",
      "r455"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r204",
      "r209",
      "r252",
      "r262",
      "r293",
      "r444",
      "r445",
      "r446",
      "r452"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r204",
      "r209",
      "r252",
      "r253",
      "r262",
      "r294",
      "r441",
      "r442",
      "r444",
      "r445",
      "r446",
      "r452"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails",
      "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails",
      "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r252",
      "r253",
      "r254",
      "r255",
      "r262",
      "r295",
      "r441",
      "r442",
      "r444",
      "r445",
      "r446",
      "r452",
      "r454"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails",
      "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails",
      "http://bowenspac.com/role/ScheduleOfMeasuredFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r261",
      "r262",
      "r264",
      "r293",
      "r294",
      "r295",
      "r441",
      "r442",
      "r444",
      "r445",
      "r446",
      "r452",
      "r454"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IPOMember",
     "presentation": [
      "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_IncomeEarnedOnTrustAccount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "IncomeEarnedOnTrustAccount",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income earned on Trust Account",
        "documentation": "Income earned on trust account.",
        "label": "IncomeEarnedOnTrustAccount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows",
      "http://bowenspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest earned on investments held in trust account",
        "negatedLabel": "Interest reinvested held in Trust Account",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r50",
      "r77",
      "r146",
      "r151",
      "r153",
      "r155",
      "r312"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r169",
      "r170",
      "r256",
      "r258",
      "r263",
      "r318",
      "r320",
      "r392",
      "r431",
      "r453",
      "r548"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r170",
      "r256",
      "r258",
      "r263",
      "r318",
      "r320",
      "r392",
      "r431",
      "r453",
      "r548"
     ]
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued for interest and penalties",
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations."
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r218",
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r333"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses \u2013 related party",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "BOWN_IncreaseDecreaseInAccruedOfferingCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "IncreaseDecreaseInAccruedOfferingCostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued offering costs and expenses",
        "documentation": "Increase decrease in accrued offering costs and expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in current assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "BOWN_InitialPublicOfferingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "InitialPublicOfferingTextBlock",
     "presentation": [
      "http://bowenspac.com/role/InitialPublicOffering"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INITIAL PUBLIC OFFERING",
        "documentation": "Initial Public Offering [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_InterestEarnedOnInvestmentHeldInTrustAccount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "InterestEarnedOnInvestmentHeldInTrustAccount",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails": {
       "parentTag": "BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest earned on investment held in Trust Account",
        "documentation": "Interest earned on investment held in trust account.",
        "label": "InterestEarnedOnInvestmentHeldInTrustAccount"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_InterestEarnedOnInvestmentsHeldInTrustAccount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "InterestEarnedOnInvestmentsHeldInTrustAccount",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest earned on investment held in trust account",
        "verboseLabel": "Interest and dividend income earned from trust account",
        "documentation": "Interest earned on investments held in trust account."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_InterestsEarnedFromTrustAccount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "InterestsEarnedFromTrustAccount",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interests earned from trust account",
        "documentation": "Interests earned from trust account."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments Held in Trust Account",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r329",
      "r330",
      "r331",
      "r332",
      "r416",
      "r417"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r119",
      "r156",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r237",
      "r238",
      "r239",
      "r269",
      "r363",
      "r435",
      "r471",
      "r522",
      "r536",
      "r537"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Shareholders\u2019 Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r76",
      "r310",
      "r459",
      "r498",
      "r514",
      "r532"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r99",
      "r119",
      "r156",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r237",
      "r238",
      "r239",
      "r269",
      "r459",
      "r522",
      "r536",
      "r537"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfOperationsParenthetical",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r94",
      "r95",
      "r173",
      "r174",
      "r175",
      "r176",
      "r211",
      "r216",
      "r255",
      "r298",
      "r317",
      "r319",
      "r326",
      "r355",
      "r356",
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r429",
      "r430",
      "r439",
      "r443",
      "r449",
      "r454",
      "r455",
      "r456",
      "r457",
      "r460",
      "r524",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r529",
      "r530",
      "r531"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r454",
      "r529",
      "r530",
      "r531"
     ]
    },
    "BOWN_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Probability Of Completion Of Business Combination [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r529",
      "r530",
      "r531"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r454"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r454"
     ]
    },
    "BOWN_MergerSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "MergerSharesMember",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merger Shares [Member]",
        "documentation": "Merger Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r60"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails": {
       "parentTag": "BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue",
       "weight": 1.0,
       "order": 1.0
      },
      "http://bowenspac.com/role/StatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails",
      "http://bowenspac.com/role/StatementsOfCashFlows",
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity",
      "http://bowenspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "label": "Net income",
        "verboseLabel": "Allocation of net income/(loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r60",
      "r78",
      "r97",
      "r108",
      "r109",
      "r113",
      "r119",
      "r125",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r134",
      "r135",
      "r140",
      "r156",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r230",
      "r234",
      "r249",
      "r269",
      "r313",
      "r386",
      "r405",
      "r406",
      "r469",
      "r522"
     ]
    },
    "BOWN_NetLossIncludingAccretionOfCommonStockToRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "NetLossIncludingAccretionOfCommonStockToRedemptionValue",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss including accretion of common stock to redemption value",
        "documentation": "Net loss including accretion of common stock to redemption value.",
        "label": "NetLossIncludingAccretionOfCommonStockToRedemptionValue"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_NetLossIncludingAccretionOfEquityIntoRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "NetLossIncludingAccretionOfEquityIntoRedemptionValue",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfNetIncomeLossPerSharePresentedStatementsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss including accretion of equity into redemption value",
        "documentation": "Net loss including accretion of equity into redemption value.",
        "label": "NetLossIncludingAccretionOfEquityIntoRedemptionValue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Standards",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_NonCashOfferingCostsChargedToAdditionalPaidinCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "NonCashOfferingCostsChargedToAdditionalPaidinCapital",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows",
      "http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering costs charged to Additional Paid-in Capital",
        "verboseLabel": "Offering costs charged to APIC \u2013 EBC founder shares",
        "documentation": "Offering costs charged to Additional Paid-in Capital."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_NonRedeemableOrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "NonRedeemableOrdinarySharesMember",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Redeemable Ordinary Shares [Member]",
        "documentation": "Non Redeemable Ordinary Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_NonRedeemableSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "NonRedeemableSharesMember",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Redeemable Shares [Member]",
        "documentation": "Non Redeemable Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_NoncashOfferingCostsAdjustedFromPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "NoncashOfferingCostsAdjustedFromPrepaidExpenses",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows",
      "http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering costs adjusted from prepaid expenses",
        "documentation": "Offering costs adjusted from prepaid expenses."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_NoncashOfferingCostsIncludedInAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "NoncashOfferingCostsIncludedInAccruedExpenses",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Offering costs included in accrued expenses",
        "documentation": "Noncash offering costs included in accrued expenses.",
        "label": "NoncashOfferingCostsIncludedInAccruedExpenses"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_NoncashOfferingCostsPaidByRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "NoncashOfferingCostsPaidByRelatedParty",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Offering costs paid by related party",
        "documentation": "Noncash offering costs paid by related party.",
        "label": "NoncashOfferingCostsPaidByRelatedParty"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows",
      "http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering costs paid by Sponsor in exchange for issuance of ordinary shares",
        "documentation": "Offering costs paid by Sponsor in exchange for issuance of ordinary shares."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_NoncashPrepaidExpensesPaidByRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "NoncashPrepaidExpensesPaidByRelatedParty",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/SupplementalDisclosureOfNoncashFinancingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Prepaid expenses paid by related party",
        "documentation": "Noncash prepaid expenses paid by related party.",
        "label": "NoncashPrepaidExpensesPaidByRelatedParty"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonrelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonrelatedPartyMember",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonrelated Party [Member]",
        "documentation": "Party not related to reporting entity."
       }
      }
     },
     "auth_ref": [
      "r499",
      "r500"
     ]
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes outstanding amount",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r74",
      "r545",
      "r546"
     ]
    },
    "BOWN_OfferingCostsChargedToAPICFounderShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "OfferingCostsChargedToAPICFounderShares",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering costs charged to APIC \u2013 EBC founder shares",
        "documentation": "Offering costs charged to APIC founder shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OfferingCostsPartnershipInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OfferingCostsPartnershipInterests",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Allocation of offering costs related to redeemable shares",
        "label": "Offering Costs, Partnership Interests",
        "documentation": "Costs incurred in connection with the offering and selling of additional partner interest."
       }
      }
     },
     "auth_ref": [
      "r515",
      "r549"
     ]
    },
    "BOWN_OfferingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "OfferingCostsPolicyTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Costs",
        "documentation": "Offering Costs [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingCostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Formation and operating costs",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r436",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512"
     ]
    },
    "BOWN_OrdinarySharesSubjectToRedemption": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "OrdinarySharesSubjectToRedemption",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheetsParenthetical",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares subject to redemption",
        "documentation": "Ordinary shares subject to redemption."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ORGANIZATION AND BUSINESS OPERATIONS",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r70",
      "r327",
      "r328"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to related party",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r459"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_OtherOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "OtherOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other offering costs",
        "documentation": "Other offering costs.",
        "label": "OtherOfferingCosts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets",
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other receivable (Note 6)",
        "verboseLabel": "Due from related parties",
        "terseLabel": "Other receivables",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r485"
     ]
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_OwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "OwnershipPercentage",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership percentage",
        "documentation": "Ownership percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentForAdministrativeFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentForAdministrativeFees",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Administrative fees paid",
        "documentation": "Amount paid to managing member or general partner, affiliate of managing member or general partner, or affiliate of limited liability company (LLC) or limited partnership (LP) for administrative services provided to the LLC or LP, for example, but not limited to, salaries, rent, or overhead costs."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r533"
     ]
    },
    "BOWN_PaymentOfOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "PaymentOfOfferingCosts",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of offering costs",
        "documentation": "Payment of offering costs.",
        "label": "PaymentOfOfferingCosts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForUnderwritingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForUnderwritingExpense",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for underwriting expense",
        "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction cost",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "BOWN_PaymentsOfUnderwritersDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "PaymentsOfUnderwritersDiscount",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of underwriter\u2019s discount",
        "documentation": "Payments of underwriter\u2019s discount.",
        "label": "PaymentsOfUnderwritersDiscount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireOtherInvestments",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Investments of cash into Trust Account",
        "label": "Payments to Acquire Other Investments",
        "documentation": "Amount of cash outflow to acquire investments classified as other."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "BOWN_PercentageOfGrossProceedsOfInitialPublicOffering": {
     "xbrltype": "percentItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "PercentageOfGrossProceedsOfInitialPublicOffering",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of gross proceeds of initial public offering",
        "documentation": "Percentage of gross proceeds of initial public offering."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_PercentageOfServiceFeeOfTotalConsiderationPayable": {
     "xbrltype": "percentItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "PercentageOfServiceFeeOfTotalConsiderationPayable",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of service fee of total consideration payable",
        "documentation": "Percentage of service fee of total consideration payable."
       }
      }
     },
     "auth_ref": []
    },
    "srt_PlatformOperatorCryptoAssetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "PlatformOperatorCryptoAssetLineItems",
     "presentation": [
      "http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails",
      "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto Asset [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r168"
     ]
    },
    "srt_PlatformOperatorCryptoAssetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "PlatformOperatorCryptoAssetTable",
     "presentation": [
      "http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails",
      "http://bowenspac.com/role/ScheduleOfAssumptionsToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto Asset [Table]",
        "documentation": "Disclosure of information about crypto-asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r168"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r479"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheetsParenthetical",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r189"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheetsParenthetical",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r365"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheetsParenthetical",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r189"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheetsParenthetical",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r365",
      "r384",
      "r554",
      "r555"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r306",
      "r459"
     ]
    },
    "us-gaap_PreferredStockVotingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockVotingRights",
     "presentation": [
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock voting rights",
        "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r43"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r159",
      "r160",
      "r432"
     ]
    },
    "BOWN_PrepaidExpensesPaidByRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "PrepaidExpensesPaidByRelatedParty",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses paid by related party",
        "documentation": "Prepaid expenses paid by related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_PrivatePlacementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "PrivatePlacementsTextBlock",
     "presentation": [
      "http://bowenspac.com/role/PrivatePlacements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PRIVATE PLACEMENTS",
        "documentation": "Private Placements [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of IPO",
        "verboseLabel": "Proceeds allocated to public rights",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of ordinary shares",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "BOWN_ProceedsFromIssuanceOfFounderShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "ProceedsFromIssuanceOfFounderShares",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of founder shares",
        "documentation": "Proceeds from issuance of founder shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Private Placement",
        "verboseLabel": "Proceeds from issuance of private placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds allocated to Public Rights",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r334"
     ]
    },
    "us-gaap_ProceedsFromLegalSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromLegalSettlements",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Over-allotment proceeds",
        "label": "Proceeds from Legal Settlements",
        "documentation": "Cash received for the settlement of litigation during the current period."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromOtherEquity",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over-allotment proceeds",
        "documentation": "Amount of cash inflow from the issuance of equity classified as other."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service fee",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r437",
      "r469",
      "r552",
      "r553"
     ]
    },
    "BOWN_PromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "PromissoryNoteMember",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory Note [Member]",
        "documentation": "Promissory Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_QianzhiMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "QianzhiMember",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Qianzhi [Member]",
        "documentation": "Qianzhi [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfOperationsParenthetical",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r94",
      "r95",
      "r173",
      "r174",
      "r175",
      "r176",
      "r203",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r255",
      "r296",
      "r297",
      "r298",
      "r317",
      "r319",
      "r326",
      "r355",
      "r356",
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r429",
      "r430",
      "r439",
      "r443",
      "r449",
      "r454",
      "r455",
      "r456",
      "r457",
      "r460",
      "r463",
      "r520",
      "r524",
      "r530",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfOperationsParenthetical",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r94",
      "r95",
      "r173",
      "r174",
      "r175",
      "r176",
      "r203",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r255",
      "r296",
      "r297",
      "r298",
      "r317",
      "r319",
      "r326",
      "r355",
      "r356",
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r429",
      "r430",
      "r439",
      "r443",
      "r449",
      "r454",
      "r455",
      "r456",
      "r457",
      "r460",
      "r463",
      "r520",
      "r524",
      "r530",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543"
     ]
    },
    "BOWN_ReclassificationOfOrdinarySharesSubjectToRedemption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "ReclassificationOfOrdinarySharesSubjectToRedemption",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification of ordinary shares subject to redemption",
        "documentation": "Reclassification of ordinary shares subject to redemption."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RedeemableNoncontrollingInterestEquityCommonCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Gross proceeds",
        "periodEndLabel": "Ordinary shares subject to possible redemption",
        "label": "Ordinary shares subject to possible redemption",
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r65",
      "r66"
     ]
    },
    "BOWN_RedeemableOrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "RedeemableOrdinarySharesMember",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Ordinary Shares [Member]",
        "documentation": "Redeemable Ordinary Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_RedeemableSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "RedeemableSharesMember",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Shares [Member]",
        "documentation": "Redeemable Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r210",
      "r285",
      "r286",
      "r303",
      "r311",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r383",
      "r385",
      "r414"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r121",
      "r285",
      "r286",
      "r287",
      "r288",
      "r303",
      "r311",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r383",
      "r385",
      "r414"
     ]
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment for services",
        "documentation": "Amount of transactions with related party during the financial reporting period."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r285"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r210",
      "r285",
      "r286",
      "r303",
      "r311",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r383",
      "r385",
      "r414",
      "r535"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://bowenspac.com/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTIES",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r286",
      "r289",
      "r339",
      "r340",
      "r341",
      "r390",
      "r391",
      "r392",
      "r411",
      "r413"
     ]
    },
    "BOWN_RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remeasurement adjustment on ordinary shares subject to possible redemption",
        "documentation": "Remeasurement adjustment on ordinary shares subject to possible redemption."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfRelatedPartyDebt",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments to related party",
        "label": "Related party debt",
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r68",
      "r309",
      "r324",
      "r325",
      "r338",
      "r366",
      "r459"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r122",
      "r123",
      "r124",
      "r126",
      "r131",
      "r133",
      "r135",
      "r157",
      "r158",
      "r166",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r231",
      "r233",
      "r234",
      "r240",
      "r242",
      "r243",
      "r245",
      "r247",
      "r279",
      "r280",
      "r321",
      "r323",
      "r342",
      "r554"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of units",
        "verboseLabel": "Gross proceeds",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockDescriptionOfTransaction": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockDescriptionOfTransaction",
     "presentation": [
      "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock holders equity related to initial public offering description",
        "verboseLabel": "Units related to private placement description",
        "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r30",
      "r71"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of units sold",
        "verboseLabel": "Stock issued during the period, shares",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Price per share",
        "verboseLabel": "Sale of stock, par share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCashAndCashEquivalentsTable",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalent [Table]",
        "documentation": "Disclosure of information about cash and cash equivalent by type. Excludes restricted cash and cash equivalent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES",
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r235"
     ]
    },
    "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS",
        "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r501"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets",
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan [Table]",
        "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r23",
      "r24",
      "r25",
      "r26"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "BOWN_ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION",
        "documentation": "Schedule of fair value of early bird capital assumption estimate [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET",
        "documentation": "Schedule of ordinary shares subject to possible redemption reflected in the balance sheet [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r473"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r477"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "BOWN_ServiceFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "ServiceFee",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Service fee",
        "documentation": "Service fee.",
        "label": "ServiceFee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r213"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Volatility rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r212"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of ordinary per share price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://bowenspac.com/role/ScheduleFairValueOfEarlyBirdCapitalAssumptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Time to expiration",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued price per share",
        "verboseLabel": "Private placement units of underwriters over-allotment per share price",
        "terseLabel": "Ordinary share price",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, shares",
        "periodEndLabel": "Balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Shares Subject to Possible Redemption",
        "documentation": "Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_ShenzhenQianzhiMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "ShenzhenQianzhiMember",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shenzhen Qianzhi [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r517",
      "r518",
      "r519"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r517",
      "r518",
      "r519"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r117"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "BOWN_SponsorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "SponsorsMember",
     "presentation": [
      "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sponsors [Member]",
        "documentation": "Sponsors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://bowenspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r103",
      "r104",
      "r105",
      "r119",
      "r138",
      "r139",
      "r141",
      "r143",
      "r148",
      "r149",
      "r156",
      "r177",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r189",
      "r190",
      "r192",
      "r195",
      "r201",
      "r269",
      "r334",
      "r335",
      "r336",
      "r337",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r354",
      "r365",
      "r387",
      "r407",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r492",
      "r497",
      "r506"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r44",
      "r47",
      "r48",
      "r96",
      "r111",
      "r112",
      "r113",
      "r122",
      "r123",
      "r124",
      "r126",
      "r131",
      "r133",
      "r135",
      "r147",
      "r157",
      "r158",
      "r166",
      "r202",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r231",
      "r233",
      "r234",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r247",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r279",
      "r280",
      "r281",
      "r314",
      "r321",
      "r322",
      "r323",
      "r342",
      "r407"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity",
      "http://bowenspac.com/role/StatementsOfOperations",
      "http://bowenspac.com/role/StatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r147",
      "r280",
      "r299",
      "r329",
      "r354",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r375",
      "r376",
      "r377",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r388",
      "r389",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r407",
      "r464"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity",
      "http://bowenspac.com/role/StatementsOfOperations",
      "http://bowenspac.com/role/StatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r147",
      "r154",
      "r280",
      "r299",
      "r329",
      "r354",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r375",
      "r376",
      "r377",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r388",
      "r389",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r407",
      "r464"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of ordinary shares to Sponsor, shares",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares issued to underwriter, shares",
        "verboseLabel": "Number of stock issued",
        "terseLabel": "Stock issued during period shares",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r43",
      "r44",
      "r68",
      "r334",
      "r407",
      "r423"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital, shares",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over-allotment of Private Units, shares",
        "documentation": "Stock issued during period shares overallotment of private units."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_StockIssuedDuringPeriodSharesProceedsFromOverallotment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "StockIssuedDuringPeriodSharesProceedsFromOverallotment",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from over-allotment, shares",
        "documentation": "Stock issued during period shares proceeds from overallotment."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of public units, shares",
        "documentation": "Stock issued during period shares proceeds from sale of public units."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_StockIssuedDuringPeriodSharesSaleOfPrivateUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "StockIssuedDuringPeriodSharesSaleOfPrivateUnits",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Private Units, shares",
        "documentation": "Stock issued during period shares sale of private units."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares subject to forfeiture",
        "verboseLabel": "Number of shares subject to forfeiture",
        "documentation": "Number of shares (or other type of equity) forfeited during the period."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_StockIssuedDuringPeriodSharesToUnderwriter": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "StockIssuedDuringPeriodSharesToUnderwriter",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of ordinary shares to Underwriter, shares",
        "documentation": "Number of stock issued during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of ordinary shares to Sponsors",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares issued to underwriter",
        "verboseLabel": "Proceeds allocated to Public Rights",
        "terseLabel": "Value of stock issued",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r43",
      "r44",
      "r68",
      "r342",
      "r407",
      "r423",
      "r470"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial measurement of Ordinary shares Subject to redemption under ASC 480-10-S99 against additional paid-in capital",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over-allotment of Private Units",
        "documentation": "Stock issued during period value over-allotment of Private Units."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_StockIssuedDuringPeriodValueProceedsFromOverallotment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "StockIssuedDuringPeriodValueProceedsFromOverallotment",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from over-allotment",
        "documentation": "Stock issued during period value proceeds from over-allotment."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of public units",
        "documentation": "Stock issued during period value proceeds from sale of public units."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_StockIssuedDuringPeriodValueSaleOfPrivateUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "StockIssuedDuringPeriodValueSaleOfPrivateUnits",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Private Units",
        "documentation": "Stock issued during period value sale of private units."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_StockIssuedDuringPeriodValueToUnderwriter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "StockIssuedDuringPeriodValueToUnderwriter",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of ordinary shares to Underwriter",
        "documentation": "Stock issued during period value Issuance of ordinary shares to underwriter."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets",
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Shareholders\u2019 Equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r47",
      "r48",
      "r62",
      "r367",
      "r384",
      "r408",
      "r409",
      "r459",
      "r471",
      "r498",
      "r514",
      "r532",
      "r554"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://bowenspac.com/role/ShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS\u2019 EQUITY",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r118",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r202",
      "r246",
      "r410",
      "r412",
      "r427"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r291"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r291"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r291"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r291"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r291"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://bowenspac.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r292"
     ]
    },
    "BOWN_SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent measurement of Common stock subject to possible redemption (interest earned on trust account)",
        "documentation": "Subsequent measurement of common stock subject to possible redemption interest earned on trust account."
       }
      }
     },
     "auth_ref": []
    },
    "BOWN_SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://bowenspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent measurement of ordinary shares subject to possible redemption (income earned on Trust Account)",
        "verboseLabel": "Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)",
        "documentation": "Subsequent measurement of ordinary shares subject to possible redemption (income earned on Trust Account)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative",
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative",
      "http://bowenspac.com/role/StatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://bowenspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative",
      "http://bowenspac.com/role/ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://bowenspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://bowenspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares subject to possible redemption (6,900,000 shares at $10.35 per share)",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r215",
      "r308"
     ]
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://bowenspac.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares subject to redemption par value",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r19"
     ]
    },
    "BOWN_TenXGlobalCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "TenXGlobalCapitalMember",
     "presentation": [
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ten X Global Capital [Member]",
        "documentation": "Ten X Global Capital [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]",
        "documentation": "Information by title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": [
      "r513",
      "r534"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://bowenspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative",
      "http://bowenspac.com/role/RelatedPartiesDetailsNarrative",
      "http://bowenspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r235"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r444",
      "r446",
      "r452",
      "r544"
     ]
    },
    "BOWN_UnderwritersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "UnderwritersMember",
     "presentation": [
      "http://bowenspac.com/role/PrivatePlacementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters [Member]",
        "documentation": "Underwriters [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized tax benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r220",
      "r451"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://bowenspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r82",
      "r83",
      "r85",
      "r86"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://bowenspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted weighted average ordinary shares outstanding, non-redeemable ordinary shares",
        "verboseLabel": "Weighted average shares outstanding - diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r143"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://bowenspac.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://bowenspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic weighted average ordinary shares outstanding, non-redeemable ordinary shares",
        "verboseLabel": "Weighted average shares outstanding - basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r143"
     ]
    },
    "BOWN_WorkingCapitalDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://bowenspac.com/20240630",
     "localname": "WorkingCapitalDeficit",
     "crdr": "credit",
     "presentation": [
      "http://bowenspac.com/role/OrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital deficit",
        "documentation": "Working capital deficit."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://bowenspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1B"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Section": "S99",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Paragraph": "3A",
   "Section": "S99",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "25",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-23"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 3.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(14)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(15)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-23"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "FF",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.FF.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476188/405-10-S99-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-12"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r493": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r494": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r496": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r502": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r503": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r504": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r505": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r506": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r507": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r510": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r511": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r512": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r513": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r514": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r515": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480341/340-10-S99-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r517": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r521": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r522": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r523": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r524": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r525": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r526": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r533": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r536": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r537": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r538": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r539": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r540": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r541": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r542": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r543": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r544": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r549": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 5.D.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-4"
  },
  "r550": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r551": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r553": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r555": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>84
<FILENAME>0001493152-24-035624-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-035624-xbrl.zip
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M63I4*F@+K,7$GW(ECA$O,9::E:X"C^.DK:8CB^).W9BD%T_<B-43;MK=;\B
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M)E;UP06L8)/<6PM6QX8_CEN!T'NS_P%02P,$%     @ %8 J67O_]J$6!P
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M5HH66'[7_NF"-8=_G E/<[C&E8Y:)=];>WZI(WH)[I=]GZ/>S=T+-7;J#!/
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M:VR&TY(=9CZL$6&H@9L2F [,9%Y=6&0=A3 '9LX,^SC<C.9)\E5H<S1/GPI
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MC:>U"C7C@N<(B9=Q$E5I"!3VT410IS4KG>=@?X38JSBQHC(:R=- D,%"%)7
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M\$QE2E^1G$DWQ_<^^=*O@1N!:2BD^YL+4GDVE"LARX&3SIL3T&$,T$IX(#Y
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MY!Q'>+J["$]X2I0>ZOPF0#41@' KUO),D>U98>@NW'WH?\4$"Q5&.C.PJTH
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MS4+J4Q#S(CI+#M0N2*LPI]I*J^2F<GLSZ U\JNYV1!X3S.;M@@UFP3B;:N%
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MG2>M3 !/@"UPW]:V<6>836B>D^_BG[MPCS:=M"*^#7J.LD@5;:^\/GI.3:'
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M?-^A*F6]7Y8X^28OE]I9(K=QFDDV>V,_?.EV'M'_T+@?\I?_#U!+ P04
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M]9[/^X<T5F2?DDJY(H$&8L4#B0@(*JAQ]=EPEZ)2%'%9']FI.F EQ>D]=T4
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MM@'T0/>(E2;0+]0(8E9<WU\^39,BV- ;8_(T27"LV'(L%W.7LT(-LDE=(<J
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MU"E+.Q)@^"*%I5Z0@I)IM$9T:T@K*A/T0@P!J)0<M^"R@RJA:4AR"RCIY^*
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MAG%0><E;\XG$%)0!,%-1(&L?_&*X*8=[$CE?A//D?[Y)LQ7.GJ+-24Y48@,
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M;2IDP;#) %!S-);+0_)7_;(8QVEJ>9]\TH_#5,)@&67>OW&U(N,J,CE$LY]
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MF5RVFW6P"7>W/YQ6N.92B&'ZWAE[!N@^^2HK**[-T',K <IK8^A!<D+@%<T
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MFJIU=C55?-_Z":Q/VX<E+"]=3;U^T/;*OS*I?E\$UB=6XA.3X;?V'_C\Z,V
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MUQ __,<Q+]AYV'4Z"4.6^3^(ET$4SI,R&RNCC'068*L,J-D,QRSFAZPMT#%
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M_YNXR30:$X^=)P69$'E%0#WDX, Z=T6 DEFR*A:._&SX#VDJM9=NBT>$IC*
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M@/?;#S<IS<4LUV@*VW"NS6EMN!J>]0C'H^621R/.)OX\]&>^ZX1)&;W-667
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M&(^<9_E-X<-20/R-F:W!^%<)AXZXQ>^ -A\UH;VFX+_]V805KN/$B]VK#^R
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MN*RB]AQ>U3*6M>X4D_Q;>'.KM&U5G:>%%="S\)O:R N/TB^ ;= 97%X+_3T
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M$%^8&26"O2?>"T;O"O^LMR]T\1#W3H\NL!&/C5VG5#R9+AUL+S$D"K/=K,$
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M@KI-J2WF[)"?!>XCY^0>S[R.\4N=7UQ=O$=GQ?R?LL@3TT<E2&8EY9<'%-#
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MKMGW,BE _0%ZH2]1F\EN2/E"-0/O:BUVS_[*F'I"_!;0.$ZBGQ$=/WHC_I#
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M8#& =MKVVE>;#-AZ+]M/>X*!^2_@M*BTI^GMT?3)6L3N#=C;W%L#NP_&:6[
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M%?E2%N5J/'HCA9;1^54AY0+>]/46\?=*EVJV^LP3LUO2XUF\D5KGQ7CTX)V
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M/\Y$K%)5*JGW\ ZS..Y1@?"Q4^BOP=7S P)&_SEL6IR"EG1(A$2;;[:EUYZ
MW?!G'.X?CD>6O=RH-#4G$8\A?4K\:03M3I3PA2@_A^H7-52H\<CISILX# [,
M<)G&^"R;P0L->X'Y%L B@.O)J-)R8 -;H[*C\>@2=DXO9:Q@.YB60/I8EM^D
M-9 ?*DL4$YS*(A9-T7F6R=OHB.^":X25,9/H9J[ S$)1F(&PJ_!IN/ON18D$
M:EH 5>%?XQ&*1A"#US)3Z)I3">J(,\47#X2R+:;:&/C_>O@P^E')-'D&1_I*
M/H<;_ZAD%N,-T<.')K3SXM7/_VU?S^-^.,W+,E\\B\Z6Y?-H"DJ:+-QW%ZD
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MH19RS)H')\^M:,_>2K"$$]UK^;P;6L8Q:AFT/P_ [HC15X[\TAK>[,Y3*>4
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M3,U*:6LJ@GXQ?C1.A;:CPT3;/$M7W)RE*#"%%1.NG?#!9-:24OHR+7UV:,L
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MJ84_QJ@#FBH5'UH.ZB!M'0JW#0>>Y[/S Y1$1=;<>.1#(W#-K,I<Y6J;*'R
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M'(^.CPZ/3W]X= 7KCL__\0O/Y:LNG'W99UVYMT6^E$6Y'H]>2Z%E='E32+F
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M/F0*_!TS!8;#TFJ]G!O(AY>,2-5KK7X_;)-SM$W"G P02(R$&M38SZH4$Q]
M$0*[)9_"8 2C(U49W=4 V]XL1G+83:X0QT"2N1JLB^/S)\>'%Z9DSV*PW:>
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M==CIHO"X[\:2'X]\&FW3=Z\6V"(,N':Z-NR\O2?7+[-@%C;/M3'RC7Z$"/T
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M/"F.\(S?)%!,@H>[_+<NGN4*JO'JHHE6XTL.G_OZRDL[*NN,ZY D+1VXJ&%
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M7JBR,OD6%&.&342WCZ<RZI *.UN5\[P@P(]"@FQ =[1@H2$H^A<KU,C=T=F
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M>KY0>['9CX/-YF8_[8EZF @<>,W7OCD0HM0,VN7G<2]]<;#T!T]@OU^AG\8
M7@2X;--"33%1U"L(+A*C2S&;[=E2[,7Q?7KP!;'[;,BK$[^OYZNW%Q1P?.0Y
MN(^<>D#_B8,4BV&?@W@#X>D$:&*NNS9K9AMX8@@=QBAB7&MM,'(\AE@K?.,
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MI==8D>1U45AQ8Y$:#,Y,528YPH@M1>PK(!S]PM],O)A^8ZAW0L>4DBP4:+=
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M1?JW;\/7%\@HHE,-?4E_.X,I#<T$A6O]LDK:P9NTCAE#'*!1.K8P*\7!QAG
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M2JFLH7!YI7)\NLCZ1NNA5XPFO'!145@B%W:+W:8I#24&XTU0."L"X"&-J0^
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MX1EY/;5Y@X!<5)O*[OX2N_NGLCB_3T!MI_NZ]^=S_.5B<'7Y_/]02P,$%
M  @ %8 J60AD/)'L"0  P.P   D   !E>#$P-RYH=&WM76U3VSH6_MZ9_@=M
M]M(),R$))$ +*3-)""TS%+*0[DP_*K:2:&M;1I(+N;_^'MEY,5SN=&D3D)S#
M3)OX1?*CYQP].CJ6G=;GP9>+D[=O6I][[5/X).:O-3@?7/1.6K7L$X[69H=;
MG:O3;^1F\.VB][$T$I$^(KOU6),!#YDBE^R.7(N01I5L1X7<,,E')2@(1?O/
M+7=,0BK'/#HB]6.BV;W>H0$?PZ;DXXDNG;3.KBX'^4IW1C3DP?3H9]6FYRK^
M)\M00$V=DW?14,7'K5H'FFWJA8^^"[A[]Q,^Y/KMF]WZH6/HYY2O"[#'(LWD
M,1E2[_M8BB3R=SP1"'E$[B9<LQ4;HDL#+PFHYB)Z^T:,R!D/>#0F9XR1 1T&
M3*W7.B_8V&+9[4S(\.V;FYUF8>Q3SIHTF,9LNQ -*I;#=<0= XEH>[<)5]SH
M!>D*&1?'_7KWU(,!Z9*&C( 07K,Q5UK22!.JR$W,/#[BS"<\(EPKTIU0"=#0
M4RUK"GAJZ^M).G1!<'%D2@;3F3&9!/O1R"==*N64@-[<4>E#55XBP:/-6/?U
M9/4._6H&'+0[%SW2[5U<W/3;W?/+3Q]+]5*ZW6^?GLZWG]VT.^[KB3FUO@6-
M$])GTC0LH+$"0/-OI30L;PVNGW^!'TQJ[M%@[CY#H;4(2[,XOS4X?7XHOS:J
M!Z>_#NN8Q-3W(=S:R5H(9:K[\0M,$7X/],SD<\S# /P[0TZ4"+C_5-]?<9MF
M77;:ZES/6F+"AA6V$0VS*L-T ZH4E-0!VN?U[0/SNIQIEG._Y4XAL^%QN6<V
M3BYW7">%LV7WRHR1EQ]+>[\P(%I@UW8(\87.F6@1\+1NOO9/RKL0J)HO!3.;
MDZ!=][6^%+%0+"<(7^@]#Y-PN>-J-(+RT7BYIR^YQTB?R>6NKQ'7!3.MDZ W
MP!_;X[%D8ZK93UVT8+9U$K3K#OD@R+HV7H?VL<D^6; T"W='CX,F^2@@-M8L
MEOTV [0%CO:SB92YXX$I#->,QH.<O%\FX1""6C2;[68[A]D&I\%R1P\"0$_S
M'SEC^L4;JUTT9;8&X>$(G(O2V0\N$A7DC-VGW-R8RV6V1!09X^;'\3NN)_G)
M)[0FYQZYFT"+?5J0X8-TF92<^7_WL4?DPW_7>//#45CK=F]DT"*HEL)"!E<Y
MY=QPYBR%A08M&"PT:,%@H4&1.82%\1LRB PB@R_!X#H21T\M/_YWM]OKG9W]
M1DYIN0AX?VN5G)PQIA:YMPY+$WLK,N8<\$KQKM3=9@@/M];M>;W;Q"S11%Y7
MS&M7A*%YC"[-)VOA?<_6WNTMUMXAX:LEW"Q$S7 V]P_+H^WTX8ZRM[UI3-N/
ML+FUYJ=RWU<.F@>5QN'AIC&+"!WPSMUZ]>"]S:QF(U5C0T<J^Q'NK]M#/^Q5
M&LU&I5$_J#8.-HU=1.B AM:K]7I]MWF(WFD=PO6/GXW*P=Z'ZGNKH[ML#&UN
MZ!CZ>+:W<A^XK+4WC=.UC_K(*7+J(*<OE2B?O:?#BCL;R]3X<@7LZO+CUGK8
M>A.(J^JK2!_2A_2Y <N1X=]2]A 6^MJ&&]526.AK" M]S07V+(6%1BT@+#0J
MLH?L(7NVI%2?6'N\>%RFT?R%]PFM>4FG>:O$@Z?]2?YUT9N=DMZTT1.?HD &
MD4'W&+04ULO^3E$!"418Z&X(RU)8Z&X("]W-'0(MA85V+28LG-4@@Z\-"QET
MCT%WWI'Q*FEH*] ZY& ;=0\)Z4/Z<-#"V]((JRB^5GP"$99%[H;2AK!0V@H.
M"^U:3%@X-B![R!ZR]S/V<"6K$SZT6#7]_C<73:_<GP9"TR #.O^199+]Y&JA
M4]4(RR(?+#Z!",LB=UO]VS,MY1%A6>1UQ2?04EA.O>W24@XMA85K@I#!UX:%
M#+K'X&:N2W/0DYS(FYB7?6[2>SX1ED5^6'P"$99%[E;PFS<(RR)?*SZ!EL)"
M#2D@+)RG(H.O#0L9=(]!5U:8').8^CZ/QCO9-:!,=3^V-2!Y9;2_E5=Y$OF+
MIEO,4A7%5K1"!1UGPU74YHF+6^9V"ZVEL!R9?;EE:[?06@H+97-=:(="^DPN
MP X#"(\SR$2)@/O. D<Q0^_^?R8,5N<"D&\K6N 66N2[Z'R[LXKH[Y3M.67@
M%T6[TMS8W@ODQBZ97F;&3A-6!",4&JVEL%R>WMEL;K?06@H+G1/1HG-NF+G_
M(;^T5]TS"29?),. .0S=J2?37/.< J!U.H6 ?"/?R+=5:%\S158;M#L7/?C>
MZC^_-2&58PZ0ZVM$VP=L@"Z%2;J]"Y,$ZIY??OI8JI?2[7[[]'2^_>P6W'%?
M3\RI]:W2ZG*&6L2_E17,N\/_$J7Y:+J 6J\V]GFT2L++N]MKB+9GN%<)M)](
ME=!HEE73@EPG 2/-W8,RW29)!%$=T1-&EB_U)VU/$S$BNQ\:C0JABM"0P6D^
M*9OSW@7^;2*.6^<G#TNT:N<G[V1Z;+MB:I2,4/,O4((,F7D3DV1CKJ"7,C_#
M0B/"H6+8$_*(0@A)HB0< AZXN.GQFHN(!D0MKP-@0CJ%Z@A7*@%(DJDDT*;R
MD10A45I 6*KB@&M@)-OR^0_N0P,4$9(H#B12:+&DD:*>N8*JKB\-O@:7ME:D
M7QSK1IFJO.>(W%RS&#HEC,9J)CB3?+>&621T=3DE:@+BH,RNCKAC$2C(;<)5
MVN5)5\BX H.^)#]HD##R1[U:A[]=$D,E:<%*VO]3R4AB*.&), Y86AAJ-)?L
M)(I'3"FH+!S")<VQRDQV%/&9\B0?@H#P*#T]EN(>0&FJ&8B=KL&VBIFG$V@I
MG,+NO0F-Q@R:FZEE3I/@@O_A-/ISPLDG*9*8?!:!B59(N4NGP-@VN0#1T<Q'
MG7'!?S==9QJ.Z$P/:@RAN\YB"24"%DP7_3-.9"P4,YT3N/>2@*9!@CF412$R
M500R8J E0ZI "42F!!0,1L=LKB,3/IY H.*30-R!2G OZ_&I!CR4L S'8QTC
M5W/%NYF=GEWFDBJ?WI*;-$3Y0N5WIDEY&5MEA_,QE2EXPV+0)R.ES0K9J^\U
M2?F/W7KUX/U2&;>K&8[!A*METZ$L;(*04<\#"::1QR RUI-9++A_6!YM0T [
M;]G#R YURX7^L.FZU71$M[JS/CD7KN&4A&8*$P?3N4)!\&'$RX>YSCT/DY#0
M\1A4"\I !YV]U3:5(M-?<Y&(-A.MW"S+U)V&3KO-PX-_Z,6N9#)L0?<8U[]V
M=L@99X%_1/HP;!Q#P=N$@;Y"@6-R%:<SS"-R094F.SMSOSP]_^\<389RD=HZ
M,(FM1S=;.D\LH%YF=O*9G,>9GMDU9O5Y(@AHK #:_-N#5,Y3K5TJQQ-Z\+"O
M!&R4EEATN0=9HKE5Y\XW=[Q6#;B8TY(CLV;8S!BSR/IV^^;3Z&J=J]-OIH/7
M/@^^7)S\!5!+ P04    "  5@"I9':(WDZH#   6$0  "@   &5X,C,M,BYH
M=&WM6%MOVS84?A>@_W!F8$$+V/$E[8;:J@'?T@1P$R-6-^21DBB)"T4J)#7'
M^_4]I*S$R5H$!=HB,^8'2Z)X+M_W'1Z)"L["C\NQ[P5GB\D<CV!_07@>+A?C
MH%L?\6YW=SN87LZO81U>+Q?O6ZD49@C]7FD@9 75<$$W<"4+(MKU0!O65+&T
MA89HNOI6NQ$41&5,=(PLAX#3[P<B:8PLW%AK')Q>7H3[OCLI*1C?#I_S[N9J
M]@^MDVF-CT2DRU'0M0X1_>I)WH;>F0[A+!-#4"S+3>WB14()IN/%7<XB9GQO
M<'(\"+K3\5>!O5@4SPCR7?,>P;Z^,16&JN^LR$P*C7Y]3Z9P+A):4OP3!JYH
MQC2&HPFLJHBS&"9Q+"MAF,C@E*GBYZFW8X&YQ'#D^"T3CYGYJ]*&I=O#D/D'
M@/F3^EZ.6D9;B&N]P4@P.04F8EYI)@6>X0#3.^$5,79P;8BAA9V/Y3&5&RJP
M#&XKIIF[/9.J!"(28$;#)I><;T%N!-:,KB+-$D;4%E[9.$<\N:WD:":+DHCM
MD7)7K['J!)Q*5<"Z\\:&D)4"14NI#"08.8&/1,4Y#-ZU8= ;O&G#AID<9^B2
MQ@Z#-2!5PER"-M!]!&TC:(=7<E9[2YD@(F:$@VZ :2#:%?^<QK2(J(*3O@MV
MXH IRIWE(S=[QC;GDM9LH0#:R/@&>4BHTKL4@")?9MMV[F*B<TBYW&@42;F$
MT9I)3$W)PO=.::0J2UK_]UT2KU A6EKWKRW>?V6)E.0,*2)E28G2S\KXP/<Q
M7#ZPC?@,858Y(GR/WI6<"&(D9E(213)%2DM[1E1BU[]5UQ#L!<AD(JO( (ED
M9;XH (D81_PV>1N$B8HBY4 @D]85CL54B>,#66D'US8(U_)ITU TQ6:"NC4K
MT#X/H,+^7)=T3%S!-HM^<8<U;O1NT=L*U156[$I)MXPK_;_X+Q!,5W=][]/9
M-2R7JP.!=%#ZX$S?NY;JINV,[-F!(%OC\\X]Y'ROWZL?_#]KF]!4R(_>C30!
M?NETL'E2G@QA13(Z0B^WE>VL&&P$EZZ-ZB$LB3;0Z>SVPL'\_(\FL2?>?[,1
M(ZFP$]^/33F);Z"/J;LW&(P>3J;+!<P6N+(G\_GYQ8?WK5[+7:]7DUESO8NP
M\Q;CRQTI-2;6G(WP92PQN:6E]^N7-A?A5>/C;^S_+":\*1IDYW$5<9HZBWEC
ML>?Z095P;O?_5_;/(L C,M&0LD=EUW)9\_4?WE)V[7>-^D.'_1[R&5!+ P04
M    "  5@"I9UVW*4D\#  !J%   "@   &5X,C,M,RYH=&W=6-MNXS80?3?@
M?Y@*:- "47S;+;"V8L"6Y,0+Q78E;8M]*FB;LIG*I$+139ROWZ$NK9.]M 'D
MA5(_2!8Y'![.G"%G:%V'-]ZPV;"NW9&#;] _*YR&GCNT6OD;>UM%MS6>.Q\A
M"#]Z[J41":[ZT&DG"D*VHRG,Z#WX8D?X>=YP#@&5+#)P( Y=O'3< '9$;ACO
M XH:0VLRGX7'.LR([%A\Z/^;EDPV98\TG]08GO%EF@RLEE:(JUQ4@6\ BCXH
MD\1L@PV2;;:50K;&0_=ARY9,-1O=WD7/:HV'U2Z@4K2U178*UY_2<N%H[+E@
MNYZW&#G.='9U:;2-[#M8C.SRNYAY*>2:2G,EXI@D*>HL_^43_;>%W;.UVFK1
M]H\Z<*W0+]7_1:5B*Q*7)%<B><KZF$;*R#81*W3*4<<"*\H5E7_/\59/84UO
MKB#P[4N#/G1[9N^/=KMS<9ML#!AYX:6A31(Z%2CM?JX4'WZVNV56KCL5:HNL
MWNC^M\B>QEX>!14?.>5N6?59\QV@V_-9X,["9F,^@>G,<1<N/E"][UY-@]#U
M70<6'\;>U(:1;<\_S$+<2V$R]6_J?;+6_?SZE1'^N&7-QI44^P2N1;QF? ,_
MV>2 PW\&C^V8HNOZ+N#TN>'M/E4L.E0)^G?:;&RII,L#'OD\Q7C"PQG4E@+C
M*R$3(8EB@@/V2QJA(%]1$!&(O<0&[%:P)N@6>+^/#]!Y=P[==O?-.8[.E/AT
MPU)5Z @42N[T%/@Q$7('@8FBDL;8SS?-1C&S!B)BENN-&"=\Q4@,:3D\U0 *
MNL"WV7+QRMSQ:CE$XE0\9] _A,$&39B(H<_W'#/-W,\DR7AQ%J_O]F+@/B28
M)J9G,OO2#$KWJ^U7*%2Q8[^C#Y^GO2_)L$^577R>\_:>Y;QU-;8O[F/"U\W&
M-=6%,TK::-M(2,Y(?5$'-$$:+ZEL-CKM?,NL&FS)PJK67BKZP31APFB\[L."
M;+ ^#.C=7@<Y*AW /(OHM \>21689G$O9#G3WTH N5H32\!B=RH:ED(IL>O#
M+[JMJ$?+MG%,5G]"!S%G!P/"J:JZ/:I9OQ08+RYACRK-)^5PZ8ZR=BPK1ZN%
MIBFM=&3;EC9N;L :DN'$>V5+WQ7FEX?ZCO$34$L#!!0    ( !6 *EGS(8@4
M\PT  &$]   )    97@X+3$N:'1M[5O[;QLW$OY=@/X'7@Y7V(#\2M(T9[L&
M_$KJ@_,X6VE1%,6!VJ4D-JOEELN5K/SU]\V0U*YD*783]ZY*FR"QM<L=SGN^
M&:X.O^N^NCQJMPZ_.S\^HY_=B^[E^='ACO^)"SOQSLF;LQ_QD_X>OA77W1\O
MS[]]U#>YVQ=[NX4373U2I7BM)N+*C&3>\1<ZXEI9W3\0(VD'.M]RIM@76#Z[
MT#/.F5&XYM2-VY*9'N3[(E&Y4_;1T5=YKRP.#G?>'GW>UKQ%_6]^,ZL'0_?H
MZ/#%F]?=Y@9;?3G2V73_KBUX;:D_*,\1*)T<G=\,=4^[=NOY]M[AS@F42M2/
M/E^23U#B@PH6+?* (GW4. \OQ,NKXW<GQU=G[=:KB\O+\ZMUE:,[5.W6Z=!.
MRTQ9<5+I+-7Y8%VE>;K[=;MUJ6X@@C.Y.!ZKO%(=\?2I&XH7F3%V707#RG;K
M1V/?=_@A^@UW]KYY^K\1Z)>J=+H_?4B)8@I8P7YS]TSUG:?P&0(]).\_>>;]
M_S]WVJW'NX]76^(/+<HZF^'$3%3>;ATGOU:ZU$XCXD^-+;;74YJGCW>7Y:[K
M2CLE'C]]^FP]Q5J5N7;74YP[XN5!LRX)_Y"\7\I4J[+=DGDJ7J)$96JD\OTO
MM8+\T=G_ <!K*,=*R,2I5,A2)*;*2Y4)9P2G-G$KLW6$%*=R"O+BHLQ@QU*H
M&S4JB$!B1H7,IV+CJ[\_?_QX]^#PG4^0ASOOCOC2WL%F1^@<"_-<)4QTHMV0
M_$$<#ZPB;W""G.,M2 O3%U?*V(',]0=)JSLBE8%3W/N7S"MIIV+O>4=0^1,;
MN"Y!(L62OC4CX2 _R4(_.\(-E6AP5I4Z5V4)L48]G3-]9/+(Q3S/C*9 5>>@
MUILRBW)D\H'8T)M>51W\&G\7KY0= ,Q>5[W[Z(NH388FRZ;"3'*5MEMEU2MU
MJDDZ".II1JW6M&O^L#7VOAZJ_ /^B7]KB5^T.-&FJY)A;C(SF$+0;7'I4C9A
MW%KG":QJ+*L5EB$=O56FR!01W_OF ,%ZI8JJE^F$6#D=0E5>_#F6Q3S'\,%3
MP_9(55_3_9[*S&1S8]X&IYZ+IJZ9]H8>;T8AVJV7UE2%^,YP7R VO#8WQ:4>
MH2ZE)$VN)F"D;^P(.RUH>XE3,G?-3;?%#P@"JT2_LKDNA[2/&^H2^<_!\$*B
M 2;.K?JU4J6K;7+;EUF#?9T1"2R3\."!+IUE_Q+7#HIF)\>'%^!77&_!;U_H
M3(G7,,^3)T^V?OH/_OR\V?3F1=]MTFRW9D3G?=:J# M($B,\\PU&X,-> O"H
M'6L)[BQ*9Y+W]$!/"5V6E7>*92(&+]P(]FVWO($[]8IWV]?;2#U)99$^D)?(
ML.<WR5#F T5!-\(&1/*V3X0[<VY100]V&5U"7VR1O7\^>=(1C12P0+C!"IZ8
M(XX65"S+!XVD5%@SUBF>A9=U0NP;;$ \0<EEQWO(R*L%[-1AZE5"XG/Z"+$Q
MSYQ?/6] ?LRO[BGOD@IQ9L=Z3)]BX!*?V*\V2KL5??UZMOBT7CP7:3T%R]."
M&,Y;R\*9766;U=2U,B\E.T/)(0.=)%;WZO2QPCFW$9B%=JAF'[ 6434J16Z<
M5^)$EVJ6*O 9X@JN3-YQRX+<;TSJ12V MF'F$E61"!GPF@P#P24LU#&W&I7_
MT0OUFN.,"_C!LAQB"IVS'ZF; D8N9[:'[RMO?W6#/=G.*\V*:I$G697&"$&D
MWDR1R<+M'7QF_ZF0*OQ*3XXV\D' #B1CJ$,0']BI2:IPP2),;(I?:'FB+#2D
M$VS .,0JXAX+)?EH65<'6DP<A3+7\;B7=UO8@=)6%#DE-E)*WVHLJ5)8U+<$
MZJ%@7)*-366C)D6I'"4H7/7R;8N+W&_H%>E15+L5]T(85:.@W0&Z/:B:<R!5
MKBP3%&/259:,2TLR-9"92&0A$^TX,_!M7"N4+6%)OTQ6^#]W.BXB4K6H2"TH
MW(YJ!H*W8MF-U?!+F04"$)&*.3V.)?%F@\9JHF)&,ZV*+!K)1J-A 7WP]!F"
M%2@(P3++>&<_C=S1!=8F*JMKVH\!!&L49M-4L,DTIG(P6*H*JD>PY)CB@UAB
M* MS+7A2N[7*E3J^#G2:567!N^@SES\H@%$*1Q8(])&M$?C@5\MLEB]C[$'T
MJ@ KS9W#@_?=N7,K(E:&1*36;LTAY-N2,-<5^-5L*1_RT6M-STE."@SR&_%4
M(A82M3R:)/Q3]C)5FRHX/Z)A9JLQZ6W@=W-#Z7R>P/(2E1(1G9LZ+@.2@3NE
M:@SP4W RZBDWH94D3\KZ\,W*9*@3G_6:$B6ZQMWM%G26*,YCI#J5)TI,\/0
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M]B4%>''\; !K5D;$_5QFN]VB.6%6FL7NR2/%&8-\EXU)#4<<_\! @%D%=R4
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M?^O_?+C]Y$"\\2/(?7%),\2_SKK_E">Z]&WI\"WIPYWPQ>K_ E!+ P04
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MY1T?+-X2EQ=_/M[VM&*H]Q;IBPSUON,74$L#!!0    ( !6 *EGP5H4R!P,
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M%B'6 0  .@<   H   !E>#DY+3<N:'1M[571;ILP%'V?M'^XM;0]U87TH6W
M08+ VDBT10FJU*?)$(=X)9@9=XWV];4#I&E:==*T2=4T'C"^Z)Y[?<ZY,KE(
M+V/OXP=R$?FA7L$\))VD<>01JUWU7ZO[38+K\!9FZ6T<C=!"5,J!@5TK2/F*
M-7#%'F J5K0Z; .',&.2+Y!.U*E)GZ?86F%:\J)R(&>58M*%%94%K[ 2M0/V
M=IL)I<1*1Y#WN<J:VB56L@?VBT07=JM)7BP5\DC@1>LES[B"X?#HE%B!]Q+X
MCW;Y6V!D<GD.L^EXA-AZ.,2G7VU[</2M+E"/^L#G:NG F6W7:P1^G(X0>I\G
MZ6$.,(8OG)5S!Q):,%<;Y/L]JW*F?008=P8DX>1F3]\>[*16+F1"SIG<QH*2
MYG<PT#9L1,GGNESJ!W$$XRB.$S\,)U?G(V2CS7Z6^.-^WU7HT')1EK1N="?]
MEPL=P0/;_N2"L3MN^$_6>MZ4F?88/YA4/*=ESXRFXKGS2K;89(1[VAGH)[+3
MT S=U+S,"?2JF7B%E$PR>H<SMA!2=U-OF-P5X633WMZ,:"5,^$G89^@[REA&
MFE:-=V:CEP-Q_.\.Q+$+U[7BHFH<B&FC_L_'V_/QEQR\E<HR=U][&9H[\Q%0
M2P,$%     @ %8 J67U>)ZC+; P <P6(  L   !F;W)M<RTT+FAT;>Q]^7/;
M.++P[_PK^.7M[DNJ9%F2[R3K5XJM)-Y-;(_M[,R\K5<I2H0M3BA20U(^]J__
M^@! D*(NZ["D*#63V!()-!J-1M_]_G\>.[Y]+Z+8"X.__W>U7/EO6P2MT/6"
MN[__=_WZY.SLO__GV'K?3N Q>#2(__ZJG23=M]O;#P\/Y8>=<AC=;5>/CHZV
M'_&95_S0V\?"YVJ52G7[MZ]?KEMMT7&VO"!.G* E]$N^%_P8/#Y^JQ]M1KZ7
M>10_49/L;/<-#=^ZZ0OFP_O;_&7FT:3PT3U^-%&/>G&X6ZL>#(.#G] O/ YZ
MMHHPPPK%;Q^NOJ2/)\7/IX]N)Y$3Q+=AU'$2V$(<:6^K4MNJ[1N#;,6BE1D(
M?B_?A?<CQSG<VJFJ<?HV)[M2_+KIQ!KCKLBA6\T)7\ ;M5WU8"_>NG.<KG[X
MUHF;-*S\(O]P%/HB+GR:OLD\[B;15O+4%7$QX/#U-GZ-[]2V*CO&:EMA+TBB
MI^(ER"\S4\51T@\4?)AYZ,/%K^?ZJ6;X((*XZ[3*K;!#CU7V=RJO\+0)QSVV
M;/SS/O$27QR_W^9_K?<=D3@VCK E_NQY]W]_=1(&B0B2K1M8R"N[Q;_]_54B
M'I-M.I+;\-8V#_G^_VUMV1\]X;MO[6N1O+//G8YX:S^ZC^_LLU/ZX7NE=OK]
MV_5?:Z>?ZO5+^ <!L[>VQGQY9_\[+O)[9G'?U>+&'V>WP2]5*]5GO+UW]%T
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MJ;=\;$$"Q<_]"7;[<&HKTC-!FPR#TQOXGPGFE4@<#QB$DD0'P;>HFT7"UP_
MU&:W$<K\\REL?P9J.TUP%L<]X9[V(@ .- (O=,DW0?;"T=I8YD(><UN/9L-?
M!@!^+A[HFS$LP,\"?FKWW%@FSP% CB2,G<H"),?!\$W$?W;R1IREP^6+[O6$
MN)Q:HYFC6V5G;^HC#]!%((^*4\'_G@4@5L*[[A?/:7H^8&J<$U\,W"P\4CG@
M+B/1A5V;RKVRLS^+LWSBQ.W+*+SW7.%^>/H6"]A.[6NLPTOWT^#N^7(W*1L
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M"3L=+\8,'&H9Q:'D$IIAF'#@=$0@%1462T8\3()7"W&DZI]B"+?"5YRIQ8N
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MQ[5T%=M11*MK?,<Z"9K.KW33<46NE/&1WRVDGP8WC;7.*+&1K;3F:%Z@SC8
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M5WQ%:$S"KM1<K\7K.IQZ-3"2.TV(Y)PSF_1&RKF^]QP;]5DT9E"&'ZA]]W1
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MYY5[4W?47N'J^"%1&,3<!\E;:7]=VO%7IRL89*7']N;XY$VQF>H&JHLHKC<
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MXP@["&F;WC(*2 1E5[PX;?J^^%Z-!:=H[)X:?FOXK>&W6\%OK\)@%$3<FRO
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MNZD,=Y):EPO5$?(MGC(!Z4RF K]4K38.*D&1YG26,=9BTI:V)R';H711Y'O
M8'D4^$!U8PD4Q='TQI5YW14'])^X.X"1WXE013\*'J=<3W%U;<[6L!?N,,/]
M#/<SW&]3N=\22:D+I,P"H\@+CBOD?SF!T_ 6PUL,;UD_;_EN#SBH<M6B:!>$
MSW2%G80NBAM,CT^!-"!.[+\Y.+1R03"&T@VE&TI?#Z6[45S5+7X&H@!H/C.I
MO6B0UH%M4H50#3Z&8AB$\$DRE$D)B$&>J!8+#(R#1U%@N])$@^S#"48J-PN3
M!USNX8R!E] #,CUB_T#FDF,>^3/D,_-[5QV^8Y<C2G9[B], R\8_WK$_L  K
M?&]:6RW?VJH9\IYK3[>UVE]75ZNGL,&YGGPS-^8I=N0RTH"1!M8O#6 _GM4U
M]W%][M,=7-+9!V0$^.\SO'\-91O*_AF4+5MVK,Y:J(R%)XVC.<9";E,KOK18
M0EM:\ZJ)^9,U[-X9IF&8AF$::V :;4#RH9_VW]MJ1^MJ'*P%IVDU2![@8)4P
MFS@^P_4,UUL[UXNK15,4B'5^18(@)',D4+DNOR*E)>*$]^Y*'*OI(HJ<#Y@8
MEBH (0S9''.+#)[X'^AJH4.!=>E@JZN,8[B8X6*&BZV'BTE5:V7FG$+C RHP
MK,04!S0\.];?!'W@)C"O:;=F2-Z0_'I)_NIR9=3N@NR IMM1TO-<&ZD: -1U
MXZB*4C(<DC\5KG=9F_O0>JX^54/OAMY_#KU7[%!RZT:QC*5$1TR\R# C9KR"
M-/\!K23=E_NL[WH/55*ZK3,<ZC,'[O%&5_;/HL!DAI$C;(^C\4< #[)CV8V@
MV Z [7P (-A%4*\$Q\'!P4O6.&GLG1SO&JYEN);A6IO(M7+MC&:RJA8/O?%[
M-W3.^,C%+.ZV;QN*-A1M*'H=%"VMF"M3/8;2*)HSCR8]*3-(%TT<X#JP//7]
M0(3"E:[H2(QXB-68[" <!?2;P-A6C*VK&E6:FU<Y;,@MDQ;&3MTX&-.2"%TF
MNYN$=^X=:DFJ4@3C_5@Y>N20E9N*H# $RPP\;_PRN/<%)5Q'KN.BD]U86 RG
M,YQN_9SN$2H\%!U!2/DZ TX7=\!P7*G^>*8AF2%X0_";2O +/, G5N/PV#HX
M.9E5Q87G'<0K*>F2Q=7\F/OWQUL<&<9E&)=A7)O*N)+>_(R^0K<@/E'O'K0M
M,:3D.ULK/R#%Y%672L 8-<<P#\,\?A+SN."1P_]:F4%'#J<J:W[FX3=A! %#
MRX:6UT/+XKX2V=)5NT .Z,.E'MSK/J7V PKKFXX8AC48UO#S6<-9L));7K<.
M_3T,DA'[&'C4Q'A':@B[[),[1$.$H6Q#V8:RUT'95^VK5B4R5KGZ9;VOIGII
M@HH_"MT[]+#V]6MXH<LJU;]0/C#^SY"[(7=#[AM)[FW_3D28LC&3W-& Y^JG
MF(JQP'DR5F'HV]"WH>^UT+>Z=U=:I*]PH4?"#C#<:$VE^K1)7Z7WHX.2@KNS
M]@\Z*W\'7DN&E)]/3;:YIVT'/[(IK(F% O/-NTP N.%FAINMAYM12EFUS!5J
M?S6_-1_Q$]4GR_5M+W%DZ /QBJ3GVNS&=V-31\/0N:'S3:7S):IGE!<:,P1O
M"-X0_)82_"#PRBM5*+)7WZ>"OTQ)-V6Q#'4;ZMYHZJ;[=XG;G)YC+FCZLE2H
M_%1=Y>VK2T/DAL@-D:^#R)4C?R5! =V!@+& D'5TP'LWN!;VP ^\X';,SH(Z
M^Q0[=0PEUB'#(,;K[,U,E!?!R!.ZFTC%@A=I^1IV-@"%X1DRDOG]/HY,:X]5
MMO9HF-8>IK6'N=G-S;ZQ-WNE^W/"RC93DE=CIQV_)MY[AK>N(7)#Y#^!R#L"
MLW<KT?@YR-HS"?N_U1[]#]59.S2$; C9$/)Z"#FKNUC-H+Y46<<P7]8Q*BGK
M>)@5'X@';H2!0M^KU<-/1WT%[V(SSCB)J+4&5C0:\3"V=-FD")0HP/DQ1@+I
M *1^& Q9#/M)73K@7\-Z#.LQK&<MK(=":!Y6WV-^+5D9FY,^K/KQ<G+L%>JY
M6L *XGLAJK$^Z37 $,6S  NSP13<,WS#\ W#-];&-RH1[,=J?O]\A)\A:T/6
MAJS70=;=UMG*"H'<U+MU ,I.0A<;Z,DZA]_M ?=O!98 &+I19"H &.(VQ+TN
MXDYIL9J\;\^7]',D#H_B_;W_YN @W]K!D+@A<4/B:R'Q+,*V$HU_%B)>5 \
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MJR;I'%5V\N8:LC1D:<AR3>*SC/-0 G1I=ICN.>' 44>8$\?)]2L]E=+F)NS
M#X:NC0Y'><]6*W< 1/\JD.EW(G8IRU#Y)I]A[8$M=WEV*>"G%OCD3QH&82[0
M1OJKX>.BNUH[S6$44MUDS)#,RY3Z6CY(@IS)TDE>&BF1H6Y-%AJD=JDA!DY-
MNO 1M>]0^7/]% B=ZAKEW?8J\DHZMV5*:.:[G^6PST<]/*43?GHXV_0\#(2)
M*/@_9O>A&\<J-B' 6IUSXDD $P"5_7FJ?^:; !R+T5D!=[R, EDBV:5&03MQ
M'+J]1(H)H-),,>D@)'(9P>@8OF1+8X>OPG9Z8L"]/D6"J  48.-_ 26D 1OR
M.0SA" 7<!(J\;)[@ H!":L4E9^E]U1*>ZQ@K+$:Q5LM49G%JBNV-)P3$HGQH
MU69G35%@:<R_4;P2,(X>H)#<?I@K&3G*E34_.@@>A05Y&! U(YX5;C\XPEJ5
M@#"9\:S'Q3>+COC$SX<ARWF?.L.8G^+TVJ0XK3+%Z<BD.)D".\\NY^DHS7GZ
MYTVKBTE/72I4T+SH?FEUNJSY_O+FFEU_;+'WEU]:%ZS[L=EI?;S\=-[JL*O.
MY=5EM_G)I#YM$H;^YE) -["O**L'P/WH'F6JGO"">S9P;P>>K#^"X<B@KVJQ
M/0ON5G(]7-I. !<["B R9AM>Z(4NW--C+:&E)7Y -1VJ &<LI9Z"4,LE*>E*
MYRH4.,O%YO*!7+R*KAN?CZ&A^%BE?&CY2(X)0Y3)E10%G+F>9NQ+6I2'0H(9
M]SSE-<\V)(US!JC=(18RX'Z<B9GY4H+U8M0-2I1)>"O%/[@BG)H-'V'=F+'<
M82E1SI&.BMGC@C5]7WP7^5(/^I *E1.R_/: R>E(_D,AC>*):P\YC308^2Y0
M!6$#6S@)N@7[*MB@Y*UZKCCDDR S8Z!<MVWQM][I/]_^]JIWNNG610#TRZ!:
MAUL^9&V@7%NX=Y+&YRI+?YO:A<>R^34VR^AG".R1":RY%03V-4BJ45<HEB<N
MRNP*X(*5&=Q90D[)I?: GK*N[$6I;_*R"W9^"YKLSDXSDBJ!02)@G<%A?\4R
M?30X )6*-'4&GTLKF&_#$UP)+O0@CU@4H.TL8CKW5=IZ6"K25 Q P&)12YQ*
M_;FRO,=?URI70#BN*A!$M6A2"NX)F=+^L$9+:?.DI1HDI0'H-2VPECY6<%)0
M+>_>6.H,\T=%7+US'97Y4UZF(5V-+J=0^RQ #PA9-^G)=,TA_BUYC*PB!RNC
MN'U+?BAC^.6V4<'R)+R37$S75-/)HVID'*4GX$O::'8/NP]B/U8C=;!:%6RW
MBX9J[0=Z) OJ>I!M^\GE*@FC!'AN;4X 5JXZOM;*6N1;1@<PCF^1NIK%; +"
M3,9KNE&4J!144,1)_T/\<(=# ?@0H[]Z%+I!J.$H3I!B-:QZQ]V=,<= >$Z6
ML5KTNDR5QRW'2TPG1AAW7)A%^A3+YY+O*?]+KGY_^=,PF<R$OH.3=&!:T)U#
MV]5)N:CX"[U@^!8)SPGYO5\#R(%P8PU^6M+8@?W,I2P+37PC=9QI3@T? Q;@
M8<J"N5CZQ<KZS24@4?)85>2@^KFAM,*HUVG"&MD,4';!0BR,W]YB:3OI4]GA
MN^S$:AP>6P<G)^6ANMC_"2]V5?]$%G0$OBQ!< 15YY/>+90F@GM5X019&^GS
M>-T-?;>ORDO6,#K)MH/0H7SN5#I:B+EXK+W=7.G;W+JP\@L:B/1]P#6XR4@F
M3!67O6\=[NU9>WM[M=(E&Y[V4U?0]FL/09!<!2-I,(O4+3=$6B42"06/ I]4
M0*!7JB0*V(&^+-N-V57[JL7:0$01I>O'08V,Q9*<D,6 K#R2=2OTK++&DR0<
MBQS!(AQ&6K0@!I-6D\C3MJ0BA'AB4B)M>-(>\$A8-71[I[4MTYVPI3"@.;;D
M'19#[RX6$P_5;R\]UT<Y*<JJ2Z71&U2M.D<4('PD,KKCEZ/Z'H.#\U3N(9GY
M",H/LA;3HU5C,?2Q9!B%JC*%*&W59MSH@ML*+UF'N.6R-S@KO\%3CC]QS02^
M>(G!!0.4"#$:J8RCUEDK P=;>TE;N!L]")3RZR\20/PH@]<T7*6@*!^$ IK-
M 1HNQRB7'-N1E[<R\"M)W_4E-*4WL02D//]EQB4HV4<A*5?.NVMH;I/54ED*
M>VG=%",'V)FL!I'U\SWC(S?&\#QUM6%S<E(4LT=()H3),39F^OO(4J-C8M7$
M6RUY.;1]]( B*5UYW)]XYMS%\#V@NY:G;%>IOJPUX*;S9Y"$/FG%V<O$;/A$
MA1N*271$S%U/F8RV&0&,,=EX:^9Y:WA<+45#]RP?2<?Y".OJT:USAQ%9^@JP
M>33(E,3K$( '%9!::2J'J]* *EIPQ[G4S#DU&(R;R%#V<W83-:OE716N/S*V
MJBJO%)\1>_!%5O:MBW5?PC3T_HH<%VD3A%=7F3N)Q(Y&M9[>7=4% ^_MFTAJ
M?A\2;-JM0RS*Z#U??HY>S<!]"!!?9 7!T4C %KA]K/,)6C2ZB# !("L,>"7+
MV!5"7K2%+;7\.4)F)B@KVM]RO0RJ9<'@XGT12]ZJ-(P>]T@0CP9"Q,H..%$Y
M+P[B M#3N>W5#DC9(7/Z3]'4+Q4+V=<DDQQ5)'=J0BC9NDI@+-KF.FMZV##K
M=E"PK\RS-I.AU$'[2+5+B2*"\I=?N>8DKSVES2HZ4]93^97 B'LR0NH[M6(@
M!=VN9(Q6PQ?N72N[F"6TV=4]%VXXY,K;@9VZ5,ML&<->/O3BL@BJKEQ/Y"FP
MHJ?5PS')A$_N(KE/ZTD<VRSI8'Y0_1L35+_*H/IC$U2__4'UQI942-T4,1:G
MC@<JF!IT00X7BF?K]"N4!#C=*Z5VR1Z/7!A>W3:ZNKU3$&IRFF%1VRLJDS6M
M3*(]$JM$YP2 "% ,6U!9K''T:_D7)[.^T$+3D']WA\FP[*$ZZ^(UDEMW5,L*
MA9/ @ZYB6M#,RUCW;D]\P0[V9.-V*KJ*#ICOM"_>F/VROU<_;M"&YN4EMA,&
MB6[D*:5"O$YCHJU=EOJ1LQV&^]B/N#2-H>KN*\GZEP-K__#(>G-X* ,_)F7%
M:%K84ZLA^JQ)/,"JKY%R)&L)"^4<KA+8=.B'<LO& VV,C_*]*8K&ZED&:*LP
M.MKN6\J%FHDK4P#,-&6GCJS4120/<%[SC$*(?>V:9*H,%70\/64DRQ@=PN=1
MK&OJE@.3=4(C5"B:.U=E@%0Z^RB>UMKQLRW*-_FI*UF+R66YF_H%7HYS[F:Y
M*R_4%5K=4O&(" !W_89#!3N.G_[7B\:D_*21K3<M!#_,!O0(2-H[;2(/TI5M
M?^N%K^320#[-_NBD%]QO43(ZW=G?A:V 7R:M7!M^5)L)U1-%(!2K9F-0PV"0
MP: %&'0R%X,.# 89#%J 09^5@C8;BPZW"HO([%&4Y1[N.Y,G"S(D'.PMZ8HH
M1P;A6Q;>]G8:>X=6X^"UU3@ZVGVX9)B*H0?'OZX\8&5*/;H E0H/&(WSJSC,
M%/K&2H%?'7?(I/RB>>S'QVO\6J1:\I>L<A..K3<R2'GE^[#1![45F+39 #XZ
M:AY9^R='!C4W#L"-W\''1\U]ZZ1A4'/S -R^^U=%O&P5'JU)_/TR<&.Q&=;0
MW\,@DB$O9^@INL):,L(AK\R$IRC.^X%('MY\=683H/IE-13PJ+2J0,R[0E('
MKWI\J:'+8,K/<W)@-5X?6B>YZT5&A*S>*;(AI[^9.+E*J'[99,0^.K3>'!]9
MC=7(,YMZ!$\=JFU@H?NOK8/&L<&T[89J&S!MA8+UDY"F5V=,7N5VM-*HI^M<
MU%-+13UM_N%M E3;0(UIZ-JF;=YF'NEF0F40[<D=Z69"91#MR1WI9D)E$&T;
M1=D-,@Q?8PP^ :)B'RZSZ'L9V7*41K9L^ND]+:@>VY#QQMH[@/\UCI_N%AJH
M-@?=3JR#_4.#;@:J]:#;@?7ZV*";@6I-Z-:P]K?E,GW6YMH+$<L(B#2Z87;&
M9EX2WOA3W02HMD(9K1^_WK1]V\S3W$RHM@''&O4W;S9MWS;S-#<3JFW L?WZ
MGL&Q+89J&W#LXE63(/O?F[9Y<X1:759KNXL]Z 4^?O_&QZM4L:5@YPH_=1)/
MO-3%G_*ELI9"%)UR<(3![-.5S>CEDK)F>?#RN(ZEJ=1_\[6I"C"N8==-X=>4
MG^7+B#WD_?^]XH*N32HU6*E8H1OEZA7^6X1!O<!--^%GVT_YQ]Z?<=23%>S,
M6>7YARIO^>IA&_YH]9QEM9M,9-G 2L[7 [=:85Q=IDY5()--^K!"7KZ"7*0:
M@\J$>BRT5U*/=STE4C>J0JJY1K> :!O/A6C3E&!#NX9VGP;M'CP7VDTK31C:
M-;3[-&CW\+G0;EK :"6T:[3EK=&6)W^V_>PH4GBE!]>6722K41F60^<3G8R/
MWT@*6Z)7BJ[(/5$P/%>4O!(TA4+CE:I]OY-EU2>7<G!L[1^IE52"Y"&KEM!?
MA>X=SCYK%97 6+3BDB4?[2U]>J[/5L?@IUOZOE/E[N^F@4R;94^4B%<L>O,,
MJY,_1NQ[AF*?:42YW \*8]2J;B1LMP]BV$@WD\4N)++)6)OQX61W6VIHJWI/
MYR0W]EF(&!XTG2,-*3[GSI'5I9BIGM(+VTFKEH!9][>4=-\:RC.4MX&VC_WZ
MIM,M-F;-"+$2 :>]TB^".MO775O+VS&FS^JGL)LI3PG8PKY6L*+@(9U%030/
MO$0V$@.^P9T =A69!C7%NA.SFT0V0>JG[K,6-B0+1M2<5HH %0U"/(ZY/0#&
M-1"AP-YB$8.=+1P3':0C[""DR=_*UDT>0/7BM.G[XCMKILCBGF8MQ7(]N")D
MBK$8CCS9G0LGZXVK=8-U21.?VSMS![_1G7"G,.U>H/+XEOE!..0>89 >I1(@
M9>B!*T\#YZC5[>YT<. J6/L\CK8FIIUGTI-,_$>8]F1KIQ]ERWA6F\55'Z%:
M[^J!;-17'Q>\'OY?X.N-E&-CHU)V-N#^K5B.G4L5"Q[*,^@HZ?V9:_<GW\!>
MCC@Z<+<^<!5MF;MWXX%N*<X.]K3!"1@'K!Z[,C=AH)V.N'-AA-WT:SZ&A;-V
MY $'C>25D+L(;+D">)BF3'/&J$^D_+5I_Y6XD9L:Q,Z"<(3#*);8&HJ0>XZ%
MS?;JNB.W:F.(G??2CI.M]",\A");=4_+]C/7X[N$\6T$76\F(6\F5.ON#6L0
M9:U0'3P-%G^0<O$S/G)C .3?2CP&T=A!\?@'^'V.^\)R0/@,!8]D@WIU!? D
M'@0AP.NHKO*VA&*"-=]T?VGL8;56BSGNG>N0BP"&:*"E7CI=0]$780A?*'\"
M###BH>I:#^_OU>&Q?28X=G-7W>D;\F4:8-(?,>=]6AB"1*6*?Q B D1#Q1I'
M#X2H-Y87'.RP]DBA2(F_PVXN')6@*-VKB8MK(9:86^Q)065NL8T[DE5"=?@T
M;K'#[!:#QV(1EEU?S<Q*%?#083<^NH JF*C*[CA]F85BJ)4,O/#<B"PV2BL!
M\%O?W0A=11I '%_>'*DUAJX["1I=);;'(VRY/L&!9P.?9[W31G%#45L&E6&]
M&W<D*VUV\318[]$RK/=]^M"5MOFD3Z/%OL""-1O;WW_'9K%@@F.&JD%Z10H#
M2M7P8,QC,O9KECS)CZV<;1Q-3QCYX[E#D'75^ .R4$7BKP1&P4M VI(B#4GB
MT7"I_:?48K;C]C68SJZE+%:+U*["2ZEG8.H:*!Y-^4MT2TGMR@_\EU'2PV@X
MM%)9],$M/!YBD%3A%H-Q/)@$;=>![XUQK_5-.$I"/$[&)ZQF=FJFH^#8>]?S
M,)W,"V [0@STRHT)P\F[C_<1(?1.+Q-<1WJ/(SQ!#[KD(G9#AB<4BEAZDG#M
MM% W3HJ/C3P."U6:4VJ,C 3,[D@,@C]S^..P(>Q?")\D0^EC0H;G224*[NH
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MUZ5.5YNATRT]VFLYVFP90P^$XLST8$54>",'*^,I.B,BE\JUE53XJ#ZZM:P
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M=;B_Y7N_?U(_W,J]/]YVCG-4/WG(QO_(G?9EX,9B^B(KJ0NQLNNL+0O\1"J
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M( 2[XF,J5:TJ@K>O+MD-UAN_#V&V\/%.<6;IGRTZ3;,O9E_,OFR?>'B5MCU
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M/@9H6#OR0([&X!6,8A)._MG*;OI<9)JTWZ-HRE%Q #@ MC)REW[TP"<AG00
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M?I()"C)D])R#@F0P[D,;Q$8RQP^;7E%PSDB$TJY:UEU%UNB18=##DKY]E8#
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M =;X9\ :%^ CUG&FD3;=$;Y3*RY9:LQB;DQ-V!?\ZD1A/K]OD W)-;4GJ >
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M1H_H3I,[ZBX>I1J)\MXQ]=ET-6Z?ZQB2QB,^ 5NT%>RM"Q_N'X3_DI?,L4^
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M# D1F.$H!:O.G9)M^WI?T#E-0X,N)W,0.G=Z1D9%&Y/2D*/SY2H-6%ZWFL%
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M9J-6RU8E$[%4%+X%.?'/),Y_AY/Q4Y(Q3%,.3SB>Q4DQCVVR.B?"YZEM#V)
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M$=S^C'IG\P^":5+ 6T&L)#F]&%N(VVPH#I>,27;,]81QJY(,5'="<13-<7D
MZX2\!,PW9#,PI@2.WE(ZK\&G4])(&G9/A9A%727$[6)KPLS^<%F9MI"[YJ1G
M(_8.DLUZOXA"A4G4+#;U=[Q2!"9"^R%^+/:ZN[*[[L:O!V:?#,#L6P5F'P_
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M!M$_XJ*(LVV=B3L^P=T3SEM&UT&R(2[?VUY.&YKM[6:7*E0:2W.V2-"EVD/
MBJHH].HX\7N25&5+\;4G%U^'/ESU-9J]L[Q #"&_Z$IMYT>\%NG%P?6,ZBVF
M<  Q_%Q=*Y6U2/&P\1'"5'6"L'12H)PZE+(%^TL<Q@<7-,J<)/@I0E%F6,HI
M:H,SC51,0G4'N,SE:PKTIXFUDH7,&$-W[9>^[D2+OM9]E6"6-?ARY1C<$(?8
MAM:54JBCDF*-**1E5"RVJ:,;R?RRO6YIG,QA&\N:VOK(3)F[+\7F[O!WL/V9
M@:>0]9(65U12MU#L7^9%I+?N8Y9?@RYB?6$+T&?4@"I#1^L2SV/5K"U!'>2M
M(\-+7X>8&\J7"H>=J6E2$>,TS"6-1S F<)N0'>VUA?!;BD"8+^I%\6= 4>'C
MJO@3_"90V552Y/I=]BE%_I'^XI;$J$\PSQ*?A^ER*I.O&=H@SS1E=+1V"(X=
MRRE"]'52R59ZTY/%_F9*?0%@1#85'_)K76#M:XRXAF.0*V";: (.^$F)94P)
MC9@22$35P64.<?K0].P]F]'M2F]KD#J9RGLKP#U\XI\COJ5AZ<6;,US]O) '
M?R$I'3I2&K]Q*4NLI5]PF](OW"3]-LNY8(V<@P-;%S$ES#8(->D$AZWA8/E>
M-^37:V<GD2WME.M"'II8NQ_6]1E<(K@9U> IW,5CMH6ND?[$I5@9&&= >@1B
M*;[B6J\,0S,)\7K(9INB(<D#D)TKT7V4/$8NV4JG0"<@.KM-N#);NB#+HZD!
MJJVG!<DZ41CXUX)4?8+QERC\E@[JE.Q2Q QB=73.%=HC$$B!FDY)IK<;9;#^
MC'282$+A5JH1J,174%W5M#Y;FC"CE8+!\2+J0?N!J[YLBNT$&R7]J#? ?G#E
MC"GAL%"[VQ@XV^@4%'AF W*;)?N.J6%(&:A=6:Y;H4FDR<$9B>I,G0*T]TZ-
M;7BA=6E@4A2;"*\1$(1ED#AF4SU';>X9(!:GRMI%77DR.@O-1,UZ_/EK3DBU
M/65:@(YC%CK'#"$SXX116/F(.V.C32#:SF-8:M_\:X7ATE=8U#^/4Z+SI5=S
M3%38]$[E60YWKV%G:L/-W+L6Z1P:V4B8$=+-Q.![FR*141#35LT72'!$?\?'
MLJL[]3K,4"$)&G_YE!;3'"=:0>HRQ.PNB!FAS!"7FZ/90P+%+=GT'RU7XG6P
MEUQY3\5]00,%4WV887,WR=D?A1?<B6!VGIS(^95N<RM&BMOLG</<M0IXR!V]
M;[$+N@=RM.US-PZZ>;(8%;URS*L&T;U\X1ZLGA&J8GYZ 2(:GU3RRR=8SACS
MD+5%CI'T!8+F[6^0]0]OKNSEO$83$P\-"W9$>K+9MW<%1R-:)6NVW%)]Y7!^
M[\[?O1%>()"K 6UXQ1#XW'[@U,YACW*)4ZJCI0SB/JLW&A*U%1<XJF85@!ND
M![E'H$-SM3&QS!.N,S-2SB]C-IVL:9;*N$'@Z( [M523_<B33UHN-N?25&#T
MVQ_83X'-A6%)5VXZ9_!A2Q-K0:]R# .Y;[FFJ'@,,OLCIN8-KL1*5>*5=7(V
MEM?DT<G!H:8TV75[?3W&\OF L;Q5C.73 6,Y8"QWU(/6-0RHG$0@[\"\=@&K
M\I;LE,!NT?V>SFX&.+KB"8Z[0_XA1[_=P+!3?V2 A)M")67H&FRF/,D8U. 0
MM8+M[#M;([W+;S/C9#>K\R,2:B:F'$%[T+B] G\L0W(;4*%3)&\W1BGZS!)Y
M=9R"E2XSVZ\:14.,0IG4_AHKTO<HI49+%WY*[C-"Z481C80M8R[]-)5 G!O(
MIV8MG-@^#H*@1#$\G!Z!/[2.:@'VYR1,P=H6EU7[F&L"#F8]&WQ *V".[8)F
MB[AF5&<&?@?FYL@D\+9+%D\.&686R-F$N6%D!ETC?GTKC+9Z^)&X6DY:%KN'
M?60R!_1!5@W&IF1# GG"#(@UWQD=.QPR/)WLQ24%#]$<(_G\V0_GOUYTW#J^
M A]\^B4["@Z$*-VZ5S!'6$F,4;$QQQUY5=@S1=RJX1B\CA,ZOIHTR?:2^?'B
M/>\&X;V6D7ZI^K2@;^:%K *X<'C!U>0UNYQF7DRM', 9!T& ]T RM8[/1+UN
MG.U_SRU+\@+9Z>=SV&[<J[T^,9VSB_=G'=&;8+LU"[O6S,98Y"%PY%*%3< >
MG2"Z#O[_2#??J^+L,D&[%ZD0R0>FB.,E5R[*Z228V03[[M!V:MEC@I?2#<CE
M$]OOA*#C+ACA:>(/XOWCL)W 4XKB&)'IP8FA(OQL#+S[8GM"!!+N@KT=K#?=
MN& U5)R_I8'A'<!Q[UGK@..:6N'XR8M&6R2#(P_@C.^Z?WWOK*M?4.0YMB+N
MI7]#?C%TI(,A><<.(!J2EBUV-;2BG3?RX08(:9*\BV<H=N$PK&D8(R W'B]U
M0N8&J#W)48!*I!:CNFE)FEI2%K$LC 73"-QZ:2']?*-SMS.1V5J407#4.2\Z
MY:XVT;)<,%&,1^./:YLF8#5G\6:N^;(>0::[O^1U2N2-5P*L\5P%IQ[?MV$Y
MM,Z_#EJ[S+.$Y1PG!.ZV$77W!0BSP5PJZDZ]!T*4$D^(CC==.F4QVJS4A &F
MM \5YG46!3K-EA<&D.V,7S0WJ3]++^F<%#_L[V8[LYSMQ ANV^22S<N)&L.>
MPIY4R4+ZL;&]^%N=T2I0CQAX/5F;8B$8H\18(<FFI(+5ODP0O#JO\'.>/3ZC
MQ$+B'[HRL/%Y-A:[HN$T-*:J078;ZN;FGX>U$7(G.T&5>(Z%H?<VP,,P@DEP
MYON:$]:6@:!=,C#B7#NU(F"HI61\(YL)IE-DETY[26C(+GG_2:*\@V\Q'1.(
M36W0F]S)+-?U$.3M4),O>I-]D?<>*_Z:=EK##UW$R41;H:]7K\QE'6O914G:
M!(1T#)<#)=JE['$[Y>$LG1ST3O)8>;@2FHI%O-15AZXPA'M,#_%EO#G!9A^<
M;5BQ.)$%Q?*J1]QV@+"C@G?R/"['UV ;TGV;0VAQG6EF=J'R:W%N2T<_KXUG
M7<&C_N!"#UR?#)DX] BOL2E"9_^T0%85[GUR)2 ^/EN#87G'K*TNP[().S%V
MP&!LWOU#V6%LMK$E7]S2I#JNFR&,;V!L>MBQYC,#1BW_F:8F6PC!US<U^6NW
M87#BH/EIFZQ.3STH,'LHDHJO9?"P'(XM(L(F KTB-/QU[$SF#!#+[_CP^"DV
M1A$DT3N$$+GZF-!&:K+K:FX]/N'%@$^X57S"R8!/&/ ).XE/./=1RSLPH]TS
M*)L<0TWNEKYTS)%&._YL^K:8FD[)SWIT/E[ \@J1P=)Y3$/9%^@#5Q41(&.$
MHK0L.&:LV)YQHJ;,EX!?(L8AL#GFE 0"2X-'X[> H_Y^8N"48'H59.[P.@3"
M\R!S?L,\-X8SAB<BW>><+R,7-29ZY-&2K>$^EES$BI;N3WE9JDZX*(;BB,A'
M/AX%EED!*_*2^8+JQ-A:)VN' D\3'=*1):F48A9G1([")&#(14)!&&18X""0
M?3(-TIKY5,.%/GZ:JDM*W6O3'SU_U#5@3XE=ZCL!9$:R"[#T"3=E Z2F@/$
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MB5Y73<A4!-@+)\5<5H&NR$BE^;61$3&R7H;U M_X_!C>71<-_BLME7#,TL<
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MN$/8[R\>_E43VK0K;D/*^U=L(?V?.5(U->;YE.9YO&*>/(&K>$#>,\[/7:4
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MI"UO=X9WOF&WF,A<O^-O)0P@<(W"B\XTCX$V8,2RQ4BI -N0?9?R)E\2!*C
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MR:BM/!@Q3>ZA$7FCVE-P=<AGA7R(D[QH85LW[:$TP0507U0Q2)A3,6F\4:I
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MGP?]./L,7^\7^6=\,GXMQZT(1_"XC-Z:9" I%5WBI==_NZ@U7B=7"2S2T&O
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M8]A?3IQQ'M$IK.:-/(!\)+S.]4:G%R]GHD#O\L.#K?OA^[.!#THDW^9IFL_
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MHQNK=[9#YKE&$^9(:)+VPM,&I SL.CC4]%#-XHR#"2SOV.+L^=R;&R=W]EE
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M?,%F 3[33[L#'NUP['E#<*=GA(9@VZ$+%QTZ- XCS?2;@DRE\U:;FLBV8S0
M1&Q18T/>+DS/X$@=CRRP@$^^UXWR:@/^[%GKA7^,,=T^:]+GN)V"'9'E@U;2
MK1#3D4$73/ GIM(E>)3T5 ]7#@[-D?G]8U9-S@,<_&66AY=@NL(KE30#Y,\U
M%L X?V0UXF 9=K6&1]MBWFPYM7GA$B@PX%:T-3%&+UT^-HC$D1W'B2W'<QAI
M@M7T(M<WMWIH*N!^A,;^4 '!1NAR+QT#VO+/\)T,HK,,@.\:RH(^HT-B2P9L
M]U,?3MQ%<5Y#"C1RRZE8,A!DSC;:0D-GOVVDRM'&*;8_P_!9T:R 8:A'I LZ
M&L86(I8H$9SH%#KZI%;T-$\7J-TLU#V/!?+E,LCJ)DJ$_W-;JK@YU4:?]ZY2
M&_V60<RQO;D$0;@!FQB.=FYP)L!F!6L/?>Z)E%#29QSFL782W,XW"H8)*EVD
MI&M\S;8&CDS3*#,GIR/](@%R1'3'5<<PL-Y'EAG![,*A/.#/$U*?5?R@J).J
MT=G.H21AG9&I%/$%;5DJ'6DJ+8FQ^!AV)"!-+F5UY)*%FU\&AJ!MU/3P'4@4
M Q1B9"_A**8%\U]A%I8^+\]![$V67\4<V4RR P9%&BPB(_S*A$$)D?38X>:]
MKO7O( 6B4 W)]63&2F/2-PP8Q2VO^>@(Q"$F%*Z#2766H[%4I> -.+YL"Z+Z
M:-?P=6WL?5W_0K4(()L.I$K73>/BZ_S_0[NV[]F,F,BVJ6XQ6C>94F@1J44-
M]^N8^%&E[W@CP!57A@.Y8N6:YC.7GQ/[6I/67RB9K^93-$33>4"/1:#M2M!-
MBO76?  SHD_6V&&6X?_/WKLUR6T<6Z/O]2L0?CAA1S3')"W+EN50!$59-KT_
MB=JBM!GGB_."[D9/P^P&9N,RK=:O/Y4K,ZNR /1<R)$T,X0BMC=GIALH%*HJ
M;RO7DE3OLO?#%%>#VK/IWYNF")E?W*LUA\MED!) 2*_\CRP1+ZYUH--O4S[P
M0 (V8N1,?>H=D38".*-,OT;47>W?8>L]'S(^3DU<%"A1J[&N%VJ6Q(RI=:)M
M3U9R+><D\[QC_'&?VW&\A0VB* (RY$5VK/NH0^XC#)?8OEP("V!JNA6_F>"[
M6WL[8<I+PR G8"L*GCIB&&5^?D*,30_'#2\6HI]<#;" NZ2Z(*')NI"TOM*)
M["D.#:BS)&-EN3H[ UT+$"G$N$3NN@KM_X:WWF+QZ: =;JNV*-Y%RMV IN*4
M.UU+O=_'?F1>#6WZ9(8VW2FTZ=D,;9JA38_;B7G5.1\(D"-*4)0.P0I;[@L"
MXTMMSUL>Q0H+J<;(1*GJK3$@XVR?\LP,SWA82VX;&<GKJ%L."S<@0XV-F"',
M2X#1MJ8R0D'3QT+09V,/#CU9L;N.<5@AEX@WE="P&]+\!#<OO2E!B4V@=EU0
MX>*(*&'K_TKQER;UD("4(5J_#V6:=1'H'_? 22MEI#X^J8O2'D;+FU$NY2=7
MI#+QR@8/Q0J2!N7S%#8=V</UI=DH/]*TFC<?V,=5=D]Z($TUF5AJW21:_YIF
MZUDXYL'G^]X6;B -P]H/ET35'0B2=_D1O?7@/"#VTY3A'BXW.$%4;XQQ!=*(
MYS= L1Y#0Q(Q3XKK_U-H?H-/#B-,9C(W"0-"+ 4$Z8-3WQ-T7]V:PY6%!](&
M-1>3&%%KX!&\Z<=G6K\F"C>*V<#:4>Z972XPQ5WL*(YC&]57^E-8<5E8<5,+
M\V[6C=%N,3N,.7ZU\5?SN5Q[,T]C\X\+80VOF\'^Y*.6NU)-6<)-M*TRT?!N
MAV;'OUG]ADU&V_F"+5D4HR"\Q[L2A)>[W#O%GQ-%SSOJI+X@/[O]W$]KN]KZ
M )X^PJ>$IM3]3V2[CVB5(G-9K,V5807UEG09RIVOR@M@MU+]B,^C[R0N#PMG
ML&%E,=8CY5SV92=\Z=#D0 X(OS6Y[<_=\&+Z47.V^6MHL)T 3RC+'&YM/@^]
MHTO_6)]/J/KH0J"#E4*"S3$^.+!?P>1C3JIMCG2SH9?Y7/($\@&_^8J0X?+.
MP-Y_0-BWHWP,LTLVZTPT4Q@0IM)^32M-F]Z/W+E>:(KPBM$AVP-5IRVP_C?4
M.]MHYMEO9VJY4K?D0/5ARAR$Q:HK8;16$[K)(3,^84344_/^AR3DQ9W@+G"_
MQ'OXBDIQ1=DB4;U,FA0CF;Y1,%1P=Z#3CJDQ;KA&U@GKM<)4HHHRTNY,4BE!
M$\58/\[@) LZM8/">J.'";F^]8!3:2CAJ*L43>+FRM([J9?29UV$#$[+E0G_
M?JPG3.W\LE?D+TI:]9C,P^,S>"\"3G=W7#@.?*PX7TA>#Z*XO@K:*X4EI1]Q
MX-_>=W*)#<RF;* Z=";DA&A2V*9Z/#$\A/&#Z4B(LD0 -\-'9082IISS3T?'
MR-3^]=:?/-5ITQVA988,%EX!8'/D0T@3J0@Q;<IBG4P/G_L['UQ_DU='-SF=
M?LADKF[N44S/9L/UKEWQDT3?W+H?,PP T5#NR44Z0R,XU8UF]T@)H]984_JP
ME+^U9" !H:T_V%& %TP49H-]8^_'^3.9J@%,8RL$9TUQD9<-ER#\NUD5ZH3A
MTFN!W&-[D)[J!;-RD#S@?$3=ZR<BP@!&G*-0(_%9W&$$6QZ3 +171'OI7PR?
ML_%9ZY-.^7AGC_1XK+O*-!D;-"HE5!U7'F!#-W%PH#VF]_N8$A]TF$VZK5:I
M++BMQ"<I;WAH;9DU2.4BZ[XCRM7D;*^U+XT:14[<2%)PVFV$2J@PZK*['NRE
MWSSMAI'6<V;B/NX2O[@:.MW@?QGM2K^$+IC7(@!6 J-1Z-IA"M*JY28&N] D
M-S%0*C(Z\B"=#Q?">G+""2<GL3!["\[U4.0"P(_ Y5'<MP '$6KSYQ2KKEHA
M]+!XGV0E<S-53 CH<[MT:.8,[BNIO=N#.'EV/H\)G13=53MEJ3S99,Y<KNTF
MK[LNTDN. 0$+$4H3CNO0'3"R9I)S&LBJC474G-737)A4#G M,1&?@I)/J]G9
MA+PVB,T-K _L,"30DW]%&U(I8ZL40KG8F\BYFM@R'=96X5WR^E@480L.>JZY
M7!B_R-JYJO8."-.2"0)SUY2L'<B_8M:]*2W.0DI###J1]844&1;=;*'NXWZA
M9389GJ+]!6^< =.E0(W]FB%[M2WRRY(MV[NJ/CS9U@>M::H?)8>S78J:IUZP
M?C%_/TG:N<BXJ#EG2C:G47! WF:0!+\86LA1!]N) )Q+X*%4J_D22LF.%66W
M4$($ <*"4Y$"9ZX[YA@=/.RKP>-'OBNX;90YP'8]")"MYM-?6XA]&-$K@:/P
M(R*;0;,!/OQ(?!@4>^CJ"11. _W]0O!B&F73[Z0W+\PEY4\IA7W1H&R"Z?=V
ML!.!:>^ZT(5=E//!4#G(JP-EO0GZF*GY' =,14WF QEJDSBQ+4UY%H5.B7JT
M_-F<=?X\7'&_*QZX8-0<<@IKV[]N (DU@441$EI0=]N7# 8RK^SKDP<KO3M:
M,MQHQ:;7'L^+0',1TLI#H?;;'9\?I:6^&G3WYQET=Z>@N^<SZ&X&W3U:WYFE
M=3O(9C?PH ,C@A@;#??RM5_Z( D/;:FK6IJ<<FHNH):575[N6[6S_FCO&Z7K
M9JA:SFR@>84B"\'"H:@!.+?^C(N@5JHA8\AS0VLN;P3VUO+!+\EQL5HUPF'_
MPQ\I5 T-Q*G67NX.]$C$L5!(OY"__PY6,#8W1*A9B^[Z]CJJRH?QVA^?=X[D
MI/>_R8U3WHR)!4U><+XIJ"]['9>L%,H89<+@ER#VPGK;%A42:\*ZGN*-_,JR
MR1*I&UL!FEB4XX::XHFXK$3H2^0]AT)IQ07A,D1613&%08>[\I^'@;DXL+!/
M55GU$H&"'Y1B:[*+[;%%%SEA! @^TW:-]MXU PG+2=]4N(FBX/>&G3_;AP>D
M4/D3^""(7C>T(NI3+MMR7>9<W:_HOC6?)?)NR>LN&COG"].Q$MO<XY.3*WGT
M@=*3MO!G43HK3%<B/^AR(%.]VG*Y7^$2Z[S+A36<NY]5+J&LX-C:DK#)J;U8
MD08ZA $6TA0B=W/AA92\4$.)&3AG?VBM0$&D@PK2G]Y3P8AH9$K_80];.-$A
MHV#/,.^U*[L_<Q1X5SV0EP^N&Z,KN0]6XH$T&7(5/!.1+HJ8^@[^#=,HMT A
MI6+V=/UMS1FWG5_F"M]ADH>)!"KDO;2S6)J(I!QKWE@'S$=.KP2.$\ SL0GI
M31'8POY>?O'JVZ]??__-BQ]>O?XV>_'EZQ]_R+[]Q]N7K[,7WWZ5_?>K%]_^
MWW^]<H",/_O<QVQRC[__L?Q"VLPT16H"=SX<TL%J\"JV;!'-&+\?CO4"!BWD
M'W7B"6:-R9>9CP*SVC ]X&DLKR*THM%LD(LF/!6H)<CNM?[@R6E$_^D;:G+=
M[3@S2G"HO-N>9=]X/[4&!5JR;.-)*@O.GXF%?8@2H+*10)@@CW0AG9HWF3,&
M-.1+U?LPVT:V!M"(%)^W ;Y-(26Q,_GCC+]"?@T*H(;X@ST&3;]4K?1"L_^P
M",X#>RS&=2C.S;E:LD!%C.&IX$[G0-$24PH_W,1JB?Z.S(4<,(4@V6T7P/CD
M7D3\5TQUNQES_K&XZ=85#=FW0=<)68@11&G25L]>['U<L)QC_D\]]=*.R#.#
MI@'!U#]^WM8]O>-_]<NBS+ZC&$U:66E%?/?]2T[:6M!5BJJVC3OP H/5!U(.
M)IT5C)L(F%6<UG]2/,F%]TF; *YKV&$K*G;0;'6&F\F#>QTC2>]$7/0PWPJW
M6QV]]5FV]:YH5P4N="WB=J%MMQ!96JVHO=?(AVH6%$ L:?\!F 5T3^5E(=&D
M'Q7!8B-QG3,JK,0O1>Z3&#%X8$P6-\B#*R)L@(ZO5XB)!XE9=@ZLK3(Y6C56
M;A((AB> >VZA9+6]*5M4(@*H&\*KK;S=@8 /7N\5YX2X+BQ5&2P,G()U3F6-
M 67)N,@:\OLGKB]HZ&4<'EV6!DAP73^^D>Z'P2LY0U:5.$!#Y%&LDB_]ELZ3
M_I>(> [IAE2W." !%J9,'3536S>N5,=BM[R918B\?NFN,?=*^^V8C0V!:+(?
MB<RW1XCFW8R+PI )=,Q=&5;G*F]HSOR^U&Z0=MMW]%;:<?L%\Y80Y<2NK1U]
MD->7>?$<#X\;-ZCT0'T6K&JFZ.\(R$[:'[+^XIS8T"C VOEM29P2!^;;I8#:
M>[GZ>MV^K/S._)GWB+J&Y"E:]+L]![5% -07R;[](.D3=XUL_-'&KBFGXL1
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M%7!:H"FQYQ]M9OYJ2-NG,Z3M3B%M?YHA;3.D[5%ZN1I2YZ$5/<(A_&D<K-[
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M@5N=RM "*(A4O7O3SQ4U@-#L-5*J_8'I%?PS 5S;6^+V6 MTW&.62ODPKQ/
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MZS";$5! Z5/>7>Q<48B!*BC64=\@$>M#/I6ZVI,;+C&7IG24GA@1Y*Y\1WL
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MX:;0#C>>&\MVB49,@X,2#'Q,_PY>!/$=>H=C"79Q?PZ<N5=5QN9!EX>>?9#
MHP--FE$9M-#QY# M(+P S:;+:L'7C0/1^N"_+4.QJP]"AX/G=5<\+^I^"VG&
M,"M34B3<Q!#>"YW[3;XO$)B,(ADZ%T$&"6UB\DFE586 "\1IB=K=R6%>]5I4
MN.0:"Q)HAEB@0]LZ =&]IL.ZM8B(:-X2U(^:0XKF(M\2U5O!H&YIE2SG'B 6
M>9=<BQ>UOFZ'UTUF0$\/FVVA"[PI_*_9(F$YH;PBJY1/F(":J>-^Q1Y#T2(V
M8C^F8_A1&I9_]WX=/7]N[0H<C[%CZ;=)L5/>S%OLIIQUT:*3\QEN]IQO1B5R
MJIU@M[X(7*I(E9SP5FBY?N</)-B'[$OZ?Q%0+ KLTW@W$JF'45DQ)-,'10IC
M&#R@N[D;C0R*-+PECM;RF*6RHK))]$S'<!(_TO(S43^.4S,@ZF-X,VD'4<L-
M]\%W#0P I[UC<6\/]=BY!0B* +/8UM[_I9?4M][.K?O )HN&/M$\Q96:\OR\
M"$\9FY[\16@M?ED?BBKDN:U%H[O($Q+;3I=,P'0 X<P!C,<>4%?D'1=1!4A,
M8YT/H7O]1/X0,O8F.8GXW:N5RHUW&STQ77:Z[?0HP/9><_1X2R_"#;P(Z^R8
MNT0G82Q8R59;H]CW=A_<-('(K^T^/*;E]B@WT""#,!$@PD)QZ !5ZPKDF1IT
M#3>3MQ[4K:R ,A,?)D&(P'G#IG"\]6CI62^0S->_\ZHGJO9GG+YZ+HS@C,!#
M=C5(GS< F ?L^2 4C'$@YZTIU9HP,T'J*I=<D?XR*H'GU_/S!':=ZW<96S49
MZ16FZO1FOV:?XD%4X;VL3HD3VAZ]Q-MZ]NG"G8@) YE0S;97CT#QOG@2NML>
M7KC%DQM$0%OO9_RO7Q,JBC8@]A9LF/<T_3?^JZ;@SDR53E0;9XI:'T8G&>&]
MTJDBX5GODM"!O:>\7">UY>39(4F95\9]^IZ,SJ?/GCZ]UKX@51#F6MK?6LSP
M,(IV8\,RG[7W^HG\XG&#&JO-81@O.PLU5*%+;.VJH&9[YG56 BA*_-")Q259
M%(6ZXP0)B43<+N2J0^%9:L<O6NQL@@ O# F$@ 77!9& %FL-W)D1F;-7<)Q'
MT0*?U%&\I#9^N6/N#G3HV "#9D?'%^:!I"%H'[#30>1?I!6./2:34$R3R_$6
M'1P@:=+>V0EJKIH^^';>+9,\9!AFW7<4408%V2PHW@SZO483E/)H\Q&5-#5&
M0HCX.@0__IKR8&07WY NPU54'6S.[(,$5C[+WV$;?0-D5J>CYE!QBO_AL9\[
M5R,__S0C/^\2^?GITQGY.2,_'[<G0(W!8CS\A\J]M_C_C_>_/\_^L3YXYW*1
M_9__\YW4BF_##:JQ!U$Z<+M#$L8P3=8Z*W9M@:Y&_RO7$4N3MPP_'>.!_D?_
M,RP4B1Q0JC\6S]'RI=G,8.50I=91[8(P\8\5RMAOZ+J"%N-QFB=!Q&7J.&5K
M;:9V:XZO9KULX1,/]E6\BE;Z)9K$O>AJ*<W!G T)!3!KL7G.3\2F0"S+!H\[
MBYDEQ"1-1^'(]_4!T<B_"L($^EE\23B=NJG*7+CXN\&3CCP#=VJ@V6T&^D.<
ME-"YLLU;XW]:3 /%(:@< LGG7[:KS8,JH<'I;#&G<)-HB!IB"&4[*!0-PDPD
M'@BQ<"C0G,>=WW3B)<A==SB)W&5,AO=_)'D\Q:"L>61:^6W:'Z49.8&UQ>Y'
M:CNRD2%&X&Z%Z:).VE+8FG.4R2/Z,:5G#E,\8 V0!9VXZHE@T6G 3 BZF70M
M.2X2_? 4Z:%^J:1L3$J%[[%$%G]?=IVV2N$V;ER6.'%4T2*F^Q]JA<;0JN12
MB#![AUK'R3S_@M6M<QNUY)4+#&DLU,7KD94"4%\8REG8HCFKZ6W'2FM+"\UY
M[![O W\B0HCWYT1$_OS3I&#XAL@#Z%_?O/XZMD_PDI9*(7[1U%WM';R%@-)X
M840;$M54 F,TQ_1IE@K1M9O.3IG45)>_BP5R8HOWIO'"K]8#"@/>^B,6O Z4
MG0RIN F,X"9)M##,L^P[8W$Q5J+0:+=$W@&+U!1B2.ID#C4!# O@)"EK,XHM
M25DR[-UZ._2UIM!6\988K[B#E<\737AL:FO>T]RB'OE;)B'UI^*FZ+@V8DBF
M0'"V*08T5W4$]22XN#_;]<0/P G!<,Z,DKI 2\AQC&,EYCS=V Y?^R+'Z^Q6
M+Q(_7=9R;E_FE*5V-).4:BJ)]F&8RPVZ,7ZFFJ.QTNT6)^,P>5HOF3,E=,,?
M2!Q4.4F%W4,3-@E42*=CPC#9J89UH/ISJ1G0T+$K3/<$^$X>8SZP[_43Z9)R
MFJ97RMX3C3#J/2@?3 QVR(45]]4O:$[54<GR%CH+#@X*VN#HDK3/_*[8DR>O
M6G#3S6885MUWZIPG*"?:BDA%QIT2H,:366'W*V>%LQ-9X87CR=/LXT'=H?=)
M![]ACL&I?'!V?3XX]A:Q3W:[?"F#7SXX2VI9CK.)+.DIEMS49;\]KG#DCL>P
M^90[/@$WO\X?!W!=//*4LF2$SZ$'Y1$?77)B7X'?ORH<F>$W#^V)J*)%)7;(
MI3!"U ;%@4GHO"_7D89$.,&9@ZUO56#GYB"T4<E:O?U/;=-"@/F%I?]6TAO_
M;.K^@E(07X=M^HVRCZM__?:?"ZUUT\_?AVKW=\+&Z*^39J1>Z7GC<!:_,;(Q
MWZ/]$;]6,Q"WNOA7'2&)(C113L;D%L*I+OF\IF T]MIZG  \*"+#&[++(GXN
M^G.JD1=3>1A;4NSF:ZYKO PI6 ],'5CJ0:?;&=/%56N.U/VP>TJAN#UEI(A]
M\ UA?$.?6D7\>*9.-QSK ;F:?10("+FOHO*K9V]FZD9GJ4-;071@S6 F;SU(
MZ?@IJ6YW< ^6:FF078[B@FM6NF;"3K]P1"^,^Q!8I7 ,1@29,=C22RA@>8!K
M74#7"+CF,1U0C_?(11(WY%:3_8]N]:Q4!YB;]%8&*SW=RFG) [O)EI^)E7^Z
M8X-=HWC63.TQ=>'?_E/6N/>(!32TVE$K#N"5^EP2]HD %C Q?MA[9$]0KL:G
MX4+P\U@UP@@HXT_F'>]&Z(!MS# &IX"T'PD4+G;X8/Z)\BF^A B3<XBL&T33
M0^F_AOG5R?G9[^NUQL'<,:DMR%<!YVY_WOW M&!Z#%@+'9/<U&E,0=$.38*#
M6WZ0"7>3)OP'66*!P1S/1:NV;EO(LD>VJV0 9>0&5-MY@_FY:J$VAG/LL1]_
M5V,9/IFQ#'>*97@V8QEF+,/C=DA>;:!E21:5G.J,:.V%G6(B_M<$#S@0!UD>
M8T$6;,8M$Z3-^-#%!Q+US-RDB+@V(.*6D1'[!#$J&KZD[CI5]0M><]W8YGQ$
M3,L"WA+#'Z2SF"I&3_P(G\#*<.;E^;//(14VN =BC#@YRT+)/N ")%(=]/%0
MU^2D8R6SE-NT3),T2;%TE)0VN71M,JJBQU$VQ%29J'3[Z8%0U$7?^%NV3'H]
MG%VX6\1Q>:"&6ZJN^B_6L:P&)2SZP;[&2#K$@(M\4O+J8,0]@GQ($ _AU95(
M? W&]MBM^,.D(GM;N UIZC(;E.D9GY"X82[4K+@HU\6^7 FC#F^)NN]@%5MN
MFVJ)E"N5A4F5Z&?%JH>SV D:%\AE3<@R/+/I#+R#93/(SZ!0\_I_7GWUY-EG
MSC\2+D*)$CIV&\D%RCV8)NJ8712U_RYK3TPMNP+@$NAD$Z&OMX#U'@GXH)_@
MG>5M+.[ 1JV:FF-F=ZB;W9H19Y,:">#U;4C2BFY4[$EAT)^#$CHB=D-[2=NW
MX/]5JZ!IGS\)B1[MPZ^+96,[K9YRF#:>$42^1M8IO!48N![H*&\X2A:MYYPL
M)DL5&7MP1@J'W,JO+1^C-Q)1"UH %/(=*"$):E!#C:%N7$TY1S+N\JQ$#B:"
M6SK0L^PK;TK\D@DWE*EKN1BOHQUIC.J%&N7V@FM2<9:- G@N)F<O6A<11Q]
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M'?NN.,9&U'E_SOMSWI^_@944QU9[-HZ)\(9P*,^[<]Z=\^Y\[V%RQ>=6&W2
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M+-(F=3\E#1-MY2G@^+9M[&<NZOP-.0%$H&I;DF C_(,-POB42*\%+W<;I:=
MTYF0Z[$ B"4<5/K#2ZB2R%B5&#8PR@WUB%7A]F849_YCX*F]'2?<)#G L <\
MK#D>"6X#]@-E5>.K&EJU.-@QIUI=C>;>"5,4-_-+7+6(B'ET+= @"6,O4=>&
M%&&")EI>[I7L%"V*X%3PC[:X>M,\]EZU!_Y$/U:;_+(&([<39QU2;X%<5SB<
M;;/L(MM+72SV1DA[==(:P1VZ?B>"*3J0QR>$"-P@86C)%NX:X: !\;\VQ[2+
M<4_)XK0$ /^)::>#"D"DDG,36D>COM2A,H\8*7-"UJ(1*J8,5'R3K*4DQ=,=
M/[:]\C"8FT@[UZ7=S]RW&VBM5G3J[G;LB43^P[4_3DL6FBRI]QW+(;O(C]P@
M#!U8]'Y!%%T.ZIGKZCXN9N*ZBB\6K#5XY_)N93EL0!H.OG!FP0D=8YOT9(08
MJBB*6").64BY'AIR7?$X+[Q]'0ANI&/J2(R^RL.2DZ\3$T,&2B!V"^37=&RO
MBP(>2^^ODB/@WQUU.:KNJG="BVR7G_N5WAW(-R//L[EDMP*MZ\(0P.<]HA(Y
M2$,G>PP]R&N0QD#_764\WQW!MDZZ9*)]ME .TRA49NR3=XI@15;TTD*U^+)P
MMG'0JA")Z0)WUX%TK$4FCD:?'\,4R[.4''X8K@/+>!&[!4^= V?N!8M$L%0-
M8Z+!I=0B'"+Y-FX,Y>^CPU'<WWB8*)VZ?6GXI)DUOD5H;BP)@A*FT.FK6002
M@6"*Y-'.LC=T=;OP5*R%9%<&QA:D%_[E^@!C4G)G<<+8*K<A6^K';N:NIB_X
M=*8ON%/Z@C_-] 4S?<&C=#S)Z6#B%\Y&P/ 16:;(X1A(1<B&"9&4$!?!DJ\+
MT>].)'3":9SE^QH$0YQ@;I7(LC-J3)S$D$LH$<[LJ=Y'>_12WZ,3IV1';WM7
MOB-O@=PIJRT;*(_*#:>;A'PRX0E-E@W\#^%]" Y**D)E.!&" ^BHXZNFI6L^
MAFL%ZL3@/(.\POLEI9^ O"%"J%2WL!9I@Y(RS40#6D2*B,'#EM4E947AP1+G
ME_=._%A7[$.*JTC##(\WT:_6Q]G))??MQWQ9LO+CE1,TH)FD!$A?[I#BD TZ
MV3H.AW'O9^X&VUHVKX8!9JZF]K&9KV[K3$Z2;K\K_[<OUW2@)%0<T6W+OI$!
MT)3!*34#D=46>5F%_))^Z*!1H[ZJ*GAJ-LG%Y<+#8/:,R!?"^6(BN,19)/F7
MK*^P1\J\*965)"4HLZ0E*9>E,A-O+$G:M## 0C@Q-4H@QE1FR5.U-I*4:IE,
M3&CK]D6A"@<F.I&D^D#J+;)[F7RZ"TI/>"Q)1*7,,-\D.3HE5*4E"EIEXOJ\
M(OJD+P<%!7_G5:&UHR7EZNQR=";%AE#2;X?BI_S\') ;G +^51#O)Z7$659/
MMN HA)!U_ YRE/NZ*<P:(61@7E(V,)*N*=M"R1DY?F\#GIE3L1F!]EEYA58\
M8FT&$_J!P3=28=DIGKQ$&R)8O$B.3A?W%VE010H)TGW@[*/#*EU>)ZY]7B,Y
MZC^;Y#3!J<?)49PQ<C#+&G%Y&PLS>O=#B750[L(2M M&RC'T=RC5T'[5,D.0
MV=LHJ2YV^*KQ*UK48['S-,S4^;!;MY=P>],WK-^XS7T06YU;*Q!/)T/OW=W(
M2WGL,>/#=)]>;=S!K#GN^:87*$R4O*X@5LQ&31C6#5EC9$9EML_$+8$=;=M-
M3Q*ZCV"^'I^[^;9PFL4DB:&A(*E6&.GE-_G^(NLO!@9PD9S>N$S+I47VZ$2M
MF(JMX,5%AI)]H$K.4C@S,4VHO.!LKLFT+LQUQ1@".;X;F.ZJZ$BT6]EXM<4K
MEJSVM7<$KCS874RLD>+S20D$B>@(S"XR"")_/([M9%N!,"P^AWJ.W3;=)1DQ
MB;5.5-K(+\"I"HZ[CDF^!U?B,YR@>_ E^:B?Z<5F:-X,S;MAG[??GZ3M=QMH
M'NUQ.$-'\I1*9KN6&'E#](3!!9J)C.8M.F_1#]VB(7%Q^UW:49A[3AJ$>=-5
MWC8B-\2&6:.]F:YAWJOS7OWMS*DXT01Y.,\K51 5R+&2&,?44+&_V-7'0O+
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M_KK>&=-F=LH[$: .^L*,JQ2(Q@CFT9YE+ZX IH0+I_K3;0 R"?T&[YKI)XU
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M"(Y)F K_?NF478?N^7A=6!$S/;'-AY:5^!5I&T*K'#7$.+*LJ7=$Z4PDXBK
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M C[$H5D3[[:+--UAO]1-PBZ9,[M;3FKH:XQ2]QZ<K$U!1R7[1B0#4^0,1R+
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M@\R^"^B.%RLV/U^__.Z%A3L/GFERB.C%=O1-.K2WY=(?VY95J28V:9@?)E$
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MH')/M2<M1@V3=R%\BR_1'TG4T54P3U_X0*+R*AR+O+B"K,(FT[16\9.<8/"
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M1@X\] :1@1*=;)5Q*\H$6N/ZW2KGSV7IW[5*V&"" JF0>5^&ABB(,5AM!XP
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M/ZQ*N9%,*G_QE\09AZ)M&.'[X8T_]@;NAU'\(]BQ^DI,0+@6<Q-UF5Z^^=X
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M/TY#DWK:Y[0(9GYE'#XG>J&&/?*,X.2(/Q2W(,8S"O)-ZUS)T5J*3+S4O:Z
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M"%L5F2PY(.6K'%S+!<-\T;MQQCO5AUL)+:R44LKWV&7HWH(>%HGPD:?&29>
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M&%SI3<QDP+3*6P2YS:[>CB[:+^7X&Y]\'[\AJ1N:"VQ_QC)<Q6'I)PPZ_7U
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ML46=O"PTL2-NEF16G'*N%W1-7)\Z> &G]CNV@9+6M;:4E@ $'Z1E,PS LQ"
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MJ.#9,QX,[R-_Z5$^$:@8]OVWJ / 0@'N#1?9<8VRO2RE<_>BMYV^4Z"*88#
MPVK+](O U3LR&Z.#L\_Y]"GC1.C+FC118;3>@&VC=NRO'KMM$%?]SD C&,E
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M]896YXNP.E^MJ-X7'9E7NYE?*FCQK@B,]ESS?VT)O6$262_:584<)^4V>V)
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MGI!7^H.F4/X4JH7$.Q$S! 7""@DHWQ<^.I]Q#FT9F[^*[,H?+]D*8W?4.[)
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MS[0MDIG NYQ]><[=B"U@,%5CV)%:V(JTB6$\?,N9-C0)SH V4A)QE1:9+<[
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MIT\?_IJ0F4;RSK_\PTWZ0!;YL5^=*-[.4^?M[/!TCEG\'X:I[D.?=_:'H7:
M73QSQ,.?]A[.N?G???L\>_H59S]^]0L^ZNKOPU$__NKDJX]TREM$S&=VP$^S
M+Y\]'6GYD]#RXY&6/^H!GV=/SD9:_B1'??;\Y,E(RQ_Q@)^-%L8G4H GSS\N
M(7\:/^.7RZ(SO\:Y&.BIO3GD)BU,ULKI]-7[HNULSB7T-I[=C+=Q0U1Y\Z0X
MJ+0>GYYGSY[^"E:_Z77>I>,[.S\YN\F3^V#M<Y<.;:2Y7T=SCT\>CS0WTMPG
MI;EG)\]&FAMI[I/2W%<G-WIRG]0@OLG ^^96K 4[V.OV.=#&E]FS)\^RQ\]O
M5"A]/JSUY.FOB9]\IN)\I+E?1W._*I<RTMQ(<\<?W[/S4<Z--/=IC^_YV<GY
MG35;/T(<E_LW7S/<;_UY&*?:USJRSP<YS3<;:/!MG*XYDUEJ^5E$]T=*_%64
M>*/VZDB)(R5^X.$]'F7B2(FWXO">W&RZ<Q\EWK58[>^^_8F1.Q2.Y(=59Z<&
M? [$<?95=OJ8_N]\]!P_[/Q.3S]*QN.>G]KS[/'9DY'J1JK[M$48V9?/1JH;
MJ>X3EYME9Z.&O7U49^U4'>5RUU&N1Y2P3<K>^/X(:3-$3@?!@:4C(M$=N;YA
M/+#Q_N[*_0T#@HWW=U?N3S# \"]%!=-?;**"_19W>B=AP?RDV/3/=JK%6X%R
M_@TH=00/N0_'.N+;C"1ZRX]U)-&11&_YL8XD.I+H+3_6$25LWUL]2MA0O'1@
MDM.'AV/O$0S$5T_/,OJ_7_WX$6]CST$_.?GR(QWR"!S#S0//GF;/3T="'@GY
MCI_OLZ\>9^<C(8^$?-?/]]GIL]&TN!>$_/&J#'08O#V?FY]_]CM;6O#_/'J4
M?E>8<O9U^F95FD<_8L;JHT??_G%67'TX]3P%)''P!/4%NWJYPQ$\I@" GOVM
M_G>P@R^B+7RT,_M(Y1A!S85=AIS8LV7G?F%]TV><G;H)-Y1>0?[EKV$2/9XO
M?A6GN3.^L=R=S#G[=3#5'[G8YZ?+HF79>NA_[+A/G=O9NM'2$58WCU&6.:4R
M'GE@-/E)=#8098$<&RG\;E#X^>="X6?9\W/&\AT)_;,D],>?"Z$_S<Z>CX3^
M^1+ZD\^%T,D)UIGA(Z%_CH3^]-83^NMJ6JYFYCABIW?G%Q>-N<@[@QDZ"MR>
M_JF^-E7Z X:OY\W:$GM78YYZ07QAQZ1/ZXIHH$41G(ZKKWW3ZE$KD3>^02RD
M=<\F!M0)\?KT/ZW:HC)MF[ZL%Q-:&_XV\M<]X*]GGP=_/7Z6G3W]->PEW_RQ
M*:[HB4<MY:99ZR,W*>DOBVIF\/!SJ6^^V=CB[7KQQV[+^@U.[0:M.). ,?)J
MRGR4^RKLVG)1*UQT791EVM+:BCF)SJHKU^D,A=J&J=Q(!4Z!>AS3=CPXSE@X
MW$L_3$[XK#7354,O@J%7S>@XUDD^ T<:>FH^GYMIERX;<Y47);Y/Q_7.X#?%
ME+XQKQO2ADW?8*3GZ&^$(T_2?\^O\.T\7115W6!YM2N_L@M%!1:.B]>5T$)@
M=:ZFLJFBFI<K4_%/9*OB5P-V:'J97]'A5?QW.O3\@HS6JL-NW9-/;I)D?@M"
M^1B$;TG_HW/M'R??_K'X]O4\$>HKVE0="]$,]):"@?#XVJ;U@MZ[9C);KIIE
MW9K6RO+7_F,O]6,OIEV6%OC:JISA:?2]J3RZ+(@I9M!0(,["8NTE1'*RD&O^
M3E5WO H85/2M90[;I%CB>_1)O&-B*C,OA*F(A$'4RI0A]=(R6)7BSUCLLNY0
MST6LG"^)F::%4TOT%3D*';W2VL?-Z[*LK^T#G.::>LW%6XF_VX@"E,V8]\N"
M7+?KNNDN2_HN$7X1=[]\?-+IL<+IR<UGT3[@_3=H,74DL^EZV[9@FH%LRM-I
MF1<+3X:+?*9_$EJ[S%OZ-?VC7IHF9[&<0VJFJXK,*!+4) YG WQPDK[NP#%Y
MV=;Q.Q,1D>X+1%CS534C*FKJ18]&7O_X U-.6RQ6);DQIEZUD.>PMM)EF4^=
MR%Q5(/09J0=:8?R0LI@;7G0Z*?/J73J]---WB:XSX^>S*LH;9A'\O&I9K3EI
MSTMK5]/+8.&9'AIQ3V/R5D1_6;PS97%9US.OM28&CYVC1!.,RF(_/M+DH"--
M%W7#1TARQVG$>D5<Q/QOV994X8)T))NXW64!1FO?(18"O<,R /N0(Z?W3O/V
M\B3];D6,9QJ\(>,+*NOJPC2\)_UH8V^-%Y?^3 =._WK;T7O:%(=]?OK-14W:
MN.)%>UW-?SN#MT++475G<CYK.J.WI+0A(,X?Y \?G#U[J#(S&9:9.#U5SGFW
M$N4\3\^^?)K.\C4)NB:%],#_TIL6=676U@J072R,81J>DB>7%VQYB^5"ECCQ
M7<-I[/0\?_2<R*PFHL,QSA+YVW91GEY?%HXX2*>7,&G(SFE@D?Q\\O8D#4ZF
M [FLR$*JR2:X8/%(7(N'DV="KY,7\:TYMF3&<6H(_@)F8-'Y#RHA8CY+(#>M
MM!*PQRY:/DP\9+H\6$X]1>:<(;/5#TK4^L/7&IB0C>QO2KQQ060*E2?KX:,E
MS31+9Z0!>W\!F=A5ZK('SF;7W2=T(O%A#ZIQR!Z2(R3"[.'2Q\Q%3<>5>06?
M?K""3VY(P>.O[FM[E/O+7<H]V:?<1ZOV@W?QT5YW\Z9S3!/YA-PR$MC,XXME
M:79PN.7N@MALVDDLG_F&?A+SQ$IP)=NW2V+HVD\%+(L%ZR=P#9PWUE]573V"
M-$Y(!+00 "!<J))_U%:5Q*8#_JY#6=SOS'O2;-SO4,_)I>5G0[ZPL*_U364]
MS4519I R+"<#)SB%7DRZ.DM?DDK,3U*D17C/B_P=!!A] S5/+)B%&P\Z-:A8
MN^"/8D+?P4C);V)KQY3_\C(OFFM\T<<-Z7ZS]/L\_;>\$!N4C)5- G14E:7_
ML:K2_P,%EY&I2L8&??;ZDLQ2)K<^M4,AR/-"YLB2D M2Y0)28)6+X&1[^<&^
MO,\7 0/@4P-<TICD$+Y( [YXX55G)M;L%B99M8=S2&+G+!7;0ZUB.)%AL* _
M6>.I74W^ 8N.?N(#A!:GQ8=6 ZGU5:GF!<ZA,5<%40V)K[QO"";0PMT:S&_P
M:KK"SG!$Z#M];F!PJ.$<6]T/U.Q^^=WKG]^JF?V0O:Y*?)?\PE33-8Y%'YZO
MNDNZVW_)EF1QB16E79-7;3Z5Q=.>ZO)*/)>-70ZN9K)V'[7R%?*9KXA>YDY3
MO"V)UA$=L3L2OCK1F)A<!)DIZDJL+3E'KY7C:Z=DUN'O?!3I=0XY3<P\\ZIC
MX%#?P,9^(S?TUYK6617_DMN'I4M/.S\]^]*=\G>OW[SYZPMWS+0EL:N,TT7@
MK&5.ONZ5R?@'LF6[ANPG'*,_/CZ7UI -SPS"9#%1&M20I'UB/B4CLBWT7.9T
M8W0>]!@8@>;*J,2O:K%2RS5>%#V/7#M>MKC1JTE+YC+?(!@%B\$W0J*5L "+
MB6NLDPU:<>.5_!V]@)4OB)K$9PCW1V=#PHZ,WYK<G#E'8UNVDP_27*3ER[(-
M_45WO9; 7$0V@7_>%%-KZAMK.:RJ(QR*CV^1CCIR((.7>*VS2Q1'Y.!D'2N=
M?Y!@:&=R_>)#LYMDVB'WD-5&OD&961*()J9R$I;T.9)_JZI#*H,\L6+*?^2W
ML^I:-O74T'.9<'>2=;WJ^ ESYDX14!IT0G H]_Y^X@082^\KL"?V-3&@>[PU
MG\-7G99UN\LA.]&GX QFY.#->.T34K[O\)"9*?/U=N<:P9,%0@%A= 3'9Z-*
MFX*9/DA"H9)+@KY>JIIDX3ZL7^?1=>EQZH'2D27SHD$L90)1XP]N6M*!(>WT
MR9W(&Z?_>\+&R 5NB&6Q2&T QH98?>1!_#JGL#,F5?X.?S#OR""80CLRW>Q*
MB9/B;@QL*HE;,AW)5X*0FQ@ZI!XN#<*<, F$G) 3Q&^NB]9D/MQ6FNJBNR33
M[+N\*%<-LX]0(L==G%!! *6^RB-EE?!?26?3M^CD8 L5M82KD)OD"&! ^!Q:
M5KMU;Y!%7^Q=0A=D"J)0[G=D[P^G7)"2[0=EPDQHE*;DFZDUOAW<8!#!7R[I
M*8C KZ/ D[WW)/R &C'%O]BT7'4XW0LZV-:F0H,D;Y@*I;\U"';S!7!*-PY?
MJ:4@.2<S<Z'0F^2O&XV0W+\86-0/ACZJ;^C;_^1,.'WK[,DWZ7_EY0K_Y@8K
M5,$,M'GM@/P8+N0ZIJ3L,-#:H>OR]6(#56"#TS!\T=0F]D@/(S<\.'MDWZ0_
MK9?T_A=-/BFFWZ3?YPLCQ_I]C?,[.SV+NM?L][C_;J- 2-K=-L^<>/'=([$O
MOB:9A#OKU<_=DR/NX[ ,'4QXG#?1!RAG>#I0@[C!M!:29E>Z^6 H&B<:/CK
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MRO+2^BF? S_<PH#2C]*1DXPALMM%32^VQM2SH>@V7%;I <S;=T&,0>L=O#%
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MHDJ-SJAJS:?;%BN':+;)M,.9&/)=GV6=%9XW 5Z"  <?7' .+*S>_.@K-M]
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MPA($>9R+O9MJ1<Z"7*'6+9 [&?D1%OH&=5,6[4_J25#:-"!L2UOVLG=;9A%
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M)=,I,N=QI.Y!\C!^-CC\X>G@\;-GU@D2YK$DIA)']L39!P"SFE\]5O.\U,)
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MQ]"%BV62C#RR#",#':C5I53;)1Y).Q.R DF2Y3,0!^ZN=QG+NM)6:UW\%.S
M72>$Z06#?Z>?;:U@>'+G!(,5!421$>"T$:!]2 AML@@.!L_DI]<YIT/%8'40
MC_S"$6%>:11>CU C;);<V''@QK;8:FB?L('.'[5BBC.PUF(FF6:*.7*I[3>
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MH[V<QT"F3C4:^&.FIGFE$PMH<XF-C@MR2?+M<@^RW=7IZ."W>H0VL[(AM&K
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MJZG)-+,*2Y<$XC!B,J/X*9)&$G$DD@V5V(\/*8 UM[7^[N#1/OQI#J8]_GD
MARDSR6\0EB6U7!DI-2XCOPGC=T\?F<?NQQ^RF(?XS R12"NQV==% 8>VH$M;
MC'1I>H;'.1CZL))ISD&H?&[:AR/5%7$MR;TCUF;'?O\COS/Z Z>R#^<4YL*-
MMHD,B8?Q/%RI$H5VZV/B/\R*>,OPQ_IE0%ZW[WZTD]_UXW4W+LD)\L5%0E+F
MV-P<M?6;DP^#.%.:" 7Y6&1,ND4B.J-+-%1G23J11D5C9@9?N(Y/YTC=7((0
M+8E/;P6;V2"2-I^+)>9!^@.<5J0>(SF^1G,PG>RN[\O=.%U'$Y!AD3!RH]!E
M@N.23Q6?IKK2*7S%$ P:V1$T)1LCA1!1X&>JIJ9:].=*LYW"75E;.82PDRK.
M#F;K-=UI[RY)AZ[LC\Y6S(+MVN!P.(KDJ:#$1Z0D=4(=,Y&HFL_.",Z 'E,[
M$Z$$7=<[X*==7ZJV#>_$U+;Y3 -F*I\?[M$2*=^C@,CM:P.97\->(RO^_2_7
M\)!KW;8?GS[[,0CR7&F -^PF_ZQ_^8UHY"GJL^E_3HRLI3[#>]:@K)&+%C7X
MB/IPK/#SF&]3V'H]IM")Q)XV_4\)BZ)!+R!K?Z'.%394)&V2%!FQTPM!?G56
MX,B(9M1C&Y[$<)C/0-=(KV#\:@8+!Q;MN!Y5G88RAM>G^1R-]H'7PTT>A:\;
M)7@SF3YVKK(2FY68O^&;RP46:N!01B(*]_*@,4O9:4!L_%L<M!F0T\ I4I^"
M/6?H49.TS#?>P4Y#6;';\!)Q)A2<Y"+'KJ E"S9F>;']=R>% F&7E."8$[LU
M\\W6:5*DBTXC\8X@&9-@<8SUB-]I#A ,124S,304)O^)0CB_P XKGUG_,-""
M&)+YWYU&0?L/+E==V(8UU"%P?RG2:L.L7Z>W^/^0S7$3#;;7J[!>A>V8"CLE
M^='I%LX<J50%%UZZK\"01M0Z/5 NW"2E)2K8HOZZB4;GOTC85AO9Q"*1]9EU
MEL;-88LN94IV]L(L>\/&@P@\LP;#%E-2$Q]KD^^_,91[);ZVG2ZXE[6]K+TA
M6?N2.UQU$C$H.Q1GF@3C<&PJ6M;Z#UXD,"^6/(B.@Q#>_[%(2^G4Q:T8N,6!
M:5\=2_MJE(7,:,UMN21C=HX]DB1V(=VINTK]89'#&XJ8V"A8N/IFI6WK# [$
M!%NYT'PQ[Y88C-&8U<10EM5VWNXTD*!+][T2X#L8"'IM F1!R+41RS=),&XO
M"9N;U3,%[F_I>UY+J4TZ2F0'4!,69FT/V[_XV32;A V:!(76@?FLO QLF%1*
M &W&%;UBD._8#T6BLSR0BS.XD>V]A09>\!<ORND<Q@@_1-1#)DG!=ALO8EIA
MG136\^?D6J8J].'*)1O']E$9R)7/Y<*7,. 2;+,RIQ8LMH/]9[5PT<FP<5*T
M''0&/[*$3P]1H@SS<T7YN=94-USW*7:04=*U%+LZX4Y<$MN>,PBQI'Y)!3JM
M:HQ9'_4%FR'Z3K?[),QQK+F-STQACA^F1HY^:9OR!;/$SB5G^6H3T$E7W(F:
MVKV".*)6)GP8-\CK4)O JTR:HA=PQF#[& O ?2#]!N3V\SJK*"S#'[0]&JLS
M78SIJ0O7%G#0+%Z"W\RY8(#ZP&*3&EW,X+<-KC3X#2-K29P[6!K]30[@$#$W
M\+^HZ^#P]:F)K9C%&VXE3'GM4BP-W%CIC9CZQZ94J4!H;,_UDE.F:T[LP+5[
M3E#4.M>*&EXDV"B(!!$+-?L[.*1(XP("?8B-RB9>+ZO29-'856LF5"_IMF9:
M]GD)7B^ARWG;DL*%($!R^"UZ$\M*I(#S3DWBVIL_]>=[.V;Q:UVP#9%4MD.V
M:0MVKM6%:G8#/7QDU;/./)@4*\L9F)#FC)J#MW2Z2_V%.\ Y<;PN28MGE@\C
MOI%BSV,%=@+>/>]D>B<NN4Q;> =Q/WJ?9WOXG#0O,0B;@,[E$*RTHH/],/;U
M1&RA</1FH*RE04'.:)HJH29WIGDAW5[8U9P:9G/FFC1N1.NE<3\1NE=A1S"O
MOPVI0;!D,+V^M#=V(5Q=&C[93EIG8(\(R$-Z^&&:@9(1"L%R&??84=$8;*0I
MI>#))JL+H_=;ING:*AM!]T"ZJHD-(=ME#<F)GN"_1$BH40(6'R\B_RZ:\"Q@
MI\<PK'-5F*:2W);73<+,_]^UHA:7&C&&:$X@&DH5^$'NW3ZG9R3IHM2EW3)^
M&S:@MR*<D2AY7:'EIO 0F/:&+-RX!QL\ $R[FJ+TK2<*#(,\/9>OEJVK)DOD
M.C+:0QWYQ]@NFGO$NHRVO27<!A0N<F9W!;$Y<6J; \(^).49=8 V>X!]$'%E
M(O[VTJBY$;9B9%@J;$5(H!.V\2LK3-P@L9C75S P*-MOC)B.D:3SX6'2<M"V
MM?X>G@[/E&':807/]K-22W%)+V?FS->&"4[JU6P/WE_J)T\R,7BKZW7IVH F
MX_.$^CZC5Q7TXB39Z/4^WH]?UP4N,P[4\\W(-.77K>J%ZB\WG0]K8*0LG?"\
M#+%KHS.?UZ\ ]TB<85#9'!Q,D@XB\V1V'K"U)>TWXK#<+IEVH&C(\V_@!(!<
MP>OAA:"QF>.ZY8F"Y=EU57HW# )J\!81I)Q;NUDQ#.ZS\J72AD((CRQI0'O@
MVS50[#00 K-%3D9XVZA[+0%+8X$-DK4[LJE[OVEIJJBEJ/P6%FG7=Z3/E_8Q
M_)N+X1\;_%RG6/$1QUFXP\Z>:;A#Q19LL(!I1;>YHL (06$$_X(]>#]D\5$]
MA4_'AR$*'9[::1P37<!#PAB.G1&,TH3\0HUX_.K#(#9=%9"/ED9DNROC=P>=
MAF&LTI'2&/1":-&<Y*8W%B\6RN&DV#E&HE*7K?E.H_#L9'^)GP1+W!*M\PWZ
MI:7AV$.781R_ID?0UP<$]2%YS5M4(4,C]N[.01%@"VF4]R34VY:J=8S=U@2K
M9J5XD=:8)HA^!IO<87Q&$M]B>X;A&J/W2F]M.PVE47!!@_&.*K=(E=.331@)
MD)#W85U2?UMMJ<L53BHU@D_6:&"*NC;O4NYA"J3;]MXTIY;E=3?QX5XD@;7]
MX$W&NI<V[_0NW^6SQYR##FAS4#/CJRS%B*%P$S;-XR5/S!O7_4J)]29&;V)\
M2Q/C9:N)4:DIE[#.$*SIN$J,K B,BX-'2]8%6PP=U6J[=?%R4^N"I=2R==!-
MJ[KWKK<D@@5XLD[GO+0ZI]-(+M-/IVI>*<I*X(N#&L-+U$ZG82RKJ)?[\4O2
M Z(P8+WG-GT9ZC>,_:&E:O4\C'[$I:#=%%GP5),EROU%./@A7(19HBG<RT&U
M/&,-JN#7Z%+#CA8E[6.G<314U4LO&$Z35WNG)T?'3MNN3-RZW%:G]X=A+(/G
M@7%@-U_T]1G (MB2/4S,L\6%"R@5B<FPY/@SQEI/CH\^O.QV+)'D*)ZG2<;-
MXF<S75$I. BG%%[6J(/=2/M?]8;>*TLA^OE_[>W%K[5*QS_%)W"07L"WP5B#
MO81O'?[X(OX[(F;AW_'>GG";C/6Y&<[E_9\;9L%3@IYU,D_D':,\39-Y"4,Q
M_VK8(\L(-V=_M%@5X1ZD:D+?L IXN0-U\#KXK+=P9LE>Q)\6<WC_49$,]>A%
M_!X\4E[6]SFNW\'!4_]KWYOOX=^6C]O/W\-*MZPY7,#/>T,2EC_%<]HSWQ:[
M.TMLSNNZA?&7$Q>:CNE.07JW>JB]<]$[%]OF7!R+<_$W$(!))MZ%H<IA, 3[
M$^/XZ(W\&8R#I,34PIRJPVS4#J$U.9;PE0OX\ZS<[S02,)@_C*J<+,4??680
M+Z//-(UA//'8]TO\7YLD6[=A4/6^7ST]0@C@4%47E.1LP#@<1DGB+Y>,MN/>
MY&Y-#G]8Y\$<;Q0U\Y[7:2"'XCWM^YOT^*";3]/BIQQW/B'O\W-Q)@Z7^&UF
M7 J$<<QV;X20(TV7Z.H1.^LZ[0<C.SR\+,R\*LK<:1S6G6Y$F56Z89AYU6&]
MHJE_#&X%!T,1BJ"Q;'7E_%,L1;8NDG>(418Q)+IK>)LY6Y.,'+W\ ER^,L!I
M,&404R.D7-D\8$P#BC]WV]D_ZUC%P>Q)^_$KD(8Q8FA,*,1'403SM*@ V!NV
M .Q?"3=]I?I=/TP_$, 09H_1C?/\8&\@=G-D22Q^Q012.D9$+!0"IU1G F.O
M&.55Z/)SR74EX<F8@Z<_9WS]?OR;YD4D]-RH+@II:07GE,%H'4-6RX%LR<=O
MZ/D&1_P^>;,["!!@^A04(@2_3+#E+<IX@\ P84I2$5(P84^AE$'@D?$"=Z3U
M/@4\+&V0D$Q-<Y ?+&,(P*0RA(OUF(O>9[ES/DL0VG:V^E_KC-G\!X)+4DCH
M@.)[[%/HWH__4'T+!6)- !9N#*;?K<<P\/T6*Z$X BS5-SEH;'K2*DMJ/WY7
M[/.B<T=AM"0O5+>0^6[_YQ]TX%;T,[/"7\<E]O[%,ZK@N"+G(R-F9EB$1_AT
MTOY(9CHO=(J?>4;<EYE7IL1.7O(%?!WR<#HC0G;[/X3U+3!!DS'@W-0W\-K"
M F;[\1NAU629$!Y/_ GWBU:=B$6I:C>-\]$H*2EE1SX$:%@*+ S<-\1EN$>K
M#4?7KIZ#,,.Y3MG.\!#.$GQ(#(LO0HW0Q<V0;C)D?GUS\H&+.<%(2O.<F'O0
MXU@&O'=.^^SV?QB::Z$]E5I5E^F7S+CS*3!<3HV[4T^;XB/)$U,H;]U<O 55
M/OI\C];:>)L8-\2XD:;*"5@#2[$=Y"C9R :A8",+*\0*K"F7"3L<-'$$+WEV
M]VBMP_PWN#B.46<_#DZJR@11)F44OA'B.5$FT,E_\,M$<K,!^/=[M,3.-1PK
MJ@75&1?KR9+]1-5%!,YSD9\L]UG.\"I0J5-25"ZF#(\@G9O$L,)Z5L^P4*7.
M*N;%*,] A]ZC9;8E:;FC8&"$2WL C"JPUJ\Z/*JD$!,6SH$0@M,_4;JBFKM)
M3I3D]VB!J0BIY! R5?X;&6#H).)ZGF>MA-FMFA(E!9>L60W(=6.*I,4]6MDA
MQMS35$[O/%F0S37*2Z23;U#7@,>-/(A&8(,[[EEUX=E?8:$\T!-88TQY),7B
M(6T#>3?W:,$](TUXLS/N54$193K>$J"GLN_59]@"Q4[K84D($R1M]_0F(=46
MK#+OT0)SN2B7>#M-9](P+KL3V+X@<RET2&(7K6UE6#_PS\9F8]]2ZMS(/Q$#
MCDO>J*8Y+^^5+^C['/<C^=#'F.]WC/E:.^)TN6I>[N=P&7%AQ-E&: L0<Q,X
MJ_#;KLB/99>UI3!O4]R%% R1U]V5D$_F>[\2G[WLZ67/MY8]*VI5B9.9*DF7
M0#T2' LP#N9[5Z6 ]D2>'<(?I\@"".9T&C]XJ4:?8;3_F<SF+^*3/-7)YWPR
M>3A8^M+)QV/SK4YC>8# IO),WO#[/^.WJLZF+2^@7!M2I)SJ&9CM_/E78P0"
M#>*W;T\>#MHFTY&@GN!$J6NF5RCD"K,55_&#UP7R!/++3VMP^,Z3["$F^DQX
M^4PMC%"7*)NIRNBF'TS;PK7L3OOQ4<K<AD1EAGJ)&P+&%TI]3@47%GMG"+&.
M756$J1]>KBVRN#O"AJ;DXGI B5ZI]$JE5RJWJ50:A?>V$).)'5?9CZY$D+![
M*TW"Z-N>KK#$Y?:_?TG;YAM8I?X*=KR"7Z-4MN(&/[9UW-BUE_M/.CR1"TJ6
MXGXVK23?M(O'13+IYA!F.6@3S<'I)KN4LTDD/-<>3\5/,6GC0&PBH23N6GIM
M7^-3PCGR-::++S"73*3)A=H#NQ"L+Z$G=KU++#U7-^2[J0CY[NFC>(:Q?4EX
M?/?<_LS T16O]C*J&/RDRIINL/-L:7O/-!;!$QN 0_:7&'U@&D^S10N58)-=
M(H5^1PS;IIBC,^8>OG3(BYVY!F.P-\27+OO- -DO%;.&\LMY[]&3(?) 6V0T
M7)A9=;5#/:IL7F$BO[9K&U,PW^FXD^]?Q3,L\IZG<'?KDI$8E!LG^'I'W+MI
M4F.9-H6#T\LU8-OP&/N&P^\K//=L_Y-=.$2R.1[\5P_!MH^T20X,I_-P#&6]
M'2:QL:8(^2&H4 :_H]ML2T3L<SN-QA\#R,5AH<?,6@M; +,SP\CG.O-/28![
M+#UV2EJ? 59T4'5%I['8]SMGT<X>H>(YM7:'29::&3 =CTXLC+0P L/T/-83
M\I:JK]\H8@=L4%3*R/;C7QT?P 0Q=I1-J8+SX?=&@B%=M4D@LG?C 0CI"@<>
MRR6Z>(@[(/Y8(_@>/_H++=8!_*^T&8#[ELSGJ>XHR62:2&0"[P\OIN276R?-
M'09FLD_(?\*U/G81.XV"./:;2HWFA(= S>;LP**00Y+<D/5SGBQ,9NMK0@P^
M#2BJ"^X'B!C4Z12!/!7IC4-8<<-)?+ERP8N<J:Y,+R-L[6"@@+C0K_\)HOX)
M[3C]\ZD3JTTUE%]DGOYQRN *&V)6&R^J)YU(UWJ+ D/191OEJW*'V*W)E;;&
M6#/&; D4BR$T,=;5LJ2AOB$M9UAW,P5QS\\4BD%.FZHT)1/+] X9ZKQ2(^2E
M1[S]<IC,VF1$#V*1 <['ZS2:%JW="E(/4Q=!^CP,AF%K#4H*=VVC1,$GM&>7
MKW!;/#3@TPO-4)?LZ30&#\"/=-+<686(B-4$]3UER?,AT9NCJ62:9- MX7:D
M<+XSY5$;DT(T[5.ZC.4XH..FFV)A8\@FETH#ARQ^8@6);T6'H@T;)2 P37=;
M$,^T7@)S4O+?I_@I!WZILRTL;C@TW:HBT<O <[5T(#RX@O-&I+M@/43N>8RH
M@E8LP59,L5T.PQ0:S6DZ"E0N+Z4S*D3VK#6SW+WU7*W@\9=RR$IG-7,DS=-\
MT;FC85X(.[M #B>$<\/J2^)Y%&BYP2'Q/9@7",XU92E&>AS[.#MX2->3,4M2
M'HW\FVMD3-*T4')-%LL%RGX5=]MP.CLPM 2@16V_8XI4X_J?Z7EIK9U&7R(#
MB*,GC,=:@$:V04ZW?7%<T:XO0OM!N#A3]&$<=5N%E=<TI3Q#L%W'*X.U'0:+
M:I&_8H -R0XVW! .]+IJ*_;C-ZRXKTBEU62@O[R^S(N%,-)0)I2X3]AA=ZYK
M;D(>6Z?LQ?S]D-\=SFOL](1N)45S.2'4<R1H@@.YA@&*DSC_(41-+B1Z.6D8
M#W0(3D7GR"D325TK24WH,Q\;._@K [XW>,AA0%==\V^_W#]^?_C\>[2E=F-]
MX6+@;__W?QPVV=1V8*W_;CQ-FLX[$\'8ZI5G]10(GJOGI%:)J&W9H);I;]M^
M]$MW(T)D6Y;QY/M76[V&MR(.=D>B"WDO30#91[=Z[W9WF4\7,[!.=V-Q=]I"
MP5QM+X"V1AOLDE+ME^[;VR.%GIY5]VP5;T @O(B'(*&G!99W8U F+V!II\,'
MAX]^&!P^?CXX?/+DX=<(#8GI/#W\2RME][4MUMLWKU_]_>C]IZ/?7G$LY</'
MDP\?CSZ]^?#^J^%S,H?#OVRK>#&PYZ?7.L*WK_]^C];NAL_GM4@7?Z=O6!H^
M?KS_[-I&>\-K^^4;R,A_G.E*79<U==T+\L?[-Y]>_;KWVQ]''W]]<_2>^Y^]
M>=]@;-TV[7;5M;S6E?OM3B[13LBV&Y5G!X_WOS;L?_>$V'4:>C>Y-L>___'Q
M^'<:&U<3_OJ/-[_]_@F,O'V0:G?RQE[O\OUZ)]>HEVJ/'^T?]%)METRSUV\^
MH:M*@WOY\>C]KZ>#N)=A&ZS;I[>O[^0B]4+LX-G^DUZ([:AI]K<W[UZ^^OCV
MGWO';X\^_LV&WN[D5;W6=7OW\DZN42_.#G[<_[$79[MDDWWZ_55\_/;#QP__
M!;+KW<G1^W_>R:MYK2[EV_^ZDVO4BZ_'!_N/>O%U8];8UAVG[;R'USFJ=Z\P
M"7(GEZD75X>/]Y^O&:'WV6\AE6RETXY7!O44;NM'>R_YHZYMF!T)H&P/Z("_
M;>"H.K ,M94I4_H!7R?'H]<IRJL9KS336-KV,%3IC.6A\R*?4E.8-763W3IT
M6X)EGUARG(]J8CGJ:25[F=3+I%N320=/5PFE5H$$'VOE#&9B&:3/[32*D&IW
MA;1;DF W*Y':7L&M0)<I:%IYVKAW]_'IQ^-NO HZI>9H#7IB)BDPS'C4=FV)
M\J.7F;W,[&7F[<G,9QMUEEA'M\E<@8:VJ9L]1W0VIG'Y.DI/PXDD#>R<O.A,
MGN'HA"QG5@*GM\+F3"N(RX0?T5)X(M$F+I3CUQQTXU:KA\A#YK7X%#*/)#XY
M/OKPLIN,OF)7+<?ODHSQ/+IG"=-9^8+[UJ':DGYL3,"D2^PG;UDC/=/[HC//
M"SS.6PU+S95B!\YZ[@Y(2'ICNL"]D*9N;BYXB'!-84FOQ,&#W\=:N1%V2I&N
M6^=,?<.3%^[ZX4*NASY7HM8<C6%,'40->5Y'-E?9<IS:^4->D;HXU^>:.GPQ
MXPU3RHP*Q:W7,I 2<G:Q_3'3-Q&M&O>IPM8#X"SEW2ZG)?USU%Q-ZAW'LP?'
MI4KX[G+[5#TC$D6DVO%XDHZY<>*+;IT79!W6LP#Q]N!/!9%MX><N\H"<9T;4
MQ25L,C*O5AVY(2V'*5M6< SL QWI'&S;N==ET&_BBZ/VKW>6Q^@O=KNU1,WT
M/C^7CO?2FX/>"J^M,TV/I$9S(#!+.#85=_@[.'R$A'>EH<7TN,=>X(SP ?IA
MI[&<O#EYY?'&&>947R"TG*&5]&Z]Y==;?KWE=WN6WX^AY:>R:3(%N? [#.MO
M=1:_32[B#Q-0:#"8!RCH#Q^]D+_13P<O'A(C+)+A@4W0D?\/*4K1Q"/ECBUY
M4G@="58BN1V#A\B_5E/D*@RZ0*P@J+Q2,\;UU&F](.H%42^(;CJ5\-@((J\#
MKK2%:H3/!@@3.&MQ5;.\,MR,?YQV&@4+&&D(5KHV $8<:B>I3'Q?')65C::O
MY 59TE]XX:2FQA$>[R;[V#X1I]"!PQW C$-KLZN.[H_?.+>UIQGYG'6?U>C%
M8R\>;UX\MG98U5E5Y& <201BENC4&FR-WM<KDAL=F]W[R8HV6\S(&I!:QV<@
M!'OAT N'7CC<GNWT0^C$M<F'WXJD'F+D[)U.4U4T^[C^L7^Z'UI!W8+9V.]H
ME:C!+.A<&NTHBXM(@G9,MGO6M7"H5V>:FCY]6;@(^??P<SD'=[&W77KQU(NG
M6Q1/KDD@)I%,^U_ZWY&>DS,E6:15_IZXA-P8I2M<S+[0-(>Q6(AZCE95:?H+
M6(08>SCKT!@.8=%9-K783]A<R_J\/.,0NV)@'!J[@Y 0P]R.<5>O8LJ99L\K
M>Q7:SC?TDP896@[$/?4;@-@V5)AHZMHDIU!Y,4TR_6?"C3ML;Z2!S3X.I%D?
M.]SLCL=)C D%/=%T<EQF9Z*+65?3ML#O8MNN2:(+VF;I 3<(NF%+N-'+&TL#
MI92;G/,HT0C&_*--T'9+"+MD+K8U:XUQ#$R7+62MM[&&2L\$1U/6PYFNEH=T
M!>!.Z8*J"/T9."R1!5R&N9]>K?9JM5>K-ZY6;=[WZ>J(J:=HQ<1?5JI&^U'7
M)X)V=&W.XW>#"D02ZB==F9:(E]KWO>#H!4<O.&Y/<!S87$LGD6&;.N:F/S)>
M?A$C71._ 2A9;!BRM*BOYDA1Y^;E3I[8H4]AVV)CK X"T_TJ;1K7V_=A30<8
MSVE>HHU<CL[4N$YQ>XQ=Y%!\78?1YA/<)YD8_?R_]O;BUUJEXY_B$S#Q7\"W
M_UWC.L"W'H,$PV8V^.]X;T]*-<?ZW SG<L;[A@!\2KVV.@GBRYMFL>1=FNZ:
M'EH@/UM+(IVH668M#UX'G_46SBS9B_C38@[O/RJ2H1Z]H%81O*SO<UR_@X-G
M_M>^-]_#ORT?MY^_AY5N6?-")9_WAM25^B<0'+AGOM:Y.TMLSNNZA?&7$Q>:
MCNG7W=,;UQ[7W3SOQ@?<FU&]&;559M23=NP<O'E8Z#%(@5,U M>,'*$JQ\:V
MV%XV3KQ.]K8?=]?^SM)(G '%+G8UZ;VM7DST8F*;Q,2A2W]@A+JLI#'\9NX'
M]BNF9N.3(I_9+&ZGD7#&=W6*=F5E+#HV@BO9CT_K84F&8I4N) K-WF(WL?5E
MA!V3031E]4P5>5W:ONCHVC&H#5X[R\=41D.-KS=;*C\]@>5AML4R%7HHEL&E
M*LY56T/IJ%E*,N"Z)Z^^AVM+O$*E1ID15P5)Q2R7) 6E;9+3:.01<+9A'#VR
MXML5FXQ&:E[Q;_R<$%4')<SI8KUJV!:_;@V!BM2WVFB+2TZ<YO7 F#^L(19#
M55@N @Z_ZLMT>U72JY)O#0*\<M"N28."N<$;BIBUX /'=:&6(,SQI"ZZ%ZT*
MX!G'TFY*;Q0X3-(<U!Y(8GA(H4$5=<SECT"O8K87;I,>]:"B7A;VLO VS>IG
M7YW$(+EJL#Z=);*5I!M*Q::T\22(U);T(J07(;T(N7$1\JL:L0AY\M42)!F?
M2]T[NDQ=!M$E!D!T'.PX>QE7(\%6T81TA'PM4XKLQT=P+W$L,.N%B7(6& 0H
M;:&=\3(-O!NV]%4V375Y9ASZJUB8.@.'&WUW>&QIP>+TPA&Q7H C3GMP217P
M>F<U^K:W/TPMW?[W5]S+9K[K6Z_2E81B+P4O^X^5@@WN)P<0IMOD$=$\E*LI
M;&X50F<-/9 -@YUW$X,IR+9RE,R5(?%I.FYSJF2!:P]2:9H7():%$X?9?F#\
M2.!$I6<J&9V9SW4#O** =:C60I>?"961<T9EE&J.Z1'T6J,P%!PLN+!#<'*K
M!<DMF 7A\,9J1F1,DUA7W:1PB>Q9J>"AV8_6H!DF(MYD+1!5EZ;YA8'>J<SR
MX1PC*F?OX$=086#,S3#[3V'"\VZ<+DN%OV59S^8<BZT1+YTNVM Y3HG 2/_%
M@P8M8@.68X0F=T09AH#CL1H1&ANF*ZM,87%89WL>2I]HJ+D<6$( 1F>!-5%9
M9[P0K,!,P[T=Q<D0 [GX6EO_K;[ 2RBD 4^&P5+,>!"7-98LP.?P:."B(4V3
MW4@N(N\T"K!A/ZMJ$,]5IBJ,(:,'DM&JF#_1P5'G*D4H.[^1_T3L46!&9%CD
M#N_.)Y-2L7U1UL4\Z1@.HKDM;P[J9',Y99>DOF.FQ^.4ZPO0&Z*X-%@9)8:P
M55FGUB!"5,DTI\MD0T4#CXEMC*D!5/^5L&!1Z)UH0T#OP-Z:9&N"5AM3O%5@
M_"NZ/$7T^I\@\IXPQR?^\ZG4EEP8X\*RPLE)QH2%(@(ZF!:A6DG:+%12M-@5
M4>^W]7Y;[[?=E,5R<' MH1\G6FX8-NH"/2Y#N&\R>\C@84K3.AHMX@GB?% 5
M^<0@9+LY((K#ZC=UMA\_YXBZ_59'Y4A54QS?;^R#/S")]]L8/E%6]J&P7J3V
M(O6;BM3GWSB:OH$X!9,[)81&4)@)XG@YH,[UJIT&X< C+6C\02@9/:G)G.:#
MU0E',&P=U?D5F R4E&-ZU9A(L>)C"S^J:0V:!KQ>7#UP4<@-,71]".0P7'V]
M6.W%:B]6;T^L.NR?X6<B+)]-'\9O2=;\"K+F5XN6^)M:Q&^07;N,W^JR(F\S
M8&OI6*9YKM7%C5U\^*C];W_]EZ__=75&9 F &[IM%_CZ.NG=II2YGGY_-R=J
M6D2(I8! 9X\*MH5<'AYVIN!/X$Z>GFE\!R%W,5+U1Z;)$!F0NY@E$S0FF+_R
M3",?/)AWBT%,=4^43D,RW_BTGL]3,KS0F')6F'!>'B=S70FYQ9L,">A+Y4.6
MT5!IO%W":V /Y86&*T)!]."M8+'\M89?FN)4]B3E56VOL7PN&- +7D>,Q*-_
MU[I0\<'^CT__TM9$P5+EXQC*JFQE^$C RN4!<$9R1ITNKF^S95 1$H[.45*#
M&0MK@)%8ZK@!(\O3FMUS,(*#73<F^4QQ8!?W7/H25,AX+PN&AP7<?UWR6IOY
M#!?QQW<OX\/]'PX.3?^*"-<-,PM2MJ]+;]KXC6"5]^''"W6.7&)RL<*_TV[#
MD4,AS'S.5:&'M8"0W;K*.)-97F<4 %X:5RS]W 9Q!N/"QPK1=%F/$,,XJ?$Y
MEO:,%V/!)WR/3KA+*./,3!R9JQ<=3]&!.7E'HU%.X1),>WM>D%U?3$3C9&D4
M=L*P.ZETH9M(!L(>O\9Q"QJ+5-PG"A8IO,>TI8U?76CTNNH4[C&W([%;2V,Q
MRVI7FY9O"-**SO1^_"'SX:0+%U1?<>;HPY>=NC0-/D,C<4?17Q!=+%\\FCSL
MGP=8#R>]WUR$ZHS*K7R9E<6O^+F?Y&TTB'5"J14GZD^#Y\9R9$SZWB+YFU-P
MN[F\PC20Q@1<4YT9\@^-XR/4]JFB)QV593[25@;9!Z_M;]H;<;T1UQMQ6VO$
M!6!5*PS>4586S2U5G&N*VAR-9SH#B6ZJ@[CP9EE0.=YQJJ<2/>!S@I%R\ G6
M:$@MEA#'NQS]&RI8TZ]F3.G9L2I'H$T8;S6EAD.8VJV06%0E1:KA1\(%Q#_K
M7R3L=/K'NW=''_\9?W@=?_K]57SR\<-__3,^_73TZ=6[5^\_?0\_GYZ\.OXD
M1.U[\8FH6+$Q6^.!>_$';SXPZ%,[:)@7;,]QWI3JAP<O0$CJ7S"5BX7YAX<#
MEN)K&4)9:"\O(=H1>7HN,4C,!A?SW)F+- *G4E_^_8W[X?>_M:AS1QYBE20\
MQE,U-(XUZJ9%6?)EYO__$TZS,07.M/->RH"KLR*OIV>21<*RN72QEU]@K+6L
MAV 2ZP21-[PJ0S7*9P9[ D_2V/0M1IWI-Z?RAL@$@HC+L,Y'/E<"7>#/P\-;
MTNB]>NM#E%NI=[98Y70/41XT0Y2<51XS+,B$*Q';E6X2KNQ3#/W][>_O+=[?
MP^7>K>8F2_OI2J5J?I9G>G19)VJZW]W&T4T6?&LP>0^Y[V_TUM_H!J^0+69)
M,K\YL?4ZOGOVQ$9*+6[5*/&OIJ+F_&% /1$VA,I-I R1;.:U;H S=!'F$MKJ
M"G;^/:]+"L?%O^7Y.#X^0Q W18VY"*$5>]M+F%["]!)FK83Y<2FGZ(< _CAM
MM(+Q@_E^=9TG>;HVE0ZD6)N=T#L-O=/0"X#K%0!_3;(:,_KL\O_P%6!/'])M
MP>4W ?ILHUS>;R<LZP:N1&O%%1*Y6F9GW03(3=OC#E/U2(FU4!7W")W4*?6L
MD8!Y-]0I/!4+ZS"1ZK/B)#,LC_(SSP*PM9U0OLP5V%XJP,(V*[8[[P=L.*9&
M$Z[T ]F$[-P2[,8&+P2^E9=1)KV$@VU"P=?<)X<+ VRW5:]1C>D@UA<)]%JC
MUQJWIS6>^%J#7=.7R* XD+L*,C2+WX$0^H?2\5NP*6>*4$.K8T[7K# &C/+@
MH<%")%.G1]ZWD?*Z'F1]^Z)>FO32Y%9MT$=&G(2][FQ*O+79G0EI+\N4;@8&
MFS9D85DR@%ASY#IL;+1>Y/1"HQ<:O="X/:'Q_-O:(,3$Y3/OMQ%-?:49THT.
ML?5Y3)JEQE[FOMG>4DC%P*NS)9639$3!?,?PTJV LN+636E=6K*N8(G>J6(*
M6W3L@^P'A#;#P0V8RB7Q661R38CP3L/ ;,7 HLAH#WQ0+Y45%(HX8I9.$<+5
M,SUC$+Z%WOF3Z#24OOM"KS!ZA;$ME-F;5)BOC#DYXHY.P^#>FK F"*1]@WR1
M')X;4+G3DE);:O?+)BD:O'.R5V%H7"R396 /CZX2<S4ANXUH3$)IZ8T91^N-
MN6M[89K2<5T4N/(?J80>G_X:V^,\W_N;-S^NM^ F#)SNOH%8HP29S>L0T%J@
M @K:-UP6>S!(WBL>%8]/')>\RK&?A8"L[Y72N*09X$'?#/!ZFP$^[YL!]LT
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M,E"8!T".%)#M47U59$]_Y"9 <K=F1AR/-35:\WY8X5LQR^48^()WIN>5?91
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M5MR*FNRGS@HW[Y&!#W8<DIWJ;7*C7-'<V":W JTTZN6D5%<K$(;'CG#K&!G
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M3=([3/N=E;R[<_??'3C_W<HI=5TP8S<7FK\YM6XU*6]K.^CN[CY"$HPCO@5
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MU"346C3*W291?*EZH1RXFH8YTMTT;=,ARP<#6+("-:4/IU&"F@="OTCP8!!
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M?P(16((>3:<6CNB8@23J#$N=XRW,FSBS<E6C$VV84P@W%9<96*ML#ROYR*(
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M QB8MD,,A]),F+1G T%FHP,CTX&!9A*!^!87"B/,MWJ"<E["&@,D$*G>:/:
M!6)/ADO:]BZ+670F$H9$$WAGA?Z3 D@J'L!=3,MDXMCG#V>?#P^(-)W4\PB)
MW(SX'QCHN$$E0;._#XJ!X2ZH$HA^6)2:J1 8''M@<T+%*Q2#J=]U%:; U*Y
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M3P&&QN&$"R3X#3&*6"!"#UA&:I+B:B]^Z7-3/2J:4'"*;Z)?*5=CB  !8^)
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M.Q1)U*[*JL1]T!*O8FZ?ABWY2;X!9'QNW!.5I#7KKB]D,K5Z)^"6$SU0FB#
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MZUWC+9JGOJ<T+F_C+:EEQWM'!_[^I[WC7P^T-C9?96SZ1!=?(;N1"N>L?9_
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MI-T0M:E!<R.^1LR*-)67V8N^8I.5..M-UK3QV,'U/%<EBQ]YZE><A3'SF)$
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M9Q%0%/Z4K014U8LUNKBDTDZVQ2X?[)6[M[$G9K2Z::3KM@S7$"W-@PH^Y%K
MJ=@A+D5L?"=O',P#KB"3>UB5%J-@5O4EB[T=[AQ5<+ 2DXO0CHSN?B[/._F!
MD'L=DD/;8@>Z=$DG\Q^4$K&Z5'54&)&HM%"J):[*K"PM507O,[OGB$0]\$)M
MQ?$B+N7<%%Y-T4D8C3.OE*>="'_IB-RCPEF 5/SLN&]=S@@OKLA]TYK7<;>E
MSH)*+RUEJY7"?^= '$]2.."G_#AI3&7,^;+C\,C]DXJPO.*Q^BJ 50GF=VEH
MAU\)2BS[<CJ4Y7^6CPO*N0VKZ[NL7W.9L%7)H0W?54LEQ>U\'XB12.(YJRE=
M7#;9)S)673H52JCC<U'[^#M69D+FW!4![4W%20-&4<%<U&4[E3L?7RIW%/("
M6>SG:[*U,17#YQ7KV2>ENA?4;4/BA&R-4(PKG$K_NH$.B3YG5)"B6)&6*G!=
M\Y _T_"'U]GNYT(Y?D=L!12#(/[Q*OL2<LF;C[-QS]/\+&\]Y691AB -XCDA
MON4*&BML4>!G&),6HV#&=$&*5]H\W) @+.-.3IF4W)D4TCS$32ZJVNZ11_9%
MQFZVW?25(N4XF/@BD;7ZU-_98#/A]6I<[*GK'PD]B.J@Q(&X.EC8\!95:$CW
M<N 9;IY[1%N$O&(=#V!YD%^L2;=VU7JU)G-5+4[7OC3S4,4=-3+7S- =;*CI
M. JQZ7XE,R6=+Z585NV\7^9QQTA6]Z&%9[:GL\VAE6K3HY(RN3G)I6&6L2UT
MR^'+/+H!1%HE;U%,_*]<#6GWB#Y)"CHFLZ'LIE!6>BSMS95ZXY2"2/FV[-AL
M$EX'8B4ZF_ +5[?AE'*=&!:HJ1:C4->&5'8-3T5[QU/4^8''.W\>I@S3O_Q\
M6UB<MXIMDKLL@KA7#1AD*%+,^5P?) UI\4/MT<028BKZX3E$M)2-X@N.9O%.
M?.//) KZ>53"1;]A*XB(,;&Z$2YB%Q7J>]F_N =A2R=F;FIQQ:V"0C7UK81Q
M*W,QD_"?"PZ!C2!_4#$4*P1!Q<1^];M<( H:]5Z*%R.^'YX=KR0AFSL_+GR(
MV[+/V8(GHH6SNVAR5[ S%8*5<P3+B6>/3__*\S@WYS7S%73&7"O)O8E[4%[.
M9?M?V397EAN8'!;*09 2BON4J_M:8^;=$G<6T+8<I6Y&I36PC6RR.=&KVT"B
MUVX3O?I(]$*BEX4\8N H1%0BPA Z.'@7\89.>?A!;43RED_B:$&U?"JXP$(?
MG+593MF:4WA,2G#@MX>NQ39G[MR<K<)Q[LVHIL ]I4@$$_+-@2=KKH@-9%^<
M!,FC6^Y-U^73>,H[\G/;PF4OIQ"#'[EKQ?&5]HH*'E_6!>>;G(OX+N0QA>H!
MRKMB\M_R(ZS)O=RH60Q9C!$RIWNX7J).M4271%@^M.9"X4=%61J.R!L7T4*^
M^/639#&EC3BZ(1O,F2?C?V2+80Y=+'GD0RDP4+)35:F61WKDGDP86@KB[@*5
M*;]F(X/NO\I2_:NW21=Q'"AM"$N=2)TU(Q4K/#%/=!*A3B*+H9O*SW%7VXZJ
MU7_%B65^D)X=2#C\:D3EEF.Z\<Y7(;I;S/+Y6#,FD>B?K GU^&YCZ8M4D'8=
M)OY 50F?;VR,A?TDQ;U-U7K5IYI0[HV8W-+L4)0ZIZL:M'O)TZVR"U /ZZ/G
M"EWF"2LSWA2!%/EA4=@8AAHXBA-GE0EYM3QQ4X673Q"9OJIE<>)/@HSR^>J&
M5(1:T!(+3LI^)=O>H%Y)J;H"SS6VU&19INWQ>N'1UUD0)[?AG%_\9#HE.V_0
ME7"J%GVO$HM%#PXJ8"!^\OB",F^8FYU/D/IVJ86B++T@#2B-V+*XL-KCW2><
MXL4>W@1#U=#@-_OE4C;/2"Y[47%57VU0C?+- 7'UK-QV9+GJ@6@,?<?EXRQW
MW5//%,M^<6127/G#H/08A=PEHE+M8I.(7P ;NU>2)@LGYY7;WYO*T'!/*XO
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M4<M%)(^<RT#6BI7':EG E1?"+WK7['WGT9';_(6GQ&T&QH?8>LT&7YBZ=_*
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M4]W!?1O!O2W&V3_VVKVFU^W"!^PW)O@ NS#!!UB$J5[C[#';[+2\5JMKJ?B
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M:M$!$U0,F+3 !!6S"I,I"PE@@GD"DQ:8H&)688('L L3S!.8H&*ZBDY'3/
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M*?IS'J6!Z2(WV'P_QR(6%PEI9[-1- WR;#33)\8@J ;K$%R GE!-T1^X +@
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MR-D$_YN."?R/6[Q:38W5F)!: 4Q0,5U%!TQ0L3W$A)#>+DRUFV>K=7QLJ_"
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MBNDJ.ATQP0/8A0GF"4Q0,5U%IR,F> "[,,$\3;N.JVI0MW9<@_IO 4U^,.8
M?38N_R9PDUL_9@^)%FF2^C-ZO^>.HNDTHE=&HS_<9#'\1S!*W31RYU&2A,-)
MX,;!.)C.T[IZE.]ZX$^L>-XZ:E')\W&T8&,63WUI1:X1=[T\T?,&C8;7:#0L
M41C[H.J(R1#?9= L&P151TS_G[UW;VX;2?)%_\>GP/;I.2%M0&J2>K=['4'+
M=%M[;4DCR>V=<^/&"9 L2AB3  < )6L^_:W,>J#P($7*I%6 <L^],6V*!'Z5
ME:_*R@<Q)$$M0JW+@:E&E+81$XG^*X9J(R9B2()*MHA$GT3_=4&U$1,Q)$$E
M6T2B3Z+_NJ#:B(D8DJ"2+2+1)]&O<7'[YDGTSD^"@4B%"(?N,!C/4C9T0Y:J
MEN53%HOLB/D)$90'\5/TP\+^%K5)@6CMMCL-89/F0;41$UFS5PS51DS$D 25
M3E8D^B3ZKPNJC9B((0DJV2(2?1+]UP751DS$D 25;!&)/HG^ZX)J(R9B2()*
MMHA$GT2?&D 4Z?*L!A">&T;A#F0ZL(G?'[.:<D ],AT:U/&AXW4.#[T#ZOA@
M+50;,9$->\50;<1$#$E0Z3Q%HD^B_[J@VHB)&)*@DBTBT2?1?UU0;<1$#$E0
MR1:1Z)/HORZH-F(BAB2H9(M(]$GTJ>/# A(]M^,#94!0KX<55['5\EKM6O#)
M=BU0D@VS 69M=KE&4&W$1 Q)4.D\1:)/HO^ZH-J(B1B2H)(M(M$GT7]=4&W$
M1 Q)4,D6D>B3Z+\NJ#9B(H8DJ&2+2/1)].O6Y\'&O2),C1(]PE1?3,1BA(E8
MS%;2V8BI+FX_82+Q)$Q68"(6:Q0FL@#-PD3B29B(Q6PEG8V8R (T"Q.))V$B
M%K.5=#9B(@O0+$PDGE3"OF0)^X/LZZ][^D<C-XHY$#]^K.CO7].[_5<+M2::
MH/Z$IO8+/Q?W9AG[H.6U:/J$M5!MQ$2:EJ!24BV)/HG^ZX)J(R9B2()*MHA$
MGT3_=4&U$1,Q)$$E6T2B3Z+_NJ#:B(D8DJ"2+2+1)]&O6^'[2Z5'C*,DR7K[
MUW2#7RU4$OHF0K4S^Z$APR?:K=T#FCYAH>39B(GT*T&E\Q2)/HG^ZX)J(R9B
M2()*MHA$GT3_=4&U$1,Q)$$E6T2B3Z+_NJ#:B(D8DJ"2+2+1)]&O<7<(&[>-
M,#5*"@E3?3$1BQ$F8C%;26<CIKJ<  @3B2=AL@(3L5BC,)$%:!8F$D_"1"QF
M*^ELQ$06H%F82#P)$[&8K:2S$1-9@&9A(O&D:G9!E^IJ]FD<\6_&$[_<]O^U
MM_JW$5--Q+E&NUPCJ#9B(H9\Q5!MQ$0,25 IN?7Y4.ULI?)3<6]6A;2/O,.]
M$Z_5.6P(QQ!4^Z"2%22H9 6ML"9UQ;UA*WC@G;3WR0H25+*"]2=TC:"2%20K
M:(\5['C[AV0%"2I9P080ND90R0J2%;3'"K:\HUI'1%]OZX"GDDI"EJY_8(*-
MBLI&3#4Q_(2IOIB(Q0@3L9BMI+,14UU.'@W'M' VC162N=7:[:QC[,P:(:UC
MODS#^8K4/F$BM6\MIGJH_7V[B$9JG]1^#4AG(R92^U9@JH7:WVO91312^Z3V
M:T Z&S&1VK<"4SW4_H%=1,NI?7VS^UOJ]\?LK>/\,54OF?CQ;1#NI-'T=[?U
MQI7_5+?.K8PEIKF?B16U6T\3_LD7K&/- .27M__I]+X/QC.X-W=[?AQ&L]2]
M%O7_6PEC[GF4,G=_>U?39OJ"I(#TE>(K-IG2(DATQ48L=M+(3>^8ZP\&T80_
M^1$(%G+B)*[\RRST.1GSM^"C(/3#0>"/.1 _91..+9E'RK6Q1S4]UK,1I<?_
M<Y:DP>AQG?3.T^<_=G;<#P$;#W]W+_U;]H;_[%\S%@[@ZP?';]R__/$,_MO=
MV9$Z9!C<S\F$>8>9,&U("W&3:!P,2\0[1  H\IQRX[%,*?FO7UJ_X+\YLH'Z
M=_X=@V@\]J<)AZ+^ZXW[$ S3.UA6ZV]5Z\R21HJY('QK\V0>LQ'^0JO'\A;G
M7L>_:Q!.D>R->_,XY>_OQGX_&+QQS_T)$V0]CX!^[?T#\V>_J=_!WS*MJ%3B
M'[]Q2E?0/&;^MYT^XQ+ 'S[%/3,YMCDD5B*UB# F.8'0R*:6"V#!HZF;QE@?
MU/7;DC_Z;[^<=[^\/[OIO7<NKR[<#Q=7G[ONZ<7Y^][Y=>\]_Z_/[\[.^7]<
MWW1O>I][YS?NQ0?WXK)WU;TYNSB__N.W?KV66SO ?$><FX\]]^9K[]-?/??S
MQ?G-QVNWQS?HO?NY>W7ZT=UK>VZG!<'JG["T]3A<3WN4X@<KJ>6E#Q++Z>]?
MUIM)N<:.7.UZ9TZ_,'R^V?#I?_W269US+%L*P2=&HIVH/7S-2,?%(T:^9B)W
M4EP^(#5=F3X_P;]!FESS)_IQ$"$EEOV_MNGC( GM76 W2683SFF(DQ]JK]B0
M3:9I$(6)L8I&,7/-X6]2%G^F-'7^Z,>_B64I)G0[!W^KY, &;5_-X3>%^_8J
MN.^(N,]R^$WAOOT*[OOL?P\FLTE#.7#]A9\4KK $OA;*_5=V.-CJ;M?(TW\7
M/;!PKD]?$2IX)9OXKDZ;*,3P[X$?_OLNH .:E? W*4H;7M5-[(>)/P#G0S@G
M@T$T"U-P3[I#N(?$A(PF;EHSX->%SR!)JHG;4&/1OXS%T43D89V%@VC"LB2L
M)FY6S>'7F-?(S-0;?EWXC,R,=5M"9J9F\&O,:V1FZ@V_+GQ&9L:Z+2$S4S/X
M->8U,C/UAE\7/B,S8]V6O!HS4[.^S;I,8G__;VNDRQ6[9^&,>8@J9.O98%70
ML4Z@:]39FX"WGFI[C6RSA?<[UI+1\EVV'%ZMF/#(:^VUO)/C$VO):?EN6PZO
M5LQ(&M$:>'M_>_'C4\,H^GK%FFQ,L^'5BAG)QE@#CVR,U?!J)=9D8YH-KU;,
M2#;&&GAD8ZR&5RNQ)AO3;'BU8D:R,=; (QMC-;Q:B74=;<S/N</_>A>DS(:!
MRZ=1DB**:.3&XN+>KO;I-O;!K\F8BG5851NI1IALX*ZM@\,3;^_PV"[BT9"=
MIO 7::^7VDE[77["9(-DDN8G_B+-WPQ,I/F;A8DT_XO#(?XBS5\#3*3YFX6)
M-/^+PR'^(LU? TRD^9N%Z=5K_MK575>6JZ^WXGX2Z58;@RC98)5]/;M0U!.U
M_3;8!B:I$53BYTU:KHZW?]SV.IV#6G#+.@XSQ-,OCIIT=,-T](]!K<MARP9*
MD^8@:TC6D'B:K&%3H9(U),UAA>8@:T@\W32>)FM8,ZAD#4ES6*$YR!H23S>-
MI\D:U@PJ64/2'%9HCCI;PSJT+Y@K_^KC,1NE<G%KH](?_;=_QE&2(.9I'(V"
M](_?^F]KL<.D#\B3(/M&_+RFA>QY)\<M;^_DL"',4B.HQ->DIYO$SW3BJYT,
MUA,U643B:^)KLH@-ATH6D32'%9J#+"+Q=1/YFBQBS:"2123-887F((M(?-U$
MOB:+6#.H9!%)<UBA.>IN$6O6-L9&&2=,-@ABHTE'F(C%"),5F(C%&H6I+@<)
MPD3B29BLP$0LUBA,9 &:A8G$DS 1B]E*.ALQD05H%B823\)$+&8KZ6S$1!:@
M69A(/.O1!6&]O0TNIBSVTR"\133L^Y2%"4O6U.'@U?$/B1YALA,3L1AA(A:S
ME70V8B+_OEF8[,\&MY%JA,D&[FHTZ6S$1,J_69A(^1.FNG)7HTEG(R92_LW"
M1,J?,-65NQI-.ALQD?)O%J97KOQ?;ZWN-1N/U;VN'P[=B1]_8W#3:_N6-0C3
M*Q<^PE1C[MK:W_?:!R=VT6X=$[QLW$H;,9'R:@HF\NF;A8D4_TO#(?8BQ5\#
M3*3XFX6)%/]+PR'V(L5? TRD^)N%B13_2\,A]B+%7P-,I/B;A>FU*_Y75I'[
M)PM9[(_UI:T_G 1AD*10HWO/[-HGDKOGR]W>T;%W<+)G%_'(XVH,?^U[>^UC
MKW78LHM\Q&&-X; ]K[U_X)WL[]M%OJ9RV(;]^JV@J82S$=.&1?/(.SK@HKE'
MRI\XC)1_XW:3E'^M,9'RMP .<1@I_UKN)BG_6F,BY6\!'.(P4OZUW$U2_K7&
M1,K_%9?C-IJS;<1$?2D($[&8K:0C3#:PV/&A=WAXU%#2V8AIX_X\.?2-$<Y&
MDXXPV<!BI/])_]>$<C9B(OU/F&K-8J3_2?_7A'(V8B+]3YAJS6*D_TG_UX1R
M-F(B_5^/ MTW[M0?#H/P=D>\X7>WO7LP7>=>7;&$^?'@3A?N#MD]&T?3"9?P
MM3#:IA?P-+/UHWC(8@V@/^:;)&"X230.AN*9+\V.&T-M?XL,&YBD1E")GS>9
MC'1PXAT?'=>"5=;A,1%#OSAJ4M -4] _!K4NC9!LH#1I#C*%9 J)H<D4-A(J
MF4+2'%9H#C*%Q-"-8F@RA36#2J:0-(<5FH-,(3%THQB:3&'-H)(I),UAA>:H
MK2FL63.#N7I ?3QFHU2N<VT$NXE2V<X^FC+H8A_>NNS[E(4)2VJQXZ0<7KCA
MT-HZY9.C3!QM T?O>_N=CM<Z64?>-?$T\;0-/+WGM;@7USDBGJ[/"8H.@*0]
M[- >1]XQUQXG:ZE$(NU!/&T#3Y-%)(M(%I&T!UE$6U 23Y-%?'T\31:Q=G)8
M3]1D$1NH/8BGR2(VC:?)(M9.#NN)FBSBRV;._%C3&!N%FC#9('F-)AUA(A8C
M3%9@(A9K%*:ZG!P($XDG8;("$[%8HS"1!6@6)A)/PD0L9BOI;,1$%J!9F$@\
M"1.QF*VDLQ$368!F82+Q;$HCA#62Z(_^V[/STXO//43XX>KBLWMQV;OJWIQ=
MG%__\5O_;2VN["G!@UH?O+;D,.+HC;8^V&][1ZUV+7B%.)HX>@D=32F\E,+[
M<^'74P[KB7KCVN/XZ,0[."*+6$ONJ"=JLH@-Y&FRB+63PWJB)HO80.U!/$T6
ML6D\31:Q=G)83]1D$1NH/8BGR2(VC:?)(M9.#NN)FBPB-3ZH4?I2@S!1-AIA
M(A:SE72$B5CL%6*JR\F!,)%X$B8K,!&+-0H368!F82+Q)$S$8K:2SD9,9 &:
MA8G$DS 1B]E*.ALQD05H%B82S]HU/EAOAX.+FX^]*T0B>AUL]?[GLG=^W;O>
M7E.'@U?'3B2)A,E.3,1BA(E8S%;2V8B)W/UF82+Q)$S$8K:2SD9,9 &:A8G$
MDS 1B]E*.ALQD05H%B823\)$+&8KZ6S$1!:@69A(/%]=#>\9R"Q+4D02A(-H
MPFS?H09AVJS =;S#@XYW?-!J*/4(DPU<MN=U]@\;2CG"9 .';5FJR-;1.<C^
MW5R[6[\5!$%326<C)E+_A*G.'$;JG]1_34AG(R92_X2ISAQ&ZI_4?TU(9R,F
M4O^$J<X<1NJ?U']-2&<C)E+_K[B,-W>YR[Y/69C0[6Y39&^GH50C3#9P%PSQ
M.#ZVBW3D-S2%NTAW-<:A;S3M;,1$>K\I.VDC)M+[3<%$>K]9F$CO-V4G;<1$
M>K\IF$CO-PL3Z?VF[*2-F$CO-P43Z?UF87KE>O^5U>'^&7'0X81++6))9OTD
M& 8LL6N'2.#(%!(F"[GK:-\[:EN?B4.8:LQBI,#(EZ\#[6S$1,J?,-6:Q4CY
MD_*O ^ULQ$3*GS#5FL5(^9/RKP/M;,1$RI\PU9K%2/F3\J\#[6S$1,J_=M6W
M;]RI/QP&X>V.>-GO;GOW8+K.;;M([UB,Z$2[9<\-6;H69MLT\J?EHA_%0Q9K
M /TQWR@!PTVB<3 4SWQIEMP8:OLML0U,4B.HQ,^;;$_>]MJ==:0@V< I-8)*
M3$U*NDG\_&-0ZW+FLH'2I#G('!)3$U.3.6PL5#*'I#FLT!QD#HFI&\?49 YK
M!I7,(6D.*S0'F4-BZL8Q-9G#FD$E<TB:PPK-46MS6(?6!INGRTV4^F-$%T%&
M#&7#D 9820.L<2R,#<Q2(ZC$UQODZY-#K]7J-(13:@25F+HN0[PVSRWK:$!H
M T_38:]V<EA/U&02B:F)J<DDOC1*,HGV4)JT!YE$8FIB:C*)EO,TF<3:R6$]
M49-))*8FIB:3^-(HR23:0VG2'F027S)+9FV-8VP4<,)D@Q0VFG2$B5B,,%F!
MB5BL49CJ<HH@3"2>A,D*3,1BC<)$%J!9F$@\"1.QF*VDLQ$368!F82+Q)$S$
M8K:2SD9,9 &:A8G$LQ[]#]9(@#-L;( XML91DFR[?3:*8B8['KBI_]V=QM%]
MD 11:/O>-0C3IOL3=([VO<[!44.I1YALX+*MO?T#[_#DQ"[BK2,-T,:]M!'3
MAOGKP#MJ=[QVQS(UUE0.(W>_69@VK?V]H^,][^"0]#]Q&.G_QNTFZ?^Z8R+]
M;P$<XC#2_[7<3=+_=<=$^M\".,1AI/]KN9ND_^N.B?0_U?%:M36-QD3)%82)
M6,Q6TA$F8K%7B(E<^F9A(O$D3,1BMI+.1DQD 9J%B<23,!&+V4HZ&S&1!6@6
M)A)/PD0L9BOI;,1$%J!9F$@\ZU''N_G.U49Y[[HK>:E!^XNCWJR<[S2$26H$
ME?AYHPE)!QUO_^B@%KS2E&$EQ-&DH9NDH7\,:ET.6C90FC0'V4*RA<319 N;
M"95L(6D.*S0'V4+BZ&9Q--G"FD$E6TB:PPK-0;:0.+I9'$VVL&90R1:2YK!"
M<]37%E)7 [MSDQJ$B5+-"!.QF*VD(TS$8J\04UV.$(2)Q),P68&)6*Q1F,@"
M- L3B2=A(A:SE70V8B(+T"Q,))Z$B5C,5M+9B(DL0+,PD7C6K:O!F(U2N92U
MT>2<I8A+SB<70\MMW[:7Q_2K]0)(,\EKC<E^!MLZ/#GVVD?[=M&-=%<36(LF
M49%K7Q/:O2[!W/?:>X=>:Y^T/C$7:?UZ,Q=I?2LPU4 P2>L3<Y'6;P9SD=:W
M E,-!).T/C$7:?UF,!=I?2LPU4 PZZ#UJ2#7IJUI-";*DB!,Q&*VDHXP$8N]
M0DSDS3<+$XDG82(6LY5T-F(B"] L3"2>A(E8S%;2V8B)+$"S,)%X$B9B,5M)
M9R,FL@#-PD3B6;>"7-5]NK/F[M-?&6P^&R) GZ_+OV5N<N?'_"'1+$U2/X3W
M>^X@FDPB>&4T^.8FL_X_V2!UT\B=1DD2],?,C=F03:;IID:4KWOASVQVWMGM
M0+?S833C:Q9/?6E&WB#NS>J)?>^D<^(=M(X;PC $U3ZH-;%T]2<T027VK3&A
M:P2U+H>Q^E.Z1E!)41#4&D,E]B6H9.<(*BD*@MIDJ,2^!)7L'$$E14%0FPR5
MV)>@DITCJ*0H;$]065OK@<V3Z)V?! .1J!(.W6$PGJ5LZ(8L52WEIRP6N2OS
MTU4H2^6G9*DL[#Y2FP25UN[)04/8A*#:!Y5L'T&M,51B7X)*9SR"2HJ"H#89
M*K$O024[1U!)41#4)D,E]B6H9.<(*BD*@MIDJ,2^!)7L'$$E16%[;DHCFZ=X
M;AB%.Y"'PB9^?\QJR@'UR$-I4+>4CM<^W//V]]8Q+<<&AB&H]D$EBT=0:PR5
MV)>@TLF.H)*B(*A-ADKL2U#)SA%44A0$M<E0B7T)*MDY@DJ*@J V&2JQ+T$E
M.T=025'8GI'R"KJE4'X*]4E9<15;[=UVIQ9\LET+E+56Q&3Q:DEH@DKL6V-"
MUP@JG>P(*BD*@MHDJ,2^!)7L'$$E14%0FPR5V)>@DITCJ*0H"&J3H1+[$E2R
M<P25%(7M&2D_UB/%QKTB3,MR22U$CS#5%Q.Q&&$B%K.5=#9BJLLA@3"1>!(F
M*S 1BS4*$UF 9F$B\21,Q&*VDLY&3&0!FH6)Q),P$8O92CH;,9$%:!8F$D]J
M,+!D@X$'.1-#S\.(1FX4<R!^_%@Q&Z.F=_NO%FI--$']"4W-,7XN[LTR]D'+
M:[5:#>$6@FH?5-++!)42=@DJ*0J"VF2HQ+X$E>P<025%05";#)78EZ"2G2.H
MI"@(:I.A$OL25+)S!)44A>V9*3_6:."ETE'&49)DDRYJNL&O%BH)?1.AVIEM
MTI11+'N[)X>U8!2:Q5(SJ*2-"2J=U0@J*0J"VF2HQ+X$E>P<025%05";#)78
MEZ"2G2.HI"@(:I.A$OL25+)S!)44A>TY)FOK?F+CMA&F91FF%E)(F.J+B5B,
M,!&+V4HZ&S'5Y;Q F$@\"9,5F(C%&H6)+$"S,)%X$B9B,5M)9R,FL@#-PD3B
M29B(Q6PEG8V8R (T"Q.))W4/$'2I[AXPC2/^S7CBE\=:E$=9N/]9T[O]5PNU
M)N)??T(35&+?&A.:H!+[UIC0-8):EP.6#92VLXW.3\6]6172/O(.]TZ\5J<>
M_70:Q=RO!BI908)*5M *:U)7W!NV@@?>27N?K"!!)2M8?T+7""I90;*"]EC!
MCK=_2%:0H)(5; "A:P25K"!907NL8,L[JG5$]/6V,7@JP25DZ?J'9=BHJ&S$
M5!/#3YCJBXE8C# 1B]E*.ALQU>7DT7!,"^<262&96ZW=SIY=1%O';*&&\Q6I
M?<)$:M]:3/50^^N( Y':KR4F4ON-PD1JWPI,M5#[>^3MUXVO2.T3)E+[UF*J
MA]H_L8MH.;6O;W9_2_W^F+UUG#^FZB43/[X-PITTFO[NMMZX\I_JUKF5L<0T
M]S.QHG;K:<(_^8)UK!F _/+V/YW>]\%XA@T'>GX<1K/4O1:]"+82QMSS*&7N
M_O:NILUT':1X>H$_2#M\[*94D:#<'WV.$O[_2L(T'O#<S=OT,J[8B,5.&KGI
M'7/]P2":\"<_ O^&G%<35_YE%OJ<J_-)":,@],-!X(\Y$#]E$XXMF<?9%FY@
MP=*L&>\_9TD:C![7"7BKN^U\T?MP%R1I%$/*2T9^-QJYT93%?AI$80+_>A<]
ML!#V"W<Q?6#C>^9.^)/O$I>%0_Z<SWX\N'/WVI[;:77V#35U,%=-V4B<&D'=
M>K?MO.=_N^?4'\711(B>W-8%>_GWP __?1?HW7QD?ERYB;E]LUH&?Y;6W^R#
M+:=QG36R\\=_[.RX'P(V'O[N7OJW[ W_];]F+!S KPY.WKA_^>,9_+>[LR.]
MWF%PK^ 4<C??8>YF&Q(9W20:!\.2O3U$BJ&3RA<X'LLDR/_ZI?4+_IM#&ZA_
MY]\QB,9C?YIP*.J_WK@/P3"]@]6U_E:U,5F:8S%[D7L#>6*/V0A_H1WZ\D[D
M7L>_:Q!.D>R->_,XY>_OQGX_&+QQS_T)$V0]CX!^[?U#\V>_J=_!WS(_7CGQ
M?_S&*5U!\YCYWW;ZC*LI_O I[IGIY#2'Q(I?%Q'&)"<0&MFTCHYB[=RE^N@]
M;@7/+VYZU\[-A?OEO/OE_=E-[[U[>77A?KBX^MQU3R_.W_?.K_EGIQ>?WYV=
M\__X<';>/3\]ZWYRS\[Q2S=G%^?U.D!MEJ&D-*]UC[A7[+3_]_\Z[K0[;R!C
M&[VR2WZXY[1!-VV3&[ !":F=2-_<,:?J)#J(N!<<)OPS?G[M!R$XUOIP&H3X
M)=@?EV]9WX?O\?_&HQ'NYM&;Q#C@&@>KJA,N9.@[TA5?_&N."IT,/\WA,1_%
M_[\AT(E_@1^T;_F1P&6C$1NDZMS];I;PY22)>XH+PU4X4"/PF3\DAL?U[O'<
M[=[,.:57T*;OCWVPZLD=8RF^-5GBM6[%:QV^@F $/WET[WQ.UL%@%L>"OO\]
M"YF[UY)'DE7PS3L#Z6/L^CCJ+F;,R9V'<[!_B#CN N)TIW$P=M5YS94RN$8B
M.4N<]7_&XO9VG;R@<74Y&Z<"9\#_=PF<?LS<H3PP]Q]=X2\B6O6P:"08 [9S
MSJ,<>)0'RX2W/L5BQMGZ/1NP29_%"L^>A_1(9OTT]@?IBE <]90Z!5=>GZ%(
M[J+9F',;["OG[B"$G_YS%@[PKP\!/P34B!Q5^[?2 6SY1>7.8T]?3!0K_99Y
M1<5)[I>W3NFR:P6TK=W.01 "G4X.CT[DB>XYS]OP/H)>=U?XO]7B^<L*1T7-
MYLON8_XDOK9]*Q[O+5BE]>SI_LCUQ"*C2TS7**9;59,M?SS37.7C?^?=>7#<
ME(.\RNLKO+GR@_->JUU[2)QJA7I<S7HOS_'J:E#P?/'XE#$]JMB50%0=R$@7
M-XK#\_[@RMRV/@$!E>I4Z>KE]*\XA8\QW":=W3L6LS3RN/<*65G\<S9.V -\
M"D>ZE*\5_-_OC]D"?^/_3J9LD,Z2-Q!H(U9O$JN_G#)/V$!XO9S'@G3,61$B
M8IW6FYMY0;?N+>=Y8$D/O]E^HWYQ)7E<?R%9"0E&XOC3KF?]9! 'T_S+DN+;
M\M&[SW[HW^(7]4?O@V0P2Q((3*\" R2V&_KC1WF/\D$KFU-^#@UTW/$JBZM=
MZ+-#$60A'K\2D(5+6@_,E0D3@>::$YI"%8=1QTAYNOP72B?/UW0K@9BO%7=+
M&K$JJ?<943#\?YU.L:F:E%WY80 A"O[D'?@BA3A_),399^/H@?\0KR\A\CV+
M.6\-V41HA&3 0C\.(HSTCZ(Q_W)",<_FQ3S727%IL@W]8*'E[B;);,+W>B5]
M>!YQ#:]D(^$O%:YC=O7/I80_%GU./^7NIU3-E[/^.!B(&H"[:#QD,?< QO*^
M[<Z_7S4,P8*XXLD)"B[7U,)C'OC)G;RR"%EV8['@?F]%X\#B29"FXC8.'XJ(
MNL"B8Y8H9YR;'KBYX[3@]A0(!49+?%6@+IN2%W<[-Z9_+!6&>4T8F[0/S=5*
MG8._K:26VMY1Y\!KM5J5.@2$5>F1E6" SO%O^0GBEKN+I@\Q]1]UT.#7]K&W
MUS[Q#EK\S.[+U;H^_[RU>]C)&ENN].9L\>YE' P8JAZ=X3.:A<-$N+_,36.^
M:7@C-@O3JN P::,7%P+21I9LQ+.TT=&*VNC :Q^]F#8ZV/=.#HY)&Y$V(FUD
M^T8\2QM-_._!9#9922,=>B=<'[R01CK:\SK'^]Y1?302!?Y>K RA(\L0NF*_
M@%4N(\ZK 4NH"&&S@+],H]"!W/[91$929<IO56C%X\#4]8+[$(S'(,@0@W4A
M4COAJNB.A0GD_<?L/N 85/KP0R1NBOB&RFL))9NPUU.YU[M.E^LEF7NL?BN>
ME'OSQ']T Q @3@MW&(Q&+(:ZOL3ML_2!L5!7_Q>>7P7'?;@+!G<>_Q^&(298
M#1MZG"20,0LQ+8YHHK+%@\G4'Z2@;> Y\VZ4X6_3*$EW!D942N8N[KKOE,*"
MS.T@Y"CX WQY*9-;YS 8.F&49FOEO\^M%]7\PQ)(?R2TONMV$T?MBO?#CW.'
M$4<.RQ+&JK0HKL&K>*-02&NU4-5."RA%O*<4,=;Q"(9.(S?KTW#)]_L#[O>I
MWN]3M=_9;>)9MM^DP#=_<Y9)H6]LG+X\#592 OEZJGEYA\5G.LN5]R3SBJ"6
M28E9H?$'>+?:,^1V:1QP!]2/'UW&-P"4)#<V-U*%<^T[ 74#]PX#J,T>HH41
M.BGK:6'J,.ETLR'5O6Q6*_T1O#5TD;.\+GHGN?@:N/B/WX*-=N:@S7H9/01W
M<G2=3]?Y2U!\J[UM>V#HBJGTE56OT=TT]L,$K!67$;POOV-C(6^Y. A7G_#7
M<A1PG;$/L7=+13\VD;5!@O63!:M3 \$:09+*ZF*5L#0=ZV(O+D7Q##Q*\ OA
M;#K@9WR1'\*^3\%ZR1-YG[N1_& [G(D(Y=1_1 Z<33$,D(5:5L(CXPH3%M^R
MF"28)'A]$KS77 F6!S\5V,RG?QO%(3%+??0ZF1^'G*&2"@E[\1J"GU$IL0J!
MU_Q_+TW@K?WM-5-W76Q[(*[Q^,M/(_<B'HI0AKC(\[A]B=U[Z!OH_MK>;5FS
MFV20R" ]TR =--<@<?^/;T$B!;M*HN&4=N1U]@^]O:,C-U)_2\K2WN+2WFJ3
MI;+G_UZ:\EN'FS)A(@2>)#.,R:VU4+;M[<L\%2:&##B)3%%)U"=X; J&\MI
MC)47%0)<6/H8!63_F@7IHQN$21K/5. 1(Q_Q$#%CT4#W^M0];AV(0CCX[_:!
M:.:FRAE*0NG(?!F\[N:OTA6/_,TQ&S"X[0;:% 8DR%@G@_9BLGP FXHE>-^)
M\1I_("O@X&(5SI. UQW<^>$M4IBO.8VC,3]'PFG3P5ME3L)HB&=!3E-QVJQX
M.6@1H!Q8J8J4KY>6DJK_(W>!W(7GN@M'UKL+9ZO%>JYEM2)T'8Q-!<P5SMA/
MDF#$]T0=#K(TOX*O $W]_BF+LZ81_Q5GPI5@&+E]\ @6\Z6".I.JENL>Z8(8
M3@EJV3 R?IOLNF=AMJ2.)U)N5JLBUGF-S$U\KOE&_D!T;1PR*/ONB]NELY1-
M$K<-M\G1[/;.Y7J^']TSS^USW>B/DT@_2->.K%;V+GTP7 "T7X62%=VB1V13
MHJBK+YI)EEDQ6_]1_B(Q"NF\U0B28J)4EGN)^9!8F))/L,P3?T]AKR;HBGOR
M7.)GJ?(E@AX=_&W5J.A:B%\DZ(KEY4L1?W\Q\7,$7>G]*Q$?@\@RFSB<85>R
MG!))UI >O *AYQ./8MSD(ZS/1SBVWD=X=DC!/)4=Y#+^"Z%"O/_EF^5SA1&$
M]PRBWR(%BR\A2^G'@J+=U2PC7_(86Y*+8\_EV65/I0.&MQ5!BTS,Q?O=Z2SF
M)Y^$Y?7!BO8YTQUN5;.CESZ=4\G1CYP_F[-[6R>U448BEUT4]F#8P0A<Z$MO
M$-:]W?:!U@);(N4+HA:^^VMG=]_X6U_5%9C)\=P2?6,8 _%5ZR9WQ)B^.I=]
M?L\N+]POW"S'#W&0LA@JB]P';B'A?\=<>8T](^?<']X'210_>D8ZN>=@ZAF^
M2#<FFL;1B&%_).@2QUBR7;ZJ7U05 0GRH.'2Q:43.1(Y&$Z*1J.$X?D,3'Z*
M"':F?C#<@7X7_C1(_7%%Z>0SY6<]WM-+Y,8MGIO%OTUSL]8Z-^N(YF;9/3?K
MIT^<:N*)R^JZR#^"M]>Z:,+)]>&C;/:7RV9_;C+[Q@M@G$(!3-"D3G=6 ]X*
MMAWM+E>5&@V?XSB[*SK.SH8=9W<IQ]E9S7&NT2Y+J-4CZ]<'>"L(MMVL$  #
M,YGRP2MG2!]A9GMH!\X>,$B*\UV0I*!98/*:8#+<:I'+'-\' W61/6 0:Q&[
M-8X2V-?%&[6Q':K!WM=0)7$V<A3@#12HE/E292Q"G237,%SW808"YTZMI<3E
M#!O,8E%YKVI4;K!&1?9^J)-.J)U3B37>^[+&^YRE[J>("SI$33% 3$[E9@%S
MBCMC17$1_'[@VID?1P<ST01]EJ@!?$9N^@,+;N_@KSY7_7!XE%=TT2SE;F4X
M%.99C@PP+P.RH)+Z2:Z-JK.PC:K1M@?-A\R"PD2F[,4N_R%_67Y&(L3#%DY?
M5(;+<(K$C6.?P3-ER@.L>,Y81IGVU&=\YT+#>,G\*%V>+=I5* )+=Z1(3Z=,
M3_2T^WX2#$2N63">X1P&+C*%#<QU7#((A?L "D^>$RII@4T[^M"QQ'BWH[Q\
MR#2+&;?L<Q9'JG+#!\!"5IW* (2MA0/@2 B=\+ Y&K"$ZGH-.(5+!I2!\??#
M35LH+]7]P5W Y.Q/@),UO<=)GK-^$@P#/P8#:23^C8($5 $,O*GL>" R&OE_
M'.Y"-3PXZAS.^#'C0Y43I$=!FB=9P>J]RVLW"OF/L!F.2%H,H%>+.PCBP6P"
M'#J /NW\("%3&=*[*,F4 SX:6KMD5)(MNN33Y=OE5\!+$..$(6< \QZ'N5>)
M0< Q!A&]BD1'1W1D3BO6DIW&R])-@F-S)_\[/Q$ZD2LZ?K(1F;92Z8F^_OZ8
M>YBA..9DC?W1FO&O347*FV/DF$#(I9 ;QZ6OJINY5.+\X,X6'8C6W+=$C='=
MKU.@AJ"6BQ,VF<FSW/7'+W#CL.#"0UQQ_2+O)=+AG&(-B5S?B.%M6>ZN0ST
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M.$8S:Y%-IN/HD4F)=B-,8.38@A"T82A2ME;4'^E=\;&!GK0Q'?LB<P-+KA\
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MS8P@UV4+$JV8T'HZ)64NNIC_(YAR_W![-R<_6"(">E_4@^O.BY6O+-,)C]Q
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M]/$</<Q'=C?,(A!R?(^']9MRM![F/('1@$0WE6$!<=6$I;#]G -%59?;Q2Q
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MBZZ<Y)5X+N\1/L?N2Z:270E(EENOQ^NI\&9_-AZSM$(W[[XJ1;7V4L*U5\)
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MA*65K(PA/!UP$+G _"BLHJ'RR[,$;T;$%*%'<<#W1)&89UA7"#H WZN@U;=
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M5]N7]@SLJ$:6T<"7'%Y,UQJPL'V:R=URKJ Y [R/=]%:32^[])J]Q')7&DA
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M7YT&S/TZ)@J[-H?AXM[H"XVR3\H)SN739!U6(OIR<FYD$>?1EQ1R42CD/K>
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MRTDAG"[]83FWRXP^$.E)*BN]]^(P,%P7M'@X/[2?2MLO6Q=0)B<\3"1Y)K1
MOYO\,V<V!\%VD6"S+GW$+GU;O/7ZK2.?6>)>$"P/6(#L9R;)D12/?\R*8SH<
MKZ3:922W,Y $KK/)20I0FL@L.CCW1R[KY(4F/?FP1!9LW8D=D7R:\%7&;6U(
MQW];%2?U.8+6G2XJ!^^9FP<E?-S@Q-YN.X+MARIU(I$VH;!Q4VX/[<US.T\K
M$.-7K_;Y;;2D.MA70-W]:'(P>X9?LZR43!39(2,_,_11!CH_1B(!YD$K2.9
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M%"T9$\#E9F2#UZZA-YJ^25VK1NU<F'X<_ZMH(O$P$$C$URM8QI-&TG8@!YE
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MW1LQDEA!G7R0L6U-S8+,XK:HP,&W=X71./F%<I*!P?"T!+O,PE$P^^J*MN!
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M[H[Q(RT-7![/0\Z.'PT2F[N0O@@8HG#-TBV:RS5+&!\Q10B]QH+9NT:[K(*
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M-#Y:DB"?Q'NLX>BUKZ01O.S'44/F 2W='?OUNVM:R'_= ._[ \#[>@'>.P/
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MO3V8L<Y IAQM:>.*BRB3)#R\9(001H^_(!_#58%=)1L.,\W+'&0LC6] S**
M)=':E:Q17[(.-7[#O_\]2XK_++/X_R;% B["H_M/X3:S'TM7^SV?ASL4^3B9
M$C2_$W2&I_PO.B_/<Y,4\HR?E/$B:TSD]XN0!QZY8+\&]/=@!/U]6=#?Q0CZ
M&T%_QRTR#GO 8%)<G)U) XO769$1\L*9>6 X2)=5^/R=[W(40?8:%<*SV<RL
M&^V+JJ'SGS,XK#7E2,(&0O%KGUXJZI'*OB<F!,2^P:R;5JB=."J&X5VT4+!
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M:E;+X.\SQ%EA]!.)?+C7Y]F_6ZE9ZRZ?F##A4CSEGG$2Q>4]80,)A'-J)&;
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M^Q%MOQ:.GS'PQ78MA4S( ;'VH;U1N$BN6_616V+1<;69_<+5$C\CC#J:6LX
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M(-GM45%+$^Q''A5U-[>U+86->]B/C)$N]F+HY/'2<]]0I!M3 .?G$RV_#KU
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MMERLYZX6'QJ,YBIKC^-WVT*HU=N_'9$[_[F_^P68<M0..2&KR) Y-K.2!8'
MK(;G;3&SC@,RRX&:AW,#/^YT+7[D[AR:-F32:_(GHOH:@J'[WCAW9DS@*,*E
MFX'H+&<?7=TZ=SZD2R(_)VR0=').N1W<X$\I@:?IV_-'(NXBE9A##8D<P\J5
M!VX7,1N&);U2JQX3S-PY6N)XO#.2/,/^*\SY%]GOO', ]A<E6#ML6PZ)>.XI
M^T!+_#Z$8[?<@(9RS8E:DLYLTX0WGA)*=T>>N;YT5(9DOU:&&L5*8L\1*K#I
MK,P!^+.NRW6-Y#\%)8BYAZ7).7!!0" P&E%:X K3^C3"^RC:+^/?F\8YL![/
MN8[$G</>N51(=L\9)=/5,<)'7,$5AFN1A-U>SZ#)#^;T)5.*7Y(S:AL&R9_M
M;X-[S&=[UU)-(FHOZV0SJ :X-1.^!%*!>.Q]0*_):-X;,YI?-*/YY&S,:(X9
MS>,6&8<]X-]1:OF:F.XXOOD,;9S:"WC:PO>?N1O>6&9R6Y0/S]H%EI<3!O ,
M^SEGGSJM1:4GHU>,Z-D4?DQ2:ODIBO[^W?-)C_F@ PGS3D04G @*ZZ^88=-U
M!O':A;Q2(]L2-K_^KV2U?OHL?M<2\Z++D"?T.,?.(!.5$$)#<5VP8!D225;H
M!5&8GSU1@YE7@@W.E7>(D\Z07==++Q0PU$F##;C.B),5AN@I/Q%ARFI13S0-
MH*P,3'.G-T6[\W:X4?N$J*YOHCA53())(#/*&" ^D)V.KA-+<5#G8.+K.(,R
M0(*Z<8QBDMZKE=QTVPB4JM,MI.T7 =;D*FLXC!W)P9I[S2<&UC!@375Y5F>@
M#O-I4E,,B8=TFW+J=_F,>DN[Q4_U6O/Z"RW=FW@)&$_/C9XT4&[[:9"E_Y[8
M5H3ANSNDB*-(22I,[^P_#D_-93;,K.7[2EZE=XJZCN4SVT_CFHKFZ/J*YGY!
M##IZ?DW,Q=E$JE)=&Y9Y_S['XD&Y!P49871\-Q2WX?;*$M^P;!@WF,U-ZK./
M2*X?HR*R05X.:& QE'<;0D7RH1K($CLBG;FS)]Z[D_\&>Z\H#XS8&;%/Q&U5
M#4'2\3U=LT1>K&^:")4T@276$E.(%RTXNV@"P>=HZ5OTP^ 37W(?-]$"?B%9
M%-P;KC*\Q]?FWD .]IHG2QA.6N145L*A""'/?A*G!H1')@7P,Y.M&X;#D^_!
MT540+Y1UGI:4V[3]^UAOG.391^,+&ZH0&]05V9 8XD[H+KRI<C4*I:P-K'G"
M78,TEC,3_MSFJ6OQ;B4!'BC6'AHPL7$6?2_IN?Y:8=!3"@IU-%(R:+-^U$N)
M G?R18R*2#\[H85=Z6^P%F&4*K=#57R#RV&#@DH@S(J:#1%MM[A"BS%CXTG-
M7L0_4;H9.X4(7;L\S>(CX,Q%MK*OW[*#NX*(S8//U-OI!0)K*1 9O#,8$88S
MAC_S2)B&)Q;I8=6@:M@ @,>-TF(F;6J,M?VT]Q2VHO>7(S:71KN3[YQB^%RR
M(1(_^$P!4WR-6[?OXSO974=E#Q^*'68!#1A/KI["U^!['%!%U2ZA7*S0D B_
ME58KU13DK6);R@([,N 4U5CWA)CO^"RD:P\A$"QV9Z#[IG  K[G_07><,% W
M'?Q,)8Q 4/RRH? ;('F3*N7"H#O9)4_XLLQ;L%@8&;%"@A4:+6HA*^3="$[!
M]HDQ:N7:X6EO46XX1UNMIXPW^X0^88G(8KV0I[FBFI7'M<>G4L+ 64-%J<KT
MQ8:6)#9*7RGK<*]0=$>%H4H<RD,D0;]3:Q?L.&]TDNC0C2)VS]!7V@IROFA3
MR1/%+5+NOJ*;1M+4LPAAWUZ[N9$6  ,P_<4VHS9PLN_>)?X5@8CLWC"*OXO3
MX:8AO\<96F>*2J=1Z%V9*1Q/HU9;0GF+:("\GF2%UTUBIS:2] ZN*8)^$9<O
MSBS*019C7O\GW[U*!4<,?XVNT7C]#B8>\C?)X>JD&\\)Y[YL@38*_.7!:PR*
MD=.SJ!W9X=6>8:ZQL3YA.+Q$2:C 1=6V I+RWV@RGQ-)H(*EWY>G3"G?*W2>
MX1P":2)DY1B &" E5&JEGKB4=/+.I1#EE$3]3GJJC F<)NQ5_;UA#BH7Q6+B
M2#SO=/8F-S@1]M1%PR<BV'F[6T& XC?NV(1,)'L2K!Z(6%DK!*$3Z'B* :^!
MI1@DCNP';G0]AM:,X@5LWJ%S$(5*I0?8\]&XHS+9XX!_ !F91M?(;#FNPVV8
M2 C#WL.8801D@6$P:,IAOBYS*>\N"]U_9F6>>%=ZMP!5-1-* M\ZUX,(YLF4
M&.)N)/P[7222Z"KA'CUD*6/7*A@P%A>CE,/;^.[U#^>3L[,S_']X7O'?9_J'
M4R7!78'DF@A.7)QH?VFT>TE9A8TDY*NP8@@^TFKJ+M)HRT[T85XWF,N#8"8/
M="*V ,W&8*GRWB>UY8@\(VLU3EO]CL%>M]A1;[&/Z*(=G63PXX,7]WOQ08$4
MA=V\WS?@9"[@.W3HGI?%/),.NNC=4QJRFBTSHH;NXYQV11"CZR.(*B#X%?#;
M@0!?O"/ Q\!R0H-OV#)+VTKQ,I;^&>>MA3">Q^H;80Y<ORU'-1G.7'&7%_M,
M3\2&'PCO090)R)]#%3ABX;9TEZ__*TF'$*26&^:@13?-4EG9X.X.4L3V:G<B
MUSS;J6UV!S,X:#9=AB5BV+5VX%QP:]>R^BA=6S&0@D3/[)$F1,<J$03LKV/;
M076>%=EG>3V,K=P%J>^UTR%CA(L6DH\QAR2)N03;%/.L*5B!^"[W,:'7V)'V
MF@J"0L&%Y2YX9&317& 0;3VK,*PK%<*-X\00'JW/V/#XLS8\LAL>^ WV /M'
M-CS,T\WP^;2\5!^15-5-@_TG,K17\'BKFC>T(A$N!1F(">HS#GG-LG7&A/A"
M R:<N)*+9/MWF-ZV60: .D:[>:2V1 5&AT#2@&L"XDF8JS"65UWC/96T-,9A
M.-JO2>PSOGIJ*K#/O7Y5 T/UV&L]8,;7U2'I_HBX^[*(N_,1<3<B[HY;9!SV
M@'\/@?,[:<H!>N)G9BL;<75_2($;4=/VPN"@>_]131-$F8#R_K%NO& =Z7Q7
ML+&+?YAZY#Z8Q.=/GH!G-$ IK!@_:>KTA$W.&X-SL)2!.AFG])_&].CV2=8Q
M9UD27U48,BYBCGB3+PX^")5@1\J9YSA'>8KX+:H?(Z/50P-)+38_"[/U/*36
MQ=+=H]CF]_"*R-Y&P0LTM85QC0%VPL!'?W!%'Z?Q#Z68=-?/V?;C<>/SPOV8
M$N7]['2G3 V6,E.;V>C5?,N[-,2Y*"W6@1\[V)L4G"<<=O\Q_: &AC3&$.:M
M<WP^!P\\CY^7J7$W2O:G1O8*/#ST?U/' TQWB2OPJ?A]TK7Z$>7FU6OQ]JO#
MD<@[(GU^/7!9.C=463J\$:HK+6>+87@U9X/8SY)/L,0.P04Y7P[%U1CWGBB;
M^T\>'A==H5+X9+9,,$A>9\$54A]JZV2CSY@L)68$>,@3/J)C>'3WQF\^R+0=
MHGU>L_0D\,E/95MK )DTY\F[%DMW7YA+DY=K;>UWHVY[&(80HP@?_;Q<K<H4
M@S;RDJVA.I=S9MK<H<Y[&AX:4*!XY7;HS_!.UM+[3\!LCM=-%*;79<PIS8GW
M)OL@#P_GM:8)$M27EJM#V6\IT\Q\I9&?XDOX@A)_+C5OHLA&6Q K+FR%XC+N
MG76Q/_#X6=YJ4*8S1FH.EW3%$HH6A/DB;QW><14MJ10E-[80O-@HJL;U3]*9
M9A+&"[?#2<'>EC"53)(WQO65MMIW$M&0=![!1S@L+!WW=+5=9EA N$])?OUZ
M!RG5;<L9A1 M)NS2@4UB#]U(HW*3&479@7ALG1JIMU69PEF(?U:CE8MIX--V
MA5475=DPM&3TXVY+*[T&(XT9TM4?^D6C[V]-N?:*+&";%A7Q&6F\>,C^&VSF
M&OI=796"-]U_!.(BC*JC-1\9SGQS\H&9/%5(;!AY,45K9]TVK&9F7#UN$8 9
MX09;Y,  O<4]0I%I'/^3PN!-AL1'4<.]7%<F10"4S8)(KL'+\'J83DI2R,&N
M0)OF.0GZ-%EA>"OA:+[PD/7FQ4N>+!959G!)R1:F)F1@LGUD[&51"ZP,GV&R
MQG%TN!EI/HXGY9Q'>HEV)977HS*9)6WM?&W^U:3W5 NE]8U?&E@&=WQ5()63
M-S9O .VZ+,+1RY Z4[5#"_;9&P.JP:@N<U'F'XORJI!Y\"QP/U*3(,47;>HE
MJLLE>*C8"03SIC72J1>9X(5P4VP^?)8GV4H2'V)S*_2&QDTH4_[)J%)N,9XD
M=/ETI?[><N(28TS7<2)AP\KP6F046UIF4X*NTRF5YH$B 3A<(V>/$]%EA(G*
ME3&-G_KJ=G;TDJ^$QTOFH.N$D6/9PB#T$.+7X31Q>IL_$9'!EA#^$B_"6QV%
MY.6B.:)^:<AMX7$ I6@",O\*<BT5USQ6'>:>Z&$9 .NSW-28"(!;\*^VVK!G
MSF 8;C8D#^2+,"BPZ#[190KO?$*L2<WG2JO7@:C&TD25U9A3+(L3Q3DU;NOD
M1E-BA.64ZW7LO=IG_0C%#N7*Q87P0A&4\ZY9RD7='\'#..2D')S,"T6L.<R:
M"";R);<N=<6,]B"557B.< Z$,YX:]U[D1:3JO4*$6T3<>;P/%A,.IQ16W2.T
MO"P_'CV]R&$/^$U;18YCN [!59?($]-LI)R#S=NU-6^EB:VKL;&6E'[WG8O@
MOE+D@V<?<QM?&S^/@FZ^Y_>&*$.EC1]3$-W'Z%:&D?0K:M!!@(,&)11C.+Q#
MV0DBXZ,ZG)A4\OT21(7YE"!69#+P!>OB@XA$(+!05_6NH(51D&6G@ MFE56X
M3$?RVA8\OCO/TF^B(I&>HALAN&CT0/%J(K8$Z]9$9$TU/O=O5CP32Z$UB=N:
M)""M+CB?N+L4.LN:34^@H-DBDX'52;*<^+H$U[NQ/G-MMAX0D4=ZKEH.FH;Q
M'BW^L;7F'!OT@%-1HF;K)!!F.&"P[LR")#]*KPD?A4P_G7.-)Z(^N9^\RM3.
M]O+K29A=EN[A7=F$[*?( 086)69\RH:!1&"KH^F/(98*X>W8*UO<P^SHS:YK
MX!H/1KC&EX5K7(QPC1&N<=PBX[ '_(7@&FC3$', XMG?BM(>@WZWM87/R_6&
M, +C6N]WP':A(PY$--P=9+JA8D?"]^LW.OV=0W8I^ %FH]^CZ\AH_Q55+EH_
M]MJ@+;:+CH2T@: UMALT]330(K)'A+,YF^QHQFG!,Q38L'E#<GV9YI2CO!,I
MXI:)ALPS@6!08J#N4C P>'>S:L7^$*?5Q2!SMD:?N4#N7(L*U2](HW505T%Y
M/&D^[JQ9Q%77-JG&]8.:J_7L=O+W=!H.J<^"CV$Y1V[2'O: /V N 3RL%K,#
M[\MY<X7Q9'>RWOEY2\=S,X _LS?*_;B#;_,[L/_R_)E_H32)'EV<\<&<*"H]
MA#EQ9TT=9GARS"=*)5\:<:"8_D7SW11S'/ZAI59PF><(I0>,$>,46M<7<CIL
M;-4Z9U2OT&-.>H"^@5>&V6$]\QS-T.^XR$7T7-  2*9>PS%0NGB*!^K3@_2R
M'2)#<K8].98G<QD!-\,(GH/TQ'RGF2N89<[6LU*[%A\^D(\ZU,FO0UZOJ:+K
M;GH (XO6T%7K_]*;WTC6=7N=,ZHD-4CR,1I(MY?Y49/(+OYU)E$ $U9#X!Y:
M,(\O^A8,]TS"SQU(.#1?(F?D\)=V63#Q@ 6S?>02JC54OMV?1-"5VDWFGBJ/
M(3"S,]HXJ(O?H\8$^))565,V&D:+%8>]5>!\V7W.(M@8IG V6,@/IE*0TX$G
M15'N\[-X8Y**N-]6*Z0+TNIA2C +Q#N4WY;3\EEL'V:_@BR&R](GZT2UE14M
MPJ U-CXT',XQXZ?FTSIC!!TR[W1G(_H@Q!I3P#>W=:.5*<Q58H%=YQ>Q=(WR
M6#'D+4D7 6NQ3DX;G%HQ7[C4E#)@)/A?,^,M-G+2ROL8\+6Q$.FT!*7(>F]@
ME[#N/M*QWV!S-AY43:;C,VC0C1EX30=K9G? EB+R/Z,.*(RA S.,0R-T(-,'
M\7"]8CZEMG0,2I;XR 2+-:J]_:J]MYA/'H,"^]9YM,IUQ%P> S$!@C_0ESIY
MOD!WN)S>!:F\X>*83A\5]=N["B7Z//==V#S497"#_:U*3WND1*++SG=Z\JR]
MSE"AK.G5%(U'7KQ"@:9MPP##59F:G"$5A.A@+C77C_)[D#R7)L<\G_P>_@\V
M-XG8LT=^ 01'*!*$GGHJ,T8$4H&2RQ/OY)C-,@:JS>(TJV=8#DZE\!7S.",-
MDP&?)N45S/Q@J-<L4+\4$52+&N8FBX)ZDU3<: N?;A@-D!392BOF<]1&4YBG
M<)A:DL[:$1]-J<B?39>BG>6@-L1QU%2H>%N\M6^0%,Q$%-T-W>/!4&[75<[J
M'E<-]_&DM"3FC;/"]JMA>X&+V-E']3BM3N,?/\W \I&A2,L9K[%@T'900SPX
MW1RO$G5'Q*J3$P:NP-)6?#J$L=I6952(@J'I6'"%U:0R+NJ;B69 *T 3_ON$
MJ["N,OEK2[53>>XUBN36;7-*N/M=B<3QU%PROX8I8-R9HV; &<^+T(YTIJ-F
ML\:#4"34PM$2N<J=J"?*RRJ?!!?$?8H;(-]@_[P^U8^>%=X5D[%E8F_1EEZ<
M16)^).+<#W[M_(%:*<R4$U[5P5^(73/J_STW6"^Q'"C"O&H]6@'[';"L-5Y7
MI?4:, 5V<( 3+J@ E<9/HFQXW8V7^^5%KXJTI?]F5)'#O'PPLV51YN5B$_DQ
MS=>O7GWP@YKJ8=_GAFQ#\?^. _UHFQ'A$8T584P6:Y6(YN:Y-,-%3'C\H5R?
M<.G-MLDRI8E=DU],0Z0P_C0E/FB[L3WVG'R/>A_QDC@9TG\1+H)&33U&P&F9
M]NG7"!G9"YERMP095\K#IUT7)LR;#CP:4*+#;ZR&%M1V%Y[A@C9V0<,1O7#_
MZ@2JY8@B0Q!XX7*\TBU?MR0ZEE'8;^.QEJ!/O,N#QK5Q 5@T6!%@Z;]0J-$B
MB@/4[0R'-F_S8"!'KC&NP0\]'/%#7Q8_=&_$#XWXH>,6&8<]8,VM1.^9^6VT
M,O\ OH9G8("=_*.8(W_(<\H$9PHJWYEB<1D'BC@]N3<8I.GE6=2>I$!QQ)1_
MZE."J24T=0T:H1QJP?B4!=9[=I!V.VX++@/3+"PQ!$ZX"(5J8OR?*WB>T>'S
MC'/G$?XO@Y_)BZ?/Q:"0>@ON *VLWMB(FX=.79"W__HT_H<-DNQ8: >2CQQ(
M7FRLH%Q)P@29=D^K!=O#<7?+H#C=<",)ATQI-#9OOV/C%UN&KDTB6AZQQJ@\
M8/F\@7%7&1P!Q,5729MBJ@%[4F/NWV 8J"H+IFNLVMI69MO&:ED.6Y4U''L2
MVG ,D>4EDQ(P-T'$L'XE..=YQUZ@)9R7#6H)GCW?, R1JN*YO<84'!-M3=%_
M7SSTOFCK^Y QPZ=3ILI\P5I0#&]1&2E0D,D'10N6\&-P$W":'XU9\[+[=Z8.
M"#B?XF^H108156)Y!LXD R=OIG-"$%/=64(>.5:$=:E!795'S-SB[JL<EXIX
MB!9<%LZJH&'KR>L]?!XNXN2FV]#;=KL:8<Q,HV3$L> 1RU#)*->&<@D*E0N+
M $$? X_&R8K#6NX,48@8J^2H_8W7]5I.6SW!L"S'5V4F6+42GLNYS('3K/Z@
M;$]KK#7&*=*H5EE-P4^0H);@8\>E/W+GYK '_$-?/&.>6N]$'_YSC<#G"L.$
MJ+WLP:Y;I%RV9<G*@)I44A7CV+TH'<']9D1XP)-7A"=SI6*>ML-;T"O#(@6S
M3*@?Y-3*^9D;:*>JT/X.CRNU$DBH,JG-I/5@TL>;ME4CSOL* PZ,B/2KV"FR
MWG\%+FYG.=*6*J;ZPXPL5:S7%%[  -1VS%:;LT"&RTD5;O1XU>9"0Z^]@[QH
M_%/7V =A:AGF/O"K6'Y5:\8!\;3!XZ4R=GC60P/>0K<[-84A,V5A,S7> #DM
M@B)$M7GD#UWDW] .HN(MVYK8=1 ]C$<&%XAP$^[AH0A38!K6G%*1(^;AVYUS
MC:QLLS--I(,8C@B,.- O!34S85(JJK9FE 5\1.T&&[JLWCNN7S;TMQ<E=>TB
MNX4QCSNW@VIMN0C3Q%Z%M?FTIH(U6.C,KG]_2?'^@AO=.SZT!YVS$W7/SK:C
M"<_M' !>ZZ%[IN3BDK8"=>MB?@SQ:+S<DC]$$"=7297V&!K<#OGM"6R<+M2T
MSX0R 0VNB==0.>#VD2YSN$[4%U&TJTMS"@64CDY0/;U#Z.JA>3)!Y:*S;#NW
MQ!*0<Y&K=CU0=C1J<!"T.[!3OD,B2<5MF%5$*6HO@O>L+=T=[HYZ^I:Y(YYK
M)>D6C_;::@FE'3U'/_?1DT$_UY%//'3(B@U(MHC\5"=D!QH+$H2[:Q*'-U3Q
M4CN.GB-,Q_ <?)YJ9X]/)CU!@1G]_^R]:W/C1I(N_!V_ L>G>T..J*8)@.#%
M[75$3[OMZ;/C5I]6C[U[OKP!D4418Q#@ *1D^=>_F5D77$F"DDB")")VUBT)
M*-0U*R]//@G[/O9!KJD@<U[6.B*LBL/[+HK3]O"03-ZN[P&7!9F#Q_R%4+JC
MJ$5C4P_-JAZF8DCU4!6A3/NN8L*9^@(59* %H]BH-HB11W6=-29!@R]J$QM/
ML(DW&T=/LH>-G>SAZF\]VQ8V=K.%S2I;&.ZB\%%QEJ BB?48T<0+^"0M0IG?
MQ^1YDE0A-!W&6DLO-?!P@K@8"1[EI# U%=W,*'XY4T^=]4G%A7?B]\66H-6@
M#5J];-"JUP:MVJ#5R>EMI]35ETEZ_S!?!-&CY@R\B:C*ZN\\F().U2:_'RS^
M../&/^#&1P^=Y. %,Z&=^",$(L4R4#2L@&S/%GW88GUIZK]B=;=< 2^AAVD4
MDB&= DAD*BT 40M-Y7HO DP[$312PL3P0E^ WYF9*^7&17$W<L5J?'>&Y"TL
MM2=SSR8K=&<8 4X"*I$^TC[=2B[!TE?QSZ*"E9RVZJ>F<!$'6==+EF\JK;NF
MNM<Q/Z2S9JR9-46@I7M*C>'W,T,K]"-%V(NPK:@>7:I0*N8-OKC0/,&9K'F!
M"D,_SC@0H$<Q06G"?9H27#[2V<0)7<0NGTA ,,7N4 "1RYO+$,RXF&"1%ET5
MCJXDZQ'#UR<KE4S&2<YSN1/D3W&)[TWO16'N@_5"D6Z8FI1A3-);&WKD&3+Q
MSP44W;I)*+R86B2"K%S2QF%9$ZKGJKY$I 6X(#-_05:_(0JYH76F"7>SJ#[E
M",L>0\INR.PG34HN=U)N^Y4/;44\W(!)HK0VO1FQ\BHB)F_Y8Z3JG<O]A)ED
M^"=R-0<^V+,LOR9J@WN/:7NJ@!^]1*^7/<[&QJ*-A2(.8CX?,A$>F3("%B0!
M!4#$!M$X>RQQ$R*J<[Z:RQ=S7@[R2R^CG.CP)(<QLEV"&7WB-F2S.PQ:A-#>
MC(]([*HK/*H"#C^#0M@J%(?/'$\5;X%W5VM#Q3#H%'XDCEO4%;QQY5W06W<7
MF(+* ^MV:#R[+L@+.R%7>>-7#^'<B'M(.P$]^J!O!BK)$2\BA:Y>?S^!!N0R
MB5S!;T)_\EPU'[+WB$&!WW^&@B0=^G<7>W/JTM^\Q!^;U\'DS3OT.GV6Y1WR
MD[2^@]*'ED_:D_![[2WO4W<'S"!<RO;>JE9_Y1-"?J6=R?9<%!'['21QIN)U
MOB,%[5'?WYCA#CV"6_Q*=NB?(4_-L/1[>O6*>JA<"%L@WB1MP-6]7 QIPZ7M
M%%,@,^MJ9((*6%AE_4:KUFB1O!@1.L*85#J9T%U3E4-IB4*]>A#&I9F,9QR/
META%!"5\(9??5SUG8,1F9B;S^[G>RYE?BCM-,D9G?B]R&R>23UK^FI2T!*^M
MQ[G.8)LCE <KPM#-5Z US55CP6D*'_6E+?1)3)#7; &Q?XM)=3+P/!4Q9^2M
M3=F@Y\CLOUJHS'+,[>-8+?@6*06T>M#>FGOL\,?0J K<YW@TA)#X-:TGG2F+
M]%EL>?@EWJ_)MOJ!):8PPJ4ZS,!S7&E3BG1JF=\TRA\_RA'51?$\5<)+T2C-
ML<?$T"22C*84Q%C):H"JWU/LMRAVO0"M7L3H/:7EDQU)Y94*C<$<K&F+PFX)
M+PF*;*D?Q:J095P@'7=!W/&&)[1;A$G(86GE%N3N'SK/:,*)'#AGX2A8VIKN
M%=1[Y*%'R$6V=ZAZ(\.[:GW=I.'T<-!_IU*\%H7>=!4$BB>]586;Z1LM5 -Z
M_XBWW8THA2X<&9]C_]X;/[:5@(ZPC"H%T<BF'N*B_.0M/;U,[4(< <Z"!R51
MYP15S (IIDK0T.FWQ/5A]17T*6=::(X/3,\5WA+RP9%S03],?X$[=>F+/%$C
M0W(IM$FZ&$*9KCK.=K&CLUBS_/\$5?,*A9]*R/B,/R5;A$ 0QQN2)W".;A+*
MPRV^KCV<XBJ0"<_*K\+@$J-2BC(A%UTN:EKGJ<XQYUAGST^HHA[JC6ENBBH)
M9>ABNS %F'B*1H*N%T4U#_&?>GZ2K)1+1"!5L^=G4T;*:ZV(4 4:+2S.K*$L
M ?47CQ)AA4]29,M69>8*'0#I+V"0,-I)4&HARY$UI5(G"-I!48Y^O7ETZ\,[
MBQEB.44[AG#-4F_H-T+)RZ;PH&J!4%+5"T8./X\F'2:1M![=PW2.T\>7R(XE
M]JI<>_FIU"8REO%*U0HCJT5_GH MFIQ#[/[2A&9\=!DC:R[&HE6CM+;#UW6G
MU"!E1Y6PE'[P39_4G]/;+5DMP 07\4*1S$&Z,XZ5DI[2?17%=UZH8P]+KO]B
MR+^4BA2EP8#LWL0B#()*1R:51&$&K%EULHL(H"IDO)\86&JD7+$9=% O$#!-
M!:FZY:(\4]YTBU'V*$)>>/H.>7I498NT$D^FQ@4G[K)5"!_&K/ [D;21:1?4
M1% A05%!";%*%FG!RVQ="Z_P-XT#GI)7/8ZY*L A051PZAX$93"_!8V6>']R
MA3'4'C+2STBT%3S*E^-67ST8[& C4&G8 I5>%JCDMD"E%JAT0K+BY(1;)<@B
M9[X)1+R7)!76@[ ,NH+^K\ITR##.*H[ U'Y(0\&87*4(]/E$Q/-]NG0EQ )O
MS@GV*AO'_WW&0Y5T2;>H? !540F9U\1XJ'*6T0U5H5B6A7R 6%Z%$T:^HC<Q
M5=*FK^04H(P=(+K+A&X%TZP242@O-/^F ',HBQET;5D=("UX188$Z0M(X2,6
MJ616F-O,"CEC\NNRQ.-723*G$WTDEU#:6%8%E]JG<)Y[<0P:XFJY8;J5Z5:5
M7Y<Q$,T=#$1:@BDRW,YXMK@<1J_R\UI$>@A+182!,*<G)MM!O*.3H8I>Y@I^
M(2:&;N+08S_Y [5K&+D(H872P;AA3G"AY3Z+Y920ZKVZ!36NV"(\B#U-2GQ'
M91I^TK&_: 51;#PO!4^ 28O,?RLP+?0)$&JD'&O1+IAPS,30 /R\;:"L!IBS
ME#> 1JV<OHM5C(E3N# YXZ'43M9D0,]U3*(K9^[#^<1%Q#PLQ.@KBN/JK6!N
MV I&MJI?81=XMW'D32J-$K1 %"MQMDZHT.$9&1.8;C<567="[9](-F*Y)=(L
MP-A('Y!\EJF!HLOA_<$G696_7!2O5?8/>1]>+V"/RT#3#553A<OC?0R*.^[1
MG\AP"\V/,KE07IIXWM^E1S]7NYP05O*LJ,:9^:_()][UO)ON%Q["00T,P:6J
MJ][ Y8L$;S&5&E%E?1102KYCYM^IH,Z%K_75I:P"P)1X&?/P;HEWJ[RJR1&&
M>]/G#P8<D]PA [$81TGR1NC$4A0$T4.:@BDS;G(W2GIEMKMYGP5G0T-C! B7
MB* $"I<*CD+::\L-I)$HIO+:H,Q%)ANB)D4D>?D(VI%K27]$-@D]HE95E+90
MC38'NK&=3LW6,AXY;VD0&DX*5)[(#TE?IO3]^M(5O,0\O&B>B"VM01*E6"F<
MJSNXA_^2N5S974Y4NY+*Z$X<2\6:JPIKZ;NH@DT7A ;/_CK3\8R*L6-#J>(C
M-6&#[BJ59P[WJJI1)500\JREEVQ'+3A.$[5%67'$-2UU']!K)9@"S6+!3RH7
M91RMXD26>T@XQ<[)Z2Q<[*1*"19@EJG +=(+E>.KH''KO\A.$P$3#U-HR0)N
M="K D[: -[U'.:@HQ02-$CPYQ>TBU$2YISO&U]PFT$.EX#;^1JSJ<OMXY6Z:
MKT+ED*RJB2M@H&7$@U'WY AEOFH?IU\6/==JL=P+POIZE +<CQ.\C4!-36DR
M\"\J[]F0V_Y173MA^BRF,&L53"CZ9=V7T=E1'R4]E>X)U8/<EW54)AN[R=!A
MA8*W7&QMF'(5"9"J:-9&PBT5*<(NY2GVQ*N%$FY@ 2X+N-PZTVM43:\V*961
M3%D$TKRL_'J%44GVX%K3+C=C-.T),\AD08OE#YY5AXG= O64L3S%&=B93%5
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MJ&1>_GL$__TOQ)3L,#0M6S;D+0@N3@G#W*:^_X,64:V]4;'V5+0)ML5J8<Y
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M:N@M5^A.4'$5X9!;<A5A)=X0-#.*'NH,4);,1X5^%5PF0BIJZI>*_8ZL)O(
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MMBRV;6>.S;KV)!;;DA?B/_[WT+:LMTTGL@6U>E NTGXB5+ ]UB\349U&WZ_
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MF"TV'#4%R6WO@%K>WW9QJB@^C[5WFP!MO[)1=:J1)K)W.G>W6R=;Y: WL3S
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MC7\LH<X+[\2&+AJY)%',3AU'\X478VIJM*:'#C,?9OYX9CYXV>0RF1*:SE[
M[^1,3WT,A?OPTS@*DU5 66/421@!_"KD8W38&P_^<D8Y9!0]QQG4'GSHUBVT
M@H^]%6FLZD/42+0M!"^25T40=-N2&77G ]NAI95CQT0X>. >AI?@3@>-U N@
M/]"[A"]Q1:#GY0S<Y9JPA;$N;$%C$8[CNMNO_MJ*#&7HWRJ&1PU*\149R(54
MX?3 U$]#/G)R,%B?KA^V4K&4'*S*E1OKRY6W-:0:FP4<;RLVGZLD%29PZ>%Y
MU^AJ2N!E,!8XWD)*8T)OS /X!0D+_B<?KU2Z;K)<3?Q28F\T-?B_5[[X[@KE
MOZ146-LY#X3^/>7[TI_6/J=N-3F8-L^WS?,]R3S?_4YHF\S;)O.>4#+OGJ5+
MF_O7D-R_4QAJN[1G.]1V:?<JSX^4_DE4:%_^PYLOWOX$C7K3:7'81\A-[#*W
M7"GC=%(3^[UR9+[IJ8D#YI13&DYGRD?#<B"\Z5/N,.N4$W![SMI=7IT1>MB"
M1\+_DFC_B9)QJ:MDSS#"7E/JVG2;@%9O2E).(^"_96;A(\V&Q2I#\GLYNT_)
M0ODI[Q;5AUB[1_>]6QJR3F\:T@^K*3#^"NSCD7IR56=.]@]9KW>,#Y@*NM:.
MT\9&/A91R]IJ,A;394-W*[3EW &I3D6*YP6!DLL9BI>V 2IJ_5[0^KML4"[4
M?&E;8,!ZHW,K=*05S[,H=&3U66][_DR+1SYK/#(<T\'3P<CM'CB'/3!DHV&;
MG_*C95?XR-H:1V< Z=L*QBQ40:(#P0BACGOBM2J'1,)R-WRZN&3-+#S=J ]/
MQU>RP.;MN$0JC83Z)WTR'=;"6Q)$<+$(0'DB<#B!N!L,-6[@OLYU.3^:Z@&(
M+_VO-V_,GWT>3+XW/WMW('UN^+]7/!Q#]VQK]-;\S0M6V%7SS1LI%B?^?7WM
M6_1*/]&GP[,3-+(>X+$*[+Q>+U]&BRHYN4;[%O'V KXR.W%JRMZ:7Q\7\/UW
ML7?KC]^:G^!$B6G]%.'\V=U^]K7OU'OXMU1$*_G\PW<PTQ5S#J?FCS>W',X0
M-+Z@-9.S#,,ZIRDN@A2J)B8[G3C1M$T/<WZ:)@".G59 _![&QW <S;EYI:3^
MMPP:6K89!0U5/S"C0%3:\HL+A[\)5A/20.!P\F2IGA&)=9@N0+H')G'=>N$?
MF",0)3YF%^@WLEH,Y1B9&"=3+X#@B:,'S*!BQET$(D0D&R6KV\2?/,K/,=(H
M@BA)Q.<F?@*?\0+*:E!AMHXIW"!B+.JKS SYDE+77MD#9@]&M;/!6#Y_*M.V
MZA2VC!J- QI-_<1 IM+'\.$IB%D:OHF:4!3NLZS9<;;7>1Z:CW)W&YF]P(JI
MI-:F5,PGINL5TBY1[?;S?<D?+R] V'>[JTYB5+]H 6@( 8C)4C$?<_\^3;""
M+37'_>"9=[$G&6SAF>@NA)8FN)&$E$H+-LI]02(,GG@U8JYETWNO;)O9PTTR
ML9@Q#"^)C0@[;H%YO&#E/7;,7]:)[EPY2DPP(S#GV$O 2GSPXHDX*QG)#QI<
M./;%8T$TIO0T.!<A_,K(5,2%1ZF\9<A7<3+S%PP6P)^O\ OR-9B2,)JK=#,X
M2X$?X94ES%9H<DS2&W]Z?_W;QY_>6"/8#S#FN3_NF#>KL>PAYL?&7$PV75Z&
MA_WG;VX?W^!_X8PE/N5?W\,XHU4BOY\9$Y;Y1317:Z,>747]C*68$W(PP)Z7
MJNI7[\\VY;6Q4A$5U(5:-N4X(H&&RR9T.W)DU79^]5@N)Y_2Z[O,L8?2D]9G
MEC,P*T@;#'D/JVM8D!>H2Q_Z0S:WNH>GYN<O[Z4\]$$V@  P83#F+ IP?J5@
M$Y(R7D1"GY92_KWW"'-C?DS@_I[ Y."7'N#%X/%-]!""7-;-/C+S__I>^-?,
M-__VVT<2=NKGO_^7"0J%&48DE?\%XAH[C9U*9U#HUO!)/U6:]5LP<2N0\3@H
MFAE\-3_*5K-HFA 0<@XL;J4/7J'A]&TKWAJZX=XEH%" -K4*M#Z"CKV["/HH
MSCW:F63\DJAS;9?9;GW3(F_'ZK90Z(UZ#NNYFE3$J+ X6I4EV^7T?P<ZQN]I
MZ?P$]!6$%M,NH;6[%MI]%"9Z(_P/]V*5 /\KQ6$<JZ"VOY@0.,Z<''Q!]W[X
MO\*I2WU PF6?\"4MZA(,$+BWYW/,CX,E1U& =!X85B%5(4ZW0U3>#N(<(Q<(
M3]"W/F$(1IJA@N'=0B,K,(4\RI?$[6& :/'P'?3#HQ==?E#ZO;0M&?-['J[X
M^J]TS*\S'YU]:*<*4'PRBU8!V'E(#N*A%+KC9*%J_J?LJ(R4/2I9PB_0@%*,
M(8*@!!03X4U$U^3$Y$'"'V9HHI'J!-^>^D$ ?<6>\#63A), FI>4=4K="<'4
M3A*R5N'RG% H\EY/Q72U7,&#8'>"1O9\N=B@7=B2EQR-O*12:->$)9X82T-+
M6=)2EK24)2WYP8N1'^#%+/61RQEUN\J7,.J+6^6&2/FZ Z\ Z,*;MCT<5C;5
MMGSR+1^$(Z>G,7;Y/?[EPV\?/OWS0_&0'(."I>MTJP#YI\,)4IE,T70>%JO+
MK.Z0N>YN##+MQ#]WXJ\<UAT,F-LO,:5L_$JI#L*1YOS*J2C"M;GG^TN_KQ!L
M[Z]OOIK7/YL% ;<O"@*W/V).>2F/0(8PW*4J]OZZ8;&1#:*EG&AY#'Z(T2[T
M$'OKA\4<M\L&HQI5'@]#WC&H18YTF%*/6]3YC:0:GPFZA0$!)!ROI? W.87\
MRF:]H<5L^^ED$ENKY31_$AQW>U;B^O&?/IL"[(*!:S'+O>A=8 ^>4>?Q#':!
M#7K%R+EX9IVK4:>D6^V\#0ZA>.YP:_WRY?KFQOS\Y?KGCU]/?H$<,-V[S"GK
M-I>V4]U^Y^ES</KRRF4]9X!JWL7O ^<9$NOT]P'8?SVWSX:]9]S>IS\)=O_(
MU]9ZN^LP)N;V!P]H[[:=:3MSB,X<1\_\YL?KSQ^^O/OZ\=,OYH?__OSAT\V'
MFP9.3MN9MC,GW9E#LX#?<,(<E\@7]S0EO1ZSW%(0]DCKTRW;4AN4Y7VY[;M#
MUNTUA0S=:@*%_U7?8<-RQ90CA';<T2[AKH-4W_AE>VGP?9]AYEBP9_M-V;-]
MJQPJ/L(Y9NYHB 0%#9D5RRT;AX>?%9L-K!%S&U.OQ1KL4J3DV#3)BM5_&S_A
MR;LRW!$;#B[>J=?M;.6+/6.?'JB&KGWQ'/\5L*<+V@.6RQRW))\O;0\XO><7
M^CAF%9JOA=S;L[FF>JQGVZP[NG@IU;<O^JJR"#O3'3Q]#LYD'UB#9Z"H3G\?
MV*P_@'U@7;SF:KGV<:^L-A+9=J;MS G%*O: >+OZQ_7-S;?FQT_OKW_]8/[\
MY?I74\8LKS_=G+R(O>KU0.WH/MTX.@/ 2_^R,=L.ZP_[5?&S2U,WG/Y%5\*\
MZC'+'K!A.0)S2<+ LNQGU,-LX6]M9]K.G&!GC@9_^_KW#U^4<GDE(7#[!B"<
M_&JUG6D[<\@3_A0(W,=\C2"JB;+G:;'<I@ B*J@M#H\2L9A3]J5?\H1<87YV
M$P!PPV'9TMJ/,ET? %<LV>+O'?$VZ+&!U11>A49 -/LCY@YJL#L<Z,B6 K*'
MGQ&76;VF3,A@!T!D0S!NU]65_'*7\<GZ*FR+6?;%!PEKU $_9Z>=S>QGY*^?
M@<.N0K.Z).^][;!>;=;OLQ4"H-EV[>X+L*XT .!6+*IZ\HLSZK-N]^E+<R9;
MM"*=Y(+NJ?Z0]=V+YUFI,"DN: _8 ^;T+GX/.,]AA6K#BVUGVLZ<7F>.%5[,
M@]?^]N'GZR\?U$]?W_TW$KG]]O'FX_6G?7M\G9[+^J,:WOB]^YY[Y1R#38;A
MGKKAL(';8T.KAAO\()O:&33!_XL0I&Z7N58C")B[H[)!N1_+L;V3V\ZTG;F(
M.WD]'[BZBDVXI#-W](?3!YD[KLUZ@Z=C:\_$\G.?X:D^?>O?ZMN@[UQ\CJMU
MT4R[UG#$^F64TL5M NL%4@U:A;/M3-N9$^I,4Q1.63#]TX>O9LX_M$T@V4\3
MJ_2:.8E6MP&O$F>E$F0[MJ+3^$9#9@VV!MGL)V,A]C3^'>Z5[9,PVLZ@L7X"
MMNH7S=X!#G-'%AN-MJH7:V>@GGIQ OO <;?K%VMGX<2WP16H-:,NB(*MD(/S
M%@66-=H..=@J#-2E]=W2@R_]:!@_++*7#ZBI7>C'5W_.$_,3?S"_1',O9.(7
MS+SAL3]]:\Z]^,Z'IO%1_;]O?OP!J]#FKK*I-_>#Q^^WM4?/)OY?7'P^G3AL
M$/J\:&H_?[C]\8LHWIW\\-WMC\WO\#XG-K_M_K5*EO[T4?[2#R<<&[?E27NY
M$?W.C?$JCJ'UX-%,>!"8T2HV%W$T68V7B;F,Z.<Q]"::\S@Q_="<(@WN;1QY
M$_6<.?:6_"Z*?9Y\;T9_12&'OL$' _\OCVKZJ?:8.7M<1.,9*'&@P)D3/_'#
M*1_C,T;ZS#A*YAPTP<QKBY@OX)Q[=WP"8X@FQ-(IL&'JH8YY#3U=$FI,EH1/
MS D?Q]Q+X*W;1_.5+M?*S"@VL?KI:X9#?*4K%QM3^ ,T:SYR+S8Y3/O$_)5H
M01V+F7;7[IG3.)J;K]*:N^:V5YS.7C?,_O;& 7;[_CK_=<9A,8,@>D!V/!+7
ML+]A2\-R+6>T8+>P-?Z81 ^A&4UIF\MMDUO1I'H7X/[#M67P4K+ +7S/H9NG
M*<+$[(SA],L+\3^_Z7Y#/\-38_7SSF.1-S78;(&W2* 'ZE]O355EN-M]_4TM
M*W"M2V:#[;>#(TS7@+=ZWVQ4-'*^K"WVYIACTN,W/_XLM]/_T';ZD-].-?U>
M%>61GV),'VH:[9>?13QV+S-9)S+:NHD<AQYM_^5'^W[FA7>\/0HUI^O=/%J%
M]9#P9W$8VO&>]WCK1?)>[.2_4'7S;WZ\\0+0?T!Y!,-I^@8TH-74&R]7,=>6
MT>:DZ8HYW>I<K^/0O[AV]Q!+D!JJ,WI=Y0_ZHBP%- 83M0TVF;[%+2[;MU]O
M])LI/;FR$R4/H7JZ^'A*;3?JL6$YX+SQ*]7"Y C==YD[Z+)^F0CX-+I_9;'A
MP&6#,J'<QL^4G*\OT/6-<[*V_XY3SM?1G3D\_=OZ*&/UX5SK>:HGJY\?)+5[
M0S;HUF!1.$C(UD+D"1MVF\*1@]6&R:G6"$:6"G#:?O;W<](9M/JQG/GQY,W"
MBY>/J>MVL8K',W1]-C#VWW;F)#K3#,%="@?L>:8&PRX;UDG..<BZ#7N8&-.4
M@G=8-7)DU:#@V;N('M2I*WI0SJSJW5N,7.U;R6!=MPN*<E,VC,4LI\^L<C6?
M(_5G9/684P;?'^MP=^LPOS6+1&J-Z9N+Q=;RYS09D@QSQ$;NTZF4ZD&G&C\-
M0P01VA=/5G+5[]G,ZC^]), 9$$L-K&=@](]K*:W%_'[-@D6V#:[9,#^-8*DU
MC+-&>Z;0G'8NKC3DZ<ES<1;H3Z=&R=<6_%FGGZ+!__7FC?FSSX/)]^9G,&W>
MPEO_7O%PS!'*U7UK_N8%*^R1^>:-W T3_[[^!20^KI_H$S1L)Y12/>Q1%29U
M_=VTC!95VV.-$BV"FP6H4W;BU)2]-;\^+N#[[V+OUA^_-3]Y<RZF]5.$\V=W
M!]G7OE/OX=_2C:EVY0_?P4Q7S#EBW=[<\FD40^,+6C,YRS"L<YKBH@.K:F*R
MTXD33=OT(H_S2V*Y?_"5<6CL$A?U?VS!WW7 W]V.[?KA2X[H>A4;F]8&_N%#
M=Z%M.-MAXB?+=#4C/S!7"*SV0_B_)3RW!,GAQ3Q]&V&T(,)GYI3/82L09I;^
MH>'DS/02\P'$BP'_+?EYX5S#RQXT?NM'\'5J '^$*9D&WAP^&<6/)I]B("_9
M+\KZP"MS?GM-)7H41<,JWB@>\@A^#$&_1NS^*QU,)_R^1C9L!>,+_+[Q2H,)
M:L#WS:\S/^V(^0![U5LN8_]V)>Y+Z $VH-'FWYM7_K>F9]JCCO4Z?0\.BACV
M?12LYG""IL;6T=-DV3UFN2X<KH0GV[N+W;$&S++JOM$S)BL:A)?KJSJD\$M8
MWPG,PLMM!NC-(DJ6;Z ]:!V.? (S1TA\)*6/?51O)@9T OO]?N:''/K$009%
M\T?3FX#6D' 02OX<M)(EC <?D_%.1/LOH@?HM]Q=:>X*BH^8P\3"&UC?P@L"
MG<$B!DESM691C/3&HE/YEMJ[\FFI^[ OC9#?>9@'(/LE%F\:P#LK:D%DSX "
M!@?/%%DW8Q!??XX)_6K&($&%1,3A>-A!^&WNSUKBPE20Z@2#_?+KWU  1^8_
M;WXRQ;,3<<C^>?/*PG7%)_J=?M=Q90>V;Z#LJX-.M]?KFG(U$M!.35RC:((S
MC/NGE;P-T[?J0%WVJ76=W\H=3S_;OI;56II^%!0FU*W"I>>'*"_^_O[C-3,?
M9CX<>1]UK F*4A(L*!K23\"SN)= =AH\O/?CB.H!83+>ZC8 F>WA56$F*V@'
M_CN+DH6_] (A9F?1D@?PZ#1>^4OZS3V_XW1=PF_IOP^H*^)?%GQI9C_0BI-&
MCVB#(E=CK^;4.819*75.@K](G9-(N=K*G,:R/4V9F\/)@"-02Z<;]CKV>IW.
MJ#\1-'M6K\=LUZ&H1U!7N;-M-NS96]\QU"1US(\A92F"<- #>W_]V\>?WE@C
MZ.Z2?$.,]"SO/_[WT+8&;V%#D,KB!>;?N1> &?8^FL_]),$QQ*")S>?B4]@6
MR(Z-MPXEU?HPYIE_-PO(8//'/M86RPD;8<>9WATL!\BP7"]!.JQ0-PKIB[%4
MPF$_@]"X*RIOVW.,S<DJIK30S5OE[Z!'@IJE=3*EB=ZEU=$"?XH**([N+QY'
M;ZC'H(""@'S,*9Q2:,YH-HTY[)X5K ENH)PX]:"YV/R)C_G\%OX!_;"9W&)U
M1UEUV!(0$3[,ND=YWF+TQL:C55)OS9=0;UO9WC!5L0)<UVJ&S1\1:H9E?UFU
MNPYDQ<U/7]Z9R1]H.&8]=$H-E-JA"9T)(],;^Q.AQ87><@56LKD(2(GD28*&
MN?#+&?,(/@""Y*]4=K?'N]DCVJ"ZE3=33E,;=/I"42/\IRU(,P1.MJ:69KZ2
M2%;UO/$LAQO,B-WI;?2NK1D7=6; >H.^4J&VDGZ0VC5@]FA06U/KF36=:NA2
MD<XOY? B;A5X1CF\QMY*+D-.)]+.LP#U,/FE #24[(<2J="9R0)ZJ9UC0I7"
M"2K=!$;%#O#&XRC&MX/'COD[F&U!$F5==:V*<,8J0AG!W&H(S1\1:@@EUJ3-
MFL*2>\R<@&GP!\J)!SB,("?@ZV ;\HF/@C?RT:D3^V/AN0'#F+?'M=$CVG#E
M%W<'"N>L<Z;;<<6=+S'SPC6C\@MJ7_LZ P#?V&ASJHM?=6.3<T8]0S=*7 E)
MQ]U9W,_")(?]BYZ:5T.[ST;ND,&P7)?U!X+6Z97=@U$.AGEJ)W%C8HZ=[P70
MH6@Z3?@2)\JK4$*@]<R1P1]?V?:0=8=#I1>(*R\QLDH!K,B4QZ1C'_)8G<H)
M.AA<I9#+</#K[E06Y#B4A81:R2U1]77V+_[ =3@"-.A9%$PRIJ\,7#!S!3V-
MQP$VB02%PMU9M).]Y1C^3(T%'KP1/\*I!X%R!X,\XA5XDJ1_!Q[1)N1)?AOE
M35Y+W7\R^T/<?R(QJ+[1*S)H<L\;+Q"8R%XYU=>?V/YR>S]@-RLW+UV$]JB/
M]>CP(NS:S.EWQ45H62Z":O(7H;K -IFUK:RLW?D:>&JKQ5._+)YZV.*I3PI/
M?=('_X6UUO=10C)[_\39K?[Q,B-2*Z9)J:6.FE5;B<2%HP]V29?WU _]9 9*
MPAT9YCEJ.;A@OXM(:QG#SQ2%QO?6$<$@"(?2(]'DA"L_8<:$@Z4Y]LDE*SQ\
MT8+C.P*A/<8P=RQ^0I0.:L\4Y/ESP4,PN3OF>_D]/21R"(--'JPF7!KPV#$O
M2(<4W2H$$JDH!@:=8B\3A4*-6VH\T*%Y)/$'-+:%YY./.XKOO!#F-M8JG-!W
MQMX<'KD3#F8/(UG(H @_O"&'. ')!7H1G];=!B$>0&L2+[F<10DO-M@J]TUA
M])8QS_S&RQ.\6\QQNVP VBPJ[H-NQWG-M!MJ9'=!C>_5 ]F\<OLC4(2'%;!7
M0\%>B7"^U".,E<#>DW"Z(4+ \2!9(\(ZB4V;8ZFO84M4LXUWC*\%2R"JZA!:
M$E)GST&:</<G((I:TO+LMUO2\I:TO"4M;TG+6]+R%YZN2R.U;L=[WN,],&EY
M2TA^2NWNEZMM,S=YR3@G")CUMNGTY':_QWINB63J--B]^]:(C=R2KG<:G;]R
M7)?URI2G)T),[@XZ);5S[\3DM6E!UQ['HQ.2NUWFC)I"A>DX(^8.F]*;*WLX
M8M:H#@GXOGLR=#LUR%P/P[6_135J:<G;SC2<EOSY8OO0=.2C+K-[-8HB'(;.
M&>Z,47-J1O2[K-^O02V]=R'=ZS9'2.^PEP],3FY9#G.<IE"3]^"*MYVF\/Q?
M.0,7CE83-O.@WZEQP@^H1*_U^:PW=<^+CARE;N_I],MG0L/MV%W6&VQELCWW
M:;BR^V J.4\GIS\#-O)AKU-2B0[*1OXBMM(68O)")'_;>)M-4"[Q%+4&T3A*
M[A>: XU!N>A9N-(HG2=/PUEPDB,\Z>DS< A.\M,"!#6QGR+-K(  W:EJ;)M\
MUB@$Y=<9-S#>D&>>4-C=G"VR@4NTP$;Q2D:/:D(39:!L*VU%;V=V,\?M#,LC
M6X5^"C'>QHZJH(;^''YSGP:>_7M? HRI):+%(DJ(MXID:BM=[M;9-)Y(ERL9
MU6K2Y2(&<Q4091E]KYKAPQ"I4)I&ZW1YM$Y%(!Q:;C>29?54%NMXTAOC:3M(
M[[I4CJ]D +.6Q#%>B=AK#6'SL@2554R=QI$(*O48$<=>3'W-<QY)L@2U6#DN
M15-S*<;\WRL_SC EE>D:_?5,F$;*A"GI'O4=E6%I5-\$J8YRF*0[.AWM[MN4
M_Y%^@>YU20-9YG24=X@@\_:R](Q&<6<^@?9Q.[GE=GI'H[V63O-::@*CXZFL
MS?%N(0P8[G +K:&Q>R7CL34-!Q%*WLI%L/NEH\<!?7=ZR!4H!R3\GWSR1I4S
M2&T)T0L_44,RQB!![K"@B_QRWI @:G 2Q'7MB=K*MK%%JN5U^!>C':Q8-./%
M: ?3O+@C<C.<=#[CH>5V\VCV3FN]CB?+,5Z^@RPOL?()42[A"#5%N812/$^6
M>]LZ7=BB1!"8HP)$CC62CGF:-2*5L=P!LT8N,U\-AZR//.:O>F@B#02Y3,]E
M;L\JDJP5Q%=R9':9-?M'[>/C;> :M#%V2QL3OBAMS*BEC3E]VIB3ON,.'IHZ
M-A/B2:_6<4;T.S?RS-R(E=DE7)7GQ)/.30&]JLN=07"U[?&I'3CO"D&64N<W
M4]\9E=1W1,MJ63:S;.2 '?;9H.=*Y:3/>C#D:N4DXXT\('7KJ>SZ%Y91GQ45
M$'&_G&ZEX#W1E4CE >_G[TUOM8SJ,)B,4!^0;\8"H(:OMJ0F+9-#2VI2,=J6
MU*0]"BWI13O>\Q_O@4E-]D%_H15&4RB,^?$<@]>"]886L^T39;:PV<"U$%%W
MFMVG;)F14\KD/Q%NBU$Y%6\G:HN7QX6??<!_7[68LF*I5B0W1VTJMS$1FXXP
MWB2J\4C1HEA.]6&MX"TUHZE!+II2B%BZ40CX-.')./9OT7-T&]T?M+S3J6RB
M%_9P_!)'26+ M37U]^C?..D9/UZAF3M<'/2&PN+L?&8MUG/[B(6D4VOWU;%U
MV&B(^,^^.K8NZSD#U'@V'%M6P,7D0J0IMW4>AZ+=N'BR_62\2A)]LHF^6(Q/
M3'J^_I>-O:7NN0[]<UOU+NR4V\^ ?_*#$![?=G,?OO,BTG,-*^%AUH+Q0?*X
MM\# A@D<!).D]-S"8YQPH2Q( GL*(&.Q6)T/HY95T_/GQ%2RF5"\Y?[.?GL_
MW-_K0^;[]@_LP4'02 _ZT69X#P[8!CO7]S/:"W*N_^;%OA>.C^9>/YXD:CVS
MS_;,PH7_PVW\W8]UZ4#.9^CM4E_,T"]NJ4\HWM+3*-)M#+!?L^6--KBO-X]J
M@W>]5B_610KZVQN0WO<!ZSI=-AIN(L:NU94MT9!]S\3&S]>?#C!^.IOB*+7Z
M4MKQ)[0?K"ZSND/FNB66QG9#7.2&N')8=S!@;IG7;->^K(\XGLA>N'*ZG4WE
M#^K-PB&)^:]+GK/O5?\;1';==J;MS$EWYM!DUS<\"+*'>L]3TD.VJ::02'<[
M)4[%#1?NGCJ!*E*W5Z-TQD&FQ"H3Q1Y^2J[Z#AL.:W1D[]S>[JC.?!ST'OZ%
MAW 1!Q23\B9SK'R]C 5IPZ'.,',LV+/]INS9OE56I8YPCID[ F/':@I?O^76
MH:7?]ZS8;&"-F-MK2@T,:]#=0<(=]C)>ZV;[PA-.04.B#N#W/(@6Q,]5// ;
MW6)-9BAW1VS84M5W.R7-J/84U'.--GGTH!JZ=LE5='E[H&X\^QSW@.4RQWUZ
MJ8(SV0-.K_/TZB7[TT5K^*2VE&@HHZ^V#;/9W/P]UK-MUAUME5K-K%"PPY;=
M.A5]>_OEM786M@JN9F\#B]((NH.G3\#9; .KHKCLI6P#F_4'L VL$ZW:\J+;
MP+6W7V';]L%>BW6<!*ZZ'G.9TS*7A2_)7&9U6^:R^E-<#%Y43<R>F<M.Y3@?
M*'5%AG0,WB:N-#-Q!3/EDD+<S8SY(N8)T38O8A]Z"TW+Y%>DN_4>8SCNY &\
MY2&?^O#[-#56)+/Q^2*('CE^^G:5()M_8BYC[YZ+]^;<"Q+]069XB?G L4W*
M:/N#YPRS$Z7E.JE4ES:?Y01H<-JDE39IY8225DX.T]UBV,]VJ.W2GNU0VZ4]
MCCS?-O -C[=O/^GMPR4+58 SO<"+1=D>9=LIZV]M!&V/I&']:M8MJ\^Z98#/
M<?C.-C:\IO].OQRSV/B1]3D8AYOS >N.=NMUH^:\"IW6]#F_LF"?[\;K=W!F
MO'5=[Y=1;YL[?DA(ZZ\E[]-&P;VVG=HHP!%SR\':(R$2;:M3@@\<'J?9<]F@
MG)9UI"GIV4T ]%XY?6:5DUF/@$(?' R%_I0,D@^H(2\]7Y2,)0=UP?E\H%-M
M6<P>U=@XASG6;A.22YP1L^VFX/2K]*PC'&M[P$9VC;79_[&V.C62!0YX$Z^U
MMJ^IR$TQ9%7+)&XRSI(X)&L:]F<+-K7Z%XTX=MFHG(]X:7O ?3[>^(1'#VK#
M=NCFN6\!,$..BCE_B72I'-9\U]NJV=C2ZKSI"P265G&H7 K >$VJ>+L++FH7
MK,F.KSW\DD_R!#= 96)^_1EHJWX<M?.5^,=\+0"QQZD0 "[U:T7]+T5@S<JJ
MXM;<0+#/C!1K6:RA>N5_6ZBC6D9)4DU4X2<T"4YISG@P,>=1S$U=P@3)&K H
MJK_TX0UHV0^75&B $R5YR!\,77A@LHJ)S'S3T-Z2D^W*+_6/U_;$4;^%(T05
M2(!/&EZ21&/?6_*)J!F;>/?0&P$Q+335@++RIW&:7A[?+1E C(T,( > ?)_F
M>AP/\GVWG;DE18%G0.!;L-_%IE(0>*S$0)IW2Z]A!?-H.O7'**3XW$<T. @2
M^#<>?BRZ1%T$*;;T_Q*_2-^8>F,_(%'&J- +B 0AXZ;P3?$U\A:N&6&+*V]Q
MY2>"*Z]R/+1U$DYDM"WD_/S/28MK;0JN]12&VB[MV0ZU7=H6C7X9;S<<C5[<
MEX<'Z?8'0]9W3QB-;KEE(J6F(Z/[_0$;=$\8CMZS3@^.;G79J"EEYI^TT<L
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M?SFC#'U"#.$:ZU E=.L66L''WHI,?/4A:F2Y:XB3\O%EC"DW,4;%YMHZ,=@
M;4*5VK_AJY7+O^3>/$%%&M1T+P@>C6@Z3?@2=P0,MLP[D/?MBL$(%]O6DU)_
ME;W$>.#FQ)^88;3$^8:5$2_2[M;B8>L7CTA=T.W8KA^>M,1?-Z(:A2I[;:'*
M\$4+55IMH<KZ4YQ5*8]4J/)"1,3+4YY\X0E'&4Z<)Q,.MUFT()*;ML9E@PE/
M8KEJYKI5RU6Z#!/0]?&ZU\EE1%;"8%1PF(6ZAIPG,0^(H0AT!?XG'Z\4/TFR
M_/_9^];FMHTL[>_X%:BLLR5701R2NB?SIDJ6Y4097S26/)[=K:TMD&R2B$&
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ML34@Q&'7.^X<W:&\FAQ\QA'0]SH,AC18&1L\>_G^K) Q\;2['V! W.PYWLW
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MRA06; *95X%W*..9:6P'Y$R]&,13G91;%(YPKJT_04[$*&40X:<::/E/W/Q
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MHDMXU!._/P:2DS)QM\!\QC%C6&BEB]EC*6,>"PD9Y-I[E-NRM]!SF!DBDT-
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MH$JUA*R?CN$2"(,TX_+O/A8"IU)'OP6C\>XY#.+:#PG@;^>,BT#-W%,L>>\
M[49^I4FJBD1#D-:D&@!65K\:J^@O^+][/LSA\8OH1J4$36F7"'X=3 (<RF51
M1< ]1WF3," \:!$NN]U,40DEW8!C<*5A&?L*2QYTY0BE*J*R=L4P7JDD<C\&
MD7O&2,8P+YS(<_<L;GGNZVS0PEX*_,2B&[>FFY;[*HDG^+&#Y9GP*Z]8DF(E
M#%Z$O1"O59;;Z_ J)TP(:Q@PV<I<]2!,QYUCESMN4\=.I>."H(HA0"]]8CRE
MRC ()(G$""-\BX*!0MCHTS3P88A1?.,3P$41R'J*!0C<Z\3'Q&SWC)0"!K7
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MC7JQ5L>,R,DQ^[_)4]D^CO$N3YS*>2] P56* 0Y!.N9+'UU8R8!.,XE!5R(
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M&A@&0?9T9 E<W] GV7SJ@:\\EXH\2Z&&S/V??__O]\:4-VQ&%T,'SK /4M8
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M["?*,@WK#JGPK%@.R%Q@6Q02W2AT'R1D,D<3)%KMC3'!DP0+K/B.DY.7S)K
MJS-9& HQ2BB"+G;5<(@B,33A+<Q8>:.2$59UN;(0,$00]ZS=00&<%"_9()HK
M%8\A?261+T 1@:EQN1HWP;(JE60B_Q:]%>+4".-HM(L!=[@[:'V'66,IJ=1:
MZ_J4:YN,&CO[>L_H;9RA;4M'RY/U#B7'44RX]4QC&G_\]:5GEUVZ0O]1S#Z8
M3ZIB6.(WM>U-U^2AJ%.K4MF-,@?%.I0.4Y*+HBB<#J N20VK>SV?8MEG#_UH
MW"=:G'1.(%?\@26@8M !UD\KCHV/2"7$.J;PRK-.VVNWV^AR<B>P3&-'4"K3
M8HPM]Q2$948!#6=Z>>#MU+U6T;_=7\.XA^C2#!/OE?";YI?2JI>DK7O9V&9\
M:$GP!S<!+++%4#")+HXBB3K&=Z"C"6+:Z_1"!%C'!4F%]UFMSZ-N%FE/EE&!
ML\70E !<[<^<O"/AS&&T!4K2YFK;VB4(S% -BAXLY%0RX.@P:/*X$!*L2[F:
MP#FYY-.S Z][P&LOO=4N=8$R4XICKF%!R.\2%4QZ>9+J)'#D67FV&P]WIW'_
MDV(0BH@+@U'"W*!F;4MU\J+*,'IJ[(=#KL[G&R\EI3=.XPS_@)7*$ "V@,25
M-8&I(B_'1P<YVJ+@W).N!YVD><#ZF8'1[1?FUI1L,HE87C@9W9&L1R"#/!([
M#-+M@NG*AI>SVA-U$P#;D+.->?NP]# (ZE\76M,M]&:XG,0+3$JK4[YY:U-)
M.4V6SKDJO+MH=.9D>?6IV#5VZ9)%&>B2S4LD2F2<4YH$Z2#@C0ID#TKO.@%%
M\(4PA9$:P,%7?3]/#?>:XW)%RNX@5GRI4JYCD6=(0Z@/IU>??4E7% ,GD+:B
M)&1GGLIPQ%@XC:D'=R/->X0"E<7E.< IH,7_GW__K^=RW0O,'1Z-T)+)I:GP
M5H\_!R 5*!CZ,WBRR%PP/2(GR2.2E$A@RZ5@(X[K>[NAUUS5>*!J)84[-WG&
MVR=5_3WXY9IAR($#.V03ES1AD&:BD#@J\LU;3)8'1H-8XI*S<JM,5HI\DZ?5
M;X ;FLP59!ZB%C$ 2:*&K&#HDJZDGJ#?[2&>V1;F(V_3EFP?D5W'CM\?!PJN
M*-EJ<_>.8C^$-S4%,%0"XO-+R<Z21LX5..E^(]<-:)(3TO$RD+'[F<>55".2
MSTD/A#%(:A3JB\Y *7)P^:$2#71@P>@9V8RO>=9$J:=Q$,9I/!W/Z T<7T)B
M^FV<?()_61?E&6I%G>;5,O/JJ1"GGU*%XM*<]#32,8%72*4M*<_:[XM(8Q<]
MILVS)$FC]*:%6&M48D;#()>W:,%VY%G+J>Z'AF,HKWN2H%#,+D?2SU,+7>"[
M3.'=L!EAD)HIW2U0%I*B6#EC!;'98"E5J#IT5!.A(4*5JPAM]8V?@*RVU]'B
M'SJ1L8JO=;*<DM;CZ_"6]*=M6NLZZGF0$VOY69=\6K;KK#WGKVR7?%S+=U'C
M#?OA%\=R?CUXM++B?_ME!8W\(NY_=JU]27N/F:[P[\"/_PPB\N\M^[_7>'\M
MB#DJF*QV)#I/NZ=ES^:W?[]N^ZJ^UJ=>HB^B\]7R(SDB%NVLVTFA M>WZF%'
MY2,E0/!9*2"<%Y^5A[3]P/]IA_X375Z:YK_Z]ERD0?<T+T/^9&HT+&!3?_];
M;Q4W^8*Q/.Y<%RSPF[1%,Q?Q.!2XS!01)SA(U \2@<ZC*/X%U5(U=CR5K2KD
M*@VH8T&9H:3&</*GH!:'(%-U.MJ]5GSC@=[ Y;.*@JE%KR\M#ZFT:2R;=U=U
MM1%^+/0]P9I_J?KL+( A' -K=$[S$2R?2_5O2449H2M%AF]^Z])H*]CY)J-(
M P^6E9WB0;_D\-7/D-N$NW!T^5VK1QGPV_A&#Y@+B4U!)>(\G+&JJW9[E4_1
MB9%R9Q9@?N!'9A-]PD/B-QQ[K8'VSN)2,0 =DXCEH\SH]EJNIBO8COTC$J:!
MGD+$6UV)(*RYR?H(PH\ZHY4:QGK%I?31+DRSX+YAIK>14UWU/CT-M5V&". ,
MO%!9R(8O2]ZW.3Y7060^'6:"&52;:+%K%YIV_1[B@A8=G!<X\9A&<3J=QIQ<
M(/9,5KL_:-C/LQ!8+$-&+^I06T[1P%G4(;0J5.(?0:ATVJBF5Q*,5FB061])
MY!O828+4T3B9XO*FG%K,Q=->Q\7VD<56,[K7\2ZH6$2L7* BJ,"'IQ*)&F [
MV]2^C-&!EB#K0?A2)+U(H9T0"\X#K5%,#$5)2/7S@F0EC<!"!$4#>U*)DQ*'
M+EGU$ XLI^KM\R;+E%.A5!4K;#$>NV.?)G2C#H(AN@#TA$"LXC"( A<6OL)0
M'C0'FVYYU+!K,@\$,X:9Y70LUL 0:9^!>\+2CYNP]-6&I1\T8>GK'98N]DD4
M:ZH6RJJHTX0SS\_@BCFV4W*N7_L:&N$5\$%@U_^%5GFTPF_R5+?3"V/=E;1K
MJ6(%D>"UBJNZ'P/;2B+[3K5=-%3/8X$D86I6#YD86*NL^&A06=XGH9@4T6U:
MY>VCFV_B2UKNCOH!KX656-29[?\@UTQQ:]TO\CR(>\'J31<TW>.FJPT_B#A6
M;') @>9!=FH\P9=BK/M[FD]_V>D\!W*!#Q6#1+W=?^E%M$2%1]ZP>AF +S;*
MR:7;;7736>V:P*'!)?]_/W2KPM_CKL^5'X)8P.NS\^QYLSSEY7D11WG:K,XB
MXL&0(%Z=4PIF:E9JP4J](T-,LU1++-5I&+KO,'245\A66.@;&F"S;G/K=AUG
M^J);[>J(#WR%PAL(C; "HP1K7:/@&"<_N<FHM]-M[WO=O6.O>W#P?%[ >W"L
MS][QCW66#LLCO3!BYLNC':3O[H]WRCX/;N_@Q_I=!RUL=8+D_E?'>FB)OW;A
MOS9FYY&6MGZPS[YZG-4MHWS4'WXYZ'C[W<-6N]VL\LH&NV"IN?45]=&L]@-6
MNUGY9N778^4?C8]WV][!4;NUW_#QQUSEHXYW<G+X;59YTP3=E491?SEA/+I8
MNO<((<AKMW)??8X>1]3<F)5;94) Z5IMUJY9NV;M-H#;K4 @^TY7;@5"UCI(
M5A_'0::^QFXX/XE2:.S"G*$U(H\UM0M^IP>K>^ ==?8: >P+EV_5L3W_^1_'
MG9/]Q\AH_'[VY+L13IJU6Q<NVCD!\>3D^^"BJUVY?;Q_NH^X<ALAV*WA9C=V
MLG4Z)HV8UEQKS=HU:[>N:[=:;B<)Z<VZK=LMH86II\6$67GZ22FUNP$T*T:[
M4D"SN6W[R8TP*RQ<Z@!R]L?JA,?%:7T/&M9I&#XHJ^5#ZZKE#C#_*!&D\%2G
MK/N]&)&NB?QN$1B\'T>XI9B&GL03][V*)D'4"PBV'6$R!= ]81#J!PVCW>KL
M=X\/W/=O7F!F_;,.,(UY7*E'..<M((5ESOKN:JAF\]-BWVJ\!.=E42H1MDS2
M9=WY=-E-GNT2^X55'8+^ND_DG,K?$@3^*9:X(*R,+9C7]J6@"N:)@[A79/,@
M\ TL#F2VD*N4+ EWXMKUCKDRPR<U*^HA"TS9B&J@,R87@88[IL01\/TLB'+,
MD+;&8..G?6]9S7(VUO=8U!YWWK(SP9V>AVC:["D_-2?HMHLJABO90K\_=FHP
MD!:><RRRZR?9C&MQU;*+\J%U/U!1+X+U,8]PX3'K99#DZ!L8CBYS?-<0N-SW
M,/B,>%P(BTYL!!IW=_:>,T("%Q!>/+X[:H%CX90@@74TP(@:!=M4+%JFW;EX
M!%>W^WL>*;=S0FT>M=QSF367SBF:=BP.+-7,&>3;SZ2R$->5(=%XQM6F<( X
M#@0S\P<W5$,^BC.J=I3,%] S)>K[&5")+B=T$\2A+]@4CF!%NM,8CF: Q(0B
MNM2_P<HX"?3K:?Z- _.#4.0UKI5-L%8!0C]QZ2%=_VJ09]0>%ND&,4^J6%,-
MMW0<1RK-<%Q2P-H9J Q[PM(TUU7B8<)90#&T=@0*65Y O4R\B#DBN>VU=P?X
ML"S<;1)DF8ID 7FCG/O@.K@*&-8\*&T,$<?=[6\/6]E*-EDO&AE4.>9)/1^K
MME'V/I9GTT7IN(95E3#IX/7C9,#4H*L]6#JQH8F53<6Y@$ZEP)EW][D)2#8,
MLE!JU0'G8-!34,=PQ)X+[Z'MQ?X*6%NQ3M;W6%QCEZJ[D:CY1Y[,'+LEQ(R+
M KA8S)<,S!KGA*LHRPQM#O-H4+=RE^_/W-!_RLH5S2E:3MBXDWU2Y;.B0")6
M-O'0!SV&ZR*1VH2N;Y ]-3^7"J]TP]873JT[OE@ %J:6P&V&%]@0*4P(#ZNP
M(?QB"L2I/O<5+!J5HZ7RC@9Q46XTHD+H%(4<& 6J/WRYU=7UJXH^B3/-DS3W
M(^K0GT[AGB6^ =3L2=U;'AI5];-AI2SD9 2)2OP!(E#U$X6W^=UO5A['FWZ^
M>$R:Q1.IJPH'T"RE^8'N;JGN5/3#3U,=.F2#E0'3C3@.DH$(DJ;";V^F)T/E
M'I&?LM9H5Q,J=]0#\O6E-N$+I)%[R J%@(*V-'ZF;)+>_:*"E>.'N&HWV!WT
MX4DMHU0J5Y;6CX=*-7<)[ MZQ^=O5!A/:9F :G)N?8K5C5 B$XJN$$0),QSK
MYR%5I"Q0P'BX?BY(T,B8>22Z*)!0Y<2: C_ %3E-HZBC]U#NT^=)X1;UB<_Z
M6.20A+SI3'>%@V"E/E0C7P_!+<J4+K=&+7?^[GD8.T DWAZ&H""Q1'&TRV49
M U-."K]+25#-F.!P61(65E-[O;768)W88@N^KSMDS8UO[_+,% D^!^X++(.A
M6MS3C)4R&R7Q/!IL\F2?^LI?O:'KE&Q\U6)2D51SOE/1IZH*>%THWG:N$OZ]
MF0'7G&*US:3DDGE50I"N T/?Y"EOWR%%)%-MWRECZ),P(E*T:TIYEM%+T3%0
MBUMZ'Q%0V3A5 .V[/>7H*NODDNC-N CR7$7G\B!9?L/BY7XA9L^5F^QC#? L
M4RS?LRN"^ZC5[!TN,%[RCE##9"4KK)%P,X%FFH-H-FM98S)&IP2K(R-:NY_Y
M+(Q%?CC#LLP"CJY%8;*%:1.</7)'3XX$LQJ-8FZJ&EN]55HDD.P&5#=](.8I
M%!T1W)UF;O#8K>KPPXK-T,G&?H9V@33'^0=*=!9=L',2 PF@9YZK=))IT:K#
M6=HTJD6N:Y7C$I& 62RG5 N/79#@0!T*TC%5H)ZR:@&=.%PK'M9F'$QAJ[);
MK#R]"+U?#+<@B!JZM4IGNC<(V[[M5\L]Z/4G#7I]M%+T^L,&O7[Y)7X*]/H[
M#^JJB^)MOJQW&:?9KE2Z<>:KC!7^8/>U@HOV'F?OFD]V^Z2\"Y(DYFR1_?M+
M%WDEB3 ,62JZ*V($"\]057B6HB(U M' N-V<E_X?.6=OT\U<R>?&>MW438\K
M9\<1R <U$F9)GJA4K;E_4J9:MHB@-%;8 85UZM#B@$*G-;N0:1J?*D>ZV#(+
M#CW(3(LTBS#X1#)@OY]/L=)@%*#'$\3 D<(R.4X2AXKC)J#)KYB0Y_;RC"7(
MDAB5D M8%\FCI;1%;I2IN+85EC^LJ0Z]36=@\YDP&E"<"UTDWKT,_4:97BL2
M@R<=/L$67Z':6G1RR619WK]%7J):KD6UVB<@#I8<*UR^;KY]!]OWW"E5TW.Q
MFAX5"I.>Q+E;%-B[!.4J3OW0W?^)HBP(2IS'J'_"\G6ZE)TN36)*F#'/%QY5
M,Y*&EZS5X=/E#DO6NTV>T/9QD\L$I 5'%YVLO?5M_RA>]+J.G\^5:D,.W9J1
M7Q9/,@HP>K^YHJVQJ[5,Y.:$(M_,6:9REU:D(#OFL#?CO]6>O6I]06$204)%
M>='O">.L-*];I6Z^-R:Q83-"8_%]%MFYF\\GEX^$@Q>EG^NLENX.4H2^D^:&
M?:O0^ZP38F!B03T;<R^)ZO&Z,AEO=&L]UT6S1<6 ,2A7#8<2W+#@+EY<!K-\
M.U_;Q:-KQF,4&S;"LA!..UA>#.K8+*B)R>CI3N/>'SS@]#[;ID.V39ITB/9L
M-*:"(E%LEFW!9:,M52^E:QOV78RYZ'PC__K<+K+6@P&@20 :B EX"^-HM$N.
M=M!)L*2I8],(AW'>N508@&:I*K95FNIV1U3+U$_',FS0Q>@W6.#Z@>*\',VG
M2-UCSR*0'2JM \7A1(7GX0X'0J*"22]/4K:>#RG"PT_CB$QQ..PHI?@?JGPZ
MJ"$KQ\?@3[36B8.#<BA,'Q,%U!:-))#9'+C:,Y8H*F9;.^G*&8-#'5/07D@Q
MW JC[13;]9=X/5$36&?Q-F#<Q8UBA9,:L)P-0)42^@C-)+#(MDO@3]BW8!BH
M,CTYUBV$4^9,05=B@2A:@[HJ#4C?>3.5P:&"GHL]W/9KY&YK_GZ[L>:OUII_
MU%CS-]B:OT;RWBIUJ-47U>66@@&05OI_[>ZA 0PX.W]_?7KQUGE__OKT^N+=
MVZO?+BZOW-.W+UWZYORE>WG^_NK=6_?Z_>G;J],S>F:#%V+SU7NZBYWW$G1_
M2>&VUR#JI#X'1&[RW+9/KWH7.:]4+\DQ9KI[1)%R>Y[(4[_!9J"@^/K2<R5T
M#L73JRGL(LFU\ 4K-3JJ]G=TJ:!_Y74>>_ 7??+<U_YM0M?6:U*CT'SP407N
M:XZY_CV/W/\>DP^FE-E;TO)H1!Y(V2#>LYIRK:)_TW.O5#0:0G/2!DJ!;AB
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M?4!#(SF2T[GGU46IHMP1)Q5FHH\QWT$BZ(ON5'!H&O7;V!XRLF )T(4GV:[
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M7)+9BH]S%5M9(/VV>EB?Q2>K'3*M=K>R1;N60^.80?IZ"Y&.0<F\/6\T]NT
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M544:/N7>\R"D#F=CH&.?BK_%Z]6ZZ?)=;RQKFZA[HBQ!\EP2S>@;<;V0!X:
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M#.]&.G\M:;1)114+NMB4E$ _8:WR+F.YT&?5=[&K0D0/%@74>!)0]@) I_6
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M'UE.H#,1"L$YFKLU_6GZ*R$:-?UI^M/T5T+$:?K3]%><L]7TI^E/T]_6T5B
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MC#5UJ%ROSR1VF8PWNP-URO3:_W=PP#[9W.G_S*XCAQ]<67><'1R\_Z5OWZ\
MH@>['PY_9K7FV_P.H.G7=#V_SWWQXP\.*&^L>MB$=P:>8_=SUEX:K,R;%18
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M^ !:IN2'Y)L$)@0#C QO,5@D)':Z9PK>4;+(U!=#"GS9%<6*/QG\3,F[V2/
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MZBG Q5 OVYVY?C&S[77]0]%.1#-\"E8,+:&QHGI,(NO)8JI4G"PK!2C$EL@
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M^6UC^);:7HK6>K;;<R(2'RDP\>?:#:W=T*]#)8W'.Q*$T^6Q.7EBF.9 Z=?
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M*6C' U5"F0&1*OP2*0_'/K8>Z:,_(VK]"79=-)(%?ZK57KQ"?-T1;"9</;:
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M]<'#)C?8SSX[=!AD$K8%LI6\ZG+'YO=<= /*/"F2&>4T8QGY N6-">R@02.
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MQDW&27PYCAN&N'UJ,>1SL)@#3!_9._>"8)^=N=0$1'F!;^&EG'WU:+!FA_S
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M!I3?#GW.V5?XT3!@'5#R^^1?)QCJ%7.%V%RJGJB,I*<9K0SY]],:^*D5#-G
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MK84"IH!G?(XZ+]RU?776<+IC'Z_=\)'.G<.QC].%% 7"9Z& V4C=W^G0<N]
MIF8-$]*#Z+0<V^K:#ADI/Q<01X4"IA#ZKM!S\)+L<?L>8Q_K5FAK9FNZF>FV
MS)2Z66V\6)_=D'$ISRI]5.P__^.H5JV^@\^HCQDER#RN&6E[[89Y-%T;/\=A
MM"Y ZJV6V:Y.N7J7\  ]^_Y[Z4GZ$9R6-QAP4FEZ7B %*/\QQD0F[>+9G"JS
MDJ-4Y\8.-LJ+^AQ7=(Y7/L<&JJRC^:^0R@LZ;>[!"O#\]?N_FS6S>E08EYO9
M:"VI+FU/0^G?4Q5<Z+$@&H\=F_OK/JMZNP*'M:0*MS9H7I0(]>9]HVW6<!;%
M=#_6*9A^*H;]<$F]<)_22-?/LGM5V$;=K#>GBF4VKY96S2,@RG9]@^&/%W'M
MN6>Y,AJYR2,K2@^9VI%9KT\UN"K6[3>;]43WD7 SL:B]6KUI5J:GI&_!]*N:
M[39<C?4EF\9L*2CL!79(YIWH';Z1PZHN2=/KTV".S$9U@TZ6E?O&QM8CWFWK
M)NEFM6T>-1<XM;4S5ZM:!ZUS\:MT:ZQUBD$@JQ>F_<YKESP@ PLQ(7ROT:J;
MK=KQ1HYI54QU:_W@&^.HUI'96L(]N#Y ZEC0>KR9DWH10PFE0A[/VEFIU31;
M1U,M+39_/G!#@1U9OALJ>UI;,KVJM1K:7@51-AK-MEEM+>F\V1Z[3:27;? :
M:U: YHN@;#2/S4I] ?6P,)?8S#*'K$66<Y:3;RE/^[-6U3QZ>DKJB]N?%1@#
M#;,Z;5$5H$?9PM2)Y0<+9Y:7]YQJ9KU9-=O3CL#71*R8IELW:]4GVX6MDV!G
M2]OBAK4*!<QF.AKF6-43%6<B1UJ7H!35/)A5;'05^;TAJI7;RJDLBHM_K]EZ
MB8*YL239_(.<>:.?$5^*8C(X8KK<;3?T\FL82GN;Y2_UVCH0KQ +A=)"YUTN
MI3TLW2\[1^)JW?.5Z"^KU#UE"S^M>Q94]YR=3^GU.._+4PR&GA\>A-P?,0>S
M3=;M!*Z:C6I1:@Q6<X);+]3*'JCCP0\V=IX[R)%;/\]K/K8>T79 TV'#_+F#
MY[FA@%'FU#;+A(4QYA=-V"M8T<_DC6CY? A*$/<#BMNVWS$J:;:[T0::A>P@
M!V[I5"4[8KL!*E$/;-4[1!>IE_MD,_QJ!T%$M0UPL -\!_<%#^N[LI3GB:U!
MJ,&/#S^U_$=]F"4^S"O?OK="SJX<J\=UKX@2':.X/2E\03+UP8?5?*D0!=@5
M1/=A*N-Y3E03Z3+H4AS@S*C-56)T9GL63.ZR=($*'5PL4'!QA=.YXSCCV/?N
M;>P;WGUD>S+HN#\WK%#:4\QW>[\V6I[A']IBJF9QKYU" ;/U7NLSA4D'[KP>
MW7X]V?^,O  ^K.8R_D-\R'P+1Y9Y+LF='6"CNMF>[HWUJK)HCRIFXVBJ:JL
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M?$"1SL.=P%?>T:>FMU_1T/H;_F?$W1[\J-8\?L=^LYP(%Z"I[L3:Z:'W3]K
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MW:W9F:8H3?7D-F=@<\8V:PTR;6-7+&#R*RB':P'*+3%E^]^'B(!)RG#J@)T
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MIQ\D[P_!PTO:E^+!H8ZV=5>QS3+]6LIIN6XB04;M]D"2>>+6EAW''!A=*8$
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M\5HKPT1&R!UT-9E)0E0(A+%;3HZ$R9!!722$>]+A_2@.ZFH4#A7=3@5XC$R
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MISW9&TJ]QJ_(CE#5J.:J$$M_]936'_K3J>^I6"MR->BY=+0;@7E\Q/.Y]T2
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M0\.3B-+IC9P[9Q3;;G%3R'L[--Z<.ZZNU<7_>+X9+HI E2C/C;KZ%#HU7^]
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MHANU\%=34'ELT<S4UHE3_J<X#5EXR-.*"_Z?^N=#K[,RS+Y;])QT*!Y_L&C
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M0\&!U"E@*YVX-N-0)N<)Z<"9SEQG2$TZT]SNFR,G'%+.GG\"9A1=_<'.WK-
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M9,9% YI%*VMC *FVZF:SV<[-!3UK/SE0=:65)\A.CK=*#BHHO+E\6$@S>8T
M:%!K]0(9RDN15-AC#\CQPMY1Q6QAC^':HY;)KB-KQ6S4ZF:IO1!SV#J^:A=^
M3A7+IV@FC_2@VBA<EB?CR>R2YZ;\'49)>;FX_YR=4]-\3C>S+9K7;IC"F/NQ
MIH>;471_KKK,4;DH,(B?RD>E$IK^[!9KX4U6%]."Q/>)X61SW] .$MULO%E(
MXW3AA<^#_H(?.@/P]4QU>[U8L*E];%N_3]YZ!SZB.F$'OK9'AUBO)09Q;YA2
MJF:I6C.K[878R"M1[C/WDQ/BO<0V;CCB5-5I;MSSTFK7S69](1+\2K=7,6N5
MLEDJ;_'V7FQ9+R'(Q.1R,281ZXQ]/N9N@+6Z6*%;>'OSH-[$&ZL^V]Q\MP,@
M ';3+BTDRCT5!-MC0/C:1YQ$CRN!A;VOFEDK-<UF92$8L&^^(L#:9LFLEYY/
MO#J<G]?-Y" RDDH">GJL?QDRYCU%1B<*;2I12/;3,C954USX9G<MW>S.76^S
MNYIN=A?!>(>;W>D6%OO=PB)JU]!GU-WAZP4H)]VS?N^/+NN=P=_= I[QX-M9
MY]L)WMB[HNT^BWIT[XR<E.P7J\$ 3I5)J)&%: ^Q@489:A+/%4WB^2H&CG2C
M23RTAVK)?)KQF =8:01/(_B6LXVC231R4I4[4N77P2\Y=(OD:C/;+Y?/#E1\
MYB[<HD.79XTFMFL'(=[J;336:R%.\0KEZ >U5L6LU!8BL@^^9"&Z\!H;;S3;
M9J6TD N_RL9U,DY.-_/*F;R/M_,M?'3BH%8U2^7G%RCO0&"QT@#JK3T_E5<S
M$<U$J!%']XJ=GO<WG;![4*_4 4E6R"1YN'_:&G;2!N91JZ^00_):)+*4LX.A
M!BJ_*TN)AO=BQ((<-&6-\''LRE%\YE9MFO7*HV&R76;OU5+#+"V2RS;9^XK%
MOTN#NVE7*?(8UKFZNNQ]_';5^7C:95?G-.8NFF]7Y*#F0;U1,9O-1]O&+(UI
M/HJR.3]_&921MEE?M&2>"H&%@&X!W=$/!F+;.A"[YD!L70=B=2!6!V+W+!#;
MZ7]AGT[/_UG$DVTY_)JEW=T)[4['9778*H^[U7%9'9?=&P3?KO\UEISLT^7Y
M5W9^T;WL8.4^ZQQ?]?Z@/&P=G]V^>W8Q_!J)L^4MSL]XF%DL]AJQS"4NWOP'
M89=XA%\_")M&B<KR(7N=R/E+XQ9]/O3<H0VZ%PX#IJ&YUXYW%[!KWYNHJ8_N
M#;-P,BBUHM($_]H$7UU^NZM'=#<$L.QPZRO=WI+(YVO6/*U,I\=CR[T1DZX3
M5"B&=6.*3:(YG*;('%/DXY-%-H;\#;/<6JB=>J5K.RB;I7K+K%96Z,WX"@+S
M@0O,12O42A.#? LEMJ]TF;5V)1==35:\PZ7&W ,=4Y\?#]Y$_7=.6VIN[:@8
M,ZR;]>IZ&C/F@K'L80_8%_FK,0-6]E*:+O2BVZ-\CQ<"\?!%X'L%O\932.=,
MF; T91V]GX/[3!NV\%CP^KQ_)P"@<UISNIFM=:;]TCG[W.VSWAF%B3<,B06D
M?:4;>>(^-)7D=#.O7#Z"%&.R 0?= EV-Z&D$66M[(RU=-  TX\CQ9EZ+<522
MC(-C+^!564:^DYH?)9>=[M.UGM.O.YT[7GTMN7*IG+"UKAVEP#Z4#-XJZ61P
M=[W)X V=#+Z0P/#JR>!;2C)- G[^8IY\@M2]++V_^233U=?/O,[G:$RKOS)3
MMUIK8O,'BXU]?OWKF__]5/Y/J=3$GN53SP]1)>BY(SX%]0 =X)=@7@1 \WS$
M+D "V4/6&0[AV.31^V3[DP\_6[^Q@XOCSOE'UCL!5EEKU=.YTAGB\GF0F.,^
MI:.Z[:X3+)\.*ZW4M)5%/6WM6+-$G7LIJCR;$0C&22)W3F M#]%ND&NL'7O>
M_+R5:]T\,TB2L#4%$BZ#8N^YI&Q09/RCY5@H4/MC3DDKF(I$F_AJ^<,QJY9-
MAKFXE,TBTERMWP3=KAOD:R71:DF3Z(Z3Z#HEW99QY17HOC)']_T0_B,23$&6
MR]Y>GDO[0%H_3LVO.#CU@N =B/RA-^&4(H6%#']RRU<5#)ME%\L<'UEH <1?
M+BYJ:#:BV4B.V4CU038BTV%I%[8+.H4%+,1SP-0*HL;_(O=Y^RQD":NH%/?Z
M-:O0K"+'K*+V,*O #*!/6,1"&\D-/Z@6]XXU/]#\(#_\8#-N2.(L]3>_G7DA
MI]*X%(OY9+N6.[0M)\%L8G:Q&4?CFOT6M4Q,6$.X[0G4F//.+,\YR0JQN[*.
MW:TY=M?4L;O\Q.XT_;]^_YKU2?1%7#.>*='D#IM8H2\NW![]^D:%^^25R?NS
M)S<L\(>XO#\)#FO_*96K1W]-;]XPRPE_?2.B)B\1KZI;0.OMQA3/5%8(6_Y_
M&WL]Z#/E9KW4 -7%L2<6K&2!<30#W9W];QE'RPXV2R&T@TOOSD&#Z@OU-H'G
MCSNL76[66MMY_15W?F'_7YD=-"J-=ZS>*A^66N4MO?N3]6/AW:6V>K="8*%Z
MO9+BM9Z\I5?E^(ACE"I@/#U58&T=U/92YFW !$LZ<@UD&Q\]RZ>\T!/;Y\/0
M\X-7.Z?\T";L@I^M-]GC=]MR_Q[;QF>PGJ?L"X  T?3@V+J'I]^Q4WL"?'NT
MHX=_90S>[.& 09U/;1=CGIY+OL<57 FOP9GT5;_T</_DQMBZY<R:C9!:Z;(M
M$#H3>,&]&&B5N/F!S(@)1$8,,#G)!-C#3( <U,DN!>P 7X2!KTKI_;%X&_U5
M?O_.H$2;92YND[:HFE>D=A>DO.BV",CC<\-4P%Y\8;)AW* F"+WA]W0TSN 4
MC3/% HFV4I[/N 4[@U?@3L([C]V39]X6I"+* ; X8,%/+Q9+[M]5OCK\,'D8
MXSHBLOA81Z M,&_F,T]0I[GP&,MZC,'A ^K?8MF^ T>"G5J. P@(8AU_"E]/
M050%8KUXB:D7V)3Y(,\J+XH]<D'Q(8.9(R\#_Z,2*43_'_SH8;@:J\(5^)6)
M# A_"M! "PP#J7=V."9DEAK4U(>KMZ?8!.5&S/IR[O%[/D7(R==\<^TH(A/@
MP3L3>/'0.MI1!K#3W T0XZ,5V(&!V"5%FI94Q3S<U1B8F/$XLP-U7'&?*?S8
MINXC]RS-PB23#^!HKG5#3QZQ<^"L<T_9Q)SY#^2@R+84YXWUHO1RCV]O8 7P
ME2?X.$E=8.O_Y+1MBTV%V9=@6M=@]L&N(L,0F9J!KY86HN+)"4OQ_!;$&/HN
MI"URD.)I[]B!E+N4<JZDKAA[Z"/<0/#AF^#@ Y26L7U*#%4*"_C:2,H$E"FP
M!7]$"@+]DMCI4?^(7?,1358,^'#F4_\*YEAW020HK.D4CD(.2'^&[!F_@#//
M'"DOY.7UX^?Q%]T?0H0;L(>)'00T&D@N26?3/#OWYO,_B:1'LR$B:$P2R] )
M",D= 4Y'*"'NF5V-O2#YK41B^(D%: O* ^BMA!N@1:!Z(- .7X5H[@U"RW8-
MGUN!YQ(:6D$P\^G5UL";P1)C3EV-5M.WD(RNL9$U;#)2LA!#U4_,:,&1Z.#%
M?1\D%/R_:Q]V=61<)2DK0#4Q19>HLIOPJ0]G@W?! ;E[ WR,OI1'1#U,'E$J
M8#:Z<5S8"IP@]#V'>< H$B?PR2D%'.2(=0+J"X?Z3^)2[O@"AQ"@PU?-7-2>
M\09D*?W*KV,#@# >466Z3&?^%.\3%I&L%WYEQ-R72>[+KZ\YML0!92X(EG'X
MIYR:, [^B4KR'8_XOHLMUE U%:]_/;:BF4CF44!P&Q'?&#HSM! D%0B]WQOR
MT<P7EA:V((4[)17!#KX'2XE4(=2C]!Y1LY%)S6:2\<SO!_F3T#E&P@Q$O*=]
M';$^XESBQ]'9^ \+QQ.[-R92@@7@#4)4+&S8"L>^4<"X@)O=6(3,@M=-4#L0
M<G-D!T/'"^2:JYU1:$<2R)83>(G=W%K.S JC-V497,8L4%X 0 +[&J0] !BV
M;2/H40T;<>QU%:MC)EJ9=QS,5/COW"N0@M& E78M*0DKW]:1 =K6@#LVOY7R
M(<'A9-\M@&E"&!!DB3DE;&_-!')V%+#UCE$Y'%J.T2&Q]]4*@:Q?U=[3=[7,
MEC.&\K*DCC*ART)7W63FPN?D;N2.=X?ZCZ6^MH UDE6$S=V)W&6;2>D=BO2=
MU10U)'_CS@K2K_7\>2,H];7TUHE7X3<V;(U+R\."6S@HOY,./B%P!$,,<-TD
MZR7>@_J4DCY&AA]PB8()[SJHO ,>?.LYMU)S)KO,)J<6V$6. RHAB8A@-OA+
MJ$DF;@&=H0[_ =<ZNI&L_6J</*)T^&7?S\CC0AVU'/R35+][=F?=)WFCTL]6
MD)RA]9V[R.(M$**>PX6P%(JF >\Q42HD]B8E0/;F"%],R<3QIP$'+19>IC86
M1#O+?!XYO)L48GAG1NK./)PF!6+9#M45[ZP@>"0GL*)S M><$]C2.8$%R0G4
M8GUY8@L%MHP+RP_O&?V%?'=L3XFQ7^$4;VQC"Y]IQ2Q_1^D$QH@'(!T'(B*&
MM03P55:$<HE CRTXI>SPD32S7'13A>A6)U\1B77/C?TRI+49"R[UL<W1#\2'
M,]1AX&=@/<+3J+:A(N*Y&,4#13  **$2, N%@6JQ$1^$J'3-?*4W!,!SE:Z(
M[P-H4% 5V6 8153E%HRQ%=NZJ&>.T#^ ;-)RN3<+Q$QZB<W"1SF9.2$:O&J7
MI/2!C6K#?Q*0@1V <>ER)[DW$>W,BF\:*K:Z%5U#D\8R3S5Z5F!96^9)**]$
M['Q8\#W*!X;1K^:F;LA(1_S9?1JI2#%.*ZN&4%91:[>#V%"QV-B^&0/*WTC'
M,_T8T$[I^2+ XR(NHV^#W$BA='/QZVOL7'0W!ET\X:@2RG':?28/S0T18U-.
M$N6!C9$\ D+B>;FV,*(D<.Z?"I,TK#5)O*X9/_5M>/-]\I;O>/JB@;GZPN4*
M")MM>2EGXB]YB=@=EHXJ:VZ.M=L-W=95)2DM@:50_R< !0$3($ KY48,T&1U
M1331M/(,Z&V8:GJN8-E1/YF86.XLYWLX]KT9<'(1>)R/7@4B?)4E;-(LD^@Q
M"$Q)6C*53RRA?BFT.M&28D%2)1WUKN<>PJY"V^4/<>8H3$MJGIWTC6R@=E=C
MW*H8=\DM@6TN/&*A@A"[$0DIX )1\Q09)H!R7GR5ZKKUE>;J2E-,Q,NPC^#9
M[_R>3?AD0&9(2FF*<S07JQ58'#C4I%XXO+CD0PY8(/ "<V%M?R*3J"AFDJ5K
M4[8W4KY,?HLSDA=%#"9(Z+O.QUU?*+V!=DNIVZ#9>7>+.0^1J653<K20\0DM
M8.JA)8BN'.4(@7^FZ'W PSO.4TF/"W::+=M;D;=G8MVG\@10^_>CW_U2% Q*
M],H5]L #+>Q?A!@++UH?GAQ8[];?X6.3:@HZ)DCI!7U%)%XLP=N54+2@4FI3
MB+96S!H4 [-Z+N4L1WQR(0O<=F<8K2<1.>$\5(/'LU4DC47KQ:)A,;!(REO9
MPC%F2 $G;SVE#B@9=\_N^""P$:F$(?\05R(6A[:9GXB7!5A^%=@#A\(E*I12
M(-3;9=6KJ[S@BJ.HE,1@AN:7S=WA?>2$CW(R8]_-6MTM0F8J7+(<#_0_^@XS
M&K'JDC()0"6#UXN,GP<;:>V^U[6@[O:?@Y^-OHTAT_]G3:;O67=T!Y+)9*>G
M%WOF-B_H!:IBZX#[F+1G!9G*B K<!3:RC*V%?3>OWHN^.D;<5P?>!9+/M:V=
M.-__S9Q[H]PVU6'6MK"H<4Z 2'=]V5BGPZK.:EQS5F-;9S46)*LQ5PVWLCKS
MWHDNSFM-6/R]USG[]Y>>\?GR_-L%^W)^>M([^\P.CCM_?NV<O6.GO:^]J^X)
MZYR=L/ZWC_W>2:]SV>OV7[,3U[9 $[<\5..1Y(F/S\_ZYZ>]DPY QOC8.>V<
M'7=9_TNW>[7[<'DXB^-U>F<^TP.0F@BZ?)#,\SMD#SQG]&1K?9[OI">SKGJZ
M;,_7VEP*#XXN?M8>]^*,Z_17"?1<E\MJ%:Q;$9T?N9;&O [R@"ZY!C+JI'LU
MK>]D^C)3-+:5RQ2&X-IN<%=@4LTU5K^:!.WT^Z21[8MTV8<S;@<]'QR7\RR<
MC/QMQ]\N+[MG5VP3R+G>>.F+5US+]:]_DQIV^>3UJ[Q5VI>'>!;Q1&0+-M!=
ME4UR5C!^/@C5W(&W:\(;9;J^S;J=GUZ\SW+C;28FU<Q6M6*6FNV7OR%SYR_%
MU!T!<Q7 W##;M<86P)P#6?A<FLVDTXYJ.N%3$B\ZE8)]8/*5LMEJEK6 ? [L
M:L#36AN#W6X(R(>(+4EKU(^\7'X_G]2\#WATJ,GO.6!K->MFI?D"89<'^MN>
MA.NYM]P-/9P 8#*7A_N (M5&V:R6M7A[GGBKU\QZJU)L^GH=^3:ZQ?[%5/X3
MS+#!-O?W0I*5VTVSOCF6O-O J[5*9J6\Q)]>%'K;GCP[IQ[>6H4DW&FTP!31
M=/<\IF6V2FVS7B^X)ODJDN[4LUP2<WM(<]IL>Y['J6V6*P77*K<MY52G9>R?
M'VZ&N%;-%U@G'FWJG4JAJK5!*M8+0J8[> 'E4M-L-?;$0[IR:'YEVK\ZO^J<
MLBT$[7<0]>IFNUHR2Z66IO[7NH*FV:C6X?\WBTW_+Y3U^Z3:Z6R;O,(N7Z)R
MK5+RPL?AMJ'H[( =>:=BA-&>A#CJ]:I9JK\@LV:?B:X*R%IN%UQ!W9XQ>HE0
M._2N#V<!A^-: 9<6Z?Y06QM-RJ(HE3D#7J51-9NMC;&J'99Q)YS&P9.(\\@C
MI#U!3PJ/@"W8;FI/T*NZXJK-7?;ZOJPR0[AZMNWBJ=#]CKS9P.$O0ZJ%I.:-
MO2]R+C3+5;-<+169I@L,_Y;9J%?,MI;FCQ#V_FAWVOF35]@553JJ6MK37N=C
M[[1WU>OVJ1=,]_=OO:L_-5YHFMIUFMIHJ?I"67""SC2":.+:=>+:GM^T/_;\
M\!!DV80YF#"7.PQY04UJEK>E;59J^Q"16"_8RK6ZV=A<L4J^)-9:Z>M8IL=-
M@<QD2V]LQ)UGBM/YJ'D!6[EA-FH%I[I7J).?6O=8=;$/&%*OU,U*0U=7/,]1
M6Z^:U=+&W+2[+-4\,1V2.;8UL!U[7^HJJLV*66D7)5B7,^ U2PVSW5S2J+ H
MY+8]<79E_>#[)<M*3;.D&[X\DS/52V9Y<YQIAV69*&.2=+874JQ<;YAEG9?Y
M3.!5L)?9+J>+;)"Z]KD.OEJNF_67]!G<:ZHKU<U&O>"ZXRN*-U6ENV?V6J72
M-JNUHB1BY0QXY5;=+-6TI%N5T*;<MW!"L"P_4*1V;RKJTQFY*U)MN6K6VD6A
MVAV\@'(5\R<+'GC(2W%\GE-7UALEKIC55LNLZ?CZ,R!7KY0 4PL>BUBSL%U.
M8:<ZA+Z+1+41=XU9VQ=)]M3SK**ZNIZKM=<G>N)K9KE9E#K<';R <J6\224D
M!Z)T'05]FU9+-UQ5]@3,6F-I6<5LUBIFH[*QOD'Z$E:YA :RV$;!E65=WU>0
ME'\-N[R3TB;G$IY__=J[^MH]NQ(%?L?G9U>]L\_=L^,\^G,V@!^I$>ESH\%Q
MX6=/3#^,AJ5KLMVC:]'"M6"8IH5K7F%7>.&JJ^4U$;TV[(HGCQ;CD&]^._?A
M(\N_9\'8\O&W/Y6/2B5,KV.WEC/C)JMCR^F2_)Y9LW#L^2#V1_/?V$$PXR/1
MSFT6!B'\ UZ6.SQ;;_Q-@& /R+-(8,N!>%MK6D '?H<UP)8#S]@C9KML:$WM
MT')RAR:;2'\U2]6:66UO+)],@Z\ U/8J*;#]T IGH0?2$00<]V_WHIJJUBB;
ME4I1PI Y UZU5C9+M8*GFV^Q^38/+=L%K9%;O@M/[$5"3MELU]MFL[4Q+-EM
M\%7,9K-EEHN>7_Y:0^IGDYFHH!(]MX?>9.KS,7<#^Y8SQPMT_^T5\?"@#GI5
MN[36%+%W&O@K A])I[G>7)UWN9&QZTC3Z7_I7':_G)^>="_[5#S9?+_))J,[
MB&- W<V262]M;'JUOH)'_41FN]TR6Y6"Y^1MI^7I0GK>IAL+[UK_=]U__W7A
MWS*;V)6LLO%F)#^'V%3@-\/X,'WZ*R:6?V.[AZ$WE84F\@,%E@7M6[3\SN(+
M=T()2*5DO"@'0QU6)F),=_"(5V-N6$,T6RSW'BL/7"_$N)3/&;S!AGW<^.0H
M]T/LF0E&3L#!RG%)')'A<VV[ECNTX4=!"!_@9+U@IT&6@17&A_\Y/&2?;.Z,
M?F$7U@V0;I__=\;=(3Q5:=7>LS\P^@<KL,-#R7A&]NWJ8G_N^ W<QP<B.SBY
MXTB+]=<WI3?T-VQMJ/Y.OP. XEC3 +:B_O6>W=FC<(RG*[W-.&Y"F,^+:+B>
M+!Z18#595Y1XW9O?/ATF0:> ]IY=W4]A!QW?&MC#]^S,FG !V#,/(0@R)?'4
MS^HQ_"IF38HO??@90)T!=)];WP\'_-KS8>TI75H2[0H#XQ0\Y_ES%A"2H$.8
M$DYNBDPU/W[2$3\,?ON]USG[]Y>>\?GR_-L%0YNS=_:9'1QW_OS:.7L'&NG7
MWE7WA+31_K>/_=Y)KW-)2;"#WW8=-&(Q>_3K&VOZGU*I\D:=^/C\K']^VCOI
M &2,_A7\1Z0*GW]BYQ?=R\Y5[_Q,Y@U_O0!#OGO6[_W190>GY_W^.]8[@X^[
M.P_ +/)Y$G];'0RK<<(WSS86YS)M]:CNPN5[:=B]T/!:HY-E4_2PH@,F^V*!
M8)%1_?JF,:]?/>H>>]$HJ4^>CV8.^Y-;?L"Z[@ALG*^6/QRS:ME<WSDWX"O+
M]S56MGN-E5)E243X6;>U*S!9XGW/"09OQ=LK%9 &6F*+?/:R^T?W[%O79&?=
MJ^?S;_F.RMLU"2VE-&5N^07)I&K=QMLE+MP2CD5^R0C/!W?^4C&Y(V NE\QR
MJ676ZR^H9U\9SCD(R*[":(Z]@#R./K_E[FPO4@4/ZHVV66VL-5=P,RD0>0-<
MV6Q7@(8::\T!VVH"PZ8*)<51+GQOXM'<JR&0E0Z7KYH5@SVKUAU!TTE)JX._
M62^;Y?HFP)\#*?@L55X<XO/E>;_/+B[//_66**DOLD^V89.L [&>]>*LPGWA
M*L5_HT?1GUB.=)_><?RU^A#+/]JMDEEM-QZLSE\[0#2+6);05*LV46;N1T*3
M]D]K_W018%=LX2H#AF>?6?=?%]VS_G[T%]+4E%?8%4T&99VGSQT'L\NPG<'$
M\K_S,(_-##91_EG3([Z>"SOTB98V-S4F!U+JF=8?=SDF92(Q6:.)[=I!B'VC
M]Z2@VJR6 2\VUW9TM\%7-NOMEEDOZWK/!\YSR0-.(7\DL1&_Y8XWG>C>ZZO;
MY6VSI5NOOV*M7<VL;ZXY=F$%YY47@MCTHBD+_,>4N\&&1O#M(EJ9M4K%++4+
MW7:]V%=0IIA(:7/S2XLFOO=)=],^FKS"+@<B\04>SU09!/MT>?XUKIK8XE22
M8G/F@UH-F+-N8/(JP*^:C59CDYXV+1;WE;5KV.6=:C86"+SZTKU44O% !0/W
M(J-2DU1>85<T091UGAZ6H_ @9+8[]"9[$;6HFI5:0]/3\Y*\JN5];P'[  U)
M)^8^8,)!U2RU='G$,\#6KA8WB7JSLNBS!SMQ,;C'@MD@L$?VAN(!.4.*9LUL
MEK5$>A;L&FVSWMQ8'\O"BJ1S:H$L=#IV(.72.Y.Y7 ?.5\2L2MDL%V98P ["
M_Z!B5MIKY8H[)"IE^#Q!Y9JVGX!;[899*A5E[,X.PK_1,AOUC6D\A9#:^Z2D
M:1=F7F&7+UFXMKCYQ^ZG\\NN^NNJ\R\LT/VCU^^=G^T#SAQ4:W6ST=[$#(G=
M!ES5;-9K9JN\\3[=6C3EY,:U:,HK['9&-&U-"NV@H7!0K5?,6E-W?7D5X)<;
M%1"&:TTQST_/%RT'M1PL NQV1@Z>=:_FN[SO/FX<--HML]S<1#>\W09<U:RW
MRS@DK=ATI4503MBHAEW>264+(DBD$:<'C^R/+-($EE?8%4(6+8]#X]PN^) -
M9[[/W>$]"WW+#1R+VMQ:(YSCJ5LV/,7I42V9Y?I:X]/:Z?$4CU-YO:.1=RCQ
MY,&A7=O"L/5-@GT"BJUQ'.Q!V2Q56F:ULHGT)GT!JQB7E6K;;+5UG$_K;UKW
MW0?==\W&Y9O?NIW+L][9YSZ[ (NR_Z5SJ4U(348[3T8O-B'E:--#/(!X(NM@
M'ZW 'HJ.?[8S"_FHB*K-PI"JS:N5U:.-9,QKN#\(]V;YJ%7PJEC=[21_'%W#
M+N]4LXYN)V]^^V>W]_D+C9'_HWO9^=QE9]^^?@2E\OR3T"O[[/S;5?^J<X;#
MYS5J:++:=;):IP=SC_3-UW&EU4MFJ524!O#Z!IY-\C^'%FSU-\/X,'WZ*R:6
M?V.[AZ$W_841"<H/%$P6R%*,R<YB#G="YB[.C+NV)K9S_\MC6Z'?!O;?7.P\
M/JP<(C?=P2->C;EA#8?>!!:\QV[;KA?" I;/@><Q&_9Q@T,LII9/<W[#,0\X
M&WHNQ=,L8(?LVG8M=VC#CX(0/L!H;G"TTS#+0 OCP_\<'K)/-G=&O[ +ZP8(
MM\__.^/N$)ZJM.KOV1^6,\,5V.&AY#TC^W;UP.7<\1NXCP]$=W!RQY&R[-<W
MI3?T-VQMJ/Y.OP. XEC3 +:B_A5/I2[AL/6%XR9$^KR@ANO)8A()7I-U18G7
MO?GMTV$2= IH[]G5_11VT/&M@3U\S\ZL"1> /?,0@M5R\JF?U6/X5<R;%&/Z
M\#. .@/H/K>^'PXXIBC\ AB.EY9$N\+ . 7/>0:=!80DZ!"FA).;(E/-D)]T
MQ ^#WW[O=<[^_:5G?+X\_W;!OIR?HG7'#HX[?W[MG+UCI[VO/;()STY8_]O'
M?N^DU[GLX?R[P6^[#AJQF#WZ]8TU_4^I5'VC3GQ\?M8_/^V==  R!EC$5]VO
MW;.K/EK*QU\Z9Y_!5.Z=":,9 =J][/^__VU5RLWWK/O[M][5G_L O$_GE\;5
MER[[L]NY[+/NV0D@T=?.Y?$75BV;K%*JU BGX!_5G0='%B=Y$JM?'0RK"84W
MS[:>1W8P=:Q[''_L\F7&]*:\MB^:8 V 0/C_^J8R+T$W,U1:X-?Z#Z2AHJ&B
MH:*AHJ&BH:*AHJ&2>ZBL/UB3;_VRL=W[.O8F$P_LE+'E+VM3G$MD7L/1.V X
M86T/^8SMT:'M[M?Y^Z$5SD+/O]^O8U_RT++=9<'1M9QZ[0=^[EFWZ I9LP.H
M,QS.)C,'PS8$GE7_3S23Q2"1S\?<#6B&><I!Q(H+%#7=)'6>M:!@$0A75&F2
MI!K#.MP/I%]44W*>D?;,<P]WAP2'\)GO.8[MWNPU'6H-OR@66;]HJOU6H-*9
M>+-EM?S["Y6A-;772]P[ 1:@'^[?+IF(M;]@X9;O@AS4O&4.+@>.%P1+BH[V
M%RK\OS,[+)*O82M0L>74/0V7#6-+OI+^5X:-3+NHM-YB?K]C8>:@%;+.U+<=
M)E)AEG38>?(KWF9CP(L6+;]]:F[\4]]0FWO#"NGD^3O$%F&_4%>JP5Y\L%?,
M=JUMEIM+RJ8UY#<&^5;9;-26='?58-\8V ]J[9+9:BZ9#;.>$[Q,@]\]F)=K
M3;-:7](B0./Z!IE[L]HT*\L&(6G(;PSRM8I9VBR/T6#/1OAFVZPVMR96<]!G
MX:EVLNQC*?RUS';_XD/,95EO%',-.]Q <X##]:RV;ST5--B>!;96W:SHL?8:
MY338--AV$FR:P6F4VRF4RU>DYWGGZ0S_.[,#2D_'7B:NYR82S]C#0</=PA5-
M8AIL&FP:;+L(MH-&U:RWRNL$WEY,5=3HIM%MFW"K-LQ291,#I'<<;NVVV2BM
M=?1ID09O9^W_Q ZF7F YJ-1;+)@- GMD6\M*,'<+'337UF#38--@TV#38--@
MTV![!?O'+!5A'NV^@&TG'/73J>]-?=LB5WWHL4!U56$/5@WN%HIHAJ3!IL&6
M<[!5ZFVSNM[)>OL#O(,-0&\OM =-K!IL&FS["K;".NK/>,A4NS5]_YIL--@T
MV#38B@BVJEEOE\UV>ZUQZ/T!G\8ZC74:ZPH"MHUCW4OT^96&/VU=O6</=6O;
M+>S01*7!IL&FP;:+8-/ZEL8ZC74% Y_&NGQB'6GYA4[+^>3Y'/YDPYGO<W=X
MST+?<@/'HBP=:_37+ @G?%G_]Q=BRZK]<=>)3YMZ9\$(58->@UZ#7H->@UZ#
MOH"@/ZC6*V:Y5,U_DID&O@:^9CH[ ?H-XGTALK_VR7.PSB7WS>NB8:=AIV&G
M8:=AIV&G8:=AMW^PRU>]]LI3 !-C\[Y:_G#,JF)NWA*+YT7C$A\RV2IDLHV\
MV<#A+YJ1^&1C<6UO7N>4MZ<11%%N96$RBKZ0?;R0JEFJULQJ^Z6S.?6=K/%.
M:F6S5'OI_#)](^N[$1STU#++-4TE^;D3TKV:M9=./5LY%J)OXT'!CFE>9JNR
M_NO0%++F6)6^BYVECU>I>MJ4'5QL---6;QYO15N]^D*TU9O/.]%6;\YN1%N]
M^;L3;?7FZ3:TU9N_.]%6;W[N8HM6K\[=W(_8OH:=AIV&G8:=AIV&G8:=AIV&
MW6[!+E^YF\\[CYZU4Z1220TV#;:]!5NY4C++K251%PV\1YSQ&X">;O"J\4V#
M38-MA\%6B&X+68? 9MS8A%O?OB8:#38--@VV8H+MH-%NF>6FUMLUOFE\RS/@
M-+[E#=_T7)T"XX4F)PTV#38-MET$F]:Q-+YI?"L X#2^Y0W?]!2=E^#)#G;:
M+@J):M!KT&O0:]!KT&O0%Q#T!]5JR2S7EY37Y\F$T,#7P-=,9R= OT&\+T1>
MUS[Y#'25DX:=AIV&G8:=AIV&G8:=AIV&W>J;S%<E]HNGZ+RLL^33S43=3_@%
M!%&46]']A/6%A+J?<![OI-8HFY5*2]](;FZD;+;K;;.YK%Y>W\DKW,E!'1A7
MNU1>^Y7H?L+/X5EFNUDRZ\MFW&L*>84[T?V$\W,7VZ$//44G-VBFK=X\WHJV
M>O6%:*LWEW>BK=Z\W8BV>O-W)]KJS=-M:*LW?W>BK=[\W,46K5[X7PMV_9MA
M?)@^W?B=6/Z-[1Z&WO07!C^//E#@H<^2NQAR-^1^ECE\)[(\/P13RTUNY/#:
MFM@.V->/;(5^&]A_<['S^*BX(!QVNH-'O!ISPQH.O0DL>&^[-\SU0EC \CF#
M-]BPCQO?<MC4\D/F7;-PS /.AIY+:<56R$?LVG8M=VC#C[!C.<>:R>#HM6"V
MX=LW/OS/X2'[9'-G] N[L&Z 5/O\OS/N#N&I2JOQGOUA.3-<@1T>2FXSLF]7
M3].>.V4#]_&!R L.Z#A3:S2"2_KU3>D-_0U;&ZJ_T^\ ?'&L:0!;4?]ZS^[L
M43C&TY7>9APWX;J:]T#!+61Q@@17R<+>Q.O>_/;I, DZ!;3W[.I^"COH^-;
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MY^S.A<7']I1Y0Y!Z<V?V^:W-[P*#*L*R,FE$@:5(.;*'HK92-EC\'J>X"VT
M-!AT>\42*(BV!*=&>8[2D:21V'@RC2=Z)>*LK-.*L6WNI"!I?7X](ZM=[?M1
M*9F2C529E7G@.Y+/(*M'A@M", @L_]Z4(G1)S1D*T.S%8MFI$I>V)#IWB%N^
MHI3LR2PR':3/^U$2-V40CPU)<&#QI7<G.*&P&'RR3F-JI/Q SF948GO'0=;1
M<YCY=\/9A(=C;W0$=!_,U;DH^R/%D4T0'+2$:0@9QAQK@)R&HAE"EDE^3E%!
M>,N86Z.4.0;? Y\6MD)LY"S* ^!WP(CX#V11<4HG_E[:HWA08^&@:&M::%Z%
M?()_V#'@A 2D1,:_A=5@"4Z,Q4+"O,$:FYFP482HB19-K',$]Y8$L2%^9 =S
M:9\!G%B63 WYHP7US,'_0>8[I,N@JH?)U %C1H@?A%\,G*24XR('E,J8X].2
M9 .]QH?+<^ZE:,-3HC#,1)+8R U4=@:\3?DM+-^G>JD()")_,_E*(2U\;GB#
MP*.=X^O<N5M49CJ6,@6(A4+ZV7X"=IG[4\F_\"?(:U#=L ,RUH7'^0D61H)-
M=#?8@M\9%$@E#+10:@UQ/3 I+2IGMEU17$)."!'*GO-!1(X+%<:505K2L]+7
M %H$^BD Q<?W 2U =2?B549\$[@LFMNDYX$&HV"5@J27ID*9AROMUR-VGO60
M1#&1=DUUY^6&V2B)HO.?*NBLK@AO<]+:3R1A4VE/9I^%A)Z1<D\;CYON;)C*
M7V$!<*S#"9 =7I0ZO(F8,K(F@ ZCU)E$4L",GHR3GE'!]V^Y5&18I,CLKMG^
M4 YQNZ1SB-><0]S0.<0ZASA?'*"@1WFB2?+)LGTC4C$RHQK:5,GU41(W2#&.
M:_+$2P>#T(5)3[RC9*(!E[YXX<8B+1>='EA$A#K!U+*%?TSY?*RH4NV>6A6X
MPA4%>E6B9AZ6#>\X=PTX_W=8"$T+>VC#$<.HNFW"K4 9(J@D@L&!<1O.#QW,
M=P3E$C12<8ZQ#=HA:#AHG=@>=AU0#8AL=SH+8R^<7#/QK,@ECA>0+CC4LD)1
M;$>>MQ]@>?PM+*^9L M ,P(5AZ2#? FYI6QWX9<S=^&W0C&ETS Z#6IIQJ.;
M)7^.A58".I)P(O .X&,6:<52-REEYZ7PDX^;$L)+A?6;9W>TSVS;^_QNDG*[
MI:-*W7:W?0\OZH.Y[9VW&\WVFK:^X;V>(K6+/O:8A%0JOY==(>5?D@=(^S(J
M'I6>()JH2ES@OS-/>',HWG$P<X5S@(_>"1\"AG:$D2Q*B.&S9 6Q[8K!?F0G
M,L&%$TF@+QWML&9"*!#FZZTNWZI&J7QNM8C<L_)L[JF\Z&D.BDPS -7-L?QE
M71>H\5:27XK1;W(=I<G&R\4\>'%M6$LN$CEE*>=&O,!4*J5(^H=?N'/;C1Z*
M54O!T+&SE7@6E!O2VBF6[&&%@>][ [3I9 /*6"F5>P<MV](R(/=$4.BM:I3*
MYU:+* .J+]*@DV9Y-M?;<+M\[;1:_2C?7 R_&B0/[^P@4<DL8E@)'\F22H],
M5Z69"$V*;LT9&:AF,N!E&DLZ_@A1G4Q*IU>7W\>1=W1R\>BG40VJ[.43C#T_
M/,34V+CI=)#8T-2ZI]T((*@_'WA-:/W@\6-1K^RD3C._E]17UG3J>S\HX&MD
MPS@.-2[M5/50^%$&C"D/C;K?QQ"@BLGH/6)Q8VYQX41+[RKNJHU-KWEZ+_%Y
M AG0CE*4:8% >D%M7^5O4 =0'H3,I_!]8@5Q?EHJ+H.V;BU0\H2;3_@PA6*5
M3-T2-9K> "NR=C<<6M"C/#$8<B&KT(VY_ETN#W40)-='R;XYED[=HNP.D?8S
M',XF,\%?1YB_#((D[E8@BD(L47EY\M#7RYN^&79B/(#(!B.6""P;$[H.$>&D
M"A-E6&%&CDI_2;:6,[<=(U@K"297 BD_=2Q8Q?60WOK'7[HGWTZ[V +_XO+\
MHGMY]2?KG)VP[N_?>A=?NV=7K/NOB^[Q5?>$?>MW/WT[9:>]/[ ?OH#!IBAA
M"Z$+"70,_O_"K%GH14[VUH/!C.A)']%(/+J^ (>:;[5T?,&+0PBU]MM"&6IR
MVY4\['HNK6BPF%;T\NM8_S0SD,'?B)G1<;"H,25 U^U#6(["_LW@H%*JF95J
MRZS4Z^]R[&KX:@W'("#\^\@)& F60MCTFW*5;&"RH32WRB7:(65DO@)N_O.E
M['7#%WJ.4XJ$2SJA75&W)=^UT;;3>+E6O*Q(O*R_*EH6B&5V0!&:> /;X8%&
MQ8V@8DUSR ?=V%; <>8%[=">H/''M<!>_W!<="IR7XW']3F6(<<.0O(V>CZK
M/X"H^SHV]W5=-%V<0C B72$P,)Y.?:RX*WIU4/43-EH)5/.[D4<1=%4,YV!Q
M&OQ\I%(Q4YWW8Z^R24X?[%YY(](NY?0#]*&HL:E'+&,S?U$5L,OOL!1:M'(-
M$9NHG%UL"1N48.O(Y=N1'5ND\QPW(@8X8@6<\&]'#6&4?S_ABS)2OJAX(9^'
M5$:.>0<>=IBAWB<3+TH'F'?>RQB#*2=XWK,;:CCLBUFQZ;H\Z=I.#9Q(#P\"
ML'D3GNQ:Z %[XV, *[Y-?HTOH&_EWYX?#9[0?O&<'>6I=<M1"R0C/;>B0_BI
M?>.Y/LII=%]&%)N4C0&S?=<RZRC$/K_4L2?!6$6'!^0[F!$5M\:BS@Q8-2ER
M4Q-]N8>V#PP.^>:0/J!FU!B!5(V*%@I=Y>Z(]27Z6$<35+"%T>7".!5K8: *
M;D3\ U7)J9PO(WITN>1B'Z&;7N;E4Q*5):HG?3N(V[)'&XP+/9,5$W-O2-<D
M Q'9 3'CN*0U,7Q-N?L-L34U.3GJM9CUDB/6NUX"N&7;PGI@G!^,E<@/[LV(
M]X:R(WG!0J+.R0ZU30&895>J7I\&S6+X6>W=2)WV4_P[>Z[5E6CZI:J3X]00
MZDQM_W?&DZ7*B<-&IQ3MW^"LZ:0_$3TV1"UL7"J/#790;2 2F4Y]RPZH2-^*
M&ZNEBF,E>Y1XA[$/:M4NR$C-;!(0B[L*S".;;R0 1<&KJ%X=BW>DB*=T0R(
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M0V,%,T@^GRJURY8H?#+/A&O8U\,3;/ K_(GMW!_5/FL=;QDZK&T*JZ,=UC=
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M?!.\Q-A4"QFZVW%59;H);C(>UO=!476XZ#1TWU,0!3K0E.C@7+"K3NB3T<&
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M@>?NH_M].LUBN(91%#YBU.ZW.OW!7&:",HQO1HFBV4/J;,\9;RI)(!CTX[^
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MP8M\/+@>[7APF8\']VF<IO'@OC"F>719F/RG<R=\W-[BN#U_\%M;H'/B/MV
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M5:<)(U_*Q>L%;1NKTK&#US5>'+(9TQ73-.WQ".F?<J$_W$RMII>:&)O&HXJ
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M>3E_E9M<5GJQ:%:O;WT9_%%\__R6-FN%OEV#<^_3<GC;\K_5W^^ UR]1+G"
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M/'BX^]2^G)C_*@]QIF#=30K&8$!,[+#:,RQW>.E^6=D%5V%[H[^,_JM\/H_
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MZ$[HIQT=S/>3"20V+>'$(D1H@KJTA +-Z)7>G@DM7?CH:!-!*HD"4EI<_-[
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MW^6#)E:V3:%ZDEDX0CE&6@YF?^Z *(*E?#:DBES0L6FALKHQ*80EA:#>W(I
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M-*O+(Z<6YP\989(J77Q<[6:YX5INL6>Q\!$9TNK/_E@Q5^J S+%BJNM1,4=
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MSZZ;0C6I7F*L$[S/B\"1,/I2EMX#%TF0Z!DM"M+#W_!@PMX? H0/=6# ([8
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M%)M_;=4I0#Y4HM$N?=.QK4[#U2MF ^B8)!)F4!$%N00"5G( 6_6="6#:=$"
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MAC#5BYL=VTE,/,=QGT/V&#BVO&VPPXT6O@\0]AG)[FO%7 ;L\(XXRSN:6K1
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M5M\V,2'!0#,8A"2.-K_B;RFDFLGJAY6M2G/\9WUO&0&V;B)#KRBQEZE=K_<
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MI'(Z?*26W2#;X K0)HOY7#*33<>2.N:8@TEJUJLO.J:[F.YV37?IF.YBNCL
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M]];T;P6[C)]%6CACL]9/Z^;'YX(Z3<U6PZ8U=&/M9W[%0%A"A\R=!,5VT'P
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M6D*'M74G334:/4DR!I9HR*2)EQK"<&7XP$3FD8N?]7V%B#=7$_ ">)\D/S%
MLP^$:#H8.OLI6$&/6(QOK!@S))+J]%[_).,[ZJ1"::DFPV3ZLJJBF5J6^"N!
M&P@B26SK*^;YMG0+R6X ,?Y 2Y84XY_82Q74_\_>NS8GKB3YP^_Y%-K^[\33
M'8$]B#OGG.T(KC9N&VS =G>_<0@H0&V0L 2VX=,_E771#4D((3#X,+$[X[9!
MRLK*REME_O*!#++"V]Y!O9$BO\S7#%^QUE+OY?W8MI>5Q%C\U7N9](^FNY(,
M/ IB[B"R-:TDCHCM<9#]^,WY?;1EEA+6\[2@@IA._BC#WL8, EQ>3A7!-7I%
M8R%E-<\3NGE\:-AT3M%%X*&6/PDP:2S2N4?[O+^(^O [!OY4GI97O^Y[%XM<
M]E5SG_?SY7N[?%FMW%]78\V:4&RW[V]N._5FHRUTFD*UW:G?0+MMK5AO"0_%
MZ_NJP6G[_QS+W)ZM!C?DW0<W +5$[M^GLD;TR XF!?B.(!"3'N,"5J-7PR<A
MH^';1@U2[;4A=Y V>>K/?KEZHLMKZ791>--R<M[,-:PN/6!=H-WYLSD=  3X
M5W^NP6Q A_6Q=]![+0'[?.?YM$<)712C!W8'TMB2]>>S@8:0@+F)=CQJQ:\M
MPHVW-Z;6K8,ZYM[P_!;_UBHSJ\:YM#!^O)21!N9E052^(Y=N?(J\0"<?2:UD
MY9V$0"F+XT'.CP!C:YBO=:B0P0:JA=EK0'O]GB_$COK:N\T:@FW?B'6^=Q!N
M^7KE/*ONMW[^F>!+LYV>?")<K']+;B/2YY[QTWK@R/_L<N35]P=UC#4/#';=
M\WG)?N+S0@))D[/\J(PRTGOM[OIE,<H=XU%Q797CE(3KAZ>G)//!IR2PG:E
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MN!RUK\U,%WFK8*Y*=YVK%L&1R:7XD<G9,*<V7(0=2) 6-E1?\7^9T]N\/F%
M?;],WH?%][?6[U&DA\X&->BZD4&2*7YG*G3=\IZT1.XL)9H_N:[( .ARW1S'
M>J-W+7U'Q)T+35;<Q/!;&+KFZE@_<II)DZDZ&%A5T%'&M!]3QIM;*>-M6ZX!
MJU@$9V1RX/H*WJQSED"09SPM47WX .5)I?OLT17OYGCQKN"LWLT_+8?WX_*\
M7%S<I/]\^=Z^++:JE\WK2K75YK>BU;O[>N?7J7+WH[>2C"M'=/)\C%:&\LR>
ML;_62USP;N:SD:KAQQ W@XRD\.W*,)Y/#@9]1]%XAA5_GW7L+%J9.TU_3%:[
MEMDX_"'TII[/K;,0L[X3V8\,/[MH5QKY<).,.#I^<ATJ.ES!\Z72-9)TE 0=
M.B0U%P2CP[K46TEK:J1ZMD_*S=PF'S#.5TNH_-[2WZ\;/IPWZ-B,XUYD;,#Y
MT*.&+)/ \(-$W^$$M$>4\!Q*$F)]I./S1XN!X\*K.N,3M%7JM[*Z4(!\(.N%
M@C,="E?( '>H[H5L)79P>-$E/I/DM@;^UYZ&-+H/NZJD@6$7^C+VBZ$:Y#SF
M$@_XP.MZS5'.KSF8="C(RE3EY<V@5D.9=CZ?^[/V3!I3:C9\=]-T<E8)^/4R
M0#?7-21IV;4$6+RE52K$33E (6J7B4*QG*E,)\GKT RHAF( >__U3TDKHYO;
MJT5N0P9LK!8I"S8XF(&G*+OKQ,TIM'!J S(#=]9%1:8/(QE:L(/"_*$QTI7,
M0F([,H.-SMXL<G*,VEXQHFP"+HQ),)>\EV")UC>?G$Z;T]G4,/\!Q30ZG[/H
MZ*)4E: .Y^!^^E!II<3'M FPP D,[6_ZD!!<917"N3R&LTE=35]W4S46NH&W
MF7?G]0:NYN#J=:"]_V[<]I$GSP-[F@%(V(#GX4;8!7 S!<9SP\T\7Q'B@CMC
M'XC;2=LJUPTFY3EDFGN 0Z0JI)W8GIJT/-W <U,SRV?4N\KTO<\!<X"IV_LE
M>$[&96S!"@6.?<BZ-5F[,.3+]TM6N(U%U2G.DF.H,^8%K('6!A#<1/+!E5R3
M)1]GX!8D;4,I#2 :C4WC6MG,E:Q0T F3R21'*2 _A0"66<J3N\='Z2[1G9M[
M">^0H!_&A4^8->P1@6?";S5F,GF6S)D_N2/,..0AW&@Z8RS=VF&SKGVR,5F!
MOLP1E%@2F5G1A8GUNTPTT0XV^2J;*(ZTB][=77_C30ZD6 .M)[(MQKS<8B2&
M;TZ%HS$Z9F1U54TQHG!.61Q81R]OH<K7&"H-4_NF'H6^P<XY^>\2-&"6.0H1
MIK*F:@,DSU _,L&(;)[A:T[\<U5ZF#Q;:H4L0VFI5.EF _6 +H64Q&ZA/=;P
M:1N!VW#^82&QI0>V7N>0QA>'TB&Y&U>^\D)?O'K2#<R;CP-,Q*9H\[/5>=@"
M[:T""""L_%7CH3'%V&H[?;0@F!:^)Q-&@;,SC<5B+I(LLUQ@K9CHP8R5]\'X
MKZ_6+GC"#/+F\8)7V7A@%'P[%QJJJ_EWYZ,.V$-N(Z3-064FHU3'6&K7Z_D0
MZ;B*7\QB9J(<OK."TH_MX?5+I3QP\=/\<U EOS<Z$E".U_XH%'H_)ZG?J)7U
M?*UOZBVUV6I9XBLM5E\?B]GJ[[)WI+!FT1Y>M>^BV=M_]?5T=7Q32O](KGO[
M!EDWC]4'#E(*B>WF;&](79AT&W9_]TGBAJDV',(>$@-=212WO6E*9K,>N,/1
M)MN<2M=#[ULTNXL>Y*X,/US,$Z"ZNZ.V4!]-B)6VUR(M.Y5.N=)__YEZ<U,/
M*QZ*9CS'MR9E+17!SX&XG0>1C:\9@!Y;7>14U6D!O+G:;Y^I,.1HB&?86"1-
M$>-)3I[CK+X#^"%KI@*GBO@),WOF$QPV.A)(>\6N/XE<C)X%R;4N-;YRO,20
M6:5E._E841\?&[?3<>09(4]TS(*8#ISY(1D<6FQ#X80(&<0_C4ESK%"D&6M:
M85D:2 "=@>L\$KZ*_Q43WTB<C+TXNQ*C#>AN,UK\NMD\LTC./O@8;"M-8P_8
M<8;R3Z8^5YM1)$L2 M-!>7TNU%:^2QUSF5Q- _P0<=O[0E]]4WCDH"#XY RZ
M L<HQB"1-7J=_28#^%"_#R@ -#Z 2E6M3Q(*1J^_-)V.98JH3*I+ =Z=N,-E
M:8%/A3"6WDA?+8E37FF8XB_4,2[4C.U6B*AU3(\+/D+@Q& ".&DR/1M@2H'-
M@%TCC&1\AF','@1",YU?ZLN R$2@HE1#?$C $%"$S+B%4$BI\A0L?I1CMH:C
M^L#)O+E".&]"::'UK:.P=:S%U.0&%" P?%;>[VF343 >:$(A,&B7.1,R#@X[
MP"NT3&"&GBCK%.:X%1K-0 YCV%B<G_ V'@33Y[&GR[RV(L:)LSX"O4\!$>P-
M@-G&>+6?R;KMN.RQ(*XDUFN2K)&<GEFEJ'N5.N8LML3W>T_+X7@HEAHW;:5R
M?-BD>2]LTLK3LG0[3PQSA?O<Y,^7[P(P@0)Y"3=( AZ0"OY3;>.'HPH-8&>,
M2TRW#)79>B%A@\?JN"RCB[":&HRQ(89J+D6B( O&E[$1Q9X[30S3HFPW,$!U
M/N['"-2B<4_D :%#  P9H8P<P J$U+7'-V;0E#V@5@_^;:6<8E00^X4MW<QL
MWXZQ+EW8F&<TH\C?/1E3.]-Y&__$%&32RD_,N9,"^B&>EK,S&ZRH.TOM(!LZ
M0L\Z1<5\ER=X_V@RDZ+OJUUH8F&( U,<20I?&<V8)@G_&9 K>5V=C*WM%-KN
M%$#'FVL]I'^C=@T_'!M'Y\/GBOGX&'\\@5I2J#C,:>"$%]#%42RV96^N'",;
MC/T@Z+5Q7_$WZO^9X_\LK!K)2(-YK6#98W.=C;$8 R338.$EE%U)-Y%35YD$
M'[>NCO]^SEPZPZ>A)%C$#? <+"_Z:S=G_SPC*T>MO/:R@&OL.8]CXE_"W5PE
M /T: <8B+CD!_:3"2/TE&<0> AV+XK!LY+E0='R-ML8K]./63]-R&_XIF4TE
MCEGTA^G_N7Q9[0',/*N>A<$9,IS'@4:1&"D:P*LZGM,:6-:;1M9& ,T4FB@A
M7C'57\I0A;]@D9=WY>2=Y#&X/";_$IHKBH560F/3IPCD4X+(_G(N5-\EB%%(
M"$#_EN3?HM 32'@)(-\Z5M]C26/2';-+-Q$J^U,"G EX$W^% ;4'D0E]_4G6
M/ES64G\)]RYFS+!^ZIP*A*Y36'##<S(L-]E7;Z,-G@ 9ZTNUC[M*^TR19>21
MY$H#G1$1%LF98P%1OZFT *<2G,42:'*/X+*0= LN S[J:7F)7AO3XITR3HM'
M$V^2.,4<#,V2:D@G^.E6>TB]4+<@AJDW0XDQY[T/SKS5*U<()#_C';6H\!$;
M:(W['3;Y+7:PL3:=(=WI[IL^+#N")H 0.[+6@(B,T6*%O$9O#,O_X&?&R#-W
M=.@B311$?5+M>892\6FIC=,/+[_ZBUS=; _MR_IT+.&WX(.,OGQOER^KE?OK
M:JQ9$VZJQ?9]JUH1:L5Z2W@H7M]7A69#:%7+]ZU6O7$AE(KM>MOC)H_P>2/D
M\.![$0QC_ O 9?N@BE.0\R\,5-O$$E^/DDXX_H8@?0B/&??="_0K6+@I3+CY
M<,8'X^GDN2Y/-/6M_?LNKW9]I.W[.UMA1Y/(]:LY]B!:>O&^@CC]WY>D$U]^
M>]J)3W!8V[/+Y9I9Q6C6#,CW0<Z7&[J<-NQ^32;2\60J'T]F,M]6SR [QDF8
M%+!C@VDKN3+4EYU%7*LXJ*%C"-PE@:_@/[XGD7TJG7%],H4<I9-&35ANS_N1
MK4@(L38QZ?@.N5#Y\EW<-_O<'_R_QC.-B^M\VCK=C[@YEYB;=:4#?&RH%&G)
M&Y[&<"%+"^/'2^ZM$(7B*(4U/E4GC@OYB,B+8;M_JL/B2[YYF3&'!6ZXY5\"
M;LF:>8/>G/#%=^&EKSZKM/OWR=#UV+E4/)E/QW.N92LAI6T;%?9( 3*= NG"
M>G?Y7G<.W*0^P$>"/GXO]'X0,;NU3#NV1BNADH=%BG8_0AJ:'6WZBOV(=K%N
M=J&\F5V@M;R[L@N50N)E+-_4"[*\M5W8N2U@E:8A;$%H.+V<&$^+A7@JDU]K
M"X)I"C; *0;_6:F6L*23BI6GY65JFLEU]4P%#8\F)_0112')E9H[!SR:9T&(
M%7G&\SM/2[G7;E:O.I/V2^IH-H(7@Q2\BD$*3\M2(J&F*\OG-['PY;O0OB^U
MJW?WU49'J#[ N-I3&<B'IU=YYA'1O*1](B6I3Z172+8[3I)-);>9))-JM"AU
MI3$IAM1'B-8AL%F>Y(_DGT8)B!NN)^WLDEXE><RK^+J(%<R?"Z3EC<\^DJ'Z
MY%5&;_8AZ/1::R#3R8Z6J@+GHB@A]*:#U9^PRC^I#YP&>N FK6_4;G'3Y I(
M>J0"\ '2NPKAN",L\,,!-"WUFXEJ:S)Y'XB'C2(<+3YH(;DCZ'EA#\,BU$%L
M/:JU-]2Q]4CY.6$B=L*6"S4[4(JH7A\<C>UWG>WJ.\^U<)KG&O4\U\RQS',-
M9U7<V&:EC1Q@ATSLYO(Q&OOH2_6N4;&PLX[-1;41*Y;O[NOM>J?>; CE9NLV
M0M_[HQ=8;U2J/V.=IM"YK JU>J/8*->+UT*[4^Q4;W"X\5F6ZB:5IAJTJCVG
M6MQXM3:MZ*D]G9?309^_FI ,3ME:-;QSOJ^_B^ZZ7W"&6R#/\[(M29SG5HK-
M=G*J0(G;3HY[6GJ#@@<OGVN'PK![%\A%&K;?ZWW+<\3[NOX"XK"W^!])&&D0
ME/P_:?*42&:^?&^AJ:J1:LJZI:.BA8:R#F.H^P(=$2L4:>8:,@\U69O\\U_I
MN_#UMEQLEH3_)XJ%S#?AF 6G=I;-[5!L/*XC#UM6:CPM1,@V< 8M;2)'N-$G
M#;&9ALA^^0Y#>L'40Y: K*7$<J)MR(F"(CAF@< G/W\Z^;XRD'.1 4,=@.5H
M3ME\8_T32$/AI!R""D9^G6"4"80%Z;VQCLDQIL(0R-KCEYE<XJ1!? 6EL%90
M8+QX;:R^?0(-DA-/&B2@8*027[[#M"S2$FZ5$,%P/BV.9W2BP6NJ(;']EW!&
M;TX^3%Z29"&8 [6SO+LFX14P>TGO'<+E2C)QNER)^G(E>[I<.:;+E3T/&0'H
M.J-J@2>'V%):U=MFJP,]9W A<5O%_]7H"*WJ1;W=J4('VNU]Z;I>%HKE<O.^
MT8'>LUJ]=1/)[<0GW]8O'\(:UU="$]'F"_&0RRBXM/MJ,34&]4\E/GZMPL>O
M07U8E/N]\Y40]-"1.1:CI+XA1;"4S6#O2IN2LC<3(EXXJB4&.(5A)'CG=#>G
ML@(P3 R_Q]VQ/:)]^*=K;$6T-:X[I_P146 N:=Z'L0(4 ,(ZF;UGC4#LE9_^
M9PK@KP!?<[P0U#>%59RR0_857@,9#^S36EKYD^+?WV(2 4IQP9 W,!"-XBP+
M96:5)D'-,I)O<:%GYEMTBT;@^19$\BWTZ3V(N <0<<<XO@\#AR3P6L80' Z!
M#V!9@%\+V,(0JP0@6B&1W5=PFE&/07 :<]H G),B!3#>&%6H,7-]G%$$CPSP
M/U1ZF.*>=:LFF *@"XSQ8@%A9CP6 +E-@\_BOT\!XLWYC*G*=I6B&AAEQ 'V
M2)^/Z5Z ')C[88B&R6MA8U['W'E-$>*@%A%@F"AHK'E#-]7P V0"Q#-$"J8'
M)!/_'3\3&1TI,$8!_XNH(4)]D53S29&6_I[,@I?%QAIB)BF X1JKJ//NS ?Q
MH\C0MFB2!._P')!K!$FX(&!9^'<]I"G'QX/H'>N]-!C8;(:K$B)FI@N@BU@=
M325#W^D$",T!O$M*E\T]I0!H/;JG9/ (5.S/.4 SI,L$$3\NYJ4"[?T#(S(%
M!EH+$'Y%G$&[\#X'_ _T3M0A!1AFA,#01?B, +.0Y0%6"LH,T-L&2-<I_C2=
MIX2IT-!$ A4+I%/88 H_V2=6BZE0"LNX^DA+"P9[(M--T[FF8UO%$6:<^,GN
M0.CGL8[+X2'*%RAX4[5GPEII*L\(3)B78F?(8!9$.ROZ,FCT*?8-P,X3\##:
M[,<U^WR*/PD8UPLD:00*4B<+Z,O4*&@2@&[KYO$7^FN.OV0>?U]1N7'!+#6P
M>6*,E98&& M1\$\7R%-8)A2$#R6MSR"S=$!JF\'8(<(G::P#KH_>T^2N0T"]
M>TO(/KD>G+Y*.,^QXHCP&-TK'."+X&I3J\MF; ,NYGR&^<X 50EL-F8* (;.
M%N="TW0=.![Y1.V3KIH8L9W,*:!4$Q Q6**_)8Q0I9JYL2/1W 2*BSB.++PY
M&9_]&!\=Q5P/CL1&28 @XP,M<WQ.=QQD\ZC3L^'XEDRL 38,,!> P'*RL\-B
M6,?CW"FRX_9!R'4N/"*J-#C O,5E!9Q^T#2\[,P /6;U9]R>6>K08*2;3I0!
MR>#$OMH\VF_"5Q99D"HU'DH050=$6,<$0$^>I?IM5258^O'<9R3<G[?/A0'J
M@Z\=L[2 CZ4WW8@4+(,4M#DXY_ 'O.;YF 4,;+M,O";RB2H?!0%C,61B@8U'
MDK5].H_]T$A^1#$PEO,>B)<ASUZR0"8@88$T]I-N$G8%5-WZ5R:!K'$3$6M+
M-A8'AQ#949DA;X))M@3^&OM;DJ[2D1#@3VKDU=1W>!LAALSJ85U![ <:(D;2
MB(=!HOA'XL8S^M0+Q+$ZS K18&S)O&\;;!)CAM1ZCL#OC>/?:G3\W1O,XAUB
M34/^R%85)SC$9%4L8C90N,&[T=0QF=!G68%&2E1A?CMXPP#L2?(>?!OBL3>T
M<J(IM^!59"R'.8QP$/QU<>QESL@:C:A]KDU5BB?.M",\TU20/,F'!@.:\2 N
MJM>XQ V63:0,_P@)#> J4\W8L2=(BNSU)SVPZUSN7(OQHT\\5..LTJR+VD/]
M.9N\2Z%JV203_5GW/'1</MQC.8\#&2,',FY5%TX20*M0P]ZG1@PDEY!R+K1!
M:BP?-I:#WB5 SP?A)P"B,Q@=1+!#XSAT@&;T'C(# A*#\ED(0(K97*[[=I<3
MKX-RDD00YOM9P,+Q>5US6@39'EYGB25C?#P#>#=],N37]'+B$"^]H3$)^ARO
M@%,'"4*6.)0L.4 /VA\AMA_+Z)6I;M,@,(!S/0;(JX:>IM"K9!RQ&8=$W&#O
MB"&.LGG*M2)IFP(G1FX&BB:B4P+_U?]+2+J__"5<7]]&4Y&T&U(CKG:/='M\
MD0-#/>20UA:I[PE4D)2BCC08*"/IK@X%T4$$/1^4-)E;'(5PG@3R))#6/<2?
M)&3\4K7G./D>_'22M(]9YPV V!%"DH55D-Q#H-!G)_9:U\IKD_R2K;OMEP]2
M^"J>"E^C+GS-G0I?C[A"\C/@B'QX+2^T<38;[>9UO5+L5"N\\J]4O"XVRM58
M^[):/8&)&"!6J83X)(KBT[*BO=9?I5ZK<_<'ZT:X@=86Y"-_6=J7SNR=*[;N
M6/T(@FRO01O;:*#=%QP>K'/C.BZ"2U:Z4'PR (J7_<KKG^;=KV;EM^@U46(K
MP!77?3DB)<9K,V(FVK9-11VP%$0:;'@#HF^-,_,AQ<('NVN?BRKW41,'2.C^
MCJ*AAQ/%%4CY8E>? 2[GDUQZ6M:+4J7_\^8NKX:!KXYRHL$AG>5BNUT%C.O3
M63Z=Y0,ZRZF5LURF(Q',(YT0\:&^2;_?U>:CA\F%M--#O35DPXY/,N,.FR09
M"9[3OU$83V=Y!V?9.NH%4$'PT4W6GR92L;RLJC^>EBET]]"_^7,CWX89\/$Q
MAIE%]+G\[L?E <LBO9%.[OA">FL"Q4@)_-]H:7/N>.2'W7]:$$B#WU@@.[I]
M*O3(GW0R&R^(*2]X^T/<Z*#Z*&'11[?0S"/WJ^]3I.BHS(=.V174J"%6TNW6
M76+<_U<[&8Q9A#Y$.:8?OE'Z7%1]J/)Q/2T;:*-TZ %DA7@Z+^Y$&1U4= .:
MIX-5SXRI'JR#EJWFV]/R5S)5^_5[>)&__7,T/M+.H3Z@Y:]G"WP.7R \T-C)
M[9K'K.E/2_2'ZC+;N=M AX6>%Y1)9..I0OK3*+%"T F>"9$X4XWE BV?EJW?
MBX4X;/0*OT;_:F>JKKPBU@0;,Z:*VF>^'KI<[&ZRQ+'2?0 :;>-!L@[]EM_)
MD-A#%V5W%5=;47%VO49=-:K8#%>MBG51JWKUHWS3/6Y7C3I8>!_/G$Y65-74
MNU0@>WF-^WD/<$K#',UT8E?SFR,OC3>/4'+E")D'AYZ7/TJQ5NF4+H;=WK_:
M(?BG2T\<(;#(3MKA7<L&KO]P/67)\R0<,\!'&:./\0?P OYWG[3OVB?H!E(X
M&ZB9;<;$%Y*9>"Z3=%$S1R3)>ZKT.J)<RV?/JAXF5:=;Y8#57M<R!=22D5Y4
M^M:Y)'0>B:T.+"U=_7QXG2^6Y3"CC#^5OW%=+Y;JU_5.O=H6BHV*T+XLMJJ7
MS>M*M=5F/:B$_.K=?;WSZQ!U^+'(\$D%[$ %I-U5@'NE6*-V^ZB/VTJNCXX[
M+(^^:,S"NU/EV.F '\X!MUTQ]'K:'/57SSFMUA@9'VQ1K.I;29LM.B8:J5Y:
M6/]2?)?UIR?C2PU5T2Q_O2%-*D_+;F,T^?WS.75SN=MKUT/W%1CS!74PP)\@
M"*7Z3"?D<L#94S'(G@O2/O*FP>LL^F49^&%[<CUKCAQ$^%N(?#PK)C[-#41R
M;QJPY:+^+A^GMV_CAZO&W?%4YNY'$]IJX,B\ U'\VQB3 ("&B\,7N=/][2?2
MJJOGUZY2,Z%OCY(9?"@_CTJM?J1*G4C7Y:7\EGY:_JG_Z.;REXO4.,RU5U_6
MIV,)<PGO"-JKI^EX\WIUZ_A"Y-HW&F_*1N4.5[!?;?8O6-5ZE1WE0C]4@X>^
MF-NA!O](&:/ZW:[=2[XY0:.^FFEAK(Z+[>IR-&H\+:_>FQWI4<HD;],G9]>E
M),$E6WB(-P+;U2=\N+?[ >1_=('"9NK2H1-#MY2(B50\GW53BD<DTWNJ5#CT
M].1AYOD^.U6GJXN@3>\PY(66^A>5/IWW-T1*#RL\WAUANB&7%V(]\7HYJI?%
MDQMBJ#\+"_F@,Y.)AZBRCT5Z=W?X(PV[K \^TU'O3'X_&\G]/L(OQP<N*;]W
MM3%V![)?OI^QY1W+#IQL^+_BP!PF52<;'K!-NX,F4U63M 6M*"Q+F@;#8HMD
M4DYQ-M/D[IQ TG;46\G:]VA:]F7I=V62*[0+V@F CNU$$V8.8:82 LE\<QWF
MJ/YA4_JFJJ[+9+8>ZF/^D]CQJXF##+M42(A/J(<I4R=G9_QQ;?*D-GU01VT9
MWWZ2ZT\]$ZU5[M9O7]K2W6L6^UHS>0;KX<]P(<>DPBL16&H^-OY:2T7P\#8;
M]-*FWJA9 ESZYB_?L_%"(A''#_)*_?%%2C/A?YU\S7I+/Y;PID;@DOL$V?X6
M:>25#O:6>Y=7UZKZ6'I(;\9>N$ 58*836I=Q#4C8!AP/FF2U<_R^7;GE7!<3
MYZF,)\>G2*-K_W9H:O&4.3NVS-G&1FF#Q-IN^H /+U [Y=8^APOWN:@Z^>4^
M?GG.XIGX-?N0NO_4?>;N93'.3'JG&C93Y1%?A;'-UNE#6/C7(2KJ8Y'9TY'?
MP9$OV3$;!TC#T0(Y^\3/YXB-.-2^G?Q\6CZWZ\I5\6$^N=AML\^A&V^#52S<
MBJ^&>0E/SOI%>5.Y;XWT!J775J)1:3RWND:D9WDW/"T>/*@+1L8&,5U07]8[
MIDN<XP=Y A"2_3>6][?@Y''&D\?T^<7Y;*1J>-_Z+KPM*W^Z@S^*]*/IS5H>
MQAO/V8S%3BJ"LS:W78(B"<F)0 D*@[95[HIKN%O7];G)V;YB9>Z%_O:KLI35
MZD-^+7=E\AQ^/,WW%]>\OSF?\6'U[D24IJVW17HJ#PO26B)4\V%A]ICR8H/]
MM:=#X.H%]O@-A] Z4M9O\.846KBU 9GI[<B$*RH7$?2JEZ.B2>6!7$=:=N7P
M+>SGHFK7.9B -X]9R\WCX3-[?5P%%^ZJXNUAE?*/]_G*X\UC7CZ%5?;+#&]?
M*^O.X T<K3^C6>>R^F-9;2.OE/H&CE8 &C;0P1_M97EP-X"+U9EKSP_*57F6
MR+EP-:2+Y4-"<*;FM_2OJ'>UK8>5]..LW;VR<%4;3OKM^N*^U7]>QU4OU\KW
MQ2Y^E>7MZ:O:(''U\*+\3*U[^P8^E<?J-]C0</=+P?PI/Q9M0&+0FEHOGSZ9
MS<8SKA+G[U#9A.'D5WUNORJH(!-KM($5"HW/G4SF/DV/HPVXMM^783'2^%:2
M^W6E+$WEF31V.G17KY/$[.[F;?[[WYTR,]DEP*R+,UD1>I1CAR\,GXNJ XGL
M\I;(3CA\;KLK!*MOW$(S2590ORII"C:L>K'7FT_FI/>P@@9R3S8&()67-U>O
M%AW11-*55)V]7-=.,1_E/^<EO3QC##U\(3F.BIY_#?+#^A.Y@?<>NG GG4C&
M4XG/XP1E?,L$C%9@IMRLE;J/L[ERT>F,YMJ_VQ>R]?^ZE RP<H%#K!8X%3,>
MF@9<5\RX>D2#*[U":' ;4'J9E-M4IB.2:7?]5]D (=D8RF JP9O&?257N)H]
MEK,G;X]N0 ?O@*$/+2PEN:I_DWX\C7'X2)0$UQ.\@;(\#7C@^O*_I#K^>^R?
MZ>:Z9B)I0UFA0Q#QQXU?<&DCO[/*3 _A_=%VZ E/O\>V6 FAV/Q_?$IDQ56C
MLE_*2A_!&\[H1R/=N)VL:->[T1FA&,SNF^ '0AN&H*@SL T:$N!2"[]NJ)&L
MHC83U($P&R$=P:$E?AK!C1S(BJ3T9/PA'6YBH=W]?&M>K"XZD.SN6$YC__S/
MV9E0D]&X_Y=P*PVQ)FZCESE2>OA;J63R;X$D_O\2,EGA[(RID[[\ZJ':7::0
M.I:4)4LBYQVS83R>2GVX5B):#OZ-:>OQ?]O?@?V4L335,2W\)W. >2+Q'S?Y
M-5M&G'X09KE]2\9H0+YA:$JW_;*\[LOWVIF5=YQK?PN=Q1134-2PG>C]+32P
M]:"<;:C P6S>^JW_\J_!GTR=R!7B/__%K'9ANH:DY[,NPM8#/WM*=LTJ2I3'
MAHQ:3J$I U/;PZTD :UDKS^1F$>FO$[J%5OS4O.QVH@5RW?W]7:]4V\VA'*S
M=6NS[L>V)+/B09H\)9(Y8W?*S4:[>5VO%#O52JS=P?]S4VUTA&9-:-Y66T58
M?7MW*S\H<3O0HQW,EO!X/)40GT0QA>/JV:_29>^GM+B"RKGY!!.^(!_!NIQ;
M?>%,*%L= ^,/.G@.S2G2) (_&R(P#V;4OC@Z']W#^=50W>V\6&=$V@."LS<$
M<10\;HPM-F.CL8?$G+M/\L1$PU;\WY>DR>%TH? $,4\"A]Y/3Y8N_V6GU[Y;
M)J^J>:=I]W$?7.AS508.:\<D<E4>L=UNMH3.957 Q[?>K/S3U?[[7:BUFC=$
MG(2(_[,)7=52Z[[8^B6(N;@ ;!.^UAOEZBVHF&^8XE;S_N*2DENIEJLWI6I+
M2(GTH]2>VW?6=1M=&!I@>JBUCH%)O3(LP^P)' -7&0#PTT0O+V]+Z:?EJW+?
MN$DKJ:OL\Q=_R0V7B&('))?_SZH/YRF^-1)J0T!/*IKX*N@(#2?OV!N2_]GH
M- 06:G["7>@G<RGLQ 1_GI,A@2;A>FZH/951T]0)264DDF=BSC.I$1H(,IE.
MQS-9C\FXJULC>FV-&TO7"KCH)N!U!0>1Z%K5]2>Y\S294>F&Z_B+1NUI>7=?
M7 R&9;W\LQ!"RGWNG'S4G:^$ Z7" &\3EVYLF:)5]U%I[=5=B?#A3.B_!I1Z
M<Y=#R?L&=6XZ)N__OIR%%?R@^MR-U=^\H!2B4,N.C?23G*!"X+*?ZS\8\*Q;
M>UB;LQ'2&JJBVJ6!:4#;O,KIHK7,J^*O\8]\=,=]E7Q"D4#).!:.6@&ZS.,$
M!XCFQ&_0;*3VZ\HKTBEV)%QS$47ZWE2?EOW&$E4K2J8Q2>[$70BL0.O@2V(:
M!0%)F@)SMB!?:% MC-"XCW\AS+0Y_A#D&.?*+- QW5*=1J<[-_8. NWGYIH3
M!S>A[XK%>"[I!6P32&6&$/%:8*5!KG")MP#";7@+EZ^UP<-#\5ZNI7:G/CPE
MFY2/""K1+;)-MWQ2L?7?HU#R&OJZ;G_R^N\UZE;XA ::K;KNY!#^N+DL#'K3
MXN =?;#+GJ3'"Y/J<1X#..K)<$>4?,UV[[[6?0P6DF[TX$"GV+:3H0YM^+D$
M\70^'<\5W-JG_ ]M<@.__'2.PZTWL#M=DG2Y1S(^?7D\AQPNW1)H;,.O@ZLN
MU0&%:6EVBQ,P3#0A&6;'YW;,46<+IG7(]B-;0I&NH#&'(47-P4JO(5D\;<9T
M)&.?+!6Y+*5='DNZCA\"%2UT@!J'<VT9/+!#JO+QE!>7B<?VQ:PUZ_XQ6CPI
MWZ/B-3[Z0!WEQ72DS)[N4ZU1_^)A]OLQDZB7$\.[9&'>2Q9TZ9'\_KE>:R1^
M_6R-NX\/\_[ES;";_#7LI$KCWJ26D![Q9]^*3ZM,3JUG<H6*T6KKZ\[9?*\/
M9UKVOK><&URN1"S3.^.SKY;?2)R#60'&U"=_GCIL1=!43IB6X VE:8>K# </
MP%>9BN?%0ES,9#?M*MZ?;=@\(>!F)A3#,S.A@J,W!RN.50!+8)W&SCM5.$S$
MGC3^]?U-.5>^O)#>T@Z-ORG;]J79<SY,8X=P]VR;B'?5GS^KOWZG,RLJ_& 8
MYZO&7.5M=\I*# >[8<4RV6P];#=VN*((<,W/1;>ZWP/1OGOSS/%BSP[&.Z]\
MG'?>4)5U>B=5%]6'^]_YB^E@*P?=G^7[4N7)CW32 W#['DFOLWJE.EZ,MG34
M/XC?'^6LK^6M0Y5NAX_S@?[ZI@O=+C!)QA.%3+R03AVNT8C.91]##83%@=J%
ME0CCM/OYG_LS!(\UL5IY7_[J_<R[^.V;\>Y3>>X!>-=LC1HML2Y-^Y*K\WX8
MW%M3]1*!_[ZI\MHHW^!:(K-/7W[#U24W"E#\5R>>IW;@USLJ?WBGW6Z+\]UT
M_!L-#(ZCS>/#%K63YC7]7]J]ECIUKT7=O5;XW-UKIR:< U2\I^ZU#;O7\@&Z
MU\J7Q<9%M2W4&T+[LMBJ7C:O*]56VT#,P-SI_#IJIKA@#H3J%ZL^B6+Z:?EC
M^:=X<?'2?+Q$(?O%RB-)&0*PKF(#*?G_!(X<L:<F,L=$\*USNX[G!4VKVK[F
M6\84Q0M<JX\V_M['K,<H<RO57*):-G02NXSX:5C42&3K!M?-(UFT>+N>O#W,
M:EES9H /2?[]@P?,K,3&S/+ Z.6,2R8JJ=?WJ]O&Q? P&+>NFV\-+\-TZ9CL
MK6S,7B>^(N=K6<IT*_G*K_>2)U\#MH&&X]EAB6WA:5EY:=Y=JH7G/F# [U70
M2)Y@)PW'_OW#V0U:@OW[?P_?,;%-6X_T/VV6U;:Y/&X;L'8_S$Z<8^>VJ=,=
M?!&.:16W% ,]V-9ZUI"O;^(/5M/.E\@5N@&Y+'RU8.9N1LZ_2"1)-\XQ2Z,+
MQF(0R0QZ11@IGD5@F8\,BZ)MNUL,+/T'M (ZN?Z85U#FLR*.=PD,<OS;,:^!
M Z]NM +#!S5\XE36]8K7'U>\_;2\>KOYU6@-V^/:;H!(W*H2QA(DQ%5%J*&N
M-H<;7Q//1<9_FH(S\LW7Y 6M3V.WT##[BKYTL%)/-%.%]A124EK<N'GVJ5J8
MFA?O>1MN^^JDK[8YZ6O]S;MK7.B7I!C\J%2G3\N+;N$M,TXM!R5KP0)A\<IZ
M0IC-H--'1(((=N9BWX+NU0XJ3+;Q%S98>/+?NO#4=@O?4 M;/TU^AGA=FTAC
MAZ[EOPS NX =F'MB9]J?G2&2,L<K6IEM1,O%/";#F<?G8AX]5GZG4#;CE6:*
MTEJN3UTRU;[_K%LA7SD :]>JEA*C82-9$-<:N_5W&T&%,64[F(>6W%\YM=$M
M/%GXERX\E?BW+ES\MRX\&='"5VV/K1V1Z#0ZBK<RU[#BO,4V4J63K.FO:ZJ&
M[>:KW$/ZTW)R>976[_^,^EDI.C@.=O&=RKB"*P:+E;SQ('VWV!?6T=/R%-<S
MT#KCV,K!/=BDZRLI69_4E1^WW2];!IR,/84P()6;,29@S2][^-/*XNU%OFEQ
MJ_X+@/_)>(S^=I6R0/*S,\'<W6:YJX%H]RH5>NZPF'-KD#EMT*8;Y%M#X=BL
M7'BPV'C>=4YT=/NU:6V%Y5U;%!A8=C5@^![4!<A[NP"1DO[I)=TAPX70,ARQ
M47#%14L^(=[CY,>*CGJO])'VIF&72GM:#GOUQL5#IJ-=A8$V#I,W7^-26*B+
M)'-N>E_9M0RB=MS.H3TX7JG)<O%PE;M/UM-!'2\+A8&R_:XGI]1\;/B[6S96
M1.QJ;8=.(^83@<Y4M)G%X*@!&S-\]7!&S.]4:'=I/9KEOX?+&_@\Z2T0"1-B
M)E[(NS4)[NUJ(IQK$*TKD\YXNS([OT8X0#%T"%CX" @+6#8"_>D%H!S$$;G5
MU!Y"?0(VW9;&J#FXG7?'<N\>4ZICQR376EZDN_J?UP@S1JNKX530:0JZ-"86
M=THH(4R+!E]F<R_$GSV[\DB6I>$PF>WKSWGS%GX]BW;I@OCR(5H3F<ELY9*0
M _4)G9)][D!HI/CLB>W1>"V9H"G0E2W(%.*%0B&>/N"=".AV9'PN4?YU0N00
MC]!A1#81D7YT=3J*FSL=30!\&H]5,MCB:5F\>E^DQ*OA2W,_LTF<OH>*7W9F
MT!.QUY$/X778^;,SCR-5GVOEUX4D]K,>+H>=,_MR-FS+C];,9<-!0W)'H_#I
MW8P=\CX3^B8BP(" ?R?'-_$N@F;]5KB?)\Y%03S<30CJ7/@4(_VKY,>A$T.[
M_H5=^A698'X%\ZTT^17;09;!T.6+FW9AIN?18)<9C#8+R-G+A?L=)"W6IW2H
M;7)AP\[\!K$R*C:+OY_?2^8L"E=>[-)A6%UPQ)Y"T#M'#PS_U&?T%';.]-")
M^]3ZPI)_&:LW\ VR0=-OJVR/)\$WR*XO$SEPWR";_2R^05C!<8A$:&<]%4_M
MSBE(!W,*;#Z1TSM(Y9J3/U?SU+(79D!=F'1#TQ9&[]IEJ 9T&?R8M#/?H?"2
M[D_O<I=WBME_L88]N_0B?'@0K67+;8<OGA+CF4_G3>R/^:$SZY_-JXB.Y1NX
M%[G04UU38CI>*!R]<Y%+?1;G8FOY<4A&>']?#%;9&<+'2)CVL]C_,V?CMSNJ
MA\1;2DETT$.RKN,/-167RHJJ6"ZKOVL_A\D(1^.NKM!"$0..T?'><,H -H&7
M$E#J(O1"O 7N[% $/^B9]:GE_B#2/>8.D$,;J:3NT!1L4,GMBN0/%529T/%%
M-) @VPM7WJ<[]"1<JW8BOX$#MSNQ<;46I6BLA>-*/'^E_<R]B'<H.]Y3C+K>
M:#2COR;_/.8B?W@NWJY.])XN+/,;^(8>9SX9L/WG@ V%3QGV2:P< K-!4?:N
M!,;51%0V,Q'-V0C&X T0Q%YE58?(X;5PL>@-+L?5WSN-',BK<6! WXWW0#_%
M!<X3^?GB@E6!VZ%6CR0 **3B^4*8YJA#T>N%SQ< A)4BNWP4(O'TMY4/5S6^
M O;EE2,#1CPMK]+='])E*].XS.VKOQ>S 6:239"DSS7$+U.:CB;6]KS[!_5F
MT,P*LQ,G!"P3\Q";9:'8+@OI?.),3)RU"P5!&DJRHL\$R=AR84I!LH6>'?PU
MHKNK=%"<%LKDG5U3U>[*U>9EJ_0R2IJ-P1_ WB!W7VO&4:YG8[27+84MAU&:
M33WAJVUWK>;#L=S4#A%S?(/.  ^=F0U58OO)V+R!&U/8/CC-9K!RS\2SN3#7
M6P?CQQQ-?!JQT#C$8?O0DXA#-IX*54H58?19Q"%X3X(_- <V;ZZCVD?U,CO7
M45N&E7M:OH]J;[^6+U/Y,K_+.-4DDJ!TV.)5,+Q.W [=S2:? EOK4183AQ>2
M;!F1;"/*.S,=8B)\,4I<3.7B^:,OMA031]7E>1BBYA"BT,V@40F15\^&9<[?
M>K;5E9Z&HRD$O] TF,5-IZ(T!^: ^%L-87YBM4TL]].RK_WHMUY:(^4JVO+-
M[Q74G]/-QYP59$8:&)@>(TYX!2\!?J,9Y#$3<S(F]A-^='[A;L1UAV9D>Y<S
M%\\4PM:5'D@ (B9R)T$++F@.$=J@)71W(N1J2'(;&A*6<RU,5+V1FF<?_^RV
M\6_>U='+'!* CF0@S=3@;^(ML48=4U779; 6EI3@5QGF-R%])B!)@P%_^'<S
M;0[YP%X/=GO79^S8C(IX>!%*!&=]MYDJ_)_M4Q/I;#R?RQR@E?@@]KO/6';P
M?8.B=\^+K$0^&4_GPS0A?"[..UB[?;X;\.(+\50FZCO"E,5N-= ,VW%U@JZQ
M\G]:%I]_/XN]HO0VR^SE/O!O80KW2LK0&#%(A@M^^8[I@N@&$^9<J\<7?"1H
MLT'2?C*VV9.\+)CK"H(3<70,"&PZ?>*Q$\\\>.;3$OROXYFOMK=INEW8TM#-
MR"(VG^EX+L#MYFE'M]Q1QY:%AAO:\9:YF>U4,<1LO^K3,EM:-BJ9FT7NHA]=
MN.F"KNQ<:)(*%Y^#*^D0>E90CQP=(2724;A.=@5_\*922[XF]-4YCG##C;<P
M*X#*_C,"J_L8"U!"B_1@H:6K/U)KAP1NSY!@,S:<K+ ?RJ+>'&Q<."(FMX/=
M3<:3V6R@Y(^KG&TU".6@A'EEJMR^A&)%+44B%:'QP)(!Q@6=1"&L* 1T6Y,^
M QA/S#^D<QC$]4V&QDY()Y+Q5.)T((]")AR;'OIV'S8]DTKO;=.C]*9_BNAM
MI#_WQ&+J$"9EKW.[G2P-_;SM#L'ZUV[@?&<.P/F^?Y\/6\^#^DLW"M][,_9\
MG"N>V@Z8.K@K[F!(]-K_B,Y!&-NP"X':C1L??O!G #?^)$8?(49!0P"?'M73
MQGV6\Q\H? @].35H^'"2IR.7)X<?$CKY$S3TV)' D$@$_S>4QGV/Q?Z96J/1
MOP0Q@7G>D2=(%QKH36BI$TF)TU_$A3;2Y,'?PD32AC)^.'S4^'^'UB5T#:2)
M/,8K6/,\\EE=7B+Z>OPDKI*G45)HYTP/0559I%1W#49W][@$MZCNC5Z91+>V
MS@C%H-IN@A](*KP5=88?@)UJ ;\!"O2&&NG*U4AYWVR$= 1GB=RKX4"G+PQD
M!<<FT!>L\\A'/]^:2V[LH)P[FZE3PCWC%_SDT,V*C#5\SRTKB?WS/V=G0DU&
MX_Y?PJTTQ,>W3>H@>_A;J63Z;X&TT?TE9++"V1G3NGWY-?A%I6-)6;(D<J8Q
M&\9CIBR(]H%_8]IZ_-_V=V"!&4M3'=/"?_I;X%.^$XG_N(GY3/.ZP\,L=U,_
M'L4W?+\LK_ORO79FY1WGVM]"9S'%%!0UJ2OW_A8:6(]3SC94X& N8?W6?_G7
MX$^FUN-*[Y__8E:[,%U#TO-9%V&MCI\]);MF%27*8T-&+>?3E(&I[>%6DH!6
MLM>?2,Q/MB-*VU%J/E8;L6+Y[K[>KG?JS890;K9N]VM+(EX2?1BX3=+D*8%]
M;+Z4<K/1;E[7*\5.M1)K=_#_W%0;':%9$\K%]J50NVX^MH]WY6Y')9ANYAG&
M5$)\PD')TW)0O+],)P:YWSA>T><3O)P%^016C=R*"F="V6IHC3^0:H>RI(^$
MVEA],[.!P;D7S$9\X9EMW\H.2P/9UI5!F S@[?]]29HL2Q<R3RX)UZ5\]3:[
M?KBIWR'DGP_U+ 0R!.18Y ^?O)JJ@1,FT*9].J2PAKK:')J]Q1PM?!&^UK&1
M)$T6WX3."'N0PY'CU G'M&B7RA[;8C:7./?BY:J]>!F.V*VFOLI]U"\M[G74
MKRO-*=*D&?0CX>#N59[)2"]V]1G$>D]RZ6GYGKV?+*K2:!ZF_V;]G4V@J)"H
MA@&H!C;$DM,L2 ;1?^VX/'[]!X,///$H*)>Q+IU(C?)MZ7[9FKX]+?7>:/'S
M[O4M=QE=,1I3A[G\?]PX[5U)SKZ7_(]O&H8K6]>'KR13^*>=M.RGH#&U0;]E
MV()&7WZL%9645\]<"^'E]N0QLC&AHVY\P!,B/N*_.F_OZ9_5']>A0.S#X)J9
MBZ$ 'FPU@H+%;XQ7 K^%GWMP\.=X&5@H74_]L1SZFF4GS0T#.:7IO!LT&ZEX
MLUX1VV.\-<G&4U]^FN@6A7"?J]V5NU?%6_G/[KHAS0P>_(M;K3IO;=203,C$
MFS+"$2/L3(?T.!9IC^/'MBD%8FX8;9$.G4;=56>2!:><=Q=COX)U&>/-T.:H
M;T.N*"K]ZOL4*3HBXF6W-3^G7:E8O4F_]Z4]-S-9I8R1[00 DI2^@!CINVY=
M]88-V9C+H>0L='E8-IX3UR?KM\0 \>3!M2QUY3%1RD2X1L976F@,X=ZMI,T6
M'4U2=$J97EI8_^(H)K'^B563V,2UVOO]-K_^\?+P\+QO3<AEE ND0-#UQ;^Q
M9B0TD]SRXD/$U*(%U^[2QET]S@UQR&WHP3_)#%89.YG[(_H*[JV& )N3'59W
M@SMNIIY_IUOW\XLP8A99BZ>[(+(%K&C&H^U@6F_;?;<PE+H-'03D"C@*$*-K
M:?(S]>E0<3R(= >KS?(R>3%YFLPL<MWJ7=ZTR@LQ]W.G;4X;=3 '=O8WJ$J.
M0N2WJ'38^N'!#D9PD0AU1+8'E4D6DO%$?CW>A,=A";0#J^<G0GV]'^R1R,+-
MW'I]0<,A[[S?[*V>O;R4\3_WJB%6DWTR)_08DWW6WL=;:<'A,WHX+M4H.*T]
MYA>9"U)>EFO73\O\W?-X]/C:ZT)4\''N!T3_!I44/@_OD:S,5/?0_[,Z(&MW
M,(QZS80/^ KQ;"$8H/J^O! 7K0)2C;V0&15I[HTL,YWN57E:S-5VVV@=W@-Q
MTSLG#V0S#\1%'$(=D0BPV;<^*R<G9$/;EU^O+FJTU,[3"9EGTG?%L;J<)U,?
M[(4,.*7'Z(6DS4PQWH$>0GV2'0?,?.C":@YJ*IEF0GN/V#UD>:F]#)Z68R7U
MVDF42R](W-/E$">1N7^,2' [!I3,_0#T^B2" S QE)H+C;"2C&>2.\F@64V^
M^ZHM/4MVP2GAG4NIE[-<(LS T\#(G79IX6.P'>,"/C09NY9O860E&_HZ"EO"
M1.@Q/&L%IKA68-B$^5OLB9#B+[O4**7NK%<;57[<?(BV8<0)!G4'*#E.!H82
MG]!!1RJ>%<..U Q2\& 8*A9K-0?6\:(562>1IBU4IG8*]>[RZL5#OQK&3@57
M-XPL4#)SEP'+?4;@Q]R"4^ODR[E0TA+Z;@?NOG<Q@-5:&=-"4V/%UENJ"NJZ
MR$E]]O+2K?R\_Y'H[4O#<)$AI2[[NR)<$[+YL2V4D(0OI\J(\92X@^&.#EWB
M&.2Q*AO:8I)HW=^UYGNY4W9D"!B1J^.//FM6S:JL'%L32OY">\^I5#*.#_5^
MDFABJ*C83**!H!I)M,H4O=R+G8*.LA]5G;L^H39ERQ.Z"]<P^M^;5 N54W.1
MCC#')1<Z@,@EXNE$/EX(,(YWFU2:A[.XK5X^LB2:]28/I '^'ZH:7W&@BTUW
M"^DS3>YAVPU_*"I]^R\LGZ3]%:LE%+WQ'+:H^MX;2<H0M; ?4,6J&!)P5.$0
M19.<CN]?2\N4+H=)Q$74!D T"J%2(/-T]=&'1F?[W8Y09SP\U%PR&R^(8<84
M;)0AV(J%3W+[:7F3RB^2/5U)WD18$>UA;DA.6)H)7324%0#H %]M2C;RZ'VT
MH$ TN73$$.IKG:0M9:3ZM*S=#&ZG-]++Y"9].%Y2TBY3T *'E'YPB8H$$B4:
MP)/]:L[@R">YT!%I4/7G 75R<F:"'6OH]FVH"EAR\Z98Z;MXN)"]&JLPE\MV
M/]AXKSW/KTO5FVJ8.X:(W)+V?#H=DTRL-";Y/THH'&6%+LXW[#G,3?N72:;E
MAI0)I"T? 5..2HOV%+K7M;K"O;,:_H>1EK=/A26W&LM,\X^DW0S?AF-Y3\G&
MIKUQAM2'X[B;D0Y^,V+$TYFHEMO52.[,5NS'9C>KT3 _C*^<#X^1OK/KD)*_
M5-(N2M2'!=HKX9GX96M_ZK_N'^ZJ=SL=GNB0.8F116_4IAY-"A\N5C[<"R4_
MH6.M?&$G75LIF_"4G<LOXY,R1'WG+#>9SW*C$I1N7E4K/R]^:84P97H1*+ >
M)1/N3DQ"!:#T#.LR1NM'R=3&3 TE6%M<OF4*J7@^0)YN._%JH=Y8TG5Y(!L#
MT]=-2*?2U9KD,G<_D31X#--S&E@_.>ES,7;6R:[F0-</D:L0W PE5J&#HVP&
M'^AL/+6;@?,)4ZZ*X[%J\,!ZS#IJ0 &[N;A0;H=O-ZF;W=R/K*[/I'GU(@^$
MZW#E;AMNAQ+ \/=U<3&5B^>S.]%K):M>L\R"-B$KFHH'/V[92&BG%-9?VH7!
MCTN4?PDCA1NH.>OH:LF$V !9]!8[ET'6'Z3WMN5V&"DLA+\&VV)0^B;QJ#F:
M_,;DCZ=1\)+!IO107(ZN7M_E_)XTH?=(]<V$$::J Z:'9::ZK>DHY%SD+:5U
MVUT)):NA0XQM($C<9#5Z4.:/0#H\%MKW &E\D "IF^,59TYXQ:8(1H-7+!X5
M7C&WH(ETV76JT3)]U:N4KE_3Z:29T#BA&Y^P@\,MB3U]!JA&8)G_$N;3*=)Z
MDHY<8(53"0-6N-'L5-NQ3E.P4>+S,"L.L< >(M3JC6*C7"]>"P8R\=[ B,$_
MEP>+78LV=5<:\PG^3B^@SX3TGC0%=FISY/"@TE\<5]%-;2@I\I+$O28X,?Y'
M4>G?8A<.;O5H3%SC-M2$+39O)3N8JM(8>GF^6[10/E&QW'A&_:JG94%KWE__
M5IM_]$$(9?8QFXQ/!0A_3*2P6<F_S3-"6)8L/2U?[J>9>5I)+Y;#+]^;K8MB
MH_Z[2)1%L5$12O?M>J/:;@O-VVJ+_+IMR,RN9/\X-3C;OKW,W0!M)W^WRK@T
MC@%NWP52D 8Y>GF'^_-QZ_Z<NUE2WY 2(R@7.KG($,JJ-A6^0ID2G-MDXN\R
MC4?(O\2_OPEODDZ@@[6IJI&@0U9(55-96N W"G5]C*5!A_!]!=[[7.C !^D#
MR8/ _D'<HFHQ>,9TCI^JDUMJ1*HA22F%@(W"$&EQH4=O5_#*L5HT+KCC@J3K
M:"9(YBKB["/X>?@S.OZ(AE2+R,8%%;O@,N:9I G=N2XK2->QU9ETL4:&#\3>
MY-D(KP'!!R?8GS4^A=EKY4Z)?[EL?IFS:OMA,IM("_FEK/01/#QQGI&5T[G8
M*A3G<BKK$(@+8RPN,WI#*9$87.[-07PPRS%A6,I!I+#(XO^!B@LFRA1&!WL!
M,"J!B;.;S-B/A@Q0J) (&R]B.)(?(HJ,"N< 'H$7_X;%DV4*X&]P!@1]WAO%
MZ5DTGV-)NDGC,<L;")JL/^MP;E3L?L"JB+R3%PJ>+XS1%\HH@C%)![;?GUZ*
MC<95G=;7T+12&4?L,P1W[Q/A4AU#QD,7KF?]\SB(J89UJ3X2'F18E*'8F=3%
MB800^\&_*ES?PO<J:"R]P=/YB8'#@GT#?21/8U;=R4I]=$-?"D5R7%:F)MB%
M>B3UR8'$A$P@1]$7X+<,2! _$3\&"SHKP%N0PTALBSEX(N8R>$(V!T_,Z.")
M53I86R>YX+-09/"6)FW!B@)OX!.R@GD(.;MY=XSC&N.>\"MC0?VVR5<?Z^-X
M1I.[T$"%QNH;9?! '>.?X2OP./QQR@L=']7>B*Q-$F90C$!.N*%HD(>:L<F6
MIP2>Q]A)L)EK&7,5^#XDCAZ\PF0[ID]#KTB98^;,E9F,^3_ $3BA%01FC/A5
M*<ED4J:X$1@WBJ2Q+L*:9G8>LQ)AO!Q$0#DSW\[N#I@O AL!+Y,YF#G[,ZE4
M(L+ T0#Z>#]>>0T38[%=%V/_(::C,8(29:M(@,:59WC3<<2&%[/ !$-E]TDU
M'L6J0#5J:"A#D3$132-A;B@,Y^G&DF%S_5K6KQL1O,U/[D.-AP88TM2;?47@
M%U_-L945F4XYCS7Y;])NVLX\TGTNGR#9]FBZD$A:Y[^#[PLUDZA?F8.ZH4U(
M]*X*LXC\2;=,A,^):9H[I3^9#YIW=;DOPSV7-$;- 7FP \ ;T\-PNY>9N^+]
M_*Z[^'TO&@/@R5=(^2FFOT^HX9J8C80/,A)U[6*\KMER9V+:_,D N3:(=J2-
M@M;*N(]RS_H KM!$'JBDF4Z^J1LVX);:AGOXI6D*JQ+6[Y8_$4&0=8)($:.!
MB?5V-2[\KU,DK+,H+"@TMY+6U(BX]LD=RBV#,GJ2ZTZ1""L(,[5U/YZEKG*-
MM"$(3?ME<!R\ N$5"%C;1;*>=H]>D6";'K0^Q;[I]^W*+=_XQ#G>=#>(:+KK
MQDJ-+3>809_ =SW.W?.RZ=F3()3<4QO?;L&_+%]"("KDES&L@#"[N;M )PG#
MCSC\'; 1+(AJ(70VPQ\>D7OZ%6D2YM@U<S'>;FJ16W.W,)H:;ZN "V^8%KB#
MZX.AEQ33)9IJ,JU/7Q%DZW0KB_S=PA=V(+VHA%H3L5 J:,^F&F-X4R2M0&67
M,&JM]O(@=PN!32:"EK)X"ZP($NLMKUAF8+/BW-MB(2#>6\-O<MNGY!I,J#J5
M%"H.O/0L>C/4'#_FWUYG#[/RT-@_;ZPY_,4P\$RN:XG$"N$/AMU?;((2ZVS0
MSOS3DRL:<E5M>3(?SR0%J7-]O*"91ZIZ>=;(5+Y& .CE'DX9L-F4HX:9;H83
M\LSP5 _)G72"GO%#?5$?RLV7R=6H*!VX;^F^ L<1#UKK[^YHIE+^;J;#OZ0$
MQ0R*[*XFL<,^UK>T!^OKM>L]J9U"M^+UXB5G4>5 Z13MPP('VLMP0<-FYGCE
M\*X:Z)D*5R.^!KJ\.6CC;D_UG_&O9/U'09O+@P"F>D6W[197<9OS'3JF@*KW
MU!H+3M)3*Q(1L_C7_-Z+](1Z)7GCU/%W]^IYFIAF(:MP,5"2M3[K;XH+=:5W
M;FB8:JEL1"/D'D]#4Z/0X=5XAP5'4>>9.B/=YB[A-$TMPZ46E,GQQ"O]DTQ0
M5,P;2&N<$2,AAO,EG"^:SFGR>NU(PG1+0PTAFFR&%Y."';B'A+:=H4(O?"#5
M#'E0C\>Q7<$?=<1\\"L:R%&^C!<\:O,BZ2MZAQ0UR?,B;2;!XAA)".G??/*N
ML36AF^N%U,E//# _L:G$:)XP9\T3V@X5>D=:3]:I+RAK@OJ*-$SJ6&4-(K30
M'@O.8#XFAXD?"(C$);/OTFDX\MNY@SG#<.0V-!Q-O( BI[])R.>VXVW4ZJ0>
M*]VWY>" /,*<^9-A,3P783<:8KBXGCL1A36Y1Z)$R!6;A/6SCD,., !,I/)N
MJ6>:I?$5C/1V@I$W!",?G6#(B=E%KS.9#=H%0S :<W)KPS,X3$1V+@UY\Z>-
MI2%<%F C:0#7?\5)S(?P]R/<O=IS6TN(XPS,^MZ;Q[_Y[H0+X':?@\NX[Q[4
MH6(OBEY6M6@2N-]4+&-:=W\N!S>UG^UR[GH,",*NSCY']2?QZP;;O'YU.SJC
MH4,_?$#7)NJPCPU4*ZAG5J3-1E#2@U<>]W3KJ<->*@OXS:HE$CA01>X5&BK7
M%?5ZGLGT)^(A:O$@4: 8+@HTLCQ>7:=40WB%"48E S/C)T?^T!SYH@X!F=/Q
M,I45Q]>90-LKK3A<T?,%EX&#[(#Q3 <%/]_^A%JN5AH_Y=_UAXMQ]]5TK3H.
MPM<F97RHW? 0>ER@)$/W>J< G]X#286>.G8+ST!!5[8EY[(M-54S!C00R%<Z
MASK2C?FA50;J_.?ON\>>:5OY/ (H:)E;*. 834%WRGT!$>W55KW.7HA<1K4%
MG?1G7?L 04LM-I%NKA/OQ2?S'NU#!**Q=I8MZ_Y(I,N91ZETU36+)."]#C01
MW_;T54(CVI;0_JT_')&Q,2H0'K.OE.3H2$NSSA.9%E@HB_,R9;!0O!\ JB![
MO?ED3H=N]-% [LDSGBS$O*! &5[?CV&?"A(B"_Q-R)CA1Y#ZA]7:!T@DGLSI
M@9E3:ZT^*5(EN5N:#14SP@1_?F1QBZ"]CJEO7D_W%13D%.1%S+//QP797HI#
MI @'*O"[&2:(EML2 ;$6V\8L*52H$,5QW$2>L389<,^*6*7V$?72 ?N62"P^
M@BHVH_WYA/R^",T%8]H[4&0U^K0R.4")+ZE1C)G-.\;OJ=MK5ICQ\FN!UCO*
M^! -!O*8]@/@W_419+D1L)X<AP&D\OO20F?Y8WRB7L%RQQ1U1@)T_'B-'[H^
MDOIC3%M<F "&!SY8F.LS.DL8_FZ#]O"WHQ7Z71V2#F$3#A:]F[\0"]J@7JW=
MF^4A_!7K+*+QN2"I!"_5&AZ0RW.P*56K(,;^U[<DLJ"AT$H^)P+6)JMB+E^X
M?WU[,S.R]+*#I62G&V9RO.C=BO]1U/N)_ID;LKIO1B4QT1TZ[3LCUT;6HQ(#
MZ ZNC?BQ.<<A_1MZA<LFAQ["P3SO?F"VRD,-0+Z M^:M: %0,S%"):T19!=>
M\&!BF=]DN!-@J@H>L87:@G52[4G3%S0A;TLUQXC>_BI_$WJ(W$9 IY+1T"&P
MBR^CD\/L$GR3%=)Y,I_&\=?Q]R62'YM,9]B:XY]AV@(V^5W\+P-RJ#N?D862
MMK[9")\63)M1OA@##4=+)LE56IQ %*$)0=<PKOGH36.;E;+2"@JDG='B22+E
M4"2X(' B;(9%7$ O<_,*4QH.-30D:IS$>?!+!<2#J<H8VSN;HHRS.T_:\<!Z
M&QA>$NP +&NJH5>9E!)!NPHBN1_\SCGI6L$TN=X$SJ1W1&T>R-C7,:GCI)>,
M,4:?M9V"/:F/C[4ZGI--YKBOW^+XU\8<('B78F1MR!*9*B"EK?,9EB2Z@PZ6
M8B^A-[*@0U$)X4(_)O88?VT.#4JTH8U<I;KL#Q=P:)"S_ONKR4KC =82V<%<
M(][X6'Z9DP9^91CK0\&_W"4K-MCUC=Z18_$+)G]F2P\T[%G6&+<VZQ$9F<),
M)6GL<4D?T] $;Y"3>\:",5'@<91422,#!RJR1OH3,>5\4;3/C^[C*UHAP"DF
M*G[+D!U*.J*7=OW&>'/86'HCPD%G&9$3VQM+\H2V0>*ERC.5D4;K!# 9%%-+
M-Z("6#9>##D[^'D[<K@/V:_>U)=N*D)#?:6-2<D$SRA)^,]8U!9GZAO6#S'=
ML.4.<8JS+KX;TF4M8)MO%':8O[*UM9A=VTY]3'!7F':"/EG7WFI25@%[CGU0
MA$#F.( <M)#-="NX/FF%.S]<[*JC%$X"MX*-*E3/?/='VLJ>D+:B1MI*'@O2
M%G%QN9@<J'0?Y?D[0#K],C4$\>5"!0>HK&)1U0 EQ'+CNEO(E^C!:_B.[!VH
M9B_;16^7 O30D]SXNC)A@+XWL@,46N_R_56_*5\_M)6D$>;#QX),@PH\U"F9
M"GV)XSW4B6PT 2MZ4[5GDG?F&607-E@0RA_IQUGU:X7FEQULD:JSUQ^/?^3[
M],A@RZ/C-2PS[9O2=WW7!GP+/PLPD8QG4FXS*F@]@JT1?T11@.::QF(YB/]Z
M%/L<2)65.4F1DL\(D$@D0/<*Q*?J 'N$-!-OX*734 9")HF!)02#*A@O^+;.
M- F"3@LHBOG^U<M5_"[LMNISF02V7I@LM@H,P>C,<<9A@#^DZQSV>*C2&PVJ
M*7M634G>"Q"O6I\4M9,GLM@>OM2&:!A':[IP/R71&7?$B^U[PP-/)L3TF9B)
M\QRO"1E'8JA[A07N,'Q*D+HXR(;:CRITAIJ17+$KCP$= [.HS+>+,)_H>8'I
M^3A[*=9Q"G8*R JQ1RYC/QUR)-(L9H#0TLL5'/%*D#H"GQZOA507P_BX&2/$
M+:B43%)Z-E)LC"2;P>]P>%;,BM$S5XA+Z9Z6WRPS1@-S5CC*X']H!@O1O)6&
MZ$U#%[\C9B0(&.Z')9ZQ)$@<E9<6AHX(4, ,+@H4DFV39I0 RXV5P6!:U4.8
MK,=VP64XY,&.G@UYF)]"-P1B3!MA(:O7)RDF$[:>"I(P(?D7RA[SL@:OA@!W
M&!T$7+9W5=9R\DW_:X/B_!XM,F<RM8+,V39M@ZD);[%@];#^\L+;S%IO-0(]
MX&E9R[XE;VXNBNVJ&!6*YK[\;X*DF>1(FH[BO7PR^[2\'97>.X^=;*+;^_*]
M?7]S4VS]$IHUH5V_:-1K]7*QT1&*Y7+SOM&I-RZ$V^9UO5RO'A>@)F8$%U@G
MN1$+:=8II"5)E['3Y9"O!?UO#R%-6\=@!GL =JXG[9^#ZVKIPC(JZ6"V8&V0
MZ!#,+!;,MZ$\OA3%B\(R^>4[X0*$)U8<7&(T;S5L'>0INSVRP>8:.WTL4>;>
MRRSVLL,KTPG63AXP##ZYRZ"2KSN2S\8MA357+5ARU?!W>JE&) ;UX6+L_KQ]
MCKV*\5BBG828%(AYP+\A+K5DNM134[!H)3W4^>"_HZD%NQ0J9_&_"+(,O;XD
MBD0R_._[MG!1+-X:6&U %8D?(*)AER7:?,Q*RS0TA%(DX@^SY;:K98I+1^[0
MC""%,X5$*V:00ML>$0#H*9*E'LER*H[ __D [R+_Q1I*5QE^Y06!KV02YZ^S
MBV;0'^3;3\O''^.W@78W^;4,,VC@ !7VX%=SOGBHM'[IXR_?.0]BE G\U)Y4
M\L&H9#MD+%-7'DBQ1CA/(LX!"3>Q!FRS_$;RJ_3-T%?X&&AD?K50[)&TAEA(
MI0C,+"\+L4%Y&A^/X8^;T%3XXQ.UC[USLQS@:CZ98ANAS83F7#,#]#;\:CXU
M7I?$Q]GS=5?-4ENPOXB8$;Q!^"72,[944)M&@&SAXIFU2Z-W=M/.R@%?)0TJ
M):!=7=48B*7E0IK$I63ZCGDA#:/]R"4U0_0T(''-3Y-L 3\WM@V CQE5!W&C
M$,5$%HZ3?W>1A92^D=%8F DH@'F>(H+U+% 40P2?9#19K-] UB:"-)N1BAVX
M>W7>N/.]3R?2QM9+6E?">W+6?!^C!;"9U,#, 6G5.O;<4@L E2Q:GY:68TD@
M3?] ,\(&C;<<@Y&G*16Y%Z,<IW9OJJGO"XO;$&?Y1/M>N94+C!CNK 1@H%U6
M"H1W7M95[#F\JC,"M^A!DJ,"RE9L 0=J"+]6 .I+ZHWF #O!Z^D=53;TBVA7
MR)\G-;A.#=9HI4X\QH593"2_=K]]%0UMQO4%DRK= TH;SB<1-O\3J&"250T
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M!0JV]@B"MPZ[N*MG%1[ZO7>(*,WF5QA<7O?TU_=4[.%.CEY?"] S1)V[U\-
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M1Z^P)NAEJ@-8'K;*U?#,1MLG<8VV7_'XNY=AO_J[_/W,JIUME@OOS0K6%KK
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M88IWH1E&+J'7U;#.ZV41Z%LBB7QCVUKD%!Z] /%B50K8ZR4DG]CNQW![[ *
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MBL5LDZ:ZK];]@N+P@!'JP:>L<'K%D7%_/]D#TG_.K!B[S>ART_4;\74+?2:
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MC\R(G+?V-)-^GUTBK'U;Y&@$Q*XJ/PB#"5RG5%BD@$7V/Z'YJV(,Z0UI4(N
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M&29U#%C7!<QDI@.U]O;RN.7J, 7H(2#T- UHV9$& <O0WXFRE@)P4$WT4>$
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M2T'6(M**O-T;$!VLN?3*WGN KODO#4LG\*H]S$J_+Q+[-$-BKP>)G0&Q_T5
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MA#ZX-5O>%Q89O5$TM4MOD0>5*N_>0[RAH;D+&(%]FQWAT9A^CRI)>BT1I N
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M0!#)00"/F .(C,Z,"C&5T.YDQF@*)P<NU^)B)4N9IWA+]ZE40<PQI/Y#VK]
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MP[L5A0Z1I(N!8Q0:MP(FC&_/@R@1UPO8\5,SV?41X]/'QC\G;!$Q#X>VOK1
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MMH\>>KH."4J'97M9RVZ1&E1TCA.-H/KGY2)%Y@:[>\!5214.I^]( "/)M)%
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M6./5ETV)TFXAFPKX_+/MR+*9A(X1L8,$RD-V?#BZ# 5>045 AKP$1TJA_QP
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MQ0TFEQQZ3CWE;LI@)@\N<NL@[5IPQ+04NQ</$XH%*Q()X/9!>'A=@\V1+1;
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M:I?J>OA$\K3BV.6I 2Z;F7TR^O>D?<\'" %?@GW5,<1WR$9 L+6%PX<Q4FV
M8F4?A?\PGI.';H)G7R8)$[2SYV$&/(\5B.\*T6X09.6 C+1.18MC2_>J]4\C
M$!\./O@X,I^W#+**4''F+JBXB_-7/WA(W(F*S&GOA_G$W","]+6[GW@V!'T#
M_\;)<2')B![7!#IR8G4< /.:69VON!*VDG\PIL_]B^3?G(7&$VJ?T)<3A!2B
M+>6$'E,5SNR_LL2U%;92X_=[&G")D+5M-.J/Z/UDO(UD"GTR)H7T<;<D)V \
M:Y59S.L8+8P8A556K_$';G7N?B.#J,O4]VBB=#21G^DV'\?=%[HN@%Y+)>U*
M/(A%D1+D<--8SOBPMVQ">A8;'!7S ;=FZ/C=-9Q1PSS#R9W9>]8P]C$T#!3Q
MS=T='DAI) <J#?.P2B,Y3&F8HY5&;05\#6E:6$B_6K<Y(&MF:+)H+8)1X?A7
MRY7DH/'Z)F>L7#KJE#^Y3EG<LTY9?(U.H60&/:*)+'2Z##%BAHLUUM!C&ZLX
MOFQ%V7"I@=,_^0OH(@E)5_RLIUZB\64(XK\T!VL3$G_SL-JDEV2YLU?;9 V#
MSU!%/^.V?>:3.[O2VU:(>;EU=B?=4-_3WKZ2O4V@0VY+((=%7XM0;!G(S5I3
M<U3TZ$#Q]2DKM"\HK23*H*<9JZ<<[TD/S&:V\+C5<,)R$=':W?0*S?&SVVM+
MJ@1/:*@>PDHJ;F?!(#7E.Q%H3=]T=/&?X^3.KB?FE^JXB-?.:.@&2\_8PR/B
M2H+=9<J"\_5X==Y@[MCMXH7- 7]H%+&0,-E(C\<H7A7*%MO=:I^,(/[AN:\?
MQMS7H^:^7KT<DU]C\NN)8,4NSK\YHI6:+^CZB.UE;BPUJ-!65]303PX#P"8
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M)G\?D'?]O5\455RW,R"0)$I7F"(,M%T(>99-FZI OA5G2M78L0BL=:?XM4>
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MH_-,HP@GNF3"XS'V#"<GI))#BN&@7@8#K0S2X?PB-3EP7W6)\5O&;:104J\
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M,1$WQB*B]0: IYR=="C3F>FM7O\M9OL\$4&@Z&&(@(P$GQD.V@0/6DY]F?C
M76=?T'M71VVF*&%:)FM3=5E%Z.[HV!.$ ;CNGLR)/%J&QVB0&Z= ]G4CD?8F
M :QHOV2:$ 5$FQR$=CZ1"5ABUR;7.9*\I&Y-4#UE^M0&ZC+(@"Y@G_+30$HA
MN>,KH: -S. 81]E\AI,[NT%>EFP.3T.MJ?QT)7)-OUOMN=C\H:6[L! EH"2>
MY:^T5UY-JWR* YJU92'.J T4N^<G^C9.7-1Z[2@5W98H]J;$ Y#.;*E'URR4
MPF4#/T#$&W9=FK<0"QY4$6'/&@\^,[M0;XET@P.+I^:>/)M2_DJ3N(>[ZL6A
MT$AQ\!XAA'IJ$",PRVS+U:L\J09Z[Y%77L[[H'2+O(&8'+ A#N$/*>&MNG4,
M 1(9A]0B.QKWU[/,"5^<O_KVB.:@Y4U>5Q(4&IL,G(!\0]Y\?\I[3-X\P\E!
M\N;8?$F\PW_.;EN @Z7-,'.X'<CZ$$D?)GV092ZTRV2ZDY2I3B#+7B^Q#R79
M<_]A[$"URDN\G/NE,C4[MU9430"UV?F7Y.QR(L[TVLZD(RVVE^+J*SKUUU5\
MRMDPX32YMEF!29^Y:;*%!02E^Q7R/1 [L#OJ9K;Y,3G[*SW-G=CS @U7Q$"0
MX3G#SK*-VTH9XA@0!D?E8)Y!TW]*;M,_LO]D];S:$#G&FCM1F+.W$V?!D(DP
M!PCHK5T7&;*CKJJ"VCF06:'<OIKKRW[?U-OP5"0_I\]42XY LS&"-9_CY#"#
M=.P>[Q&VP5W>>''D]B!_P;I<P(<SVVO3< "@ELWN_M#=1^ VD5HQ3JW\R,6X
M$'NST _90MO3NB(L9^W\O1?\%^!ZIK!OFQ<,4->X[11 IG/]S0KZ":-@%YOE
ME,*C5;&=71=.R5"KS&F^NK;EMFA24V?SO.(.T7)/W!;NBZK\,72W"Z"<L"2^
MP3.H ND[@3AY7 <@RN8FN^R^]K$/RU*9OJ4"#?QD-N8?GE+[;DRI/6Y*[?LQ
MI3:FU)[&07?/G62_575/C$_#@ZT=J>SFH12/<D=5-\D9C [0Q= AW!;5[81/
MNI#HP<Q.(!3TM0APZEELN0[50O5&\ZGU<)@T55XTB-%U4[R%HPN(F^M%!@<3
M_9GE=6JFF[S@9FF>:)^YV: O.W>444:DGVR_71K-,5%S[$Z2Z+H++K8%TSY,
M=<<DD0RJ?TR]XU'DV9QZA-H[]\BZN<Y7J8YLJ><"T7R'$O*0(JOYQA-2$A:,
M'@IK<!,+$#?I4!VINH%+/R,3+']Q'J0N4!GW%" ,>4VT\%>;J1/)@(<^\X'(
M:045731S?%4L+[JN:[VLFA6FF9W'@9(#[_.FNQ="++5IJED>2TK'S2%#:)^7
M T_J;CM#=6HSF]]P6IHJ[<!Y7&+'I\*N4<2IG0?:GB'QI*&%;LO:*]_>3C\'
MHJA3+"V\R:O".X7,^5=8$TH(.QO]1^*3N<GS?6^<Y IX/L7SC5E PZ[L!8+W
M-JS W%KT!-"ZRY*_X]OY_H+^'6FQT3F;()4#4P:+G18Y_*AO*SX94W7T(8\K
M^+OC&>H9_!(D02"\.!R2-MHPS=H=65;*%%1,IO%@6-%(V(^RV4V3Z&[S7U4=
M4?1&E*(4S<QKW8TMG$JIHACU)X.NA2'PQ#7H+08B,VD2')70EK1L#4C5-TLK
M,T$P4\VDU/MR(S12->VD*?X>5HISGSITI7.FU,>Q=7*-3<Z>=XK![:;OCF"+
MKZO/[D!Q[ALJ=*SU3MXQ=^>#U')\%]O*::]MX';0AOH= 5P$.79S_C0U\QP
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MX'O.W6WR6GM5:$.9;N,&ZEP:;8-1_$]E<F=7W68I^PS-I,_0[+$M"0=U116
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MIS1.X*@>5CS2=8*:=3F_/:^E9VN#-<[-KI-X5"V/,;D'8$:]>'DX$^;[LMD
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MS1E3U92B/=QDBVPIK-J);2B#H'=4+_F:,>C815OCT;5Y9]LA*/P3C#.X2K5
M"1C7M\[RD<Z4;@QEZ3E R$9HH%:W7!/.7M@75Q"7<L?GG^AP.:5@BQ/@BV-"
MUE2\X\3T V9WM.7FP]@#NPM$[$X[[$)OK\O% O'A-F+VI.ARZB/+F.-W;A76
M'#FKJLN Z"2<+'#WU36U:D%XZ1+2]$B>@BOJ(Q7^N6+KM3$WR=GQD>MX-5MQ
MZY1R?D1CW6+%@:6H)?,?6N[PM6=4%+.$G-K<%T\7558V1&7BMO$\QA03\F$B
MZ3IL$^,V/I<WIT;!58'Y5W4#PFN1[!<_91)'\'AAIJ#9D.$W0JGBE3X)9P.N
MU;G8E*\<:H&:&FZ3Q(/@WJ9"9^Q95E&%>MA&S*T#CI-/30R*ZU>**OOKNU$>
MG?TD+8VZ/.<(L_6\7S3MT!G(E^)QS1%7(*&FOKVNEJ;E6F8BS7-QA/"R3N@D
M\^33&]5_*,00"&[M),2-*V5W13W?]Q>VT T+ZZ,B(69O""_#++/@JN$ET_Z4
MDK&\%J<6BK1;VQ3.,4 )N3529$=O_A\1'EW>@07\0.1.]$J0^ZTS2 ?-<%0$
M3<K6>#\>>L!DA^SO PI-I[.P4;L^0,_KKOCDC:A <1[EK]2+",4VX"4-)Z]U
M!3+J =^/SF3\TJVH"J4GO)0K65TDLVR5@RW$S G[.3VJNO>F@4+=M-_'Y#RY
M+/K0/Q1X"A&">37C+FR=HREZ(\DME&]'4#NVQUKP-8.H-P#AR3A?, AOFC5Y
MPS%&;!S^W)HEGWABYR%,J=>'FU*ZD1:)B6ZU-6;YGK73<->.J!>OW2][\!R9
MCY[W8#6E)2KHD#);!GWJ%B4!4-79JY<31:+G%-D<(DTU=_R\J0JG$\TJRP,D
M(ES=8F,4W /T]896)TX[MF/9%\D9@K3<J(^UB/6F:*,XDE^JTG.#NPM-V#U@
MJ6!WUM [ HQ;1)>UD&6MZ3C#TYV)C3LMFS75C>64;;&E$ _YF^)7VN#I,6C0
MU+W;@PDL&_HK#E>=IA "6!5@S6/YE_/]K8FHB_#'_X8J6,8A,\MZDV@+G2IP
MUYXZONDO/"1C^ZA)F3M.:FX;3#O@M$KG5ZUS6?BX_T/+7%ASQ]0&SE)?]"MF
M4^A3$J9>D9QK@7LRNO:D(Q@/D$B^HZ:=/I"F;>0,WZ=I6YP6*)#RXT=0M&)K
M[%6TWB@9%>U7*EK10^U@SB-J61G+_:G:*+;@*:#]Y*GL@A8%SQ>O>$6N_D2*
M=T]>\LV8EWSDO.2W8UYRS$L^$9?8627?'&[,_+7*ZGERR6A+GWP!K/L4OP)R
M)@^T;_-N>2P;T;D+.DVR!I;94*_J:K.B6%>U@*(YHI'BN\$98WK.&&=C;1D'
M"OF'Z%N/[]&IHR=S IQXF.,A1/;-X2+K=.ZE.W[@\ZQ(/EJ&&*K\]'\C"><Z
M%'%$]YZZTPXDLIS#Z535?P$#9.UNK./Q@=<PF'Z^Y",O#8KCP4.^_/C;^[<_
MOTO>OQ=G 6"3OJ-#RXH7!Z.92 TVI@Z!T@H39&J/])0+QO5TH>UL:D*^,4Z#
M^*1D0PG!H>N\'@B%.%%U#H;F*57:A!XS:4C!P-W"VW+VG0G 64I$+K//B(P-
M]8N\_/@](!?M/+H)@>ANZ84#86JV;BI[(UVF5<^0:(G 0%73I@)DHO("'$.;
M_X=68ZGJ;WAULL4BRV&.@IC-"<5[ _:7AZ"OU7IR"93O*XKE3CX%9_P]F$QP
M4Q#=H2X"JOHGEP$>,Z-:;7$V2^Y INDVH<TEK1RF-Z.D)B%B4Q.O3[)#*%IO
MU,DR\8*JS&L:0WA]NJ=N;=WP(KEXRH2]AY#:S*F1^7GRWQHV+9X*9VG#6H><
MNH;F*D<N3MW$9X_:5S[^X[<&U=5R=SF=8=8Y3VK;6&/2O$GY?!R26R@\M0/B
MSLUX6]UOG"[ZG:B>&J14M+.L(7_1.I6]E+<VW<ROK"2R^]YT<N<W#4?V8@.D
M6^X;YV]N4)#E@Q[!14 !%N2Z9:I*.,7%)/ _=+.X3A;. <61\(<A01UV!]_+
M=._58:*4I:T0<\Q;..0OW0$E'93;KX>OV+=QS'TL9](C70QY!U_[L$UCH.*P
M=]-XV^%$38C3MY"^/09@%=I^OR]O0",0KO]'0/!_M(3_/]8V4NPKHNA /-TD
MWE9,P5FMG!Y=8]W7W$A"H/8E,J$Z!,L-;LNH07FN1^J.4%@*!LI#:==-[E:+
MSH^LV$)6O--_01^24FH<G;,#!VJ/@G$GNIU=EVX-KK;"1X);%W_,I![P.?5<
M!CLK%9AC/ \:N8E&?ALM1LO\"XNZKJY(=>%Q#_"F>@TTBGF#1E@P1@I[A8-'
M1A&.SKD?;@DT0#3'6%=#52Y<-DAN7O>Q[%OE'7--T9UX6QB'AE4Q49 ;N%H:
M'Z)LW2>-FD^2+0D68Y%)T1(CD[*9?W73JOI,W]4@]//A]Z!NH'5V:U' 644<
MB^DG3LSK^$7N?ES'%77[CH ?!(7%=8A-#-O=3T:]@]EG@>^$R.\UP6:H"5P!
MA!.^.",#&V!)87 \VWID,-X],NSV@>(^-\H,&YSV@"5U!Y_(.T6=($"OF\3#
M$2]I<FY^Z2=-":K)+=H6>37I0(>(-[^%7389D (E@3TH[37.!&5-HX+R'[5&
MAQ__!]BH7[.RP^MH_#KV$T@,G@C]NF.QJ==4I*OD%^4.WFD3D@$ML4/1/T3L
MXB7I.<)VINYXD[\^OWASW/'W)[2?]F09OAVS#(^<9?ANS#*,688GHB^<0_+=
M$9")37V3WV18:=P*V*8J6@N!(FGQ 6H_5.)&B8FZ?8=;=8=9=(<LU/)6"]-O
M9>\(!#'718/#MU%YT]TQVWP&?7?^)L#T_M2IBRET]'DF_379MC)@6TWK__I_
MS<=W'SZ^^_3NE]\N?WO_ZR^?DLM?_I;\]^7'CY>__/;^W:?DUY^2#Y<?W=?X
MQ3_???S[NX_)IW_]]0]=D/8['T,Q1TSO$S&D&G9MR6Q'S^DK:SA>B[&>K=<9
M?,CD%<G9^@Z$9BTOJ5T51NP5W?(3PW4,\O-W;T%ANV^(Z6-N%WEY+*^%-[J_
MXU&XQP]$4'ZO<B0+08HT2.-DV+$<%F*J NB)\A8,-1F;*\U/3#^]VAX3SX1Q
M:OYRLC)ZXEOP]?D1+&B_*@)GE(/_HUFAQO/W.6/CH$)"XM+]X0(,=#E%9Y?
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M/FFWDC=Y5?CX.5YHZV4:PQQ\.[_>0&EG29Z,KAXK+.[0EF*7SD&MS*2-5!3
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MZ^<2\_F@ 72FBE$[V7!<L>1_2T\P<7M0>;*7%A5/MVG>)OL$\\DHOA,/FSR
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M^[]?7G[H2#+DH\"3<&,2HE9,Q64-%"Z0YH/R@Z :(-ES Q#*>7(60)>^]-%
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MM"HW\<CP$\O!.88P??T #EO!QKH]1\7;M29;@/$;OI/[J1N(YKYE[X<(!]9
MB>;#9Z!AJBUK%+EY&MT:3U*W&\H@'UG$FPY>CN=APS)F?J&A56C&\;Q@'F*%
M 7;3C"Y2W!;(4@%Q,FD,&B@3R*)4*2E&U@3B:6& 9*LS4J:@W*9;JNX=7*S"
MO9RRX6X_K78(4B)X!12(K-2U<B#C3[ HAM_C>S<$K,%P!DKR@=659A:D1]J#
MTFN[+3)Y*U)4#>J4RXE[.R6$R88YTL&%VB&RV'W9":]8W_UZ"_JA+MI0-3N?
M(.Q71S3-(#8*N[5T^KZ:HQT8Z-]J/].(OLX/=(I$!2SN&ICCG8344!$V=YR"
M44A-Y882=D'YX<CEXM 0=M%6\.%Z-+>_3!C$"SW,L]Y#PW"RBLA+E"E/V#9
MCV%.D@]02=+-,1]P;;D[>A@)TG^ZG>">4-5H LM/(#%([@<VBN*D<D@EB^Z
M7"\.KD.G$L3T:Z5S-*>?Z?1>G[]Z>;@]_;.3/'+-O-4<1?0P.PT(] T>_0-Y
M7W?4SUD)=S-@*GD$E;=.K4 8K\6%&84VTH2BS$-:ZD\EFWOR+Q=C_N61\R^O
MQ_S+F']Y(OK"*?M7ARO[=^A&6)O\E4Q_9!P*X9)?=H:;/6J#$$(4=O"A/L\]
MA[1MW+-L[B/8Z^LCB/!+=CSVM6&B[AMG'=(_\1)5H99RFC9E\*:,=E/3Y K
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M1#.U4Y@*W"MV7BBSDJ0YH*_'GIZ!.VH<MNAJF7?6=H<(%LW=W3@NQ(C BCA
M'/1SJAS2M?:<6$&9Y8*#/TZAM31E_7'.W.LC(XPX$]=%BKANPVZ9^FZU*.#:
M(G$!.OD$M1I-7I!@9^\802 OIM6)M0<HPI IE5+C:H6^S.9(D3U.DF>H'.D
ME>#C]0T.N=75TJW8)!#CG%%6@=NRWB&G,NSZU0!_5W=#RTI8_7-6J O#I63-
M+A!K;^DY?'6C@]I!BS7G]D#,N2U:1-E%6W&62=@%V=1;;P;%!-OT^,ZXQ8R*
M23G5AF8_IS7:_F:/C>\LW+*R.X'7&RO[]29T<]$AC=8B%9-E220%6GY1[F!3
M*Q]KO%OLV@]&N"0M3LM&6#_S,!U;-VHWAZ>#AM =:;07?1KM@=-H+_LT6I]&
M>R3ZPGH6.S"(O"OR)Y?+\B;C#%$M%!6K.!04S=ZDN;,7?3EMD'TKZT^X54\8
M!4_P58MF[:V"A$P964[4GFR,O>FJI7U,U&*]"8G3IM\@ !V4RP1=&P)[58L2
M<VN&&\=N8 #=]'[*I'F ""5\ "0><9+J;%H 49:UH<C0*U.??M,-;ZWIN."0
MM?P$J7\X!$)DH ,N&IB4Q8P6M?ZCV,-IJ,NZAXQY:(TOI,Q4STU, )9UFD9'
M=[7 -@B 2H32'4^$1%]S<QK:>QMZ47'I /@2R)?HOG"=>)@.L+[05%:,8%23
M=A@Y*)&M4&QA5>XE<CJR)>Q@LZQJFIW8^\Z528";XPU1>7@<K*GU%(5 YGN+
MK@E$-_HZT0VX2G1 $/.S7,[*\<)F#LBHQ/-!,N!*S'7+KV8*@IRQ9TA6;59R
M(84WN*&.;85$NT FR.4?$(1M"KSX?<#?Q@TXZC@OVL]& PTJJ,&&A\U3M+%H
M>5=#MXI.#D^P/1/ISH.SL!#<'NNM'WERZ IA#ZQ!<H:5-:=\GGRF:;=''C]S
MSWR;LJ=PS@!ATCF[NSW_ZQ[Y"Q4) J4-'9:JVYFO(?20^2YS=';M-YL.[Z:Y
M^/N_#\M_^P]S]O[=F]_//D4?/EZ\_QA]>A]]^MMY=/[V[?G9IXN_GT>?+GX[
M_U/G7M_>/DZ]P_2>'^Y0[W'F6[?^K%JWMD>I%  Y-/F<-?FF03B*EL%Z& *'
M0R$WO\1":_NO*>GWQ [1@V/$.G,!Q> I^HKT-7U%[3K0A=J-V<4&V4/!M,FY
MV=,:/%/!7-)H.]"W^1X-KR8'<2HDH&8-+K*@_)T-/9 I_"Y\],1:$7+9X98T
MV.^^FC/0BHIC.*&!H8%+_T0*W6:L+0@8+XJ!&5G3:@6+ @OOJ+<9C;6TVS*%
MF.G5$@K2,<!<X^"&%0"@AG!PS@'?)0V+X0X'.P;H18@>EBP;Z\X#;"M'SG)5
M\FUT8VZ.4$-T41!BK2S%S/T)P7E?>D^U\["Y\X0*1:'<AT.]S.J.#<-233EZ
M58#,)Y#I!8[:):8D(?F+-C ]@2!F&,I/I%TK1-M93MSP- 9-WD6""1N3+8A'
M,2U'M"ZJ+ CA>ND$)*,R&]>7YC.'$C]N3@98R3FST==6'NH#H:AUX9IX**KU
M@(\ *9T_I^G<)VXQ#01/Q;?:4Z@?\SE=N0P^N5^2Q%?H03<J^*70J4*%#6_@
MR.K78D9\-TO82.*6M7,OL^$280*&6',P*<0$.I)8Q\7G)W%^BI($E57>:+KK
MZ8Y3J]3S*\I-)(P+B5L(EUOUGPDAI7^B_C->_T7?6?^MUWQ&<)-_IN:#RG#4
M?L0;2GX/=JEOU8-AX@Q^;'5A--9(##N^Z;2XM1-[-$U3]SSG_QVHR;"5%B6Z
MKHFKP)%K$7M*C$G<*5*WVW_/N-;SP*>@0&10@4PUFFM"-8W6C1X Z6U^E6JU
M >CW+Z#:!:5N$%[C "> PRXSO.<0Y!0+E@GY&OA[5UAM*CA*F(,OQ(33MYPN
M,! B,"I5F(@U8Y!I)D0-=;_YI[U>D^I:&JSA)6^G28.7@,SZETLD"!^[KS*S
M>^[G99_[>>#<SZL^]]/G?AZ%M@!2-%24=,, 3!0]%56O"@8?^ ELFI,B14L9
MKYF,_^8U.U\\000Z<&MBQ^^CLSFZ%27X).(2I%^D5#;W=BPE,B@^'-354#S<
M]UEA4LR@X9H+DM=!G4:1,.$@L.H%IY?;)?7+ S<(?4&N6\18X.N3Z8)2(H24
M)1<Q6%SZ=1(8E+[#A-DPX7T5P_T^8Z.!P28!$SHR[/=)7F%.&:L@D4*4'7%#
MO (2"2;/X\>TTKYCHBTG>5P4=-(I@7'G>"9+('^U9P%=*3$U%4_%W1W-6B,K
M1CQ_;XD2(B[W1&6<#PU!6.P,RF@1_45E<158R,.D(IZ.*D60XYH5V5<AV^\3
M-(8R42R?C='QMGL]QDL*+B;8:V1Y2Z'4J^ <Z.=4P?E=#(:XA'7>VOH3<71.
MR>A+18>B<K,H. .($TA*4&H%! K8^#VQRMA+;X&LQL,L3\E!LI.H*CG*=_P^
MJRHJCW#N#UY2\&>ZI'7%@J)R41G_8H(!S&F6+CV!( ;5L@45YTZ*,KYC,/LJ
M5OM]9M*!0]]#_'MLC8WPDD$B(3A1ZPB,L*M4\V1,VC7SOB[D?DO)9(#Z!#N^
M(0XDQ@LT]CH' /]$*1I8*-;&1H*L5B&)0\.CWNNLBAQCF3 3& 2I7"=@'*2>
M^AWP2^A!U .;97I5V$_W=5_V6^BN!H8L6T@5-'@J]G7:^[VGUW9/Z4)!BT62
M%_*W(3#JE5?L?8-C )%#.N'@&\3<4X&O+,13052!-(MN=H44B\ 0J$I[7).%
MF!G$O5U$'CA=9BI92*"XHIQSEB:.I#H7&Y/:!Q:CS.'YZ%&MN48D0<X8OL<
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M42\Q=05[+R  :[8/^-:/]-8ZNG-/-W*_I71D+88%-N):$+CVX&00C9-5Y:]
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M?XTO0OJS]1Z/&Q!"4T.FM,)5&@+K]$3;V8FEIRXIWLH_BZ$RU@D1FD;"ZN!
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MU*."[E^$=5P5]N*?)!BU*@B1C?T&&!))\$@/BN0+FY:" 9("7K4:R-Y8KI.
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MZD? NET\CQ8[!>A*[>3&1.5)M,5X*S@$M>1&0FQZ&.2B:\I:<@YA'TMM^ZR
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M"=8$Z@X3H'%+I;F4^MY=%"A=N-R6CLWZQCQ18/($V#ATXL(]?5=C<['S0Y-
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MZAK[A-4"5K6WGMF?0Y;O39""/ABJ$4;< ),"TV$CS9BAMF&59Y*[+9;P.1@
M0T9RN\A_W0/+L)*3P-_@$CN?PJV?='LECAWD6AFKD6*>$0O6K"?S)6"+1'L)
M7VM@>99S^/)?[/45/WWZE+)L_/+MWC'-K-DR]CZBW7U[[5+[9LC_6I>_ NZ4
MME/$84G3.$T8=6@"P#$<@(XB<Z-NY%,#8U#8^L--B-0F0 0.'FI4,6.=ANMN
M6=&,LD-'SRDUA]AH@1E@ KE&W/ ,B& J9O:YMK>2B+O?[T/H1H1IW:OI:HU.
M<DS9W!11P8OOVQ<QUI:U'GC<M&W%3*8H"^1O<.F]F4P?J!=28P0J.:=J>3 ;
MP$S.%M,T-DX0X<"A7N>,D?5 [)-8QWMI!)L,#E";OL$L"ZJC0*R+6]?<8J:(
MK2431QZ#N;6_J HHD [2Y$O*.Z'S3X])(K!AA)<C"*+[A_.S<VOV6Z&4T)1\
M$2,:7H6[K)!P%A](/3K+R#RI%G'$>X'E&4LH5V48DN,HPE _I%!0,<O:U1>)
MDI2$BPF6(/)+ -X<\" EI1US,K^F=U3+\H9J$8)9!V.@T$?XMR'L/)6MLZ=Z
MFX3P9_LK9)2JP:!-V'M3G8A..4_[-+V3PZ.GVQM[GI(3LYQ$P!?]1GU.G;EW
MSJ=Q3;T;RB&#H#SF@F/)7$VC$T ^:XVF2&PTF3_9!4R&2"DA:^ 0+HK03QS*
M\;EU=Z6$I-#<OY1HH3D[0-P TK_4OLMW_ 2\"<4W,:))#-08PN#*\,WL"S&:
M.=<))(OL<<LJIH1 ACALVR0&B(8_T;P\E9S<EZ;&Q^?"L>'5?#"BZJ4JK"]Q
M"@>?,LU2U"FLF%Q!4SM#TCW8;@P+BM9'FO-F/$!F!@AV66L!9(UL?=32?(<(
M0!& 8F,DT7  'L=X'COKOPK%Y,!QS!O-=SIH-'@ 8S0=.)0=A:OP_H><N,A?
MM9PSYE3&H/MB^Q;89)#-F\EB'':8)/:/A"L!,_#Z" GU"LFLM.]V?[P?CM6?
M;?>D6GZ#S27F)$G'39.<;P\F,&FYDMO82:E/<N3:W5N;,Q,"7Q!ISM#B:4,C
M%<\+GT$Z*PQ(:*<%CM>>&V%<<A*-C"O5J,R&J;,(VQ:&]E*9^*:&!8"IX;;5
M!&3-\VAE([^RL!A4#XMRXG  HA6$XQ@JBQL.MO$%>NV"RIY0O47>_:FK=N@V
MJ+B3[]5UL(5[^=^',(!_&_X'K$Q-JYN:5F_%; RIJ[-(I^"?I#JA;<.H:\**
M9%'D3X+VC1-@E# J6 'M42ZX)VBG [S ^'1PO.ZG:AUWTW,']PB)G=F\(^C8
M!F(8@[X-(^&:".^[ET5?8<U>FGMK5.T><'_9!]P?..#^J@^X]P'W1Z(OK!-V
MM$/$/:G&R3^B7\D&6M,;@1V&Q759+*_(+#L7GDX<3BS7H"?MNHN\3.5NI;,O
MVJY3&HFZ6EN"Q"Y<!_@;SAGS7SYB" HN"YX:48MR[V#$"_DR?PDK4HD#U'D!
M9M#(&%1"%^]Z>B*9:\%DVVO^9 !N3OQFLI=T"2-Y6/Q]; D T<R;U+5Z<JQD
MZZ+F '?D*>$/A&XNS*;OPB:'#J_9[>7U4LP6QCE7J 7VHMML&C0M0&#48" 3
MG"OOO./;B 1DZR*BUM"RBUA15B) 3(3RW2GK8I^F9Y7A\6YX'VO_C!@*YK3A
MFT;/M4FYN7=,J%"XE0RZLXE]%Q4%H8W?3'\H^D-]G# 3),T<E-,62V$+U%$F
M=[$S2A7EIL"LM",+*A\QT]>: I+(BXI7.X;C,'.A<Q4:\,,PG378(%,OP2-$
MX@;T%&UAR-T15.-1IY2P1TQ,WX?XNAU0S*2.&%:T\]55KOAR*O,IYX6CI;'K
ME-O17V=S7_J:$AD(5)/9JW,>':B]JG&8CM/*'@R[( /-F$*U):3*JV2:0F2@
MN)7W2'[%I5=E=P1_%KR0>I"4UBMD#QUN'ZB/]_"Q6L<]]Q@J1Y(M,V%HJ\[!
M&;1IE4<,:/P2?.5N)'(,A$ASE^>:Y@RSF2/9Y"=:67"AET)N+<ZAZ):NR!Q5
M+5Q0"9(R<I] *L;*%K&!,M%UK AAC6Z<$B+SFONQ,_B;GP#_CR5&^DYM%NI#
MQ=%PX%!P2L:XH-XNHEE[8FOEX,PG"C4M]SNZC>K9^M$U#W!TH[N.KMGYZ-85
MX7;G5\Y>U'Z&#7$S.=;6NLAI"N+6-+@6PYWEC"5E&S%#UF8A (B-,."WWPS?
MZU9H%%/#SMKSGX[A41",P@9!,B B@V)KLR9/.H_K29T^4$4@$_!R$'51(%E:
M6]R9IV]:5] Q!-YQ--N7[+['TFQ[++_WVID[UFZ3\*U#GDCBCZS_@X8USUP1
MB]L"J^N%5M,@K68QH?+O^6) 96&^(_9$*B*$A9GKQ E.E&F&YJ^58U.T-1B6
MMWD>0B@11&09Q=VET+ZYE-'&VV*-3V0V4'<'^.80M4)4&)[6TS>&VS1DX."V
MCQXE[/8!,297GSEVRZP*.ZHT#&O[AV4NW.KK-'V93@6^LZNM8N3ZH9"!VH>*
M:, GV/*^9(2^R%UP%D*VON!*N&.7$+=1(<4)=5,.YD_%XFCP4:L4%XWP_6/<
MDC(>A\\\G.^4H(NY'0XV--'<.??J]&[]*\D*,.N& 7F$0DOPE7 _T%<':E=,
M2RFHV)CT"XQ94;,( @=V"AK:I5C03G_46K'$H L'/?Y84H\"F+6=W1/Z/@1S
MYJX/&N&&BCQ=V0,P2R U0KD\+CYG.;)WF[6,X83@FJU<,SU^3:>" 7>D&E[U
MJ88'3C7\U*<:?IQ4@SY*>ZXH]FEZ]E9[MD/?/P83?RB+12KUQ&_$R).R<;B
MWK,-*'_[-1-\UT5>+9'PHV\0^",7ST*#P%.'@Z9"@'$ZRSWO!%IW#"(KA#$K
M*D: ?"*+V^?8-"S'VBBWW@L#DICDIG!A9,9-*=<">>Y9W+2[67G&.(D9UK'P
MZNM$V$RF=3@/!7>F])+'#VOR1N.(V2$4GA*[C?V#709F%DL9[-C*YIB5%/-^
M-,=AKXNMOT-SC;<@[HYS>Q)5V1>D1%JE2:F[6VA1C]MB)-II8YE2G2LEOTM2
MS2*E#H:98V"1PM[C-M5<U%3SU*GF3%2S?HLO!J@-+E8A 8A+0"R2WPUA<^N
M0!D.#:X"KDM,\X*5@ZX05Y(P41,J!-=F5*%F"2O,Y!I3" 0B)=?"/J=85H.X
M$1J@GGF"A:2"K@GJ(3R#-WB0T3\B502TNCH=&B($+[AM%>#^\X0ZZ"WG(9@P
M#C/DQ +IF7+L?TTYH&C\"N-2<4B ]53E5PAUIRQ@ K+T!.1(Q&N=-+74Q6F=
M*3MOJ/9)XF1>_#:O)>5&8"EC6<= M8>+FA#O1,O2ZJ:+=]&5W!.3^Z_);/[Z
M??3)+GW#X/ Y!'QYJU1*4K,NF49)ID/X42$]]A0%/K9RB80=GME#,Y0R G9N
M_>UL.?/^=ON(/<QRGF2$(W#'\= $4D<Z8M.SVO1'ZPT5NYI/_!@FK]$5UT5>
M,-R"@!/PS2"Z!!^%!+OR&SP>OKYOX5KP]-?>#S@Y8#&_T!:4:K9A)1'Z:184
M/H06RU=PFC/,&6$\!&4#CR#4)X =55$2S+,'<G3=RQZ7/7!EA6 .BM*038:U
MT9S-<OUOY&V<6)(<%10I8,=9T#82YK3?ODFA&15Q.KKN)%0Q,9W*[&I]!BF1
M)=UQ:-080\Z1:L^S6XZ2JM&<I=D]&N\##"*',.NJ\/%.M;X\ ES@8F*<_5M9
M(S<*BR3:^G3?)Q+Z[+$Y;_VQW>'8C@>&+B$6L\K!>KY&%O N)!),5R'2-$CT
M30*LVSG>/@3+6TDS SKVM]><^\)J'RQ 29S9PND)L&>4 8-V$V3+T$ZJ(NFJ
MG*O^3PU_DV"3*U$N5$O@._.RLI%"3K: J;U!+_\_9&3&2NWS[:->%]QJ[=<B
M4718[;E:#T EG[X5:DI2+H^M5\\Q:4?H;)G P$)L1VA?BT3##0O9HE4M'2C/
M79<5I(+&J9UB#1H5_M"T_% *<M1M[:]PLJBI>-U1-=,7=QP@MX<@FQ,^NEHF
M4)VTTG 1+%BZ:F(*/:5>\W5)VVH  PF_(&4"$KNH BQ4^3XCK8S5)>OJ9MU$
MD\@WJ!>6:D]2JYL($"*!>QXGV-@9-)Y V (@G$9CJ+'[6%9@1E'?A(4UR__)
M',<YN.7L7/UWEN3_O,Z$Q)6M.2N@V0WZO62L%Y-'H_(>04[PI]?1^SEN^5_A
M/7PIND3AR=,^45C+U#63@VY SY[_R_T2A2=/[Y$H[+.".Y\T/]K',)IO:@V<
M[) #8[#,6RF&MQ>YP^(\-K>HSVGMFM/Z'P+3<:/J:&.C:JQ3GY U-[,/NW9]
M2.OU9&+-U6HB&FZ(_,Z@^T,F2P"*RBIE-H0P-3(]N11><5\M\V0Y1M8?%7D9
M1X[,(:J$::$.2S<N/(FSTX1"231,IARB3%.HSI:'(.97D4D$'R#!V61:W'(K
M'?V9YFR2W 09/;'OR3*".PD(+Z@ I$33B-OV(">XLUZOLW02G5-!N;5>."&-
MWZ7/_ %^[_W(P$+D6K=:#P&*65^\_7A)56[$>99H8/TPJ3)JH(3FN7BC!TRA
M9H?.?!R,$/0I2NN#IAP7713$D3=)LA([[R!XDG.B=JN-JP#@^#G9='Y?YU:X
M=.F!\U84Z<.B)J#V4<LI"0*2V+J-Y'BOVS[V[ UG)-Q$'$\<;AD*CY*O'&QI
M\+,YN,[S%0\<."4\'C(G<OED#(=_YO,V3*VF.W89:O$$E#JT)*?,;D+%;8[]
MX9&Q+NVUU_X=<JS:Y\;(4)TW>4W9K2 >=9JK!N9W[$;81P!X)%0? 705Y1O8
MP-'K45&NK?H43@E>#Y.LLI8T)H/#H!3=)K\EI?W2,^+/?"XZ++>WSB)+8; _
M/?WW:CG_C\6UW5W[_^ &3^USDM*,DU6M?PA?2WCVU'MCCG??:\[AW8%.:#;S
M<S:U.9,BPE?_8TF@"PH+ODE'U-WSF7"%VKG2[(].:/:Q<H:_Q08U!KMI@]1H
MZWOTG\L\C9X]Y2T*RLW:?VU8ZTPAB0O;A-Q,:D<&LM$@J*LG8'/8K7Y^LF:K
MH[5;[1,,X4 .HU-[3TA/V;;Y,P&6X\\)RYKM)0:+^O3%]JE7%1@^L4=68L/W
M2N.>NM:;ZK)VO%!UEB4CA);NVJ84["^GIQ_N<?6VP'3J1?+PJP]GI^]_9D8@
MX()%TO0$R!LI1'C''!CF343K7+7?O-==':LJZ(?!+?-F\3Y5U"RNL9Z]=&17
MNJ<K#_WR_(PLR/,O%//&]K%B":AV /!G;,S9)D$U3JA,&MO0JIIV3B^B,2B+
M+ZLZS]=6ZQ6:1.O7+1![X^PA6@]GZ"@CIV8IK54UV!:9OTP5)J73>V+M-4TB
M^,V"R81,(']U.RF!_ATLER,NI-NDQ^*PCL1*Q[!*N:G:I"@6WLPBM:6IGHR]
MOAAW0P43:'5!#-'7F(*V>I)B2QIGC(4A\!VO8]U-,M4]=N5Y?I:ZU.7 >R >
M=6&?0HV(6I=FT-Z#+B10Q<=65-6*8EN3S5I0F]N!:H>(^ES/HE=/_BMV4(MQ
MJM[C#K$]=[T%^D-&/^RE]F+[2-$I9NA!&#;&BAK'J+4J$LU,R/9#[@<H"AS0
MM&G?2J&NT!P;Q/$D;C@,9&@SKMJ/W;+RUR3=KHDXEO">5D6-(* 696YJWX$B
M;M^Q'D:Z\N65U-NKDGQ+<&X9H^2XG'7SV?;@1M!.]-$<P3V/T7V/0_AR^T/(
MPO)S499H-NL$;@-_7D-R(N'S5'BWA_@(*Z'0Y!.AD-1"4YC(/0B=R]MU0 NP
M0= YE2N<W:W(A>^!"1=[^4=AAJ1LI>\4+"9-JOK%)@SP"/D1FT:!([+<C)>I
MXX0 OP7J!QUU^3"EOJ\4O>+JZ61%UN;"9Y@%)U4N,JI(Q/:<+8V9.- D/VR)
MHBV8&,894V : "D_-1%DPB5:_Q14' (9 5 B^QESG!17BA[E^4H;W(OU9A2#
M3FF!S=G,GY[VB<L'3EP>]8G+/G'Y53?A#BW^5/.$-]SU!JX;=Q]"-9?4@H1Z
M'&X-]!UOF5TZR]>#_$,ZN3J"W:IW0QA_W\F!8Q;75F';-Z'#35&NZJ_6D"NA
M9P22&3(V7ZXDG^$*VI2DT%<#'42\H\2IJS6G-@3/NBD\-325<KV&JZP ]QO>
M*0T[DB_!TF#]!- =NRB3M A'WFU50C"3ZHC7'%C)RN#11O,AG',+&N6HZ[?*
M-O "V!U#"WG&10J4G D[2;N&?6.UXXJ]6<#/S(4?9(F@/5.5^F9+\D'KB&MC
M<]$$Y]<4Y6<:)-D[\/E5FELC9>H8BE)'JMVI6WF?IF<UT@X]T,Z1.P;C*R[#
M[>WS#^NJLF+MY_Y/FD%Q,1B"^'^W5HO\#_[G?RZ_P!^BORU5TP"F&$^E#R?2
M=:L*3[*R4Z?#?)C/ZS7,UF=8X#H3LWRY6%*- #%\8(G8O6+>F];$T5+MK?SL
M_?$XWJ%KS#NBK@%0@Q.%[4]'L_/6KUGTOUE2Q-'_P;'X/SPD_[=,%TEA/\I;
M#PF$0G,_#'50OI?\MTVZE_\]F9Z5_QT(NS]<?#B7N*$B[(;BBQ3_!-JY*HK\
M#D9D@KC$FVNL-Z0NC$I="&UC9FW+"N.Q]Y)RG-J%/*/>+@:"'9X3$HK01F4V
MKY,1J,Z0T0$8T3-,L0.EUZP8$TB*R'O!#@=-D0%].7>>PZ)MTA&[#OY2#VCM
M(8TC[GE8>2+L&NGJ 01M#'V:3)DR$]3),E>A+9@G=!J,?5DX]7P:I]-DE8X'
M<1/I'X.W +X*)^DI6T/%17KI>?-Q58U?ZZ'TE!M[*DM<2E&MBH5=/0%9,"!>
M1>"V%(IG"Y6<#UX=M[6D49V!?(#,!2<Q2[U$^$3A*RO6<94[@?_@.[,PB[FG
M_J2B@D+^]<3N\.=TK,)YJG==(YJFLM'M,D'5CY)==@E265+K-XYT@Q3,O6=4
M,PFPBBO[G"N$1N)482A_.8'6G]C^\T!E=\G=J[%!KQM5=3^Q;U5'GBGT,ILM
MIXLD!UH"<C'Q#%/@D^_IC>,)=0++E=(#">3P?2Y="._"%E&[ZX/[+$60U.<V
M!'4395<]$(D>,-]=#P0G]ZI,N,%4N %F;#WKG'C[YMG5U6H(T<ZV+4#^172Y
M:9=W;1VP1BI<<\WI"L!$ZLE?=: EHK[E*(+T)'/<J$WQF3NP(.ERE.A#N)XQ
M$V,$G[KCQ-0)D%J4+ZQ;%J!AV"B 6$B*#!P@X5,@\,SS%/%O TZ5PCN8Y]!G
M.:6.FI@:P*A0C:*;( +@ [8/1/EQS_-)UGD!4&!(0=8.MFYU&S*B,CA)O<J>
M 5<>+OK3_A"B+>/,FFX@ [%1Q6/)DE(M'("J4S,(KEJ1N=KW@R=AURCANKE%
MFLQH"D"U22VV:#U5XDKNH0FFM?!<F:"!6!R510*5OL4M,,&6UBC#54HI'A:'
MDW!_;W"0-&6EI2M)W7HS[<"31?*92+,UHP[\,><0HS1O)J;7<='X\M@J'?HN
M*9.6ZGVXFB$GC::C*_EL$7EZHF[ES!8!:<O&=;OV]O H%+_[6ZP&' ?7+F8M
M7=6FH]A.9<7C7XC=C<>$.E6N3*'.)2<:B37+T:H4FQ7%MLOBL>+*3"%Y,AY!
MH!@K&A0FPJM\[8BH:ZUZUO\^5N<Q;;O=%X69+-D1J4VPV1QR+8_.078S$/!@
M<V'=?M1:@NOVBYZE9JUTH7:Q[^%2_;8G\D5XY\/HY.8I4AZ-TI03Z<:M@@M,
M0^0YENB_5/5_NV@\LQ!PI)^?+V)Q_Y \X-/(WF\E^@#N7<F"1+4L2$MR_#Z8
MVU<#G\]!HF:]U&MR \LJ;4\)U!FEUZ4$VI,8?4K@>R7JC_I$_0,GZH_[1'V?
MJ/^JN.<NO;F0F.+2)[6C4W:-14GH)X%;"GU;\C&<Q:+\*WB^"_L8>P.TAT?#
M>^#R_,P]GQ,(U!H@8#.$;ZX?5QR0Y6"1WP0-Y^F4BD5%K[.O@!T&=<E.D,*/
M(3[@;$!3[]DE"/=Q,=?-Q&J=$UQ4D4TV7CK-+;C=,FJV0@\3B/TE+L #?I%W
MC&B]ZF$ [\^ML9[/DI65*;XFI?S",<S(BID&F2W/\/7V=H/PX^XD5C$9UKP;
M[?Y:0U*,DS ITN%8@<2DB%C0+63KTATV.'; [&YGV&D=!:(PP>MIM!-Q@&CK
M7+>^.W88ZZ\61_.MQ#'2X@@O032+E:IB[DI=J L4(#DG)9QC7&P7 VDY6W'0
M#$>J1:0G"&\]=)((HQ2J%I?B<51 8LW=DNM1B&*V5F #^^7\7U.?#W41HEPD
M6_E4W$Y!* KUCEG^?0P'''J*QC %D?0KPT[N5DYD%$+>+-:OGY(9IF&M" E%
M$T>DGN,MU.X8JOLT/7M)[T"%_S9EIU#\G0!'-Y%/4_&&'&2.8]_2QJ95I!KJ
M@YQ%18N+ FL$5A?&TSOE*M6G-X0VB-]ECN),A%/\MA,\_?CIXNS7<_/WBSV>
MY-G[=V\N/EV\?W=I/KV//OWM//KT\?3=Y>D9_&V/Y[WG^O/%X0[8CK,@X/L^
MY,X[QSR],.6=^S@T7;1!X9S*9-08^-+@*36E"GEY?*XR.GP,K%9,2[%K:2VW
MEM><,OA2;>^<+!_;_NO>[OWC$NWO0 NU:[W9!N\]2%^U?4\C\;",:;R<BD/L
M#0BL^+)6?DIFOX^]D_]HFOYC+6C?<" ?C=VPUT7)WX$6Y]M%ED@VUW_M>XEF
M& SJ)7,?)@?= >Z'*'(5XH%40J!2B9]]T!197D"PUK",.!Q_#-UC*KM $68M
M&F),F!@CL#'[)JHJ;?0@;0UWM;^=8AAY(0DX2EZGGSU6I'U$Q'2N&H)BP54&
M_585LJTQQ#F1#G7HJ-R1)3ONLV0/G"5[UF?)OO^1>B0YLN_0DV)[,R:IQLD_
MHE^I16!P24RY;>!:5#3"9;B?E7+]S@IBXT\TS1"SI$O3>OH]QOR2,B^6"T-_
M&@#VAL=4OU@$\NH)FJ@3>$%L$1G!WC-B:D*$:#[R5+"*%0*[*!')9;7$GR*D
M!)-- (S&7$$T+1:21NG01; _DSM(=S@&?[O\" 9T(/\*ZW:;$ B*&5J]%<Z_
M Z-&#)DP(1)4@LV15@3;IZ1Y0#Z,!#RFX1&D])VPY7DMZHUY)&L:$9$6/.GN
MT2JJN<;(-0*IE_P?<7('DQTD_^SMQ>^73=\U_'-#%SLW%>1RN+Y#:R\_/^#D
M#JYVD9_+CV=-\3E5D!&0'(6\)[X_<O[.KJT"U/28'XE:$SB+SAS$-#K8M:@&
M!E6O!*0T7R_"W1#AZ]WCS.]2.]DDOT(FKE-L0]@69E:JT+65=:5T1R#P@!1>
MR(.HGR%6D:GKO(E7,A^7]MO/DI.C)T?V !X<#1Q;@J*4?3SUVKTT[B"-V0[2
M"*HSR2JK.ZD8R\G@WSRF"YLW(U_V!+)UUM ;8:GBR;\XJ6E'S''!&B+PEPNH
MSL)86C:;I6,(BB&1;%:4II:."PD-RE%6I:[R"D:)6"7[<!6K4R%#+KX8E\EM
M+F57]&4P5^TK%NN>91PTD.UI76I7,=+C^-DK!X9J ?SU1^:'S(.^.-P!YZO8
M43>FPQ6T)]#MQ=JOA;BZ>C67]O+,UV>[I87]NJQW+$52%*]F^G7K[V%8Q%XJ
M7*T3F_0+LC#CV0LA37WF_(<\[3MESC^F0?THL3MA/T>PLIWD(SBD#+Y+U7KT
MU94*_7&3&3)==JVFJJ)GAT>N?<'[\LKJYG^ZUYG_7MJ%G "#N_W+(-[^\<\.
M7</<@S,J?>+G[O:4Y^XII\O%=5$"NO8C5J+?8)WCIP#P0JV$=GC\T4OW_)_+
MXK.]PP>Z1FR9&BJIHPY,S,#OB/?K[/AMF.@&9WW8C_@^U6]/><S(.4#EW!(@
M"K260^Y6T "S4?)J?Y5-A&JWJ?,.7(>CHDIKHEAI6721KF0\MM^IH&/3 JTA
M)O#%AB"P9,3.,,;J"X1+CZQWF8R4VG1KK^-K/#MHM!0\I+X? SXVB(<V]S@\
M=?04O#*C=NYJ$Z5= +3L6M^*B:D*C+1L_8<^27$C:@.R%FV0-=_)'<RW'4=C
M'''"5XZFT7O"-W['_@UW'0CST <B^JH#8;[-@8B^]D"8+0_$(&395[MJ-S$%
M2P0:N%%ON9%;D%J:WU?,5O8*I7+]86H?-5$D.<,54M>02OXG?*G1I'SGR!#_
M3M;\S(_SL1*C_>G)_V=]\O^!D__/^^1_G_Q_  QCR 1D5?I-FB<!;VQ(\R?9
M^^50JWW?4 2[&<RHCR?U71 Z-_^2D;S$I2 )*E:'E \W/IA<VADWE5OK4_L.
MF@%[!-V;T!DIR:;+$FQ\PR]SKUK5VM)!L>5D.54_B9H_@=95FS[G9A2*:0P_
MHQ71-7/M?"FT'8-H7$#Q:[&@O#'^4]<0J@)")/BR8K? LK^UAF3]BF9N/B,;
MO_[69$%@D(=]A3.T,$('V+P^C?+#3FXGW.D[X+Y=<!C-J1#[5XI_@4F><0C,
M@S@=I;UTB2PU7)-N)SRJO]A34N98G3J-SJW]:STLLEZQ"AGK:*VQ? ,.@(O7
M<1$Q!\WJE7],IT2_I5KG-=]DA61/R"C#WIM!<$Z]JV2R(GRF2>ATB4,SY6)@
M.GND+EP3N\A>\53NCK1/V6+JZE_6H*^X22!%]'TOIW:"_J 8."\(*1M;*1I?
M$<#6;JK52=!C.IMS=T-"R_ZQS$=<_^S[Z+ SX[;/@7K[8_X#3FXGQ. 9LQ74
MC01E$;C4.M]?%;%?89R:6?NDB+_1]%(70&R6Z/HI;QYO=8'?-0HJK'>-'IGQ
M,LVHZGU:Y"F=!OJBL*G&AI1'[0*N%?'?W5!;<^'>][XU_7W[PT]N)\RB,)A.
M$W_;;J"R5W(%/VG":X%UHQ6:<*]PF0QI3W=JO\5P%P#A>U21;XA.1&>73L-\
M9WM?0*X_DI[9-98\,.U&Q9Q;*%FCIY@N?234&6? .FK<?>%JWX9%4F)/;]=8
MD*@*=8NC-30D(>71G1P2GF/%*+(4H5-!3F$5$:W::%*B81K5.P]JLD B(EW:
M6VR*O#18Z13FINNCZL_>#SBYG<"7'U,(GU-R(, SS*ULP]& &HY=<[:CZW0,
M6+07A\=V,)*Z#.+\'+1W=%..\$G(DICD$^/U07L%#"GX.%(OHC\DTN+%X0[T
M/FNQ.:"O:O@<%7#T0K()J=/Z@R9FQZS!['P#AHK=,#MF/68GJF%V:&H]7.>'
M5 !_%ERG;C80#/0KT3O':] [J,SOC=XY_B;HG>/OB]XY;D'OO(9'EN,G2(AC
MA+1LL#/<XL^ ]ICOB&38$=ICOA>284=HCVF%]MP'%_<5T!ZS!MKSM6":G: ]
MYBZ@T8- >\PCPKIM=2#,=\:Z;74@S#<X$(.V8.Y]4#VFCNJI7TV;H#U! &#G
MRB_^80_PV1[@\[P'^#PPP.>D!_CT )_' /#Y5',7?.68YOK^!F@?$\8V[X?V
MN<L;WPKL8UJ1.0\-]C&U;GSMS9%X:W9!_&P'^!'H,3W?)QXW7)\]TF>OXQ4_
M M*'DNW4>O ^2)]O@?&)/<BG >\Q(;P':8>PHI5?=[DL;[(;/%>^N+"XA6=R
MYT?4$*0"U#"YAAQ#ZG,F5FK4*;KA]G"?_JQ_1[C/FN(/3Z<QG3;1-C'<CS-I
MI;D5^$?)MEF3I7U@!)!I0P!%WP8!I&:[U6UL^MMXGT_H+CB@-5*E[^5M<=^+
M-6=[Q TWK!1RU\KV^%PO;#_@Y'9"^YQ;UZ98H3>C>I%*A@3NAM9O-"+$W(IH
MK'L1B=Z'\.@'!C#4(3'8#]>THW+H'=Y$Z>F<]F5R.X%BWA4Y>."I55"Z7:ZT
M"8,(1]LW>A'M1?3!&,>"-M4ARUBM17=-*'6+\V9W:Q41ZY 0W9'>..G3&P^<
MWGC1IS?Z],8#4.7M##U?X]\$^'.&W>V*/5>/O@N ?OF= .@&@YS?"H"ND)7W
MP)['QO=6S2%2 F"LI*J6)9:53%-"-"""6!Y=<T";( PPF"#'@I;4<@CTA:-4
M3\%A-X% UNTEAF492&#M/FAO*P-@,(#O0%S?0BB%6>9(ISW)[*LU_^#I[]&+
M9\]=E>9R.,U&;O2G_H?OP>>&.+#Y&07"3\PQ).8 \^ _MK= Z=!]OC^3._AC
M!VWVQC[DA@Z*9T3VX$_*;2*-;#4JLZ% SOR!>9-5(WM2("$I(/Y*Z3:.,JY'
M5L'A,I4G8^;28GY+:)BB+BU3GQ+0=**0<)BS7L($" 9=$=M4>2S9V,]7O32%
MA,]4TABB)?%E,&C(,:&.PN3$B&"C=G4+:[)YE)I_7)@DZ0_1#SBY@\\['*(+
MZCT2_5K8N^AU=&YE9;&*WM_F5HJNLSD(\Z6].;)QE@06 ]SVIU#)HEEQ[6.'
MUM$BY7SK/7Q^2=6XL>AFEK1Z\*:&)U>FV&^8@P#U7N3!NS'QAY*MJQ^\'BCN
M4]YS?'A\+'WNR7)(:O._6B8"1\0;E[&?>)"O.&BB[T-*TNH%L2<2\Q?U]5C9
M=:CD^2D7BL\3C!I"EH7!% GG8O!18=V'RH[JW4A K=DK=HZ]2ANP5-=QX[44
M["$@5A[!/RAN =F^8JLM2DF&,G".TFJ!)MN:65&"",>&VT4A(H*@6.-Q:J4:
M?PX&50X84K9*_CM+\G]>9V*-\+)Y!6E8_W58?_W8_8I/73/J?>Y&??'NS?EO
M[R[>7IR=]OVG?^32K)>[])^^L/^<Y:X:0!5'\"=6P[N+=F^7['%)Q'>H9KL,
MJRXPR\$83U?4*6[%]@!5THN1UXO2, X,$(B&6(,DFEK+@\MPX-7^/ZU5E2[
M;5E<WZ>RS;P\/.'7#F)'PM*.U*IA,AQ( [H6^+[INJKC!E:T6HZ@\XV$?@@%
M@TFE"FHDJN@ #,9[LI@VSY<4-\0:J\7'$\I-Q^DD17 ;#.8ZM2KX.BEGV$Z"
M;=LF^C>._B@RS#&@%9A:;Q+!;B',5IJ56)NTN&6**K=(99I,%NB8\8^CX7*!
MF!E^=,RUY-CE#'JP+M :_;6H*HQ656F)BT:?Q;#DR^D"O<3"FLZS>0$-*99S
MQN=E.0,6L,YDU=1'\ '%C>S [3"YBR$(FYU(4?H7X, >31%N[S?N%DJFHJC%
M$@*I@.*:IE<8T?"%4F4$B00JX091J97]83N]]O):^U%+=:W]*U: *<?(A*&6
M6%">FWY#X0V%OJXEH%N&X>*=P7-JW-AKPLT<80778T^E8<]%G64]+_(GD^5T
MDDVG4G$0BK<C&X7CX L3MI'L'NKUPT\.BH=.JVA9J1W]"ELM=I9@M*L%0S=[
M:+74*TSLOZ?XM=B:?,DPFV)(UQHQR2RY@G\(G!T,#:NEQU5L,#>%<.,\F=+7
MK8FXF*;\O5%1,0@YY;I]97#&+19G[ (_P4-'Q;)<J*>Y)!3DMJZ2J9FD:?B>
M01CB P21F!UL^T#$Q^[B&!X_3;)91844,#O)\M$+H;]Q;LU+*<&(N?$Q?G*3
M%0[/;W)".MGERT=I3 40%#_C2@U?H<%Y35COBA?K]CJEJ&.)MAK>452^Q2$V
MC+"7]>^!X32C9F*^ZM@0POO&BONX0[KC#FS*BQZ;\L#8E)<]-J7'IMR_1NXM
MN1%@8H//^4U"'O%=CL>=SL(F!\,\G'>Q#LPB^!LCC"A,'\(..ED0 -7!F!("
M6))*3 HIKXO%2JC]?;J*5=Z$/UQ3\,!?-(H5(X6*8^+L**,K@&(X(P '$C"=
M$$L'?WQ% 2)A%N.JFUNK3'OFQ1]Q<E 69R^)P+("H?B<%[?3='R5RMEH1M^H
MF)5B@4$ D*A:E M6.^8.%[&*?6EXW36S\Y,8^PHD[H-*;B:>UZY,P2@%L_(F
MR:9H '"(KF7 J)"^6G/U<OY#YBI>[M):M26]H^C/K&X'3R6 L&?U7ZC4/2A0
MY<Q](SD,"MG,HO .D_)OK!>9W+)#%1QR<"G)\?(0(G+ [,DMEE# +4'I-:<)
M;S%.]ON24Q,P&24[^\B-96YM:=]"8>DKU]NR-(\FF-WGX+X;H^0[C ? 6=6"
M$_2QU_(+?"=H_#  5=]A<(1F=M& IG1AK2,*-424T"%R,,S5A1]3N-$T1!A.
MV#BKX*XK!>LD^L#>@5Y5$+T*L"2RG55"DQ2QLIK/O<?Y:E\DET(SA&?RWVJ^
ME Z@ST$"B@RN^RR=,#QKKFO3\V0!X$RI5*\_CEDJ,*96 *PQF0&$V/#W(63&
MAD8$L*Q1-L<RH'D!"3@P=O$;*G]* =^*0)<NWD73\J@H] \8_NV0U"Z#%ICT
MA$,"93N(%8)*XC^X-3@(?B!N<PI?LU;U=3&5)AH0.QJP[H=!6MW*P'!)LX)V
MIBHG6@18-/=X$[2_EI?0X_!+[GF]@?(#3FXGBJLWD-&NTD##U128@@$Z2I88
MR*0 AD= Y>B@=H5^,XQ!9(VM@]' P0R@5J2F*]=:Z3&ZZE6UG''1/<UUK0(!
MK]GA,/$@U%0<PB[AT!OT=&-5DPJ,%0B]IBJ89#Z'S#PZ+*/B*D>21@ITSY<<
M7>2R#:4UDA& U.]P/2@0#+"':9J,=6%)/7: 4^!)']IG,*_%C8-IM#R];;.1
MGPO"U:0RX57ZT48"%=9_*VYS&5&,( 6TIR26;V^N(;A87%0S46L0$I>L'1C$
MQS4H ]>*DB$&="L*D)WKI.TFMD:R I! ;F&*/,)>2O2T'HV=U^N^W4$+K2IL
M;*VDJ]1!<:P87Q7%&%CH%KSKXW7FD3_HG]-TODY&50?*+!<V/A+%RHYD6;EK
MF&4,<=1[NA5[+F<L:&LUU:@04C*H3U@UR,M==+>NI'+/&\92$B,EHG4CP(0O
M2I61E<(>52[8GH1%$41UQ_:T4]*UGFG-B<R2SRTQL=JH,:8/ ?&<4#)8?N!"
MOKZ04N(5<%<P4UN';,P[LIDO^VSF V<S7_79S#Z;^0",G[\J=\@JWX]B59^2
MV5EWPD[S%5#:7CF0D7*&1 &C]H2B*6L2@\:7LK/>;/T!)P=FZUK/FWV>P+TD
MN:G1'=_EW_K+7L&M&D K<Q^_;(U/%CF?+(;>#@<<GFO:UR4TG"'G%M)W$*RL
MVL"V&)(K,RA#G*KD1.P 6784V6A!:7S$*[MH:)"S>.UCA2UAR33]#&NBZ%PA
MJ8B%C#@Y.UH(46[.:KSFZ!X5>MM#G.AEMV,?<MB6ZAN3EH% A"[L?FT\/:Y*
M76[*J 9%M)JEFP8$,'T0F%F1IRN!!OH\#OV92TMQ2C<X(U.+F@90O#4^%#%]
MKF?Y!/IQKF7]EN&C$Q\^>@W;>&!GD$VD+%]M23'/\M ZWA1:.O@B6VL_)-"B
M',!JBQ0R83G@I^/,;B1^BHL'XN\[ON'/B[:D=%NA"<QN)<-*OV2(KH0S-)EF
MHP7A'@F,:==^<0N!K/9';?(*<."C)&>U1)W8.F3$[\_DT(F];ZBL=N&P^HJ"
MZP8"@,#QC[]K!%CT=TV"!6"MD1E*H*'&"W-F23T^BR> VQ4L,AHDUTZM#7AB
M[NX 2I^LHU["#TP87QZT1$-1T0!WD5Z&#6ZZA'T:\\:F1PM4] [KRQ7N1JDF
M2/G9NQAON&WN\'O%5N^.J^[I.=CW0WZ'<>DC1B >(OS,]^WHF5JN0!)P:=G!
M@H_%GB,QNN0I=&D9^\]R);4T4G[0B]4/.+F=2/"):$XYP<[3?>L[P%PIL$0]
M[T8\=,C1/DX#6KEI>@-86F\>!:1M]D=6J>=9=>V^:M17DT6B?"QE4(='Q;&9
MC9<+A/1J1-:W06#%[<UW#L#DQ[9US:8\3%4G/714XJ[N([!1+>Y&T7KC^QM:
MW!HLXQTO[3[ ;>10)GBL$ZR!HE)AN(A2OMB#;Z$+<0M*@;]/_%GD8DRP\$48
M;YKF!Z^QZVUPA;U.2H/."T7'^4GD5WA QG6RUG8E@/)ZD YGE%4F\;*(I@78
M&E7+STQ6\:()7(3 U]S\>*U)<T?V%5M,DFY5S^O5Y \)JGNY2Z_O%K#H&V)1
M:L&)?AL@FA2VHIZ=X(D.QN"*#E!%M@65Z!3SXR3YA=43<4UM)?.Y=41!]W)&
M"CB<@F11U33JD5:OY<6M6!5< &X78AV8K. $; 8_.WCV=&"UQJK2GL3<6^<>
M3P)9ND*X%Q:%  I,[6W25LQ_OPB>Q)W)\$_U,<1,DP"_JS9^DW$C?Z #!M\P
MM%DMH+#-7H[5HI,RI79K4(3"ZJ6$&@YD*7/ ,W]'JNM-%<C 6C!5Q:ENS^8W
M./HUN7TT&NLAD+)WY/9>];F]!\[M_=3G]A[B4#V2[-YWN+>?[T2;R0#<6O.@
M3^V]-#D[XF+ "CU9K_YHE M^39T'O(OQO@"D]+AAY-*$V[]6O]C6+%2HGOBN
MAYZ UO^?I>6(TA0J,#6$4',Z@? ]Y7:P01D^;)9\R6;+F0%\I!W0JA5__'K[
MV;)S.'8.%2YN,-(<Z)/LNXFO*<RH#4N***ZU@^A=YJNW(,M=QRB-R4Y]S!TC
ME]\T R+O9A9@W&>8KYJRP>1 RXSK-:HN5KBP=P<T/E^Z0@1H36EU[,I-S,O7
MR%MLF)>0-G&RX(XPW<#@9D4.]@CS.M!CB!_!L5LI%H55;4WE@.D(UW5Q"YL/
ME4K3A$BM.*E5.V"-\BOC.L-5JI 85C++/;,L>KFJ1SSYK.,E(?*IF&@M0QB:
MERRI@#!V+>,7BM9U0P-@Q[[>DLA1Y0S#E=0IXPX%5&.#=6N(!6>)C[NGE>&T
M*^^/WV.7-*22@VJ=J*/Y""%NWB [PS6HLH,)UVL,TSR=9"X8B?,T>IY03U&I
M3 '\&]QFLD4#<]]^TXYE!NG<Q&7X:E426T[1[51LEG/W*.EMJ!ZJY$UM[Z9]
MVUPEWK:LAW*"P(:'-<5/8*;V!RQ=[TLK"0 :H5VON6=KOG0+V43AO)DEG^6X
M6ZW#_HNP/0?'AH_7ADE2+H-R'W-[M7#)^)IA0--4$ME:C.S+()1E/V"SPX"C
MK0<,*58<:.VM/@QE/2K'-T!C-@E/#I0[]!0,,#N*\EAIFP;)? QG)JM82V'^
MW1='?6 ^&;SV\B)0FO)TTV1WMEH*4!D!N,0=-_L_WYZS=F&R%+N.GK[U)Y50
MVC-0M"ZSFV!LJ!7P@/ 4-QXL3;M498*/*%">79A"!P]I15RPL%,NYSY-SUHI
M]X33^>I^%K''5ER_YZ+P9];I$L]L,GV-3U49IB!0&G)&D$W#O!'-'A?X*:G^
M!FF?(JB'*"JH-\?\8NYF?FFE=PF>?Q!V,= 4,[56S^L89XPV'';V%5X</K/K
M+\5V4I^+BYQJ%S 2PXQCK'CII,@ H+JD2.1X<5M$!\>#:)4FI<1>U</,&VP$
M+0DPA!=Y-4_D'WZ;[MC,>WA(571\>.3HD]^75TF>_=,7+_RW9K 9Q-L+Y_'A
ML7NJ1N%96W6'9SQSSSBC;BT\MMV>\MP]Y72YN"Y*N%8_ N:24W^A'.[V["._
M>-2\-DVCG\F",!^F2;[CA(^<NWKP*?FRZW(=O?"#R6^RLLAA0M;0_RW!CE4[
M/NVE>]K/9?'9_OYU@.$Y%W)"E)1='OS*/?C"6G)30%=9.3,?2J@:6E@+$XBM
M=R[)O[1> 1%#?0R/23OUA9QL:+0U99MZGI6)MBM52!]KV*C[D0I/F/N-E#4W
MT'Y8#5(;'T+@&Z;CB$&QXTU40D'$2CJ6^/D8-9_:&+Q%C$M7@D$ZMI9HQOW9
MH&4:1I$7]>>2ST@/019(EU +0C<JM64$:0P!"#WBC1O0/N!P%R<(C?;]]J1$
M3+? <J,R;+UG,T@!$>?D'"Q[O()@="D27UI_XH[ V-?')MWJ.](8=U$ *N'.
M[:.[7EB@F([3MR=>>\MO(.FM+3!,W"YO!LOT:*S+/[UJ[:<^L_6PF:T73_O,
M5E^U]@#<(#\GU>?4Y[*L]'%$TU^4R4JA!+Y&^R_SJ;1J\]9(:R@5*:Y;8,H^
M#B^CHH*2*OK+L_CER=/XZ=.G][.J@G7P+4(0?Y$)H\:Z0*Y;*^W V1%"\&M(
MY$U3C)=%=-5@VJ2EDLJ%)2=962VB,>BWLAE)#(-O_@:'O],\-.+17J;8B*3U
MC7=U]8#43+,YA"9K7&>.=NCRW)_)[53P>NI.[BF=W#6A&7_"%7)TLNXLP2EA
MX;Q7F&.=U6G@,'!@APXSUZ+]Y>B55QV@FZPAW!B7/^+J,,^*,J5".V!)FI=%
M5#+:V#.8_<KL_$/$SQ(]&&'B[/?GUCZG  <%_(G2[+>TO+)OY)0#/,N^NA@)
MTQ<I@-F@/V _9&#WY>&+[8_8!\XGZJKQ#=RA&X[5-R,1939-A"Y#4! =.9=T
MEHY7S6Y2#H"YG TA955+3D<'=,^Z['7KG3I,*33 4,H))I!/!M'/2WN+@6WQ
MQB$_#=VC.99LMOGR:ME +8SL$HPQ >R#ME\%PV&D1QU".4  +-1N8F[:OOH&
M/"M9.!QQT!5"V47-*QP0IEAV;956N)Z4GT0.-W2O%2],,PL?1VF&R4.JW@[W
M= -/67-3:\JK;:I"KDZYZVNK R<)=/?E:FU\N4LM;WQW\RD8?T^J:ZJ3S=03
ML4AV-@PC1=Z,HJN*Q^=>:.H):L6*[O9'5#L%Q=%FBVZ*Z7*6/KE-H9H0]A":
MNEV!TL]\ G5-$IR?9+^: QG;5/<;MW?6-706IMI#]V>KV\#J*W)-;,>?KSB=
M;)]:)N,0S3/)[%&QGQP<V4,$'V.Z [ %%'SBJ@<:D=&G+(QH^8;IK1+<E-M'
M<WGM>>+N.UQ?+[>_OLZ_C*969FY W<S2\<I=8])'T@K6,+5':H+:;5&ETXE3
MG-P>NJ4F$8*=0"<]<K3S*A)(Z C?+-$T<E%<EU @R0,,:WW]8T":+7H+7P4%
M$#Z!%3(KM#E5D(;!5HQKL7;.VD4>NI!JD^_ (,JY'G011J2_FL#>M")9:OH3
M^RLAGTTSUOKU$6-)R%J]D\WF26;OO%DQMN(>EJ!AQF(=99LK[&88J,3OA=D<
M5>HR"XG,G1!:-4IZGJK(RV0YCCU Q]YNLZP*TY;@_(.Y-%GBAT NOAP]GD+8
M7O'MJOA>[> :CV%48L"P370&<*=Q6H8>\BD#*1TZNSWU\DVR+MS*A0QIB.RX
M88KYV394E[9/*G76-%:UKP-2V9+G3Y_VV9('SI8<]=F2O@[H:W3[3]OK]AI^
M_2R!LP=>V.OHE!+7XF"20UZOYT6'3=FNA(9J^N2.D:"=B6"'RZB]1@@,8(+1
MAQV7;M):'MT-I-(!)5?BD^?8M3RP.)MA#T-F?>M,-:]!7H#O614,<- 0X0G#
MG!T!CFYA?DW%LNCXCFA+5H?1^^7B23%Y,B]&X!YK]KN64>#SK2"6UI:O>-*>
M=H=[WD"KB+!+:8I_Q' $L"818/!NLB T4YL$:E\%[0,>_:% ^U1_^R',27:&
M<DM@X6*TRU7E2)$W$=(!'[#"@Y1I-G.T[H;A)EB"8<?.SAO'NDG0I?4I\RTU
M!1Z&QBV(A.[>OC3WXY$^'FWX'UXDYTY]S5G@US1*G7T1%(Z+8B!9*0ZKAV0B
M@U9*TW9/P06ME1TURZE;?%/:'NY<!KD[/3J*$&$=C/VL+.9EAKA*J$FWDZTF
M 7I^79GAMUBVYG2Y+M^J!^[5"/%'. V<Y1"M$H8IUP":. E,DS%MD[$>,E.7
M-2-16X)26VLTR(FM$[#Z5I%4%1;?K<9\LLNA@V.M5F,.T[-6:Z:<1-\QU0B+
MH?5W:=Y&GQK%P<E9]AI5"[*8^) E-.,2;B8< 7=K1DZQV3S%JIL_EF56 =4F
MOKZ0NA?(#ZO*)G-50A%9GEXA\SXDHEL]W_;(\V%8ODE,*[';;8JVH%#9E9GA
MS-I5MX&?2R]LU_YZ8R]K7<4JBM]==D[QM_>3'K1$>;+<U+#?L0"HD?Z"U6W+
M^%F!CI=D',!UTTX_I.J$MMAG\RWW.?JZ?>Z2?UB?WA#D][O,43RH<(K?=H*L
M_(U5_A=[/,U/YQ]_NWAW^NGB_;L]GN6>1^E>'1YM[QA]\EEA9=4$T7GFRI'\
M,63R%/5H&W/"H^%FW_, [W<H2;.WY6R)6#?ASPIZ#+.A(ODIAS+W K&OB[/?
M.S_$G2< 1,WWE#W.)CHZ[L&5GI 02%"7,VK':)_V)AVE"(EX=A1'QT^/GW\-
MRXDCMI#XB7&Y+*>8ZFG%^^!])(Q@E:@/(X0-"@**<E@9BEW<$G^YHX2=>,I/
M^T<C+?6 L$U0#<07&8!.)668NM\7P;H#N<QHM"PC>@E%8H4G<I%RXM23,P8#
M ?9IW*5%!@5.5=!S/%R\?97T_3[&HZV.<1+] E1$4C%X#FP'*^VY9U6U1#[T
M"!,HD!T>6;F( S>J7$[1]2O9_?;<#MRCPG#&>I18&;?/E5!A2ORS5N2 >CV!
M3EK(IE0M2HJ6Q%&:_U%0X"3(;5NM<)T-J2#9GPD)VM7&2N,SGLJ$#H05<HJT
M$,PU3^;S-,'CO*]2L=\B/Q[4*M)C@B=HU4:Q. U,B*66>A6[4CKB77+&#B/0
M.+8K$9H&JL1'(T#4LK:788R 7Z>?Y0_<T%Y&,ZQL+)<I5ESP&<:SPVR9G#?P
M'=KO29CE?5F':-7D)Q1$A6*&Q.%LT-(7H*.L:UG_ K-LKIWZV@EO[ZZTLY]E
MC9'9$PZW9#+":!#\"VG:7%R]S6N)J#Z?8()*8X+_ VOC[ SSC>V,L;,SB&Z@
ME<154UK5J&U==$I&[*D8>,\,K<P.->&UA9;G00PXRY=$J91^ 2Z\'6CQ1DNQ
M57BG#C(0.5A[?'6U*)ADP6S<@+JA=W_NP/9M@+8YP?E4S8F8IV%<&P,??CTY
M+VTD@AYVBM]Z]O2)1YD.]E4_[XX<.>J1(P^,'#GND2-]G>T]S:\4S2])[7T/
MRTO?!(YLJ&&'&945VM8.:W_RUUIEYJNLLNBAK3*S?L)B ^QN9;6N[!TVE^'+
M\L[;_FO-K?1;F%M<&R.SD;D&2^17, R6<O"TI4)-S*N=K2NSDW45;;O4W\:P
M2ML,*[.E816U&E8U 4L"T$!O;NWGY XF=X:W8@E3\Z=:+$X!+00\.MSD@TBZ
M0;VQ0"&<NP(:I)MBX5M" +YQ9<?'[\A2>]F,* =";W%XB3/[-E >;Z0WDRL]
M1(8 K&M.,7JE !BH$L9_%$L*R"&V Y!EO8S^B),[N H,HBRT,BX7Q>CS-Q?'
M2,01;Q211M,BC5PS7.1I=' 4E@PK:%A-6/=UJ_9;#J_K<IA$9V\O?K^,/EE%
M,RYN<Z1@QUR2O2I?6SVZIRNQW]N<Z2M177SMR=M$= YC2_-T9(\_@#LG&61+
M*BG\M[^\_'B&(D(.", N64&AJL$FJM%D:1]B#=!1BMAVRNP\&IC;7@O2=X -
M'6\?A_>]RQ2 Z#5WA:G]N>>I_I&E'D!!P+C2H!AM\<GOXQVZ<IQA(7WMAI(C
M1C)*1=F)X:4#9OM8U'A/L[ FXBM3 ,7]9J-\77'SJ2:](+,^PW&&_0';X@\#
M O(W@Q#&MS,,%@!J#!"&PA$)7[0-!B*W]]M3$=WO\S<<F N*B!)E5WWG6\\C
M-8FAV--]FBGY@QFO)6LHD'%'BIO0"H!C0T?7B/@'>#% 3PWM)P7Z.5Q2334>
M#;Z'23&=8D.AOV+GCMW9SD\.3SS)>W1P5N23#+;(NC;98K4+0?;)X4_\&'/P
MKN JM5.F2/A46C&(WMJO[_;(8\]X_E;J+!S/]@Y/>J7HUUOOWQU)NR40_;_N
MJ;^D>5H"_[!CUQB8)F7^1H'DCC+ 120<&:P.Z4'<&47!Z3#*ZFLZI!!(:BTH
M%&@:+^J0CKLCCWK<YU$?.(_ZK(MYU#^C%&13+O7'+DT1;-;%_V[48S_V)-^<
MO[UX=_[&0+71Y1[/\W'9I=_<[?UIESJC-]!1P!JC8)>H]N[P7]&8/VOV)4 2
M66I4 W&GZ?PZ&:9X&1!K ]F(T&FQN$K1#'7Q*[%D$RBEO05C0[M=QCI+R569
MS*]C(6YT--?<_(#M&,PX4J[?#A:\-^:A[5:1D[_U]2U?MP+NNP1P@_\U2I:+
MPEW#KTZL6;#!?.!?8A4(_?3_P;VE[(;M1]%B8?P_O@3]G;W]XW@&+U[]2ZN=
M\@WW"?G=3_\UF<U??\3Q_I;.[.G+QTOD_;.FBIW7E(A"3ZNJ&&5X,IG;W>VP
M-3V^>K;'H2GSU<][]O0[KQXK"!SHT>%S7^WC3;%'(D\/(4-C0B\E4QSF6^O(
MY9@#O%Q878?9PV\H--](4AY*.DX.CTXZ+AX3R ]92>BN$!P]/3SVX:1."H&8
M9=T2@@_6X9Y9XZ?+.\]IXP[? <>'1QT__4MK(:3CWCQH$8V7W18-ZK?470%X
M>=AQ\U!PA#C(-\FJNZ)PY))Q792#L',S#O747@[C[AF--?>QV_<#X95QB %F
MF44BZHA,?$Q'<#IP<.==%@> (7=9';P\&'5:'<#^T^7 ?F4O#+TP %W8-*',
M82\/O3Q$!#'O1:$7!5>RU M#=X6!BAGIII""QN[*0^?#T<P?T5T)Z'BDB;:?
M XXN+]V54$(O"&V"\+8H9]&K)__57:5P<OBLXV:"$H</)5 ;?$RG:5)UVH_H
MNDP4XXYMOXXT_ZW3.\^-R;JU_:%U<-1U3\%W<.R."/2@-=EW2CLRV^ 9S +;
MYW58);RP!D&O$40RL ,<R,:G,LDK:A+07=DX.3SJM#<92 ;TO1QU/,KX4Z\J
M1" N\D4ZG=KE61(7PMS.9M7AP).5CE>]=(AT6(& SI]5+Q"]0. 8/Z976;5(
M@8=XD^;HY:3C<G()I-?+:<<<$JY,IHOU(NK]U5 FEL,J&V=)F:6=-C\[7G$)
M+DB68Y>^[DK!T>'1TT[+P'R%)!>=5@2=-Q@N/YYU=_]?'!X=7'5Y^]\@Q<M[
M D,FV=1Z%-6R3/)NXV./GG6[[/)-LD@D]K!@NJN/T#2B[$NRNWYAO,FJT;2P
M2B(-G,P.R\1)M^U(*Q#0_TW 4=@8J</2< 2W1]<U1$,@N ]=+Q8=%HL/I]W=
M_@UE-LS*_-V8/FNLQANIO9_UU-X/3.W]O(O4WM](LK?AL'WRO">Q[32)[7E2
MYL5R\7ULTWTAJ3WIMFER+DVA* YF?]-=2Z7;55_GL_FT6$&0"X?IF$D[[+F<
M'![]U&6)R&^RLL .RESX\FMRVUUI.#X\>M'QR^(?RVS!:(ITM"RS1:>Q%$A?
MW>ELR7DU*HO;\+[HL#QT.QJNA*&/A'=:$K;N8*1$1C571/8)7KY>ACHJ0^=?
M1M=)?D5^J2<V[:(@@)G1:;8!X,:?"BJCF@/HO\.7B^^<VU59P#X)9&CTO1+Z
M7@F_%';,.DQQBHOS;V^S::?IS(X/CSO.4]&0C/-\D76Y3 QMB7&71>)OR3^3
M<EPLJ;$&% 4MNHWY[<.:?[O\V'L9QUUON'/Q]F.'.RB $=GM[<^K;)R6W94
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MWA1>^:87P>3E-$R!=,Y_;V'K@$[/X5;"XT5*:61YLL@HHV/9)C4H%43)956
M >@DT)#NR?X8X)9?46)[DM5QC5E+D9GBCZ6U"]%JFV.RY&\IJ*T!<X47X>2
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MBR:'F2,EF=T;K[3%_R#R8A(GVL8_<$V_EM6'@+-;<VF^BL_@XW21E]1URS(
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M3H4=.:4YS"( O9<.)/M:ICE+ UOQG7Y<L:>'Z/$R9EVQGI<K(Y"9FWJ38>%
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M)DI?ZXPP,64QT4")<T1Q"O*88H9=)1HAHS=TQYIN%":#$A+?-MGGVM2W%<P
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MP)&$!I[I9E/,UN+(4VI#>3TGN\Z4JQ!,Z/FZU@H0J6#(@*LA@DBA3@:)F\-
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MH"1XL"HNSS?(R)K-OI%5W-/E3,YV8!7'Z5*!LH\]05/T:?!*_<[M,D-N<(E
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M E5"RZJUH/L,H['#<>"RS;'9".R1HFPP7U^7%_Z@TL!371K39XS8A)XX[:%
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MMB9,@^CO99FX.<^O%S+'<VM@8VMJT*;V9JP2/97&>X?5)I:LCS!"^: I'R!
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M-@E#IIYCQKR,^NA30?A'+/S7E^DK\<S>HEZ8>:\7TJ(&JQQI,JZD'0C6&?6
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M2\*&3>HBFI7)RNIS7ZNE<!I&5[R=B;-:MW__V59IG;!$7U"SR$E,NL7A5SI
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M*:;OU>,8=U 9,=]80;=AT!/LR6BO4+.9P5B696TE^[HF'BL=S\&P4[FV6U?
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MK"S:6@M\9[:X0UT/=!]J(?U,'(<ROR[U\/X/NE.&;^Q*'[IR0<\$/7,;>N;
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MY,\R+?"^G[EI%NU<+,%>H;8PM&:X$FC%@=>U"(V*9<,8<4ST7!VI-6%?-P2
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MRTPRL+S.H!-0$16QU??WHL^(V(2C36O3H)"7A6O1#!CQ-MB37B'E2:M!J6:
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M[W]"S;E^R>*\S\47[C"5ML["KI>^,NH4D=(?*L\^#4FY(+T>2Z__2;FK2:_
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MYIQ=TT.XIN3E =]&*NKL[M8A>&!LV\-'@G(,U6(.[O_'N()LN-EPSV2XR>,
M8V,* 796"3_#=-!4!TLULCN@;0>Q.W^"QV)E="G$2G") ]02OEECEX8[=M\$
MH[.M1&T:]ZUA54\43>4^O51?,*T,R4_7XEZ0<[[LGX_TS\G7SF/]\[CY1-9Q
M((?J"/O9P:$OU=UETSJW:;U*W;3>+6*[4LBBVB)E@^D7"U4JG'\># YW(]W
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MHA\6DHFM9[>"W"U;W5\O;;)?J7Z%X62I&^+T@<VPD[5<+W4C9P5.B.G8EO\
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M]S:2<GH\WA<0"W$(Q?1",\OAQYP[X^"*)(:00 A"*6SWKFM11D.NL97L7''
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MP61VH68X,>VCA6ZOJ$:YA@]HFO:N4#:<7NMDNS(H!ES6?65GUX@@.)AL$X1
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MGJG/GB<'+U\[>)D Z?Y1LU"S<13#4#@7R^RH_G'+B5GY:1P6_V'!<OAE2%G
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MH^]!B&;PIBN#'65F*!XLT)HC3C +BZ5UMHEH5^%4.AEV6PUL65%KN=8WR+R
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M\<YZAY 7K=M-XK;R&HR1&-'=(-!B3'(*9LS?%/5&;%'<+ [.MF:$K6H(*1?
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MW#W=OJEDP/3__!D\DQ?J[![)J46PZKS.K#HG8-5YE5EUDF;52=D\'\E)/3X
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M?2'UP$Z=O::_HB FTK@A?#U5KG?3=CEG#Z+Z>RM\CO2--ZOW<6\?,YKJ3OX
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M<&EG&ZTQ6UZL;?2Z[CRU8HRU$"F5"O0L4*"R4"DZ''P12#@9S6:QB7H(+'3
M@_Y$+4T;JU5TI8MFO!7;7E[Q&$MC.(YDN48:!B8="\HX]WBJL 9'C[SR40LT
M[S; W;3+,2 *"Q>#Q]52S+-6\:>@/GJF1[N(%2P=![N:G')ZO]TZ5%*-KIDI
MKE@\Q6G6E]FQAY0OV8HM3W"5C:,M+1;?/4">3,9L1"#3>PNY^84SJZR$VUHI
MI^BZ=A-+;#?QIB'M)HY"7PQ#H*J*/2?6G";6@!PJM'-<F7:2>V\*71YJW$_R
M,JHL]\RHS5+H+.#C<B&U5GBDY@G]&SV97/R42D=F8E0"0(_)%)%*4&S(T M2
MZIF5Q=*S)VVV"RH J1EEE:6L/A0?52V6"-J84 DI.=R_EDJK0]B W1_*$ ?4
M<0SZP[^!!'O<Q[^RM!QI%2=0A]!K!D9ZF/ $=+9J7='Y%9>A<CV%';^MK;.M
M_BYX7G$T@YXB!0\<Q9$GJ'<?_.%%*L$? T 0?)OX.1*APM^"2-%/GP\Y?*59
M N_)0$^$!@Z4QC'EO5>K/X:= .K/<Q=N8:\56&9%*"Q?E=2DD/>P%Q^-K(A"
MC 1,\-ML;'TO50"Z4L9 Y#*F7\W4T<P_5=4\]:72!V#?>\N>9+#<NC?VJN(>
MV<^J0F?V*GNQGR(" !YAD@/\M(:IU$B"BX$7(JZYSLB.R=>9R=<_HH(]6JNV
M) TD:+B<FILF$1OQF%_%?#1@(-/:F)!D>?XDJY_+X2<8=57^\1BF7F34ON@+
M:E;+-L8#43GTJU+/ ];=3S&H;'V"V+IBDQ+L/'DM Q"$L:3VL>VB0@P*KF;S
MJ#O+*_U!08Q6,P,,\+"GL8"EAUC@,C(KPT%$('," 1;*)DHC6'N(7Y2[RE*_
M(2N 3(<F+TKCBKUK 08<=43+M5 965;NZ827BD )ZF.TIJ[#.RJ&7[F*X054
M#.^YBN%:3Z NAW]?OMK>?X746;F[V(,#SJ@#/$%S]!;-?5N4:6*E6!N[E>D&
M=5D_/.MLDKJ6,19J)+0!@BU\ASQ)<-1!+!7!H5N&8SE&- YQ-'#J&YU[$(%A
MDA3B.HO<]ML/VBG2#0[6[+VI?_?,!;E[9_;-'/(?F$(T GT';M 5R%>QH.&4
M$]]5 L+J4_#>,:=^:MR_QD&;J&[SL*2!MDUP^0:$P!4W"GI)_X8;GE7]GO _
M5RQ@*3,U9IB:]&%3,\9GDKT8AB PPHV>&*F-F(%)%9BQA&H>L'LOE_K-Q<),
MI2A-FC'&D-T)W:2U$A@&-6E9NB5H&B02-@73(_KP)IWKAJ980&B8QR/F[$*^
ML@>ET4_N D%FMZ)/'T1*%'%S34V AN7.G8L TTR:O 2G$#R'0E#[EJ?+5 C@
M\PN05A)XW;D (YT\^B ,B)9(?A7,@HI]1QXAB6^+!U>#(HZ&F9_O)M<\(AW6
MT.$>_(W,3)0_Z)$2H=(N1=VBE3J.Q]CWU9@D%;="DH /A:>?:4>/9Q&4F5&1
M^P<>JJ;FD4%%6_N!,LL3ZM=M\LO#*#O]B;V;,,MT)"A?5S5]4>\!3TR(/0NW
MW&GH.1%<7_EU%*HT1JV_R8MP0O@YA'#MNW\M4PB#Y54VQ>D#G@WV+'G**B;(
M X-.8@YW2B1.Y-^4YC55**SYL++92B /U0^55QMGIF!6C5PQ+=T$@> TYDJ4
M>?(@%P,NA\KQG[J&UQN00U5-1UMT/( X'-Q3-9,TZCNR=V0/E]:0Z&7MB;ZJ
MO];H):XU@".YFI)<_6F.5Z(XSU@"VM<DR;LSY@K;!:0])7U)8K3D G/4Z:BS
MKM2YJN0IK3>X:+T/.)'K@&.].5P"JC#8J7G6HT\JL?:5ZM\W79JXH]\ZV['U
M3Q.O1K])#! (H=,QF!B.@NA&Z)"/2( DJ3JP)T+1QS1CY0W$4.0A*+H[IWU*
M2#:S3K7#K&)J2%]0D@OE.92SU0N2W_*1:D-3F\HHUJ:_S:T9U:]=1O4",JI?
MNHSJ6F=4UXM(UX;SN#XPRU><L _,VX;T@3F)8#>%6N,N,,W*2?@<Q4/L"1C:
M<VON4IQ9^/3I%6\+?6YJRI0N^'6U. 459TZV3AW%T;7T1;'6 )NYJ+3W%[IA
M=/HZ.Q2Z#RO881=)! IU]R=V5 7MYCR%IU0<Z0X6H29+T]_N2EX+JD6.8EW+
M<&/[[XW26*4\M' 4 ;<%4FL:Z6RMSNH<9VN:PZO^B1L5"Y#&F"4<7ME>GW-:
MGR*?R@K@AWK4CA())6/U! YRP61I?%8"_,QH'A\JUF.M)SMS9-\ LJ^_G]NH
M+=6\W5K%"0$RJUVT=<^,0J=X=BZ\*/;OQ2#@R\>VF,\:^F(%I,?-'%ON(0R8
M+:ZK 3)=2/>G*EQ/%1+]AX*AUZK<&#_'C6K,C>H_QH\,KJHY\$4;1_S$'IHJ
MN#$9\>W)ZF+X<RAXJ"A4Q\:BIV2RKOUW&N;5*?!F+QH.T]#P;>>J6@->NEA7
M5>W[<W0J,4'C&\(RGRBDB1"YAZC<9&*VCB9=]KLCM=JJ+?7WG53-?\^G;2JL
MA%91<"U*[6O0<!$CW:-%$[<S+1R-UIA&Z^_HJ-K4(2M#*Q27F="/*K@NC!_#
M2&!,_LNE*V K&B,HA?.L7GUEM1&;NFN"HA$#Z.:PKY-*?TABGB?9"]'7@;(>
M> O'V0)(/V /29S3"?#"1CF+I^+2GJ-IXE&_A1@3YSU3X,!C<1W]H";Q[)K'
M$EO=ZHNN(^O&TM_H/W30SVB%'HYX%?T^-M, B0/6=DA];['^6K$!A\]Z CZC
M >H\#G34$?N)N2:(ZR!5%FMDU;[GT8.-+#,X5=M8)>>UM:B (W,;DB^T)2@:
M8VD8D'"HJ#N"5)(CB5P?ZT(L?98E4MG(FQ)#A948L;*NXL Q@64S@=KW7+EX
M>  LZ[-R1[*/'O84Z<(.8@8Q?3Q5ZE6MX9=B/6IM"4_6+5:FF[[P  Q,('"_
MF$*4U9UDPSFGDH8J 9(YWXGI?1/#G@[IC=)>(-5 ]]H'[73NZZ,P=\7KG"OG
MCG+\J*ZF[NJYHRS',#/I+ F3/4#MHHC'8$<_^(C:L=#<CRP/(*/KF11==:*?
M2@0G.U6BDD4Y1L;&'<CAIJM*=YRAKIRA_DZPJIQA!FEC!6DHBCXM=#PAE] C
M,$>C0 KER-21:5W)M/YI,%7)U AL6? ';,S(?D,9'XM_IZ8@7;$ V^_[V/[0
M9,F 18-:@,[F,PF[51LRTX/0QVRDM]$@>B(9HV\1A'BF:%C%P]X%=L@HPO%A
MKAV;8R"U[3ZS<NR##/4\!_8>.KT3[XXZ:TJ=JT>>UG]ONQ=;&G0]GAP=UI@.
M5X\01P%'F1B6R# O$IXE-$V,33O,,%:/JN\@&J-S:^*[:F5O:TO[=[0X>N-:
M'"V@Q=&^:W'D6APY";WBCC!_Y23T;'^U"41CTMR$[$X&<91>#2(]H*ID".M\
MR;;-^?0K5J7QI,WD7%OZ5J!H?ACV;<3JM93BYHR2^/K5NH;,6]$<F++YR0EP
M;DQEX,IX\')0\_VJO!TV =5L2I_+ ,MV<1"-?GPY2:"? U8ZI,*#,($"!$"U
MK F>)+&$7;630#T9PVM4@EY2FY$!NMDX2@/?YGD5LF@Q"HEA4?$3)^4(_\'9
M&[CN6%R38P6.^SJ2_C9;3XUN^4FYYD.<^HHOV%DL'_T<Q:V"]]H8ZH">V0#>
MM]O[#*<-[>U\F"9(^F+W@RE+Y85$;9I9JW,$,7=P#,#?;&'PS><WBFU$<=NV
MUO XS@WLMWB!?JY$*&(>P',%=NIHLS1,9  $P'#RGF9X7H0C5E3!\6>NGI6S
MCC/[@#&H36!+ G8_I+DM&@"?2L_T+2U[2]\N=*(E;7%?-CQJ2NMC^-"?R$5\
MJE3CY:)'\PMOSTP78FR5D 3Z&%V7N+516Q>;$/JJ[CKG Q-",Z:VM[W?OCW=
M<J*'6Y8S:1Q"65HYL4TTO!^2G!H#BU:)S@?7SU>HT8%N@\J.KU 0T+AUC-2:
M@B'3<MS6"94%3B4@M-V?B89LX'Q>N*17B6.^M .-"IN4SA_QD HWLS*F+&U6
MPU;-9U<8C-@V\V0GX^)ZNPIQ<="TV8;91S-@L0A7.>6W6K^:.>G!+TP$?&XF
ML=IF)Z"MZMO,416.^ 'I O#>?B+,;'K" FT!R/ :B,OGB;!%!23G^TRE>>U
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M\J$@KYKB?+:\-%,T_%042OJ*!7K4IJ_ZO$S*U,<RX[9]8%:V2*.XLP)8X$N
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M^UJL/V"BR':ZJG7U,,($ U"BKBM&'&08@=%?@Q$4.!(4%\9/K;M0);$0B:V
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M=?NYAX*QQM7H=Q3"[KI"V 44PKYUA;"U+H2M/94Z3:(!FD3]C7H>5$L@0B<
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M_$(?O\&%(HJVZ&!U7@%\K=(>90SH( FV1XM :<=X4G;D!D?QI#L'Q0$2)I>
MZM-LJIL]KXG78D-*'**<Z*8>+?V6Y&X$T_O#3?\/_Z\HU?$?:B 7BZC?-E$E
M@#A+F%!3KQ]'*6 )I57(?DO'0."6&UM\O<W^,"7.@1S*?,*T <:$FOZ7L,B>
M%LX:@CU37/H9A<-.:8@%QX@+;?^09G_)4,&!>4EA_1@*\J@YG$8,*L">1_JT
MV;"+9X2G#>67C6;VI%1U6Q=?.^?="W;>/8,?W9-,IP(M2ZM;?QP='Z.>@?KP
M(>M<&!4+?O_:/>\>G6RSH\^LPRZ.OIS@]R>'[+"#WV;*VGGW\OLY?O?I^R4[
M.37W'YV>7#!X-?MR]'OWI$WJ3D58#$<&9<EP9-:!K^'*L].+SO'%ME,CGA6S
MD+U.Z^5PN@>GW[YU3P[A^.D@9YPCJ?3?+XY.NA<7#"[_! HP^9;LX;*-[+?=
MS?:<)YQTOG5;!U\[)U^ZLV[<FWOC0>?LZ+)S?/0O_=(.0@O_7<YZRLNY3]%K
M_WYR]/GH@![4FG'[_MS;]26 YK""\\ON.>L<GI[-VX17MVS"Q6'GGS/N:;V>
M>T_WG]^/+H%V3PY@T4">[.RX,_.U;^8^PIXWZQYK8I]U^]O-%O*+V4_H'/X&
M9OC)O'U_M^GH^_GH^^RXV[GHMKYUSO_1)M;?)JY/[%_S^R+;[J#%CH0$'YQ>
M7!Q].NZZPWLV8_MH. (5C(=)ZP04>H_&R/'8MTIBYYK+P/1R1)6/-#3V#8RL
M6*(.9ZR%1OL;2CIZ:T)'+YIUTQ;<DR'NXA=^"0IW*]1G#@=[JZ%B.KT*[%>H
M\[F,G3?'"F_FCH!]T^(:WP,TX-X_A;V]0M;.'3E-+S^PTQ'E)+[']UQH7\P'
M]COV+(?'KEG*TS0NEU[WR\?NUD.2GG;=-,*96XQ?3FSP<PPCK &9-@?X9HH1
M2DAYPB249RT<?TRA^"](8P^HV_G%T.9#BF!F,A$#T_[?%KF'NZ5"Y 5#/#.[
MTRSC]6+7@?X;TXSS4ZI VU$*D_I[H"B2P_C,^',1W<EXW]W[8)K[FQF2.E@@
M=*B 9PY@4^N1^^+C0F4X=F/0Q0&D=]HW$QC%MW>N8D':9Z:BTC!*KHL?:,*
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M232$>XH@S]A68RO8RS\%W/O!=K=?P9M4%$A?;\##-_Y%C79G31'V @?:#J(
MSME.NR58+^"%/$EC44]<7M/3<NS%L9=&(:QC+TTZK3JSES4]DHQ0"$(UB-+
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M 02=F/>D]X&= +GJC3V)< ?WBC>]L'?A-SG.6X3_]07L](P]CP7_L=43?>
M[T%APS,SNPS+:N@6EX)$>H,G<T%G;4MQ,W&3"4D72GLSB;D'VE"%I^IS(18T
M00Y3;,FF7=C%/\_;%\=QSCKGEZVCHUM98Y/6<W3R^?3\6P>]["WT_)]W__G]
MZ+Q[R(Y.T#E^<=8]N/Q^L3++G24P*G&6!T:X2TN?7GB)\3Q6F7W42)KM5S)<
M<!SK*!%#XF[W_6=O9SH:4T,U&)<6^F(8RCXJCS(**ZT2U$0[74V15GK:A^>
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MMH/T4QX$-PB2@9A?7<';X UM>.(H%I1XRUD?I!\^"Z?-> /T&M@;9 BVUM"
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M),\*(>5R,*G5\9+VS *&R=(%%HM1+!0\EI.M9P)"WT,X-U_'R;-@U72AA8E
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M)$QN&:^L[)K-)IA_'/YX$7 W/5.K+@=M5L?YU&J,]<;UK(_=2)HP>[VJAT&
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M++HF/\0SJFHW,O)6G-BE$5#*#238>O39G6G$6VH;K4[4M_M6O<+'XA;>H::
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M#/N2J3Y8RR&5;' 9T[/6KE=F-15#3B"=N#1*NU1PXER^8H@B9GJ+(.8!(66
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MC?YTN/>LU:4VW"RFF2NO&AEFK\WN'*/?]9#^MSI<RA"Y74P57-V0D9@@"N
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M?11/<<Z95CE\2#&WPBN@]]?:12[JN ?!DV>-OY?G!]$ICW[-M-[:AF/5Y5>
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M'PT*)"P0IY$^:U@B0A"=WY3S[1..V=!*CQ7S ^+ 3FO?*V\N=7KW>VZ&(DQ
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M00><=AN]%[C-3C$*-\:PKU*3O.EY]QZ,6U1J2T[<+*V(P]27XYWA$V9_*"Y
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MN.GK2UME:2\D5FJ+IJ"M@[+R0QCT*);VG@'K/*T.YE:U]<FJ;X:<TP:$9NF
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MMZJ00%K>FHMU;92>%T[<;NDM;[;(#-&3([@D/#!\"M^8KVL]*QX'GAL9Z/%
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ML+F.ABP%.&PF%8)SYB8E&)+#9LBRQ6\L=&99=AW-C333S#.8GV\C8(,&H$,
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M(P":$(OE+Q;+"8NK@RSDZZV0G%<%DI-,/'&EQ"-'<BX.2\+Q&28YK[9*?BE
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MMZL>ZI2MWMD?XC+%BB<"+V?WE*.-^5I^(NH/4SOKA=,<&; *(8RO)\,O),F
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M._&8(4YT;R8Z7HVV<^FZ;UN,E<(TJ@Q6MH?^V]36"Z0G^%M$ZN(%*L#'T63
M7$UY^39MPV1&P/7L32ZH'+/*)D2ELF2L!^/U^ TG[3N$\;>I;7NYN711OGFY
M 9RI$)0AJE29(#%>E/V\2F#DQK;81':I7OUTR504OK3K,">P0>J.;T0/%H<?
M:JUZ])9)#JDG-^#U:Y[?MAC(FHBD5YQC+D_!?AOV8>?6*V37&8=9U3@"TP\0
M'TD"2*X_#[G;U2S+DO?DJ?G>T[UUZ^+J7$GA!023 ;(J'@#F1B7!$DJ8S6#N
M%_#+W.LP_UYP#1G0+D,':].8:(:@P2S!%KA7,1@HT];63O$VSYW2K_-/EV:A
M7+NO"_4#EC]^3>WQ=Q.^RN/;$*79$@+%"%14P$0[YQ))%3CY8T%]?N-]Z-5Y
M6R)HJOD!%LRYF9FU^*%2H1+EC(198$YB48?]-;,UGW:E?2LT]'G<$#\N<JAG
M<CS%JVGDU<XJ'=\..#]OK7J'BBA(2"M[]3247MRLV^YN<XVSG;AIA:U+)0=*
MV5=,4Q3H*)X>B?YMMY^@Y2OE_JUCK ][%[3V]"/61@G][9YL7/&M2IY"<>,B
MA;B"GUA]YOL%,LY713X3JD41RM?J'K#DL13630G1#PR^UWFE94GLY1+/^,E+
MI]1+T4_K81WH&,"0<+0=G@J%A0Y!&4C<-C!Z!O>X4)YD(SS3C@K*%4Y+HH<A
M2"/&&4Q1^QM-IG5U9  /(DA$1S/ZI*?%HF.1)L4&$A*&6TS'LQQ)+SWY5MM8
MTWZ1'0S&_>CB\=_1I=UAQ_TB),VW+W+C1B(5%%,D8X/=<?76,Z&BL\$J>,X$
M57:FN8K7NZKN: ;7'^5##[1G6+8U)]UKUK\WO;WGVU*]7-%-@*DNYERC4>%\
M)EX164#/!7^^O5;5;7_WMT/@[Y<NI@D2)NVOTLL<:ENK)&QGN&-0,46WS6':
MH#@^H;BR[[IF?<MW?:JS07(UVW8V9MIB""#UNZ&[A][.C[++3$BC R4:\AV3
M7;W5,"G-:P:606)V6 AFH2];7'&U*K46IM(/",MC3M'I:!?D>#C8<,8TTD;)
MU:M.M1PAIY* AS[7Q.G-HW>0.^)(6-+20_QPKNNYFE,;,XF!J%T3H>L#9=YH
M6N\=B5X$CH7>(F@NFMW/] _DJ+[$Y^+/H8EP]-"3K5"!J=?H*9]W/PFXE^']
M&WD"ZZO&<C E88$ )5'1;(O2L"&/QH(>5;8"XPP>2QT-5CH]TRJ3WN6"Y(A"
M))=IX<9$VK>CS:D$2>-N=-4]UT?I+F:EQOAJO@+NM*\2?5JFVW8O$DI5[V&Y
MS#J[J!-AW$TI44C#,I3"-0/ZM"(),X_9;#47^7*M"HE:X?714$>B&!]3=^ZO
M5"WMMA5X9T(R_"<9$.W;J&2U\RRD8F+FUP%U_D?=]=777AI><MKJD>W\6A!:
MYR&)#$$6I.K*-<]^@=;)1"&N6O^0Q>&%YH];XHO/[)4 Z\@GM*#LU-'U[6WM
M#%+Y*1"?-^K&MB=]8;$/QAHX?'@X1\FB7:>\OL3'].O<R'<!8.R8HB9[-GX=
MNU=)6]*_OG\V"CH(!0ZD!MYODB1)$GN;SD)+N.HU 0AEG.P(W%:,"KO&I=9.
ME3PBD-9"R@O]5%3!9H>I7)C[4;W;P@5__TF #/A !ER6I&2 $(FMYA,_>&1]
M/+,*^9\M*\I5PB4D7/NOJ=S_HTK7=SJR_]\-+NU+/3)@69\8N4+"_3PA)A.>
M,,*A$W'_TQIC[CO2JV+3O)3JP-;-PQ<3KL'M%Q3;'<.@9G_@Y$0!4/X:14XA
M1?9UY'N5$]HM9W$SRQ?A0!\/;=7E#X0/?<6>3QLD%<K]7&:V)NHA]QA\()K_
M7>30@N2!?JN>^^Q9MPZC]E%$!A*%[; M-) 1NP'/&I]0O]WXI(&VP%$)1 9H
M&%:6Z?;2Z3Y=J$.%+$RW1M5,7W >E1AILN=%_,N$O\";P<O0?@F7Q!FE+2Y'
MYW5N00I$]TO&0\[K2\BMV,T\;"0"6;4+6T?"H=-ICL("?WRY5*\HARJ=A<]%
M3N"A:V+W4@Q<MPFR3OEQU_XWM_Y7Z"_F+];(@-%$-G_WD\]DP*-[3RZ+EO^(
M2%J-_]B2]IN,OS\+M]JT2*Y&=W\*$8^0\@X_PB@9#0W5N95V51ASY,.SC5EH
M3\D U:##BA<XE,7IM^]Z"U)GVXY!V^X/1@WZ)BY;)0,PSNJ7DP,*(P.LK)X_
M5\Z%0'?CJI5Z-$50+3D+9]#O6Z L,L"S;<%]Q5F#<G32N)'+=BC,0R[T=7*[
MAU=HVHW[_^UP07T9<?2RHK;YSUJ-J,92WE_(X[,09SIA/ADJ#R^5DQ[E@E>=
MUVXP#=!BM&!G/$U!;9#)SG)/%_T M3>5-;KE;J??03ND _B&UGLRP.B,6?]"
M5W3+T(#]^T(@ZM?:O.T<2>QK>SF+5NB!C-J[]7K:W,'DLDSJ*\LKU+01V@-:
MH2W7U2;O8T<67C_'>5!0+JE>>.X8)>7&P^5MF-Q_X,F "'^OXOSFU-.MW,&*
M'Q?=8]\D:)6>4/SL4\R'-(26DP%?Z-\]3:L;Y15^Z;T!PVXB7(S-2,8!:@]5
M(Y1ZM8O%GJ%,'6^_&O_-;*0[^F&$*BF$0C $U@?.D7ZC\R6B7G"?23UU,C3W
MPH4_,KT7-NPENZ#3A])S]SP$#SF[I!6FI[=B$;I*]6[N+4O_5$QW&-#FK0L&
M!CX/!4<KIS:< ==J"VVF%E"H]=EWY;T7M>=_:SGBQ,K^3S&N[)-,*=:"[^<+
M?Z^KFKT2(CMBTN[5S*[4"UL_PB(DVBFT:-41S4=*12C5HT:A>;PD):([1$O<
MQ9&;:Z$>T1R$']+^!A^!7-!$6"M,N,LQB6LO"(>V?2'Y[D I05+.N32J^E\)
ME7!J)D[7&1#_I _XVM88 ;'7>88,?W,4FS5H@@>_W?U[.*3?CU<:+\J%C/LZ
MVSD?BC9^-I[X)S!;.60J,\'.;+43FS>?XKTK/P$@*:)L"1JX>3W"^U")1(C9
M5$V_*B7.L3>7M29M_*_;WC.+J6;)^Q_XZ][!,EFT1BVAB>8:W@'N:W_F/^9;
M?H'+'I]^FO0Z=8#-OJJ$_ZZ.EH"-.)APZA4467"'?;FJ92DQ*<N2@%?\RB<Q
M8>*SKCF=&.@K5I:VOKGR_A<94.L!$4OD_-3I6_9"K:E++RN'3P#,;-96T>DC
M=#NZTUXM>R5=Q_SX3E1![+&TI?L[$!-N9SH2(Q/5QN2;^Q8$QO6].W1G<;*5
M!;,J +D4XC>3@Z0R"K0FFY6*GQJZBV;TK#4TN,9F,>A^?5-Q9\>7^X-_)4@R
MF&?2]VFP05GHD!4#(6/-\3+'#@EAP/&'X.B9P,)]U8D1,N"J0C,GSW1NL;X7
M*8C@KX<?2LJX,>+PIJZ.-59P/92-*%.-/\KM&<QQN0S$,=JNW$B0%*&@*)Y?
M>>[%5Y=6OLEFL+W;EZ6ZO-':ENB_@9,I@P$O15KJ925N-W_=8$S(K6Y+1N-#
M(]'R 6AQZ6!=W#F)H_@3=L.W?X7@?(FYQ]=YMLTF@_7],2-_1S,RYJ2.+1!\
M,\M!HDT3JLZO%]F"_IFVDI1,IF]"9\&RM>A;7R04);6K/VIQ^33M#6&6DK8&
M'B=X*,C3)L*R0^D>)5X;V6+S3"=]X7LE=%V;ON4'DLDO%?/IA<?L@.6UV\&,
M(&=T29_(H 1Z6@(!/A>QW/L[-PMQR'C%BKC52E,LPQR9AR]GT.:V8+^M:U;^
MS)2PB4EF!B;6AXK5U4XK)"?.@:/OJ6F1%MJJ_@9+(PG@'@%>/&.B/7J'8T#D
M>[S.Q&NB#!+FKCO645<[7N-DGS1%_&D4/4)%#,%S1I*8@_4(\KY%LX343I+J
M>-:$1J[)IW$R #U<$%#I%#@3J\!$/\C'N.V J<=-1]+&UM YQNM-&N:XA0C#
MY^YJ^KFKGRMM@W^3KC1/DL2(C+BIO6[4]4T!*1PB!I/,LQVHA?(M@$4:MXT?
MOE.XHGK3,W]CR#>D>&&^[1C1Z,9>IG4']49J)_<7VU\RP!'%-;]YEE&.W?%N
M)P-H#RM4>@0$<?\\@+(>#5[<67^&MXBJG'B,-_R,7J#MR@+'$751<S!_XPP5
M-7OK;V//NK)"B.\WC;>]7$(=JM9+3:(DG\"<(33?R #;P2JNP+MO7^R$UJ9B
M;X:WS[1KO7UZ-%![]^.?_'MK^S_M;PY&=X_U>#\J!A7?*IW NG!EQD?)MEG!
M'G<Q6;4\7;ZIO_6[E[$.#(SI&V3]%*(7+67+JN2-O"@WH?J#MPQL>&/U?K!D
M;'P&)!]\#Y^4L_S,G8_(G F=:F; [74"&06GI4*EMA' 9-/Q9GXWM=KHH]Y,
MIN@C+ND]44Y67>4>^78&B5O7\W(YIWU#;A,?^RY1;9PLTE;7-$ZXU^A3XZ^O
M_2C9J#_S\5"VZ</0[7R]L_N&II1URZ^:UPDT)/15)]J>?8LU=+B-E;77%H@S
MB\Z-43C!.\;L-3N@45P; B+C>Z&\6XM7Q\U/C_9XDOD@:L7)A037+HW'DW9X
MF[U8X?$]56G/%[YNE<[']?F\ND[;2S2Y^F.[1SF<F/H.=W[U8IO-Z<"6W*A@
MYQ)^EW:7IIS65.< QG<8%",,8H2_GU$_<[?'NX0 NNXU-_;J67D'=2F%7\=(
MS+?08:['/BT(B;0%*>G'?2J_<#6@QKC>J5682U7O<[DY7UF9NVG.=F3 =ZRA
M82W7!%+B330HV!<DU-O[H_=YZ?GKVU:>%7%)-A\<8$W?VU]\,UU!B*1V8 \D
M)CVV9:+*7@B\V>J;G?%UU4+5E4]OM_&0^&%[5HWX^FYX6)-V+$EPRYM?HT<9
M%0,2)*2VA[+C%W^(LT)=29*XMY]?P*6LBFL]1OQ1N5=AD9UU<[5_ZRTB&'CC
M&[DEG,#\->5!(PEP7"I1$C>,_$)\.494RM]"<."T"GQQ$QJXU=QHHGHA(48W
MN0OO?*R\K<5BP]$[M_:LRML[B.6/C>T?ZRV+>LZ*876<?*\%E+<6^/N,=XD!
MWAE21$!V"S U-H2\,D)[?R6\6CQ;-[>LK:NY,_TA\<ZQ9%#&!/8 ^4]"E)RD
MS$T,$X6K+2^NOBN7"SI2.%(8;#1V=.'=N?TBZ';/OB7!NT<9&:7 M%/^5'J9
M--+HYJT]R3&W()P]Z,CF7Q1E'*;T(@)=SP?B2#0G-49V0*2[^I2&MK6X)%4G
M[I &$ZT'BJ2DE0_WYV;C3$L;S$SO;D5OHK]->JS5RM^1C"I?8Q<K4:61 ?*%
M2A0;I(VM]ZDX!.0>IY4ZI&W9N3S)<*1GEVAS4\=X2C('8&1]71$5RV1 0NYU
MD@!L'KW7#;Y"Y&@::[Y$U#X$/[ZB:BI4TH5T\]M410W=G3M,,>OUJ5W*SYQQ
M2XN\XFN37W_OWHH;?J895?$W1?N7#>S'<O#Q3/[\\OTJ>[A:T1^_>BS6L-Y/
M"H6,T*E 74]#,-<_^UGA^.%.:^?,76W_E0#6'U+[>LAH$-UVZ"U<>GVR;QM[
M,)C@NIP#,6L=;09CF&*;C@N*@>Q;<]9^XRY5,,BCT7M %L)GZ^HQT+PK8_W7
M>:<4)V6'J6YEM^FRIG)=>TX-MW-YXJ,&_-M<M/E4, 5U!@IWW@/GN >)U<<4
M!.%&; @!RQ4/C*94(2AG6]'QF@7CH%(?IYH06WZ-?S(-JO'L;[\4C10L;7(T
M57>X^Y7!R],\V9%2(_P0UI@"\T2K9.7A[-5K(G=@?[18*F"3Z==<.B['D*7C
MA:?E%L'2SF4"P9&C_5?H*WPZCN#"5NI@R=,@<5!D%:WT\I.HL$-R 5\]0WR1
MEF?T:]KC*(_W1KV8;PU\]R6*>1)U[-8-IWXVZY[K!9NT*@OD+KMSP_;0T$BB
M/)KI.DSF(0X2081C0L!:$X=D ./FA[D_2ZI^G%8V+<>E& .;(PC+]DSJ7,#$
M5M/0QE,>KHH,%=M[%WE%^%("*LA_>5O%P!^K'47BW2"I3MM/ORE4SHT/IBO?
M"%RKPE-_-4CP(P/F0>#)&BY?&9:GJZ^_3/E*ZY'ZTU<MM\(N$,&0(+>B+1 '
MOKXSF7_3*B8I&(C;>S+9S(U9>+0KPT"(Z<O,Y(%'OPF&V'^%^?\S]5=5I<SV
MJ6W'19LS<HOCOHGFL61I6PV57SUO(/!O/T;-RYW3THIH2.!U+2<P&>(K49@+
MH"F^LL6A#!:DCV-L\T3OW7#AB6X.9?P1O?.EL>[9H.77O=LMK1.^#.+H,+V7
M2:"G9$"II8)A,[SZVY0'8N!-,9 NN0-S*T.>,M;KEXOQ (<\KW+ S+&;$T3Q
MK1"KA7S/DV[#'U_BTK;>%/7!VISU](%QR#A?H:-@+1F9GA<NAI:J?0SL88G6
M"R_NWBU-@<A&85,'DG@0T(CRF$3J=UT:O^T(VMB^6%49G#WF00=#BT1?-X@'
M7YM@/D>]^T5%HS18M3&W.Y0?+](F^O:-4-W[1,F>>@'.,0LHCEB9Y= SG>E<
MKLD7F*_V"\$X5BJ9C3/3-FRGB%X1!'C0 NS#H>I6I)&FZ)&8(Q1'?4]NN-_B
MC3%5BT*8!)3]#ZRONT]C4M6@ N:RW9-QS/,XHY6ZN;51W^;6^([,FSM?I6]%
MD*:#W!46OK $0.*;%=S1:L;704R<A >]HP8O7$//^L)]^2U,1Y<?R"U(9;#:
M;#4)1,.:H@O]OE1B.&X*G6M6]HNP!"#'![=?+EG^NIFN+,.=T#/9LZ;/]+9O
M O;5VN.CA._JNU(+R2[TS5@8[/F66?)T@;$U/MW)L+ELLARSYN.]^4+N]]I6
MS;>/4NRJ C8FS._:)WV^C7#&E\<<LVV^FOUJO:FJ^=J RPM=IAG$R6.2R.1@
MF*R@&2)32AI8O#=!? K'K<UC.#ML_#$.T0.;2[C*0SC_%C.AVG@Z\>L#7?0"
MHYI[YYQ 9!DA;@/"QO,FV16E-ET>(N&<%3A2HOJDC?8+D>FRVGDGU<H+=1K;
MD-?$:ZUCV)2E_+-6E)]MF.?2%\1A^^9F$ATGEVNJ<<71Z(O[]N4+6R>9G/<[
M.P=(V)>O%BK$NY0'1 T57GQ$VR@);PY[H=1-X[NF>\YUI&R9J!_H;S6\-KQI
M;IK#/=XUY5,VE17-,W:'?^3RB4.&7<O7VW_7Z5V2;G:BIIV?YW >J=K>!RTJ
M_M'BI%,&39E'!]L*R!=P&?J6$,X;!$MH;X9M]@W\.2  R0 ;YN3FA20 &1"6
M00M>1Z[:CH3@C"TG#$(H,7T=,KPY&MVM_+B:C%96/*+BHN)%*:'@"<^;SYZ@
M1 ST&LS;9/+>RZ;@Q>TF:D0%TNK1K2QT01*&"6QW?NQ"^(R$\6)0R:,P1],Q
MT#6BQE0K-P$SJ#UC==+-,=?[SM/-L1P6;S#&TRM9H=VA['9$RG4K@7T2?J:F
M[*9M:* N^*S(_W;.*MN"V.0OCQJD;2V?PE6+R\Q9'MN-*8CH>I+@">/C*[!@
MCL]19BLPOY>&-,_9*AF<T]8+5LOI-SL.L+WS_8M>JTCSMVVFN$0^$"^U5!>K
M+80VN;?4N.MYZ52W>;KXE$>17F&.9!$=09I]!\1*8,*0 5QD0*?@L=5,Q+W/
M[CRPRVJB6^6Z1C?/Q6(N<C.4FV 64#$'Z\5"74. 3QJK&FK=&;<.-J<S1A?U
M2ZPZ>,NUI<(-W\;CZ ]Z0#=QJ&A5(;SWLG\<41/+Q&H%<WP\X0/FA'WF^+XP
MZQ(8/N6KGVC1/N=BM9%16J3KYN_/-+?[HKEE0NB9[JVF _.R=6XS\9DH_&3
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M2=?/R8"(J$;WA6!ZH^Q$,H!U3_WTG5KS[?XC_B9'-5OX\I([04P'[+\,4C[
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MK2OWKIB<%)PFV J_-\<@Y?4@H<!9R.0$.*CE^WQ>6^+3)5V@J2":-C?'/)X
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MV+;;&SXY9IW'8M8I'D,*Y-OF9;2I_B"$@L[*I^0( AH!>Q@*87K\"#(Q]Y+
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MB>295O[B\?E[(9!//!J@,*0YM;8\E@7_UXX[V&(R<_6Q5W"^DZV\/E=J_+A
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M[!@O,/L?!0<@"3^..:>2W(M_3 LAIN6 ]ZJ(:U3E\L9ON$VV!8D[V>6^[^/
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MC>*Y7Y="-3A-Z\]<5(E>X$%Q@8G=^ZRIU XI2@J:#\&]8DD+3PY-J:0&F+8
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MNMN(:1WZ9'RJBR9PJMV75%EY2>/@8L_^\!XASFZ4NB/;]''B0S*,YZ"@L;W
MT-R>W/*6NO6XY<'9B.8TM#=^VHQB7%Z&M#YZ7W(7ZQ )PS>'$+0"TP\AO%A+
M(+OZ'1$870K%G#"D!7S*8!B-XM"B/@*1N(-A[/L9T+?'X$(C[7Q3_6C>O38S
MH>K'\S1,;VT<6L2 WQO*8:!EMS98"JJ074HH!1P;D5TX4I)_C4:![ HLF8K3
MOR9[MO/->*BC_0;["W' 0O.<-,+K( []4,LM.:1QRC7C&#T)3?)#I,\M7DB:
MX\L+= WZDGBS-J[A:;D;M!YT[),X0]+B2* 4K+Q=MB>\09[NH50N9=4S;+BK
M=>Q>6*1+?! 5+GCXSKB$WX)_]7'1G5#7I%3Y_M2*L0^D?[8O]#3)8BV4%W41
M,.Z'#1OM?'FN[F8G\TW$XS[=ZR'_P5D(?15PS;S7Y[$3A+<ON/WX*:,_GC-'
M/'N\]'E\!-F'4FZX>L#*/"T(;.WV@#%DS/3>XI%-V_G7F">9B)*:6@$+R)72
MP/S;*E\;VQG-!"5JHR0GZT0HHM%[H4^IS*S<U]R]_.)U/\I(S<67=_<7Q Q$
M?$0P?<YG9WAX&)IMUW*;GX<>0O@9=PNGNOF(*GTJ'#-K^^$)>J;/@.4]VUBZ
M#8WU>8CI7ZJHV;CR^]:6\";<>+7(#'GP*!F8>,G34'>5Z?9^#@HQ41+(,*M9
M$V#MV=N&(]8)\P;7F.)=$^IIM@]RIVZ_LC?_9R Q]BAVS?16C-3M%/6')^E[
M V@Q%#LBTQ!^QONH!-3Y6Z_)<&,B;<9L32X:0[U&_$,&-;;+/M5*GZGBT2\W
M=3,+S;^#_*J5EX[4ZO5XTR;&E??HDGM(?;[B))_>UZ?@,O_5+0Z;0EU1(3/U
M2HNKUC(W2U0\Y=$V][-6K4HT?9 _+W1W1,"42I,H%D+]RV\+GKCXQA59J7P)
MWJIX%-BR_R/2#NHIUG[2R)#O3KS\]WB=B:L/?.0;2E^4RH?*6&!7M@;PB5VJ
MS> K0)<0CN;ML,AT-".E=$KUYO)O5GH^:5..)Z/%$"EDSB:4F+G_5*].6BG!
M3[!/A#NI]EN-RFSC""G-F3,W>=5%=/O 87*6 &W$]P]1Y<CPWED_:#>6HT.M
MQG?&"POG"B]WF#.O1L![;&SKC%Q+FV=7G$5AM/<&::'EW@$D/)_7*-K;1?UC
M55<292L5RZ9G"+3?PH\AO3\H5Q?]D"E\]VZ^IN$#B!UN3/_=O>MWROZ_[-5S
MWRXTNHVIN#PEB+Z_>MJ0@A9#<DRI4SU-@ $"'O([$D^ G?(.KGVQN6EKTC:B
M$27[C".I:#+@/?"A0193XVS7LZ]ND_NY"9\[=.U,5H%XWI(\#7XBZ)0H74K[
M&^C2Q2K\G+3&6VFK-N1^!Q%IMV:])/3=;DF0G?SQ>Y%-?LV*T%"AZ8,L3%EO
M8*F@VVO7-[_>0@4>!>N=VX9Z#[U>E@^M>U.AT5GM]?A"3MGW73N]T !7(?GM
M(F73 P^+W%YLIH1*7<H=FFV*.@(B,&.2%%IM,,2S? CYSW'A:Q/DB^E\_]CG
M^4CVN]$"]X0.(>?@ -SJ$"(\58S9;UY(X +%8?U''HM2C'VR=\)V-YZF2Y@7
M!/J(!)@$ N, [,5UL+M6KD<N[25K/*-'L?;H>"2=&]-=LUS+;?OAZ."])>87
M5NCCV%'WN8[ N6W$RX1 %TL6<+)Q=&?FE L4+%G\O,D:K=[.Q4%:Z9UMG[57
M4M[!G$:HBN;=[K@1[*LV*,U!%K?9LIY4?/A6:271O+.NN356X;/_/;0LR/+J
M<0EY@6]Y&B40JH6^W!ND?%IKS4>%7:0UP9UM,?"OO%76JG7\'<1=([L*:Q]Y
M=:\*O^),]*2$CJ=6. G*Z3Z=+:N^S2#R]K8TQY03Q:Q*8X;6;+X&"26'2IUN
M7+.J?=%KE8,KL;#VF<P:];=L[G9LX<(U97RZ9F!Y[WA@I.>),VJ9JV.RIJ*!
M+=Q.5X1<"[[P)_WZC[ZF>XU;6YH%89[ZJX9\TVWC1#0[QTN6AZ[Z8;31U&@+
MV']R"TH#S?\1/]9NW@[XP\!!4T[*248/$C]<_[12+NVJY=*J7B4L5I2J6E"E
ML[AX9EK8N;K%;W!P/=F5<^558^WY*,IG_1LGRB&<44'CX_6WQP97##X1C-G2
MU9."Q'Q%EJ1.MS>5_?S*<76(KV6YG:_-)>E@%=U]7"V?EFZ"W(4>!)E(LZ3?
MT&:9E4HEY[3L2RXW<F-3T&H./52MSNI_S>-?'$P9V/F"0TA--'?PK"2S:\'!
MX<9$%_Z[Y:2?/:X&4_LY\2!JX,/ 'M]!%ANJPD[L621:/J9;3AL2D8>1VRR7
M?Q:J-:SS;+QB]IZ8IPP^3XP)G7P303S!4OA/6SK#I-1%84#_LU)$NS-R+J;A
MU<#=2'2XV,,Q>T-N"NMYS/;8N%5LQO7;\[;GJ;?O=50]\.^Y&&OWLB0HUF+3
MX(E(781G:*FSDSW\AA+N6V,UY\=O?'T7=4)/NAEIGX]+#9?X6\O?\1[KL3-5
MG>'Q*N7.WLBW3LEP],6L_[] 5"ER;V.]ROXWO%'NDQ_,9L+OKQ^/&3@'%#E.
MJN#$;^KK&M?A1I'>Q=\,*LN=G,P#/ ,$<DKSIK'W6K(X1+55S%0-%?A^^<?7
MQ<6J;76O0:] Y6,2OH?SQOVY"I5_[==JK'>*-=JZGDTW**'[5U^_4+X^4C$O
MEG"OUNA;A4TBKI=\V?CI[DB^DO!$2D/:['U;6S>20I0C7SSA4K]%6B1_A-M:
MC?N=:I'ZY!!/]O([ZN[\GKYW;!TU#J21ST!Q.C=J"MT\1:VF&S+"#AKU>!:W
M8K$\H<08H #Z":4$]$T,$+Y=HR^BXZC9*SWH,Z/KA$C_:D^)6A(UN#=\WS-.
M'<J'>#]F,U;S*&!C4"8Y>.HW'G!8F!9=Q!VU0K0'/$ZR 98DNBOQG:%-5F'Q
M;6L=5ZE"1I4Y(A+,,%1]VUX#OO%02GCX?_"FDLHY1*P*'P(#HY6^R'O@9_,E
M@'-N>L [G-%SPNC'+9]K9[_<+'/S\/OJ>EZ F]JX9/#T]GD&X:U;NIUT-GM1
M[B1Y;N;R8J%V=<VCE^R:,E]5BX,'Y(:=)Q]8PK;8I!5XAI9(+K:IO8M/F5+#
MVQV'$(4O3W^><GZUI$:P^O)Q^LZ0ZA<M[^60C].NSVGVJ2O&H45)?6TCO3:$
M9XH:@G>L/%>'"(P!+D?^-X&;L,Q?VME^F'X/X7D_$7ZU)QX/MQ6)?"]*LHE\
M;[<-N:)3%6YF?6R!N2H:<4(;"=:I%#9L';SI$+(10S_Q&WVL]* :^KAVQF+6
M#D@OH?!P@0^1IR9JE1@FM:LZ^*3BMI8H.7/-M ^(K>Z/OR-ML%%EQ!)PSVA2
M0M?7N2F2VD/T5"*NA&^TDO%QJ),'[U$\8._N<\!O"]/%Z26A,;K#(X&P(?S+
MF%]]I3=O/==?N"H=R7S]?@WC6;7F(O#(OU#ZX]CRB%$/;M?W4Q-77Q/7P-95
M(^4?>J=<LY_X/U%KN&+[D@67?C?0Q$-Z>TW85$X/(LR[^ZKY4J)H%N].JX=)
M4K?;FXZ<JV3.68,2^/K?R\MO,<J2:KT/KV;Y6)8D[D_"Q:1+7_3(9X34;694
MZM1D+4D@C,R6@A6W.=*&K[1.VK]RUQ8#MHZY1'@X?G-4[',%<.63M2_L[O;;
ME7(:J$SW:US18PZ?LW;P*55<"EAEM3QR9QM@ !G:AT_%<C-UD;QQ_=B/S01]
M^:U/(H)Q'1J/3F%I)K>!OIHG[VG*99B:WTT.K33]#F)4&>A"O/=]!6A^730+
M!MQ/6#<;_S71H8,^CN[N8LJ\VE)$J3"G%KA1XTRO[YM*&NTMC43U7S-]TH<0
M3N3=(3'=IF/7VLL_QUSW'2J4#NC-:NSTU=ZBU'=$&<Q[52NK6(XNF^O,KX5F
MV"GY^T]J-C;G(C),$MB+3=P3C-/83"Y^7--U#TH%PM)56V>,(YQ<D_]501.F
MKYU2UM/,#9([;33:,\#'+4D4EX^(=])0\81=[5^D-5YMG/0ZV'^3V_"K^D6E
MID-]Z>7B@[5Y:4^M;X@41=+\99R3M9/2W6WIW=>!YVBA425.[2=3NF'LEO9/
M+$MA/!9G7XN<^Z]L]/7M;AP]&WL2O1A-&^0CTNU1$VK=G7?KC(K79 W9_.J-
M8U#LFE]76\_%/Q$X:9TOC^WC$<)PH'M<R01 86W@TSH9>\9DL73*PS$MB"&=
MBR,C?,Q]W)H;34/M0QZYR_[7,SIV<+GD6R/KI9:'$O]^8=NNW/YMC/@$312+
M*S2T.WM,BSJ>P7,W:/@4JX6Q-@OK\KXBYGQMYCCA"_XL3?/,@?N]I83PU![R
MN]@L_W] 8Z"6XME@0F7%9E6IO9*4S? =N'[!RKA:<HB482+",W%.>VJY/&.1
M9N?PIBL@S&"^"2J:&F3GR"19IEX:;!].#HK#K.]MV-*O'D*Z-7=@L0(+C0/4
M OI])V]@=?[R5 @'=IK8V]R&3D2:1%0@(OQ4_FO,%E=?/X2<Z7 N7M\WIZ91
M&^?YQ_04/LC-&!4,=P:$!H1\I**FL8#U"]0%I-X(U$/R!Y;TX^#MT8!M3<?\
MKT*)G3W"=T!"HQW8?"=16C(86OH[W#82G?"772/%D>>,R\S/!41<GX3\9 B=
M8TM@?2K(6)W <#-OY0Q:=DN-K?@ABG**%3KISEUTY,+/L0N_^2*,N%!_K*?@
M4VR@J/Y34R&Y@'NJ"(U?79R]9+5IS[?+[GF>.Y=<G9_DR7\M-4XW>?7%U#C_
MH[T-!U>"7;XY6W %XFOONO7[TDOS_E^I.<+DC],JNY(\2Q$V-T1^:"0.!R.;
M-'Q7WOZ)Z[1-_Q;T(_7NQQ_(6_]D;-ES#EQ2"[1P0[XJOU46<QC\?(O-U(#%
M.95=CR/(58.LO<QK(RM_&HDGF>,B8:].Y9 Q;&M[OKN70FL%UT0"G0U['.KU
MO^Z%2_+J24%&2]]\TG-?I-[\NK#V%*7-G(1S,(60 @?O#609RN!5FG[7%886
M@.IJDI"@T9R5#B&XB[DS,[O+GWS:U+=_=TDQ^[-7_[Y%FA95-[VN=;+O*GGD
M[>NG%U0;G145:Y-&.&LNTS;\..OZWM7W@TKU7P:7-+[>&Q+[=ORS1[JFZ=N;
M]=K7RV.OE0E+7Q(2R]BXWA^NUJ!6:/JX+TDZL\FJYPVWY->Z-S^QO&G=[F_6
M0L5=Q$KL'WSV<JT@E]@O:XDIV=K4V#MT:D:^N:OO8V=+=6.6)F:=NQOLKS3@
M.1W&QY)/"K3;()ZTQ-:3';+$]?YTG<H6.2< 3^^S3).W+Q#AYTO3<X\,#;(M
MKDTA&#]]=<SO'4).ZS[&4G>?6V?LL[N'C9#[X](39X)^GH&=>)BZF+H8C7A_
M[T5\RL.0Q]_B>X]K2T>K!A[3_RPV?BN>(WM&*):=$O0D9$4Z,S5^95D"MW-_
MKRHCN[K$)SC\/D;#M,8.=VDD$6_?OYFOOYSK+:DZ8]I$>6\^'VBN;9:1[Y"5
MF5H)^UGTS=W2NZQ35.(&18B(1W$?VYV+ SVK0[I8)_WT="FUQQ&9EMZS,& A
M#2E5 _]W]5\SQX??+N?'0A7J LZXJUDH^7G\><?Y[M>EY$]-QF)AMML./Q<,
M'Z$UXM_"FQ:ZW2,TTEX&M1I,/Q-3\?-PONTFR&?2:K&D=7Y";_$U49Y=(>/T
MCF7$+\Z$[O/IHM]S^Q^,%^D$9S:N?E'=?6IQ/W7.1S6U*$KN\YR1!;(^I)2]
MY%G)_?SR+_P7.W]_T3A?(GSI6T]@EK;;1+[X'637I-AW2Z<:6Y]#R+K^(EZ2
MH00VD_SXR+:] 9((M7X75EH-UH\,Y0+C>IFR(Z$<'%0UZQ?SA%N3>U4/6^)E
MSBS869Q=AW4FD_LW+_E3/R3IQ'&GJAU"^*+$SK R^M69I=+(!=_9]O_8[+1_
MEMQ@E6)D*-:6UO\3V+9I;AS2=?3.?3U?R%G]TJFDU:O@;;.@$D=#!J%.,7RO
M\#(MOGQB9P*X.W]Y]*^XC8*CE5\5&+.3]Z.:G#[J>76AS_?A!8_.F)_Z_\7D
MRO+J#K:F,)5LNS=T*B;TYGVRLM9N!@]=^G.3M_Y^@:VST2#]9\?'/9S_5/U!
M>DZ*5JFQ:GFV5:AVE@P;I<*BN/A?7D;IQK^B<ZT1M2JA[<IN->C*Z41C,;2O
M-ZM$[F0!IE?S<>:7D;9#B,^JP0K=UYR!7OJ#'WSDWW']8<8&'/%J@_+RYE[L
MGK.O5HFKD%UI!Y\H0O;B+<+3NV)OI?ZA0KZR6DW40\E!U:["AY"7_>6Q.F[+
MOX' H'1]1!7VN5;(#/-G0L92 -T@K7:0G8[OVGM=*F[IL&!17"M0T>R>:=[\
MS/%*U:Z%^=">R_+D7FVM,W&GEM>K&/T9?GL?[>?=^G?XY,*Z2681^KOC[2.*
M'CZ2_X.A3-/2^Q.!MR<U2IX("$V&ZCW\PRH8Q2:/V#W_ZE/JVLS'AZ6.DW%7
MSU^>W+ENE]Y^HWWPO!LIG%MG L_JI8#N&=WKDGA2G^_4,:7AUS%KNB>&=*J@
MA&;.R7S]%ZS34!_N;7#'%&X2DNG]>XZXT_0G)&"?PUL2U![#_U/.^3*"_ZU4
M= A9I)@?0GY5'$*D,51G)T^FG AI0,_7H=1P(:]NX(,:=C)_)J%=Q%"Z#?OB
M?7)(6*QWJ)+_I<U;[H:XQ@PG$_&>=R%GU17)JD,=:5^XGP()L1;3/Y7SQM:T
M_#W>CR+K]GNS"N9&DY]Z:_K*6M)\&C-]9<I&[_L=! M^:1W+6,[YN!0[.FP5
M%)MIEDN%'_C==;A*H3N:;!U"KJ9I188+PIGXGIA3F'&?MAOK&#!_=>###4G:
M'N:)1*<"(^-4=67040U7^XH?0LBA%6ZA^C6T5%?6L5PX51_.C'.8U(<VA<(&
MF'#=@\MHPH6CM1J6=36G.QN5;EN'_PGS]7@YE1(Z@]]5-94KKL,YO6ZV#<07
MF0]4^/F@JX^DTE&>3([RU)]WE"?KY07!+B6&)'@26.B7%$0I(:\#V"-7OIC&
M<G]RIP#^@';J-<?MEPY.U35OBV?U9XB5ZVTX4IS92,BSDX7T!Q/*U"=5I&R/
M5X\.(9>A5&>[X -<-??/=1WL4WW_@R#S[+7]/S*".3G-'P<N>$WN[F[^46^!
MOW6[O>GYFI> (+RS[M;B2K4> 3 \I\<]K;2RRL>JC:M(G%VI,AIWJN3+^BV*
M[OO?2RMH7'"T)SGV5=TZ<N1Z1=/#(15CS^<?V=Q1KM8>]1MX)9OEHZ_>^O9)
MR2/,TR=^*:WL0_V]%R8^!EZY[A*M5IQGW\1G)=X!Z/ZY#I&T'( <^YD!V332
M'A:*/L<9?>6_LW:0:%=AT1?W=" 0R,.)YPF>!%/1I#K9Q^Q2@V_&.ZH^Z%%Y
M(:/MVO?*V%FEI'8UM_\US:<,4Y74;<-,%3J)GQVR?I84+3^-DJI\ZF>O]&0)
M#U?"S&+ \RK0)MA F) 44[R/'@&P>:PL?J5^*=?G>#(PK\A]#)[;L<WDHHXR
MS\./4N&,?A1E0OHUU:2*T.V/'$A#7? -&S-S+07#%R?C@17"'^2#">3]BJU8
MXAV T'4N=\L$WSJA?'%L<Q/GIVD>GKN\//F#X4N_S)R5E(0^7A! # TL0&J9
M$MZ%5VDK<0Q#@$[(W4M'G47J@R6AH8L804<C3_(6IX,)C>76U$;(-X6^:T%*
M'_!<)56J:S8&[B5?B2<:C&1K*ND(U B U*1-]? D[M?V!L1 >9ARJX-%#(=1
MO$?M<TF.KI-S#.N1QX6F1<! NIXWL- 3R8-!FB_&9N"QB]5F?;82?.W>_N:[
M:3I$19/;-J4B(7S+RR7:L%M5LY;-UA_PR^[R?%GKT-#^J@LGPS9;(_RI'K4?
M"IUKB".2*9/HAH$^'E!N@<'?0.'IP3S'LU-2>@\A@/56?!C\&%/Q-Y-W;!%\
M%P#XDE=>X+V@O X(R]Y^*]&A K5NVQG_5Z3!D&K!F^:J7VY?M*KH+N-X)EF_
M#Z.B 5=28BK:+6!&:O?YP7,JW@.6(EE_"'FN#H\.FS< N<B8> DAT)$>=928
M:QI4EKYYKN^,&Y)I?IF]N>@TIBS(0H:F5NU@V!@WP$0_BM\3\/TZ@7=M/YH/
M1-M/%#.\ "P53HOKAC; "9AIE=X&\!0T%B[0X4H*>&&@,Q+ %$6H6='\&R@J
MIPRC!&-#Z3")>>]ZQ(!)*U#2551A_[MN5:0S'O?Z0V7Y;!47_\$7Z#OD@X,N
MO!=/2A-4Z.*4GP$/:&MS\/X\,)%#92<3$R39D%+ ;!]<M!'+[KMOFZ)>P#,P
MY2+2W#CV:U09:?T? DV85ZP'/N20/M"V7C3Z*;B ,="D4(7;-9+HZI$HZ9I.
M*O]LVX[Y:A2UNJE-%>%3OGIIR(6J(+W1U.;H%V5KZX&^B>7NXF0.AZ,!FP!0
M1C(^X!#B#IM&K9 2J7R'D!,EH!5-C2S9@V"*K@8B-+IDC]IY_5X_/$6'2."2
MZO5%RT^#_=M],]<PP=X4<3\]LXJ+#CFFFY[-R8A#R!5&$!EV_/^/,%2_0;]#
MI.LPO\&YF%>8W[" I63" DO',3+V^2'D5(<&*2*4&#<//2C4"Z8I'T(^'4($
MS4=];;&BU55ZKHL%NE9Q#F #FL)S#EY35&WO.]-5Z5?6^?'?D,71W#6H'Y&P
M?F(<NE$_H0CPF27O;6P#ED.[$: 2.0\]O;"X$<8\!9J6(IY9 0EYI&<!/%AV
M+(]/HAF0C:M&^)J.[Q3H'$)L/X[L1%F.<OPR*U<C\:)^'$*$WAT4Z%G1+W6[
M AD\T4PUL,^=1G$&_)J[,8DT)S,:S*2N8Z01S>?-E#$71IH6&WU A%M/Z*F4
MK.KX5_H5VR,"'HRKOZG*F-\EP2]-)6[Q%^^$U3O^IN_@<-3:\(9W!CY^3VL<
M@WUV3#7<-]>WJ4NE?]-H*Y]R8=36_VU=.5J9*>H;_)P>*[#B $"3T(L9Z ;!
M@?4%=I!G<:]7DAW12Q9,84J@!M%"3'GPV6)A"IF'R]N CZ8(YSF*/)[=VX"_
M#K0M0E1>!P@VN9FK\Q*)U]MSY_>G_G=\BD[S1@P]:AW?(+<10$;'%>I^[U)9
MEVSV[(:=!%-V2P';C0- <-<VX 1J&"O8<<-[$2:)(D+/A!Q]5EM-98EO;D)Y
MU6"X-Q#@0@N+[I("\"^V6!/-#Y;S?&730O_A:9K,TQ?HM@QK,!,0I2A74@(X
M$+IDXD8["9Z(X@)Y:1PD>&\ "_(RS21&3Q)(ODQEBH(PBT[ /ZG4L/SWO$!C
M:^O'CV,:90&/VT>76\<TCI5Y_QGRFCER'W*,<P.[]0<U.#B/+_2LGA&PU9U;
M$T_IA)+GAHL UJ/8X*>WK&@Y_=6RU\Q5*#""N2?))?&=[Q$%%!0I3OF1CF@T
MEDECR,F^JS G/=/GQ158FN7M?U-"4R<\.9IQ.VWMJ]75[B,7]>,?3.*'#V;2
M[)OE)!N6:]TVQR9<5NJ0R(/_-AH]#UK0'OK/=KE <7?RUG.\V"9N*T[B(C#0
MJ\(..A*P=0GQ@ *Y^A 2KV=&XCEW0S!&0]^58M*+%5[E^0]4Z9^1'$#S@@E*
M<,*> $I^4D7#V=$F5[1V%I;\OV#VXT%MOETE4(.&7<1OK-!@I-J4CI-T0:_]
MO>>,^X *J4I ) NE?Y#.%%L/'UT;0< - 8HO#0R_WYC$8'\'O@J%LR-D"6E2
MO?,B#:,NNG),%-H'!LH+4A/IC\%K].X%D0Y3X(M=AS5/ A^9F(J28'"#]P$\
MV9-Z,GCQG2#CHD/B #$)Q0;TOZ;P))OT;M_PB_BPFCM<TR6>:(UKG)B]I8.K
M[OSID(T&K-&S-Z&I4,@AQ(N=80L,[U$T-T86B3P(!1*,8+80?0AA+:&="$(8
M]NS.LP*)2<SS"YIQ60Q+6NWS#EY/P00]-7*MI&G5VKY =CW:XUM >+#^>(U=
M[KW.K:%O'^HBNS#9MF,V?YU#GSQ]IWT)'XQ]W3?77NDRZJ _:JJ4G:N$B<20
MLA/I1Q#NOLI*Q0.'D!XH-\.6AB4W,\X5D6TWIH,H4'&D+F#;!^5!"H&^0"\I
M%[%]"Q"(6\2\$.%)0@H7([#DKN8*'X?:%[B\ X$5APZ )_ZO"H>7FK>.TLJ+
M,;L#?<#D$WJ:CRFB0CJ$],WR3*,79383Z8_0W<<,])@_7?0/L!I$=HV%& -N
MYL@1C<-H+F,VM)Q/:1=%_^:0).,[0LGPQ%$PL^=:I'<K'KC<.<D3LZ,O<EO]
M<@AF!4_:H^)I[:3Y1%KMI]TF].D.1R!N]SG-"(\YLN!L8 S0T&L@"TJ%TC@L
MVG-73,!XDN3Q)W7-H#?%C\O?7YVJ28#SJ# T4?,2A0&<:SQ1I*8H];\27/^[
M H(Y@3H)XBGH= =8,H.W'$$?@)]4.81XK"_3;'O0B2Z7@9P$O.?Z%H<C0@ 6
M!^=FL%8A4'!6A@X8Q1I3?1$(RWL'JIB,OFL$-IJSP]*A.(W+M>Z40*KCJ\IR
MXT&_4.F\"06?!9<FAWI4M>W<P5*K6UXD??"+4N7,VI=K!Y:F*D<(\*8:?EIH
ME&2<-=MU.*C:,CC&),)/&:@B/'<7P6FZE&D%DRAYNA']W &>UL6%\%T4[,$G
MSY^-(Y_*?#=TA9:8PM EP\_Z-(5):$Q^:*=I[+Y656Z(JEP8#'H6#'Y_9Z?@
MEI^:H'AJ":I:M_1Q^%J#JT)&&*.EMG2G=F:(PMU.5_5"UW.M,,X+0!OF8VCA
MUN!L\6\=6 _ZY._]^3R:B<N(DIY&+0*'#'8O,2&O!@1T*'F7@I%;YIEV>1:9
M-T<;*V$?7VPHY4)SV.ZQG\@8#LM@4[TL?#;ZDVH.\<T-,4]A\L?"BWQ!OUS6
MDE.6?\_M.'1:CJ$VMX(_O-8VQ+XMC3"XE5>?EKW7U#RU7Z=]C1APMD]L]=G*
M7<]PK[ZB[A=I+0D:</4[5;)J:G4WJX7NGIDX2#JJY(\V\B@>YEAN#(L:PQTH
M^1"4 W4%Q+-F687$YO/%8@.G9P)Y:'.Q%E?S(:>.L;(:%"YZ-K&6H%WA@._/
M&"8W:LRF^]<IE=0N_I:'UF'H8H2H>=K-*QZ>X7;LF4\KXF^,O(D+R>*W&<_?
MXB^:4:8S"KMLUCR3F))'8N32(<3%9)>/U!+;E38 D\9^&ACX)^:)N4,/[Z4=
M>\+CY'AI@/XS_>IWU_6=VE0]70E1D[G/LLK/\M\<0 T*Z%,S.GR:TRTG6(X?
MB\E_"?FD]U<1?2%S==5J.I)9]J=B\PB<AY!K87>B"57:(99/%Z@9;$+2T:=N
MKN0#)OPOHV,'4YO?OGP6HC!;J),??75!O6'>I?<JKBGA<G[%2VE%X90SO.Q.
M+^WS*7$MBSE&G+"OX?@FP8V)D@4?G;!W=",&Y]B._K7]+8MQQ0"]T-(;X:YH
MUV"9:NKK7^;;1D'>H><^.O4/7!T2K05B7#X(LJ0-W"F^HJ7H?RWDM?:#= [6
MY/[AW$KY5W'EG#*GMY\'6-AFO<\PU[>F;D\WGW$3/G$)ID]4?9*A5?ZE4,"^
MWS=G*9 PS+M2+L+W]6K+;>O76HU+0D-O@XVD9VWW0T<&(1_%S@;:!2(DWDJQ
MUHKME;TYUW][YLJ-U;1B,4TA8>J&ON]2_T$#U,,XX)\V.EH*$K4@N3K/$)]>
M/8 ]>0"CNS&_?FOAF7%=E&#KAY(>>A> FSRHE5*'C8A32/RR40'^+E;CX.E?
M1"4!QE/X,[S[2-/^JB01F:C_X^BJXYKZWO\4%*4FTCD4%"6EFZE(B8!TRD0$
M!$0:!LQ-ND$:J>D'D.X4D-&(I'0(;*.D-V(,&..W[^^_^[KW]3KGW.<\SSM>
MNWL.2 .:KY=M/5;U_DZR@N,7PV]^[Z^(2O5+7?_=R)HE>RU5&O"$UCO):^EA
M84/3X>_YO]>>I3W[&ZF=?O_!;W^6E)R:UW-"GP)A'8CWB+G"I\'GSTE7^9,Y
M@*#-A*L>^II7!A8Z"0I]#(__][B@1N1<EW1EK>F:FM)$Q",/FA<28XSM!9.7
M@-<;%)[N8@QHNKA99PWG#!(AWV4'N)-_>MA? EKK(BX!-L?@CK,TGUB652UF
M@&>]@>3YM\>C^S0\?OQKB8:]%J%ZM8T!!2$BV@4_F*+G_".R!Z\)W%:^/5HK
M=X<*]#/A\2JLY!+ D'@NQQ-Z_@)V];&V,@KSVD)"08#WBG+S<2?GRGTDY7GL
MN1S.8%<61QT:MX)ES ,,[/X"%\U,UP5<AQ_9@'-%_ 8.'9>7,][?PX(B+Z#[
M(2OKQ+J(Y<'%T;>7 ."78WOG:7>1MO6;!1[R,O'B^M()ZG>/%/@EJ*B\Z=U\
MS,S,.F(=ZB.'3PN@G5II^ 9;+=JW ;<<6 N<-8<7S%1VP<+_:T3BO'^N1[JV
MHG )B TOPN>\]=WLZ!@]0+LO  GOYB7/]6'7?G7270+H:/0X5 &_0%U &A5[
MQ4)RU<8EX.C.*!@WG'4).&P#8^\0*?NKL7$-?-Y"]+X$(".G;EO,#0L,2ENW
M)=]^]?>'HPI]4BL5/^"C7T+'%5J+N5Z!AA\-X85T/+7\#DX+N:V-#_UH@;1>
M0 &AF%.*H7\O,5>0@YSW1U_A?[W1WRC^F'.M^KKT"-#SJ#B;T'61U7D-[#SZ
M*2QM8&%E5]GEP&OA^89 <,H WQ<T#(RL.!#=12QRRUX"-CPN =@['C2V2NB&
M_X_=6E[=]D<SK'RHP<1N;H&N=N6+%*7/#GE[ZH+E"O?LS3I>>CP6]8L9/)A]
M'2&@L)QRNKLEN=GL!/!9-?]-<7^SH#H[P?^M2H0YCD*R047V(09/$@H3O&=P
MWY&4A"(X7P+R<X@T2 .B_HYRX&KXV=HGU>%[GYWVWT>J7 *ZY=PN 2,K%L3_
M=>,3;N+%62^379:X]N<V!L@T4_3>'4Z"DM0\]L$[)H=)"0$;,2^J00%1G"/:
MH ?'OU97BJE31J0A8EKG$/(P6&Y_WAT-$N0!\FQ6' O=#I'N;^+QD=DGNH[.
M9:R+G>N3:/8;$!BEB4^"&]QP1Y$1FD5^WP^*5+^D5RLIP1'S#9!S'9=.N01\
M\=ZD.?3<+T3TJ%-DB0%QI%G\[X BHJ)-^MVAMR6*:/MAN&]I*Z75RMITK^42
MP)234)T 7AQY<@EHC]PFDN;PM')RN 3PREJ"]VRRVH_1@RH(+C)!A17OJM&*
M!W97@:#J6,9@AZ#[2;[E4&634/.)W0:+"K?]>Q-./X+S!%L3YM>GL=K^=<(V
M^;B$FJ)DV&/J)XR/Q<4] JF0DL$CJC_ZUR#@3,.*)]@'YOG60-O4'\)_>HS*
MGC8H%O?A<X4G-TU#S:WT<ZS-DMNL4L[:FKA#AZJ;8=T2O1C/61Z'!V9=*X\L
M<M0D&*(*'ZI9I7IR6,W&J5K(<VIEY;I$/Y>*^^' J0%U*T7T@HMWJ6*WUUX<
M,ZP5O_&<36[>T]39J%JY!.P>4[N?*\+'/6I,M(@B>&?.[-1K;>REL*&K-7,3
M"F8*&Q\40-6-H , :NFG+W>;O:H51_2(\MN-,= ON 9\J0PYMT!(8^B A"RS
M!0(4*58?9#VP4B3Y\-?NB*9.E5*9/HL\<7-PC5M^ [X4E+<(BC&H1YB2M4Z;
M%BX!9;&?EUM?WABY<>4QYI/ 3)'BZ'C?I/#.6U.'A5KIW/$]05@S]:T"N8NA
M9HX^G=XG5X9NW0:>97:(3-9H=*C2*/2I1@1F?>FQ>T/'\F>D]!+@ZNP0/ZW#
MI</%3*W#XT[M>KW';?1.NL?L:VXARF21YYT2?HL3EX"!RIGUZ-NW?Q7HW%A@
M.4@>=\C4:(C)C>E0OJK2EB,I)"J9%><]>DI23=S6^<SY+.%?LP-]<,+88\'/
MC%>3K]9)TS-^N9_S[TV6=I[V(+]]9F(N2QPCIY&I(%^ V2K3*'\,?9;SW,*J
MNL0]>!R0.H<G\*,RN8%3Y34C2J)1IX\&WDS5A+K^W?[3F@$_8PYZ%7],* [\
M[/VWT>"Q/U6R:BUTUUH= P$/K58(!?DLK.X@-ZJLWT4=R#>+#K9^&%.@CJ,:
MV'I"34^5TK&1)*[=:73=>Z>Y4R5$*=")@P?_2ZQ+[@;MU6+3.P %HWZ)X,';
MPX?R0UJ<O%?Q]<S]^EH<H]]I>.&? FGG\_8GCGF!,1 ,Y.SEF &',D5E8 59
M.5;N-+%15RO[A6S0_JC08[>9)LF6;[;SXY;JRHC^K\8_&.T_GZEGH#A^S6F9
MLF9./I%AL/&$N)A$A=#3&/R@FPISOF9Y<@V JV]OS_I!_:D3@X.S:N_4SQ06
MB__R-M^P2]UGD906%"ZGN]5\Y>I:G?5_(1;I\_[73D-J\\JU^!,-^]3E'C&*
MZ^@H#&@:)GNFODW-?S @,_G?A%&L7HG&]RPWF0GGH\4RF7E/%T//#V(Z+CEO
MLU+?9NGI/!>3R7(NF)EL C>Q[Q;<K;=&+*@3&G(:VK?+ L#OP+&X?GL/01^V
MZ1VRU&<;#=Z6QX,/Z$+6.)I-[Z; %U"-0;7[%]67 )?U)UR?:N%CRVRO!J/(
M7MSDV^7"G/#77R5-T:U,A["!-("?PDO&O[RMT3:\^<)>EA^]^[Q?=/Q.^AO'
MU'\M:H6CH_/H;(:=8&OIJM(D[M8D]/#U(Z_6AL:SRMQ]A$!@0/IK[/),W8U2
M]W1A!=);(RM"[W&3Z_L+M?1+0,3L13U0C()[DY8".? Q"-MC]!F%O2U'L5=8
MF>'SX$;=M6Q"\T4Q9UVR]<I^K]]BLG)3S$&0DT *1%[[^E[!:T92LJ[GLBJ@
MO^&^JO<_+VV"(L_K,]RCCYO]#W^O[ARTE51(P/(?I$T=3W]_I=A:H;HI/S<_
M\.80]J=Q)<O1AU"7X)!5HNSS@3/U;M7%;-F'"7_4G\1S1_AL1;K[_" AQ['_
M7KLJS$0P>"(%^Q\49!5*YF8GH#PC+\H0SIJC@O+]D.@-U9LC^\QR!KSG*^/M
M ;/MN="M(+(LT$OI==+R5T%& UO)$9<EW635@_>%9ZNG%/NCS'OTY^1Q7=RB
M6XXC_FBX+O(2\/-9(#*A79'TGHAT</\.TR<.XXVQFMFN#W[43\ "\* ^/HF:
MAAR&,AFS//ZIJMVOF>*/LY8X5N<]<SQ@O?IC)J_+6.T^WT3_^*7 <3[' ?C,
M_?74A2%_S&^%BN<M C(6:/)/S52M5"V7YJ ?9/RJ_MW+[J<L%#"5XPKC*>)2
M>*_*(QJPGG/OH:BJDDQ]K-L#HY 48N5"RDJ5;?O]#Y4"3-$]TS,GLSD:[U^<
M6M4ERMVM<&E,;EE/<VXN*DPVU#X_D-L5."]*R8._]Y!<\)_Y9]/\:N-W?&Y7
MB=\(<]K@W=4/0I_IZ+T,WH_C.&ZW-G<.K.3LDC)73S;'/TL\]?Q,\^%)/S]?
M]Z1]WD?76C#MT25 ^LXC!'!C(:]9887J$Y :;?RI_W7[8++"GM=UG3W/T6U=
M#6>]K1D?Y&(^:>SZE2UI[1O\I%^M3W/CM/WH.^%/0AC_KM5J 9(61 Q/(#]/
M3%+ZQG7] <=[\O0G''=;^,<#CVLA09> 3QIZ&66DR(2*8W)(QL1LZ.DM1*$,
M4\JO[>V=AU-2Q,+M,P%Y,B1954;<\ H9^ZBS_Z4F</LLT#'?8=YSY,:*XNIA
M#FCP0.U834T[.V='0RUSWN!P7QMC 0@"]MPR,(!K&=B8QP6]_-_!S>1 7SJS
M8/&OKBD>8CVQZ]EFSW+X^6LT8?P*U P]#+U>6DO7UA9[+R9GO$<]/07'V]H=
M_NZK]$C>L5P<6"*!,EDY!&@EA[W* 7^O SEI%%<4!,96P$4OQDM#'J\R%'WK
M?PK@ZWB+4UBO24O]6U[ET-(^\V^X<O=#1GM7K9VNN*:4]AL#*D6.S9S@L3,R
MN!2$TX+<@O\N.7^]B:!#N"Z'M5\GQN-.",&X]CJ<4W>>(+ZB=%&"XI3XB.TW
M*;O!N)VE-5]IKEO=BE<Y,4#/DM2][7U+H>:64S#ERG]-@3;3$\/>I^^NF].T
M>R^4R(X3:;KXA/ ;B20&-(3JB>IHO(K#B@$MT;K+<.$%X9!2W(95V]-6[I%K
MNIG^!B[3\^73&6"7\&>-_TG[E'>Q4@V.X.KQ4!XX(S0K4\FW>LI.U$$XN4A%
M."3--"I>N_X2X"LLF1V_JU#291:7K>2U574M$UTC@QOKTX\03DFX76"JC<TI
M*%%1CJO7+RU%%Y5_$[K9JRB(W&7O," *7@(22,J7@&OA?U#V")[-LX0&W"AZ
M/U:4K 1-[#-/3^FTQX[.+7?+F^4]Q-F6>2M;B]4N03=>DCN(B&(-^C<**@;R
M46+VGQF$ RAR[SD*70#"&1A$H)I0NYXKR'D&,/H[JAK9'2]@^(>DC#%@(-YL
MLT9;QQMT!X+#?:9B=ER;L@QZ])3H+MQ-\*S+4;*QYQF?M)'OFR:^)VO7KU*A
MW=G)<\M\"'2>+?5%$]AQ/\$*&'5\"2 ^V.\?'*5_@G6?_^X>,V_0L^V)2^G)
M$ILT(Z1;909]A'2U1(1CW Q,FG&V&?:9:C/8;3=_XXDC\(Z8B'[STD6E&AT4
MU(W$:2"(]]D394?#6KB>.%,$$.T6B!.F@P$Q$.V[4;<;$JFA<VIWMKC\TOQ7
M[H\A7V:=VXP7Q/#R[;]*)G>-7QSYY]V\^Q"2:M;O5#<,]0>9*T:PY3D?JW'^
MEOSA2]_*J:5DZO7[1[L]$E/=O'6T9GTSMBKL6TA'7TP\5,,L)SE>W_0LGH=/
ME[XIRH.E%EG>U@(=N3^,LTRS\6-LU%&RC.<IDOCEJ9##RY737"[+8VKC*,74
MIKBFS_:!9W2UBOB AG0[R.@B#$X#$R?N41Q". JD(H:W[R]#)](CNG[\<;>K
M:6E$,+@N";HS;\(%U?BGZS_Z:YC\88@=+%#!R2[N&,FN9M*"I=382%)X5!\R
M6HV:J(5;T%3CQU\">E L_Y88<?!H0MDK55D&A$V+M:Z(<]5^8<CX[UL;P\T_
MFK_8Q_Q502I>$=E'$!]N[(YBJA:TL.;=#/+H_7!?9,1R':A#(IP,^E^?'TQ"
MG4/1IKG2#3=Y W>6+?GY#TD?BS<-MX!BWY&86,7RO3U3$ACS4_S?\Q07>4.)
M=7)*^58>SY3/,M._K,*ER$IBD/'$\2*S[41E8<VDC*J]1ENBT7B#FQIY$9LU
M<O@"%<*]X)IY+\9"*$91P-?!#/0-1ZH[^W*?ZWN F>1(#0M>UD8$<_KJQDQ9
M]+=THUY,=5TJO.:I1U>; ZUT?<T'G^+A<R7CC(V<)SS)>0&VG'HTHM_#W\L"
M79^7;RGMA8NJPL:_LS.;/?+L-@_#B]RT;5 6%;1[V&M2-0#:=>JFP,$EX&W5
M+(KP'$F^V>N[4C6+P%9%%\WLMFF=NSF#ZR-W[V%1G_2J2-:M$VWWL&[",]WQ
MZ$O 56)H3Q8JLIY;VV>8VR &>Z+C=G]0,T3L.7/95E8?TO6 2!2Z!%!C?U',
MJ@#EPGE4<93$DD*(5E2U.,3MQ_=D. R\M @_]1!!7>1< MXE\A'ST<#.Q%M:
M>'="T>3U,MQ*UXF\4L*W\V>(SKL^YXOJQDI>&F7+-O.P5[CAT5YMO;T*WJ,:
MB1[=V"H.7;ZYX];!P;GOF1=.N#(K8C3>V@QO%@GJWY\W[S1^!V)L<U@)<K-=
MP4)(MUVQ:6TG2URUC5F#SW_@^CM1860)/,SOY'!1*+N45V[Y1;W&N>SBQ<]%
M<FH*F3UZV/,'#'\L^>7['=,(X9\VO]LDO8NXFDO,"*;;\ UVT-M"HULA8=5)
MN0^$35ST"[7E+@$>W])>>VY?XV&C8=A1*]-4A+-B_LVDB=[-WWUG;&2A1%Y(
MS]D0NF?89^0KM+?T 9P!YFF3I@1HC:B!R^Y;9A*[!#@D$N\E]KBB&#>OZX*O
MP_[73",8%HB']%2\V3!L#M5MS.A2X_Z),\MVK8!L)L):)JQT Y-T[.V]'][6
M8@XF=9765HXO( 65C_[V[\O;%/LI!X^@E3]_1?[S)LP2U_!TA&3*B +D7R .
MLOC6&22F_1XQEM""__G]!W803$\T[Y:&S/\S0[$?O6*;VB$]S/\W[R66]\7!
M]0.]7\QA_8.)^LK@LM-UPW0JSM-'+)Y)]?9C.2E_5_-69[;_WBY#.#G&LENU
M"W"J*PW5QNF6Q:8_-"Y+TS/,ZC*L^+7]5+_BHBS_J;6LF=CW2X#@RKV(HOC!
MM;"BY^EL 6:668;QP@HVRB^'[:SJ[\27A1GYE-Y[2AZ1W9[X<VB4.Y%X+$()
M5&TH>F/W&FZTRY89[T1BRL",]@!I26 B,]ZR$N'*O0S<:ME%]H%C43=40 &E
MF[:W6UM2*.0W]Y+8A 5'&?5W&[CSM7H76T"VF'X6AA^5L@91P BX<PGXZBH-
M!1-,_]?&(1%)K\8&C25\QB%WU@JARH2&\VL;P?6(,!1G^_TYYW89O%9W4*Z?
M._!^)%L#QEDF\191WJB1JW8[*^1)$(^2SN3\A$&&,?DF<@4<1:DP,#K-EH>(
MQ" X7?/HB!]Q7Q#H@G85XK?2S?GL60O9XZHNY5TA])'_8_$/#0IJ#UU:Q"LP
M42\'O!EKWHG_IU,8H@#9 LU+R1#SS^] @_K #>R[EECWT.4K,/N5T5EF[&@P
M7!GJU,.N=F_FR)VH<0EP?*5L18RG"6T ,OP=1: 1W-!!;'HNUMBI2C67A"=V
M&X6^?"5B_ -57P-.6Y'>(JJ)])M^@]H]V,C<^1Y.:YEXRY'5UL& P:R!LUO\
M6[QGSPIS3%];7FJ),"XT7S<Y0PKR'5W[W&*)K=.X0DCE%2R%)MLTUZ:5O\.H
M)&.JQRC?ZO:0"(:E.E-F[5@CVZS(T"A-PPQV;,/] PNA\%5LFRQF=+:* *B[
MR-LG>9Y?(4GC]9"]EX %]A7>IIZJJQ0XW^B[!"0N"?ZI@JGZ8WGEQ@ED=UZA
M;L35D6G_L\B(<55V2SQCBFL^T5MCTK*-U3Z@'"&*Q!DNSQKW0:II=A]B@6&!
M=8NN2$:8.N],')F:2'B7\1M?U"UR878PJ!.SA^7 -E#L?5/7P>-V/KQ;6NDU
M7:);@[)%7TK9YCCJB.9<"SX(;O FCT%J)7;ESZ7)?34PZ$5./21D_GY2*7GD
M?PWW^*$QW;WF+<",8I7 _ET!^1[W:+]YN3)\=D\>-][5U2SK9QO?'<HDYJ;U
M#?7$X (7J_8DK@$BQ;1?<R5ZXI =8-9VGE[<(#:R)]JA 6>Z''J\/P?";D3M
MM3FO),Y^JZ=;G\HG*@-CW(Y?^7>GP,!!B<Q+?Z'R.A/'N4^U1>=?/16#&$YD
M]4:V=BJ."+<[?"HT5NET]*DY];,SYX[L,B(T9RFF>F8.Z3T_K5"RS)-G35W9
ML"Q]WJ@6\MO5;H6>D9M918]+OVD4_]T@XENZ_;;6_=ZUJ6K."(@!#835B&(A
M7K1 1=GX<GG*MCD_,#C.WC V0M9T3B4X:+;FJ?U4R@S<'3^E(D@2$_-)W!?Y
M*G3XR!Y476[BKB&%/YFVR KXY2X]8RW4=+US&ZO=VS/'5NSNAW$&L.GXW3I<
MG%66B^1?Z.B+GS@3JXQ9+%ZLN $A!5Y0!?=#<,]  /CD,AU< *9$] 3VNL\M
M$&:(QBL&-"1GHBZV@MUX\A@X:VZ"-X\2]7E'\L84]^7[D1E105\:E!FL=>N;
M\&Q5:"#0"LD'NX<O#]0[SH@\EOAE,"M/V">64>"#HK[ZO?&ZF/8TS"CKNSS1
M/Q4JG'B##K4'$^_7&_#+GS3+W$J7_K'!^8.<CR%TRS^'Z%1SC[\@=9)W[2!,
M_UKV4I/GS(^ E(&ZB5_.%4G/*%#:#A_+4[U(A],18]$2P2H:YRROMO+X<< 8
MF4T9SJ_$_#*2%O%)%;&/W-VYRFUPXYWG%E>.E8J29I+ NXP9)=69J/HHF5:Q
M-V)J0$@L7K9::EB2F'/?B?XZ>V3I]-G(J^SR^R".DND.+:;@H>JI>\=QC (W
MH_HQ=3SY[*&%4>G"/MMV-3;- 9JI;97 [O'^?I$.C.<7GYK9//XB';LZ^D)L
M#8>\68(JIF;NP_U4>%5\-_8?6E+Q@VM$[W1W-QU7?0V')IXI32,2EX]&=1L$
M@W'ZHT3QF8[E4"1K.5P")O('?@=JH(,SZ+WB5&S@[%VXZ)S'=;L3$6!7^%M%
M(P ]( Y1Q[/'P'CM2IQM[R)U6J955,0QJ(;ZR,-(,NU##'!6F0"Y2"=?@?\"
M 63V;\#'D/4V7.D9^+(5K=W\KP/>8F'F?**XWK8B3%.X;*M.!7K*1U6__USX
M$J"'^U!^/[:C'50=:]A>WT@,Q;IYZ0F<'&U? G >?!M,T&SRS49^QB[^Y?FY
M@Q.IOF1JC_#,!^94N2.[OP#FE%RR>66PLKM!8F8FV"42D*U$SP#\,,)Y(0 6
M(-\%5H"I)*^0F0QBEV>1N(0OWN+LW47:U@=R_VT-^-C3LNK!\M1[3 M[+%^)
MZCMDK&"R-ZHIA:2/4#%UMF=[7.VSO:[@F[2V54B+F)N->U'\M.6;<//6AY>I
M)24@ZUR/Q0>KG(4OU"!?7ML:)XWD"#O^X'E4;\;IY,HJS F_LV%QJEFAD? M
M(MYYC%#*P54I'5.,1=PMN%4+^U4@ !L.-U6^,2@I_/23KJ26<=R>'6<@.0O\
M5N+3): &V2\QUX2!]"@@T-G(NO[H_57<CAH[7CY6C8(VG69B:O30HCXU&9R1
M1 3,'GM>%:%4%%$IKG+'&5O%M#F?WE2PZ2PS[6SG?[,^;?>%Z/+P<BCIZ=(M
M?&08R;9%+APKA$/&J*AB__=OXQ@9PI2*9"4J\MA:U=+'@&FS1-  \75K]YW,
MHFV7XK?D@ZYU5X<\D/RPP58H08?8"'8!SW5CA78A>!JT.XG)F^!(M,8=8EU@
M4I,-^]&@&D3T\;#<*R,]<#?[9QOQ&CM\D%[,B.(>R:Y@T\]OZ=7?OCV3M(($
M1B2BGV/(#$@5DG;/*EP^-E\?^ILS3X!FV*SQ?B40&'KVG:M DJ/D#02E8[?@
ML^O\U(;TARA^HQ.#)_ZU$5%1=4GIF*G$9<95)HC+X)K?WU,QDV"K,=T<!882
MQ/J8T^\4#P_^=>XM.G/##1)@Q"OYB$Y5U+NJ\$#(CAV.JGL9V&:*5WX\35+'
MR>M22CMLDT\*1Y,@J^PZ&@D$1ODNSW]]%PWLRM4?J/^H!H4)$*3F8_\UFNW\
M:A?QAGQ9O@5V=)^-Q;@'JSCC17K!.%WWN="7N/WN?=KM)3G\M8RP2P"Z5DY-
M$"^[%X^ID-JVG'0C*6(N)+KTBK<#APB-!^)?"N8T3S).&%C8R&^KFB\FOJ*B
M7E]\@>E@D3=A+RD+D@+O1&.M#RN(BVV@<RX89%*-UB4P/=;_/6J!3PFW$0E7
M_?N/(J?_[,/ 13)91=$RF043V1H33EF^UJ[^(#Z8+QX53F:#_R*K7E2WLQ"I
MR#>2SK6)[)C^V#9E=+R51 0EQ21BCO[MPPRQ#*Y/ZU[=5_4ZQQZO582O9SM7
M;)Y-31I;C3@U/JJ7?C9:@[C_NT[4J\\LIA=;UN;HJ9]5I"4Y\FCB;&A*V,2+
M9/K>5.4^"!C=6_JRNW^;N?S;PW-SK@1)W>/W$P\HFN^_M?#.<8L7I=\%Y@W$
M?GM*^K!P563:.=MM1%=!Z,+"<@.".(R\5E^VK#M? @0F!MU4)OY:/?ML9>#K
M*5M/IZ2WNJ"GDJQQY3.+5#:TK9E^_9&#@Z/?^]*JS4L B=D=>PG8^8*;WL8:
M!",^(.:R%K!:.POGFC90;XQCQ;F&^G^N8MC13VI"$VI_RF=MH-*]-U*<YY_5
M-NQ&-& -,:&N*X-Z<M,SIK>(V4]JD=WLRS=)GL3Z95ZX,+$;.XD"DCE(HBE]
M&8&^FSA@)XJ^*4R-"XHX!S\;/Y($AI-DSB**S]ZRNQ96?@L"$>+W?'4'Y^BC
MZC0CC^K(-S$4 <")0W961:I)7<2!725"<>0Q<(U\SW>\1%1#U8UW<):)8W"4
M&C7>9OY]2_Q,+$Q6\"I%<9A'./ML.W^H<IPL)SU!!XBYD=0Q%5Z_Q_M.GD]2
MW'-A7(2NI5''FZV9<"7OJM"NE7209.&-!T$6:\2SY+,\(5!D3D"Q<>KFR[[I
M?*-<YZY<S66L)7 2W+@I/!?!%7_S=X6*FC3K)P*1MC:E^-\@*,,PIM?ND>S7
M4Y?)U5S8/>&CK?&PK2?/S@X)OI0L=*- S1VXTBA^OZN=YZ+X$N"*C+6]<X&,
M[ 5R$%=Z(/2PA^A=H8YAG'476;QMHDUYA5?:=$:%M7CS;&>&C^>=>*73N.R<
M$/ZI<V#$S_Q_Z5R(LVN)_T"[3>X48DTG;IPSD#OYY"Z^MDO#_[0S$>]@>,&]
M_^]4G1#QMNRXZ[$%)!UBOAMF45H;AXAY@U^/E0C>/Z8K\UBBJIG2_^&*8>!^
MT3Q9(.^Y6'"VZH%BQC&3;T[@W3$TI-N#V/UN1/@9[WXPI4SVB0]HXLB<FVIB
MH=:M>NX61(US56@9EBW;P0Z#N.TZ-KMY?1U" ^.9@AE@@7Q;#QW>'[BT\\^(
MBKTW(BRQ@EY1%.(M-7X8;>,,^*W[7$8'JI8QOP0^A*BCQ$?,G>!!&<^4)#O9
MIE%*\L"9_LUHIR-FE!-I^FY#)[KYN,?:S+]"LT:[6Q@VPB;T,\RG25HR)RV-
M9=<J490LJ2$KQF%]8T;X:\EWASSQ@W4PDX?W<APRN5*KFU5J(X"20XN(G2%3
MVD<!(VZ:\;03W69=8YUKI[D!@ZP1<9XO+U*N=4L 4W56B$%B';J/?C\P*5TR
MS%QY:-:+/:37EY 89&7-Q&R;91#4C,T:7%[V&%99<V:NI;)X3&T<NR '+@&[
M)6@$\;Y0. R$(Q\2KA/WSY_ (/CX_1C?,D@T%Z(/ K1Z-Z\?B5&H+[.L?Z7^
M+&^Y8XG9^5AWU^Y#A?A*4%F!W)AHB2N71"XD3R2'<36-^HA3@?J(8S4'/R-[
M3I'?--30_D[V2P#ELAL5KL:,F^G>9]Q&7E>[#H4\)R+!W2BZ=V3FL0]J=XA[
M"**>^.XEH/8HR.*[1?TPX[YZ^HBJY=ZQ;A"OY@.G9FB/,NKF[S!1NCVF7\:!
M#R617^+>2@,>^[SZS7'5A#DTQ/68S-FKR_MY+7.SS1OZ%SR-/135$#63G:@P
MJRL4GBJVPZ5N[#Y\REIR@"F1U?PI_JZDR?V70@8=#Z/_E]=V/"QFC$U3A3PM
MX39R#":%SY&-\5RL95@78X*ODY+LW>VI!BO6-]__"O8D<?/DA'@\7?53A7Y0
M"U7LESG^97.@.73+<\ P. _9?7#0QKBH]\!K+X:UW<D$_5WG_2>IH5+%C92X
M3XQ7RN3],N38S=/]VU^PR\D;6;ZRJA\0J.B1:F,6]5)?U_#D,>K9EJG1QM?N
MO(N].D=8G=>I),QOC#ZYOTAHVHKIH;DGG\=.#Z!]++07M\'/\UE+LY.F\($-
M?:/E2;KHB(7;^W2;1V+IHKK:O#I[16T10J8Z+XR$=5O?#DG57N-X7<[R^J'B
M_&P'I\H& \V6[L?.T,/5S[27 *C3ZJF75%&[JUI 0* EMV!ZK/LAZ_,O+QMW
MX_[Q:"[+#2_D:%J49IC2OUEZ&KG0?,O3R(#1],/=F#T1NI*]Y#[K< ,ID^ I
M&VU\XKV"R)$HFX"@?!U>=AH/EMF7 [[NS'?;3P46Z%Z(G=3)L03LO-3D8![1
M]T/["HK,M;'Y91C]M=+9L%GL2A\(8)E)/["2_9;NO#/^]'53B^7"S@1\3[DV
MV<WIG=\7JX,CM[G^( G3C:),'S^; 9$2V_FE!=;%L5X6.C=:&6F;NE= Z5WV
MJV\XM!XNO7G(Q!$GZN*9Y]G[Z$)1$#B3^"O+O.-TH$]!487IX"#PXXZ]O^U2
MVAN%BO8!?T]98L@!=ZQ,7;6K96[5FXQA>>8*+")_X>)S'_)'&I?.8'+5K?A0
MICJ]0\&]G8JYS8J9#"SW[P'+XMZ?[BVHM0FC!WJ-;UTCFE\F74]0^,_L<&'X
MB>!M[7&AN23,<K2?S@C+ _JA\@3>L5?:==9WZ@]"%@;YK<M21&J97:]^90X0
M9&]>:!J,BWYD6FL!M^^^X_CKNGJ:8-)!T[EH/\._GL"<H3%;J4&1?@]<'[6>
M5'Z;Y""72-3WC*CT=_F2&28*&H!/M^(F!3>;!C^X-NZEO,K+_G >,F/'IXNH
M?1Q[[5=;POJ6Y7=G^W/1]*IKI0OJ/'Q/GV<\E%I4.9'2?].L<U>$19]7PRQZ
M!0 273.M+@=YO&$)N3*RIB*5IP^W.2[36_O=&RT9X7N#1R;L_I%>G(ZH1U6;
M+UB!%U <Q90R<"\I77VM:*C9[.\5_C*')W\!#O]H7/J,70PT?LXWGM2Y?F2>
M<F[HJ\RJW?8MW'?ZV+);\^UCZ27 V=J9+5_O3WUWP6:1?O*V7D,6W<\/ZOZ^
M/KZ\7LZ5]^6S,G72)_7_HSZ7D=1:(_U7-VB=^1]=VF?FMMP0_O+2/[5@T:'?
MG!R/]+5?>G@)6JY']XRATO&8IG+/+U=;TGY'/JWDM$Y&H^TR:AATTN6 !Z<U
MCV[R?"[_T_QN45<IN4,G-$S9XGKW[OV,OHM?\WM[<FZ]KC/F;GXS>SK4.07[
MOW[D;8EDX,S%K2Q__K99;'DEGNTDRK3%GCYVKW].L#T@OT8KOBC4>U3&2+-
M\8IZ4DZ)+)L&5(#//*-VK6TP40HB&U83RMNZ<#H451,0U/U=Y8=%_BV//NB4
M+UWHO:7\:Y^9VN!O/RM7IX_,RK8T5)2*N'GS>/2+H_-<E74R'(=YOFF?_/=0
MKT/RFH/)^5 /VMUHU@!YS^_KH%2H&3H]J6TU;5YG,S_0N:+"D>V/7(ZUFVS[
M4'U374/PQ$9+.YNA_DPZP;"VHKH]2R1(IS+NQ:-R0LT MU**"//MG/BABG??
M$R^X+(:D^^AJ!_A%<6VV/O:<)IKO//ZQ?LG]8C@C6O:"5O"VI,--=^:1U9:^
M3H57'=)W4M>?-+"HF<:Z8?1DUW2X^*NC&OFC EQ8K0>5_7.N#:!Y5QUR37]X
M9OW>F]X\F[NX('P\NV'D5Q9Z.]GDH6AKKIH/K&\AV.R>N6<WFTT5H!%1+T&4
MH](/(X]> NHCOCN$[TNHJ3E+#E67/*'V@"GC)FM$^IC8Y)8]O0P%EHK+"W4^
M=B#8X[A==][^36HE[7QMI"VA!4K)<0,>*".B^"0O\B@<7,% 6 X#-3CD**^$
M+*S0A(J'?5A8=/B!X\UMZY$JI5IO^.]U;9SP)YHEV:D0LD#=1(;U-B'#[&AJ
M>7HS\PTBLK%MYN<2@>1C#1O=H7F<Z.JL(L?^:]XZX5'8&7HC0FWV?OL [G0X
M)F^=N1^6EDA5)?05]*DJU2?H=6SA!VK>53;56OLM11XX->#:1\^O$F?4NL%#
M"@HTY( :&K IQ#-X1V3QOQ02!)O(5>=/4CM&C*Q7_G7!_T:71M1[:%\"\APL
M@[='V!773&!#3T.T\)< /!5!^J*LS1!/AX5$DQ3/%4GFTVU@+#"*K#PMH^JD
MCVN;F'5IT;@$Q,D&#:I:]?FD_$[^?3!N4<G_^9:MD#G=H3F!SJ/5'2LV\LS"
M>&)?*R?(1\5^G5,16Z_&H BBA[$F-2D) B0=.NE\/>O#:<"*;^29FD0.Z1G!
M6FBX?#].QMO&#Q+29>]BOP0)R?%T9\N_1A/;LR1!HZ#/B(N4*5742L<GKZ:
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M"C_U9,<PS=#->&RUX:YLG V\N/&MR3LG9?)D!63PY+AH2AU["6B"K'\2ENH
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M)>W6^YM=)\.Z0;I)M<\0WNFZ6'%M]I>/Y3D> QVN^67S5F?[5%]E0+%# J+
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MUQ<6\=V\:B..-)M9OK?S;FXEDF5GN+I+<QE]RB"(*@%*\.6RYN9<VR6G6_\
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M ;49 &'E*#@E#UQ@9;& <YX4[B,@?Q<Y8VIRX4I& &QDC!] W4<$'DXX'7)
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M$9C==Q1V*D NK!%*MD@;1SD$\@BOZ@?^#;33KWQ7I'[:_@C0O&MUX+\0)??
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MIVIK1@7%M(5.%AN$<X(.9=C=^OS*<XZ9X]*NK""<,3D8^7/&X<CYONG=C/\
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M99;#5].GN-.N5*AMWEW.$(=9"KJR)_FQ6>GZR-.TC5%U<:9J,J337-ND86/
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M7X@?^',\4#_VM0?^",7[$0! \*_$ +@\_P#"R_$Y('<@^>#GN.A%2\D\-?\
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M\-PM RBA?.O AWN2)/"UU;T&L;KU ,, V"_S/FM72U7&.34H7+.,.+;7WH_
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M^Q6K[8U.6W]5:0]\P5S-[TG.5=U#9=:W)*W\Y/V;V3_<J9X_2$@/ESB5MP3
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M#,PCK'NN+!V9'UIF&NXO721+TQ8G*VY+KQ[+_;0_2S=7S*4,,-6AHB4T7JO
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MC#?=(/)6PD*H'+;+M] Q2&@*9X)\"E6J !O59RB&RXOXD*8Z">8L!I5]^ N
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MCW5B&IJ,;N1+1/B(A3B*"8VJE#&TK+8OEN8/YV,9/%\;?LF$29/$WAE?#?!
M>\VW*7^4,5-T6OM^?/AT_4MH I*?E.:;V(^.I "CZ T^@<;F,.=M&9:*3>LP
M#$Q$=# +V1HE_%2-#^5@I*,5VTXG(^U=ZQO3<A"4KJA:IKZ<:A,,$PEH+]4
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MKE5WS4D:@U.[K6"<W!_/,)D5^I12//X,-VP^%73:5GDXK5%W&(2$W*SO?)$
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M>_V8Q\H[+\$<Y/(D,3*!][<K$_[(88QR>!@YP>.M9L,<MSF3&(U.T8.,Y(Z
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M)'X@9/\ $.N*ZN50+.(KDR@ L1[;>,#N,]R>A/&:S+=XT3:J[B=F6.2P8YW
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M-2%6E"<KS=.?/"T?9TZD$Y4H.[?/%<ZY4E&S9[7^Q+^QO\-/A/\ '[Q1X?\
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M>\1Z\G]HSM;B62TTFUBM2;:W>00VT\K^8J6MG&8EM(#/+<-4OP=^+7B;XO\
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M\*-\$Y)QW#\GWK_,SL_"D=G=Q/*J'<R AHV/!5N2?16*-G(^[\WRDU_I6?\
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M>;IO?4]!T76)K2W6,R9381T. 6#%3CKD #//?IUI+?Q 9-;21B(XEF20GIC
M! .< DDD\'D].*PK=76'*8550#&0<KDL&W<@KA6)(X(W$'KC-8GST).#M/((
M/S$84Y[L55B!GLQ&"":CV$9-S2^)WO==;6O_ .!+U35EJKSS2=DW=7^^S5[6
M\[)I=;+>R/UE^%OQFM=-\,Q64E]Y96 )@."<JJKM.XE><<\9X_+RKQ5\<7L/
M$MO+97Q,GVC: K#.2SG^!1C)Z ]CC(.*^(].U348(5\FZN$C&6)#GD<YZ$<
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M4JI4[CO^0Y]>N<@8R*_*CPG^TOH%SX.M'-RAF6W7YEFC)=A&A*\.6X&U\ Y
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M[55:'DN-<.X9]=7]@A&?,%><O]SIN1W"M7,%H'A+..Z).A:L,=_ )I4AFF?
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M+KD[!ZY< KX+R)J]/N?O7IH:W:]^+@8^_[.JW63\;S/%D[B(J5MX2PHE:F'
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MSNPFB  2N 2">-5!C'BXG<]'X(:A_:9(5(6;<]U\Z0@_]M-(!P)W:84<I&6
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M0'-Y/_BX9@6F%%.J/J4"CCYSS>]RPJHW'4V^^Z@M]3O5_UMMX\UOKO_)^9C
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M*'CZ\5;ERQD;43:]-)1X3DBJ">FZEBFW_[45PKV2LZX +&-&;C'_\J$JDTU
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ME+/A\MTM3[)GG 4)%!BGIW(9?,2[!\5VE !FH"GWY-^D;<>WWT ,$]-8Z*9
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MG&B<O:=1WK8_]#B#VN>SNPH6(8ZX]]H34K95Q?S[U/7$FJM7Z<&'IAX1RDT
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M6UTDY*Z;/@=OU5A/[/RH#BWO29YXU#[K,?N14<-16?OUM'^/E\ZY:C+GI8D
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MD%FW7>2U"T@[4R3\,]]5ZS)M'L0[$Y,3D-!CS3#EWC&QU'X_QKM#?KUDW89
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M6!+*#-1+G'%7M>X5B#ZXX.EO-:F.U!FTW[*._C!OMM@0M]9!YVI.HRM))/_
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MFZBP# C*EPI72JFRN,QM#I[ZOC@H73AO7#^/T@/DB<810HM SW]4PZ1*Y/;
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M/1%SD&4QGOZAH=CC\R80.]_!#%M''__")W4SJ/FCI#:OF^J+#&M;2+,S3QW
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M8@& Q371S[>T/FX= <P#N#C[>ELIDKQK!&R/CU#=K;Q1K8*?O0!2/8!LZH[
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M;7+R3%*P&NM%(:)_/PF1S%%F.P"%^I^Z^YYNU9UX$ER\#Q89J 9Z1,<RXW6
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MQ]DW E5G"]WF]+\P]S*88?OT? 96@!4RRR;&W9/O'/AE5)O9\07&7JE23D-
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M33DV$L9BM:9?<O><3$>.FV3VU'I2-[3XSO@+1$DL:)QY&E#A]RA0D#QD+]:
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MH9-N-XW%I%$@7"9A(95,+^O1YUL'NS5TJMM^UY\B8B;J/<;M,*U%BL7-#"O
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MNEK.9,,>E;"[$6 /?T@,7)&)\$^D$<XZ3-ABE$>;Q.FYE(4.F>IXZKF,UB,
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MH=I/!HY=+_V3R)WKNBN1M4S<K*G&+]1M_PH7W498F%Y\J),SL8C:D!QMR@J
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M-6 B_5K'_>(N*A,.#8Y29OGV+HRHCJ7@&MD9]\AGDT:70]:C\B\'_1.J\*\
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M3,#H8IL13(;_['.N3R[]_EC]WF:PSQ($@:@PXTT9%25W#8/$$#!C*]? %[O
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M1!\<F^R4(@7L>=>^BG35.F6+-\:1N$B>P"NTJ.NW^2# FNQ,NBOK%_0Z%Y&
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M<@()1GSS:T<47;-%HZ 7?.+Y%D$(AJJZ0Q/)<Y=?VLGURT,9?[NNYH00(3#
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M?#HF0UZQ_\Q_7R<#F5FU$^O.I$[+O][4&N_J>0J>$D*35J)F1Y344*\_N;U
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M+EPG-7DOU\[3$SMX\NA3*L-4$^IF/JD_2C5T,3=WGR=EQM9 K(YI@I'#/GF
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MOD>U>*A]BP>8U-TF@BWS,26WPA-8<)!""MS0I(K4;4FSD"12W$]">TO&VS<
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M7_##%)4L-DT!:!AW#6<R@;M=:!38=@9=?]Q @O(AC,7J<98:9#%OC]BX<;^
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M"A44"'8AL=Y?A%(%1B>WGLW#W+(]?&;Z,A -[A7L>QH->J-*7.F/:!=E$XF
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MHCWC:1PUH$QXW9B$$?Y[!-!=A?VNMHW_&$BE4Z6[:79"M!KLEG2"VIUIE 2
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M.BB[9/+G8<K4DN7->K(6/.X*#N95G."9#12D7!.3-3]0?WZA5S(BJ8(L_OQ
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M4ML&;6\X33BWDNX N3 M\,E^BW&,;?D4=SC\DARWCK-ADJ#$T)T"5&KJ7Z1
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MJ]6VY(GG)Z34G)"0_A+'TV>'OK0)\@%C>J32 9VZ1D2ON)5\?Z!U@O<64'A
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M/"LJWP0B#/W&;H9QO-E.<. 70H!$M87<S[=\2^/*H[)DT[KT[T%%';/,IJ\
M-ZUW1X/Y\276.' \F,:>.OS^Z$6YCZ55<.!1_T+"D=;V1UNT"VZ#^I2.M=HI
M4<<OV7[_.);N:#]3_?J294\V60A/?EEKY<5UM#KEWQ(X?RG^\_H-B<N:$EW$
MP><_J'\E(;H!?P<@H6YA"08!)'<!,/#=-;-KZK=P!_W/LZ@?6MVK*ENJC=A2
M84N,!M-T?V&1Z$2'*VGJUYXQ<B'10'6=:$M[*F-F.IGB%?EPC90-6^WZNSJ(
M).Q$7]0I&E'>Y2.QVZO8V B/R1;"(-I"< ]N/:N-YZRDVX.E0L%#++)%H->T
M21D6Q\?TS''6T&2N>$\^S*EQSK, Z2,F2GOUN_(-#9 %HMO9A@+,)1:087NG
M*=T3U=-KZG? 0VU63P?08)&=7*N%@B[,[ 1G:#,^*[A$W IHCQ/U8<^TVR/C
M"<I=">IOH#Z.\"5Y[;X4R*8%95)FM5R:;H>9(9CT](=/)!/WK/!3Z0JHU7<'
MVY7R/.9Z^3H:K2NS'(]UN5"T[I9U?N#MCX&G;!_Y77:P;O-+TY=\NIM 5;73
M?@\:S?QT\_Z:5]9'-GP(LNPY675Q0/2#[ -0*ZD+BR*NJ\KX(ZX/N,Z&3_,F
MQW[58 QQ"@T&[<B>:+0'7)SO3N!807('2CM?<>IS)M\K+=2OPT/2LUY7H'T%
MX$9(2\;,QS>9@#P)"AAAZU%$+XJ9AUM'=[M)\Q QUSB]WROTD %32E#>?%G\
M-DH;S,E#2,Q3,J8I[>1K;Y]-]>^)XQJ,R/@RJS+^#!/TP[*>.&<Q*=3!":E@
MR@TJ[F ^U)[<*V=F B9SIDPYR@=VPTH%N>M/596C:824BUAW:L&C"A:<+,=B
M)AB+&C@MC<QUJ.@L@^-GVHW-6)"-J(32E;R,[O[D, /7A-1"Q2QDCPR7AP,/
M[.4,]RA8$#Z+L3,>9R2(GUBQBAREJB)N4?^A=H9XS1.D9<AI\,ND$/)HYR\#
MG46XK& 7;!%Q^V '*/AN(/EMT][*\7+7/GK *; Q^()?5Y-;-;QS@J!O)!_1
M/7_7*J MYI-D\G%L'JO:]J\+E3K^OMB=68?+RS>?<?,]?.PO^G'#G97XF$*A
M;[E^C:V32U^L5W+DAJ?Z[,!QZ[>IIP)W))TX<:%V_?.[.HI.;&Y'CZK?Q-0W
MU/J^XM<:YO!T-OD^<_(]M%<J3E=O#H<SU#J)DJ=,8SC&'7(DKH,OH!.T"YU#
M'KQ%ALT."'N0#L>5.X",.N41CVHX0?0DMDSA$^/VK##V_K/LA)38MUN/2U =
M<F+&1K/AW\2-,$YQ&0M;4S9\XZ&M:/O\[6<7.7\A&DYR@ZS/!7/:R&^'I0*1
M.)>_%[91FM./0)TBSDKD)%P#SK27[X #[C06UA+TXU%DI-8?!TSX9@DCQM"7
M5A^\++8 WY#YH!\QE&%7P1=$?#PXD$58%"TS<8-^G/^IX2L%M%"D]SFN.J P
MAZ]",XH*6%R)[.T3'!? UJBGEG$,Z#[P#$1M&<%"ANE)IB'RSBP@EK<$\;C/
M$8UL )\B^Q\\!D.RZX%L_A;(_$(LM)MV;_VL:D4HT:JW(&3;-MLC->%9V_9?
MK-.W]*ORO_NGU$]FO]ME=_@E"U)9<'5!T;IL,_TCT/H"XLYL%[WX4QZK\FWV
M1'^R%C2)=OM7^M^D[#L;ZUOE\C:OOW"WLL'J38O4_FW!CV.W_5L[M:V=(O$4
MZ[=DU&N<;IP<97^U%(.'%@VK_87H=/AVK#=E2A_LWC W.UI%K[Z-K%.QC@GB
M^U6%4L@0T=^NE"GI6A!N"IM XX#^8MCZUE5P)@!DYM"#I )MGXI/Y42TM*HR
M#H6%!?<:>'ICOR>5K8[T)KV1_,'?T8<X;/O,7LV%(5GGT.L!$0XDH53#;#&)
MS6ET$TPY5R#VJ#@4QG.T?H#(4]N4[NJ7J*JOI7N# 3)? 9!.]Y3A6"63QBD=
MU*%&&2F=;I@FM0<;I09Y]Y  D%SD: $-H?8_Z[TX\]@<>YDRM@TWO%=*%"@]
MZ8908RXS@:=#-X;+>,R69>J]M/.C,J?& A3V.G08XT2K D2"Q?3DV%I::H?,
M_=<[<91J6A&P&'XJ*C>\3%XQ'IRJP63-E@6T$74C7FWN%X>QRAO<5NZR,7CV
MS&LWW2 Z,J JN]K6??-:"3*0>S\9_-7W@2BP,F3[)6/8.G#"Z]:F[A8O7UJN
MNV]IC?\M$^SZ_67TP]4]!34^=W93NF4(-QNR%_UV$JCIRW:IBE_?X)+4IQ_<
M%#!?%LS(H"? %DH'.A:,%:XB!8'%B+Z@ V>@M@N-#QE9J[K"7P@J" &.OS\E
MKQ7QC< +\'#'?,*CFH7#<:C+;AEFH8-<LM*!L^81&SH;<+\_>5]L!?R-LKVD
MO4$ZL2KD'6,U0RA81+1#@#<(,RUA00Q@(N';A^\I:AVX#7V[ .DNT5)DBUWV
ME.^[&3\OSFYR5=+@NJ8=0XIRN[D$YDJX9.8[Z'7&DB$*PQGD9A%("=6?=N$6
MB,2@TH8>LQ"MN%1!WP<_5\82!.OH84HCN*TI6D;38(Z33&'\H5[B9B'X1?HH
M3WH5\3XJ184G?'O&"3G>!#G6K=Y$,VSK3U47NXK;!7JP=P <!AF_[#A$VP7H
M4 X'LY1'Z=_#5Y6V]-5OQ&J=/4MRFLLB%'^IFABZC#= (U"$),AY^J&T^,Y6
M8"T28C%Y5BI@<5 Z\B,5I7*.D',+3@<)!NL?A8NS4"D&\LDZ1&.R4V.ZXZ C
MB_T-S!\0#G54Y;4&M_2_^OEAILU \^AC?HC1F[*CV8HSL?I'X"B'BO '#5ZA
M^5="8S:%F/@[<5?^%)ES?2*DHSM@QX H&J1=LK[X*:CY*%RMI!/DK(MUC\VC
MK_GBL=K;S_AE?Y,41-#?XQ6@F*E>%M#Z6H-Y1MX@B&:_U6"DI);I/.9:QA9:
MC5K'5<9>1 -:&!L'"$>EXA4+(7V I!:W;NX]51B<>FSZ[EAJRB]->Y7A$RZ"
M_')%1V=ZY.:![Y]ZL\Z8*_VKSG=:^ZG*!4<ZWRKEQ<W,#,"(;T(3JG4V7:<3
M4'/XM)F\!EE5L7#0(U"#@:U&"N_$\== .5FSSYC")\&5-^/$CQYQ;U)2GC#8
M3$K"*2ZEY)*"<]261*6DN-;[O1!?(>NJ-],RA.''2Y6NZD&@$2\2&"#$;F8T
MV816K/A1=8.^O)9.4EVN)PWC%'D:3*90'LR6V3G5$ASDO+7>D) ,XEJ?V4B/
M$9? WC*R*=T?[&Q_A8OJY5OS,A"F045L-04XC3KVCORF?1K,8D=5>06<(E=%
M2$(*+R@<8 N)G4T[<1<H:,-^0Z:1V^8]L@BF$COWCJ#Z>G NIPV[8FSH7F/L
M;1H#FVMFT/6ZHFK,Y2)N+5W_=N3;X3'C/]XE#]P7_N34JQ+T04;TN"<_HY,A
M[*LNET V^E,QRP^UI5%M"L8E$ZWK_UBR>[^^Y:N/ZST"G((K14=[-T1KYW-9
M9>21_0^/[V$$78F.7!Y06A6R^E-,O*6L^OD;4=^IFUQ?VLK Z+E&9&^ XO3O
MVC+\E ;#1A'BDK\A#&/A=.T6Z#6P&@N?YDY.%&@PK>TJ@?(:4_A6(*D6L,G#
M&Y._=,PXP0T2\E"'5XE8L126R@"6P)"XEFX-QDZI(!-%/-PF?\D>GI'E3*U0
MFL'3S?R-JD(D-D'*8J]D=)5P<IN<*U#F&)8&Q;K#E%NT$)EAN\K\BRPDDQEG
M#G5DAHA.P#=&@])(S0Q#=?=IOTZEP2>Q"?,X?N&,*7GRK:!!C.@72X"VJ0C9
M0 >I"*>=1%U',VPF;H3K[B':?70_Y2'$S<P$?G\GC!;1\J0S'=E[ SE8#W\N
ML<AR\MGY<O^%P"[^9AH#'IPC+1OK&4W^Q$NU+[EX,:WXT4E:2I3/4&:=HT5&
MFU^5W_ZFZAAP^JUE=6!J;TG5@6%/[[(#5Z45A@0?*=DD6]2N%_3>([/V%]&!
MM=;TWK$7UCNKC8MO"E"\!Y_NF!SK41LX(WI:/?_AT7S&O<[U*'X'1B1R;DP;
MO4-./H>K(YT#*)WIG ?''\KQL/5B@2Z?0(OH&+$'HZH7UCNW+X"21N$51U+V
M4!J_4O9C'\(\H_PQ+&[%O8/%3^A^M!@/3BBT=8M_3X.IMU=/?<3O3AY()<AK
M%^O#$3+<I-,-]1#0R)M: 3Y5[(,KI%C8*C;'$6] ZU$4]3&TAI$#L /(18EI
M5A)GT%"N+<*S^28XK-IF")YH8ZYJ.E55:"C3SN5;45+X.S-\X+3JH;N,;=!Q
MOMIA%I_%Q!U/6H@%42][7\'H%>/N-ME#1T:EG8B>3-RJMH.Y<F!9'&#DU)F>
M^GZ.ERTXRF29.=5#67?76!2HM]#MP'N%O/!XHCGXEJ1+8_OTO:ZX^3[^\M#'
M4D,[KV3*69WN2TX>$TZ4P H_5=2S@_?I'OB:0$6W-_Z/^W-_W36W,2R6N=[:
MLBI]OA>*>G'9T,A?/Z\JO"#>W:%J%TC2]]#/*>X'/Z\1?? *O;:7N_3A2G[2
MQ!&PQF3?':QNQ#?5C_O:?I!&* "4;H(DX%RY>9>@?JYFP>C@A1/B*9]3*"+(
M3&D3@\$"V++O\X-$QT+JH>YZU:DI,RU5$Y(H[:JBW6EO'Q8-Z0'#W/!';QH*
M=XE%\T!VD_?J6NF43345-N=.CFLC%ZG#&LSNK<SVMTQ)-?>6!PD^=FHR-:DS
M*N?K>5![*ADBRSN:Q6]G6AB;T=FN"*5O0U'HJQC%%U" ^LM$4AX1#U?([/:*
M</6QF<QXHV$)7CB=AS/28'YB#W4H'(&5R%&@V2YX& 6<.DU+9.(-870SZ$LV
MU2[I*3G3S'R!I_;4L[N8V6;;>PD+Z6VW]0 _,5EBT$^<+S9*%N2@(^!+S=!@
M]#>]<23EI4Y/]D2G*??!!]H<^'60P82""0,RYE+XZ6$S/!B;78]G,>QA/R@F
M%*ZJB!\Q@K*O%Z<F=@B!-7%#MN86JG*[%_X7_NP(JO+5&[?NB_OPSN6WC+5^
MW7>J5>%-M]TBM NJLVN,0^\897X@65>3]'V#OHXN?E?F<B4U^6CL<U\:?\MA
M5X_+-[?L/K*CJRTHG=9DPUL>5!6"+XC_J6Z>OV7N,+/%"8@-T&"<3%!(MO$"
MVF[LD?]8O;97QLC'GIO^G,:(5M4R?Q0L8KQB+((]H12I81MGF.D%/;JDI*(.
MRYF^]3SMH5K'#1V+%2C;C?1N%>@#D@J4/K5R<LN-(+Q0D*_!U'\IY)O1!$(U
M'C7P5'U:0%A74Y T,L;WMYZ&TO-VY\?L/F_Z$P7YOW*,")$\VE,YN06?:^8T
MH+:GB:7D#*)1%*U&'I*IP<0SS=0] BUZ(@_.\8=&JJK'#<.=VVH=%L""%:/+
MN/="880L99)S1\5MY:PD;$'G43'0O&,LRLQ^4# (@/Z/<.!KP6IW7X^_8R$6
M<UR?H&PC9?)4N> SI[N1YR8=77_VN[Z *M]ZZ_T.F=8!U5-ZL<OZ"JQO-[I7
M/:NU=K+#,2[B1-6] <FZOCNY1$^W%^LH2I>@(^^J7U19O/)Z9IS76O7=;[VL
M *6]ZIL;^39;#O%*[VDPQ]B#AB1^;_W3Z:$+BI2'O?6)(8%O&M*($W(/X15\
M4BWU0._Q^L($C][$HY!QY]$[%./:2Q^OW@D]?#,EV#BKZE59[Z%W^VP3('8F
M8J'\3MW-J6=/S<7&*M,8/2B];](%M14<4+N%E"U>Q="A:2D,^."]4FF$!O.6
MC'I2J";>.+L6DJ,OY9!N,+24!^G*V46\>_=X3<GF952N9Q4E/.H2-X+2[$,6
MBD%OO#X<W)J&1[UR^E6U6&'@["+.H[L1<& !LV77\<8)X@[(K$8VO7;D3*,
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MRP2Y1 P>6J'!&%(XJ"Y?&6(+5=K"$2NHC3W5!OTTT1IE J7D)^.U8'(DM!@
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M5VH69QV=##+=X L2WBJ/&R.(%VAVXZ]XHJEJ80GQZ*?YCFRRHJ*+845WA*O
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M>;FM1TP^59E1VLL\+3UC?E[OZ6-I?2+;G+]K=T&LDU<=,[C0UM:JN\R9_'9
M](;'3MJ17.VDY !3#4JCH2'XEF)"T:BZ,G6W:97DV189OO >%YX!']B0M>G
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M)B<R"[\"V2[/F:X&HDS49:+3.3)WZND.0 ?M*EX'D7-G22IDF@.<!+:U%KO
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M/[X\R"D2Y)!K5/F "=SI+R_U1=5FQ?@5 MHORA0&_0>NKI3>F<C*)(;* _C
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M=>WK@7K(G$=9/CQ,NA5)<("6L""5H"Y$6YPTK24C/)6=H;>C)N#HQ4:ORBC
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M@*I7RM2,*9@_F48.6UUV0FZM''VZ 4* *4E@K*0LG\\TH/T(&S[+0&S(ZA&
MR@G4:">4^W4_F-=10+BQ(5H8:EKUX%!DH-:Y+=7W)VXZY,@4RG"^DMYDX)30
M/%%E)WE/7]V'V@TB;DP1DPMH(/8P5\S)85L\@7]Z]AK9\T8"JXDX&8,L_@M\
M2[%Z(RBMO1-=K-6'J+"H#_IY6S;#1R,ZQ:H9>ZZ ',D\)IWMB+:0Z\PG%XN
MBT0#()2D30N#GRH,?(2\2HGQ>IZHZ=!I0N4(&S*(HA6P -21=.2'B9C&5%E
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M>8'%#>6T70VR)0Q1^PZ-8+/]+UX\SL7WS&$L;F?^)UP*EU@O"Y^@+X1E8N)
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MGXXV&\VNDUJDVKA6F&U_&M?ICZYK\3[5_,P2,P<*2FT=E:^ A\UY-!?:TT5
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MJ&&0[-XRP>>J@K_4LU[%&8Z;#B[L=D]/DL0S>A)'L;(BB# +R.VH0?U<UTE
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MO(T7 ?QRHMCE7"M)DJA+>Q$:\9A->>: B8_8 I^O^V#Z)8\35E<8((BO17Z
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M0;=\^^$>QB@@=GZ9PKL/1&>4@.V*:[)$#D#VEO7NFI%5! \)P=M +'811[0
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MHJAEN83Q=QB]= [_\!_GJO\C+S;C[TB(\6E18B<AB[<*9REW1@#%[>5Z7S
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M,*&V2M5=/_S7PB-)0-\/V/]:>&3Q%X7^BG\1A5DL1C7Y5_GA6%*351=08 2
M7HRQ6T1-ZGXX"73I,-U8W"R8@S=^GOZEI91O'RQUEK7AZQ(<$/TS9L9V)\5P
MWJTMES?>KLXXC2MIN34>%F)GR,A8E"XG2OBO'88%"^>7<RO_UP[#EA\*8JB
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M)\K8+Y'=8O9K1K<&&" ;5UP$8E#<G#;MN@KM:]>% =&7V;-:'7"R(D: -VF
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M6ZDK'+!E]!0EIYCX[;>4]6B6^-7QSQ^L5.?TAK>3MYG= 3_*I52FY+/YE_=
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M'QX61,RF*H9AXRVEN?2F/JFM8TM3GV&.=>_,K#/[7S-6 >+@;U!+ P04
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MK9O(78\;NBI0P70M9HO2%E/7? '/U?2V6?V9]O"&,H(.1Y_OQ-^=:ZL]Y;W
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M3$UR2-,@C)7\%>@Z @,D]7](_$:[!;L6_5'K=4G1% ,3?G%SHY3O)Z)5A/2
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M?AH1Z4] HL19B/#"(*[&6XYD=-^R99/+7Y)](:]6CXLK)1V6B)\$7,?0\H,
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M-WP5T4L6-%**EMQL?#^2BQM7;-R(V4-&YOE:,BX[R&6**,?.:F\ N?64E-E
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M$9LM!=.6C:'7="\0^'K.UU>5X=4\-7K_ /$N\7:'>+J?AJ^;.1"VH1A3IEZ
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M^ZMH^NG_  3+LK=5+("-JF)@ N-K*8UX/( (/(X&XY/MH7L,84,V[(D<;L\
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M'G'*#%M(!\PC<E5R5^8B$LZ8+$$,*ZJ/6[YC&3?L4DP LBPP*H48VG[+!:W
M520 9+AT)'*'MMZ=J*2:A<W&VT/EV%K;S20O&#++)?&-$5KN620NR2,7(9=R
MQ^4@*GY/1H5H4YM*;E=;7E=RNK6E9M+?72VC?=<56DE3:M9NZ;W5K=MM^G6S
M/*(=*CL;6PO[J-+K3-5=K+4K::(RPM%()!$[I(H567YGBE #@AC&<YKSGQ7H
ML>EZY=:-I4<*632P3SO$@MP\4@CF2W<2*&F$8<* 3Y:XR5P<#Z(U'Q%IM]<7
MOAZQM+B]L-*C>>\N ]OYL-TLOG0QV2>5(K-'(F3]H1H2H*2(0[&N:UR&SO\
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M^9!UMNT#"&,RK&YV@L[LJJ<@'OQD\# X!W= 36K$ZDA/,#$9&\(2IPQ ()*
MABP&=V1C_::LB"Q\V(;D.-P9EV\G!P.2#R5'S E1C@'()J['!(@5<$D,V%"L
MR@'#*,<#  QUXY;&#P7CUG%/LWM_P?EVU#WNL6ET;M9_KMJO(ZRPC9TVM+M\
MLY9 J$N@*A"A8,%PH!ZDXSELYQU26LI+;"1%Y*[=P3(8@!P<$Y&% )!&TCA0
M#@</HH.Z8GS(4<(I4!<E@^=Y5M^=P*@HI"C/?"[NXM;J")B)1-NVD!HW4;B#
MSC<&4!3G/R@@8R,<JI2C&SE)*[LK]>NGX/YA=J]O^')Y8YEM[=FD*DA& *+Q
MN($@W*NX@[A@ C!Z'H:G>>YBC=O,*,I"DKN8%,<$*Q.2.A P%Y)Y Q.S03V\
M;*PV18V9=26"NN4;=M;(!SM*=.^ZM0V<=T'&8LGS%4%B"3\H.,97*(,8.?O9
M).<#GJTJ:6E."?*[6BD_TT[O0Z.B^14MII9$.9V" %CPK;AQVVDCYLG/(X&,
M8&<75PJV<I/W@PP<G=@.V22#G.2S'GN!R,"NFBTJ2*!$C<1CRW^8\,5 =A@\
MCDH<?[.?H>5UN&2*TD:5P&()P1_</<9')P".3D]<<$>?B*3IPYFX\OPZ*2U_
MK2_7R!>:^7?^ON*OAE?+\1?!UIWVR'XM_#J.,, #A_$MFZ)D84G:[$9!8C+$
MY7(^T-&^$7@OXL_"+PC8>*;"1;K3=4\0:UX?URP>*#6O#VIS>+M;N7O--NY(
M9X628,$NK*\@N;"\B \Z#S$@D3X_L1!/X@^$<\<(6$_%GX;W%ON<F2*2TUFT
M+DX!5@\1E&=PP2K$'G'Z-?"&(P_#;PFAQ\UE<3G;D@&XU._G8<@?+^]"CCDG
MC->WE56=.,:E.3C.'O1G!N,HRNE=-;;7M;7;9Z\U>G3JJ=.K"-2G-)2IR2<9
M*SW3_#M9>I^9?C#_ ()0Z3XRM+[PU?\ QAU"/PAJHOH;Q[3PQ!;^*K:&[E:5
MFM[VYU2_TFZNRQ2%Y[G3DB,>Z1K:24E3^0G[97[(?PU_9G^-ND?#?X;^*=0U
M;PIIW@S3O$6LZ?KL]O=Z_IVI7/[B&QU/4K'3]/LRVI(PUB&R2W1[73"BIA;F
M)X_ZWO$6MV'AO1M4U[4KB*VL]+LI[R>6:XAM8L1)B.-KFX98(6GF*01O,0@D
M< D#)K^27]MCXR6_QD^/6M:GIS:?!8Q7T>D1&VO8[M=0$8NYM;U66\7F[%K9
MV%I9V&Q42#1+6TB6 +)OD_2N%<QS"MF-3$5Z[J4X89T9+V=.'M)SDE#6"BVX
M6]I+5*3D]+MGY]Q;0P>"P,,%@Z$U6Q%?VRIPC5K1I45!QJ5.5*4:49?!"3Y;
M--W2=CY-A:WNM>M_+MXX+>%PL<:O^[\J A8VDE  C,\A!\P$,G+9+ 8_27X!
M:H%-Q'#=1K/96UC PO-ISIFIQ2/I=_*D*B.9?M$-Q8:A"02)4:4.\4T40_-?
MX=^'KGQ3?:Q''J%MINGD9O-0NF4&"Q%V"3#$&.Z29(FMX!\JF1V^<#YA^A?[
M+5QX0UW5[OPU(56^TZ-] :YN)?+&N:3JP2YLY(XGD#I)I/B:UMVMC&I+6C1[
MV0NVW]SR#'55[._+RS593<TVU2A!N:BFVU-I^[K9^]?5J_X%Q/AU2P\YPG4Y
MZ?*Y0I3:G!W3C.>MN7FV5TVTNVGPE\??!4G@GXN>,K#^SKO3M$?7+R[T$RHZ
MPW-E.(KV,64K)&M]"KW 2-H P9G6,J#A*YKP^]UI]W::O;P-!J$1900"R)'\
MQ>!H@$#VL@):2%C\DA/ER(&-?NMK_ACP5XN\(VNB^.O!VD>(H-$U&QBO1=PM
M*[:1<7Z:6VOZ-."?+31;^[BC\1P(VZSMTCOKD)#!('L:=_P3X_9J\<Z1+J7A
MFX\9^'KJ[L96@.C^(I[JQTV:X1DM;K^R=6@G8-"KP3RZ;*85<EK9U3.Z/YWB
M'"PR+ZYF'+-X+ZS.4VJ=2JZ+E[Z<E%.$:<U-SIV=^6Z:YHRBO:X:SNEGM7!Y
M)&FUF=6DZ5*55VIUHT::YE>:TE/E4W)Z-MM[IO\ #_4O'>NQW3O%JDJ2W,A2
M1]OEB-=RE%#P[&1 -W[I78,.I)&:N:/KAF<SWE]-=W\SJD<EUYLN2Q908H99
M67]VNXB3)9L_*5P*]Y\>?\$Z_P!K[0]6\30Z?X1\/^+]#T=+Z[TO6= \3:';
MS^++*TVO:)I.A7LL&I6&M:A;3QXTW5X+.WCO8KJSBU&=([*XN_@7Q'K_ (B^
M&OB75/#/B_P;XM\*>,_#4ZPZIX:\2[-%U33GV)($ECN8)DB25) T<\:M%*N&
M@E=2'/R]'BK)%%3>/A34K-1G[6-[6=THPGMU3::NK[NWVE3@S.ZD7&GEW/*_
M+S4_924=]92<X63U;:NDDV[62?WWHVOG3[4:<]]J#WE]/;PI8Z6UM"DI<@O/
MJC/"RK80QD&6-!++*-P7$C!H_4],\3ZQ;:YKUWH>FW?@FZN/#^B>$K6,3V>J
M6GF:';+<)(WDV?FVT,][<SRV%S'+<#[,D<,T<#2RQU\0_#+Q)\9O%%[IVH^&
MOAE8Z%I;L#+K?B2[U#1].GAD(+SV+S3G7=>,Z$N9=$TJZ@$F SP*PDKZ8N[+
MXAZ/JELFG^+/[0#[)F\.&*XN/L\CF=B;5IH;^1$5TC,,<DT\KABD\<6U@?N\
MDXWR"O&G1CF,YSC9R@L'4C%VWFIUZ?LG)))+EYKWMJ?(9SP5Q'AKUI83#TTN
M91G'%4*\ES>[+EAAYJI3G)72<G!:J[2NSZ&U_P >>*/#.BZ/-J-MK]KXNN].
M72!8:1>1B/7+V>?[1<ZSH4EM<RW"R7UMG[1+#;I'97V5.UWA"7_"?AC7])T;
M5M6\82MHK^(;2WAFCFO;K4]0TC2]QN9CJ5[J=Q?WVHZ]JS!8!;K>B*&W61GC
M@1DC'@.H:Q\5_ 4,^MZ3X(9/&NNV;3V5[X]UBZLKO6;:T#RRP:%JSVND:)IM
MO;LH>**]ET[38(T=[_4($0R5XW>_'7XLM/-;Z[<>'M+U)(IX=::RM9YX+&:W
M202SVESJ4\SQ2VXC9S<0K%"\C-M1D9-_VF#XIX=IU)5Y5)SQ%*FZLZE+*7&I
M3BD_=K8R5&G1DU&*;Y927+RJ5XV1\A7X4SO&Q@G*G'#5:L(*CB\WYJRJ)J/-
M'+_K5>$::O>$]*EW)**:.\_:P^(TUYX"U);*WEM=,L;-=*T1)=J!$0VZ+)A9
M!EYE96<*9F<CF509(V_-;X6V3MXIL;Z0K*UC8W=ZZ@8V3.K6EN'8 9R;EIFP
M2<1D+@@"L;Q5\0OB/XTNH_\ A*=>UG6K&*]*6T=Q_P >V7N%821PQ1QQLSE5
M!D92P^52<#->A_#G3+G3XM;O[GS(I+A88(V8#,3P!G=26*G)DD52,\8X!P*^
M.S+.WQ/G6#GA:%6A@,)[T/K#C)5)N3J^W48-I<S3Y&[--V2Y;V_7<JR"?!G"
MV882OC,)B<7F$ZM1UJ$Y3BO:4Z6&IT$ZEJEZ4'.4TU&/-)J*W:VM5NVF\16A
M!C02SG< -VT' W88]0-V0-F<\DD#'O5MXVT35?"^L_"BUTVZL;VXUW1-,US^
MT-2@DFO"MVL$R6=E"8VDCD22XGC M;G:D&^6Y1%*M\QW4I?6K>9OF,4K*2">
M0>@48)^\6 R"06&>N!ZIX,C1O&;>/KX21VT&EVFD;I$)%_XITV(VJ30NB[6-
MAX?O%GU!E,LD%[-8^<JBZ22O2RW,*U&OCZ=*%.2J8F-*K3G%27U>JIPJU&E[
MK4$I+6^E2UO>DCQL1@,,\-1JXA2]I@\N^LX247&*>-HUZ=:E3E_S\<HR3HWU
MC4I)QU2:_2CX<:3!X^^&WC;X;H(+/4?#XT[QIX1C4&W%O'<R/:W=M%NMY! E
MMJ]K:RPQEDC$5PL2JID97]&^&6MW7BW0)K2[-G]OT=H8M9MWV0:E&+:-+:6>
MU:92AAEELHV;RH%=-X:6/>[,WRW\+?BC;>"_'G@SQ=!)"^D7;7/A+7GN506L
M=EKW[BVNKMI3#&(-/UE-,U5YIF0006$\CLJ,U?3_ (J\-:#X:\37>M"UDMM9
MU/5)[7^SHI9(Y;;;YEO,IM3)Y,TAFMX6@E=1*)%D98VCQ*WZ/D<W4IXW"QG&
M5.FZ-6AR.-51IU8J4X>QIVJ0@I)--VA%RY8N_NO\;SV/LL<I\LH1Q?+7A-_!
M&O2E[.M"GORRJ<SJ2Y=)*\I7;/3_ (*65UXI\4>-?&21&X_L2X^P^&H)1YD9
MG$%RL<J*(U8164,=R%=0 DNV0,&VFOHWX=!I]:\173P2SI"H9;DF4;+F<-))
M&%Y BBE#J75B_P#&60-@>%?!<)X9^$NOZB+M4EL=8O1<.' N+B:Y6UBLHX)&
M \Y5>]U"-D@,K7#P2.@98BU>Q?#^VU_P[X9N-3N]9BO3J-LVHII_D2A+1=1'
MFK%]L!99;D(NUE4-%$P,9P5+'Y[-I3JT\VC.M&$JN)PV58>E45>#:C*E6J0C
M+DY(14'S0C*45^]E=2NDN;FDL0E>2BXW<;NVJYMO-IKJ].Q6\>ZI/N6X:.V$
M\,JN4_>!3'+$\,VZ5)UEF)Q$ZK/(ZEPF5^0$?.=_%H-SX@TRRU_F"ZDN+K3X
M6,T4,USI$:W$BW%PBEK&,Q*#&['R'U"WM8I8;E7C2O7_ !5J(DL/(E )D9V4
MXQ(LCQ+<XW9R(V\Z,,O4,C8#=_AOXVZUX@COM$TSPX;Y=1DM-:DNKFV265H;
M2YGM#/'$T<3,!(++=)M0LRN$7=N"GZ;*<*\-E5903A:E*FN6Z;M)1O!J]DK:
MIW:ONTT9SESXG#V32=1RUTNE"SZZZ]5=/HCTWXS?&+3]$T^?P[H$EK=W$T+7
M @CM&AOK*6Q9GMH)4CE>(RP.YD-S$8S(KOOPCLE>.:?,(#!JXNHKJ;4[_3((
MM03S4A4W\UH[P)+N&(K>&26VC=%V?>41@""48_PXTK['=7>GZUI%W+)>J[1:
MJ+6:247:2-M>1+V/S86GC+Z=(T2>3'.T9DW1 25[QXPT/1?$W@&ZL=)T2ZT"
M"PS<0:BRLEM%=@1NL*S11F"-6F\KY@1Y.[;-# ,R40B^10]FU*6DF[-RDTES
MMJUW=)=[VZ(]"<>:4(J7*W)7DT[62[+WMSV;5+Z&RLO#^GS9.H"0WL<*"9IP
M)[J5PQ18(FV212*JF1QR PPP);G?%PBNO%-[;W*EHKB.#S5/RR)*VG6Q<DLK
M*&4]%&<MQR_(^?\ P=XI^*VF7VD:+<W=C?ZJUS#9V<&LV46H2/;EHQ&D-R"+
MTJ$4&&>WDG&,M%,0./;/%4U]+XOU@?(;Y(X))XXV#I#?QZ?;RWEO'N(8A)A/
MM,DCDJH 9V! :ISC4ITK>\J5:4FG=OVE9.32=W;6[;;OJDD82G3C)J4XNSMY
M::=5U]+JYUW@G79("^BO=1S7VG1JMEN ?[?IT860V1[8@)<[MI: S"2W\MMS
M5]*:$MM?VT-S$K'>JI)'D[XIF4DPR*%<JYV/RK;'09!P37QIX-L[R?78-49C
MY%E#>22N%!;8;:5I5<@YCQ_ _(8[5RK$ >\_!CQ3*-3%I=2[K2\O8M(Q<*^T
MW%X^W3/,)+J)//#68ED9!_I2 $[<'\K\4N"*.<93B<XP5-QS?*\*JS=)1YJ^
M'C*3>$J0:Y9<JO5A/X]X\UDN7]+\-N,*V3YO0RJOB82RG,:\83I59R4,+7J+
ME>)IRB[\U2T83IVY-4U'F;/HZVTX!594& !N]0,@#:"3A0<L?XCST!XZ6WL2
MJAL@JQ!4%0< @X/3=@#D9/;'7%;=MIH97545"-P)P<Y5L%B1N4 X)!(7<,\9
MK2BTTJP!QA54#(;(P1D@$8)_AXY)(X/;^4W\4EM9ZJS5G;56DDU9W5FD[+;J
M_P"J-NM_/OU3MINFGMU(;&PWE3M!R>,C:N >,8P#@<#OR23VKL;"S3Y \:C#
M#&&)!(.#G!X )Y[\\$<U6L;/C@[=I4YQMP&YP,]RI/'7@X((&>KL[0'88N\@
MSA=IVDX]\$YX!R.<@XY" T[*U4E61=H4'<I]1][&3G)X&X=-HX.:ZNUA5 ZY
M; "\_+PN>>% !. >3D^]9-O$\;QJ5"XPS[<D;6P2#D DX'/&WL2#C/3VEJ6^
M8;'5SCYB0>#N8$8Q@CD8/4^M '1649"+M.2'0L2< KG)P#T&[H/O>^#6U"3Y
M@&3MPY ] 3W/4YR"<GJ!GI6?9QE$#8&UURN,G&, @Y P2<G&3GG.",5?B(\U
M>^-VX?[.#D8]<XX]J +M%(,XY]3^63C],4M '\F'[.WP'TKQA^WW^U[\9KWQ
MWHMAJO@/]KC]IO2/#OPY$EH?$OB6\U#XI^.VN-76"XGCF.C:=!,4=K*WN;F6
MZ=$_=H&:OTJ\0Z7)$\V[[ZHR.N&+<8R&Q[@ YR 1T!(%?S0_M<:J-%_;)_:=
MOK&U6UO;3]J#]H.[CO\ 0-3UC1=329?C-XW/F"]2YF6._9EWR300QQ"1B8UB
M0#']0FF>1KO@[PEK<=O<PQ:MX3\.W^V^<R7X-YH]K/\ Z9)EB]P3(3,S$[W!
MD+<D5@W=N_IVZO0JE)M2B]5S<VOG=:+7L?.^K::2)L9 PH.XLV02>"-W'!&1
MCG&.<<</?V@R6$:@X< L Q&1@<MG;@YX& <=.E>]:]IVP2,(U7:K%& ^]@G[
MV<L> . W<\D8KQ;6YI;9WS&Q 0 [E 'R@\D!F)Z]<@]1UP1S&UEV7W(Y);-V
MPQ<*>R[<[@IX)/7KZ?A69>0*W!5&*A\$H&.=W7)&3P>O4C)SD"M ZK&-P^QJ
MSC)!$DB L 3C"C R<#T'(SC&,>\UU@V%TF1L*1A'F/KRS8P%P<$<]>>": .:
MO;"YNY(;"UB\RYO)8+2VB500]Q/*D,"!0.3)*ZJ,==V,C%4OC]NE^*ND^#["
M9W\/_!SP/INCZ?!&S)&FLZU9W%E/>ML?]Z_]ES:[JL4DF,3>.]19<%N?3/A[
M?Q77C32;F[LVM+70C/XBNI96S&%T:![ZT39)"\H>345M-H216<N0NT[<?/NK
M^(&U7Q'XV\0WMKYUWXC\6:E-(T;;A%!ID<6B6EN&,.Z2."UTZ-(_O#:SDN"V
M C*=^;RL<3J5Q<B-Q#<7 $:$@K)*JB-%(XPP 4 *<*, 8 X''K7CKP+X9U70
M8=0\0)>W4]KX9TNXTYVNG5+>XNQ9B>4@G,C""$J@;<BY=]I."/)]0NK9A<;8
MY8PT<@*H20H Z;2O.,@G##)],8'J?C&]N-8M[VW4RPPV^E:7:PP@#88K9+7.
MT97&9#*I4\X^8'YMM,@]>A^&/PZN[>QDDCMV#V&FJRR1VTO"V<*LI9X6+#(;
M.2>N<<G,4GP2^$-S*WG>'_#4ZN,_Z3H>@SX8J-S-Y^G-Z<L0>Y'/-16>FWC6
M=D1-@-8V*JKJ2RG[+$H& !D]6V@#)^7<.M6#I5_&KXG=F,;8VQLI##E67=P'
M!&5;.0V"H&,,GR6]^_+KM??Y=-V[Z:!9/=7,+5O"W@/X6Q_8?"/ACPQIVH>-
M] O_ /A)=4T[PUH=EK<GP_M=7@M(_#]AJ-C8V]Y!!\0_%VG'P_,]K<033V>@
MZMILS/;7PC:/Q%\*?AQXHNY-8\8Z!H>N^(;B&'[5-';3_9;"X6*&-K+1Y1<K
M<0:7:+#'9V$,<J!8($D($K,:I>*6NM=\;Z38,\4T&DQ^ O"UO#&P*Q6GA[PI
MX@\<W,3SAI [2>,;.;4KD@1R-?7-QYZ[F2./N[32-4))$!<* 5W*IY7 # Y;
M<1G/W>C'G.#7!1BJN)JU$_=IR48IIR4D];IWLOQ>ETUU#RS_ (9=T+Q6%MO#
M?AC1?#$)<1MJ\U]K\#HC*.88H]:3:VT[E.#D_-CL?0_!OPNNOV<[6U<1P7KZ
MI9+H-SXJ7QAKFM7'B._M;(2W33Z!JDL\&A%Q;K=6QM)S!;&)K33K>%+FZ#=?
M'!XE1 D*R(/DX!*KQC[JC9A>NT;GP, $XR=*33)]3BLM,\2R7 B:Y>\L"&X%
MQ!Y<EXS&1G!)ML1HN4W-( 2<#'=4473J)V<;+F6B;^*UG]FS[-7OU!7YXI:7
MZ[V>B6B[W_,]$TG4'U*RDNO*(,]J)!D$X\Q0& +9/88).",#IQ7!ZA;RL6C(
MPT>8W#9(WA0&)SP6(*@,3D $YKUK3=,>&&&.SGCD5U"JFP)MC(( 51Z8Q@D
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M+Z_<WMA;O^U!^T3<(EO HGFM7^,_C@PS1"YV!HI%;B55>-CC87R*_7OX7_\
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MVB!H;V-S)&TBM;1_A'H=UKGA_4%N8-/@N"5DMY+74;)KNTDCF WB6W,D<4O
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ML;_=>E^)FAB6:1U0A0[M&ZDH47!4JK?*!DDJ0"?Q%2:IXILS:N5N2Y*Y;O\
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MG_".ZD3'M5?*ZAAG "Y T;]UU; ]1@YQSV.23G@5[U?VA)8A,#*D?,,G!/3
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M-V9]-X?Y_'*>,,CJU)<M/$XFG@L0XZKV6-O03E+X4XU94V^9I6:;Z7_3^V1
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M+H[H_OO*<9/&Y7EV-Y))8O!8;$)R6KYZ5-.3=]7*2E.^EU?MK+%)*#M)4JI
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M'GG2^U)VL;4-J4MU96UQJTMS=VT]I9B&3Z^MO!7A!W8/X>TIG.Y=K6<;+@#
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M@6UW8>%K[1M*N0ADUW5HUM8D0@,TD;W"KGY2'$C.H&2QW=_O?P)^S?\ L]?
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M+::W+\1_'FK:[\/+[0]/5-/M] O='DTW4=(DMYO#]U-H[0R5QFJ7?PA\+?\
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MMR<95U5&#* DE=MK]YH'P]TEIM8G^SW)@_T.R:1GN;N1(S$L2H?WDT9>,AF
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M)/4]>3FO6OVW+4?\--_M+.V<-^TI\?&S@@G=\7?&! &3E@.>0/3BO(_#**-
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M^NENZO>UD*$U43TM9I:M/5KH_+TZGV+>7]T6NK*.6.VTZ[\;QW#VJX9))?\
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M_A[6KO3-4L-&34]"_P"$AT:Q\00VEU+ D$37EE9ZE;B]A=&BW,H>#(VI]0^
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M)=3U&.WL;:SDCM+K4)H$-@?T3_:"_8__ &>?V3_AOX-\"_"+P#)+K-Q8:AJ
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M[IK7MWZ&U%RIX RX&/3.T9_$8(QSSUS5E+<O+&J%O-8K&C*2F"6! ^4-G.<
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MD)99(6BO%6'Y5@*IN0\-3%X92;PTL4Z;T7MW3;M]E*,)24;*RO?56T5F==/
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M,D)\MI588XJM&3=*,_<6KC*R<FK*,M[Z;*V[VV8'M/[7W@A?'O\ P1]^"/Q
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MI;WL[36Q=Y8K5LW"[+8-);M((?.F!6(2!)=OV+\!?%5OI7@[4]4GM5N4T_\
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M>M+=;70AVLY8U** 7*F5RI900,KS_%6SK9\0^*I)+S4[R06JY7+ Q(." $0
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MYE.6^ZO%O_!-7XS:]X%CT"VU/X3C6K:.ZCMKBY\0>)DM51K/[/9Q&YC\"37
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MBL@D1!0$,2:M-M!"8V00%(6T(C*)$8$F2DQ4AC"G%9%N$"(B(@)&9'+ 1$B
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M> ##Y/7]%_VGL: R ;3^:=._Z.=;/*L/.2>'E:BQ_S'8@NH!2@!P,'?6>*<
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M9QR5*Q@LD)\/?J#E"(S(DE_$#P@=:!K&39BI&E%QB&4OGJ@&!@)4)0RMF!1
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ML$/$AJR3V%&EXCR@QHCFLMWX."#=<AT0TE5:YM-]>+B)<H&*(<<1QD-F2!N
MY955>J0XCA$R<&Y;J6R'7XC/2-+3]78A(<"'0IM\5&S=$3<7"W4)6=3&#_5
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M:#S/$7&TX* 6P.ENN0V@-QUGB>U_#W% '[FTBRWSEQ8!R8("1Z;^$6B"FDX
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MR(I&\V2NBS,Z()V;25!:H[)Y:=OJZH\UD<#K$;EC^:\ 5SK!J60$- _AA&@
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MO:?K[.O*CYSJ1=6,5R8CI;W6@H?T@%?U_9&FA:Y.:*_RR NU;HQ/UT B'[?
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MQ"$C;. Q]*2EK_3^KE'<V<1+8T+\-8HA6?$68D+^=NP,@"&?N*GLXIS;P6H
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M;"2 /N%KJ.@BW'B#$,=&3_1T%,K/2^^3L2">P]*)*O2[9]8:QL?G$![US#>
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M5% E/#=D'W">%+3=H>N$_5.7O5EDX6-*MS=#>RR$%#J(MI&[0&( +H9W,Z%
M;1%RM$^43%4BIE6@<Y!IAL):7B>K(ZC-I&U0 >@NQ.670G7BL%BYD7"JPQY$
M*TU->A*.QS+VW6(YA$0H:%_$TBL*)GFS?(NBE$+03I3> -KF:"+\JG E#]$P
MV<74(#E :9A9L#*>UL29G/,0O-;D'F@<=J2O)@4,*#>] .K[1.ZY7\^LHVR0
M;^4QG(@C2K;?@),=6=;K73;=/E(\C\^G" H8NR%^I%B2P31EQFKKA"GJYS\J
MBAX#ZMS\-/Q*=S8%1MKY3'$+O3T>8XA>9^HLH&23=Y#PG;PY)T0&>BO/"9N]
MYW(?YU&)\Z!D"=:$VF?)?G?ZPHO31/Y&%>A:HG=!'PECMWHG[!6M/W9 SV0>
MI!\4^>C=X]X/E*]+S/J5&BK23Y>93//7D0X).B_RA,63/>\3191,TGZ1*UXX
M&U0XF490Z>LPN"7[<LMB$J-I<;XLPKJ@_L:YV^ ]SW?4H( [FO=(+XN- N]8
M'Z/CMMTOOSKIV7HT,#28=+E^QI_=P:BS<D?VB*Q$TU4S?O?CCMVW?DV?\.MY
MFU2P?:MANV/SJ=[B0(^^=0V.MJ*&FZ5^3A7^]NSJM[_MNA#7SVZ>RF *RFE:
MATCX_ACH$#C&$U%9?6-7R;^2$=#N10(KNR^#L@F-G)#O[E<Z0&<Q-QRF,/H2
M.8QD+2*D79YGYD6"& YRDWQG$U"2&EW[7NZ9WU53RL\@M?6HQ#/6K!L<E-I#
MAQ\JV?P6Z3UFRYM2< !A,DHZ-,!83T1RF5IVZ%497_/U,TGVM:1S@W,DWZC2
M:9<GV>)8.1Z0!$"Y0J:)W#'P.62%MHV_K*3%1W*\_RJF!9:Y2AOYN7SIRZ%;
MXLEL9APBG=\ZR=8.PEZ+,$"L)F^0!P/)7?OQHZ\X(]Y ;U_O1<QZ5(H F[D$
M6UOD!Q1DHO;7RI,&6TV1;-H[<S9C\V!';$4\&0WB^LD[%=F,?:0#4+/,G-QO
MME/QN&.+02]FM$DFUD5;/@<*9A?VY (2+D,7X@B1ZZ"H$(!_76Y )T6#A RE
MR?%WKX3:6K@V7H<O"!>;#MV*(%;WAW6?J8*2E1O6EE6Y$0U\_&DV71V]3ILZ
M;]*D>W8:MJ9?$!J=B,7NN3!SPMPRC7BRX7;3-QS+93"7=WM;#1?N4QME8_@L
M\H-?G-Z6\!,-9].LZ1-N]\G5C>O9PT6UTZ^'%[]:O_ GY$"^*BS64]"<D*D1
M.F";2O=0,:T8CG>*V)F[+%[7D4U(FCQQ1ZKT.IC?@TE3VH&WEV!&)QH&*''(
M;#/X(%F7:-+%0R/ 51Q&*NC I6BA[($OA_,/ MM_%C(U^>'$^.[=H0,801V^
M>3(K&G(6\K^3VRL>DV) !S$^&[U7[J BYJ>8ZB=;0,OKZ%W*-XMNS=5R'^@
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MNAV&%,(],HM^@C8Y[GOX"TWX<B-GE^+8L,J".D32:[%!853D;VBZ),A,$M#
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M0 46>KI8H)P]N:#V9,T>%*VOL%'>RYH9!#F5S3]!SI#Z .\4(&0"*Q3[(^3
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M09VM<"1H2/!@)QVPN\@S:!*2$)L9U  S2W=!XVD1R@)VO#:V'=0!H@ L=4B
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MX=Y'1@]/FK9GTJPH^('OX(OB-V<R?"/[%<3$NXFF;;-S3[X%NL)I7[O,ZL2
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M0F=XV[0'5[LRH?1>8%^#?6N-^N&Z?>ROSG2-<)^7W L&GQUNO-1@O#=PDUV
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M]MP)GPI>WX8:P\[ZZFT$'7&,Y=G;UYC$_!0@UB[@E+-M]AWE[7L_!Q,J2 9
MERTG09C7(,7J*\+@X_+55+_!SW1X"YTO'-_ZB+ *V0JW]PB-::NH)#@#JA87
M,M0[@L%QJ3ZR75GN\!Y.EC+63995$(MP:Z'5/ !-VS[YDG+S1/,?8&-;V^WP
MQI'^!KD.;9"!QN.I&^$"^1[D.0 2.=D$=9HQ[3'0YL7UA-W >0F+C[Z$F+^@
M62,OD4WP>6EN8X?S38J9C#!,W5E/(7X/N7"QZ%'*58E>_ 0:4BL8Z:790#_
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M#*?I)E3GNYH^S!-2)S:_G)S7;@6F2P@%>'/(3]D,DAC)<SK4A$&J+DB6;F.
M^@+;%?05"66\M533NE@:^B9_"66Z-=F&Z .4Y6N&8NY_B!/O2UA" ;^@UT%L
MY7N>^B'NN.HH%-:].PD.5K.I*=(9M(WF31V(E<VSKO 2Z*,J&:93"]@5#;'
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M<<E<%NM1K6*32HO6W594JL*+I!A#Z@[HM,K'6QIE%PF6]8S_![]S>I'<0\=
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M!NA UQA:0,\E&,$G:F'\6T0::OD"$X\??BX^<"*5'4\;X0$!O#&2+$RQ#+'
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M)O/+10SJ>=L"62_=>&)*8_/HK:MS]+A@=[DY5I6*8(6#!J49HZ^AZ4-X$1%
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M&1P_DO9[RH+7-=N9'N?Z6"][8D5Z;&CIGONM6U[=2@@9T3^:,-K]_4[8M9-
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M3/ O)ITVT-RLGPMRO/7X<4%04F/0GJ/WZKN/%$KU7];[V#NZQ.2Q>+,3]K;
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M#QG!BS0CRC9"P<2.00T&QO?1[*&O,]Y-;V%7N4U"MRT&/'@M57)IMUQ@NQV
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M5#5DIO_QFTPHK<Z-?-P8C-:(KF8T>+X,S0Z'PJ&T7?XA65&.KDX/O,(O!#\
MH+3MC8P:T+BAT;V^Y+3J:>C9AT9G*T(JU@W<R:N-;MX\,G?*L7D*R;?NN8&4
MZ>&Z@'8I(XM0(7I'[EE"<1@"I/@8:X1]+=6MFBW3EI,"$K3)&S8F*_O UAY"
M/A?;H:YM]P+LE3GJV]]916,,!:8&=NB'2;(0C$$*(6]B!73^7H(M"DK87&W.
MQV3B-V:(A95F4&IB=?RNSY9-W)_BQ(;T6,2O8F'#7;YOZ7&$<2<^O86L& +X
M2B\(4PL?@])5<;0!WAH6OW(=.4M;/JEP4_E21CJYJR"VE+4:/@E52=G9E6;@
MR_X45FY+^4=-DYRX%O+ ^:?4Q[K_UI9./XR@PQ(JAGZ9I.W"M(3H4O,7<YD\
MO69,7KBR4<;.;;/GTW.B]0 \\\=&[XRRX=1#J+B[C9SCXK%-) S7<$Y;7TCC
MLA_RZ??C=]__,SK2WZ@^M-%-8O_B@RD776$EX74E;J2)PE.4!<#J*=Z:=LRO
M-.W/;;6(1)3J#'YG92*&N>_.$BH[IB;>=K5]E_FPK;Z[,V<2.2[S3#(I)RYN
M2N;H#I5ZF^L%-V8USCJTJC@Y/9_^>GEBRV!Q4(ZA%/QKZT/=B:;.7^M]FRKM
MUM9Z;VG5Z7[]ZFX.WOH;IP8\3HO*J@J_M^'9Z7"+!YOM=M2S7\Y?_67]@='^
MZCTG"59+J+/L<7.I[4W@FVRRDY ?[8BHT1+-2]8:PF\\<ZIY!UC;+=:!]X%S
MESG,\9RQ[J_=O7S>D[G99RK?J;%YA@!K0ST(C<N>P7OO0041T/&'E.">!>4%
MV\W?J!&WH6BY<&+](S@&&@"KE#-0(+!?U,5K=E-X@C,2L@ ]VJ#17:\*TGP0
MK[+OX\45!BP(VG@*XSNT<5$-=15T7/4S'#I 5L [5+\B2F2N\SA^-=4 *@94
MLI6LHA_;V";4 X@89!X"O1'R12#%!#V;*0^;_0:@E<5 (^,*/99U1:S-Q5/L
M?4<4U+!JRCXYB4]<"8< #_^6%3@30OM_;_<Y(9VSB2U77HMACTZY?VJJB4@P
M&[XVO3UND=MPVO35>+QYX.L78S0!XK,9.1H3RLX>Y2'U7P]@#. D3,7CH/52
M/^)EEEXB[ J0>]S*QR@W%KKI>LU[J)O+27R1Z02ET)CT##3/<DZ^=/)2G''H
M#7!NZ*PY-L;-/BC4T?%)J9O[GXF$V(Y[]:?N^+P,+-KM&J/W%\77=>?B]KN?
MU>&!W2>G#X2GV/D'9U0%))^PS NNN^AW(UJXG\%)'*3$!2-5M+[UV/5T5$CH
M[4=/TU((QO= -R'!$H'7D(U Z@ORF$K)&&X_+J&OI8AE&$7O0PI?EE6GLJ*]
MXNE18U0N">%NG>QWJA>$IODO#8E >@_/MAF#.2#%%)67,5UX:+Z<C8YML\]/
MP>9-;!O<B@LD9&U5$S0Z+V582^K^'^_WZ,KG&)AF>X45^$UI0]*"[2$Z4" +
M4QP'R4*Z"8ZN.@BG =N:Y"HLD\?Q[E*8]X2W5+-A.VBE_,93A/9PFR0?; VT
MI)\Z'E*($2#V"M5)JG"MSO\VO^J;1O>;:N4TQA#G"9Y;0BGMU'^R-8Y0RQ)*
MF%:6K[&?H+TFK?S"70^Q@L&/-^IJ*?(C(+K0'@BIW#3,;C]=.U,^Q,C_,F\3
M\$DN.!K>W9#XP.>B@?K]^?DEE-82ZA1K%*,\/3BO2%"2U:4("F!&%XZ#7H4/
M2V51) GC!>)E,'JN!,.X&V[HU-.U":T3RX$>QI?Y=/U]M=>G^P<";\@F)CZ6
M4ZJ.6W0D^!PTGGQ2.'5J0]W^X%*+P>Z3UNJ2T(LA-SLE]QV3'X5\M,_+63_R
MWQT6#[S2FH'OE(\!05F_3OM6%1ZVKCYZ-[ N:,]A9_=M]]0E52OSA#+3<*CN
M("%,:52;R9?>[S+=X<K]$R7)2/ISC_+E_$OK/]PO[71X-R5"T;CWEE"L\&5O
M*';:U@L2:_7>ZGJ?C3S"S*+XV9/Q10VO4="S(N;AQ1=R@FA=%4;:0ZYV-IGE
M@GF9,S/C-4DP3^2[XZI$;K\Q'8274(W.)L=79O7L_3XUOH0:$7]S65:4I6%)
MF4NH(Z^10ZCL<^>+!VRX'3V-F_MN%1&PD1H&YK+0/7_K<^2J@/-7,N?\-$G_
M(@OJRM_R9';YLJOTRLO?O\^,9>S<<8O.^L:*+FD.?K3ZW?:#Z9F5'?M^5<[\
M^TWL:+[BSS3YP",4W8[%_ETOQ>3!<WJ$7N^BIKT[&U5$L>E0^\R]I2\^K>[A
M'6#Q!Z:8_Q@@2UG#OU"T5W)!_NRE"$.L<4CZDC;Y:(Y%%(V4ASM</H5$LDAG
M<+20D(B]U29!3S1L-3WB\E\+A$EX<D8A=#8)_$UK^;+W\RMB6MF3,[,[!LKZ
MO+:_VW(W'_7C%WV Z0M_1'"PFL*7BOC_BZ\WCVHB:_M%XXB($)EE3"LBDX#*
MI(!)*R\@(D1!9B&M-#)$I!&0*#%1F2?3+2+=*$0$C(@0%0(*F A)H)5&9I"@
MA"2MC)$JA5"2I#CAW/NM^YV[SCE_[%I9%(%=>S_/;ZC:^ZE5Q)A5.-C,747P
M$D3(^7:%9H)=H-0ZPE2XG)IB%.8&"<"DXPV@:<,8_)ZJ0G03A-5AA*AL61!(
MCX"[@#OZ5+:JOP<X\*'G&OYL?<S5J/=UM2%P8=#OQ!@YE;2!-&"LU0B8B9&
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MG()2)SJ/U"\XD+?-Z:/R75.3U!1L/M"SBIA7DJK$E6\<8>K&D9_CYHL?RPZ
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MAH7Y?U<6^0CFNIEFS-I6=B=_@,Z^1]\.1;\9U1V V%SC[:.P!=1[<@!M)',
M/B\7$!.?GADCZ \&%)T!=7-AJ';P;EE=ZO'T4A\OR_I,W9 ]]XN+4\.*+;P\
M;/9-%654#24L3$@"\.9.^):XI\-[Q/'AZ/]\+;IH$]A8>2G/_,&#AWGFB/]]
M^X&4/)<SR9&8#Y%L$RZ.014; :V3Q?<EGB<'&A.TH3P]8J(PS/TEWO->.U\M
M^==A5[)HOW:'EZ&H@ZD_S/OHYEJRWKSNR^U]2#JF]X=LEO'Y\Z.RV)3'<;J!
M(XXZCH,3$1,36&U&=5EUH\_AGN'A?^9_'Q\/ZZ#8?_]G1NN4B9>)I87)C]&F
MM7W/I$^KB.83L=5K,GRMV-.$8QN KOM<3Y5>4/SHJ*Z_G$H^_SS2=*C/-K=-
M%9!ZOFJ%ZD J.^AD3G73$-$TA3:[DO+NH_L3@L>1"^#?<SAH9W,GDO=-.,CA
M R%8R%RWLW?\Z(#7.6;"F.=D\?#H/$-J,%WUL3O-.+\&P@GNK^@6HLV8-R[U
M=0GXJ+BKU!MMO\9;BWRB& :%H]O6+> :HV6ZHY)MD+LH&K( #$Y#V:N(39OD
MCVQV,<.M)$1YNJM1HM0->NC=NCUP'E^^%VA< ):/-O;30I3RA#C-6=)N8)C!
MD"V3=I2FG8JV_3=;/ ,HP6IVBHNO)(0)FCFKB*P)'2!;IL$_ 2 +&^N<!'PV
M<AUIE*^33.%10@$JEZ]!0'4PG<#43KX^<?=PFPM A[=3$-#5$4QN":SN8XS-
MTS^<G=WF+N!OFPY=SDW9T8C;OHHXS6J@S]=('4E_3VS.%S3/OP5<!"5O>C=6
M'K%^GPOP.YP]L[*>IVVTNEA*SW50,?AUF.A?[[KECX]XI@ES..5>]2G)O1F*
MP\+BNN]F\ZE2ESG,B^;Y&6!\DI(+'R)&RJM=SPJL?Z+J$Q,A4$36('P7FG%P
MNG'^;Q\3TL^T#+EBG\Z-ENZYF:*2&^]J-BD-]_W6K8B>ID%[<G/<:--HRP1M
M\9/6R77N_ZWA=G9)K\'< \0 W(U$>(BZ$2>R@_YP_8FE$M3%4P?'">7A9%@]
M9C$%Z.*]?WKQ7W!/LBDJZMMXP.:WN-[-^Y?&DS%NLEI!Q23." F9?U[@L""/
M)2H4A)5JQ#(W8G6O*$G7R?"HKO@P7!'[J*BG?7C0K=3(Y\%^,,H2/:G&ZV1X
M^?G=3B\M-'3W#:XY=#SYV5+M48NJQ?LS'L5WSGRV_./D\H]($^_#/UZ_#Z)9
MEX6>_OQ/<__II):X=_?K2ULIHTQED)7.-"6XK.T,5F P]2A(OT&,KX@EF0/D
M?-G^&AX^PA#$9#MT'V08&83W,=*4HU\,+=;Y=1!L]]K6[;G+F^7%?,GR+!RF
MG/I#EBU,O'[-F?*>5<S*0CT?%6, ?\D%>9'"R$L%V6*O1V-XW#/;^3E=<=':
MO1ZR+I%<36CFD,R@!*D?_/?57BXV&VU\[PQTKVH,0@FYH_.?TJ0^!,^C Z[K
M:B$S_^$V#1NF 2'U]*!PH$TYOD*N,JEJ("F"CH!;QX79F<QUI ^IJX@7D@8A
M=AS;3EU'VL:L>PR5""GL7E59$.0CU?I(W$/6@30[6>IA. !U@^@.\@6V8I\:
M(MK8=:0"=Z,4R;'=%MOR$:-"-*BW21>$)_J=-LTOT*J]%GJP1%O%:[@FNWS/
M]DKESOY[W.,9)ADUOG8!'VD6_A6;/ +*S-\]I*5N20N\?X9O*;EX>M0.^U='
MLL I]+7SK5*:EWM']966.S-DMQ]&2>(?9.KWT@.8.K(==0NL1?J 42/M)W4;
MFV&46;'4/-AE -Y ZKD:Q$&I$7V&X9T$%-L8256X;(?FF^@]7L"4Y$^@1+R+
MM./1=;[&0T>F':0B]8#?3YB"4WFLF+2%[3(_0-(06<&=I.:@]4!Z%FL]^0)+
M*T[_?09:C33 VD;2E)U@*?+Y[$=HO,/1N4ML)@AW\QI1,$1*S"72$.]\)6@G
MS!;;*HZI%*)7E6S3*.,>LH!L;%]H.]F(T2?JT0HOO6=W.H::-C73YFN^GS,]
MZF Q=IHS&%#U>2MV%GKW,L#_WL3KM:>+0U,Z(C/S#FNNU,TVYLY9Q^IN3&UC
MI=YQKZ .^;GCIS[G%\P</UEM[KL_]5+J:R<E><A<RQ>*H$PW&$3EI'BK:OX,
M2(H?XTN_,IY\<HNJGEY!%\5:P[2:V:"&QM]"/GP(;C_\Z=,_WW8[2H"W]@6/
MG[+?,DT5EZA01.V]ZPE!0C(76T!58Z(4!/F^HF(&O0TLR2,&5,T8&X/G:X7Q
M.E(.R7B0>.CQIX^>FQNNU1'(WD-+KQU'L?C<^L4ZM 3>C<?'5F&GNH7-\TO@
M@AM YRRL(W1/4L1%H/^D;E:E8A2+B1CY/9*Q;">4*Y)2U GX+O+V-MRD$5F2
M &Z250I)V<)P;(<N4X<)W1-0;TXX@Z3G3PG(26XI'JW75M3>8L,2Y$3)MT$+
M@*THH1"MKNC[7E>+R1#B%6"9RU*!78F&(_!.:+0#;01DL82HC%"=;*D>J:]\
M*ZCVZO$T[-)']!+L5K!31A$GU/-&PJ\CKH>>N$>E"?,O,QAY\OB+\4#A%+8L
M_%!0=PW7P>!)\+L J\ DO_OZM5D%9WNURLR3NLJ;&=3AF:&J"N=35U^=^L>R
MISY:>RE@1]\IQJ'8'*K]M2]/G/0\RLQV2*^R8F)P3;WS9&'A!K:Q!; @/@R8
MA  +!?"^:7Y#;^92/$9(2?]J[4"A1)@,^$?TH57"#L1QBX3UC(<^\76Q$>O*
M=H$>%543'V8=6\XTE8PD8?MEOO(GF/.]-U<H>8O4?+(14YOH-$Q4F:1N)1X#
M[_XEPAA,ZV^N%) 1T$*7+=#;3MH_NG?)8-HFF:\&T86[#RCRHZ7NG]C8IX0:
M [?GMZ^YDWIQUU<1ZN2S*%ZDL$?" DJ$3*J(OT.6,LR:K A=YGY*D_0HA@O/
M;L&Q<9J$,!_%-,8K=-=F>0'L# 5U,+?W-QHA!1^I#5.<5DPZ3A7^"=HI=J!L
MIW%7$4ARQZ_PSE&9-8CJH$1-H?1)&TG#JPB="JA.&@B52)+E#YC&1&_Y0Y(Q
M_ ]50\$ZF/4Q^K;YS'W$GYH@;P4;Z\A+EC!J,CN@D%XD+$0%09F 2$* G-+
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M&%/(I1<?'W&8PZ^E].J+IN)I<MN^6YA8WG7VA.0<XQ.U!(Z#<D0Q#D:X>A*
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MKO^PK2TT5WEK:=>/D$*H+XH'QM)P1M8S'.C0&6Y!_"I!OIP1PI\T:\''WT[
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M5D!Q:)BR(:^]TU UEZS#X>7LV914.'!(FD<G+_ZNI75+746#IF>;B("]4]4
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MW7"TQK5EQ1\YAU9=<IQL:?+G)=>@G0MW"-9Z-628G,BLL+Z=L3I_9N5 [.M
M7^>33@#A2VP*SV#2<@ > -H/ \$1"Z-O^ L(*S(7#E1$B>0D5#I#2Z-;K]WH
M@C)B0H[D^>B4I.KD-!![F!&%<]/%KUW1#Q'A<H%)K^ITT+KV7[" .)MNFRFA
MVXCOI,#!AMB*(QV*R/8YY"-J-;]>.N$$L]6*FM!\2A/28_(&*1>-=;S#8I:]
M"5:%XS&8BQ@::R.-*IA!+2&OV2]'12R\^1ZN5R;;E,:1/W2P)/2PL'/Y4B,\
M^C>\K0..>YZZ^+L,:-A:N&12R)W@8'A6-4>'\$M674BP@)L35='GYN.MH0\=
MLD*Q%1YQLJ13J18OZN^?J<K7_>R?$O?*YM@K<\*034WYCM82>US'%MK>+\/J
MRGP7H^R*N#.,9F9G^<KV%2CGLL@FVZ6R?=J;?':D," '+;AD(]#C1OAB3M%Y
M?^:1##9F]C*+*_#(?=VHG/1F ]N/W"6'U>:A"&'3::FE/6#-)0-D$K795PAG
M ];\(JD7X0MT(ZF%GZBWJ2;X+2Q8SJA0F 1+\QQ$#WE\5!Q9M *O<\>:8HHF
M\A;B\1S_3!X#7[ZT('NCV;.3V?A&V2/NH4ZY:WNZ39V4\&G@_^(;:/D ]V+1
MN; C.4TD87Y"J(G[-=/YK:>UM(N4"?\M>UH^>T:0<'+AG/3>I**8,%0D#RAK
MG6U4FN,KOA,HW"\4FTU#VU-.&H1-KP@PC$JQ'YZV(;9_8O%K\?>04ZL>FS%_
M\N7N_<-H>D1YR0;W,GG@SKM>TS/-3O]^T^[J)7D&_;1EUA:[K+2&4CGZHF=Y
M^3[,X/CN4R\7[BJKC_3:<2QQR8V <?+/_O>OA;$V<1G]VX%SBC5.<+,N7J*E
M/5*4&U+.,QC8UP MS?<*_'T!TBA5/=32KON1:4A?!+$/T$68?"*(+'%T?" 7
M!+#-T) ^NP"WHKK+8951(MRS<@G! 6CS^#I5$DHGMY3.Z.V!/OE1K$05"+"Y
M[\D;L!(F[$6)%O_RXR8KYLB,;VS5TG>04F<6?P_PB_ 2^-,A.@@4:(:Z&*:I
M&:,L$X?K L7PW65'$_8;Y*BEW2^F"@5L1[7PVTV@1D8;S JI%DAEA(-L^_BF
M!FKZXL]_"7SLE);VE0D]%Y"1U$]P[WR^1#EBS&[>"_+$O&\@9Q[8"NANV[*N
M 2&@U*KUJ? GZ6C0>I7FC6BR20L2D&Y')(#L6.:G+JI<8@JR2"M&PK<ZP[2T
MDT@Z_(!!3$.H[8Z:62#)W^J$26\^))(0@"NNC@-$ZC=*VZ]GA(LBX0'[=U#?
M3D2Y9BH_MVD@64O3W0M7%?"K$-6QU+E@EO?([:C'6?\:G?GNQ8R!/:B61D;M
M!*-;<EP=!JY799X"?[*!2)<21OFZ_PN,\V1U&.=;H*@.A=X'J]_T4;#F./%7
M 9M)YE%@ 3OJI",6P@)=\KKP+%M]@^<KZO\=B85PZV%J2U<_L(F#71U&5#K#
M*$NS5_15H@=\)N\]TMON ZQ%;3XDB(8'G/VERF&&EI:93_^?;A'0_&_8(1 -
M@/D7+0W2TGQT[ZI-!MCQ7I%4,LJ1MZ<_D+9WO[HL1,OD8_NCTO:'K8TG(_LS
M+N3'Q;FTFK8&7.[Y,% K7_7#\DGVU\MG3J4YWSUYU2#^:;VON7YDV:8M>A4'
MCGTZ_,'Y1>GNVVZ,*<953NW'+SV;?OM&>-?,?,:IM+CEE>*EQ7[/!C,6/RW>
M=_S32-V%-./Z*-VQ\94?;L^'?K?*G&R06>D^/'?QU1MO/OU%O &BZ_QAGC.J
M*%4T#V_(Q6R+)7%>BF+1)4:!DT#$G\$[B;(NVCMKUA*_U2)'1/&0OL.\0*\/
M&7?*0L-/IO$\<*N[>/L4W;)49O(ZS-HD.EHIO>0P)B\/5296,' 7GLT0\_SH
M8W!:!!V*OAI4I/H=]\,Z9>TO@T>[!?J4LK46%0Q]A]D]7L/$TO>L$J.B974.
M#CP(3[\7=%H1:UJ"Z/+GXS\1DV2*2"LN<T]C83@:X9Y?K[ AO>6BZ*&_[)ER
MYK=]_#HXKU*7.!C0/^4C_#X$?[ZZ6*);>603ZX#;(ECV *1'@7J5M 5X'SVL
M J&.9&F<R0FK\E<B3>U&-?E:VJ]'YW]OT=*$J4XC=Y @W>A&-O9HE51+TW.;
MHJ5]"U6QRQFH*]3RMJY8.I6:S@T50[E.EY" >CP1>ZTZAXLUR[F/JN6)9=)S
MJ4OQ-,Q%7HCHV>NBJ>+UZ$&'.4@]Y,\ZWSC8!DQ)U\8TQ;Q4.(L(?QCDNQ)/
MD6TF+$XX&%9HGJ7#@2E6KG:UGY;F' %_F)_H$AQ59^2NL8<Y/JN?-"QM*?8Y
M=>_]D^U+IR )ASRN/&6(!7T*C2/_HUK</P&E;VZ@(%Y8PXD4S\[HTBE6'K7Y
MG$N0P<G93/=:)2/&S"BGWKK?A56$'5%YJL/)VX/-TCWMK9_WM'E)+/,;"E'7
M>2%DW&_.E<ZK>@<#GG8)0__J.WVB@C^A4_>"<49$<ZI3PJ%;C3XI]9(5GWW]
M-SWWOO!NV8WO[B7?# :Z:[,F5^ZXW65WTW#SV^1MV]Q6#/?!N\-G.UQM9M3:
MSI=?ZITKN]05%7BLZ'CB03S6N'+_C6^&QT^&SGKT(&3BD/F-N@RWFW8[NU]9
M11[LV9*V(^++R[4P0XJZ,T8<X!8=JA2:BB@W$>:BOG&(0($O$A!"J/\G+6T_
M(YJM3N/K-_6R-T(C=L9=Y)5;(NK)[_HCPZH$N"I.QM'8G3*G<GD[>;]*01"7
MPN3DNC."NU2P&Z=02U,@5%3@&S%("3:BH6X2 ;*TOPMG,V)@GU]@$'U1-]:(
M%>,LHF+B<5J:NW"&YV?+CR1]0!2-=-P&/ /]!/>Q,2,JPV&)Z(7W737C*UNN
M>Q$9.(9KJ&K^4BVM\;H=U,,J$8Y8M1N &)/7P23]7IP8I:_SS2#T,G$C$-VU
MM!A$:6Q(=(=QAD%$WV!#SOC/3*BEN?!CD(&#.73-+(Q-B7Z!HZ5YNM2.X#BH
M+[6#31XZ.)U4X'KP]QXJ&NZX" V8\S\R5 S\#% R6IJ1YV %HUU+.V=.719]
M#Z/&1P#3#_M[-K6T:$3-P4X&#ST"R7M^.:*REL'DX4#!=Y /%ZTI@56_=@I(
M_\7"5\QAEHRHX(5I^'!5,O\CI)I3K:5EA*\L*H=?P?1O%IU(ZR"UM55U#HQ_
M*IM<TYU/^:$,(M$>Y")_X42XU_F*\ <K#AX(XKF!D!XJ1M3BX\N)H+][RA.N
MCC+$SGQ*SA@H'>:+!@-:$-1--+*6 R:-JH3U0&#&*N #Q[6T;,XPC"=1:Z".
M%/; :2G(3.0E"L!@ Z<SEBH?[4>7@LB/V5#^I#7TY1N@NZLS(?*P51E92MX2
M#OCC8NK#(5LM;8^O&>,_LAOY7/(?C@0 D;:!,[+D12]599\!+AK%A?__^N3_
M2_7)ZW.;B$Y[];&%(99M9XF>T1<9C#Z<RF'R:/F"P;>DJLUL4*,RV(RW C_5
MR6+T^J[&"B(SL ]I=W#W4H>IV+C7)X1TWGRK,EF*B_A5Y3._>]^3W-(Z8YB\
M^;(XRXWNV,HTF=!8DN[%=?<<8K36>9-WECB,"331[4-$&9&4-6\CWH3J%MLQ
M+R:62R?R%F4&.M ;^9;XEL'.L>V1F<0!M.DR;Y9-'1K@@D=,O;T?#\:<RO_0
MV]+2%$F9X)(]M=G6+L*YY&OD* M?T%7ZPMY3,Y?Z#,\8@J:68&=D:]JX6;+G
MV3))7*(0O<ZSP-JD,86_#C@_(6S1AM[=WL%&OJ;8TC\=$][LS_8V-5XPZ<BU
M%I9MI=0 ZLA@H!L$EP:Y15URS_ZY&=QKG96-C/%]2N<*07] FDM:&S$>@V,+
MSZ#7*\Q^NKX._79#.HG_"VY1:6;59-,/R=EE5C+F1<^PK+OQGN5-*)BN9X>+
MTB<+UI379%PL^]+\_-?(PYFUV1LMQ1YINZ;D9;AEVUMW?["L=-ZB?ZWPH.A$
M_S>/#SFG#0,V%04GU&1O<3-<Y"&6+:K/F'^HTRZT?-.Q:ZXKTPV47D%Q(,WV
M;]1XMO#?06,*UZ--\L;T!\%28#<=:4)@7?Y0JY,7KDP#*W@3R]A3V B//AB4
MK6/OBE;+=KU!DV6))<BY'-RT@J^'"[+>9_!\7^">:=S&,ED@VG 5-8]V6-'K
M-7R1;\97>788"@B#,FJ\509O'BHMKF8)'*8)9-&1_+E<=[GJIFS$?KYFJ^24
M;04TCK>OS@'ZCDP#RLU@+[Z2/0//K=0G#M<NH>9Q$\O-%C?EI[A4%BT,!B9J
M_#E8VM+RR)=Z3^C@(%-$J^[@+!GG,O2S?4 (IB-CQS/*E^-^%<]/'WJ=UAHD
MDK$,>OD3,9K #5N:>*]W%S#R=G/T6W[ZZL*ZD NUN]]49*:^]3YS*[?BZ^HG
M/]\.]LMY)QZ[Q7UGIZ?1N8K]F6_3+MW/K$P_;7#G6Z>Q\WKGJLH5@7M6YI4=
MNG5TY?W,?8.3IRY]O*]G2ZJI491H5=V.[:$W%C9FSA^[:--2M\6+=VP9#H0.
MB+Z94E,S@5O.)5-T1?T"F83<QL[3Q9N&!MGO;(G9[H#IG#5V<',G'JJE[302
MJU6XD2]3IM#,%&MIVY]UQ5<B RX!L&J<EC9$3:/T_[CRN^F0+J%1IP;^<;T!
MA-Z?#'HLU+6[AO-\^.]X6MHK>)F/L#Z#,+FW7+.=WW"[BUIB=.'-*V*#>QTQ
M+/JQ XF2X#8NE)M !0)+SE@9@]SMPOZ< C/QU.S*6S?S@!V\?5Y'[3/R4]N6
M"4;FH6R5_B@)!=O3_Q_ 92]'LQ.N>D;52%7KJ65PSVML+'S-,9HX!8"JZ3Y#
M/4'T @T@ZRYJ:7U,D*GKC^S!BI; ;PX*59/^A'MV32M@;Z?*& ,\Y!F=3.7T
MI8$TH*7)OO)>_NO/^2]OP7\5K #I[H_]H\72SH%W1IH?DZBR9; Z,1)JU/DG
M>=:SBQVB_\_3RG/43'*!KO++:36S7DNS%N%,B$CO4M5H:4^18B9Y4-1,(7,M
ME!)JTFA /$7FP7W,T=+C'@L5+/KK+?56)AHQ7T'7Z/FSU>>BH1NX@-HR>9"J
M'!%0Z0TF;5I:&Z>;W3V*/TR /]OY8DBU@ L4[2ZIH)>0F/XG..7#G73BX@J)
M9A98?(]/N?T\"T"CW\"]'4@'S/8I5)F*W)#B=IV4ZVL5P,W<"QB#>B29WJ3T
M9[_E$+-!;E[0IED S+R4*P#?$'"Q=R"5IJ5=DX#A]*W(H.[Z">I>=%'.]KU4
M";#*'M_QU*^ZK KDU@.$50P$6<9481QLY<H7GJ."V0V*@$$MK57PS?'5"-R?
MH11J:>-201+>2[Z ^FZ/UK/KT^1*./@FL1U(IPQDP!,Z2M>80S1$N1!_PV[Y
M"B_E)FII\Q^$:&F^ PK2LP:ZSUL#1N,"EE[T J@&UX>\JQH^^,H8?@NB"F3D
M15.9TIE-([^54 ^8PT8CGNK7__%P_'#[%/@OY"+4YW]NM P<*BL$(@&N@OMT
MP81FYDT([H-P\S#BOJE*'TQ6!9D$*W_'5Q39_YM#\21[)9ANMV PW8_KP/2]
M&!S<*J(VG0H@+^4HR-W[6,I]K!?"]4 -6KIL-__,NJ.E?4Q(%\E?G%1"3XS8
M[,&)"^\]'GT!Z4^FH[(4I,!6(1B8,7"/WX1RB+K;TH0GJ5;^7?>XS#L)9F(.
MEDQ50>4<<F-^TH_1NG#P#2WM4Q-8]88'N[D\%^!?P]/ <JX%<]\3O1:*-ORP
MJEAGEM\GL_*I0X5JP5]:6ORO0P0R9)CAJ1'/>YE^#T^O@:T+!2/0R04I-[[Z
MD]WP@%,!_YUPX'<D-_48#,">T%L-EOI>AFRZU/REHATI^.L5'>C>[XO$=;?)
M8#R"O 5_^0H'0!JF= RB#,0WC/X%'U9//DG]'FYK+2^BY;A0RWF]!Q.)^D]'
M_QI]I;1_+^=LX9Z0Y\#)^29M@&RMHQ:=/)+TKZE!I<,6#Q,&8HHE_+OH(2@3
MD=N1";W%:F-@"1\E4-^%][ R](HP4.,"?:E "\@4^^O _8H6.TS_'_@AP[8=
M'@:NM=&ZO?,[G-2D/D%)[VMIJD&"*2A'GER!P#KCYN;$+4$Q6V-$. *CD,19
M_)CQ]PJ42?\M:6 ZY>R15;SPT=.11D VIS"4YAT2XI9B(MS7<LR(>O;9CO\_
M5T)*1_Z'$E*9XG]Q"<E(DX%2!XK6D CTY3URF*&9]A5\=U$R^P#4!D4/&F+2
M?J!&%X1HUH$;B&92*4- /RS'Z91+ZGB0.221D/+^7ZQA\PIDQ,;!'&Y^V2D%
MF/4G9?./8M'F-[H?X<5>6MIQ^LC^,XCG2&X_&S?W)%)'7ZX ^ N*@93>N!QY
MM@H 6X$&(5SAV<+_R!M:V@HJB3$0NNH,]=<E!I5G+*-D_'>2D16C-8P *^#Q
MCT5TNI#<BORP'1#)751@4:[?)^]#?44\((P;KLL?4:T!8)V9FG@B"[]&/H:_
M=$.!= U3: PI#^*/WL!W;8F$O< O#Z:"O)R]T1YJ >Z[H+,4T3 'I>2![1U_
MEV RYV@ 3#1Q04;VW_3W;5YC( PR#$3<39YJ^R([6#G 4.]D8;]# X.$/G$?
M/BK,D1+) :/R_J"5C$YE2>F>KYW_;XX/3P_XQ_'A\'\>'Q[\[\>'C?^_?'S8
MT+CG^&=!V=<CU&ULASMTB72BSC=8M:I_Q(2OA3>.[@1'W(&_SN/_9 ]7_4G\
MVGT;PQ)5UWJ%@]T5L-U-$D!+R4=HX!H3F%+S+=[H)NQ[C;/G8":[:=;41/7=
MLE?,D1D[OB-=*MN_*&]Y(["Q(X.> +%,VM@#^R\<C?X.WX3O.Q&FX.X7QI(W
M2'Z;Q@F H"=Q0OP<JE)I:;9__!TDU+_!)470P$51,XM"X,,*,DA+NWQSP'=9
M8-ENAF;VMM$*6,"(T%W&(03/6I 1 X]>(-M>6*DNG)C]HKO[WV@\*C5X) K<
MXB/X2Q44P-+8PU/AGO- T;*OH$SBYJB7^XV'>U;:DY[Q\)>$#V BIVAIW<0<
M8N%V1T,RV#)]D&1]'53?!-^Q$_GR74L+DFA^\068WW AGZQJ0H$+C<N$JVJH
M!J%J72&8GJP)P9KK(N#A!M"7O'=(G]%B,/(Q\"8<<.>\U$E4:2B#=+W: ><[
M$<F,_MG 3AF=NE06,LUS9-YN6'Q32)X&,>8.<$)ON"6-<A6H+H,@0,<B0)J4
M7K0@KBV!.M]*J#>_@.CF&HY$0#]N@_G<?RJ,2CL@N8SYD;WS1HVM3$O;\33R
ME5J@ GQZ_2MY$>X;A/T9)%M+HUM\??NO/U>^JZ8<7R:2<;ET<IV8D; /D1YC
MJXS!I>L+%U%/&?^4=O>HGX:@OS>&M]-KX.YED&AN4PT_8R0=_M>EA"<PZ@N/
MN$CZ@9S<#Y]EJZO8N21_DZ?*<PI<M?H*_.GZZ"1-7DUDE,,#VP*$*MMWL'+I
MPT8%U0MOT=*V0O@<F+@7IUH-',RJ4DM3/R=@]C?N?U: 0%'-A+^L3X _?8/4
M3RJ$P3(V(;"B:PR9I%N9\+'RW_3992W^5^<:V3=072*!!X'QWX24DV;Q4\30
M@',76S6%-5J#<<*FV?$MB?<V:K[N2/:J_WID470&$@+\76'95#WZ4&W  O^Z
MBB 74%. -5Y[J3D&-Z\>]<M,IXH>JLEB)+0<&;&TXJB'$^&>HAARKDQ*7-L3
M1H8#Y=H3LO&+X#^5#I"&5A4)%EJ/S(?[:D$,)MV+EHL&8B+(K>P?S %1$1I,
M.1+ X/R6@&#9*YPB%VLH((;VK9*2KG=<V$ 0EZQ!OOXB?2HD4YE]0*ME)9;<
MQ+[^FZ)#ST@!$1O*UA@>$JJSQ<(D?WC JAJ(1C#RLI_AK)__V707\\^'&\&&
M9:),\M@KM9;V)W X_]%W$(W_1]\+)KF,#/SF8 4WF^/Q@#G^R/6M_'>_\6EF
M$_&_"S4F7V%U7O7_T=Z[AT/9O_W^T]U&*J9"=C$5LHNID#"92A)BLK\CII+L
MPBUDTIBK[":[A$JWW11I0DQ"RF[L%=64;8C9J&27:\*XF(UU^7Z_SWJ>]:SU
MK/4[CM_Z:QW^X'#,,3['7.?G/-_GZ_VYN$XD,A[XELM!\=57#LS.C%%!3AT6
M+5SOV],[O@C\U+:E+:3AI>FM:*&6A2#WR, TLQPMR*:M2*@7GY4A*L%N=.$M
MRN)@5W+L#@R] QDB6Q<>K"@OA2 <&V=*C#:?F$B%W_ZH'3^FWATBLJJ'Y?$E
MWAA6OZPM0#GEY:SH%'H',/6*31->.G"B5P  C:>!;XLK_P'.WRB W]>K".;2
M7RB(L'364^QON'-4B EC2$K 1#*$PV/G]. ]>YP+#(C#.C QMMNT?_6\=_6\
M=_6\]_^Y\UY-2AL);HK'_"+U($8/\%/'[DB]_^R)^ESJRD&(&.P(.D[5PO1X
MV0N$.=/%<%H-_[$ , ? 4*3@26(#EG<9#WN$^1!2EY-@PF6^'W[KN]W-=-Z^
M C@.9=3?_7#MO;/)!;ZT58E2X[95HQZ+G$2I*# H19"GS8-YB<8<A&V-*WVT
M ,BJ"<6:"8J%>[ L)FKQA,L4O/5X>D6XJ!)HMUI$P<TT$[:S7R921(]&D45@
MN<CB]0Q?V@F^RJ_R?+/_GP!V6.CP7P/8C[6K +8*8*L M@I@JP"V"F"K +8*
M8*L M@I@JP"V"F"K +8*8*L M@I@JP"V"F"K +8*8*L M@I@JP"V"F"K +8*
M8*L M@I@JP"V"F"K +8*8*L M@I@JP"V"F"K +8*8*L M@I@JP"V"F"K +8*
M8*L M@I@JP"V"F"K +8*8*L M@I@JP"V"F"K +8*8*L M@I@JP"V"F"K +8*
M8*L M@I@JP"V"F"K +8*8*L M@I@JP"V"F"K +8*8/]W :SE7P!F\>X=@G\I
M;-$-G!&%..C02W_^'3J/O1D$&<.E8,Y"\?70,<#2&[JOEBA,>VG_RN-;SV?#
MA76*A'H===E%F$3:=N_"EIB#*4FPEF1ZG?(XZN6E&GJ^X_H&>@YN#[#(Q@H7
M,Y81MVF3=^ +3C,C U-GK>&ZH'QAZBT&)=Y_3<'@YP^4U%,\)4:8Z#T[?I+B
MZ%TJ(@EX=^^9DSJ >3[? EAY?"MMEGAH]JY%*KQ>.BVP"/N0-@?'(9IXOU\D
M+L/7+,[7A@,V>%C&:U<4X#=SA_1(*C4ZQ=9"C)+&O86/>W&H7[3C)S A:<AX
MNT39C/T6F>SJ?\]9<."U'H]$?PA?+E5T.H4'YTYY.S@F>H9-F1=B^F?A6(HY
M-&(H+V! ^\5MWG>;\LHB[OZ RC5S7],UI$\G#:Z=<3K;<E5ZR[$+BO<_=J>\
M)<B*K$0P794E8><5=Y(*V^B_K<8 WKJ5A_Q+D*A@QEV L3C.[*[3.:53NN9=
M%(";MR4];,K^ZV#$56#7T->MP>N&]=X?])QW%56F#8?3 ZMFL0]-K@\5"D_!
M02^R$!U,_$_/]Y=$@7X%M>_X9TB]=\#3MTW_(!PSK W<:B(PVY?X^MF9]]O^
M=LQI44G->6ZQ@,)WCJC#1>?[-_!%UP7N8!M%=\!1D24&*8R!8263KRSV?WK*
M__P;86'J-^'?=)^69/EAT3JBQXD3SM[A0>21W4YG'FU___[XLS.6JFO26X$T
M9TK07_M*L)_'?O0Q4=5W61O[[TBEO.__2M 3C;5X$&JKN$VCJ''A%6)0(FKF
M.BI7%DZNGN>:1R(M^%N =[]%+5C>=?K+%!$-UM/[L\A4K "DB 2P0+:X]%!>
MU%5VDKXRR_XHJ6P^("RG>R&DS?9:8BO$FE\@%*\;M2&^\>1I_7K8?\VQ,Z8M
M(=JO4QZPPMK//UAH8_4^H)V[O,VGNESH08^)1*X@P0F].^3"4;E?]<QSJ,Y;
M]OW<TZ8WT,*]F^=6*//[_W:F7<W*3+N+]^FLTF7$JT15^^H</$M97N7:3M([
M +'FNV-2BFWEHN(W&-DP</CI!V$IE1&F-^-_VUY"\50[JN$/U[Q(Z3AGOHQ0
MVW"]2I \JUPLBIK<:@@LN"VY+*W $)S;WZ6!,H8P/O<0K$=5W#_H']:7E"*M
MKR^A%KUVS:D4S797_= 6PCS*BM. BZ=1$_ L2#-,)D<)_$Z%73H<E ALE2<Y
M(WX_V7^X67N#O6,TG@+!M*XJ@F5X(@2%7<S@U$3\.ZWB?[7#NO1>>)GVW5 D
M^1K6H4!A.C#%QL#47U3>$B8\Z_(;=EMB9QLQ]'+OJ5RN&5P<%8:WG?Y9'#L(
M#]N>=VQT!G2/WTQ]K7)WHT-*!V&MR'K?+5[;_S0N#_V/<7ER_S8N#W JC*UK
M^'B>0A-PTY=TL:CF%P4^N@=2U\'MMOKNUL/OY/&S[07 GP;5DS3F#,PCSMB_
M=TPZP9 8L$CILQ H1/XO1\MS8<^V@3+T5;T5&(JRB J+)RF3&#\O$8;/8'+5
MH(;/^0?./![VO)>7)O_ T&O='Q:\8GPG26VE7+* _EIXCYWFD.,H21@HTCKI
MD[]@)G?P6T:D_K;XWT^<GYCF1ZH83FGR?8OBO(,&M'DI3D[VUE)@>-M1#<2E
M!YYW$:KIMW*U!?F/JU[_OKB,L* (78%.>:!:3W"$@;7BSVR@?W.G+/XX+#LD
M.J^]\.\CZ^%/]"4,\5],/%@4>TL1$>",(WDM(SC:*^,2PF!4 T'\%[O:^)OX
M(2F>G^K#)X@UW)3&UGBUDX@SED<0'_WGKPR)S(UHPH1RTV)1++SK>O\^*.%7
ML2A.3DKHW/^+"H?ZLNN#?/FF;Y?FU>6,OII<>ZLZ*M"R$NG<8?3/84M=\).O
M8:PV6QEN_T_W/4I1 K[=)EZ&]P3'55Q&G)F^7)<TAS7SP'*[-"]!*MSD[49*
M3+9%BV.RB@6L)V*36K>+BJQ-#FQ*>+.O!;'Y8LU+^J+"=RS/H ,V3+X/E%';
MX9TQ:4&+"O_QV'E'(Z[ 4+-A9J@,VW1DO:X%_1O01"N]7[AU8_?,J5U;S<M9
M25MV+C!HD /]925V20P/L/3Z^9WH!#PG S\#:VOZ$-[-8XGZOA+G3??LIU\V
MHPS^&WOCRE"SCH(]-_C_G<ZM1*K Y4@].]R@ R_T\HM:)Q2*M&F[Q^#1#:8:
MD+41BWLGN/_FT<,&PJJ3<FONJZQ;D_JV(XE"A9:27!;;Y[[BN0_^$A.F+?93
M!#U?@-_8 ?K C; &#QW?*D6P:V89H4_2G(.9H++,X!]3V]#_\]2VNP"D2:)$
MHJ<[^4<M)>[W/ L2[9R^5!5N+]:(C+4B><EAXI3T[AZ/CA)C"+?0O_V$O>WQ
MRW0LY/HV5("K%!90?E^$W$0?'ZQ,#NZ7P7X6MC=,D;PG%YAEV);(]7NO*T4H
MM_?ZGQIWS?T!<W7DS$C@@Y>28V7MHT-'#AH]S=&V9QA'@FSZ]T';;.]'6"H&
M1*H"U(.?K;NL28)E1+!(KO5&9]ZUOO%?C[O@I&N?7]FB==_@*!^ )& B@GF
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M77NQEW$)I#\>,'GWR+P8X7/!#:YA"U:&J$.#9)O)O,.?!4AN\>BO6+XYX9+
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M9RPC$*1=PYT<.J3AGC)MQM<@'N&2HXE!;*R\3Z9W%MR9,?VFVGB!1-^>SY6
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M7LSN8FNUV+D#XZ)=E=V_<OT5?SIC#WW\OJ>5RQ1(98DVK@5KV +4#E,UTGL
MM*&3Z9M+B3:&T3KUJH31$] !-F[-5T(UTZ57?S-E<R-G^MJOYJ-9+8<&1^*?
MCQLJG(B(Q@]-*)PL#M 7UZ40[EY'3UF 8BVF!VN%]TVW$$]#,MP;#8>PY3"W
M)8XRIZ+Y%PCD5F5I;G]3)*IM&2%-4A6<$&8Y'T&RJUK=3H)UC-82;&L&2ER$
M)KK@$R@;,-8<"5F+E]QK6:;YG \JK?5ZU5WI'VF -U.9> A"\<6AP/8F5 5V
MZAW8R<IH8T :#IU<,9ZE,&>:I"4(A-0"1H';6'F!)HAN),E 4H9-Z#N98>3&
ME 1 LM:7IC@C-T!BB R!3<E(=FQN:A%A[4FN.S-A^KJWZYD8Q8(/1MTQG$??
MV":.M$UI26_0&UUXH5[1R2<F/AI07E'%BQPG4K.'76PZ@A-HKO>>= 4>2-;X
M2*E.M[__M:[</EFC0,8VI.YLEW =[(6C]@&-NRH5_?TG49 Z>>K&#:\;03+?
M<X8IC<P-YUR'!\^=3'<;=F6L3VP\4@&^36O&[/MLK9C?UGIJ+T-@A!:)RR\C
M3OWC-/,] ?8T=[5_TK^H-XJT(8 O0WJGO([+:!["QHR@0<.I8="[L7JA65NL
M^@8>@8?P;-ZMQ]B8>QZ$K+:J,Y:/+2XH4T*\@D=Q<IV>8>OZ<!SF=D5@.FNF
M%&<V9\ \_,RQ>&-GKOY$3XP:M6ZC;7!,Q6>C8\<JLNS2[SD0,PA=V44.,6/*
M9SLT.PP#N_R=KN4-UDU-E69[5:1"_5Q_D?C*D;\FM(8M;[J+&"I,H;,HP :B
MF(SP02IZY= =RW:YB='(?/7$2^': ^(QSH!^CC;_Y#+B[<.!@<AGP^=N7][?
M,BD=>]4@"-H[)MBJ?8QKT32S;A)XV2^0(EMP,]HWR_2(-A.L'3^1MGR!,CB_
M,GF\!?]GQ .?=4LY/;77+_*JKE4=&(9<^QVK'FS.NK[]>'F+VW@0I(%LU6;&
M& .-.&G83.O6<"U&(QG) AQ[)@9FXNEEA#<]F5Z!C0&\TCG(=7Y+^#LB \)H
M$Z5\)@9S@6N\U$*PXDPV*<A&U6HCR97HA%P5KF06R\:Z'2M!E"^$VCFX:+I&
M)7J :0\!8 V'-C4)!K%QT_*C0_C!M2P+@=0D;+9>6K2F;"6N@_+9;RI@U26W
MX+=/P';RMJG^5S^\I$"M0-19S6Q@W#9^6LBW?O>(Z-15O]W5F-!:P8A2V/"&
M$VF*WS#^^OCL/;?$8$+UX?##E4^\8"OJYVQW_["SDZ?1ZPL_GKD\EO_X7-WY
M3J6:EN.]?&SDYQPGFY&/7=GGNZ.RWYP;_]V1F53\[*/!&]_&+FJ\4.P-G)C'
M@4;9?97)^.9^RHN,J2/>M)_*"J^X3VORW 4'H/"@XI^Y$G75O5>>U[H]]WW9
MD)'I'5<ZHZ\4\7'(O2Y.0I<S>:*7%3?^O3O(61G/1@FV3XHVXOA'(7,B &KS
MCL+K$P4^H&8/3=^)2VT*VBC0@&+99L7CG6LG%,YPD3&7>BOR"\^J]59D.)^<
MG#YC'A*@6O8\I(713OI$+T/%A:$34:##[=K=()8#FQDRW.EG(/7Z6-_1G!!V
MDT_&" 9B<*,FV[$5#WMJU1\1JD:5AI<1M\)2% 8('OS&050L1F(TP I+]E $
MZV;B:K7W9N1!.WR>Y_,8\#*)W.(6^LYEQ!7T((IS96F:&2?2'J>7 U%$]'-_
MH!S;@OLR@92',MC(.--=*0I0?S.]O+U-)[R%*8\Q>*2DUUZ_'B+!15A6RB04
MMYFJ0>$<%Q!\!=GD"PZ^2LI;'/._^IL]ZHQS\LOME[)I]-#L.!CJVX0<OC]A
MG':N]M[7ZC0_TNRUUHZDB[T%QE9RUT^6I/F-]Q5K5AJNWV27L/!=T\)!M!/F
MFG5)RX@G,"TSH<L8&.S?RCC#M%8&OWZK^\JO2L65/I@R==WSPH6 (]/3\S.-
M,^N'S@X,NK9T?QUV_\JX=-=M<*AQ9_HYG-Z3,RW)JDG/GEM,!(\O(R9GV@/]
MF[&^Q2GKW4@,E"(52@&I+70EXCK3'80?:#FB%!@>]:M^#Z&8,T.F@M,"!6KS
MD;4-?45NK1&TY.DGZ<W.$?MFUL=.#=Y-=*BNZ,[\-2'K2BVG&@VKR5G9O/YH
M>38LV4 K[7?2GC%UG_:1['.!FS,+#OO/V&Y;..=8F>U2_6-TW?SGCW91(P$G
M#WI_&Z'PMP"-U1%534HW>+>ZZF%[W*@;AKXIDNZS(!/A1HI;1L0B;X#YS=50
M3?=SX,4\X[;STI-<J:[YO]%AD7OZE [RG>-XU^<#=#4>W:_<?,S0C(.#U+T%
MBO.L269,9E B<)D"[:7%H4780[GT/Y[7FA40I3^7BO1R''W&8.B(=0AZ-N+V
MCKO1S[M%8=,X@[V[N& N\U>\4KGUWF)J">,F9$0TXV#CL5NP@3,H@2XT7 KE
M]?->@OCD980O*DY94GB'[C>SA=8 Q!G+3J7P[8@2PMQ09AQ)#$H%S1J!'8"?
M]DQLK@942^;,M.+B1']P)<LB2Z"^H*WCN9(@OCEE+80_"BX\-&>;E!C"6;>,
M\$(IDSX BJ*M/OB*&7*][@10@6L;5N090D)N<2M)09A$4B-]P5>DM%)N+B/*
ML-$.+%P3(]X5?<M4=QPE:8KV4PBZ'894\HO03>3K^BH(/X@2\R$*9_V/G"#6
MQ!G;O.B8471 ;$&GNM5T;WF)7(>,NKA5LNP^ZT*4[TF[ N=8S8O:QC+:GM-%
M?#6[0[#Q=KU:X4TM3_R>GO18_IEQX1D_TL?BL&=.?ST6<Y4VG>BBLQ[BP>-*
M (>1 &,L\-)0(-7])_2=E?-'9ZN''F100'!@ZS[FNC5YR/4X6#QH;_%0@R*]
M]>MU/LV9O*XU8R\&S-M86U6^?* #F*5>/C"Q%')NB2HPTH,[(&5QY2PH*7@9
ML0/?M'-N&4&5S$[IYRXFLG'-*?%([@SO*G2&N:%>@Q#"036@(4TLK.M\%X$7
M5%E$/,C=D0%2/(044\PX_I4_4;\&I+<G6]@FPKJ\K3(%Y4KJPI:71J.;L9N@
M?#RW/W:%HS:C% A!S4M 4XW_8WZ-PGW/U)2,TI#TWV,I@ =48%-EF[3H)>LL
M:9_XN=W*QE#Q5<:,FDT;[F_'YGY;[C<OHW=]Q1NRDHTTV@*>/J%4]!XN=<Z,
MV9OM9BLS/M)5#3P4$VW\1VTW,@12E'_=?D&)CM)VO5@YM(23?_T\-K&:,25\
M^L_;*A\L1NGDT,,"&YI@QTN0T:1(3U10)U^.Z_BA$^X"7=_RFU"%ZU(><NC6
M!2ITYQZ6.#,=NJF^)PQY08;36V[>.Z^7=J 1,?MK )4#F& 5B#H WU;P)S0#
MXM@9C?1$H#Q<H)6UC!CRM!-F;\<-F/&BP;8LOIEHD")/OTQ/08G5^O.MH7[>
MPPRVAI B6 ->BT1SF"GP/L1U&;;T<'%MJ)U^QD%)E4<\CW;-,=<0#-NZC0SL
M#U3VEY?8U5B^+G+\MC@-FU?YJR'=4?<C4J\F;YP]'K8[KSKIZ9NTI&>MKZM]
M1;RB*.?"PWN'O[[)SK>]M]OXOE?'8UO:<]]EQ(L@@6)=,?$0E]%V1)N%%$B)
M.4"68/.YUV!["RU!(12U%DU2%F"Y.@7?[U""V4P%0L>074:S2*Y_#[UG;DCO
MR:1K['W^N0G74/' +J;K\_K4 J!1:QG!(AN/1=6J<[7-A4GT\T?P[/Z40(RZ
M+PM0'B=M@-R>$=!MX:8FO5.AR'5ND$L++_=:/$<Q16ZR.C<KG^ AH;7TRSW<
MJ6=?A?" [J]?C^-%YCT"[W"V38B[D(J1XJ\5!/:%TC<)UJ[0.HE!V6"J /%Y
M?T(,:B>XC.#E038EI#Y9!7)*&)TLDH"".90$KD!;F(Y9RPUDV/23T (-$)F,
M,>3DTVQ8,[>6%I+#_BQ1?\E3\N:90M<YM & I\]EQ!&5N-JC0:WXV&5$U4PS
M*F4_8:B=N;9>5R#)-237AG$9HDUH%CJ)6;G0&J#("X3@'NCF!KFQOP2I<_F0
MB0L7'UL9M)T@RW+O*_%^0CS>/X>2)S!:<PV[SB2IN4[84ZWJ-NV<6U1EFNIM
MB[NW>#WS6R&9:J9TW,_VG@^G\'.QO9.GYO/($N]-5VOSM5)+>]0#QMG/^I/<
M$GXDQOK=WQ]VCT4UOJ?5FV]CEQ"R%/I/MQH V\,HN*=1QT%\D]P894ELE.Z'
M%&R#65?.:.5PB/3O[6X)D)S)N@;$A+2?'KMSI,8Q9>7/9-NI^GL7I2)\*J9#
M*P3 GIG\R#"!(I[*(>D(5FX:^@*-ZT1K+-C714:D#CQH2XO>#XVZX24(!X,2
M1(K0,5"$W0'%/S!4D(U[P@UH2\L<*7GIX_Y<OSDD-'%?@*K5R]V'"N!E+L)U
MN/$\5!/$QW[@JP"-F,?03#C[*3>'VGB6J ZFFNYS)QQ3" .DCX'< F6=K.:.
M@-)P_VWC$M1;02:1^5<.WAN$5[D'I=LN(V+(9I!U/E$.2I:-)V&)$M!CD,Q)
MF8YD(P=0H^W3IO1URXC+P Z_S/64%GP<"?FY?J- $RHP+>>F<UHY \/0YJ:1
MPR^[1#(_Q9HRZ+!YPB9AV1(@N7$9D<#4:P5I+1&R+7C(H5X94N(^[7<DBS99
M@OF\*I#<>K9^.]&V1["9*GI7OT'X0*1$L'#F*A=RK>W!J24KPJ@]A&,QI$5M
MAM@-E<EA=!\;:_O^7>0ST#6FQ+PO!O^G4;VY_>?O8<4.5P,+[OETUUG6.*1'
M/08"G'JLAR[\Y(@*;4NLI+\GO+%LU6@+&0LM_'"\\_I'8J&K8**(_#+FPO4N
MFHO$_-\.U+-M*<]^8E^H"Q0_<')D.?1XC-[*__4U'B":L9<1-V>_#@J"^D.M
M@VY5/TT$KW$Z806_0N;<*?1Z]L&3)5MI[%Q4GB+-*+AN[QMQ[VI 6M/XA3DZ
MW"5!2PJTQ[ -M_XG?GO]=E$+3+*M2'*N9M0-B@1ADLUL9L:-' 1)]"#?\!#J
M\(=\*+TY\=G/I017OQWAF9$#%37W8$X_-_#U>OBAWRV4G40L=R&*AI'E;N8]
MYLI.8;E+DPZ0"QC-"X&T5VX@8:]@+\P,YC?TT3>0I& C.L:BR1*1&>WU&OVF
M:X"+A&Z.]RV2IF_N&HC*W<-D.=%: 0G1>ZRD2'H?:GVM$3?(O0MC-HI/I!=2
M0%O&YB__N&/CRYFLP[>Y+K2D)%$4B)'<E-&X$@[M)DH.3@H;+7QBKMXK\/?D
M8%!S4 Q>B2C/2KD= 7NC+3X1^+A:=98PY.R+/@.4;.-C=T)^2[T&5RRY$B_-
MI#MJCCM/V(7^9(_Y6V0-NF1G^WXX&6(MS-&J5+,-NT N48O*N7)29= J+J30
MU.?D>)O3I-E9PU_V3[/NN<9(!3\?UO_VJ$QZ&3&HT46U>.!DLHP8Z.2M%R;0
M+^D +1Y:P@RZUTP4?4VM)6=8F=DLVMLGDH6DS,'<_%*?!U7%SX;&(^Y_S A8
MEW'(#I_G_F3[]BA"U_'->U+G>W<A0AFD-PPL_E'!DS/VY[VQ8X+?@+'&HW6#
MQ^0PGCU\WO@=4NV:U+Z[ZK;9.Y?FUXY_M3/7UF;2YH7 W>?TI[HFUQK6C65+
M?@520J :P3*",MM>)VUWX>9/S2<[P8B[MB%#XTMCM%<:>5DN".V[>OT(9=PB
M9G9H\MBY).0RXNP11F%;Y %!@J9JVHL_;9Y$A"Z,[KQI-)Y++S!-T+ :0L3\
M=90UNP0O*ZKR"^P*2?^:^JYA[F.DT4\Q:3OSN\]UNX>8;^8_ LIZ2YX[J[QI
MF,()@#S+&(<D-?(2=3!TVJ=]\4<T\A(\Y2M^O3VLG$TYMQ1N-)E2H(C;>?-H
M^UHYUMS'&Y3?/GD96C(W-4=UNH_HS41GSX]U@]0UW?4'@>V16"PXI_'87#WX
MBZNO_,^_ -1O[%)3@H8?J[<YR&-QGC$YUS">Q)+4:!S.YHX//5+.;5=>1CPV
MWZ09SF_U>OU:].;=$2.L+;U 1]I!+N:2Y[R(;M<_.7YZT_"0ZLX[M4@<:21'
M(^\^G3:Y-+MY0Q-2[,[!@Q;]_4LH>]_CKR+2^]^@<"+Z,L(M+<'()6CW6>#T
MM<-KQY="!7175XVG^_,2-! K7T_:SX5AOX5,B\RE[?U8^L4[9QM-EQ'""U#$
MDGULH_J;A>E%23K53^.Q:NR%X/&AJF."0I^\G#CI#]3^.U>-?H90VE,9/9P$
M3?V'"/O](6\92C4+T_U=<?9_'6M<XLU]U(,=BFF%G7D&O.?N@=J[G:XMA1[1
MFQ;M[*Z_9W?<6:Y+O&T_TF@2 E*JKBP< D.B*>?FE8P8N*!SK#EI.PLMT<.2
MR85H36SN=0;$S\UMKMRT<7)*[).WP"<O)FUSF-(IBW-AC>VCC-F\A&MRP]2U
M3RUL<33<TR/[(R*NRABMV[GEQN\;Z4DAT.\(OK3C;]IXPML_6+F1P?TJ&%(=
M3BFR#-=NQ%.9;8?LS/73^I]-GW\J$T@*?--V-?+ ./397&+O'U=4'H\APJ?O
M_,.WNGWN>#WY;GXB0G(LE]Z5H&&Y^\\P:;O3GJ>,6*-KJ8<_ADQV5[WX>43*
MVXCQ%[#S]XVE[,CK"QH%';&7%-WX(W7B J,C=$;$7^O"X.8XG[N,.&UGOL-Z
M2523Y*J1]Q"U//#? %!+ P04    "  5@"I96X3P31?%  "1!P$ #P   &9O
M<FUS+31?,#$P+FIP9[R[:513V?<M&D5$1(A*)R"D;!"E+1M :9)2! H0(J"
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M9"P0 4@AFN"2=>$,42[01E=K(&(0G 42Y12X4;%[UB5]J12_GOHK7X6)PQ4
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M9(6N2E>$4GT@Y@))0EZ/CK!UJ.%X)ZJZ[65?4W>]<XWP98 >E%BI5ZI(0@Z
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M(Z3.NWPD?S/S8TB9XCCZE+8)"N7)EL<1V@9[S:,'A*V?RN\E,LR[+>]03\!
MIH208[KM@J4*DYL3"C?61<#9:GV)F:59.$WH,!,LK#OX=GMBL\,6]R55FWOG
M4%>K$\B@\0AM (]0R-"AK47.P(!$*B(;JCNAQ44(ZP7G@<.1\#&H8I!A3-61
M H6=5A=IJ^ N#G[OA!8=B56+.CWJ7NAVS2[P'R=3VL-;PVJG,=3*?LQW-.LB
M_1W/%N7@C-TBP*'#RJKN+(4_0N#C-:EF2@8AF7E1^*BA"-$".=PK2,S$?3;9
MP7 VRAF*+2$D>(]W)Z"&D#^;XQYZ@#^?[.8J2FT ^K^P6-W03-$B$S-WW<C%
M3[Z$ WU5F"E^!/Q, DSI1,)_*\R.T4;5--GN/5^N.!1O803*..1+3L)EGU08
M,4/M0X%2QJ.*8F23Q*8(.::65=JR=J8&]7@[!.0C,8:\MU?F\!O:P.0Z\5R6
MQGPGKY*S[WF:LK/4-+G<RM7I;=/1\KU_WY8ZB'<<>7]KZMHY\_#RIL#R[0/-
M47N:,PT:COEV/'B?%)QR^UOC0-*QCL(&$^>CEJM3JZW7WIG+#+^BI(^RDW&O
MV-Y\EE'"=_9"HL(I/IPTB#.80[5@A[L)!#.665@X-1RJR$5"<1?=@L7D_"7C
MJ*V7'4SGIDV@[@>P!]>4F/^\+O,67!.WQ\[++"D@;H$QPUX.])$(HBIT[PN6
M+7P+F-(2&7.$.H@YK) 0)]G<Z<WJG:'6.9QG5L%PJ;@KHNH)-C^9ZB'5.35&
MW<?<5B[Q$"G/_#Q_"\IKR$7\6B@T'14&^\J[^35*HNY3U\@.VI@*L[+;'*P1
M]@HW B>Q)I3/4E$'3X69K)(B#',5)A:WEGH4]B9P2$6DC@HZD&2^6^+=+\L[
MSRR)S@F"[A01+G]JT_435W#]S\[TAX_7W8&C RWV/GH"5M]O:%Q $M7?XJ)6
MO_9TZ2Z*AB1VGMOY^*'B%#K.:)OI91:BFTF"BEZ""=[L ^ZQ<\$O'=!$_B^0
M"M,'E. -^?.;P.<=L4GUE*I>_!:0SF/\VS2]+^::$BYW[Q;]G29QM/09E<>/
MORL/]37.,__AH?%0]5'M\:MGZG")EXXD^H^44OJ< _)\]=,[K5:[C1E:#T\V
MC==;-XW%>"HSKJ;6&XS&)%!"0]:5^P2?26:TYU&\*CXQ><,"XUZAUGV:IF!N
MUJF)W:8U0%I#70]ZOB^7$ I,(ROA,A[+  (NJ75O"#1X&3%W+OQZ9\3-N/'*
M;>J^G$$\ON?+3?:(FV'CA\?G/S762:GKE8_8)TD"4M@XXJK8AXX"K1.#[+64
M:"\^=;_$7T<D'" 7 /J.61H'QDWT_<;:6W;WL3:/.^SI<4&]?TZ2.?R2O?)Z
MF.3UUO)U+#+<H=!'?H:OB,CP-EG>?98U)3@<,IX/5!Q0"])GD-5 AL6R-M"P
M@E=(,Z#JPG^ #=P@F*C>S=G3P!K$E0V=>B)M)J^;I1GSWY7UHT;\7YZ\N+<M
MSFZ^A#JI4)>;37>ZPH+2(=\,&75(A?F"=QWS/6I3"L-U"AR%)>QWT6/>>4UA
MJZ7Z6M2%Z@+W4\EU_NE)21O/KR*OFJL[6G+DZ)C,<>&L/W'(+C5SRZ*7P;6$
MU*/)@8._?N"_*VD#'S18Y7([MK:8EM4/;?_<7_?]'[,\1T\>V!B2]HX0.Q2T
M-]SPZ+:Q^L+RA"-S)Z[5[;#</M+B\K#\#?ZX+?]:0XC3UZQ45&>?PBY.V)['
MF.\@@S)Y(V3_'Q5FXU?"9&*4LL7-4D&@E'$)#QDY0 )A[=R/E-A#RNKN8]"C
M@<4[;?!UMZ--E-1^05/\M,&8FZ7X#9G;&<,LI!ZM]XR6N);JL.%T=0-,5);0
MK!$K>!8R[A/J4PGI4H=):3^A;?@R:DE['L[@$K--L0LF=3!!'@)-E*(XBH)G
M2K^PR"AQ<B'D(G;WYZ)67?W2;V$'YTG8*RF!;3A]V.,8E/]$I/"/"HX136LH
M<]BBF[CE>)>YF@W*&L)I62Y>0YG;G:$@44KD Q C+YUY(1BND]_F;X7+H95S
MDHP!YF1./VO?J%NH \<$7:,6JUD#[8T1U(-C5$,L3Z@Y"4N#7^YIGE(XK([?
M-<=P@*?0570HAPMH(CM!H1_,!IL&PU^RUJDWUQD\[J-+R:S%CGQ.B)H 1$V=
M<F8S]<?1M]=U3,C^3(Y.1,^NH<&KQWDIZ=1*JI\89EZ=GB*[6\0?*&Y1//%;
M-AR4TO8Z%1?K=;NQ,^FS]5JNMV'>+>D.XKJ"L-/'RTW+&O439-=WI?WPT2=Z
M8[0Q(45T+<'Z3-!ON6/A#],2CG8G%=QO>E'<[&5-EE?Y*!\33OH'2R[G@"9
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M6/DQI)3V(@IV/?S2T>RWQQF[CODNI)_04,/,CE!SE"\AT6=EG1JSH?J--FH
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MI(--34']DA.>BHW!W*/-><W.U@\.O\W=?J"^COQKT]ZQ:LN 8-_R\*!R4F+
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MZ\-4I%JK"6$:-.[+4QA\5I'R?@Y,!*=^!Q^#DT9WAP@#W/4"EZA(;T,@&D=
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M05O)[+9 7A/$ =3L@/<%S?3Y3L824/T#JM8(Z/R$,%(GY=U 5 1KE4/#*$5
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M"HODVU"K^_NUHB2G,ZR(+CX&BG.X534C@TBHW+H:J>%3YNYCOQ95M(S("B(
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MZ:Q?P$CM7TB8\QC-S6\VRWV5CW$K+!K-A3U$S?T4-#X*KI%#J)O"C16MY!Z
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M$GP+TIPU/ 9^X$4$4.D*X(V@K_]&(ER\?0 8XU536'U/-G;G!&T_&.CU;@(
MV*FRQ<5W3?.4U?18>+?-#Y]7T>G"RKK7Q3ZE![^<R/Z2ATEG@^L/$!<SQWP0
M4T#W7?R#S [5S\X:\\;SW:$Y&](XN"A/RYI)\4E&F/P\XPKTR=Z3.6;KMO@!
MFA_, &W^D?@->(D?<?YJ'*3Y,2,&BX.60W<FD3V6_[62%=15WF )?.?%(F'D
MHG/,P1[\G-6U'#!QN0*0HPZTL"XL7&?1E3. :(?>,9+%,;^RQ>IR\,'%Y95;
M7@!ZN@G>)NNX^9>%JC=_FT:=YV+0]G^M5_U(. DGL,:#%R0T@Q<%9D\'M8T^
M7UX92#1CO?[K=:R]<S :"Z ODG@&)E1A*78 <&FU)S2V>_UB[.^J_-.B5.;U
MK9]7 <[T@4J3 F:A7P3#;\I$8$*&^X2)C$0!'OLA;Q+=BQ,?/8[+&H3FM#_1
M!-PO?:+%C;6P#K[#\G<*D#\)I@)O['DV#9Z1Z])!(PQH<\N&Z4(<J)EM:YWG
M9]#_])*)]%4+$DNBF:,8B,K]PB8N=3M<^8XX,P3T4\>30]:_S1 9TP;%7\[]
MZ7,:>D?PQM;#P[N@2MS?=<UN_FVG[3HPM#:K =(*LXCBG9>AG+W[,2L*#6N8
M7I"8%AK\WSAEIS(O%K,LQXNO[6**77XF' ((O*X'A,:)O-;/;<>YZ'\QL>%%
M*G%^94>N:/<\VOJ.]53Y'WME6(#N?VBVW4!J *8^N /85D#SX=<@&WX19HFT
MBN1 L>Y\NTFD92[G/)4CXJ"?_K[43X-:& X"_U[Y#-S32 &JO!U29,TAGU..
MV$X%HOWY5L#MI%OPQ%5TBDM";^1B#1?@H3B%.W3Q,?H$7KQLY.)_+5UE=/ $
MEEU4'_03<545_EWK#%4<QGS7R/3$BPPF>\",')&\HC.J/+?_+Q>Q(LGK,5$\
M*)]C).S^B=91%">Z*8T]X]/GKUY9^P^M,JPJ]1^Z; _YLYB-"0VK7H2M.\W,
MFP:]N]&R(#'Z"K_(P):"E/_)P"&?&?CEET6KYP: $KD^^XPN-"&##+57U6.^
M61I$8DS+8]#?_@HA $DSN0$ Z.>Y;"R]!E],MD6W3V%,+_:\M]*B$8O!/_I\
M1!S5%J[Y%<R^'%P*B:]Z ,KN*AHT%GLQGC,0/2*:01,V+9[57L.>+Z5(>C!!
ML)X?^ WP^JCV8NMVU2<PSKEUWOC_:MW>:O_WUNUCI^8VZ@\8(:20]@]E_0-%
M#"U!NYD=DM@*0#O;[HJ!/1P[+)C$"H DF(/BH$\$+Z+0F+;(T!TF.F#@$Q#6
ML.@SQW;.=RT"K5S4@P[ -6W0)_"G443A>:8,-.-"\64,_O+ED$K EQ_I<Y9P
M'4.TGQA)G\\S,V#Q=WU9&FU#M@58!FCPOT4E[Y[KJV?.:8$!G'CY]%.CM.,D
MD]<^BE6!'[3]>N1%=NB"A%HR<692'XM-8/Y(:\)]YLZK<VCU^HO0"\OY'NI?
M./LA=L]NS-93Z /$1BBR$XB-T;J2:7EX[0EH8"<DE =2I//V 7%$Q(+$^3KX
MC2E.O/,['60 9$<1DS>%20&+<HSI#XE51+M9PD-_TPNHKJMCS.GN(@H\X1FW
M:V:$>MS<EB(2GP//0,MAM='_T:]U,OW<K^W\W*]]\+>U'+Y.^'L-,#@ (E %
M:G'82>)\<B3DRT\5LTU  MV6Q#*Y$8MWS+P_WS&;^WK'[.L=LZ]WS+[>,?MZ
MQ^S_CSMFSG_IZ[M=41"<,("8%R#I3L&B=97 BN5Z/PL:Y0.+?V,]3GSM,0.H
MRE9U /SK6\_^-U69]K]4I<:I*L5WM'>S3Y7^J93_7W+W1_[E[K=]-?=?S?U7
M<__5W'\U]U_-_5=S_]7<?S7W7\W]5W/_U=Q_-?=?S?U7<__5W'\U]U_-_5=S
M_]7<?S7W7\W]5W/_U=Q_-?=?S?U7<__5W'\U]U_-_5=S_\_F?J>=)+7_*K;V
MHU8/X#T TI78<S=]\SGU.=-\%]8P@O]0@OT.\0^VSIGCQH"O.$$#\OL,>H@Q
M9>IYG9U]QC)HAC%="RY# 7ZQ#?9DBN0H(> BHKBJ5 (/AR;V.(NO+6)/*7.:
M#33;NQ#@$ M_9,[L7T4M63QL=H(Z#1L!ITA ,YD<ECB-44<0.^&5_9'U7PXS
MK28AQIK8839_%'O%XF1CN;AX:- ?49(<[11JED_+BW7_]U8]\#'_VJMG_#]V
MYN5>^'.,.:$M62PB,IM<B/_TBN JW@5M@!KP8FW-H?;/#Z'6PH]ZB;;"S_.H
M+7@AB;D<FG$GGZ\.8]#A7UKG#&D]F5C+[& 3ELM8S7I]!#6/7I @UX/(. &0
MVY^5%"HHBOM Z?MY&IIND&#P0K#5@"9IK8@F2_SKXK:J:=)8*[%'!E9A\\\'
MHU2XQ@R +GG1F67")R^*<*N9[XJ?PPV @KI.[YV#UD#O$EJ8=4!:=*+KT9#/
MA>5FRHIGHZ_/0QR;ZY-S>#YCI&EQQPB4TAN\B,8<RG_4 S02XLZ4,HZ#6P[R
M68S7K+_;OF?Y_]KVO3P:#)(K G;C&Z'7T?T 2[WP_'4:E+RW#K.^+<(:0> Z
M3ZTH^6M1\!+]\N?4W^&:]<SW6NQ"+2#"_NP"C/][%\!(X_^[+@"H%?^M#0 J
MPI<^@.1?] 'N_3&+TI##7T($M(*_6=,T< W+P4!>_!A$$!D2XZ#YVQ0%QO3Z
MSZ0"TXW^8<\?VL9M0I. &RNT Y]X[P3M(W$5\]TMHG#72V@Z;UMQ5#:7^=*^
M78U]^/_&GKZIQ3U]Q5_V](&!?R@B#W6,Z R]_#-8_W82]5[9.<GU_^TDZLO_
MI![6;EE\UA88^;^>M?7O&P UN1!Z_2@;.8.??UR+MWU&_W3D/9[7L-@7W(ZU
M;LN(P9R@^X0=__GIQ#.C?_D:$]^+WL0YR5ZA)N9B/OP_SJ.^U82/(?_%>=1M
MGV-U[]4/HZS7UYHZG1?W^VTM_E-(U/P_$A*. -X4*;%E#?N3S2]$H3Y 7';A
MW;_<V$?,#OK+?8#O?R%^,ET4(6>3P"#KOKVX?A*]&@B+Y$]^V81UX$N/("?F
MS'[A&(%/.V#W&8#.0N^9.?ISQGGU_W1&]4XE4^KD&4N!Y@/&=/+_>DTV9N#\
MWFP'_'Q?,OQF I@Y'JT=W0X"BQEA#?) A:^@OE@D]1$J ILP^8%$--,.)]K;
M>@4_;\D%%0_ZID- ^N O!DCZ7SL"0P?%%]/K9\W"F/=0D+P)P-"]80,.ZI>=
M&ZUGSVDYBV, \EN5C/_/OL&I+Q@]L$_\-HW*&8,K9N8IU&WSC!9\VG.SHQ>A
MYW1@P?]JM]^GX#'Y!8FMAB(E$,=LZBOZ_ ,3/-&%)=#;+9Y569 X_H8M_K&!
MSD+PL]L5Q9<YT(SLBB]&8@Z4\?!"^-UA<20\%H"(0:4F102)0[[PR&]T9+\B
M9HY_XXTULFGL^9.(,_$(9Q*]>0$O#EV$]5,U2BN YW,M$%C6;0C+'J3Q#!=S
MV['XM86D1W@AJ$W'_LR\/^7%ZX[/6P'A_[P5$+@5AZ8KQH(%B=VKDT?_=CM@
M#[H54PCYB^V N(A*=QX3T8JGQZ $WT&HARA4$"A>SJ>8Y_<ANXF"X/%9@:BF
M6H=EHKD\*U QRI FBQRR *7?'YFTY#.B2TQ53TT&,5?[>A@)KJ7>'7%X.WS3
M3%L@DY_G6C4$1E^F6*N/:)>-TT5:%"_Q[UGB-'B0CE_MS!V(ROQ8U]B&L=G%
M<*Q*W?@]I.P[@64O+4H%D[K.88P?/V.PIW"-3,B/.PW?5$QE*7SHAOM2CB])
M3(#,]O%*+]+.[&O*]SVTUEG*(U+[2KD.)[>]_J<<'Z:W:\0/1[+,CN98'$O2
MJCWV."YCW-?\?D?3VH,WMT:<,B2'6.^-,?1Q"O\U)DV[<\@N;U\&;]N4PVT>
M^<4NYXH$7T,L%!9(LU%Y"(N"$,W9]?A/9Z!B>%H<M_SLZ  -B9C$5MX%CH..
MR@)AODY2^!LP\3L9 ZV])![^:G'K-6:)4Y5(E=H.?!LE4# DI" !(B>D@QN?
M'%V]GTA.Y9RB&K4S?YE4&4#7BV.Q9=1&7ZX&$LR#K\*X2I)^;>LULWU(? :J
M1Y!%3K+JRJC2 EK]I"*2R/6.,Y'EH)-X_VJ=6.%I$($L9+_P.W$9U< /6FHF
M2VVD2V-[$75A;"DRE(=U$->=8U^=GZQI[35J@!7198.X7DDN/9JZ>92ZHDJ@
M?XDB+=I+.;1N6/G57:-:Q$R;C61R[!('50D-Z6K=T[1<#XVSB5<^3%W-6K5=
M0! GZB:<X^S-UM@[F#_VWOQ5OG'I^UQM0RV'*[<?S9R%]"I-.?N<(_!C*7Y'
M=LH]\'#)H[BFG79D2,9_&!*6;%*T>M)R\&RND;5VOC%TA?ZO^24@FL(0/.*#
M[X6F6\=^OH#=8@R3A.L1P+/+G(#G],*'TXM6045EJ"R;:TS9VE8RKH/)>HN9
MD,^"A-2>ZEYV',626W?&9"\T>,M,0_F'4O?0<PL2&T<K;OW>4\).6U.N<!-3
M%7E03B%9F=1^L_6=T_A8JA:?%4F5 R)A:7O[:2J>,8X7X#F3L26_8T;4-C.C
M-JJZ%3]*>/BUGAO'>SS64\"L"\;PB#L/OQ8EI30Y(.:*813?/(JR<>NU<YI%
M^+9=A0/?G#0-O.UYZ:+GAK,U&V7CK@\\V4W5YJZ:Q:W:$T C5YJN.K^I/3PS
M_%X2Q4"PEW J*^JN]?DTXR#7*^R*M'OE;5V)?.S0#6>7V[E+-AB><EHBHV7K
MU& KVF"?>55H'[DYK_W,[1R/>R=NL)_-G8/I=/XC0*2Y]&D@'/D$(NJR(#&^
M:4&B/2\34\"C\H%8W.)CDD87)&+QXGO0_)&D>7ESRMQTU-3BPZT/B&GPX$,Z
MWY[8PZMC?G,2T5U\)@>RYQPN-ET1N9>N0Q,.B3.K-ZHP$$N3G3QXM:I4\1X
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MB[&@QT.-[)X"8L]33&IR<!G2-)C+D 1I?I+._PF@H4&&4Q<4XA4LSER06"$
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M7@XQ^<8[XHEY'W[-;G&3WV!<MG7KD2VWO94?E6@8)QQY\-!QY/A("6("#[+
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MDM<R9^)TK?6"'DPYAJ5D&0<=5S1VR-ZK[[^2=,O6OUE>.>&V5NM<Z+_K>Z8
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MJM?PT[,+$+A!F19I8OJ G%I[V.\WLG.]<X5>:E !<E+F]("*K1\>-S+59_7
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MSBFS5\9[SY?QJTN"3.,21ZI5R_Q3PY=?I4P-7U__0<OOOJ6F?NV"!+@X9/-
M"&$9JHL$<E1L\IT)K-/Y%/U!VJJ/"BSC#PDNPZXO^;[&[O<<_"J.>QN?S]Q<
M\OYZ\)X."Y>AMH\9S<X!'N,^_:D)3YVJ[KU-FO0UTO UVIJ7EU3LIA=KKJK0
MW&]M9&7FF$EUS*AD-D)+,&G*H2Y/%@7F1W'@:T%_Y!\OC#TJB+IDHLD-<-+1
M\4YP"]D[H^IO5?W4QF5+BN^FLJ-7=IH\-MX,].'MZ.N;+96WGVU\&!T-_KND
M_?#AI8</[V@_O"0G(2'QC5U&@I6.KORB&AN8>/%B8F*"%1Q\>F)\9&+F?,E
M07_!Q/C[$)_B-I>,&*U+P&Y\L]#S?P!02P,$%     @ %8 J69S^#YK8G0
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M,GH9>8#^(D)05-R$MBCE)I(@)&2Q, H LG45A\#M0IHV_*U7YC),B6V,H]K
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MFM.A(MFUVK&YJ<T*?)[>K\!G7SOIL4#\3H@H\S (E>;- K/J[M]F<RP9G\W
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M5";'<$P1A@Z/L@&F23S)2;WEQJ,4=WQ6<LSI4:HE'"BX2!?R-&.)ZV6&9*8
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M\%RG^9?9=:MX,_9S=:5#J)_5S7Q1FZ]>R3&UB62IQKU^])K1T;J*::Z]0+]
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M9;I2R TO*,[SK#K ;"J'4/@^4;M#:7"(PWSW8IRK'Q31*RI.^HOA*L97P9'
M*398Z/(>'L[#QI_"\ZC59G>&HY/T!EXH6B8N*SSV:*W/F$$S(9HG2<4F7')K
MB5 )5*BO86R4^(+%2O2GW@I9\@AJ9A5#DRY.XJW:+A%P\46MOO8TWX*/62V8
M??J=RJ#5FP[C&3VS.$NX.O5J*#"P2@O@U]J0'T6QD'@GD#=19@TTUFXZ>V9E
MK]ZKHZ9XN,GF"@_]$-/3#K+#L;_K.G2S-TSHO-%Y8^!\NM3"J:#7>_FC9RLS
MM]9\Z)&U[I]CN'1?JOD'V<WUM@]-N^C?K)+UD\WK7KQX\9)_I1A"-PYCB[BN
M:"ZB-<9I@^V:B.WKBM/HURVV]+,+QBOS=HL+Z3'<Y.-W'J A[K3(I/,CZ,O@
M/"7+NB>7="R;+!\;/GFYU;KAQ(;,*\TUS>N? CZ\,CQ)JE#=&&P8WOZ.,S@A
MOA/@*7QWN;Z<W/^8^1I:^$MCN6K?B>5:)J+BT8N%G^@:K\)/M*'N;@8?PT_P
M:CDB;Z5&@BVR)&?C4"5R#Q(OE60R!).DA8"@;E$K@45>)S7!K2=)DBLTK!6^
MP 0&/?2?ETA8S) :QF'>0EH896F9NGB2%)5\4X-7Q5)#J;) B7>$^3ZIDE.Q
MR;J60]+RTC3T"M]!ZIY^(BAHOWK[6!/>N.YK-T]O8F28N&SQ$^8C"1I:(7$5
MG>>Q(V)R#2\S#5!M;B<D24:O5!CEG?2Q6-<@:ARM>]17\+'3RNN2S+=+L:?0
M[<B&@UZ.WJ3-DR3M!11[.1P&9TV2L"7>A%V28B[<EH=I 3MHLI]S63KSRDC@
MBC<CF/MA:7Z^CI:]BM/ X>)(5M&U)8=:UCBN8FUX7E_&T>?M"[807*:7;!-O
M8)JIW+IDWR:2.$A5B;SPLVN'UD8[T+8&]W^SNOXE-W>LM!57?A"M/Q(_VC5!
M!Q')@;O?0\=9"C,S<M#$ \J*E_JHVZMQC(^VC.\!V05XL?8N\QU%=NX<19Y&
M;'62O*0U=*K#M5JADZ3'@RW ./=1WKNO@6N=8L +YD!.V/G-NSP\P9;FOCQ)
M'G2C<; K8PM[B4OKQO-<WK1 W?-SX5;# Y.D^KTYHW]@=D#NPZ-9[#D=1:-P
M/-2:!%3'R(PZ:'!QQB2I3]68X[R*,DGZQ\*H2=*?<4#K_'$_[R)!8?,@*: M
MZ^LXBQ(.B5A$_*+O"3^B+0>]#<;)@;J+B6I8MH\)7'B_LZ2]_!O7<&)#H4 N
MO0WWS[87,\!P;U#!'Z.-#.,VE['4NCUJ^.^P"=N)  )VA"EXS,)3!8.@8O/(
MDDZDZ3/R6E.F-$F*E^%7X4$94*%!N \</D9PC%%*+'MDR]_PH.LUH(KBM,?)
M\Y!NMQ2XE3L/R*^EP*,CFM!AZ/T L=!RDG0S#2TE_G:JH.+KI'N8"YV&*=A*
M\%=TK:3G\7]PKK#E-N)H;"5GX.LB<().$<B@'5!-]7J4UQ\!EZ\UN 14W!$:
MD;!?_SN=$2S\.VHQ+0KNO@O".+@7R-O^.3]S(Y!N^/HDJ;5K(TB_=B6Y$P@!
M=AH^/!M.[,74(HB#-,5)$-M*],TD:5?# /['P+2];PX="&'MNUU$M1$RYK$?
M*ZJ&)U2]:+*MV6#TQF3^(S#^>ZQ*5I\GH7)\*H!3<W4\0LS'CPAF#0"*%2+?
M>>,S30WJYH 1'/V8 Q)-JC3J%(Z,6 .C_!@#YT2MFPJMJ07ZS_N<_1</_=<6
M6[$#9:B5D(-:GT7":4LM-ODGE:^6<*Z.DDD,'0G^]+DXSM-9"D=N,(>\@B^<
MS_%SH825K17M) _Q.70^;]56Z<++HJ#Y='^;QC$S?$^^=E'#\$OW\F-X/J&!
M,= *H-_0,PI3['@]<P;ZK4K.B3@!I)\ZL;*%L3N[#?UIIWMG+^^BTM5\AID8
MGCM@L5!*BV7L5!&$&?$CDRU I.:1_Q(V&S)L1',:&%Z9]//N=17;$GO8H4BQ
M.I<?/749'E7:<"C"#MTMXD2X#-=0E3'70C0SBVZ_/UY$C03B?7@YRGF%J \Q
MG,5!9'I\52KISA^2P%(A9_'>\^(\I>IV7OBQ^MP[!XC&F#>E5UJZ-8-0O?%*
M'!;I<.%H]QDX&Y 36\M/L/1//*-X2$<XA%PMFSUUPQ6GRY,D+TJ<MM"PBK5H
MH'PQ>E^J_:I99K&NA?C%;Y7:!^8*3$/C":*)!>31N;8?A.@%CVQZB'B!Q8)1
M_ARBQL1$4-3"Y;1YBYN02BTSH=/5LIT++I9<1KQ53+J05P/<+NI,S%$25$4-
ME?>&,<YG8.<:S;TS?>1^*.Q8CF9FTED'I;:E4GN>1D))9#%+U=67(W:;635)
M6M8/22Q+&C"5#)].+90MA"(M#%0F2;/)DJ=%.<PFA%S^,]&0NHI*8@K@E49!
M,4D:K(BSR$K,BU6E 54%7970H<KVH_VGZ _IL/AX>A[F(B5'G4TQK!(L"63L
M>:C/&2!6&I0"B#BEN)[AM\BO/9#]J)UW22T_T],WRW5/=E]R8DRV55!(D-;;
MS?T:VXI\/7+Z3&I7/BJY>#S'TRO[\)%Y&X/R-GX]FJCZ\LAY+G^NE63\E862
M9);+>!3CD/KE,HJ(K50M9JWH9^73N54%J/>>PCI[FM3]B717.R\J.*Q0XUKI
M(Z/-V^X_.O+ITZVNK6I:<9LS3TY9&^SL?6 ^$6"&/[2G9_V'YYROZJ5C\&TL
M4 U_#%=DL4=^1TX$*3:P%TZ2QDC)2)2<:(6$C=2)U;2G)G@B-0*6_V5#FRGV
MQJX_3P+N&!ZS4.J@GP= $TB;)+EO)>._W<:/V0%<> ;OI6@3 F*SE,I%6B%9
M*WI9& #;2S+CRE04VD3]JLV2\]%&KN%%S0P3,7L!ME*:6BP:@O>6[G)IL:\;
M\]>TL:P4_>ICD">^N2"+\RUVDA21"U?L@[Y,0#X(9I )?*3?).EW8!!U65@:
M3"@#K#UNI0"$U!\I'8(34I@#HG4S9\2^_G:[:]/V#4=$MST\YAV5T(_LOZ^4
M9&V[*5&;['(@)JFL2UVU9]BH,[-KU?JN@F?[N>NOJ:^(J:RA+W#(7+E-?W%$
M;'?!X^B;3<J--Q^F?<U<NRXQ*OW^^#"V$S@LYTF25:T"\((H&)AG;<!5Y,-
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MYX6IVM'BV+F4WN#IEW;&6=/*FK'QN7"M/LB/]15PGQJY)U /R)DD"S"I^89
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MD-M*X.C7?(;!\?:#=#ZP><Y*<&QMC$7P5@01&1^@^G(0@*YX^:O_#UQ==FQ
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MR(T5%5"^ OM%XN^O<85N)6)=+5LK>I:OH66P"?FL,X7!"@9<-\[L0- D]A-
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MC7=:7J+8U)\E+X?"G+@OWF=F^<E*=AR*"V=G'W%S ZC96K$@:5.MQH>IY?;
M29*'/Q0YPEA9"L#[.5K3(AXT292?%2A_#80]OUAH5V=]ZOO'P+FG2]!5M 69
M45UES^L" \9\-M+V+7V7057!?)IO\'3Q?<3J\04O+3)3!&X6F6'(B^?IP6,*
M18'?P89/,0?/Q1R$[TSU/.:;C'U,KG5#<L5#QR?LD<8 ;_UJL[;:[1G==ZGL
M[]QZ]R#T)Q]=XU1!_8N]W-Q>3&V%B/F>G'YD>3 M(CDSG$'U$ :094O1=_E[
M)'B9C>B2_:$;O95%=,WJ@,RVW>*=^ER[C_[[,EXUMRQQ;37^" <M>B?O /@Z
ME1XD(<SMLK X!O[:0V;%LS&@1)7).Z%;'![:LK-"NNJ2O=&KAJIZ;F.%T,=R
M^XN3Z8?>D*US=0P..^0HS?MO'9U[/)1I_\>U'80T"CG%U*()E0HYS_VDQ6*9
M=:B)RCP=Y/1H%CF4:>YG0U,.S>:0?9PF.4P.L8HDFL%@5I:1(1DQIR2'R7UO
MC#MS\)O]_7__<;^N[_5Y?S^?U_5]79=SHX]UWJL :0QG]=JN@6;G;?ZX0_TA
MK+'>X+Y+"\-GHX>OC_:&T)V\5JU&BXMST/87G"9Y$V%-8W4VO4HUDBM2#[&$
MZZD$,5JR543C7>[W>QKS*EWN#U/^JS0D.;VS&%T.W\-=V2QD9H3O@<",/1->
M9S_ZI:V\[:>G8JXR7[V\DM/T C] "_C_^8^OCI('28(T8#)1W,?N9=Z> 125
M\BVT'9V^#"MD$]36XS)')=V":7[%0Q5%0MH=N:GPV_XQ-^\DL94%U:-]=+:<
M[T7#O>[<4,O(2R6Y./@$SQ=[V'V[O.4*6$XKXAJ-I]<&_!(TFW F:#;CPP6N
MOU=5Q+;QQ@+QP6G/EP/>#T]K) 3HMCE:%+3?J-X9ZWZ9HV[4YW.B)#O(9["P
MADO]&B$ -.;%?>'&BCKR4>5??$/L(<1.A,YEQEZ(E=Y#C(3$]Q3I[6=OL6C2
M-:1=!I#_HFF2]3YOJ.TD;R6%(PX"W#VF 6EK+'1*L$;%;D:*I(_&&";SQBDY
MI'C8KZ^8D[W"R2#LE$?4I]H)V5S^I@VU"-LLPG92HBJ$#<(3V9VZ(K2A<H2O
M#0C*P@\AZG!'?Q@[VRU4A%;_S'""B#W\R75N '1]_1L#]D[OU#+()>^;)UO1
MPF"#S):7#NB[:SP+EW>MF&Q41HL%%XA-CL^1K8B=V#@E,\!NIN#(,<[)G+5E
M[E>WQ*G1XJRL6D/OR7[RN'=AK6^!M:#YI9&7[A.ZE8.W::!UX:V&CQ7;QY/T
MZE[][D(:<F;$>N@4A 72@<B[K$N7IIT2>K1HVB;<FHJ OX.S,N:#XN7:*F$Z
MD[1@?C=G=^RNA1DUI+4BZ@703%E*A"+[\'P#Y5;;)9DCBWF/MGF5<Y^:)G.7
M'^$^;2FS1N>".Y1[IT@^XTU/L0Z$&+1^T@6?U5L.D8IJLEO9-2*"YS,*1A[=
M3,+09ZD! +W:I?9Z9U",E:M-HOV"[[(*DD[U[7YY1^=JS]#=8UH-$U[E=5RK
M]@YL#^UXV0-</89?.\++T2VH$FO&Q]._RSI8$PI%RO5<^XL)+.9M+!INX#\'
M<H$8CD%JFEB=%><GQ+&:-$D 4@T;_ C-]<5>\/A"5)>?1QY4D<P@[UZF\3Q?
M6[G[KR*LXT3GJ6JY*_RNMHHP[V)?O@MJ;(*_(ZA/T?JU"=+8L15B)JA#,A!0
M;S--R-:+&VHM14NW!!MJ%.#96I_I*>D/R#WH(9!):%UBOHB4G(,'11MJV:O4
M3.41:+RF7J8I=X68?;A<]#:L@]R^A#WQ:MOO?!1V)Q(^R JW@]=RE$:I9^+2
MUA^88\LG30$")(_N<$GD3KE%6B1RW8'^9JD?S[KXJ_58'7W/HV_1O@7B /C\
MX%I+93"OIM[F54Q 7DB?Z[ 9)V+@C/9TAPQ_.(Q8V',L/[O"XG-(9UU(>CW&
M <F5_:C\<U<,PUU5W3H?8=,=0+_S9 UY%-V,7N+4+MSLIT;$PS8A2#T,=#-U
MP;C#I\XAB<+7KB+.70G)0!Q[6+<G0>X\HBI2)(CX=-H(XORZE >X<OWO$1P.
M_AJKF[8FU_7[YQ7HEI=@+/H>L,N^O>66N9@BV1\A;MKD 48NZRG?J&QY405)
M#;&$)OJP;EP@$K@;;@U3>U4<X($Y;FD"HJY)G+DHN3U13-5I_(V4],3"F)#5
M$E6T(LEW-NHR-V1S1Z@G%:[_#IE:_J_W3[\$W(K_=GE";SXXI/2IX:*O_>E*
MPR<>#AA72[W\9T46)OB:]FIU3E!"XL&OUV9:E7],3W]0Y!K[.Z:];/,,R4L)
MRL^Y$437PF8=?.JG*:]0K4Q9:@V'];/<I.4M>'794$Y *L1GL<=)6(C6'XM3
MP8X@B8"FI&<A?$ZG>544<P_9/'5"Z-W=M"7U[^5^K!6,H33:;ZBIRQV1M(;H
M&;,7R(/$-!%.>X&FXZ8+K3+,%X*43<$_<LZ3+[2O-=1Q<\\F!%C_G!*<D1=?
MJ^'18*D1/N057R?&&'F1&N-S*B61EC^7T"V=Y('O7":M,!I>_C$UE0>]SN<'
MT4]4<HR\-(\KB?)C,L '^MIOC&+AU$G;D0VU)X1Y6JOZT@5X3K#,7MY%,D'N
MW7HZCV[&=]'>=PCH/:#!_,QQA(;)O/[ZG"II&%R%UEC_#-1L32),K@M;<#DW
MZ=E8NP\+/%M6\DAGBN@"WE] UDL]]Q,\2\G<4(LR14O=D$7H<A=_!_E[9<_-
M,QTR0^K[#ND]R*P:XDK=%<6M3=0)]+;,CV;V2'!%FR087A1.]"YGO<*ST?>P
M.H@-BMJ@W/59J0FUI9/U>7)/."#]!HP3$U?6?T8''!N[^9U+CMF*GCH@Y):J
M-#8[W^?45QN0\-IG..@)/; _+J3\@/Z<XY>^@-/F ?8+X<=RJMV\++W*,;K.
MW.'!29E]^^4!8V)AR[33B/38[?RY6OT]BJK#)P05?J@;%^=?GD% I890<"NM
MB_#<_V%) V*"1R[^\V"ZP3\7*-^EH<C&L3P]LSWOR&:D?4BES$L>A&1#Z=WK
MM PA"3G^U1=)%($[[<NWEFNY,K_3RH1N?:'53'_.CY9NJ,5S3\??3^P'_AQ8
MIG%*RZ/' [-R+NNG>>@)&K]\BPZJ]#H2].Q32>YVYZ&J.4?GEI)GYF8AZ^V^
MB2G*F$+KTWG3'5:G\_!Q3ZH:5__S.,LZ"] !!152Y0Z8)D$)^;>+*4O3<-99
M[!&2/7(J%A9+.R%PJ43F07Z[*QI4[]2"6;UF1R!@Z1L4&88$0F)VN"ZDWJ<X
MQ]Z%%/4I;9!*D?NY[MTD+6B6?YMASO,6@X94"J6+:1W#U+:$<ADO^;K@)=1]
M<$^$JD,R$:MANBP4(7:#W[G%-CI*B(_)HX26(U1Q4R:@1=Z+% 6\?2H!HLZ"
M4>?>=V+$BDA/B%$I>FTB9%+<#.I2(\559&T-L_2Z#;6?9C>Q_P.N*\BO$]_E
M_WN #;)?N(-FMY]]C-F;[34=ZNL3'!!<6N?D5Y07&/Y&W]+?LS:XKM!Y(M.W
M8.SC<L.U]DJCX.A$'U>/8T'II>>OBIU/^J<-C.07_1$?U *6QYV2)G"94;;O
M;:2/8,93J%YTM0-N$SE*,!$ROT7T]J?*[\BCP'-F>J<CS/>&P"[F%N3<3T@T
M1!$U_:K42^6*BS*Q1@BJ:T:GHQEI%]/4^-&@#O9$%/D(,E2-X(6<>]<5YBJ=
M: ,5=[L'\[9I[?U%/7EE8?O^7Y?S_)V.; ,(9&<Y.Z"\?3' Z$LB/H*#T5\2
M6@7E5>]1E#GZ:>WX_F/ E[^K??,*JF8#94ZU(;4-Y?'I0<$%I9\JK$FC/P?%
M%]ZXY/ QYU)>K?/+'DU[0764A]4^5?6SC3?4DIC3P)\3@B*V8O>@B"-I%2UG
MFFU!-.!TP8MJ8=,],AIA8R3'P0@<#^C3(8_06JO0ST.8.QFZ,6131:4]\0Z/
MTP.D \_YW>"V&228I72#.Y789V/R6Z)IUUZ^9@/IL-!6,RR5WXLV -,X^ZAA
M%W]:<=I06]QQ<T.-%AYKW'+YM(,-+R3>_M;,V6%;78_JK6?T]UX1!F756[=,
M'*I]TQ#MVV#M51#=00\*H6O^%IB0&:8?$N,94@E<#"\#(\-R%&]:ZEP"Z4&Z
MK?.^+=^+%E6A]!8T4TQ3EZ,K26=&5$%()7'CU0ZTBBS/F^2Z15(06NZ.PTF)
M")M(GR)/\C>[A<(3I]N0;!%3FW0"B1?C]B)LH?I2(3V5,=%7/"?9)$!1T'IR
M U&9]_D1O.!%!;Q99'MGI<3?2+D?28'J R!B-VZ2[JTH8T;'>?LCX]""=J(T
M5_$,HP+^-?*[/<:-A8(R;VD?T@I7!B-:D*Z@GP)E]U)E1U,'PQ&A"+@[<P2J
MJ11W\#4OD(< ]2-8%.G'Y@G&T=2'+.'5CLH--=S,V3GU)G>7!%23<$4J*FO[
M+;&+;7HS<4*^?KV1$OBF97&X=.\"_O[W,58>A]F[[O9;Q_O]KZ<@/I425JI[
MK>#@Q:-U03T7"XT_P/0!+[W]UJ6_/?[L.59KS2VXX'(VR>5Y[?+I)]!*N[5O
MG'5K_:7XYY1WBVEAW^_8F9'@PVE?1-;+<<&EW">/*Z+R'(R[=@V#*%4O \*0
M4TI-$[&IN7"M:TB]/U\Y9.:@J.O$"_DYX X'8B9A)\E*@,HB[+:GH>3XYG<1
M+R%\W_(]8_0_USB2?H2KBUC$]+5F/W@S8:*%0REW&6_)GD9YMT,IF0ZTNR!T
MA]<VXQY=G>#NS%E1GCY.=7@X$%#:V%#])80>/%U8DD&SK S"*JP<SI2<CN86
M_"!)N;*L^>#YY%=N+6XFS,HSD6Z=L&;=?Z30;[3^M-^W:V/ U2'O'Y (\8::
M!H(1%/6K&L:RQ%*&3L4+VY;:8-<@Q0/L/KEYMM! DI\D(Y+?@69D&V0J%"&(
M^%IAL;0_^"SB-I6[XT!^8CI+:T/M+C[,X3;)"3$7_DBR%=O>Q=HAB8)YDL^2
M=!WH6<XF&*O0->0MW:WJF9$01V7G,H$XW/;48&D*..DJYM].6I[2)Y^0_VMD
M=4.-UR1*N<^,(MR;V0$5=0^E>2/S#9^+EB&T-(5+QLS0[A5OXYNJ='2<GUK9
M0]!B:($_?-H7SYG_@FIZ(I#)@K.NZ. (UUR3MI26N\A& P,+?0YZ\S_-4@_=
ML!I\[ZT=$"*,W%YW_89 ^$:,+]:MO?G[?QQ\$VT&+#Y47VV<]G%TDGF>B4\8
M#0PNC6X1B.9?#G!]SCPU JUXRSTH]#S9!J+TWF@A3.FR ,U6SM2R] %">RR/
M@ZARW2\@6GYS@H01@^\I0MRO3TG>L+K4KT0:#2MI$->C1!1YQ\T' EE*Z]>*
M$JS>0CEFI!-5@=##1BTGY)$-)#Q2J=!7ODE)3J&I8??Z7:R3![R35')7S^$D
MU!QP<Y6BA&&Q\/P]DHU_]FK,+1 *5!J3T+C-G)3$'<\FSTV1'*'6ATW5)6B=
M][SSO 5HP9%V2M+%-EIE?Y/T'0'*O=N^S7WM.^_^ACR(1R>,%K33HX(K ]R&
MZH?^'LFX\7KB2FG!Q])/OF[<TR;G9_Z.MC1D1)[Q[S\6F*-;&#I8B#&<[B^N
M]N\O.WI]&1$#=+V<30MVW4I:+3W0NR83G8^&0MQ!_[=+2IW//,+2M!B73=B-
MW:?*>7NQ1I\!DP8@@ID+M-)8_,E8H2JP[G\<!1B2B"):)J#>J0UO$_<Q[. B
MRE5NIQ$TT17VI?#1/-F]6-R[?H(IYFB2L#@S[7,B?[3@.&+#/H%5@]A+,ME)
M_H?WY#'"LS7)5FA07/,<2A1Y?GH=+=M#^EZ%&Y)\/V(NMB'HDG!F>[@.-$WY
M%5B=XJ8.ITFOCP.1\XW7"?>+FW*4&([HH')O&!+;_XI]+PZLVG9^'46ZHA+U
MUT6?YY^F:0%JXMNXVM6&,IMZAQ1)662247#^K&]I3&!LWE,GG_"& [R^T?HL
MUB5;;UW;"-\XQRM+\SWY:\7)V45NE3:.!D[^_9JCF4;<RC,%-^;)7[\QD,T0
M1P2P5=)3"1_H(DR^6)9>*V&3-13_8VQ)94E_0B:A)FFE@B)W5.GD_3E!A_SJ
MF!P-J>P" Z/XW2TT%L:()WJU\?VO&K/A"3Q"%"B(++2F$I6:J]PA=X*W8 \W
M<X%HYEV".\D%"843A7SY\0RF$>FP[ QY:/<\&O*UG=PLU'O'?*Z^M+^6_,'E
M0EN6TCAU33PZ0W*'DSC9X"5BUJC\$)R2(3=M1.PNO"-M9Z @^X<N;5G+G8X'
MZ&*)8X_Q :;MZGV#+;3@\C* QOQTZX]'B:529=6Z#)Y?# M-M#JX4&AY,T\Z
M;NM;?D3C57Y@0<',\5:?_IA?I.,V8S]3WUEJAE:-SL:]CG&M]YH93?5Q];3R
M3&C0U_0K/"DSOGX18Q5TVOHK5KNS=:QSO]#?:]@]W,1/90T^XQ_^L:C<VP'=
MZ=!OG2F*==L52]8=LQ_:LZ'6L_[,\_L#U<*I:;1/QUO;'WAQP_^[Z%#/Z^..
M;OKU?N>EAT\9T;[);?;5-N'23P75D38V4\43L[D2\EE^H0[58C]Z-N=R:TO.
M9=-&"30SD?RZ49(\JH[9*VYJVI*6*%F9X\(&2LW#<0*JD7*DW!C!/"$/,8TP
M%!&;!6;\0KJN:'(SD1T@CS!;W%R\N_G?D9+&.XD"SN2:8*8-*A$RJ:1C EPV
M;^)^PZHJ-I>(\'=;B9O;NOBH#XBK*.D!3,\]S##S%"Q/O8D^7PHOL\.]"7^&
M6(R'.3B&Q/0\RXHY$E0S]JA]:=8LM%^W$V]W75 FH!MG%-E;GPI9\/CY55O'
M7ZNDINDRD>J#J/8/A71#7_1?,\W0,$[#N]&QE_:>*J;VA2JW3H+=.-))V6DD
M4?6/G7&-( N/G)/F*1[O@U5+:)N)WMF)K_H<R%.._"8'&45=_%VK33M3_8+@
MY&QH@C6C.4ZR@5^AU#^\1^T@M#*,SB+U/2X FZJ/F$B%T$16YRW9*>4(WPB[
M+Y3\UX9:,R9+#ER$BJ04V'&I'J((F*JMFHH74"6>,I=I4BC,80T2,Y2[*-TG
MF"W-R+D:59[+A%E*746:B"L_ -G>7\8:I=JN1TP.)R*7[__^)<"[::7J6/I]
M;Y..E'W4\_'EO\_I%T0]&0G!'X\IIALW%UP^8]SF\EO,[L 2\G!(\.G]F07H
M9OK N5V^C7FEU>>F'#IGK8*9[98'2B_:T#&&LGF>'\\KQH[Y[+%0/D0R'B$?
M3<6HF%XD(O*N*]_1M!@8A"T"EJ+%U#V(G0 EUTU&\\RE)"1=12.IJ2*'A(9=
M8FVI-R.7*F&V4H>IS88CNT$=AE%,,G8',BA,0ZO-F^G&@5[Y'F-?OI""TQ1V
M@DBFQ?WT)D+ H[\U.*>\1C9M9HH7Y;5\!7'TE27&8N+0Q9NM,3S-$6IK;1C=
MXG*][\[ZG'.UMLG'?(]VO#B6646S2Z[V?5B+B0GYS,7Y77O2Q^,4#LC^;O$H
MCD_OO^&.?0F4NR;RG[ID%7V,5H"$B<_D+:H-BWZ&=,NB5 U8F,)B3FZHB5'=
M_F!/./ 2:;HL\W%<:I9Y+>XBOZ6UOJB4F2W0U,G&".6DHGJ%1@FC]>#2"6I8
M;42K-]P,2LERBTR$=[-#$8J8AEH$M.+D=D*<6C09,ZX\(5^M#O6$\O_5K#*.
M- 03V5\6Z8.D08!28QI"J:QQ*SA)$[L97Z/(+LIUQYA1)\:P-@BS"]BAW(LP
M^QF."$YFC=BQP_R'.&ST5A(6R1;P#199/>O$;H(.TM1W4YW2"J) G.6FQ>%$
M6J]9>5F"^S=G=YT#=B-S8Y'K2O1#ES.!-97;O?&#Q@_R.X.O-=#<'HT1_3[$
MZ%6J#U!J_;2R*O6S6%Y/?\Q+*)T=C</BERT*'?1-R19SAL/GWWS-@9UN.%+Z
M0C* @FSB9 J;H3,A/_9$;@<!DDWP;GX_N'U#[>I+9N0@H$ON60?3&2@D6YS\
MZS\'$HI'8)0MC\@BM.!Z^#FT[:TT(_( 89N]BKS>T$2?[9UB]:PDVIT]X:8(
MH0)Q#$'LQ)R[:"/E;OGQ?V84&H"+%S;_C*3)/!9=T#D.U"D<JUC"D5!EMV*3
M02T')H+Q'*)W;1MAF)/'@!9FEEQ+A%<T6R@>B,>%T/(]-[2(AB+]-$H* *(Q
MHZVFP6>?0>UC_!\81'7J9W1DP(W-Z,#??KDQ+U$:5MM\_M?'^/M'-9S83/!O
M:T%IC-7"V*VZG"MBV^0&,=;3RL/_8$+_L6MV18?=7'+F%>$[*RRMO.(_%7ZJ
M#0^*N3F:(ZH26UZ='9ZU\2W^5.@UIF@H/''_-0K;NVF>0[H^GSZV4GMPKYK[
MP7HK;<&OF8OO%:"9,X9KU/3)7.3(DJ%X)N&*QTM*8_*?X%ZEWCQ-8X7&L^D)
MWX0<:U .\%LPMU=!7DDW4X<9 ]Y![P'B0"-$)E[N!2GKJ!Y %V2=/BMWA\-S
M(7.!/J47V#V%+++";<&[3)U5OF1#S3":H(W="N(,!=3S2N:</+IZTS"N=GWO
M'# W56'4\ U(K;LFUNBWF8[_5/!XK*;:*,U3WP = 4P#L4%5CQ=D5F\M;YST
MD-A&:^;6VO,R(@U,,!%#P[26[-P?7:Y_LZ@T\FKZZ@Q[OWE+9#BD<EF$9F*_
MQ@J?-ZABQH!Z%^HN^: BDQD%9A5[+[&AX#YT,WNI'?*3YB.#8MM)7+<J#C29
MSI/M$0Z\6;B<V^D L83L7O [DEL'4D<DX43\W4@^B[^C,U0DXQC<&A#2)I^?
M@@WZT7=&5%YJA]LEOCIP!?7^G'"%O\GM%(P6*I]7IGX5&;"!+*4Z/->-./#W
M+,Q80#._BER7LS;4-O_SR#TEF;R3,9JDE187RYH@M!1E'>KT?!QM_)IQ3Y^V
MN%;4;62:R%T<BZ1MJ!&>.AUQ7OA%_>0(&A(]KC8<KPS*_G1^I2[HM'/30:M_
M'S/4#/+SM'I+SVH*.IX?D(39/OZ)?@JE:5U\?<[H<-S T)ZB0^WQ9TD_C>>1
MZI[UO*VTSX^OJ?/=Z6 S48CK9B+F[_)3!+1MI)V0[;U5_I2M4I>((@_0M$DV
M(AR%8,H4E-FI4M].K&DJE8750](NBTRUO)$OX!4PO:C\R#C)_<G\6KC1J/TM
MHHB34]++^T]*\3RUM^W5%?*^%PJQT0<76L)1C2GYL'OSG^P#!8WQDBDT17A_
M.CZ@\7\#P^>'K8";4A_,D//8Z-O[PY74SKD#>0FU!PH++HD^?FLL\;]@,1KX
MW+\^\<0J\U#0I.=ACZR#M8<V)O\/4$L#!!0    ( !6 *EDDDB",6ZX  .'P
M   /    9F]R;7,M-%\P,3(N:G!GQ+MI5!-I^^X;145$168!)2I"&,2T"B)3
MTFH# @V164%(VTA#0$PK(%'*1&6>S*N O#)%YDE,*Y,@)$(87K4E,@LHF41D
MB*E2"269=OI_SMKGR_EP_F>?M4]8#VLE*:IRU_/<U_6[*H7BG8*+V.'AZNZ*
M6+=N'>(WY0]",8,X^<^S_Z7'/SOY7]W'.L4+A.;F=83U#BKK]B'6:ZY3T5RG
MZ$,@$8AU&_^/#1#_YV/=>I4-&S>I;E;;HJ[<H'4'8OTZ%97U&U0V;MRP0?GN
M#>7[B V:&[7V'CJ^2=OGO.J^RSJ';]TMWVQRXDF/KN\PN/_([U=NJVW1T]]I
M8&AJAC*WL+2Q/6IWS-[AY"\NKFZGW#W\_ ,"@\Z<#0Z_$/%'9!0A.BX^X6HB
MZ=KUY)34M/2,S*Q[>?D%]PO__:"HHK*JNJ:VKK[A:7-+:UO[LX[.7E9?_\#@
M?UZ^&AD=&Y^8?#<US>,+/LY]FO^\L A]_?9]1;P*_UC[IZYU")7_6?K_;5V:
MRKK6;]B@LD'UG[K6K4_\9P/-#1OW'MJD==Q']?QE[7V';VW6.7&W_$F/FLD1
M7U#W]RO#6_3VV_!,H7]*^Z_*_I\5=OO_567_L[#_JZYIQ%:5=<K)4]%$8!%R
MN7E%%L*<_C<;/H 6&D!Q8A\%XG8,>9+2@GI!U#S.52"R%0AU\JZI&/(&R'DB
M_2'I/L=MXE(7@1>[8];](5R+&^_"UMT*;PC=U]^P,'DU:^1 DUK4>"$4PU.5
MZ@K$?="JD*9 ;%B$3];#]%^(ZV \C]JO0*120!^B^@)#!XZHBL;O8%YDIV)5
M*1??Q V$Z8TXN0DV=SG7 (?QZHNTI][ID.6; UUGN>A-+WGX.[.;QYP\&Z9(
M'E\,A/M*>#YC'AZ6.3S#I[3#I_UZ!1!Y>%KK4LG>FP7VKRR>3?1Q>7\TSIIT
M9MW+J:IJ?%8WX-5QNO%VQ<+L^X9J]_#?/M=['*HWW%GX1M_S/F6B7U>Z#!O)
MU64\IC'LR-\U:R@KI#OA(5P/OL5N.1Q4]031O0K$= P7UT]%P.S3LL[?)L[#
MQQ-XHFF5'H>T<K!M-1@49739TDF1_*O%-=&&S&0GY[J0:=Q#P -**%D=62 I
M$,T*A%2/$CJJ0$339V+$X;+R[W<;8)'X.K0ZP*3BM5J\K + N3N9DGWR?NPF
M9H3&%'W0\.-5P]D'W";D65EUEU\2Q!E$[I"B>3?0O6NNM?S7,U$)-!W2ZT 0
MFQPK5:U9.F(YG/+#K 0[U<@O^=CD;?,G''QFL3F_X'WXKMUXHL6S8P,V\VK/
MQ@NV)(BFAEY.A8Z7NQ[Z1+6ISJ0[69L]'KL6F9D3U=-1ZUL='%UT69Q7+4/Z
MX/_&="@0&T5P.E0ICIH@[Y6_PC?_W ;75Y"':7^A;Z'>2A,@Q][@VI0$7+("
MT4;K^X#NE2.[1X#$F@413^;(_YYX?ZVPEV9,LCO]UW@+)SGLX.1W&I(2!9P&
M,:5&,=A*+.A#@RV/YBJ7"]@%JU3#E=PY478D/&>7,]X5PJ=EE6V M<&@'FT2
MTOOMP<=.2+X&%:F#&039I^ '@A#FCIYP<) U>VRB2Y4KTARL)%7Z0:@^_";"
MF@/NAO?56(_#*??WW3>Z7_$G>:+-@/^P^V,3,L*@WN-<@RUAK&JT**LIJRCN
M([5+3O?3)MF:2RQ)J6EYH[//ZWCFP8?]JH^-YW0X5U:N,5W(FP&"LDU:8VC-
MWR@]+@S+LR05/#S(U9A"#F"??@P6I0#G(2*WEA6KWCNK R](K.$0?ELZ$0S"
M@T262&>1H^,4(* C296]89M&I+L?DYH'"\GF<*H@YBJHD1W/4>DGU%9_IG [
MRE1'E,N$FLQYFDBE_*% 9,RJP51^H>P^8 *Q3]$&C W'I7X2+! N>R3='<EG
M;X W438%GSU>)W4#YUGSDU*C2FDT3'WX82$X\I;(B5"#J_DLMVA]VW51KMM2
M-;?35/+2HT3WJ$Q^/3\Z*.=:PJ7O]1UQKJ"'/]T\*?A21<!O/,O,QZ<&JMVL
M%I87//)1CH3]^0W]9P<??!U[FE?K^Y.,5\%$4V+1L(4+<[D:4@^"P[G,*05B
MD-;BEDTV(+^91<F:F5&[L;UAUF#D+5PO;2JHA[&_"YQH%G@9"P8+ _60FO+]
M,?J=Z.QJ$-?;9+;J[C#'O W\G,#6A]WGP1%2>B_V/'(&)<Z0T14(;@6M;9G(
MW] JRR1O :QE#P0R&F#_D,Z:LJ$:TJ:->+ADAB-,%*AF7TK KIN11F?W8RQ
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MVT&M7==+!]/)2!*V?ZD.L.\</VA#S#VZUIX9+V%N(H5TO\5RVX+CY;MA6JR
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MY.IL'B6%UAP"Q$%!RUP;HCX)S5\5QH&) F(O45L^AD5(C1K@D_WX)W\TFA5
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MFM+,[J6OD]IW/YT0)FQ&)?^2UW?/A,0Z,PF<K!<!]K)TI=XR4XO8Z5TXI9;
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M$CTYFZ)NC8UFIS&;T]/D/RU06B*SI#$-LT 4[-Q$0O9BU:5&F#P0S:>R1)J
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M5PISR3I18,S7:*2FDVEB>?U$;)<[3STVW)7F$3CV>W?23W\@C#DNUYC)C,/
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MNV[X=[ P&0VH\#0V1P7Z+!D^;FPD-?8;FX^7CP*HB@6:=A06],?!>W!I\LW
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M CZ^A[C#A7 +(@L%?>+PA=>7U1'OY59MXS5)]*$<YXJ):FG9,BD-KGD/(GU
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M?"&XPY&B?+0CH3T6U:[B>H OK=28<=LE&@-E% #-U>!4\T0&2G,OK<K=$11
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MC0\J=MO.KRFU.<L/VU/H^=(SE9(<.&DW*T#?CVZ@7+4''3GN#NCSYWA.^BB
M!%=?^QMGXD'AS[&!U&MH[]][$N?0S7'O"D?CNS%?-5_):#-7/U+2\]2N"DER
M@9?\'&>\'!J"NV"P4Y+[.LVN$K]6R7UR-'90<=F=&=)/S2]VZO^^OL5)24N
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M_ TA4'@,N@B!U"_C_@K@I_8]Z>.D!=:6K5<#"ED3%>=([/SZ7F&'*W$9;5
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M_#,W"_GFHU+??X9*F"CM\/T=4BTS O\]07N():B 1,#9H>#4+:-&&A]RN4X
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M0O] Z!\(_0.A?R#T#X3^@= _$/H'0O] Z!\(_0.A?R#T#X3^@= _$/H'0O]
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MX>E+B;7_Y6&-41AY0ESR>?UA=:MOT$3W[=/&ZYV3/H>0T ;?36]]33""0@2
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MR+(P27)U9%^$#4\'?$-\.%%&0(]5/(9;VW)(4S!\^*L'O+<*<8*);(K"!WX
MG7*'FY^,-[VX!W)),$DZ8W*6 W ZD0/Q,N^%L/CEH=ZX\49A:L6'&U*N2=PZ
M@DXO;6-DC,4Z:%U%C-1\S=G-X=#[WNN_I5S6S)B]!!UF/83/Q99MN[NER^ZK
MW)SDV=G^>=8RN.?I.4)7LK%4E$$S5_>2#%J"I.0A;_G<5#,T<W2A@KH,4DA#
M^#,Y:%61SQ,TQD9T_X U9>Q,;@.Q#8M5?UC$U.E\N <U\IW)#'O2P,SQA2IJ
M.%0GQ_*)N<[9/-%:A K=>5;S&';T!<OR:?K4M3 YL)8R&"^NR.-W/M!8_3:
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M/N;@O6)EKW5 1D*%UK>8FRROIZ=-N_*KO@9$+NP+SCSQJ"?:.2#SNT)SYJW
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M2!N[6VP4)OW\(@>'$$?(<GP4<=ZKQ(]%+SQO5:@O_C=Q"P/*Z+)G"6]6] L
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MXHYPSE4Q_21Y$-\F:="<JH*R6^=#>*$$/0I=>#?U<)%,6[1\,LR83QPXI0P
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ME\L1=9+?H5U+D\@!BP/_!U!+ P04    "  5@"I9N0 ==S"C   6I0  #P
M &9O<FUS+31?,#$S+FIP9Z3[9U!3[Q?'BP85Z2+2:U2:]-X#^0D* M)[%Q"1
MWB5(3)3>41"0+D*(]-Z1E@ " M)[22(@31(0#!#"Y7_OG7->W/OBS#F[S>S9
MSSRSO^M9>ZW/]\6^G+]<!]S6T];5!E!04 ">7>V RR6 UO_N_A]M_YOD_^D<
M%)<] "9J@#U%WW6*^X!K3!37F2@NT0 @ $!!^?\9 /C_;A37KM^@O$E%34-+
M=S6@Z3;@&L7UZ]=N7*>DO''CZNF;J^> &TR4=^[)/+S);.),=3^ 1?;=AR)J
M?LVZ7E;3";R G$M@! TM&SL')Y>@D/ #$5%Y!44E9155K4>/M76>Z.J9F5M8
M6EG;V+H^=WOA_M+#,R@XY%4H).QU9%1T3&Q<?$):^L>,S*Q/V3E?BDL0I<BO
M9>7U#8U-S2VM;>U]*'3_P.#WH>')J>F9V;GYA44,%O=K8W/K]_8.X?#H[_')
M/^+IV?]T40"N_Q_2___J8KK2=>W&C>LWJ/ZGB^):Z/\&,-V@O"=S\\Y#$RKG
M .;[LN^H630_%-7UTO#+F>)970(G:-D$Y#&"A/])^W\K^[\F+.+_EK+_0]C_
MJ6L10'^=XFKQKC,!P  R^<&7][6.79]A0J6FQHD?<Y)<<M-?"V14+\V../96
M+ 5X=DZ6^-P.U @<;E,^K:7NX87<2/\)")K-WQ+2UC6&=U9*A^U^>%< &(=1
M@:P^01V)+?BC]<*W)!V"%C8U01S$N0ZGV@[E*NW ,ICDB'E!7$7K;%"<-W:X
MDDE)$M[R(P$2&ROHK[5]^V\97YLB#3.;Q!2X3'3;#/>=,D64A(</W*K:K>,-
MTZ+U,@19]3X*FU;^FHQ6GDK,0ZCH#8N*!"F>Z#9,V5IK4_!OTAO[A]Y^Z,+!
MO%\0MG[TE(%=1>!=S-WWTC2 YQ1C-JU;:3K>%,2Y\QN7@%Y#!:<EKY./Q!7\
MX12&G+$^'EW @@_)BB=S.CI==)"95QSI# )Y1?_@!M[G;DTU+B6>VYV_T1Q\
M/.4CF-8WY)RV>:+K'FPTPQ@'O@.EP]?TKMXG'*#!K-M\-'B_J+^)W_SZ^<0)
MO-.O#>-+MML#8_*KC[F_O1= OEJR>RZTL]_<[\/\73,EZ15?LYWJAP$%399:
M MHB0U>;J<A I\!"=+2)XZ%6]IBA97).N$>,D6,!M#95%.Z0J=I0%&G]Q(C9
MC%M0D!I%8YBA,HL>LQ VE,=H1MLV"2H/L&PNMA11:2[I!SX1<'^OQ!,"H'@?
M,#W3.PZ.T8BZ!,BDK'1+Q5X"7/V6X.ON^_T8*7;BU+K#6L+&3Q(O]CR5SK,0
MGPUY;<2P$ZIT']SHL3@:';FRIA?\QG+!%OM]3;  P>-F9CK5N#N3-@MNF4X*
M&7<TXAP2_GL)H/U5%(?"_IY"8[Q,T9@*24_E!&8+$8OH_5&:05TQ)+MO78,Z
MZ>CNN+*=R@_E\+C#2IAN_D:(LY;,L)R]X--;;F]K5.7K9(H3^RP^EO_,JR4F
MJ4,&3#.V+:,^5@E]V7GPI0GT^4O" \#_[RFKZEZH!WCP)>'_/(]/_I9\!V^M
M 7]8A%6[O'W'STI?N4"]_\_&.+V1QSE?%9=4D/ $7+-[<+SMU9B]$!)HHE_A
MLR"XTO+%KOF) X7/#PI[&:I:Y=Z_ZK>DPX^F9ZY= K:9W8>-O]) W]T[M8!Y
MN[VE[PFFXDEID^CH;H[T''9HN5/.GV"CN[A,JBW.'Z9MMA;]J\(S]]V)ZA+@
M#8\&<G4I0KV(]S!J;V!2S%#NS =^QSZ.LQS!1EQ+#\N7B>[VW7BW9;,AQ1IW
MC!.[QS\8"X%E\C']ZU=U@.2UH9Q5CX8JVP)>,XLVTQI3>1>D6ZAZCD'%XM"K
M#A/;QA02FU'."\C3)>D>M^. 5CY@S\2HW \W54.$.%*R)LG&AS[$IC1#R0IH
MRF&OIE>)M)@V*2TR1-C"G>2DHSXRW:1\>R,Y]L U Z>RFZ(.4+[&*9FF9$TW
MV$W72D5-=+';>'Q]8S\">1=@]U9GV D(]EARBEB]3W3 _WM$=,*-)P*98#).
MQ-*1/@TVO,%XA'R$*]XW,V<PKB9$(A0KG-C)BPFGKMSC%'BH47<C*X5+3'GC
M/<?N..:B W:K,*:>I#7M#8*70MI16!LB1^&U/YWW)6%JGD >0>W,*4QH;*<(
MY7+SV4!#^,NTW=M>BBV'$,,E%-M<EW3WW#Y)!+FZ>[O,!2\O9E%D:?YY6W?
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MRL$9/-E>L\=W.B,@%?US<O,01C174@X\-GA4^W3/M<G+*\SQ;%4NJ-_Y97E
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MUB[RSW/!?PD@)FQJ8A=O)#HKS6Z[SAYBI3/EUB'KJ2BM?T[PP?R^*]M4F["
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MVE:]N860A=EL4._S.+35#75]4[28&R]<@)UY'+G0V4(!+14^OA>\P"7X*&_
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MNM-9IG5>)LC2[)"@O\"]-KS^R=5G%)$-O3G5Q=4R^$"#&S;6?4WBH%.JQ*M
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M1<2M4X1\U%L34DSOS)E<5*W^4,/(9J']#\CBT5$14]6F,J"Q_^XQ6^PE6-7
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M#86L2[V((A'8B^C"FU&R$=_=74]E,_D,0*/=>[4[K9V/?#,N5&?6J3?Y>O:
MAX"GZ&.VTW^1X9/8\%2(^U$E2GP19G1Y4DN:;R,22]OH":G_48_UD"^KG9O3
M;*F$E7=,RK:U[R3=^D:$^Q.N.PZC 1T;RD=7$)9D27;&* L+D<L ]QJ/VV>3
MN.ZPZ 5FZM+WL]5%=S9'*4=1:;+/^8N&A)2]R9HC+:MK;/4ME'QA\M5DVT#8
M7X]5*Q/=<A\=W]JY-N6.=&$?Q.:.H.6EP4]_Z-.OK0ON>MY1?%4"NFV?\JC$
MSE%&+/S16- YVJ*YW($C2Z3-Z3;/>1D"2I2R[4[8R*DY@-M]$F10Y.'%T-#7
M-!)W9S69H&MYPN0,0_OCKV((KN?3(I4]SPXU^L9H^T<\X[Q #YKG#S@1C0N3
MNC*)*Q#OUR]_B;RD$"<S5:\D>2D(=Z9>Y0XB3T5SX2O\0F9R49E5\$IN$\Q>
M1KT>YXL/8?(P":AS-)M-O6)F#_[\:B,=$^]'<VHG8\4V\L[R%J$# [QD)K;K
MW=N]S9+NC4$;/UI&2N3DJOYP-ZM+.;'R%B6W@.YJPPN!R9J/1M'0]-/N2#WA
MS^(J08=="[+I%,^.S* );V'MB)84?=F#I8_R)/?QMK2!K;##VY/_#MQ[VG36
MRUD"KSD(HU39IJD)B"J[I^/"G_RI?27)(2>TKEEV-31TQO2Z39[3;FAUG0'2
MA/!FBU>M)+$RU_:5TOV)I[:$OO BJ,U\:G&EA4U6CD[]UC+BR]\2)K??X3V$
MQC*6*D[&LS-TIJJ1-F3(ORC!B3^6J7"+ E5</E824?C3$_%&LQ4HH+2EW_E(
M_),,K5V.>&&L/ K];1%;=W21V0,Y0T4JL#CN #"D]<%N@V?1)[$^X^^N.+YO
MI@^G1T<^R[HZ*_/&WN7, G3AUH>LWU>E<\"B+)7Z5XG"8]^Y!S[5<1V =QD)
MT!J?XZC";FAAP-Z1SI'4YK=<%!4<3.&56,\KQ#R%E4\76"^XJ&SB8 C9^H^_
M7SYIZ+F'+K9A!]QX3R/ W5X"C=Z:1B*TR2SR1+; B4=C8:W1H.$$%\QB/?YU
MY?"I(FMBTJ#6MVM\ ^IM6!6L/NZ:2R7EQ[I]V.JW]BR+>U85E?5&OOG!OU;Q
MO"M_>T*'+PV%5MS2JN/2*'OY5D[4Q*[GZH=7.8VV!%--,J<1).#]7&8$>.28
M;<\1V%#87*3-[F6FC>UNHBX"4TL-N30,H?&.;Z-/4\NX\F,0I$(6FLA'5:FN
M-XCR!_5R_^"OC"-$/SBT80[JIV]NLZ ;.$IKNUGKX@%=T /Z#^\@\ON]U!J:
M4B]VQ((>T""])SL/M#;+V/M)# ,R+WNO_NR5\RH+6$H?FQ$V1!5M F*A>>HD
M72J+GFY.QZ1VZ /./1B>Z@Y93V#$@1:1NU3C-N4Y\2>&(KJ[87ABV;FMK:6^
M-:5MU&U1#W?G_;]WD\XH<ZS;,"XD[XE.@H/ +*Y&74"8]2Y( D^C:(>4'XET
M_KYC-L_OV-W4RYXREC3I'NF3X/B2S\2@0%45+QA<K!?1R#=P.167'/4PWX]7
MNNZUW]] #]_3B,?VJ:# .\[]$_=6P\JMD\MV [>]^,P=?N2D&EQ9T#&"LW<W
MMY_%ZA,F"'UE'N?8R2%) GG!?7H4OT27U+DGQ"!K'ON08'.#<@7X#RQA06R"
M531ED :SS5^TB&'8!C8>?ZZ#EW&=%I\2?DJVMQPATR7F4W#,EEZ;7>394(?(
MW!FDC9^;E74-LAXIE"S92 =T-5R;/P+)AU>0"F.!I]\LH<\BK]/W\"50$M+R
M=*%:4'@Z#\)47"GJSH1*21*!T(+\^"[M8L:L!T@I0=8'/CD"R)<S!.+4IBU-
M@1@T!2WBC^$WD@.V=JSKF^E!\>2-(:ZIN[2T#*Y\:=X9Z'ZCL/TM^7$I]Z.;
MDY&'#B^NRGK7<>#^][X"NLNP3>$P$N EB#DP+^=V+O(Q)>;6(R&\;0$D^%Y]
M;)O8N/9'6*$T_73NVJP5NFA#X2YQ1<-U3H59H D+_^=HV4SM!.7L!=UXE:HK
M9H=J_XB]>O+1VNI6:.9;NII-.FG 44^LCK3W:?,>N7KDR*G?MN:P;4<S5:SI
MY_OR<(O,DK-B%:N1TO=+A VV5]+SP$MO(&)X/_"_$-I=^#^,VY.@P*5YH1&"
M$TJ';M,K>5#[YMQ'IA%S88)G(5<[SU=XJ';>73[?YP%<XE1]7;?C;9-4- A<
M)SG43W5ET;0>8$^A1A#W,8)H:"5*;B/"G@)1NTVCSA5J9YF^9:QG&!?[ZP=F
M]]Q(4##+5*^12"K?;=U[P@+EY+J7%/"\!,#NY0.M9(P8 "8\J\5\2(^'G'N,
M=%%A0+1?BUF*@,PI8'[/F76A/(=(7SVLII6!=9ZDZ0*X;LZ+_8O1]J$**T5<
M!$4>&J%F\ORH>E7(AS3A!(9.&2*=XM3,^QR'/@'3E]PJ@"\G[ X&RA,L)TS^
MY%P]%_M^<7HZP6WB7F^ K0NOVK>-RC<K36+-PS*\KR=['X;J3N57*6OZ*X94
M;SC@] )L"G:&O.BIS255G\UX]YSY?FCJPCG=U8J>#_R>L2N"_".V,._L8N-S
M9J+2*> M631*_N\ET87?@529M1% UYMR&0/XJ;VD>62FZB0QT%4SG)(]&7RG
M$WWD0[K><HR/VCZ7D^6K($V#WX%IIFHQ;O#N8[9I!7)\@G7!62E98#F: DXQ
MDAUOJQC[<3#E.1E4C>3@_U91QZUK)/6+*05S<3--6J"LV>;-.RP,N/?AETK
M- O>9$@C1U\5/)$DW _A (1O$$$</DM4;@+J(BVBD:*'V_CROCUOW\&\!ON8
M^LICWJ-7O;9?9N!46AP>TL''T,,!)K0J<F1WC<I#C!40N*3&C9 :+:H_!*F[
M ?8FC=_)+;@&Y^"@NO['"DGS!=-]MTT(2H8(W38"IY%(E\^X8N@$-B46Z:C
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MZI,5>2-SEO,P?6FQ7SI6FI5@;<X@'P)7EZ,%*#H$-<E?596 <R]3\LTJ,=S
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M_IH6I3'J\>FE!_6_/(^>2#*\]//]"EW&,WP@N]ZSOC.G0D5N_;?58/J%9NH
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MS$T77)<9X/(KH58=M"QB-9GD5P^J#LR&ROO/9F>6>46L,-M0D&965+,"WTE
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M*95&!N_28')JQYY,YX,\M7..P*;G;Y\_;"\VU[/NMYB<*L^^E["Q+TS._],
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M09CR\^J-@;7HEV$BQ@_G?-=<I+XK?)M9+YM+KA3:^IF?TR^A^)UW;A":LCT
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M,ZDV-.3M3Q5$6AG7-T3\'0,MWINPGNP?Q](C@)2!XFC8\;IBXMDCN4%?^EL
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M.(1@B+WT2'SGOD3LHU1-7[W#\EM R O #@#W\O_O&4@O>/1-)XC%$R90M[#
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MB^\$2!:K=Z48F9HF?9'ZO7I1)&-M%L_J-9?!LV#T]Q;0;7['=<3FQ%HK^'_
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M SYVO"14^Y%B!L+:W@+(/\$*LC> DXF(+M>!* Z @B#)@+]U3OOY>9X5G#\
M<X[;<2Y\#"Z6&Y?]-2 ^+D\F5?GB7Z;C\MZY6?H*.W%!8_D"GL#GB8&'NM^
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MY;'<)F=CTLHNXM97,N6OR$HP_!JO9B=,V@,:2 A5YI:T(IQYFIN*]H0%*8[
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M@..WF5;32UF@0[N_TQX^]Q!G+7R'V\XR!'TK_[8CO">3:;'N#_V*N/3XCV6
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M/'C43#V<&1MN^[X3J6;C8._S3V['?63]/>.U#*VU\(-K:>;1;^1.VI]<%K_
M$&6 *WS$1)K0%!A>$2R7XMF=<&(X0(><O#TN=(CL5+H?(]20\?/OS8B3@ZLG
ME%4[X]:]Q08+\C,*J>V9)W(KC<0T,;W&@)'X,G1U9=]UTY["2*2<A_6)?*,E
MG@+<;PVA>I3/B7X5N?U)8"F!,\ND $UM<<U/U;1<!$9IG:P<B*B[Z513R&>!
M)' 62/JZW/1)>&-H'WR^I!^I_*-+F6((&T<P3=)Y"AF\.VJS/U52'Y#]S_(3
M9$#@3P4R\^[@X)R+\V07'16TJ-34 5;%YD=+)*>O[\&HCY#E])XD-73P>Z=
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M:JZ;%6>8H(]_Q!^: #72B@+AKL_-1&F+'1SV3@@9??.]'5:__@G"H+_\&._
M!;;>N3U8>O5SB;GPY(!%<F;T]>T=?EE)^<[/V)VMP?!-V:ZD@D!CK?3O7B:R
M^YICH_.#)DQ6E;KN]=*WP1VG *=W)0\N01?]R@M>J6RKW!3[Q -WTS\%Z-3"
M$,%?0>92FB"34X"X&]Z5(YD;#^>2D?;*)HHVZC[3@F+(W]8;Q,;_@_.0WSJ5
MG,&$;'H,*][YZ<,,E7-K;TG4P,X,%8P((1!V3J*>WO!X&O:JA/.RI-\QQ5)
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MI;X;/K)662KDC4$Y'L=;,<2/\%J,YG]=BI64>#044)U\FUIEPG&5X3T'6V*
M.6Y8(M\#%"'2:-AB)VG%I=G#P+ (8-.F!=Q=+]4U;'7T]DGQ)\V%C<T1V7_V
MZY?P32Z^[W,+"+Q>\/SBHS!'#0E;K0]?2\+40^>&I5_LG@+DW^NO56YT_@=L
M$ D/GS:IT% X=Q3@?WAU^+#G J(G%R72W?"ELS/ROHS2D_;FQ$4S[XA*:604
M'+BT9!B2'AG+,_W=WR_*GLMX[G?80P=U>:.B3"&K/;<O%VT\/!0XS]?]F)>.
M<>YLO/N;.N21D.D[ZL/E[]!2UOT*:SW9FG-O82[<X8P83@$K'._-#RU^GL-
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M*:V"]RXW@GO]YE$6,R]!CWQ7$IT&*:*XMNTKD\#>#@8B4[YG)=2^1VY!-R#
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MPXC0<P#_;=:"&)7MY'. )Z(&^UO7^+^SU^ Q>&F5CWU<>&/HUCG@H=SR[W-
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MFH/#3&^%H][6'-JO)]FN!FD6(D+\<3I6V:W6P2B"'9(L^C5_@Y3]<6#H&I&
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MAYKR^W>,^U&+JFU[_Z%RWU<*&XU;VN1S4BVT#;TL[[1!W"9](9^=&D%GQW'
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M2+_M>P0T;MS25> _ N8EZ\,O/3"X=4>=MX^ %;<'XOG8D$.6!_3DGZ5*TT<
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M.>#<=8K2ZREH2 !^3*F@)(MUXU[9=<KRC$O^4HRC>W!<E$_ $[@!?V8Z;T^
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M9.15\$-.)V7P.'UN-PLV9 '\7[T6_OXC@!$8)!3MTFX06''/C-SQK9ZL7'6
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M-VD$AG0!"'8#&C;1"T4(-J0['WN>C9S\69XXV9X8O9-AN(F -U4%/1NC?@3
M:=+FJRNZEMP0G>1+9JNKVQ-_5H[\WM%5\G/2X'P=:_Q,*S=>(U'G]LUTZ,S-
MH>MG+OH%3G%TN\$C -O\'_#I+MZ_F+D4L-KBB3RZ5\ZE]#XE5O (L:7I:SL&
M]N>/5YGN_S=Q&"(498_^[$9D;O8NZ3"S_(VE[&B6C= XBMG%2@"N&-8SU[UY
M:-_2YUGX'5&BU[=9B^8G$:(_4/MR8,T&M/4+3^7G BJ+\-87(-1&1-4WACR7
M_6-%LRT<MH7%SMZUW:D9$P,/%,D2K$Q[K.TU1?,U&]G3:$AJ$ONVR[4+]6#"
M1I8S:4(HYZN<AX1.6<R@%85XUQ>6>JU0=B1IW$4;DY!I0WVRP72#A60_G&6^
MN+EI!JJRN6:DUMI>@Q*,/5M>Y=JYTLVX"/S&4SOO<O&@3.=BM$<+4Y?]MO/5
M<F2;@ /V<ML+&UF[V8=2?]HOI@D@9N*.5\6<CHPF/5"%=#N=-&S=L85T<WJ3
M1D^;2QX_VTH(#6:M1T>+EZ>D]U\%O.UD1EO9%IA!4L8> <ODYH-E^YDI).<W
MTTIEBX?._%$>>\->]\=BGP B;_3C*E?FIC*X ,H4L@JZ"NZKL&:>6 -DD=M#
M5]+[<WXE1I"XVE($_<_>P:4M#Q^1^QFZ=/T!ZWW]+X>*SV+BF=.X4ZC\E+/+
MM):4"^FF*GBW&4MW3#H^=:::WJ>4O#^<^>JLULD,E\129R&FYCKE;3;9+M=)
M-1&W+-B2M,QY69#;BJZS;$-G(%M[!RU?P%T4MVG"VUUL-C7L^R6M*\7=&"'V
M?:8DI95H3S<*)Y<7Z3H+[2Q>6\=ZZHWSKJQ9VO]8RTBKMJLUQ2&MJ%TA(& O
M^_8NUVOV$5"O$6#WW??^&2H-'R=8X%Z.HXNCF^7Y0\#F%3#0*(,9,"@E]7LG
M4?3W:?)_GB20\<!Z?QO"I+AC^@9="XY3(5^9>^&._,8<4O9?5N("53)B.:=S
M QI-"V9$]RI_055H0E-G/G;.6/THRM1>/NDE6'^25S7,_<<.X\>GP^6OC ]H
M1,VZ<7)FKVD\U.4J.MJ%/,20K^LZ^I+Z\>ULF\P<E_4:U#AUA7$,X%%@SM5,
M,/=*$,SH$3"=N%U!F:M4Y;*Q575/1&7,G+\8: ^T[Y0^GO _XEO]/QR==5Q3
M__?'AX(H-;I#!:1!Z9Z@Q$! .@;LHX#D0'K 8$I+2@L2*MW24D,879.6CDG7
M!@@3!OSX_OZX_[S_NN=]SWF=U_,^[CUO%#7B-KZIM]SC0]9&K&\^W'7U?R=G
MWZKN[HB[!C"T6:K\[0A7Y80K;G9;R87Y*.5H.Z=;Y;97[N9*X)NBB2HKF#MP
M<[25?DTU/,QFZG4"I7S]/#7$<(*HH,UG'WJ/NQEP/,_I^5%["SB-FK[,0#HE
MWD7($@PO;*Y&H8R5,O,>$<L-UP"T090JRQ3">Y5+=<(6;]YU#> A,A&JOR#^
M(T#7MA " 25.0U@@Q=).BVWERB$'(7 >,BXC6&_ +!%3'QO;_JRK\?Q1:YJY
M##,V7W?1:-N,R8$;/G=F&,=7G;]Q5!<PD_PRS/;(>"/+JC'5.L!T[_/TB%->
ML/L/$'?($)(1P;6:%W&EBMO(X^G!1'1P2=^4\S*5ZD.BW"^$<:6EJR3Q"9X[
M;Q7Y(8NF\,:*L^CC_<.(D!4@K4L@4U%' 3SQ6:U$,;RX2_7!N+@OB(90ISXE
MH6R+_8E2:IQ0!E<LP#EZ&^= H8<^EU*]5@U]X6W/:-)6N0S,DWC'I3&,+I+.
MWS#HIO/L6C3S9X>*$3O/8+[I;1AGD>GB.1:G>XJ]_*S*0%2^S DAWS'G85*V
M60'-FH3\6N9HDPM<(FU*Z5SFN@:X0A,49[J&.NZ@\9#5$L+GU?9G5VS%*XK$
MAP1?+"N"JP0>:S@9(@G'HF?\ED1^M:FL7/IQP*1\D)T:(< Y9]0=O,-A#$KF
MIKU4WE#5#= S\JYF=$.6.>&\X(E*I%O[L]-]7%_LC8>*&,&KZ_)P[?I=4>,%
M0HF.V!I@#%&A9 A+N6C<!2*[HK:&&UA/$)^.7 /NN@FI.G($Y>[Q/AK/X$W[
MMK0M:%)J59".PL;J#6X[[I?WBEV0"RV59X@DMLMK^K]L:S_TT(^@\,F9VI'O
M-;/%$S:#<<=KW!FR[V&E1%7\4J;WVHCFH2:N@CTC# %^!?KP-_;>_KX,EP#Z
MXY+SQY&JG70Y\VFSL[F0] S_]":Y](]ZMP84A3JG?-HAZI-_J1ELQQO$**W'
M#MWKV^V>3Y]<+/*:C_LJ"2F7[TN93,BPBE7[7*J/:CQ9G%U$,_6TKMK'D<=U
MG-B4WI2#%?)-(CO1A-!71M1KO_S6]FH%^>%&#/JZ\YCA!I9X 73B+<)F=QXY
MBH5H<QE!]+P0V^&6P\V$(?SQ(CVJ0!3^+/R&;6$,/>9(:@_06B:^+ZQ-$F\#
MK]:>D?!QDC[L <YAL&*8OKP$E  AWA?/V]/!RF[#\'.)MIZ0ATV,0I$1#-:@
M[-L\-&TL7P@<:I/B*':BHAPW&\XF(O+]ZJ62UJ\3IBDBN-QR2_%-MB^&#NK2
M)&>K1=J0U5XIHB#2Y&H[,QN<2JRJ#(95"@T:9V5;V]V3WVMV=-?5X;)V&/[K
M1W#PR0(3EY._QF2K,I8.4-TEJ2WP>167$);0T.1:LO D:+XO]]^CR+6Y+?62
M&=F:5XF?^='S_:7.8CT+'H_Y=)^$=R5W/NQ-C-V0?LZ:,/ \J=X+@/AMQ0)F
M&HL2]*\(,".#4%31/*V\C?27Z9E:;<DY\&7,N% 'ZW3,.[2D[,L]6E47=:^U
MUDSH?QE@)+X5[DX#+RL9A=F E6S$]BJK&L<W3M:PPR?U.6<GPN& -#!=*FP^
M0H"-M&EP7INLF3S[I)B<CO=MS.#HE1?OO?=/2"U2RQ%AZU1\@,=\U,6,TUY<
M_1HD,3_0;\&LIO<10[TFR<$TWB,RW@_^1 !>I5)W/063BX:XT<1BN(*RCX_T
MC9V/BCE\D12VAWI[R6_R68:&V-(&R;S,5.\Y='7W>0N]K,SY2:^MH%1GU/;@
MN;W<IW'U.D#)#LNFX.#\% F?$%^OM5WHC9?N_;J@?MSCP2:YX8S^E-__YM_@
MG11Z1HL)IP>68?3Y"J&R;^Y:%E!1O"N<]_KCD&]-%ZKJ%HV[-P0@J1!NEIUH
M:MGW4((:2&"\M@\N08;=CYW4'@(*2-Z:UI;49F,$8X<_\3FZ]:3RWJ8_\C(Y
M84];/*@K6QB2[I@[#\]@H0RH?-YT!JP<@7F_/7*50/'R/2G\:@9K'$MR]> \
MTOP<[SW4.I!Z\( W64&YCEGK4_\/I)2[:9/0J#X-JQW?QIZ<,UETC* 1QWM/
MK\/@VXO/2E3:TE__GAWP2A%KM0BU?7;K:1.]]#!?#I8B1FV.6&,](,.FM.V+
MREJ$:C2,![J[C >5+VNV%N=#I?4\_$YGWF)@-0YU]^<7+)6GSZCPLO@ IH4@
M1]UO[ KA9;Q)'Z+_>7X<*X:ZX#6*=B1'?"NW%6$'*;Z. 625/8L]U='*:AZ/
M)RM\1O32M<,L%M1/O[WY:%V9TU// GICN:D5PB@4.T1CF=^[M<0I;5_VWZN%
MA[2UC&!3$J'9'__YH_J0 =\X6EUU!^I'5/?U2[I%K4S8(WKRVRO+EVY'3'K
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M:X!^2/.H]PEV[ET:>%"<QI2?>:)^%UPP/<)7<<F=Z([=^A9SCT*=A%5%4HI
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MN$E5X'3(0V=5L8Z)*];?L\@N?_PSLZC.K+ZHDT0&*^?&F1!:G%GE"I#3FH"
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M*\AH*.U?RKS(*WG<-:"+Y\[5Z(T1:6!!7P-8%US.#]&'@)!I5:Y?RGHXAM[
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M@9H#??9J3\S=R$;.M"E];D=,HON\,<)Y%>;0=@TXW;ELZG!,3(36+EX#.GD
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MD4-EN&XCPZ X?9@O K(2E!<=\@ '^E =PK5XU85DN@8X V?/CZ_H1X!F$]<
M1XEYT)I$EP0U@<=BHLWSB^VVX6Y&1B,/&XK1DG"A@1LM_0*/ZA3"&Z.3G11'
M:TJ<KJ0\**&$G@LRFP,\>4P;M3?NK'/YKD]U? ?.L'71U;:AD1!5#I]9->B\
M!LQR]($H$>)S'K&KT[[.)U#VI\E$,$XS%O=MHO/7LS7*0P9XGTGLFD",?6V0
MZS6 PN7&+=S 7"6<LBOK3O$:)@S)1.1QP*6@>6B4Y<J)FGB6O1F8<^4."'@-
ML/-@AWO<$! UD0=OUZ/8%,$?VXNBNLQ#6!;"A?6T-/ Z2V(YN>]7N(!KHBV]
MB2N'=]%%\/3$BY"K&6[.R9-V:WC3S\"(PJCHFPVIIMT)89E1I2 ^G&QCP#)?
MUD"?\]1'1:'N$ZP)*M(=; 2E-26"/SH2T\7>+=<B@=X=(==H)WBSA!_ZS$,(
M:Q9QRCFF^WP+SD.SFN+<>]\*FJL.X=+Y(D.:!9M^A?ZCI7:<I?5?OA5S._*+
M!,D(]H*/&@Y%Y =ZIS\[>PTM0E\A/"_#KJ@E>G:II5;WSVZ4 2=B0BB_!I#&
M$90J;NHW!Q]E2H@OV%ENE-BSS">^QGO$MP$=L08,+EF^U9%7]^&-,WWL,]'*
M2FOI,VUJJTAZB0BW-M%SB7#I?V(-MJZG\9=QRBQK-A)F>)Y.CWL(5H(I+FBE
MN@<Y'];907_%2W!0!;DNTQZTT5WPN>:1BQ;BH8EM(GB1M1LLED.66<OU82)!
M-$2N0L03/3IE@[6^*653K(TN^E0Q;7\I\?B&7P_G@:<+8[X>E*Y(^@HB_\IN
M(OOBU2"H/N_]WN%-5PJ[8A]OTW"^> RG-"-H78@0CI_]FN^D4_-?R;M'H.>R
MZSI_D_W0@Q+>.TK^8^:DTBO(53=I!.YZ12%Q84%0@GRVFE VP&T<+!WW@>KE
M$HFZJS#7%5 GS+R36VX*Y+((1-MR7W[S 7'#U0]_;FK@#4)5^;=5J7"!M@1*
MTR95-ARJ=+4:Z)I+.:&L4N7<V+15;AZV&>Z6P?>5/ @5$C#^.06U-""=$JB[
M1,BFW9JHIO"Q$T(A'5B;0B#RO]"-?UN,C(V2D\^J_7+C.=B!1(:KS=X06@(>
M"XJ"UAMT>7RPDNA4X<$"8Q_.(-A6EZ,9X+J](?<(0JO0.X3=[I:&IAB$00'\
MM9@(=*:-8ZVU_5DG$A@1V;XF,H\A):"6;U(8%[6-1I\?-)U $SI6TK*ZH717
M2HC[!#8\R\]K /T^B@WA3>#!-5[TY2KB-A/:6+#ME"^FD0[5<=> ^IEN QZ(
M\S1[^S4@@F'U-'$%&7ZE,H,PSQ]YM8:)IN^((HH5$I[L';R9!$83-2=.)R];
MI*&A<NQQ+3SO##I![(2HTW@"Y!N\S_0R"T4-_F)AC7A+\%R%L6"K.S%15JLX
M:,8J" @*K4305<X20%WX.0A<84]:S$ M"%B_.+NPJ7$-(&._;,3B@P_C3S#1
MMM0X3*P$(@@7MN974TU KA1W7DK>I B45I6<*(<'=1[>@8=U3VBMS-+\:(E"
M8S@(0UT=M#Z4/3]PF.X<N1[VGN(XGV"#?7MNMC4G\/19<NI6Z?@4/WLR>L(S
M=;ZC>=]W':QD"9[]49DF:FRRZ2"H6;%0D5N/-:NP-A?[9Q7^\//,/E@\0.E$
ME>M&29R'JHBJ$U<*+CSU&+0!5<CHW"8:&@%E;I/ RUD0D'C%,\MI92D\S^F'
MF6N 0[N_1C/!>Q7&"YVN]V G2A.J5Q>M^J"_Q&5B<Y0@O]Z,$XU7@70[YWIG
M.2QH$/L5(^'S"D^O02SR-L)1-M,7"PS+HT=XX%I[6++XNV>LN$:;5Z"T.S=J
MX^'C&OM)K(I_W+W*S6I3/WEC:6EE#@S,H?(*S=^ZJ)XK/DW+ZYP[?.>S;][)
M+H#^WYRDG[:T()H3:$0',*/KBA.'1$O$SF7T70/N$;P[?[DH,N>7$HP->%C;
MGI43L-U>VX&EK?BJ0J1,=:QX0SS;E_&U(U#,7-Y-;L7G,:#N$^T(7WWM*HB:
MA 8LD!:ACE\J+=Y2)(_8DTED@I>_S#"=^:OD00,W0^O@#B);(O.5SSR*G<Y#
M\HKG]41CF0I_O(D/> +?0XWGL">%F0HKC9I=3GXEUZ$1\A:NR:M/S>C:U@EO
MR-YT;Y/EX'"WJE_XLVUD:!B78LIK5%8MX%HNKR@LDF\$&SQ31=Y5+S^AL8CZ
M3_V'&:_7)F?0\0& L>9/(-?OVUSR_;N[V8YL1$*U9CTAN+3A9\PVE]V#Z(40
M$['LO7_1UMCBVSORE;J'$6>-1V3'.G=(DAK?JIDJD'Y48-TL]IZ<R;DL?U\H
MWSP3L9$A9; X 7-PYB^J=K6=M]X_3Q!S_NLRTK$>,;6?;PX^WWZ#>2B6SD<2
M&IA,SGH[(6 [)0X;-_$L6YY,IX51WO3-G(4"A274-9UMF<V2Y&F)";/+21^.
M0^WM_?_L1<N\?QVIL!*;[[^#DR8EQ<5,UQ <5.:Q;A&,8<(?P^SMCXRI[O%Q
MOZ.]1^IUKTKG7]$=&7Z!Z,+#H-UTO25%2)"(BHQ!49:+L\'MF/1RH*E,_H:9
MWM^&!M1G%SA>W?AKYWQ<7!Q5[IY4]F:R-J8!S#H7EW__UN]>,!M@\WZ<EX$G
M1ATP$K2+$&H",CJQE@[X>167]._(HQV+).\=0F1OLL--++^E[:T-\YSZ%UFI
MAW]"H_R\GNS&Q6$G,O%WH#J*IE[NV_Q<5?LC1;N0OV,0.]^,UUD==:[!7.=0
MW;FY?52&*HQ>2KC7_HWV\7J^5&JTU)T'ILT<"> ^6Q*07[5E_9CV6(59"O^<
MS)<+IR08;#W'=HECO'\LNF!B9/B,UEHA\[6_H].<M%/>7/V-'DDMZJU7&/$\
MZ2>SD#5I[E0"#G4"SEA5-]J57EQF5XE7IHVT[7U9GY2Z-1R0R/I15HV7M1?[
M^YU9&]& T8'50L^\1UUY1.<X%HP:J/R\#''*VO&(&J@3WE>4EA!H.)AQ',<$
MN2/"O%U5VC+N]E)&-.3LMUV D^'BI%XME-'\I '31_\TOF8#DI^;9F27?&!?
MI3>F2GDXQ*"YIK)5RXNHY65$,Z:X:7RXG_[B\A<["C,=0A:<I^=D-FIOFFP>
M\'U^2! D--==EWU+US[WBY=WF"O.)JNSIZN-VUY3FRV#7G(?+<[I^."3]EU2
M'"/MG0E&^2:!;%YAT_R#Y<R>)?%#K47^PKTF@_Z6?]QV^GK**J;\%:FOL]JK
M]H.45):R?%!1@YZ?(X%D*&8V/D@2N];&BUI(MRGK"Q,;6CMQ^QB%,=9T_P5>
MUO+L^PKS>9F>R8_51$*]DT)57VLK,_.E0)]V=.; ^)WO.PJ&6C(U2LI.F9D)
MX[^#=N9)/=O!I(_Y:/2/5QT_N/&*BK5-I@O 0QO]-(LC7WII,LJR?+P#X!3D
M;N#<%>O65!UBB3S[]B^E]#!HW,A_2N<,8K4=O,GUHH,%+*0?/NGA6C(XTW"V
MWK06H%3VX[7U [K1WTHU#YYJQ\M63?"6*0#>>KZCA#$=!-* ZMPF;\G.6;ZC
MD>JF<_R*W2"E#>#.-B<C#U?6<+(]");)'1UT-6F5>G8Z=,LQ9;2IJ>/I6,5;
MFR'*!YH.SHW2X&8K;4S^]L=/^0E"=';VC774]+?9M3X[66M&6\;PN>S4E#]Q
M>)K)WZQ:2'$B7)94:,3$EPI)4_#6'%P4WQ^LAVV'-/TB8KN%C2(MH[SCOF%C
MX](F=#,G&N,+/J][+.J=-<;G\!>?HT]2K@%/=<94'*\!/LBM.W65H&F>M]>
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MI@L,E8-HV9W%KZ:_F'I7_BC6_!3(3NOL?0OO%1YIU=O,MZK3\JIE>^B4?PT
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M$LCJK%B"2N.Q8#YB"Q!!'OS]X<5IB-;:W"G<20,!EQ@JI ;*C'TQD8ZC K]
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M2ZDX#W1]9,'+9D1?W6'O?/ ^#_C!=UU(_H+ X4LQ8J4T>:_U1_;LPF9S'LJ
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ME).XN7D&B\T3-U@>61#^6TLS3V!$1@E)/.YN\KV-V"K:[,EY4#U%4">-LH^
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M14=!LP"VJVJOSG("J<$XQAN1@+7]3_QITJ&Q\8:M;I&JJ9Y'^0C  \P_\!4
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MS]7\*9*.:YG3E\=3 X9PBM925/%RJ3LD[KECJ^:U[72Y;-^N?',X^&GC/_L
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MV MIYKMD+N'<*W10""?Q(((/.![$5S<J@W!"99<J&.,D?O.G^R!R<X4@XZ#
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MKS-=N9561GY;"E2!P2P"\]%(/!;/'L!@XZKIOW7Y7L)PDNOWW7ZL:TS+$H/
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MM:/:1[:V)WMK$<G2S*:$\!4>:]F_P,$]'&&([E(B[2'Y8':^E?LQ;9;WF$=
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M^5X[V:)CDW$R?[>M40,AXIL"==8]'=D--&L&DM3":T_@;=%0A8NK8LO9P2V
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MEC6!)H^(9C]KO'L6%929OG6]B@)>6#S7(::GQL(G0K!!@>^@['_PHZACO\[
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MN "X_'(/S?3>_-*'YQ:0V_ )SZU>O"#WF_T=8H/VY-ZW4,"2FT]*R"#>^H8
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MM-&54SBG=I)VYD6>F)B=DA?J#$M1L ;XC%"M\4F!A[DP3'2U*1Z*;!9Z+)P
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M2G8A<O)FH5Q=H9!9=5D]>>@*8.9GH:G-:"Z&UM14$.?PRGW!V_9B;?E^-B&
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MU\;2T)#)_;W+],J)9>A6E++\7 DU]P2;I#@830&F1<P_17C+(C=L1<<!BVT
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M-?I(\+<@558LS9X??"TLH ]\WFPI*5YW@R&HCWOR%7XF]!A71B-L#H;<2!]
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MA$ I/0KI@VDSJE]8X4TO$9JU0+<][)R?(2K1V6M&JS[_]O"3>F8# 8N<0)K
MN#C#AZ!C1MY,# V";C6L/8)/(-.ERUWD>].0B0P6C7MRB\/C;DF934;*##6
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M$2C9_9&!EKV+#[-,";)%(69">LL9"6G#ZWUAN]4X(O-R#]Q=7RX8TS+2XIE
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M"NZX#_(*"YRR@I2=0G4I?H(GW!_3$;3HF8AY6[2WTA0ZZ4+4@,;LNR(B1H^
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MO-?_-/A"Y?AWJ:#O_5[<*UP_:'($!.N?!WFC.V.XX-+'@2.XWO<U5[H7G#C
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M5XXG;<M$*/)G3#QG1N;>#/LW:&5L,0$R7K4TCH5R_J95I+ 4W=*;Z!Z"'I1
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MM=-JAFOJGH@R7S_&CY"(<[^[77,?[/K^==T6_T\) 4:,6+2GXCI#)2,*Q_A
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M8ROD>AL_&N+[W/!M04,S)W/4E"\W\:QUUNBI_LGL.=+Y<S/JZF_OA9"NVII
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M7Y0Y>H[Y3R ;4&>56VZ\K'I_J@N!,:%3&'C&BU'"Z+F3;\O,Y]@ZL5 SH5!
MJW<^/&"AI3QJ2M:SI*T"!,.GK[KKT@\^FL*L D8KQOQ6)9"JFI(E;H#@^)''
M\_M.CM&]032-<)?M^7CMX SYC6XY_#H]CO5!$Y2'XX@[I_+\5 W:A/ZA&$N\
M.-[W%6G?FRKGZ'\("0$F;OB>NMNS6[4;1$4$"B-4AHG9'NP:(E/ I&>-UF"-
M&.>A[XD^B *MSLK&2?OU_S1PG&=L5L+R'2*;T!Z;S+*+P +[#LX ^7!SPSYK
MZ;%EWO*^]B X:8=\4IYR._9+'3D!HH<QF1_%IA[9U;S8T_PYF:$V%B2 0EN)
MT]RMW\SNTWJ)VED2C>SD)!NG</%P@^6!=_@8-L>]<L%-Y;-P<R)=(OZ!\O"]
M[RLJ<L1SJ:H46A5G)K?YQ!M*M(4HY!02Q1(TBS*U:/N,S2WZ%5""A- &@9[6
M[(6QOL*@GF*_$Z_7D"JEA]?2]C+LYOF6!%-U22,L&*HIYC+V4M;0#1.%Y6KA
MC$?7>6P!GZLATD3!!J/((_9E936=6>75+XN#X+)ZUUF9BI[.(2LHHD)3T_6"
MO'<%N9"WI[?GLNJ6 '#N+RND* '7V8/RN/Z T-#<()*_$^@&P;>G7-%X_T=1
M^(#C\LG]#\PS%^SNG,*GD[+MZWZ+\T(JKAEO]YIW%XZ1IJ4/."LH:OC<0,%9
M%-;1[_M6UD@:XR*<;S!8R<IPL6Y>F6Z4#KQM5G&Y3U?5-O07H5>!FOC/5<='
M7.3VKJ2'^5>@ENO6*?B&N,TA<KFRI1S=J"0U,$(3J<469>0*VA*7R.>]/>@I
M*15B<EMCH<O;VM^U[$]?5J:RON,F-\2"VU?2_UJY<XJQQ\/>#6[;<<SG6FE]
M.MG"2=K^PG5CRMD"\,8:@&$4104U@G^_RT*=M^@VC' &R:S0T[P1N?<;ZB83
M=\2DQRQ]N@<E3E_Y]*9!58LOE+2BX/%MG>B5PTDFP[F9Q2%+KQMNY,&?::+8
ML'")"#8]:3]%^GI1<7-" (084'6A]#]S!-A?RP9CT(-\)]H&+_31FI/<;J]\
ML:$FPO6IQQ2!00QN1'06GOZXN6E9UI^'5E5@Z7S+I YNZX41Q\$@B=Z1W1[<
M<WG<BA>4<T?3YT@VZ"]H)>%T&ZW^/'C(ZG?AEAR<GB*!X]X^IP5&OE&,1 V'
M_L^[)"8Y#2&HFR[1 =,5L_:8V3,_:G;^2B@ZZ[Z?9G66OL5:3(GB\I(;-.QL
M%A1B&A2UEEI-U4NI]"WX-CKHZQ6]$%4530R^<P7$.=MQY?KHJ%$[?99F"+DG
MW4Q3L]SHN:=\,I>79!QCI?$MS7N9^>..[RKP:,,$F%%WO=LT!6.CEQM X-&G
ME/:?LG70.8]% [S%^=#Q7R7M? H;1*'?),2_U!2!L%&"WT5,<9DEWP8!$Z8_
MC[KRZD*J45G:\J/;KY^_+(_KZFLE=!:P1BQ./' 8)$K5UQR=%8J)_\TX6G]6
M+^@ZE1HX#Z[ 5(<8=]LB$;F6Y#[$QO2[GL; P(:/,-&0LSX0A*9Z,.BBD;:H
MBXGMAZ!5+9X88G)Z2]I;'?11VW4?*7^HE/@\#0S$[3^U=_[*B,*](RMDG97R
MT+DWA;HGZ'P!%ZWCER^V.Y"=OS/$$WL4WTNSA.#<?[B/#<IYM:M @IK!;((Y
MYP*5NJ"7&$G",G-BK/UK+1233 <;?4W= DT?C1+:E/8_F-?+E\C"E^T[/M?W
M-U[H;$O*#M:C;_^68]KG%;1&H,:S7%G;=@/#G>?5(H)T4_0 _9W$9*8!0Y3<
M>N[N2=$SS@90N*RWW&E*5QB$>;]_D]&FEX]0&YRPCNQY/ET:[KCHL??IY_'N
M'ZU(QQT/A9Y)E_U#.<X>EV"I!^@NA<$]T_L.I_!:I+*X3*Y9)GYQ#TP:.(([
M>Z]W-D71;?H!4E1'G/Y5\#;I34-Q_HG6"9SN9AX8YLD@MM?YFF2X!FT QA.9
MH>+6,-'['+FO?4$NQW?X9\SGI'=5'%M;".^N9,Q:$^U!&;GZZ)"F8+VR;E&X
M3ZM-(URA4E!D/?>#<$Z7>>)?O0P.>LH?SX5RP,BWB<XQC@A&YHN *^__B !9
M90-Z2F7"XEWO-MR7YW672!*3"[O>.U_W1S&=]-!JSZ$PJ5"B<3K8D7;R(..&
M2+.AU6K6K-:LDK-\?H-*3W3HFLJ&\8-&3:9YO^D+3D_XH,_N-"2H0N\]$M$;
MG#/V>Z)S\B;I:&?$U]DBSI3Q!=[W]0F[J-3)5D*;_"==E4]@FT6^-$@UASZ$
M:WUQ4XW\(LAD?8!))4KO3W&%?N?-AU4TM7L5J'PU)1(+?NW,5WC1H"_$+524
MR0(H[+$ TO!\2#]GD/R]P,RQ[ <'ZWL,U"R@,]*/ZF=EZA+B7;UC1+>:EP ,
MBJUERB<&C7>6>1QI^5?W;H/ UUQ3JMT%G@:CN=N#@8U/&!8HF+_RL E=@.;'
MYQ<$[IJ8Z%B&5SNM0 K0XI+EGQ%75BXZ[[W)NDOHT?H((-%3H=HOSNW<LP/)
MUO5\'54ITN*T)-F23\?EWI-UJ30B8=/1P9$FHF+;2-HG\PE\BX8%536X]9>U
M4$CG:[,J?SA[6>YCLZ5E\J!Q4<UAW&A35]-1?SC;F2[8$2JWRL,SP1I/I[/^
M[=:_K-6@'@/W-^!%&XW0(-X?9P'_'7?P+5H9?/7H<-BFT,DHIK_1$+ZJ3]\H
M*@F%8@Y4C;(2] T:X#1)EG9GA3WT'FYP:9>19O^@T^2F,,5I*F0 YG$4$_$\
M9\?YA.\JNOC2*04T U=\+S#_LMH27 "NUPH 1%2%-M4@Z _P#IM&S?4/+/A4
M 5) ]<<8C#O>FC\G_8]]@(DOG3C0A1Z\I!=7'\H7@(! IO(<W:2J<9FE\+X/
M KRJ!")#1RVTRYX5<W[,@7WU XPZ::&M1 $8[=#SQWVM.EL"VC)"0I@ F(/9
MESCEIJ:]WVYJ?O-\PP0'"7/SS& 2?IQT1_D])PVMZ,S'+SLD5NH>#4ZW8"KS
MZ>YUIQE=]C3FT\JFZRM^+T&](JT2^O)<YG]]*36CZR\>SV9D!=Y?]HCBHN-3
MZ1$.C2FJ)[1M,-6;H\V>"XISKK"JUL(B#P_)ARN8[WRJNK&%8<[1%=$%@^.M
M:N&. 6>J>1Q99!H*_L?LUBC19U@%@$U9BQ),!71[ZL<]!SQTU6S-,5(=U]D?
MCNK['C1Y3#G@J:^ZI $6D[T.EE>4X15:IQE*7+90G6E$B?]<%G,DQ-?G$\^Q
M3\'TFJE2STX^$487@;3IX0+T[(47N1@/<2=H5H22>6<&HT"#BLF)K1;PZ3]!
M@@(!VEXQZ0'H]CXUH\2D*O$<Z\C/[9N"DZ_FD>SJ:.*\I'5L1?HS.  H+K!1
MS:QB"U9$&31^<LL?NS,ZJ71M'$HBR,7;B "5H'U@_"QY)\NO\.*S6PKS0DHB
M?4J!<S=0"^(2JM&F&%#^"[ +4/M; Z)N0FF9ZR&9.!>"([Q1C\!/Z!H-NSO;
M Q-ZB+0?,"8:J'%?)E8!3ZANNK.P7=&O]6\2#IBE58(R!,; ;_,^S<BJ1N$6
MI#B98= ^0UIO_6'?WY5I@:+0+7F8P"L^C@$?V<4$M S!=B@M-3!&2<E$,FFE
M%>$\-_@0M:#)7[[XX<FEVK)KAT[F[3#U[KYCFX:Y]FORUU@:2M6\Z$</O3S$
M?7(3P-QX^=(MX4XH(KH)IE7;B8DU)U+GWK@K1ON;[V\3@8)M1EA:I)BS<"BP
M33>9A41O.3HM;GZ+\AC?_S:743U9,9+I4;(>GB_0W%%"IP>Q-/X=@9A^H$]'
MXH>-F/AS!Y.C 3 " 'WFTQFU^![Z-,N8!;_W))&%H--"06:5>CV2W&3?;SS3
ME8>5+2^Z?WB1OR1'M<^Q15437E2^O_(!BP;8L@<CTKVXN*^QU7N7T<(CO[-\
M@20#,(KJ3%XA;_^]-\>SKB;L8^R[*/-+<)]6+KO9/;D-3X44P-LSIT+V*L(\
M/-:%(L<3PD:HC!17W4U&[%9PD<G/*#K?$\6Y-R=V6/^,Q-+US^"+H*T8*V"3
MI?=_(4 27146"\X$<[&B'&,#9]$!6U1S<R.<&(C0F\OXX*MF+M)#'<#!Z>%2
MQX#2WZDE3@@?KA[C:.VOX*XR\IFPE=?;"/1[=+K$MX7V.N&9GFH7.+]!2XT8
MGP,H_(HVAR* D$)J3XW?G1JJJ8-@9X 1&STGT<N;RSY4W[^1&_^206+#@M#:
MZ_4,R_4MF 2I/0EL1W2720F6M<><B"/NT-,V93W-OOJ][HS>Z=$ FU%\HD22
MH>J.Y+N1XT<6 U Y.VQ0R 8D$A,&A@7"U/](T+>>RS(Y6H:V&^; 'UHAIT<S
MS[SDI7GE=884B5]7+\F^"/M7@4[)PZXGVF;#/DUTWR4\*Q<'G=A74PR'"8 H
MKK?P;ZB$!0^2>]^+C)AAU!H:4(E2D>3-S+\W-C T4@F!BKX[4AE-!VDB2D,C
MAM?)3QVV7DPT;^9<9,$%B^')PQ$O=M$?YE[Z)O11#%KN:6>8Q1;;MO<FSS"5
M%=X[O7<&,<.%20:M$+3;(\I]N&\O<GZ$81@N%4UE]SC])]_N^N*"]Z'QG)\N
M4OF7#+=#^DA0<3&N. *[:Z^-""HSBN_4:8] Y5=0J(>L%Z"@'DT9&QXD,1X?
M#=OYH=>]7N>Y'"G]64T\0D)WGIN763]]ZFI\-;FV.]SOIY_<US1](GUY;!6(
MVWE N?L%?Q78!!-Z%G.+[1E/7PH:AR%WJ1$8$SN5K16Z"GT5D.*SGD58N>->
MY-V<_4N%!T>E8W9OOV>G/>:>\:H1DX^?8@\F>&):0QM&:)C0.>E/NEKZ5ZH:
MY3#-[$7N"W7L/05.7KD)9=+Z^[NC;ZG/G+4_32C2\9R*LQUOR\*/#-8/E,K.
MWIK,\ZW74Z]>!3[52S<5S+*U(W6^)\KW0687::=.W]\$L8_47&C6@K0E+W5P
M4D;3?,K"326DPT)S:8#G@5I#%7";["VWO@+;QO52L[2&;U(SD-5;7 @N#W:[
M\CIA4Y.N\#SN @._.-L@OQ/\N]Q[Q*R@QXK;#(:D>NEJM2084$F\(N)<0VZ-
M^X%MD5DA;@""O@:-X:0]O;8*YS/4U,+]U];;YZ]PGU+DH!K$-GV/U49.IK'2
MSLEPPF19\JVV!<?YD/"1NE=W3PV%1]3+O;T21!/JDGL1S[.OEY7/-K="+K 5
M24;<::V"["B&I=7=G\$+/K(D6=)!=FW?RF1;BK\YDCE@ 46[K]EGM?8W7XPS
M5.4-:OA(*Y0X<7QQ?JM"Z9[6,&R^N_SV^A ;^MX=AE^F>W2>P\/=^U/Z"DG'
MRE^ND./B=D[)!TJVW;RKT4-?:+X;W+"F1;V4[E2X@ 9<3W=./XNG$AE]L^>6
MLW8_0$)9N:&3DYW<&4<AOIDMFL9VRF@I7^W0'T\;>!_]V=5ST\=UB9854_CO
M)"EM;F8K-1K[Z5VVU!.,G.3F:7E7H@ IM2/M'5)33]%M4T1TQI>KMW<\LJ4S
M2*$0;KP=$E-BFV=9;X#$A&("_!OXX0I4Z887N8+LL+2._\9YU]H$U7.N^7.*
MZKT$#HQA--F=?K:7P#6+18*Q+G*LR],M84ND^.^FG;"JE[X72KCG@L_8BF[0
MMUQZ5GZQXE"YRUL7*61];!^2<]>#1(H7+-YBP!N:/!@!QZ?;!7GE^_0M)LQ>
M;"W#(A:P,WM+*[RP1U.'V)D),?#WX STQD_T(LO082M-ENVI<T.K !?7N0I\
M>(./Z04 65Y4O..<=*7L&.8C=I(.$=N-5!T=F[M60RQ;@I[+0027.WUL2$B.
MN9>  M,#YS5%L!7ZM+&G;OZU3'Q438@=*1;OX)YB_C?BEI _VTF=4N!3=>YI
M$[]]?-6GO/14VUS+4F$4YU(GWW_(YB!WJ6?F](!-BV]G/2[Y]V#W/GC CVAE
M/L,:HRP!_<[)WF@\MC"SOP6*U=>C>@["HRCI VN6P("QA!S2_!.]J=@23A<D
MG.&OPX2*N6F?+"W F?R.@+>?8I:L63\B^R)!6I784($6^&KK!9O;U4L?!9<2
M\_X;+W]TK;ZF)7-?R;&IJ%5@W2HP%E&?8IINL90^]28GVV9KD)TY$G;,GBYU
M(W#."O*/Z"=3Q^<$B ]F7^+SD"-7NEZ&7\8X".O.1-3JN(H#;$G@(?)GVO^-
M6;.0!2NYA+R8AFZ2_UP%2#HK_T7.)ZR$D5I6@43M@'#(\G"\<-_)&QMR^T5#
M?>D7)9PRBR&=B?CEX55@VO@)XKO)NK )6[4  NONO&:&=_914;*?#_;;[FCS
MA"3#=>-\3\8.I R_"H@+-)Y&42&^L44F)&_ 8D=4:X"-F.Y/UL6>CA.>;('=
MM&Z$T05Z%9U4H2#*(BO)2<Z;^D%.])J/2EYT+T"B(84'/+V%-)U!?K2%ZJ4_
MC+SW#3!IQY'T[T*Z+FR+\E*MK95_Z#@UY.UI,P?!*TZ-G%L9WX3,'F 41AS8
MU9["K9Z9F?.;-?["N)$)U32+7 64=2D]^<A&SHG^=U^$AK[L<U48<$ODCTC4
MG "#_W/1P>J.CY:F6Q!?N([LG)Y7=83DT>CZ=,I<5]M@(5C*IVXQX-$Z?KA0
M4;OWO#U3VR/;43X/K2QNV-< :H4L;C&8V#MPD=6W<4(3(*OJY-PLT!OZ9R%6
M-X8?'<8IF  ++@X$'*=N7G*;L1DS8/D3J>YPS_BDBW4O73D^1%\=P[;4Y8;#
MN38H\7#>FM#.[L#O,U33M^BV F&LL \%B>=TM3-T"D^.&6HX:;;RLST"F58B
M^QDR8170A8=Y*!+H0CZ#3N,'V%J2&EE7W_W8K_XS=FJ6JM,"!S%J205G @R_
MS$UR?)%0G;S:'>TA#5*=J4*O7T\9!3E#V=72@]+ ,Y=^ HDMAM8:D::-C<T"
M7YP>@X4)%?6_.Z57,LL=VA^MI,Q!L@J@X+P3:<551@F] BBT6?O5OLLOAPY<
MIJL9FD1%6X8*)1QM>@R*D+.G['9Y\:UWDFL3U;)NXI$"VW.3!035WI@##81G
MW99$P)QI0'=SC[<_G5-G9SV82MV+?K]R -1*X-)2MKVDQ^4Q,C9S/DRR\K3D
M([G.P*=UYDP;12+,!]D(%7>_OG"ZMX+47_PZW"F+.Q=>)K]<AE!506_RAV@R
MC>8XKG<=/5$(QK:#XDJ@UNP%4E3L9VD4[3_CRT+>T#<TD0;F7_MV[QL_6@T
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M*[6B_?X\@PJ9UUL='"'.Z/X^)>-<OJ+_0D<,8 ?B"HQNRN1133H_8GB[/_-
M'K8:40J#'@IM 23#-+>@."[6-P1?X!H_@_>?P_V9)X^\4K&^*>8^@DKQ:[X,
MUC1T%<USI":SRL,STQNN):K<+FZ6VB7,CDK"">@0C9HA'-,F#;6(D][T:?E@
M2(CK%$M@99@A<7$S!68\,6VZ2ETV?G!57)E[-=JA8"WB[M\W53H.L\2#>H81
M>-"\%]S?$SHYZI7>=X:5ZOF=B^6Y?!G0'+4&/.C]#NZN3[H!P(K9)GC0KV.
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M>E5>5(Q<"-I:Y<YN_)CVR<VDUOKZ[3C/MI-A_@W.I5GM5L8(C=;/C%'1JOK
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M75Z6-6U5TKS(:S5UKM8D4 *M2>>>:0HOR/YPLX2\K3Z^UP&2RB/QQ6QD*]U
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M7U*3WWG,4.@*)3E2Y?3V*+(R8:[VVJ'B>5T5;BDA<U97[Q9#.G4B)/"#8_F
MWK$]D3#*YY5WWU3U6@,4O728E5GEK\=F8K#+TP@AY,B5.N2R%=JES,DH?-T&
MN&C6M8_P;3;X8;+U&7^9]\;"Y5=:%T"%7K'B01D'D$&717/F-I/ PO>X.T<2
M3DMN%^%,]_ @A/@<]N;-I3IRAUY7,'W#\EM4.]9C%@]:?P%A-$DFQEP_*$YI
ML^@W *39D3VY>[1FE.'.'QLIM^Q2M$=BP8^Q17V;"_H452WUJNEJ?]C,IR6/
MX$&!4GQHG8809ULMG?+1AZBCGC7YFGJO'&2OG;DIJTBL40<MW]3V]QTDA4.B
M\_&$MWYZK[VMA$$BV=WQPFP9G<X99\;15$+:6[3,K RV;.A>F^O+KWUUV5PZ
M)!S"X0;CDUL9H3,J_!]/IQ;X/UVH,*XUU3'KUS2,W-$HKQE],)+!(]?R<#+$
ML&^&I)63WLVQ8V,DG^Z,+E'6=MK-UL[-%1SVM.*CA^ZJ0)R("E,*B@/WO*;A
M_.9EQJL(><0SS!T\B,5X#NMO#S]T@@"^),P[!KZH,G+F";[J0_X-,"R?8RN
MHGKM83FC*NV#*6#5-M5VN0L[*MMND&BYU'ZJ7Q;^FHLZSZNT-]:>]U8ZD]X+
M6*_<WK6;'UY%,\Z,Y-O#['.M!56Y?4;D*F.^1?P Q:OXF+<M;HXAN2MG%S<G
M$??#E&9X0#D"Y,<*7U-.!A!YP:N95%[,(@]'Y7><6@HE= HL?1]75RJZ!*"T
M9/D#"LJX:R96WJ\$ /+Z94.\>=0*GZF P,+[B&0BQS&IQ^C,P, +[K1.G]P9
M:Y4%3A>A45.9?B<K_@D11?<'1;:C15_>4+JFO]QCJ<]LGD])F,:#4C)E'9S+
MN6F_]<#8\BG?/.D):PHGACII;L#=&V#8X2Y?^DTD&YBBC(R[&?+3VH!UX\.*
MW4LT0WP!VZ?;W!U1=I;LMGV@N8.@B9@N/Y-T-UR#,N C"B-P7UIU->>ZNC)>
MB3QQI'*HJDEQVM/9<ZP0TV,E%39D\,.#H$\TV+N553J4#K1##J02K0_X(YCW
MB5!KV !@@@?O0++&OWF[ _7G#X1O/V'&!<776Y!?6'JFR$(QFH<2<QC8+YLC
MV"-O):^',8LDW2F,%:%\O(:*N-%XLZ<LAP6I.RI?AX0KIAO+BX;RI#M!YZCS
MM+P9Z^-8M[&G@M,%$$C/!HRD^)JYW&Q7W:>;)*9%!))A/L:*!RY2UI0K,\Q"
M,Y?PYF_&*K0,;AJ$K20R71D>.ILQ_K889<D75*_F=H,U4LN#X0O;D;3!+#=:
MN#PN>XLN.=?+ QPJ=/X5UYVM@.C,[BO_( QS*_4CC>/ER&J;W1<K/GTK]7Y8
MV-#8X ;'CRK#G/1X/3J]3_>5Z*DBI7=UWA,SMG'U?%Y\[J8^^]!5D+^G:LMO
M2CBB!-YCNZ-U?O\9:.GJOD+J8='://CBXP7@-*"N#6?*,<WC#BAZG(POX"\0
M-5 L>W@5>N[7:?Q\REY<NJ1K+>$B_T5,F#VN,1Z."W0QP8-,"-#T..4V8*I?
M]H+Q(-EJ!#_!A;.GWMQ\R<-*7H5V W5_'+]D5@7"P$HWVM(URK#1QYE%B>W<
MN./U^R"B'[<9X"7&DFO!0F%2DB8JA<JSLY(LPG$OK SM)S6^_"Q9*P;-AZY=
M=;FJV\03>FW4\=Z;ETP*1=SK29DE$RA(3?4TBIP8<W)^<\:N5@610 ]+(=\$
M6R1H5D_\G);+G<Z]KG<QQ&/^H-1[8NI]J^=:<VE]!,!L 33:!PVE;3&6?/4#
M2G%]^UJ^%P<US_KK8:GNI,&9Z;,4?GPK??><60?.Z(+%@Y;K8@=OP+Y&FKD?
M)^85O\P6;6<WS,X>^G(G?-LQ*FKP5C36$ ^JAL=XV3?!3]GK;P'S*IR""U)&
M/Y.FJ&0EML+I[*3<  1V+$8<]VL,?O: N[.G_/VFV7G',#KP(EAL#NL.^+HT
M9+TC"@^Z"#F#8CTO9?A8?=C_/.PT %Z&#C5L#3%CJ4M_SBQ+P"=%YX+C;BOD
MN%M/Z=?'_8E*:HF[@MOD;B_1361)L#3[=O-+V-<.]1X",SF.1";67U+/ M70
MQ(%V+F3JY]Q- ]/68]<6#XQHROGO4T<]_^2Z<#6X8>-FYJ?[&<'W=EJ]9+;B
M;=LRI6(KGJAXACZ(G;C2DYE^<*6"P>S96D[&J+"MH%*"ZO#1C=0 59E7MA:V
M+&M];T5L=4"'A%)^$=9'9O05W,DV;]*^V+BK?W11(3/H:L91\P<AA.HD2S/K
MA]CC=)-_J2&<',V_BE7'Q;R8LI51TN;2\7T-F_"E,[&N#FS&7EDS/ "7L9?I
M?LM2C1+MG-BMI#>.-GW\JYGRL1CDS^-53<(VHWQB^CC15[_L$296RN4DMR=V
M'=0H'-QL-..C?LK-$0$>6Q.5<CX./U.#K=L;G*XUPO>U:SEP1W.XZ/@S^K%Z
MK\<XD8[C'^"FTV01=#]./H48#QJGQX.P%45B-<SA\'TA=S"N$HH'[=1YI'R2
ML$]U!V]O%5AK3"J]I4T+DM_OV/Q._3*H8 K"RAM*&@X;_04G,CHH#CXJ"+4/
MAABT%D8$@G\D$XV8C1>^)G%ABVQF^1+GV/&"&NDP0-C'_6G 6S_/TE>BO H=
MD&^6.8$'V6S&NE'R3A4E(X[%:0(>[^^T7W&E?[?F*W:P[2HRALS\2%/N1C$S
M:?3\8< B,1E#<>3GKN8/UP^S9=D,"C\*WC^7*VR!L=#(!FIUB+["S(\;I;LY
M][GWLL,8XAJW\KOW L6,1P^'C53?G@BRE13SH,IZ>N\X]9&:"X GIXQC1/,3
MBTGE/82$;-+9%9DR=(L'[W4<(MXU[', ^4^8_]9>GM);)O8H&MSS+3P(\,YP
M8.<I2L*6N>&4)MDC@[B[ZDG>@$%A)VQC/KZMCGWX(5]C255F2A$=&&Z/,#?T
M$H<U"AT\50RC'J+L>2OXCD#X&_.GTBK^V"YQC'GU&_^FYRH7/P.?,.2PDE)T
M="Z3'K+4I]P:_QF1>E 6[<*^Z2 EU(#6AM[F\&LNS)+@7FB+MSS27PNCJCTA
M6*+@-D,]Z1-M]9@V$:@OPS@M&M+7N1K"*:T-J ,?AMD+#QKF?V(O?G_O5\:N
MN=7'=SMKKDKM!F=@V&&S#V<A@:N"Y8G8&HPB2K"Q$4NFY5<W3*1AT$OR4**M
M_<]$7Y?H1<0IM8O]V1%@4J6%"U?J;R G&-6XN5N#NA=\M&/NT^M[1AR367$[
MEMS;C<B-PQI@B?<15S'^0"54C  2Y>;'%IH<-VR.KX-CW)E;^$^Y#-:P'OKP
M'>O3'F+T>,\9J06*-M+$%!VM.6Z;-5182R_<C2E.2YKM8Q!( M^+ERF2N:%3
M[L%V%$?2%=?NX[8HR:].]ZVJ/H BLZ5DS@Z,WJ/5;$P))] QQ>A^#4.!=!]$
M$#*J^C!$197UIX3-#Q<?S%8MP7A%FL&W>84:*'JD9KY/,)/PMA[0Y\=ZN84\
MWA6?U7I,@(XE/REN];GZJ^@N=J$1#P(;#8RM*E'$\^[+.X9"V)66[A_WJW%E
M9N7#<HR5[.WY$R2\*K[KWFLNM<C![3^^D.24=MSMBM:<I(3"V\/ZL8YP[-7Q
M.F]Q/"@*OI!R3H0$%%(F@JB>>%O$R/G3 1[D'7^""(3OJU\( HL#V#.49<OF
M\#>'^]AECXC6AE/.M\#4,8(/O<8%C47^M]\QX/GG2ZUP.@5)--.B%SA0BC<9
MJ1"PRDAWK)@1^GE]<:;K9^3 AVN26Q'#WBZFBV&F"S_7J['U^4RGT1J&W*F/
M9K )@@1\P^..:\E;\8>&C-;M6M6QR+X5BV16EH[B#ZY?EY]TW&@3*+J9;.V^
MMQ!_MMKY<,[#)K);XAE[.H2_. &[QXO&;11]XJZ9;N)E-R]CSV['%8-GJ4PV
M-[GYN?M-;T?I^#MFK$REH437/=&Z@/S02]F[.="S)O$([ 9L@AR7"EQH<F5#
M:!PR.2[':JR<)NXS.=4?WD\C;'IQ80YL'=UB\PNT+V'ET\^P0V<W=[PY<5G\
MY\2&\/7.K>^=:_'+F4S62HQ4[-TZ-<P"JHL1-!A_:#.=UI:(P6YBRH1@"/W7
MA:^2"37];O46<K8KAZ-LB9$\[RPB=6LUT/0FT3C*!AI#53AU#/-'7BV-P72V
M,O^6%%LECJ!;SS_WWU:8&A68WC8X8SK1*1M>_?EA<^5EU/XK6YM0^%AW6>+]
M$V0XG% 7YWN=;/@9E4DK'O1$^2=.:TW]GGLP/8FQE^:H_6Y*ZYA(<+DN!<;_
M<".J1S[,[OC'1:?C/L/R79^>W6R"/YC_V$Q!+_D,8_],ND8\(RS.59(>HXE>
M3J>( O0),G\3ND]>AP<54<+7KY6%&KF9"T1%*;'L%N-!#Y+H<:T^(J>]1LQM
M5LG,5[HK='&MD)IRA5I[X0?7S8PR]I\__]R$00[E$A%:B/:Z>;9?!)3:GU.5
MSJT)R_=1/N5-^LZ 4F?$,,)(Q>JN-A3V;M7HVJ"8B3'1T&KTPT_9&,O))Q4U
M(XNQXCMV2R^&,J_0ZUZ;77X0):>YMO+2]4FD]"^JMLFM8< L1S,'"W<_,CRG
M6Y17E6UUJW[^\%7^G'R;X.V>RN=R].\>Z'!O]'*T(/ERJKT-S+!U7;,&]%.*
M.^&R4Q\(/H,>T_ 0BZZQYHA.:CPXKRD>#QWUDJIM<H%7>^_DND>;# C3&D%G
MYRS%QL-L> JSPG4_ZXE-&_C=]EZ>ZK^U9[LYB0<9M@]TGP2.)9W_(CA]9Q<8
M&6^-73D+'DIDL"_LR5./1^H=X4%^X'T5"6% G<$N>MU'X/NWQQNVA7,OGQIM
MSUUK +0(#%<[?AJ/_@H($W:$1?;Q&.!-,J,A$>]Q@/ KRLX-Q9&JP1>U?TH#
MHJ1%0"[':$. ]\O7AM+W6;%3K$ROTR[:[1Q=/_^Z(MU!M41WJRQ7UN56TD)-
M DE"V>CAL8 !)GA-:S!+_T'UM,0X&8^:S#7+G\TKGRK9QFN-W-,5BP,U*A.T
M/CPJG8R:14_^N!_91*5[R*;"C#WF.NKY;'G<RS91YN>9^S*0*.E#N%\-1?^:
M29WB0>FP1(=JV]/B15]:M&]AVL4?P5MM!F59W[*+*O(GISOX&9T/X3_U)"@"
MX^S$U"!O&?9:/<F;2+KK%!;&HMV\)"H$C81;-H1:2B3XG;AE)B5#S:X?L]30
M\EZL6"X']IB$AM<$,NR3#X/]GT6>LHE4"2T1T^3?S<@H?[3I([1W3F+5<&9,
MY",]#>D^BU,5P34A[7%QTM 7GI 0H(84GDSEA/,64=YN@,,(]&O8VEW#@Y1F
M:P,7G4L:4?UM @:=;!"EM#DA 1GECB+>9:1VN'3?8P6IF*TY1J ##^;WSLZK
M\* A-P0+FKD%<,KJ+PPEM33.>5:%XU4_JW 9MK2\9^L+?OY($2SX6532W_6E
M[9&/F@TP7(.+R4\&^6OIYZ$W5/+4LS;@-N.\L9NZXT?J/R7 KZKNJW,S/[D1
M34RR'WLCOB9KT]._J.S[EB_]B);.L'/2K5VO'1'Y^JHZ0!?O6+-3E.)!XJIT
M"\,2JP)^!%NSAS/*4]KA5C9VU NOXU7<+".46!W#LZ<%(C$Z*8\K=><^MP?T
M7SW&@Z1&1[>'1Q77CL//F9_45YC/DJGTWYU5XBM WOIZQN 97N:0=8,%)HJT
M^AY)56%TNOKG"BTF]"5A_Z )?77\>3-2=;1'T'!Z6E]:Z,<T0S>]D&5/T5NI
METK$[SO6Q;0_;Y6[49?,2+NL-E_MOUIXW9R;Y5G8.,@B\"J3.%W=AP+I)49X
M$NQZ3EW/&@=[\7H# 7B9\/)+0FM[+!69IX\'_!?T% 0(EF.Z!#Q(3LXD!<IA
MB!DZLAC2P#'X$*4%<[.^3 M^1'BG[?(Q$VSN:,'AM]J&Q6X:,A/SH*SZ"_Z,
MO0E1#\J!1:^\8^UF_/[TK=(\*0ZLAHE0BX,,N-#?T]=42;!ZH&M?3?+@A7JY
MJGMF1),] U+?\)=-Z;4G\L6[N(F4Q$>T>%"$\M%CG5>J*DG(M6^AV6*)M<''
M4F\':XF7F*],(#=BG\*1;JJY!M;\.9/3'D^^4M.:BGF5,#8],NS6Z[MEZAU9
M^=11@C\5@Q/W,#0<DE!_ZG\<PEE46F,LG5Y7R:3:U;NB.!XE);%DLWLU<H_D
M\_<WS/G@!8C[$LY;B/R"01T/ZHA1UT:1APDE:#D\34H5\(ALW]^Z8\&W0'Q1
M[?GC0M"X?I@<6/NWY-2JSXF[SK)2T"1RI4/72KWEGE:YN%G9VN;H;[[39R.S
MVSA6&GQ#L"JPW_\C0-S0EX9J"@-IJN>I0-^*RX,:P:[)C?4XM3Y,V[$3VMO^
M4?EXCS.BC'29;"K *?@D%F.Z9-%F(R'A%8%)5#_%@]HSG_G28B8;5KJ;UYB/
M[J7@09&<>2,L>WW/M(I&O]S$$0+Z(65A[FS!"P_ZSNX%F.Y:OT;H+6_U+,RX
MVJBPJ/-77IZ%),62AE@/V@P=PA7+VP2-:V!_3]SPRE*=Q[VNR%Q(_*WUP[>?
M8\2,?NI:^'DK Q<LSH=/<*CA08,5,?MKP;B;F&S=<6\SQLS,&LOZ1W75E2,4
MNR\\/EQOGEA1OZK$367WD>=E,IE/S!+<WW,O2,+,J="J.C;)GJPUJ2Y?ULN>
M]<<3H=Y**H?&@VI3C,\6*^[N6DC#.F\J?)X-L'.N=73".5Z/FAQ+%!B5A7WR
MOYAZI7!8,]_T?5 1XG*.X>>[45E>$SZV*EZ9'BIS[&M$W;XV]R6.>)>(2&1O
MV2^=HQD:I+JD%"/\,*09:H/K#TT8XQ-J!D]Y+V9$F5&*3(KYK>1(<F^28[1\
M>9=P#Y'D. + ++9;)Z>@*EH-/KK=JBX*O!=L]4"\T&(YMQ&\Y5OF.T5VT=,_
M^1H<P\SC?F?^).R!=BF:MW6TM;;"534WI8+'RK=CGW:5R<B_XR5$O%SP&E*+
MQ*0==2);@QK_^'IH]X00)CEDF/^G.;?M\2>RZEVVZ*#@6TJL]R3\3.*E;F-*
MWF.+4[UGP(,<>-!2:?;\20@;-$YO0$V!>3T:#T+/91HYB+H7LOV9 TE&2Y(O
MJ%]$[1'#)^B H)^SFWL#(B\*E@,?;TW!Q<@9\_LYBZ#:/Q[:,BGI+AR>/[(E
MS:N1_;JDS7--C:#-0;N>U=UDK<V$HG;(EH^EM"IF(>I9=FCUE:B,KUS7V1@K
MYT\05P0TXNUAR2/17WB7W<U6"FB.#Y#3S8R]I5V#W:1YM&SR]\Q>>GX09:E-
M;YXE'J\EMT\SGM@X@-%\WA(I]&) !G\R+YD4HA;/< I03-N_-MQ!GT!4DI(*
M7E##5.Z[V)* CS; >!!C.N[N7@C\OSI>'^!>37FNX$\J[+YS9VE&9+ZAA:10
M>>[<?-.#6E72]LTW>ZUN/;6DY;J"L 8/+$X)^57\8T+C56U[5-PBY:R[TSE3
MYX78F4]88; Q'F25'^(^U-QEVV-NOKCP:>)3Z;LB_:\[S,8S%[QHX\R9+QS:
M Q,SXO+TVR5H?UX\2!(\F0]&Y7A# *L2!KA9@LLVE,65-=OW].I(R-=O2F@M
MD'\\8B8IRE_;T%JG<T8C"^C,^C+L$_H5)XS4&YP(5BG]:+L]S((T)Q#6&$";
ML[->?I$OQ'PF90#%:.&X-["([WC0/,-EIM7J 0VW7* W,0D:HRZ2\DU;_27A
M0Z(V+R.?[D1.E]"X]KDM$0Z5((+2N?ANQTPZ6XZ&F3WC)5="?,T0X$M=A'+J
M+./&1Y2Y$SGM2U7>J;]*=(*JE;LFNB!HJC%/%C7RK*.1UF=_E-?45=;(599]
MJ?YD9O4TZB?(H8:6L,QA?K/IRU1">: )WY>\QD?,HAL&%J$9:"],Z\43X81>
M'TN+@2F-=\H;C!\'Q -(3=_<4<Z4?A!<M/-]GNGUUD)#BW[IYSP^%M8_GO);
M,?V4E<H_5E#<\Z,$/>==L>W3#_J2\TCP*.Z"LY\:<"IW;$G^+F1I&,JM-7]<
M=Z .OC0$QSTS"6EYX=4S?RSJ?ZRQKU:,:FBOS@XKXT;#V!-IDKT%^ZURMREE
MWH1T-7NT_;G]9V3Y$WK*VPRQ><SWG&EKR;,WCV^8^KAE3#_,\1;/GK)VDA\;
MYR>KB.9ZNAU+2=O46EG1,Z7]H=6W<A!'XXZ #/$@VG)3VRH>LYW3C3E5./J%
MGB8?N?A28LH<(08#;>[BMGS/ (XOXRMG&M,RXW(/F6EE8([C$=,-BKYVIW#W
MRT^[K4KCJ=W^>B>H5FZO.Y <_(ZQD?ZGHS":CH!]Y*(T649C5ZN8LO:=!Z"D
MKYV,6U.L?<.1X3 _6ETJ"QIBGUL][)S#(5H*\1>>#YS!Y'>&S\WYL53"WA5,
MD8OK$B(<@3O.]/E*<2VJ.6&J_(5CQ.6VACL\4OH2_?'4+R$6.7O0E]XO4,9[
M88>&]+92N[-]FT-'?*-%Z1;R!(S*GPNNGV.=D)7J&*UD8(B_EP/>^=TE72#G
M2 QBQ%P3"WJ*A?+4W(*KI910*4WV=+V%1DEV?8:2?#A#6OX%/VUQMDB^;VN-
M^O$*FF'O=G62?#7S'G-SMXA1G01>*)DN3-48GF_E\A<L#?CVY_T9J/X3-_JU
MXRO9^<!8F^1TL<X+AAPYWF/H!6<#-1XT8"B#!_U2PH,P.]IQ"W$AMD<J/N+G
MD.=XD.('_0H2V+MKS?<:F>R?'1"O&$M-D<.<OGF)85]'Q!;BJ"^TH[R^)IB<
M<ZE<+4?/T*\]O&-!TIJM#%H?%DIVKGO[FK;/P\W/E\3=']=HM7@=$?#^N,J\
M:FAYA(H&_,JR^36MH6-IJYK(_HMG.FQKF_T8;2EN8IPLW?7_T P5>0AX_<DE
M^G[S3(1M(,Z^)\(L:..N#C9R^TA5I#$NUG,ZC*_,+I;"I*:+G5=@X@^&.&;W
M92:O(X1K$?V"_?LC\FMAMF7<4RK=83(+',RFGY:>ZWQB!>V^5CJ]T5_G!FUN
M=2^+_S(5WEXHI_Q8V3"%SOV@N<*7#Z.SQ$NN?G,<&33*^Y*,(Y:DKF?>>Z[Y
M:,?(+=CWMO7G+1H: Z/XP$]"XQ'JY[HIA3!UUKD,P6FA\M1ECM<Q41S("5W.
MTL\W$.FO,.R+(;J5BL)A5*E>"9^6#@I69ZF5DO^@IS1E]14]S 4OJ&(J<!^0
M-+@K@&)IAR'U0L6#-6.S([>YY57;.+K/F!N3?&FS:FH^B-J_JAY:&=)PH?EB
M]:,]1Y4'Q4U),&6';H]ZO.#J6-;H;M%4'1A2]OS#>!,B-XG=%EP>-ILJ7#G&
M9UKM%JLDL4+ 9M8YX=CR=*R)B&/'"_$QF:>T+-Y\U)F%5=XG;<@AD10/ZE=6
M ?N;\-;_K$@Y-Y0E8;->("M8SKG/ "\\R=AZ-9L'?V^=_,"JR[LUU9L>S3![
M?Z"M/G+:W>[9]Z@U%5OIS/![VM9RMD$<)_G,2)YACH#]@PYIDW34N.R(A/!"
M2F"U;E[K$;VDK/H'<ZO0!M<%F8NUV*;Y-V>0'#RHZ3OZ)7B?9J!D&"<!&(FE
M&/:4Q@:*\N),=8_\#5Y;"Q^BI<RZ@B9YBDJ?[]^NT[8)*'BR0\D[V3+SG[?Y
M^SHOEU;MW!1%W,>LX$&LQ!_A,X"A'C!%0*7+/(J(%RV:L5IM;I["?0E>%A9\
MR>9$]@\\J,;D--K&C"A*/8\0K.3L:J5OCJLVQT*21*BJ5KB'*E,8##"!!J/.
M.WSC"L'&-#OE-(@\;/'M7R^K]#,A01>],6%7[O:I,$[]07O\6XK\@V&G2PS_
MT]/;>%#%;UQY#;6]B$V<>[^H0&+"=Y'=3<??V'!G$F/&QV<&@U-/U055C%+N
M9$<A'VV/<7:%S8GT&<6T05>V]N,'L EO:.),V&K+!]D'#H_+AFV/A0Z4HXWE
MHTD^$7_-#V2/=J/M)$)-$JY_Q=%@<LNLML%E0O=1S7>G<-U2MXX_$T0(5L3"
MQ:KGKM<:7"19R-I-(W]/F3"4G/9A-H:N6GBY8-%Q= .@>\"4J=8"BZ_L!!=A
M#91QX06F()',5+H?ZW$IL& #OK3N\B>-OHQ13;A5DIIO?&O55KSI;R).HFA
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MU<:O[<(:&K"0>?)(V3 7X4=M2(8TOPN1F4/:X= #E@%D7:IQ.'PT"82'_V1
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M;>_^-8M19TBF&T/@;FF* N/?IT[=+;Y.>&)%F0@]BS%[]4.9%$#I])SHL5)
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MOTHPJBL:Q'XFN_9\INF)5 W?4]#2,]>,NQK)^M3]F-QTQ.<<>O(>WN9 OMY
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M,799'OT36FJO8R*INIRW'L5[JTC!V#QS1I?02VMRNK]TZ[<& RK"NP?=_O<
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M2.%)4%LA>21E^"3BN\\5:Y#X;T6XU&>*ZEBA RMG;27$@R0,B.,%F SD[02
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MFE:I:3K;6L>H27,W]FRP0G]];_8?+D<8;=$UP2%)(V_/@@5ZP9%H\Q2<?TH
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M&17G?B;X[:];V,&M:-<^&K_0Y/#K:OYF9)?*F5X(W1I%DV[5>?<> 0J$<$Y
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M@![=U60 !2H^RPJ%  P&X^9B8-#_ &:O!7AV30A8Q7\=KH[V\T%I)>/)&\T
MQ#,^[+&11QN!!8 !]V!6;X_^,6IZ+<>--.T:318]9T$V<T-KJ#,[W,$JKO?R
MU96PK. &'''-1^"OC!JVM?%"Z\*Z@VBW+1W%Y;-;Z<9!=VOV=(B9I5+-B.0R
M87IC*_>Y( /:ZYIRY^($BFZA,7]EJ?LO_+4'SC\_3[O;KU[=ZZ0=*YTPR?\
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MQG&!G)\:? GPC\0+[4KO6K.:YFU"V-K-MG9!MV% RX^ZZYR&'((!%:EB8_\
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MP!R3D LY !=LR7_[//AW6KNXGU;4=:U87 5IHKJ] CDG$!MQ<,$5<R>42O\
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M?2CYU=EH$T,Q-T2G"?N?^9ST1RHP%/#89>*D@F=\L'TNE/']!"\IZGUWL7'
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M+B"TV>L5,(C)/YR+#E0[>P7(+<7GWB66W0%'ZCI^7AM1CUFUQ>6\R*3<VWW
M3>;'_^9J/+J)>6D<PR;B6!PC^EG/T(X@_9]8F6/E<Z; G&ESO(Z$ F),<BMK
M"%_RVI$- BA@U($V7IF>D]9.D])F(G01897DEZ];[?L'U^W:#W^-<6H=&%I[
MF^;3=I\FW3TKFQ>U__"L->@4L(UPD_D1?%16O;: @!;.$DH +FK^>2\$#=?\
M8/%Z94KV]/WG_ #AQ@>S&C]^6_V=\W",-P%Q/9/QW?@D&%&XJV2F+^__QJXX
MJXRS]%XT+(LWC^X%6CC V +\-[V>#S@7R-R?F)3#G5'%R!Z,.&UY@Y38UF2J
M^^GEG?&>8N51: K&R(544#[/528J2?& )<EL6 O02!UE5CFJDSWA5O=2\ERU
M;/+1S>4:=*T3]:0/OA70.[)8R2!%8CA? PSCL3W$2G\>\BG!!:WUF5!]BIDT
M;"-'YHR'7E>ZJ2"H$O""BNSNX,L?0JWOL(H.''#_6S/#F?U=<,1W.<SZ(=3S
MCJ*@0?+]<ZY4 T6T1_;[FWPL"O+>BU _<3XU:3)D0W[;'E3RHJL'!$$**\Y[
M[QO>0WPH-TN*%W\?*X\QZ.JY\IMG+A[8=?^:'R%U5B1(\-0H3@)7R1ZSCUIG
M6341;&!A018:NDYBKP-NBOL8PDT#('Z+'+@QQ/MA91F 6H3,PNE.2S0SJ<UN
M,U$P'AT\2Z"3^?X3D_$)3)76Y9W7CR2VQ123]:(_% -5JA*H C7Z(U9;,-=^
M*6?.GT?G>ZAWI]=B@Y[WUT_"GC=085^KCM\'3[HB=4<O[^7/7J:2CV*396;_
M2?WW\.>'?8X4X"3NN2* "$^)\1BW6TO@G:PO]%R#S6KZ[H *QJ*+9V(M.$[:
MX*3=PES!1-*N_*YTB]"KOV?H#G;..IL[_-]BEL\Q!P:Q)OY;Z2(5YYG';_F;
M1M H.TZ+.TZ*@6^)] U;2JQIO,F7--TS<P8M5[(9)+\4@]67+$BI=]&+ZT4S
MVDJR$DG;G*"2YGVV*>U/&(G!87AXX+6J*X/RU) UCDV9\0.D (0ZCP(O6L1Q
MO:P5E<2UYV_A@)[E7[[OY#X[6BRP?B&0A_ZJMWXL^F[2LR7$LRYU$"2*?>+D
M"BO_9_)45 H8W4-Z9X_H(A+"HTL+$ D"3*%(*/M<,OJ]VS7&M0-1'_/YI-;>
M\4>YOXOH,C1-%IY$,[J2!\@7CZ-.6_&UC8&#.+ < F9?WE\:AYV>:0]Q&.M^
M7N9S5D N^/W<7=:M\@JP;9?N_F$#*R)U'5?SJ'7"MDS<4:CEZ;KJW2%^J+XC
MD.FXKO$;+(]\F:%[F0DEGM&>!#<*1]PW#OL8Y!T=S_!6T'9>I ^C0J]YVY9J
M"@W%X">II$W18 (?7=NC:/%1GDU&1510BMDWC$MH!LEBWS'5DW.)HVO"*D<$
M:KAWEU.J[8VP<\%2W+PK(-9-&]:SZ:I6OF.FIC_%6U?3.0B8:^3.J3,2*#H@
M_^+8X?RHC)0),Q4\=5@9&+R919!BCC:EY7&9DZNE1D?)<.]%+EH)/7Q"N82W
MSQ$!@8X\HF/@#]44=J49YZ1F3OE!$4_=A)'YH,^];J7;8JY_ _@6190J;'W<
M9V(*C:LWLZK BJXF;&919]5#IL6HPW=<H?3S:,2<+=PC$J+HBJ3>^*G;<:G!
M&"62;S4"1I(FL,RC(8,:S8$O"Z!(O3:.[,%[* 4='$&^U:^PG];<VF?]: P=
M:ABDY6S.9.UTM W'9^#&^ZULL+UM_E<9$[RE^^"I&*K>IM_]A5DG^6A'#F\"
M!\7Y1)_A,A]#/,;XO_E2[C7/=5.L ;.P08<//?Q8P6U/1P?-!X$#"CO3"0X5
MT.D#M)!S\78_;V^HX'%KB^NP]D/^@MRVJ.7I.=Z 9>@GYX\?5<[(<K&O*MR;
M,7<=,>J;DET:9SY/R.-8H>S7<;C>>X_2!PGI1=OKU* 3F^NB<[AO<C='2(EB
M=RO* #2S%!O;XMV2YPD57@$KS+*H*;%^ZZZCU91K'KX%XI81;LP-W/NQA1 B
M(P&BFTH-%:3 $YBIDS7!9=3$R;44 .;/O4*Q9!;-B)"^W)7PH-S%WUWR_CGS
M>A*=T)2R8Z-3!%K*>:[V))94>A'P\]R-/:=PO-U@5SIE; SE&CY.3T%[I .=
M=4+NO?Z&8]#SH?.^2;QX1"[DW+/D(?!#W8.XHD(U4FP, <F&)#QWV^4XPVT^
M5E"YR.);D<]5C01+F5E?HW\@5;06KC_._1_*;JVUY-DD!S8,0L=R]2?WXZ;:
M&6P%QHEI(>L+X@TL,KV)K!]QS"E48A%I:CACS1D$*G^J(-!$?8PS_ZPA0Z2I
M&@3X"RC\>GE;MNA*V2$Z#/#V#"V(><$]_U$*VO27W3!%<J3#B$/_7Y\^8FSK
M1C^M99O@L$^UMT/(,7W>16HMV]PY$5[I",\5?6"=8B>IT^]?XZ2R @CPW5^"
MT!D+@]!+*NL-^4ZJ<M51#2)$"?=%7O ]*NS1]94ZX<5Y8]D0_9ZV/D'B YD
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M:'O6]WZ>L^H22!]4)9!X7P[_J5=4WRL!O)^,+'L'60%*7'^OHKYK]HPF!V5
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M7"594&_^:%Z!-BH9/P%U5P5 )XW;VGY;T3/Y=A&_X]Y.Z=MU^TPZWT ;$5S
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M>Y<.8*GC(FMGV+<%_HVQD1DAB*COBI(,P 769;D_.Q)Q<$8A/P7VV(,ZCQH
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M4-9V[^]8*?$M[;8:/O=EAYT<\YO3I*Q !Y%O.GPE4K528BAV#J_2^?/HF+/
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M^FW4,.NXC,R6Z3N-%Q0TL]V_=OTQU9F^&S%Y-T:%Z32A?Z$ F2;M1BP19>!
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M%G<V7 T7Z(_L:[1DKOB8=<WU[+VR.F']M\54!&,Y@7LD_R :/T/&=53]5%<
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M(Y XUTD@*GE/SJ[#-H?S9/V)!P-$(N 2);S#75&1BP.Z 3FT 3D>6:?5T#L
M52NAQ_L_ A>P>*)^WLDQ&+'_$ON29)T D_'/BRE@9I#%_V0M!N]8"L:^IS&]
MJB5BAP,%5NI.X4!?BM?7;W@L_G$G.V2:I'M;>5\I75EM_K)7$<Q,O+Q^=?DD
M?"4[\'&;B!V4X[3U2,:!NGF&L">!0$KH@2U16N% 7HV,(P580VRWXEJ"NHDR
M=%YV/B\"]L?+ *(A=HF*<2#$,_C:(F;Z)!'QX2CKQ5[*B[V_7PF &LR<=UXB
M<TS<?$S<:AX*X#'TB "(Q,E\N7_I/.58& >Z^\O*.QQ[_.5YL5ZT2R4TT 8<
MB*0Z+ELCAT73<@$\6N9J.'44--3SSL#1C2?HD+9\4K8@Y[*5EB>%BA;]&1F*
MQ_\[_C4(X1Z NX3&U"7L-1T?2NFI.R'H('.FJ(P3NQKL8TTP5-$;>W9/XB4M
MQGGI&7JTH0?-6WLT@>"Z.<W?SFZ#B;A[AT+UWF+)HW/N9@+?+./%MC3KL]XY
M;#EN?/*\FI&V0HE23+?HHNY;+'[U"+5F(5^F%(-J3'GV^+*0W0I-9(Q5ML60
MF^?NA9<FSD2C7?B^G"PV:=K*^?CPIJKMR2F&4/K=G7$K[+4!IIB'93W8KL\&
M+%_ V?E<,D:'9S0O9HIU;!HFWGZJ_U+-=OR6;P#G G6V5S<-88" 1=&);.\&
M'QU9VPT2&P/3P)%</6Y$K*DZ6W" R45EV@IRF]G9^U<U1*H[)_WV1A7XLUQL
M;:S3CJ\Y%G^4?Q8CX37YL:&]4+3>T'I.W:IK9+$.^;KOT\T!OZ(^O>_69&M<
M3(IOC/U-F\8['BC>%"*CR$<2/AC>8JVCYVM@N%8ZR%(SL-MY[XQM?G8NF.+P
MK,H%8P>39S4OW\M/K3_U.?/98! 9=1R3157!V*28A2!=*=&!^SLJTDO0/VA7
M#MF;]?-J.Q LV9:C6UV(G%QXI!+(R3%_QS7++: AYI,8T=2XG/PVCX R>$Q'
M6TO1%4_N(G]/50YG0VX#00@[K>E.&-CYTD(I=PV]Q5?="3GNQO6YTJC]BKC&
MQH;$5J[]U8M-#9G>/M?@URZ[+D>SH.U26J?BA.J&RY4@2O)7V\P7.>ULNF?;
M0EGH O0<E^RE\,G8/_<7QS#M;N:W+$.OWNSE%2!F.%#)WUHHM/4D?GT;[<12
M4L&GL##/ZJ/@=!^<")MPC9$GO 9>.%ELYN94+"VOKND5<%>ZX=4?B7S72!JR
MK6B-];#['.["W/[^B^/%Z0N$WG%*O-,:<49Y-ZL],RTK-FK@>##S%:&+4&.F
MIQ12S#+!*EX][-\>*SQ3$##8F<H+$& L:71"1@S&O>"IJA94'#P63]';V)D
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MMHH'L6M2;6.L03^)"8FV/?'=.)VKWI2=$$Y#LM_A4PQ5#21.#DX."KS#]N.
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MM4"VT4G8/14+X"5Z%AN N J;LH1M4<#JTLH LIN-"6B:!(R,V\T>V1[UO6B
M%7Q&];31+4![1YB;'T@.Z3$ZL(UK"1B;*"Q8+&%7U 6PPSD V)I6NP5[2C)&
M!S88-3)&?X3DS]>7 "Z564\N3W #H>8#VZK8)3XM1GZL'SZ-Q"?;L.[UF4D,
M%>LO8O_U=+BM9AG OU$7#C1]BA[2I>]@*$. ERQ$;2CS51@UNOPC#M3_D 1
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M\XB20(9%B<"P/+$)A4#MH.(+,Y9'KQV$W\*\&TKID1ODA(D>UZ\4P4(]F\\
M?/!^ P+HC'*3*PR="9F603-B7P'UXN0A,-T$PO>4P-KIPV"48R\84<D8$H
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M6V&):;KL,\<(<BS<1(M<&L_%(82](/SA7_TIY]^HX4AQKA73@+N>(%3'1S"
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M0',-[?(((BFUR_6_/R2OJ:B(632K21*FOE[*=\-SP*%C<+Q<H5?,':15S-J
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MYFR>80IV&*E9O4A)_QG,'%!N!6;]U'P3*FE0>?4<2#16'Q'\]5FOPV:G7I1
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M7S P,2YJ<&=02P$"% ,4    "  5@"I9>__VH18'  "@!P  #@
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M+3(P,C0P-C,P7VQA8BYX;6Q02P$"% ,4    "  5@"I9&5D,& HZ  "2O@,
M%0              @ 'MWP  8F]W;BTR,#(T,#8S,%]P<F4N>&UL4$L! A0#
M%     @ %8 J60T<$=+H00  \/L!  L              ( !*AH! &5X,3 M
M,3$N:'1M4$L! A0#%     @ %8 J60>G'"L,0@  UOT!  L
M ( !.UP! &5X,3 M,3(N:'1M4$L! A0#%     @ %8 J65K]&?[700  #?T!
M  L              ( !<)X! &5X,3 M,3,N:'1M4$L! A0#%     @ %8 J
M6:\8OMP4#P  JI<   L              ( !<. ! &5X,3 M,30N:'1M4$L!
M A0#%     @ %8 J60AD/)'L"0  P.P   D              ( !K>\! &5X
M,3 W+FAT;5!+ 0(4 Q0    ( !6 *ED=HC>3J@,  !81   *
M  "  <#Y 0!E>#(S+3(N:'1M4$L! A0#%     @ %8 J6==MRE)/ P  :A0
M  H              ( !DOT! &5X,C,M,RYH=&U02P$"% ,4    "  5@"I9
M\R&(%/,-  !A/0  "0              @ $) 0( 97@X+3$N:'1M4$L! A0#
M%     @ %8 J66E *Q/7!@  62D   H              ( !(P\" &5X.3DM
M,BYH=&U02P$"% ,4    "  5@"I9J\)CP@H#  "?#P  "@
M@ $B%@( 97@Y.2TS+FAT;5!+ 0(4 Q0    ( !6 *EDW.W8"$ ,  "$/   *
M              "  509 @!E>#DY+30N:'1M4$L! A0#%     @ %8 J6;TZ
M<( 5 P  ]A    H              ( !C!P" &5X.3DM-2YH=&U02P$"% ,4
M    "  5@"I9\%:%,@<#   F#P  "@              @ ')'P( 97@Y.2TV
M+FAT;5!+ 0(4 Q0    ( !6 *EE=6!8AU@$  #H'   *              "
M ?@B @!E>#DY+3<N:'1M4$L! A0#%     @ %8 J67U>)ZC+; P <P6(  L
M             ( !]B0" &9O<FUS+30N:'1M4$L! A0#%     @ %8 J6<K$
M>4L7U0  ?>8   \              ( !ZI$. &9O<FUS+31?,# T+FIP9U!+
M 0(4 Q0    ( !6 *EF4&Y,!BX0# "Z( P /              "  2YG#P!F
M;W)M<RTT7S P-2YJ<&=02P$"% ,4    "  5@"I9G7\+X,T( 0#K,@$ #P
M            @ 'FZQ( 9F]R;7,M-%\P,#8N:G!G4$L! A0#%     @ %8 J
M63]<.Y,!U@$ ^]8!  \              ( !X/03 &9O<FUS+31?,# W+FIP
M9U!+ 0(4 Q0    ( !6 *ED5;:7Y\#(! +9D 0 /              "  0[+
M%0!F;W)M<RTT7S P."YJ<&=02P$"% ,4    "  5@"I9,X-T"Z#^   "7@$
M#P              @ $K_A8 9F]R;7,M-%\P,#DN:G!G4$L! A0#%     @
M%8 J65N$\$T7Q0  D0<!  \              ( !^/P7 &9O<FUS+31?,#$P
M+FIP9U!+ 0(4 Q0    ( !6 *EF<_@^:V)T  (/0   /              "
M 3S"& !F;W)M<RTT7S Q,2YJ<&=02P$"% ,4    "  5@"I9))(@C%NN  #A
M\   #P              @ %!8!D 9F]R;7,M-%\P,3(N:G!G4$L! A0#%
M  @ %8 J6;D '7<PHP  %J4   \              ( !R0X: &9O<FUS+31?
M,#$S+FIP9U!+ 0(4 Q0    ( !6 *EE8IZN-HT8# +U) P /
M  "  2:R&@!F;W)M<RTT7S Q-"YJ<&=02P$"% ,4    "  5@"I9ZD-RUM&C
M 0#TYP$ #               @ 'V^!T <&EC='5R93$N:G!G4$L%!@     B
- "( YP<  /&<'P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>forms-4_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:BOWN="http://bowenspac.com/20240630"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bown-20240630.xsd" xlink:type="simple"/>
    <context id="From2024-01-01to2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-04-012024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_RedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_RedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_RedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-06-30_custom_RedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_NonRedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_NonRedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_NonRedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-06-30_custom_NonRedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_custom_RedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_custom_NonRedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_srt_MaximumMember_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-06-30_srt_MaximumMember_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-02-16_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-16</instant>
        </period>
    </context>
    <context id="AsOf2023-02-16_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-16</instant>
        </period>
    </context>
    <context id="AsOf2023-02-16_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-16</instant>
        </period>
    </context>
    <context id="AsOf2023-02-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <instant>2023-02-16</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-142023-07-14_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-14</startDate>
            <endDate>2023-07-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-14_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-14</startDate>
            <endDate>2023-07-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-14_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="From2023-07-172023-07-17_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-17</startDate>
            <endDate>2023-07-17</endDate>
        </period>
    </context>
    <context id="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-18</startDate>
            <endDate>2023-07-18</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-18_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-18</instant>
        </period>
    </context>
    <context id="From2023-07-182023-07-18_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-18</startDate>
            <endDate>2023-07-18</endDate>
        </period>
    </context>
    <context id="From2023-07-182023-07-18_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-18</startDate>
            <endDate>2023-07-18</endDate>
        </period>
    </context>
    <context id="From2024-01-182024-01-18_custom_MergerSharesMember_custom_AgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BOWN:MergerSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-18</startDate>
            <endDate>2024-01-18</endDate>
        </period>
    </context>
    <context id="From2024-01-182024-01-18_custom_EarnoutSharesMember_custom_AgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BOWN:EarnoutSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-18</startDate>
            <endDate>2024-01-18</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ShenzhenQianzhiMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BOWN:ShenzhenQianzhiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-07-18_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-18</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CashMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_USTreasurySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_RedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_NonRedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_RedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_NonRedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_RedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_NonRedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-06-30_custom_RedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-06-30_custom_NonRedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_custom_RedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_custom_NonRedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BOWN:NonRedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-142023-07-14_us-gaap_OverAllotmentOptionMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-14</startDate>
            <endDate>2023-07-14</endDate>
        </period>
    </context>
    <context id="From2023-07-142023-07-14_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-14</startDate>
            <endDate>2023-07-14</endDate>
        </period>
    </context>
    <context id="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember_custom_SponsorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-14</startDate>
            <endDate>2023-07-14</endDate>
        </period>
    </context>
    <context id="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember_custom_EBCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:EBCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-14</startDate>
            <endDate>2023-07-14</endDate>
        </period>
    </context>
    <context id="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:UnderwritersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-14</startDate>
            <endDate>2023-07-14</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_SponsorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_EBCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:EBCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:UnderwritersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:UnderwritersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-02-272023-02-27_custom_SponsorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-27</startDate>
            <endDate>2023-02-27</endDate>
        </period>
    </context>
    <context id="From2023-02-272023-02-27_custom_SponsorsMember_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-27</startDate>
            <endDate>2023-02-27</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-15_custom_EBCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:EBCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-15</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-15_custom_EBCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:EBCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-15</instant>
        </period>
    </context>
    <context id="AsOf2023-02-27_custom_PromissoryNoteMember_custom_SponsorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BOWN:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-27</instant>
        </period>
    </context>
    <context id="From2023-02-272023-02-27_custom_PromissoryNoteMember_custom_SponsorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BOWN:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-27</startDate>
            <endDate>2023-02-27</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BOWN:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BOWN:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_SponsorsMember_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-02-172023-03-31_custom_TenXGlobalCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BOWN:TenXGlobalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-07-142023-07-14_custom_AccountingServiceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-14</startDate>
            <endDate>2023-07-14</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_AccountingServiceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_AccountingServiceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_AccountingServiceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-06-30_custom_AccountingServiceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-112023-07-11_custom_SponsorsMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BOWN:SponsorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-11</startDate>
            <endDate>2023-07-11</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-27_custom_PromissoryNoteMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BOWN:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-27</instant>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RelatedPartyMember_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RelatedPartyMember_custom_AccountingServicesExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">BOWN:AccountingServicesExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_custom_TenXGlobalCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BOWN:TenXGlobalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-02-172023-12-31_custom_AccountingServiceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-17</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AccountingServiceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_AccountingServiceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_AccountingServiceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AccountingServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2023-03-152023-03-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-15</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-15</instant>
        </period>
    </context>
    <context id="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-15</instant>
        </period>
    </context>
    <context id="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-15</instant>
        </period>
    </context>
    <context id="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_custom_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">BOWN:MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-15</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_BusinessCombinationMarketingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:BusinessCombinationMarketingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_BusinessCombinationMarketingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:BusinessCombinationMarketingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_QianzhiMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BOWN:QianzhiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_QianzhiMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BOWN:QianzhiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_QianzhiMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BOWN:QianzhiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-312024-07-31_custom_QianzhiMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BOWN:QianzhiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-31</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BusinessCombinationMarketingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:BusinessCombinationMarketingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-182024-01-18_us-gaap_SubsequentEventMember_custom_MergerSharesMember_custom_AgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BOWN:MergerSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-18</startDate>
            <endDate>2024-01-18</endDate>
        </period>
    </context>
    <context id="From2024-01-182024-01-18_us-gaap_SubsequentEventMember_custom_EarnoutSharesMember_custom_AgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BOWN:EarnoutSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BOWN:AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-18</startDate>
            <endDate>2024-01-18</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-15_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001973056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="RMB">
        <measure>iso4217:CNY</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-01-01to2024-06-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2024-01-01to2024-06-30" id="Fact000004">0001973056</dei:EntityCentralIndexKey>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0047"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0082"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0083"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0099"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0100"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0141"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0142"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0154"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0159"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0169"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2023-02-172023-06-30"
      id="xdx2ixbrl0171"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0174"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-02-172023-06-30"
      id="xdx2ixbrl0176"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0179"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-04-012023-06-30_custom_RedeemableOrdinarySharesMember"
      id="xdx2ixbrl0187"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-04-012023-06-30_custom_RedeemableOrdinarySharesMember"
      id="xdx2ixbrl0189"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-02-172023-06-30_custom_RedeemableOrdinarySharesMember"
      id="xdx2ixbrl0195"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-02-172023-06-30_custom_RedeemableOrdinarySharesMember"
      id="xdx2ixbrl0197"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-04-012023-06-30_custom_RedeemableOrdinarySharesMember"
      id="xdx2ixbrl0203"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-04-012023-06-30_custom_RedeemableOrdinarySharesMember"
      id="xdx2ixbrl0205"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-02-172023-06-30_custom_RedeemableOrdinarySharesMember"
      id="xdx2ixbrl0211"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-02-172023-06-30_custom_RedeemableOrdinarySharesMember"
      id="xdx2ixbrl0213"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-04-012023-06-30_custom_NonRedeemableOrdinarySharesMember"
      id="xdx2ixbrl0223"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-04-012023-06-30_custom_NonRedeemableOrdinarySharesMember"
      id="xdx2ixbrl0225"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0241"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0247"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0248"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0252"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0253"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0258"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0264"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0265"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0269"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0270"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0275"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-16_us-gaap_CommonStockMember"
      id="xdx2ixbrl0281"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-16_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0282"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-16_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0283"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-16"
      id="xdx2ixbrl0284"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-02-16_us-gaap_CommonStockMember"
      id="xdx2ixbrl0286"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-02-172023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0290"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-02-172023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0297"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0302"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0303"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0307"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0308"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2023-02-172023-06-30"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2023-02-172023-06-30"
      id="xdx2ixbrl0359"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2023-02-172023-06-30"
      id="xdx2ixbrl0362"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-02-172023-06-30"
      id="xdx2ixbrl0365"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:ProceedsFromIssuanceOfFounderShares
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0379"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0397"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-02-16"
      id="xdx2ixbrl0404"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2023-02-172023-06-30"
      id="xdx2ixbrl0428"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:DeferredOfferingCostsPaidByRelatedParty
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0430"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:PrepaidExpensesPaidByRelatedParty
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0433"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:NoncashOfferingCostsAdjustedFromPrepaidExpenses
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0436"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:DeferredOfferingCostsIncludedInAccruedExpenses
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0439"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0442"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:OfferingCostsChargedToAPICFounderShares
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0445"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0535"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:AccretionOfTemporaryEquityIntoRedemptionValue
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0540"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:AccretionOfTemporaryEquityIntoRedemptionValue
      contextRef="From2023-02-172023-06-30"
      id="xdx2ixbrl0542"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:NetLossIncludingAccretionOfEquityIntoRedemptionValue
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0545"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0567"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0569"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0575"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0577"
      unitRef="Shares"
      xsi:nil="true"/>
    <BOWN:OwnershipPercentage
      contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0591"
      unitRef="Pure"
      xsi:nil="true"/>
    <BOWN:OwnershipPercentage
      contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0595"
      unitRef="Pure"
      xsi:nil="true"/>
    <BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity
      contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0603"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity
      contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember"
      id="xdx2ixbrl0604"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity
      contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0605"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount
      contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember"
      id="xdx2ixbrl0609"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount
      contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember"
      id="xdx2ixbrl0611"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount
      contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0612"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount
      contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember"
      id="xdx2ixbrl0613"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount
      contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0614"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount
      contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember"
      id="xdx2ixbrl0615"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0621"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember"
      id="xdx2ixbrl0622"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0623"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0642"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0644"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0650"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0652"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0674"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-04-012023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0676"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember"
      id="xdx2ixbrl0678"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember"
      id="xdx2ixbrl0680"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0682"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-02-172023-06-30_custom_RedeemableSharesMember"
      id="xdx2ixbrl0684"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <BOWN:NonCashOfferingCostsChargedToAdditionalPaidinCapital
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0745"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0956"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0966"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0986"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-16_us-gaap_CommonStockMember"
      id="xdx2ixbrl1022"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-16_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1023"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-16_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1024"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-16"
      id="xdx2ixbrl1025"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-02-16_us-gaap_CommonStockMember"
      id="xdx2ixbrl1027"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-16_us-gaap_CommonStockMember"
      id="xdx2ixbrl1029"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-16_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1030"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-16_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1031"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-16"
      id="xdx2ixbrl1032"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-02-16_us-gaap_CommonStockMember"
      id="xdx2ixbrl1034"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1038"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:StockIssuedDuringPeriodValueToUnderwriter
      contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1045"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits
      contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1052"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:StockIssuedDuringPeriodValueProceedsFromOverallotment
      contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1059"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:StockIssuedDuringPeriodValueSaleOfPrivateUnits
      contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1066"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits
      contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1073"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1078"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits
      contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1080"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1083"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment
      contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1085"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1088"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts
      contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1090"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1095"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1100"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
      contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1102"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1105"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
      contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1107"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1110"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1115"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1116"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1121"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1128"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-02-16"
      id="xdx2ixbrl1174"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:IncomeEarnedOnTrustAccount
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember"
      id="xdx2ixbrl1294"
      unitRef="USD"
      xsi:nil="true"/>
    <BOWN:AccretionOfTemporaryEquityIntoRedemptionValue
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember"
      id="xdx2ixbrl1297"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1506"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1507"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2024-01-01to2024-06-30" id="Fact000011">S-4</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2024-01-01to2024-06-30" id="Fact000012">Bowen Acquisition Corp</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-01-01to2024-06-30" id="Fact000013">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="From2024-01-01to2024-06-30" id="Fact000014">420 Lexington Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-01-01to2024-06-30" id="Fact000015">Suite 2446</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-01-01to2024-06-30" id="Fact000016">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-01-01to2024-06-30" id="Fact000017">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-01-01to2024-06-30" id="Fact000018">10170</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-01-01to2024-06-30" id="Fact000019">(203)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-01-01to2024-06-30" id="Fact000020">998-5540</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000021">Jiangang Luo</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000022">420 Lexington Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000023">Suite 2446</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000024">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000025">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000026">10170</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000027">(203)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000028">998-5540</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2024-01-01to2024-06-30" id="Fact000029">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-01-01to2024-06-30" id="Fact000030">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-01-01to2024-06-30" id="Fact000031">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2024-01-01to2024-06-30" id="Fact000032">false</dei:EntityExTransitionPeriod>
    <us-gaap:Cash
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000040"
      unitRef="USD">272630</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000041"
      unitRef="USD">426913</us-gaap:Cash>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000043"
      unitRef="USD">42209</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000044"
      unitRef="USD">79481</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000046"
      unitRef="USD">45199</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000049"
      unitRef="USD">360038</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000050"
      unitRef="USD">506394</us-gaap:AssetsCurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000052"
      unitRef="USD">73284700</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000053"
      unitRef="USD">71419358</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000056"
      unitRef="USD">71419358</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000058"
      unitRef="USD">73644738</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000059"
      unitRef="USD">71925752</us-gaap:Assets>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000067"
      unitRef="USD">189730</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000068"
      unitRef="USD">78610</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000070"
      unitRef="USD">30000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000071"
      unitRef="USD">25250</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000073"
      unitRef="USD">30000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000074"
      unitRef="USD">25250</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000076"
      unitRef="USD">219730</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000077"
      unitRef="USD">103860</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000079"
      unitRef="USD">219730</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000080"
      unitRef="USD">103860</us-gaap:Liabilities>
    <BOWN:OrdinarySharesSubjectToRedemption
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000088"
      unitRef="Shares">6900000</BOWN:OrdinarySharesSubjectToRedemption>
    <BOWN:OrdinarySharesSubjectToRedemption
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000090"
      unitRef="Shares">6900000</BOWN:OrdinarySharesSubjectToRedemption>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000092"
      unitRef="USDPShares">10.62</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000094"
      unitRef="USDPShares">10.35</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000085"
      unitRef="USD">73284700</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000086"
      unitRef="USD">71419358</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000102"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000104"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000106"
      unitRef="Shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000108"
      unitRef="Shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000110"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000112"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000114"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000116"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000121"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000123"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000125"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000127"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000129"
      unitRef="Shares">2266500</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000131"
      unitRef="Shares">2266500</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000133"
      unitRef="Shares">2266500</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000135"
      unitRef="Shares">2266500</us-gaap:CommonStockSharesOutstanding>
    <BOWN:OrdinarySharesSubjectToRedemption
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000137"
      unitRef="Shares">6900000</BOWN:OrdinarySharesSubjectToRedemption>
    <BOWN:OrdinarySharesSubjectToRedemption
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000139"
      unitRef="Shares">6900000</BOWN:OrdinarySharesSubjectToRedemption>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000118"
      unitRef="USD">227</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000119"
      unitRef="USD">227</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000144"
      unitRef="USD">140081</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000145"
      unitRef="USD">402307</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000147"
      unitRef="USD">140308</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000148"
      unitRef="USD">402534</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000150"
      unitRef="USD">73644738</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000151"
      unitRef="USD">71925752</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000153"
      unitRef="USD">125096</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000155"
      unitRef="USD">262226</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000156"
      unitRef="USD">3105</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000158"
      unitRef="USD">-125096</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000160"
      unitRef="USD">-262226</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000161"
      unitRef="USD">-3105</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000168"
      unitRef="USD">941850</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000170"
      unitRef="USD">1865342</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000173"
      unitRef="USD">941850</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000175"
      unitRef="USD">1865342</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000178"
      unitRef="USD">816754</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000180"
      unitRef="USD">1603116</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000181"
      unitRef="USD">-3105</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-04-012024-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000183"
      unitRef="Shares">6900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-04-012024-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000185"
      unitRef="Shares">6900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-012024-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000191"
      unitRef="Shares">6900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-012024-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000193"
      unitRef="Shares">6900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-04-012024-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000199"
      unitRef="USDPShares">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-04-012024-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000201"
      unitRef="USDPShares">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-012024-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000207"
      unitRef="USDPShares">0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-012024-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000209"
      unitRef="USDPShares">0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-04-012024-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000214"
      unitRef="Shares">2266500</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-04-012023-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000215"
      unitRef="Shares">1680000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-012024-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000216"
      unitRef="Shares">2266500</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-02-172023-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000217"
      unitRef="Shares">1656774</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-04-012024-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000219"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-04-012024-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000221"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-012024-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000227"
      unitRef="USDPShares">-0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-012024-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000229"
      unitRef="USDPShares">-0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-02-172023-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000231"
      unitRef="USDPShares">-0.002</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-02-172023-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000233"
      unitRef="USDPShares">-0.002</us-gaap:EarningsPerShareDiluted>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-04-012023-06-30_srt_MaximumMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000236"
      unitRef="Shares">225000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-02-172023-06-30_srt_MaximumMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000238"
      unitRef="Shares">225000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000245"
      unitRef="Shares">2266500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000240"
      unitRef="USD">227</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000242"
      unitRef="USD">402307</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000243"
      unitRef="USD">402534</us-gaap:StockholdersEquity>
    <BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000249"
      unitRef="USD">-923492</BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount>
    <BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000250"
      unitRef="USD">-923492</BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000254"
      unitRef="USD">786362</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000255"
      unitRef="USD">786362</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000262"
      unitRef="Shares">2266500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000257"
      unitRef="USD">227</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000259"
      unitRef="USD">265177</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="Fact000260"
      unitRef="USD">265404</us-gaap:StockholdersEquity>
    <BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000266"
      unitRef="USD">-941850</BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount>
    <BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000267"
      unitRef="USD">-941850</BOWN:SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000271"
      unitRef="USD">816754</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000272"
      unitRef="USD">816754</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000279"
      unitRef="Shares">2266500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000274"
      unitRef="USD">227</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000276"
      unitRef="USD">140081</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000277"
      unitRef="USD">140308</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2023-02-172023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000293"
      unitRef="Shares">1725000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-02-172023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000288"
      unitRef="USD">173</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-02-172023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000289"
      unitRef="USD">24827</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-02-172023-03-31"
      decimals="0"
      id="Fact000291"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-172023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000300"
      unitRef="Shares">180000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-02-172023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000295"
      unitRef="USD">18</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-02-172023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000296"
      unitRef="USD">1015982</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-02-172023-03-31"
      decimals="0"
      id="Fact000298"
      unitRef="USD">1016000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000304"
      unitRef="USD">-3105</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-03-31"
      decimals="0"
      id="Fact000305"
      unitRef="USD">-3105</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000309"
      unitRef="USD">-3105</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-03-31"
      decimals="0"
      id="Fact000310"
      unitRef="USD">-3105</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000317"
      unitRef="Shares">1905000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000312"
      unitRef="USD">191</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000313"
      unitRef="USD">1040809</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000314"
      unitRef="USD">-3105</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact000315"
      unitRef="USD">1037895</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000324"
      unitRef="Shares">1905000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000319"
      unitRef="USD">191</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000320"
      unitRef="USD">1040809</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000321"
      unitRef="USD">-3105</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact000322"
      unitRef="USD">1037895</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000331"
      unitRef="Shares">1905000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000326"
      unitRef="USD">191</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000327"
      unitRef="USD">1040809</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000328"
      unitRef="USD">-3105</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000329"
      unitRef="USD">1037895</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000338"
      unitRef="Shares">1905000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000333"
      unitRef="USD">191</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000334"
      unitRef="USD">1040809</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000335"
      unitRef="USD">-3105</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000336"
      unitRef="USD">1037895</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000343"
      unitRef="USD">1603116</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000344"
      unitRef="USD">-3105</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000349"
      unitRef="USD">1865342</us-gaap:IncomeLossFromEquityMethodInvestments>
    <BOWN:IncreaseDecreaseInAccruedOfferingCostsAndExpenses
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000355"
      unitRef="USD">69143</BOWN:IncreaseDecreaseInAccruedOfferingCostsAndExpenses>
    <BOWN:IncreaseDecreaseInAccruedOfferingCostsAndExpenses
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000356"
      unitRef="USD">3105</BOWN:IncreaseDecreaseInAccruedOfferingCostsAndExpenses>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000358"
      unitRef="USD">4750</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000361"
      unitRef="USD">-34050</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000364"
      unitRef="USD">-154283</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <BOWN:ProceedsFromIssuanceOfFounderShares
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000380"
      unitRef="USD">2520</BOWN:ProceedsFromIssuanceOfFounderShares>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000398"
      unitRef="USD">2520</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000400"
      unitRef="USD">-154283</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000401"
      unitRef="USD">2520</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000403"
      unitRef="USD">426913</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000406"
      unitRef="USD">272630</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000407"
      unitRef="USD">2520</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000427"
      unitRef="USD">1865342</BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption>
    <BOWN:DeferredOfferingCostsPaidByRelatedParty
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000431"
      unitRef="USD">144108</BOWN:DeferredOfferingCostsPaidByRelatedParty>
    <BOWN:PrepaidExpensesPaidByRelatedParty
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000434"
      unitRef="USD">1600</BOWN:PrepaidExpensesPaidByRelatedParty>
    <BOWN:NoncashOfferingCostsAdjustedFromPrepaidExpenses
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000437"
      unitRef="USD">639</BOWN:NoncashOfferingCostsAdjustedFromPrepaidExpenses>
    <BOWN:DeferredOfferingCostsIncludedInAccruedExpenses
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000440"
      unitRef="USD">2505</BOWN:DeferredOfferingCostsIncludedInAccruedExpenses>
    <BOWN:DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000443"
      unitRef="USD">25000</BOWN:DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares>
    <BOWN:OfferingCostsChargedToAPICFounderShares
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000446"
      unitRef="USD">1013480</BOWN:OfferingCostsChargedToAPICFounderShares>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000448">&lt;p id="xdx_80F_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zB2oomZDbBha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 &#x2014; &lt;span id="xdx_82B_zG09NjEIsedf"&gt;ORGANIZATION AND BUSINESS OPERATIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Organizational
and General&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bowen
Acquisition Corp (the &#x201c;Company&#x201d;) was incorporated in the Cayman Islands on February 17, 2023. The Company was formed for
the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination
with one or more businesses (the &#x201c;Business Combination&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early
stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth
companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s sponsors are Createcharm Holdings Ltd., a British Virgin Islands company, and Bowen Holding LP, a Delaware limited partnership
(the &#x201c;Sponsors&#x201d;). As of June 30, 2024, the Company had not commenced any operations. All activities for the period from February
17, 2023 (inception) through June 30, 2024 relate to the Company&#x2019;s formation, the initial public offering (&#x201c;IPO&#x201d;)
and initial business combination, which is described below. The Company will not generate any operating revenues until after the completion
of an initial Business Combination, at the earliest. The Company is generating non-operating income in the form of interest income from
the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
registration statement for the Company&#x2019;s IPO (the &#x201c;Registration Statement&#x201d;) was declared effective on July 11, 2023.
On July 14, 2023, the Company consummated the IPO of &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zXkIXqVCmuq9" title="Stock issued during period shares"&gt;6,000,000&lt;/span&gt; of its units (&#x201c;Public Units&#x201d;). Each Public Unit consists of
one ordinary share, $&lt;span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z6ca4ejeCCl5" title="Ordinary shares, par value"&gt;0.0001&lt;/span&gt; par value (&#x201c;Ordinary Shares&#x201d;), of the Company and one right (&#x201c;Rights&#x201d;), each Right
entitling the holder thereof to receive one-tenth of one ordinary share upon the completion of the Company&#x2019;s initial business combination.
The Public Units were sold at an offering price of $&lt;span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zF5aCDIpxIue" title="Sale of stock, par share"&gt;10.00&lt;/span&gt; per Unit, generating gross proceeds of $&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z72vmFIlHsx4" title="Proceeds from issuance of IPO"&gt;60,000,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the consummation of the IPO, the Company consummated the private placement (&#x201c;Private Placement&#x201d;) of &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zhrlXbAF2FXb" title="Stock issued during period shares"&gt;330,000&lt;/span&gt; units (&#x201c;Private
Placement Units&#x201d;) at a price of $&lt;span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zM0dBaFGobXf" title="Price per share"&gt;10.00&lt;/span&gt; per Private Placement Unit, generating total proceeds of $&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zxVLExIfYjwe" title="Proceeds from issuance of private placement"&gt;3,300,000&lt;/span&gt;. The Private Placement
Units were purchased by Createcharm Holdings Ltd, one of the Company&#x2019;s sponsors, and EarlyBirdCapital, Inc. (&#x201c;EBC&#x201d;),
the representative of the underwriters in the IPO. The Private Placement Units are identical to the Units included in the Public Units
sold in the IPO. The purchasers of the Private Placement Units have agreed not to transfer, assign or sell any of the Private Placement
Units or Ordinary Shares or Rights underlying the Private Placement Units (except to certain transferees) until after the completion
of the Company&#x2019;s initial Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 17, 2023, the underwriters exercised their over-allotment option in full to purchase an additional &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230717__20230717__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zyjl9lYzFfma" title="Stock issued during period shares"&gt;900,000&lt;/span&gt; Units. As a result, on
July 18, 2023, the Company sold an additional &lt;span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zRUXFuEHgEWe" title="Number of units sold"&gt;900,000&lt;/span&gt; Units at $&lt;span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zR0RnGh00WH3" title="Sale of stock price per unit"&gt;10.00&lt;/span&gt; per Unit, generating gross proceeds of $&lt;span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zkKjR6O89hX4" title="Proceeds from sale of units"&gt;9,000,000&lt;/span&gt;. In connection
with this sale, Createcharm Holdings Ltd. and EBC also purchased an additional &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zv3df78rOIn3" title="Number of stock issued"&gt;31,500&lt;/span&gt; Private Placement Units from the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of July 18, 2023, transaction costs amounted to $&lt;span id="xdx_90D_eus-gaap--PaymentsOfStockIssuanceCosts_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zVlleXFyNmz3" title="Transaction costs"&gt;3,318,898&lt;/span&gt; consisting of $&lt;span id="xdx_907_eus-gaap--PaymentsForUnderwritingExpense_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zL7glKeIRxJh" title="Cash underwriting fees"&gt;1,725,000&lt;/span&gt; of cash underwriting fees and $&lt;span id="xdx_90A_ecustom--OtherOfferingCosts_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5S3xmFQghrj" title="Other offering costs"&gt;1,593,898&lt;/span&gt; of other
offering costs. These costs were charged to additional paid-in capital or accumulated deficit to the extent additional paid-in capital
is fully depleted upon completion of the IPO.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will have until 15 months from the closing of the IPO (or up to 18 months, if the Company extends the time to complete a Business
Combination as permitted in its Amended and Restated Memorandum and Articles of Association) to consummate a Business Combination (the
&#x201c;Combination Period&#x201d;). However, if the Company has not completed a Business Combination within the Combination Period and
shareholders have not otherwise amended the Amended and Restated Memorandum and Articles of Association to extend this period, the Company
will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business
days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit
in the Trust Account, including interest earned and not previously released to us to pay the Company&#x2019;s taxes, if any (less certain
amount of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption
will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating
distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#x2019;s
remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject to the Company&#x2019;s obligations under Cayman
Islands law to provide for claims of creditors and the requirements of other applicable law.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 20, 2023, a wholly-owned subsidiary of the Company, Bowen Merger Sub (&#x201c;Merger Sub&#x201d;) was formed for the purpose of
entering into a business combination agreement. See &#x201c;Proposed Business Combination&#x201d; below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Proposed
Business Combination&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 18, 2024, the Company entered into an Agreement and Plan of Reorganization (the &#x201c;Agreement&#x201d;) with (i) Bowen Merger
Sub, a Cayman Islands exempted company and a wholly owned subsidiary of the Company (&#x201c;Merger Sub&#x201d;), (ii) Shenzhen Qianzhi
BioTechnology Co. Ltd., a company incorporated in the People&#x2019;s Republic of China and a wholly owned subsidiary of NewCo (as defined
below) (&#x201c;Shenzhen Qianzhi&#x201d;), and (iii) &lt;span style="background-color: white"&gt;Qianzhi Group Holding (Cayman) Limited, a newly
formed Cayman Islands company (&#x201c;&lt;span style="text-decoration: underline"&gt;NewCo&lt;/span&gt;,&#x201d; and collectively with the Company, Merger Sub and Shenzhen Qianzhi, the &#x201c;&lt;span style="text-decoration: underline"&gt;Parties&lt;/span&gt;&#x201d;,
each a &#x201c;&lt;span style="text-decoration: underline"&gt;Party&lt;/span&gt;&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Pursuant
to the Agreement, at the closing of the business combination, Merger Sub will merge with and into NewCo (the &#x201c;&lt;span style="text-decoration: underline"&gt;Merger&lt;/span&gt;&#x201d;),
with NewCo being the surviving company of the Merger (&#x201c;&lt;span style="text-decoration: underline"&gt;Surviving Company&lt;/span&gt;&#x201d;) and becoming a wholly owned subsidiary
of the Company. In the Merger, the holders (the &#x201c;NewCo Shareholders&#x201d;) of the ordinary shares of NewCo (&#x201c;NewCo Ordinary
Shares&#x201d;) will receive ordinary shares of the Company (&#x201c;Parent Ordinary Shares&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Pursuant
to the Agreement, at the effective time of the Merger (the &#x201c;Effective Time&#x201d;), all of NewCo Ordinary Shares issued and outstanding
immediately prior to the Effective Time will be automatically converted into the right to receive an aggregate of (a) &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240118__20240118__us-gaap--StatementEquityComponentsAxis__custom--MergerSharesMember__us-gaap--TypeOfArrangementAxis__custom--AgreementMember_zsC8X59Cpna1" title="Number of stock issued"&gt;7,246,377&lt;/span&gt; Parent
Ordinary Shares (the &#x201c;Merger Shares&#x201d;), and (b) the right to receive earnout consideration of up to an aggregate of &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240118__20240118__us-gaap--StatementEquityComponentsAxis__custom--EarnoutSharesMember__us-gaap--TypeOfArrangementAxis__custom--AgreementMember__srt--RangeAxis__srt--MaximumMember_zRFpl16lJ2Sk" title="Number of stock issued"&gt;1,400,000&lt;/span&gt;
Parent Ordinary Shares (the &#x201c;Earnout Shares&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Going
Concern Consideration&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2024, the Company had cash of $&lt;span id="xdx_906_eus-gaap--Cash_iI_c20240630_z1nK0Gly7TI3" title="Cash"&gt;272,630&lt;/span&gt; and a working capital of $&lt;span id="xdx_908_ecustom--WorkingCapitalDeficit_iI_c20240630_zvWgVVhBHkVg" title="Working capital"&gt;95,109&lt;/span&gt; (excluding $&lt;span id="xdx_903_eus-gaap--OtherReceivablesNetCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShenzhenQianzhiMember_zvn2MGHDrVEf" title="Due from related parties"&gt;45,199&lt;/span&gt; due from Shenzhen Qianzhi). The
Company has incurred and expects to continue to incur significant professional costs to remain as a public traded company and to incur
transaction costs in pursuit of a Business Combination. In connection with the Company&#x2019;s assessment of going concern considerations
in accordance with Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-15, &#x201c;Disclosures of Uncertainties about an Entity&#x2019;s
Ability to Continue as a Going Concern,&#x201d; management believes that these conditions raise substantial doubt about the Company&#x2019;s
ability to continue as a going concern. In addition, if the Company is unable to complete a Business Combination within the Combination
Period and such period is not extended, there will be a liquidation and subsequent dissolution. As a result, management has determined
that such additional condition also raises substantial doubt about the Company&#x2019;s ability to continue as a going concern. The consolidated
financial statement does not include any adjustments that might result from the outcome of the uncertainty.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-142023-07-14_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000450"
      unitRef="Shares">6000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-07-14_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000452"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-07-14_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000454"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-07-142023-07-14_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000456"
      unitRef="USD">60000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000458"
      unitRef="Shares">330000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-07-14_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000460"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000462"
      unitRef="USD">3300000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-172023-07-17_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000464"
      unitRef="Shares">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000466"
      unitRef="Shares">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-07-18_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000468"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact000470"
      unitRef="USD">9000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-182023-07-18_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000472"
      unitRef="Shares">31500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-07-182023-07-18_us-gaap_IPOMember"
      decimals="0"
      id="Fact000474"
      unitRef="USD">3318898</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="From2023-07-182023-07-18_us-gaap_IPOMember"
      decimals="0"
      id="Fact000476"
      unitRef="USD">1725000</us-gaap:PaymentsForUnderwritingExpense>
    <BOWN:OtherOfferingCosts
      contextRef="From2023-07-182023-07-18_us-gaap_IPOMember"
      decimals="0"
      id="Fact000478"
      unitRef="USD">1593898</BOWN:OtherOfferingCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-182024-01-18_custom_MergerSharesMember_custom_AgreementMember"
      decimals="INF"
      id="Fact000480"
      unitRef="Shares">7246377</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-182024-01-18_custom_EarnoutSharesMember_custom_AgreementMember_srt_MaximumMember"
      decimals="INF"
      id="Fact000482"
      unitRef="Shares">1400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:Cash
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000484"
      unitRef="USD">272630</us-gaap:Cash>
    <BOWN:WorkingCapitalDeficit
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000486"
      unitRef="USD">95109</BOWN:WorkingCapitalDeficit>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="AsOf2024-06-30_custom_ShenzhenQianzhiMember"
      decimals="0"
      id="Fact000488"
      unitRef="USD">45199</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000490">&lt;p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zg1xV1GwNg0d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2014; &lt;span id="xdx_82F_zA83al8Onr2a"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zDGTG5XmeChh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zUxqRnHjUOqj"&gt;Basis
of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#x201c;US GAAP&#x201d;) for interim financial information and in accordance with the instructions to
Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the unaudited financial statements reflect all adjustments, which
include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The
interim results for the period ended June 30, 2024 are not necessarily indicative of the results that may be expected through December
31, 2024. All intercompany accounts and transactions are eliminated upon consolidation. The information included in this Form 10-Q should
be read in conjunction with information included in the Company&#x2019;s annual report on Form 10-K for the year ended December 31, 2023,
filed with the Securities and Exchange Commission on March 29, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--EmergingGrowthCompanyPolicyTextBlock_zSmJyp9e1Gmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_ztfXEU3hhLC5"&gt;Emerging
Growth Company&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#x201c;Securities
Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#x201c;JOBS Act&#x201d;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--UseOfEstimates_zd8txaf1Tr45" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_864_ziK8M0jpATv7"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the consolidated financial statement in conformity with US GAAP requires the Company&#x2019;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zipcGUzRtCtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zNGkI8nRUxtd"&gt;Cash
and cash equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had a cash balance of $&lt;span id="xdx_902_eus-gaap--Cash_iI_pp0p0_c20240630_zAlO8iPeSzX7" title="Cash"&gt;272,630&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20231231_zmztkBWTdqn5" title="Cash"&gt;426,913&lt;/span&gt; as of June 30, 2024 and December 31, 2023, respectively. The Company had &lt;span id="xdx_909_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240630_z2CKN0fZxdza" title="Cash equivalents"&gt;&lt;span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zkEELsKcwKJ" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt; cash
equivalents as of June 30, 2024 and December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--InvestmentPolicyTextBlock_zL5lotToLD14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zgn1LlvFy8Aj"&gt;Investments
Held in Trust Account&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s portfolio of investments held in the Trust Account is comprised of investments only in U.S. government securities with
a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which
invest only in direct U.S. government treasury obligations. The Company&#x2019;s investments held in the Trust Account are classified
as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains
and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable
securities held in Trust Account in the accompanying statements of operations. The estimated fair value of investments held in the Trust
Account is determined using available market information. As of June 30, 2024 and December 31, 2023, the Trust Account had balance of
$&lt;span id="xdx_907_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20240630_zTCSUZQOVlMi" title="Trust account balance"&gt;73,284,700&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231_zqPrkszMnHZc" title="Trust account balance"&gt;71,419,358&lt;/span&gt;, respectively. The interest and dividend income earned from the Trust Account totaled $&lt;span id="xdx_90B_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_pp0p0_c20240401__20240630_zsiiM69cBkFd" title="Interests earned from trust account"&gt;941,850&lt;/span&gt; and $&lt;span id="xdx_901_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_pp0p0_c20240101__20240630_zXYhRnbC0yXk" title="Interest and dividend income earned from trust account"&gt;1,865,342&lt;/span&gt;
for three and six months ended June 30, 2024, respectively, which were fully reinvested into the Trust Account as earned and unrealized
gain on investments and therefore presented as an adjustment to the operating activities in the Consolidated Statements of Cash Flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_ecustom--OfferingCostsPolicyTextBlock_zJohv5TrH4Le" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zDoEB7BkwZVg"&gt;Offering
Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering
costs consist of legal and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that
are directly related to the IPO and that were charged to shareholders&#x2019; equity upon the completion of the IPO on July 14, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_z71YEBUcSXue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_869_zhUqkdxrCMji"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#x201c;&lt;i&gt;Income Taxes&lt;/i&gt;.&#x201d; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were &lt;span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20240630_zbzapixzmQ0k" title="Unrecognized tax benefits"&gt;&lt;span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zSaQfj8d9C6d" title="Unrecognized tax benefits"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits and &lt;span id="xdx_901_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20240630_zcLDqJZK7E8c" title="Interest and penalties accrued"&gt;&lt;span id="xdx_900_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20231231_z7FZkptnHQR8" title="Interest and penalties accrued"&gt;no&lt;/span&gt;&lt;/span&gt; amounts accrued for interest and penalties as of June 30, 2024
and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals,
or material deviation from its position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax
regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#x2019;s
consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zlFO4bhF6Kk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zHGM35ZCbFJk"&gt;Net
Income (Loss) per Ordinary Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include
a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income
per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company
first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed
income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss)
ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement
of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public
shareholders. As of June 30, 2024 and 2023, the Company did not have any dilutive securities and other contracts that could, potentially,
be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per
share is the same as basic income (loss) per share for the period presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
net income (loss) per share presented in the statements of operations is based on the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zFiYCcWKe56f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zZaHA01dQnV4" style="display: none"&gt;SCHEDULE
OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20240401__20240630_zEPV8mzuxNO8" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230401__20230630_zgwKQxKgn7vh" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240101__20240630_zNbVNk9ZmBQe" style="text-align: center"&gt;&lt;b&gt;June 30,&lt;br/&gt;
    2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230217__20230630_zcd2NavKx0ld" style="text-align: center"&gt;&lt;b&gt;June 30, &lt;br/&gt;
    2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Three Months Ended June 30,&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;Six Months Ended&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;For the Period from February 17, 2023 through&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;June 30,&lt;br/&gt;
    2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;June 30, &lt;br/&gt;
    2023&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NetIncomeLoss_maNLIAOz10T_zbrmeHprLolh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Net income (loss)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;816,754&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0535"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,603,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(3,105&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz10T_zAbKlpGMN215" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accretion of temporary equity into redemption value (interest earned)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(941,850&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0540"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,865,342&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0542"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NetLossIncludingAccretionOfEquityIntoRedemptionValue_iT_mtNLIAOz10T_zuPmzF721cVd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net loss including accretion of equity into redemption value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(125,096&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0545"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(262,226&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(3,105&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zsq1envgUrs1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zNJHbGlybjOl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_z4YUe7BJfSVk" style="display: none"&gt;SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSBy0peTNeqd" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zHFJtctmQ7Af" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zrGeGu54Bja" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrUDxN5tolnh" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zoS3vQSHFBhl" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCvvcjVvYjp1" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zN0D5o5bki2k" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zco4vS2BZfp7" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    Three Months Ended&lt;br/&gt;
 June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    Six Months Ended &#160;&lt;br/&gt;
June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    Three Months Ended &lt;br/&gt;
June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the Period from &lt;br/&gt;
February 17, 2023 through &lt;br/&gt;
June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Particulars&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and
    diluted net income/(loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRlmacH7Veaj" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z7aUZCzHX6wh" title="Weighted average shares outstanding - diluted"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zOQnfAKWBQC4" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zw7LQikX1Owc" title="Weighted average shares outstanding - diluted"&gt;2,266,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zlAbDpzpBcE5" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zwdZB8aavyb4" title="Weighted average shares outstanding - diluted"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z4xwsqmQRZs5" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqoTpOOCEHOh" title="Weighted average shares outstanding - diluted"&gt;2,266,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zvYEr2B32Nu2" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zADwgPj1Bpz9" title="Weighted average shares outstanding - diluted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0567"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0569"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFN1VzmKwYAa" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFBwNIxZYrE8" title="Weighted average shares outstanding - diluted"&gt;1,680,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 11pt; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zfVl1CLuVOr" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_znOvNmn9lYB4" title="Weighted average shares outstanding - diluted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0575"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0577"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYEWjo6tCvF5" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zuALVTokWFIa" title="Weighted average shares outstanding - diluted"&gt;1,656,774&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ownership percentage&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--OwnershipPercentage_pid_dp_uPure_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRX0VSo5MI3e" title="Ownership percentage"&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--OwnershipPercentage_pid_dp_uPure_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zI77K3HjvqZd" title="Ownership percentage"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zcTLuYDNbyS5" title="Ownership percentage"&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zq3nXiuDFsM3" title="Ownership percentage"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zz6QDtUW3A9l" title="Ownership percentage"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0591"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zd3pzYuFsn3k" title="Ownership percentage"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zzQDZ6b20zb" title="Ownership percentage"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0595"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFLbzzGvCPba" title="Ownership percentage"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Numerators:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zshkQfUYiUi6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation of net loss including
    accretion of temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(94,165&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(30,931&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(197,388&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(64,838&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0603"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0604"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0605"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,105&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_z6JeXvyniSQ4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    earned on investment held in trust account&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;941,850&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0609"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,865,342&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0611"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0612"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0613"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0614"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0615"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLoss_znOk6211LrT4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation of net income/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;847,685&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(30,931&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,667,954&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(64,838&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0621"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0622"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0623"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,105&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominators:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted-average shares
    outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQzV0IDvSyj2" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zOT1zbMGB639" title="Weighted average shares outstanding - diluted"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_ze0K9wVa10dd" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zcDkDRb7KoM2" title="Weighted average shares outstanding - diluted"&gt;2,266,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zYvu0Nr3kbJf" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zGimqSbrnS3g" title="Weighted average shares outstanding - diluted"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMUgytbR5TI3" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zC3p20bgWXld" title="Weighted average shares outstanding - diluted"&gt;2,266,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zyptN8z7J0zk" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zC95eqOTAu9k" title="Weighted average shares outstanding - diluted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0642"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0644"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zbyRYDgivH3e" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zXbDy5TMdmMb" title="Weighted average shares outstanding - diluted"&gt;1,680,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTdaJvG0QYge" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z9t6Q9aH3u9i" title="Weighted average shares outstanding - diluted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0650"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0652"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z34tVg8XqKUi" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYR4raUHLa09" title="Weighted-average shares outstanding - diluted"&gt;1,656,774&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
    and diluted net income/(loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z34oXUuyBQ39" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zvLOYwYGlhe1" title="Diluted net income/(loss) per share"&gt;0.12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zuL9mXv5DD1l" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrvsnXUJxtbj" title="Diluted net income/(loss) per share"&gt;(0.01&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQpX6slT0dG2" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zG7Oo29qJ0Wc" title="Diluted net income/(loss) per share"&gt;0.24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zJDyTrubNsA" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zzlN34jafbG5" title="Diluted net income/(loss) per share"&gt;(0.03&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zg0u4HGHo3va" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zdFuSn87WLE2" title="Diluted net income/(loss) per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0674"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0676"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zhEKTZF2Z2Pd" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zsHEHZzJIhbc" title="Diluted net income/(loss) per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0678"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0680"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z6KC1AJBXhJc" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zA2v4GYzuEPk" title="Diluted net income/(loss) per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0682"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0684"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_za6AczHeao4j" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zKdoRSOAcBi4" title="Diluted net income/(loss) per share"&gt;(0.002&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p id="xdx_8AE_z9AwGfR5raC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_z3lZhr9911K6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zPYpyu6KgvTj"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $&lt;span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_c20240630_z3L1nYZwLMTb" title="Cash FDIC insured amount"&gt;250,000&lt;/span&gt;. The Company has not experienced losses on these accounts
and management believes the Company is not exposed to significant risks on such accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zcJebipTI21i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_z7zkLhnilQEl"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC 820, &#x201c;&lt;i&gt;Fair Value
Measurement&lt;/i&gt;,&#x201d; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zVKEDCaCr3jb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zRwInfBS5jUe"&gt;Ordinary
Shares Subject to Possible Redemption&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Ordinary shares subject to mandatory redemption (if
any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary
shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, ordinary shares
are classified as shareholders&#x2019; equity. The Company&#x2019;s ordinary shares features certain redemption rights that are considered
to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject
to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; equity section of the
Company&#x2019;s balance sheet. &lt;span style="background-color: white"&gt;The Company recognizes changes in redemption value immediately as
they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.
Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital
and accumulated deficit.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zGAuRR7PPSeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2023 and June 30, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are
reconciled in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zpc5XAu9ccQg" style="display: none"&gt;SCHEDULE
OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 84%; text-align: left"&gt;Public offering proceeds&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPTO3JbwgL46" style="width: 12%; text-align: right" title="Public offering proceeds"&gt;60,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zC2iWnioAnWf" style="text-align: right" title="Proceeds allocated to public rights"&gt;(3,272,724&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3GYLMyaZGMg" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(2,925,140&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3ebkpA4pQAi" style="text-align: right" title="Accretion of carrying value to redemption value"&gt;6,797,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Ordinary shares subject to possible redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20230101__20231231_zMmdN8mzOY43" style="text-align: right" title="Ordinary shares subject to possible redemption"&gt;60,600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic"&gt;Over-allotment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Over-allotment proceeds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ProceedsFromOtherEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zhdg83vT3Rme" style="text-align: right" title="Over-allotment proceeds"&gt;9,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z6J18rD4Rk1b" style="text-align: right" title="Proceeds allocated to Public Rights"&gt;(490,909&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zojTNcHsWDO" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(212,727&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zHWQ4CTJT1de" style="text-align: right" title="Accretion of carrying value to redemption value"&gt;793,636&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zim6byzjMXwh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"&gt;1,729,358&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Ordinary shares subject to possible redemption, December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20240101__20240630_z6P1opG3tZBi" style="font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemption"&gt;71,419,358&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Subsequent
    measurement of ordinary shares subject to possible redemption (income earned on trust account)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20240101__20240630_zGjItKI6Dbd7" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;1,865,342&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Ordinary
    shares subject to possible redemption, June 30, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iE_c20240101__20240630_zwYfAIm1ZNUh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;73,284,700&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_z6s9ZdWbnonf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zvlTHZ2lITda" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zCZJ7hRWs7j2"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_854_zffhMR6q4hoi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Correction
of an Error&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;While
preparing the Company&#x2019;s Form 10-Q for the quarterly period ended June 30, 2024, the Company identified an omission in the disclosure
of the non-cash item in the Cash Flow Statement related with the offering cost charged to APIC for the EBC founder shares in its historical
filing for the quarter ended June 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with SEC Staff Accounting Bulletin No. 99, &#x201c;Materiality,&#x201d; and SEC Staff Accounting Bulletin No. 108, &#x201c;Considering
the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements;&#x201d; the Company evaluated
the error and has determined that the omission of non-cash item in the interim period of six months in 2023 does not have any impact
on the consolidated financial statements in the full year of 2023 and 2024. Accordingly, the Company has corrected such immaterial error
by adjusting its statement of cash flows for the period from February 17, 2023 (inception) through June 30, 2023 related to the supplemental
disclosure of noncash financing activities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following analysis provides a comparison of the supplemental disclosure of noncash financing activities as reported on the Form 10-Q
for the quarter ended June 30, 2023, and the final revised disclosure to correct the error:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zrIeFQGHFK63" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B2_zalQH45DorYe" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SUPPLEMENTAL
DISCLOSURE OF NONCASH FINANCING ACTIVITIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230401__20230630_zDUmkvO9Pav2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As reported on Form 10-Q for the quarter ended June 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240401__20240630_zTiJTaglAq4j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As revised on&lt;br/&gt;
Form 10-Q&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Supplemental disclosure of noncash financing activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--NoncashOfferingCostsPaidByRelatedParty_zILkhYJtkzLb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Offering costs paid by related party&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;144,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;144,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NoncashPrepaidExpensesPaidByRelatedParty_zpSTUAqjtyp1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Prepaid expenses paid by related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NoncashOfferingCostsAdjustedFromPrepaidExpenses_zA7wCbaY8zRg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Offering costs adjusted from prepaid expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--NoncashOfferingCostsIncludedInAccruedExpenses_zzWV27yzB3p4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Offering costs included in accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,505&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,505&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_zyq3q4cuHGo6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Offering costs paid by Sponsor in exchange for issuance of ordinary shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--NonCashOfferingCostsChargedToAdditionalPaidinCapital_zEU2RD3p88W7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Offering costs charged to APIC &#x2013; EBC founder shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0745"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,013,480&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;


&lt;p id="xdx_8A8_zGyc7i1BEQZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000492">&lt;p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zDGTG5XmeChh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zUxqRnHjUOqj"&gt;Basis
of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#x201c;US GAAP&#x201d;) for interim financial information and in accordance with the instructions to
Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the unaudited financial statements reflect all adjustments, which
include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The
interim results for the period ended June 30, 2024 are not necessarily indicative of the results that may be expected through December
31, 2024. All intercompany accounts and transactions are eliminated upon consolidation. The information included in this Form 10-Q should
be read in conjunction with information included in the Company&#x2019;s annual report on Form 10-K for the year ended December 31, 2023,
filed with the Securities and Exchange Commission on March 29, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <BOWN:EmergingGrowthCompanyPolicyTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000494">&lt;p id="xdx_84D_ecustom--EmergingGrowthCompanyPolicyTextBlock_zSmJyp9e1Gmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_ztfXEU3hhLC5"&gt;Emerging
Growth Company&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#x201c;Securities
Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#x201c;JOBS Act&#x201d;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BOWN:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2024-01-01to2024-06-30" id="Fact000496">&lt;p id="xdx_84B_eus-gaap--UseOfEstimates_zd8txaf1Tr45" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_864_ziK8M0jpATv7"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the consolidated financial statement in conformity with US GAAP requires the Company&#x2019;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000498">&lt;p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zipcGUzRtCtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zNGkI8nRUxtd"&gt;Cash
and cash equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had a cash balance of $&lt;span id="xdx_902_eus-gaap--Cash_iI_pp0p0_c20240630_zAlO8iPeSzX7" title="Cash"&gt;272,630&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20231231_zmztkBWTdqn5" title="Cash"&gt;426,913&lt;/span&gt; as of June 30, 2024 and December 31, 2023, respectively. The Company had &lt;span id="xdx_909_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240630_z2CKN0fZxdza" title="Cash equivalents"&gt;&lt;span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zkEELsKcwKJ" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt; cash
equivalents as of June 30, 2024 and December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000500"
      unitRef="USD">272630</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000502"
      unitRef="USD">426913</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000504"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000506"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:InvestmentPolicyTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000508">&lt;p id="xdx_84D_eus-gaap--InvestmentPolicyTextBlock_zL5lotToLD14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zgn1LlvFy8Aj"&gt;Investments
Held in Trust Account&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s portfolio of investments held in the Trust Account is comprised of investments only in U.S. government securities with
a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which
invest only in direct U.S. government treasury obligations. The Company&#x2019;s investments held in the Trust Account are classified
as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains
and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable
securities held in Trust Account in the accompanying statements of operations. The estimated fair value of investments held in the Trust
Account is determined using available market information. As of June 30, 2024 and December 31, 2023, the Trust Account had balance of
$&lt;span id="xdx_907_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20240630_zTCSUZQOVlMi" title="Trust account balance"&gt;73,284,700&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231_zqPrkszMnHZc" title="Trust account balance"&gt;71,419,358&lt;/span&gt;, respectively. The interest and dividend income earned from the Trust Account totaled $&lt;span id="xdx_90B_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_pp0p0_c20240401__20240630_zsiiM69cBkFd" title="Interests earned from trust account"&gt;941,850&lt;/span&gt; and $&lt;span id="xdx_901_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_pp0p0_c20240101__20240630_zXYhRnbC0yXk" title="Interest and dividend income earned from trust account"&gt;1,865,342&lt;/span&gt;
for three and six months ended June 30, 2024, respectively, which were fully reinvested into the Trust Account as earned and unrealized
gain on investments and therefore presented as an adjustment to the operating activities in the Consolidated Statements of Cash Flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000510"
      unitRef="USD">73284700</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000512"
      unitRef="USD">71419358</us-gaap:AssetsHeldInTrustNoncurrent>
    <BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000514"
      unitRef="USD">941850</BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount>
    <BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000516"
      unitRef="USD">1865342</BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount>
    <BOWN:OfferingCostsPolicyTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000518">&lt;p id="xdx_84F_ecustom--OfferingCostsPolicyTextBlock_zJohv5TrH4Le" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zDoEB7BkwZVg"&gt;Offering
Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering
costs consist of legal and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that
are directly related to the IPO and that were charged to shareholders&#x2019; equity upon the completion of the IPO on July 14, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BOWN:OfferingCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000520">&lt;p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_z71YEBUcSXue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_869_zhUqkdxrCMji"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#x201c;&lt;i&gt;Income Taxes&lt;/i&gt;.&#x201d; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were &lt;span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20240630_zbzapixzmQ0k" title="Unrecognized tax benefits"&gt;&lt;span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zSaQfj8d9C6d" title="Unrecognized tax benefits"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits and &lt;span id="xdx_901_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20240630_zcLDqJZK7E8c" title="Interest and penalties accrued"&gt;&lt;span id="xdx_900_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20231231_z7FZkptnHQR8" title="Interest and penalties accrued"&gt;no&lt;/span&gt;&lt;/span&gt; amounts accrued for interest and penalties as of June 30, 2024
and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals,
or material deviation from its position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax
regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#x2019;s
consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000522"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000524"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000526"
      unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000528"
      unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000530">&lt;p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zlFO4bhF6Kk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zHGM35ZCbFJk"&gt;Net
Income (Loss) per Ordinary Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include
a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income
per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company
first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed
income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss)
ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement
of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public
shareholders. As of June 30, 2024 and 2023, the Company did not have any dilutive securities and other contracts that could, potentially,
be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per
share is the same as basic income (loss) per share for the period presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
net income (loss) per share presented in the statements of operations is based on the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zFiYCcWKe56f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zZaHA01dQnV4" style="display: none"&gt;SCHEDULE
OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20240401__20240630_zEPV8mzuxNO8" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230401__20230630_zgwKQxKgn7vh" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240101__20240630_zNbVNk9ZmBQe" style="text-align: center"&gt;&lt;b&gt;June 30,&lt;br/&gt;
    2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230217__20230630_zcd2NavKx0ld" style="text-align: center"&gt;&lt;b&gt;June 30, &lt;br/&gt;
    2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Three Months Ended June 30,&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;Six Months Ended&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;For the Period from February 17, 2023 through&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;June 30,&lt;br/&gt;
    2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;June 30, &lt;br/&gt;
    2023&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NetIncomeLoss_maNLIAOz10T_zbrmeHprLolh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Net income (loss)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;816,754&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0535"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,603,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(3,105&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz10T_zAbKlpGMN215" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accretion of temporary equity into redemption value (interest earned)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(941,850&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0540"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,865,342&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0542"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NetLossIncludingAccretionOfEquityIntoRedemptionValue_iT_mtNLIAOz10T_zuPmzF721cVd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net loss including accretion of equity into redemption value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(125,096&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0545"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(262,226&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(3,105&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zsq1envgUrs1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zNJHbGlybjOl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_z4YUe7BJfSVk" style="display: none"&gt;SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSBy0peTNeqd" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zHFJtctmQ7Af" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zrGeGu54Bja" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrUDxN5tolnh" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zoS3vQSHFBhl" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCvvcjVvYjp1" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zN0D5o5bki2k" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zco4vS2BZfp7" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    Three Months Ended&lt;br/&gt;
 June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    Six Months Ended &#160;&lt;br/&gt;
June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    Three Months Ended &lt;br/&gt;
June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the Period from &lt;br/&gt;
February 17, 2023 through &lt;br/&gt;
June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Particulars&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and
    diluted net income/(loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRlmacH7Veaj" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z7aUZCzHX6wh" title="Weighted average shares outstanding - diluted"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zOQnfAKWBQC4" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zw7LQikX1Owc" title="Weighted average shares outstanding - diluted"&gt;2,266,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zlAbDpzpBcE5" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zwdZB8aavyb4" title="Weighted average shares outstanding - diluted"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z4xwsqmQRZs5" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqoTpOOCEHOh" title="Weighted average shares outstanding - diluted"&gt;2,266,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zvYEr2B32Nu2" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zADwgPj1Bpz9" title="Weighted average shares outstanding - diluted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0567"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0569"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFN1VzmKwYAa" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFBwNIxZYrE8" title="Weighted average shares outstanding - diluted"&gt;1,680,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 11pt; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zfVl1CLuVOr" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_znOvNmn9lYB4" title="Weighted average shares outstanding - diluted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0575"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0577"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYEWjo6tCvF5" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zuALVTokWFIa" title="Weighted average shares outstanding - diluted"&gt;1,656,774&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ownership percentage&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--OwnershipPercentage_pid_dp_uPure_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRX0VSo5MI3e" title="Ownership percentage"&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--OwnershipPercentage_pid_dp_uPure_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zI77K3HjvqZd" title="Ownership percentage"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zcTLuYDNbyS5" title="Ownership percentage"&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zq3nXiuDFsM3" title="Ownership percentage"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zz6QDtUW3A9l" title="Ownership percentage"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0591"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zd3pzYuFsn3k" title="Ownership percentage"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zzQDZ6b20zb" title="Ownership percentage"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0595"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFLbzzGvCPba" title="Ownership percentage"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Numerators:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zshkQfUYiUi6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation of net loss including
    accretion of temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(94,165&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(30,931&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(197,388&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(64,838&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0603"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0604"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0605"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,105&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_z6JeXvyniSQ4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    earned on investment held in trust account&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;941,850&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0609"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,865,342&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0611"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0612"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0613"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0614"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0615"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLoss_znOk6211LrT4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation of net income/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;847,685&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(30,931&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,667,954&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(64,838&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0621"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0622"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0623"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,105&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominators:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted-average shares
    outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQzV0IDvSyj2" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zOT1zbMGB639" title="Weighted average shares outstanding - diluted"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_ze0K9wVa10dd" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zcDkDRb7KoM2" title="Weighted average shares outstanding - diluted"&gt;2,266,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zYvu0Nr3kbJf" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zGimqSbrnS3g" title="Weighted average shares outstanding - diluted"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMUgytbR5TI3" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zC3p20bgWXld" title="Weighted average shares outstanding - diluted"&gt;2,266,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zyptN8z7J0zk" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zC95eqOTAu9k" title="Weighted average shares outstanding - diluted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0642"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0644"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zbyRYDgivH3e" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zXbDy5TMdmMb" title="Weighted average shares outstanding - diluted"&gt;1,680,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTdaJvG0QYge" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z9t6Q9aH3u9i" title="Weighted average shares outstanding - diluted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0650"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0652"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z34tVg8XqKUi" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYR4raUHLa09" title="Weighted-average shares outstanding - diluted"&gt;1,656,774&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
    and diluted net income/(loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z34oXUuyBQ39" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zvLOYwYGlhe1" title="Diluted net income/(loss) per share"&gt;0.12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zuL9mXv5DD1l" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrvsnXUJxtbj" title="Diluted net income/(loss) per share"&gt;(0.01&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQpX6slT0dG2" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zG7Oo29qJ0Wc" title="Diluted net income/(loss) per share"&gt;0.24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zJDyTrubNsA" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zzlN34jafbG5" title="Diluted net income/(loss) per share"&gt;(0.03&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zg0u4HGHo3va" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zdFuSn87WLE2" title="Diluted net income/(loss) per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0674"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0676"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zhEKTZF2Z2Pd" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zsHEHZzJIhbc" title="Diluted net income/(loss) per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0678"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0680"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z6KC1AJBXhJc" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zA2v4GYzuEPk" title="Diluted net income/(loss) per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0682"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0684"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_za6AczHeao4j" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zKdoRSOAcBi4" title="Diluted net income/(loss) per share"&gt;(0.002&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p id="xdx_8AE_z9AwGfR5raC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <srt:ScheduleOfCondensedIncomeStatementTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000532">&lt;p id="xdx_89F_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zFiYCcWKe56f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zZaHA01dQnV4" style="display: none"&gt;SCHEDULE
OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20240401__20240630_zEPV8mzuxNO8" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230401__20230630_zgwKQxKgn7vh" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240101__20240630_zNbVNk9ZmBQe" style="text-align: center"&gt;&lt;b&gt;June 30,&lt;br/&gt;
    2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230217__20230630_zcd2NavKx0ld" style="text-align: center"&gt;&lt;b&gt;June 30, &lt;br/&gt;
    2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Three Months Ended June 30,&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;Six Months Ended&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;For the Period from February 17, 2023 through&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;June 30,&lt;br/&gt;
    2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;June 30, &lt;br/&gt;
    2023&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NetIncomeLoss_maNLIAOz10T_zbrmeHprLolh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Net income (loss)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;816,754&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0535"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,603,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(3,105&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz10T_zAbKlpGMN215" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accretion of temporary equity into redemption value (interest earned)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(941,850&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0540"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,865,342&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0542"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NetLossIncludingAccretionOfEquityIntoRedemptionValue_iT_mtNLIAOz10T_zuPmzF721cVd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net loss including accretion of equity into redemption value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(125,096&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0545"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(262,226&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(3,105&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</srt:ScheduleOfCondensedIncomeStatementTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000534"
      unitRef="USD">816754</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000536"
      unitRef="USD">1603116</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000537"
      unitRef="USD">-3105</us-gaap:NetIncomeLoss>
    <BOWN:AccretionOfTemporaryEquityIntoRedemptionValue
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000539"
      unitRef="USD">941850</BOWN:AccretionOfTemporaryEquityIntoRedemptionValue>
    <BOWN:AccretionOfTemporaryEquityIntoRedemptionValue
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000541"
      unitRef="USD">1865342</BOWN:AccretionOfTemporaryEquityIntoRedemptionValue>
    <BOWN:NetLossIncludingAccretionOfEquityIntoRedemptionValue
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000544"
      unitRef="USD">-125096</BOWN:NetLossIncludingAccretionOfEquityIntoRedemptionValue>
    <BOWN:NetLossIncludingAccretionOfEquityIntoRedemptionValue
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000546"
      unitRef="USD">-262226</BOWN:NetLossIncludingAccretionOfEquityIntoRedemptionValue>
    <BOWN:NetLossIncludingAccretionOfEquityIntoRedemptionValue
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000547"
      unitRef="USD">-3105</BOWN:NetLossIncludingAccretionOfEquityIntoRedemptionValue>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000549">&lt;p id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zNJHbGlybjOl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_z4YUe7BJfSVk" style="display: none"&gt;SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSBy0peTNeqd" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zHFJtctmQ7Af" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zrGeGu54Bja" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrUDxN5tolnh" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zoS3vQSHFBhl" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCvvcjVvYjp1" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zN0D5o5bki2k" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zco4vS2BZfp7" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    Three Months Ended&lt;br/&gt;
 June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    Six Months Ended &#160;&lt;br/&gt;
June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    Three Months Ended &lt;br/&gt;
June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the Period from &lt;br/&gt;
February 17, 2023 through &lt;br/&gt;
June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Redeemable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Particulars&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and
    diluted net income/(loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRlmacH7Veaj" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z7aUZCzHX6wh" title="Weighted average shares outstanding - diluted"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zOQnfAKWBQC4" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zw7LQikX1Owc" title="Weighted average shares outstanding - diluted"&gt;2,266,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zlAbDpzpBcE5" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zwdZB8aavyb4" title="Weighted average shares outstanding - diluted"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z4xwsqmQRZs5" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqoTpOOCEHOh" title="Weighted average shares outstanding - diluted"&gt;2,266,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zvYEr2B32Nu2" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zADwgPj1Bpz9" title="Weighted average shares outstanding - diluted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0567"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0569"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFN1VzmKwYAa" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFBwNIxZYrE8" title="Weighted average shares outstanding - diluted"&gt;1,680,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 11pt; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zfVl1CLuVOr" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_znOvNmn9lYB4" title="Weighted average shares outstanding - diluted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0575"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0577"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYEWjo6tCvF5" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zuALVTokWFIa" title="Weighted average shares outstanding - diluted"&gt;1,656,774&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ownership percentage&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--OwnershipPercentage_pid_dp_uPure_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRX0VSo5MI3e" title="Ownership percentage"&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--OwnershipPercentage_pid_dp_uPure_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zI77K3HjvqZd" title="Ownership percentage"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zcTLuYDNbyS5" title="Ownership percentage"&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--OwnershipPercentage_pid_dp_uPure_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zq3nXiuDFsM3" title="Ownership percentage"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zz6QDtUW3A9l" title="Ownership percentage"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0591"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--OwnershipPercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zd3pzYuFsn3k" title="Ownership percentage"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zzQDZ6b20zb" title="Ownership percentage"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0595"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zFLbzzGvCPba" title="Ownership percentage"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Numerators:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zshkQfUYiUi6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation of net loss including
    accretion of temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(94,165&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(30,931&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(197,388&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(64,838&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0603"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0604"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0605"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,105&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--InterestEarnedOnInvestmentsHeldInTrustAccount_z6JeXvyniSQ4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    earned on investment held in trust account&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;941,850&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0609"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,865,342&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0611"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0612"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0613"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0614"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0615"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLoss_znOk6211LrT4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation of net income/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;847,685&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(30,931&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,667,954&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(64,838&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0621"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0622"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0623"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,105&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominators:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted-average shares
    outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQzV0IDvSyj2" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zOT1zbMGB639" title="Weighted average shares outstanding - diluted"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_ze0K9wVa10dd" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zcDkDRb7KoM2" title="Weighted average shares outstanding - diluted"&gt;2,266,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zYvu0Nr3kbJf" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zGimqSbrnS3g" title="Weighted average shares outstanding - diluted"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMUgytbR5TI3" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zC3p20bgWXld" title="Weighted average shares outstanding - diluted"&gt;2,266,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zyptN8z7J0zk" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zC95eqOTAu9k" title="Weighted average shares outstanding - diluted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0642"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0644"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zbyRYDgivH3e" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zXbDy5TMdmMb" title="Weighted average shares outstanding - diluted"&gt;1,680,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTdaJvG0QYge" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z9t6Q9aH3u9i" title="Weighted average shares outstanding - diluted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0650"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0652"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z34tVg8XqKUi" title="Weighted-average shares outstanding - basic"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYR4raUHLa09" title="Weighted-average shares outstanding - diluted"&gt;1,656,774&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
    and diluted net income/(loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z34oXUuyBQ39" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zvLOYwYGlhe1" title="Diluted net income/(loss) per share"&gt;0.12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zuL9mXv5DD1l" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrvsnXUJxtbj" title="Diluted net income/(loss) per share"&gt;(0.01&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zQpX6slT0dG2" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zG7Oo29qJ0Wc" title="Diluted net income/(loss) per share"&gt;0.24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zJDyTrubNsA" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zzlN34jafbG5" title="Diluted net income/(loss) per share"&gt;(0.03&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zg0u4HGHo3va" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zdFuSn87WLE2" title="Diluted net income/(loss) per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0674"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0676"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zhEKTZF2Z2Pd" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zsHEHZzJIhbc" title="Diluted net income/(loss) per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0678"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0680"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z6KC1AJBXhJc" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zA2v4GYzuEPk" title="Diluted net income/(loss) per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0682"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0684"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_za6AczHeao4j" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20230630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zKdoRSOAcBi4" title="Diluted net income/(loss) per share"&gt;(0.002&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000551"
      unitRef="Shares">6900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000553"
      unitRef="Shares">6900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000555"
      unitRef="Shares">2266500</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000557"
      unitRef="Shares">2266500</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000559"
      unitRef="Shares">6900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000561"
      unitRef="Shares">6900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000563"
      unitRef="Shares">2266500</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000565"
      unitRef="Shares">2266500</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000571"
      unitRef="Shares">1680000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000573"
      unitRef="Shares">1680000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000579"
      unitRef="Shares">1656774</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000581"
      unitRef="Shares">1656774</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <BOWN:OwnershipPercentage
      contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000583"
      unitRef="Pure">0.75</BOWN:OwnershipPercentage>
    <BOWN:OwnershipPercentage
      contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000585"
      unitRef="Pure">0.25</BOWN:OwnershipPercentage>
    <BOWN:OwnershipPercentage
      contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000587"
      unitRef="Pure">0.75</BOWN:OwnershipPercentage>
    <BOWN:OwnershipPercentage
      contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000589"
      unitRef="Pure">0.25</BOWN:OwnershipPercentage>
    <BOWN:OwnershipPercentage
      contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000593"
      unitRef="Pure">1</BOWN:OwnershipPercentage>
    <BOWN:OwnershipPercentage
      contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000597"
      unitRef="Pure">1</BOWN:OwnershipPercentage>
    <BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity
      contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember"
      decimals="0"
      id="Fact000599"
      unitRef="USD">-94165</BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity>
    <BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity
      contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="0"
      id="Fact000600"
      unitRef="USD">-30931</BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity>
    <BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity
      contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember"
      decimals="0"
      id="Fact000601"
      unitRef="USD">-197388</BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity>
    <BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity
      contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="0"
      id="Fact000602"
      unitRef="USD">-64838</BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity>
    <BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity
      contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember"
      decimals="0"
      id="Fact000606"
      unitRef="USD">-3105</BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity>
    <BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount
      contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember"
      decimals="0"
      id="Fact000608"
      unitRef="USD">941850</BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount>
    <BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount
      contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember"
      decimals="0"
      id="Fact000610"
      unitRef="USD">1865342</BOWN:InterestEarnedOnInvestmentsHeldInTrustAccount>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember"
      decimals="0"
      id="Fact000617"
      unitRef="USD">847685</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="0"
      id="Fact000618"
      unitRef="USD">-30931</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember"
      decimals="0"
      id="Fact000619"
      unitRef="USD">1667954</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="0"
      id="Fact000620"
      unitRef="USD">-64838</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember"
      decimals="0"
      id="Fact000624"
      unitRef="USD">-3105</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000626"
      unitRef="Shares">6900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000628"
      unitRef="Shares">6900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000630"
      unitRef="Shares">2266500</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000632"
      unitRef="Shares">2266500</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000634"
      unitRef="Shares">6900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000636"
      unitRef="Shares">6900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000638"
      unitRef="Shares">2266500</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000640"
      unitRef="Shares">2266500</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000646"
      unitRef="Shares">1680000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-04-012023-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000648"
      unitRef="Shares">1680000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000654"
      unitRef="Shares">1656774</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000656"
      unitRef="Shares">1656774</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000658"
      unitRef="USDPShares">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-04-012024-06-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000660"
      unitRef="USDPShares">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000662"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-04-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000664"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000666"
      unitRef="USDPShares">0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-012024-06-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000668"
      unitRef="USDPShares">0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000670"
      unitRef="USDPShares">-0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-012024-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000672"
      unitRef="USDPShares">-0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000686"
      unitRef="USDPShares">-0.002</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-02-172023-06-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000688"
      unitRef="USDPShares">-0.002</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2024-01-01to2024-06-30" id="Fact000690">&lt;p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_z3lZhr9911K6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zPYpyu6KgvTj"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $&lt;span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_c20240630_z3L1nYZwLMTb" title="Cash FDIC insured amount"&gt;250,000&lt;/span&gt;. The Company has not experienced losses on these accounts
and management believes the Company is not exposed to significant risks on such accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000692"
      unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2024-01-01to2024-06-30" id="Fact000694">&lt;p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zcJebipTI21i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_z7zkLhnilQEl"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC 820, &#x201c;&lt;i&gt;Fair Value
Measurement&lt;/i&gt;,&#x201d; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000696">&lt;p id="xdx_84D_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zVKEDCaCr3jb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zRwInfBS5jUe"&gt;Ordinary
Shares Subject to Possible Redemption&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Ordinary shares subject to mandatory redemption (if
any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary
shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, ordinary shares
are classified as shareholders&#x2019; equity. The Company&#x2019;s ordinary shares features certain redemption rights that are considered
to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject
to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; equity section of the
Company&#x2019;s balance sheet. &lt;span style="background-color: white"&gt;The Company recognizes changes in redemption value immediately as
they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.
Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital
and accumulated deficit.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zGAuRR7PPSeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2023 and June 30, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are
reconciled in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zpc5XAu9ccQg" style="display: none"&gt;SCHEDULE
OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 84%; text-align: left"&gt;Public offering proceeds&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPTO3JbwgL46" style="width: 12%; text-align: right" title="Public offering proceeds"&gt;60,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zC2iWnioAnWf" style="text-align: right" title="Proceeds allocated to public rights"&gt;(3,272,724&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3GYLMyaZGMg" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(2,925,140&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3ebkpA4pQAi" style="text-align: right" title="Accretion of carrying value to redemption value"&gt;6,797,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Ordinary shares subject to possible redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20230101__20231231_zMmdN8mzOY43" style="text-align: right" title="Ordinary shares subject to possible redemption"&gt;60,600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic"&gt;Over-allotment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Over-allotment proceeds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ProceedsFromOtherEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zhdg83vT3Rme" style="text-align: right" title="Over-allotment proceeds"&gt;9,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z6J18rD4Rk1b" style="text-align: right" title="Proceeds allocated to Public Rights"&gt;(490,909&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zojTNcHsWDO" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(212,727&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zHWQ4CTJT1de" style="text-align: right" title="Accretion of carrying value to redemption value"&gt;793,636&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zim6byzjMXwh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"&gt;1,729,358&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Ordinary shares subject to possible redemption, December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20240101__20240630_z6P1opG3tZBi" style="font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemption"&gt;71,419,358&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Subsequent
    measurement of ordinary shares subject to possible redemption (income earned on trust account)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20240101__20240630_zGjItKI6Dbd7" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;1,865,342&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Ordinary
    shares subject to possible redemption, June 30, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iE_c20240101__20240630_zwYfAIm1ZNUh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;73,284,700&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_z6s9ZdWbnonf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <BOWN:ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000698">&lt;p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zGAuRR7PPSeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2023 and June 30, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are
reconciled in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zpc5XAu9ccQg" style="display: none"&gt;SCHEDULE
OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 84%; text-align: left"&gt;Public offering proceeds&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPTO3JbwgL46" style="width: 12%; text-align: right" title="Public offering proceeds"&gt;60,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zC2iWnioAnWf" style="text-align: right" title="Proceeds allocated to public rights"&gt;(3,272,724&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3GYLMyaZGMg" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(2,925,140&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3ebkpA4pQAi" style="text-align: right" title="Accretion of carrying value to redemption value"&gt;6,797,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Ordinary shares subject to possible redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20230101__20231231_zMmdN8mzOY43" style="text-align: right" title="Ordinary shares subject to possible redemption"&gt;60,600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic"&gt;Over-allotment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Over-allotment proceeds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ProceedsFromOtherEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zhdg83vT3Rme" style="text-align: right" title="Over-allotment proceeds"&gt;9,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z6J18rD4Rk1b" style="text-align: right" title="Proceeds allocated to Public Rights"&gt;(490,909&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zojTNcHsWDO" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(212,727&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zHWQ4CTJT1de" style="text-align: right" title="Accretion of carrying value to redemption value"&gt;793,636&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zim6byzjMXwh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"&gt;1,729,358&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Ordinary shares subject to possible redemption, December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20240101__20240630_z6P1opG3tZBi" style="font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemption"&gt;71,419,358&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Subsequent
    measurement of ordinary shares subject to possible redemption (income earned on trust account)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20240101__20240630_zGjItKI6Dbd7" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;1,865,342&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Ordinary
    shares subject to possible redemption, June 30, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iE_c20240101__20240630_zwYfAIm1ZNUh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;73,284,700&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BOWN:ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-01-012023-12-31_us-gaap_IPOMember"
      decimals="0"
      id="Fact000700"
      unitRef="USD">60000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2023-01-012023-12-31_us-gaap_IPOMember"
      decimals="0"
      id="Fact000702"
      unitRef="USD">-3272724</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:OfferingCostsPartnershipInterests
      contextRef="AsOf2023-12-31_us-gaap_IPOMember"
      decimals="0"
      id="Fact000704"
      unitRef="USD">2925140</us-gaap:OfferingCostsPartnershipInterests>
    <BOWN:AccretionOfCarryingValueToRedemptionValue
      contextRef="From2023-01-012023-12-31_us-gaap_IPOMember"
      decimals="0"
      id="Fact000706"
      unitRef="USD">6797864</BOWN:AccretionOfCarryingValueToRedemptionValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000708"
      unitRef="USD">60600000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2023-01-012023-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact000710"
      unitRef="USD">9000000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2023-01-012023-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact000712"
      unitRef="USD">-490909</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:OfferingCostsPartnershipInterests
      contextRef="AsOf2023-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact000714"
      unitRef="USD">212727</us-gaap:OfferingCostsPartnershipInterests>
    <BOWN:AccretionOfCarryingValueToRedemptionValue
      contextRef="From2023-01-012023-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact000716"
      unitRef="USD">793636</BOWN:AccretionOfCarryingValueToRedemptionValue>
    <BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2023-01-012023-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact000718"
      unitRef="USD">1729358</BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000720"
      unitRef="USD">71419358</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000722"
      unitRef="USD">1865342</BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000724"
      unitRef="USD">73284700</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000726">&lt;p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zvlTHZ2lITda" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zCZJ7hRWs7j2"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000728">&lt;p id="xdx_898_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zrIeFQGHFK63" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B2_zalQH45DorYe" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SUPPLEMENTAL
DISCLOSURE OF NONCASH FINANCING ACTIVITIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230401__20230630_zDUmkvO9Pav2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As reported on Form 10-Q for the quarter ended June 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240401__20240630_zTiJTaglAq4j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As revised on&lt;br/&gt;
Form 10-Q&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Supplemental disclosure of noncash financing activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--NoncashOfferingCostsPaidByRelatedParty_zILkhYJtkzLb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Offering costs paid by related party&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;144,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;144,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NoncashPrepaidExpensesPaidByRelatedParty_zpSTUAqjtyp1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Prepaid expenses paid by related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NoncashOfferingCostsAdjustedFromPrepaidExpenses_zA7wCbaY8zRg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Offering costs adjusted from prepaid expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--NoncashOfferingCostsIncludedInAccruedExpenses_zzWV27yzB3p4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Offering costs included in accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,505&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,505&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares_zyq3q4cuHGo6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Offering costs paid by Sponsor in exchange for issuance of ordinary shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--NonCashOfferingCostsChargedToAdditionalPaidinCapital_zEU2RD3p88W7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Offering costs charged to APIC &#x2013; EBC founder shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0745"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,013,480&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;


</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <BOWN:NoncashOfferingCostsPaidByRelatedParty
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000730"
      unitRef="USD">144108</BOWN:NoncashOfferingCostsPaidByRelatedParty>
    <BOWN:NoncashOfferingCostsPaidByRelatedParty
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000731"
      unitRef="USD">144108</BOWN:NoncashOfferingCostsPaidByRelatedParty>
    <BOWN:NoncashPrepaidExpensesPaidByRelatedParty
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000733"
      unitRef="USD">1600</BOWN:NoncashPrepaidExpensesPaidByRelatedParty>
    <BOWN:NoncashPrepaidExpensesPaidByRelatedParty
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000734"
      unitRef="USD">1600</BOWN:NoncashPrepaidExpensesPaidByRelatedParty>
    <BOWN:NoncashOfferingCostsAdjustedFromPrepaidExpenses
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000736"
      unitRef="USD">639</BOWN:NoncashOfferingCostsAdjustedFromPrepaidExpenses>
    <BOWN:NoncashOfferingCostsAdjustedFromPrepaidExpenses
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000737"
      unitRef="USD">639</BOWN:NoncashOfferingCostsAdjustedFromPrepaidExpenses>
    <BOWN:NoncashOfferingCostsIncludedInAccruedExpenses
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000739"
      unitRef="USD">2505</BOWN:NoncashOfferingCostsIncludedInAccruedExpenses>
    <BOWN:NoncashOfferingCostsIncludedInAccruedExpenses
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000740"
      unitRef="USD">2505</BOWN:NoncashOfferingCostsIncludedInAccruedExpenses>
    <BOWN:NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000742"
      unitRef="USD">25000</BOWN:NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares>
    <BOWN:NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000743"
      unitRef="USD">25000</BOWN:NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares>
    <BOWN:NonCashOfferingCostsChargedToAdditionalPaidinCapital
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000746"
      unitRef="USD">1013480</BOWN:NonCashOfferingCostsChargedToAdditionalPaidinCapital>
    <BOWN:InitialPublicOfferingTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000748">&lt;p id="xdx_80C_ecustom--InitialPublicOfferingTextBlock_zQN4fgvRk3Fg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3 &#x2014; &lt;span id="xdx_82C_zvmZL6zwQNOj"&gt;INITIAL PUBLIC OFFERING&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 14, 2023, the Company sold &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ziNBSwTUyVal" title="Stock issued during period shares"&gt;6,000,000&lt;/span&gt; Units at a price of $&lt;span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zAIhRA4mUEN7" title="Sale of stock, par share"&gt;10.00&lt;/span&gt; per Unit. &lt;span id="xdx_905_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zSh5Bk8iblQ4" title="Units related to initial public offering description"&gt;Each Unit consists of one ordinary share and one right
to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company&#x2019;s initial Business Combination. Ten Public
Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares
will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional
shares underlying the rights&lt;/span&gt;. The Company also granted the underwriters a 45-day option to purchase up to an additional &lt;span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_z9RlZCZnFcSc" title="Stock issued during the period, shares"&gt;900,000&lt;/span&gt; units
to cover over-allotments. The over-allotment was subsequently fully exercised on July 17, 2023. See Note 1 for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BOWN:InitialPublicOfferingTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-142023-07-14_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000750"
      unitRef="Shares">6000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-07-14_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000752"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockDescriptionOfTransaction
      contextRef="From2023-07-142023-07-14_us-gaap_IPOMember"
      id="Fact000754">Each Unit consists of one ordinary share and one right
to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company&#x2019;s initial Business Combination. Ten Public
Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares
will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional
shares underlying the rights</us-gaap:SaleOfStockDescriptionOfTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-07-142023-07-14_us-gaap_OverAllotmentOptionMember_srt_MaximumMember"
      decimals="INF"
      id="Fact000756"
      unitRef="Shares">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <BOWN:PrivatePlacementsTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000758">&lt;p id="xdx_808_ecustom--PrivatePlacementsTextBlock_zSuAeT4mq32e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4 &#x2014; &lt;span id="xdx_826_zkjgIAqZ1Sxf"&gt;PRIVATE PLACEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsors and EBC had agreed to purchase an aggregate of &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zMXlx0qQXuGa" title="Number of shares issued"&gt;330,000&lt;/span&gt; Private Placement Units (&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorsMember_z8uyaXrHNnPb" title="Number of shares issued"&gt;312,000&lt;/span&gt; Private Placement Units to be purchased
by the Sponsors and &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--EBCMember_zy0I1mPXndQ1" title="Number of shares issued"&gt;18,000&lt;/span&gt; Private Placement Units to be purchased by EBC or its designees), or &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_z75nPHOfjBYl" title="Number of shares issued"&gt;361,500&lt;/span&gt; Private Placement Units if the
underwriters&#x2019; over-allotment is exercised in full, at a price of $&lt;span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zdJXxhSitFPf" title="Unit exercise price per share"&gt;10.00&lt;/span&gt; per Private Placement Unit ($&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zoojZRuJhkyk" title="Value of stock issued"&gt;3,300,000&lt;/span&gt;, or an aggregate
of $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zHmhlGb5hN3f" title="Value of stock issued"&gt;3,615,000&lt;/span&gt; if the underwriters&#x2019; over-allotment is exercised in full) from the Company in a private placement that will occur
simultaneously with the closing of the Initial Public Offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the IPO on July 14, 2023, the Company consummated the private sale of &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zPvRTKkuTfjj" title="Number of shares issued"&gt;330,000&lt;/span&gt; Private Placement Units. &lt;span id="xdx_903_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z8nQtTj8eqre" title="Units related to private placement description"&gt;Each
Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the
consummation of the Company&#x2019;s initial Business Combination.&lt;/span&gt; The proceeds from the sale of the Private Placement Units were
added to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the
Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the
redemption of the Public Shares (subject to the requirements of applicable law). The Private Placement Units (including the
underlying securities) will not be transferable, assignable, or salable until the completion of a Business Combination, subject to
certain exceptions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 17, 2023, the underwriters exercised the over-allotment option in full. See Note 1 for more details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BOWN:PrivatePlacementsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000760"
      unitRef="Shares">330000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember_custom_SponsorsMember"
      decimals="INF"
      id="Fact000762"
      unitRef="Shares">312000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember_custom_EBCMember"
      decimals="INF"
      id="Fact000764"
      unitRef="Shares">18000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember_custom_UnderwritersMember"
      decimals="INF"
      id="Fact000766"
      unitRef="Shares">361500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-07-14_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000768"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact000770"
      unitRef="USD">3300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember_custom_UnderwritersMember"
      decimals="0"
      id="Fact000772"
      unitRef="USD">3615000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000774"
      unitRef="Shares">330000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockDescriptionOfTransaction
      contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember"
      id="Fact000776">Each
Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the
consummation of the Company&#x2019;s initial Business Combination.</us-gaap:SaleOfStockDescriptionOfTransaction>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000778">&lt;p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z3GywOdgSHI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5 &#x2014; &lt;span id="xdx_82A_zaXgTC9OiXe4"&gt;RELATED PARTIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Founder
Shares and EBC Founder Shares&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 27, 2023, the Sponsors received &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zglblFNDvW7d" title="Number of shares issued"&gt;1,725,000&lt;/span&gt; of the Company&#x2019;s ordinary shares (&#x201c;Founder Shares&#x201d;) in exchange
for $&lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zkZoz5c7plq9" title="Sponsors received ordinary shares, value"&gt;25,000&lt;/span&gt; paid for offering costs borne by the Sponsors. Up to &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zVcODg9xyeBc" title="Number of shares subject to forfeiture"&gt;225,000&lt;/span&gt; of such Founder Shares were subject to forfeiture to the extent
that the underwriters&#x2019; over-allotment was not exercised in full. On July 17, 2023, the underwriters exercised their over-allotment option in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 15, 2023, the Company issued to EBC &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zVWcQHN6JEha" title="Number of shares issued"&gt;180,000&lt;/span&gt; ordinary shares (&#x201c;EBC founder shares&#x201d;) for a purchase price of $&lt;span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zp3zDrlFqLY4" title="Ordinary share price"&gt;0.014&lt;/span&gt; per
share and an aggregate purchase price of $&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zOcA9RsGMA3h" title="Value of stock issued"&gt;2,520&lt;/span&gt;. The EBC founder shares are deemed to be underwriters&#x2019; compensation by FINRA pursuant
to Rule 5110 of the FINRA Manual. The Company estimated the fair value of the EBC founder shares to be approximately $&lt;span id="xdx_908_eus-gaap--DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zYPoSV8plTk1" title="Fair value of shares issued"&gt;1,016,000&lt;/span&gt; or $&lt;span id="xdx_90E_eus-gaap--SharePrice_iI_pid_c20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zaU5F0wQ6GYd" title="Fair value of ordinary per share price"&gt;5.65
&lt;/span&gt;per share using the Black-Scholes option pricing model. The Company accounted for the difference between the par value and fair value
of the shares as offering cost.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zOCn0l1Ycqmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair
value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zJYUcGy76vr" style="display: none"&gt;SCHEDULE
OF ASSUMPTIONS TO ESTIMATE FAIR VALUE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 84%; text-align: left"&gt;Time to expiration&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--EquitySecuritiesFvNiTerm_dtY_c20230315__20230315_zLaPy9wr7i8a" title="Time to expiration"&gt;1.84&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_ziZuy1TovcP6" title="Risk-free rate"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zh5axFQLqyh7" title="Risk-free rate"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zgEwwIudNqN1" title="Risk-free rate"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Probability of completion of business combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember_zRD7Tcv0CwE5" title="Founder shares measurement input"&gt;60.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zjmPdDVpjt96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur
of: (A) six months after the completion of the initial Business Combination and (B) the date on which the Company completes a liquidation,
merger, share exchange, reorganization or other similar transaction after an initial Business Combination that results in all of the
Company&#x2019;s public shareholders having the right to exchange their ordinary shares for cash, securities or other property. EBC has
also agreed, subject to exceptions, that the EBC founder shares cannot be sold, transferred or assigned, until the consummation of an
initial business combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Promissory
Note&#x2009;&#x2014;&#x2009;Related Party&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 27, 2023, the Sponsors issued an unsecured promissory note to the Company (the &#x201c;Promissory Note&#x201d;), pursuant to which
the Company may borrow up to an aggregate principal amount of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20230227__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorsMember_z6PXcjJFr5V7" title="Promissory note aggregate principal amount"&gt;300,000&lt;/span&gt;. The Promissory Note was non-interest bearing and payable on the
earlier of (i) December 31, 2023, or (ii) the consummation of the IPO. The Promissory Note expired on &lt;span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20230227__20230227__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorsMember_zBMTlxby19xa" title="Promissory note maturity date"&gt;July 14, 2023&lt;/span&gt;. As of June 30, 2024
and December 31, 2023, there were &lt;span id="xdx_902_eus-gaap--NotesPayable_iI_do_c20240630__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember_zMGyFeQuVqGa" title="Notes outstanding amount"&gt;&lt;span id="xdx_902_eus-gaap--NotesPayable_iI_do_c20231231__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember_zGFILMtmypLk" title="Notes outstanding amount"&gt;no&lt;/span&gt;&lt;/span&gt; amounts outstanding under the Promissory Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Underwriting
Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company granted the underwriters a 45-day option from the date of IPO to purchase up to &lt;span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zvvNXvDisHv5" title="Stock issued during the period, shares"&gt;900,000&lt;/span&gt; additional Units to cover over-allotments,
at the IPO price less the underwriting discounts and commissions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
underwriters were entitled to a cash underwriting discount of $&lt;span id="xdx_90E_ecustom--CashUnderwritingDiscountPerUnit_pid_c20240101__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zFo1GPhiffRg" title="Cash underwriting discount per unit"&gt;0.25&lt;/span&gt; per Unit, or $&lt;span id="xdx_90C_ecustom--CashUnderwritingDiscount_pid_c20240101__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zGRUy9PNOYw7" title="Aggregate cash underwriting discount"&gt;1,500,000&lt;/span&gt; in the aggregate (or $&lt;span id="xdx_90C_eus-gaap--PaymentsForUnderwritingExpense_pid_c20240101__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zQtc3S5fKzq5" title="Payments for underwriting expense"&gt;1,725,000&lt;/span&gt; in the aggregate
if the underwriters&#x2019; over-allotment option is exercised in full), payable upon the closing of the IPO.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 17, 2023, the underwriters exercised the over-allotment option in full to purchase &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230717__20230717__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zXGXoLPdIJE" title="Number of stock issued"&gt;900,000&lt;/span&gt; Units. As a result, on July 18, 2023,
the Company sold an additional &lt;span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zaMFNVboA7p6" title="Number of units sold"&gt;900,000&lt;/span&gt; Units at $&lt;span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zYUYa8VCiJ1l" title="Sale of stock price per unit"&gt;10.00&lt;/span&gt; per Unit, generating gross proceeds to the Company of $&lt;span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_ziu6bwz3pv3d" title="Proceeds from sale of units"&gt;9,000,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Due
to Related Party&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsors paid certain formation, operating or offering costs on behalf of the Company. These amounts were due on demand and non-interest
bearing. As of June 30, 2024, the Sponsors had paid $&lt;span id="xdx_901_eus-gaap--OtherLiabilitiesCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zh40yas4j7Jl" title="Due to related party"&gt;151,318&lt;/span&gt; on behalf of the Company for expenses related to IPO, which was fully repaid
upon closing of the IPO on July 14, 2023 out of the offering proceeds held in trust account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2024 and December 31, 2023, the total accrued expenses due to related parties was $&lt;span id="xdx_902_eus-gaap--AccruedLiabilitiesCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHgUxc2wuXme" title="Accrued expenses"&gt;30,000&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z4AFaZSrMok2" title="Accrued expenses"&gt;25,250&lt;/span&gt;, respectively. See
following paragraphs for details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Initial
Accounting Service Fee&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has engaged TenX Global Capital, a related party of the Company, to assist in the preparation of financial statements and other
accounting consulting services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
initial accounting service fee was only related with the initial accounting preparation which was incurred in the period from February
17, 2023 (inception) to March 31, 2023 with total amount of $&lt;span id="xdx_90B_eus-gaap--ProfessionalFees_c20230217__20230331__dei--LegalEntityAxis__custom--TenXGlobalCapitalMember_zRvuXhchtJ5l" title="Accounting service fee"&gt;10,000&lt;/span&gt;. There was no such cost in the subsequent periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Accounting
Service Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has engaged TenX Global Capital, a related party of the Company, to assist in preparing quarterly and annual financial statements
commencing following the consummation of the IPO. The Company has agreed to pay for these services at a fixed quarterly rate of $&lt;span id="xdx_908_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20230714__20230714__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zOX2X97FTQb3" title="Accounting service fee payable per quarter"&gt;5,250&lt;/span&gt;
each quarter. For three months ended June 30, 2024 and 2023, a service fee of $&lt;span id="xdx_905_eus-gaap--ProfessionalFees_c20240401__20240630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_z2a0wkbhHnch" title="Accrued liabilities"&gt;5,250&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--ProfessionalFees_c20230401__20230630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_z4qlek3Fzw52" title="Accrued liabilities"&gt;0&lt;/span&gt; has been accrued and paid for these services.
For six months ended June 30, 2024 and during the period from February 17, 2023 (inception) through June 30, 2023, service fee of $&lt;span id="xdx_90E_eus-gaap--ProfessionalFees_c20240101__20240630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zByW5qAe5wb3" title="Service fee"&gt;10,500&lt;/span&gt;
and $&lt;span id="xdx_909_eus-gaap--ProfessionalFees_c20230217__20230630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_z1LzqKOYjc84" title="Accounting service fee"&gt;0&lt;/span&gt; have been incurred for these services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Administration
Fee&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commencing
on the effectiveness of the Registration Statement on July 11, 2023, an affiliate of the Sponsors will be allowed to charge the
Company an allocable share of its overhead, up to $&lt;span id="xdx_90C_eus-gaap--AffiliateCosts_c20230711__20230711__srt--TitleOfIndividualAxis__custom--SponsorsMember__srt--RangeAxis__srt--MaximumMember_ztqYf0fhDEJa" title="Affiliate costs per month"&gt;10,000&lt;/span&gt;
per month, until to the close of the Business Combination, to compensate it for the Company&#x2019;s use of its office, utilities and
personnel. Administration fee of $&lt;span id="xdx_90E_eus-gaap--AdministrativeFeesExpense_c20240401__20240630_zoRz0cYYRfOe" title="Administrative fee"&gt;30,000&lt;/span&gt;
and $&lt;span id="xdx_909_eus-gaap--AdministrativeFeesExpense_c20240101__20240630_ziyK2jc0nw98" title="Administrative fee"&gt;60,000&lt;/span&gt;
were incurred as &#x201c;accrued expenses &#x2013; related parties&#x201d; for the three and six months ended June 30, 2024,
respectively. For the period from February 17, 2023 (inception) through June 30, 2023, the Company did &lt;span id="xdx_90F_eus-gaap--AdministrativeFeesExpense_do_c20230217__20230630_zRb1uQYvrZEk" title="Administration fee"&gt;no&lt;/span&gt;t
incur any fees for these services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-272023-02-27_custom_SponsorsMember"
      decimals="INF"
      id="Fact000780"
      unitRef="Shares">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-02-272023-02-27_custom_SponsorsMember"
      decimals="0"
      id="Fact000782"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-02-272023-02-27_custom_SponsorsMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000784"
      unitRef="Shares">225000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-03-152023-03-15_custom_EBCMember"
      decimals="INF"
      id="Fact000786"
      unitRef="Shares">180000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-03-15_custom_EBCMember"
      decimals="INF"
      id="Fact000788"
      unitRef="USDPShares">0.014</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-03-152023-03-15_custom_EBCMember"
      decimals="INF"
      id="Fact000790"
      unitRef="USD">2520</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
      contextRef="From2023-03-152023-03-15_custom_EBCMember"
      decimals="0"
      id="Fact000792"
      unitRef="USD">1016000</us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued>
    <us-gaap:SharePrice
      contextRef="AsOf2023-03-15_custom_EBCMember"
      decimals="INF"
      id="Fact000794"
      unitRef="USDPShares">5.65</us-gaap:SharePrice>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000796">&lt;p id="xdx_89D_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zOCn0l1Ycqmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair
value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zJYUcGy76vr" style="display: none"&gt;SCHEDULE
OF ASSUMPTIONS TO ESTIMATE FAIR VALUE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 84%; text-align: left"&gt;Time to expiration&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--EquitySecuritiesFvNiTerm_dtY_c20230315__20230315_zLaPy9wr7i8a" title="Time to expiration"&gt;1.84&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_ziZuy1TovcP6" title="Risk-free rate"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zh5axFQLqyh7" title="Risk-free rate"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zgEwwIudNqN1" title="Risk-free rate"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Probability of completion of business combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember_zRD7Tcv0CwE5" title="Founder shares measurement input"&gt;60.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <BOWN:EquitySecuritiesFvNiTerm contextRef="From2023-03-152023-03-15" id="Fact000798">P1Y10M2D</BOWN:EquitySecuritiesFvNiTerm>
    <us-gaap:EquitySecuritiesFvNiMeasurementInput
      contextRef="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact000800"
      unitRef="Pure">4.0</us-gaap:EquitySecuritiesFvNiMeasurementInput>
    <us-gaap:EquitySecuritiesFvNiMeasurementInput
      contextRef="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact000802"
      unitRef="Pure">5.0</us-gaap:EquitySecuritiesFvNiMeasurementInput>
    <us-gaap:EquitySecuritiesFvNiMeasurementInput
      contextRef="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputExpectedDividendRateMember"
      decimals="INF"
      id="Fact000804"
      unitRef="Pure">0.0</us-gaap:EquitySecuritiesFvNiMeasurementInput>
    <us-gaap:EquitySecuritiesFvNiMeasurementInput
      contextRef="AsOf2023-03-15_us-gaap_FairValueInputsLevel3Member_custom_MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember"
      decimals="INF"
      id="Fact000806"
      unitRef="Pure">60.0</us-gaap:EquitySecuritiesFvNiMeasurementInput>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-02-27_custom_PromissoryNoteMember_custom_SponsorsMember"
      decimals="0"
      id="Fact000808"
      unitRef="USD">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-02-272023-02-27_custom_PromissoryNoteMember_custom_SponsorsMember"
      id="Fact000810">2023-07-14</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-06-30_custom_PromissoryNoteMember"
      decimals="0"
      id="Fact000812"
      unitRef="USD">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2023-12-31_custom_PromissoryNoteMember"
      decimals="0"
      id="Fact000814"
      unitRef="USD">0</us-gaap:NotesPayable>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-07-142023-07-14_us-gaap_OverAllotmentOptionMember_srt_MaximumMember"
      decimals="INF"
      id="Fact000816"
      unitRef="Shares">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <BOWN:CashUnderwritingDiscountPerUnit
      contextRef="From2024-01-012024-06-30_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000818"
      unitRef="USDPShares">0.25</BOWN:CashUnderwritingDiscountPerUnit>
    <BOWN:CashUnderwritingDiscount
      contextRef="From2024-01-012024-06-30_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000820"
      unitRef="USD">1500000</BOWN:CashUnderwritingDiscount>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="From2024-01-012024-06-30_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000822"
      unitRef="USD">1725000</us-gaap:PaymentsForUnderwritingExpense>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-172023-07-17_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000824"
      unitRef="Shares">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000826"
      unitRef="Shares">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-07-18_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000828"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact000830"
      unitRef="USD">9000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-06-30_custom_SponsorsMember_us-gaap_IPOMember"
      decimals="0"
      id="Fact000832"
      unitRef="USD">151318</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000834"
      unitRef="USD">30000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000836"
      unitRef="USD">25250</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ProfessionalFees
      contextRef="From2023-02-172023-03-31_custom_TenXGlobalCapitalMember"
      decimals="0"
      id="Fact000838"
      unitRef="USD">10000</us-gaap:ProfessionalFees>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="From2023-07-142023-07-14_custom_AccountingServiceAgreementMember"
      decimals="0"
      id="Fact000840"
      unitRef="USD">5250</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:ProfessionalFees
      contextRef="From2024-04-012024-06-30_custom_AccountingServiceAgreementMember"
      decimals="0"
      id="Fact000842"
      unitRef="USD">5250</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2023-04-012023-06-30_custom_AccountingServiceAgreementMember"
      decimals="0"
      id="Fact000844"
      unitRef="USD">0</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2024-01-012024-06-30_custom_AccountingServiceAgreementMember"
      decimals="0"
      id="Fact000846"
      unitRef="USD">10500</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2023-02-172023-06-30_custom_AccountingServiceAgreementMember"
      decimals="0"
      id="Fact000848"
      unitRef="USD">0</us-gaap:ProfessionalFees>
    <us-gaap:AffiliateCosts
      contextRef="From2023-07-112023-07-11_custom_SponsorsMember_srt_MaximumMember"
      decimals="0"
      id="Fact000850"
      unitRef="USD">10000</us-gaap:AffiliateCosts>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000852"
      unitRef="USD">30000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000854"
      unitRef="USD">60000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2023-02-172023-06-30"
      decimals="0"
      id="Fact000856"
      unitRef="USD">0</us-gaap:AdministrativeFeesExpense>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000858">&lt;p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zyLIYCmATNUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6 &#x2014;&lt;span id="xdx_823_zKJ1iHLnOPih"&gt; COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Registration
Rights&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of the Founder Shares, EBC founder shares, Private Placement Units will be entitled to registration rights pursuant to a registration
rights agreement dated on the effectiveness of the Registration Statement on July 11, 2023 requiring the Company to register such securities
for resale. Subject to certain limitations set forth in such agreement, the holders of these securities will be entitled to make up to
three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain
&#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent to completion of a Business Combination
and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the
registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration
statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear
the expenses incurred in connection with the filing of any such registration statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Business
Combination Marketing Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has engaged EBC as an advisor in connection with its Business Combination to assist in holding meetings with the Company stockholders
to discuss the potential Business Combination and the target business&#x2019; attributes, introduce the Company to potential investors
that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and
public filings in connection with the Business Combination. The Company will pay EBC a service fee for such services upon the consummation
of its initial Business Combination in an amount of $&lt;span id="xdx_90E_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20240101__20240630__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_z8kVxINh0KM2" title="Service fee"&gt;2,415,000&lt;/span&gt;, equal to&lt;span id="xdx_90C_ecustom--PercentageOfGrossProceedsOfInitialPublicOffering_iI_pid_dp_uPure_c20240630__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_zyk8isjetBP6" title="Percentage of gross proceeds of initial public offering"&gt; 3.5&lt;/span&gt;% of the gross proceeds of the IPO. In addition, the Company
will pay EBC a service fee in an amount equal to &lt;span id="xdx_90A_ecustom--PercentageOfServiceFeeOfTotalConsiderationPayable_iI_pid_dp_uPure_c20240630__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_z2VYbFe6dlTh" title="Percentage of service fee of total consideration payable"&gt;1.0&lt;/span&gt;% of the total consideration payable in the initial Business Combination if it introduces
the Company to the target business with whom it completes an initial Business Combination and the amount will be payable in cash and
is due at the closing date of the initial Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;Business
Combination Transaction Cost&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company has engaged several service providers including legal and valuation services, specifically for business combination between
the Company and Shenzhen Qianzhi BioTechnology Co. Ltd. (&#x201c;Qianzhi&#x201d;). Per the agreed terms, Qianzhi agreed to be
responsible for all expenses incurred by the Company in connection with business combination. During the three months ended June 30,
2024, $&lt;span id="xdx_903_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20240401__20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zNbVaVR6mQbd" title="Business combination related cost incurred"&gt;45,199&lt;/span&gt;
of business combination related cost has been incurred which $&lt;span id="xdx_909_ecustom--BusinessCombinationAcquisitionRelatedCostsReimbursed_c20240401__20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zn5QdfCt14gi" title="Business combination related cost reimbursed"&gt;0&lt;/span&gt;
was reimbursed by Qianzhi. During the six months ended June 30, 2024, $&lt;span id="xdx_90C_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20240101__20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zTnFCog0Y3k8" title="Business combination related cost"&gt;252,002&lt;/span&gt;
of business combination related cost has been incurred which $&lt;span id="xdx_904_ecustom--BusinessCombinationAcquisitionRelatedCostsReimbursed_c20240101__20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zF0rcg51FBh9" title="Business combination related cost reimbursed"&gt;206,803&lt;/span&gt;
was reimbursed by Qianzhi. This activity has been recorded net in accompanying financial statements. As of June 30, 2024, the
receivable from Qianzhi and accrued to service providers was $&lt;span id="xdx_906_eus-gaap--OtherReceivablesNetCurrent_iI_c20240630__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember_zT1W5C1zhSL6" title="Other receivables"&gt;&lt;span id="xdx_902_ecustom--BusinessCombinationAcquisitionRelatedCostsReimbursed_c20240731__20240731__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXqmxgAxwRZh" title="Business combination related cost reimbursed"&gt;45,199&lt;/span&gt;&lt;/span&gt;. On July 31, 2024, the outstanding amount was paid off by Qianzhi.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="From2024-01-012024-06-30_custom_BusinessCombinationMarketingAgreementMember"
      decimals="0"
      id="Fact000860"
      unitRef="USD">2415000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <BOWN:PercentageOfGrossProceedsOfInitialPublicOffering
      contextRef="AsOf2024-06-30_custom_BusinessCombinationMarketingAgreementMember"
      decimals="INF"
      id="Fact000862"
      unitRef="Pure">0.035</BOWN:PercentageOfGrossProceedsOfInitialPublicOffering>
    <BOWN:PercentageOfServiceFeeOfTotalConsiderationPayable
      contextRef="AsOf2024-06-30_custom_BusinessCombinationMarketingAgreementMember"
      decimals="INF"
      id="Fact000864"
      unitRef="Pure">0.010</BOWN:PercentageOfServiceFeeOfTotalConsiderationPayable>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="From2024-04-012024-06-30_custom_QianzhiMember"
      decimals="0"
      id="Fact000866"
      unitRef="USD">45199</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <BOWN:BusinessCombinationAcquisitionRelatedCostsReimbursed
      contextRef="From2024-04-012024-06-30_custom_QianzhiMember"
      decimals="0"
      id="Fact000868"
      unitRef="USD">0</BOWN:BusinessCombinationAcquisitionRelatedCostsReimbursed>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="From2024-01-012024-06-30_custom_QianzhiMember"
      decimals="0"
      id="Fact000870"
      unitRef="USD">252002</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <BOWN:BusinessCombinationAcquisitionRelatedCostsReimbursed
      contextRef="From2024-01-012024-06-30_custom_QianzhiMember"
      decimals="0"
      id="Fact000872"
      unitRef="USD">206803</BOWN:BusinessCombinationAcquisitionRelatedCostsReimbursed>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="AsOf2024-06-30_custom_QianzhiMember"
      decimals="0"
      id="Fact000874"
      unitRef="USD">45199</us-gaap:OtherReceivablesNetCurrent>
    <BOWN:BusinessCombinationAcquisitionRelatedCostsReimbursed
      contextRef="From2024-07-312024-07-31_custom_QianzhiMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact000876"
      unitRef="USD">45199</BOWN:BusinessCombinationAcquisitionRelatedCostsReimbursed>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000878">&lt;p id="xdx_806_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zeIgVsuanBU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 &#x2014; &lt;span id="xdx_828_zgUlCuCAyM4j"&gt;SHAREHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Preferred
Shares&lt;/i&gt;&lt;/b&gt; &#x2014; The Company is authorized to issue &lt;span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240630_zyR5QrsW2Eb5" title="Preferred stock, shares authorized"&gt;2,000,000&lt;/span&gt; preferred shares with a par value of $&lt;span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240630_zEBeCxRsxLN5" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share with such
designations, voting and other rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors.
As of June 30, 2024 and December 31, 2023, there were &lt;span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_do_c20240630_zMfFFe5S887j" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240630_zYqfeMLFear6" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_z09AC5Dpm2L" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_zLXarCeMPJy7" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; preferred shares issued or outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Ordinary
Shares&lt;/i&gt;&lt;/b&gt; &#x2014; The Company is authorized to issue &lt;span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240630_zfUpVDR31W4a" title="Ordinary stock, shares authorized"&gt;200,000,000&lt;/span&gt; ordinary shares with a par value of $&lt;span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240630_zfJvfrxZNPde" title="Ordinary stock, par value"&gt;0.0001 &lt;/span&gt;per share. &lt;span id="xdx_909_eus-gaap--CommonStockVotingRights_c20240101__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4o5zkecJ5da" title="Ordinary stock, voting rights"&gt;Holders
of ordinary shares are entitled to one vote for each share&lt;/span&gt;. On February 27, 2023, the Sponsors received &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zimQWWaQ0bua" title="Issuance of ordinary shares to Sponsor, shares"&gt;1,725,000&lt;/span&gt; of the Founder Shares
in exchange for $&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zJ60AhrGcQQd" title="Issuance of ordinary shares to Sponsor, value"&gt;25,000&lt;/span&gt; paid for offering costs borne by the Sponsors, of which an aggregate of up to &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zv71jJBVmkbd" title="Number of shares subject to forfeiture"&gt;225,000&lt;/span&gt; of such Founder Shares
were subject to forfeiture to the extent that the underwriters&#x2019; over-allotment was not exercised in full or in part, so that the
number of Founder Shares will equal 20% of the Company&#x2019;s issued and outstanding ordinary shares after the IPO (excluding shares
underlying the Private Placement Units). No ordinary shares are subject to forfeiture since the over-allotment was fully exercised on
July 17, 2023. As of June 30, 2024 and December 31, 2023, there were &lt;span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_pid_c20240630_zne4WSgLqDCf" title="Ordinary shares issued"&gt;&lt;span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240630_zK99cXm3ZeR6" title="Ordinary shares outstanding"&gt;&lt;span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_z41EvWA6EZCe" title="Ordinary stock, shares issued"&gt;&lt;span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zYds4ElMB4K2" title="Ordinary stock, shares outstanding"&gt;2,266,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; ordinary shares issued and outstanding (excluding &lt;span id="xdx_90D_ecustom--OrdinarySharesSubjectToRedemption_iI_c20240630_zTDTCDdxX3we" title="Ordinary shares subject to redemption"&gt;6,900,000&lt;/span&gt;
shares subject to possible redemption).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Rights
&lt;/i&gt;&lt;/b&gt;&#x2014; Except in cases where the Company is not the surviving company in a business combination, &lt;span id="xdx_901_eus-gaap--CommonStockVotingRights_c20240101__20240630_zS2WDoWWNPpl" title="Ordinary stock, voting rights"&gt;each holder of a right will
automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination&lt;/span&gt;. The Company will
not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole
share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company is not the surviving
company upon completion of the initial Business Combination, each holder of a right will be required to affirmatively convert his, her
or its rights in order to receive the one-tenth (1/10) of one ordinary share underlying each right upon consummation of the business
combination. If the Company is unable to complete the initial Business Combination within the required time period and the Company will
redeem the public shares for the funds held in the trust account, holders of rights will not receive any of such funds for their rights
and the rights will expire worthless.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000880"
      unitRef="Shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000882"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000884"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000886"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000888"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000890"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000892"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000894"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockVotingRights
      contextRef="From2024-01-012024-06-30_us-gaap_CommonStockMember"
      id="Fact000896">Holders
of ordinary shares are entitled to one vote for each share</us-gaap:CommonStockVotingRights>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-272023-02-27_custom_SponsorsMember"
      decimals="INF"
      id="Fact000898"
      unitRef="Shares">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-02-272023-02-27_custom_SponsorsMember"
      decimals="0"
      id="Fact000900"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-02-272023-02-27_custom_SponsorsMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000902"
      unitRef="Shares">225000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000904"
      unitRef="Shares">2266500</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000906"
      unitRef="Shares">2266500</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000908"
      unitRef="Shares">2266500</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000910"
      unitRef="Shares">2266500</us-gaap:CommonStockSharesOutstanding>
    <BOWN:OrdinarySharesSubjectToRedemption
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000912"
      unitRef="Shares">6900000</BOWN:OrdinarySharesSubjectToRedemption>
    <us-gaap:CommonStockVotingRights contextRef="From2024-01-01to2024-06-30" id="Fact000914">each holder of a right will
automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination</us-gaap:CommonStockVotingRights>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000916">&lt;p id="xdx_807_eus-gaap--FairValueDisclosuresTextBlock_zglg1BNMSnDb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 &#x2014;&lt;span id="xdx_82D_zBPu0g79U7mj"&gt; Fair Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s financial assets and liabilities reflects management&#x2019;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which
transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets
or liabilities and quoted prices for identical assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zHevNpAQnl41" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis at June 30,
2024 and December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair
value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zrl4VqYdy7I6" style="display: none"&gt;SCHEDULE
OF MEASURED FAIR VALUE ON RECURRING BASIS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Date&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Trading Securities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 20%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 45%; text-align: left"&gt;Marketable securities held in the trust account&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zbjEgAq8OH5k" style="width: 12%; text-align: right" title="Marketable securities held in the trust account"&gt;73,284,700&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Marketable securities held in the trust account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zD90qliMI9ii" style="text-align: right" title="Marketable securities held in the trust account"&gt;71,419,358&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p id="xdx_8AD_zH3p57bs5Deg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000918">&lt;p id="xdx_892_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zHevNpAQnl41" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis at June 30,
2024 and December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair
value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zrl4VqYdy7I6" style="display: none"&gt;SCHEDULE
OF MEASURED FAIR VALUE ON RECURRING BASIS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Date&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Trading Securities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 20%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 45%; text-align: left"&gt;Marketable securities held in the trust account&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zbjEgAq8OH5k" style="width: 12%; text-align: right" title="Marketable securities held in the trust account"&gt;73,284,700&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Marketable securities held in the trust account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zD90qliMI9ii" style="text-align: right" title="Marketable securities held in the trust account"&gt;71,419,358&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact000920"
      unitRef="USD">73284700</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact000922"
      unitRef="USD">71419358</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact000924">&lt;p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zicSOEJTmSq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9 &#x2014;&lt;span id="xdx_829_zB00o4Dzkw19"&gt; SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were available to be issued. Based upon this review, the Company identified the following subsequent event that would have required adjustment
or disclosure in the financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;On July 31, 2024, $&lt;span id="xdx_909_ecustom--BusinessCombinationAcquisitionRelatedCostsReimbursed_c20240731__20240731__us-gaap--BusinessAcquisitionAxis__custom--QianzhiMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zBdO0ERmmxf1" title="Business combination related cost reimbursed"&gt;45,199&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;of
business combination related cost was reimbursed by Qianzhi.&lt;/span&gt;&lt;/p&gt;
</us-gaap:SubsequentEventsTextBlock>
    <BOWN:BusinessCombinationAcquisitionRelatedCostsReimbursed
      contextRef="From2024-07-312024-07-31_custom_QianzhiMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact000926"
      unitRef="USD">45199</BOWN:BusinessCombinationAcquisitionRelatedCostsReimbursed>
    <us-gaap:Cash
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000932"
      unitRef="USD">426913</us-gaap:Cash>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000934"
      unitRef="USD">79481</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000936"
      unitRef="USD">506394</us-gaap:AssetsCurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000938"
      unitRef="USD">71419358</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000940"
      unitRef="USD">71419358</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000942"
      unitRef="USD">71925752</us-gaap:Assets>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000948"
      unitRef="USD">78610</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000950"
      unitRef="USD">25250</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000952"
      unitRef="USD">25250</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000954"
      unitRef="USD">103860</us-gaap:LiabilitiesCurrent>
    <BOWN:OrdinarySharesSubjectToRedemption
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000960"
      unitRef="Shares">6900000</BOWN:OrdinarySharesSubjectToRedemption>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000962"
      unitRef="USDPShares">10.35</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000958"
      unitRef="USD">71419358</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000968"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000970"
      unitRef="Shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000972"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000974"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000978"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000980"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000982"
      unitRef="Shares">2266500</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000984"
      unitRef="Shares">2266500</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000976"
      unitRef="USD">227</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000988"
      unitRef="USD">402307</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000990"
      unitRef="USD">402534</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000992"
      unitRef="USD">71925752</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact000994"
      unitRef="USD">244568</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact000996"
      unitRef="USD">-244568</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001000"
      unitRef="USD">1729358</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001002"
      unitRef="USD">1729358</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001004"
      unitRef="USD">1484790</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-02-172023-12-31_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact001006"
      unitRef="Shares">3819156</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-02-172023-12-31_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact001008"
      unitRef="Shares">3819156</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-02-172023-12-31_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact001010"
      unitRef="USDPShares">1.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-02-172023-12-31_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact001012"
      unitRef="USDPShares">1.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact001014"
      unitRef="Shares">2095943</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact001016"
      unitRef="Shares">2095943</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact001018"
      unitRef="USDPShares">-1.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact001020"
      unitRef="USDPShares">-1.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001041"
      unitRef="Shares">1725000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001036"
      unitRef="USD">173</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001037"
      unitRef="USD">24827</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001039"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <BOWN:StockIssuedDuringPeriodSharesToUnderwriter
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001048"
      unitRef="Shares">180000</BOWN:StockIssuedDuringPeriodSharesToUnderwriter>
    <BOWN:StockIssuedDuringPeriodValueToUnderwriter
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001043"
      unitRef="USD">18</BOWN:StockIssuedDuringPeriodValueToUnderwriter>
    <BOWN:StockIssuedDuringPeriodValueToUnderwriter
      contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001044"
      unitRef="USD">1015982</BOWN:StockIssuedDuringPeriodValueToUnderwriter>
    <BOWN:StockIssuedDuringPeriodValueToUnderwriter
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001046"
      unitRef="USD">1016000</BOWN:StockIssuedDuringPeriodValueToUnderwriter>
    <BOWN:StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001055"
      unitRef="Shares">6000000</BOWN:StockIssuedDuringPeriodSharesProceedsFromSaleOfPublicUnits>
    <BOWN:StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001050"
      unitRef="USD">600</BOWN:StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits>
    <BOWN:StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits
      contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001051"
      unitRef="USD">59999400</BOWN:StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits>
    <BOWN:StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001053"
      unitRef="USD">60000000</BOWN:StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits>
    <BOWN:StockIssuedDuringPeriodSharesProceedsFromOverallotment
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001062"
      unitRef="Shares">900000</BOWN:StockIssuedDuringPeriodSharesProceedsFromOverallotment>
    <BOWN:StockIssuedDuringPeriodValueProceedsFromOverallotment
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001057"
      unitRef="USD">90</BOWN:StockIssuedDuringPeriodValueProceedsFromOverallotment>
    <BOWN:StockIssuedDuringPeriodValueProceedsFromOverallotment
      contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001058"
      unitRef="USD">8999910</BOWN:StockIssuedDuringPeriodValueProceedsFromOverallotment>
    <BOWN:StockIssuedDuringPeriodValueProceedsFromOverallotment
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001060"
      unitRef="USD">9000000</BOWN:StockIssuedDuringPeriodValueProceedsFromOverallotment>
    <BOWN:StockIssuedDuringPeriodSharesSaleOfPrivateUnits
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001069"
      unitRef="Shares">330000</BOWN:StockIssuedDuringPeriodSharesSaleOfPrivateUnits>
    <BOWN:StockIssuedDuringPeriodValueSaleOfPrivateUnits
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001064"
      unitRef="USD">33</BOWN:StockIssuedDuringPeriodValueSaleOfPrivateUnits>
    <BOWN:StockIssuedDuringPeriodValueSaleOfPrivateUnits
      contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001065"
      unitRef="USD">3299967</BOWN:StockIssuedDuringPeriodValueSaleOfPrivateUnits>
    <BOWN:StockIssuedDuringPeriodValueSaleOfPrivateUnits
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001067"
      unitRef="USD">3300000</BOWN:StockIssuedDuringPeriodValueSaleOfPrivateUnits>
    <BOWN:StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001076"
      unitRef="Shares">31500</BOWN:StockIssuedDuringPeriodSharesOverallotmentOfPrivateUnits>
    <BOWN:StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001071"
      unitRef="USD">3</BOWN:StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits>
    <BOWN:StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits
      contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001072"
      unitRef="USD">314997</BOWN:StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits>
    <BOWN:StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001074"
      unitRef="USD">315000</BOWN:StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits
      contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001079"
      unitRef="USD">-1500000</BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001081"
      unitRef="USD">-1500000</BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment
      contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001084"
      unitRef="USD">-225000</BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001086"
      unitRef="USD">-225000</BOWN:AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts
      contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001089"
      unitRef="USD">-1593898</BOWN:AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001091"
      unitRef="USD">-1593898</BOWN:AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001098"
      unitRef="Shares">-6900000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001093"
      unitRef="USD">-690</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001094"
      unitRef="USD">-65235677</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001096"
      unitRef="USD">-65236367</us-gaap:StockIssuedDuringPeriodValueOther>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
      contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001101"
      unitRef="USD">3137867</BOWN:AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption>
    <BOWN:AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001103"
      unitRef="USD">3137867</BOWN:AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
      contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001106"
      unitRef="USD">-7591500</us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001108"
      unitRef="USD">-7591500</us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2023-02-172023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001111"
      unitRef="USD">-646875</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001112"
      unitRef="USD">-1082483</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001113"
      unitRef="USD">-1729358</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001117"
      unitRef="USD">1484790</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001118"
      unitRef="USD">1484790</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001125"
      unitRef="Shares">2266500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001120"
      unitRef="USD">227</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001122"
      unitRef="USD">402307</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001123"
      unitRef="USD">402534</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001132"
      unitRef="Shares">2266500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001127"
      unitRef="USD">227</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001129"
      unitRef="USD">402307</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001130"
      unitRef="USD">402534</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001136"
      unitRef="USD">1484790</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001140"
      unitRef="USD">1729358</us-gaap:IncomeLossFromEquityMethodInvestments>
    <BOWN:IncreaseDecreaseInAccruedOfferingCostsAndExpenses
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001142"
      unitRef="USD">6714</BOWN:IncreaseDecreaseInAccruedOfferingCostsAndExpenses>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2023-02-172023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001144"
      unitRef="USD">25250</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001146"
      unitRef="USD">79481</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001148"
      unitRef="USD">-292085</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001152"
      unitRef="USD">69690000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001154"
      unitRef="USD">-69690000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <BOWN:ProceedsFromIssuanceOfFounderShares
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001158"
      unitRef="USD">2520</BOWN:ProceedsFromIssuanceOfFounderShares>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001160"
      unitRef="USD">69000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001162"
      unitRef="USD">3615000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <BOWN:PaymentsOfUnderwritersDiscount
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001164"
      unitRef="USD">1725000</BOWN:PaymentsOfUnderwritersDiscount>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001166"
      unitRef="USD">151318</us-gaap:RepaymentsOfRelatedPartyDebt>
    <BOWN:PaymentOfOfferingCosts
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001168"
      unitRef="USD">332204</BOWN:PaymentOfOfferingCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001170"
      unitRef="USD">70408998</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001172"
      unitRef="USD">426913</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001176"
      unitRef="USD">426913</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <BOWN:NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001180"
      unitRef="USD">25000</BOWN:NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares>
    <BOWN:NoncashOfferingCostsAdjustedFromPrepaidExpenses
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001182"
      unitRef="USD">894</BOWN:NoncashOfferingCostsAdjustedFromPrepaidExpenses>
    <BOWN:NonCashOfferingCostsChargedToAdditionalPaidinCapital
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001184"
      unitRef="USD">1593898</BOWN:NonCashOfferingCostsChargedToAdditionalPaidinCapital>
    <BOWN:ReclassificationOfOrdinarySharesSubjectToRedemption
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001186"
      unitRef="USD">65236367</BOWN:ReclassificationOfOrdinarySharesSubjectToRedemption>
    <BOWN:AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001188"
      unitRef="USD">3137868</BOWN:AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption>
    <BOWN:RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001190"
      unitRef="USD">7591500</BOWN:RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption>
    <BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001192"
      unitRef="USD">1729358</BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2023-02-172023-12-31" id="Fact001194">&lt;p id="xdx_80D_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z9rOULZoOjsf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 &#x2014;&lt;span id="xdx_82B_zqUp5u4n4yzg"&gt;ORGANIZATION AND BUSINESS OPERATIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Organizational
and General&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bowen
Acquisition Corp (the &#x201c;Company&#x201d;) was incorporated in the Cayman Islands on February 17, 2023. The Company was formed for
the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination
with one or more businesses (the &#x201c;Business Combination&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early
stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth
companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s sponsors are Createcharm Holdings Ltd., a British Virgin Islands company, and Bowen Holding LP, a Delaware limited partnership
(the &#x201c;Sponsors&#x201d;). As of December 31, 2023, the Company had not commenced any operations. All activity for the period from
February 17, 2023 (inception) through December 31, 2023 relates to the Company&#x2019;s formation and the initial public offering (&#x201c;IPO&#x201d;)
described below, and following the IPO, the search for a target to consummate a Business Combination&lt;span style="background-color: white"&gt;.
&lt;/span&gt;The Company will not generate any operating revenues until after the completion of an initial Business Combination, at the earliest.
The Company  generated non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has
selected December 31 as its fiscal year end.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
registration statement for the Company&#x2019;s IPO (the &#x201c;Registration Statement&#x201d;) was declared effective on July 11, 2023.
On July 14, 2023, the Company consummated the IPO of &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5QAUuQbyZU1" title="Stock issued during period shares"&gt;6,000,000&lt;/span&gt; of its units (&#x201c;Public Units&#x201d;). Each Public Unit consists of
one ordinary share, $&lt;span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ztoRUlt3J7N4" title="Ordinary shares, par value"&gt;0.0001&lt;/span&gt; par value (&#x201c;Ordinary Shares&#x201d;), of the Company and one right (&#x201c;Rights&#x201d;), each Right
entitling the holder thereof to receive one-tenth of one ordinary share upon the completion of the Company&#x2019;s initial business combination.
The Public Units were sold at an offering price of $&lt;span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zeBeRm19B9rk" title="Sale of stock, par share"&gt;10.00&lt;/span&gt; per Unit, generating gross proceeds of $&lt;span id="xdx_902_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zOlW8wvtVtCg" title="Proceeds from issuance of IPO"&gt;60,000,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the consummation of the IPO, the Company consummated the private placement (&#x201c;Private Placement&#x201d;) of &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zGIgiOqmJhAa" title="Stock issued during period shares"&gt;330,000&lt;/span&gt; units (&#x201c;Private
Placement Units&#x201d;) at a price of $&lt;span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcaS3eP1Lyq7" title="Price per share"&gt;10.00&lt;/span&gt; per Private Placement Unit, generating total proceeds of $&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zjlY2IK9ruif" title="Proceeds from issuance of private placement"&gt;3,300,000&lt;/span&gt;. The Private Placement
Units were purchased by Createcharm Holdings Ltd, one of the Company&#x2019;s sponsors, and EarlyBirdCapital, Inc. (&#x201c;EBC&#x201d;),
the representative of the underwriters in the IPO. The Private Placement Units are identical to the Units included in the Public Units
sold in the IPO. The purchasers of the Private Placement Units have agreed not to transfer, assign or sell any of the Private Placement
Units or Ordinary Shares or Rights underlying the Private Placement Units (except to certain transferees) until after the completion
of the Company&#x2019;s initial Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 17, 2023, the underwriters exercised their over-allotment option in full to purchase an additional &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230717__20230717__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zwhRT3WDbwzf" title="Stock issued during period shares"&gt;900,000&lt;/span&gt; Units. As a result, on
July 18, 2023, the Company sold an additional &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zi0tGcTmtfS9" title="Number of stock issued"&gt;900,000&lt;/span&gt; Units at $&lt;span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zFkSr01l5ss" title="Price per share"&gt;10.00&lt;/span&gt; per Unit, generating gross proceeds of $&lt;span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zfMFXSC7Ll66" title="Proceeds from sale of units"&gt;9,000,000&lt;/span&gt;. In connection
with this sale, Createcharm Holdings Ltd and EBC also purchased an additional &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_znLDoLu55dm1" title="Number of stock issued"&gt;31,500&lt;/span&gt; Private Placement Units from the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of July 18, 2023, transaction costs amounted to $&lt;span id="xdx_909_eus-gaap--PaymentsOfStockIssuanceCosts_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zNXiZIVGlbv9" title="Transaction cost"&gt;3,318,898&lt;/span&gt; consisting of $&lt;span id="xdx_907_eus-gaap--PaymentsForUnderwritingExpense_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zKrDfouXZQWc" title="Payments for underwriting expense"&gt;1,725,000&lt;/span&gt; of cash underwriting fees and $&lt;span id="xdx_905_ecustom--OtherOfferingCosts_pid_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zbK04C5WaBJb" title="Other offering costs"&gt;1,593,898&lt;/span&gt; of other
offering costs. These costs were charged to additional paid-in capital or accumulated deficit to the extent additional paid-in capital
is fully depleted upon completion of the IPO.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will have until 15 months from the closing of the IPO (or up to 18 months, if the Company extends the time to complete a Business
Combination as permitted in its Amended and Restated Memorandum and Articles of Association) to consummate a Business Combination (the
&#x201c;Combination Period&#x201d;). Sponsors or their affiliated or designees, upon five days&#x2019; advance
notice prior to the deadline, must deposit into the Trust Account $&lt;span id="xdx_907_eus-gaap--Deposits_iI_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z8G19rfIEFUg" title="Deposits"&gt;690,000&lt;/span&gt; (or $&lt;span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z2E1789Uvww" title="Shares issued price per share"&gt;0.10&lt;/span&gt; per share) for the extension, on or prior to the
date of the deadline. However, if the Company has not completed a Business Combination within the Combination Period and
shareholders have not otherwise amended the Amended and Restated Memorandum and Articles of Association to extend this period, the Company
will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business
days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit
in the Trust Account, including interest earned and not previously released to us to pay the Company&#x2019;s taxes, if any (less certain
amount of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption
will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating
distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#x2019;s
remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject to the Company&#x2019;s obligations under Cayman
Islands law to provide for claims of creditors and the requirements of other applicable law.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;On November 20, 2023, a wholly-owned
subsidiary of the Company, Bowen Merger Sub (&#x201c;Merger Sub&#x201d;) was formed for the purpose of entering into a business combination
agreement. See subsequent events disclosure below.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;Going
Concern Consideration&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;As
of December 31, 2023, the Company had cash of $&lt;span id="xdx_90C_eus-gaap--Cash_iI_c20231231_zHxvsMCLVSn2" title="Cash"&gt;426,913&lt;/span&gt;
and working capital of $&lt;span id="xdx_900_ecustom--WorkingCapitalDeficit_iI_c20231231_zaEtvKWjiU4h" title="Working capital deficit"&gt;402,534&lt;/span&gt;.
The Company has incurred and expects to continue to incur significant professional costs to remain as a public&lt;span style="background-color: white"&gt;ly&lt;/span&gt;
traded company and to incur transaction costs in pursuit of a Business Combination. In connection with the Company&#x2019;s
assessment of going concern considerations in accordance with Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-15,
&#x201c;Disclosures of Uncertainties about an Entity&#x2019;s Ability to Continue as a Going Concern,&#x201d; management believes that
these conditions raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. In addition, if the
Company is unable to complete a Business Combination within the Combination Period and such period is not extended, there will be a
liquidation and subsequent dissolution. As a result, management has determined that such additional condition also raises
substantial doubt about the Company&#x2019;s ability to continue as a going concern. The &lt;span style="background-color: white"&gt;consolidated &lt;/span&gt;
financial statements do not include any adjustments that might result from the outcome of the uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-142023-07-14_us-gaap_IPOMember"
      decimals="INF"
      id="Fact001196"
      unitRef="Shares">6000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-07-14_us-gaap_IPOMember"
      decimals="INF"
      id="Fact001198"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-07-14_us-gaap_IPOMember"
      decimals="INF"
      id="Fact001200"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-07-142023-07-14_us-gaap_IPOMember"
      decimals="INF"
      id="Fact001202"
      unitRef="USD">60000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001204"
      unitRef="Shares">330000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-07-14_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001206"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2023-07-142023-07-14_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001208"
      unitRef="USD">3300000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-172023-07-17_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact001210"
      unitRef="Shares">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact001212"
      unitRef="Shares">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-07-18_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact001214"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact001216"
      unitRef="USD">9000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-182023-07-18_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001218"
      unitRef="Shares">31500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-07-182023-07-18_us-gaap_IPOMember"
      decimals="0"
      id="Fact001220"
      unitRef="USD">3318898</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="From2023-07-182023-07-18_us-gaap_IPOMember"
      decimals="0"
      id="Fact001222"
      unitRef="USD">1725000</us-gaap:PaymentsForUnderwritingExpense>
    <BOWN:OtherOfferingCosts
      contextRef="From2023-07-182023-07-18_us-gaap_IPOMember"
      decimals="INF"
      id="Fact001224"
      unitRef="USD">1593898</BOWN:OtherOfferingCosts>
    <us-gaap:Deposits
      contextRef="AsOf2023-07-18_us-gaap_IPOMember"
      decimals="0"
      id="Fact001226"
      unitRef="USD">690000</us-gaap:Deposits>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-07-18_us-gaap_IPOMember"
      decimals="INF"
      id="Fact001228"
      unitRef="USDPShares">0.10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:Cash
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001230"
      unitRef="USD">426913</us-gaap:Cash>
    <BOWN:WorkingCapitalDeficit
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001232"
      unitRef="USD">402534</BOWN:WorkingCapitalDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-02-172023-12-31" id="Fact001234">&lt;p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zF6w2MMGASE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;NOTE
2 &#x2014; &lt;span id="xdx_826_zPhBxTWT60bc"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zHmSXfLEBGWa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zwgilH11G9z2"&gt;Basis
of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary and are presented
in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (&#x201c;US GAAP&#x201d;)
and pursuant to the rules and regulations of the SEC. All intercompany accounts and transactions are eliminated upon consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--EmergingGrowthCompanyPolicyTextBlock_zWKlwfrQmYzd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zfYOuyVDRYsl"&gt;Emerging
Growth Company&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#x201c;Securities
Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#x201c;JOBS Act&#x201d;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--UseOfEstimates_zCA91RayHq8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zHOe49ZxvDKe"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the financial statement in conformity with US GAAP requires the Company&#x2019;s management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zmfCyCJVr811" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zAwsvaka99Lf"&gt;Cash
and cash equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash
equivalents. The Company had a cash balance of $&lt;span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20231231_zFK1kspiUhB5" title="Cash"&gt;426,913&lt;/span&gt;
as of December 31, 2023. The Company had &lt;span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_znrFr9kvJLR2" title="Cash equivalents"&gt;no&lt;/span&gt; cash equivalents as of December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--InvestmentPolicyTextBlock_zqRWTWIBXBQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zJ3NmQZbipc9"&gt;Investments
Held in Trust Account&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company&#x2019;s portfolio of investments held in the trust account is comprised of investments only in U.S. government securities
with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company
Act which invest only in direct U.S. government treasury obligations. The Company classified its investments in treasury securities
as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period.
Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on
marketable securities held in trust account in the accompanying statements of operations. The estimated fair value of investments
held in the trust account is determined using available market information. As of December 31, 2023, the trust account had cash
balance of $&lt;span id="xdx_90E_eus-gaap--AssetsHeldInTrust_iI_c20231231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashMember_zOzfr1rK79ag" title="Trust account, cash balance"&gt;8,208&lt;/span&gt; together with U.S. Treasury Bills of $&lt;span id="xdx_905_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zZqLbbU6cr9a" title="Trust account, cash balance, with U.S. treasury bills"&gt;71,411,150&lt;/span&gt; which subsequently matured on January 11, 2024. And the total balance was reinvested in the money market
fund thereafter.
The interests earned from the trust account totaled $&lt;span id="xdx_906_ecustom--InterestsEarnedFromTrustAccount_pp0p0_c20230217__20231231_zWbX4N8uaJVj" title="Interests earned from trust account"&gt;1,729,358&lt;/span&gt;
for the period from February 17, 2023 (inception) through December 31, 2023, which were fully reinvested into the trust account as
earned and unrealized gain on investments and therefore presented as an adjustment to the operating activities in the Statement of
Cash Flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--OfferingCostsPolicyTextBlock_zTKkNdQFKHJk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zamlBjzlDZ2b"&gt;Offering
Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering
costs consist of legal, accounting, and other costs (including underwriting discounts and commissions) incurred through the balance sheet
date that are directly related to the IPO and that were charged to shareholders&#x2019; equity upon the completion of the IPO on July
14, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zGDLIhZAEBn4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zjwJMGXFhF8i"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#x201c;&lt;i&gt;Income Taxes&lt;/i&gt;.&#x201d;
Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the &lt;span style="background-color: white"&gt;consolidated &lt;/span&gt;
financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and
liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is
recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce
deferred tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were &lt;span id="xdx_90B_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zsYWbZ380F1h" title="Unrecognized tax benefits"&gt;no&lt;/span&gt; unrecognized tax benefits and &lt;span id="xdx_90F_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20231231_zSsfZpwbEj33" title="Accrued for interest and penalties"&gt;no&lt;/span&gt; amounts accrued for interest and penalties as of December 31, 2023.
The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation
from its position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax
regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#x2019;s
consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--EarningsPerSharePolicyTextBlock_zHgK6ZKKHid" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_z0ppd2hs22Oa"&gt;Net
Income (Loss) per Ordinary Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;br/&gt;
The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include
a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income
per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company
first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed
income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss)
ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement
of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public
shareholders. As of December 31, 2023, the Company did not have any dilutive securities and other contracts that could, potentially,
be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per
share is the same as basic income (loss) per share for the period presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
net income (loss) per share presented in the statements of operations is based on the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_z5fqU2qlhri2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zHiJwUlqeU1k" style="display: none"&gt;SCHEDULE
OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230217__20231231_zbKQnV15xwDe" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the Period from February 17, 2023 (Inception) Through&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NetIncomeLoss_maNLIAOz10T_zOJii0vLKohb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: left"&gt;Net income&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;1,484,790&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--InterestEarnedOnInvestmentHeldInTrustAccount_iN_di_msNLIAOz10T_zo7AJGrk1xXi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest earned on investment held in Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,729,358&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz10T_zAg74kxuxLM" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of temporary equity into redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(7,591,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NetLossIncludingAccretionOfCommonStockToRedemptionValue_iT_mtNLIAOz10T_zKdGwxjFuO41" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net loss including accretion of common stock to redemption value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(7,836,068&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zYKcI8lxkzp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zcpFV3BsqmD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zMFGGaplzlue"&gt;SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSbd0Fp6rMFl" style="font-weight: bold; text-align: center"&gt;Redeemable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zGAERQ6dGDUi" style="font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the Period from February 17, 2023 (Inception) Through&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Redeemable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Particulars&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Basic and diluted net income/(loss) per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;Weighted-average shares outstanding&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zU6CljOH48ac" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zFYq4I4GQtSh" title="Weighted average shares outstanding - diluted"&gt;3,819,156&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zNfgYAWx4Gr9" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCzo2RWqf9bk" title="Weighted average shares outstanding - diluted"&gt;2,095,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Ownership percentage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zECPHfL2glR8" title="Ownership percentage"&gt;65&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zsjNSrA2WIZc" title="Ownership percentage"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Numerators:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zVCdrxP2wiac" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Allocation of net loss including accretion of temporary equity&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,059,453&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,776,615&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IncomeEarnedOnTrustAccount_iN_di_zAHwZN6mpoR2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income earned on Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,729,358&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1294"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_zDB0ptiEw1dk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of temporary equity to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,591,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1297"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--AllocationOfNetIncomeloss_zq0KsXBOf1Ke" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Allocation of net income/(loss)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;4,261,405&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(2,776,615&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Denominators:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Weighted-average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRIL4Yi3jFe8" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTMeIKfe5D67" title="Weighted average shares outstanding - diluted"&gt;3,819,156&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zZ4GwgKssWo7" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqU9AdEZFfK1" title="Weighted average shares outstanding - diluted"&gt;2,095,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net income/(loss) per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zftFIOmZjSkl" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zVuMWGvFHwTb" title="Diluted net income/(loss) per share"&gt;1.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zHHmNNLje0E9" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zg1zZTQ3WBvh" title="Diluted net income/(loss) per share"&gt;(1.32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zWjFEaPV48a9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z2d9dRUEHMr8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zOFadp8Mtut6"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $&lt;span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zMylsduoDCS4" title="Cash, FDIC insured amount"&gt;250,000&lt;/span&gt;. The Company has not experienced losses on these accounts
and management believes the Company is not exposed to significant risks on such accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zeMFmxxmd9tb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zpDX0PpSV6R5"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC 820, &#x201c;&lt;i&gt;Fair Value
Measurement&lt;/i&gt;,&#x201d; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_z1WqK5dF6HTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_864_zyQLC8aa7lud"&gt;Ordinary
Shares Subject to Possible Redemption&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Ordinary shares subject to mandatory redemption (if
any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary
shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, ordinary shares
are classified as shareholders&#x2019; equity. The Company&#x2019;s ordinary shares features certain redemption rights that are considered
to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject
to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; equity section of the
Company&#x2019;s balance sheet. &lt;span style="background-color: white"&gt;The Company recognizes changes in redemption value immediately as
they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.
Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital
and accumulated deficit.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zd2wBE9lAYs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;At
December 31, 2023, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following
table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zpu6m2fUs7rj" style="display: none"&gt;SCHEDULE
OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: left"&gt;Public offering proceeds&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231_za2ZKsoTet4c" style="width: 18%; text-align: right" title="Public offering proceeds"&gt;60,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230217__20231231_zYj5oSuFxqL7" style="text-align: right" title="Proceeds allocated to public rights"&gt;(3,272,724&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231_zFJ7buaNy8O7" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(2,925,140&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230217__20231231_zW9JCGlmekni" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;6,797,864&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Ordinary shares subject to possible redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20230217__20231231_zgqwa1e5dh05" style="text-align: right" title="Gross proceeds"&gt;60,600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic"&gt;Over-allotment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Over-allotment proceeds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ProceedsFromLegalSettlements_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zfFMrSFQSlFi" style="text-align: right" title="Over-allotment proceeds"&gt;9,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zYxgPuaVAyvk" style="text-align: right" title="Proceeds allocated to Public Rights"&gt;(490,909&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_znuXsHmUR8Gk" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(212,727&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zcZb6OK0dWm9" style="text-align: right" title="Accretion of carrying value to redemption value"&gt;793,636&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zeDGC1VR9Hp5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"&gt;1,729,358&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zgIlv0x3m5Tl" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemption"&gt;71,419,358&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zxvw1Qtx8jLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z2k0Bblpjmqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zNLZGX6jgbxd"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_856_z0JNTepPBrP2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2023-02-172023-12-31" id="Fact001236">&lt;p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zHmSXfLEBGWa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zwgilH11G9z2"&gt;Basis
of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary and are presented
in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (&#x201c;US GAAP&#x201d;)
and pursuant to the rules and regulations of the SEC. All intercompany accounts and transactions are eliminated upon consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <BOWN:EmergingGrowthCompanyPolicyTextBlock contextRef="From2023-02-172023-12-31" id="Fact001238">&lt;p id="xdx_84A_ecustom--EmergingGrowthCompanyPolicyTextBlock_zWKlwfrQmYzd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zfYOuyVDRYsl"&gt;Emerging
Growth Company&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#x201c;Securities
Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#x201c;JOBS Act&#x201d;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</BOWN:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2023-02-172023-12-31" id="Fact001240">&lt;p id="xdx_840_eus-gaap--UseOfEstimates_zCA91RayHq8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zHOe49ZxvDKe"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the financial statement in conformity with US GAAP requires the Company&#x2019;s management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2023-02-172023-12-31" id="Fact001242">&lt;p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zmfCyCJVr811" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zAwsvaka99Lf"&gt;Cash
and cash equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash
equivalents. The Company had a cash balance of $&lt;span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20231231_zFK1kspiUhB5" title="Cash"&gt;426,913&lt;/span&gt;
as of December 31, 2023. The Company had &lt;span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_znrFr9kvJLR2" title="Cash equivalents"&gt;no&lt;/span&gt; cash equivalents as of December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001244"
      unitRef="USD">426913</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001246"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:InvestmentPolicyTextBlock contextRef="From2023-02-172023-12-31" id="Fact001248">&lt;p id="xdx_84F_eus-gaap--InvestmentPolicyTextBlock_zqRWTWIBXBQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zJ3NmQZbipc9"&gt;Investments
Held in Trust Account&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company&#x2019;s portfolio of investments held in the trust account is comprised of investments only in U.S. government securities
with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company
Act which invest only in direct U.S. government treasury obligations. The Company classified its investments in treasury securities
as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period.
Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on
marketable securities held in trust account in the accompanying statements of operations. The estimated fair value of investments
held in the trust account is determined using available market information. As of December 31, 2023, the trust account had cash
balance of $&lt;span id="xdx_90E_eus-gaap--AssetsHeldInTrust_iI_c20231231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashMember_zOzfr1rK79ag" title="Trust account, cash balance"&gt;8,208&lt;/span&gt; together with U.S. Treasury Bills of $&lt;span id="xdx_905_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20231231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zZqLbbU6cr9a" title="Trust account, cash balance, with U.S. treasury bills"&gt;71,411,150&lt;/span&gt; which subsequently matured on January 11, 2024. And the total balance was reinvested in the money market
fund thereafter.
The interests earned from the trust account totaled $&lt;span id="xdx_906_ecustom--InterestsEarnedFromTrustAccount_pp0p0_c20230217__20231231_zWbX4N8uaJVj" title="Interests earned from trust account"&gt;1,729,358&lt;/span&gt;
for the period from February 17, 2023 (inception) through December 31, 2023, which were fully reinvested into the trust account as
earned and unrealized gain on investments and therefore presented as an adjustment to the operating activities in the Statement of
Cash Flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:AssetsHeldInTrust
      contextRef="AsOf2023-12-31_us-gaap_CashMember"
      decimals="0"
      id="Fact001250"
      unitRef="USD">8208</us-gaap:AssetsHeldInTrust>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2023-12-31_us-gaap_USTreasurySecuritiesMember"
      decimals="0"
      id="Fact001252"
      unitRef="USD">71411150</us-gaap:AssetsHeldInTrustNoncurrent>
    <BOWN:InterestsEarnedFromTrustAccount
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001254"
      unitRef="USD">1729358</BOWN:InterestsEarnedFromTrustAccount>
    <BOWN:OfferingCostsPolicyTextBlock contextRef="From2023-02-172023-12-31" id="Fact001256">&lt;p id="xdx_841_ecustom--OfferingCostsPolicyTextBlock_zTKkNdQFKHJk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zamlBjzlDZ2b"&gt;Offering
Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering
costs consist of legal, accounting, and other costs (including underwriting discounts and commissions) incurred through the balance sheet
date that are directly related to the IPO and that were charged to shareholders&#x2019; equity upon the completion of the IPO on July
14, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BOWN:OfferingCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-02-172023-12-31" id="Fact001258">&lt;p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zGDLIhZAEBn4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zjwJMGXFhF8i"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#x201c;&lt;i&gt;Income Taxes&lt;/i&gt;.&#x201d;
Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the &lt;span style="background-color: white"&gt;consolidated &lt;/span&gt;
financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and
liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is
recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce
deferred tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were &lt;span id="xdx_90B_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zsYWbZ380F1h" title="Unrecognized tax benefits"&gt;no&lt;/span&gt; unrecognized tax benefits and &lt;span id="xdx_90F_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20231231_zSsfZpwbEj33" title="Accrued for interest and penalties"&gt;no&lt;/span&gt; amounts accrued for interest and penalties as of December 31, 2023.
The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation
from its position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax
regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#x2019;s
consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001260"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001262"
      unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-02-172023-12-31" id="Fact001264">&lt;p id="xdx_841_eus-gaap--EarningsPerSharePolicyTextBlock_zHgK6ZKKHid" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_z0ppd2hs22Oa"&gt;Net
Income (Loss) per Ordinary Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;br/&gt;
The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include
a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income
per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company
first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed
income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss)
ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement
of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public
shareholders. As of December 31, 2023, the Company did not have any dilutive securities and other contracts that could, potentially,
be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per
share is the same as basic income (loss) per share for the period presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
net income (loss) per share presented in the statements of operations is based on the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_z5fqU2qlhri2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zHiJwUlqeU1k" style="display: none"&gt;SCHEDULE
OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230217__20231231_zbKQnV15xwDe" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the Period from February 17, 2023 (Inception) Through&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NetIncomeLoss_maNLIAOz10T_zOJii0vLKohb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: left"&gt;Net income&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;1,484,790&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--InterestEarnedOnInvestmentHeldInTrustAccount_iN_di_msNLIAOz10T_zo7AJGrk1xXi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest earned on investment held in Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,729,358&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz10T_zAg74kxuxLM" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of temporary equity into redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(7,591,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NetLossIncludingAccretionOfCommonStockToRedemptionValue_iT_mtNLIAOz10T_zKdGwxjFuO41" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net loss including accretion of common stock to redemption value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(7,836,068&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zYKcI8lxkzp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zcpFV3BsqmD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zMFGGaplzlue"&gt;SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSbd0Fp6rMFl" style="font-weight: bold; text-align: center"&gt;Redeemable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zGAERQ6dGDUi" style="font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the Period from February 17, 2023 (Inception) Through&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Redeemable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Particulars&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Basic and diluted net income/(loss) per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;Weighted-average shares outstanding&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zU6CljOH48ac" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zFYq4I4GQtSh" title="Weighted average shares outstanding - diluted"&gt;3,819,156&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zNfgYAWx4Gr9" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCzo2RWqf9bk" title="Weighted average shares outstanding - diluted"&gt;2,095,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Ownership percentage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zECPHfL2glR8" title="Ownership percentage"&gt;65&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zsjNSrA2WIZc" title="Ownership percentage"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Numerators:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zVCdrxP2wiac" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Allocation of net loss including accretion of temporary equity&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,059,453&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,776,615&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IncomeEarnedOnTrustAccount_iN_di_zAHwZN6mpoR2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income earned on Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,729,358&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1294"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_zDB0ptiEw1dk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of temporary equity to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,591,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1297"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--AllocationOfNetIncomeloss_zq0KsXBOf1Ke" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Allocation of net income/(loss)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;4,261,405&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(2,776,615&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Denominators:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Weighted-average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRIL4Yi3jFe8" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTMeIKfe5D67" title="Weighted average shares outstanding - diluted"&gt;3,819,156&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zZ4GwgKssWo7" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqU9AdEZFfK1" title="Weighted average shares outstanding - diluted"&gt;2,095,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net income/(loss) per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zftFIOmZjSkl" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zVuMWGvFHwTb" title="Diluted net income/(loss) per share"&gt;1.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zHHmNNLje0E9" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zg1zZTQ3WBvh" title="Diluted net income/(loss) per share"&gt;(1.32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zWjFEaPV48a9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <srt:ScheduleOfCondensedIncomeStatementTableTextBlock contextRef="From2023-02-172023-12-31" id="Fact001266">&lt;p id="xdx_89A_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_z5fqU2qlhri2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zHiJwUlqeU1k" style="display: none"&gt;SCHEDULE
OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230217__20231231_zbKQnV15xwDe" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the Period from February 17, 2023 (Inception) Through&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NetIncomeLoss_maNLIAOz10T_zOJii0vLKohb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: left"&gt;Net income&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;1,484,790&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--InterestEarnedOnInvestmentHeldInTrustAccount_iN_di_msNLIAOz10T_zo7AJGrk1xXi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest earned on investment held in Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,729,358&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_iN_di_msNLIAOz10T_zAg74kxuxLM" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of temporary equity into redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(7,591,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NetLossIncludingAccretionOfCommonStockToRedemptionValue_iT_mtNLIAOz10T_zKdGwxjFuO41" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net loss including accretion of common stock to redemption value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(7,836,068&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</srt:ScheduleOfCondensedIncomeStatementTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001268"
      unitRef="USD">1484790</us-gaap:NetIncomeLoss>
    <BOWN:InterestEarnedOnInvestmentHeldInTrustAccount
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001270"
      unitRef="USD">1729358</BOWN:InterestEarnedOnInvestmentHeldInTrustAccount>
    <BOWN:AccretionOfTemporaryEquityIntoRedemptionValue
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001272"
      unitRef="USD">7591500</BOWN:AccretionOfTemporaryEquityIntoRedemptionValue>
    <BOWN:NetLossIncludingAccretionOfCommonStockToRedemptionValue
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001274"
      unitRef="USD">-7836068</BOWN:NetLossIncludingAccretionOfCommonStockToRedemptionValue>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2023-02-172023-12-31" id="Fact001276">&lt;p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zcpFV3BsqmD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zMFGGaplzlue"&gt;SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zSbd0Fp6rMFl" style="font-weight: bold; text-align: center"&gt;Redeemable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zGAERQ6dGDUi" style="font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the Period from February 17, 2023 (Inception) Through&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Redeemable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Particulars&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Basic and diluted net income/(loss) per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;Weighted-average shares outstanding&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zU6CljOH48ac" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zFYq4I4GQtSh" title="Weighted average shares outstanding - diluted"&gt;3,819,156&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zNfgYAWx4Gr9" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zCzo2RWqf9bk" title="Weighted average shares outstanding - diluted"&gt;2,095,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Ownership percentage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zECPHfL2glR8" title="Ownership percentage"&gt;65&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--OwnershipPercentage_pid_dp_uPure_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zsjNSrA2WIZc" title="Ownership percentage"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Numerators:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AllocationOfNetLossIncludingAccretionOfTemporaryEquity_zVCdrxP2wiac" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Allocation of net loss including accretion of temporary equity&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,059,453&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,776,615&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IncomeEarnedOnTrustAccount_iN_di_zAHwZN6mpoR2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income earned on Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,729,358&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1294"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--AccretionOfTemporaryEquityIntoRedemptionValue_zDB0ptiEw1dk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of temporary equity to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,591,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1297"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--AllocationOfNetIncomeloss_zq0KsXBOf1Ke" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Allocation of net income/(loss)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;4,261,405&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(2,776,615&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Denominators:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Weighted-average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zRIL4Yi3jFe8" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zTMeIKfe5D67" title="Weighted average shares outstanding - diluted"&gt;3,819,156&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zZ4GwgKssWo7" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqU9AdEZFfK1" title="Weighted average shares outstanding - diluted"&gt;2,095,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net income/(loss) per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zftFIOmZjSkl" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zVuMWGvFHwTb" title="Diluted net income/(loss) per share"&gt;1.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zHHmNNLje0E9" title="Basic net income/(loss) per share"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230217__20231231__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zg1zZTQ3WBvh" title="Diluted net income/(loss) per share"&gt;(1.32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact001278"
      unitRef="Shares">3819156</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact001280"
      unitRef="Shares">3819156</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact001282"
      unitRef="Shares">2095943</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact001284"
      unitRef="Shares">2095943</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <BOWN:OwnershipPercentage
      contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact001286"
      unitRef="Pure">0.65</BOWN:OwnershipPercentage>
    <BOWN:OwnershipPercentage
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact001288"
      unitRef="Pure">0.35</BOWN:OwnershipPercentage>
    <BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity
      contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember"
      decimals="0"
      id="Fact001290"
      unitRef="USD">-5059453</BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity>
    <BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember"
      decimals="0"
      id="Fact001291"
      unitRef="USD">-2776615</BOWN:AllocationOfNetLossIncludingAccretionOfTemporaryEquity>
    <BOWN:IncomeEarnedOnTrustAccount
      contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember"
      decimals="0"
      id="Fact001293"
      unitRef="USD">-1729358</BOWN:IncomeEarnedOnTrustAccount>
    <BOWN:AccretionOfTemporaryEquityIntoRedemptionValue
      contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember"
      decimals="0"
      id="Fact001296"
      unitRef="USD">7591500</BOWN:AccretionOfTemporaryEquityIntoRedemptionValue>
    <BOWN:AllocationOfNetIncomeloss
      contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember"
      decimals="0"
      id="Fact001299"
      unitRef="USD">4261405</BOWN:AllocationOfNetIncomeloss>
    <BOWN:AllocationOfNetIncomeloss
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember"
      decimals="0"
      id="Fact001300"
      unitRef="USD">-2776615</BOWN:AllocationOfNetIncomeloss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact001302"
      unitRef="Shares">3819156</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact001304"
      unitRef="Shares">3819156</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact001306"
      unitRef="Shares">2095943</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact001308"
      unitRef="Shares">2095943</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact001310"
      unitRef="USDPShares">1.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-02-172023-12-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact001312"
      unitRef="USDPShares">1.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact001314"
      unitRef="USDPShares">-1.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-02-172023-12-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact001316"
      unitRef="USDPShares">-1.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2023-02-172023-12-31" id="Fact001318">&lt;p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z2d9dRUEHMr8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zOFadp8Mtut6"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $&lt;span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zMylsduoDCS4" title="Cash, FDIC insured amount"&gt;250,000&lt;/span&gt;. The Company has not experienced losses on these accounts
and management believes the Company is not exposed to significant risks on such accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001320"
      unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-02-172023-12-31" id="Fact001322">&lt;p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zeMFmxxmd9tb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zpDX0PpSV6R5"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC 820, &#x201c;&lt;i&gt;Fair Value
Measurement&lt;/i&gt;,&#x201d; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="From2023-02-172023-12-31" id="Fact001324">&lt;p id="xdx_847_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_z1WqK5dF6HTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_864_zyQLC8aa7lud"&gt;Ordinary
Shares Subject to Possible Redemption&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Ordinary shares subject to mandatory redemption (if
any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary
shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, ordinary shares
are classified as shareholders&#x2019; equity. The Company&#x2019;s ordinary shares features certain redemption rights that are considered
to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject
to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; equity section of the
Company&#x2019;s balance sheet. &lt;span style="background-color: white"&gt;The Company recognizes changes in redemption value immediately as
they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.
Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital
and accumulated deficit.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zd2wBE9lAYs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;At
December 31, 2023, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following
table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zpu6m2fUs7rj" style="display: none"&gt;SCHEDULE
OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: left"&gt;Public offering proceeds&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231_za2ZKsoTet4c" style="width: 18%; text-align: right" title="Public offering proceeds"&gt;60,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230217__20231231_zYj5oSuFxqL7" style="text-align: right" title="Proceeds allocated to public rights"&gt;(3,272,724&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231_zFJ7buaNy8O7" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(2,925,140&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230217__20231231_zW9JCGlmekni" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;6,797,864&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Ordinary shares subject to possible redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20230217__20231231_zgqwa1e5dh05" style="text-align: right" title="Gross proceeds"&gt;60,600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic"&gt;Over-allotment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Over-allotment proceeds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ProceedsFromLegalSettlements_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zfFMrSFQSlFi" style="text-align: right" title="Over-allotment proceeds"&gt;9,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zYxgPuaVAyvk" style="text-align: right" title="Proceeds allocated to Public Rights"&gt;(490,909&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_znuXsHmUR8Gk" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(212,727&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zcZb6OK0dWm9" style="text-align: right" title="Accretion of carrying value to redemption value"&gt;793,636&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zeDGC1VR9Hp5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"&gt;1,729,358&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zgIlv0x3m5Tl" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemption"&gt;71,419,358&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zxvw1Qtx8jLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <BOWN:ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock contextRef="From2023-02-172023-12-31" id="Fact001326">&lt;p id="xdx_89E_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock_zd2wBE9lAYs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;At
December 31, 2023, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following
table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zpu6m2fUs7rj" style="display: none"&gt;SCHEDULE
OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: left"&gt;Public offering proceeds&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231_za2ZKsoTet4c" style="width: 18%; text-align: right" title="Public offering proceeds"&gt;60,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230217__20231231_zYj5oSuFxqL7" style="text-align: right" title="Proceeds allocated to public rights"&gt;(3,272,724&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231_zFJ7buaNy8O7" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(2,925,140&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230217__20231231_zW9JCGlmekni" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;6,797,864&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Ordinary shares subject to possible redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iS_c20230217__20231231_zgqwa1e5dh05" style="text-align: right" title="Gross proceeds"&gt;60,600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic"&gt;Over-allotment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Over-allotment proceeds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ProceedsFromLegalSettlements_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zfFMrSFQSlFi" style="text-align: right" title="Over-allotment proceeds"&gt;9,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zYxgPuaVAyvk" style="text-align: right" title="Proceeds allocated to Public Rights"&gt;(490,909&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OfferingCostsPartnershipInterests_iNI_di_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_znuXsHmUR8Gk" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(212,727&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zcZb6OK0dWm9" style="text-align: right" title="Accretion of carrying value to redemption value"&gt;793,636&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zeDGC1VR9Hp5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)"&gt;1,729,358&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RedeemableNoncontrollingInterestEquityCommonCarryingAmount_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zgIlv0x3m5Tl" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemption"&gt;71,419,358&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BOWN:ScheduleOfOrdinarySharesSubjectToPossibleRedemptionReflectedInTheBalanceSheetTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001328"
      unitRef="USD">60000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001330"
      unitRef="USD">-3272724</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:OfferingCostsPartnershipInterests
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001332"
      unitRef="USD">2925140</us-gaap:OfferingCostsPartnershipInterests>
    <BOWN:AccretionOfCarryingValueToRedemptionValue
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001334"
      unitRef="USD">6797864</BOWN:AccretionOfCarryingValueToRedemptionValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="AsOf2023-02-16"
      decimals="0"
      id="Fact001336"
      unitRef="USD">60600000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact001338"
      unitRef="USD">9000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact001340"
      unitRef="USD">-490909</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OfferingCostsPartnershipInterests
      contextRef="AsOf2023-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact001342"
      unitRef="USD">212727</us-gaap:OfferingCostsPartnershipInterests>
    <BOWN:AccretionOfCarryingValueToRedemptionValue
      contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact001344"
      unitRef="USD">793636</BOWN:AccretionOfCarryingValueToRedemptionValue>
    <BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact001346"
      unitRef="USD">1729358</BOWN:SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="AsOf2023-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact001348"
      unitRef="USD">71419358</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-02-172023-12-31" id="Fact001350">&lt;p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z2k0Bblpjmqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zNLZGX6jgbxd"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <BOWN:InitialPublicOfferingTextBlock contextRef="From2023-02-172023-12-31" id="Fact001352">&lt;p id="xdx_805_ecustom--InitialPublicOfferingTextBlock_zHDaCE2xECgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;NOTE
3 &#x2014; &lt;span id="xdx_822_z93dWclkbSi4"&gt;INITIAL PUBLIC OFFERING&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
July 14, 2023, the Company sold &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z70KqMXJ81qd" title="Stock issued during period shares"&gt;6,000,000&lt;/span&gt; Units at a price of $&lt;span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zjzkwGZXp3Hh" title="Sale of stock, par share"&gt;10.00&lt;/span&gt; per Unit. &lt;span id="xdx_903_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zkBlcL0EsE5e" title="Stock holders equity related to initial public offering description"&gt;Each Unit consists of one ordinary share and one right
to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company&#x2019;s initial Business Combination. Ten Public
Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares
will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional
shares underlying the rights&lt;/span&gt;. The Company also granted the underwriters a 45-day option to purchase up to an additional &lt;span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230714__20230714__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z7DTOAlYEYM5" title="Stock issued during the period, shares"&gt;900,000&lt;/span&gt; units
to cover over-allotments. The over-allotment was subsequently fully exercised on July 17, 2023. See Note 1 for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BOWN:InitialPublicOfferingTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-142023-07-14_us-gaap_IPOMember"
      decimals="INF"
      id="Fact001354"
      unitRef="Shares">6000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-07-14_us-gaap_IPOMember"
      decimals="INF"
      id="Fact001356"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockDescriptionOfTransaction
      contextRef="From2023-07-142023-07-14_us-gaap_IPOMember"
      id="Fact001358">Each Unit consists of one ordinary share and one right
to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company&#x2019;s initial Business Combination. Ten Public
Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares
will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional
shares underlying the rights</us-gaap:SaleOfStockDescriptionOfTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-07-142023-07-14_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact001360"
      unitRef="Shares">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <BOWN:PrivatePlacementsTextBlock contextRef="From2023-02-172023-12-31" id="Fact001362">&lt;p id="xdx_808_ecustom--PrivatePlacementsTextBlock_z6RicVGoIEY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;NOTE
4 &#x2014; &lt;span id="xdx_82A_z3OdyWOSDWga"&gt;PRIVATE PLACEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Sponsors and EBC have agreed to purchase an aggregate of &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zGzG654MNrnb" title="Number of shares issued"&gt;330,000&lt;/span&gt; Private Placement Units (&lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorsMember_z41JzLzYhRC5" title="Number of shares issued"&gt;312,000&lt;/span&gt; Private Placement Units to be purchased
by the Sponsors and &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--EBCMember_z9ap4lEPiFsj" title="Number of shares issued"&gt;18,000&lt;/span&gt; Private Placement Units to be purchased by EBC or its designees), or &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zF3PYUh11omc" title="Number of shares issued"&gt;361,500&lt;/span&gt; Private Placement Units if the
underwriters&#x2019; over-allotment is exercised in full, at a price of $&lt;span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zDhaSGaytAxe" title="Private placement units of underwriters over-allotment per share price"&gt;10.00&lt;/span&gt; per Private Placement Unit ($&lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcVkGIuQPWNh" title="Value of stock issued"&gt;3,300,000&lt;/span&gt;, or an aggregate
of $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zAF9PtaDHstf" title="Value of stock issued"&gt;3,615,000&lt;/span&gt; if the underwriters&#x2019; over-allotment is exercised in full) from the Company in a private placement that will occur
simultaneously with the closing of the Initial Public Offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Simultaneously with and soon after the closing of
the IPO, the Sponsors and EBC purchased an aggregate of &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zn6CdMyaY08b" title="Number of shares issued"&gt;361,500&lt;/span&gt; Private Placement Units ($&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zuiz5k7UbKcc" title="Value of stock issued"&gt;3,615,000&lt;/span&gt;), including exercise of over-allotment
option. Each Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon
the consummation of the Company&#x2019;s initial Business Combination. The proceeds from the sale of the Private Placement Units were added
to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination
Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the
Public Shares (subject to the requirements of applicable law). The Private Placement Units (including the underlying securities) will
not be transferable, assignable, or saleable until the completion of a Business Combination, subject to certain exceptions.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
July 17, 2023, the underwriters exercised the over-allotment option in full. See Note 1 for more details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BOWN:PrivatePlacementsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001364"
      unitRef="Shares">330000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_SponsorsMember"
      decimals="INF"
      id="Fact001366"
      unitRef="Shares">312000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_EBCMember"
      decimals="INF"
      id="Fact001368"
      unitRef="Shares">18000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_UnderwritersMember"
      decimals="INF"
      id="Fact001370"
      unitRef="Shares">361500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember_custom_UnderwritersMember"
      decimals="INF"
      id="Fact001372"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact001374"
      unitRef="USD">3300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_UnderwritersMember"
      decimals="0"
      id="Fact001376"
      unitRef="USD">3615000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_UnderwritersMember"
      decimals="INF"
      id="Fact001378"
      unitRef="Shares">361500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-02-172023-12-31_us-gaap_PrivatePlacementMember_custom_UnderwritersMember"
      decimals="0"
      id="Fact001380"
      unitRef="USD">3615000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-02-172023-12-31" id="Fact001382">&lt;p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zQXb3zCQnIz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;NOTE
5 &#x2014; &lt;span id="xdx_821_zWvrpnCnpcQ9"&gt;RELATED PARTIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;i&gt;Founder
Shares and EBC Founder Shares&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
February 27, 2023, the Sponsors received &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zCIr7Y2Pgur6" title="Number of shares issued"&gt;1,725,000&lt;/span&gt; of the Company&#x2019;s ordinary shares (&#x201c;Founder Shares&#x201d;) in exchange
for $&lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zAr2KHkDuVQ" title="Sponsors received ordinary shares, value"&gt;25,000&lt;/span&gt; paid for offering costs borne by the Sponsors. Up to &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zr1jFfUVVRJf" title="Number of shares subject to forfeiture"&gt;225,000&lt;/span&gt; of such Founder Shares were subject to forfeiture to the extent
that the underwriters&#x2019; over-allotment was not exercised in full (See Note 7).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
March 15, 2023, the Company issued to EBC &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zMUErzboSoLf" title="Number of shares issued"&gt;180,000&lt;/span&gt; ordinary shares (&#x201c;EBC founder shares&#x201d;) for a purchase price of $&lt;span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zjkuABniQ4Zh" title="Ordinary share price"&gt;0.014&lt;/span&gt; per
share and an aggregate purchase price of $&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zwQh6yIRA2u7" title="Value of stock issued"&gt;2,520&lt;/span&gt;. The EBC founder shares are deemed to be underwriters&#x2019; compensation by FINRA pursuant
to Rule 5110 of the FINRA Manual. The Company estimated the fair value of the EBC founder shares to be approximately $&lt;span id="xdx_900_eus-gaap--DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_c20230315__20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zCwAnFuddb2" title="Fair value of shares issued"&gt;1,016,000&lt;/span&gt; or $&lt;span id="xdx_90E_eus-gaap--SharePrice_iI_pid_c20230315__srt--TitleOfIndividualAxis__custom--EBCMember_zQ7ZMcax1Dt7" title="Fair value of ordinary per share price"&gt;5.65&lt;/span&gt;
per share using the Black-Scholes option pricing model. The Company accounted for the difference between the par value and fair value
of the shares as offering cost.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_ecustom--ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock_zmfEjAVBnFBg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair
value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zG9F7VFpDzH4" style="display: none"&gt;SCHEDULE
FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: left"&gt;Time to expiration&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0VXkd1AhY94" title="Time to expiration"&gt;1.84&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAKlvigTYDI8" title="Risk-free rate"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_znAtmI8QBi6f" title="Volatility rate"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWmPu4yISRsa" title="Dividend yield"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected likelihood of a successful business combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ExpectedLikelihoodSuccessfulBusinessCombination_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zDmVhFcRiIid" title="Expected likelihood of a successful business combination, percentage"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zfiEO9D8VNCc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur
of: (A) six months after the completion of the initial Business Combination and (B) the date on which the Company completes a liquidation,
merger, share exchange, reorganization or other similar transaction after an initial Business Combination that results in all of the
Company&#x2019;s public shareholders having the right to exchange their ordinary shares for cash, securities or other property. EBC has
also agreed, subject to exceptions, that the EBC founder shares cannot be sold, transferred or assigned, until the consummation of an
initial business combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Promissory
Note&#x2009;&#x2014;&#x2009;Related Party&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 27, 2023, the Sponsors issued an unsecured promissory note to the Company (the &#x201c;Promissory Note&#x201d;), pursuant to which
the Company may borrow up to an aggregate principal amount of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230227__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zLzIAFDWTmPh" title="Promissory note aggregate principal amount"&gt;300,000&lt;/span&gt;. The Promissory Note was non-interest bearing and payable on the
earlier of (i) December 31, 2023, or (ii) the consummation of the IPO. The Promissory Note expired on July 14, 2023. As of December 31,
2023, there were no amounts outstanding under the Promissory Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Underwriting
Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company granted the underwriters a 45-day option from the date of IPO to purchase up to &lt;span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zRyZzePx7WJ9" title="Stock issued during the period, shares"&gt;900,000&lt;/span&gt; additional Units to cover over-allotments,
at the IPO price less the underwriting discounts and commissions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
underwriters were entitled to a cash underwriting discount of $&lt;span id="xdx_907_ecustom--CashUnderwritingDiscountPerUnit_pid_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zMYmFuKKNyXd" title="Cash underwriting discount per unit"&gt;0.25&lt;/span&gt; per Unit, or $&lt;span id="xdx_90A_ecustom--CashUnderwritingDiscount_pid_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z8k88KDa3uE7" title="Aggregate cash underwriting discount"&gt;1,500,000&lt;/span&gt; in the aggregate (or $&lt;span id="xdx_90F_eus-gaap--PaymentsForUnderwritingExpense_pid_c20230217__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z3tJwdw31Mhd" title="Payments for underwriting expense"&gt;1,725,000&lt;/span&gt; in the aggregate
if the underwriters&#x2019; over-allotment option is exercised in full), payable upon the closing of the IPO.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 17, 2023, the underwriters exercised the over-allotment option in full to purchase &lt;span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230717__20230717__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zpp2EAKNx8Ie" title="Stock issued during the period, shares"&gt;900,000&lt;/span&gt; Units. As a result, on July 18, 2023,
the Company sold an additional &lt;span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zQhAMBESvvie" title="Stock issued during the period, shares"&gt;900,000&lt;/span&gt; Units at $&lt;span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zZkiQYbsTnza" title="Price per share"&gt;10.00&lt;/span&gt; per Unit, generating gross proceeds to the Company of $&lt;span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230718__20230718__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z0IlAoK699Cj" title="Gross proceeds"&gt;9,000,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Accrued Expenses &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Due
to Related Party&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsors paid certain formation, operating or offering costs on behalf of the Company. These amounts were due on demand and non-interest
bearing. As of December 31, 2023, the Sponsors had paid $&lt;span id="xdx_902_eus-gaap--RepaymentsOfRelatedPartyDebt_c20230217__20231231_z2pzuxMiLAL1" title="Related party debt"&gt;151,318&lt;/span&gt; on behalf of the Company for expenses related to IPO, which was fully
repaid upon closing of the IPO on July 14, 2023 out of the offering proceeds held in trust account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the total accrued expenses due to related parties was $&lt;span id="xdx_901_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zdH8fz41AjNb" title="Accrued expenses"&gt;25,250&lt;/span&gt;, which include $&lt;span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zlZpdlDUxZc8" title="Accrued expenses"&gt;20,000&lt;/span&gt; payable for administration
fee and $&lt;span id="xdx_905_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--IncomeStatementLocationAxis__custom--AccountingServicesExpenseMember_zB6Ukb3G5L25" title="Accrued expenses"&gt;5,250&lt;/span&gt; payable for accounting service fee. See following paragraphs for details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Initial
Accounting Service Fee&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has engaged TenX Global Capital, a related party of the Company, to assist in the preparation of consolidated financial
statements and other accounting consulting services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the period from February 17, 2023 (inception) through December 31, 2023, a service fee of $&lt;span id="xdx_901_eus-gaap--ProfessionalFees_c20230217__20231231__dei--LegalEntityAxis__custom--TenXGlobalCapitalMember_zZlGfEKPQcTk" title="Service fee"&gt;20,000&lt;/span&gt; of offering costs have been incurred
for these services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Accounting
Service Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has engaged TenX Global Capital, a related party of the Company, to assist in preparing quarterly and annual financial statements
commencing following the consummation of the IPO. The Company has agreed to pay for these services at a fixed quarterly rate of $&lt;span id="xdx_90C_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20230217__20231231__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zY2C0ZoW5wz5" title="Payment for services"&gt;5,250&lt;/span&gt;
each quarter. As of December 31, 2023, a service fee of $&lt;span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_z0a3avIHDclj" title="Accrued liabilities"&gt;10,500&lt;/span&gt; has been accrued with $&lt;span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrent_iI_c20230630__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zkcPy0KNJbw" title="Accrued liabilities"&gt;&lt;span id="xdx_908_eus-gaap--AccruedLiabilitiesCurrent_iI_c20230930__us-gaap--TypeOfArrangementAxis__custom--AccountingServiceAgreementMember_zlbmcucShdHk" title="Accrued liabilities"&gt;5,250&lt;/span&gt;&lt;/span&gt; paid for the second and third quarter accounting
service.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Administration
Fee&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commencing
on the effectiveness of the Registration Statement on July 11, 2023, an affiliate of the Sponsors will be allowed to charge the Company
an allocable share of its overhead, up to $&lt;span id="xdx_90A_eus-gaap--AffiliateCosts_c20230711__20230711__srt--TitleOfIndividualAxis__custom--SponsorsMember__srt--RangeAxis__srt--MaximumMember_zmzVt8HJElkh" title="Affiliate costs"&gt;10,000&lt;/span&gt; per month, until to the close of the Business Combination, to compensate it for the
Company&#x2019;s use of its office, utilities and personnel. An administration fee of $&lt;span id="xdx_90E_eus-gaap--AdministrativeFeesExpense_c20230217__20231231_zYQyOU6H0wik" title="Administrative fee"&gt;56,667&lt;/span&gt; was recorded with $&lt;span id="xdx_90C_eus-gaap--PaymentForAdministrativeFees_c20230217__20231231_zP0trXX3c145" title="Administrative fees paid"&gt;36,667&lt;/span&gt; paid for the period
from February 17, 2023 (inception) through December 31, 2023. The unpaid amount as of December 31, 2023 was $&lt;span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zVcmXvdbCOlb" title="Accrued expenses"&gt;20,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-272023-02-27_custom_SponsorsMember"
      decimals="INF"
      id="Fact001384"
      unitRef="Shares">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-02-272023-02-27_custom_SponsorsMember"
      decimals="0"
      id="Fact001386"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-02-272023-02-27_custom_SponsorsMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact001388"
      unitRef="Shares">225000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-03-152023-03-15_custom_EBCMember"
      decimals="INF"
      id="Fact001390"
      unitRef="Shares">180000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-03-15_custom_EBCMember"
      decimals="INF"
      id="Fact001392"
      unitRef="USDPShares">0.014</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-03-152023-03-15_custom_EBCMember"
      decimals="INF"
      id="Fact001394"
      unitRef="USD">2520</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
      contextRef="From2023-03-152023-03-15_custom_EBCMember"
      decimals="0"
      id="Fact001396"
      unitRef="USD">1016000</us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued>
    <us-gaap:SharePrice
      contextRef="AsOf2023-03-15_custom_EBCMember"
      decimals="INF"
      id="Fact001398"
      unitRef="USDPShares">5.65</us-gaap:SharePrice>
    <BOWN:ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock contextRef="From2023-02-172023-12-31" id="Fact001400">&lt;p id="xdx_898_ecustom--ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock_zmfEjAVBnFBg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
fair value of the EBC founder shares was estimated at March 15, 2023. The Company used the following assumptions to estimate the fair
value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zG9F7VFpDzH4" style="display: none"&gt;SCHEDULE
FAIR VALUE OF EARLY BIRD CAPITAL ASSUMPTION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: left"&gt;Time to expiration&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0VXkd1AhY94" title="Time to expiration"&gt;1.84&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAKlvigTYDI8" title="Risk-free rate"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_znAtmI8QBi6f" title="Volatility rate"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWmPu4yISRsa" title="Dividend yield"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected likelihood of a successful business combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ExpectedLikelihoodSuccessfulBusinessCombination_pid_dp_uPure_c20230315__20230315__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zDmVhFcRiIid" title="Expected likelihood of a successful business combination, percentage"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BOWN:ScheduleOfFairValueOfEarlyBirdCapitalAssumptionEstimateTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="From2023-03-152023-03-15_us-gaap_FairValueInputsLevel3Member"
      id="Fact001402">P1Y10M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-03-152023-03-15_us-gaap_FairValueInputsLevel3Member"
      decimals="INF"
      id="Fact001404"
      unitRef="Pure">0.040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-03-152023-03-15_us-gaap_FairValueInputsLevel3Member"
      decimals="INF"
      id="Fact001406"
      unitRef="Pure">0.050</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-03-152023-03-15_us-gaap_FairValueInputsLevel3Member"
      decimals="INF"
      id="Fact001408"
      unitRef="Pure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <BOWN:ExpectedLikelihoodSuccessfulBusinessCombination
      contextRef="From2023-03-152023-03-15_us-gaap_FairValueInputsLevel3Member"
      decimals="INF"
      id="Fact001410"
      unitRef="Pure">0.60</BOWN:ExpectedLikelihoodSuccessfulBusinessCombination>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-02-27_custom_PromissoryNoteMember_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001412"
      unitRef="USD">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001414"
      unitRef="Shares">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <BOWN:CashUnderwritingDiscountPerUnit
      contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact001416"
      unitRef="USDPShares">0.25</BOWN:CashUnderwritingDiscountPerUnit>
    <BOWN:CashUnderwritingDiscount
      contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact001418"
      unitRef="USD">1500000</BOWN:CashUnderwritingDiscount>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="From2023-02-172023-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact001420"
      unitRef="USD">1725000</us-gaap:PaymentsForUnderwritingExpense>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-07-172023-07-17_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact001422"
      unitRef="Shares">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact001424"
      unitRef="Shares">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-07-18_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact001426"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-07-182023-07-18_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact001428"
      unitRef="USD">9000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001430"
      unitRef="USD">151318</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001432"
      unitRef="USD">25250</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact001434"
      unitRef="USD">20000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember_custom_AccountingServicesExpenseMember"
      decimals="0"
      id="Fact001436"
      unitRef="USD">5250</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ProfessionalFees
      contextRef="From2023-02-172023-12-31_custom_TenXGlobalCapitalMember"
      decimals="0"
      id="Fact001438"
      unitRef="USD">20000</us-gaap:ProfessionalFees>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="From2023-02-172023-12-31_custom_AccountingServiceAgreementMember"
      decimals="0"
      id="Fact001440"
      unitRef="USD">5250</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_AccountingServiceAgreementMember"
      decimals="0"
      id="Fact001442"
      unitRef="USD">10500</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-06-30_custom_AccountingServiceAgreementMember"
      decimals="0"
      id="Fact001444"
      unitRef="USD">5250</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-09-30_custom_AccountingServiceAgreementMember"
      decimals="0"
      id="Fact001446"
      unitRef="USD">5250</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AffiliateCosts
      contextRef="From2023-07-112023-07-11_custom_SponsorsMember_srt_MaximumMember"
      decimals="0"
      id="Fact001448"
      unitRef="USD">10000</us-gaap:AffiliateCosts>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001450"
      unitRef="USD">56667</us-gaap:AdministrativeFeesExpense>
    <us-gaap:PaymentForAdministrativeFees
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001452"
      unitRef="USD">36667</us-gaap:PaymentForAdministrativeFees>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact001454"
      unitRef="USD">20000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-02-172023-12-31" id="Fact001456">&lt;p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zDW4iBFCPjua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6 &#x2014; &lt;span id="xdx_82F_zWCny5HvGM6g"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Registration
Rights&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of the Founder Shares, EBC founder shares, Private Placement Units will be entitled to registration rights pursuant to a registration
rights agreement dated on the effectiveness of the Registration Statement on July 11, 2023 requiring the Company to register such securities
for resale. Subject to certain limitations set forth in such agreement, the holders of these securities will be entitled to make up to
three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain
&#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent to completion of a Business Combination
and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the
registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration
statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear
the expenses incurred in connection with the filing of any such registration statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Business
Combination Marketing Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has engaged EBC as an advisor in connection with its Business Combination to assist in holding meetings with the Company stockholders
to discuss the potential Business Combination and the target business&#x2019; attributes, introduce the Company to potential investors
that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and
public filings in connection with the Business Combination. The Company will pay EBC a service fee for such services upon the consummation
of its initial Business Combination in an amount of $&lt;span id="xdx_90D_ecustom--ServiceFee_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_zGCuHHR5bgnd" title="Service fee"&gt;2,415,000&lt;/span&gt;, equal to &lt;span id="xdx_903_ecustom--PercentageOfGrossProceedsOfInitialPublicOffering_iI_pid_dp_uPure_c20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_zwsYgwylXRvg" title="Percentage of gross proceeds of initial public offering"&gt;3.5&lt;/span&gt;% of the gross proceeds of the IPO. In addition, the Company
will pay EBC a service fee in an amount equal to &lt;span id="xdx_90C_ecustom--PercentageOfServiceFeeOfTotalConsiderationPayable_iI_pid_dp_uPure_c20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationMarketingAgreementMember_z1MHaUYqhHte" title="Percentage of service fee of total consideration payable"&gt;1.0&lt;/span&gt;% of the total consideration payable in the initial Business Combination if it introduces
the Company to the target business with whom it completes an initial Business Combination and the amount will be payable in cash and
is due at the closing date of the initial Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Business Combination Transaction Cost&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has engaged several service
providers including legal and valuation services, specifically for business combination between the Company and Shenzhen Qianzhi
BioTechnology Co. Ltd. (&#x201c;Qianzhi&#x201d;). Per the agreed terms, Qianzhi agreed to be responsible for all expenses incurred by
the Company in connection with business combination. During the year of 2023, $&lt;span id="xdx_90A_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20230217__20231231_zhFSJN0oMyzj" title="Business combination related cost"&gt;181,022&lt;/span&gt;
of business combination related cost has been incurred and reimbursed by Qianzhi and approximately &lt;span id="xdx_909_eus-gaap--AccountsPayableCurrent_iI_c20231231_zzlObPMfAG48" title="Commited for future expenses"&gt;$200,000&lt;/span&gt;
is committed for future services as of December 31, 2023. This activity has been recorded net in accompanying financial
statements.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <BOWN:ServiceFee
      contextRef="AsOf2023-12-31_custom_BusinessCombinationMarketingAgreementMember"
      decimals="0"
      id="Fact001458"
      unitRef="USD">2415000</BOWN:ServiceFee>
    <BOWN:PercentageOfGrossProceedsOfInitialPublicOffering
      contextRef="AsOf2023-12-31_custom_BusinessCombinationMarketingAgreementMember"
      decimals="INF"
      id="Fact001460"
      unitRef="Pure">0.035</BOWN:PercentageOfGrossProceedsOfInitialPublicOffering>
    <BOWN:PercentageOfServiceFeeOfTotalConsiderationPayable
      contextRef="AsOf2023-12-31_custom_BusinessCombinationMarketingAgreementMember"
      decimals="INF"
      id="Fact001462"
      unitRef="Pure">0.010</BOWN:PercentageOfServiceFeeOfTotalConsiderationPayable>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="From2023-02-172023-12-31"
      decimals="0"
      id="Fact001464"
      unitRef="USD">181022</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001466"
      unitRef="USD">200000</us-gaap:AccountsPayableCurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2023-02-172023-12-31" id="Fact001468">&lt;p id="xdx_806_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zxzDqZ7DJ07a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 &#x2014; &lt;span id="xdx_822_z0FvqJdQcbBj"&gt;SHAREHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Preferred
Shares&lt;/i&gt;&lt;/b&gt; &#x2014; The Company is authorized to issue &lt;span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zLLMAE4iHR01" title="Preferred stock, shares authorized"&gt;2,000,000&lt;/span&gt; preferred shares with a par value of $&lt;span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zQN4FecLJtH" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share with such
designations, &lt;span id="xdx_90C_eus-gaap--PreferredStockVotingRights_c20230217__20231231_zkZ7SrAVjtb3" title="Preferred stock voting rights"&gt;voting and other rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors.&lt;/span&gt;
As of December 31, 2023, there were &lt;span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_z8Ity03v6p7d" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_zOAsmf68SbH7" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt;&lt;/span&gt; preferred shares issued or outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Ordinary
Shares&lt;/i&gt;&lt;/b&gt; &#x2014; The Company is authorized to issue &lt;span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zWizlRhR6Eue" title="Common stock, shares authorized"&gt;200,000,000&lt;/span&gt; ordinary shares with a par value of $&lt;span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zTVpTrwnUc3a" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share. &lt;span id="xdx_904_eus-gaap--CommonStockVotingRights_c20230217__20231231_z9JBDOFQkyL3" title="Common stock voting rights"&gt;Holders
of ordinary shares are entitled to one vote for each share.&lt;/span&gt; On February 27, 2023, the Sponsors received &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zuujyD6O0fd9" title="Issuance of ordinary shares to Sponsor, shares"&gt;1,725,000&lt;/span&gt; of the Founder Shares
in exchange for $&lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember_zKcPZ1vI09rd" title="Issuance of ordinary shares to Sponsor, value"&gt;25,000&lt;/span&gt; paid for offering costs borne by the Sponsors, of which an aggregate of up to &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230227__20230227__srt--TitleOfIndividualAxis__custom--SponsorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z4EUK7diXbe9" title="Number of shares subject to forfeiture"&gt;225,000&lt;/span&gt; of such Founder Shares
were subject to forfeiture to the extent that the underwriters&#x2019; over-allotment was not exercised in full or in part, so that the
number of Founder Shares will equal 20% of the Company&#x2019;s issued and outstanding ordinary shares after the IPO (excluding shares
underlying the Private Placement Units). No ordinary shares are subject to forfeiture since the over-allotment was fully exercised on
July 17, 2023. As of December 31, 2023, there were &lt;span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zQC5NH2oeJ7j" title="Ordinary shares issued"&gt;&lt;span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zvJxokkXZFGl" title="Ordinary shares outstanding"&gt;2,266,500&lt;/span&gt;&lt;/span&gt; ordinary shares issued and outstanding (excluding &lt;span id="xdx_90D_ecustom--OrdinarySharesSubjectToRedemption_iI_c20231231_zWpy2SOMaTy9" title="Ordinary shares subject to redemption"&gt;6,900,000&lt;/span&gt; shares subject
to possible redemption).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Rights
&lt;/i&gt;&lt;/b&gt;&#x2014; Except in cases where the Company is not the surviving company in a business combination, &lt;span id="xdx_909_eus-gaap--CommonStockVotingRights_c20230217__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zh7bguN3OHx6" title="Common stock voting rights"&gt;each holder of a right will
automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination.&lt;/span&gt; The Company will
not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole
share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company is not the surviving
company upon completion of the initial Business Combination, each holder of a right will be required to affirmatively convert his, her
or its rights in order to receive the one-tenth (1/10) of one ordinary share underlying each right upon consummation of the business
combination. If the Company is unable to complete the initial Business Combination within the required time period and the Company will
redeem the public shares for the funds held in the trust account, holders of rights will not receive any of such funds for their rights
and the rights will expire worthless.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001470"
      unitRef="Shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001472"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockVotingRights contextRef="From2023-02-172023-12-31" id="Fact001474">voting and other rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors.</us-gaap:PreferredStockVotingRights>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001476"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001478"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001480"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001482"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockVotingRights contextRef="From2023-02-172023-12-31" id="Fact001484">Holders
of ordinary shares are entitled to one vote for each share.</us-gaap:CommonStockVotingRights>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-272023-02-27_custom_SponsorsMember"
      decimals="INF"
      id="Fact001486"
      unitRef="Shares">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-02-272023-02-27_custom_SponsorsMember"
      decimals="0"
      id="Fact001488"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-02-272023-02-27_custom_SponsorsMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact001490"
      unitRef="Shares">225000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001492"
      unitRef="Shares">2266500</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001494"
      unitRef="Shares">2266500</us-gaap:CommonStockSharesOutstanding>
    <BOWN:OrdinarySharesSubjectToRedemption
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001496"
      unitRef="Shares">6900000</BOWN:OrdinarySharesSubjectToRedemption>
    <us-gaap:CommonStockVotingRights
      contextRef="From2023-02-172023-12-31_us-gaap_CommonStockMember"
      id="Fact001498">each holder of a right will
automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination.</us-gaap:CommonStockVotingRights>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2023-02-172023-12-31" id="Fact001500">&lt;p id="xdx_807_eus-gaap--FairValueDisclosuresTextBlock_znVM2BK1Thll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 &#x2014; &lt;span id="xdx_826_z0bbJURugr27"&gt;Fair Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s financial assets and liabilities reflects management&#x2019;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which
transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets
or liabilities and quoted prices for identical assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
significant assumptions which the Company used to value the EBC Founder Shares are referred to Note 5. The following table presents
information about the Company&#x2019;s assets that are measured at fair value on a recurring basis at December 31, 2023 and indicates
the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z6NnfmmBvQmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zSlcIVF1yKE1" style="display: none"&gt;SCHEDULE
OF MEASURED FAIR VALUE ON RECURRING BASIS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20231231_zoAXwkwUOHz2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zwEAR7ev2ltj" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Quoted&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_ziheDFnDL1pl" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zeYDvkFcb7vc" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Prices in&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Active&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Observable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unobservable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Markets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Inputs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Inputs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Level
    1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Level
    2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Level
    3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Assets:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AssetsHeldInTrustNoncurrent_iI_zO45lkmG0Kef" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 44%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investment held in trust account&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;71,419,358&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;71,419,358&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1506"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1507"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_zbyOkNUMQ2mi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="From2023-02-172023-12-31" id="Fact001502">&lt;p id="xdx_894_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z6NnfmmBvQmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zSlcIVF1yKE1" style="display: none"&gt;SCHEDULE
OF MEASURED FAIR VALUE ON RECURRING BASIS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20231231_zoAXwkwUOHz2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zwEAR7ev2ltj" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Quoted&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_ziheDFnDL1pl" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zeYDvkFcb7vc" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Prices in&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Active&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Observable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unobservable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Markets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Inputs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Inputs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Level
    1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Level
    2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Level
    3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Assets:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AssetsHeldInTrustNoncurrent_iI_zO45lkmG0Kef" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 44%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investment held in trust account&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;71,419,358&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;71,419,358&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1506"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1507"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001504"
      unitRef="USD">71419358</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact001505"
      unitRef="USD">71419358</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2023-02-172023-12-31" id="Fact001509">&lt;p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zEoeOS28HpNb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9 &#x2014; &lt;span id="xdx_824_zMsFDRBzlrP6"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated
financial statements were issued. Based on the review, management identified the following subsequent event that is required
disclosure in the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 18, 2024, the Company entered into an Agreement and Plan of Reorganization (the &#x201c;Agreement&#x201d;) with (i) Bowen Merger
Sub, a Cayman Islands exempted company and a wholly owned subsidiary of the Company (&#x201c;Merger Sub&#x201d;), (ii) Shenzhen Qianzhi
BioTechnology Co. Ltd., a company incorporated in the People&#x2019;s Republic of China and a wholly owned subsidiary of NewCo (as defined
below) (&#x201c;Shenzhen Qianzhi&#x201d;), and (iii) &lt;span style="background-color: white"&gt;Qianzhi Group Holding (Cayman) Limited, a newly
formed Cayman Islands company (&#x201c;&lt;span style="text-decoration: underline"&gt;NewCo&lt;/span&gt;,&#x201d; and collectively with the Company, Merger Sub and Shenzhen Qianzhi, the &#x201c;&lt;span style="text-decoration: underline"&gt;Parties&lt;/span&gt;&#x201d;,
each a &#x201c;&lt;span style="text-decoration: underline"&gt;Party&lt;/span&gt;&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Pursuant
to the Agreement, at the closing of the business combination, Merger Sub will merge with and into NewCo (the &#x201c;&lt;span style="text-decoration: underline"&gt;Merger&lt;/span&gt;&#x201d;),
with NewCo being the surviving company of the Merger (&#x201c;&lt;span style="text-decoration: underline"&gt;Surviving Company&lt;/span&gt;&#x201d;) and becoming a wholly owned subsidiary
of the Company. In the Merger, the holders (the &#x201c;NewCo Shareholders&#x201d;) of the ordinary shares of NewCo (&#x201c;NewCo Ordinary
Shares&#x201d;) will receive ordinary shares of the Company (&#x201c;Parent Ordinary Shares&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Pursuant
to the Agreement, at the effective time of the Merger (the &#x201c;Effective Time&#x201d;), all of NewCo Ordinary Shares issued and outstanding
immediately prior to the Effective Time will be automatically converted into the right to receive an aggregate of (a) &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240118__20240118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--MergerSharesMember__us-gaap--TypeOfArrangementAxis__custom--AgreementMember_zdnqll8HqLSg" title="Number of parent ordinary shares"&gt;7,246,377&lt;/span&gt; Parent
Ordinary Shares (the &#x201c;Merger Shares&#x201d;), and (b) the right to receive earnout consideration of up to an aggregate of &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240118__20240118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--EarnoutSharesMember__us-gaap--TypeOfArrangementAxis__custom--AgreementMember__srt--RangeAxis__srt--MaximumMember_zcVhP7HKEhTa" title="Number of parent ordinary shares"&gt;1,400,000&lt;/span&gt;
Parent Ordinary Shares (the &#x201c;Earnout Shares&#x201d;).&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-182024-01-18_us-gaap_SubsequentEventMember_custom_MergerSharesMember_custom_AgreementMember"
      decimals="INF"
      id="Fact001511"
      unitRef="Shares">7246377</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-182024-01-18_us-gaap_SubsequentEventMember_custom_EarnoutSharesMember_custom_AgreementMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001513"
      unitRef="Shares">1400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000215"
          xlink:label="Fact000215"
          xlink:type="locator"/>
        <link:footnote id="Footnote000234" xlink:label="Footnote000234" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Excludes
    an aggregate of up to <xhtml:span
  id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230401__20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zUCnGgKbTQq4"
  title="Ordinary shares subject to forfeiture"><xhtml:span
      id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230217__20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zGqdNySigYo3"
      title="Ordinary shares subject to forfeiture">225,000</xhtml:span></xhtml:span> ordinary shares subject to forfeiture depending on the extent to which the over-allotment option is
    exercised by the underwriters (see Notes 5 and 7). On July 17, 2023, the underwriters fully exercised the over-allotment option.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000215"
          xlink:to="Footnote000234"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000217"
          xlink:label="Fact000217"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000217"
          xlink:to="Footnote000234"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
